<SEC-DOCUMENT>0000950170-23-007609.txt : 20230313
<SEC-HEADER>0000950170-23-007609.hdr.sgml : 20230313
<ACCEPTANCE-DATETIME>20230313165441
ACCESSION NUMBER:		0000950170-23-007609
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		115
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230313
DATE AS OF CHANGE:		20230313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amylyx Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001658551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464600503
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41199
		FILM NUMBER:		23727982

	BUSINESS ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-683-0917

	MAIL ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>amlx-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-03-13T16:49:57.8316+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:amlx="http://www.amylyx.com/20221231" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonFraction id="F_6b62c9fb-950f-40e5-9d9e-19b1fffed063" name="us-gaap:CommitmentsAndContingencies" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_4c616ba1-bcf9-44f8-ba0d-55b6ca0585d4" name="dei:CurrentFiscalYearEndDate" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad">--12-31</ix:nonNumeric><ix:nonNumeric id="F_9f564487-ff34-4d2f-b0ff-436e6a65bf58" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad">http://fasb.org/us-gaap/2022#ProductMember</ix:nonNumeric><ix:nonNumeric id="F_9c291edc-58ba-4f9c-ac9d-0a380913dd6e" name="dei:DocumentFiscalPeriodFocus" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad">FY</ix:nonNumeric><ix:nonFraction id="F_b039e0ef-4988-44c2-972a-7c7c312db5b2" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_27fb4f7d-84bf-4d9b-ac32-a8b2960229dc" name="dei:AmendmentFlag" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric id="F_7b9b8af2-0606-4a01-834e-0e2c33cc428d" name="dei:EntityCentralIndexKey" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad">0001658551</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="amlx-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_ff0690db-c77d-4b96-bbff-fbb506dbb3a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_faa2db82-5a0b-4d5e-9899-d4b010e01200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_42ba167d-3f2c-43b5-ad10-97d7aff55f3c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandFifteenStockOptionAndRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-06</xbrli:startDate><xbrli:endDate>2022-01-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_67f5ad96-461d-4e37-81d1-e8d93683af31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ba447dcc-85e2-40e6-b77e-267406ab1bf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">amlx:SpecialPurposeAcquisitionCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d20162d-ff61-483b-a925-f567b613c421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2a15f4cd-3251-4bce-9c79-87754008eaad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_170cdc21-0444-4686-8e31-4471213a6c12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_94da0a41-0a0d-4e46-8905-4827ae10dd95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f298d27-3cb9-4705-bfa0-9f414a329ed2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c50598d2-a8bf-4f26-8081-1ada38713c0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba231c4d-9d94-4fef-ac80-e42200cc6579"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amlx:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_08bb19c6-0e5b-4b98-a719-c56d723fcf27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_757a8685-f087-44ba-8d70-37f526a1bd6e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b327429-7b70-49b6-86e4-f2ad018fde8a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:ALSAssociationAndALSFindingCureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_52a2983c-7983-4d91-9733-cf784aff7361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d36ae52a-d040-4a0e-84cd-85b87bbcff10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2e22bd72-1889-4145-ab70-577df3f62afd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1b19ab6a-5a41-473b-9be7-fb23ebcb6e9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amlx:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_296321bd-7a9d-4b09-ba9b-7ad1355d4097"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_549fc533-bfde-4f49-a811-86f15c3760d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f4747adc-8a33-4cb0-a970-1b814ab522d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f604d797-a8f0-453f-a9ea-26ea1f4f44d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ef664f3-dcfa-4413-9356-692945d9514a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c82ec6e0-6442-4924-93c4-7e12f30f5bfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b984d10b-9ff4-48e7-8949-0e6695ddfaee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ad669f7-07c3-4bda-a43c-720981a44374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_84e93efe-e53b-4b00-b1fc-338b910d8572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bd71111-9adf-43ab-8fd0-05a1882632a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_642dd1b3-56a8-4be2-8e97-15c6ab673ca1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d64feb49-4e55-46df-a08d-e78148f7d88d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eba29517-fdf1-4a5c-9472-881601db2461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ccd2bc7d-177e-44f8-89c8-d26a5a47b261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40b2caa1-f574-483f-8a57-fe01ea935692"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a535ad1-aee6-4191-aba0-d4c01e4db958"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a875587-3d63-4295-98d5-e68474ee09d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ffaedee-aadb-4322-b862-e53422451646"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8766c930-41ee-4314-b087-45deb048d199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f70242f-b16e-425b-9687-ab456c6af1c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">amlx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_847bc730-56b4-47a9-b047-316c0d25ef30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_789d884f-c53b-4300-99ea-5e96e8f7db99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9108caa7-2bf4-44fb-ab90-32ee41737a03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6313c55-c8cf-4075-acc2-41e176752918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_683b28ae-40e1-400c-8515-d6776df26f52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amlx:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c32475bb-ba9c-415b-a298-afa0b3f8ef62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c2fe59ba-c379-4ba7-bfa5-0166ee9ba79d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f58d364a-a071-43d1-a2d5-b038a25fdc37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75aa067a-4ce0-4ee0-849d-a679d624a87c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fe5ff12-27cd-44f5-a115-8904def1b494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:AgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_43c44a69-a3b4-4167-b97c-320dd91b42d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-05</xbrli:startDate><xbrli:endDate>2022-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e0804e9-955a-4a85-ad28-2816b77d859c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c9812622-5be1-41f9-acc6-5b7dabd03559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23c45f4e-2e33-4b8f-99a6-4527909a36c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:ALSAssociationAndALSFindingCureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-08-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aabbe5a4-0d80-4d34-9c12-1bc6e30e9fa6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c2263c4-ca40-4e95-b8e3-4cde9fa39697"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0b1a141-4c14-4d2b-920f-b03009062e23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_28f824cb-b9d8-44c0-9120-7b7fefbb119e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5c14c4d0-550c-4966-97a1-233f1dab5e56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_81aa5a36-a608-4d01-ab23-6149905204c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4df5bd26-0f2a-4551-be73-d1993ae98fe2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0aaedbf-19e6-4bcf-9bde-7bfed9c560a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f45a549c-ba7e-4586-8301-b2aa4abaaf62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4805cb1e-b970-4249-8630-12fe8c6937d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5eab5a92-c382-47c2-b472-12d901ce62a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_02064c71-3a83-4801-8486-d127eb43b8ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1795c86d-1f84-4b6f-bce6-5ee68242829e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_85caa5e9-c564-49a9-b13c-652337260e60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32feb0a1-4b4c-4d84-ad01-dc752482f3d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_abc06de1-757c-40f3-a5ee-6a4936862ac3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a166ab8c-a37b-4070-99b9-bc8f9b0a2693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d1f4d907-06b1-4446-92c9-69df12bfc090"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dded4a35-c564-4067-87bb-39604cfdd2aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e92dc208-a141-4607-b82a-3789bb5e1d48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a7844b97-2442-4785-bc7f-5bd8385fcab8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71f685c9-8c92-4d6f-9328-36c56365bbf5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fa66652-e292-4b4a-b46f-3914e1bb1423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f1dd14d9-2a2a-42df-bd70-17b7c328d628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39501136-cb81-4f29-8e8b-cfc14116de19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7285cd01-49fc-4356-bb9e-b960696d9340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49ab84be-37c3-426d-8cbc-3170c1c749d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b17b133f-82b6-42e9-990f-003823835ec6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f388b78-2a24-4c12-8623-a7395b18ffe4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_150e2ef8-74e4-47ed-95d8-3485e13c0048"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00648e08-92ac-4b7a-9c05-679ac28e6a0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">amlx:AgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_16551b59-7779-49cd-bf47-05ce2620a5c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_75199396-3f49-47e9-a99c-3a0ee563bfe5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03c3a593-4c98-403a-bc7f-a023ed103fae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amlx:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bc9f9a5-11f9-478f-9984-e116f2928e91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">amlx:FinishedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_64429dd7-c70d-4084-9c4c-b6db110ed37a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dda99674-7cd7-4b03-a6bb-3b26b37d15e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6f624b0-506d-4092-ac12-59f88d4944f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_678b6484-4368-49d8-8272-6da1055ccb1c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e174e74-e289-47a5-a2ba-1168ba02dae5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50031187-fee3-48b0-9289-0c569c7a76e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b787ec26-9aa6-4a5e-a368-bb18c3c09dfd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d9bce4d5-f683-4b45-978f-ca52168d39ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d897e60a-b2ef-40ae-84bb-e64354962e11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6847e6cf-32c0-4a9e-820c-301e7187f960"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e5f309e-abea-4f3f-9d05-817063bff016"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_126e9271-cfbf-4f0e-811b-b2e260d1b8e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_18f249a1-455e-407f-aa84-667f43ef7f97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d394f0f-75d1-48be-a6ab-deb2d20f1179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandFifteenStockOptionAndRestrictedStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-05</xbrli:startDate><xbrli:endDate>2022-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amlx:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e6d67a4d-2001-440f-b683-73f5e52c53fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_96d72263-9f43-4d59-8a5d-034e72d9be8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b214c460-3b77-4ddc-9510-02c9f4c9c9c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_adb5fca4-6b49-414c-ae2a-8352bcf3a331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_638aa53f-8b90-4d77-82c0-fa3b9eb25f93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c14457e2-814d-4d72-8c26-189bdc3fa207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5213ac10-0852-427d-9169-258edff8126e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201811Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_13345d35-56b6-4c29-9548-08d0bb84c9d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ebd36ac-5798-4f88-97b9-7e44c07d4319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amlx:MorningsideVenturesInvestmentsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e05504eb-0e44-40fb-b852-5368d3b9651a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35fc1ceb-01e4-49e3-8c88-0259fd467fd7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_46b98ed8-5467-4391-ad5a-f70e2d057d60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">amlx:IncentiveStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d94ca99-5668-447a-a76f-db70b18b7074"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7b990e5-1180-4f67-85bb-6d7b96c69b5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:AgencyBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_850c76e4-ca88-4f27-b305-1aade8432744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f6726908-1236-47a4-adbd-73f904c12140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7fb78ab-3ece-4f31-af8a-d8d9b755bc94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_39eac193-4dc1-4fb2-9a13-3e7cfe206bcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_553959d9-0a46-4ddf-909a-9d7b7705481a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb130967-b508-4202-8fe2-6a4e676525e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0863d34e-dbd1-4004-8428-eacbe8227644"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-05</xbrli:startDate><xbrli:endDate>2022-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_73f1a92d-0191-4388-a5a7-d6dd11c4cb90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bd82984a-e7c6-40a2-8123-1c9deb800381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3abbf489-5362-4633-bc8b-b7daa3c678ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_489ebaa1-e175-4c12-b766-93bc771353fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">amlx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_031b3770-76f9-425a-9800-d1c8d734148f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_70137d1c-ebe4-41cf-9891-6c732ce3bf02"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc698754-4dd5-48cc-b030-8ba72e728f61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4e947744-cacb-43d4-857f-1094d22ea491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ee7aed98-f0b4-4a0d-9d1c-9a20e0229bc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c9061aa3-fdfb-412c-afec-524e4df56961"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_abe6a82a-1d40-4eb5-8cb4-6e4904b35dfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:CollateralizedCreditCardSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d3cc07f-ae47-4903-9e9b-b86bea983319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fb6ca0c6-e436-48d9-af45-2ac4f63346d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">amlx:FinishedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_99d7352d-e522-4ae7-bfb0-933bd5a40ea8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7b22ec5-138f-422c-b0c5-18df666aa608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61ca1749-7a0a-470d-9b8c-19819b5915bb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_91613165-4e43-4b91-b6e5-9c7be336afa8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b59b87a6-8c0e-42c4-b13a-2b0067aad963"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_965b6cf6-b979-4df3-ac71-5437159cc716"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3fc7d41f-a882-4639-88a8-f660f437b33b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b1aaf8c-dd58-4214-a024-8c65bee77c8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-08-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90ba1a94-3a9c-4e3a-98be-4dbb6a1f0412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32879b2b-a939-4f66-b85c-34c2c940aadb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56faeaab-7811-48f5-9a7b-1727a455eccf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f38b7408-04be-4eb8-957e-fdf39e6193be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ec1205e-1c76-493c-b003-ad047009b28c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b1c0dc1-9115-4d8d-97b5-2ec93c4885e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-08-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_268c76a6-dcfb-4bac-8647-bc6361c204b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroTwoOneNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8b5b9ca1-4558-4404-bf4b-7219032bb989"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">amlx:NonemployeeDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-05</xbrli:startDate><xbrli:endDate>2022-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_49ffe463-5c72-4589-94f5-b0914efbf208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">amlx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658551</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_Customer"><xbrli:measure>amlx:Customer</xbrli:measure></xbrli:unit><xbrli:unit id="U_Rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Vote"><xbrli:measure>amlx:Vote</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="border-top:2.25pt double;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_edacf154-1c65-4746-94df-ccc43d900837" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (Mark One)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_26879116-79e0-442c-84a8-bf8d7d6fcc5b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:DocumentAnnualReport" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cfdd0a8f-ffd2-4f2b-9574-749f84134a75" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b5f51c26-1aee-4867-906b-c1c76420803b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6264ed2e-a38d-4f72-8922-5308b29d5bba" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:DocumentTransitionReport" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                     </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission File Number </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7fa93574-cbde-4970-8e4d-3740478ceba4" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-41199</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:20.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_733b1d31-2076-4f9c-bc8e-b919e83d6e40" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:20.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b8f7f4cd-ebf7-4a85-b474-4a794c9738aa" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d8f203b8-3ce5-4d3e-b534-e46ef2d5e866" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46-4600503</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_07d6a54b-1c02-403a-b95e-4f089c22e896" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43 Thorndike St.</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6d380b7b-a4c2-4b30-a550-4f011147b661" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cambridge</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_30a1e9f1-20a2-474e-8f7c-0ec8810c336d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e2844c77-34e0-4c4a-8d6b-a40a7c4cf69d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">02141</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7735246a-0914-4918-aeab-c6fb869118dd" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">617</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d3f62703-a7d6-4012-82ef-683d1c9760c1" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">682-0917</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:39.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b5fa9542-4a32-4539-8a7f-3d375620ebbd" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6f4d7fb2-4288-4497-9987-6e9b27041662" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMLX</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ed1983c9-9d3b-4c9c-a603-1df1d18f8c58" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Global Select Stock Market</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: None</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES &#9744;     </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_819efd2e-cc9e-4b84-92ac-a2f5c32b66e3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">N</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">o</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  YES &#9744;     </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2f5d2d52-3d14-41ad-93c6-00426a7fb007" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">N</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">o</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e6e1d8a7-c831-4d63-afd0-26b3272eb21a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;     N</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">o</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9744;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bc0e54c8-1514-4869-8e7d-2665ce894a3a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Y</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">es</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;     NO &#9744;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.898%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:55.843%;"></td>
    <td style="width:1.056%;"></td>
    <td style="width:20.102%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.102%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f74978d2-7dcb-4bd4-92df-1d87bab5b5b0" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e1de8ce6-c457-41a9-9f40-e45e1e543915" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntitySmallBusiness" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fdbe3e19-801c-422c-b5cd-0fac636c2591" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityEmergingGrowthCompany" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5e30c0d4-6dac-4d6a-a98b-77a8599fe5ea" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityExTransitionPeriod" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_25e85a38-50f4-4f5d-bf5d-3a7890033a43" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#x2019;s executive o&#xfb03;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES &#9744;     NO </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3a07d9a5-290b-4d43-a16a-5569c8c71702" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:EntityShellCompany" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate market value of voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on the Nasdaq Global Select Market as of June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, was $</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0fd93ae1-aebd-4e68-96cf-94ba6c77f46b" contextRef="C_f45a549c-ba7e-4586-8301-b2aa4abaaf62" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">788.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of Registrant&#x2019;s Common Stock outstanding as of March 8, 2023 was </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e5e3bb9-36f4-4b65-b247-1f9d988ea0eb" contextRef="C_5d20162d-ff61-483b-a925-f567b613c421" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">66,716,388</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <div style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9d733a2c-527a-40f8-a60c-dd9f4f4a49d3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant intends to file a definitive proxy statement pursuant to Regulation 14A relating to the 2023 Annual Meeting of Stockholders within 120 days of the end of the registrant&#x2019;s fiscal year ended December 31, 2022. Portions of such definitive proxy statement for the 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.0%;"></td>
    <td style="width:82.0%;"></td>
    <td style="width:7.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#special_notes"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Special Notes Regarding Forward-looking Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Properties</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reserved</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quantitative and Qualitative Disclosures about Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_other_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="special_notes"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SPECIAL NOTE REGARDING FO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Annual Report on Form 10-K, or Annual Report, contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical facts contained in this Annual Report are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expect,&#x201d; &#x201c;intend,&#x201d; &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;project,&#x201d; &#x201c;should,&#x201d; &#x201c;target,&#x201d; &#x201c;would&#x201d; or the negative of these terms or other comparable terminology. These statements are not guarantees of future results or performance and involve substantial risks and uncertainties. Forward-looking statements in this Annual Report include, but are not limited to, express or implied statements about:</span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain existing and obtain additional regulatory approvals of AMX0035 and any future product candidates;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to successfully commercialize and market AMX0035 and any future product candidates, if approved, and the timing of any commercialization and marketing efforts;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to contract with third-party suppliers, manufacturers and other service providers and their ability to perform adequately and to produce sufficient quantities of clinical and commercial supplies;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential market size, opportunity, demand and growth potential for AMX0035 and any future product candidates, if approved;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to build and maintain our own sales and marketing capabilities, or seek collaborative partners, to commercialize AMX0035 and any future product candidates, if approved;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain funding for our operations;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the initiation, timing, progress and results of our preclinical studies and clinical trials, including our Phase 3 clinical trial of AMX0035 for the treatment of amyotrophic lateral sclerosis, or ALS, known as the PHOENIX trial, and our research and development activities;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> our ability to retain the continued service of our key professionals and to identify, hire and retain additional qualified professionals;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to continue to advance AMX0035 and advance any future product candidates into, and successfully complete, clinical trials;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to successfully recruit and enroll suitable patients in our clinical trials;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing or likelihood of the accomplishment of various scientific, clinical, regulatory filings and approvals and other product development objectives, including the timing of a decision by the European Medicines Agency, or EMA, regarding whether to approve AMX0035 for the treatment of adults with ALS;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the pricing and reimbursement of AMX0035 in the U.S., Canada and in any other jurisdictions in which AMX0035 is approved, if any, and of any other product candidates, if approved;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the rate and degree of market acceptance of AMX0035 and any future product candidates by physicians, patients, third-party payors and others in the medical community;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the implementation of our business model, strategic plans for our business, product candidates and technology;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">developments relating to our competitors and our industry, including any regulatory developments;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimates regarding expenses, revenue, capital requirements, cash runway and future and needs for additional financing;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our financial performance; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effects of rising inflation rates and the impact on operating costs, liquidity and access to credit on any of the foregoing or other aspects of our business operations;<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effects of global economic uncertainty and financial market volatility caused by economic effects of rising inflation and interest rates, the COVID-19 pandemic, geopolitical instability, changes in international trade relationships and conflicts, such as the ongoing conflict between Russia and Ukraine, on any of the foregoing or other aspects of our business or operations; and</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other statements about future events, including those listed under the section titled &#x201c;Risk Factors.&#x201d;</span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any forward-looking statements in this Annual Report reflect our current views with respect to future events and with respect to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those described under Part I, Item 1A, &#x201c;Risk Factors&#x201d; and elsewhere in this Annual Report. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of our forward-looking statements are as of the date of this Annual Report only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or risks and uncertainties referred to in this Annual Report or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the Securities and Exchange Commission, or the SEC, could materially and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this Annual Report, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this Annual Report that modify or impact any of the forward-looking statements contained in this Annual Report will be deemed to modify or supersede such statements in this Annual Report.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may from time to time provide estimates, projections and other information concerning our industry, the general business environment, and the markets for certain diseases, including estimates regarding the potential size of those markets and the estimated incidence and prevalence of certain medical conditions. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events, circumstances or numbers, including actual disease prevalence rates and market size, may differ materially from the information reflected in this Annual Report. Unless otherwise expressly stated, we obtained this industry, business information, market data, prevalence information and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources, in some cases applying our own assumptions and analysis that may, in the future, prove not to have been accurate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRADEMARKS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Solely for convenience, our trademarks and trade names in this report are referred to without the &#174; and &#153; symbols, but such references should not be construed as any indicator that we will not assert, to the fullest extent under applicable law, our rights thereto.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Introduction</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our mission is to one day end the suffering caused by neurodegenerative diseases. We are committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Our first product, RELYVRIO&#174; (sodium phenylbutyrate and taurursodiol), previously known as AMX0035 in the U.S., is approved in the U.S. for the treatment of ALS in adults. AMX0035 is also approved with conditions by Health Canada and marketed as ALBRIOZA for the treatment of ALS in Canada.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unlike most other cells in the body that regularly die and are replaced as part of healthy function, mature neurons are normally resistant to cell death and generally cannot regenerate. We believe AMX0035 is the first drug candidate to show both a functional and survival benefit in a large-scale clinical trial of patients with ALS. The results of our Phase 2 clinical trial of AMX0035, known as the CENTAUR trial, were published in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New England Journal of Medicine</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, in two publications in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Muscle &amp; Nerve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Neurology</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Neurosurgery</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Psychiatry</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 is a dual UPR-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). Through the resolution of the UPR and by inhibiting translocation of the Bax to the outer mitochondrial membrane, we have shown in multiple models that AMX0035 can keep neurons alive under a variety of different conditions and stresses, including in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> models of neurodegeneration, endoplasmic reticulum, or ER, stress, mitochondrial dysfunction, oxidative stress and disease-specific models of a variety of other conditions, as well as in vivo models of ALS, Alzheimer&#x2019;s disease, or AD, and multiple sclerosis, or MS. We believe AMX0035 has the potential to be a foundational therapy, meaning that it could be used alone or in conjunction with other therapies to change the treatment paradigm across a broad range of neurodegenerative diseases. We are pursuing ALS as our first indication as it is a disease of rapid and profound neurodegeneration, and we are focused on the development and potential commercialization of AMX0035 for ALS globally.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have received marketing authorization with conditions by Health Canada for ALBRIOZA for the treatment of ALS. We announced commercial availability of the product in July 2022. We have submitted to and received from the national reimbursement authorities, known as the Canadian Agency for Drugs and Technologies in Health, or CADTH, and l&#x2019;Institut national d&#x2019;excellence en sant&#xe9; et en services sociaux, or INESSS, recommendations regarding reimbursement for ALBRIOZA by the Canadian provincial governments, and are negotiating with both public and private payers to obtain reimbursement coverage.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We received approval by the FDA for RELYVRIO in September 2022, and commercial product was first available in October 2022. This decision represented Amylyx&#x2019; first regulatory approval of AMX0035 in the U.S. and its second worldwide.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also actively pursuing regulatory approval of AMX0035 for the treatment of ALS in Europe. Our MAA remains under review by the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA. We submitted a Marketing Authorization Application, or MAA, to the EMA in Europe in the first quarter of 2022, which was validated in the same quarter. We completed the Scientific Advisory Group meeting. Certain major objections remain, and the CHMP has adopted another round of questions as part of the regulatory process. We are now in possession of those questions. In order to respond in accordance with the updated timelines, we now expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2021, we initiated a Phase 3 clinical trial of AMX0035 for the treatment of ALS, known as PHOENIX trial, at clinical trial sites in the U.S. and Europe. On February 2, 2023, we announced completion of enrollment in PHOENIX, which enrolled 664 participants. We anticipate topline results from the PHOENIX trial in mid-2024. This trial is designed to provide further data evaluating the safety and efficacy of AMX0035 over 48 weeks for the treatment of ALS to further support our global regulatory efforts. European participants completing the 48-week trial have the option to enroll in an open label extension (OLE) phase. During this phase, all participants receive AMX0035, and continued safety and efficacy measures will be assessed.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also developing AMX0035 for other neurodegenerative diseases by leveraging our deep knowledge of and relationships in the neurodegenerative space. We believe the approach of a dual UPR-Bax apoptosis inhibitor designed to help keep neurons alive could be clinically meaningful for the treatment of other neurodegenerative disease indications in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">addition to ALS. Many common and rare neurodegenerative diseases are characterized by substantial neuronal cellular loss, including AD and Wolfram syndrome, as well as Parkinson&#x2019;s Disease, Huntington&#x2019;s Disease, Progressive Supranuclear Palsy, Multi-System Atrophy, and others. We conducted a Phase 2 clinical trial in AD, known as the PEGASUS trial, to obtain safety data along with initial efficacy and biomarker data which could help us prioritize additional indications to pursue with AMX0035. We believe the topline results from the PEGASUS trial, reported in November 2021, provide further biological knowledge about AMX0035 which will help inform future clinical development of AMX0035 for the treatment of AD and in other potential indications. Based on these topline results, AMX0035 met the PEGASUS trial&#x2019;s primary endpoint of safety and tolerability. The 6-month trial was not powered to evaluate differences between groups in efficacy outcomes and no differences were seen in a newly developed composite outcome of cognitive, functional, and imaging measures, or secondary efficacy endpoints of cognition, function, and imaging. In this trial, AMX0035 showed significant effects on biomarkers including neurogranin, YKL-40 or Chitinase 3-like 1 (CHI3L1), and fatty acid binding protein 3 (FABP3). These results build on previously reported findings that AMX0035 exhibited significant effects on the tau protein, tau phosphorylated at threonine 181, and the amyloid beta 42 to 40 (amyloid-&#xdf;1-42, amyloid-&#xdf;1-40) ratio in cerebrospinal fluid. We will continue to evaluate these data and discuss the results of the PEGASUS trial with scientific advisors as we consider potential next steps for the development of AMX0035 for the treatment of AD within our clinical development strategy. In March 2023, we completed site activation for a Phase 2 clinical trial of AMX0035 for the treatment of Wolfram syndrome, and expect to enroll the first participant in the near term.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also intend to prioritize our development efforts around neurodegenerative diseases that result in substantial disability, and ultimately death, and where unmet medical needs are greatest. For example, we recently presented initial </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> data from our new, internally developed compound, AMX0114, targeting Calpain-2, a critical effector of axonal degeneration.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since our founding in 2013, our goal has been to improve the quality of, and extend, life for patients suffering from neurodegenerative diseases. One of our key strategies towards achieving this goal has been to form direct relationships with patients, their families, advocacy groups, and healthcare professionals to bring much needed innovation to patients. Throughout the development of AMX0035, we have partnered with members of the disease communities we serve, including the ALS Association, the Northeast ALS Consortium, or NEALS, ALS Finding a Cure, the Healey Center at Massachusetts General Hospital, the Cure Alzheimer&#x2019;s Fund, the Alzheimer&#x2019;s Association and the Alzheimer&#x2019;s Drug Discovery Foundation, to ensure our goals are aligned with patient needs. In addition, many of the key opinion leaders in the ALS community were and are investigators in our recent and ongoing trials. These relationships are a cornerstone of our culture and corporate strategy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current pipeline, including the stage of development and approvals of AMX0035 in our target indications, is represented in the table below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img109617586_0.jpg" alt="img109617586_0.jpg" style="width:672px;height:314px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 is a proprietary oral fixed-dose combination of two small molecules: PB, which is a small molecular chaperone that reduces the UPR, preventing cell death resulting from the UPR, and TURSO, (also known as</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">tauroursodeoxycholic acid, or TUDCA), which is a Bax inhibitor that reduces cell death through apoptosis. While the PB and TURSO molecules individually are not proprietary to us, we own patents and patent applications covering AMX0035, including the fixed-dose combination of AMX0035 itself. We believe that our proprietary combination of these two mechanisms of action will allow us to target abnormal cell death to better prevent neurodegeneration than treatment with either mechanism of action alone.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The results of our CENTAUR trial were published in September 2020 in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New England Journal of Medicine</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and in October 2020 in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Muscle and Nerve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Trial results showed that patients receiving AMX0035 experienced statistically significant benefit in retention of function, as measured by the Revised ALS Functional Rating Scale, or ALSFRS-R, as well as nominally significant improvement in overall survival, or OS, when analyzing the full randomized population through the OLE trial in a post hoc analysis (July 20, 2020 and March 1, 2021 data cutoffs). Results of long-term effect of AMX0035 on tracheostomy/ventilation-free survival and hospitalization were published in May 2022 in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Neurology Neurosurgery Psychiatry</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. AMX0035 was shown to be generally well-tolerated with the prevalence of adverse events comparable across placebo and treatment groups. We believe AMX0035 is the first drug candidate in ALS to demonstrate a statistically significant benefit in function as measured by a prespecified mean rate change in ALSFRS-R and a nominally significant benefit in a longer-term post hoc analysis of OS, which are both important outcomes for people with ALS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Company and Team</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx was founded with the ambitious goal of improving the quality and length of life for patients suffering from neurodegenerative diseases. From a dorm room at Brown University in 2013, our Co-CEOs and Co-Founders, Josh Cohen and Justin Klee set out to determine why neurons die, and have ever since been working to develop AMX0035, which we believe is the first drug candidate to show function and survival benefits in patients with ALS, and other novel therapies. To help realize our goal, we have assembled a team with deep scientific, clinical, business and leadership experience, bolstered by expertise in biotechnology. Our Chief Financial Officer, James Frates, brings over 20 years of experience as the Chief Financial Officer of Alkermes. Our Chief Commercial Officer, Margaret Olinger, brings three decades of expertise in commercial launches and operations, most recently at Alexion. Our Chief Technical Operations Officer, Tom Holmes, brings more than 25 years of leadership experience at Biogen in supply chain, pharmaceutical manufacturing and program management. Our Head of Regulatory Affairs, Tammy Sarnelli, brings more than 30 years of experience from Biogen and other companies in early and late-stage neurology and rare disease development. Our Global Head of Human Resources, Debra Canner, brings over 20 years of experience, having served as the Chief of Human Resources Officer at Akamai and as part of Genzyme. Our Chief Legal Officer and General Counsel, Gina M. Mazzariello, brings more than 20 years of corporate and commercial legal experience in the healthcare industry, including holding leadership positions at Boehringer Ingelheim USA, Inc. Our Global Head of Clinical Research &amp; Development and Chief Medical Officer, Patrick D. Yeramian, brings over 30 years of medical and pharmaceutical industry experience. This team brings a diverse set of skills uniquely suited to drive successful commercialization of AMX0035 in ALS while continuing to advance AMX0035 in other indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective December 1, 2022, Dr. Yeramian shifted to a part-time role and we expect he will ultimately transition out of his role into retirement, although no definitive date has been set for such transition. We have engaged in a search to identify a full-time successor as part of our management succession process.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recently appointed Karen Firestone to our Board of Directors, effective as of March 16, 2023. Prior to founding her current fund, Aureus, Karen spent 22 years with Fidelity where, among other responsibilities, she managed the Biotechnology sector fund. She has a demonstrated track record of applying her strategic acumen and commercial mindset to drive progress in the space and look forward to her counsel as we continue working toward our mission.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Strategy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our mission is to one day end the suffering caused by neurodegenerative diseases. Key elements of our strategy to achieve this mission include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Effectively and efficiently commercializing RELYVRIO for ALS in adults in the U.S. and ALBRIOZA for ALS in Canada.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We received FDA approval in the U.S. for AMX0035 as RELYVRIO for the treatment of ALS in adults in September 2022 and launched RELYVRIO commercially in the U.S. in October 2022. We received marketing authorization with conditions in Canada for ALBRIOZA for the treatment of ALS in June 2022 and launched ALBRIOZA commercially in Canada in July 2022. We believe our commercial capabilities, coupled with our understanding of the ALS patient and medical community, will enable us to successfully commercialize </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:5.602%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RELYVRIO for ALS in the U.S. and ALBRIOZA for ALS in Canada and to launch AMX0035 for the treatment of ALS successfully in other key territories, if approved.</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining additional regulatory approvals of AMX0035 for ALS, with an initial focus on Europe.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA in Canada for the treatment of ALS and in September 2022, AMX0035 received approval in the U.S. as RELYVRIO for the treatment of ALS in adults. Based on the results from our CENTAUR trial, we have been exploring pathways towards regulatory approval in several additional territories, including Europe. We believe that the CENTAUR trial may also be able to support marketing authorization in Europe and other jurisdictions. We submitted an MAA in Europe in the first quarter of 2022, and we now expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest.</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Effectively and efficiently commercializing AMX0035 in other key territories, if approved.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We are continuing to build our sales team, internal capabilities and outside vendor network to support commercialization in the U.S. and Canada. We will continue to build our capabilities in Europe and other jurisdictions to support commercialization of AMX0035, if approved. For example, in January 2023, we entered into a distribution agreement with Neopharm to commercialize AMX0035 in Israel, Gaza, West Bank and Palestinian Authority, subject to regulatory review and approval. We anticipate that our commercial infrastructure will be scalable for subsequent launches in other key markets if we receive marketing approval in these territories as well.</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Maximizing the therapeutic potential of AMX0035 by expanding into additional neurodegenerative diseases.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We believe the data from the CENTAUR trial showing functional and survival benefits for ALS patients treated with AMX0035 support its potential mechanism of targeting ER stress and mitochondrial dysfunction. Based on our extensive understanding of disease pathways, we believe AMX0035 may provide benefit across multiple diseases characterized by neurodegeneration. As we select the next indications for AMX0035 we will prioritize those indications which we believe, if successful, will most rapidly lead to marketed products and to patient benefit. We conducted our Phase 2 PEGASUS clinical trial in AD to obtain safety data along with initial efficacy and biomarker data, which will help us evaluate the development of AMX0035 for the treatment of AD within our clinical development strategy. In March 2023, we completed site activation for a Phase 2 clinical trial of AMX0035 for the treatment of Wolfram syndrome, and expect to enroll the first participant in the near term.</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Continuing to cultivate a network of patient advocacy groups, key opinion leaders, research institutions, and healthcare professionals to inform our patient-centric approach.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We have cultivated a network of key constituents, which we believe will continue to help us to develop therapies in an efficient and impactful manner. Integrating the experiences and insights from these parties, which include patients, their families, and organizations such as the ALS Association, NEALS, ALS Finding a Cure, the Healey Center at Massachusetts General Hospital, the Cure Alzheimer&#x2019;s Fund, the Alzheimer&#x2019;s Association and the Alzheimer&#x2019;s Drug Discovery Foundation, continues to inform our approach to developing therapies that can potentially transform the lives of patients and their families. We intend to continue to engage with each of these constituents through conferences, clinical trials and informal communications as we further develop and pursue commercialization of AMX0035. </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deploying a strategic approach to design, acquire and develop new therapies. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We follow a scientifically rigorous approach to evaluating new opportunities to broaden our portfolio. We plan to target assets that allow us to leverage our experience with neurodegenerative pathways and AMX0035&#x2019;s mechanism of action, focusing primarily on preventing neuron death. When evaluating assets, we consider not only our ability to apply our experience with AMX0035 but also a variety of factors, including unmet medical need, biological rationale, feasibility of clinical development, potential for regulatory approval, costs of development, competitive landscape and commercial potential. For example, in July 2022, we announced that we entered into a two-year sponsored research agreement with Sunnybrook Research Institute to expedite the identification of novel drug candidates that inhibit Bax and Bak for the development of therapeutics for neurodegenerative diseases, specifically ALS. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neurodegenerative Disease</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The prevention of neurodegeneration represents one of today&#x2019;s most significant unmet medical needs. The development of therapies that preserve neuron health has historically presented unique challenges, including an imperfect understanding of underlying biology and a lack of translation of activity observed in preclinical studies to results in clinical trials. Currently approved therapies for many neurodegenerative diseases are generally only symptom modifying and have demonstrated limited efficacy. There remains an urgent need for novel approaches to address most neurodegenerative diseases, especially for progressive and severe conditions such as ALS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The Role of the Endoplasmic Reticulum and Mitochondria in Neurodegenerative Disease</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unlike most other cells in the body that regularly die and are replaced as part of healthy function, mature neurons are normally resistant to cell death and generally cannot regenerate. Neuron death is only triggered when multiple stress factors are activated beyond the neuron&#x2019;s recovery capacity, a circumstance commonly seen in neurodegenerative disorders. Most neurodegenerative disorders have complex pathophysiology, with multiple pathways contributing and converging to eventually cause neuron death. A large fraction of these pathological changes in neurons can be linked to dysfunction in the ER and mitochondria that affect metabolism and secretion of lipids and proteins, calcium homeostasis, and energy production. Dysfunction in these two essential cellular structures is implicated across many neurodegenerative disorders, highlighting the central role they play in maintaining neuron health and survival and providing the rationale for our focus, which is to rescue ER and mitochondrial function, and to protect and preserve neurons.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ER Stress</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ER is responsible for protein and lipid synthesis, folding and quality control of proteins, and storing calcium for cellular energy production by the mitochondria. The ER is also a primary sensor of stressful intracellular conditions, activating a wide number of molecular pathways that belong to a specific process, referred to as the ER stress response, that controls protein homeostasis. ER stress, or dysfunction associated with protein misfolding and aggregation, has been implicated in the pathogenesis of neurodegenerative disease. In neurodegenerative disorders, misfolded proteins and accumulations of protein aggregates can cause oxidative stress and a feedback loop resulting in ER stress. When the ER stress response is activated due to misfolded and aggregated proteins, the UPR, is engaged as a regulatory mechanism to reduce the load of misfolded proteins and restore a healthy cellular state. Molecular chaperones are the critical regulators of protein homeostasis under ER stress. Pathological conditions such as neurodegenerative diseases that disturb protein folding and maturation can trigger ER stress and engage the UPR. When the natural protein homeostasis in the cell cannot be achieved, the UPR triggers cellular death, or apoptosis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Role of the ER in Neurodegenerative Disease</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_1.jpg" alt="img109617586_1.jpg" style="width:604px;height:367px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Mitochondrial Dysfunction</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The mitochondria are a central regulatory point for the control of cell death. When mitochondria detect sufficient cell damage, they signal for the cell to initiate a cell death cascade. Among other steps, this cascade includes the recruitment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of a series of apoptotic proteins including Bcl-2-associated X protein, or BAX, the release of cytochrome c from a pore in the mitochondrial membrane called the mitochondrial permeability transition pore, and finally the activation of caspase 3, an executioner protein for apoptosis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In neurodegenerative diseases, triggers such as altered calcium homeostasis, glutamate excitation of the cell, damage to the mitochondria or mitochondrial DNA and detection of aberrant double-stranded DNA and accumulation of unfolded proteins at the mitochondria all lead to mitochondrially mediated cell death. Inhibition of proteins such as BAX could result in a greater threshold for cell death and longer survival of key neurons implicated in the progression of neurodegenerative disease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Linkage Between Mitochondria and ER</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The mitochondria and the ER are often physically linked by a membrane called the mitochondrial associated ER membrane, or MAM. Through this linkage, calcium and molecules are shuttled between the two organelles. It is our belief that this connection, or crosstalk, allows the cell to integrate responses between the two organelles and that activation of mitochondrial damage pathways will activate the UPR and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">vice versa</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Both the mitochondria and the UPR in the ER can trigger cell death. As such, we believe both pathways are crucial to the pathogenesis of neurodegenerative diseases and both need to be addressed simultaneously to effect a substantial change in survival of neurons undergoing neurodegenerative processes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Role of the ER and Mitochondria in Neuron Death</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_2.jpg" alt="img109617586_2.jpg" style="width:605px;height:318px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Background and Rationale for AMX0035</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have designed AMX0035 to reduce neuron death through simultaneous mitigation of ER stress and mitochondrial dysfunction. AMX0035 is a coformulation of two small molecules, PB and TURSO. PB has been shown to reduce ER stress through upregulation of a protein known as DJ-1 that is a master chaperone regulator, recruitment of other chaperone proteins, and as a small molecular chaperone. TURSO is a bile acid that has been shown to recover mitochondrial bioenergetic deficits through incorporation into the mitochondrial membrane, reducing BAX translocation to the mitochondrial membrane, reducing mitochondrial permeability, and increasing the apoptotic threshold of the cell. Through our research, we identified the specific ratios at which the combination of PB and TURSO target these critical, connected pathways and show synergistic activity in improving neuronal cell viability </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We then developed AMX0035 as an optimized oral formulation to be tested </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and clinically.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our preclinical studies have shown that PB and TURSO, in combination, can inhibit a number of pathological pathways associated with neurodegenerative diseases in cell culture and animal models. For example, in an </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">model of neurodegeneration, we tested the potential abilities of PB and TURSO individually and in combination to prevent oxidative-induced neuronal death, or cell viability, which was measured using a PrestoBlue reagent. In this experiment, hydrogen peroxide was applied to rat primary cortical neurons in a concentration sufficient to kill approximately 40% of the neurons. Particular doses of PB and TURSO individually protected against some of the neuron death, and cell viability reached approximately 80%. However, when these rat primary cortical neurons were dosed with particular ratios of PB and TURSO in combination, nearly 100% of oxidative-induced neuron death was prevented. The results of this </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> model are shown in the graphic below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_3.jpg" alt="img109617586_3.jpg" style="width:617px;height:287px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, we have observed benefit from the administration of particular ratios of PB and TURSO across </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">models of ER stress, mitochondrial dysfunction, oxidative stress, and disease specific models of ALS, AD, Parkinson&#x2019;s disease, MS, Friedreich&#x2019;s Ataxia, primary mitochondrial myopathies and a variety of other conditions. We have also conducted </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vivo </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">models of PB and TURSO, in combination, including models of ALS, AD and MS. Additionally, academic groups have conducted studies with monotherapy treatment with TURSO and/or PB in models of ALS, AD, MS, Parkinson&#x2019;s Disease, Huntington&#x2019;s Disease, Progressive Supranuclear Palsy, Multi-System Atrophy, X-linked adrenoleukodystrophy, and a variety of other models. We believe this body of evidence collectively supports the use of this combination to treat neurodegenerative indications and led us to pursue the development of our proprietary drug candidate, AMX0035.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 for the Treatment of ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Overview of ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are initially developing AMX0035 for the treatment of ALS, an adult-onset, progressive, and fatal neurodegenerative disorder of the neuromuscular system resulting in muscle weakness and paralysis leading to death. ALS involves the progressive degeneration of motor neurons in the spinal cord and brain that are responsible for controlling voluntary muscle movement. This progressive loss of motor neurons leads to muscle weakness, loss of muscle mass, and inability to control movement. ALS remains universally fatal with a median survival of less than three years from symptom onset and less than two years from diagnosis. Despite being classified as a rare disease by the FDA and the EMA, ALS is considered one of the more common adult-onset neuromuscular diseases worldwide. We estimate based on public sources that there are approximately 29,000 ALS patients in the U.S. More than 30,000 ALS patients are estimated to be located in the EU and the United Kingdom, or UK, and about 3,000 ALS patients are located in Canada. Over 90% of patients have no family history of ALS, known as &#x201c;sporadic&#x201d; ALS. While other development approaches seek to address genetic instances of ALS, AMX0035 is designed to target all instances of ALS, regardless of whether it is sporadic or genetic. Due to the two-year median survival of patients diagnosed with ALS, a high proportion of the patient population has been recently diagnosed and a therapy that is able to improve the survival of patients with ALS has the potential to increase the number of patients who are able to continue living with their disease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Medical costs for patients newly diagnosed with ALS in the U.S. are substantial and increase rapidly with each disability milestone. Care of patients with ALS is intensive and requires a team of medical professionals, special equipment, and assistance with daily activities. Caregivers are often forced to miss work or give up employment opportunities to provide care, leading to increased financial strain. The disease also impacts the patient&#x2019;s family, who generally provide the bulk of caregiving, which often entails the provision of 24-hour care. The constant adaptation of caregivers to the demands of the ALS disease progression requires significant physical effort and mental exhaustion particularly during the advanced stages of the disease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Significant Unmet Need in ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ALS is a heterogeneous disease that arises from multiple mechanistic underpinnings, leading patients to experience variable onset and delayed diagnosis, persistent progression and loss of muscle function, and shortened survival.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is a significant unmet need for ALS therapies that target multiple pathogenic pathways, are disease-modifying, and can provide both functional and survival benefit to patients. Only two FDA-approved therapeutic agents for ALS, riluzole, an anti-glutamatergic agent, and edaravone, a free-radical scavenger, have been shown to modulate the course of ALS. In pivotal clinical trials, riluzole demonstrated longer time to tracheostomy or death compared to placebo and edaravone demonstrated longer retention of function compared to placebo. However, a need remains for ALS therapies that demonstrate both retention of function and longer survival, allowing patients to maintain greater independence for longer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the multi-pathway pathophysiology of ALS, experts agree that successful treatment will likely require concurrent targeting of multiple key neuronal death pathways. There is a strong rationale for treatments that target identified convergence points of these critical pathways, including in the ER and mitochondria, and we believe that a therapy that targets multiple pathways at once, like AMX0035, aligns with the emerging ALS treatment paradigm.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development of AMX0035 for ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We designed our Phase 2 CENTAUR trial with input from leading ALS experts from NEALS to detect a significant difference between AMX0035 and placebo. The study also provided the option for participants to continue with available approved therapies, riluzole and edaravone, for the duration of the trial. The FDA granted orphan drug designation for AMX0035 for the treatment of patients with ALS in September 2017. The EMA granted orphan designation to AMX0035 for the treatment of patients with ALS in April 2020. In December 2019, we announced positive topline results from our CENTAUR trial. The trial met its primary endpoint, and we published detailed trial data in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New England Journal</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of Medicine in September 2020 and in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Muscle and Nerve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in October 2020. We submitted a New Drug Submission, or NDS, in Canada in the second quarter of 2021, an NDA in the U.S. in the fourth quarter of 2021 and an MAA in Europe in the first quarter of 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and we launched ALBRIOZA commercially in Canada in July 2022. In September 2022, AMX0035 received approval as RELYVRIO by the FDA for the treatment of ALS in adults following the second virtual meeting of the FDA&#x2019;s Peripheral and Central Nervous System Drugs Advisory Committee, or the Advisory Committee, held on September 7, 2022. As a result of the FDA&#x2019;s approval of AMX0035, we launched RELYVRIO commercially in the U.S. in October 2022. In Europe, our MAA also remains under review by CHMP. We completed the Scientific Advisory Group meeting. Certain major objections remain, and the CHMP has adopted another round of questions as part of the regulatory process. We are now in possession of those questions. In order to respond in accordance with the updated timelines, we now expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">CENTAUR, Our Phase 2 Trial of AMX0035 in ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2020, we published detailed results from the Phase 2, randomized, double-blind, placebo-controlled CENTAUR trial. The CENTAUR trial was conducted at 25 centers of the NEALS, and evaluated adult patients with ALS. Key inclusion criteria were definite ALS defined by the revised El Escorial criteria, which entails having various clinical signs and symptoms, defined as upper and lower motor neuron signs, in at least three defined body regions, less than 18 months from symptom onset and slow vital capacity, or SVC, greater than 60%. These criteria were chosen to select a homogenous, rapidly progressing patient population to potentially increase the likelihood of observing a treatment effect. Participants were allowed to continue on their selected standard of care, including treatment with riluzole and/or edaravone. Eligible participants (n=137) were randomized two-to-one to treatment with AMX0035, one sachet (each containing one</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">gram of TURSO and three grams of PB) given once daily for the first three weeks, and if tolerated, the dose was then increased to twice-daily for the remainder of a 24 week treatment period, or matching placebo. Two participants did not have follow-up efficacy assessments and were not included in the efficacy population (modified intention to treat, or mITT, n=135). These two participants were included in the safety population (intention to treat, or ITT, n=137). Upon completion of the 24-week, parallel group phase of the trial, participants were eligible to enroll in the OLE trial in which all participants were followed up to 35 months while participants and physicians remained blinded to the original treatment group. Of participants completing the CENTAUR trial randomization phase, 92% elected to enroll in the OLE. The first protocol of the OLE was completed in March 2021. Actual duration of patient treatments across the randomization phase and the OLE, both with the PB-TURSO combination and via placebo, are shown in the graphic below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_4.jpg" alt="img109617586_4.jpg" style="width:573px;height:517px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary efficacy outcome measure for the CENTAUR trial was the rate of decline in the ALSFRS-R total score. The ALSFRS-R scale is the most widely used ALS rating scale in ALS clinical practice and in ALS clinical trials. It measures patient&#x2019;s functional ability and is broken down into four domains: bulbar (which includes speech, salivation and swallowing), fine motor (which includes handwriting, cutting food/handling utensils, dressing and hygiene), gross motor (which includes turning in bed, walking, and climbing stairs) and breathing (which includes dyspnea, orthopnea and respiratory insufficiency). A decrease of one point on the ALSFRS-R scale can reflect severe limitations in a patient&#x2019;s independence, and a two-point increase on the ALSFRS-R scale would be associated with:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eating successfully with some difficulty instead of needing a feeding tube; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">being short of breath only while walking instead of having difficulty breathing while sitting or lying down; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">being able to dress independently instead of needing assistance. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The CENTAUR trial met its primary endpoint with a statistically significant reduction in clinical decline among participants randomized to AMX0035 (n=87) compared to placebo (n=48) (p-value of 0.03) over 24 weeks. These results showed that patients receiving AMX0035 scored an average of 2.32 points higher on the ALSFRS-R as compared to patients receiving placebo after 24 weeks, a difference of 25%, as shown in the graph below. In a survey of ALS clinicians and researchers conducted and sponsored by NEALS, with the objective of determining what percentage reduction in ALSFRS-R would be considered clinically meaningful, a difference of greater than or equal to 20% in ALSFRS-R total score was considered clinically meaningful by a majority of clinicians and researchers surveyed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_5.jpg" alt="img109617586_5.jpg" style="width:618px;height:367px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Secondary efficacy outcomes measuring disease free progression were the decline in muscle strength as measured by Accurate Test of Limb Isometric Strength, or ATLIS, testing and lung function measured by SVC, both expressed as percent of predicted values and key study events including death, permanent ventilation and hospitalization. Neurofilament was also measured as a biologic measure. The analysis also indicated statistically significant preservation of upper limb strength with AMX0035 treatment measured on ATLIS (p=0.042), while the lower limb measure did not reach statistical significance (p=0.34). An average of these two, referred to as the total ATLIS score, trended in favor of AMX0035 (p=0.11). There was also a trend in favor of AMX0035 therapy preserving lung function as measured by SVC, with a numerical difference of 5.11% although this was not statistically significant (p=0.076). These efficacy data are summarized in the table below. In addition, a time-to-event analysis was conducted on key study events including death, permanent ventilation and hospitalization events over the 24-week randomized phase of the trial. Because enrollment of patients in the CENTAUR trial was limited to patients who, in the investigator&#x2019;s opinion, would be able to complete 6-month follow up, few events of this nature were expected during the initial, 24-week randomized phase of the trial. As a result, we observed a positive, but not statistically significant, difference between the trial&#x2019;s treatment and control groups during the 24-week randomized phase of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the study. There was no statistically significant difference between the rate of decline in plasma levels of the neurofilament observed in the trial&#x2019;s treatment and control groups during the 24-week randomized phase of the study.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_6.jpg" alt="img109617586_6.jpg" style="width:618px;height:280px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phosphorylated neurofilament heavy chain was measured in plasma in the CENTAUR trial. There were no statistically significant differences between groups in this outcome. A limitation of this outcome is that it was measured in plasma rather than cerebrospinal fluid and the ultimate relevance of this outcome in ALS is still under investigation by the field.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is important to note that most (77%) participants were receiving riluzole or edaravone at or before study entry, with a greater proportion receiving edaravone in the placebo group (50%) compared with the AMX0035 group (25%). Pre-specified analyses were conducted to determine if the use of concomitant medications impacted results. These analyses found that AMX0035&#x2019;s effect on the primary outcome was consistent regardless of baseline use of concomitant medications (riluzole and/or edaravone).</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OS was analyzed for all subjects randomized in the CENTAUR trial (ITT analysis) and compared patients originally randomized to AMX0035 (n=89) with those randomized to placebo (n=48). In this post hoc analysis, the vital status of each participant was measured by a participant locating service which used sources such as the U.S. social security death index up to July 20, 2020 even if he or she did not continue into the OLE, stopped study drug, dropped out of the study or was lost to follow-up. Over the duration of follow up, the risk of death was 44% lower among those originally randomized to AMX0035 compared with those originally randomized to placebo (hazard ratio, or HR, of 0.56; a 95% confidence interval, or CI, ranging from 0.34 to 0.92; and a p-value of 0.023). Median survival duration was 25.0 months (95% CI of 19.0 to 33.6 months) in the group previously randomized to AMX0035 and 18.5 months (95% CI of 13.5 to 23.2 months) in the group previously randomized to placebo as seen in the graph below. As reflected in the data tables below, participants originally randomized to AMX0035 showed a longer median survival of 6.5 months (data cutoff July 20, 2020) and 4.8 months (data cutoff March 1, 2021) than those originally randomized to placebo. The FDA considers that the survival data available for</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RELYVRIO are exploratory and should be interpreted cautiously given the limitations of data collected outside of a controlled study.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post Hoc Survival Analysis (July 20, 2020 Data Cutoff)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_7.jpg" alt="img109617586_7.jpg" style="width:593px;height:375px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post Hoc Survival Analysis (March 1, 2021 Data Cutoff)</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_8.jpg" alt="img109617586_8.jpg" style="width:533px;height:377px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also conducted three additional post hoc analyses of AMX0035 survival data which we provided as confirmatory evidence of our findings in the CENTAUR trial and which were provided to the FDA in support of our marketing application for AMX0035. These analyses consisted of the following: a new analysis utilizing a statistical method to adjust for the effect of treatment crossover; a new analysis comparing observed survival in the CENTAUR trial to predicted survival using the European Network for the Cure of ALS survival prediction model derived from an ALS natural history database; and a new analysis comparing observed survival from the CENTAUR treatment group to survival of matched treatment na&#xef;ve participants from historical clinical trials of ALS.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also performed sensitivity analyses on the CENTAUR trial data, including a joint rank test, which showed no bias in the estimate of the primary functional outcome by loss of data due to participant death. Sensitivity analyses were also performed to account for missing data and death or death-equivalent events. These sensitivity analyses yielded results similar to the primary analysis. In sensitivity analyses designed to account for concomitant medication use, the treatment effect size was consistent between primary analysis and analyses corrected for concomitant medication use.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 was generally well-tolerated with an adverse event rate substantially similar to placebo. Adverse events, or AEs, were reported in 97% (86 out of 89) of participants receiving AMX0035 and 96% (46 out of 48) of participants receiving placebo, with the nature of the AEs being substantially similar in both groups. The most commonly occurring (greater than or equal to 5%) AEs in either treatment group are shown in the table below. Because of the progressive neurodegenerative nature of ALS, many of these AEs (e.g., muscle weakness, falls, dyspnea, fatigue) were likely attributable to the underlying ALS disease. Events occurring in greater than or equal to 5% of patients in either treatment group and more frequently (greater than or equal to 2% of patients) in patients who received AMX0035 compared with those who received placebo were predominantly gastrointestinal events, which were non-serious and mostly mild in intensity and declined considerably in occurrence after three weeks on treatment. A total of 19% of the patients in the AMX0035 treatment group and 8% of the patients in the placebo group discontinued their participation in the trial due to AEs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The most commonly occurring AEs were diarrhea, abdominal pain, nausea, upper respiratory tract infection, constipation, muscular weakness, fall, headache, dizziness and viral upper respiratory tract infection. Health Canada also noted the occurrence of hypersalivation. Consistent with the known safety profile of TURSO, diarrhea and nausea occurred more frequently in patients who received AMX0035 compared with those who received placebo. In contrast, muscular weakness, fall, constipation and headache occurred more frequently in patients who received placebo. The observed AEs from the CENTAUR trial are summarized in the chart below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.51%;"></td>
    <td style="width:1.399%;"></td>
    <td style="width:12.778%;"></td>
    <td style="width:1.399%;"></td>
    <td style="width:12.778%;"></td>
    <td style="width:1.399%;"></td>
    <td style="width:12.738%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adverse Events (AEs)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Occurring in &#x2265;5% of Patients in either Treatment Group<br />(Safety Population, n=137)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MedDRA System Organ Class Preferred Term</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo + SOC<br />(n=48)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 + SOC<br />(n=89)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overall<br />(n=137)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gastrointestinal disorders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29 (60.4%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60 (67.4%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89 (65.0%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Musculoskeletal and connective tissue disorders</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21 (43.8%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38 (42.7%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59 (43.1%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Injury, poisoning and procedural complications</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (47.9%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35 (39.3%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58 (42.3%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nervous system disorders</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19 (39.6%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (37.1%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52 (38.0%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Infections and infestations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21 (43.8%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28 (31.5%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49 (35.8%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Respiratory, thoracic and mediastinal disorders</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10 (20.8%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29 (32.6%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39 (28.5%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investigations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10 (20.8%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26 (29.2%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 (26.3%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General disorders and administration site conditions</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (27.1%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20 (22.5%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (24.1%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Skin and subcutaneous tissue disorders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (16.7%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16 (18.0%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24 (17.5%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Psychiatric disorders</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (18.8%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (15.7%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (16.8%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Renal and urinary disorders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (16.7%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10 (11.2%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 (13.1%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Metabolism and nutrition disorders</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (8.3%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10 (11.2%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (10.2%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cardiac disorders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0 (0.0%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (7.9%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (5.1%)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Eye disorders</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (2.1%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 (5.6%)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (4.4%)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid;margin-right:79.602%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:5.731%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.731%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Includes serious adverse events. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Serious adverse events, or SAEs, occurred nominally less frequently in the AMX0035 treatment group (12.4% of patients) compared with the placebo treatment group (18.8% of patients). This difference was largely driven by a higher incidence of respiratory events, including respiratory failure in the placebo treatment group (8.3% of patients), compared with the AMX0035 treatment group (3.4% of patients). ALS disease progression often leads to respiratory failure, and it is the most common cause of death in patients with ALS. The observed SAEs from the CENTAUR trial are summarized in the chart below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Serious Adverse Events (SAEs)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_9.jpg" alt="img109617586_9.jpg" style="width:558px;height:190px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overall, a total of seven patients (two (4% of patients) who received placebo and five (6% of total patients) who received AMX0035) died during the conduct of the 24-week, double-blind study. None of the deaths was considered by the investigator to be related to AMX0035. Consistent with the most common cause of death in patients with ALS, the majority (four of seven patients) of deaths during the study were from respiratory failure (two patients in each group). Other causes of death (in the AMX0035 group) included post-extubational supraglottic and infraglottic aspiration (attributed to aspiration pneumonia), diverticulitis, and subdural hematoma secondary to a fall. Death equivalent was defined as either tracheostomy or permanent assisted ventilation, or PAV. PAV was defined as more than 22 hours daily of non-invasive mechanical ventilation for more than one week (seven days). One patient in the placebo group (2% of patients) and none in the AMX0035 group experienced a death equivalent event (i.e., tracheostomy/PAV) during the 24-week study.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe AMX0035 is the first drug candidate in ALS to demonstrate a statistically significant benefit both in function as measured by a prespecified mean rate change in ALSFRS-R and in a longer-term analysis of OS, both important outcomes for people with ALS. In summary, patients in our CENTAUR trial showed a statistically significant improvement in function and a statistically significant improvement in overall survival and AMX0035 was shown to be generally well-tolerated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development Plan of AMX0035 in ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We submitted an NDA to the FDA in the fourth quarter of 2021 and, in September 2022, the FDA approved AMX0035 as RELYVRIO for the treatment of ALS in adults. We submitted an NDS for AMX0035 for the treatment of ALS to Health Canada in the second quarter of 2021, and in June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA in Canada. We also submitted an MAA for approval of AMX0035 for the treatment of ALS to the EMA CHMP in the first quarter of 2022, and we expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> In November 2021, we initiated our global 48-week PHOENIX, randomized, double-blind, placebo-controlled trial at clinical sites in the U.S. and Europe. The PHOENIX trial is designed to provide further data evaluating the safety and efficacy of AMX0035 for the treatment of ALS to further support our global regulatory efforts. Enrollment in this trial was completed in March 2022 in the U.S. and in February 2023 in Europe. We anticipate topline results from the PHOENIX trial in mid-2024. The primary endpoints in our PHOENIX trial will be a composite measure of survival and ALSFRS-R total score progression over 48 weeks and safety and tolerability over 48 weeks. The secondary endpoints of our PHOENIX trial will be SVC, ALSAQ-40 (a questionnaire which provides a subjective health measure to specifically assess quality of life for patients with ALS), EQ5D-5L (a standard qualify of life measure), decline in King&#x2019;s (a staging measurement in ALS based on the number of central nervous system, or CNS, regions involved and requirement for gastrostomy or noninvasive ventilation) and MiToS stages (a functional staging measure that can be derived prospectively from the ALSFRS-R subscore</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">using standard methods), ventilation free survival, and long-term survival. Key inclusion criteria for the PHOENIX trial include ALS patients with clinically definite or clinically probable ALS by El Escorial criteria (2-4 body areas with clinical signs consistent with ALS), &lt;24 months from symptom onset, SVC &gt;55%, and riluzole/edaravone use permitted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2022, we announced a planned OLE for the PHOENIX trial and in March 2022, we announced the launch of a U.S. expanded access program, or EAP, that the FDA authorized for people with ALS who meet certain eligibility criteria for participation. The EAP will be wound down alongside the commercial launch of RELYVRIO in the U.S., with a target close of the EAP in the first half of 2023. On February 2, 2023, we announced the completion of enrollment in the PHOENIX trial, which enrolled 664 participants. Because marketing approvals we have obtained may be limited, subject to restrictions or post-approval requirements, we may need to provide post-marketing support in those jurisdictions. For example, as part of our approval for RELYVRIO in the U.S., we have post-marketing requirements to conduct carcinogenicity studies in mice and rats, drug-drug interaction studies, and studies in patients with kidney or liver impairment. In addition, one of the conditions of the marketing authorization in Canada for AMX0035 (ALBRIOZA) for the treatment of ALS is the provision of data from our ongoing PHOENIX trial and other additional planned or ongoing studies. The outcomes of the PHOENIX trial could have a material effect on our business. We anticipate topline results in mid-2024.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any additional regulatory approvals we may receive may be limited or subject to restrictions or post-approval commitments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 for the Treatment of Other Potential Indications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our extensive understanding of disease pathways, we believe AMX0035 may provide benefit across multiple diseases, including AD, Wolfram syndrome, Parkinson&#x2019;s Disease, Huntington&#x2019;s Disease, Progressive Supranuclear Palsy, Multi-System Atrophy, primary lateral sclerosis, ischemic stroke, MS, Friedreich&#x2019;s ataxia, Leigh&#x2019;s syndrome and Leber&#x2019;s hereditary optic neuropathy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are prioritizing these conditions on an indication-by-indication basis, based on the strength of the data supporting AMX0035&#x2019;s potential, including the data from our recently completed PEGASUS trial; the urgency of the unmet need; the practicality of conducting clinical trials in these conditions; the efficiency of clinical development activities; and the commercial potential. For some of these indications, given the data already produced by the company on AMX0035, we believe it may be possible to move directly into Phase 3 evaluations of safety and efficacy which could allow for a rapid development pathway. We will prioritize those indications which we believe have the greatest chance of providing patients with benefit and the most rapid pathway to market.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2023, we completed site activation for a Phase 2 clinical trial of AMX0035 for the treatment of Wolfram syndrome, and expect to enroll the first participant in the near term.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development of AMX0035 for AD</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We designed our multicenter, randomized, double-blind, placebo-controlled Phase 2 PEGASUS trial with AD experts to evaluate the safety, tolerability and activity of AMX0035 in patients with late mild cognitive impairment, or MCI, or early-to-moderate dementia. The PEGASUS trial was designed to have broad entry criteria to include participants at different stages of AD to allow us to assess the biological effect of AMX0035 across the spectrum of disease and determine if there are any patients who might see a greater benefit from therapy. Eligible participants (n=95), adults ages 55 to 89 years old, were randomized three-to-two to treatment with AMX0035, one sachet (each containing one gram of TURSO and three grams of PB) given twice-daily over 24 weeks, or matching placebo.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary investigator for the PEGASUS trial, Dr. Steven Arnold, presented topline results from the PEGASUS trial at the Clinical Trials on Alzheimer&#x2019;s Disease conference, or CTAD, which was held during the fourth quarter of 2021. Based on these topline results, AMX0035 was generally well-tolerated with approximately 80% of patients completing dosing in the trial in the AMX0035 arm. Safety results are depicted in the figure below. As in the CENTAUR trial, a higher</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">percentage of patients in the AMX0035 arm had gastrointestinal adverse events. However, no SAEs were attributed to AMX0035 in the PEGASUS trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_10.jpg" alt="img109617586_10.jpg" style="width:322px;height:185px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 6-month trial was not powered to evaluate differences between the AMX0035 and placebo arms in cognition, function or imaging.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary endpoint of the trial was to compare the safety and tolerability of a fixed-dose combination of AMX0035 versus placebo in subjects with MCI (high or intermediate likelihood due to AD) or dementia due to AD over a 24-week treatment period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The secondary endpoints of the trial were to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">determine the effects of AMX0035 treatment on whole brain and regional brain atrophy, as assessed by volumetric MRI; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assess the impact of AMX0035 treatment on clinical symptoms as measured by the Alzheimer&#x2019;s Disease Assessment Scale-Cognitive Subscale, or ADAS-Cog, the Dementia Severity Rating Scale, or DSRS, and the FAQ; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assess the effect of AMX0035 treatment on measures of neuropsychiatric symptoms, as assessed by the Neuropsychiatric Inventory Questionnaire; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">measure the effects of AMX0035 treatment on functional MRI measures including connectivity with resting state Blood Oxygenation Level Dependent imaging. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, the trial evaluated differences between the AMX0035 and placebo arms as measured by GST, a newly developed composite outcome of cognitive, functional, and imaging measures named the Global Statistical Test, or GST, over the 24-week treatment period. The GST is a combination of three change-from-baseline to end-of-study endpoints: Cognition (Modified Alzheimer&#x2019;s Disease Composite Score, or MADCOMS), Function (Functional Activities Questionnaire, or FAQ) and Total Hippocampal Brain Volume (Magnetic Resonance Imaging, or MRI). The GST is calculated for each subject as a mean score across the above three component endpoints for each subject in the trial. This mean score was then analyzed as an efficacy variable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finally, the exploratory objectives of the trial were to measure the effect of AMX0035 treatment on biochemical markers of amyloid-&#xdf;1-42, amyloid-&#xdf;1-40, total tau (t-tau), tau phosphorylated at threonine 181 (ptau 181), neuronal injury markers, mitochondrial redox and function markers, and neuroinflammation, as assessed in cerebrospinal fluid, or CSF, from all volunteers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While functional MRI analyses remain ongoing, no significant differences between dosing groups were observed for any efficacy endpoints in this trial (p&gt;0.05). Key efficacy results are included in the figure below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_11.jpg" alt="img109617586_11.jpg" style="width:479px;height:197px;" />&#160;</p>
  <p style="margin-left:12.467%;text-indent:-4.041%;padding-left:3.4%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:4.69pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 	Hippocampal volume component is based on standard ADNI MRI algorithm but was also assessed via additional MRI algorithms included in the Statistical Analysis Plan and yielded similar findings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img109617586_12.jpg" alt="img109617586_12.jpg" style="width:513px;height:171px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant impacts on multiple biomarkers of interest in AD were observed in the trial. In CSF, the AMX0035-group showed significant reductions of tau protein 181 (p&lt;0.001) and phosphorylated tau protein (p&lt;0.001) compared with the placebo group, modulation of the amyloid beta 42/40 ratio (p&lt;0.05) and increase of 8-hydroxy-2&#x2019; -deoxyguanosine, (p&lt;0.01). These topline results from the PEGASUS trial are still subject to further audit and verification procedures and additional biomarker results are not yet available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the biomarker and imaging outcomes from the trial have substantially improved and will continue to inform our knowledge of the impact of AMX0035 on the neurodegenerative pathways relevant to the progression of AD, which have been and will be informative as we continue clinical development of AMX0035 in AD and other potential indications. We believe these insights will help us to examine any effects of AMX0035 on AD&#x2019;s progression, which could inform future work in AD as well as clinical trial design for other indications. We will continue to evaluate these data and discuss the results of the PEGASUS trial with scientific advisors as we consider potential next steps for the development of AMX0035 for the treatment of AD within our clinical development strategy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Development of AMX0035 for Wolfram Syndrome</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2023, we completed site activation for a Phase 2 clinical trial of AMX0035 for the treatment of Wolfram syndrome, and expect to enroll the first participant in the near term. The trial is an exploratory open-label proof of biology study assessing the effect of AMX0035 safety and tolerability, and various measures of endocrinological, neurological and ophthalmologic function. Amylyx anticipates topline results from the trial in 2024.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Researchers from the Washington University School of Medicine in St. Louis, in collaboration with Amylyx, recently published preclinical data exploring the potential of AMX0035 as a novel therapeutic approach for Wolfram syndrome. These data were published in the peer-reviewed </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Clinical Investigation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, characterizing a pathogenic variant in the WFS1 gene (WFS1 c.1672C&gt;T, p.R558C), identifying a platform for further genotype-phenotype analysis, and providing initial proof-of-concept for the therapeutic development of AMX0035 in Wolfram syndrome. The study</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">demonstrated that iPSC-derived Wolfram syndrome models can provide a model of genotype-phenotype relationships that correlate with clinical observations. Study highlights related to AMX0035 included:<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Administration of AMX0035 improved WFS1 protein expression, increased insulin secretion, and inhibited cell death in &#x3b2; cells with the WFS1 c.1672C&gt;T, p.R558C variant. AMX0035 also prevented cellular death in patient-derived neuronal progenitor cells. Gene enrichment analysis revealed that treatment with AMX0035 ameliorated organelle dysfunction, mitophagy, ER stress, and apoptosis.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, AMX0035 delayed the onset of the diabetic phenotype in vivo in the Wfs1-knockout mouse model of Wolfram syndrome.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Wolfram syndrome is a rare, pediatric, life-threatening disease thought to be caused by variants in the Wolfram syndrome WFS1 gene, or WFS1, and, in a small fraction of patients, pathogenic variants in the CDGSH iron sulfur domain protein 2 CISD2 gene, or CISD2. Wolfram syndrome results in deafness, blindness, ataxia, neurodegeneration and ultimately death. There are currently no drugs approved for Wolfram syndrome.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Wolfram syndrome appears to be a disease of ER stress. WFS1 encodes and produces the vital wolframin protein, which appears to be involved in ER regulatory processes. WFS1 deficiency leads to chronic ER stress and the UPR. WFS1 also negatively regulates activating transcription factor 6 (ATF6), a UPR molecule, resulting in cell death. Furthermore, a recent study suggested that WFS1 impacts mitochondrial function by transporting Ca2+ from the ER to the mitochondria through the MAM.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 targets pathways central to Wolfram syndrome, including the UPR, and has shown beneficial effects in a variety of models of Wolfram syndrome, including cellular models and patient-derived cell line models. For example, to test the potential effects of AMX0035 in the modulation of ER stress in the context of Wolfram syndrome, the effects of PB, TURSO and AMX0035 were tested in an </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> model of wild-type and WFS1-deficient pancreatic beta cell lines. In these cells, when compared with the control group, only AMX0035, but not PB or TURSO alone, was able to significantly prevent tunicamycin-induced cell death in WFS1-deficient pancreatic beta cell lines as measured by caspase 3 / 7 activity (p equal to 0.017). Additionally, a combination of PB and TURSO was studied </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in human patient-derived neural progenitor cells harboring mutations in WFS1, which cause Wolfram Syndrome. Both PB and TURSO, when applied alone, were observed to inhibit cell death in each of three different human cell lines as compared to control conditions, and the application of PB and TURSO in combination was observed to result in significantly lower levels of cell death in three separate patient-derived Wolfram syndrome cell lines differentiated to produce patient-derived neural progenitor cells, as compared to either the control or treatment with PB or TURSO alone. Thus, in relevant models of Wolfram syndrome, use of AMX0035 was observed to have synergistic effects lowering cell death as compared to either the control group or treatment with PB or TURSO alone. For these reasons, we believe AMX0035 is a promising clinical candidate for Wolfram syndrome.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patient Advocacy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patient advocacy landscapes for ALS and other neurodegenerative diseases are large, and encompass groups at the international, multiregional and country-specific level. We have built strong medical and commercial relationships at the international level, with our current emphasis being on ALS advocacy groups in the U.S., Canada and Europe. We plan to engage country-specific groups in Europe based on clinical trial results, as well as our medical and commercial priorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Working with key advocacy groups is critical to our mission, as patients are at the center of everything we do. This starts with transparent communication and awareness about our science, data and development plans. We seek ensure that these advocacy groups are informed and able to answer questions from their members about PB, TURSO and AMX0035.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We engaged with patient advocacy groups in the U.S. and Europe for feedback on the design of our ongoing global Phase 3 PHOENIX trial of AMX0035 for the treatment of ALS, which is emblematic of the partnerships we are building with the community. In addition, we treat patient advocacy groups as important stakeholders as we address access to AMX0035 outside ongoing clinical trials, such as expanded access and compassionate use programs. We have sought and will continue to seek guidance and insights from as many patient advocacy groups as possible and have plans in place to engage groups on an ongoing basis. These groups have also reviewed messaging and press releases from the company to ensure they take into account the patient voice.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since obtaining regulatory approval, we have seen strong interest in AMX0035, and we are encouraged by the early success of our commercial launch. We believe the global commercial opportunity for AMX0035 in ALS is driven by its being the first and only treatment for ALS of which we are aware that potentially provides a combination of longer retention of function, improved survival, a generally well-tolerated side effect profile and convenient oral administration. AMX0035 has been shown to have a significant impact on clinically meaningful endpoints, including reducing time to first hospitalization and permanent ventilation in ALS patients. AMX0035 is also being considered for other neurodegenerative disorders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ALS is a rare disease, but public sources estimate that ALS affects at least 200,000 people worldwide, and we estimate that there are approximately 29,000 ALS patients in the U.S. More than 30,000 ALS patients are estimated to be living with ALS in the EU and the UK and about 3,000 ALS patients are estimated to be living with ALS in Canada. In the U.S., ALS is treated by neurologists at certified ALS Centers or by other neurologists. In Canada and in Europe, most ALS patients are treated at ALS Centers. The vast majority of people with ALS (over 90%) have sporadic disease, showing no clear family history. Most people who develop ALS are between the ages of 40 and 70, with a median age of 55 at the time of diagnosis. However, cases of the disease do occur in people in their twenties and thirties. People with ALS spend approximately one-third of their disease course searching for a diagnosis and, once diagnosed, there are few approved therapies available. ALS is a relentlessly progressive and highly heterogenous disease that arises from multiple mechanistic underpinnings, leading patients to experience variable onset, persistent progression, and shortened survival. The disease remains universally fatal with median survival of less than three years from symptom onset and less than two years from diagnosis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have conducted market research with physicians, patients, caregivers, nurses, and payors in the U.S., Western Europe and Canada to understand the unmet need and potential of AMX0035 in ALS. Clinicians universally report dissatisfaction with currently approved therapies and state the need for additional options for their ALS patients. When shown a target product profile for AMX0035, the majority of ALS specialists and neurologists with whom we spoke are open to utilizing it in early-to-mid-stage patients, with some also stating the potential for use in late-stage patients.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We submitted an NDA to the FDA in the fourth quarter of 2021 and, in September 2022, the FDA approved AMX0035 as RELYVRIO for the treatment of ALS in adults. We submitted an NDS for AMX0035 in ALS with Health Canada in the second quarter of 2021, which received marketing authorization with conditions as ALBRIOZA by Health Canada in June 2022. We also submitted an MAA in Europe in the first quarter of 2022, and we expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest. We also plan to discuss AMX0035 with other health authorities around the world to determine the most appropriate path forward in their respective territories. We also initiated our ongoing Phase 3 PHOENIX trial in the fourth quarter of 2021 to further support the safety and efficacy of AMX0035 for the treatment of ALS and our global regulatory efforts, and in February 2023 we announced completion of enrollment in that trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our pre-launch activities in other key jurisdictions include building awareness of and education regarding the disease severity and pathophysiology of ALS, increasing understanding of the clinical impact of a change in a patient&#x2019;s ALSFRS-R score, and building general awareness of our company through active participation in key neurology conferences, patient meetings, partnerships with patient advocacy groups, targeted omnichannel initiatives and payor education in each of the key territories. In addition, we intend to continue to pursue an active public relations strategy. For example, the double-blind results of our CENTAUR trial have already been published in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New England Journal of Medicine</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, while the long-term survival study results appeared in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Muscle &amp; Nerve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our initial plans are to continue to build out our commercial operations in the U.S. and Canada and to build commercial operations in Europe to be prepared for potential approval of AMX0035 in the EU. There are approximately 186 ALS Association certified, recognized, or affiliated centers in the U.S., 17 Canadian ALS Research Network Clinics in Canada, and an established network of ALS Centers of Excellence per country in each of the major EU countries, which we plan to target with a specialty key account management team. We will continue to evaluate market entry opportunities beyond these geographies either on our own or with a partner.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The biotechnology and pharmaceutical industries are characterized by rapid technological advancement, significant competition and an emphasis on proprietary products. We face potential competition from many different sources, including major and specialty pharmaceutical and biotechnology companies, academic research institutions, governmental agencies and public and private research institutions. Any product candidates that we successfully develop and commercialize, including AMX0035, may compete with current therapies and new therapies that may become available in the future. We believe that the key competitive factors affecting the success of any of our product candidates will include efficacy, safety profile, dosing, cost, effectiveness of promotional support and intellectual property protection.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors, either alone or with their collaboration partners, have significantly greater financial resources and expertise in research and development, preclinical testing, clinical trials, manufacturing, and marketing than we do. Future collaborations and mergers and acquisitions may result in further resource concentration among a smaller number of competitors. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market or make our development more complicated. These competitors may also vie for a similar pool of qualified scientific and management talent, sites and patient populations for clinical trials, as well as for technologies complementary to, or necessary for, our programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">AMX0035 for the Treatment of ALS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to AMX0035, in the past 30 years, only two product candidates had been approved for the treatment of ALS in the U.S. and Canada, and only one product candidate had been approved for the treatment of ALS in Europe. These two previously approved drugs, riluzole (marketed under the name Rilutek) and edaravone (marketed under name Radicava in the U.S. and Radicut in Japan), are often used in combination. We expect that further therapies and drugs which may be approved in the future will also be used in combination with existing drugs, absent incompatibility or other barriers to combination. For example, in May 2022, Mitsubishi Tanabe Pharma America, Inc. announced that the FDA approved an oral formulation of intravenous, or IV, administered alternative to Radicava for the treatment of ALS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe there are currently no other approved treatments for ALS which show both a functional and survival benefit for ALS patients. Patients with ALS in North America are commonly treated with riluzole and edaravone, which are palliative in nature. However, we are aware of several product candidates in clinical development that may compete with AMX0035 for the treatment of ALS, including product candidates being developed by Biogen, Seelos Therapeutics and Prilenia Therapeutics. To date, we believe none of the above product candidates has shown statistically significant clinical results on prespecified outcomes in any prior trials. We anticipate that ALS will continue to be an area of research in the healthcare sector and that drug candidates will continue to be developed and studied for treatment of the disease.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While we anticipate the general practice in ALS will continue to be the use of approved agents as single drug therapy or combination, our commercial potential could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or tolerable or are less expensive than AMX0035 or products that we may develop. In addition, we are aware of one ongoing clinical study in Europe which is evaluating the effects on ALS of TURSO, one of the two components in AMX0035. The outcome of this study could have an impact on the commercial potential of AMX0035.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A large number of trials and studies are ongoing in the many additional neurodegenerative diseases which we are evaluating for future clinical work for AMX0035 including AD, Wolfram syndrome, Parkinson&#x2019;s Disease, Huntington&#x2019;s Disease, Progressive Supranuclear Palsy, Multi-System Atrophy, primary lateral sclerosis, ischemic stroke, MS, Friedreich&#x2019;s ataxia, Leigh&#x2019;s syndrome and Leber&#x2019;s hereditary optic neuropathy. Some of these diseases also have therapies approved which impact disease progression. The competitive landscape in these diseases will affect the potential opportunity for AMX0035.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supply and Manufacturing</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely, and expect to continue to rely for the foreseeable future, on third-party contract manufacturing organizations, or CMOs, for the production of AMX0035 in compliance with current Good Manufacturing Process, or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cGMP, requirements, for commercial supply as well as for use in clinical trials under the guidance of members of our organization. For AMX0035, we utilize two active pharmaceutical ingredients, or APIs, PB and TURSO, which are manufactured and released to us from third-party manufacturers. We have long term, single-source supply agreements in place for these APIs, including authorization to reference the relevant drug master files with these vendors. We have single-source arrangements for the manufacturing and packaging of bulk drug at established CMOs for commercial supply, clinical trials, and other potential needs. We manufacture AMX0035 bulk drug at Patheon Inc., or Patheon, a subsidiary of Thermo Fisher Scientific Inc., located in Whitby, Canada. We have scaled-up our third-party manufacturing capabilities in a manner that we believe will continue to support commercial demand and have entered into agreements covering the manufacture of AMX0035 through 2025. Following manufacturing, bulk drug is then sent to PCI Pharma Services in Rockford, IL, for primary and secondary packaging. As we look to markets outside of the U.S., we plan to add additional manufacturing and distribution sites to support local market demand. In addition, we utilize a risk-based approach to bring on additional manufacturing sites as needed.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have built a team of pharmaceutical industry technical operations leaders. This team has significant technical, manufacturing, analytical, quality, regulatory, including cGMP, and project management experience to oversee our third-party manufacturers and maintain quality and regulatory compliance. In addition, members of this team have been involved in commercializing and launching rare disease products across the globe. We plan to continue to build our technical operations team as commercialization continues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also have a Quality Management System consistent with a regulated industry that outlines Standard Operating Policies and Procedures that govern the oversight of our CMOs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Manufacturing Agreement with Patheon</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2019, we entered into a master manufacturing services agreement, or the Manufacturing Agreement, with Patheon, pursuant to which Patheon provides cGMP manufacturing, quality control, quality assurance, stability testing, packaging and related services to us. We have executed an initial product agreement under the Manufacturing Agreement, which covers AMX0035. The Manufacturing Agreement has an initial term ending in December 2025, and will automatically renew if there is a product agreement in effect, with the renewal period ending upon the termination of the last product agreement in effect. The product agreement covering AMX0035 has an initial term ending in December 2025 and automatically renews for successive terms of two years, unless either party gives prior notice of its intent not to review.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may terminate the Manufacturing Agreement or any product agreement: upon 30 days&#x2019; prior written notice if any government or regulatory authority permanently prevents us from selling AMX0035 in Canada, the EU or the U.S., if approved, or upon 90 days&#x2019; prior written notice, if we no longer intend to order manufacturing services due to AMX035&#x2019;s discontinuance in the market. Patheon may terminate any product agreement under the Manufacturing Agreement upon 30 days&#x2019; prior written notice, if we project zero volume for twelve successive months during the term of such product agreement. Additionally, Patheon may terminate the Manufacturing Agreement or any product agreement if payment in full of any overdue, undisputed invoice is not received within 30 days of Patheon&#x2019;s suspension of manufacturing services for nonpayment or, in certain circumstances, upon nine months&#x2019; prior written notice if we assign any rights under the Manufacturing Agreement or a product agreement. In addition, either party may terminate the Manufacturing Agreement or any product agreement for cause, including the other party&#x2019;s uncured material breach and upon written notice, in the case of the other party&#x2019;s insolvency or bankruptcy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Supply Agreement with CU Chemie</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, we entered into a supply agreement with CU Chemie Uetikon, GmbH, or CU Chemie, a division of the SEQENS group, pursuant to which CU Chemie agreed to supply to us, on a non-exclusive basis, bulk drug substance of PB, for use in the manufacture of AMX0035. The agreement has an initial term of five years and will automatically renew for successive terms of two years, unless earlier terminated. After the expiration of the initial term, either party may terminate the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">agreement for convenience upon three months&#x2019; prior written notice. Additionally, either party may terminate the agreement in the case of the other party&#x2019;s uncured material breach or upon the insolvency or bankruptcy of the other party.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Supply Agreement with ICE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2019, we entered into a supply agreement with Prodotti Chimici e Alimentari S.p.A. (now ICE S.p.A., or ICE), as amended in July 2021, pursuant to which ICE agreed to supply to us, on a non-exclusive basis, bulk drug substance of TURSO, which we use in the manufacture of AMX0035. The agreement has an initial term of five years and will automatically renew for successive terms of five years, unless earlier terminated. ICE may terminate the agreement upon three months written notice. Additionally, either party may terminate the agreement in the case of the other party&#x2019;s insolvency or bankruptcy, or in case of the other party&#x2019;s uncured breach.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual property is of vital importance in our field and to pharmaceuticals generally. Our commercial success depends in part on our ability to obtain intellectual property that protects AMX0035 and its uses, and any future product candidates. We seek to protect and enhance proprietary technology, inventions and improvements that are commercially important to the development of our business and AMX0035, in particular, by seeking, maintaining and defending U.S. and foreign patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are actively building our intellectual property portfolio in our therapeutic area, including around AMX0035. Our current patent portfolio as of the date of this prospectus includes three patent families. In those three families, we currently own a total of 100 issued patents and pending patent applications directed to our technologies, including AMX0035. Currently, our patent portfolio includes six issued U.S. patents, 52 issued foreign patents, 11 pending U.S. patent applications and 31 pending foreign patent applications. Our issued patents and pending applications cover the relative amounts of a phenylbutyrate compound and a bile acid (such as TUDCA) and some of our issued and pending claims cover the specific ratio of those two drugs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our earliest in time patent family relates to compositions of a bile acid and a phenylbutyrate compound (including TURSO and 4-PBA) and methods of treating neurodegenerative disease, and its associated causes at a cellular level, using those compositions. This family includes four issued U.S. patents and 52 issued foreign patents (including rights in countries in which our issued European patent was validated). The foreign jurisdictions in which we have been issued patents include Albania, Austria, Australia, Bosnia and Herzegovina, Belgium, Bulgaria, China, Croatia, Cyprus, Czech Republic, Denmark, Estonia, the EU, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Iceland, Italy, Japan, Lithuania, Latvia, Macao, Macedonia, Malta, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, San Marino, Serbia, Slovenia, Slovakia, South Korea, Spain, Sweden, Switzerland, Turkey, and UK. We also have patent applications pending in Australia, China, the EU, Hong Kong, Japan, South Korea, the U.S. and other jurisdictions. In this family, we have composition of matter claims issued in the U.S. (U.S. Patent No. 11,071,742, which was issued on July 27, 2021) and Australia. These issued patents and others that issue from this family may first begin to expire as early as December 2033.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our second patent family is directed to specific compositions of a phenylbutyrate compound and a bile acid (including TURSO and 4-PBA) and methods of manufacturing those compositions. This family includes two issued U.S. patents. We also have patent applications pending in this family in the U.S., EU, and other jurisdictions. In this family, we have composition of matter claims pending in applications filed in the U.S., Argentina, Australia, Brazil, Canada, China, the EU, Hong Kong, Israel, Japan, South Korea, Mexico, and Taiwan. The issued patents and others that issue from this family may first begin to expire as early as July 2040.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our third patent family is directed to methods of treating particular symptoms of ALS and/or reducing the associated adverse events with combinations of a phenylbutyrate compound and a bile acid (including TURSO and 4-PBA). We have patent applications pending in this family in the U.S., EU, and other jurisdictions. Currently, we do not have any composition of matter claims pending in this family. Although no patents have yet issued from this family, we expect the term on patents issuing from this family to extend until at least August 2040.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be sure that patents will be granted with respect to any of our pending patent applications nor with respect to any patent applications that may be filed by us in the future. Further, we cannot be sure that any of our existing patents or any patents that may be granted to us in the future will be commercially useful in protecting our commercial</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">products. Finally, we cannot be sure that our granted patents, and any future patents granted to us, will be found valid and/or enforceable following a litigation or administrative procedure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2021, Bruschettini S.r.l. and Lederer &amp; Keller Patentanw&#xe4;lte Partnerschaft mbB each filed oppositions at the European Patent Office to our issued European Patent, EP2978419. At a high level, this patent claims various methods of treating neurodegenerative disease (and or the causes or conditions thereof) with a bile acid and a phenylbutyrate compound. The opponents contended that the patent should be revoked in its entirety on various grounds, including for allegedly having an insufficient disclosure and for lack of inventive step. The EPO issued a preliminary opinion dated October 13, 2021, and a summons to attend oral proceedings (also dated October 13, 2021) that set a date of June 2, 2022 for the oral proceedings. At the oral proceedings on June 2, 2022, the Opposition Division maintained European Patent, EP2978419 as granted. The scope of the issued claims was not limited. On June 17, 2022, the Opposition Division handed down the written decision providing detailed legal reasoning for the outcome of the oral proceedings. On August 4, 2022, Bruschettini S.r.l. filed a notice of appeal. The other opponent did not file a notice of appeal. On September 29, 2022, Bruschettini S.r.l filed a request to withdraw the appeal. As the sole appellant has withdrawn their appeal, the Board of Appeal has  closed the appeal proceedings and terminated the opposition proceedings with communication dated October 14, 2022. The decision of the Opposition Division has become final and EP2978419 is maintained as granted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent term is 20 years from the date of filing of the first non-provisional application to which priority is claimed. In the U.S., patent term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-filed patent. In the U.S., the term of a patent that covers an FDA-approved drug may also be eligible for a patent term extension of up to five years under the Hatch-Waxman Act, which is designed to compensate for the patent term lost during the FDA regulatory review process. The length of the patent term extension is calculated based on the length of time it takes for regulatory review. A patent term extension under the Hatch-Waxman Act cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only one patent applicable to an approved drug may be extended. Moreover, a patent can only be extended once, and thus, if a single patent is applicable to multiple products, it can only be extended based on one product. Similar provisions are available in Europe and certain other foreign jurisdictions to extend the term of a patent that covers an approved drug. Following the approval of RELYVRIO in the U.S., we have applied for patent term extensions for certain of our issued U.S. patents covering our product and/or their methods of use.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also rely on trademarks, trade secrets, know-how, continuing technological innovation, confidentiality agreements, and invention assignment agreements to develop and maintain our proprietary position. The confidentiality agreements are designed to protect our proprietary information and the invention assignment agreements are designed to grant us ownership of technologies that are developed for us by our employees, consultants, or other third parties. We seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical security of our premises and physical and electronic security of our information technology, or IT, systems. While we have confidence in our agreements and security measures, either may be breached, and we may not have adequate remedies. In addition, our trade secrets may otherwise become known or independently discovered by competitors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success also depends in part on our ability to operate without infringing on the proprietary rights of others and to prevent others from infringing our proprietary rights. A comprehensive discussion on risks relating to intellectual property is provided in Item 1A of this Annual Report entitled &#x201c;Risk Factors&#x2014;Risks Related to Our Intellectual Property.&#x201d;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have conducted searches of the patent landscape at certain points and in certain jurisdictions with respect to AMX0035, and based on these searches and our analyses, we have not identified any issued patents that we believe are valid and could be successfully asserted to block our ability to commercialize AMX0035.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">European Patent EP3016654, entitled &#x201c;Tauroursodeoxycholic acid (TUDCA) for Use in the Treatment of Neurodegenerative Disorders,&#x201d; is owned by Bruschettini S.r.l. The patent relates to use of TURSO in the treatment of ALS in a mammal. An opposition has been filed to the grant of EP3016654 at the European Patent Office (EPO), asking the EPO to revoke EP3016654. The EPO issued a preliminary opinion on November 18, 2019 finding that at least the main claim of EP3016654 lacked novelty. Oral proceedings were held before an Opposition Division of the EPO on June 11, 2021. At the end of the oral proceedings, the Opposition Division announced the decision revoking all claims of EP3016654. A written decision has been issued; however Bruschettini has appealed the decision of the Opposition Division to the Board of Appeal.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A response to Bruschettini&#x2019;s appeal has been filed on June 7, 2022 requesting that the appeal should be dismissed and that the decision of the Opposition Division to revoke all claims of EP3016654 be upheld.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and comparable regulatory authorities in state and local jurisdictions and in other countries, including Canada and member states of the EU impose requirements upon companies involved in the clinical development, manufacture, marketing and distribution of drugs, such as those we are developing. These agencies and other federal, state and local entities regulate, among other things, the research and development, testing, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, approval, advertising and promotion, distribution, post-approval monitoring and reporting, sampling and export and import of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">U.S. Government Regulation of Drug Products</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#x2019;s refusal to approve pending NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process required by the FDA before a drug may be marketed in the U.S. generally involves the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the FDA&#x2019;s good laboratory practice, or GLP, regulations; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Submission to the FDA of an Investigational New Drug application, or IND, which must become effective before human clinical trials may begin;</span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approval by an independent institutional review board, or IRB, at each clinical site before each trial may be initiated; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Performance of adequate and well-controlled human clinical trials in accordance with current Good Clinical Practices, or cGCP, requirements to establish the safety and efficacy of the proposed drug product for each indication; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Submission to the FDA of an NDA, including payment of application user fees; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A determination by the FDA within 60 days of its receipt of an NDA to accept the marketing application for review; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Satisfactory completion of an FDA advisory committee review, if applicable; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product is produced to assess compliance with current Good Manufacturing Practice, or cGMP, requirements and to assure that the facilities, methods and controls are adequate to preserve the product&#x2019;s identity, strength, quality and purity; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Satisfactory completion of FDA audits of clinical trial sites to assure compliance with cGCPs and the integrity of the clinical data; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA review and approval of the NDA. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Studies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preclinical studies include laboratory evaluation of product chemistry, toxicity and formulation, as well as </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and animal studies to assess potential safety and efficacy. The conduct of preclinical studies is subject to federal regulations and requirements, including good laboratory practice regulations for safety/toxicology studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An IND sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data and any available clinical data or literature and plans for clinical studies, among other things, to the FDA as part of an IND. An IND is a request for authorization from the FDA to administer an investigational product to humans and must become effective before human clinical trials may begin. Some preclinical testing, such as animal tests of reproductive adverse events and carcinogenicity, may continue even after the IND is submitted. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to one or more proposed clinical trials and places the clinical trial on a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may not result in the FDA allowing clinical trials to initiate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Trials</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators in accordance with cGCP requirements, which include the requirement that all research subjects provide their informed consent in writing for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. In addition, an IRB representing each institution participating in the clinical trial must review and approve the plan for any clinical trial before it is initiated at that institution. The IRB also must review and approve the informed consent form that must be provided to each clinical trial subject or his or her legal representative, and must monitor the clinical trial until completion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information about certain clinical trials must be submitted within specific timeframes to the National Institutes of Health, or NIH, for public dissemination on their www.clinicaltrials.gov website. Information related to the product, patient population, phase of investigation, study sites and investigators and other aspects of the clinical trial is made public as part of the registration of the clinical trial. Although sponsors are obligated to disclose the results of their clinical trials after completion, disclosure of the results can be delayed in some cases for up to two years after the date of completion of the trial. Failure to timely register a covered clinical study or to submit study results as provided for in the law can give rise to civil monetary penalties and also prevent the non-compliant party from receiving future grant funds from the federal government. The NIH&#x2019;s Final Rule on ClinicalTrials.gov registration and reporting requirements became effective in 2017, and both the NIH and FDA recently signaled the government&#x2019;s willingness to begin enforcing those requirements against non-compliant clinical trial sponsors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 1: The drug is initially introduced into healthy human subjects or patients with the target disease or condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness. </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2: The drug is administered to a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage. </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 3: The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites, in well-controlled clinical trials to generate enough data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate information for the labeling of the product. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-approval trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials as a condition of approval on an NDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA and more frequently if SAEs occur. Written IND safety reports must be submitted to the FDA and investigators for serious and unexpected suspected adverse events, findings from other studies or animal or </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> testing that suggest a significant risk for human subjects and any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for reporting. The sponsor also must notify the FDA of any unexpected</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor&#x2019;s initial receipt of the information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 1, Phase 2 and Phase 3 trials may not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#x2019;s requirements or if the drug has been associated with unexpected serious harm to patients. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides authorization for whether a trial may move forward at designated check points based on access to certain data from the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concurrent with clinical trials, companies usually complete additional animal studies and also must develop additional information about the chemistry and physical characteristics of the drug as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of product and, among other things, companies must develop methods for testing the identity, strength, quality and purity of the final product. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the drug does not undergo unacceptable deterioration over its shelf life.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expanded Access to an Investigational Drug for Treatment Use</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expanded access, sometimes called &#x201c;compassionate use,&#x201d; is the use of investigational products outside of clinical trials to treat patients with serious or immediately life-threatening diseases or conditions when there are no comparable or satisfactory alternative treatment options. The rules and regulations related to expanded access are intended to improve access to investigational products for patients who may benefit from investigational therapies. FDA regulations allow access to investigational products under an IND by the company or the treating physician for treatment purposes on a case-by-case basis for: individual patients (single-patient IND applications for treatment in emergency settings and non-emergency settings); intermediate-size patient populations; and larger populations for use of the investigational product under a treatment protocol or treatment IND application.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When considering an IND application for expanded access to an investigational product with the purpose of treating a patient or a group of patients, the sponsor and treating physicians or investigators will determine suitability when all of the following criteria apply: patient(s) have a serious or immediately life-threatening disease or condition, and there is no comparable or satisfactory alternative therapy to diagnose, monitor, or treat the disease or condition; the potential patient benefit justifies the potential risks of the treatment and the potential risks are not unreasonable in the context or condition to be treated; and the expanded use of the investigational drug for the requested treatment will not interfere with initiation, conduct, or completion of clinical investigations that could support marketing approval of the product or otherwise compromise the potential development of the product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no obligation for a sponsor to make its drug products available for expanded access; however, as required by the 21st Century Cures Act, or Cures Act, passed in 2016, if a sponsor has a policy regarding how it responds to expanded access requests, it must make that policy publicly available. Sponsors are required to make such policies publicly available upon the earlier of initiation of a Phase 2 or Phase 3 trial; or 15 days after the investigational drug or biologic receives designation as a breakthrough therapy, fast track product, or regenerative medicine advanced therapy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, on May 30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under FDA expanded access program. There is no obligation for a manufacturer to make its investigational products available to eligible patients as a result of the Right to Try Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Combination Rule for Fixed-Dose Combination Products</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the combination rule, the FDA may not file or approve an NDA for a fixed-dose combination product unless each component of a proposed drug product is shown to make a contribution to the claimed effects and the dosage of each</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">component (amount, frequency, duration) is safe and effective for the intended population. To satisfy these requirements, the FDA typically requires a clinical factorial study, designed to assess the effects attributable to each drug in the combination product. This is particularly true when the ingredients are directed at the same sign or symptom of the disease or condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA has accepted a variety of approaches to satisfy the combination rule. In December 2015, the FDA proposed regulations that would allow the agency to waive the requirements of the combination rule for certain drug products under particular circumstances. The FDA has not, to date, finalized these regulations, but the FDA has stated that factorial studies may be unethical (e.g., omitting a drug known to improve survival) or impractical (there may be too many components to conduct a factorial study, meaning the trial cannot be conducted). The FDA has also stated that it may be possible to use other types of clinical and nonclinical data and mechanistic information available to demonstrate the contributions of the individual active ingredients to the effect of the combination.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar requirements may be imposed on us by the EMA in the EU and comparable regulatory authorities in other jurisdictions. While no similar combination rule formally exists in Canada, Health Canada may consider the contributions of each component in a combination product in connection with review of the NDS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">NDA Submission and Marketing Approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assuming successful completion of the required clinical testing, the results of the preclinical and clinical studies, together with detailed information relating to the product&#x2019;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. In most cases, the submission of an NDA is subject to a substantial application user fee. The FDA will initially review an NDA for completeness before it accepts it for &#x201c;filing.&#x201d; Under the FDA&#x2019;s procedures, the agency has 60 days from its receipt of the NDA to determine whether the application will be accepted for filing based on the agency&#x2019;s threshold determination that the application is sufficiently complete to permit substantive review. Under the Prescription Drug User Fee Act, or PDUFA, guidelines that are currently in effect, the FDA has a goal of ten months from the date of &#x201c;filing&#x201d; of a standard NDA, for a new molecular entity to review and act on the submission, and six months from the filing date of a new molecular entity NDA with priority review. Accordingly, this review process typically takes 12 months and eight months, respectively from the date the NDA is submitted to the FDA. The FDA does not always meet its PDUFA goal dates for standard or priority NDAs, and the review process is often extended by FDA requests for additional information or clarification. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective for its intended use(s), with the latter determination being made on the basis of substantial evidence. This finding can be substantiated based on two adequate and well-controlled studies, or in certain circumstances on a single, large, multicenter, adequate and well-controlled study that is very persuasive or from a single adequate and well-controlled study together with confirmatory evidence. FDA regulations and guidance also allow for greater flexibility and tolerance for uncertainty in the context of rare and fatal diseases. The FDA also assesses whether the facility in which the product is manufactured, processed, packaged or held meets standards designed to assure the product&#x2019;s continued safety, quality and purity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, under the Pediatric Research Equity Act of 2003, or PREA, as amended, certain NDAs or supplements to an NDA must contain data that are adequate to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. A sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration must submit an initial Pediatric Study Plan, or PSP, within 60 days of an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before initiation of the Phase 3 or Phase 2/3 study. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs. PREA does not apply to a drug for an indication for which orphan drug designation has been granted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the application must be resubmitted with the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may refer an application for a novel drug or a drug that presents difficult questions of safety or efficacy to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA also may require the submission of a Risk Evaluation and Mitigation Strategy, or REMS, if it determines that a REMS is necessary to ensure that the benefits of the drug outweigh its risks and to assure the safe use of the drug. A REMS may include one or more elements, including medication guides, physician communication plans, patient package insert and/or elements to assure safe use, such as restricted distribution methods, patient registries or other risk minimization tools. The FDA determines the requirement for a REMS, as well as the specific REMS provisions, on a case-by-case basis. If the FDA concludes a REMS is needed, the sponsor of the NDA must submit a proposed REMS. The FDA will not approve the NDA without a REMS, if required.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with cGCP requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a Complete Response Letter. A Complete Response Letter generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for FDA to reconsider the application. If a Complete Response Letter is issued, the applicant may either resubmit the NDA, addressing all of the deficiencies identified in the letter, or withdraw the application. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#x2019;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if the FDA approves a product, it may limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#x2019;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Orphan Drug Designation and Exclusivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug product intended to treat a rare disease or condition, which is generally a disease or condition that affects either (i) fewer than 200,000 individuals in the U.S., or (ii) more than 200,000 individuals in the U.S. and for which there is no reasonable expectation that the cost of developing and making the product available in the U.S. for this type of disease or condition will be recovered from sales of the product. A company must request orphan drug designation before submitting an NDA. If the request is granted, the FDA will disclose the identity of the therapeutic agent and its potential use. Orphan drug designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a product with orphan status receives the first FDA approval for the disease or condition for which it has such designation or for a select indication or use within the rare disease or condition for which it was designated, the product is entitled to orphan product exclusivity. Orphan product exclusivity means that the FDA may not approve any other applications to market the same product for the same indication for seven years, except in certain limited circumstances. If a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">drug designated as an orphan drug ultimately receives marketing approval for an indication broader than what it was designated for, it may not be entitled to exclusivity. Orphan exclusivity will not bar approval of another product under certain circumstances, including if a subsequent product with the same active ingredient for the same indication is shown to be clinically superior to the approved product on the basis of greater efficacy or safety, or providing a major contribution to patient care, or if the company with orphan drug exclusivity is not able to meet market demand. Further, the FDA may approve more than one product for the same orphan indication or disease as long as the products contain different active ingredients. Moreover, competitors may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the orphan drug has exclusivity. U.S. lawmakers have also recently raised the possibility that regulatory or legislative changes might need to be made to the Orphan Drug Act to foster competition. This includes the introduction of legislation that, if adopted into law, would require us to demonstrate to the FDA that AMX0035 would be economically unviable when facing competition to maintain our exclusivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expedited Development and Priority Review Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and accelerated approval, and the purpose of these programs is to either expedite the development or review of important new drugs to get them to patients earlier than under standard FDA development and review procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA has a FastTrack program that is intended to expedite or facilitate the process for reviewing new drugs that meet certain criteria. Specifically, new drugs are eligible for Fast Track designation if they are intended to treat a serious or life threatening condition and preclinical or clinical data demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to both the product and the specific indication for which it is being studied. The sponsor can request the FDA to designate the product for Fast Track status any time before receiving NDA approval, but ideally no later than the pre-NDA meeting. Fast Track designation provides increased opportunities for sponsor interactions with the FDA during preclinical and clinical development, in addition to the potential for rolling review once a marketing application is filed, meaning that the agency may review portions of the marketing application before the sponsor submits the complete application, as well as priority review, discussed below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, a drug may be eligible for designation as a breakthrough therapy if the product is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening condition and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over currently approved therapies on one or more clinically significant endpoints. The benefits of Breakthrough Therapy designation include the same benefits as Fast Track designation, plus intensive guidance from the FDA to ensure an efficient drug development program. A product may also be eligible for priority review if it treats a serious or life-threatening condition and, if approved, would provide a significant improvement in safety and effectiveness compared to available therapies. The FDA determines at the time that the marketing application is submitted, on a case-by-case basis, whether the proposed drug represents a significant improvement in treatment, prevention or diagnosis of disease when compared with other available therapies. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug designated for priority review in an effort to facilitate the review and to shorten the FDA&#x2019;s goal for taking action on an NDA for a new molecular entity from ten months to six months from the date of filing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A product may also be eligible for accelerated approval if it treats a serious or life-threatening disease or condition, generally provides a meaningful advantage over available therapies and demonstrates an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, or IMM, that is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of accelerated approval, the FDA may require that a sponsor perform adequate and well-controlled post-marketing confirmatory trials with due diligence and, under the Food and Drug Omnibus Reform Act of 2022, or FDORA, the FDA is now permitted to require, as appropriate, that such trials be underway prior to approval or within a specific time period after the date accelerated approval is granted. Under FDORA, the FDA also has increased authority for expedited procedures to withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, the FDA generally requires, unless otherwise informed by the agency, pre-approval of promotional materials for products considered for accelerated approval, which could adversely impact the timing of the commercial launch of the product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. Fast Track designation, Breakthrough Therapy designation and Priority Review designation do not change the standards for approval, but may expedite the development or review process. Drugs granted accelerated approval also must meet the same statutory standards for safety and effectiveness as those granted traditional approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">U.S. Non-Patent Exclusivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data exclusivity provisions under the FDCA can delay the submission or the approval of certain follow-on applications. The FDCA provides a five-year period of data exclusivity within the U.S. to the first applicant to gain approval of an NDA for an NCE. A drug is an NCE if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an ANDA for a generic version of the drug or a 505(b)(2) NDA for another version of such drug where the applicant does not own or have a legal right of reference to all the data required for approval. However, such a follow-on application may be submitted after four years if it contains a certification of patent invalidity or non-infringement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA has previously taken the position that NCE exclusivity is not available for fixed-dose combination products if one of the active moieties in the combination product had been previously approved in a drug product. In October 2014, however, the FDA reversed that position when it issued final guidance stating that an application for a fixed-dose combination product will be eligible for 5-year NCE exclusivity if it contains a drug substance with a single, new active moiety, even if the fixed-combination also contains a drug substance with a previously approved active moiety.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDCA also provides three years of market exclusivity for an NDA, 505(b)(2) NDA or supplement to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, new indications, dosages or strengths of an existing drug. This three-year exclusivity period covers only the conditions of use associated with the new clinical investigations and does not prohibit the FDA from approving follow-on applications that do not reference the protected clinical data. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pediatric exclusivity is another type of regulatory market exclusivity in the U.S. Pediatric exclusivity, if granted, adds six months to existing regulatory exclusivity periods or listed patents. This six-month exclusivity may be granted based on the voluntary completion of a pediatric trial in accordance with an FDA-issued &#x201c;Written Request&#x201d; for such a trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Post-approval Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval. There are continuing, annual user fee requirements for any marketed products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#x2019;s safety and effectiveness after commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA regulations require that products be manufactured in specific facilities and in accordance with cGMP regulations which require, among other things, quality control and quality assurance, the maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs, including those supply products, ingredients and components thereof, are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Manufacturers and other parties involved in the drug supply chain for prescription drug products must also comply with product tracking and tracing requirements and for notifying FDA of counterfeit, diverted, stolen and intentionally adulterated products or products that are otherwise unfit for distribution in the U.S. Changes to the manufacturing process are strictly</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Once an approval of a drug is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market, such as if, based on new evidence of clinical experience not contained in the application or not available to the FDA until after the application was approved, there is a lack of substantial evidence that the approved product will have the effect it is purported or represented to have under the conditions of use prescribed, recommended, or suggested in its labeling. Sponsors may also voluntarily withdrawal their approved products from the market for similar reasons. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Any of these limitations on approval or marketing could restrict the commercial promotion, distribution, prescription or dispensing of products. Other potential consequences include, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fines, warning letters or holds on post-approval clinical trials; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or withdrawal of product approvals; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product seizure or detention, or refusal to permit the import or export of products; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted by a manufacturer and any third parties acting on behalf of a manufacturer only for the approved indications and in a manner consistent with the approved label for the product. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other U.S. Healthcare Laws</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare providers, physicians, and third-party payors will play a primary role in the recommendation and prescription of drug products for which we obtain marketing approval. Arrangements with third-party payors, healthcare providers and physicians, as well as patients and other third-parties, in connection with the clinical research, sales, marketing and promotion of products, once approved, and related activities, may expose a pharmaceutical manufacturer to broadly applicable fraud and abuse and other healthcare laws and regulations. In the U.S., these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency, and patient data privacy and security laws and regulations, including but not limited to those described below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Anti-Kickback Statute, or AKS, which makes it illegal for any person or entity, including a prescription drug manufacturer (or a party acting on its behalf) to knowingly and willfully solicit, receive, offer or pay any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, that is intended to induce or reward, referrals including the purchase, recommendation, order or prescription of a particular drug for which payment may be made under a federal healthcare program, such as the Medicare and Medicaid programs. The AKS has been interpreted to apply to arrangements between therapeutic product manufacturers on one hand and prescribers, purchasers, and formulary managers on the other. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Further, courts have found that if &#x201c;one purpose&#x201d; of remuneration is to induce referrals, the AKS is violated. In addition, the government may assert that a claim including items or services resulting from a violation of the AKS constitutes a false or fraudulent claim for purposes of the federal False Claims Act, or FCA; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal civil and criminal false claims laws, including the FCA, which can be enforced by private citizens through &#x201c;qui tam&#x201d; or &#x201c;whistleblower&#x201d; actions, and civil monetary penalty laws, which impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid, or other federal health care programs that are false or </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:5.602%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Pharmaceutical and other healthcare companies have been, and continue to be, prosecuted under these laws, among other things, for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product and for causing false claims to be submitted because of the companies&#x2019; marketing of the product for unapproved, off-label, and thus generally non-reimbursable, uses. Similar to the AKS, a person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Like the AKS, the Patient Protection and Affordable Care Act, or the ACA, amended the intent standard for certain healthcare fraud statutes under HIPAA such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates that perform services for them that involve the creation, use, receipt, maintenance or disclosure of individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#x2019; fees and costs associated with pursuing federal civil actions; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which require manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program to report annually to the Centers for Medicare and Medicaid Services, or CMS, under the Open Payments Program, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), to certain non-physician providers such as physician assistants and nurse practitioners, and to teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration of pharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available, it is possible that some of a pharmaceutical manufacturer&#x2019;s business activities could be subject to challenge under one or more of such laws. Efforts to ensure that business arrangements comply with applicable healthcare laws involve substantial costs. It is possible that governmental and enforcement authorities will conclude that a pharmaceutical manufacturer&#x2019;s business practices do not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against a pharmaceutical manufacturer, and it is not successful in defending itself or asserting its rights, those actions could have a significant impact on its business, including the imposition of significant civil, criminal and administrative penalties, damages, disgorgement, imprisonment, monetary fines, possible exclusion from participation in Medicare, Medicaid and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other federal healthcare programs, reporting obligations and oversight if we become subject to integrity and oversight agreements to resolve allegations of non-compliance, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of operations, any of which could adversely affect a pharmaceutical manufacturer&#x2019;s ability to operate its business and the results of operations. In addition, commercialization of any drug product outside the U.S. will also likely be subject to foreign equivalents of the healthcare laws mentioned above, among other foreign laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., numerous federal and state laws and regulations, including state data breach notification laws, state and federal health information privacy laws, and federal and state consumer protection laws, govern the collection, use, disclosure, and protection of health-related and other personal information. For example California recently enacted the California Consumer Privacy Act, or CCPA, which creates new individual privacy rights for California consumers (as defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA will require covered companies to provide certain disclosures to consumers about its data collection, use and sharing practices, and to provide affected California residents with ways to opt-out of certain sales or transfers of personal information. The CCPA went into effect on January 1, 2020, and the California State Attorney General has submitted various versions of final regulations. Since July 1, 2020, the California State Attorney General has had the authority to commence enforcement actions against violators. Further, a California privacy law, the California Privacy Rights Act, or CPRA, was passed by California voters on November 3, 2020 and entered into force on January 1, 2023. The CPRA creates additional obligations with respect to processing and storing personal information. We will continue to monitor developments related to the CPRA and anticipate additional costs and expenses associated with CPRA compliance. Other U.S. states also are considering omnibus privacy legislation (with one additional law already passed in Colorado, Connecticut, Utah and Virginia) and industry organizations regularly adopt and advocate for new standards in these areas. While the CCPA, as modified by the CPRA contain an exception for certain activities involving PHI under HIPAA, we cannot yet determine the impact the CCPA, CPRA or other such future laws, regulations and standards may have on our business, as these laws either do not yet apply to us or are not yet in effect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event we decide to conduct clinical trials or continue to enroll subjects in our ongoing or future clinical trials, we may be subject to additional privacy restrictions, under state and federal law or other obligations. We also may become subject to laws in other countries, including the General Data Protection Regulation in Europe.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Current and Future U.S. Healthcare Reform Legislation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payors, whether domestic or foreign, or governmental or private, are developing increasingly sophisticated methods of controlling healthcare costs and those methods are not always specifically adapted for new technologies such as gene therapy and therapies addressing rare diseases such as those we are developing. In both the U.S. and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to the health care system that could impact our ability to sell our products profitably. In particular, in 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, was enacted, which, among other things, subjected biologic products to potential competition by lower-cost biosimilars; addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program; extended the Medicaid Drug Rebate program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations; subjected manufacturers to new annual fees and taxes for certain branded prescription drugs; created the Medicare Part D coverage gap discount program, in which manufacturers must agree to 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#x2019;s outpatient drugs to be covered under Medicare Part D; and provided incentives to programs that increase the federal government&#x2019;s comparative effectiveness research.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the ACA. On June 17, 2021, the Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#x2019;s decision, President Biden issued an Executive Order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The Executive Order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. In addition, in February 2023, HHS issued a proposal in response to an October 2022 executive order from President Biden that includes a proposed prescription drug pricing model that will test whether targeted Medicare payment adjustments will sufficiently incentivize manufacturers to complete confirmatory trials for drugs approved through FDA&#x2019;s</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">accelerated approval pathway. It is unclear how these or other healthcare reform measures of the executive branch or other efforts, if any, will impact our business.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, other legislative changes have been proposed and adopted in the U.S. since the ACA was enacted. The Budget Control Act of 2011 and subsequence legislation, among other things, created measures for spending reductions by Congress that include aggregate reductions of Medicare payments to providers of 2% per fiscal year, which remain in effect through 2031. The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Inflation Reduction Act of 2022, or IRA, includes several provisions that may impact our business to varying degrees, including provisions that reduce the out-of-pocket spending cap for Medicare Part D beneficiaries from $7,050 to $2,000 starting in 2025, thereby effectively eliminating the coverage gap; impose new manufacturer financial liability on certain drugs under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs and biologics without generic or biosimilar competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January 1, 2032 the implementation of the HHS rebate rule that would have limited the fees that pharmacy benefit  managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one rare disease designation and for which the only approved indication is for that disease or condition. If a product receives multiple rare disease designations or has multiple approved indications, it may not qualify for the orphan drug exemption. The effects of the IRA on our business and the healthcare industry in general is not yet known.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Canadian Review and Approval Process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Canada, our small molecule product candidates and our research and development activities are primarily regulated by the Food and Drugs Act and the rules and regulations thereunder, which are enforced by Health Canada. Health Canada regulates, among other things, the research, development, testing, approval, manufacture, packaging, labeling, storage, recordkeeping, advertising, promotion, distribution, marketing, post-approval monitoring and import and export of pharmaceutical products. The drug approval process under Canadian laws requires licensing of manufacturing facilities, carefully controlled research and testing of products, government review and approval of experimental results prior to granting approval for commercial sale of drug products. Regulators also typically require that rigorous and specific standards such as cGMP, Good Laboratory Practices, or GLP, and Continuing Good Clinical Practices, or cGCP, are followed in the manufacture, nonclinical development and clinical development, respectively, of any drug product. The processes for obtaining regulatory approvals in Canada, along with subsequent compliance with applicable statutes and regulations, require the expenditure of substantial time and financial resources. For further information, see &#x201c;Risk Factors.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The principal steps required for drug approval in Canada are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Nonclinical Safety Pharmacology and Toxicology Studies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-clinical studies are conducted </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and in animals to evaluate pharmacokinetics, metabolism and possible toxic effects to provide evidence of the safety of the drug candidate prior to its administration to humans in clinical studies and throughout development. Such studies are conducted in accordance with applicable laws and GLP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Trials</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar regulations apply in Canada regarding clinical trials as in the U.S. In Canada, Research Ethics Boards, or REBs, are used to review and approve clinical trial plans when trials are performed in Canada. For clinical trials that involve the administration of an investigational new drug to human subjects, an application must be made to Health Canada and approved before the trial can commence at a Canadian site. Trials are performed under the supervision of qualified investigators, in most cases a physician, in accordance with cGCP requirements. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, the trial procedures, the parameters to be used in monitoring safety and the efficacy criteria to be evaluated and a statistical analysis plan. The protocol and the informed consent forms that are signed by subjects, are reviewed and approved by the REB affiliated with the site where the trial will be conducted. Human clinical trials for new drugs are typically conducted in three sequential phases, Phase 1, Phase 2 and Phase 3, as discussed above in the context of government regulation in the U.S. Similar to the FDA, Health Canada also accepts foreign clinical</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">trial data in support of marketing applications. Additionally, the manufacture of investigational drugs for the conduct of human clinical trials is subject to cGMP requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Drug Submission</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Canada, upon successful completion of Phase 3 clinical trials or earlier stage trials if agreeable to Health Canada, the company sponsoring a new drug then assembles all the nonclinical and clinical data and other testing relating to the product&#x2019;s pharmacology, chemistry, manufacture, and controls, and submits it to Health Canada as part of an NDS The NDS is then reviewed by Health Canada.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Health Canada will not approve the new drug unless compliance with cGMP&#x2014;a quality system regulating manufacturing&#x2014;is satisfactory, and the NDS contains data that provide substantial evidence that the drug is safe and effective in the indication and at the dosage studied. If Health Canada is satisfied that the NDS contains sufficient information, then marketing authorization for the new drug may be granted. In Canada, the marketing authorization for a new drug is called a Notice of Compliance, or NOC.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The testing required to generate data for inclusion in an NDS, and approval process for an NDS, requires substantial time, effort and financial resources, and may take several years to complete. This is necessary to help ensure the efficacy, safety and quality of the product. Data obtained from nonclinical and clinical testing are not always conclusive and may be susceptible to varying interpretations, which could delay, limit or prevent regulatory approval. Health Canada may not grant approval of an NDS on a timely basis, or at all. In Canada, NDSs are subject to user fees and these fees are typically increased annually to reflect inflation.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Health Canada has authority to grant conditional marketing approval following the review of an NDS for a new drug that would treat a serious, life-threatening or severely debilitating disease or condition. A Notice of Compliance with conditions (NOC/c) can be granted when there is promising evidence of clinical effectiveness based on the available data that the drug has the potential to provide (i) effective treatment, prevention or diagnosis of a disease or condition for which no drug is presently marketed in Canada or (ii) a significant increase in efficacy and/or significant decrease in risk such that the overall benefit/risk profile is improved over existing therapies, preventatives or diagnostic agents for a disease or condition that is not adequately managed by a drug marketed in Canada. When a NOC/c is granted, the company to which the NOC/c is issued must make certain commitments to Health Canada, which typically include a requirement to provide confirmatory data to Health Canada to support the safe use and efficacy of the new drug.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if Health Canada approves a product candidate, it may limit the approved indications for use of the product candidate, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#x2019;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution restrictions or other risk management mechanisms.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Health Canada may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements, notification, and review and approval before the change can be implemented. Further, should new safety information arise, additional testing and/or regulatory notification may be required, or Health Canada may require an update to the product label that impacts the scope of the approved indications or other conditions for clinical use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">European Union Approval Process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process governing approval of medicinal products in the EU generally follows the same lines as in the U.S. It entails satisfactory completion of preclinical studies and adequate and well-controlled clinical trials to establish the safety and efficacy of the product for each proposed indication. It also requires the submission to the relevant competent authorities of an MAA and granting of a marketing authorization by these authorities before the product can be marketed and sold in the EU Following the UK&#x2019;s departure from the EU, a separate marketing authorization is required in order to place medicinal</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">products on the market in Great Britain (under the Northern Ireland Protocol, the EU regulatory framework continues to apply in Northern Ireland and centralized EU authorizations continue to be recognized).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Trial Approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2014, the EU adopted the new Clinical Trials Regulation (EU) No 536/2014, which replaced the Clinical Trials Directive 2001/20/EC on January 31, 2022. The transitory provisions of the new Regulation provide that, by January 31, 2025, all ongoing clinical trials must have transitioned to the new Regulation. The new Regulation overhauls the system of approvals for clinical trials in the EU. Specifically, it is directly applicable in all Member States (meaning that no national implementing legislation in each Member State is required), and aims at simplifying and streamlining the approval of clinical trials in the EU. The main characteristics of the new Regulation include: a streamlined application procedure via a single-entry point through the Clinical Trials Information System, or CTIS; a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure for the assessment of applications for clinical trials, which is divided in two parts (Part I contains scientific and medicinal product documentation and Part II contains the national and patient-level documentation). Part I is assessed by a coordinated review by the competent authorities of all Member States of the European Union, or EU Member States, in which an application for authorization of a clinical trial has been submitted (Concerned Member States) of a draft report prepared by a Reference Member State. Part II is assessed separately by each Concerned Member State. Strict deadlines have been established for the assessment of clinical trial applications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">PRIME Designation in the EU</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2016, the EMA launched an initiative to facilitate development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIority MEdicines, or PRIME, scheme is intended to encourage drug development in areas of unmet medical need and provides accelerated assessment of products representing substantial innovation where the marketing authorization application will be made through the centralized procedure. Eligible products must target conditions for which there is an unmet medical need (there is no satisfactory method of diagnosis, prevention or treatment in the EU or, if there is, the new medicine will bring a major therapeutic advantage) and they must demonstrate the potential to address the unmet medical need by introducing new methods of therapy or improving existing ones. Products from small- and medium-sized enterprises, or SMEs, may qualify for earlier entry into the PRIME scheme than larger companies. Many benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and accelerated MAA assessment once a dossier has been submitted. Importantly, a dedicated contact and rapporteur from the EMA&#x2019;s CHMP, or Committee for Advanced Therapies, are appointed early in PRIME scheme facilitating increased understanding of the product at EMA&#x2019;s Committee level. A kick-off meeting initiates these relationships and includes a team of multidisciplinary experts at the EMA to provide guidance on the overall development and regulatory strategies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fixed-Dose Combination Guideline</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As with the FDA, the EMA has also issued guidelines to address review and approval of fixed-dose combination products. This EMA&#x2019;s Guideline on clinical development of fixed combination medicinal products came into force on October 1, 2017. The basic scientific requirements for any fixed combination medicinal product are justification of the pharmacological and medical rationale for the combination, and establishment of the evidence base for the relevant contribution of all active substances to the desired therapeutic effect (efficacy and/or safety) and a positive benefit-risk for the combination in the targeted indication. For products that involve initial combination of two active ingredients, the EMA has indicated that the design of clinical efficacy/safety studies to support a fixed combination medicinal product application for initial treatment will depend on its rationale, specifically to achieve superior efficacy or improved safety compared to use of the single active substances. In situations when it has been established that monotherapy will not be adequate, appropriate or ethical to reach the desired therapeutic effect, initial use of combination therapy should be easily justified (e.g.,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIV).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Marketing Authorization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To obtain a marketing authorization for a product European Economic Area (i.e., the EU as well as Iceland, Liechtenstein and Norway), or EEA, an applicant must submit an MAA either under a centralized procedure administered by the EMA, or one of the procedures administered by competent authorities in the EU Member States (decentralized procedure,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">national procedure or mutual recognition procedure). A marketing authorization may be granted only to an applicant established in the EEA. Regulation (EC) No 1901/2006 provides that prior to obtaining a marketing authorization in the EU, applicants have to demonstrate compliance with all measures included in an EMA-approved Paediatric Investigation Plan, or PIP, covering all subsets of the pediatric population, unless the EMA has granted (1) a product-specific waiver, (2) a class waiver or (3) a deferral for one or more of the measures included in the PIP (for example, when this data is not needed or appropriate because the product is likely to be ineffective or unsafe in children, the disease or condition for which the product is intended occurs only in adult populations, or when the product does not represent a significant therapeutic benefit over existing treatments for pediatric patients). Products that are granted a marketing authorization with the results of the pediatric clinical trials conducted in accordance with the PIP (even where such results are negative) are eligible for six months&#x2019; supplementary protection certificate, or SPC, extension (provided an application for such extension is made at the same time as filing the SPC application for the product, or at any point up to 2 years before the SPC expires).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The centralized procedure provides for the grant of a single marketing authorization by the European Commission that is valid across the EEA. Pursuant to Regulation (EC) No 726/2004, the centralized procedure is compulsory for specific products, including for medicines produced by certain biotechnological processes, products designated as orphan medicinal products, advanced therapy medicinal products (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">i.e.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> gene therapy, somatic-cell therapy and tissue-engineered medicinal products)and products with a new active substance indicated for the treatment of certain diseases, including HIV, AIDS, cancer, neurodegenerative disorders, diabetes, auto-immune and other immune dysfunctions and viral diseases. For products with a new active substance indicated for the treatment of other diseases and products that are highly innovative or for which a centralized process is in the interest of public health, the centralized procedure is optional. The centralized procedure may at the request of the applicant also be used in certain other cases. We anticipate that the centralized procedure will be mandatory for the product candidates we are developing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the centralized procedure, the CHMP is responsible for conducting the initial assessment of a product and for several post-authorization and maintenance activities, such as the assessment of modifications or extensions to an existing marketing authorization. Under the centralized procedure, the maximum timeframe for the evaluation of an MAA is 210 days, excluding clock stops, when additional information or written or oral explanation is to be provided by the applicant in response to questions of the CHMP. Clock stops may extend the timeframe of evaluation of an MAA considerably beyond 210 days. Accelerated evaluation might be granted by the CHMP in exceptional cases, when a medicinal product is of major interest from the point of view of public health and in particular from the viewpoint of therapeutic innovation. If the CHMP accepts such request, the time limit of 210 days will be reduced to 150 days (excluding clock stops) but it is possible that the CHMP can revert to the standard time limit for the centralized procedure if it considers that it is no longer appropriate to conduct an accelerated assessment. At the end of this period, the CHMP provides a scientific opinion on whether or not a marketing authorization should be granted in relation to a medicinal product. Where the CHMP gives a positive opinion, the EMA provides the opinion together with supporting documentation to the European Commission, who makes the final decision to grant a marketing authorization, which is issued within 67 days of receipt of the EMA&#x2019;s recommendation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The European Commission may grant a so-called &#x201c;marketing authorization under exceptional circumstances&#x201d;. Such authorization is intended for products for which the applicant can demonstrate that it is unable to provide comprehensive data on the efficacy and safety under normal conditions of use, because either (i) the indications for which the product in question is intended are encountered so rarely that the applicant cannot reasonably be expected to provide comprehensive evidence; (ii) in the present state of scientific knowledge, comprehensive information cannot be provided; or (iii) it would be contrary to generally accepted principles of medical ethics to collect such information. Consequently, marketing authorization under exceptional circumstances may be granted subject to certain specific obligations, which may include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the applicant must complete an identified program of studies within a time period specified by the competent authority, the results of which form the basis of a reassessment of the benefit/risk profile; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the medicinal product in question may be supplied on medical prescription only and may in certain cases be administered only under strict medical supervision, possibly in a hospital and in the case of a radiopharmaceutical, by an authorized person; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the package leaflet and any medical information must draw the attention of the medical practitioner to the fact that the particulars available concerning the medicinal product in question are as yet inadequate in certain specified respects. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A marketing authorization under exceptional circumstances is subject to annual review to reassess the risk-benefit balance in an annual reassessment procedure. Continuation of the authorization is linked to the annual reassessment and a negative assessment could potentially result in the marketing authorization being suspended or revoked. The renewal of a marketing authorization of a medicinal product under exceptional circumstances, however, follows the same rules as a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;normal&#x201d; marketing authorization. Thus, a marketing authorization under exceptional circumstances is granted for an initial five years, after which the authorization will become valid indefinitely, unless the EMA decides that safety grounds merit one additional five-year renewal.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unlike the centralized authorization procedure, the decentralized marketing authorization procedure requires a separate application to, and leads to separate approval by, the competent authorities of each EU Member State in which the product is to be marketed. This application is identical to the application that would be submitted to the EMA for authorization through the centralized procedure. The reference EU Member State prepares a draft assessment and drafts of the related materials within 120 days after receipt of a valid application. The resulting assessment report is submitted to the concerned EU Member States who, within 90 days of receipt, must decide whether to approve the assessment report and related materials. If a concerned EU Member State cannot approve the assessment report and related materials due to concerns relating to a potential serious risk to public health, disputed elements may be referred to the European Commission, whose decision is binding on all EU Member States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The mutual recognition procedure similarly is based on the acceptance by the competent authorities of the EU Member States of the marketing authorization of a medicinal product by the competent authorities of other EU Member States. The holder of a national marketing authorization may submit an application to the competent authority of an EU Member State requesting that this authority recognize the marketing authorization delivered by the competent authority of another EU Member State.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conditional Marketing Authorization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The European Commission may also grant a so-called &#x201c;conditional marketing authorization&#x201d; prior to obtaining the comprehensive clinical data required for an application for a full marketing authorization. Such conditional marketing authorizations may be granted for product candidates intended for treating, preventing or diagnosing seriously debilitating or life-threatening diseases (including medicines designated as orphan medicinal products) or in a public health emergency, if (i) the risk-benefit balance of the product candidate is positive, (ii) it is likely that the applicant will be in a position to provide the required comprehensive clinical trial data post-authorization, (iii) the product fulfills an unmet medical need and (iv) the benefit to public health of the immediate availability on the market of the medicinal product concerned outweighs the risk inherent in the fact that additional data are still required. A conditional marketing authorization may contain specific obligations to be fulfilled by the marketing authorization holder, including obligations with respect to the completion of ongoing or new studies, and with respect to the collection of pharmacovigilance data. Conditional marketing authorizations are valid for one year, and may be renewed annually, if the risk-benefit balance remains positive, and after an assessment of the need for additional or modified conditions and/or specific obligations. The timelines for the centralized procedure described above also apply with respect to the review by the CHMP of applications for a conditional marketing authorization. A conditional marketing authorization can be converted into a standard centralized marketing authorization (no longer subject to specific obligations) once the marketing authorization holder fulfils the obligations imposed and the complete data confirm that the medicine&#x2019;s benefits continue to outweigh its risks.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Regulatory Data Protection in the EU</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the EU, innovative medicinal products approved on the basis of a complete and independent data package qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. Data exclusivity, if granted, prevents applicants for authorization of generics or biosimilars of these innovative products from referencing the innovator&#x2019;s preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization, for a period of eight years from the date on which the reference product was first authorized in the EU. During an additional two-year period of market exclusivity, a generic or biosimilar MAA can be submitted and authorized, and the innovator&#x2019;s data may be referenced, but no generic or biosimilar medicinal product can be placed on the EU market until the expiration of the market exclusivity. The overall ten-year period will be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. Even if a compound is considered to be an innovative medical product so that the innovator gains the prescribed period of data exclusivity, another company nevertheless could also market another version of the product if such company obtained marketing authorization based on an MAA with a complete and independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Periods of Authorization and Renewals</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A marketing authorization has an initial validity for five years in principle. The marketing authorization may be renewed after five years on the basis of a re-evaluation of the risk-benefit balance by the EMA (for a centrally authorized product) or by the competent authority of the relevant EU Member State (for a nationally authorized product). To this end, the marketing authorization holder must provide the EMA or the competent authority with a consolidated version of the file in respect of quality, safety and efficacy, including all variations introduced since the marketing authorization was granted, at least nine months before the marketing authorization ceases to be valid. The European Commission or the competent authorities of the EU Member States may decide, on justified grounds relating to pharmacovigilance, to proceed with one further five-year period of marketing authorization. Once subsequently definitively renewed, the marketing authorization shall be valid for an unlimited period. Any authorization which is not followed by the actual placing of the medicinal product on the EU market (in case of centralized procedure) or on the market of the authorizing EU Member State (for a nationally authorized product) within three years after authorization, or if the product is removed from the market for three consecutive years, ceases to be valid (the so-called sunset clause).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Orphan Drug Designation and Exclusivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulation (EC) No. 141/2000, as implemented by Regulation (EC) No. 847/2000 provides that a medicinal product can be designated as an orphan medicinal product by the European Commission if its sponsor can establish that: (1) the product is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (2) either (i) such condition affects no more than five in ten thousand persons in the EU when the application is made, or (ii) without incentives it is unlikely that the marketing of the product in the EU would generate sufficient return to justify the necessary investment in its development; and (3) there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the EU or, if such method exists, the product will be of significant benefit to those affected by that condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Once authorized, orphan medicinal products are entitled to ten years of market exclusivity in all EU Member States and a range of other benefits during the development and regulatory review process including scientific assistance for study protocols, authorization through the centralized marketing authorization procedure and a reduction or elimination of registration and marketing authorization fees. During the period of market exclusivity, a marketing authorization may only be granted for a &#x201c;similar medicinal product&#x201d; with the same orphan indication if: (i) the marketing authorization holder for the original orphan medicinal product consents to the authorization of the second orphan medicinal product; (ii) the manufacturer of the original orphan medicinal product is unable to supply sufficient quantities of the product; or (iii) it is established that the second product is safer, more effective or otherwise clinically superior to the original orphan medicinal product. A &#x201c;similar medicinal product&#x201d; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. The period of market exclusivity may, in addition, be reduced to six years if at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation because, for example, the original orphan medicinal product is sufficiently profitable not to justify maintenance of market exclusivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Regulatory Requirements After a Marketing Authorization has been Obtained</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Where an authorization for a medicinal product in the EU is obtained, the holder of the marketing authorization is required to comply with a range of requirements applicable to the manufacturing, marketing, promotion and sale of medicinal products. These include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with the EU&#x2019;s stringent pharmacovigilance or safety reporting rules must be ensured. These rules can impose post-authorization studies and additional monitoring obligations. </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The manufacturing of authorized medicinal products, for which a separate manufacturer&#x2019;s license is mandatory, must also be conducted in strict compliance with the applicable EU laws, regulations and guidance, including Directive 2001/83/EC, Directive 2003/94/EC, Regulation (EC) No 726/2004 and the European Commission Guidelines for Good Manufacturing Practice. These requirements include compliance with EU cGMP standards when manufacturing medicinal products and active pharmaceutical ingredients, including the manufacture of </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:5.602%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">active pharmaceutical ingredients outside of the EU with the intention to import the active pharmaceutical ingredients into the EU.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The marketing and promotion of authorized medicinal products, including industry-sponsored continuing medical education and advertising directed toward the prescribers of medicinal products and/or the general public, are strictly regulated in the EU notably under Directive 2001/83EC, as amended, and are also subject to EU Member State national laws. Direct-to-consumer advertising of prescription medicines is prohibited across the EU.</span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The aforementioned EU rules are generally applicable in the EEA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Data Protection Regulation in the European Economic Area and United Kingdom</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The collection, use, disclosure, transfer, or other processing of personal data regarding individuals in the EEA, including personal health data, is subject to the EU General Data Protection Regulation, or EU GDPR and similar processing of personal data regarding individuals in the UK is subject to the UK General Data Protection Regulation, or UK GDPR, and the UK Data Protection Act 2018. In this Annual Report, GDPR refers to both the EU GDPR and the UK GDPR, unless specified otherwise. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to countries outside the EEA/UK, including the U.S., and permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#x20ac;20 million (&#163;17.5 million) or 4% of annual global revenues, whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. Compliance with the GDPR will be a rigorous and time-intensive process that may increase the cost of doing business or require companies to change their business practices to ensure full compliance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Brexit and the Regulatory Framework in the United Kingdom</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The UK formally left the EU (commonly referred to as &#x201c;Brexit&#x201d;) on January 31, 2020, and the EU and the UK have concluded a trade and cooperation agreement, or TCA, which was provisionally applicable since January 1, 2021 and has been formally applicable since May 1, 2021. The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal products and GMP documents issued, but does not provide for wholesale mutual recognition of UK and EU pharmaceutical regulations. At present, Great Britain has implemented EU legislation on the marketing, promotion and sale of medicinal products through the Human Medicines Regulations 2012 (as amended) (under the Northern Ireland Protocol, the EU regulatory framework continues to apply in Northern Ireland). Except in respect of the new EU Clinical Trials Regulation, the regulatory regime in Great Britain therefore largely aligns with EU regulations, however it is possible that these regimes will diverge more significantly in future now that Great Britain&#x2019;s regulatory system is independent from the EU and the TCA does not provide for mutual recognition of UK and EU pharmaceutical legislation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pricing Decisions for Approved Products</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the EU, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies or so-called health technology assessments, in order to obtain reimbursement or pricing approval. For example, EU Member States have the option to restrict the range of products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. EU Member States may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other EU Member States allow companies to fix their own prices for products, but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. Recently, many countries in the EU have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage health care expenditures, especially in light of the severe fiscal and debt crises experienced by many countries in the EU. The downward pressure on health care costs in general, particularly prescription products, has become intense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result, increasingly high barriers are being erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various EU Member States, and parallel trade, i.e., arbitrage between low-priced and high-priced EU Member States, can further reduce prices. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Rest of the World Regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For other countries outside of Canada, the EU and the U.S., such as countries in Eastern Europe, Latin America or Asia, the requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. Additionally, the clinical trials must be conducted in accordance with GCP requirements and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Coverage and Reimbursement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successful commercialization of new drug products depends in part on the extent to which reimbursement for those drug products will be available from government health administration authorities, private health insurers, and other organizations. In the U.S., government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which drug products they will pay for and establish reimbursement levels. The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford a drug product. Sales of drug products depend substantially, both domestically and abroad, on the extent to which the costs of drugs products are paid for by health maintenance, managed care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular drug products. Third-party payors are increasingly challenging the price, examining the medical necessity, and reviewing the cost-effectiveness of medical products, therapies and services, in addition to questioning their safety and efficacy. Obtaining reimbursement for our products may be particularly difficult because of the higher prices often associated with branded drugs and drugs administered under the supervision of a physician. We may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain FDA and foreign approvals. These studies could result in delays or disadvantageous coverage for products we develop. Our product candidates may not be considered medically necessary or cost-effective. Obtaining coverage and reimbursement approval of a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the use of our product on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement will be obtained. A payor&#x2019;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#x2019;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the product. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on its investment in product development. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize any product candidate that we successfully develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In many countries, the prices of drug products are subject to varying price control mechanisms as part of national health systems. In general, the prices of drug products under such systems are substantially lower than in the U.S. Other countries allow companies to fix their own prices for drug products, but monitor and control company profits. Accordingly, in markets outside the U.S., the reimbursement for drug products may be reduced compared with the U.S.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., the principal decisions about reimbursement for new drug products are typically made by CMS, an agency within the HHS. CMS decides whether and to what extent a new drug product will be covered and reimbursed under Medicare, and private payors tend to follow CMS to a substantial degree. However, no uniform policy of coverage and reimbursement for drug products exists among third-party payors and coverage and reimbursement levels for drug products</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">can differ significantly from payor to payor. Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#x2019;s determination that use of a drug product is:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a covered benefit under its health plan; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safe, effective and medically necessary; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">appropriate for the specific patient; </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cost-effective; and </span></div></div>
  <div style="margin-left:5.602%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be sure that coverage or reimbursement will be available for any product that we commercialize and, if coverage and reimbursement are available, what the level of reimbursement will be. Coverage may also be more limited than the purposes for which the product is approved by the FDA or comparable foreign regulatory authorities. Future coverage and reimbursement may be subject to increased restrictions, such as prior authorization requirements, and to changes in the rates of reimbursement for orphan drug products both in the U.S. and in international markets. Reimbursement may impact the demand for, or the price of, any product for which we obtain regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The MMA established the Medicare Part D program to provide a voluntary prescription drug benefit to Medicare beneficiaries. Under Part D, Medicare beneficiaries may enroll in prescription drug plans offered by private entities that provide coverage of outpatient prescription drugs. While all Medicare drug plans must give at least a standard level of coverage set by Medicare, Part D prescription drug plan sponsors are not required to pay for all covered Part D drugs, and each Part D prescription drug plan can develop its own drug formulary that identifies which drugs it will cover and at what tier or level. However, Part D prescription drug formularies must include drugs within each therapeutic category and class of covered Part D drugs, though not necessarily all the drugs in each category or class. Any formulary used by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic committee. Government payment for some of the costs of prescription drugs may increase demand for drugs for which we obtain marketing approval. Any negotiated prices for any of our products covered by a Part D prescription drug plan will likely be lower than the prices we might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment that results from the MMA may result in a similar reduction in payments from non-governmental payors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For a drug product to receive federal reimbursement under the Medicaid or Medicare Part B programs or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the average manufacturer price, or AMP, and Medicaid rebate amounts reported by the manufacturer. As of 2010, the ACA expanded the types of entities eligible to receive discounted 340B pricing, although under the current state of the law these newly eligible entities (with the exception of children&#x2019;s hospitals) will not be eligible to receive discounted 340B pricing on orphan drugs. As the required 340B discount is determined based on average manufacturer price, or AMP, and Medicaid rebate data, the revisions to the Medicaid rebate formula and AMP definition described above could cause the required 340B discount to increase. The American Recovery and Reinvestment Act of 2009 provides funding for the federal government to compare the effectiveness of different treatments for the same illness. The plan for the research was published in 2012 by HHS, the Agency for Healthcare Research and Quality and the NIH, and periodic reports on the status of the research and related expenditures are made to Congress. Although the results of the comparative effectiveness studies are not intended to mandate coverage policies for public or private payors, it is not clear what effect, if any, the research will have on the sales of our product candidates, if any such drug or the condition that they are intended to treat are the subject of a trial. It is also possible that comparative effectiveness research demonstrating benefits in a competitor&#x2019;s drug could adversely affect the sales of our product candidate. If third-party payors do not consider our drugs to be cost-effective compared to other available therapies, they may not cover our drugs after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our drugs on a profitable basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These laws and future state and federal healthcare reform measures may be adopted in the future, any of which may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outside of the U.S., the pricing of pharmaceutical products is subject to governmental control in many countries. For example, in the EU, pricing and reimbursement schemes vary widely from country to country. Some countries provide that</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies that compare the cost effectiveness of a particular therapy to currently available therapies or so-called health technology assessments, in order to obtain reimbursement or pricing approval. Other countries may allow companies to fix their own prices for products, but monitor and control product volumes and issue guidance to physicians to limit prescriptions. Efforts to control prices and utilization of pharmaceutical products will likely continue as countries attempt to manage healthcare expenditures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employees and Human Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 262 full-time employees. Of our workforce, 83 employees are directly engaged in research and development with the rest providing administrative, business and operations support. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider the relationship with our employees to be good.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our human capital is integral to helping us achieve our goal to end the suffering caused by neurodegenerative diseases. Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards and cash-based performance bonus awards.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available Information</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements and other information with the SEC. Our filings with the SEC are available on the SEC&#x2019;s website at www.sec.gov. We also maintain a website at http://www.amylyx.com. We make available, free of charge, in the Investors section of our website, documents we file with or furnish to the SEC, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any exhibits and amendments to those reports. We make this information available as soon as reasonably practicable after we electronically file such materials with, or furnish such information to, the SEC. The other information found on our website is not part of this or any other report we file with, or furnish to, the SEC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Careful consideration should be given to the following risk factors, in addition to the other information set forth in this Annual Report and in other documents that we file with the SEC, in evaluating our business and our prospects. Investing in our common stock involves a high degree of risk. If any of the following risks and uncertainties actually occurs, our business, prospects, financial condition and results of operations could be materially and adversely affected. The risks described below are not intended to be exhaustive and are not the only risks that we face. New risk factors can emerge from time to time, and it is not possible to predict the impact that any factor or combination of factors may have on our business, prospects, financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Summary of Risk Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Financial Position and Need for Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">       </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant losses since our inception. Until we are able to generate sufficient revenue from approved products, we anticipate that we will continue to incur significant losses.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have only recently obtained regulatory approval for and launched RELYVRIO in the U.S. and ALBRIOZA in Canada and, prior to their launch, we have never generated revenue from product sales. If the commercial launches of RELYVRIO in the U.S. and ALBRIOZA in Canada are unsuccessful, and AMX0035 is not approved in other jurisdictions or for other indications, we may never be profitable.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have a limited operating history and our only product, AMX0035, has only recently been approved by the FDA in the U.S. and only recently received marketing authorization with conditions in Canada, which may make it difficult to evaluate the prospects for our future viability.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Commercialization of AMX0035 or Future Product Candidates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have limited experience as a commercial company and we may not be successful in commercializing AMX0035 or any future product candidates in the U.S., Canada or anywhere else, if and when approved, and we may be unable to generate meaningful product revenue.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities approve generic versions of AMX0035 or any future product candidate of ours that receives regulatory approval, or such authorities do not grant our products appropriate periods of non-patent exclusivity before approving generic versions of such products, the sales of such products could be adversely affected.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare insurance coverage and reimbursement, both from public drug plans and private health care insurers, may be limited or unavailable for RELYVRIO in the U.S. and ALBRIOZA in Canada, and for AMX0035 and any future product candidates, if approved anywhere else, which could make it difficult for us to sell any product candidates or therapies profitably.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to the Discovery and Development of Our Current and Future Product Candidates</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently depend on the success of AMX0035. If we are unable to maintain, or obtain additional, regulatory approvals for, and successfully commercialize, AMX0035, or experience significant delays in doing so, our business may be materially harmed.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The delay or denial of regulatory approval, inability to maintain regulatory approval, inability to complete post-marketing requirements, or the requirement to resubmit any marketing application with additional data or information for AMX0035 in any jurisdiction could mean that we need to delay or even cease operations, and a delay in obtaining or inability to maintain such approval would delay commercialization of AMX0035 and adversely impact our ability to generate revenue, our business and our results of operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 is a fixed-dose combination drug product and certain regulatory authorities may require a demonstration that each component makes a contribution to the claimed effects in addition to demonstrating that the combination is safe and effective for the intended population.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have concentrated our research and development efforts on the treatment of neurodegenerative and CNS disorders, a field that has seen very limited success in product development.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The regulatory approval processes of the FDA, Health Canada, the EMA and other comparable foreign authorities are lengthy, time-consuming and inherently unpredictable, and if we are ultimately unable to obtain or maintain regulatory approval for AMX0035 or any future product candidates, our business will be substantially harmed. A finding that our global Phase 3 PHOENIX trial is insufficient to support current or additional marketing authorizations in ALS could lead the FDA or Health Canada to restrict or withdraw prior regulatory approvals for RELYVRIO or ALBRIOZA, respectively, or we could decide, after consultation with regulatory authorities, to voluntarily withdraw RELYVRIO or ALBRIOZA from the marketplace.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitive products may reduce or eliminate the commercial opportunity for AMX0035 for our current or future indications. If our competitors develop technologies or product candidates more rapidly than we do, or their technologies or product candidates are more effective or safer than ours, our ability to develop and successfully commercialize AMX0035 may be adversely affected.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">          </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have entered and may in the future enter into collaborations with third parties for the development and commercialization of AMX0035 or any future product candidates, and our prospects with respect to those product candidates will depend in significant part on the success of those collaborations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our use of third parties to manufacture AMX0035 and approved products in compliance with cGMP may increase the risk that we will not have sufficient cGMP, compliant quantities of AMX0035, products, or necessary quantities of such materials on time or at an acceptable cost.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Intellectual Property</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success depends on our ability to protect our intellectual property and proprietary technology.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Business Operations, Employee Matters and Managing Growth</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">         </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A pandemic, epidemic, or outbreak of an infectious disease, such as the ongoing COVID-19 pandemic, may materially and adversely affect our business, including our preclinical studies, clinical trials, third parties on whom we rely, our supply chain, our ability to raise capital, our ability to conduct regular business and our financial results. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability, an ongoing military conflict between Russia and Ukraine, and high inflation and rising interest rates, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We depend heavily on our executive officers, principal consultants and others, and the loss of their services would materially harm our business. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Common Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">     </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unstable market, economic, political and geographical conditions may have serious adverse consequences on our business, financial condition and stock price.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Financial Position and Need for Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have incurred significant losses since our inception. Until we are able to generate sufficient revenue from approved products, we anticipate that we will continue to incur significant losses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect or an acceptable safety profile, gain regulatory approval and become commercially viable. We have invested substantial resources into our product development efforts and toward the commercialization of RELYVRIO, which has been recently approved by the FDA, and ALBRIOZA, which has received marketing authorization with conditions from Health Canada, but we have only recently begun generating revenue from product sales to date in the U.S., Canada or elsewhere. We will also continue to incur significant research and development and other expenses related to clinical development, commercialization, approvals in additional jurisdictions and ongoing operations. As a result, we are not profitable and have incurred losses in each period since our inception. Since our inception, we have devoted the majority of our financial resources and efforts to research and development, including preclinical studies and our clinical trials, preparation for commercialization and, more recently, commercialization activities. Our financial condition and operating results, including our revenues, expenses and net losses, may fluctuate significantly from quarter to quarter and year to year. Accordingly, you should not rely upon the results of any quarterly or annual periods as indications of future operating performance. Additionally, net losses and negative cash flows have had, and will continue to have, an adverse effect on our stockholders&#x2019; equity and working capital. Our net losses were $198.4 million and $87.9 million for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, we had an accumulated deficit of $354.2 million. We may continue to incur significant losses and our financial results will be highly dependent upon the successful launch and commercial sales of RELYVRIO in the U.S. We will continue to incur expenses related to our research and development activities and pre-commercialization activities in Europe, among other things.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We anticipate that our expenses will increase substantially if and as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">further build out our sales, marketing, pharmacovigilance and distribution infrastructure and scale-up manufacturing capabilities to commercialize AMX0035 and any product candidate for which we may obtain approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continue to develop and conduct clinical trials for AMX0035 for the treatment of ALS, AD, Wolfram and potential other additional indications, including our PHOENIX trial;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">initiate and continue research, preclinical and clinical development efforts for any future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek to identify additional product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek to maintain regulatory approvals in the U.S. and Canada and obtain regulatory approvals in the European Union, or the EU, and other geographies for AMX0035 for the treatment of ALS, AD and other indications that successfully complete clinical development;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">experience any delays or encounter any issues with any of the above, including but not limited to completion of post-marketing requirements, the potential that the EMA or other regulators require additional data to support the approval of AMX0035 for ALS, failed studies, negative or mixed clinical trial results, safety issues or other regulatory challenges;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">establish sales, marketing, pharmacovigilance, distribution, manufacturing, supply chain and other commercial infrastructure to commercialize any products for which we may in the future obtain regulatory approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support our product candidate development and help us comply with our obligations as a public company;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hire and retain additional personnel, such as clinical, quality control, scientific, commercial and administrative personnel;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintain, expand and protect our intellectual property portfolio;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">add equipment and physical infrastructure to support our research and development; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">acquire or in-license other product candidates and technologies.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are continuing to build out our infrastructure, including sales and marketing, distribution and manufacturing capabilities, for commercialization of AMX0035 in the U.S. and Canada. As of December 31, 2022, we had 262 full-time employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our expenses could increase beyond our expectations if we are required by the FDA, Health Canada, the EMA, or other regulatory authorities to perform clinical trials or conduct other studies in addition to those that we currently expect, or if there are any delays in establishing appropriate manufacturing arrangements for or in completing our clinical trials or the development of AMX0035 or any future product candidates we may develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have only recently obtained regulatory approval for and launched RELYVRIO in the U.S. and ALBRIOZA in Canada and, prior to their launch, we have never generated revenue from product sales. If the commercial launches of RELYVRIO in the U.S. and ALBRIOZA in Canada are unsuccessful, and AMX0035 is not approved in other jurisdictions or for other indications, we may never be profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to become and remain profitable depends on our ability to generate revenue from our approved products, RELYVRIO in the U.S. and ALBRIOZA in Canada. Other than RELYVRIO in the U.S. and ALBRIOZA in Canada, we have not yet launched any other approved products for commercial sale and have only recently begun generating revenue from product sales. Successful commercialization will require achievement of many key milestones, which vary by jurisdiction and may include demonstrating safety and efficacy in clinical trials, obtaining and maintaining regulatory, including marketing, approval for these product candidates, manufacturing, marketing and selling those products for which we, or any of our future collaborators, may obtain regulatory approval, satisfying any post-marketing requirements and obtaining reimbursement for our products from private insurance or government payors. Even if we successfully launch and commercialize RELYVRIO in the U.S. and ALBRIOZA in Canada, we may be unable to achieve or maintain profitability, unless AMX0035 is approved in other jurisdictions or for additional indications. Because of the uncertainties and risks associated with these activities, we are unable to accurately and precisely predict the timing and amount of revenues, the extent of any further losses or if or when we might achieve profitability. We and any future collaborators may never succeed in these activities and, even if we do, or any future collaborators do, we may never generate revenues that are large enough for us to achieve profitability. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure to become and remain profitable may depress the market price of our common stock and could impair our ability to raise capital, expand our business, diversify our product offerings or continue our operations. If we continue to suffer losses as we have in the past, investors may not receive any return on their investment and may lose their entire investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have a limited operating history and our only product, AMX0035, has only recently been approved by the FDA in the U.S. and only recently received marketing authorization with conditions in Canada, which may make it difficult to evaluate the prospects for our future viability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have only recently commenced our transition from a clinical-stage to a commercial-stage company. Our operations to date have been primarily limited to organizing, staffing and financing our company, raising capital, conducting research and development activities, including preclinical studies and clinical trials and preparing for and commencing commercialization of AMX0035. We have not yet demonstrated an ability to generate significant revenues, or clearly conduct sales and marketing activities necessary for successful product commercialization. In June 2022, AMX0035 received marketing authorization with conditions from Health Canada for the treatment of ALS. One of the conditions of the marketing authorization in Canada is the provision of data from our ongoing PHOENIX trial and other additional planned or ongoing studies. In September 2022, AMX0035 received  marketing authorization from the FDA for the treatment of ALS in adults. We also have a pending MAA before the EMA, and we expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest. Accordingly, you should consider our prospects in light of the costs, uncertainties, delays and difficulties frequently encountered by companies in the early commercial stage, especially pharmaceutical companies such as ours. Any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer operating history with these activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At a second meeting of the FDA&#x2019;s Advisory Committee, on September 7, 2022, relating to AMX0035 for the treatment of ALS, we stated that if our PHOENIX trial is not successful then we will do what is right for patients, which includes voluntarily removing the product from the market. We will work in consultation with regulatory authorities when the PHOENIX data are available. We could also be required by regulatory authorities to withdraw AMX0035 from the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">marketplace. The outcomes of the PHOENIX trial and any potential withdrawal could have a material adverse effect on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not satisfy all of the conditions imposed by Health Canada for marketing authorization of ALBRIOZA for the treatment of ALS. If we fail to do so, we may be subject to additional conditions imposed by Health Canada or we may have to cease commercialization of ALBRIOZA, which may impact our prospectus for profitability. We may encounter unforeseen expenses, difficulties, complications, delays and other known or unknown factors in achieving our business objectives. We are transitioning from a company with a development focus to a company capable of supporting commercial activities. We may not be successful in such a transition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may require substantial additional funding to meet our financial needs and to pursue our business objectives. If we are unable to raise capital if and when needed, we could be forced to delay, reduce or eliminate our product discovery and development activities or commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts to commercialize AMX0035 in jurisdictions in which it has received regulatory approval and to continue the clinical development of AMX0035 and the preclinical and clinical development of any future product candidates. If we are unable to obtain and maintain marketing approvals for AMX0035 or any future product candidates that we develop, including any indication for which we are developing or may develop AMX0035, we will require significant additional amounts of cash in order to continue to develop AMX0035 and any future product candidates and fund our operations. In addition, other unanticipated costs may arise in the course of our development and commercialization efforts. Because the design and outcome of our ongoing and anticipated clinical trials is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of any product candidate we develop.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future capital requirements depend on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, results and costs of researching, developing and commercializing AMX0035 for the treatment of ALS, AD and potential additional indications, as well as any future product candidates we may develop; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of, and the costs involved in, obtaining and maintaining marketing approvals for AMX0035 for the treatment of ALS, AD and potential additional indications, and any future product candidates we may develop and pursue; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of future product candidates that we may pursue and their development requirements; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of commercialization activities for AMX0035 for any approved indications, or any other product candidate that receives regulatory approval to the extent such costs are not the responsibility of any future collaborators, including the costs and timing of establishing sufficient product sales, marketing, distribution and manufacturing capabilities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to receipt of regulatory approval on a jurisdiction-by-jurisdiction basis, revenue, if any, received from commercial sales of AMX0035 for any approved indications or any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we in-license or acquire rights to other products, product candidates or technologies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our headcount growth and associated costs as we expand our research and development, increase our office space, and establish a commercial infrastructure; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights, including enforcing and defending intellectual property related claims; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ongoing costs of operating as a public company. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be certain that additional funding will be available on acceptable terms, or at all. As a result of the economic challenges caused by the COVID-19 pandemic and economic uncertainty in various global markets due to geopolitical instability and conflict, including the ongoing conflict in Ukraine, the global credit and financial markets have experienced extreme volatility and disruptions, including diminished liquidity and credit availability, declines in consumer confidence, high rates of inflation and rising interest rates, declines in economic growth, increases in unemployment rates, and uncertainty about economic stability. If the equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly or more dilutive.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have no committed source of additional capital and if we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of AMX0035 or any future product candidates or other research and development initiatives. We may need to seek collaborators for AMX0035 and any future product candidates at an earlier stage than otherwise would be desirable or on terms that are less favorable than might otherwise be available or relinquish or license on unfavorable terms our rights to AMX0035 and any future product candidates in markets where we otherwise would seek to pursue development or commercialization ourselves. Any of the above events could significantly harm our business, prospects, financial condition, and results of operations and cause the price of our common stock to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that the revenue we have begun to generate with commercial sales of AMX0035 in the U.S. and Canada and our existing cash, cash equivalents, and short-term investments, will be sufficient to meet our anticipated operating and capital expenditure requirements for at least twelve months after the date of the filing of this Annual Report. Our estimate may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Further, changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate, and we may need to seek additional funds sooner than planned.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our expenses to continue to increase in connection with our planned operations. Unless and until we can generate a substantial amount of revenue from AMX0035 or any future product candidates, we expect to finance our future cash needs through public or private equity offerings, royalty-based or debt financings, collaborations, licensing arrangements or other sources, or any combination of the foregoing. In addition, we may seek additional capital due to favorable market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that we raise additional capital through the sale of common stock, convertible securities or other equity securities, your ownership interest may be diluted, and the terms of these securities could include liquidation or other preferences and anti-dilution protections that could adversely affect your rights as a common stockholder. In addition, debt financing, if available, may result in fixed payment obligations and may involve agreements that include restrictive covenants that limit our ability to take specific actions, such as incurring additional debt, making capital expenditures, creating liens, redeeming stock or declaring dividends, that could adversely impact our ability to conduct our business. In addition, securing financing could require a substantial amount of time and attention from our management and may divert a disproportionate amount of their attention away from day-to-day activities, which may adversely affect our management&#x2019;s ability to oversee the development and commercialization of AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we raise additional funds through collaborations or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in tax law could adversely affect our business and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rules dealing with U.S. federal, state, local and international income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been made and changes are likely to continue to occur in the future. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and its financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership. Although a statement by the Department of the Treasury, the Federal Reserve and the FDIC stated that all depositors of SVB would have access to all of their money after only one business day of closure, including funds held in uninsured deposit accounts, borrowers under credit agreements, letters of credit and certain other financial instruments with SVB, Signature Bank or any other financial institution that is placed into receivership by the FDIC may be unable to access undrawn amounts thereunder. If any of our counterparties to any such instruments were to be placed into receivership, we may be unable to access such funds. In addition, if any parties with whom we conduct business are unable to access funds pursuant to such instruments or lending arrangements with such a financial institution, such parties&#x2019; ability to pay their obligations to us or to enter into new commercial arrangements requiring additional payments to us could be adversely affected. In this regard, counterparties to SVB credit agreements and arrangements, and third parties such as beneficiaries of letters of credit (among others), may experience direct impacts from the closure of SVB and uncertainty remains over liquidity concerns in the broader financial services industry. Similar impacts have occurred in the past, such as during the 2008-2010 financial crisis. As of March 10, 2023, we had less than $1 million of our cash and cash equivalent and short-term investment balances on deposit with SVB, and also held securities in a sweep account and asset management account purchased through SVB but managed in segregated custodial accounts by third party asset managers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inflation and rapid increases in interest rates have led to a decline in the trading value of previously issued government securities with interest rates below current market interest rates. Although the U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by certain of such government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments, widespread demands for customer withdrawals or other liquidity needs of financial institutions for immediately liquidity may exceed the capacity of such program. There is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a timely fashion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we assess our banking relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial institutions with which we have arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations. These could include, but may not be limited to, the following:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss of access to revolving existing credit facilities or other working capital sources and/or the inability to refund, roll over or extend the maturity of, or enter into new credit facilities or other working capital resources;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potential or actual breach of contractual obligations that require us to maintain letters or credit or other credit support arrangements; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, any further deterioration in the macroeconomic economy or financial services industry could lead to losses or defaults by parties with whom we conduct business, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition. For example, a party with whom we conduct business may fail to make payments when due, default under their agreements with us, become insolvent or declare bankruptcy. Any bankruptcy or insolvency, or the failure to make payments when due, of any counterparty of ours, or the loss of any significant relationships, could result in material losses to us and may material adverse impacts on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Commercialization of AMX0035 or Future Product Candidates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have limited experience as a commercial company and we may not be successful in commercializing AMX0035 or any future product candidates in the U.S., Canada or anywhere else, if and when approved, and we may be unable to generate meaningful product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recently launched ALBRIOZA in Canada and RELYVRIO in the U.S. and, if approved, we also intend to commercialize AMX0035 in the EU with specialized teams, given the relative rarity of ALS and certain of the other indications we are targeting. We are currently continuing to build the global marketing and sales team for the marketing, sales and distribution of AMX0035 and any future product candidates, if approved. In order to successfully commercialize AMX0035 for the treatment of ALS, AD and other indications, or any of our future product candidates that may be approved, we must build, on a territory-by-territory basis, marketing, sales, distribution, managerial and other capabilities or make arrangements with third parties to perform these services, and we may not be successful in doing so.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are risks involved with both establishing our own sales and marketing capabilities and entering into arrangements with third parties to perform these services. For example, we have recruited and trained a U.S. commercial organization which is expensive and time-consuming. Factors that may inhibit our efforts to commercialize AMX0035 or any future product candidates, if approved, on our own include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to recruit, train and retain adequate numbers of effective sales and marketing personnel; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to supply the market with our drug product, including manufacturing or distribution challenges we may face;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of sales personnel to obtain access to physicians to prescribe AMX0035 or any future product that we may develop; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any views or opinions expressed by ALS or community organizations about the safety or efficacy of AMX0035; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the lack of complementary or symptomatic treatments to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of adequate coverage by and reimbursement from government and third-party payors; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unforeseen costs and expenses associated with creating an independent sales and marketing organization. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we enter into arrangements with third parties to perform sales, marketing and distribution services, our product revenue or profitability from these revenue streams is likely to be lower than if we were to market and sell any product candidates that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market AMX0035 or any of our future product candidates or may be unable to do so on terms that are favorable to us. We likely will have limited control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market AMX0035 or any future product candidates effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we may not be successful in commercializing AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our efforts to educate the ALS and other neurodegenerative disease medical communities and payors on the benefits of AMX0035 or any future product candidates may require significant resources and may never be successful. Such efforts may require more resources than are typically required due to the complexity and uniqueness of AMX0035 or any future product candidates, and the indications we are targeting. Even if AMX0035 or any future product candidates are approved in any</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">jurisdiction, if we are unable to successfully market our products successfully, we will not be able to generate significant revenues from such products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to expand our marketing, manufacturing and distribution capabilities or enter into agreements with third parties to market and sell any of AMX0035 or future product candidates for which we obtain marketing approval, we will be unable to generate any product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To successfully commercialize any products that may result from our development activities, we need to continue to expand our marketing, pharmacovigilance, manufacturing and distribution capabilities, either on our own or with others. The development of our own marketing and distribution effort is, and will continue to be, expensive and time-consuming and could delay any further product launch. Moreover, we cannot be certain that we will be able to develop this capability successfully. We may enter into collaborations regarding any approved product candidates with other entities to utilize their established marketing and distribution capabilities, however, we may be unable to enter into such agreements on favorable terms, if at all. If any future collaborators do not commit sufficient resources to commercialize AMX0035 or any future product candidates, or we are unable to develop the necessary capabilities on our own, we will be unable to generate sufficient product revenue to sustain our business. We compete with many companies that currently have extensive, experienced and well-funded sales, distribution and marketing operations to recruit, hire, train and retain marketing and sales personnel. We also face competition in our search for third parties to assist us with the sales and marketing efforts of AMX0035 and any future product candidates, if approved. Without an internal team or the support of a third-party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The market for AMX0035 for ALS, AD, Wolfram syndrome and other neurodegenerative diseases and for any future product candidates we may develop may be smaller than we expect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We focus our research and product development on treatments of neurodegenerative diseases. We base our market opportunity estimates on a variety of factors, including our estimates of the number of people who have these diseases, the potential scope of our approved product labels, the subset of people with these diseases who have the potential to benefit from treatment with AMX0035 or any future product candidates, various pricing scenarios, and our understanding of reimbursement policies for rare diseases in particular countries. These estimates are based on many assumptions and may prove incorrect, and new studies may reduce the estimated incidence or prevalence of these diseases. Estimating market opportunities can be particularly challenging for rare indications, such as the ones we currently address, as epidemiological data is often more limited than for more prevalent indications and can require additional assumptions to assess potential patient populations. For example, as we begin to commercialize RELYVRIO in the U.S., ALBRIOZA in Canada and AMX0035, if approved, in other jurisdictions, and learn more about market dynamics and engage with regulators on additional potential marketing approvals, our view of our products&#x2019; initial potential market opportunity will become more refined. For example, we are now initially focused primarily on the annual incidence of ALS. This means the initial market opportunity for AMX0035 and any future product candidates may be smaller than the total addressable market opportunity that could be achieved over time. If we are unable to successfully commercialize AMX0035 or any future product candidates with attractive market opportunities, our future product revenues may be smaller than anticipated, and our business may suffer. Patient identification efforts also influence the ability to address a patient population. If efforts in patient identification are unsuccessful or less impactful than anticipated, for instance, because of a lack of diagnostic initiatives, inadequate disease awareness among healthcare professionals, or otherwise, we may not address the entirety of the opportunity we are seeking. As a result, patients may be difficult to identify and access, the addressable patient population in the U.S., Canada, the EU and elsewhere may turn out to be lower than expected, or patients may not be otherwise amenable to treatment with our products, all of which would adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">AMX0035 may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if AMX0035 for the treatment of any indication, or any future product candidate of ours, is approved by the appropriate regulatory authorities for marketing and sale, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. Physicians may be reluctant to add AMX0035 to their patients&#x2019; treatment regimen, or may cease to add AMX0035 to their patients&#x2019; treatment regimen. Further, patients often</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">acclimate to the treatment regime they are currently taking and do not want to add additional treatments unless their physicians recommend it. Further, they may be unable to add AMX0035 to their treatment regimen due to lack of coverage and adequate reimbursement. In addition, even if we are able to demonstrate our product candidates&#x2019; safety and efficacy to Health Canada, the FDA, the EMA and other regulators, safety or efficacy concerns in the medical community may hinder market acceptance. Our ability to proactively educate health care professionals and patients may be limited based on the marketing restrictions in a given jurisdiction, specifically as they relate to the particular labeling approved by the applicable health authority.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Efforts to educate the medical community and third-party payors on the benefits of our current and any future product candidates may require significant resources, including management time and financial resources, and may not be successful. If AMX0035 or any future product candidate is approved but does not achieve an adequate level of market acceptance, we may not generate significant revenues and we may not become profitable. The degree of market acceptance of AMX0035 and any future product candidates, if approved for commercial sale, will depend on a number of factors, including:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy and safety of the product;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential advantages of the product compared to competitive therapies and our ability to successfully publicize these advantages or highlight them in any marketing materials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the prevalence and severity of any side effects; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the product is designated under physician treatment guidelines as a first-, second- or third-line therapy; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability, or the ability of any future collaborators, to offer the product for sale at competitive prices; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the product&#x2019;s convenience, tolerability and ease of administration compared to alternative treatments; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of the target patient population to try, and of physicians to prescribe, the product; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations or warnings, including distribution or use restrictions contained in the product&#x2019;s approved labeling; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the strength of sales, marketing and distribution support; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the standard of care for the targeted indications for the product; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">availability and adequacy of coverage and reimbursement from government payors, managed care plans and other third-party payors. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure by AMX0035 or any other potential product candidate of ours that obtains regulatory approval to achieve market acceptance or commercial success would adversely affect our business prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Off-label use for the treatment of ALS of PB, which is available as a generic drug, along with the potential sale in some jurisdictions of TURSO, which preparations are of unknown identity and may not be legally sold for the treatment of ALS, expose us to additional risks that could reduce or eliminate the commercial opportunity for AMX0035.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing and advancing AMX0035 as a combination of TURSO and PB. PB has been approved by the FDA and other regulatory authorities for the treatment of patients with certain urea cycle disorders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TURSO is being marketed in preparations of unknown identity and without approval for the treatment of ALS in some jurisdictions, including the U.S. We face the risk that healthcare professionals may prescribe PB for the treatment of ALS and recommend that patients obtain a commercial preparation of TURSO not approved, labeled, or marketed for the treatment of ALS on the belief that this combination could replicate the benefits of AMX0035. Patient-directed treatment with TURSO for ALS may also arise in certain jurisdictions if the Phase 3 clinical trial to assess the safety and efficacy of TURSO in patients with ALS conducted by Humanitas Mirasole SpA in the EU reports positive results. While these practices are not recommended by the medical community and have not been approved by any regulatory authority, they may nonetheless impact our sales of RELYVRIO in the U.S., ALBRIOZA in Canada and AMX0035, if approved in other jurisdictions, and/or public perception of AMX0035 in the U.S. or abroad.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities approve generic versions of AMX0035 or any future product candidate of ours that receives regulatory approval, or such authorities do not grant our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">products appropriate periods of non-patent exclusivity before approving generic versions of such products, the sales of such products could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., once an NDA is approved, the product covered thereby becomes a &#x201c;reference listed drug&#x201d; in the FDA&#x2019;s publication, &#x201c;Approved Drug Products with Therapeutic Equivalence Evaluations,&#x201d; or the Orange Book. Manufacturers may seek approval of generic versions of reference listed drugs through submission of abbreviated new drug applications, or ANDAs, in the U.S. In support of an ANDA, a generic manufacturer generally must show that its product has the same active ingredient(s), dosage form, strength, route of administration, and adequate labeling as the reference listed drug and that the generic version is bioequivalent to the reference listed drug, meaning, in part, that it is absorbed in the body at the same rate and to the same extent. Generic products may be significantly less costly to bring to market than the reference listed drug and companies that produce generic products are generally able to offer them at lower prices. Moreover, many states allow or require substitution of therapeutically equivalent generic drugs at the pharmacy level even if the branded drug is prescribed. Thus, following the introduction of a generic drug, a significant percentage of the sales of any branded product or reference listed drug may be lost to the generic product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may not approve an ANDA for a generic product until any applicable period of non-patent exclusivity for the reference listed drug has expired. The FDCA provides a period of five years of non-patent exclusivity for a new drug containing a new chemical entity, or NCE. For the purposes of this provision, an NCE is a drug that contains no active moiety that has previously been approved by the FDA in any other NDA. An active moiety is the molecule or ion responsible for the physiological or pharmacological action of the drug substance. Specifically, in cases where such exclusivity has been granted, an ANDA may not be filed with the FDA until the expiration of five years unless the submission is accompanied by a Paragraph IV certification that a patent covering the listed drug is invalid, unenforceable or will not be infringed by the generic product. In that case, the applicant may submit its application four years following approval of the listed drug and seek to launch its generic product even if we still have patent protection for our product unless an infringement suit is timely filed by the NDA or patent holder in which case the FDA cannot approve the ANDA for 30 months unless a court decision in favor of the generic manufacturer is issued earlier. For fixed dose combination products, the FDA has taken the position that a combination product will be eligible for NCE exclusivity (also known as data exclusivity) if it contains a new active moiety, even if the fixed-combination also contains a drug substance with a previously approved active moiety.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have received NCE exclusivity from the FDA for RELYVRIO and such exclusivity expires in September 2027. In addition, in connection with our Health Canada marketing authorization with conditions, ALBRIOZA was added to the Register of Innovative Drugs, which provides an eight year period of market exclusivity. The regulatory authorities in the U.S. and Europe may reach different conclusions from Health Canada with respect to exclusivity for AMX0035.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any product we develop does not receive five years of NCE exclusivity, the FDA may approve generic versions of such product three years after its date of approval, subject to the requirement that the ANDA applicant certifies to the invalidity or non-infringement of any patents listed for our products in the Orange Book. If an infringement suit is timely filed by the NDA or patent holder, the FDA cannot finally approve the ANDA for 30 months unless a court decision in favor of the generic manufacturer is issued earlier. Three-year exclusivity is given to a drug if it contains an active moiety that has previously been approved, and the NDA includes reports of one or more new clinical investigations, other than bioavailability or bioequivalence studies, that were conducted by or for the applicant and are determined by the FDA to be essential to the approval of the NDA. This form of data exclusivity is known as New Clinical Investigation, or NCI, exclusivity. If AMX0035 is approved for future uses or if future candidates are approved with only NCI exclusivity, generic manufacturers may file their ANDAs anytime following approval of AMX0035 and seek to launch their generic products following the expiration of the three year market exclusivity period, even if we still have patent protection for our product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, in the U.S. the FDCA provides a period of seven years of orphan drug exclusivity for drugs that treat small patient populations less than 200,000 patients or for which there are more than 200,000 patients but there is no reasonable expectation that the cost of developing and making the drug for such disease or condition will be recovered from sales in the U.S. of such drug. AMX0035 has been granted orphan drug designation for the treatment of ALS, and with the approval of AMX0035 (RELYVRIO) by the FDA in September 2022 for the treatment of ALS in adults, the product is entitled to orphan drug exclusivity and the FDA cannot approve a generic or a brand product that contains the same active moiety for the same orphan indication as AMX0035, for a period of seven years, subject to certain exceptions. This period runs concurrent with the NCE exclusivity period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Canada&#x2019;s data protection regime provides an eight year period of market exclusivity for &#x201c;innovative drugs&#x201d;, which is independent from patent protection. An innovative drug is a drug that contains a medicinal ingredient not previously</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approved by Health Canada and that is not a variation of a previously approved medicinal ingredient such as a salt, ester, enantiomer, solvate or polymorph. If a drug qualifies as an &#x201c;innovative drug&#x201d; in Canada, generic/and manufacturers are not permitted to seek approval for their product on the basis of a direct or indirect comparison to an innovative drug for the first six years of the data protection period, and Health Canada cannot issue a Notice of Compliance (NOC or marketing approval) for eight years. One of the components of ALBRIOZA (ursodoxicoltaurine) is an innovative drug, and therefore ALBRIOZA was added to the Register of Innovative Drugs upon its approval. The data protection period for ALBRIOZA runs until June 10, 2030 which is eight years from the date its NOC was issued.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no regulatory provision in Canada that provides orphan drug exclusivity to approved products for rare diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the EU, innovative medicinal products (including both small molecules and biological medicinal products), sometimes referred to as new active substances, or NAS, qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. The data exclusivity, if granted, prevents generic or biosimilar applicants from referencing the innovator&#x2019;s preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization, for a period of eight years from the date on which the reference product was first authorized in the EU. During the additional two-year period of market exclusivity, a generic or biosimilar marketing authorization can be submitted, and the innovator&#x2019;s data may be referenced, but no generic or biosimilar product can be marketed until the expiration of the market exclusivity period. This 10-year marketing exclusivity period may be extended to 11 years if, during the first eight of those 10 years, the marketing authorization holder obtains an approval for one or more new therapeutic indications that bring significant clinical benefits compared with existing therapies. However, even if an innovative medicinal product gains the prescribed period of data exclusivity, another company may market another version of the product if such company obtained a marketing authorization based on an application with a complete and independent data package of pharmaceutical tests, preclinical tests and clinical trials. We have applied for NAS status for AMX0035 in the EU. Irrespective of the NAS status, we expect that AMX0035 will be eligible for Orphan Market Exclusivity if the orphan designation is maintained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competition that AMX0035 or any future products, if approved, may face from generic versions of such products could negatively impact our future revenue, profitability and cash flows and substantially limit our ability to obtain a return on our investments in those product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">AMX0035 or any future product candidates for which we, or any future collaborators, obtain regulatory approval will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. AMX0035 and any future product candidates, if approved, could be subject to post-marketing restrictions, requirements or withdrawal from the market and we, or any future collaborators, may be subject to substantial penalties if we, or they, fail to comply with regulatory requirements or if we, or they, experience unanticipated problems with our products following approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 received approval by the FDA for the treatment of ALS in adults (known as RELYVRIO) in September 2022 and marketing authorization with conditions by Health Canada for the treatment of ALS (known as ALBRIOZA) in June 2022. We have a pending MAA before the EMA for AMX0035 for the treatment of ALS and we may seek approval of AMX0035 in additional jurisdictions and in additional indications. AMX0035 or any future product candidates for which we, or any future collaborators, obtain regulatory approval, as well as the manufacturing processes, post-approval studies, labeling, advertising and promotional activities for such product, among other things, will be subject to ongoing requirements of and review by the FDA, Health Canada, the EMA and other applicable regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration and listing requirements, requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping. For certain commercial prescription drug products, manufacturers and other parties involved in the supply chain must also meet chain of distribution requirements and build electronic, interoperable systems for product tracking and tracing and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or other products that are otherwise unfit for distribution in the U.S. We and our contract manufacturers will also be subject to user fees and periodic inspection by regulatory authorities to monitor compliance with these requirements and the terms of any product approval we may obtain. Even if regulatory approval of a product candidate is granted, the approval may be subject to limitations on the indications or uses for which the product may be marketed or to the conditions of approval, including the requirement in the U.S. to implement a Risk Evaluation and Mitigation Strategy, or REMS.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA, Health Canada, the EMA and other regulatory authorities may also impose requirements for costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of a product. For example, as part of our approval of RELYVRIO in the U.S., we have post-marketing requirements to conduct carcinogenicity studies in mice and rats, drug-drug interaction studies in human volunteers, and studies in subjects with kidney or liver impairment. Additionally, the FDA and other agencies, including the Department of Justice, closely regulate and monitor the post-approval marketing and promotion of products to ensure that they are manufactured, marketed and distributed only for the approved indications and in accordance with the provisions of the approved labeling. Regulatory authorities impose stringent restrictions on manufacturers&#x2019; communications regarding off-label use. However, companies generally may share truthful and not misleading information that is otherwise consistent with a product&#x2019;s approved labeling. If we, or any future collaborators, do not market AMX0035 or any of our future product candidates for which we, or they, receive regulatory approval for only their approved indications, we, or they, may be subject to warnings or enforcement action for off-label marketing if it is alleged that we are doing so. Violation of laws and regulations relating to the promotion and advertising of prescription drugs may lead to investigations or allegations of violations of federal and state health care fraud and abuse laws and state consumer protection laws, including the False Claims Act and any comparable foreign laws. In the EU, the direct-to-consumer advertising of prescription-only medicinal products is prohibited. Violations of the rules governing the promotion of medicinal products in the EU could be penalized by administrative measures, fines and imprisonment. These laws may further limit or restrict the advertising and promotion of our products to the general public, and may also impose limitations on our promotional activities with health care professionals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-marketing requirements in Canada are similar to those in the U.S. Following the approval of our New Drug Submission, or NDS with conditions, Health Canada requires that we submit a Risk Management Plan, or RMP. Health Canada may, as part of the RMP, require that we conduct additional clinical trials. For example, one of the conditions of the marketing authorization in Canada of AMX0035 (ALBRIOZA) is the provision of data from our ongoing PHOENIX trial and other additional planned or ongoing studies. Standard pharmacovigilance activities are also required for any marketed drug product. Any labelling changes or changes in the product supply chain would require a submission to Health Canada for approval before the change may be implemented. Our advertising may be scrutinized by competitors or by health care providers, and complaints could be made to Health Canada or other agencies. Reimbursement in Canada is complex and requires submissions to both public and private payors to gain access to prescription drug formulary lists. In addition, if there are any patents associated with AMX0035, the product will be subject to price regulation by the Patented Medicine Prices Review Board, or the PMPRB.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, later discovery of previously unknown adverse events or other problems with our products or their manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various results, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the manufacturing of such products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the labeling or marketing of such products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on product distribution or use; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements to conduct post-marketing studies or clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">warning letters or untitled letters; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">withdrawal of the products from the market; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal to approve pending applications or supplements to approved applications that we submit; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recall of products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on coverage by third-party payors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, restitution or disgorgement of profits or revenues; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusion from federal health care programs such as Medicare and Medicaid; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">suspension or withdrawal of regulatory approvals; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal to permit the import or export of products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizure; or </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not able to comply with post-approval regulatory requirements, we could have the marketing approvals for AMX0035 or any future approved products withdrawn or restricted by regulatory authorities, or we may voluntarily do so, and our ability to market AMX0035 or any future approved products, to develop AMX0035 in the U.S., Canada or additional jurisdictions or for additional indications, and to develop and seek approval for additional product candidates could become limited, which could adversely affect our ability to achieve or sustain profitability. As a result, the cost of compliance with post-approval regulatory requirements may have a negative effect on our operating results and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Healthcare insurance coverage and reimbursement, both from public drug plans and private health care insurers, may be limited or unavailable for RELYVRIO in the U.S. and ALBRIOZA in Canada, and for AMX0035 and any future product candidates, if approved anywhere else, which could make it difficult for us to sell any product candidates or therapies profitably.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The success of AMX0035 and any future product candidates, if approved, depends on the availability of adequate coverage and reimbursement from third-party payors. Because AMX0035 and any future product candidates represent new approaches to the treatment of the diseases they target, we cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from, AMX0035 and any future product candidates or for any product that we may develop. If we are unable to obtain adequate levels of reimbursement, our ability to successfully market and sell any such product candidates will be adversely affected. The manner and level at which reimbursement is provided for services related to any current or future product candidates we may develop (e.g., for the administration of our product candidate to patients) is also important. Inadequate reimbursement for such services may lead to physician and payor resistance and adversely affect our ability to market or sell AMX0035 or any future product candidates we may develop. In addition, we may need to develop new reimbursement models, in order to realize adequate value. Payors may not be able or willing to adopt such new models and patients may be unable to afford that portion of the cost that such models may require them to bear. If we determine such new models are necessary, but we are unsuccessful in developing them, or if payors do not adopt such models, our business, financial condition, results of operations and prospects could be adversely affected. For additional information on coverage and reimbursement, see the section entitled &#x201c;Business&#x2014;Government Regulation&#x2014;Coverage and Reimbursement&#x201d; in this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors, such as private health insurers and health maintenance organizations, are critical to new product acceptance. Government authorities and other third-party payors decide which drugs and treatments they will cover and the reimbursement amount. Coverage and reimbursement by a third-party payor may depend upon a number of factors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., no uniform policy of coverage and reimbursement for products exists among third-party payors. As a result, obtaining coverage and reimbursement approval of a product from a government or other third-party payor is a time consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the use of our products on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement from third-party payors will be obtained. There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products, which uncertainty may be heightened where the product is subject to post-marketing conditions or requirements to provide additional clinical data. In the U.S., the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare &amp; Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services, as CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare. Private payors tend to follow CMS to a substantial degree. Even if we obtain coverage for a given product, the resulting reimbursement payment rates might not be adequate for us to achieve or sustain profitability or may require co-payments that patients find unacceptably high. Future coverage and reimbursement may be subject to increased restrictions, such as prior authorization requirements, both in the U.S. and in international markets. Orphan drugs are typically placed on the highest cost-sharing tier and a substantial percentage are subject to prior authorization requirements. Reimbursement agencies in the EU may be more conservative than CMS.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outside the U.S., international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Canada, the EU and other countries has and will continue to put pressure on the pricing and usage of drug products such as AMX0035 and any future product candidates we may develop, if approved. We may also incur additional challenges when seeking reimbursement from public and private payers where AMX0035 or any future product candidate has been approved subject to post-marketing conditions. In many countries, particularly the countries of the EU, the prices of medical products are subject to varying price control</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">mechanisms as part of national health systems. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. For example, in Canada, price negotiations with provincial authorities can take more than 18 months before there are agreed-upon pricing and reimbursement rates. Prior to these negotiations, a review by CADTH and INESSS are conducted to assess the value that a medicine will provide to the health system. For patented medicines, the PMPRB has jurisdiction over the price at which the medicine is sold, and PMPRB&#x2019;s assessment of an acceptable price can impact negotiations with payors. Such negotiations may also result in additional studies and rationale required for combination products before reimbursement will be granted. As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay or might even prevent our commercial launch of the product, possibly for lengthy periods of time. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. In general, the prices of products under such systems are substantially lower than in the U.S. Other countries allow companies to fix their own prices for products but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for product candidates. Accordingly, in markets outside the U.S., the reimbursement for AMX0035 and any future product candidates we may develop may be reduced compared with the U.S. and may be insufficient to generate commercially reasonable revenues and profits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, third-party payors may not cover, or provide adequate reimbursement for, long-term follow-up evaluations required following the use of product candidates. Patients are unlikely to use AMX0035 or any future product candidates unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of AMX0035 or any future product candidates. Because AMX0035 and any future product candidates may have a higher cost of goods than conventional therapies and may require long-term follow-up evaluations, the risk that coverage and reimbursement rates may be inadequate for us to achieve profitability may be greater. While we have received a positive response from some providers in Canada following Health Canada&#x2019;s approval with conditions of AMX0035 for the treatment of ALS, there is significant uncertainty related to insurance coverage and reimbursement. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for AMX0035 and any future product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, increasing efforts by governmental and other third-party payors in Canada, the EU, the U.S. and other foreign jurisdictions to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for AMX0035 or any future product candidates. There has been increasing legislative and enforcement interest in the U.S. with respect to specialty drug pricing practices. We expect to experience pricing pressures in connection with the sale of AMX0035 or any future product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, cost containment initiatives and additional legislative changes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Ongoing healthcare legislative and regulatory reform measures may have a material adverse effect on our business and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall or discontinuation of our products; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. For more information, see the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business &#x2013; Government Regulation &#x2013; Current and Future U.S. Healthcare Reform Legislation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., there have been and continue to be a number of legislative initiatives to contain healthcare costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These laws and future state and federal healthcare reform measures that may be adopted in the future may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for AMX0035 or any future product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, increasing efforts by governmental and third-party payors in the U.S. and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. There has been increasing legislative and enforcement interest in the U.S. with respect to specialty drug pricing practices. Specifically, there have been several recent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. The effect of these reform efforts on our business and the healthcare industry in general is not yet known.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional state and federal healthcare reform measures are expected to be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for certain pharmaceutical products or additional pricing pressures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While some of these and other proposed measures may require additional authorization to become effective, Congress and the Biden administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Governments outside the U.S. may impose strict price controls, which may adversely affect our revenues, if any.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some countries, including Canada and certain Member States of the EU, the pricing of prescription drugs is, in part, subject to governmental control. Additional countries may adopt similar approaches to the pricing of prescription drugs. In such countries, pricing negotiations with governmental authorities can take considerable time after receipt of regulatory approval for a product. The EU provides options for the EU Member States to restrict the range of drug products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. EU Member States may approve a specific price for a product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other EU Member States allow companies to fix their own prices for drug products, but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after coverage and reimbursement have been obtained. Reference pricing used by various countries and parallel distribution, or arbitrage between low-priced and high-priced countries, can further reduce prices. In some countries, we may be required to conduct a clinical trial or other trials that compare the cost-effectiveness of AMX0035 or any future product candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval, which is time-consuming and costly. We cannot be sure that such prices and reimbursement will be acceptable to us. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if reimbursement of our products is unavailable or limited in scope or amount, our revenues from sales by us or our strategic partners and the potential profitability of AMX0035 or any future product candidates in those countries would be negatively affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our relationships with healthcare providers, physicians, patients and third-party payors may be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare providers, physicians and third-party payors in the U.S. and elsewhere play a primary role in the recommendation and prescription of pharmaceutical products. Arrangements with third-party payors and customers can expose pharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations, including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act, or FCA, which may constrain the business or financial arrangements and relationships through which such companies conduct research, sell, market and distribute pharmaceutical products. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials. For more information, see the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business &#x2013; Government Regulation - Other U.S. Healthcare Laws</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., to help patients afford our approved product, we may implement programs to assist them, including patient assistance programs and co-pay coupon programs for eligible patients. Government enforcement agencies have shown increased interest in pharmaceutical companies&#x2019; product and patient assistance programs, including reimbursement support</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">services, and a number of investigations into these programs have resulted in significant civil and criminal settlements. In addition, at least one insurer has directed its network pharmacies to no longer accept co-pay coupons for certain specialty drugs the insurer identified. Our co-pay coupon programs could become the target of similar insurer actions. In September 2014, the HHS Office of Inspector General, or OIG, issued a Special Advisory Bulletin warning manufacturers that they may be subject to sanctions under the federal anti-kickback statute and/or civil monetary penalty laws if they do not take appropriate steps to exclude Part D beneficiaries from using co-pay coupons. Accordingly, companies exclude these Part D beneficiaries from using co-pay coupons and the same is true for our Amylyx Care Team. It is possible that changes in insurer policies regarding co-pay coupons and/or the introduction and enactment of new legislation or regulatory action could restrict or otherwise negatively affect these patient support programs, which could result in fewer patients using affected products, such as RELYVRIO in the U.S., and therefore could have a material adverse effect on our sales, business, and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third party patient assistance programs that receive financial support from companies have also become the subject of enhanced government and regulatory scrutiny. The OIG has established guidelines that suggest that it is lawful for pharmaceutical manufacturers to make donations to charitable organizations who provide co-pay assistance to Medicare patients. However, donations to patient assistance programs have received some negative publicity and have been the subject of multiple government enforcement actions, related to allegations regarding their misuse to promote branded pharmaceutical products over other less costly alternatives. Specifically, in recent years, there have been multiple settlements resulting out of government claims challenging the legality of third party patient assistance programs under a variety of federal and state laws. We may, from time to time, make charitable grants to independent charitable foundations that help financially needy patients with their premium, co-pay, and co-insurance obligations. If we choose to do so, and if we or our vendors or donation recipients are deemed to fail to comply with relevant laws, regulations or evolving government guidance in the provision of charitable donations or operation of these programs, we could be subject to damages, fines, penalties, or other criminal, civil, or administrative sanctions or enforcement actions. We cannot ensure that our compliance controls, policies, and procedures will be sufficient to protect against acts of our employees, business partners, vendors or charitable foundations that may violate the laws or regulations of the jurisdictions in which we operate. Regardless of whether we have complied with the law, a government investigation, including of any business partners, vendors or charitable foundations, could impact our business practices, harm our reputation, divert the attention of management, increase our expenses, and reduce the availability of foundation support for our patients who need assistance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The distribution of pharmaceutical products is also subject to additional requirements and regulations, including extensive recordkeeping, licensing, storage and security requirements intended to prevent the unauthorized sale of pharmaceutical products. Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations. The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, exclusion from U.S. government-funded healthcare programs, such as Medicare and Medicaid, or similar programs in other countries or jurisdictions, disgorgement, imprisonment, contractual damages, reputational harm, diminished profits, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the delay, reduction, termination or restructuring of our operations. Further, defending against any such actions can be costly and time-consuming, and may require significant financial and personnel resources. Therefore, even if we successfully defend against any such actions that may be brought against us, our business may be impaired. If any of the physicians or other providers or entities with whom we expect to do business is found to not comply with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs and imprisonment. If any of the above occur, it could adversely affect our ability to operate our business and our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Compliance with global privacy and data security requirements could result in additional costs and liabilities to us or inhibit our ability to collect and process data globally, and the failure to comply with such requirements could subject us to significant fines and penalties, which may have a material adverse effect on our business, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The regulatory framework for the collection, use, safeguarding, sharing, transfer and other information processing worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Globally, virtually every jurisdiction in which</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we operate has established its own data security and privacy frameworks with which we must comply. For example, the collection, use, disclosure, transfer, or other processing of personal data regarding individuals in the EEA and UK, including personal health data, is subject to the GDPR. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining the consent of the individuals to whom the personal data relates, providing detailed information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to countries outside the EEA/UK that are not considered by the European Commission and the UK government as providing &#x201c;adequate&#x201d; protection to personal data, including the U.S., and, as a result, increases the scrutiny that clinical trial sites located in the EEA should apply to transfers of personal data from such sites to countries that are considered to lack an adequate level of data protection, such as the U.S. Such transfers of personal data outside of the EEA and UK are prohibited unless a valid GDPR transfer mechanism (for example, the European Commission approved Standard Contractual Clauses, or SCCs, and the UK International Data Transfer Agreement/Addendum, or UK IDTA) has been put in place. Where relying on the SCCs /UK IDTA for data transfers, we may also be required to carry out transfer impact assessments to assess whether the recipient is subject to local laws which allow public authority access to personal data. The international transfer obligations under the EEA/UK data protection regimes will require significant effort and cost, and may result in us needing to make strategic considerations around where EEA/UK personal data is transferred and which service providers we can utilize for the processing of EEA/UK personal data. The GDPR also permits data protection authorities to require the destruction of improperly gathered or used personal information and or impose substantial fines for violations of the GDPR, which can be up to four percent of global revenues or &#x20ac;20 million (&#163;17.5 million), whichever is greater and it also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. In addition, EU member states have adopted national laws to supplement the EU GDPR, which may partially deviate from the EU GDPR, and the competent authorities in the EU Member States may interpret EU GDPR obligations slightly differently from country to country, such that we do not expect to operate in a uniform legal landscape in the EEA with respect to data protection regulations. Although the UK is regarded as a third country under the EU GDPR, the European Commission has now issued a decision recognizing the UK as providing adequate protection under the EU GDPR and, therefore, transfers of personal data originating in the EEA to the UK remain unrestricted. The UK Government has introduced a Data Protection and Digital Information Bill, or UK Bill, into the UK legislative process to reform the UK&#x2019;s data protection regime, and if passed, the final version of the UK Bill may have the effect of further altering the similarities between the UK and EEA data protection regimes and threaten the UK Adequacy Decision from the European Commission, which may lead to additional compliance costs for us and could increase our overall risk. The respective provisions and enforcement of the EU GDPR and UK GDPR may further diverge in the future and create additional regulatory challenges and uncertainties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar actions are either in place or underway in the U.S. There are a broad variety of data protection laws that are applicable to our activities, and a wide range of enforcement agencies at both the state and federal levels that can review companies for privacy and data security concerns based on general consumer protection laws. The Federal Trade Commission and state Attorneys General are all aggressive in reviewing consumers&#x2019; privacy and data security protections. New laws also are being considered at both the state and federal levels. For example, the California Consumer Privacy Act&#x2014;which went into effect on January 1, 2020&#x2014;is creating similar risks and obligations as those created by GDPR, though the Act does exempt certain information collected as part of a clinical trial subject to the Federal Policy for the Protection of Human Subjects, or the Common Rule. Many other states are considering similar legislation. A broad range of legislative measures also has been introduced at the federal level. Accordingly, failure to comply with federal and state laws (both those currently in effect and future legislation) regarding the privacy and security of personal information could expose us to fines and penalties under such laws. There also is the threat of consumer class actions related to these laws and the overall protection of personal data. Even if we are not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could harm our reputation and our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with the above requirements and any other data privacy and data security laws and regulations is a rigorous and time-intensive process and requires significant resources and an ongoing review of our technologies, systems and practices, as well as those of any third-party collaborators, service providers, contractors or consultants that process or transfer personal data. The GDPR and other changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, such as healthcare data or other personal information from our clinical trials, could require us to change our business practices and put in place additional compliance mechanisms, may interrupt or delay our development, regulatory and commercialization activities and increase our cost of doing business, and could lead to government enforcement actions,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">private litigation and significant fines and penalties against us and could have a material adverse effect on our business, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to the Discovery and Development of Our Current and Future Product Candidates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We currently depend on the success of AMX0035. If we are unable to maintain, or obtain additional, regulatory approvals for, and successfully commercialize, AMX0035, or experience significant delays in doing so, our business may be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently only have one advanced product candidate, AMX0035, and our current business and future success depends entirely on our ability to develop, maintain, or obtain additional, regulatory approvals for, and then successfully commercialize, AMX0035, which we are developing for patients with ALS, Wolfram syndrome, AD and other neurological diseases. To date, we have obtained limited clinical trial data supporting AMX0035, having only completed a clinical trial of 137 patients with ALS and a clinical trial in 95 patients with AD. We are conducting a global Phase 3 clinical trial of AMX0035 in ALS and intend to conduct additional clinical trials for other indications in the future. This may make an investment in our company riskier than similar companies that have multiple product candidates in active development that may be able to better sustain failure of a lead product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recently received approval from the FDA for RELYVRIO for the treatment of ALS in adults and marketing authorization with conditions from Health Canada for ALBRIOZA for the treatment of ALS and we have a MAA pending before the EMA for AMX0035. Accordingly, we are investing the majority of our efforts and financial resources in the further development and commercialization of our product candidate, AMX0035, for the treatment of ALS and other diseases. Successful continued development and additional regulatory approvals of AMX0035 for our initial and potential additional indications is critical to the future success of our business. We will need to have sufficient funds for, and successfully enroll and complete, our clinical development of AMX0035 for the treatment of ALS, AD and other indications. The future regulatory and commercial success of AMX0035 or any future product candidates are subject to a number of risks, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">successful completion of preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">successful patient enrollment in clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">successful data from our preclinical studies and clinical trials that supports an acceptable risk-benefit profile of AMX0035 or any future product candidates in the intended populations; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">satisfaction of applicable regulatory requirements, including to satisfy applicable rules governing fixed dose combination products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the interpretation of our preclinical and clinical data by regulatory authorities to support marketing approvals; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential unforeseen safety issues or adverse side effects; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">receipt and maintenance of marketing approvals from applicable regulatory authorities, including with any expected NCE and new clinical investigation data exclusivity and orphan drug market exclusivity; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for AMX0035 or any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">making arrangements with third-party manufacturers, or establishing manufacturing capabilities, for both clinical and commercial supplies of AMX0035 or any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">entry into collaborations to further the development of AMX0035 or any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">establishing sales, marketing and distribution capabilities and launching commercial sales of our products, including of RELYVRIO in the U.S., ALBRIOZA in Canada and AMX0035, if and when approved in other jurisdictions, whether alone or in collaboration with others; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">successfully launching and conducting commercial sales of RELYVRIO in the U.S., ALBRIOZA in Canada and AMX0035 or any future product candidates, if and when approved in other jurisdictions; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">acceptance of AMX0035, or any other products, if and when approved, by patients, the medical community and third-party payors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining third-party coverage and adequate reimbursement; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintaining a continued acceptable safety profile of the products following approval; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">effectively competing with other therapies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ensuring that we promote and distribute our products consistent with all applicable healthcare laws; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enforcing and defending intellectual property rights and claims. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of these risks are beyond our control, including the risks related to clinical development, the regulatory submission process, potential threats to our intellectual property rights and the manufacturing, marketing and sales efforts of any future collaborator. If we are unable to develop, obtain or maintain additional regulatory approvals for, or successfully commercialize AMX0035 for the indications we are developing it for, or if we experience delays as a result of any of these risks or otherwise, our business could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, of the large number of drugs in development in the pharmaceutical industry, only a small percentage result in the submission of marketing applications to regulatory authorities, and even fewer are approved for commercialization. Furthermore, even if we do receive regulatory approval for AMX0035 for any indication, any such approval may be subject to limitations on the indications or uses or the patient populations for which we may market the product. Accordingly, even if we are able to obtain the requisite financing to continue to fund our development activities, we cannot assure you that we will successfully develop or commercialize AMX0035 for any indication in any jurisdiction. If we or any of our future collaborators are unable to develop, maintain, or obtain additional, regulatory approvals for, or, if approved, successfully commercialize AMX0035 for our initial or potential additional indications, we may not be able to generate sufficient revenue to continue our business. In addition, our failure to demonstrate positive results in our clinical trials in any indication for which we are developing AMX0035, or to satisfy other regulatory requirements could adversely affect our development efforts for AMX0035 in other indications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The delay or denial of regulatory approval, inability to maintain regulatory approval, inability to complete post-marketing requirements, or the requirement to resubmit any marketing application with additional data or information for AMX0035 in any jurisdiction could mean that we need to delay or even cease operations, and a delay in obtaining or inability to maintain such approval would delay commercialization of AMX0035 and adversely impact our ability to generate revenue, our business and our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not successful in commercializing AMX0035, or are significantly delayed in doing so, our business will be materially harmed, and we may need to curtail or cease operations. The research, testing, manufacturing, labeling, approval, sale, marketing and distribution of drug products are subject to extensive regulation by the FDA, Health Canada, the EMA, and other regulatory agencies in the U.S. and other countries, and such regulations differ from country to country. We are not permitted to market AMX0035 until we receive approval or marketing authorization from the relevant regulatory authority. In September 2022, we received approval from the FDA for AMX0035 (RELYVRIO) for the treatment of ALS in adults and, as part of our approval of RELYVRIO in the U.S., we have post-marketing requirements to conduct carcinogenicity studies in mice and rats, drug-drug interaction studies, and studies in patients with kidney or liver impairment. We also received marketing authorization with conditions from Health Canada for AMX0035 (ALBRIOZA) for the treatment of ALS. One of the conditions of the approval in Canada is the provision of data from our ongoing PHOENIX trial and additional planned or ongoing studies. We are also actively pursuing regulatory approval of AMX0035 for the treatment of ALS in Europe. Our MAA remains under review by the CHMP of the EMA. We completed the Scientific Advisory Group meeting. Certain major objections remain, and the CHMP has adopted another round of questions as part of the regulatory process. We are now in possession of those questions. In order to respond in accordance with the updated timelines, we now expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest. It is possible that we may be unable to successfully address the outstanding major objections to achieve EMA approval in this review cycle.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA, Health Canada, the EMA or any other foreign regulatory agency can delay, limit, deny or withdraw approval to market AMX0035 for many reasons, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to demonstrate to the satisfaction of, the FDA, Health Canada, the EMA or any other applicable foreign regulatory agency that AMX0035 is safe and effective for the requested indication;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to gain agreement from applicable foreign regulatory authorities that AMX0035 is appropriate for approval under applicable regulatory pathways;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA&#x2019;s, Health Canada&#x2019;s, the EMA&#x2019;s or any other applicable foreign regulatory agency&#x2019;s disagreement with the interpretation of data from preclinical and clinical studies and trials, such as the FDA&#x2019;s differing interpretations of certain data, including sensitivity and statistical analyses, from our CENTAUR trial and OLE as presented at the meetings of the FDA&#x2019;s Advisory Committee on March 30, 2022 and September 7, 2022;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to demonstrate that the clinical and other benefits of AMX0035 outweigh any safety or other perceived risks;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to enroll an adequate number of patients in and successfully complete our ongoing global Phase 3 PHOENIX trial;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA&#x2019;s, Health Canada&#x2019;s, the EMA&#x2019;s or any other applicable foreign regulatory agency&#x2019;s requirement for additional preclinical or clinical studies or trials, including studies to satisfy applicable rules governing fixed dose combination products or post-market requirements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA&#x2019;s, Health Canada&#x2019;s, the EMA&#x2019;s or any other applicable foreign regulatory agency&#x2019;s having differing requirements for the trial protocols used in our clinical trials;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA&#x2019;s, Health Canada&#x2019;s, the EMA&#x2019;s or any other applicable foreign regulatory agency&#x2019;s non-approval of the formulation, labeling and/or the specifications of AMX0035;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA&#x2019;s, Health Canada&#x2019;s, the EMA&#x2019;s or any other applicable foreign regulatory agency&#x2019;s failure to accept the manufacturing processes or third-party manufacturers with which we contract; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential for approval policies or regulations the FDA, of Health Canada, the EMA or any other applicable foreign regulatory agencies to significantly change in a manner rendering our clinical data insufficient for approval.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Of the large number of drugs in development, only a small percentage successfully complete the FDA, Health Canada, the EMA or other regulatory approval processes and are commercialized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA or the applicable foreign regulatory agency may also approve AMX0035 for a more limited indication and/or a narrower patient population than we originally request, and the FDA, Health Canada, the EMA or any other applicable foreign regulatory agency may not approve the labeling that we believe is necessary or desirable for the successful commercialization of AMX0035. Any delay in obtaining, or inability to obtain, applicable regulatory approval would delay or prevent commercialization of AMX0035 and would materially adversely impact our business and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">AMX0035 is a fixed-dose combination drug product and certain regulatory authorities may require a demonstration that each component makes a contribution to the claimed effects in addition to demonstrating that the combination is safe and effective for the intended population.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the FDA's combination rule, the FDA may not file or approve an NDA for a fixed-dose combination product unless each component of a proposed drug product is shown to make a contribution to the claimed effects and the dosage of each component (amount, frequency, duration) is safe and effective for the intended population. To satisfy these requirements, the FDA typically requires a clinical factorial study, designed to assess the effects attributable to each drug in the combination product. This is particularly true when the ingredients are directed at the same sign or symptom of the disease or condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA has accepted a variety of approaches to satisfy the combination rule. In December 2015, the FDA proposed regulations that would allow the agency to waive the requirements of the combination rule for certain drug products under particular circumstances. The FDA has not, to date, finalized these regulations, but the FDA has stated that factorial studies may be unethical (e.g., omitting a drug known to improve survival) or impractical (there may be too many components to conduct a factorial study, meaning the trial cannot be conducted). The FDA has also stated that it may be possible to use other types of clinical and preclinical data and mechanistic information available to demonstrate the contributions of the individual active ingredients to the effect of the combination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar requirements may be imposed on us by the EMA in the EU and comparable regulatory authorities in other jurisdictions where we intend to seek regulatory approval. In the EU, we have only submitted preclinical data to demonstrate the clinical effects of each component in AMX0035, PB and TURSO (also known as TUDCA), in our MAA. There can be no assurance that the EMA will conclude that our preclinical data are sufficient for these purposes or, even if they are, that the results from our preclinical studies demonstrate the clinical effects of each component in AMX0035 for the treatment of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ALS. We may be required to produce clinical data supporting the contribution of each component when present at the levels included in the fixed-dose combination in order to obtain marketing authorization in the EU.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While the FDA has approved AMX0035 (known as RELYVRIO) as a fixed-dose combination product for the treatment of ALS in adults, we may be required by the FDA and comparable foreign regulatory authorities to satisfy the fixed-dose combination rule for AMX0035 or any other fixed-dose combination products we may develop for the treatment of any other indications we may pursue in advance of approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the FDA, the EMA or other comparable foreign regulatory authorities require us to conduct one or more clinical trials to support such a demonstration, such as a factorial study, the design, duration, and scope of such clinical trials will be decided upon after further discussions with those agencies and other comparable foreign regulatory authorities. As a result, we are unable to predict with certainty the estimated timing or scope of any future clinical trials of AMX0035 we may be required to conduct to satisfy these requirements governing fixed dose combination products in various jurisdictions. Ongoing third-party data in neurology, specifically within ALS, on our products or other products may influence regulatory decision making, including for fixed-dose combinations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have concentrated our research and development efforts on the treatment of neurodegenerative and CNS disorders, a field that has seen very limited success in product development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have focused our research and development efforts on addressing neurodegenerative and CNS disorders. Historically, efforts by pharmaceutical companies in the field of neurodegenerative and CNS disorders have experienced limited successes in product development. The development of neurodegenerative and CNS therapies presents unique challenges, including an imperfect understanding of the biology, the presence of the blood brain barrier that can restrict the flow of drugs to the brain, a frequent lack of translatability of preclinical study results in subsequent clinical trials and dose selection, and the product candidate having an effect that may be too small to be detected using the outcome measures selected in clinical trials or if the outcomes measured do not reach statistical significance. There are few approved therapeutic options available for patients with ALS, AD and other neurodegenerative disorders. Our future success is highly dependent on the successful development and commercialization of AMX0035 and any future product candidates for treating neurodegenerative and CNS disorders. Developing and commercializing AMX0035 and any future product candidates for treatment of neurodegenerative and CNS disorders subjects us to a number of challenges, including ensuring that we have selected the optimal doses, executing an appropriate clinical trial to test for efficacy and obtaining and maintaining regulatory approval from Health Canada, the FDA, the EMA and other comparable foreign regulatory authorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The regulatory approval processes of the FDA, Health Canada, the EMA and other comparable foreign authorities are lengthy, time-consuming and inherently unpredictable, and if we are ultimately unable to obtain or maintain regulatory approval for AMX0035 or any future product candidates, our business will be substantially harmed. A finding that our global Phase 3 PHOENIX trial is insufficient to support current or additional marketing authorizations in ALS could lead the FDA or Health Canada to restrict or withdraw prior regulatory approvals for RELYVRIO or ALBRIOZA, respectively, or we could decide, after consultation with regulatory authorities, to voluntarily withdraw RELYVRIO or ALBRIOZA from the marketplace.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, and any future collaborators, are not permitted to commercialize, market, promote or sell any product candidate in the U.S., Canada, or the EU without obtaining regulatory approval from the FDA, Health Canada, or the EMA, respectively. Regulatory authorities in other jurisdictions may have similar requirements. The time required to obtain approval by the FDA, Health Canada, the EMA and other comparable foreign regulatory authorities is unpredictable, and typically takes many years following the commencement of clinical trials and depends upon numerous factors, including substantial discretion of such regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#x2019;s clinical development and may vary among jurisdictions. The FDA in any approval needs to determine that there is substantial evidence of effectiveness. This finding can be substantiated based on two adequate and well-controlled studies, or in certain circumstances on a single, large, multicenter, adequate and well-controlled study that is very persuasive or from a single adequate and well-controlled study together with confirmatory evidence. FDA regulations and guidance also allow for greater flexibility and tolerance for uncertainty in the context of rare and fatal diseases. In June 2022, we obtained marketing authorization with conditions for AMX0035 (ALBRIOZA) in Canada and in September 2022, we received approval from the FDA for AMX0035 (RELYVRIO) in the U.S. While we have received approval from the FDA and marketing authorization with conditions from Health Canada, and have submitted an MAA to the EMA, to date, we have not submitted any other similar drug approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">submissions to comparable foreign regulatory authorities for AMX0035 or any other product candidate. Our MAA for AMX0035 is still under review by the EMA, and there can be no assurance that we will receive approval. We completed the Scientific Advisory Group meeting. Certain major objections remain, and the CHMP has adopted another round of questions as part of the regulatory process. We are now in possession of those questions. In order to respond in accordance with the updated timelines, we now expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest. It is possible that we may be unable to successfully address the outstanding major objections to achieve EMA approval in this review cycle.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One of the conditions of the marketing authorization in Canada is the provision of data from our ongoing PHOENIX trial. There is no guarantee that Health Canada will accept the data from our PHOENIX trial as satisfying the conditions and grant a marketing authorization without conditions for ALBRIOZA for the treatment of ALS. Health Canada could require us to make further undertakings with respect to confirmatory clinical trials if it is not satisfied with the data from the PHOENIX trial, in order for AMX0035 to continue to be marketed in Canada.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our approval of RELYVRIO by the FDA was granted following a positive recommendation for approval at the second virtual meeting of the Advisory Committee held on September 7, 2022. The Advisory Committee initially met on March 30, 2022 and voted 4 (yes) and 6 (no) on the question of whether the data from our randomized, controlled Phase 2 CENTAUR trial and OLE established a conclusion that AMX0035 is effective in the treatment of patients with ALS. At the second meeting of the Advisory Committee, the Advisory Committee voted 7 (yes) to 2 (no) in response to the question of whether available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS, taking into account the unmet need in ALS, the status of the ongoing PHOENIX trial and the seriousness of ALS. Although the FDA subsequently approved RELYVRIO for the treatment of ALS in adults, at this meeting and the previous Advisory Committee meeting, the FDA presented concerns regarding choices of statistical models for the prespecified primarily analysis and the interpretability of the survival results included in our marketing application. Other regulatory authorities may present similar concerns regarding our data when reviewed to support marketing applications for AMX0035 for the treatment of ALS. For example, the Rapporteurs Day 190 Joint CHMP Response Assessment Report contains major objections relating to the sufficiency of the clinical data in CENTAUR to support approval. If we experience delays in obtaining and maintaining regulatory approval or if we fail to obtain or maintain such approvals, the commercial prospects for AMX0035 may be harmed and our ability to generate revenues or obtain additional approvals and the value of our common stock will be materially impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical testing is expensive, difficult to design and implement, can take many years to complete and is inherently uncertain as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all. The clinical development of AMX0035 for our initial and potential additional indications or any future product candidates is susceptible to the risk of failure inherent at any stage of development, including failure to demonstrate efficacy in a clinical trial or across a broad population of patients, the occurrence of adverse events that are severe or medically or commercially unacceptable, failure to comply with protocols or applicable regulatory requirements, and determination by the FDA, Health Canada, the EMA or any other comparable foreign regulatory authority that a product candidate may not continue development or is not approvable. Additionally, our expenses could increase if we are required by the FDA, Health Canada, the EMA or any other comparable foreign regulatory authority to perform clinical trials in addition to those currently expected, or if there are any delays in completing our clinical trials or the development of AMX0035 in additional indications. It is possible that even if AMX0035 or any future product candidate has a beneficial effect, that effect will not be detected during clinical evaluation as a result of one or more of a variety of factors, including the size, duration, design, measurements, conduct or analysis of our clinical trials. Conversely, as a result of the same factors, our clinical trials may indicate an apparent positive effect of AMX0035 or any future product candidate that is greater than the actual positive effect, if any. Similarly, in our clinical trials we may fail to detect toxicity of or intolerability caused by AMX0035 or any future product candidate, or mistakenly believe that AMX0035 or any future product candidates are toxic or not well-tolerated when that is not in fact the case.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 could fail to obtain additional regulatory approvals, and any of our future product candidates could fail to obtain regulatory approvals, for many reasons, including the following:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities may disagree as to the design or implementation of our clinical trials and may require additional data to support regulatory approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate to the satisfaction of the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication and, if necessary, that a product candidate and any active components thereof are safe and effective for the proposed indication;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of clinical trials may not meet the level of statistical significance required by the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities for approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate that a product candidate&#x2019;s clinical and other benefits outweigh its safety risks;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, Health Canada, the EMA and comparable authorities in other countries may disagree with our interpretation of data from clinical trials or preclinical studies and may require additional trials or studies to support marketing approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the data collected from clinical trials of AMX0035 or any future product candidates may not be sufficient to support the submission of an NDA or other submission to the FDA or other comparable foreign regulatory authority to obtain regulatory approval in the U.S., Canada, the EU or elsewhere;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities may find deficiencies with clinical trial sites or fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the approval policies or regulations of the FDA, Health Canada, the EMA or other comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This lengthy approval process as well as the unpredictability of clinical trial results may result in our failing to obtain regulatory approval to market AMX0035 or any future product candidate we develop, which would significantly harm our business, results of operations and prospects. There is no assurance that the endpoints and trial designs used for the approval of currently approved drugs for the treatment of neurodegenerative diseases will be acceptable for future approvals, including for AMX0035. The FDA, Health Canada, the EMA and other comparable foreign authorities have substantial discretion in the approval process and determining when or whether regulatory approval will be obtained for any product candidate that we develop. Even if we believe the data collected from past or future clinical trials of AMX0035 or any future product candidates are promising, such data may not be sufficient to support approval by the FDA or any other regulatory authority.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA reviews an NDA to determine whether the product is safe and effective for its intended use(s), with the latter determination being made on the basis of substantial evidence. This finding can be substantiated based on two adequate and well-controlled studies, or in certain circumstances on a single, large, multicenter, adequate and well-controlled study that is very persuasive or from a single adequate and well-controlled study together with confirmatory evidence. The FDA may not agree that this standard is met. Accordingly, there can be no assurance that for AMX0035 or future product candidates the FDA and other regulatory agencies, including Health Canada and the EMA, will not require additional clinical trials beyond what we may plan to conduct. This may be the case particularly as these regulatory authorities may consult with one another or as we may be required to apprise the respective agencies of studies we are conducting of AMX0035 for ALS in conjunction with our requests for marketing approval or in response to post-marketing requirements from the respective agency. In September 2022, we received approval for AMX0035 from the FDA for the treatment of ALS in adults, and as a part of our approval, we have post-marketing requirements to conduct carcinogenicity studies in mice and rats, drug-drug interaction studies, and studies in patients with kidney or liver impairment. In July 2022, we received marketing authorization for AMX0035 from Health Canada, with conditions, for the treatment of ALS. One of the conditions of the approval is the provision of data from our ongoing PHOENIX trial. There is no guarantee that Health Canada will accept the data from our PHOENIX trial and grant authorization without conditions for AMX0035 for the treatment of ALS. Additionally, the EMA may also find that our CENTAUR trial, together with any data from our global Phase 3 PHOENIX trial that may be provided during or after the review period for these applications, is not sufficient to support our request for marketing authorization in the EU. It is typically the case not just in the U.S., but also in Canada and Europe, that marketing approvals are based on two Phase 3 clinical studies. Moreover, any finding by another regulatory authority that our global Phase 3 PHOENIX trial is insufficient to support additional marketing authorizations in ALS could lead the FDA or Health Canada to restrict or withdraw prior regulatory approvals for RELYVRIO and ALBRIOZA, respectively. At the second meeting of the Advisory Committee on September 7, 2022, we stated that if our PHOENIX trial is not successful then we will do what is right for patients, which includes voluntarily removing the product from the market. Any such findings by a regulatory authority or decision to voluntarily withdraw AMX0035 from the marketplace would materially harm our ability to generate revenue and become profitable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, disruptions caused by the COVID-19 pandemic may increase the likelihood that we encounter difficulties or delays in initiating, screening, enrolling, conducting, or completing our ongoing and planned preclinical studies and clinical trials. Clinical site initiation and patient screening and enrollment may be delayed due to prioritization of hospital resources toward the COVID-19 pandemic. Investigators and patients may not be able to comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. Similarly, our ability to recruit and retain patients and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19, could be limited, which in turn could adversely impact our clinical trial operations. Additionally, we may experience interruption of key clinical trial activities, such as clinical trial site monitoring, due to limitations on travel, quarantines or social distancing protocols imposed or recommended by federal or state governments, employers and others in connection with the ongoing COVID-19 pandemic. As a result of the COVID-19 pandemic, we may face delays in meeting our anticipated timelines for our ongoing and planned clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since March 2020, when foreign and domestic inspections were largely placed on hold due to the COVID-19 pandemic, the FDA has been working to resume pre-pandemic levels of inspection activities, including routine surveillance, bioresearch monitoring and pre-approval inspections. Should the FDA determine that an inspection is necessary for approval and an inspection cannot be completed during the review cycle due to restrictions on travel, and the FDA does not determine a remote interactive evaluation to be adequate, the agency has stated that it generally intends to issue, depending on the circumstances, a complete response letter or defer action on the application until an inspection can be completed. Further, if there is inadequate information to make a determination on the acceptability of a facility, the FDA may defer action on the application until an inspection can be completed. During the COVID-19 pandemic, a number of companies announced receipt of complete response letters due to the FDA&#x2019;s inability to complete required inspections for their applications. Regulatory authorities outside the U.S. may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic and may experience delays in their regulatory activities. For example, with respect to new sites or facilities in the EEA which have never had a cGMP inspection or authorization, the EMA has stated that a distant assessment may be conducted in order to evaluate if the site could be authorized without an on-site pre-approval inspection. If an approval is granted, it should be indicated that the certificate has been granted on the basis of a distant assessment and an on-site inspection should be conducted when circumstances permit. If a cGMP certificate cannot be granted as a result of the distant assessment, a clock-stop in the regulatory approval process will be imposed until an on-site inspection is possible. In addition, even if we were to obtain approval, regulatory authorities may approve AMX0035 or any future product candidates for fewer or more limited indications than we request, may not approve the price we intend to charge for our products, may grant approval contingent on the performance of costly post-marketing preclinical studies and clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for AMX0035 or any future product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Canada, pre-approval GMP inspections are not performed in association with the NDS. Instead, Health Canada relies on a Drug Establishment License, or DEL, to determine the site&#x2019;s compliance with GMP. DELs can only be held by companies in Canada, and that company becomes the importer of record for the drug. To import, the sites of manufacture, testing and packaging of the Drug Substance and Drug Product are required to be listed on the DEL. Listing is dependent on having an inspection report from a recognized sister regulatory agency such as the EMA or the FDA. As a result of the COVID-19 pandemic, inspection reports can now be up to three years old. The site of manufacture of the drug product for AMX0035 is in Canada and is subject to routine inspections from Health Canada. These Canadian inspections are currently being performed remotely as a result of the COVID-19 pandemic.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may incur unexpected costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To obtain regulatory approval to commercialize AMX0035 and any future product candidates, we must demonstrate through extensive preclinical studies and clinical trials that such product candidates are safe and effective in humans. Preclinical and clinical testing are expensive and can take many years to complete, and their outcome is inherently uncertain. Failure can occur at any time during the clinical trial process and our future clinical trial results may not be successful, which could impact our ability to obtain additional regulatory approvals for AMX0035, to satisfy any applicable post-market conditions or requirements or to continue marketing AMX0035 in the U.S. and Canada. We could also be required by regulatory authorities to withdraw AMX0035 from the marketplace. This could impact our development plans for AMX0035 for other indications and future product candidates and could impact our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may experience delays in completing our clinical trials or preclinical studies and initiating or completing additional clinical trials. We may also experience numerous unforeseen events during our clinical trials that could delay or prevent our ability to receive marketing approval or commercialize AMX0035 or any future product candidates we develop, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulators, or institutional review boards, or IRBs, or other reviewing bodies may not authorize us or our investigators to commence a clinical trial, or to conduct or continue a clinical trial at a prospective or specific trial site; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not reach agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of subjects or patients required for clinical trials of AMX0035 in an indication or any future product candidate may be larger than we anticipate, enrollment in these clinical trials may be insufficient or slower than we anticipate, and the number of clinical trials being conducted at any given time may be high and result in fewer available patients for any given clinical trial, or patients may drop out of these clinical trials at a higher rate than we anticipate; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our third-party contractors, including those manufacturing AMX0035 or any future product candidates or conducting clinical trials on our behalf, may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may have to amend clinical trial protocol submitted to regulatory authorities or conduct additional studies to reflect changes in regulatory requirements or guidance, which we may be required to resubmit to an IRB and regulatory authorities for re-examination; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unforeseen safety events may occur during the course of a clinical trial and these events may result in the temporary suspension or termination of a clinical trial, or require urgent safety measures or restrictions to protect human subjects during the conduct of a clinical trial; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulators, IRBs or other reviewing bodies may fail to approve or subsequently find fault with the manufacturing processes or facilities of third-party manufacturers with which we enter into agreement for clinical and commercial supplies, or the supply or quality of AMX0035 or any future product candidate or other materials necessary to conduct clinical trials of AMX0035 or any future product candidates may be insufficient, inadequate or not available at an acceptable cost, or we may experience interruptions in supply; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential for approval policies or regulations of Health Canada, the FDA, the EMA or any other applicable foreign regulatory agencies to significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulators, IRBs of the institutions in which clinical trials are being conducted or data monitoring committees may suspend or terminate a clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Negative or inconclusive impressions of the results from our earlier clinical trials of AMX0035 for the treatment of ALS or AD, or any other clinical trial or preclinical studies in animals that we have conducted, could mandate repeated or additional preclinical studies or clinical trials and could delay marketing approvals or result in changes to or delays in preclinical studies or clinical trials of AMX0035 in other indications. We do not know whether any clinical trials that we may conduct will demonstrate adequate efficacy and safety to result in regulatory approval to market AMX0035 for our initial or potential additional indications, or any future product candidate. If later stage clinical trials, including our ongoing global Phase 3 PHOENIX trial in ALS, do not produce favorable results with very strong statistical significance, our ability to obtain or maintain any prior-issued regulatory approval for AMX0035 for ALS (including our FDA approval and our marketing authorization with conditions from Health Canada) or potential additional indications, or any future product candidate, may be adversely impacted.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure to successfully initiate and complete clinical trials of AMX0035 for ALS, AD or potential additional indications and to demonstrate the efficacy and safety of AMX0035, including each component thereof, necessary to obtain and maintain regulatory approval to market AMX0035, including if our global Phase 3 PHOENIX trial is not successful, would</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significantly harm our business and ability to continue developing and marketing AMX0035 for any indications. Our product candidate development costs will also increase if we experience delays in testing or obtaining and maintaining regulatory approvals and we may be required to obtain additional funds to complete clinical trials. We cannot assure you that our clinical trials will begin as planned or be completed on schedule, if at all, or that we will not need to restructure our trials after they have begun. Significant clinical trial delays or the need for additional data from our clinical trials also could shorten any periods during which we may have the exclusive right to commercialize AMX0035 or any future product candidates or allow our competitors to bring products to market before we do and impair our ability to successfully commercialize such product candidates, which may harm our business and results of operations. In addition, many of the factors that cause, or lead to, delays of clinical trials may ultimately lead to the denial of regulatory approval of AMX0035 or any future product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we complete the necessary preclinical studies and clinical trials, the marketing approval process is expensive, time-consuming and uncertain and may prevent us or any future collaboration partners from obtaining or maintaining approvals for the commercialization of AMX0035 for our initial or potential additional indications as well as for any future product candidate we develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any product candidate we may develop and the activities associated with its development and commercialization, including its design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, and distribution, are subject to comprehensive regulation by Health Canada, the FDA, the EMA and other regulatory authorities in the U.S. and in other countries. Failure to obtain marketing approval for a product candidate will prevent us from commercializing that product candidate in a given jurisdiction. Although we have invested substantial time and resources to date in pursuit of regulatory approval and toward potential commercialization, we have only received regulatory approval for AMX0035 (RELYVRIO) in the U.S. and marketing authorization with conditions for AMX0035 (ALBRIOZA) in Canada and have not received any other regulatory approvals to market any product candidates from regulatory authorities in any jurisdiction and it is possible that none of the product candidates we may seek to develop in the future will ever obtain regulatory approval. We have no experience in filing and supporting the applications necessary to gain marketing approvals and rely on third-party CROs or regulatory consultants to assist us in this process. Securing regulatory approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the biologic product candidate&#x2019;s safety, purity, efficacy and potency. Securing regulatory approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Any product candidates we develop may not be effective, may be only moderately effective, or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process of obtaining marketing approvals, in the U.S., Canada, EU and other foreign jurisdictions, is expensive, may take many years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity, and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. The FDA, Health Canada, the EMA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide during the review process that our data are insufficient for approval and require additional preclinical, clinical or other studies. For example, during the review of our NDA for AMX0035 for the treatment of ALS, the FDA requested clarifying information regarding our preclinical and clinical data and during the Advisory Committee meetings noted certain concerns with interpretation of our clinical data. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit, or prevent marketing approval of, or limit the approved labeling for, a product candidate. For example, while we have conducted preclinical studies in various models of neurodegenerative diseases, it is the view of the FDA that the mechanism by which RELYVRIO exerts its therapeutic effects in patients with ALS is unknown. In addition, in the approved labeling for RELYVRIO, the FDA noted that the post hoc, long-term exploratory survival analysis should be interpreted with caution given the limitations of data collected outside of a controlled study. Additionally, the FDA has discretion to refer an application for a novel drug or a drug that presents difficult questions of safety or efficacy to an advisory committee. For example, our approval of RELYVRIO by the FDA was granted following the second virtual meeting of the Advisory Committee held on September 7, 2022. The Advisory Committee initially met on March 30, 2022 and voted 4 (yes) and 6 (no) on the question of whether the data from our randomized, controlled Phase 2 CENTAUR trial and OLE established a conclusion that AMX0035 is effective in the treatment of patients with ALS. At the second meeting of the Advisory Committee, the Advisory Committee voted 7 (yes) to 2 (no) in response to the question of whether available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS, taking into account the unmet need in ALS, the status of the ongoing PHOENIX trial</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and the seriousness of ALS. At this meeting and the previous Advisory Committee meeting, the FDA presented concerns regarding choices of statistical models for the prespecified primarily analysis and the interpretability of the survival results. Additionally, in July 2022 we received marketing authorization with conditions of AMX0035 (ALBRIOZA) from Health Canada for the treatment of ALS. One of the conditions of the marketing authorization in Canada is the provision of data from our ongoing PHOENIX trial. There is no guarantee that Health Canada will accept the data from our PHOENIX trial as satisfying the conditions and grant a marketing authorization without conditions for ALBRIOZA for the treatment of ALS or that the PHOENIX trial will be successful. Health Canada could require us to make further undertakings with respect to confirmatory clinical trials if it is not satisfied with the data from the PHOENIX trial, in order for AMX0035 to continue to be marketed in Canada. As such, we may be unable to obtain or to maintain the marketing approvals we are pursuing and any marketing approvals we ultimately obtain, including any conditional approvals, may be denied, limited, withdrawn, or subject to restrictions or post-approval commitments that could render the approved product not commercially viable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we experience delays in obtaining and maintaining approval or if we fail to obtain approval of any product candidates we may develop, the commercial prospects for those product candidates, including for AMX0035 in other indications, may be harmed, and our ability to generate revenues will be materially impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The results of early-stage clinical trials and preclinical studies may not be predictive of future results. Initial or preliminary data in our clinical trials may not be indicative of results obtained when these trials are completed or in later stage trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The results of preclinical studies may not be predictive of the results of clinical trials, and the results of any early-stage clinical trials we commence may not be predictive of the results of the later-stage clinical trials. In addition, initial data in clinical trials may not be indicative of results obtained when such trials are completed. There can be no assurance that any of our clinical trials will ultimately be successful or support further clinical development of AMX0035 or any future product candidates. In addition, the clinical results seen in the CENTAUR trial may not be repeated in our global Phase 3 PHOENIX clinical trial, which may materially impact our ability to obtain authorization without conditions for ALBRIOZA in Canada, to maintain our approval for RELYVRIO in the U.S., and to continue development of AMX0035 for additional indications or of future product candidates. There is a high failure rate for drugs and biologics proceeding through clinical trials. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier studies, and any such setbacks in our clinical development could have a material adverse effect on our business and operating results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, we have in the past utilized and may in the future utilize an &#x201c;open-label&#x201d; clinical trial design. An &#x201c;open-label&#x201d; clinical trial is one where both the patient and investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. Most open-label clinical trials test only the investigational product candidate and sometimes may do so at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. Open-label clinical trials may be subject to a &#x201c;patient bias&#x201d; where patients perceive their symptoms to have improved merely due to their awareness of receiving an experimental treatment. In addition, open-label clinical trials may be subject to an &#x201c;investigator bias&#x201d; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the treated group more favorably given this knowledge. The results from an open-label trial may not be predictive of future clinical trial results with AMX0035 or any future product candidates when studied in a controlled environment with a placebo or active control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may publish interim topline or preliminary data from our clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary or topline results also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed with caution until the final data are available. Adverse differences between preliminary or interim data and final data could significantly harm our reputation and business prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Enrollment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside our control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patient enrollment is a significant factor in the timing of clinical trials, and the timing of our clinical trials depends, in part, on the speed at which we can recruit patients to participate in our trials, as well as completion of required follow-up periods. We may not be able to initiate or continue clinical trials for AMX0035 or any future product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials to such trial&#x2019;s conclusion as required by Health Canada, the FDA, the EMA or other comparable foreign regulatory authorities. Additionally, certain clinical trials for AMX0035 and any future product candidates may be focused on indications with relatively small patient populations, which may further limit enrollment of eligible patients or may result in slower enrollment than we anticipate. The eligibility criteria of our clinical trials, once established, may further limit the pool of available trial participants. For example the number of patients suffering from ALS, is small and, in some cases, has not been established with precision. If the actual number of patients with these diseases is smaller than we anticipate, we may encounter difficulties in enrolling patients in our clinical trials, thereby delaying or preventing development and approval of AMX0035 or any future product candidates. Even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. For example, ALS patients have significant mobility issues, morbidities and other complications that have historically made retention in ALS trials, more challenging. These challenges are also present with many other neurodegenerative indications, including indications for which we may run clinical trials in the future. In the past, we have had discontinuations in our clinical trials, including in our CENTAUR trial and CENTAUR OLE trial. Discontinuations may occur in current or future trials and could result in delays of completion of our clinical trials and affect our ability to enroll additional patients in our clinical trials and impact the integrity of data from our clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patient enrollment and retention in clinical trials depends on many factors, including the size of the patient population, the severity of the disease under investigation, the nature of the trial protocol, the existing body of safety and efficacy data for the product candidate, the number and nature of competing treatments and ongoing clinical trials of or expanded access to competing therapies for the same indication, the proximity of patients to clinical sites, the eligibility criteria for the trial, the ability to adequately monitor patients during a trial, clinicians&#x2019; and patients&#x2019; perceptions as to the potential advantages of the product candidate being studied, and the risk that patients will drop out of a trial before completing all site visits. There are limited patient pools from which to draw in order to complete our clinical trials in a timely and cost-effective manner, including due to the fact that the neurological diseases we target are rare.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, our efforts to build relationships with patient communities may not succeed, which could result in delays in patient enrollment in our clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any negative results we may report in clinical trials of AMX0035 or any future product candidate may also make it difficult or impossible to recruit and retain patients in other clinical trials of that same product candidate. Delays or failures in planned patient enrollment or retention may result in increased costs, program delays or both, which could have a harmful effect on our ability to develop AMX0035 in ALS, AD and additional indications and any future product candidates, or could render further development impossible. For example, the impact of public health epidemics, such as the ongoing COVID-19 pandemic, may delay or prevent patients from enrolling or from receiving treatment in accordance with the protocol and the required timelines, which could delay our clinical trials, or prevent us or our partners from completing our clinical trials at all, and harm our ability to obtain and maintain approval for such product candidate. Further, if patients drop out of our clinical trials, miss scheduled doses or follow-up visits, or otherwise fail to follow clinical trial protocols, whether as a result of the COVID-19 pandemic and related illness, the integrity of data from our clinical trials may be compromised or not accepted by Health Canada, the FDA, the EMA or other regulatory authorities, which would represent a significant setback for the applicable program. In addition, we may rely on CROs and clinical trial sites to ensure proper and timely conduct of our future clinical trials and, while we intend to enter into agreements governing their services, we will be limited in our ability to compel their actual performance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in methods of product candidate manufacturing or formulation may result in additional costs or delay.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As product candidates proceed through preclinical studies to late-stage clinical trials towards potential approval and commercialization, it is common that various aspects of the development activities, such as manufacturing methods and formulation, are altered along the way in an effort to optimize processes and results. Any of these changes could cause AMX0035 or any future product candidates to perform differently and affect the results of ongoing clinical trials or other future clinical trials conducted with the materials manufactured using altered processes. For example, in seeking approval of AMX0035 in Europe, we submitted data supporting a different formulation of AMX0035 from the formulation evaluated in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the CENTAUR trial. Changes to commercial formulations from those studied clinically could lead regulatory authorities to delay the approval of our marketing applications until we can demonstrate through additional clinical data that there is comparability in the bioavailability of the two different formulations or may require us to revert to the prior formulation evaluated clinically. Should we have to conduct comparability testing to bridge earlier clinical data obtained from product candidates produced under earlier manufacturing methods or formulations with the planned commercial formulation, regulatory authorities may disagree on the interpretation of results from this testing. This could delay completion of clinical trials, require the repetition of one or more clinical trials, increase clinical trial costs, delay approval of AMX0035 or any future product candidates and jeopardize our ability to commence sales and generate revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">AMX0035 or any future product candidate may cause undesirable side effects or have other properties that could delay or prevent its regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following regulatory approval, if obtained.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Undesirable side effects caused by AMX0035, or any future product candidate, could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay, denial or withdrawal of regulatory approval by the FDA, Health Canada, the EMA or comparable foreign regulatory authorities. Results of our preclinical studies or clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics. In clinical trials of AMX0035 to date, AMX0035 has been generally well-tolerated, with most common treatment-emergent adverse events including diarrhea, abdominal pain, nausea, upper respiratory infection, constipation, headache, fatigue, proteinuria, and decreased appetite. In animal studies, administration of AMX0035 to rats throughout pregnancy and lactation resulted in increased offspring mortality at all doses tested, which were less than or similar to the clinical doses tested in our clinical trials. However, there can be no guarantee that we would observe a similar tolerability profile of AMX0035 in our ongoing global Phase 3 PHOENIX clinical trial or in other future clinical trials for ALS or other indications. Many compounds that initially showed promise in clinical or earlier stage testing are later found to cause undesirable or unexpected side effects that prevented further development of the compound.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If unacceptable or severe side effects arise in the development of AMX0035 or any future product candidates, we, the FDA, Health Canada, the EMA or comparable foreign regulatory authorities, the IRBs, or independent ethics committees at the institutions in which our trials are conducted, or the independent safety monitoring committee could suspend or terminate our clinical trials or regulatory authorities could order us to cease clinical trials or deny approval of AMX0035 or any future product candidates for any or all targeted indications. Treatment-emergent side effects that are deemed to be drug-related could also affect subject recruitment or the ability of enrolled subjects to complete the trial or result in potential product liability claims. Undesirable side effects in one of our clinical trials for AMX0035 in one indication could adversely affect enrollment in clinical trials, regulatory approval and commercialization of AMX0035 in other indications. Additionally, there may be negative findings regarding components of AMX0035 or future product candidates by other parties. For example, Humanitas Mirasole SpA, or Humanitas, is conducting a Phase 3 clinical trial in the EU to assess the safety and efficacy of TURSO in patients with ALS which may lead to additional findings as to the safety profile of TURSO. Any negative findings by third parties may impact the future approvability or labeling of AMX0035 or other product candidates we may develop. In addition, side effects may not be appropriately recognized or managed by the treating medical staff. We have no relationship with Humanitas. If their Phase 3 clinical trial is successful and TURSO is approved by the FDA or any other regulatory agency, TURSO may become a commercialized product competitive with AMX0035, unless our intellectual property protections and any regulatory exclusivities we possess or may possess in the future prevent such commercialization. Inadequate training in recognizing or managing the potential side effects of AMX0035 or any future product candidates could result in patient injury or death. Any of these occurrences may harm our business, financial condition and prospects significantly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bitter taste was frequently observed in our clinical trials of AMX0035. While bitter taste, by itself, does not present a safety risk for patients, it may lead to higher levels of patient non-compliance, which could have the effect of reducing the observed efficacy of AMX0035 in our clinical trials, including our ongoing global Phase 3 PHOENIX trial, or limit its commercial adoption.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, clinical trials of AMX0035 are conducted in carefully defined sets of patients who have agreed to enter into clinical trials. Consequently, it is possible that our clinical trials, or those of any future collaborator, may indicate an apparent positive effect of AMX0035 or a future product candidate that is greater than the actual positive effect, if any, or alternatively fail to identify undesirable side effects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finally, AMX0035 is a combination of TURSO and PB. PB has been approved by the FDA and other regulatory authorities for the treatment of patients with certain urea cycle disorders and TURSO has been approved in Italy for diseases of cirrhotic liver disorders such as primary biliary cirrhosis. It is possible that one or more of the active moieties in AMX0035 has also been approved by FDA or other regulatory authorities. Even if AMX0035 receives marketing approval and is commercialized in a jurisdiction, we would continue to be subject to the risks that the applicable regulatory authorities could revoke approval of PB or TURSO or any active moiety in AMX0035, if applicable, or that efficacy, manufacturing or supply issues could arise with PB or TURSO or any active moiety in AMX0035, if applicable. This could result in our own products being removed from the market or being less commercially successful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Increasing demand for expanded access to AMX0035 could negatively affect our reputation and harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing AMX0035 for the treatment of ALS, AD and other potential future indications for which there are currently limited or no available therapeutic options. It is possible for individuals or groups to target companies with disruptive social media campaigns related to a request for access to unapproved drugs for patients with significant unmet medical need. If we experience a similar social media campaign regarding our decision to provide or not provide access to AMX0035 or any of our future product candidates under an expanded access policy, our reputation may be negatively affected and our business may be harmed. On March 18, 2022, we launched an FDA-authorized EAP in the U.S. for AMX0035 for certain adults with ALS and this program will be wound down alongside the commercial launch of RELYVRIO in the U.S., with a target close of the EAP in the first half of 2023. We may launch additional EAPs of AMX0035 in the EU.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the past, media attention to individual patients&#x2019; expanded access requests has resulted in the introduction and enactment of legislation at the local and national level, including the Accelerating Access to Critical Therapies for ALS Act and prior &#x201c;Right to Try&#x201d; laws, such as the federal Right to Try Act of 2017, which are intended to allow patients access to unapproved therapies earlier than traditional EAPs and the former of which is intended to support research and development related to ALS, specifically. A possible consequence of both activism and legislation in this area may be the need for us to initiate an EAP beyond that which we have submitted to the FDA or to make AMX0035 or any future product candidates more widely available sooner than anticipated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, some patients who receive access to drugs prior to their commercial approval through compassionate use, EAPs or right to try access have life-threatening illnesses and have exhausted all other available therapies. The risk for SAEs in this patient population is high, which could have a negative impact on the safety profile of AMX0035 or future product candidates, which could cause significant delays or an inability to successfully commercialize AMX0035 or future product candidates, which could materially harm our business. We may in the future need to restructure or pause any future compassionate use and/or EAP we initiate in order to perform the controlled clinical trials required for regulatory approval and successful commercialization of AMX0035 or future product candidates, which could prompt adverse publicity or other disruptions related to current or potential participants in such programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The increasing use of social media platforms presents new risks and challenges.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Social media is increasingly being used to communicate about our clinical development activities and the diseases AMX0035 is being developed to treat, and we intend to continue to utilize appropriate social media in connection with our commercialization efforts for RELYVRIO in the U.S. and ALBRIOZA in Canada, and in any other jurisdictions where we obtain regulatory approvals. Social media practices in the biotechnology and pharmaceutical industries continue to evolve and regulations and regulatory guidance relating to such use are evolving and not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business, resulting in potential regulatory actions against us, along with the potential for litigation related to off-label marketing or other prohibited activities and heightened scrutiny by the FDA, the SEC and other regulators. For example, patients may use social media channels to comment on their experience on treatment with AMX0035 or their experience in an ongoing blinded clinical trial or to report an alleged adverse event. If such disclosures occur, there is a risk that trial enrollment may be adversely impacted, that we may fail to monitor and comply with applicable adverse event reporting obligations or that we may not be able to defend our business or the public&#x2019;s legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our product candidates. There is also a risk of inappropriate disclosure of sensitive or confidential information or negative or inaccurate posts or comments about us on any social networking website. In addition, we may encounter attacks on social media regarding our company, management, AMX0035 or future product candidates. If any of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face regulatory actions or incur other harm to our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to develop and commercialize AMX0035 for additional indications or fail to discover, develop and commercialize other product candidates, we may be unable to grow our business and our ability to achieve our strategic objectives would be impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the development and commercialization of AMX0035 for the treatment of ALS is our current primary focus, as part of our longer-term growth strategy, we plan to evaluate AMX0035 in other indications and develop other product candidates. We intend to evaluate internal opportunities from AMX0035 or other potential product candidates, and also may choose to in-license or acquire other product candidates as well as commercial products to treat patients suffering from neurodegenerative diseases and CNS or other disorders with significant unmet medical needs and limited treatment options. These other potential product candidates will require additional, time-consuming development efforts prior to commercial sale, including preclinical studies, clinical trials and approval by the FDA, Health Canada, the EMA and/or other applicable foreign regulatory authorities. All product candidates are prone to the risks of failure that are inherent in pharmaceutical product development, including the possibility that the product candidate will not be shown to be sufficiently safe and effective for approval by regulatory authorities. In addition, we cannot assure you that any such products that are approved will be manufactured or produced economically, successfully commercialized or widely accepted in the marketplace or be more effective than other commercially available alternatives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research activities to identify product candidates require substantial technical, financial and human resources, whether or not any product candidates are ultimately identified. Our research activities may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for many reasons, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the research methodology used may not be successful in identifying potential product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">competitors may develop alternatives that render our potential product candidates obsolete; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product candidates that we develop may nevertheless be covered by third parties&#x2019; patents or other exclusive rights; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a product candidate may, on further study, be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are unsuccessful in identifying and developing additional product candidates, our potential for growth and achieving our strategic objectives may be impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be successful in our efforts to expand our pipeline by identifying additional product candidates or indications and modifications for which to investigate AMX0035 in the future. We may expend our limited resources to pursue particular product candidates or indication or formulation for AMX0035 and fail to capitalize on such product candidates or indications or formulations of AMX0035 that may be more profitable or for which there is a greater likelihood of success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because we have limited financial and managerial resources, we are focused on specific indications and modifications for AMX0035. As a result, we may fail to generate additional clinical development opportunities for AMX0035 for a number of reasons, including, that AMX0035 may in certain indications, on further study, be shown to have harmful side effects, limited to no efficacy, or other characteristics that suggest it is unlikely to receive marketing approval and achieve market acceptance in such additional indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We plan to conduct several clinical trials for AMX0035 in parallel over the next several years, including multiple clinical trials in patients with ALS and other indications, which may make our decision as to which indication to prioritize more difficult. As a result, we may forgo or delay pursuit of opportunities with other indications that we believe could have had greater commercial potential or likelihood of success. In addition, we are continuing to evaluate plans to explore the use of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 in patients with AD, Wolfram syndrome and other indications, and other product candidates in ALS and additional neurodegenerative diseases. However, we may focus on or pursue one or more of our target indications over other potential indications and product candidates and such development efforts may not be successful, which would cause us to delay the clinical development and approval of AMX0035, and other product candidates. Furthermore, research activities to identify additional indications for AMX0035 require substantial technical, financial, and human resources. We may not successfully develop these additional modifications for chemistry-related, stability-related, or other reasons. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development activities for specific indications or formulations of AMX0035 or other product candidates may not yield any commercially viable products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, we may pursue in-licenses or acquisitions of development-stage assets or programs, which entails additional risk to us. Identifying, selecting and acquiring promising product candidates requires substantial technical, financial, and human resources expertise. Efforts to do so may not result in the actual acquisition or license of a particular product candidate, potentially resulting in a diversion of our management&#x2019;s time and the expenditure of our resources with no resulting benefit.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, if we are unable to identify programs that ultimately result in approved products, we may spend material amounts of our capital and other resources evaluating, acquiring and developing products that ultimately do not provide a return on our investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Competitive products may reduce or eliminate the commercial opportunity for AMX0035 for our current or future indications. If our competitors develop technologies or product candidates more rapidly than we do, or their technologies or product candidates are more effective or safer than ours, our ability to develop and successfully commercialize AMX0035 may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The clinical and commercial landscape for the treatment of ALS and other neurodegenerative diseases, including AD is highly competitive and subject to rapid and significant technological change. We face competition with respect to our current indications for AMX0035 and will face competition with respect to any future indications of AMX0035 or other drug candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. For example, Humanitas Mirasole SpA is currently conducting a Phase 3 clinical trial in the EU to assess the safety and efficacy of TURSO in patients with ALS, which, if approved, may be commercialized as a competitor to AMX0035. If this study meets its clinical endpoints, this monotherapy treatment could be approved by the FDA, the EMA and other regulatory authorities, and TURSO may become a commercialized product competitive with AMX0035, unless our intellectual property protections and any regulatory exclusivities we possess or may possess in the future prevent such commercialization. There are also a number of large pharmaceutical and biotechnology companies that currently market and sell drugs or are pursuing the development of drug candidates for the treatment of the indications that we are pursuing. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Several large pharmaceutical companies market FDA-approved drugs for the treatment of ALS. These drugs include: Riluzole, marketed by Sanofi-Aventis U.S. LLC, and Radicava, marketed by Mitsubishi Tanabe Pharma America, Inc. Additionally, Mitsubishi Tanabe Pharma America, Inc., or MTPA, is developing an oral alternative to Radicava. In the first quarter of 2022, the FDA accepted MTPA&#x2019;s application for priority review of its oral alternative to Radicava and in May 2022, the FDA approved its oral alternative to Radicava. Our potential competitors include pharmaceutical and biotechnology companies, such as Biogen, Inc., Orphazyme A/S, Biohaven Pharmaceutical Holding Co Ltd., UCB S.A., Alexion Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc., specialty pharmaceutical and generic drug companies, academic institutions, government agencies and research institutions. In the third quarter of 2022, the FDA accepted Biogen, Inc.&#x2019;s NDA for toferson, an investigational drug for superoxide dismutase 1 (SOD1) ALS.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors have significantly greater financial resources, established presence in the market, expertise in research and development, manufacturing, preclinical and clinical testing, obtaining regulatory approvals and reimbursement and marketing approved products than we do. Accordingly, our competitors may be more successful than we may be in obtaining regulatory approval for therapies and achieving widespread market acceptance. Our competitors&#x2019; products may be more effective, or more effectively marketed and sold, than any product candidate we may commercialize and may render AMX0035 or any future product candidates obsolete or non-competitive before we can recover development and commercialization expenses. If AMX0035 is approved for the indications we are currently pursuing, it could compete with a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">range of therapeutic treatments that are in development. In addition, our competitors may succeed in developing, acquiring or licensing technologies and drug products that are more effective or less costly than AMX0035 or any future product candidates that we may develop, which could render such product candidates obsolete and noncompetitive.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following approval for AMX0035 or any other future product candidate, we may face competition based on many different factors, including the efficacy, safety and tolerability of our products, the ease with which our products can be administered, the timing and scope of regulatory approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Existing and future competing products could present superior treatment alternatives, including being more effective, safer, less expensive or marketed and sold more effectively than any products we commercialize. Competitive products may make any products we commercialize obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. Such competitors could also recruit our employees, which could negatively impact our level of expertise and our ability to execute our business plan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our competitors may obtain patent protection, regulatory exclusivities or regulatory approval and commercialize products more rapidly than we do, which may impact future approvals or sales of any of our product candidates that receive regulatory approval. We expect to face competition with respect to our commercialization of RELYVRIO in the U.S. and ALBRIOZA in Canada and any future product candidates, if approved. Following approval by Health Canada, the FDA or the EMA for the commercial sale of AMX0035 or any future product candidates, we will also be competing with respect to marketing capabilities and manufacturing efficiency. We expect competition among products will be based on product efficacy and safety, the timing and scope of regulatory approvals, availability of supply, marketing and sales capabilities, product price, reimbursement coverage by government and private third-party payors, regulatory exclusivities and patent position. Our profitability and financial position will suffer if our product candidates receive regulatory approval, but cannot compete effectively in the marketplace.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites, as well as in acquiring technologies complementary to, or necessary for, our activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining regulatory approval of AMX0035 or any future product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of those product candidates in other jurisdictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Obtaining and maintaining regulatory approval of AMX0035 and any future product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even though the FDA has approved AMX0035 (RELYVRIO) and Health Canada has granted marketing authorization with conditions of AMX0035 (ALBRIOZA), comparable regulatory authorities in the EU and other foreign jurisdictions must also approve the manufacturing, marketing and promotion of AMX0035 in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the U.S., Canada or the EU, including additional preclinical studies or clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the U.S., including Canada, and certain jurisdictions in the EU, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have received approval for AMX0035 (RELYVRIO) in the U.S. and marketing authorization with conditions for AMX0035 (ALBRIOZA) in Canada and have submitted a marketing application in the EU. Regulatory authorities in jurisdictions outside of the U.S. have requirements for approval of product candidates with which we must comply prior to marketing in those jurisdictions and such regulatory requirements can vary widely from country to country. Obtaining other regulatory approvals and compliance with other regulatory requirements could result in significant delays, difficulties and costs for us and could require additional preclinical studies or clinical trials, which could be costly and time-consuming and could delay or prevent the introduction of our products in certain countries. The foreign regulatory approval process involves all of the risks associated with FDA approval. We do not have any product candidates approved for sale in any jurisdiction except the U.S. and Canada, and we do not have experience in obtaining regulatory approval in international markets outside of Canada. If we fail to comply with the regulatory requirements in international markets and/or obtain and maintain</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of AMX0035 or any future product candidates will be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even though we have obtained orphan drug designation for AMX0035 for the treatment of ALS in the U.S. and the EU and for the treatment of Wolfram syndrome in the U.S., we may not be able to obtain or maintain the benefits associated with orphan drug status, including market exclusivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory authorities in some jurisdictions, including the U.S. and the EU, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 people in the U.S., or a patient population of greater than 200,000 people in the U.S., but for which there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S. In the EU, the EMA Committee for Orphan Medicinal Products grants orphan drug designation to promote the development of products that are intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting not more than five in 10,000 people in the EU. Additionally, designation is granted for products intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition when, without incentives, it is unlikely that sales of the drug in the EU would be sufficient to justify the necessary investment in developing the drug or biologic product. In either case, the applicant for orphan designation must also demonstrate that no satisfactory method of diagnosis, prevention, or treatment for the condition has been authorized (or, if such a method exists, the new product would be a significant benefit to those affected compared to the product available).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2017, the FDA granted orphan drug status to AMX0035 for the treatment of patients with ALS in the U.S., and with the approval of AMX0035 (RELYVRIO) by the FDA in September 2022 for the treatment of ALS in adults, the product is entitled to orphan drug exclusivity and the FDA cannot approve a generic or a brand product that contains the same active moiety for the same orphan indication as AMX0035 for a period of seven years, subject to certain exceptions. In addition, in June 2020, the EMA granted orphan drug status to AMX0035 for the treatment of patients with ALS in the EU. We also received orphan drug status for AMX0035 for the treatment of patients with Wolfram syndrome in the U.S. in November 2020. Generally, if a drug with an orphan drug designation subsequently receives the first marketing approval for the indication for which it has such designation, the drug may be entitled to a period of marketing exclusivity, which precludes the FDA or the EMA from approving another marketing application for the same drug for that time period. Another drug may receive marketing approval prior to AMX0035. The applicable period is seven years in the U.S. and ten years in the EU, which may be extended by six months and two years, respectively, in the case of product candidates that have complied with the respective regulatory agency&#x2019;s agreed upon pediatric investigation plan. The exclusivity period in the EU can be reduced to six years if a drug no longer meets the criteria for orphan drug designation or if the drug is sufficiently profitable so that market exclusivity is no longer justified. In the EU, during the ten-year period of orphan marketing exclusivity, neither the competent authorities of the EU Member States, the EMA, or the European Commission are permitted to accept applications or grant marketing authorization for other similar medicinal products. A &#x201c;similar medicinal product&#x201d; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. Orphan drug exclusivity may be lost if the FDA or the EMA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug to meet the needs of patients with the rare disease or condition. In addition, even after a drug is granted orphan exclusivity and approved, the FDA and the EMA can subsequently approve another drug for the same condition before the expiration of the seven-year (or ten-year in the EU) exclusivity period if the FDA or the EMA concludes that the later drug is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. In addition, if an orphan designated product receives marketing approval for an indication broader than or different from what is designated, such product may not be entitled to orphan exclusivity. Even though the FDA has granted orphan drug designation to AMX0035 for the treatment of Wolfram syndrome, if we receive approval for AMX0035 for a modified or different indication, our current orphan designation may not provide us with exclusivity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval process. Also, regulatory approval for any product candidate may be withdrawn, and other product candidates may obtain approval before us and receive orphan drug exclusivity, which could block us from entering the market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we obtain orphan drug exclusivity for AMX0035, that exclusivity may not effectively protect us from competition because different drugs can be approved for the same condition before the expiration of the orphan drug exclusivity period. For example, even though AMX0035 is entitled to orphan drug exclusivity, that exclusivity may not prevent the approval of TURSO by the FDA, the EMA or other regulatory authorities as a monotherapy treatment for ALS if those regulatory</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">agencies determine that TURSO is a different drug product from AMX0035. In addition, the regulatory authorities may find that this monotherapy treatment is clinically superior to our fixed dose product and approve it even if we are granted orphan drug exclusivity. U.S. lawmakers have also recently raised the possibility that regulatory or legislative changes might need to be made to the Orphan Drug Act to foster competition. This includes the introduction of legislation that, if adopted into law, would require us to demonstrate to the FDA that AMX0035 would be economically unviable when facing competition to maintain our exclusivity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may pursue orphan drug designation for AMX0035 for the treatment of additional indications. The incidence and prevalence of the target patient populations for these indications will be based on our estimates and third-party data. If the market opportunity for these target populations is larger than we estimate, we may be unable to receive orphan drug designation. Additionally, if orphan drug designation is granted, we may be unable to maintain any benefits associated with orphan drug designation, including market exclusivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Periodically, we make estimates regarding the incidence and prevalence of target patient populations based on various third-party sources and internally generated analysis. Our estimates may be inaccurate or based on imprecise data. As described above, under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 people in the U.S., or a patient population of greater than 200,000 people in the U.S., but for which there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S. If our incidence or prevalence estimates for future indications for which we may seek orphan drug designation are incorrect, we may be unable to receive orphan drug designation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if the FDA grants orphan drug designation for AMX0035 for other indications, exclusive marketing rights in the U.S. may be limited if we seek FDA marketing approval for an indication broader than the orphan designated indication. Additionally, any product candidate that initially receives orphan drug status designation, may lose such designation if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. In addition, others may obtain orphan drug status for products addressing the same diseases or conditions as products we are developing, thus limiting our ability to compete in the markets addressing such diseases or conditions for a significant period of time. As a result, our business and prospects could suffer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may pursue priority review designation for product candidates that we may develop, but we might not receive such designations, and priority review designations may not lead to a faster development or regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the FDA determines that a product candidate offers a treatment for a serious condition and, if approved, the product would provide a significant improvement in safety or effectiveness, the FDA may designate the product candidate for priority review. A priority review designation means that the goal for the FDA to review an application is six months, rather than the standard review period of ten months. For example, we received priority review for AMX0035 for the treatment of ALS, and we may in the future request priority review designation for any future product candidates, however, we cannot assume that any application for future indications of AMX0035 or any other product candidate we may develop will meet the criteria for that designation. The FDA has broad discretion with respect to whether or not to grant priority review status to a product candidate, so even if we believe a particular product candidate is eligible for such designation or status, the FDA may decide not to grant it. Moreover, a priority review designation does not necessarily mean a faster development or regulatory review or approval process or necessarily confer any advantage with respect to approval compared to standard FDA review and approval. For example, the FDA originally set the PDUFA date for AMX0035 for the treatment of ALS, for June 29, 2022, and then extended the review timeline for our NDA to September 2022. Receiving priority review from the FDA does not guarantee approval within the six-month review cycle or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek Fast Track Designation by the FDA for a product candidate that we develop, and we may be unsuccessful. If we are successful, the designation may not actually lead to a faster development or regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek Fast Track Designation for future product candidates we develop. If a product is intended for the treatment of a serious or life-threatening condition and preclinical or clinical data demonstrate the potential to address an unmet medical need for this condition, the product sponsor may apply for Fast Track Designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, we cannot assure you that the FDA would decide to grant it. Even if we do receive Fast Track Designation, we may not experience a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">faster development process, review or approval compared to conventional FDA procedures. The FDA may rescind the Fast Track Designation if it believes that the designation is no longer supported by data from our clinical development activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek Breakthrough Therapy Designation by the FDA for a product candidate that we develop, and we may be unsuccessful. If we are successful, the designation may not lead to a faster development or regulatory review or approval process, and it does not increase the likelihood that our product candidates will receive marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek Breakthrough Therapy Designation for any product candidate that we develop. A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over currently approved therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA are also eligible for accelerated approval and priority review.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe a product candidate we develop meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of Breakthrough Therapy Designation for a product candidate may not result in a faster development process, review or approval compared to drugs considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if any product candidate we develop qualifies as a breakthrough therapy, the FDA may later decide that the drug no longer meets the conditions for qualification and rescind the designation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product liability lawsuits against us or any of our future collaborators could divert our resources and attention, cause us to incur substantial liabilities and limit commercialization of AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of pharmaceutical products. The use of AMX0035 by us and any collaborators in clinical trials, and the sale of AMX0035 in the U.S., Canada and in other jurisdictions, if approved, in the future, may expose us to liability claims. Product liability claims may be brought against us or our partners by participants enrolled in our clinical trials, patients, health care providers, pharmaceutical companies, our collaborators or others using, administering or selling any of our future approved products. If we cannot successfully defend ourselves against any such claims, we may incur substantial liabilities or be required to limit commercialization of AMX0035 or any future product candidates. Regardless of the merits or eventual outcome, liability claims may result in:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decreased demand for any of our future approved products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injury to our reputation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">withdrawal of clinical trial participants; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">termination of clinical trial sites or entire trial programs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant litigation costs, including with respect to potential class action lawsuits; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial monetary awards to, or costly settlements with, patients or other claimants; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product recalls or a change in the indications for which they may be used; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of revenue; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">diversion of management and scientific resources from our business operations; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to commercialize AMX0035 or any future product candidates. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the clinical trial process is designed to identify and assess potential side effects, clinical development does not always fully characterize the safety and efficacy profile of a new drug, and it is always possible that a drug, even after regulatory approval, may exhibit unforeseen side effects. If AMX0035 was to cause adverse side effects during clinical trials or after approval, we may be exposed to substantial liabilities. Physicians and patients may not comply with any warnings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that identify known potential adverse effects and patients who should not use AMX0035 or any of our future product candidates. If any of our current or future product candidates are approved for commercial sale, we will be highly dependent upon consumer perceptions of us and the safety and quality of our products. We could be adversely affected if we are subject to negative publicity associated with illness or other adverse effects resulting from patients&#x2019; use or misuse of our products or any similar products distributed by other companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we maintain product liability insurance coverage in the amount of up to $5.0 million in the aggregate, including clinical trial liability, this insurance may not fully cover potential liabilities that we may incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial. We will need to increase our insurance coverage as we commercialize AMX0035 in the U.S., Canada and other jurisdictions, if approved, or any future product candidate that receives regulatory approval. In addition, insurance coverage is becoming increasingly expensive. If we are unable to maintain sufficient insurance coverage at an acceptable cost or to otherwise protect against potential product liability claims, it could prevent or inhibit the development and commercial production and sale of AMX0035 or any future product candidates, which could harm our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we, or any future collaborators, obtain and maintain regulatory approvals for AMX0035 or any future product candidate, the terms of approvals and ongoing regulation of our products may limit how we manufacture and market our products, which could impair our ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Once regulatory approval has been granted, an approved product and its manufacturer and marketer are subject to ongoing review and extensive regulation. We, and any future collaborators, must therefore comply with requirements concerning advertising and promotion for AMX0035 or any future product candidate for which we or they obtain regulatory approval. Promotional communications with respect to prescription drugs are subject to a variety of legal and regulatory restrictions and must be consistent with the information in the product&#x2019;s approved labeling. Thus, we and any future collaborators will not be able to promote any products we develop for indications or uses for which they are not approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, manufacturers of approved products and those manufacturers&#x2019; facilities are required to comply with extensive FDA, Health Canada and EMA requirements, including ensuring that quality control and manufacturing procedures conform to cGMPs, which include requirements relating to quality control and quality assurance as well as the corresponding maintenance of records and documentation and reporting requirements. We, our contract manufacturers, any future collaborators and their contract manufacturers could fail to conform to cGMPs and be subject to periodic unannounced inspections by the FDA, Health Canada and the EMA to monitor and ensure compliance with cGMPs. Despite our efforts to inspect and verify regulatory compliance, one or more of our third-party manufacturing vendors may be found on regulatory inspection by the FDA, Health Canada, the EMA or other authorities to be not in compliance with cGMP regulations, which may result in shutdown of the third-party vendor or invalidation of drug product lots or processes. In some cases, a product recall may be warranted or required, which would materially affect our ability to supply and market our drug products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accordingly, in any jurisdiction where we or any future collaborators, receive regulatory approval for AMX0035 or one or more future product candidates, we, and any future collaborators, and our and their contract manufacturers will continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we, and any future collaborators, are not able to comply with post-approval regulatory requirements, we, and any future collaborators, could have the regulatory approvals for AMX0035 or any future products withdrawn by regulatory authorities and our, or any future collaborators&#x2019;, ability to market any future products could be limited, which could adversely affect our ability to achieve or sustain profitability. Further, the cost of compliance with post-approval regulations may have a negative effect on our operating results and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Laws and regulations governing any international operations we expect to have in the future may preclude us from developing, manufacturing and selling certain products outside of the U.S. and will require us to develop and implement costly compliance programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have operations in the U.S. and Canada and expect to engage in operations in other jurisdictions, including the EU, as well as other potential jurisdictions, and we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we currently or plan to operate. The Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the U.S. to comply with certain accounting provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Various laws, regulations and executive orders, including export control and trade sanctions laws, also restrict the use and dissemination outside of the U.S., or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we expand our presence outside of the U.S., it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the U.S., which could limit our growth potential and increase our development costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#x2019;s accounting provisions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce hazardous waste products. Even if we contract with third parties for the disposal of these materials and waste products, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain workers&#x2019; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees, but this insurance may not provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek to establish collaborations and, if we are not able to establish and maintain them on commercially reasonable terms, we may have to alter our development and commercialization plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The advancement of AMX0035, and any future product candidates and development programs or activities, as well as the commercialization of RELYVRIO in the U.S. and ALBRIOZA in Canada and the potential commercialization of AMX0035 in other jurisdictions and of any future product candidates will require substantial additional cash to fund expenses. For some indications of AMX0035 or future product candidates, we may decide to collaborate with additional pharmaceutical and biotechnology companies with respect to development and potential commercialization. Likely collaborators may include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies. In addition, if we are able to obtain regulatory approval for product candidates from foreign regulatory</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">authorities, we may enter into collaborations with international biotechnology or pharmaceutical companies for the commercialization of such product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#x2019;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#x2019;s evaluation of a number of factors. Those factors may include the potential differentiation of our product candidate from competing product candidates, design or results of clinical trials, the likelihood of approval by Health Canada, the FDA, the EMA or other comparable foreign regulatory authorities and the regulatory pathway for any such approval, the potential market for the product candidate, the costs and complexities of manufacturing and delivering the product to patients and the potential of competing products. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available for collaboration and whether such a collaboration could be more attractive than the one with us for our product candidate. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop AMX0035 or any future product candidates or bring them to market and generate product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaborations are complex and time-consuming to negotiate and document. Further, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators. Any collaboration agreements that we enter into in the future may contain restrictions on our ability to enter into potential collaborations or to otherwise develop specified product candidates. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs or activities, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have entered and may in the future enter into collaborations with third parties for the development and commercialization of AMX0035 or any future product candidates, and our prospects with respect to those product candidates will depend in significant part on the success of those collaborations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may rely on collaborations for the development and commercialization of AMX0035 and any future product candidates. For example, we may utilize a variety of distribution, collaboration and other marketing arrangements with one or more third parties to facilitate commercialization of AMX0035 or to identify novel drug candidates for neurodegenerative diseases as with our partnership with Sunnybrook Research Institute. Our likely collaborators for any distribution, development, sales, marketing, licensing or broader collaboration arrangements include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies. If we enter into such collaborations, we may have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of AMX0035 or any future product candidates. Our ability to generate revenues from these arrangements will depend on any future collaborators&#x2019; abilities to successfully perform the functions assigned to them in these arrangements. In addition, any future collaborators may have the right to abandon research or development projects and terminate applicable agreements, including funding obligations, prior to or upon the expiration of the agreed upon terms.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaborations involving AMX0035 and any future product candidates pose a number of risks, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not perform their obligations as expected; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not pursue development and commercialization of AMX0035 or any future product candidates or may elect not to continue or renew development or commercialization programs, based on clinical trial results, changes in the collaborators&#x2019; strategic focus or available funding or external factors, such as an acquisition, that divert resources or create competing priorities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with AMX0035 or any of our future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution of such product or products; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreements with collaborators, including disagreements over proprietary rights, including trade secrets and intellectual property rights, contract interpretation, or the preferred course of development might cause delays or termination of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. If any future collaborator of ours is involved in a business combination, it could decide to delay, diminish or terminate the development or commercialization of any product candidate licensed to it by us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely on third parties to assist in conducting our clinical trials. If they do not perform satisfactorily, we may not be able to obtain or maintain regulatory approval or successfully commercialize AMX0035 or any future product candidates, or such approval or commercialization may be delayed, and our business could be substantially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have relied upon and plan to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions and clinical investigators, to conduct our clinical trials and expect to rely on these third parties to conduct clinical trials of any future product candidate that we develop. Any of these third parties may terminate their engagements with us under certain circumstances. We may not be able to enter into alternative arrangements or do so on commercially reasonable terms. In addition, there is a natural transition period when a new CRO begins work. As a result, delays may occur, which could negatively impact our ability to meet our expected clinical development timelines and harm our business, financial condition and prospects. Clinical trials involve multiple clinical sites, vendors and other third parties and we are dependent on these vendors to ensure appropriate study conduct, statistical analysis and randomization. Errors or deviations they make in any of these activities could impact the usefulness and interpretability of clinical trial results by regulatory authorities. For example, at the Advisory Committee meeting on March 30, 2022, the FDA noted a number of concerns that, in the FDA&#x2019;s view, impacted the interpretability of the results from the CENTAUR trial. Clinical trials from time to time have deviations where a protocol or standard operating procedure is not perfectly carried out and where corrective actions are taken. While we may perceive these events as low risk, our perception of risk and appropriate corrective actions may differ from that of the regulators&#x2019; view. Deviations from protocols or standard operating procedures during studies could result in negative regulatory opinions and outcomes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, although our reliance on these third parties for clinical development activities limits our control over these activities, we remain responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards. Moreover, the FDA, the EMA and competent authorities of the EU Member States require us to comply with Good Clinical Practices, or GCPs, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. The FDA enforces these GCPs through periodic inspections of trial sponsors, principal investigators, clinical trial sites and IRBs. If we or our third-party contractors fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA, the EMA or other regulatory body may require us to perform additional clinical trials before approving AMX0035, including for additional indications, or any future product candidates, which would delay the regulatory approval process. We cannot be certain that, upon inspection, the FDA, the EMA or other regulatory body will determine that any of our clinical trials comply with GCPs. For example, our clinical trial sites and investigators have in the past and may in the future engage in protocol deviations which could impact the overall interpretability of the outcomes of our clinical trials. We are also required to register certain clinical trials and post the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">results of completed clinical trials on a government-sponsored database, such as ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, the third parties conducting clinical trials on our behalf are not our employees, and except for remedies available to us under our agreements with such contractors, we cannot control whether or not they devote sufficient time, skill and resources to our ongoing development activities. These contractors may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other drug development activities, which could impede their ability to devote appropriate time to our clinical activities. If these third parties, including clinical investigators, do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we may not be able to obtain, or may be delayed in obtaining, clinical data necessary for regulatory approvals for AMX0035 or any future product candidates. If that occurs, we will not be able to, or may be delayed in our efforts to, successfully commercialize AMX0035 or any future product candidates. In such an event, our financial results and the commercial prospects for AMX0035 or any future product candidates that we seek to develop could be harmed, our costs could increase and our ability to generate revenues could be delayed, impaired or foreclosed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, quarantines, shelter-in-place, and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to the COVID-19 pandemic or other infectious diseases could impact personnel at our CROs, which could disrupt our clinical timelines, which could have a material adverse impact on our business, prospects, financial condition, and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or regulatory approval of AMX0035 or any future product candidates or commercialization of any resulting products, producing additional losses and depriving us of potential product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our use of third parties to manufacture AMX0035 and approved products in compliance with cGMP may increase the risk that we will not have sufficient cGMP-compliant quantities of AMX0035, products, or necessary quantities of such materials on time or at an acceptable cost.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of clinical or commercial quantities of AMX0035, and we currently lack the resources and the capabilities to do so. As a result, we currently rely on third parties for the manufacture and supply of the active pharmaceutical ingredients, or APIs, in AMX0035, and for the blending and packaging of AMX0035 in accordance with applicable law, regulations and standards. Our current strategy is to outsource all manufacturing of AMX0035 and any future product candidates to third parties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently engage third-party manufacturers to provide the APIs of AMX0035 and for the final drug product formulation of AMX0035 that is being used in our clinical trials and for expanded access and commercial supply, and we engage separate third-parties for the blending and packaging of finished clinical materials. We must be able to demonstrate comparability of drug substance across suppliers along with stability data across suppliers. We currently rely on a single manufacturer to supply one of our APIs and a separate manufacturer to supply the other. Although we believe that there are several potential alternative manufacturers who could manufacture each of the APIs in AMX0035, we may incur added costs and delays in identifying and qualifying any such replacement. In addition, we typically order raw materials and services on a purchase order basis and do not enter into long-term dedicated capacity or minimum supply arrangements with any commercial manufacturer. Moreover, the extent to which the COVID-19 pandemic impacts our ability to procure sufficient supplies for the development of AMX0035, and any future products and product candidates will depend on whether the economic challenges caused by the COVID-19 pandemic continue to impact the global economy and supply chains, among many other factors. There is no assurance that we will be able to timely secure needed supply arrangements on satisfactory terms, or at all. Our failure to secure these arrangements as needed could have a material adverse effect on our ability to complete the development of AMX0035 or any future product candidates or, to commercialize them, if approved. We may be unable to conclude agreements for commercial supply with third-party manufacturers, or may be unable to do so on acceptable terms. There may be difficulties in scaling up to commercial quantities and formulation of AMX0035, and the costs of manufacturing could be prohibitive.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we are able to establish and maintain arrangements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the failure of the third-party manufacturer to comply with applicable regulatory requirements, including cGMPs, and reliance on third-parties for manufacturing process development, regulatory compliance and quality assurance; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing delays if our third-party manufacturers give greater priority to the supply of other products over AMX0035 or any future product candidates or otherwise do not satisfactorily perform according to the terms of the agreement between us; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations on supply availability resulting from capacity and scheduling constraints of third-parties, or as a result of economic or political developments, including the ongoing conflict in Ukraine and global economic instability;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible breach of manufacturing agreements by third-parties because of factors beyond our control; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible termination or non-renewal of the manufacturing agreements by a third-party, at a time that is costly or inconvenient to us; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible misappropriation of our proprietary information, including our trade secrets and know-how. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we do not maintain our key manufacturing relationships, or if any of our contract manufacturers fail to perform their obligations, we may fail to find replacement manufacturers or develop our own manufacturing capabilities, which could adversely impact our ability to commercialize AMX0035 in the U.S. and Canada, and delay or impair our ability to obtain regulatory approval for our products. If we do find replacement manufacturers, we may not be able to enter into agreements with them on terms and conditions favorable to us and there could be a substantial delay before new facilities could be qualified and registered with the FDA, Health Canada, the EMA and other foreign regulatory authorities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any change in manufacturer may also involve changes in manufacturing procedures and processes, which could require that we conduct bridging studies between our prior clinical supply used in our clinical trials and that of any new manufacturer. In addition, we will need to verify that any new manufacturing process will produce our product candidate according to the specifications previously submitted to the FDA, Health Canada, the EMA or another regulatory authority. We may be unsuccessful in demonstrating the comparability of clinical supplies which could require the conduct of additional clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some cases, the technical skills required to manufacture AMX0035, or any future products or product candidates may be unique or proprietary to the original contract manufacturer and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills to a back-up or alternate supplier, or we may be unable to transfer such skills at all. Furthermore, a contract manufacturer may possess or acquire technology related to the manufacture of AMX0035 or any future product candidate that such contract manufacturer owns independently. This would increase our reliance on such contract manufacturer or require us to obtain a license from such contract manufacturer in order to have another contract manufacturer manufacture AMX0035 or any future product candidates. If AMX0035 for any of our initial or potential additional indications or any future product candidate is approved by any regulatory agency, we intend to utilize arrangements with third-party contract manufacturers for the commercial production of those products. This process is difficult and time consuming and we may face competition for access to manufacturing facilities as there are a limited number of contract manufacturers operating under cGMPs that are capable of manufacturing AMX0035 or any future product candidates. Consequently, we may not be able to reach agreement with third-party manufacturers on satisfactory terms, which could delay our commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, seizures or voluntary recalls of AMX0035 or any future product candidates, operating restrictions and criminal prosecutions, any of which could significantly affect supplies of AMX0035 or any future product candidates. The facilities used by our contract manufacturers to manufacture AMX0035 or any future product candidates must be evaluated by the FDA, Health Canada, the EMA and certain other foreign regulatory authorities. We do not control the manufacturing process of, and are completely dependent on, our contract manufacturing partners for compliance with cGMPs. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA, Health Canada, the EMA or others, we may not be able to secure and/or maintain regulatory approval for our product manufactured at these facilities. In addition, we have no control over the ability of our contract</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA, Health Canada, the EMA or other comparable foreign regulatory authority finds deficiencies or does not approve these facilities for the manufacture of AMX0035 or any future product candidates, or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market AMX0035 or any future product candidates, if approved. Furthermore, if we are required to change contract manufacturers, we will be required to verify that the new contract manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations, which could result in further costs and delays. Contract manufacturers may face manufacturing or quality control problems causing drug substance production and shipment delays or a situation where the contractor may not be able to maintain compliance with the applicable cGMP requirements. Any failure to comply with cGMP requirements or other FDA, Health Canada, EMA and comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop AMX0035 or any future product candidates and market our products, if approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA, Health Canada, the EMA and other foreign regulatory authorities require manufacturers to register manufacturing facilities. The FDA, Health Canada, the EMA and corresponding foreign regulators also inspect these facilities to confirm compliance with cGMPs. Contract manufacturers may face manufacturing or quality control problems causing drug substance production and shipment delays or a situation where the contractor may not be able to maintain compliance with the applicable cGMP requirements. Any failure to comply with cGMP requirements or other FDA, Health Canada, EMA and comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop AMX0035 or any future product candidates and market our products following approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If any third-party manufacturer of AMX0035 or any future product candidates is unable to increase the scale of its production of such product candidates, and/or increase the product yield of its manufacturing, then our costs to manufacture the product may increase and commercialization may be delayed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to produce sufficient quantities to meet the demand for clinical trials, expanded access and, commercialization of AMX0035 in the U.S. and Canada, and any subsequent commercialization of AMX0035 in other jurisdictions, if approved, or any future product candidates that we may develop, our third-party manufacturers will be required to increase their production and optimize their manufacturing processes while maintaining the quality of the product. The transition to larger scale production could prove difficult. In addition, if our third party manufacturers are not able to optimize their manufacturing processes to increase the product yield for AMX0035 or any future product candidates, or if they are unable to produce increased amounts of such product candidates while maintaining the quality of the product and compliance with cGMPs, then we may not be able to meet the demands of clinical trials, expanded access or market demands, which could decrease our ability to generate profits and have a material adverse impact on our business and results of operation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since the beginning of the COVID-19 pandemic, several vaccines for COVID-19 have received Emergency Use Authorization by the FDA and a number of those later received marketing approval. Additional vaccines may be authorized or approved in the future. The resultant demand for vaccines and potential for manufacturing facilities and materials to be commandeered under the Defense Production Act of 1950, or equivalent foreign legislation, is having rippling effects across the contract manufacturing industry, which may make it more difficult to obtain materials or manufacturing slots for the production needed for our clinical trials and, if approved, our future commercial supply, which could lead to delays in our trials and commercial distribution.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may need to maintain licenses for active ingredients from third parties to develop and commercialize AMX0035 or a future product candidate, which could increase our development costs and delay our ability to commercialize such product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should we decide to use API in any of AMX0035 or any future product candidates that are proprietary to one or more third parties, we would need to maintain licenses to those active ingredients from those third parties. If we are unable to gain or continue to access rights to these active ingredients prior to conducting preclinical toxicology studies intended to support clinical trials, we may need to develop alternate product candidates from these programs by either accessing or developing alternate active ingredients, resulting in increased development costs and delays in commercialization of these product candidates. If we are unable to gain or maintain continued access rights to the desired active ingredients on commercially reasonable terms or develop suitable alternate active ingredients, we may not be able to commercialize product candidates from these programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our commercial success depends on our ability to protect our intellectual property and proprietary technology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success depends in large part on our ability to obtain and maintain intellectual property rights protection through patents, trademarks and trade secrets in the U.S. and other countries with respect to our proprietary product candidate, AMX0035, and any future proprietary product candidates. If we do not adequately protect our intellectual property rights, competitors may be able to erode, negate or preempt any competitive advantage we may have, which could harm our business and ability to achieve profitability. To protect our proprietary position, we have filed patent applications and may file other patent applications in the U.S. or abroad related to AMX0035 or any future product candidates that are important to our business; we may also license or purchase patents or patent applications filed by others. The patent application process is expensive and time-consuming. We may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the scope of the patent protection we obtain is not sufficiently broad, we may not be able to prevent others from developing and commercializing technology and products similar or identical to ours. The degree of patent protection we require to successfully compete in the marketplace may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any of our patents have, or that any of our pending owned patent applications that mature into issued patents will include claims with a scope sufficient to protect our proprietary therapeutics or otherwise provide any competitive advantage. Other parties have developed or may develop technologies that may be related or competitive with our approach, and may have filed or may file patent applications and may have been issued or may be issued patents with claims that overlap or conflict with our patent applications, either by claiming the same compounds, formulations or methods or by claiming subject matter that could dominate our patent position. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the U.S. Furthermore, patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally twenty years after it is filed. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our patent portfolio may not provide us with adequate and continuing patent protection sufficient to exclude others from commercializing products similar to AMX0035 or any future product candidates. In the event that an alternative combination, or TURSO as a single drug product, is developed and approved for use in indications for which we may seek approval and falls outside the scope of our patent claims, the marketability and commercial success of AMX0035 could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if they are unchallenged, our owned patents and pending patent applications, if issued, may not provide us with any meaningful protection or prevent competitors from designing around our patent claims to circumvent our patents by developing similar or alternative therapeutics in a non-infringing manner. For example, a third party may develop a competitive therapy that provides benefits similar to our product candidate but falls outside the scope of our patent protection or license rights. If the patent protection provided by the patent and patent applications we hold or pursue with respect to AMX0035 or any future product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our product candidate could be negatively affected, which would harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We, or any future partners, collaborators, or licensees, may fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Therefore, we may miss potential opportunities to strengthen our patent position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is possible that defects of form in the preparation or filing of our patent or patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we or our partners, collaborators, or licensees whether current or future, fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our partners, collaborators, or licensees are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or enforcement of our patents or patent applications, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies carries uncertainty. In addition, the determination of patent rights with respect to pharmaceutical compounds commonly involves complex legal and factual questions, which are dependent upon the current legal and intellectual property context, extant legal precedent and interpretations of the law by individuals. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are characterized by uncertainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. Assuming the other requirements for patentability are met, currently, the first to file a patent application is generally entitled to the patent. However, prior to March 16, 2013, in the U.S., the first to invent was entitled to the patent. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions are not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patent or pending patent applications, or that we were the first to file for patent protection of such inventions. If third parties have filed prior patent applications on inventions claimed in our patents or applications that were filed on or before March 15, 2013, an interference proceeding in the U.S. can be initiated by such third parties to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. If third parties have filed such prior applications after March 15, 2013, a derivation proceeding in the U.S. can be initiated by such third parties to determine whether our invention was derived from theirs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, because the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, our patents may be challenged in the courts or patent offices in the U.S. and abroad. Also, while we believe that we have disclosed all potentially relevant prior art relating to our patents and patent applications, there is no assurance that we have found all such prior art or disclosed it in every relevant jurisdiction. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions are typically not published until 18 months after filing or, in some cases, not at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions. If such prior art exists, it may be used to invalidate a patent, or may prevent a patent from issuing from a pending patent application. For example, such patent filings may be subject to a third-party submission of prior art to the U.S. Patent and Trademark Office, or USPTO, or to other patent offices around the world. Alternately or additionally, we may become involved in post-grant review procedures, oppositions, derivation proceedings, ex parte reexaminations, inter partes review, supplemental examinations, or interference proceedings or challenges in district court, in the U.S. or in various foreign patent offices, including both national and regional, challenging patents or patent applications in which we have rights, including patents on which we rely to protect our business. An adverse determination in any such challenges may result in loss of the patent or in patent or patent application claims being narrowed, invalidated or held unenforceable, in whole or in part, or in denial of the patent application or loss or reduction in the scope of one or more claims of the patent or patent application, any of which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pending and future patent applications may not result in patents being issued that protect our business, in whole or in part, or which effectively prevent others from commercializing competitive products. Competitors may also be able to design around our patents. Changes in either the patent laws or interpretation of the patent laws in the U.S. and other countries may diminish the value of our patents or narrow the scope of our patent protection. In addition, the laws of foreign countries may not protect our rights to the same extent or in the same manner as the laws of the U.S. For example, patent laws in various jurisdictions, including jurisdictions covering significant commercial markets, such as the European Patent Office, or EPO, China and Japan, restrict the patentability of methods of treatment of the human body more than U.S. law does. If these developments were to occur, they could have a material adverse effect on our ability to generate revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or any of our future development partners will be successful in protecting AMX0035 or any future product candidates by obtaining and defending patents. These risks and uncertainties include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process. There are situations in which noncompliance, whether intentional or not, can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patent applications may not result in any patents being issued; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patents that may be issued or in-licensed may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable or otherwise may not provide any competitive advantage;  </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our competitors, many of whom have substantially greater resources and many of whom have made significant investments in competing technologies, may seek or may have already obtained patents that will limit, interfere with or eliminate our ability to make, use, and sell AMX0035;  </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">there may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent protection both inside and outside the U.S. for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns;  </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">countries other than the U.S. may have patent laws less favorable to patentees than those upheld by U.S. courts, allowing foreign competitors a better opportunity to create, develop and market competing product candidates; and  </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">countries other than the U.S. may, under certain circumstances, force us to grant a license under our patents to a competitor, thus allowing the competitor to compete with us in that jurisdiction or forcing us to lower the price of our drug in that jurisdiction.  </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issued patents that we have or may obtain or license may not provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner. Our competitors may also seek approval to market their own products similar to or otherwise competitive with our products. Alternatively, our competitors may seek to market generic versions of any approved products by submitting ANDAs to the FDA in which they claim that patents owned or licensed by us are invalid, unenforceable or not infringed. In these circumstances, we may need to defend or assert our patents, or both, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with jurisdiction may find our patents invalid or unenforceable, or that our competitors do not infringe our patents. Thus, even if we have valid and enforceable patents, these patents still may not provide protection against competing products or processes sufficient to achieve our business objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we rely on the protection of our trade secrets and proprietary, unpatented know-how. Although we have taken steps to protect our trade secrets and unpatented know-how, including entering into confidentiality agreements with third parties, and confidential information and invention assignment agreements with employees, consultants, collaborators, vendors, and advisors, we cannot provide any assurances that all such agreements have been duly executed, and third parties may still obtain this information or may come upon this or similar information independently. It is possible that technology relevant to our business will be independently developed by a person who is not a party to such a confidentiality or invention assignment agreement. We may not be able to prevent the unauthorized disclosure or use of our technical knowledge or trade secrets by consultants, collaborators, vendors, advisors, former employees and current employees. Furthermore, if the parties to our confidentiality agreements breach or violate the terms of these agreements, we may not have adequate remedies for any such breach or violation, and we could lose our trade secrets as a consequence of such breaches or violations. Our trade secrets could otherwise become known or be independently discovered by our competitors. Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating our trade secrets. If any of these events occurs or if we otherwise lose protection for our trade secrets or proprietary know-how, our business may be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">It is difficult and costly to protect our intellectual property and our proprietary technologies, and we may not be able to ensure their protection.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success will depend in part on obtaining and maintaining patent protection and trade secret protection for our proprietary product candidate, AMX0035, as well as on successfully defending these patents against potential third-party challenges. Our ability to protect our product candidate from unauthorized making, using, selling, offering to sell or importing by third parties is dependent on the extent to which we have rights under valid and enforceable patents that cover these activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent positions of pharmaceutical, biotechnology and other life sciences companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved and have in recent years been the subject of much litigation. Changes in either the patent laws or in interpretations of patent laws in the U.S. and other</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">countries may diminish the value of our intellectual property. Over the past decade, U.S. federal courts have increasingly invalidated pharmaceutical and biotechnology patents during litigation often based on changing interpretations of patent law. Further, the determination that a patent application or patent claim meets all of the requirements for patentability is a subjective determination based on the application of law and jurisprudence. The ultimate determination by the U.S. Patent and Trademark Office, or USPTO, or by a court or other trier of fact in the U.S., or corresponding foreign national patent offices or courts, on whether a claim meets all requirements of patentability cannot be assured. Accordingly, we cannot predict the breadth of claims that may be allowed or enforced in our owned patents or patent applications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot provide assurances that any of our patent applications will be found to be patentable, including over our own prior art publications or patent literature, or will issue as patents. Neither can we make assurances as to the scope of any claims that may issue from our pending and future patent applications nor to the outcome of any proceedings by any potential third parties that could challenge the patentability, validity or enforceability of our patents and patent applications in the U.S. or foreign jurisdictions. Any such challenge, if successful, could limit patent protection for our products and current or future product candidates and/or materially harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to challenges during litigation, third parties can challenge the validity of our patents in the U.S. using post-grant review and inter partes review proceedings, which some third parties have been using to cause the cancellation of selected or all claims of issued patents of competitors. For a patent filed March 16, 2013 or later, a petition for post-grant review can be filed by a third party in a nine-month window from issuance of the patent. A petition for inter partes review can be filed immediately following the issuance of a patent if the patent has an effective filing date prior to March 16, 2013. A petition for inter partes review can be filed after the nine-month period for filing a post-grant review petition has expired for a patent with an effective filing date of March 16, 2013 or later. Post-grant review proceedings can be brought on any ground of invalidity, whereas inter partes review proceedings can only raise an invalidity challenge based on published prior art and patents. These adversarial actions at the USPTO review patent claims without the presumption of validity afforded to U.S. patents in lawsuits in U.S. federal courts, and use a lower burden of proof than used in litigation in U.S. federal courts. Therefore, it is generally considered easier for a competitor or third party to have a U.S. patent invalidated in a USPTO post-grant review or inter partes review proceeding than invalidated in a litigation in a U.S. federal court. If any of our patents are challenged by a third party in such a USPTO proceeding, there is no guarantee that we will be successful in defending the patent, which may result in a loss of the challenged patent right to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the EU, third parties can challenge the validity of our patents by filing an Opposition before the EPO. An adverse determination by the Opposition Board can result in the narrowing or invalidation of a European patent. If any of our European patents are challenged by a third party in such an opposition proceeding, there is no guarantee that we will be successful in defending the patent, which may result in a loss of the challenged patent right to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not be able to generate sufficient data to support full patent applications that protect the entire breadth of developments in one or more of our programs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that one or more of our pending patent applications will not become an issued patent or, if issued, that the patent(s) claims will have sufficient scope to protect our technology, provide us with commercially viable patent protection or provide us with any competitive advantages; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if our pending applications issue as patents, they may be challenged by third parties as invalid or unenforceable under U.S. or foreign laws; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not successfully commercialize AMX0035 before our relevant patents expire; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not be the first to make the inventions covered by each of our patents and pending patent applications; or </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not develop additional proprietary technologies or product candidates that are separately patentable. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, to the extent that we are unable to obtain and maintain patent protection for AMX0035 or any future product candidates or in the event that such patent protection expires, it may no longer be cost-effective to extend our portfolio by pursuing additional development of a product or product candidate for follow-on indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected and our business would be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to patents, we also may rely on trade secrets to protect our proprietary product candidate, especially where we do not believe patent protection is appropriate or obtainable. Trade secrets are difficult to protect. We seek to protect our confidential proprietary information, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and collaborators. These agreements are designed to protect our proprietary information. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, our employees, consultants, contractors, outside scientific collaborators and other advisers may unintentionally or willfully disclose our information to competitors. Enforcing a claim that a third-party entity illegally obtained and is using any of our trade secrets is expensive and time-consuming, and the outcome is unpredictable, and we may not be able to obtain adequate remedies for such breaches. We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our IT systems, but it is possible that these security measures could be breached. In addition, courts outside the U.S. are sometimes less willing to protect trade secrets. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how. Notably, proprietary technology protected by a trade secret does not preempt the patenting of independently developed equivalent technology, even if such equivalent technology is invented subsequent to the technology protected by a trade secret. If any of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on our products for an adequate amount of time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patents have a limited lifespan. In the U.S., if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. The patent term of a U.S. patent may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office in granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier-filed patent.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., the Drug Price Competition and Patent Term Restoration Act of 1984 permits a Patent Term Extension, or PTE, of up to five years beyond the normal expiration of the patent to compensate patent owners for loss of enforceable patent term due to the lengthy regulatory approval process. PTE is limited to the approved indication (or any additional indications approved during the period of extension). We anticipate applying for PTE in the U.S. Similar extensions may be available in other countries where we are prosecuting patents and we likewise anticipate applying for such extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The granting of such patent term extensions is not guaranteed and is subject to numerous requirements. We might not be granted an extension because of, for example, failure to apply within applicable periods, failure to apply prior to the expiration of relevant patents or failure to otherwise satisfy any of the numerous applicable requirements. Moreover, the applicable authorities, including the FDA and the USPTO in the U.S., and any equivalent regulatory authority in other countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. If this occurs, our competitors may be able to obtain approval of competing products following our patent expiration by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case. If this were to occur, it could have a material adverse effect on our ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in the interpretation of patent law in the U.S. and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. Congress is responsible for passing laws establishing patentability standards. As with any laws, implementation is left to federal agencies and the federal courts based on their interpretations of the laws. Interpretation of patent standards can vary significantly within the U.S. Patent and Trademark Office, and across the various federal courts, including the Supreme</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Court. Recently, the Supreme Court has ruled on several patent cases, generally limiting the types of inventions that can be patented. Further, there are open questions regarding interpretation of patentability standards that the Supreme Court has yet to decisively address. Absent clear guidance from the Supreme Court, the USPTO has become increasingly conservative in its interpretation of patent laws and standards.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to increasing uncertainty with regard to our ability to obtain patents in the future, the legal landscape in the U.S. has created uncertainty with respect to the value of patents. Depending on any actions by Congress, and future decisions by the lower federal courts and the Supreme Court, along with interpretations by the USPTO, the laws and regulations governing patents could change in unpredictable ways and could weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to enforce our intellectual property rights throughout the world.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing, prosecuting, enforcing and defending patents on our product candidate in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. The requirements for patentability may differ in certain countries, particularly in developing countries; thus, even in countries where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover our products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in foreign intellectual property laws. Additionally, laws of some countries outside of the U.S. and the EU do not afford intellectual property protection to the same extent as the laws of the U.S. and the EU. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. This could make it difficult for us to stop the infringement of our patents or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. Consequently, we may not be able to prevent third parties from practicing our inventions in certain countries outside the U.S. and the EU or from selling or importing products made from our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop and market their own products and, further, may export otherwise infringing products to territories where we have patent protection if our ability to enforce our patents to stop infringing activities is inadequate. These products may compete with our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceedings to enforce our patent rights, whether or not successful, could result in substantial costs and divert our efforts and resources from other aspects of our business. Moreover, such proceedings could put our patents at risk of being invalidated or held unenforceable, or interpreted narrowly, and our pending patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Furthermore, while we intend to protect our intellectual property rights in major markets for our products, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market our products, if approved. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Others may challenge inventorship or claim an ownership interest in our intellectual property which could expose it to litigation and have a significant adverse effect on its prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A third party or former employee or collaborator may claim an inventorship or ownership interest in one or more of our or our licensors&#x2019; patents or other proprietary or intellectual property rights. A third party could bring legal actions against us and seek monetary damages and/or enjoin clinical testing, manufacturing and marketing of the affected product or products. While we are presently unaware of any claims or assertions by third-parties with respect to inventorship or ownership of our patents or other intellectual property, we cannot guarantee that a third party will not assert a claim or an interest in any of such patents or intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to AMX0035 or any future product candidates. Further, regardless of the outcome, if we become involved in any litigation, it could consume a substantial portion of our resources, and cause a significant diversion of effort by our technical and management personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are sued for infringing intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success depends, in part, on our ability to develop, manufacture, market and sell our product candidate without infringing the intellectual property and other proprietary rights of third parties. However, our research, development and commercialization activities may be subject to claims that we infringe or otherwise violate patents or other intellectual property rights owned or controlled by third parties. Third parties may have U.S. and non-U.S. issued patents and pending patent applications relating to compounds, methods of manufacturing compounds and/or methods of use for the treatment of the disease indications for which we are developing AMX0035 or any future product candidates. If any third-party patents or patent applications are found to cover AMX0035 or any future product candidates or their methods of use or manufacture, we may not be free to manufacture or market such product candidates as planned without obtaining a license, which may not be available on commercially reasonable terms, or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is a substantial amount of intellectual property litigation in the biotechnology and pharmaceutical industries, and we may become party to, or threatened with, litigation or other adversarial proceedings regarding intellectual property rights with respect to our products candidates, including patent infringement lawsuits in the U.S. or abroad. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the composition, use or manufacture of AMX0035 or any future product candidates. While we perform periodic searches for relevant patents and patent applications with respect to our proprietary drug candidate, AMX0035, we cannot guarantee that any of our patent searches or analyses including, but not limited to, the identification of relevant patents, the scope of patent claims or the expiration of relevant patents are complete or thorough, nor can we be certain that we have identified each and every patent and pending application in the U.S. and abroad that is relevant to or necessary for the commercialization of AMX0035 or any future product candidates in any jurisdiction. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that AMX0035 or any future product candidates may be accused of infringing. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. Accordingly, third parties may assert infringement claims against us based on intellectual property rights that exist now or arise in the future. The outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance. The pharmaceutical and biotechnology industries have produced a significant number of patents, and it may not always be clear to industry participants, including us, which patents cover various types of products or methods of use or manufacture. The scope of protection afforded by a patent is subject to interpretation by the courts, and the interpretation is not always uniform. If we were sued for patent infringement, we would need to demonstrate that our product candidate, product or method either do not infringe the patent claims of the relevant patent or that the patent claims are invalid or unenforceable, and we may not be able to do this. Proving invalidity is difficult. For example, in the U.S., proving invalidity requires a showing of clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents. Even if we are successful in these proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel could be diverted in pursuing these proceedings, which could significantly harm our business and operating results. In addition, parties making claims against us may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources, and we may not have sufficient resources to bring these actions to a successful conclusion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are found to infringe a third party&#x2019;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product candidate or product. Alternatively, we may be required to obtain a license from such third party in order to use the infringing technology and continue developing, manufacturing or marketing the infringing product candidate or product. If we were required to obtain a license to continue to manufacture or market the affected product, we may be required to pay substantial royalties or grant cross-licenses to our patents. We cannot, however, assure you that any such license will be available on acceptable terms, if at all. Ultimately, we could be prevented from commercializing a product, or be forced to cease some aspect of our business operations as a result of claims of patent infringement or violation of other intellectual property rights. Further, the outcome of intellectual property litigation is subject to uncertainties that cannot be adequately quantified in advance, including the demeanor and credibility of witnesses and the identity of any adverse party. This is especially true in intellectual property cases that may turn on the testimony of experts as to technical facts upon which experts may reasonably disagree. Furthermore, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us; alternatively or additionally it could include terms that impede or destroy our ability to compete successfully in the commercial marketplace. In addition, we could be found liable for significant monetary damages, including treble damages and attorneys&#x2019; fees if we are found to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">have willfully infringed a patent. A finding of infringement could prevent us from commercializing AMX0035 or any future product candidates or force us to cease some of our business operations, which could harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise additional funds or otherwise have a material adverse effect on our business, results of operations, financial condition and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to claims by third parties asserting that our employees or we have misappropriated their intellectual property, or claiming ownership of what we regard as our own intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our current and former employees and our licensors&#x2019; current and former employees, including our senior management, were previously employed at universities or at other biotechnology or pharmaceutical companies, including some which may be competitors or potential competitors. Some of these employees, including members of our senior management, may have executed proprietary rights, non-disclosure and non-competition agreements, or similar agreements, in connection with such previous employment. Although we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such third party. Litigation may be necessary to defend against such claims. If we fail in defending any such claims, in addition to paying monetary damages, we may sustain damages or lose key personnel, valuable intellectual property rights or the personnel&#x2019;s work product, which could hamper or prevent commercialization of our technology, which in turn could materially affect our commercial development efforts. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such a license may not be available on commercially reasonable terms or at all. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, while we typically require our employees, consultants and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own, which may result in claims by or against us related to the ownership of such intellectual property. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to our senior management and scientific personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our trademarks and our business may be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We rely on both registration and common law protection for our trademarks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. During trademark registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. Moreover, any name we propose to use for our products in the U.S. must be approved by the FDA, regardless of whether we have registered it, or applied to register it, as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA objects to any of our proposed product names, we may be required to expend significant additional resources in an effort to identify a usable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Intellectual property rights do not necessarily address all potential threats to our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may be able to make products that are competitive to AMX0035, for example a TURSO monotherapy, or any of our future product candidates but that are not covered by the claims of the patents that we own; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may independently develop similar or alternative technologies or otherwise circumvent any of our technologies without infringing our intellectual property rights; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or any of our collaborators might not have been the first to invent the inventions covered by the patents or patent applications that we own; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or any of our collaborators might not have been the first to file patent applications covering certain of the patents or patent applications that we or they own or have obtained a license, or will own or will have obtained a license; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that our pending patent applications will not lead to issued patents; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result of legal challenges by our competitors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our competitors might conduct research and development activities in countries where we do not have patent rights, or in countries where research and development safe harbor laws exist, and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;  </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ownership of our patents or patent applications may be challenged by third parties; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the patents of third parties or pending or future applications of third parties, if issued, may have an adverse effect on our business; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patent enforcement is expensive and time-consuming and difficult to predict; thus we may not be able to enforce any of our patents against a competitor. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our reliance on third parties for research and development and manufacturing requires us to share our trade secrets, which increases the possibility that our trade secrets will be misappropriated or disclosed, and confidentiality agreements with employees and third parties may not adequately prevent disclosure of trade secrets and protect other proprietary information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consider proprietary trade secrets or confidential know-how and unpatented know-how to be important to our business. We may rely on trade secrets or confidential know-how to protect our technology, especially where patent protection is believed by us to be of limited value. We rely on third parties for research and development work, and expect to rely on third parties for future manufacturing of our proprietary product candidate, AMX0035, and any future product candidates. We also expect to collaborate with third parties on the development of AMX0035 and any future product candidates. As a result of the aforementioned collaborations, we must, at times, share trade secrets with our collaborators.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trade secrets or confidential know-how can be difficult to maintain as confidential. To protect this type of information against disclosure or appropriation by competitors, our policy is to require our employees, consultants, contractors and advisors to enter into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar agreements with us prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. However, current or former employees, consultants, contractors and advisers may unintentionally or willfully disclose our confidential information to competitors, and confidentiality agreements may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. The need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#x2019;s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have an adverse effect on our business and results of operations. Enforcing a claim that a third party obtained illegally and is using trade secrets or confidential know-how is expensive, time consuming and unpredictable. Moreover, the enforceability of confidentiality agreements may vary from jurisdiction to jurisdiction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our trade secrets, although our agreements may contain certain limited publication rights. Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of our agreements with third parties, independent development or publication of information by any of our third-party collaborators. A competitor&#x2019;s discovery of our trade secrets would impair our competitive position and have an adverse impact on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may need to acquire or license intellectual property from third parties, and such licenses may not be available or may not be available on commercially reasonable terms.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A third party may hold intellectual property, including patent rights that are important or necessary to the development of additional future product candidates. It may be necessary for us to use the patented or proprietary technology of one or more third parties to commercialize our current and future product candidates. If we are unable to acquire such intellectual property outright, or obtain licenses to such intellectual property from such third parties when needed or on commercially reasonable terms, our ability to commercialize additional future product candidates, if approved, would likely be delayed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The risks described elsewhere pertaining to our intellectual property rights also apply to the intellectual property rights that we may in-license, and any failure by us or our licensors to obtain, maintain, defend and enforce these rights could have an adverse effect on our business. In some cases we may not have control over the prosecution, maintenance or enforcement of the patents that we license, and may not have sufficient ability to provide input into the patent prosecution, maintenance and defense process with respect to such patents, and potential future licensors may fail to take the steps that we believe are necessary or desirable in order to obtain, maintain, defend and enforce the licensed patents.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Business Operations, Employee Matters and Managing Growth</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">A pandemic, epidemic, or outbreak of an infectious disease, such as the ongoing COVID-19 pandemic, may materially and adversely affect our business, including our preclinical studies, clinical trials, third parties on whom we rely, our supply chain, our ability to raise capital, our ability to conduct regular business and our financial results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to risks related to public health crises such as the ongoing COVID-19 pandemic. For instance, from 2020 through 2022, we experienced certain impacts of the COVID-19 pandemic, including alterations to our preclinical and clinical trial activities, such as scheduling certain work off-site and performing off-site assessments. There can be no guarantee we will not experience other impacts, such as being forced to further delay or pause enrollment, experiencing potential interruptions to our supply chain, facing difficulties or additional costs in enrolling patients in future clinical trials or being able to achieve full enrollment of our studies within the timeframes we anticipate, or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The economic challenges caused by the COVID-19 pandemic has been and may continue to be extensive in many aspects of society and could continue to result in significant disruptions to the global economy, as well as businesses and capital markets around the world. The full extent to which the COVID-19 pandemic could ultimately impact our business, preclinical studies, clinical trials and financial results will depend on future developments, which are highly uncertain and cannot be accurately predicted, including the emergence of new variants and subvariants of the virus that causes COVID-19, such as the Omicron variants and subvariants, for which current vaccinations may be less effective or ineffective, among others. Other global health concerns could also result in social, economic, and labor instability in the countries in which we or the third parties with whom we engage operate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any negative impact the COVID-19 pandemic or any future pandemic or similar disruption has on patient enrollment or treatment, or the development of AMX0035 and any future product candidates, could cause costly delays to clinical trial activities, which could adversely affect our ability to obtain regulatory approval for and to commercialize AMX0035 and any future product candidates, if approved, increase our operating expenses, which could have a material adverse effect on our financial results. The COVID-19 pandemic has also caused significant volatility in public equity markets and disruptions to the U.S. and global economies and any future pandemic or similar disruption could lead to further market dislocation. Any such increased volatility and economic dislocation may make it more difficult for us to raise capital on favorable terms, or at all. If we or any of the third parties with whom we engage were to experience business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business and our results of operations and financial conditions. To the extent the COVID-19 pandemic or any future pandemic or similar disruption adversely affects our business and financial results, it may also</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">heighten many of the other risks described in this &#x2018;&#x2018;Risk Factors&#x2019;&#x2019; section, such as those relating to the timing and completion of our clinical trials and our ability to obtain future financing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability, an ongoing military conflict between Russia and Ukraine, and high inflation and rising interest rates, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. and global markets are experiencing volatility and disruption caused by the ongoing Russia-Ukraine conflict and the effects of sanctions imposed on Russia as a result of the conflict. In February 2022, a full-scale military invasion of Ukraine by Russian troops began. Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine has led to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions, which has contributed to record inflation globally. We are continuing to monitor inflation, the situation in Ukraine and global capital markets and assessing its potential impact on our business, including the impact on the supply chains we rely on for the manufacture of AMX0035 or other future product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although, to date, our business has not been materially impacted by the ongoing military conflict between Russian and Ukraine, geopolitical tensions, or record inflation, it is impossible to predict the extent to which our operations will be impacted in the short and long term, or the ways in which such matters may impact our business. The extent and duration of the conflict in Ukraine, geopolitical tensions, record inflation and resulting market disruptions are impossible to predict but could be substantial. Any such disruptions may also magnify the impact of other risks we face.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inadequate funding for the FDA, the SEC and other government agencies, including from government shutdowns, or other disruptions to these agencies&#x2019; operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, the ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We depend heavily on our executive officers, principal consultants and others, and the loss of their services would materially harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success depends, and will likely continue to depend, upon our ability to hire and retain the services of our current executive officers, principal consultants and others, including Josh Cohen and Justin Klee, our Co-Chief Executive Officers, James Frates, our Chief Financial Officer, Margaret Olinger, our Global Head of Commercial and Chief Commercial Officer, and Patrick Yeramian, our Global Head of Clinical Research &amp; Development and Chief Medical Officer. We have entered into employment agreements with Mr. Cohen, Mr. Klee, Mr. Frates, Ms. Olinger and Dr. Yeramian, but they may terminate their employment with us at any time. The loss of their services might impede the achievement of our research, development and commercialization objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to compete in the biotechnology and pharmaceuticals industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. Our industry has experienced a high rate of turnover of management personnel in recent years. Replacing executive officers or other key employees may be difficult and may take an</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to develop, gain regulatory approval of and commercialize products successfully.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these additional key employees on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by other entities and may have commitments under consulting or advisory contracts with those entities that may limit their availability to us. If we are unable to continue to attract and retain highly qualified personnel, our ability to develop and commercialize AMX0035 or any future product candidates will be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We only have a limited number of employees to manage and operate our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 262 full-time employees. Our focus on the development of AMX0035 requires us to optimize cash utilization and to manage and operate our business in a highly efficient manner. We cannot assure you that we will be able to hire and/or retain adequate staffing levels to develop AMX0035 or to run our operations and/or to accomplish all of the objectives that we otherwise would seek to accomplish.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, independent contractors, consultants, collaborators and CROs may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for us and harm our reputation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, consultants, collaborators and CROs may engage in fraudulent conduct or other illegal activity. Misconduct by those parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA regulations or similar regulations of comparable non-U.S. regulatory authorities, including those laws requiring the reporting of true, complete and accurate information to such authorities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing standards; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable non-U.S. regulatory authorities; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">laws that require the reporting of financial information or data accurately. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Activities subject to these laws also involve the improper marketing, use or misrepresentation of information obtained in the course of clinical trials, creating fraudulent data in our preclinical studies or clinical trials or illegal misappropriation of product materials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. Additionally, we are subject to the risk that a person or government could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, disgorgement, integrity oversight and reporting obligations, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could have a material adverse effect on our ability to operate our business and our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We expect to expand our organization, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently expect to continue to significantly increase the number of our employees and the scope of our operations, particularly in the areas of regulatory affairs and sales, marketing and distribution, as well as to support our public company operations. To manage these growth activities, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Our management may need to devote a significant amount of its attention to managing these growth activities. Moreover, our expected growth could require us to relocate to a different geographic area of the country. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion or relocation of our operations, retain key employees, or identify, recruit and train additional qualified personnel. Our inability to manage the expansion or relocation of our operations effectively may result in weaknesses in our infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could also require significant capital expenditures and may divert financial resources from other projects, such as the development of additional product candidates. If we are unable to effectively manage our expected growth, our expenses may increase more than expected, our ability to generate revenues could be reduced and we may not be able to implement our business strategy, including the successful commercialization of AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Common Stock</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The price of our stock may be volatile, and you could lose all or part of your investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this &#x201c;Risk Factors&#x201d; section and elsewhere in Annual Report, these factors include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the commencement, enrollment or results of our ongoing and future preclinical studies and clinical trials, or any future preclinical studies or clinical trials, we may conduct of AMX0035 and any future product candidates, or changes in the development status of our current and any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any additional regulatory submissions for AMX0035 or any future product candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority&#x2019;s review of such submissions, including without limitation the FDA&#x2019;s issuance of a &#x201c;refusal to file&#x201d; letter or a request for additional information; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse results or delays in our preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our decision to initiate a clinical trial, not to initiate a clinical trial, or to terminate an existing clinical trial; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse regulatory decisions, including failure to receive regulatory approvals for AMX0035 and any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in laws or regulations applicable to AMX0035 and any future product candidates, including but not limited to clinical trial requirements for approvals; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the failure to obtain coverage and adequate reimbursement of AMX0035 and any future product candidates, if approved; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes on the structure of healthcare payment systems; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any changes to our relationship with any manufacturers, suppliers, licensors, future collaborators or other strategic partners; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to obtain adequate product supply for any approved drug product or inability to do so at acceptable prices; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to establish collaborations, if needed; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to successfully commercialize AMX0035 and any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions or departures of key scientific or management personnel; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unanticipated serious safety concerns related to the use of AMX0035 and any future product candidates; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">introduction of new products or services offered by us or our competitors, or the release or publication of clinical trial results from competing product candidates; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of significant acquisitions, strategic partnerships, joint ventures, or capital commitments by us or our competitors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to effectively manage our growth; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">actual or anticipated variations in quarterly operating results; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our cash position and rate of expenditures; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to the public; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">publication of research reports about us or our industry or positive or negative recommendations or withdrawal of research coverage by securities analysts; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the market valuations of similar companies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">overall performance of the equity markets; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issuances of debt or equity securities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">sales of our common stock by us or our stockholders in the future or the perception that such sales may occur; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">trading volume of our common stock; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in accounting practices; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ineffectiveness of our internal controls; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disputes or other developments relating to proprietary rights, including patents, litigation matters, and our ability to obtain patent protection for our technologies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant lawsuits, including patent or stockholder litigation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general political, geographical, and economic conditions, including the impact of the COVID-19 pandemic, historically high inflation, rising interest rates and the ongoing conflict in Ukraine; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other events or factors, many of which are beyond our control. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the stock market in general, and pharmaceutical companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unstable market, economic, political and geographical conditions may have serious adverse consequences on our business, financial condition and stock price.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As widely reported, global credit and financial markets have experienced extreme volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in the rate of inflation and interest rates, increases in unemployment rates and uncertainty about economic stability, including most recently in connection with the ongoing COVID-19 pandemic and the conflict in Ukraine. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued unpredictable and unstable market conditions. Our business could also be impacted by volatility caused by geopolitical events such as the war in the Ukraine. If the current equity and credit markets deteriorate, or do not improve, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. Furthermore, our stock price may decline due in part to the volatility of the stock market and the general economic downturn.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay, scale back or discontinue the development and commercialization of one or more of our product candidates or delay our pursuit of potential in-licenses or acquisitions. In addition, there is a risk that one or more of our current service providers, manufacturers and other partners may not survive these difficult economic times, which could directly affect our ability to attain our operating goals on schedule and on budget.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are an emerging growth company and a smaller reporting company, and the reduced reporting requirements applicable to emerging growth companies and smaller reporting companies may make our common stock less attractive to investors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are an emerging growth company, as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2022, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We could be an emerging growth company until December 31, 2027, although circumstances could cause us to lose that status earlier, including if we become a &#x201c;large accelerated filer&#x201d; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, or if we have total annual gross revenue of $ 1.235 billion or more during any fiscal year before that time, in which cases we would no longer be an emerging growth company as of the following December 31 or, if we issue more than $1.0 billion in non-convertible debt during any three year period before that time, in which case we would cease to be an emerging growth company immediately. Even after we no longer qualify as an emerging growth company, we may still qualify as a &#x201c;smaller reporting company&#x201d;, which would allow us to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. Investors may find our common stock less attractive because we may rely on these exemptions. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of accounting standards that have different effective dates for public and private companies until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption from new or revised accounting standards, and therefore we will not be subject to the same requirements to adopt new or revised accounting standards as other public companies that are not emerging growth companies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">A significant portion of our total outstanding shares may be sold into the market, which could cause the market price of our common stock to decline significantly, even if our business is doing well.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. As of March 8, 2023, we had outstanding 66,716,388 shares of common stock, which may be resold in the public market immediately without restriction, unless held by our affiliates. Moreover, holders of approximately 15.9 million shares of our common stock have rights, subject to specified conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We do not anticipate paying any cash dividends on our capital stock in the foreseeable future. Accordingly, stockholders must rely on capital appreciation, if any, for any return on their investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared nor paid cash dividends on our capital stock. We currently plan to retain all of our future earnings, if any, to finance the operation, development and growth of our business. In addition, the terms of any future debt or credit agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of ownership of our common stock among our existing executive officers, directors and principal stockholders may prevent new investors from influencing significant corporate decisions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our executive officers and directors, combined with our stockholders who own more than 5% of our outstanding common stock, own a significant portion of our common stock. As a result, these stockholders acting together, could be able to significantly influence all matters submitted to our stockholders for approval, as well as our management and affairs. For example, these stockholders, if they choose to act together, could significantly influence the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that our stockholders may feel are in their best interest.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Delaware law and provisions in our amended and restated certificate of incorporation, or our certificate of incorporation, and amended and restated bylaws, or our bylaws, could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provisions of our certificate of incorporation and bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our certificate of incorporation and bylaws:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permit our board of directors to issue up to 10,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate (including the right to approve an acquisition or other change in our control); </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that the authorized number of directors may be changed only by resolution of the board of directors; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that our board of directors or any individual director may only be removed with cause and the affirmative vote of the holders of at least 66-2/3% of the voting power of all of our then-outstanding common stock; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">divide our board of directors into three classes; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing in a timely manner and also specify requirements as to the form and content of a stockholder&#x2019;s notice; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose); </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that special meetings of our stockholders may be called only by the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that the Court of Chancery of the State of Delaware is the sole and exclusive forum for the following types of actions or proceedings under state, statutory and common law: (i) any derivative action or proceeding brought on our behalf; (ii) any action or proceeding asserting a claim of breach of a fiduciary duty owed by any of our current or former directors, officers or other employees to us or our stockholders; (iii) any action or proceeding asserting a claim against us or any of our current or former directors, officers or other employees, arising out of or pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws; (iv) any action or proceeding to interpret, apply, enforce or determine the validity of our certificate of incorporation or our bylaws; (v) any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction to the Court of Chancery of the State of Delaware; and (vi) any action asserting a claim against us or any of our directors, officers or other employees governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court&#x2019;s having personal jurisdiction over the indispensable parties named as defendants; provided these provisions of our certificate of incorporation and bylaws will not apply to suits brought to enforce a duty or liability created by the Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction; and provided that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the U.S. shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, or the Securities Act. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amendment of any of these provisions, with the exception of the ability of our board of directors to issue shares of preferred stock and designate any rights, preferences and privileges thereto, would require approval by the holders of at least 66-2/3% of our then-outstanding common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, as a Delaware corporation, we are subject to Section 203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time. A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of this provision.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other provisions in our certificate of incorporation, bylaws and Delaware law could make it more difficult for stockholders or potential acquirors to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delay or impede a merger, tender offer or proxy contest involving our company. The existence of these provisions could negatively affect the price of our common stock and limit opportunities for you to realize value in a corporate transaction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are obligated to develop and maintain proper and effective internal controls over financial reporting and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and, as a result, the value of our common shares.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will be required, pursuant to Section 404 of the Sarbanes Oxley Act, or Section 404, to furnish a report by management on, among other things, the effectiveness of our internal controls over financial reporting for the fiscal year ending December 31, 2023. This assessment will need to include disclosure of any material weaknesses identified by our management in our internal controls over financial reporting. Our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting until our first annual report required to be filed with the SEC following the date we are no longer an emerging growth company, as defined in the JOBS Act, and are not a smaller reporting company with less than $100 million in annual revenue. At such time as we are required to obtain auditor attestation, if we then have a material weakness, we would receive an adverse opinion regarding our internal control over financial reporting from our independent registered public accounting firm. We are required to disclose significant changes made in our internal controls procedures on a quarterly basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We continue the costly and challenging process of enhancing our financial reporting systems and processes as necessary to allow for the operation of effective internal controls over financial reporting to comply with the requirements of Section 404. We may not be able to complete our assessment, testing and any required remediation of internal controls over financial reporting in a timely fashion. Our compliance with Section 404 will require that we incur substantial legal, accounting and other compliance expense and expend significant management efforts. We currently do not have an internal audit group. We will need to hire additional accounting and finance personnel and consultants with appropriate public company experience and technical accounting knowledge to develop and maintain the internal controls over financial reporting necessary to comply with Section 404.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have identified past material weaknesses in our internal controls over financial reporting. If during the evaluation and testing of our internal controls over financial reporting, we identify one or more additional material weaknesses in future periods, we will be unable to assert that our internal controls over financial reporting are effective. We cannot assure you that there will not be additional material weaknesses in our internal controls over financial reporting in the future. Any failure to maintain effective internal controls over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations. If we are unable to conclude that our internal controls over financial reporting are effective, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our common shares could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal controls over financial reporting, or to implement or maintain other effective control systems required of public companies, could also negatively impact our ability to access to the capital markets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, effective disclosure controls and procedures enable us to make timely and accurate disclosure of financial and non-financial information that we are required to disclose. As a public company, if our disclosure controls and procedures are ineffective, we may be unable to report our financial results or make other disclosures accurately and on a timely basis, which</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">could cause our reported financial results or other disclosures to be materially misstated and result in the loss of investor confidence and cause the market price of our common shares to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our bylaws provide that the Court of Chancery of the State of Delaware and the federal district courts of the U.S. will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our bylaws provide that, to the fullest extent permitted by law and subject to the court&#x2019;s having personal jurisdiction over the indispensable parties named as defendants, the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any derivative action or proceeding brought on our behalf; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action or proceeding asserting a breach of fiduciary duty owed by any of our current or former directors, officers or other employees to us or our stockholders;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action or proceeding asserting a claim against us or any of our current or former directors, officers or other employees arising out of or pursuant to any provision of the Delaware General Corporation Law, our amended and restated certificate of incorporation or bylaws;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action or proceeding to interpret, apply, enforce or determine the validity of our certificate of incorporation or our bylaws;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction to the Court of Chancery of the State of Delaware; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our certificate of incorporation further provides that the federal district courts of the U.S. will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These exclusive forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive forum provision in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Future sales and issuances of our common stock or rights to purchase common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that we will need significant additional capital in the future to continue our planned operations, including conducting clinical trials, commercialization efforts if we are able to obtain marketing approval of any of AMX0035 or any future product candidates, research and development activities, and costs associated with operating a public company. To raise capital, we may sell common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner we determine from time to time. If we sell common stock, convertible securities or other equity securities, investors may be materially diluted by subsequent sales. Such sales may also result in material dilution to our existing stockholders, and new investors could gain rights, preferences and privileges senior to the holders of our common stock, including shares of common stock sold in our public offerings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to our 2022 Plan, our management is authorized to grant stock options to our employees, directors and consultants. Additionally, the number of shares of our common stock reserved for issuance under our 2022 Plan will automatically</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increase on January 1 of each year, beginning on January 1, 2023 and continuing through and including January 1, 2032, by 5.0% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors. In addition, pursuant to our ESPP, the number of shares of our common stock reserved for issuance will automatically increase on January 1 of each calendar year, beginning on January 1, 2023 (through January 1, 2032), by the lesser of (i) 1.0% of the total number of shares of our common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (ii) 1,210,000 shares; provided that before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii). Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience additional dilution, which could cause our stock price to fall.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Risk Factors</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We incur significant costs as a result of operating as a public company, and our management is required to devote substantial time to compliance initiatives.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a public company, we incur significant and ongoing legal, accounting, and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, which require, among other things, that we file with the SEC annual, quarterly, and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and the Nasdaq Global Select Market to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas such as &#x201c;say on pay&#x201d; and proxy access. Emerging growth companies and smaller reporting companies are exempted from certain of these requirements, but we may be required to implement these requirements sooner than budgeted or planned and thereby incur unexpected expenses. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition, and results of operations. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cyber-attacks or other failures in our telecommunications or information technology systems, or those of our collaborators, CROs, third-party logistics providers, distributors or other contractors or consultants, could result in information theft, data corruption and significant disruption of our business operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, our collaborators, our CROs, third-party logistics providers, distributors and other contractors and consultants utilize IT systems and networks to process, transmit and store electronic information in connection with our business activities. As use of digital technologies has increased, cyber incidents, including third parties gaining access to employee accounts using stolen or inferred credentials, computer malware, viruses, spamming or other means, and deliberate attacks and attempts to gain unauthorized access to computer systems and networks, have increased in frequency and sophistication. Cyber-attacks also could include phishing attempts or e-mail fraud to cause payments or information to be transmitted to an unintended recipient. These threats pose a risk to the security of our, our collaborators&#x2019;, our CROs&#x2019;, third-party logistics providers&#x2019;, distributors&#x2019; and other contractors&#x2019; and consultants&#x2019; systems and networks, and the confidentiality, availability and integrity of our data. There can be no assurance that we will be successful in preventing cyber-attacks or successfully mitigating their effects. Similarly, there can be no assurance that our collaborators, CROs, third-party logistics providers, distributors and other contractors and consultants will be successful in protecting our clinical and other data that is stored on their systems. Any cyber-attack, data breach or destruction or loss of data could result in a violation of applicable U.S. and international privacy, data protection and other laws, and subject us to litigation and governmental investigations and proceedings by federal, state and local regulatory entities in the U.S. and by international regulatory entities, resulting in exposure to material civil and/or criminal liability. Further, our general liability insurance and corporate risk program may not cover all potential claims to which we are exposed and may not be adequate to indemnify us for all liability that maybe imposed; and could have a material adverse effect on our business and prospects. For example, the loss of clinical trial data from completed, ongoing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or future clinical trials for AMX0035 or any of our future product candidates could result in delays in our development and regulatory approval efforts and significantly increase our costs to recover or reproduce the data. In addition, we may suffer reputational harm or face litigation or adverse regulatory action as a result of cyber-attacks or other data security breaches and may incur significant additional expense to implement further data protection measures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to use net operating losses and research and development credits to offset future taxable income may be subject to certain limitations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had U.S. federal and state net operating loss carryforwards of $203.2 million and $164.1 million, respectively, some of which begin to expire in 2034. As of December 31, 2022 and 2021, we also had U.S. federal research and development tax credit carryforwards of  $4.6 million and $2.7 million, respectively, which begin to expire in 2029. These net operating loss and tax credit carryforwards could expire unused and be unavailable to offset future taxable income or tax liabilities, respectively. U.S. federal and certain state net operating losses generated in taxable years beginning after December 31, 2017 are not subject to expiration. Federal net operating losses generally may not be carried back to prior taxable years except that, under the Coronavirus Aid, Relief and Economic Security Act, federal net operating losses generated in 2018, 2019 and 2020 may be carried back to each of the five taxable years preceding the taxable year in which the loss arises. Additionally, for taxable years beginning after December 31, 2020, the deductibility of federal net operating losses generated in taxable years beginning after December 31, 2017 is limited to 80% of our taxable income in such taxable year.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In general, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, and corresponding provisions of state law, a corporation that undergoes an &#x201c;ownership change&#x201d; is subject to limitations on its ability to utilize its pre-change net operating loss carryforwards or tax credits, or NOLs or credits, to offset future taxable income. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who owns at least five percent of a corporation&#x2019;s stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a specified testing period. Our existing federal and state NOLs and our existing research and development credits may be subject to limitations arising from previous ownership changes and, if we undergo an ownership change, our ability to utilize NOLs or credits could be further limited by Sections 382 and 383 of the Code. We have not yet completed a Section 382 analysis.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Sections 382 and 383 of the Code. Our NOLs or credits may also be impaired under state law. Accordingly, we may not be able to utilize a material portion of our NOLs or credits. Furthermore, our ability to utilize our NOLs or credits is conditioned upon our attaining profitability and generating U.S. federal and state taxable income. As described above, we have incurred significant net losses since our inception and anticipate that we may incur significant losses in the future; and therefore, we do not know whether or when we will generate the U.S. federal or state taxable income necessary to utilize our NOLs or credits that are subject to limitation by Sections 382 and 383 of the Code.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We could be subject to securities class action litigation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because pharmaceutical companies have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&#x2019;s attention and resources, which could harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our failure to meet Nasdaq&#x2019;s continued listing requirements could result in a delisting of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we fail to satisfy the continued listing requirements of the Nasdaq Global Select Market, such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to delist our common stock. Such a delisting would likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the minimum bid price requirement or prevent future non-compliance with the listing requirements of the Nasdaq Global Select Market.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If securities analysts publish negative evaluations of our stock, the price of our stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The trading market for our common stock depends in part on the research and reports that industry or securities analysts publish about us or our business. If one or more of the analysts who may cover us issues an adverse opinion about our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">company, our stock price would likely decline. If one or more of these analysts ceases research coverage of us or fails to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unresolved Staff Comments.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Properties.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Details of our principal properties as of December 31, 2022, are provided below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:25.199%;"></td>
    <td style="width:1.912%;"></td>
    <td style="width:25.209%;"></td>
    <td style="width:1.424%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.218%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.912%;"></td>
    <td style="width:14.108%;"></td>
    <td style="width:1.912%;"></td>
    <td style="width:14.108%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property Description</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Location</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Square<br />Footage</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property<br />Interest</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial Lease<br />Term End Date</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office space</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cambridge, Massachusetts</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,850</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leased</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">October 2026</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office space</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cambridge, Massachusetts</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,400</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leased</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2025</span></p></td>
   </tr>
  </table>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that our facilities are adequate for our current needs and that suitable additional or substitute space would be available if needed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are not currently subject to any material legal proceedings.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not Applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock began trading on The Nasdaq Global Select Market on January 7, 2022, under the symbol &#x201c;AMLX.&#x201d; Prior to that time, there was no public market for our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holders of Record</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 8, 2023, we had approximately 28 holders of record of our common stock. Certain shares are held in &#x201c;street&#x201d; name and accordingly, the number of beneficial owners of such shares is not known or included in the foregoing number. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend Policy</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared or paid a dividend on our common stock, and we do not anticipate declaring or paying dividends on our common stock in the foreseeable future. We currently intend to retain our future earnings, if any, to fund the development and growth of our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Authorized for Issuance under Equity Compensation Plans</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We did not purchase any of our registered equity during the period covered by this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unregistered Sales of Securities and Use of Proceeds</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Sales of Unregistered Securities</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, we did not issue or sell any unregistered securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Proceeds from Initial Public Offering</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 6, 2022, our Registration Statements on Form S-1 (File Nos. 333-261703 and 333-262046) relating to our initial public offering, or IPO, were declared effective by the SEC. As of December 31, 2022, all proceeds from our IPO were fully utilized primarily to advance AMX0035 through clinical trials, manufacture drug supply, prepare for potential commercialization and for working capital and general corporate purposes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_6"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6. [Reserved</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">]</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The following information should be read in conjunction with the consolidated financial information and the notes thereto appearing elsewhere in this Annual Report.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">This discussion and other parts of this Annual Report contain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. As a result of many factors, including those factors set forth in the &#x201c;Risk Factors&#x201d; section of this Annual Report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our mission is to one day end the suffering caused by neurodegenerative diseases. We are committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Our first product, RELYVRIO&#174; (sodium phenylbutyrate and taurursodiol), previously known as AMX0035 in the U.S., is approved in the U.S. for the treatment of ALS in adults. AMX0035 is also approved with conditions by Health Canada and marketed as ALBRIOZA for the treatment of ALS in Canada.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unlike most other cells in the body that regularly die and are replaced as part of healthy function, mature neurons are normally resistant to cell death and generally cannot regenerate. We believe AMX0035 is the first drug candidate to show both a functional and survival benefit in a large-scale clinical trial of patients with amyotrophic lateral sclerosis, or ALS. The results of our Phase 2 clinical trial of AMX0035, known as the CENTAUR trial, were published in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New England Journal of Medicine</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, in two publications in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Muscle &amp; Nerve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Neurology</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Neurosurgery</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Psychiatry</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 is a dual UPR-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). Through the resolution of the UPR and by inhibiting translocation of the Bax to the outer mitochondrial membrane, we have shown in multiple models that AMX0035 can keep neurons alive under a variety of different conditions and stresses, including in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> models of neurodegeneration, endoplasmic reticulum, or ER, stress, mitochondrial dysfunction, oxidative stress and disease-specific models of a variety of other conditions, as well as in vivo models of ALS, Alzheimer&#x2019;s disease, or AD, and multiple sclerosis, or MS. We believe AMX0035 has the potential to be a foundational therapy, meaning that it could be used alone or in conjunction with other therapies to change the treatment paradigm across a broad range of neurodegenerative diseases. We are pursuing ALS as our first indication as it is a disease of rapid and profound neurodegeneration, and we are focused on the development and potential commercialization of AMX0035 for ALS globally.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have received marketing authorization with conditions by Health Canada for ALBRIOZA for the treatment of ALS. We announced commercial availability of the product in July 2022. We have submitted to and received from the national reimbursement authorities, known as the Canadian Agency for Drugs and Technologies in Health, or CADTH, and l&#x2019;Institut national d&#x2019;excellence en sant&#xe9; et en services sociaux, or INESSS, recommendations regarding reimbursement for ALBRIOZA by the Canadian provincial governments, and are negotiating with both public and private payers to obtain reimbursement coverage.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We received approval by the FDA for RELYVRIO in September 2022, and commercial product was first available in October 2022. This decision represented Amylyx&#x2019; first regulatory approval of AMX0035 in the U.S. and its second worldwide.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also actively pursuing regulatory approval of AMX0035 for the treatment of ALS in Europe. Our MAA remains under review by the Committee for Medicinal Products for Human Use, or CHMP, of the EMA. We submitted a Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMA, in Europe in the first quarter of 2022, which was validated in the same quarter. We completed the Scientific Advisory Group meeting. Certain major objections remain, and the CHMP has adopted another round of questions as part of the regulatory process. We are now in possession of those questions. In order to respond in accordance with the updated timelines, we now expect an opinion from CHMP mid-year and a decision in the third quarter of 2023 at the earliest.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2021, we initiated a Phase 3 clinical trial of AMX0035 for the treatment of ALS, known as PHOENIX trial, at clinical trial sites in the U.S. and Europe. On February 2, 2023, we announced completion of enrollment in PHOENIX, which enrolled 664 participants. We anticipate topline results from the PHOENIX trial in mid-2024. This trial is designed to provide further data evaluating the safety and efficacy of AMX0035 over 48 weeks for the treatment of ALS to further support our global regulatory efforts. European participants completing the 48-week trial have the option to enroll in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an open label extension (OLE) phase. During this phase, all participants receive AMX0035, and continued safety and efficacy measures will be assessed.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We were incorporated under the laws of the State of Delaware on January 10, 2014. Between 2020 and 2022 we created wholly owned subsidiaries, Amylyx Pharmaceuticals Canada, Inc., or Amylyx Canada, in Calgary, Canada, Amylyx Pharmaceuticals EMEA B.V., or Amylyx EMEA, in Amsterdam, Netherlands, Amylyx Pharmaceuticals Distribution Ltd., or Amylyx Ireland, in Dublin, Ireland, Amylyx Pharmaceuticals Germany GmbH, or Amylyx Germany, in Munich, Germany and Amylyx Pharmaceuticals France SAS, or Amylyx France, in Paris, France. Since inception, we have devoted substantially all of its efforts to research and development and pre-commercialization activities, including recruiting management and technical staff, raising capital, producing materials for preclinical studies and clinical trials, and building infrastructure to support such activities. Other than RELYVRIO in the U.S. and ALBRIOZA in Canada, we do not have any products approved for sale and as of December 31, 2022. As of December 31, 2022, we have funded our operations primarily through the public offering of our common stock, private sales of preferred stock, and convertible notes. We have also generated grant revenues through five grants from ALS Association, ALS Finding a Cure Foundation, Cure Alzheimer&#x2019;s Fund, Alzheimer&#x2019;s Drug Discovery Foundation and Alzheimer&#x2019;s Association, or Grantors.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred operating losses since inception, including a net loss of $198.4 million and $87.9 million for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, we had an accumulated deficit of $354.2 million. These losses have resulted primarily from costs incurred in connection with research and development activities and general and administrative costs associated with our operations. We expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution of our approved products. We may continue to incur significant losses and our financial results will be highly dependent upon our successful commercialization of RELYVRIO in the U.S. We will continue to incur significant expenses as we advance AMX0035 and any future product candidates through preclinical and clinical development, hire additional clinical, scientific, management and administrative personnel, seek regulatory approval and pursue commercialization of any approved product candidates. To date, we have primarily developed AMX0035 internally, with assistance from our network of contract research organizations, or CROs, and other advisors. This has resulted in increased research and development spending but has enabled us to manage AMX0035 efficiently through the development and manufacturing process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also expect to continue to incur additional costs associated with operating as a public company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company. As a result, we may need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate sufficient revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, including potential collaborations with other companies, royalty financings, or other strategic transactions. Our inability to raise capital as and when needed could have a negative impact on our financial condition and ability to pursue our business strategies. There can be no assurances, however, that our current operating plan will be achieved or that additional funding, if required, will be available on terms acceptable to us, or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had cash, cash equivalents and short-term investments of $346.9 million. On October 11, 2022, we completed the sale of 7,697,812 shares of our common stock in an underwritten public offering, or our 2022 follow-on offering, pursuant to which we received net proceeds of approximately $230.6 million, including exercise in full of the underwriters' option to purchase additional shares, and after deducting underwriting discounts and commissions and other offering costs. We believe that the revenue we have begun to generate with commercial sales of AMX0035 in the U.S. and Canada and our existing cash, cash equivalents, and short-term investments, will be sufficient to meet our anticipated operating and capital expenditure requirements for at least twelve months after the date of the filing of this Annual Report. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. See &#x201c;&#x2014;Liquidity and Capital Resources&#x2014;Funding Requirements&#x201d; below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Impact of COVID-19 and Other Macroeconomic Factors</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The development of AMX0035 and any future product candidates could be disrupted and materially adversely affected in the future by the continuing COVID-19 pandemic or any future pandemic or calamity. The spread of COVID-19 and identification of new variants and subvariants of the virus has impacted the global economy and our operations, including requiring us to make certain alterations to our preclinical and clinical trial activities, such as scheduling certain work off-site and performing off-site assessments. The COVID-19 pandemic could also continue to affect our employees or the employees of research sites and service providers on whom we rely as well as those of companies with which we do business, including our suppliers, thereby disrupting our business operations. Moreover, the full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations, liquidity and financial condition will depend on future</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">114</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">developments, which are highly uncertain and cannot be accurately predicted, including new information that may develop concerning COVID-19, the emergence of new variants and subvariants and the actions taken to contain it or treat its impact and the economic impact on local, regional, national and international markets. We continue to monitor COVID-19 levels local to our research operations and adapt our employee working practices to ensure essential staffing levels in our operations remain in place, including maintaining key personnel in our laboratories.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, economic uncertainty in various global markets, including the U.S. and Europe, caused by political instability and conflict, such as the ongoing conflict in Ukraine, and economic challenges caused by the COVID-19 pandemic, have led to market disruptions, including significant volatility in commodity prices, credit and capital market instability and supply chain interruptions, which have caused record inflation globally. Our business, financial condition and results of operations could be materially and adversely affected by further negative impact on the global economy and capital markets resulting from these global economic conditions, particularly if such conditions are prolonged or worsen.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although, to date, our business has not been materially impacted by these global economic and geopolitical conditions, it is impossible to predict the extent to which our operations will be impacted in the short and long term, or the ways in which such instability could impact our business and results of operations. The extent and duration of these market disruptions, whether as a result of the military conflict between Russia and Ukraine and effects of the Russian sanctions, geopolitical tensions, record inflation or otherwise, are impossible to predict, but could be substantial. Any such disruptions may also magnify the impact of other risks described in this report.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information on the various risks posed by the COVID-19 pandemic and global economic uncertainty, please read the section entitled &#x201c;Risk Factors&#x201d; in this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of Our Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product revenue, net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and we began commercially selling ALBRIOZA within Canada in July 2022. In September 2022, AMX0035 received regulatory approval as RELYVRIO by the FDA for the treatment of ALS, and we launched RELYVRIO in the U.S. in October 2022. All product revenue net, recognized during the period relates to units of ALBRIOZA and RELYVRIO sold in Canada and the U.S., respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cost of Sales</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost of sales consists primarily of costs associated with the manufacturing of RELYVRIO, ALBRIOZA and certain period costs, which include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Direct materials costs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Packaging services;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transportation costs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing overhead costs; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalties related to grants provided to us for the purpose of furthering the research and development of AMX0035 as a therapeutic benefit for ALS and AD. For additional information refer to Note 18 to our consolidated financial statements appearing at the end of this Annual Report.</span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of global macroeconomic conditions, we may experience some disruption and volatility in our global supply chain network, and we may in the future experience disruptions in availability and delays in shipments of raw materials and packaging, as well as related cost inflation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses consist primarily of costs incurred in connection with the research and development of AMX0035. We expense research and development costs as incurred. These expenses include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses incurred under agreements with CROs, contract manufacturing organizations, or CMOs, as well as investigative sites and consultants that conduct our clinical trials, preclinical studies and other scientific development services;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing scale-up expenses and the cost of acquiring and manufacturing drug product for our preclinical studies and clinical trials, including manufacturing registration and validation batches, as well as pre-commercial manufacturing activities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses to acquire technologies to be used in research and development;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">employee-related expenses, including salaries, payroll taxes, related benefits and stock-based compensation expense for employees engaged in research and development functions; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs related to compliance with quality and regulatory requirements. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Advance payments that we make for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. Such amounts are recognized as an expense as the goods are delivered or the related services are performed, or until it is no longer expected that the goods will be delivered, or the services rendered.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain of our indirect research and development expenses are not tracked on an indication-by-indication basis for AMX0035. We do not allocate employee costs and facilities, including depreciation or other indirect costs, to specific indications because these costs are deployed across multiple indications and, as such, are not separately classified. We use internal resources to oversee the research and discovery as well as to manage our preclinical development, process development, manufacturing and clinical development activities. These employees work across multiple indications and, therefore, we do not track their costs by indication.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development activities are central to our business model. Product candidates such as AMX0035 in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials and related product manufacturing expenses. We expect that our research and development expenses will continue to increase substantially in connection with our planned clinical development activities in the near term and in the future and to fund commercialization activities in the U.S., Canada and any other jurisdictions in which AMX0035 is approved. At this time, we cannot accurately estimate or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">know the nature, timing and costs of the efforts that will be necessary to complete the clinical development of AMX0035 and any future product candidates. Our clinical development costs may vary significantly based on factors such as:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">per patient trial costs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of trials required for approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of sites included in the trials;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the countries in which the trials are conducted;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the length of time required to enroll eligible patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of patients that participate in the trials;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of doses that patients receive;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the drop-out or discontinuation rates of patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential additional safety monitoring requested by regulatory agencies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the duration of patient participation in the trials and follow-up periods;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost and timing of manufacturing our current or future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the phase of development of our current or future product candidates;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy and safety profile from clinical trials and preclinical studies of our current or future product candidates; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of product candidates we are developing. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The successful development and commercialization of AMX0035 and any future product candidates is highly uncertain, due to the numerous risks and uncertainties associated with product development and commercialization, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and progress of preclinical and clinical development activities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number and scope of preclinical and clinical trials for separate indications we decide to pursue;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">raising necessary additional funds;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the progress of the development efforts of parties with whom we may enter into collaboration arrangements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain our current development activities and to establish new ones;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish new licensing or collaboration arrangements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the successful initiation and completion of clinical trials with safety, tolerability and efficacy profiles that are satisfactory to Health Canada, the FDA or the EMA, or any other comparable foreign regulatory authority;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the receipt and related terms of regulatory approvals from applicable regulatory authorities, including our marketing authorization with conditions from Health Canada for ALBRIOZA and the post-marketing requirements from the FDA for RELYVRIO;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of drug substance and drug product for use in production of AMX0035;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">establishing and maintaining agreements with third-party manufacturers for clinical supply for our clinical trials and commercial manufacturing;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain patents, trade secret protection and regulatory exclusivity, both in the U.S. and internationally;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to protect our rights in our intellectual property portfolio;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the commercialization in Canada and the U.S. of AMX0035 (known as ALBRIOZA in Canada and RELYVRIO in the U.S.) and in other potential jurisdictions, if and when approved;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining third-party insurance coverage and adequate reimbursement;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the acceptance of AMX0035, if approved, by patients, the medical community and third-party payors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">competition with other product; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a continued acceptable safety profile of our therapies in pre-approval market access programs or in commercial access following approval.</span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A change in the outcome of any of these variables with respect to the development of AMX0035 or any future product candidates could have a significant impact on the cost and timing associated with the development of our product candidates. We may never succeed in obtaining or maintaining regulatory approval for AMX0035 or any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Selling, General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative expenses consist primarily of salaries and related costs for personnel in executive, finance, sales, marketing, as well as administrative functions. Selling, general and administrative expenses also include legal fees relating to patent and corporate matters; professional fees for accounting, auditing, tax and administrative consulting services; insurance costs; administrative travel expenses; sales and marketing expenses; information technology; facility-related and other operating costs. We anticipate that our selling, general and administrative expenses will continue to increase in the future as we further increase our headcount to support our continued research activities and development of AMX0035 and as we continue to increase headcount and incur other significant costs related to our pre-commercialization activities as we prepare for potential near term regulatory approvals. We also anticipate that we will continue to incur increased accounting, audit, legal, regulatory, compliance, and director and officer insurance costs as well as investor and public relations expenses associated with being a public company. We have received marketing authorization with conditions for ALBRIOZA for the treatment of ALS in Canada and marketing authorization for RELYVRIO for the treatment of ALS in adults in the U.S. and are pursuing regulatory approval of AMX0035 for the treatment of ALS in Europe. As we implement our commercialization plans in Canada and the U.S. and prepare for a potential approval in Europe, we have been incurring a substantial increase, and anticipate further increases in, payroll and expense as a result of our preparation for commercial operations, especially as it relates to the sales and marketing of AMX0035.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income consists primarily of the amortization of premiums and accretion of discounts on our short-term investments, and interest income earned on our cash, cash equivalents and short-term investments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Expense, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other expense, net consists primarily of realized and unrealized losses on foreign exchange transactions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Change in Fair Value of Convertible Notes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of convertible notes is comprised of adjustments to the fair value of our 2021 Notes. As permitted under ASC Topic 825, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ASC 825), we elected the fair value option to account for our 2021 Notes, and as a result, we measured our 2021 Notes at fair value at each financial reporting period and immediately before conversion in July 2021. All changes to the fair value of our 2021 Notes for the year ended December 31, 2021 resulted in a loss. Our 2021 Notes converted into shares of Series C-2 redeemable convertible preferred stock concurrently with the issuance of our Series C-1 redeemable convertible preferred stock. Immediately prior to the conversion, we determined the fair value of our 2021 Notes based on the fair value of the Series C-1 redeemable convertible preferred stock and the conversion price at which these notes converted, which was at 85% of the fair value of the Series C-1 redeemable convertible preferred stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The provision for income taxes primarily consists of provisions for foreign taxes payable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, we had federal net operating loss carryforwards of approximately $203.2 million and $115.7 million, respectively, and state net operating loss carryforwards of approximately $164.1 million and $102.9 million, respectively, which are available to reduce future taxable income. Of the $203.2 million federal net operating loss carryforwards, $1.3 million begin to expire in 2034 and the remaining $201.9 million net operating losses carryforward indefinitely. Of the $164.1 million state net operating loss carryforwards, $113.0 million of Massachusetts net operating loss carryforwards begin to expire in 2034. As of December 31, 2022 and 2021, we also had federal tax credits of $4.6 million and $2.7 million, respectively, and state tax credits of $1.2 million. The tax credit carryforwards will expire at various dates beginning in 2034.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">119</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comparison of the Years Ended December 31, 2022 and 2021</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our results of operations for the years ended December 31, 2022 and 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.788%;"></td>
    <td style="width:1.314%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.22%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.314%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.22%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.314%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.062000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.773%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$ Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,230</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,230</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*NM</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">285</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(285</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(100</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total revenues</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,230</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">285</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,945</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,700</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost of sales</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,993</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,993</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*NM</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,450</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44,040</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,410</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">127,128</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,933</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88,195</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">227</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">223,571</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82,973</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">140,598</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(201,341</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(82,688</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(118,653</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">143</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,291</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,255</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*NM</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of convertible notes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5,228</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,228</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(100</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other expense, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(551</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(51</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(500</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">980</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,740</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5,243</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,983</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(171</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(197,601</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(87,931</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(109,670</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provision for income taxes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">774</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">774</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*NM</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(198,375</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(87,931</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(110,444</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.75pt solid;margin-right:79.63%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* NM - not meaningful</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product revenue, net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We began commercially selling ALBRIOZA within Canada in July 2022 and RELYVRIO within the U.S. in October 2022. For the year ended December 31, 2022, we recorded approximately $22.2 million of product revenue, net. For further discussion regarding our revenue recognition policy, see Note 2, Summary of Significant Accounting Policies, in the Notes to the consolidated financial statements included this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cost of sales</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost of sales of $3.0 million for the year ended December 31, 2022, consisted of costs to procure, manufacture and distribute our marketed product, RELYVRIO and ALBRIOZA. In addition, included in cost of sales are costs to manufacture our marketed product which has been provided to patients at no cost to them while insurance reimbursement is established. We expect these costs to continue into 2024, and to a lesser degree, indefinitely. Drug product given to patients at no cost to them is not included in product revenue, net. Based on our policy to expense costs associated with the manufacture of our products prior to regulatory approval, certain of the costs of units recognized as revenue during the year ended December 31, 2022, or approximately $3.4 million, were expensed prior to obtaining regulatory approvals and, therefore, are not included in cost of sales during this period. We expect cost of sales to increase and gross margin to decrease as we deplete these inventories. We expect to use the remaining pre-commercialization inventory for product sales in 2024.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our research and development expenses for the years ended December 31, 2022 and 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.67%;"></td>
    <td style="width:1.31%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:8.972%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.31%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:8.972%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.31%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.031%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.995%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.429%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$ Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMX0035 - ALS</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,742</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,756</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,986</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and personnel-related</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,501</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,972</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,529</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">218</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,207</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,312</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5,105</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(55</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,450</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44,040</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,410</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses were $93.5 million for the year ended December 31, 2022, compared to $44.0 million for the year ended December 31, 2021. During these periods, most of our research and development expenses were related to the development of and clinical trials of AMX0035. The increase of $49.4 million was primarily due to a $35.0 million increase in spending on AMX0035 for the ALS indication, a $19.5 million increase in payroll and personnel-related costs, and a $5.1 million decrease in all other costs. The increases in spending on AMX0035 were primarily related to costs associated with our global Phase 3 PHOENIX trial of AMX0035 in ALS that was initiated in November 2021, including its open label extension phase, and consulting and manufacturing development expenses in anticipation of potential commercialization, which includes inventory raw material purchases made in anticipation of the lead time necessary to have it available to meet our clinical trial and potential commercialization needs. The increase in payroll and personnel-related costs was primarily due to an increase in the number of employees supporting research and development efforts. The decreases in other costs were primarily due to a decrease in costs associated with research and development spend for AMX0035 in other indications, as we focused our efforts on ALS leading up to our approvals. We expect to increase research and development for AMX0035 in other indications in future periods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Selling, General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative expenses were $127.1 million for the year ended December 31, 2022 compared to $38.9 million for the year ended December 31, 2021. The increase of $88.2 million was primarily due to increases of $55.4 million in payroll and personnel-related costs, including stock-based compensation, $15.9 million in consulting and professional services and $17.1 million in insurance and other expenses. The increase in payroll and personnel-related costs was primarily due to hiring additional personnel in commercial and general and administrative functions to support our growth, as well as commercialization and launch preparation initiatives. The increases in consulting and professional services and insurance and other expenses were primarily due to an increase in spending for commercial readiness activities and operations as a public company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="margin-left:3.4%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income for the year ended December 31, 2022 was $4.3 million compared to less than $0.1 million for the year ended December 31, 2021.  The increase was primarily attributable to higher investment balances driven by our proceeds received from our IPO and our 2022 follow-on offering, resulting in higher interest earned.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:3.4%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Change in Fair Value of Convertible Notes</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The change in fair value of convertible notes was zero for the year ended December 31, 2022, due to conversion to preferred stock in July 2021, compared to $5.2 million for the year ended December 31, 2021.  The $5.2 million recorded for the year ended December 31, 2021 represented a loss in fair value related to our 2021 Notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">121</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sources of Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since our inception, we have incurred significant operating losses and generated revenues through five grants from the Grantors. In the second half of 2022 we commenced generating revenue from the sale of our approved drug product RELYVRIO, known as ALBRIOZA in Canada. To date, we have financed our operations primarily through revenue from the sale of our approved products, the sale and issuance of common stock, convertible preferred stock, convertible notes and grant agreements with the Grantors. As of December 31, 2022, we had cash, cash equivalents and short-term investments of $346.9 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From inception through December 31, 2022, we have raised $663.6 million in aggregate proceeds, net of issuance costs, primarily from the issuance of convertible preferred stock, convertible notes and grant agreements. In July 2021, we issued and sold shares of Series C-1 preferred stock for an aggregate purchase price of approximately $135.0 million. The 2021 Notes automatically converted into shares of Series C-2 preferred stock pursuant to their original terms in July 2021 in connection with our sale of Series C-1 preferred stock. In January 11, 2022, we completed the IPO of our common stock pursuant to which we received aggregate net proceeds of $196.4 million after deducting underwriting discounts and commissions and other offering costs. On October 11, 2022, we completed the sale of 7,697,812 shares of our common stock in an underwritten public offering, pursuant to which we received net proceeds of approximately $230.6 million, including exercise in full of the underwriters' option to purchase additional shares, and after deducting underwriting discounts and commissions and other offering costs. Based on our current operational plans and assumptions, We believe that the revenue we have begun to generate with commercial sales of AMX0035 in the U.S. and Canada and our existing cash, cash equivalents, and short-term investments, will be sufficient to meet our anticipated operating and capital expenditure requirements for at least twelve months after the date of the filing of this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Capital Resources</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the preclinical activities, manufacturing and clinical trials of AMX0035 and any future product candidates, implement our commercialization plans for ALBRIOZA in Canada and RELYVRIO in the U.S., and prepare for the commercial launch of AMX0035 in other jurisdictions, if approved. In addition, we expect to incur additional costs associated with operating as a public company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company. Our expenses will also increase as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continue our research and development efforts, including our ongoing global Phase 3 PHOENIX trial of AMX0035 for the treatment of ALS;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continue to commercialize AMX0035 (also known as ALBRIOZA in Canada and RELYVRIO in the U.S.) for the treatment of ALS in Canada and the U.S., and pursue launch of AMX0035 in Europe, if approved;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pursue INDs of AMX0035 for additional indications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conduct preclinical studies and clinical trials for AMX0035 for additional indications and for potential future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek to identify and develop, acquire or in-license additional product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">experience any delays or encounter any issues with any of the above, including but not limited to failed studies, complex results, safety issues, or other regulatory challenges;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">develop the necessary processes, controls and manufacturing data to obtain additional marketing approval for AMX0035 or approval for any future product candidates and to support manufacturing on a commercial scale;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek additional regulatory approvals for AMX0035 or approvals for any future product candidates that successfully complete clinical trials, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hire and retain additional personnel, such as preclinical, clinical, quality assurance, regulatory affairs, manufacturing, distribution, legal, compliance, finance, general and administrative, commercial and scientific personnel;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">122</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">develop, maintain, expand and protect our intellectual property portfolio; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continue to transition our organization to being a public company. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are now a publicly traded company and will incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act of 2002, as well as rules adopted by the SEC and the Nasdaq Global Select Market, require public companies to implement specified corporate governance practices that are currently not applicable to private companies. Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, we are required to furnish a report by our management on our internal control over financial reporting for the current year ending December 31, 2022. However, while we remain an emerging growth company, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section 404 within the prescribed period, we have engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and demands significant effort. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. We expect these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current operational plans and assumptions, we believe that the revenue we have begun to generate with commercial sales of AMX0035 in the U.S. and Canada and our existing cash, cash equivalents, and short-term investments, will be sufficient to meet our anticipated operating and capital expenditure requirements for at least twelve months after the date of the filing of this Annual Report. We have based these estimates on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we expect. As we progress with our development activities and the regulatory review process, we expect to incur significant commercialization expenses related to product manufacturing, pre-commercial activities and commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">123</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the numerous risks and uncertainties associated with research, development and commercialization of product candidates and programs, we are unable to estimate the exact amount of our working capital requirements. Our future funding requirements will depend on and could increase significantly as a result of many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, results and costs of drug discovery, laboratory testing, preclinical and clinical development for AMX0035 and any future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs, timing and outcome of commercialization activities, including manufacturing, marketing, sales and distribution for ALBRIOZA in Canada, RELYVRIO in the U.S. and for AMX0035, if approved, in other territories or for any future product candidates for which we receive regulatory approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs, timing and outcome of regulatory review of AMX0035 and any future product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain collaborations, marketing, distribution and license agreements on favorable terms, if at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to enroll clinical trials in a timely manner and to quickly resolve any delays or clinical holds that may be imposed on our development activities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">timing delays with respect to preclinical and clinical development of AMX0035 and any future product candidates, including as result of the ongoing COVID-19 pandemic or other pandemics or disruptions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of expanding our facilities to accommodate our expected growth in personnel, and the costs of such additional personnel; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire technologies or other assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the sales price and availability of adequate third-party coverage and reimbursement for AMX0035 and any future product candidates, if and when approved; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of operating as a public company. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until such time, if ever, that we can generate product revenue sufficient to achieve profitability, we expect to finance our cash needs through equity offerings, debt financings, government or other third-party funding, marketing and distribution arrangements and other collaborations, strategic alliances and licensing arrangements. To the extent that we raise additional capital through the sale of common stock, convertible securities or other equity securities, current ownership interests will be diluted. If we raise additional funds through collaborations or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. In addition, debt financing, if available, may result in fixed payment obligations and may involve agreements that include restrictive covenants that limit our ability to take specific actions, such as incurring additional debt, making capital expenditures, creating liens, redeeming stock or declaring dividends, that could adversely impact our ability to conduct our business. If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">124</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash Flows</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comparison of the Years Ended December 31, 2022 and 2021</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our sources and uses of cash for the years ended December 31, 2022 and 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.43%;"></td>
    <td style="width:1.297%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.146%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.307%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.146%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.307%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:8.989%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.993%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.383999999999999%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$ Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(179,871</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(74,799</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(105,072</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">140</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(238,988</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(46,406</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(192,582</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">431,789</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">158,506</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">273,283</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">172</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effect of exchange rate changes on cash, cash equivalents and <br />&#160;&#160;&#160;restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(65</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(78</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(600</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase in cash, cash equivalents and restricted cash <br />&#160;&#160;&#160;equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,865</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,314</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(24,449</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(66</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.75pt solid;margin-right:79.63%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, operating activities used $179.9 million of cash, primarily resulting from our net loss of $198.4 million and net amortization of premiums and discounts on investments of $2.1 million, offset by $21.7 million of non-cash stock-based compensation expense, $0.5 million of depreciation expense and a $1.6 million increase in net cash used in our operating assets and liabilities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in our operating assets and liabilities primarily consisted of a $26.1 million increase in accrued expenses and deferred rent due to increased spending for external research and development to support our growth, a $1.9 million increase in accounts payable and a $0.5 million decrease in interest receivable from short-term investments. This was offset by a $15.3 million increase in accounts receivable, a $9.8 million increase in inventories, a $0.5 million increase in other assets and a $5.2 million increase in prepaid expenses and other current assets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, operating activities used $74.8 million of cash, primarily resulting from our net loss of $87.9 million, offset by a $5.2 million change in fair value of convertible notes, $3.1 million of non-cash stock-based compensation expense, $0.1 million of depreciation expense, $0.1 million net amortization of premiums and discounts on investments, and a $4.6 million increase in net cash used in our operating assets and liabilities.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in our operating assets and liabilities primarily consisted of a $8.4 million increase in accrued expenses and deferred rent due to increased spending for external research and development to support our growth, a $0.7 million increase in accounts payable and a $0.1 million decrease in other assets, offset by a $0.1 million increase in interest receivable from short-term investment and $4.5 million increase in prepaid expenses and other current assets due to increase in sign-on bonuses as a result of an increase in headcount and increase in other receivables related to milestones achieved under the grant agreements for which we were owed by the grantors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, net cash used in investing activities was $239.0 million, resulting from $2.5 million in purchases of property and equipment and $415.9 million in purchases of short-term investments, offset by $179.4 million of investments matured during the period.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, net cash used in investing activities was $46.4 million, resulting from $0.4 million in purchases of property and equipment and $49.1 million in purchases of short-term investments, offset by $3.0 million of investments matured during the period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, net cash provided by financing activities was $431.8 million. This amount consisted of $200.9 million of proceeds from our IPO, net of underwriter&#x2019;s discounts and commissions, $231.6</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">million of proceeds from our 2022 follow-on offering, net of underwriter&#x2019;s discounts and commissions, and $2.2 million of proceeds from exercises of stock options, offset by $2.8 million in payments of deferred offering costs.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, net cash provided by financing was $158.5 million. This amount consisted of $134.8 million of net proceeds from the sale of our Series C-1 redeemable convertible preferred stock,  $14.3 million of net proceeds from the issuance of convertible notes to related parties, $11.9 million of net proceeds from the issuance of the convertible notes and $0.3 million of proceeds from exercises of stock options, offset by a $2.5 million payment of deferred offering costs, $0.3 million repayment of PPP loan, and less than $0.1 million of issuance costs related to the conversion of the convertible notes, which was related to the 2021 Notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Critical Accounting Policies and Significant Judgments and Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements appearing at the end of this Annual Report, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our accounting policy for revenue recognition has a substantial impact on reported results and relies on certain estimates. Revenue is recognized following a five-step model under ASC Topic 606 - </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Revenue is also reduced by variable consideration related to certain gross-to-net, or GTN, adjustments discussed below. These GTN adjustments involve significant estimates and judgment after considering historical experience, payer channel mix (e.g., Medicare or Medicaid), current contract prices under applicable programs, unbilled claims and processing time lags and inventory levels in the distribution channel. Estimates are assessed each period and adjusted as required to revise information or actual experience.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We enter into arrangements with wholesalers, specialty pharmacies and specialty distributors, or Customers, to distribute ALBRIOZA, RELYVRIO and future approved products. In accordance with Topic 606, we recognize revenue on product sales when the Customer obtains control of our product, which occurs at a point in time (upon delivery). Product revenues are recorded net of applicable GTN adjustments, including discounts and allowances. Payment from Customers is typically due within 30 calendar days of the invoice date.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following categories of GTN adjustments involve significant estimates, judgments and information obtained from external sources.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provider Chargebacks and Discounts</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We participate in programs with government entities such as the U.S. Department of Veterans Affairs, and other parties, including covered entities under the 340B Drug Pricing Program, whereby pricing on products is extended below wholesaler list price to participating entities. These entities purchase products through wholesalers at the lower program price and the wholesalers then charge us the difference between their acquisition cost and the lower program price. Product revenue and accounts receivable is reduced for the estimated amount of unprocessed charge-back claims attributable to a sale.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Customers are offered cash discounts as an incentive for prompt payment. Product revenue and accounts receivable is reduced for the estimated amount of cash discount at the time of sale and the discount is typically taken by the customer within one month.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Payor rebates</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We participate in state government Medicaid programs and other qualifying Federal and state government programs requiring discounts and rebates to participating state and local government entities. All discounts and rebates provided through these programs are included in our Medicaid rebate accrual. Our rebate accruals are recorded in the same period in which the related revenue is recognized, resulting in a reduction of product revenue. The estimated amount of unpaid or unbilled rebates is presented as a liability.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rebates and discounts are offered to managed healthcare organizations in the U.S. managing prescription drug programs and Medicare Advantage prescription drug plans covering the Medicare Part D drug benefit. The estimated amount of unpaid or unbilled rebates and discounts is presented as a liability.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other incentives, returns, discounts and adjustments</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other GTN adjustments include incentives which we offer and includes voluntary patient assistance programs, such as our co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with prescription drug co-payments required by payors. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that we expect to receive associated with the product that has been recognized as revenue for each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated product returns for established products are determined using quantitative and qualitative information including, but not limited to, expected experience with returns, projected demand, levels of inventory in the distribution channel, product dating and expiration period, and whether products have been discontinued, among others. The Company has received an immaterial amount of returns to date and believe that returns of product in future periods will be minimal.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in the consolidated financial statements based on facts and circumstances known to us at that time. We periodically confirm the accuracy of these estimates with the service providers and make adjustments if necessary.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The estimate of accrued research and development expense is dependent, in part, upon the receipt of timely and accurate reporting from CROs, CMOs and other third-party service providers. Examples of estimated accrued research and development expenses include fees paid to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">vendors in connection with preclinical development activities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CROs and investigative sites in connection with preclinical studies and clinical trials; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CMOs in connection with drug substance and drug product formulation of preclinical study and clinical trial materials. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We base our expenses related to preclinical studies and clinical trials on our estimates of the services received and efforts expended pursuant to quotes and contracts with multiple CMOs and CROs that conduct and manage preclinical studies and clinical trials on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">127</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exceed the level of services provided and result in a prepayment of the expense. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, we adjust the accrual or the amount of prepaid expenses accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period. To date, there have not been any material adjustments to our prior estimates of accrued research and development expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We account for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for tax attribute carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. Realization of our deferred tax assets is dependent upon the generation of future taxable income, the amount and timing of which are uncertain. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#x2019;s evaluation of all available evidence, including our history of incurring significant losses from operations. Our evaluation of all available evidence also includes consideration of regulatory approvals of ALBRIOZA and RELYVRIO, including revenue generated from the sale these products in 2022.  Given the early stage of our product launch, we are uncertain about the timing and amount of future sales. We may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability. We may become subject to income tax audits and adjustments by local tax authorities. The nature of uncertain tax positions is subject to significant judgment by management and subject to change, which may be substantial. We develop our assessment of uncertain tax positions, and the associated cumulative probabilities, using internal expertise and assistance from third-party experts. As additional information becomes available, estimates are revised and refined. Differences between estimates and final settlement may occur resulting in additional tax expense.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging Growth Company and Smaller Reporting Company Status</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Jumpstart Our Business Startups Act of 2012, or JOBS Act, permits an &#x201c;emerging growth company&#x201d; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, we will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies, and our consolidated financial statements may not be comparable to other public companies that comply with new or revised accounting pronouncements as of public company effective dates. We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will cease to be an emerging growth company on the date that is the earliest of (i) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more, (ii) the last day of our fiscal year following the fifth anniversary of the date of the closing of our initial public offering, (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which we are deemed to be a large, accelerated filer under the rules of the Securities and Exchange Commission.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also a &#x201c;smaller reporting company&#x201d;, and we will continue to be a smaller reporting company until the first quarter of the fiscal year following the determination that the market value of our stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter, or our annual revenue are more than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter. Similar to emerging growth companies, smaller reporting companies are able to provide simplified executive compensation disclosure and have certain other reduced disclosure obligations, including, among other things, being required to provide only the two most recent fiscal years of audited financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recently Issued Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">129</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7a"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Quantitative and Qualitative Disclosures about Market Risk.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_8"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Financial Statements and Supplementary Data.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our consolidated financial statements, together with the reports of our independent registered public accounting firms, appear beginning on page F-1 of this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9a_controls_and_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A. Controls and Procedures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, are designed to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the Exchange Act) is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management, with the participation of our principal executive officers and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2022. Based on the evaluation of our disclosure controls and procedures as of December 31, 2022, our Chief Executive Officers and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management&#x2019;s Annual Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d&#x2011;15(f) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />As of December 31, 2022, we assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting under the 2013 &#x201c;Internal Control&#x2014;Integrated Framework&#x201d;, issued by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO. Based on such assessment, our management concluded that we maintained effective internal control over financial reporting as of December 31, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, we began generating revenue from the sale of ALBRIOZA in Canada and RELYVRIO in the U.S. We consider the accounting for our product revenue to be material to our results of operations in future periods, and believe that the additional internal controls and procedures relating to the accounting for product revenue, and related commercial inventory, have a material effect on our internal control over financial reporting. Other than described</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">above, there was no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inherent Limitations on the Effectiveness of Controls</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, in designing and evaluating the disclosure controls and procedures, management recognizes that any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9b_other_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B. Other Information.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9c"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_10"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Directors, Executive Officers and Corporate Governance.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 10 will be included in the Proposal No. 1, Corporate Governance and Executive Officers section of our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_11"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Executive Compensation.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 11 will be included in the Executive Compensation and Director Compensation sections of our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_12"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 12 will be included in the Security Ownership of Certain Beneficial Owners and Management sections of our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_13"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Certain Relationships and Related Transactions, and Director Independence.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 13 will be included in the Certain Relationships and Related Party Transactions and Corporate Governance sections of our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_14"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Principal Accountant Fees and Services.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our independent public accounting firm is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_df27c47b-fbc6-4fba-bc6c-fc51d30467a3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deloitte &amp; Touche, LLC</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b99a564e-e23c-4639-9457-97ea68963ea9" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, Massachusetts</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, PCAOB Auditor ID: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d011412f-0431-444c-91d3-9fa9edb5ec01" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="dei:AuditorFirmId"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 14 will be included in the Proposal No. 2 section of our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Exhibits, Financial Statement Schedules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Statements </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For a list of the consolidated financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report, which is incorporated into this Item by reference.</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:18.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">b)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Exhibits</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.097%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:89.901%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid rgba(255,255,255,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;3.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522006731/d273128dex31.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fourth Amended and Restated Certificate of Incorporation of Amylyx Pharmaceuticals, Inc. (Incorporated by reference to Exhibit 3.1 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 11, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;3.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522006731/d273128dex32.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amended and Restated Bylaws of Amylyx Pharmaceuticals, Inc. (Incorporated by reference to Exhibit 3.2 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 11, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex41.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specimen Common Stock Certificate (Incorporated by reference to Exhibit 4.1 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex42.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amended and Restated Investors&#x2019; Rights Agreement, dated as of July 1, 2021, among the Registrant and the parties thereto (Incorporated by reference to Exhibit 4.2 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.3</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000095017022005157/amlx-ex4_3.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Securities (Incorporated by reference to Exhibit 4.3 to the Registrant&#x2019;s Form 10-K filed with the Securities and Exchange Commission on March 31, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex101.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2015 Stock Option and Incentive Plan, and form of award agreements thereunder (Incorporated by reference to Exhibit 10.1 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex102.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022 Stock Option and Incentive Plan, and form of award agreements thereunder (Incorporated by reference to Exhibit 10.2 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex103.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Employee Director Compensation Policy (Incorporated by reference to Exhibit 10.3 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex104.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Cash Incentive Bonus Plan (Incorporated by reference to Exhibit 10.4 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex105.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022 Employee Stock Purchase Plan (Incorporated by reference to Exhibit 10.5 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex106.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease Agreement, dated as of October 23, 2018, as amended, by and between the Registrant and Bullfinch Square Limited Partnership (Incorporated by reference to Exhibit 10.6 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex107.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Employment Agreement, between the Registrant and Josh Cohen (Incorporated by reference to Exhibit 10.7 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex108.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Employment Agreement, between the Registrant and Justin Klee (Incorporated by reference to Exhibit 10.8 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.9#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex109.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Employment Agreement, between the Registrant and James Frates (Incorporated by reference to Exhibit 10.9 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.097%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:89.901%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.10#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex1010.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Employment Agreement, between the Registrant and Margaret Olinger (Incorporated by reference to Exhibit 10.10 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.11#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522000260/d155225dex1011.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Employment Agreement, between the Registrant and Patrick D. Yeramian, M.D. (Incorporated by reference to Exhibit 10.11 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-261703) filed with the Securities and Exchange Commission on January 3, 2022).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.12#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex1012.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Director Indemnification Agreement (Incorporated by reference to Exhibit 10.12 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.13#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex1013.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Officer Indemnification Agreement (Incorporated by reference to Exhibit 10.13 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.14&#134;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex1014.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Master Manufacturing Services Agreement, dated as of November 12, 2019, by and between the Registrant and Patheon Inc. (Incorporated by reference to Exhibit 10.14 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.15&#134;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex1015.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supply Agreement, dated as of October 29, 2019, by and between the Registrant and CU Chemie Uetikon GmbH (Incorporated by reference to Exhibit 10.15 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.16&#134;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312521359405/d155225dex1016.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research, Development and Supply Agreement, dated as of December  9, 2019, and Deed of Amendment, dated as of July 26, 2021, by and between the Registrant and ICE S.p.A. (formerly Prodotti Chimici e Alimentari S.p.A.), as amended (Incorporated by reference to Exhibit 10.16 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-261703) filed with the Securities and Exchange Commission on December 16, 2021).</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.17#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1658551/000119312522299375/d356648dex101.htm" style="-sec-extract:exhibit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment to Employment Agreement, effective as of December 1, 2022, by and between the Company and Patrick Yeramian (Incorporated by reference to Exhibit 10.1 to the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 6, 2022).</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.18#*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex10_18.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Employment Agreement, between the Registrant and Gina Mazzariello</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex21_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">List of Subsidiaries of Registrant.</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent of Deloitte &amp; Touche LLP, independent registered public accounting firm.</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Co-Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.2*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Co-Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.3*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex31_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Co-Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Co-Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="amlx-ex32_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.INS*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Instance Document &#x2013; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.SCH*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.CAL*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.DEF*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.LAB*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.PRE*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid rgba(0,0,0,1);text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* Filed herewith.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+ </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furnished herewith.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This certification will not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such certification will not be deemed to be</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incorporated by reference into any filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference into such filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"># Indicates a management contract or any compensatory plan, contract or arrangement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#134; Portions of this exhibit (indicated by asterisks) have been omitted in accordance with Item 601(b)(10) of Regulation S-K.</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">c)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statement Schedules</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No financial statements have been submitted because they are not required or are not applicable or because the information required is included in the consolidated financial statements or the notes thereto.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Form 10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.742%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:7.877%;"></td>
    <td style="width:46.379%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Joshua B. Cohen</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joshua B. Cohen</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:32.976%;"></td>
    <td style="width:1.042%;"></td>
    <td style="width:43.304%;"></td>
    <td style="width:1.042%;"></td>
    <td style="width:21.637%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Joshua B. Cohen</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer and Director (Principal Executive Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joshua B. Cohen</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Justin B. Klee</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer and Director (Principal Executive Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ James M. Frates</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">James M. Frates</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ George Mclean Milne Jr.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">George Mclean Milne Jr. Ph.D.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Paul Fonteyne</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Paul Fonteyne, M.S., M.B.A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Daphne Quimi</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Daphne Quimi, M.B.A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:88.998%;"></td>
    <td style="width:11.002%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_of_independent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_balance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_of_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_of_comprehensive"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#convertible_preferred_stock"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_of_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_consolidated_financial"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="report_of_independent"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">REPORT of independent</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> registered public accounting firm</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the stockholders</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.695pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and the Board of Directors of Amylyx Pharmaceuticals, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opinion on the Financial Statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Amylyx Pharmaceuticals, Inc. and subsidiaries (the &#x201c;Company&#x201d;) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, redeemable convertible preferred stock and stockholders&#x2019; equity (deficit), and cash flows, for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basis for Opinion</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on the Company&#x2019;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, Massachusetts</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have served as the Company&#x2019;s auditor since 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_balance"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED BALANCE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> SHEETS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands, except share and per share data)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.941%;"></td>
    <td style="width:1.586%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.835%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.576%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.063%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b263bf7-0aa5-4e77-b5d1-1e5145c10e1d" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2552a673-4262-453a-b851-83b88d911fb4" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,191</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acd8844d-67f8-458c-9258-93444208c398" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">284,419</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e5c4f1e-963d-46d8-8bdd-726c0f1b0d51" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,927</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b2ebdc9d-18c8-440b-82e5-013ca539dd3a" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,113</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa9be9a7-c1bb-4f31-afc2-e5b0057c87b1" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,392</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d86fd4d1-706e-452d-a92a-b283f6f71b39" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,306</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventories</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c9bd857-a519-4701-ba57-4ea182cf9a51" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,769</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred offering costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9e74d8a-ea26-445f-b590-fcb8882ac152" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,441</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d3c5c5d-f2c4-4e49-9e01-fc8057e24cc0" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">382,133</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae2f8a97-973d-4faa-9939-96c36e171ea5" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">104,951</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4718bef-be08-435a-8bcf-b6e58f913033" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,611</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12b127f0-4275-46ff-adf6-6c6c229bdfa1" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">474</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32584c5b-008d-47f8-b0d5-0eac6771f5ad" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c91ad058-73f9-449a-936e-cc46644d2f42" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">189</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4bd58ba-a105-4322-9fd8-372057099f3b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,524</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7504176-86f1-4501-ac74-1822e5c1539e" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">466</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4a573e6-177e-4bc6-b8db-be86bb67e0d7" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">391,453</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3cb76cf7-102b-44ce-aab3-b46bca711eff" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">105,614</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities, Redeemable Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_05372cb0-b316-49e8-a434-633976eb179b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,257</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0299c31-a285-47a7-b9e4-698dc2072a85" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,372</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a04f695-2ca3-45e1-a68f-0f71501623b6" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,312</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25a31934-5b39-49e8-991a-57207c3f4740" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,024</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities, current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d5193f3-1e52-4b8d-bd90-2b052c460816" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,040</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73e93671-9415-404e-be63-4e074a123be4" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,609</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d73f3715-7804-408a-8d3b-57548b29287f" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,396</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5169c1e1-93e6-4441-8a9a-a848b1ebe5b4" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,237</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred rent</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21ac45e5-0edd-4d45-8333-491d6eac9bf7" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredRentCreditNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77b554ad-f96c-4202-bdd3-cc7e56db5ce7" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,846</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c1e459fa-5e21-4060-bb41-e9cac085e511" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,431</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_b039e0ef-4988-44c2-972a-7c7c312db5b2;"><span style="-sec-ix-hidden:F_6b62c9fb-950f-40e5-9d9e-19b1fffed063;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitments and contingencies</span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;(Note 18)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A redeemable convertible preferred stock, $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_921f8b11-61ec-42f1-ba9e-cbbdd96a3cd3" contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_85f3c4cc-b4b2-41b6-bb22-efd0e1199704" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca3c96f2-a793-4142-a801-65f1ee450cd9" contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_7fa5bafe-67a9-471b-bdef-9199e32abe9b" contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_d32291b5-ebd9-4dfa-86a8-b70488c5c3cc" contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f2ed99f-a27a-4272-af16-8175d61e0e0e" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_8ca0ab97-d79a-4d58-8945-c14fe1ef3712" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_3d7436b2-aad3-45cc-90b4-a650e5ff9c85" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,289,609</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />&#160;&#160;&#160;shares authorized, issued and outstanding as of December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_99a59eed-5e83-439b-b759-bb216521586a" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,675</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B redeemable convertible preferred stock, $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57540da8-b125-43be-8210-2403916a02fb" contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_37c712d3-5aea-4967-9a1c-942052092d80" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd3e1779-4abf-4a0b-abc5-b2799eed7c49" contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53699229-6afc-4b35-8c5f-4a8f6dfa781e" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,100,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />&#160;&#160;&#160;shares authorized as of December 31, 2022 and 2021, respectively; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9c26e42-7a09-4cf3-b575-5fe51a0ff280" contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_7b24c2a1-6aab-4ad5-9fe1-6c24dcac70ae" contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5bc0de45-1b5b-4f39-a7d0-2b935869673c" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,496,835</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;<br />&#160;&#160;&#160;shares issued and outstanding as of December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43e24fc4-ccbc-4ae7-bd3c-9655e548218f" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,387</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 redeemable convertible preferred stock, $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb38404a-fe8a-4b1f-b8d2-ab2898ce50c7" contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_42b6f1f5-b8ec-4906-a102-ac36c14dfba3" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8cd87d8f-44d1-4905-9e05-d7e94a074a1e" contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_6a134407-746a-4c9b-945b-f739443bba44" contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_d2502331-ce36-47fc-af86-c0a9fac868c1" contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7bb7f369-53f7-4b8e-b310-c54a5cad9770" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_38e2f816-7236-4999-8a9b-0e1798cfd7eb" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_5e6058d2-564e-442c-be29-309ebe5278f3" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />&#160;&#160;&#160;shares authorized, issued and outstanding as of December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de1146d4-b76e-4296-a321-80aaed067fd8" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,791</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 redeemable convertible preferred stock, $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55ce2034-82d5-403a-9ebf-11f957e821bf" contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_2d3eaf0b-801b-4f3e-a101-7cf911c45776" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78f5d5ec-1474-4721-bd50-8da2f3eae553" contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_201e37e6-4fff-4d5e-b7ba-45b7e13f25df" contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_9fdd8ed7-61f1-448e-80e8-18f366c10683" contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e229f28-cb50-424d-9cb8-0ad52b0e24af" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_80b63237-7c9d-4d1b-b296-6d04f3944300" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_58e0acb5-6312-4f59-837c-37cace6ec684" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />&#160;&#160;&#160;shares authorized, issued and outstanding as of December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91a29295-ea11-4f24-b325-022c227d371b" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,498</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders&#x2019; equity (deficit):</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred stock, $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95610720-6870-4490-8488-ec66334a97a3" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_af2721b1-7367-4ab9-88ba-474c8ecb5a5d" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f602a89-fc21-4504-8cbc-168edf8693a0" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_98bfd3dd-6a11-46dd-9bda-ab5302dcdb15" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized as of <br />&#160;&#160;&#160;December 31, 2022 and 2021, respectively; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a31a54d-8280-4191-996f-070299d3f7f8" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_c3a21a94-5a76-420a-be88-35a830a8ee08" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_c242fd63-bcbe-438f-89fa-dfaea5e755c6" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_588a2eed-6e67-4382-b24b-0afcd818dff4" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued <br />&#160;&#160;&#160;or outstanding as of December 31, 2022 and 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, $</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ecc2f9c6-d063-4eaa-9637-3916be559c48" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_4ca54ee0-964c-4663-a365-ec50f8117239" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5841946f-14d5-4054-8060-215297571c8e" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">300,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d45352f2-8533-4b34-9987-3c9d1acbb82b" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">56,500,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares<br />&#160;&#160;&#160;authorized as of December 31, 2022 and 2021, respectively; </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9fc2442-50c7-4a1d-8da4-414864a6311e" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_9ab4342c-3fcb-4c82-b101-695d4e05959d" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">66,512,011</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_175482af-8948-4007-92f8-b178d5b54b60" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_dd220efd-f851-4442-ad89-34781288607e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,020,487</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />&#160;&#160;&#160;shares issued and outstanding as of December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d504c0f5-8bc4-4b20-864b-b1d5d50ea8e3" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_785af556-daf9-4d54-8c6d-3e5a7145a4dc" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8147b71f-fcef-47c6-ba18-908e3746607b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">694,906</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64b3dc27-d79c-4914-9b6e-418c77f08164" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,667</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54af923e-a25e-4bf5-946b-321dee417093" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">354,220</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b39216bd-bfb7-432c-a770-bd0b53d77482" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">155,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive (loss) income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77b6a07f-6188-4489-9f64-ab1229de76be" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">86</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf6bc82b-84f1-4905-916c-38959f7bd140" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders&#x2019; equity (deficit)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_edc1aabc-0140-485f-8c2f-1f0712d2fa54" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">340,607</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1dbde163-98c8-443c-bc91-72e354bb42da" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">151,168</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities, redeemable convertible preferred stock and stockholders&#x2019;<br />&#160;&#160;&#160;equity (deficit)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93cd0071-ca9b-46a4-a3dc-27f4690a6f91" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">391,453</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d1c2be0-a580-4a25-8652-5c4dba2744c0" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">105,614</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_of_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STATEMENTS OF OPERATIONS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (in thousands, except share and per share data)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.475%;"></td>
    <td style="width:1.731%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.962000000000002%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.731%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.101%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_9f564487-ff34-4d2f-b0ff-436e6a65bf58;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, net</span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6c04ada-a444-49d8-9fd5-46be01718b98" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,230</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f43571c-57e0-4676-9427-10ca6c93cbff" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:RevenueNotFromContractWithCustomer" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">285</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total revenues</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_adf801e0-ee0a-4cab-a61a-c6acb1e61698" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,230</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d788fda-8940-42f0-b35e-4e59a3f33abd" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">285</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost of sales</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8671ab6-02ce-416b-a620-cd3cfdd24963" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,993</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9259333a-46a2-4757-b072-211eb544d823" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93,450</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a30b62a-d511-4b5b-8fbf-8148632342db" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,040</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78356684-57c0-4916-ba47-3739eae72fe6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">127,128</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f7625cf3-1264-469f-9fcb-02d38256e2e1" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:SellingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,933</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b282279-bd3d-4fdc-8093-99e83c0f9828" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">223,571</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2827989-0fa6-4589-99d8-2e2b51d57e04" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">82,973</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de879a22-13af-48d9-8238-23d33c058ea3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">201,341</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a667ab2a-a046-4279-aec3-32a818b741ac" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">82,688</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cd62184-8684-40df-bae4-450144d9aca2" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,291</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b9f85b3-fb85-48d8-953f-e7d6159dea7a" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of convertible notes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96965e58-1623-4aeb-8484-fe0772de849d" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other expense, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f74d02d-6d1c-4dc1-8f69-5c35a83e990b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd920260-53ec-456c-9bff-878b96786ca3" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">51</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0808000-5f7d-4857-b961-8c25c415e5c6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,740</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4414f728-c1fb-41a0-ba3a-b3c84b7f1573" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,243</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfa36716-e68b-4811-afe4-8d59808b58ba" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">197,601</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8cd5503a-ad2d-4814-a271-846226410f04" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provision for income taxes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3ef9d3e-9807-416c-af1f-2f917db5d86f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">774</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e27b6b42-069a-46cd-99e6-1a1e9fa1cb11" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b9424878-92a9-48a6-8ee9-bcacce7adba1" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share attributable to common stockholders &#x2014;basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d42ddaff-2dae-4d1b-8499-0de4f2c16a80" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_3b451039-7752-4db0-869d-e9709144fce8" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">3.39</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48a00a70-6018-47cb-9a1a-8c949ed914ae" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_afe2ee3c-bf3b-4d29-8495-43d717c9c820" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">13.35</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average shares used in computing net loss per share attributable<br />&#160;&#160;&#160;to common stockholders&#x2014;basic and diluted</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77795725-d3ee-4316-926d-a0b62606cb96" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_92f013d5-efd4-4bd2-9c3a-7dac64b77cd5" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">58,495,587</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1357e06e-3ef5-42ca-8b6d-7af669bd75cf" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_96d50733-9919-4026-912d-cd852328724a" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,586,349</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_of_comprehensive"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STATEMENTS OF COMPREHENSIVE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> LOSS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.951%;"></td>
    <td style="width:1.616%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.839%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.616%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.978%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10df8f56-bc75-479b-b975-8915c4583a61" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7db9de1f-9610-4890-9a09-ed43370fc891" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive (loss) income:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign Currency translation adjustment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1add0c3-1547-4c53-a55b-ff9622f11a5f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">69</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d7aadb0-b5d6-4066-a487-d00c316c3bfc" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on short-term investments</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d3238af-7a3c-4510-8cfb-b794733082a8" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c1ebbbbb-0f80-4a80-bfd6-285f78eefef1" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive (loss) income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_126d588a-4162-4d04-9580-5d057ce8a5c4" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba0c18d7-fb4b-43cb-a5fb-8b281b70a7a7" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f02a1c92-eeac-444c-be75-b7b88d3d0077" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,470</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_842e0725-2db5-4f2f-ad66-68e32610a087" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,922</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="convertible_preferred_stock"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED STATEMENTS OF REDEEMABLE </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONVERTIBLE PREFERRED STOCK</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> AND STOCKHOLDERS&#x2019; EQUITY (DEFICIT)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands, except share data)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.053%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.54%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.444%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.2249999999999996%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0840000000000005%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.769%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0840000000000005%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.3129999999999997%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.54%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.769%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:3.604%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.707%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.508%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.716%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.51%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.716%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.51%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.716%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.51%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.716%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.598%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A<br />Redeemable<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B<br />Redeemable<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1<br />Redeemable<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2<br />Redeemable<br />Convertible<br />Preferred Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional<br />Paid-In</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated<br />Other<br />Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total<br />Stockholders&#x2019;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income (Loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity (Deficit)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of<br />&#160;&#160;&#160;December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4eaf2f7-690d-4356-af22-d4fc936a8f3e" contextRef="C_70137d1c-ebe4-41cf-9891-6c732ce3bf02" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,289,609</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a10b758-46d7-40d4-b6d6-4a292d768b88" contextRef="C_70137d1c-ebe4-41cf-9891-6c732ce3bf02" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,675</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1d49af8-dcfb-49a2-b9f0-01f32e53ce4a" contextRef="C_f6726908-1236-47a4-adbd-73f904c12140" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,496,835</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_120f6fb7-e5be-4610-b712-70355d2ed360" contextRef="C_f6726908-1236-47a4-adbd-73f904c12140" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,387</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d67e7ed4-b474-4f67-a0aa-c79004e2656a" contextRef="C_553959d9-0a46-4ddf-909a-9d7b7705481a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,137,206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77d0c028-670a-44f7-9381-dd9d6b21225c" contextRef="C_553959d9-0a46-4ddf-909a-9d7b7705481a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_482c4b76-1c6c-4066-af1c-4960dfd15887" contextRef="C_5d94ca99-5668-447a-a76f-db70b18b7074" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,188</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f921130-5e95-4a5a-8e92-e5fe90d097f3" contextRef="C_5c14c4d0-550c-4966-97a1-233f1dab5e56" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,914</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_715c1ce0-4417-445a-9abb-0ead215008a1" contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">66,725</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of Series C-1 <br />&#160;&#160;&#160;redeemable convertible<br />&#160;&#160;&#160;preferred stock, net of<br />&#160;&#160;&#160;issuance costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2458640-69b0-4ee1-a469-34999f1f6d01" contextRef="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">209</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a428ca72-7c91-4844-b7f5-8585d409c97e" contextRef="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74ade447-cd63-4874-8db9-a6d84dabb0d4" contextRef="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,791</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conversion of convertible<br />&#160;&#160;&#160;notes and accrued<br />&#160;&#160;&#160;interest into Series<br />&#160;&#160;&#160;C-2 redeemable<br />&#160;&#160;&#160;convertible preferred<br />&#160;&#160;&#160;stock, net of issuance cost<br />&#160;&#160;&#160;of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7025a0a8-dac6-4ed0-b94a-b77c665b9bef" contextRef="C_39501136-cb81-4f29-8e8b-cfc14116de19" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52d17210-9c4c-4555-af54-ebae339d2605" contextRef="C_39501136-cb81-4f29-8e8b-cfc14116de19" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62733c63-a55c-47a2-89a1-bae5e01fe55b" contextRef="C_39501136-cb81-4f29-8e8b-cfc14116de19" name="amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">32,498</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common<br />&#160;&#160;&#160;stock upon exercise<br />&#160;&#160;&#160;of stock options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b09ef21e-500b-4b08-adba-0cf59b1a9ca4" contextRef="C_94da0a41-0a0d-4e46-8905-4827ae10dd95" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">883,281</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ef94586-623e-4bf2-af96-9e147c7ca17e" contextRef="C_50031187-fee3-48b0-9289-0c569c7a76e8" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">343</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a96d9e3-133e-4fb1-9b2f-b95136cda7dd" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">343</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based<br />&#160;&#160;&#160;compensation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b128fe9-8242-4b65-9c0b-13229535fce7" contextRef="C_50031187-fee3-48b0-9289-0c569c7a76e8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfb08a89-ff4b-46de-a4e4-a0b74ce5b3f2" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2b394a15-374c-4b53-acbe-6704948db3f3" contextRef="C_56faeaab-7811-48f5-9a7b-1727a455eccf" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2581ae2-dbea-4c92-b4ac-90f201b1a11f" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ba7fc18-fd0e-4d19-a287-b17679e3b67e" contextRef="C_a7b22ec5-138f-422c-b0c5-18df666aa608" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9819c65c-70c1-497c-8d86-0c803b10e6c7" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of<br />&#160;&#160;&#160;December 31, 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbf8ac07-9d10-403e-9cde-1c1e08c80483" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,289,609</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_515010ad-8400-4e99-b37d-43fbee4a6ac7" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,675</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4685c34-30e9-4142-8cd2-a3ff51713107" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,496,835</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cce84d09-13a9-446d-99d8-0930a28ed546" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,387</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30c75b98-8810-456a-9bea-0540413fad68" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf78226f-e98d-4752-bd03-fcdb1bb1dce5" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,791</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2577c469-d2da-4dad-bde9-5435cefa0fcf" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eff6f5d7-5be6-4838-8a28-543c2fcaeda3" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,498</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb5b7519-4615-44a0-8b91-5c5faefb1ff5" contextRef="C_1795c86d-1f84-4b6f-bce6-5ee68242829e" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,020,487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_930903ff-b895-4af0-bb5c-5610c0c7a09c" contextRef="C_1795c86d-1f84-4b6f-bce6-5ee68242829e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d37c5afc-855f-49a6-bf36-327856f1c6f8" contextRef="C_f6313c55-c8cf-4075-acc2-41e176752918" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,667</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ebf19b58-9f4a-42d2-bd08-9451de14d151" contextRef="C_549fc533-bfde-4f49-a811-86f15c3760d3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_967a7f2a-abd2-44e5-9f42-40750b765ddf" contextRef="C_d64feb49-4e55-46df-a08d-e78148f7d88d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">155,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b19714fd-c555-4d28-9cbb-86c1d45c447a" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">151,168</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conversion of preferred stock into common stock upon initial public offering</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b31d0fc-9178-4fad-8751-90f64f4a422b" contextRef="C_9ad669f7-07c3-4bda-a43c-720981a44374" name="amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,289,609</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_709b3faa-33d6-4812-a298-6d77a670ed9e" contextRef="C_9ad669f7-07c3-4bda-a43c-720981a44374" name="amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,675</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_431b2af8-1611-4428-bf2a-6f9e8a2657d4" contextRef="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6" name="amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,496,835</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52787390-f4ae-4c42-bb1e-d83249db6311" contextRef="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6" name="amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,387</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dddce9ea-282d-4c89-8f4c-0d9d55ea7d50" contextRef="C_67f5ad96-461d-4e37-81d1-e8d93683af31" name="amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbf32cee-4415-4e9b-89a9-52c754268a1f" contextRef="C_67f5ad96-461d-4e37-81d1-e8d93683af31" name="amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,791</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_03ebb67e-b5f9-4372-af03-a7363947dd02" contextRef="C_8d3cc07f-ae47-4903-9e9b-b86bea983319" name="amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b376110e-6d5b-4059-ac05-400c1580cbf5" contextRef="C_8d3cc07f-ae47-4903-9e9b-b86bea983319" name="amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,498</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77fcc160-192b-4eea-81b5-516b45ca7a36" contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">39,474,330</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf16ab3f-e122-4ed0-8617-92cc0b12299f" contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d233e510-f05d-4fc2-94a0-626dcce6efb3" contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">239,347</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7cae7abc-419e-4d41-b925-50d3ad1ad2a5" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">239,351</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon initial public offering, net of issuance costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f7b9033-3859-4f5f-bb26-523da1051769" contextRef="C_9a535ad1-aee6-4191-aba0-d4c01e4db958" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,639</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29ee0000-df6d-42f9-8ca0-ff9b7b66c2c8" contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,369,369</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ab23498-6186-4338-8fa6-c14417d9d664" contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63981630-3785-4b17-9da7-c53a6aa8cead" contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">196,378</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b92d08ba-70bb-41f7-8506-917519e5e5ba" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">196,379</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon follow-on offering, net of issuance costs of $</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc6273ba-a298-45d2-9674-0619faf24cdf" contextRef="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_13e24e91-96c2-49b5-8cc5-ff2bde5fad06" contextRef="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,697,812</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6781111a-0971-423c-b47b-b1f46feefb6e" contextRef="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_902c25f5-0118-48e7-be8c-610ca037d9bf" contextRef="C_683b28ae-40e1-400c-8515-d6776df26f52" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">230,611</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1870168d-0e54-4e32-aa47-68bf6b837571" contextRef="C_1b19ab6a-5a41-473b-9be7-fb23ebcb6e9d" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">230,612</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common<br />&#160;&#160;&#160;stock upon exercise<br />&#160;&#160;&#160;of stock options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d218acad-c9b7-4f22-9075-ce2dbe6ff097" contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">950,013</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_667bec94-1ee0-43bc-843a-3516d1cfe034" contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,189</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_07e85c93-340b-42c0-9c02-5e6b1c0c4a0c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,189</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based<br />&#160;&#160;&#160;compensation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16e73cb9-2a0a-47b6-b7f0-9a75f3f832fe" contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,714</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a1311ba-12f6-4c83-bbbe-ff516cb498f4" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,714</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80f738ab-c2ec-4e0c-a4a9-8cd02141c0ca" contextRef="C_40b2caa1-f574-483f-8a57-fe01ea935692" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb603e47-4d1c-4cd7-a897-0e84fa99ee2f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad04c1a4-ff9a-4b9e-b30b-4332e44b4f6b" contextRef="C_16551b59-7779-49cd-bf47-05ce2620a5c0" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2445f560-baf5-49b5-9a1e-c220cc668ab1" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of<br />&#160;&#160;&#160;December 31, 2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ca360c8-407c-437b-85d1-fecb400f2cf0" contextRef="C_7285cd01-49fc-4356-bb9e-b960696d9340" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">66,512,011</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db8fb878-5eb4-4b60-8b4e-cda6a4020cbf" contextRef="C_7285cd01-49fc-4356-bb9e-b960696d9340" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73eefcef-24a0-499c-a3c2-e9624947af63" contextRef="C_3fc7d41f-a882-4639-88a8-f660f437b33b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">694,906</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e240e7cc-8f24-411e-8e11-58129cda666d" contextRef="C_0ffaedee-aadb-4322-b862-e53422451646" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">86</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf21373b-8039-42a5-b19d-ee2b2cf9a65d" contextRef="C_f1dd14d9-2a2a-42df-bd70-17b7c328d628" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">354,220</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6bf8016-50f6-4983-b648-b35544fec227" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">340,607</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_of_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STATEMENTS OF CASH FLOWS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:67.094%;"></td>
    <td style="width:1.631%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.667%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.621%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.985%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ffb7842-4a50-4dd8-adb4-32e745841b02" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_296184ce-8a11-4b1c-8b30-3feebed60844" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67e52394-9b60-47ed-b4cb-0f312508b11a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,714</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9118c96c-116d-45b2-8dc8-b1a118207cc1" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb9d8b50-1b58-4fd5-b20b-9c5ca24bf6a7" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b851dc8e-3a4c-40b8-beb7-509c9f3ea984" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization (accretion) of investment premiums (discounts)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1b193df-b0eb-4a8e-b2e9-4c78f3ace5ca" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,056</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79476912-474f-4913-9620-359b178ccfb5" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">121</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of convertible notes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_171c28a8-7c82-4212-8bff-2bc8bfe9fef7" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e8121577-1b73-4208-a870-3bcddf95ef6e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,306</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventories</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7827ab9e-4fdf-4946-9a6a-30423b0bd566" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInInventories" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,769</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest receivable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e52a35e3-bfcb-46e4-9426-d7915a1d545c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a71dc772-bbde-400a-9dd7-64c125494818" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a348c29-9ead-44be-97a0-66c0ec34e181" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,221</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_87f613a8-2010-4dd7-bf30-14d9575994cf" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,486</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ca0c8bd-df3b-4be6-bd6f-c518cd725614" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,635</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6ad4723-bb1e-49a1-a89c-838c8603e6bb" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">456</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_df404ec1-b9fa-42a4-8ea6-d29b4a11ba6e" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">125</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_537a5951-e101-4a0c-a2f3-eacd154b6415" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,854</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c11ea84a-94d9-4b0b-85f2-9fa2b0ecba97" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">670</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and deferred rent</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_09af080e-e2d6-4f72-9caa-e60143985cc9" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:IncreaseDecreaseInAccruedExpensesAndDeferredRent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3d4013b-3d0c-480a-a1f8-3fca49df1e62" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:IncreaseDecreaseInAccruedExpensesAndDeferredRent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,432</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_577a5323-555a-469e-9618-ee451dd4a5e8" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">917</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest and accrued interest&#x2014;related parties</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ec2dd4f3-5bc1-467a-87ff-4fcb54427904" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d4a0610-2474-45c2-b6db-295183386b4a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">179,871</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da21cf56-10d3-4f54-95cc-6d19c98d6e51" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">74,799</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows used in investing activities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46f9efab-1888-4897-b6ef-f41b64519462" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a030d41f-219d-4134-b773-20d095b99f9f" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">353</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of investments</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8b81113-37ca-456d-a151-d6c4d6111051" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PaymentsToAcquireInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">415,873</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_075837b3-975e-4287-8089-02f7c515f7a2" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:PaymentsToAcquireInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,053</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from maturities of short-term investments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24e7ac8d-bd18-4887-8a43-8c56b2471d8b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">179,411</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_faa8c861-f275-4b8f-96ac-3dcb1f3c8e9e" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb80f597-532c-4531-bcd0-02a7f5fb37c2" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">238,988</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4281d363-8291-4293-99e5-102ddee912c1" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">46,406</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows provided by financing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Repayment and proceeds from PPP loan</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72222c3a-a4dc-4a9d-95c1-2c85a4121621" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">263</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from initial public offering</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1bafc2bf-7ce9-437e-b1fa-249c2ea525ea" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">200,897</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from follow-on offering</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34e6bdba-00d8-4e4f-bd3e-bd6b71dd08ab" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:ProceedsFromFollowOnOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">231,550</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initial public offering costs paid</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ac2e0395-df24-4706-adf5-677d382968bf" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:InitialPublicOfferingCostPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,044</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Follow-on offering costs paid</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_085b6ea6-22ac-472a-bbb7-f94ee3ad09a6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:FollowOnOfferingCostsPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">803</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of convertible notes&#x2014;related parties</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f03d42e1-e413-4104-91af-3848c58f01d9" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:ProceedsFromIssuanceOfConvertibleNotesRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,272</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of convertible notes, net of issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34d823e1-a5a6-414c-a1f9-19eceeb7a5a1" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,887</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance costs related to conversion of convertible notes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0617186-f960-423e-80d2-c4f9acc5bd0a" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:IssuanceCostsRelatedToConversionOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of Series C-1 redeemable convertible preferred<br />&#160;&#160;&#160;stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46a37e85-b281-42f0-93c3-654d180bebe9" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance costs related to issuance of Series C-1 redeemable convertible<br />&#160;&#160;&#160;preferred stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2e1d7f7-dcb5-46c9-93a4-3997c11e61bf" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">209</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c9a69d5-f557-439e-923f-2bd315bac325" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,189</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49655d51-8eb1-4395-8551-4009e2b20d74" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">343</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payment of deferred offering costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17dbdf4f-e9eb-4b5f-906f-1b65ee7e20fd" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:PaymentOfDeferredOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,474</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c7ce382-9a5c-4338-8af8-49e6f723ea5e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">431,789</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fde1c17f-aa3b-46e6-b7e2-9d87e784bfe5" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158,506</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4ded8f6-1820-440b-9f11-eac4004f9981" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">65</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc6dce5b-427f-4db1-9680-6113a06c8986" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase in cash, cash equivalents and restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e38ab01-727c-4ecd-beb9-5318bac65382" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,865</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_638377f0-ed5b-45a5-b152-d8d146c38acb" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,314</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash equivalents, beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_22a859d5-3d97-47d5-b7e1-24a03e6368f5" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,380</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31916ee8-9723-4563-bd18-95b866633568" contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,066</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash equivalents, end of period</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53c710e6-d91d-4f9d-92a3-bb937bfdab46" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">63,245</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8eb89bdc-181e-4c95-a504-b95515847101" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,380</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosure of cash flow information:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conversion of convertible notes and accrued interest into Series C-2<br />&#160;&#160;&#160;redeemable convertible preferred stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54ef2f67-2abd-4b87-9238-ae7c9035e02d" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,548</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on short-term investments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5666c126-ef4d-4624-82d1-e5570b919537" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f9cad788-42ed-4816-85f2-82bf67ae0f56" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment included in accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4b7d804-4869-4648-b9dc-6c6268d1a1ae" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">98</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16a2275a-4d03-4489-ac57-1c84c7d785f9" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred offering costs included in accounts payable and accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39904bdd-1ba6-4669-bdb4-009ca959e8db" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">967</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets and liabilities upon ASC 842 adoption</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1aaa4cb2-ca7e-46e5-9468-6ac3ca574f9b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,201</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d21a9e4-f731-4875-b1be-e60314460cf2" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,958</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Movement of deferred offering costs to equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc0b2059-dad6-491f-8f07-baf13e11d0f3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:MovementOfDeferredOfferingCostsToEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,457</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Follow-on offering costs included in accounts payable and accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf21ea94-6fe7-4a77-a04e-6d8d3b59a33c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Conversion of preferred stock to common stock upon initial public offering</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c58d2203-6b18-4d4f-959b-60b9b8f12e64" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">239,351</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes paid</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_206e96c7-061d-4163-bdfe-85a98669b02a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeTaxesPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_consolidated_financial"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO Consolidated FINANCIAL</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> STATEMENTS</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_06a527fb-e069-4cc5-bea0-19e23bda161d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NatureOfOperations" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Nature of Business</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals, Inc., together with its wholly owned subsidiaries, known as Amylyx or the Company, is a commercial-stage biotechnology company with a mission to one day end the suffering caused by neurodegenerative diseases. The Company is focused on the development and potential global commercialization of its product candidate, AMX0035 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis, or ALS.  Our first product, RELYVRIO&#174; (sodium phenylbutyrate and taurursodiol), previously known as AMX0035 in the U.S., is approved in the U.S. for the treatment of ALS in adults. AMX0035 is also approved with conditions by Health Canada and marketed as ALBRIOZA for the treatment of ALS in Canada. The Company&#x2019;s Marketing Authorisation Application, or MAA, for AMX0035 for the treatment of ALS remains under review by the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA. The Company is developing AMX0035 for other neurodegenerative diseases by leveraging its unique knowledge and relationships in the neurodegenerative space.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is subject to risks and uncertainties common to companies in the biotechnology industry, including, but not limited to, the outcome of preclinical studies and clinical trials, market acceptance and the successful commercialization of ALBRIOZA, which received marketing authorization with conditions in Canada in June 2022, and RELYVRIO, which was approved by the FDA in the U.S. in September 2022, potential difficulties with or delays in timing with respect to the regulatory approval processes of the EMA and other comparable foreign authorities, development by competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, ability to secure additional capital to fund operations, and risks associated with the economic challenges caused by the COVID-19 pandemic and economic uncertainty in various global markets caused by geopolitical instability and conflict. The Company and its contractors may experience disruptions in supply of items that are essential for its research and development and commercial activities, including, for example, raw materials and bulk drug substances that the Company imports from Europe and Canada used in the manufacturing of AMX0035, and any future product candidates.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Going Concern</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with Accounting Standards Update, or ASU, 2014-15,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Disclosure of Uncertainties About an Entity&#x2019;s Ability to Continue as a Going Concern (Subtopic 205-40)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company has evaluated whether there are conditions and events that raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. <br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since its inception, the Company has devoted substantially all of its efforts to research and development and pre-commercialization activities, including recruiting management and technical staff, raising capital, producing materials for preclinical studies and clinical trials, and building infrastructure to support such activities. Expenses have primarily been for research and development and related general and administrative costs, and we anticipate that our selling, general and administrative expenses will continue to increase in the future as we further increase our headcount to support our continued research activities and development of AMX0035 and as we continue to increase headcount and incur other significant costs related to our commercialization activities. The Company has generated revenues through five grants from the ALS Association, ALS Finding a Cure Foundation, Cure Alzheimer&#x2019;s Fund, Alzheimer&#x2019;s Drug Discovery Foundation and Alzheimer&#x2019;s Association, or Grantors. In addition to money received from its grants, the Company has also financed its operations through the public offering of its common stock, private sales of preferred stock, and convertible notes, and more recently through revenue from sales of RELYVRIO and ALBRIOZA in the U.S. and Canada, respectively. <br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and negative cash flows from operations since inception. As of December 31, 2022, the Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">had an accumulated deficit of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffee74a8-87d2-40ed-bfbc-a9a5f501e859" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:numdotdecimal">354.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company expects its operating losses and negative operating cash flows may continue into the future as it continues initial sales of ALBRIOZA in Canada and RELYVRIO in the U.S., and continues to build capabilities and develop AMX0035, and any future product candidates. The Company expects that its cash, cash equivalents and short-term investments as of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and product revenue from RELYVRIO and ALBRIOZA sales, will enable the Company to fund its ongoing operating expenses and capital expenditure requirements for at least the twelve-month period following the issuance of these consolidated financial statements.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_8ee9d560-4899-4412-8fb7-e8835b6d3f71" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a4c0c452-cc03-4c1f-8e61-726f7714b3f3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation and Consolidation&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the U.S., or GAAP, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification, or ASC, and ASU of the Financial Accounting Standards Board, or FASB.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_15e0ed86-4128-4146-b34b-20131c07073a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. Management&#x2019;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: Gross-to-net, or GTN, adjustments, inventory, determining the fair value of convertible notes, accrued expenses, stock-based compensation, operating lease right-of-use assets and lease liabilities, valuation allowance for deferred tax assets and research and development expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_66d2b1c0-f594-4e20-ab43-145bf9ee25f9" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue recognition&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and the Company launched ALBRIOZA in Canada in July 2022. In September 2022, AMX0035 received approval as RELYVRIO by the FDA for the treatment of ALS in adults, and the Company launched RELYVRIO in the U.S. in October 2022.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company enters into arrangements with wholesalers, specialty pharmacies and specialty distributors, or Customers, to distribute ALBRIOZA, RELYVRIO and future approved products. In accordance with ASC Topic 606 - </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or Topic 606, revenue is recognized when the customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To determine revenue recognition for arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the Company will collect the consideration the Company expects to be entitled to in exchange for the goods or services the Company transfers to its customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product Revenue, Net</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company sells its approved products to its Customers. These Customers subsequently resell our products to specialty pharmacy providers, other retail pharmacies, health care providers, certain medical centers or hospitals, and patients. In addition to agreements with the Customers, the Company enters into arrangements with specialty pharmacies, health care providers and payors that provide for government mandated and/or privately negotiated rebates with respect to the purchase of our products. The Company&#x2019;s customer identification process considers a number of factors, including contractual and legal factors, and who controls the Company&#x2019;s product and bears inventory risk. The Company evaluates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">these factors on a customer-by-customer basis to determine the appropriate customer for revenue recognition purposes. In some cases, the Company may use a third-party logistics providers to deliver the Company&#x2019;s product to its customers, but the Company recognizes revenue upon delivery to the customer, as its determined that the third-party logistics provider is acting as our agent. Changes in these factors or our assumptions regarding these factors could impact our revenue recognition</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue on product sales when the Customer obtains control of our product, which occurs at a point in time (upon delivery). Product revenues are recorded net of applicable GTN adjustments, which are described below.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If taxes should be collected from Customers relating to product sales and remitted to governmental authorities, they will be excluded from revenue. The Company expenses incremental costs of obtaining a contract when incurred, if the expected amortization period of the asset that the Company would have recognized is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3bb6a212-5202-48e8-be80-9156035c551d" contextRef="C_5eab5a92-c382-47c2-b472-12d901ce62a0" name="amlx:AmortizationRecognizedPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or less. However, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c11a6564-82fd-4808-9553-3aeea08475d5" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:IncrementalCostsExpenses" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2147b744-5125-4f42-bc9e-f0c8ac0d4ca9" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:IncrementalCostsExpenses" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> such costs were incurred during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">GTN Adjustments</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration related to certain GTN adjustments. Components of GTN adjustments include trade discounts and allowances, product returns, third-party payor rebates, and other allowances that are offered within contracts between the Company, its Customers and payors relating to the sale of our products. These GTN adjustments, as detailed below, are based on the amounts earned, or to be claimed on the related sales, and are classified as reductions of accounts receivable (if the amount is payable to the Customer) or a current liability (if the amount is payable to a party other than a Customer). These estimates take into consideration a range of possible outcomes which are probability-weighted in accordance with the expected value method in Topic 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. In certain circumstances, the Company applies the most likely method in Topic 606 . The determination to use the expected value method or the most likely method is based on the type of GTN adjustment and what method better predicts the amount of consideration we expect to be entitled to. Overall, these GTN adjustments reflect in the transaction price the amount of consideration to which the Company expects to be entitled to in exchange for transferring promised goods or services to its Customers.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amount of variable consideration which is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from our estimates, the Company will adjust these estimates, which would affect product revenue, net and earnings in the period such variances become known.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Trade Discounts and Allowances</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company generally provides Customers with prompt payment discounts and pay fees for distribution services and for certain data that distributors provide to us that are explicitly stated in our contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. Payment from Customers is typically due within 30 calendar days of the invoice date, without consideration to the prompt payment discounts.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product Returns</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consistent with industry practice, the Company generally offers Customers a limited right of return for product that has been purchased from the Company based on the product&#x2019;s expiration date, which is set to lapse within a specified period stated in the contract. Additionally, our limited right of return policy allows for eligible returns from Customers in circumstances where product was shipped in error or was damaged in shipping, or product was returned pursuant to an official drug recall.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the amount of product sales that may be returned by our Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net on the consolidated balance sheets. The Company currently estimates returns using quantitative and qualitative information including, but not limited to, expected experience with returns, projected demand, levels of inventory in the distribution channel, product dating and expiration period, and whether products have been discontinued, among</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others. The Company has received an immaterial amount of returns to date and believe that returns of product in future periods will be minimal.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provider Chargebacks and Discounts</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase the product from the Company. Customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These GTN adjustments are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable, net. GTN adjustments for chargebacks consist of credits that Customers have not claimed, but for which we expect to issue for units that remain in the distribution channel inventories at each reporting period-end that we expect will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which we have not yet issued a credit.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Payor Rebates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company contracts with certain government and private payor organizations, primarily government and commercial health insurance companies, for the payment of rebates with respect to utilization of our products. The Company is subject to discount obligations under state Medicaid programs and Medicare. These GTN adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities on the consolidated balance sheets. For Medicare, the Company also estimates the number of patients in the prescription drug coverage gap for whom it will owe an additional liability under the Medicare Part D program. The Company's liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product that has been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Incentives</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other incentives which the Company offers include voluntary patient assistance programs, such as its co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with prescription drug co-payments required by payors. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with product that has been recognized as revenue for each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1eacd81a-1574-4b4d-a5c8-0cf52120949b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:GrantRevenuePolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Grant Revenue&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant revenue consists of amounts earned from performing contracted research and development services. The grants between the Company and the Grantors generally provide for the Company to meet certain research milestones in order for funds to be provided. The Company accounts for grants received to perform research and development services in accordance with ASC 730-20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which requires an assessment, at the inception of the grant, of whether the grant is a liability or a contract to perform research and development services for others. If the Company is obligated to repay the grant funds to the Grantor regardless of the outcome of the research and development activities, then the Company is required to estimate and recognize that liability. Alternatively, if the Company is not required to repay, or if it is required to repay the grant funds only if the research and development activities are successful, then the grant agreement is accounted for as a contract to perform research and development services for others, in which case, grant revenue is recognized as the related research and development expenses are incurred. The Company obtained funding from the Grantors of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e189312e-893c-4c75-b12f-f45a32f69855" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ProceedsFromGrantors" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32351270-aa1c-46b5-83d6-c78dab0a5317" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ProceedsFromGrantors" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> during the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, which was recorded as grant revenue in the Company&#x2019;s consolidated statements of operations. Under the terms of the grants, the Company will be required to pay royalties upon occurrence of contingent future events (see Note 18).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eb944dcb-523b-4712-b122-77cdf9ac09f4" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss includes net loss, as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders. Comprehensive loss is composed of net loss and other comprehensive (loss) income. Other comprehensive (loss) income consists of unrealized gains and losses on marketable securities and foreign currency translation.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6b85999a-bd14-40ec-88c4-62fe7096b296" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents&#x2014;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_55502d5b-af75-46b4-a9fb-b4323bd824b7" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:CashAndCashEquivalentsMaturityDateDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Cash equivalents represent funds invested in readily available checking and money market funds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_00d208d5-226f-4e2f-8acd-603d78421473" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash Equivalents&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents consist of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5873ee4f-954f-49f9-967e-b8951c63d39d" contextRef="C_13345d35-56b6-4c29-9548-08d0bb84c9d1" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of cash serving as collateral for a letter of credit issued for the Company&#x2019;s office space, and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_22702601-9360-4b00-811f-7223550fe26f" contextRef="C_abe6a82a-1d40-4eb5-8cb4-6e4904b35dfe" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as collateral for a corporate credit card program. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company&#x2019;s restricted cash equivalents balance was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d31a67b-3b9b-4682-9266-89429aa6ce17" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d8119c3-8a47-48a4-aee0-24b6780fbc11" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p></ix:nonNumeric></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c43ff9c8-42b1-46c0-be1e-9ba0cea339c3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ReceivablesPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts receivable, net&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s accounts receivable consists of amounts due from Customers related to product sales and have standard payment terms. The Company analyzes accounts that are past due for collectability. Given the nature collectability of the Company&#x2019;s accounts receivable to-date, an allowance for doubtful accounts is not deemed necessary at December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6c46f693-7eaf-4b17-8ca7-e212c4e9d057" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:InvestmentPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Short-Term Investments&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments are composed of treasury notes and bills, corporate debt securities, commercial paper and agency bonds with maturities of less than one year from the balance sheet date. The Company classifies all of its short-term investments as available-for-sale. Accordingly, these investments are recorded at fair value, which is determined based on quoted market prices. Unrealized gains and losses on available-for-sale securities are included as a separate component of other accumulated comprehensive loss. The cost of short-term investments is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. Realized gains and losses are included in other expense, net. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other than temporary-than-temporary are also included in other income, net.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. As of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were no impairment charges on short-term investments.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_76404fde-1459-4807-91b9-90c555cb7991" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable, net. The Company maintains its cash in financial institutions that it believes have high credit quality. The Company has not experienced any losses on such accounts, and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s accounts receivable, net at December 31, 2022, represents amounts due to the Company from customers. Amylyx performs ongoing credit evaluations of its customers and generally does not require collateral. The Company monitors its exposure and records a reserve against uncollectible amounts as necessary. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e71ccca3-1b19-4233-bf44-062b694ec5fd" contextRef="C_ba231c4d-9d94-4fef-ac80-e42200cc6579" name="amlx:NumberOfCustomers" unitRef="U_Customer" decimals="INF" format="ixt-sec:numwordsen">Four</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers individually accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea131083-f5e4-4dd6-80b9-aa580529b054" contextRef="C_ba231c4d-9d94-4fef-ac80-e42200cc6579" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">97</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of total gross product revenue in 2022 and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2b426b2f-f431-4299-97ac-a6534f99a0be" contextRef="C_03c3a593-4c98-403a-bc7f-a023ed103fae" name="amlx:NumberOfCustomers" unitRef="U_Customer" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers individually accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2a7c0ea-59b9-4095-b4f1-f11783f90116" contextRef="C_03c3a593-4c98-403a-bc7f-a023ed103fae" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">98</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of total accounts receivable, net as of December 31, 2022.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Note&#x2014;Derivative&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company reviews the terms of the convertible note issued to determine whether there are features, including redemption and conversion features, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at the end of each reporting period and immediately prior to the conversion or the extinguishment of the convertible note. Changes in the fair value are reported in the consolidated statement of operations. When the convertible note contains embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those host instruments being recorded at a discount from their face value. The discount from the face value of the convertible note, together with the stated interest on the host instrument, is amortized over the life of the host instrument through periodic charges to interest expense. The Company&#x2019;s convertible notes, as further discussed in Note 8, had embedded derivatives that required bifurcation from the host instrument.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Note&#x2014;Beneficial Conversion Feature&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the conversion feature is not treated as a derivative, the Company assesses whether it is a beneficial conversion feature, or BCF. A BCF exists if the conversion price of the convertible note is less than the price of the stock into which it is convertible to on the commitment date. This typically occurs when the conversion price is less than the fair value of the stock on the date the instrument was issued. The value of a BCF is equal to the intrinsic value of the feature, the difference between the effective conversion price and the fair value of the stock into which it is convertible to and is recorded as additional paid-in capital and as a debt discount in the consolidated balance sheets. The Company amortizes the debt discount as non-cash interest expense over the life of the underlying convertible note using the effective interest method. If the convertible note is retired early, the associated debt discount is then recognized immediately as non-cash interest expense in the consolidated statements of operations. If the conversion feature does not qualify for either the derivative treatment or as a BCF, the convertible note is treated as traditional debt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1ef299d0-ffb6-4308-addf-df9af63111d6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets and liabilities recorded at fair value on a recurring basis on the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Quoted prices in active markets for identical assets or liabilities. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </span></div></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s financial instruments consist of cash, cash equivalents, restricted cash equivalents, short-term investments, accounts receivable, net, accounts payable and accrued expenses. The Company&#x2019;s short-term investments are carried at fair value, determined according to Level 1 and Level 2 inputs to the fair value hierarchy described above. The Company&#x2019;s 2021 Notes (as defined in Note 8) were carried at fair value, determined according to Level 3 inputs in the fair value hierarchy described above. The remaining financial instruments are stated at their respective carrying amounts, which approximate fair value due to the short-term nature of these assets and liabilities.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7fdfed1c-e182-42fd-8a93-ccc048cac368" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:InventoryPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inventories&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company values its inventories at the lower of cost or estimated net realizable value. The Company determines the cost of its inventories, which includes amounts related to materials and manufacturing overhead, on a first-in, first-out basis. The Company performs an assessment of the recoverability of capitalized inventory during each reporting period, and it writes down any excess and obsolete inventories to their estimated realizable value in the period in which the impairment is first identified. Such impairment charges, should they occur, are recorded within cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required which would be recorded as cost of sales in the consolidated statements of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company capitalizes inventory costs associated with the Company&#x2019;s products after regulatory approval when, based on management&#x2019;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory acquired prior to receipt of regulatory approval of a product candidate is expensed as research and development expense as incurred. Inventory that can be used in either the production of clinical or commercial product is initially capitalized and subsequently expensed as research and development expense when materials are released to production for use in the manufacture of drugs still in development.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_deddcaed-c6fd-4113-ba77-ce5c20cf2e4c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:DeferredChargesPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Offering Costs&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings, including the initial public offering, or IPO, as deferred costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">until </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such financings are consummated. After consummation of the equity financing, these costs are recorded in stockholders&#x2019; equity (deficit) as a reduction of proceeds generated as a result of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. After consummation of equity financings, the Company recorded deferred offering costs in stockholders&#x2019; equity (deficit) of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4d7143e-9e60-4f18-aaa8-5116d9b8bc2f" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:DeferredOfferingCostNetOfEquityFinancing" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca1b3bcf-a8ad-4ed1-928f-39d76688e4b8" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:DeferredOfferingCostNetOfEquityFinancing" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. The Company recorded deferred offering costs of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bce9c64f-7e97-4905-902c-3703a0a9f92c" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c7d8c93-6d8e-41e4-86a8-2c896447c16e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which are included in the consolidated balance sheet as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6545078b-b2b5-4564-a696-64341d063d84" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, net&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not improve or extend the life of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and accumulated depreciation are removed from the consolidated balance sheets and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_176b2cbc-8d26-4ca9-9fb2-af1b69f88609" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" escape="true" continuedAt="F_176b2cbc-8d26-4ca9-9fb2-af1b69f88609_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The range of useful lives of property and equipment is as follows: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_176b2cbc-8d26-4ca9-9fb2-af1b69f88609_1"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:49.087%;"></td>
          <td style="width:1.835%;"></td>
          <td style="width:49.077%;"></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ca84df1f-6eec-4757-9c2b-60d5e3123498" contextRef="C_39eac193-4dc1-4fb2-9a13-3e7cfe206bcc" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lesser of the estimated life or remaining lease term</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_50341cb1-d683-455e-bfaf-4470334c9d0f" contextRef="C_dda99674-7cd7-4b03-a6bb-3b26b37d15e6" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6526736a-0be6-45f2-a0a5-ddb1f4b80076" contextRef="C_7f70242f-b16e-425b-9687-ab456c6af1c5" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_278e090a-5833-4c82-a3c1-c24f6a121fbe" contextRef="C_4df5bd26-0f2a-4551-be73-d1993ae98fe2" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not depreciated</span></ix:nonNumeric></span></p></td>
         </tr>
        </table></ix:continuation></div></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4d6f402f-87b8-438a-bb8f-49e1c0e86b63" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company evaluates assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9eba8e0f-62d9-4164-9c37-e56d0f727909" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_669c4dcc-a790-417a-9eac-b6ec950fa3b4" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recognized any impairment losses in the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6134d605-a386-4c94-a6bb-6850541b6763" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses include costs directly attributable to the conduct of research and development activities. Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. In addition, research and development-related salaries and benefits, facility, and overhead costs, supplies and other related costs are included in research and development expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a7f1420d-0029-406d-b046-1dd91fd88c06" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:SalesAndMarketingCostsPolicyPolicyTextblock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales and Marketing Costs&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.</span></p></ix:nonNumeric></div></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7eed0ca0-be71-4a6b-9686-d335ab9c4755" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:PatentRelatedCostsPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent-Related Costs&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as selling, general and administrative expenses in the accompanying consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5203796c-5585-4233-837b-8b82a208ec88" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" escape="true" continuedAt="F_5203796c-5585-4233-837b-8b82a208ec88_1"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for stock-based compensation under the provisions of ASC 718-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Compensation&#x2014;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations based on their fair values on the date of grant over the requisite service period, which is generally equal to the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues stock option awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company classifies stock-based compensation expense in the same manner in which the awards recipient&#x2019;s payroll or service provider&#x2019;s costs are classified.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the award, the risk-free interest rate, and expected dividends. The Company estimates its expected stock price volatility based on the historical volatility of publicly traded peer companies. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain vanilla&#x201d; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. There is no expected dividend yield since the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future. The stock price of the Company is based on the closing price on the date of grant. Prior to the IPO, as there was no public market for the Company&#x2019;s common stock, the estimated fair value of common stock was determined by the Company&#x2019;s Board of Directors as of the date of each option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#x2019;s Board of Directors&#x2019; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of Privately Held Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_5203796c-5585-4233-837b-8b82a208ec88_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></ix:continuation></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c690a7d7-6267-4e0f-a63c-f3b04cfa5032" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" escape="true"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contingencies&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability on the Company&#x2019;s consolidated balance sheets. The Company does not accrue for contingent losses that, in its judgement, are considered to be reasonably possible, but not probable; however, it discloses the range of reasonably possible losses. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e64890c2-871a-4058-898c-82d9d02542b8" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:GainContingencyRecordedAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d678a744-88d1-484e-b9a1-7baba3850975" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LossContingencyLossInPeriod" unitRef="U_USD" scale="3" decimals="INF" sign="-" format="ixt-sec:numwordsen"><ix:nonFraction id="F_daf0ed07-d667-43b8-97ed-4e2ddb8656f2" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:LossContingencyLossInPeriod" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt-sec:numwordsen"><ix:nonFraction id="F_62567656-34c3-4606-b3d1-4d253e6ec0cd" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:GainContingencyRecordedAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> loss or gain contingencies recorded in the Company&#x2019;s consolidated financial statements as of and during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_acaed8ae-1eca-4895-b77d-3472deaf0760" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company adopted the FASB, ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 842, on January 1, 2022. ASC 842 allows the Company to elect a package of practical expedients, which include: (i) an entity need not reassess whether any expired or existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existing leases; and (iii) an entity need not reassess any initial direct costs for any existing leases. Another practical expedient allows the Company to use hindsight in determining the lease term when considering lessee options to extend or terminate the lease and to purchase the underlying asset. The Company has elected to utilize this package of practical expedients and has not elected the hindsight methodology in its implementation of ASC 842.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its offices, and may from time to time, enter into other lease agreements in conducting its business. The Company determines if an arrangement includes a lease at the inception of the agreement. For each of the Company&#x2019;s lease arrangements, the Company records a right-of-use asset representing the Company&#x2019;s right to use an underlying asset for the lease term and a lease liability representing the Company&#x2019;s obligation to make lease payments. Operating lease right-of-use assets and operating lease liabilities are recognized at the lease commencement date based on the net present value of the remaining future minimum lease payments over the lease term. If the interest rate implicit in the Company&#x2019;s leases is not readily determinable, in determining the weighted-average discount rate used to calculate the net present value of lease payments, the Company utilizes an estimate of its incremental borrowing rate based on market sources including interest rates for companies with similar credit quality for agreements of similar duration, determined by class of underlying asset, to discount the lease payments. Lease expense for the Company&#x2019;s operating leases is recognized on a straight-line basis over the lease term and variable lease costs are expensed as incurred.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company elected the practical expedient not to apply the recognition and measurement requirements to short-term leases, which is any lease with a term of one year or less as of the lease commencement date. The lease may require the Company to pay additional amounts for taxes, insurance, maintenance, and other expenses, which are generally referred to as non-lease components. The Company has elected the practical expedient to combine lease and non-lease components. If a lease includes options to extend the lease term, the Company does not assume the option will be exercised in its initial lease term assessment unless there is reasonable certainty that the Company will renew based on an assessment of economic factors present as of the lease commencement date.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the adoption of ASC 842, at the inception of each lease, the Company evaluated the lease agreement to determine whether the lease was an operating or capital lease in accordance with </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ASC 840, Leases (ASC 840)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. When any one of the four test criteria in ASC 840 was met, the lease then qualified as a capital lease. If the lease agreements contained renewal options, tenant improvement allowances, rent holidays or rent escalation clauses, the Company recorded a deferred rent asset or liability equal to the difference between the rent expense and future minimum lease payments due. The rent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expense related to operating leases was recognized on a straight-line basis in the statements of operations over the term of each lease. The Company did not have financing leases as of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_069425ff-2dda-4e89-adb3-3f95e1c6db64" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the position is sustainable based on its technical merits. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has not incurred interest and penalties related to uncertain tax positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#x2019;s evaluation of all available evidence, including our history of incurring significant losses from operations. Our evaluation of all available evidence also includes consideration of regulatory approvals of ALBRIOZA and RELYVRIO, including revenue generated from the sale these products in 2022.  Given the early stage of our product launch, we are uncertain about the timing and amount of future sales. We may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a485619c-979c-43c0-b71f-6a7164f5be0b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment Information&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An operating segment is defined as a component of a business that engages in business activities for which it may earn revenues and incur expenses and for which discrete financial information is available that is evaluated regularly by the chief operating decision maker or makers in order to make decisions about resources to be allocated to the segment and assess its performance. The Company has determined that its CO-Chief Executive Officers are the chief operating decision makers, or CODM. The CODM reviews consolidated operating results to make decisions about allocating resources or capital to specific compounds or projects in line with the Company&#x2019;s overall strategies and goals. The Company's entire business is managed by a single management team, which reports to the CO-Chief Executive Officers. The Company has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorders. For the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all of the Company's long-lived assets were held within the U.S.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6fb4dbbb-64ad-4a2a-9e98-c29f4deeae1e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net income (loss) per share&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. For purpose of this calculation, stock options, convertible notes, and redeemable convertible preferred stock are considered potential dilutive common shares.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s redeemable convertible preferred stock contractually entitles the holders of such shares to participate in dividends but does not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reports a net loss attributable to common stockholders, such losses are not allocated to such participating securities. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_727ffaed-b103-4a45-bf3a-407782aa52b6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:EmergingGrowthCompanyStatusPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Emerging Growth Company Status&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company is an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act, and may take advantage of certain exemptions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">various reporting requirements that are applicable to other public companies that are not EGCs. The Company may take advantage of these exemptions until it is no longer an EGC under Section 107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#x2019; effective dates. The Company intends to take advantage of the reduced reporting requirements and exemptions up until the last day of the fiscal year following the fifth anniversary of an offering or such earlier time that it is no longer an EGC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a0cd6f3e-2f8b-49ac-b7f8-c2d0be297104" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Accounting Pronouncements Not Yet Adopted&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU No. 2016-13,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Financial Instruments&#x2014;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2016-13. The provisions of ASU 2016-13 modify the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology and require a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the consolidated balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Financial Instruments&#x2014;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except Securities and Exchange Commission filers that are not smaller reporting companies. ASU 2016-13 will be effective for the Company for the period beginning January 1, 2023. The Company intends to adopt the ASU when it becomes effective. The Company is currently evaluating the impact of this ASU and does not expect that adoption of this standard will have a material impact on its consolidated financial statements and related disclosures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_96cc8369-74e5-48d5-bbb2-6d59fd9745d5" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective January 1, 2022, the Company adopted the requirements under the ASC 842 using the cumulative effect adjustment transition option. Comparative periods have not been restated. This standard requires entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet. The Company elected the available package of practical expedients which allows it to not reassess previous accounting conclusions around whether arrangements are or contain leases, the classification of its leases, and the treatment of initial direct costs. The Company has made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet. ASC 842 was issued in order to increase transparency and comparability of financial reporting related to leasing arrangements. The main difference between previous GAAP, or ASC 840, and ASC 842 is the recognition of right-of-use lease assets and lease liabilities by lessees for those leases that were classified as operating leases under ASC 840. At January 1, 2022, the Company recorded right-of-use assets of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d6dcabda-5c0f-4a7a-9f99-0fb0cda45435" contextRef="C_5213ac10-0852-427d-9169-258edff8126e" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and operating lease liabilities of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a11219cd-2a02-46b1-b3a5-1730fafbef7e" contextRef="C_5213ac10-0852-427d-9169-258edff8126e" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Adoption of the standard did not have a material impact on the consolidated statements of operations. For additional information regarding how the Company is accounting for leases under ASC 842, refer to Note 10.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_47295d9d-1009-404e-9287-4f9ad9a9e203" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:RevenueFromContractWithCustomerTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. PRODUCT REVENUE, NET</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, the Company&#x2019;s only source of product revenue has been from the sales of RELYVRIO, known as ALBRIOZA in Canada, which it began shipping to Customers in Canada and the U.S. in July 2022 and October 2022, respectively. Significant judgment is required in estimating GTN adjustments considering historical experience, payer channel mix, current contract prices, unbilled claims, processing time lags, inventory levels in the distribution channel and estimated product returns. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_84dffdba-11e2-49a9-8ca9-db8745f23058" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:GrossProductRevnueToNetProductRevenueTableTextBlock" escape="true" continuedAt="F_84dffdba-11e2-49a9-8ca9-db8745f23058_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reconciles gross product revenue to net product revenue:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_84dffdba-11e2-49a9-8ca9-db8745f23058_1"><p style="margin-left:4.533%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.792%;"></td>
        <td style="width:1.612%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.923%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.612%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.062%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, gross</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c6bd7030-fb61-451d-8e66-e05c5cc0065f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:RevenueFromContractWithCustomerExcludingAssessedTaxGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,104</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GTN adjustments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a776f693-2f11-4b21-b7ae-cd66baa64837" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:GrossToNetAdjustments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,874</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e9851ff-d25f-418f-a813-dfd72b694b0c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,230</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f44cbe22-a009-4cc0-80cc-060a9c54573d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:InvestmentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. SHORT-TERM INVESTMENTS</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b08c19b9-d1a5-4ea2-b94d-0063c26438d9" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true" continuedAt="F_b08c19b9-d1a5-4ea2-b94d-0063c26438d9_1"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments, which are classified as available-for-sale, consisted of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:49.58%;"></td>
        <td style="width:1.194%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.402000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.205%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.402000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.205%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.402000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.205%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.402000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br />Cost Basis</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Gain</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br />Values</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury notes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_735aef08-71d9-4159-b3d4-ce8d0b8163f3" contextRef="C_71f685c9-8c92-4d6f-9328-36c56365bbf5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,173</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e38fcd6b-2542-40f4-b04a-111cf82e52e1" contextRef="C_71f685c9-8c92-4d6f-9328-36c56365bbf5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32cf7a54-7b4f-4101-aead-dfa931ae5c1f" contextRef="C_71f685c9-8c92-4d6f-9328-36c56365bbf5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,159</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury bills</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_479b4cb0-640f-4850-9d9b-352dc44c49de" contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,326</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37f40ec1-ea3f-4544-896a-cc5697800751" contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8cc6136-8365-4a4f-b3d5-da70317b9054" contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfe682f1-090d-49a6-bd2c-83d8f408bbfc" contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,334</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1037e50c-1d21-4b04-8ad2-ad665f36377d" contextRef="C_b17b133f-82b6-42e9-990f-003823835ec6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,375</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1ecff95-f0c1-4ab1-960e-9be75e16af30" contextRef="C_b17b133f-82b6-42e9-990f-003823835ec6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,375</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11e7f53e-387f-44c7-8d2e-9cf9c7f8b818" contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,795</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_774972b1-cc21-4461-83a5-54f4906dd931" contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b6641f0-872a-4063-bdea-20ec212c3490" contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bed0b880-07e4-46ef-816a-8a12768ecd49" contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,753</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46b3c5e9-567d-4b65-aeff-fee7305b843b" contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,781</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c8ae070-6c00-491d-93f8-525dbbda75b6" contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbe2eb48-9823-46aa-bebb-b7c1e3aae313" contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3fbc84be-c35f-4cff-83ca-e03e443e393e" contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,798</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b91ae30c-e38d-4c90-99f9-e40459059e7f" contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">284,450</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_709b1633-c8d7-4b08-8032-94b400954990" contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6df95f1-801b-4ac2-a5eb-b81bb7efe715" contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4332b0d-3233-4504-b292-03057fe5393f" contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">284,419</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;">&#160;</p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_b08c19b9-d1a5-4ea2-b94d-0063c26438d9_1" continuedAt="F_b08c19b9-d1a5-4ea2-b94d-0063c26438d9_2">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.805%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.013%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.024000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.024000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br />Cost Basis</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br />Loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br />Values</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_094b6cf4-8bd9-4c2c-961e-44b0eab34302" contextRef="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,979</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2840ba0-52fe-49ca-929a-588072aa135d" contextRef="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c18b625-ddc8-4dfe-93c3-a453b01a05e7" contextRef="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,978</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9bcf178a-c6e8-4c21-8c56-19a6d79c0753" contextRef="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,953</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d4332c8-1c2b-4cee-8b8b-513fefa4bb8b" contextRef="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_664382c4-1486-4d6b-bbd8-0b2505904fea" contextRef="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,949</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_210705c5-ac35-4d4d-b2e4-dd29e34df88e" contextRef="C_7ef664f3-dcfa-4413-9356-692945d9514a" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,932</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f905466c-fc5f-4465-ad49-ffac4d52cd59" contextRef="C_7ef664f3-dcfa-4413-9356-692945d9514a" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7a54e4b-8a48-435e-9210-47de53d77667" contextRef="C_7ef664f3-dcfa-4413-9356-692945d9514a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:continuation></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_b08c19b9-d1a5-4ea2-b94d-0063c26438d9_2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></ix:continuation></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all investments had contractual maturities within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_90084be2-d681-4bc7-ac15-adc92fe5471d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:AvailableForSaleInvestmentsContractualMaturityPeriod" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_78812923-e62c-4f77-bde7-5bbfabd08a80" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="amlx:AvailableForSaleInvestmentsContractualMaturityPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5d966a6-849d-447c-acb3-c6a423f182db" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d0fa3583-58e4-445f-b4aa-c317ee44ae88" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8a6ac6ed-208a-4a48-97d5-3e6be901348d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ec486df6-53d0-4963-8841-53b6ec3e1c1c" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> realized gains and losses recognized during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other-than-temporary are also included in other income, net.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. The Company has the ability to hold its investments until maturity and generally does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e537603-97b5-4578-81b5-a2f8db30a5bf" contextRef="C_6847e6cf-32c0-4a9e-820c-301e7187f960" name="us-gaap:AssetImpairmentCharges" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a50da534-f36b-4e54-afac-1a5ab297bcec" contextRef="C_90ba1a94-3a9c-4e3a-98be-4dbb6a1f0412" name="us-gaap:AssetImpairmentCharges" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> impairment charges on short-term investments.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b8797344-f452-4657-aafc-d30ff78669be" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:InventoryDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. INVENTORIES</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_92cb0a1a-d41b-4180-bbf5-8545529ca70d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventories consisted of the following:</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.938%;"></td>
        <td style="width:1.615%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.737%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.615%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.094%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Raw materials</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1aa04ae-94b6-4924-bcd6-f8234681d623" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:InventoryRawMaterials" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,151</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Work in process</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a021fd88-32ca-4f35-9487-d7a40e5e0be0" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:InventoryWorkInProcess" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,681</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finished goods</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b888207d-7d23-4d60-b906-4b356613a897" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:InventoryFinishedGoods" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">937</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total inventories</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb07bdf9-15ce-46bf-be1b-c143040b65c9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:InventoryNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,769</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company capitalizes inventory costs associated with the Company&#x2019;s products after regulatory approval when, based on management&#x2019;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory on hand determined to not have a future economic benefit and acquired prior to receipt of the marketing authorization for ALBRIOZA in Canada, totaling approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63e7e0b1-c555-4628-8690-eb2fa55475b7" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">22.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, was expensed as research and development expense as incurred. The Company began to capitalize the costs determined to have a probable future economic benefit associated with the production of ALBRIOZA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon receipt of Health Canada approval in June 2022. Finished goods have a shelf life of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e9a01020-ee09-4a8f-8803-8e631e2fc139" contextRef="C_9bc9f9a5-11f9-478f-9984-e116f2928e91" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d0d558bc-3a85-4d9b-be63-c354401b61a1" contextRef="C_fb6ca0c6-e436-48d9-af45-2ac4f63346d8" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months from the date of manufacture.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Of the inventories reported on balance sheet at December 31, 2022, the Company had </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55a0b86a-ad6c-4c08-a96f-4107a8927e28" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:LongTermRawMaterialsNotYetRealized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of long-term raw materials that are not expected to be realized in cash, sold or consumed during the next 12 months.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_733f8c6c-67ef-4591-8210-ae2999869b23" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. Property and equipment, net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_33f79e84-b916-4c30-81d4-750ccadc557e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.332%;"></td>
        <td style="width:2.63%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:22.134%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:2.63%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:22.273%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1422d616-9b90-4456-bc21-cbffc75a41eb" contextRef="C_96d72263-9f43-4d59-8a5d-034e72d9be8e" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">362</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_240d2b3a-4d2a-4820-b8b7-523f978b4f28" contextRef="C_28f824cb-b9d8-44c0-9120-7b7fefbb119e" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72313716-21c2-41df-93ef-1568a50ffd1e" contextRef="C_489ebaa1-e175-4c12-b766-93bc771353fd" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,810</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0fe5244b-bcf2-46c4-b46a-405beb3ecf79" contextRef="C_49ffe463-5c72-4589-94f5-b0914efbf208" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">250</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ab94e21-b8be-4bdf-985c-d71228f7dc2d" contextRef="C_75199396-3f49-47e9-a99c-3a0ee563bfe5" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c3a4e88-dc1b-4eba-8c21-fb413d212b51" contextRef="C_ccd2bc7d-177e-44f8-89c8-d26a5a47b261" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7c54742-9b67-4e59-88ef-6919dea2b6ff" contextRef="C_9c2263c4-ca40-4e95-b8e3-4cde9fa39697" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">803</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0a106d8d-7cf5-4c5d-a8c1-cd2370e2d327" contextRef="C_789d884f-c53b-4300-99ea-5e96e8f7db99" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">139</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d147a11f-9728-4338-8c57-5cb729664d42" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,151</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7735d904-4ca3-4c50-89ba-6159bc4eb16e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">527</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a262cbf-3a93-4b81-aa19-dab60ae00dfb" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">540</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f9965ea-f992-4b26-8d75-724c5cd1205e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73a9dbaf-d01f-4d13-9d46-28157125d758" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,611</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e957b7a9-f504-4699-88a3-43a7ace7cc76" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">474</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7ac53db5-ebec-45f5-b3c1-a5da8fe5bbd7" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. Accrued Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_113baf84-40f5-4c59-b4f0-8df2bf695681" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"></td>
        <td style="width:1.734%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.776%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.734%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.133%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">External research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14ab100a-4d41-4460-a112-6d9295ca0a3f" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:AccruedExternalResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,424</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a26932b-e531-4531-bfba-8a892463477c" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:AccruedExternalResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,666</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and employee related expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16a4e5d0-0307-4c36-a3ad-9996d01433af" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,231</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5997a5b6-0043-4b82-bdd3-bcf1cdee7472" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,280</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a64431d4-4bd7-4b6e-bbc8-9dfe4ae3a824" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:AccruedManufacturing" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,596</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued consulting and other professional fees</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8fab4e7b-3a6e-46b6-b13f-14176222e88f" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:AccruedConsultingAndOtherProfessionalFess" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,116</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e36a75d1-df78-4fd1-9f21-c8a91f5d464e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:AccruedConsultingAndOtherProfessionalFess" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,820</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rebates and other GTN adjustments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7dfc7df-80bb-44f1-9f8b-1e89a7fd0ca5" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:RebatesAndOtherGrossToNetAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,582</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty payable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_76e5fca9-bd73-43b3-9ffc-a4fde83c83d2" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:RoyaltyPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,358</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75736972-4c36-4dae-8521-56cacc640151" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,005</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc0d361c-77eb-4825-bf54-30b61b806cb5" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">258</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a31c3319-f5c2-40af-beac-fc28b72cfa00" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,312</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d376a30-52cc-45c6-813e-4663e69a8868" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,024</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3f2281f6-caf2-4919-bb9d-eadcb28b8702" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:ConvertibleNotesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8. CONVERTIBLE NOTES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Issuance of the 2021 Notes</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2021, the Company issued, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e08412b1-e9ba-4e15-8a07-d23ec0946c43" contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">27.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in convertible notes, or 2021 Notes, to certain investors, including related parties, of which proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c0732329-c4c0-4225-9b46-549b72766a11" contextRef="C_847bc730-56b4-47a9-b047-316c0d25ef30" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were received in advance of issuance of the 2021 Notes in December 2020 and the remaining proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3d0b307-a7c6-4d52-a1e1-97fd6eb168a3" contextRef="C_3abbf489-5362-4633-bc8b-b7daa3c678ec" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal"><ix:nonFraction id="F_c9789693-68a9-4ae5-b04d-0933fd6fa51d" contextRef="C_5fa66652-e292-4b4a-b46f-3914e1bb1423" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">26.1</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were received in January and February 2021. The 2021 Notes were to mature on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3196402d-327f-42f1-8728-4ff4c1745590" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and carried both automatic and optional conversion features. The 2021 Notes were secured and carried an interest rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_42074d31-aac9-443a-bdfc-f53b7d1ebc1b" contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e44fed9e-1022-4e40-899b-2fb48f965447" contextRef="C_126e9271-cfbf-4f0e-811b-b2e260d1b8e8" name="us-gaap:DebtInstrumentDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded the $1.2 million of proceeds received in December 2020 as proceeds received in advance of issuance of 2021 Notes in the consolidated balance sheet as of December 31, 2020, as the subscription agreement and commitment to issue the 2021 Notes was not effective until January 2021.</span></ix:nonNumeric></span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2021 Notes contained the following features:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Automatic Conversion Features</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The 2021 Notes were to automatically convert into Conversion Shares upon (i) an IPO, (ii) any transaction in which the Company merges with, consolidates with or enters into other similar transaction with a Special Purpose acquisition Corp, or SPAC, resulting in some or all of its shares being registered for sale under applicable securities laws and listed for trading on a national or foreign exchange, or De-SPAC transaction, (iii) the acquisition of the Company by another person or entity by means of any transaction in which holders of the outstanding voting securities of the Company immediately before such transaction held less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2220499-f144-4d18-bc02-21320bd7ac9f" contextRef="C_ba447dcc-85e2-40e6-b77e-267406ab1bf1" name="amlx:PercentageOfVotingSecurities" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the voting securities of the Company or the surviving corporation after such transaction or a sale of all or substantially all of the assets of the Company but excluding De-SPAC transaction, IPO, and the occurrence of equity financing in which the Company sold shares of its preferred stock for new money and which was neither an IPO or a Qualified Financing, or Change of Control, and (iv) the closing of a sale of an equity transaction in which the Company sold shares with an aggregate gross proceeds of at least $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25088cc8-618c-4fc9-8173-9a84cda47722" contextRef="C_5f298d27-3cb9-4705-bfa0-9f414a329ed2" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">10.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, or Qualified Financing.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of a Change of Control, De-SPAC transaction, or an IPO, the Conversion Shares would be common stock of the Company. In the event of a Qualified Financing, the Conversion Shares would be shares of preferred stock issued in such transaction.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Optional Conversion Feature</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The holders of the 2021 Notes had the option to elect to convert their notes into Conversion Shares at the Conversion Price upon the occurrence of an equity financing in which the Company sold shares of its preferred stock for new money and which was neither an IPO or a Qualified Financing, or Non-Qualified Financing, and together with the IPO, De-SPAC transaction, Change of Control, and the Qualified Financing, collectively, the &#x201c;Conversion Events&#x201d;). In the event of a Non-Qualified Financing, the Conversion Shares would be the class of equity shares issued in such transaction. The 2021 Notes would be deemed to have converted into the Conversion Shares if no election was made by the holders of the 2021 Notes.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion Price</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Upon the occurrence of an IPO, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4202ee7c-10a9-4536-8aea-89adc15f46b0" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:PercentageOfPriceOfferedToEachShareOfCommonStock" unitRef="U_Rate" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the price at which the Company offered each share of common stock in the IPO without deducting any amount for discounts, commissions, fees, or other costs and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2c4cbb1-f649-475b-a380-3faf3601305d" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:DilutedCapitalDividend" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">600.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of a De-SPAC transaction, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1b29326-ec3b-4655-b401-f14873b000fd" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:PercentageOfPriceOfferedToEachShareOfCommonStock" unitRef="U_Rate" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the common stock price in the De-SPAC transaction, which would be determined by dividing (x) the total consideration to be paid to common stockholders upon a De-SPAC transaction less the principal amount of the 2021 Notes including accrued and unpaid interest by (y) the common stock issued and outstanding immediately prior to the De-SPAC transaction and that would be exchanged as a result of the De-SPAC transaction including common stock that would be issued upon the exercise of stock options immediately before the Change of Control transaction but excluding the common stock issuable upon conversion of the 2021 Notes and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cdbfba96-fbbf-479b-a6fd-e38c2852329c" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:DilutedCapitalDividend" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">600.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of a Change of Control, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5effb778-67db-46f1-8036-4f9654ff0076" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:PercentageOfPriceOfferedToEachShareOfCommonStock" unitRef="U_Rate" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the common stock price in the Change of Control, which would be determined by dividing (x) the total consideration to be paid to common stockholders upon a Change of Control less the principal amount of the 2021 Notes including accrued and unpaid interest by (y) the common stock issued and outstanding immediately prior to the Change of Control and that would be exchanged upon a Change of Control including common stock that would be issued upon the exercise of stock options before the Change of Control but excluding the common stock issuable upon conversion of the 2021 Notes and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3543c3f0-5dc4-4068-b8d5-7d83dd1c36b3" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:DilutedCapitalDividend" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">600.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon a Qualified Financing, the 2021 Notes would convert into shares of preferred stock issued in the Non-Qualified Financing at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_427cce55-7768-48b4-8ed3-154f9d8cfdd1" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:PercentageOfPriceOfferedToEachShareOfCommonStock" unitRef="U_Rate" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the lowest price at which the Company sold shares of its stock in the Qualified Financing and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d291b28-e98b-4083-98e9-9e964b8c046e" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:DilutedCapitalDividend" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">600.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Repayment</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Each holder of the 2021 Notes had the option to elect to receive a payment in the amount equal to the principal amount plus accrued and unpaid interests upon a Change of Control. If a Change of Control occurred and no election was made by the holder, the principal amount and accrued and unpaid interest would be deemed to have automatically be converted into shares of the Company&#x2019;s common stock of the Company immediately prior to the close of the Change of Control.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company qualified for and elected to account for the 2021 Notes under the fair value option and, in doing so, bypassed the analysis of potential embedded derivative features. The Company believes that the fair value option better reflects the underlying economics of the 2021 Notes. As a result, the 2021 Notes were recorded at fair value upon issuance, which was determined to be equal to principal amounts of these notes of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08dd2dff-6002-4017-930d-42303430f7fd" contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">27.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. At each financial reporting period, and immediately prior to conversion, the Company remeasured the fair value of the 2021 Notes. The change in fair value of the 2021 Notes from issuance date to the conversion date totaled $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_188ca7ca-3301-48be-ab5c-1f95972da0e2" contextRef="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is recorded as change in fair value of convertible notes in the consolidated statement of operations for the year ended December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion of the 2021 Notes</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2021, the Company consummated a financing transaction in which it issued shares of Series C-1 redeemable convertible preferred stock. The consummation of this financing transaction resulted in the automatic conversion of the 2021 Notes into shares of Series C-2 redeemable convertible preferred stock (together with the Series C-1 redeemable convertible</span><span style="color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preferred </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">stock, the &#x201c;Series C Preferred Stock&#x201d;) pursuant to their original terms. The Series C Preferred Stock was determined to have a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29ee42bf-1f5c-444a-8e15-0b7068373f1c" contextRef="C_52a2983c-7983-4d91-9733-cf784aff7361" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">10.265809</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Under the fair value option, the 2021 Notes were remeasured to fair value immediately prior to conversion at a price per share equal to the fair value of the Series C-1 redeemable convertible preferred stock. The Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b0d194f-8059-4cac-9adb-b66b8bae3a9e" contextRef="C_d36ae52a-d040-4a0e-84cd-85b87bbcff10" name="amlx:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million loss related to change in fair value of the 2021 Notes in its consolidated statement of operations for the year ended December 31, 2021. The 2021 Notes converted into </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d810321f-96b4-46eb-9c53-9d33e46c5270" contextRef="C_61ca1749-7a0a-470d-9b8c-19819b5915bb" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-2 redeemable convertible preferred stock at the effective conversion price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_765ffa29-44be-479f-8faa-55373484a796" contextRef="C_61ca1749-7a0a-470d-9b8c-19819b5915bb" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">8.725938</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8f22fc8-d95f-4f4a-accf-1af70fc27591" contextRef="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c" name="us-gaap:ConvertibleDebt" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_be2bee61-1e56-48b5-a6c4-a6de815c4f21" contextRef="C_f7fb78ab-3ece-4f31-af8a-d8d9b755bc94" name="us-gaap:ConvertibleDebt" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> convertible notes outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Notes&#x2014;Related Parties</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed4d0127-7e7e-49e3-ad22-577372012c49" contextRef="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c" name="us-gaap:ConvertibleNotesPayable" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_98044d9d-c2a4-455b-8d67-f44b8ecce832" contextRef="C_f7fb78ab-3ece-4f31-af8a-d8d9b755bc94" name="us-gaap:ConvertibleNotesPayable" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> convertible notes issued to related parties that were outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In connection with the issuance of the 2021 Notes, the Company issued, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a2a7cb5c-b2e1-4909-9286-ee96fbcabf92" contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3" name="us-gaap:ConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">14.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of convertible notes to certain related parties. These notes were issued under the same terms and conditions as the 2021 Notes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of the 2021 Notes</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the issuance date of the 2021 Notes, the Company determined that the fair value of the 2021 Notes approximated the principal amounts of the 2021 Notes as the transaction was deemed to be at arm&#x2019;s length. Subsequent measurement of fair value of the 2021 Notes at each reporting period was estimated based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The Company used a scenario-based analysis to incorporate estimates and assumptions concerning the Company&#x2019;s prospects and market indications into a model to estimate the value of the 2021 Notes. The most significant estimates and assumptions used as inputs were those concerning timing, probability of possible scenarios for conversion or settlement of the 2021 Notes and discount rates. The fair value of the 2021 Notes upon settlement in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_60ffaf4d-0e7e-4c99-bd8e-32c0d08ce992" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:ConvertibleNotesSettlementDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was determined based on the fair value of the Series C-1 redeemable convertible preferred stock issued. This method was selected as the Company concluded that the contemporaneous financing transaction was an arm&#x2019;s length transaction. The issuance of the Series C-1 redeemable convertible preferred stock was considered to be a Qualified Financing (see Note 11) pursuant to the original terms of the 2021 Notes. Accordingly, the fair value calculation for the 2021 Notes immediately before conversion considered both the fair value of the Series C-1 redeemable convertible preferred stock and the conversion price, which was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e51ea9e-dd9e-4dbc-a1d3-74b09e0f578d" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:PercentageOfPriceOfferedToEachShareOfCommonStock" unitRef="U_Rate" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair value of the Series C-1 redeemable convertible preferred stock. The fair value of the 2021 Notes as of June 30, 2021 was determined to be the same as that on the settlement date in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_501b9b3f-3dfb-46e5-8ec1-1d7695bfa9fe" contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a" name="amlx:ConvertibleNotesSettlementDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> based on management&#x2019;s determination of no material changes to the assumptions underlying the determination of the fair value of the 2021 Notes.</span></p></ix:nonNumeric></div>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5102b67b-8dd3-424b-befb-388f283ddbe1" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. FAIR VALUE MEASUREMENTS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c5f560d-3505-4a9e-a6ad-bc6e50bf58ac" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.287%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.032%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.032%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.388000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.388000000000002%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e3eba935-d071-4368-8ae4-9d33474a0155" contextRef="C_f58d364a-a071-43d1-a2d5-b038a25fdc37" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,567</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa5503bb-8c30-4758-a29a-897fc61959af" contextRef="C_642dd1b3-56a8-4be2-8e97-15c6ab673ca1" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,989</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b72ec7c-4e9f-4154-adb4-53883ca5a5d5" contextRef="C_02064c71-3a83-4801-8486-d127eb43b8ad" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,556</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury notes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5e47029-b1ab-4738-b96c-24a61afda396" contextRef="C_ff0690db-c77d-4b96-bbff-fbb506dbb3a1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,159</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd68c6c6-bafe-4337-a52d-3e991c4f136c" contextRef="C_d1f4d907-06b1-4446-92c9-69df12bfc090" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,159</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury bills</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3db2a17e-4a06-4f78-8636-c45fd09605e1" contextRef="C_f38b7408-04be-4eb8-957e-fdf39e6193be" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,334</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e0cfea2-b293-4195-a994-7c41fdf1d1a2" contextRef="C_757a8685-f087-44ba-8d70-37f526a1bd6e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,334</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c956d4a8-0094-449d-8508-350e003f8da8" contextRef="C_49ab84be-37c3-426d-8cbc-3170c1c749d8" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,375</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_726eb181-d993-4ee9-b4e3-cb365438e4d0" contextRef="C_08bb19c6-0e5b-4b98-a719-c56d723fcf27" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,375</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba7f5380-24e4-4f5b-8313-0cd2b87c4f0e" contextRef="C_b59b87a6-8c0e-42c4-b13a-2b0067aad963" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,753</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3708dbbd-a599-4134-bc32-53109095d69e" contextRef="C_d9bce4d5-f683-4b45-978f-ca52168d39ec" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,753</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_152c4ecc-0907-4094-84d2-c36fe30002ba" contextRef="C_1fe5ff12-27cd-44f5-a115-8904def1b494" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,798</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fba2bc4-0346-46f8-9410-23e8092b9fee" contextRef="C_d7b990e5-1180-4f67-85bb-6d7b96c69b5a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,798</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1d5fcbe-d882-4cd0-91a4-c270252bc945" contextRef="C_dded4a35-c564-4067-87bb-39604cfdd2aa" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">86,493</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ecfe1ee3-7c0e-428b-8b77-344bf04b9836" contextRef="C_faa2db82-5a0b-4d5e-9899-d4b010e01200" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">197,926</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b62e1112-1f01-4cc0-a336-5faa88dd53c9" contextRef="C_c14457e2-814d-4d72-8c26-189bdc3fa207" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">284,419</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84cac7fa-6b1b-4867-9000-1f1c26063079" contextRef="C_23c45f4e-2e33-4b8f-99a6-4527909a36c6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">719</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0cafeab0-a5d8-416b-9444-e38ba1b76c2e" contextRef="C_150e2ef8-74e4-47ed-95d8-3485e13c0048" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">719</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40ae619b-1d02-4994-94fc-5c67ee1769ff" contextRef="C_9bd71111-9adf-43ab-8fd0-05a1882632a5" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">110,779</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8213a4e5-26b2-485d-8e28-cb515623dd7c" contextRef="C_e6d67a4d-2001-440f-b683-73f5e52c53fe" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">207,915</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a563da42-73f4-4348-8d57-4335694272a3" contextRef="C_f4747adc-8a33-4cb0-a970-1b814ab522d7" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">318,694</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.287%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.032%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.032%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.388000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.218%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.388000000000002%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f068adc-bfa2-4154-b52e-1eeaacf02d9c" contextRef="C_4e947744-cacb-43d4-857f-1094d22ea491" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62685a84-ed8f-4928-8f23-09a6b2c82051" contextRef="C_eba29517-fdf1-4a5c-9472-881601db2461" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ddd124b-b776-4e9c-8680-d63c83c5bcd8" contextRef="C_00648e08-92ac-4b7a-9c05-679ac28e6a0e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,978</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74fbe4bd-7326-4f6f-aee4-235026029715" contextRef="C_91613165-4e43-4b91-b6e5-9c7be336afa8" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,978</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0be63c9f-55dd-4c32-ac99-a551bee2f31a" contextRef="C_18f249a1-455e-407f-aa84-667f43ef7f97" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,949</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af861a3f-6752-4c1f-aaa2-a0abe907840c" contextRef="C_296321bd-7a9d-4b09-ba9b-7ad1355d4097" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,949</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20dfe943-557d-48d3-9af3-99b14e5b056f" contextRef="C_c82ec6e0-6442-4924-93c4-7e12f30f5bfe" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf649478-bc5d-4fa9-a3cd-14c5541f96fa" contextRef="C_c2fe59ba-c379-4ba7-bfa5-0166ee9ba79d" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aaa9467a-aba9-47c7-a572-5651aa296c14" contextRef="C_e05504eb-0e44-40fb-b852-5368d3b9651a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">189</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_809fa9cd-3e90-44ab-9eb6-2be1de3b6c02" contextRef="C_e0aaedbf-19e6-4bcf-9bde-7bfed9c560a4" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">189</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21111aa8-c9e1-4ab5-9f7c-23a872a0a40c" contextRef="C_bd82984a-e7c6-40a2-8123-1c9deb800381" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,460</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7cb29ea-3454-40eb-bc78-3e7f83167aed" contextRef="C_c50598d2-a8bf-4f26-8081-1ada38713c0c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32d78d05-1145-4e2e-882e-267ec01027d7" contextRef="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">95,387</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of Short-Term Investments</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair values of the short-term investments by taking into consideration valuations obtained from third-party pricing sources. These pricing sources utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include market pricing based on real-time trade data for the same or similar securities, issuer credit spreads, benchmark yields, and other observable inputs. The Company validates the prices provided by our third-party pricing sources by understanding the models used, obtaining market values from other pricing sources and analyzing pricing data in certain instances.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19a3df40-49e3-4a35-a7c4-df86075602be" contextRef="C_9ec1205e-1c76-493c-b003-ad047009b28c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t hold any short-term investments classified as Level 3, which are securities valued using unobservable inputs. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_88a53a04-4e8c-4a25-b0af-704d521038fe" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has not transferred any investment securities between the classification levels</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_428ba480-dc0f-4b99-ab2e-298cc60a4cda" contextRef="C_f4747adc-8a33-4cb0-a970-1b814ab522d7" name="us-gaap:OtherAssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0bfbec43-48d4-4dfb-98be-8a3a597334ea" contextRef="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e" name="us-gaap:OtherAssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6555fcc1-371f-42f2-bab8-a1a50ded5cd2" contextRef="C_f4747adc-8a33-4cb0-a970-1b814ab522d7" name="us-gaap:OtherLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_db23ee78-d867-42c2-b669-4db86dc0c1d5" contextRef="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e" name="us-gaap:OtherLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> other assets or liabilities that were measured at fair value on a recurring basis as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_0a760bcf-5084-4d02-810d-98602ff659e9" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. LEASES</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its office facilities under non-cancelable operating leases that expire at various dates through October 2026. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_52476e21-1fa1-4500-9ca5-a185a9f4181d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LesseeOperatingLeaseDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3a47cfba-31e6-4c9c-ad54-2c506c640b49" contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with an option to extend the lease for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0d14dc60-0e90-48f6-8ce3-5aefe41b8d2c" contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Because the Company was not reasonably certain to exercise the option to extend the lease at inception, the option to extend was not considered in determining the lease term. The Company initially recognized a right-of-use asset of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8850788b-5597-46c7-8b02-539d35879ce8" contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and a lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b6b6ded-e9ed-4145-a47e-6b412b05e422" contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upon commencement of the lease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2c8790da-a07b-4693-ac1b-6812914bd57f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of lease expense required by ASC 842 are presented below for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.071%;"></td>
        <td style="width:1.919%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.009%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lease cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9001342-26a8-4d40-972a-e682c8707ad7" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92a51a4d-ed37-4f08-93b8-a8f358b80ea6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities are measured by calculating the present value of remaining lease payments under the lease arrangement. Since the rates implicit in our leases are not readily determinable, the Company uses estimated incremental borrowing rates in determining the discount rate used to calculate the present value of remaining lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments over a similar term equal to the lease term in a similar economic environment. The incremental borrowing rate is based on the information available at commencement date. As the Company has no recent external borrowings, the incremental borrowing is a hypothetical rate based on our understanding of what our credit rating would be and adjusted to reflect a collateralized borrowing.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s leases contain renewal options that can extend the lease for additional years. Because the Company is not reasonably certain to exercise these renewal options, they are not considered in determining the lease terms, and associated potential additional payments are excluded from lease payments. The Company has elected to account for each lease component and its associated non-lease components as a single lease component and has allocated all of the contract consideration across lease components only. The Company has existing net leases in which the non-lease components (e.g., common area maintenance) are paid separately from rent based on actual costs incurred and therefore are not included in the operating lease right-of-use assets and lease liabilities and are reflected as an expense in the period incurred.</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_69aa2e62-75ce-4318-8f58-35d62555e26e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the presentation in the Company&#x2019;s consolidated balance sheet of its operating leases (in thousands):</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"></td>
        <td style="width:1.921%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.092%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br />December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb7b5e3f-3b38-4f43-8822-efc95d8e0ef4" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,524</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use liabilities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1fab006c-0286-46ec-8433-2821b1e92b04" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,040</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use liabilities, net of current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01008f24-f424-420e-baa2-28739f75b61b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,237</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45eaf6c8-ea23-4fab-b1a7-f4e033433d9c" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,277</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, the Company made cash payments of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_51d3d463-ea0f-4fd7-a956-3a242737d75f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for operating leases.  </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d48496fc-d110-4935-8307-b6c78d6cc9c3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true" continuedAt="F_d48496fc-d110-4935-8307-b6c78d6cc9c3_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum lease payments under non-cancelable leases as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, were as detailed below (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_d48496fc-d110-4935-8307-b6c78d6cc9c3_1" continuedAt="F_d48496fc-d110-4935-8307-b6c78d6cc9c3_2"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"></td>
        <td style="width:1.921%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.092%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br />December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b170d751-8782-4c3f-9a30-4651473b948d" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,417</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f60cf76f-65fa-4dd2-8cad-65ca87040b8b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,478</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9fc3d0cb-573c-4649-a2de-094d9416e67e" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,586</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_922246e9-c3b7-49a1-9a18-abb2726ee9d5" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">476</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e420a875-9870-46e5-a4ce-8c32dd3e79a4" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,957</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10f8f10d-07a5-4350-87c1-7bd466fe0c18" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">680</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a86b07f1-00e4-4fda-8f17-21bdd385b4f8" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,277</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the weighted average remaining lease term was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9642ccda-723a-4cd0-8c50-cf0387c9fbe2" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the weighted average incremental borrowing rate used to determine the operating lease right-of-use assets was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2a24586-7615-43df-8ce1-3a5099a3385c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:OperatingLeaseWeightedAverageIncrementalBorrowingRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">7.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ASC 840 Disclosures</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_d48496fc-d110-4935-8307-b6c78d6cc9c3_2"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum lease payments under non-cancelable leases as of December 31, 2021, were as detailed below (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"></td>
        <td style="width:1.921%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.092%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br />December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c4b93dbd-9a13-4f35-ad0b-9aea61eaf553" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">532</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_788bfb48-5341-49a0-95b0-af456774770e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">541</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01b4a0da-8db2-473a-997d-5e9da910c89b" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">555</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8233f865-a663-4e72-b3cb-54aa59ae29c3" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">563</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8db59c0c-b5e6-49bc-aa50-0d726038e10c" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">476</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55436a36-8e93-4121-b13a-7ae8c6e8aa8f" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,667</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_55733ed3-6189-48eb-ab4b-edaed52d67e6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PreferredStockTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 1, 2021, the Company amended its certificate of incorporation in which it authorized </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4c4f840-c6d0-4f5e-be43-5e2434b97a80" contextRef="C_abc06de1-757c-40f3-a5ee-6a4936862ac3" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-1 redeemable convertible preferred stock and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a8fc1f2-b02f-4005-945d-fba5bb2413b3" contextRef="C_64429dd7-c70d-4084-9c4c-b6db110ed37a" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-2 redeemable convertible preferred stock.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2021, the Company consummated a financing transaction in which it issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f4b8b36-5199-4090-8c8a-c29b94503cf5" contextRef="C_abc06de1-757c-40f3-a5ee-6a4936862ac3" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-1 redeemable convertible preferred stock. In connection with the issuance of these shares, the principal including accrued interest of the 2021 Notes totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c77a34bd-682f-4747-9059-95d21778373f" contextRef="C_268c76a6-dcfb-4bac-8647-bc6361c204b4" name="us-gaap:NotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">27.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million automatically converted into </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c58c78f-b8f6-43dc-8989-8625032506f6" contextRef="C_268c76a6-dcfb-4bac-8647-bc6361c204b4" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-2 redeemable convertible preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0c92309a-986c-49bf-b31a-d664d204a95c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:TemporaryEquityTableTextBlock" escape="true" continuedAt="F_0c92309a-986c-49bf-b31a-d664d204a95c_1"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s redeemable convertible preferred stock consisted of the following:</span></ix:nonNumeric></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_0c92309a-986c-49bf-b31a-d664d204a95c_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:26.627%;"></td>
        <td style="width:1.071%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.395000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.071%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.395000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.357%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.446000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.357%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.446000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.071%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.762%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(dollars in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred<br />Shares<br />Authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred Shares<br />Issued and<br />Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Carrying<br />Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidation<br />Preference</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock<br />Issuable Upon<br />Conversion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c3276726-bb81-4c1f-84ce-82482a2f7dc8" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,289,609</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80b77208-8c61-489b-9e5c-91305bea9b92" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_931c6aee-f328-4858-b77a-938c47ab2d8b" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,289,609</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5c13f34-f7ef-43b3-a92c-c3e04c835a29" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,675</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d48501a1-9f10-44a5-9872-ceecb77e2e3d" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,730</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49a7b76e-be00-49e0-8cba-16769ae8a4f5" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,407,256</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52257089-83ae-4754-8a52-46a508587a45" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,100,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_efd082a1-786f-44ea-b7d3-4496d7b1ee6c" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_79d9240f-f219-4a5a-b234-5b3a3b744405" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,496,835</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93c1f11d-6039-4c33-a1d9-412410197317" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,387</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_07c3d740-bd86-4f6d-9b22-bb2d341d1f4e" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">246,070</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa0ec132-1121-45fa-8b6f-a526a0c8fb1c" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">16,746,059</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_141b0cff-a1be-45b5-a51c-3a0b372707de" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b6e69c1-dec8-40ce-915f-28201ef19998" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_ead9b1cc-eb06-4d0d-84bd-ba34d361848d" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c59c1db0-df6c-497f-8149-4c57e929d9e9" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,791</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e5fcacf7-36cc-4c16-a9b8-052649834fdd" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_212b8209-6cc5-4121-a4c0-a8848e62dd9e" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cad0a752-62f1-45d6-a6f2-b2df7f9a3c68" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b1db14c-93ea-4523-bf19-06003e7390e4" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_2a6a4d3d-17d0-4c98-b5d8-18d405ab7392" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_15ed1a9c-e67c-4aeb-82d0-ac15de11076f" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,498</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8fe513ab-440b-43f7-b750-c022037c9f0b" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,666</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc8e49b0-55bb-49f4-a01c-1b8771a4d414" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_467ce3ee-1bed-4ff4-8b74-a4ad869e2050" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,710,624</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08eb0f29-c113-48e7-bd2f-939254f2d371" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_e12560d5-7541-4e2a-9caf-ec042f90db0d" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,107,459</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2ab8621-5b05-4cef-aa26-db015a5e521f" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">239,351</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7cee1771-df78-4a37-adf9-2bf65b379b6c" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">416,466</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a86a29eb-728f-4073-8dbb-24c12f5a937a" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">39,474,330</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021, the holders of the Series C Preferred Stock, or together with the Series A redeemable convertible preferred stock and the Series B redeemable convertible preferred stock, collectively, the Preferred Stock, had the following rights and preferences:</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> On June 18, 2020, in connection with the conversion of the 2017 Notes, the Company adjusted the conversion price for the Series A redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_58584f47-2c48-4dce-be4a-d9e6af28d8cb" contextRef="C_a166ab8c-a37b-4070-99b9-bc8f9b0a2693" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">1.229073</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_200044ea-bb3c-4654-b82a-32379f90991a" contextRef="C_35fc1ceb-01e4-49e3-8c88-0259fd467fd7" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:numdotdecimal">1.2065</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The adjustment was made in accordance with the anti-dilution provisions in the certificate of incorporation then in effect immediately prior to the conversion of the 2017 Notes. The adjustment to the conversion price resulted in neither modification nor extinguishment of the Series A redeemable convertible preferred stock as the terms of the Series A redeemable convertible preferred stock were not amended. The adjustment to the conversion price resulted in additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e17421c7-d435-41d0-9064-f3c3ea9923b3" contextRef="C_35fc1ceb-01e4-49e3-8c88-0259fd467fd7" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">117,650</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock to be issued to holders of the Series A redeemable convertible preferred stock upon conversion of such shares into common stock. As of December 31, 2020, these additional shares of common stock were not issued and outstanding.</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2021, in connection with the conversion of the 2021 Notes, the Company adjusted the conversion price for the Series B redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_60d3190a-2d05-4dde-81a6-c6a22697e3b1" contextRef="C_8766c930-41ee-4314-b087-45deb048d199" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">16.974077</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acfeb3b9-d370-4bcf-acd3-550726d3610c" contextRef="C_170cdc21-0444-4686-8e31-4471213a6c12" name="us-gaap:PreferredStockConvertibleConversionPrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:numdotdecimal">14.6942</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The adjustment was made in accordance with the anti-dilution provisions in the certificate of incorporation then in effect immediately prior to the conversion of the 2021 Notes. The adjustment to the conversion price resulted in additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b684cea8-6666-4151-abdd-f77745b7d079" contextRef="C_170cdc21-0444-4686-8e31-4471213a6c12" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,249,224</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock into which Series B redeemable convertible preferred stock would be convertible. As of December 31, 2021, these additional shares were not issued and outstanding. Each share of Preferred Stock is convertible into an equivalent number of common stock, at any time, at the option of the holder. The initial conversion price for the Series C-1 redeemable convertible preferred stock and Series C-2 redeemable convertible preferred stock is the respective original issue prices.</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The conversion price for the Preferred Stock was subject to adjustments for stock splits, stock dividends, or similar recapitalization, and subject to adjustments in accordance with the anti-dilution provisions.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The shares of Preferred Stock were to automatically convert into common stock of the Company immediately upon either (a) the closing of the sale of shares of common stock to the public in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in at least $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f0842f1-312f-4bd6-911b-080ffd0a2e48" contextRef="C_85caa5e9-c564-49a9-b13c-652337260e60" name="amlx:ProceedsFromUnderwrittenPublicOffering" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">75.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of proceeds, net of the underwriting discount and commissions, to the Company, or Qualified IPO, or (b) the date and time, or the occurrence of an event, specified by vote or written consent of the holders of a majority of the then outstanding shares of Preferred Stock.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Dividends</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Dividends may be paid to the holders of the Series A redeemable convertible preferred stock. The holders the Series A redeemable convertible preferred stock are entitled to receive non-cumulative dividends at a rate per annum of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c87bab6-cb95-4ba9-8a52-3d1885b5e06f" contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37" name="amlx:NonCumulativeDividendsPerShareEntitledToReceive" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">0.073744</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">share when and if declared by the Board of Directors. The holders of the Series B redeemable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">convertible </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preferred stock were entitled to receive a non-cumulative dividend at the rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_420f3071-7c66-4512-a747-c5645e5bd033" contextRef="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6" name="amlx:PercentageOfNonCumulativeDividendsEntitledToReceive" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% per annum of the Series B original issue price per share when and if declared by the Board of Directors. As of December 31, 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7ef6b45e-6205-4083-91d9-97d199a20af8" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:DividendsPreferredStockCash" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cash dividends were declared or paid. From and after the date of issuance of the Series C Preferred Stock, the Company was not to set, declare, pay or set aside unless holders of the Series C Preferred Stock then outstanding shall first receive, or simultaneously receive, dividends on each outstanding share of Series C Preferred Stock in an amount equal to (i) in the case of dividends being distributed to common stock or any class or series of capital stock that is convertible into common stock, the equivalent dividend on an as-converted basis or (ii) in the case of dividends being distributed on a series or class not convertible into common stock, an additional dividend equal to a dividend rate calculated based on the respective original issue price of the Series C Preferred Stock. The original issue prices per share for the Series C-1 redeemable convertible preferred stock and Series C-2 redeemable convertible preferred stock were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0a30a1d4-f26c-4298-abdf-36d9b3c22b44" contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">10.265809</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88198a30-5c4e-4f94-8c2b-e554adba507e" contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="6" format="ixt:numdotdecimal">8.725938</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Voting Rights</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014; The holders of the Preferred Stock were entitled to vote on any matter presented to stockholders of the Company for consideration. Each holder of the Preferred Stock was entitled to cast the number of votes equal to the number of shares of common stock into which the shares of the Preferred Stock held by such holder were convertible on such date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Redemption&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Preferred Stock did not contain any mandatory redemption features. In accordance with FASB ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, preferred stock issued with redemption provisions that are outside of the control of the Company or that contain certain redemption rights in a deemed liquidation event is required to be presented outside of stockholders&#x2019; equity (deficit) on the face of the consolidated balance sheets. The Company classified the Preferred Stock outside of the stockholders&#x2019; equity (deficit) as mezzanine equity because in the event of certain deemed liquidation events, which included events such as a sale or merger, that were not solely within the control of the Company, the shares of the Preferred Stock would have become redeemable at the option of the holders. The Company did not adjust the carrying values of the Preferred Stock to the redemption values of such shares since a deemed liquidation event did not occur and the shares were not probable of becoming redeemable in the future as of the consolidated balance sheet dates.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidation&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of a liquidation, deemed liquidation, dissolution or winding up of the Company, holders of the Preferred Stock would have been entitled to be paid out of the assets of the Company that were available for distribution before any payment is made to the holders of common stock. The amount to paid would have been the greater of (i) respective original issue prices plus any dividends declared but unpaid or (ii) the amount that would have been payable had all shares of Preferred Stock been converted into common stock immediately before such event. If upon any such liquidation, deemed liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution to its stockholders would have been insufficient to pay the holders of Preferred Stock the full amount to which they would have been entitled, the holders of Preferred Stock would have shared ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After the payment of all preferential amounts required to be paid to the holders of Preferred Stock, the remaining assets of the Company available for distribution to its stockholders would have been distributed among the holders of the shares of common stock on a pro rata basis based on the number of shares held by each such holder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2022, upon the completion of the Company&#x2019;s IPO, all of the Company's outstanding shares of preferred stock were converted into shares of its common stock. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc54cfa8-1c15-424b-8745-5ed82b6f03a9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> redeemable convertible preferred stock outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1ff51752-190b-4457-8afd-235219aba9af" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. Stockholders&#x2019; EQUITY (Deficit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each share of common stock entitles the holder to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfe95133-c473-428a-8afd-3211cd0c7a4f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:CommonStockNumberOfVotingRights" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> vote on all matters submitted to a vote of the Company&#x2019;s stockholders provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#x2019;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the Delaware General Corporation Law. Common stockholders are entitled to receive dividends, as may be declared by the Company&#x2019;s Board of Directors, if any, subject to the preferential dividend rights of the Preferred Stock. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf7f12c0-5c25-4b98-8d1d-5e5061d2f686" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:Dividends" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9fa7e4d7-cbe2-4c87-9b02-936023df7ac4" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DividendsPayableCurrentAndNoncurrent" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a14f7b3e-6768-41ea-bc4c-ceda77ea4174" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:Dividends" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9a7e093d-8037-4eee-876e-a6954d4ee46b" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DividendsPayableCurrentAndNoncurrent" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dividends were declared or paid during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_841b385b-3231-43ce-9be3-bf81da0ce0f3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company had reserved shares of common stock for issuance in connection with the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.389%;"></td>
        <td style="width:1.294%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.832%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.294%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.193%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock authorized</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bab57481-c537-4db3-ad10-13e8f81710c7" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">300,000,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1059b75a-d1a8-4a9d-bfa9-1e8f9f060577" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">56,500,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock issued and outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34841636-5036-4a98-801f-acd695038bf5" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:CommonStockSharesIssuedAndOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">66,512,011</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af744eac-0c63-4cac-b9ac-8f6b89a8faeb" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:CommonStockSharesIssuedAndOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,020,487</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock authorized and reserved for future issuances:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f8bd8fb-c0d6-44dc-96b0-86b6ed9c4411" contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,407,256</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f95378e8-7777-4095-9b12-0cc961639e24" contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">16,746,059</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06b8e266-aeac-438e-aef1-acdb46e712f0" contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">13,150,430</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83d18638-1902-43c1-a17f-4f5c5f894e39" contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,170,585</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for the exercise of stock options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5461c92d-80ac-46f3-84db-69e102191b71" contextRef="C_c9061aa3-fdfb-412c-afec-524e4df56961" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">8,480,950</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16c54a2e-ae1d-4e71-af00-c052a511bc99" contextRef="C_aabbe5a4-0d80-4d34-9c12-1bc6e30e9fa6" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,339,011</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for the unvested restricted stock units</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a73d2d85-6a59-4ace-a9b6-08a42cace834" contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">740,297</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance of share-based awards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31839ce2-0d8d-429f-a7ee-90ddea9cd618" contextRef="C_adb5fca4-6b49-414c-ae2a-8352bcf3a331" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,817,751</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b4889e4-48ba-4bff-a45f-9db560062c8e" contextRef="C_32879b2b-a939-4f66-b85c-34c2c940aadb" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,444,492</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total common stock authorized and reserved for future issuance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33b3a76f-11de-4de1-98f6-192eee7ce8ed" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">12,038,998</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23809fd5-6754-445e-8422-68de6c78f4d1" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:CommonStockAuthorizedAndReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">46,257,833</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unreserved common stock available for future issuance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb9eb6fb-245b-49f8-a977-70c98a2fa7c4" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:UnreservedCommonStockAvailableForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">221,448,991</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7bb4eaf9-b20e-4aa8-af22-0467caf851a6" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:UnreservedCommonStockAvailableForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,221,680</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2022, the Company completed its IPO in which the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_904580c9-6911-4918-b506-924f0a74b49e" contextRef="C_ee7aed98-f0b4-4a0d-9d1c-9a20e0229bc8" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,369,369</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39a5538f-eec4-4238-9165-f186b78d02df" contextRef="C_32feb0a1-4b4c-4d84-ad01-dc752482f3d4" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">19.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. After deducting underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(24,24,24,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b73f8af8-a83b-4e63-a50d-ee36c56cb588" contextRef="C_ee7aed98-f0b4-4a0d-9d1c-9a20e0229bc8" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">196.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Upon the completion of the IPO, all of the Company&#x2019;s outstanding shares of preferred stock were converted into shares of its common stock.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2022, the Company completed a follow-on public offering in which the Company issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2033fb0e-5fb9-4262-ac82-79ed9505e57a" contextRef="C_9108caa7-2bf4-44fb-ab90-32ee41737a03" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,697,812</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65dec296-7de6-40dd-804b-b5b1291f2005" contextRef="C_9108caa7-2bf4-44fb-ab90-32ee41737a03" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:numdotdecimal">32.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. After deducting underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_231f49ee-bff5-4330-a7ae-41e7ccd7574f" contextRef="C_84e93efe-e53b-4b00-b1fc-338b910d8572" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="U_USD" scale="3" decimals="-2" format="ixt:numdotdecimal">230.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_0b257eaf-8bb3-4cf4-9165-fdaedf2b53de" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13. Stock Option and Grant Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Incentive Plan&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2022, the Company&#x2019;s board of directors adopted, and its stockholders approved the 2022 Stock Option and Incentive Plan, or 2022 Plan, which became effective on January 5, 2022, at which point </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c6cc523-755e-42f0-9c25-c6c9c04186f8" contextRef="C_5d394f0f-75d1-48be-a6ab-deb2d20f1179" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> further grants would be made under the 2015 Stock Option and Restricted Stock Plan, or 2015 Plan. Under the 2022 Plan, the Company may grant incentive stock options, or ISOs, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and other stock-based awards. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24fffafe-f12c-4735-9211-ee8f5f4102ec" contextRef="C_7f388b78-2a24-4c12-8623-a7395b18ffe4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,817,751</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares available for future issuance under the 2022 Plan. The options issued under the 2022 Plan expire </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_71e1c841-9feb-4f71-b581-39bf6eddf1e7" contextRef="C_75aa067a-4ce0-4ee0-849d-a679d624a87c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years following the date of grant. Stock options and restricted stock units typically vest over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a7349418-f281-4471-ad56-62a4b7e968e3" contextRef="C_75aa067a-4ce0-4ee0-849d-a679d624a87c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years. We recognize the compensation cost of awards subject to service-based vesting conditions over the requisite service period, which is generally equal to the vesting period of the respective award.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initially, subject to adjustment as provided in the 2022 Plan, the aggregate number of shares of the Company&#x2019;s common stock available for issuance under the 2022 Plan is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a488f181-e301-418b-96ae-dd97df7794c5" contextRef="C_965b6cf6-b979-4df3-ac71-5437159cc716" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,650,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The number of shares of the Company&#x2019;s common stock reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year commencing January 1, 2023, by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75fb727f-3c50-4e72-b9a0-5a62966f7a6d" contextRef="C_43c44a69-a3b4-4167-b97c-320dd91b42d2" name="amlx:PercentageOfIncreaseInCommonStockReservedForIssuance" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total number of shares of the Company&#x2019;s common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors. The maximum current number of shares that may be issued pursuant to the exercise of ISOs under the 2022 Plan is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bba16d0a-8993-4916-93ef-a1b8c862bc82" contextRef="C_46b98ed8-5467-4391-ad5a-f70e2d057d60" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,650,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The maximum number of shares of the Company&#x2019;s common stock subject to awards granted under the 2022 Plan or otherwise during a single calendar year to any individual nonemployee director, taken together with any cash fees paid by the Company to such nonemployee director during the calendar year for serving on the Company&#x2019;s board of directors, will not exceed $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a045edf4-942a-4b5c-86b6-8071d30656de" contextRef="C_8b5b9ca1-4558-4404-bf4b-7219032bb989" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">750,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in total value, or, with respect to the calendar year in which a nonemployee director is first appointed or elected to the Company&#x2019;s board of directors, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16002ed3-b00d-43a4-aed0-a80ab80fcea3" contextRef="C_0863d34e-dbd1-4004-8428-eacbe8227644" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All options and awards granted under the 2015 Plan consisted of the Company&#x2019;s common stock. As of January 6, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d0c879b-ddaa-472d-a440-59236dd6cee6" contextRef="C_42ba167d-3f2c-43b5-ad10-97d7aff55f3c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> additional stock awards have been or will be granted under the 2015 Plan. Although the 2015 Plan was terminated as to future awards in January 2022, it continues to govern the terms of options that remain outstanding under the 2015 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General Option Information</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><ix:nonNumeric id="F_9686c35f-5e37-496a-9783-f4cde52dd115" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.447%;"></td>
        <td style="width:1.752%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.103%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.605%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.094%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2af5a54e-bb9e-4f61-a323-e2c163bca852" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">20.29</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1afc7bab-a8f9-469f-9610-125055f4bbe8" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">7.69</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a3dff11e-2424-41db-b45d-206702794f99" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.97</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c4663eef-3d1c-4ebd-94eb-c2b3be6b88f7" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.01</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0ec51598-debb-48e5-8670-890f3173366c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.07</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ac50c9ce-9539-4945-b4a6-1428280daf3e" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.73</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_896510e7-3571-402d-bd14-8cde7a89e912" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">88.75</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0386bf07-3e19-4fc0-b3d8-bb99739d1c51" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">81.61</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c700b10-1fd2-4b78-a84c-26e458c245be" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.00</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d094f0e-9afd-40a3-a086-64f9764ab14e" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.00</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The per share weighted average grant date fair value of stock options granted during the year ended December 31, 2022 and 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3cc80560-469b-4a0b-9bc5-6132452b9e77" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">15.10</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_137ea969-a5ea-48df-8873-594500c0e30e" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">5.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of option activity for </span><span><ix:nonNumeric id="F_af0dc11b-0c16-4db0-b0b3-b44407cbd79d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true" continuedAt="F_af0dc11b-0c16-4db0-b0b3-b44407cbd79d_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, is as follows:</span></ix:nonNumeric></span></p><div style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><ix:continuation id="F_af0dc11b-0c16-4db0-b0b3-b44407cbd79d_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.716%;"></td>
        <td style="width:1.004%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.386999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.327%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.408999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.993%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.275%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.327%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.565%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br />Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br />Average<br />Exercise<br />Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br />Average<br />Remaining<br />Contractual<br />Term<br />(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br />Intrinsic<br />Value<br />(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_054b904b-417a-474b-8ddc-426030c143b1" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,339,011</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fcab25b2-70b8-486a-9109-4150185e563b" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">5.54</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_606e69d6-61f0-4a26-812a-26d9671b76b0" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.7</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38cd9e59-bd9f-46b1-b299-bc5c49051bcc" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,627</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32f6cc2e-6a66-4210-aa6e-305df09a78b1" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,237,720</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39afc636-63fd-4d9a-b0bc-9ae966f4536c" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">20.29</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c022b9bc-fce1-47d2-bfb8-31eda789f4b9" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">950,013</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a369ea70-c8c0-4334-835e-4b110614a8a8" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.33</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a57c5bd7-a5f3-4ad1-9670-59f834a2e375" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">145,768</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25a146a2-12d6-431f-bc55-0527d8a4044a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">10.98</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c6816fb-bd20-4734-8822-089a2943809c" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,480,950</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84bab803-ed6b-40c5-9283-a908b06c14b9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">13.19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0b212539-1f0e-4b1d-b981-7d74c8f51e7b" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1b90b51e-4fa6-4989-9e72-99cb5081ae19" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">201,765</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable at December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2b88f8d-fa3b-4544-b283-bb4b18b0f56b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,055,416</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aedc4a16-1669-4cda-9320-27d75c435a47" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">6.03</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eac08500-80b8-47c3-a615-56b7880d4f76" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d49e4d2-46a1-4130-bc5e-14b293258fb3" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">63,408</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_18047e32-e744-4f71-ae1c-d1afd003628b" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,425,534</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a045c03-b144-4c59-a91c-44cf1d2bf7cc" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">15.47</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e6a06a86-a9b1-4253-9658-5cde8e01341e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.6</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_613e9654-1026-4556-9c28-05cdd6b42de5" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">138,357</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the options and the fair value of the Company&#x2019;s common stock for those options that had exercise prices lower than the fair value of the Company&#x2019;s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2022 and 2021, was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6201678-888a-4181-906e-6fefec86b1f3" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">14.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33e96eff-2b59-4828-8c35-d576d68297c5" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total fair value of stock options vested during the years ended December 31, 2022 and 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_376ac7c8-85d9-4589-8a3b-f077bbe2ea35" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e545de8-c2b1-40d9-8152-429e6459b5a4" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Stock Unit Activity</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_20b79d32-b929-4e38-8b8f-5eae852dce50" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of restricted stock unit activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, is as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.004%;"></td>
        <td style="width:1.166%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.039%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.619%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.173%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average Grant Date Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonvested as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83f61cf1-564c-49a3-81e2-627460c221ba" contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">752,613</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_433e06a1-370b-4198-8756-b28adcba7c2d" contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">19.98</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d54af78f-9195-4b7b-ba7d-fe26d50b86fe" contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,316</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_baa9dd61-b2db-4941-bad3-9c97f26ae88f" contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">17.82</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonvested as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffb51d28-713c-4724-93fe-e49df97b11bb" contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">740,297</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a69356c5-497d-455a-9b8a-dfb9703be61d" contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">20.02</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense&#x2014;</span><span style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><ix:nonNumeric id="F_cf41d2c6-073e-4248-a12f-1553561ad070" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true" continuedAt="F_cf41d2c6-073e-4248-a12f-1553561ad070_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded stock-based compensation expense in the following expense categories of its statements of operations: </span></ix:nonNumeric></span><span style=""></span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><ix:continuation id="F_cf41d2c6-073e-4248-a12f-1553561ad070_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.097%;"></td>
        <td style="width:1.619%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.652999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.619%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.01%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92c7bd5a-c70d-4906-b154-3289f5ffd8f0" contextRef="C_a6f624b0-506d-4092-ac12-59f88d4944f4" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,639</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35c62b3c-e7e2-4782-9988-3eb3b2a3d562" contextRef="C_fb130967-b508-4202-8fe2-6a4e676525e0" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">888</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19031b5f-9325-4a24-a2a0-eef40019358b" contextRef="C_73f1a92d-0191-4388-a5a7-d6dd11c4cb90" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,075</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29d587ce-4638-4948-8302-db51a33da546" contextRef="C_638aa53f-8b90-4d77-82c0-fa3b9eb25f93" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,248</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d085b87-c382-414b-b34d-60bdab1a8fce" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,714</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_435b3303-8677-43a7-9985-014cebe9e793" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_21aae312-89b6-4555-bc6a-4fc2d9b24a03" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes stock-based compensation by type of award:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.938%;"></td>
        <td style="width:1.615%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.737%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.615%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.094%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c1c1d79-69d9-44b4-a1cb-c262e7b63ec3" contextRef="C_c32475bb-ba9c-415b-a298-afa0b3f8ef62" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,844</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90253bb7-fb3b-46be-9ecd-0480c0792b34" contextRef="C_f604d797-a8f0-453f-a9ea-26ea1f4f44d7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_152be67d-b172-4465-a737-e3a8f98fe7f1" contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,870</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f600cc1-7657-483f-a32d-7faebd17584e" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,714</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4fb787f-501e-4777-8f50-ce9c705611c6" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7012ed4b-ab48-4e0a-a860-5cc5f416e9ed" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="amlx:SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" escape="true"><p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes unrecognized stock-based compensation expense as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, by type of awards, and the weighted-average period over which that expense is expected to be recognized. The total unrecognized stock-based compensation expense will be adjusted for actual forfeitures as they occur.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.053%;"></td>
        <td style="width:1.613%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.042%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.17%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.121%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized Expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average Recognition Period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90f2529f-c59d-484b-9b37-db3fb6800163" contextRef="C_c9061aa3-fdfb-412c-afec-524e4df56961" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">61,049</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1ff96206-42eb-484d-adbd-b81ef5f489be" contextRef="C_c32475bb-ba9c-415b-a298-afa0b3f8ef62" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.79</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b19d172-e114-45ac-b860-57ac0dba03e4" contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,950</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4e3e22e1-aebc-4c8c-80dd-f56125d6e767" contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.25</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_5a2456ca-7e39-4c70-8bfe-07d5c70b0bbb" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14. Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_870988fd-8d8b-4250-afc6-df6ad31edca5" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of net loss before the provision for income taxes are as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"></td>
        <td style="width:1.731%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.962000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.731%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.101%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f813747d-80c9-44d4-ae5f-b9ff290cb83a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">198,704</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0bb8c8be-48a1-42fb-bba7-c0ab30828220" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,904</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fdff5b9-4967-47b1-a182-009d1ea75882" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,103</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad42f842-cc5a-4314-bd6e-b0984fd169be" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7aefe3a5-650b-42b5-82f1-2eaa7311a735" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">197,601</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_effbc121-7e4c-4035-8043-55826f3a0283" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">87,931</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_aa1e8007-3ef2-4da8-a6ea-e4fe94bad4a7" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The provision for income taxes for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 is as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"></td>
        <td style="width:1.734%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.776%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.734%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.133%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current income tax provision</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. - Federal</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. - State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_205258c9-1ad3-4be6-b37d-9f921b8716cb" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">774</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provision for income taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f46fee41-e1dc-4ce1-acad-0568491d8127" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">774</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_795df624-f5f8-4835-9e01-831f0943c0fa" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the Company&#x2019;s effective income tax rate to the U.S. statutory federal income tax rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_080afa34-7642-4744-ad7e-5cdeb76b6d8f" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_a5c78284-5c00-492f-8aa9-7e56a4079d77" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">21</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.416%;"></td>
        <td style="width:1.275%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.521999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.275%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.511999999999999%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax at U.S. statutory tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1946569-8c88-470d-bb67-de3b5fcfdece" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40df6936-9d1b-4906-80c5-e0512b0b419a" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9fada5eb-e6db-47a8-9a5c-05195190ee28" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8effe5c3-97ec-4ffe-a032-c77491c68825" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">4.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c06314c-f0a9-4f03-ad71-b9ac3f4235ba" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc6dc8ca-c27e-4d66-8b1a-ac370c6f6ea5" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowances</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16d5d9e0-4a8c-488d-8930-944530483e17" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">25.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d35c7a8-a5b4-494f-9715-4d71fb4b43ba" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">24.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d76a7894-9a2a-4903-ac5d-7416a247c710" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54c6b3f6-1568-4591-8cc0-5da30b543b05" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">2.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a7f0b0b-b687-4c0f-9e08-01af033250f1" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0944f62-3aff-429b-a206-1b8d1b2cd2d4" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets and liabilities reflect the net tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting and the amounts used for tax purposes. </span><span><ix:nonNumeric id="F_1090a1b6-a6ab-4c79-b533-dc593fb2d781" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_1090a1b6-a6ab-4c79-b533-dc593fb2d781_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_1090a1b6-a6ab-4c79-b533-dc593fb2d781_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"></td>
        <td style="width:1.731%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.962000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.731%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.101%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da2ca7ca-78df-4aeb-89af-148601e4cc16" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,673</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1aa52fa7-a609-495c-815d-347834855573" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,303</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_924ef26d-9fef-41f2-908c-8e21dbfd71a9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,628</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b989797-c5b9-46d0-b5cd-29ded0f91699" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,474</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research and development costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd8a5832-f5e0-404d-8a0c-6d94f8262123" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,079</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b9b8bc0-faab-4578-8e73-890f3033cdc6" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="amlx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,205</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventory</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f4af233-ce4c-48cf-87ba-b0b9aa2c25e0" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsInventory" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,721</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax credits</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dcd6c50c-c85a-4e88-ba4a-6b15e707f5cc" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,581</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08f60998-dab1-49cd-8fd0-c4990d7f5c5e" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,808</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accruals and other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a21a5078-bac5-4375-b59b-8a4547943d2f" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,284</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f20938c-df6a-483e-b372-bca2b1cc1ff0" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,556</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93e710e0-435e-405b-bd62-052004e4047d" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91,966</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee6de6b7-0992-4deb-8610-cf77c4d446f8" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,346</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_242dba43-8349-464b-9cc5-26c471efbb9d" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90,587</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f0d4487-52a2-49ee-96cd-b944464838e4" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,346</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1145ea92-5bf4-4bcb-9f84-ca719e662634" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,379</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d395d61e-b023-4934-8993-46ba24ceb9b9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,379</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a798bf77-1411-47c5-bb88-3b2aea147ff9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,379</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. The Company has considered its history of cumulative losses, including significant losses incurred in every year since inception, including 2022, and has concluded that it is more likely than not that it will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2022 and 2021.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On a periodic basis the Company reassess the valuation allowance that has been established, weighing positive and negative evidence.  In 2022, the Company reassessed the valuation allowance and considered negative evidence, including cumulative losses over the three years ended December 31, 2022, and positive evidence, including regulatory approvals of ALBRIOZA and RELYVRIO. After assessing both the negative and positive evidence, the Company concluded that a full valuation should be retained against the net deferred tax assets as of December 31, 2022.  It is possible that all or a portion of the valuation allowance will be released in the near-term.  The release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, levels of profitability, revenue growth, clinical program progression and expectations regarding future profitability.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ac2c514-870d-457f-82f9-7ecc396e208b" contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">203.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_521da9cd-c5ce-4ec9-917e-ddd1f6d24412" contextRef="C_b984d10b-9ff4-48e7-8949-0e6695ddfaee" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">115.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, and state net operating loss carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bc16ab1c-669b-492b-b8bc-ef502b7405ac" contextRef="C_2e22bd72-1889-4145-ab70-577df3f62afd" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">164.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_618d24e2-fc53-45e0-a290-cb30e04bbd52" contextRef="C_4a875587-3d63-4295-98d5-e68474ee09d8" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">102.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, which are available to reduce future taxable income. Of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80b71311-6d65-4bda-90f6-3e7cfd092f2d" contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">203.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> federal net operating loss carryforwards, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ac2caf0-70d0-4d19-95a0-7df884875452" contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e48a8c4a-d77c-4c4e-932c-12ae96b28b8b" contextRef="C_a7844b97-2442-4785-bc7f-5bd8385fcab8" name="amlx:OperatingLossCarryforwardsExpirationPeriod"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2034</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the remaining </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa3b5f07-a110-4b98-8471-65a96ceca967" contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">201.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> net operating losses carryforward indefinitely. Of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc70d20c-3f68-41fe-9d4b-5adfa3fb8dc8" contextRef="C_2e22bd72-1889-4145-ab70-577df3f62afd" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">164.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> state net operating loss carryforwards, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b6adf0d3-da9e-4c21-bd01-696bee1c8c76" contextRef="C_6e0804e9-955a-4a85-ad28-2816b77d859c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">113.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of Massachusetts net operating loss carryforwards begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_13d44073-5c7c-4792-91da-6ce46856594c" contextRef="C_1e5f309e-abea-4f3f-9d05-817063bff016" name="amlx:OperatingLossCarryforwardsExpirationPeriod"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2034</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company also had federal tax</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">credits of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a9832c1-deac-4afb-a425-0526bb211f17" contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e312df89-816c-4ca0-99dd-1198552121b9" contextRef="C_b984d10b-9ff4-48e7-8949-0e6695ddfaee" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, and state tax credits of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64464562-f7e5-493a-9c27-9cd8124399c2" contextRef="C_2e22bd72-1889-4145-ab70-577df3f62afd" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a878b807-6a1e-46f4-8b57-2e3016009bbe" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:TaxCreditCarryforwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tax credit carryforwards will expire at various dates beginning in 2034.</span></ix:nonNumeric></span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The utilization of the net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. The Company has not conducted a formal study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382 and 383 of the Code, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards may be subject to an annual limitation, which is determined by first multiplying the value of the Company&#x2019;s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has not yet conducted a study of its research and development credit carryforward. Such a study, once undertaken by the Company, may result in an adjustment to the Company&#x2019;s research and development credit carryforward. A full valuation allowance has been provided against the Company&#x2019;s research and development credit and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a valuation allowance against its deferred tax assets as of December 31, 2022 and 2021, because the Company&#x2019;s management has determined that it is more likely than not that these assets will not be fully realized. The increase in the valuation allowance recorded during the year primarily relates to the net operating loss incurred by the Company as well as the increase in research and development credits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_38d90570-fb79-44ab-86d1-3cbbc397f2c5" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SummaryOfValuationAllowanceTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reflects the roll-forward of the Company&#x2019;s valuation allowance:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"></td>
        <td style="width:1.734%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.776%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.734%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.133%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance at beginning of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8ce3e6b-6cb8-402c-8c7b-99279889fd13" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,346</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30321fc6-5c91-480e-99c9-2cdb67a0748c" contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,900</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases recorded to income tax provision</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9cb757f4-f7ac-4b62-9551-de5e1adde53a" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,241</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08a0d779-2ec7-41a8-9ef7-177e886637d9" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,446</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance at end of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f03ce93b-2323-45c4-9ef2-0b6b8fc72ba9" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90,587</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc0d140c-8faa-4f8b-b807-7f04c272cf7f" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,346</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for uncertainty in income taxes under the provisions of ASC 740 which defines the thresholds for recognizing the benefits of tax return positions in the consolidated financial statements as &#x201c;more likely than not&#x201d; to be sustained by the taxing authority. The tax benefit is measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlemen</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_97f7586a-467f-4d67-b978-964cd4ab4577" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true" continuedAt="F_97f7586a-467f-4d67-b978-964cd4ab4577_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the beginning and ending amount of gross unrecognized tax benefits</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021 is as follows: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_97f7586a-467f-4d67-b978-964cd4ab4577_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"></td>
        <td style="width:1.731%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.962000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.731%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.101%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at beginning of the period</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e3fba3e2-fdd4-4a87-8610-90b9b0b7f4d1" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">564</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d247aaf-4801-4728-bc98-9339edcdb938" contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">349</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases (decreases) related to tax positions taken during prior years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ad52a36-eb00-4be3-8da8-7e22f470f500" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="amlx:UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">32</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases related to tax positions taken during the prior years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e312262d-9de3-454f-a6b9-e09f21c98bde" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">481</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a2b23c3b-f518-40c7-b773-23604dd20908" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">215</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at end of the period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23ad9cb7-a659-4a5d-a70c-631023423904" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,013</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_076cbc64-1b49-41c2-93d1-3cb2a2527479" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">564</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has reviewed the tax positions taken, or to be taken, in its tax returns for all tax years currently open to examination by a taxing authority. Unrecognized tax benefits represent the aggregate tax effect of differences between tax return positions and the benefits recognized in the consolidated financial statements. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_55119ad3-939d-4bc2-b32e-91e7d0b34665" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does not expect the amount of unrecognized tax benefits to change over next 12 months.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The Company accrues interest and penalties related to unrecognized tax benefits as a component of its provision for income taxes. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80d512cc-5fe6-4f32-8d0c-325212067ae6" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_e09ac029-90b9-459d-8dd6-68f96ecc719e" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recognize any interest or penalties related to uncertain tax positions during the two years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company files U.S. federal, foreign and state income tax returns in various jurisdictions. The status of limitations varies by jurisdiction. There are currently no federal or state audits or examinations in process.</span></p></ix:nonNumeric></div>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b91d9e4b-536a-4fda-b870-17d8ac62fc2d" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EMPLOYEE BENEFIT PLANS</span></p><p style="text-indent:10.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company maintains a tax-qualified retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax-advantaged basis. Plan participants are able to defer eligible compensation subject to applicable annual Internal Revenue Code limits. The Company provides a safe-harbor contribution o</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">f </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b80ff7d4-9eb5-412f-bb63-52199f6b6718" contextRef="C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of employee compensation to employees who satisfy the minimum service requirements. The Company made </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_992bd047-8702-4f7e-8553-65bb5ed9b2f0" contextRef="C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88d4b39a-8d69-47ae-b5cb-953b37e2014c" contextRef="C_c9812622-5be1-41f9-acc6-5b7dabd03559" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of safe-harbor contributions for the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_0a108695-9467-4668-9978-3fb618e6d823" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16. NET LOSS PER SHARE</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share Attributable to Common Stockholders&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because the Company reports a net loss attributable to common stockholders, basic and diluted net loss per share attributable to common stockholders are the same for both periods presented. All preferred stock, stock options and restricted stock units have been excluded from the computation of diluted weighted-average shares outstanding because such securities would have an antidilutive impact. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b724ed5b-32c8-4782-868e-b02c6820c713" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_b724ed5b-32c8-4782-868e-b02c6820c713_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following common stock equivalents outstanding at each period end have been excluded from the calculation of diluted net loss per share because their inclusion would have been antidilutive:</span></ix:nonNumeric></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_b724ed5b-32c8-4782-868e-b02c6820c713_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.389%;"></td>
        <td style="width:1.294%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.832%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.294%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.193%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ccef4132-e0f8-494a-aceb-6f50e55df2d2" contextRef="C_b787ec26-9aa6-4a5e-a368-bb18c3c09dfd" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">8,480,950</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b07e2c42-a0ed-4cd8-82dc-798f0bb4a2e7" contextRef="C_a0b1a141-4c14-4d2b-920f-b03009062e23" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,339,011</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06140410-4d9f-4d49-bb47-ea2208d9c702" contextRef="C_99d7352d-e522-4ae7-bfb0-933bd5a40ea8" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">740,297</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f78713d-37c0-4172-bdab-eec36ea3e724" contextRef="C_b214c460-3b77-4ddc-9510-02c9f4c9c9c1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">39,474,330</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total excluded common stock equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c6989da3-cc49-47fd-b3c2-72a01b451204" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">9,221,247</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e5bf542-c6c9-483a-a40d-690b863cbc2d" contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">44,813,341</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cfa6df9f-3a8c-44fc-81d5-7d5849a89c97" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17. Related party transactions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Notes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the issuance of the 2021 Notes, the Company issued, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_865c8ad9-e1be-4e8b-a0b2-1121ee51bb2e" contextRef="C_3ebd36ac-5798-4f88-97b9-7e44c07d4319" name="us-gaap:ConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">14.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of convertible promissory notes to Morningside Ventures Investments Limited, and certain members of the board of directors of the Company. Morningside Ventures Investments Limited is a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f3e3572-a431-4f99-8c66-48396a56f252" contextRef="C_3ebd36ac-5798-4f88-97b9-7e44c07d4319" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% significant stockholder of the Company. These notes were issued under the same terms and conditions as the 2021 Notes (see Note 8).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Supplier Agreements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of business, the Company may purchase materials or supplies or services from entities that are associated with a party that meets the criteria of a related party of the Company. These transactions are reviewed quarterly and to date have not been material to the Company&#x2019;s consolidated financial statements.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d0970a6c-bd10-4ecd-82ac-325f74ad8f49" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating Leases&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its facilities under non-cancelable operating leases that expire at various dates through October 2026. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6736fc9e-9c97-4af5-9805-7b4fae04ef23" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:LesseeOperatingLeaseDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7c030abb-58ea-4366-a194-bcd58b7cb63b" contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with an option to extend the lease for</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_388077ca-a4df-4f1c-83d0-d35052bb6d3f" contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 3 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> As of January 1, 2022, the Company adopted ASC 842 which requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by leases. As a result of this adoption, the Company recorded a right-of-use asset and corresponding lease liability on the consolidated balance sheet. The Company continues to recognize rent expense, which is calculated as the remaining cost of the lease allocated over the remaining lease term on a straight-line basis. See Note 10 for additional information regarding the Company's operating leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Letter of Credit&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents consist of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1691f98f-7897-4553-9c0b-d81ef7669259" contextRef="C_13345d35-56b6-4c29-9548-08d0bb84c9d1" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of cash serving as collateral for a letter of credit issued for the Company&#x2019;s office space, and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f2f9218-b0b8-4237-a5d4-8a236388e5c4" contextRef="C_abe6a82a-1d40-4eb5-8cb4-6e4904b35dfe" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as collateral for a corporate credit card program. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company&#x2019;s restricted cash equivalents balance was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b2a51ecf-2558-48e9-aa1b-dabf94fa7cbc" contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62d82ee0-6362-464f-a0e5-36b7a70d509f" contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Legal Proceedings&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is not currently a party to any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or potential range of loss is probable and reasonably estimated under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company recognizes expenses for its costs related to its legal proceedings, as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalty Payments&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between August 2016 and February 2019, the Company entered into agreements with the Grantors. Under the terms of the agreements, the Company was granted, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f5736c4-65b8-48dc-af5d-b90fa451ba70" contextRef="C_5b1aaf8c-dd58-4214-a024-8c65bee77c8f" name="us-gaap:ProceedsFromGrantors" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. These grants were provided to the Company for the purpose of furthering the research and development of AMX0035 as a therapeutic benefit for ALS disease and Alzheimer&#x2019;s disease. Under the terms of the arrangements, the Company would receive a tranche of funds as it completes certain milestones. Pursuant to the terms of the grant agreements, the Company has certain payment obligations that are contingent upon future events such as the achievement of commercialization or the receipt of proceeds from a revenue generating transaction resulting from the projects for which the grants are used for.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of the respective grant agreements among the Company, ALS Association and ALS Finding a Cure, the Company will be required to make royalty payments to each Grantor in the total amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8442ed6-d7da-4c25-b6c2-5126e5fe4d63" contextRef="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3" name="amlx:RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">150</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the grant received. The royalty payments will be achieved through a combination of the following payment methods: (i) an annual installment payment of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94d35562-4a2a-4deb-970c-34981ccdb75f" contextRef="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3" name="amlx:RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net sales of any products developed under the project for which the grant was used for and (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3536379-6fef-438d-be77-bb84e79e8dcc" contextRef="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3" name="amlx:RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of cash proceeds resulting from revenue generating transaction under the project for which the grants are used for. During the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company recorded </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91ee0b70-883d-434f-8802-a08f4ab269f1" contextRef="C_0b327429-7b70-49b6-86e4-f2ad018fde8a" name="us-gaap:RoyaltyExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in royalty expense, which is included in cost of sales in the consolidated financial statements.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the respective grant agreements among the Company, Alzheimer&#x2019;s Drug Discovery Foundation, the Alzheimer&#x2019;s Association, and Cure Alzheimer&#x2019;s Fund, the Company will make royalty payments up to the maximum amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ddff995-d10e-4e3e-83c4-10320a3ae1bb" contextRef="C_e92dc208-a141-4607-b82a-3789bb5e1d48" name="amlx:MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">15.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to each Grantor (or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9eb3768e-5d2b-433c-aa1d-faa4e95641c0" contextRef="C_e92dc208-a141-4607-b82a-3789bb5e1d48" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">45.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in aggregate). The royalty payment will be made through a combination of the following payment methods: (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24d8741b-3043-4009-b1da-43dc4828d9bd" contextRef="C_e92dc208-a141-4607-b82a-3789bb5e1d48" name="amlx:RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of annual net sales of any product commercialized from the project for which the grant was used for and directly related to the treatment of the Alzheimer&#x2019;s disease and (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cdc4d57-7f40-434d-aaa2-f4cf06073418" contextRef="C_4b1c0dc1-9115-4d8d-97b5-2ec93c4885e8" name="amlx:RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of all royalties and cash proceeds resulting from revenue generating transactions associated with the projects for which the grants were used for under the grant agreements.  As the conditions that would trigger royalty payments under the agreements have not occurred, no amounts have been recorded in the consolidated financial statements for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_293071b7-0a0e-4563-98da-fd325f396a25" contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="subsequent_events"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company has evaluated all subsequent events and determined that there are no material recognized or unrecognized subsequent events requiring disclosure, except as described below.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Silicon Valley Bank (&#x201c;SVB&#x201d;) was closed on March 10, 2023 by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) as receiver. At the time of closing, the Company maintained less than $1.0 million of its cash in deposit accounts with SVB and held sufficient liquid assets at Bank of America to manage its operational needs. The vast majority of the Company&#x2019;s cash, cash equivalents and short-term investments reside in custodial accounts held by U.S. Bank for which SVB Asset Management is the advisor. The Company&#x2019;s investment portfolio currently does not contain any securities of SVB. On March 12, 2023, the U.S. Treasury, Federal Reserve, and FDIC announced that SVB depositors will have access to all of their money starting March 13, 2023. The Company does not believe it will be impacted by the closure of SVB and will continue to monitor the situation as it evolves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 13, 2023, the Company announced the appointment of Karen Firestone, Chairman, CEO, and co-founder of Aureus Asset Management and prior fund manager at Fidelity Investments, to the company&#x2019;s Board of Directors. Ms. Firestone's appointment to the Board of Directors is effective as of March 16, 2023.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>amlx-ex10_18.htm
<DESCRIPTION>EX-10.18
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.18</font></p>
  <p style="margin-left:28.32%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:28.472%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EMPLOYMENT AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;text-indent:6.838%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Employment Agreement (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is made between Amylyx Pharmaceuticals, Inc., a Delaware corporation (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and Gina Mazzariello, 12 Bridle Path Trail, Newtown, CT. 06470 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;text-indent:6.838%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company beginning on February 22, 2022 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) on the terms and conditions contained herein.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;text-indent:6.838%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:0.0%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.2155241455442765%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.755%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.13%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">this Agreement commencing as of the Effective Date and continuing until such employment is terminated in accordance with the provisions hereof (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The Executive&#x2019;s employment with the Company shall continue to be &#x201c;at will,&#x201d;meaning that the Executive&#x2019;s employment may be terminated by the Company or the Executive at any time and for any reason subject to the terms of this Agreement.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.736%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.0%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Position and Duties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive shall serve as the Chief Legal Officer of the Company and shall have such powers and duties as may from time to time be prescribed by Co-Chief Executive Officers (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEO</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) or other duly authorized executive. The Executive shall devote the Executive&#x2019;s full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing, the Executive may serve on other boards of directors, with the approval of the Board of Directors of the Company (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Board</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), or engage in religious, charitable or other community activities as long as such services and activities do not interfere with the Executive&#x2019;s performance of the Executive&#x2019;s duties to the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.699%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Location</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive&#x2019;s primary work location will be Newtown, Connecticut; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that the Executive will be expected to travel to the Company&#x2019;s headquarters, currently located in Cambridge, Massachusetts, from time to time, as well as to engage in other reasonable business travel, to perform the Executive&#x2019;s duties and responsibilities under this Agreement.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.2155241455442765%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation and Related Matters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:14.269%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776650219873791%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Base Salary</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive&#x2019;s initial base salary shall be paid at the rate of</font></div></div>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.102%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$400,000 per year. The Executive&#x2019;s base salary shall be subject to periodic review by the Board or the Compensation Committee of the Board (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compensation Committee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The base salary in effect at any given time is referred to herein as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Base Salary</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d; The Base Salary shall be payable in a manner that is consistent with the Company&#x2019;s usual payroll practices for its executive officers.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:0.935%;text-indent:13.85%;font-size:0;margin-top:3.95pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.796%;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incentive Compensation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive shall be eligible to receive cash incentive compensation as determined by the Board or the Compensation Committee from time to time. The Executive&#x2019;s initial target annual incentive compensation shall be 40% of the Executive&#x2019;s Base Salary. The target annual incentive compensation in effect at any given time is referred to herein as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Target Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d; The actual amount of the Executive&#x2019;s annual incentive compensation, if any, shall be determined in the sole discretion of the Board or the Compensation Committee. Any annual incentive compensation will be paid no later than March 15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">th</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the calendar year following the calendar year to which such bonus relates. Except as otherwise provided herein or as may be provided by the Board or the Compensation Committee, the Executive must be employed by the Company on the date such incentive compensation is paid in order to earn or receive any annual incentive compensation.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.87%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.935%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sign-on Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company shall pay the Executive sign-on bonus in the total amount of $250,000 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sign-on Bonus</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The Sign-on Bonus shall be paid as follows: $125,000 shall be paid within the first 30 calendar days after the Effective Date $125,000 shall be payable within ten (10) calendar days after the six (6) month anniversary of the Effective Date. All Sign-on Bonus payments made to the Executive pursuant to this Section 2(c) shall be treated as wages for withholding and employment tax purposes. Notwithstanding anything to the contrary herein contained if, the Executive resigns without Good Reason or is terminated by the Company for Cause (as such terms are defined below), in any such case prior to the one (1) year anniversary of the Effective Date, the Executive agrees to repay all Sign-On Payments made to the Executive on an after-tax basis (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Repayment Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to the Company within 30 calendar days following the Date of Termination (as defined below) and the Executive agrees that the Company may, to the extent legally permitted, offset the Repayment Amount from any compensation that the Company owes the Executive upon written notice to the Executive.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.718%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.87%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by the Executive during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company for its executive officers.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.699%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Benefits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive shall be eligible to participate in or receive benefits under the Company&#x2019;s employee benefit plans in effect from time to time, subject to the terms of such plans.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:14.165%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:4.935%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Paid Time Off</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive shall be entitled to take paid time off in accordance with the Company&#x2019;s applicable paid time off policy for executives, as may be in effect from time to time.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.928%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.333%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to the approval of the Board, you will be granted an option to purchase up to 182,000 shares of the Company&#x2019;s common stock (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and 41,000 restricted stock units (&#x201c;RSUs&#x201d;), subject to the terms and conditions applicable to option awards and RSUs granted under the Company&#x2019;s 2022 Stock Option and Incentive Plan (the &#x201c;Plan&#x201d;), as described in the Plan and the applicable award agreement, which you will be required to sign. The Option shall vest as follows: 25% of the shares subject to the Option will vest and become exercisable upon the first anniversary of your date of hire and the remaining 75% of the</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.37%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shares subject to your Option will vest thereafter in 36 equal monthly installments, in each case, subject to your continued Service Relationship (as defined in the Plan) with the Company through each such vesting date. The exercise price per share of the Option will be equal to at least the fair market value per share of the Company&#x2019;s common stock on the date the Option is granted, as determined by the Board. We will recommend to the Board that the Option be designated as an &#x201c;incentive stock option&#x201d; within the meaning of Section 422 of the U.S. Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;), to the maximum extent permissible under the Code. The RSUs will vest as follows: 25% of the RSUs will vest upon the first, second, third and fourth anniversaries of your date of hire, in each case, subject to your continued Service Relationship with the Company through each such vesting date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.849%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive&#x2019;s employment hereunder may be terminated without any breach of this Agreement under the following circumstances:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:14.269%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776650219873791%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Death</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive&#x2019;s employment hereunder shall terminate upon death.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:14.269%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776650219873791%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company may terminate the Executive&#x2019;s employment if the Executive is disabled and unable to perform or expected to be unable to perform the essential functions of the Executive&#x2019;s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 180 days (which need not be consecutive) in any 12-month period. If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive&#x2019;s then existing position or positions with or without reasonable accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive or the Executive&#x2019;s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. The Executive shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise and the Executive shall fail to submit such certification, the Company&#x2019;s determination of such issue shall be binding on the Executive. Nothing in this Section 3(b) shall be construed to waive the Executive&#x2019;s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. &#167;2601 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">et seq</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. and the Americans with Disabilities Act, 42 U.S.C. &#167;12101 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">et seq.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.661%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.463%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination by the Company for Cause</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company may terminate the Executive&#x2019;s employment hereunder for Cause. For purposes of this Agreement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cause</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean any of the following:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:20.437%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.204%;min-width:20.0%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conduct by the Executive constituting a material act of misconduct in connection with the performance of the Executive&#x2019;s duties, including, without limitation, (A) willful failure or refusal to perform material responsibilities that have been requested by the CEO; (B) dishonesty to the CEO with respect to any material matter; or (C) misappropriation of funds or property of the Company or any of its subsidiaries or affiliates other than the occasional, customary and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">de minimis </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">use of Company property for personal purposes;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:20.935%;text-indent:0.0%;display:flex;margin-top:3.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:8.432302535888194%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the commission by the Executive of acts satisfying the elements of</font></div></div>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(A) any felony or (B) a misdemeanor involving moral turpitude, deceit, dishonesty or fraud;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:20.833%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.065%;min-width:20.0%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any misconduct by the Executive, regardless of whether or not in the course of the Executive&#x2019;s employment, that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries or affiliates if the Executive were to continue to be employed in the same position;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:20.775%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.796%;min-width:20.0%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continued unsatisfactory performance or non-performance by the Executive of the Executive&#x2019;s duties hereunder (other than by reason of the Executive&#x2019;s physical or mental illness, incapacity or disability) which has continued for more than 30 days following written notice of such unsatisfactory performance or non-performance from the CEO;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:21.277%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:5.065%;min-width:20.0%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a breach by the Executive of any of the provisions contained in Section 8 of this Agreement or the Restrictive Covenants Agreement;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:21.428%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:5.731%;min-width:20.0%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(vi)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a material violation by the Executive of any of the Company&#x2019;s written employment policies; or</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:21.158%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:4.537%;min-width:20.0%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(vii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Executive&#x2019;s failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to cooperate, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigation.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:14.269%;text-indent:0.0%;display:flex;margin-top:4.5pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776650219873791%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination by the Company without Cause</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company may terminate the Executive&#x2019;s employment hereunder at any time without Cause. Any termination by the Company of the Executive&#x2019;s employment under this Agreement which does not constitute a termination for Cause under Section 3(c) and does not result from the death or disability of the Executive under Section 3(a) or (b) shall be deemed a termination without Cause.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.699%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination by the Executive</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive may terminate employment hereunder at any time for any reason, including but not limited to, Good Reason. For purposes of this Agreement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Good Reason</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean that the Executive has completed all steps of the Good Reason Process (hereinafter defined) following the occurrence of any of the following events without the Executive&#x2019;s consent (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Good Reason Condition</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:20.935%;text-indent:0.0%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:8.432302535888194%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a material diminution in the Executive&#x2019;s responsibilities, authority or duties;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:20.935%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:8.432302535888194%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a material diminution in the Executive&#x2019;s Base Salary except for across-the-board salary reductions based on the Company&#x2019;s financial performance similarly affecting all or substantially all senior management employees of the Company;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.728%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.87%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a material change in the geographic location of the principal office of the Company to which the Executive is assigned, such that there is an increase of at least thirty (30) miles of driving distance to such location from the Executive&#x2019;s principal residence as of such change; or</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:23.329%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:13.333%;min-width:20.0%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a material breach of this Agreement by the Company. The &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Good Reason Process</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; consists of the following steps:</font></div></div>
  <div style="margin-left:7.602%;text-indent:15.362%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:5.602%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.215367965367965%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Executive reasonably determines in good faith that a Good Reason Condition has occurred;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.904%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.935%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.215367965367965%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Executive notifies the Company in writing of the first occurrence of the Good Reason Condition within 60 days of the first occurrence of such condition;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.662%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.463%;min-width:13.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.215367965367965%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Executive cooperates in good faith with the Company&#x2019;s efforts, for a period of not less than 30 days following such notice (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cure Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), to remedy the Good Reason Condition;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:16.156%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:9.87%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.215367965367965%;">(iv)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">notwithstanding such efforts, the Good Reason Condition continues to exist at the end of the Cure Period; and</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.771%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.13%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.215367965367965%;">(v)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Executive terminates employment within 60 days after the end of the Cure Period.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.2155241455442765%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Matters Related to Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:14.006%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.87%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except for termination as specified in Section 3(a), any termination of the Executive&#x2019;s employment by the Company or any such termination by the Executive shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:14.75%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:8.667%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean: (i) if the Executive&#x2019;s employment is terminated by death, the date of death; (ii) if the Executive&#x2019;s employment is terminated on account of disability under Section 3(b) or by the Company for Cause under Section 3(c), the date on which Notice of Termination is given; (iii) if the Executive&#x2019;s employment is terminated by the Company without Cause under Section 3(d), the date on which a Notice of Termination is given or the date otherwise specified by the Company in the Notice of Termination; (iv) if the Executive&#x2019;s employment is terminated by the Executive under Section 3(e) other than for Good Reason, 30 days after the date on which a Notice of Termination is given, and (v) if the Executive&#x2019;s employment is terminated by the Executive under Section 3(e) for Good Reason, the date on which a Notice of Termination is given after the end of the Cure Period. Notwithstanding the foregoing, in the event that the Executive gives a Notice of Termination to the Company, the Company may unilaterally accelerate the Date of Termination and such acceleration shall not result in a termination by the Company for purposes of this Agreement.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.102%;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.625%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.204%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If the Executive&#x2019;s employment with the Company is terminated for any reason, the Company shall pay or provide to the Executive (or to the Executive&#x2019;s authorized representative or estate) (i) any Base Salary earned through the Date of Termination; (ii) unpaid expense reimbursements (subject to, and in accordance with, Section 2(d) of this Agreement); and (iii) any vested benefits the Executive may have under any employee benefit plan of the Company through the Date of Termination, which vested benefits shall be paid and/or provided in accordance with the terms of such employee benefit plans (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.718%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.87%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Resignation of All Other Positions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. To the extent applicable, the Executive shall be deemed to have resigned from all officer and board member positions that the Executive holds with the Company or any of its respective subsidiaries and affiliates upon the termination of the Executive&#x2019;s employment for any reason. The Executive shall execute any documents in reasonable form as may be requested to confirm or effectuate any such resignations.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.84%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.602%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Pay and Benefits Upon Termination by the Company without Cause or</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by the Executive for Good Reason Outside the Change in Control Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If the Executive&#x2019;s employment is terminated by the Company without Cause as provided in Section 3(d), or the Executive terminates employment for Good Reason as provided in Section 3(e), in each case outside of the Change in Control Period, then, in addition to the Accrued Obligations, and subject to (i) the Executive signing a separation agreement and release in a form and manner satisfactory to the Company, which shall include, without limitation, a general release of claims against the Company and all related persons and entities that shall not release the Executive&#x2019;s rights under this Agreement, a reaffirmation of all of the Executive&#x2019;s Continuing Obligations (as defined below), and, in the Company&#x2019;s sole discretion, a one-year post-employment noncompetition agreement, and shall provide that if the Executive breaches any of the Continuing Obligations, all payments of the Severance Amount shall immediately cease (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Separation Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and (ii) the Separation Agreement becoming irrevocable, all within 60 days after the Date of Termination (or such shorter period as set forth in the Separation Agreement), which shall include a seven (7) business day revocation period:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.793%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.398%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall pay the Executive an amount equal to nine (9) months of the Executive&#x2019;s Base Salary (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); and</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.967%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.602%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to the Executive&#x2019;s copayment of premium amounts at the applicable active employees&#x2019; rate and the Executive&#x2019;s proper election to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COBRA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the Company shall pay to the group health plan provider or the COBRA provider a monthly payment equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (i) the nine (9) month anniversary of the Date of Termination; (ii) the date that the Executive becomes eligible for group medical plan benefits under any other employer&#x2019;s group medical plan; or (iii) the cessation of the Executive&#x2019;s health continuation rights under COBRA;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.102%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if the Company determines that it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly to the Executive for the time period specified above. Such payments to the Executive shall be subject to tax-related deductions and withholdings and paid on the Company&#x2019;s regular payroll dates.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amounts payable under Section 5, to the extent taxable, shall be paid out in substantially equal installments in accordance with the Company&#x2019;s payroll practice over nine (9) months commencing within 60 days after the Date of Termination; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if the 60-day period begins in one calendar year and ends in a second calendar year, such payments, to the extent they qualify as &#x201c;non-qualified deferred compensation&#x201d; within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Code</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), shall begin to be paid in the second calendar year by the last day of such 60-day period; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, further</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.849%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Upon a Change in Control, except as otherwise explicitly set forth in the applicable equity award agreement, any stock options and other stock-based awards held by the Executive with conditions and restrictions relating to the attainment of performance goals (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Performance-Based Equity Awards</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), to the extent then outstanding and unearned, shall be deemed earned based on the greater of target or actual performance as measured through such Change in Control, and such Performance-Based Equity Awards that are deemed earned shall be subject to time-based vesting, based on Executive&#x2019;s continued employment, for the remainder of the performance period and shall be subject to accelerated vesting upon a termination of</font></div></div>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.509%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive&#x2019;s employment to the extent provided for in Section 7(a)(ii) below. Any Performance- Based Equity Awards that are not deemed earned upon a Change in Control shall be forfeited for no consideration upon such Change in Control.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.849%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">7.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Pay and Benefits Upon Termination by the Company without Cause or</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by the Executive for Good Reason within the Change in Control Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The provisions of this Section 7 shall apply in lieu of, and expressly supersede, the provisions of Section 5 if (i) the Executive&#x2019;s employment is terminated either (a) by the Company without Cause as provided in Section 3(d), or (b) by the Executive for Good Reason as provided in Section 3(e), and (ii) the Date of Termination is on or within three (3) months prior to or 12 months after the occurrence of the first event constituting a Change in Control (such period, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Control Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). These provisions shall terminate and be of no further force or effect after the Change in Control Period.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.87%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.935%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the Executive&#x2019;s employment is terminated by the Company without Cause as provided in Section 3(d) or the Executive terminates employment for Good Reason as provided in Section 3(e) and in each case the Date of Termination occurs during the Change in Control Period, then, in addition to the Accrued Obligations, and subject to the signing of a general release of claims against the Company and all related persons and entities that shall not release the Executive&#x2019;s rights under this Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Release</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) by the Executive and the</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.824%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Release becoming fully effective, all within the time frame set forth in the Release but in no event more than 60 days after the Date of Termination:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.621%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.204%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall pay the Executive a lump sum in cash in an amount equal to 1.0 times the sum of (A) the Executive&#x2019;s then-current Base Salary (or the Executive&#x2019;s Base Salary in effect immediately prior to the Change in Control, if higher) plus (B) the Executive&#x2019;s Target Bonus for the then-current year (or the Executive&#x2019;s Target Bonus in effect immediately prior to the Change in Control, if higher) (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Control Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); and</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.599%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.065%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">notwithstanding anything to the contrary in any applicable option agreement or other stock-based award agreement, all [stock options and other stock-based awards held by the Executive that are subject solely to time-based vesting &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Time-Based</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Awards</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and any Performance-Based Equity Awards that are then outstanding and eligible to vest based on Executive&#x2019;s continued employment as provided for under Section 6 above shall immediately accelerate and become fully vested and exercisable or nonforfeitable as of the later of (i) the Date of Termination or (ii) the effective date of the Release (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated Vesting Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that in order to effectuate the accelerated vesting contemplated by this subsection, the unvested portion of the Executive&#x2019;s Time-Based Equity Awards and Performance-Based Equity Awards that would otherwise be forfeited on the Date of Termination will be delayed until the earlier of (A) the effective date of the Release (at which time acceleration will occur), or (B) the date that the Release can no longer become fully effective (at which time the unvested portion of the Executive&#x2019;s Time-Based Equity Awards and Performance-Based Equity Awards will be forfeited). Notwithstanding the foregoing, no additional time-based vesting of the Time-Based Equity Awards or Performance-Based Equity Awards shall occur during the period between the Date of Termination and the Accelerated Vesting Date; and</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.75%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.0%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to the Executive&#x2019;s copayment of premium amounts at the applicable active employees&#x2019; rate and the Executive&#x2019;s proper election to receive benefits under COBRA, the Company shall pay to the group health plan provider or the COBRA provider a monthly payment equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (A) the 12 month anniversary of the Date of Termination; (B) the date that the Executive becomes eligible for group medical plan benefits under any other employer&#x2019;s group medical plan; or (C) the cessation of the Executive&#x2019;s health continuation rights under COBRA; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if the Company determines that it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly to the Executive for the time period specified above. Such payments to the Executive shall be subject to tax-related deductions and withholdings and paid on the Company&#x2019;s regular payroll dates.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amounts payable under this Section 7(a), to the extent taxable, shall be paid or commence to be paid within 60 days after the Date of Termination; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that if the 60-day period begins in one calendar year and ends in a second calendar year, such payments to the extent they qualify as &#x201c;non-qualified deferred compensation&#x201d; within the meaning of Section 409A of the Code, shall be paid or commence to be paid in the second calendar year by the last day of such 60-day period.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:14.269%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776650219873791%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional Limitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.621%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.204%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or distribution by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Code, and the applicable regulations thereunder (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), would be subject to the excise tax imposed by Section 4999 of the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the Executive becomes subject to the excise tax imposed by Section 4999 of the Code; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that such reduction shall only occur if it would result in the Executive receiving a higher After Tax Amount (as defined below) than the Executive would receive if the Aggregate Payments were not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following order, in each case, in reverse chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from consummation of the transaction that is subject to Section 280G of the Code: (A) cash payments not subject to Section 409A of the Code; (B) cash payments subject to Section 409A of the Code; (C) equity-based payments and acceleration; and (D) non-cash forms of benefits; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that in the case of all the foregoing Aggregate Payments all amounts or payments that are not subject to calculation under Treas. Reg. &#167;1.280G-1, Q&amp;A-24(b) or (c) shall be reduced before any amounts that are subject to calculation under Treas. Reg. &#167;1.280G-1, Q&amp;A-24(b) or (c).</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.599%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.065%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this Section 7(b), the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After Tax Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the amount of the Aggregate Payments less all federal, state, and local income, excise and employment taxes imposed on the Executive as a result of the Executive&#x2019;s receipt of the Aggregate Payments. For purposes of determining the After Tax Amount, the Executive shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:14.904%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.935%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(iii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section 7(b)(i) shall be made by a nationally recognized accounting firm selected by the Company (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounting Firm</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which shall provide detailed supporting calculations both to the Company and the Executive within 15 business days of the Date of Termination, if applicable, or at such earlier time</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:7.587%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as is reasonably requested by the Company or the Executive. Any determination by the Accounting Firm shall be binding upon the Company and the Executive.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.605%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.065%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For purposes of this Agreement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall have the meaning ascribed to the term &#x201c;Sale Event&#x201d; as used in the Company&#x2019;s 2022 Stock Option and Incentive Plan.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.2155241455442765%;">8.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 409A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.68%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.602%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive&#x2019;s separation from service within the meaning of Section 409A of the Code, the Company determines that the Executive is a &#x201c;specified employee&#x201d; within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement or otherwise on account of the Executive&#x2019;s separation from service would be considered deferred compensation otherwise subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (i) six months and one day after the Executive&#x2019;s separation from service, or (ii) the Executive&#x2019;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.661%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.463%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.775%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.269%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that any payment or benefit described in this Agreement constitutes &#x201c;non-qualified deferred compensation&#x201d; under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive&#x2019;s termination of employment, then such payments or benefits shall be payable only upon the Executive&#x2019;s &#x201c;separation from service.&#x201d; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section</font></div></div>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.409A-1(h).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.625%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.204%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. Each payment pursuant</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.37%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to this Agreement or the Restrictive Covenants Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.755%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.13%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.602%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.2155241455442765%;">9.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Continuing Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.87%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.935%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictive Covenants Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In consideration for the Executive's Base Salary and Target Bonus provided for in this Agreement, such amounts the Executive acknowledges are consideration that is fair and reasonable and independent of the Executive's continued employment with the Company, the Executive is required to enter into the Employee Confidentiality, Assignment and Nonsolicitation Agreement, attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictive Covenants Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). For purposes of this Agreement, the obligations in this Section 9, the obligations that arise in the Restrictive Covenants Agreement, and any other agreement relating to confidentiality, assignment of inventions, or other restrictive covenants shall collectively be referred to as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Continuing Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.793%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.398%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-Party Agreements and Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive hereby confirms that the Executive is not bound by the terms of any agreement with any previous employer or other party which restricts in any way the Executive&#x2019;s use or disclosure of information, other than confidentiality restrictions (if any), or the Executive&#x2019;s engagement in any business. The Executive represents to the Company that the Executive&#x2019;s execution of this Agreement, the Executive&#x2019;s employment with the Company and the performance of the Executive&#x2019;s proposed duties for the Company will not violate any obligations the Executive may have to any such previous employer or other party. In the Executive&#x2019;s work for the Company, the Executive will not disclose or make use of any information in violation of any agreements with or rights of any such previous employer or other party, and the Executive will not bring to the premises of the Company any copies or other tangible embodiments of non-public information belonging to or obtained from any such previous employment or other party.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.699%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Litigation and Regulatory Cooperation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. During and after the Executive&#x2019;s employment, the Executive shall cooperate fully with the Company in (i) the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while the Executive was employed by the Company, and (ii) the investigation, whether internal or external, of any matters about which the Company believes the Executive may have knowledge or information. The Executive&#x2019;s full cooperation in connection with such claims, actions or investigations shall include, but not be limited to, being available to meet with counsel to answer questions or to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually convenient times. During and after the Executive&#x2019;s employment, the Executive also shall cooperate fully with the Company in connection with any investigation or review of any</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal, state or local regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse the Executive for any reasonable out-of-pocket expenses incurred in connection with the Executive&#x2019;s performance of obligations pursuant to this Section 9(c).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:13.755%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.13%;min-width:13.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:6.729788930723652%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Relief</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Executive agrees that it would be difficult to measure any damages caused to the Company which might result from any breach by the Executive of the Continuing Obligations, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly, the Executive agrees that if the Executive breaches, or proposes to breach, any portion of the Continuing Obligations, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any such breach without showing or proving any actual damage to the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.859%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.87%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">10.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent to Jurisdiction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The parties hereby consent to the jurisdiction of the state and federal courts of the Commonwealth of Massachusetts. Accordingly, with respect to any such court action, the Executive (a) submits to the exclusive personal jurisdiction of such courts;</font></div></div>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.964%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.333%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">11.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver of Jury Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each of the Executive and the Company irrevocably and unconditionally WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE EXECUTIVE&#x2019;S EMPLOYMENT BY THE COMPANY OR ANY AFFILIATE OF THE COMPANY, INCLUDING WITHOUT LIMITATION THE EXECUTIVE&#x2019;S OR THE COMPANY&#x2019;S PERFORMANCE UNDER, OR THE ENFORCEMENT OF, THIS AGREEMENT.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.821%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.333%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">12.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Integration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement, together with the Equity Documents, the Restrictive Covenants Agreement and the Officer Indemnification Agreement, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.877%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.13%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">13.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Withholding; Tax Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. All payments made by the Company to the Executive under this Agreement shall be net of any tax or other amounts required to be withheld by the Company under applicable law. Nothing in this Agreement shall be construed to require the Company to make any payments to compensate the Executive for any adverse tax effect associated with any payments or benefits or for any deduction or withholding from any payment or benefit.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.906%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.537%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">14.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assignment; Successors and Assigns</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Neither the Executive nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that the Company may assign its rights and obligations under this Agreement (including the Restrictive Covenants Agreement) without the Executive&#x2019;s consent to any affiliate or to any person or entity with whom the Company shall hereafter effect a reorganization or consolidation, into which the Company merges or to whom it transfers all or substantially all of its properties or assets;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.389%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, further </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that if the Executive remains employed or becomes employed by the Company, the purchaser or any of their affiliates in connection with any such transaction, then the Executive shall not be entitled to any payments, benefits or vesting pursuant to Section 5 or Section 7 of this Agreement solely as a result of such transaction. This Agreement shall inure to the benefit of and be binding upon the Executive and the Company, and each of the Executive&#x2019;s and the Company&#x2019;s respective successors, executors, administrators, heirs and permitted assigns. In the event of the Executive&#x2019;s death after the Executive&#x2019;s termination of employment but prior to the completion by the Company of all payments due to the Executive under this Agreement,</font></p>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company shall continue such payments to the Executive&#x2019;s beneficiary designated in writing to the Company prior to the Executive&#x2019;s death (or to the Executive&#x2019;s estate, if the Executive fails to make such designation).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.849%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.731%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">15.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforceability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.955%;font-size:0;margin-top:4.5pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.204%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">16.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Survival</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For the avoidance of doubt, the provisions of this Agreement shall survive the termination of the Executive&#x2019;s employment to the extent necessary to effectuate the terms contained herein.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.935%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.935%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">17.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.877%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:2.13%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">18.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Board.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:7.092%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:5.065%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">19.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized representative of the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.821%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:1.333%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">20.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effect on Other Plans and Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. An election by the Executive to resign for Good Reason under the provisions of this Agreement shall not be deemed a voluntary termination of employment by the Executive for the purpose of interpreting the provisions of any of the Company's benefit plans, programs or policies. Nothing in this Agreement shall be construed to limit the rights of the Executive under the Company&#x2019;s benefit plans, programs or policies except as otherwise provided in Section 9 hereof, and except that the Executive shall have no rights to any severance benefits under any Company severance pay plan, offer letter or otherwise. In the event that the Executive is party to an agreement with the Company providing</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for payments or benefits under such plan or agreement and under this Agreement, the terms of this Agreement shall govern and the Executive may receive payment under this Agreement only and not both. Further, Section 5 and Section 7 of this Agreement are mutually exclusive and in no event shall the Executive be entitled to payments or benefits pursuant to both Section 5 and Section 7 of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.944%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.065%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">21.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This is a Massachusetts contract and shall be construed under and be governed in all respects by the laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws principles thereof. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals for the First Circuit.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.935%;text-indent:6.984%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:3.602%;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.776468804311058%;">22.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:28.32%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:28.5%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Signature page follows]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:28.32%;text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:28.454%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:0.92%;text-indent:6.838%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.778%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the parties have executed this Agreement effective on the Effective Date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.405%;"></td>
    <td style="width:5.002%;"></td>
    <td style="width:3.175%;"></td>
    <td style="width:46.418%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: January 21, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:7.9pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXECUTIVE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.405%;"></td>
    <td style="width:5.002%;"></td>
    <td style="width:3.175%;"></td>
    <td style="width:46.418%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: January 23, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s Gina Mazzariello</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114587611.4</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:28.32%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:28.435%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:28.32%;text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:28.509%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictive Covenants Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:23.533%;text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee Confidentiality, Assignment and Nonsolicitation Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;text-indent:7.87%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.519%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration and as a condition of my employment by Amylyx Pharmaceuticals, Inc. (&#x201c;Amylyx, and with Amylyx&#x2019;s subsidiaries and other affiliates and its and their successors and assigns, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and in exchange for, among other things, my eligibility for certain severance benefits as provided for in my employment agreement with Amylyx (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) to become effective as of the closing of the Company&#x2019;s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (such public offering, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IPO</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which I acknowledge and agree is fair and reasonable consideration which is independent from the continuation of my employment, I enter into this Employee Confidentiality, Assignment and Nonsolicitation Agreement (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), the effectiveness which is subject to the closing of the IPO and to my Employment Agreement referenced above becoming effective, and agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proprietary Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I agree that all information, whether or not in writing, concerning the Company&#x2019;s business, technology, business relationships or financial affairs that the Company has not released to the general public (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proprietary Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and all tangible embodiments thereof are and will be the exclusive property of the Company. By way of illustration, Proprietary Information may include information or material that has not been made generally available to the public, such as: (a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">corporate information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including plans, strategies, methods, policies, resolutions, negotiations or litigation; (b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">marketing information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including strategies, methods, customer or business partner identities or other information about customers, business partners, prospect identities or other information about prospects, or market analyses or projections; (c) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">financial information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; (d) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">scientific information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including plans, specifications, manuals, forms, templates, software, pre-clinical and clinical testing data and strategies, research and development strategies, designs, methods, procedures, formulae, data, reports, discoveries, inventions, improvements, concepts, ideas, know-how and trade secrets, and other Developments (as defined below); and (e) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">personnel information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, including personnel lists, reporting or organizational structure, resumes, personnel data, performance evaluations and termination arrangements or documents. Proprietary Information also includes information received in confidence by the Company from its customers, suppliers, business partners or other third parties.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recognition of Company&#x2019;s Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I will not, at any time, without the Company&#x2019;s prior written permission, either during or after my employment, disclose any Proprietary Information to anyone outside of the Company, or use or permit to be used any Proprietary Information for any purpose other than the performance of my duties as an employee of the Company. I will cooperate with the Company and use my best efforts to prevent the unauthorized disclosure of all Proprietary Information. I will deliver to the Company all copies and other tangible embodiments of Proprietary Information in my possession or control upon the earlier of a request by the Company or termination of my employment.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rights of Others</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I understand that the Company is now and may hereafter be subject to nondisclosure or confidentiality agreements with third persons that require the Company to protect or refrain from use or disclosure of proprietary information. I agree to be bound by the terms of such agreements in the event I have access to such proprietary information. I understand that the Company strictly prohibits me from using or disclosing confidential or proprietary information belonging to any other person or entity (including any employer or former employer), in connection with my employment. In addition, I agree not to bring any confidential information belonging to any other person or entity onto Company premises or into Company workspaces.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitment to Company; Avoidance of Conflict of Interest</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While an employee of the Company, I will devote my full-time efforts to the Company&#x2019;s business and I will not, directly or indirectly, engage in any other business activity, except as expressly authorized in writing and in advance by a duly authorized representative of the Company. I will advise an authorized officer of the Company or his or her designee at such time as any activity of either the Company or another business presents me with a conflict of interest or the appearance of a conflict of interest as an employee of the Company. I will take whatever action is requested of me by the Company to resolve any conflict or appearance of conflict which it finds to exist.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Developments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, data, databases, computer</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.528%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">programs, research, formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship, and other intellectual property, including works-in-process (collectively &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Developments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by me (alone or jointly with others) or under my direction during the period of my employment. I acknowledge that all work performed by me is on a &#x201c;work for hire&#x201d; basis, and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Employing Company (as defined below) and its successors and assigns all my right, title and interest in and to all Developments that (a) relate to the business of the Company or any customer of, supplier to or business partner of the Company or any of the products or services being researched, developed, manufactured or sold by the Company or which may be used with such products or services; or (b) result from tasks assigned to me by the Company; or (c) result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company-Related</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Developments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">sui generis </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">database rights and other intellectual property rights in all countries and territories worldwide and under any international conventions (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.528%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To preclude any possible uncertainty, if there are any Developments that I have, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of my employment with the Company that I consider to be my property or the property of third parties and that I wish to have excluded from the scope of this Agreement (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior Inventions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), I have set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> attached hereto a complete list of those Prior Inventions. If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. If there are any patents or patent applications in which I am named as an inventor, other than those that have been assigned to the Company (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Patent Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), I have also listed those Other Patent Rights on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If no such disclosure is attached, I represent that there are no Prior Inventions or Other Patent Rights. If, in the course of my employment with the Company, I incorporate a Prior Invention into a Company product, process or machine, research or development program, or other work done for the Company, I hereby grant to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, worldwide license (with the full right to sublicense directly and indirectly through multiple tiers) to make, have made, modify, use, sell, offer for sale and import such Prior Invention. Notwithstanding the foregoing, I will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company&#x2019;s prior written consent.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.528%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Agreement does not obligate me to assign to the Employing Company any Development that, in the sole judgment of the Company, reasonably exercised, is developed entirely on my own time and does not relate to the business efforts or research and development efforts in which, during the period of my employment, the Company actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the Company. However, I will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion. I understand that to the extent this Agreement is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this Section 5 will be interpreted not to apply to any invention that a court rules and/or the Company agrees falls within such classes. I also hereby waive all claims to any moral rights or other special rights that I may have or accrue in any Company-Related Developments.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.546%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the purposes of this Section 5, the term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employing Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the entity employing me at the time that the applicable Development is created, made, conceived or reduced to practice. If I am jointly employed by two or more entities at such time, the Employing Company means the entity that is the primary employer.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Documents and Other Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I will keep and maintain adequate and current records of all Proprietary Information and Company-Related Developments developed by me during my employment, which records will be available to and remain the sole property of the Company at all times.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.528%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to Section 5, all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company to be used by me only in the</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.528%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">performance of my duties for the Company. Any property situated on the Company&#x2019;s premises and owned by the Company, including without limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to inspection by the Company at any time with or without notice. In the event of the termination of my employment for any reason, I will deliver to the Company all Company property and equipment in my possession, custody or control, including all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, and other materials of any nature pertaining to the Proprietary Information of the Company and to my work, and will not take or keep in my possession any of the foregoing or any copies.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">7.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforcement of Intellectual Property Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I will cooperate fully with the Company, both during and after my employment with the Company, with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in Company-Related Developments. I will sign, both during and after my employment, all papers, including without limitation copyright applications, patent applications, declarations, oaths, assignments of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development or related Intellectual Property Rights. If the Company is unable, after reasonable effort, to secure my signature on any such papers, I hereby irrevocably designate and appoint each officer of the Company as my agent and attorney-in-fact to execute any such papers on my behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development and related Intellectual Property Rights.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225612069058946%;">8.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonsolicitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to protect the Company&#x2019;s Proprietary Information and goodwill, during my employment and for a period of:</font></p>
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.528%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i) one (1) year following the date of the cessation of my employment with the Company (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Last Date of</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) or such shorter period as the Company designates in writing to me in connection with the ending of my employment relationship; or (ii) two (2) years following the Last Date of Employment if I breach my fiduciary duty to the Company or if I have unlawfully taken, physically or electronically, property belonging to the Company (in either case the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:7.874%;font-size:0;margin-top:4.55pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:7.602%;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I shall not, directly or indirectly, in any manner, other than for the benefit of the Company, solicit or transact any business with any of the customers of the Company. For purposes of this Agreement, customers shall include (i) then current customers to which the Company provided products or services during the twelve months prior to the Applicable Date (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One Year Lookback</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and (ii) customer prospects that the Company solicited during the One Year Lookback and with which I had significant contact or about which I learned confidential information in the course of my employment. The &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Applicable Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (i) as applied to my activities after my employment ends, the Last Date of Employment and (ii) as applied to my activities during my employment, the date of such activities.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:7.874%;font-size:0;margin-top:0.05pt;justify-content:flex-start;margin-bottom:0.0pt;margin-right:7.602%;min-width:6.667%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I shall not, directly or indirectly, in any manner, solicit, entice or attempt to persuade any employee or consultant of the Company to leave the Company for any reason or otherwise participate in or facilitate the hire, directly or through another entity, of any person who is then employed or engaged by the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">9.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I acknowledge that the Company may have from time to time agreements with other persons or with the United States Government or its agencies that impose obligations or restrictions on the Company regarding inventions made during the course of work under such agreements or regarding the confidential nature of such work. I agree to comply with any such obligations or restrictions upon the direction of the Company. In addition to the rights assigned under Section 5, I also assign to the Company (or any of its nominees) all rights that I have or acquired in any Developments, full title to which is required to be in the United States under any contract between the Company and the United States or any of its agencies.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">10.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I hereby represent that, except as I have fully disclosed previously in writing to the Company, I am not bound by the terms of any agreement with any previous or current employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of my employment with the Company or to refrain from competing, directly or indirectly, with the business of such employer or any other party. I further represent that my performance of all the terms of this Agreement as an</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.556%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">employee of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or in trust prior to my employment with the Company. I will not disclose to the Company or induce the Company to use any confidential or proprietary information or material belonging to any previous employer or others.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">11.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remedies Upon Breach</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I understand that the restrictions contained in this Agreement are necessary for the protection of the business and goodwill of the Company and I consider them to be reasonable for such purpose. Any breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in addition to such other remedies which may be available, will be entitled to specific performance and other injunctive relief, without the posting of a bond. I further acknowledge that a court may render an award extending the Restricted Period as one of the remedies in the event of my violation of this Agreement. If I violate this Agreement, in addition to all other remedies available to the Company at law, in equity, and under contract, I agree that I am obligated to pay all the Company&#x2019;s costs of enforcement of this Agreement, including reasonable attorneys&#x2019; fees and expenses.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">12.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Voice, Image and Likeness</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I give the Company permission to use any and all of my voice, image and likeness, with or without using my name, in connection with the products and/or services of the Company, for the purposes of advertising and promoting such products and/or services and/or the Company, and/or for other purposes deemed appropriate by the Company in its reasonable discretion, except to the extent prohibited by law.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">13.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Employment Obligation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I understand that this Agreement does not create an obligation on the Company or any other person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement signed on behalf of the Company by an authorized officer, my employment with the Company is at will and therefore may be terminated by the Company or me at any time and for any reason, with or without cause.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.463%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">14.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Survival and Assignment by the Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment. I further understand that my obligations under this Agreement will continue following the termination of my employment regardless of the manner of such termination and will be binding upon my heirs, executors and administrators. The Company will have the right to assign this Agreement to its affiliates, successors and assigns. I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be transferred without the necessity that this Agreement be re-signed at the time of such transfer.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">15.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notice of Resignation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If I elect to resign from my employment with the Company, I agree to provide the Company with written notification of my resignation at least two (2) weeks prior to my intended resignation date. Such notice shall include information in reasonable detail about my post-employment job duties and other business activities, including the name and address of any subsequent employer and/or person or entity with whom or which I intend to engage in business activities during the Restricted Period and the nature of my job duties and other business activities. The Company may elect to waive all or part of the two (2) week notice period in its sole discretion, and such waiver shall not result in a termination by the Company for purposes of this Agreement or any other agreement I may have with the Company, including, without limitation, the Employment Agreement.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">16.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Post-Employment Notifications</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the Restricted Period, I will notify the Company of any change in my address and of each subsequent employment or business activity, including the name and address of my employer or other post-Company employment plans and the nature of my activities.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">17.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosures During Restricted Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I will provide a copy of this Agreement to any person or entity with whom I may enter into a business relationship, whether as an employee, consultant, partner, coventurer or otherwise, prior to entering into such business relationship during the Restricted Period.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">18.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver; Reduction of Restricted Period by Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No waiver of any of my obligations under this Agreement shall be effective unless made in writing by the Company. The failure of the Company to require my performance of any term or obligation of this Agreement, or the waiver of any breach of this Agreement, shall not prevent the Company&#x2019;s subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:7.773%;text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:7.546%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">breach. Notwithstanding anything to the contrary in Section 8, the Company may reduce the length of the Restricted Period by providing written notice to me of such reduction in connection with the ending of my employment relationship.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">19.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In case any provisions (or portions thereof) contained in this Agreement shall, for any reason, be held invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">20.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Choice of Law and Jurisdiction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Agreement will be deemed to be made and entered into in the Commonwealth of Massachusetts, and will in all respects be interpreted, enforced and governed under the laws of the Commonwealth of Massachusetts. I hereby consent to the exclusive jurisdiction of the state and federal courts situated within Massachusetts for purposes of enforcing this Agreement or for any other lawsuit relating to or arising under this Agreement, and I hereby waive any objection that I might have to personal jurisdiction or venue in those courts.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">21.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Independence of Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">My obligations under this Agreement are independent of any obligation, contractual or otherwise, the Company has to me. The Company&#x2019;s breach of any such obligation shall not be a defense against the enforcement of this Agreement or otherwise limit my obligations under this Agreement.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">22.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Protected Disclosures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I understand that nothing contained in this Agreement limits my ability to communicate with any federal, state or local governmental agency or commission, including to provide documents or other information, without notice to the Company. I also understand that nothing in this Agreement limits my ability to share compensation information concerning myself or others, except that this does not permit me to disclose compensation information concerning others that I obtain because my job responsibilities require or allow access to such information.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">23.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Defend Trade Secrets Act of 2016</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I understand that pursuant to the federal Defend Trade Secrets Act of 2016, I shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;margin-right:7.602%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225768693032178%;">24.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Agreements; Amendment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Agreement supplements and does not supersede any other confidentiality, assignment of inventions or restrictive covenant agreement between the Company and me. To the extent that this Agreement addresses other subject matters, this Agreement supersedes any other agreements between the Company and me with respect to such subject matters. This Agreement may be amended only in a written agreement executed by a duly authorized officer of the Company and me.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:23.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:23.333%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Remainder of Page Intentionally Left Blank]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:1.107%;text-indent:6.804%;font-size:10.0pt;margin-top:3.55pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.907%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. I ACKNOWLEDGE AND AGREE THAT THE TERMS OF THIS AGREEMENT WILL APPLY TO MY ENTIRE SERVICE RELATIONSHIP WITH THE COMPANY, INCLUDING WITHOUT LIMITATION ANY PERIOD OF SERVICE PRIOR TO THE DATE OF MY SIGNATURE BELOW.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:6.823%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.38%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned has executed this Agreement as a sealed instrument and it shall become effective upon the later of the full execution by both parties.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AMYLYX PHARMACEUTICALS, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.461%;"></td>
    <td style="width:5.038%;"></td>
    <td style="width:3.041%;"></td>
    <td style="width:46.46%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: January 18, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:44.267%;text-indent:0.0%;font-size:10.0pt;margin-top:7.9pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXECUTIVE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.462%;"></td>
    <td style="width:5.038%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.462%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: January 23, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s Gina Mazzariello</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:6.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:14.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:0.0%;font-size:10.0pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.827%;text-indent:0.0%;font-size:10.0pt;margin-top:1.85pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:26.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.173%;text-indent:0.0%;font-size:10.0pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SCHEDULE 1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To:	COMPANY</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:0.0%;font-size:10.0pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:0.0%;font-size:10.0pt;margin-top:4.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUBJECT:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior Inventions</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.107%;text-indent:6.756%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.407%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.45pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;display:flex;margin-top:0.05pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225612069058946%;">&#x25a1;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No inventions or improvements</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225612069058946%;">&#x25a1;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See below:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;display:flex;margin-top:4.95pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225612069058946%;">&#x25a1;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional sheets attached</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:7.76%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following is a list of all patents and patent applications in which I have been named as an inventor:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225612069058946%;">&#x25a1;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:7.731%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:7.225612069058946%;">&#x25a1;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See below:</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.25pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:28.32%;text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:28.509%;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.187%;text-indent:0.0%;font-size:10.0pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ACTIVE/114318524.1</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>3
<FILENAME>amlx-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 21.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUBSIDIARIES</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals, Inc. had international subsidiaries shown below as of March 13, 2023. Amylyx Pharmaceuticals, Inc. is not a subsidiary of any other entity.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:61.324%;"></td>
    <td style="width:2.0%;"></td>
    <td style="width:36.676%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:1pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiary</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:1pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:1pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction of Incorporation</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals Canada Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Canada</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals EMEA B.V.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Netherlands</font></p></td>
   </tr>
   <tr style="height:5.75pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals Distribution Ltd.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ireland</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals Germany GmbH</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Germany</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals France SAS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">France</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>amlx-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consent to the incorporation by reference in Registration Statement No. 333-262125 on Form S-8 of our report dated March 13, 2023, relating to the financial statements of Amylyx Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Boston, Massachusetts</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 13, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>5
<FILENAME>amlx-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Joshua B. Cohen, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Amylyx Pharmaceuticals, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(5)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.466%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.036%;"></td>
    <td style="width:46.458%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Joshua B. Cohen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joshua B. Cohen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>6
<FILENAME>amlx-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Justin B. Klee, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Amylyx Pharmaceuticals, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(5)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>7
<FILENAME>amlx-ex31_3.htm
<DESCRIPTION>EX-31.3
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, James M. Frates, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of Amylyx Pharmaceuticals, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(5)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.466%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.036%;"></td>
    <td style="width:46.458%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">James M. Frates</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">James M. Frates</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>amlx-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Annual Report of Amylyx Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.466%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.036%;"></td>
    <td style="width:46.458%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joshua B. Cohen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joshua B. Cohen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>9
<FILENAME>amlx-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Annual Report of Amylyx Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.466%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.036%;"></td>
    <td style="width:46.458%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Justin B. Klee</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Co-Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>10
<FILENAME>amlx-ex32_3.htm
<DESCRIPTION>EX-32.3
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Annual Report of Amylyx Pharmaceuticals, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.463%;"></td>
    <td style="width:5.037%;"></td>
    <td style="width:3.037%;"></td>
    <td style="width:46.463%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 13, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">James M. Frates</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">James M. Frates</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img109617586_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R"/P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %%%% !1110 4444 %%%% #68*"2>!S38Y$E7<AR.E$_P#J)?\
M</\ *J^G_P#'NW^\?Y"G;2Y#E[R1<HHHI%A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!'',DN=C9QUJ2J&F])/P_K5^G)6=B*<G*
M-V%%%%(L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@".?_42_P"X?Y57T_\ X]V_WC_(58G_ -1+_N'^55]/_P"/=O\ >/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+W_/_P".[OPS0U?3T!.VK\STJT^(WA"^U4:;;Z[;O=,VU1A@K'. %<C:2<]
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MYU?JA=?\?\/_  '^=7ZJ6R,J?Q2"BBBI-0HHHH **** "BBB@ HHHH ****
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M=+G$5]#'*468K)EL*&PP(X^;%>E^.-'\'7EE9'Q.\%K%"VRVD,GE$<?=!';
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"8[BVE*D RJ#AE/ID<4TFW8&TE?L=O1573V9]-M78EF:%"2>23@5:J2B.?\
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M =WJ!W]A7I"?#V\L=3OGT?Q1=Z=I>H3-/=64=NCL7;[VR1N4S[#\:H+\)_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCX=:!J>A?\)!_:5MY'VO5)+B']XK;T/0_*3CZ'FI7PLIKWD=O1114EA1110
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MBBI+"BBB@ JA=?\ '_#_ ,!_G5^J%U_Q_P /_ ?YU4=S*K\)?HHHJ34****
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MB-0ARH P<YXI]1PQ+!!'"F=L:A1GT Q4E9F@4444 %%%% $<_P#J)?\ </\
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MV3-)H6HJRCI_K%W$G.??N>/3IM3\ QWMAI(@UF_@U720WV74I&$LF2.=X/#
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MP,]3DG)JC;^$/'/P_P!5O6\&Q6FI:7=ON%M<N 8^N,Y9>1TR#SQD4U)7>O\
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M 4444 17-O%=VLUM.@>&9#&ZGNI&"/RKS[3?"WC;PG9-I/AS5-'N-+#LT/\
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M01U'I6O13N[W%96L0VT"VEK#;QEBD2!%+=< 8&:FHHI#"BBB@ HHHH ****
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MH=PPQ[_=SGW-2XV5QJ=V>@T445)84444 %%%% !1110 4444 %%%% !1110
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MFDT)Q3:96LK&TTZV%M8VL%K O(B@C"*/P Q46H:1IFK(J:EIUI>*ARHN(%D
M/MN!J]14E6(;:U@LK=+>U@C@AC 5(XD"JH] !P*J3Z'I-W?+?7.EV4UX@ 6X
MDMT:08Z88C-:-% 6*%MH^F65W/=VNG6D%S<$F::*!5>0DY.Y@,G)YYHT[1],
MTA9!INFVED),%Q;0+'NQTSM S5^B@5BA::-I=A=375GIMG;W,^3++# J/)DY
M.X@9///-)-HFE7%^E_/IEE+>H $N'MU:1?HQ&16A10%D4;/2=-TZ>>>RT^TM
MI;@[II((51I#R<L0.>2>OJ:O444#"BBB@ HHHH **** "BBB@ HHHH ****
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MKZ?_ ,>[?[Q_D*L3_P"HE_W#_*J^G_\ 'NW^\?Y"J^R9/^(BY1114FH4444
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M_P"$>TZ.[-O]HWRB/;OV]03G.#_=KF/^%GI_T"6_\"/_ +&K_P 2O^1=M_\
MK[7_ - >O+:[\/1A.%Y(^?S''5Z-?DIRLK+HCT/_ (6>O_0);_P(_P#L:/\
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M:Y7^P?\ IY_\<_\ KT?V#_T\_P#CG_UZ/8T.WYA]=Q_?\CJO^%GK_P! EO\
MP(_^QH_X6>O_ $"6_P# C_[&N5_L'_IY_P#'/_KT?V#_ -//_CG_ ->CV-#M
M^8?7<?W_ ".J_P"%GK_T"6_\"/\ [&C_ (6>O_0);_P(_P#L:Y7^P?\ IY_\
M<_\ KT?V#_T\_P#CG_UZ/8T.WYA]=Q_?\CJO^%GK_P! EO\ P(_^QH_X6>O_
M $"6_P# C_[&N5_L'_IY_P#'/_KT?V#_ -//_CG_ ->CV-#M^8?7<?W_ ".J
M_P"%GK_T"6_\"/\ [&C_ (6>O_0);_P(_P#L:Y7^P?\ IY_\<_\ KT?V#_T\
M_P#CG_UZ/8T.WYA]=Q_?\CJO^%GK_P! EO\ P(_^QH_X6>O_ $"6_P# C_[&
MN5_L'_IY_P#'/_KT?V#_ -//_CG_ ->CV-#M^8?7<?W_ ".J_P"%GK_T"6_\
M"/\ [&C_ (6>O_0);_P(_P#L:Y7^P?\ IY_\<_\ KT?V#_T\_P#CG_UZ/8T.
MWYA]=Q_?\CJO^%GK_P! EO\ P(_^QH_X6>O_ $"6_P# C_[&N5_L'_IY_P#'
M/_KT?V#_ -//_CG_ ->CV-#M^8?7<?W_ ".J_P"%GK_T"6_\"/\ [&C_ (6>
MO_0);_P(_P#L:Y7^P?\ IY_\<_\ KT?V#_T\_P#CG_UZ/8T.WYA]=Q_?\CJO
M^%GK_P! EO\ P(_^QH_X6>O_ $"6_P# C_[&N5_L'_IY_P#'/_KT?V#_ -//
M_CG_ ->CV-#M^8?7<?W_ ".J_P"%GK_T"6_\"/\ [&C_ (6>O_0);_P(_P#L
M:Y7^P?\ IY_\<_\ KT?V#_T\_P#CG_UZ/8T.WYA]=Q_?\CJO^%GK_P! EO\
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M ,J7_P!JKZ HH ^?_P#AIK_J4?\ RI?_ &JC_AIK_J4?_*E_]JKZ HH ^?\
M_AIK_J4?_*E_]JH_X::_ZE'_ ,J7_P!JKZ HH ^?_P#AIK_J4?\ RI?_ &JC
M_AIK_J4?_*E_]JKZ HH ^?\ _AIK_J4?_*E_]JH_X::_ZE'_ ,J7_P!JKZ H
MH ^?G_:6WHR_\(EC((S_ &E_]JJ.W_:2\B,K_P (GNR<_P#(1Q_[2KZ!G_U$
MO^X?Y57T_P#X]V_WC_(4^A#:YT>%_P##37_4H_\ E2_^U4?\--?]2C_Y4O\
M[57T!12+/G__ (::_P"I1_\ *E_]JH_X::_ZE'_RI?\ VJOH"B@#Y_\ ^&FO
M^I1_\J7_ -JH_P"&FO\ J4?_ "I?_:J^@** /G__ (::_P"I1_\ *E_]JH_X
M::_ZE'_RI?\ VJOH"B@#Y_\ ^&FO^I1_\J7_ -JH_P"&FO\ J4?_ "I?_:J^
M@** /G__ (::_P"I1_\ *E_]JH_X::_ZE'_RI?\ VJOH"B@#Y_\ ^&FO^I1_
M\J7_ -JH_P"&FO\ J4?_ "I?_:J^@** /G__ (::_P"I1_\ *E_]JH_X::_Z
ME'_RI?\ VJOH"B@#Y_\ ^&FO^I1_\J7_ -JH_P"&FO\ J4?_ "I?_:J^@**
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M_*@3V/GZW_:2\B,K_P (GNR<_P#(1Q_[2J7_ (::_P"I1_\ *E_]JKW33_\
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M7_VJC_AIK_J4?_*E_P#:J^@** /G_P#X::_ZE'_RI?\ VJC_ (::_P"I1_\
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M ,J7_P!JKZ HH ^?_P#AIK_J4?\ RI?_ &JC_AIK_J4?_*E_]JKZ HH ^?\
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M)I?^%I^"O^@]#_WZD_\ B:.678.9=SL**X[_ (6GX*_Z#T7_ 'ZD_P#B:/\
MA:?@K_H/1?\ ?J3_ .)HY9=@YH]SL:*Y&+XG^#)I BZ_;@_[:NH_,C%6?^%@
M^$/^ABT__OZ*7*^P<R[G2T5S7_"P?"'_ $,6G_\ ?T4?\+!\(?\ 0Q:?_P!_
M11ROL',NYT,_^HE_W#_*J^G_ /'NW^\?Y"N>N/B-X/6-T_X2"S)*G&UB>WL*
M@LOB/X/CA(?7K4'=GG=Z?2JY7R[&;:]HCM**Y/\ X67X-_Z&"T_\>_PH_P"%
ME^#?^A@M/_'O\*7++L:<R[G645R?_"R_!O\ T'[7_P >_P */^%E^#?^@_:_
MDW^%'++L',NYUE%<G_PLOP;_ -!^U_)O\*/^%E^#?^@_:_DW^%'++L',NYUE
M%<G_ ,+,\&_]!^U_)O\ "C_A9G@S_H/VOY-_A2Y9=@YEW.LHKD_^%F^#/^@_
M;?DW^%'_  LWP9_T'[;\F_PI\LNP<R[G645R?_"S?!G_ $'[;\F_PH_X6;X,
M_P"@_;?DW^%'++L',NYUE%<G_P +-\&?]!^V_)O\*3_A9O@S_H/VW_?+?X4<
MLNP<R[G6T5R7_"SO!G_0?MO^^6_PH_X6=X,_Z#]M_P!\O_A1RR[!S+N=;17)
M?\+.\&?]!^V_[Y?_  JQ8>/O"NJ7L=G9ZU;2W$APB9*[CZ#('-+E?8?,NYTM
M%%%(84444 4--Z2?A_6K]4--Z2?A_6K]5/<RH_ @HHHJ34**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** .-^)7_(NV_P#U]K_Z ]>6UZE\2O\ D7;?_K[7_P! >O+:
M]3"?PSY3-_\ >7Z(****Z#S HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYZ9'49J6N5T?_D?_ !#_ +D/_H(KJJ E&S"BBB@D**** .9U7_D)S?\  ?\
MT$52\7_\D['_ %])_(U=U7_D)S?\!_\ 015+Q?\ \D['_7TG\C6E3X$88+_>
M7\SRJBBBLCW@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO23\/ZU?KFGN:T?@04445)J%%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW<RW$[EY9&+,WO45=44TDF>34DI3<HJR;"BBBF0%%%% !1110 4444 %%%%
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MW_5'_</\Q55G:G<RP"OB[>IX7_PK'QI_T+]S_P!])_\ %4?\*Q\:?]"_<_\
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M !5?5U%'MY![&)\G2_#;QC$F]M NL#TVM_(U$GP_\6R#*:!?$?\ 7.OK*?\
MU$O^X?Y57T__ (]V_P!X_P A3]L[7(=-<RB?*_\ PKOQA_T+U]_W[H_X5WXP
M_P"A>OO^_=?6E%+V[[%^Q7<^2_\ A7?C#_H7K[_OW1_PKOQA_P!"]??]^Z^M
M**/;OL'L5W/DO_A7?C#_ *%Z^_[]T?\ "N_&'_0O7W_?NOK2BCV[[![%=SY+
M_P"%=^,/^A>OO^_='_"N_&'_ $+U]_W[KZTHH]N^P>Q7<^2_^%=^,/\ H7K[
M_OW1_P *[\8?]"]??]^Z^M**/;OL'L5W/DO_ (5WXP_Z%Z^_[]T?\*[\8?\
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M<^6O^%=^,/\ H7K[_OW1_P *[\8?]"]??]^Z^M**7MWV+]BNY\E_\*[\8?\
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M^WXAR4?Y_P /^"8%%;__  EM_P#\\K;_ +Y;_P"*H_X2V_\ ^>5M_P!\M_\
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M117F'U04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%% !1110 4444 %%%% !1110 4444 %%%% !5"Z_P"/^'_@/\ZOU0NO^/\
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M8W['J>MZ_9Z7J2F&6&,1LVWGRP,YSW^OO4T+>&+O4!IJ6$\:.WEI>B<EBV<
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MD>Z?\- VG_0O3?\ @4/_ (FD_P"&@;7_ *%Z;_P*'_Q->&44>QAV#VLCW/\
MX:!M?^A=F_\  H?_ !-'_#0-K_T+LW_@4/\ XFO#**/8P[![61[G_P - VO_
M $+LW_@4/_B:/^&@;7_H79O_  *'_P 37AE%'L8=@]K(]S_X:!M?^A=F_P#
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MG_#0&G_] *Z_[_K_ (5X111[& >UD>[_ /"_]/\ ^@#=?]_U_P */^&@-/\
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MH;UO8+:6/._LWQ?_ .ADTW_OU'_\9KO]*N]6BT&WBU.6*;4UBQ+,F K/Z@
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M ![M_O'^0JQ/_J)?]P_RJOI__'NW^\?Y"J^R9/\ B(N4445)J%%%% !1110
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M7(WGB&^M?!FFWB,DE_>&.(2.HP&;))('':NCTV"\MK18[Z]%Y/DDR^4(^/3
MXXH&X-*[+=%%%!(4444 %%5-3U"+2M,N+Z8,8X5W$+U/8#\37.'6_$J::-8>
MPT\V/E^<8!(_G"/&<YZ=.>E!48.6IUU%5M/OHM2T^"]@SY<R!AD<CV/TJS03
ML%%%% !16'HNLW.HZUK-G,D2QV,JI&4!R0=W7)_V>U;E VFG9A1110(****
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M_1114FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!(;E-VX2D@#'7H#71S1:7I_B"+3AH]U?7:NF;B6X<$GCY@!U%6;4@?$Z[4D
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ML:%=V0QOD3*9/\0.1^HIDN:YTRAXRLA/X0NHT&/(19$]MI'],U@%!XLDU6Z
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M1 L_^O\ 7_T!ZTG\",,%_O+^9YC11161[P4444 %%%% !1110 4444 %%%%
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M35F<[X)G2Z\,V\HTE=+EY26!8/*&X'D@8Z$\_G71445+U92"BBB@!"0H))
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MOI__ ![M_O'^0JOLF3_B(N4445)J%%%% !1110 4444 %%%% !1110 4444
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M,J?Q2"BBBI-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ.?_ %$O^X?Y5)4<_P#J)?\ </\ *A;BELROI_\ Q[M_O'^0JY5/3_\ CW;_
M 'C_ "%7*<MV32^!!1112+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "J%U_Q_P /_ ?YU?JA=?\ '_#_ ,!_G51W,JOPE^BBBI-0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CG_ -1+_N'^
M55]/_P"/=O\ >/\ (58G_P!1+_N'^55]/_X]V_WC_(57V3)_Q$7****DU"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AIO23\/ZU
M?JAIO23\/ZU?JI[F5'X$%%%%2:A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!QOQ*
M_P"1=M_^OM?_ $!Z\MKU+XE?\B[;_P#7VO\ Z ]>6UZF$_AGRF;_ .\OT044
M45T'F&O>:K!<>&M.TU4D$UL[L[$#:<L2,<Y[^E2P:S;3Z ^EZFDS^6=UK-&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<SJO_(3F_P" _P#H(KOOA[_JC_N'^8K@=5_Y"<W_  '_ -!%2:GXGU/PGX2M
M[_2I(TGDN1"Q>,,-I5B>#[J*JLKT[(RP#MB[^I[I17S-_P +I\9?\_5K_P"
MRT?\+I\9?\_5K_X#+7#["1]-[:)],T5\S'XT>,S_ ,OEL/\ MV6D_P"%T>,_
M^?RV_P# 9?\ "CV$@]M$^FJ*^9?^%T>,_P#G\MO_  &3_"C_ (71XT_Y_;;_
M ,!D_P */82#VT3Z:HKYE_X71XT_Y_;;_P !D_PH_P"%T>-/^?RV_P# 9/\
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M^?VV_P# 9/\ "C_A='C3_G]MO_ 9/\*/82#VT3Z:HKYE_P"%T>-/^?RV_P#
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MU_Z",/\ X"Q_X4?\+D\;?]!&'_P%C_PI>PD7[:)].T5\Q?\ "Y/&W_01A_\
M 6/_  H_X7)XU_Z"4/\ X"Q__$T>PD'MHGT[17S%_P +D\;?]!*'_P !8_\
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M_E5?3_\ CW;_ 'C_ "%5]DR?\1%RBBBI-0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH H:;TD_#^M7ZH:;TD_#^M7ZJ>YE1^!!111
M4FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <;\2O^1=M_\ K[7_ - >O+:]2^)7
M_(NV_P#U]K_Z ]>6UZF$_AGRF;_[R_1!11170>8%%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH V=!_P"7
MC_@/]:V:QM!_Y>/^ _UK9K"I\1Z6'_AH*P?&&I'3?#=RR$B:;]Q%CKEN./PR
M:WJ*@WB[.[.)B\':L/#XTS^W56V9/FM_L2$9SNQNSGKWK(_M!KW0?#T4I/VB
MTU)+>0'J-O3],5Z;12-%6?4\]\1Z]8:EXA72KZZ-OI=H^ZX^1B9Y!_#P,X'^
M/M5C7=3L-5?P]+ILHD@CU)(N$*@$;3C! [$5W5%,/:)6LMCDM?\ ^1Y\._\
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M,JOPE^BBBI-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH CG_ -1+_N'^55]/_P"/=O\ >/\ (58G_P!1+_N'^55]/_X]V_WC_(57
MV3)_Q$7****DU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"AIO23\/ZU?JAIO23\/ZU?JI[F5'X$%%%%2:A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!QOQ*_P"1=M_^OM?_ $!Z\MKU+XE?\B[;_P#7VO\ Z ]>6UZF
M$_AGRF;_ .\OT04445T'F!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ;.@_\O'_  '^M;-8V@_\O'_ ?ZULUA4^(]+#
M_P -!1114&P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <SJO_(3F_P" _P#H(K+\;_\
M(@6?_7^O_H#UJ:K_ ,A.;_@/_H(K+\;_ /(@6?\ U_K_ .@/6D_@1A@O]Y?S
M/,:***R/>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "K.GZ==ZK?1V5C;O/<2G"QH
M,DUI^%_">J^+=1%IIL)*C'FS-]R,>I/]*^EO!W@;2O!MCY=HGFW;C]]=./G?
MV'H/85G4J*/J:0IN1S7@#X36?AT1ZCK 2[U/JJ=8X3[>I]Z]-HHKCE)R=V=4
M8J*L@HHHI#"BBB@ HHHH **** "J%U_Q_P /_ ?YU?JA=?\ '_#_ ,!_G51W
M,JOPE^BBBI-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[M]_X$?_ %J]'HH]I+N')'L><?\ "D?"']V^_P# C_ZU'_"D?"']V^_\"/\
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M *U'_"D?"']V^_\  C_ZU>CT4>TEW#DCV/./^%(^$/[M]_X$?_6J4?!?P8
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M,_Y\[G_P)?\ QH_X4QX,_P"?.Y_\"7_QKT&BCGEW#DCV//O^%,>#/^?.Y_\
M E_\:/\ A3'@S_GSN?\ P)?_ !KT&BCGEW#DCV,[1M$T[P_IR6.F6J6]NG9>
MI/J3U)]S6C114E!1110 4444 %%%% !1110 4444 %4+K_C_ (?^ _SJ_5"Z
M_P"/^'_@/\ZJ.YE5^$OT445)J%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% $<_P#J)?\ </\ *J^G_P#'NW^\?Y"K$_\ J)?]P_RJ
MOI__ ![M_O'^0JOLF3_B(N4445)J%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% %#3>DGX?UJ_5#3>DGX?UJ_53W,J/P(****DU"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWY5]!T4?7?[H?V'_ -//P_X)\^;'_NM^5&Q_[K?E7T'11]=_NA_8?_3S\/\
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M_P"&FO\ J4?_ "I?_:J^@** /G__ (::_P"I1_\ *E_]JH_X::_ZE'_RI?\
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M5+_[57T!10!\_P#_  TU_P!2C_Y4O_M5'_#37_4H_P#E2_\ M5?0%% 'S_\
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M 'S_ /\ #37_ %*/_E2_^U4?\--?]2C_ .5+_P"U5] 44 ?/_P#PTU_U*/\
MY4O_ +51_P --?\ 4H_^5+_[57T!10!\_P#_  TU_P!2C_Y4O_M5'_#37_4H
M_P#E2_\ M5?0%% 'S_\ \--?]2C_ .5+_P"U4?\ #37_ %*/_E2_^U5] 44
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M5+_[57T!10!\_P#_  TU_P!2C_Y4O_M5'_#37_4H_P#E2_\ M5?0%% 'S_\
M\--?]2C_ .5+_P"U4?\ #37_ %*/_E2_^U5] 44 ?/\ _P --?\ 4H_^5+_[
M51_PTU_U*/\ Y4O_ +57T!10!\__ /#37_4H_P#E2_\ M5'_  TU_P!2C_Y4
MO_M5?0%% 'S_ /\ #37_ %*/_E2_^U5!)^TAYEPDO_"*8VXX_M'WS_SRKZ'H
MIIV$XI[GS_\ \--?]2C_ .5+_P"U4?\ #37_ %*/_E2_^U5] 44AGS__ ,--
M?]2C_P"5+_[51_PTU_U*/_E2_P#M5?0%% 'S_P#\--?]2C_Y4O\ [51_PTU_
MU*/_ )4O_M5?0%% 'S__ ,--?]2C_P"5+_[51_PTU_U*/_E2_P#M5?0%% 'S
M_P#\--?]2C_Y4O\ [51_PTU_U*/_ )4O_M5?0%% 'S__ ,--?]2C_P"5+_[5
M1_PTU_U*/_E2_P#M5?0%% 'S_P#\--?]2C_Y4O\ [51_PTU_U*/_ )4O_M5?
M0%% 'S__ ,--?]2C_P"5+_[51_PTU_U*/_E2_P#M5?0%% 'S_P#\--?]2C_Y
M4O\ [51_PTU_U*/_ )4O_M5?0%% 'S__ ,--?]2C_P"5+_[51_PTU_U*/_E2
M_P#M5?0%% 'S_P#\--?]2C_Y4O\ [51_PTU_U*/_ )4O_M5?0%% 'S\_[2V]
M&7_A$L9!&?[2_P#M51V_[27D1E?^$3W9.?\ D(X_]I5]"T47%97N?/\ _P -
M-?\ 4H_^5+_[51_PTU_U*/\ Y4O_ +57T!10,^?_ /AIK_J4?_*E_P#:J/\
MAIK_ *E'_P J7_VJOH"B@#Y__P"&FO\ J4?_ "I?_:J/^&FO^I1_\J7_ -JK
MZ HH ^?_ /AIK_J4?_*E_P#:J/\ AIK_ *E'_P J7_VJOH"B@#Y__P"&FO\
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MK_J4?_*E_P#:J^@** /G_P#X::_ZE'_RI?\ VJC_ (::_P"I1_\ *E_]JKZ
MHH ^?_\ AIK_ *E'_P J7_VJC_AIK_J4?_*E_P#:J^@** /G_P#X::_ZE'_R
MI?\ VJC_ (::_P"I1_\ *E_]JKZ HH ^?_\ AIK_ *E'_P J7_VJC_AIK_J4
M?_*E_P#:J^@** /G_P#X::_ZE'_RI?\ VJC_ (::_P"I1_\ *E_]JKZ HH ^
M?_\ AIK_ *E'_P J7_VJC_AIK_J4?_*E_P#:J^@** /G_P#X::_ZE'_RI?\
MVJC_ (::_P"I1_\ *E_]JKZ HH ^?_\ AIK_ *E'_P J7_VJC_AIK_J4?_*E
M_P#:J^@** /G_P#X::_ZE'_RI?\ VJC_ (::_P"I1_\ *E_]JKZ HH ^?_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 4=2U2RTFW6XOIO)B9P@;:3S@G' ]C6=_PFOA[_H)+_WZ?_XF
MLSXE?\B[;_\ 7VO_ * ]>6UV4,/&I#F;/$QV95</6]G%*W]>9[+_ ,)KX>_Z
M"2_]^G_^)H_X37P]_P!!)?\ OT__ ,37C5%:_4X=V<?]M5_Y5^/^9[+_ ,)K
MX>_Z"2_]^G_^)H_X37P]_P!!)?\ OT__ ,37C5%'U.'=A_;5?^5?C_F>R_\
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M11]3AW8?VU7_ )5^/^9[+_PFOA[_ *"2_P#?I_\ XFC_ (37P]_T$E_[]/\
M_$UXU11]3AW8?VU7_E7X_P"9[+_PFOA[_H)+_P!^G_\ B:/^$U\/?]!)?^_3
M_P#Q->-44?4X=V']M5_Y5^/^9[+_ ,)KX>_Z"2_]^G_^)H_X37P]_P!!)?\
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M .)H_P"$U\/?]!)?^_3_ /Q->-44?4X=V']M5_Y5^/\ F>R_\)KX>_Z"2_\
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M.Z_YZ1?F?\*/[#NO^>D7YG_"CZK2[A_:F+_D7X_YGJ7_  FOA[_H)+_WZ?\
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M=OP\_P"AA_\ )*X_^-T?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/_CE
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M ..4 '_"[?AY_P!##_Y)7'_QNC_A=OP\_P"AA_\ )*X_^-T?\*2^'G_0O?\
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M .-T?\*2^'G_ $+W_D[<?_'*/^%)?#S_ *%[_P G;C_XY0 ?\+M^'G_0P_\
MDE<?_&Z/^%V_#S_H8?\ R2N/_C='_"DOAY_T+W_D[<?_ !RC_A27P\_Z%[_R
M=N/_ (Y0 ?\ "[?AY_T,/_DE<?\ QNC_ (7;\//^AA_\DKC_ .-T?\*2^'G_
M $+W_D[<?_'*/^%)?#S_ *%[_P G;C_XY0 ?\+M^'G_0P_\ DE<?_&Z/^%V_
M#S_H8?\ R2N/_C='_"DOAY_T+W_D[<?_ !RC_A27P\_Z%[_R=N/_ (Y0 ?\
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M#S_H8?\ R2N/_C='_"DOAY_T+W_D[<?_ !RC_A27P\_Z%[_R=N/_ (Y0 ?\
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M .-T?\*2^'G_ $+W_D[<?_'*/^%)?#S_ *%[_P G;C_XY0 ?\+M^'G_0P_\
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M_A=OP\_Z&'_R2N/_ (W1_P +M^'G_0P_^25Q_P#&Z/\ A27P\_Z%[_R=N/\
MXY1_PI+X>?\ 0O?^3MQ_\<H /^%V_#S_ *&'_P DKC_XW1_PNWX>?]##_P"2
M5Q_\;H_X4E\//^A>_P#)VX_^.4?\*2^'G_0O?^3MQ_\ '* #_A=OP\_Z&'_R
M2N/_ (W1_P +M^'G_0P_^25Q_P#&Z/\ A27P\_Z%[_R=N/\ XY1_PI+X>?\
M0O?^3MQ_\<H /^%V_#S_ *&'_P DKC_XW1_PNWX>?]##_P"25Q_\;H_X4E\/
M/^A>_P#)VX_^.4?\*2^'G_0O?^3MQ_\ '* #_A=OP\_Z&'_R2N/_ (W1_P +
MM^'G_0P_^25Q_P#&Z/\ A27P\_Z%[_R=N/\ XY1_PI+X>?\ 0O?^3MQ_\<H
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M;C_XY3:L[$QDI*Z#_A=OP\_Z&'_R2N/_ (W1_P +M^'G_0P_^25Q_P#&Z/\
MA27P\_Z%[_R=N/\ XY1_PI+X>?\ 0O?^3MQ_\<I%!_PNWX>?]##_ .25Q_\
M&Z/^%V_#S_H8?_)*X_\ C='_  I+X>?]"]_Y.W'_ ,<H_P"%)?#S_H7O_)VX
M_P#CE !_PNWX>?\ 0P_^25Q_\;H_X7;\//\ H8?_ "2N/_C='_"DOAY_T+W_
M ).W'_QRC_A27P\_Z%[_ ,G;C_XY0 ?\+M^'G_0P_P#DE<?_ !NC_A=OP\_Z
M&'_R2N/_ (W1_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY0 ?\+M
M^'G_ $,/_DE<?_&Z/^%V_#S_ *&'_P DKC_XW1_PI+X>?]"]_P"3MQ_\<H_X
M4E\//^A>_P#)VX_^.4 '_"[?AY_T,/\ Y)7'_P ;H_X7;\//^AA_\DKC_P"-
MT?\ "DOAY_T+W_D[<?\ QRC_ (4E\//^A>_\G;C_ ..4 '_"[?AY_P!##_Y)
M7'_QNC_A=OP\_P"AA_\ )*X_^-T?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\
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MKC_XW1_PI+X>?]"]_P"3MQ_\<H_X4E\//^A>_P#)VX_^.4 '_"[?AY_T,/\
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M/^A>_P#)VX_^.4 '_"[?AY_T,/\ Y)7'_P ;H_X7;\//^AA_\DKC_P"-T?\
M"DOAY_T+W_D[<?\ QRC_ (4E\//^A>_\G;C_ ..4 '_"[?AY_P!##_Y)7'_Q
MNC_A=OP\_P"AA_\ )*X_^-T?\*2^'G_0O?\ D[<?_'*/^%)?#S_H7O\ R=N/
M_CE !_PNWX>?]##_ .25Q_\ &Z/^%V_#S_H8?_)*X_\ C='_  I+X>?]"]_Y
M.W'_ ,<H_P"%)?#S_H7O_)VX_P#CE !_PNWX>?\ 0P_^25Q_\;H_X7;\//\
MH8?_ "2N/_C='_"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_ ,G;C_XY0 ?\+M^'
MG_0P_P#DE<?_ !NC_A=OP\_Z&'_R2N/_ (W1_P *2^'G_0O?^3MQ_P#'*/\
MA27P\_Z%[_R=N/\ XY0 ?\+M^'G_ $,/_DE<?_&Z/^%V_#S_ *&'_P DKC_X
MW1_PI+X>?]"]_P"3MQ_\<H_X4E\//^A>_P#)VX_^.4 '_"[?AY_T,/\ Y)7'
M_P ;KI_#GBG1O%NGR7^AWOVNVCE,+/Y3IAP Q&' /1A^=<Q_PI+X>?\ 0O?^
M3MQ_\<KI_#GA;1O"6GR6&AV7V2VDE,S)YKOER I.7)/11^5 &S1110 4444
M%%%% !1110 4444 <;\2O^1=M_\ K[7_ - >O+:]2^)7_(NV_P#U]K_Z ]>6
MUZF$_AGRF;_[R_1!11170>8%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!LZ#_R\?\!_K6S6-H/_ "\?\!_K6S6%3XCT
ML/\ PT%%%%0;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!S.J_\ (3F_X#_Z"*[[X>_Z
MH_[A_F*X'5?^0G-_P'_T$5WWP]_U1_W#_,4\1_",\O\ ]\^\[JBBBO,/J@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CG_U$O^X?
MY57T_P#X]V_WC_(58G_U$O\ N'^55]/_ ./=O]X_R%5]DR?\1%RBBBI-0HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H77_'_  _\
M!_G5^J%U_P ?\/\ P'^=7ZJ6R,J?Q2"BBBI-0HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J.?_42_[A_E4E1S_P"HE_W#_*A;BELROI__
M ![M_O'^0JY5/3_^/=O]X_R%7*<MV32^!!1112+"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "J%U_Q_P_\!_G5^J%U_Q_P_\  ?YU4=S*
MK\)?HHHJ34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** (Y_\ 42_[A_E5?3_^/=O]X_R%6)_]1+_N'^55]/\ ^/=O]X_R%5]DR?\
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M@#9T'_EX_P" _P!:V:QM!_Y>/^ _UK9K"I\1Z6'_ (:"BBBH-@HHHH ****
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M^0JY3ENR:7P(****184444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 50NO\ C_A_X#_.K]4+K_C_ (?^ _SJH[F57X2_1114FH4444 %%%%
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MD^Q)+)-M8CYLX55' X!/!-:-BEW??%BWUG^SKZWLYO#X7=<0%-CF;=Y;'H'
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M#5O$7B30K6;4KGQQH$U] H>70A%&!VRBMN\PG'(K<EN1>_%#PS=JNU9](FE
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MJ_5"Z_X_X?\ @/\ .K]5+9&5/XI!1114FH4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5'/_J)?]P_RJ2HY_\ 42_[A_E0MQ2V97T__CW;
M_>/\A5RJ>G_\>[?[Q_D*N4Y;LFE\""BBBD6%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %4+K_ (_X?^ _SJ_5"Z_X_P"'_@/\ZJ.YE5^$
MOT445)J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M459TZS?4-1M[1,YE<+]!W/X#FANRNQQBY-16[*U%=GXG-MJFER36: ?V7/\
M9B!WC( !^F1BL#3- O-7M9Y[4Q8A958.VT\]^F,#J<UG&HG'F>AT5<+*-3V<
M/>]#+HK7O_#EU8V'VY;BTNK8,%:2VEWA3[\5JW/ABVC\,QSK>Z=]I$C%IQ<G
M8ZX)VKV+>V*'5BK!'"57=6M97.3HK;U$7W_".:0)A;_9F,GD>6I\SKSN[?E4
MJ>#[\[8WN;&.Z==RVLD^)3^&/ZT_:12NQ?5JC=H)O1?B<_15VVTF]N]1-A%
MWVA20ZL<;,=23V JY>>&KNULY+J.XL[N*(XE-K-O,?U&*;G%.UR(T*DHN2CH
MC&HK;@\+WDUC;WIGM(;:92WFS2[ G. &R.I]LU4U71;K2)8DG,<BS+NBDB;<
MKCV-"G%NR8Y8>K&/,XZ?YF?170)X/OSMC>YL8[IUW+:R3XE/X8_K69;:3>W>
MHFPB@;[0I(=6.-F.I)[ 4*I%[,)8>K%I.+U*5%;-YX:N[6SDNH[BSNXHCB4V
MLV\Q_48K&IQDI;$5*<Z;M-6"BNOU2_D\*"#3-,6.*Y$2O<7!0,[,>W/:H+MT
M\0>&KC4I8HTU"RD42R1KM\U&.,D#OG^59JHW9VT9TRPJ3<%+WDKM6T\]?+T.
M;DMYH4C>6&2-)!N1F4@,/49ZU'75:MYGV7POY6WS/*79O'&=RXS[50U*QU+4
M_%5Q:M'"]Z[#<(<A!\HYY[8]:<:E]_,FIAG%VCKM^*N8E%=''X,OIIC%!>Z?
M,RY\SRI]WE_[PQD?E69I>BW>K&0P!$BB&9)I6VHGU--5(-7N0\-632<=69]%
M:NHZ!=Z=:I=^9;W-JQV^=;2;T!]":F@\+WDUC;WIGM(;:92WFS2[ G. &R.I
M]LT_:1M>XEAZKDX\NNYB45JWGA^\L;^UM)&A;[45$,J/N1LD#KC/>J\^F30:
MN=,=HS,)1%N!.W)./3.*%.+V9,J-2.Z\BE16DVAWHUIM)C59;E6VG8?EZ9SD
M]JM7'A:\AMIIHKFSNO(&94MIM[1COD8H]I'N4L/5=[1>ACM;S+;K.T,@A8[5
MD*':3Z ]*CKH[W_D0M-_Z^G_ *U!;^%KV:"&66XL[5IAF**YFV/(/88J545K
MR+EAI<R4%?1/[S#HJX^DWR:H=--NWVO=M\L=^_7IC'.:U)/"%^JR"*XLKB>,
M9>WAFW2+]1BJ=2*W9$</5E?EB]#GZ*ZC0/#UM?Z7>W%Q<6>_R6\L/,5:!@2-
MS@=!]<U6TV"]MK76X;66REB2';.Y)8,O/,9']:GVJU2Z%K"SM&4MI7_ P*D-
MO.MLMP89! S;1+M.TGTSTS6CIOA^[U*U>[$MO;6R';YUS)L0GT!Q6QK%C+I_
M@:S@E:-S]M+!XFW*P*M@@T2J)-104\+.4'.2LDKG)45N6_A:]F@AEEN+.U:8
M9BBN9MCR#V&*RKRSGL+N2UN8S'+&<,,U2G%NR9E.C4@N:2LB"BBBJ,PHHHH
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MW9-+X$%%%%(L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVU.%[I;&U\427=Q);96:*'C]XO&0R[L]./PKW&XT;2[N\CO;G3;.:[C^Y/)
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MDLX*VLB*L>[HTF3T^G'^13-=)_X1;PZN2%*2G&?=:RM1UK4=6VB]NGE5>57
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M;B]N!,2H_>#>1\WKQQS1RI+4+M[&MJ7Q"\)Z3%;R7>MVX6X021^4&E)4]#A
M2!]:V8]7TZ;2AJL=[;M8;#)]I\P; HZDGIQ7%?".PM(?"-T8[>-3+?3I(=OW
ME#8 /L!QBN'NOM$?@&TT^T6W6U?Q2\#)< ^1M#DJDF.=F[&<>E/D3=D+F=KG
MJVD>/?"^N:B;#3M8AFNLD",JR;SS]TL &Z'IFNEZ"O,=8\.>/]<BLHKP>$X5
ML[B.:&2V\]9(RI& I(( /3%>@:Q=6UCHM]=WBEK6&WDDF4#DH%)(_+-3)+H4
MF^I@R?$GP=#J7V!]>MA.&VDX8Q@^\@&T?G6QJ?B#2M'>U74+V.W%UN\IG!VG
M:NXDMC  '.217FE_)XIO_AU>SV&C^&].\.26$DR6SF1IQ%L+;EVC;OQR,]^M
M/>"&_P!.^%L5W&L\;!2RR#<&Q"",^O(%5R(GF9W6C>.?#7B#4'L-+U:*XNDS
M^[VLI;'7;N #=.V:;J_COPQH.HII^I:O#!=-C]WM9]N>FXJ"%Z]\5E>,X8T\
M8>"KA8U$POWB#@<A2AR/I4/PLA@FT+4[N54?4;C4;@7K-RV[=]TYYQC''O[T
MK*UQW>Q'\,)8Y[OQA-#(LD3Z[.R.AR&!.001U!KL=8UW2_#]D;S5;V*T@S@-
M(>6.,X4#DGV KCOA?%'!=>+X845(H]=G5$08"J#@ #TQ5[Q??LOB/1[#3='L
M[_7G266VFO&VQVJ@89N.3DXX'/%$E>0)VB;.@^+] \3^9_8^I17+1C+IAD<#
MUVL <>^*V)IHK>%YII$CBC!9W<X"CN23TKS"S3Q#'\7-&D\0)HZW,MC.JMI@
MD^9 .CE^3@]/QK:^*I)\)6\3MMM)M0MX[LYP/*+\Y/IG%#BKI(%)VN:6G?$+
MPIJVIC3K+6H)+HMM5"K*'/HK, &_ FIM6\;^&]#N;FWU+5([>:W"&1&1R</]
MW&!\W3MG'>HO%FD>'[GPLUMJTR:?I\!0QW$3+&;<AAM*,00I[=.]9.CV\+_&
M#7YWC5Y8K"V$<C*-RY!S@]LXH2B]0N]ADWBS1]#U7Q!J=SXFFFC*VZK926\A
MCMF:,LFW YW@9.,8[\U7TWQS8^+OA[?RRZS_ &9J$%KNO9[6"7_1"20"O<]/
MX23]*71_^2@?$7_KA:_^B6JA#_R;F?\ L'M_Z&:JR_(5W^9WDVLZ;H7A^WO=
M3U1%MEB0?:9N#*=O7'4L>N ,TS0?%^@^)_,&CZE%<M'RZ89' ]=K ''OBN1D
MBCN_B%X/M[Y4>VCTAIK9).AG &2!T)"X-=%K=EH,7BC2]5O;MK;4X8IQ#'$P
M4W,83+JPQE@HY&",5%D5=C;SXC^$+#4CI]SKENMR&VL%5F53G&"X!4'/J:RO
MB1(DT7A"6)U>-]?M&5U.58'<001U!K'LI/$NJ^$)9= T+PSIOAV>&1DMKPR-
M(Z'.6(3Y<D=C6>S%OAQ\-RQ)/]LVH'X,X%6HI,AR;1[/11161J%%%% !1110
M 4444 %%%% !1110 4444 <;\2O^1=M_^OM?_0'KRVO4OB5_R+MO_P!?:_\
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MVO\ Z ]>6UZF$_AGRF;_ .\OT04445T'F!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %='I(\GP=KDZX\QC%%GVW<_SKG*Z'PTPN[35-')&^[A#
M0@G@NG('^?2LZOP_=^9TX3^);JTTO5IV(?">G?VCX@@4KF.']\_T7I^9P*Z6
MVT?6KR368M1M#'#?*70F1&V2 Y3@'\/PKEK+4H;#0]1M DHO;HJA8J-JH.HZ
MYR>1TJA8W;V%_!=Q_>A</UZX/2HG"4FVC>C7I4HQC)-WNW9]]+/373\R[HVH
MW6CW-Q(MJ9X2IBN8F4X*GL3V_P#UUI6]AHNL3A=(N;BPOCDQPSG*DXZ*PY'X
MTS_A(;.#6K^6&U>73K\8F@DPK<]2,$]R3^-+:ZGX=TNX%[96FH2W2Y,:7#J$
M0X]N3CWI2YGJEK_6Y5-TTE"4DXI]>GFFN_Y]!X26/P)J"/GSEU#$V>O0=?QK
M*\.;O^$CT[9G/GKT],\_I4VFZ^;::]6]A%S:WQ)N(MVWG.=R^AJY!J^AZ0S7
M.DVEY)>8(C>[9=L6>,@#K^-.TDG&VY*E3G*$^:RCO??1]/7\RK?2"+QK-)"<
M;;[(^N_G]:3Q;&L?BF_51P75OQ*@G^=1:#;/J/B"WWL2JR>=,Y/15.YB3_GK
M4&M7HU'6;N[4?))(2OTZ#]*J*M-+LC.<KT')_:E=?<[_ )HHT445J<84444
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M3@Q,2 KMD=0.:4I7N.*M8Z.BBBH+"BBB@ HHHH **** "BBB@ HHHH ****
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H77_ !_P_P#
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M%%% !1110 4A&1@BEHH Y23X;^#I=2^WOH-L9R2Q&6\LGWCSM/Y5U*JJ*%4
M*!@ #@"G44VV]Q));!1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M\*P3_H+'_P !_P#[*C_A6"?]!8_^ _\ ]E1]9I=P_LO%_P OXK_,\\HKT/\
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MF_[<MO[DWY#_ !H_MRV_N3?D/\:Z3_A6"?\ 06/_ (#_ /V5'_"L$_Z"Q_\
M ?\ ^RH]M1[A]3QW\OXK_,YO^W+;^Y-^0_QH_MRV_N3?D/\ &ND_X5@G_06/
M_@/_ /94?\*P3_H+'_P'_P#LJ/;4>X?4\=_+^*_S.;_MRV_N3?D/\:/[<MO[
MDWY#_&ND_P"%8)_T%C_X#_\ V5'_  K!/^@L?_ ?_P"RH]M1[A]3QW\OXK_,
MYO\ MRV_N3?D/\:/[<MO[DWY#_&ND_X5@G_06/\ X#__ &5'_"L$_P"@L?\
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MIO\ ]MH ^@**^?\ _AF7_J;O_*;_ /;:/^&9?^IN_P#*;_\ ;: /H"BOG_\
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MT?\ #,O_ %-W_E-_^VT ?0%%?/\ _P ,R_\ 4W?^4W_[;1_PS+_U-W_E-_\
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M_P"&9?\ J;O_ "F__;: /H"BOG__ (9E_P"IN_\ *;_]MH_X9E_ZF[_RF_\
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MO_VVC_AF7_J;O_*;_P#;: /H"BOG_P#X9E_ZF[_RF_\ VVC_ (9E_P"IN_\
M*;_]MH ^@**^?_\ AF7_ *F[_P IO_VVC_AF7_J;O_*;_P#;: /H"BOG_P#X
M9E_ZF[_RF_\ VVC_ (9E_P"IN_\ *;_]MH ^@**^?_\ AF7_ *F[_P IO_VV
MC_AF7_J;O_*;_P#;: /H"BOG_P#X9E_ZF[_RF_\ VVC_ (9E_P"IN_\ *;_]
MMH ^@**^?_\ AF7_ *F[_P IO_VVC_AF7_J;O_*;_P#;: /H"BOG_P#X9E_Z
MF[_RF_\ VVC_ (9E_P"IN_\ *;_]MH ^@**^?_\ AF7_ *F[_P IO_VVC_AF
M7_J;O_*;_P#;: /H"BOG_P#X9E_ZF[_RF_\ VVC_ (9E_P"IN_\ *;_]MH ^
M@**^?_\ AF7_ *F[_P IO_VVC_AF7_J;O_*;_P#;: /H"BOG_P#X9E_ZF[_R
MF_\ VVC_ (9E_P"IN_\ *;_]MH ^@**^?_\ AF7_ *F[_P IO_VVC_AF7_J;
MO_*;_P#;: /H"BOG_P#X9E_ZF[_RF_\ VVC_ (9E_P"IN_\ *;_]MH ^@**^
M?_\ AF7_ *F[_P IO_VVO4/AQX&_X5_X>N-*_M'[?YUVUSYOD>5C*(NW&YO[
MF<Y[T =A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%<_XMUNXT#2HKJVCBD=YA&1*"1@JQ[$>E<=_P
MLK5O^?2R_P"^7_\ BJVA0G-71Q5\PHT)\DWJ>HT5Y=_PLK5O^?2R_P"^7_\
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M )]++_OE_P#XJCZK4#^U\-W?W'J-%>7?\+*U;_GTLO\ OE__ (JC_A96K?\
M/I9?]\O_ /%4?5:@?VOAN[^X]1HKR[_A96K?\^EE_P!\O_\ %4?\+*U;_GTL
MO^^7_P#BJ/JM0/[7PW=_<>HT5Y=_PLK5O^?2R_[Y?_XJC_A96K?\^EE_WR__
M ,51]5J!_:^&[O[CU&BO+O\ A96K?\^EE_WR_P#\51_PLK5O^?2R_P"^7_\
MBJ/JM0/[7PW=_<>HT5Y=_P +*U;_ )]++_OE_P#XJC_A96K?\^EE_P!\O_\
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M )]++_OE_P#XJCZK4#^U\-W?W'J-%>7?\+*U;_GTLO\ OE__ (JC_A96K?\
M/I9?]\O_ /%4?5:@?VOAN[^X]1HKR[_A96K?\^EE_P!\O_\ %4?\+*U;_GTL
MO^^7_P#BJ/JM0/[7PW=_<>HT5Y=_PLK5O^?2R_[Y?_XJC_A96K?\^EE_WR__
M ,51]5J!_:^&[O[CU&BO+O\ A96K?\^EE_WR_P#\51_PLK5O^?2R_P"^7_\
MBJ/JM0/[7PW=_<>HT5Y=_P +*U;_ )]++_OE_P#XJC_A96K?\^EE_P!\O_\
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MB_\ ]"'_ .4>[_\ BZQ.X^@**^?_ /A:?Q?_ .A#_P#*/=__ !='_"T_B_\
M]"'_ .4>[_\ BZ /H"BOG_\ X6G\7_\ H0__ "CW?_Q='_"T_B__ -"'_P"4
M>[_^+H ^@**^?_\ A:?Q?_Z$/_RCW?\ \71_PM/XO_\ 0A_^4>[_ /BZ /H"
MBOG_ /X6G\7_ /H0_P#RCW?_ ,71_P +3^+_ /T(?_E'N_\ XN@#Z HKY_\
M^%I_%_\ Z$/_ ,H]W_\ %T?\+3^+_P#T(?\ Y1[O_P"+H ^@**^?_P#A:?Q?
M_P"A#_\ */=__%T?\+3^+_\ T(?_ )1[O_XN@#Z HKY__P"%I_%__H0__*/=
M_P#Q='_"T_B__P!"'_Y1[O\ ^+H ^@**^?\ _A:?Q?\ ^A#_ /*/=_\ Q='_
M  M/XO\ _0A_^4>[_P#BZ /H"BOG_P#X6G\7_P#H0_\ RCW?_P 71_PM/XO_
M /0A_P#E'N__ (N@#Z HKY__ .%I_%__ *$/_P H]W_\71_PM/XO_P#0A_\
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MH]W_ /%T ?0%%?/_ /PM/XO_ /0A_P#E'N__ (NC_A:?Q?\ ^A#_ /*/=_\
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M?Q?_ .A#_P#*/=__ !='_"T_B_\ ]"'_ .4>[_\ BZ /H"BOG_\ X6G\7_\
MH0__ "CW?_Q='_"T_B__ -"'_P"4>[_^+H ^@**^?_\ A:?Q?_Z$/_RCW?\
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MH]W_ /%T ?0%%?/_ /PM/XO_ /0A_P#E'N__ (NC_A:?Q?\ ^A#_ /*/=_\
MQ= 'T!17S_\ \+3^+_\ T(?_ )1[O_XNC_A:?Q?_ .A#_P#*/=__ != 'T!1
M7S__ ,+3^+__ $(?_E'N_P#XND/Q6^+BL%/@903T!TF[_P#BZ /H&BOG_P#X
M6G\7_P#H0_\ RCW?_P 71_PM/XO_ /0A_P#E'N__ (N@#Z HKY__ .%I_%__
M *$/_P H]W_\71_PM/XO_P#0A_\ E'N__BZ /H"BOG__ (6G\7_^A#_\H]W_
M /%T?\+3^+__ $(?_E'N_P#XN@#Z HKY_P#^%I_%_P#Z$/\ \H]W_P#%T?\
M"T_B_P#]"'_Y1[O_ .+H ^@**^?_ /A:?Q?_ .A#_P#*/=__ !='_"T_B_\
M]"'_ .4>[_\ BZ /H"BOG_\ X6G\7_\ H0__ "CW?_Q='_"T_B__ -"'_P"4
M>[_^+H ^@**^?_\ A:?Q?_Z$/_RCW?\ \71_PM/XO_\ 0A_^4>[_ /BZ /H"
MBOG_ /X6G\7_ /H0_P#RCW?_ ,71_P +3^+_ /T(?_E'N_\ XN@#Z HKY_\
M^%I_%_\ Z$/_ ,H]W_\ %T?\+3^+_P#T(?\ Y1[O_P"+H ^@**^?_P#A:?Q?
M_P"A#_\ */=__%T?\+3^+_\ T(?_ )1[O_XN@#Z HKY__P"%I_%__H0__*/=
M_P#Q='_"T_B__P!"'_Y1[O\ ^+H ^@**^?S\5/B\!D^ P .YTB[_ /BZ1?BK
M\7&&5\"AAZC2+L_^ST ?0-%?/_\ PM/XO_\ 0A_^4>[_ /BZ/^%I_%__ *$/
M_P H]W_\70!] 45\_P#_  M/XO\ _0A_^4>[_P#BZ/\ A:?Q?_Z$/_RCW?\
M\70!] 45\_\ _"T_B_\ ]"'_ .4>[_\ BZ/^%I_%_P#Z$/\ \H]W_P#%T ?0
M%%?/_P#PM/XO_P#0A_\ E'N__BZ/^%I_%_\ Z$/_ ,H]W_\ %T ?0%%?/_\
MPM/XO_\ 0A_^4>[_ /BZ/^%I_%__ *$/_P H]W_\70!] 45\_P#_  M/XO\
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MCW?_ ,71_P +3^+_ /T(?_E'N_\ XN@#Z HKY_\ ^%I_%_\ Z$/_ ,H]W_\
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M\7_^A#_\H]W_ /%T?\+3^+__ $(?_E'N_P#XN@#Z HKY_P#^%I_%_P#Z$/\
M\H]W_P#%T?\ "T_B_P#]"'_Y1[O_ .+H ^@**^?_ /A:?Q?_ .A#_P#*/=__
M !='_"T_B_\ ]"'_ .4>[_\ BZ /H"BOG_\ X6G\7_\ H0__ "CW?_Q='_"T
M_B__ -"'_P"4>[_^+H ^@**^?_\ A:?Q?_Z$/_RCW?\ \71_PM/XO_\ 0A_^
M4>[_ /BZ /H"BOG_ /X6G\7_ /H0_P#RCW?_ ,71_P +3^+_ /T(?_E'N_\
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MWI)^']:OU0TWI)^']:OU4]S*C\""BBBI-0HHHH **** "BBB@ HHHH ****
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ML/\ PT%%%%0;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!S.J_\ (3F_X#_Z"*[[X>_Z
MH_[A_F*X'5?^0G-_P'_T$5WWP]_U1_W#_,4\1_",\O\ ]\^\[JBBBO,/J@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CG_U$O^X?
MY57T_P#X]V_WC_(58G_U$O\ N'^55]/_ ./=O]X_R%5]DR?\1%RBBBI-0HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H77_'_  _\
M!_G5^J%U_P ?\/\ P'^=7ZJ6R,J?Q2"BBBI-0HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J.?_42_[A_E4E1S_P"HE_W#_*A;BELROI__
M ![M_O'^0JY5/3_^/=O]X_R%7*<MV32^!!1112+"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "J%U_Q_P_\!_G5^J%U_Q_P_\  ?YU4=S*
MK\)?HHHJ34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** (Y_\ 42_[A_E5?3_^/=O]X_R%6)_]1+_N'^55]/\ ^/=O]X_R%5]DR?\
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MXQGU(KD]3LX[#4)+>&ZBN8UQMEB8$,/P/6O2]/BU41P_\3.QU+3,#S))8R'
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MT(H"%.[5]CT&BBB@S"BBB@ HHHH YG5?^0G-_P !_P#017??#W_5'_</\Q7
MZK_R$YO^ _\ H(J])XON?!?AF'4K6VBN'DG$!24D  J6SQW^6JK)NG9&6 =L
M7=^9[517@/\ PO[6/^@/8?\ ?;_XT?\ "_M9_P"@-8?]]O\ XUP>QF?3^UB>
M_45X#_POW6?^@/8?]]O_ (T?\+^UG_H#6'_?3_XT>QF'M8GOU%> _P#"_=:_
MZ ]A_P!]/_C2?\+]UK_H#V'_ 'T_^-'L9A[6)[_17@'_  OW6O\ H#V'_?3_
M .-'_"_=:_Z ]A_WT_\ C1[&8>UB>_T5X"/C[K.X;M'L".^'?_&O6?"'C72O
M&.GB>QDV7"C]];.?GC/]1[BIE3E%78XSC+1'2T445!84444 %%%% !1110 4
M444 %%%% $<_^HE_W#_*J^G_ /'NW^\?Y"K$_P#J)?\ </\ *J^G_P#'NW^\
M?Y"J^R9/^(BY1114FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN<WJ%%%%,S"BBB@ HHHH **** "BBB@ HHIWEOY8DV-L)V[L<9],T -HHHH
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M88T+.3@<!1SGVK5M7,DM# UR74[WXF:%)HSV\%Q<:0[>;<*76)"P).T$;CV
M]_:M+1;_ ,1Z/XVC\.ZYJL.K07=HUS!="V6!T92 5*KQCOG_ /53;:PO%^('
MA^Y-I.((M#:*24Q':CY'RDXP#[&KFH6=T_Q3T:\2VF:UCT^='F"$HK$C +=
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M,6SZI/XWT35)H603Z+'%$I +*"$96WDC.>1TR>U2-X;\2ZIH'C/4XK5].O\
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M.PU<S["?Q]J_@RV\01^(+.U=;7SUM?L2/]H &<NY^Z6P>% QG\:LZQXZO_\
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M/R;&WB\PR;(E7?C&[ QG';-3TSG"BBB@ HHHH YG5?\ D)S?\!_]!%9?C?\
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MIM8UB6+SOLT<JQ+''G&YW/"\_P"1D5RVFZG=:C\:K:;4-,FTRYBT,I+!,ZN
M?-)RKKPR\]?8^E"CI<'+H>IT5PK>/M2NUDO=$\*7FIZ-&6!OEN$C,@4X)CC/
M+C@^F:T[GQI;'0-/U32[&[U-M1P+:"!,,3WWD\( >"3WHY6',CIZ*XW3O&E^
MVLP:/KOAR;2;^[21[-3<I/'/L&2N]> WL?ZUSOACQ'XKN_B3K=M=Z),L1^S"
M>V?4E=-.4I]Y1T;=U(7'O1R,.='HFEZUI^M+=-I\_G"UN'M9CL9=LBXW+R!G
M&1R.*T*\B\&Z]JNGCQ-::/X<N-7G&N7,LA$Z01HIV@#>W5OE/ 'IZUZ#X6\2
M0>*=(-]#;R6TD4S6]Q;R_>BE7JI_,?G1*-@C*YN45Q^L>-;G3_%3^'K+0I]1
MO#9BZB\F95#$L5PQ8811C[V3U Q4OA[QC)JFL3:)JVD3:/J\47GBWDE659(\
MXW(XX/\ GK@X7*[7#F5[%_6?#_\ :VLZ)J'VKRO[,G>;R_+W>;N7;C.1C]:W
M*XF?QIK4L\SZ/X.OK^P@<H]R]PD!;'4QQL,N/3IFN?\ &?C;4]0\'V&J>';&
MX&GW3Q,;Y+Q87CD\S:82@Y.2,$@XYJE%NR%S)'H][J]CI]Y96=U/Y<]\YCMT
MV,=[ 9(R!@<>N*OUY?XKUB_CO_!>I:IHLUK=K>SYL()5N')V[5"LN 2>/IGG
MI6[8^-=0'B*UTC7?#=QI)OMPLYC<I.LA49(;;]TX[9-+E=A\QV=%<UH_BZ+4
M-#U74;NW%FVESSP747F[]IBY)S@=1STJOH_CF#5/ MSXFEM#;_94F,]J9-Q1
MH\_+G Y(QV[TN5CYD=;17(S^,;Y-,TIK7P[=7>J:A;BX%G'( D*D9^>5@ /R
M]:KVWCJ\?^TK&]\.S6>N6=FUZMB]PKK/&#CY)%!&>W3K]#A\K%S([:BN8;QG
M:+\/O^$M$0,7V7S_ "?,_CZ>7NQ_>^7./PJG>>-KZ.:RTZP\/37VN3V:WDMD
MMPJ);H>/FE88SGCI_,4N5CYD==/!'<V\D$R[XI%*.OJ",$4RSM+>PM(;2UB2
M&WA0)'&@P% Z 5B>&O%0UVXO;"[T^?3=5L=OVFTE8/@,,@JXX9?>NCH::T!.
M^H4444AA1110 4444 %%%% !1110 4444 <;\2O^1=M_^OM?_0'KRVO4OB5_
MR+MO_P!?:_\ H#UY;7J83^&?*9O_ +R_1!11170>8%%%% !1110 4444 %%%
M% &QX;OX;/4'ANFVVEW$T$I_N@]#^!I(Y[WPOJ=U%Y49D:)H3YBD@H2#N&#W
MQ613GD>0C>[-M 49.<#L*EPNV^YLJ[4$ENMGZCH)Y+:X2>%RDL;!E8=C5_4=
M>O-2U.+4'*0W$:JJ&($8P20>2?6LRBFXIN[(52<8\J>AT)\8Z@29%M[%+IEV
MFZ2 "4_CG%96GZI=:9J"WT# S#.=XW!L]<^M4Z*2IQ2LD7+$59-2<M46;^\^
MWW;7!M[>W+ ?) FU/RJ"-S'(K@#*D$4VBJ225C)R;?,]RYJFI3:OJ$E[<+&L
MC@ B,$#@8[FKEEXDN[2R%G)!:WENIRD=U%Y@7Z<UCT5+A%JUC15JBDYIZO<O
M:AJ]WJ5U'/,RH8@!$D2[5C'L*EU;7)]9\MKFWM4E7[TL4>UWXQ\QSS6911R1
M5M-A.M4::;WW+>G:E=:7="XM)2C]#QD,/0CN*U#XMO%5S;6>GVLS_>F@@VN?
M7G-8%%#A&3NT.%>K!<L961U>@7LUEX4UJ[B*F59(OOKN!RV#D'KD$UF7_B.[
MOK'[$L%K:6Q.YHK6+8K'WYK'HJ53C=R9I+%5'!03LDK>NK9K:?XAN["S-F8K
M:ZM<[A#=1;U4^HJ*_P!;O+^>"1C'"+?_ %$<";%CYSP*SJ*KDC>]C-UZCCR<
MVAT!\8:@1O%O9"ZV[?M0@'F_GT_2LVTU:YM(+Z)0C_;$V2M)DGZCGKSWJC10
MJ<5LARQ%633<B['JL\6CS:8JQ^1-()&8@[LC'3G&.*/[4G_L;^R]L?D>=YV[
M!W;L8ZYQBJ5%/E1'M9]^EOD;5KXFNX+*.TGMK.]AC_U8NH=^P>@YJI=:S?7>
MHQWSS;9X\",H-H0#H /2J%%)0BG>Q3KU9)1<G9'1#QG?K.+A+/3TN.-\RV^'
MD]F.?Y4NAMNU.Y\0WJA8(':4@<!Y6R0BY^N:YRG>8_EB/>VP'=MSQGUQ4NE&
MUEI<TCBI\RE-WMJO4=/,]S<2SR$%Y&+M]2<FHZ**T.9N[NPHHHH **** "BB
MB@ HHHH **** -G0?^7C_@/]:V:QM!_Y>/\ @/\ 6MFL*GQ'I8?^&@HHHJ#8
M**** "H9+2VFGBGE@B>:+/ER,@+)]#U'X5-10!%<6UO=Q&*Y@CFC/)250PX]
MC1+:V\\'D30120]/+= 5_(\5+10%R*WM;>SB\JV@B@C_ +D2!1^0JO\ V1IF
M)1_9UIB;_6?N%^?G//'///-7:* NR!;.U2X6X6VA695V"0(-P7TSUQ[4EU86
M=\%%W:07 7H)8P^/S%6*Y/7;[56\7Z?I%AJ/V..X@+LWD))R-QZ$?[..M!44
MY/<ZI8T2,(B*J 8"@8&/I53^Q],V.G]G6>R0Y=?(7#'KD\<UB1ZIJ>BZS::=
MK$\=W!>96"Z2/RV#YZ,HXYR!Q6GILEV^J:DD^H6EQ"CKY4,6-\ YX?'(/U]#
M0-Q:UN7[FTMKR/R[JWAG3^[*@8?D:@NK:6#2Y(=*CMH90N(E9,1_B![4^'4K
M"XN#!!>VTDRYS&DJLP_ '-.NKZSL5!N[J"W#< RR!,_F:"5?8X^XT/4M9D@M
M9=%L])M4F$MQ+$Z,9B,] HS^?]*[&YL[6]C"75M#.@Y"RQAA^M2B2,Q^8'4I
MC.[/&/7-06NH65ZS+:7EO<%?O"*16Q]<&@J4I2^0K6%F]H+1[.!K88Q"8E*>
MWRXQ3IK.UN41)[:&5(V#(LB!@I'0C/0BF3ZE8VTRPW%[;Q2M]U))54GZ G-3
M22QQ1&621$C49+LP  ^M!.I'=65I>HJ7=K#<*IR!*@8#\Z22PLY;46LEI ]N
MN,1-$"@].,8I;:]M;U"]I<PW"#@M%(&'Z4S^TK#[7]D^VVWVG./*\U=^?]W.
M: UV)IK>&YB:&>&.6)NJ.H8'\#4,>F6$30M'8VR-#GRBL*C9GKMXX_"K5% K
MLK-I]DT\D[6=N9I%*/(8EW,IX()QDCVIZ6MO':_9D@B6WVE?*" )@]1CIBIJ
M* NR.&"&VA6&")(HE^ZD:A0/H!4/]FV'VK[5]BMOM/7SO*7?_P!]8S5JB@+L
M**** "BBB@ HHHH YG5?^0G-_P !_P#0167XW_Y$"S_Z_P!?_0'K4U7_ )"<
MW_ ?_0167XW_ .1 L_\ K_7_ - >M)_ C#!?[R_F>8T445D>\%%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !5"Z_X_P"'_@/\ZOU0NO\
MC_A_X#_.JCN95?A+]%%%2:A1110 4444 %%%% !1110 4444 %%%% !1110
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M"2K,0 ,],CT]*E5;NR1K+"*,7*4MK].NB[^?X'/36<]O;P3RQ[8YP6B)(^8
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M'<#.1_6NDA\&V$<T32W5_<PPMNBMI[@M%&1TP,=NE6-0\,V=_>F]2:ZL[M@
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M_</\JKZ?_P >[?[Q_D*K[)D_XB+E%%%2:A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!0NO\ C_A_X#_.K]4+K_C_ (?^ _SJ_52V
M1E3^*04445)J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%1S_ .HE_P!P_P JDJ.?_42_[A_E0MQ2V97T_P#X]V_WC_(5<JGI_P#Q[M_O
M'^0JY3ENR:7P(****184444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 50NO^/^'_ (#_ #J_5"Z_X_X?^ _SJH[F57X2_1114FH4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S_ZB7_</\JKZ?\
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MW[7<77GGSKA625]H^8-U[<?A5.BCECV!U:CU<G]YN:1K30222W-SAK>R>&T
M3HQZ#@>Y.36==:G=WD*PS2+Y:L6")&J#=ZD*!D^YJI124(IWL5*O4E'D;T_K
M<L6=]<V$IEM93&[(4+  \'KUH%[<K8&Q$I%LTGFF/ Y;&,^OX57HJK(A3DE9
M,N#5;U;BUG$Y$MJ@CA8*/E49P.G/4]:9+?W,ULULS*(6E\XHD:J-V,9X''';
MI5:BERKL'M)VM=D]U>3WLB/</O9$6-> ,*. .*FM]6O;:!84D1HT;<BRQ))L
M/JNX''X52HHY5:U@52:?,F[EM]3O)%NE>X9Q=%3/N )?!R.3R/PH@U.\MX(H
M8I@(XIA.@**=LGKR/TZ54HHY5V'[2=[W8^:5YYWFE8M)(Q9SCJ2<FF444R&[
MZL**** "BBB@ HHHH **** "BBB@ HHHH V=!_Y>/^ _UK9K&T'_ )>/^ _U
MK9K"I\1Z6'_AH****@V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F=5_P"0G-_P'_T$
M5WWP]_U1_P!P_P Q7 ZK_P A.;_@/_H(KOOA[_JC_N'^8IXC^$9Y?_OGWG=4
M445YA]4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% !1110 4444 4--Z2?A_6K]4--Z2?A_6K]5/<RH_ @HHHJ34**** "BBB@
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MNN?]^(O_ ([0!Z_17D'_  T=X0_Z!NN?]^(O_CM'_#1WA#_H&ZY_WXB_^.T
M>OT5Y!_PT=X0_P"@;KG_ 'XB_P#CM'_#1WA#_H&ZY_WXB_\ CM 'K]%>0?\
M#1WA#_H&ZY_WXB_^.T?\-'>$/^@;KG_?B+_X[0!Z_17D'_#1WA#_ *!NN?\
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M<_[\1?\ QV@#U^BO(/\ AH[PA_T#=<_[\1?_ !VC_AH[PA_T#=<_[\1?_':
M/7Z*\@_X:.\(?] W7/\ OQ%_\=H_X:.\(?\ 0-US_OQ%_P#': /7Z*\@_P"&
MCO"'_0-US_OQ%_\ ':/^&CO"'_0-US_OQ%_\=H ]?HKR#_AH[PA_T#=<_P"_
M$7_QVC_AH[PA_P! W7/^_$7_ ,=H ]?HKR#_ (:.\(?] W7/^_$7_P =H_X:
M.\(?] W7/^_$7_QV@#U^BO(/^&CO"'_0-US_ +\1?_':/^&CO"'_ $#=<_[\
M1?\ QV@#U^HY_P#42_[A_E7DG_#1WA#_ *!NN?\ ?B+_ ..TR3]HOP@\;*-.
MUP$@CF"+_P".T(3V/5M/_P"/=O\ >/\ (5<KQBU_:'\)0Q%6T[6R2<\0Q?\
MQRK'_#1WA#_H&ZY_WXB_^.TY;DTTU%)GK]%>0?\ #1WA#_H&ZY_WXB_^.T?\
M-'>$/^@;KG_?B+_X[2+/7Z*\@_X:.\(?] W7/^_$7_QVC_AH[PA_T#=<_P"_
M$7_QV@#U^BO(/^&CO"'_ $#=<_[\1?\ QVC_ (:.\(?] W7/^_$7_P =H ]?
MHKR#_AH[PA_T#=<_[\1?_':/^&CO"'_0-US_ +\1?_': /7Z*\@_X:.\(?\
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M] W7/^_$7_QVC_AH[PA_T#=<_P"_$7_QV@#U^BO(/^&CO"'_ $#=<_[\1?\
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M<_[\1?\ QV@#U^BO(/\ AH[PA_T#=<_[\1?_ !VC_AH[PA_T#=<_[\1?_':
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M%#^Q-*_Z!EE_WX7_  H_L32O^@99?]^%_P *OT4<TNX>RA_*ON*']B:5_P!
MRR_[\+_A1_8FE?\ 0,LO^_"_X5?HHYI=P]E#^5?<4/[$TK_H&67_ 'X7_"C^
MQ-*_Z!EE_P!^%_PJ_11S2[A[*'\J^XH?V)I7_0,LO^_"_P"%']B:5_T#++_O
MPO\ A5^BCFEW#V4/Y5]Q0_L32O\ H&67_?A?\*/[$TK_ *!EE_WX7_"K]%'-
M+N'LH?RK[BA_8FE?] RR_P"_"_X4?V)I7_0,LO\ OPO^%7Z*.:7</90_E7W%
M#^Q-*_Z!EE_WX7_"C^Q-*_Z!EE_WX7_"K]%'-+N'LH?RK[BA_8FE?] RR_[\
M+_A1_8FE?] RR_[\+_A5^BCFEW#V4/Y5]Q0_L32O^@99?]^%_P */[$TK_H&
M67_?A?\ "K]%'-+N'LH?RK[BA_8FE?\ 0,LO^_"_X4?V)I7_ $#++_OPO^%7
MZ*.:7</90_E7W%#^Q-*_Z!EE_P!^%_PH_L32O^@99?\ ?A?\*OT4<TNX>RA_
M*ON*']B:5_T#++_OPO\ A1_8FE?] RR_[\+_ (5?HHYI=P]E#^5?<4/[$TK_
M *!EE_WX7_"C^Q-*_P"@99?]^%_PJ_11S2[A[*'\J^XH?V)I7_0,LO\ OPO^
M%']B:5_T#++_ +\+_A5^BCFEW#V4/Y5]Q0_L32O^@99?]^%_PH_L32O^@99?
M]^%_PJ_11S2[A[*'\J^XH?V)I7_0,LO^_"_X4?V)I7_0,LO^_"_X5?HHYI=P
M]E#^5?<4/[$TK_H&67_?A?\ "C^Q-*_Z!EE_WX7_  J_11S2[A[*'\J^XH?V
M)I7_ $#++_OPO^%']B:5_P! RR_[\+_A5^BCFEW#V4/Y5]Q0_L32O^@99?\
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MZ!EE_P!^%_PH_L32O^@99?\ ?A?\*OT4<TNX>RA_*ON*']B:5_T#++_OPO\
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M4T/_ ,%T7_Q-'_"">$/^A4T/_P %T7_Q-=!12+.?_P"$$\(?]"IH?_@NB_\
MB:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0
MJ:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^
M)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\
MA!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_
M^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^
M$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_
M ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH*
M* .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"
M'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+
M_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(
M?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z
M+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?
M_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J
M:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")
MH_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"I
MH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XF
MN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$
M$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X
M+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X0
M3PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\
MX+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH
M Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?
M]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_
M (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_
MT*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO
M_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__
M (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH
M?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC
M_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA
M_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z
M"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03
MPA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@N
MB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/
M"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@
MNB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#
MG_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T
M*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\
MB:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0
MJ:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^
M)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\
MA!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_
M^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^
M$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_
M ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH*
M* .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"
M'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+
M_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(
M?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z
M+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?
M_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J
M:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")
MH_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"I
MH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XF
MN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$
M$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X
M+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X0
M3PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\
MX+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH
M Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?
M]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_
M (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_
MT*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO
M_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__
M (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH
M?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC
M_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA
M_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z
M"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03
MPA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@N
MB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/
M"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@
MNB_^)KH** .?_P"$$\(?]"IH?_@NB_\ B:/^$$\(?]"IH?\ X+HO_B:Z"B@#
MG_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0J:'_ ."Z+_XFN@HH Y__ (03PA_T
M*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^)KH** .?_P"$$\(?]"IH?_@NB_\
MB:/^$$\(?]"IH?\ X+HO_B:Z"B@#G_\ A!/"'_0J:'_X+HO_ (FC_A!/"'_0
MJ:'_ ."Z+_XFN@HH Y__ (03PA_T*FA_^"Z+_P")H_X03PA_T*FA_P#@NB_^
M)KH** .?_P"$$\(?]"IH?_@NB_\ B:T]-TG3='MVM]+T^UL8&<NT5M"L2EL
M$D* ,X &?85=HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUX9O]64@G4]6N[HM_P!M"@S^""E^&Q^VP^(=:R"NHZS</$P.08HR(UQ_WP:
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M4(Z/SYCD]_N]>XQ7C?BJ":]TR3Q-9>%M9FDN9%:Q\17VM".9#(X$>R!. GS
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M*3':7(;802%##C..3Z5BZ) FF^&O#6I1RNUC8^*IH;8R,6\JV=Y( -Q/0'%
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M%WX8\3Z9;V5I)=R3:AIXA0JG55);ESV'UKH/#/B&R\5^'K36M/$HMKD$JLH
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M4\J"$?[HD+'_ &B:@\!:[XRBT*:XTGP,M[;:I?3WJ7TNJQ0AO,D/S-&06P,
M>IQQ0!Z?X;\2:=XJTA=2TQY#%O:)TE38\3KU5E/0BK5G<WT]Y?1W6G_9H(9
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MUA:(([>VB6*)/15&!^E6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH8DO=,N?(E\LG)0G!R,\]*8OP^T2+1H-,A^U1PQWT=_+)YN^2YE1MP\UV!+
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M1U4=JUZ* ,#5?"&E:P-&2XB98=(G6:VA3 3*C"JP(.5'!QQT%6?[ M#XI;Q
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MH'\1'3T]*[6B@#C],^'&BZ=-?S2W&HZC+J%D+&YDU"Y,S21\Y)8C.3GL<<#
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ME<]0,=.M:M% &1I?A^VTF;5IH)KAI=3NFNIGD9258J% 7 &% 48SD^YK,E\
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M%%OK[R3FY@M'M8XLCRPK,&+8QG=\H&<XQVJA<>"=(O/[?%ZDMTNN&/[4LC#
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MX1N_'_A7PQ8:''\./.%JA5ICKENN]BQ9FQ@XR6)ZF@!_Q!>S/BT)XR@U5_"
MLU\HV@D^S^=N.\S^4=V0,8[=:W?A[HVG:?\ ;KOPWK/VOPU=!/LEKYK2BV=<
MA]K,<@'CY3S4,MW\0M U:_BM]#@\1V%U=--:S?V@EL]JC8_=L&7D#G&/QZUJ
M>!O#=UX?L=0FOQ;1WNIWCWLT%H,0P%@ $7CG ')[G- &=XR\4^(=)U+[+IS^
M&=-@559;O7[_ ,L7!(.5C1#N&/5L=^.]4(_B'K>J:+X3GT?2K1M0UN6='@GD
M;RU6(,&<..BY .<'@^M8]_X2\1C5?$0D\%Z/KD][--/:ZQJ%Q&WEH1^[B$;
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M4/%%Q (HHF?=\P^\[M_<0$9;OP!DD51^%NG/;WOBZ\ENI;R:75C ]U+UE,2
M,1Z+N9P!V QVJUJ?P[&NZL^OS^(/$FF:C<0(DEOIVH+&D0 _U:D)R,Y//4DF
MJ'P^\+ZYX,T*T>>+4;_4=1N1]OMKC4$,5DI9RTJ]=S8*[L$ECZ4 >ET444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM'O*;C]]N1A!U)H O451L]7L;^]OK.UG\R>PD6*Y78P",RA@,D8/!!XS5Z@
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MI;1[6)D*J6;H,#"C.3BKU !1110 445#<W$5G:RW-Q((X84:21ST50,D_@*
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M9)7()P/H.2>V!6-HGC%=<G@2/P_K]HD[R*LUY9>4@"*K;B2>%;< I(Y(/H:
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MH%;]V77<HSC!)'/!..]7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG&4)(8 ''7L.E '(^%-7U"W^(NG6L5WXU^RW$5Q+?IXEC"QLB+E7A7^'#D9
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M2TC+))*23F7[Q7)^Z,9'>@#&O-8\67OPY\*7C_VU-;W<!?5+C0XT-Z01^[V
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M9PNW;P%& /?G,2?#J_9]:N;SQ1/>7^J:7_9YN9K508<EB60*0 OS?=&.>YH
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M$$C;%;(W,IP,#( !''KZ#?\ @Z^G\87&NV.O/:1W5E]DN+4VJR"3"N$;<2"
M"V<#KC&127/@5+CX<6G@X7^R&**"*6?R<^:J,K-\N[C=M/<XSWH Y75].\0Z
M2WA?6Y?%FK3ZM?ZC:VTUD'5+,J_+J(@.RAN22>,_3&U?Q7J7B75]1?RO'L-A
M:W3P6)\.68\IO+.TO)(3ER6!^7@  =\UZOK/A[^U]9T*^:Z$<6E7#W!@\O/F
ML8RB_-GY<;L]#GVKG$^'FK6.HWG]B>,[[3-&O)WGEL$MHY&5WY;RY6R4!/.
M.* ,#3Y?%/B?5O"^EW>L:GI%U%HTEUJ?E)Y<K[I!&FY6&U7.TG)!Q\V,5C:Y
M::E%X/\ &FF2>)==NK?3+^*WLI'NB9IWE15,4K8RZ9E&5]NU>LZ=X;-CXJU#
M7'O6G:ZM8+6.-DYC6/<22V?F+%L]!CWK#N_AVUSX;U/3DUEH;R]U5M5^V+;@
M[)-X904+8(4*HZCI^% &MIFGV_@/P7*DE]?7MOI]N\[RW<WF/M5<E0<#"@#
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M_P#$)MX%MI=@G4,ELJR<?,GWSM]A7H>C>"K^'4X-4\1^(Y]>OK0,+/?;)!%
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M=BWUN36'::'YYG9"JAFW=5Z[L<^@H YWQQX+F\KP_IDOBKQ%=S:CJZ)+YEV
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M#\[>Y/TQ7'OX1NO^$L\/>&M)UR:QN/#FAM*E_% K#S9'"?-&Q((8*Y*Y].:
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MYSS3I/$>KS^$-'L=7U'Q-;ZG()VEL=+TT_VG<0K(4C=B>(N.2<?-V/'/62^
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MQ<>%KTZ[KFL66L"UO=0M(;6VD^RB3[+LW$M@MA\ELX(&,=ZZ.)62)%D<R.%
M9\8W'N<4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZJH_N!<L03C/.*OZ9K\$>C6TVMZMHR7<EN;IWM;D>08L_?0L<E "OS=,GWH
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ME7'/* Y'Y5Q_B7Q[<IXH@\,>&+KP^^INA:674KO$<;[PHA"H=QD)S\O4<<4
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MB^^UP?9-N_S_ #!Y>WUW9QCWH LT5E)XET&339-2CUO37L(F"R72W<9B0DX
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MFM)<DB!!=H3+@X.T9^;GCB@#5HK/O-<TG3VE6]U2RMFA57E$UPB;%8D*6R>
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MQZ=':Z9# FG2M-:K$2H20J5+$ _,<$_>S5W^Q[#^VVUGR/\ B8-;"T,I=O\
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M'?"2RC0]+BM&EX=PS.[#T+,2<>V:T+O2+&]U.PU&Y@\RZL"[6S[V'EEUVL<
MX/''(..U ' Z9I&A:WX^U^RU.PL6L]"CA@L--DB40PQNF]Y?*QMY9L9QQBN5
M:TM)]$U71]+!30=:\506=G'$Q";%*M.4QT3,;<CCCBO4M?\  'A;Q1?Q7VLZ
M/#=740"K(7="0.0&VD;A['-:+>'=);^S +&-%TMM]DD9*+"=I7A00#P2.0:
M"ST'1=(TN:QL]+LK:QD!\Z&*!520;<'< /FR!@YSFO';?2-./P?M6M[&VMKG
MQ/JL<!>")4?R9+K(3(&=H1>G05[HRJZE64,K#!!&017-Z;\/_"VD+"MAI2P+
M#>?;HU$TA"S;=N[!;LIP!T'I0!Q_B/0]&\.^-_#+Z'H]I:W%G;7U](UO"%>1
M8X=JJQ'+99^I/KZUQUAX1\3>)?!JW\D7@67^V%\PZG>><;T22'C]Y@A7!X"K
MP,8Q7O#Z/82:VFLO!F_2W:U64NV!&6#$;<[>H'.,^]85G\,_!FGZV=7M= M4
MO22P;+,BD]U0G8I]P!0!%X_6&T^%VKG4(H+MH+ X\] ZF7;A6P1U#$$5R]UX
M2T<:CX$\)#3K;[(L4M]?(D843M'"J!GQ]XLS\D]<'UKTS5-+LM;TNXTW4;=;
MBSN$V2Q,2-P^HY'U'-4-)\(:%HDUI-IU@('L[9K2#]Z[!(F?>PP2026YR>?>
M@#RJ;1=4USQWKMMHVF>#9;+1BEK;Z?J\3E+9"N]GCB0;0'9B2Q'8>E20:1=6
MFCZ9X0_L[0=6U*\N;C5+>(7,HTVWC!X&WK( S'"$$=?2O1M>^'OA3Q-J<>HZ
MOHT-S=Q@ 2;W0L!TW;2 W_ L^E/UKP#X6\06=G::EHMO)!9#%LD>Z+RA_=&P
MCY?;I0!Y1I5H+2W^(MWJFF>'"ECI\41M])@/V-Y@CNIVN,%@2N3C@^XK;_X1
M+2OM/@#PJVGVQM_(DU#4%2,*+AXX50%\ ;LL_?MQ7H-IX*\.6.G:AIUKI4,5
MEJ&!=0*6V/\ *%X&<+P!TQZ]:-&\&>'_  _-:RZ7IXMWM;=[:$^:[;8W?S&&
M&8@DMSD\]LXH XK3?!GAF]^+.NQKHEC]AL+&U5K00 0&9][;C'C:6"8[=_6N
M2NDF@T"[TW1!I]E9:YXLFMTBN&:*V\J-<>6VSD*[1XP.HX[U[G9Z18Z??7UY
M:P>7<7\BR7+[V)D95"CJ>,  8&*SI/!?AZ7PVWA^73(Y=+9VD\F1V8[F8L6#
M$[@V6)R#GGB@#RN]\/:YX8_M#7KRW\'Z:=/TBY0PZ$LD4DOF+M0NK#! 8 @_
MSK1UKP1H6A^%/"-C:Z7:KJUQJ5C%]L\H><6'SR,7QG&%;CITKN+/X;^$;#1K
MC2;71(8K.Y*F=0[[Y-K!E#/NW$!AG!.*W+W2;'4+NQNKN#S)K&4S6S;V&QRI
M4G .#P2.<T <1X6T/2+GXE^+=432[%6LYX+>W=8$#))Y>^5P<9#,9,%NIQ4G
MB&.U\0?%/3?#FKJLFEP::]^MK*?W=U/YFP!A_%M4$XYZUT]KX4T.R\2W7B*V
MT](]6NH_+FN S?,O'\.=H/RCD#-,\1^#O#_BZ&*+7=,BO!%DQL69'3/7#*00
M#@<9H \\GM-%TSQ+XXGTRQLUT&TT-1>VL<2_9WNP7=1M VY"@9&.K5VGP[\.
M67A_P9I2PV%M;WLUE"UW)'$JO*^W/SL!EL%CUK17PEH,?AN7P]%IL46DRJ5D
MMX2T88'KEE(.3ZYS6I+:0S63V;J1 \9B*JQ4[2,8!!R..X- 'D<_C6/4O&]]
MJ4GAKQ)JVEV<3V.G2Z98&:(DDK/)N) R2-@QG@'UJE;W[ZI\!-+T9A)'<7&H
M1:*Z,NUQB?&TCJ#L7D?6O9M.TZTTG3K?3["!8+2W01Q1+T51T]S]36!J'PZ\
M*ZK9SV=[I1DMI[UM0DC%S*H-PPPS\,,9'8<>U &;\3;V&3PRWA>SDB?5M9*V
MEK:YRVTD;W(ZA54,<GC@5<^(=DI^%FO6J@LL6G.1G_87(/\ X[5[P[X'\->%
M&9]$TB"UD88,N6>3'IO8EL>V:VKRT@O[*>SN4\RWN(VBE0DC<K#!&1ST/:@#
MR&_U*.^U/1OB'=3LFEV-^EI:N2=OD&*19I<?[4A SZ1CUJQ+I\LJ>%EODV:A
MXBU]=5NXR>0D:-(D?T55C!^A]:]%G\+:+<Z#;:'-8(VF6WE^5;[F 7RR"O(.
M3R!U//?.:M7&D65UJMGJ<T)>\LED6WDWL @< -\H.#D <D4 >03VND6.A_$O
MQ%::=90S0W,NGVDL4"*T3")8FV$#()>0Y(Z]ZT]?\$Z%HECX*T^PTJTAU%]6
MM$-VL8\XB,%Y"7QD\)T)[CTKLF^'OA5KR_NSI"";4)4FNBLLBB1U<.#@-@?,
M,D#J>N:V;O2+&_U&PO[F#S+FP=WMGWL C,NUC@'!X..0<=J /(-35=:L]=C;
M=M\0^+H=.!1B"T,.P,<CG&(GKHY_#6BZ;\6O"L6C:;;6#VUE=W$YMD"&5"JQ
MJ'P/FY8G)KL+?PEH=J+$0V1 L;F2[M\S2-MEDW;V.6^8G<W7/7BK@TBQ&NMK
M7D?\3!K86OG;V_U6[=MVYP/FYSC- ''^*4M=<^(NA^&M5"OI9LYKTV\APES,
MK*JJP_BV@LV*X[Q/'IV@:SXSN/#4$%G8V_ATVU\MH@6(74C[8QM7@.%)SCU]
MS7JOB/PEH7BVUCM]=TV.\CB8M&69E9">N&4@C.!D \TZU\*:#9>'WT&VTNWC
MTN12CVP7AP>NX]2?<G- ''>*H[:#0_!/A."2+?<WMF@B#<F"$!V8#KCY ,^]
M2>"-#TO6=:\0^*+S3[>XNY-9E2UFFC#F)(=L:E<_=.4)R.>GI6SH_P ,_!^@
M7UK?:9HD=O=6K,\4WFR,P+*5.2S'(P3P<X[5O:3I%CH6G)8:= 8;97=PF]G.
MYF+,26))R6)Y- '':]#:^(?BGIWA[5D273;;3&U!;67_ %=S,9-@W+T;:H)P
M<_>K \5:'X:M[6]LO#KQQMK.J6.F7EE:[5@1A)O;"@8#; <^W:O0?$?@WP]X
MNCB37=,CO!#GRV+,CKGJ RD'!],T^#PGH5K;Z;;V^FQ0PZ;,9[2.(E5CD((+
M8!^8X8]<]: /,?$DAU!?'LD;_/J&I6.@Q,I^Z!L#@>_[Q_\ (K:UCPQH&B^.
M?!5KI.EVEE,DMQ<RSQ1!7,4<1SO8#+99EY)KLQX1T,",?8B0FHG5%S,Y_P!)
M.?WA^;GJ>#Q[<5:N]#TZ^U)-0N+<O=);R6JR"1EQ&^-P !QS@<]?>@#R#0TA
MUN#PCI6I[4T_7[S4-7N(6;:+E@Y,49]1A@Q'?:*W_$-EX-\,SZI?Z7:H+V2W
MCTNXTO3YA;0N9G 0R; -C=?F!!VYX-=AJ'@?PWJOAZUT&]TJ.;3;156WB9WW
M1A1@8<'<...O/>B/P-X8B\-R>'DT:V72I?OP 'YCV8MG=N_VLY]Z /+['0=1
MT[XF>%+&[TGPEIQC>:Y T6.03I&D1&)G8<@[@,GJ<UWGPO'G^%[K5B,G5M2N
MKW=Q\P:0JIX_V56KVD?#WPKH$T<VE:1':S1Q21+(DC[BKXW!B6RW0<G)';%;
MFF:99Z-IEOIVGP^3:6R".*/<6VJ.V223^)H \TT*R\-ZYIGB;Q5XGMK&^N1>
M7,4AO0KBUBB8JD:[ON<#.1@DM7&Z3IVK7EEX-\+Z;#HTD:Z2VKFUU@R?9[EY
M96(^5.7*#D \8)..*]<U#X9^#=4U:XU.]T*WEO+E2)9-SKN)ZM@' ;_: W=\
MU:UGP)X8\0:=9V&IZ1#<6]F@CMQN96B4  *'4AL8 XSVH \PN_"FK:+X8\6:
MM=KX>@,36EPEGH)=88Y+>3>Q9&&%8J1P.OMWT/%.KW%UH/B#QM9RB)0JZ3I%
MPY(6*)I526?..,L2 1V0>M>E6OA?1++0)="M=-@ATR:)HI((P5#JPPV2.22"
M><YJP-%TP:(NB_8H6TU81 +9ERFP# &#0!Y+I_@'Q#%JOAZ26W\#6"6MW'=+
M<Z9YZW<Z+RXWM_K RDYR3US5?37CU:'P]87KE-+\4ZWJ%_=G=M%PJ$^5&2.S
M83COMKTK0OAYX3\-S2S:1HT-O-*I5I=[NX!X(5F)*CZ8JQ=^"?#=_P"'+?P_
M=:5%-I=LH6"%V8F/ P"'SN!P>N<T <)KEOH_ACQ_%>>';2UL1INBWMQJJ6<0
MC39M'E!@HQNW D9YXK&U'PMX8T_X&6,O]GV4NMWUM ;6XC :XFNI"I 5_O'!
M/3.,"NW\0^!K;3_AYJ7A_P (:1#!)?;(G". 2I8!V9W.6PF[J36GI7PX\(:)
MJ_\ :VG:%;07H.5D!8A#C&54G:I_W0* .;T#P_IGB/QGXIU+7K*UU'[$]OI\
M0NHQ*B>7"&D.&&,EG//^-<QIOACPY#\#M9\03Z/:2SW,%W-;23Q[V@4NXA"$
M\H!D'Y<<FO8[+0M.T^WO;>UMS''?3R7%R/,8F223[S9)R,^W3M4$OA;1IO#4
M?AV2SSI,:(BV_FN/E0AE&X'<>5'4\]\T >37&E^(-7\46/AVTB\/WJ:#HUJJ
MVNOB5XY'9,-*J+PS#:%RPX[=:!X7NX;33]!U-M'\C7?$23O;:*[_ &9(HHBT
MBJ",KEHQD#I_+T_Q)X$\,^+I8I=<TF.ZEA&U)-[QN!Z;D()'7@U;@\+:):W&
MFSVVG0P/IJR+:"+*+$' #_*#@D@ 9()H X.[T'P[IWQ,,5IHVGP65EX>FGO8
MDMU6.56<!0Z@8;A&/-;?PGT2QTSX?Z5=0V=M%=WUN)[B:.)5:3>2X!(&2 &P
M!V%=.VA:8^H7U\]JKW%] MM<LS%A)$,X7:3@#YCT SGFHO#WAK2/"NFG3M%L
MQ:6ID,I02,^6. 3EB3V% 'E_B?2G:^U_Q?;VWAOQ/HS BXBU#(N+41)M:.*0
M@JO()Q@')]>:M1>'/#VH^+?!%@NCP-:Q:/+>/#>Q+)(8RJ+&DA8?,%+M@=B*
M[&Y^&G@V\U[^V[C0;:2_+[V<EMC-ZLF=A/?)%:.I^$M"UC6=/U>_T]);_3SF
MUFWLICYR. 0#@\C.<=J /.-/70++PQXF\<ZII4=[//J=PMLPP)%7>((UC?K'
MDC[RX(S[5CR>'-0T[Q=X.T^?2/".EB34(YX1I0D:]"1J7822,/F7 P3SDXKV
M*'POHL'AL>'4L(SI.PI]FD9G!!;<<EB23DYR3G-9FC_#?PCH%Y9W>EZ+%;7-
MHSO#*LLA8%E*G<2Q+<$@!LXR<8H X(1V.CZ9\1O%>DZ;917EG>26EE-%;H&@
M*1JCLN!Q\SL2>_>J=EX"\120:*##X$@7[3#<QZC:F?[;/M8.2LK EV8 DY]>
MW;U:S\&>';#4M4U"WTJ%+C505O22S+,#R05)VC)))P!GO5/1OAUX4\-WLNH:
M-H=O#>L#MD=W?:?]G<3L_P" @4 <'I5KX:U;X9ZSXT\0V=G?:A>"ZEEDNU5G
MA*EA'"F>4( 4 #!Y%-9XO 5G\/=8NP1''ID]K<*HR6D>(2JH]RZD?4U#<?#B
M^\1:G<QW?@32M&FNI!]KUB/4//5ER"YAAQA&.,9('4FNWN-&U3Q)XFLX]5TB
M"RT#1+GS[3,RRO>2JI6-L#[B ,3@\DA: -3P7HMQI&B&;4,-JNH2F\OW_P"F
MK_PCV484?2NCJA%H]A!K-SJ\<&+^YB2&67>QRBY*C!.!C)Z 5?H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJT-VD]W<P
M)S]G*J[9Z,1NV_\ ?)4_\"%6: "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTZ$XKHZ)--W0132U"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YW5O!'AS7+PW6H:
M8LL[##.LCQ[OKM8 GW-9_P#PJSP7_P! ;_R:F_\ BZ[*BG=]Q61QW_"K/!G_
M $!O_)F;_P"+JYIO@'POI-XMU9Z/"LZ<JSLTFT^H#$@'WKI:*+ON%D%%%%(8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img109617586_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_1.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" Y-%XD# 2(  A$! Q$!_\0
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M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
M/E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_
M[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G
M_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X
M5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2
MC_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#/
M/]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\
MA"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/
M^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RK
MZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\
MSS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q
M_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^
M4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N
M'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^
MX?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6
M<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/
M^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_
MTH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$
M)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X
M0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJ
MS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#/
M/]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_
M ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3
M_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?
MRH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A
M_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q
M_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X
M5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2
M@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F
M?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"
M9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/
M^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_
MTH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\
MSS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_
M (0F?^X?RH_X0F?^X?RKZL_X5G'_ ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*
MC_A"9_[A_*OJS_A6<?\ SS_2C_A6<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\
MJ^K/^%9Q_P#//]*/^%9Q_P#//]* /E/_ (0F?^X?RH_X0F?^X?RKZL_X5G'_
M ,\_TH_X5G'_ ,\_TH ^4_\ A"9_[A_*C_A"9_[A_*OJS_A6<?\ SS_2C_A6
M<?\ SS_2@#Y3_P"$)G_N'\J/^$)G_N'\J^K/^%9Q_P#//]*/^%9Q_P#//]*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BDS[44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %)FBFT /HI%Z4M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
M;:6B@!*6BD)H 6BFAJ=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4E+10 S-&:7;1MH =1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UJ=10 T=:=11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 E&ZAJ;0 [(HR*;10 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $HI:* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **3(HH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!E.6BEH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HI*;0 ^BD6EH **1J;0 ^BDI: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BDI-U #J*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MI#0 M)MI-U.H 2EHHH 2C;2T4 %%-W4HH 6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* $/2FT^B@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1J6B@!E.I:* "BBB@
M I*6B@!E.6EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **:SJO4XIOVB/^]0!)
M12*P;H<TM !136HR:  &G4E+0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !136
M8+U-)YR>M #Z*3<#WI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,BEH **** "BBB@
MHHHH **** "BBDR* %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BDHR* %HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDS
M1F@!:*** "BDR** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3I0
M!SGB36ET]22V*XV'QTC7.SS._K6/\9/$?]GQR8;'XU\\V'Q$9M8"^9_%ZUZ5
M&ASQN>+B,5[.IRGVYH&I"^A!!SQ6Q7F?PGUK^T+2,[LY%>F5PU(\LK'JTI<\
M$Q"*3;3J*S-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **3
M(I: "BBB@ HHI,B@!:*3(HH 6BBB@ HHHH **3-&: %HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHI* %HI,BEH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M44 %%%)0 M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !13=U+0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P *!C_Y]Q^5 7/@3_A ;O\ YYM^5-_X0.[_ .>;?E7WXWP!CQ_Q[C\JAD^
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M]62>#T/\'Z57?P;'_P \_P!*"K'Q_>?!OS<XA_2L.\^!ADS^Y_2OM=O!D/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:;02%%%% !1110 4444 %*%!I*5: $9:;MJ2FT )M%&T>E+10 RF'-34FT4
M5V9Z9YDGK5O:*3RQ0!45G]:L1D\9I_EBEP* 'BC--HH 23D4R,;6S3S36X6@
M#IO#.L&WN$&>]?4GPAU\S-$"V:^,K*[,=T.>]?1GP9U@K-#EJY:\;Q.JA/WC
M[FT63S-/C-7ZYCP?J8GTV,9SQ73*VZO EN?0+8":3=0U)4C%#4ZFCK3J "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTWXM6%\%PZ$GWK\7?#?[0%W;2(//;\Z]V\ _M$2R-&'N#V[T"L?JKIOB*WU
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M !1110 4UNM.HH :M.HHH **** "BBB@ HHHH **** "BBB@ HHHH ***5:
M$HIU-H 1N:CD7:N:EIDOW#3 CL-0-O=KSCFOJ;X"^("+BW!;N*^2E4K<@U[Q
M\&]6^R74/..17-BH\T#LP4W&JC].? .IK<:2@SG@5U@.:\-^%7B@2V<2;^U>
MTV,XGA!KXBI'EDS].P]13@BU1116)TB-3:?24 %+110 4C4M% #*=12T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %)2T4 >1_%"ZDABE*GUKY$^('B2
MYAN),,W6OM#XA:3]KADX[5\D_$WPKMDE;;ZUZ>&:/-Q"?0\2OO%]QN(+M^=4
MO^$BEFZN:CUS3?L\S#'>LVW@YKUTE8\=MW--[YI>I-0L/,ZT+#3PM,"'[*#V
MI1;*.U3T4KB(A"!1Y8%2T4T Q5I]%% !1110 4444 %%%% !1110 4444 %%
M%% #6ZT+UIU% !1110 4444 (U-I]%( HHHH ****8"KUIU,HS0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !39/NTZD;[M %&-<7 /O7L
M?PQU3[+/'SBO(EC_ 'F:[+PKJ7V.9.<<U$]8V+@^5GW7\.?$7FV\2[J]>L9O
M.B!SFODWX6^)MWE+O]*^G_"]S]HLP>O%>!6CRL]^C/F1N4445S'2%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[>C)2@?F&(@XU&75Z4M1!JEK4P$IM.IM(!R]*6D7I2T %%%% !1110 4444
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M<^]>O6NJ6UY&'CD7GWH$6MM+2*P;H<TM !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C^5?;#?"Z/_ )Y#\J8?A;'_ ,\A^55]>$\L\CXG/PKD_P">1_*HI/A;(O\
MRR/Y5]LM\*T_YY#\JAD^%2'_ )8C\J?UTC^S/(^(Y/AG(O\ RR/Y57D^&\@_
MY9'\J^V)?A.A_P"6(_*JLGPC4_\ +$?E5+&D_P!F/L?%$GP]E7_ED?RJI+X$
ME7_EF?RK[6N/@^"/]2/RJA-\&]W2']*TCC49RRU]$?%4O@N9?^69_*J4WA*9
M?^69_*OM*;X+9S^X_2L^X^"+-_RP_2M?KL3F>6S['Q=<>&YUS\A_*LV?0YT_
M@/Y5]GW/P+=L_N/TK)NO@'(V?W'Z5I'&0.>675.Q\:7&G7"9^4_E5*2WN%S\
MK5]@77[/LK9Q;_I63<_L]S#/^CG\JW6+IG,\OJ]CY0\NX'8TX1S^AKZ;G^ ,
MT>?]'/Y5GS_ ^:/_ )8?I5_6H$?4:JZ'SMMF]#3E67T->ZW/P=FCS^Y/Y5FS
M_"V:+/[H_E5*O!D/"SB>0JLGH:<%?TKTNX^'\L7_ "R/Y5EW/A"6+/[L_E5^
MTB9^QE'<XM=U2+FMNZT.6+/R'\JR+BUDBS\IJN9,AIH16IVX>M9LTTD9Z&H/
MMC^AJK$<QL[AZT9K*CNG;M5B.8T6'<O45'&Q-25(PHHHH ***3- "T[(IM13
M2;15 .D8>M0,Q;I4#3,QXK4T?39+V0*%)S1L&^B*=M:RSR@ $UZ5X*\ RZK-
M'F,G\*W_  /\,9=2DC/E9SCM7U/\,?@\+80LT..G:O-Q&*5-:'KX3 RJN[1S
M/PQ^"V/*9H/TKZ9\'>!8]+CC_=XP!VKI?"OA.WTRU7,8SCTKIUC5/NJ!7R];
M$2J,^YPV#A1BB&UMEMXP ,58HHKB/3"DI:* &[:44M% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2?9R/* K^E/4/7HLW@.2//[L_E6=<>$I(_X#^55SIBY6<<NZG#-;MQH,D?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:!'7>'_B)=:?,H$A&/>OH[X3_'*:TDA#SGJ.]?(*VNQLBMC3_$$FE.I5R,4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW^B_"%I=N8?TKZ;TGX/I;[?W7Z5V&E_#N*WV_NQ^5>?4QW8]FEE=MT?..B_
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI#0 M%-W4M "T444 %%%%
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MLK1+2$*JXJQ7E2FY;GKQBHK0**:6HS4&EAU%)2T""BBD)H 6BDW4M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M112-TH ,BEIE.7I0 M%%% !1110 4444 %%%% !1110 4444 %%%%2 4444
M%%%% !11118 IK4ZF-WH0!13,BGYI@&:3=2FHFS3 <V&JM-;AQTIVXT]*D#!
MU#1%G5LKFN%\1>"8KD-F,'\*]:>'<M9]WIHE[4[ ?*/C;X613QR8A!_"OF;X
MC_!@MYQ6#U[5^D>K>%UN%.5_2O-O%?PWBN8I/W0/X4BD?D?XU^%\MA(Y\DC!
M]*\MU729+%F!4BOTR^)OP>6192L/Z5\H?$+X32V\LA$1[]JHJY\R;V#$$5(H
M##I75:YX1EL&8E",>U<K,IMV((Q0,:P\LY%.M]8GM9058BF+,'.*>8%;F@#U
MKX<?%"YTF>(M,P /K7VQ\&/VA0BP(USSP.M?F6UT]G@J<8KL?!/Q&N=+NH_W
MC  ^M FC]RO 7Q8AUJ&(><#D>M>LV-XEY"'5@:_)_P""OQZ,+0+)/Z?Q5]P_
M#/XT0:A!$#,"2!WH(L?1%)65H^O0ZI&I1AR*UJ!!1110 4444 %%%% #:%IU
M% !1110 5%<)YD#KZBI:;ZB@#Q?X@>!1JSO^[SFO*/\ A2X:ZW&#OZ5];S:?
M#-]Y<U!_8-IG.SGZ5V0Q,H*R/-J8.%25V>"^'?A3';A<P_I7I.@^ ;>$+F,?
ME7;QZ;!'T6K*1K&,*,5G.M*1M3PT(="A:Z%:6J@")2?I5L6<(Z1+^5345A<Z
M^5(C$$8Z(OY4X1J.BC\J=12&%%%% !1110 4444 %%%% !1110 444E !FC=
M2-0O6@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFTT\U#*,9H E$PIWF"LUI"M*DQH&:+,#35J%),U.AH$/I]%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444E "T4FT4M !1133UH =131UIU !1110 4
M444 %%%% !1110 4444 %%%% !133UH'6@!U%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4E+5>\F$,>2<4P,#QMJ"V^F.,XXKXC^-6M;IIA
MN[FOJ+XE>(E6SD7?VKXO^*$SZA=2A><DUZN%C;5GF8J>ECR*>X:YO",YYK>T
MGP[+>,N%)S[4:!X5FN[U?D)&:^AOAW\,S<"(M%^E>A5JJ*/,ITW-G-> /AR]
MQ)&6CS^%?3W@#X:1PQQEHN?I6OX,^'$=G"C>4!QZ5Z=IM@EC"%48->/5KN6Q
M[%&@H[E?3]"AL0-H'%:=+17%>YV[!1124ABT4S-.6@!:*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 44FZB@!:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "D-+2-0 FZG4RGT %-(IU% #0*=110 4444 )10>:!
MQ0 M%%% !1110 4444 %%%% #2* *=10 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !129HW4 +112;J %HI*6@ K \571M[4D''%;]<WXPA,UJ0/2JCN3+8^<_
MB+K$DS2(":\=D\-RZO='*DY->X^)/#<EW=-\I(S5SPK\/PTH+1]_2O3A-01Y
MDH.<CAO OPIW2(QB_2OHCPAX(CTZ./,>,>U;/AKPI#91J2@&/:NK6-8P HQ7
M'4JN3.RG241L,*P1A5& *DHHKF.D**** "DI:* &[:44M% !1110 4444 %(
M32TUJ  -3J:.M.H *;NIU-H 4&EI%I: "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% %2\!VG%85YIWVPX89KI
M9(]PJ);4 YJE*Q$H\QRL/@F"1MQC%;VGZ'#8XVJ!BM,#:,4M-R;%&G&.P444
M5!H%%%% !1110 4444 %%%% !1110 4444 %%%% !24M% #*<M%+0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M% #*
M<M%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% #6H7K2T4 +3*?24 "TM%% !5#5+;[1'C
M%7Z:RANM,#AYO"Z339*5N:3X?CM0"5 K9%NM2#BJ<FR%&PBJ$& ,"G445!84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %HINZE% "T444
M%%%% !112$T +130U.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6BF[J44@%HHHI@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%-+!>I H =152XU*" <N,UD77B:&//SC\Z=F*Z.AW#UHW#UKCI/%\(/\
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M$_\ "81?\]!^='_"81?\]!^='(PYT=MN'K1N'K7$_P#"81?\]!^='_"81?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (3W3?\ GH/SK\_)/CQ-_P ]S^=,_P"%\3_\]S^=7_9\C+^V(GZ#?\)YIO\
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M/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?GW_PO>?\ Y[G\Z/\
MA>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\ ST'YU^??_"]Y_P#GN?SH
M_P"%[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/0?G7Y]_\+WG_ .>Y
M_.C_ (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?GW_PO>?\
MY[G\Z/\ A>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\ ST'YU^??_"]Y
M_P#GN?SH_P"%[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/0?G7Y]_\
M+WG_ .>Y_.C_ (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?G
MW_PO>?\ Y[G\Z/\ A>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\ ST'Y
MU^??_"]Y_P#GN?SH_P"%[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/
M0?G7Y]_\+WG_ .>Y_.C_ (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_
M ,]!^=?GW_PO>?\ Y[G\Z/\ A>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)Y
MIO\ ST'YU^??_"]Y_P#GN?SH_P"%[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_
MPGFF_P#/0?G7Y]_\+WG_ .>Y_.C_ (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^
M='_">:;_ ,]!^=?GW_PO>?\ Y[G\Z/\ A>\__/<_G1_9T@_MB!^@G_">:;_S
MT'YT?\)YIO\ ST'YU^??_"]Y_P#GN?SH_P"%[S_\]S^=']G2#^V('Z"?\)YI
MO_/0?G1_PGFF_P#/0?G7Y]_\+WG_ .>Y_.C_ (7O/_SW/YT?V=(/[8@?H)_P
MGFF_\]!^='_">:;_ ,]!^=?GW_PO>?\ Y[G\Z/\ A>\__/<_G1_9T@_MB!^@
MG_">:;_ST'YT?\)YIO\ ST'YU^??_"]Y_P#GN?SH_P"%[S_\]S^=']G2#^V(
M'Z"?\)YIO_/0?G1_PGFF_P#/0?G7Y]_\+WG_ .>Y_.C_ (7O/_SW/YT?V=(/
M[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?GW_PO>?\ Y[G\Z/\ A>\__/<_G1_9
MT@_MB!^@G_">:;_ST'YT?\)YIO\ ST'YU^??_"]Y_P#GN?SH_P"%[S_\]S^=
M']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/0?G7Y]_\+WG_ .>Y_.C_ (7O/_SW
M/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?GW_PO>?\ Y[G\Z/\ A>\_
M_/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\ ST'YU^??_"]Y_P#GN?SH_P"%
M[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/0?G7Y]_\+WG_ .>Y_.C_
M (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?GW_PO>?\ Y[G\
MZ/\ A>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\ ST'YU^??_"]Y_P#G
MN?SH_P"%[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/0?G7Y]_\+WG_
M .>Y_.C_ (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!^=?GW_PO
M>?\ Y[G\Z/\ A>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\ ST'YU^??
M_"]Y_P#GN?SH_P"%[S_\]S^=']G2#^V('Z"?\)YIO_/0?G1_PGFF_P#/0?G7
MY]_\+WG_ .>Y_.C_ (7O/_SW/YT?V=(/[8@?H)_PGFF_\]!^='_">:;_ ,]!
M^=?GW_PO>?\ Y[G\Z/\ A>\__/<_G1_9T@_MB!^@G_">:;_ST'YT?\)YIO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB?/?_"HH_P#GC^E'_"HH_P#GC^E?0G]EQ_W11_9<?]T4>W8>QB?/?_"HH_\
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M4>W8>QB?/?\ PJ*/_GC^E'_"HH_^>/Z5]"?V7'_=%']EQ_W11[=A[&)\]_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ#I2 ?333]IIA[T!8;NJ16J/;3EXH&/.*0"BE H -M.HHH **3=1F@!:***
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MH_\ Z8?I1_PH_P#Z8?I1]=B']F3/CC_A';[T:C_A';[T:OL?_A1__3#]*/\
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MCM]Z-7V/_P */_Z8?I1_PH__ *8?I1]=B']FS/CC_A';[T:C_A';[T:OL?\
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M;[T:C_A';[T:OL?_ (4?_P!,/TH_X4?_ -,/TH^NQ#^S9GQQ_P ([?>C4?\
M".WWHU?8_P#PH_\ Z8?I1_PH_P#Z8?I1]=B']FS/CC_A';[T:C_A';[T:OL?
M_A1__3#]*/\ A1__ $P_2CZ[$/[-F?''_".WWHU'_".WWHU?8_\ PH__ *8?
MI1_PH_\ Z8?I1]=B']FS/CC_ (1V^]&H_P"$=OO1J^Q_^%'_ /3#]*/^%'_]
M,/TH^NQ#^S9GQQ_PCM]Z-1_PCM]Z-7V/_P */_Z8?I1_PH__ *8?I1]=B']F
MS/CC_A';[T:C_A';[T:OL?\ X4?_ -,/TH_X4?\ ],/TH^NQ#^S9GQQ_PCM]
MZ-1_PCM]Z-7V/_PH_P#Z8?I1_P */_Z8?I1]=B']FS/CC_A';[T:C_A';[T:
MOL?_ (4?_P!,/TH_X4?_ -,/TH^NQ#^S9GQQ_P ([?>C4?\ ".WWHU?8_P#P
MH_\ Z8?I1_PH_P#Z8?I1]=B']FS/CC_A';[T:C_A';[T:OL?_A1__3#]*/\
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MNFW1116)T!129HW4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C,%4D]!2,P5
M23TKG?%'B:'3+)SO ./6JBG)V1,I**NR/Q%XPATJ"3+ $"OFOXJ?&!(UE59>
M?K63\7OBU]G$RI-Z]Z^2O&'CZ?5KIU$A.3ZU[V%P=]6?*8[,>7W8FUX\^*4]
MY<2!9"<GUKSTW%WKDN/F;-6=-\.W&N7"DJS;C7N_PU^#+7+1,\.>G:O;<H4(
MGS485<5(\S\*?"VYU1D9HB<^U>X^"_@>5,9>']*^AOA]\&;>"&,M".GI7K-A
MX!M+-5PJ@CVKPZ^/N[(^EPN4I).1XUX/^#\$2INA'Y5ZQH_PVLK6-=\:C\*Z
MNUTN*UQM J[7D3K2GU/HJ6'A36QBQ^$=/C&!$/RJ5?#=BO2*M6BL>9]SIY8]
MC-_X1^S_ .>='_"/V?\ SRK2HI78<J[&;_PC]G_SSH_X1^S_ .>=:5%',PY5
MV,W_ (1^S_YY4?\ "/V?_/*M*BB[#E78S?\ A'[/_GE1_P (_9_\\JTJ*+L.
M5=C-_P"$?L_^>5'_  C]G_SRK2HHNPY5V,W_ (1^S_YY4?\ "/V?_/*M*BB[
M#E78S?\ A'[/_GE1_P (_9_\\JTJ*+L.5=C-_P"$?L_^>5'_  C]G_SRK2HH
MNPY5V,W_ (1^S_YY4?\ "/V?_/*M*BB[#E78S?\ A'[/_GE1_P (_9_\\JTJ
M*+L.5=C-_P"$?L_^>5'_  C]G_SRK2HHNPY5V,W_ (1^S_YY4?\ "/V?_/*M
M*BB[#E78S?\ A'[/_GE1_P (_9_\\JTJ*+L.5=C-_P"$?L_^>5'_  C]G_SR
MK2HHNPY5V,W_ (1^S_YY4?\ "/V?_/*M*BB[#E78S?\ A'[/_GE1_P (_9_\
M\JTJ*+L.5=C-_P"$?L_^>5'_  C]G_SRK2HHNPY5V,W_ (1^S_YY4?\ "/V?
M_/*M*BB[#E78S?\ A'[/_GE1_P (_9_\\JTJ*+L.5=C-_P"$?L_^>5'_  C]
MG_SRK2HHNPY5V,W_ (1^S_YY4?\ "/V?_/*M*BB[#E78S?\ A'[/_GE1_P (
M_9_\\JTJ*+L.5=C-_P"$?L_^>5'_  C]G_SRK2HHNPY5V,W_ (1^S_YY4?\
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M?L_^>5'_  C]G_SRK2HHNPY5V,W_ (1^S_YY4?\ "/V?_/*M*BB[#E78S?\
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MWPMXBCU&!/F!R*^7K4'39]YA<3&M$Z<BD7K2@YYI:Y#O"BBB@ HHHH ****
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M 49Q3-&TU+&U0 8-:=>%.;DSVH044%%%%9&@4F:&IM #Z*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@".6%9EPPS7(>+O!\-]:N0@.179TR:,2QE2
M.M4FTR6D]SXF^*WPV"-*RQ_I7SAK&F2Z/?' *X-?H_XZ\'IJ$+_)GCTKY+^*
MG@$6LTK"/U[5[.'K75F>/B*/5'._#'QM)9W$2L^.1WK[(^&OC-+NVC!?/%?G
MM;S-H]\.2N#7T!\)_';*T2&3]:6(I\RNA8>KRNS/MRUNEN%R*GKC/ ^L_;[=
M#NSD5V=>.U9GM)W5PHHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M XH :$IV,49I-U #J*;NI: %HHHH ****3 ****D HHHIH HHHJ@"D:EI&H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !13=U*#0
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MJU8;0;>E)+#MK(DSUC"U*I IDS;<U4DN=O>H: T1(HI5F%8CWV.],_M YZU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BDH/0T >+_ !>NO+@FY]:^+_B%=^=>.,]Z^O?C5-LAF_&OB[QC,9-0
M89[U[.%6AXV*>MC3^'MCYM]&<=Z^V/@_:>5!%QV%?(7PPM=US$<=Q7VA\+8O
M+AB^@K+%2+PL=;GI]%%%>6>L%%%% "8HI,FE6@!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBFM0 ZBFCK3J "BBB@!/XJ6DI: .0\>0^=:,/:OD#X
MN:5\TIQ7V9XLC\RW;C/%?+GQ<L1ME.*[L.]3AQ$;H^8;%3;ZH,<?-7UA\"[[
M_4C/I7RS<0^7JA_WJ^B?@E<[)(1GTKTZ]G X,/I(^R+&026L9]JL5E>'YO-L
MX_I6K7S[W/<6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)F@!
M:*3=2T %%%% !6-XBU9=-MF8G'%;#,%4D]!7B_QJ\8)IEC/A\8![T >6?'3X
MK)!8S1B;! (ZU^:_QN\:OJ5Y/MD)R3WKU/X]?%9Y+BX02\9/>ODWQ!K[:M<.
M2V<F@I'.M.\UPQ8YYJZ,8&:KK%ALTR28JV*"R26,R' YKM_ .@R7=W%E">:Q
M?#>DMJ4RC;G)KZ5^%7PY+-"YC_2@3/3_ (0> PT<3-'^E?37AKPRMG#'A,?A
M7*_#GPXMC#&"N*]IT?31(JX%!)9T/2]VT;:]"T/1PNT[:HZ!H^W:<5W5C9B-
M!Q02.M;<1(.*E<XJ4K\M0LM "KS4JK4<8J44 '2F-S3F-,H C*T]%I=M!;B@
M )Q30W--9LTBT 3JU.%1KVJ04 +1110 4444F 4445(!11130!112;JH!:CD
MJ2HIFZTP*-TV,UAWTV,UJWDG!KG-1FQGFM(@9MY-UK(GES4MY<<GFLJ2XYZU
ML@)G;=FLK4(=^:NK-FD=1)6B X^\T\LQXJE_9I]*[.2Q#9XJ!M-'I5(#E5T\
MCM3UL3Z5TAL .U.73QZ50'.IIQ/:K<.FGTK?CT\>E6XM/ [4 8MOIO3BM:WL
M0,<5>CM57M4X4+2 2&U51TITD:J*1KA54\U2N+X8/-,=Q+B15JE)=!>]4[S4
M/>LBXU'KS30S;-\/6GQWH;O7)OJF.]/M]4^8?-6B).U@D62M"*!77I7*V.H!
ML9-=+8W08#FDQH?-IX8'BL/4=-X/%=8&#BJEY;AP>*0V>8ZKII&[BN2U&U*,
M:]7U33]RMQ7$:UI^W=Q6B(.#N&,9-+;W6UNM2ZE"48UE;RK5LD,[#3=0VD<U
MV&F:I@+\U>7V=UM(YKHK'4BN.: /3H=5!7[U2G4@>]<)#JY"]:F&M>]8R0'9
M_;%;O4L;J]<;'K'3FM6SU3=CFI: Z>.)6I_V<5FV^H@J.:MB^4CK4V D,(H\
MM:@:\7UJ,W@S0D!<VK3@%K/-\/6F-J '>F!K*RTOF*M8IU(>M0MJ?O3L!OFX
M4=Z:UXOK7.MJ7O43:E[T[ =*;P8ZU%)?#UKG&U$^M-^V,U)H#>:_]Z;]NSWK
M%$K-4\>3BI: V8[HD]:OV]P:Q(,\5HV[=*5@-R"3=BK\;<5CV\@&*T89A4M"
M+>[BJTS;:DW@BHIOFK-C*%Q,16=-<GFM&>'.:SY[8U-@*3WA7O4,FHD=Z6XM
MV K+NE9<TTAEJ35/>J[:M_M5CW$K+FJ#7#;J=A'5PZEN/6MBSNMV.:XFSF8L
M*ZG2V+;:M =39OG%:4;<5FV*]*TE7"TAH:\E5Y+C;WHN&VBLNXN"N:JP,OM>
MCUJ/[:/6L62Z-1?:SZUFP-TWP]:8UX/6L(WA]::;P^M2!LM=#UJ-IP>]8[79
MI#>&E81JM*#49<&L[[92?:O>G8#1!!IZH#6<ES[U;AN <5#0%M;<'M2_9>G%
M/AD!JW'@XI6 H-;FHVA*UK^4&IK6P]*=@,^$%36E:R%<5%]GVFIHTVFBP&Q:
MW!&.:U8;KWKGHG*XJY'.?6BP'01WGO4\=Y[USZW'O4BW?O4M =-'=@]ZM1W&
M[O7,PWGO6C!=9[UDP-U9:=Y@]:S$N?>IA<>]*P%T/3@U4UFJ>-ZD":HI#UJ3
M-0S-3 SKYOE-<?K+<-75:@_RFN/UA_O5M$#B=8;EJY+4#G-=5JQY:N5O!G-:
MH#(DSFF+VJ>2/--6/FM$!/"QJVAJM"N*G!Q5 .+5$S4.U0EJ8$H:EW5&M*U4
M CR55FDZ\U+(U5)3R:T B:2ECF/K43+DT^..D!<AG(QS5^"Z/K66JU.C%:=@
M-R&\]ZOPWGO7-QS8JS'=[>]"0'517OO4XOO>N7COCZU*M\?6E8#IUO <<U9C
MF#9KEX;P\<UHP7GO2 WE9:?E:R%O0!UH;4 .]%@-9F6HVVUF#4!ZT_[:#CF@
M"X46G+"I[53%UGO4T=R/6D!<CME/:IOLB^E5XKH>M3_:U]:EE"FW5:?#&G>J
MLMX/6H%U *>M%A#->TJ.]A==H.17SI\6/ANEU#,PC!X/:OI$7BR<$US/B[3X
MKRT<8!R*SE$1^7'Q6\#MI\\I$>.O:O!-2A>WNF4C'-?H)\:O!*W'G,J>O:OC
M7QMX4>SNI#LQ@UQ3C8M'#1C<O-1S_NUR*DF4P,5IC?O%J$4;7@O7I;'4(R'(
M&:^]/V<?B9]E:W5YO3O7YW6;&VF##CFO9?A?\0WTF[B'F8P?6@3/VP\!>-HM
M5LX<29^4=Z](BD$D:L.]?"'[/?Q2_M".W5I<].]?;GAN_6_TR-U.3B@S-:BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BDW44 +1110 4444 %%%% !1110 4444 %%%% !112;J
M%HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ HHHH *:U.HH 93Z** "BBH+J[2VC9F/09H
MYWQEXE31[.3+A2!ZU\-_M$?%D-'<QK-Z]Z]A_:$^(@TZWN LN, ]Z_-3XR?$
MI[Z]G3S2<D]Z!H\O^*7BB34KZ4A\Y)KSZSD,C$FM+4IO[0D9B<\U5C@\E:"R
MQQ26^GM=3@ 9YJ*&3?(!7I/@3PS_ &E<1_)GI0,ZKX4>#3/-&6C[CM7VM\,_
M!<<-K$?+YQZ5Y?\ "WP!Y"Q-Y?IVKZ@\&:/]GB1=M!)LZ+HOD%0JXKTWPSIA
M94R*S-%T?S-IVUZ'H>EB%5XH)9KZ7IXC1>*UU7:,4R%-B 5)0(2F,M244 1J
M*6G4-0 QNE)3J* "HV!J>F,O- $(7FGJM/"T[;0 T#I3Z** "BBB@ HHHI,
MHHHJ0"BBBF@"F4^BJ *AF'!J:F2+N6F!A7V0#7+ZK)MS76WZ<&N0UA>&K5 <
MKJ%QM8\UCR7?S5<U1BK&N>FF(8\UJ@-6.\YZU=AN V.:YI+@ANM7K>ZZ<U:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'\*^X_A]_P @U?\ =KP<=\1]/E;]TZVBBBO*/H0HHHH **** "BBB@ HHHH
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MV5\-_P#4Q?2N?$[G3A3T6BBBO,/2"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EIK=: %I::M
M.H **** $HI&ZT+0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@!**1J%
MZT .I*6F4 .S2TRE6@!U%%% !1110 E%(U)0 ^BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** &M0O6G44 %%%% !1110 4444 %%%% !1110
M!C>(O^/=OI7S=\6O]3+7TCXB_P"/=OI7S=\6O]3+770W.3$;'RYJ_P#R$S_O
M5[?\&/\ 6PUXAJ__ "$S_O5[?\&/];#7IU?@/+H_&?7WA;_CT2N@KG_"W_'H
ME=!7A/<]Y;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK8B.-%Q7I&B:7N93B@EF[X?T[Y5XKM;.W$:CBL[2;,1JO%;JKM44"'44E+0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K(\3?\@N3Z5KUD^)O^07)]*J.Y$_A9\)?M#?ZZ
MX_&OF32_^0P/]ZOIO]H;_77'XU\QZ7_R&!_O5]AA?X1^<X[^,?7_ ,$O]7#^
M%?7O@_\ X\U^E?(/P1_U</X5]?>#_P#CS7Z5X6-^(^MR[X4='1117E'N!111
M0 4444 %%%% !124FZ@!U%(*6@ HHHH **** $Q1@4M% !1110 4UJ=2$9H
M2G4W&*-U #J*** "BBB@ HHHH **** "BBDH 6BF[J44 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4E+10 E+110 4444 %%%% !1110 4444 %%%%
M !24M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 (>E-S3J3;0 M+110 444AH 6BF[J-U #J*04M "4;12T4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %4]6_P"0=/\ [M7*IZM_R#I_]VFMQ/8^)?VAO]9<?C7R%<?\
MA@_[U?7O[0W^LG_&OD*X_P"0P?\ >K[+!_PS\ZS+^*?27P17][!^%?<OP_&-
M-7_=KX;^"/\ K(?PK[D^'_\ R#%_W:\/';GT>5?"=91117D'T84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4C?=-+2-]TT ?//QS_ -3/^-?%
MOBC_ )";?[U?:7QS_P!3/^-?%OBC_D)M_O5[>%^$\3$_$>E?"G_715]E?#?_
M %,7TKXU^%/^NBK[*^&_^IB^E<^)W.G"GHM%%%>8>D%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1132U #J*:&IU !1110 4444 (>E-S3J3;0 HZ4M)2T %%%% !11
M10 4444 %%%% !28I:* $Q2T44 %%%% "8HQ2T4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% "8HQ2T4 %)@4M% ";112T4 %%%% !1110 F*,"EHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH QO$7_ ![M]*^;OBU_J9:^D?$7_'NWTKYN^+7^IEKK
MH;G)B-CY<U?_ )"9_P!ZO;_@Q_K8:\0U?_D)G_>KV_X,?ZV&O3J_ >71^,^O
MO"W_ !Z)705S_A;_ (]$KH*\)[GO+8****0PHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8>D%%%% !1110 4444 %%%% !1110 4444 %%,ED\N,MZ5S&J>,H]/8AF H
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M **** "BBB@ I-U+3* '9I::M.H *3=13: '4M(O2EH **** "BBB@ HHHH
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MWG6J/ZBK% @IK4ZDQ0 B]:=28I: "BBB@ HHHH **** "BBB@ HHHH ****
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M<.,?6IK?Q/:R<%Q^= &U15:'4()ONN#5@,&Y% "T444 %%%% !1110 4444
M%%%% !1110 4444 8WB+_CW;Z5\W?%K_ %,M?2/B+_CW;Z5\W?%K_4RUUT-S
MDQ&Q\N:O_P A,_[U>W_!C_6PUXAJ_P#R$S_O5[?\&/\ 6PUZ=7X#RZ/QGU]X
M6_X]$KH*Y_PM_P >B5T%>$]SWEL%%%%(84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 444E "T4W=3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG&*\,\>?$;^S_, DQCWKTKXC7QMH9<''%?&GQ8UZ5II0&/4T"9W^D?%A[C4
MGFYY]:^A? GB ZA9HQ;.17Y]>#;V>;5$))^]7VW\'2\EC"#Z"@$=?XLU9[92
M0:Y32/$DLMT 6/6NR\6:,;B$X%<=I?AUH[O..] 'J6@733Q*370KTK"\.VGE
M0KGTK>H&%)6??ZDEN#\U8DGB95?&^@#K**P]/UM)F +5M(XD7*G(H ';:I)K
MFO$.M"TA?YL<5N:E-Y-N37CWCS72D<@#4 <EXS\>-#*X#_K7(Z?XUENKH#>3
MSZURGBB\DO+IL'/-6/".CRS72'!/-,5SW_P;?27.PDYKUW2<_9QGTKS;P!HA
MCCC)%>IPQB&(*/2D,DI,CUK/O]22W!^:L23Q(HDQOH ZNEK$TW6$G89:MI6#
M*"#D4 5=0D\N'->>>(/$!MV;YJ[_ %K_ (\VKQ/QI(ZL_- $\?C F;&_]:[/
MP[K9NF7YLUX-#<2?:NIZUZGX'=F9,T"/8K=MT*FI:@L_^/=/I2W-PMNA).#0
M,FJ.X;9"Y]JP+CQ JR8W5(VK++:O\W:F!YWX^\5'3V?#8KC-!\?-<7H7S._K
M53XO71W2;3ZUYAX/NI6U9>3]Z@#[2\)WGVRS#9SQ6]7(?#EBVDJ3_=%=?2 *
M2H+JZ6W4Y/-85UX@6-B-U '2T5SMGKRS,!NK>AF6900<T 24444 %%(S!>2<
M5G7VJ) #\U &CD5S_B+4/L\+$&J[>(E+8W5B>)=06:T<ANU ' >(/&K6]R5W
M]_6MCP;XK-],H+YY]:\<\:7+B];![UTGPOGD:ZCR>] 'U%8OYEJC>HJQ5/2/
M^0?%]*N4 %%)4;3!3R: ):*8)5/\0JO=7R0J?FH M4M<U/X@6-L;JFL]=65@
M-U &_144,RS*"#FI: "BF22"/K5:34(X_P"(4 7**R9-80?Q"F)K"LWWJ -F
MBH+:X$R]:F9@HR>!0 M)67?ZLD&?FK*'B1=V-] '545F:?JB7&!NK2H 6L#Q
M!JPLHV.<5LW$HBC)KRCXBZWY,4F&[4P([CQX$N"N_OZUV7A?7AJ 7YLU\IWG
MB1SJ)&_^*O9OA;K1FV9;-(#W6BHX)/,A5AZ4^@!:2J%]J26ZGYJQ6\2*),;Z
M .JHK'L-72<CYJUU8,,@YH 6N0\7W[6L+$''%=?7(^,+$W$3@#M0!Y)=>+)5
MO"NX]:]'\#ZH]X$R<UYS=>%W:\)QWKT?P3IC6:ID8H ]!HJ-IU3J:B^W1_WA
M0!9HK+NM52-3AJS?^$B7S,;J .FHJA8ZDEPOWJOT %%%-9@BY)P* '4F:Q[[
M6$@S\U9?_"3+OQNH ZVBLK3]62XP"U:@8-R#D4 +1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %4]6_Y!T_^[5RJ>K?\@Z?_ '::W$]CXE_:&7]Y
M/^-?(,X_XG!_WJ^O_P!H;_63_C7R#<?\A<_[U?8X/^&?G&8_Q3Z3^"'^LA^H
MK[D^'_\ R#%_W:^&_@A_K(?J*^Y/A_\ \@Q?]VO$QVY]-E7PG64445Y!]$%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(WW32TC?=- 'SS\<_
M]3/^-?%OBC_D)M_O5]I?'/\ U,_XU\6^*/\ D)M_O5[>%^$\3$_$>E?"G_71
M5]E?#?\ U,7TKXU^%/\ KHJ^ROAO_J8OI7/B=SIPIZ+1117F'I!1110 4444
M %%%% !1110 4444 %%%% %+6/\ D'3?2OD?XO?\?LGUKZWUK_D'2_2ODCXO
M'_39?K30F<_\-O\ D(I]:^P/!/\ R#D^E?('PU_Y"*?6OK_P3_R#D^E-@CI:
M:WW33J:_W34C./\ %'^I>OGOQU_Q\/7T)XH/[EZ^>_'7_'P] B#P)'NO4^M?
M0^EW7V'2\YQ\M?/_ ,/U_P!,7ZU[9J,QAT4D?W:!G">.OB8=-D=1)C'O7"V_
MQ<EN),"7/XUY_P#%G5)FU"558]365X!T6YU2X7ACDT"/9_\ A8%Q,F=YJC-\
M1)[=LER/QK4M/AW<>2OR'IZ5RWC3P9/81L=A'% K';>%_BB]Q,J&3]:]?TW7
MOMEAG=G(KXT\/R3V>IJ"2.:^EO MXT^GJ"<\4#,#XF:L\*2D&OGK5/$DGVX@
MGO7T3\1M):ZAD(&>*^>M8\+R_;"=IZU2$SN/ >O%I(\^M?0WAGQ$([1><<5\
MZ> _#\BR)Q7LT=K)8V.>F!5,2.FUKQJMNAP^/QKS;7OB1(K,%D/YUROB[Q)(
MDS('/6L72=-GUR08!;-(HZ-?B#<2-]\U.?B%/#R7/YU):_#>XX/EG\JSO$7@
M>XM8B0A'% CK_#/Q+>>55,G?UKV;0=<%]: ELY%?(FE6T^GWHSD8->V^$/$1
MAMT5F[4AG5>--K1N17CNI+_I1X[UZ1KVK"ZA/.:X"^BW3%O>D!U/@@ 2)GUK
MU.;5ELM/)!QQ7C?A_4!:,N3BMS6O$F^S*A^U4(R_&'Q(>SE=5DQSZUR-O\1I
M[B3AR?QKF/$L,^I7;;<G)K2\+^";BX*DH30!U7_"?3QQ'YS7GOC3QK+>*X+$
M_C7H=U\/[@0'Y#TKRGQIX8GLV?*GK0!0\)2?:]20GNU?7WPKC$-G'GTKY"\"
MPF+4D!]:^NO DPM]-1NG%(:.TUW54L;=CNYQ7C?B[XA-;LP1_P!:N?$CQC]F
M5TWXKQA[I]>NB <Y-(9NR?$6YDFX<_G5M?'5PBYW&DTOX;RW$:R;#S6CJ7P]
MDAM<[>U421:5\2I?/"F0]?6O8/!?BH:@$W-G/O7S5<:!-8W6<$8->@>#-:;3
M]NYL8I#/I82+MW9XQFN \;>*AIZ2;6QCWK-/CY5@V^9V]:\V\::\VI!PK9S2
M&9^L?%"9;AE$A_.H[7Q]/,N=YKB5\.7&H760I.37;:-X!N&A!*'I3)(=4\?3
MK$07/YUYQKGB1[ZX.6SS7?>(O ]Q#&QV&O,-2T>6UNOF!'-,#T?X:KYES$?>
MOJWPJNW35_"OE3X8_)<1 ^M?5GA8YTU?PI,9LTAI:1ONFI&<_K6H?948YQ7E
MOB;QXUB6P^/QKN/&$A6%\5\Y?$":4R. 33 V;KXK2-(0)/UI5^(,\R9#G\Z\
MBL;&XNKH#D\UZCX=\#W%W:YV$\51(YOB%<1R??-==X7^(CRR('D_6N5OOAS<
M*K/Y9X%<K,LV@W&"2N#0!]=>&=<2_B'S9XJ7Q+J7V.W9@<<5XU\,_&!F9$+U
MW7C;4"^DNP/\-(9Y9XV^*3:?-(HEQCWKBH?B[/<28$I/XUYM\3-0GFU*1%8_
M>J;X?^%[G5IE.UCDT"/:-)^(-Q,5RYKTCPWXN:15+O7GFD_#JXAVYC-:=];R
M:"AW97%,>IZ-J_C(06Y(?G'K7E/B+XDRK.RJYQ]:P-4\6/<L8@_M5.S\+W&M
M2A@I;)H$;%OX]N)!G>:'^(\]O(/G/YU>L_AO<)'S&?RK U[P)<PL2$- 'I?@
MWXB/>,@:3]:]4AU]9+/=NYQZU\KZ&LVCSC=E<&O4=%\3F>$1[\\5(R'XG>(G
M6.0*U?,GB'6)9+]CD]:^B_&&EOJ-NS 9KP'Q%X=>*^/R]Z9+N=A\,=:ECN(^
M>]?4OA;73)9Q[F[5\R_#?PZ[2(0M>Z6Y;2;,$\8%(I'5>(O% M;=B&[5XWXD
M^)4T<[*LAZ^M/\3>)C<,T8?VKC5\/2ZO/N )R:8&U;^/;B;G<?SI'^(5Q!(/
MG/YUIZ5\.9/*!*=JIZS\/98U+!30(ZOPC\0Y+B1 S_K7M?A_5DO[<?-DU\FV
MMO+HMP,DC%>K^!?&6-J%_P!:0SUWQ!?"SM2V>U>/:W\0A:WA3?W]:[KQ'J)O
M-,9@?X:^7O&]U-'JC8)^]0,^DO!_BL:DHPV:T_%/B#[!9L^['%>3?".XDDC3
M<:Z'XH7C1:8^#VH XC7/BPUO=,@E[^M0VOQ.FNEXD)_&O#-9FGNM6902?FKT
M?P+X1N=0C0[6.:8CK;KQU<;2=QK+_P"%H36\V#(1^-;UU\/9_L[GRSTKRGQ7
MX;N+&X/RD8-(9[WX(^(K:A(@,F?QKW#1[H7=HK9S7Q=\.[B:VNHPQ/6OJWP9
MJ7F6* GM0!V=%,C;<N:?2 ***0T +13=U.H **** "BBB@ HHHH **** ,;Q
M%_Q[M]*^;OBU_J9:^D?$7_'NWTKYN^+7^IEKKH;G)B-CY<U?_D)G_>KV_P"#
M'^MAKQ#5_P#D)G_>KV_X,?ZV&O3J_ >71^,^OO"W_'HE=!7/^%O^/1*Z"O">
MY[RV"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1NE+10 RG4M% !1110 44
M44 %%%% "49%(U)0 ^BBB@!,T4C=:%H =1124 &113:<M "T444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444AX
MH &.%)KYO^/?B[^RK:XP^, ]Z][US6([&QE8G!Q7PA^U!XW'EW063U[T#/DO
MXV?$AKJZG3S,\GO7S5K5U_:$S-G.36Q\2O$,EUJ<OSD_,?YUREI(95R3058$
MB$8S26\A:X ]ZLNFY<5-I.EM/>+QWI#/4OAKH/\ :$T65SR*^POAGX&$<4+;
M/3M7A'P5\-[I(25[BON3X<^'46UB^7M1L(Z+P?HIMU0;<5ZUH.GG:F16+H>B
MA67"UZ'H^G;$7BF2:6FVOEJ.*UT7Y:C@AVJ*L4"(9%J+G-66%1E.: &K4ZTQ
M5VT]>E "T444 %%%% !36IU% #*=FEIE" =NHS4>32K0!)135IU*X!1113 *
M*** "BBB@ HHHJ; %%%(>E"T #TJ-J=2[35 1T\-Q3&6DR: &S#=6#J4.[-;
MK5FWT>5-:1&<#K-KUXKB=4M?F/%>E:Q!UKB-5AZUTQ07.,G@^>I+6#+58N8\
M2&G6J_-6B0C3L[3<!Q6Q;V7 XJK8 8%;4 '%5R@$5L%%2_<4U)P%JK<3;5-3
M80R:ZV=ZR[K4MO>H+Z\VYYKG+Z_//-4,T[K6>O-9=QK&>]8MQ>LV>:I-,S&G
M89K3:J3WK-N-09L\U!M9J/LC-VHL(ISS-(:@6W:1NE;,6DLQ'%:EEH?(XIC,
M2QTAI"/EKIM-T/I\M:^GZ*%QQ71V>FJ@'%*XC(L]&"@<5I1Z:%[5K) $7I4,
MK!:+@4_LJKVIC0+3IKK%59+SWI7&)+;*U5VL58]*<U\/6FK>CUHN(CDTM/2H
M?[+7TJ[]K![TZ.3<U',.Y';Z> 1Q6O;VNT"FVL>[%:D4'RT^816^XM5IKH+W
MJS>GRU-<OJ6H>7WI7 UFOESUIR7"MWKBY-:VL?FJ>UUK<?O5# [-2K4NP5AV
MVI[L<UI0W.ZLQEV.,5<AAZ<54@.ZM*W4\50B>*$<596.HUJ;=3 1ABF9I7:H
M6:J E\RD\RH-U.4$T 65:I14*Y%2*:0A=QQ49DQ0[8%5I),4#)S-[U"\HJI)
M<;>]5Y+OWI@76D%1/.!WK-DOO>J<VH>]%@-.2\"]ZIS:A[UD3ZC[U0EO\U'*
M(VI=0]ZJR7WO62UUFHI+KWI<@S0FO/>J4EUG-57N,]ZB\TT^0"W]HI&N*J^9
M[T;O>GRC'22DU79C3V-1-6BB ;J7S*CII:JY219)*9NS36-"]J+#)%IXZ4BB
MG4P"F,U*U,I#0NZC=2455ADFZG!JAYIPS5I$DX;B@M48)Q02<4[ .W>](6IF
M32K56&4[YOE-</K\F U=MJ'W#]*X#Q%)C?3L(X+6),L:YYV^<UK:M)\YK#:3
MYJJP&I9MTKH-/[5S%G)S71Z8V2*8'4Z>O2NGL$X%<YIH^[74V*C J9(#3A7B
MIO+I(,<59517+) 1K'4J)3]H%&X"DD C+Q529>*LM)UJ"0@TP,R>/K55H36J
M\>ZF?9\T<H%".$U<A4BIUMQ4JP@4^4!]N2M7%F(JJJ[:5FP*KE ==7'RFL*^
MNNO-7KJ;K6#?3=:'$"E<7!W5#'+DBH9G^:B(]*7*!M6C9Q6Q;]*P[(]*V[8_
M**?*,O+4BOMJ -Q1FAQ$:=M<;36]I]YTYKDXW.ZM:QN-N.:R<0/0=+NLXYKI
M;.0,HK@=+O.G-==I]SD#FI<0-QONUE7A(S6DC;EJC>QY4U SG;RY*YK.;4MN
M>:LZHI4FN8O)C&QJ@-\:UM_BJ"?7O]JN2FU(KGFL^XU9L]:GE&=>^N;C]ZIH
M=5#=ZX#^TF)ZUHV.H'(YJA'HMG=!\<UKPH)!7%:9?=.:ZBQO.!S3)-0V(9>E
M5+C2P<\5>CO%V]:;+=KZT6 YJ]T<'/%<_>Z'DGY:[:XF1N]4)$22BPSSZZT'
MK\M85[H)Y^7]*]7?3UD[50NM#5@?EK:GHR['CEUHI4GY:J-I;+VKU.\T$<_+
M61-H8';]*]*-2R)9P2Z:WI1)I9]*[9=&']VAM&R.E*52XCSJYT\J#Q6-=0LN
M>*].O-!+*?EKG=0\/MS\M<\I@<!,Q4TQ6)KH[K0'!/RU771&!^[6+D!6TY,L
M*[&PCW1 8[5DV&CLK#Y:ZBPL650,5BV!PWC+P_\ ;+>3Y<\>E?+WQ,\&^2TK
M;/7M7W3<:#]JMSE<UX;\6?!FVWF.SL>U<E1%)GP-X@MS9S,,8K%23S!BO0/B
M-HK6MW)\N.:\_AC*M@US%C(X=LV[%>H_#GQ3_9%U%\^,'UKSC;WIMOJ;6ERI
M!QS0!^GW[/OQ,-S]GC\W/('6OO;P'J'V_2U?.?EK\</V=?&CQ7UL#)_$.]?J
MG\#_ !4EYI<2L^<IZT$-'LE-:FQS+(,BI*"1J]:=110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(WW32TC
M?=- 'SS\<_\ 4S_C7Q;XH_Y";?[U?:7QS_U,_P"-?%OBC_D)M_O5[>%^$\3$
M_$>E?"G_ %T5?97PW_U,7TKXU^%/^NBK[*^&_P#J8OI7/B=SIPIZ+1117F'I
M!1110 4444 %%%% !1110 4444 %%%% %'6O^0;+]*^1OB\?]-D^M?76L?\
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M_P#R#%^@ILE&]2-]T_2EILGW#]*DHX/QAS&]>%>++$7$S<=Z]R\7?=:O'M<
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MSU2 ?YE1R2<&F;ZAEDJP*MY+UK"O).M:=Y)UK$NFZT@*<C_-3XFZ56=OFJ:
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M@C/S5]7?$!=VD-_NU\[0P#^WAD?Q4(1[=\&_A^EQ;(Q3/RYKV&/P6EO"V$Z
MUD?!I572Q@<[:](E_P!4_P!#4E'RQ\5F.FR2*.*\Q\.R-J>H*A.<M7I7QSYN
M)<>M>:_#M?\ B;1Y_O50F?2?@;P"EQ8K(4["NS_X0E!"5V=JT? ^W^PXL#L*
MZ&I&>(>+/AXK*[B/]*\GU33SHMP<?+@U]7>)(XVLWR!G%?,_Q*VK<2;?6@DM
M^$];-PP0MFNE\0:6+JP9L9XKS/P/(WVQ1GO7L5XP.D\_W: /!+W2 NJ8Q_%7
MM?PZT<"T5L=J\OU'']K?\"KVWX>X_L\<=JH$<]\1KXZ?;N <<5X<VK&^OMI;
M/->N_&4L(9,>E?.UC=O'JO7^*@&>Z^$="BF57(KO%T^&.';@=*\[\):RT=JM
M=!-KTF.*5AHK^)-#BF1B *\UOK=K"Y&WCFO0KO5FFC(-<Q>V7VN;..],#I_A
M_JTI>-237=^*B9M+8G^[7)^!M#\N1#BNP\51^3IK#VH ^>-2MR-:_P"!5[K\
M.UVZ:O\ NUXEJ3?\3@_[U>X?#[_D'+]* /.OC4IDC<5X]X-\._;=87(S\U>U
M_&"/<'KA/AS$JZLF1_%0'4^BO WP_0:3&_E^E:GB;P6BZ3*=G:NO\)X_L2#'
MI4_B#']DSY]*5P/B?QUX=%OJ3$+CFNS^%:?9WC%5?B-M_M"3ZU:^'+?Z0@]Z
M8CUG7O,FTTA>>*\"\8:5<-=.<&OJ"STM;RQ ([5QWB;P3'(6;:*$,\ T*T>"
M8;QCFO6O#<D+1JK$5S6K^'VL&8JO2L;^W)]-]1BF(]?DT6SO@"0IK9T#PO;0
M2*5"UX3#\3Y+>0*S?K7H?@WXBK>2("_6I#J>]Z7"(80H]*O5A>']46\A4Y[5
MN4BA&H6E(S0!B@!:*** "BBB@ HHHH **** "BBB@ HHHH *IZM_R#I_]VKE
M4]6_Y!T_^[36XGL?$W[0W^LG_&OD&X_Y"Y_WJ^OOVAO]9/\ C7R#<?\ (7/^
M]7V.#_AGYQF/\4^D_@A_K(?J*^Y/A_\ \@Q?]VOAOX(?ZR'ZBON3X?\ _(,7
M_=KQ,=N?395\)UE%%%>0?1!1110 4444 %%%% !1110 4444 %%%% !1110
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M["^%+!M''^Z*^,]#M9O[=7@_?_K7V3\)5*Z0,_W12 [FZ_X]Y/\ =KY^^)3
M32?6OH&Z_P"/>3_=-?//Q-A=II,#O30'G^DR#[:.>]>X^"F'EQUX/H]O*+T<
M=Z]U\$1L(X\BADGJ=C_J15JJNG_ZD5:I%!1110 4444 %%%% !1110 4444
M%%%% &-XB_X]V^E?-WQ:_P!3+7TCXB_X]V^E?-WQ:_U,M==#<Y,1L?+FK_\
M(3/^]7M_P8_UL->(:O\ \A,_[U>W_!C_ %L->G5^ \NC\9]?>%O^/1*Z"N?\
M+?\ 'HE=!7A/<]Y;!1112&%%%% !1110 4444 %%%% !1110 4444 (31NI&
MI* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A-&ZD:DH ?11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.:D#TC2[[@<UT5O> KUKSJQOMH'-;=OJN!]ZLI(=SK)95D'6LVZMUDS5&/5
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !63XF_Y!<GTK6K)\3?\
M(+D^E5'<B?PL^$OVAO\ 77'XU\R:7_R&!_O5]-_M#?ZZX_&OF32_^0P/]ZOL
M,+_"/SG'?QCZ]^"/^K@_"OK[P?\ \>:_2OD'X(_ZN#\*^OO!_P#QYK]*\'&_
M$SZW+?A.CHHHKRSW HHHH **** "BBB@ INZEIM #A2TBTM !1249% "U!??
M\>DOTJ>H+W_CTE_W: /FOXK_ /'Q)7#>$9,7RCWKNOBLI-P_UK@O"N1?K]:H
M1[C86?VK3P,9XKCO$&A_9YF?;CG->F^#[3[19J".U5/&^B".T=PO:DAGC5QX
MD_LV,INQ7(ZEKC:I<X#9YJAXZO)+6[=1QS57P7"^HWJ9&>:=B6>V_"S2V9D8
MBN^\>1B+1W'^S3OASH/V>TC?;BI/B@IBTR0>U SY/U;_ )#Q_P!ZOH;X6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[J8JRJA1@4ABTU_NFG4V3[A^E(#A?%S?NW'M7SYXZM3<2/BO??&#':]>)>)
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M]_2O1?#^AFT51C%=6--@'\%3+;HG08H8"6Z;$Q4U)2T@"BBB@ HHHH ****
M"BBB@ HHHH **** ,;Q%_P >[?2OF[XM?ZF6OI'Q%_Q[M]*^;OBU_J9:ZZ&Y
MR8C8^7-7_P"0F?\ >KV_X,?ZV&O$-7_Y"9_WJ]O^#'^MAKTZOP'ET?C/K[PM
M_P >B5T%<_X6_P"/1*Z"O">Y[RV"BBBD,**** "BBB@ HHHH **** "BBB@
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M+FL_^>R_G7YU_P#"WKW_ )[-_P!]4?\ "WKW_GLW_?5']FA_;)^BG_"YK/\
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M ,+>O?\ GLW_ 'U1_P +>O?^>S?]]4?V:']LGZ*?\+FL_P#GLOYT?\+FL_\
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M%(!BD4+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&-,V(O%>@:?;^6@XK&T6Q\M1Q71Q@*HH$245"\N#3?.%,18IK5#YPI/.'K2
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MV[<!JU(8;V=<$-7T$WPHB9L^6/RJ:#X711_\LQ^5,5CYIO/"MQ=29*-UKMO
M'A.6UN$)0CFO:E^&T7_/,?E6KIW@V.R8$(!^% 6+GAZQ'V$*P[5@>-/"*74;
M,$SQ7<6MN+>/:*6ZMQ<1E2*D9\H>*?#L]C(WEJ1]*XQI-0CDVC=@&OK36/ L
M>H$G8#^%<Z_PAB9R?*_2J3$?.++?W  .ZN@\+Z'<RW"EE->Y1_"6)?\ EG^E
M:VF_#R*S8'8!^%.X6*_@?0ML2;EKL)M#ADC88&<5-INGK8I@#%7J@9XEX_\
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M 8HN%B;P[HJV]J,C'%;\<8C&!1#&(HPHI]2,***:U #J*93Z "BBB@ HHHH
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MX6A,-N 1VJM:^%$MVSLQ^%=!:6HMUP*8BQ1112&%%%% !1110 UJ :7%&!0
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M?#^RCX5_X57=?\\F_*C_ (57=?\ /)ORK[J_X5+%_P \A_WS1_PJ6+_GD/\
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M^5?=7_"I8O\ GD/^^:/^%2Q?\\A_WS1]?#^RCX5_X57=?\\F_*C_ (57=?\
M/)ORK[J_X5+%_P \A_WS1_PJ6+_GD/\ OFCZ^']E'PK_ ,*KNO\ GDWY4?\
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M@ HHHH **** "BF[J6@!:**:U #J*93Z "BBB@ HHHH **** "BBB@ HHHH
M***3=0 M%(#2T %%)NI.: '44G-+0 4444 0W?,#5YCXNM6DW<5ZC,NZ,BN8
MU?1_M&>,T >#7NFO]ISM[UV/@VS\N5,BN@N/"!:3.W]*U='\.FU93MQ0!V>F
MX%G'@8XJU5>RC\N$+5B@ HHHH **2CF@ H'%+10 4444 %%%% !1110 4444
M %%%% !1124 +12<TM !1110 4444 %%%% !1124 +13=U.H **** "BD:DY
MH =1110 4444 %%%% !2$9I:* $VTM%% !1110 4444 %%%% !1110 4444
M%4]6_P"0=/\ [M7*IZM_R#I_]VFMQ/8^)OVAO]9/^-?(-Q_R%S_O5]??M#?Z
MR?\ &OD&X_Y"Y_WJ^QP?\,_.,Q_BGTG\$/\ 60_45]R?#_\ Y!B_[M?#?P0_
MUD/U%?<GP_\ ^08O^[7B8[<^FRKX3K****\@^B"BBB@ HHHH **** "BBB@
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MH =12"EH **0TFZ@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[LVLB#[##_<%'V.'^X*GHHN%D0?8X?[@H^QP_P!P5/11<+$'V.'^X*/L</\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M)\3?\@N3Z5K5D^)O^07)]*J.Y$_A9\)?M#?ZZX_&OF32_P#D,#_>KZ;_ &AO
M]=<?C7S)I?\ R&!_O5]AA?X1^<X[^,?7OP1_U<'X5]?>#_\ CS7Z5\@_!'_5
MP?A7U]X/_P"/-?I7@XWXF?6Y;\)T=%%%>6>X%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 RBGT4 (M+110 44QY!'UJ$WT8
M.,T 6:2HDN%DZ&I%H =1110 4444 %%%% !1110 F113:5: '4E+10 RG+TI
M:* "D:EHH 93Z** "BBB@ HHHH **** "BBB@ HHHH 3(I#24JT "TII:1NE
M #:<O2FTY>E "T444 %%%% !3&B5NHI]% $7V6/^[2K;HO1:DHH 0#'2EHHH
M ***BDN%CZT 2T566^0]ZF60-TH ?1110 444C=* #(I:93J %HHHH ***1F
MVB@!:*@:Z5>M,^WQ^M %JBHDN%?I4E "T444 %%%% !1110 4444 %(U+10
MRG4M% !1110 4444 %%%% !1110 4444 %%%1R3+'R30!)169<:Y!;]2*AC\
M26\C8!% &S14%O=+< %:GH **** "BBB@ HHHH **** "J>K?\@Z?_=JY5/5
MO^0=/_NTUN)['Q-^T-_K)_QKY!N/^0N?]ZOK[]H;_63_ (U\@W'_ "%S_O5]
MC@_X9^<9C_%/I/X(?ZR'ZBON3X?_ /(,7_=KX;^"'^LA^HK[D^'_ /R#%_W:
M\3';GTV5?"=91117D'T04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4C?=-+2-]TT ?//QS_U,_P"-?%OBC_D)M_O5]I?'/_4S_C7Q;XH_Y";?
M[U>WA?A/$Q/Q'I7PI_UT5?97PW_U,7TKXU^%/^NBK[*^&_\ J8OI7/B=SIPI
MZ+1117F'I!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% "-TI,9IU)0 4M-\P4;QUS0 ZBJTU]'#
MU-0KJT3' (H O8H%,AF$PR*DH **KW%XEO\ >-46\00JV,B@#6HJE;ZG'/T-
M7!S0 M%%% !144UPL(^8U1DUV",X)% &G16=#K,,W0BK\<@D7(H =113&E"]
M: 'T5&)U/>FR721C)- $U%9S:S"K8R*GAU".;H: +5%)UI: "BBFR2"-<F@!
MU%4)=6BBSDBF)KD+MC(H TJ*AAN5FZ&IJ "BDIAF4=30!)14?GKZU#-?QP]3
M0!:HK.76H6;&15N&X2;H: )J*** "BFLP1<FJ<VJQ0]2* +U(1FLQ=>A8XR*
MNPWB3=#0!-MI:** "DI:BEG6$<F@"6BLZ36H8S@D4Z'5HINA% %ZFTJ.)%R*
M=0 F112$8I5H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&\1?\>[?2OF[XM?ZF6OI'
MQ%_Q[M]*^;OBU_J9:ZZ&YR8C8^7-7_Y"9_WJ]O\ @Q_K8:\0U?\ Y"9_WJ]O
M^#'^MAKTZOP'ET?C/K[PM_QZ)705S_A;_CT2N@KPGN>\M@HHHI#"BBB@ HHH
MH **** "BBB@ HHHH 9(_EQLWI7G?COQ<FFVLGSXXKM]=NA9Z;*Y..*^0OCA
MX^-JLRK)CKWKKP])U)'GXRO[&%SS+XT?$;SI9T63U[U\S7TDNN:CP2VYJN^,
MO$TVKZFZARV377_"OP3)JU[$S(3D^E?84X*A"Y^>U:DL55LCKOA-\+Y-0DB=
MH\_A7VM\+_A;%96L;-&!@>E9?P@^&L=G:1.T6./2O?--LDL;98U7%?-8S$N;
MLC['+\"J<5)H9IFFII\850 <5>HHKRCZ#8**1J3)I#'44E+0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 444TT .HIE.% Q:***!!1110!%<0K<1
M%&&0:\[\<?#V+4[&0B,$\]J])ILD8DC*L,@BKC)Q=T9SIQJ*S/SO^,/PE:W:
M9TB]>U?+^KZ3/H>I'@K@U^KGQ(\!1ZG9S,(L]>U?#'QH^&[6-S,ZQ8Y/:OJ,
M'BE)<K/A\RP+IOFB8_PD\>&PN(5:3&".]?<?PM\>)?6L2^9G@=Z_+NUO)M#U
M(#)7#5]3? _XB-YD"-+Z=Z>-PZDN9&>6XQTY<C/T&L;H74(8'/%6JX_X?ZRN
MI:>OS9)6NPKY62Y78^]A+FBF)BC I:*DL**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***1CM4F@#QGXP>(/[/M)_FQP:_.WX[>-O/
MFG7S,\^M?9'[2VO_ &.UN<-CKWK\OOC!XL:;4)EW]Z!H\Q\87/VRX=LYYKFH
M8]F35^XN3<DD\U69<*:#09;MNN *]F^&.E_:KB+C/->-Z?"TETO?FOI7X*Z.
M9)X,KZ4"9]/_  J\.;(XCM]*^G/!=G]G6,8KS'X9Z"%M8CM["O:]#L_)V\5H
MB3MM-^X*T7;Y:S;%MJBKDDHVUH2032XJA/<4^[F"YYK%NKS;GFFD!9GN1@UG
M7%T.:I7%_P!>:S9[_.>:W0%JYN^M95Q>=>:@N+SWK-GNL]Z=@)YKSWJG)='U
MJO)-5=I.M5R@3R7%59IJ8[U7D:J 222FK)4+MUI%:K0%Q6I2U0JU*7K2P!(:
MA:E9JB9Z8#S2;JB\RDW58%CS*C:2F[O>HV:J E$E!;-0;Z57JX@*ZU _%3EA
MBJ\K=:T A:3;4334V5NM5F;FHD!9$F:7K59&J>,]*YV!)MHIR]*&K)@,;K1F
MANM-S6; L1KNK0M;4MBJ=K\S"NDTNU$A%9L";3]/)8<5U.FZ?M XI=-TX<?+
M71VECM4<4@'6-OMQQ6G&X4"J^WRQ5:>ZV9YH MW5T%4USFJ7@YYI;[4NO-<U
MJ>I<'F@"IJ5Z-QYK$FO/FZU#J%Z68\UF^<6;K30%R:?<IK(O,MFM%4+BFM8E
M^U;(#F)K4N3Q3K?2V9QQ72QZ.7;[M;&GZ!N8?+3 Q])T0L1\M=SHNB85>*O:
M3H 7'RUUFGZ6(P.*BY14L=+VJ.*U1;A%Z5:$:Q+52ZNE2@1!<.$6N>U*_$>>
M:MWVH@*>:XS6M2Z\T")+K6-K8S5==4+]ZY>XOF:0\U;L6:0BD!O><9J9]A,O
M:I]/M6;'%=!9Z;G'%2!C6FCG</EKH;#3?+QQ6I::6./EK2CL0J]*0%>UC\L"
MM&&;;BH&CV5 TA4T@-J.Y]ZL"\ '6L".XQWI7O<+UHW&:MQ?@*>:Y_4=2Z\U
M6OM3VY^:N9U+5NOS4TK")M3U3&[FN.U;6/O<TFJ:M][YJY#4M0+$\TP$U35"
MQ/-<]<R&9C2W$C2,>:LV-BTS#BF58CT_36FD'%=]X;T$[E.*;X?T#>R_+7IF
M@>']NWY:39)=\.Z7Y2KQ7=6,8C05GV-@(5'%:2,$6HL,EFDP#6-?35<N+CWK
M$OKCK5(#,OYNM<]>3=:TKZ?KS7/WDN2:8BO--47F5#))4?F4[ 6]_%&:@5JD
M5J %:HWI^:8RU2 B[TJMS2[?:C;5@/5J8S4OW:C9N* &,W-)N--9N:3-58"9
M6/%/W5#FAFI) .=^M5I9L4LTE4+B;KS38#+JYQWK,FN?>GW$FZJ,F320"M.<
MTGFDTQ8R:E6$U0$;2&G1S&E:$TBPFJ OV\QK1BFZ5EV\9K1B4T 3F7BHS)2[
M::$H <K581J@"TI?;4@6?-P*C>X%5)+C'>JDEU0!?:XYI5G!K(^U?-UJ2.Y]
MZ: W$DS4F:S(;CI5R.7-4@)6J&2I2V:C>M$@*\AK-OCA36C)67?M\IJ[ <GK
MLGRM7F^N-EFKT'76^5J\XUIOG:J0'.3?ZRK5JO(JE(W[RK5JU4!T>G]JZC3>
MU<KI[=.:Z?3&Z46 Z_3>@KI;)N!7+Z:WRBNDLVZ<TF!MPMTJY&:SH'Z5;23
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MK_>'YT>8O]X?G0 NT4M)N!Z$4M !5*YU2.V)#$5:E<1QLQ["O&OB%XT&FR.
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M&?%2W<:#?G\: /0NM%5K.X$Z@BK5 PHHHH **2DR: '44BTM !1110 4444
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M1R,M68KIABF,[2'4 W>K:W 9:Y"VO&]:U[6X+**D1KLH:D6W'I386W5<C6D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%:G]W0QGO%O_ ,>Z_2N!\;2E%>N^MQ_HZ_2O/_',9*O4C/'=2O6^TMSWK?\
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M%>?R:3.]Q\P/6OH/5-)@D0E@*XG5M-M[=B0%HN48'AS0XPH+K6GK>GVL-N>
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M<*>BT445YAZ04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]7M_P8_UL->(:O\ \A,_[U>W_!C_ %L->G5^ \NC\9]?>%O^/1*Z"N?\+?\
M'HE=!7A/<]Y;!1112&%%%% !1110 4444 %%%% !1110!^(EC>F5@,UZ;\/[
M?S;N,X[UY!HLA:1:]O\ AI'NN(Z^^KZ(_)\-[TD?9'P6M1''!QZ5])6_^I3Z
M5\_?!^/$,/X5] P?ZE/I7QF)^,_2<&K4R2DI:*Y#O"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHI-U "T4@.:6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI-U "T4FZEH **** "BBB@ HI*6@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BD)Q1NH 6BBB@!I-"T$4** '
M4444 %%%% !1110 4W)IU-VF@!5I:1:6@#R?XNP"6WF^AKX'^,EF%N)3CN:_
M0'XIJ&M9OI7PA\;(P))C]:]_+WL?)9LM&>2>"9C'JJ#./FK[_P#V>9_,@M_H
M*_/7PK)MUA?]ZOO[]G&3,-O]!79F"]P\[*'^\/J:BD%+7RA]\%%%% !1110
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M[>M"-N*8%UI.*J2M3F?@U79NM "AOF-2QO5=>M2K5 3-)\M4+B2K+=*I3\T
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M444 %%%)0 M%-W4M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%>B1-M@%>5^#]2,TH&:]2ARUL#[4",35/O'-)H>W[0OUIFK9W&F:&3]I7ZT
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M@UY7\4M126&3::RK7QVT[%=_ZU@>+M1>]MV.<TQ,\FNVW:F?K7MWPK95\O\
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MG_715]E?#?\ U,7TKXU^%/\ KHJ^ROAO_J8OI7/B=SIPIZ+1117F'I!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !5'5EW6YJ]4%U'YD>* /(O%EBTF_ K@&T=_M.=O>O==4T/
M[1GY<U@GPB/,SL[^E-"9E^"[)HF3(KUNUXMT'M7+Z/H?V4CY<5U4:[8U%# P
M_%>EC4+1AC/%?/OC'P05G=PG?TKZ>EC$J%37*>(/#:7:-\F30@/F.TO)=!D&
M,C%:+?%"X5@N\UVOB3X=O,S%(S^5<7)\+;DRD[&Z^E4(IZEXHGUK@DG-:'A3
MPX]U=*Y7O6UHOPUEC9=T9_*O3_#/A%;/;E,?A4C+6@Z 8[%5QVKB_'G@]YM[
M!:]KL[588@,52UG28[R$C;GBBXSY-DM9M$G+ $8-:4/Q(GLXUCW'BO3/%'@,
MW#-MC_2O.K[X7W#3'$;?E3$0WWCZ;4K<(6)XK(TW2WU2]#%<Y-=-IOPRG5AN
M1ORKOO#'@/[*ZEH_TH N>#_#?V>Q4[>U<A\4;416[U[K8::MK9XQC KP[XP3
M;5D I#/G:YD9-0./6NY\.Z[/9QJ02*Y*VL3>:ETSS7JGA_P+)>6JD(3Q57)*
MUQX^N?+V;C6$VH7&K3\DG)KLI/AG.S?ZL_E6SH?PV>&12T9_*DP(? _AMIF0
MLM>O6OA5/LZ_)VIOA?PVMBJ97%=JJA5  X%2,\L\6>#Q]G)"]J\1\1:7+I]P
MQ4$8-?6NJ6:W=N01DUY9XH\#_;&<JGZ528'B6G^+KG3>-Q&*OR_$BYD!3>>:
MW+[X8RLS;8S^59\?PON/.!\MORIB,J-IM>D&[)S7H_@;P#F59"E6?"GP_:U9
M-\?Z5[!H.DQV%N,+SBI&94^D_8]**@8P*^</B1I+W%\^ >M?6.H0^=:LN*\N
M\0>"?MMPS;,\^E SS3X4Z.]O>1DC'(KZ>L1MLX1_LUYSX7\(#3YE.S'X5Z5"
MNV%!Z"A@8/C*(RV.!Z5\_P#B#27:\)QWKZ2U>U^U0[<5P>H>$?.F)V=Z:$<#
MX9TQMH!%;^H>%VN8<[>U=5I/AC[.P^6NHCTE/)P5I#/G/6M!ETYF8 C%84?C
M"?2WV[B,5[[XH\)BZC;:GZ5Y-K?PSFEF8K&?RIH1EM\2)IH=I8UB3:M)JEQZ
MY-;UO\,;A?\ EFWY5OZ/\-I(Y%+1G\J8AO@W0FN&0E:]*_X0D30+E,\5;\*^
M&!9;,IC%=VD810H' J64>&>*/ XMU9@E>9:D\NDS':",&OJK7M+2^MS\O->0
M^*/ #74C%8_TIIB/-[/Q]/;+C<:CN_'D]V=NXUKS?#"?<<1M^5%M\+YQ("8S
M^5# H:3%+JTJD@G)KU?PEX1(VL5J#PGX%-F4W)T]J]9TG3TM(1\O-*X!I-G]
MDC QCBM"EI*0Q%I3S2**=0 W;3J** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QO$7_'NWTKYN^+7
M^IEKZ1\1?\>[?2OF[XM?ZF6NNAN<F(V/ES5_^0F?]ZO;_@Q_K8:\0U?_ )"9
M_P!ZO;_@Q_K8:].K\!Y='XSZ^\+?\>B5T%<_X6_X]$KH*\)[GO+8****0PHH
MHH **** "BBB@ HHHH **** /PPT/_6BO=?AG_Q\15X5H?\ K17NOPS_ ./B
M*OOL1L?E&$^)'VQ\(?\ 4Q?A7OT/^I3Z5X#\(?\ 4Q?A7OT/^I3Z5\7B/C/T
MG!_PR2BBBN4[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;CFG44 )2
MTUF"C)J!KY%.* +-%0QW*2=#4U !1110 E&1110 M%%% !1110 4444 %-;K
M3J* &KUIU%(W2@ R*6F4Y>E "TE+10 @%+110 F113:5: '444C=* #(I:93
MEZ4 +1110 4444 %%,>94ZFH_M:>M $]%1K,&I] "T444 %%%% !1110 444
M4 -:DI]% !1110 4444 %%%% !1110 4444 %%%% !1110!YE\4O^/6;Z5\(
M?&[_ %DWXU]W_%+_ (]9OI7PA\;O]9-^->]E^Y\IFVS/$O"__(87_>K[_P#V
M;_\ 4V_T%? 'A?\ Y#"_[U??_P"S?_J;?Z"N_,/@/*R?^(?5*_=%+2+]T4M?
M)'Z %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54U*7R;5F
MZ5;K'\43>3ICMTX- '@7QH\2^1:3+O['O7YN_'O6/M=Q<?-GK7V;\?/$AB2X
M&[UK\^OBMK'VJZF^;/)H&CPC4X]UZQ]Z>/E2GWB[K@GWJ.7A10:&]X=3S)U'
MO7T9\,-+#M$<>E?//@]?,NHQ[U]8_"G3MT<1QZ4XB/?/ ML+>*/C'%>N:3=;
M8E&:\PT&/[/"GTKM--O. ,UO%".JDN..M5))_FZU76XW+UJ-I.:Z5$@MF3*U
M5FYS3E>FR5?)<"HRFE&:>U(6 JXP #TJ)N:>6%,+<UT(9"V12;J5VJ)FZTQ$
MVZEW56\RCSJFP7)F>H9&ZTQI*8SYS2 9)5:058:HF7=2L!1EJG(^VK]PN!6/
M=R;<T6 5K@ TW[1NQ69)<$$TB7&XTN4#763-.JG#)FK:FIL M,9J5V J!I*T
ML,>STW=DTP'=5NVMC(PXJ1#K6$NPXKI=)T\N1Q4>EZ27V\5VNBZ+C'%3S 3:
M/HX;;\M=CI^CJ%'RT:7INP+Q726T(C7I6<I%%6'30HZ5)]C"U<,@6H7F'K61
M)6>';5>2,BK;2!JA;YJH14VFK5N.E1F.IH1MI6&78XPU5[JQW \5<MZL-'N%
M(#A]5TWY3Q7"ZY:;-W%>N:I9AHSQ7 >(+'[W% 'E.IL8V;ZUCR7S*>M=-K5B
M=S<5S%Q:%6/%4@)(=0;UJW'?$]ZS([=JM)$15@6S=$]ZC-T1WJ%_EJM))MH
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M1Q1R@(R\56E3-6F:HV7=3<0,]X>M,^S^U:/E4>360%)8.G%6(X\5-Y=+@"D
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MN0Z'G^&J6@',QZ>S=JN0Z26[5UEMH73BM.WT0#'RUT*0'(6^B$X^6M6TT/\
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MEZ4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5D^)O^07)]*UJR?$W_(+D^E5'<B?PL^$OVAO]=<?C7S)I?\ R&!_O5]-
M_M#?ZZX_&OF32_\ D,#_ 'J^PPO\(_.<=_&/KWX(_P"K@_"OK[P?_P >:_2O
MD'X(_P"K@_"OK[P?_P >:_2O!QOQ,^MRWX3HZ***\L]P**** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO?H?]2GTKXO$?&?I.#_ADE%%%<IW!1110 4444 %%%% !1110 4444 %%%%
M!1124 (S!1D\"JEQJUO;*2SBJ?B+4ELK5CNP<5X1XT^(CVLCJLA'XT >PZIX
MQ@7(5Q^=<W/XQ3?P_P"M>"+X]N+Z4@.3SZUH1ZO<2+G+4Q'NUAXTC5AN<?G7
M46'BRUN% +KGZU\IW_B:YLP3N84FC_$J>.X"F1OSH ^Q8+Z*X&4;-6*\@\"^
M-/MPC#/G..]>LVUPLT*N#VI#'/,D?WCBF"\B/ :N1\6>(!IX;YL5Q=GX]$ET
M$\SOZTP/9U8-R#FG5@^'-4%]"#G/%;U( HHHH **3-+0 4444 %%)N'K1F@
MVBEHHH **** "BDR*,CUH -HHI:* "BBB@!-HI:3-&X>M "T444 (6"]:I7V
MIQVL9);FHM6O1:QDYQ7E7C+QE]G5P'_6@#K=3\71QL0'%5K/Q0L[@!Z^?]2\
M;R2W! <]?6NA\)ZY+<R)EB>:=@/H?3;WSL<UMK]VN+\+S,\:$UVB_=%(;%HH
MHH$%%%% %:YNA "2:SGUZ-6QN%9OB[439QN<UY/?>,FCN"-_?UI@>X6^K)-T
M-7XI?,Q7DGAKQ(;K;\U>DZ3<>;&*0&O1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 >9?%+_CUF^E?"'QN_UDWXU]W_%+_CUF^E?"'QN_UDWXU[V7
M[GRF;;,\2\+_ /(87_>K[_\ V;_]3;_05\ >%_\ D,+_ +U??_[-_P#J;?Z"
MN_,/@/*R?^(?5*_=%+2+]T4M?)'Z %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4UJ=2$9H 1>M.I-M+0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %<UX]E\G1)&Z<&NEKC/BE<"'P[+SC@T ?GS^
MT=X@\F2X7=ZU\)^--6^U7<O.>:^HOVH-=,=W<#=W-?%>I:D;B\?G/-!:(91N
MDS4,RY Q5@?-BI%@,C 4%'1> [8M>1\=Q7V5\)[']Q%QV%?*_P /=+)NHCCO
M7V)\+K3RX(N.PJHDL]4M8?+A6M33W.X5'#;[H1QVJS:P;6Z5V11)LPR?+1YG
MS5 IVK3/,^:NF(B^LE*TG%5(Y*5I.*V13'238[U7:Z]ZKW-QMS6=)=^]:V)-
M;[52?:*QEN_>GK=9J6!J--4;253$V>]/$F10!/NINZFAJ=MH$-R:,GFG;:3U
MI#$HV\44Y3P: *=TGRFL#4%(S72W"Y4UAWT><T@.:FSN--BSNJW/#\U,CA]J
MFX%JW:K2R8!JK&-M*TF* )I):8OS&H-VXU=LX3(PJK@2VUL9&'%=-I&EF0KQ
M4>EZ67V\5W.B:3C;\M9L"?1=%&U<K78:=I80#BG:78A%'%;T,04"N>5QB6]N
M(UZ4^6;RUI[-A:S+V0X-)"$N-0VYYJD^J#/6LZ\G/-94MTV[K3$=,NI!N]3I
M>AN]<<M\R]ZL1ZB1U-,9UOVH5)'<CUKE!JGO4T6K#UH&=E;W0]:O)= ]ZXVW
MU4?WJOPZH/[U2Q&[>,)%-<EK-J)-W%:YU(,.M9]U,LF:8'GFK:5N9OEKG+C0
MRQ/RUZ;=6JR$\53;1PQ/RT ><#02/X::^CE>U>E#0L_P_I4,WA__ &:8'EUS
MIK+VK*N+-ESQ7J%YX?//RUAWGA]N?EIW \]:W8-TJ6WA.X<5TMQH;*?NTEOH
MK;A\M,"'3;,LR\5V^C:;G;Q531]&.5^6NZTG2]BKQ1<";3;((HXK=M\1J*A6
M(0K5>:["'K68&NLP]:EC8-BL".^W,.:U+.;?BI UX4S4IBXJ.W;@5/GY:2 @
M8[*BFOO+'6DN7V@US^I7A0'FAL:)=3U<*I^:N,UC5\[OFJ/6-4/S<UQNIZIU
M^:M(@Q=5U+=NYKB=:O>&YJYJ.I?>YKD=6U#=NYK=$HRM4N-S'FLN#,DE)=7!
MD8X-6M(MC+*..];*PSJ/#NGF21>*]?\ "VC_ "K\M<9X1TDLR<5[1X9TO;&I
MQ45'H!O:'IH55^6NHM[;8!4&FVX11Q6IPHKQYO4"-OD6J-W=;5/-6;J8*IKG
M=2N\9YIQ J:EJ& >:Y34KPOGFKFHW)8D9K&E4R-71$1EW2F3-4&LB2>*Z2/3
MR_:K*Z/G^&NF(SEHK4KVJY'"<5NG1R.U*NEG^[6R PS"?2HGMSZ5T?\ 9I]/
MTJ*333_=K5- <T\!J"2/%=#-IY':L^>S([5#0&._%1-)BK=Q"5JA*I&:R8AW
MG4]9:IY-.5N:S&:"MFD:H8Y*?NJ0#^*IEJ -UJ9:Z(@25&QJ2HWJAD+$\TS=
M[TLC5#NI7 GW>],=N*9YE(6S30B*1JK-WJTRU"R]:H" \TPCK4K+3<5:: BI
M5I:3C-7H X"I56HE84_S!57 EI"U1^8/6D9N:+@/WTJM4!;FE5Z8%I>U.R*K
M+-2^=6$A,F9JA9Z:TE0NU8@+))UJ(RTQVJ)FH&3>93@WO57<:>KTX@7%;WID
MC=>:C#TV23BNF+ @G/6L#5&^4ULW$G!KG]5D^4UTH#CM;;[U<7?-\YY[UU>M
MS?>KCKR3+&M4!"B_-6Q8QYVUCP<L*Z/2XMVWBLI =)HMJ6V\5Z'H.EE@O%<S
MX;LMVSBO6O"^D[U3Y:XYL"UI.A%MORUVFE:#T^6M'1M$&U?EKL=/T<*!\M<$
MI 8MCH8"CY:UH=' _AK=@L@@Z5-Y87M6#N!DQZ6JX^6K"V:KVJZS!:@EF I)
M@,VA*B>X"U7N;O'>LR:\]Z -5KP"F?;O>L-KHGO3!<$]Z -UK[/>H)+SKS68
MLQ:G\M0!++=$YYJE)*6J;RBU)]E+=J ,^4%JJR6[-6\MB3VJ9=+SVH Y?^SV
M;M4J:63VKJX])_V:L1Z6!VH Y6'1_:KT.C_[-=''8!<<596U"]J ,&'1QZ5=
MBTL+VK76%5[4[Y5IH"G#8JO:K*6P':G^8!2^<*T 88PM,>0+1-.*SKFZ"]Z!
MD\EX%SS4#:D >M8MY?[2>:S)-2.[K0(ZPZD/6C^T-W>N3742<<U8CO2V.: .
MC^V>]02W7O66ET3WH:;/>@"T]P?6H6N#S59I,TW<: )FN#S4+W!IC&JTK4P)
M6NL=Z;]LQWJA)-[U4DNMO>I&;?VWWI#>;N]8/VSWJ2.ZW=Z+A8V/.W4;JIQ2
M;JL*U.X$V:7<:C#49H$39-.J*G@F@!U%-W&AFH =FBH]U.W4 %*O>FTM #\F
MC)IJTM !3:,FDH 4#-*12 XHW4 /1MN*<1YG%19J>U^9Z .&^(&E^98R';VK
MX,^/FF^3-/QCK7Z->,;02:>_':O@_P#:(TWYK@@>M8U-BD?#FK+MOF'O2;<Q
MU=\069COWX_BJLJ_)7(:&EH<ODSJ:^E_@KXA\J[A&_N*^789/)8'I7JWPGUX
MQ:E"-W<4R3]:_@/JWVJW@^;/ KZ6C_U:_05\;?LRZM]HM[;YL]*^R(>84/\
MLC^5! ^BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1ONFEI&^Z:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>>)FN&)#?K5-?$3P'):F*Y[[I^H)<*/F&:O5X)8?$@6L@4R8_&N\T7QXNH1
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M1]*LV\=*P&E;,:OITJA;KC%7TZ4P'4NZFT4 2[J=NXJ+=3P: ';J3.:*5>M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'-+10 W;3J** "BB
MB@ HHHH **** "BBB@ HI*,B@!:*** "DI:* $YHI:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JGJW_(.G_W:N53U;_D'3_[M-;B>Q\3?M#?ZR?\
M:^0;C_D+G_>KZ^_:&_UD_P"-?(-Q_P A<_[U?8X/^&?G&8_Q3Z3^"'^LA^HK
M[D^'_P#R#%_W:^&_@A_K(?J*^Y/A_P#\@Q?]VO$QVY]-E7PG64445Y!]$%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %(WW32TC?=- 'SS\<_]
M3/\ C7Q;XH_Y";?[U?:7QS_U,_XU\6^*/^0FW^]7MX7X3Q,3\1Z5\*?]=%7V
M5\-_]3%]*^-?A3_KHJ^ROAO_ *F+Z5SXG<Z<*>BT445YAZ04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !39'"+DTZL[6KK[+:ELXH +C4EC
M_BJC)K SP:\\UKQ@(K@IO[^M3Z3JS7^"#F@#NUUCWIW]M*O\5<K>3-!'G-<Q
M?>)C"Q&[]: /58=860CYJT[>;S%KR+1_$9FD4;OUKTO0;CSXP<YXH V:***
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MFM&WORHZUS20CO(=0W8YJPMX#CFN.M]2Z<U>BU+..:YP.G\X-WIZL&K CO\
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MJ"&?0*-N4&G5!9MOMT-3T$A1110 4444 %%%% !1110 4444 %%%% !1110
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MM['+*":0%RBBB@ HHHH **** "BBB@ HHHH **3%&* %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***2@!:*3;2T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%)MH 6BDI: "BBF22>6N: ',P7K4;7"CO67?
M:J(@>:Q9->!DQNI@=>LP;I3ZP-,OO/QS6\OW12 =1110 44FVC%  U-I])0
M4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5/5O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I&^Z:6D;[IH ^>?CG_J9_P :^+?%'_(3;_>K[2^.?^IG
M_&OBWQ1_R$V_WJ]O"_">)B?B/2OA3_KHJ^ROAO\ ZF+Z5\:_"G_715]E?#?_
M %,7TKGQ.YTX4]%HHHKS#T@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** ,;Q%_P >[?2OF[XM?ZF6OI'Q%_Q[
MM]*^;OBU_J9:ZZ&YR8C8^7-7_P"0F?\ >KV_X,?ZV&O$-7_Y"9_WJ]O^#'^M
MAKTZOP'ET?C/K[PM_P >B5T%<_X6_P"/1*Z"O">Y[RV"BBBD,**** "BBB@
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M4B:26(^6NRCT?VJW#HHR/EIW Y2ST4[A\M=1I.D[<?+6M:Z2JXXK5MK58J3
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M\>>*I?:I(V[T-"/5+/Q'NQ\U=!8:T'Q\U>-V.I.&'-=7I>I-D<TAGKUAJ2L
M2:VH+Y"O6O,++6"JCFM.+Q!M_BJ&(] >Y1N]5FD5FKDHO$(8_>J_;ZJ).]2!
MOQXJW'Q61!>!L<U>CN1ZTF!>W?+4;-FHO.'K1O!K-@*\8851N=/$@/%:"L*D
M7:PI] .0O- 63/RUG-X;4-]RO0&MT:F&S0]J0')V.B"/'RUNVMJ(@.*T%M56
MDD4**JX%:9PJUC7TW7FKUY-M4\US]]<?,>:FX$$S;V-.BMO,(XJJLNYJUK$@
MXJ 'P:>,]*TK>U"=J=#MQ4DDRJM:10%F.01BB2\ 7K61-?A<\UG7&J;?XJU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6O/?#/C)=0"9?K[UW=M<+-&"#2 GI"P'4@56O;Q;>,DG%<#XD\;K8[L/T]Z
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M+3R8_>?K3L(^B/-3^^OYT>8G]X?G7AD/Q0)4$R?K5JW^)RR2 &3]:+!<]K#
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MT[ ?0XD4]&!_&EKR;P_X^^W,HWY_&O2M)O/M<(;.>* -"BBBD 4444 %%%%
M!1110 4444 %%%% !1110 53U;_D'3_[M7*IZM_R#I_]VFMQ/8^)OVAO]9/^
M-?(-Q_R%S_O5]??M#?ZR?\:^0;C_ )"Y_P!ZOL<'_#/SC,?XI])_!#_60_45
M]R?#_P#Y!B_[M?#?P0_UD/U%?<GP_P#^08O^[7B8[<^FRKX3K****\@^B"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,D>E>U0PB.';[5(S@_&C8A<5X3XB;_2F^M>Y>-_]6]>%^(/^/AOK2$:/A/\
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M=AT[5Y3K<96Z;CO7T3K&C!K,J%[5Y1KGA9Y+IB$[TAE'P8I\Y/K7MVF1[M/
MQVKS7POX?>WD4E<<UZSI=OMM@N.U(9X/\7M(:9)2%KPW29&TC5-QXPU?7?CC
MPZ+Z%_ESQ7SWXJ\#RPW#LD9'/I3$>E>#/BHMCIZQF3''K6CXC^*:W6ENHDSG
MWKP"/3+ZV;:H8"M"/3[Z>+:0U(9Q_CK5'U/4F(YR:]"^#-DXFC)'>L)/ D]U
M=!FC)YKV?X:^#SIX0E,?A5$G=ZHI72<?[->)^(%/VYN.]?0.J:>6L=H':O*]
M7\+O)=$[>])#8WP4I5DKVG0?]6M>;^&-!:W*Y6O3](A,:"I&;5%%% !1110
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M3T:Z!4=Z]A\)6YCA0>U '644E+2&%%%% !1110 4444 %%%% !1110 4444
M%4]6_P"0=/\ [M7*IZM_R#I_]VFMQ/8^)OVAO]9/^-?(-Q_R%S_O5]??M#?Z
MR?\ &OD&X_Y"Y_WJ^QP?\,_.,Q_BGTG\$/\ 60_45]R?#_\ Y!B_[M?#?P0_
MUD/U%?<GP_\ ^08O^[7B8[<^FRKX3K****\@^B"BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M  8_UL->G5^ \NC\9]?>%O\ CT2N@KG_  M_QZ)705X3W/>6P4444AA1110
M4444 %%%% !1110 4444 ?AAH?\ K17NOPS_ ./B*O"M#_UHKW7X9_\ 'Q%7
MWV(V/RC"_$C[8^$/^IB_"O?H?]2GTKP'X0_ZF+\*]^A_U*?2OB\1\9^DX/\
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MT5% 'G5U\+8)VSL6HX_A3 ASL7\J])HI@<19_#R&W8'8M='I^BI9*  *U**
M()K43)MK(N/#,<S9(%;U%(#%M?#Z6YR *U881&N*EHH J75@MRI!%<WJ/@6&
M]))5:Z^B@#S:3X4P,V=BU)%\+88_X%KT6B@#AH/AS!$P.Q:WM/\ #L=B!A16
MW10!3FL1(FW%9DOAF.1L[16_10!C6^@K!T K1B@\NK%% #5IU-Z49- #J***
M "BBB@ HHHH **** "BBB@ HHHH **** /,OBE_QZS?2OA#XW?ZR;\:^[_BE
M_P >LWTKX0^-W^LF_&O>R_<^4S;9GB7A?_D,+_O5]_\ [-_^IM_H*^ /"_\
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M]:^\OV4+O;<6O/<4"9^KW@N3S-!@^E;U<I\.I_.T&(>BBNKH,PHHHH ****
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MMSZ;*OA.LHHHKR#Z(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_ADE%%%<IW!1110 4444 %%%% !1110 4444 %(32TUJ %W4M-'6G4 %%%%
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M7PQ_PL2?_GJ?SH_X6)/_ ,]3^='U!!_:LNY]S_\ "[D_Y[_K1_PNY/\ GO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K)\3?\@N3Z5K5D^)O^07)]*J.Y$_A9\)?M#?ZZX_&OF32_^0P/]ZOI
MO]H;_77'XU\R:7_R&!_O5]AA?X1^<X[^,?7OP1_U<'X5]?>#_P#CS7Z5\@_!
M'_5P?A7U]X/_ ./-?I7@XWXF?6Y;\)T=%%%>6>X%%%% !1110 4444 %%%%
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MJK(LFRJ^GSW$2A23536]-EU)2,$YJ2CRV">6;4 !GK7OGPSLY7CB)!KA]"\
MR/=JQC[^E>]^!?#?V**/*X_"JN*QVVBVYCC7-:U10QB.,"I:@84444 %%%%
M!1110 4444 %%%% !1110 53U;_D'3_[M7*IZM_R#I_]VFMQ/8^)OVAO]9/^
M-?(-Q_R%S_O5]??M#?ZR?\:^0;C_ )"Y_P!ZOL<'_#/SC,?XI])_!#_60_45
M]R?#_P#Y!B_[M?#?P0_UD/U%?<GP_P#^08O^[7B8[<^FRKX3K****\@^B"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ3N(X'PWX/6UVY3%=]:6J6L051BI%B1.B@4^D,1AE2*R;[3_ #L\5KTFT>E
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MPUZ=7X#RZ/QGU]X6_P"/1*Z"N?\ "W_'HE=!7A/<]Y;!1112&%%%% !1110
M4444 %%%% !1110!^&&A_P"M%>Z_#/\ X^(J\*T/_6BO=?AG_P ?$5??8C8_
M*,+\2/MCX0_ZF+\*]^A_U*?2O ?A#_J8OPKWZ'_4I]*^+Q'QGZ3@_P"&2444
M5RG<%%%% !1110 444C?=- $;S!.M0MJ"+5'4+@Q@\US-YJQ5C\U ':I?(_2
MK"/N&17#Z?JAD<#-==I\GF1@T 7**** "BBB@ HHHH **KRWD</WC5=M7BZ
MB@"_15..\$AX-6H^5S0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *BDF$?6I*YCQ'JHLU;YL4 ;HU!"V,U,LP89KRRW\7
MAKK;O[UVNG:EYUL&SVIL1M27R1]321WR2< UY_XC\3"SD(WXJ+P[XI%Y.%WY
MY]:+#/3E;<,TM0V;^9;JWK4U( HHHH **** $)Q437"KUHN&V1DUS6IZMY&?
MFQ0!T7VY/6GI<*_2O/3XF'F8WUO:1JPN&'S4 =32TR)MR T^@ HHHH ****
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M37'7F@"^DU64EK#6Y]ZN0W'O0!I%LU$]1K-GO0S9% !2KUIE.H ?43T^HVH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "JNH6XN(2IJU2$9H \_U;PHDSEMG
MZ53L]#-G(,+BO1Y+99.U5FTQ2V<4 9FEJR@9KH(_NBJ\-F(^@JR.* %HHHH
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MJ27<8(:D!H4FX>M07DXAC)S7+ZAXF6V8C=BF!U^X>HIOF(/XA7!'QDNW._\
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M6D7I2TQA1112 **** "BBBD 4444 %%%% !1110 4444#"BBB@ S2,:6D(H
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M0 4QJ?3&H @:HFJ5JC:@8E.IE/J 8Y:<M-7I3U%.PA1S2[:55I2,50"44A-
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M%9J^'$#_ '?TH)L>/V7PY,TH)C_2O0O#/@<66TE/TKM['1XH0"5%::QK&,*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !2-]TTM(WW30!\\_'/\ U,_XU\6^*/\ D)M_
MO5]I?'3_ %,WXU\6^*/^0FW^]7N87X3Q,3\1Z5\*?]=%7V5\-_\ 4Q?2OC7X
M4_ZZ*OLKX;_ZF+Z5S8G<Z<*>BT445YAZ04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "&D#4II-M #J*04M !1110 4444 %%%% !1110 44
M44 %%%% !1110 F*,4M% !1110 4444 %%%% "4F32TFV@!5I:04M !1110
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M:CD_US?6I%ZU].?$(D7I2TB]*6D,**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP*L#BEHI#"BBB@ HHHH **** "BBB@#S+XI?\>LWTKX0^-W^LF_&ON_XI?\
M'K-]*^$/C=_K)OQKWLOW/E,VV9XEX7_Y#"_[U??_ .S?_J;?Z"O@#PO_ ,AA
M?]ZOO_\ 9O\ ]3;_ $%=^8? >5D_\0^J5^Z*6D7[HI:^2/T \_\ BQ_R"7_W
M37YW_&[_ (_)OJ:_1#XL?\@E_P#=-?G?\;O^/R;ZFO?R[<^2SG8^?I/]<WUJ
M1>M1R?ZYOK4B]:^G/B$2+TI:1>E+2&%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110,****0@HHHJP"BG;11M%(!E+0:0MBD'47=MJO<,&%+-)38X6
MN& '-,;(+>S,TF *]#\#>'9Y+J,JIJKX/\(S7]P@\LG)KZE^%/PE,WE,T/Z5
MR5ZRIH[\)A959:'9?!329[98=P/:OK;0 5TZ,'TK@/!_P^72X8CY>./2O2;.
M'[/"%KY#$5%4E='Z%@Z+HQLRQ1117&>B%>*?&+_CUF^E>UUXI\8O^/6;Z4#/
MSP^.G^NN/QKX[\7?\?$GUK[#^.W^NN/QKXZ\7'_2'^M!:.;CZ&EM?^/D?6F1
M_=I]K_Q]+]:!GOWPB7,T/X5]D^ X_P#1(_I7QS\'Q^]A_"OL[P$O^AQ_2MH$
ML[>).E3%>*(UZ4]A7;$D:M2K4=.5JU0@8U$U2G%,9>M:#*["H66K3+43+6B0
MBLRTPU89:B9:;0$+=*B>GO4+&L0(WJ!ZD<FHF)IH"&2H&S5AAFH]M4!%25+M
MIAZ58"4UZ=36K2($#+3-M2M3&ZUH@(&%1/4SU"],"O)4#=:L/4#"J0$$@XJC
M<+Q5^2J5QTJ@,FX'-4)>]:%QUK.F[TV!);M\PKH=+DP17,PM\U;VER?,*YI
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M:W_X^17O'PA_X^H/K0#/T.^!+'RX/H*^Q/"O_'BOTKXZ^!/^K@^@K[%\*_\
M'BOTH,V;=%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** $I:** "LGQ-_R"Y/I6M63XF_Y!<GTIK<B?PL^%/VAO\
M77'XU\Q:7_R&!_O5].?M#?Z^?\:^9-+_ .0P/]ZOL<)_"/SC'?QSZ\^"/^K@
M_"OK[P?_ ,>:_2OD+X)?<AKZ]\'_ /'FOTKP<;\1]=EOPHZ.BBBO+/<"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ JGJW_(.G_W:N53U;_D'3_[M
M-;B>Q\3?M#?ZR?\ &OD&X_Y"Y_WJ^O?VAO\ 63_C7R%<?\A<_P"]7V.#_AGY
MQF/\4^D_@A_K(?J*^Y/A_P#\@Q?]VOAOX(?ZR'ZBON3X?_\ (,7_ ':\3';G
MTV5?"=91117D'T04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MC?=-+2'H: /GGXY_ZF?\:^+?%'_(2;_>K[3^.2YAF_&OB[Q0N-2;ZU[>%^$\
M3$_$>D?"G_715]E?#?\ U,7TKXT^%3?OHJ^ROAJV88OI7/B=SIPIZ-1117F'
MI!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*X'%7I*I3=ZT0&7<+69<<9K6N%ZUE77>A@01M\U;FF/R*Y\-AJUM-D^85C)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !5/5O\ D'3_ .[5RJ>K_P#(.G_W::W$]CXE_:&_
MUD_XU\@W!_XG'_ J^M_VBI0LT_XU\B,V[6/^!5]C@_X9^<9E_&/ICX(_ZV'\
M*^Y/A_\ \@U?]VOB'X'Q'? ?I7W!X!7;IJ_2O$QVY]-E7PG54445Y!]$%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@/QLA+0S8]Z^+?
M&$134&..]?<GQ@MO,AFX]:^+/B!;&&]<X[U[6%>AXV*6MSH_A?<!;B(9K[/^
M%\F^&+Z5\*_#N^\N]C&>]?;?P?N1+;Q<]A6>*1IA6>N4445Y)ZH4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWP=7==0?45X!:_\ 'TOUKZ&^#$>ZZ@^HH!GZ$? J/]W!^%?7_A?BQ7Z5\F_
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M)S_#7CX^%G<^ARF=U8[^BBBO&/I@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(\T3EP\N61]BQRB1014E<[X<U07D*'.>*Z*O#:LSVD[A1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*** "BBDH 6BFX-+0 M%%% !1110 4444 %%%% !113<GTH =12"EH ****
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MN7_AG(_\^_Z4?\,Y'_GW_2CZ_ /[+J'PU_PC=W_<;\J/^$;N_P"XWY5]R_\
M#.1_Y]_TH_X9R/\ S[_I1]?@']EU#X:_X1N[_N-^5'_"-W?]QORK[E_X9R/_
M #[_ *4?\,Y'_GW_ $H^OP#^RZA\-?\ "-W?]QORI?\ A&[O^XWY5]R?\,Y'
M_GW_ $I5_9Q);_CW_P#':/K\ _LJH?#7_"-7?]QORI5T&YCZJWY5]SG]F\X/
M^C_^.UR?B;X&'3HV/D8Q[4XXZ$G8F665(J[/D<6,D?44NW;7IWBSP?\ V:SC
M9C%><ZA'Y+$5VQDIZGG3INF[,@HJ%)-QJ6M#(*BE?WILCX-,6)YF  S0 ^.!
MIR .:[+P?X1FOKA/D)R?2G>#?"DNH31C83D^E?57PG^$9E:%VA].U<5>NJ:/
M0PN%E6DA/A+\*/-\EGA].U?67@WP)%I4$1\L# ]*3P/X)BTF-,Q@8'I7H*J%
M4 # %?*8C$.I(^_PF$C1B)&@C0*!@"G445PGJ!1110 4444 %%%% !7DOQ4C
MW6LOT->M5Y?\38]UK+QVH _/+X]0?O+C\:^)?'*[;J3ZU]V_'ZWPUQQZU\*^
M/UVWDGUH+1QD)ZU+;_\ 'POUJ&$YS4]O_P ? I%'N?PI;$T7X5]A_#V3_1H_
MI7QI\+Y-LT7X5]??#N;_ $>/Z5M EGKUGRHJTRU3T\Y05=D^45V(@BZ"HV;;
M2NW%5)I,9K1 /DN*KR7(]:J7%QCO5&2Z.:T0&FUQGO31-NK)^U9J>&;.*T0&
MJOS4/TID#9%2.,K5"*,TFVJ4TWO5JZ[UFSDUF,BFFJHTU),QJJQ- %M9N:G2
M;BLU6-3QR4 :*R4C-4,;4[-6@$9JC8\4]A3&%.X#*;3J;5(!K5%)4K&H7-4!
M U-Q3FIF>U5<"*3O5*;H:O252F7@U8&;<5FW"]:T[@&L^9:+@9\BTZW^5J=(
MOM38^&JP.BTJ3YEKN=&FZ5Y]IK_,*[;1Y.E0!W-E)\HJYG-9=@_RBM%6XK)@
M1O2+3I*96; G1JG4U51JL*U18":DVT;J-U(")UJK*M6I&XJG-)5 59:C4TZ6
M3FHE?F@"RBYJ394,<GO4P;WJA!Y=-*T\O[U$SU:&(R]:B9>:<STS=5@,9:C8
M5*U,*TP*\BU"PJX5J)HZ0%>EW4]DYINV@!-U+NHVTUJ=@&L:A9JD;O41%(!*
M:U.IK4[ -VT;:7!I=M(!E-:GE>M1M0 UFIC-Q0S'FHV:F [=4=)NIN[WJP"G
M#I311NJ6P'T8IN[WI0U8,"Q$M:-LHXK,B:M*U;I6; U[-.175:/'RM<Q8C<1
M78:)%G;6; [31(N%KK;:#*CBL+0K?Y5XKL+.W&T5DQF=)9[NU4KJSQ&>*Z:2
MW [5FZ@H6$U-Q'DGC"WVJ_%>&^*+7S)6XKW?QM*JJ_TKQ376#S-]: .>T;2-
MUP#M[U[;X#TG9Y?RUYYX=M \R\=Z]N\%V854XI<PT>AZ#:^7&O%=-"O[NLO3
M8]L:\5JJ<+4L97N.!7+:[)MC:NFNFPIKCO$4VU6JHC/-?%%Q][FO,]6GS(W-
M=MXKN\,W->::E=9D/-;(@K2/EJ0#.*K>;EJMQ?-BJ U=)CRXKTOPO;_=XKS_
M $6/,@KU'PO#]WB@#T+0X=JK77V:X45S>D1X5:Z6WX6L9%%O=P:QM5EVHU:3
MOA37.ZY<;4:I2*/-O'5YMADY[5\N_$*ZW2R\U]#>/KS]U)SVKYA\=W&^XDK7
M8DX509+K\:]1\$Z;YC1\5YIIL1DNQ]:]Q^'^G[O+XK3F$>O>!]) "?+7L.BV
M8CC7BN+\&Z>%C3BO2K&':J\5E)@7%CQ&*S[R/@UK;?EJI<1[LU"91RUY!\W2
MJ+0UT%U![5GS0XS6MR69OET]4J9DI%7FIL(8L=!CJ95I66JL!6VT;:E9>>E+
MMI; -5:L1K353VJ=1BI 8RX%96H'"FM61OEK%U)OE-6@.&\4-\C_ $KQ/Q8W
M[QZ]E\4O\CUXIXJ8^8]6@.-;_7&MO35Z<5AKS-70Z8O3BMD!T5@O K8@K+LE
M^45IPGI5H#4MVZ5I0-6-#)6C;R53V V[<]*V+7M6':MTK;LVZ5RR$S:M5Z5H
MQ"LZU;I6E#TK-C+"K4BK3%J1*S E5>E.VTU33MU0 QZA;O4C-43&D VBBBD,
M*>JTW;3Q3$&*2E)H%6@%Q3@:2DW4P';J-U,W4A:F!.K5)OJJ&IV^D!,QW57D
MCS4JMFG[: *GDT^./;4S)3/NT@)HVVU.).*J!O>G!Z )7;-1;<TH^:GJ*8$1
MCIA2K!Q434P*Y6D-/:HV:I8F%)NIC-UIA:J0B6G8J$-4BM0,?MI&6EW4UFI#
M(V%,IYINVF E(U+2$50T)12[:3%!5T%)MI:7 H)(BM)BI67FF,M AE)MIQ&*
M2@H***7;0,2EI=M.5:@5QNVDVT\BDJQ B\U:(_=U73[U66'[NDQ',>))-MNW
MTKY:^,LW[N;\:^G/%<FVV?Z5\I?&*?Y9>?6N68SX[^(#;KR3ZUQ,?>NS\=-N
MNI/K7&QC@UR&@EK_ ,?2_6OHWX)Q[KJW^HKYQM#_ *6OUKZ9^!<6ZZM_J*8'
MZ(? Z'_1X/H*^J_#XQ9K]*^9O@C:XMH..PKZ=T5=MHOTH,V:%%%% @HI":3=
M0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFEJ-
MU #J*:&IU !4<XW0N/:I*:PRI'M0!\U?&W1C=1SG;G@U\(_$C1VM-0=MN/FK
M],/B1H?VRWE.W/!KX<^-7A9H)I6"8Y/:OI<OJ=#XS-:'VCAOA/JQM;^-2V.:
M_0OX)ZXLUA"-W4"OS,\,W3:;JJY..:^V/@7XR400*9/3O6^/I<T;HYLJK<DK
M,^P <]*6L;0]46^A0@YR*V:^4:L?=IW5PHHHI#"BBB@ HHHH **2DW4 .HI!
M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44AI-U #J*2EH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 TT4-24 .VBEI-U+0 4444 4[RS%PI!&:\&^,'A
MP-;RD)V-?0M>?_$K21=V;X7/%;4Y6D95(WB?GAXSLVL;]SC&#72?#'Q,UK=1
MJ7QSZUK_ !6\+O'<2L$[^E>7:'-)INH#)P :]^-IP/!E>$S]!/A?XB%U#$"V
M>G>O8%;<H([U\?\ P=\7!?*5G].]?4V@ZPEY;I\V>*\2O#ED>U1GS1-NBDI:
MY3I"BF[J4&@!:*0TFZ@!U%-W4Z@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^%>_0_ZE/I7@/PA_U,7X5[]#_J4^E?%XCXS])P?\,DHHHKE.X**** "BBB@
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M;3Z* $6EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/:BK*P4445)04444 %%%% !1110 4444 %%%% !1110!^&&A_P"M%>Z_#/\
MX^(J\*T/_6BO=?AG_P ?$5??8C8_*,+\2/MCX0_ZF+\*]^A_U*?2O ?A#_J8
MOPKWZ'_4I]*^+Q'QGZ3@_P"&24445RG<%%%% !1110 4444 %%-:B@!U%%%
M"8HI::TBKU8"@!U%0FZA'61:3[9!_P ]5H GHJ(74+=)%/XT]9%;H<T .HI*
M1F"]3B@!U%1&ZA7K(HIOVR#_ )ZK0!/14(NX6Z2+4BR*W0@T .HHI"P'4XH
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M^$/C=_K)OQK[O^*7_'K-]*^$/C=_K)OQKWLOW/E,VV9XEX7_ .0PO^]7W_\
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M6%FC].U?6NCZ.EG:Q   @5RO@'P>FDVL?R8P*] ''%?(XBJZDKGZ%@\.J,+
MHVC%+117(>@)2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!*1J=28H 1>M.I,4M !1128]Z %HI*6@ HHHH **3('4TUID7JP%
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M?=_Q2_X]9OI7PA\;O]9-^->]E^Y\IFVS/$O"_P#R&%_WJ^__ -F__4V_T%?
M'A?_ )#"_P"]7W_^S?\ ZFW^@KOS#X#RLG_B'U2OW12TB_=%+7R1^@!1110
M4A%+10 W;3J** "BBB@ HHHH **** "BBB@ HHHH **** "O)OBHW[F4>QKU
MFO*?B="98Y<#UK>C\9RXCX&?$'Q8A>:XE &>:\GTWPG+J%Z 4)R?2OI?Q9X1
M?4KMP$SD^E:/@?X1E[A',/?TKZ:->-.!\3/"RK5#%^$/PD\YHG:'T[5]>>!O
M!$6DQQYCQ@>E1_#WP/%I<*%HP,>U>BJBH,*,"O"Q&(=1V/J\'@XT8IBJH50
M, 4M%%>>>J%-VTZB@! ,4M%% !1110 4444 %%%% !1110 5#=1^;"RU-24
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M.:KR+3N!3QMHW4Z1:BJDP)-V:D6HU6I!Q3N!+GBF,U(S4QFI7 5J;BBEQ3N
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME/I7@/PA_P!3%^%>_0_ZE/I7Q>(^,_2<'_#)****Y3N"BBB@ HHHH *2EIE
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MZ9E#LU>F>$=9#,A=J /9?#MJ5C7Z5U,*[17->&]2B>->1731R"3I4%$E%%%
M!1110 4444 %%%% !1110 4444 >9?%+_CUF^E?"'QN_UDWXU]W_ !2_X]9O
MI7PA\;O]9-^->]E^Y\IFVS/$O"__ "&%_P!ZOO\ _9O_ -3;_05\ >%_^0PO
M^]7W_P#LW_ZFW^@KOS#X#RLG_B'U2OW12TB_=%+7R1^@!1110 4444 %%%%
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M!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRT?\+?LO[RU^>'_"YKG_ )['\Z/^%S7/_/8_G1_9H?VR?H?_ ,+?LO[RT?\
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MI8QVB@(.E6:**\\]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M +S4?\)A=_WFKN/^%62?\\S^5'_"K)/^>9_*CG@'+,X?_A,+O^\U'_"87?\
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M #S/Y4?\*LD_YYG\J.> <LSA_P#A,+O^\U'_  F%W_>:NX_X59)_SS/Y4?\
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MA_U,7X5[]#_J4^E>!?"'_4P_A7OL/^I3Z5\9B/C/TK!_PR2BBBN4[@HHI":
M%HINZG4 %)MI:* $Q2T44 %8OBI#)IK 5M52U6W^T6I7K0!\I^/-.<WKG'>C
MP/.MG<)N..:]&\<>%R_F/MKQ[4)I-'NCC(P:JXK'U)X5UJ%H%&X?G75_:HMN
M=XQ7R[X1\>2*RJ7KT&7QV4M<[^U)C/4KW7K>V4C>,UQ/BGQ4K6DH5^HKR[5/
MB%)),5#T0:A+JT>,DYIH1YA\1))+Z^<\GFK?PP7[+?1%^.:ZG6?![W&7*9KG
MDM7T.;(&,51)]:>$=5@FTV--X! K?\^/^^*^9?"_Q"DMV5"]=]'X\+6^[?\
MK691Z3K^J06NGR@N,E:^2OBO,+V^DV<\UV_BSXB/(K('KS:8R:Y=9(SDTT!H
M?"S3G6Z0X[U[-XF'EZ*0?[M8?PZ\*F%4<K6]X_C-OIKJ/2F!\\:C(O\ ;'_
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MYYK0#7EU,_WJJ2:@?6LR2<\\U7>8^M4F!I27Q]:S[J]//-5WG]ZHW4Q(/-4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"F4^F[: %6EI!2T %%%% ";:*6B@ HHHH **** "BBB@ JAJ6F1WT9!4$U?H
MH$U<\Q\0?#&+4MW[H'/M7F7B+X"QS!B(!^5?3=,DA29<.H85TPKSAL<=3"4Z
MFZ/A/Q)\ _+W$0?I7F.N_!>:-FQ"?RK]&]8\+V]VI(0<^U<-JWPWAN&/[H?E
M7HTL=);GCULKB]C\Z]0^$]S$3B-ORK(F^&]W'_RS;\J_02^^$,<N?W(_*L6X
M^":/_P L?TKNCCT>7/*7T/@QO =XO\#?E3#X&O/[C?E7W1)\#%)_U/Z5'_PH
MH?\ /#]*OZ_$Q_LF1\-_\(+>?W&H_P"$%O/[K5]S?\*+7_GC^E)_PHL?\\?T
MI_7HB_LF1\-?\(+>?W6H_P"$%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_
M9,CX:_X06\_NM1_P@MY_=:ON7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY
M_=:C_A!;S^ZU?<O_  HL?\\?TH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY
M_=:ON7_A18_YX_I1_P *+'_/']*/KT0_LF1\-?\ ""WG]UJ/^$%O/[K5]R_\
M*+'_ #Q_2C_A18_YX_I1]>B']DR/AK_A!;S^ZU'_  @MY_=:ON7_ (46/^>/
MZ4?\*+'_ #Q_2CZ]$/[)D?#7_""WG]UJ/^$%O/[K5]R_\*+'_/']*/\ A18_
MYX_I1]>B']DR/AK_ (06\_NM1_P@MY_=:ON7_A18_P">/Z4?\*+'_/']*/KT
M0_LF1\-?\(+>?W6H_P"$%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_9,CX
M:_X06\_NM1_P@MY_=:ON7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY_=:C
M_A!;S^ZU?<O_  HL?\\?TH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:O
MN7_A18_YX_I1_P *+'_/']*/KT0_LF1\-?\ ""WG]UJ/^$%O/[K5]R_\*+'_
M #Q_2C_A18_YX_I1]>B']DR/AK_A!;S^ZU'_  @MY_=:ON7_ (46/^>/Z4?\
M*+'_ #Q_2CZ]$/[)D?#7_""WG]UJ/^$%O/[K5]R_\*+'_/']*/\ A18_YX_I
M1]>B']DR/AK_ (06\_NM1_P@MY_=:ON7_A18_P">/Z4?\*+'_/']*/KT0_LF
M1\-?\(+>?W6H_P"$%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_9,CX:_X0
M6\_NM1_P@MY_=:ON7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY_=:C_A!;
MS^ZU?<O_  HL?\\?TH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:ON7_A
M18_YX_I1_P *+'_/']*/KT0_LF1\-?\ ""WG]UJ/^$%O/[K5]R_\*+'_ #Q_
M2C_A18_YX_I1]>B']DR/AK_A!;S^ZU'_  @MY_=:ON7_ (46/^>/Z4?\*+'_
M #Q_2CZ]$/[)D?#7_""WG]UJ/^$%O/[K5]R_\*+'_/']*/\ A18_YX_I1]>B
M']DR/AK_ (06\_NM1_P@MY_=:ON7_A18_P">/Z4?\*+'_/']*/KT0_LF1\-?
M\(+>?W6H_P"$%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_9,CX:_X06\_N
MM1_P@MY_=:ON7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY_=:C_A!;S^ZU
M?<O_  HL?\\?TH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:ON7_A18_Y
MX_I1_P *+'_/']*/KT0_LF1\-?\ ""WG]UJ/^$%O/[K5]R_\*+'_ #Q_2C_A
M18_YX_I1]>B']DR/AK_A!;S^ZU'_  @MY_=:ON7_ (46/^>/Z4?\*+'_ #Q_
M2CZ]$/[)D?#7_""WG]UJ/^$%O/[K5]R_\*+'_/']*/\ A18_YX_I1]>B']DR
M/AK_ (06\_NM1_P@MY_=:ON7_A18_P">/Z4?\*+'_/']*/KT0_LF1\-?\(+>
M?W6H_P"$%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_9,CX:_X06\_NM1_P
M@MY_=:ON7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY_=:C_A!;S^ZU?<O_
M  HL?\\?TH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:ON7_A18_YX_I1
M_P *+'_/']*/KT0_LF1\-?\ ""WG]UJ/^$%O/[K5]R_\*+'_ #Q_2C_A18_Y
MX_I1]>B']DR/AK_A!;S^ZU'_  @MY_=:ON7_ (46/^>/Z4?\*+'_ #Q_2CZ]
M$/[)D?#7_""WG]UJ/^$%O/[K5]R_\*+'_/']*/\ A18_YX_I1]>B']DR/AK_
M (06\_NM1_P@MY_=:ON7_A18_P">/Z4?\*+'_/']*/KT0_LF1\-?\(+>?W6H
M_P"$%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_9,CX:_X06\_NM1_P@MY_
M=:ON7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY_=:C_A!;S^ZU?<O_  HL
M?\\?TH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:ON7_A18_YX_I1_P *
M+'_/']*/KT0_LF1\-?\ ""WG]UJ/^$%O/[K5]R_\*+'_ #Q_2C_A18_YX_I1
M]>B']DR/AK_A!;S^ZU'_  @MY_=:ON7_ (46/^>/Z4?\*+'_ #Q_2CZ]$/[)
MD?#7_""WG]UJ/^$%O/[K5]R_\*+'_/']*/\ A18_YX_I1]>B']DR/AK_ (06
M\_NM1_P@MY_=:ON7_A18_P">/Z4?\*+'_/']*/KT0_LF1\-?\(+>?W6H_P"$
M%O/[K5]R_P#"BQ_SQ_2C_A18_P">/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:ON
M7_A18_YX_I1_PHL?\\?TH^O1#^R9'PU_P@MY_=:C_A!;S^ZU?<O_  HL?\\?
MTH_X46/^>/Z4?7HA_9,CX:_X06\_NM1_P@MY_=:ON7_A18_YX_I1_P *+'_/
M']*/KT0_LF1\-_\ ""WG]UJ/^$'O/[C?E7W)_P *+'_/']*/^%%C_GC^E'UZ
M(?V5(^'?^$#O&_@:IH?AQ=R'_5M^5?;Z? U1_P L?TJ[;_!-$_Y8_I2^OHK^
MRI'Q9I_PHN9&&8S^5=IH?P7FE9<Q'\J^N+'X01PL/W/Z5U6E_#>&W*_NA^5<
M\\?V.VEE5MSYK\-_ 7S=F8/TKU7PY\!(X=A, _*O=M'\+P6B@E!Q[5T$<21+
MA%"BO-J8R<MCVJ.7TX*[1YEH/POBTTK^Z Q[5Z#I>F1Z?$ % -7Z*XI5)2W/
M2A2C3V"BBBLS4**** "BBB@ HHHH **** "BBB@ HHINZ@!U%(#2T %%%% !
M1110 444AH 6BF[J44 +1110 4444 %%,:9%ZL*B:Z4]#0!/2U#')NJ44P%H
MHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%-+4 +BC%)NI=U !3<TZDVT *M&*!2
MT )BEHHH **** "BBB@ HHHH **** $//!JA>:5'<9^45H44 <I=^$8YL_(/
MRK*F^'\<F?W8_*O0**OG9#@F>9R?#6-O^60_*HO^%8Q_\\A^5>HT4_:2%[.)
MY?\ \*QC_P">0_*C_A6,?_/(?E7J%%/VC#V<3R__ (5C'_SR'Y4?\*QC_P">
M0_*O4**/:,/9Q/+_ /A6,?\ SR'Y4?\ "L8_^>0_*O4**/:,/9Q/+_\ A6,?
M_/(?E1_PK&/_ )Y#\J]0HH]HP]G$\O\ ^%8Q_P#/(?E1_P *QC_YY#\J]0HH
M]HP]G$\O_P"%8Q_\\A^5'_"L8_\ GD/RKU"BCVC#V<3R_P#X5C'_ ,\A^5'_
M  K&/_GD/RKU"BE[20>SB>7_ /"L8_\ GD/RH_X5C'_SR'Y5ZA11[20>SB>7
M_P#"L8_^>0_*C_A6,?\ SR'Y5ZA13]HP]G$\O_X5C'_SR'Y4?\*QC_YY#\J]
M0HH]HP]G$\O_ .%8Q_\ /(?E1_PK&/\ YY#\J]0HH]HP]G$\O_X5C'_SR'Y4
M?\*QC_YY#\J]0HH]HP]G$\O_ .%8Q_\ /(?E1_PK&/\ YY#\J]0HH]HP]G$\
MO_X5C'_SR'Y4?\*QC_YY#\J]0HH]HP]G$\O_ .%8Q_\ /(?E1_PK&/\ YY#\
MJ]0HH]HP]G$\O_X5C'_SR'Y4?\*QC_YY#\J]0HH]HP]G$\O_ .%8Q_\ /(?E
M1_PK&/\ YY#\J]0HI>TD'LXGE_\ PK&/_GD/RH_X5C'_ ,\A^5>H44_:,/9Q
M/+_^%8Q_\\A^5'_"L8_^>0_*O4**/:,/9Q/+_P#A6,?_ #R'Y4?\*QC_ .>0
M_*O4**/:,/9Q/+_^%8Q_\\A^5'_"L8_^>0_*O4**/:,/9Q/+_P#A6,?_ #R'
MY4?\*QC_ .>0_*O4**/:,/9Q/+_^%8Q_\\A^5'_"L8_^>0_*O4**/:,/9Q/+
M_P#A6,?_ #R'Y4?\*QC_ .>0_*O4**/:,/9Q/+_^%8Q_\\A^5'_"L8_^>0_*
MO4**/:,/9Q/+_P#A6,?_ #R'Y4?\*QC_ .>0_*O4**/:,/9Q/+_^%8Q_\\A^
M5'_"L8_^>0_*O4**/:,/9Q/+_P#A6,?_ #R'Y4?\*QC_ .>0_*O4**/:,/9Q
M/+_^%8Q_\\A^5'_"L8_^>0_*O4**/:,/9Q/+_P#A6,?_ #R'Y4?\*QC_ .>0
M_*O4**/:,/9Q/+_^%8Q_\\A^5'_"L8_^>0_*O4**/:,/9Q/+_P#A6,?_ #R'
MY4?\*QC_ .>0_*O4**/:,/9Q/+_^%8Q_\\A^5'_"L8_^>0_*O4**/:,/9Q/+
M_P#A6,?_ #R'Y4?\*QC_ .>0_*O4**7M)![.)Y?_ ,*QC_YY#\J/^%8Q_P#/
M(?E7J%%'M)![.)Y?_P *QC_YY#\J/^%8Q_\ /(?E7J%%/VC#V<3R_P#X5C'_
M ,\A^5'_  K&/_GD/RKU"BCVC#V<3R__ (5C'_SR'Y4?\*QC_P">0_*O4**/
M:,/9Q/+_ /A6,?\ SR'Y4?\ "L8_^>0_*O4**/:,/9Q/+_\ A6,?_/(?E1_P
MK&/_ )Y#\J]0HH]HP]G$\O\ ^%8Q_P#/(?E1_P *QC_YY#\J]0HH]HP]G$\O
M_P"%8Q_\\A^5'_"L8_\ GD/RKU"BCVC#V<3R_P#X5C'_ ,\A^5'_  K&/_GD
M/RKU"BCVC#V<3R__ (5C'_SR'Y4?\*QC_P">0_*O4**/:,/9Q/+_ /A6,?\
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M=H/@1WN%8Q]_2O5M/\(AF&4_2NQTGPG'"H)04#,#PCX7%G&F5QQ7H5E"(8P
M,4MO8QVZ@ 58 Q4@+1110 4444 %%%% !1110 4FZEIE #J6D6EH \Q^*/\
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MU"]JD6$8Z5',,Q8](5?X:F7347M6HR@5"QI78RF+-5[4\0JM/=J@>3%',(E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %-,:MU44ZB@"/[/&?X%_*D^RQ?\
M/-?RJ6B@1#]EA_YYK^5'V6'_ )YK^5344PL0_98?^>:_E1]EA_YYK^5344!8
MA^RP_P#/-?RH^RP_\\U_*IJ* L0_98?^>:_E1]EA_P">:_E4U% 6(?LL/_/-
M?RH^RP_\\U_*IJ* L0_98?\ GFOY4?98?^>:_E4U% 6(?LL/_/-?RH^RP_\
M/-?RJ:B@+$/V6'_GFOY4?98?^>:_E4U% 6(?LL/_ #S7\J/LL/\ SS7\JFHH
M"Q#]EA_YYK^5'V6'_GFOY5-10%B'[+#_ ,\U_*C[+#_SS7\JFHH"Q#]EA_YY
MK^5'V6'_ )YK^5344!8A^RP_\\U_*C[+#_SS7\JFHH"Q#]EA_P">:_E1]EA_
MYYK^5344!8A^RP_\\U_*C[+#_P \U_*IJ* L0_98?^>:_E1]EA_YYK^5344!
M8A^RP_\ /-?RH^RP_P#/-?RJ:B@+$/V6'_GFOY4?98?^>:_E4U% 6(?LL/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E% "T444 %
M%%% !1110 4T]:=10 RE'6G44 %%%% !1110 4444 %%)FEH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $S[44M% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)F@!
M:*** "BBB@ HHHH 3\**6B@ I/PI:* $I:** "BBB@ HHHH **** "DW44V@
M!U+2+2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'X8:'_K17NGPR_X^(OK7A>A_P"M%>Z_#/\ X^(J^^Q.Q^4X3XD?;'PA
M_P!3%^%>_0_ZE/I7@7PA_P!3#^%>^P_ZE/I7Q6(^,_2,'_#)****YCN"BBB@
M HHHH **** "BBB@ HHHH **** ()[59NHJL-)C#9P*T** (H;=81P*EHHH
M**** ()[59NHJK_8\>[.!6C10!7@M%AZ"K%%% !364-UIU% $?DK3E4+TIU%
M !360-3J* (_)6GJNVEHH *:RAA@TZB@"E+IJ2=A1'IJ1GH*NT4 -50@P*4J
M&ZTM% #?+%'EBG44 -\L>E+2T4 )UJ"2S23M5BB@"I'8HAZ586,*,4^B@!OE
MBEI::6H =44UNLPP:D6EH SFT>-FS@58@L4AZ"K-% !1110 UHPU((E%/HH
M0+BEHHH 0J#2>6/2ES10  8Z4M%% #)(Q(N"*HR:3'(<X%:-% %&'2TB["KJ
MJ%&!2T4 %%%% !112-0 M%-IU !1110 4444 %)2T4 %%%% 'F7Q2_X]9OI7
MPA\;O]9-^-?=WQ2_X]IOH:^$?C9_K)OQKW\OW1\IFVS/$_"__(87_>K[^_9O
M_P!3;_05\!>%_P#D,+_O5]^_LX_ZFW_"N_,/@/*R?^(?5*_=%+2+]T4M?(GZ
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6BB@ HHHH ****
M$I:** "BBB@ HHJ*:XC@0LS  4 +),L(RQQ7->(/%D-E"P# 8'K6+XP\:16<
M;XD Q[U\]^//B@5,@67]:ZJ=%S.>I54#?^)'Q.$*R!9?UKYW\0^/I=2N&42$
M@GUKG_&WCB2^D<>83D^M<YH"OJ%TI)SDU[-.BH*[/%J5G)V1Z]X%L7U*ZC8C
M.37UG\+]'^RQQ'':O"?A-X;+>2=OI7U1X1TW[+!'QCBO.Q$NAZ&'AU.O7[H^
ME+117FGI!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% #6I*=BC;0 M%%% !1110 4444 %%%% !1110 4444 %%
M%-:@!U)2#K3J &4Y>E&VB@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BFGK0.M #J*** $8[1FJTE_'%U-273;(&->;^)?$ALY
M&&[%,#T%=4B;H:E^VQ^M>2:7XM,TF-^:V;KQ+Y,)._M0!W4VLP0]3^M4V\30
M[L!A7BNO?$#R68"2LC3?&\EU< "3/-%B6SZ-M=26ZQ@YJ^.E>>>#=1:ZV9.<
MUZ&OW12&1S7"P_>JM_:\.[&:Q/%^I&QC)!QQ7F$GC<QW97S.].PSW*&X6;[M
M35PWA/Q(ETJY?-=HMQ&R@AQ2 EHIH=6Z'-.H **1F"]3BF&XC7JXH DHJ,7$
M;='%/#!NAS0 M%%-+*O4XH =14?VB,?Q"@7$9_C% $E%,\Y/[PI#/&.K"@"2
MBH_M$?\ ?%/5@W0YH 6BBF-*B]6 H ?147VF+^^*59XVZ,* )**3.>E+0 44
MUI%7JP%,^U1?\]%H EHJ-9XVZ.#3Z %HHIC2(O5@* 'T5%]IB_OBG"9&Z,#0
M ZHVN$7J:9=7"PPELUPVL^*DMI6&^@#O%N$;H:D!S7GND^*EN) -]=KI]XLT
M8YH O4FT4WS$'5A3?M,7]\4 24M1B>-NC@T_<#T- "T44UG5>IQ0 ZBH_M$?
M]\4"9&Z,* )*@FNE@^]4VX>M<EXJU!K;<0: -\:M$6QFK<4HE7(KR*V\12-=
M8W'K7H_AVZ,\ )/:F!M44QID7JP%-^TQ?WUI 2T4Q94;HP-/H **** "BDR*
M3S%'<4 .I*89HQU84?:(_P"^* )**:K!NAS3J "BFM(J]3BF?:HA_&* ):*C
M6>-NC@T_<,9H 6F-*J]35&\U);<')Q7+ZCXLCC8C>* .T%PA[T]6#=*X/3_$
MHN),!\UV.FS^='G- %VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /PPT/_
M %HKW7X9_P#'Q%]:\*T/_6BO=?AE_P ?$7UK[[$;'Y1A/B1]L?"(_N8?PKWZ
MW_U*?2O ?A&/W,/X5[];_P"I3Z5\7B/C/TG!_P ,DINZG4RN4[API:1:6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I#2TC4 )NIU,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4W;3
MJ* $ Q2T44 %%%% !1110 4444 %%%% #6ZT+UH(H44 +2;J6FT +MI112T
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MH\4Y%H 3:2*88S5M8\BG^30!0\NF-'[5HM!3?L^: ,SR32>2:U/LWM1]F]J
M,P6_M0+7VK6^S>U.6V]J5P,G[+1]DK96U&*7[**0&)]E]J/LOM6Q]F]J3[/3
M QFM?:FM:^U;#6M)]EH QFM?:H9+4^E;QM:CDL_:D!S<UI5*:S]JZF2S]JJR
M6.>U ')R6?M4!L>>E=5)I_7BJ[:?[4P,2WL]K#BMNQAVXI4L]O:K<,6VF!IV
MC;<5HK+Q61&VW%64FZ5(&CYF<5&R[JBCDSBIUPU %2>'=65=6>[/%=%Y>ZH9
M+4-GB@#B;K3^O%9LFG_-TKN;BP![5G2:<,]*8',1:;[5JV>G=.*TH]/'I6E:
MV0&.*8$-E8@8XK9M[4*.E/M[<+5Y(P*A@,CCVTXG;3FP*@E:C<!LTG%9MS)U
MJQ._!K-N).M4AE*ZDZUA7OS9K5N'ZUCW3=:8C'NH0Q/%1PVH+=*MR\DU-;1Y
M-2!<TRUP5XKJ["#&*Q].A^[73647 I 3+'\M1R+5Y8^*AECI("H!@U)FADYH
M]:L"&49JN4JU)450P(U2G[:>%J3968%?RZ58ZL>72A,4P(/+]J!'STJ?;2[!
M5("+RZ/+J7;1MJ@(O+IC)S5C;366@!L*U>AJHBU94XI@.E;@UE7C<&K\S<&L
MN\;@T 8UYRQK+FCSFM.Y/-4F&<TP*RPBK,4(]*5(ZLQI3 2.'VJQ'%Q2HM3J
MM #5BIZP]*E5:E5>E- 0K#4JQ5*J\=*D5>>E*X#8XZE\NG*M/J0(O+IC+STJ
M>HVI 0,M1-'5@BDVT 4VBJ&2&M QU&T=4@,N2#VJ!K?VK6>&H7AJT!D26]59
M(?:MN2&JLD%:JP&,\-5Y(:UY8:IR1U8&/-%UJE(E:\T=4)4I@4]M2*O2E(Q3
ME/2@ V\4Q\4]FJO-)BD UF'-,WU7DFJ!KCWH O!_>G9XJBMQ[U,LV:8#FIN*
M<32&F4%(332U&:8"$4W;[5)2[::)(]OM2$XI[<5!(U4(=NJ16S57S*DCDH&6
M=M.V\"DC:I.U5<8T#%+116;$%%%%(:"C&:*<M PVTNWVIPI=M)DC=M*%^6BG
M+2 8RTSR^M34;: &+"..*LPPBD1:LQBI8$L<=2,M(M#-2 C9:L6/RR"HL;C3
MXV\LYH C\6W(337Y[5\&_M&ZIM:X /K7V;XZU81:?(-W:O@7]H34O.DN.?6L
M:CT&CY)\1WQDU!^>]4TDRM0:PQ:_?ZT*VU!7)U-"Y''YQ KU#X4Z"9M2A.W^
M(5YWHD?GS*.M?2/P8\.^9>0G;W%,3/NO]F'2?LT-MD8Z5]G0\0QC_9'\J^9/
M@'I/V6V@XQP*^G(_]6GT%! ZBBB@04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 (:3=2M3: 'T444 %%%% !1110 44FZEH ***R-:UI--C)+ 8I[BO8N
MZA?1V<#,[8.*\F\:_$2.Q20"3'XUE^//B@ENDBB7MZU\U>//B))>-(%DSSZU
MVT:+EN<=:LH['1>./B@;AI%67]:\/\2>)I;Z1OG)S65JVNRW4K?,360TK2-S
MS7KTZ:BCQZE1R9GZBTDLF<GK7:?#FS,EW'D9YKG!:^=CBO3?AEHY-W'\O>M)
MR]TSA&\CZO\ @_H8:WA)7TKWRQM1;QJ,5YK\(]/$5K%D=A7J]?.UI7D?1THV
MB%%%%8&P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-9MJYH
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M:I8P3GFO?]#A#V:-2&:4/W*;>?\ 'K)]*D VBJFI7"QVLG/:D!\[?%2Z=)I
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M["M&I*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<4\PEI863T];GM]%%%?,GW 4444 %%%% !1110 4444 %%%% !1110 4444
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MZJ MB8TOG545N:=NI 32352N).M2R-5&X?@U(%*ZDZUCW#9:K]U)UK,D^9J
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MJ>-O#GVIVPN:P/#/A=K:[5MN.:H1[;X38M8+GTK=K%\.1F&W"^U;52,****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)2TC=* #=2TRG4 +1110 E&ZANE
M-H ?124M "9HW4C4E #Z*** "L37M86QMI/FQQ6S(VV-CZ"O$_BOXL&G0R@/
MC@]ZUIPYY6.>M4]G&YX?\?/%JR+.H?U[U\=ZBS:EJQ[Y:O2_B]XX-Y=2KOSS
MZUP7@RS.J:DAQG+5]AAX>RIGYWC*OMZUD>\?!'PN9#"Q3TK[:^'ND_8[>+C'
M%>'? [P@%MX6V=AVKZ=T6Q%K"HQCBOG\94YI6/KLMH<D$S6HHHKRCW@HHHH
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M%D,]AM95;FK#RJ*YFSU0>6.:6;6!_>KT(DFG>2#FLN2456EU+?WJLUUGO6Z
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MAXQ@"OD/X!>#]RVS;/3M7W1X!TO[#:Q\8XH,V=K1110(**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MI&.T9K,OM:2S!)(II7$VEN:E%<-J'Q*MK$D,ZBL>3XTV<;8\Q/TK14IO9&#K
MTUNSU&BO+E^--DW_ "T3]*?_ ,+FL_[Z?F*?L9]A?6*?<].HKS+_ (7)9_\
M/1/TI#\9+/\ YZ)^E'L9]@^L4^YZ=17F/_"Y;3_GI'^E+_PN6S_YZ)^E'L9]
MA_6*?<]-HKS/_A<=G_ST3]*7_A<5I_ST3]*/8S[!]8I]STNBO-/^%Q6G_/1/
MTH_X7%:?\]$_2CV,^P?6*?<]+HKS,_&*S'_+1/TH7XQ6;?\ +1/TH]C/L+ZQ
M3[GIE%>?VOQ3M;A@ ZUT>F^)8]0QM(.:EPE'<TC5A+9F[135;<H-.K,U"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU)I1<NW>GB$4OE"@!HD+=:7&>HIVP4N*8A/+%'ECTIU% ";11M%+10 4444
M%0O'EJFI,<T@+&GW'V>13TYKV3X:^("MQ$N[N*\-FD\L@UVWP]U0QWT0SWJ9
MQYHFD)<K/T#^&-[]IMX^:])KQ'X-ZH'MXN:]L5@RY%?.U5:1]#2=XCJ***Q-
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J.5=RXJ2B@#+DL [=*?'IJCM6AM'I10!EW&EHW:H8=)56Z5M4;1Z4 0
MV]N(EZ5/110 E4;JT$QZ5?I-HH R(]+4-G;6A%:K&O2I]H]*6@"M+ &JJVF(
M[9(K2HH KPV,</:GS6J2+C%344 <SJF@I+G"UAKX;VR_=KT!D#=14?V6/.<4
M 8^DZ*D:@LM:DFGQ,N M6%4+P!3J ,O^S5#<"K,=FJCI5K I: *<EN&[5!_9
MBN<D5I8HH JPV:P]!1<6HE7!%6C2;: ,E=&0-G;6C#;+&H&*FI: *5YIZ7"G
MBN8U#P\"Q*K7:5&T*-U% '':?H.V096NJL[&.WC&%&:G6!%Z"I* $VCIBJMU
MI\=PIR.:MT4 <7JGAU68E5JO8^'<2#*UW#PK)U%(MNBG(% %6QTN*WC!VC-7
M/+4C&*?10!G7FDQW"GY:Y?4/#@W$JM=S4;6Z/U% '$Z?H)5QE:ZNSTN*&,97
MFK2VZ+T%2TP*EQ8QR1G"XKG;K0P\GW>]=;4;0JW.*0&)I>CI'U6K5_I:21'
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M3TW2HK>,$J,UH>6NT@#%+TXI: .>U/1UN6.5JG:^'UA?.WO75E W44GEKZ4
M5[.'R5 JW2;0*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_&&CI>:
M1* N3BOAKX[>"7\R=EC]>U?H'=Q":W=",Y%>$_%;P&-0MY2(\\'M7HX2M[.1
MY&88?VT-#\P[R&71]6)P5PU?0OP2^( M+B!6DQT[UR'Q8^'LEA=RNL9&">U>
M:^']:FT'45!8KM-?522Q%,^"@Y86J?K3\-_&4.I:?&AD!XKT%'$BAE.17P?\
M%?BT%$*/-Z=Z^P_!/BR#5K-!Y@)(XYKY+$8=TY,_0,'BHUH(Z^BFJP89!R*=
M7">H%)2T4@&4Y:-M%,!:1J6DH ;3Z3;2T %%%% !24M% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:A6K=O'FH8BW:QY(K<LH>E9UG%TK>L8^E8R OVD/ XK7ACQ56UCX%:,:]*R
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MKPXXH,Q:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYQ?2K-?,'VRV"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<^M'+$7-([ >.)A_RT/YTO\ PG4__/0_G7&_9SZT?9V]:.5#YF=E_P )U/\
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M3)K+?6HU;&Z@#:HJE:7JW&,'-7: "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK%^($GV?2Y'''RU+ \F\9_$Y='9P9<8]Z\UNOCVBR%?/'YUXY^T%X[DTVXN
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M*%S)<'$K'GUJ;CL?H!_PO08_U_ZTQOCF/^>_ZU\-P^/;N11^\;\ZD/C:\/\
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M5?POLQ9Z*BXQ\HKM:Q?"]G]CL57&.*VJ9 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M05)5D,;G%**3!I5I"%HHHH ****8!1110 4444 %*#244 +NHW4E% !1110
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M _\ /?\ 6C_A>!_Y[_K1]18?VI'N?</_  L2V_O+1_PL2V_O+7P]_P +P/\
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MHHKSSU@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#DO&&C#4+:0;<YKXD_:*\$^3#<-L]:_0.:W692#7S5^TEX
M962QN"$['M0-'XW?%:U^QZA,,8P37GEB^YJ]R^.WA]H=3N"%Q\QKQ.UMC#(<
MBD66X5VR9KN/".K"UFC&<<UQ?2I+74#;W"<]Z>PS[9^$>L"\,2YSTKZ;T311
M>6*MC/%?#_P)U\M=0@MW%??7P\F2ZTR//)Q7;1F0T<%XKT'R=WRUY]=6WEN>
M*]\\9::'1B!7CVN6/ELW%>C&1)S#'%,9J+C*N14#/S71&5P)E:K,,F*I*:GC
M:KL!LVTU:4$WO6#;R=*TK>2LY1 UDEJ17JE&]3*U<LD%S8L'^85VF@M\R5PE
MBWS"NVT!OF6N=H1Z?H/W5KMK!?E%<3X?^ZM=SI_W16=RK&G#'5I4J"$U8W#%
M*0C.U9?W)KR#QUPLE>NZL_[HUY!XY.4DJX#/G;QM+M=_K7E6I77[P\UZ;X\8
MAY*\>U6?$AKM@(LPS;C5R-A6%:W'S5I1W''6NR(B\S 53GFQ2/<52FD+-52V
M&:%K)YCBN^\)V/FNG%<+H\!DD7BO8? ^E[F3BO,F]0/4/!.C_P"K.*]HT&Q\
MN->*XGP=I>U$XKU#3;?9&O%8<W0HTK5=JU*PIL/%2-]TUF!DZE\JFN%UV;;N
MKN-5;"-7GGB"3[U:(1RU]<98\UES25+>R_.:HO-5"1)NJ:.JBR58C:I&V:$%
M:MIVK'@;I6O9]J=A&]9]JW;/M6%9]JV[2IL!L0G@5:1JI0]!5I:0%A6Z4]:A
M7M3UJ6A@U1-4U-*5B(A535B%<FFK'5F&.@"S;QUJ6\/2JMM%TK5MX^E2!)'#
M\M/:&ID7CI1)0!1:.F+'4[]:8M,#3T]<1FN5^*3[-#D/^P:ZO3V_=D5QOQ8D
MQH<H_P!@U'4#\LOVI-2=+RZ /<U\=PW$MSJA )ZU]<?M/KYE[=?[QKY=\.V*
MR:P,C^*LVM2CU'P/X/GU58\*3FO8-)^"US<PJ?*)_"NA^!GAJWN%M]R@]*^S
M?"'@.QDLT)1>E6D!\-S? ^X4_P"J/Y4P_ ^Y9,>4?RK[\O/ -@&^XOY4VW\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 5M0_X])/I7SK\7)-L<WXU]%:C_P ><GTKYJ^,,F(Y
MN?6NS#?$>;C7:!\<_$J3-Q+]:\7U+_7-7KOQ&EW7$GUKR'4/]8?K7V5'X3\Y
MQ.LF-A^[4E,A^[4U;G&AJTZBBF,****0!13J8U !2TU>M.H @GJ73_\ 6BHK
MBI=+_P!<OUJN@NI[!\.(LW,7UK[4^#L>V.'\*^-_AG#NN(OJ*^T_A''MBB_"
MOGL<?696M4?0EG_QZQ_2IZAM?^/>/Z5-7S)]NM@HHHH&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 A&:YSQ;I:W-DYQGBNDJKJ47G6<@]J:=F)ZH^(OC/H
MWEO-@>M?,>JVYCNV^M?;/QDT/SO..WUKY.\4:,8+ISC'->_AYWB>!B(VD<U!
MPM2U&P\OBG*<UU'*.HHHI@%%%% @HHHH **** "BBB@ HHHH **** "BBB@
MI5I** 'TRBB@ HHHH *,TC4V@!]%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4UNM.HH 92KUIU% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%U]VIZAN!E: %
MT*8QWB_6OJOX+ZMY?DC=Z5\HZ6NVX4^]>\_"_5_L\D0W8Y%<]9<T3IHOE9]V
M>&]2%Q9(,YXK=!R,UY3X!USS[>,;L\5ZE;MOA4UX$XV9[T)<R):***S- HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ***1NE !FEIE.7I0 M%%% !1110 4444 %%%% !1110 4444 %9VM9
M^RDCTJ^T@7K6+KVH(L!&: /)O%EQ*)& )KA+IK@ECS7H&M-'<3GIUJJNAQS1
M$XJF2>47VK7%K+R37:^!/$SM,@9N]<]XTTE;=F(&*QO"VH?9;Q1G'- 'U';Z
MT/L.=W.*\V\9:^[2,JM5FSUHR6( ;M7-WUN]_=]SDTBC&7[3>,2,FI%M+F%P
M3NQ7IOA+P4MQ&I9*W-7\#QPPE@E-"L<1X7OY(2H8UN^(-2\ZQ89[5BW%L--D
M..,5GWVH>=&5S0,\M\6:>UU>/M&>:F\-Z#<188 UVUMH']H70)7/->BZ'X)B
MCM02F./2F2>4R7$]CC)(Q75^$?$[&55+4SQUHJ6H;:,8KA=%O&M;P#/>D,^A
M9-0%Q9]<\5YOX@G\FX+>];6CZH9K4#/:N?\ %2$QLP]*$(DTWQ8MJNW?BHM8
M\2-?1D(V:\GU/6I+2X*[B.:Z+PK?'46 8YH&-U!;F20L-W6MCPY>3V\J[B17
M8V_AJ*:W#%>U9]SHZVKG:,4".FM_%'D6G+=JY#6O%YDN2 _>J&IS211D#/2N
M.EDDDO.<]:!'M_@/4'NF4DUZ9<:@+6SR3CBO'_AY,(50DUUGBK6O+LR%;M06
M5-;\5!I&4-7/W&I22 L#7%S:M)/?X+'&:ZJUP]GD]<4A7,R\\2/:Y!:LN77)
M;S(#9K(\42%;@@>M6_"MK]J8;N:87*E]<W$9W9-;?A+7I%G4,W>M+6-!3[/G
M;VKG-/MS:W@P,<T"/?M$UP"S4ENU<[XM\6!0RAJQ;35&AL< ]JX;Q!J4EQ=%
M<G&:0RW>ZA-J$C;236)?074.6^:NZ\#^'_[0VEES71^)O"$=O9LVSM57 \/%
MU+))M8FNN\+:7]HE1B,UCW&GK'>D =Z](\$Z5N"'%#8CT'PC8"WC3C%=?65I
M-MY,:\5JU!04444 %%%% "44C4E #Z*** "BBB@ HHHH **** &M0O6G44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4-2TN.^C
M(*@DU?HI[":ON>7^(OA;%J2N?*!S[5Y!XN^!",'(@'Y5]7U4OM/BO(R&0$UT
MT\1.#.&K@Z=1:H_._P 6? ]XV?;#^E>6:Y\*;FV8[8B/PK]+-<\!PWF[]V#G
MVK@-8^#T=T3^Y_2O6IX]K<\"OE2>R/SHNO!5[:DX5ORK/?1]0A_A:OOC4/@(
MLQ.(?TK"N?V==Q_U'Z5W1QT'N>3+*JB>A\0FSU%>ST?9M1]'K[/D_9P/_/#]
M*C/[.)_YX?I6OUVF1_9E8^-/LVH_[='V74?]JOLO_AG(_P#/#]*7_AG$_P#/
M#]*GZY 'EE8^,_LNH?[='V74/]JOLS_AG$_\\/TH_P"&<3_SP_2CZY3%_9E8
M^,_LNH?[5+]FU#T:OLH_LXG_ )X?I2?\,XG_ )X?I2^N4Q?V96/C7[+J/^U1
M]EU'_:K[,_X9Q/\ SP_2C_AG$_\ /#]*?URF/^S*Q\9_9=1_VJ/LNH_[5?9G
M_#.)_P">'Z4?\,XG_GA^E'URF']F5CXS^RZC_M4?9=1_VJ^S/^&<3_SP_2C_
M (9Q/_/#]*/KE,/[,K'QG]EU'_:H^RZC_M5]F?\ #.)_YX?I1_PSB?\ GA^E
M'URF']F5CXS^RZC_ +5'V74?]JOLS_AG$_\ /#]*/^&<3_SP_2CZY3#^S*Q\
M9_9=1_VJ/LNH_P"U7V9_PSB?^>'Z4?\ #.)_YX?I1]<IA_9E8^,_LNH_[5'V
M74?]JOLS_AG$_P#/#]*/^&<3_P \/TH^N4P_LRL?&?V74?\ :H^RZC_M5]F?
M\,XG_GA^E'_#.)_YX?I1]<IA_9E8^,_LNH_[5'V74?\ :K[,_P"&<3_SP_2C
M_AG$_P#/#]*/KE,/[,K'QG]EU'_:H^RZC_M5]F?\,XG_ )X?I1_PSB?^>'Z4
M?7*8?V96/C/[+J/^U1]EU'_:K[,_X9Q/_/#]*/\ AG$_\\/TH^N4P_LRL?&?
MV74?]JC[+J/^U7V9_P ,XG_GA^E'_#.)_P">'Z4?7*8?V96/C/[+J/\ M4?9
M=1_VJ^S/^&<3_P \/TH_X9Q/_/#]*/KE,/[,K'QG]EU'_:H^RZC_ +5?9G_#
M.)_YX?I1_P ,XG_GA^E'URF']F5CXS^RZC_M4?9=1_VJ^S/^&<3_ ,\/TH_X
M9Q/_ #P_2CZY3#^S*Q\9_9=1_P!JC[+J/^U7V9_PSB?^>'Z4?\,XG_GA^E'U
MRF']F5CXS^RZC_M4?9=1_P!JOLS_ (9Q/_/#]*/^&<3_ ,\/TH^N4P_LRL?&
M?V74?]JC[+J/^U7V9_PSB?\ GA^E'_#.)_YX?I1]<IA_9E8^,_LNH_[5'V74
M?]JOLS_AG$_\\/TH_P"&<3_SP_2CZY3#^S*Q\9_9=1_VJ/LNH_[5?9G_  SB
M?^>'Z4?\,XG_ )X?I1]<IA_9E8^,_LNH_P"U1]EU'_:K[,_X9Q/_ #P_2C_A
MG$_\\/TH^N4P_LRL?&?V74?]JC[+J/\ M5]F?\,XG_GA^E'_  SB?^>'Z4?7
M*8?V96/C/[+J/^U1]EU'_:K[,_X9Q/\ SP_2C_AG$_\ /#]*/KE,/[,K'QG]
MEU'_ &J/LNH_[5?9G_#.)_YX?I1_PSB?^>'Z4?7*8?V96/C/[+J/^U1]EU'_
M &J^S/\ AG$_\\/TH_X9Q/\ SP_2CZY3#^S*Q\9_9=1_VJ/LNH?[=?9G_#.)
M_P">'Z4A_9Q/_/#]*?URF+^S*Q\:?9=0_P!JC[+J/^U7V7_PSD?^>'Z4H_9Q
M)_Y8?I2^N0#^S*Q\9_9=0_VJ<NEZA+QAZ^S5_9P/_/#]*M0?LY[2/W'Z4?7:
M92RRL?&5OX3OKDC*L<UT&D_#&ZN77,;'\*^QK']G\1XS#^E=3I/P52W9<P_I
M64\?&VAT4\IG?WCY;\+?!.29DW0_I7M7A'X#K\A, _*O=M#^',5GM_=#\J[[
M2=$ALHQ\@S7EU<;*6Q[N'RV$=T>7^&/@_#8JI\D#'M7I6B^'8M-4#8!BMOIT
MXI:\R524]SVZ=&%/9"4M%%9&X4444 %-IU)MH 1:=2 8I: "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **0FFT#'T4@-+0(*\G^-NE?VAI
MLHVY^6O6*YGQGI8U"S88SQ0!^2O[0'@-OM5R_E]SVKY-US23I\S C'-?J'\?
M? (*7#^7Z]J_/+XLZ.=/NI?EQR:"T>6^9\Q%5),^>"/6FK)^^(JPT>6!H+/9
MO@UJWV.\ARV.17W[\)?%2O8PKO["OS4\$:D;&XC.<<U]<_![QI_J4W^E:Q=B
M6?7NJ.M];DCG(KR[Q58^6&.*[OP_J*WUBISGBN<\:QA8V->C!Z&9XYJ"[9&%
M4,U>U5O](850%==,"=*D0U$O2G;L5W16@%Z%^16A;R>]8L<N#5V&>H: VTD%
M3))65'<59CFKCJ(#H-/;YA7;^'V^9:\_TZ;D5VV@S?,O-<; ]9\//\JUW%@_
MRBO._#UP-JUW>GS#:*Q8S<CDJ4S<51C>G[J8BOJ<FZ-J\L\9Q%HY/I7J-XI9
M#7"^)[$R1OQVJXC/ESQ]:G=)Q7BFM0E9FKZ3\>:.6\SY:\+\1:0RS-Q77 1R
M%O\ +5Z-S2#3W5NE3QV3^E=D0$Y:IH;,R,.*M6^FNS=*Z;1]!:5E^6B6PQ?#
M.BL\B?+7NO@70ROE_+7-^$_"IW)\E>V>%/#_ )*I\M>9)ZB.K\-Z?Y:)QVKM
M;6/;&*RM+L_+5>*W85 6N=E ORU'-)M%2.P K,OKG:#S0!0U>X^4\UY[KTVX
MM73:O??>YKB=6N-Y:K).8OI/F-9LDWO5G4)/F-8TT_)I@:"7'3FK4,V[%8<<
M]7[>3D4 =!:MNQ6U9M7/6;=*Z"Q/2F!OV7:MVT[5A6/:M^S'2BPV:<':KD:U
M5@ XJZ@I"%Q3EIIH#4I; 34NVF*W3FI%YKF8#DCJY#%4,:U?MTH LVT73BM*
M&/I5>W7I5Y!2 D5<"HY.E2;J@E;WK,"M(U0%\4^9JJ2-5CL:^GS<$5Q/Q:F_
MXE$PS_":ZK3Y/FKB/BQ)G2YO]TTQ'Y@_M,'_ $RY^IKY<T6\%OJ^2<?-7U!^
MTP?]*N?J:^0'N6AU D>M9/<U/L[X/^/HM-6 F0#&.]?5?ACXX6UO:H//4<>M
M?F%X?\57%FB[&-=I9_$N_BCP';\Z:E8EGZ,WGQUM6;_7C\Z;;_':U5A^_7\Z
M_.N;XGZ@?XV_.HXOBAJ&?OM^=/F!(_3G2?CM:R2*//'YUZUX/^)$.K(H60'/
MO7Y(>&?B=J$EX@,C=:^RO@'XNN;X0;V8]*6XF?:>HS_:[-F'I7RG^T'&19W'
MT-?3NER&;203_=KYM_:$C'V:X^AJN@D?FG\3U\O6)2?[U=9\$]>BL;Z'<P'-
M<S\8%\O4)C[FO/?#?BR72[P%6(P:RZFA^M'PO^)-E;V<(:51P.]>V:-\6M/6
M,?O5Z>M?DEX?^-EU8PH!*W'O776/[1UU" #.P_&M>8BQ^EWBWXLV+6[[95Z>
MM?)WQJ^)$-U;SA) <@]Z\#U']HN6ZC*FX_6N#UOXC2:\67S"V[WH<@M8X7XC
MWSZIJLFWG)KJ_@OX=GFU&%BIZU%I/A"37KQ7V%LFOIOX-?"AK>2!S%Z=JA+4
M9]#_  6T1[>QAR.PKZ'TA3#&HKA/ /AX:?:1C;C KOX5\O K81MQS9 J>-NE
M9L+]*NQ'I2)-F/#0'Z5\[_M :"VH6%P%7.0:]_BFVQXKB_&VAKJ]O(I7.12
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M6'8XW5]*_"G1DNHXM_.:$4:5S%>&W++NZ5QNI:QJ6GS$@N*^J-'\ VU]:KD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHI %%%% !1113 5:6D!Q1NH 2BBB@ HHHH **** "BBB@
MI-HI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****!H****
M "BBB@04444 %% IVV@!M.IM+NH &I*4FDH **** "BBB@84444""BBB@ HH
MHH **** "BBE H 2BEVTE !111FD 44F12,P]:8#LU',1MH)J-U9A0 MNPCD
M!KO_  ;KBV\\8W8YKS=XY%Y JQI-U/#=+C/6E*-T.,K,^Z?A3KZS^4-V>E?1
MVDR>;9(:^*/@GJ4S20@D]J^R_"\ADTQ":\'$1Y6>]AY71L4445QG8%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 FT4M%% !1110 4444 %%%% !1110 4444 )_%2TF.<TM &9JEQY*
MDYQ7FOBKQ 8PPW5WWB(GRWQ7BGC+S#OQF@#(F\0;KGEN]=/IFL(UOR>U>3S&
M5;C/-;FGZA+'%C/:K))_'5XDBM@UY[I<A^V @]ZVO$UU+/D<U0\-Z7)<70)7
MO2$>F:#(SVZ@GM70:=#'YP+51TS2WM[4'':LG5-8?3Y#SBI&>[^&;ZWA@"[@
M.*T]4O86M6 8&OGG2?'TJN%W'K79V/BI[R'ELTQE#QA<K'(Y!Q7%V]^)[C;G
M/-:OC*Y>2-B*XK1&E?4%!SC=5"/:/">FB38V*[I[E+*UQTXK \%V_P#H:$CM
M1XHNFA4@5.Y1R/C2X%YOQS7F,EN;>XW=*]!F5[MFSSS7*^(=/>%2P%4(V/#N
MI X7=6]JUG]JLV(&>*\Z\-S2B\4'/6O9-/L?M&F\CM2$?-WC#33#=,<8YK1\
M"3^3.N370_$71629R%[UR&@1R6]QTH ]UL]:2.T )[52DOTNY< YKA;C5I8H
M, ]JE\/ZE+-=KG/6D4=M/H/VR$D+GBN3U/PX;68MMQS7K_ARR^U6JY':LKQA
MHOEPNP7M1<1P>BZPNFX!;%:>HZX-1BVALYKS/Q)>2V5PP7(YJ]X1OI;ZX16R
M>:!'16^AO)<>8%SS71^2]O:X(QQ78>'_  R)[-7*T>(O#YM[/(7M5 >*>(%#
MW!)K1\+W"6[+S63XL62WN&X[UDZ3J4B28H ]6U#4$DM\9[5ST,(DN<CUK._M
M"21!UK6T"-[B89%) S>6W;[+T[5RU]:K]KRWK7I?]ED61..U>8>*YGL[AL>M
M(H]3^'T\-O&N2*TO'6N0K9N PZ5X_P"&?%<D*XS3/&'BB6XMV )Z4"*?VY;C
M4^#GFO;OA_9B2&,XKYH\/W$MQJ2DY^]7U+\-4/V)">NVFP.UCC\L5)114C"B
MBB@ HHHH 3%&!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ";0>HS33$AZHOY
M4^B@"+[-$>L:_E2?8X/^>2_E4U% K(K_ &&W/_+%/RI/[-MO^>"?E5FBG=A9
M%;^S;7_G@OY4?V?;?\\4_*K-%%V%D5O[/MO^>*?E1_9]M_SQ3\JLT478616_
MLZV_YX)^5']FVO\ SP3\JLT478616_L^V_YXI^5']GVW_/%/RJS11=A9%;^S
M[;_GBGY4?V?;?\\4_*K-%%V%D5O[/MO^>*?E1_9]M_SQ3\JLT478616_L^V_
MYXI^5']GVW_/%/RJS11=A9%;^S[;_GBGY4?V?;?\\4_*K-%%V%D5O[/MO^>*
M?E1_9]M_SQ3\JLT478616_L^V_YXI^5']GVW_/%/RJS11=A9%;^S[;_GBGY4
M?V?;?\\4_*K-%%V%D5O[/MO^>*?E1_9]M_SQ3\JLT478616_L^V_YXI^5']G
MVW_/%/RJS11=A9%;^S[;_GBGY4?V?;?\\4_*K-%%V%D5O[/MO^>*?E1_9]M_
MSQ3\JLT478616_L^V_YXI^5']GVW_/%/RJS11=A9%;^S[;_GBGY4?V?;?\\4
M_*K-%%V%D5O[/MO^>*?E1_9]M_SQ3\JLT478616_L^V_YXI^5']GVW_/%/RJ
MS11=A9%;^S[;_GBGY4?V?;?\\4_*K-%%V%D5O[/MO^>*?E1_9]M_SQ3\JLT4
M78616_L^V_YXI^5']GVW_/%/RJS11=A9%;^S[;_GBGY4?V?;?\\4_*K-%%V%
MD5O[/MO^>*?E1_9]M_SQ3\JLT478616_L^V_YXI^5']GVW_/%/RJS11=A9%;
M^S[;_GBGY4?V?;?\\4_*K-%%V%D5O[/MO^>*?E1_9]M_SQ3\JLT478616_L^
MV_YXI^5']GVW_/%/RJS11=A9%?\ L^V_YXK^5)_9UM_SQ7\JLT478616_LVU
M_P">"?E1_9UM_P \4_*K-%%V%D5_L-O_ ,\4_*G?8X!_RR7\JFHHNPLB(6L0
MZ1K^5.$,8Z(OY4^BD,;M7T'Y4ZBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\EK(4@7H>U5RDW/REUJ>_P!/F96+#!KH? -U-?7D:N2>:]=^+?PE.GW$S"'
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M"?Q$TZ^F3YT/XU]%>!M8M;NU385Y%?D;X#^*ES9WD:O,PY[FON'X%_%+[=%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\^@I)VJ]#J"MCFK O$:INRCG7\-I_=J,>'44_=KI6N4JM)=**M-@94>AHO\
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M5O"J^>1QZUHI$L_36\^--GNXE4?C38/C39C_ ):K^=?FQ+\=+IO^6Y_.F_\
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M@H\P4 .HIN\4NX4 +12;A1N% #EZTZH]U+N]Z "BDW"C(H 6BC-% !11FC-
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M@ HHHH **** $I:** $W4"C:** %HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH PO&$PCTF7/I7P%^T1<;I+CGN:^ZO']WY>
MFR#/\)KX#^/UQYDMQSW->SEZ]ZY\YF\OW=CY.U)MVH-]:O6OW*H:A_Q_'ZU?
MM?N5]>]C\]6[)Z***@H**** "EVT@IV10.PVB@T4T(**2EH8%'4/NFK_ (/^
M;4$^M4-0^Z:T?!"[M2C_ -ZB7PA'XT?;?P%M=X@X]*^R_"]OY=BG&.*^3_V>
M[/<L''I7V#I$/DV:#V%?%XV7OGZ3EL?W:9>HHHKS3V@HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** ///BA8BXLY..U?$_P 4O#[?:I3M
M[FOO?Q=9_:K9AC/%?+OQ0\,\S';^E>CAI6//Q,;GR5/9FWD((Q4>_K72>*K'
M[+,W&.:Y/S/G(KV4[GBO1C9)/W@%=MX*T\WLR#&>:X9E+3"O8/A-I_G7461W
MJ:CM&Y4%>1[E\/? 0N(XV,>?PKV&R^'B"$?N_P!*O?#+0HUL8V*]@:](6-47
M 48KP*E1MGOTZ:2/)+[X:I,I'E#\JYV\^$*S9_<_I7OVU?[H_*D\I/[H_*H5
M62-'3BSYFO?@DLF?W/Z5@7WP/VY_<?I7UNUO&W5%/X57FTNWFZQ@5HL1(R>'
MB?&5Y\&3'G]S^E85Y\*&CS^Y_2OM2^\*V\N<(*YZ^\$Q/GY!^5;1Q#,)89=#
MXQO/AN\>?W6/PK#O/ DL>?W9_*OLN]^'L;YQ&*Y^^^&*OG]W^E;QQ!C]7/CB
M\\(RQY_=G\JQ[KP_-'G"G\J^P+WX3>9G$7Z5AW?P<+9_=?I6RQ",I8=GR)=:
M3.O\!_*LZ2RN%/W37UE=?!-V_P"6/Z5DW'P.DY_<_I6JQ$3%X>1\O&UG_NFE
M%O-_=-?1MQ\%9%S^Z_2J,WP?DC'^J_2M%6B3[&1X&MO-Z&E\F7T->VS?"N1?
M^67Z54D^&<B_\L_TH]HB?92/'Q%)Z&E$;^AKU.7X>R+_ ,L_TJG+X&D7/[NG
MSH7LV>=>7)Z4;&KNY/!TB_\ +,U6D\*R+_ :?,A<K..VM2[6KJ)/#<B_PFH'
MT&1?X33YD+E9S^#2\UKR:/(O\)J!M,D'\-%T%F9_-'-73I\@_A-,:SD7^$TQ
M%<45)]FD7^$TQH9/0TQ"9HS2>3)_=-'DR?W30 N:,TGDR?W32B"3^Z: $_&C
MFGK;R'^$U(MG)_=-("OS1S5P6,G]TT]=-D/\)HN@*!S2;36LNDR-_#4Z:'(V
M/E/Y4KH:BS!*M2;6KIH_#LC?PFK$?AB1OX#1S(?*SD#&_:D,;^E=NGA.1OX#
M5F+P7(W_ "SI<R*Y&>>^7)Z&D\F3TKT^+P%(W_+/]*MP_#F1O^6?Z5/M(C]F
MSR3R9?0TAMYO0U[1'\,)&_Y9?I5R'X3R/_RR_2CVL0]E(\)^SS]@:5;.X/9J
M^@X/@W(__++]*T;?X)2-SY/Z5/MXA[&1\ZPZ;<-CY36I:Z'/)CY37T7:_!!^
M/W/Z5LVGP79,?NOTJ'B(FL</(^<[7PS,^/D-:]KX-EDQ^[_2OHZU^$!3&8OT
MK:L_A6%Q^Z_2L7B$;+#L^<K/X?R28_=_I6[9_#%Y,?NOTKZ/L?AJL>/W?Z5T
M-CX"CCQ^['Y5B\0:QPY\V6?PB,F/W/Z5O67P3\S'[G]*^E['P;#'C*"M^U\/
MVT*C*"L7B6=$<.NI\S6?P-'!\G]*W+/X+K'C]S^E?1:64$? C6I/)3^XOY5B
MZ\F:^PB>'6/PI6''[K]*Z&Q^'J0X_=?I7J/EK_='Y4NT>@_*H=63+5.*./L?
M"4<./W8'X5OV>CPP ?(*T:6LW)LT44AJQJG"J!3J**DH**** "BBB@!*6BB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***0]#0 M)FL/5M:%D#DXKEKKQ\D+8W_K0!Z+FC->:+\0D
M/_+3]:=_PL!/^>GZT["N>DYHS7FW_"P$_P">GZT?\+!3_GI^M%@/2<T9KS;_
M (6"G_/3]:/^%@I_ST_6BP'I.:,UYM_PL%/^>GZT?\+!3_GI^M%@/2<T9KS;
M_A8*?\]/UH_X6 G_ #T_6BP'I.:,UYM_PL!/[_ZT?\+ 3_GI^M%AGI.:,UYM
M_P +!3_GI^M'_"P4_P">GZT6$>DYHS7FW_"P4_YZ?K1_PL%/^>GZT6 ])S1F
MO-O^%@I_ST_6C_A8*?\ /3]:+ >DYHS7FW_"P4_YZ?K1_P +!3_GI^M%@/2<
MT9KS;_A8*?\ /3]:/^%@I_ST_6BP'I.:,UYM_P +!3_GI^M'_"P4_P">GZT6
M ])S1FO-O^%@I_ST_6C_ (6"G_/3]:+ >DYHS7FW_"P4_P">GZT?\+ 3^_\
MK18#TG-&:\U_X6$G_/3]:FA\>I(<;_UH&>BT5RFG^)ENL?-FNCM9_.7-("Q1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFW4;JB!-.I@2;J=NJ.G4 /I&H6G!<T@&4X+4BQU(L/2F!$J5,J=*D6*I%CH
M8L=2+%4J1U.L= %=8:D$/'2K*QU(L?%3<"GY-/6*K/ETC+BES ,6.G^6/2BE
MR:@!?+'I3UC&*;NI^Z@ "@4N*3=1NH 6EINZC=0 M%,W4!CF@"2BFK3J "BB
MB@!#FDYIU% !1110 4444 %)FAJ;0 ^BDI: "BBB@ HHHH **** *%_JB62D
ML0,5\N?M$^/%6QN5$G8]Z]7^*GBG^Q[>8[\8![U^?WQZ^*0N&N(_-SU[T#/E
M[XY>*'NM0FP^>37BEO<M-(23WKL/'.H?VI=.V<Y-<A;P^7DT%V+V:@CTUKJX
M7 SS3$N/WP7WKTGX?^&3J]U%A,Y/I0,]7_9X\'--?6Q,?<=J_5;X$^%4M=,@
M8IC"CM7R#^SW\,3";=_*].U??_P^TW^SM+5<8^4"@R.J2-8_NC%.HI&H 6BD
M6EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOK*W7;"@]J^7_P!GFWVPP<=A7U$GW5^E?#XM_O#]/R^-J*'4445Q'IA1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBD)H 6BF[J=0 4F!2T4 )BEHHH **** $P**6B@!&IN:<>:3;0 ZBBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCJ'3FLIQT [ZSN<D<UOV,U<-I]YG;S74Z?<;L<UY\HZ@==:R<"KZ2\5B6DW
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M444 %%%% !1110 4444 -(H^[3J:U "[J6F4^@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FL*=10 W!IU%% !2;J6F4 .S2TU:=0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !39/]6WTIU-D_U;?2@#Q/XI_=EKYD\2_\?3_6OIOXI_=EKYD\
M2_\ 'T_UJT2S(C^[4BU'']VI%JQ"T444@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *1NE+2-TH C_ (JUM+_U@K)_BK6T
MO_6"@#V+P#]^.OHGPK_QZK]*^=O /WXZ^B?"O_'JOTJ&4C?HHHJ1A1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,<=(J8J9:FXT"K2X%+10,2EHIK-UH 7-(33&:DSF@"2G4U:=0 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%FI6*'*:LQM550:LQ*::0%E6J=6JLM3(:L"RC5.C572I0:D"RK4[?4 :EW4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF@M"QQ^7S3#=_O=M3R8V\5!I^GO=7R@#/-!1V?@[PT^L746$SDCM7V_^SO\
M"5_.MW,/H>E>.?L_?#LZC<VY://([5^EWP7^&L>GV<#^5C@=J#-L],^&?AE-
M(TM,I@XQ7=*H7@"H;.V%K L:C&*GH$%(U+10 RGT44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX+T-H9E;%>GS:C]@LL9QQ3$=E=>+([<X+"J;>.HA_&*\3U_Q@XF8!^_K6/\
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MHHH *1NE+2-TH C_ (JUM+_U@K)_BK6TO_6"@#V+P#]^.OHGPK_QZK]*^=O
M/WXZ^B?"O_'JOTJ&4C?HHHJ1A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%2?Q4M)7DGO"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5L[HG;CFM?P'BW8"KWQ'F59W^M<]X5U(+,!GO0'4]"\23&2S(![5YS:QM_:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ:-NE0T]*F0%M6I^ZH%:I=PK#F #3&:G]JB;O4W 7S*D3YJA5235VVA+&ES
M36\9.*VK&$Y'%06=GG'%;MG9XQQ2Y@+5G#P*UX4X%06T&U:N(N*3 <!BEHHJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS';N4T".<US27O"S8S7.)IK64FXCO7N$?AD21<I7.ZYX1.T[4H0['#V_B?[
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M0!'\.U:2]C)'>OI[P^NW38Z\8\$^$GLYD)3%>W:5'Y-FJTAHN4444AA1110
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M8'% $5G8XQQ6Q;VVT=*?#;A>U6E7;0 B)M%/I":0=: '4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!MLG0+^52+X1MAV7\JWZ*8&9;:'#;8V@5HQJ(UP*=12 **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM-%22J<TS::8#UH(H6AFJT A-0NU+))5:22KL .U1[_>F-)3-WO5 2EJ8W-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %-W4ZF[30 HI:0#%+0 4E+10 RE6EVT4# \T4M% @HIK.%ZFH&N!GK0!9
MHJ&.3=4U "4M%% !24,=JDUGW%YY?>@#0S16&=6^;&:M6]]YG>@#3HID;;ES
M3Z "D(S2T4 )MI:** "BBB@ HHHH ***2D M%1-<*IQFG+(K]#3 ?252OKT6
MZDYK+77E,F-U '1456L[@7"9!S5F@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHJ":X$?>@">BLB;5%5L9I]MJ E/6@#4HIJMN4&EH
M6BD%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!00211B*,*.@I]%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "F3';&33Z@O6VVLA]J /._'NM?9K63#8XKXN^-&N?:'F&[U[U](_%S7/
MLT<HW8KXL^)FO?:+B4;L\FOH,#2UN?(YI6W1XEXC_>7C'WJO9K@"IM4_>3$^
M]-MUVU]/T/BNMR>BBBI **** "BBB@ HHHH 1NE-I](W2@9!<'$=5--;=>J/
M>K5QRE,T.U,FH+QWJNA#U:/ISX'Z7]IE@XSR*^[/AYH8M[*)MO85\A?L\Z7N
MDM\CTK[N\+60M]+BXP<5\ECY>]8_0,II^Y=FO"NR,"I***\4^E"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*;)_JV^E.ILG^K;Z4 >)_%/[LM?,GB7_ (^G^M?3?Q3^[+7S)XE_X^G^M6B6
M9$?W:D6HX_NU(M6(6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !2-TI:1NE $?\5:VE_ZP5D_Q5K:7_K!0![%X!^_'
M7T3X5_X]5^E?.W@'[\=?1/A7_CU7Z5#*1OT445(PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME6]L=PXKH],@QBH[?3?:MFSM-N.*0&C9)@"M6/[M4;=-M78VXI 244W=1DT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,"N]0LIJWY>:1H?:M"C/DCJK-'6M)#5*XCQ33$94J]:J25>G&#5&3FK IR5
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M:UJV,5E(#:BDZ5-))\M4(Y*E>7Y*2 P]<;Y6KS_5QEFKN]8.Y6KB=37+&D]
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MF:3=32U #MU&ZHMU/6@!]+2+10 M%-W4NZ@!:2DW4C-0 C&D5<DT[;DTX#%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.D(IJE2I'FI!'4T<=6!&L'M2-#CM5U5&*BFQMJ@,V==M9=TU:=TW6LBXSDT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@H ]B\ _?CKZ)\*_\>J_2OG;P#]^.OHGPK_QZK]*AE(WZ***D84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4\+3MOM3 BV4;*EV^U(5]J+@0E:B:/-6=M CK52 I-;Y[5&;7VK46&E,%5S
M9!M<4GD>U:CV_M4+0]:7,!2\FE\O%62E)M]JKF A6.GK'4BK3]M+F 6*.K<2
M]*AC6K4:TFP'AJ21N*,5#*W%9M@4;PYS68R;FJ]<MDU61=S5G<#8T.WRZ\5Z
MQX5M^%XKS?P_#\ZUZSX7A^5>*RDQH[[28PJ+6_#]VL;3UP@K7B;I7))C+"TN
MVB/M4FWBLB2A<]#6#J$FT&N@NUX-<UJF0#3 YW4+K&[FL"ZO#D\U?U.0@M7-
M7DQR:UB-!<71.>:R;R7<*FDD)JI-\U: 8]YEB:RI$.[\:W+B'.:H26_S=*+
M2:;'\PKO?#Z_=KB["+##BNXT)?NTF(]!T7C;796/W17&Z/T6NRL/NBL&!I*O
M%-VU+&M!6L9 1JO-31BF;:D137.P)TJ>.H$4U8C6A 3J:DJ-0:DK8 HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I*6B@!-HHI:0M0 ,<5$S>]*S=:C;F@
M!0U2+4:K4JB@!=M 6G44 %9^JZO!IMN[NX!Q5+Q%XAATJW8EP"!ZU\S_ !<^
M-\>FPS*LX''K0!K_ !A^,46E0SA)@, ]Z^ _C5\=9+Z2=%FSR>]4OC/\<)=2
MEG59\YSWKY7\2:_<:I<LQ<G)]:"TBSXH\03:U<.Q<G)]:P+>%E;)J2U5CC=5
MF3"KQ04+N&VJ$ZO(X"TGF.\H4 UW?@?P3/KEQ&/++9([4 ,\">"[C6;J,;"<
MGTK[9^!/P),K0.\'IVJ/X%_ <NUN[V_H>E?>OPN^&<&D6T68@" .U!+9)\+O
MAO#HMK%F+& .U>O11K#&$48 IMO;I;1A$4 "I:"!#29-*U)@T +2TW=2B@!:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3;
M2T4 (.*#S2T4 -VTZBB@ HHHH 0C-)MIU% !1110 4444 4K^,NIKD]2T@SL
M>*[61-U5FLPQY% '"VOAD>9DK78:+IRVJCY:NQV:+VJPJA1@"F ZBBBD 444
M4 %%%% !124<T +13=U*#F@!:*0TG- #J*;DTM "T4ASVHYH 6BBB@ HHHH
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M69$?W:D6HX_NU(M6(6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+.N30!Z7152UO%FC7GFK= !114<DRQ]: )**IMJ4:G&:EBNTEZ4 2[:6EHH
M**:T@7J:@>^1.IH LT57CO$DZ58H ***:\@3K0 ZBJCZ@BG%217:2]* )Z**
M* $I/+7^Z*6H9+Q(^IH F"A>@I:ACN5DZ5*S!1DT +151]0C0X)J2&Z2;H:
M)B*0+3J* "BDR*8TRK0!)158WB#O4L<RR=* )***1FVC)H 6BJKWZ(<4^.Z2
M3I0!/124M !1378(N355M2C5L4 7**@BNTEZ5-0 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO?VO]E&=U 'LUKJ$<T8.[FI)KQ(USFO(]-\9?,%W_K6W=>)MUL2&[4#.HO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1<$5NV7:L&!MV]7HUJE:BM&):A@*J5((Z>L=6(X?:LV!"L-3I#5B.'VJ=8:
M*RPU(L=61%2^71<"'RZ<(ZFVBG*M',!$L=2+#4BQU*L?2DW<"(0^U'D^U6UC
MZ4ODU@Z8%(P^U1M%6CY5(8::@!F>2:3R:T6M_:F-![5HH@9_D^U.6*KGD^U"
MQ56P%7RZ#$*M^52B&CF&4Q$*D6.K'D^U.6/I1S"(5B]JE\GBIECJ0Q\5#D,Q
M[J'VK->'YNE=!/#5+[+N;I6=Q#M)C*NM>B>'V(5:XW3;3!%=KHL>W;4M@=I8
MO\HK<M6Z<US]@>!6Y:MP*R8&K&U2AJK1&K"]JS ?]ZD>/(IR]*<P^6@#)O+<
M,IKFM2L\YXKL;B/(-8U];;L\5K&0'GU_9=>*QI;/GI7<WUGUXK#N++&>*U4P
M.=6V]JE%O5]K?:>E"P\U7.@(;>'D5M6,73BJT,'3BM6SAQBI<@-?3TQBNCL^
M,5A62XQ6[:]JRE*X&M%T%2U!">*GK!@-(I0M+@TX"LF@'(*F6HE[5*E38"1:
M=35IU6 W!I5I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "FL*=10 W::*=2'I0 FZG4RG4 +1124 +13=U+NH 6BBB@ HHHH *;NIU
M,H =0:*6@ I.G6H+V\2SA+L0*\Q\9_%:#1XW'G*,#UH ZWQ9XL@T>W<^8!M%
M?,OQ9^/D>GQRHL_ZUPGQ=_:$3RIE2X'?^*OB'XJ_&"XU.:4+.3GWH&=Y\6OC
MI)JDLRI-G.>]?,?BGQ5<:E<.V\G)K%U+Q%<7UP2S$Y-0K^^P3041B628Y8U*
M%"K39,1+5?[09&P*"A\CLQP*OZ3IDUY. %)YK3\-^&Y=4F4!"<^U?0OPQ^"4
MNH31,8"<X[4".=^&GPCFUB:$F'.?:OMOX+_L^BW6&1X.F#TKI_@S\#$LEMV>
M#'3M7UQX7\)VNC6: 1+NQZ4$&3X!\$V^B6B?NP"H]*[@ #@# I%4(,*,"G4"
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,B@!:*** "BBB@
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MOD\?/FD?H&54O9Q-JD:EHKR#Z$;@TZBB@ HHHH **** "BBB@ HHHH ****
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MPWL5DMT)':MKQAY=M;G&!0"/-#;E&P*O6\+U%:R+<76T<\UT?V00V^XCMFI
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M!1FN-O/"DL;%]IQ0#':?"VI3J?4UZUX*T0P[#BO+=$G73IE5^,&O9?!>J1W
M0 BD!Z#:IY<*BIJ;']P?2EJ1B;J-U)10 X4M(M+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %-D_U;?2G4V3_5M]* /$_BG]V6OF3Q+_Q]/]:^F_BG]V6OF3Q+_P ?
M3_6K1+,B/[M2+4<?W:D6K$+1112 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I&Z4M(W2@"/\ BK6TO_6"LG^*M;2_]8*
M/8O /WXZ^B?"O_'JOTKYV\ _?CKZ)\*_\>J_2H92-^BBBI&%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!*;3Z3:* !>E+12$4 +131UIU !1110 4444 %
M%%)G'6@"MJ4GE6<C>U?+_P :?%7V59UWXZU]$^+]42STV09[5\-?'SQ+NDG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOTJ&4C?HHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD2K3 RY(?:JDT'M6P\=5I(:H#(:&E6.KS0TWRJ8$4:5=A%1+'4\=("S'4R5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8NIS3/TG+Z2C33'4M%%>>>L%%%% !112-TH ,TM,IU "T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444C
M=* #(I:93EZ4 &?:C/M2T4 %%%% !1110 444C=* #(I:93EZ4 (<T#K3J*
M"BBB@ I,TM-;K0 N:6FKUIU !29]J6B@!,^M%(W6A: '4444 %%%% !1110
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MA:***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(W2EI&Z4 1_P 5:VE_ZP5D_P 5:VE_ZP4 >Q> ?OQU]$^%?^/5?I7S
MMX!^_'7T3X5_X]5^E0RD;]%%%2,**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!*6BB@ HHI&H 6BFY-.H *K7UDE]"48 U9HH \T\4?">WUB
M&3]VK$^U?,/Q:_9ZC\N9DMQGG^&ONFN?\3>&X=8@8&,$D<\4#/QB^*7P4N+.
M64I"1U[5\^:]X#N["5LQL,>U?M-\0/@+#JBR,( <Y[5\K?%']G06JS,MOZ_P
MT%)GYQ?8WM&PP(J7[0O3->O?$3X6W&ES2[8B #Z5X_?:%=6\Q!1A@^E [C74
M2TL4!C;(I(X7B^]4^\8ZTQFIIVMO8XPV,5VWA_XF2VDB#S"/QKS"0;NAJ.)7
MC;()%"=@/KKP3\769D#2_K7T)X)^)4,\<>^4?G7YRZ)X@EL&'SD8KTWPW\5I
M;'8/-(_&MXU&B6C])M(\76UQ&OSJ:UOMT=Q]T@U\1^#_ (V,Q13-^M>Z^#?B
M5'?;-T@/XUU*K<D]H^S&3H*1M/;TJ+0_$%M=1J=P-=#Y\$B\$&MN81SS6A':
MF_9SZ5N/&KG@5$UF3VI<P&3]F]J7[.?2M3[&WI2?93Z5%P,W[/[5/##5K[-[
M5+'#TXJ;@$,57(HZ6&'I5R&&E<!(HJM1PT^*+VJW'%4<P%7R:7R:N^51Y5*X
M%+R:D6&K/E5(L=%P*RP]*F6&K"PU*L--,"NL=/6*K'ET]8ZOF&B%(J?Y?%3K
M'4@CI@4VAXIODU?\FF&'BE<13\JD\FKABH$51<13\FG+#5L14X1U-QE4P\4W
MR>15WRZ3RZE@01PU92&G1QU86/VJ0*K0U%Y/-7VCJ(Q\T@&0PUH0Q=*AACK0
MACZ4@!8JD6/I4RQ^U/6/VI@-1*L1TBI4JK[4@)8ZM157C6K<0Z5FP)D%2;:1
M:=4@1-43+4V*0K3 JLO6H9(ZN,O6HVCI@4&BIGEU=:.H66F!!MIRTYEI0M.X
M"I5F.H$6K$:T,"PG:I*8G:I>M9@-I5H- ZT .HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***0T +13<FE% "T444 %%%% !1110 4444 %%(6"]2!^-
M5[K4;>TC+22J!]: )I)DA7+G K/N/$5C:J2\P&*\Z\>_$ZVTV&39*HQ[U\P_
M$3]HK^SVE5;C'_ J /J+QK\6+*QMY%251@>M?*7Q6^/BVWF^7<>O1J^=O'/[
M2TURTBBY/_?5>$>,/BC/K&_]\3GWH+L>F_$#]H:>>211<'_OJO$M>^)T^KNV
M92<GUKAM6NI[V1B6)K.AMW5LDT#L:NH3O?2$DYS6?]APV35N-@O4T.=W2@H2
M-EBH=A*N%YJ)K&>8_*#72^&/!MWJ$RCRV//I0(PK+P[/?2#:I.37I7@CX675
M[<1YB8@D=J]D^%WP-DU%H2\!.<=J^NOAM^SC'&L3M;^G\-!%SQ3X2? -KDQ%
M[?K[5]C_  W^ L%G#$Q@ Q@]*[OP3\*X-%6/]R!CVKU.SM4M(5C10 !0(P-"
M\&P:.%VJHQ72J H '2EHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %)2T4 8OB'2Q>:?,,9XKXN^/7@DN9V
M">M?<\Z[H7'J*\+^+/A47]O*0F?PKOPM3DD>5CZ*J4S\R]<T^71]08\C!K:\
M/_$J;2F1?-(Q[UW7Q8\%M:W$S!,=>U?/6K0R6MR1DC!K["GRUHZGYW5YL//0
M^NOA_P#&IRT8:;T[U].?#WXJQ74<8:4=N]?F'X=UR6Q93O(Q[U[!X,^+$M@T
M8,Q&/>O/Q&#4MCU\'F4H6YF?J-I?BJTOHE/F#/UK3&I6YZ25\3>"_C:71 9O
MUKT^S^+BR0@^=^M>!/"2BSZRGCX35ST?XK>)HK2Q=5?HM?!7Q@\9&2ZG D[^
MM>T?$_XF"]MY )<\>M?'OQ!UEKVZD(;.37L8&AR[GSN:8KGT1S.I7QO)6.<\
MU06/YLTR$EFYJUMKWMCY/?44=*6BBD,**** $HI:*8!1113 ****0"CO5*ZD
MVFK>[K6;? LW%"%(Z#PO;_;+A%QG)KZB^$/@LS20ML].U?._PSTUKB^B!'<5
M]\_ _P *JT$+%/3M7F8VKR(][+*/M979Z[\.=#_L^WB&W&!7I=9NF::MFB@#
M&*TJ^0J2YI7/T&G#DC8****S-0HHHH 1J;3J-M #:=1MI: "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*;3Z3;0 +TI
M:2EH **** $I:** "BBB@ HHHH **** &M24[&:-M !2T44 %-:G4F,T -I]
M)MI: "DI:* $I:** "BBB@!**6B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "F9I])MH %I:2EH **** "BBB@ I&I:2@!N:=1MI: "BBB@ H
MHHH **** "BBB@ HHHH *:U.I,4 -IU&VEH 2EHHH :U)3L4;: %HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFVTOI5W)(?+I=M/I=M2!$4I?+J3;2JM4 Q8^E2!:55I^WVI#&[:<J\4[;2T
M(JT]5I%IZ^M24*J]:=MI56EVU+$,VTH6G[:,8IC$VTM+10 4444 %%%% !11
M10 4444 %%%)0 M%-W4M "T444 %%%% #<FE6DVTH&* %I*6B@!NVC;3J* &
M[:"M.HH 9M-.I:1F"C).!0 M(6 ZD#\:Q=8\1V]@A'F#(]Z\Y\1?%.&Q#8F
MQ[T >NFXC7K(H_&J]QJUI:J2\RC'O7RQXB_:'CL=V+@#_@5>8^)/VJ F\"Y_
M\>H ^O\ Q1\1K.SC;;*HQ[UXCXV^.$5DK[9_UKY2\4_M,-=!P+G_ ,>KQKQ=
M\:IM0#XG)S[T#L?3/B[]ILVS2!;G_P >KQGQ/^TY+<,P^TG_ +ZKYD\3>-+J
M\=\2-S[UPEUJEW-(278T#2/H'Q)\:)M2W8F)S[UYEKWBN;4=W[PG/O7$1W$[
M?>8U:C9FZT%E6\6:=B2QJ&&W=3DFM4@56FW<X% $D3!1R:DW!AP:RF:8M@*:
MU])TVYNI%&PG\*!E2XM9)/N@FBUT2ZG< *QYKU[PC\-)]6V9B)S[5[CX+_9S
M>]\LFW)S_LT$W/FSPEX!N[Z508F.?:OH;X?? J74#&6@)SC^&OHKP/\ LRBW
M:-C;?^.U]%>!?@O#IBQ[H ,8[4$MG@7@3]F=66-FMO\ QVO?O!OP'ATL(3 !
MC_9KV_0?#-KIMNN(ES]*W%4+T 'T%!)S7AOPG!I,:_NP,>U=+TX%+2$T +13
M=U.H **** $Q1BEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I-M+10 E+110 5Y_P#%#2A?
M6,@QDE:] K*US3Q?0E2,\5I"7+*YE4CS1:/SJ^,7@AO/F;R^Y[5\X:UI9L9F
M!&*_1;XP>!U:&9O+['M7PY\4='-C=2@+CDU]=@ZW.K'Y]F.']G)L\R67Y\5:
M7I65&S><1[UJ1_=%>JSP4[CJ***D84444 %%%% !1110 4444 %%%-9L4 1W
M#?(:H6I,ET![U>D^=<"IM#TM[B^3"]Z=[(-V>O\ PI\-F_FB^7-?;WPF\&"V
MAA8ICIVKY[^ _A4R20ED_2ON/P;H:6=A$=N.*^8QU;6Q]OE6'5N9G1:;;BVM
M54#%6Z0#:,4FZO /JQU(30*1J!ANIU,I] !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVFG444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVZ@**D9#8Z9%:QCY1FKH 7H*6BI&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110 4444 %%%% !1110 4444 %%-:C)H =1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 )3:?2;: &TZC;10 ,-PP:R=2T..\5L@&M>B@#QWQAX$217(C
M_2O"_%G@U[=V*I^E?96H6*7D9!7)KSWQ3X'2XC9A'^E-,5CXVNM+>WD.1BJW
MW.#7LGB[P0UNSD1X_"O+M4T>2WD8;<5H(SPXIU0-&T9YJ1&'K0(?13=U&30
MZBD6EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IRU'DTJM0 ^FTNZDH **** "BBB@ HHHH ***3</6F %@*C9@W ILF
M6.!5BST^2X<8&:0#8;-I^ *Z;0?"\EQ(OR'\JV?"_A-[AURAKVGPCX! "$Q_
MI2;&8?@OP&&V%H_TKV?0_"D=G"IV@5:T;0$L0/DQBMX<<"H*&0PB% HI]+28
MS2 *6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5IOP%GO-O^CM^5 'SE''<L?NFM[2]'N;AA\AKZ<TO]F6XFQ_HS?]\UWOA_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 8?A7P.MN%)2O3=)TU+.(87FK5K91VR !>:L5)04F:#FDI .HI,BEH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEV#X?SW'2,_E6A#\)KJ?I"WY5]KZ#\ R^W,'Z5Z1H/[/,;[<V_Z4"N?G=;_
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M[_K1]2D+^TX=S[+_ .$TM?[RT?\ ":6O]Y:^-/\ A=X_Y[_K1_PN\?\ /?\
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MRT?\)I:_WEKXT_X7>/\ GO\ K1_PN\?\]_UH^I2#^TX=S[+_ .$TM?[RT?\
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M?\)I:_WEKXT_X7>/^>_ZT?\ "[Q_SW_6CZE(/[3AW/LO_A-+7^\M'_":6O\
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M;?>D^W>]:*^%;AC]P_E4G_"'W+?P-^53S1'RS[&2;\>M-_M >M;/_"$W3?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME'_#.LO_ #P_2CZU2#ZA7/EO^T-0]7H_M#4/5Z^I/^&=9?\ GA^E'_#.LO\
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M67_GA^E'_#.LO_/#]*/K5(/J%<^6_P"T-0]7H_M#4/5Z^I/^&=9?^>'Z4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6H7K2D4
M@% #J93Z3;0 +TI:2EH **** "BBB@ HHHH **** "BBB@ HI,T9'K0 ;:*3
M>HZD4GG)_>% #Z*:)%/0TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "FMUIU)B@!!UI:,4M !1110 4444 (W2FTZC;0
M 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME)QY'8_0*=15(\R%HHHK,U"F4^DVT -I5I<44 +1110 4444 %%%% !1110
M4444 %%%% !1110 UJ2G8S1MH 6BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV<UV%N^^,&O-?!MC(L:$@UZ1:KMA KS*B2>A[=%MK4FHHHK(Z HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/[T_G6?<?%*Z/_+5OSKSYLMWJ)H2U7[&'8S]O4[G;3?%"[/25OSJH_Q.O/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "4M,I5H =1110 4444 %(1G@TM% 'F_Q4T%;VQD(7.5KX'^-?@\PW$S!.Y[
M5^DGBBS^V6I7&>*^4/C9X-$D<S>7Z]J]G UN1V/GLTP_M(W1\-Z#(^FZL!TP
MU?:G[/OB;F %O2OD3Q%I7]G:LQQC#?UKVKX'^(/L]S"N['(KW,5%5(7/EL#-
MT:MC]&M'OUNK*(YSQ6E7G'@+7/M=E$-V>*]$C;=&IKXZ<>5GZ+3GS1N*U*O2
MBEK,U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA_31;6<>%QQ6W388Q'&JCL*?7R3=V?H4596$:B@C-%2,6BBB@!&IN:<>:-M
M!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "
M;:,8I:* $:FYIQI-M #J*** "BBB@"&XA$RX/->-?&300]C,VWL>U>UUPOQ2
MLQ-I#MC^$UO1ERS1S8B/-39^97Q6LOLFI3$#')H^%>KF#4(QNQR*Z#XX6/EW
MT^!W-><^ [DPZH@SWK[&/O4C\XG^[KGZ'_"36/.M81N["O?K%M]JA]J^4?@I
MJ!>. $^E?56DMNL8S[5\IBHVD??8&7- N4445Q'I!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ KFO&5U]FLV.<<5TM<!\4KS[-8/SCY:TIJ\DC&J[0;/EWXP^)=OGKO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2;J*;0
M ZEI%Z4M !1124 &ZEIE.H ,T;J1J%ZT .KE?B''OT5_H:ZJN7\?_P#(%?Z&
MKA\2,ZGP,_//X[6H^UW!QW->*>&&\O5E_P!ZO>/CJG^DS\=S7@VA_+JJ_P"]
M7VE#^$?FF*TK'V?\"[@LL'/I7V%H9SIL7TKXR^!+?ZC\*^R]!_Y!<7TKYG&?
M&?:Y;_#-&BBDKSCVA:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3- "T444 %%%% !5
M>ZLX[B,J5%6** /,O%G@]+A7(3->(^*O!+1R/B/]*^M+BU2X4AAUKB/$OA%+
MC<0F:I,3/D&[\*2><1L[UT?AOP8\DBYC_2O8YO  :;/E]_2NCT'P2L++E/TJ
MA&'X-\%B-4)C_2O6-(T:*UB4[:DTO2([.,<<UI 8X%0, H7H,4M%%(84444
M%%%% "49%#4V@!]%)2T %%%% !1129H 6BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!K,%ZUXU\:M8$=G, >@->HZU?"UB8YQBOFGXU>(
M]\,Z[O6NS#0YIH\_&5%&FT?&/QBU8R7T^&[UX_#,9)#7>_$VX-Q>2G/>O/K-
M2'K[FFK0/S&O)RJ,TU7@4^F \"E'6@R'4444P"BBBG884445(@HHHIH8UJ!U
MI<48H$0R)NJ[IM\;&0,#C%0%:AF7TI;CVU/;?AS\3)-/N(U\P@9]:^Q_A/\
M%1;M80\N>G4U^:6EWKVDP8-BO:?AS\27TV:)3+C!'>O,Q6&4U='MX''2I229
M^INEZU#J%NCJW)%:5?,?PK^*B7L<*M-GIWKZ+T?5HM2M5=7&<>M?*5:3INQ]
MYAZ\:T;HT:***P.L:U"]:7%&* %HHHH **9FG+0 M%%(>E "T4S-.H 6BFM0
M.M.P#J***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% "44M% !1110 4444 >+?&;_CWF^E? OQ:_X^I/J:^^OC-_Q[S?2O@7XM?\
M?4OU-?19>?&YN<Q\/?\ D)Q_[P_G7Z!? '_CWM_H*_/WX>_\A*/_ 'J_0/X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_C__ ) K
M_0UU%<OX_P#^0*_T-7#XD9U/@9\ ?'3_ (^9_J:\%T/_ )"P_P!ZO>OCI_Q\
MS_4UX+H?_(6'^]7V='^$?F>,_C'V+\"?^6'X5]EZ#_R"XOI7QI\"?^6'X5]E
MZ#_R"XOI7S>,^(^URO\ AFC1117FGMA1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>]O]!7Y^?#W_ )"<?^\/YU^@?P!_X][?Z"NC,?A,<H^,^AZ***^5/N HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPJYV&EH/4C604\'-56@EC/(-2QDCK0!-129%+2 **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?+*!S5T$'IS5G$TT]1*%IU% "&D!I2,TG2@0ZBF[J=0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%(QVC- %;4Y!%8RD^E?'?Q^UKRA<?
M-ZU]4^+]4%MILG..#7PO^T#KGF-<8;UKU,##FF>'F=3EIV/E_P 8:P9KZ0;N
M]<I-<$J34?B'4BVH/SWJ;3;5K\  9S7V48\J/SB4N:3([5FF< "NX\+^$Y=4
MD0;"<^U:7@_X<S7\J'RR?PKZ7^&/P@*O$6A].U<E?$1@CT,+A)U7L<#X5^"T
MM["A\DG\*W]0^ LB6Y;R.WI7V1X)^&]M:VJ%XP !Z5U5]X'L+BV9%C&<>E?/
MSQ[YM#ZN&4Q<-3\L_&7PSETIG_=$8]J\FU:W>QE*E2*_2+XM_"N-TE*1>O:O
MC+XD?#V2RN)2(R/PKV<+B546I\[C,$Z+T/(+:<LW-7:K7%F]C(01C!I([K<<
M5Z?H>-Y,M44B_,,TM2 4444 %%%% !1110 4444T 4444P"D(S2T4@(FC !J
MM]H>"0%<CFKI&:B> -0A,[?P/XXFTV>/,A&#ZU]8?"OXQ!5B5IO3O7PDTS6K
M94XQ77>$?&T^GSI\Y&#ZUQ5\.JJ/2PN+E0=KGZO^#O'T6IQ)^\SGWKT*WG6X
MC#*<U^?WPK^+AC,0>;T[U]4^!_B9%>Q1@R@Y]Z^7Q&&E3>A]WA,;&JM6>NT5
M2T_4X[Y 5(J[7G['K)WV"BBBD,**** "BBB@!NTTJTM% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >+?&;_CWF^E?
M OQ:_P"/J7ZU]]?&;_CWF^E? OQ:_P"/J7ZU]%E_0^-S;<YCX>_\A./_ 'A_
M.OT#^ /_ ![V_P!!7Y^?#W_D)Q_[P_G7Z!_ '_CWM_H*Z,Q^$QRCXSZ'HHHK
MY4^X"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOF\9\1]KE?\ #-&BBBO-/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC<7'<7%.HHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?'<#I4ZMN&15*ZLY+68AACFIX9 JX)KO/(79D]%)NW4M(844UJ!UH =1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHIF: 'T4BTM !1110 4444 %%%% !1110 44TF@&@!U
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%(>E-S0 ^BDI: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N7\?_ /(%?Z&NHKE_'_\ R!7^AJX?$C.I
M\#/@#XZ?\?,_U->"Z'_R%A_O5[U\=/\ CYG^IKP70_\ D+#_ 'J^SH_PC\SQ
MG\8^Q?@3_P L/PK[+T'_ )!<7TKXT^!/_+#\*^R]!_Y!<7TKYO&?$?:Y7_#-
M&BBBO-/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#*#@[,^LIU(U%=%@TFVG45F:B4M)NHS0 M%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!XM\9O^/>;Z5\"_%K_CZE^M??
M7QF_X]YOI7P+\6O^/J7ZU]%E_0^-S;<YCX>_\A./_>'\Z_0/X _\>]O]!7Y^
M?#W_ )"<?^\/YU^@?P!_X][?Z"NC,?A,<H^,^AZ***^5/N HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*-U "T4
M44 %%%% !1110 4A-&ZD/-  &IU-'6G4 %-VTZB@! ,4M%% !1110 4444 %
M%%% !1110 UNM"]:"* * '4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 AI-M.HH ;NI13>:<M
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_C_\
MY K_ $-=17+^/_\ D"O]#5P^)&=3X&? 'QT_X^9_J:\%T/\ Y"P_WJ]Z^.G_
M !\S_4UX+H?_ "%A_O5]G1_A'YGC/XQ]B_ G_EA^%?9>@_\ (+B^E?&GP)_Y
M8?A7V7H/_(+B^E?-XSXC[7*_X9HT445YI[84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^$QRCXSZ'HHHKY4^X"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** $:FT^DH 6BBB@ HHHH **** &4JTM+0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
MOX__ .0*_P!#745R_C__ ) K_0U</B1G4^!GP!\=/^/F?ZFO!=#_ .0L/]ZO
M>OCI_P ?,_U->"Z'_P A8?[U?9T?X1^9XS^,?8OP)_Y8?A7V7H/_ ""XOI7Q
MI\"?^6'X5]EZ#_R"XOI7S>,^(^URO^&:-%%%>:>V%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%(U !FEIE/H **** $:FT^B@ HHHH *9)((UR:;)<+&#DU
M@ZIK2QJ<-2+C%R=D6[W5EA4\URFL>(0 <-61K'B _-AJX^_U=I"?FK&4SV\/
M@[ZLT=4UQI&.&KGYKYI&/-1/,9#DFF;:YFVSWX4HP5A2V[DT;>111FD:B[L4
MC24Y8C)5J/37?M5)$2FH[E,'=4T<!<CBK\>COGI6E9Z2=PRM;PI\QYE;&*&Q
MG6NFF0CBNCTO0R2,K6GIND#CBNIT_2U4#BNE4U$\&MBI5"KI>CB/!Q71V]J(
MUZ8I8;<1J.*=))L6K.%MO<G5@M'FUES7WEYYJHVKJO\ %2L!O;A3@:P$UA3_
M !5:BU,-WI:@:34PBHH[@/WJS'AJ8#%CJ18ZE5:=MJ;@1[<"HV%3M43=:0"+
MUIQZ4BT-]TTP,Z^?:#7&Z]=;%;FNKU.3:K5Y]XEN,*U:1 XCQ%JA4MS7G.K:
MH3(>:Z3Q)=$LW-<!J$A:0UZ%-: *VI'=UJ:/4CZUC-FI(L\5JT!TEG?%F'-=
MAH5T2R\UP6GJ2PKM-#0J16,@/5/#]U\J\UVMG>?(.:\VT>;RU7FNFM]0VJ.:
MQ<1G5F\'K6=J%X%4\UCOJNWO67J.L?*?FJ>0"MKVI85N:\XUS42V[FMC6]6W
M;OFKBM1NO,)YJTK <[K4Y8MS7%:GN8FNRU!=^:YR]M=V>*T$<A-$2344=N2W
M2M^6Q]J2'3\D<5:8V4K6U)(XK:M+'=VJU9:9DCBNALM)Z?+57$9=MIIXXK5M
M]-/'%;%KI73BM*'3]O:K QH[':.E)+:X!XKH_L/M4,UCP>*5P.5GAVU2E<KF
MNCN[$\\5BW=F1GBDF,R)KHKFJ<EX>>:MW-L>:SY(#S6J8A1<%FJ[;,6Q6>D)
MW5I6<)R*KF$;FG1AL5T5K"-HK$TY,8K<ADVK5\P$EQ&%7-85](%S6E>W@53S
M7*ZIJ'7FES%7$FO K=:LV-UN8<URTU]F3K6CIEUEA4\PCOM.Q(!FM?[&)$Z5
MSVCSYQS756K[E%+F&8>H:4&4\5SMUHXW=*]!FA$B]*R;JQSGBLVQ'(1::%8<
M5=2W6,=*T9K79VJI,I%1<5BNTNUN*GAN">]4I%):KEM":Z(Q3#5;"SSL!UJB
MVI-$W)K3F@^0\5S>JJ8\XK.=-2-85919T%CXB"$9:NET_P 1+)@;J\6FU!X6
MX-:NCZV^\?-7F5<-V/:HXZVC/;X+X3 <U84;JXK0]4,BKDUU]K.&05YDZ3B>
MW3K1FB5DINRI,[J-IK#U.GT(UD*=*LV^HO&PYJ!HZ;Y>WM0#2>YUVCZ\R%<M
M7=Z1XB!49:O&([@PM6SI^M-&P^:M8SL>9B,(JFJ/=;34UF4<U?5MRYKR_1/$
M'W<M7<Z9JZ3( 373&5SYRMAW3-BBF1RK)T-.JSC"EINVG4 ,I5H;K24 .HI%
MIU #*<O2BEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH **** "BBB@ HHHH *Y?Q__ ,@5_H:ZBN7\?_\ (%?Z&KA\2,ZGP,^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI8B%1:,ZBDIL4@E0,O0T^L#J$R*6DQ2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'BWQF_X]YOI7P+\6O^/J7ZU]]?&;_CWF^E? OQ:_X^I?K7
MT67]#XW-MSF/A[_R$X_]X?SK] _@#_Q[V_T%?GY\/?\ D)Q_[P_G7Z!_ '_C
MWM_H*Z,Q^$QRCXSZ'HHHKY4^X"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HI"<#)K*U#7$L@<L!B@#6HK@-0^)<%F2#(*S&^+D&
M['FC\Z8'J5%>6CXN0+_RU'YU=L_BI;W! \Q: /1:*Y_3?%45]C# YK=CD$B[
MA0 ^BBBD 444E "T444 %%(3@9K(U+74L 23C% &Q17%CX@0F7;O&:Z#2]87
M4%!4YS0!J4444 %%%0W-P+>/<: )J*YRZ\6Q6[[2PJ6S\31W1 #"@#=I:AAG
M$J@BIJ "BBB@ HHHH ***CFF$2Y- $E%9DFLQHV,BK,%\LPR#0!:HJG<WP@7
M)-8\_BR.%L%A0!TE%<];^*(YVP&%;%K="X7(H LT444 %%%% !1110 4444
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M5\:? G_EA^%?9>@_\@N+Z5\WC/B/M<K_ (9HT445YI[84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$E%Q=F.HHHH)"DR*6F4 .I::M.H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!112'I0 M%,S3ATH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_>'YTL>OVK_Q@?C0!IT56CU""3[K@U.LBMT.: '4444 %%%% !1110 4444
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M)@JCY_UI >L?V@K#K5=Y%D-<-;^)PW\=:EGK8D(^:@9T:QC.:D92%JK9W@D
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M?XG2+.RB0]?6KGC37#=0LJMVKS&/1IM0O.YR:KH!UTGQ&GQD.WYTEG\39Q,
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M\RR#$]J^>?"/@>XL)$=E(KT]=0.FV>PG! H M^,/''V'> ^/QKS:X^)LLDI
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M:D 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_C_ /Y
MK_0UU%<OX_\ ^0*_T-7#XD9U/@9\ ?'3_CYG^IKP70_^0L/]ZO>OCI_Q\S_4
MUX+H?_(6'^]7V='^$?F>,_C'V+\"?^6'X5]EZ#_R"XOI7QI\"?\ EA^%?9>@
M_P#(+B^E?-XSXC[7*_X9HT445YI[84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)1NH 6BB
MB@ HHJ.:41KF@ FF$:\FN<UC5EC5OFIVKZL(E/-<!KFN;BPW5G*5CT,/AW4=
MQ-<UO<6 :N.O+QIF/-%[>-,QYJDN=V37(Y7/J*5%4T&TDYJ0?**.U-J3I0M2
MV\+2,!BG6UN96'%=-H^BF1E.*:BVS&K55-:C=)T8RXRM=79Z*(E!*U?TK2EA
M49%:<@6-:[:=,^8Q.*<G9&3Y"Q\8IFT4ZYFYJ!9<M74E8\QNY?MH\D5LV</
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M!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M-:@!64,,$9%9&K^';?4(F!09Q6N#2TTVMA-*2LSYV^(_PMCNTEVQ9_"ODSXD
M_"&2%Y66$]^U?I;?Z3%?*0P'->9>.OAC#>V\A$2G(]*]3#8ITWJ>#C,OC55T
M?E/KGA272YFRA&/:N>DE,+;37V1\4OA"T;2LD/KVKYK\3> Y[&X;,9&/:OIZ
M-=5$?$XC"RHO8Y".?=4RMNIMQ9M:Y#"HDG"\5U'#ZEFBF+(&I]( HHHH ***
M* "BBB@ HHHH&%%%% [A24M% F%%%%!(C+NJ-K=34M% RN5$?(J6/6);7&UB
M*&3=4+VNZGZAJMCJ_#OCRYM95_>,.?6O>?A[\6I(6CWS?K7RRL/D\CBM33_$
M$EBPPQ&*PJ48U$=5'$3I.]S])O!/QFBV(&G'YUZ]HWQ(M]0C3]XI)]Z_+#0/
MBA/:R*/-8?C7N/@'XR/NB#SG\Z\*O@.J/J,-FU_=9^AMCJ*7RY4BKE?/G@3X
MM0R1Q[IA^=>N:7XXL[Y%^<$_6O$J4I0>Q]/2Q$*BO<Z>DJM;ZC#=?<:K58'3
M<*3-+2;:!BT4E+0 4444 %%%% !1136H 6EIE/H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \6^,W_'O-]*^!?BU_P ?4OUK[Z^,W_'O
M-]*^!?BU_P ?4OUKZ++^A\;FVYS'P]_Y"<?^\/YU^@?P!_X][?Z"OS\^'O\
MR$X_]X?SK] _@#_Q[V_T%=&8_"8Y1\9]#T445\J?<!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% "-]TUX-\8\[9,5[RW0UXS\5-.-PLF!3
M0'S;8@_VH/\ >KZ2^&./L\7TKY_DL39ZAN(QS7L7P[UY(5C7=3$CW^U_U0J:
MLS1+P74 (.>*TZD8444R201(6/04 <;\2O\ D%O_ +M?%OC?/]L-_O5]:?$K
M7T:UE3=VQ7RIXC@^W:J2!GYJI"/4_@BOF-$#[5]$:CX=CO-/VE<G;7AGP7TU
MH7B.,=*^DMP2%<],4 ?-?Q"\*+I;/($QWKP?Q1XFELI&C5R,<5]6_&)HVMGQ
MC.*^,O&T9:_?TS3$6O#]W/JUXN23DU],?"OPJ)O*9U]*^>_AM#%]ICW>M?7W
MPU$2Q1;<=J 1Z)9Z/!:P*H7! KRCXJQA(Y0*]GKQOXK_ '9:@;/GF,!=6S_M
M5[;X2OO+TT 'M7B$G&J'ZUZSX79O[/'TJA(Y3XD73S3,,U#\,]'6ZODWC/-2
M>-,-,<^M;/PO51>)CU%*Y1]#Z3X9M$T^$-&"=N>E9?C3PO:R:.Y1 "/:NKT_
M_CQA_P!VJ'BK_D$R4@/C3QIH"PZBVU>]=A\,[8QL@Q4/C2$-?O\ 6MOP#"$=
M#3 ]<CMR]H/I7.ZE;K&Q+5TBW\=O:C<0.*X/Q5KR?,$;FD)ENWU.SM9/F*UL
M+XGL?*QE:\-U34KJ28^66JFM]J.T\O5!<]6\2:Q9SQM@K7E.M7D?V@[,=:J7
ME]>G.XM6%))+),-V:!'KWPYD,\\8SD5ZOX@TU&T=B0/NUY/\+5_?1U[%XBDV
MZ*?]VAC1\G^-K)%UAAC^*O6O@WI$4JQDKFO*_&TF=:;_ 'J]B^"Y.R.I*/4?
M$&DQPV!(4=*\3\1*([I@/6O>O$N?[//TKP3Q-_Q]/]:I$,G\-VHN)E!&:]!E
M\.I]@+;>U<3X-&;A*]B6W$FF$8[4,:/F;QPOV&^8#CFNJ^%>H&29 36;\3])
M;[8Y"]Z@^'=Q]AG&XXYH ][US5?LVED[OX:\+U[7_ME^R;LY-=EXO\3+_9Q4
M/V]:\8M;QKS6!SGYJ0ST[0=!6\C#[<U/JT1TJ,XXXKK_  +IH>P4D=JPOB-;
M>1$^!CBGN2]#R_5/$ :8JS5J>&=6MUF4L17G.M22?:6QGK2Z7)<JR[=U,FY]
M2Z-X@L19J"5J#Q-KMBVFOM*YKQ2PO+\1#&ZEU*XOYK=@=V*19R?C35E;4&\L
M]Z[?X0WDDEQ%DGJ*\VO-)GN+S+@]:]>^%6D>3)&<4"/IW16W:=%]*OU0T5=M
MB@J_4E$=P,Q-7!^*[%YH7P,UWS?=-96HV\<D3 T ?+OC#1&$SDK6-H4L.GW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1J;3Z2@!:*:M*S;5S0 C
ML%7-8&L:F(5/-6-3U(0J><5Y_P"(-<SN :LY2L=N'HNHRKKVN$[@&KBKZ^:5
MCSFGZC?&9SSWJCC=UKE<KGUE"BJ:%4[N33MN*%7"T=:@Z0ZFK5M:F8CBHX;<
MNPKI]&TW<1D5<8MF%6JJ:'Z/HI8J=M=OI>F+"HR*9IMBL2 XJ_)<"$<5WPIV
M1\OB<2ZCLBTV(UXK+O+CJ,TDM]N[U1FD+UM8\PK7$Q8TR*0Y%*T):I(;4Y'%
M,#1L7Y%=!9OP*P[.W(QQ6U;*5%# U8VZ4[[PJLDF*>LP]:RL KQU T=6=X:D
M9<T 5L8J&63:*N-'5.:(FJN!7\\[NM/63=4#0G-/B4@T 3&W$G:JL^EJ^>*T
MH!P*L>5NI7 Y6;1QZ53;30IZ5U\UMN[53DL^O%4!AVUGM8<5LVD.*?'9X[5=
MAAVTF 1Q=*G1<4[:!3)) O>HN V9]JUE7=QC-3W5S[UD7$I;O6D4 OGG=UK0
MMI<UCIG-:%N2,50&A(NY:P=4M]V:W/,^6LR^8,IJ0. UBSY;BN9N+++'BNZU
M6,'=7.30C>:I 94&F;NU6?[)^7I6G;*HJ]M4BNB#L,Y2;2\9XK,NM.QGBNWF
M@5JSKBQ#9XKI0C@[BQ(/2J,EFWI7;W&F;CTJE)I/M5 <=)9L>U4[C3F;/%=R
M=*'I4,FECTK1 >9WFCL^>*P;[PZTF?EKU^71U;/%59-!1L_+5I >&7'A5F8_
M)3;7P>?,'R?I7M4GAQ/[M1KH"*WW16@'%Z#X7$97*5Z'I&AHJKE:DM-/6+&!
M6S 1&!4,!BZ-'M^[3&T2/^[5X70]:D68-4 9@TE%_AI_V(+VK0=A5>24+FG8
M5BI)#MJK(VVI;FZ [UE7%Z%/6I&:"-NJ7R\K6(NJJIZU+_;B8^]3 NW";1FL
MFZFV$TMQK2%3\U8%_K*\_-2N!;GU+R^]49/$03/S5S&J:X%SAJY.^\2%6.&H
MW ]+;Q LAQNIRWZ2=Q7DL?B8[Q\];>G^("^/FI =Y<;)%-8UU:HS'BJ\>K;U
MZTC7H8]:0 NGH3TJ5--3THAFW$5>BY I 0QV"+VJCJ!6%#6M(VU37)^(;WRU
M;FA 9MYJ_E,<&F0Z\?[U<=J6J'S3S2V=X7[U5@.NN/$#X(W5C76K239^:J,T
MN>]%O'YC5?+H ;9)CWJS#I\C8XK;TO2Q)CBNGL] #8^6DMP.,M].93TK:L;)
MN.*Z=?#V/X:LQZ/Y0Z5N@L9MM"8U%/FN?*7K5JX40I7*ZSJ@A!YQ3 M7.M>4
M3\U9]QXFPI^:N)UCQ%L9OFKE[SQ1U^>BPSO=6\1[E/S_ *UYSXCU7S=W-4+O
MQ(7_ (ZYW4=5\W/-;1$4=0G#2'FJ+2#%5[NZ^;K5-[NNV" M3R5FS-3FN-U0
MO\U=D4(A9J56I?+)I#&:!DROFI8FV\BJRJ>*M6\):L) ;&C:I);S+AN]>Y_#
MKQ9)&\89_P!:\.TVQRX.*] \-LUJZ8XKRJU-35C2G4=-GV5X+\5":% 7_6O1
MK.\6X4'-?+?@GQ T.P%J]P\,Z^)8TRU?,8G#.+NCZ;"XI35F>@,O%1&.H[>Z
M$RCFK&*\O;<]=.ZT*Q;:W%:>FZBT+#G%4#'FF9\L\4"DE)69Z?H&N_=&[]:[
M[2[\3*.:\(TG4C"PYKT3P]K@PH+5O"9X&+PW5'HX.:6J%C?"91SFK]=)X#3B
M["49I&I*"1]%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^$QRCXSZ'HHHKY4^X"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***;NH =7$^,-(^V1OQFNU!JI>68G4@C- 'RKXT\/M9RNP7%<]X>UU]/O%4M
M@ U[]X\\*">%R$[>E?/GB/0Y=-NF=5(P:I$GTE\._%D,UNJNXY%>@#4K8])1
M7QAH/C:XTE@NXC%=M8_%*:3&9#^=*P7/IDZE;C_EH*Y[Q5XHM[*U95<9Q7AU
MU\4)D7B0_G7'^(OB-<7V5#DY]Z+#N;GC?Q4;Z615?.37)Z+HKZE>*Q7/-4M-
MCGU>Z4G)R:]L\ ^#?N,R?I5".D^'N@_V?"C%<5U_B#Q%'8VY^;&!4GV$:;8\
M#'%>+?$KQ)+")%5CWJ2BEX\\5#5"\8;/:O$/$GAR2\9I%7.>:Z+3;J?4]0 ;
M)RU>LZ+X &I6:DQY)'I3$?.7A^&;2;Q<@@ U]*?"_P 5+&(E=L5RWB;X9FQ9
MG6+&/:N9L;R?0[@ $C!H ^R;'5H;JW#AAG%>3_%20/'*16?X)\92W,2HS_K3
MO'K-=63MUXI >%+AM4Q_M5[/X5L=^F@@?PUXO#;R?VP.#]ZOH;P'9&335!'\
M--@CR/XA1-;S-]:E^&&J+#?)N/>NK^)WAQG5V"UY1ILTNCWN1D8-*P[GVGI.
MK6\NGP-Y@!VUG^,-8MX=(DPX.:\#T_XD30VZ)O/ ]:H>*/B)/<:>R;S^=%A&
M'XQUN.34G ;O74^ KD2(I%>"ZAJT][J6<D\U[/\ #-9&A3(IB.U\4ZZ]G:G!
MQQ7ETOB1KR\VLW>O1/&&ER7%F< ]*\7O+&:QOBV".:$-GKOAG08-4568 YKM
M%^']KY.=JUY+X3\6OIX4$XQ7HEO\0M\(&[M0!D^)/"%O:HQ"BO*]8M([>X.,
M5Z%XG\7-<1M@YXKR/6M2EGNCC/6JL(]:^&<P$T8%>O\ B!MVBG_=KPSX5M(U
MQ'G/6O=-6B,FBD?[-2-'RKXW<)K+$_WJ]>^#&I11K&":\=^)EM+%JCL >M7?
MASXDFL9$!)% 7/K7Q%J,4FGG!'2O"O$C!KIL>M="?%$EY:A=V>*Y;5(WFD+8
MS0(V/!\@6X3ZU[?I.)K$#KQ7A/A>-TN%X[U[MX44O; 'TH8T>=_$+PW]H\QP
MM>07%Q_8<S9.W!KZH\0Z0MS:RG;GBOD_XO6TEC++L!%) S+UCQ=]L7RP^:M>
M"M+:\OHWQGYJ\ETN:YNM1"G)&ZOIKX4^'2\<3LM4!Z_X/L/L^GJ,=JY7XC:>
MT\;X%>GZ78""U  [5D>)=#%U!(=N>*D'J?)NI:+B[;<.]=+X7\.P3.H8"KOC
M?2VL)G(7&#7+:-XF>QN@"<8-42>YZ3X'M6M@=HI^I>"K1+5S@5RNF_$8Q6@&
M[MZU5U+XF&2)DWTBC&UCP[!#=':!UKL? -B(I$P*X)==?4K@=\FO4/ <)+(2
M*8D>PZ:NVT05:J&S7;;H/:IJ@HCF;;&37,ZMJ!A##-=/*NY"*Y#Q-:D1,10!
MR>I:A'.Y#&LU?#]IJ74*<UR?BS5Y-/F8@D8-8^C?$-X90I;O5$]3N]0^&MHT
M9;:*X77/"\&FEBH Q772_$+?:_>[5YWXD\5-?2, <YI%$-GJ36EP%4]Z]6\(
MZM)<0J"3TKR+0]-EU"Z4X)R:]Q\'^&VAME8KVH$<_P"/&_T9B?2O,]!OHX]6
M'/\ %7I/Q0C:WM7 ':OGN/5)K?5N_P!ZFA;'V+X9U*(Z6.1]VO,OB1<H\S8-
M5?"?BB4Z>JECTK!\6WTEY*>] 7&^$Y!]L7ZU]$^"Y1]G3Z5\Y>$K>3[0AP>M
M?07@W<L*9]*3&CHO$49EM6QZ5\_>/M'>21SCBOI"YM_M$./:O//&GAD-;L^W
MM0AGS7#HJ_:/F'>O1O"7A:VN"F0*Y#Q(KZ;=-@8P:N^%?&;VLB@G&*HD]HB\
M"V@C4[5Z5C^)?!MI%;Y '2LUOB45B'S]JP]8^(C7B[=V:0[F6-#B@O?E'>O5
M/!\1@A7Z5YEH]XVH70/7)KV+P_8E;,-CM0P0:YJRQQE6/:N0$=OJ4Q#8.:C^
M(%Y):*Q7->::?XREM;S!8]:5@9Z\WP[M+R$-M7FN=\5?#^VT^S9E4 XJUIGQ
M&VVJ@M61XL\=&^MF0-GBF!X[K%Z=)U JAQ@UZG\+_$TLQC!8XKR/5+&75-0+
M $Y->O?"_P ,R6ZQL5- 'M,VJ*;++'M7%WRV^H7!5L')JUXHN'L+$XXP*\BF
M\9RVM\<MWI"/5XOA_:7R;MJ\UE:Y\.K6RMRP4 XJMH/Q$VVXRW:H/$7Q ^TP
ME0W:G89Y?XD8:3=$(<8-=7\-_$DLEU&I8XS7#ZYYNKW1(!.37<_#3PW)'<1L
M5/6@1]1>&YC-IJ,:U:R_#L/DZ:BUJ5)04444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5R_C_P#Y K_0UU%<OX__ .0*_P!#5P^)&=3X&? '
MQT_X^9_J:\%T/_D+#_>KWKXZ?\?,_P!37@NA_P#(6'^]7V='^$?F>,_C'V+\
M"?\ EA^%?9>@_P#(+B^E?&GP)_Y8?A7V7H/_ ""XOI7S>,^(^URO^&:-%%%>
M:>V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 -I5HVTGW: '44@I: $Z51U"^6&,\U->7 AC/-<+XA
MUS;N :ID[&]&DZCT*?B+6\;@#7GVI:D9I#S5G5M2,['FL-LLV:XY2U/J\-05
M-:@PW<T]5P#0JTIXJ#T!5I\499A4:MS6A9JK,*N,>9G/5J*FKFCIECNP<5UV
MFVPA4<5DZ;L516G)?I#'UKT:=.Q\MB<4YNR-.34EA7&:RKK6PQ(W5SNK:\JY
MPU<U/X@RWWJZ.4\WS/08=4#GK5V.X5^]>;V>N_,/FK>L]:#8^:JY1G:Q*K5?
MMX!Q7,6>K XRU;EIJB''-0XC-V&$+BIBP05F+JB =:AN-57!YJ+ :;W@7O4?
M]H@=ZYVXU0;C\U5&U<9^]56$=K%J ;O5V.Y#8KAK?6!G[U;%KJ@..:30'3>8
M&H\L/65#J />M&WN@V.:R: )+7VJ+[/MJ_YBL*AD84 1QKMJRA%5#*%I1<#U
MHL!:;!J-HQ48N >]-DGXHU 5L+49NE7O5&ZO-O>L:ZU0KWH Z.34%QUJA=:D
M%[USDFL'UJC<:H6[U5@-^:_W-UJ/S-]<\E\6;K6E:W0;&330&I&M6?,V526Y
M55ZU7NM055/S4P-&34 J]:R[K4QSS6'?:R%S\U8=UK?S'YJ+ ;=]?!L\UA7%
MR-U9\VK[OXJHR:AN/6JB@-A;[:>M3+J?;-<[]K'7-1OJ C_BKLA$#K%U -WI
MWVE6KCEUM5XW5-'KR?WOUK=(#J&96J&3:*Q/[<7;]ZJUSKZ+GYJ0&O-,BU0F
MO$7O7.7OB9!GY_UK%N/%"Y^_^M:Q&=DU\GK4;7R5PS>)E/\ '33XD7^_6UA'
M9RZ@@[U3?4ES7(3>(E_O?K5)_$*[OO4 =_%J(;'-6&ON.M<)9ZXK?Q5IMK"E
M?O5+ Z ZIANM6[?5!QS7 W&M!6^]2P:\/[U9@>C-J2[>M9=YK"KGYJY9M>)7
MAJPM4UYAGYJ .IO->7/WJRKC6 W1JX:XUQV?[U3VEX]QCFH91OW&J-G@U4;6
M''>G0:>\X'%22:&^.E("G)J\C \UFW=](X/-;2Z&Q)XIQ\.LP^[0)G!:@\LF
M:YN]MY6]:]8D\*E_X:JS^#"1]S]*M,#R'[/*K=ZVM,9U*@UU=YX2\LGY*K1Z
M*86^[2; 6&X*KS4@OL-UJ.YMS"E8EQ<-&_7O0@.PLKT,1S706L@917G.G7S;
MASWKK]-O<J,FDT(V+IL1FN \42G:U=C>7@\L\UPOB"=9-W-4D!Y]>[FFK4TN
MV9@*;]E$DU=3HVEC:.*H#)DM&]*LZ?:MO'%=%-I(QTJ6PTL>8.*=P-+0[,X7
MBNXTRQR!Q69H>FCY>*[73[,*HXI):@4_[/ 4'%4;Z-84-='=!8X_2N+\1ZB(
MHWYKJCL4<MXAU185;FO*?$WB( OAJU?&7B IO&ZO%_$GB!F=OFJ[$EG6M>W,
MWS5REWK))/S5F7NJ&0GYJRI;AFSS2L!LMJI8]:BDOC)WK%\TYJS"2U;12 EG
MD+52D8YJ^T>X53EB/-=<"1(VS4ZJ*KJ-IJ19,5UK85R=5%!C%1K+4JM5 *D-
M7[2$9JK&:N6\FTBL)E'0Z;&!MKK-+4?+7$V=UM(YKH].U(+MYKSY(#TS0[KR
M"N#7J/A?Q 5*#=7ANFZGG&#7=^'=0.Y.:X*L%)&M.HZ;T/I/P_J_G(O-=;#*
M'45X[X6U0@+\U>E:7J =%YKYK$4.5W1]1AL2I*S-K;WJ)TS4D<JL*5J\[8]9
M=R%28^:V])U8PNHS6*XI(6*,#3V(E!35F>P^'=<#!<M7;6ETLT8YKPK1]7:!
M@,UZ1X?UL2JN6KKA+0^:Q>%<7=';4;14=O,)HP14M:GBA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK>L=2''->/Z=KWW?FKIK'7NGS5FP/3HM0&T<TDE\/6N(AU[Y1\U2/K>[^*I
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M:UY3X9D:1EKUGP_:L\:\50&LZ@BIK%!Y@J:2Q95SBHH@8GI =?H^T!:ZJWD
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
MK*'4J>AK#U7PI;ZC&P*@DUO44TVMB914M&?/7Q ^$L4RR%81^5?+'Q&^$LD;
M2E(3^5?H_J6G)?1E6 )KSCQ5\,(M0C<^4#GVKT\/BW3>IXF+R^-1>ZC\J_$7
M@2XL9&S&17+M9M9MAAC%??'Q'^"ZJDC+#^E?,'CKX;3V,LA6(C\*^EH8J-1'
MQF)P4J+V/)1<CIFI%F#4^\\/SVTS94C%0>48?O<5W:/8\S5;EBEJ)95Z4\.&
MZ4@'4444 -:DIU&T4@"EHHH*04UJ=10#&4^F[:6@D*6G4C4 )11157 ****0
M"K377-+14@59+7=319[><5<I#57"PEO=-:8P<5L6'C:>R88D(Q[U@RQ%JJM:
M$FERI[C4I1V/7_#OQ:N89$'G'\Z]H\%_&)]R;I_UKX]MT:%@<UT6F>(Y+$CY
MR,>]<E7#QGL=M'%SIO5GZ/>"?BY$RINF'YUZ_H_Q(L[R-0TBG\:_+K1?BM-8
M[?WI'XUZ3X9^.4JL@,Q_.O%JY>WJCZ7#YLHJS/T<M_$EI<_=8?G6E#.DRY4Y
MKXY\&?&47#)NFZ^]>Z^$_B1;W")NE'YUY=3#R@>_0QD*IZK1679^(K.[0$2@
M&KJ7L$GW9%-<EF>A=/8GHI%8-T.:6D,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#Q;XS?\>\WTKX%^+7_'U+]:^^OC-_Q[S?2O@7XM?\?4OUKZ
M++^A\;FVYS'P]_Y"<?\ O#^=?H'\ ?\ CWM_H*_/SX>_\A./_>'\Z_0/X _\
M>]O]!71F/PF.4?&?0]%%%?*GW 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !2$9ZTM% "!0O2EHHH 2EI,4M "8I:** "FE
MJ=28H !2T44 %%%% !1110 4444 %%%% !1110 F:6DQ2T )1M'I2T4 %%%%
M !1110 4444 )2T44 %%%% !1110 4444 %%%% !1110 FT>E+110 4444 %
M%%% !1110 4444 -VCKBG444 %%%% !1110 4444 %%%% !1110 4444 )M'
MI2T44 %%%% !1110 TJ&[4H&.E+10 4444 %%%% ",H;J* H7I2T4 %)2TE
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ME)F=&K1T>XD\P?6J&CU/1[".95X%:E]H*/;GY:R/#-PQV9KM=P>WI6&?/WQ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOS\^'O\ R$X_]X?SK] _@#_Q[V_T%=&8_"8Y1\9]#T445\J?<!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M17<:)IZ*J\5B6L(C85T6GW"QJ.: -IK=%CZ5F3VZM)C%6VO59<9JLLP:3K3
MN:?I228^6MR/145/NU5TN9% YK<6Z3;C-(#G[W2EYPM9$FEC=]VNRD59NE02
M:<#SBI Q=-L4C8<5V>CS1PXZ5SLD?V>HDU7RFQFLF!ZQIVI)M'-;<%\&7K7E
M6DZT68#=7:Z3=><HYK)C.F-T33/-).*+>'S%!J?[-S2 ;%DM6C"E00V]6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7+^/_\ D"O]#745R_C_ /Y
MK_0U</B1G4^!GP!\=/\ CYG^IKP70_\ D+#_ 'J]Z^.G_'S/]37@NA_\A8?[
MU?9T?X1^9XS^,?8OP)_Y8?A7V7H/_(+B^E?&GP)_Y8?A7V7H/_(+B^E?-XSX
MC[7*_P"&:-%%%>:>V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%% !1110 4444 %%%% !1110 E136L4ZD.@/X5-10!P7B[P/;W\;XC!R/2O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBO-/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6D\8.W\=<<%D;UI/L\K=:ATT6=7_ ,),\C?>K6TW6G;'-<5:V;Y'!KH=/A9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH 9)&LJE6'%8]YX5MKS.X#\JVZ*:;6Q+BI;GE_BCX56UU"[+&K?A7
MS[\0O@^,2;(?TK[190RD$9!KF]9\(Q:EG* YKKI8B4'N>?B,'"JM$?F+XQ^$
MEQ'(Y$)Q]*\RU#X?W-H[$QL/PK]1_$7P;@NHV/D@Y]J\7\;?!)(4D*P_I7NT
M<P3T9\OB,I<?>1\"W.E/9GE2*IM<>7P:]]\<_"^6V>3;$?RKQW6?!MU;R-\C
M#\*]BG4C-'SM6C*F[6,9;L-4JR[J9_8LT'WE-"QF+KQ6VG0PUZD]%0^>M.$R
MFD!)12!@:6D 4444 %%%% !1110 4444""BBBF,****8!0**8S<T@*M\?E-:
MW@N'SKY!CO69<1F08KLOASI#2ZA&=O>E)VBQTTY31]>? GP_YR0';Z5]@^&=
M+%K:IQC KP/X!Z+MMX"5]*^FK>$0QA0*^*Q<[SL?IF7T^6FF24M%%>>>L%%%
M% !1110 4444 %%%% 'BWQF_X]YOI7P+\6O^/J7ZU]]?&;_CWF^E? OQ:_X^
MI?K7T67]#XW-MSF/A[_R$X_]X?SK] _@#_Q[V_T%?GY\/?\ D)Q_[P_G7Z!_
M '_CWM_H*Z,Q^$QRCXSZ'HHHKY4^X"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-T)4'.:\5T74/+=1FO2_#]_YBKS75"1\SC*.O,==UQ2TV,[D!IU;GAA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 126L4OWD!JE
M<:!9W*D-$*TJ*=V)I/<\T\6?#>VN8W*QJ<CTKP7QM\'1-YFV']*^PI(UF7:P
MXK)N_#-M=9W*.?:NJEB)4SSZV#A5/SB\5?!&7<Y$)_*O--8^$\UF6_=$8]J_
M4;5_AG9W:L5C4_A7E'C#X/Q,K[81^5>O2S#HSY^OE-M4?G#J'A:2QSE",>U<
M]=;K=B"*^Q?&WP?9=^V$_E7B?B/X3W,<C8A;\J]FGB(S6I\[6PDZ;T1XZ+X[
ML5/'<%JZ6\^']S:L<QGCVK+N-$DM>JD5U<T7L<'+*.Y55]U256DD\G@TP7@]
M:8BY15=;H-4T<F: '@4N:.U-I %%%% "5EWA^:M'=VJNUN9I ,52$SO/A;9_
M:+Z'CN*^^/@IX;#6\)V]O2OC/X-Z(6OH3M[BOT1^#.DB&QB)'05\_F-2VQ]7
MD]*[U/2=*LQ;0J,5I4BJ%&!2U\R?<)65@HHI*0PR**;3EH 6BBB@ HHHH **
M** /%OC-_P >\WTKX%^+7_'U+]:^^OC-_P >\WTKX%^+7_'U+]:^BR_H?&YM
MN<Q\/?\ D)Q_[P_G7Z!_ '_CWM_H*_/SX>_\A./_ 'A_.OT#^ /_ ![V_P!!
M71F/PF.4?&?0]%%%?*GW 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_
MC_\ Y K_ $-=17+^/_\ D"O]#5P^)&=3X&? 'QT_X^9_J:\%T/\ Y"P_WJ]Z
M^.G_ !\S_4UX+H?_ "%A_O5]G1_A'YGC/XQ]B_ G_EA^%?9>@_\ (+B^E?&G
MP)_Y8?A7V7H/_(+B^E?-XSXC[7*_X9HT445YI[84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+)AJOV\F<5B^=AJOVLN<5SR U"WRUE:@Q -:T*[UJK>6993Q6=P.*U*9OFK
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M/>B2-1FMQ6W#-=:/CYQY6+1113,PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<UI1YY6/<?@WX7VSP-M]*^Y?AO9_9;!1C'%?._PA\,[5A;9Z=J^H_#-H+:V
MQCBOD,94YF?H&6T?9Q3-RBBBO+/?"BBB@!-HHI:* "BBB@ HHHH **** /%O
MC-_Q[S?2O@7XM?\ 'U+]:^^OC-_Q[S?2O@7XM?\ 'U+]:^BR_H?&YMN<Q\/?
M^0G'_O#^=?H'\ ?^/>W^@K\_/A[_ ,A./_>'\Z_0/X _\>]O]!71F/PF.4?&
M?0]%%%?*GW 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO6G<#9M[944'%.G9%6LZ35D5?O5EWFN#/WJ8%R^F7FL6XD!)J&74O,/6J[W
M;O5 -F7=FLN[MPV>*TO-!J&8@@T@.0U.R!SQ7*WUA\QXKT"^B#9KG+ZURQXJ
MDP.6CL\-TK2MX=N*E:#:>E-9Q'5C'O($JJVH"-NM4K^\V@\U@S7S,^ :EB.W
ML=<*L,&NHTWQ"=H^:O,M-620BNJL89%4'FN>3 [Q==W+UIK:L7/6N9C$G'6K
M]I"\C#BN=L#?M[QF[ULV<TC8JAI.EM)MXKL-/T,[0<5+8$%OO.,UIV\9;K5A
M=+\L=*DCA\MJ0#H[/?VJS#I.XCBK-FF[%;=K;;L<4 9UMI07M5Y;41CI6EY(
M1:K7#!:: JLP7-4+IMP-37$V,UFW%T!FM$!GWT8;-8-VH4UJ7U\JYYKF-3U1
M5SS5 /EO!'GFLG4-8"J?FK'U+6PN?FKEM0U[.?FK>(&CK6K!L\UQU]-Y[FH]
M0U8R$\U2MYS))5"N:-EI/VB0<5V&B^&1N!VU2\/V^\J<5Z/H]F !Q0,ET;0A
M&JG;75V5F(U'%)I]N-HXK6CAXZ50%"Y8QK7*:]>,JM787T7RFN.URWW*U(#S
M+Q!?OO;FN4DU1DD.379:]I^68UY[K$9@9J0&]::V.,M6]I^JB0CYJ\F;5#"V
M,UO:#K!=UYJ0/7+67S%&#2W"G%9NAW'G*M= ;;S%K-@<]<;JR[I7;-=:VF%N
MU5IM&SGBES <1):/(>E6[+1VD8<5U":)T^6M;3]%"X^6H<@,G2_#^<?+756.
MA!5'RUIV.G+&HXK45%C7I2N!0M=,6/M6E';JE1F<+3&O .]*X%AP!4#@57>]
M'K4+WP]:D5R21@M4Y6#5%<7P]:9;R^8W6MX,9%<6>_/%9LMCM;I76QVHD4<5
M1OK4+FNZ,AW,#8J+6%K2JR-6W?-Y>:YK4IMRFMTRKGG/B:W&6.*X"^D\F0UZ
M/XB^96]:\QUP[7:J90)K!C7&ZHFUP^9]ZN=FN"&/-5_.8G.:YI%'J7AGQ089
ME^>OH+X?>*O/$8W5\;6.HO#,N#BO<OA9KK--$"W<5X^)IW5ST,-5Y96/M'P_
M<?:(4/7BM6Y3"URG@6]$UK&<]JZ^Z(9:^8FK2L?4P=XW,Y1\U;FDW7E.O-8V
MWDU)#.8W'-..@IQYE8]:\.ZEN"C-=S9R>9$#7D'A>^.]>:]6T>7S(!]*ZXZG
MR>,I\DC1HHHK0\P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<OX__P"0*_T-=17+^/\
M_D"O]#5P^)&=3X&? 'QT_P"/F?ZFO!=#_P"0L/\ >KWKXZ?\?,_U->"Z'_R%
MA_O5]G1_A'YGC/XQ]B_ G_EA^%?9>@_\@N+Z5\:? G_EA^%?9>@_\@N+Z5\W
MC/B/M<K_ (9HT445YI[84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYR_A=2:Z(@0W>I%L\UB7TYDSS4]P&4FJ,U:@8EY&6)JFL'S=*UIH]S5$MO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(7_4?A7V9H/_ ""X?I7S>,^(^URS^&:%%%%>:>V%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!X]\7XM]M/]*^"/C%;E;B4^YK]!_BC:^;;S
M?2OA7XU::5DE..YKW\ ]3Y+-HZ,\D\"3>7JJ?[U?H+^SW<!K>WY["OSQ\+L;
M?5USQ\U?>7[/.H@0VXSZ5V9@KP/.RB5IGU;14=O()8E8>E25\H??!1110 44
M44 (U)DTII-M "TM)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1112 *2EI*8"9-**3::44 +1110 5RGQ$DV:*_T-=77"?%
M*\$.D.N?X36E-7DC*J[09\#?':Y_TNX&>YKQ3PNOF:LO^]7I_P ;[[S+^?!S
MR:\\\!VYFU1#C/-?9TO=I'YIB/>KGV)\#+8JL!^E?8&AC;IL0]J^6O@K8E(X
M#CTKZHTE=MC&/:OE\6[R/NLOCRTRW0**%Z5P'K"T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/:M0+NIWV?=VKIC(9S\EC[5G7FG=>*[$V.1TJK<:?D=*OF XR/3PLG2NATN
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MM0&_K4_B35/++<UQ%QJQ:;[W>K [6SN!)CFN@LQG%<-HMYYFWFNYT[YD!JD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU:-XG6LN8;6-6@';Z@F;BFM)MJ&2:NF.H%&\'6L2XB+$UNR?.:B6R\QNE;;
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M(VKKKB$LIKF]:L2T;<4 >.^*IVWMUKA9+AO//UKTWQ+I#,S<5P=UI+1S'BJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 ,D
MC$BX->0_&;P^+C3Y2%S\M>PURWCO3Q?:>RXS\M:TI<LDSGKQYX-'Y>?&#07M
M+Z9@N.37&^ ]<?3M20%L8:OISXW> VD:=Q'Z]J^5KS3)-'U0G!7#5]I0FJE.
MQ^;8JG*C5N?>_P "?%PF6!2_IWKZKL;I;FUC=3G*U^;7P3\;_8KB%6DQT[U]
MP^ ?&4>H6D(WYX'>OF\;1<971]EEN(4H69Z;13(9!-&&'0T^O*/?"BBB@!*,
M"EI* &TY:;3EH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]4A7YP<CUKY*M1=-GZ)AL1&M%6.@HHHKE.T*2EHH ;MI12T4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/:K?4U+'#NK5 9C6OM56:UP#Q71_9,K52YL_E/%:I <A?1[0:Y^^[UU^I6N
M:YC4+<[C6R8'.S+\U,5*OR6YR:8+<^E:H!L?RT_=Q3A":/)- %6;YJH30[L\
M5K-;EJ9]C+=J ,,VN>U'V/VK>73R<<4\::?2@#GQ:X[5#/#@'BND;3CSQ5*Z
MT]L=*!'(7:[2:H>=Y9KI+W2W.>*PKO377/%6F,JR:H8QUK,O-<?G#4^\MF7(
MK*ELVD:G<"&34I+AL9-6+:QDN,<$U:TW13(ZY%=]H7AD,JY6G<#A1X?DVYVU
M0O-*>'^&O<E\)KY/W:YO7?# 56PM3<#Q[<T#UKV.J%<#-2:SHYA<\5AX:)JN
MX'7Q:MN7K4G]I GK7*03MZU/]H8=Z=P.WTW4!N'-==I^H#:.:\JL;XJ1S72V
M.K;0.:8'?M?!EZUF7USN4\UC1ZMN[TLMWYBGFF!EZM+G-<1JS'=7:7ZF137)
MZI:G<: ,BT;]X*]*\&S;73FO.88MD@KN?"<^R1*E[ ?0GA&X_=IS7HEK,3"*
M\F\'W@*IS7J>EL)(UKR*L=1C[@LV:SY0^ZNA6U\P=*KR6(YXK'E$9MKNW5T.
MFYXK-2!8VK1M)E3'-/E Z2U7Y14TD?%9]M>+M'-7%N0PIJ(%&ZBZUCWRE0:Z
M&1?,K/OK/<IXK5 <7>R,K&J#73#O6]J&GG)XK#N+,I6T4!1O+HLAKA?$K;E:
MNROE*J:XO7?FW5T1 \YOH?WQ^M6K$[%I]]'^\)J&.396Z FO)_E-<W?2;F-:
MEY<?*:P;R3K75 #'U#G-84R9:MJ];K6/,PS52>@$MG&,BM^R^7%<];W 4UIV
M]\!CFN*6X'56=QMQS72:5?;<<UP,.H#CFMW3=0&1S4@>G6>IG:.:?=:D2IYK
MF+&^!4<U8FN\KUH 6[OB6/-):7A+=:R;B;+&GVDWS4QHZE;C<HIT4GS"LV&7
MY>M6X6^:D-G2:=*>*WK8[L5S%A)MQ6[9S=*"3I+&V5NU:@T]67I63IL_2M^*
M3*TAF'J&FJ >*Y75+';GBNZOFZURVJ8YI".)O(=I-8EWP372ZB5R:Y?4) N:
M ,Z8BLV\"E33[JZVL:SI;@MWJT!F7T(?-9C:?N;I6Z8S(W2I8;'..*LR,&/1
M0W\-:%OH(_NUOPV8&.*NPVX4=*:U+B8"Z&%'W:<VEA.U=)Y(V]*KW,8 JS9'
M.2P".J%Q+MK6OOES6!=M\U,&BG<S%LU';J6:I?),AJ]9673BI,F:6DJ5(KL+
M"_,*CFN=L[;;BM( JM29F^VO%5QNK+NM::0GYJS)F:JC9K-@D27UV9,\US]W
M(036I-]TUC7[?*:S.F!8TG4-EPO/>O>?AM?>8T8S7S59W.VZ'UKW?X5W6Z2+
MFO.Q<?=/9PLM3ZAT/YK53[5+=CDU6\.2;K-/I5J[ZU\L_B/I([$$/WZZ31IM
MK"N;3[U;&ER[9!6D3&JKH]5\/S;E6NOB_P!6*X/PS+NV5W=O_JQ77'8^0Q*M
M(DHHHJSC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDSLKTZU_U*UV0V/D,8K3)J***T/."BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM?\ A2*_\\!^5'_"D5_YX#\J/KD"?[/J'R5]CU#_ &J7['J'^U7UI_PI%?\
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MY4?\*17_ )X#\J/KD _L^H?)7V/4/]JC['J'^U7UK_PI%?\ G@/RH_X4BO\
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M_M5]:_\ "D5_YX#\J/\ A2*_\\!^5'UR ?V?4/DK['J'^U1]CU#_ &J^M?\
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MRH_X4BO_ #P'Y4?7(!_9]0^2OL>H?[5'V/4/]JOK7_A2*_\ / ?E1_PI%?\
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M_/ ?E3^MP#^SZA\F"QU!O[]31Z/?R=FKZP7X)+G_ %'Z5HV?P33C]Q^E2\9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0R#^ZM=/11SR#V<>QS'_  AD']U:/^$,@_NK73T4<\@]G'L<Q_PAD']U:/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %9NM-BW/TK2K'UQ_P!RWTJ9;&E/62/)?%C9D;ZU
MQ7_+6NR\5']XU<=_RT_&N*6Y]MA?@1<C^Z*IWS80U=C^[6?J1_=FICN;2V.!
M\4-E7KQ[Q%;B21N*]=\3='KR[6HMS-7T>#/F,9*[.*:Q&X\5#-IH;M6TT.&/
M%-:.O=N>*C 71PQZ5>M]+"CI6G'&M2.RJM%P*7DK&*:9E6H+ZZVYP:QY+YMW
M6J Z>WF!/6M*WPV*Y.PNBS#FNKTT&3%1<9H0PUIV\9&*;:VNX#BM.&UZ<5$M
M@)M/B_>+7I?A&']XE<-IMF3(.*],\)V9#)Q7S^(W ];\*Q_(M>@Z>GRBN*\,
M0;57BN\L4PHKC NK]VG;J,?+2'I3 =NJ*1NM!:F,U,#.OEW*:Y/5H?O5U]UW
MKG-4CR#6\0. U.+K7-7B_,:[/5(>O%<K?1?,:V0&'(M1;:M31\U'LK4",1TA
M7;5C;44O%" C$FVG?:O>JDLFVJKW..]:; 7YKKWK(OIMV>:2:ZZ\U0GFW&D!
MGWR[LUB7$6W-;TPW5F7<?6J0&5NVFM"RFP16=,I#4^WEVD5: [73;CI70V]U
M\HKA]/O-N.:W(;[Y>M6@N;EQ>?*>:Y[4KSKS3KB^^4\U@W]YG/-;I 4KZXW$
MUD2DL:LSS;C59F%4 S.*BDFP*)I0*SKBX]ZH"6:X]ZK-<<U4FN">]0&8T@-'
MS_>F^=[U1\PT_P PT6 FDD]ZK2/[T\Y(J"3-2 UI*%DYJ)LTL:G-*0&SII^<
M5Z1X9P-E>:Z?E66NYT*^\O;S7++<#U6QD7RQ3[B05SMAJPV=:N&_#]Z+@27$
MNW-4YKW:.M1W5P,&LBZN3ZT[@.O[[.>:YN]N"Q-79W+YJF]N7[5HF!C7$AK&
MOY^#70WMKM!KF-14@FM4!S6I+YC&L6:U//%=+-#NS5.:U]JU0'*W5OC/%8MU
M;$UV%Y:]>*QKBUZ\5H@.8DM3D\4B(8S6X]G[54GM=N>*T0%>*^,)ZUIVNM$?
MQ5S]TI4U!%,RMUI@>AV.KER/FK=M;HR <UY]IEP<CFNQTF8-C)J@-Q06J159
M0:LV<2NHJX]J-II-#L8LUPT?>LZXU(KGFM/4(=N<5S%^"I-1RB+7]L%3]ZK-
MOX@*_P 7ZURDLC#O48N&'>I<0.]C\3LO\7ZT/XL*_P ?ZUPGVIO6J\UXW/-9
MV [J3Q:?[_ZU6D\4&3C=7"27;^M.AG=FZTK =7-JIF[U6:Z8GK5&V5FJT830
M!(+@XZU'+<>]0R*5S56:0C/-:(!9FWU6-IYE/C;<:UK*W#XJQ&/'I)8]*U++
M1N1\M;UMIZMCBM>UTU>.*+A<R+/1\8^6M:WTS&.*V+>Q [5>ALQZ50S/M=-!
M(XK?L=+''%36=C\PXKH;.R 4<5DQF8NFA5Z5GWUJ(\\5UTT(2/IVKE]:E$>Z
MD(Y:^81DUERWBJ>M)K%_M9N:Y>ZU3YCS3 WIM07GFLNZU(#/-8TNJ%N]9]Q>
M,V>:!&Q)J_O2QZMN[URLEP^:FM9FR.: .K^U^8.M5Y9:@M7W+3Y5]*+#)8+C
MD5I0W/ YK%B4[JT8%; I 6Y)B1UJC,VZK?E$BHFMS0!2[U+'4OV?K2>7MJK
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M29-T*UY)X7;YEKU31V_=BNNF?*XY>\;%%%%;GC!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 444F10 M%)2T %%%% !1110 4444 %%%% !1110 E'-+10 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 444E "T4F12T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E+0 5A:ZW[E
MOI6X>E8&NM^Z:D]C:C\1Y1XG_P!8U<C_ ,M/QKK?$Q^=JY+_ ):5PRW/M</\
M!<C^[6?J(S&:OQ_=JC??=-*.YI/8X'Q!%NWUY[JUF68\5Z?K$.[-<E>6.]CQ
M7OX9V1\KC-SSZ:P.3Q6?<PF/M7H$FC[L_+6%JVD%0>*]/G9Y)QKS%*:TQ88J
MU=6#!CQ4EGI;R,.*OG&8=Q;/+T!JBVE2%ONUZ79^%VE4?+^E69/")1<[*?M0
M//M.TQE89%=IH]C@#BI#H_V=ONU>L_W;#BLG48&Q:V8VCBM"&T/I4=@V]170
M:=9&5AQ4NIH(FT;32TB\5Z?X7TPKMXK#\/Z*69?EKT[P_I.P+Q7DU7=C.FT"
MUV(O%=9:KM45E:7;[%7BMR-,**Y@%)XI,\4K+UIH Q5"$-0N<9J=L8JM,>M"
M&4[AZQ[Y=P-:<YJA<?-FMX@<IJ=ONSQ7*ZA:_,>*[R^ASFN8U*WZ\5J@.-N(
M?F-5ME:]Y#\QK/9*L" KP>*JW#8%7F&!6?==#5H#*NI,$UFRS<GFK=YQ67-U
M-5< :;-1$YI*":8 W2JMQ%NJ9I*;N#52 Q;FWZ\518%#707$.X&LJZM_:M$@
M(K>Z*GK6M;WQV]:P-A5JL0R%:T0&U->97K6-=W/7FDFNMJGFL:\ONO-;("::
MZ&3S4#7G'6LJ:^YZU UT6[U0R]<7?O5"6?<U,9RU1-UIB%8EJ%4TE31T "QU
M*L)/:IX(]V.*T[6PW8XI 9J6I*]*AN+4KVKK8=)^7I4-YI/'2H; XLQ'=5NW
MM=W:M"332K=*LVUMM[5G("O#;E,5IVMP8N])Y/%1^4<]*YI =!8:HW'-;=OJ
M!8#FN2L8FW"NALX6VBA :,ET6'6J4C%JL-":@9=IJ@&I#NJ7[. O2EC8<4LT
MH53S6B R=2C&TUQ^I1@L:Z?5+H8/-<AJ5V-QYK5 4&C&344D(-127HW=:9]L
M![UJ@(+FU#9K*N;(<\5MM,&6J=QALUH@.>GMPN>*S+I>HK=NUZUC72]:U3 P
M+R+<35+R3NZ5L31Y)J$P>U6 VT8QXKH=,U#8PYK!6(BK5JK!J: ]$TS5!@<U
MMK?!DZUP.G2.,5T%O,VT5IRC+]Y('S7.ZA'NS6M)(<&LJ\?K1RB,*XCZU1D&
MVM&Z<<UFS.*S:$1,U1-\U#O31(,UDQBB M5RTL_F'%1PN":U;-ER*SL(O6=I
MTXJVUL-M.M2,"K+D;:5AF'=0XS61<C&:Z"\Q@UAW2\FJL*Y4B;#5NZ;+TK$6
M/YJUM/0Y%"&=78R!L5NV>#BN:L0>*Z"SSQ5"L;ENH-:-M"&(XK*MGK7LY!N'
M-*XS9L;4<<5O6]N%2LBQ<<5K"X"IUI 5]0(6-JX#Q%<;=W-=7K&H (W-><^(
M+_=NYJ1G(:Y<'<W-<E<SG<>:W=6FWL:YR;[QJT(16+'K5F.U,G:H+<?-6[8Q
MJV,T6 S&TL^E1BS,;#BNI\E=M9UY$%SBBP%."3;@5=C_ 'E9P^_6OIL7F,*9
M)8M;(MSBM6#3S@<5H:;IX91Q6_;Z7D#BD4<RNGGTIKV/M77?V6/2JUQINW/%
M%K"./FMMN>*I3)MKI;VUVYXK!O(\&F,H@_-4T;578[2:?'(*1++6":BD4TY9
M!2,U6*Q5?Y:C:3%/FJE,^,U2+B3//59YJ@:;K41DR:T++/VC%-:\*CK59F)%
M02YYI@Q]U?=>:R;B[+=Z=<YP:SI6(J6S-CIIBW>L^9C4DDO6JLLF:S,&-\PB
MGB9J@4%C5R"W+]JS9<2,,[5/!;NU:5IIA;'%;MCHF<?+4,ZX&;I5BY=>.]>G
M^$K-E9.*R-+T,!E^6N_\.Z;Y;+Q7/5V/2H[GIG@V/:J5ZGI?^K%><>%XMNRO
M2--_U8KY;$[GT-'8N3-Q56+_ %OXU9FZ56B_UOXUQ'4=IX9/S+7J6BM^[%>5
M^&S\R_6O4=%;]VM==,^8QRU-]>@I::OW13JW/#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!*;3Z2@ 6EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *1J6B@!E/I*6@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3/F\=N;\?W13J:GW13JW/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M34-0+ \U3EO-S'FJ5Q-N%78#-U*Z+9YK%W$R5H7K=:S-WS4P.AT@_,*ZZSD
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M/F,=N;"_=%+24M;GAA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN_T72?E7Y:DTW01&P^6NLT[3Q&HXI7 KQ:6/+'RUGZAI8V'Y:[!855>E4+R
M-GBE>P(\NU;2SEN*YVXTL[NE>IWNFB0GBLUO#OF?PTV]!,\^M=)9FZ5TFEZ
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M'UKF.E;'>>%1EEKU71U_="O+_"*99*]7TU-L KLIGR>/?O%VBBBMCQPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/W5Z%SYQ%Q9*E62J2M4\;5+*+T;=*MQM6?$U6XVJ'% 6Z:>*9YG%,>;WK%Q
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M'\R5ZA:_ZE:[(;'R..^,FHHHK0\L**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M58$35!(:ED;K5:5CS3$0S,.:HS/UJ:>2J$TM R"X<5G32[<U/<25F74O6M$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-(W9^6KYA'EU_I).>*P+S1^3\M>LWFB9_AK$N]#Z_+5J0'ETNCG/W:KMH_\
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M84444S,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME66IL,OK/M-7;6\YZUAF;WJ6WN/FJ7$#L;.^Z<UHQWGR]:Y2TN#ZUIPW!I6
MVVNZ<MU6-]H-*MT<]:+ ;L=QGO5A9-U84-UTYJ]#<>] &@5#5!+;[NU/CDS5
MA5W4@,>2S]J@^Q^U;YM]W:F-:>U2!D1VQ%6XH2*M_9?:I%M]N*JX%?R^*IW4
M&X5K^54,L.15<PCEKJSSGBJ#6/S=*ZJ:UZ\56-E[5/,48L%F1VK4M;;:.E6H
MK.KL-K3Y@*T=OD=*E6W/I5^.W]JE6W]JEB*"0^U68X/:K'D^U2I'C%3<!D=O
MTJ=+?VJ6-:LQP[JS; KI!5B.W]JL1V_M5B.'VK-@5T@]JL1P5.L/2IECQ4W
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M..:T+>['K4V Z:WFZ5H0R5SUO=#CFM.WN : -R/#"IO+!JE;3 XJ_&V[%9M
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MI-U)2X-40-:FYJ3;[4QEI ,9J;3V7BDVT -I-U.VFF[:!V -3U:FJO/2GJM
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYM5G'1&YX=UFYU:X7YF.37N/@[PK+>1(S*3FO#_AN88;B,R$5]6^!]7L8;1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *0]#2T4 8&M6(F5N*\U\0:;Y;,<5[%<0B13Q
M7#^*-/RK$"LIQT/4PE9QE8\ANE\MS38^U:&K6I20\=ZSU&VN2Q]9&7-$>U02
M+NJ7-!&:%[H2CS+4I.E(&VFK$BU5DXKW,/4TL?*XVC9W1.LU/\S=6?YA#5/'
M)7>>1MH3-UJ2,U%G-2+0,M+)BIEF]ZI[J56I\I1H1S5;CDK,A;-7(VXK-Q)+
MZRTOG50:;;437H7O2Y2C8A8-6C;KTKG;>^7=UK9M;Y2.M9N(K&JJXJQ$W2L]
M;I3WJ>*;I4 :\+=*NPM67;R5>C:H:$:<;U,KUGI(:GCDK-H$7E;I4RFJL3=*
MM1BH&QXIVZC:*;FD(3.<59C;]V:I[JE63"XH8T<CXRC+0R8]*^1/C5IDTT<^
MU37VCK-G]JC88S7D?C3X<_VL'_=YS[5W86JH/4\?'495HV1^<9\/W7]LYV-]
M[T]Z^OOV==/EM_(W CI5W_A0G^F>9Y'?TKUOX>^ ?["V?N]N*]3%8J,X61XF
M!P$Z-7F9[=H[_P#$OB'M4.I6"WBL",TRSD\JW5?:K4,PYS7SG6Y]IHT>#_%?
MP.D]O*5C['M7PG\8O!$\4T^R,]?2OU(\3:6FI0,-N<BOG[QY\&UUAY"(<Y]J
M]?"8GV;U/F<RP/MD^4_,32_"]XFJK\C<-Z5]G?L[Z;/;M;[E(Z5T,/[.'EW>
M_P"S]_2O7OA_\,/[#:/]UMQ[5Z6)QD:D+(\; Y;4HU.9GNGA6V$FCQ@CM7"_
M%#P>E];R83/'I7H>AXM;14/%-UN!+Z(J1GBOFHR<9W1]Q*FIPY6?GI\3OAZ\
M%Q*RQ^O:O)@UWH=P2H9<&OT%\:?#M-2WD19)]J\/\2_ UIG<K!^E?0T<5%JT
MCX[%9?-2YH'@UC\4+^T79YC#\:JZMX]OM34J68Y]Z])NO@+<"4XA/7TJWI_P
M'FWC,)_*NCVM%:G![#$OW6>6^&=/NM4O$+!CDU]3?"7PHT8B9E].U5O!_P &
M39.A:'&/:O<?"GAA=,1!LQBN#$XF,E9'MX# R@^:1TNG6(@L0N.U>:_$G0?M
MUM+\N<BO6MP6/;6)J^FK>1L"N<UY-.7+*Y]'5IJ<.4_/OXG> Y%GE=8SU]*\
M<EM[O1[@E0PP:_0OQE\-DU!7_=9_"O%?$GP-::1RL'Z5]%1Q<;6D?$XO+9\W
M- \1\*^.+Z JF]A7H"ZY=ZI:X)8\5IZ?\#IH9@?)/7TKT#0_A2\48!B_2BK5
MI[H*&&KVY9'S-XPT6YN'9MK&L3PUH%PM\I*GK7UYJ7P>^T+_ *G]*I:=\%_L
M\P;R?THCBX\MA/+:CG<A^$=A)"L6X&O9M<A+:2P_V:S_  GX,_LP+\F,5V-]
MI?G6A3':O(J5%*=SZK#T7"ERL^&OC1I,\UU+M4]:\T\&Z'<+J2DJW6OL_P 9
M_"_^UI&/E9R?2N;T?X,?9;D-Y..?2O6IXJ*A8^:K9=4G6YC0^%EF\<,.X&OH
M;P_\D*Y]*X/POX3_ +-C0;,8KOK)?)0"O%KR4WH?582FZ4;,N7J^<,5Q_B3P
MVEY;O\N<BNM,FYJ295D0@BN>+<3OE%36I\C_ !*^'N[S&6/]*^?];\.W&FW#
M%5(P?2OT"\3>&(]0C<;,UX]XF^$PNF<K#G\*]K#XJRLSY'&Y>Y/F@?*]KXDO
M=-X#,,5=E\<WTT>TNQ_&O6-4^"DA9L0G\JSH?@M-N ,)_*O0]M2>IX_U7$1T
M1Y$TEWJTW.XY->A>!?A_)>3QL\9//I7HGA_X+M'(I:']*]B\)?#U-/"$Q8Q[
M5S5L9%*T3LPV73E*\Q/AWX%2QAC;9CCTKMM<MOL]FR@=JWM+M8[2$ #%5M8M
M_M$; #->%*IS2NS["%%4Z=D?)?Q@L9;@3;0:^:Y]#N?[4SM/WO2OO7Q9X#_M
M3=^[SGVKSF3X*[KK?Y/?TKVJ&*C"-F?)8S+ZE6I=&)\"["6&2'<#VK[7\*MM
MTM!_LUX5X'\!_P!CLG[O;CVKVC2[C[-;!/:O*Q=15)71]/EM)T(69Q_Q00R0
M/CTKXS^*6ES27$N%/6ON#Q-9_P!H(PQFO'/$_P ,_P"T9&/E9S[5OA*JI[G%
MF.'E7V/COP_HMPNI*=IZU]9_".VDCMXPP(XK.L/@[Y-P'\GOZ5ZIX1\*_P!E
MJHVXQ75B<1&HK(\_ 8*=&5V1>,]&-]IKC&3MKY&^)'@J1+J1PAZYZ5]VWFGK
M<6Q0CM7EOB[X=KJ!<^7G/M7/AJWLV=^/P?MHW1\/V_VG1YN 1@UV6@_$*\M\
M)O:O5-<^#+2LQ6']*Q+7X*S)-GRCU]*]=UJ<UJ?,1PF(I2]TI_\ "476JVY!
M+'(KSKQCH]Q=%FVFOHC0_A1)$H!B/Y5IWWPA^T1\P_I7-&O"G+0[)X.K6C[Q
M\F>%M%N8;Y3M;K7U1\,O-AAB!!Z"FV/P9^SSAO)[^E>D>&_!9T]5&S&*G$8B
M-1:'3@<#.B[LA\1*\VGL.O%?*_Q2TF>6ZD(4]:^T;S0?.M]NW/%>9^*/A?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI0C53MK>$;GBXS$<JL;&EVHBA'&*T*9&FQ0*?72?,R=W<****9(C=*;3J-M
M O2EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $(H%+10 54U"
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MHHHJSD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/UK2CAG/4RQ681I:'T'>>/8%D/[T?G4UCX[@=Q^\'YU\@3?$>YFD)#M4UO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>I-KV=D?/45+VUV?9'@-O^);'_NUSOQ2C+6<F!VK;\ R$V<:^U/\>:6;JS?
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MJA5P*=116AYP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M](;C/>J M-)[U"TE0--UYJ,S<4 3LU02-Q3?-J)Y,B@""=ZSYI*MSG-9\U-
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MQ$JC$50HP!3J**LX@HHHH *3=2TR@!V:6FK3J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*Q\Y5JRJ,0# Q2T451SA1110 4444 %%%% !112-0 M%,S3Z "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I&I:0T -I]-VTZ@ I":6FL*  -3J:!3J
M"BBB@ IDD8D4@BGT4 8&I:,MPI^6N-UCPQU(3]*]0(!ZBJ5]8I,AXJ'&YVTL
M1*FSPO4=(:!C\M8<T+*QXKV/5_#PDR0M<=J/APQY.VN>43Z&ABU):G% &I%]
MZNWFGM"?NUG.2IK'8])-25T34,H-0JQJ4&A#*MQ;!L\5FSZ=N[5N;0::T8-:
M1J.)A.A&IN<I<:?MSQ69/ 4[5VD]J&!XK+N--W=J[Z>([GCU\%_*<H^X4@8U
MMS:6?2J4EB8^U=\:J9XT\/.)!&QJPAJNRE#2"8K[5MN<S]TN[L4JR8-4_/H,
MWO0!I+-Q0TE9WVCWJ19MU $[24BL:1%W5.L-6 BR&FRW6T=:=,NU36-J%SY>
M>:H!]YJ6T'FN<U#5^OS52U34RN[FN6OM49F/-(#5O-5+$\U#;:@6<<US[7+2
M5>T]69A181W>EW195YK:.9(ZY_183\M=;:VNY!4V&<]>6!DSQ6+=:6>>*]";
M3@R]*H7&E#GBA <#_9Y4]*L6]F<]*Z:32L=J(M-VMTH HVFGEL<5KV^E].*O
M65B..*VK>S7;THL!@?V;M[4?9=O:NCDM1S51[;YJ=@,V&U.X5H6]KMQ5B&W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 W;2@8I
M:* $)I-U*U)M- #J;MIU% #?NT!J&ZTE #Z*3=2T %%%% !112&@!:*;S2T
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M78SRE':G8 I:*!!1110 W=2BEHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!,TM)BC% "T444 %%%% !1110 4444 )@>E&T>
ME+10 FT>E&T>E+10 FT>E&T>E+10 E+110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -(H44ZB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***;NH =12"EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2FT^B@!%I:** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FM
M1DT?>H %ZTZDVTM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %-;K3J3;0 B]:=2;:6@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!":-U(U"]: '4444 -P:5:6B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHI,T +129I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHIK,%ZT .HJ%KN)>K5'_ &E;C^.@"U153^T[?_GH*7^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
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MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
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MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
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MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
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MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
MYZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_
M &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*
M/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E
M %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I
M6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^T
MK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:
MHJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_
M ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_
M .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J
M_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/
M2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#G
MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
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MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
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MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;
M_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M
M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JB
MJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\
MSTH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\
MYZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_
M &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*
M/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E
M %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I
M6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^T
MK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:
MHJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_
M ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_
M .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J
M_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/
M2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#G
MI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_M*W_ .>E %JBJO\
M:5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4 6J*J_P!I6_\ STH_
MM*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:HJK_ &E;_P#/2C^TK?\ YZ4
M6J*J_P!I6_\ STH_M*W_ .>E %JBJO\ :5O_ ,]*/[2M_P#GI0!:I*J_VI;_
M -^C^U+?_GI0!:I:J?VG;_\ /05(MY%)T;- $]%(K!N12T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %9VK7/V>,G.*T:P/%#%8#CTH
MXG7_ !:;-F^?%<9=_$@QL?WOZUE>.KJ1&DPU>0ZIJ$WF'YJ"CV?_ (6<=W^M
M_6G?\+./_/7]:\ _M&?=]ZI1J,W]Z@#WK_A9Q_YZ_K1_PLX_\]?UKP7^TIO[
MU']I3?WJ L>]?\+./_/7]:/^%G'_ )Z_K7@O]I3?WJ/[2F_O4!8]Z_X6<?\
MGK^M'_"SC_SU_6O!?[2F_O4?VE-_>H"Q[U_PLX_\]?UH_P"%G'_GK^M>"_VE
M-_>H_M*;^]0%CWK_ (6<?^>OZT?\+./_ #U_6O!?[2F_O4?VE-_>H"Q[U_PL
MX_\ /7]:/^%G'_GK^M>"_P!I3?WJ/[2F_O4!8]Z_X6<?^>OZT?\ "SC_ ,]?
MUKP7^TIO[U']I3?WJ L>]?\ "SC_ ,]?UH_X6<?^>OZUX+_:4W]ZC^TIO[U
M6/>O^%G'_GK^M'_"SC_SU_6O!?[2F_O4?VE-_>H"Q[U_PLX_\]?UH_X6<?\
MGK^M>"_VE-_>H_M*;^]0%CWK_A9Q_P">OZT?\+./_/7]:\%_M*;^]1_:4W]Z
M@+'O7_"SC_SU_6C_ (6<?^>OZUX+_:4W]ZC^TIO[U 6/>O\ A9Q_YZ_K1_PL
MX_\ /7]:\%_M*;^]1_:4W]Z@+'O7_"SC_P ]?UH_X6<?^>OZUX+_ &E-_>H_
MM*;^]0%CWK_A9Q_YZ_K1_P +./\ SU_6O!?[2F_O4?VE-_>H"Q[U_P +./\
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M_"SC_P ]?UH_X6<?^>OZUX+_ &E-_>H_M*;^]0%CWK_A9Q_YZ_K1_P +./\
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M3?WJ/[2F_O4!8]Z_X6<?^>OZT?\ "SC_ ,]?UKP7^TIO[U']I3?WJ L>]?\
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MK^M'_"SC_P ]?UKP7^TIO[U']I3?WJ L>]?\+./_ #U_6C_A9Q_YZ_K7@O\
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MH"Q[U_PLX_\ /7]:/^%G'_GK^M>"_P!I3?WJ/[2F_O4!8]Z_X6<?^>OZT?\
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MM*;^]1_:4W]Z@+'O7_"SC_SU_6C_ (6<?^>OZUX+_:4W]ZC^TIO[U 6/>O\
MA9Q_YZ_K1_PLX_\ /7]:\%_M*;^]1_:4W]Z@+'O7_"SC_P ]?UH_X6<?^>OZ
MUX+_ &E-_>H_M*;^]0%CWK_A9Q_YZ_K1_P +./\ SU_6O!?[2F_O4?VE-_>H
M"Q[U_P +./\ SU_6C_A9Q_YZ_K7@O]I3?WJ/[2F_O4!8]Z_X6<?^>OZT?\+.
M/_/7]:\%_M*;^]1_:4W]Z@+'O7_"SC_SU_6C_A9Q_P">OZUX+_:4W]ZC^TIO
M[U 6/>O^%G'_ )Z_K1_PLX_\]?UKP7^TIO[U']I3?WJ L>]?\+./_/7]:/\
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M_M*;^]0%CWK_ (6<?^>OZT?\+./_ #U_6O!?[2F_O4?VE-_>H"Q[U_PLX_\
M/7]:/^%G'_GK^M>"_P!I3?WJ/[2F_O4!8]Z_X6<?^>OZT?\ "SC_ ,]?UKP7
M^TIO[U']I3?WJ L>]?\ "SC_ ,]?UH_X6<?^>OZUX+_:4W]ZC^TIO[U 6/>O
M^%G'_GK^M'_"SC_SU_6O!?[2F_O4?VE-_>H"Q[U_PLX_\]?UH_X6<?\ GK^M
M>"_VE-_>H_M*;^]0%CWK_A9Q_P">OZT?\+./_/7]:\%_M*;^]1_:4W]Z@+'O
M7_"SC_SU_6C_ (6<?^>OZUX+_:4W]ZC^TIO[U 6/>O\ A9Q_YZ_K1_PLX_\
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MOZUX+_:4W]ZC^TIO[U 6/>O^%G'_ )Z_K1_PLX_\]?UKP7^TIO[U']I3?WJ
ML>]?\+./_/7]:/\ A9Q_YZ_K7@O]I3?WJ/[2F_O4!8]Z_P"%G'_GK^M'_"SC
M_P ]?UKP7^TIO[U']I3?WJ L>]?\+./_ #U_6C_A9Q_YZ_K7@O\ :4W]ZC^T
MIO[U 6/>O^%G'_GK^M'_  LX_P#/7]:\%_M*;^]1_:4W]Z@+'O7_  LX_P#/
M7]:/^%G'_GK^M>"_VE-_>H_M*;^]0%CWK_A9Q_YZ_K1_PLX_\]?UKP7^TIO[
MU']I3?WJ L>]?\+./_/7]:/^%G'_ )Z_K7@O]I3?WJ/[2F_O4!8]Z_X6:?\
MGK2?\+./_/7]:\&_M*;^]3?[1F_O4 >^1_$XE\>;^M=CX9\:&^D4;\Y]Z^48
H-1F\X?-7K?PYO)'FCRU!)]3Z3/\ :+4-G-7:Q_"[%M-7/M6Q0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img109617586_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_2.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" QD%Y,# 2(  A$! Q$!_\0
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MTW=2[J+@+13=QIU*X#EI&I,TFZG<!K=ZB>I6Z5!(:5P(F(I%;%1R-4>[WIW
MLL:%ZU$K9J=%I7 <M2K356I-M%P%7I1111<!&IC=:>U,:BX+4CI5HI5%%QMC
MEZT[-1]#1NIW FS146[WI=U%Q#VIC4;J-U*X"44HZTZBXF0M4>#NJ9EI-M%Q
M(1>U2Y%1]*3=[T[E$AI*;NHW4K@*U,:AC2"JY@"G4F!29J;@2TC4@:@G-4F
ME%%-+<4-@%%)NI:FX"K2TS- :G<!]%-S2[J %I&HW4UFYHN M%-W4;J+@.HI
MNZEJ6 M%%*M0#$IK=:DIIH$1MTJM(U69.,U0F>J&*IYJ0-MJNC9ISMQ0!(T@
MJ+.35=I3NJ6,YI@3QU)4.[%/4YI, J:.F;:4'!I(1<1O>AJ@5Z?NJQB&@4A;
MFF;J+D]2PM/J!6J56IW*%:HV[U(33:+@1TII6%,+5+8"-24A:BIN(#3&2IE7
M-.V4QE=5Q4Z4FSVIP% A]+3*1FIDL?FFTQFI-U)A$F6INU55:IBV%HBS5D%V
M^%KGM0;.:U;^;:#7/W4V[O7; YILQ;YNM<-XLF"V[UVFI2!58UYIXROML+\]
MJ].E"YQ2G8\5\83!KA_K65H W7"_6I/$UP9+EOK3_"\):X6MI4S+VAZ[X6A.
MQ*]*T>,A5KB_"=IF-.*]$TVWVJ*P< ]H:<*X45.S?+4:_+3)9@!4\HE(BNI.
M*P[R3K5V[NASS6+=7&<UM&!E.=BG<&J;+4\C;C3=M7[,P]H0;336%6&2HV7V
MI>S+]H5W7K1&N*D9:<B<]*KD)]H2QK1(M2QK2R+Q1[,7M#.E7%5]W-7+A>M9
M\K8:G[,M5"Q&]64D&*REFJQ'-3]F#J%TFBHE?-2;J3ID>T%HH%.I>S#V@T]*
MBDJ<]*ADIJ _:%.2H&JS)4++1[,KVA'3Z3;33Q2]F5[0=N%1LU-9L4S=5J)#
MF3*U3QL*I*U3*_2JY0]J70U(W-0J]3+S1RB]H,9: M3[*0QTN47M!J"K$8Z5
M'&M6$%0X"YQRT-1FFLU3[,.<!3JCW4Y6S1R![0D7K4ZFJZ]JDW>]'('M"1FI
ME-9Z531[,/:$JU,O:H5Q4@:CV8>T)&-5Y33FDJO))2]F'M"-J:M*3FA:OD'[
M0D%!I%-.H4 ]H-:F-3VJ-N]58?M!M% IZK4\A7M156I%%*J4_;Q1R"]J-IRK
MFDQ4D=3[,.<!'3)(SS5U4&*BG4 4<@<YE3< U3<_-5^X7K6;+]ZG[,I5">&0
M+6A#,,5B+)MJU#<=*7LP<S79\U#(>M11R9I[<U7()3('&<TQ5]JL>7FE6/FG
MR%>T&H*F6D$=. Q1R"YR>-JDS4*FG[J.0GG)*=4*T^I]F',/+4TM36J,L:7L
MPYB=6J3=516-2!Z/9BYBPII6Z5"IIQ-'(5SD,QZU":ED&<TP+1R%JH1,I-1-
M&>:N^72-#3Y ]H4=F*>M3-'BHF&*.0?M"16Q4J2"J#2;:;Y]+V8N<UA(*3=5
M".>ITDS2]F+VA/N]Z&;CK4>ZFL]-0*]H)(:KNIJ4MFDQFCV8O:%1UJ CFK\D
M=5)%P:?(/V@^&M&W:LV+K5Z$T<@>T+F[Y:C9A3=W%1,U+V9/M"<,*1G]Z@W4
MUI#4^S$YCV:HV84QGINZK]GH5&8I:FAA3349)%9\AKS%V*2M"WDZ<UBQMTJ]
M;RT<@N8W(Y*FWUF1S5/]HJ' .<MLU1-48FSWHWU7LQ^T%:H9*DSFHWI<H*H5
M)159EJY(M0M'3Y1<Q$B_-5B.HPE2QTN4.8M1U,W2J\;5+N^6IY YB.0TU#S1
M(U,5N:I1#G-&W/2KL9K-MY.16C"U/E#G)14BTU:?1RASBXI&6G4N*.0GG(=E
M,D3K5H*/2D9!1R%<YDW"=:H2+AJV;A!S69<*,FCD#G*=(U#4E'(/F$6K$?:H
M4%3K1RBYQ)*K259<\5 PR:GD#G(E7FK$:4U$JU''[57*'.-5*D5>E3+&*"H%
M'('.(IQ3C)[U#(VVH&F-)Q#G+#2"H6:HBYI%:HY"^<E%6H%Y%58UR:T+>/I1
MRASEJ%>!5@=*;&G%/VT<I?,1M5=S5B2JTE'*+VA&3S2K3=U*IHY0]H/7-.YH
M6GXHY1<XVBE:DJ7 KF"CGK13@*7(-3'+4JTQ:D7%1RFEQ::U24C"BP7*DW>J
MU79%JL5YI\HKC[?K6A%]VJ,-7H^E'*.Y(U5I),=ZDF;K6=<3[3UJ>47,6Q,*
ML12#BL1;KGK5J&ZZ<U7*',;2O2[ZH)<\4_[12Y1\Q/(V:K24K39IC-FCE#F(
MVZU(E- J1%]:?*+F'TAIU,;O2Y1W%W4E1M)CO0)*7*%RPM,D/6F>94<CT[!S
M#9#UH2H6;FGQFCE%S%N.IUZ5!&W2IMW%*P[DBT\OQ4&^F-+5<H7)V>F[ZK-+
M2>=0HC6I:9A5:9J:TU5IIJT4")2Y0=J16JNTO-/5JVY3+VA86D:,M48?;2_;
M4CZFLI:"Y7,9) :A\EJDDUB!>K"H?[8@/<5AS:FRPLFKV)XXR,5,K;:IKJ<3
M="*/M8;H:WB[GGU*;IO4N%JDCJG')G%6HY!71;0VH5-;%KM52Y;K4S3#%4;J
M;K6/*>LY>Z4;EZSY)*FNIJS9)33C3/,J2U)V>G*]43(:59C6WLS'G--7J3?6
M:LWO4HF]Z/9ASEQGJ-I!59IZB::ER"]H7ED%6891Q6-Y]68)SQ6-2!T4YG00
M/N%7H^:Q[27.*V+<@XKGY3?F'^73?*-6U44;!1RASE;RZ:RX-6F05"ZT6#G(
M6IK=*<U-JU$.8;12&F$U?*.Y-D4FZF*U!:GRCYA6-1,:&:HV:ERD<PC4E)2B
MCE(<[$BDTZF"ES1RD>T'&F$XI"U1LQI\@<Y*C5<MY *RO,([U+'/M;K5<@N<
MZ.WG&*L^8"O%8$-UC'-:$%QN[UP5(ZFL9V0^[&Y37.:E"3FNF;YEK,O;<-GB
MNFC Y9RNSSW6;8[6XKRWQ+I[-(>.]>X:II^Y6XKA-<T/?GY:WK4_=-:.YQGA
M,_8[I">.:^DO /B2*.%%+#I7SA=6[:?(2.,&M[PQXP>UF52^!7YGFM&5V['U
M.%FK'U7?7RWEOA3GBO'?'VBR7"R$+ZUTOA/Q0M_&H9LUTFJ:3%J-J2!G(KY>
MG4=-ZGHNUCXN\6:')#,Y*FN3C_T>3GUKZ2\?>"2%D94KP'Q)HLMG.WRD5ZD:
MUT3%&CI=^H51FN@M;D/C%>;VMT]NV":Z?2]4&!DUG.L="B=I;RUI6\PKEX-0
M!'6M&WO/>N.5<I0.GBF'%6HI17/PWG2KL5U7+*M<ITKF]')4PDK'BNJG6Y]Z
MCV@O8FCYE-:053%Q09N*3J$^S)))!Z54D<<TLDAJI-)2]H5[$;<.-IKF-8^9
M6K<N)N*PM0;<IKLIXCE)E2.$UJ$LQKGVMR'KL=2@#,:QI+49KT*>)YF<_L]3
M?\#_ "W4?UKZ?\!M_HB?2OF7PA"5ND^M?2O@7*VB?2NC$5K0+Y-#5\628M6^
ME>&>() ;AOK7LGC.XVVS\]J\,UJXWW1'O7%EU7GK)'FUXZ%C3/O#ZUVFD_=6
MN,TE=V#7::7\JBOV?"Q_=(^6KRLS9YVU"ZU,IRM(RYKHL<G.5=M&VI_+H:.E
M8?.4WZ57=:NR1U6GPJYJN4.;H1-,(T-<;XHU1(U;FM76-66WC;G%>2>,O$N=
MX#5E6J*,3OP^!G6=TCH]'\011WB_-WKZ"^'/B6)DC&X5\.P>)GBN@=W>O9_A
MMX\96C!?]:_-\TK:NQ];0P,H1U1]I7%^MU9$ YR*\0^)FCO<)*0,UVOA/Q$-
M0MT&[.16IK^@+J%HQVYR*^)]O[Q52/+H?$OB+27M;IB1CFJ5G=K%P:]<^)7A
M,VS2,%KPK46>TNF7WKVJ5:\1TXW9WNGW(DQ@UMPR=*X70M0R!DUU5O=!L<UR
M5JFIW*F=%;29K3@;I7/VL_3FM:WFKC]H5[,V(FJ=6K/BEJ=9*F50/9EB1LBL
MK4$+1FM MFH+B/<N*='$>SDF3.G='E/BZQ:0/Q7EFH:2_G$X[U[_ *UI?GAN
M*XB_\-C>3MK]5RCB2&'BHMGS>(P[;/.(=.94QBI;.Q9+@''>NU_L';_#43:/
MY9SBO0QO$4*\6DS.G0:.T^'5ZMK)&"<=*^G_  3K*26R 'M7QOINI'3[A><<
MU[E\-?%GF-&I;TK\KS"I[>3:.Z%-GM/B:V-Y:MCGBO /&FAND[G'>OI72U34
MK,=\BN$\?>%1Y3L%KS<+'EJIG1*G[C/GBUD%I)@\<UT=M?K)'@&N9\4PM87+
M8&,&J^B:DSN%)K]MRJHO9)'P.-O"H7_$L)EB8BO)M?MS',Q(KVRZ@%Q;GZ5Y
MKXMTDKO(%=6+I<T3['(,<H329P<=TL38)JZM\K*1FN=U))(9FXI+.X<\&OS3
M'47&9_2.5XJG.DM32NGR^?>MCP[?K!,F3CFL%U+#-5A<O;R C-<=.G)K8\K.
MZT.1V9]:?"_Q!'F(;J^BM%NA=6J[3VKX7^&?B22.XC!8U]?_  ZUM;JVC!;L
M*XL12E'4_%L1-2J,;X^L&:WD.*^8/'D!AF>OLOQ3IZW5BQ SQ7RK\5=%:%Y"
M!7%2J6=ATXW/(;:8?:,>]=MH\P6->:\\#&WO#NXYKJ+/55CB'/:O6]BZRT.G
M2!W=M?JO&:U[6[$G>O,X]:^<8-=%I.LAL9->?6RVIO8CZS':YZ#:R#BM&%LU
MS5AJ <#FMJWFW=ZY.5TE9FB7M-36C:K4;5G0R=*MQO7)*9?LR^C5('XJDLE2
MK)6?M!<A9W4!O>HMU(&K:-07(6-U,:F[J"U/V@^0BDJK)5B0U6DJE4*Y"G<5
ME7/>M6<9K-N%ZUI[0/9F+=#K6'?+\IKH+I*Q;Z/Y36D*W*1*F<1JO$QKLOAW
M=".ZCY[UR&L1GS#6AX3OC:W"'..:]6GB>96(]F?:7@+4E:UC&>PJWXT;SK-L
M>E>9?#WQ0/+C7=Z5Z+J%P+^S..<BN:4[3N<M2EH?+7Q*LS]HE..]<#H:^5>#
MZU[=\1M!9VD;;7C[69L[HD\<U^B9-BXV2/G<5&QZKX9N@L""NNM;@-BO+=!U
M0(JC-=UI-YYFWFOLIP]HKH^8F_>.F9MRUEWRYS6A$VY15>ZBW*:QC3Y3NIO0
MYNX0Y-4I.*V+J#K69,FVM_9W%.=BIC)JK>1G8?I5Y5YIEW&/+-1*D9PJJYQ&
MI_+(:BLVJ?6D*N:I635C[,]_#3YC-\4QE[=OI7C.N6Y6X/UKW76H/.@/TKRC
MQ+INV1CBCDT/H(4[HYVTD$:U(MP#*.:S+B;R,C-5[>[+S#GO7.Z9LJ9ZSX/F
M&5KT;=YEM^%>1>%+SRV7FO3].O!-"!GM3C ' Q]43$A-)IEP(Y!GUJ[JT.5)
MKFVN3!-70H&$X'K/AZ\5E7FN[LI@T8KQOPSJF649KTW2KW=&.:TY3D<3;F;<
MIK+NAUJ^&WK5.X7K6D= Y#(FJG(U7[I<5F3-C-;)7#D&,U*K5 S<TY6JK%1B
M6MU(6J(,<49-0;\NA*I%/#"JX:EWF@.4GW4S?4#24SS.:">4L[OFILK96H0Q
MS2DYHL'*9FI+\C5YQXH7&ZO3KR/=&:\Z\66YVO6D(W9#B>7WC#SC]:LV;C;5
M/4D*S'ZTEO/M6O0C0N<DH&S'.%85UF@Z@JE>:\Z>\PW%:6FZL8V'-7+#,A(]
MKL]25HQS4S7 :O/--\0\#YJW;?7%8#+5R2H-,WB=-YE*TX45@_VTG]ZH;G7$
M"GYJGV39J:%]?!0>:YV\U9%SS6;JVOCG#5Q>J>(3N.&K:&'9DSJ+_64PWS5R
M6L:BLBMS7/7GB!V)^:LV35&E[UO]6;)&ZDWF,<5F+&=W2KK-YE C K2GA6F%
MKA%E15A9 ,569@M1F0D\5U^Q(Y31$X]:<+@&LL;VZ5-$KY[UG[(.4TT;<*<;
M<OCBF6BG(S6Y9VH?'%')87*5M-@,3C-=WH-\L>T$US3VOEKD"FPWK0R"LW3Y
MC6&C/8--U!748-;4,P91S7F.AZP3@$UVECJ =1S7G5*5F=T%<Z!9*9(]5DG^
M7K0TE<;@=*B5KSH:P;SBMRX;*US^IR!0:UA3,I1,V>X"=361?7RD'FH-5U#R
MV;FN;N=2+,1FO0IX>YP5$3W\@DSBLEH2S5:60R5,D(-='L;'.D06\97%6P:0
MJ%IC-3C18^4F+<57EC+4Y6JW!&'K3V=A<IDM:MG-6K3]VPK5-D&7@52FMC&W
M2L)PYBXHWM*N ,5U=C<# YKSVSN#$PS73:;J'09KD=([(*YV4,@XJPLE8UK<
M;@.:MK-6?+8[% TA)36DJE]H(I&N:7()P)I7X-9&H2?*:MR70P>:Q-2NP >:
MI4[G/)6,;4IOO5SUU,-QJYJEZ,MS7/7%WN8\UV0P]SDD66N!ZU!),&[U0:X.
M[K3D8M74L/8Q+<?)JY&,J.]4H5-7X*AT36.HUH"W04Z.Q8XXK3MX0V,UJ6]F
MAQ7+*F68D5FP[5IV:^5C-:8L5V\56N("G2L?9DFK8:@L>,FMVWU=-HYKSJ6X
MDA)IUOK#JW)J?87-(GI1O%D'!IOF9KE;'5M^,FMF&\# <U#H,U2->%JO1-TK
M'AFS5V*6DH6*Y31#BE9ZJ"6D:6AQN5RDDTGRUC:@_!J_)+Q6+J4V%-3&EJ92
M@<[JL@YKF;F3YJU=6NN6KG9I]SUWPHG),GW9K-OJNQMD52OA6CHDQ1'8C]Z*
M[S05.U:X;3E_>BO0-"7"K7+*C8[(HZVQ^516DK<5E6\@515HW "]:P]F=2C<
MM&8"H9+D"J$UYCO5&:^//-7&F#B:LEP/6JDDPK/:[)IOV@U3I7.62L6)&ZU3
MF[T\S>]5[BX 4\U*HLQ;*EQ)MK&OKP 'FIM2O0H/-<IJ&H$L>:WCAR&69KI2
MW6G0W(K!-PS-UJ2.=JT6'9%C8N)@PZU55OFJ%9&;%2(IK18<EHOP-4DGS"JT
M;;:G5LU7L+$J)5:$[A6IIS>7UJ':N*:TWE]*/9'1&)LS7:^7C-94CAVJHUTS
M'%3VL;2-TH]G8OE-"RCZ5L0C"U5L;8X'%:#)L6N>4-3>,;$$S[:9'(,U7NYM
MM5$O &ZU2I%LVFD^6LC4)*F:\&WK61?78;O5*D9V,ZZ;YJIEJEGF#$\U3DF&
M>M:JB9\H7$E%FV)!52:7=WI;:3:PK3V!FT=[HLPPM=3;S?**X#2;X+MYKJ;&
M]#*.:YYTK'1 Z)9,T_=5"&;*U.KURN!UQ18W4NZJ^XTH8TU&PG$L;LU'(U,\
MPTQWHL"B1R-UJA<R?*:LS28K(OKG:#6D87(E$J7DPYK)D?+4MW>?,:IB;<>M
M=*I&#1>B;;3;B48JN)MHJO<3'FG[$Q9+',/,K;L)AQ7+1LQ:MFR9N*B5 TBC
MI$F%.^T"LM6;%->1A62HE6-1KH8ZUAZLWF*<4YKAJK3,9,YK3V1G*)QFK6Y9
MR<5EJOEMS787UF'!.*YV]M"A/%'LC%P9 LP%2>8&J@P96IRL:Z(T]#FE$N;L
MT8J%)!4JL*?LB>04*<U9AXQ4&X4]90M7&G8OD-6&7;3Y;@>M9)NPO>HVO-W>
MK<="DK%\N&:K]BO(K'MI-S"M[3\#%<52G<[:9O6/&*V(9?E%8<,P4"IUO@O>
ML?8G0D;!N .]5Y[Q:RIM2 [UFW6J=>:CV 2-"\NU8'FL*[D#9J*6],A(S38X
MVE-/V)RR14DB+9^M026C'M6]#I[-U%2-8!1R*:H'/)')R6K#M4?E%37075LJ
MYXK+G4+G%=$<.(@C.W%2B0559L4PRD4GAV(T4F%6(Y@U8C7!%6;6<LPJ'0$;
M4<1DJ_:Z:[,#BG:/;^<5KM=,TM=H)%0Z?*:110TG3VCQQ7:Z6WDJ,U4CM8X5
MZ5%-J"V^<'%0HW"QV-OJ2QKUJXNM(/XJ\SN/$?EY^:J,GBPC/SU?L2CUY=>C
M_O"I1KD;#[PKQ<>+SG[U6H?%Y_OTOJXN4]-U"\$ZG!KB->M3)NP*DL/$"W&,
MM6E)LN(ZS<.4VBCS"_L620\4VS;RV&:ZK6;!1D@5R%VQ@D-:PI\QLD=':W0V
M@5?CEKC[34OF S6W;WP9>M6Z-C>,3:\P4GF"J NLTY9JSY#7E-!)*F608K.6
M6I4FHY".0N;ZAE>F^9[U#-)UYI<@_9E*^D^4UR^HR#=6]?R_*>:Y349OF-:P
MI7,90&*V339A\M1V[;FJ:XX0FNATK(XY(J1MB2M[3YA@5S+2;7K5T^XSBL/8
MW,U&YT:MFKEN*SK4EL5JV\=2Z5CKC$E93MJLPVFKPCXJI=+MJ.0MQ+6G3!7%
M=AI\X:(<UYY!<%)*ZO2;S<@YIRI'.XES6FW*:Y"9L2UU6I-OC-<G>?+(:(4K
MD6-W2)AQ79:;)D+7G>EW&U@,UVVDS;E%<V(I&JB='NHJ%9.!17E^S*L?IU11
M17RQY04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4FZEIK=: #=1NJ-C2;J 'LU1-)2MS4+4"8_P S-/5JJ[JE
MC-,$6 U.IBT]12 ****8,*7=244"&,W2H]U/:HMU!0]>:D5:B0U,M(!<XIC-
M2L:BW4"%*YIM.S2;:!6%%(U*.*&H :JTZD6ER*"A#3=M+10 @%+113 ****9
M A-)NI6]:;2EL-"[J2@TQFK$H4M1N]ZA9J<II6$2&F5(!FFL*8QA:F;J5N]-
MHL ZD:E'2D9N* &,V*3=2-S0JT@)5.:DJ-5J2F C4VG-24 (>E0R+4U,9: *
M4B4SRZN-'FD\FD!#&E646A8ZE5>E "!:6EI*8!1110 C5$Q-2M43=: $IPI%
M'X4[% #&IHIS4T=: ' 4ZD6G;:1(TTA:E:F-0-#E:G[JA7K3P:90XT44UC03
MU!J;MI=PHS4C#H*0M2,W6HV;FF!+]ZG!?:F(U2;J &TA%+FFNV*8!NQ3#)4,
MDM1>;2 N>936?BJGG8I#-GO2N!/YE2H]4=U2I)BF(MGM0*C5\T_- "_C2Y%-
MHI"%+4QFI&:HF:F,DW4;JB#4[;0 _=3@U1;:>M R56IRFH=W%*'J0)BU,W<F
MF[J.YH$))TK.N,\UH2'BJDR;J8KD$6:E9=PIJKMIQDQ2&56C^:I$^6D9\TJT
M[C']:FC%,C3I5B-* %"\4F,5)MI-M #*7=1MI-M.X",W--#4C"A>M,DE5JF5
MJ@6D:3%!19WT!JJB2I%:D!,S5&U&ZD)IB&4H-'-&VI D5J>K5"*<M("2DW4V
MB@0^F-[4M)5Q(ZB;:-M+1FHD:Q!5-/D;"TQ6YI\OW:F#U+EL8.J3;<USTLV2
M:V-9;;FN;DD^8UZ=,\^HS.UJXVQM7CWC74.'&:].\27&R!^:\-\97^7<9KV*
M.B.%ZG ZEF:Y/?FNE\(V7[Y.*Y^%?/N/7FO0?"=C^\0XK24Q<IZEX5M]L:<5
MW5FH517+>'X=L:_2NIA;:M<LI!RCYI=HK,NKS;GFK%Y)P:Y^^F/-0GJ%AEU?
M=>:S9;C<3S5>XN#N/-5?.KIBSFFKF@C[JL+BLZ*2K4<U:<QCRDSXJ%N]2;MU
M,84<P^48%S4JK2*O2I*7,Q\HH;%(S\4UC43-5)D\I#<-P:S;@\FKTW.:IS+5
M<PTBIS4L;4QEH7BES#L7HY*G5ZSXVJS&U5<7*6A3ZA7I4BU#D/E',W%0R-4C
M56D:BY/*1NU,Q2,W6E5J?,/E%VTQUZU,*"N:JX[%%UIFTFKK0YS0MN<]*SYA
M\I36,U($([5:\CVH\FES"Y2)%-6HEJ((5J5&VT^8?*6XXZ<T7M3(Y.E2&2ES
M!R$>S%+G;0S>]0NU/F#D'-)BF&0U [T@S1S!R$V\U(K57'6ID%*X<A85J=N-
M-44N*JXN41C2JW2F,*05/,/E1962E,E0;C2,_O1S!R#VEJ,MFHF:D5N>M','
M(3"G"HU:GKS2Y@Y1<\T;J=MI/+-+F(Y1-U,:I-AIK+4\S%RC1UJ>(=*@4=:G
MC-5S%<I81:5A0K4,>*7,Q<I [;:(YL5',>M0>95<Q?*:J3#%))(&%9Z2FIU8
MM3YBDB*==U4)HZU6CW5#);YHYA6,9HS4D*FKC6_M2I!BCF"P^%:M*F:2&+%6
M46I<@Y2-8Z=Y=2TA:ES,.4C*TTK4FX4=:?,*PP#%.IVWVI57FCG'8%6G[30O
M6I@M4I&G*0-'43+5QEJ%UHYA\I7V^M/6G;:<JBES"Y07/%+3L<4UC3Y@Y1C"
MFT,U1-)S1S$\I8R*,BJWF4X,:.8?*/DQS562IVJ)T)HY@Y2E+GFH"35V2+VJ
M)H?:ES"Y1D;5:C>JK*5I/,*T^8?*:&^HGDJ!9LTC/0I!RDOF5*C51W$4])<4
M^8.4O-C;528#-/\ .XZU&[;J7,)1&I5R'M5)>#5N!O>CF#E+87(IC1U/'\U2
M&'/:CF'RE!EJ)AUK0>'VJK)$:.8.4K[:>L>:>L=6(XZ3D/E*Q@XJ%X>:UO)&
MWI4,D(]*SYBD9RQ'-6(U*U,(>>E/\K%%RK"*V!3O-I&7BHFI7)L65F-3))5)
M:LQ T^8+%E6I=NZD1:E5:5PL0^7FF-#5Q4H:.CF*L4#'2;:L2+4+=:+BL/CJ
M3M4<=2[?EHN%BO(:C7[W6I9:A4?-1<I1+<!Z5I0UFP+6A".E%PL6UJ3/O5;=
MBG&2CF"Q95J-U5EEI^_-',+E)U<4YFJ%:=1S!8@GK.N%ZUHRJ:JR0T<P[&3(
MN*BYJ_-#51H\&CF%8%IVZD [4FVES!87=F@+FA5J5$I\P*((M6(^*18Z<%HY
MA-$H:D9N*3;04-',+E*\G-0-&35SRZ58*ER+42HL)J1;?%7E@]J?Y/M6?.7R
ME2.'I5ZW6F;0N*59 M/F#E-"/I3]O%5([@5.LH-',4)(O%4IJNR,*J2X-',3
MRE2E5L4K+BFDT<P^4G5JE4U45JF1Z.8:B2L:2D'-+BCF'RA3Z93AS1S"L/4U
M(IIBK3@IHT%=DBT]1FHU!]:E5:-!W8R2.JS1\U=:H)%IB(D7!%6DXJKG;3O.
MHT"XZZ;Y36+=2<FM*>3*UF7"[LT:"NRJ)#FK$,I%0>6:EC4T#+T<QQUJ3[0:
MICBG;C18+LN+,3WJQ&=V*SX\YK0MUZ4!<M1QT_;MI4^7%#M0 PU%)2L_-1LV
M:"6V0R-BHQ)2R<U#0/F9962AOFJ%6J3=18=V,VT].*;FFLU%@+:25(LE9WG8
MIRSTK!=F@9!4;-5;S_>G";WIV%=CV-1,^*&>H9#4/W3:G(1YO>J[39HD[U V
M:J,KF5:[)0^:E23%0Q+DU'?3?9XRQ-6Y61RT]96)[R^2&,DFN!\2>,EL]V'Q
M^-9_BSQDMHCKOQ^->*^*/%S7DC!7S^->76K\I]SE^5RK)-([74OBDT<I E[^
MM06_Q29F'[W]:\8NFGN),@FH_P!_",Y->:\9%,^WI9'[FJ/I#1OB +A@#)^M
M=_H^N)=*IW5\B:/XBDM9%RY'/K7K/A'QID("_P"M=M'%1EL?'9ODTJ5W8^@D
MNEV@YIRWWO7%:;X@%S&OS9_&M:.ZW#.:]RFW)'P/(Z,M3HC?9[U4N+P'O62U
MX5[U3N+\CO6LHV.GVUU9&A<7 />J;2 ]ZR;C4R#UJH=4/K4J5CE:<F;^\>M!
MD''-<\VK$5&VL&KYA\C.D\\ ]:=]I'K7*-K)]:8=:/K1S(?LV=:;@>M,:<>M
M<K_;1]:=_;!I<PO9LZ?SAZU;MY!ZUR$>K'/6K]KJI..:B7O&D8\IW%G*,BMF
MWF''-</::ITYK5@U3CK6?LP]HD=@MP/6G"X'K7-1ZEGO5B.^W=Z?LF'-S;&[
MYP:HVD%9RW8]:=]J'K63M'<.;EW+184PMS5;[0*//![U/-V&JB+!:FU%YP]:
M42U2N7[1$H'%&VA3FGXICO<A8&H6!JRPJ%A0/E9'MI=M+MIZK31,HM;C:1JE
MV\4QEIW)L0FF-4C?+43-1S":&'K303FG&BGS"'QR$5?MI\8YK-Z5)'+MJ''F
M.F$4T;T<_%)*P:LV*X]ZF$VZCX12@B*[A# \5SNI6(93Q73L=RU0NH-RFM.?
MF5C->Z>4>(M'+[L"N)EM);.;<..:]KU+31)GBN)UW1AAL+7F8G QK19UT\0X
MLB\(^+'LID5GQ7O'A7Q5'?0(K,#D5\L30R6<V5R,&NN\)^,'LI45G(YK\\S#
M+73=TCW*.(YD?2&M:-#JEJQ"@DBO#/'GP]W,[+'^E>L^$_%D>H0JK-G(]:Z+
M4M#@U2W) !R*\2'N:,[XR/A3Q%X9EL)&PA'X5S\-Q);/@\5]3>//AZ&\PK'^
ME>$^)O!\ED[D(16[BI'5&1F:;JA8@$UTEI=C:.:\[D>2QEP<C%:>GZV> 37+
M.B:^T2/0X;KWJY#=>]<K9W^\#FM."[Z<UQ.*1HJJ.FAN/>K:3].:Y^&Z]ZN1
MW%+E12GS;&P)O>I5F'K63]H [U4N=5$'>KC1=3X12?)JSHFF7;UJC<3+ZURM
MQXH5&QNJ%?$2S?Q?K5RP<X*[1,<1&6B-VXGZ\UD7<W6F?;A*O6J=W/P>:Y7'
ME'*1GW\PYK-4B1P!3-2N?F-&CJUQ.HQWKT<+'FD<O-J=KX.T\M<(<=Z^A_"5
ML8;-<CM7EG@/0]S1DKZ5[98VHM+$=N*]3%T_<!RT.*\?7@2%QGM7A]Y=>9>'
MGO7IGQ,U+RUD ->+PWWG7W7O491A_P!ZF>1B)V1Z%H<>Y%-=99_)BN>\-1[X
M5-=,D>W%?LU+W:21\Q5]YE^.3BK"C-5(5/%7HUJ>8Y7 %CH,=3*M.50:.8:B
M9TT>*QM6N!#"3FNAO5VJ37!^*KXQ0N,U3J:#C'WTCSKQMXB,)<!J\AU35'OI
MB,YKI/'%\TLSX-<9I\1DN.?6OCLPQSC*Q^X<.Y3&O24K#_[.<X;%=)X5U"2Q
MN5&<<U8CM%^S].U9,C?99\CCFOEJTE6W/K,1D_+%V1]6?"_Q.&6(,_IWKZ$T
MV]BO+$#(/%?"7@+Q@;2:-2^.?6OJ3X?^+!?01KOSQZUY4\+&]S\XS'#.E(7X
MC>'5O(9"$S7RWXV\+/;7,C;.]?<UUI*:E:$D9R*\+^)W@\1K*P3L>U9IJ&AX
M]&=F?,-M(;-\$XKI-+U#S,<U@^)K5K.Z88P,TW0;H[ADTW#FU/2Y]#TFSEX'
M-:]O+TYKF;.X&P<UKVL_O6#IV#F9O0R5<C>LF"2K\4E82B4I,N;J21J8K4-6
M#@+F*UQ&) :R+RP5L\5N;<YJO-'FI2E'9F;IJ1RL]B!GBLZ\M0L9XKJ+BWZ\
M5E7D'RD5W4I-[LCV*/.-45HY^/6NU^'NK-;7"9;'-8>J:?N8G%1Z7<'3YASB
MO244T/V:1]G_  _\0)+;Q@MVKH?%$27UFV!GBOGSX=^+?FB7?^M>]:5<#4K0
M<YR*X9IPE=&4K;'SI\1/#K>=(P7O7GEG:M:7'/'-?3WCCPT)$=MN>*\$\2:?
M]AF? QS7V>3YAJHW/G,=@5/WBQ:7 >(+FL[6-)%XC<9JKI]X?-"YKK;.%9H@
M2*_3:?[VG=GRRE+"3NCQ;7/!Y+,0E<V_A]K=C\M>_P"I:2DBGY:Y6^\.AF.%
M_2OGL7@54EH?;8#B6K1BHW/+(],9N,5(/#+SL#M_2O0H_#/SCY:WM/\ #:\9
M6HHY6ET._$9]/$*S9Q7AG17T^1&QC%>_?#SQ%]D,:%L5Y_>Z<MI&2!BH]"U9
MK>\4 X&:\[,,OC&#:1XD<1SRN?6UGJ*ZE9 9SD5Y7\3/"OVJ&1@G;TKIOA[J
M/VJ&,,V>*[/Q%H:7FGL=H)Q7Y=6C[*K8]JE4T/S]\9Z.^EW,AVXP:XU=>9)-
MFZOH+XR>%O):9E3U[5\P:I;R6U\V00,U^FY!@UB;7/-QF*E%:';V-\9%#9K4
MM-9,#8W5R&F76V$9/.*<UXQF&#7Z%B,DIQI-M'S"QLG,]E\.ZQYVT;J[_3YM
MT8->+>#[ABR9->MZ3-^Y6OQ#.*,:-5I'W>!J.4#HHI*MQR5DPR5=B:OEY0N>
MAS,T4;-6(ZI1M[U;C>L?9V%S%A:7%(K4_-:1Y1<PF#12YI&HY44I$;BJ\BU:
M:H76A117,49EJA<)G-:LRU0G7K6ED/F,6ZCZUCWD.0:Z*XCR#Q61=1]:F42)
M2.,U.QWL>*R!FSDSTKL+R$8/%<AKW[O=BNO#Z/4R4G<[[P+XF,<R+OKZ)\*Z
MD-0M5!.>*^,O"^I-'?+SWKZB^&&J"2&,$]A6^(CI=#GJCH?&'A\7%LS;<\>E
M?//C#2?L4SG;BOKG4;=+FQ/0\5\]?$[2]AD(7UKLRO%2I329X6)IJ1Y-IU^T
M=P%SWKU'PO-YB+DUX^J/%?8QWKU+PC,!&F37[-@:_M::/EJU&TKGHMMC:*GD
MCW+6?:W VCFM.-@ZUURT9$6DK&3>6_6L*[CVDUU=W'E37/7T>":I31SU4[&-
M]TTRX?<A%/G&TU6;YN*IRN<<;IG/:M;>8QXK(6+RFKKKJVW*3BN;U-?))K%G
MOX*I9E:?$D>*XGQ1I^8V.*ZZ&;<V*I:]9^9;L<=JQ<C[2G431\_Z]&8Y6'O5
M+34+29KHO%5B5N'X[UCZ>GEM7.Y'2F=-IEU]GV\XKT#PWJWF;5W5Y-+>>7C!
MKJ_"%^6F3GO51D#D>LW$?G6^:XO5H3',:[JP EM1WXKG=>M,,3BMXR.:6I7\
M.W!CD7FO4]"O-RKS7CUC-Y,HKT#P[J&2HS6M]#F9Z?:ON2DN$XJKI<V^,<UH
MNNY:1:L85XO6L6X^\:Z.^A^4U@W4?S5K%B,\GYJDC[4UH_FJ6):V&2*O%!&*
M>!Q2,:BQ-V,I<9I13U6BQ=R$QTSRZN;/:F^7[4!<K;*?M]JF$=&VBY2U*D\>
M4-<;XCL?-5N*[J1,K61J%EYJGBJA*S%(\'U_2VC9CBN5F9HF(KV?Q%H8=6^6
MO--9T9HG8[:]NC431RR,&-S)5A<IR#46PPMR*4S C&:[>9,RL7(M3:'O5J/Q
M*T?\5<_,Q[50F9^<5#@F"9V+>+6Q]_\ 6J\_BQF'W_UKBW:3UJ"1WJ520^<Z
M:ZUYIL_-6-=7!FSS6?YC=Z>LWK6T86$V1R1%J1;<BI_.%-,PK=1,VQ/NU%)<
M;:<\FZJ,V<T2:B@3)#,6/%7;*U:9AQFJ5G;F1QQ7:Z!I.[;\M<4JYK8@LM ,
M@'RU?_X1LHN=M=QI6CJ%7*UIS:2OE]*YG7'RL\LDT\V[=,5:LY/+8"NLU#1<
MYP*YZXL# QXIJIS$69<3$RXJK-IYZBI+%\, :UV56BS[5?-8+V,:SF-LXYQ7
M8:+J1?:,UQ-\VR3BMGP_,3(*QJ*ZN;TYGI=K)N6K&ZJ.G',8^E6V/%<%D=ZG
MH5KN7:M<MK-WA6YK:U2XVJ:X36K_ .9N:Z:<#GJ3,/5K@NS<UCJA9JO3,9F-
M"Q;1G%>G'1'"Y7"&,*M/:X"56N+GRQ65<7Q9N*TN!LM=!N]"ON[UB17#-5V.
M8U'.D(TE-6[><*:Q_M'3FE^UE3UJ'.Y1UUK(LF!5Q]-\U,@5S>CWFZ11FN_T
M]%EMP3Z5S29#.)OK8VS'M3M-O#Y@&:U?$=N%S7/6&1/4WN:TY-'?Z;)N05I@
MUB:6^V,5HM<8K"1ZD)Z$\DNVJDMR1WJ.2XW=ZA;+T(B4Q);PX/-8.K7Q"GFM
M6XC.TUS.LDJIK2)RRD<]J5^68\UFK(9&IUVI:0U-8VI8\BN^G*QS28Z&V+MF
MK\-GTXJS#;A *>\JQBNCG,=R+R0M"L5---R&.,U+%%YE8REW-HENVN2M:EOJ
M&W'-9D=FWI4OV9EK"Z93N=!;WH?'-7HX%N*Y>&1HV%:]CJPBQDUG)"29=N=!
M#J<"L&]T9K<D@5U]GJL<W&:LW-BEU'D"L.>QJCSJ.9[>3FMO3M1W8!-1ZQI)
MA8D"LB"1H).:TOS(U3._LY@R@YK1C:N4TW4!A>:Z&UF\S%821O'4TE:AC1&.
M*1JP-K$<G2N=UF;8IYK<N)1MZUQ_B*Z"JW-;0,),Y75KOYCS64C%GJ+4+K?,
M1FI+%=_->E"]CAG8O1#Y:K7:U<8;%K-NIOFK5['/S6)]/4"05V^CS!5'-<%9
MS?.*ZG3;HA17'4U-XS9V"7@"]:9)J'O6$U]M'6J4VHG/6N6SN=<:AT,EYN[T
MSS-U<]'J&6ZU>AOACK6\8E.H:HQZTCL%K/.HA>]5;K55"GFGL92DF7KB\"9Y
MK&O-6QG!K.O=6W9P:R)KII&K:,>I@RS?7YDR,UF-&TS5:CMS(>:NPV87K6Z,
MW(SH=/)QD5973L5H!5CI&G44U)&3966SQ3_)VU)]H':HI)N#3Y@3N-*[:;YF
MVF-*30J&2AU$:Q0K79[4BLTU2QZ>TC=*U+/2#D';6,JB.B,2I:Z>TC XK?L-
M+VXR*NV.GJB\BM':L2UR2J&W*10VPC7I45TP5:2ZO1'WK(NM1W9&:A28G)(H
M:I-@FL<W3!ZMW;&4FJJ6;2-TK=2,G,<UXVWK6==7#,:VX]+9EZ5'+HC'M5J=
MC-U#F9)6JM)*>:Z.?165>E8UY8LF>*UC,R]HR@K%JD#%:8(RK<BG2?=KKC+0
MS<RW9Z@8V S76:/J&_'->>[BKYK;TG4/+89-<E1-FT*AZG9S!E'-7XSFN3TK
M4@RKS72VLX91S7!*Z.Z%0MA<TO:A7IQ85*=S:]R-LBH9)*DE;BLZZN-N>:JP
MKV&W4P&>:YW4[KKS5J]O>HS7.ZA<[LUM!I&<IE.XNB6/-/MY-W>LUF+/6A:C
MY:ZTSDE4++/@4Q5\QJBN)-M,M;H;Q5\UC#F=S9L]/#XXK=M=,'I6;IMPN!6[
M;W:C%83J'1"0\:?QTIDFFC%6UO%H-VK+7/SNYNC$N+#;G K-EC*9KII=L@K*
MOK?J:OG95C%==W%4;C3?-SQ6BZ[6JU;H&I<['RIG'W6CE<_+63<6;1GI7I%Q
M8JZ]*Q+S2-V>*UC4.6=)W.(;<M)YQ6MVZTDKGBLJXLR@/%7SOH9\MBNUT1WI
MOVHFHVA;=4\%FTA'%+FD9W(6F=C4D*NS5IP:.S=JU;/0\L/EI\S*T,VSA;BM
MFW9HP*U[30>/NU>'A\^E3S&BE8PC=,*KS7SK71R:"VWI67>:*RYXHYD:^T,2
M34&]:C\\R'K2WEDT)/%1V49:0"E<3J%VTM6F<<5UNDZ'YB@D4WP_I'G%3MKN
M[.P6UAR1CBLY3.=R;.=FTE88\XKG=2=82177ZW>)'&PS7GFKW7F2'!JX3'9R
M,Z^O.M9$UP6)JY-"TF:IR6K+GBNF-5$\C(,YS2;::_R4++FM.9,6PR13FK6G
M)^\%,P&J:U;RWS638)'=:#M55)KJHM42WCZBO.K/5A"O6ENO$!VD!JXY.[-#
MN;OQ*J@X:N=OO$18G#5R<NJO(3\U1><TG>DE8#8N-79_XJI/?NW>J@5B:?Y=
M:<Q6@_[8_7-*NJ.K?>JK(<51FD(-'.2V=EI?B(Q,,O79:7XF$B@%J\8CN71N
M#6SINJO&P^:H<>8SYSURZODN(SS7&ZT1N)%0P:X?+Y:J&I:@) >:J*<3>-0J
M+=&.3K6O9ZETYKDYK@[\YJ>UO"I'-4Y,Z(U#O;:ZW8YK0CDS7):?>].:WK:Z
M#8YK(WC4-9:E1CQ5:*0,*LI3-U),?NJ&9C4E0RYK+F&Y&7J#?*:Y34,[S767
MP^4URFH#YS733D<LF0VOWJL73?NZKVOWJGNE_=UU7NCAD]3&E;]Y6MI?.*R)
M ?,K7TINE<[G8N!U=A'P*VH(^*R=/<<5M0D$5A*=SO@D.VXJE>+E35\U4N5^
M4THLN2,;:1)FN@TJ7:!6*P ;-7K.;;@4Y2;..1OS/OCKG]0C^8FMB.7<M9NH
M+P:*<FF9)%*Q;;(*[C0V)5:X:U_UHKMM";Y5K+$2T-TCIE^Z**:&XHKR>8=C
M]0:***^//$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BFM0O6@!U%%% !1110 4444 %%%%
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M4329J+<H[W(F7M52XLA(O2KIQFG\;:-PCHSB=7LO)!.*YWSRLN,UVVOQ[D;
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M+<TJTT%RE/'51HN:U9(\U7:*J$5$BJQ'!4B15:CCI 11P5.HVT_;@5$[8IV
M>TF*59JJM+UHCDHL!I1OG%/;FJL358#96F!#(M5F6KC<U"ZT@(,4E/;C-0LU
M #Z:QINZD:BX"[J>#FH.E2*W- $C+4$BXJQNXJ";H:0RH[8-(K?-39?O4L*D
MM3$7+==V*T8X*ALX<XK52' K*9M&S,R:' K*N1C-;MX HK!O&K>BS";U,^5]
MM9.HR H:L7UP(^]8-Y?>9D9KLE)*.IPU(OF3.<UNU6YW#&:YC_A!OMT^1'G\
M*[^UTUKR4<=37?\ AGP>K;69/TKY?&3AK<^MR_%3IQLCS_P?\,5C=&:+]*]G
MT'PW;Z?"NY5&*TH]/@TVWSA1@5Q_BCQO%IJN X&/>OA<955_=/7G7G4W.DU;
M5+73XSAE&*\R\4?$B*T#@2@?C7G'C;XM??"R_K7AWB?XA2WCOMD)Y]:\F/-+
M<B*9Z]XB^+GW@)OUKSO6?B9+.6Q*3^->27VOW%Q(?F)_&JJ7$LS<DUM[,VY6
M=O?>,9[@G$AK$N-8N)L_,:J6L+/C-:=O8AL9%=%.E'J*[1EO=7+=VJ/S+@]S
M731Z6K=JG71U_NUI+EB7&3.4#3^II^9_>NL71U]*D&CKZ5S^T1N<A^_]33\3
M_P"U76_V.O\ =J5='7^[3]LAG&E9_>C;<>]=JNBI_=I_]B)M^[3]M$I'#/-<
M1]S5:34;D<;FKM+W1U"GY:P+K3E5NE=.%BJU1(X<54<8Z&0M]<GNU6X-5N8\
M?,:E6%%ZTR1$[5^OX#)85:-VCX7$XJ?,:5KXHN(L?.:W]/\ '$T9'[P_G7"2
M+SQ3X0^>*^2SC+*>'NT>QEM5SDDSV'3?B++'C,I_.NDL?BF\>,R_K7A49E5>
M,TR2[GCZ$U^?3@I.Q]I.'N71]-:?\70N,S?K74Z;\6HVQF4?G7QS'K%S&1\S
M5J6/B2ZC8?,U<KPNMT>9K<^WM+^)$%QC,@_.NMTWQ5;76/G4YKXBT?QK<0[<
MN?SKO="^);P[<R_K3]G*!IRGV!!/;7"CE32SZ;!,N1BO -&^+*C;F7]:['3O
MBE#* #*/SK6.(J4S-T8L['4/#:29PM<KJ7@TOG"9K=L?&]O=8^<'\:W;/4+:
M\[@UTQS2I R^JH\@O?!3C/R&LR3PW);_ ,)KWYM+@N%X K'U3PNCJ<+7MX3.
MGU9YM?"]CPY]]G[8J!O$30MC-=_KG@]CNVK^E<)J?@^=7.%-?34LWC+J>5*A
M)%JQ\4%V'S5T=CJWFJ/FK@8]%GM6R01BM.UO&M5 /%>Y1QD*G4Y94Y'?1W8/
M>K$=T/6N$7Q"%_BJ[;:\'/6O1]G&HC'E9VRW ]:D6:N;M=1\P=:TH;C('-8R
MI\FPK6-%F#56F YI//XZTUI,UF.Y Z]:9MJ<X)H"@T!<@VTX9XJ?RZ:8>: N
M1=:1EW5)LIZK1R&B293>WW5 UBK=16KY8(J*2.LU6=-V,9Q['-ZAI*,IPM<;
MK&B$[MJUZ7+%NJC-IJ2=17:I1K1LQ1FXL\5NM&GCD) .*M:==7%BXR2,5Z;>
M:%&RGY1^5<KJVBA=VU:^8Q^5QJ_"CU*6+<2[I?CQ[,*&DQCWKJ]+^)B-@-)^
MM>*:E93QL=H-4H9+N%L_,*^-K9'.]TCWJ&,C):GU/IGC:WNL9<5T5KJ%K=8Y
M4U\M:1X@N+<C<QKMM+\=-"!E_P!:\2O@*M(ZXUH-GORV=K,.BTC:-:-_"M>3
MVGQ)55&9/UJ_'\3$_P">GZUC1E6I,UE&%1'H;:':#^%:(]-M(NRUYW)\2H_^
M>GZU1N/B4O\ ST_6NJKB*TU:YC'"P6IZRTEK;KGY17/ZUXL@LT;#"O+M0^)6
MY2!)^M<3KGC":\#!7)_&N?\ >U%8PG45-V.Z\2?$X1,P63]:\RU[QQ+J195D
M)S7+:G)=7DA(W'-3:+H<UQ*NY37K8'*IU9IR,95KHDM=.GU*?)!()KTCPGX5
M\O:62KOA7PNJJA9?TKT&STM+=1@5^FX7"0P\%H>+7KD-CI:0QC"XJUY&VK:K
MM&*7:*Z7/FT."_.55AP:M0KMQ2;0*>M%K%<MBTE/VU'%5A1Q1<+$?ETW95C9
M1Y= 6*S)5>2,M6CY=1/#2N%BA]E#=14$VFQ..5%:$B[:K2,:Z+IQL8VE?0R)
MM%A;^$54.C1*>%%;,A-1%37"J*YKG1[[6YF_V7&/X:JWFFIL)Q6WM-0W$)9#
M7MTY1C&QRNG)L\L\36YAW;15+PUJ$D-XO) S76>(M-,N[BN6@LC:7&2,<U\K
MFN&56+:/2PZY6?1/@+41-"@9L\5TGB;38[JQ8XSQ7D7@GQ +=D7=BO6X;\7]
MD!G/%?E&(I.G,^EI2T/EGXKZ+Y,DI5?6O"61XKPCMFOKSXG>'3<I*P7UKYKU
M_0S9W;'&.:N"NCNILOZ#-B-<FNEMYNG-<-8WHAP,XKH]/O/,QS42C8[$=7;R
M]*U+>3I7/VLO2M:UDSBN.6X&Q$V<5**JPM5I34C!EJO*M62:@D7-18HSIUK,
MNH^M;,T=4)XNO%:)DO4Y35+7S >*YUK/R)-V,5W-U;@YXKG]5MPB,:Z8.S,^
M4T_"6OFSG1=V.:^C/ OB#[9 @+9S7Q_:WK07@P>]>]?"W6BWE M7367/#0X9
M/6Q[9KNEB^M"<9XKPOQIH/V>9V"U]&6!6\L1WXKS+XB:2-DC >M<V!YJ56YA
M6I7B>#)>&TFQG'-=CX?U S8&:X'7%,%XPZ<UT7A&<LRU^QY?B5*FD?(8J-I'
MJ-J=T8I\L>X5!8-^[%7=NY:]:6IR15S'N8JH30YZUN3PUGS1XK2G*S(E"VI@
M7UN%C)Q7%:E>-;W'!QS7?:BN8S7!:U9,TI.*K$TU5@S>E6Y#N/A_K[><@+=Z
M^BO#EREY9KDYXKY'\-W1L9U)XYKWGP/XJ5HT7=^M?CN<4?92;L?08?$7-;XB
M:(DUO(0N:^2OB)I+6]S)A>]?:&K*-3LSCG(KP#XE>#V=I&V9Z]J^?P^*L[,^
M@I56SYUTMFBN.:[K3;@% ,US.IZ:=.N&R,<U/INI#<%S6U:]35'5S'=VLO2M
M:VFZ5SFGS;U!S6Q;/TYK@=*3)YCHK63.*U8'XK"LVZ5JPOBL_9N):D:L<E6(
MWK.BDZ5;C:IYFM#0O(W2IE:JBM4R&KW(+:FG9J)*?2L,1AFH)%JQ4;BJ#<HR
M+5.:.M"5:K2+42$8US'UK*N(ZZ"XCK*N8JTH[@E<Y^ZA#9K!U*U"J2!74W$?
M)K$U2/\ =M7INI9%'$O>-;70P<<UZ[\,]>;S(P6KR#4K<^>3[UU?@G4/L<Z9
M..:RLYF<C['\/S+>62Y.>*Y/Q_HZM!(0O:HO ?B-9($7=74:];C4+1L#.164
M9.E43.&HKJQ\B>,;=K:Z? [U1\/W#"09->C_ ! \+L)G;;^E>;)&=/F.>,&O
MU'*,<I12N?+X[#VU.]M;K$8YJPMYSUKD;76 P S6I#=;^<U^@T9*4;GR<M)'
M0K=;N]2I/G%8<=Q5J.XK"IN=4-4:XDIS2<506?/>G>=4Q1$GRE;4D\Q37,W5
MIM8G%=5)^\%9.HPA5)J)1/0PM74Q%;;\M4=3M5N(FXIUQ-MDQ5F-?.A_"N.6
MA]A0GH>/>,+'R2Y Q7G$V?/(]Z]M\;:661^*\CO+$QW)R.]8G>G<OZ3^[4&N
MRT75_+D4;JXB&00QU:T_4#]H'/>K1T)'NVCW0NH5YSQ577K/<I(%9?A&^W1H
M":ZF^C$\.:UBS"<3A+<&&X_&O1/#.H;0H)KB;VW\F4G%7]&U#RF49K:YRM'M
M6F7@D4<UK_>6N(\.ZAY@7FNTMVWQBF20S1\&LVX7K6Q,ORUEW"\FDF7L94R]
M:JO5^9>#5.5>M:IFA7:F[J23C-0-+BM +!;BHV:H?.I=V:!#C)5>Z;"&G'.Z
MJ]ZV(C]*:W&<GKVH>2K<UY7XDU8LS -79>,+PQ[^:\EU6\\R9AFO3HQ,I,H7
M$S22$YJ>T^;BH5CW<U=L8?F%>@DDC!EZWL?-/ K:L=!+8^6KNA:9YNWBN]TO
M0UVC*US5*EAQ1R]EX<Z?+6M#X=''RUV-OI2JO2K2V"@]*XI53=(XZ/P^O'RU
M;AT%1_#74K9KZ5*MJ/2L7499SD>B(/X:M1Z.G]T5M_9P*7RQBES$,Q9--CC7
MH*Q-6\N%6[5OZM<"!&KS3Q1KPC#C=6\+R,S-UW5DCW -7$WVI>:QP:K:QK#3
M2-@UDQS&1N37H4H-/4SEL:&YI#UJ>-6Q3+=AQ5M<$<5W/8Y["1R%:G6XJ+RR
MW2IHK)F[5EH,E6XR,4%3)BK5OI+MCBMBST-FQE:R<TC:*N8EOIK2,.*Z+2=%
M.02M;.GZ&%QE:Z*STQ8P.*YJE4ZE"Q6T_3Q$HXK2D0)'5CR0BU5NFVH:X92<
MAV.=U:XV!N:XW4+@R,1FN@UV?;NYKDW?S)*ZZ,2),B6$LV:GV^6M7(+?*=*J
M7Q\L&NY2L<TF9%^^2:AL;=I)!@=Z=)^\DQ6_H=AN=<BL*DM!1U-/1=+9@.*Z
M>#2P%Y6K.CZ>JQKQ6NT(5>E<E]38Y>_TU0IXKD-5A$6:]!U1@L;5YYX@N!N:
MMZ>K'N<W=89\4ZUBYJNTFZ2KL9"KFN^.B(9>5PB8K,OK@\\TZ:ZQQFJ<K>96
MB,)E&1BS5-:G:U-:/!J:WCR:SD3$U[-BV*V+:$MSBL_3;<G%=%;PA5%8W-T0
M-&$7FLB]F"DBM>^?:IKE[Z0ES0#1+')O:K@&%K,L\[JTF.V.M(F=BK-)VJK(
MN^DFE^8U+#\RUK):"D9LUO\ -TJQ:0'/2K<D.:EMX@N*Y&A1+$49513]V&J9
M5&VHFB)III'3%$BR TK<U&L)J4?+UJ[IF][#%)6KEO>&+O51F%022>E3(S;.
MCCU;Y<9HEO5D[URK73)WI8]2.[&:QL0S=:7Y^*V=+?.,UR]O<>8PKI=+^Z#3
M:T,BWJ7^IKA]1FV2GFNMU:XVQ'FO.]:OMLAJ;!S&@NI;5ZUDZEJFYCS62VI$
M]ZI37)D:E8OF-*&7S&]:THQM6LC3_O<UJO)MCKMI1)([BXX(JM&IED_&F.Q=
M\5K:79^8P.*55V11H:/8DXXKIX++"CBH--LP@'%;<48VBN'FN-1*L5J,]*M+
M;C'2IECJ7;Q1(U2L4I(1Z54N(1M-:,M4+QL*:A7!G(:TPCS7+22[I*Z#Q!+U
MKEE8F;\:Z81N<TC8M1P#5J2;8O6JUKP@J.ZDKNBK(R6I2OK@LQ&:J0PF5ZF:
M,R-6A8VO3BN&M(V6A9TVUV8.*Z[29_+VC-8=O$-HJ]"Q0YKE4'(V4CN;&\!4
M<UH?:017&VNH%,<U?CU/..:OV=C6,S:FESFL^XFQGFH_M>X=:H7UUM5N:J(I
M.Y5U2\VAN:X_4+PLQ&>]7]6U#J,USDDWF2'GO71%'*R5"9&J[#%TS4-G'W-6
MW(1:V2,KDRL%%/63/2J'F[C5JW'2M- 42SY)D%0RZ<QYQ6K9JK$9K9CT]9(^
ME92E8O8X26$PMR*FM9AN S6WJVE%<D"N<:-H9*QN6F;L>&44^*,;ZSK>ZPH&
M:OVLVXTV:Q-_3;<$BN@AM5V]*Q-,D'%;T,PVBL),Z45KBR4@\5@ZA8CGBNF:
M0-6=>J&S6(VCA-0L]N>*YV[A*L:[C4H0=U<O?0=>*VA*QS3,!N#3&^;M5BXC
MPQ%0JO->A#WCD80IAJW-+F\MAS62%VC-20W.QA2J141(] L]1"Q]:J:IJ)93
M@UA6M\2O!HN)BW6N'=FI&TS/(>:<WW:AC^9JFD7"UW4XZ&;17S\U:^FP;V%8
MR_ZRNFT6+=BE4?*;4S>T^U"@<5LPQ?**K6D6U15^.O.E*YZE,-@IZXI&(J%Y
M=O>I2N=3DK%AB*HW; *:2:\"J>:R+[4ASS6D4<\I(R]:FZUR5R2\AK:U"Y\Y
MC5:UL3-(.*Z3BG(CTW36N&'%=AI/ADM@E:FT'1PNTD5VUG'%;QC.!64WV.1L
MHV.AI;J"5K162*W7M5;4-6CA0@$5QVJ>(BK-AJS2;,6=I-K$,>>15=O$,.?O
M"O+;SQ$[$_-5(:[*S?>/YT^0TBCUUM8BFXR*K7$<5PIQ@UYU9ZU)N&371V.M
M#: 6HY2^4AUC1U;) KD+W3_)8\5Z!->).O7-<WJ\(.2*VBB>IST.$.*T[;#8
MK'E.V2M3326Q1)'7&5D:!A&WI65?PCTKH8[<NO%4KS3V;/%96!R3,>P4+(*[
MG1;C:J\UQZVIA>MK3;KR\#-/EN9L["XN=T5<=KAW;JV_M.Z/K7/ZPW6M:<3&
MQRTX_>5<LWQBJ<[?/4D$VW%:S=D:1E9FWYGR=:S[AOFIAO/EZU5:XW-6,=6=
M7-H:EJU27#?+5.UDXJ>X?Y:Z5$XYO4SI#\U*L8>HI6^:IK5N:XZNYI$9)IOF
M=JK/HY SBNEMXPPYJ:2%-O2IC)D2C=G%36)C[56*[>*Z>]MPV<"LJ2P);I6G
M."@4%4L.E/6W+=JTH--/'%:%OI?3BI]HS14S&AT]F[5=CTT@=*Z"WTT =*G:
MS"KTJU-FOL]#EIK3:O2JJP@-TK?O80N:RF4!JU1SN(^&$;:BN8Q5R+[M0W/>
MF38SU4AJNP3&.JRXS1+)MJKB.HTFX\QP,UU]O8B>$'%>>:#.6F7ZUZUH</F6
MR_2N6I(1PVO:;Y>3BN=A7;-7HWB:S 4G%<')#MF/UIQ]Y&D7J;>GR?**V(7Z
M5A6+8Q6O;MP*FQZ-,FFY6L>^CRIK6;[M4+Q?E-,TJ;''Z@NUC5".X\MQ]:U=
M43&:YZ1BK5O%GE5$=1I]UNP,UKJHD6N0L;@JPKI+*ZW <UJSD&7ED.2!63+$
M8FKIVQ(M9MY9;LX%$6;Q,J.\,>.:NP:B&XS6;<VC*W2H%WQUHTAR.FCF$E*T
M8QFL:UNBN.:U([@,O6LV<\BM-\I--BG^8<TMTW!JBDG[P<U)M2W.ST1\LM>@
MZ.W"UYGH4WS+S7HNBR?*M>3BCT+Z'2YHJ/<:*\@D_46BBBOE#Q0HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,T&FT"N/HIH-(S4
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M>:#08)#4J2$TSRJDC2@:)ES4RYID:U*,5(ARU,M,6I%[50#PN:-@I5-.7K2
M:%Z5*HIJU*O>I)(I%JI-'FK[+430TQ6,UH^:>D>*N?9^>E'D[:8R%/EJ?S<5
M%(-M0-*5J2[7+$D]59)-U0O,3WIN[-.PT2KS4\:U!'VJPE R;^&HI*<6IC-F
MD38JR4Q,[JG=:;''\PIE$\,>[%/>+%6+>/Y:=-'A:FX%'.VIX)JK3<&DB;#4
M S6W;EJI<]ZDCD^6H;EN*"#.FZFJ[$YJ:8TQ(RQIFB0U5)JY"G2ECM_:K4<.
MVD,=%'5E8<T0I5N..F253;Y[4?9O:M 1TGEU-@*J6^.U3QPXJ0 5(H%(0Z,
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MV^U.45+LI, 4P&LN:C,=6*<$S3N!66.IE7BI?+I2M# A;.*JS5;DJM(OM33
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MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7/#9);"5Q][X?=2?EKZ OM"64'Y:P+SPJK?P?I7="O8EP/"WT&3/W:0:$_\
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MTVEW4TM0 $4VAFIK-0(4&E-,W4UFXI,8K-3E:H2U21T@)****H!5I6%(M*U
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M]VC_ (1Y?[M=7M'I1L'I2NR;'*?\(ZOI2?\ ".+Z?I76+&OI3O+7TIA8Y/\
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M1FK QBD(K21XJ+[IJS*1BJ<C8-,"Q')4V_BJ"2<U8C;=2 D9Z133A'NIZQ4
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MR\?ZU7\/Y$R_6OK>;W2Y'T1\,?OQ5]#V<FW3!_NU\\_##K%^%>^1R;=-_P"
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M I&I:1J (V[TS::<S<T4 %.6DQFE'% A:?3*?0,**** "BBB@ HHHH ****
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M6QF)?RKK--^%]BP&8E_*K5*XO;'Y^Q?!'46P?*;\JU+/X)WZXS$WY5^AEO\
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MKKJ"A>36J:,^5FDTVWO2"\V]ZQY]30?Q52;5%S]ZJT)V.E^W>]1M/NK#AO\
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MO825Z:/EL0DI:'8J_P M-:3=4!8[::&KN9Q:BO416I**0R%H>*K26]:.*AD
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M*DCL7;H*W;#1VEQD5TFG^'0<96E*HDC2)PL>CROCY35V'P_(V/E->EVOAZ(
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MU:/J,/1V9+-&EC9D].*\*^*WB(1Q3*&KU7QIX@2SM9 &QQ7RG\3_ !-]HDE
M?-?%2;J2N?1T:=D>1^,M8:XNW^;/-8VFJ9F!J'5&:XN">O-:6CP;<5UQC9&C
M1T.E0[66NUTA>E<MIT?(KL-)3I7%68XG4:?'P*WK1.G%9.GI\HK=M(ZX&:E^
MW7IQ6A$M5(%J[&*@1.M.IJTZD!&U0259*U$ZU!6Q0F7VK/N(^M:DRUGW'>MJ
M:LR%N85XO!KC/$*\&NXO%^4UQGB!,YK>_O&LMC'\.DK?+]:^I?A7+^YC_"OE
MW04VWR_6OI?X7R;8XQ7J6]P\VIN>OZH UB?I7SW\3(]K2U]!W3;['\*\$^)T
M?^MKGPKM61SS7NGB\;8O?QKU7PCS"E>3JV+[\:]7\'M^Y2OU_ N]-'RN)W.O
MV?+3=AJPO*BEVUZ,C@*I&*;NJQ)'UJNPIHI"LU022=J>QJM(#FF3(1FW4UK<
M,IXI56K"_=I)WT.=:,X[Q%;;4; KE+&Z>WO!SWKT+6K7SD/&:XB\T\P3%L8K
MFQ6#52FV>SAZA[+\/=<^5 S5ZQ(T=[8^N17S%X7UXV<R+NQS7N?A37A>VZ*6
MS7XWG&']C-V/HJ-2Z/-?BEX<\V.4JGZ5\S>(M%>VO&.,<U]V>)O#ZZC:N=N>
M*^;_ (C>$?LLDC!*\_"5&U8]6+/)])F\C -=38W ?&#7#7TS65P5Z8-;>@W_
M )A&37=*)T)G?6<G2MBWFKG+.7Y16K:R]*Y9H#H;>2M&%ZQ+:3I6G;R5R2$:
M<;59C-4H7Z5;1NE<M]0+*M4@-0(U2*U;($2LHQ4;+4F>*:U(H@9:K3+5QJKR
M#K5"*$D?6LO4%VH36TZUG7T.Y2!2C\0[\J/.O$4Q56KROQ"YD9Z]A\1:<S*Q
MQ7E'B*S:-VXK]5X9E24E<^6S)RFFD>?7-@9)L^]=-X7F.GR(<XK/9?WG(J7S
M3'C'%?K^,E0EA['Q,*%15+GTQ\,?&AB:)-_ZU]'Z'JPU2S4$YR*^$O >K21W
M4?S'K7UQ\,]6\Z&(,W85_.V?0@JK:/N<#?E29H>./#(NH7;;^E?/OBC1S87#
MG&,&OL'5+..ZL2<9XKYX^)VC^6TI5:YLDQ2C42.C'4U*!Y9I^I&.8+FO1O#=
MQYJJ<UY%L>&]Q[UZ7X3GQ&O-?M-&LITT?#R@XR9Z9I[ XK4NH ]L>.U8.ESC
M<O-=)N#6^/:IJ >-_$"W**^!7A^J3&.Y;)[U]&^.M/\ .C<@=J^=/&%NUK,Y
MQCFN-R/8P,4YH;#?+LP35>YD5ZY,ZT8I-I;%:%IJ'G=ZAGZC@HKD1<D^6H6N
M=G>B:8 =:R[FZ'/-9<UCOG33+[:GM[U6FU8<\U@W=\5SS6/=:J5S\U0Y',Z:
M1OWVIC!YKG;[4CD\UGW&JELC-9L]T9.](V@DBQ<:F?[U49;UG[U X+4BPFFC
M:35@),E2PVQ8T^& \<5?MX>1Q6ECD6C&PVN%Z5#+;G=P*WK>UW*.*F.EEN=M
M7$SJKF0SPW*T,R<XKW/P7JV%0;J\2AMS:L#C%=OX5U8QR*,UZ%,^?KT[,^DM
M%O!(B\UTD4GRBO-?">J>;&OS5Z!:S!D%=#//9;?YEK,ODZUI]5JG=+NS2B-'
M$ZY'\K5P&JQ[6->F:U#\K5Y]K$)W-Q7HT6(P5;:U7(9.E4V0AJ>C;:[0-VUD
M'%:L,PVUS,-UM[U:34=O>N>464G8Z%KH+WJ.34%4=:Y^XU;:OWJP[[7MN?FJ
M%3;'S'77&K#^]6?+K04'YJX>?Q$2Q&ZJYUAI,\U7L69RD=%K&M;E/S5P&L7S
M2.:UII6GK.N--:0]*Z81L9-W.<DNFYJL]PQ:N@;16]*A;1#Z5VJUA;$.EW3(
MPS7>Z+JNT+DUPZV)A/2KUM>-;GK64HW#G/6M-U-'QDUT=K<QLHYKQNQUXQX^
M:NCL/%'0;ZXITV;QD>C[D+#%;6C[?,'%>?6.M"9A\V:Z[1;X94YKFDG8VW1[
M?X*V_)7HMTR?83]*\9\*ZTL.WYJ[B?Q*K6I&[M7BU8OF..47<\\^)& TA%>,
MRWQANSSWKU+QUJ N=^#FO(-00^>3[UZ^'7NV9T17NGI'A'7#N0%OUKW+PCJL
M<D:9;M7R?IFL&Q8?-C%>D>%_B +?:#)^M9UZ#EJCBJ1/=/&4T<EB_/:OD'XK
M86XE(]37MFL>/$N;-AYF>/6OGKXC:J+J20YS3PM-P>I$#D=!U+[/?#GO7T)X
M \0!HXP6KY8M[DQW6<]Z].\'^)S:E/GKMQ%+G1I(^MK..+4H #@Y%9.J?#N&
M_8GRP<^U<KX-\<(RH&D_6O4-.\46TL8)9:\.4)TGH8'&V?PIMX90WE#\J[;1
M_"MOIT8.T#%+=^*K6%<[UKG=6^(D$$3 2 ?C4.52>@:G2:UJT.G6[ ,!Q7SY
M\3O&*LLH#^O>G^-OB<&60++^M?/WC+QDUZ[_ #YY]:]/"T&G=E)&+XJU[?<.
MV[O3_!_BHV]VGS=ZXC5+IK@DYJMIMT]M,#G'-?21BG&S+/N?X9>,$FCB#/V'
M>O8?+M]4M.<'(KX5\"^/6T]XP9,8]Z^AO!WQ12:-%:7]:^?Q-!J5XF,D=5XB
M^',%^[$1@Y]JP[#X5PV\P;RAU]*] TOQ5;7D8)=3FKEQK5K&N0RUP^TJ1T!$
M/AWP_;Z5&IV@8J_K6O0VMJRA@.*Y#6_'$5LK!9 /QKS7Q!X^^T;@)?UK.-*5
M1W9M&-R'XAZR+QW .:X30]/,U\&QWIVH:H;V8Y;/-;'AM%692:]:,>2%CJ4-
M#W+X=V*QPQY]*]*N-/CFM\'TKROPIK*6L:#=BNR_X2Z-8^7KQZL&Y7.:47<P
M_$W@N&\W90&N)D^%T#2$^6.OI7=WWC*#G+BLX>,K7=]Y:UIRJ1V(U.<C^%<&
MW_5C\JYCQ7\,H((&(C'3TKU%?&EJJ_?6N3\8>,K62W<!QTKH52JWJ2?.^H>&
MX[&_.%Z&O8?A6J1M&.G2O*/$>NQ27C%6'6NI\!^)UMY$^?%=M2,IP ^M=.6.
M2S7GM61JFBQ73'@&N,TWQ_&ENH,G;UJ]'XZAD;F05X_L9Q>@(==>!X9F^X*A
MB^'D1;[@_*M:W\86[?QBKD?BRV&/G6G>HA\[,H_#J 1Y\L?E7$^*_!L5JK$*
M*]3E\96WE??6N \7^)(;B-\,*TI2J7U&I,\.URU^RSD#CFMWP1J'EW,>3WK(
M\23+-,Q%5]#NS:S*<XYKUW[T#KCL?7O@&\CFMXPQ[5UFL:1#>6YX!XKY^\&>
M.5LU0&3'XUZ7:_$*&:, R#\Z\"K3E&5T823N8^N^ X;B1CL'7TK.T_P'##(#
ML'Y5U<OBJVE4G>*S;GQ9;0Y.\4N>>Q-V78M/ATV'L,5P7CSQ$D-O(H;MZTWQ
M1\1(HHG D'YUX3XV\??:#(!)G\:[L-1E*5V18Y+Q[JGVJZ<YSS6/X4U86=XA
M)QS6-JVJ&[E8YS67#>-!,"#WKZ5P]RQLEH?:/PS\71R1Q*6'2O:K58-4M1T.
M17PS\/\ QD]M-&"^*^FO _CM9(4#2?K7RN(H.,KHS<3H_$'@6&\8G8/RKG[7
MX;Q13;O+'7TKT"'Q#!<("6%$VL6T:YW+6<*E1*PDV)X=\/Q:>@X Q5GQ!KD>
MGVS -C K$O/&$-NC .*\N\<>.O,C<+)^M.-*525V,J^-O'"^9(-_ZUYI>:XM
M](03G-<MXH\123S.=YZUD:7J3M*,FO9I4^1"D=J^FK=*2!FN?UC1_)!(%=9H
M]PLD8S1K%JLL9P.U:-ZE1/+VS#)BM&UO-HZT:I8F.0G%932&.M8QYC92-YM0
M^7K5.:X,C=:S5N"U6(<L:Z5!#YBW"NXU:V[5J* ;13II,"C8DBFFQQ4'+TNT
MR-5^TLRV.*&[&D45H+4L0<5H16H5>16C#I^U1Q3+I1"IK'F-+'.ZHP137'7\
MQWGFNHUB;[PS7'7QRQ--*YC(8&SFD#?-BHHVJ_96AFD''%7:Q@]2:QL6N&'%
M=AH_AO=@E:E\.Z*&P2M=Q:VJ6L8R,5G*H-(H6>BI"HR*L2;+6DN]42/(!K$O
MM2,@.#62;99IR:XL/&:@;Q./[U<E>3.S<&J:^8S=31RC.X_X28>M*OB,>M<;
M'')ZTK>8M0T)G;)X@5N]3K>)<+UKSW[4\1ZU<L]<V, 6K6,+[$HZRZTU+@9Q
M7/:AHFW) K:T_6$E4 FKTR)<(<<U7*XLH\UO(6@R*KPW!W8-=3K>F=2!7+-;
MF*7I5N6@SH-+_>$5U^FQX45R>AK\RUVEDHVBL).YU0-*'H*ES44-2X-8M'4M
M!,TAIK'FFLX44BFQDS!0:R+ZXVYYJS>7.U3S7/WUUN)YK6*,)2*E_-NS6-+!
MYC&K\S%N:BX%=$4<4F4A9>U0S0^7FM)Y%45FW<P.<5NG8@I23%3UJ>VO<'DU
MFS,2U1B1E-#D,ZVWO RU+,@D6N;L[PAAS6];W D0<UFY"*%U#M)J*W!W8J_=
MXJO;J-PK!R9<4:=I#N K4M[/)Z57T]1Q6[;*O%3S&\2&.SVCI1<*$2M!B%6L
MC4K@!3S1<LYG7)<;AFN&U"3YS75ZQ+N+<UR5ZA+&M8QU,I;%:,U8"YJ"->:N
M(ORUWQ6AQO<K,OS"M;28PS"LV1<,*T=+D"L*YJB-(G8V-N-@XJ2XC"CI4-C<
M#8.:EN) RFN9W-3*NFVYK.E;K5Z\/6LF9L52D0RG=_-FDL5_>"FS-N-3V*_,
M*U6I@S>M5Q&*CF^]4\/$8JM<,-U=$=C6)=L1\PKI;)?E%<UIOWA746:C:*XZ
MIV0-*%:CNHLJ:FAI9A\N*QB=70Y74K;KQ7-72;6-=IJ4?RFN1U!=K&NBF]3D
MF5X6-/N%S'4,+?-5B89CKMZ')(Y^^7FJ*MAJT-0')K*9CNKGEN9%^%\FKD:[
MJSK4DM6Q:Q%L5M#8VB0LF*L6+;7%/FAP*AM_ED%9R.B)V>DME16TW*U@:._R
MK6^O*U@=2>A0NH\@US^I0]>*ZB9,BL'4X^M4F9S1S#1XDJW$ORU#(O[S\:NV
M\>Y:Z(LX):,S;Q3S5*/(:MRZMMV<5F26Y5JMLA!U6JUPHYJ<DBH9LD5RR5RB
M@YVL:;'S3Y(R6I(U(J(Q$31P[C5N&$+44-6 P%;VLAH=( %JE)'N:K3-NI8X
MMU<LI:FZ06MOTJ_Y044R%=@%+--@4KB:&M4L2[B*J"3<:T["$NPXIF;9)':E
MATI);=E'2NBL=/W@<5H_\(_YB_=I7)N>?S*_I5"XW[N]>DR^%2<_+67=^%BO
M\-;4Y*Y7,<?IY?S!7:Z.S;5JC#H)A8?+6W869CQQ48AJ2T,Y2-)6.!13E4XH
MKR.4QYC]BJ***^',PHHHH **** "BBB@ HHHH **** "BBB@ I,TM,H =FC-
M-HH =FC=3:09H DHHHH **** "BBB@ HHHH *1NE+10 RG+12T""DS0U,8T
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MDUQL_>J!M9;N:UA!ARFNUHC-P*GAT\=A65::F)&Y-=)I\RR*.:BM=&<HE?\
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M"M=*S?Z/^%<WI7WA71LO^C_A7/+<U1PGBALLPKF+.S\^;I72>)OO-67HN/M
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M%K@-6T]].8D#&*^B]2TU9%;BO+O&>BCRW(%*OA(55J>C1J<SY3@]'\82:?,
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MQU1$=S$N^AKF-8[UU-XN,UR^L=#6"C[YTO8S=+7_ $E?K7MG@'_EG7BFE_\
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MQGBL72+@&->:Z6T82)S58E<K,*<G%GB'Q*\/CR96VU\E_$&U%K<2#IS7W/\
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M "BBB@ HHHH **** "BBB@ HHI* %HI-U+0 C4VG'I3: $W4;J;10 II***
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MGWKS?4UOK]SMW'-82JOH=L:*ZGLNJ?'%[G*B;/XURFH>-9]8R Y.?>O/M/\
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M^3=UK6M;E6QS6=>]CGJ,D6R&.E%6!*N.M%>78YS]7Z***^1.0**** "BBB@
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MTI*=10((S5E?NU6J56H JWD>[-9AM"6Z5N,H8<U']G%;QF9.)6M+?:U;-O\
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MS5I;K<.M8LNQ1U2/S,UA_8B9.E=+-'YE0K:C=TK6,[$.)7T^WV8K=MY1'6>
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MB$MCS(:6))^G>NGT;1!\O%5K6$&<?6NUT:V7"\5Z=.1YE7<OZ/I@C XKJ[6
M1J*HV<8515XSB,5U'(7&8*M5Y)P*JRWGO5.6\]Z07L6)[CK5&::F-<;J@D;-
M'*0Y TU1--4<C579ZM&99\RE#54\RG>;6B(D6MU)NJL)J7S*T1FRSNIK&HQ)
M1OJB21:?BH1(*42<T $BU2F;;5R1LYJC<4#*LDQ%5VF+4Z5>:B"T#)$):K*K
M4425;C6@9$T=-VXJTR<5!(,4"&4QJ4T;: *[5$0<U:*4PQT 1*#4RL: F!28
MH%<F62IXIO>LXL:<DAS04;T$WO5V.05A6\WO5^.?IS02:+-FHN:C27=4J_-0
M W!HVU)MI#2$5Y(ZKO'5UJKR47&563K3<5)(U1;J8[B5(G:FYS3TZT@N6(ZG
M5JKQFI@U2!)UJO,O%2;ZB=LTAE*1:B$?-6V7--6.F!&L52+'4JKTI^V@"/;B
MG!L4K5&S4 2[J2F*U/H$,/6G8IC-3D/2@8-'D5$T-7%7(I'CH S_ ":ECCJ7
M9S2XI7'811BG44NVF E)3]M&*0R(TN[WI67K3&[4W(!2W%,9J:S4TTUJ [=4
MBMTJ"I%-)H3995JE#574U*.E T,FSS6;<"M-QG-4IXZ0S*D4[J5":EDCYIFV
MJ-"6-JN0OTJDJU.C8Q2N0:D4E3%A6;'-CO4XFH#<L%N:?&U5#+4D<E2&Q;/(
MJ&2/-2(V:E"YI"*'D4-#@5=,=1R+Q049TD?-,5*LR+S3%7I3 15I?+-3*M."
M4@*WE5(J[:E*\5&S8S3 <K8I?-]ZK-)BF&:@9<W[J>L>XU5A;<U:5NF<4F)C
M5@YZ59CCVXJ98^.E*5VUF JU*IYJ!3_.I5[4@)-U,:2AN]02$TP'-)S2;JA+
M4Y<F@98CJS&N:K11FK297K3*)5B)IWDE>:KR:E';_>8"LZ^\76MO&<R*/QI;
M!J:DEXML,DUGW7C:WL<[G KSKQ3\1H(4?;*OYUX1XY^*DJE_+E_(UG.IRFT*
M;D?1WB#XL6D:,!*OYUXQXV^*"7"N(Y?UKYSUCXE:A=2L!(QY]:71[J]UB0!R
MQS7*ZSEH=<:"CJ7_ !9XNO+N9_+9C7(0MJ5]-SO.37LOA_X9/JI5GC)S[5Z=
MX=^!<6%8P_I4>SE(U]I&"L>$>&?!MS?;?,0G->K^'?A2DX4O'^E>QZ/\*X;!
M1^ZQCVKJ+/P_'8@83I6\:5MSEG6OL>;Z7\(;:-5/E#\JZ2S^'L%GC" 8]J[>
M-UB &*5K@-QBNF,4CFYFS&L-*6SQ@8Q70V<QCP*JC#58A7&*LDTUNBPIDDI-
M0QU+MS68QBL3FIHUI%CJ:-<4#)47%2"D!&*8ST(1/N]Z-U5Q)[TX/TIC)&%0
M,M2EJ8>:06N0LM,VU.5IC=:8;#!4L;5"W%*K4$7+JMD4-]VH(Y,4KRTBTR&X
M( -49)=I-37$N<UG2L2:0%R.Y]ZLK<9K(C)JW&32*- 2;JECR:JPU=A6F(GC
M4U.JG%-C2K2QT 5VCR*KR0UI>744L= S)D3%59.IK0N%ZUGR=30(:G-7(8MU
M4XZTK7M0%RQ#:[L5/]C%3VZBK6T4#,J6U"UGW$>W-;=P*QKSO029SMM-.CDJ
M"9N:6 \T#1K0+N(J_'!FJEFN<5KQ+Q0,J/!5=XP*T)C@51D89I 0,N*B9L5.
M>:CD6I J22&D20T^2'VIJ1\T 6H?FJY''FJL/%7H6H ##Q5>6&K_ &J&1<U0
MRAY-(8:N>72^52*,_814JY%3M#3"N*!H534JM4(%2+GBD(L+4B]JBC!IZY%2
MP)<U$V*"U1LU3<!CTQ>M*S4+0!(O:G\TU%J95I@1]*<C4K+43'%("1I*CSEJ
M8S4*:19.HJ4)3(JG JBDBNRU&15IUZU#MYH 115A>E1J*=NH ':H3S4C'FF[
M: 9'LS2K'4RI3MF*6Q*(U6E84XC%)1<=R/&!3&-2-4,C4R1-U+NJ+/-.6J&V
M.9J;NI:1J8A&:F^936J-B:0%CS:"V:KAJ<&I7 5U!JO)%UJT.<4,E,DSVCQ2
MQ9%6FAS35AYI@6;>3I6@LWRUG1KMQ4P:F-"WGSH?I7F/C>UW1R<5Z>WS*:XG
MQA:>9"^!VKAQ$7*.A-"7)73/FCQ1;B.=_K6#;S;&KM_&.EOYSX!KB#9O&_(K
MXK&49W/Z)X?S*"I*,F.N9/,4U@7UL&SFNB\@E>16;?6C'H*\RE1DY'W+QM"U
M[G._V:LC<"MK2-#;<"!5G2])>:8?+^E>E>'?"N]5)3]*^MPN$36J/R/BG&0D
MGRF'IEA);J.#5J:]GM^A->@1^%PJCY*JW7A(29^6NNIET9=#\@CB7S'&6/B2
MYAD'S&NZ\/\ C::/;N<UBR>#_+.0OZ56FTQ[/.!C%>75RMV]U'IQQ-CV?1OB
M$%5=S_K74VOCR"8 %Q^=?+TVL3V9P&/%%MXTN8F^^?SKY+&996B[H[J>*C+0
M^M(=>MKP?>!JTFG6M]V4YKYIT?X@3*RYD/YUZ-H'Q$^YND_6O+I0KT9'HQ]G
M/<]-F\#VMP,A!^58NH?#V'G;&/RJSIGCZ*11EQ^=;$?BJWN.K+^=>I]:J6M(
MB>'@]CS/5/ (4'"5QVK>!Y%SA*]^DO;6Y'53FJ<VF6MSV6L_K2ZF<:/*?,E[
MX-F4G"&LBX\*7"_PFOJ67PC;S=%%4Y_A_#)TC'Y5V4\13EN=,9\I\KR^';A/
MX338M)FC;D&OI.\^'$?.(_TKG;_X?B/.(_TIU%3FM >(9X_';O''S7,>)'95
M:O9]0\(O&I 0_E7$>(/!\LH;"'\J,#R4ZJ9G5K<T;'A]U,WG'-/^T*(ZZO5O
M \\;DB,_E6!=>&;J,$;&K]SRK%4?9+4^!Q]&<I71C+>A9A@]Z[OPGJVW;S7'
M1^%[EI,[&_*NGT30KB';\K5\YQ-6A4IM1-\LISIRU/3K;6QY(YI?[8!;K7-P
MV<ZH.#2_9YP>AK\#EAYRJMGZ32J)PLSJ5U@>M2?VL/[U<PD4WO4FV7WKTUAY
M*)G*23.E751CK2_VH/6N;59?>I%63WK/V,A>T1T']I#UH_M0>M86V3WH,<OO
M3]C(/:(W?[4'K1_:@]:YXQ2^]*L<OO3]C(?M$=$NICUJ0:D/6N=5)/>G_O/>
ML94)#51'0?VB/6E^W#UK 5GJ57;WK/ZO(?M$;?VX>M/6]]ZPO.(IRW!'>FJ#
M'[1&^+OWIWVCWK#6["GK3OMP'>CV#'[1&W]H]Z=]HK$_M!1WI_\ :2^M9^Q8
MN9,VUG]Z?]HK"&I+_>J1=0![T*FT3<V_/I/.%92W@]:>+D>M:Q5AW-99:D66
MLI+GWJ9;CWI\R$7R_%1LW6J_G4>;[UG)C)PU.S5=7J56J+E6)-N>U,:.GJU%
M425VCJ)HJM4FVK0&>\/M4+6]:7ETGDBM4PL936OM4#6OM6RT/M430T^8@Q6M
M/:H7L_:MSR/:F-;>U+F*.?DL_:J\EKA:Z.2U]JK26GM3W)9SLEK[5"UKGM70
M/9\]*B:S]JSE%G.[W.=DLO:J[Z;N[5TK6GM3/L8]*WA4=K';1DEN<K)HX;/%
M9UYH8VGY:[EK/VJM+8;NU9.,G*YK6M*.AY9J&A[<\5BR::(VY%>JZEI&5/RU
MQ6KZ>T;' K]6X;Q%.G;F/@L?1FV['/1V\8I[6"R=!33#(LF,&M73[-Y,9%?H
M^-S&C[*R9\U"E4YRE:Z)N8<5T=AH0VCBM33M)X!(K<@L=B]*_",ZK*K4;B?H
MF61<4KF#_8:XZ4]=$7TKI5MN.E.6V]J^>P[Y=SZB4HV,"/2 O:KL-CL[5JK;
MCTIXA KJJ0Y]3QZD;O0J+#MILJC%7)% JI,<UR\O*..A1F6F);F1NE6A"7:M
M.QT\LPXI-FA%IVF].*ZO3;':HXHT_30H'%;EK:[<<5BV,DMK?':K\4>!2PQ5
M85*R;&+&M3JM-5:F1:E@*B^U3)357I4BK4B'KVI6I12-0(@>JTO>K,E5)CUH
M*12N#6;<=ZT)SUK-N3\IJEH58R;QN#7(ZXWWJZJ];@UR>M<YJZ>LR)2*GA_Y
MKQ/K7TA\-X,QQG'I7SKX9AW7J?6OISX;V^V",X[5[DY<M,\^HM3N=2'EV)^E
M?.GQ2GYEYKZ(\13"*Q//:OF7XFW/F22@&O/P7OUS.H[0/( VZ^_&O5O!V3"E
M>66\)>]S[UZ[X-@Q$F:_;,#'EIH^,Q<O>.I\LE135A-:*P_*.*/(KU&<<2K'
M'5E5%(R;::SXK)EDAJ)J3S*3.31%!(;NHW>]+MII6IJQ:5QP:;)4:G-)MJ./
MK4&H2^7&365%WW)J1UT,OQ!J@BA;FO$/&VO.S. U=]XJU(A6&ZO(M=)NIFKS
MLQK>SCH?<9!@57DKG*R-)>7'//-=#I,1M=K=*CT_3!YF<5IW<(ABXKXB6,YW
M9G[A3R6/L=$>C^ _%IM9XUWXYKZ>\">(QJ$,8+9XKX6T74VMKQ?FQS7T?\+?
M%@7R@7].]>)BG%ZH_/,TRN5&;=CZ*UK2$OK-CC/%?.'Q0\+",RD+7T9IFL+?
M6(&[/%<+X]T'[=#(0N<BO,IUN61X-->S9\3ZM:O:W;<=ZU=%NMJ@&NI\<>%6
MMIW;9CFN&5_LDF.E>A)*I$JI+F.\L;G=BMVSFZ5Q&CWGF8YKJ;2;I7D5(<K"
MG%G36LO3FM2&2N>M)NE:]O+69TLV(6]ZMQL:SX9.E7(VI 6UJ1:A0U,M $M%
M(M+6;06(9$JO(G'2KC5!(M: 4)4JA/'6I(M598Z ,.YAZUD7D&X8KH[B/BLJ
MYAZUK$1Q^I:>"I.*Y*^D-I-QQS7HM]#\IXKA=<LRTA.*[J+U$U<[/X=>)&CN
M(P6[U]5^!=46\M4!.:^)?#,QLKE3G&#7T=\-_%@C6-=];UH75S&43UKQAI"7
M-HY SQ7S#\1-'-O-(0.]?49U :A9XZY%>1?$+PV;@2,%IX'%.A42/(Q$.9'@
M&CRM#=#/K7JGA^_'E+S7GU_I9L+DG&.:U-'U;RV5=U?LV5UUB*:N?+5Z-G<]
M:L9Q)BG:O:B>W/&>*Q= O?,V\YKIY,20XKNKQ2V.'GY&>!^/O#:R&0[:\7U+
M1TM)V.,<U]3^,-+\V.0[:^>?&UDUO(YQBO.<;GTN6UVY(YRWD5>!6M:KN&:X
MU+XQSX)KJ--U%/+&36+B?IN&FG%$VI+LA-<!JT[?:",]Z[C5+Y&B.#7#WBK-
M<GZTXHQQ4E8W_".F_;)DR,U[5H/A2/R5;;7FW@*U"R)Q7N.ER+#:CZ5T16I\
MU4F[E+[!'9]L5&=32'C-4_$6M+!NYQ7G>J>+A&Y^?]:UE'0F+/41JZR<9JM=
MVZWBGC->9:?XR$D@&_\ 6NYT?6%N8QSFH2+.8\1^&EDW';7'KH:P7'W<<U[#
MJ5N)XR<5Q>H66R0G%:Q,I&AX3C$.VO7/#\F56O']%G\F0"O3O#-X&VC-;=#F
M9Z?IOS(*T]HVUCZ5,"@K6WY2N?J4C/O:YO4CUKH[SG-<[J"]:WB4<5KV?*:O
M&?&4FUGKVW7XOW+_ $KPSQUE&>O5P^I$MCBX[O;-6O\ ;-T-<>UUMN.O>MB"
MZW1CFO643F>A;5O,F%=WX6M]VVN!L3NF%>E^%$X6L:VQI [S3H=J"M>$XJE9
MKB,5:4UXTCK3)G;BLV]^8&KC-UJI,-U3$HYC5[,,K'%>=Z];>6QXKU>_AW(>
M*X+Q%8[MQQ7I496,JBT.!#[7YJ\F'6JEY;F.0TZUEPV#7?)W1QCFMSNR*L0A
MU6KMO&LBC-6_LJXKE:*N8]Q$9%.?2N;U6PZG%=T]L,5E7]D&!XJXNP7/.)(#
M&YXJ9?NULZC8B,DXK$D8(V*[J;YC-D9C^;-;.F7?D8YK(60-2&<H>#14IZ".
MS75/,4#-7].4S2"N.T^Z+,,FNUT21/E)->-4B[FD3J+.U'ECBLS6DVJ:TTOD
M2/K6%K5\K*>:B,6S:YQNJMAC6.LGS5?U2;<QK*5OFKTZ,6@;+4DGRU1,V&J:
M:3Y:SV)9J[I/0PN;]C<=!6LDQ88K!TV%F(KI[&Q+8R*XY B#RW>IH;.0GH:W
M;/35.,BMFUTN/N*Q<K&IS=M9R<<5H16<G'!KI8=-B'85<CL8O:LY3"YS"6,G
MI3FL7QTKJ_LL2^E1R0Q8[5ES!S,XB\LWP>*P+RU=<Y%>B7D,>#TKF]4ACYQ6
ML62V<CM*M5J+[M-NE"N<4L)XKMB9V*=^>#6?;R8D'UK4U!?EK( VR54EH%['
M6:7< **V)+Q?+ZUR-G.5 JW)>-MZUR.)/.-UF8-NKCKV3]X:W;Z9I :YR\SN
M-)%)W+FG3?-726_S1_A7(:?)MD%=982;E%=$1E>\AYJK"?+:MBYBW*>*RIEV
M,:<M2HFM9R;L"M)8 ZYK L;C:PYK?M[@,O6L;&Z'+9@L.*O0Z>I'2H8Y15R&
MZ K-W-D-DTU=O2J%Q9*N>*V#= KUK)U"YQG%1SM&4CG=2MUYP*ATK3Q)...]
M2W4AD8UJ:##^]7BKNVCG>C.Y\-Z2J1*<5K:E<+9PG''%1:9.L-N/I6%XDU3Y
M6 -8:W&C$UK6"[, :Y\;KB3)YITC&YF]>:V--TPM@XK6]C6,;CM-TW=@XKHK
M33Q'CBBQM?+ XK27"XJ7([(QL)M\M:R-3N-H-:5S,%7K7,ZM==>:@J2,B^N?
MF/-9%Q<4Z^N.3S61<7/'6M8G'-#I+KYNM+'>8K*FN.O-56NR.]=21RN5CHFU
M  =:IS:ANSS6,UVS=Z%=F[U5B/:%_P"TD]ZFCNB!UJE$M6EC%7&)5[DQOG7O
M2"\9CUI/(S1Y&*;B/E+44W.:OPW07'-8YRM)YK+6;B4=-%>#UJW%=9KEH[HC
MO5VUO>1S4\H,[*RDW$5TFGGI7&:9<;B.:Z[36X%<E4Z:<CI;5ABK3,*S;>3
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MHW5(B;S*<LE5]U&ZF!<$PI?.%4MQH+&BX%OS5IK,#57<:=N- R1J;Q24FZF
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MK2TQJ %S0O6F4JGF@"6BF;O>B@ --S124$W"@]*6DI#0VG#I113&%.6DHIW
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M5JHQM5E&I,U6I.:8W>@-[T4KC&,M0R+Q5FHG'%0P,^6.J4T?6M61*J3+UIQ
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M2NLLM&# 96M#^R$5?NU@Y:E\IP;::WI4#Z?[5V]QIZKVK-FT_GI5*1:B<O\
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MJL10[J;L:<I0DC9LU UF2>E="MF&[5(; >E8N1KRF!%:[1TJY$H6KLEGM[5
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MC(K\^.06BDS1D4 +1110 4444 %%)1D4 +1110 4444 %%%% !1110 4444
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MBXADG-1TZG;:0QA6HF3-6:CXI"&1QU9CCJ$-BIHY,5(RU''4ICJ*&059!!H
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MV_% %1D-0.IK3:'VJ!X:!E- :E5":E6&K,=O3;$5XX3Z58CC]JM1VU2K;XJ
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M@V\WF3?C6L8F<F;=I;_+FG7$@B7%6;7 A'TK'U2;:Q%:1,V5+F3S&-3V$'S
MFJ=N#(]:L/[I:ML$:'GB&/K6/?:F6) -%Y=Y4@&LSRVEDS65BF2K"]T:MPZ.
MWI5[3(%0#=6JTT2+03S&5'IA]*>VDEQTJ]]NC%6+>\B;TIV9'.<]-H[Q\XJN
MKM;-78R>7,O&*P-2T_.2!Q2?F73D2Z?JO0$UTEI?!E'->>EFM9.>*U-/U?!
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M*2G4M PHHHH **** $:FTZC:* "EHHH **** "BBB@ HHHH **** "DQ2T4
M)2-UIU)B@1&U1MFIF6F,M ABU(M,QAJD6@H6F4YC4;-0 [-%1[J<&I+0!U)M
MI5HJMP$VBC;2T4 1M1FAJ2H 7)I*** "BBBJ :W6A>M.Q1B@ HHIN34@.IPZ
M5'DTNZD YJCI6:F$\4P'J>:22F*U.9@: ,G5#^[;Z5YCXJS\U>GZI_JVKS+Q
M2/O5+&>>7'^N_&MW1!R*Q;H?OOQK;T7JM- =WI7W!6TOW16+I/W16TOW16;-
MEL%%+24V2-HHHJ0"BBB@ HHHH **** "BBB@ HHIN30 ZBD6EH 1JCJ1JCH
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MJ[&N<4"+L,AXJ]&Q(JC E7X5IV!$G-,?O4V*@FZ4-%6(F?&:C\P4R1JKLQI
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MJ +'FYIRL342H:E532N4A]&#3E6I!'TH 8N>*GCIHCJ55H FCJ914*]JE5J
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M*\[%8*C4CHCU*.+<3&T3Q-<6LBY8BO7O!OCY@4#25Y1>:#]E4D"H--U"2QN
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M4W=3V&:;MH$(&IZTP+3UH&+1110 4444 %%%% !1110 4444 %%%% !1110
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M&U6%:J*MMJ99*-BT6E:GK)53SJ!+S0I R[YE'F56$E'F4<PN4MJ]/\P"J@E
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MFINZD,?WIV*8&YI^:8",VVHFN-O>DF;@U0FD-("VUU[T?:,]ZS/,.:FA<G%
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M%(!II,4M*HI ,VT;:>PI*0#*:*EVFDVT "T-WIX%-:J C+4M(12U(!1113L
M4FT4M%%@"BBBBP!112&IL M%-W4NZJ0"TNZF[J:6J@%:H'6ILTC+FI8%4YI,
MFIS'3'2I R]1;]VU>9>*V/S5Z?J2_NS7F?BJ/[U)E(\[F_UYKHM"_AK!N$_?
M'ZUOZ&,8JEL([W2ON"MD#Y16-I7W16R&XK%[EC?6F-3LTE588RGT;?:EVU("
M44[;2$4 )1113L 4444(  S2[:%I:H8VDP*6G8% $9I*DVTUEJ!#:7<:2BF
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MNXT.3=&M77:1Z=-Z'4V[5JVK=*PX6K7LVZ5YKU'(W+?[HJ[%6=;MP*OQ-47
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MNT^8D53B8O0N6ESQUIMY-E>M9BW'E]Z1[GS.]18CF'#YVJ_!#@51AZYK5@Y
M%:(UBQR97I5VUA9R.*+6U,C#BNDTO2"V#BL*DK&\8W*UG8%@.*L2:&9&'RUT
MMII87'%=#I>@_:'7Y<UR^UL;J-BU\)_"?F7T64[U]H>$_#Z:?HROM PM>)?"
M_P ,BWN(F*8KZ#N+^.QT4KG'RU\[CJKJ2LCFJZ['C7Q'\7'2[QE5\8/K6O\
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M_C"#4I53<#GWKT%?"\&L698*#D>E8^VG1?O"NT?GUXF\&RVDS9C(_"N=L=$
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MBAIN*K[J@FFVJ:CE-(CY[C;WK%U#4-JGFB^O=N>:YW4+POQFMXQ'(EDOFF;
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M73;$*HXKG] A!5:[2TCVQBN"I*YVQB.CA 85Z#X)T@74J?+GFN#C4F85[/\
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MQ-'=:>@9L\5^<?P]DE6^CZ]:^S/A??RK9QY)Z"L\RH);%/4[_P"*,<5U9R$
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MC8RBG8HQ3*B+13J;0 444JT!<2BE:DH&%%%%!%PHHHH&@IE/I-HH&"TM)2T
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M9: 1 U1,U/D.,U79J"K QJ,#YJ?UIZQT""-:M*M1*NVGAJ!#F7K4;4XM3>M
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M-+MI$7#=2JU)MI57FF%Q]%%%(=PQ[4;:<O2BF(8U-S3]M&R@5Q*6G;?:C;0
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M?9\N,5[-;7.+4+GM6M/1')5?,SR;XI6[2I)@>M?+7BS2)7O'PO>OLOQ7I/\
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M-"V7(K0ABJM:IC%:,2T 'EU#*M66JO+2%8JMWI-M/9>:04#!4I3&*<II^ZI
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MBO$?'FCPHLC "L\'4<?=9I!GR_>:((7.5Q69=6JJIXKM?%)2WE?%<1=789B
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M %%%% !1115 %%%** &[:44[BHVH =2-TIM%*X >E-IU-J0"BBB@ HHI-PH
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M-U(V33**<R]:K,E7W3-0-#4W%<K>7FGBWSVJPL?2K4<-,+E2.WQ5J-=M3>6
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MHP:.+D1QZU%AZ[F3PNW]RJC>&V5ONUFI7)Y#F8;=WQQ6E:Z:S$<5LP:-Y?\
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MRR_)98A7L>#BL=RZ'J=CKR[AEJZ:QU9)%'->$+XD\EA\WZUTWA_Q29I%7?\
MK6V/R=X:-[$X3%<\CV2.<28P:L+)BL#1;S[1&IS6NS[:^'E\7*?3J2<2]')F
MIE>LZ.;WJPLOO425A<J:N75>GB2J:R4]9*A&31;5Z?NS519*E5ZH1*U0M4F[
M--84A%:2JT@S5MP:@D7K4R15S.N$ZUG3Q]:V)EZU1GCX-1%69HC#N(^#7/:M
M;>8K5U-U'UK%O(]V:[X5+$RB<)=6?E/G%:OAW6C9W"C=CFI-6ML(2!7)^<T-
MWUQS71?F.:2/J_X=^(_M$<:[L\5ZI+8C4+,G&>*^9/A=K)22(%J^H/#-\EQ9
M*"<\5+I\NIRNZ9X1\4O"H"RML]:^8?$FF&WO&&,<U]T?$C3%N+>0A<\&ODWQ
MQH;)>.=N.:]W+Y*4DC.IBJE..AS_ (/L?,F7BO9-!TD>4O%>:>$[<6\RY&*]
M<T6X58E&:_2\'15DSY7%9G4D^5LV[.P5%'%2SPA0:DMYPR\4LWS U[D4HGG6
M]HN8P+Y>M9,C;6K;ODK N<JQK523/-J2<78/,S2_9Q,.14"<M6A;G %#.:SO
M<YW6-,"J2!7%W.Z&<UZ;J2"6,BN+U+2SYA.*YY(^HR_%^ST8FGR^9%@U@^*=
M)%Q&V!6S:_N#@U8N(UN8R.M<\D?60E[57/!M7T@V\S'%8\DFWBO3_%VC[58A
M:\MOH&CN".V:YV=D?='VR_.#77^']4^S.HS7*VR[8P32QWAAF&#4)B9[SH.J
M"YC49S5[4K/S(L@5Y]X-U?[@9J]0M72ZMP.O%:Q9FS@[B%H)L].:W=#U;R64
M%J76M/QD@5S!F>WF].:ZHF;/:]"UGS-OS5W>FW0D45X9X9U8[E!:O5-#U$,J
MC-$D92T.T7YEJC=0Y[5-:7 =1S4S('K'8BYS%]:DYXKG;RUQGBN[N[4$'BN>
MU"SZ\5T0D4<E(I5J-WRU<NK<JQXJDRXKH6HS UZ/=&U>8:Y:D2,<=Z];U*'S
M%:N"\0:?MW$"NBF]2)JYQ2L$ZU6N(_,/%+?,89".E2V.)B,UZ479'-RDFGJ8
M9 :[72-56-5!-<I<1B-,BJ*ZH\,F :B4><WB>O6VK(RCFK$FHKMZUYG8Z\VT
M9:M%M=.S[U<KI:FBD=)J.HKL/->>^)M3"A\&I=2UX[6^:N(UG4VG+#-;TZ02
MJ&/JE\9'/-9RJ6YJ253(Q)IVW8M=\86.:3*\C!5K)NV+5>N6)) JO%:-,W2M
MN:QSO4J6\;,U;UC;L5'%6=.T)GP=M=1I_A\[1\M8RJ6-(P,BWL6;'%7X]*+=
MJZ6UT$C'RUJV^B?[-9>U1TJ%CCX]$+8XJW#X=W?PUVL.CC^[5ZWTD#^&IE5'
MRG%0^%]V/EJ_!X3!Q\M=S;Z6HQ\M7XM/51TKEE4*43B8?"*_W:M#PJJC[M=H
MMNJ]J=Y2^E8.5RE X>3PNI'W:S;SPN%!PM>E>0GI5:XLE<=*(R-.0\BNM!,;
M'Y:HMI[)VKU*\T=7S\M9,^@CGY:ZHU"7$X#[*WI3?LS>E=K)H87^&JDFD;>U
M;JHB.4Y7[.?2E:$@5OMIV.U5I[/:#Q6W,A&#)%4+1UH7$9&>*ILM7S$%9XQ0
ML5/ER*B60@U$I%(M0PU;6$**J1S;:>UX%'6LMRAUPP5:YC5I1R*U;R^^4X-<
MWJ$V_-/DN829DS+NDJY91;<5"J;FJ_" JBNRE&R,'J7HY-BU4NIBV::TW;-.
MBA,S"G4DD7&)G^6[M5RWM6]*VK/1?,QQ6W:Z" /NUP2F;*)SL-BQ'(J_:Z?E
MQQ6]_987M4L-F%<<4XR!Q)=,TP!1Q6SY(A2DLU$:T7TV%.*-V05);[R^]5Y-
M6*]ZHW,A9JK,I(IN)JC7AU@[NM;-K=B9<$UQ:Y5JU+&]V,!FI<2C?O;!;B,G
M%<)XAT7;N.VO0[&X$T>*SM;L%DC8XI)V,9'B=[;&&0\=Z+=JW]>T_P N1N*Y
M_:8VQ75"1EL3L-U-"5+%\V*5UVUHS0CVU8M<JP-1(-QJY##C!KFDP->SNMJC
MFK,TPD0UA>:8Z7^T.V:-Q#=0A#9K),.UJUS)YU5Y8>^*Z8(D@C7Y:M6\8W56
M^[5^S7<PJ*DBU&YM:>", 5K+:F9.15?2[,MMXKJ;/3_E'%<3GJ;J!R%YH_4X
MK#N[%H\\5ZC-I@93Q7/ZIH_4[:UC4!Q//VC*TPQAJV;ZQ,;-Q64ZE:WYC"6A
M4FM0:I2Q>6:U'8U2N033N05XG.16G:J6K.ACRU;5I#\HIHFQ.K;%JA>7'7FM
M"9=JD5CW0R36G-H)Q,V>8LU0;6>K?V?<U6([.L)79*BS*^S-3UMC6Q]C]J7[
M+[5&IIRF.UJ30MH:V1:4-:]>*M28<IEBUI&LS6I]G/I3A;,>U/G9/*8GV,BI
M%A*UK&T/I339FCVC'RLHJQ6CS6J[]A/I1]@-/F#E*2LQJ386JW'8^U6DL^.E
M4I$M&++;DU4>W;-=(]B?2JSZ>V>E7S,G4QH[1F:MG3=(:1AQ5RQTSYAD5UVC
M:4N1D5A4FS6!6TCP[G&5KJ[70Q'&/EK2TVQ2-1Q6NL(V]*\^4V=L8G)7FC@H
M>*Y75-'V$G%>G7,(VGBN7UJ 8;BH4F.43SN2W,;8JU9+\PJ:\A_>&GV<.&'%
M=,;LXIHW+)]J"JNIR%E-2QG8M5+MMV172D3$PRS++D5OZ7>.H S6?'9F1NE=
M!IFDDXXK"9T1+T$C38S5^'3S)U%6++2]N.*W+6R"XXKCOJ;1BS,M]%'7%7DT
ML*.E:BH$'2HY)E455V=2B9TEKY=9=],(E/-:&H7RJIYKC]8U(G=@TN5LSD[%
M/5M2V[@#7)WUTTC'!JS>S23.>IJ"'3WF/2NN$3GE(R6C>0YIT=JU=-#HAV\K
M4PT?;VKK1A(YR.U88J7RW6NB_LT<<4QM.'I3N8LQXHV-7H;<G%7(['':K<-L
M%J+&BV*L-J<]*N+:X&:L1QJM/D8*M,5BE*?+%4+AM_%3W<I)XJM&K2-3*1''
M8^81Q6C#HVY>E6K.WZ9%;$$84=*QE(ZXQT.?;1,=J<NG^7VKH9MH6LJ\F"YY
MKD;;9G(ILJH*JS7"KTJK>7QW'%9<UR[FKBC.QH3WWH:S;BX+YIGS-UI?).*Z
M8Q(,^8G=4MM,4(J:2WSVJ+R=IK51,S9L[P\9-7_M(:N<CD,9J=;P^M:6$:\E
MP%[TD-\%8<UD/=$CK5?[45;K7/)7-(G>:;J ..:Z"&\!0<UYMI^HE<<UT5KJ
MF5'-<SB=,9G4->>]5;J]&T\UC2ZCCO69=ZJ=I&:7(:\Y)JU\#G!KFYF\QC4U
MQ=&5C4*+ZUO&F<LM6.AA YJX)1&O%56DVK5=YBS<5T)\HB>ZNB>E95PS2$U>
M6%I*F&G[NU*4AF!Y+9J:.,UKOI^.U-%GSTKF;>Y213C4U,JG%7H[//:K"V/M
M4JLUH296T^E-96]*VQ8>U-?3^O%:JJR#%7=4T>:NO98[5$T.VFZC $4-3_L8
M9<U$K[:L1W Q6$JS91$L/EN,5UWAFX*NHKEV<,U=!H+;9%K6/O(@]5TZ020K
M5?4+?>3Q46CS?NUK1D425Y]70F1SQL:*W/LWM17(9GZN4[;2T5\29!129HH
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M AR*:L1YIJ1^U3*N!0(D5NE.+5'G%)NH$)(U5I%J=JB:@HA*TF[;3V[U$]2
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MNNM;$F.R_/6WH]KN8<5E*O[S\:ZG0XA\M<E5G331TND6>,<5U=K:C8*R-+C
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MY\V2.1H_TKG/AEX%DN[J-GCSG':OK7P1X.2RM8R4QQZ5G3AS.[-*M7ET1?\
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M5QL&H)*0%=J@D7-6-I;-)Y)JBR@T)JO-^X&35N\N%ME)8XQ7#>*_&MO8P/\
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MJ&1J!H7=5F%ZSR]2QS8H!FLLHQ1YP]:S/M/O2K<>] D::R4_<*STFYJ=)-U
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M*Y<?G7RVWC"=CNW&G1_$Z73V&9,?C4JH:NB?;6FZI;W"###I5JXF55R*^7O
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MNFNX$).:<97*E'E.X6Z..M#7!:JI4J*%!K4Q+:RDU,K55C4U9C6HD -R#4+
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MDKFM[2O!H&TE*['3M%BLU!( Q7S&+S96LF>Q0P]MS$T[P@FT$I6[:Z;!8XR
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M_A'Q5)9R(&<C\:MZOX<15)"\UR,UL]C-D<<UX.,RF#@VD>E@<=--)GTOX/\
M&'VE4!?]:]/LQ%J%KDX.17R/X2\3M:S("V*]]\&^+!<0HN^OR#,,-.C5/NZ5
M6-2!2^(OA1)H9"J5\O\ C/P[)9W3D*1S7VU?68U2W/&<BO%OB)X)!61@E%*>
MEF"EJ?.&FWC6C8/'-=7IVJ"7:,USWB/2VT^X? QS532+XI( 353C<TN>F6\^
M5'-:,,W3FN5L;\,@YK6M[C/>N5HVB=%!-TJ]#)FL&WGZ5I6\W KG<3<U5:I
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MK8A\MQLB\._",.J,8?TKM(? L6FQC<@'X5[!H>CV]O8JQ Z5P?Q#UZ'3%?!
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MU2TTK2N! V:CP:LF.F-'1<"OS4D>:&2I(UI@2*M+MIZC I&J0(F6F4]J;MH
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M;3 2BBB@!IZT#K2XI56E<$)BBGXIM.Y=API>:0.!3MPI7 8U)3CS1B@04VI
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M5-0(VYRWI7H/ACX,DVHE\GMGI7)RN3.WF448'PZC\F:(R^HZU]@_"N\@6.$
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M!KJ])\.O-C*UW1PMM63.HCE?L,LG0&K%OHL[M]TUZCIO@OS,93]*Z>Q\"QJ
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M$2A2:[I^]J=4=$>CVL^<5JVLW3FN8TRX\Q <UM6\GO7+)A<Z6UFSBM*%LXK
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MS_$:3_6<UXE._P#IOXU[^1MRDCAQ<58].\&/\B5Z/!)^[%>8^#&^1*]&@?\
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MC?A#HL,S1$@5[WJ.CI;Z22H_AKYG%5VY\H.6IY_K'CB'1<J6 Q7+WGQDM]I
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M_#@_W*^6_BE;#^V6/^U7UE86P_X1P?[G]*^6/C!BWU1S_M5\[@?XC,%N>F?
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MY['RR50F;-22256=JI"&X^:IX5Q4*U,E,196D:FAJ8TE!(UU]JCV4_=2K0-
MJXQ2FG8ICYQ0 F^EW5 QYIZT#)3TJ)ZE_AJ&2@$0M35CW4M2Q"@!4AJ40CTJ
M1,4YF H$5VCP*KMQ4\TM4)IJ"B;S */.%9S7!H6XH TO,%/0YK/6:K4,G-!)
M?C6G,N!TJ.-ZD8Y6@15FXS42M\PIUPU5M]!1I0O5N-LUE12U=AFH$6C3&!IZ
M,&IVW(H K\TUFQ4LBXJK,U #9)*K,V:61JA+4#2)D-6$JI&:LHU F6%IU1JU
M.W4QB4FWI2TY:SZBL-V^U%/J-J"AI:C?3&I.:!%A6H:HUS4BTQC<<TNWVI^V
MG;:EC1#MH'%2[*:R]>*+E K4]6%0DT;J0%E6YJ13556Z5*K>]5<FQ*30M1[O
M>I%H$*U0/5EJAD'6E89#N]ZDC.3497FI(A\PI@:%O#N7-9&N:D-/A8DXXK=A
MD6.$DGM7DOQ8\2"RMI<-CBE+17*A'F9YS\5/&JR12QB3UKYLOK636-4) + M
M6[XN\4MJ&H,F_.374_#?PG_:DT<A7.37E3?.SUHKV<;GH'P4\&E3"S)^E?56
MDZ.EM9)\O:N!\!>&1I<,9VXKTU9]L 7VKMIQY4>;6ES,R[G]VQ JNK9J>Z.Y
MJKJM;7,;%J+%2,N:CA4U8"^U*X%5D-,6,YJYY?-(L8I#0R.$U,L-31J*> *J
MY3*WET>74[$5$T@I6$-5*EVTB,#4V :"AG2E#\4DE0LU0P+'F>](6JONI=]
M$H:GU IS5A<T7+0N<4>9BD:H';YJ0F65EJ0/D5062ITDZ4$EG-,;O2!N*3-
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M6O?$1L-M>IYIRV.RFH4MSUJ^\86UJIPXXKEM4^)T4.X"7]:\$U_XAS?-AS7
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ME'-,"W'*JXS3VN8_052P>*CD4B@"VUU'Z"HVNHSV%9TF<U&-U4BS1,BMTI5
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MKSSQ)XF:_P!V'SFO.(=8E;JQJ?\ M!G')JXX>,#.Q#J>^20G-9$S%:TKBXW
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MIM/HI ,I&J2D:H A:F[LU(RTW::8"BGXIJ]JD6@!N**<U-H **** "FM124
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M0&@ZX-4MU ;.17'-2HNZ.1N,M#R3QUX;VLY5?TKSF&%[.XY&.:^F?$GAO[7
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M/K22IYE<KI^J$,%)KJ;&82H.<U]!&M[1:'/:QD:I8[D/%<-J>GM'*2!7JEU
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M//L;$>9C\:M)DW/6;J2TE4CY:YC5M#MKW("BO+E^**F3!E_6NHT'QM%>,,R
M_C6RBS3F,[7/AO'=*Q6/K[5YEXD^$9&XB+]*^F]/OK:[C&2II=2T:UO(6P%/
M%7L&Y\&>)/ ,EB6Q'C\*X'4--DM68;2*^XO%GP]2[#E8\_A7B?B[X7O$7(B_
M2M%(FQ\^+GN*1H\]J[#6/"LEBS90C\*YFXC,+$$5HI7),\;XY,@UU7AOQ%)9
M2I\Y%<X<-VIFXQL"*M1N!]0?#_QY_JU,GZU] >%]=2^B3+9S7P;X4\026DR_
M-CGUKZ)^'OC?B,&3]:SJPY5<M,^C+ZVCFMSWXKS/Q5H^YF*K79Z-K:WT"C=G
M(J74]*%S"3C->/[>4)V)DKGAC6[VTU=!I-]MP":G\2:5]G9B!7,V]T89@,]Z
M^TRVOS6N<\HGHEKB8#O3[RR5H^E4-!N1(BY-;T@#+7U\6FB-CSC7M#\QB0M<
M[%$VG39Z<UZK>V:R*>*X+Q+:^46*BN'%X93A<J%;E9U_@OQ5Y;(A>O7;"Z74
M[89.>*^6=#OGM[I>3UKWKP'K'F1H&:ORK,*#C-GTV$J7*OCGPDMQ$[!,\5\Z
M>,-#-A,Y"XYK[.U6VCO+,\9XKYW^*&@[3*0M<-%6W/H8;'@T-XT<VTGO77:3
M/N4'-<?>6K07AX[UOZ3<;%'-.K$SD]3L[6;I6G;RYKFK6ZW8YK8M9<@5YLD5
M$WX'JVK9K*MY.!6A$]82-2?;2,M/7G%.Q60RG)%5"]C_ '9K99,U4NH=T9K:
MF[21,MCR/QH64/BO)[R5C<$'UKW'Q9I1F5^,UY7J6@NDQ.WO7[3PYC:=.*YC
MXK,HRD]"A;R;8<]Z+/5I+>Z7!(YJTE@RKC%0#2G\S=BOI\SS&BZ;1Y^"PTN:
M[/?/A-XJ=9(@S^G>OK'PCK,=W9H"V3BO@;PCJC:7<)SC!KZ9^&OC+SDC0OZ=
MZ_"\UY*LG*)]W2?LX69ZGXRTU;R!RJYXKY\\5^'WAN6(7O7TW:QC5+4'KD5Y
M]XX\,!5=MM<F78SV-1(RG351,\8T1S:. >*[[2]0$@49KS[6";"X8#CFM3PS
MJAEF4$U^QX/%*K23/E,51Y9'K>FKO -;T$(VCBL#0V#1J:Z:WQ6TG<\WFLR.
M2W]JJR0UJLH(JK,E<O-9G3'WD9<D=0,E7I%JO(M=,=4-Z%&3Y:@\S'>K4RU2
MD7%#@92=R=9J?PU5$S4Z4XQMN91A=C_(1NHI1:Q>@HIC,0:W5D=RAH.:VB X
M JG-$@S@5*TIJK*Q-:QE$XJE'6Y3ND4HPQ7%>(-,\[<0*[692U4+BS$@.16\
MIQM8S4O9['D\MO)8S;AQBNV\&^+VM9$4OBJ7B'31M8@5Q\9DL[C(R.:^"SC
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MMFT(/%<T).YGN4Y6W"F0C:P-5WD96(Q3A(=M>CRW1JD==H>H>60,UZ)HM\)
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M3: )::6]Z*93 *7%*M. I ,VT+3\"FU(#ATH8TF>*C9J8"L,YI-E.4CFG<4
M1[:6G8IM4D UJ:U24QN]0P&Y-&313N*0#2:C:INU1L!0 RE6C:*5: 'T444
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M?->'_#3Q()(XP6KV9+Q;BT&#GBN>20[G">,+\V\;XXKYX\>>*9(9' ?%>_\
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MTKLIQ5/<YY5.;8Y70_ WFA24_2NPT_P?%:X)6NFMX[>QCYP,5D:UXF@M4;#
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MB/S 5Y]XF^(D5NK 2#\Z\Z>(D]B^8[J_\506*D;@,5P/B3XEQ0JV)!^=>/\
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M.HF]@YSV5=8B P,4V34U9>*\ST_Q0MP1\^?QKHK:_$L>0U<MW'<SE*Y9UG4
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M*]STO4EU"S SG(KBO'/AW[1&[!:X<)5=&:N35C[2-CP+2Y'AO #QS7K/AO4
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MFGKZU]-?L_\ Q _M"2 -)G)'>NG$X-TX\PV>]^./!4<^G2.$[>E?&OQ7TO\
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M#2*.:U?'^M26.COM)'RU\$?&?XC7EK?S!9&P#ZUY^ P7MW<F*/KW2_C!IYF
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M3>2SN$SG-=.6U7"7O!&5CX?^RM%<$8[UK6MH9,<5N:_H!L;I\KCGTJ'3%57
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MAK"0T,IE/IE(H*?3*<.E(!:***:)"GJ*93UJ@'A>*:PZT[--8U*$-HQ2TC4
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MK$CFF67C"[UC 9F.:=K'A:75;5F*DY%.4G-:$P@H/4^<+J[EN-6RV?O5]-_
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M\>P 8IZPA>U/4A:%> N9L>JYH*A:/.4#K56ZN.N*Z8S3W':Y8:Y1*@FNPRD
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M355DN.O-0R3$]Z@8EJH1.UQ[U'YQ-1A2:D2(T 21Y9JNP0YJ*&'I6C!'C%
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MI**!,D\RF,]-W4QF- "LW-*I%1%CFE5J +&X4C4P-3J &LN:B,.:M!<U(L5
MBBMO4\<-6/)I=NV@=Q@&V@R8IDDF*K23>]2T!?6:I?,K*6X]ZFCN,]Z7*!H;
MLTC5 DU/,E-(0C 4BJ*:STBR<T%$NVFXI/,I-U(0A S12;J5:!BTULT]:3;4
MW'88M3+357FG]*:&(U1MWIS4V@0VG*M."T[;2*);4?-4.OOY=FY]JLVJY:J7
MBOY-/<^U5?0GJ?-7Q1UCRII!N]:\HT^X^V7PYSS73?&+4O+O)1GN:X?P/-]J
MU)!U^:O+F[RL>O3C:-SZ(^'NDY6-MM>ZZ!#Y,*BO./AWIO\ HL9QVKU*SC\I
M0*[J<;(\VJ[LN3&JA%6&YIFVMS!$++3?+JQMHVU-RBH8>::8:N;!2^72+6AG
M-&14$@Q6JT/%5)H:"KF?FGK\U+)'BF+P:!%F.,&K<4(XJK"U:,'2@8Z.';4Z
M_+136H EWU&26INXTY:3)L*!37J55IL@I7&59&ZU$9*DFJH[=:I,+%I)N:M1
MR5E1M5^%NE9R&RT6IE28XI&6I$-#5)&]0D=:5#TH N(W2GM4$9J<=*8#<5*N
M*C:C=31:+2MBG>=MJIYF*/,I@6&NF'>H6O&]:9NS3'J6(;-=L:JM<'/6GR"J
MSBG$9+]L(IKW1:JY!S2;338$OFG-312&H%CS5B.,BI N6[FK\9R*SH?EQ5^,
M\4 .D7BJY;::L/FJTBGFD \3'%+]ZH5!J9%H'<;Y6:/)JRJ4NRD%RK@K0)F6
MIV45"RC-(+B?:&I?,8T>73Q'0,;\QJ.2,MUJXD=.:+BG<=C*\CGI4T,>*L-%
M2HF*0R2*+-6XX:9 M78UQ3$5VBQ4+?+FKT@JG,.M [#!<E:<+]AWJLU1[34W
M&:"ZDWK4JWK-WK+ -6H5-%P+WF%J6F1J:D(HN TR%:7[8RG@U$]14K@7!J#>
MM*;QF[U45<U*%HW'8D:X..M0M<&D9343*:FXR<2EJ1CFFJIJ3;0%BI(2.E5)
MY&P:T7CJI<0\4PL8MPQ8G-5E'S5=N(N357;AJ!EJW;;BM:UO"@ZUC1Y&*LQM
M0!OQZHRCK4K:L[=ZP5E-2+(3BJ$:S7C2=Z9RU0VXW8J]'%GM2&4WRM59+AES
M6I)#Q6?<0\]*0%/[0Q-30S<U$T/-21Q$4 :=O<%<5HPWI7O6(F5JS')TJ0-L
M7S>M-:\9N]9ZRT>957 M^>6/6E\X^M5U:G9%2(L>:3U-*#5?=3P_2BXRPLF*
MCD;<*3?4;2#'6G<!DB]:K21]:F:3WIO6D-%-@5I89F605-)'4<<7[RI13)-8
MD+:<_P!*^(_VCHRSS?C7V]JT?_$O?Z5\8?M$6VYIN/6IJ+0JE\1\W> UVZ\G
M^_\ UK]$O@;)_P 2V#_=%?GMX/A\K75X_C'\Z^]_@?>;;& 9[5E1-ZVQ[S<+
MOC'TK-GM=P/%:<,@EC%.DARIKL<N4\_EN<E?:2LB-D5Y[XI\/_*Q5:]@N8."
M*Y[4])%P"",UDVJFY*DZ;/G/4+.:TG) (&:V/#_B26Q==S$5W.O>%%;<0M>=
MZUI+V3,5&*\7&9>JBT1ZN'Q?0]8T'XB!0H:3]:[:Q\80WB@%P<^]?),FN3V$
MA^8C%:FE_$F2V8 R$?C7PF*RV5)W1[].?.M#ZS06M]R=IS39/#=I/SM6O"]#
M^*PPH,GZUV=C\3D=1^\KQY8FK1T3*=&4^AV\G@VU/\"_E47_  A5O_<7\JP(
M_B1$>L@_.K<?Q$@9?OC\ZUI8ZM+XBX851UL:Z^$(%_@7\JD7PS;K_"M8[_$"
M''WQ52;Q]$<X<5U2KR:V.ATTD=*-$MD_A6G?8;6+LM<3<>/%Y^>LF\\?=</7
M-[:HGHCFE%'I3/:P_P!VJEQK5K".JUY'??$!N?G_ %KF-2\>3-NPYKIIU*T]
M"/=1[;=^,+:'/SK6#??$**/.)!^=>#:CXTN'8X<U@W/B6ZE)^8UW0PM29FZL
M4>YZC\2!@XD_6N4U3QY)/G$A_.O,(]0N)SR2:T[*TEN",YKUJ.5REN<L\4EL
M6]3\07%R3AFKG[A[J9OXJ[K3_"YN,96M^U\"JP!V5[=+*TMT>?/%OH>5V>G7
M$S#()KJ-)\.M)MW+7H-KX(2,CY*VK3PRL./EKU*>$A3Z'GU,5)G)Z?X41@,I
M6U#X5C51\@_*NFAT\0CIVJP(<=J]&G"$>AS>TE+<YV+05CQA:MI8"/M6QY=,
ME7;7?%HJUS.\K;366I9Y0G>J4E\JYYH;)Y;#V;:*K27PC[U')="3I6==0R2?
M=%<527*4HW+,VH"3@&J;VTEUT%266DS2R#(/6NST/P_NQN6O,J8KE.F%.QQU
MGX<FDD!VFNWT#PT8]I9:ZFUT6&!02 *+S4K?3XS@@8KRJF-DW8WV+EKI\-O&
M,@5G:IJUO8J<,!7(:_\ $2*T5@) *\D\6_%0?.!+^M<<INH0Y'HWB;XA1VJN
M!)C'O7D7BKXK9W 2_K7F'BKXC//OQ(?SKS#6/%DMP[?/4JCU,')L]#\1_$22
MX9\2G\Z\ZUCQ++<,WS'\ZP)=5:9N6S0H$WO6R@A(CN-0>1N34<=QNZU>71VF
MZ"KEGX2GE880UIRI%*)4M;<7&,"MS3_"LETPVIFND\-_#^XED7,9_*O:_!?P
MO9MA:/\ 2I;L:J)XYH_PRN+EE/E$_A7JG@_X1R[T+0_I7O\ X7^&,$<:%HQ^
M5=Y8^%[335!VJ,5GS7*V///!_P ,8[>--\0_*O2;/PQ:V,8RJC'M45]KEOI:
MD @8KBO$'Q.CMU8"0#'O2%S'=7U]:V$9P5&*X?7_ (@1V08+(!CWKROQ-\6M
MVX"7]:\E\3?$F2=GQ)^M22YGK/BCXL%=P$WZUY)XD^)<EQNQ*?SKSC6/%LMP
MS?.:YR74GN"<G-(R<KG1ZMXNFN';YR?QKG+C5I9FY8TU83+UJ==/]J1G(K+(
MTO6K,=N'ZU-'9[>U6(X=M3<E$*V2U*ML%[585:E6/-4F4BKY-31PFK*P9[5,
ML'M3N5<K;=M/CC\X@"EN$VU;T>+?,,^M2Y&L6:&D^%Y+R087-=_H_P -99HU
M/E?I6Y\/])AG>/<,U]$^%?"=O+;I\HJ.8JQ\MZQ\,YHXB1$?RKSO5_"LMA(<
MH1@^E?H#JGP_@FMSA >*\+^(GP\6(2E(Z7.)GR\LGV<X/%7;>X$G>KOB?PW+
M9SM\IP#6):;H6PU:*5S*QO1KFIU7I56UF#8J\E,6Q%)#O[5$;<1\XJ^HIEQ'
ME32L%R]X=U0V]PHSWKZ%^'>N>8L8+>E?,5GF.X!]Z]>\ ZU]G:,%J4D4?5]A
M(MQ9^O%><?$+21/%)@5O>%]>%Q;JN[/%6==LQ>P,<9XKSJFX'QMX\T$I-(=O
M>O.S;_9Y#Q7TI\0O#?\ K#MKP37[+[+.PQCFNBCJ(KV<F[ K22WW@&L73W_>
M >]=-;KE176T-,2V86K ]*] \&^(C#(@W5Y]=(>U7M G:&X7MS6$D7<^MO!>
MK_:HXP6S7;:A;K/9GZ5X;\/]>$8C!:O9+/4A=6P .:YI:&;/%?B7H?F+*0OK
M7S3XHT=H;ASM[U]I^+M'^V1.=N:^=?'OAOR7D.VM:<A'CD/[DXK3M9-V.:H:
ME']GD84_39=Q%=" Z.V[5J0KTK*M#TK8M>0*HDL)'3]E21KQ3]E1U&4KA/E-
M9*QD7 /O702P[E-4A9YE!Q3'>QZ7\-[CRI(Z^D?#M\K6@&>U?+GA*X^RR)VK
MW3PEK'F1*N:QD4M2_P".8?M$#\9KY@^(>D?O)#M[U]5ZQ%]KMV[\5X9\0M'_
M -8<5F#1\VSVOD7!X[UH6,G058UZT\F=N*S;.3$@%=$3,Z>W&5%6T3-4[,[E
M%:<,>:U!#)(_EZ57M%_TI?K6E)%^[JK:Q_Z4OUKGDC6)[E\*_P#EG7O<(_XE
M_P"%>$?"U>8Z]XC_ .0>/]VLDC;H>'_%3_5S?C7REXR'^D/]:^KOBI]V6OE/
MQE_Q\2?6NF&AA(Y[2@?,KKK-/E%<KI2_O*[*Q3Y5JFS,N01\"K/DTZ&+I5GR
MZ$R3.EBK.O(OD-;TD?'2L^\A^0\55RTSA-0A_??C7<_#M_)N4[<URNI6_P"]
M_&NB\&MY5PGUK.2NC2*N?77P]U#_ $>,9[5U7B"3SK4_2O,OA[>'RXQFO2;S
M][:_A7"XV9;5CY[^)=EN\SBOG?Q#;^7._%?47Q'M_P!W(<5\T^+4\N>3ZUZ5
M*5D3<XBY_P!979>!SMN$/O7%7!S-79^#6Q,GUHGJ3<^J?AK>;8XQFO8C)YME
M^%>"_#FXXBKW&S??8CZ5PR6I3V/,?'D7WZX#3_EO/QKTGQXG#5YQ9#_2_P :
M]C _$<[W/4/#S_N5K<:2N?\ #_\ J5^E;9/2OLX+W2)[$5WS&:XO6(\R&NSN
M/]6:Y35(\R&M5HCDBO>)?#/R3K7M/AN;,"CVKQ;0OEF6O6_#,W[M:_/\Z5V?
M78&5E8=XUCW6;_2OE+XE1[;B3CO7UEXK^:R?Z5\L?$Z+]])]:^*B]3VKW/,=
M+.+K\:]!TEOW:_2O/K ;;K\:[O2G_=K6CC<ZH'46C#BMJTDZ5SUJ_2MJT?I7
M-/0W1T%LW2M.&L>U;I6O;5RR%(O1=!5A:@B^[4PKGD0A]1.N:EIK5%BRC,E4
M9HZU)%XJI-'06C%N(>M8]]#D&NDN(^M8]Y'UK1:%'(:A;[<G%82WWV:Y'..:
MZS5(OW;5P&IDI=<>M=N&ES.QS5$>\_"_6O,DC&ZOH;3[?[98COD5\E_"V^,=
MQ%D]Z^L_!MTLUB@SVKLQ$>57.>$K,\U^(&@A1(VVO"-:;['<,.G-?5?C^Q$E
MM(0.U?+/CJW,5T_UKU,FQ'+42//S"G[2)-H.HF1P,UW=JVZ$&O+?#+GSA]:]
M-LG_ -''TK]APT^>*9\+*'LY%/5)-N:HZ;-NN ,]Z?K4F%-9NCS;KM?K6.-L
MH,[*/O,]J\'V_F*AQ77ZH/)LSVXKG? J[HD^E=+XB7;8M]*_&\TJVFSZ[!QL
MCYD^,5Z=LPSZU\E^)W\R^;ZU]1_&!LF;\:^7->3-XWUKFPOOH]FY'IMJ'4<5
MH?V>OI2:3%\HK6\G(KLE[A+U,A;?RSP*T+'5Y+.1<,14WV3=5=[#OBL^=2*2
M/6O /CZ2UDC!D/YU]0?#WXA)=)&K29_&OA"QN&LF&#C%>H^ _'3V<T8+XKBJ
MT4]4#1]]07$6K6XP0<BN6\4>$5FB=@G:N.^'OQ"6YCC5I/UKUV&]BU.UX(.1
M6=*I*B]#@JTTSYD\6^&6M9'(6N(^>UFP>.:^F_%GA472.P7->+>)O"K6TC$+
MCFOL,NS5J2BV>-5PZW,_2=1&T FMM;Y=N<UPTDC6+<\8J-_%*Q+@OS7Z#]8C
M.GS'F_5?:.R.VN-76->6K#OM6BDSR#7%ZEXJWYVM6%)X@D9OO5YZQ\8.S.N&
M35/B2.POKY%8E36AX;\2/;W"X8]:\\.JM)U-7M/U(1N#FN#&4X8R%SKIT:M!
MV:/K3P'XM\U(U9_UKT^01ZE9]CD5\C>#_%WV>2,;Z]\\(>,!<PHI?.:_+<PP
M;H3NCU82NCFOB-X,\])&5,_A7S;XJ\/2:?<,2N #7W)>6<>K6IXSD5X5\3?
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MQVXK["OK>+4[3C!R*\<\>>#2V]@E?097C72FKLX\5152%CPO3]1:WF )KO\
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MK%RU*Y78HPWTJ8&36QI]\S,-QJJVG@=J=&GDU:DFC'E/0/#!CFF3=CK7T?\
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M%P"DI:*@!5%+2 T,U(!"U,)I&;K4+28I@6-PIK&H/.IV[- #Z<K<TS=0K>]
MB7=3&:C=Q4;-0,5FIE+C)IVWVH 8JU*O:D"\T\+0 M(U+3&:@!<\5%-2F2F,
MVZ@"I(*CJU(E5V7% #:<HZ5%NYIZMQ0 LE1KG-2XW4+'0!/"*E-11_+4O6@
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M=0 M)NI:;2 =2,*-U!- "4444 ,IN:DVTW;[4P%7M3J0"G <4 )FC-!6HV-
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M?1'Q"M-ROQ7@NN0^7<-QWKK@<\B*QDQBNET]LA:Y2S;#"NITOYL5JR+&TO\
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M%V5I&5*\DEM'L[HYXYK]*R?'?6$KL^5Q.#<7S(]<\/ZEN1>:ZVUNMZCFO)-
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M.3[OX4UNM<XPHHHI@ I6:FYI&:@!=U&ZF9%** ) ,T$4+0U #&IFTU(U)MH
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MN'Z:Q%=19Y.93Y*=SB=8F,TIP:O>&;J2SG1LXYK!>X+SG/K6DEQY,>17[_\
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M\PXS7I7A?1]RJ2M8/AGP\TDBDK7J>CZ:MI"I(K*4AW'K MK!Z<5POBS5 JL
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MYI2W%,[T;J"2K??ZLUYKXJ7[U>DWS?NS7F_BH\M0:'"$?OOQKL_#8^[7'?\
M+?\ &NR\.\;:VB2ST72_NBM1NE9>E?=%:S+\M3(9$#3J3;2;J@0;>M)3MU)B
M@!RBI%IJKS3Z$ 48I12G J@&U&PI[-SUIO6D,CVU(BTAI\9% BGJ ^4UR.J
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M.602**HWUJ'4\57L-0$@'-:AQ(M<_/RNQZ3^$XW4+'KQ6#=6N&/%=Y?VH8'
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M^ZSUK3]0#(!FMB*0..M>;Z;JQCVY-=-9ZTN!\U%COC(Z7;3MM9<.J*W>IUU
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M25@C5L8K0N-2%G'C=BH+O44L;7DXXKSOQ%XL&6"O^M>Q*7LT%' RKST.JO\
MQDL+$;ZRY/'"N<;_ -:\HU;7I)&)#&L8ZU*AY8UQ_6U%GUM/)I<E['M\?B1;
MC^.KUI_I4@/6O%M(\2,9@"W>O7_!5Q]N:/O6=;&)Q/)KY>Z4MCU'PC9;=IQ7
M0>(;G[/8MSVIWANQVVX.*Q?'MY]GM9!GM7YWF%93J6/4PJ]G&[/GOXG:Q^\E
M&[O7C<^I;YCD]Z['XE:H9+B49[UYI&&FD)%>YE.7O%+85;'*#M<ZC3]1"LO-
M=AI-\)-O->9Q[XF!KJ=!O3N4$UZ6:9%[&ESI&5+'*3/4-/&_!KH+./&*YO0Y
M?,45U5H.E?E<GR5.4^AHS51&E:KTK4AJA;KP*T(16M3X;BJ19;CJQ&*KQ]JM
M1UPIW'!6)D%2K35%2J#BJ+"D:G4UJ (6JK-5INM5)^]1(I[&#KDFV%J\3\<7
MS*TF#7M.N(6C:O&O&>GM(S\5]=PWR.NN<^6Q\*C^$\HNKQWN#SWK=T>1OEYK
M,NM/,<Y)'>M?2EVE1BOZ(IQPT:2/BIQJ1GJ>M_#^X(GBYKZ8\+ONL5^E?,G@
M",M<1_6OIKPJNVQ7Z5^/\65*:3Y#[+*YRY=3E?B&O[MZ\6F/^F'ZU[9\0O\
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MUJ,/A)57>01CW.W\??$_*R!9O7O7S9XZ^(TDAD'F_K63XL\>/+YF9#^=>/\
MB+Q"URS?-7U%#"*FMC561/K_ (PDN)F^<_G5?2[]KN1<G/-<3=7#2S=:ZCPM
MS(N:[I+E-%J>C:;IIN(P<9XJV=#\ML[:UO#<*O&OTKHIM-5DX%<DI&MCE[.
M0C&*G:-97 JQ>6C1=JJ6[%9AGUIQ#E/2_AWHZ231DCN*^G/"&CQ):H<#I7S+
MX'U9+5TR<5] ^$_%4;0HN_M7CXR,F]#"<34\90F"V?9QQ7S7\0M0N4DD"EN]
M?3>LR+J5N0#G(KR'Q=X)-X['9G\*QPLE%^\3#3<^:?,O;F]QEL9KVSX6Z#<W
M$D18-VJ"U^'HAN0S)CGTKUOP-8V^E[-P Q7H8BLG&T1RD>B^'?#ICLU)':N
M^+4(M[&;Z5ZA#XFMH;7:&7./6O'_ (M:PEY9S;6[5XU%R]IJ<[/BWQ[,3K##
M_:KV[]G=2TT/U%>'^-8S)K#'_:KV_P#9^D$$D1/M7T6(=Z(^70^N]2(CT'/^
MS7R'\8+\+=3 'N:^G?$6M*FA$!OX:^._BIJ!GOI>>YKR<#%\Q4$>4:Q(TS-@
MU#X9L7?4XR1_%6G%9_:&SBNA\,Z0$OHR1WKZ"4K(ZHQ/K3]GVQVVT6?2N_\
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MXM\(_B+':VL2&0#@=Z]7U;Q-%K5D5#@Y'K7Q%6$HUKLP=[GQY\36NXKJ786
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M8UX48/VXZ;]X^2/$;_\ $PD'^U6'=9*UIZY)YE^Y]ZHR1[EKZR"T1Z46=?\
M#-?^)A'G^]7V_P##55;38QG^$5\.>!9Q:WB$G'-?6WPV\6QQV\2%QTKR,P@Y
M;'-6-;XK:/\ :+1\#/%?'WCCP^T=W(=O<U]O^(98]6LS@YR*^>_B!X8&Z1@O
MK66"JN*Y68TWJ?.,-F8Y.F*Z334PHIVI:;]GN&X[U+9KM6O7E*Z/2CL,OQA#
M7$Z\^W=7;7Y^0UP7B%OO5$=Q2.0OI/G-4&.:FO'_ 'AIL$9=J]&F<$WJ26\1
M<UM65G[5#96N,5K)B-:ZNAG<LP*L*U.UX , UD37FW@&F1W!D:N>1K$T)KAG
MSS47ELQJ6WBW+5Z.W'I629IRE6"W]15Z.'VIZPU8C3 JWL:1B0F.L^\3K6TR
M\5G7D>:YE\1=C+A^5Q72:9)@"N="8>M:QDVU=;X3"1T:S# YHK,6XX'-%><8
MG['U&U24UNM?!'(-6EHH/2@!M%%% !1110 4C4M%4!$:>O6EVT8J+ +36IU-
M:F RBBBI ***0MBD M%-W4;J %IK+S2[A36;FH 55I=M-W4H:F 4RG-3#UH
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M#/G/O3ENH[A<YSFM:=/V:L:+0Y%;$VL@(&,&O0O!7B9M-D3+8Q[US]Y;*P)
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M "@8HHS10(*3=2TF#0(0T444%"-4;=:D:HVZT )3EZ4VG+TH 6F-TI],;I0
MVBBB@ IPIM*#Q2 ;)4!JPQR*A8<U)-A5/2G'FF5*M,97D2HME7&J(CO2&0[:
M1N*EQ4;K3)*5\?W9KSKQ3U:O1+X?NVKSOQ1U:@T1Q!_UWXUV'AW^&N//^O\
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M@UCW5:+R;EK/N>]7<12W%35JWF((JE)2QR$-2&=%;W''6KBR;JP[60UK6OS
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MT.F_=%>Q1/(KF]#TJ0YS3;=<@5.(Z[^AYK&+3C'Q4JQU((^*0BGY=)MJTR5
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MTOC+_CR?Z5)X77]VM-\:?\>+_2OQC&_Q6?:8;9'RO\1/^/B3ZUY[;_ZS\:]
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MPV+-_I7XSC?XK/M,-L?+/Q$;_2G^M<':\R?C7;?$-_\ 2G^M<19']Y^-:1^
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M?CA+B%%+YX]:^++2ZDLY\YQ7I_@GQBUNR*9/UK@K)2U1E23CN?7EQ%%K%N>
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M;(P3]*^>/$EBUC<-QCFOMSQOHBW%O)\N>*^7_B)X;*32$+WK2,Q'FVDWA\T
MGO7?:3<9C7FO/8[9K6XY&.:ZG2;[:%&:V4K@=U:N&Q1>1AD-4-.N-P'-:G^L
M&*;0&!Y;1S9'K7>^#M6-O(@)Q7,S6H'.*9:7QM9A@XYK&0KGTUX;UQ9[=1N[
M5>UC3Q?0DXSD5Y/X+\0%MB[J]CTF075NN>>*R0SPCX@>%PHD8)^E>">(K4V<
M[C&.:^RO'&BK-"Y"U\R?$#03'-(0M=$!GGVFWI\T#-=OI5T-HYK@(X6M[CD=
MZZ72[S&!FNM*Z'8Z]Y=R\5=T;Y;A3[UC6\F\"MG3?E<&N><0/9?!EYM5!FO1
M)&$]H>_%>-^&-0\ME&:]2TNZ^T6X&>U<VS+/+/B1I7F)(<5\X^)--,-TW&.:
M^P?%VC?:H'.,\5\\>.M \B5SM[UM&5B3@-+E\L@'BNRTFXW8YK@Y)/L\V.G-
M=/X?NMV.:Z5[PF=[:/E16E'AEYK&LWR@K2C8UE*-B1;BW63M6;)IH9NE:Z_-
M3Q",5S]1F7;Z:J]JT(K95Z"I/+Q3Q71&0AK+3,8J4TVM+W)8BFG.=RXIE K.
M0BC<VN[)Q4$-R;.0&M=D!4_2L#4U*MD5BRCT3PGXBRR#=7L.@S+=1+DU\Q>'
M]0:WF7)[U[9X1\1CRT!:L;%(ZOQ1I"36[<9.*^=?B)X6):4JE?2[7 OHL#FN
M,\5>%1>1N=N?PJXZ%6N?$VL:;)9W#<8YJ*TU!HSBO8_&O@,J\A$?Z5YA=^&9
M;>8_*:W3N5REFSU!B!5]=49>]4[+2) !E36I#H,DW 4FF@Y2%=88G%7K-7O7
M QFK=AX)GFD'R'\J]$\+?#R3<A:,_E5\HN4P]!\%27S*=G7VKUSP?\/!#L9D
MQ^%=3X5\'Q6J*60<#TKKI&M]-A_A&*#HC:(FFZ=;Z7",@# K*\3>*K>SMW <
M# ]:Y;QAX]2S5PLF/QKPGQE\3FD\Q1+^M:(F4SJ/''Q($?F!9/UKP/Q=X\DN
MI' D)_&L7Q1XRENY&PY_.N*GN9+J3)YS6G*<SD6-0U26[8DDFJ]K$TK<U:M;
M'S.HK6MM/"8.*R9G(99Z?D#BM2*W\OH*?:J%XQ6WI^EM>. !FME%-&D8%&SL
M7N&  S7HO@_P:]U(A*?I6EX1\ O<NA,?Z5[QX+\!K:K&6CQ^%8R5CIC&Q!X'
M\#+;K&S)C\*]22WATNU[# J#9#I-OG@8%>?^-/'BVL;JKX_&LUJ$I6#QQXT2
MUCD57Q^-?/GBOQ1)J$[ ,3DU-XK\62:A.X#YR:Q=+TN34)P2"<FNJG2<CD;N
MQNDZ3+>S!B">:]8\)^'A$J96D\+^%56-24_2N_T_2A HP*]_#TN49+8Z>(U&
M!6Y9VO3BFVMKG Q6Y8V? XKV;I(9+9V@&.*O2*(UI\:!%JG?7&U3S7EU6[Z$
M&9J=T%S7(ZM> AN:T-:O]N>:XN_U(LY&:ZL/*RU(ZF;J4ADE./6M;PSIIN)%
MR*JV=D;R0<9KT;PKX?\ +56*UX.98_V;LCVL+04M6;^AZ6EO"&(QQ63XSUE+
M&V<!L5NZG>IIMJW.,"O OB=XV"K(H?\ 6OA,74==GO1IJ*T/._B5XN,DLH#_
M *UX[)>-?7)R<Y-:'B;6&U"Y?G/-4=(LRTP)%<4(*GJ=E/<V]-T_< V*ZG3[
M?:!Q5?3;3$8XK:M;?IQ5.;>YTR5]BY:0]*V+6#I56TBZ5L6L=<\["42S:P]*
MU;6'IQ4%M'TK3MX^E<,HJ]RK$T,>,5>C7BH8EJU&M:1E9$V)56IT6F1K5A5K
MDJ>\PL/1:F5:9'4ZBL5H JK05IZ]**8A *;)4O\ #4$II@5I&JC<-D5:F-4I
MC1(T1S^M0^9&1BO)_%>B&;>=N:]DO%# BN7U;35F5N*][)\<\+53.'%X=5HV
M/GJ^T%HYB=O>MKP_8D.HQ76ZWHJAR0M0Z-INV9>.]?JSXD<J:C<^0>7>SE<]
M)^'VG_O(SBO?--A\JP'TKRCX?V04Q\5[(D>RP_"OS[-\0L2[L^DP--01Y#\2
MIL;QFO(('W7GXUZC\3I<-)7D^GONOOQJLCCRU- S&2Y;'H.DQYA%6KA,9HT6
M/, ^E3W<=?KD9>XC\^DO?,U!\U=%H:Y=:P57YZZ30T^=:\_'O]TST\*M3T_P
MVO[D?2LKQV<6<GTK:\.KB$?2L/X@'%G)]*_&<;_&/L\.M#Y0^(3_ .E2?6N-
MT]LO^-=7\0G_ -+D^M<CIAS)6T?@.XZRQ'2N@LATK L/X:Z*RZ"N*6Y1LV8Z
M5LVJG K(L^U;-KT%92&C3MUK3MQ6?;CI6E#6#*+<=3QU73M5F/M4QT8$ZBI-
MM-CJ5:56TT9-7&A:7;3]M%8TUR,459D+QU6EBJ\:AD45M4]\[8R1FR0U3FAK
M5E6JLD=91]PF2YC(FM]RFN5UYO(5C7=20_*:XOQ5;EHWQ73A9<]9)G-5C[.-
MSRW7=2W.RYKDK^/SE)K=UZW=)F..]833!5(-?ON1X.E.FFT?#X^K*;L<_ODM
M;H$<#->Q?##Q<]K-$&?N.]>4705W)K1T'4FLKA<''-=F=X6E"B[(\W"3E&9^
M@?P\\7I=6L:EP>!78:U8QZI:D@9R*^4OA?XR<-$N_P!.]?47A'4AJ%LFXYR*
M_GW&1E&JW$^[H/GAJ>->.O!;*[N$KS.2%M+F((Q@U];^*M"BN+5FV@\5\X^/
MM$-M-(57%?39'CFI*,CR\=0NM"AI>N>80N:ZFSD\U0<UY5I\CPW(!]:]"T6\
M!C&37ZQ":E%-'RG)RNQO+"&ZU5U*Q5H3QVJY;R!L5)<1^9&15[Z,TY.IY9K5
MF\4Q*C'-:OA/5GL[A 3CFM?6-+#Y.*Y.X;[#-D<<U\WF>#4XMI'HX;$<KL?3
M/@KQ(LT**6[5O>(-/CU2T; !R*\ \#^)F69%W]_6O?O#=V-0MUR<\5^58JDZ
M,V?3T9<Z/G7XE>!3NE<1_I7A6I6;:7<'(Q@U]U>./#<=Q:N=N>/2OD[XF>'3
M;S2%5QSZ55&2J*QVJ-CC-,UC<X7-=AI]QYB@YKR^U5[>ZP?6NXTF\Q&N34UJ
M5MA<VIV5O-TK8M9O>N6M;C<1S6W:S\"N..FYVPV.AADZ591ZRK>;Y:NQR5%1
M]B9EP'-)MJ..3-3J:X>5W,DK$>VH9(\U9:F,M=<4C=/0S)[?.>*H2V^,\5MR
M1U2FBK7E[ MS#N(>M<_J5F'4\5UEQ#UK)NK?/:EJ5*S1Y[J&FE6) JE:ZA)8
MS#G&#7<7UBK*>*X[5]/*.2!733?<XI1/3O GCAH9(P9/UKZ-\%^*DO(T#/G/
MO7PUINI2:?,O)&#7LO@'QZT31J9/UKH<;K0RL?5NI6,.I6YP 217C_CCP)O\
MQE3]*[KPCXH74(T!?.?>NLU#2X=0M2< Y%7AZTJ$KF%6FIH^-]4T>33)R2I%
M-L=6*L%)KV/Q]X+!WLB?I7BFJ:3)I]RW! !K]%P&/51)-GSV(PO+JCK;*X$J
M YJZGS'FN/TW5O+PI-=-87/GX(-?20J=8GS52+C(O26B21]*Y'7=')W%17<1
MI\M,N-.69#D5Z.E6-I'31J<IY$&ET^;/(YKOO"/C![=D4OCGUK-U[0QR56N7
M4R:?-GD8-?%9GE<9)M(^AH8FQ]5^$_$RWBH&?]:[&\M(;^U[$D5\Q>#O&#6[
MH"^*]Q\+^*!?1HI?-?FF)PLJ,CU(S]H<5\0/ HN%D94_2OGGQ-X7ETVX<[2,
M&ON6ZTR/4K4D@'(KQCXB>!E=9&1/TK2C)6LSTJ;Y$?,MOJ36K;3Q72:7J/G8
MYK*\3>'9+&X8[2!GTJAIU\;5@&-<N(@GL#ES,]%MKCI6M:S9[UQNFZD)<<UT
MEI-T-11CW.F,;(Z&"3WJ]#+6'!<=.:OPS9[U%9);&BL:Z2>]3!JH0R5:C:N-
MW6Y5D6*"M-5J>K9KIIN+6HFDB-HZB:.K+5&U.3CT,6T49H>M4)K>MAES52:*
ML=RHF!<P=>*R[FWSVKH[B'K6=/;UI'0NYRMY9!@>*YW4M/PI(%=W<6_7BL:^
MLPP(Q71[1F<M3S:X62WFR,BNK\(^+)=/F0%R #ZU7U'3 23BN<NE:UDR..:W
MIROHSBG$^NOA[\0EF5%:3/XU['8W,.K6XY!R*^#?!_BZ6QF7+D#ZU])_#OX@
M"9(E:3]:52-M45!=SMO&'A))H7*J#^%>">+_  R]K*Y"_I7U-;W$6K6PY!R*
MXCQEX-6XC=@GZ5W8/%RI25V<F)HJ2/EZ&:2SFP>*Z[1]=PJ@M4?BGPRUE,Y"
MUR2W;VDF.F*_2,OQRJ))L^,Q=#DNT>L6NJ"4#FK+7(8=:\^TO6OE&36['JN]
M1S7UM./,KGE4V[V9K7+!LUCW29)J?[9N[U7DD#4Y+E-I-%-H^:>L-2X!J:-1
MBG%W)2BRH;>F- :T_+!IK0^U$KD3@DKHQ)[/>#QFN;U?3>#@5W;6]8NK6X"'
M(KF9-&LXRL>:7"-;R$].:U-'UGR6 +<5#K2JK-BN;\YXY,@UA)GV6"DZB1[#
MI>K13*N2*VA-%Y>1BO']+UEX<9:NGM_$1:/&ZN9R/?LXHZ>]OUCS@USFH:ON
MR,U4NM4,P.#6)<S,S=::D$;R9+=W!D)YK/EDVYS3GFVCDUFWUUM4\T.9ZE&E
M;4@U"X&TURVH7>TGFK>H:AMSS7)ZMJ?7FN:4KGLPT1#J6I8!YKE[R],C'FEO
MKXR,1FL_EFJ!O4FCS(U7([?<O2J]NO(K:LX=ZXQ2L9\J1ER0E.0*O:3>R6\H
MZXK5_L?S%Z4BZ(48$"NFG+E.#$0YCT+PAXB*; 6KUS0]<$R*-U?/6EJ]HP[5
MW.@^(C"R@MBNR,[GC3IM'OMC,LRCG-76M5D'2N#\.^(!,%&ZO0-,D$R@UU)G
M%)M&5=Z5NSQ6'>:25SQ7H36JLO2LZ\T]6'2M(U+$;GFEUII&>*R;K2]V1BO1
M+S31SQ65-I?7BNA5#:,3R_4O#GF@_+7'ZKX/9LD)^E>[OHX;JM4KGP[&R_=K
M>-6P2@?.%YX3>/)V?I67-H[P]5KZ"U+PLA#82N3U3PIUPE=L:YRN!X]+"T?:
MJ<LQ6O0=1\*ODX7]*YZ\\,2#/RFNA8@.4Y9KHYJ(W&ZM6XT&2/)VFLZ:R:'J
M*M5.8B2(&8FHFW4]FV]:03"F[&8@D=?6K$=\Z=S4.X-32N:%"X7:.BTG5F\Q
M<FO1O#NJ#:N37D%K)Y; UTVEZT8<#=6,Z92D>VV^M(D0YJM=:@;K@&N$L=6>
MXP :Z_1+5[AES7#)<ITQ]XLV>FO/(#C/-=?H^E>6%R*GTG255!Q6]%:B/&!7
M+*9T*)&UFJQ5RNO6 8-Q7:2<1US&NS*JM4P>HI1/+]6MQ Y-9*7V&QFM'Q->
MA6;!KCO[0_>]:]:G&Z.61TEQB:$UQ^L6G[P\5TEK<^9%5'4(1(V:TY=3F9B:
M78EI.E=MIFDLT:\5BZ;&L<@S7:Z5<Q*B@XJ9OE+BQ;712.U7ULQ"O(J[#=Q[
M>U0W5PK*<5Q2=V:&3J,BI&17GGB28'=BNVU1F96Q7GVO(WS5O3(:..NN9#3H
MVVJ*;<?ZPTBYV\5Z<7[IDU8UM/N L@KL](N%VK7 68/F"NQTF-MHKSZFY43J
M&N5V5E7ER"3BGR*X6JOV5Y6J(U+&Y5DFW-3?O5J1Z*[\[:5M(:/JM=4:EQ.)
MC3*>U9UPK5T,UKL!R*R+K -7N-(S,-NQ6G8H2PS5=$#$5J6L6W!K1:&<D:=N
MH""FR]<"FJ^T"F[MS"HE*Q*+%O:F0UH+I9QTIVEJN1FNAC5-O2N*=1G2F<G=
M631U165H9.:ZJ^A5LX%<WJ%L5R0*UISYB6KFUI&K#@$UV5G+'=1#Z5Y%#,\$
M@YQ7:^']6/R@FE4B(T-?T=9$8@5QGV$V]QT[UZ3)(MU#Z\5S.I6(5BP%8QET
M)L-L;SRXP,TR>Y$K]:R;BZ-OD5%:WOF2#FM+".UT1?F%=K9I^[%<3X?DW;:[
MFRY05QU#MI;$X6G]!2]Q44S;0:PL=*9%<28!K(O+CKS5FZN<9K'FD,AK:,26
MRO<2;VJC-;B3M5TPDT>7BMTS-ZG-ZAI@93Q7)ZII.,D"O1YXPU9%]IXD!XK6
M+.643RRYM6C8\5 &*\5VFHZ(3N.VL&XTAE)XKJC(RY#,^\*@DAW=JO/:M'VJ
M!AM/-;IW#E*#6>>U(+0BKWF+36D6GRHEQ*ZP8%./RU+Y@J*3YNE*]A(C:;J*
M?;PF5NE$=JTC5N:7I_S D5G*8]R?2]++8)%==I^GB-1Q5?3K=8U&16GYPC6L
M6[FT8DC.(UJA=7!-$UQNZ5#Y9:L'#4Z+V(?F8U-'%CK4B1!:)9 BUI\*%*8R
M681KUK'OK\<\TFH7VW/-8%Q=&1NM)3U.:4KDLTQE:I;2U+'I45G;F1JZ"TM/
M+7)%=D9&(6ML(UR13KBZ$*\&EN;@0J>U8-Y>&1L U,I&L437&I,S$ TMMYDS
M=ZJVMJTTG2NLTC2<A<BN?G.F,1FGV;MC(K;CL?EZ5HV6FJH'%:'V4!>E<\I7
M->4Y:ZLSM/%<OJRM"QQ7H=Y;C::XSQ!".>*(LSE$QM*U)XYQD]Z]/\/ZEYD*
M@GM7D$?[NXX]:[?P[?%549JG&YS/1G7ZQ$LT9K@M2MQ'(2*[=IO.A_"N2UQ=
MI8U<=!Q95T^XVN!FNOTM@RBN M9L3"NVT:;*CFHDCT(&G?1AHS7#Z]9[MQQ7
M=R?,M8>J6/F*3BE#0)1/+[F,Q2=*@\TGBNAU?32K' KG)HS$QXKOC/2QPR5B
M:,<YJU'+MJ@L^VC[3GO4<O,R+FDTP856FCWYJ&.;-3JU:QIF4I$4=H,]*N10
MB,"FK(%%-FN1V-:VY11U)9+H(.#5*2<R$U!)(9#5BUMS(>E<\YFR@+!;F1A6
MU96?S#BG6=F..*UH;<+BLEJ;I6-/1X_+*UW6DS!56N)L 0PKJ].8[17'B%="
MD['2BYX'-%9^\T5Y?(1S'ZFTUJ=36KXX\YB4444@Z!1110)!11104%)MI:*D
M"-EJ)A4K-4,C4 1L:9D4CFF\U# >:3FBGJM(!5S4BFD5:=C%,!=WO36:F.U1
MM)0!)GYJD6JZM4JM0 YN]-W&EIIH -U%,H% @9=U,:.IUI=M %;RZ<%J;;2;
M: 8RER:>5IC4"0E%*M+04-IN^AC5=Y,&@1,6S4;-47G<4>9FI&.5ZD62JY;K
M0K4Q%K=FBHE:I%J1BT44C4 +2-3:=2 B9<TS94^VF$4Q$?E9H,/M4JFG-S0%
MBD\=5YH\5?9:@ECS3 PM04^6:\_\19W-7I.H0_NS7G?B2/#-3+1R$?\ KOQK
MMO#G\-<6O$WXUV?AO^&M8!(]&TO_ %8K4;[M9>E?=%:Y'RT,D@IQI2M)2 1>
MM24S%&ZID-BM4#9J4MFDVU*$1#-2+1MYHSS5C';J7?3::30(E\RI8W^6JRU-
M'TH&4-8PT9KS?7X1N:O1M8?;&:\XUZ8;B*I&,SF&^62K4$IJLWS-4\:XI'&R
M^LGRTC&H@U/#4B&1RKP:S;D=:U)"-M9MU1<S9F3=ZR;UB :V)5SFLB_3Y36]
M&6I#,"[DYK.FYJ_=KAC5"1>M?2T-CCFS,N%ZU29>:T9TJFR5V'/?4K%<TNVI
M=E*%J6Q,;&M3QK2*G2K$<= P5>E2+'3DC-6(XJ>P"0PUJ6</2H;>'FM:TM^G
M%)O0TCN7[*/I6[9Q]*S[.WZ<5NV=OTXKR,0SM@BY:0]*UK>*H;.WZ<5J0PXK
MP9+4ZXH(TQBGFI/+I&6D;6*LPXJA.O6M*1>M4IEZU+,VC&NTXK+9=K5N7,><
MUES1XS4$$^F2;9!7H/A^3*K7FUG)LE%=[X;FSMK=;&]-ZG?6_P#JQ]*).M)9
MMF,4Z04CNZ$#-2 TK+0JTQ#U[4K4E%2 RG+2-0O6A $_^K-<KK&/FKJI_P#5
MFN4UA3EJ<=QF"&_>5IVOW163]V2M&UE%=)1HK44O2A9ABH9I:0[E>9JHS&IY
MI!5.:3WK11)YBK<-Q54-\U2W$E5U&YJV6B)-C33\PKM-)^Z*XS3(SN%=GI:E
M0*XZK$=!']VFGM1&WRTE<@QU-;K3A36ZTP"D:G**&7BF S)IU)MI: "BBFGK
M0 ]:6F*:?0 4VG4VF@"E6DI5IL!:***D!VT4-1NI,T@&-WIN33F[TRJ0#J6D
MI],88HHHI6$%%%%, I<TE%2 C5"_2I&J,U8$+"H96JP_>J<YZUM$"C.V33(_
MO4DQ^:G0]12D!=A6K2]*AA7@58Q4 +36ZTZD:@=R-N],J4U&PIV$)1112 :U
M)2M24 %20]14=20T[ 5=9_X]V^E>*>-O]8U>TZV?]'/TKQ/QLW[QZJ.Y+//?
M^6_XUNZ?T%8 /^D?C6_I_05ZU$\FN;MNN5%3&$5';G@5*SXKO/,MJ0/&%J"1
MMM32253F:@H:\M*LF359C3XS0!HPG-6TQ6?"U6TDH M#&*C9J9YM-W9H$(W)
MI"M/ HVT%7*\@J&K,E5F[T"%49J>-*@CJ["*!#UCI'6IEIK]* N4I*@-69*K
MM0 +VJ95%0K4RT B9%J54Z5$K#-3HPH -E2*,4QG%,\[I5 75Q4<J<5''-3V
MD!%2QHHSQ]:ILN*TIN:I2+4#(H^M3QK[4R->:L1K0)CMM+PM.8X6JTDF* )V
MDI-]5/.J1'J66D6:1J%.12T[ 0L*%ZT]EI5C)-("6$5=C4XJI'\G6I/[0CB7
MDU0BPT1JM)":CDUV!>K"H&UZW/\ &*0:CY(34#(:D75(I.C T]6$G2A@BL5-
M-JXUN?2H7A*THC*YH7K3F6A5YJP'!C3BQIRI2F&DT%R!FI\=(T=/C4T 6(P:
MEYHA2K*P[J5@(H25:JFN*TUHP]JO,OE\U4NKB-E*DT[Z!U/GKX@^%GO9G.S/
M-<CX?\&O;WBML/7TKZ0O]"BU!B=H.:KVO@A(V#!/TKEE3N[G7&I96,SP=8M;
MQH,8KTG3F*J*S;#0Q; 86M>*/RUK1*QSRES%X24;LBJN[%2*],S0]H]U5WMS
MZ5<651UH:9/44R[&<T)6E7Y:LR,K=*A(J&46(FXJ4O59#3]U(0KM3-U(QJ/<
M=U4F4BS&QJRC53C-64-)B)\U&]&ZFLW%,1#(.M0,V*EE-4Y&-2 YI*8V&J#S
M#FE$G2F -#NIOV4U(;I$ZFD%]&<<T#U!8-O:K$<=,CD$F,585: L*O2I*14]
MJ?MJBAH7FI%XIE+NI 2@C%2*U5?,IZR4A%AFJ)F-+NS01FD W)HW44R@984U
M+5=6J7=4B%-)3"U&ZJ91*),5*LG2JFZI%:L^I2+#-D5$PHW49R:H&R-UJ%EJ
MUMR*8T=(1''UJ['C JH!MJ6.2@998C%5I.]/:3BH7:G<")UR:%7VIPYIZK4@
M"K3SFE XIU,"!JCP<U9,>:;Y1]* $B2KL450QKBK49Q0,=Y>*:>,5(S<5"YI
MC'JU'6H=U/6@!S+3/+J5:<%I," QU&T=7-M,9.M2,JXVD4XR[12LN*K2-B@"
M;SLTJG=516Y%7+<9Q0(LPQU>B3&*AA6K<8QBDQDBK0RT9HS4E%>2.HC'5IN]
M1M0!&BU:BJ 5*K<4#L6@WRTTM4>^FF2@;)&(J-L4UGH'-*Y*(WJ)C4S*:A9:
MH9'UJ,K4^VD*U B#;AJGA.,5$U"M57 T8VXI=WO55)O>G^9UJT*PYV]ZKR38
M[TDTE9]Q/C-!)+/<=>:J-)DU7DN,TWS* +D;>]3HU48VJ97I,"=I*C\RH9):
M@,U2HW%<MM)FJ\AS3/.J-IA6_LQB255DJ22856FNE"T<W*1RC)+D1@Y-95]>
M[@0IJ#4;HDG::AL+62ZD&0364\0DC2,-1L-O+<2#@FNLT312VTL*T-$\.C:K
M,M;L@BTZ/L,"O'K5[G5LA(]/CMH\D 8K$UOQ%%IT;88#%9_B3QM%9Q. X&/>
MO"?'?Q*&) )/UKQJDW(5SIO&7Q,$6\"7]:\&\9?$1KDOB3]:Y7Q=XV>YD?$G
MZUY[>ZI)=,<L36<=S%E_6M?DO)&^8FL-0TSY/-2Q0>8W-7H;,=JZFK(45<@A
M@7O5N.R\[A14\.F2S. H)S7=^$?!$U](N8R?PK+F-^4P?#_A.:\D7"$Y/I7N
M/@'X9O*T9:+]*[3P!\+!MC9XOTKV_0?",.EQJ2@&!Z55PV,/PC\.8;6)&:,#
M\*[H0V^D6_9<"J]_KT&EVY&0,5Y=XP^):1JZB3]:1+E8Z7Q1X^2Q5P) /QKP
MSQQ\3#)O E_6N0\:_$1IF?$GZUY%K7B22[=OG/YU'*9.5S=\2>,Y+IW_ 'A-
M<5<7[W+G)S4)9KALDU)':XH(&+;^8<FK$=J%Q4BIM%/W4 *ORT[=2#FGJE2
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M)B?ES^%3&95SYUB\ E6_U?Z5T6C_  _W,N8_TKU__A&8U;.P?E5F'3XK0@D
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M$8M.A5B@&/:L?;M:'5&-D5_!_@N.UA0L@''I76W$T.E0]@0*JW6M0:7"1D#
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M&/I6+D,FB6K*+[4R-:G1:BX$D=6%J)!4R]J3 E6I5Z5&E2+TJ+$L6G4F!2U
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MP,=E*J1<K'L8?%*.Y]?^&?$R7D"KNSQ6IJFCKJEN3MSFO ? /BXHT:L_ZU]
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MG2;-^ZU!83UJG_;J!OO5Y=JWQ%B9B!(/SK$D\?#=GS/UK)S1JJ;/>[/5%FP
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MVGS+SC%>X?#OQR5:-=]>"ZI:F%\@8K5\*:X]C<)EL<UZ4TIQL<\_=/N[POK
MU*%<MG(I/&'A^.\LW.W/%>3_  V\;*5C!D_6O:8=075+0 '.17FQYJ$KG&TI
MO4^._BQX-99)2J>M>$3:(]O=G<O>OO7Q]X)%]#(WEYZ]J^:O&G@X:?,[;,<^
ME>Y1QK:W/K\HE"$DF>=V=JBQ<CM5'5+==AP*L7MQ]ED*]*IR7'GJ:UEBV?L.
M%HTJU(YQV>.;BNW\)Z@ZLH)KFWM5:3-;FB1^4XQ7T.6UG.2/S'BK+X0BW%'L
MFC7^^->:WH8Q,O-<-H,QVK7:V#G:#7Z-1C>)_-&+O3JLQ_$6AK-"^%KQ+QAX
M7=9'*K7T=/&)@0:YO7/#$=U&Q*UE4B>C@\6X6U/EAK&6SD.015ZWU4PJ 37I
M'BCP:(MS*GZ5Y-X@MGT]V&,8KS)H^_P..<K:FA<ZT&0\USNHWYD8\UBSZP0Q
M4FB.X\\9S6'*?7T:G.ALSEB:B5?FJUY.ZI(;,LW2LY*QTN(EM:F1NE='I6ED
MLO%+I.E[L9%=CINF!5'%$6 :;IXC49%:<C+ M)(!;KZ5BZGJ852 :Z8D2E83
M4=9$>1FL&:X>\; YJM-YEW-QSDUU?A?PV]Q(I9:WBCSZE2QC6?AV:X.=IK8A
M\)3%?NFO6=$\)1+&NY!^5;L?AV!>-HI2B<4JMSY\U+PC.J$[37&ZAX?GAD.5
M-?6EUX4@FC(V"N*U[P(A+$1_I6E.)C*5SQ/P[9O%,N1WKVWP:P14S7(R>&OL
M<N=N,5T.AS?9F Z5UQB<LU<]O\.SC:O-=I:R!E%>4>'=5^5>:] TW4 ZCFK:
M.*46;L@RM49H\U:202+2M%N%9LJ+L8EQ%5&:.MRX@K.GAIQ-N8R9$JI*E:LL
M?6J4L?6M47<SG6HFJU*N*KM3L6B%ES4?EU9VY-/6+BJ HM'5&\M]T9K8DAJM
M<1CRSFM(F;9YUXBA\M6KR[7KC#,,UZKXP<)&]>*>(+@M,PSWKT\.<\F8MU^\
M)JDJX:KRC>M0,N'KV4]#GDS3TV#<PKN=%7R5!KEM#AW8KK8QY,>:\JLM2X&M
M<:EMBQFN2U2Z,DA-37FH?,1FLJ>7S.<TZ<1MDMM<;>]327!;I61YVU\5K:;"
M;AAWKIE'0BY:L;5IVZ5T,&C?N\D5<T71P%!Q6_):B.+&*\RI*S-HG$7NGK%G
MBL6X 4UU6M+C.*Y.[;YC771D$BLS<U$T>ZG9J>*/=75(Q2(H+0LPXK9M-+9P
M.*ETVS#,O%=CI>EJP'%<<Y&BB<Q_8K;>E9]]X?9E)Q7J*Z2FT<56O-)3RSQ7
M,YEI'@^LZ28,\5R%]\C$5[%XNTT*K8%>2:Q;E9FX[UZ&'E='+4=F4[;A@:Z3
M2=1,##FN;A^45/%<%9*NI$B+/6]#U@NJ\UU,.HGR^M>3:'J7E[<FNOAU<&/[
MU<4H&G,=%<:@6XS63?3.PSFJJZ@&;K4S3(\?6LU#4U4C"O9F&>:S60R-6I?1
M[FXJ*WMO45U0B5N5HX?+YQ5:]N-J$5J72B-#7.7S%F(K:Q$C)O)=SFBWS4WV
M0N<XJ1;?95&*W(&SN%;>BR;66LAAS6AI[;6%*6J.A'J?A^==J\]J[*SD7;UK
MS'0[PKMYKKK75-L?6O-J+49T-]<!8C]*X37KC<S5J7VL KC-<O?7/GL>:VI1
M$S/1OWE37$G[NH57:V:CNYOD/-=J),FXDW25?T]-PK+8%I*VM/7:HS3<C-DT
MA\NGVUP=V,U%=&DL8RT@KEDKE)F[#ND6IEM6S5G3[<;16D(D%18JYFK"56JM
MT36S,J[36-?,%S18=S-D<@GFHS>-'WJ*XNE7O67>7PP>:?**YO0Z]Y9^]6G;
M^*0N/FKS2XU!@QP:KKJTB]Z:IW'[2QZ[_P )6O\ >H'BA?[U>2#6),_>-2KJ
MTO\ >INB6JAZP/$Z\?-4T?B5#_%7DRZM)CK4\6L2?WJGV1HJAZ]%X@5L?-5E
M=9#?Q5Y5:ZT_'S5JV^M'CYJ/9%*9Z/'?^9WJ=&#UP]KK8[M6Q:ZXO'-9.%A^
MT.D\A6J&:S7!XJE'K*D#FG-JBMWJ.4?,4KZQ7GBL*ZC\EC6]=7RLIYKFM4NU
MYP:TBC*3$34!&>33+K4A(F,US]Q='=P:(7>3BMU$XY;D5\IFD.*=8V!W9(K3
MM].,A!(K2CLUA7-"CJ4BDL8ACK,U"ZVY&:O:C="-2,UR]]>;F/-=*5E<9(LA
MEDKI-%M]V*YBQ;<PKL-'8+MK@JUK:&T3I[&':HK7A;:HK)MYPJBK2W0 ZU@O
M>.Z!H^94%Q+@&JOVH>M5+R^"J>:>PY%;4KS:#S7)ZG?]>:MZMJ749KEKRZ\Q
MCS6D6<<V5;ZZ+,:RI1YC58F;<QIL<>XUV0.6XZSA^85T-J=B"LNWAV]JNB7;
MQFNI(M!?7'RFL&XS(U:\@,M$.FF3G%0ZB6@.G<P/LY[BIH_E[5ORZ20O2LJY
ML6C/ K/G1*C8C\P8I&;TJ+R76GKD=:T4D5L,?=48D9:MA0:9)"*TLFAWU'0W
M17'-7H[[Y>M9+QE>E-4O7.XEW-S[7NX!JU;'S#6!"YW5M6$F,5#B*YTNFPCB
MNDM"$45RUI=A .:OC50O>L7$TC(Z5KH+WJ*340HZUS4NL>]4YM6//-9.F;WT
M.DN-6"@\UA:CJV[O6+<ZH>>:S9KXN>M;TJ9A*H;$=Z6DZUT>ERD@5QNGON<5
MV>DQ_*M1B8Z&$IFP)#@44\1^U%>1RF?,?KQ36%.I&KXLYAI%-H8TA:ES"%S2
M,U-W4FXTK@#=:2EQF@C%2,5:<W2HLTNZK 5J2BBD JBEVBD6EJ&!&RU&R\U+
M2;: (:5:<5]J-M "J33LFF@8I: %R::6I:0B@!-U&32[:-M $4C<57:3FIY%
MJLXYH /,IK2TE1-F@"PLE2;JJQYJ=: '#K3U6F@=ZDH :>*5301F@"@0N:::
M=2;:0$=+NI",44AA3=M/6EI 1[:;MJ2DVTP&!:#'3\8I:0$.REZ4]12;<TQ(
MBIC<5*RU!(: 8Y6J16JLK5(K<4"+*_-366FHU.+4@9G:D,1FO-_$_P!YJ]*U
M'_5FO-?%'WFJC2)Q?_+>NP\.=5KCB?WWXUV7AL9*UM'84CT72/NBMS'RUB:3
M]T5L[OEJ=F(:RC%,VTK-2;J; -M'2C=3@M2,;NI:5EI*0!11FF%N:0"TFZA:
M1NM ,=OXJ*2'S%/>G4]*I".7UO2?.5N*\\UG0RKL=M>SS6PF4\5SNL:(K*3M
MJTS"<+GD4=J86Z5HV[=!6CJNG^2YXK,B4AJEHY[6+RKD4QHZFC7BE9:RN#*3
M+4#+5QUJ%EJC%E1H^:/+Q5G9FD,=(BQ$(Z/LVZK"Q\U/''36A5C+>Q]JC;3_
M &K?6WW=JD%F#VKHIUG%BY#EGTX^E1?V:<_=KK_[/![4JZ4,]*[XX@/9G+0Z
M6>/EK1MM,]JZ&+2QQQ5R'3@.U'MRE2,6WT_':M2VL]N.*T([$#M5J.UVUA*K
M<VC3((+7IQ5V.#%21Q8J<+BN=RN;QC8C6/%.VTYJ:S8J2Q&XJM+)4CR55E:E
M<1!-)5222I9FJG(]3(Q;&2M525\5)))6;=7&W-9$L?+*#5.4ENE1K*9&K1M+
M(S8JN4FUS'DC<]J8L#YZ5UT6@EATJ1O#^%^[36A7LSE[=FA85T.EZH8R 34-
MQH[)G JBT+P-Q6RU*2Y3T'3=44@9:MJ.^1@.:\NM]2>''-:=OKS<9-0XFJF>
MA?:5;O3UE#5Q]MK6XCYJU[74@V.:5C3F-T<T;:K0W2L!S5I9EI;%#?+INS%3
M>8OK39&&,TKCN1[MHYJI>7"@'FF7ET(U/-<WJ6K;<\U:5P+%Y<KD\UFR3@YK
M*N-4+-UJ-+HM7/5ILWI&BS FGQ3!6JB)":CDG*US1B[G7+8ZJQO%&.:W+:\4
MJ.:\ZAU%D/6MBSU8X'-=RB['#,[<S!J;NS6#;ZGOQS6M;S>90U8S+*]:=2*M
M!-" -HI:**0#6H4G-#4+UI@.R:.M%%(!NVEI:* ' T4VEW4 )DT44N!57 <H
MI2*2ESFI ;13MHI* &Y-)10.:H HI=M&V@!,FGYINVEI,!:2BD)I +2TU33P
MM PIK4^HV:FA$;4RI&:HV-:)"94N?NFLJ8_-6G=-\M9,K?-6H(EM^M:$?2J%
MN*T8UJ&,F6GTQ:=NJ0&M3&IS4UJ &-36I6/6F9IV&%+DTE% A:5:;2@T *U.
MA/S4PFI(5Y%-@4]:YMV^E>(^.%_>/^->W:U_Q[M]*\4\;#]X]$=PEL>;"/\
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M@?P2-?D1V&<U[EX=^$L,,*945C&,I'1*48Z'A.H27UNNX!JJ6/C2\T^X =V
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MC;NC_2O1M)^&L,:J3$/RKJ-/L;;35&0!BK%WXHM;-/O 8K5- TD4H?#MOIR
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MC&I&%-VT#(@#FGJM.5.:D5:!D?ET!<&K CI&6@"->]2K4=/6@"5>E(U)NIU
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M$'1A=CZ _9^G_<QCZ5Z=\3K<W&EMCTKR#]G^?B(?2OH'Q/I)OM)/&?EJZ:O
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M%/E:.2JY)Z'$R_!6) 3Y0_*N<UCX>6FFYWHHQ[5[Y?>++#[(Q#+G%?.GQ?\
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MQ;V^!TJ:0"-*1I8IN1&*SKJ\VYYJ34+K:#S7.7E_ACS50,627E]UYKG[_40
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M:VL!L(WRU'-#YE-AESBKD:[A6;0&9Y/DMFNC\.ZZ;651N[UDW4/!Q6=&S0R
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M.9FAY;-I/E-TJW868+ &N@U6S"Y..]9$,@BDK52;(:+[Z2KP].U<KJ^D[6)
MKM[6X$B8JMJ%B)E)Q51DT9,X*TL=LG(KIM/T]6 &*K36H@DZ8YK0TVX 8"M'
M)@C<L]&5L'%:L.DJO:C39@5%:T<BURRDSIB9S:> .E4KK2@RGBNA;!J&1 P-
M2F78\_U300V[Y:Y+4-%*,2!7KMU9B3/%8=YHHDS\M=4*EC*43RIK%XVZ4^*%
MAU%=U=>'Q_=K,FT<QD\5U*I<YVC'A7;5@7 C%236;1C@5DWLAC!H<KF+1:N-
M7\H'!K*N=<+Y&:R+V\.2,U160R-UI*(C5:X,W-.4[:AMT^6G.>U:K0M#9,MP
M*LZ?;DR"DM;<RL.*W[/32N#BE*19JZ/;KM&:Z!+5=O2L*US#BM6&\[$US-W'
M8CO+;;G%8UP[1L:Z2219%K$U"'KBJ0^:Q2CNSGK6C;R;JQ"I5JO6\V,4-%*1
MLQMQ4J_-5&"7=BM.W7< :R9JM1R0[L5(T045,JA5JG>701>M9LI[%.^90IKF
MM0&]CBM*\N3(2!56.S:8]*J+.5[F"UB9&Z5;MM*/!(KH[?20!DK4LD"0K77&
M1)EQ6:QKTH=TCI+RZ"Y -9$]TS'BM49LNS7H4'%9ES?GGFF[7DH^P/)VI2T(
M,R:Z=C59IF)K=&BLW:H9=#=?X:RC+4U1#ILF6&:['2V&T5R]GILD;CBNITNU
M=57BLL3+0F1KC%%.6W;:.**\:YF?L(W2HFJ4]*B>OBFS(;3E:F$T*U9,"7=3
M2WO2;J2J0#MWO06IM%7<!2:2BBE< I M+2K0 !:,"ES14,!M%%% #MPIC&EI
MK4 -:FTYJ;0 4A%/VT;:!$3+3:E9>E-9: &4[;2;:7- !MHVT;J-U "$4E*3
M24""DVTM% A ,4&EI#0 ;J6DVTO8T#(VIFZGM3=M04 I12#BG"@0E)NI:90,
M=NI"U,W4A:F@',U-I :>%I"8W%'2G;:0B@1"[8J(R5+(M0%30,EC:I<YJNOR
MT_?3L-$&H']V:\U\4M]ZO1K]LQFO-O%'+-04CC,_O_QKL?#O\-<:!^_KLO#H
M^[6\-A2/0])^Z*V5^Z*Q]*!VBME?NBD]Q"#O3EZTGK2U(#J*3=0#4@+2J*4"
MGKBD!&PIAJ=L4W:,U2 AIV12N0HJG<70CSS5#+;.M4KJ\6//-9MUJPCSS6!J
M.M9S@T6);-#4=6 R-U<Y=Z@7/6LZ\U)I&/-4A<,YIG,Y,OR71]:HW%T?6I8X
MFDJ8:6TG:IL2[LQ9+EZA:1VKHU\/LW:IX_#+-_#561*@SD6+U"TC+7:S>&2J
MGY:P=2T@PYXHL*46C)6Z*D<U>M[P'O6)<@QM4<=\8VZUG)&7-8[*WF!QS5V-
MJY>QU#=CFMZUFWXJ4:IW-%6]ZF1O>JRFIE:J*+*M3U>JX:CS/>@:+:R>]2+)
M[U1#U(KT7'<MF2D\RJK24WS:8[EII:@DFIN^J\S]:$S.3(YIO>J$US[T74VV
MLB>Z.XT7N9EB:X/.#5.29R:?"C3-6K:Z*TH!VUM%(7*V8HD>E$SBNG7PVS?P
MT'PTW]VAI%^S9S7G.:55,G6N@;PZR_PU7DTTP]JSL'(RA GEL#6]I=Z4(&:Q
M95V5+9R%7'-!2T/2]+NO,5>:VAC;7%Z->;0H)KJ+>Z#J.:DZXLM=Z-M(O/-.
MIF@4VEW4F*"0IZFF[:,&@8DRAA6=<:>),\5IU)&@-,+',3:*.NVLRZL?)!XK
MO)HEV&N8UA0N[%-2U%8Y2?Y6Q1 QW4VZ;YS2VX^:NJ+T*1M63=*U$;Y:RK/M
M6FK?+4LHBN&K+NFZUHW#<5EW!ZT$E"X;DUFW!K1N.]9US6T2&00?ZRNQT%NE
M<;#_ *RNLT.3:16=38#M[=OW8J:J=I)E!5H-7&4*>E,:GTQJ0"444JK2*#;2
MTN,4F:"1-U**3%)G%(!6I*3=2U: 7;1MHW4;J6H"T445+ ***3=5(!*>HYJ/
M=3MU4 YA3*7=24P'44FZC-0P%HHI<9HZ &:=3=IIU V#<U7D%3FH)*$(AJO<
M-Q5@U5N&XKH0C/FY-$2TDA^:I(5IB+4/&*M+SBJ\:]*L+TK-E#B*8U/9N*C9
MN:0#"O-,:I*:5JA,9N-*#1MH6F(6BEVT8J $)II-*U-IHH*EA;D5#NJ2$\TV
M@*NM-^X;Z5XGXX;YGKVK6O\ CW;Z5XIXW^^]$=R9'FLC?OS]:V;"3IS6,R_O
MOQK6LEZ5ZU$\FN=#:R_*.:MB3-9EN2 *N*]=Z/.ZDY&ZHV6GJU#4Q$/2I(SB
MHVH#<T 75;--DJ%9.*=YG% #67K3=HIQ:FT# #FGBDVT,V*!DNX4C$$57,E.
M63M0,=BC/:EHV\T"%W&G[J9MIV#0 ,W%-S2D4!:!"#K4BT@3VIVV@!V_%+OJ
M-@1100/W4F^F-24%$A:D\RF4TU((LI)4RM55%-646E8;'MTJ%JGV_+44BXH)
M(N]2(M19YJ6-J"R54IK+4BFF,U $6VC;NH9J16YI(9%?:<EQ"01G->/?$+X>
MC4$D*QYS[5[8LH9<&H+JQBND((SFIE'F1<).+/A?Q%\-Y=/N&=8\8/I69;ZY
M=>'\#++MKZ\\5^!XKQ&VH#^%>(>+?A3+,[[(S^5<$J;B]#TH55+1G Q_&2ZM
MN/-88]Z63XX74B[?-;\ZJZA\'[S<V(V_*LU?A%?"3_5M^59_O#6U,M7'Q&NM
M2;&]CGWI;/2KCQ!(,@MNK8T7X2W*R+NC/Y5[-X%^&OV=HR\?Z4U&4MR)5(QV
M.1\!?"-I)HW:+]*^F? OA--&AC^3&!Z5H>%?#,%G&OR ?A75R0I"F%XKOITU
M%'GU*CF0:SJ*V]@P!YQ7RS\8_$$VZ4(QKZ,UQ6FA917A/C[P=)J4CD+FIJ)M
M:#HVB]3Y@VW.J:E@[B"U>]_"KP'YOE.\?IVK/T/X8M#>AFC[^E>_^!M!CTZ!
M 5P0*PIT]=3KJ5=+(N)X9BM]/V[ ./2O#/BIX)^V>:RQ_I7TW=*K1;17(:]X
M=2^C8%<YKHG"ZL<D)V=SX5ET&XT:_+!2,-7M'PQ\33Q,D;,:Z7Q/\,?M$K%8
M_P!*9X5^'TMC<@["!FN6,7!Z'9*<91U.I\63/J&C.>N5KXX^(FAS-K#$*?O?
MUK[N?PVTNG;"O:O(O%'PG-Y>%_*SSZ556+D11J*#.)^ FGRPR1!@1TKZZM]'
M%UI(!7^&O)OAYX!.CR)\F,5[QIJK'9A#Z5O2C:)C6GS.Z/G3XF>"?,\QE3U[
M5\\:YI<^CW3,H(P:^[/%&BI?1O\ +FO#/&GPU-VSE8\_A6-2%]C:E5MHSQ;P
M_P#$RZT?:/,88]ZZM_CA<W$&SSFZ>M8^I?"*Z\QMD;?E5>S^$MZ)!F-ORKG7
M.M#I?(]3G_%7B*YUYFY9LUB:'X:GFNU<H>OI7LNE?".9BN^(_E7<Z)\*?)VD
MQ?I3]FY:L7M8Q5D9?PST9X1&"M>OWF@FXT[&WM3?#/@_["R_+C%=\NGK]FVD
M=JZ8QLCCE.[N?&GQ6\&NLDKA/TKRG2=0F\/7F1E<&OM?QWX+74HY,)G/M7@?
MB3X12O,Q2/OZ5S3@[W1U4ZB:LQF@?&^>PA5/-88'K6_'\7[C5/E\QCGWKSP_
M"6^63A&Q]*ZGPW\+[N*1=R-^52N<JU/<3Q->7&L6K').17@'BCPS<-J#-L/7
MTK[(L_AV[6P5H^U<_K/PB^T3%O*_2G*FY"A546>5?!739;2[ARI'2OMSP:Q?
M3$4_W:\1\'_#=M,N%/EXQ[5[SX9M3:VZJ1T%=%*/*M3GK24GH>=?%C13<6\I
M"YXKXO\ '^F3V-](ZJ?O5^B/BK11J%NXQG(KYX\>?"5M0>0K%G)]*FK&XZ-3
MEW/GOP#XTN=+ND7<PYKZ:\(>-IM2LU5G)XKR2U^"US;W881'KZ5Z]X'\"SV*
MH&4UE34D;57%ZF!\1+%[ZV=@,Y%>.:7HDL>KCY3]ZOK/5O!IN[4J4SQ7'6_P
MQ*7P?R^_I5R@VS.%1)6.Z^"UNT-O%D>E>[3L#:@9[5YIX%T;^RX4&,8KOVGW
M1@5TP5D<L]97.1\4:,MW;R?+GBODGXV^%6C\XHGKVK[8NHUEC8'TKQWXC^"Q
MJR283.:FI&Z-:4^5GYWQZ%='5L;3C=7U'\%?"K,D3.GZ4Y/@X1J&_P KOZ5[
M;\/?!XTJ% 4QBN:G3LSJJ54UH=MX=TL6<*?+C KKX[G_ $?;GM67%&(XP!4J
ML<5V'G/4X[QOX=&L1O\ +G.:^;_'?PR,,DDBQ>_2OL7[,LRX89KDO%7A.*^A
M?" FLIPYC6G4Y3X<DGN/#LQV[EVUO:/\8+JP(4R,,>]>F>,_A.]S(Y2/]*\S
MU/X0W-ON;817+RRCL=ZE&6YT,GQXF:W*&8]/6O-/&WCY]<W#S"<^]9?B'PE<
MZ;NZC%>>ZE=/:38<]ZB4GU-(PCNCL?"^GM=:BKYS\U?7OPAMQ;6\(/M7QSX)
M\11QW"9;O7U)\-_%,?E18;]:JFR*USZATZ=?)49K4AF3'6O,]/\ %2>6OSUJ
MQ^*D ^_79='G<K/0HI4/>I]RUP-OXK3^_6A'XFC;^/\ 6G<.5G5,Z^M)N!KF
MAK\;8^<?G5NWUB-B/F%%PLS9:,-4,EOUXJ2TO8I/XA6G"L,@ZBJW$87DD'I4
MB(?2MN2UB]14#1Q+W%%@,UHSCI5:536UY<9[U!/"E%B;F!(#3%S6C-"M56C"
MT7*'1-5A3556"U(LE*X$Y:HRU-WYI :!B[J*4+FGK'4C$7-6%6FI'5F..J C
M9::%YZ5;:*F^3STI"L)"M78JACCJU&E2:"[J2G[::10 W;3@M-W4Y6Z4 2*M
M3*M,2I1VI,"*0=:J2BKTBU2F[U $&:FCJON^:IHVJT!8V_+52ZZ&KG\-5+KH
M:T P;Y\9K*>4[C6EJ'>LAU.XTP+43YJSMW"J< Z5HQ]*1F59(:?;PDMTJYY6
MZK=G9[B.*EE(FT^T/'%=#:6^W'%0V-IMQQ6F%$:U!JB3B-:S[ZZ"J>:6[O-@
M/-<[J6H9SS2CJRV]"KJE]][FN6U&^QDYJ;5=0QGFN5OM0+Y -=#CRJYRW)+G
M4"[8S4=O9M=2#C-5;.%KB;UKNO#^C@A2PKS:M;E-8H?H.@A=K,M=3YD5C#S@
M4[$=C;YZ8%>?>,O&"6<;@/C\:\:M5YC0B\<>,H[6-P'Q@>M?-?Q!\?&9I )/
MUJS\0O'C2-*!)^M>$:_KDEY*WS9YKS>HV,US7)+R9OF)K%6-I'R:;&K229-7
M(DPP&*VB96$6%@!@5T7AO1Y;V9%VYYJ30M#?4)% 7.:]T^&WPT:1XF:/]*U-
MHQ+GPX^&AN6B9HOTKZ1\*^#8=)@5C&!@>E2^#?"L.EVZ%E (%;/B#6H-/M2%
M8# J9%-V&W^L0:?"1D#%>?Z[X]CA=@)/UKC/'7Q $+2!9/UKPSQ)\1G:9L2=
M_6L-S!S/HVV\=+<2X\S/XUV6AZL+M1\V:^//#GCIYKA<OW]:]]\ ^(_M"QY:
MN:K 1Z_J'S6I/M7A?Q*C+)+7MGV@7%GP<\5Y3\0K$R12'%80CJ2?*'BV(_:'
M^M<BR8SFO1?&5B8YWXKS^Z&QB*]".Q#(HUJU$O-5H?F-785K/FU$BQ"OM5R-
M:AA7VJ["E66.6.I5CJ2..IECIV$1I'4Z)3UCJ58Z $5<4_&[ IWEU(D=0V!6
MDMRXJHVGL#G%;:(*F\I2O2DB4S%M)I+1QSBNRT'Q5);L@+G\ZYRXL]V<"JRQ
MO"P(J^4T1]$^#_&89D#2?K7L6@^((KJ-06!KXWT379+-E^;%>J^$?'!W*"_Z
MUC)&J/H;4K2&^@. #D5Y5XS\"K=(Y6/U[5VGAWQ$E[&F6S72W-G#>6YZ'(K'
M8JQ\4>,O!#VLCD1_I7G%U;R6<A!!%?97CCP>EPLA5/TKY\\8^#6MY'(3'X5K
M&1FT<-I]P>,FMJWN.E<_-"]FQ!&,5:L[HLP%=2EH9G56LW2M6WDZ5SMK+P.:
MU;:;/>I<B&S59?,XJG<69QD"KENP.*M-&&6L[7),*WF>VER#BNZ\+^(6B907
MQ7(75F<D@5#;W3VD@/05DX&B/IWPKXD1HT!?]:[,20ZA#C@Y%?-/AOQ0T3(-
M]>M>'/%2LB[GJ+##QIX3BN(G8(*^=/&WAY;263"XKZ=US7H9+5OF'2OGWXA7
MD<LDA!K:*$>1K'Y<V*Z#3^@K#9MUP:V]/S@5T)6 W[0\5IPMTK,M.E:4*U+D
M!>C^:G[*CC.*G7FLN88U>*BNH1*O2K.VG)'GK6L7<#G9; QMN K2T?5&LI ,
MXJ]<6X:,\5@W$+1R9%*:$>T^$?$WF*@+?K7J>F31W4 )YXKYA\.ZPUI(H)[U
M[-X4\3"2-%+5RM6 U/&&@I=0MA<\5\Z>//"+))(0F/PKZL&S4(?7(KS_ ,;>
M%UFC<A,U-QGQ[=6+6<QR,59L+DY KK_&GA]K:5R%[UQ$:-#-@\<UM&2$=5:3
M?**T[>;WKG;6XX S6I;2UT)W Z&VDSBKQ8&,UC6LO2M6)MRTF49MUN$F174>
M$;TPRIDUC36NXYJ6RF^QR ]*Q8(^B/"^J+)"H)[5<\06ZW=NV!GBO,O"/B [
MD7=7J=CB^@'>L64SP+Q[X>+%R%KQK5-/-K,W&.:^N/&7AT20L=O:OG;QOI/V
M623"UK 3."2XVMC-:]C<9QS7,S,4F(]ZU]/DX%=%B#K[&;I6Y;3?+7)V<^,<
MUN6MQP.:D#=62EWU3CFXJ0R4P)7DJM)+39)JJR34#'2355DFIDDU5))J0$LD
MWO566;KS44DWO59YJ!$K3>]1&X'K56:<#-9]S>E<X-,#5>Y7UJI-<^AKGYM4
M?=BK-C))=,!BJ1:C<ENKJ3^&H[7SYI ,'K77Z/X1DU+;\F<UZ#X=^$[R,I,=
M:<IHH'%>&_#4M\RY0G\*]3\/?#'S@A,7Z5V_AOX=I8[2R8KT+3[.VT^(9P,"
MBQ5CBM'^&L5LH)C _"NNL-,M]+49"C%3ZAXEM;.-AN7BO./%'Q$B@#[9!0+F
ML>B7GBJVL8R-RC%<#XF^(L2JVV3]:\:\3_%!OG E_6O-=9^(4EQN'F$_C18B
M4CU+Q-\2/OXE_6O+->^($DC-^\/YUQVI>();HGYB:PI_-N"3UK-HRYC6U+Q5
M+<$_.36%->2W#'DTHT]V[5,MBT?:I2'<J1V;RGGFM2TTEB1Q3[2%MP&*ZO1=
M/-PP&VMXQ"QDVNFNF/EK7L[67@;37>Z/X+:\V_)^E=OI'PK:;:?+_2JD:1@>
M9Z3H\MP0-GZ5W>A>!VNBN8_TKTG1?A:(=I*5W>D^$H;$+E16+9LHV//-&^&"
MLJDQ_I78Z?\ #F&$ F,?E7:QO:V4?.T8K/U'Q9;6JG##BI4BM"&Q\/V]CC(
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M:<M.HN,@9:;MJ=EII6BX$.VC::>U)1<9'MI56GXJ14I#"-*LQQTD<=6%7VI
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MNCUH5HU3J?$?P_M[F-B(Q^5>->+/AG\S[(_TKWJS\5PWT8&\'\:E;2H-2!.
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MUKL/#^D<JQ%<UX2M?M#+D5ZC8V:V]N#C'%<<Y=!<PDFRTM_3BO/_ !1K6W<
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M,C=:DD/%5G;FAB#=1G.:9G-2JM0!FZEI/VY"N,YKSOQ-\)4U0,3'G/M7K\.
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M&'''MIS-3I%VM4#]*WY0(;J3Y37%>(6'S5U5])M4UQ.O39W5K3C9F<CC;_\
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M0F<_6M*QC/%1^1NG/UK6L[3Y17M4=CQJVY;M,C%:<;U3AAVU/]VNLX>I9+Y
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MJ?M52,U84YJ64F.%/5<TQ:F2D,8T/%5)H:T^-M5YE%,#&FCIB+TXJY,O6H5
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M0 !5U&)XJ+:<=*>L@CZUM91,FF2^633)(33UO(U[TV2\1N]1)BLR#;M:IXI
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MF#<CV</AW!'T+<1?:[/IGBO%/B#I/EM(VVO<M&_TBQ'TKS[XC:9F.0@=J\+
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M4YN]: 9MSWK&O.];-SWK'O.]2QF'>=&KEM47,E=3>=ZYC4.9*]"@BIOW3HO
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MZ5#C<M(Z>R**HJU),FWBN275#'QFK=OJ1FP,YK"6@[&A=,6SBJ+J]:MM;FX
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M'YUTUCK\$RCYQ^=?((^(<MJ<ER/QK6T?XQ,LH4R]_6FJBZB=%GUG)>QR+\K
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M8WR7D0!.>*S=<\/QW<3$+FN=TW5'M9 ":['3]22ZC )S7/*)]/0J\R/(]?\
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M3EH 5J;3J*>P O2GTRGTV 4A-#4PYI6 ":%I,&G58QRT-2TC5'40VC-(U)3
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M8[K.WO7MNI:*GEGBN/O-)59B<=Z)85*!Z<\VG-;F_P##O_1VC'2OH30[K?9
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ME<52G?5';1JVT9Y3\-_'#:7<1HTF,'UKZM^'_C>/488P9 >!WKX0U:SN=#U
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MT!X;\+Q:1;H2H&!0:J-BWH6@QZ?:@E0,"LWQ)X@CL(W&[&!5S7_$T.GV[*&
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MC) K6,A%_P /ZSY;*"U>A:5K2LJ_-7BPD>SDK>TG7V5E!:M=P/;;>^61>M6
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M4=Q9AE)Q65)FWDR.*PD,]]\*^)A(J@M7<P^7?1<D'(KYL\.^(6MY%!;%>O\
MA;Q,)44%ZQ8QWC#PO'<0N0N:^?/''@XQO(0GZ5]9-LU"'US7#^+?!RW43$)G
M\*TIO4&SXNO]/DLYCQCFDMKMD(!KUSQAX&,3.1'^E>6ZEI3V4I^4CFNDS-2Q
MNLXYK;M;S&.:XFWO#&V#Q6S9WF['- SL8;KIS5Q9L]ZYN&ZZ<UH0W.>]2!K^
M93&8U62?WI^^FB6.9J8QI&:HY'VK5B"5@%K U2\,9.*MW6H;<BL\6CZA( HS
MFD;Q1%I\+ZA,!C.37L'P_P# !N)(V://X5F^ ? CS31LT??TKZ3\'^&X=-MT
M+* 0*#HC&Q8\,>&(=+ME+*!@5)XFUZ&PM6"L!@4OB;7HM-MV"L!@5\^_$#XA
ME5E42_K0$B'X@^/MOF!9/UKYW\8>+I+J1\/G\:=XN\8/=RN-^>:X"ZN&NG)/
M-!@1W$[W4A.<U:L+4[AD4ZSM=V.*V+>U"\XJN43)K.W 4<5:V[!Q3(VVU+&I
ME8 "M$9L2/<S "NHT#0WOI%&W/-/\.^&7OI%PF:]Q\ _#PGRV:/]*4C6$2AX
M)^')E>-C'^E>^>%_"L.F0(64#%6]"\.PZ9;J2H! JOXD\2Q:; P5P"!69J_=
M+VLZ]!IMNRA@"!7A_COQ\5:0*_ZUG>,O'[2.ZK)Q]:\JU34)M4D."3FMZ<.9
MF,I!K'B*?4IF 8G-3:'H<M]*"5)S4^@>%Y+J0%D)KU_PKX26%5)2O8HX>YF9
M_A?PB(MA9/TKTG3-+B@C'RU8M=-CMXQ@8J8ML&*].%-0,VQ_EHO2H9%S36D.
M:<K5TQ8(C\NI%CIW%2+BJ<AB*E3(E(M/W8K%L1*H%.:,&H1+BI!)GO31-QDD
M=595ZU=8[JKRIFCX3-P<BD>*Q-<MA<1L,5MS+MJE)&).#6GQ*PJ=Z<KGB7B[
MPE]H+G9^E>6ZGX/:&0_)C\*^JM2T>.:-LBO/M<\/Q[SA*\O$8+VBN?;9=FSP
M]M3P2'PZXF VUZM\/_"9EDBRG?TK4TWP<+BX7$>>?2O9/ O@D6^QBE?'XJA]
M7=SZ>IG$J\+)G2^ _"4<$2,4Q7:ZI-#I=J<$# ID+1Z3:\X&!7EOQ(\>+;Q2
M*).WK7SV(KJ7NH^<J2G.5V<_\2?'XMXY563]:^6O&_C&6_GD <GGUK6^('C)
M[R:0"3//K7F#.]W<9//-<U&F[W9T0CS*PU4DNIMQR>:Z?2;#"C(J/2]-!4'%
M=)9V87'%>A.:M8WC1<'<6WLP.U:EM:].*=;V_M6G;VW2O+E+4Z.;2PEM;]*U
M+>V]J+>U]JT[>W]JQE,E"06_M5^&W]JD@M^G%7H;>N=NY:&0V_M5V*W]JDAA
MJW'#32+(HX?:K<</M3XX>E64CQ42T$QL<-3K%TIZK4BK68ABQU((Z>%I^V@!
MBK4BK13MU9M@&VDH9J9NJHR%)V0K&F%J1FJ)I*51Z&,?>9)G-$_RQYJ%9/FI
MM_.%MS]*PHT'5FCT.6T;G*^(=<%DK?-BO/=3\<8D*[_UJ7XA:HT8DP:\0U'6
MY3=$;CUK]@R/)?:)-H^&S+$N#LCV.T\6F0@[_P!:Z&P\3!@/FKPFQU=U4'=6
M_IFO/N W5[F;9*HTG9'+@<>^;4]J_M;SEZU2N+UN:PO#]T]X%'6NVL?#<EX
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MZZ^^7Y37&:U]\_6N2$OWEC ZGP#/_IB<]Z^IO!9\RQ3Z5\F^ Y-MY']:^K/
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M/B;S9)0&]>]?/.N7C7%PW/>ER7U.7FU*TG^E2$T^.S"]J;8IFM!UVK1RL+D
M3;1BFR2;331<+ZT6 F\G=319@MTIT=POK5B.0-6>S&AL5J%[5)YC0XP:E2I!
M:^95W-4Q]GK<L###&N]\,^,Y(&7+G\ZX)=-Z&IXU:UZ'%)PY@N?37A3XBA0@
M,GZUZEH_C5+M%&_/XU\5:7XDEM9%&XC'O7IGA/QRRL@9_P!:PE3"Y]6PK%J4
M?.#FL'7O!$-W&Q" Y]JYCPOXZ5HT!?\ 6O0;'Q!%>QXR#FL&N4=SY^\;?#G
M?;'^E>(>)/!4UK(YV$?A7W1J6BQ:DI^4'->;>,/ARDL;L(_7M5QJ=!6/C"2V
M>SD(88Q5NUU$+@9KT+QMX#DM9)"L>/PKS*XTV6TF.0177'4S:.EM;S<!S6K#
M-TYKD+6X,> 36Q;7P..:IJPSHHY,U:C;-8\%UNQS6A#+FHN,N5)'Q44;9Q4Z
MT")T&[K4<]J&7I3XVQ4V=RXJ1W.?DC:&3(XKJ?#.M-:R*"<<UG3V889Q5#FU
MD!'%3RW"Y]'>$?%094&[]:]$M;@:A&.<YKYA\)^(&AD0%J]W\'Z\LB)EJQE"
MP]QOC+PJMS;N=N3CTKYD^(WA0VTDA5._I7V5J#K>6Y'!XKQSX@>$_M22-LS^
M%0MQ6/CJ:W>VN.1CFM[2[W: ,UM^+/#!L[ASMQ7((QMY<5U18G ]!TRZW8YK
MH(&$@%<-I%U]WFNJL;KI6MQ<MC2FL5=2<5C7$;6\F170Q2"1:AN+$3=J3'<=
MX=UY[61<MBO:O!_BP,J M^M?/\ENULV1Q71>&]>>WE4%JYI$IGU%;WHOXP,Y
MS6'XE\+K>0.=N<CTK%\'^)%E"!FKT'[0EY;XZY%8#/E3X@^#?):0JGZ5X[>6
MTEC<'@CFOLWQEX76]CD.S/X5\[^./")MI'8)C\*TB/<Y'2]2^4 FN@MKA67.
M:X27?9S$=*V],U'<@!-=,1VL=SI>K&WF7FO7O!.O&38"U> 6MQNE!SWKTGP=
MJGDLGS5G-6&?2-@5NK89YXKA_'6B":%R%S6QX9UP20J-W:M#6+<7T!XS7*(^
M2/&FAF&X<A>]<A:@V\O/%>_^.O"^?,;;^E>):Y8&SF;C%;4UJ38TM/OAP,UT
M5G<[@.:\]L;PK(!FNLT^ZR@YKL2&=5!+FKL9!K#M+CI6K%)TH"Y9D4,IK'OK
M7=DBM3?FFM$)!65K@<T&:VDR.*ZKP[XD:W906QS6-?674@5E[FMWR.*AP&?0
MWACQ2LX4%J[A?+U"'L:^:/#?B-K>1 6Q7L/A?Q8LBJ&:IMR@6/%'@]+F)R$[
M>E>$>-? [1LY5._I7U,+J.^M\<'(KDO$7A=+U7(3-'M!V/BS5M%DLY6^7%5;
M:X,+8->Y>-? 97>53]*\=UK09;.5OE(Q5*=Q6)[6^#8YK4M[C@<UR=JS1/S6
MU;70XYKHCJ38Z&*XJS'-FL6*?IS5N*Z"]35.(&D\FU<FL^ZO@.,T3W@:,@&L
MU+>2ZF  )R:RN"01V[WDP &:].\!^"7NY(RR=_2J_@GP6]U(A9,_A7T/X-\)
MQZ?;HQ3&/:G<Z(JQ-X4\(QZ?;HQ0# ]*NZ_KT>DPL V,5<UC6HM,MB,@8%>"
M?$KQ^%60"3]:T6I;G8@^(7Q&XD D_6OG'Q?XQ:[E<!\_C1XQ\8/=2N ^?QKS
MNXN6NI,DYI/0S<Q]Q=-=2DDYJW:6F[!J&VM,\FMFSAV@<4D1<?;VNQ:N*P44
M[ VT06[328 K6X6'P0F:3 KLO#?A62]D3Y,TGA?PK)=S*=AY]J^@_ '@#:L;
M-'^E,M0*O@'X>D;"T?Z5[=H^B0Z3;J2 ,"I-)TN#2;<$@#%<]XN\91V,3JK@
M<>M1)W*<N0L^*O%T>GP. X&*\'\9^/&N7=5DS^-4_&7C=[R215?OZUP*K-J5
MQSDY-:TZ;D8N=PN)IM2N,\G)KJ_#?A5KAE++FK?AOP@92K,M>JZ#X;2UC7Y:
M]FCAR+E;P[X3C@524_2NP@L5MU  Q1"HM\ "GM/NKV(144*XYI#MQ41RU*/F
MIRK5-W%N1E3Z4'(J?;4<BBI!(B\S%/66H9!31FF.Q=6:DDFXJKN(IDCU#0R?
M[14L<^>]9W)-6H5--"Y;LTDDW"AV%1QJ<4R9MHJ9&UE%%>X8<U0>7:V<U)<2
MUDWEQM!K>B^YPU):EFXN@R$9KG[JS-U+T[T_[87DQGO6_HNFFZD4XS6>,Q4:
M,&S>A3E-Z%CPGX8#LI*5ZC8V,>G6V< 8%4=#TY;.$-C%9WBSQ,MA;.-V,"OS
M',,P59M(^JPU&45J8'Q \8+8PR /C ]:^6/B+XZ:YED4/^M=3\3?'/G-*HD_
M6O =:OWOYV.<\U\W&FW+F9ZW*K%:XO&O[@DG/-:&GZ;E@<53TVQ+2 UU]A9X
M4<5W<ZBK&U)<KN2:?9[5'%;=K;=.*9:6V,<5KVUOR.*Y)R9V2DFM M[?IQ6E
M!;].*6WM^E:$$'2L7(XN74=;P>U:5O;TEO#6E!#TXK"1I8(8:NQ0^U$4-78H
MZR10D,7M5N.*ECCJS''5\P[C%CJ0)[5(L=2^72D[E$(6I4%/$>*7;6$F0V %
M.Q0*<::U)N,IC-3F-1,U92T-(H#)33)4;-4#28S6$9-L4XDS25!))4;355FN
M,+7H\ET9TU9DYN-O>JNH768&&:I37H4GFJ=U?!XR,UIAYJE-';.2Y+'FGCY3
M+YE>-WUF?M)R.]>[>(K+[9NP,YKA;KP?)--D(>OI7[1D>:PIP29\'F.'=1Z'
M+Z=IS3* !77:#X1FN)$(0FNF\*^ 99I%!C/Y5[QX)^&:[8RT?Z5[.89M2G!J
MYY=#!RC(X?P3X%F5DRA_*O<O#/@T+$A9/TK=TWPG;Z;&I*@8]JOS:O;Z;&1N
M Q7Y+C,3'GYHGU6'@XJS)H='M[.,9 &*S-4UZWT]3\P&*YCQ)\1(X%<+(/SK
MQ[Q9\0Y)=^V3]:\N6(EB/=2.F<;:GIGB+XC1PJP60?G7E?B3XA//O"R'\Z\[
MU+Q1<WDC#<3FJ]K#-?/\V3FNS"934J2YK&"Q<:(NK^(KFZD.&:J=FD]U("V2
M*ZJQ\(_:,$K6W;^&4M5!*U]WA<KC%)R1X>,Q[J/W3%TO1PR@N*VX]/@A'(%1
MW5PEFI .*YK4O$3(3@U]%3C1H(C#8.MC#K-\$?0BIX;I>@->9_\ "2R;^6K6
MT_Q#N8;FK1XV&R9PX[*J]#6QWZS%J:V6K+T_5$F YK424,,UO2E[1G#AZ;C\
M8QEQ43/MJ260>M5F4R=*[:G)3C=G9+EZ#OM Z9J2-&F; IEOITDKC -=AX>\
M,R3,N5KY3%9DH.R8J=/F>QD:?H,MPPPN:[?P_P"$W++E*[#0/"**JED_2NF6
MR@T]<D 8KY+&9I)K1GN4,+U*>C^&XX(U++BM.ZDM["+JHQ6%K7C*'3XV <#'
MO7E7BSXJJJN%E_6ODJF(JUI:'LPIQ@M3T/6O'$%EN <#'O7FWB7XJ+'O"R_K
M7C/BKXH/(SXE_6O-=5\<373']X3^-73PU26LD;QJ0O8]5\4?%!YM^V7]:\LU
MKQM<7$C8<_G6-]MDOFY8FIHM%-QR17>J$8K4[E%25T4&UB>=^6-7[4//C=S5
MR'PV%P=M:=KI/EXXKBJRC'8S<;%:#21( 2*LKH:^E:]M:[0.*OQV_M6"J29*
M3,"/10N.*LQZ;M[5O+:^U2K8^U0Y2-XLR(;/VJY%:^U:267M5F.SQVI787,Y
M+/OBI5M/:M6.U]JE6T]J7,09*VG2I!9^U:RVG3BIDL_:GS(5C'%C[5*ME[5L
MK9^U.^R>U3S(M(REL_:G?8_:M9;7VIZVWM1S(#'6S'I3OL/M6PMK[4_[**.9
M",(V7M3&L?:MYK7FF&U]J7,@,'[%[4TV?M6ZUKUXIC6OM34K&#C(QEM/:JUY
M9[U(Q70_9?:F26>[M6;5Y<QI=\MCS/5M(+$D"N=FL7A8\5Z]=Z.) <K6#>>'
M02?EK[O*\Z^IQ2/GL5EOMW<\TDMY)#C%6K322[<K78_\(W\WW?TJ[;Z&(\?+
M7TN*XJ5>ER7,,-E*I3N<[;Z&"HRM2R:"OI76)I^S'%-DM?:OS#%5'4J.9]+*
M/+#E1QSZ&J]JJ369@SBNQEM?:LZYT_?GBL%4MN<\><Y"74);9N"16EH_C"XM
MY!\[#\:GNM"\SM69-HIAY Q73&<9:$RHSD[L]E\&_$AXV3=)^M>X>%OB8DJH
MIES^-?%<%])I[<'&*Z70?'TMK,H,F/QJ*F&<U>**BU35F??&FZU#JL8^8'(J
M+5/#,=[&Q"@UX#\/_B>&\L-)^M>^>'?%D.HPJ-P.17'&E6HRO8S?),\S\5>#
M?+#%4_2O,-4T>6TE/!%?5&I:7'J49(7.:\\\4>"1M9@GZ5]-@LUE0:4CBQ&'
MC*.AXQ8WQMV 8UT-OJ:R*!G-8GB'2)+&9L#'-9=C?/'( QK],R_,88B)\?B*
M,HL[J-M_-5KR'S%(-,T^\5HQS5QL2=*].I'FU1RP?*]3CM0TT*2V*@T[5#I]
MP.<<UTFIP?NSQ7#:A&T=QD>M>+F&#C5IL]>C7L>]> _%ADV*7_6O5TB&J6G/
M/%?,'@?5#;SH">]?1/A'7$FMU!;/%?C>/PKP]1L^EPM3F/.?B3X/0QR,$]>U
M?,/C#3S8W+@#'-?<7C*R%]:O@9XKY<^)'A5A-(VSOZ5>'Q*:Y6>['8\JTBZ;
MS ":ZVWGS&.:Y06ILICGBM6UO0<#-88BDYNZ,^:[L=-:S5'J9+Q$56M9> :L
M2?O!BL\,O9SU'4343SS7K5FD8XKGBICSFO1]4TT29.*XW5--,9.!7ZMD^94Z
M*2/C<7AI3E<Y6\&^6N[^'LGV>XC/O7'M8LTO2NO\,1FVD0U])F.;0KT.5,XJ
M.#E&5SZ[^&NL?N(EW=A7H.M#[59D]>*\'^&^K;6C&?2O<[>3[58^O%?@^/IO
MV[FC['#0M&S/ ?B)9;))#BO/-/4K=?C7LWQ&TW=O.*\D6W\FZ/'>OLN'\1RR
M29XF9PLKG;Z.W[M:W(>E<QI-P%4#-=):MN45^L5)WIH^8I/4G>/<,5GW5CNR
M<5LQQYHN(1Y9/M7FQC[1V%):G'O+]DE':N^\#ZT6D4;J\YUS,<QQ6[X%NB+I
M.>]?*9QA>6+9])@*MM#W\Q?;;'UXKQ/XF^'>)6V_I7N?AUA-9J.O%<;\2-)#
MV\IQGBORVI)PJ6/I8O2Y\9>(;?['<-QCFJFEWN9 ,UT7Q#L_(N)#C'-<1I<F
M+C\:]""YU<VC*YZ?I<FZ-:Z"T?I7*Z/+^[6N@M9.E<5;W=#HMU.BM9.E:MN_
M2L&TEZ5KV[YQ7+N9FM"U7(ZHVYS5^.HL46$J5>U0K4RTP)5I&H6E:E>P$+]:
MJS"K356FK"6X&7<+UK*NEK9N%K,N5ZUUTW=6+;T.>OH_E-<7K4?S&N]O8^M<
M7KD?S&LXPM4N<[9;\$MMNT^M?4OP_F_T6,9[5\K^$FVW2_6OI?X?3_N8Z^D4
MN:E8RDSK_%2>99M]*^9OB+#MFDKZ<UX[K)OI7S=\2H\225QY?+DQ!PXI<T#S
MG1VQ>#ZU[!X;;]POTKQO2SMO!]:]=\-R?N%K]FP[]I!,^&K1Y9'0S2?+67</
MFKEQ)\M9<TG->O#6+00DHC(O]<*]"\(KPM>?VOS2BO1/"B_*M?F^>I1;/KL#
M:<34\48^PO\ 2OEKXF#]])]:^H?%38L6^E?+GQ)?]_)]:^#@_>/:4;'ER_ZX
M_6NATOJM8$?,WXUT.EKTK:IL4CJ]/^Z*W;3M6)8=!6Y:]JX4M39,V;2M2W[5
ME6W:M2#H*<EH,TH.E7(ZHPGI5Z$]*YU))ZC1.JT^FJU+NK7EA,4H<PUJKS-Q
M4S-569JF5-6T-8>Z9FH0B137G_B;2]RL0*]$N&X-<YJL(E#5WX'&?5)J1P8K
M#^W5CP;Q%I+[FP*R]#TAVO%^7O7K6J:$DQ/RU%HOA4?:E.WO7ZWE_$ZJ4>2Y
M\;BLK<97._\ A9H)Q$2OI7OUK"+.Q';BN&^'>B"WA0[>U=GX@NQ9V1 XXK\V
MSW'RK5M#UL#0=.-SRSXE:J-LBYKYTUK]]?,?>O5?'^L&::1=U>9>1]HGS[UZ
MV1474:;+QE9<K1T/A.+;MKN2,15RGA^#R=O%='<70CA//:OV&A"-.!\!B)<T
M]#-U"]6#.3BN0UC7E&0&IGBO6O)WX:O.+K6GFF(W=_6OGL?CXTW9'V>39++&
MM:&_>ZXVXD-4=EXG:*09:LA5,\>:HR6KK(<9KYY9LTS]$EP<HT^9GK>A>*/,
MV@M^M=OI]P;Q1CG->,>%;.>29.#BO?\ P)X=DG6/<IK7^U+GY_CLK^KRY42V
M.@RSD'::ZO2/"KDKE?TKO-!\)(L2EE%;AT^"QY( Q7FXC-;+<XJ."<F8.D>%
M%P-R_I73V_AN!%Y45G3^(K>Q!^8#%8]Y\2((,CS!^=?,5LSJ5':)[=/!J"U.
MO;1[9.RU"VGVP_NUYQ>?%:($XE'YUER?%:/_ )ZC\ZX98BN;>SAL>N#3;9NP
MIRZ#;2=E_*O)8/BK&2/WH_.MJP^*$3$9E'YU*Q-9;EJA&1Z!)X1MY%X45B:G
MX)CVG"#\JCL_B1;R8S(/SK23QE;70QO4ULL=5CU(EA$><:YX+*YVI^E</JG@
M^;)PA_*O?S<VU]_=-12>';>Z_A!S7L8/-91?O,\JK@U)['RKK7A:>-&.TUY=
MXFT^YMV;AJ^X-8\ Q31G$?Z5Y%XS^%OF"0K%^E?2_P!KIQW.["X&$&FT?(5P
MTJRD-FM;20CD;J[?Q/\ #>6VD8K&>OI7)'0[BQ?[I'X5X6(Q;K,_3<HJT:;4
M6:_V.)XN@Z5@ZI:K%DK6FDDD:8;-9FH3!E.:X/>@[H_5*-+#5:-S-M-2:WF
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MZ0"'I4;4]C3#30";:D6F4]2*; CD7-0[-IJTU1NM(1%NQFHI'YZT^3O4#=:
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M?-?CWPFT<TC!/TKZV>$:A#TSFO-O'?A16BD;93IRLRK'R.T#64QXQ5^SNM[
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MWFI5%,EC/)IC15;XIC+0-%;RZD5:5J;1<8[O3EJ,FE5J0B=>U/S4:<U,JT7
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M@Y6/.?:E<K<^)+[29;61N"!26DQC8 U[GXO^'9A\PB/]*\AUO09;&1L*173
MAEJSNU('-:<,H-<;;S/"^#70V5T"HR:Z!&LR^8*K3::#SBIH)@>]70P=:RW$
M<^I:SDX..:['PQXE>"1 6K"NK#S,D"J2J]I("#BLW3!'TOX/\8#:@+_K7IVF
MZRE]&!G-?(WAWQ(]NZ@M^M>S^#?%0;9E_P!:PE'E*;/2/$/A^/4(&.W)KP3X
M@> ?]8RQ_I7T1IVJQWD0&0:SO$GA^._MV.T'(I0G=V ^#?$'A][&X;Y<8-9-
MO<- ^":^A/B'X&\OS&6/]*\(US1Y+.=OE(&:["#9TN^W <UT%K,&Q7 Z?<F$
M@$UU&FWF['-(1U<#<"K2FLNUFSCFM"%\T@+,9J1H_,&*CCYJW$M4@,^2SV\U
M)I^I&SF&#5RX7,9KG[A&$V14319[9X)\1&0("U>O:;(MU;#//%?,?A'4#;R*
M"U>Z^%=>62%!NKB; S_'NB":"3"]J^8O'?AUHYY"%K[(U*W74(6XSD5XYX^\
M(!DD;9^E:P$?+]O";6;GBNDT^]' S5;Q1IIT^9^,<UAZ??,LP!/>NN]D)GIN
MGW 8"MZUEX%<;I%UN5>:Z6SFR!24KD&UNW#%4[BSW@G%3PMG%62 R55KE'+R
M,;63CBNX\&ZT5E0%JY#4K8EB0*GT2=K693FL)Q*1]-^&KY9X%R>U1>*[,7%L
M^!VKB_!_B$;4!:N\,HOK?UR*YMBCYG^(?ATLTA"UX_=6)L[@\8YKZV\;>&Q-
M$[;*^=O&FBFUF<A<<UTTY7$<W:W&[ KI-,?RR&S7$PR&.;'O746-Q^Z%=%K@
M>H>%M>-O(@W8KVKPOK@N8T!.:^7M*OFCF7FO8/!.N;?+RU<\XV&>RW^GK>6I
M.,Y%>(_$7PSQ*0M>UZ7JB7%L!G/%8/BG1UOX7PN<BLH[B9\7>(-->WN&X[U%
MI<IC(!KUCQOX/,;.P3]*\LOK-[*4C&*Z^A)OV=UD=:V+6?@5QFGW1#8-=#;W
M(VCFI$=)!-Q5I9<UB6]QG'-7XYA3N!<9J:S5#YM-:3BCF 69NM9ES;>9FKS-
M3"157N4<[=6_D-FM3PWJS0W"KN[U5U;&WBJ.CY^U+]:E@?3/@'43,D>37J]K
M-B$'VKQ+X;[MD?X5[-:@^0/I7%4++7V[;FJ%]K0A4\U#=3B-3DUPWBC7EMXV
M^:H@R2'QAXN6&-_FKY[\>>,_,,@#_K6EX[\8']X!)^M>%>(]=>ZE;YL\UW08
M%37-6:ZE;YL\UAB$R/FE4/-)6K:V>1TKIL,;9VO3BM:.W"K3K>WVU<$65XJ&
MR2"&'<V!71Z%X=>\F7"YR:JZ+I,ES<* N>:]Z^''@0W!B9H_TI&T-2W\.? 1
M;RV:/]*]^T+1(M+M5)4# I_AOPW#I=JK%0,#TJAXL\2Q:?"ZJP&!3-7H4/&'
MBN.QA=5;&!7S_P",O&+WDCJ'SS5SQQXP>ZDD57Z^]>?0V\NI7&3DY-=5*-V8
ML6UM)-2N,G)R:]'\*^$?N,5J+PGX6.Y"RUZUHNCI;QK\M>Y1HW,V.T/2%MXU
M&*Z&,;%&.*9$@08J0\UZ48<@D*6W4W;3<[:>IS5.0P\G=4BVO3BIHQ5F-*PD
MP(X;?!Z5H0PXJ-5VU81JS$3H@ J0,!4"R<4UIL4M2T6&D JC=2 J:;)/5*XN
M.#S5#*-YCFLYE^:K5Q)G-5E^9JJXK$L"_,*W]-7I6/;Q9(KHM,@Z<5+ V[-<
M**GN)-JT6Z;4%5[^3:IK"4M;!8Q=7N/E;FO-?$5X?,;GO7:ZQ=<,,UY]K0\Z
M0]^:Z;<L+DQW(]'!N)P/>O4O#^GB.)6(KS[PQ8GSE)%>G6T@M+/)XXK\YSC&
M.[B?186-[&1XPU-;.S< XXKY-^*WB1I))0&]:]Q^)OB98X95WXKY-\=ZM]LN
M)/FSS7RF'I^TE<]WX4<3<7375V<G/-=!I=GN4'%<]9P;KC/O7<Z3;_NUXKV)
M+V:)3N7+&';CBM^SASBJEK;^U;-K#C%>?4F66K:'I6I:PU#;0]*U+:'IQ7$Y
M#)[6'I6K;Q]*@MX>!Q6C#%TJ+FD26&.K<<=-BCJU''293'1KTJTG2F1QU.%K
M,6X@6I%6DQ3Q1<!57BANM+NI#4,3$S2&8+UJ*>X$8.:PM2UM(5/S5T4J#J/8
MR=3E-Z2^0=ZIS788'FN'N/%(\S[_ .M6;/7EFQEJ]981\NQK&LF;]Q-UK,N+
ML+GFDDOU=3S6+?71R<&O#Q%!I[#]LBS<7P]:SY&:;IS59?,F?O72:%H4ETPR
MI-=N#P]WJ82KF/9:3+<2# KT+POX/:1D+)72>'?! .QF3]*] L-)ATV$$@#%
M?0N,:2.*<N<IZ'X9BM8E++BM*ZU*#38SR!BLG6O%D&GQD!P./6O(/&7Q&/SA
M9/UKR:E9R=HF"CRZL[;Q=\0(X(W"O7A?BSX@2W$CA7)_&L#6O%L^H2,H<G)K
M.L](FU*3)!.37=A,!4KM-FCQL::L,74)]0FY).:Z;2?##7V"RYJ_H?@LJ5)7
M]*]&T'01 %ROZ5^AX'+HT4G)'SV*Q'M=C#T3P.L>#L_2NVTW0Q:J,+6YI]DB
MJ.*TEM1Z5]!SQ@K(\A7N9<=MM4<4\PX[5I_9P%Z55G4+7/*HV:\C93*A:3=M
MIDLG-0--[UDF[CY$BUYHIWF;JH^9S3EDQ75&,;:BYDB2[MUEC/':O,?&VD[D
M? KTUKCY<5SVLV:WBD8SFL:M-35D.C>$^='RGXNTZ6.5\#C-<68I=^.:^CO%
M?@T3;R$KSYO!)\_&SOZ5\]6RY?$S]5R?/72BHMG*^&]&ENITXSS7T-\._ IE
M,3,GIVK&\#> <RH3'^E?1O@[PY'I\"$ICBO"KUHX;0]',,ZEB(V3-/PSX;CT
M^W4E ,"K&M>(8]+A8!@,"I=7UR+3[9AD#BO _B1\0!'YH63U[U\M7KO$2LCX
MQ1E.?,R?XA?$@*L@$E?-_C+QM)>2. ]5_%_C*2\D<!\Y]ZX?]Y?29.31'#\J
MYF=_V;"2R/?39)SDUI6.BYP<5+8Z65P2*Z6QM0 .*Z*=1)V.;E;95LK#R\<5
MLV]OTJQ!9].*OPV?M6>*]Y71UPILK1V/F=JG70Q)VK6M;7IQ6G!;CTKBP^)J
M47H$Z<>IAV_A]1_#6O:Z2(^U:UO;CCBKT=L,=*VQ.-J5%9LBG3C<SH;7;CBM
M"&W]JF2WYJW#;UPX>:B[L]:+4401V_M4ZV]6EAJ9(:[*\O:(XJL[E6.W]JM1
MPU.L/M4J1UY,8^S9A&',,2&I5BJ5(ZD6.M[\QK:Q (J>L56%CIVRD,A\NG;*
MF\NG>74B(52C94^RE$=*XROY=+LJQY=.\JIN! L=.5.*G6*E$=%Q$&RC95C9
M1LHN!7V4;*L>71LHN!7VT;:L>70(Z0%;RZ9Y=7?*IC1]:=AE1HZ3;BK#)3&7
MK5C96:H6%677K4#C%/H$=RNZ5 T=66J)JP<-;FDM$1A:1EIS4QFKU*-?D5CF
M534K21U4DAK1V[J:8:\W%+VSNCI^-&/<6N]2,5AW^AB;/RUV+0#'2JTT(]*Z
ML)5GAMCSJF&5[L\]E\,J&)VU7DT41 \5W5Q".>*R[JW!SQ7?4QM6OHV72IQB
M<'J5C\A&*YPV!BFW8[UZ->6.[/%8&H:?L4G%91BT[LZY0TT-7P5KYT^:,;L8
M-?3OP\\9?:(8UWYXKXO2Z>UNA@XYKVOX6^(F62,%OUKI=)25SS9Q:9]3:A"-
M3M2>N17BWCKPR$:1MM>Q^&;Y+NS3)SQ7/^/-.62!R!VKCA6=&JDB96Y#YEOO
M]!F(Z5<TV\\U@,U%XPM6ANGP,52T%CY@R:_7<GK\\$SX[&1]X[2/_5YKGM>.
M0:Z.-AY(K UB,R9KZFK5O"QY,-)&7X?8K>*?>OHOX=W@\J,$U\[:?&89P3ZU
MZ[X'UH0F,;J_-LUPOM+R/J<'+8]IUJ%;BQ/?BOF#XN:3@S$+ZU])V]\+RSQG
M/%>3?$S0S=12D+VK\^Y_8U.5GT\=4?&FI6[0WI^M=!HLFV,9J[XHT V]TY*X
MYK'M9A;\$U[491G'0J,-3IA(#1YE9MO=B3O5Q6W5YF(IRZ'4E8F:8]S6?>?-
M5ECBJDS<UQT6XRU,Y*Y-I/[N93[U[+X!U+RWC&:\9M6VL*]#\%WFV9.>]?31
ME%TSSJD+,^GM&O/.LA]*X+XB6OF1/Q73>$KCS;1>>U9WCBWWV['':OGT[5BX
MQNCYRU"UV7A..]='H;;5453UJWV73<=ZL:6VW%?KN42YJ:/D,S]UG::>^[%=
M!:GY17-Z6V=M=+:K\HKZ'FLSQ*/O,FF_U9KA/%+?>KO)E_=FN'\30EMU*?OZ
M';+W3GM F*WJ_6OHCP#<!K>,9KYTTM#'=@^]>X> [[:J#-?GN>4^5-GMX&=V
M=[XHMQ+8L<9XKY1^+5GY<DIQZU]9:G()K _2OF?XOV>6E./6OAJ'Q'UR?NGS
M--E;T_6NX\/-^[6N.OX"M\?K76>'VVQK7?46AR7]X[.S;I6W9MTKG[-^E;EF
MW2N"1Z*^$W+9NE:MNW2L:T;I6M;MTKE9F:4-6XZHPM5V.I G6GK3%IRUG(=Q
M34,@J:HW6H6Y:*<HJE<#BM"452N!\IKLCL)HPKWO7-WX^8UT]\O6N;OE^8UR
M7]\PD9\?RN*[;PC)^^0>]<3]UJZOPG-_I"?6OH*.L#&1[YH?S68^E</\1(?W
M;UVOAMMUFOTKE?B%'^Y>N&6E0Q>IX'>+LO#]:V]+FPHK%U8;;QOK5S39L <U
M^JY$[Q1\ICEJ;[OE:I[OWE2>9^[JGYG[RON)_ SP*FECM/#?S2+]:]<\/K^Y
M6O(_"OS.M>OZ"N+<5^,Y\_WC/L,I=XG-_$!L6DGTKY'^(DG^E2?6OK+XBOBU
ME^E?(GQ"D_TN3ZFOF\/N?4/8YO2SF05V6G]!7%:,<R5W&GK\HKJJ[&1NV?:M
MRS/2L2T[5M6G:O/1O$W;/M6M#VK(L^U:T#'BB131?B'%6$JM"<U:6N&<&Q)C
MU-#-1BF,:S5:5+0N4[$$S8K/N+@+5R\D"*3FN0UK5A#GYJ[Z.'EC#DE61>NM
M01>]<]J=TLF<&N8U+Q1LD(W?K5*+7C<,!NKVZ>15*?O6..6(MU.Z\,0[KM3[
MU]%^"4\NT3Z5\^>!<33H:^C?#,8CL5^E3B*$J<;,QC6YF4_&U]Y=JXSVKYL\
M:W'G7#BO=_B#<E89!FOGKQ _G7+?6N3+:-\0BL1%NF<U;VN9LX[UVFD+Y<8K
M%M+3D'%;]G'L45^^X%<E%'Q%67))W+<KU'YF1BB3I4:_>K>52[/%K2]H]"G=
MZ;]J?I77^!/"Z_:$.WO5'3[43.O&:].\%Z>(V4[:^-S6HDF?296IQL>D>';=
M+"S7C&!7(?$CQ.MM:R -CBNFO[X6=B><<5\Y?%KQ:5$JA_7O7YK77M):'WE*
MG=79Y5\2_%37$TH#]Z\:N)7O+HDG/-;WB+46OKI_FSDUGV-B6D#$4Z:]GN9U
M.R+VEZ9N )%=%9V?E]J33;<*HXK7A@SCBJE44M!TJ>MV1+#N7I2-IGF=JU+>
MUSBM2WL1Z5P2E.F[Q/0E:<>5G.V^@ G[M:UMH@3M6[#9A>U6X[<>E>E3S2LH
M<K9XT\'%3YC(BTW;CBIUL\=JV5M0>U.^R>U>'B)2K2YF>S12C&QD?8_:C['[
M5L?9?:AK;VKOP\XTUJ<M2EK<PVM?:H&M\=JW)+?VJK);^U9U\3K:(XWL8DUK
MN7I65>Z3YF>*ZW[)G/%,FLAMSBIYY-7",K,\PU#1=K$XK-#&S;(.*[G6[?:K
M8%<1J$9WFOJ<GP_MZB3.'&5+1-C3O&$MEMPY%>@>$OB=)'.@,GZUXLUNU6;&
M9[60'=TK]:>34E0YCXQXQQJ'W;\/OB5'<1HKR9_&O6X-5M]4MNH.17Y[^$_'
MDNGS(/,P![U]#_#_ .)XG6-7E_6OR'-\-[&H^4^JPN)52.IZ_K7A&.^W,$SF
MO+_%O@'RU8JE>RZ#XBM[Z!<L#D>M2:KIT.I*0 #FO(PV-EAY#Q%%54?&^M:'
M-8S-A2 #3-*NGMY &XKW_P 6?#T2J[+'^E>.>(O#,NFR,0A&/:OT/+LX4K)L
M^5KY?K>QKZ;K"@*-U=)I^J!L<UY%#>2PR@$D5U6CZH?ERU?7JHJT=#S)4W1/
M5;*\#XYK5CQ(*XC2]2!Q\U=-9WX;'-<THN#'3J<Q?N+(2*>*Y[4M+Z\5U44R
MR**ANK<2*:J,C:4.8\UOM/*L>*SS"4KNM0TT-GBN?N[';GBNB,C"5'J94?RF
MI3<#&*;-&4JE))M-;(Y)/E)+JU6Y4Y%<CKF@CYF KJX[H"J]YMN%/>LIQ+IX
MIQ=CRB\@:TD.*L:=K#1L 371:QHXDW$"N4N=/:W<D"N=Q/H<+B'([*UO4NHP
M":S]8T=+B,D"L.QU%K=@":Z:QOEN%P36+B?5T)W1Y9K_ (?:-F(6N-NK-XV(
M(KZ"U#1([R,D+FN"\0>%?*W$+^E19':>9_8QMR14#YMVXK9U&U>W8C&*R6B,
MAY%0S-FAI>O/;R ;J]-\+^+/N M7CK6YC.16AI^JO9NOS8YJHR)/IW2]6CO(
MU!(J34=.2XC) KR#PSXP*L@+UZCI.OQWD8!8&MDS-HYS5--:%B0*S[:X>&3F
MN^O+-+I"0*YJ^T<QDD+6BD38OZ7K!4+EJZ[3=:# ?-7ELC/;M6CI^L-&PRU;
M+4QE$]BM;Y9,<UH+(&%>>Z3K@;;EJZFSU)9 .:EH(QL;#*&JK-!UJ6*X#"I#
MAJG8LQ+BUW=JQ[S3MV>*ZR2$&J-Q;C!XK6,BU(X6ZTO&>*S)K,IG KM;RU'.
M!63<6>[/%=$9#N<E<*RYK-GS7676G]>*R;G3?:NB,D%SG),FH&C)-;<EASTI
MGV#VK?F0&(832>2WI6^NF[NU2KI/'2IYQ',2(5'2L;5#\IKLKZP\M3Q7':T-
MNX547<RD<7J&6D-6-,B!(S3+J/=(34]B?+(KK2.:2-5W\N/BLFXN#(Q%79GW
MK@5#;V#2R9QWK0C49:Z>9F!QFNCT[31'@XJ?3-+*J.*V%M3'CBN:=0WB/M8Q
M& *U(;C:*H1*:M(M<S]XU3L:MO>5'J%]^[/-4U;:*S=6O-D9Y[5*CJ5<YGQ-
MJ'WN:\XU2?S&:NA\27Q+-S7&S3;Y#S7JT8Z&,I&==KEJM:4XCD'-07'-01S>
M6U;R//G+4]'TG4A&@YK5.MXZ&O.K/4F4 9K2COF?O7.X7-82.XAUXJ?O5HP>
M(BO\5<#%<'CFK<=T?6L'2.I2/08O$I'\5+-XF^7[U>?MJ!0?>JG<:PP&-U)4
M;E.1V]WXA\S(W5G^=]I;/6N/BU)I).M=-I+%PI-:>RY48MFY9XB7-5=:U#;"
MPS3[BX$,=<OJEZ9"1FDD"U.9UF9IIFINEV#2,,BKZV/GR9K=TO3!'@XK.4BK
M$^E:.,#BNGM; 1*.*991K&HXK221=M<_-J-%66/BLZ:/:2:T[B0<UE7$N<UT
MP9I;0?:7!1@*Z?3Y/,CY]*X^W4F0?6NFT^7RXQD]J=38Q8W6"$C-<%J5T?,(
MSWKL-<NP4(S7 7[;IC7/".HC>T"3=*/K7I>FM_HP^E>7>'N)!7I6GR8MQ]*N
M0T8GB-AN-9VB$?:!]:M^(7RQK-T>0BX'UH2T&MSU;16_<K]*V5YKG="F_=K7
M0Q,#7)/<Z>A3U)ML9KS/Q5J'E[QFO2]98"%L>E>,^-KC:S\UK1W.>HSC=4O?
M,=N:Q)V[TVZNLS'FHF<NM>Y3V,$6K)BS@5UNEZ6;A5.*YK1K<O,*]0\/V($2
MDCM7GXBIRE(R&T$*O*UF76E!>@KN[Y5C3%84L/FMTKFIRYG<V.8CL=IZ5)+#
MM2N@;3\#.*H7D&T8KTHRT):./U!<$UD25T>I6Q;) KG+M3'4RJ]"&RK)BH?,
MVTR20YQ2*I:E%<QGS:EA+IAWJ>.Y?/6HX+0MCBM&WT[/:K]E8V3'0W;\5,9I
M&%6H=-Z<5;CTX8HY4,PWD>FK,W>MV32QZ51FT\J>E"1FV):MN(S6S:L!6#S"
M:GM[X@XS4RT)CN=.DG&!4BR,:I:?)YQ%=%9Z;Y@SBLHSUU.I(73=VX5V6EJ=
MHK*T_2<$<5U%A9[%'%<N(J*VAG*).%..E%7!!P.**\GF9ERGZ9R55D%6GJK(
MU?'LY2(*:D6D6G4@#=[U&6I34; \T@';Z<&J#FGK0!,#FEI%I: "D(S2TF:
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M)4/\5("['-TJPLFX5GQGI5J,]*99))S5:3K5ACQ4,@S0!4<U$2.:ED6H2*I
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MYMQ]*Y#3;/=,#BNMW?9[7TXKYO$RNS5'(_$+5?*MY.>U?)?Q&U3S)I1N[U]
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MH>=\V,UVQ)9<5JMPU3@^:KH^5:HE&A9G<P%=+IFF/<;<#-<UH_[RX ]Z]O\
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MJ\AOD*ME:UO#=\]O.N3CFN"4=0/JG1;Q;Z%<G.:H>+-%2XMGPO:N:\%:\"B
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M>3-Z&O0_^$97^[3AX:7^[1SL+'G8MYO>C[/-[UZ,OAE?[M+_ ,(RO]W]*KF
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MS#$6>?2OK'6_A<\]TW[KC/I6]X0^#@>9-T/?TKC=/4[U521\V>'?@G<2;&6
M_E7LW@7X47=C)&?*8?A7U=X-^#ELL2;H1T]*]"L_A=:6J@B( _2M52,)5CR/
MP)X?GL8XPRD8KU.$F.VP?2M23PY%8K\J@50O%$<9 KKI1U.64KG&^(INO-9W
MA^3==+]:G\1-EC5;PVO^E+]:SQ;M$R6Y[)H*_P"BK]*Y7XA3>7:O]*ZO1FVV
MB_2N!^)5UBWDY[5\74E>9OT/E3XHWFZ:7GUKQ.9]UT?K7JOQ+N-UQ+SZUY+]
MZZ_&NVFM#-LZ"Q7Y!6WIT>]A6':?+&*Z#0_GD4=>:YZCU(/2/!>F;YD.*^E_
MA[:>1''QBO#_ (?V.YHSBOH?PG;^3"G':L9/0UB=]$W^C@9[5FSKEC4OVH)'
MU[5FW%\H;K7F3;N)ZE75;,31D=:\@\>>%1+'(VS]*]C%P)CUS63X@TE;JV;C
M.15T[W,V?#_CC0S:2R?+BO-9,K,1[U]1_$KP<6\U@GZ5\^ZYH+6=PQ*XYKU:
M;31)3L_NBKS#Y:SHI?*XJ_"WF"M.4:1?T4^7< GUKZ#^&>L16XBW,*^>[-?+
M8&NPT+7WL2N&QBH94=&?;.A^)+9K=1N7I6RES;WG=37RAHOQ&DAV@R?K7?Z#
M\2=Q&9/UK)FMSU_5O#]O>1G"J:\K\8_#Q9E<K'^E=MHOC!+Q5!?-=*L,.I1\
MX.:GG ^,O%GPSE1G81_I7F6J^&I=/D.4(Q7WYKW@>"ZA8A!S7B'CKX:_ZPI'
M^E5S$N)\OB\:W;!K1L]3+8YK9\2>"IK.9CL-<PUJ]F>134C-HZFSO-^!FM:$
MK(M<3:ZAM8<UOV.H[L#-.YF:-S#Z4RUNGM9!SBK4+"5<FH;BW':@9WGA7Q88
M&0%_UKVGPEXL$P0%_P!:^5K6Y>VD!!Q7H'A/Q4T#H"U93B:(^L[6ZCOK< D'
MBN8\4>%TO(F(7-<_X4\6^<J#?7H]G,E];\\YKC=[E'S)XT\&F%W(3]*\QOK5
MK.0@C&#7U_XN\+I=1N0N>*\#\9^$6MY'8)6T) <'IUX01S70VMUO4<URL\+6
M<ISQ5_3KW<0,UW0?,2;\L(D[5$C?97!Z5:MV#H*K:@G7%$XC.S\)^(#'(B[J
M]O\ #.H"ZB7)SQ7R[HMTUO<*?>O7_"OBQ;>-07[5QRB2>I>(;6.2S8G'2OF[
MXFVJ*TN/>O6=:\=1M:L-XZ5X7X]\0I=M)ALU<(E'DE]E+LX]:Z'19L*.:YN\
MD\RX)'K6UI+8 KI<="&=M8S9Q6_9MD+7*Z=)TKH[%^E9=3);FY#BK"U3@;WJ
MP&K=+0U*VH)O0XK!^SE)LUTKKYG%4[BU"C.*AHHZ'PEJWV5T!.*]FT#6!<PJ
MN[M7S=;WQMIP <5ZIX'U@R,@)KDJZ(:.[U_3!>0L<9R*\)\?>&_+:0[?TKZ3
MMHA=6OKQ7FOQ"T0-%(0M84V[@SY3U&,VLQ'3FM#1;HLPYJUXMTPPW#\=ZR]'
M!CD_&O2CL0>@6$GRBM:%_EKG]/E^45LV[<4I;$%]:@O%_=FI8S3;H;D-9112
M.=,A2X_&O3? 5T<IDUYM-#^_''>NT\(W'D.GUK.HBSWVQ8268^E>=_$"Q#1R
M<5UV@ZAYEN!G/%9?BZW^T0.<=JRAN-GRGXPL]EP_'>L+3?W<E>A>.-+VS.<5
MY^%\F0UW)Z".KL9^!6W;.&45R-C=<CFN@M9^!2YAEVZA#J<5B7$)C;(K=1M_
M6H;JW5D/%/XB2EI>L-:2#G%>D^&?&."@+_K7D=Y&T3DBI--U9[:0<XYJ'3&?
M5V@^(%ND +9K<FM(KR,DX/%> ^%?%Q0H"]>LZ#XD%TBC=FN>7NA<K:YX32?=
MA!^5<FW@#=-D1_I7L%NJW>,\UHQ:+$>=HI1J,VB>=>'?!*VY4E/TKT&SM(K&
M'H!@5<:S2W7(%<WKVK?98V .,5T1D.3LC*\8>(A:PN V*^</B%XL,S2#?Z]Z
M[3X@>*#M<;J^?O$VK-=3/SGFM$VSGN8&JW+7DS=^:;IVGEG!Q4ME:^?)DUTU
MAI@4 XKHBS1$FGZ>-HXK2%KY?:K-K;[0*N?93)@ 4VR[%6SA\Y@H%>@^$O";
M74J'9G\*Q_#/AYKBX7Y>,U]">!/"BQQQLRUEN6E8O^#_  L+.%&9<8KHM6U)
M-/MF&<<5HW6S3K/CC KR/QQXF*EU#5<8ZDR9@^-O$QN'=5:O./LDFH7&<9R:
MOW-T^H7/KDUUWAGP[YVUBM>I1I7.?4C\*>'=NTLOZ5Z;INEB&,?+BF:3H8MU
M7Y:Z"&WVK7J1ARH"*WCVXJQG;2[=M5Y9=M:<P#Y)NM5VFR:AEFZU$K;C3Y@+
M:MNJW&M4X*OPK5;@2J.*=0.E+Z4I&D!ZU*O:H5(J16J2R4"G*F:B5O>IHV%*
MY0OEU%)'5H<BH)CQ3$RF^!FHF843R8S55I?FI7)))&XJG+5@_,*B>,FJB92*
MRG#5KZ>W2LP1?-6E8J0:T9,3J+#[HJY(OR&J6GGY15^4_NZYF]3IB<AXD;;&
M]>9:E-_I!Y[UZ7XG/[MZ\IU1L7!^M5+X&:JU]3I/#OS,M=_#'_HOX5YSX9D^
M9:]*M?FL_P *_+,TJM5;'O81(\:^*[$6\OT-?'GCIR;V3ZU]E_%>#_1I>.U?
M'/CR';?2<=ZQP[YD>O*5EH8NAL=PKM+$<"N,T5<,*["S;&*52"N8QDVSH;/
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M.;0Y/Q,P :O-[YQYS?6NL\2:N&W &N$GN_,F/->K15C%LT[496H+WY:L:?\
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M$W&F[J3-% A5IP&:8#BEW4T [;3-M.W4FZFP$VTNVC=1NI( (Q3:5FXJ-FH
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M*CT_5)+>0 FN]U71!< D+7&ZCHC6[$@5SNF?24,38Z33=7690&-6I[**\7.
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M[;390O2EW5$TE*K5F!.M+SBB/FI=E/<"K)FJ[5=DCJK(M,01U?M^U48JOV]
M%Z/I3G:FKTI),TA"%J56J'FEW8IC)C4$S=:&FJI--UYJ0&2/R:8K=*A:3=3H
MVY%4(M*M/V^U-CJ;%*XT0-T-029JRXJ%ES3&5FH4FI6CI/+J0%C:IU;BH=F*
M<O%4(L4UA2*U*QXJ1D$E1-4S=ZB;O5;"&J*E5::J]*E45)0FWVI&7VJ3%(5J
MD20E:2I=M+Y=,+D07-3(M.6.I57%0Q@JU*O%-&*<M0T/8DW5&S4M1M3 :S4W
M=0RTE%AI"[J3=1MIAJADJM4BFJZMTJ5&I /84W:*D'-!&*1-QJBGK3"U)NI
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M11PU-Y=2!<4M 6*S1U$5JZ^,55D-)B(JBD:G,]02-3 AD:DC;FFR4V-N?QH
MT(VXI77-10MTJ?K0!3N(04/%<#XKLRX; KT.X^[7-:Q9B<-71**E&PXRLSRB
M"-K6ZSTYKU?P/XA$.P%JX/6K'[.S,!BLK3_$#6,X&[&*^ S7!MW:1[6'J'U-
M'?1:E:;<@Y%>9?$#P*FIPR%4SGVJ/P=XN\_8K/7J%JL.I6X#8.17Y]/FHRL>
MY&5T?#OC+X8/;3.PC[^E>;:CHLNGL1M(Q7W[XK\!0WT;$(#^%>&^+?A.7D?;
M%^E>O0J^T5F"9\Q1W4L;=ZT[/49,]Z]'OOA3+&Q/E'\JS?\ A7TL#?ZL_E55
M:+>QT1K):&+:WSMBM.&Z:KL?A62+^ _E5I?#[C^&N!X:;-E*+*4=XU6H[YO6
MK*Z"_P#=-68O#\C?PTEA9ENI&)46^>E-\];,/AB1\?*?RJ]'X-D8?</Y5TQP
MTV<\JZ.4;4)*8-0E]Z[5? <C_P#+,_E5F'X<RM_RS/Y5TK!]S/VW8XB.\D>K
MUOYDG8UW=K\-9./W9_*MJS^'++C,?Z4GA8Q,G69YW;Z?)+CBM2U\.O-_":].
MLO .S&4_2MZS\'I'C*TXQA'<GZPSRVS\$M-C*?I6D/AF)EYC_2O7;/0H8<9
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M%A13PO%1I4FZC<!&[U&RY%244@*$T55O*.ZM5H]U0M"*8%>-<4YJ<5VTB\T
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M4+AN*NS-UK/N#P:WCJ@B9-XW6N>OCR:W;QNM<_>MR:S2]X<C+D7+5TGA-/\
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M0T9IKM0,:U,:F/+3/,S042%J;G--SFG+28"&F[J>1FF[:0"JU/%1A:=NYJK
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MMC%6EVFI=E!3VI$D6VG*M.VT=*"=R&1:JS+5UEJO(M!93V\T].*>4I-N*OH
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M TVXETNX')&#7Q.:9=S)R1ZM&HT?97A_5HM0MUR0<BLOQCH:7ENY5<Y%>8^
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M/C%(HE"U,BXIL8XJ8+0 HZ4PTZFT %.6E5:4C H 2DI:2@!M)M%+10 4444
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M6W)6\D9L=IC[;H?6O?OACJ?E-&,U\^6IV3 ^]>J>!-6\F2,;L5RU5=%(^O\
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MFK#+NI5BI7&0Q6^X]*O0V? XIUO#6G;P_+024?L?M0L?E]JU6A&VJ<ZXH"Q
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MJ%AFI6IF#4L"!HZ01\U8VT;:0#%&*>6HVTC+0 %O>BF[33]M #@U!:F[324
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M*M%QICE%.\OBE45,* 96*8H'%2N*A:BX7'[JDCF*=ZKTZF,L,/M7RM7*^+O
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ML_2NETWPJ+?'R?I7U&%PD:>Z/&K2E+8I^&_#"1JI*UWVGZ>MNHP,56T^S\@
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MLDE-@"_>J["]9JMS5F)ZD#45Z<QJI')4ZMFE8!6J-J>6IC4P$W4NZFXHI 2
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MSX>ZHLEO'D]JZ?Q'&MS:MCGBO$OAWXF"HBEOUKV&UO!J%N!G.17%*"N!\_\
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M?%2,2-<5)BD Q3EIB "EHHI %--.-1M30#E/-2+4(ZTY6I@2-TIC"EW4-TH
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ME!./6O==+UB/5(U*L#FNI/F.9JP\1TX+TJ]]CPN:B\FG81#MI=E6%CI6CXH
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MX--F&X/UK7L=095 S5_5?#;K*QVUG+8M"W2OA<PPMV['[?E><0]FDV:J71D
MR:CN5$BU#"" *N10F7 Q7F8?#24CZ#^UJ7*]3GKBR+/P*T='L94D4@&NEL=
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M6IZTC+0!$W6E6G;:7;3 6FFG44[@-R:2E-"U  O6G4G2DR:8#J*** "BBB@
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M**<O045Q&9^LQZ5&QJ0]*B;O7Y\C-B;J6FCK3JH0P]*;3C3:AE"AJ":2C%0
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MZFG8S42MTJ16H 7;32*=NI#TH ;1111:X"%: ,4M)FF M)MI-U.I %%%)D4
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M5J=FH*)U:AVJ /39)*I(!DS]:HR2'FIII,U69=Q-4,3S3FE\PTWRSFEV&HN
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MS(H K;:5*E9*0+06F3P\U;CJI'Q5@-20[D^ZD+5#OI=],!S=Z;C-)NS2J:
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MK;#XFI%6;-94%%\Q\%>+?A;);,["(_E7F>I:#-ILI^4C%?H5XO\  ,%U&^U
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MK,V:I2FKDHJLR9J0*V3FI%!J18?:I5AQ3 2)35^'M555P:M0T 6EHI,TNZD
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M+NKRZO-%Z'5&S6I0:E&-O2K)M]U!MS771FVM3RZL6I71@ZKIBW:$;<UP&M>
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M/2H!I!]*Z%-",15;-685(Q6H-*/]VGKIQ7M2<T6HE>%BM,N)3MK06R/I3)+
ML.E1<.4X?7E+(]>5^(P59J]LUS33Y;<5Y%XKLRC/Q772U.:9Y])_KJZ?P_\
M>7-<^T)\[\:W--D\G;7JI>Z<=]3V#PG*J[*]0TF[14%>$^']9$;*,UW]AX@
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M4AH;MJ6.H\BG+062MR*KR+UJ9:&3=3&4F3K0JU9,=)M"TA")Q3BW%1YQ3=U
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M3Z93Z8!36%*332U ";:=Y=(&J16Z5(">72[=M/W4UFXHN(C;O4;,:5VIG6F
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M$^.J>_(X74YC),>:T]!AW,*Q[CYY_P :Z;P[%]VNB)Z>#HV.IL8=JCBM: X
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M3_PT#*-Q%UJB]N"U:TPS55DYH"Q%:VP#"MRS4**S8AMJY'-M6F!K"8*HIK7
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M5:5<4 2JU.J(9YIZT@'4JL*B9L4SS?>@"SNIF\9J$RTSS.:5@)\TM1*U3+0
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M-THH;I0(;28%+2;J"D.VT,O%)N]Z-WO0-$,BU R5:;FF;*0%?93MM2[:8U2
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MH'3%7CC%02**0%/D5*C<TC"DW4K#N6X^:G1>E5(GZ5<B/ JA#MM,9:F[5$]
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M7,ZTO!KNA57*<GLW<YBTC"W X[UZ7X6;A:\Y@7%Q^->A>&6^Y7QV;2YDSZ#
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MMU**D"+;3U6I-M&V@!M%!HH *3;3MM(:0#324IZTE4 $T@-#4+3 D%%(M+0
MC4S=S3VIC+UI  :GAJBQBEW8I6 EHJ+S*<K46 ?1114 )NIM+@TNVJ %I: M
M!XHZ@.7%*V,5'NYIVZK AD7K46<58>J[+2 DC:K&ZJBU,K4 .9N:6FFESBD
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MM='HOAU+7:2M=%((;>'' XHY#YO%9@[Z,\KU3PX+=3Q6%]G\J3%=WXEOX_F
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MW ZUFJW-6(W(IB+FH:?%?1%2H->-_$CX9I?P2E8O7M7M5FV3S4^H:;%>0D$
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M1"J\D(]*O-4,B52);,Z2*JLD&:U'CJ%HJM,1D26OM5*XM>O%;[PU4FA'-5S
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MM> 1QRQMGFMO3=8EM6&6(I\QGRL^F['6(KI!\PJ:XM$N5XQ7BVA>-#'M!?\
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MX4\?V^I6L8$@)(]:ZI)!=+N!S72<W4SYABJS-S5^YB(S6=,I7- R19<5)]H
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M8:0B14IVVGH*?LI#(-M/5*E\NI8X:2W&5_+IK15?,-1M'@59+*#18I,;:LR
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MN)GL6(/%?5?BKP3'-&^U.OM7B7BSP%)'(Q5#^5?:X'..:R;/G<3@SAK36"[
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ME@/I&:E:HVI /SQ32:0-0:8API=M-6GF@8QJ;N]Z>5IC+S0 A:FLU#"F-TH
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M\M3XXJ&1:0#=]2(<U&JU.B<4 .HHQC%% !112CK0 ;:7;12T )MIC"GTUN]
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M(8K*G%Z(]&.9*.A]0Z/XTBF5<L/SKIK;7+>X09(KY8L/%$MKC+FNDL/B(T.
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MK=SC-%WN?<W@OX@1WL:!I ?QKTNWNK:^@['(KX3\)>/);!T#2$8]Z]S\'_%
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MI>M<CX@8*K5UFJ3"$-7G_B+40VX U[6%I2J221R59*.YC07PANLY[UZ]\/\
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MZZ:<A'-1R&-173^$=7:&Z3YN]<O,I7BK^BMY4P:NRUT#/L+X5^)/DB!;TKZ
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M"O*/'GCU8XY%#X_&M7Q_XM2W@D ?'%?,/C[QDTLD@#_K4W,Y2*WC;QHUQ+(
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M]H^'_P 6I))(Q)-W[FD!]J17 N@"#FGM;D#->?>!_&L6H1QYD!S[UZ?#*EQ
M&![4",.YU!;+.XXJB?%T"MMWC\ZY/XFZZ=)CD(;&!7SU>?%QH]1,?G?Q8ZT#
M/KN#5X[S[IS4Y^;FO&OASXS.K*GSYS[U[%9MYT:FI$+Y9ZU'+J2V/+'%:J6^
M82:\E^*7B3^Q(9#OVX% SO/^$RM\[=XS]:FCU1+S!4YKXW;XS'^UO*\[^+'6
MO>_AOXH.L6Z-OW9IV ]/:Z$/)--_MJ-.K5SOB+4C9VY;..*\LUSXD+8LX,N,
M>](#VZ;Q=!;=7 JA+\3+2$X,B_G7RIXH^- C5@L_/UKS'5?C+=22'9,?SIV
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M.Q5C]';7X@6M\<+(#6I#?+>+E3FOA7P/\6YVF022GKW-?2WP_P#B##>QQ!I
M2?>AHD]:\DKS33="'K4MOJ$5U;!E8'BN5\3:@;568&H Z5=:C7^*FR>((HLD
ML*\1U3XA"RE(:3&/>N<U3XLHL;8F&?K3L![_ '/CRVM<[I!5%OBM9*<>:OYU
M\A^)_BK.V[RY3^!KSB^^*NH+,<2-C/K5<I7*?H7;_$NTN6&)%_.M:U\017V-
MK U^>.@?&6ZCG023'KZU[_\ #GXJK?>6&FSGWIV%8^GE_>C(IK1E:R_#.M1Z
MA"A# Y%;EQAAD5F(JTJTUNE(#18"6BFJU/6D N*1NE!-)F@!K4JTC49IC)EH
M)I@:E+50@+4UFI&--:@D7=0M,[T]:N]A[$RTXK35XI]0!"RTQ5%2M4=,+DBB
MJUU]TU83K4-TORFLGN,Y;4NIK'D^Z:U]4X8UBN>M>EAGJ8R.?U[_ %;5Y+XH
M^\U>LZ]_JFKR?Q1]YJ]^.QYU0XA1^_'UKN_"RG<M<1&/W_XUW?A9?F6L9G,C
MT?3?]6*TU7BL_31^[%::+Q69H0LOM4>WVJRRU&5JC(BVTQNE3,M0M3((S2!3
MFG@#-2!15#(6R%JE,U7Y>E9MU31) 9.:%:J[9W4^,U118/(J,QU,HR*5EH)(
ME7%*U+G%,8U)20VI86J*G)Q3$S0CDI[-517J3?2$A6J%J>324QL$J7S,5%36
M:I)%G<;367<2<U:FDXZUF7#<U2+!9N:NV\F:RUSNJ];46 U$YI&IL+=*60TB
M!E%-R:0DXJ@"FT44Q!43"IL"FLM*P7*CKFA$YJ9EIR1\U87)85Z5=C'M4$2X
MJPM0 ^C(IK-3&:IL,DW5%(:3?0/FIV$5Y :K296M!H\U5FBZTQ%0O3EDIDBX
M-,SBA,T1;62C@U75ZD5JHL>5%,84X&C&:9#1&&Q4T<NVHBM)R* 1HQS5-YFZ
MLQ7*U,LQ]:@9>5LTU_FJ))*F'S"D]R-BJ\=1E?PJZ4SVJ)XZ=RKE)\U6D8U>
MD3K5.5:0R-&-6X6-4U6K</%,1<5J1FIJM32U Q-V::RT]5I[+Q2 J,N*94TP
MQ5=C3 E%*R4V,U8"Y%("G)'3%7FKDB=:J/\ *33 DCJ0KQ4$;59C&X4 1F/-
M,:.KRQT-#0245C(-68Z<8\4 8H*)U-(S4Q6I>M K"JQI]-5:DV\5(BO+TJON
MP:M2*2*K,I!IE$T;U<C;BLZ/(-7(6-9L"W1CVI(ZF5*0$>*FC--V4]5]J ):
M:QZTK=J9WH *5:%!I=OM3N 4FVG;32,,4 1,M1LM/>HS2 ;MJ2-::H-6(UH&
M/6/I3_*IRK4BJ:5RBNT-0M'6@5XZ5"T=,"O&E6HUZ4U8ZL(M/8 V\5')WJ?^
M$U"ZTMP*[=ZB:I9%--"YH 9@T]:D$5/6"D 1DYJW'T%0QPFK"H0M,!6-0LU.
MDS4!S0 IZTO-"K4RQFI&B+!IK U:\D^E(83Z4BBIS3ZE,)IIC(H1+&,*@D7B
MK.TTPQ$TRC)N(ZSIH_FK=FMR0:H36YSTI@9\2\UIV_ JL(2K58CXH8%M9-M.
M$U5LF@9I@6UDS4\66JI&IXK0MTZ4B258<BHIH3Z5H1QC%)+$,4BT8<T-0>6:
MU9H:@\CGI045HU(JU"Q%.6W/I2B$BF(G20T]9*B"FF\U(%I&SWJ=<53B)XJR
MO2F(FR**CR:4$XH G5A2LW6H=QIK.>:!CV89I.*@:0\T*] $^VHW6I$YI_EU
M+&BDZU'MJZT.>U1M"?2D#*PJ:,TAB-/1*!$J5)MIB5,O2@I(A=:B:K,BU RY
MH*&K3]N:58Z?M([4T(JR1U4:.M*1:JR1T 5NE/5J:RFA5-("7.ZAD-/CC+5:
M6W..E04F9_EFDVD5H-;\=*@:$T#N5N:49J7R32B$T&L6,7-2*31Y9IRH:"A,
MU&]3%>.E12"I$5WIOE[J<]+'4L=QT<-3>5A:='BI#C%18UYBI)'4+1U;DJ,K
M2L7&14:.F^6:M[/:D,?M3Y37G*FRF,N*M/'4++6?*;1D1@4UEJ95-#)2Y2_:
M%-TJ+R^:N/'[5'LYJ>4M5&0K#FG_ &:K,:5.L8I<INJI0^S4TP8K190*KR<4
M^43JLIF+%-*@5+(U5VDYI\H_:#J45#OJ132<275)D7-3)#385J[$E1RD>U(?
M*XJ&1:T&3Y:JS+UK11,W4964<U;@6JO2K4#=*KE(YVS0ACZ596.HK=A@5=CP
M:M1,W)E=HZ IJYY8-,:.E8SYR -BHY9:?)\M4YGJN4RE(CDER:6)LFJ^<M4\
M/45=C%R+\*U91>*@@JW'56(N,9:C9?:K++FHV6@KF(U6AEXJ15IVV@7,5F3B
MFJM6FCIOE>U(AB1BIU6D2.I5% K#-M0R"K!JM,U,+%.>JIR35F3FHUCR:$2.
MA4FK*Q4L,/2K2Q]*3&5UA]JE6*IO+IVT50R)8:E6&E&*E5J#0:(\4C+3S)3=
MU,179:CVFK##--V4$W&+D4[=2[:C8T,0CM[U$6YI':H\FDA$JU,M5U/2I :
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MJE36&PUI'Y1C:TL9B^6)ZE\.;#:B<5ZC<67^CCCM7,>!=),$:$K7?74(%O\
MA7Y%G,XSJMH_<.'\.Z>&2D<.Q^SS9Z<UV?A/5\.HS7$:VWE2'%3^&=2*W"\]
MZ^-JQYCV*BY&>_1R?:K+UXKR/XB:26WG;ZUZ?X;N/M%JHZ\5C>--)$T+G;VK
M@IU/9S.=Q]HCYL:W^S773'-==H>H;0HS69XDL?LL['&.:SM,OMLH7/>OO\MK
M>T2/ Q=/D/7=+NO,4<UL;MRUR7A^XWJO-=3&_P HKZJVESS82U(;H?*:P;X'
M!KH;@96L2^3K50E8NH<Y>1[JYS55\L$UU-TO6N9UP?(U36C[2)G3ERLS='U
MQWBC/>O?? %YY\"#-?-=FQ2\'UKW7X:WVU8P37P>986UV?08>K<](\1Z4+FQ
M8XSQ7S'\3]%\EI3MQUKZUD9;FP/?BO OBQI6Z.4A:_/:DG&I8^@AJCY/U)S#
M=$>];_A^8L%K)\2V9BOGX[U>\/-MVUZ/+[MRCOK.3 %;-K)G%<U:S<"MFREZ
M5S2*.CM7Z5K6S=*PK23I6Q;MTKFD@-:$GBKT59T#5=C:LAEQ*E6J\;5.IH;*
M'TUJ=25($3=ZKRBK3 <U7D%-$,IR=ZS[HG!K2D7K5&=:OF8D8-Y'G-8U]'\A
MXKHKJ/K61>0Y!I1YFQ2BC@M6M2TA.*=HMU]CG4YQS6SJ%F&SQ7*Z@QM9..*^
MCP[7+9G%.Y[_ .!/% PB[J]55_[1M/7(KY3\#Z\T=R@W=Z^FO ^HK=VJ G/%
M<=>+3NCF=SAO&WALMO;;7E=S:&QG/&.:^HO$VCI<6K$+VKP/QMHYMY'(7'->
MYE.)<)),\O':P*FC:MM91FN\TG5 J DUXS9WAMIL$XYKI8_$RPP_?[5^FTL4
MN5'SF'H2G,]&U;Q!'Y)!:O-/$.I1R2,0:P]7\7M(Q"O7-W>JR7 )S7-B*RDC
MZ:GETFMCK-+\1+:W ^;'->L>$?%@N$5=U?+=QJDL,W4]:[_P%XG994#/^M?&
MXI\S(J8.5-'TK>VXU.V/&<BO%OB-X-\Q9&V5[!X4U1+RW0$YXIGB[14O;=\+
MG(K@I^ZSRY)IV9\(>+M!-G,_RXYKCDAVR\U]&?$CP>RO(P3]*\-U;2VM)FRN
M.:]&,KHR*D-X;=@0:]!\$^)FCF0;N]>73-\V*VM"NC;R*<XJ91N.Y]I?#_Q*
MLD<>6[5ZY8ZD)8Q@]J^/O 7BXPM&N_\ 6OH;PCXA%Y&GS=JY)QL(])^V%12B
M^+*:H12"2,&IE7@US-M!J96NWFV-CFO#?B+J1,<@S7L/B9ML+?2O /B!*29.
M<]:Z(2N5<\#\8MYUP_UK TNW(F'%=-KT/F3,:S;*WVR#BNZ)FV='IZXC%;5O
MQBLFSX45K0-TJFB32@;I5Z)LUG0FKT38Q6=P+JJ,4R2\-L#@XIHFXQ56X'F
MT%1(KGQ1-'D!C6+?>)9YE/S&K5QIID-5&T7=VJC4PI;F6ZD.236EINDF8@D5
MHV^@_-G%;MCIXAQQ2,VRM:Z&JJ#MK1M['R^U:$,?R@592#VJ""O#;U.MO[5.
ML>WK3C(JU20(9'&%I6N%2FR3!AQ6?<+(Y^7-6C5(LR70?@5$UJ]Q]T9J33=)
MFFD'RDUZ)X;\'-<;=R?I6J9HHG V?AV>9Q\IKL]!\'R,R[DKU/1_ ,:JI:/]
M*Z6W\.0629V@8J67RG):#X-7:NY*["T\,P6ZC*BDDU*#3U(R!BL'5O'T-LK
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M3MSSZ4RXQN6_!_A4WDJ$IGFOH3P/X/6TC1BF*Q? ?A'R5C8I^E>M6ZQZ?:]
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MJD?]X5,-4CQ]ZBS*+3QBH6C6J\FJ1_WJKMJD>?O4N5@7Q&#4JP#TK-CU2/\
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M2106#T-%6/3/&'CC^U%D^?.:^??&<PN+AF]Z]&N-%NQ$=X:O._%%@\;G<*:
MZ7X/+C48O]ZONGPCQH2_[E?#7PA7;J47^\/YU]R^$O\ D K_ +E#$SP+XY_,
MTH/O7A?AW1X[G5.5S\U>Y_''_62?4UX_X3/_ !,A_O4= /ICX4^'8HTA(6OJ
M'PC9*MLHQVKYY^%A_=0_05]&^&),0+]*AB.#^-VG(VDS<?PFORX^-FGI_;TH
MQ_'7ZE_&R8_V3-_NFOR_^-3;M?E_WJJ('H7[+^BQ2:C!E>XK]/O VF16N@V^
M%&<5^:7[+K;=0@^HK]-_![;M!M_I27Q#..^*4 ^S2<=J^+OBCIZ-<2G'>OM3
MXI/_ *-)]*^,OBA)^^DI1$>9>'85AU-<#'S5]9_"VYQIZ#/\-?)FAMG4E^M?
M4_PPS]@3Z4,HX;]H^?=ITWTKX;M+5+CQ1@C^/^M?;/[1F?[/E^E?%6EMM\4#
M_KI_6FBD??W[-GA^'[';MM'05]/WEJEO8X48XKYO_9NF/V&V^@KZ/U9V:R_"
MLV2>)?$A1+%*#7R+\1]'BENG)4=:^MOB$3LE^E?*WQ 8_:G^M:1$4/AGH,*Z
MC&=HZU]^?!'34BLX2!V%?"OPWDQJ$?UK[P^"\_\ HD0]A2D!Z-XLA$FBS\=J
M_._]I"P1KN;([FOT3\4MC19_I7YZ_M'-_I<WU-4]QH\&^']JL>M)@8^:OO+X
M0INL81["OAGP!'NUE/\ >K[D^%=PMKI\1)QP*B0V>J7]G$+?+XZ5YGXHU33M
M.9BQ0$5J>./'$=C9N!)@X]:^1?BI\3+B2:412D\]C31![TOQ8L--DPDBC'O5
MIOCO&T159A^=?#,?B35=0NOE:0@FNUT2QU6Z0$B2AQ-+'N'C;XF?VI$X\S.?
M>OGKQE?"^D<YS76W6B7WE'>K=*XK7--ECSN!JD25?!D>-23_ 'J^WO@O_P >
M,7TKXL\(P[=03ZU]I?!IMME%]*F0F=+\3O\ D&/_ +M?'?B[_D*/_O5]?_%"
M7_B6O]*^/O%C[M4?_>HB@1Z'\*/]?%]:^L?#_P#R"Q_NU\H_">,M/%]:^L?#
M\1_LL?[M#!GB_P 9!E)*^;)H0=1/UKZ6^,JX66OFR4_\3 _6FA'I/@VX-NJ$
M&MOQ9J[2:>ZY[5S_ (74M&N*N^)XBMDQ]J /G[Q)8"^U<EAGYJ^B_P!GGPW$
MDL+;17@6I3(FK<_WJ^F?V?I!(T.VJ>Q1]A>'[-+?34 &.*TK=1,Y!JKI,+MI
MR?2K5E&RRU@2>;?&708I])E)4'BOS9^+VAI;ZY*0O\5?IU\7&*Z3+G^[7YN?
M&:X3^VI@3_$:N)438^"5R;6:(9QBOHC4]6:32\9[5\X?"$B29,5[Y?1-_9WX
M530,\4\>6RW5P^1GFJ'@?P_$=0C.T=?2M7Q=\MPWUI_@=O\ 38_K3V ^O?@O
MI<<,,.!7O5Y&/[/<?[->'?!^7]U%7N%X_P#Q+W/^S69)\G_':R203Y&>M?(.
MK::D>J$@=Z^P_CE)\LWXU\C:P^=2/UJT-'K7PI;RS"!7UEX%DW0Q\]J^3?A:
MOS0U]7>!?EAC^E2P/16;]V*I.V6J=Y/W8JD9/FI A66F!:?NHJ26.C;;4XEJ
MJ31N/K3N!9:3-1,U,!-(V:H8&2ES47-2+0)BU-'46*E2F'0EHHHI$A2;J1LU
M&V:!DFZG9JN&J533 E2F77^K-21U%>?ZLU-M1G(ZPW)K!D>MG6B<FN>9OF->
MIAS"1E:U\T;5Y7XH3EZ]6U)=T9KS7Q7#@-Q7L+8X:AYWTN/QKNO";?,M<'.V
MVX_&NT\(RY9:R9S+<]=TGF-:W88^!6%HK;HEKH[=<J*QD:D$D=59(ZU'CJM)
M%23!HSFBJ&1*T'CJG-QFM4S"1GS?2JDAJW-55J9B0MFE44NVGJN*L0S;3XUI
M#0K4%(D/2J=QTJRT@%4YFS6B&4Y!DT1C!I^W=2A<4%V+,+8Q5I9.*H*VVG>=
M4L@N,]-JLLFZIE:@H1JA:K+57D6@FQ%NIK24-FHW!IH:9%(]5=WS58D4U!LY
MZ4%$T+=*OQM\HJA"IJY'GBD ]FJ%JD:HFIB$S3@U14Y:!6)EJ6.HXUJQ&E(1
M+&*DXQ3!Q2,U2(&:H'I6:F,:H8UJ;NI&IF[WH6H%A9*F62J.^E\ZJL(O^93=
M]4Q-3O,I"9;6;WI?,S5'S?>G+-3L%RS(P-5I *5I*C+9J6,11S5B-:@5:L)D
M4@)\#%0S=\5)NXJ&4YII"*DC5'N]Z?(N:CV^U!5R5&]ZG2JT=6HQ2N.X[;2K
M3MM"K0%QZTC=*>O2FO2$5WJ!JLR57DJAHA:HF6I6ZTW&:!D&VI$&*=MI&XH
ME5\4K2U6W8IK24 2L^:;48)-3*OM3 5>U.HI57- "J,U8CCS38XZM1IQ28F*
ML?%(QVU-VJO)2$.5J20\4U:&^[3&BN_6A:&I8_O4#)X^HJTKA%SFJ^W:N:R]
M3U46L;$G%))R9)<U#6UM%.6Q7'ZM\0(X,CS!^=<9XT\:B$. _P"M>'^)/'DC
M2,!(?SKU\/@^?5G/.I8][O/B.C$XD'YUF2?$%6/^L_6OG$^,IG)_>'\Z;_PE
MLI/WS7I_4%8R]L?1O_"?+_ST'YU+'\0$'_+3]:^;O^$LE_OFE_X2R3^^?SI?
M44'M3Z77XAH/^6OZU)_PL5?^>OZU\R_\)=+_ 'S3O^$ND_OG\Z/J*#VQ],_\
M+&7_ )ZC\Z3_ (6*O_/4?G7S.?%\O]\_G2?\)?+_ 'S2^H(/:GTQ_P +&7_G
MK^M.7XC+Q^]'YU\R?\)=+_?-+_PE\O\ ?/YT?4$'M3Z>7XC1_P#/4?G1_P +
M'3_GK^M?,/\ PF$H_C/YT?\ "92_WS^=/ZB@]J?3W_"R$_YZC\Z/^%D)_P ]
M1^=?,/\ PF4O]\_G1_PF4O\ ?/YTOJ"#VI]/?\+&0_\ +4?G3O\ A8R?\]?U
MKY?_ .$RE_OG\Z7_ (3*7^^?SI_44'M3Z?\ ^%C)_P ]?UI?^%D)_P ]1^=?
M+_\ PF4O]\_G1_PF4O\ ?/YTOJ"#VI]0?\+(3_GJ/SI?^%DI_P ]!^=?+W_"
M92_WS^='_"9S?WS^=-8!![8^H?\ A9*?\]/UIR_$I/\ GJ/SKY<_X3.;^^?S
MH_X3.;^^?SH^H(?MCZC_ .%E)_SU_6E_X66G_/4?G7RW_P )E+_?/YT?\)G-
M_?/YTOJ"#VQ]41_$I/\ GJ/SJ4?$Z/'^M'YU\ICQI-_?/YT?\)M-_P ]#^='
MU%![8^J6^)B'_EJ/SJ,_$Q/^>OZU\M?\)K,?XS^=)_PF<W]\_G2^H(/;'U,/
MB8G_ #T_6I%^)R#_ ):C\Z^5O^$TF_OG\Z/^$UF_OG\Z?U%![8^K1\4$_P">
MH_.D;XH)_P ]1^=?*G_":S?WS^='_":S?WS^='U!![8^IF^)J?\ /4?G4?\
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M-9?$"=)A^\;\Z]4\#_$=_,0-*?SKBKY;RJZ-(8J[/M>QOEN5!!!J]Y8:O)O
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MU6X]/]JVUL?:IEL\=J86,>/3QQQ5N.P'I6FMK[5*L&*9%BG%9CTJP+4*.E6
MH2FR7"A<9I7+C<IRR"&JS$W+8 J::%KEL**Z+PUX5ENI5)0D9]*#>)'X;\+O
M=R*2A/->U^$?!JPJC,F/PJ;P?X/6&-"R?I7<R"/38>PP*HZ8V2(VBCTVW[#
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M_+GXUPRMX@EP#]ZJB,]>_9?D#:A!]17Z<>"_^0#;_2OR^_9;CD74(-P[BOU
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MOMQ3U;%.]B2P6J-CDU$TWO3?,S1N [;F@Q96GQ\U,JC%(+%&2'VJ$PUI21U
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MU#-$CBO&7@J/4H'^3.1Z5\Q?$KX2;6ED6+WZ5]KR,DRX(S7&>+O"L6H6\GR
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M,N8>M:19FSF;RWW9KFM7M?E; KM;B'K6'J5KO!&*[(,R:/.6+0W/XUZ=\/\
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M ****0T%%%% PHICMMJK)=;:=B&7:7-4X[K=5I/F%&P(6BBB@H:S?*:SI/\
M7#ZU?;[IK/D_UP^M.)#/3?AO_P ?$7U%?7?P]S]FB^E?)'PS7=<1?A7V%\.K
M?-M%]*^8S,]7#'H$:G:*GC7I3Q#M0?2D/RU\TCTB>-A3F88JEYVVD:XK2Q-R
M21LM2H*A5MU6(JS9I%DT2U=AXJO&M68UJ;&ERPII33%IP-(=R.1:JRQU>Q44
MB4$W,R2'FHMNVK\D=59%Q0',,$NVGK<^]59&Q5=IBM4%S4^U>]1/-N[UF_::
M47%185RVY#&A$JNLFXU:A:K%<MVZ5?0X6J4358W8II V.E:J<G)J2:6H-_-
MT*JT\<4B]*&^[4V$V(S4@;-,;O2IVIH5Q66H7C/I5Y(MU#V_%#8&=M*U-&34
MDD--5<4 3*U.9^*8O:A^] Q&FJ/SO>D<'%0L#026EFJ02U05B*D63I0!=\RD
M\RJX8FI%S046 ]+UJ-5J4+TH  M/6.A:D4B@"-DXJM(M6W-02=:0%;RZ<(>:
MD45.JBF!5^STGDXJ\5J&2I$5V3Y:A=:LL:C9<]J: K[:-M3%:902,9?:F[:E
MHXI7*(POX5*@IAQ3T:@"S'5J-*JPFKL-(:8[R^]1R)5GC%1R55@*,BU RU;D
M6J[TP(J<M(32K20(E7K4BK3$J5>U,!RI2[?:E6G5)(S;[4]*0M3%:FAHN)0[
M5 LE(TE,M"2-4>ZD8TV@9)FG;:8M2!J"1K)3=E2[N*3B@9%M]J0K4^VFLE R
M'I3E:D8<TQFQ02R??1YE5FEIJS<TP+NZF-3$?-/:D!$W6GQK36J2-N:EB+4<
M=3".F1,*F!I#&]*C;FI&:H]U,16D6H57FK;KFH2M!5AR=*21:%XI&:A!8IRK
MUJ#;S5N2H"OM5 /A[5;C%58N#5N.F"',O%4;A:OM569=U(#'GR*A5B#5Z:'-
M56BQ0%B>";BKL<WO66N5J5)C2L!IF;WIC/59),U*#FF N[-**8*>M2,>M2*U
M0TY<T&;),TUJ!FD8<4A"%J>C5 QZT+)0-%]6H<YJ!7J4?-0;(KRIG-4Y8SZ5
MJ&/=4,D/%!1DF/FIHUJPT--"8IE1$[5!(<5.W2J[#-9LV2%B8[JLR1K+&0:J
MJ,4_S#BI1H<CXL\+PWT+_(#^%?,'Q4^&ID,K1Q>O:OL:Y43*P-<9XB\*Q:A&
M^4!S4R1K%'YS:IH-UH-V6"LH4UW/@'XF2Z7(D;R$8/K7KGQ.^&*M'*R1\\]J
M^:]>\.W6BWC,JLH!KG:L7L?9G@?X@)JL48,F<^]>F6]PD\(8'/%?"G@'Q[)I
M4R)(^,'O7TCX-^(T>H11KYF>/6J3.VG),]2GQ5;=\U-M+I;R,,#4ICYI]#MB
MB2,_E3F6FHN!3V:L6=<2M(*@/6IY#59JAG9 D4U.E5%;%31R5FSL42VOTJQ&
M^#5)9.E2K)46"4;(VK648 -%]:I<QD8!K+CN"O>KUO=;C@FIC4=-W//JT85O
M=9QNO>#Q=$D)^E<+JGP[/S$1_I7OT,,<P&<43:'#,I^45]%A<VE#2Y\SC^'X
M3CS6/E;4/ LL3'"'\JS3X3N$Z*:^H;[P?%+G""L__A D;/R#\J^CI9G"6Y^>
M8GAIMNQ\Q7WA^XC0_*:Y/4;26W8Y!%?6VK?#M6C;$=>4>,/ )@#D)^E=\<SA
M=(\.KP]4I^\>'_;&C.":&O2W>KNOZ.UG(PQC!KGO,9&Q7NT_W\;H\IP]B^5E
MN;4FAZ&LZ?5WFR-WZU6U"X.*J66990#ZTOX>YNZ;E'0TK:W>X8'&:WK6R,:
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ML[WLN3S70:-I8)&13,&1Z3I)W E:[&PTY54<5)8Z<JJ,"MFUM<8&*3,QEK9
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MP.*9:V@7'%;5K;]*5R+DEK:=.*U[:SZ<4EK:]*V;6WZ4BB.WM<8K1CM\"GK
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M'96ZB7&:UK/3T<=*YJQO.G-=1IUX-M%.K.]SYR--36I#J&F1+&<J*\G\>64
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M3U6E9>* *[+STI<4]EI-M #-II57FG 8I: $:H\<U(U,_BH >JTI6D4T[--
M- I:7%&V@!:6DW4FZD -3=M.S0M4 S;1MJ7;[4TBIN W;2[L49IIH =NYHYI
MHIPI .%+113N "@T=J*+@-:DW>]*QIAH >K4NZF+2U0"EJ3=[TUC30:0$P:E
M5:8O:GYQ0 [M4<F*:TF*A:;F@!W>C-,W4H:D4*S5&]/:H)&IH!:*:&S3PN:
M%C;#5;C;BJZ)S5F->*$2R3=\M.#5'C%,:3;3))&I@^]49EIT;9IE$J]*=N-(
MHH/%") M2!Z:QIJFIDQEA6IZM4*T\5EN)#^IJ3:&0U&*?NXKIAH!S/B+2Q<1
MOQ7D/B;06A=F Q7T!-;B92"*XGQ5H8DC8A:[8U&B.6^YX7#?/938)Q76Z+K*
MS* QKGO$NCO;S,0N*Q+'49+.8 G'->C1J7W.2K32/5+FQCO(NF:X[7/# ^8J
MM;.B>(%F4*S5OR1Q7D1Z'-=4K,Y.4\3O-/>U8X&*?I^H26[=:]!UGPZ),D+F
MN0OM#:W8D+BN=Q+5T=%HNN$[06KL]/U,.H^:O'X9WM)/2M_3=>*D FHY2N8]
M;M[M3CFKBS!JX?3=9$@'S5T-K?!P.:3T&F:L@W55FAXJ59@PZTYL-20F8]Q'
MCM69<+UKH+B'=FLZ>UZ\5HF9-'/W"'FJ#QG-;]Q:]>*SIH=IZ5HF9-%6%<$5
M<C^[5?;M-2*W6J,I(LAA3&D J%I:KRS>]4D0BPTU-\[/>J#S'UH6:M+#+3R5
M!YE1E\TQFJ^5#+2S5,LE9XDJ99*B2&7?,]Z0M5<24[?60QS-4;-0SU"S4PL/
M+9[TG6FBI%6@9'LH\LU96+/:I/)QVI,ELJ;#32OM5IH\5&RTKBYB'&*<O:C&
M:*+B%9JC;O3STIC=*I -IZBF5(M4@)HUIS1T)TIS-3&5F7K36J5JC9:"2J],
M'6IVCIJIBI&20KTJRL8Q4"-MJ991BFP!DJ%OEJ1I :@9JS2&2JU6HFJDM6HZ
ML1>C;WJ;=5:-JEW<5.@#9&JK)5AN:C9:0RE)'4>SFK<B5$5ZTT7<8O%2*U1M
M2;JH&6/,H,E5=].#TA="5^:A9>:?NZ<TA:A B/;3UI,TJTP8[K2%:5:=2)&J
ME/VTNZE)XJ=1D,G%0E\5+,U4I'YJBB?S*%;-5U8U8C% $RC-6(UID:U85: %
M7BGY%-Q36:@DD&#3U'S5 KT]9/FJ9#(=5XMFQZ5\]_%0_+)^-?0FJ?\ 'LWT
MKY[^*B_++^->A@?C,:FQ\S>(?^/MOK5:U^[5GQ#_ ,?C?6JUK]VOLOLGG=2Q
M39/NFEW4C_=-2!ERY\\?6O9?A"H-W%GUKQR0?OQ]:]D^$*YNHOK6.*_AFE'X
MC] O@D8DMX-P':O;-2DB-C(&(((XKYZ^%MT;6SB.<<"O1K_Q-F+9OK\WQ%-R
MJW1]92DE \.^.FAI>+,56OB?QMX=-M>2';CFOT#\968U6W<XSFOE'XK>&_L[
M2MLQUKZ7+JSC[IY&+A?4^;YOW+8JM<2?)5G7/W-TR].:I',B5]8MKGBLO^'%
M,UX@]Z^LO@EX=6XF@)7/2OESP;9,U\G'>OMKX$V:I]G+#TKQ\RGRPT.["1O(
M^L_A[HD-GIB'8,XK"^+30QV$HP,[379^'9$ATU<'M7E?Q<OBUO,,]C7P-*\J
MUV?35/=IGPW\9-K7DV/4UY=X>OOL=Z#GO7I/Q8??=3'W->56,+277R^M?H>'
M7[JS/E*C?.?1G@WXB?8;-5W8XKG_ (C^//[2@==V<^]<UH.C7,L VANE9OB7
M1KB/.X'%<L:5-5+F[J2Y;' RV;:AJ&X#.37LWPT\(O(8\IZ=JY/P?X?%U?(&
M7O7UI\*O 2-%$VRGC,0J<;!0I<SN8;>$/+T[/E\[?2OG_P"+&D/;M)A<5][Z
MEX.2.Q(V=J^;_B]X%$@E.SUKRL'B5SZG97HOET/B&976Z8'UJ_'_ *NNC\4>
M&_L-U)\N.:YI8VW[0*^O4E-71XKBXL21&;I5=K6=NBFNV\.^&9-29?D)S7J?
MA_X/M?*I,/Z5SU,1&GN:1I2GL?.HL+G^ZWY4X6<Z]5-?6#? <>7GR?TK UCX
M-&U5B(?TK%8ZG+0MX>:1\Z1QNN,BK"MZUW'B3P:^F[OW9&/:N#O%>WD((Q75
M&:J;&/+R[DM(U5TD+"G1;I)  ,UJ3<22-VZ57:TG;HIKN_#?A>34F4;"<UZA
MH?P=-Y&I,6?PKGJ8B%/<UC2<]CYR^PW/]UORIRV<Z]5-?5B_ G<N?)_2L+7?
M@V;*-B(?TK!8ZG)V*^KR6I\ZM&ZKS5" _P"F+]:]#\4^%9-.WC81BO.]K1Z@
MH([UWTYJ2NCFDN5GU]^S6$,T&X>E?9>HQQ?\(\?E'W*^*?V<9MLT%?:$P,V@
M8']W^E?$9E_&N?1X/^&?"_[0D)-Y/M'<U\SS6D[3G"FOLOXP>%VU"^E&S.2:
M\]T7X/F^D!,7Z5]!A<3&G25SRZU)RGH?/"V-S_=;\JGCMIEQD&OJ:3X#[8=W
MD]O2N+\2?"Q]-5L18Q[5U1QM.>B,70E$\512.M3#I6OK&C/9R,"N*Q9,IG/%
M=:?-JC'8D8BH9%9NE0+,SO@5TNA:))?LHV9S1)\NK$M3F7MIFZ FH_L-RW13
M^5>[^'_A8]\JDQ9S[5VMC\"?.4$P_I7)+&TX:,WCAY2/E1;&X7JIJ9(95Z@B
MOI[5?@=]FC)$/Z5YSXD^'KZ?OQ'C'M51Q<*FPI491W/+5R.M2*U6=3L)+5R"
MN*R3.5;!KI7O&&Q;D4MTJJT,N> :W]%T\WQ4 9KM['X>R7$8;RB?PJ)58PW-
M%!RV/*1;R^AI&M9VZ*:]>_X5RZO@Q?I71Z+\)3>$9B_2L7BH1U*5&3/GHV-S
M_=:GQVLR]0:^J1\",P[O)[>E<EXD^$KZ>K$18Q[5,<;3EHBY8>4=6>&1JR]:
ME%;FN:')82,-I&*P&RN<UUIJ6J.?8>6%0R MTJ%IB9,"M_0]'>^D4;<YHE[N
MK#<YUK69N@)JI>6-SL^ZU>_>&_A:VH*I,6?PKJI/@7NASY/Z5RO&TXNS-E0E
M)'RYX7M;A=23<IZU]J? V/;;Q;A7G=O\&_L5XK"+H?2O<_AQX8;3(4&W&*\[
M'8B-6&AV8:DX2U.[\2K%_9;<#[M?*/Q.5?M$N!WKZ?\ %DC1V#@^E?+OQ&/F
M3R5YN ^(WQ+T/#]94^8V*QEBD+<"NRN---S,0!GFM;2/ \EV1B//X5]3[116
MIY/*Y/0\Z^SS'L:A>RN&/ ->ZV?PM>3&8C^5;UG\&FF7/D_I63QD(E^PDSYZ
MT^WGB<9!ZUZ=X+ULV$B$G&*ZS6/A0=/0GRL8]JY"30Y+.XV@8K*5:%9:#4)4
MV>U:?\1A'9A=W;UKS?XA^*/[25^:BL]*N9(00&Q7->*+&6%6W@US4J4(SNC:
M<Y.)YU?KYERS>]*JG;@5%>2%9R/>MK0]->^91MSFO9O9:G"M68LEO*W0&H_L
M-R>BFO;/#GPU;4%4^5G/M7<V/P-\Y03#^E<<L93AHS>-"4M3Y9^P7/\ =:G+
M:SKU4U]8R? 8+'GR?TKE==^#[6:L1#T]JB..IS=D:2PTHK4^>O+=>M6[7J,U
MUOB'PG)I[-\A&/:N4DC,$F#Q7;&2DKHYFN5GI/PZQ]NBSZU]O_"M8SID>0.E
M?"_PYDS?1?45]O\ PK8_V;'S_"*^;S-:'JX1F+\<%C&GRX'8U\!^/O\ D*2X
M_O5]Z_&PDZ?+]#7P5X\!_M27ZUTY5\)EC-S)T_[M7=M4]/\ NU=KW9'FH:R\
M&L^3_7?C6BWW36=+_KOQIQ&SU3X7_P#'Q%]:^T/AF/\ 18OI7Q=\,6Q<1?6O
MLSX:R_Z+%]*^:S(]'#GK"J/+%0R*,4++\@J.23BOEKGIW(&C%,\H4_?S2[J3
M8B+;BD_"I&INVA2 %J91356I56F-2$YJ-N*G*\5!)07<%DQ4\<E4LG-315(C
M1C;BI,96J\561TIL"O*HJE+'[5H2U5=:$"13\GVJ2.V![5,L=6(U I7&11VV
M.U6(X@*D7 IK/BG<0-@"J-QS5AY*KR?-2 H21Y--6/#5=,>>U-\O%.X;BP_+
M5N.052SMH6;%%P-,,#4;-5>.:G[LTABEJ3=2#FG;:H88W4>3FGJM68US2$46
MM_:F>36H8ZA:.F@N4ECJ5(ZDV@4]*&@&^35:9=N:T=M5KB/K4AL8MQ,5JM]K
M.ZK%]$>:RI%*M5"-6"ZSCFM&&;=7/6[$8K4MGH&C29N*JSU.O(J.1<T S/<X
M-/CDHFCJ$9!IW"YI1/FK4=9T+5?C:H D:HVJ1C4+-3!" 5*AP*B!S4JU0,;)
M3-Z+UHN)5C0DFN-\0^*(]/5OGQBFH.;LB;\NYUEQ?0QKRPK&N]<ACS\PKQO7
M_BNENS#S?UKCKSXMAB?WWZUWT\#.6IC*O%'T.WB2(-]\?G0OB:(?QC\Z^:&^
M*G/^M_6F_P#"TSG_ %OZUT_49&/UA'TVWBB+^^/SJ-O%$7]\?G7S0WQ3_P"F
MOZTQOBE_TV_6G]0D'MT?2[>*H_[_ .M1-XIC/\?ZU\U?\+0/_/7]:;_PM _\
M]?UH^HR#ZPCZ4/B>+^^/SH_X2:+^^*^;/^%H'_GK^M'_  L\_P#/7]:/J,@]
MLCZ57Q-%G[P_.K">)HO[XKYD'Q1P?];^M/7XI?\ 37]:7U&0?6$?3J^*(O[X
M_.IT\41?WQ^=?+P^*G_37]:D7XJ_]-?UH^HR#ZPCZD7Q1#_?'YTI\4Q?WQ^=
M?+O_  MC_IM^M!^*_P#TV_6CZA(?MT?3K>*(O[X_.H6\41?WQ^=?,K?%;_IK
M^M,_X6K_ --OUH^H2'[='TV?%$7]_P#6A?%,0_C_ %KYC_X6I_TU_6C_ (6I
M_P!-OUH^HR)^L(^H!XJB_O\ ZTX>*HO[X_.OEW_A:Q_Y[?K2_P#"U#_SU_6C
MZC(KZPCZE'BJ+^^/SI#XJB_O_K7R\OQ6/_/;]:7_ (6L?^>WZT?49#]NCZ>;
MQ1%_?'YTQ?%$7]\?G7S&?BMQ_K:;_P +6_Z:_K1]1D+ZPCZA'BJ(?QC\Z1O%
MT7]\?G7R]_PMC_IK^M-/Q5)_Y:_K1]1D'UA'TZ_BR+^^/SJ%O$\3?Q_K7S*?
MBI_TU_6E7XI?]-?UH^HR#ZPCZ87Q)%_?_6I5\21#^,?G7S,OQ3_Z:_K2_P#"
MUO\ IM^M'U&0+$(^G!XGB'\8_.E/BJ+^^/SKYA_X6M_TV_6D/Q5/_/7]:/J,
M@]NCZ;D\41$??'YU"WB>+^^/SKYI/Q4/_/7]::?BF?\ GK^M+ZA(?UA'TROB
M>+^^/SJ9/%$7]\?G7R^/BG_TU_6I%^*G_37]:/J$@^L(^H!XHB_OC\Z0^*(O
M[X_.OF/_ (6M_P!-?UII^*W_ $V_6G_9\A?6$?3R^*HO[X_.I/\ A*HL??'Y
MU\N?\+5/_/7]:</BL<?Z[]:/J$A_6$?3[>*(O[X_.HO^$JB_OC\Z^9/^%J_]
M-OUIK?%0_P#/7]:7U&0OK"/IU?%47]\?G3O^$HB_OC\Z^7U^*G_37]:>/BJ?
M^>WZT_J,A_6$?3O_  E$7]\?G3O^$JB_OC\Z^8/^%J_]-?UH/Q6/_/;]:?U&
M1/UA'T\WBJ+^^*0>*HO[XKYA_P"%JG_GK^M)_P +4_Z:_K2^HR*^L(^H1XJB
M_OC\Z#XHB_O_ *U\O_\ "U?^FOZTO_"UO^FWZT?4)"^L(^FI/$T7]\?G4#>)
MHO[X_.OFMOBI_P!-?UIC?%+_ *:_K2^H2']81]*KXFBS]\?G4@\31#^,5\S#
MXI?]-?UH_P"%I'_GK^M/ZC(/K"/IL>*HA_'^M.'BJ(_QC\Z^8?\ A:7_ $V_
M6E_X6H?^>OZT?49$_6$?3X\41'^,?G3QXHB'\8_.OE]?BH?^>OZT[_A:O_3;
M]:7U"0>W1]0#Q5%_?'YTO_"51?WQ7R]_PM7_ *;?K2_\+4/_ #U_6E]0D/ZP
MCZ<;Q5%_?_6F?\)1%_?'YU\R?\+4/_/;]:/^%J'_ )Z_K1]1D5]81].KXHBX
M^<?G4J^*HO[X_.OEW_A:A_YZ_K3A\5O^FOZT_J$A_6$?4?\ PE47]\?G4<GB
MJ/\ OC\Z^8?^%K?]-OUIK?%7_IM^M'U"17UE'TL_BJ(G[X_.EC\0Q2$?./SK
MYB/Q2/\ SU_6I[?XK!6'[W]:B6 E;0N.*B?44>I128^84]ID;H:\ TCXI+,5
M!E_6N_T/Q@E]M^?.:\RIA9T]SOIXB,M#N)&]*A8FBSF6Y4'-6)(,+7&]-#L6
MNIGR,:HS2$=ZT9(_:L^XC//%(Z([%0SE3UI?,$F<U7F4J:C5B":S9O$K:QI<
M=Y"PVCFO$?B!\-1?+(RQ_I7OJD/P:CO-)BNH2"H)Q42.CEYD? 'BKP=/H=PS
MJI&#Z4SPOXVN-+N$1G(P<=:^F_B3\/5O(Y"D6?H*^9/%G@FXTFY=UC*@&LSG
M<7!W1]'?#OQXMXD8:3]:]GTW4H[J%<,#FO@KPGXPFT6X5&8K@U]%_#_XAB\5
M TGZT'IT*R>C/=)E#*2*R+E2,U8T[5([JW!W \4ZXC5@2*AGJP,B3K4):K-P
MF#55@:S9UQD)YE/22H<4Y<U$MC?FL65DJ0/58-2^940E9G31DY,T(9>:U[.?
MIS7.1S<UI6LW(KIFE*(\9%.)U]E<=.:Z;3[K]WUKA;.X.1S72Z?<905Q0^*Q
MY-.DK7,[QM>D6TG/:OF/QY?L9G^;O7T-XXD)M9/I7S%XZD;[0_UK[[*N6-C\
MFXJC-7L4?#<OF7RY/>OIOX:V,<L,>0*^5O#$Q6\4GUKZ7^'.M);PQY;%>KFE
M%SIZ'R608A4ZMI'IGB+P[!+I['8.E?*OQ;\.I#)*57UKZ?U?Q1#]A8;QT]:^
M;OBIJT=PTN"#UKRLII2C.Q]EG5>G4HGB6A0FWU10/[U?5GPON?\ 0D'M7R[I
M<9EU,$#^*OJ'X4V;O;QC'85[&:Q5.%V?'Y1/][:)8^(L;36K8':OG+6M/?[<
MQ([U]C>(_";7EF3LSQ7A_BKP2UO*[>77F9=CHM\C/;S/"S:YT<7X3OAIK*3Q
MBO0YO'RQV>S?V]:\PO[*6S8A0169-)<MQ\U?23P]*JN8^7IXNK!\K'^-]=.I
M2N0<YKD-/5A(2:VKC3Y)22P-0?9/(!.,5M1C&GI$5:-2LKR":08%='X1D7[2
MGUKB;ZYVMBN@\(71-PG/>KQ24J>IYV&H.%=-'U+X#BCFB0$"O3[7P_#,@.P?
ME7D_PWN!LCR:]OTNZB\E?F'2ORW'^[-G[GEDDZ*1570881G8/RIK1Q0\8%:U
MU<(R<&N?O9N3@UX<[-7/IZ<$R*ZF7G%8EU)DFIKB8\\U0D?.:SHVN=D8I"*W
M-3P\FJR]:N6Z_-735M;0?LVM4;%DORBDU&'=$:ELL*HS46J721PG)K"A1E*5
MT<V(K*,;2/*?&UM\KUX-XM@^9Z]T\;:I'M?YA7A?B:\621^:_3,G4XI7/Q7B
M2TFW \[NK8F0TMJICF7ZUI.JNYJ)H0'&*^Q<E+1GQ.'C*$>8]0^'-T%FC!KZ
MO^'DT30QYQTKXY\$W'DSID]Z^C/!?B9;6!,OCCUK\]SRG_*?I^18I\NI]!W#
M0_9^W2N \4S0JK<BL;4OB)'#!CS1T]:\R\5?$A9-P$GZU\CA<%.M+8]W$9PJ
M$MS6U34(EE/(JG'?QN>M>87OC4S2GYZ2W\7%<9>O9KY'4<+I$T>(Z?-[S/78
MVCD6F21#M7":7XP61@"]=CINH+=J#G-?#XC+949ZH^YR_.*=9)19+Y-+Y>*O
M^6"N:A:.O/J.-.-C[&G44E<A5MM2K*?6F^6:>L1KCA)R^$B4U<7S*7<:3RC2
M[#1*$F]3535M!"QI.:E$1-/6 ^E3[%F3N]2JR&H)$X-:1AJ":&B5.*6A/M&C
M(F6JC+6I-![54>'KQ7'))Z,T=6\;%95Q2MQ4ICQ4;+7-.7(M#RJA1NOFS6'?
M6_!-=#-'FLZ\A^0UA3DW*[/$K1N<;<7)MYN#BO3/AMK3>=&"W>O+=:C*RG%=
M-X!O#!=1Y..:].RE$\B4;,^O]#(O+%>_%<1X^T0%68+6]X&U59;5%+=JO>+;
M=;BU8@9XK@3=*=XF7+S(^8-<C-G<-VYHT;4"TH&:T/'EF89Y"!7+Z)(5N.?6
MOTS)<0Y)7/&Q5'EU/5-/N-T8K06<9K TZX"PKS4DFH*AZU]7B*G+'0\>,92=
MD="K*PIDRC'%8":T!@;JM1ZHLG>N*C4N]3K^K3M>Q-<+G/%9-W9^;GBMA763
MO2^2&!KV(21Y53]W+4X?4;/R,G&*9HNL-;72C=CFMS7H!Y;8KBU1H[K/O7AY
MKAXUH,]+#5CZ0\!ZO]JC0%LUV6M:0EY8D[<\5XS\/=5\EHPS5[E87J7=CC.>
M*_&\;2=&>A]31::/EKXL:%]E\Y@N/PKYC\07#PW;+TYK[B^+&@_:H)B%SQ7Q
M]XV\-R07CG9WKZC(U"M-*9YN.J2BM#"TN1I%R36K%=&&0<UCVO\ HJX/%.-U
MODX-?N&&R?#5*-VCXN6,JJ9Z-X;U8[E&ZO3-'O\ ?&O->)^'9&\Q:]1T*8^6
MM?C7$V%I8:HU ^IRZM.HU<[NWDW8K0B-8MC+P*UHFKX"G[Q]Q&*Y"[&U6HS5
M%&JU"U<<FU.QYLW[VA;7I4BFHHS3Q74MBT2;J8W2EHIB()%JO(M7&6H)%I#*
M,BU1G7K6E*M4IDZ\4#,FXCSFLB\AZUOS1]:S[F'--,3T.7NH>O%<SK5H74X%
M=O=6_7BL2^L]V>*[:<FCGG%2W//%MWMY]W3FO1? _B1K.5 6QS7,:E9>6"<5
ME6=X]M=#!QS7HJ7.K,Y^7DV/L7P?XH6\A52V:Z;4M+34K<G&<BOGKX=^)"K1
MAG]*^AO#FJ1W5JH+ \5*I*#YD9U)N2L>/^,_"_D,[!?TKS*ZG>RF(Z<U]->+
MM+2Z@<J,Y%>!>+= >&9B%[U]?EN/E'W6SQJ^'3U%T#4C(5!-=U9RAHQ7D^F2
MM9R 'CFNZT?4O,"C-?=T:WM$?-5X.&QOW-H)U/%<9XBTORPQ KO[5@\8K)UR
MR$Z' HKTU.)G1F[ZGE=M=R6MT.<<UZKX+UH/L#-7G6K:2T,A8"GZ'K3:?.H+
M8YKXK%X1J5T>JY:'T4\<5Y:=CQ7D7Q#\*B:.4JGZ5V?A7Q(MW$JENU;NK:3'
MJ-LQQG(KSE[FC.;6Y\+>-/#;6T[G;C\*X*ZC:'(KZL^(_@H?O&$=?.OBC1'M
M9G&W'-7&:N:6.8M699 1ZUWGA77FLI$^;'XUPT,91N:N6]RT<HP>]=\$F!]8
M^ ?&'F+&I?\ 6O=/#^II<0J2<U\2>"?$C6LB9?'-?1'@OQ@)(XP9/UK@Q-/3
M0D]6UV%+J%@!FO%_''A$7 D8)^E>O6%XM\HYS4.M:.EQ;M\N>*\F#<9%H^,/
M$_AYK*1SMQ7GM\SQS8/K7U'X^\);EE*I7@7B7PX]O,QV8&:].$C0TO 6IBVF
MC)..:^B_#7CI+6U4;\<>M?)VGW+V$@YQ75VOBZ2.+&\CCUKL5@<CW#QG\1O,
MB8"3MZUX+XI\1/?2O\V<U5U7Q%+=9&\FL,![B3)YH:,GJ,MXVFFR>>:ZO2[0
M!1D5FZ?8[2"172V,84 5GL07K.(+BMNUXQ67"O2M&!NE3=F9JPFK<?2LZ&3B
MKD<E(9:6EJ)7IX:D+E),TM,IQP!3(D2 BJ-]-M!Q3+J\\OBH(5:^D  SFD:0
M3(K=9+J7:.:[_P )^$&NF1BF?PI/"?@]KB1&*5[7X7\.QV,2EEQ5([H1MN1>
M'?"Z6,:DIC\*Z&YOX;& \@8%2:E>PV=N<$#%>1>-O&JVRR 2?K3'*5B]XQ\;
M);JX#_K7@GC3QXTS2 2?K67XR\<M-(X$GZUYCJ6J27CMR35'-*5R?5M<DO)&
M^8FLA87F?)YI\,+,V2*TK>$+C(I6(([>TVX.*OQQX[5)&@]*LQ6Y8CBI9%V,
MM[?<U;=C9].*CL[/VK?L;7IQ68KLDL[7&.*VK>(*M,AMPJYQ3)[CR>*M#6H^
M[D\L'%5(5>ZD"@9I\*M>2  9KNO"7@]KB16*55CHC 3PGX/:Z=&*?I7M?AGP
MQ'8QH2F/PJ7POX9CLXD++BM_4KR&QMS@@8JDCHY5$EN+Z&SMST&!7EGC;QHE
MNL@#X_&JWC+QPMJK@2?K7SWXX\>-,[@2?K3,Y2)/'7CYI&D D_6O(M6UZ6\D
M;YB:KZQJLM[(WS$U3L[5Y&!(S4G.Y7%AM7N),GFM[3M+(Q\M6-,TW[N1736=
M@,=*8K7(-/L]N.*W[.V QQ26]D%[5:;]RM!:BBSY:K'Q6?*':3 J6.X:4[:Z
MKP[X7?4)$.S.:#:**/AOPW)?S(2I/X5[MX'\$+;JCLF/PI_@WP*MLD;-'C\*
M]'@6'3;?L"!2-K(L6ODZ;!C &!7#^./%<<$+@.!QZU!XP\8)9JX$F*^??'?Q
M ,GF*)/UH9+93^('C5G:15D_6O%]4U"2_N#\V>:LZSK$FH3-\Q.34>FZ>TL@
M)%0<\AVFZ6SL"179:98A%'%.TW3 J#Y:W+>SV]J""&"WQCBM&*' I\=MBI6&
MU:T1/+=D3/MXJL;=KEACFB3<TF!73^%]&:\D7*YYJ9'1&!9\(^&6DF0E?TKW
MWPCH:6L*$KCBLKP?X46-$8IBNSNGCTR#KC J#7X2+7+Z.SM3@XXKP3XA^,/*
M60*_ZUU7C[QFL,<BB3'XU\R>._%C7,D@#YY-:QU,I2.?\9>(FO)G&_/XUPQB
M:XDSUJ>[N&N9NN>:T-/L]P!Q5,YW(L:/:[<<5UMA;YQ67I]GM8<5U&GVWM6,
MB2U:V^%%:,4>*6"WPHXJTD-9IB*\BTR./+59F3BDB3YJU2&;_AVW'G+Q7M_@
M] D"_2O'/#L?[U*]E\,#;;K]*PD[,[(;$WBRX*V;\]J^8?B1<&2609[FOI#Q
MA)_HC_2OF3X@-^^DJHNYG4/(]1AWS'CO3]-M]KBK%TNZ0_6K.GV^6%;I',;>
MGPYQ706<845FV$.T"KK3^70RT6;F/>N!5WP[I+RWB\=Z@TM3>2*.M>L^!_"?
MG2(Q3O65]3HC&YWOPXT01PQEEKTZ^:.SLCCC K(T'3%TVV7(Q@5D>,O$2VMK
M(N_'%:K4T9Y]\1/$XMUE ?'7O7S+XX\2-<RR /GGUKNOB5XH,LD@#^O>O#-6
MO'N;AN<\T62,RK)&UU+GKS6KI=CL(R*;I=MOQD5TEG9XQQ4.5C-DMI;_ "CB
MM.&V]J6VM?E'%:,<&T=*CEYC#J5D@J58JM+#TIMP-BT<MC6**LB@+63?9YP*
MMR7!9]HK4TW07U''RYS5HTY3@KKS">E9EQ!(U>Q3?#U_+W>7^E<QJWADV9.5
MK1-HF4;'G?DO&V:T=/U:2T8?-BI=0A$3$8K(D1B3BAJYG<]*\/\ C:2.1!O_
M %KV+P=XP,^P%_UKY8LY)(IAUZUZAX)U9XW0%JYI1-4?7_AS5%FC0DUTKR1S
M)@BO'O!NLF2.,;J])T^X,BKS7)+0LI:]H<=XK?)7EGBKX=)<*Y$?Z5[B5##F
MJMU813QG(!K+VC3$V?$_C+X=M:[RL?Z5Y)K&B26LA&TU]Z>*O!,=]&^(\_A7
MA7C3X9F-G81?I7H4IWW$CYCFLVQ@BLR:S96S7IFO^&7LG;*8Q7'WEJ4R,5TD
M,S-,U*2QD&&(KUCP5X\>W>,&3'XUX_/"V[@5/I]]):2J<D5$HBV/NKX?^/EF
M5 TF?QKV+3]3AU*$<@YKX(\$^.'M70&3'XU]'> ?'RSK&&D].]<[AK<I39ZA
MXE\.I<QL0OZ5X_XD\/M;.Q"U[KI^I0ZE;@9!R*Q/$GAI+J)F5<UT4ZSIB:YC
MY]CD>WDP:Z#3]0W* 33O$GA]K21B%Q7-QW#6\F#Q7O87&-M)D<IWEO*'Q5M2
M*YW2[S<HR:V8Y@PZU]A0<91N<\T33892,5AZE8B8' K:^\*1K<,.:JIV/.E[
MKN>=ZCHS;B0*IPM)8N""1@UZ'=6*L#Q7-:II?#8%>/B,%&M'8ZZ.*=[&OX6\
M;26DJJ7(Y]:]R\'^-DNXT5GS^-?*C02VLA89'-=/X;\72:?(@+D<^M?GV897
M*+;1]-AJZ9]@_P"CZA;]CD5PGBGP7'>*Y"9_"L;P?X\6Y5%:2O4-.N8=0A&2
M#D5\JXNC+4]N+4EH?+7C3P"UOYC+'^E>2ZE:S:?,1@C!K[@\5>%H;Z)MJ Y%
M>#>-_APRL[+'^E=D)*:&DT]#Q_2]2<L QKJ[2Z#*.:YK4=%ETN8_*1BF6NI,
MC!36-:G='9&3L=Q%-TJ]#-7-6-[N YK7M[@'%>+*BTSHC8WH9JLK)FLF"6KD
M<F:ZX)Q1KH7U;-(W-0JU2JV<5G.1@XW&-'4$D=7,9I&C#5BF)4TC*FAJC-!6
M[)![54DM_:M;\QJI6,&2W'I5">U&#Q71R6OM5.:UZ\4)<HGJ<=J%CN4\5RNH
M:.^XD"O2)[3.>*SKJP5E/%=<:K1GL<!9W$VG3 Y(Q7HWA/Q]):LBF0_G7(ZI
MI9RQ5:Q%66SE!Y%=#_>1U'S-Z'V%X%\>+<>6&DS^->Y>&]7@ND0D@Y%?!'@_
MQ9)9R("Y%>]^#_B-Y<:9E_6HHT5S')6B?5"O;;1]VBO$T^)R[1^]_6BO3]F<
M'*?1!-1-3Z8U?>'G#:*** "BBBDP"BBBI ***<JDTP$5=QJ;RA4$K>2I8UB:
MAXKBL\@N!^-,#8N)!'GFHX;@,<9KBKKQE'*QPX_.H(_&"0\E_P!: /25C#*#
M220CK7!+\2;>(8,@_.K-O\0(+HX#@_C0P.M8;:83FJ5EJ:W@!!S5_P LU(#:
M0TIXI&H ;FE#4QNM(I-*P$C-3-U%+L/6D)$L,>^K'V< 5FS7ZV2Y8XKF-<^)
M%MIRL#(H(]Z!G832+'WJ..X1OXJ\0U;XVVL<A'G+^=5K'XV6TC_ZY?SH ^@4
M56[TDD8Q7DMC\7K63'[Y?SKI=-\>0:A@+(#GWH ZJ08S4++STIMM<"Z4$'-3
MM&5H A"BI%44QJ56- A[=*C;K3J* (]M)4FT5&U2QC6I**5:0"4NZE;I4;9I
M@/W4=Q48S3U[4@%VTE/IE K!2-2TUJ!(*=3*?3N4%%%%(!C=*;2M0M "4E.:
MDQ[4P'**7::%IU(!N*2G-3: &[?:F5+3: &K3J**: 0TVE:DIC"G+TIHIRTV
M(6I88]],V';FJTVI+9_>.,5!+-,VORYJK,NTUF_\)9"3MWC\ZLQ7RWG*G--
MAQ-)4GE^U)0 VG444A!1110 4444 %%%)F@!:1J6D:@:&T^FKUIU9E!3)*#1
M3 JS+UJI)&<UI,F:881Z50%&-"*NQ*:<L(STJ0)CM4@)36-/:HGH -U :H\T
MJYI@3=JC8TX'BHGZ4T GF8-+YF:KR4BL<T 6^M 7FF1MFIU%,!4%/IM*#4L
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M6C(0*<U\E-\7KC[5Q,<9]:]0\ ?$LWLB"23/XUI/!SIKF,XXB,W8M>._A?\
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M -YJ7_A()O[QJI]E%+]E%*T1799_X2";^\:/^$@F_O&JWV44GV846B%V6O\
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M))'R>?8)5J;=CY66)M-N,XQ@UV>@^-C9*!OQBI_%O@]XI'*I^E<%/I=Q;R'
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M'Q,-E>2()<<^M>X_%3Q EOIDJAN=IKX)^)VO2W&L2!6)^;UI@>W^&_'$FJ2
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MQ1':0W&V3'![TTA6,>U^+7F:EY?G9^;'6OH#X<:LVL01MG=D5^9VC^.V;Q(
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M\I3:/SKB##4W2;1Z[H*^9"M6=6M]T1^E'AV'; OTK2U"'<I%?H6'7NJY_/\
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MO<OA]XO\HQJ7].];RCS*Y%K'N?B#1DO+<L%SQ7B/C#06MY'(6O;=)UN/4+4
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MZY(S1AVW4(A'L]I^U TD^TS]_P"]7HWA'XZ)JDB SYS[U\&WG@_5M-8R,L@
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MIR5BW.N1V_5@*J?\)G%&<;Q5*A4ELCFEBH1>K.K_ +-3%1-8 =JR++Q;%<$
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M=JTS9(S74:9I?3BGZ7I&,?+746>GA%'%!F1V=@%7I5LP^7T%2\1<5;L[4WC
M 9S0S2,;C+"S:Z<+C->A>%? K73(Q3]*L^"_!;3R1L4_2O=O#/A>*RA4LH%4
MCKC'E,/PWX0CT^-"R8Q[5U<EU!8P=0.*-;O(;"W.T@8%>0>,/'@M5<"3'XT#
M;.E\4>-X[-6VN!^->(^,OB:VYPLOZUR/C/XA/,S@2_K7E.K:Y->2'YB<TKF,
MF=-KGC*6^9AO)_&N7=I;N3)YJO90R3N,YZUU6EZ4#MR*5S&YGZ?I)9@2*Z[2
M]-"@<58M--50.*V;.SVXXJ&!)9V84#BM2.W"BD@C"C-222!5-"+2&,=M0;V9
ML"D\TR-@5NZ)H;WDBX7/-%C51#1]%>^D7Y<YKU3PCX'"E&9/TJYX-\&A0C,E
M>EV]K#IT/( P*JQM9(JV=C#I< R ,"N9\6^+8[.%PK@<>M1>,_%:6<;A7Q7S
MSX\^(#-YH$GZTC*4BYXX^(9^<"3]:\,\3^*GOI6&\G\:H^)/$TEY,V&)S7-J
MSW#Y/-5$Y)29(V^XDR>:U-/L_44MC9Y R*W+.SY'%:D7"UL^!Q6O:VN,<5-:
MV?RCBI\>6V*RD:Q5RQ;P].*ZC0](:\D4;<UEZ'8M>2J ,\U[7X#\'F0HQ2B)
MNHF1I_P_:>,$I^E0:KX+^QJ3LQ^%?0=GH,-G:C<H'%>?^.YH($?!%*6I4DK'
MAM];BU8CIBJ:W/.,U+XBU)#.X![UB0W&]^M8V9@:%Y)E#5;39-UT/K2W+$Q5
M'H_S7B_6M5L58]Q\ VV\1\>E>M"'R[/\*\[^&]ON2/BO3]0C\NP/TK"9IT/#
M/BA<[$E&:^7_ !1<;KIN>]?1GQ6N,>=S7S+X@DWWC?6B*.9EC2?FQ736I'%<
MSI7RH#6W9S_O ,UU($CI-/T_[1*N!WKV7X>:.8VC.VO/_!UC]JD3C->^>#]%
M\F%6VXXJ6=4=CL;2X%I9#M@5Y1\3M>VPR@-7?:]>?9+5AG'%?/7Q*UPL9!NK
M-BE8\:\<:@UQ<OSGFN5TV$R3@X[UJ:Q(;FX;OS3]'L_W@.*T1@SH],LQY:\5
MOVEKMQQ4&F6H\M>*W+>W Q57)'V\'2K(AXJ2..IMH"UE(DKM'A:QM2N#$3@U
MM32!017/ZE&9GX%"#E9:T/-Y.HQGFO<? ?A<2B-BOZ5Y3X%T=I+I"5[U]/>!
M]-2"U0D8XJTCIAH7ELUTVT!QC KROXB>*/(BD4/^M>G^,M02ULWP<<5\I_%'
MQ(?,D ?UH+N>=^.->-Y<2#=GFN&BM3--NQWJ2^OVNKHY.>:VM)LQ( <47,I%
M_1[?RE'%;L;!L"JBV_EIP*EL26N%'O6;9E9F_H^@F\F4[<\U[A\/?"_V?8Q2
MN4^'NBBZ:,E:^@- T-;6U5MN.*M'3!$AF2PL\=,"O$_BAXF"QR@/^M>C^-=5
M^Q0N V.*^7?B5XF,CRC?ZU14CR_QSK;W$SX:N 61Y9>:VM6N3=3-SFJMI:@M
MTK1)',R);5VP0*U]+DDLW!SBKMK:*5'%3R6( X%-Q5BT=[X1\7/;,@+X_&O<
MO"'C#SMF7_6OE.T>2VD!&1S7H7A+Q,UNZ O7'.(C["TK5$N81ELTNIZ3'?0M
MP#D5Y=X0\5><J#?7JVDWBW$(R<\5QRN@3/%?'G@A9%D(3]*^>O%_A-K>9_DQ
M^%?<NN:.EY$WRY.*\2\>^"PWF,(_TIJ3+W/D6^T\P[ABL"X@99,BO5_%F@FU
MD?Y<5P-U:[6.17H4K,$-T'7)-/F7YL8->_?#;X@'=&ID_6OFJ\4QOD<5T7A'
M7I+*X3YB.:JK3NM#16/T&\*ZXFI0)ELY%7?$6E)<6Y8#/%>%?#'QON$:F3T[
MU[U8WR:E:#G.17D24HRT(E8\&\9:6;>5RJUR-A(\=P ?6O<?&GAWSE=@M>/Z
MEIYL;@G&,&OHL#B-4F<LD=3I4^Z->:V8OFQ7#Z9J@7"YKL=-F$R@YK[:CRM7
M1Q2DS5A7BIUQ4(P*<LE;NJUH@6I:1:<T =:9"=V*OPQ[L5@_>W+Y3G-3TM9%
M/RUQ>K:&P)(6O6VL?,'2LV^T-9%/RT^6-K KH\;2VFM9<C(KJ-!\52Z>Z@MC
M'O6IJF@A5;"UQFJ6,D$A*BO!QN71JIM(]2A7<=#Z!\&_$(2;%:3]:]4T_4(-
M4A&2#D5\6Z/KTVG3#YB #7K_ (+^(FW8K2?K7Y]C,OE3>B/HJ%6+W/6/$GA2
M&^C;:H.17CGBOX9[M[+'^E>VZ#XABU-%RP.:W+W1+>^MR=H.17D+]V[,]125
MM#X;UWPK)ILA^0C\*P/M[VK;>E?4_CKP LRN4C_2O O$_@J6UF<A" /:NCF4
MEH1S.YEZ?JQDQDUNVMUNQS7&F"2Q;!!&*MVFK;< FN"<6G<Z(SCU.ZCN .]6
MH[C-<I:ZGYF!FM:WN-V.:YW)&G/'H;T<WO5A),UE0R]*M1R5-KE+4O@YI&7-
M1QO4NZI<64R-HQ5>:.K9J)Q6U[1*BBJL&6Z5>MK?I3(4RU:5O%TK3#ZLPJHC
M%OQ15[RZ*]:QPGVO2-2TC5^AGA,;110W2@2&-WIM*W6DI,H*5?O"DIXZU(%B
MO ?VE+[[/I4_./E->_5\Q?M37F-+N #_  FJ&?GAXPUXR>)G7=_'_6OK;]EV
MS^W&V)&>E?#WB"9I/%C<_P#+3^M??7[(-N'CM2?:F-GVAI]BMO9Q+C!VUXW\
M8'\N.8>QKW!1M4"O"_C1]V?\:"3X^\8W!^W/SWJQX3F)E7FJ/B]?].?ZU8\*
MC$B_6I91Z1>2E=,8@]J^6OC!J$PNY I/6OJ*9=^FD>U?._Q+T(75ZY([TT,Y
M#X2Z3+JVK1*P)RU?H+\(_@W!J&F1/)$/NCJ*^4O@3X35=4A.W^(=J_2'X:V*
MV?AZ( 8.!0(\H^('P'LETV21(E/'85\6?%/X?KHEY(T:;<$]J_3WQ;@Z/*",
MYKXH^-6BI<23';W-3U$> ?#_ %R73KY(]Q !K[,^&(77M/C#\Y%?&5EIOV75
MACCYJ^OO@7=&.WA!/:AC9S7[0GPZ@329I1&,[<]*_/36-"2/Q28]O&_'ZU^H
MG[0=P&\/3?[M?FIKK?\ %8G_ *Z?UH0XGV#^S7\-K?4;.!VC!R!VKWGQI\/8
M--TTE8P./2N$_95G"Z?;_P"Z*]U^)DP;2F_W:ELEGPC\1K46]Y(H[&G?#)]N
MH1X]:E^*3?\ $PE^IJ'X7H7U&/ZBF@N?2DD<]QH)$>2=O:OEKXG^$]2OM4DP
MKD;J^X_ _AY-0TM ZY&VLSQ1\,M/\YI'1?7I3N*Y\O\ P5^$DMU<Q&>(G)[B
MOL'P_P#!.P&FH7B7./2N:\/Q:;X;=2NQ=M=@_P 6+:UM=BR*,#UJ0/.OB)\*
M=.M8I,1H#@]J^2_B5H<&D22&, 8/:OJ+X@?$Q+V.4*X.<]Z^3?BEK)OC*0<Y
M- SFO!_BQ[35417_ (O6OM?X4>('O=(3+9^6OSX\,[FUE?\ >K[H^"JG^QX_
M]VFP9PO[3=Z8["<Y[&O@D327GB3:"3\]?<_[4'_'C,/8U\;>#=&%[XJ7(S\]
M,:/K?]GSX?MJT$!=,@@=J^HW^!]M-IFYH5SM]*R?V9?!T<6EV[E!]S/3VKZ-
MOXUM]-D ' %(1^?'QH^%,&EK,T<8!&>@KY!\1-<:3J3*FX -7Z0?&RW6Z2<8
M]:^)O&G@];C4W.W^*FAHL?"2ZN-4NHD<L02*^WOAG\)8-<LHWDB!R,]*^7O@
MQX16WOH3M[U^A/PEM1;:0 !@[:D3/)?B5\![2UTB65(5X7TK\^/C'HI\.:PX
M0;<-_6OU]\?1B7PW<@C/%?EO^TIIH;6)B!_$::6H(M?LY^*)?MD2%SC([U]D
MZKJ'G>'<D_P5\-_ &U\C48_J*^Q-2NBOA[&?X*&#/DSXT73?;)=I[FO-/"<,
M]YJ"KR037I_Q,M?MNH2#K\U/^&O@U9KR-MO>F6F>U_"'X;KJT,/FQYSCM7M.
MJ? &TDTMG\A<[?2I_A#HJ6,4/R]J][FC5],9<<;*@AGYA_'CP*OAGSC&FW;G
MH*^5U\43PZQY0<XW8ZU]_?M8:8K17) ]:_/Z'1?-\48Q_P M/ZU2&CZQ^ _A
M^3Q)Y.]2V:^N-.^"%O<:8&:$$[?2O*_V3_":?9[<E>PK[42U2UL60 <+0)L^
M"?C%\(8-/65EB Z]J^=HK$Z+JF%XP:^\/C3"MQ'.,>M?''BS31'J#$#'-)#1
MZ9\//%4D<,:AS^=>@ZK>W6I6)"ECD5XW\.X2T\:^]?4'@[PO'?6J;USQ0!\G
M>,O!=_J-XWR,03Z5U'PM^$+SW$9FB[]Q7TSK'@'3X?G=%JMI<FG:&XVE 10*
MYT?A7X+V']GJ7B7./2N&^*_PNT^QM92L:# ]*[^/XK6]G;[%D7IZUY1\4OB8
MM];2 29R/6D!\B_$#38M)U"3RQC![5=^'/BB2&[CCWG&?6L7XA:D;^\D(/4U
M3\ QL-2C.>]:(NQ]M^"[<:YIJ[_FR*\A_: \#PPV<SA!T/:O8/A')MT],^E<
MA^T1(/[,F_W34]2#X.TCP\DWB81[?X\5]\_L_P#PXM_[-AE,8Z9Z5\2>'V_X
MJY?^NG]:_1#X(W8M_#\1_P!FA@S1^(%U%X<TYU0A=HKXR^)_C::_O)(T<GGU
MKZ$^/GBDK'*@;''K7RK#9G7-6Y^;+4@-7X=^&9=<U",R*6#'O7VG\+_@?:WE
MC$TD*].<BO*_@[X#6$PR&/T[5]D^!8%LK%4QCB@FYY9XS^ ]E#8NT<*GCL*^
M2?BE\-#I-Q(T<>,'L*_2/6PLUJT?7-?/7Q4\#I>PROY?8]J+CN?#&C:[/H-\
M%+%<&O>? OQ(-Q"B&3/'K7B'Q2T7^Q;V0@;<&LSP#XF=;Q4W]_6J*/>?BAK)
MN=-D96S\IKXO\874UQK3)DXW5]7>('-_HQ).?EKYXU3P[YVO9(_CH*1Z)\"_
M 9UJ2+>F<X[5]?:5\"89-*5C",[<]*\\_9H\+I'Y!*^E?;VGZ3''I:+M'W*E
MD,_.OXU?"--/CF*18Q[5\[:5IKZ-K0X*@-7Z2?&3PBNH1SX3/7M7QCXV\$G2
M[YY-F,'TH0TSW[X ^*O*A@0OZ=Z^L-/U87-DK9[5^>7PN\4?V7>1Q[\8/K7V
M5X(\1?;M+0[L_+ZTK$EWQUXF%C:R#?CBOC?XO:__ &I<2H&SDU[A\:O$WV*&
M3YL5\HWFK?VUJI3=NRU-(9+X#\,M<:LC[<_-7WC\%M+^QV<0(QP*^>_A3X'\
MYHI=GIVKZP\$Z;_9]N@QBA@SN+A1Y8'M5*2']TQJQ)+NP*=,O^BL?:LQ'EWC
MG7O[-AD^;&*^1_BYX_>5I463]:][^-^J&SAFP<5\4>+]3;4=2="V<FJB.QD6
M,,^O:F,Y8,U?4/P9^$L>HK$9(@<^HKS'X5>"UO+B)RF>_2OM'X7Z&FE0Q?+C
M&.U#8$[_  'L?[-SY*[MOH*^8OC=\)18+-Y,6,9Z"OOK[8GV?WQBO*O'?@U/
M$/F#9G=[4D%S\U=&\(7T.L8",!GTKVVW\.3QZ'EU.=M>\Z?\!8_MGF>0.OI6
MMXF^&JZ?I#H(\87TJFP>I^<?Q$\VSU9NHPU>S?LWZ\RWD(9N]8/Q@\"M'J$K
M!/XO2JOPFD.AZA'D[<&GT _4/P)J"W6CQ<Y^45R7Q1U'[#;RMG'%<_\ "GQH
MLFG0H7[#O69\;-<!TN9@W\)K- ?-7Q'\<![N2+S.^.M<)8:'_P )%)G&[=7'
M^-M=>?7W3<?O5[A\%=#_ +2AA9ESFK'L84?PM2.'<T6./2N,\5>"HK=B-@_*
MOK37_#ZV.GD[<<>E?.WCZ81W3CWJ1&3\,_!L4VH1C8.OI7UCHOA.'2]%$@4#
M"YKYV^$\P_M&/ZU]/ZE?B'PRQ']S^E4!\V_&3QM_9$DL2/C&1UKPS3]7F\3:
MAMW%@QJ[\?M>:36)4W?Q&K/[/^@?VQJ4)8;LM5 >U_#'X0C4O*>2+.<=17T;
MX=^ MF]JNZ!<X_NUT'PU\%QV.GPOY>.!VKU/3V2WC"8Q6;D!\H?%CX+P:;8R
MM'"!@'H*^*/&VGSZ'J[; 5 :OU1^)MDFH6,HVYR*^%/B[X%5KR20)W/:KBP1
MF_!OQM+;[%=R/QKU[Q1XJ6\TT_/GBOG'0H6T2? ^7!KJ;KQ(TUOLW9XI.(S-
MUBZ#WS-GO6_X>\41:7M)<#'O7GVKWY5BV:X;Q'XT>PC;:^,#UIE;GT]??&**
M.U,:S#.,=:\H\4>(KCQ)=$1L6!-?/</Q$N+N^$?F'&?6OHSX*Z4GB":$RC=G
MUIBM8ZGX6?#FXU"[BDDC)!.>17VQ\-?A]%8V49:, @>E87PW\ VUG:1.$7.!
MVKV728Q:0[5&.*S;);/&?CC;+8Z3,%X^6OS3^)=\W_"3.,_Q_P!:_2[X_/OT
MN?\ W:_,;XDIGQ0_^_51*B?4'[--P6MXN>PKO_CM<%=%?G^&O//V98_]&B^E
M=U\>L_V.X_V:3W$? OBJ627Q X4G[]>Z_!?PW+J1A#*2#BO)&TH7WB0@C/SU
M]H_L_P#@I!!;ML[#M5] /0_"?P=AU"U3?$#D>E1>-?@+;06,DBP+G']VOH+P
MQIJ6<*+M[5?\66$=QI,GR_PUFV2?D[\8?#I\,W4FQ=NUJC^"?C&5=6BC+GKZ
MUZ9^U-HJQRW! QR:\!^$F8?$2<_Q5JMBC]*/#?B$IX=60M_!G]*^:/CC\3'M
M[B5!+CDCK7L&DZAY?A,<_P#+.OBSX^ZPYU64;OXC4]234\,ZP_B+4 &;=DU]
M-_#;X=6]]'$\D8.1Z5\B_!><27D98YY%?;7@GQ%'IMC&<@<55RCU#3_A+IS6
MN3&F<>E>/_&+P':Z3:S-&BC /05Z7:_%)(HRGF?K7F7Q8\8)JUG* V<@]ZCJ
M2?&7B3Q))H^M,J,0 U?1G[//Q >XFA5Y.X[U\S^.-'>[U:1U'\5>H? Z";3[
MJ+J.15]!]#],/"NL)=Z?'SG(K78>8<UY-\.=6=K.)2>PKU:Q?S(P36=A#7CQ
M3<5--U-19I$[B8IRTM%, HHHI"'TUJ-U&:!D+ U7D6KC+FH7CS0.Y1:/FA8Z
MG:/FFJE.P7(O*J2.(U*L?-3I%0*XV..K"QTJ+3Z0[C0.:>M1M2JW-,8]JCIV
MZDI  J56(J):EQUHLA6'&8L,54O-*2\C.14Y^6I8YL<56P6/-O%'@M)%<JGZ
M5Y'X@\,O:.Q"XKZ?NK9;I2",UP_B;PJLR.0E7&I),B44SY_LY9+24 YZUVFB
MZJ74 FJ>N>&S:RL0N.:S[&0VLF#QS7O4)\R..4;';7$"W4)[\5P7B;21'N(&
M*[/3[X21@9K/UZT\^-CBNBIMH<LCRGS#!/Z<UV_AK4/N@FN6U33S%,3CO5K1
M[SR'49Q7#K<5SV'3;O<HYK<B;<HK@]#U+S-O-=E9S;D'-:E(L2IE:S;J/K6M
M]Y:HW2<5-Q2.=NEQFLF;(K=O$ZUC7"UJC!E%NM*BFG,O-21I5IF;!0:-U2[:
MC850T&XYIZU&M/':I:!HF44_;42M4FZA"&E>:7I0::3FGN)BTUEIRBG;:0B&
MDJ1QBH&/-5N K-36:FG-)2 6F-2T'FF(A8FHFS4^VD\NF408-."FIQ#3O)IB
M*VTTW;5GRZ;LH8R#::<J]*E\NEV8HL Q5J55I*E6DQ L?%/V4]%J3;0!!MIZ
M]J>RTF*07'TM,I=U)@.-&T8IF^E#<4D(1J;NQ2LW6H&:J*)UDJ56JBLE2K)3
M$6F8'--%1!^M/4U+&B3;[4QAUXJ132,O-!97:H6JRRU"RT[@1TUC3FJ-J8A-
MW-/6HZ>O%,9)4,E2;OEJ&5JSL BMS5N ]*SPWS5:A>J8F7B/EJK,.M3JWRU'
M(N<U(D46!S4D=.,?2GJNVF621U,A^:H%-/C;YJ"!^H-_HS?2OG[XJGY9?QKW
MW4&_T5OI7@'Q4^Y+^->A@_C,ZFQ\R^(O^/QOK56U^Z*M>(O^/QOK5:U^[7V"
M^%'F=2Q37^Z:=2-TI#,R13YX^M>U?!^Z%O<Q9..:\>:/]X#7=^"=4^P2J<XK
M&NN:%C2F^65S[D\.>(8TTQ06_AKS#XK:NEQ'+@YKD],^(!AM0OF=O6N5\7>+
MOMJO\^?QKYZCAG&I<].=9.-CS'Q!AKYC[UW7PQU[^S[J+YL8(KSK5+CSIB?>
MK.A:H;.92#CFO>G#FA8\V,K2N?HY\)_'T36L2M)V'>NK\=^)+:?37(9<[:^)
M_!'Q,?3D0>;C ]:ZW7/B\UU9E/-SQZU\G4P+]K='M0Q2Y+,\X^/&M!IYPK>M
M?..FW32:P"3_ !5Z9\1M:.K2R'=G->;:=:^7>A_>OK\+#DI6/#K/FG<^Q_@'
MJB6T<.XXKZ!\2>)(FT=AN'W?6OC'X<^*?[+1!NQCWKT?5/B.9K(IYG;UKY[%
M89RJ\QZM*LHPL<%\6KY;B[E(.>:Y+P)<"+5$.>]1>,M:^W3.=V>:QO#VH?9K
MI6SCFO8A!JERGG2G[]S[U^%WB**'2XP6'W:XWXZ:U'<V<NU@>#7F?A'XA&SM
M%7S,<>M8WQ \;?VE;N-^>/6O$IX5JMS'I2KIT['BFK76S6&/^U7OOP9UY(6A
M!;TKYLUF<M>LX/>NU\!^*6T^2/Y\8KW\12]I3L>;2GRSN?HMX?UBWNM/4;@>
M*\W^*FEP74,K #I7GOA'XI&.!%,GZUH^(_'2:A:L"X.1ZU\M'#SIU+GL2JQG
M&QX!XJB_L_4&*\8-=Y\*?&@M+J-7?'([UP7CJZ6:5V!KB]-\2OI5T"'(P:^C
M]E[6G9GE\_LY7/T>\/\ BJUU#35!=22*X3QWH=OJC.5 .:^??!OQ?EBC1#+^
MM>GZ7\0$U)5W/G/O7@?59T971ZBKQJ1L8B> XUNMVP8SZ5ZEX)\.VUFJEU48
MKG6UNWV[LBJ%Y\0DTV,[9,?C53]I55B(\L'<]@UC7K32K([64$"OFSXK_$ 3
M>:BR<?6LGQ?\7))E=1+^M>+>)/$\FI2,2Y.?>NS"8)Q?-(YZ^(35D)-K)FU#
M?N[U[=\*O'@L&B4OC\:^;EE.[=FMS0_$DEA,I#$8->Q6H*I'E.&G4Y'<_0K1
M?%EOK%FJNX.1ZUS_ (J\-VM^K.JJ<U\\>#?BC)!L4R_K7J^F?$)+Z%0SY_&O
MFIX6=&5T>M&M&HM3+/@6(W?W!C/I7?\ A?P[;::JL548K#7Q!!]_(K-UCX@I
M91$*^/QIR52I[HDXQU/2]>\76^EV+(K@8%?+7Q2\9+J%VX#Y&?6F^,_BC)-O
M42?K7C.K>(GU"[)+9Y]:]+!X/D]YG)7K\VB/H#X):FL>H1L3WKZ[E\3P_P#"
M/[=X^YZU\"?#GQ!_9\B-NQ7M,WQ-/]G>7YG\..M<N,PSJ5$T;X>MRQL<'\=M
M06ZNI\'/)KYWD'[YOK7J'Q"UW^TII#NSDUYHR?,37NX6/)32/-K2YI7'Z9\M
MXA]Z^N?V?]62U:'<V.E?(]K^[F!KV7X<>*SI;)\^,>]8XV'M(61>'ERRN?</
MBOQ+#-H++N!^7UKX4^,E\#JDK*?XJ]=U7XF&;3RGF]O6OGGXA:I_:%Q(V<Y-
M>;E^'=.6IUXFKS(V/AGXP:QO(P7P,^M?8GP[\9P7MK&KN#QZU^>6C7S6-R&!
MQS7L?@OXFR:;L7S,#ZUU8W">TU1EAZW+N?9_B6UL]1M6*[22*\0\2>"([BY8
MJ@//I2Z+\5OMD2JTF<CUK>C\0P70W%@:\2%.I1.^4HU"CX0\'0V=PA9 .?2O
M<-)OK/2[ <J"!7BUYXJAL5W*P&*X[Q#\8&MXW19?UIRHU,0QQJ1I([[XN>.(
M5MY520=#WKXV\;^(GO-2?YL\UT_B[XARZLS@R9S[UYEJ&;JXWGGFOH<'AO8Q
MU/+Q%;VCT/<O@3J CU"!F..:^[=#\40Q^'PN\?<]?:OSC^'.K_V7<1G=C!KZ
M%L?B@8]-V>;V]:\K,,,ZL[H[,+45.)S_ .TEJB7DD^TYSFOD*6/_ (F#'WKW
M;XH>)O[79SNSGWKQ=[?-P6]Z]S!1]G2LS@Q$N:=S;T4[72OHSX.:DEO-%DXZ
M5\W6+>6PKTWP1XC^P2)\V,>]98J'/%H*,N5GVY-XDB;12NX?=KY*^-E\LEU*
MRGN:Z\_$<FQV>9V]:\;^(.N?VDSG=G->7@\.Z<[G=7JJ4;&)X/\ %#6&HJ-V
M!GUKZX^%OCB*XMXE>0'CUKX4MYF@N]P..:]3\%^/I-+:,>9C'O7H8S"JJM#C
MH5>1ZGW;J*V>J6)/RDD5X[XK\'0W%PQ" C/I6)X;^+1N(51I?UKHW\50W:[B
MP/XUX$*-2BSU)3C417\)^$;>SND9D YKZ'\'WEIIMFHRHP*^;KCQE'8MD,!3
M1\7S;Q[1+^M*M1J5ATZD:9[I\2O%,#V<JJXZ>M?&OQ'OEGO)"#WKJO%'Q2>^
MC8>;G/O7D'B'7#>2,=V>:[\%A73.3$5E4.J^'MX(M00D]Z^O/!OB2*/25!89
MV^M?"WAO5_LEPK;N]>SZ'\1#;V87S.WK58S#NH.A544;GQXU=+JWFPV>M?%W
MB!=VI,?>O??B%XL.J1O\^?QKPO48_,N2WO7IX&G[.%F<>(ES2N:&@?+MKW?X
M7WRPW$))]*\&TUO*Q7H7A/7?L4B'=BM,1'FBQ4I<K/M;2_$40T?&[^&OGGXQ
M:@DUT[ YJS9_$+99[?,[>M>;^.O$7V]G.[->+AL.X5+G=6J\T;'6?"/Q0NFZ
MFF6QSZU]C>'O'D%]I*QF0'*XZU^:^D^)'TV\#!L<U[7X+^*TD:(AEX^M7CL%
M[1\R##8CD5CW?X@Z'!K3.P ;=7C=_P##N-9B=G&?2N]T_P <)J$8W/G/O3=2
MU:#RRV1FN*DZE+W3>:C/4Q/"G@VUM9D9U7KZ5]#^!;RRTNW3!48%?,>I>-ET
M]CM;'XU!:_&9X?E$N/QIU</4KHFG4C29]8>-/&$#V+JKCIZU\C?%2]6ZN)"#
MGDU:U#XKO?18,N<CUKSSQ)XA^W%B6S6N$PKHLBM64RGX;F$.IH?]JOK/X7^(
M(X;% 6'2OB^SU+R;L-G'->L^$_'QLH%'F8X]:[,71=1&-"IRL]@^,VO1W&GR
M ,#Q7PQXY;S-2D(]:][\=>.#J%LPWYX]:^?O$#?:+IF]ZZ<OINDM3+$SYV4+
M$845<J"W7:!4]>K)G&(WW36?)_K1]:T&^Z:SI?\ 7"G$1Z=\-_\ CXCK[ ^'
M)/V>+Z5\>_#7_CXC^HK["^&ZYMXJ^9S+<]/#GJ</W!224Z$?NQ2R#BOF3TK%
M:IHFJN_%.C>E81I1L,4-)5>.2G$YJP)/,IC-FFX-)@YI +221DU)&FZK @W"
MI&C(DCP:@^[6M-:UGS0[:19#YE6H):H-P:?')B@9MQR#%*YW50AG]ZLI)NI,
MA@T>:58ZG4;@*?Y=,I$%.7K3S'0J\TA$T=6E/2JRU)OH F+5&TE0O-BJ\DU,
MHL--[U!+<>]5FFJ%G)SS0 VXEW54W<U)(I:D6,T"%4FI$8\4JQU(L?2F38>G
M2I:8BXJ3'%3<!C4+37:D1Z"D7(ZF7I5>%JL;N*=P8%:5>M0O-BF+-4@6Z@F6
ME63--D;BJ&57;;1'-S39JA7.: +PEW4Y>:KQY)JW$O2DA"JE/V[:D5>E-I@1
MM24K4PTK#'KS4T*U74XJU;\T,"KJ2?NS7D/CY,125['J2_NC]*\B\?K^YD^E
M=>'^(RJ;'RK\0_\ 62?C7CE]_KC]:]E^(O\ K)/QKQC4/^/@_6ON,+\)X-7<
MEA^[3ZBA^[4M=1B#?=JJK_O />K$GW:I(?\ 2!]::&>@^#=/%U,@QFOH_P
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M8?\ B;3?[QI]01D? W_D()]17U9JQ/\ 8/\ P&OE/X&G_B8)]:^J]6_Y /\
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M/A7_ &?:L2F./2@D^2-=M7DF8L.]:G@FWVWT?UK<\<:2NGW#C&,&LKPC(O\
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M2Z=.57L:$(_/VUUQ]+\0!=VT!_ZU]D?!WQ8L^CIN?G;ZU\2>.K&73?$$C $
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MMJX^8BN]T3QF]HJYDKSX_+T%1M.Z]#42@I[E1ERGL[?$@^7CS/UKG=8\:/=
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M*.K_ "WS#WJ>U^Y4.KKNOF/O4MO\L=?;/9'S_4GI&^[2.V*2/]X<5 R#YF;
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M9:KTK;LU Q3N9NYKV<?2M>W4 "LRUXQ6E&XQ2(+T9 I)9M@J%9*J:A-MC/-
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M.*#NA%)#+K4(M/MB,@8%>.?$+Q@L:R!7Q6GXZ\7K:K( _P"M?.'CGQDUQ)(
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M;W$1*D<TV!]#:;X3@N=&P$&=OI7R]\?OAVRO*Z1_I7V3X0B,EBB$=JYOXF^
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M1!:0H2N.*Y3P#X?#)&Q6O4)(ET^USTP*LZ>709K6J)9VK ''%?._Q-\7;?-
M?]:[7Q]XN^SQR#?BOF7QUXH-W-(-^:DQD<EXGUY[JX<;LY-9>GP_:&R14,D9
MNIB>M=!HUAMV\51G<N:?IX7'%=#:V_3BF6MK@#BM6W@]JD1);P=*TX(>E101
M5:#>6*!DCKM6J,DYW8JQ)<AAMJ33]*>\F&!GFD5&)>T326OI5^7->R>"O!P7
M8S)^E9O@7PB1L9DKV"QLXM.M<X (%:(Z4K(FL[>+3;<= 0*X[QMXL2UA<*^/
MQJ+QAXN6Q5P'QBOG[QY\0#)Y@$GZU)A*14^('CQG,@$GZUX;KNO27DS?,34_
MB+7GO)F^;.:P(83-)DTS!R!(VF;)K7LK4<<4^VL1M'%:=M:<CBD9[DMG9YQQ
M6W:V6%!Q4-G;[<9K7A*A<4QJ(Q"(:GBC-TV ,TBV;W,F%%=QX1\(27$B$H>O
MI2-5"XGA/PB]U(A*=Z]W\'^#DMXT)3'X5)X/\'+;QH2F.*[.9DTV'L.*LZ%%
M1%G2/3[?C P*\\\7^,A:QN ^/QJ3QCXU2WA=?,QQ7SOXZ\=&9Y )*1+E8C\?
M>-FN&D ?/XUY#?WDE[,3DG)J;4M2>_F/S9R:M:9I9FP2,U+1A*5R31=.\S:2
M*[;3=/"*,"JNE:7Y>WBNDAM]BCBFD3N+%'M6JMU;^8>E69)O+.*LV$'VN11C
M-6-&EX-TTM<)D=Z^BO!]J(;5#C'%>8^"_#QW(VVO6K-?L-J.V!6,F=,=$4O&
ME\(;-^>U?*?Q0U@M)( U>Z?$3Q $@D&ZOECQYJGVJ=^<TXHPF]3@[BZ,UV>>
M]=9H,6Y5KDK: R7&?>N\T&WVHO%6S.YT-A","M)[8,G2J]K&1BM)%W*!4#.8
MU.W8 [17-75I([]#7H\U@)<\52?1%)SMK1(1Q=EI)+ D5TVFZ:% R*U(])6/
MM5N*U\O'%0Q-C;>V"@<5>C3 I(XZG"<5(1!5JG?2>2":L27 B'-9&H77G<*:
M9LD5FO/.?;73^%_#IOIE.WO6#H6BR7ETIVDC->^> /"?EK&S)0D;1B;?@OPR
M+.%&*XKK]2U%;&U89Q@5-)&FGV?&!@5Y1X\\8"U20!_UJ)(4G8Y+XH>*N)0'
M_6OF3Q5K#75R_P V>:[7QUXJ-Y,XWYYKSAH3>39ZY-)'+<FT:U,T@)%=SI]B
M(U'%9.B:88@#BNC5Q$ *V0%6ZC.0!73^"].::Z3([UGV-E]ND4 9YKU;P)X4
M*R1MLK1,Z(H]0\":(B6Z,5[5T7B"9;&U;!QQ2:3&-.M1GCBN,^('B98;>0;^
MU2V7)GE_Q'\6&-91O_6OF[Q5KQNYV&[/-=I\1?$9FDE ?N:\AN)FN+@GKS69
MC<FCA,SYKH]+L]N.*I:7:;E!(KJ+"TZ<51#)[6UZ5JVUOBBVM>G%:$<.VIN3
M<:L=#)BGEMM1/**5AD,E59*M2'-5Y*T&0.."*Q]0AW9K8:JDT>ZI8&+;W!M9
M >G->D>"O%!CD1=WZUYIJ4?E\BI_#NH-#<KSWK.4;H2/LKP7JWVN./+9KOI[
M59[/\*\$^&^N_+$"U>XV&H">U49SQ7"]&6>3?$301,DF%KYG\8Z"8;B0[<<U
M]I>)=+^U1.<9XKY]^(7AT1F0[<5T0D58^;-2A\M6&*R+./;< ^]=9XDM?)E8
M8KGK>/:V:Z=Q-'JWP[U?[++$-V*^I_ >O?:+5%W9XKXDT'5OLMPHSCFOI'X5
M^(#,(ANK&HK(:/8?%%E]LM6.,\5X)XHT?R;ICM[U](QP_;;$=^*\K\<Z*(VD
M;;44)^\2T<%H-U]E8#.*[6SU 3*!FO,KFY^R3D=.:Z;P[J!G*\YK[S!2O$Y9
M([04Y6P:2)<Q@TSD-7L]#,OP25J6MQMQ6+#FK\#>]2K&B.DM;LCO6M;WG3FN
M5AF(J_;W1]:SJP3CH:'41S[AUJ.?#"LV"ZZ<U:\[<.M>-[T9&$C.U"$,#7+:
ME8ALY%=A=?,*P;Z/K7MT*UU9F;;.&O\ 24;/%<;KFE[=VT5Z9>0]:Q;S35FS
MD5M4PL*R(YW'4\JC:>TF!&>M=[X3\626;+N?%4M4T1(U8[:Y+4+PZ>Q(.*^/
MS')HM-I'K83$3D['TOX;^(0;8ID_6O3M$UJ'4HP"P.?>OA33O'KVLX'F8P?6
MO7? _P 5-K1AIOUK\SQ6"EAY71]G1I3G&Y]*ZIX:M[Z$D*#D5Y+XR^'ZR;]L
M?Z5W/AOQY%?PJ#(#FNA\J'5%SP<UC3Q<J>C,ZE.46?(7B#P!) S$(?RKD9])
MDL7.01@U]G:]X&BN8V(C!_"O(/&'P[*[RL?Z5?UA5653DSPQ=4,!P35VWUK=
MCFK6M>#9X9&PA_*L-M+FM6^92*B<;H[821V.FWWF8YKJM/FRHYKSC3;OR2 3
M75Z=JJ[1S6^%CJ54EH=?YE%8W]K+_>HKV;'%S'WP:C85)3&K[,\(9BEHHH *
M***3 ****D"RIXKAOB)I?]HVD@QGBNT5ZJW]B+R,@C-,#X7^)W@0PS22[.Y/
M2O/- U8:'J"KG;@U]C_%OP<O]FR2"/G:>U?"?CV.;2]:<*" &H*/M'X1^,!J
M$,:!\\#O7K>JZ*-4L<[<Y%?'W[/>O2-<PJ[>E?<.@R1W6EQ]#Q3)/!M>^&ZS
M7#'R^_I3=,^'*PL/W=>ZWVDQR2$[:@72$7'RT#/,/^$+'D[=G:N3UCX9+=2$
M^7^E>_\ ]G)_=J%]'C;^$4AW/'_!_P /UTV=&V8KV_0X_L]JJ>@JI!I:0]%Q
M6A#^[XJ22/6(_/@*UY7XH\'B^+?)FO6)?WE4YK%).JT@/GK_ (5@OVG=Y??T
MKT3PAX6&FJN%QBNY_L>/=G;5B*R6'H*@#A/''AL:I8LA7.17@-Y\%4EU4R^3
M_%GI7UQ<6:S+@BL\^'X6;=L'Y50'"_#?P>NBVZ*$Q@5V/B'3/M5N5QVK:M;%
M+=0 ,5+/")%QB@#Y^\1?#E;R=CY>>?2E\-?#5+:93Y>.:]OFT>.1N5I]KI4<
M+#Y10!R/_"$QS6.PIVKR+Q]\%8[YG?R<_A7U#%&BKC%4=2TV*Z4@J#3 ^%KC
MX1G39CMBQ^%7;'P7+NV[37U/JW@F*X8D1_I69!X!2.3/E_I0!X[H?PI%]MW1
MY_"MG4/@'#-;DF'MZ5[OHOA^.SQE!71M;PF$KM% CXU;X&QZ?>[A#CGTKUWP
M+X5_LVV5-N.*]-U#0X9G)"#\J2STI;?@+B@9Y3\0/ BZU;LI3.1Z5YKH/P92
MTU,2^3CGTKZHFTM)UP5S5>/P_%&VX)^E %;X?Z8-)LT0#'&*ZS4&\R KZU0M
M8A;@ <59D;< *5Q'G7BCPV+[?\N<UYKJ'PS668MY??TKZ"GM%DZBJCZ1&Q^[
M0,\E\,^!5L9%.S%>P>'(?L<(7IQ3(]-2/HM6XE\OI3 3Q!_I-B\?J*^=O'GP
MU75KEF,><GTKZ+F'F#'45E7&CQS-DK4W \"\&_"]=-N PC _"O3+KPN)++9M
M[5V5OH\<+9"U<-FI7&*8'S_J_P ,UN+@MY>>?2M7PYX 6S9<1XKV"328VYVB
MECTU(^BT 9^AZ9]D5>,5TDDG^CE?:H(X@G:F3-\N*D#RCXE>$UUI9 5SFO&+
M?X,HNI>9Y/?/2OJJZLUN/O#-58] BW9V#/TJKB1S_P ,_#W]B11@+MQ7J,\V
MZW(]16+9V:VZ\#%76D^7%(#A_%6@B^W_ "YS7EVJ?#M9IB?+_2O?9H5FZC-4
MI-'CD.=HHN!XOHOP[5)!F/\ 2NN;X=QR6N/+[>E=]:Z5'$1\HK62.-5QBFP9
M\M^./@ZEQO(B_2O++CX6-8W!*QXY]*^X]4TF*Z4C:#7&:EX&CG<D1C\J$QIG
MS)I_@F5L*5-=1I_PB%\ 6CS^%>UV?@-(I ?+_2NMTGP_';*,H/RJKC/GQO@/
M$4SY(_*J\/P<2QN PBQ@^E?4WV&';C:*SKK1HI&)""D(\^\$^&_[-15VXKH/
M$GA==6LV4KG(Q70VNFK">!BM..-67!%2)GR!X]^!$5[-(XAR2?2N4\/_  =_
MLF\!6+&#Z5]L:EHD-T#E :YN;P?%YA(C'Y50SE?A_H)M;>-"O;%=)XD^'D6M
M6I!C!R/2N@T?1UL\?+BNJ@:-8\$"H)/D7Q5\!XTF=UA'7TK@+_X:O8L0J$8]
MJ^X=8TZ&Z5OE!K@-7\%1W#,1'^E4,^5K7P!)=-M*&NL\/_ Q+R57:+/X5[A8
M^!$AD!\O]*[K0]&ALPN4%%QG!>#/A+#H\:$1 8]J]"_LE;>WV!<<5T:M$D8
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M?\+<;_GM^M*/BXW_ #V_6G_9LA_64?7L?C2#CYQ^=3+XV@_OC\Z^/O\ A;K
M?Z[]:7_A<#?\]OUH_LV0?6$?8'_";P?WQ^=*OC:#^^*^/?\ A;S?\]OUI1\7
MV_Y[?K1_9TA?6$?9*^-K?'WQ^=))XTMS_&/SKX[7XQ,/^6_ZT'XQ,?\ EM^M
M/^S6'UA'UQ)XR@_OC\ZKMXR@_OBODMOB^S?\MOUIC?%QO^>WZTO[-D/ZPCZV
M7QI /XQ5A/&T Q\XKX__ .%N-_SV_6E'Q<;_ )[?K1_9L@^L(^P&\<0?WP:K
MR>-H?[X_.OD=OBZW_/;]:8?BTQ_Y;?K1_9LA?6$?63^-8?[X_.F_\)K#_?%?
M)Q^+#?\ /;]:9_PM9O\ GM^M']G2#ZRCZZC\:P_WQ^=2KXV@Q]\5\A+\66'_
M "V_6G_\+;;_ )[?K1_9TA_64?7#>-(/[XJU8^-( P^<?G7QZ?BVW_/;]:EA
M^+[)_P MOUI?V;(7UE'UOXD\9036;@..GK7RW\6-02Z>3!K*O/BZT\9'G9_&
MN%\0>+#J6[Y\UW87!NB[F%6MSHXS4%*W3$'O5FRUQ[,CYL55NG\QR:HRQL>E
M?0636IP=3TC1?B%+;;1YA_.O2O#'Q0<L@,GZU\UQK(ASFMK3-6DM&'S8KDJX
M:$C>-5H^W?"OQ"2?9ND_6O4]%\5P3(,N*^"-!^(+V97][C\:](\/_%IEVCSO
MUKP*^7OH=]/$+J?:,6L02+PPJQ%=))T-?/'AKXC-=[1YF<^]>J^'-<-YM^;.
M:\6IAW3W.V-12.IU,_NS7D7C[/DR?2O6;IO,A_"O*OB O[F3Z56'^(=38^5_
MB(?WDGXUXY?_ .O;ZU[)\1%_>2?C7C=]_KV^M?<8;X3P*NX^#H*GJ"#[M2[J
MZS(;-]VJ*?\ 'P/K5Z3[M48_^/@?6FA'KOPU3,\?X5]9?#^;R;=#7RA\,_\
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M^U_YY#\JC_X5E;YXB'Y47'<^(/\ A4]U_P \C^5(WPJO%Z1M^5?<?_"L[?\
MYYC\J7_A6-O_ ,\A^5%QGPRWPPOEZ(U,;X97_P#SS;\J^Z?^%8VW_/)?RIK?
M#&V_YY#\J3D%SX2?X:7R_P#+-ORJ+_A6]_\ W&_*ON>;X8VW_/(?E5;_ (5?
M;9_U0_*CF'<^(?\ A6]__<;\J9_PKB__ +C?E7W%_P *OMO^>0_*HF^%]O\
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M+7+T22L1ZU]7A>?E]X\6LE?0SV;GK2JW%5/.+-5J+E:[SG0ZE6E;Y14+/MI
M34C55:XYJ2.7=3L.Y+2CI36;BJTER5)HL(N4526Z)IKW1%*S%<OYI*RVU BG
M)?%JTY0N:%.6JT<^ZK"G-0QCJ*7;4;MBD,?1FJDEP5JNU\15<I-S0I:S?MYJ
M1;PM1RL+E[=3T&ZJ N,FM/3U,S"DU8:-+3=+:Z8 #-=1;^"WDBW;/TK2\%Z)
M]HE3Y:]LT[PBOV#)3M7F5\1R.QUTZ?,CYGUC038YRN*Q+>'=,%]Z]=^)>EBS
MWX7%>.0WGEZ@ >F:ZJ,W4A<QJ1Y78]2\&^"QJNSY<YKT:;X/JMGO\L=,]*P?
MA=KD%OY9<BO:[CQA9'3MNY?NUY%>K5C.R.VE"#CJ?*?CKPR-':0!<8KS8S?O
M2*]H^*^I17DDNP@]:\2:,_:":]C#MRAJ<-726A=7[M+47F;5JO)>%:Z;&5S0
MS167]O-.6_-/E87-*BJ2W1;%6(Y-U389+114;OB@"2C-5&N-M,^UFG85R^II
M<BLMKPBF?V@:.5A<U<T5GQWA:K4<FZE8=R:BBBD 4444 %%%% !11120!111
M3 :XX-9L@_?#ZUJ,/EK.E4^<*N(F>J_"UMMQ%]17VC\-)P+6+Z5\4_#-MMQ'
M]17V+\-YC]EB^E?-YD>CASUUILQUCZJV8VJRLA:.JMXN^,U\Q?4],\E\:;]C
MXS7SIX]EN%:3&ZOJ_P 0Z*;I6^7->1>*_A\UYO(CS7LX.K&+U.&K!RV/D/7+
MRZ$K?>K+AN9V/S9KWG7OA1)N8^4?RKBM0\!/8[OW>*^IIXBG)61YCIR3.+A9
MFZU:4"I;RQ:T8C%9[7)5L5T?%L3>Q="BF3$J.*K"ZJ]90_:V J;6#<R;BXG3
M.W-4GO[L="U>F:;X':_ (3.:VD^$LL@!\K]*GV]..Y7LY/8\6_M"\_VJ7^T+
MO'5J]J_X5!+_ ,\C^5-_X5')_P \C^53]:I![.1XK_:%WZM2_P!H7GJU>V+\
M'Y6_Y9'\J7_A3LO_ #R_2G]9I![.1XE_:%W_ +5']H7?^U7MO_"G9?\ GD?R
MI?\ A3LO_/(_E3^LT@]E(\1_M"[_ -JC^T+O_:KVW_A3LO\ SR/Y4?\ "GI?
M^>1_*I^LT@]E(\2_M"[_ -JG+J-W_M5[7_PIZ7_GD?RIO_"H)?\ GE^E/ZU2
M#V<CQ8ZA>>K4W^T;S_:KVK_A4,O_ #R_2D_X5#+_ ,\C^5+ZU2'[*1XM_:-Y
M_M4?VC>>K5[7_P *@E_YY?I2CX/RG_ED?RH^M4A>SD>)?VE>?[7YT?VE>?[7
MYU[?_P *;E/_ "R/Y4O_  IN7M#^E'UJD5[*1XA_:%WZM1_:%W_M5[=_PIV7
M_GB?RIO_  I^7_GD?RH^M4A>RF>)_P!H7?\ M4?VA=_[5>V?\*?D_P">7Z4?
M\*?E_P">7Z4?6J1/LIGB?]H7?^U0-0N_]JO;A\'9?^>1_*E_X4W+_P \C^5/
MZU2'[*1XE_:%WZM2?VA=_P"U7MW_  IV7_GD?RH_X4Y+_P \3^5'UFD+V4CQ
M'^T+O_:I?[0N_5J]L/P=E'_+(_E4;?"&1?\ ED?RI?6J17LI'B_]H7?JU-;4
M+SU:O9O^%2R?\\C^5/C^$,C_ /+(_E1]:I"]E(\8CU"[)&2U:-K<2O\ >S7J
MEQ\)9+=2?*_2N;U/PHVG9RN,52K0GL')*.YSR\KS2X%+,OE,1Z54DN=M:6)+
M#**J7#LHXI8[@R'%:5GIK7F/ES1\.X;G.?:IUDXS70^'[R[,R\M73Z7\/Y+M
MA^[_ $KOO#OPK?<I\K]*QJ8BG%%1IR;-+X?RW#&+.:^E? 8?;'FO.?"'@%K7
M9\F/PKV?POI/V55XKY/&58RV/8HP:W.E?_CW_"O,/B#_ *F2O4KI=L)^E>5^
M/S^YDKS</\1UU-CY8^(G^LD_&O&K[_7M]:]D^(A_>25XU?M^_;ZU]SA?A/GZ
MNX^#[M2U%;_=J6NIF0V3[IJE'_Q\#ZU=D^[5-%_T@'WIH1Z_\,S^_C_"OK7P
M!&)+:/Z5\>_#RZ$,\7/>OK#X<ZLGDQ GTKYK,(OH>MAF=AXGT47%JV%SQ7S;
M\1O!)FDD(CSU[5]9/)%=6_4'BN#\3>&8KHL=H->5AJ[IR.RK34D?&3?#T^<?
MW7?TJXGP_8*!Y7Z5](-X%B\PG9WJ=?!,6/NBO:^O'G_5SYK'P_8_\L_TI&^'
M[+_RS_2OIA/!,7]T4RX\$Q*I^44OKI?U<^5]2\'M!$3LQ^%<3<::;6^'&.:^
MJ_%7A6.&W?"UX%XHTT6]\>.]>AA\1[0Y*E/E/:/@"P66$>XKZ\.TZ+_P&OC#
MX*7XM;B+)QR*^JU\0)_8X&[^&OGLPBW5T/4PTER'SY\9XU\Z6OF;7HQYK\=Z
M^B?B[J FFEP:^>-8;=*_UKW<"FH(\_$/4YKR@)"<5:M=1>UF7:<<TFWYJKRQ
M_-FO6WW.'8^CO@GXT:WN8 \F.1WK[=\&^(K?5=-1&8$E:_,3P7KK:9<(0V,&
MOJKX4_$P_ND,GMUKY?,<)S>\CV,)6Y=&>I_%KP-%JD$CH@.1Z5\:?$3P6=+N
M)2$P,GM7WL=6@UC3?F8$E:^;OC5H<3><RCUKEP%>4)<C-L53C)<R/CRZ8Q3%
M?0U8A;<M6->TXPWC\=ZK1?*N*^OO='@]19FP*73VW3@&FR_,*6Q_=S ^]/H'
M4]<\$Z0EUL!%>OZ;\/5N[8%4'3TKQOP+KB6TD88XKZ:\!^(K6X@1685\_BY3
M@[H]*BHRW/'O&7P[GM8G9$(KPOQ-8WVGS,!N&#7Z!:UH]KJUJ=H!)%>*^+/A
M.EY,S+'G\*6&QRVF76P_8\ ^&UU?-J408MC(K[\^"Z&33XO,/8=:^<_#?PM_
MLV[1_+Q@YZ5[_P"$=43P_9JI;;@5RYA4C67NFN%BZ;]XZ3XK)!'I[],XKXO\
M9748U20 _P 5>]?%;XB)-:R().WK7R3XG\0^=J3MN_BK3+Z$E'4G%5$WH>U_
M#)UEN(^>]?26FZ>)M)'^[7R%\*_$2K<19;N*^NO!^L1W6G*N[M7-CHN,C7#R
M4D>"?&7P^6:4A:\&T_26@U,$K_%7V1\2-"2^BD(&>*^?=3\/"SO"V,<UVX6O
M^[Y3FKT_>N>F?"M0D<0/M7IWB(+_ &6W^[7C_@74ELV09Q7H.MZZDFFL-W\-
M<%6#=2YUTFE"Q\L_&H?OI?K7@EFNW4,^]>Z?%VX%Q-)@UXG%'MNB?>OK,+I3
ML>-6^,]P^&>O"Q>(%L5]5^!=<&I6Z)OSQ7PCH>K-9RI@XYKZ(^%'CL0R1*[U
MY..P[DN9'7AZEG9GN?C+PK)?6;NHSQ7R?\4O#=Y9R2[0W4U]GZ;XFM=4L I9
M22M><>//!L&M;RB YKRL)B'1E:1V5J:G&Z/A.&UO_MNWYNM>N^ _"=YJ'EY#
M&O0H_@XJW>_RN_I7JW@?P3;Z6B%T Q[5[%?&QY?=.*EAWS:G$V/PWGBM0Q0]
M*X_Q;H;Z>K9XKZ:UB^LM/LB/E! KYQ^*'B*W9I C"O/P]6=61TU81@CS*"W$
M]\%//->U>!?A^FI6Z'8#QZ5X-IFKJ=2!SQNKZF^$/B:VCAB5V'05V8QSA"Z,
M<.HREJ<C\0/AC)9VCLD>./2OF'Q=IE]87K!=P -?HUXE6SUJQ(7:<BO ?%GP
MI34+EW6,')]*PP>,Y5:9IB*%_A/G_P"'LU]]JC#%NM?8/PN$C01^837FOAWX
M5BPN%;R\8]J]?T&%-%MQGC K/&5HU=(CP]-PW.]U*2%;$[B,XKPOX@?9YGD
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M50'1>$/^/M/K7U=\*O\ 515\H>$O^/I/K7U9\*_]5%7S>:_">[EGQ'NMN?\
M1A]*J2-\QJQ;M_HR_2JDA^8U\(I6D?=\ONCU8U8@;YJI;JFMWYK:6J*A[K-@
M']W7->))BL+X]*Z!7S'7.>(U+0O7%3@^<6(J>ZSP'XA7AW.,]Z\MMX!>7F#S
MDUZ7\1H3N?BO.]'.R^&?6OTS 7C1N?D&:R3KGHOAOP2+V%2$S4NO?#AHHRP3
M]*[OX>S0F&,''2NQ\01VSV9.!TKQ<1BI1JV/5PV#C7HW1\A>(-#;3V<$8Q7
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M&M'%1J:,^I=5L8KRW. #D5Y7XL\'^9O94_2NP\->*4U.)!OSFNDN--BO+?.
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MJ8.LTTC&1Z-I-UN51FNBMEW@5PN@W6XJ,UWFFC<@-?=X9\T3FE$NQQU.J[:
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M 34C4@4FGK&: (VIAJ9D-,H A9>M1MFK)6HF2@"+FGHQHV4Y5YH$/HI12X%
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M4$PYD'YU\@V_Q!EA_P"6A_.K2_$R7_GJ?SKS'E^NAV+%'U7_ ,)=;==ZTO\
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M:,5KTIK]=/ML=,"E<UY2+QEK2V=N^&QQ7S/\1O&!9I!O_6O1/B-XL'E2 /\
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M:3 90M/VTFVI **** &TRGTS:: '+VI],':GU8!1110 4UJ=12 :M.HI,BF
MVFGK3J:>M)@)GFIX8]U0,IYJE=:TECG<<5(&UY*^E'DKZ5RK>/+=6P76HYOB
M!;0J6+K3 Z_R4]*:UNK>U>;W7QEL;=MID2K.G_%2UU)@$D7GTH [22, XI8H
M]S"J5CJ*WZAE.<U)<WRV:EB<"H TU@44ODIZ5P^I?$RUTTD/(O'K6'+\=-/C
M8CS4_2GH!ZF;=#VJ-[5>HKS"'XYV$S;1*E=#IOQ"M]4QLD!S1H!UL<(6N?\
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M!^>=K\.]277M^Q\;Z^R/@;I,VG6L D!& .M1+X;TW[7D*N<UZ-X7LH;.-?+
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M>:Q+I1P:OZY$8]0?ZUEW5P%XK] ALK'S+?<]2^$=\\.H0X..:^Z?A_JKMI*
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MT_=S?C7R+XC3_29/K7?EUN0Y<5?F.&U#_CXS[U[Y^SW<,NH08/<5X-J"_O\
M\:]Y_9]C_P")A!]17IXS^"SBH_Q$?H)H$S-X;7G^#^E?*/QX^:_ESZFOJO0>
M/#:_[G]*^4OCL3_:$OU-?(8#^,SWL5_#1ROPOTY9;U3CO7TC9Q_8],!7CY:^
M>/A7,%O$^M?1B?O=+&/[M=>,;Y[&&'^$\9^)6M2*LJ[C7S)XPF-U,Y;UKZ/^
M)UJ1YIQ7S1XME$,SY]:]? I6T.+$;G.6\"QON [UJQ:]+8K\C$8K&MKP2/@>
MM:T&DM>XP.M>O*WVCA7D-F\;W+-MWMCZUN>&]:DNIE+$G-9?_"$RR,#L-=-X
M=\*R6TBDK6$Y4^70M*5]3W/X:GS&BS7NL<8&FGZ5XA\.[<V[1@U[<)?^):?I
M7R>*?OGKT-CY[^,2C=)7S]"H&I_\"KWWXQ3#=)^-?/\ ;S;M4'^]7OX3^$<%
M?XSZ;^#!YB_"OH+6&/\ 8K?[M?/OP7Y\FOH/6/\ D"G_ ':^>Q7\8].A\!\H
M>/DW:V1_M5[Y^SW9*T49QVKP?QX1_;A_WJ]^_9[E_<I]*Z\7?ZN94/XIZ)\7
M)C9Z))M./EK\[/BMKDC:I,NX_>-?H=\9%\S0Y<?W:_./XJ6Y75ICC^(T9.EU
M%CVTSBMWVA<FK>C*(;I2/6LZ.41IS5O2;H/=*/>OJ^AXJW/HOX8:Q)"8@&-?
M1FAWSWEHH8YXKYJ^%]L9FB('I7TGX=M3#9J2.U?*8VW,>WAV['/>,=-5HW8B
MN#T5!;ZH,<?-7HGC"<+&PSVKSO36W:D#_M5E2NX%3^(^@/#-\ZZ6,'^&O"_C
MQJ#M'-SV->U>&U_XE8^E>&_'2/,<WT-981+VQK6?[L^-M>D,FJ-G^]7;>!QM
M="/6N+UQ,:DW^]7;^"%^9*^RJ_PSP(?$?3?PUN658AFO8+J0OI_/]VO'?ALG
M$5>P77RZ?_P&OCL1\9[U'X3YS^+Z_P"MKYKU'_C\;ZU])_%\_P"MKYLU'_C\
M;ZU])@O@/*Q'Q$]O]P5+45O]VI:[3GN%%%% @HHHH8!1112 1ONFLZ7_ %PK
M1;[IK.E_UPJXB/4/AG_Q\1?6OL7X;I_HT7TKX\^&/_'S']17V5\-D_T:+Z"O
MFLR/2PQZ3'%^[%->/"U;C7]V/I4<J\5\PSTC.D;;FHUF]Z=<?>-5>=U2(T8Y
M,XJW&W2LZ#/%7X118997FID/%0K3]V!0)D_FE:AGN#ZU&TE5KB0XH+1%<3^]
M5?M.UNM1W$AYK/DGVFE89L1WG/6KL5Y[URRWAS5VWNLXICN=-'<[JF\S-8]M
M,6Q6E%DTA7N2TJ=:4+Q2@46 =Q43U(>E1M1L.Q"RU'T-2LPJ)C0@'H:L(:J*
M:G1J!EV*K Z52CDJQYG%(02-M%59).M/FDJJS9-(JY8C;.*LKTJE#VJT)!BB
MP7%:H6YS3I)*BW9IE#E%.--!H9LTR6-8U!+WJ8CFHW2F3<IMUI\?442+MIBM
MMI"-&$\5/N&*H1S4_P [B@1+-(.:I3,.:=+-UYJK))3+$8\TY&.:C'S5-&M2
M!(O-+M-.5:<%IC&JM.VTY1[4_ Q3)ZD.VI8:"M*O% RIJ?\ JFKR+Q]GRI/I
M7K]_\R$5YAXXL2\,AQVKIP^DC.HM#Y-^(7WY/QKQZ_\ ]>U>V?$NV,+29'K7
MA^H2?Z0?K7V^%?NG@5MR>'[OX5+M-06YRM6:[#(912M24@"BBC- !29%+3:
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M4?!!4RLJ>M?/>J:;+8W;9! !KIE)-:'10@KZG;:9>>8H.:W[:?I7GNDZGY>
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M=/$*43T*<D7;K35=2<5S>IZ<4S@5V"7"R+BJMU9"8'BLJD>8]:GRR1YM<^9
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MD23&6J[#JT,G<4S%TSC)O!@8_<_2J,W@?=G"?I7I2W4#=Q3PT#>E U3/(YO
MI_N?I523P&W]S]*]G\J!O2D^RVY["JYAJD>)-X!?^Y^E1MX!?_GG7N7V&WQT
M%(=/M_04<Q7LCPS_ (0%_P#GG^E*/ +_ ///]*]Q_L^W]!2KI]OZ"CF#V1XS
M:> 64C*?I77:#X,\EURE=]'8VZ]A4\?E0\C%-2)E3+>@Z/%;1KD 5O32)#'A
M<5S?]KB$8!JO+K1?C-838E29J7%Z<D9KF]<B-U&PZU.U]N[TW<)>#7/=B=,\
MB\5>%C<;B$_2O,M4\)O%(QV5]/WVDQW"'C-<?JWA-9&;"UT0D<LJ9\^KH+AL
M;:T+;PK).PPI_*O55\%9E^Y73Z'X)7<N4KT(R5C'V3/-/#?@&22128_TKVSP
M;X+6U\LLGZ5T>A^$XH%4[174V]FEJHP!6-22,I4RWIULEG" !C%5M;O#]G8
M]J?-=;1C-96H,9HV%<_4Y)1/"?BE</B7FOF7Q+<N;IL^M?6OCS0&O$?"YKP'
MQ+X#E:=B$/7TKLIM'-*#.$T>3)Y%=1:-TJ&V\*RVS?<-:D6F/'U%6V<\HM%N
MUDK2AEZ5E*IBIRWGETD8V9O)-TJPEQ[USHU0#C-2IJ8..:9+3.D6X]ZE6X]Z
MP(=0![U:CNLXYI$&A*WF4D,GDMFJZ39%)+)\M*Y!L+XD>W7 ;%96J>*I)5(W
MG\ZR+J8\UF2 R-06BMJ5W)=2'DFDT^Q+."15^WL0S#(K7M+-8\<4KEEK3;4(
MHXK42,+56'Y<59#XYJKF3+2# IS7(CJH;H*.M5VF,C8%%AI&@+@R'%:%EH\E
MXPPM,T/1WNY%^4FO8/!_@SS-A9:$:J)S'AOP/)(ZDI^E>O\ AGP>EJJ%D _"
MM[2O#<-E&"5 IVK:M%IL9P0,59JK(OM#;V4/88KE->\516*MAP/QKD_$WQ'6
MW5P)/UKQ?QA\2S(S@2?K4L&[G;>+OB9Y>\"7]:\:\4?$![K<!(3^-<?X@\62
MWCMAB<USJS2W3<DFA&$F7K[5IKV4_,33K&P>9@6&:MZ7I'F8)%=-::<D*CBJ
M,FR'3=)55&16PJK;+212+&,"G/"UQPO-0(ADO#+\HK0T7P[+J-PIVY!JWH/A
M.:\F7*'&:]Q\"^ !'L9TK2VAU0B4/ ?P_P!H1FC_ $KVO2-#BL;=> ,"G:?I
M,6FVXX (%9.O>*$L8G&[&!6,C9V0SQ)KR:?&P#8Q7@WQ \>[?, D_6K/Q ^(
M VR 25\\>+/%+WDKX:H.69'XH\4/>2N Y-<U;JUU+SS4,2M=39-=-H^D\@D5
MM$YR;3=+'!Q75Z=8;<<4NGZ=M4<5NVMGMQQ5%C[.UZ<5JI$%7-10Q[,5)+,%
M0TR2&XNA&,9K,EC:[DP!FEN&:23 KIO"^A->2IE<TC>"-#P/X9:29"5[^E?0
MWA724L[=<C'%<YX/\+K;QHQ6NKU"]73+<\XP*#?9%'QAJB6=JX#8XKYA^)/B
MH[I0'_6O1/B+XT"QNN_]:^9O&?B WD[@-FE8YY,YS5M2:[N&YSS4VF67F8)%
M9=O$9IL^]=?I=KL04R";[/Y</2F:<A:\ ]ZTFCW)BKNA:09;Q3CO06CVGX3Z
M*MQY6Y?2OI#2O#]O#8 E5Z5XU\+=.-O'&<>E>PW6J_9; C./EHN="/./B3';
MV\,@&.E?*7CRZ3[5)M/>O<?BGXG.V4;O6OE_Q9K!GNGY[T#NC-FDW@UCM_Q\
MBK<,N]351O\ CX%6]CF>YZ]\+WQ-']:^LO!+_P"B)]*^2_A?_KHJ^L_!/_'H
MGTKDF-$_BS_CW?Z5\Z?$)?WCU]%^+/\ CW?Z5\Y_$)OWDE8":/'-37]XU<M?
MI\]=7J',C5SE['\]=<"#I/!/RW"?6OIWX?2GR8_I7S'X-7$Z?6OI3X?MB./Z
M5E4-X['?ZZVZQ;Z5\W?$;_CY?ZU]'ZQS8GZ5\Y_$<?Z2_P!:6'^(QD8O@AL7
MJ?6OHOPVW^AK]*^<_!?_ !^K]:^AO#;?Z*OTK[S!_"82-&[ZU66I[@\U M=U
M0Q)X^M7H:H1U>A-9&EU8MCI12H>*>J9-0)78T+D4UHJMI"34ZVN:5Q\K,HV_
MM2?92W:MC['[4X6H]*I%QT9C+8^U/%ECM6Q]G J.2,+5*1525T936X454G7:
M#6K/@ UE73\&M8W9C&?*9-V>M9%R>M:%],%SS6#=7@&>:VL85)\X,U2Q<UEM
M?#=UJQ!?#CFIEJ339LQQY%/,-4H]04=Z>VI+ZUI3@KZEU(IER*+FM*WCX%8<
M.I*6ZUIV]\IQS6E3EL%&#N:?ET5!]K%%<>AW\I]@-TJ)ZFVTUEKYH]HA7K3P
M*=MI=M #=HIVVC;2T@';::R]:=NIK&E8"-J2E:DI )BC;2TFZ@!&H'6BA>M,
M!U-S3J93 <.E+3=U#-2 5J9NHW4E.X!FEC^9OQI*? /W@I 331XC8^U>*?%+
MQ,VDQRD-C%>WS?ZE_H:^5_VA+IH8+C!QP:8'E6J_&9[6\93/CGUJEJ?QH>2T
M;;/SCUKYD\<>(IH=2D <]?6I/#MY=:N%3+'/%(H[_6?BU?S7Q"2MC/K7I_PK
M\:7]Y-&7=B,UP7A'X17&M7$;F,MGVKZ/\#_!A]'MDE,6,<]*0'LO@WQ-Y5BC
M2-SCN:S_ !U\1(K6UDVR@''K7G'B[Q%_PBEJR;]NT5\\^+_B\U]</")L\XZU
M(&Y\3/BM=>=((I3U[&O(+OXD:O*[%9)/SKJM)\/R>+I@<%MQKTWP_P#L[_;8
ME8PYS[4[@>%Z3\1M7CN5+228SZFO>/AG\5)T>,32D?4U-K/[.O\ 9MNT@AQ@
M9Z5X]XICD\&7! .S::-Q'Z$^ /B%!?V\:F52?K77:S<K>6S,ISQ7Y]?"7XR-
M]NBA,W<#K7VCX/\ $BZQI:,7SE:5K"/*/BU#MBE.*^1_$R_\31OK7V)\8,?9
MY<>E?'WB9?\ B;-_O50SV+X&QG[5!]17W-X3F2+1X]QQQ7Q/\"[?]_"?I7U+
M>>(1H^BYW;<+2ZD]38\?>+H--M759 ,#UKY+^*'Q4DC:412^O0TSXN?&']]+
M$)O;K7A,FH2>*+K 8MN-"*L5]:^)^IS3/LD<\^M8:?$+6?.!WR8SZFO7_"?P
M4;6=K-%G=[5W$G[- 6V,GD=O2AC/-_ ?Q1O898_.E8<]S7U'\.?B='=1Q*TH
MS]:^4O''@=_!^]@NS;6!X,^*,FFZDD)E(PV.M(#]/=#UF._12&!K9OKR.VMV
M8D#BOGWX0>/!J=G$3)G('>N]\9>)C%IS[6[4$G._$7XA0Z;'(!*!C/>OEKQY
M\8)6FD6*8GZ&F_&+Q=>2SRJC-CFO&-+TF]\0:@ RLVXTT,MZQ\2=5N&)CD?\
M#6-'\0M9C;)>3'U-?0O@G]GE]9MU9X,Y'I6KXA_9E%C9,_D8./2F-'A/ASXM
MW\-R@DE;KW-?2WPK^*!O&B#RY_&OE_QEX!;P[=,0NW::M_#_ ,52:7?1KO(P
M?6D-GZ=^$=:COK5#N!XJYKNH):1,V<5X7\(O&IN[6(;\\#O78_$+Q";?29)
MV/ES4,S.0^(GQ*CL(Y%$H!^M?,/CGXIWEQ)((96/7H:YSXM?$Q_[2DB\T]<=
M:J_#O2!XQG0,=^XTQG,7?CS6FN"0\F,^]7M/^)VJ6K+YDCC\:^E+']FV*\LU
ME\D$D9Z5YWX_^!,FDJYCBQCVIHM&A\.OB]+)-&LDQZ]S7UC\.O&,>I0QY?)(
M'>OSML='O=%U  *P :OIOX-Z]<QM"KENU#$S[+\Y7MPP]*YO7O$D6FPON8#
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MJ:<3A22*\(^(GPUAN))"L8/X5R8+&<CLSIQ&'YE='Q%H_AVXDN@-K=?2O<O
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M^$(4CM$,GIWH8'C7BKX.MJDK.8\YJ/PC\'8=,NE9T P:]O\ $WB33]+@8LR
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M(_9ISN@KY]^(T8'B)_\ ?KZ&_9K'S0?A5O8H^J_$SXT$_P"[7P_\;[=KB[F
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M^(R-IQ7S/X?6OE2/7GADR&QS6FOC"7RMN\_G714PBF[D0K<JL;/Q-UL7TTC
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M0D_N?I7TNOPS'_//]*&^&H'_ "R_2CZ\@]@SYG_X1&3^Y2?\(C)_<KZ3?X<
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M:CX/D_N4G_"'R?W*^EA\-Q_SR_2E_P"%;C_GE^E'UY#^KL^9_P#A$'_N4?\
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M-LQQU\@_"68;XJ^N? 4@\N.I8V>EZDV-+?\ W:^$?VI'RMQ]37W-JLP&E/\
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M5&'-(NJ[(M^ U_TM/K7TAX:'^AI]*^?? MJ5N$/O7OVA3""S7)[5]KA5RQ/
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M -TU\>?M*0O(L^T=J^P9FS"WTKYY^,GA5M667"YS0QH_/**QG_M[H?O5]@?
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M5Z!+'D&LN\L1(#Q6DZ:K*S,H57%GF4<;V4P/3FO1/!GBYK5T!?O7.ZUI97)
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M73Z* N-V"EVTM% 7!5IPH6EJ@"F]Z=14@@HHIOK56T =2-3:*D0A'-&VEHH
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M#.*VI[<Q9R*H2X[U-C'E,@O*IXS5VSU":-AR:E$:,:D6W7J*3;):.ATGQ)+
M1EC^==OH_CQH=OS_ *UY1M,?2D%W+&PP34\MQ6/I31/B5MVCS/UKO]$^(0EV
MYD_6OCRQUR:)A\QKL=%\82PE<N:7*+4^R])\41W6W+#\ZZBUFM[I!DJ:^3M!
M^(1CVYE_6O0=%^)@.T>;^M3L7<]MOM%MKB,_**X?Q!X(BG#;4'Y5+I/CI+K
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M]?A&G_/+]*7]HQ#V#/DW_A$[C^X?RH_X1.X_N'\J^M?^%1I_SQ_2C_A4:?\
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M;.$?PBHS;0>@IDDQQUJJ\QI692+/V>'T%*+>#^Z*I>8?6E64BIU*N:*VL''
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MU=PY##>Y<8JK)>NM=0?#<C?P_I31X/ED/W#^5 U%G)MJ$GO49U"5CQFNXA\
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M3ZT?93ZT@*[4PBK#6["HS'CK2 @VTE3[::8^*:$B*DXI[1M2+;N>U(8W:*4
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MOH8OO$"A=<LUZR*/QKPOQU\4%TG?B7&/>O%->_:*DM9&"S=/>H ^X/[?L?\
MGNM']M6DGW9 :_/AOVH)_.V^><?6NY\'_M OJ$B!YNOO1J.Q]G+=1R'Y2#22
M-FO+_!?CV/5$3,@.?>O2+:Z2XC!!S2$<UXU4FPE_W37Y\?M(6[M=3X/>OT0\
M91_\2^3_ '37P#^T6G^E3_6A#B>0?!:"0:_%D_QU^B?@M3_PC,>?[G]*_/\
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M/KKX8Z@]U'&S'->D>(/%":/IS,7Q@5Y#\)[H)9H<]JS?C=XN:PTR4*^/E]:
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M,4) --1MUJP5J)N]$@(-HHVT^GJM2!&JU(O%.VTH':J 7FG8I0M/9:DLKO3
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MIK/0 [<!2K+55I.>M"O4#+?FT]'JD&-3QL:!%Q3TJ16JNK5*I.: )5J91@5
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M^]5($?0G@'3S-9 X[5P/QRLWMK.4XKUWX4P"XL4!':L;XZ>$VNM-E*IGBEU
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M.^(#>;?FSFNYM9#(@-40XV--9JLQR9K.CJY :=@+R#=2&.GP5/Y=2!6535A
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M6KM]%UK/C78]'LM+';1DHQNT>F^$]2$>S)KM[S6$>S(SSBO&=/U,VV,&M?\
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MA)U%,6;+5<A((%,HSY-,C;JM$5@B=%Q6FV*K.X% #0H48%1,NZI-V34D<>:
M*IL5DZBHFTE,_=_2ME8QBAD%!)1M=/5.0*DNKX:?&<G%:L$8\O\ "N#\?WS6
MD$A4]JHH\\^+7BH3VDJ!^<>M?%_B[1I=6UAF4%@6KW/QMK$UY=/'DGFJ7A7P
M.VK72NT><GTICV+GP#\(M:RPED[CM7VKX?M5BTY!C'%>4> /!*Z7'&?+Q^%>
MN6;"&W"^U0R6R*Z7YC58BK$S;FJ TP(MM.5:=MI.10P'5'(V*7=4,C5( 9>:
M<LF:K]:E1:8QY:F,*=1C-,"!ABF;OFJQ(O'2JY7YJ0R16S37%/1:;)Q3)(&6
MG1+0.:FC2D!9AZ5/4,8Q4]4K -8TS=0YI@;-)C'-TI-U+C-)MJ0'+3^V:8.*
M"U!(]:6H/,VT@FH FIN32*VZEH =CFEQBF;J&?WI@/SQ24P/3Q2&/HHI>*!"
M44O%)0 4444"$-)NIV*3;[4%6$W4NZD(IA/- B>/[U2S']V:JQM\U3R']V?I
M4,HXSQ(?O5Q9/[TUVGB09S7&LO[TUZV%,*AEZZ3]G;Z5XUXJYF:O9M>7_1V^
ME>,^*O\ 7-7M=#S*ASVGK^_''>O1?#2?=KS_ $U?WP^M>C^&U^Y7-(F)Z%I
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M5GF^;UKZ6\=74FH6+E#G([5\8_&+3KCS9CAN]9U"Z2.!M?'WE:C]_OZU[_\
M"_XC*?+&^OCB33[G^T. W6O;_A9IUV6BX:L8MW.F25C]!O /BX7D,8W>E>BS
M7Z_9]Y;M7SM\-UGLX(V?(Q7?:YXP6SL2"^#CUKJOH<7+J6_%?Q CTA7^?&/>
MO+-6^/,<,C*)OUKS7XH^.);II%CD_(UX?<2:CJ5R=I<@FLI2-8TUNSZ=F_:#
M5&_UOZU<TW]H))F \[]:^7O^$3U:X7<%D-0_V-JFF'<PD&*CG9?+$^Z/#?Q7
MCU+;^]SGWKTG2-534%4ALY%?G[X-\97.G7$:R2$<]S7U-\,/&XO%B!DS^-:Q
ME<RG"VQ[Q]E_=%JXGQ1K=OIN[S"!BNUM[Q9M.+ _PU\T_'SQ%+IL<Y1B, UI
M)V1G&-V=7;^/M/DNM@9<YKT3P_JL5W"&C(_"OSFTGXE7;>( AE.-WK7VA\'=
M:?4-+C9FSQ6<97-I0Y3T[5O$8T]22V,5S4_Q1BAR/-Z>]<W\4-5>SMY"K8XK
MYA\3?$*>UFD'F$<^M*4K$QAS'TWX@^,T4$;8E[>M?.WQ7^,BWD4JB7/XUY)X
MB^(US.& E/YUYMK6I7>K,W+-FLY3N;QII%V^\8K/JA?=_%7T)\$?B;'I[Q*9
M,=*^3SX?N]Q?:U=#X7U:ZT>Z099<&LXRLS244T?JQX1^(L>J6D:B3.1ZUV=O
M(+I=V<U\1_!OQ])(85>0_G7UYX/UI;JU0[LY%=D97.&2Y6=2L>TU.JU&C"3I
M5A5JR;#6!J-E)S4])M%(97\NHWAXJ[LIKK04C,DCQ59N*T)EZU0E6F:#0_2E
M:2H>:1F- "M)UIHDJ-B:BW&DRT7HY*G5JSXV/%3K)4,VBR>0U3F&:E:2H7;@
MU#**,RU3=>:OS=*J2"I.F)#MIZK13UJ#JBQ&6F;<5-[TFVI.J(Z*KT SBJ2#
M%6X6(Q2-U&YJ6\*G!K=TY57%85LW -75O/)7K4WZ$5$DB_KFH):VS$G'%?.G
MQ2\811K*NX5Z%X_\4?9[23#=J^._BAXPEN+F50_?UKZ/+<+[9W/E\=7]DG8Y
MCQIK0U"X=5.>:XA?"\VI39"$Y-;^@:=-K5\,@G)KZ#\ _"<74*,T6?PKZ;$5
M88.!\C"G+%U+GSS:?#Z:*,,8S4DF@O;Y!6OKG5?A?'9V9/E8X]*\;\5>'5M+
MAQMQS6.!Q_MW8QS#!>RL>1G1&D[5)#H;1L.*[RVTU/2GS:>B]!7JJ3<SRZV#
MBJ/,8FCZ:1@$5TL>@F>/I4=A$J2"O0O#&FK>;1C-1B,1[)7./+\.JE2QY=J'
MA1ERVRN<O[(6H((Q7TUJG@@-9LX3MZ5X+\0]-_LUWXQBL,+F'M)6/HL=E//3
MN>>7B>8V!52+3F:0'%,&I+]H()[UN6,T<FT\5[567- ^9H1^K3Y6=CX%@6&1
M-U>O&YA_L_'&<5X[H]QY)!%=0NL2-'MS7Q];!RJU+GV5'&4X4CD_'UNLTSE1
MWKGO"\/D7JY'>NOU>W-UDD9KGX[<VMP"!CFOH,-12I\I\?B<=4]M=;'TK\+-
M1CC6($^E?27A[48VMUP>U?$_@7Q$UL\8W8YKZ+\'>*#+"@WU\3G&'Y97/T_(
M<1&K!7/3]6N P.#7':I,>>:UOMAN(\YK#U0]:^7A%'W,(N]T<]>2GFLFX:K]
MXW)K*N'KGJ1UT/HL/\.I7E;K5:0U)(U0/67(=7,1M3-U*U,')K:,;&<I$L9J
MS'5:->E784S6J.*0]4-*(ZLI%3_)Z4&+D1Q1=*N1QTR-,59052.>4AIC]J3R
M<FIU7=4\4&:9QRF-MX>E:4%O[46]MTK0BAVBJ.?G&1P 5*L8%28VU&S8S3%S
M7%9:A=:?NI=N:M(SDRJRT*M63%3?*K0YY2(UJ112;*E1::1BY$D:U.JTV-:L
M*M49ME=DJ+RZN,M1%:+&;9 L=2K%4D:=*F6.K1E)E8QU$R[:O,E5)A5I&5QD
M<FTUH6UUMK))YJ6.4K0XF3F=);W?3FKJS!EKFX+@\5H0W7O6?*+<LW:!E-<Y
MJ5N#FMYY@RUDWW.:W@82T.,U6Q5@W%<5K6DAE.!7HM_'G-8=U9B3(Q7=RQDK
M,Y_:-,\AO--EAF) K9\.Z])ILJ[FQS75:EHB%&.WFO-?$TG]FLQ!Q@U\_C,#
M"I=GMX3$R6B/H3PGX]1D16D_6O2=+U.#44&6!S7POI?Q">QN%!DQ@^M>R^"?
MBH&6,&7]:_/\=A?8NZ/H;SJ(^@-;\/P7L#8 ->,^-OASYS.R1_I7I/A_QE'J
M2J"X.?>NN_LJ#5(,X!R*\2.(E%V9QR@X.Y\4:OX)EL96.PUAS;[$X(QBOKCQ
M=\/HY(Y"L?Z5X;XJ\!21R/MC/Y5ZL8QJ1N=%/%RCH>>VNL$'&:WK'4/, YK$
MO/#LUG(25(J*"Z-I@'BN2=+4[%6OJ=S;W'3FM"&Z]ZX>WUP'C=6Q::EOQS7+
M*F/GN=?#<U<CG]ZYRVNMV.:T([GIS7-*(UJ;B7'O4R3>]8J77O5J.X]ZCEL(
MV(YO>IUFK)CGZ58CFIE&D)*7?5%9JD62@5BVS5%)T-()*8[4@()5JC<+5Z1J
MI3&LI;C,JX3K65=)UK8N>]95U73174EF'>I\IKB=>4AC7;WAX-<?K,>YC7=&
MIK8P<K%KP/,T=XGUKZS^&]_NM8P3VKY+\+KY=TI]Z^D/AW>E8XQGTKME3YH7
M);N>J>(HQ<6;'VKYU^(-KY<SFOH:\F\ZQ/TKPOXC0C<]<&!DZ>(.+%_ >9Z2
MQ6\'UKV+PO)^Y3Z5X[IXVW@^M>L>&9/W*_2OV? UN:"/CYQU.T60<4/\RU5@
M8MBK\<>Y17L3VN<\BBZG-+'GBKK6Y]*:MOCM7DR>H18L8JQ'FECAJQ'#6L=C
MHL20U95<U%''MJS&N*=Q<HY(ZL1H!4>X+37N HZT@V+7 %12,M49+['>JTE_
M[T"N7GD&:8;@+WK(FU+;WK-N-:"?Q5:I\PCI_M@]:3[6/6N+D\1A?XJC'B8?
MWZOZO$FS.[%X/6@WP'>N'7Q*/[U-?Q(/[U+ZO$+,[1]2 [U"VI^]</+XD'][
M]:@_X20;OO?K0\/$-3T*/4 >]7(KX>M>;Q^)1_>JRGB@+_'4^SC N)Z*+P'O
M3OM0/>O/E\6+_>J:/Q4K?QT-HJYW/V@>M-,H-<C'XB#?Q5:CUD-WK/<EFU.P
M;-9TV*B;4-PZU6EO,]ZS<9$$C*":<L8JHMQN;K5J&3/>JC&1C(F6,4C)Q4BL
M*5JV%%-E9H_:E6.I=M/5:#7E*SQU7:/FM%XZK2)S4#*RK2LO%.I&K2*1!6EJ
MK(V,U;E'%4IE-3*3B]#&2*%XHD4BN5U?30X8@5U[QEJJW%F)%.15J*J+4TA)
MQ9Y9=6KVLQ(XP:W?#WBR339E!8BM75-'#*2!7#:M926\A*@BOG<PR^-1.R/;
MH8CE/H?PG\0TG1%:3]:]#M;JWU2,$D'-?&NC>()]/F7+$#ZUZUX5^(WEH@:3
M]:_.\3AZN'E[I]#0G"LM3U?Q%X1M[R-L*#GVKQKQ?\+1,SE8_P!*]4TOQK%?
M;07!_&ND@MK?4H^0IS7*L7.UI%U*2^R?&6K?"^6WD8B,_E6'-X9DL>JD5]JZ
MMX%M[B-B(Q^5>9>)OAR#NVQ_I733Y:CU.9*46?-QD>UXIR:LP[UZ'K7P\E5F
MQ&?RKE[GP5/"Q^0BNJIAXRCH>C2KJ.Y1M]6)[UKVNH$XYK*;09;<\J:<L;P=
M>*\:IA6F;2Q$9;'3P7F<<U<CNO>N1&H^3C)Q3AKP7O6?L&0JESM$NO>IENO>
MN-BUX-WJ]#K ;'-92IM%\QTZW&>]2K/[U@PZ@&[U92\Z<UCRL=KFY'<>]2K<
M9'6L-;OWJ>.Z]Z=BD;*S5(LU92W'O4BW%%@-59LT[S*S%N/>I5N/>G8#1\RD
M:3BJ?G4>=1818:2J\K9HW[J8U4H7#FL5)AUK/GXK1E'6J-PN:KV:#F,V1\5
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M6EO,O&*S;K0XI < 5YS9?%"-L9E'YUN6OQ$@EP#(/SK2-243GE01?O/"ZOG
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M2'-0I'BI1\M(![4V@FDW4A"T^-MI%1BGT 6A<X%0RS;B:B)I* "BFL:3=[T
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M^M->IA78PJF?K?\ Q[M]*\=\5?ZUJ]CUK_CW;Z5X]XJ'[QZ]E.Z/,F<]I_\
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MJ$A QS6K\"M8?^T8EW=Q7)>SL=4ES1N?7OQ(N?MV@NV<Y6O@[Q]'CQ _^_\
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MU]2_$2Q>2*3\:^9?%%BT-\Q([U]_E<>6)^;9I4?-8[#X3Z+%+=1%@.HK[-\
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M%#&2@]*5O:H3)BD,E(0V9NM0=:)6IBM\U,98C7VJ7I3(SQ2DT@'TX4U>U.H
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MC(!5=YO>H&F]Z6X;E]9A3EFK-64U(LE/8+FAYH]:1IJH--CO3/M'(YI!<O\
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ME?5G[/VBR6,,.Y2.E<\-SLJVY3W;Q8V-)/\ NU\@_%2X"W4OUK[!\40&32R
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MB:(U!X>M=L*@CM6Q-;UUW.4Q_)S2BUSVK26 5(L(XJ&-&='9^U7(;3':K2Q
M5,H -"!D/V< =*K3)BM%B*IS#-,"@R\TBY%3&.FF.I9HF*KTK25$WRU&ST%H
M)'J'=S2.U-I%$M,:EJ.1J=M!ID4C8JO)(*=,U5)&-82-T*TM,\T5 S\U$TE2
M;Q9;:05$\E5_--,,E.QUQ9,TG- DJL9*3S#64D=E-]RWO% EQWJKO-/7-<DH
MNYZ"E&Q<CD\S@TLVF)<1G(J.'BKD<V%Q753FXHX:GO/4Y'5O"44N?E%<[)X+
MC\S[E>G2XDZU3:V7GBM7BI1ZCAA*$M9(Y#3?!\2XRGZ5UFF^'H;< A14L>(Z
MG%YM'6N=XN<M+G;'"48KW47X66U''%64U8KQFL*6\)[U!]KP>M9RH\ZYF:4Z
M:3L=?%JQQUJ"\N/M*$9S7/17WO5R&\W=ZSA+V;.Z5"$HG'^,-!%W&_RUX)XP
M\$LTCD)^E?55W;K<QD'FN4U?PK'<Y.S-?28+'^R/B<URJ-=/E1\DKX+E6;[A
MZUTVE^#964?(:]P_X0./S,^7^E=!I/@>)<?NQ^5>_+-4T? KAF3G>Q\WZUX%
ME:$Y0GBO+]>\+O8S,VW'-?=.K>!XFMV C'3TKQ3QY\/_ /6%8_TK&GFBE*S9
MZD\A]C3ND?-2ZI)8J5SBJ,^LO=28)SS7:>(/!,L<CX0]?2L"S\'R_:!\AZ^E
M?4X?$4G&Y^>8RG7A5Y4;7@[33<S(<=Z^CO .C&..,[:\U\ ^$VC:,LE?0GA;
M2A;P)\O:OB,\J\]U$_3^&</+1S1T6GKY,8'M4>H2;@:L-^[6J5TV:^.PRY97
M9^KU4N2R,F;K5*:K\RUGS#K736U9RTY6*K=:51F@J<U)&E8V-'(6.*K,=OGM
M3H8^E7(XZT2,)S(5MZ&BJWM%,9:NQQ.96\NIDCI1'S5B..FD8.0U8ZE1*E2'
MVJ41>U58AR(U7%/5:<$YJ15JT<\I#%6I5%."TN*HY9,FBQ5J,BJ<=6HS2L26
M-U*KFFK3@M!#9*K9IU1K4B]JD@-E+MJ0"EVTT0V5VJO)5R1:K/'S6_0D@6IT
MIBQU(JFDAMDRFI-NX4R.,U:CBS3,FRE)#FJTD!!K;:WR.E5I;4^E4C,R54BI
MXJE:'':A(\$51+)HQ4WEYID0Z5:1:0BI)#4#0\UJ-'4$D6*8F5H5VTS4(?-C
M(J?;M-.V[Z:,9*VIY-XT\-&Z1SMKP3Q;X3>&1R%K[)U#1TN(C\N:\N\9>#5E
M1R$Y^E<.)IJHK'M9;FDL+-:GR3<6K6LF".]6K:[VKS7?^)?!3K(VU#^5<I+X
M7F1ON&OE:N6N4KG[7EW$L?9J[*;2?:% %+:: ]U,#MS6[I'AB5Y &0UZ3X;\
M&YVDI79A<O<&M#P<[XD4HM)F5X+\'XV%DKU2U\,QK;CY>U7-'\/K:QKA:VQ'
MM3&*^TP]&*5F?C6*QDL1)L\T\0:'Y>[:*X2\BN+>0[<U[I>Z6+K.1FN?O_""
M29.REB,!3J+1&='$.+U//]!URXM9!EFXKU'PYX^:W"AGKB[[PS]ER56N=NFG
MLW^7(Q7Q&,R.^J1]%1QL;69],Z5\0(ID52]=-8ZG;ZEC)!S7R+I_B:YMY "S
M"O1_"_CN2)DW/^M?)5\#/#O0[_;QEL?04WAVVO(\A0<UQOB3P'&R-M05)H?Q
M"C9%#2#\ZZ'_ (22WOEQN4URT\7.F[,QG%RV/!/$/P_?<V$KB[SP+.A/R&OJ
MJ33[6^'13FJ<W@NWG!(0?E6SJQK/4J'.CXYU[P;.(V^0UYEK7A66.4DH:^[=
M<^',<J-B/]*\L\4?"W[Y$7Z5^BY#B*6&LV>'CZ,JA\L6NGFVZBK1DVUZCJ_P
MYFA9ML1_*N>E\!7&[_5G\J^WQF<4W3LF>-A<)*,[M&/H][Y;#M7:V.N!8P,U
MC0^"KF'_ )9M^578_#=RHQM;\J_%LV7UN;:/T+"RC3@D6[K7 >]9TFK;L\U8
M;PS=-_"U+%X1N6/W&_*O"AE\HZG0Y791CF,TE;^CZ"][(ORYJ[I'@>X:1<QG
M\J]=\%^!"NPM'Z=J]6E#V>YG*2L0^ ?!;*Z,4KVVQM1IEF,\8%,T/0XM-A4E
M0,5F>,/$<5E:NH8#BE6ES*R.1RNSC/B%XH6*.10U>!ZS>'4;IL<\UL^//$[7
M=Q( ^>:Y[P];M>70+#/-/+,,W63.'%32B=-X1T<^<C8KW#PW'Y,"@^E<?X8T
M98XT.VNZL8_*4"OURA#EBCY:4]30F:J<C<U8;)%0.*ZJFJ.>3$5N:G5JJYJ1
M'KS)1UN7 ?(W!JA/)5N1N*R[R3;FO1H+0TE*Q7N9N#6-<2,TE6IKH%L9I;>U
M^T2#'-<>.J*G$NE'F9>T.S-Q(,BO1M'TE(XP2*P?#^E^5AB*V]0UA=.MSSCB
MOS?&8MMM)GTV&P^A+J^J1:;$>0,5Y)XU^)2VJN!)C\:ROB+\1A LJB7]:^:?
M&?CZ2[D<"3//K7@OFJ,]1T^5';>*OBD\S.!+W]:\OUKQS/,S$.?SKE;C5I;N
M4Y8TJVAGY-;0AR[F2CJ+=>*+F1OOFJXURX?^(U>CT,/VJW%X?']VNCFB=:6A
MDKJ4[=S4BWT^>IK=C\/CTJ=?#Z_W?TI<T1&%'>S>IJ<7TVWJ:W$T$<?+^E2_
MV"/2I<HDI'.-J$X[FF?VI<+T)KI?^$?!_AH'AM3_  T*44:QB<RNLW*G[QJW
M;^([I,?,U;?_  C*_P!VFMX;"_PTW*+*<1EKXMN4Q\[5OZ=XXN(V&7-8)T+;
MVH_L\Q]!6?,C)Q/3=(^(DL>W,A_.NXT?XI%<9D_6OGG<\/3-*NM30]&-9M<Q
MERGUQI?Q87Y<R_K76:;\3H9L R#\Z^(HO%]Q"WWS^=;NE_$"XC8?O#^=1[%E
MJW4^Y]/\56][CY@<UT%K%;7F.G-?'GAGXF2*R9E_6O6_#?Q27:NZ7]:34H;$
M2A%GN<GANWECR%%<SK7A--K;5JCI_P 389$ ,J_G6O#XLM[W^-3GWK2GBITV
M<4Z29YEK?A*3<=JURUUX7G1C\IKZ 2"VOO[IS4<_A2"8'"BO;HYI*.[.&>'N
M?/D>D2V_)!JW'*UOUKU?5/!JJI(2N(UCPW)'NPIKZ'#9MW9YE7"LQTU\0G!:
MKUOXD5L#=7*:EI-Q&YP#5.&&XB<9!KZ*EF$)=3@^KM'IMKJPEQS6A'<AJX+3
MKIXE&XUMPZL% R:]*-:,T0Z;B=0LM/605SBZTG]ZI%UI3_%43AS;&7-8W205
MK'U9]B,:='JBMWK-U:ZWQMS62IN&IK&K%:,X7Q/?%589KR_5I#<3'-=]XF8L
M6K@KK E.:\/'5Y13/T7AJA3G44F3:/I:R,"PKHY-$A,/W16)I]V(\8-;?V\O
M'C-?G6*Q4N:Q^Y4XJ%K'$>)-#C^;"UP[:&//X%>IZJGG9R*Y[[ #)TKIP55R
MDKACJ5.I1?,+X9TD+MXKN8]/_=<#M69H-CRN!7>:?I?F1CBOTO!8:%2.J/YG
MS_\ <UWRG"7EG*N<"LN07*'C->N-X:65>5JM)X-1OX/TKKJY;3DM$?-PQDT>
M6Q7%TO<U=AU*ZCQR:]!/@R,?P?I4,OA!5_@KP*^3J6R/0IXYHYBU\17,>,LU
M=#I_C*:,C+FJUQX9\O.%K.GTMX3P*\2ID;Z([X9@>B:;\0'CVY?]:Z:Q^(X&
M,R5X1)YT/3-1-JEQ'T)KRZN2U([(]"GBXU-SZ6M_B5%QF2M2W^($$V 7%?)_
M_"1749^\U7;/Q==(P^=JXGE]6!T>TB?7-KXDMKG'S"MBU:UNL?=.:^6M)\<3
MIC+G\Z[K1/B(R;=TGZUR3HU8%^ZSW@Z#:SKT6L;5?"$,BG"BN7TWXE(5&9!T
M]:W(?'4%PHS(I_&N252K$I03..U[P"DP?"?I7E'BKX8N^[;'7T<-:MKK^)>:
M:VEVNH=E.:[<)F4Z,]3EJT>;0^(-;^%]PLC8C/Y5B1?#Z>V;)C-?=EU\.;:Z
M!(C!S[5RVL_"Z)%8K$/RK[A9ZYTN6YRPP"O>Q\KV.D-8XRN*TEU 6XQTKTSQ
M)X$>WW;8S^5>:ZQX=N(9#\K5\5BO]HJ79Z\$J2'PZP&;&:T(;H2=ZY,6DMNW
M(-7[>^\H8)KG<?9K0[*-8VIFW5DW2]:>=0#]ZCDD$BUPMN3.F51/8RY&V-4M
MO<\BH+O@FJT,F&HY"$SI;>;=5Z.2L2TFX%:$<OO1:PS4CEZ5,LE9\<E6$:@$
M7XWJU&_%4(VJPK5DQ2+RR5*K<535JFC:D065-.6HTJ9:+C"FD<U)3:HHA9:C
M>.K.VFLM42RDT=0LM776J[K[5<618J-'43)5MEJ"2J JNM5W2K;5"PIW"Q5,
M=,:+K5LK4;+2YA%&2&JSPUH.M02+S5*0%)H:C:&KVWVI#'5J15C,:$^E0M#6
ML8:8UM[5I<+&:L'M2M;^U:0MO:E^S^U-3L-(R&M?:HVL_:MK[/[4UK7VH=0'
M$PFLO:F-8CTK<:U]J;]E]J7M&+E,,V(]*:=/]JW?LOM2&T]J7.'*<^UA[4S^
MSQZ5T)L_:F_8O:M(U">4PET\>E2+8#TK;6SIZV?/2J]H*QB_81Z4[[%[5M?8
M_:G?8_:IYP:,06?M3UL_:MM;/VIZV7M2]H"B8HL_:I5L]W:M?['[5*MG[5SU
M)/<W321A2:8&!XK-N=)ZX%=HMGD=*4Z6'[5Z67X^5![GGXBC&H<)#I!W=*W-
M.TKIQ70QZ, 1Q5V#3A'VKU,=FTZL+7.2EA(P=[%&UT\*!Q5Q;/':M".VQVJQ
M':U\?&<IRNSVHM)6*$-K5V&U]JMQVV.U68X/:MG(AJY##;=.*N1V_M4L<-64
MCXK-R"Q56WJ:.&K'ET_:*AR%8C2/%3QKBD%/6DGJ78<HI],W8I#)71SJP<HY
MC33)4;25"\U<%26IJBSYE30S8%9C3TW[9MSS6]%W9,F1^(YRT+8]*\-\8;S,
M_P!:]@U6Z$B,,UYSXCL5GW'%?58!J,TSS:^L6>9+<>6YW5'<7BL:T[[17WG:
MIJ&T\*W%S,/D8CZ5^W9?C*<*%FSX#%4I.IH3Z!$T\RXKV'PKX?EN$3Y:RO O
MP[F:2,F,_E7T5X+\"B&--T?Z5\/G6(I5&['KX+G@<UH'@MW924XKU3P[X.2%
M59EK9M='@L4!( Q1?^)+?382 RC%?F-2LXR]T^FC5;6I>D6#3(3T&*XSQ%X^
MBT]7 <#%<SXN^(RJCA9/UKY^\=>/I6:3$A[]ZN,JE1'/**J:'H/C7XJ[A(%D
M_6O#O$GC274)6 <G-<;J_BR:ZE8%R>?6ETB-KZ0%N<FKC1:=V?;9%ECJ:V+3
M1RWN2<FLV^T-QSBO2-'T-#&"14^I:"GEGY:]*E)4S[^.5QYK-'EFG[[*0=J]
M,\)Z^5V#=7&:QI_V>0D"I/#]PT=PHSWKZ/!XQW2N?,Y_E=.%%M(^AM#O/M*K
MS72(/E!K@_!MP7C2N[5OW8K[_"-5(W9_-F-BZ==I%J&3;4QNMJ]:SQ+MJ&:Z
MQWKKJ\L41%.1HF^YZU+'>9[UB0R&5L#FMFQTV291@&O K5DF>M1ID_VOWHJT
M-!EQ]TT5Q^W._D/K[;1MIU%<QVC*3=3BM-*^E "AJ7%,6I%Z4  &*"<4$XIC
M-0 [=1NJ/=[T;O>@"3=1NJ/=[TN[WH 5J9MIV<TE !1BBB@ Q1110 4444 -
MIE/IE# ***4<U "4RI-M-VT 1T4N#0%]J0 M24T+3JT ****8$$O>J4V:T66
MJ\D.:A@4 3NJQ$YI&@YI5CQ2 L*V:F45!&*G4\5( U1Y-/:F[: $IV*;3A0
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M=?2O1_!?@T:*J@)MQ[5Z,MC#UVBAH$C^Z,5'+8KF<M#)U"Q^T6VS':O.=?\
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MF[M5#,R.$BM&U!7%2K9=.*GCM]O:@"Y;OP*N+)\M48U*U87M2$R?=37:FTC
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M0M \+K;A2RXK<T70([>(%@*-9U:'2X3\P&*^"S#,.>]F?2X7#\I/-=0Z=#U
MP*XW7/'2VS-B3&/>N(\9?$A86=1+^M>1:UXZ>Z9L2?K7S$*DYR/8]FHH]R/Q
M-P<>;^M%?-A\3RY/SG\Z*[>61G9'ZET445^BGSPRBBBF0%%%%(JX5#(:E:H7
MH&QH.:E05&B\U8C%!(NVF,M2,:B9J"AC=Z;3^M+MI 1T5)MHVT6 :,XI:?MI
M,=:0R)N]-IS4FVD2 I:04M,84444[ %%%.VBD VF-WJ0TW;0!$S4FZI&6HR,
M4 *&YJ1:AIZM0!(U(M*#F@]: %IC=Z-U-8\4P&,QIM#4E8L +8INZD:HBV#0
M,D,G%1M)4;,:C9Z1-RPLG-2K)5)6YJ5&IC+BM3]U5D:IE/2J =3MM-H+4$W&
M2<5 S<U.W-0.M!0*]3*:KCK4\= #J***!!1110(**** $VT$4M(U #&/6F;C
M0W6DH*"BG**7% #:=110(*:U.IK4"0E%%%2R@IIIU-I %%%% !1113 936%2
M8%-9>:0$;4JTK4"@0]A435*3FFD4#$7/%2#I2*M*>* "FTNZDH *;3J3 H 1
M:=1BBD 4UF&*20XJI)-C/-,"9Y!47F<U6:8M2J],9;5JF5A6=YV.].CF.>M(
M9H9%,W4Q9,BF.] B;?[TN:JJ]3*U,!]+24M @HHI5I )13J;0 9HHHH 5:6F
MYI=U,!K&H9#BI6J&2G<5R$R<T^.2H67FA<U(R]&V:E/2JT+59'(H)(7IN*E8
M5$W%58H-M*%I5I^*0";:=112 *4"DHW4 *W2HI*EZTC+F@95*Y:GHM2^72[<
M4R&(HI6%!--H*0FVD/I3J:>](3&_Q5(*8HJ510 QNE,W5,RU"PQ5C'JU.+5
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MRE4N[(Z(4;*[.NU+Q?=R3$J[=?6ET_QE=0LI9V_.NBT7X>R7\(<QY_"H-?\
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M+O3U:C91BD!*#130>:7=02+12;J-U "T4FZC=0 M(U&ZDS0!&RTVI&'6F4%
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MK73Y)G!/-6]/TUI&!85U%CIH4#BNB<?9JQ"5V+X?T_;MR*] TNU&U>*P-+M
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M/[U?07Q&\90O'(@<=^]?/NH'^U-3RO/S5Y]34]2@G%:GKGP74_N^*[3XK?\
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M6[=ZT89.E9D:[:M1OB@DTA)Q36;-55DIZOF@HEHVBFJ:7=0*XNT4C+3J=C-
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MFE(YQUJHR:W%**:NC[PFU!9K?<ISQ7G'C+Q(UB&(;%3^$_$@U/3U.[/%</\
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M!I-M'2@!PI]1K4E !1110 4444 %%%% !2-2TUJ &M4=2-4= !3EZ4VG+TH
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MO*1_I7K<8+<4-I:7'WEJ914A*3BSY?U#X<RM*=L9_*I]-^'$N\;HS^5?2O\
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M/%2NU0L:0$BO4\<E4U:I4:I NAJ*@62G"04@'$<T@6G*>:<!3&*JTYEH%/I
M598ZJ21]:TV7=5>2.F",UDH5:L2)UJ/I0421K5A%JNC58C- %F-:G45#'4U
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M;FFJW-/G7FH!]ZF!?A:K:FJ,%6U-,0]FJ)I*DVEJK3C;0!(K FK"[?6L&XU
M6_4XJI_PDB*V-](@ZA\"J[&LNUUE;C@&M!6WC- KB[J-])MI-M!1'(U49I*O
M2)Q5":/F@S(UD.:LQDFJ\<?S5?AAXIE)B*M+M%2R+L%49KI4[T#9<515F$#B
MLN&Z#G@UIV[;L4$E^->*DVTV&IQ0-,@=*A9>M7&6HWCI"*17FG(N:64;:B68
M#O3$7(TJ94XJM#,#WJVC"@$AI6HWJ=J@DI%,IW'>LZ7K6M)'NJI);YH,BBO6
MKMN]0F';4D:TP+T<E6(Y*H*Q%2QR4F.YIHU2JU48Y>E68Y*D9<5J':HE:A^]
M!)'(U1,U-FDV]:HRWH7O30RXS"JTDE5&O@>])Y^[O5 D$KTQ>M+U-*JTQDD=
M3+346I-M(0UC4#/4[@U79:!"!ZDZBHE3^=3QI2 3;FGJM/"=*",4(8^,XH:3
MBH&DVU!)<>]6(6XDS5"3K4DDV[O47WJ0AJ]33U6E2.I@G2@179/:H_+YJVRY
MS3-E [$<<=3+'2# IX8"D-#&CIGE^U6%P:7RQ5)@T1JM3JM&VI%6I8F.5=U3
MQVX:DC6IA*J=30@0W[&,=*@DM<5<6X5N]$F"M,&8\T&.U5)(]M:EU@9K,F:J
M0B!J94N-U+Y-:$$8-2PMS2>6:0?*:F2N6:MK)TK3BPRU@V\N&%:UK-G'-96L
M,O?9PPJG<:>&ZBM*$[E%220[A5<]BT<!X@T19(VPM>3>)?#;(S,JU]"WVG^9
MGBN2USP^DD;?+VK.5I;CU/GV%Y=-N.X -=]X6\:-"R*7K.\3>'#&S%5KCAYM
MC,.HP:\''8%58NR.NA4:EJ?4_A?Q)'?1J&?-;VK:+;ZI;G@$D5\Z>%?&#6C(
M"_ZU['X:\9+>1JI?/XU^=XC#SPLKH^CC4BXGG'Q ^&RR>8R1_I7A6O>#)+&5
MB$Q^%?<%Y8PZM > <BO,?&7P^25798_TJ*.(<G:1G[2S/D>9WLVP1C%7;'5V
MR 37;^*? ,D<KD1G\JXBYT.6Q;E2,5VSHQJ*Z/3IRNCIM/O/,4<UL0W6 .:X
M2VU+[-P36K;:T),<UYL\.XLB^IVL%UTYJ]#<<URMG?;L<UK6]U[UE[,OF.AA
MFJ['-6!#=>]7(KKWJ'$>YMK,/6IUEK'CN<]ZLI/[UDXE)&FLE.63WJBLU2"2
ML^1ME>SN7O,I=U55DJ5&S6JIKJ1R6)Q3JB#4_=5VA$UBA]+BF*U/#5FUS;$2
MIW#;3&6I<U&QH<>4P4+,B9:3;4E%0:W(MM-9.:GINV@5RNT=1M'5IEII2BP%
M3RZ7RJL^72;:L14:&HV@JZ5YZ4TQTQE%H*C:W]JT6CXIC0^U &:UOUXJ)K?I
MQ6FT/6HVAH RVMZB:VK6:'VJ-H?:KB!CO:^U0M9YZBMIH:C-O5\PC&;35;M4
M$FDI_=K>\BHV@/I2YYK9ARHYYM,0?PU"]B!T%;\EN?2J\EO3YI/=ARI'/R6?
MM5:2U/I71-:9[57DLO:F,YU[7VJ![//:NADL_:H'M<=JJY-CG9--4]JJR:6G
M]VNF>V]JKR6O7BJBVP.7DTM?[M4;K3 JDA:Z\V>3TJ"ZT_\ =GBJ<G=(I'E>
MM;H=P%<A=232.0,UZ)XFL=I;BN1BM5\[D=Z_2,AP,*]G(^9S'$.&B,!K6YQD
M9IL-U=6[XRU=R+.$P]!TK'N-/1I>!7Z16RFBJ+=CX^.(FZFY+I.J7)Q\QKI[
M?5+@(/F-9NBZ4#CBNGCTH!1Q7XAFE&-.NXH_1LN]^GJ9K:I<'/S&J5Q=W$G<
MUO\ ]F#/2GKI*MVKELJ<;GH5,.I'%S+<2'G--AL9689!KN!HJ?W:>NCHO:N#
MVRE*Q'L>0YRST\C&16O#9C:.*T%L0O:I4M_:B3*12CM>>E:-M:X[5/#:U?AM
MO:N=L8EO#TK2ABIL,'M5^&'IQ6+$$,?2KL4?%$4/3BK4</M0(2-*L*E.CAJ=
M8^*S8)%:1< U0N.,UJ2IP:S;H8S2CN485^W6N<OI.M;^HGK7,:D^ :Z8V-%M
M<IQR;I,5V7AC2S<S)QFN%LVW70'O7M'PZTT3M&<5Z=*JZ>IPU:UM#U/P#X?$
M:QLRUZ;-<Q:;:$\# K'\.V2VMJIQCBN<\=:\UK;R -CBHK8EUO=1PMWU,;QM
M\0%M&<"3&/>O*-4^(SS.P$GZUR7COQ+--<2 .>M<?8R374W))YKT,%E,JSYC
MFEBU2.[N/%,]PQPY_.JK:A<R_P 1IFEZ2\F,BNFLM!# 96OKHY$N75'%+'*7
M4YQ)[GU:K,=U<+W-=6GAT?W:)-!"_P -3_8<+[&/UPYV/4[B/^(U/'X@GC_B
M-7YM%QT6L^?26&>*O^P8LUIX[E=R_!XJE7^,_G4DOCQ[5<F3]:YZ:S>-37'>
M*+J2WC;!(KAKY'&*/1ABEB-$>A2_%XV[8\[]:FM_C$9/^6WZU\OZMK5P+@@,
M>M6](U"ZDQRU?.ULMC ^EP. E4UL?4D?Q8/_ #U_6GGXNA?^6OZU\[-?7,<>
M=QK%O_$%S$3\QKSOJMG9'MULIE*%TCZGA^+PD./-_6M*'XF>8 ?,_6OD+3_$
MUPT@^=OSKN]%U>>95^8UUPR]SV/CL1A98:5V?0K_ !(*_P#+3]:9_P +,/\
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M!90\"LZUA^85NV<?%*A\0JNQ+Y-%6O+HKU3AL?5]%%%?HIX 4444 %)BEHH
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MI\J?$B0^=)7FNG,3?#ZUZ)\26 FDKSG3)%^VCGO7'+<[H['T1\+[CR_*YKZ
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MJ?9I;'+[:1S_ /8:K_#2C3$3M6S)(HJC/)GI3<E S<Y2*ZVZ+4\:J*J[9'/
M-6[6QFD(X-<L\9&/4J-.<F2+'GH*4VKMT%;%AHLDF,K716/AEI ,K7F5<S4>
MIZ%/"R.#^P2^AI?[-F;L:]4M_"(8#Y*O1^#4QRE>14S77<[XX9H\<.DSM_":
M8VASM_"U>X1^"X_[@_*K"^"HO[@_*L/[8MU-5A6>#?\ "/SG'RFD;P]/_=->
M^_\ "%Q?W!^5+_PAD1_@'Y5D\\\Q_5?(^?6\/7']TT+X?N/[IKZ /@J'^X*1
M?!</]P5E_;C[E+">1X/'X>N/[IJ8>')_[AKWF/P;#_='Y5)_PA\ _A'Y5?\
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MO3E[4 65:G5"K5)NI@.I"M)NHW47 <D>ZDG86\98U+;\YJAXFN/L^FN^<8%
M'"^./&Z:9;2C?CCUKXK^-GQ0>XDF2.7U[UWWQV^(#6+3H),=>]?(6L:Q-XCU
M0J&+;FIE% 6-YXIU# W,&->U_#O]GJXU...1H2<\]*U?@K\,C=7$,DD.1D=1
M7W?\-_!-GINFQLT*Y ':HN2?-6@_L\O9JN8?TKHY?@<6AQY/Z5]6_P!GVW3R
M5_*E^PV__/)?RIV8SX=\2?LX/=*Y$';TKYS^)WP7NO#;2.L3+M]J_6U]/MI%
M(:%"#[5X7\<OAK:ZE:S&*$<C/2AW _,KPCK][H.JHA9@ U?>?[//CB:\B@#N
M3P*^<-9^#,T6L%D@(&[TKZ#^!O@^?2FA#(1C%(IGULMP9=)=SW0U\'?M6*^Z
MX(/K7W9'&8]%(/\ <KX>_:E /G_C1N0?'O@IIO\ A)%Y/W_ZU^C?P!9O[-M\
M^@K\^/!< /B)>/X_ZU^A?P-7R]-@/^R*3&?0UG(H5<FM)9H]HPPK@-7\0#3H
M-Q;&*\^U3XR1V4Q0S <^M"$>^S21LO4$UGR#YLBO+O"WQ,369%42[L^]>I67
M^DVROUS0 Q?O<U822,=2*IZD_P!EC+=*X77/&RZ>6R^* /2/.AW=15HF+R3@
MC&*^?YOBW''-CSA^=:UI\5$FMR!+GCUH J?&34$M;>;:V.M?'7BCQ05U)AYG
M?UKV?XT^//-M)B']:^(/&GCQH=2<[_XJ:0T?6WPQUA;B2/+YY'>OJWP),C0Q
M\CH*_-'X5?%3RYXAYG<=Z^T/A;\11=QPC?V% 'U1$R^2*8K(&Y-8.CZT+BT#
M%NU<_P"*O&<>DQNWF8P/6D(]#-U;H.6456EU*U7^-?SKY8\3_M!II\KJ)\8]
MZX^X_:6SG%Q^M C[335[7^^OYU9CU*U;HZU\)M^TUM;_ (^/UK6TG]IA)I54
MW/ZT#/M:2XA8?*P-4)3N;BO$O!OQ>CUK8/.W9]Z]BT.Z74HE8'.12 M1\'FK
ML,L*]2,UE:[<#3[=G)Q@5X]XL^+D>BR,IF"X]ZD#W[[1;_WEJ*2\MEZNM?*7
M_#147F%1<C\ZIZA^T,JQDB?]:H#ZT&I6N<%UJ5;NU<<,M?$-W^TP(7.;C'XU
MIZ!^TLEW,JFYZGUI6 ^R)&A[$4L<D"]2*\-T+XMQ:A &\X'CUJGXF^,":;"S
M"8#'O181[Y-J%J@Y=:J_VK:LW#K^=?%?B#]IT6LS*+COZU1TS]IT7$@!N._K
M56&?<ZW5O(O#"H9MIZ5\Y>#?C=%JNP>>#GWKVCP[X@3540A\YJ;!8W@IYJS;
MLB]:G^RCR2WM7%^*?$R:,KDOC%(#M_/MU7EEJM<7EJO\2U\U>)OCQ'IKNOGX
MQ[UPU]^TH,G%Q^M.P'V VJ6H/WU_.I8=2M&Q\Z_G7Q')^TES_K_UJ>Q_:64S
M*IN/UICL?:L\T$@^4@T^PC5FKY\\$_&*/7-@\[.?>O9-'\0));APW:@@=\0V
MCM]+E.<';7P7\8_$1M]1E"OCGUKZH^,'CL6^GS*'['O7YW_&7QL9=0F;?WH1
M:/6?A9XB^T7T8:3OZU]G_#^XCDM(CNSP*_*_X=?$LV.HIF3'S5]M?";XL"ZA
MA7S.P[TP/L.U92@Q4W&[FN3\(ZX-1A4ELYK=U?4$LX2Y;&!181MPS0(/F(IE
MQ?6JY^=:\'\9_%Z/1=X\[&/>O*M2_:2"R,!<?K4V$?8BZG:[OOK4RWUJPX=?
MSKX=E_:8V-_Q\?K6UH/[2"W4B@S]?>G8JQ]CR31-]TBJ<I':O(?"?Q2CU=5_
M>@Y]Z].TN^6^C!#9H L-G-)MJZUO\N:K,O-(@1.*D#4S%&>*+ A6:F=J&:DW
M<4@!JCIS-49>F.Q(*>.:@5JE5J 1*HI<4BFG4QC#3:=2;:38@6G4!:7;0,1>
MM/IO0T;J )**9YGO0'I"$84VG]:3;0%@7K2T8HI@-VU&RU-36%-#(-M)MJ;;
M1MH8B)5J4K\M.5:=CBD(H3K57RSNK3DCW5#Y/-,HKK'TJ15J98^E+Y=)DC4'
M2IDI@6GKVH E6GTQ:?065YONUG3,16E*-U4I8LFF(K+*<U9CE-0>214D:GBI
M N(V:E5:ABJ=>U.XAV*#BC-(U(D,BDXHHH*04444#"D-+2[:H!G.*7%.VTC4
MA,3I1NIK-2!JH!^:FC:H%J13TK-Z%(AOE\Q#7':S:=3CFNVD7<#6#K5O\A.*
MUIRU%):'G-X?*8]JJ/)YB&K6N?)(U9D,FZO=H'GU$<GXLM]R,<5YI<PE+G\:
M]@\0VWF1'BO,]4L_+F)QWKNDCBW-[PK-MV\UZAHMSE1S7CVBW'DL.:]%T*^W
M!>:YI&L4>AV\FY!3I.]4;&;=&*O$YK!EVT,^X6LR9:U;FLV?O3B<\D5CBHFI
M[G%1,U:HYV1M]ZH]M2'K32:L:(RM1LO-2LU,)IB!:=35I2<4RB.2JKU9<U78
M4P&JM2I'1&M6548I -5:&J0XJ)VH C9J56J-C2JU0264:E9JB7M3FJB1K-35
MDYI&%,QS0(M))4BM5-6J9&H L\4U@*:&H+TF UEJ,K3V<4*V:2&1^7S4B)3P
MM2*M4 S[M-9JD9:A:@ ^]3UBS35J=33 C\FD9,588\5!(U6A$3"F&G,W--ZT
MF-#&7K3"M3[:&CJ2BOMIK5,RXJ&0XJB2!^]1,M/=J:&S3$(%]JE5*%%2JM Q
M%6GAJ-M,8<TF"+"2U/'+TJBM3(U),9?5Z?D541JD\SBJ9)*V*8R#%,,U,:<8
MJ"A)%XJL[5*\F:A;FJ1(S=1NI*2F!*K4NZHJ:S4 2,]0N]-9JBW9HN.PK-3T
M[4P#-/4XI#1.M2+S4*-4T?:F)CMG%1M'5D+Q37I7 J,E*JT]C2+3$.VTTK4E
M&V@" @YI.E3,M1-Q0-!NI5IFZGK0 ]5J41TL:U8514C*^VI8PO<4C]Z@9B*H
MDLLL?856DQVIH8FG;<TQ#1UJ513-M2J.E9,U%V_A2$XJ3'%,9:1(RDI3UHIE
MD;"HF6K.W-'ETP*RK4JK3FCH^E #J1NE&ZDS0*Q&V<TL:KWH:HR2*8RWMBQT
M%0/MSQ4'F'UI58T!8F5JF4U O:I5/2DP'-4;<5(QZ5$[4D):C,\U+'4&[YJF
MC-,-BRBU*$ID>*L**DE JT]:2DW&H+'%J3=3">::S4[C)MXI=]5=]/WT@'R?
M-5&:.K>ZHY.: ,B:'FHU7::T)HZJNF*I%$L#[:O1R5EAMM3QS4,5B^WS55DB
MJ>.3=3]NZI$45CQ5J'(Q3O)IRQXH GA:K2MQ51.*F5J=RATF*A/6E>2HMU("
M96IS2?+4"TK?=H CE>H0W)HE-1!N:M 7X7J[&<UEQ-5Z%NE("PR96J[PU;7E
M:8RT 55AYI_D5.BU)M'- %&2+;1"VQJL3"JC\&D!/?LLUN5]J\7^)'@T7\<C
M;,_A7L"L6.*KZMHZ75JV5SQ42CS(VA+E/@'QMHKZ'>.P7;@UI_#?QQ);WT<9
MDQSZUZ%\;O"F/.9$]>U?/.EK-I6K G( :N!^[(]*-IQ/T6^%^N+?6<9+9XKT
MBXD4QY%?*GP=\;"*")&D_6OH?2M:74(5PV<BNZ$KH\RI%IFFS9S4+-4K+\N:
MJ.U60*S4PT4NVE<8S;2[:=MI138$;+30M2L>M-W4D BBI*;3U%*X"4UN]2;:
M-O'2F!!14K1U'MI@.45,JU'&M6%6D(0"D/%2[*8RTAHA8TS=4C+45 PW<TY6
MJ*C.*!D^ZD9NO-1;J-U #MWO4B&H*FC% KDZKFGM%D4Z%>E65CS0,H-"?2F^
M7BM%H:ADCQ0!3VT]5IS#%*M(!ZK2LO%.CJ0K\M %&5:J.O-:4JU3=>:D"./.
M16C;K52*/D5I6\?% $\:]*'^45(O%1S'B@"M-)BJCR\U)<-UJJV<T%CF?-.7
MG%1A:FC7I0!(JTK+3E%(] $1;%*K&FMS3D2@"5>E/&:6./I4JQT $>:E2FA:
MD44@' 4[90HJ04RAH2EQ@4I--9JDD7-6H&^6J):I8Y,"J0CE/'A)M7QZ5\G_
M !*20S28!KZ[\36INX& &>*\/\7^!6OI&(CS6<U<Z*;L?-6DQR_;AP?O5](?
M"I'S%D>E<K8_#%X[H-Y7?TKUWP/X8;3]F5QBLHQ:9M.1['H<FVS7Z5S7B_3/
M[1C<8S6]8-Y-N%Z<4R5%F;FNK<X^I\K?$CX=AEE<1^_2OGK7(Y?#]VV 1@U^
M@OBKPW'?6SC8#FOFGXC?">2ZFD9(OTKGJ0['53GW/,?!_P 4)[&15+D8/K7K
MVG?&YXK4 R=O6O&7^%MY:3$B)A^%6/\ A#K^-=NUJQ3DC9QC(ZOQQ\8I;R-P
M)#^=>0_\)#<ZMJ&<L<FNJD^'E[>-@QL:Z/PI\'YUN$9X3U]*7O28>[$ZSX7:
M++>+&6!YKVB;P>WV'<%[4SX=^#1I:1[H\8]J]8DLHFLMN!G%=48Z')*6I\:?
M$ZQN--\PKD8KQB#QS=Z7J&"S  ^M?9'Q,\#_ -J)+MCSFOFCQ-\'[E;IG6%N
MOI7/.+OH=$)*VIW/@+XS2V\*;I>WK7:ZQ\;O/LV7S,\>M>!V7@>^L5P$85</
MAB_F&W#5*;2*<4RAX^\</JUPP!SDU'\/]+DU*]1MO4^E:=K\+;N^N%+1L>?2
MO;/AC\*FL6C9XL?A4I-L;DDCL/ _A0QV4;%>U9/Q,L?L]C(,=C7MVEZ.EA8@
M;<$"O)_BTH^S2@>AKIMH<R>I\+?$K=#J$C ]Z7X=>.I]'NDPY&#ZUJ?$2P^T
M7L@ [UB>%_!-Q>7"E$-<C6NAVZ6U/J3PS\=IX;-%\T]/6L[Q=\:KBXA;$I_.
MN%TWX?7\4 (1NGI45]X!OKCY2C&M+LRM&YS^H>-[K6KPKN9LFO2?AGX1?5KB
M)W3.2.U8WA;X0W,EVC/"V,^E?4GPM^'ZZ;'$7CQT[4XQ;W%*2BM#IO!?@I+'
M3U^3''I7'?%GP:-0LY0$SQ7OUK:QV]J%  XKG-?TE+Z-P5SFNBVECF4G>Y^;
MWC+P7+H^H/*J$8.>E7O"?Q*N?#[+'O*[:^F?B-\,1?+(4BR?I7SMXB^$EW#=
M,R1,!GTKFE%QV.M24EJ>B:5\<IY(1F4]/6JVN_'2X\ED$I_.O.;/P+?6ZX*,
M*ANO -]=-C8U*\@Y8F1XJ\77/BB=@6+;JW/AMX#DN[Z.1HSU]*W/"OPCN))D
M,D1Z^E?17P_^'2:>D9,6,>U7&+;U)E)):&IX,\.C3].0%<?+7+_$F,K!)@=J
M]JCTM;>WV@8XK@O&GAUKZ-P%S71*.A@I:GQSXA67[>>#UKTCX3;UN8L^M:FK
M_#5YKHMY1Z^E=9X'\%OITR$QXKG4=39R5CZ,\!O_ *#'GTJMX_.ZU?'I2>%Y
M/LENJ],"F^)F^V0,!SFNGH<O4^2/B;&YFDP*\STF.7[>.#UKZ/\ &/@MK^1S
MLS^%<CIWPS=+L-Y7?TKGE'4ZXR5CK_AC9/)#'D=JZ'XA:+(VEN5!Z5O> ?#)
ML40,N.*['Q!H*WUBR;<\5JEH9<VI^=GCC[9I>J.P+ !JZCX<_%>YTED5I",>
M]>I_$KX2M>32ND/?TKR"Y^%EY8RDK$P_"N9IIG2FI(]ZM/CNTMF%,O;UK@?&
MWQ>-PK@/G/O7%6_A/4(AM*M4-Y\/[Z^;[C'-'-(2BC&DU^37+O:!G)KUOX9^
M"7OI(W*?I6+X)^$-R+J-GB/7TKZF^&_@E--ABW1XQCM5QC?<F<K;$5GX)$.E
M@;,?+Z5\^?&3P*S-(ZQ_I7V[-81BUV@#I7EGCSP6FI0R?N\UM*.AC&6I\ Z?
M-/X9U#(!7::]I\'_ !PFL84C,A&/>E\;?"&5IG:.$]?2O/\ _A6M_:3<1L!G
MTKFLXF_NR/:;[XX226^?-[>M>:>*OC+/>%D$A.?>LYO!=^T.W:W2LE?A??75
MP"8V//I2=PY8HI6<UQXBO WS')KZ#^$OA.2WDB=E(Z5@_#WX4R6[1F2(CZBO
MHOPKX:33X4^3!K6$3*4^AVWAT_9K-%Z<4^^FW,:AA;RUP*9)EC70<Y%NW5-&
MM-2.K,<=,$.1:D% 7BBD#&GK2BDI5I6 0YI-IIXJ=8<KG%,8^SC&.:XWXB:H
MNGV<C!L<5T=_J2V$;$MC%>!_&3QLOV695D[>M1*5D$5J>$?%7X@.UU-&LG<C
MK7G?AO39/$6H*2-V6K&\5W<VJ:N^,L"U>U_ SPB;B:%GCST[5R)\S.RW*KGK
M7PC\!_8?*<QX_"OI[0%2UM$3I@5ROA;PZEE9H0F.*Z..3R>!76E9')*7,7+N
M3<QJO3?,W4;J9 I:HV;F@FFXS5&B -4BM3-OM3E% R933J8M2"D(512T@-&Z
MA#'4;:;NJ0'BF)D3+STI"M38J-S2$,S2[JC9J3=5%#F:HV6EW4NZD3<A9:%'
MM3V;K49>@!](1FH_,IVZ@8UEIICJ0T"H8"1QU.J<4Q:F4U2 8R4C+BI]M1L*
MD"'IFDW4]A3-M!-QCMQUJO(U3LM5I* N"R59BFJ@S8I5D-,=S82:G-)FLZ.6
MK"MNH*3%EYJI)QFK;"J\B]:1:9&C<U81JKA.:GC4\4%W-*QYK'\8#%F_TK:T
M]>E9/C)<6;GVH&CXT^..]O/ /K7Q/XTTV>;4'89ZU]P_&)!)-*#[U\XZIX:6
MZN'.S/-<DE=G1'0\]\ M-I]Y&6)'-?9WP>\6D0PH7YX[U\I7NF?V2X8+C!KT
M?X5^*&CO(DW=Q2CHPEJC]"?"^H?;+=#G.174>7R*\X^%-U]MLXB3GBO4I(MJ
MJ:[5L<;W)%C"VY/M7COQ6UC[%:S8;'!KURXNECM6Y[5\V_'#5"+><*W:IEL.
M.Y\@?&SQ5)/-,JOW]:\'TV.>\U+=DGYJ] ^)4\EQ?2=3S61X/TP27*DKWKAM
M=G:M$?0GP-MY(7@SGM7VMX1N"VGHI/:ODKX3V:PM#@>E?5WA%=MFI[8KL@M#
MGF]3&\>>"5UV-\KG(KRW3_@O';ZD)-G?/2O:_$WBJWTJ,^8P&/6N+L_B987%
MX(Q(N<T-*XDW8]#\!Z(-'@10,8%=[YP91DUROA748]2B5D((K7U:[%C"6)QQ
M6JV,GN;,-Q$H^8@4DVI6Z+]]?SKQ'Q7\4DTG>/-QCWKS34/C^%D*B?\ 6H<D
MBN5L^K&U6V9OOK^=31WEL_\ $OYU\>O\?2O/G?K6CH_Q^$TRJ9_UJ>=!RL^N
M8Y(<\$5/(R",\UXGX7^)R:EM/FY_&NY?Q0K6I(;M57(=QGBS4TA@D^;%?*_Q
M@U);@2J'KTCXD^.#:Q2_/^M?)_Q ^(GFW$@+]_6LIR-X1.<D\-G5-2]<M7T%
M\'_A>CF)BGZ5\^^&_%T37:LS#K7U#\(_'UNAB7<!TJ(V-)7/H;PQX)33X4(7
M&!Z5W5A;K"H!K&\,Z_!J%HA!'2G:_KT>FP,V\# KI1RO4Z)IH%'+"JDU];+G
MYU_.O _%7QG33I&438Q[UY_J'[0@1CB?]:ES12@V?6_]H6W]]?SI&O+=NC"O
MCN']HC<W^O\ UKH-'^.RW4B@S_K1SH.1GU TD;=#6CIOM7D7A/QTFK;/W@.?
M>O7_  Z5N80V<\52=R&>:_&W/]CSX_NFOS,^+1D_X2"3!/WJ_3OXW1A=)G_W
M37YH_%F,?V])_O5SU3>F>H_LUL_VNWR>XK]"?"+?\2V/_=K\^_V<5 NH/J*_
M0KP;%NTR,_[-:TMC.IN:990W-#7$*#DBLGQ!J2:>C,6QBO'?%WQ:CTMG'FXQ
M[U<I6(2;/<TU*V5_OC\ZMW&JVQM3\Z]/6OC>^_:#$4AQ/^M1#]HK>FWS_P!:
MGG1?LV>L?%:^B:.7:P[U\I^+)BUZV#WKI?$_Q?&J*P\W.?>O.;O7%O[C.[/-
M82DF:1C8[SP$[^?'SWKZL^'+'R8LU\L?#[$DT?UKZK^'L>(8OI5P)J'IRM^Z
M%202Q*WS$55NIEM[7<3CBO,O%OQ#CT??^\ Q[ULW8Q1Z[)J%M&OWE_.J3:Q;
M;L;UKY4UO]H%8)643_K6')^T&>OG_K4^T0W!GV=#J%M)_&OYTYY86'RD5\>:
M5^T,))0IG[^M>I^$_BM'JVS]]G/O1S)AR-'L<^&Z52DC)[5#I>II>Q@ALUMV
M]J)5S0B3*CC"]:NQR11CYB*I:Y<)I\+,3BO(?%WQ6CTEF'F@8]ZJZ0DFSVY=
M1MD8?./SK7M]4MFMS\Z]/6OB^^_:"$<Q G_6I+?]HKY<>?\ K4<R'R,]E^,5
MU#):R[6'0U\6>-&+:D^#_%7HGC+XT#5(6!ESD>M>/WNN)J5X3G.36,I7.BG&
MR/0/ARK^='7U%X%4^6GTKYH^'6TR1U].>!_]4GTK6!-1'I]I_J14@QFH+9OW
M(J16^:MSG+&!3&6E5J4U!1$H]:MPM$OWB!6;?W*V\98G%><^*OB,FCAOWF,>
M]%[!J>O-=6R_Q"JSZA;?WU_.OEC5?V@%AD91/^M8\W[0G&?/_6L^=%\C/L%-
M0MF_C7\Z=)<6[+PPKXVA_:+ < S_ *UU6@_'B.^=5,XY]Z:FB739]%7VQL[:
MQ+A/F-<_X?\ &4>L(N) <^]=/M$D6ZM+F31!;[5;FMNSFA&,D5P>N:TNF[B6
MQBN%U+XM1:>Y'G 8]Z?,D-1;/H99;?;]X4QKBV7^):^:&^.T:Y'G_K6;>_'P
M)G$WZU'.BN1GU3'?6O\ >7\Z=+<6S+PPKXZE_:+$+X\_'XUN:#\?DU"15\\'
M/O3YTQ^S9](WK(V=O-9;CYC7*^'?&2:NBGS <^]=7&1(H-41:Q-;CFM."2-?
MO&LUF6&,L37&>*O'$>CQN?,QCWIMV!(].-Y;JO+"I+'4K;SA\R_G7R=KWQ\6
MTE91/C\:I:7^T%YDP_?_ *UESHKV;/LWQ%?6[:1)AA]WUK\]?VGI@US-L;UK
MV*\^.PN-/93-V]:^6/C1XX76+B3Y\Y-34DFC:G!IG&?#&27_ (2"/DXWU^B_
MP=F/]EPY_NBOSR^%*B;6(VQ_%7Z$?"7Y=-B'^R*FD@K'I=Z=U4>E6KEJINU=
M:.4=YFVF/<>]0/)4#2&J$323;JKR-D4F<TNWBK4K"9"U.C<C%#)2*M$O>1!H
MV\Q&.:V+.Y/'-<_#G-:5K(1BN9TRKG4VUQTYJVT@9:PK>;I5U9^*2CRFB&WR
M!@:YS4+4$'BNCF;<M8NHX"-75"82U1YIXJV0H]>%^-=6$>\ U[%\0+SR8Y.:
M^:?&6I&2X=<]Z\G'UDD=V!P$ZU1-'-7VN2K<$AN]=!X7\>3V,RYD(Y]:Y:.P
M:Z;.,TYM'E@;< :^)J\M5ZG[+@<K_=6:/IGP=\5&98U:7T[U[9X3\<1703=(
M#GWKX.TO5I]/=<L1BO1?#?Q*>RV@RD8]Z\VMAN57B?.YEE<H2ND?=MKJ5K>Q
M@$J:RM:\/VU^IPH.?:OGSPS\7PVT&;]:]3\/_$**^V R UYM/GC*S/GW'DT,
MK7?ABEQN(C_2O/M8^&)@+$1?I7TMI]_;7T0R0<U'J>A6UU&<!:ZI30DV?'6J
M>&)+/=A#^5<U=+-;L>"*^I_$'@-+@MM05Y_K'PQ9BQ$=<LG<T4['AZ:E,K=Z
MTK349&(YKL;[X;R0G/EG\JRIO"TEJ?N$4X1N;JJ):WAVYS4TFK>2O7%49+=[
M=3P:YK7=0D@4XS42IR<K(T=;W3;O_$P7(W5SUYX@WY.ZN#U/Q!*LC<FJ2:U)
M(#DU^E\.Y7&O;F1\ECL59G;CQ(T<GWJZG0/$ID91NKQIKQV?/-=1X;NW61>:
M][/\DI4J-TCAPN)YI'T'I6I^9&.:V$NMW>O/= OSY:Y-=5;WF1UK\-E0Y)M'
MV]"3E$WUGIXG'K6.MV/6GK=>]<CLI6->IKK.*>LU9*W/3FI5N/>MBC56;-2+
M)68D_3FIUF]Z0%]6I5>JBS T]9*!%K?2[A57S*<)*0RSNHJ)6J16J>8!<4HZ
MTF: W-/F$/IK"EW4A-(!C+2;34E%%QD>RF;:GQG-&RG<1#MIC+UJSM]JC9:+
MC*QCIOEU:V4ACI7&5/+H,=6=E(5IIB*;0]:C:'BKS)36CXJ@,YK>H6MZU&CJ
M)HJ=PL9,EM436WM6P8:C:'KQ33 R_LHQTJI=6*N#Q6V8?:HGM\UT.32T+DO=
M.5DTE=WW:?%IX7'%= ]J/2H_LOM7&JLV[-GGQIIR,G[&/2HVLZVQ;].*1K:N
MAQNKGIN*C P3:^U'V/VK9-K[4?9_:N=2<6<$8*4C'%G[4X6OM6M]GH^S^U=/
M,FCMY$D9/V2E6S]JU?L]/6W]JGF,C.CM?:K<=OCM5M;?VJ98:+C*R6_3BK"0
MU.L-2K#TI,"NL52K'5@14Y8Z@1#Y=(T=6O+IKQU+&C/D6LR\CZULS)6;=Q\&
MI11RNH1=:YC58?E-=E?1]:YS4(<@\5T0=G<I;'#B$K=9]Z]5^'NJBUD3)Q7G
MUS:[6)Q5C2]8-C.OS8KUEB'R<IP5*5W<^S/".NK/:HN[/'K3_%.GB^MVP,Y%
M>0_#GQ9YQC4O^M>]:5&FI6HSSD5Y?.X5.8TB^6-CYH\8>%66=V"=_2L#2X38
MRC/&*^C/&'A))%8A/TKQKQ!HC6<C$+BOT7*LQ7*HW/FL?A_::FKHNI [037<
M:7<*RCFO&;/4'MIL$XKN-#US(4$U]G%JHKGS/U?D9Z9 P9:?)"&%8VG:@'4<
MUJK=!N]._*=-.*11O+4<\5AWT&T&NHFPZFLF]M]V>*Z(U%8*B4E8X35K S*W
M%>6>,](*JYQ7NUQ8Y4\5P_BS11-&^%[5P8J/.CT\MFL/439\KZ[OMYVJ+2[Q
M]V,UW/BSPH_FN0G>N071Y+63[M?#XO!\[/WC)\]IQ@HW->*<LG)[55NYRM+
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M'_EK^M5I/B5(W_+4_G4.$R?9Q/JB;XB0K_&/SJA-\2(AG]X/SKY:E^(4K?\
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M%N0'->:Z]HDK:HQVG[U>Y_ ^P>"6'*]ZYXK4Z9?">\Z?\-;:2Q4B,=/2JO\
MPK&W,_,8Z^E>I:$@;3T!':I?L@\S.*Z+(X[M'(:1\.;2U4-Y:_E701V,.FJ
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M $ICOJ?'/Q8&;N0>YKRZTTU9W.17J7Q6_P"/R3ZFO/\ 2/FD(KF;U.CH>?\
MCS1_+C)45@^ &>WU>/M\U>K>*M'^V0'Y<UQVCZ";'4 ^W&#4/<=]#[6^"&I#
M[# ">U>X75PIMP0>U?*OPEUX6BPINQ7T%;ZM]HL0<YXKICL<<MROX@UT6L#C
M=BOG'XIZE_:"RJ#GK7?_ !&\3?8PXW8Z]Z\4N]3_ +8N&7.<FE)FD%U/ ?&F
M@--<.VWO6?X;T\6TZY'>O;O$?@_S+=I-GZ5YI-8_8;S&,<US[,Z5+0]H^%X
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MT9L=M[59AM_:KBVU2)#MKG=[C(HX/:K"PU+'%4ZQ^U4F,BCAJ=8Z>J5*JT7
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MT_S,U2B:K*T7$2[J57Q4;4PM2N,G:05!(V:8S5$STDB22I%%0*U3QF@:)-O
MJ-JD)IC#-,H;C-%+S1BE80JT-WI5H;I18FQ6;O3K=<.*D6/<:2Y=;5"QXJAE
MZZO([>T))Z"OG?XQ>/ET])E63'7O7<>-O'$=A:R+YF#CUKXZ^+WC-]4N951\
MY-8S=C:G&[.2\4^)I/$%^T8<MN:NR^&?PY>^N(Y3'G)STKS_ ,#:#/JFJ(S*
M2"U?;?PA\$I%:1,R=JSBN8VF^5:'3_#7PR-)MX@4Q@5Z9-(/) %0V^EK9Q@
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MNHS4;6L+=8U/U%?/VF_M)6DR+_I _.M<?M#V2KGSD/Y4[^1)[5]EA_YXQ_\
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MF,&OT&O+-+BU8%>U?/\ \6O HOHY2L>?PKEJ0NCJHU+.Q\F>"_%,VDZBB,Q
M#5]C?"GQY'<6L*L_.*^//%7A.71;YG"E<'TKIOA[X\DTNXCC:3&#ZUS4Y.+L
MSKG#G5T??\>HK>Q@J<TC(0":\R^'/C1-2ACR^>/6O4O.6:$%3GBO13YE<\YQ
M<78IL_-,W4]XSN)IFTB@ W5(K5'MIZTP)U:G^94"T[=2#8D:3--S3<TM%Q;C
MJD7%14NZA"2)>,4T\TW=3A0QAMYJ15I%J95J2QIZ57E[U:;I5::F(K-UJQ;K
MFH>]3V_44A&K;K[5;S\M58&XJ9FH*!FJ%C3]V<TUJD!-U.6H6IRMQ043KCBD
M8BH_,P.M123=:!!(U5I*5Y*A9LT ,:FBES0M6(>J]*DZ4U>E*QXJ1B[J:7J)
MI,4SS*HDF9LTE1ANE/I%(6F,W%.:HV[U)0UFH4G-)0O6@">/J*O6_:J,?:M&
MW7I3 NPU84'BHX5JQMI"$J.1J<QJ%VH&-9J9NIK-S0IH D'-(14B\TAH*1'0
MM(QQ3=] FBPK4[=5=6Z5(&H0AS4C4UFIK/3 1JB*\U(6S24@&>7Q44D=6NU-
M,>ZI"UC/:+FGQQXJWY/M2>5M[5(@CXJ4-4).VD\SWI 60U/5AQ559:>LO3FG
M8JQ;5J9(::LF:<?FH917?-(K8J1EYIFVD,>IJ6HAVI^XU2&2;:>L>:C4U9A&
MZDP8D<?S5<N9!#:,?:HWC,:[JY;Q1XD2QM) 6Q@4B4>/?&KQ=_9\4P#XQFOC
M_P 2>)VUC4FCW9RV*]9^.GBK[8TRH^>O>O!O#6FRZAK"D@D%JYYO4[8*R/9_
MA=X$_M*2*4IG)STKZX^'_AL:3#'\NWBO/?@CX6"6<!9.<#M7O\5BMK",#'%:
MP1A.5W8N&?\ <A:SW^9J<TG&*BW5J1<E114ZI4$;=*M1MD4KDD,D=4Y8?:M5
ME#5 \0H!1ZF7Y/-3Q0\U8\FI8XQFF-C8XZ>T=3JE*RU)!29::JG-3NO6F;=M
M46*JU(J^U-6I5H*N/H+45%(U42MQ'>J\DG-$DE5G>IN62>94BR54YJ5*""QO
MJ&4TX<TUJKH! 5]JDC6@K3EK,1/&!3FQ3%-#-3L%B.3O3%I[4E&PR1*DV#%1
M)4RGBBPB-HZ9Y=63S2>73*V(-M.J4QTQEQ3)3&TS/-.84W:=V:0R58B>:9-J
M"V*$L<<5,;A8(<L<<5Y5\2O'$>F6\FV0#CUH)M=F9\6/B!%:VLJK( <'O7Q)
M\0O&$VJ:C(BN2":Z[XD_$:34[B6-9,@G'6N)\-^%9?$%\KE2VXYKDD^9V1VT
MX\JNS<^&7@U]:ND=TSDU]=?#_P"'R:;;Q/Y>.*Y3X1_#L6"Q,T6/PKZ)T[3T
MMK50%QQ6L(F520S3A]EC"CCBK+2;FJ!^&XIRBMCG+*OQ2/)3/X:B<U-AV)0V
M:D4BJJYXJPM%@),BDH'-."5206$%(RT[%+MI@,5*FC2A5J91TJ08@6EQ3\4N
M,TB4B/%-9:FVTC+3+*Y%-J8K2>73&B+%)MJ;92[:!D'ETTQU:VTTK[4#*FVE
M6IFCIFV@0JU,C5"!BE!Q0P1;WTQVJ'?1OI)#!J9BAFI :HD>M2K47)IZDU([
M$ZK32!B@-1NHN(05(M14;J86+&:C:D\SWI-U #&I!0S4W=0,F5J5GXJ OBF^
M94L"5FS3*3=06I#$8XI-],=ZBW4R#5L),&LSQB/.L7 ]*GMY=M,U%?M4)4\Y
MI#1\@_%;P]+=7,I5<\FO,=#\(3IJ .P]:^QO$/@9=1D8F/.?:L6S^%J13!O*
M_2L7$Z%4TL8_PRTI[6.,$5[ ]C]HLMI':J&A^%QIZJ N,5U,-N!'MQ5Q,9/4
M^6_C9X'-Y!.53/!KXK\3?#>Z76&*QMC=Z5^J?B?PFFK1.I3.1Z5Y+JGP+ANK
MHOY&>?2LY0N;PJ61X)^S]X)F@N(=Z'J.U??O@G2$M](0$8.VO*_!?PUCT)T(
MBVX]J]BTZX^RVHC''%:07*C*<KL\J^,FEFXM9@HSQ7Q-XV\&SRZH[!#][TK]
M"O%&FC5$8$9S7E&L?"N.ZG+^5GGTHE'F+C*QX)\)_#<UG<194CD5]9^'5,>D
MA?\ 9KD=#^'Z:;(I$>,>U=]8VODP!,8XIQCRDR=SYC_:*T&74HY]BDY!KYB\
M&>!;F#Q(KF-L;_3WK]#/%W@M-<5@R;L^U<9IGP9BMKP2B''.>E92C=FL9\JL
M=;\%M-:'1XD<?PXI_P 5O":WUK(P7)Q79^%='&D6ZH%QBK^N6*ZA"5(SGBM[
M:6,;ZW/SR^(7A6YL;J1HU8<UQVCW^HV-P!\P K[C\5?">/52Y\K.?:O.;[X%
MI#(6$./PK%P?0W4U;4\BL_&FH6]N!N8<5BZUXDU'5 4)8@U[8WPA(&WROTJ[
MI_P361P3#^E"BQ\R/GC0?!-QJU\KNA.37U+\)_ ?]GP1L4QTKH?#?PBBLV4^
M3C'M7J6B^'4T^)5"XQ[4XP(E(YS7M)QI[*!VKYN^(WAF:>:3"GK7V#?Z<+B,
MJ17#:S\/TOF),>?PJI1,XRL?)GA3PG/#?H2AZU]:_"?3VAAB5ACI6?I_PPCM
MY@PBQSZ5Z+X;T8::% &,5,8V'.5S:U_0([S3B"N?EKY/^,G@$L9F2/\ 2OL*
M2Z#6^P^E<%XJ\)QZPK93.:N2N1&7*?FOK'AV]T^^8HK#!K9T76-0L8P,L,5]
M8>(?@C%<2,WD_I7)W'P36)B!%^E8\K1TJHF>%WWB34+B(KN8UR-U97^I7/(8
MY-?3D/P8#-CROTK>TKX&Q[U8P_I1RMASI;'BGPS\"S2SQM(F>1UK[%^&GA:.
MRM8\KCBLCP[\-8])VGRL8]J]!TW&GQA0,8K>,>4YYSYCEOBS8^9I,J(/X37Y
M\?%#P3<WFN.RH2-WI7Z0^(K<:M R'G->3:Q\((M2NC(8<Y/I4SAS%0ERGA?[
M/OA2:QN(-ZD<U]PZ'I2R:.JL.=M><^#?AK'HK(1'MQ[5ZW8?Z/;A/:JA&R%-
M\S/!OBYX+%Q'*53/6OC[QKX/N;.]D9$8<U^COB+1UU-&!7.:\?\ %7PCCOF=
MO)Z^U*4"HSY3XRT;4+_3> 6&*W9O%^HR1[=[=*]JU#X+K&[8A_2JD/P<RW^J
M_2L^5FW,F?.>M+?ZHQSN.:J:3X-N9+A69#UKZKM?@JC$9AS^%;NG_!V.$@^3
M^E+V;9/M$>>?"G0I;%H<J1R*^J?#66L40^E<9H?@-=/*D1XQ[5Z!I=K]F0#%
M;QC8RE*YQ'Q&\&)JELYV9./2ODKXA> YM/N)6BC(Y[5]\7MJ+N/:1G(KSSQ/
M\,8]7W$Q9S[5,HA&5CX*M+K4M/N-HW  UU]KXDU".W^\W2O?=3^ J"1F$/?T
MK.;X,[!M\K]*Q46;<R/GG5=<U&\)7+'-1Z#X6O-4O%9U8Y-?1]G\#5E<$P_I
M7=^&_@O%9LK>3C\*.1LES1R7PC\"M:^4S)^E?3VAZ#']A52O:L/0/"<>EH,)
MC'M78VEP+=-O2NF,;'/*5V>/?%;P2D]O*53G![5\8_$/P?<V=Y(T:,.:_1O7
M;-=4C92,YKR7Q7\(HM3+MY6<^U1*-S2$N4^'-"N+_39!]X8-=9)XOU+R=H9^
ME>WWWP/6&0D0_I5:'X+^8V#%^E9<K-N='S-XBDU'5B0=QS6-I7@*[N;H.T;=
M?2OLNT^ L<F"8?TKH-/^!\-O@^1^E+V;#VB/$_ACX/FLVC)0BOIWP;9&&% 1
MVJ+2?AY'IY&(\8]J[#3M,%JH &*WBK'/)W-2$8C%,;[QI_1:C:K,BU93;&ZU
M2\5?Z78NG7BA9-M,N&\]=IYHL(^1_C)\/VU!I7$>3SVKYNOO!]SH]Z61&&#7
MZ/:]X/34T;*9S[5Y7XC^#,=P[,(?TK"4#IA4MH?+?A_Q!J%GM3+8KN+/Q1?R
M1_>:N^;X+B*3(B[^E;NE?"3H/*_2ERLMR1X9XAO-0U")E^8YKS#4/ UYJ%T6
M9&.3Z5]T6OP3CG49A_2IF^!<,?/D?I1R,/:)'RC\._ LUC/&Q0C\*^IO \+V
M]HBD$<5H6OPOCL6&(L8]JZ/3M!^R* %QBM(QL8RG<\V^*&G27EA* ,Y%?).M
M^![F36BP0XW>E??^K>&1J$)4KG-<7)\'XYKKS/)[^E9SA<<9V.8_9XT&33U@
MWJ1C%?85I.(]- ]J\H\&^#5T-4PFW'M7?->>7;[<UM"-D92?,[G.>+)/,5\5
M\X?%#2Y+I9,#-?1FK?Z1NKAM<\*KJ.<IFJDAQ=CXWL_",_\ :P;8?O5]3_!W
M2GM[>-6%.M?A<GV@/Y7?TKTKPKX;72U7"XQ6*C8J4[H9XM\(IJ6G-E,_+7R5
M\4_AR]M-*\<>#SVK[KF59+?:1VKSOQ9X#BUA7_=YS[54HW)C+E/SIFMM0TVZ
M(4, #76Z'K5^L:@EJ^C-<^!<<DC.(?TK)@^#@MVQY7Z5ERM'2JB9X7KUW?WE
MNZC<<BO%_$O@^^U*\)*,<FOO2W^#*7"X,6?PILWP"A9MQ@_2DZ;D/VB1\J?!
MSP#/:WT+-&1R*^]_AE:FSL(E(QQ7'^'OA/%I,BD18Q[5ZAHUB+&-5 Q6\(\I
MSU)\QT$K;L5)",U45MV*MPU;,2;R^*3RJD##%&ZD4,V@"J]QTJU4$R$TQ6,V
M;[U-CJ>2*FJAS0Q$\(J[$:IQ\58C:E8=BX,8HD6HEDI[-FF!5F2J<BXK0D7(
MJE,IJ32-NI7:DQ22$BF+)51DQSBK$JMMJ>.X*U55LT^NI,X)1U+RW51RS[JJ
ME\5&TO6H;+C$9<?-FJ;QYJTS5"U9E3BK%7RJDCAZ4ZI8EILYTBQ;PYQ6G;VP
M/:JMNN,5J6]8N3.F,421V8]*LK8CTI\)%6XV6LG.1T1IHI_81Z4?8?:M($4\
M**<9-[ENFC%EL,@\5GW.D[_X:ZT0JW:AK-6[5NZCBC"4;'GMQX=$F?EK)NO!
MJR9^2O49+%?2JTEBOI6'UAW,W='CMYX$C.?DK#O/!*)GY*]LNK)<'BN=U&Q&
M3Q6T9QGN9>TDCQB]\+K#G"USM_I;0YP,5[%J&F[L\5S5]H(DS\M:/!T:VZ+C
MBIP/(+R6>%CC-58]8NHFX+5Z5=^#Q(3\M9[>!QUV5Q5LHI6T1V0QTF<]I_BB
MYCQEFKK-)\;31XRYK/;PCY/\-5)M':WZ BOF\1E/9'ITL2I;GJ6C_$1EVAG_
M %KKK#XB(Z@&3]:^<)+B:V/!(IJ>)+B!OO&OG:V55.B/4A4@SZKMO&D$W5Q5
M^/6+6YZE>:^5;;QQ<1D?.:Z#2_B%,I&7/YUYWU>MASI_=L^COLMK==@:&\)V
M]PO"@UY/HGQ")*[G_6N]TGQY&ZJ#(/SK)U*BW,W&/0DU'P#$RMA!7%ZSX!V[
MML?Z5ZE!XJM[A>66EDN+6Z[J:E56]S-RY=CYSUCP3*F["'\JX[4/"=PC'"&O
MK"XT&UN_X5-95YX!@FR1&#^%=<&GN9.M+H?)SZ!<1MRIIR:?+'U!KZ.U#X;H
M 2(_TKD]4\!&+=MC_2KFE;0TA5EU/)XW:'K5A-4$?4UNZMX7EAW80_E7)7^D
MW$1/RM7$X'2JAL1ZTOK5J/5E;O7%?9[B,\@U;MVE5N<U+IFJD=M#?!N]7[>Z
M]ZY.UN"H&35[^TEC7[U82I&RD=%-J0C7K6'?>(A&3\U8&K>(%C5L/7#:QXF.
MXX>OI,JRMXF6QX./QGL3T=?%0\P?/^M;^E^(5D(^:O (?$3-)]ZNLT/7VW+\
MU?8XO(_8TKV.'#8UU&>]6VI"11S4ZW&ZN"T76#(J\UU5K<[PO-?CV8471JM'
MTM)\R-J.2IA)FLY9JD6;WJJ:O [=D7Q)3UDYJDLU2";WK-[F;9<\RGJ<U363
MIS4R24R2RM/7M4*M4BM4C):,9IJM3U/2D(3;[4H6GXI0,4$C-M&*?1M% #:=
MBC HH ,4JTE+3 =3*7-)4,I!1110212+S5=U]JM/TJ%ES6J*B567KQ4,BU=:
M.H)$JALHR1U1GCK6=:J31YI 8D\.:S;FVS70S0]:S[B'CI0M!LYBXM^O%9=Q
M;YR,5T]S;^U9LUM[5TQ9E8XZ^TD39XK O-#"L3BO0IK7@\5DWEGN!XKLC+0?
M*>>W6^RSMXJWHOC&:QG7YR #5_5M,WAN*Y+4+/[,Q(XKIIT_:.QR5)<FI]%^
M _BEL\L/)^M>[^&_B)#=QJOF Y]Z_/6Q\23:?,,.1CWKT[P;\2IHY(PTI_.O
M963U)1YDCD_M"*T;/NVWEAU:/L<UA>(/!B7$;,JUYYX!^)"2+&&D'YU[!IOB
M&#4H -P.17BU?:X.0[PKH\*\2>%WM7;:N*Y-8YK67H17T=KF@1Z@K%5SFO.]
M>\&>4&8)^E>[@,V=TFSS*V%MJCE-)ULP, S5V&G^($D51NKS75K&6RE. 146
MGZM)#( QQ7WV'QL:D4>:X\NA[1;WPEY!J\K;JX+1=<5E&6KJ;34EDQ@UV<RF
M821H31@@U0GBJYYP9:AF^84N0PD9,ZX!KG=73<IKI;H=:Q+R'?FA73L8WZ'$
MW$?E29KH/#>M"WE4%N]4-8M?+C8XKE%U-K6Z'..:^?S?#>TIMGLX&*O<^FM!
MU87EN!G/%87CGPR=3M7.W.17._#[7_,\M6:O9H+6+4;+H#D5^3RYL/4/KM'"
MQ\(_$;P(;>>5MF.O:O&]0C^P2,N,<U]V_%7P2)8I2L?8]J^._B!X7EM+J3"$
M<GM7ZUP[FBII79\CCL%[1W1R]G>>96G&NXBN=LXVMY,-QS72V#!\5[V>9Q&I
M2:BSEPN!<&;.EQ88&NOT]?E%<[I\8P*Z&S;;7XC6JNI-MGVV&AR1-6(=*OPB
MJ$+9J_">E9'8RY&M7(4JM#SBM"%:AD7)8XJLK#[41K5E%%24D1K#4JPU,BU(
MJU@V,KK!3EMZM*M2>72N!4\FG"&K6RE$=%P*ZQ4Y8JL+'3ECHN(K>33O*]JL
M^6*791<"KY=/6.I]E*JU-QC%CZ4_RJD5:E"T"*_ET>75C92;:8$02G".I52G
MA*BXR#RZ>$J;93ME4!&J4\+Q4FRD:E<0BK[4N!2+3J5[@)BEINZC=0 ZE!J-
MFI-U $C&FEJC:6F-,*"R4OQ4325 TU1M-4R)9-YO-,::JS38[U6DN:K[(XFB
MD_-78;CI7/)=<]:O0W&<<UKAG[Q%4VOM)]:*S?/]Z*]DXS[(I-M+17Z4?/C?
MNT;J5J3:: #=3J;M-.H ***2@!:*3-+0 44FZB@!:*** "BBB@ HHHH 3;28
MI<BC(H$-IK=:=36ZT#&,*;M-/(HVT@&;33MOM2[:6E8")EYZ4;?:I-M&VJ :
MJ\=*DV^U(.*?F@!FVFT^F'K0 UJ:U.:FM28#3TIM/*TW;4@)BI%'>D5:<* "
MFLO%.I#TH 9MJ2F4[=5(!K=Z=&1GFFM3>E)@7EVXXQ39(8Y!AD4_A5/>RT[S
MCZU-P*6H:);S$_NU_*L=O#$&_/EC\JZ?=NZTA5:D#,T_0[>$C,:_E6W';Q1C
M"HH_"JW2CS&]:: N$*.PJM.P[5&TC8ZU&Q)H :6]ZECBCD^\,U!@YJ1<T 6/
MLD/914,D2K]T8I^332: (HQAJO*T;+R!5/%,;=0!#JFGV]P#\@/X5A_V!!YF
M=@_*NAVELYIC1 4@*$.FP1+]P4_[/ #]T4^;(JH2=U &I#;P_P!T5.T:+T%4
M+>0\<U<5LK3 <K 4]HXI1\P!J$]J1<YH$13:3;R?P"H5TN*-LA16BM,D[T#"
M"-(^PJ22.&1>0*INY%,$I]:0K%6_T>";/R UEKX=B5\[!^5="IW=:=L&*8RK
MI^GP0XRH_*M)EM]N-HJC(VW.*@,C$]:8%J:"%NBBH/LZ \"A<M4JJ<4A!&B]
M"*L+:PL.5%0U*I.*@!'M8DY50*A'RG%2R-UJ&F,D W=:<(8VZBF9I<T@'_9X
MO[HIC1HO049--+4 )0J!_O4E*K4 3"S@(&5'Y4UH(T/R@"DWGUIK,: )HV%2
M-'$ZX(%5 U+N/K30%:_TN"8'Y!6*WA^'S,[!71XW=:3R138%;3=-AAQE16TL
M<"K]T5GXVYQ1O;UJ0+%Q' <_**SI8XUZ"I)&8]ZKN#3 D1@#5A421>15%<YJ
MS$332 9-I<$@Y0&JW]BPJ20@_*M->U.VC%# S/LJQ=!BG1LJ-S5B>LRX<KG%
M2!KK-"RX(!JA>V%O<9^5:S/M#@]:N6\Y;J: *W_".PEL[!^5:=CI%O#CY!^5
M3QN"*5I,=* -"-8(UP%%5KAU[52:=O6F^86H)'YIZ]*C5JD4TRB2D(I:EACW
MM2 K*N&YJ];7$,?WR*K:FGV6W9Z\1^(/Q6'ASS/WF-OO0!]"+?VG_/1:/[0M
M/^>BU\(:E^U9]FN&3S\8]ZCB_:M#+_K_ -:JP'WH+^U/_+1?SH:^M.\BU\(#
M]JK_ *;_ *T-^U8/^>_ZT:@?<LVH6?\ ?6J_VZSW??6OAJ3]JD'_ );_ *U&
MO[4PW?Z_]:.4#[NCU"S_ +Z_G4RZE9_\]%_.OA ?M4#_ )[_ *TH_:H&?]?^
MM%@L?>:ZE:?\]%H;4;3_ )Z+7P>O[50_Y[_K0?VJO^F_ZTQ'W=_:%I_ST6D^
MWV?]]:^$?^&J?^F_ZT[_ (:I'_/?]:5@1]V_;K/^^M']H6?]]:^$_P#AJD?\
M]_UIO_#5(_Y[?K2L59GW=_:-I_ST6FMJ-G_ST6OA+_AJK_IO^M)_PU2#_P M
M_P!:=B7<^[?MUG_?7\Z=]NL_^>B_G7PD/VJ?^F_ZT[_AJH?\]_UIV ^[!?6?
M]]:7^T+3^^M?"7_#57_3?]:3_AJK_IO^M(H^[AJ%I_?6G?VA:?\ /1:^#_\
MAJK_ *;_ *TO_#50_P">_P"M.P'W?_:%I_ST2F'4+3_GHM?"?_#57_3?]::?
MVJA_SW_6E8D^[/MUG_?6HVO+-C]]:^%_^&J1_P ]_P!:4?M4#_GO^M)H$?<Z
MW5GG[ZU)]KL_[ZU\*_\ #50_Y[_K1_PU4/\ GO\ K4\K*L?<[W5G_?7\Z@:^
MLU_C7\Z^'F_:J&/]?^M5Y/VIQG_7_K3Y0/N1M1L_[Z_G2&_L_P"^M?"W_#4G
M/^O_ %I?^&I!_P ]_P!:.4#[KCOK/^^OYU;COK/^^M?!:?M3#_GO^M68_P!J
M@?\ /?\ 6CE"Q]X?VA:?\]%I1?6?]]:^$?\ AJH?\]_UI1^U4/\ GO\ K5V$
M?=OVZT_OK2&_M/[ZU\*?\-5C_GO^M-/[50_Y[_K18#[K-_:?WUIC7UG_ 'U_
M.OA0_M5#_GO^M-_X:J'_ #W_ %HLQ6/NHWUG_?7\Z3[=9_WUKX5_X:J'_/?]
M:</VJ/\ IO\ K0,^ZOMEG_?7\Z=]LL_[Z_G7PL/VJ!_SW_6G?\-4#_GO^M(1
M]T_;K/\ OK^=02ZE9K_&OYU\.-^U2/\ GO\ K56;]J8'_EO^M!)]TKJUG_ST
M7\ZOVNH6LG"2+GZU\ ?\-2?]-_UK0L?VJQ&P_?\ ZT6-+'W5J]];0V;EY%Z>
MM?./Q1\=P::92LH&,]Z\DUK]JH7%JP$_;UKYZ^)WQV?5!+MESG/>GNPL>NZI
M\?A8WA47&!GUKJ?"?[0J74B*;CK[U^<WB/X@7,UVS"0]?6K7AGXH75C<(3*1
M@^M:(NQ^QW@CXD6VJ*A:8'/O7JFGZI:W48(=3^-?E+\//VA)+%8@TWIWKZ/\
M!_M%?;C&IFS^-1-71%C[1N/+;E2#4:+\M><^#?'/]N1QG=G->DVJ^9"&KDY7
M<G0Y7Q-:^9&V!7E^I:>4G)QWKVO4K/SE(Q7!^(-)\O<V*]7#U.7<RJ*YRU@P
M3 -3:A"LT)K-N+C[/-BKD-P)HL5[4'S'GRB>8>+M/*LY KBK?=#<#ZUZWXGT
M_P Q6.*\QU"T-O,3BK:L<S3.Y\,:AM5<FO1-+O-ZKS7BFBZ@8V49KTGP_J'F
M!>:Y):FL3OXV#+3)8]P-06DVY15S[RU*7*:.-S(N8]M9EQP:WKJ/BL6[CYK1
M2N<[C8S)*@*U8E&*AW&M4C*XW'-.6A1FG!:HAC6%0R+U[U99:A=:I#13<4Z/
M(-.=:%3FAE,LQMQ39#3E6FR4D05)#S3X::R_-4L*<T%EN&/BI]NT40I\M.DX
M%(S()'VU5DN-N>:+J3;FLN:XJ@+WVC/>I$FK*CDW5=BH&7UDI))JK[L5#)(:
M+"%FN,GK521RU*V32K'NIH9"5)H535Q;<GM2M;X[4R2LI(J96Z4C1[:9R,4%
M7+*M5A&JBKU(LU &I')5A7#"LA+CGK5N&X]Z0B]MS3'6G1R9%+)3$4Y%JG-Q
M5Z2J,W>A@5R?FJ1*9MYJ2->:DL=MR:D6.E1:E6@"$QU$_%67-5I6IH1 [5'U
MI6;FD6@!56K44>:A1>:N0K5"%\KBHY(\5;'W:C=:5A%!EIM66CIHCH B4&IH
MZ/+IRI0,ECJ85$HI^[%# <S8J-I*1FJ)J+ /,E,W4VE"]* !J9T[5(5-1MZ4
M .4T]5J-.U6(UJ1C-OM3:L^7Q44B8H CW>])NI&ZTW/-- 29HIJU(JYIB(F4
MU"ZU>$7M4<D/%(909:1:GDCJ(KMH1(O\-)MS3EYQ4R1YH&1+'3O+-64A]JD\
MB@91V$4A!S5\V]1/#0A%=<U/&U,*8IR5,AHMQM4H;WJNM2!J20AYIC"G;J".
M]-B*\B^U5W!YJV_>J[TAD2BK,=0#-3Q&G<M%E!3]O%$:U-LXJ1E9EQTI@:IW
M7K4#+38F2*V.]3+)53=3M]"$6_.J*23.:B#4C=Z0$<C<TQ6YI6%(JTP9;A;I
M5M&JA'Q5E'I$EG=3&;%1%ZC:3I0,E+>]-:H_,I=V:HK0CDJLQJT]59!BF,<C
MU.K\535JFC:FPL6U:EVU&G2IEK,2&[:;MJ1J3%*Q1'M]J55J7;1MJ1"!L4&2
MFLM1/0 ]YJKO+[TUVJ%B:JPR3S*D1JJAC5B*I$7H>:MHM5(:N)0 K#BH9%J8
MM4,E,"L](&ISK3*11(K5(&Z<U"JU(JT[#)=U/S48Z4[-4 [<::QHR*:S=:0#
M6:F;J&:FU($RM3MU1+2DTK /9Z;NIE.5:H"5>:L0MAJ@1:D'RT@--)@8\5C:
M[H<>I0/\H/%65D/'-:4+*T>#2W)3LSY0^+WP_P#DE9(^Q[5\N:I8W&BZD2 5
M :OT?\;>&X]4MY!M!)%?*?Q2^&Q@,LBQ^IZ5R5*>MSTJ-32QF_"?QZUFT:/)
MC'O7U;X/\61ZE;QC?G/O7YZ+>3^'[['*@&O>_A+\1BSQ(\GIWJJ<[:,=2G?5
M'V9'&LL88>E5)HMK&LKPKXBCOK5/F&2*Z%E65<BNHX7H9C#%)NZ5+<)M-5BU
M D3*U.%1+VJ5: ' 4M+24F@"EI*7O0 4]:;3EI B>,595:K1FIPW%!8V2JDG
M-69&S4#+F@5T5F%20M@TK1U'C;0!I0S=*G\W-9"S;:L1SY[TF"9?$E!>JGFT
MOFU(R;=2>94'F>]-9NM.P$K2]:B:3-,+9H HL [DTW::E1,U)Y=,"J5IOW<U
M/(N*K2-UIB)%;BFR/48:ACUH&12-UIJMFG[*<L- A8ZF[4U8\4XTAH:S4T\T
M,U,W4B[C@M+MI5IVV@5Q\*UHV^.*H1U=@;IS18+FI"14_&*J0M4^_B@!DK<5
M4D>IY6!JI)4E#6DYI4:H6IT="$7$:G,W%0*W%.9N*91%-)BH?-YI+AL9JIYO
MS4"N:D+;L595?EK.MY:T8VRHH$,D^6J[-5B;FJDB\F@!=]/5JA45,JT#)4YJ
M95S4"G%3+)2L(E\NHI$%/\SCK4$TM38"";BJK28I\TU568FA 2+-4BS54I=Q
MIC-&*:K2R9K*ADJU')0!:9O>DJ$24]6I6-"1:=35IZ]: '#K5^Q7+BJL4>ZK
M<3"$Y-)DLLZNRP63-[5\P_&3QL-/691)CKWKW7QIXDCMM/D&_'%?"WQT\4/<
M7<RHV>:SF[(VIQN<!XBUI]?U!D#;LM7H/PP\!--/'*8^^>E>8_#[3Y=4U9-P
MR"U?;WPK\$HEC$Y3G K*"YM6;S?*K':?#K2AIMK$I7&!7?7,@:/ K*M; 62J
M ,5:W%ABN@XAE-QBG4;=U "*U68VJ)8ZF6,BJL!85J&Q3%XH9J0[C&XI!)@U
M%))59IL=Z8S366G[ZRH[KWJPDV14DEEL5&Y%,:7BHGFH*1-OJ16JCYW-3QMF
MJ'L6MW%0R&I!TJ-UH**[Y.*9Y=3;*D6.@17\GVIZQFKBP\4&.@16"TUEJPRX
MJ%Z0B%J55I=N6IVVA A*1C3MM,:F E%,9L4GF4 29J16J$-2AN*D"TK"I%(J
MHLG2IHWH$RQMYIDB]:<K<T],-5$[%98_FJ>54CAW&GS!85R>*X_Q9XJCT^U<
M;P"!04M3'\<>,(]+MY!YF"/>OD?XN?$9KQI427/7O6W\8OB8S-,B2=_6OGIK
MNX\0ZACE@37-.71'7"G;5B:?8W.N:D#AF!:OJ+X-_#L[87>+T[5S'PG^&+73
M0R-%[]*^LO _A./28(_EQ@40CU8JD^AJ:#X=CT^W3"8X]*V6PJ[15R3:D>!6
M>WWJZ#EW*YCW-4J1T]8ZE"T6"Q#MXJ-DJRRU&1BJ&0K'4B+3A3U%(0Y$J98Z
M:II^^A#&E!3"-M.:05$TE(0[=3E;I4&[FGKVH$6%:I5J!:E5J90^DZT;J44$
M78@2G;*7=2[J#1$;+49J1FJ)FZTKE!NI>M,ZU(J]*8AK*3496K&VFLO% B#;
M[4;?:IME)MH**[9II:IF3K4+*<T"8FZG**%2G[<4 ARBG4U6I=PH'<7=[TW=
M1G-,I6('%J;NIK=:2F-$GF4[=4-.H*),TUJ6G;<T 1-FF&I67BHFXI,@;OH\
MRHV-,W4K 2,U-6FYI5H*)5;%2*V[K42U,BTB2Q';HP&14RVL0_A%11\8J93Q
M3*#R5'04@49I:3-38":.-&ZC-2?9X".5%5?,QWIK3'UI@2311+]T"JLC8/'2
MAYL]ZCW9IB' !NM.-M$W5148S3LFJ"Y7EM8^RBJYA"M5U@33?+^:D!'#"A^\
M*L_9X>RBHMA%'-,!S*%Z4+@]:;FF[J3*+/EQ,O(!JA>:;!+_  BI-Q]:=&VZ
MDF!C-X?B+9V"M"STB*/'R"M!5%2!:TT)'0V\4:\ "GNJ]J8%-/534@,6,%NE
M3+;1G&10JTY3S0 _[+$O113&C5>E/W4QFJ"B-LTY-G>FL<U"^13)'7,,,BG*
MBL2ZTR&1ONC\JT)&-1$T"*$.CPJV=@_*MFTLX(U^Z*KH:DWD+2*18N%CVG %
M8MTOS'%7Y&)%4IN<U8B& 9;FMFSMX6 RHK'3[U:-K(1CFF(U?L\2CY0*C9*2
M.7@4_=FF,CVCN*@N;>*12"HJ9Z@8'-1<# OM'AD8G8/RJ@NCQ(WW!7321U1F
MC%,+E:WL(5Q\HJ_'8P_W15>,'-78:8#39)V%(+<+T%6UIRJ,T,9'##\W-7X8
M(NX%11J*DZ5(7(KS3X)%/R#\JQY=%B+'Y!^5;3MZFH'84PN5;32X8_X!6Q#'
M"BC"BL_?Z4]9#ZT"+\K)CBJCM\U&32+0-$T&.,U=,<4D?(&:H)4ZDT",^^TN
M&5C\@JM;Z+"K [!^5;6S/6@1@5+*%M;&"-?NC\JM-# %^Z*K;B,XIC,?6@!L
M\<?85391VJ:0FH.:I$C=M-9*G5:=Y=.X&?)'UIBCYN:NR1U688-(5KEJ (V,
MBEGL(91]T57C:KT/.*!6,:;086/W!^536>BQ1,#M'Y5M>6#364"@HL6<,,8&
M5%3W"P,OW16=O*]Z:TC'OQ2)L5KVWB.< 5E26Z[N!6K,":J2+S5!8;:VRL>1
M6U;V$.T':/RK-MNHK9M_NU+!D,]ND:_*,5C7C%<UO72_+6#>KUH0C)F;<U/M
MX5;J*;(OS58MD^:FP-*UM(L#Y15X0JHX&*K6HX%6F/RU($3R!:19(R>:@N&Z
MXJDTAW=:H9>NK>"1?NBL:;2X?,SM%7?,/K3&85(AUG:PQXRHJ\R0%?NBLOS#
MGBI8RS56P#YH8NP%57C Z"KGDEJ1H: *T:D595MM)Y>*9(VVD!(T^*1;CFJ$
MLU,2;YNM-#-N-MU2^5NJE:29Q6K$NZ@90D@]JA\G':M62,8JI(H!H J[<4!J
M61JCZU(KEB-NE68_FJI&M7H5%,8[RLBJL]O[5I+C;4<B TR;G/W$)6J396MZ
MX@SFLV6VYZ4B>9E:,U**<L)6G;,5HF!"V:A-6&6H66KT$QE1M4C5$:6A*N]Q
MH^]5B!<FHD7YJNV\5!?*BU;J>.*OQ\5##'4^W%39,HF67;4Z7&.]9[/MI!(:
M7+$?,S66Z]ZF2Z'K6,LIJ03$5S5(VV-(S-^&Y'K5J.<&N<CN"*N0W7O6<5)[
MCNF;#,#4#@&JZW'O1YP]:U]BF5H17$88&L:]LPV>*V7DJG<$'-7&FHF;C$Y2
M\L1SQ6-<68&>*ZV[4<UBW40YKKA+EV.>=.)STENOI4#PH.U:DT)YJE)$:V]J
MV<_*EL9<]LK9XK*N])$N?EKI/(RU/6U'<5G92W)YY1V//;OPN9,X6LFX\%NQ
MR%KUK[(G<4?88F_AI>PA(/K-6)XVW@V13]VFGPW+;\X(KV0Z;$?X16=?:2C*
M<+7'6R^G4Z'13QM5;GE6Z:Q[D5)%XNFM6QO/YUTNKZ$7S@5R%]X:E+'"UX5?
M)HO9'=''2ZF]9?$B6-@/,/YUTVF?$UN,R?K7E#>&[A6X!J:/3;B#'6OGZV33
MCLCOIXN,MSZ$T7XBI(5R_P"M=QI?B^"X RP_.OE.UOI[,C)/%=!I_C:6UP"]
M>1/+ZT-D>K3JTI'U0NH6MR@Y4U3NM/MKE3PM>$6'Q/,> 9/UKH]/^)Z28!D_
M6N?V,X_$;-1E\)V6H>#H;K.%!_"N:U#X:)+G$?Z5NZ3XXAN=N7%=;8:M;72C
MD5+DEN3R,\0U#X8>7DB+]*Y;4O!#VN?W?Z5]236EM<J?NUSNK>%H;A3A16?M
M(FB;1\LWVERVN<*17-ZE--%G -?2FK?#U9LX2N)UCX7NV<1UK%J1I[2Q\WZQ
M>3G=UKC[Z69V.<U]!Z]\,9(]W[O]*\\UGP/):[OW?3VK]/X<J4J5G(^0S2+J
M/0\YL]_F#-==HKLK+S69<:2]K(?EJW8.\;#@U]GF>84)4[(Y<#0G$].\/W&
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MG%: (Z:V*>RFFXH 2HWZ4\]*;0!4F7-5C'S5^1:@9: &1#%7(S\M5D%6%Z4
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M^[)^M+_PB>LC^&3\C7Z._P##/-G_ ,^Z_E1_PSS:?\^Z_E1<+GYP?\(KK/\
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ME2K^SS:?\^Z_E3N,_.L^%]9_NR4QO"VL'^&3]:_1<_L]6G_/NOY4T_L]VO\
MS[K_ -\TKDGYT?\ ")ZQ_=DJ:'PGK)Z+)7Z)+^SS:_\ /NOY5H6/[.]HS?\
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M7!^M7K33S(HXK^J,/1PT<,E8_*JBJNJ;&G>(G60#<:[_ $#7#*J_-FO/-/\
M#TLD@PIKT7PSX7G^7Y37Y1G^#ISD^4^WRN3229U4=X9$J-K1KEN!6YI_A.=E
M7Y#^5=7H_@QV8;D_2OS]8",3Z>I)6T.'TWPK).P.PG\*[/2?!$A5?D->C:'X
M1CB5=R"NQL='MX5'R@5VX>,*;/'J2;9Y'_P@[_W#^5%>V?8[;T6BO4]I$YKL
M].HHHKZDXPHHHH **** "FM06I"U !2CK2#FG;:  U&S5)32M "*U24P+3Z
M"BBB@ I&Z4M)0 VBG;:-M AM-;K3J:>M Q**** "BBB@ HHHH *4=:2EH =4
M;4_=3&H 8324K=:2DP"BBG;:D!FT4M!HH ****8";1032TUNM #6IC4XTF,T
MF!&S<4RIF6F[>:@!J]*D5N* O%-;BF XM32M(&IU ";:0TZDVT 1,,T]%H*\
MTJT 2J>E!?%*JYJE?7 MU)8XH M&84>8&KD[CQ5!#(09 /QJ_IVN17>-K T
M;E'ED]!1%\R@U9C=%^\<4 4I(F]*JR BMIYH=I^85FW.UC\M %5#5F.H5C.>
ME6(UZ4 28%-9:?28H C\NF;:FIC"@!BK2D<4OW:3- KD;"H]IJ>I4V=Z N5U
MC/%/V$5:$D2KU%1O(C=#0,AJ-AUJ1J:5ZT@(FJ)B<U,RTS;2 1:F7O486G;L
M4@'<4FX"HFEQ4+3<T"+7F4>8*H><?6C[0<T#- -DTZJ4<V:LJ] $E-;K2;J!
M0 M%."TC<#- "JVVG^<*R;W4DM@26Q60WBJ /M\P?G0!U3-NIM9NGZFEV!M8
M&M4)\N: &4444 %--.I,4 -VYI=N*>M.V9H B#;:>LHJI>7 MP23BL6;Q)#&
MV"X'XT =-N#4QJQ;37(KC&U@:U(Y?,Q0!/M+4ODGTJ>W=%^\:G:X@Q]X9I@9
MS*1UJ,]*L3.K?=J#%%B04GBG4!:4TBANVG;:;NIVZ@ Z5-&ZCJ*@)IN[% %_
MS(_04>9'Z"J*R>]/#>],"WYB>E-:9/055+TUFH$3M(GH*%D3TJJU-W8I!8T/
M,C]*:9$]*I+)TYJ130261(GI09$_NU6I104B?<GI1\GH*AX%+NIC)0R>GZ4O
MF(.PJ#BFM3 M;T]*-Z>E5J=@5($_F)Z4>;'Z"JK&HC)3%<O>9'Z4OFIZ"J2M
M3LTAEOS4]!2>9'Z54W4JM3 M[T]*-Z>E0#%(:1),9(_04GF)Z"JS-3-U %EG
M3TIFY/05%2[: )]R>@J19$]!57:**8R[YD?H*/,C]*J*U+FBPRSYB>@I?,3T
M%5:3-("PTD?I2"1/2JC-2*U!)>\R/TH\Q/2JFZEW52&BWYB>@I#(GH*J[J1F
MI,"R9T]!432HW:JS-S35:@$6,(W:GJL>.@J!6J53Q2&.94QTIFU/[M&WBC'%
M,EDBJGI5NUDC1NE4>*<K[:0R;6V2:V88[5X)\0/"JZG)(-F<^U>Y7#>8A%<_
M>Z*EPY)7-,9\M?\ "CH]0NMQASD^E=IX=_9_@MMK>0/RKWG3=!@A;)0?E736
M\-O'&!M%%P/-?#?P\ATE5Q&!CVKN[&W2T0 "K\IC["J4C#M1<1-).&&!51C2
MYHI"L.1JAN8_.!%/SBGQ#<::*1QFO:3\K'%><:M']GF->W:Q:AH6X[5Y'XKL
MRLK8%>G1J6,JB,NPNMW&:75K+[3">,\50L<QR#-='&%EAQUKU(RYD>=.)XYX
MDT7RW9@*YVUE-K-C..:]8\4Z:&C8@5Y-JT#03G''-)Q,ST'POJF[:,UZ3IET
M'C7FO!_#FH&*1<FO5=!U/S%49K-HT3.]A.Y:2:/*U!I\P915UL%:2T)DSG]0
MAZ\5S]Y%C-=?>Q!@:Y^^M^M6F<[B<\ZX:I(2:EFAPU)''S57)<2S&U.S2(M*
M1S5(C844ZE5:=5%#0:7=36XJ)I* )&:HVDJ-I*B:2I$2F;KS4;2;J@9CUIH8
MU20B7;NIZVX--C:K"N *HDC^SA14,@"YJQ),*I32YZ5-F(3S*1I.*KL_O2;_
M 'JADK-3D?%0[J3=0(N+/BIEN<UF[Z<DAI#-=9A4H8-69'*:M1R4%$[1[J@D
MMMU6$?-2JH:IN!D26GM4?V?;6R\(JI-&%S5HDJ*F*D6D8TZ/YJ87'A:8ZU:2
M/BFR1T@L4L8IZFB0;:CW4P)A3@O2H4:K40S28QOE9I##5Q8Z'C]J2$R@4I-M
M3R+BHJ8 JTC+FG+4JKNHN(KK#4R0^U68XA4PC%2RBLL>VI5&*D9*-M,0RH9:
ML;?:HI$J1E%Z%4U8,?S4Y8:L9!Y>:/+Q5H14C1TA%=5J=:393E6GL*PC$XJK
M(U7&'%5)EIW$0;N:GC>JY'-2(:DLN+)44S4U6XJ.1J9)'(>M1=Q3V[T*O- Q
M57I4JK3HHZF\O@5-Q(A#8J5'J-UVTP2;:HHMYS0%&:KK-4BR47)L3C%.W5!O
MIP:I6HB>H9.E+NIK-Q5 BN]1%:L$4W;0,@SCBHV:IW6J["@!RM5B/-5XAS5R
M-:!BTC5)MIK4$$=/5:-N>U/5>E Q56GJNVE H-9ED@;%1NU(6Z\TPG-,H:QI
MA%/IP7- $:K4\:TJQT]5VT$V'**E6F"G+07I8&J"2K'6F,M)$(I/3:FD6H6X
MJ[%#EJ6-:A5JF5L5+$R=5XIU1AN!2[JD0YJB=:?NS2-BG8=BLZU'MYJP]0-W
MICV')5F,56CJS'3 E5:FCP*AW4>9@5+*++,,56F:AIJB9MU(1&S4+2[:55H$
M+BGK'2JO(J=$H C6.D9*M;?:F.M0!2;@T*U/D6HU7% RQ&:E[5!&U3JW% AK
M4BTZG*O2@8W%-R:E9>*C88H*&%NM,)S2L:CR:: =3EIJ@U(JT +M%/I=OM2[
M: '"F,W6E+4T\U "*34RM42K3^@J@)MW%,9JC+TPO0(G5JD7FJZ-5B/F@8[:
M:FA.TYIH6G 8H 9J$*W4)4C->0?$#X<IJ<4K>7G(]*]C%1WUK'<6Y4C.12<>
M8N,K'YY?$7P'+HUP[QH1@US7A7Q9<:-?*C,0 :^R/B1\.TU6.4K%G\*^5_'?
MP[FT6X>1(R,'TKAG!Q=T>I3J*2LSZ-^%OQ*2:&(/)SQWKW?2_$$6H1KM8'BO
MS?\ #/C&YT.Z5"Y4 XKZ:^%OQ*%VL2O+Z=ZTIU+Z'-6I=4?3#+YBY%0_9SZ5
M4T/7(;RW0[P>/6M=KJ%5SD5U;G'L4VC*U$RFII-0A9L!A0"LG2FD#*^RGA*E
M\L^E/6.D*XV..GLM3)'BAUH&BNJ\U9C%0'C%31M2&+(O6J\B[:N[<K4$RTF!
M5W8J6-NE1,O-/6A 6EI)%IBM0STP(66H]M3'YJ3;[4AC46IU6HU&*?NZU5@$
M:HV;K1(U0,W6D,DWTN^H5-3*M PIZBDVU(JTA"4JTX+1MJA!3&:G-4;4A$3M
M2*N[%.VU+''0,1(JD\GVJ5%J0"@93:'VH6&KACXZ4TKMH @\NF.N*M=::T>1
M0!G2 \U 0?6M"2'K4#0TF-%;G-/4G-2>53EAYJ"B6$FM&WYJI##5^W7;3&6?
M+RM4[J/%7MV%JG=,#F@1E2_>J-#3I^M0JU %Q&Q2M+[U75N*:TE $YDH5JKJ
MV:FC!H&24R0D5.D>:;+'Q0(I-)0LF:;,N*;&II 2\M3E0T^*,FIUBQ3 ;%'5
MM%J#[M21R4@)&CJ-HZG#;J4K56 J%::IQ5ATJNZXJ64B9):G6;(K/!-2QOS4
M,LLL^ZGQPEQTJ.,;B*U[.-1'DT"N<?X@U#^S8F8G&*^>_BIXZ62&6,2<\BO7
M/C!JRV-G,5;! -?#GC[Q=+=:F\8<GYO6L9RL;TXWU,/6K"37=5++\V37O'P/
M\%-;S0LR>E<5\+/"[:Y/&[)NR?2OKSP#X'73H(F\O''I40CK<UG)+0]$\,V:
MVM@@Q@XJW<3!6X-+#B"$*..*HSR%FKJ.4E,F:3=4*DFGKF@G4E62I5EJJ<TJ
MM28B]Y@I/,JJLE/5Z0#V/--89I:*8$;1YIRV]/6IDQ0,C6' IDB8%66:J\S<
M4 C-NN,UDS9S6O<+NS5%[<L>E,HJPYS6S8L>*IQ69]*TK: KCB@#6MVXJX&R
M*SX?EJRKT%$K=*@=J<6IC<T@&%_>E62FLM-IB)LYH;I48:EW?+3$1RFJK-5B
M0]:JM4L8Y>:G6/-0Q"KL2T@L0^3GM3#;UH>6,4"+-.XF4 FSDT[SEZ9J/5)A
M:QENG%<5>>+8[>?:7 _&I)M<[5OWG2E;$:$FL'2?$UO<*"7!_&HO$?BB"TM7
M(<=/6JN/R&>(O$T6GQ-E@*^=/BI\3%6.94EY^M5?BM\3C#YJI+^M?->O>)KK
M7KMD#,V36$Y]$=,8=2+Q%XDNM:OF569@37=?#'X=RZS<1O(A.3W%0_#OX9S:
MQ<)(\9;)]*^N?AG\-TTF*)FBQCVJ(1;=V5*5M$3_  _^&<>EP1.8P"!Z5ZWI
MZ+9Q!0,5/:P1V]N%"@8%5Y&^;BNO1(XV22R;VXI@&:113Z!C2,4E#4@-381*
MO6ID6H%:K$1IH8\1U#(F*N+BJUP1MH)91D;%02247$E5&DYH&ATG-0NA-3HN
MZIA;[J8F9GEGFGQC::NM;^U0-'MI"+-O)C%:4,G2L:-MIJ]#)THL4:BM14$;
MU.O2F#&,V*8TE.EJOR:?0"0R4W=0%-+MQ4#0]*G6H%XJ5&H*1-2K3-U.S2!H
ME4\4I-,4T[% A"U,+TLG%5I'JBB5I.M,:6J[2=::7H0$K/DTRF!NM.6F(44X
M+0JU*%H&1TUC4Q7K4;+0 S)HHI57-!*$IR\8IX2D*XH*)8VJ3S!BJOF;:C:?
M% A]Q)Q6=,U/N)ZIO)N:@DF5JG0U4CZU:2I9)(::U.IN#33&"U-'VJ'!%2(U
M(194>M2*M1Q\U..E6:)V&-'FB..I!S3TXI%;@L51R1BK.:AD:@3*,D>#2(,5
M(],HL268VJ=7JHK4_P RI+N6?,%(TPYYJE)<8[U UU3N(T3,/6H7DW"J8N,]
MZ>LNZF ]J;MI0<T_% F,VTJK3PM2*E2R2%E]J83S5IHZA9* $5JLQOFJJK3P
MVTTAHM,W%0R/UIOF9[TUC0@(9CD&J;?>JXXJ$IS6@T)#5V,U6C6K*4@N/W4Q
MJ?BF&@1&_>JTG>K;+4$B<4",^89JN8ZOO%S49CI"971*L1+0$Q3DIV&6XQ4O
M\-0QM4FZD3U%W4C<T4Y2!UH**[JU1\@U?\R+;R1569D8_*:8#5>HIWX-2+&3
M4<\9VTA,R[AZCB^]4TT?S&FQQ\T"-"T.,5I)(,5DQ-MJP+CWII%%J22JS]:8
M9LTW=FJ*1(O6K$38-5=U*LF#4E,TXWZ5;B.<5DPS<UHV\E!F7UIQ.VF1]J29
MMJT,!6E J!Y<UF7FJ)#G+ 5277(V;[XK(=C>#9IZBLRWOUDQ@UH0R;@*H8YE
MIC+4U-:F!&JU(M)2K21)'-]VLB][UJS-6;>+G-4,Q9&PU3VLF&%0S1G=20Y5
MJ8SHK5MPJXJ\5FV+=*V85W**!D#K4$F:OR1\55DBI"L4)LU0G4FM.6/K522&
MF29VS#5:M_EQ0T/6EC&TTTQ&C&WRXJ&XCW41-4C?-28S*F@YIJIBK\D=1^3S
M00T1HAQ3Q&:L1PU,L-)C((XJG6.I5CQ3MG% RI(E5VC.:NR$+UJLUQ&O4T"%
MA7&*OPMBLU;R//!%68K@-T-!9I+)TJ17JFL@Q4OF>],ED[-D53N%W"GM-44C
M;J!)F3=Q=:H-'6Q<+NS5&2.@;U((QMJ828J-ABFT"0^1Z133';;UJC-JL<!P
M6 H&:3+FF;2#56UU:*=L!A6I'&)%R.:5Q;$ <K0<M3VCVM4D<>ZG<"LRFE!V
MU;>'BJ\BT 'FTC,6%1]ZFCCW4AE612:1(S6BMKN[4IM=O:F(C@CZ5H1Q\554
M;:L1R4D!(T?6J\D76K._=4;8H @6.K,7%-5:FC6D@+$9IY-,'%(S590K-2*W
M-5VDJ/S\=Z0&DC"FS2 "J0NAZU%-=<=:!,;<S=>:H/<9--N)N35/S,M5B+N[
M<:D5:KP\XJZBU($>VHV6K16F-'S3 KLM1,G%7?+XJ"1*9FRFRTT#%3LE,,=!
M)&W2JTL>:N^6:3R:L5C):WS3?)VUJ-![5#)#57 H[<4N*F:.F+&<U+&-"9I?
M)S4\<=3K#3C(SE$H?9O:IH[?VJZL/3BK,-M[5;9*B5[>SSVJ_'8@]JM6]N.*
MT8+<<5C*-SIAH8TFDAEZ5FW6@AL_+7<1VJL.E*VGJW:N?GY37V?.>3:AX5\S
M/RUS]WX#\[/R5[D^CHW\-0-HJ?W:M24]R50Y3Y^N/AOU.S]*Q[OP.;?)"5]'
M7&C)@C;^E8&I>'5D!PGZ5$\+&9M&3@?/=QI<MIT!JM_:4]J>"17K^J>#S)G"
M?I7+WW@1V)^3]*\NKEL7T-5C)1./A\87-OCYC6]I'Q#F1QES56[\!RKGY#^5
M94WA>6TYP17@8C*.;X4=$,<WN>S^&_B(&V[GKT'3_&T$T8!85\H+?3::>I&*
MM6_Q FMF \P_G7AU,MJ4]CTJ=>,]SZQ?4[6^7D@YK-NO#]M?9PH.:\&TGXH/
ME09/UKT'P_\ $19MNZ3-<$J52&YU)1>QMZA\.X95)"#\JY#6/AT(P2(_TKU+
M3?%%O=*,LM7YOLUXO8YI+S'9K8^9M6\(R0;L)7%ZKH]Q"3A37UC?^%8+O.%!
MKE-5^&J3Y(C_ $KIC*"-(U&MSY=\F>-^0:UK"X=,;J]7UCX9F'<1'^E</JWA
MJ2QW80C'M6<J<9['0IJ0RWU!5QDU=CU)?6N-NFFA8\$4R"_E#8)->?4PC6J-
MCT"&_![U>AO/>N+L[X\9-;%O?#CYJX9*5,5SIDNJL1W%<_'> ]ZN0W73FLN=
MR"YO1W'O5J.;WK#BN>E6XK@>M&I1L+-TYJ035F1S].:F66J40-%9JG62LQ9:
MF2;WK2Q1I>91N]ZJ+-4@DJ&C.Q8W4W=48>GKVI!8D2I=M1KVJ3=2N(8PQ3:>
M>:;B@0W;FC;3]M+@47*1$RU7=:MM43+S5J1139*8R5;:.HV2J I21U7>&M!D
MJ,QU:!;F7);]>*J36_7BMJ2.JLL-6\.IHZ5:VI@3VH]*S;BT'/%=++!5*:US
MGBN+V$H2T//J4DY7.8DM/:JDUM[5TDUK[51GM?:O9H2Y59G13M$Y"_L?,R,5
MS.H:#NR<5Z'-:YSQ6==68(/%55?-L:S::/-&LFLY,CBM72_$TMC(H#$8K2U/
M3=V<"N;N-+</D"L*<VWRL\J6Y[AX$^(S1R1AI/UKZ&\(^-H;R% S@DU\*:?>
M2Z:P.2,5Z1X1^([VCHIDX'O7?]63CS(WC3YD?9=YY.H0\8.17$>(/!ZW"LP3
M]*P?!_Q#2\5 TF?QKTRSU&"_@'()(K@^L3P\]#"K05CYX\3>%Y+-F*K7(J\U
MK-@Y%?3NN>%8]01B%SGVKRKQ/X%:U9F5/TK[S*LYV4F>!7P]SFM+O-RC<:U@
MZLO%<G<+)I\A7! %7M/U(O@$U]Y#%0K*Z9X,\.X.YMR 8K*OM/%P#Q6BLP=1
MS1N7%>A2J);G#4F]CAM2T7RV) K+6[DL7X.*[K4(Q(",5R]]I)D8D"O-Q^!A
MBXL[<'BW2>IL>&O&4MO*H+FO<O!OCY7C17>OF@69L_FZ59M/&K:7(!YF,>]?
MF&.RB5"3:1];3Q/UA61]HKJMMJ=OC*DD5RFO>#H=2W$(#FO'/"?Q8#NBM-^M
M>S^&_&5O?QKEU.?>OF)<\96.N-"2U/,?$?PN7YRL?Z5Y;X@\#26>XJF/PK[#
MF6UU",_=.17(Z]X)AO5;:@.:]&C-=3:*<=SXLU'2;B"0_*:AMHYHV&<U]+:U
M\*@^XB+]*X;6/AVUH6(C_2NB4H-:&G/8X&SN"BC)K2AU!5[U#J6C2VF0%-84
M_G1D\&O*J1;>A7/<["/4E]:N0ZBO'->?QWDRMSFM&VOI.,FL52;W*4CNX[X'
M'-68[L'O7)6UXW&36C!>=.:ET65S'1+<U*MS[UB+>C'6I%O5]:RE19K%FXMQ
M[U*MQ[UAK?+ZU*+X>M9>P9H;*W/O3Q=5B?;1ZTHO1ZT_9M!=&W]J]Z<+CBL4
M7P]:7[</6GR,+FR;CBF_:?>LC[:/6D-]_M4^1BNC8^T^]'VBL;[</[U)]N'K
M0XL+FW]JQCFD:[]ZQ3J _O5%)J ]:GFDBKHV_MGO2-><=:Y\ZE_M4UM0R.M'
MO,GF1M27@]:KR7H]:QI+T^M4YKMJ/9R9#D;SZ@H[U7?4AZUS<UW)VJLUQ,Q[
MU4:$[F,I7V.G;4 W>HS=;N]8</G/V-:UE8RR$?*:]*.7^T6HZ5XN[$N9'="!
M7&Z]I$UWNP#7JVG^''N,90UT%I\/!<XS'^E>Q@\/]3ES(G%5(SC9GRZW@R=Y
ML[#UKJ=!\#S/M!C-?1L'PJBX)B_2MG3_ (>P6K F,#'M7U?]O2IQY;GR,\*I
MRNCR;PW\-RY4F/\ 2O4M!^'T<"KE*Z^QTJUL5&0HJ>YUJVLU."HKP,9FKK'K
M8;#.FKD5KX7MX%&5%6?)M;/GY17*:MX^CMU8*X_.O/M>^*!7<%D_6OGW7G4>
MAVSJ<NC/8[CQ-;VO 8<5E7'CQ%R ]> 77Q$FN)#B0G\:6W\1377\1KOH8>I/
M4XIS1[I_PL#_ &_UHKQ3^T)O4T5Z'U2H<_,?H-1117UY@%%)10 M%%)0 C=:
M:U.:F-0 Y:?4(:E$E $M%,\REW4 +1NI,\4E A]%%% PHHHH **** &4VG4V
M@!**** "BBB@ HHHH **** "FMUIU-/6@!K4E*U.5-U)@,I^*E6,"G8'I2L!
M#MIK+5C:/2C:/2BP%6BK/EKZ5#(NTT ,IK=:EC7<:E\I:H"D>M*M6VA4^U5Y
M(]M0P&-3?XJ>JYJ9;<=34 5MU1NW-7_LRU6GM]M,"NM/W4P#YL5:A@WT 0TX
M+5M;913O(6G9@4&7KQ3-V*T?LZU&]FIZ4K,!+==R9KB?B5JATJQD<'&!7>1)
MY<>*\[^+>GOJ&F2J@R=M/H!\D^+_ (T26.J-&)2/F]:]0^#_ ,1'UQX@7)SC
MO7SWXZ^%]_=ZRSJC8W5[)\"?!-UI,D/F*1@BD!]=Z;^\L5?VS7&>+O%R:-NR
M^W%=K8KY.DJ#V6OF7X_>('T^.8J^* .F7XPQ/=>7YW?UKT?PMKZZQ&C!LYK\
MY]-\?3RZ\$\PXW>M?</P#N&U&S@9CG@&@9[']GP,XI@XK3905(Q5 1Y8TWH(
M;2A:M):C@FG_ &=:5@*.WVIC"M'[.M(;5319@9;4Y5S5R:S &1THC@H$9=U)
MY*DUS6K^*%L5.7Q6YXC;R(7/2O ?B)XD:V60!\?C0.QVEQ\3(XYMOF_K6_X?
M\7KJ3J ^<U\>7/C"634,!SU]:]K^$^I274D66SS3&?25H/.C#4LB[:GT6(?8
MD)]*=<0_O,4A% C-&VM".SW#FG?81ZU(&>%J*48K76R6H)[$;:0&%(W-,Y:K
MTUIM)J/R=M BIY9I/*)JWY8JW#9"1:8,RT4K5F-^E6Y[$(*HM\K8H$BVJ[J?
MMHM?FQ5^.U# &D45-ORU!<'9&36LUF-M9U]!B-OI0!XY\2O%+:3!*0V,5\]W
M7QDD34_+\T]?6O</BYX?FU"WE" G.:^6[SX9W[:QOV-C=5(#ZN^$OBYM:6++
M9SBO=XX=UNI]J^</@CX;GTM(A(",8KZ1AF'V95]J0%&3Y6Q3:LB'S)*L+8C%
M(#.I*T&L@*1K&F!0#5=MX]ZYJ-[/:15JWQ'&10!Y]\0]4.EVTC XP*^:/$?Q
M8>UU!D$A'..M?1OQ2T][ZTD5.>*^1?%GP\O;C4W94;&ZF4>O?#[X@/JDB N3
MG'>O?=%G,UJK^U?,GPI\&7-G<1;U/45]5:#I9ATL9Z[:3).5\5>+DT6-B7VX
M]ZX.W^,$4MYY?G=_6N5_:(\0/H\,^UL8KY.T#XD37'B)8_,/W_7WJD@/TF\,
MZZ-6B5@V[-=.8<+FO)?@/<-JFG0,QSD"O;IK5?+P*3$9%-/6M!;/<*;)9[*D
M9G[:6GR+MXJ/- "U$X-3HNXU:CL?,&:8&8N>*DS\M79K'RQFJ$GRMB@D4FDI
M%;-+0,0U$^:FIC+F@9$N:G5J9MIRTP'DTJFFTJT@'DTF:2BD YNE,/6EIHI@
M2+3L<9IJT'I2)&2&H&SFIGJ,C-,;$7-2BHUI](D&^M-SC-*W6F[:8R024>93
M*B9L4QDI;--YJ(2<U*C9I!8D4T^F**6D(<1FFT-UI*8QRTM(M*:!@33&:D9J
M;U[TB0/M0,TM+ZT  -+D4VF%N:!DNZF,U)FC;3$1,WO3%>GLM1;:!DZ-4ZM5
M2.K*4@1+0>E%#=*!C<T9HHH *D6-34=+N- $NT+TIAD([TFXFF\T +O)[TSF
MG44 (M+110(0BI(OEI@IU5T*0E]^\C(K@?$FD^;N.*[QCN.*S]2L1)"QQ2C.
MS)D>(ZA ;20\8YJ73]0RP!-:OBZQ\MFP*XVUD:.XQ[U[6'ES'%-'2:C;BZ@/
M&>*\Q\3:*59CMKU.Q;SHL&L;Q%IBR1,<5Z;6AR2T/&8=UK-Z<UW/AG5#N4$U
MRVN69@F; Q4GA^[,4RC/>N<S4CW;1[L-&O-;<<@:N"T'4<QKS766=SN YI,T
M+UP RFL:]CZUKNVY:SKI:SN/E,">/FH52M":/FJQ3;5HPDA%7BC;3UXHW5H9
M,3;MHH9J;NS02))5:6K#5!(M,"LS5'4CK30O-,L N:7RZE1>*5J:9!!]VF-<
M;1UHF:J<CFK))7GSWJ,L6J'DFK,4>ZA@B(K28(J\+<FHY8=M)#*NZDZTDGRF
ME0T *!2A:=2%J0R13BK$;U3$G-2QO5 :$;5;C?WJA%5N.IL!.S"J5PW7%6'J
MK(N:M$E5F^:IH:C\OYJFB7&*@9=C'%$B\4D;8%.=^M(=RA,E5F7FKLIS59ER
MU"8AD8J]!51!5N$XJM!%U1Q22?=IJR<4UGXI,97EJNS5/)59ZH0!ZFCD%5":
M!)MJ&4:L<HJ99!6.MQ4R7/O3 T]^:4516>IUFIDE@K3&6D$F:4M28QFT;J>J
MBF=Z>K4@%VTW%(S=:9YE Q=M&VA6IQZ4[!<C:J\@S5AA43+4[ 5O+IZPU*J5
M*J52$0;/EJ"1:NLN!568=:H16/6GIVIIZT^-:0RU#4K?=J*-3Q3W!Q2L!6F;
MK51Y.:GFSS55E.ZKL-#TDJ>-LU65:LPBHL,G6I*1.U.:IV$(:8S>]/:HF!JR
M0W4[=4.#ZTI;% "OTJLU2L]0L:!V'Q=JNQM5%>U6HV]Z3&3%J86S0V:C+?-1
M<5B9:E5>E1P\XJP%XIB&_=IC-3G-0.U9EB[J.:8&IZT[ +4BU'M-/CJ0+*+F
MG%:;&U2'&*=PN1EMM-WT25%F@"<-0S<5%NI-] A)#5=ZE9JB:FF4,W4]9*B9
M30"13&6E:G;JK+)3O,I!L60W%+NJ!6IZFD*XXBF>74JC-2;:!%=8ZD7Y:E$=
M(R<50T,+4QFIS+2;34E#-U2+T%)MIZKTI" +3@M*M&Z@!R5.E5U:I5:@98J)
MZ7?3&:H$1LM1%<5.:8U.P#%J56J*I%I /IZ]J8*<O2@!S-4+M4C5$U!2(VIJ
MK3R*<JU0Q52I56A5J2DA#=M)3LTS=38Q#UI=M,W4]6Z5 #@M(RT[-+C- $#"
MHZM&/K4;1TQ#5/-6$:J^W!IV_;0,NJ]/W516:I5FH&6AZTO7BHTDIQ:D.PVX
MTV*ZB;<H/%>._$OX?1ZA#)LB!/TKV43'&*@N=/CO$(89S4R7,5&3B?GEXZ^&
M]QIMS)(D9&#GI6-X7\3W'AVZ569EP:^U_B#\/(+ZWD*Q@DCTKY2\??#>:QN7
M>.,@ ^E<<Z?+JCOIU%)69[!X#^+ >% TOZUUVJ_%Z*WA_P!=V]:^/[;5;CP_
MD,Q7%<UXH^*TJY02G\Z%5L@]BI/0^U=%^+4=]=A?.SD^M>S>%=834H4;=G-?
MF9X ^(DTFH1DR'&?6OM?X0^-!<6L(+YX%;4JG,95*7*M#Z$:(;<TP+BH-/OA
M=1J0<\5<9=JYKI.(BW8J.22HYI-M5FFYJ2BP7J2-ZJ*^:F5J +ROQ3)&SFHE
M>D9LYH 8RY-.5:5>:F6.@1$13&J=UXJ!QUH&"U(%J)>U3+_2@8TC%,9JD;I4
M;"D,B<YJ)A4VVD*TP(TJ=#TJ-5J55H ?3EI%7BE'% B114@CJ%6Q4RO0,8T=
M0LGM5O@BHV7- $"I4BK2[<4#K0(>M2*M1K4JT#%/2H7J9NE024 (&YJ16S50
MMAJDCDH G*9S431U(K4K<YJ6-%4QU)''TI6IR-2*)XTP!4V=M1(W%*U PDFQ
MWJG+/G/-.F8\U1D8\T""0[J8J4Y:DXQ0!$:81FI&:E5=QH 2..KL4--ABJXJ
M;: $2/ ILR\5(SA15>2:@"I-%N--C@YZ5/PQJQ#'S0 00?+TJ5XL"K4,/RTL
MD/% &1-QFF*QJW- >>*@\DBF!)$]65/%5%7%64[4K@.9=U1-#FK*BGK'NJ&6
M9CQ;:K^9M>M:ZAPIXKEM6O/L>6SBA =-:NFW)(J+5->AL+=OG X]:\OU;XD1
MZ7&V9 ,#UKQ[QU\=XTWHL_ZU,I)&D8-FW\;/&2W4,R(^>O>ODZ;3YM4UK."0
M6KL-2\;GQ-=%1)NW'UKNOA[\/O[3N(Y"F<GTKE?O,ZX^XCTO]G_PELCA+IZ=
MJ^L;'2X[>S7"]J\V^&_A,:/!'\N,8KU;S-MN%]JZHQLCCF[LQ;E=K8%4)%YK
M2N.6-4Y%ID$*+TJ55I%'3BID6J*(FCJ-EJX8\U&\=0)E6GJQI62@+0@1(K5(
M!42U*#5@.Q2[L4TM3":0,>SU&WS44Y:D"$P[J>EGGM4ZXJQ'BF,ACL1Z5,MK
MM[59CQ3^.:H=RJ(\4]5J5E%"K4C&;:3;4U,:F,@<5$:FD;K4)H($IW\-(M.H
M+(9*KN*L25 U!(^,5=B[54CJU&>!0.Y89N*L6JB2JNW*TJW0MU.32L2<]X\N
M%L[.1LXP*^1_B)\2/[)OI!YN,'UKW_XO>*4@T^8;^<&OSH^.GC5TO)RK]S7/
M4ERF]*-SWS0?CTD?RFX_6CQ-\<!=6[*L^<^]? ]K\2;F.Z*B1NOK79:/XHNM
M6D1=Q.:Q]HSH]E;4]IUK6I_$UR0I+;C76> ?A;/J%Q&[Q$@G/2L_X2>%WU2:
M%I%SDBOM7X:^ K>&VB)C&<>E7"/-N93ERZ(S_AC\.HM-AC+Q $#TKV2WT^*U
MA4* .*;'IT=A& H I)+CC&:ZEH<EQLK=A5;GO4A?<:8U #E:G[J@IZM51&*U
M-/%.W4QJ; 57JS"]4AFIXVQ4@7_,^6JMP_RFCS#BJ]P_!I@9]R_-5U/S5-<=
M:B5>:3$7+=<UHQQU3M5K3C6D20R0U0FCK6DZ51F7-"&C/VX:IHFZ4-'S3HTJ
MQ[%N%JMJ_%5(ZD!J0W)';=3%2G+4BK5 "I2-'4RBE*5!17QB@-BI62FLM(0*
MU/#5#TIXZT%HL1M4RU6C:I=W%(3$E-4)6ZU=D:J,M6@1!N^:G+S30OS582.F
M#&*M2HE+LJ:-: 0+'4@6G 8I&H&QK"HF6GLU-H)(MOM3D6ITBW5:BL]U %,+
M39%K3:Q JO):C-,$94WRYJA-+BMR6R# UF75GMS4E&7)-DT1_,:22+:U.A7I
M3,V6HHZG6.GVL>ZM&*QWU(=#/5?:G>76I_9XIRV%!%S(:.H^E;4FGC'%59+'
M;3+17B>I]U)]GVTFW;57&2J:E6HHUYJ[#!NI#6A"?NU#)6FUH-M4[B$+WIV"
MY0>HF:IV4<\TGV;=4C17\ZFM<>]2RVNW)JC(,9%, DF/K58S&K*6YDJ5=-+4
M)!<IQR&K43&K,.D]*NQZ5M[4Q;E)6-/W5;>QV"JTD94T /1N:L1CI4=O#NK0
MCM>*@96*\5$R5IBV![TOV$$4A,Q_+J-EK7DLPM4YH=M %+[M(STZ3CM4)YH$
M(STT-4BQ;J>MO5%Z#4J=5IR6XJQ';BJ((6%1-6A]EW5%):[12**=,85,Z;:C
MQDT"(66HG2M.&UWU(^FY%(3,)OEJ+?BM2>PVU5:SYJA7(8Y:G62G)8TK6^VE
M8":-=]96N:@-/A9B<8K<LH\UPGQ4F-GILK XP*'L-:LY#5/BA':W!3S<<^M=
M'X5\7)K#+A\YKXJ\=>.9;?6F42'[WK7M_P"S_P"('U22'<V<FL%.[L;RA97/
MK&TL_,A#8J"[MMN>*Z+2;8'3D;VK*U%1YA%;',<U/#AJA5<5K26^]J;]AX)I
MC9FYQ3"QYJ]):A:$L=YIB**YS4ZJ>*OKIG'2E:SVB@LI,IJ-LU>:WYJ+R*0R
M*-B#6C:R<"H8;/<:O0V>T4R2]:G=BH]8;R;<M5S3;<%@,TGBBSVZ>Q'I4L#P
MWQIXP_L^1QOQBN)L_B.)+H+YG?UK)^,5T]O--@]Z\7TO7)O[1 +'K7,Y:G5&
M-T?8_ACQ+]L5/FS7HVF2>=&I]J^=_AO?O(L>37OWA^3,"_2M8LRDC:;Y:8S4
MRXFQ5=;C-49%JAFQ4"S5(G[RA%$4C55F7=FM-;7?0UA5[B.;F@YZ5 (MK=*Z
M*6P%5&L!FI*(K)L8K;MI.!6=#9[35^-=E4@+1;(JO)2-)BF[MU%A7*\@YJNZ
MUHBWW4&QS028\BU#CFMB2Q%5VL@M38DJQ#I4^WVI/+"&K$4>[% %=EI@7FM+
M[&&%-^QBJ&5HQ5A5J:.SZ596SXI6$4=M/$>X5++#M)%36\.]323&<MKMY]CC
M))Q7FNL>.DM9F7S,?C7:?$F0VEG(V>U?(GCCQ<\&H.H?O2E*QM"/,?06F^.%
MNG W_K7::3K'GJ/FS7R[X!UR2]E7+9KZ$\,;FA0DT1=R91Y6>A6]QN45-]H]
MZS+=]J5.K;FJS(N>9NIZ_-3;>'=5Z.U!IB90DCXJK)'70"Q#"HI=+H*1S<B5
M#M^:MFXL=N:SY(=K4@,76+C[/;LW3BO#/''Q";39V4.1@^M>Z>(+1IK5P/2O
MFSXD>"KJ\N9"BD\UG/R-H6ZFSX'^)+:A>(A<GGUKZ.\+S?;K-&Z\5\D?#WP3
M=V.H(S*V,U]9>"8S;V,:MZ5$+]15+=#1O(O+:HHVK1O(Q)53[/@UO8Q&LPJI
M*U7&A]ZB:UW4 4=W-6[<BE6SJQ%:[:+ 68@-M),HQ3E7;0Z[EI,1GRMM-1";
MFIYXC51E(-"*1<CFIPDS5:.IXU)IC+$9SBK<8JK&N*M)Q2L,FVU%(M2JU-?[
MM,5S.F.VJ4DVTUH7"]:R;C(8T /$_O0[EJKIDFK CR*I 5)LYJ%>M6Y8:C\O
MFF02V_:KT=5(EQ5R,&@"4+2^7S3E4U)M[TAD+1U!)'5MJC9<FAL3*7DY[4OV
M>KBQ^U2",5/,09YMZ8T>VM)T%59$JQV*3BJL@J])'4#1U8BF8]U.6W]JLK%4
MBH!1N,K+#M[4]4J5L"HMU%A6)XUJY"H%5(6Z5=CH"Q8C8+5N*8<5G\[:19,&
MIN!OPS"KL<BD5SD-T1WJXE[[UFZ?,:1J\INKM84K1*165'?>]6%O?>A4^4V5
M6Y+):ANU0-I:R=JG2Y![U:AD#57/8;M(Q9M!1\_**H3^'(SGY/TKLE0-4<EJ
M&K*55D>R3/.K[PY'M/R#\JY'6O#:E3A*]ANM/W9XK"OM&$F?EHIR3W*5%(^<
MO$'A9SNVI^E<+J'A6X60D*:^IKWPLDF<K6#>>"8VS\@_*MI4(5.A$INGL?-L
M6CW5N>C"MS3[RXL<9)&*]8OO!:+NPE<IJWA<Q[L+7CXG+826B-*>,E%V9%IO
MCJ2UP&<C\:ZO2_B>-P!D_6O*-2T:>-CM4UFQV]U!)G!KY7$9;*/PH]JCBHRW
M/J+0_'<-UM!<?G7=:9J5M>(,E3FOD;1]<N+-EW$C%=_HGQ$-L%#28KYBMAJT
M&=4JBEL?0%]I%M>1G 4UY_XC\!I<;MJ#\JAT?XE1S;09*Z_3_$%OJ&,L#FBG
M*5/XBH29X=K7PS;YB(_TKB]2\%26;,=F/PKZZ?2[:\BX .:Y'Q%X*CF5BJ5Z
M"KPDK,[%-V/DR^CDL21@C%48];=&QDU[%XH^';NS[8_TKSS4? <]LQ.P_E6,
MZ,*FQ+F1:?JQDQDUO6][D#FN6_L^2PZC&*!JQA.":\^6&Y2XRN=O'>=.:N17
M@]:X:WUK=@9K8M+_ 'XYK!TSH1UT5UG%6XY_>N=M[KIS5Z.Y]ZSDK ;2S5-'
M-60ES[U:AFJ!FJDE3+)TK/CDJ=9NE2%R\LE3H]9Z258CDI 75:GAJJK)3PU3
M818W4N:@W4]32))**!2-4,H1J;3J,52"XRHV6I6'--:K3'<K,M,8589:B9:N
MX7*["J\B5;=:B9*CZQ*.@N<HO'4#PUH-'3&B]JZ(U')7'N8\T%4+B#DUO30U
M1FM^M9N;(>AS\UMUXJA/:]>*Z.6WZU2EMNO%==*?<5W(Y2ZL0>U9-SIPYXKL
MKBU]JS+BSZ\5NXI:H%3.!U.P.TX%82^=:2Y&17HUUIX;.16!J6EKM.!6T,5;
MW3>/NE[PGXSEL94#.1^->]>"?B$)@BM+^M?*$R/;3$KQS72^&/%,MC,H+$4Y
M48UM3.;3/O?PWK4%] N6!R*FU[1(=0A;:H/%?//@?XD;5C!D_6O;O#?BR/4H
MU!?.:\Z49X>5XGGRIIL\M\9>"VC=V5/TKSNXM)+"0Y!%?5>K:/%J4!( /%>2
M^,/!)5G94KZS+,RE&RDSSL104HZ'F5KJ1W $UH)=;EZUG7VDR64IR",&JJWA
MC.*_0:.*C46C/D:^'<6;G#]:KWBI&I)JK%J QUK.UK5 L+<UZ5.JXJ[.:-%S
ME9&-XBU9+>-@"*\FU[7G,S;6[UN^)M4:21@#7*#3VO')ZUX^/KTYJS/TC)<K
MG*S99T/Q9<6MPIWD#/K7LW@_XI-;J@:7'XUXA+H+PC< :KB]GL6X)&*_/\11
MA)MQ/T665I0O8^W/"_Q32?8&E_6O4=$\4V^H*N7!S[U^>_A[QQ-:R+ESQ[U[
M)X0^*31A TGZUXE2C-?"?+XS#>R9]DK':747\)S7/:UX7M[I6VJIKR[1?BPK
M(H,OZUV&F_$*&ZP"X-<L8U$]3YR;U.:USX<K.S;8_P!*XO4OA:W.(_TKWNSU
M:VO<9(.:OG3;6Z7HM>E"44O>+C<^4KSX=20DGR\?A63/X5DM\_)^E?5VH>$X
M)E.%%<GJG@5'SA/TI2E'H;7:/F^:SDM^QJE)=20^M>VZI\/6;.$KEM0^&\IS
MA#^53H5S'FC:PZ^M"ZX^>IKL+CX;3@_ZL_E51OAW.O\  ?RJ^5,%4L8,>M/Z
MU836&/>M3_A!ID_@-+_PB$R_PFK]FK%^U1GKJS>M/_M1O6KO_"+RK_":/^$:
ME_NFL71#VA5_M1O6G#4F]:L_\(Y)_=-/'AZ3^[4>Q%[0J?VDWK2?VFWK5T>'
MY/[M.'AN5OX31[$?M#-;57]:B;5G]:V%\+2M_":4>#Y6_A-'L63[0PFUA_4U
M"VK.>YKIE\#S-_ :GC^'LS8^0_E5K"B]L<@-2D/K5J&ZD?'6NOA^&\QQ\AK4
MM?AS*,?(:UCATMQ>U1QMO')-CBM.WT5YL?+7>Z?\/W4C*?I74:;X'";<K71&
MG36Y#J=CRN#P<\V/DK3M?AX\A'[O]*]FL?"L48&5%;-OH]O#U K6])"4F>.6
M?PU/&8_TK?L?AZ(R,I^E>F-]EMQ_#6;>Z]:VN>5K"KBXTU[HW4D9.G^%(K?&
M5%=#:V=O;*,[17(ZAX\MX<X<5S&I?$Y%R%D_6O(EC:M1VB8OWMSUBYU*UMU/
M*UR6M^,K>UW8<5Y5J?Q):3.)/UKB]:\63W@;:Q.:[J&&K5M6%HPU/2=:^*"1
ME@)/UKD+_P")37)($A_.O,KUKNZ<X+&G:?I-S(XR&KUHY7*6YSU,=&&AU%_X
MBGO,X8\UB3VES>-W-=%I/AUY-NY378Z7X73Y=RU]%@\FCNT>;/%<[/-]/\+W
M$C E378Z3X7D11E37H&G^'84 ^45N6^CQ*!@5]/3P%.FMC+VMSSU?#C8'RT5
MZ7_9<?I16WU>F/G/IZBBBO$-AK4+UI<48H 6F4^DQ0 VFMWI2<4M KD#<5'O
MJ:1:@VF@!ZM4BM3%6I%7% $BTZD44Z@84444 %%%% !1110 RFFI*:5YH 91
M3MHHVB@!M%.VBEH 910W%-S0 ZBFCK3J "F]Z=2JO- #=N:&81J2:EQMYKE/
M%'B:+3(7W/C%)@:5]XHM]/!,C*,>IKF;_P"+VFV9(,B CWKY[^*GQ>%MYRQ2
M\\]#7S!XI^+FI3W#^5(Y&?6D.Q^B!^-VGEN)D_.K%K\:-.E8 RH?QK\S[7XD
MZNRDEY/S-2V_Q4U6WN!N>3&?4T#L?J=IOCRRU+'ENIS[UOP2"Z7<#Q7P)\*?
MB]/)-$LTIZCJ:^Q_A[XR@U2S0&0$D>M,DZ^\NUT]2S'%<[=_$:RLWVNZYJ/X
MA:@8M-D:,YPO:OBWXG?$2]TJ^DP[  GO1<9]MV/CZSOB CK^=;<-T+I0RG-?
M 'P\^-CM>(DLQZ]S7UO\/?'4.JVL?[P$D>M2(]-_U?)K/OO$D.GJ=[ 8JEK7
MB".TM&<L!Q7S=\5OB^FG^8J38//>IL!] S?$ZRC<KYB@U?T_Q5#JN-C@YK\]
M(_C#=7VI[4E8@MZU]*_!GQ!<ZAY1D)/3K3 ^DH[<NH853O-8CTT$NP&*M+J$
M5OIX=VQA:\#^+GQ*33DF"28(]Z+ >F:A\5K&Q)#2H*RG^-E@I_UR?G7P)XZ^
M-%W]J<1RMU[&N/7XK:I,I(D<_B:+#L?I9#\;M.9L&9/SK<T_XF6>H$!)5.?2
MORM7XK:M#<<N^/J:]3^'7QJN%N(Q-,1R.II\H['Z1V>J+>IE3D52UR&.:%A)
MC'O7EWPK^(D.KV\8,H)('>NJ\?>(A8Z7)*K?PYI6).>U#0]*DN<N(\YKHO#N
MEV-J T04?2OCKQI\?'TS6FB\['S8ZUZU\)?BHWB"V0^9N)'K18#WWQ!XHBTN
MQ<%P,"OBK]HKXB07"S*)1^=>U?%G7IX]*E9"?NU^=GQN\57DU[,I9L9-%AC-
M#\41_P#"0*Y?^/UK]!OV;OB!:QVENAD7H!UK\E=+UB=+X/DYS7UC\ _&M[#/
M;J&;''>BPS]6;'68+]<QG-1W%P+?<Q.!7E?PRUZ6XLHVD8\BMGQQXRBTVQD)
M< X]:&2;]_X]MM.X>11CU-<_=?&K3[<X,R#\J^1?BA\:'AFE6*;N>]>#ZO\
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M7TKRJE[Z'MT;6U.C\'>(A:3(Q;'-?6'P=^) 5H4\WT[U\7PZ#=V6/E85ZO\
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MKS^[KM%UVV;^(4_^V+7U6NA8@BS1PI\#JO\ RSJ/_A"5_N?I7=OK%KZK4?\
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MW$,I5:C;2?=I%#RU,W4F[WI :: EW4A-)0:!!NH#4FVC&*0A^ZDIN?:G4#%
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M(Z=J[?X7_!U+*.(M!Z=J^B?#GA6WTZ)1Y8!QZ5M&F<M2KV,3P3X7.CP1@C&
M*]!6;;%MJ.2..),*,54:7K70E8YMR9FYIE1B2G@TQDJBI%J)33MU(5AS-4,C
MTYFJO(:+C R4AEJ+O2X-%R6*TE-#4C+3E7VI 2+5A#4*K3PU4ADNZF,U)N]Z
M8<T7#0C<9IJIS4N,TY5IC%C7%6HZA5>*GCXI,"8&@TBT-TI(D:6II:E:HC3L
M _=3U6HA4JM69:)%6G4BTX"F%R-ES430YJT%IWET"*2QX-3IE34C1T%: 'M<
M;8\9KSGQYH!UF*1=N<UWD@-1?94F;YAFJZ%(^0?$WP%.J7+-Y.<GTJOH_P"S
MJL# FW_2OLV/0K5\%D6IET.T7HBUG[-&G.SY?T[X'10@?N,?A706?PGCM\$1
M8_"OH+^R[=>BBHY+"%>@%5RH.=GE^A^#18LN$QBN[T^W^SQ@5>:WC3. *B<A
M1Q5HS9#=-N6LJ5?FK3D^854>/)H)(85YJ]'TJLJ[:D$FVI$B=L4UA47G4JR;
MJHH=BC;3T7<:E\N@1%MI=M/*TVD*PUJKR-UJPU59FZTA$3-0KU#(]-62J NK
M)222?+UJ%6.VE;.* (9'S3HF^:HW!YIT6<T@-2W/2M&.LVWZ"M"(T(:'OTJM
M(V,U/*WRUG7$N&-" EW^]2QUG+/\W6K4,E)@7!0U,63BFO)[T"'>93?-JNTE
M)NR:918+4UF]Z8*=M-(0F:>M,QBEW8JADH-.WXJ#S*CDFJ1%AI:A,W/6JCSG
MGFF"3--"N75>IE:J4;5:5NE# GW4ADJ,M3=U"&6[7YG%2ZPWEV3,/2JUO)M:
MGZHWG6K+[4P/EKXU>*)[-I51B.M?-4MU=Z_J!0[B":^MOB=X!?6)'(3.:\YT
M+X5BPOA(\??/2N:2;9U1DK',^$_@N^KQK(T9.?:NT'[/P6/F+]*]G\)K9:3;
M*K!1BMF]\56$2]5JN1&?.[Z'RKXF^ XLX7<1]/:O$/$FEMX8O" =N#7VKX[\
M9V9L90"O0U\2?&+Q$EQ?OL/>LY61T4[RW/3_ (/>,'ENXDW]_6OLKPKJVS3$
M<G^&OSW^!<CSZE"?]JON#3[HVGA\'./DK2$M#"M'4Q_BEX[$$<J!^WK7RGXP
MU6;6[MPK$Y-=I\6/$KO>2('[XZUQ_@_36U:\0D;LFLY/F=C2$>57(_"OPQGU
MF=24)W>U>NZ9^SK)<6H<PGIZ5ZG\+?!\,*Q%HQV[5]'Z'H=DMB 47IZ5K&FK
M&<ZCZ'YV>./@S+HL3L(R,>U>%ZQ#<:5>%<D8-?IC\8O#MM+:S;(UZ5\+_$;P
MKMOY"J=ZRG&ST-*4F]RO\,+^6:ZB!8]:^U_AI)LT^-B?X:^,OA[IYL[M"1C!
MKZL\&ZT+?3U&<?+5P"H:OQ5\:?V3I\@#X.#WKXU\9>.)M9U)XA(3DXZU[+\;
M]<>XM90K>M?-&BV<MYKPW D;ZSFW>PZ<=+G?^%OAC/XFVN4+;O:O1;']GB2%
M QA/Y5[!\!_#$#6<!>,$X]*^A&\/V:P ;%Z5M&FFKF4JC3/A36OA'+I]LQ$9
M&!Z5\W_%+0[C39G&",&OU,\6>$8+BSDVQCIZ5\.?M">$EM9)V"8ZUG.-D:4Z
MG,>)?!FZFCUF(%C]ZOT?^%\V_08\G^&OSD^&L?V;Q @QCYJ_0SX5W'_$ACY_
M@HICJG$?'"9HXY2#CK7Q[XDU>;[:Z!CUKZY^-TGF12CZU\EZGI;7&J'C/-3/
M<JGL'A_PM<>(IE&"VXU[=X,_9UENU23R2>_2IO@OX7C:: NF>1UK[J^''AJR
M^P1YC7.WTJH03W,JE1Q/F'3?A2_AF,.4*X]JJZ[XO_L6%H]^,#'6OIOXJ:9;
MV>GRLB@<5^?_ ,:/$C6=[,JOCDU<O=%!^TW)_$WB9M<F9 ^<GUJGH/PY;6)@
MQ7.37FGA?Q$;K4!N;(S7TG\/]8@ACC+8K*/O;G0URK0ETGX K>6X)C[>E8WB
MSX'#2(6D$>,>U?0WA_QK8PPJ"5Z5S?Q(\86=Q82!2I.*T<58RYG<^0KHOX=O
M]H;;@U[C\(O'A,D2F3OZU\_?$;4O-U!S'ZU?^&NNS6MPAR1S6<79FDE='Z.:
M#XL233E._P#A]:\J^+GC(0V\NU_UKD?#_CAUL5!D[>M<1\2->?4(7 ;-;REH
M<\8ZGCGC+Q)-JFH.@8G+8K6\%?"^;Q*RDH6W>U8FGZ')>:P"5R-U?87P(\+P
M1QP^9&.U8)<S.F4K+0\MM?V;)%MQ)Y!Z>E<WXD^$LVC1OB,C'M7Z*)H-D-/
MV+G'I7D/Q&\*07$4NV,=^U:NF<T:CN?FWXRLKC3Y&7D8-2_#>:9M2CR3]ZO5
M?BYX/$$DC"/'/I7G/@VV^QZJ@QC#?UK#ELSKO='W-\(Y#'ID3?[-6OB;XBEM
MK)U4GI6=\'Y//T^)1Z5TWCCP>^I6[$+G-=70Y+ZZGQ[XMNKK6+UU^8@FJV@_
M"Z;5IE9D)S[5[9+\,Q%>%W3OZ5V7AS1;33-NY5&*R4;[FCGV/.?#O[/XN8EW
M1=O2E\5?L[K9V;N(L<9Z5]%:1X@L;%0"5%8_C[QU8G3I%#+G%:.$;$*3;/SX
M\;^%6\-WS;?EVFN[^#/BY[>[BC+]P.M<W\:?$45U?3;".3VK ^%5V[:I&0?X
MJY=I:'0]5J?H/X?D.N:2HSNRM>(_&[X=M);SR;.V>E>T_!UO.T^(-SP*L_&*
MQA;2)CM'W:ZG&Z.:+Y6?EAXQ\-FUU1X]N.:]+^"_PY;5KJ$A,Y([50^)5NB^
M(' '\5?0/[,EG"TEON4=17+&.ITRE[I]"_#/X8G2=/CD*8POI4GQ$\2_\([9
M2+NVX%>S6;6]KH0*@#Y/Z5\C?M&:\RI.$:NM^ZC@C>4M3Q/Q_P#$Q]0OWB$O
M4XZUG>&_"K>*)%8_-N->+:MK$LFMG<Q/SU]&_!/6(HUA\PBN6_,]3M:Y5H=/
MI?P)#QJQC_2I=1^!(6,L(^WI7MFG^*+*.W7)7I4E[XJLI+=QE>E="C&QAS2N
M?)'B3PFWA9V8#;MJWX#^)+6-\D1EZ''6M3XY:Y$T,QB]^E?->AZW/_;RX)QN
MK"3Y7H=$5S+4_4#X;>,!?6,;E\\>M:'CWQLMG8N ^./6O!_@_P"(9(])C+,>
ME5?BIXR?RG4/6W-H<O+>1Q/Q*\72:I<2(KYY]:\WT_P;<:[=@[2=QJ]:2/J^
MH8/S9-?0/PN\%I)Y3O'^E9)<QT7Y4<5X5^ <M["I,1.?:KGB;X!RZ?:,_E$8
M'I7V=X)\.6D$"!HUZ>E3?$#0;1]-?:BYQZ5M[-6.?VKN?E+XT\,2Z)>.-I&#
M6A\.;U_MT:D]Z]<^-?A=?MDQ1.YKS/P9HS6VII\N.:YFK,ZXNZ/KWX5CS+:(
M^PKW?28_W*_2O"OA6NRWB'L*]^T==T*_2NF.QRS"XCIEO#\PJ]<1TVVC^855
MC,U(8?\ 13]*\)^-N5LYL>AKWZ,;;4_2OG_XY2!;6;Z&B6PX[GP5\1YY1J,F
M">M4_"-I<WTRKR<FMKQI;?:M4<8S\U=[\)_!_P!HFB)3OZ5RVNSNO9&UX7^%
M<VL1J2A.?:NINOV<9)+<R>2>F>E?1/PV\)06\46Z,=!VKV%M LO[.(\M<X]*
MZ535CDE5:V/R\\<?#6;PRSD(5V^U8/@WQ9-I>I)&7(PWK7UU^T!X9@,<_EH.
M]?%VH:7)9ZT2!@;JPDN5F\)<RU/MGX6>+/MUG%N?/'K75^-[CS-/=@?X:^?O
MA#K36\,2LWI7L6M:G]KTQAG/RUO%Z&4HV9\D?&;5I;>>4*Q'->*:5;W&MZB$
MR3DU[3\9[(S7$A [UR_PK\/B;5X]R9RPKFEN;QT1VW@WX%S:U;(_E$Y'I7H&
ME_ .329%D,1&/:OI[X,>$;5M/AW1K]T=J[CQEX?M+*S8B-1@>E;JGI<YI5'>
MQ\Q6B_\ ",V>TG;M%>6?$7QP]P'C5R>W6N^^+&LK9M*B''6OG>[EDU74,9)&
M:AOH:PCU8S3?#]QXBONA;<:]B\*_L]R:G;JYB)R/2M#X1>#E>:)WCS^%?9_P
M]\/V=O9QAHUZ>E5"%]Q3J6V/B_7OV<Y+&W9A">GI7D/B#X>SZ%<%@A7:?2OU
M#\6Z'9S6K@(N<>E?+_Q6\%Q-'*R1_I3E30HU&]SYY\#^+9=%N$1G*X/K7TKX
M+\7#6K5$WY)'K7QYXMC?1]2;'RX->M? _P 4--<PHSYZ5G%V=C22TN>I_$SP
MB;ZQDDVYXKXM^(OA(QZA(NWOZ5^BFOK%=>'RQ /RU\:_$ZVC&L2<?Q551"IR
M.!^&WPY:\O(SLSSZ5]@_#GX:M96L;E,<>E>8_!>QA>XARHZU]C^&["&/2U(4
M?=ITXD5),\[UN^_L"S89VX%> >/_ (AF:22/S/UKUOXY:A]AM9]IQ@&OAWQ;
MXJD;5'7><;J4Y6T'3CS:G;M8MX@N,YW;C7:^&_@^;X*2G7VKC_AKJ2RF,OS7
MTAX3U^UM8TSMJ8I2W*DVM$<1<? ,?9]_E]O2O-O%O@4^&W8@;=M?7$_C*Q^Q
MD97.*^=OC)KT-P)?+QWJY)6T,XRDWJ<%X1\9OIM\B&3&#ZU]5_#'QN+R&,&3
M.0.]?G^VI2QZIE2?O5]$?"'Q-*HB#,>U1"6II4CH?5OB[4OM&F/AOX:^)?C1
M-+]NE()ZU]5SZDUUI1R<_+7R[\8HP;J0^]74>A%/<H_!6:7^U(@6)YK[#CD/
M_"/#G^"OC_X-@+JD?^]7UU&__$@'^Y13V%4W/EKXR3R+=2X)ZUY%IL\\]UMR
M>M>P_%Q/.NY?K7">$M!,]\IVYYK*6YTQ?NG5^%O DVN!/E)S[5Z':_LYR7D&
M_P D]/2O0?A-X;BC$.]!V[5]1^'=#L_[/&8USMK>-,Y9U&GH?FYX^^"LN@Q.
MPC(Q[5Y-8WDVAZH$W$;6K]$?CYH=LME-L1>A[5^?7C2Q,.N/M&/FK&<>5F].
M7,M3ZF^"'BYYEA!?/3O7U%IFJ^;:KSVKXB^!;2*\0YKZ_P##K-):IGTKHIO0
MYJNYT$UP6S5)V):KBVY8=*;]D.[I6A@F,M\UJVYXJO#:[<<5<BCQ291*1NJ%
MXR:M*F:<8:D93CBJU&M/6.I52F!7F7Y>E9-Y'S6[+'Q6;=0Y[4 8ZJ0U6H\[
M:/)^;I4\<7% R%E-(JG-7A;TBV_M5#$MUZ5I0C@56ABQBK:KB@8YC5=ZF;FF
M;:"2-5S3O+ZU(JXI&-(&5Y1@53E;K5N9NM9UPU")&M)0LM5F?K2QMFF(NJ^:
MEZU7CJPM2 C)FF-!NJRJYJ98ZI%6,X6F3TJU#9^U7HX!Z5:CA'I3*L5HK7 Z
M58CAQ5@( *3@4AD;+BJTV*M2-UJG.U,DIS-UJL6J29OFJONIB8]ES3/*J16I
M],D@$=2**5J%H"Y(&(IPE(J$FF[J +L=P?6K<-V?6LA6YJ=&(Q42U&C<CN_>
MK"78]:P!.5[TX7F.]9<IIS'2)<*U2;@U<_#?>]7X;O<.M'*.Y>>,-5>6S5NU
M.6X'K4@F4U7**YF3:<I!XK,NM,1@?EKHV(:H)+<-5*7*'L^;4X/4]#60'"UQ
M6L^$/.W83]*]IDT]7SQ5*?14;.5K=33,Y4N4^;M2\ ON)"?I6#-H$NGMG!&*
M^F-1T*+8?D%>?>)/#ZG=A:XZ^'C56Q=.;@SR>/Q%-IK8W$8KHM%^)$B, TGZ
MUAZ]X:D+L54USO\ 8\]JV<&ODL7DW/=I'K4L7;0^C?"_CQ;C;N?]:],TW6;>
M\A&2#FOC[2=8FT\C+$8KN]!^)#0LJF3]:^5K9?.@]$>Q3J1FCZ!U?1;?4(SA
M0<UYMX@^&Z76\B/]*V?#GCR.\"AI :] T^XMKZ,$E3FLHR<=R)NVQ\N>(?AP
MUKN(C_2O/-4TN73V(P1BOM37O#5O>1MM4&O'_%WPZWLY6/\ 2K=12(C4E<^>
M8;V5),'-;5C?$XR:V=8\$26;L?+/Y5RUY%)8L1@C%8RI*9Z5*=]SJH;Y0O6H
M+O6A"IPU<-<>(F@R,XK-N/$339&ZN_ Y.\1-:&.*QGL8Z'92^+#&V U7M-\7
M>8P!;]:\OFN7?)S4=KJCP2\M7W_^K*5&]CYB6;2E.USZ'TG6A.%YKI;>YW*.
M:\6\*ZV9-@+5ZAI=YYD0YK\KS3"RP=1I'T^#K.I&[.@\_P!ZD63-9JR\U8CD
MKR(RG)'7.5S01JF1JI1R58C>K47U(1:!^6GK4"R>]/5ZIC9-13 WO2YS6;0)
M@>::5IX&:-M2,CV^U)MZU+MII6M(B(2*8RU/MXIC+57'S%9EJ%TJVRU$RT7'
M<IM'4;QU;,=1M'28&=-%5*6'/:M>2.JTD5.(&)-;=>*SY[7K7130^U4)X>M;
M(1SD]M[5G7%N,'BNDN(/:LVXM^M=$62<?J.G>9GBN9OM+9&) KT::W'.16/?
M6(93Q73&0^AR&GWLFGR Y(KT[P7\0'MI(U,F.?6O.=2L2N<"LRUN)K.;()&#
M6JBIF5M3[E\#^.H[V.-6<'(]:])7[/J%KV/%?#W@GQY)8R1AI,8]Z^C/ WQ!
M2\B16ES^-#C[+5&56G=%SQQX+6^60JF?PKYL^(/PV:(R,(_TK[6M6@U.$$D'
M-<7XT\&PWL3X0&G',)1]VYR45R3N?G;K.BRZ;,WRD8JOI]^\<@!-?0WQ$^&A
M0R,L7Z5X)KVARZ7<-\I %=E.V(U9^K9-F"II)FY:70D49-%T>,URMCJK1R!3
M726K&Z05W4\)KH?2XS.8PAN,MV+2 8KN_#-CYI7(KGM+T5I) =M>E^&=)\I5
MR*^IP>!:LS\>SK-E6NKG1:3IZI&O%:4MFK(1BK-G;A8QQ5M8-U?844J<;'Y-
MB8NK*YQU]HGG9P*Q[CPBTG\->EBS4GD5*EG'W%958JIH;8=^R/(W\$OUVTS_
M (1.2'G!KV/[#$1]T55N-.C8<**\^65PJ:M'H?6VCRD:?+:^M._M*:V[FNXO
MM'#9PM<[?>'V;.%KSZN20?0VCC3+'BV>'^,U(OCR=3_K#^=5KCPS*W\)JD_A
M6?\ NFO+GD,;['5''F]'\1)E_C/YU:C^)$R_QG\ZY,^%KC^Z::WAFX'\)KF>
M0Q70U_M"R.UC^)D@_P"6A_.IO^%GR8_UGZUP/_".W _A--/A^Y]&KDEDWD;T
M\9&1WW_"SI#_ ,M/UJ5?B5)_ST/YUYXOA^YST:IVT&Y6,G!KDEE#70WEC(Q.
MUN/BFT?63]:SI/C 0?\ 6_K7DWB=;BS5N2*\_FU>X\_&X]:XY9?R'KX*+Q3L
MCZ5_X6X[_P#+7]:AN/BK)M)\W]:\)TV:>91R:T)HY_+ZFN25%1T/J(Y)4DKV
M/2K[XM2*3^]_6LIOBS)(_P#K?UKR;5([A<]:P_.G2;DGK710P=.I*[,\1EDZ
M$+V/H*U\?2W6,2$Y]ZU[?59KQ?O$UY!X366XD0')KW#PIH331J2N:^OPV5TI
M(_/<;BY49.)7_L^:Z'>HF\(2W'\)_*O3+'PZ% RE=!9:#'@?)7LPRJDNAX4L
M7*9XFOP]D<_</Y5;A^'KK@[#^5>\0:#%Q\@_*IFT2)1]P5Z4,!1@KI'+*O*Y
MXI9^"S#C*?I70Z?X=\K'RUZ%)I,:]%%-7357M6G)&.B#G<C"L]+6-?NU8DMT
M1>E;7V0*O2J=S;GGBG<-3%D50>E/AQ3I[<AJ2&/;57"QI6J]*U[>.LNS7I6[
M:Q\"DQ6'+#Q2/#5^.'Y:22&L9%(H1P\UH6\(VBHUC^85<A7I7-(Z8AY-%6:*
MBQL>X4445P':%%%% !1110 4E+10!$V:9MYS4^VDVT ,44ZG;:6@!*6BB@ H
MHHH **** "BBB@ HHHH 2C-(U)0(=FF-WI33*!B$4E.H/2@0BTM-IZ]:!CTZ
M4RY;;"Q]JD6HKH;H&'M0!XS\3]2:*TF /8U\$?'"4W=Q-GGDU]Z_%#3VDM9C
MCM7P=\:H?L]U+N]30-'A6BZ>4U)64<[J^C_ -]=6EK&%+#BO%/"-NEYJ:*!G
MYJ^N_AK\.CJ%E$PCSD#M4W&8<WB*^'\3?G5>ZUB[N;=E)8Y%>MW7PF?'^J_2
MJ4GPO>%23'Q]*=Q'Q[\2/!]SK<SG:3DU%\*?A7/:ZM'(8B/F]*^F-<\%06[G
MS$ Y]*T_!>AV,-VF%7.:5QGO/P#TY].L8$(QQBO:;J(36\B'H17"?#>S2&",
MH. *[75+H6=E)(3CB@D^=OC;X;MWM9W*C.#7YI_'BX&C7T_E<8)Z5^A7QT\>
M10PSQ^8._>OSP^+D)\37TNP;LGM5%'E'@WQ1->ZLD;,2-U??W[.N@P7\-N[
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M:D25Y*CVFIG7-*L=3<JPS93MM2[::<4<Q(Y*G3M5=:L1U-P)*1C2M4$DF*+
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M!Q_#7R/\>+(V_G9%=-38Y:>Y\?ZE:[M48C^]7L7PU\V"./;GI7F$@635RO\
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M";AD(&:];CMS%8\CM1$<V>+?$ZU669\BJ'PML575(SC^*M/XD-^^<5#\+_\
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M2+<Q<G/%>M&I<Y'"QY3XBT=ED9L<5AV<AM)O3FO6_$&C+)&Q"UY9KEDUK,Q
M[UO>Z,[G8^']7RRC=7H6DWF^->:\,T.^:.8 G%>H>']2W1IS7--%J1Z%!)N
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M %I_.HF^*DO/[T_G7D6V7U-)Y<OJ:G^UH]P_U%Q'8];_ .%IR_\ /4_G3/\
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MQ)9:A)IVK $X :OKKX%^-K>..$22 =.IKY?\=>%I=/OG=4(P:H>'?B!=^'9
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M96T"4&]3[=86 M2?EZ5Y!\2-<M+)9-C**\WN?C=*MJ5\SMZUY/XV^)EQJC,
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MZ&R>FI]3_"-3<6,2D=JZ+QYX"75;-OW><CTJK\)=-:UAB##'%>TR:?'<6H!
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M\%QZE;. F21Z5V=C9BU4 "M1+-+@885JUT,+NY\1>.O@U--<.R1'KZ5QUO\
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MU5@_-2QM0.Q;3)J3FH8VJ3?0(?366E5J<<4QD/>I5IK4;J0B;(I#BH]U&ZF
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M5(,RVAHC4J:O215"8Z=P1+#<%:E9_,%5U6IHZ+EB?90S9Q5VUC$;5&K5-&U
MC:M+S9BKS7F]:P8Y,8J?[3A1S3 355$D+GVKYM^-$$JP3;,]Z^BKJYW1D5YI
MXV\-KK$;@KG-*6I43\^/$E[?VNIN1NQNKT/X;^-[FS*>8Q'XUZ%XN^#:R3/(
M(N?I7$2>!9=)8[4(Q7+9Q9T73/6/^%FL;+;YG./6O)?B!XPN+XR!&)S3TL[G
M.SYL5?M? TFJ.-R$Y]JIMLI)(\FTVPO-5U!<AB":^B?A=X%;;$SQ^G:M3P?\
M'T21',7/TKW/POX.3384&S&!Z54(]S.4^Q9\+Z2-/B3C&*Z];HK&!51;<1+@
M"E4&MSG)6D,G6HFA$G:I%6G]*@"LMN%YQ4\<YBXH9J85S0461>$TOF[JKJN*
MDH)%:J[U,QJ%J (6D(J%FW&I66F'BK1(B+4ZMMJ'=1OH8B?[1MJ*2Y+"F=::
MRU(%>:,2=J;%$(^U3-Q3<T[@2&X*KBJL]P6J5US4$D5,+%<R%C5F#M5?R\,*
MLQ?+28%^.X*+45Q/YG%1[J:U)#L5VA#'.*ECCV#I3UJ5<&J A9B*%;-2L!35
MQ0.Q)&F:G6&F0FK4=0R2NT%1^7AJO%<U&T?--#&-G[.?I7@OQGLVGMY<#/6O
M?I%_=$5YEX^T/[?$XVYIRV*CN?"VKZ%+_:Q.T_>KVOX2VCPB+(Q5W4/AYOO"
MWE]_2NW\&^%?L.SY,?A6$5J=$I71ZKX=_P!2F?2NEW!8ZY[2XS#&HK6\PE<5
MT+0Y6$EUM:HS>%N]0R*6--6,YI/41-YFZD3[U(J=:/NFA#1H6TF*THY :PXY
MMM6X[NF6C5XINT9JHMUGO4BSY[T#+L0P:T8+@H!61'-5R&3-"8F6KBX,BFL2
M\@$A/%:YY%5)DZU3),/[+L/2K<-P8^E221U%LJ+#N2O?%A4/G%J8RTT4BBW%
M+BK:W!-9T578UJQ"2?/GBJLD YXJ_MJ*2D,H[-M/28QT]EJ%UI,DL?;C3&Q+
MUJJQP:ECDQ1<=BS';@=JOP-Y?2J4<U6%DI@7&NCC%4;AMU.9Z@D:@1"W%/CD
MQ43')I5J;$V)VES4&ZG$U'2$*TAQ528DYJS44BYIB,UU/--45;>.HFCH-$3V
M[8Q6K;S8 K%CRM7H)#5) S6\S<*:W-0QOFIAS3 B9:3&*F9:8RT )NI.M(33
M0:3121(HZ5*O2HE/2I%:LP)-QI-U-W4=35"0F:>JFA5IZK0-L<J<4R1*F4TR
M5N*1)GS#DU7QFK$U1*.:L9)%%FK2P<4D"U;4"@"JT/RU3N(>M:DF*IW"C!I#
M,2:+K4*I\U7YEYJMMYJ0)8>U78VX%5(5JY&M,@?FDQ2T4%6(F6HF6K6WVJ*1
M<4@L5V.*9YF#2S-5;?3)>A;66I#-5-6I6DI@+--54R?-22M3%&XTP+<+9Q5G
M;E:KVZ]*NJORT#*,RU5;K6C,E477YJ"0CJY$N:JQKS5Z!:EB)5CS08:L1K3]
MM445/(]JECAYJ6GKC-"$/CCJ4PT1U..:3**4D-1>36@T8-1M'4@01QU848IJ
MI3Z8A&-02/UJ5C5:2D58C9ZB+4YA496F1+04-0PXI56I-G%49W9FW,>0:Q[I
M<9KHIH?EK)N[<G-:(#$=N:%8U9>U.:3[*?2J$5RU&:G^S&FF ^E.Y$B!ES4#
MQ[JOB"C[/018QIK:J$T)6NDDM>.E9]Q9^U:JPC"8[::1OXJY-:D$\5"L)4]*
MM2:V):*KZ2MP#D5@ZUX;5$)5:[.'Y1534F1HR#45(*HO>,E>,KH\?OFDTV0D
M9&*U/#OCUK*90TF/QI/%Z1*CGBO'M8U=K.X)5N]?%9C@X:M'U>"K5*R4#[+\
M'?$R.944R?K7J^F:E%K$ !(.17Y\>#_'TMO<(#(1SZU]-?#GXCADC#2=AWKX
M.M%TWH?3K"ODNT>H^)_!,=]&S! ?PKPGQQX :W:0K'^E?2VC^((-4@ )!S6;
MXF\,Q:E&Y" Y]JSIU+Z,\]Q<9'PUJFBRV<S?*1S45C>FW?#'%>\^-OA[Y8D9
M8_TKQ/Q!H$MC,V%(KK^KJ>IU1EH;FGZLK*!FMRWNMP&#7FEG=/!( 3BNMTS4
M@R#)KFJ4^0Z(G80W&,<U?M[C/>N<@NPW0UI6L_2O*DW<VL=!#+5R*2L>":K\
M,O2M(*YE)&FCU*K]*I1R=*E62JDK$EU6J7=TJI&_2I5;I60RPK>]2"JZM4BM
M64@1-3ZB#4_=68P:HFJ7K3=M6A$.TTA%3%:::8$#+[4PK4[4UA3N,K.OM4#+
M[5<9:A>.F@149*@DAJZR5$R5:&S,E@K/N(?:MN2.J<T.:JXK'-W-OUXK*N+?
MK74SV_7BLNYMNO%4K$;'+W-MNXK$OM)$F3BNON+?KQ6;<0<=*UBVAWYCSG4+
M5K63*C%:GAOQ+)8S+EB*T=2TOSLG%<S>6!LVW 8KL4N96(]D]SZ6^'OCX;8P
M7_6O=-&\0)J$*C=G(KX,\-^*GT^=07Q@^M?0/P^^(2R>6&D_6N:4)P]Z**<H
MVLSW76-!34("=H/%>/>,/!9C9V5/TKU_1?$D5];J-P.13]4T5-2B8[0<UKA,
MQJ4JMF>/B,-&>J/E>:UET^XY! KHM%UH1@ M75^-/!QAWLJ8_"O+;Q9=/N".
M0,U^KX#'JK!79\S6HNF]#U*QU 3XP:VK=^*\U\/ZQ]T,:[BSU%9 ,&OH%*,E
MH>?;4V_O"FM#FDMY-U7(X]U92B;Q,]K?VIGDUK&W]J8]M46+,U4JW;K0T..U
M/C^4T&31=A45-M&*KQR5)YG%6-(:ZT*O2C=NJ2/%(L3RZ:8ZLJ!3@@J645E4
MBIU<BI!#2^74MEI(C,IQ43-4C+4++4:A9$D;9JW"NZJ<:U?MUZ4RB=8<U')!
MP:N+39!4",J6&H/).:T)%S35AS3U J"$XZ4>36@+?VIC0XI\PBFL52K'4OET
MY8Z?,%AFV@+4IC.*85Q2Y@%&*<S"H&8BHVE-/F$/E(-4Y!4WF9Q44E42$/#5
MH6[BLI6^:KD+&N:1TP-+S**K<T5F;'N5%%%<ATA1110 4444 %%%% !1124
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M58K3E;-*W2AB8S;2"EW4*O- (<%I=M*.**!BJO%#"E7I0U(")J;WI[+2;:$
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M21U%MI6 DC:K*-5=%J84P)&DJO(]/:H)*1+#=FI%J):E7BD2*QJ)FI[5$PI
M)OZTPO2-WIAIB9)UH\L&H@^*>LPJK#0_R:ECCIBRAJGC8&F6D3PCI5E*ACQ5
MA>U(04UA3V:HV:@1"WTI@J1C3*&4.4TY6J.G!J@9*#3U[5$&IZM0!,HIU,5J
M<33(#=4<C<4\+2/'2&BC+WIB]:GECZU PQ3119CD JPLU9ROBGK(:8%QY:JS
M24UI*KR24Q7&2-487<U.^]3XU^:I$20QU:6/BDA2K(7Y:3&B#;2[:EVT;:10
MT1^U0S1\&K@7BH)AP:9%S(N%-5-IS5^X6JXC]JI#8B+Q0R&IXXZ<8Z&09[1F
MG)'5OR:3R]M%P%A7&*MJ.*J*V*F62I$$RU1D6KS-561:8R%!@U=A-5!UJQ$U
M,9H1MQ3F:H$:B1J1'4<TG-*LE5V8U)'5%EV)JLHU585JW&M2QDB\T%<TH%+F
MD S;BHVI[R57>2F(&J-EI=]/49I%D!BIC0GTJ\L>:&A]J1+U**QU,L7K3_+V
MTY3BF18KR0BJ4UKN[5J-S4945=P,4V.>U!T_VK96,4\PC%7<5C :Q]JA:Q]J
MWY(1S59XQS3N+E,4V>.U*MK[5J&'K2>2*+DN)E/;#TJC<6H]*WI(Q5&=*T3(
ML<Y<6?7BJCV>,\5T,D.XU%):_(3BFF9LYR91"IKCO$NM+:HWS5U?B*7[+&W:
MO$O'&L,=ZAJSK5E")ZF!P;Q$U$YSQ7XL,K.H:N NXWU!R1S4UYYEU<'D]:W=
M%TG<OS"O@<=C'*5D?M&4\-QIP4Y(Y6WM9+.0-R*[KPOXSDT^1 9",>]4]6TT
M)&2!SBN+O))+6;(R.:\"WM'J?08O*DJ?NH^POAY\3@WEJTOZU[[X?\30:E N
M7!R*_.3POXNEL9$^<C\:^@OAS\33F-6E_6L:F'Y=4?FV*PSI3=SZ=\0:+#J%
MNQ50<BO$O&WP_P#,WLL=>N>%_$T6J0("X.1ZULZMHT-];$@ \5E&NZ>C/-;L
M?#OB+PS)I\S$)C%8,%X]M)@FOI'Q]X+#>:53]*\$\2>'Y+*9B%(YJ95/:&].
M1H:5J/F8YKH[6X! P:\SL[Q[9\'BNLTK4?,P":R^KWU.M,[.WN*T(+CWKGH+
M@;>M7(;CGK7-4_=B9T<-QNJW')6%;W%:4,WO7/S\Q!IQM4Z-5&.2IDDIB+JM
M[U*&JJC]*G5LU+0B=6IX8U$IIZUG86I*O-+M%-4]*?F@0RDVTM% #"M1LM3$
M4UEH BVYIK1]:G"TI6F.Y1:.HFCJ])'4#K57+91DCJL\5:#K4#+5B,R:$5G7
M%OG/%;DD=4YH<YIDV.<N+7KQ69<6GM74RVW7BJ%Q:>U7S%Q1RTUF,'(KEO$%
MF/+;BN_NK?:#Q7&^(OEC:O4P%/VU11#$5/9T[GENI3-9S$@XK;\)^.);*X0>
M80,UA>(/G=@*P[6&2.7<,U^MX;A^-:AS6/SNOF<E5LC[)^''Q$$RQAI?3O7T
M-X<UZ&\MERP.17YU^%/%DFES("^,>]?2/PW^) F6)#+^M?!9ID;P\^:*/H,%
MBU65F?0/B#28]0A;:N<BO%?&G@XQ.[!,?A7MOAW5(M1MU)8'(JMXGT6*\A;"
MYS7C4<9+#3Y3MQ&%4XW/E*8RZ;.1R,&NE\/:X790S5K^,/!SQR.RI^E<)&DF
MFS\Y&*_0L%CU4@M3Y>IA^5GM&EWBR(.:W;:0-BO*_#^O[BJEJ]&TB[$JJ<U[
MU.HI',X\IO1QAJ<]OQTI+>0'O5T*&6NEK0@QYH<9JFWRUMW,(YK)N(L5R2W+
ML0K+@U*)?>J;?*:/-K2(F7?,J6.;WK-\[WIZS'UI@:JS5/',*R(YC5F.4U++
M-59!2-(*IK-Q1YU24BSU-+Y>ZJZ2<U;A85(Q4AJS&NTTL8'%2A120#E;Y:9(
M]!; J%VI '5JGACSBJZ]:NP=JH9((JAFCJYQBJTS#-9LDJ[*DCCI54&K$:CB
MD!'Y.14;P5?4#%,910-&5+!562$BMJ2,&J4ZBA"9EM\M5Y7JQ='%4)'R:W6Q
M!/"NYA6M:6Y:LVQ7<PKIM/MQ@5SR.B)"+(^E%;8M1BBLC>YZ31117*=(4444
M %)FBFT /HI%I: "D:EI&H C_BIZTS^*GK0 C=Z94K4V@!E-8TX]*C;-1S -
M8T@ZT;32JOM3 <M2*M(M2#%, "T^BBA %%%%, HHHH *1J6B@"-J2G-WIJT
M#+Q5>2.K6>*:RT@*JIBG@5(5I"/2EL VBBE7K3 -M1..M6!3&7K0!5(.:50:
MFV"C;4@(O:GT8HH **** $:HVZU(U1MUH *D2HZ>O6F!+4;4M% $#+4+1\U9
M.*3;2 A5<5,O:DVX-*M,"1:6F49IW 1J2BBD 444+UI -9:B*<U9Q3"O-0!&
MJTYDJ15I2*8%;932*F:HF/- $;5$S&IB,U&R4 (KFI V<4Q8ZE5*  +FG[:5
M5Z4^@5AN*8S5(U5Y#0,1FIH[TW/S4]>E $JM2EJBS1DT /W5!)4G-(5S0!3;
M-"YJPT5-$>#0!#M-*,K5@1BAHZ0@B:I]V14 0BG\U(QDBYI%2I** $6,4NW%
M+10 E-IU(W2@!M.6J[2X-2129H FJ,FI,\"H6[T )NHW4E)0 ]6IRM45+F@"
M7=3&--W&DS0 C$TJTQFYHW4 3*U.J%6]ZE4]* %P*3;3J* '*Y%#RGFFTAH
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MI:!LNB6G;ZSUFJ99J5P+>ZEJNLF<5*K4Q$R]J>&J$-2,]%QD^^C=57S*=YE
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MLT]%H&(JTIJ3;@4QJ"B)A0J\T_%.5>E7< 1:E"TBX%.5J3 3;3=M2YS3=M2
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MZGA;<M4M68K?./>K%N?D%?/]3]GM[B99[U%>?ZLT]:9=_P"K-,/LG)WO^O\
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MKHX<5Q)&5!QEU.B\*JT&D@,,?+7B/QTF#12_C7TG/I T_32 ,?+7R]\<)?\
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MZDIW :M.HQ13 *1NE+10!&PI,&I-M&VD!'S14FVD(HL RBBBI =36ZT9-(U
M#:1FH:HS0 C$TJ]J ,TZDP ]*C;%/:HFS4@&ZGC%0C-2*:8#LXIC-0S&DH 1
M<U,N>*8JU*%PM $BFFL>M,+8I-V<T"$:A:1J%H F'2EIB]J?0,:RTF*?2-2
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MK[1UV^B&D, P^[7QG\:%6:\FP<\FO1QZ7)8^*X/D_K3E(\I\%J?[07ZU]/\
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M&2J(7::GCSBL)&Z+OF45#14%'KU%%%<1VA1110 4444 %%%% !1110 4444
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MH 3;Q2M0W2F;J8 U)3MU% #:*&ZT+UH **?24 -VFEVTM.XI 1XQ1BGG%)5
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M?#N>XFC/EGK7T3X/\$RZ;"C%2,"O6PE.:=S\[XDQF&G%POJ>Q6OB+9IH!?\
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MF RFU)MINR@!M&,T$8I5H -M!-+3: &,U1$YJ5AFH]M(DD2G.WRTU139,XH
M8TG-(6J,YS3NU,=QC'%+&U-DIJ4#1<W';4,TFVGJ,BJUY\JFA*XRI<7749K)
MO)-V:6ZN"&Q5*XF_=DUV4XF4V8FM7@AB;G'%>&?$+6<!P&KT_P 7:CY,;<U\
M]^.M3,TCC->S21YM21P>HWIFNCSWKJ?"MOYFTFN-2,S7/XUZ+X1M=H3BMY''
M+<]!T*W"A:[C3X_E%<MI$6U5KK; ?**Q8TS7MQQTJ8FHH6^6E9JS'<CE-5)*
MGD:JLK5I$EE>0U7:IY.:A:MB".BEVFDI6(N.I&Z4M!IE##0%IX7FEVTA#5HW
M4ZF'K0-#U:I U0 TNZD!-OIFZF[O>FT@)UDJ59?>JBFG!N:M"+7F9I&Q5;S<
M=Z<)LTF(EP*=MIBMFI*5QC&6HG6K!7BH9.]!5B"G"FL:0-S31),%IC+3E:AC
MFAC(66DVYJ1J1:-@&>7Q36CJRJ@TK)20%!HJA,5:+)431BJ#<JA*E5:D$=/$
M>!2 :M-9JDQ3=F:8"HU/S0D=.*5(#0?FJ>)<U!M^:K,(JA$PCIDB587I4<G0
MT"*$WRU4=\5;N>]4).](8OF4ADJ*FL:8A[24Q9#4;-0M,HLJW%.%1)4G\-*P
M#]U,:3K3':H6DZT@)=VZGJM0Q-FK<:[L52$,$=/7BI_*IK)Q4M#&-)@5$TU$
ME1[330F*K9-3)4:ITJ1?EIL=AQIA:D=NM1[JFP#Z=]*8O-2A?EIDV(V-1,34
MK+3=E/0H1*LQK3(X^:M1QTA"KFG;L4_RZ8RTADBR5,K554&I5[4R28M43/0S
M5 S4#',U(*9FGKS0(>LF*&EIA4U$V:5ACVDIIJ/=2AJDHE%(S4FZFL:LD8S4
M8YI*=0,*B9JE;BJ[]: $W9IP6HU-3QT@&^72,E60N:1HZ: J[:7%.88IM.XA
MZU-NXJOG%.WTADC-43-2LU,:@0FZDWTQLTS-,T+*M[T[&:KJU68>:8["-'3&
MC-7HX]U*T''2I)N9C+BD[U<>'GI4?E4@N-C6K$:TD<=6$2D,1:&J7932M*Y(
MQ14T8Q3 ,4]33*)E-/W5$K4ZIN);CF:HF-#-3:8QK+4;+4U1M3 CIK4YNM%
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MV8T\)3I.]B8W#S9W4;1Z4JJ*5JDZM%L)11103<****104AI:1J"1-U.IE.H
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MS05JI <K=V_!XK#O;4-GBNPO+?KQ6'>6_7BM%(EG :Q:E,E14&AZA)9W*G.
M#72:E9;\\9KG;BU^SMD"NBG4Z&5M3Z ^&OC3RS&K/^M?0^B:Y%J5FH+9R*^#
M_#7B%[.X4;L<U]$_#OQ@95B#/^M54I\VJ+<4T>C>,/#:7T+LJYKP?Q/X:>QG
M9@N,&OIRSFCO[09(.17!>./#B3([*M=6#Q[PLK-GD8BC<\1TG5FLY I.,5Z=
MX7U@7 3)KS'6](DL[EB%(YK1\.ZT;1E#'&*_3\OQ:Q<3YNM2Y6?0.FW0VCFM
M^TD#@5Y7H?B(3;1NKN])U 2*.:[ZD>5F,3HFB#+6;>6OM6E;S!U'-)<1[EK,
MHY*\M\$\5ER1X:NGOK?KQ6+/#AJN(6*D:\U;C7BH57;4T9K;H*Q,JU.B5&A%
M3*PK!C)56@\4*U(S4QH:SU%))22-59Y*8PD;-5GYJ7.:<L>ZI$5E2IHUQBIU
MAH\O;5] ZDMOU%:4+=*S$;!%7(9*YY&T2_YE%5O-]Z*S-+'L%%%%<AU!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4E#4V@5Q]%(M+0,8W>F-TJ1J8_2@")JA:IVII6D#1 *<*=MQ3:D"6-J
MF4\U67M4RU2 EIIZT9-)3 **** "BBBF 4444@!NE1L.*D;I4;5# ;M%/5:8
MM2+3 :W%)3F[TV@ HHHI ,-0259:H9%J@*K-@TU9/FI95J'!W5(%M'SBITJK
M$*LQTP+"TUJ532-5 ,'WC3QTJ.EW4@),TUJ;NHW47 &H6DHK-@#5!(M3TTKF
MD! !3A4GET;*8$39IJU,RTS;S0 Y:=2+032 ,"E4<]*0-3EIB%P*0]:4TQB<
MT#$;K24Y:6@!E%/Q2;10 VF/T-2GI44E %.8FJ^XYJW(N:K2+MH 3S,4PS=*
MBD8U%N.: +\<IJW')6?#5N/M0!<5LT5&C4_M0 UN]1M3V-1T *M/%(JT\B@!
M**;2KTH ?36[T^F-WH C:FL,T^B@"+;[5(M&VEH <O2EI%I:!!3J;2[J"1:1
M@*-QHS0 T]*;3FZ4VDRD-IE/I*D8VE6G!:&%,!&Z5&QI6Z5&U" *5:B)Q3U-
M!-R9>U/J-:=2*$IU%+3 :U"]:&H7K2 =1110 RBE:DH%<?44W2IUJ"XH&9\T
MG-$9)ILB_-4L,=,"Q"<58W56Z4]318"5N],IW:D-(!5Z4M(O2EH **** "BB
MB@044455QK4****D8[BHVI],:D(C9J :1J$%,5AW-&TT]5I=M4,3%**6BI$%
M%%% PIK5+3&[T"(]QIRFFM24Q$P:D.*A#5(&I#&M2KTH:D6@0IIN#3Q2D4RB
M/;[4QEJ1J2@D04UQFGT8S0,KF.E*_+4VVFLM!)5=::J^U3LG-(L?-2:Q)(UX
MJGJ'^K-:*?**S=4;$9K>$;A+0Y2^DQ(:H7<V(3]*EU&3]X:R[Z;]R?I7H4XG
M!4D>;>/+_8K\UX!XENO.N&&>]>R_$*?A^:\+U9M]T?K7IP1YTV)IEKOE!Q7I
M/AFVVA>*X;1(LLIKT?P_'C;6LCG;.TTV/"K726? %8.FK\JUO6U8,I&E&W%*
MS>]11M3ZS+(Y#5:0U8?FH'6M(D-D#"FLIJ;;2[,UL9%;93*LNM0L,4QC N:D
M\OBA:F6H+(_+I"E6>*9)BJ)M<JLM1FI)&J!FIL +<T!O>HRU*K5 R:BF!J7>
M*H0ZAB*;NHZT"0UVIJL:<R%J5(^:!D\9JPM0QKBIQ2V "W%02-3V:H&- $34
MW=2M43&F,E62G"2JN[%/5NE.VA)8W4Y:A5LU-'2*)%I]"K2M021-4=/D-1;J
M+%CJ&;BF,U1-)0!+N&:DCPU4P]686Z4F!<CCI6CHC:I1@T(DK>7\U2)Q3V6H
MV^6@9+YF*9))4+28J)I*0#)FS5-^M69#FH=OS4@(PG6FM'5E4I3'5=!%%HZ%
M2K31U'MHN%AJK4FWBE1:EVU0BI(IJNRG-7I%J!EZU+*(8^,5?@;I53;BGI)M
MH0&FK5&YXJNMQ0TV:H!6&:15IF_)IZM2$.QBF.:=NJ-C28R-FIJTI%"K0431
MU,/NU"M2;J+$W$9?:E5:6E6F!)&M68UJJIJS&U*P7)]M,9*D5N*,T6%<BV45
M(U1,: &N:@:GLU-I@(H-3(*8M2KB@!=OM4,BU/NXJ-O6@"JR\TW-32+4#TD,
M<K4M1*>M2+1U =2GI2TPFF UN]0O4C&HFI ,_BJ6-L5$:,XJ["N7$D%*T@JE
MYFVE\VH91.QS4=-WYIPID"-29-.--% #Z2G+TIM T-9>O%1LM34C+060XJS"
M:AVT^/@BE<HT[<C JQ@$52@?I5GS.*9F,D05 RBIW:J[M058<F!4\?:JBOS4
MJ25 RUFF,14?F<5%)+[TK"2)&>CS*IM-S2K+3&7E>I U4TDJ=6J;$V)&:F]S
M0S4B\YJBARY-#=*>HI"*2$B!N]-J5AUIE4,<M2I4*G!J56J6!.K<U.C563'%
M68\5F63J#2-3E(IC&FB2&0U U2R=Z@:D(F0U90\525JL1M0 MQC;69<8K0F;
MBLZ<')JBD0I]ZKUNV*SP<&K$<F*0F:BRX6F/-FJGG4SS,]Z8(G=MU0-3E.:7
M::2&0MUJ-LU.RTS9S5C+FGKDUE>,H?\ 0W^E;NFQ\UE^,H_]#?Z4^A$CY$^)
M\>+B6O+[?_7'ZUZM\4%_TB6O*[?_ (^*^1S;X3]?X#_WA&S#]T5)4<7W14E?
MG_4_KG_EW$6BBBF9!1110 4444#"DI:*"0HHHH&%%%% !1110 4444A,****
M8!1110,***=3 ;12M24@"BA>M.H ;1110 4A[4M%, I5%)12$#44A:F;Z"B2
MGK;F3M4:-N-=+X?THWDB@#-7%<VAC5J*E'F9A_V6YYQ43VK0]17K]OX'9[;=
ML[>E<;XHT(Z>6RN,5K*DXJYYU',85I\B9QVX4M5Y)-LA%3+TKG/7L.I",T4F
MX4"&F.@1TNX49H+U%"TZF4^@@**** %6EIN:3=0,6BFEA3=U [$E%-6G4[DB
M%L5&TF*>5W&I8=/>X(P*-QW4=65O.%/5]U:(\.S;=VTU5DL6MV.12LUN0JD)
M:)C%C+4\:>9>U6K&'S7 KMM$\,FZ4';FKC#F.2OB505V>?-I++SMJ$P^7UKU
MC4/!K0PEMG:O/-=L_LDA!&*J5-QW)P^-CB'9,RU:G56CE!;%3AA61Z,HCJ*2
MEH,[!11104%%%% !1110 ZD:DR:* "BBBD 4444P"BBBD 4444QA1110(***
M* "BBB@ HHHH *=3:,F@ ;K1110 4444 2+UJ*\_U9IZ'FF77^K-(T7PG)7O
M^NKK/!38ND^M<I?_ .MKIO!K?Z2GUKW<O^)'Y#QC_!9]6_#*;$<5?0?AV?\
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M58CFIC+)[4S^*FF2F^9S2 G6EVTR-J?FF*XA&*2GXS2;?:D,-HI&I=U,+<T
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M110 4C4M(U #&I*5J2H **** "BBBF 444J]: #;2[:<M+FF S;366I<TC4
M5RM&VI*3 H 9MHVT_:*7;0 U>M.I<&DI@%-:G4UJ &M24K4E0 4444 %%%%
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MI&FZTSSJ3 9)#FH&M_:K:L&I& I(92\O;2]*EDQ4+4 /7I3)#MI=W'6H9FH
MC:2E5ZK.W-/C)IB+J&IEJO&:G5J&-#F6HV2G^93&<5-AD1&*;FE9A4;-30KC
MF:HV:@M[TQC5#Z#'.:CQS3S28I"'1BIEZ5&O:G4,+"M3*<>E,J1W)%JQ&U5,
MU(KU1)=##BEXJLK]*D5J $>H9%J>F,M*Y149<4VII%J)A5"'!J>&J&GK2$2=
M:B>/-2KVI^W-"8]RGY>*2K3)4#+[4QB T]>U,534J+0(D7M3J1>*&-(8N:*:
MM.H :>]1LW-.:H6;GK4FA(><4A3-"]:G1-U(17\JG".K/ETW93&,5*E1:%45
M(M #EIZTQ:>M(ADB]*<.E-7I3Z@ J*2I:C9:I#*S=Z133Y%IBCFJ&6H>U7(U
MSBJ4-78SP*D@<R5 R<U9W"F,HYH A"[:=3MM,:K*1%)3-IJ9J:%YK-B%CJ8?
M=-1BE+<=:S*!L4(HIISFI(P:H9*J5(J]::O:GT"'4R0\4N[WJ-Z0%.X[UG2M
M@UIS+G/%4)X^:8T6M/FVUE>,;C_0WY[5?LU(K#\9,?LK_2FQ2/EWXF2;KB7Z
MUYC;_P"N/UKT;XDO_I$OUKS>U_UU?*9M\)^O<!+_ &A&[%]T5)3(?NBGU^?]
M3^NO^7<1:***9D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% T%%%% !1110(**** "HI)-M29JG<9W 4%Q5RY;QFX8#K75:#X/DU!
ME^0G/M5+P;I+7UP@QGFOISX<_#Y7BC=H_?I79AZ#JL^6SC-HX"+UU//M ^$K
MS*I,7Z5TZ_"?R8^8_P!*]ZM](M-)MQO"C K&U37K"/*AEKV5A806I^82S_%8
MF?N;'A=W\,=SX$?Z5U_@'X<O9W2-LQSZ5VEGJ%G=3#E3DUZ-X3M+5MI4+5T\
M-!RNCDQ^=8F%%PD-CL6T_2=I&/EKY:^.UQN,_/K7V'XHC6'3FV_W:^+_ (X.
M6EG%/'>["QGPE+VV+YV?,EW*3?L/>NO\.>'WU38 N<U@V^CO=:EPI/-?0OPJ
M\&AO*+Q^G:OFZ%)U)6/W7-<?#!T.9/4R?#_PDDN%5O*/Y5V-G\*C H!CQ^%>
M\Z+HMI8V:EE4$"LC7M;L;%B,J,5[RPL(1NS\@J<08K%5'&!Y/+\- RX\O]*P
M=5^$;2*Q$7Z5ZW;^+K&64+N4\UU^EFRU*'HIR*?U>G/8B6<8S"^])'QAXB^'
M<FF[CY9'X5P&I1FQD((QBOMKXA>$H)K>1D0=*^4?B%X;>VN9,+@9KR<3A_9;
M'Z%D6<+')*HSC[.3[2P%=9HOA)]0883.?:N>\-Z>QNU4CO7TG\,_"J7"QLR>
ME94*/M7J>GG&8+ P<D<=HOPG>95)B/Y5UUI\*O)49C_2O<[/1[/3;4%E4<5D
M:MXAL+7*AE%>TL+""U/RR>?8K$SM!'F,?PU#?+L_2J^H?"$R1DB+]*]$L?%5
MDTWWEZUVVE:E8:A&%RIS51HTY:'-5S7&X=\UF?(7B;X826:N?+/Y5YG?:"]G
M<D%<5]]>*O!T%]:NR1@\>E?,GQ&\(C3[IR$QS7!B,+R:H^SR/B%XOW)O4Y3P
M/I/VB>,8S7U1\,O"9V1L%KYO\"SQV]_&K8'-?8GPOOH&MHN1T%=."A%L\+BS
M$U81?*;VIZ$5L"N.U?.OQ/\ "AF>4[:^K]6N(OLIY'2O!_B-=P+YF2*]+%07
M*?"\/XNK&M='S-;Z%]COLXQS7NWPS<JL:UY9?7$37QVXZUZQ\,83))'@5X^'
M24]#]&SFK*IAKS/5-2T5M2T\@#.17A7C3X5O=7+MY??TKZLTNSC6P!<#I7&>
M+I[*W9MVT5[%:C&4;L_.,LS6MAJSC2/FG3?A7Y;8\O\ 2M.Y^$!N(B1%^E>F
M1:U8_:,!EZUW_AUK*^A&=IKDCAJ<M$?1XK/,91M4=SXX\3?"J2P5V\LC'M7E
M^L:.UC(5*XK[^\>>%;:XLW*(IXKY1^(OA;R+B0JG'->=B<+[/8^SR#/WC/=J
M,\:7(-*&S4]_;FW<@C%4HWRU>5L?I$?>5T6****!!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 JU'=?ZHU(M
M1W7^J-!I]DY2]_UWXUV?@4?Z1'7&7O\ KOQKM/ G_'S'^%>YEWQ'Y#QA_!9]
M5?#6,>7%7NVCQ@0K]*\*^&K?NXOPKW32'_<K7Z%3^!'\JUOXS+=UQ4$9J:Z[
MU!']ZJ LJ.M(RU(@S3G2@"FW%,W5)-Q4.:3&2*W2K,8S5->M78:8$RQTC)4R
MCY:;)4$,JNN*9BGR=:C!YJRT/VY(IRQYI%85*K"D,58:<L-/5Q3U:F)B+'3]
MM"D9I^:!HKR1U6DCYJ^W-1-'044/*J6.*K'D\TY8\5(B(1T,E38IK50%;;S2
MA:DV_-3E6F25V2JDT9K4:.JTD=22S+\GYJDCA]JM^3S4RP\=*8(J"'BF21'%
M:/E"HI(^*"C(DCI(Q@U=DBJ-8>:3$20]JM+TJ*.+;4O04QCMU!.:B9Z%:@3%
M9:%CJ1>:D51Q4B&+'362K&*1ESVH INM5W%7I%JO)'1<=RFV:%S4I3VH5* '
MPU;C[57C7%6%K1#)1Q44W0U+NJO-T-2RBC/58+\U6I%RU-CCYJ1C[=#6I;KT
MJI#'TJ_"N *HFQ,.E,:G]*8U R-EJ)A4Q-1M5$D.VI%6A1S4JKTJ2K@%H/%/
MQ[4U@:5Q,;NYIZR5":%S3&BV&S2U K4_=BE8HGQ37%,$E(TM-(DBD6JSK4[R
M"HBP-,1%LIZK3\"EQ2&)MHVTX=*7;09-E>1:K21FK^W=3&AJ2TC)=#3=E7Y(
M:@,>VJ K^72&.K!XIM %<K3XR13RE&W%!5BS"U7(VJC'5E6XH'REG=2U"K5(
M*"1],;O3J&H @9:CVU89:;M]J0R$+S4BK3MOM3PM%@(=M-/%6&7VJ*1:8%65
MJ@+'-33*:AVG- B1,FIE6FQI4ZK4E#0M2**3BE6F!/&>E3QFJZ"I%S3N*Q:#
M5!,WRT>94$KYS0,@F>H<_-3I,YI%7FBP#TI]"+3FZ4$C.E)NI&IHZT%$E+0H
MS2[302.63%2>=\M56XS30YJ!ELR9IN>142DU.J]*"1ZTUUJ95XIK4D4R'RJ>
ML-2*.E2**";#%CZ4K)Q3]P%1225H.Q#(M0=\5+(^:B_BH*)%:IE;VJNJU("1
M023[JCD:F[J8S<5(V5YJB7DU))3!1<@GCIS-4:TC$TT(&>I8ZK<YJS#VIE%N
M,5-MJ)"*=OH "N:1D%)YE+NH&5)XZI21UH2U59?FH K>74BQU*(ZD5*.4=Q(
MUJ5>*% I2::$&X4'I3:*!!36IU1N:0[$,C5 U3,*B9:5RK#HZL)5=>*L1TA,
MF44N,4Y.E*PH$(K5*'JO3E8T 6"V::R]*:IJ1>E2,9Y=.5!3UH)% -#/+&*8
MT(]*EW>]%,1%Y J"2WJ\.E(R;J8[%!;?GI5J&'&*F6&I%CZ4A L=-=*FIK<T
M(JQ!Y=+Y56%49IVT50C.F7BLJ[X-;T\=8]]%UI@8TDNUJ?#<_-UJO=*5:J\<
MA$E F=19S;L5H[LBN=L9L8YK9AEW+3L VZ[UGR/AC5VX^:LZ;-2P)H9JT(9J
MPUD*U<@F/'-"&;:MN%1S1[@:BMY,BK7#"F#,:ZM=V>*H-:?-7031BJC0C=0(
MAL;?&.*U0H5?PJ"%0M32R86@"C=,!FLQSEJMW<G6J:_>-(9-#'N-6OL^5Z4V
MU7)%:L4.Y:91CR6_M5<Q[36[-:^U9\T&#00RJM(W>I?+(IC1GF@@A8X(HW4Y
MD--"F@8O6GJE"I4RK[4#$1.E2QK0J]*FC6@"Q;QYQ6C#;[E'%5K5>E:UNHVB
M@"LUK56:UVYK:91BJ=PHYI#,&>'&:I2)6O<KR:S9L4#1#'QBK4355J>/-(;+
M744NRB,9J9>U(E(A,=*(JGVT[;2 ;"G-7HQ\M55XJ9'XH&2R#BJDB]:LELBH
M9*9)5*\TY4Z4\CGI2KVI,:'K'TIS)0K4CM3**\B]:JNM6I#4++F@EE5N*C+5
M9:.H6B]J!"*U68:@6/%3*VW%,"ZE/:JJS5,LFZI+1)MHVTY>:=B@!@6E\NGJ
MM/VTR;D&VCI3Y/EJM))MIB)=U.7YJHM<#-30W )'- &@D.:F$-10S#CFK'F"
M@")HZK25;D<&JTG-2,KTC5)L]J1H^*0%9J8U3.M0/5#0QJA9<U(:3&:I R$Q
MYIAA%6_+XI/+K1&$BHT/2HWCQ5]HZK3#K5F9GS"J4RU>F[U49<U:%8H2)FJ-
M]:+)&1BM9XZJ3+6ES,\Y\0:/N9B%KE/,?3YL],&O7+ZQ69#D5P'B71R"Q5:Y
M,3@XUX;'HT*W+H=!X/\ &#)(BEZ]J\.ZDNH0KDYS7REI\LEA< G(YKV#P-XN
M$8C5GK\GS;+WAY.21[M&IS'J/B3P[%=VK':"2*^=?B-X,V-(53]*^F+'4TU*
MW !SD5S?BSPD+Z!VV9R*\K"8AI\K/4B?#FI:?)8W1XQS6CI>J>7@$UZ1X^\$
MFWDD81X_"O);JW>RN",8P:]:M352-QM:G?Z;>>:!S6[;S=.:X#1=0V@ FNIM
M+P/CFO"E3Y6=-,ZFWN/>M*&:N;M[CI6K;S5FT;-FY')5F.2LN&;I5R&2LVA&
MI%)5@-6?"]65:L)("QNI^ZH >G-/6JB)EA34B]*B2I5Z4C,,T9%-;K10 ZBB
MBE< IK=Z=2,*8$3=:C(J=EIC+5(I$%,9:F(IK#VIC*DBU4DCZUH.OM562.@:
M,N>/K69<0]>*W9HZH30]>*J,C0YRYMNM9=U;_*>*Z:YM^O%9%U#UXKHC*YE(
MXG5+#S,\5SLT;6<F1Q7H5Q:!L\5R^M:?P2!71%LYV;'@KQ2]M<1KO[U]-?#W
MQ*+N.,,V<X[U\9V,C6=P#G&#7LGP[\9?9Y(U+X_&NCEYEJ96/K:YM(KZSR0#
MQ7BWQ#\-#]X57]*]"\+>)1J%L@W9R*L^(-#&H6[-MSQ2HR=&=T954I*Q\E7=
MI+9WAX(YKM/"^L&((":T?&?AG[+([!*X>"Z-G<;>F#7Z-EN.51*+/F<1AVG<
M]WT/5/,5>:["TNLJ.:\<\*ZMN"Y:O0['4,J.:^IE%.-T<$9\CL=9N#K56XAJ
M.SN-^.:O,H9:XM;G6GS(PKB/;FJ,@K9NX>M9DT)JEH8RT(8SC%7(6JEC%686
MH T$/%.J&-N*E#5+ 1HZC,76K"X-.V9IHFQ4$=2*N*F*4QN*OH-#XNHJ_$16
M9&W/6K\+5SR-XEOBBH\FBHL:'K%%%%<9U!1110 4444 %%%% !1110 4444
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MJ8U*W>FCF@!**?MI=M 7(Z*DVTA6@:8RBE;BFAJ!BT4JT&@08XI&6GKVI6%
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MIF:1S4>Z@9*6J"0YIVZC;NH&52G-2QQGBIUA]JF6'VH$1*N*?NQ4WDXJ.1:
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M>] RV6J*0]:C$F:4M2&,QS4JK4=2*:I$CU6I52FJU/W4A@8ZC8;<U)OJ&5J
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M413/5&1MU3329S4.-QI#(A&6-2+;GTJS%%S5D0@"A$,IQPXJ=1MIY7;3":3
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M$XJ-7H9N* (YFZU2D8U;D&ZJ\D1H A5CFK,+'BH5B.:L11XI 6$-24Q14BT
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M7!ZKHC1,6"_I5+3]2DT^8#)&#7Q^9X'G3D>WA:_0^NM%UZ*ZME4L#D5G^)=
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ML:9YF*"1^*2F>92AP: '49IK4+UH'8=1110(*7%)3EZ4#Z#:3(IS5'02/IC
MT^FM0-#*5:&I*!V'9IC-2TW;0!&U(*E\NCRZ@8+3VIH6EH C9:;MJ7&:-M-
M-5:?1M]**0A,BBFT4#'XS2[:%I=U,!IXIK4YFJ)FI ,:FXIU-:G<0E/6H^:<
MM(">FT+UIU,8Y:6BB@!#TIC5)36H B+4JM2,IIH6D!,.:7;Q21U(U %>1:@:
M+FK;4W;3$0K#[4_RZF"B@B@"'RZ<J4^C-(0PBH9%ZU9IFSVIW*,Z2(TU(S6B
MT-"P@4A$,:U.M'EXH(I@(W--VT[::<JT@$5:1FVU)CY:KRYI@.^T4Y),U3.<
MU-%F@9=5J1Z:N:1C28F,VTUUZTNZDW9S1$$5VCI\:U)MS3@N!3& IRTE"]:
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M<U-H$%%%% 7"E6DIPH&+1110 4444 %%-:A: %:F%J<U,;K0 E/7M2 8IX%
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M1&I/+YIRIB@"933ZBIRM0 ^BBB@ HHHH$%%%%!(5&U24PB@:$6EHQ104%)N
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MS76?\(;-_<-'_"&S?W#2_LAA_P 1 7<Y/<:-QKKU\&3?W#^5._X0N7^X:?\
M8[#_ (B NYQVXTGF&NR;P7-_<-0MX-F'\!_*C^R&'_$0%W.3\TT>::ZK_A#Y
MO[AH_P"$/F_N&G_8[#_B("[G*^8:/,-=3_PALW]PT]?!DV?N'\J7]CL/^(@+
MN<IO-&\UUR^"YO[AI?\ A"IO[AH_LAA_Q$!=SC_,-'F&NN/@N;^X?RH_X0V;
M^X?RH_LAA_Q$!=SDMQHW&NO'@R;^X?RI?^$,F_N&E_9#'_Q$!=SC]YHWFNN_
MX0N;^X:5?!<W]PTO[)8O^(@+N<AN-&379KX)F_N'\J7_ (0B;^X?RH_LA@^/
MUW.+W&FF0UV;>"IO[AJ)O!<W]PT_[)8?\1 7<Y%9&IV]JZL>#)A_ :=_PALW
M]T_E1_9+*_XB NYR6]J;O:NO_P"$-F_N'\J/^$+F/\!IK*1?\1 7<Y%9&I=[
M5UR^"IO[AJ1?!,W]P_E1_9#%_P 1 7<XW<U&YO2NT_X0>?\ N&C_ (0F;^X?
MRI?V2Q_\1 7<XO<:-Q]*[+_A"IO[AI/^$+F_N&E_9+#_ (B!YG';S2>8:[ ^
M"YO[AIO_  A4W]P_E5+*&P_XB!YG)"0T[>WI77+X)F_N'\JD_P"$)F_N'\J/
M[(?8?^OZ[G&,QI-Y_P BNQ;P5-_</Y4G_"%3?W#2_LEA_K_YG',Q]*3)]*[+
M_A"YO[AIZ>"9C_ :7]DL/]?_ #.-&['2@[J[A? TQ_@-*W@:;'^K/Y4?V2Q?
MZ_\ F<-S1N;TKMF\#S?W#^5(O@B;/W#3_LE@N/\ S.*RWI2\UVW_  A$W]PT
MUO!$W]PT?V2P_P!?UW.)+$4GF'TKL7\%3?W#43>"Y\_<-']DL/\ B("[G)^8
M?2CS#Z5UG_"&3_W#1_PALW]TT?V2P_U_7<Y/S#Z4>8?2NL_X0V;^Z:/^$-F_
MNFC^R6'^OZ[G)^8?2CS&]*ZU?!DW]PTY?!4Q_@/Y4?V2P_U_7<Y'>:-QKLU\
M#S_W#3U\#SX^X:/[)8?\1 7<XG<WI2[F]*[7_A!Y_P"X:5? \W]PT?V2'^OZ
M[G$Y;TI-S>E=Q_P@\W]RF_\ "$3?W#1_9+#_ %_7<XG<U&XUV?\ PA,W]P_E
M36\%S#^ _E2_LEC_ -?_ #..WG_(HW&NM_X0R;^X:>O@N8_P&G_9+#_B('F<
M?N-)O;TKM?\ A!YL?<-1OX)F'\!H_LEB_P"(@+N<=YA]*-YKK#X+GS]PU(O@
MJ8_P&C^R6'_$0%W.0W-Z4N6]*[9/ TY_@-//@6?^X?RH_LEA_P 1 7<X7<U&
M]O2NW;P+./\ EF?RJ%O!,P_@-']DL?\ K^NYQOF'TH#FNM;P;,/X#2KX-F_N
MG\J/[)8O^(@+N<EN:CGTKLU\%3'^ T[_ (0>;^X?RH_LEC_XB NYQ6XTA8UV
MK>!YL?ZL_E4?_"$S?W#^5+^R6'_$0%W.+;<XQ6=>:;-<?=4UZ9:^!9F890_E
M75Z+\,S<,NZ/]*UIY79G!BN.G4C9,\"M/!=U=2#Y&/X5Z;X%^&,S2H6B/7TK
MWSPU\'XVV$Q?I7J7A_X90V:J?+ _"O;H8.-/H?FN99[6QC>IQ_P]^'XM8XB8
M\?A7L-EHZ6L( &.*MZ=HR6* !<8J[*0%(KTU&VQ\FVY:R,:0%6P*09.*M20[
MFS2+#R* &1IFK<:XI8X<5)MQ3+0=JB=:GQQ2,E2,INIJ)E-76CZU$T630@*;
M*:55-6?(]J<L..U%Q"PQ]*O0QBJ\:[:MPTT!,(J=]G]JEB7=BI_+^6FQF<\/
MM5=HZTI5JG+Q4B*A6DV^U/:DH&"9S4Z-4*TY7VT[A<M4UN]1":G>8#3$+MH"
MTN12U(!1C-)N]Z7=5V*Z"%:.E!D%,+U-B4AVZD9JC9Z:S46*!FJ)N33Z>(\T
M,FQ!@YI_EDU.L/2G[=M(+E-H:9Y8%69&Q4#-0-#DXJ934%2+18";--IFZDW5
M1-M16YJ*2/-3J,T[R\T%F5)#[4B*5K1DA'I4#1;: %A8U<C-4U^6K$<E(1+(
M,U4E6KF_-0R*":5A[%2I8Z1EQ2J<50(LQU-GY:K*]2>9\M)B8K$5'NI&:HPU
M) 6XS3FJ*-JFJPN5Y%J%DJTR]:C912$RMMJ)P:M,O%0NM*X%9@:1>M2,M)MI
M@/C;%6XV]ZJ**L1TAED<TC+0II](1%Y=*(ZDQ0U.XR!P!4+U+*:K,U4 C=Z:
MO6D#9IZBH8B2.K43575>*F6J12+:M3]N:@C:IT:E<LCDBJM)#6@:AD4&BXMC
M-92#3U)J9H\FD6*J :<U&V:M>72&&IN5T*>TYJ1<U/Y-)Y=29$?--*DU.L=2
M+%0455B-3+'BK*PT[RN*!$'W:/,Q2R+MJLY.:8RV)J#)NJBKFK$;;J:&#J:A
M8&KNS-,DAHN!4W[:1IJ=+":IR9%- R?S@:7S!5+<:EC8T-A8LJV:GC[563-6
MHJ!DRCBG%33XUI[+0!1E8BJLDY7O5NX7K65<,12 F^V>]-:Z)[U0W<T]<FJ)
M'33&JQ<EJF>,U%Y?-)ZC9- QXK2A[5GP+5^&G8DMKTIRTU*D5:0Q,5&U3-TJ
M)J8B+:2:0H<BIE6G^7FHN(K[:6I_*IK)BG<9%3*<U1YH8#6IJK3S3D6D0*JX
MJ56]Z;QBF[L&@LF7FI46H(VR:MQ\BD X4W?BGLM0-2L5<DWTQJ;TI10%B&2'
M=4/V?':K^WBHY,"@&5@NVI%-1LU/A^8TR258RU2>215BWC#"K+0C%,925<5(
MJBDD7;4/G;32#<L-"&J-K<>E.2X'K4GF TBDBMY.VHY%Q5IR*KRU:8-%";O5
M205=FJF]601JM3+\M-7M2M3$R:-L5,IJHIJ>-JD$B?;NI#%2JU29&*BY+*K1
M5#(M76J%U!IW*N5*FC-#)2J*$-$T=2;C4:5,JYIE#&8TW=S4K1U$RT#)%DJ1
M9*J\BE62@3++/29J'?FG*U.XK$H7-*8\T1U,.E3<=BG)#59UVUHR+5*:D!6:
M3;0LU0S-UJ)6YJD(T5;=3F7-1V_.*NI'G%)@4FA]J:(L5I>3\O2HVAJ0*RC%
M2H:1EVU'OVFJ$6X^:M)T%9\<PJU'-P*5BBV?NUB:M=^2IYK9W[HS7%>,+SR(
MF.>U!!Q/C'Q$(5D ;%>)>(O$+W$S ,>M=#XWUPM(Z[N]<'9V[:A=>O-)LT1/
M86LU](.">:Z2W\'SS1@[#^5=CX%\&B=H\KUQ7M>D_#Z)K4'RQT]*5A-GRS?>
M'9[,$[2*H6NH26,P!)&*^DO%W@%$B?:GZ5X;XG\*O;SMM7O3:&='X3\5;BBE
MJ].L[L7EOUSQ7@GA^QFM[A>".:]J\*([0J&]*$)G,^-+1E5F KRZ34'M+SJ1
MS7OOBC2/M%NQQVKP_P 4:*UO<.0,<TF-'H?@'Q(6:-2U>Z:'=^=;J<]J^3_"
M&H&TND!..:^@_"_B!/L:Y;M0A,V?%FIBVMWYQQ7S[XV\1&25P&KT?Q[XB#0N
M U>#ZO,U]=GOS28T6M'F>ZN/7FO0[/27FM00.U<SX/T,R2(2O>O;_#WA]6ME
M!7M3B)G@_B;P[.6.%-<D?#URK9VM7U9J'@>.Y_@K'O/AQ&L3$1]O2JY0N?,L
MT$UIUR*9#>.6QDUZ1XX\,K8[\+BO/;.T'VL+[U(S0M[*:Z48!-:5CX<N&D'R
MFN[\&>&4O(TRN:]0TKP%$VT[/TIV%<\S\.Z#/"%)4UV*W1L8>>.*[QO"4=I!
MD*!7FWCB06"2 '%.U@6IROBSQ7Y:.-]>2ZQK$EY.<,35GQ-JSS3LN[O5?0=)
M:^F!(SDTMS0-.TF:\_A)S6VOA&;;G8:]-\'>"UD5,I7HJ^ XOL_W.WI18BY\
MP76CS6O.TBFV.J2V4@!)&*]O\3>"%5'(2O'O$NAM93,0,4BCT#P5XJ+2("]>
MTZ1J N;8'/:OE/PO?M;W2#..:^@/!^K>9;+D]JI,5BYXN<K"Y]J\,\4WS+*X
M!KVOQ5,)+=OI7A7BA=UPWUI,$<PS274F!DUJ6?A^XN "%/Y5H^&-&%Y<*",\
MU[QX1^'L=U A*9X]*207/GV;PW<PKDJU94RS6<G.17U5K_PW2&W)\OMZ5XCX
MR\,K9R/A<8H&8OAW7GCD4;J]A\+ZT9HU^:O ;4?9[H#WKU;P7<Y"<T7(DCM/
M$UP6M2?:O#?$MXRWC<]Z]LUKY[(_2O#O%$?^F-]:8D='X'NF:9.:]V\.R?N5
M^E>"^!8_WJ?6O>/#Z_N5^E4@9U*S83\*S[RX]ZGY"5G7&2U420-(6:K5FA9A
M4$4)9JU+.WPPI%&O:V_[NN3\9'R8'/M7;0L(X?2O//B!?*L,@SVH+1\_>.M5
M*2.,]Z\Z_M9O.SFNG\:3&:X<#GFN/CL&9LXK-E'=^%=>*RH-U>[>#=5,RQC-
M?,FD,UO<+]:]R^'M]N:(9IHD^@-*7S(0:-17RT)I?#K!K=:-=;;&<>E4S,\T
M\9:EY,3\UX+XKUIY)F4,:]<\>3'RY!7ANJ+YUX<^M9,T14L;&;4)!P3720^!
M9YH]VP_E6_X"T>*>1-P%>]:)X2MI;0?*,X]*+ ?*>J>%Y[$$E"/PK,L-0DL;
M@ DC!KZ9\:>!XVB?8@KPO7_!TD-RQ5.]%AG?^ O$VXQ@M7NFCZB+BT'/:OF3
MP?IL]K,F0:]W\-S.EJ ?2FF1(S?'TNV&0CTKYC\9ZBT=RXSWKZ0\>3;K>3Z5
M\Q^-(_,NG^M#'$J:'JS^<OS=Z]E\%:L6\L$UX=HUJ1(*]4\(2&-X^:$4?06D
MW1DM1SVKFO&5P8X7.>U:7AZXW6HY[5S_ (ZFQ;O]*HD\+\8:L5F?YJY2VU9F
MEZU9\97!-U)]:YRPRT@K,H]2\+Z@6D7GO7MGA.X\R-.:\ \+9$B5[MX+R5CJ
MT#6AZ;9_ZL5,K8:H[./]T*>1AJ9CU-&%JGSGO5. ]*MQTC03;2@5)MI.*I%(
M;@U'*O%2K39%S5;"L8UZG6L"\4Y-=3=0Y4UB7=J68\5HC-F T9+5/#;FKBV1
MW=*N16>!TJB2I'!A12O'5]H=O:H)8ZS4M3-E!ZK2U<D2H&CS73&1)1932>7Y
MG!JYY&:18<4Y.X&-J.C)-&?EKSWQ!H1B9BJUZW(N5Q6)JFDK<*W%<%2FI#BW
M$\=MYY;&8=1@UZ1X/\9&U907Q^-<[KGA_P HL0*YAYI;"3@D8KY7'98IWDD>
MM0QO+HSZM\.>,([Q%4OG/O6QJFEPZM;DX!R*^9_"_C-[61 7KVGPOXXCN416
M>OBJ]"=%V/<IR574XSQU\/0RNRQ_I7@WB7P;+:S.0A'X5]KW,,.K6_8Y%>=>
M+/A^LZNP3]*FG)/21V*FD?(C0/9OR,5IV&L!.":[?QAX&>W9R$Q^%>:WFF36
M<AR".:ZI48R5T9.IRNQV5GJ0DQ@UK6]UTYK@=/OC#@,:WK;55;'->;*C9G3&
M?,KG96]UTYK0@N.*Y6UO-V.:UX+CWK"4+&R9T,=Q[U;CN*Y^.Z]ZO0W'3FN>
M6A?*;D<U6%EK)AGZ<U96:HY@Y#066IEDK/6:I4FI;B:+ZM3MWO559*?YE,DL
M*U*S57$E+NI6%8>33&I,FD9J+ 12"JLBU;?O5>2FFAO8HRKBLR[^8&M6:LNX
MK7IH9QW.?O;0/GBL6\M%53Q71W35AZ@WRM2C*5SHLK'":Q'ME_&NC\"R^7<I
M]:PM87=)6MX1^2X3ZU[U%WCJ>?6BCZJ\!WFZWC&>U;OB0>9:L?:N)\ W)\N,
M>U=OK/S61^E>7B5[^A-/8^?/&R[+E_K57P?)NNE^M7/'PVW#_6LSP:W^F+]:
M^^R6_(CQ<>?0OAC_ (]D^E=)7-^%S_HJ?2NCK[!GB4=R&=>*S;B.M67I6?,!
M5Q-JJ*2Q\U)Y=/4#-.(K0XEN)&OS5<AJK&.:NPKP*PDSKCH2[:*=@T5E<TN>
MP4445PG:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2EI#TH ;2@TE%
M-DBDT=:.M+MI%"&DIS5&:D I,444P$VT;:6E%,!*?2;:-U ",*;MIQ-)0 C*
M,4W;3Z3;0 NVF-3Z0K2 BSS3E:D9>O%"\4 3K2-2*U*33 :U-9J<1366G<!*
M7:*3;3JD!-HI#UI<U&S>]2 ]:=4(:G;J %IN32[J3;3 0\TFVI-OM2,,4P(R
MM,VXJ7(IK+0P&;J-V:1AS0HJ0'+3@:55]J1N*=P';J3=4):G*W2FP)EI6Z4U
M6I6;BD AZ4RG;J2D FVEHHH <.:0K0#2[A0!'BE#4'I3:8#\YI#0O2@U "9-
M(6I=M-:@!DC56=^M22&JLC4 .W<T9J#S,4]6W4@)5:I8Y*@Q0I.:8%P-D4US
MBECY6DD7B@"/S.:>LE0-FD5J +8:C=[U '^6CS* +:M3JKQM4ZM0 TGBFT_;
M2;?:@!5;BD9J3[M-9J!#@>:6F*:?0 4N:2B@D7-,<TZFL* 1'NHW4F#1M-!8
MNZDS1M-)0(<M/VTU14F.* (F&*CW5+)4#=: )5:E8U$M-DDQ0,>W-121YIJS
M?-4P.X4 47AYH2&K;)S3ECYH B6*I42I=O6DH <HXI&I<BD- "4;<T4Y: (9
M(<U#Y&#5VDVT"(HUVBG-3]M-9>E QM%!&** "BEVTE2P"D-+36I &ZG[JCJ0
M#O0 M-84[-(U #:6BB@ HHHH **** "BBB@ J-JDII6@".EIVWVHV^U, HI=
MM)2 **3=0#0 M(:6D:@!I;FE':HVIRMTJ@'XI"M.%%("/;0#3V%1-3 =NI5I
MHIPXJ0'T4FZEH =@4PT[=4;,: '!J6HU8YI^ZG8 VBEI-U+2 **** "FE:=3
M2U ##2XXH/6EJD!%(M1^74[=Z0"A@,5<4[UI2M,;BI&@:HSWI&;FDW>]4 %:
M88ZD%2JN:0B*&/YJDNX@83]*FC3FG7"[HR*$(\L\66I9FP*Y"WMBLW(KU#7]
M-\X$XKB;RS^SR$XKU*%2QS3B300@PX]JY7Q59CR6(%=)#= <9K-UZ,30-WXK
MU8OF1PRB>$>($,5PW;FG^'KDK,O-7_%5F5F8X[UB:2QAG'UJ91L9;'LN@7&Z
M-:[&S.Y17FWAV\X7FO0=+FW(*P+1I21_+69=P]:U_O+5.Z3O5)DLYZ>.JC1\
MUJ7$?)JDR<UJC-D 6EVU.(Z:4K1&+*S<5 S5;D6JDBTQ#5:K$=5U6K$= BPM
M+35:C=2L,7;1LIOF>].5Z8A?+]J/+]J=NIK-0 U@*B:AY*C\RF2+MI=M-W4W
MS*10^EW5#YG-/5LT$C7:HF8U8V\5&R<T 5SS2;*FV4JI041I'5A%P*15Q3LX
MH8#F-5I6ITDF*@9MU- 5YF-0 '=5SR=U"VOM0 ENF<5?CAS4446VKD8I"&K#
M3UCQ4G04QFI7 =TIC=Z:TE,WTQB,M-6/K3^N*=3 %6E:C=@4TM4@0R+3%CJ8
MG-"BJ0"QI5A!3$%2JO2AB'[J8TE*W&:KR-UJ1"22U7D;=0S5'NJ@#%31K42\
MFK$:T#)HUIS+BE04/WI@59*K,O6KDB]:@9*$,K[:-M2[<4PU0TA M+MI<\4;
MJ0$;+Q4;+4I:F,:!$16G*M-9J<K5-RB55IS=*16I&:@0F:-^*B9J;NH"Y8\S
M-1N:8&IW6LVM0&,:3=3V7VIFVJ0#UJ95J%*L)0,-M1O4Q-1/3$0,U.22FLM(
M :8)%E):E62J8:G*]0RBUNIM1JU/':FB6.VU$_RBILU#)3 @9J0-2-FA:!DJ
M\T]5IBU(O2@&/6I%6F+4RK3 1EIA%3,*C9:0ABU,G:HU6ID6I99)2[J#24A!
M3U%"K3U6GN4.5:D%*BT_RZFPA%I:%6I-M4&I'FG!Z"M(14=1#U>G[JA%/7ZT
MPL25)N_"H=U+NI(8LDF*J235)(QYJI(3FF%QPDJ:-LU3&=U6H<UF47(Z?CBF
M1U+M^6@"&2H'JTR9J)HZ&!2;--W&K#QU$R4@!&JQ&,U J\U8CXQ3&3J,4\-3
M%-.Q3)%+4!J4+366D,M0W02DN)HYE(P*H-FFKFJ"QG:EI$=UGY1S7,7W@F.8
MG]W^E=^F.].VI2)L>3R?#N-C_J_TI%^&Z$_ZK]*]8V1^E3111<<"BR"QY,OP
MT3_GG^E/7X91_P#/+]*]ACAB]!4RV\7H*+(?*SQQ?AC'_P \OTIQ^&*8_P!5
M^E>T);Q?W14OV6''04N47*SPU_ABG_/+]*C_ .%9IG_5?I7M\MM%SP*K-;Q>
ME4HH?*SQG_A6:?\ //\ 2D_X5FG_ #R_2O93#$.PIK1P^@H<4+E/&S\-8Q_R
MR_2D'PU3_GE^E>P,D7H*01Q>@HT#E/)%^&J?\\OTJ3_A6T>W_5?I7KBQQ>@I
M6CB Z"IT"QY ?AO'_P \_P!*3_A7,?\ SS_2O6)!%Z"HLQ9Z"BR+Y3S!/AQ'
M_P \_P!*G7X:QG_EG^E>FQ^5Z"KD0B]!0'+YGE#?#2/_ )Y_I5>3X:)_SS_2
MO9]D)["H9(83V%+0.7S/%S\-4S_J_P!*5?AK'_SR_2O86MXL]!2B&(=A3T#E
M/(!\,X_^>?Z5(GPS3_GE^E>O+'%Z"IHXHO2GH'+YGD2?#)/^>7Z4_P#X5BG_
M #R_2O8EBA]!4GE0^@I!R^9XLWPQC_YY?I47_"LX_P#GE^E>U/%%Z"H##%Z"
MBQ#1X]_PK./_ )Y?I1_PK6/_ )Y_I7L'EQ>@I/+B]!2LBE%GCX^&<?\ SS_2
MI8_ABG_/+]*]>6.+T%68X8O05-BN4\@3X81_\\OTI6^&$?\ SR_2O9DAB]!0
M\</H*?*/E/$I/ADG_/+]*@;X9I_SR_2O;)(HO05!Y,7H*5@Y3Q@_#./C]U^E
M!^&<?_/+]*]F-O%Z"D^SQ9Z"DD'*>,_\*SC_ .>?Z4]?AFG_ #R_2O8_L\7H
M*>L,7H*JR#E/((_AC'_SR_2IU^%\?_/(?E7KT<<7H*L*D7H*!<IXY_PJ^/\
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MK?H<2W-6'FKT*]*R[:3.*TX6XKFD=,2?;12T5E8L];HHHKC/0"BBB@ HHHH
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M84@*<BU'MJTRU$RTP(L]J:#4I2D6.@!\=64J&-<586@!:**3=0 QJ9BGM24
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MI?,H&7&G/K5>:8^M0//5>2>@!MQ(?6JWF'-.D?=4#4 3B8U)'<'UJGNIT;T
M:L,S''-7HW-9,#]*T(7H LLQ]:KR.>:D+9[U#)6<@(&)I5!I&IRTP' ?+36.
M!3_X:AD- A-]21O54L<U+%FA#+\?-2LORU%#TJQMXH>I:*[+496K16HF2IV*
M&1U<A7@546K,38J@)6&%JO)4S-Q4#FE<17:E4TK4RJ&68Y*?YQ]:JA\4GF4N
MHBUYFZG[=PJHKU8C>DP$DCXJC/Q6A(WRUG7)ZTQE*2H\9IS'FG1KNIDD#)UJ
M+;AJT6AXJM)%C-2 R-\5;CDJETJ6-J91?5MU*%S4<-6D6@AD:Q\U*JTNVG+1
M8I %IRQU(H%*V *!V(L8I0V*8[4P-2W'8M;LU'(N:$:E+4]A%.2*HA'5Q@*C
MVTMP&QU,!3-M/!Q185A&[TPU(>:8U %:6JS'FKCKNJ!HZ2 5'I^[.*A52*EC
MJPL!7-)Y=3JM+MH0%1H^*C9:N,M1,M2P*A4TY5Z5(RT**H"2,596H$-3I0.P
M[;0.*=VIC-B@"53BE+5!OHWTACV:D4\TS=3UI7))EZ4C#BG)2E:2$0A:"G%2
M[:5DK0HK[:*D84S::@0E%+29IC%I=U-SS0S4$I@S5"WS4]J;28[D16G+3\44
M($21\5,K5"M.IC',U-HP:7;3*'I4JU&JU,JT"L)3E:C;2=*0[#]U(:CW4A:@
M!Q:DW5'G-%0(F4U*O:H$J9>E(?0G0U+NXJNM.9J9(]VJ%FH+5'FI*2'#FI56
MH5-3J: '!<4O2D9JC9J L6%DJ93N%45;FK<.3023>5NJ&6W]JNPIFG21<4QW
M.?NHMM94RG)K?O8ZQYD^8UH,JH#NJY"O%0HG-7(5I%#9%^6LVZ[UL2+\M9UQ
M%G-,EF0W6I(FI9(3NIT<1IB1(S\5$6^85/Y)IGD'=2&/AK2MUZ<51@C(K2MU
MQ20RPO2FL:<34;=:&*Y&U,VU+MII^6F!"ZU7D.,U9D-5)FZT,DB:0TGF5%(U
M,#=*2$7%;-2 ]*K1M5A:0A6J-EJ<+3O+SVH I^7FI([<FK2V^>U6X;7VI%D-
MM;[:U((\8I(H<595=M KDB"FR$4F['>H)I*8$<TF.]5)'HFDJLTE [CV.:7;
M4:MFIDI "PY[5(D>*<,4%@*![$J';3FDJOYE+NZ4@"3YJA:'=4]/5:+A8K+;
M<]*D6';5H*,5&[8S3"Q"PQ5>1JFD>J4TE:=!$4S\52E;+&GS35#NW&@3!5YJ
MU$M1Q)G%6TCZ50#UJ13TJ)N*9OQ4W%8M4;,U!')5F-LT@1&8*/)JVJ@BE,=)
M@5/+P*0K[5884PXH0(JLM-!Q4[+46WVIC)8WJ96JJ#4BO062,,U&T>:E4\4X
M+NH)(%CZU(L=3+'3O+H*(@,4,<5(5]JB>@DB9J8!FE84Y*!$L,-65@%-AQ5E
M<4BD1>7BF^74[8IN!28R/;3EZ4[;1M-(D8PS5*XCZU<?BJ<[<4 9DT?S4^&/
MD4LF-U2PJ,B@"TL?[NO./B#'^Y?Z5ZA$N8Z\Z^(47^CO]*!'S3X@&+UOK74>
M"6^9:YOQ*NV\;ZUL^#9]LB#WI(M['N6AS8C6NGANB%KD?#O[R-:[&WL6:,'%
M:&8];P^M3+<;AUK-O%-OS6/-KRV[8+4@.K+;N]-V_-7,6WB9)&QO%;=G?+<8
MP:;*-FW/%9^LVHGC;BKT*G;FF3C<I!J1'BWC/1>'.*\AU6V\J8C'>OHKQE:C
MR7X[5X5X@A NC]:AEH@\/:;]HG7BO:_!NB^6J'%>=>";,22)D5[IX>LA'"N!
MVIH;9NV<8BA'':H;J3FK:KM7%4KI>M49D4<Y##FI+RY_T=N>U4^5:DNV/D'Z
M4["/'_B1(6$E>/VZ[K[\:]=^(*[O,KRZUA_TX?6I9HMCUWP OR1U[%IO^J6O
M)_ D.V..O6=/_P!6OTJB&5M<8_9VKPGQWGS'KW[5[??;MQ7AOCZUVR2'%)E1
M//\ 24'VP?6O<O \8\I*\*L9O*O!]:]G\"WP94&:42V>M6:?(*N,O%5M*_?1
MK6G);X7-60RE(=L9KRWXB2?NI.:],OI/+C;FO'_B)>_NY!FDP1XKJDG^G'ZU
MU_A:0[%KB+I_,OC]:[[PG:EHUX[5!9O7C'R?PK@?$!^]7H>H0;83QVKSOQ!]
MYA38CF4NFAEXK6@UN54P"15"VL&N)L 5U&G^$I)T!V&I&<Y?:O/,",FLQ8I;
MB3G)KT!O!+]T/Y58L?!I6092F!D>&=!:1E)6O6_#^CF&)3BH/#OAM8=OR8KN
M;6P6*'IVJTB6SA_%'[FW8>U>(Z]-_I;?6O<O&\>V%\>E>#:YG[8WUHD*)U_@
M>;]XM>W:'<_N5YKPCP2#YB5[=H2GR5I1!G6P7&5%6%DW$52MHSM%7H83D4S,
MO6AZ5>N/EMR?:J=O&5Q2ZE=".W//:K11YEX\O_)5^:\*US4/-N6&>]>I_$2_
MSYG->&:G>?Z43GO6,C1'=^#ROG*37L5E=QK98SVKY]\/ZT+=E.ZNTC\9;8<;
M^U-,0>/761G(K@--N/(O!SWK7U_7OM>[G-<K'=XN ?>I8['N7@W5"P09KV/P
MY^^1<U\]^ [KS'3FO??#<PAMU)--$LZ.^TU)X2,5YQXL\&K<*^%S7<7GB*.$
M8+"LF;7;>ZR"P- T>!:[X!99&(2N0OO"LUNQPIKZAFTR"_' !S6+J/@-)E)$
M?Z4K!<^7[JUGM?44_3-8GMYA\Q'->N^)O HA5L1_I7F>JZ(;.1N,8J;#/1?!
MOBI]R O7KVF:Q]IM1SGBOF#0;YK>X49QS7MGA'4C- HS31#1!X^^:.0^U>(W
M4>Z^_&O;O&WS6[GVKQIH]VH?C3943I-)M/\ 1QQVK.U9O(D_&NKT>SS:#CM7
M+^+(S$S4%=2;0]8\M@-U;=Y??:H>N>*\TL]0,4P&>]==IMT;A ,YH$9>I6'F
M2$XJM#9^61Q76RZ?YBYQ67<6OEMTHL!-HL>)5^M>Q^#6VJE>1:0N)1]:]:\)
M'"I31+/3K>;]R/I5:XF^:F6[GR15>9CNJB2U$_-:$+5E0GI6A": +>[BH9*=
MNXICFI-(C-U*K4PC+4]5I":)!01FDYI-U4B1-M(RT[(H[59!4D2H6CJXX%0-
MBLVKBL0%*-E.:E44UH40LE5I$K1\O*U!)%6JD.QFM'N-.6&K1AH\NK3(L56A
MS52:US6MLJ*2+K5.2+Y58YN[TY9,Y%<QK6AJR-A>:] EM]U4;G3?,!XKG<>;
M0Y)73T/ M>T*2.1BJFL[3;Z?39ADD8->VZIX9216)6O._$7AOR=Q5:X,1@85
M(['11J23.C\-_$ VZJK/^M>H>'/&4=]M#/G-?+DBSV<W&X5U?AGQ-+9LNYB*
M_/<?E4U+FBCZ6AB%:S/K.*VMM2A['(KC/%W@:*XC<H@KG?#/Q&&$5I!^==_9
M^(H-4C + YKR(QE1]V1W<W-JCYQ\5?#=_,<K'^E><ZIX/EL6)V'BOM:Z\.V]
M^A.T$FN \5_#V.17*Q_I6W,I#4K'RBTCV)P>*EM]?(;&:] \5?#V6-VVQG\J
MX2Y\(W%LY.QL5#C<WC,U;+5S)CFMVUNMW.:XN&%[,_,"*OQ:P(Q@FHE2T-.<
M[:&Z]ZM)>>]<9#K@;^*M&WU+?CFN&46F4F=0EUGO5F.X]ZYZ&ZW8YJ]%<<#F
MI*-Q)JF6;WK'2Z]ZE6Z]Z0S7\_WI&F]ZS1=>]'VD>M %]IJBDF]ZIM<]>:BD
MN?>A1NPEL2W$M9=Q)UJ2:X]ZSKB?KS6W+H8+<BN)>M8]ZWRFK5U/C/-9%U=9
M!%$%J=:V,+4&/F5TO@V(R7"?6N=FC\Z7CFO0_A_I!DFC.VO>HQ]T\^L>W>!;
M/$2'':NF\1-Y=BWTJ/PMI_V>U0D8XJAXUU!8;5ESVKSL5\9--'@'Q!GS=2?6
MJ/@8EKQ/K3/&4WVF[?'/-7? =J?M:''>ONLF7N(\7'GT=X/C_P!%3Z5V,,7%
M<OX/3;:I]*[*!.E?33/&H;D4T/RGBL;4(<9KI)E^2L34%ZU42ZIRMTOS&JZY
MW5HW4?S&JHAKI6J.-;EBU)K8M^U9=K'6M;K\HK"9TQ+&TT4^BL;EGK%%%%<9
MZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM1+5"N3C[M0R-4]13+5(159J?')4,G%(C46&6]U)4:M2[J+"''&*C9\4C25
MTE%@)&FJ-I33?O4C*:+#%\PTJR&HC3E%*P$ZMFG5$O%2*U%A$J+FKD*BJ2R
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M[+X(3]VE>I::ORK7EW@=OW:5ZII?W15)DV+UY;;K<\=J\6^(FG\R'%>Z3?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 3%-VT^DH 9MHVT[&: * $V^U)MJ2B@0S;[4;?:GT4 ,Z
M4N:&ZTE,0X4M(.E+2*"BBB@ HHHH 2EI",TM !36IU-:@!E)2TE !1110 44
M44 %%%&: $:F;J5FZU'NJ0)-U+N]ZBW4H.:H!Q:FE<T[%&*0$16DJ0TS;2L
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MLE&[FFNU:(@JRK357VJ23O35-4,D5>*1QQ2[N*9(_'6D%B"1J@R:ED^:FHE
MQ\:]*D:.I(XZD9: *12FM\M6'6H)!0 TM1YE,9:0*:!$HDJ6.0BH40FIA&:
M)A/[TOG9JNRFF;B*@"ZDM6(YO>LQ9*FCE/K0,U%DR*:WS57CDJPAZ4F(18ZD
M5<4HQ1NH&*U,Q2TC&C4!M,9:&?%1/-3$-=12QBF%MV:?'3&7(0*LIVJK&U3J
M](1,QXJM-S4A:HV^:@"G(M5G6KLBU T=,"!5YJQ#Q3=M/7B@9;C;@4\MFJRO
M4BGBH$.-,9J?MIC+5 B-I#43-NIS*:0+0,9MI-M3;>*-E,1$JT[%.VTAXI#&
MLM1,,5*6J)VH&0R57:K##-,,=%@N18I^VEVTO'>DP1&R]:CVU,PIFVFA#56I
M%6D"U(JTQB4C"E/%-9JD!IINZ@M3:8AX[5*M1+VJ16I,HDVYH\JG*U/R*$!%
MLI0*><4E,5ARU,K5 M/7I4C'LU02?-4C5'WJ^A)$5I52I=M."U-RAJ+4R"A5
MJ0 587'K4ZK4"U.K5'H(?LH\O-*&'K2AAF@8JPU*L5)&PJ=2,5$AD3+BH9'J
M6:3'>LZXN*2'8626F+)51IMQIT;$FK N^933+3!]VFL#04B42FI$>JZ*:L(E
M(EDRM3Q)4>W II:D(F:2H9)*CDDJ$R4%$P-6(JJ1G-78EH$T6HJG%11K4XI"
M2&LU 8T[;FG+%5!<6-JEW<5%MVTQI,5(Q9JJ25(TN:B8YJBA*7=Q3:*D 9JC
MW<TXK2;>:"A5.:F44R-*F5:5B1K<5$S5+)WJ!J &ELTWFG;:7;4@1EZB>6I7
M2H6CJD,A:0TL<QS2F&A8CFJ"Q;AF/%7%DJC#&15R-:S$/+$U&V:G5*:R<4%E
M1F(IH>I)4JOCFF(NPM5@=*I0M5I6XI ,F;BJ<C5:EJJZ\U6X#HY*LQRFJBK5
MB-34@6EDJ53NJ&-:L*M #PM-9:?NIK-3 K-4>?FJ=ES4?E_,>*3 $:IU:H56
MI%H+'T44N*9(;J:QS3]M,(S4#1%MYJ2-:%3FIXXZ %5>E*U3+'3'2@HKFCFG
M;>:-M($)MINVIMM+LIC*^VG*M3B/-+Y?- #5IVZE\OVINV@0UC2"G;>:-N,T
M#"DS0U,W4$V+"&K2+FJ,;5>A;I4LTB.,=-\JIZ.*11$(Z794E.VT 1>74T<=
M 6I4H$/5*794BBAA56$0L*@DJ61L579Z (W6F@4\_-^=&VI*%'%%%%!0QC5:
M1JLO5:1:""!FI%S2LO-2*E "J*7;4JQTXQTF,K-4+9JVT?6H7CHL(@5<U8CC
MIJ)5J-:8 B5*J4+BG*:+ 21K3V7I34(I^[B@"%D]J15Q4K&HBU R1<4%JA\R
MFM)0(61LU6=<U+NS2[<T@*XCJ58S4RQ^U2*O%,96*U!)5YEJ"2.@&9S+0D=6
MFBI5CH$)''5J-<5&@YJ4&@"55!IKQ4*U2[LXH H31XJNV:T)%S5:2*@9'&_-
M6HWJLL?-31\4"+&[WJ.1Z:9*@DDI@.\SYJEC:J&_YJLPMTI- :<*U.$J&WZ"
MK:KQ0@(F&VHGDQ4TW%4)GVU):1-YU.\[-9IF.>M/6;IS2&: ;)J16JI&W2K*
M4ALE S0RTJTCM2)&9Q3U:H&>A6H G;I5:;O4F[BH9FZT)C14E)J'G-32=335
M6J&%,8&K(3BFM'0(KKP:L1S;:@9>M,+%:!E]KCCK56:;=4#2&HV;-*P@=LDT
MZ-C46W-2QB@1=@/2KT350@/2KL;4RT65Q2\5&K4Z@!&J-FIS5&W>@!K<TT#%
M.VT;:2))%-(_-"T-1897DZTL=))1'3$7(UI^VF1M4A;BI$-SBE4U$S]:%;I5
M%$_6J\PJ;=4,AS29)2?BEB:E=:(XZ$,M(W%.;D4V-:<W IW$0,*5337:A6I%
M#VJ)DJ9:",TQV*OETY(ZFV^U+MQ2(U%3BI-U1;J4FF,9(U1!N:>W--5:07)D
M&:E5:CC&*F5J5Q#E-2*U0;J<K5198#4,?2FK2TBK$3M4+5,PIFVD,8JU.L5*
MB59C2J)(/)IC18J[M%,D6@@HLE1LM69!5>1J"D(M3(U5]U.5L4 RV.:0XJ%9
M*<)*DE:#\8I5ZTF[-*M,L=2[J:3BF,U,0YI*A9Z:S5$6H"Y+FG5"&J16H'<=
MLIP7\: U.W50AGW<5(K5&U(K5(%@-3@:@5J?NH*)\TY:@#<5(K4@) M+MIH>
M@O[TB6AW%3)BJOF<TY9J0TB^I&*&DP*JK-Q3))O>F(EDN=O>JDUYUYJK<7!]
M:SY+@YH O2W&[O5*1MU,64FG#YJ!$:YJU Q%,6.I57%4!=BDJ=I*H(V*F\RD
M(=(U5]U2,<TS;5#L21FK"U745,#BI*)*C;%)OIC24Q#AQ3MU0M)3&EH'<DDD
MZU5F:AY*A:3-(&5Y*K,.M6V7=3?)S5$D$:5:BC]J58:GC3%20*L8I&.VI*KR
MM0-#UDJ=)*I*:G2D-EV.2IA)Q5..IATJA#FDZTWS*8U,SB@"QN]ZBD;WI-],
M=JD=B"5JJ,U696JJYIV&-W4Y6-1T]:8$ZU*M0K4FZI))U:IT;I5-9*F22F46
MU-29%5U:G[Z0B5C4,BTGFTF[=4EC:1ANIQ7-*$XIDE"XBXK/9=K5N2QY%9\U
MN: &VLFW%:]O-\M8:Y0U:AN"O>A ;)PU021YJ*&XSWJP'#50BN8:/+Q5FF-C
MFF,KM\M0-)3[B3;5"2;YJI 6Q)4T;50C?-6X6I 75/%(QJ-6I&:E8H4#-2*E
M1H:L1C- "%/EJ%QBKC+Q5684#&*W-6(VJGWJ>%J@3-"/%-F.%-,C>H[B3Y30
M04;N3K5+S,M4MTQ.:JK]Z@#0@YQ6C OM6=;'I6E"U!:+*]*7;35<4[=Q0 5'
M))@42-5.>;@\TP&7,E4&^9C2W$_6JPF^:@DNPK5M%JE!)5Z-LT 3J<"J=]:B
M92,9JVO2EX[T >:^*?#8F1_EKQ;Q1X;:WD8A:^HM2M4F4C&:\[\3>&5N V$I
M#/FV5IK*0XR*;_PDD\?&XUZ-K7@EF=L)^E<M<>!9MYPAZ^E*Q29S<NL3W7&2
M:T]#LGNIAD9K8L_ TN1E/TKL_#WA$PLI*?I0-FQX-T/;L)6O6-*M1!&N!7/Z
M#IHMD48QBNF20*HJTC/F-1)?EQ5>XY!J".X]ZESO!JAG!^-$)MVQ7@/B*%_M
MC<=Z^F?$&EFZA88KS#5O!+37!;9GGTJ6-'.>!(G$R<=Z][\.Y6%*X#PSX3:U
M=3LQ^%>FZ7:>3&HQ0ALV;<U*^*@C.VG^9DU1-R-DR:AOH_\ 1VJR.:9=+NA(
MH8(\+^(\+?O,"O);>"3[=T[U]#^+O#YOMV%S7#1>!76XW;._I65BS8\#HRQI
MD5ZKIIPHKD/#NAFUC4;<5V-LGEJ*NPC3>3,>*P=5T\72MQFM0R<4JJ''-2R>
MIXUXL\*[MY"?I7D^LZ+):R'"GK7U/JVDI<HWRYKSS7_!?GEB$_2I*/!H;R>U
M/<5:_P"$BN,8W&NZOOA_)DXC_2LW_A7TVX_NSCZ4%'&3:A/=-CDU?TC0I+Z1
M25)YKL;/X>R;AF/]*[OPWX)$&TF/OZ4"N4/!G@W:4)3]*]6L]+%G;@8QQ5C1
M=(CM8Q\H%:%XH$9 JS-GFOC)3Y3XKP?Q)"_VEN.]?1WB#3C<JXQFO-=6\&M/
M,3L[^E(:9RG@=76=,CN*^D?"4F+-.>U>2^'_  FUI(I*8YKU31?]%A"]*!,U
MM4DRO6N>F8[C6K>3[U/-9,GWOQJD236_2M)&PE9D)JUYGRU12.3\:-^X?'I7
MSGXRW^<^/6OI'Q);FXC8=:\E\0>$7NI6PG?TJ&BT>1V%Q+')WKH[?4YE4#)K
MH+?P#(&_U?Z5H+X%E'\'Z5)1S*ZS,.YJ_8ZQ,6')K9'@>7^Y^E7;3P3*I!V?
MI182*T&K2E.IJEJ&I2L",FNLB\)R*N-AJ"X\'R,?N4[!H>>-%)<S=,UZ'X%T
MK;(A*]ZDL?!3>8"4_2NZ\/\ A_[+M.W%(=ST/PS#%';ID#I6W-Y)/05SNGL8
M8P.E6VG8FM$22ZI#$]NW Z5X-\2+ 'S"JU[C<2%XB*\\\5Z*;P-\N<TF!\TS
M+);WAP.]>B>#+N238IS3]0\#NTQ(3OZ5T?A?PL]K(N5QSZ5-BCIH]'^V6O*Y
MXKSWQEX9,>Y@E>[:3I@%N 1VK)\2^&5ND;"YH(/E:>&6SF. 1@U-#KUQ",;C
M7J>M> &:1B(_TKF+GX?S!CB,_E4EG)W&N3SKC)-1V=M+>3#()YKL(/ ,N1F,
MX^E=+H?@8QNI*?I4A<K>#_#)9D)2O9M&T<6]J/E[51\.^'UM]F5Q7;1VX2#
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M:=3L"@1'2K2MWIE(8YJC)YI6J,]: 'T4B]*6F UJ2E;K2A?:D M.H7I29-(
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M$+=:C(IS&DH)$4#-/I%]Z=MIE$9'6F,M2[:0K0!#WI5I^SFE$= @%2AJ9M-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH ;MHVTZ
MB@"-EI,8I[4UJ &T44-TH 3=2,U-:DH =FG TQ:7-("1FJ-J6B@!E%*PI*+
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M,4AJTLIQ18+EN23BJDDGS4KN<56D8\T6"Y,LE3";;5)6.*&<\T!<N_:!3UN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:0]* &YHH
MIVV@!C4VG,*C8]: %W4F:3=2T"&FFMFI*3;0!&.M/6E"\T[;0*P@HIU&!04(
M%H9:D5:7;0!"JT[;3]N**!#**?BFM02)2-2TC4 1T4^B@JPRBGT4 ,HI]% 6
M&44^B@+#*#3Z2@+#!FEIVVFT#$:F-2L:8S5D]P$:A>M&:2BP$BTM1[J7=3L
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MB+"_=J*0T451:*S]:%[445/4DG7[M#444 ,;K3UHHH*B2"BBBD61M3#UHHH
C=4B]Z**9FP:H6HHIL1+#]ZM*W^Z***YY'3$M8%%%%2:G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img109617586_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_3.jpg
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M 0$! 0$! ?_  !$( 1H"70,!$0 "$0$#$0'_Q  >   ! P4! 0
M    ! <( 0,%!@D""O_$ %,0  $$ @(! P," P0$"@<!$0(! P0%!@<($1(
M$R$)%"(5(Q8Q,A<8)$$S-%%X&24F-S@Y0D.VMS4V4F%WN+D**$1Q=2=%2&*!
MD4=46&.7UO#_Q  = 0$  04! 0$              0(#! 4&!P@)_\0 2A$
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M8;]E5C7X7:"^]&>L7FGWX+;;4A''SCJF!G)P)V_W\Z<_^VGG-&_U_@W@TOI
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M#C;@$H&!BHF*J)(J*J>E*UZ[PS#\FQ:9@^28IC60858UPT]AA]W15=KBTZI
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M:S_Z,^H3SAK/R\D3W^(UYTBCXF/_ "MXD9$JB:]'\JI-DG[)- 1B2DCH/O\
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M0+'_  S\S4.GH<ZLU#Q'U<\:K5S-KYE:XB=M$!NLS_<^<7(,?<J9(Q 3.?\
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M)<XQPO\ DJTK.Z4MJXBH*!4X2@A*=-<=CN#OZN[8?MR9(4TZ00.B6E)6DD1
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M"DJ2<A25))!!&002#6B(()!!!&""((/0@[5>147Y1>T_VIZJJ*/2E'I2H/\
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M6UHEI"<]Z]87R(0$@%9+=PN"0-;BH2)F(2D)J>X:2-14I1(R$*3O@@0I($=
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MMJXKWMY;)?R^]PRGAUUG/S[75$=B *GII$ C))\R,G'3H)Z;5.+^S7E3RO\
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M$PG5C)7]J!@JLUE?A<2-XA14?(C&_P"R"1)H$E%4ITGR'R$O:;<;O)PQH_\
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MTI4(.*?_ #^_4R_WT]>?_3GX$>E5*V1_A/\ YJJ;_I5-'I2CTI1Z4J$&!?\
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MB6'1Y'[]9K;7--AFM:-S\Z7$*]PW#<5!)/IT&W[\ZDUZ5%0AW?\ ]-C@M_\
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M&]:P!/BRF!DDS;]G0G$$ 3A, #)F)F)Z',S !S55=D2Y"HX<T(L8OS5Z76,
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MA1TIA>0N$I]HTVVB^X:JJ(K0.J-]JPU-ZR'E-(,J#;K=ZVHJ)(D"'0G8'6)
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M$!!!3$UJ7+]%XO!#8&$HZ]%(DR#$P,[Q$8JQ*?%CS_%77W/P5LFQ^X04'_\
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M$+D.4Q);(0-6R439,Q5!<10)4540T45Z)%3TI2STI4(,"_ZR/E9_N0?3]_\
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MIQYLZB9 U%^4F8$-M-Z$H)\.25ZB?LU6EQ"_<< @"8\.).,S)/D-\\S%\7P
MPBPW8C*(**X3$NM:=:;Z3\ *)7//_</>)=$+IF ^;Q?G[:.8Z[%H)#RDN%U4
M=WWP>)]2AY]I.F( ($F/%@S6253&B#C,>+;F=,_(D20,<J5?<(Y_@XRR8W@
M^\ZG\031:85"$0#P2,)./>*B*_B@ AN+V0MBYAJL^[AQ4K4XF$H0FV83(,RH
MDK*D@[@1F#J)!FH$.8*-.F))0L2=C[L"?@?QJ\[XNJW#88 Q$01\PJ!9<9C(
MB@@ 4^4A";R H-(@]"($XOR (5I-FZ62ZL-$J4L(4;J)4=6"III.1!)&J-0Y
MXJ=*8*0E,' 6 0<>[,S)YC<S/0TM21*1 @00GPP$!5Q6FZ..VS&%?!!#P R1
MTT16VD[$A1#=%>VD0L$\/9:^MNDL.N*R07KAU2US*E  (*LS)DCGN1%O0(B%
MF!$%3:1@1C 5\^FW(6G9A";<$)(M=A\JM[]J4>*'2? 1&@ ")$1EE/RZ52<Z
M(63'U0W:-%'>!@ZI(;4FR6ZI1YR5*!7&=1!D#>9I 4(TE)V)4Z% #,>%) $S
MMMB8JZ]-B (0F'J]HS! !5O)<H8T<?@C1MU0!%^4!@10D1Q?-1( /JVWPV[5
M]<M%RK2KQ*59H;2I4^!*"I1G2($23"3@0:@-@0%$#?Q J(Y_TF3(QUYT.R(P
M^U$BM5PFXG@)A239JL-"@HZ^IB[^2@A"@^0%YO. A)T1DARQ=0E3CIOBG5.D
M*88*E$R '/$01O(SI$2)JA3:0"EO1C:6UD[SU!Z\\C:*OD4:(TU&AC&;>)$;
M:]K&)B$+8JGN/F<A34T:\D,E(NW7"; C[<\DP$6URZI2WA<%I"I5WG$ D%,@
M)2 D:Y]T'2) S$9J4MJ3*=.?ZDI*8F3OF?7KN#M2P9CL..W&BG,5U?P818,-
MCS,O(G'G%?1"+I?)]\NT4B^.U<<%/5H\,4^\M;A;T[Z?;WW .83$)2<" DD<
MA,Q5OV4DF''843(&@B3N ='3 W,>M>_NI41D6XY6[[[AJ#8JW1B3\ESMQQQP
MB'^2KY.NFB*C;:$2)T(!ZI7PYDK+CB;9"&SLIZX2$-C( "5*D*,A/C$J.2!F
MH5;AM D+401N6TF"(YH!C&_PH\YL%GLTNG'W312[_AX2D2G?A>D%#(14OA$[
M(8[ (G:--?%OV6UN'82FW#: !*3='0CR/>*YDF<Y)WJGND2? ?\ ,WZ3MSB@
M79D)@WI)62O&J&^8+2+[CQ*( TR"HI>**HL,M_)=>/DJN$9%/L5JZYH0VR&V
MT@&!=$C E1^M(E1DF#$^Z(@"ON6Y("3T$K;&>0/ACKTFO33DZ.V[*DN6:.&G
MF\398^X#8 A*VR'DBDHLB1?THBNNFXYX IH P;5@J#;;3"THG"A=Y!)R8= 5
M@^4")QFH2TG/A*08GQ-D>6XB#SVWKW&.<I'+E#:@9"7MHX- HL1D_+Q7P,?%
MQU$1R270]*@M=D#(&M#EM;%7<L%I(3X7-"KH%Q8,F/K!*!/A,'GOFJ4VZ%$[
MIC8'0J2<X(23R&_/G(PD$3DOA+D1D5EI5^S"32!+[0T1%E']D\G3A(I(R*CV
M#9*2]&\0!*K9EMM3;3Y9<PE]37$EHU3D( <94-/)0!.1$R!% MT @J6I1!D:
M@#F0#[J01C>2#'ED6%D,RC)M$B,Q&C\B((UI2!)=%5[;5Y%<0663$?->T5QY
M$!4]MIQ';Z+5QL)<+;[TRA *F+D)00I)4H$-J)!$)TD*S,2<2+8)4I2T A4P
M"EP1)D$R8VG'*9]%"RY+SRQ($MSR\!604&XC3S:;+OR$$M 'QDN(BH"@2*V"
MHZXB*K2.$VELA(=?80E8)".]M7&2HF=)4MI20I)B84228R8-7 A)^P!',*3/
M*)!!QM$B9$3,QXE.-P_;%6!)\U 8X2*DU>1!%$4BL(#BLLM,I^3KY"OM?"=$
MX8(5UAI=RI*0 4A7UA;O E $P98?04GD $*Y^&0*E2=82C2% &!J!(&YR40-
MS@P=YS7F*\+ .FKTDS)?<E/Q)[%@V?8KT3C5A^ZTV"(+;33/ET"(*$1(2E?7
M:$JTMM,@B4H/=K84(D J?:A49DD@)($&!-74-AN4I2@3$J209(CDHE7QWV/F
M$8.>XZCYBRP:E_AFFQD4<H?YH3ZMDJA+DNB71=J++0JC2=$3A'EIM0VT 969
M(6YWB;A!,JE*7 E*DMIC3XI5@G5RJM" 2I1TDCE[A$@;J/A5OB(@0#D9I,G&
M\Y]L\HD(=B\_8,ML.-(2)W'CVL)%9C.FGBAD/D\T/]*H\0$WE6O"P1WR2IM*
MM10@/$H4H1)7;K*R4JE1 "0"1(D U! U>$PE,%6I*E SF0X#I)G,P8&/3R],
M8CQ0!SL6E4&V(\MMNPB&B)V#;,ILE)I$Z11>FN"+8)Y^" "^-UNQ?N'"D#Q)
M@:PDH*$@D@J0Y[R4@'W4R=I)JO6$I UZ1F)2"E1) /B@:9ZG S-)D)SP)U]S
MY?\ @U)5M*KVD55!ELU+WV(X"O\ 4X3$9%\C(2(E[V" PT@I9;"QJ!6D-]VZ
MLI(.I97X59!(2$@B<3O4:0J5)(4J#', ]2<$^<$3.(FD$B6Y(;*.#GLU_P @
MZ:*MA62>E7MA%41<8C"*^+_C[$7M"95'$%T2VEKPYM+@N%)A]*M;3:DZ%LR!
MXP $A>),*2I)'NB:Q7KA:I;0J!!"U) 4->00F).0=R3N 3(KR4U832>:(#;W
M33;!K][6R5+Y%MMPD XPD/7R?LQ@%%/VS$25<Y'#A=ND-I^O.5.I.A4 2=2%
M^$B,CPQB,FL<7IMFM2UCNTDB%0!J(C)QGT(SYTG!3!360@(<E14F9!?<5I"*
M^0,Q)*B11VP4D]IIP1\B\W B*1$:[1KA[3:4(96K6F8*4F53D!0((,$8.G$X
MDD5@JO7'-2G -) A(RD;XD&8!V,G\JL2'E><^S%#\$+M]J2]^2+TJ>W7SQ4E
M1U44C(E(G60413[4S0VKK'#UKTON!LA.4K24^(\PM*BK3&($"94.58[W$$I2
M$MZM9D*(( 0,$:5&09D@@2<<]6;BFT+:JO:A%#R43(6+"&VB(B^TX)($IGH1
M%.B4'5145V27X+E(;=4L(*-))A(2I);$Q[L0)ZR0",#G6/[0V$J7K!"0)*@4
MK^,D2-P(3OY5C/>=D._>F1(@*HM.@'BZRG77_&<1417'E!4$S0$5@%4&PC)[
MKSN^MK!EMGQI"GEJ!<<@2#I@!$#ES@F#M&9T%WQ%;SH2A7U:0=*)(U '2HJ'
M(R<1I$1O,UY?EML@(>#:G(Z]F-WY0)A)T7N-N")_9DJ^)DOBH^2_MA)>(561
MPYYUW*>];"22X)&E (&E0Y[B3 )(,'E5A?$6+=GO7%I0Z?"V@[J4!DI(4,8@
MYQ(D[TA\G4<)PW'C?%$\R7_7(P?*H#2*KB/PQ5506^W.U0E,GY!$H[1NW990
MI#0 03*B )*B3"C,F=](F",&8,<X_?75S<%UXJU<@9TI2G9.,$03D[CF(@VY
M%@( +8(TX\]T8BA$D1P^R1'Q=%?.%)\O)0:\O)YU"02\D=D,9+%@ZZ0K7I:!
M&IPI)_PP(DE7NE21 F3SJW>\<M[.WUGQW*@H(91N2!X5A1D  R5!63!"<UA'
M6O>+W7U1]P7._-\4#VW_ (\1)E!5J&^J>(H^T",RQ\0?0T< BZ-AI-J EM*
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M;P08JXR^R:E*?C0Q[%49$J>?(]N/WY*XJJV"HZ_TAN=J*@ M@J"0F1X[E@"
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MIS\7"PW7=Y&N\.XW4]@RJE$R+9\'-ML_;N.,O:IUC=LQ+EM4X$<S]P\O/SV
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M$X:M101 $112_P @!!;;%?P#T%L-!/<RGF$H,0.H*E$G$DD\H@9%2;V?=?0
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M(R>FPU7[6T86+]N<CZDX)QVTXU;I6T>ZN4)2;BU41K;40)*9RMK5(2L 3$$
MXKL. =I^%]HF5.62M#[1A^S?\%RT 8"R@*\3:OLN)P>>DXJ5']UCD1'[6O\
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ME+0V"S*<9S &)QF=A\:B^*>W&@*RVK:)[CD=*T59:_F@@$.'9&3S@]^*(2$
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MV52'7N@B==&\BHHI^+1*?;C4%"R !!<,P(!)$;^(&2#N#\1F*O)4$G,Q,G)
MP<Y$C8?[=?93Q1/%'9$2((_!FM@R)@G\_8./:&V#*CVBOHVGX*OM)TH.)@/6
M:@90A;KJA*D)0D)!$ 2E 2"8G)!C> )K-1<(5JA>@ @)2!/+KCT$"K:6'OM(
M+,H8\4!Z]Y)EF!&*?S%D71- 'KX)YQ$^%[;0O)'0L*:T$!Q&IP^ZR4:TQC<@
MI$R3'.?.KI5JY1D8D9\L 9G:)% 33=Z:B/"C:*J>\W)LS\E)>R]@!;+W7%)5
M57C3VU)?/R>_(?0LZ?[0%*CNF48Y?;6V#Z">6P.:@XE1(20( DK4 (\O"<@=
M#Y8I7]P8C[<?WR)#5''73L@9 _A#)V1)M(B.O)UY* _EVG3JLHHKZN(LU+4D
MN@);'V5JTJ.V"!($CGD'YFK+MQI TY,D'(V S&-L],#&:MB\TTX3:(DV40H2
MH(1Y3[A(G0JJ-1+16F0543\W@;'R52-7#53RDVS2@$Z5-M@S*"%@1(!UZ4Y@
MDZ<<S/7'%TL9B9,0H2 29!@QTQGTI0!EY^[(>$3;%7!CM/&VTRH)\N^RQ,1P
MR%.T-QRI3Y0O%D$,T.IMI#?A:2%DJPXK*PD%6T#"3@Q'0' JE3ZW2>\4$H2G
M"4ITI)Q&)@JB1(S\35A'2D.=!VP*_*N-@ SG@1>_VQCC4V3+:HJ#[BQG2(>U
M;1/(#+8)MPF''25Q[J"2D))! Y08CISF(K6O7*3*4$:ISSQSSG//>9VQ)KV[
M+%HA:1L'I(AXM,H"/.LLHJ(CA%X0[:,B+VGGXR"[_P!&CA] 5;=D+DZ@2D2"
MM4=V@1B"N3)(  ,"3 \1VQC>J90 H!1Y(.Q/,DD$"#\/QJR)DIJXZJ2#;3Q(
MB$IR1P+LD!M"]JUB%VB]]JZJ=(X1$2(J9XM&T )9UH,"2E7B68.5F-1 )\/A
MV@9P:UJ[]U;JBY"D3(1L$0G[&\$Q)]3M-)GI?W:(H=K$ E%7U<*4A]HO:,3
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MNOCD/77[3-@0E^2$ZX"JB7)4TI24M0K(*E!2E#)$IR #G<CY'>REU*R84@$
M[D#<8B1'+IC!JA!\*$5MH&E04^Y2.PC(('XDC+Z,VK9&'2IYN2@9:/X53('!
M&MEM.K6\M,<D9*E9$ZTE((2<[&"<15IVY0 4M*"B9!6G.GH4G )!!GX=<^%5
M([?D(N2E=)5$E7[SWC .E(WD<MF6@;14[<6'&;:'Q%$$? /65[.E]7@08D%2
M\H;",X2""%*$@B!.D'.#6&J[6R"HNJ.(2E49)RD @""1)Z&"<YBJ"3P^<AQ'
MQ140&0)7(+2@O:KXLI-B$8I_WTFLBKY)VV$?R,?5Q5F6P.[2%G5IU$@0F"/
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M >GF"[3_  DEI$3M![57GO$5: _P5ESRE-Y-IP9QU N7V=2$+A"2""H &#(
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M8=)03IQU3,&R0C+R,OE.U555%^/5EVPN7'#JLW2G4!*FI2(,$A4%,2#$9G$
MS&8UQ:S*4]U?,ZCA* Z$KYC*)!!C[LS58+T$&A<2S5N0^92746T5X@-Y>Q:\
M'GW6U1@/!@.FT10:%$1$^$LK85K*0QX!X=)0>[P-). !!()!Q)W@S68+Y2H7
M[4GG"2M)$21/7.^T>57X92'O.8U8"][ZH+).M,.BL1M21KKV/M>T=53D(7?R
MCR J%X#ZLNV[*1 8*(/B6009,GWM(TY)@F/3E5P7BE>+O$+5 YISY;P(V_WK
MR@NR9)O/Q:^8VP9,M>39L(KP_#[BHH3$(FU1(XEVB@02%3X)%2A;(0D!MU4D
M2=E(@C(.5DD21&G'*0:NIO"K2%MI5G)!S'0$$CJ#^,35I]Q3=]@8\Y@&Q0Y*
MQIB/,=DA*W'%F0Z(*"I^ZZW]ITH*T! K;Y=Y-O9N*0I:EI>$0A)!0-2A!^R#
M($:<$3TS6/<<22E02A)1$$G<3(R3[W+/IU@58E3&P\?%R)[[JEXG80/MG&D0
M?W'%DHD8?Q14$5!HU(R$>T%3)+K?#5%1+B2V(]X$+F,E)U0-1@08)VWJTKBI
M""I.AP[8E*I,1@#('F2/7%>7%"/&4W D(S\&JH;=NVZ9$(B9)*%)SSCQ*GXL
MHB*7PB_RZOBU</A0VAP)]T$E) .5 RD D]/M8 DUA^VM@ZW%%"C,G:2.D'S/
MW=15EA''2)SR0R$/]!#>\1B@?\VRK9JFPV1#W[SJ*+CA(HM@@H(^LH6K24A/
M=IUF3JD@A1RH#3) F,2#&!O6.N^6YJ#3A4@$>$%)*ADYU$#'(R<#/2D_W/O.
M%'850!M/WRB*Y7254>Q< (;I?;/KY?B]))! 5[;;4W/,F[S5B4$.E:CR2U(T
MJC)!,A1Y#()S Y@8[W$T)!;"$I) !6E6HH.?#XOM]8Y1GI<.0W'#MD@-[M!%
MAE3K9YDG8@)-!TU*%$[4B(&HH ).?(*J^K@MU.K <;TI5(,#5IR,@Y5[N\P#
MN,@3:=O6K=E3Q>"0@@@:IDJ.83.3&3'2.E)6T-UXG3,7IA"GGY^4&>(BO2BT
MZR@"['#Y$!$1:<55)UXR,E7(%LEA.D-@-A<@&5!9R!,@J2")(B(V!SG3N<0>
MO' X+DPDX0-*4@#GI)WR-Q.8Z@)G7CG/FQY(0@JB0O=19SQ!_I19F15$7H[2
MHB.@'N"\XBM.NBV)HYEM6*4I#[B%)"RDH2DZD@+!4"9\0( B ($D$B*P+SBK
MI+MHVZ"4D*+@"2M)_HC(TB<G)) @G->7WT:)$02.2:H+;1*D.8ZHAY+XOM(4
M:8RV/9$)@;0)VKKBE^*WA:]\HEJ8F%+$P1B2HGQ3 @#21U/7$/% B.]"8$9!
M\2U;^Z83))R,#IBD@#V1$Y^XX@JI-HR(JT/DJJ)UR],/ J]H<J&HR'U$1120
M!$<WV4,_V1&DCQ'.HD\ASR<&8Q!(S%:PWZG5$/2E()TQ)TB3& >8'(1.>M6G
MY:(0ML$V;H+X(\KKA,QR5$5 66G4J.ZJJBE!D^XVJ^#)&"$'>1;6#UPDK(+3
M:2=1.#OC23@R<?'X5@WO&+:Q(0%H==4(0D*"DA2@#XLD@@28C>-I)JP@$).*
MOD3IIY2#-H2<-%)43[J&"(TZUVJHCT-!153H1$!<7UNFV4-(*$( !!D'EF23
MS4#D]!) KEG[AVX=+KJB5&?() P !M  &=]B=S2:1+(_&-'\"7Y03]WW&A7Y
M0AKIJ+YI*045%8=1$;1%1$1L%\LJSX8E]T.K"NZ0%:DI 2EP]%:@%:9YB3OD
MF8PKWM Y:MEA!0M\A&E7O%I,&% B0%3R4 /A5MHQ%/CW$)OH2> %^Y;5?Y)-
M8Z7[@5557W4%2/R5QM$55>];-VU"<--R @Z4"24JSF3F=H!\.,;DUS[=]WQE
MXPZ 25 B%"9U'5$9)G)  I"<I))(TVK'VA*B"B*AP+,D5%_;5?)(XJ2*H"/D
M,D_(^I#8^9YEGPM>@7#R E9RE(WU'^OE$>+&J=XS-:F\[1H[Q5C;.A:1ET@P
M3$ !M1.WV8! F=YRAO;=JCI;.Y.%;604T-^<=94L),R(VX[:F3-5&)YM;5]W
MQZ8@BZX],=08['W$D@BEG6]HNXN6+36RQW[O<H=N7 RPEP@J 6Z04H3YK$21
M)VJREYKNB\IU#;:1J6I:@GN]61JR-SB0<D9.]!&[(\'7D$&C5";;)%"(ZI_
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MS>I!*8<;;$0KQ9#@.X.01N#)B,G07O:5Q@KM>'N!6%!U\C^R/]34D@DQ"B1
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M2V$I*UZ4I(*1))(0 ) V@ P  >< :^UXHL:ENK)205+<$!?]6I>08WD DR1
M.81M/K+0I JLIA?VVXK_ &DF,TG1#TKBH7O.KXOD$GQ=\2;[>1&10LU'#?96
ME)+92XHI4X%@  \])$XV(! V/2M7=\<]K>"FUA;#80EI:% J)V4I?BF/,F8'
M*O$R6B(#+1K(4E4C$E\)L%M$3R-LR47$>7\!9!X@<-2)[WG&VU;*JUX0NZ6L
MMH 2UXBF?"M0DI QB#$IQ(G)V--[VB38VZ0XL+6^=#:D$:VP(!4J")!!@*.H
M](%6@0/!7&B4VT3P]\0_>#Y12;FQUZ5].R52)11X4-541)2>7.6GNSW2TP4X
M#>GF1J(T#!!F1$'.P)FM(AU+X[Y"DN!9*BXE0.QP5DY\,"9&(Q'/&NRW7T!I
MDO\ #E\M.-.=+(3I5[JY**A,(H=]MD:(X"*C"BSY2'-C;<,0H)?>3I($I:(\
M.-]22(&,QD;$<B=3><>>;[RWMU#(*"Z0%Z<9*)*@8!( ,1R Q7EM5;%11&U;
M7H34P\67%3KIN4TJ=Q9/?BGO"" 1()$*HH,IM"RA:!I "AX=H3').),>@SG&
M]:!FY<0J%*6XD#Q**I4H\R9,&?-1]:0O3$D%[0$ZC#2*CCO\Y8(OPC8DB%]W
M +Y4S)#]U15$]T44DS[7A;@!>='B'N-J/ATD#ZPP"5?W01ND9DUJN)<?92I5
MM;*U!0TO/HR4@R.[!D:1S64Y@['$>_)$'R_:3W?R5"5$@S1\/-2 E\O9=4$\
ME_FBIY=B\@HZ&80N2(DZ@- SJ5$ @'!Q WDD;8,:,.HC4DQ$E*H!@[ZA) )G
M.2)(.=S6%<EE-5#%3*)'/]IOI?OHSJ)\2"5/(W6NNT:#]Q2;4G%5\'$!C=6?
M#A;+6XZC0X\T "L"$(,& HY2J<"!$;J.(Y7BG:)V[2&+9]*K="R'%I)4FX6@
MZ2AP$Y2G^D@I)&H TJ_4 C-$[),/:41\713RCRQ+H1#Q[7I\B7Q;!%)75)/:
M5SLFAK<L%/K"&T%:G%A @$Z9G*H$A(ZB2# B*HM>,HMT*6XL(0V@O.H5X&PV
MD05I@R$IP%!("E2" 0,:^Y+.4ZCZ^ZB,+VW%3\I-<!(B(3*HI(^!H/9](:*B
M*T'N,@C =+:<&9L&2TXD./*@K=*01JS*4Z@"$C,1$DD1B*X_B?:-WBSZ7F%:
M;1HGV=H&$J$#Q.)!.H]"H&),$S K(LF(K/NO*VCC_0M-ITL6R<)%\ $24D:D
M*B%Y&B+^V*FJOM@K39OA+S]RAEEM;C:R9=$D( RI2A$%(YR8CE5E?%[>UMW+
MB[<[GNB% @A+[IP4!N5 J$X@J'H08&$&2;YK),W7"%1\Q[7[N!_/Q%C^LG(@
M_EXCVXKGYJJR4,P'HVN&,632F$MY6=17[VM4;F=XW3@Z>6)%<G=<9>XH^F\6
MZ5I0"AIL'2$"9 4DG"H!UQ(F22>=JPNAB-"K9,K.E(B,FGY090+^'NR0%?VC
MZ7Q;Z52</Q;;,P5UIN_9<'=NW='A[@RIQQ6HKPH2E"M)E1))@E((!)VJW>]H
M&;"U4\[#C\)[ID&%%:MAK!"D)1.J0<Z0F()C",N>2$0(X:B2./,F2_<LFO:H
M_'<3Q]P%7OQ$5\?'MMGP0%C+TAM$6[:;?N@EL"$>!,$#&L0" HX5DA6<<A7&
MF_<NW5WBKA2W7%2I4J2I1R=*DCU@)\21$ 0:06U\;:)&8<1'R\0>L6T\15OO
MXB2FP\4"0XB^)D*MJRAK[:QG76T3,X5V?1<O%U\N"V:T*:&@!3A!DSN%M@B,
MDSD!(C-CBW:(VEL&$)0;Q0&HE146FB!I6DSX%';PY$R2.6.CNBX"MM-^!(B$
MY \T'Q\%3MZO=10\$!414%%;0?Q7J.:JI] ^RI![I: 4'#8(E! !  &1,>%.
MV0 -A7,,W(>)=2YI6!J<\1"TG=4F=1"E$DD$R#*LR*P-ED!S%$([W^$:)066
M/PL@VU[5B<TGC_AFE^/-$#R-2<46!$'']GPKLZVA:[JX0L+4E)90M,=W($D?
MWIF!MD0>5:;C/:9TA-G:+2H#%PX(4ETC(;1G8" X?#*P1!]XV DM@).=I'1D
M5D.QU<0! &_ZI$!Y5%!Z1>R1?!![3OV5)?//>M' H-%LNAQ00B)(451 F)!Z
MX&01*@:P+>]:+8=0Z&E)25.!6"V$D@DC T9D"<BM6M;Y^U3Q%Q AHJ@A>)-C
M+(/Q']481$5MP?A&NQ% +Q5P1-083J.$]GFK%7M#Z4N/S*$.(2I" 8(*0I)A
M23)2H"9S,BN=XOVD?ODBVMEA%L)UNMK6E;BP3.4D0@P I)(SJD9@J:%BVN[.
MMHZV#/L[>QE1J^M@P8[LZTD2Y;@QXL-B.P+C]BU(?(&VFV@=>4U007W$[8R;
MZS2VA=RVK" %+0%!,"3*D@G2=CC"IP,UC\':ON+W]CPFSLKF\O[Q]+%I;6K:
MWGGG5*2$H2$)60KQ"5J3H0#J) "H[^<0/I?T^.L5&PN1\&-<Y (C+JM6BXW*
MH:3R$5!<HD,D07,E>A<6@8<.EBJ -RW+/LH['.NW*G,)E*2,G91Q&3.!$8WF
M<U]^?19_#QPO@+=IQOMJRQQ;CFE+J.$JTO<*X>M201[0A6MOB%VV<:U3:MJ
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M]L>WG$]M%$OMR_S^,6ZM>Z"4%3:5*@^ :I!Y&$CF<[Y$5E6?$M9+BE..$3I
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M(U0/+7/LJ(UJ6=""G2@I)4HGER5&V95@=*Z"RNVI0VVDJ=*07G"1I0F-S_5
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MWMY>>25N)U1K+BX!!R))3@;8Q'*K\68^Y[SS<< 1YXT I#O9HVS^R'3;(D!
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M;5'6R_%B8R/0]H/2B*HBBG\E)@E05563%5VMW9*ME)!.IEU1+:],)21(*3.
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M I%)%=!")(]FXWV)&/P2*D9%\0[\U![LR1YD6C7/X%V>]D4GB=RWK<>0H6I
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MO,M$BOQFV]B9&V+2BJ)(%!;OO$14G&W43Y4C==[1!%%7E4WO:D0!QN\]/:7
M,_\ S$_&O/?_ .H?$$B4<7XF=.5%2UX]-3KFJ3R@'GT U21LS+96TL)V[?W>
M3YCL' 6YK>N\BSZU78CF"39HJMC/PZLSF;?T>-W-G$$HTN]IZZ#=O0FBA'8.
M1#^W'*:XUVP8 [OB_>!)G3<-M/%1@XU.-K6!&_B@<HDDY5M])W%6C XK=%&\
MO6S-P/\ Y:T=X4Q/NK/IFF?SRE@YMEEYF-Y;6J9#E]S:7MU8R(<=UN5>6LN1
M8SY1M0H[45D9+[[[@M,&PQ&1I666P;4&Q[?@?TE]L;!'L]U9\,OFT%.G0S[.
M\M*49!>:)4-LRV03G3D1X7VU[ =D^U_$[[CS_$.(,<4XI<O7M\^F[=#"GWC!
M6FUN&@RVG* AEI20VA 0E02#+8RM<6<-0&LL*VX;<)]Q#;=2*\KIN./DRK1F
MZRA>!DH>4OM4;<^$\53UZ!PKZ7^'ORWQ+AM[PU95)4PM-VW@@$A:NX>*#,@!
MF2!O@ ^/\;^A7B-L#<<*XQ9\1:2 C2ZS[.^D)!"$DLKND**A[Z]:$E62 (K3
MGZ.XJB=2?73(SCK\AQ3-HG&" 7/ "20U[D8D1GV/Y/*J>2?">O0.&=J^S_%?
M%:\7MEDX*'7!:W).,%I:D.DC,A.H#$G85YKQ?L;VGX2=-WP>YT!()=MV1<M$
M"947&4K@;&5Z3&X&:Q+'9J^]VBHX^0C_ "3H60;95._\T]P'%3YZ3M5Z3M57
MH$*&O4%*TDRA84HZI&Z53*H$9!,#GC'+N:@D-D#P#2I&@ H6%Y"A$@^1B=LU
M;!MMR1),@ E#V8Z^0(2]@"OJO9(OROW"(J=]_C\^H4E+KA"@EU!(U:]+@5L<
MZM4P0(F8(Q&PN!YQ#2-#CK:\JA*UM@0HI!TRE(D&, 3DF9I5&9$Y3AHV'3+(
M /0"B(;Q*3B?R04(1:95/^TB'\=(2]ZZ]8MN]0GV=C2 92EIO45&#LE(4923
MO/Z;>PN[U#!/M=R MP:=-PZ9TSJPE9 VY[F>9RM_-938BI#[+1NDHFH]$]VT
MTOPOSV(2!7_8BI_M[3!59V3I*%6K)1@J0MI(VYZ2D$B)\CG!Y;9GB%^AMU3=
MY=A2B@ A]X$@'($JS Y 3R$S 61B966VLIUM&V0<?/WW!05)1]IH55PNE\O<
M<,$Z+Y97I._E-=Q"RM6T-IM[1E)4L:0U;IDJ&\D()G;<C\9SK.^OG.^6[>71
M*4@?67#J1I,SA2@#N=P1UY5DAGTR2XZ>['<1I3?<6.TLE.F4$&P4H[;GBOO.
MM.#VHI^TJ]](O6ENK&Y6@(;M2%$C_I(28)&0I03'G!%;6ROD!PN7-T5);'@)
M>*P%JA.-*E2<CT]X=1DW+IN6XU%AQ7'.B%\R<1N.V@,$A!VJF;XJKRLDJ*QV
M0"8]+V2>L1?"KJW +A2T#, D*)CF U.V=R/EFMBCC%HX5]VZXZ4 CPA0 6#[
MLKD$F#Y1.Y(I2<Z6Z^R!G"BM@HOO&:D\@HT8JT*FX484(W_!10FE$A:=^.^Q
M]85U9Z$%*G'5]X"GP*G B?$3MD04D=>59%C>)<<+J6$(2ULIPA)#GV<$HGKE
M) I:-B,R4VVLJ=-:9ZD.BP@QVU4218XH\TL1HT)U%=%?=<^(Y#\J2>M9<V 2
M@)0@!2B!J*M)2G[1 4>>!@8\L5O+/B*M;CI<2@-:VQW0[W6O *1"%;2(4,&3
M!P85MV+9RD\0BQUC*CCB@VY.DN.JBJTVXVP@$)M]>^?FKJ>Y["J1>7?K7N\,
M( 2E*E%P3X4(!*=@2J!$G;(.QY5LK?B23]:I2CI!T%:Q 5S\(A1QG ) VVBE
M3=FLI]3<<==;CDH"+SO@1O)Y(9?8UX$K[3(EX(,@@[,C0U0FA)=9<<-2W#1R
M0E2UE0UX)@(,RDP,DI$XWR9VEKQ%8'?(2O63I2$H2 4J^T"XDJG^],Y!\POB
MSVP0I+RH(HIHQ'8ZC^VT7Q[R1X"29RNOKXB@NNL*C8HB>*O. FDN;5QQ26VD
M*2TTF2I2 G6H8D'3 2G(&1((W -;^QO&[=D+=(<N75*@:TDM()!2A0*B5$F)
M"9(()@<\@S8?;HX]X(,I_H2:9)&71'M/::$8BRYYND2J4AQR2QY%\&2@V)#J
MG+'O"0M0.F0(4 DD;)\ (5.\D]9)K<,\5*$A"0F50I:HT!,$:O"H).)'*9^,
M+$FE%:04+QDS7$0G'#"N:<<4/R+W5-^Q(8X(I*AN-D3;?9)[I$I8XX7 +JQ@
M'ZM($QL(&DJ*ASW)'W#+'&4K6AI+JHSJ7H"$D@DF5+1IY1N.4232UJ6+0MQ8
M3Y*Z_P!BKD.'^ZZB]K(DO3I0.M/GXJ1"?FWYND (HH:(F*Y8EH%Y:"2L1#L)
M0K&F0"0K&\I'O"3B:S4<3#J] 6A#:=*E>);BDQL2ALJ05*5R2D[A2@ ":R+S
MI"+$=B$(>XB,@Y,D'(D,L **\J(GO* "VBMBH2PZ<<#I!547UB(X>5I5#B4F
M5'ZM"2L3D:5*!6L\CN8D8%9Z^+P0I2'UI0I( 2>[$@ B C2(GQ&8D3.9%>I=
MFI$W$?M8\47B$'6658CH,8$4WA572>DAYMC[(D#H*A."J)_+JR>#L(0OZMY]
MU6H@J"@ 3D$F0"-\3SVVF6N/7+K^>YMD %6I80E1/V94L"3/(& 2)WBO4FSJ
M4)ELG''R=? 5<5F7,/V117'A1\P=_$V@-KM'?$/=3Y1/CU0GAER&CW%H LDI
M!*$IW B5*C$@^(&1R,U=7QQ@O!=WQ!+@2DK6 \22<Z E+7B,Q&E ^%*[#(V%
M;1EF+*<*0;;*^2, V0$OF^*J3ZF/; .HBJU_4J?S_P [+'9KB"E%:U,(!!!!
M.LIG) (6=O$H3)G!Y56KM9P9L%04Z\4IF$,&,S!*G2VK43))A4#,\J23<EE$
MRK0P&1]\VX_92R,O%XQ%U5 8S:+X-*X?XN=_BO\ EVOK,:[*$A17>\Q[C6J
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MAB!)SX1B< #%>;V\6R?C5KAB$F"RDIU0Z%3<>/Q8D@/7X$R#:^8*G0F^BH*
M0HM/9KLZFU5?W+B0JW? MK91)*0A*@M82L&=044RJ0HIA.HI)!N]J.T"KECA
MUNT2AU!7=O:3$E*2A!4B2"E2=1"3X0H Z02(O0;!4;62J@#\0262*JH@;7CY
M'\JA*++P@I"2>7M&'2^:MFA4\2X<M)+."X5'N%Y3WN90@%/.<0/%.><F.&<1
M;<;[\R&\)>3(^J)'B40HQ[IF<B!SC&I.V_ZI*.::D$6:XB,"J].0" ^F6_\
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M7MK)I##QL+9ND"HLAE A,NCXJO3K:*W!)54'%0T\21$!T0'I ^)'9=L^Y;W
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M"XDJ #>H?&,C,3\_*M:[VE4VXM";0*2T$A2@LD QD3,=>D3ML:&LBF'(??\
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MST.,VH& "5*QH7&% DXC>9 (&"#*2)B$3KSLUYM2<5%;%1@/=_B;2$OF3O\
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M2.]%V2HMUOLY?P2Z$,HC4(*'5QN92C4 !F<S D@5?%U;DEN5+4HRDIU*2%
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M^/2LVJ^E*A%QM_Z47U$O_C?I#_Y1-$>E2=D^GYFIN^E11Z4H]*4>E*A#J_\
MZP;F+_NU\&__ !IS5]*GD/4_@FIO>E11Z4H]*4>E*A!$_P"LCR#_ '(,/_\
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M2DG?DP2]?"HJ=(9*OHURP4+6VXCQ(GPG$P.>-C$XCK,5R39TD!2BMMP ZC
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M#-+_ "BXW#DU)CEYG>1YY:9#*SG)K:?25Y,Y!D=E6L,K%@L.&JA1DG,[08C
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MJ+T*$O2+\=(@JORO2)X%VOP/R&U4E(2< I4!*09T&)^ !D"9,;SO5]YEXJ6
MDI?;40Z%),PDPH&,Z@H9!)!$@#G20G$>E$TI>*,H21G?C\WD3]Y57^DC%.FU
M'I$(4>\4Z[0+2&DZ]:H)3"63'B2(4)!(,!75, @;Y%;?A/"@FU<NBVD"\25)
M23I* D@H* %#<>,%0,DB,ID[5AV+7^<Y5CN&XQ >L\GRBYK<?IZJ,V;CUC96
MTMF#"8;\ 541Z0^(B]X],"I&[^ FBX7&^*6O!.&7W&;UY+%MPZW<O+E:X*>Z
M:E10E!4DJ6Y"6VTE4*>6@09@YG!^S'$.T?'N%]GK%ARXO^+WK%G8!M!4KOGU
M!#;BX2I*6D!2E.K*2AEM*GE_5MJ-?=EQ3X]X]QAT7A&H:)(\B120$FY3;LMH
M!9!F%HJ3,BN7%41<)IZ>9QZX7NW(U5%@1%54CHOK\R.UO:2[[6]H>)\>O2H.
M7SY4TT3(M[5L!NUMQ$)^J92A*BD)"W-;FD%9K]J/H^[%<,^CWL?P/LCPH L<
M)LT-OW&G2Y?7SGUM]?O;DN7=TIQV"3W:%(920VV@"1?KG*[.H0<4_P#G]^IE
M_OIZ\_\ IS\"/2JE;(_PG_S54W_2J:/2E'I2CTI4(,"_ZR/E9_N0?3]_\^?J
M8>E3R'J?P34W_2HH]*5P2YU\".47U$MGY?A-]I?@UH'2V/6K-5B'*7,L.L-]
M<S;N!$C1'V<HUB%"[KVFU-'^[61&C1+_ #JWMXCT*%/^P,41D55A02,%1)Y#
MPIS,SO/+D/6NM7%30K_&#CYK+0TG:^SMX/ZXIIE4YM+<5\62[$RE9UW:7:'=
MVY").1*@;1*#&X)$^5/B]52TY2YBP%EO*I)DDP!/(;4[6;9G0Z]Q6ZS3)RMP
MH<?BC,LRH<9R7,;=&"?:CHL'&<.J+[)K=[W7F^XU143I(M^;Q,HRTZX"HI@]
M6<U>,6Z<HQ+"]:[1BY#DV<X6N?XK5O8QFU =KC/N3O;<23DN-4\*'=2(5;.O
M8F)V$F)EDW%8Y9?$I'L6)NW-4P8GSCXU*7TJ*/2E<U.%VYM5Z&^F/P_V%N+/
M,<U[A\+COIR"MQD<\(B3[:?B58U64%'!!';+(LFN9")#HL8H(=ED%[/-N!45
MLV8ZVP:JB"5&,Y/XUGOXLY:\L^FM;UF1<+./\U%%S:6P,:K9/++8E2ZB";FM
MM19+$L\:X_5DUM%.'ENZZW*=CHR1LNZ/PZ>D*_;?O]_[U&!YGIR^?/X?.E62
M?3$X>Y5K:1@%IKJ8];SK&1D-IMZ?DMWD>\K[,)L>/&L,PRS;&52KO*\UNYS4
M5AEX,NEW-0U#8BUT*JB5L&!#B])V<[6\?[*70NN"\0<MI(+ULL!ZRN4B?!<6
MK@4RX""1J*0M()TK237!]N_HT[&?21P]7#^UG!;>_*6U-VO$&Q[-Q6PUY)LN
M(,A-PR-0"E,ZE6[I [YEP"*X$93]+3<U[E7)!CC[;1<[I>/.[O[)$HKVQA5>
M<Y$R]I;4&WUM822HL?'7O9:VVU2_9+;0GWWJ%9<=@EL B1?H#L[]-_ +]:6>
MU/#;C@KI@?S#@Y7<V9( ![VS6?:64J)40&7'DIA(TA,D?"G;_P#@?XI:>T7?
MT?<:M>-6SGU@X/QW1PSB300HE*;?B%HV.'7JU$ ?\Q;\+"$ZH6M2\1.J.)6\
M[31+?)+*(E+JC426-K7-9!NK)*'5-@Y;4UU88U^E,8OF!UN5R+6YN($RLQFK
M@U+UIDT@F Q^%9',AB_U]S]+_P!%K9\-]Q^\( 5">'*""KF-2WFSJ@D$Q&\'
MKYA9_P &?TQ.I(7PKL_:AQ)2KVKCS?>(3*2%:;5R]2HI("P%2%%.>1J6W$OZ
M2_(3D1.K<OV7&L..VD7%8?;M,LI)0[OV!7D:$;F):VR.+%E:VJYC"N#%R'<%
M?"R>(^(J6FY]9(CVA^>=HOI_N!WEKV-X0UPYH@H'$N)I1<WB@2J5MVJ2IAJ9
M$!YVZ3&%-Y@>_P#T?_P0\)LE,7WTD=HWN,N)2DJ[.]G>\X;PI*D_9N>)D-WM
MTE0 UIM+?AQ"YBY>3E7:70W'+4?&3G34Z_T_BX4%,?"BWL+B?*ER;3(,FNAW
M?CD1R[R*YFFY*L;!UIM1 !5BNKVB6'40*Z C<1OP'BO&.*<;NEWG%;ZXOKA9
M)*WUE03.2EIL0VRCHAI"$#DFOM3LQV1[,]B^%M<&[*\#X=P+AK61;</MT,AQ
M>Q=N'8+]T^?M/W+CKROM+-=4.D_GU\I_)?\ 9W_/UK:Z*CTI7([Z@O*[4?%7
MDOP]S[8TK([QW&<.Y/VQX!K7&['8&S[:+;XM@U+3OUV%T0NSXU587(%5_P 5
M7[E)A=9*$UO,DJF&W'@54 3/IORW!W]*8!>8FK.4W<SE;S P/BYI24AN!Q7U
MAL"]Q78.45PJ@N0^17(UN!C=HS'E1R[M=7Z$?Q>DCMK(B76W=HXS*=C>E(C8
M3YP#@[8S'J?@ 1-3@UUSK^E7JC$:/7&M>77!G5N%8O$2OH,*I=X:3P&CI(@K
M[WL0:(LDIX\3WR=*49!&%R8ZZ[+<)YQQQTE00HY()/4@TS6POJ[<>,CS:TTQ
MQ,VOQSVKL:L]MG)MI;#WMA&O>,^LU?:1SW[/.G;9Z]W!D$5EQN4U@FD*?*4-
MU$KLSS76H2&[9M4Z2(D$3Y9/I_O\)K==3X1Q;M,SHMS;^Y;:GY<[[HY96.+9
M/D6>Z[A:MU)9JR2G_=]T=5Y1<8EK-]B&XK YK82LTW+/KR.-D&T[B"81FE,G
M ! ],D3(DQG\,8&*Z*UF>8-=>'Z/F>*6WN>/M_IF15$_S\P]P/#[68[Y>;:*
M8^/?D">2=C\^E4UM(&#@B;9"8&*$!@2$)"J=H0D*JA"J?**BJBI\IZ4KUZ4I
MLMN;GU5H;#)FP=Q9YCFO<0AR8T#]7R.>$5+"VGFK57044 $=L\CR:YD(D2BQ
MB@A6607DXVX-16S9CK;!*1-1 _BSEMRQ_9UQ5Y%PJX_S?Q<VCG^-UDKEGL2I
M=Z%QS6^HLEB6>,<?*^:WYE"RW=M9EFR 9,V7M&8;/^ROFE58&^?*<?$C)]!'
MKRJ2VC.-FG>.M7<P]8XL42[RR8S;; V#D=K:YGM/9U^TU[*9%LS9F53+;-,X
MN4;4FHLB_N9C-5$4:RECUM4Q&@LJ@F?WMZ4^WI44>E*/2E07S#F:66Y1=ZHX
M=8%_>=VA16#]%EN5P[W^&.-6G;EGIN3&VOO-NNO*Z9D-4Z75CJ[4U/LC:41\
M6V,BQK$ZZ5^O1E3'7 ^\^GZ[;^E&&\,4RG*:/;/,//%Y/[5H;!B]Q'&Y]'_#
M/&[3ERRON1I.HM%N65Y5G?U3BK^G;1VG;[(VO&<]XZ3+<:K)*4492>F!MYD>
M9^XQ /3>IT>E11Z4H]*4S^Z=^:@X\8LSF&X<XJ\.JI]@S2T$)UJ=;Y1F61RD
M58.*8!A5#$M,PS_,+'I4K,2PRCO,BL%$OLZUY -15(!.U11\^7_+3M&AR7@O
MQZFI_IW0H;+F=LJK/R1?9CFF18%QBH;2.8D+LD=A[I*(ZHE$TKE$5#94P/,_
M</U/W=)J5>E./^G^.^,2<3U!A-=B<&TL'+K);59%A>9AG&1R$ZEY9L/.LBF6
MV9["RZ<G^OY5F=[>7\L4$'[ VVVP!0DG>GC]*BCTI5I]]F,R])DO-1X\=IQ]
M]]]P&F6&6@5QUYYUQ1!MIL!(W'#(0 !4B5$15]*5 6SYB95NNRGX7P0P:HW8
M_"FRJC(.2>93+&BXD8%/AO'&L6*_,:ML[_D%D]6Z#@%B&DV;#&PL&7:3-=KZ
MXFJCJ*F(WQY<_P#;X_?6YZOX:XW29I4[IWYFEYRAY#5!.2*+8^QZ^!"Q+6$B
M0'MR(V@-.UQOX-IJ)[2E#7(*QFZVK=5RI#S79V7( N(I/(8'X^IY_@.0$FIF
M>E11Z4H]*5&'>/+35ND;NKU\3>2[3WGD\ ['"^/.H*IG,MP9/"%Q6$N7J-)M
M?48+A82$6/-V5LZ]PC6]6\BL6.61I1-1W52!/01S/[R?(9ID%X^\@>4O_&',
M++AUCJ69V<?A_H3+[>- NH!^2MQ.16_:QK'LPV23[)^W;ZWUFSKW5JH4NAR>
M9N&E)NP>4P-OG^@Y?&>H@U.C#L,P_7>+T>$8!BN.X1AF,U[-3CF)XE2UV.XW
M0UD9%1BOIZ2HC1*VMA,HJ^W&AQF61525 15555%;+Z4H]*4FFS8=;#EV-C+B
MU]? C/S9T^;(:BPX4.*T;\F7+E/FVQ&C1F6S>??>,&F6@-QPQ 55%*@%-Y;Y
MWR#DRL6X(812;+IQD.U]ORQV8%K6\5<:<9<)N0[@+E:[!ROE!=1#;<1B!JB1
M6:P<EM.U][O#&;2.=>XJ8C?'ES_0?'/E6T:MX(:GQC+RW#N>0]R>Y#RX,V!)
MV_MZCQZ6SC%?:KYVN.Z>UK @-:_TWBDHE)B3&Q&G3+,BA"P.P<TSBQ96T<4U
M&(&!T'/E)Z_AO $T^UGQNX[W7G^L:$TO;>Y[GN?J>K<&G^?NCX.^?W5$[Y>X
M"(+GEWYBGB7:?'I45H<[@[PML7@?F\0^,$J0#@/-RWM"ZL*;'D-!X,28TO\
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M2*H/ *HO^:>"$'=Y.E8B,IWCD1N1SQC)'SBMSQ?A8!4'<L/"6"5"02H $B0
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MN:[+O<MRNY>%)-YE>3V5OD=W+4I=M:3))$ZJJ:=3TI1Z4I!:6E91UMA=75C
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MW2$)0V/Z0CW,<PF3CG."*K-E*X[']M$]R.A.N@JITA&J@C2_S^"%'2$D3X[
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M6ZZM%.&BGD(@G<[QMGH/@/C4^VN=^N*]EN/,T#S>I&(S2,M,,<&N3ETRPTP
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MB7)19#T2:F@N-6=9/CUT\ON-.LP]E;Z:Q7'*^8#$^HU5M6CD"X2JM!&2E1Z
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M?!'QP6^41Q"U4\R^R6G>\MRPZI##7?+/=71=0%K2XSJ;[O3*U$U@7)A3'W9
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M#>.P LGL3UW2?K%G#I@KCM[)Z1-B55545BW%C3TS4^XN+"OJXDFZN*BFBOS
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M5'Q]4G8).-B))RD3 .(.HYB#[NXWKHNS]@5"YOR#*3[,VDI^V=*GB#!)TIA
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M62$2HXB."3JN&':LB21B5A51(Z#[_P!:%XE[R855K?J4\UHJ*O:,S</X!W3
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M#J+<<3MBG3<JX;>+!=6IDI3=(8;>:N.[+S9:>A"QQ?">S0X)Q)Q/<B]X==I
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M^O[]/NJL"-]S@1!CSQ((Y$3$'.XB77&GZ;N?YE)PW8O*783F3XT&Q]F[=O\
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MX6Y"JB?2%T2DK9IVPK2*2+'Q/W?I21T'W_K6=USPMP'&L]KMP;9S?9'*?=5
MXY_!VT.0<K"[:5KEAQH6%#5FO->83KG3.L+)^.BL6N68+K:BS?(F3*/DF3V\
M46([,T)\@!T$Y]9))_+E%3#3X_FO?RORO7^:JJ)\=?R3X3_/I/GM>U]*BJ^E
M*/2E'I2CTI1Z4J+^]^6>K]'.S<6*2YL'=#F+9%D^(Z%PF76RMFYXN-XY<9@_
MCV/P9TJ'5Q\JN\6QK*[O"\=O+.JM<[B8CE:8?%NW,:O!KU3$_KR_>:X)7L'F
MM]0BNE;@T_N.CR/9V&7F:8+4ZJC8E2L<7;+CWOG'<HM=(;VA/9]F81<MU[L?
M7-FWANZV9V ;&W+66-?FNO,4@Z_RW7EA,O8Y_P#O]_C^-5>$8C'KG5&=AR)\
M.PQ)F:[F<7>%VN^*\G+K7',RVKL:_P PQO66#.7>WLO8S2QQG7&F0RU-5ZUQ
MF<%-4S"Q;!',\S!RHLLH?R;.[$[MUS)\ROW8L%R+-4DS& (Z?>?C\N@ J8/I
M44>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>
ME*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/
M2E'I2CTI1Z4I+.@PK.'*KK*'%L*^='=B38$Z.S+AS(KX$V_&E19 .,2([S9$
MVZR\!MN 1 8D*JGI2L!*P7"9WZK][AV*S/UZTK;N\^ZQZHD?K-U3?:_I%O:^
M[#/]1M*K[*'^FSYGO2X/VD7[5UK[=KP4K:?2E'I2CTI6$R7&L=S/'KS$<OH:
M;*<4R>HL*#),:R*LA75!D%%;Q'8%K37518LR:^TJK*$^_#GU\V._%EQ7G6'V
MG&C(54VVIEX?$OBW7K0K#XYZ/CKB^&Y)KO'E;U;A7=/@F8KD"Y;B$%5I5]G'
MLG7+LN7(*H?\'<+EV5K8-2%R6\^_5,GJ?G3K8+@.$:PQ.GP37&(XW@>%8^U(
M9H\4Q&EK\?Q^J;F39-E-^QJ:N/%A1CG64R98SG&V1<F6$R7.DF[*DO.FJ*VW
MTI1Z4H]*5R;SSZ46*[4>V?.V1R(V[E5UMC8>793DN1R*36;&1+@>P-?9WJ3+
MM+,6J8>\^WKMO66<+C&#1 ]N9KU^AAWV/OC<7N:R,I55J(CE &!.X,SZSO\
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M4>E*A#Q3Y?67)?8&^<#=U]2X<[QSRA[6V<V4/8];F 7FQ8F4YE42W<)A5]-
MDV.M$I<:@O1\YN/T2:>>NYQJR7C$+*=4YG["I(@#SS^_WM!V(J3^S-6Z]W)A
M.6:ZV=B5+F6&YOBN083D])<Q ?9LL7RF($*^J??3PEQ6I[+4<S=AOQY#4F)"
MF,.M2X45YE45$_5/ W7-&>F\PWW(9Y&;ST/12,"P7=&7-7U?<VNO<:R;+9FG
MUV/BK>3SL'V'LS7>-9/)CL;-R''G[F/F-MF>9XBQA\W,;B.\JHJ.1@ F2 !O
MY=!Y#%3O]*IH]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'
MI2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*5PVY!?3'YP[
M6YPXWR2P?ZI>[=>ZF@UN90H.LHF*8*Y.U&M]2R(,:/KFD/&)>JLMBSS>&HL+
MK-L'B;"KJ,?==SK*+#Y1584D)C0">I)_(@CX$#RIU?\ @[N8[G^L?6*YD%_2
MJ_;:TXNP_E/A>O;U"?2*G^7:IW\KY+Z4U)__ !C_ #*_6J)]-_E8?^L?6#YS
M'\=+]OC7&F)_GVG]&FCZ7_)5_F2?':(G7I36/Z$?]W^JI=<6.-6S./1YT>Q.
M8'(#E9_%Z8VE2&\F];-A@BT2WRSRQ8=?8-AJHN2_K,1+E+4K$42@J4@#$ZEK
M)5"C.R0GTG[Y)_*N'&LOI%;JE<.<KRO:MWE<G>NOM0?4]H^/7&FNQK2V/Q*;
M,>5 <A<(I#R/:M%%?RC/&<UP[.8-O25.49U%H<:L<JA'8-QCQUB/"57K&H8Q
M*)5DX3'+EM^E*<VXG?4CUOB&0Z\T[>\E)6EV[/Z>F19-2N[US;/=@V=)4:BW
M?0\ML5U/.3D]I?8F+U<;9K.@KG)=?:WWCI>DD4,&X@:PDI5+8XO9JB4[F)\7
M+&XTSX<XG><Y/FOON+GU1K;7DZZG;)Y8W.T-=\.^)YZ?^RWL_JYJWY$4G*C;
MEWLJ)L; L-Y YE@F:9C2<=;/ \4V#.SW+=A8ML2& 3K*WR7*H,%RC?O]S-)3
MMB"53B<0F() (R#M$>E-IG6$<L^6\;ZKW&376U,PW_JGC+K?DWK#194FYY.3
MPMW;8YC_ ,/;0QS56P,CM<E_1<EO.'M''RC4=739S=R5P8,LH$0ZV1 8",J9
M2-!VDI)QL$G<>2LGX8IT,>XK<Z\5Y+;2EZHP?D=K*VV)SGW#M>QVN&_ZBNXM
MWG%G(^-#.%O4EKJ&IVQ()=OW>VZS%)6*Y*_IP\PJ?TZJO(N?UU/CTRJ@*I!$
M9@P(B#,ZB=P!RQOSV---M+CO]1OD9HC%:3;&G^8"L:BXP?2\H,AP:=R+Q^OR
MO;/(SCCR?D77+'9>(.8;R#6);YCD.MGW+^ASO-\@QG*<JN<<Q'*H<J+E&.X3
M9PU52D3!!DK@Z>2DD ;#8[@"!F)!K+3F>=&\K_ZD^E.-N^-QYO0\.\+WQ5\<
MLCP?D5=2LRS3>'+IO"]A8=J#.MB+G1M668<+(=;LW7%=79/F<Z3@Y95ASI3H
M,JL@>VJ/"-)(WW$<DXD'?Q'/K/*G_P![\=.=>-\L="X[H>/RVL-%ZMS_ (F+
M;[,G\J=F9M'SS5-]MZ^MN6A9RF2\J,,AM6M9C^22*YVKR;26\LRN<=BXZFKL
MHUI2X;7U;$9_#_?I^^50"(,Q)G 3D'EL( )Z$<Y!FH2X9PU^J+K35^B]5:LC
M<L=28_@<#>E"P..[+/8+M!R)N.3!9-C6WK"L?YSZ4Q^^TO<Z7F53=-6[!/9^
MN_UFMVN61:,:R?8,/*[Z?W^_W\JJU)R2 9CD!B(CW3!GF(]>G7+ZC$_*L2Y!
M:/SMZUL:FBJN$_U+*77V0T\J73N8_P ECU5K+,\/M*V='D!)K\J<U+@F[I>)
M28DK]3KH%3EKD5\$<?<-5"8@CF2G_+)G[RFN75[H'FQ]2'16"4&R-8[Y'1.Q
MM9?1^J):;6V7@^15N3'A^:9Q;\M]]8[1P]I9.J?JV%Y/C&06F0742CV%L"OK
MJ=R72R;&)'KXJJI"8@P05["(D  3\_(9IEZ_AKS5UOI+F+R"Y4:^E4W(;DYP
MZQ#627$/(\:O)Z<M:;D=@>E>*F+4LBGN[:<]=2:[7>E=@T$B"V_!KK#(Q9^[
M8OF9\-AR_P#4_I^5"02D#8$X.,')Y1U'P&.5?9RPCPL,C(,') M-H^XV*@V;
MR B.F *JJ($?D0BJJHBJ(JKUZ5;J[Z4H]*4Q=SHFBR3D)@_(/([61;V^KM?9
MK@VL\:?J* :W$)FS+#&G]@Y=&N4KBR63=7]3AF-8['CG:M5595!>(D*7(N_>
M@*3RZ_E3Z>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1
MZ4H]*4>E*/2E'\_2E-[B>I=6X%)K9F#ZZPC#Y=/BK.#5<K&<7IJ.1 PR/;2K
MYC%8KU;#C.-4#-Y/GW+52))";M;"?8 RDN;*>>4IPO2E'I2CTI1Z4H]*4>E*
M/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E
M'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4B@UM=5MO,
MUD"%7-2)4F=(:@Q6(C;\Z8ZKTR8\$=ML794IXB=DR#0GGW25QTR)57TI2WTI
M1Z4I%!K:ZL"0W6P(5>W*F2;"4$&*Q$"3/F.*[,G2!8;;%Z9+=579,EQ">?<5
M3=,R7OTI2WTI1Z4I)+@0+ 61GPHDT8[JOL#+C,R18?)A^*3S*/ :-NE&DR8Z
MN @FK$A]E5]MUP24J^TTTPTVPPVVRRRV#3++0"VTTTV* VVVV"( -@"(( *(
M(BB"*(B(GI2K<F'$F(R,N+'E#'D,3&!DL-/HS+C&CL:4RCHDC<B.XB.,/AXN
MM&B&V0DB+Z4I1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*
M/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E'I2CTI1Z4H]*4>E*/2E
*'I2CTI1Z4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img109617586_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_4.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M20I43<MF,MCD(3(NHS;:5#-K;JE'YA@/^N.%.HXKIRPX+=#M=*5<+$$"I+-
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M)-*UH0J/:$RFAO4OJ8T+6-+G%4"E4N54U;E5#=0$
M             !3'D8Z7]->T75,2UW*^4<18?CS#1!R&;=V'7*Q8_>DN/MR2
M:]6@YW I/9[-9U4FV1#R U4BX>9Z65*%;JHZ*5EV7CB101):"I$N;?=?>MRZ
MN9$NNU->_P"K-XR$D-;7S+6K'MD':V5!LO.YEX2Y'Y?OV49*?2O$&DP1MC'D
M?($-4K#%;C39;B2J7+,##:C=>R0>JM(C,(*K@OGJ:;:#?1R)E^OU<5JQJ+JJ
MGSFIKHBJU%767,M_GN37).1CMA'S+F0Y5FM+&I7T@XQ)Z+"9QQJ!*3K<@-]W
MK>.*7D!9>B\H6XZJA(JTR1A:3F2=8],H:REHG7;DFVD2ML6]2(7^+\%^_4*%
M;<F=;EU;E\>>ZY/'Y[]0^O%O:SRM(UEEN*><=BB2TY3P<;N:["3,::I.GV3Z
M$,U*[1B-79RE'2;'Y%<7EDP?>R,[BO0\NIVT! M*Q54N*6B;>6M14K$2^Y;U
M1V%;[D2_/GSKFU%OO)!8/9/N":<EMH*0=;L<Q%D-B2L8KL+QY)B3<8CK8#8D
MK$*'9(56T=9C@)I3H;RX8=3H4C[@;R^6YY2' :/)ANR5O%ZBML4N2[#YT6_/
M?GQ.3U:B)J9BK+(#;%3N^80RT36*D,IBWD''5$R1@&=XJ7Y53DA3::=EPPH0
M/D;*_,D21[8=Z2O)B[K>MRHRD.ZP[UO1?))%2T7+656I^OU[2I&)>V^_.MRH
MJ>:],R+??YM4DW(6UUGR.)$<6,:O D9K.2R5D2C0^47X^6YLE2#+[87\:#&4
M!1;LDH]B)>FI9>))NV.AB@T$=A7+=@[<K?9I3(M8F;*6WZS9R$;X\^&Z^_,G
MCN\:W)GYM4WS@?EW*.466,EJ3I3W3'K*6<$\,I@38-7SUE0*QM(,B/7(U+?]
M9(]003[JEJI=#T0I86;A4EHL(Z4D*'-B=<,7"M A41$2ZY?G.2]/&B(V[[U+
MAP*0                                                 #$'W'[%
ME%KGF3)+.;+^9RF:1CRBUG@B)SC;YXXW5M.<J ;-I"L7-D#!A%<2.E+B7>NV
M*KA!632*@6JM&BMF[0!K"2<4\99C47*LROC_  [(JP\D1MMMUK#RCMJN!6<:
M"S5NMR-!)65)22S!U0)-5?N7%EN63-^YHB*5RX<3>37KE==0F]<V=<VIGU+]
M6[UGY-W$O%MGD+J4T\=(1;"7>:<@,.XF-^+V8C)NK'EA4)K<GL[0@G(Q<I0U
MY"6$X@J/-!HLTI;D4"98VK%3=^S;KI"]==?%X];4]GBUB+^4+=V7V."U%4NY
M.Q'CPUW5?--*,H>>2Q Q)Y.XN8C O2\F,V6A=:[&<CA3*6"5:]"RU^26BMEM
M6$>G5+O$Z+.EL"4Q+>B*OC5<]R9\RJOKU%/SAJYLL9A?IAYPBS<7GC(N8T92
MXKKCI:<6-NIQ37&C;<*(R9P)/5:I:M@P>+4.9S(J%(S8=QDLJK"H;MVUY*/W
MB=ZLL"XD2Y<2(BIF6_,JWJF;Q9K[B7=W&S'J_P MXZ#XGN\Y?V3\X<8P&O7R
M[^P<YJH0EROA)FO*/[)#]51R-^-X70PU5K?;_-]S76H"F]=?7^O,OM3,IJ=X
M;// V0C2<=?>&>+[R.)%M9M)1ISP9&ZX83K3B=KB?R_;(WE)N&;A6A:?#N=3
MO5*+-5%)]RN-<6C.EQ15#IB\)Q.34<J?O76N^[-ZC*$["G#Y(=+P?"7BY !!
MXR#;>]A\N@K$C&LKSN*R84O$9%).)4H0]#BL0?94T;MN\@=NWB3CJ.GKRM8-
MWCQNY>"]<V=<VIG7-=J7:UQ_"F%.(!%A.6+2F,$#68Y>;>9[3=S)TBMEU-IS
MMN/;RD982,O)-:/44523)-+*L<:=L];OZMTZHG#B344-&+MVH+UOOO6_.M]Z
MWWKJK?Y_&94W,8<<&@D,IOM6!XA;:''#3>K$8"2AQVU$M/9K,DFI/KD5KMHJ
M32K-E'1'[=24R^\TXC39+.@P1+&%N@]?M4W- O7/G7/G7.N=4U%7U&U6LUFT
MQFPW&4S$!':C/9Z"CM9J-9NII1';[:;3?3RZ2A("$D$+5@@E(Z,EE"J<F)I*
MQ9*$21:P5+6K=FU112(/>                               &,/9YMB.
M68[I">RO80&8PVPOO-W+QJV9O%D1L-=*-K:\KF+1.R9-W;":E$39R];*E[YF
MNW9JIL6;MW6FBH-4CACSG1BSE8N'F[ 4GW'\JIS:H>!FBEB24V26K;NFT\C:
M52BL\6<WDA0LWC*J0TL6B!XR9O6C&AFU9K+6[MZV)5%35]2ZF9=9=8]'(J%\
M-IX78MCO*:+X"EIS+*@YC$/-*8VBRGBOGCB"D6EQYW6,F.8B>4JBR>C%"9MU
MU)5O0A25T3+:UK5QZ?;N BN2]454UU153VW&MY&V<.)DO3>S9EE*)6+()&/8
M.38)8\0O!@L)P1$TT%%?)=\(;@;C44VR9T17$C7+%;<3M4TT62+#7-&TC1+U
MLF+FM08E1+D6[/??GOUC>U_%S&PS,%.09B!(?OSG2DZH=,O78[:E<BZ)>J-6
MW.2=+JDK5;\&C;N7&W3=Y9Q]+=N7$&F[HDW*R>H7K==>MVM?FU_O/*BQIXR(
M3]5FG$<?QXUWYCLQFU#5^PUX[+M<S',:NXJF2 W8W;:Q904TA0R3]!))<.K;
M:Q\TADE$D4U/EBJF5HM6PO7QJN=;_6NOZ\_UGCNS!_#5^RMK.KWQ5QZ=TU5+
M+><=4LN2(&&M2-JOM$NEE&LM:O)00C#@U56X50T8LB'^7\I2["4G6B=VS03+
MTVPQ.NNQ+=K7K=GU<Q'6;8HV5N%S+-O288$QEB1GS"XJ8E4#97'U$5/[05MW
MJ6LGT,101V8QEM47":JLQK9>%".;3[R/0K-)//TV[)XD0U )B745<V?5U#&X
MO3MD%-T91W T4QWB:](HG)]2D\F+%"##S=MM9?D^'"J53*:V<:E;0*%FM(;(
M2UY&)J=3E)H+G+(2D132-%Q(N6RP$KB1<ZK>ER:OBU42_P!6H6%,Z'(ECQ5J
M7&#&+!9"Q4RVC'&JDTFB@MTYI'S YSZ"L>B^D$"E=MI,WGI7T:[=HUI24+13
M/Z)A0MH;OZ5B+U7555SJO[UU5]:^,V0!
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MBI"R6*"ARHJYM:Z_/G]N=?WI>6& 4@
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M>,JL>P9M+=TU1[W ,/I-]H\958]@S:6[IJCWN 8?2;[1XRJQ[!FTMW35'O<
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MO6#Y+ULOIGDIX[P>P#QRT!^SYFWNY*'>0/"F2W%5MXKU@^2];+Z9Y*>.\'L
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M+ULOIGDIX[P>P#QRT!^SYFWNY*'>0/"F2W%5MXKU@^2];+Z9Y*>.\'L \<M
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MC3$1&HQ'QXL2,]&(JN1B.B.<Y&HYSE1J+<BN5;KU4]$5'"
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M0]&= EVJV##70H<-F&&U51MS;\^=5-ICL&/
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M*QZW)19J% EYRJ24S.34Q#=$EY&#,09.,V'&D7S,Q"BXGJJ-GB+P:?
M                                                   C'FS]#/+C
M^&.>_P"53K ENJGK3[R3@$  5HXB_3QVLW[Y,4?Z+X? E=1OJ_%2RX"  ./G
M-%O.DSE=/Q@HT9*.%KLF..NP:2]CQC1-2=?MZFOV;I.6'2I6G$_[%6GSVW,L
MVZ#ZCI_>WZ=*OF&LJK#B+4IU4AS"HLP^Y6V8D)MJI?JI,Q'(^,G^(_YSM53T
MTR63M-AY.K&LBU.@08C:#(H^%,]TU;ZRT=CM#SMBV=I\NZ1HST\<A*N6#+_L
M,6XC%T7>/H1+/448D]K"WZ%$VJ9XH4WI&?=\*5Y7LS\7&4KLPZ+O'T(EGJ*,
M2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B;5,\4*;TAWPI
M7E>S/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7&4KLPZ+O'T(E
MGJ*,2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B;5,\4*;T
MAWPI7E>S/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7&4KLPZ+O
M'T(EGJ*,2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,>2LM)8O%RM*XR9,T+4*J5=
M)\OV%V(UBUJL6C]BXCZ6:KBS;TK.:J-)?0G9IUJKO&>+MT45UU:4ZUP],0E<
ML-)R&KF/AN5ED:<U70XC59$8JH]%5KV*K7-U'-546]%.G.I9NIPX,*H3=CYZ
M%+S<I4($.;[K'*-,,@SU/F&3<C.0FQ9-R,F9.9A0YF6CM1(D"/#9%AN:]C7)
MZW1=X^A$L]11B3VL*-"B;5,\4*;TCN=\*5Y7LS\7&4KLPZ+O'T(EGJ*,2>U@
MT*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B;5,\4*;TAWPI7E>S
M/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7&4KLPZ+O'T(EGJ*,
M2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B;5,\4*;TAWPI
M7E>S/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7&4KLPZ+O'T(E
MGJ*,2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B;5,\4*;T
MAWPI7E>S/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7&4KLPZ+O
M'T(EGJ*,2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B;5,\
M4*;TAWPI7E>S/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7&4KL
MPZ+O'T(EGJ*,2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM8-"B
M;5,\4*;TAWPI7E>S/Q<92NS#HN\?0B6>HHQ)[6#0HFU3/%"F](=\*5Y7LS\7
M&4KLPZ+O'T(EGJ*,2>U@T*)M4SQ0IO2'?"E>5[,_%QE*[,.B[Q]")9ZBC$GM
M8-"B;5,\4*;TAWPI7E>S/Q<92NS%NF(&S!=#W_L@G&1W3 +DBE;UT7W)"3_V
M9F,,1OU21]-3Y'5!7S2&BGU1HJ.IJU:.\,B=OWN3T6M.,X)BJG3):99^)&TM
M-QXDG$EG_/B2D:@4^6C.;\Y,#U8U70G7W.S*JW7:Y\UY3,OU/I/A-9*A4^V$
MC:*4_J<C:RC9>+?VCH\"9_H8VG)*'-S<&7J4#0W.A71H+&J]7?-O8BKT4EBQ
M<F7L%"EBT6*E;-HL6+6+=%JP7+V**;5FQ9M4:4T6K5JW33;MVZ*=****:::=
M-----!FZ(B(B(ER(B(B)J(B9D3]Q\1O>^*]\2(]T2)$<Y\1[W*Y[WO57.>]S
ME57.<Y55SE5555556]3]A)2
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M@0U>C7(CV8F.O:Y4+#Q>S2@
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M3-0FYB<CI"8KG,AI&F8D2(D-JO>K68L+5<Y41%<M^1BLZ(
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MO%AN@-B22U)(CGLB,5S7LGKD1B7:K6HY777+AO/BONJK8+-,I5B*E-91^_\
M2I^!6IF0MG#R<NI\*3FY"9A0(\I-6&1[XDX]8B(L*8CN@L@K$5S$BX+N@<9H
M?&0
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MBRS%9H[)1'Q$;'CWXH[\7SW(BW(;X'<,/
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M1H,1N'YS(D-[F/3QM<J$VQ=35(
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M-5;Z8YVT](B?6\,/X<,7IIQGEQH"[CB_#56^F.=M/2(GUO##^'#%Z:<9Y<:
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MV:F)>F9-X]C(T*620G8*QHD_%B/2:AI%BPF:31$57/;&ONA%VPRP^40
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M>-$<Z)%C18CG1(D2(YSWO<YSG*Y54^X2<(
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MGI2GQY68LK+0X<25?)S$VCX4:,Y=%5'.8F%EU^(S(^.@
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M?"UFCS<>+,QL#;\+-$C/>_"V]<+<5R7K<B7GL"HZP
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MN)(I5FTN68D&0@SZTV'#DW3$& UK'N@M5KE2_$Y<Y)0=\P4
M
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MZ*AQQIG4#O-0OH]8'X/,IOYP.G4F>M#)SKZ\/>X@:/%W14..-,Z@=YJ%]'K
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M3L9T_-I'EV(NB,AX688J([$NH34%V-6
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M<^(]SG*JJJGLBLZH
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M4K#2-GJ_*3L6Z/,2S$A87RZPX>EWPXS$57-BN2]2]H9@?(8
M
M   %"NT/=,L7IZ8TGX[L/,!GS3'S:FO'A0<+7PD8>5T>O6)'7=AMX.!PI#8<
M\UQD<3"MQP6T4FT'N24:B"Z?0GLU76V3Z:4(7*GZ_7L*VW9T6Z[5SK=GSIK+
M?K_^5+1,'V4U(XP\QE83')OP@TFC",<H" 4E!/34B1;2>FME/+V^FJ.C'%!&
M1G)<JHKNJJ.C'#"0E&J[B>EU\@+%Z:12NJOK74U-4E,!! N2]GO&4ER*ZI)N
MRWD@R5)WR<V)F44&/)6U;;3*R>T6 U8S17DEHM2 ?Y$K6FBS$ C>KT-7+%ZZ
M6K,56=*[M0$WKYO8GKUM<F4R&MJR6FA-35QNIW:H9&@CTE>ZM2NNQ8X%==?+
M%U7I+$Z3YZKA\"N_H5LZ:T444\#3@^'40:-S9^AGEQ_#'/?\JG6!+=5/6GWD
MG (  K1Q%^GCM9OWR8H_T7P^!*ZC?5^*EEP$  <D&8[6ETWE+.YE&8V7J@E7
MY(<-P@=9FS?@B3FH9+5&?[N\@2"X5NPMN]-KT^<NN*=FV;.T_MW:--1K6J0I
ME:C.*V#4W-6.]4="H4G,0U2_59&>]'Q6ZSW)>OC/23)A4+-0\GMCV357R:P9
MAE#DFQH53RYVNL_4(<1&7.;.463E'RM,F$7_ )DI+N="A.S-54(U=#IP]76<
MG52XW]X1T-!FMSU?B[(],SSOG9/RYDG^(NV_8AT.G#U=9R=5+C?WA#09K<]7
MXNR/3'?.R?ES)/\ $7;?L0Z'3AZNLY.JEQO[PAH,UN>K\79'ICOG9/RYDG^(
MNV_8AT.G#U=9R=5+C?WA#09K<]7XNR/3'?.R?ES)/\1=M^Q#H=.'JZSDZJ7&
M_O"&@S6YZOQ=D>F.^=D_+F2?XB[;]B'0Z</5UG)U4N-_>$-!FMSU?B[(],=\
M[)^7,D_Q%VW[$.ATX>KK.3JI<;^\(:#-;GJ_%V1Z8[YV3\N9)_B+MOV(=#IP
M]76<G52XW]X0T&:W/5^+LCTQWSLGY<R3_$7;?L1HC(.J>V.UV0HDFKEZA7%B
M;80:%TRZ]FKCVRB1TH\).;3>-HR8H$E,_<5G(LEU"XG-MIWK5DH[5DP3;YLZ
M2L'ZS-KNR,O&=$C)%EJBJ))SCFZ/09*&U(C9>(L)6*CEQ14>C5@PUN2)$PL5
M4154PZVU;HLM3Z0^EVAR?08T2UMD8$RZC9>K9U..ZG1[02$*HPYN#%EX22])
MBRCHK*M/L<Z+(4]T>;APXCX2,=((K'T_'N'R*+<[SG%<'C.2[)S'4QQ?#X7
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M1#V16=4
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M62&Q[T=. 78U.
M                                 4'[2:?W4V\AV$O15F-ABRF5&D03
MHU)0@#)F=X0;<<SU*=+BA,V8Q^=J6['87=+#>]Z+70JN5&?I1 /D68IWVBG/
MLGJTGY6642^;]?K]:Q4B9E147/=<J(MZ:N?6N7_QJ%D6SHK>E>!>'E4C.(H[
MGY\G*)*7<YR#U;LCD5U?MLQ)H4E,D_6BM.-KO H;,TUW2[A;R\L(ZI9JH-)Z
MB:*W+=VH0Z[$Z[4O6[U7YB9P$   !&/-GZ&>7'\,<]_RJ=8$MU4]:?>2< @
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MN342];[D\R:B'Z 0
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M,2*BENHNIJ@
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MS>M45ZF$ZPYVZFW5)/JTTMJ!.F\4N5T47=:M!*+=[%3VHJ+]2FW@(
M
M               YR=J0Q9\3)X:M<A9#9(*.)[[0'V[&TB,#9T8YYMH$436V
MS#&3(]81-#/8^2&^T3I$EJ3S<)%W.\T:U5U I4W4]Q(%!:_>U'(U4NU&WZEZ
MN5N;/G_:1-;,FLN;4NNBPV49=5L3<<%2?2"XES8H0M')N5"#F2VZA.$L^K[7
M3;CCH6T!I):(VV\IZJ55^LXWD=(3B:#?JK2*"MJHG52!0ZZ];M2];O5?F)*
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M##47&H<5$MUIYJJI*4$ R?**UJZ0O7[=0J;=?GV+O;A6[Z]3SD^@*0
M
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MAMVU0G%#EVV:<3J6DM'*W[]NT1+WS=%T\:*E:+M^@/U[-4V"
M
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M6EI:M>N+ZHA-@\1;]@S8+)QA7OE+2BIIA.N\=LB46Y;_ #*GM14_$ER!
M
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MKKY:LIIK7=44!/=)A632UWP%C)PK9L&M=+%=>H$HEZ_N<OL15_ E4!
M
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ME]*5*"]1%5)'2%^^6N"454U-94_<J7+]2FT (
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M[+M77PK=^^^Z[SD^@*0
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MYL*PL>PE0EJA6EEYE92?I\R]T::AI39:ESLG'5K6M9/QD:KL2X;@!DQ\S@
M       &L)7F2.X216TX9+7;C?2'=),:Q&WS5M)6%C4\_P"77HCQ\P$2JPB$
M%$P5H6W8OI296J&[5A)2Z3.IY7/$4^Q?-6A*(JZFLJ_N1+U^I#9X$
M
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MJ!*+<O[G)[45/Q)5@0
M                                       !S73W!C?:>0>;M>36R7DC
M:)NC)%^6%['F<6>QHDDI#38NOQ0R6<UX66'M(#R07-B]_9V\$5QWKSD;R?9L
M&[2U4]R9LVIV"]%Q^D.1%S-PNPW7WIG3/KYDSWIZUNS77%VF%4<2E#^(>,\5
M3<O]*)=CN#HS9TC+FJE<6M3CN;[32TU:HU7+VM5]>U)FR]PCJO7ZM3"WJ6U5
M;^NMXW6!0Y45RJF9+UN]7B).@0   $8\V?H9Y<?PQSW_ "J=8$MU4]:?>2<
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M<Y?8BK^!+D"
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M*OR#?S#E:'YS8?6:ZAC9_A</_P 1H<YM%7Y!OYARM#\YL/K-=0QL_P +A_\
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M'[QE'IO7-"7"U$+=>MVI?F)% 0   $8\V?H9Y<?PQSW_ "J=8$MU4]:?>2<
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MA-OAPFX8;'3,W%C1G,AM^:QJO5K&YFHB9C*1R%N
M                YMMJ=#S!)9N10[T(LO%Y8E>"Y,OJ3BDK:>2Q@K"1!ML9
MRPZCF6\SK;'3'(M'GNKW32&KJS7;!AJ-)2()1QV.-#=3F+EUIO"MJYE3Q)<O
M[#7+X]>[4SYU7-XM4N]Q":+?8.+>/[+:K=9;2;K8B5D(R.VHZD-3EMBHQ(DA
M$[5HBU)16BI)7D)$M>#7D+R5"A8^XK6NBH;LV[YFNG04KJKX\_J^HD8!
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M:=FV2LK)MC:2D9:G2UTM)09>6AZ'*2DO"70H+,:L6(_%$<]SMM#LF-@
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M#15O555=ICL&/
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M/<]60F7K@AM5V%C;UPM1$O6Z\^X2<0
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M-]7XJ67 0 !6_*Q4W7(KNKH(*5VBI7NZTW+6/#1=-NK3B[7ST.$[<I-JU/\
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MCVUF9M$QS(53F83%AUZ=NFZS"5K$T*IS*)&G8>"8B(CHBH2#'=,+
M
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MJW*LJ*B^".=+O_A*E>/_ "%N8R4^:P
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MAVOKU<9/0(,&.QLE'DJBC9=&),1(,VV+<Y[(LM#PHEZJEEXOYH8
M
M         *R,_P"9$N!GK!4@.UVQT;9)AN3*S#D+OS(8] EUZ.1W78Q3$&0T
M>S83%5+?_P#9X2K7&I?35NS8T:ZG+""Y6X:I=EE%L&!*)??^[/=?=_Y_"[45
M23F&9\VJXNPNK&Y 3)0T5F?:54][(KL<+_1U-"4E \>;I)*D1W$DYUR0G-Y
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M:B(GJ2[[C#8D6)%=CBQ'Q7W(F*(]SW7)J)B<JK<GB2\^@24
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MJJ(P2BDDII0V69:,IG#BBE->S>H1$X\;,FB9&S?OW:ZPO77\_P"_7-C@
M               JEE+$?+,_,C\>T4/'&TNT'%EC'66*#:D-OR48>9!R,G'F
M-H%--=1/-M3+)=:0I$&*<,T'2=NV?H3EJZF7*JK.EVBL57I=GOU+O%KWWZOU
M?668LC1[:--"TDBMJW'SH1HZ35LBVKV6G4I<.OC-4*TO7;ZQ01XOB^!2H7KA
MCA\/A5<'@@4FC,V?H9Y<?PQSW_*IU@2W53UI]Y)P"  *T<1?IX[6;]\F*/\
M1?#X$KJ-]7XJ67 0 !6C+=LAK)+QUN4H.MS58O<+4S%:BLW_  \7:_YJI9HU
MMG:O\[]&O@U^;3_'345)J:J^^B?4<:KG7,W5751;_N\9KKBDWZC:_1A6_P!@
MF]==??0B]/0]B\PXI-^HVOT85O\ 8%ZZZ^^@O3T/8O,.*3?J-K]&%;_8%ZZZ
M^^@O3T/8O,.*3?J-K]&%;_8%ZZZ^^@O3T/8O,.*3?J-K]&%;_8%ZZZ^^@O3T
M/8O,.*3?J-K]&%;_ &!>NNOOH+T]#V+S#BDWZC:_1A6_V!>NNOOH+T]#V+S#
MBDWZC:_1A6_V!>NNOOH+T]#V+S$<,H7+$#7C]LEY98S=?[4?,PPW%=I!IA>N
MJU:<,I2*WV(VUD[2J'DRS6GHBPNE5)0H+7[ZE63+WJ$TB>.ZV2MWKS,M+SD)
M8$U";'@N5KEAQ'(YJJU;VJJ>9<Z><O\ 9JTU?LG58=:LS59BBU:!!CPH4_(N
MT.89"CPUAQX;7JU41L6&JL=F6]%N-D8J;,C'U?5I>=$P0UCP^V"J+Z,2B%"1
MHC/,==9I5/M*QAREW'?OW+%:_JIVE-LZ$#6E=VDO6F*%.FNFM_76JP2]FY)D
MQ-NF920BR[WL63AL@(U\%B8\;8CTNT17(K+ESW85U\^]K0=T?;.:H5E)>S=J
M[<TVOR4I-LM?49VM-FI.LSKTDM)QJ;+*UVD84!63NB,PLT1(\+,NAYKLB90L
M0*%2!.S07)DB]@H4+V]/!;L%BUJFS8LV]-==?!1:M4444:>'7P4TZ:>$9&B(
MB(B)<B(B(FLB9D0^<HL2)&B1(T5ROBQ7OB1'NSN?$>Y7/<Y?&KG*JKYU/H$E
M                                                    %!/_ +1G
M]!R-_P"*)B_RMF@89;G_ -TR_P#^(P?_ ,M-GV/W$'_VLU[_ /M]5O\ _HK*
MG%*-5'JB?])K 7Z#6'7\,,%?RS;(WM1O_=%+_P#P^3__ "\,\+LL7_VM93O_
M .O[7_\ ^_GRBV,(\R>TV>R'DVBGGS%2>E;.R<Y%DR25#,Z=I9=,^JKFQ)=M
MQFJ).)7'I?9D9+Z;(9M"EFT]4I?)N=F'6U0TFU0;3'2N&2-R->+=C5/2N2Y$
M1$^=J>=$3-_X).8<RZ[8UF]WH*&W#<ND%G%EDOTA"V,.:3CS4+U.%%DM.;#B
M>+O<V5"Q"21##X64]^)M: T$<V41WZV69(*A=6EU=8:0D6A2MRI^_5NN\7F1
M;_;FUDO4D@NP:Q7+M"88.J5F;&X7?F,$ZSLYV$<R#FI.3"<GM:8<5RK=OJK3
M:LN'6"7,M@D]W4BFF\W>6,4SHI'[%)96(:%+X#Q+J:J)?<GCO\UYIZ)YVNN&
M&MGK&Y28;ZW.%S,57:$HLJR_KRA)M1*,OE#7Y+0W^ATJMUS:I+1LMPMJY"SB
M+ZIA+D2-09TX5Y)TO B:OF1?K3-]_P"_Q7YB+6&2K,+9M;-UYR'HZHB1)6B=
M8?1Z=B65>1>1^N3ZOICP[E#6$G?!#S:B:PV)*[FNJ):?VU9)U/S6NY#Z^S(]
M5513/'**Q*W?.NS^+]E$NSZZ7WIXO$JWIK7'P,N5G[%<;..]#\HFYGF!Y8/S
M>\F--<#90R-D/8ET^TDEA*BA.4TXHS*D+Z]#4T(7+#:G'Q%AN-W(%YW+JQ$+
MCM7]#;0:Y(3F5<]R(BI>BIJ:OS45,ZIJZUVKKE@<<'X<9V3N*"+B!-[BEE$E
M9IR@K3TD:Y"O?(1%6(B2X]O+#-G5SW7>]WQ9;KOKEZEC,U)>!*M!.O0B_'.D
M'>?"R 2M-T4JBY[TNNU+TN\>=+LWK767UK?;<!2                !&/-G
MZ&>7'\,<]_RJ=8$MU4]:?>2< @ "M'$7Z>.UF_?)BC_1?#X$KJ-]7XJ67 0
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M*J>(^X"
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MPYZ4<V9EM.R3YB2B18*H]L*8>J(O[*]"XK+2
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M"O)SOT5K3D*"%3,NKF5$O\2WHJ_AFU;TSYM1;'@(
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M]2VFM)5^N<S4
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MAGEQ_#'/?\JG6!+=5/6GWDG (  K1Q%^GCM9OWR8H_T7P^!*ZC?5^*EEP$
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MV4PK<O*:I<+TD4LH;/7[!>X):MRY]9R>UJHGUJ3< @
M
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M)#@0
M                                  1ZRY0%MUXHY.M=LI*@ON1R8]32
M@-]"2"EX^JK2VL1NY4Y*24PB6HN&#J@HGS)<F2*6+==XR9O6K-JBJNNFG42F
M94]:&?1U*S0E,JIFFG0\+&B/?+%E(H](VDB,E4K?-6[MVS;U1I*:;25[FO L
MW.-ULDKE)>K32V8UM7*Z*:A!L< 5HXB_3QVLW[Y,4?Z+X? E=1OJ_%2RX"
M( OLL^5N3'>FM>F3E6[8/WS&B<UL@FLC6[!2WR:W7>LM2M$.J2*4HNWK5NJR
M:KKUM7+M&E5SPWJ--:T5+DOP_O:JK[;SC6]56Z_574>GW>(_9JQK*BROIZ:X
MK,^-1&-5&-#K@N3JBJ]"=3;*W[UFK5.*MNP8,\H,V[)332W=HUMZW]+U7AHM
MU4ZRJIXL*^;"J?B$1;\^)//B1?P)"MV#]&\N)JW_ &J2\L\VF:3/-:X\-#R0
M=X--5/$'R?(+7*+&O"\-5OC*?#KI3KX?F%*NO\34]29RK#Z3O:;S%)4
M   &C)^@!H9%MEE-5Z*CD22#$FJ%)U2;[8-)A0X9=<$R6W)3:::HUJJ2LV;K
M>4E]L$"3A+%K!12-)%XW8355*.UV3]@2BW>Q4]J*B_>;S @
M
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MM%_NNK>^Y"'=H!<W9?94?*>VB_W75O?<A#NT N;LOLJ/E/;1?[KJWON0AW:
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MG6KIE1?#SCQ%EE766]$3:4#RX<4S*()NS7Y_'=^[]_KU,Z:NH6? 0
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M2@:!5ON\R7)YDO5?O53>($
M                 &+FWPRT]UI3#/N]KDGPO)YI60V8;7TDLZUE*(Z7M3JF
ME-V\;H5U%/)Z%C&IHX3)WBQ?2Q>UO7*.*KX(!HOAE/\ 3+RTPW>UWLC%U VD
MF%9HN!)<B9852&M&AY,O'T8V=*VE EK=MZ&R5=VDR6UN4:7K='#I\(&4 #PE
M!T-E).):<JN)"3%!<6-&ZBD5!73R1Q8<&J7?7-$-+*F3%J^H+&J(5,K&B84H
MO'=4LO?4.(Y):N7J0/= 'AN5SMIF(:BYW@X4-J-I(LTF%9PN56((2&EEZ[ML
MO1?4594,%2!*S7?O6K--TR8M457;MNWI5K7733J!Y;CD-@,^\UB[N?+/:U]\
M+9%LLJPXW,BHEYX.13UIT36^UK:F=*UN!;4-:Z-"*4DTFSYO6NG0N7N:U:>$
M#*[-^R9LVS!>]:,6+U%-RS?LW*+MF[;KT\--RW<MZU45T5::Z:TU4U:TU::^
M'3770 ?J -5LN=81DA6NH$=S'%;]7;!>Z;OHK+D)HNE6LE;%5%%\S=3D-7/'
M+9>S7<HHNWJ[--NW5713753K5IIJ!M0 ?YN7*+5%=V[71;MVZ*KERY<JTHHM
MT4::U5UUUU:Z4TT4TZ:U555:Z:4Z::ZZZZ:: #RT)>0G2C)CB;*TDN)OK1.R
MHHZZA*)-71E9/,T:7"YY,5$^\8)'R=^C72NR9*W[MF[1KI5175IKX0!ZP \:
MPXV\:75!K%EU&,.9(3TY756[85"-Y=3$I7O'2Z2IJ"1;OU*!)/5+Z:HV$XZ9
M+VBQV\GG;9:[=K*WZ;8'L@#PCCI;*<JHZ$H.-"(K;A/'4M 1SBNGEE5<4TU)
MNKRBG(Z??,4&U,\00K%]:.E"5F^8*I-FZHW[=LG;KO: >Z
M
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MSS<I4:^8.1DA0Z[YMUV=MZW:]Z^+Q9KOO+!@*0
M
M
-              /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img109617586_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_5.jpg
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M 0$! 0$! 0$!_\  $0@!:0)> P$1  (1 0,1 ?_$ !X  0 " @,! 0$
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M9%%").UW0\,GE2[+:8GM0H,<CQ(S2&2-"K<R1-"A9-8D(*.0$4DL*KDO8D:
M+F19B2'19& 30[!AH1@QU)I* ZE!+$ "MH=&\S_'GE=BM-8MEIM3Y"@L0I71
MIM-Y)U_I%:YE'(CF3$1WIEOYY1+15.>^X'DQC+C5O,AWXP:3',2FF1;J)FZH
MK&YF5'1$Q+GE"2:")Y<'2>4DLB/+U J-"ME@5&6!%6274$;,K,V4 ,A6.1UC
M!&1S'1&5-M^HC P3@$&N??=2TOROY]Q,*BLE.=W;QCO_ ')JRQ=2Y9B45K?1
MN4U0"D44CE-A7JR2!WTC/>U\7)ERI+0R1$*,1$/QY?/+J+*2X;6)8[N*WT'
M 5XIG;4"-0<-&!W  R""<$.<?-)"-)1[=YM0R22LD:  @XTD.3G![#!J<]:\
M@.6\3>K(^^&#F[!=7"K=/IE*HU[Z??K1H$S&D')(*A<TK5MN!$<$:FP5F2S
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MEXY8IE63!/+<Q.X1\ ]+Z6.#@'!J4=Q%*VE&8-IU!722-BN<:U$BJ67<=2Y
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M<X[A1DX]?B.]7R,RQNRH795)5!L68#(7?MD[?+X>E4<,=B\P>"V#@!OR"(\
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M1NDK"TO2NI8W8M"J2&-P%#$KI=5R-@P(VQ5\NF>2 /K7.B"&/$;M/8>20K*
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MX:CPSY>RQ)HWHW0PA^*4.2C,N>B/:0MI'V5D1K9XC$'UULLFO!A6AX4.+@"
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MRMG2P.D@'!S@E0P_.K*1\B*DF1J582S60#3:W8+?:2D0'6*H$*V2QFR#GLP
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MJZ7B_538_GFG[>$,PVH/1.J3^10KZB7-OE0Y,;MY=5)$D)1YV;8@[CE;<8U
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MZ*0*PZ4A'Y([:96HOXO-V-U&-C_EI(XYZO"U5C.'1L:$]NMS%:& ZC@B>4$
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MV]V[_P!*W[6&J)O>M_\ /7]G)5B<RU?3%*8I3%*8I3%*8I3%*J'YN<DI_3N
M= *VID@[+YA2.@="JNX4Y<-MJQ@Z4:DP')R$(5J9$2ZTC;L5>T)<3]=;5KZY
MZ?"KZ>RNEY!0<]HX9-2ZN@R+G&XP?G6'B%I#=0,)0QY2O(FEM.&"'&?B/E4
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MI"P\E+N.+4[(0#<4ZZ?H,V2XI;BGPTE^$Z[IAA<6+";4C/7'$H+P"/BL'-;
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M&UM:G-MQ(3#<:.WMQ>]K7M#+2$[6O>U*WKU*WO>][S$26))[DDG[2<FM(&
M.P 'YJI1TKDJ:AT'QL/ZZ5UNS[5Y!0F/AKA=7#@!/W7+NK*]Y(U4".G3\?T_
M2*Y[O^Y2I6M:5]<]"&;7'=+RH$_FK'4D>EMI8?7)V/K622+2\#<R5O;C9G++
MO')Z'X>E7DSSJV4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2JJ^8UMK52Y*"E64U "QY/<?&Y<=V>_IE+R 7?^:VHTXCZZWM38JM
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MAN-R%OJZ^R@\M)F0$KL,8 SU'.$./1RI)V SM3SEMACSDPAPW?.YQL,9;?\
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MG:HM=P:05FCU/D)JU8SG'6 -2C/JP&V_:M>^/-]J_+.55[BMSN@@O:^!<T#
M+"4K%0Z!&KQ !1  T1%(AIA4(Y%L)B6.C1I$@+5B)R:[-<?C#8TCV5)39<V=
MU-.\Z6LZI<S,ZJX76K2,6(8 Y10Q(U.% &-1&:A!/#'$L3S1%H8U5BI(4A%
M!!(PQ(&<*2<Y SBMH/>2G&V*Z"M3EE+?#6,E)%"E(HG072:ID1UQA[1  U55
MGPL73C:O;(&A@\>^CTNL2G6EH6JGZMOM3)Y:3*C)SI"X/P<MH8_$*Q(]15GG
M+;2&YRX8X'<G/S7&H?:0 ?2H5U)SQ5[43.\PZL!KUX(5H(^7F;-4JQO,C!VX
MD*:\[5^@,!&87R:HY&-](=0LRS:WE28B(^Y,2:RQZG";[Q+P*1;OA%QQ"P9V
M&1 [!9""0!/:MJCE0:>UQ"R8P3L1GY;Q5X1\$>-[4\.\6<#X1QV%$81F^MD>
MXM@PRS65^@2[LY"#N]E<PR[D:NXJATBDL<.JD?HOA_Y8WZH4IPXX#A\;[#0>
MF](HCI!N,]-V-'A%TZ5T>D!=L1]Z6?CUV<F2[IN-^0I><997]R/$MGQUN1XT
M\(PWMP5!;CG!.7PSBHR<<R8*ZV=[)N<1R/%&HWY1[U^)-]$'BGP.#<_0U])W
M$>#62,3'X*\9\WQ'X58=Q;6DLD<G$N#VYP TL$5U=.=C=J-A6?R._20>0=#Z
MORRL7_C_ #$7;^%7'5_*[#60P> 72;8>:76BL/@YD68CX4))I_3#$EF-)?.$
MX5BCCU$7&TCR8"5]GP#Z)O#'&N&W'$;+C?&9+7B$;PV8EM;>UGLS#.A=+R.2
M)C<2+/  3$+6-XCF,D.DH_%O'?\ *K^E/P+XCMO#/'? _A&SXKP8P3<;Y5]Q
M'B%IQ:.Z@$L%QP:X@NXEX=!-:7'2+D\5EAGRLZI)%+;#U0M?4O''R#Y%S^_W
MF?9X53 W:JVQVN+I=PDET6UNKRGV 1,$U3IYPH'@L69S;EDK<%(OY6$PZ-L;
M;L9:=_CULO&O#/$N*VUDBO.T-YPIKI-6@PBZ0//;N)$0-(;4:4E+AHG8/$P;
M;^PK[A_ASZ3?#?A+B7%XKF&Q\QP7Q?!PV41K*+F3A<[067$$D@D<+ G$W,C6
M_EYX[J"*2&XB:/!ENX/B*Y:^:4S=1J.SP6O0YW/6_P  -I"AP<=^79X,:38_
M@=5<<[%)C)!V.&LI9DE%L7M3T06SL^,Y)S_6/B@+?/YSB>+Z1S>^UDUSR/'Y
M>1].=>7@;R[O$ &M\PDF$%1N/@CP 6X,I\-\!)X##'%P<&Q@T64,-R+Z&-3I
MT.L-\OGXDN.9R[_-Z@6[8S'.T-CQKZPU<0U/JHTK':%V6M6Z&3H-JK4>8&Z-
M8R-GM0U6[2!#,EX%HLVB)DM\<N8S(GK5)?6GWFMKSR\1X]:/;RRWEW%)%-:7
M-LYFZHY^&VZ6EE*FEB5>TME2"$[&.,!16Q?"7@ZZAO;=>!<+E@O;/B_#[Z(V
MBZ+FR\0<0EXMQFUF!4!X>)\2EEO;M-Q-<.TC;FIV:X%QFQ$C1@SSBL32MB)1
M2YL@J#[,L@3BB70*)SS\=QES4B0%>6)(+:4WLJ/VF(3^[8;;0FN#Q!QJVC@A
M@XE=)%;1/#!&)-21Q/,+@QJK!AH6<":,'(BES)%H8DFJ^^C[P5Q*YOKR]\-<
M+GNN)7,5Y?7!@T37-U#:-8"=Y(V1A+)8NUI<LI4W=OIANN=&JJ-I#A\ 0/@B
MA4*(-%C(<8>-'0([,."/@0F41H<*%$CH;8BQ(L=IMB-'8;0RPRVAIM"4)2G7
ME2223222RN\LLKM)+)(Q>221V+.[NQ+,[L2S,Q)9B222:^KMK:WL[>"TM((;
M6UM88K:VMK>-(8+>W@18H8((8PL<4,4:K''&BJB(JJH"@"NYD*NIBE,4IBE,
M4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KRC[
MIX/=8[#Y)F24R1R4GXU=1ZOX]]9[#JQO6"3THH$\=*V]$ \$;K&P4RI6#F-C
MNS,6]27B=@@?833UT:<"S5RXRYOL6_$(8+50!,+N&&YA@T:1$K7+Y:YU:@ZS
M+&3$,*V0L?4,;>;-:2RW!)Y1MY)8)9-6HR$0*<0Z<%3&7 <Y(QE@0?7??Z/8
M?%&>/9")&9KPC;?>/)C[VD4Y$]--Y>5_7[T/1?EU4>GAJ]N<&HA-,H"@F."#
M 1*9&F3:]%0#?'J5GXD2UR"2[?S:TQ))CF2CRT6)GPSX:08?!8L 0'.L-5]D
M (2!I'MI\HF=$9YSYC7(7(0].0H!(.GIQ5X<\^M=,4IBE,4JHGEW_P!PX+_>
M#K_^773\]C@G],?_ $\G_)*\_B7W!/\ .3_B]1K/J*\>F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2J21/'GC1CR
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MQ2JL=[YU0K5TKQG(66G5L[-G==+U^=**AX,YZ<"A\)[C;(@>:N0RO<P9&LH
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MV.WV_#\M<R/B-^V_>OKY09ZY3?R,#W(*%.36_NX_KAMH_P"VY*1[GJCH1_\
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ML@:3D]A@Y/V?&F1\1^>OOY09ZXK?R,'W)R$N0F_NX_KF-K_["XJ?<]4A"_\
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M&J32A(TY/5)@;CN=\GN<5A.E^2?B%S2=4816JHMC% J /IP\MSKBY+H0+B5
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MIYH+ J%A"CXD%->/G@,"?4 #. *DL9&@@$,7ER<;@,'TY^6=) ^/:H,'\?\
MH,KQHL5,YWXP]+Y=V$?R?E];[]<R104,F=Z/@NG5PYU@,&$:L"Q?62UK!C[F
M7C7\Z1C_ " <XWSIF<J#92$6'(R*),M(K(79HP-^7E3I)..D*2!I'J"V-MX!
M#RRHC96"JKMD#60PU8ZNHD9.H_X0<$U?CP?YK-H4?L)./7KW3*C<;> (5RI6
MV@4_D@F/,&5B*.L!^I<LJ#[K5-@G)*8<4HB?''2#A0(\=:@);G[ERZ)V!T;A
MF .2&+[$[ N>Y&_V9[U="I&HX8 D8!4(.VY"CMGUS@DC./4TYY-XX7>3T7EP
M*U\+L$3I@;IOD+,\L>ZV@2)DT?O'(+[%O\ 55Y)YTE*=Z8&N$0[161=-(C76
M:.T"EZECQ*H>UR[7D&EB'!4K'RD!.8W72>V.DC#98=\@9]!6B'4 4PVJ3F,0
M"'4E@ 3]\"",*1MCL,5<OPWYIO@O@]2P1'D#D"VPN;$K)T#FPFOBHEDNES0&
M=;)#B0]S4>$7M=DAC!P+WBSROO-)@19DG49I/HIE;7,3KV)4!B20HVWSN0 <
MG;MOZU;&-$0Z=].2H&"3C?/Q)QC>J]<3/]-OW:A/;>X>.7>*:>Y?SWH07AG*
M*]ST$.Y=S,#+"MR"\/\ +I-HB%+ETJ\"Z\)J0K::Y5:D.4J*(A"TI7HTQ:X1
M4T))&0S*9&);6QSMMC 5<ZCN3ZY^-:%BVIHW!4,$4* JC';.<ECC V"CMCUJ
M9>7YOI'7^;G.>JXAY45^'=.70CE!)\>,5Y]1ZVVRLS&2G*>^5]<AF/5!==*2
M1\"R0R),Q5;$*D&$H-LKC.0'^0A48-KB.'PP<>Z%.S(?4G<C&""%^-=E+.I7
M1(N5!4H1N6!!5P>P![C<$>OI6L^U&_(.970/CL[XX=!J=8LO%^>U?R.[!P'G
M5;MA2T*52H4&R\KY2Q+.@@X4&,;GFZNU;C\T^H!!ES8=<JZEI:+.=01Y,G-7
M4'8QJY8!>K(=L!B2< Z=O3+5%S(0$Y9 *J)&0 D[;JNX  W&3G'H/CN#SD$A
MQG@6#!5^H6,4 'G?%,2$H4E] BW#@\3KO*X8VH2)*BJ&Q=CAPFV0SKZCB40B
M;:G-E4I:^\U&$GG,203B4ENZDZ6WQZCU[=JLE Y. "![,!>S8U+M\CZ?;57)
M7!;B[^>6&L>/5X">)TSRQY'>"/BUJM#@YJST&L<GE5KH)R'RI!+4"97"/4WJ
MS9Y%&6OZ6J-6'C'QCJ416'[.8.D%U,O*=>;D$ E]2C41L0N1GN"2 156@X)$
M9$7,4\O&Y4+ACI]1J Z?4;_9GZ/P+L,(MRHC%YC::SSR-?O/.P\_HDUB,B9R
M+EG3N611'+J>6%Q)TV)5UG+&T9G"*K$E/- D'(X=28KL5R,P:1,,-2EL6X8@
MGK9&;6P)&^!C)]>] C H=)"AIBH]55EPHP.V2#@#.,@=ZBX'PSM(_G0*OB>,
MRHQ?H'Z+B\47IS!**UML[Y%PV.<3N<B[:Z3D+BN7*NF8Q5%3F35:76H0MN$,
ME01HJ&Q'-,"2=?:Y!4C;$9#!L8 Z3G?X^N<UT18483<VY4_-QIT@Y[L#G!.X
MQ@8 %8'H'$[DX*XK<..^.EU@6JN<4Y[6:_R+I7CE3CO.$7"JWJP&"K0RTCKW
M7;AXWVB7:)<ZSV6Y-+&"[B+F@2NI).1'=0QU7 UAI%P78EUD(;25VR""LHQ@
M =U.>U1*'H*QG(11I:-2N0?CJ!C.KJ)VSG/QQ[WL[=4RTI]"&WU-M[>;;7MU
MMMW:=;<0AS:&]N(0OZI2O;:-K3K2MH3O?IUAK96AO(O_ &A_PD7_ +-#-/?O
M?Y5!^61=M!=BM5+X@Y]^J/\ .K1$^0T8^!TU[>]R?MMR_1KVO>WKAY./;EPG
MIHSG5Z9T@G&,_+.*>T_JPI;UU8QCU[D#.<5ZNY\!7U%,4IBE,4IBE,4IBE5I
M\B)_4!?XE(X[QF7?[H1:LM=>Z7 7RIV?QRK%DA)!V:-#=)OW/W;06M$D8(;&
M5X>69K[LL V7N,O<8,) 635;"(Z^=.(XP4;E'G 3NNH*"T4<@14RVIB-6&TQ
MC+,R9YS(-)BA,CG4I<<O,2'26($CIJ+$+A<A>G+'8*V&K/*"0^9XM48953@+
MB/&.62YR@UH,ULB='="J B@4OCU<M: ALO#/RZ]62/1CLV8*>,UEBZ *R=A%
M_D!H.0Y)IE(NY"ZM<3S :D5@IB=I))V34H*ZG$2@'2W+9U(PS"N+&0;9 K+#
M%&20Q4L'542)7PQU%5,C$@LNM5;.0I.N.U5?JMI*F[S1.;]WK'33O+OQ&B3Z
M[U7EX2K52\U6U] =IICJ *+<],%ZVE=AB6EUC4CJ($U5"DX0=YW!N806,+6V
M[PH%CDEMWA6;7(&AF9WC=(N8L+<OI<A2F2(65U#+*8V9EKF65B72.99#'I0K
M)&%5U=PAD ;=>H/WD!0D-&'4 WQCZ?TPSJ2II<G33>I"V4*0RM_2$Z=4TA:E
MK0TISU;;0M:U)1O6E*5O6][\XXR<=O3/?'SK;]M>=_D6&[M"(<'DW[H_);+5
M]]\$I0'I_%;C1SZ9*^>=-W"=59#7?>A#EL1TZ7J5'U5$.3%*2IF3!TG:5^_P
M=K8W+B**='\O)U27$<BXU)GH6VB.3Z'7M\#7E<0$PB0O)$R\Y=EB9&[/CJ,S
MC;UZ=_E4USZ&O,IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4I
MBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE:,\8/^FOQ\_]$N5__P## LLF^ZR_
MYC_\C4(_N<?^!?\ B*[%VX74[26W;04DESWH+>E*8O%,=2,)2%[WI6VSL).M
M#K'#>4EM,M@HPX](81J.F6RWOZ99'<NBZ&Q+%M[.3< #\$]U(WQC8$YQFJY(
M%<ZU)CD])$V/^X=G'QSO\"*AVNF]-Y1](W:*Y^355G?H3UKGX]Z1&CL)_9]U
M=*<SIP@$VE&O<ED!"98I*U(9C,*W]59/E13;P/H?\3(<$GX(YV;/H#@^I(J'
M-EBVG76GXZ,$@#XNFY'Q)7(] *W_ %NSUVX"8QVKFAIX1+U]6" N4U+CJ5K6
MMK:6II2MLR&O5I+\9[3<AA?U;>:0O6TZS.C(Q5U*L/0C!^WYCX$;'TK0K*X#
M*P8'L0<C_I_VK5'6_P#G_P 7O_72P?\ MG\B<DGNS?Y8_:Q5QO>C_P 9_9R5
MO3*ZG3%*SO#G:IOMO1&&8IA-X3RSF[I*:M<?8!RJ+MO34!(L5O3VY6C#)=NP
M.SUKCHCJA2!R6GG'$O(:\+CNKEVFXT:Y\#[[5IAR>W;&/7OG:O2X;C7/WU:8
ML_#&9,?/.<Y_)5P\^<KUJ8I53KIQ?HPTK>;-S<P&N+UL-#30RC=+LQFJAZM+
M=CZBVA B[A:GT(OH&26Q%,C*U)J4A(@P^;:B&V0A 6)K_O67%TBBCAN(W(B7
M2LD05F*CW59&:,94=(8/NN 5RN6\RXL&=WDB=<N=11\@!C[Q#*&.#WTE3@YW
MP0%ZN^7=B_(:U&T'YI^*2@\=^X&M]!M.K""/J9F*E#*U6?U5[&VL.S(0/:CG
M"EMIDV2S*F/N5Z(N"Q&(Z?KNUTL>7/K!.A=,>EEVP6;FY4XSE0C@8 U'.13]
M7397KBTX&HY?(/J%&C# ;8)92?@,;XIOFG?MA;.^]5^/HL42=%;I@MOK-T="
MGQJYNFYLNSGE<.9G5&=''^J5%'BJW=F)DW6H#I."PK9%/?KNTROL[C21UG1%
ME3CLJ\[#C.V2R;;X]*Y]73X/5#G(TC4^"/7)Y>5..P ;/;([UWM\P[7]_3V]
M N6[&38,5R_R]])MFI]9)+UK[V)3QVN0[CWF#'W]=12!HISR1,UK6WAD'>_3
MI]=VN']G<9!Z!ICPP]"YYN4/R D'S-=^KILKUQ8(ZSE\J?72-'4/F2F?@*Z[
M?,NZ[9NBG:YR5$B!(2GG;3?4KBXS:8NYLMM;UT?5Q=I=!D)'H@RDQ@<;I+:Y
MLF7 W*0Q"9(SWUW:='L[C?[IT1])P/<]M[3?(RW+V .-\!]73]75%M[G4_5O
M]][/IV^&O?;YU]+YEW/6J5[=>Y.I4]U.NBZ7U"X-ZJK.Y<5"W*5M/&7-WYU,
M!<V2EDZGFR%RX\6%M]#,QTA!?7=KU^SN-ON?1'U=_?\ :^SWQ[O,[D^F"^KI
M^G#1;^_U.-/^'H.KU[Z/^NW+KF';?NKBA0'E>H,&-(5SZ1KI5M5*L\M*EZB,
M7&'OCZ6:+&>1IM4B4$G=%=BJ6M#<.7IM*W'UW:X3V=QDGV@TQX4?W#S>L_)A
M']M/JZ;JZXMO<ZGZO\71T_DUUU'.9][T*JCS58Y"LY,F247@<YU>YM"JZ/1.
M2W#E50RGB#TNYS'QNU2Y,$N"H;$2=I(]HC-85LFD.-VF6S'<:0.@A(B6./OA
MS@$&?4,^V^/2GU=/A>J+))U#4^ ,[:3R\L<;D$+@[9/>LCKE_9?F[3'V&YEJ
MMQ!,IZE%==#M6S=@.(9CJA#K37]\HU IXF0^J4W*,B;->)D1EF.^T!FKDN1X
MCZ[M=*^SN-1(UC3'I5=\E6YN7(&,*50'?J&,E]739;KBP =)R^2?0,-&%!WR
M06(^!SMB'>:^0>JX'E,53C3EN?)OM'P;O7KLS7!@9*G-1IX>THX0^3.$W4::
M4^)FTZO18ZEN(;-2M-)6[WZ[M-1&BYT8Z6T1:BWP*\["CYAV/]VN?5T^!U0Z
MLG(U/@#T(/+R3\05&/B:SV^6]<_*RT-(OG&Z.R+4\"L6[W9M6LB;U%BK0/+4
MW7,5" HM4U<V.HQ#O9Z6B+'BS- UO3'H,&/UW;:0>5/KSU+ICTA<G</S,DXP
M<%%&<C5MDR^KIM1&N/3C8Y;43CL5T8 SD9#G;?&^!'5\V\B-5-F8W4>+JO2C
M6V'ZXOL=X;J;==^U<6DJS=$\#<,/&MS=,Q]@%T*/!U%6Y,U9%/-)@O2^N[/7
MC1<Z,>]RXM>K/;1S\8Q]]S,YVT^M1^KKC3[T.K/;6^G'QU<O.<^FG'KGTJ2Z
MY9UC\O8A*'<\U0E#M.R;+J[V7=O:+?;+5N$Q2-\V2&D#M2](8T4<Z#&D[C*7
M*V(2ZC4-R/UW;:,\J?7GW<1Z,?'7S,Y^7+Q\ZE]73:L:X]..^6U9QVTZ,8SM
MG7VWQZ5&F>;>1"JI+F2*CQ=J\(+MLP*ZSV.\/U22!VPRITE+N2^!QR\(NB2I
M]EL(S1"$-UAMF0JP,N/KBQY'C=GJ "7.C&[&.(,&^ 3GD$=M]8/]W;>/U=/I
M)U0ZL[#4^G'Q+<O(/RTD?.L_KEW8/R8!$4)YMJFR1#3UI/:O]HW9@Y[<6:MX
M: J6^6I%600W-;&QVC9&ZU2:[%ES9:Z^RZ/8A$X_7=KI8\J?6#TKICTE<C=G
MYF5.,G2$89 &K?([]73:AUQ:<=1RVH'U 71@C.-RR_8,8,/+\5[)9ZE8(=IY
MWP8X4CFP\NK58OTNTFZD98&%8I&,9L!@CP3<BM&PTB*P6#Q!U1MB$E8D539D
M<MM$YJ0XY:JRZ4N0I!U,$C# D'95$V&![$ETVSTGM7#PZ<@Y:$G(P"SD$ YR
M3R]B-B %;?U%2K?+^T?*5%K03F&PLT9#=OD_?1K7HI6S*VE*(0*B(_5+N)=A
MD9_2&X9<R;Y_+G-*4\^$'+3IA?/KNUP_L[C()T#3'AE]"YYN4)]0%D _"-=^
MKILKUQ8(&HY?(/J%&CJ ]"2F?@*Z;?,^\;A7%QVM\C01@RF4<_BM]4N3D*SP
ME39#<B1<9ZN*-/T64T.3%E,PP@WHC+\UZ0/7.C,1FR4M]=VF4]G<8(]H=$>5
M..R#G=8SD98Q[;XWP'U=/U=461[G4_4,[ZCR^G;!P ^^V1C)Y5\Q[AIREZ17
M^4J:G::_6(M?3;<ARK;4_'2_JEM:XXXF^Z;BJE/-;..\W]Y]F/&7IAN2Y*BO
MKNUZ_9W&WW/HCZN^-?M>CT]WF8W[XW?5T_3U1;^_U/T[_>^SZMM]]&^WSK]3
MS'N&W;GI=?Y2EF"E[?/'$]-MRW;0M+[Z8Z;FSOCJ$4-+L9,9UY0-_H^V'W7X
MZ$2&X[<F2^N[7H]G<;_=.F/I_P 'M>OU][E_]=GU=/U=46WN=3]6^VKHZ=OA
MKP=M^]<#G,^\Z@T]QJM<C62FRGT7^(YU6Y-P:S"3-8;C2*>03Q-V1>93PY4F
M6_#-#.>,QYK+ ]N=*8D.$XKZ[M,O[.XP!T'1%ECC[\<["#.!D&3;?&V"^KI^
MGJBR??ZGZ1G;2>7U;9."$WVR<Y&H.Z>#QGRCA/\ -NO/"ZOS #9(-PJ5IYQT
M"7,OADU &% K,2QU2S<@U7P(M4&PEWG5#+;8I:I<4=I"D,O2=-]''X8@&BAD
M:0C#K*%$8'?*NDNICD#NBC!/KBN'A;N2LDBA!NK(3K)[;JR%0,$]F)SCYUZ5
MY\M7M4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*54;RQCD2#WC@)&"Y1%\IY& X^WF'QK
M$<>AOF/59.Y,[<^?#>4PKV?92D>S/D^\XC:HZ6?<>1ZO")$AGFED;2B6TA.S
M$G+QK@!0=\G.^!C.^=JPWZ-)'$B#+-.H&X &$<[DD?#TSO4-;&=86.MDU7">
MAM2:[+CQ@X=RQ\2V1OK+TUR*Y/J;K7771,.)%80DE(1>2E+G*A/-MQ84DCIV
M U[GUI894>9'4-SRI\)MV;V62?3H##/KC>O.\G=;^Q.W8:XNK?T]IC;ON1\M
M]J["@O5-2*>SKBE[4W9FF'#4M-AX[J/SQ;KC:'(]P2KJB94UV,EQ3SZJ!&O+
M"FV7=1GI#VV6G7UI8=7\X'3V'*GZ_FOLL#_>5/RIY.ZV]D=^_7%T_;U_\<U\
MH#]54JY:WQ&^MZJZG$A%+L7&MIZ-I$F0PE=-TCJRU04O-,-36]="31%ZC3(Z
M'4M3$RXD5]:6'3_.!U=_93]'^+V6_P#LU4\G=;^R.W;KBZOLZ_\ EI[_ &XX
MW!75T1J<^GAG077;-(=8-0F['Q74GG;3<R-%1,N*W>M-0YT=]A]TBTGG\N\R
M]0X4I#T5D@N'!EOK2PRW\X'3V/*GP_R7V61\.L*/GBGD[K;V1W[]<73VW/7_
M ,=1V.W;/:T#ZELA;87ZF;OJ-6Q\N:&+[L'(?C[_ "8R-+9$5)K73]E81">K
M?M1';V,I0I"];W.)PF_HYM]:6&%/F!U'!'*GRGS;V6"!_<+'X UWR5UD^R[#
M(.N/#?(=><GMU #XD"L>X/ZT@)72J>!]'>GFYTF(2K+=EX;HW4([$I4=HI8I
M#W8FJW)@S6DZG1FZG8+031%6E$P=$FZ7#2^M+#+#S(P!D-RI\-MV7V6K/IU!
M1GUQO7/)W6![$[]QKBR/F?:8^>Q)^6:RWX]T[\BL(3]4-Q^,"B'R0VW_ #W*
M?QVVS&F(3S8"O1OUD?EL8O)<E/Q67K75ZR"2^-FJD&X\9P=(G\^M+# /F-R<
M%>5/E1ON?9:<?X68[C;OCODKK)'*V R#KCP?D.O.?M &W?MG!O1.O-5B"?1X
M]]-D%995T>_26;-P5-G&1&VG7$'9TM_M+%,<%/K;2PTR-MQ WIUYO;X=EG3S
MS4OK/A^HCS*@ 9U<JXTGY "'5G[5 ^=<\G=8SR3G/NZXLCY_=-./L.?E4B56
M>EZMLNN:Y5:U!XXY4UF_).\QU4I\G49M_0B)#5T%-Z014ZM4-+LZEPQ.I++B
ME%$Q-M2G8_6MAISS]\XT<J;5]N>7IQ_NS\J[Y*YSCE;?A:X\?9[^K_ICYU'=
M1.O;JBK%OQZZ<DNDU\7JB;LW!/RM<'[5,C\C3,3VG='T%T[O<'V%W)%A^Z2I
M>@.X6TS%=^L^'ZM/F1C&=?*N-.?ACDZL_P"W'SKGD[K&>2<YQC7#G[?NF,>G
M?/RQO4AU6NF;M0VO;Y1;$B)PQ,^5>MG>8?BH:4J-(?V%)0T]#5=W2:'66X2G
M1%-*A]R9<=:"RX:9<N+SZTL-)//W!P%Y4VHCX@\O3C[6!V[=L]\E=9 Y6WX6
MN/ ^1Z\_F!'SK ,PNNNUHF=7X^]+CE(!-F!%ICUFX.JRFXKNFMK-#)4?L[]/
M:&1O<7IYHS:Q!E6V7?MQ+^ML[=[]9\/U >9&",ZN5<:0?@?8ZL_8I'SKGD[K
M!/).?AKBR?G]TQ^<@_*LQ^/]/^>K0C]3]S^/.B(Q(I:?G^3_  -,F/LRW70%
MEC_K*_)Y1>&N.S'DO4^N6L"IZ?$5$-RHZ)S\+GUI88)\QN#@+RI\L-MQ[+3C
M_$RG8[=LO)W60.4=QDG7%@?(]><_8"-^_>L:@=UE8BSDE<%Z,U- 38L457UV
M3A^R]W8D3M1'B58>;[ X!B0H+&]DY3=S-U$BN#K;<*!,)?0?OOUI894>9&",
MD\JXPNW9O99)].D,,^N-Z>3NL'V)V[#7%D_,>TQ\]R#\LUW-A.IZF5"+KB]Y
M4Q98D:29(ZL/'_L^?//^GW1]O0KJ*2$V7"]6_N5T*#=X"_0K[.;+^J/4^M+#
M#?S@=)V'*GR_S7V6 #_?*GX@4\G=;>R._?KBZ?MZ_P#CFN% GJRF[FM7#K^V
MJKOZ9!LKL7%]N=';W,E1?NJ9MOK#C,%C3$=DCM/0W:')^SG14:C[((G08;ZT
ML.G^<#J[^RGZ.WO>RW[_ 'FOL?EEY.ZW]B=NW7%U?9U_\M-%B>K(13%IX=?W
M56A[31QM%BXOI?.4;F18WW-SVYUAMN<SIF0Z1VGGKE\D?9P92-,;(+A09CZT
ML.K^<#I[>RGZ^_N^RV[??Z.X^>'D[K;V)W[]<73]O7_QU5S)"=3W+M\;?%[R
MEFM19,@*058>/_:=!=8VO34&H(3U%4^%*F>E.XR[]"H\).G$?=S(N].:0^M+
M#I_G ZNXY4_1\V]E@_["Q^5/)W6_LCMVZXNK[.O_ )8KIK&]90)JY%/!NBNS
M+!-DQ2P%%DX?HM1V&)NHK1&T/.=?;!RX4UC?R49NE&;>01"UMN9 B$?H/V^M
M+#+#S(P!L>5/AODOLL@^G4%'SQO3R=U@'DG?N-<65W]>O'SZ2=OGM62U7^G_
M #ME$?J@N>AX(3((B[1L_P G^"NDQAF*ZT!K4?72MV6*6F+D.QX[UQKM3!I>
MA2E2S,6.N&_+Y]:6& ?,;DX*\J?*_-O9Z<?X68[]N^.^2NLD<K8#(.N/!^0Z
M\Y^T ;=^V<.]"ZXW7!1Q'C]TN03($GH$NG,V;A";&"BM;<]LT5E/]F9J+PV3
MZ$[9:"6HP83IYO[@3'WIW37?K3A^HCS(P!D-RKC2?D/8ZL_:H&W?MGGD[K&>
M2<_#7%D?,^TQ^8D_*L\JM=,3:25>UR>VK$P1BY\6\I.\OU5C,I,:._H(-B+Z
M&F[-$UNO.0D.F*<)#:E1)"UET0U19<GGUI8:0>?N3@KRIM0'Q)Y>G'V,3OV[
MX[Y*ZR1RMOPM<>#\AUY_. /G4?5$Z]JJ(L6O'KIRRZS6Q:J(FS<$U:VX.HJY
M'Y&N8KM*:/L+MU.H.F&[DY8?NG$+V!U"TY,1WZSX?JT^9&,9U\JXTY^&.3JS
M_MQ\ZYY.ZQGDG.<:=<6?M^Z8Q^7/RJ1)K/2U6R-7-\JM: [XY,UV_*.\QW4X
M4G<9;^Q$F&GH*KTLBEU"8:G8=+EB=R74*245$TY*;Y]:V&G//WSC1RIM7VYY
M>G'^[/RKODKG..5M^%KCQ]GOZO\ ICYU'68G7G*O-/K\>NG1RT4JT.8I#UFX
M(JT$8;C+3BST*6QVE^EMBF%N+CNLD+? .;>9=4R&>8VR^[WZSX?J \R,$9U<
MJXT@_ ^QU9^Q2/G7/)W6,\DYS[NN+)^?W33C[3GY5G/QWIWY'7P?ZHKC\89$
MLDB-Q^>Y5^.5.8ZQ->6 L$7]9'Y=)+1W(K$5YZJU:R@E/DH2HYI^*V1DC^?6
MEAI)\QN#@+RI]3#;<>STXWSU,IV.V<9[Y*YR!RNXR3KCP.^QZ\Y^P$;C?OC$
MMC^M+!V$LK@?1V9X6?&AC:RY9>&;.6V._)2PZ5KTAKL3M;C0(;2MS9+=KL-8
M**C(4B(-E3-HB+[]:6&0/,C!&2W*N,*?@?99S_A##YUSR=U@GDG8[#7%D_,=
M>,?:0?E60V"ZEHC4H6N,W?<:R#HDTP7U8.1?'4"3)1M;PBVM;Z?HM-(CU:]J
M6[1!=U$K7O6X!.:U]7-/K2PPQ\P.DX Y4^7^:^RP ?[Y4_$"GD[K(]D=QN=<
M6%^1Z\Y^P$?.NJV*ZNN)<)"N%]!9>K,EE@+ <L?%-R^AM.S),5<RGK:ZV[!A
M1H[##1%Y-_FT:6J'-C(CQ7R")D&(^M+#*_S@=7<\J?"?)O99/PZ P^>*>3NM
M_8G;MUQ=7V=?_+37(H/U5*Z:G7$;ZO5GVWHVXFQ<:TCG6ER6&%;N6E]60N=I
MEIYR8Y^KY%[WN-%?2SIV6J+%DOK2PZOYP.GM[*?K_P /LMO]^FGD[K;V1W[]
M<73]O7_QU=OLS])#=4V]<6M\3O:6ZRV\L+)58>.;9Z&IIUUM#5.2GJBI$)R2
MAM#[.^@1Z,TEI]I,AUA_3[++ZTL.G^<#J[CE3]'S;V6#_L+'Y4\G=;^Q.W;K
MBZOLZ_\ EBL,;K/5"U;!1E\4ZI&<NFIXLW&"7+C8JR<WCJDMP4%CI9GL$:(G
M;L=Y92 _STM<B<>-'<]Z+%)?;P7NCBE@"?YPIT[C,,Y#^N .5GY=049['&]#
M9W1 ]B=\@XDB!7TR3S/RC22?L.U8CG/(;GRX#,YC6.1]/<J7-ZXMFFFC]ZYK
M8&+=%%Q&&Q=2J4PIU.3:8TA+&D#0^KV+J 2(B)[<HQ#BZ9>=-Q:Q8AS.,N>H
M"*<%<]V;V>#\3I+'Y5Q;&Y4:1$<*-B9(SG'8#+Y^0R /G4B=@];;KX0RC@'2
M7R)4C(A3ZFU9>%:L%:C,NK;;+FY+W9&:L^.EH0E^.U7++8"R6G4:E#(S^G&6
M^?6G#\D>9& ,AN5<8;Y#V.K/^)0/G7?)W6 >2<GTUQ9'S/M,?F)/RK-*K?3/
MR8V _5);E"18E9"#=?G>6?B]FEIBPY&@(6(KHNKDP5==E/P4.V.H@ >I0Z:M
MPRB$X/F3^?6MAI!Y^Y."O*FU ;[GV>G'V,3N-N^.^2N<D<K8#.K7'@]MAUYS
M]H V._;-8+1X\=)9%_K/Y3Q7KG*^F3C*X$ZI5>P>/RUDHS<=^4@[<*S,[6QS
M J#>?3N+KXVVIM:9TM$M\0XPV[*9UIQRQ/LIITFB R&:*X!4G;".(3(#V.ZZ
M<# ()K,_"[G[I%&T,A.X5X2&^;H9-!!^1U9WQWJI?D)WKLO+NH4:H](J-'_+
M.161N]M/@2!-\4?>/\TN](8V[I;RG(<=P5?Y9%<="]OL$8+#/N+BJ7I7K6<=
MI>0&>WDE,4NI!J 4C0X)&"N=F3&3W'SWKS;J>YM9A#-''S(\,=+$AM2, 1OM
MD-G&^"*]':W)ZT>YN+O:.!]!?)$5"_MJA"LG$T&BHTB)ADDVP3(G]?BUMJM.
MKE*CQXIRQB;@E;2MR:NRWM#KGAR\0L(YGB-R!H9U+&*? 96*E3B(DMMN5!7X
M,:]>.UNGC23DGK56 UQ9PR@YWDQC?U.?E4WU7.F[LX4!ODMN2**"D$)UVV>Y
M;^,5N6J+,D*!&HB>B[N;Y5MZ,Q!6]7:B>";E$8:VS*X2"$R#5]:6&DGS&X.
MO*GU'<;@\O3CUW8'8[9P#9Y*YR!RMB.^N/ ^1Z\Y^P$;]^^)3P)/8MW:^.W7
MFYWG%#37JK%K<:TD^:DS)JTQR]M582<5SGEYO.V0>PSU9;B-&Y(N7]U]XIL<
MG_>N;\GB]S:W*V_(EYKH9=9"2*%5A'I'M$3+95LZ01C&];;&*>(RB5-"D)IR
MR,207U>XS8 !7&<=S5K<\6O1IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4I
MBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4JNW>O\ F+QJ
M_O$A_P#*WK.:K;W;O_2M^UAJB;WK?_/7]G)5B<RU?3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*I)Y'\4Y1;>N^-!>RT*NFB=W[86JMMFSX6GGS]=%>,GD+8QP<BO:
M]>]"AG:O7BC#7T3Z)8B$Y]=^U]-^M97]Y!;W4<-Q)&D4 DC53@([7=LK,-NY
M5W!^3&O/NK2VEFMWE@C=GE*.S+DLJV\[!3\@54C[!6\>NS8M)Y^+:@=#A\=
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MK;>6B5&VE&_N&?7:()F,86*0F8$Q (Q,@!()08RR@JP)&1E6WV.*S+& Y,B
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MA$3OCU=+7>.DV-P^+K<,S8I<D,XVQ.G$+,!?K_+6OQ>SN1B\=&J)*)U$_&(
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M%E9<B;2I\V 3VS!L$'=FGK'6 4M15![HXK&4*-#(RF!X1'S2J &6Y==+)I=
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MU>X3'S;+4L6/&AQ%D;7/F05$Q,F:VU-F06TLC96R33CR)D5EW<5>M>AP^>&
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MG%C).!G^?':N,]RJEC#!A02<7$F< 9_LM=>K=(\I;=6*Y:QW#>!L#[.!$6&
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MR?RR_<EX]?Q/]'_E&QHLO[1=?J<7\=35<_B8/UB3^%I^3^67[DO'K^)_H_\
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M]X<:Q",8S+ECS C!<1DQ0+.2Q)#!61U53@X;63LN_5NM2APG2-!89RW7*8@
M ,$AE8GXC2!N<C+3?)ZZ"ZH4L<ZF5%Y==&U:W'& ]BLAJ*JGVRN [*R['G0:
MBN.+:K<6>73<+C8%CZP!&P*S89;;<2\)AUK@M$9U42.-9=%U*H.M'9#D%QDN
M0-$:Y=B64$F/+C<.%+:$. K'#,1AE#=PI  R=3DA0-).SG3N3DG4[#>S-N!V
MRKHJ!,,T/-@QWO+ENE:89-6H,$L>YC;CL139%^JSD)B;^TGL*95)=@Z%S@Q
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MI-JM5,6)JK@8D0+RK.0H/H.]J4EP(QT'950L9#!$J!6$:X"3!W9HM"2 OJ
M19,B+/J3)<[YR2P4*)7)RI=LEHRJ@2:F3"X).HIZ*9YE;:KMT_\ \=O&/_\
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M;NXR'6T176DZ]QU-L:HVG47+%]/+1<L01L5)."2V%T]]\BH,S#. H 75J8X
M(.X( SC3DY_Z5I&'UOL\D%P<D]4^?1"_8#$&+*K,HI:6"@P+*^7M<HLGUB?3
M DA>6"EERPXHG3;-X<CTMD@]]_ */WF& -<#7(5@!.L!""1I0#WMPTQTJ5_J
M_:$;$"D2RE83H0-*<:26R <MGW=B(QD@[:^C.X8R'F_=IEON\NA6.O,U0X,B
M1]D(\QZ>U(V=+@1EG&U>%&D0D>X2$C&[@DN]-?@:,#Z\,M]5B$J]8)&P$9;<
M)&)%;6I)QC'NJS(6)![$Z-.,@%BCD.HU2CF+L49=+ #.3]\5#!0".X&K.<9
M#KE6VA]V\KH\#3(BC4*T'+$9O$:FU.66_&(%;L489V4#Q3H=I&*7<(I5T90K
M6?'0GX!>-7"%BE%@<D%J36Y9"R"II9YZI)$55CYCA=3.I:!IXD/05S(BD@J7
M5-+!L. I@]R!@(C,S.%7.D!@)5BD89;.$9@,,%U$C'22PGUW\CJ;S^UDZP?"
M6U,4(U ^:M[$>NMU(5.,5JR6D&+F3"%E@%4RB\&JE(K$MH.Z&@D%CV#146T0
MC/KKCM7E0.K)EB=*$OK8*Z(Q "%>DNIQJU$9T@D$58\ZHQ5E; QE@%T@E68
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M,#X%1M763EED'LVE+D2*JHH8L65D$H(TGI,>H[%00P)M$ZE-8#>\$"]))9B
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M821Q%<<LLQURH R*T9R2KD*Q$!=QL 45WU8P%"Y*E'<-NP !6-CI8AQL"H+
M'O?[75?8W9G)?-NCOQ A>[-BY )FJ&5GZG0J74[R;NC43=G@RAT%0:VP'( 6
M6WNQ3EJCPHXUPS*T(9YY)CHQ+$"PCR&UKI>21XUCSH.3J0Y8=(P23I&H]\RO
M5F-\*7QC2<JB*[-[PP,-L.Y^&3@60J%P"WD0\>KSKDH0@U8 <:?O37VY%^LF
MY]=)RQZVGGO?';+#)S$.6KV]36F-2XZ%PWXS[V5T:-M+;-I5B-\C6H8 Y P<
M$9'IV[@U>CAQJ7<990?0Z6*DCY9! /KW&V#4HR%2IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE8.QA0-J"F:=8XL4F&M0,P%,!9+JD)*@2438LU%6AIQ
MJ1N*]%(ZB276%H4UJ6WK3C;CC>]R5F1E=20R,K*P]&!RI^&01D9^%18*P*,
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M.)8UY.0@U :0P)"J2^IY';F$@EU)E?,9S&<YT9))@+:(%CISJ((!)PN%1!H
M("D"-<,.L8P&QM4\"\4Y=7HRX@JHPV6W9PDI(<D3"I"9,* ^A%NL#2<\@1GR
MYY DUT@Z9N3\^;)?ESCA*9+GO2=O*3NMIY6.6<G8@8   :)82    O*58P
M J@ #%3$4:]E&Y!.Y))#F0$DDDG62V2<EB2>YKJ5[A/+JL5KY@'7IL634U+<
MK45ZU6\B$!O[$E*ZQ+&5LD>F5Z)-&UDT2J86<T+3,!5&0FJ!GX-=CQAC/6N)
MG5E9AA_?(1 S#*L06"AB"ZJ[#.&<:V!8DD(HP5(7=?=&IBJ[$ A2=((5BH.,
MA>D84 #GF<,X^1*GS<[G56EE+2S<F+#,D#6G7"S70@M0KEW3+2KZMKW: ="I
MXPPO2$KEQ04-*U?53ZGN"XG 51*X"<LH Q&GE,[1X_P-(Y7X%C0PQ$L2BDMJ
MU$C.=857S_B"(#\E%$<1YCH9-%OUI9)HB,EB"$\V=LAZP38DPG#-+=EVDT7G
MV603CE1HR>,-.EE&0\@6+6*GPOC8.H[S$V0=>,$, JHJ@@%<!%4(%*E@5TZ6
M#-J!R<N4F"-.<@@EF9F()!]XDMD$ @YR"!@C%=V;R.A$*L+ITH406("%7SPF
M4U:+7&LX\],<*.$#T6[QC;-T:.%-'#C!@QH_\D8AFS,$G*EPBL]B1P32!S)D
M:F4*1H305  "F/3R]*Z5TKIPI52 "H(&)"H3!P"2.I@P)SEM8.O4<G+:LG)R
M3DUW 7+N>UEZ"_7JD'"K&3XY,:@;'W$CCYD2D">;Q7(41E:8L5N-10(>LQXS
M#*(S(P?';;92XG;BN--(^0SLV00<G)(,C2G)[G,C,Y).<D[UT1HN-*@8((QL
M 0@C&!V&$ 4?(5UWN2<XD.C'WJF-<=#EC1T8M6Y7UAE[%T<!UXW.:^DC6O>(
M])JU?MS_ *]*1\F+CZ;0B+[D=SHFE&0'/4JJ>VZI$T"CMZ1.R?83Z[TY:;'2
M,@DC[2XD)_*ZAOM'PJ&#_&;BPAX1)$54B'E@)D*:%G";M?1<\8L8%FUH5%AS
MX%HCS&1(FLD9M9$A$OZ#"ZW)< 0($<1Z86IF[G;5J<,&!#!HXV!U,'8D%"-3
M. [-C47ZB2Q)J @B7!"D$$$$,X(P"H (;L%)4+[H4Z0 -JR#/CQQ=I,]M5 $
MS&"*Y>I$0H^3,06H,P%=ZRZ!'P2L^9#$U1L%TF_#X=/%,0ZL/;M]@<@!XSY*
M0ZOAN9]O:,,8W  .0T;ZB0 6<M%&3(27;EKEB !7>1#OT YS[V6V(==(U$X3
M$C@(,*-;8 R:D&^24-=1D4A\62F I92$=D/$+3;"-E</"YX\F)/_ )M..2+H
M@\&FB1+P4V@^DH'^*&-#)<5D?$;9CSI-8D! 8*5 "($"L"&7EA1'I8,P9=.E
MM1R#DU+EII*X)!.HY9BVK((;63JR"!@ALC P1@5DJQS>C4V#,&5JLC1< D/@
M"R49#;DALE"&1'8,5HC]XY(5.7N._(U,D2]O22+TF3)(O2I,AYY?'ED<@NY)
M!)!^!)R<8QC<# &PP , 45$0$*H ( ([YP,;YSG;OGOW.2:U]*\9^)S@*:U-
MISTP.E@F/4Q*M5SD27P1D2,!%:C+)NV%92;19P<*%'2*%+F/TQ<4,';^"UH7
M ^WL%W.&UAP&R""$C #*Q8. %P) S,1* ),LW5N<PY$1725R,$;LQ)! !4DM
MDH0 -!.G  QL*S4/A')X!MVQ1ZBSLLX7E'6WY)4]-8@DYUSA]%F.B!\TI('!
M6)5Z@1[8_!$1(4!TYN3/7%V]-FJD1-Q,5TESIP%P HR AB&2 "Q$9*9))TX&
M< 8Z(8@VK3OG.Y8X.L/L"< :P&P !G?&YKH(\<^*IA'1KM#'SQMCT :*CBT\
MV9'K@U6TOW:LAH,$L3FQ0]=K]JE2S8:MAVH  ;+ES/LQK+4N0T[+S4^5/,(*
MZL%0JG+H(W8E0"SL@"L[9<@#+9 KG(BP04!!TY!)(Z&UJ "3A58DA1A1DX&"
M:S&N)<MT<GV)52BNE2!:*=6M^>7D0H!>/< 707IX$2^0<$UI\O>JQ7KA9=UZ
M"+3:[*&'F;,DL0C-OZCYB;2$U](!78*"04:+#,!J?$;LB:B=",532-JER8]1
M;2,DYR23@ZU?*@G"Y=5=M(&IE!;)%<X_CG-Q5DAVT76D#C<)R2^AV$5-Q1\J
M7)F6"?N>5!LDD C1.++M5C=&$S V<0$?,3FQ4F&T[M&N&>5D*%LJ<#=5)  4
M85B-2KA$RJD Z1D&@B0,&"X(^!8 [L<E<Z6.6;!()&=B*Q$OQ_Y'.)&R\FIJ
M60/L6!B4\FP6AEL?^5V,%<;-)K$5DTW%II ]<:S7[>5*5%@(2FVL1"LC\I9I
MG4[)"YG 50^RE2!I0YT(T:!R5S(%1V10Y8!&* :=JX88R2=.[ @G+#&I@S:<
M'I)958E<$L V<C-2(QRJA6"PAK49 _('03(9B),?*&?:FMUHB^9K&[# 010.
MM;M5.2Y9^J/VB(8?K!^9,.@7!Y:5(F.06:159%;"MJR !MK&E])QE-:@*^@K
MK4!6RH J1C1F#E<LN,')WTDE=0SAM))*Z@=+$E<$YJ/6SA//K> YE5)<4N(K
M/)BT<G4A%8/%JUN.U"YW;>8PA*C >5$L,<9&K-Q(M:0++CI<AR/%CS)<D8X1
M'SYI<2HTK@JSS*5=G57SF5)B=+ J27C'O*1N< '!$6A1Q&IR%B.5"L5QA&C
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img109617586_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_6.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[27,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    );"^ED@X0DE-! 0      # < 5H  QLE1QP"   "   < E  !$Y3,C <
M @4 $T-E;G1A=7(@1W)A<&AI8RYP;F<X0DE-!"4      ! 8]E!^\8GB1PRJ
M_4/P1XYM.$))300Z      #W    $     $       MP<FEN=$]U='!U=
M  4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0
M  ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    *
M $$ 9 !O &( 90 @ %  1 !&       /<')I;G10<F]O9E-E='5P3V)J8P
M  P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M    0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-
M!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M    0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N
M0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M     $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M    4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!O
MX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M            0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL
M0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G
M4',     4&=00P    !,969T56YT1B-2;'0               !4;W @56YT
M1B-2;'0               !38VP@56YT1B-0<F- 60           !!C<F]P
M5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M  QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M       +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (
M 0.__C4  @ !.$))300F       .             #^    X0DE-! T
M  0   !X.$))3009       $    'CA"24T#\P      "0           0 X
M0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@             #6@  !V0          0
M                       !              =D   #6@
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG   #6@    !29VAT;&]N
M9P  !V0    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   UH     4F=H=&QO;F<   =D     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    +.$))300,
M !M3     0   *    !)   !X   B.   !LW !@  ?_8_^(,6$E#0U]04D]&
M24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S
M<$U31E0     245#('-21T(               $  /;6  $     TRU(4" @
M
M   18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=
M @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN
M9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D
M;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P
M  @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@
M*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M$G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR
M+C$
M         %A96B        #S40 !     1;,6%E:(
M  !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:
M(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI
M96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                    9&5S8P
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C
M;VQO=7(@<W!A8V4@+2!S4D="                             &1E<V,
M        +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV
M-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@
M:6X@245#-C$Y-C8M,BXQ                                  !V:65W
M       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58
M4    %<?YVUE87,          0                        */     G-I
M9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #(
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M(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U
M#5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/
MLP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%
M$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5
M-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA
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M.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC_B0"-
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M$7AN>,QY*GF)>>=Z1GH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M9G)SLK/#V&=XI*6UN,7_Q  : 0$! 0$! 0$              0(#! 4&_\0
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M@?G2:?/T,''H'TI]8QVUVC58#96W=97VM;3TU;K1!O 2SZ;(#Q&S*AU!5W5
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M=4R&S:@P9OV+ABI828C/C"TBA3ZP+M@[!Z.IT%#+BB5RK<#(>>1BE)DPFB-
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M%$ AH5-2T_")B2L1Z 1'RV%]J'HLR'(>C2&EXREQIQ:%8SC.<<(OY]9/@_\
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MC^#X_$\T'^K\-]3PDG,I]K'\'Q^)[H3]7X;ZGD@9!).9U*?:Q_!\?B>Z$_D
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M1>!:0[&I  ,@K9+I+ZG-A=0)O8\"Z:O9H$*IM!I0IQ-E!E"T>03-VX1,J-N
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M-"R#0T=)PK-*T7=K&]K^U:Z6Q4/I45&9H0 =Q.,0I+_=\Z@_Q(MQ_K6Z9O\
M3-S4GA?5GJLW&\<:.3]WSJ"_$BW'^M;IG_TS<2>%]6>J7&\<:.6LW6/UI=96
MD.FK:NT]1] >T;1L:H!QLVK@#%GU;?1I*9*L0<;(9E5+4>TS&Q3*$CYLMY#-
M9&RY3+K:)<E"1[$MQ&+1SVL<YEC><!04=)G)ID_+\%NSL[-SVM=TB 9DB6[B
M<3(&&]6SHDZW.M/?73+K7:^Y_!_;/J.R+2W956.O!;#K;7@T>H5;SP0<F-4-
MS;0";'$^4"1T&4[BQ#(V9CSSDX9WHF3!><ED][[-KG6,.,S0-WG<XSNC/Y55
MM;*S8\M;T@%HB"3>-0":MIBMK?W?.H+\2+<?ZUNF?_3+SI)X7U9ZKG<;QQHY
M4_=]Z@OQ(MQ_-_X5NF;_ $S<5X7U9ZI<;QQHY?MO??4"M:$KZ)=Q-)4M*5.*
MVKTTJ2VE6<84XI*-R*6I*,=JLX0E2\XQV)3G/HXD\+ZL]4N-XXT<ML$N.*2G
M.<K3G.,9RG*NW*<Y]].<XSG&<X][/9G..WWLYQV9YNZ,AH%QDYG4K]>.O[I7
MK9]O$#(:!).9U*>.O[M7\>?;Q#<AH/1).9U*>.O[M7K9]O%T9#0))S.I3QU_
M=*];/MX@9#0))S.I3QU_=*];/MX@9#0))S.I4%=2]SM>N](7K8=1FNQ"=!C!
M[N0[H>@L[-J53L0@_?!#,%;,E;CYFD#[ )9>BLKGQ7IB)0_Q9K,=2<OAK2X
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MUVI6>R6Z3=!,(Z2KI2G#ZZ[ +\[-\O>'!H !@%H%V#$G>"9O02Z=Q %>MI9
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M\208'--9AI><EP&GE2&D1U$!Z)2E-X\E7/@HD=TJ9&P[&77ASF .:QUUQ $
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M,85PK-/FKGV8]'HQV8^#_+C/O>_C/Y./QI]-WDIZS\\_/Q5JC@0L4R2L487
M8/&(0P:5,-Q6DDB X*LBZ(@RYF$]^]#&.ERKT&,M>68SI*>ZTA#DM]2U/FJ7
M.(@DP-TY_P!!HKM_;^W]L?GX]^_9^2B<(HMWC?"&K-+;=V:)A0R1376L;Y>1
MHXCEY,"?/J=6*GH<.:J,MN0F)*D0&V)*F'$/89<7EI:5^*K&7N+6.<,0TFN%
M!-=%NS:'/:TS!(!C'V5IC<.N,D.V'5Z/2!E.M+%:AU!6[29MNXTN9[K67;FO
M].30.K1!86ZDM-$%;MFRKF.DC8:5$BB:U&).S3>#8_EUU0&@.(NWS48N:V&9
MD%TUD08Q,CNVP%UY<7"7.%G@10.<"Z(Q#2-QD3&XV78?6_?@.Z=P:X% *%4:
M;KB)<Q@_8%ZAW,XJ?9];ZNH6Z[?G("L*@.SH6:+;2$: +20#JQ+&1"D2P&I)
M!RIPH^U<'N: T!L]ITFK6A\P-QFF&$XP#6V#2QKBYY<X ]ES?XG%@B1N../D
MIX);2M.H>E2T=2^S=:"AVWF=51KUL"DU-F8VV_91XE> E>G.J>,RVW Z)4$0
M;(8?,*&LQIJHTDC"@1,+Z7R++K'@7@V\X":F!2M<@<2/&%R+ ^U%DP]B]=:2
M1,;S-!),P*5@448S.JG<Z^FTWLP'2]<R]LT:Y[(JEWHY"?98B9+^L8=B)E!%
M5!QTRIY.UDH@D;Y2.'V,\$K0^88L:;#:(=><'S\]8\V9<&MOM<6N!FL23 F9
M,#? %23%>AL6"TNESKA <V(_BH))$4,S0&!17=[J%M#EU-GHNMZ2)8:)=(84
M#:GR\FQ&[KJ[J(OY*K2);:H<8+BINA#3\HH#'2'3J)\:)Y66C1))5F*&KGN!
MD-9%ZR ,DES;1P:<H(-0)(QH%.K;= O.,-MR6T :^S;(&^?$T\(6_/.J\RIG
MTXSCX^W'"+5&F:,N%0W"1OF2%=)5V%*VR[6XJIY1DY,;WI=]=W"VY.J<$R8<
M%--72),>LQ(#\]JQM$HT>>]6/(,R97+HS#8V1LG .']I9@AQK9/Z?]I_:)>Y
MEUK3:&TZ?9]'#<&6=E:VHM'&WZFS]5K;MM ^.SUMKT7I%I+!+;7H?V9T?[+L
MF63@[X'LLK2WMWN <^T?9L# ++K+2TN]+RT#;5 @R*M$P5ZH=<[WKN&!666Z
M_7J::U$1)5R*EN.G$,B2BZXGQ6G(.&X781B(>SAI#^$NC69L&]#!(+NB6GVS
M48NL?M.U^UGV=DTD2UMF.GV%]GP$]'[,Q9D9Z3:MMCTBZ"T6]A]GL((!BVZ'
MT;HMB^U(DWG/=8VQ:[X@+8R1+IW%YU7G6:5#_P X_P#%/^E<^?T__E?_ &?^
M"^CT'"T\V_\ DO=/J;LR9)E)FMHP^ZIW",LJSE/C9[?%SG#F,9[/C[,=OQ<X
MV73VV=FQALR2T 2'"L;\*>7U7:VZ"ZTM'/%H '$F"TF)).,KR>93_P!_M?0+
M^LYTVDSA.YAZ+ELU_%;RGU3S*?\ O]KZ!?UGY>-I,X3N8>B;-?Q6\I]4\RG_
M +_:^@7]9QM)G"=S#T39K^*WE/JGF4_]_M?0+^LXVDSA.YAZ)LU_%;RGU3S*
M?^_VOH%_6<;29PG<P]$V:_BMY3ZIYE/_ '^U] OZSC:3.$[F'HFS7\5O*?5/
M,I_[_:^@7]9QM)G"=S#T39K^*WE/JGF4_P#?[7T"_K/1QM)G"=S#T39K^*WE
M/JGF4_\ ?[7T"_K,\;29PG<P]$V:_BMY3ZIYE/??[7T"_K.-I,X3N8>B;-?Q
M6\I]4\RG_O\ :^@7]9QM)G"=S#T39K^*WE/JGF4_]_M?0+^LXVDSA.YAZ)LU
M_%;RGU3S*?\ O]KZ!?UG&TF<)W,/1-FOXK>4^J>93_W^U] OZSC:3.$[F'HF
MS7\5O*?5/,I_[_:^@7]9QM)G"=S#T39K^*WE/JH6V]5WXAC2#?NIW7E^Z!<'
M.&MAQ]>8=PNB; D]TX.E94K9[>?)?&SK6)E$J?E*;2E7<U)Y*H?M)LM(LG=E
MP/Q@30B#2HK,9@'$+3?L]XO?VK.TV[\!)%09':$&D3D2-ZFGS*?^_P!KZ!?U
MG+M)G"=S#T6=FOXK>4^J>93_ -_M?0+^LXVDSA.YAZ)LU_%;RGU3S*?^_P!K
MZ!?UG&TF<)W,/1-FOXK>4^J>93_W^U] OZSC:3.$[F'HFS7\5O*?5/,I_P"_
MVOH%_6<;29PG<P]$V:_BMY3ZIYE/_?[7T"_K.-I,X3N8>B;-?Q6\I]4\RG_O
M]KZ!?UG&TF<)W,/1-FOXK>4^J>93_P!_M?0+^LXVDSA.YAZ)LU_%;RGU3S*?
M^_VOH%_6<;29PG<P]$V:_BMY3ZIYE/\ W^U] OZSC:3.$[F'HFS7\5O*?5/,
MI_[_ &OH%_6<;29PG<P]$V:_BMY3ZIYE/_?[7T"_K.-I,X3N8>B;-?Q6\I]4
M\RG_ +_:^@7]9QM)G"=S#T39K^*WE/JJ9I;V,9SD@SC&,>G.658QCY\YRYZ.
MSC:3.$[F'HFS7\5O*?5?E%/4YC&6R<=>%8SE.4-Y5C.,9[,YQE+N>W&,^C.<
M>]GT9XVDSA.YAZ)LY_%;RGU7[\RG_O\ :^@7]9QM)G"=S#T39K^*WE/JGF4_
M]_M?0+^LXVDSA.YAZ)LU_%;RGU3S*?\ O]KZ!?UG&TF<)W,/1-FOXK>4^J>9
M3_W^U] OZSC:3.$[F'HFS7\5O*?5/,I_[_:^@7]9QM)G"=S#T39K^*WE/JGF
M4]CTY(-=G_W"NS'S_P",XVDSA.YAZ)LU_%;RGU5,4QU6.U)%E6.W..W#*LX[
M4YSC..W#GOXSC.,X]_&<9QGT\;29PG<P]$V:_BMY3ZJOF4_]_M?0+^L_+QM)
MG"=S#T39K^*WE/JF:4_\$]KM^=A?UG&TF<)W,/1-FOXK>4^J>93_ -_M?0+^
MLXVDSA.YAZ)LU_%;RGU3S*?^_P!KZ!?UG]OAXVDSA.YAZ>]R;-?Q6\I]4\RG
MOO\ :^@7]9QM)G"=S#T39K^*WE/JGF4_]_M?0+^LXVDSA.YAZ)LU_%;RGU3S
M*?\ O]KZ!?UG&TF<)W,/1-FOXK>4^J>93_W^U] OZSC:3.$[F'HFS7\5O*?5
M/,I_[_:^@7]9QM)G"=S#T39K^*WE/JGF4]^$&OH%_6<;29PG<P]$V:_BMY3Z
MK\>9J_%RY[I1_$QV]J^ZSXN/3V9[5=[V8]/HSZ??XVDSA.YAZ)LU_%;RGU5<
M4QU79V$6,X5CQD]C*L]J?NL=COIQZ<>G'H]/O^G'&TF<)W,/1-FOXK>4^J9I
MCG;A/NDQA2LYQC'<Y[<Y3V=N,8RYZ<XQV=OHSV8]_C:3.$X_ZAZ)LU_%;RGU
M5,TY>/&[24?'B8[5]K6<>)C/O95VN_O<9^?LXVDSA.YAZ)LU_%;RGU7ZQ2WL
M]O809SV>C/8RK/I[.WLSV.>_V9[>SY^WX>-I,X3N8>B;-?Q6\I]57S*?^_VO
MH%_6<;29PG<P]$V:_BMY3ZIYE/\ W^U] OZSC:3.$[F'HFS7\5O*?5?E5,<0
ME2ED6$(2G*E*4RI*4I3CM4I6<N8QA.,8SG.<YQC&,=N?1QM)O"=S#T39K^*W
ME/JO/FKLIC)F*-P,1%X;RB5G*,1EX=4E+64OY?[I6'%*2EO.%9\=2DX3VYSC
MC:3.$[F'HFSG\5O*?5?5%2PZMUILM$<<8RG#[:$>.MG*T^,C#J$NY4WE2?WR
M<+QC*D^G';CT\;29PG<P]$V<_BMY3ZK\-U5MUW+#1F$Z]AO#V66_%6[AI2LH
M2[EM+V5X;RK&4X7G'BY5C.,9[<9QQM)G"=S#T39SN*WE/JJN51#7^-,0VNUU
M#&.\QA']V<PG+;./&>Q_=5X4G*&_\-6%)RE.<9QVMI,X3N8>B;-?Q6\I]5]D
MTQU>.U)%A6.U6.U+*LX[4JRE6.W#F<=J58RE6/?PK&<9].,\;29PG<P]$V<_
MBMY3ZJOF4_\ ?[7T"_K/[?/QM)G"=S#T39K^*WE/JF*4_P#A!K/_ ,!?UG!^
MTF<)P_U#T39K^*WE/JL/V'I(7LV@W?6]E(2<5S8%1L=*/Y&+7!(X"VD/,!E,
MP)N,NYB3?(9S_DLG#;F6'O$=PA7B^+F.^T&.!:;)T$$'M#?\EIOV?:,<'"U9
M+3(EICYUP6MP,/TG;2LGN%.)4G9M_P"D^'E>;1L"CY)6FF*KLU\$7M0&VV*N
MPHI)V'9J1,A62PT>3('C[E6WX<QR"9%-QHTVA94FQ+BR(+B"1&1@;ZF-ZIZ#
M:RXBV#0\F6M#@WRB\:#=,QN5CJ8_HANAW7QX4&UC#NN_ Y_5VO,VS3TVC[#V
M35*A4<V ]7QHNZU4#<"E)%TT$Q(?E/Q/-=P=!%PVY3N<C8R[M"RF1T>)$?PF
ME*3&%/R3[C;4_P#D8&1\5#,R*T,C%9IM&Y=-.KC%S%[+L@]J==F8X+8 ]VD7
M&ZC9@B+66%S$VV*&!GQ RIAZH<@OVTH91#K@(38A3UIF0F3PU4R[196;$F8!
M!<#,"/PW8*;/M(:.N;V22V&D$$F<9G&OL*.-G4KH"UX[!TEM&L:3#CQ=6?O,
M*HF=1,SJ6+!A(6P+9B5Y4U6)E/'F'QP_9YX:%<FLV0_"CW.8.'$6,EE*S]_L
MHC[O3+LP ),1&%?=5?N5N"3]X,F9/:FL3@9W#0+.PP+I[ZG, LTVX/(G K#2
MKK*'#J\;U_92&=(W:1)KU<MP6S@1%BP$J-S4U)F5B7#@2AKLX6^ZB+ /1%$S
MNGV;H_LGB'-=1P$W3(!I43NT1O0;1H(%JTR'"K28O"'16A(Q6VOF4_\ ?[7T
M"_K.:VDSA.YAZ+&S7\5O*?5/,I_[_:^@7]9QM)G"=S#T39K^*WE/JGF4_P#?
M[7T"_K.-I,X3N8>B;-?Q6\I]4\RG_P (-?0*^LXVDSA.YAZ)LU_%;RGU3S*?
M^_VOH%_6<;29PG<P]$V:_BMY3ZJ^!0+@KRGQY*'N_P"Y[/%;4CQ>Z[WM[>U2
MNWQN\^;L[/GYYND]+%O<NL+;MZ;QF;UV(B(B/%>KHW138W[SPZ]=B!$1,S,X
MR-%DO/$O8G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(H5V_#FRS.C5PV3;R
M(6Z14R?D-1@US99A)HFP6%/'9I9QMVA!$R)$9#UY"I<,PY[@ZOLH\BL<]22*
M:N$3A$X1.$3A$X1.$3A$X1.$3A$X1.$4#]3E"MNSM$[#HM'=:Q8SPT>W&@2"
MSX&+8Q\$X+)GJ9,.16W9 >%> $(G3YA1IM:H$8X[*\7*6L\(N<WV*V^1;BK;
MH#4HSI/77G\KU_JZC[>BL ^[*[3T 3MV;D! (DZZ'Q+#2ZALM"JA78YRJ1_*
MXAK*';P:D/1"GN=_O'RW!6BIZ*\(\\"MJ#FPKH((P]>FC5$9<VSWC\C=K0>G
M,@_=U]R[7ORZH+,C;#*?"NE!]*FM2UN/4<*Q/>$-E5$0"O>$;VB6FM4BT[JK
M(.O56IP;Y(N-A)@)=HWD^YN%HM=-<>=K].S7M<"G\T"<;H.<$0S,.2 QBB6!
M$(F$GD6UN^*]UIW'J4V.!TH;O-<#AM#:CDTJZ3;,T$TV,O!ECJ6'[ CSZFXR
MG%VLQ>1$U1Y.]&:GYI;L8*9=>!,.K:L!%F'2AJ#JXKNS[)8M]7N^3M>PJZ_C
M6M3-;%CFG!YL@]B&3:M,(:=M,@WAME$LF&78[M>/<W)!A40E!7&AA01%"0[I
MW\(.$!-S(^W;\8L<R/K1NQPRNYO*F90U6FX6=UCZUF6AT77K >VR.7'IIR-'
MCHK&)^9@*2" O$,+)7\?V^F*^4OILZ\+35[Q"L.QKTPR=E[#KU3J\C=/E#@?
M4]JIO4Q'K8*SDQF8T<W? A4_T\#)UO?DERT>762$T=9)\95@+'B+8?I+T7U
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MJ:.@6 94?)TV#)T:WMS+$'AC3"X\BOF$-Y0R3W[E9#NOIWM.U3])VP)ZF -
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MYJ^U&PTYX*0+U@@5*.T"G5XG0Q(J+C7^%C[#+<CGAPY18.;O5.($/B#) <:
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M8YI<3</9+&D2(:8Q; !)-36=P(Q72TM6. CK!#KYF"2Z#$.+C ;@*>)$E:T
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MNZU*)09M+I8XYK9C5%E)CKEN%HGFA#B.P$OTV95 1NN4N\UBYU^Y(&E&C$8
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M5Z/\G"0<C3&B>GXE>JKV<)!R.B>GXE>JKY\?%\V>$@Y'1/S9S\'H3G/\V.$
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MUZ,MYF\P!)"-8SBI^9<A)VP+AQL&R(,M8VQ0A9)8D*U:B-;"2K4T*A0T6-V
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M8$2%5L&@U8@]?EVVT)B28,E=6I<,K(MMF0R0'+6""D$X)#NW,UA)S.I2!D-
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MH:LA -S">JYQ1 @&':U8AG=%[BINM:<'#SBEMFQY\NP#"IDN0A+PY+?EI;1
M0U&B.8<-M#_9WW-[?628CX2 ,716=\&DYA5]DP]9<:Z6&R J73?!),0#0?O&
MZ*-9^$$VW9-I:8K=K*ZSAA-@'*U7)X4($C/V;RZQ7J\5E#D\(6V('O:(4^*$
M$8KUIUU1]ETX/*A6)6Q2%=CL3'P6&VSG.8"6P\Q %<708)DR "")$R"0MNL+
M,,>0UT@.<TS(AH;%8NP23(/:/\- I)7X0>]"MK[KUA^YE6K?.UGL.17@<)FY
MNU2W7(<?/V>MU 92*PY7["FVS 4ZI2YVQC3A0'&!!2T&?&'RU1I#"]=<0YXN
MAUUT"L.(<XAI:-\$0XS J:P5D]':6L=+FWF@GLW@"&ASKQD1,D- !)-)D@+'
M;!X6($X()':%J*8: 0+-[A-6JW6URFU0E!(4ZZ;*J1R 7;JA_#D"XZ^I4PR,
M<6TVB%*(1(A%;2&);[</26C!A,F.T2VE2#G!:)PSW E&]$),%X!B8 DT(!&.
MXF#BM@K'UI'Z_I"Q;I=U.QB%C<8O3U-"+M\EV0Y.(75NA/6"_P V#4Y<6J#8
MIQ2O%:">=_E"5PXZ93<B8G"-&UAA>6T#@V)S($N('9%:X_FL"P!>&!_\!>3
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M.R9NF!)$S()((@&6E0=-\)JF(*@DD4?7;JGY@"IOP)^V3E:,YNM@L!"O/E(
M.QZK'%96IZ7)&$<WZ_O1HK@3(*T+'!#<,&B:2QUX@&Z*Q0N(),@8$3=WET#
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M@$L79:]9*O U3172<F[F2A.P;8JY^4:4#/5&F&Q!H02"CHI9,&>N'R;;.+W
MQ%TN$;C2ZW$DETBD2#(W+L^P8&,(D$N#2:F1_$XB(#6F@,D$5)JH5'^$CW.U
M;:X 2<U9L,.3O-&K-8LM J\-V#M<G;('3L1M-0&HG;9:= /Z]3MZT#Y!L W=
MWGB848.+"()>%-$'<=>\.#9:X%T-<V.T8LS$7C$7R"1,W<!5;/1[.";KFD R
M"3V8-H X2RMZZT@$B Z:B"=KNIWJON^K)^RVA&S-/:XS6+E7-<Z[KM]KSQBP
M;0OI34CNQV@H^=,O](!AAY">< (*&BC[(ZM5*K7 K*F8>G0Y87I:6A%\!S6E
MI#6R!VB6WH,D 3,$X "5RLK)C@TN:YP,EQ!(N@.@0 #)WQOG=$J->K3KSV]H
M[:[E:H==I-O! -,";Y@!">%FK/M2]E).X Y"E4"*B["+"415CFMQ$:QR*S5[
M+(K$<X]/L+26T,Q$YM+9S7D"Z0& Q$EQ-Z@,B< * D8G&%;*P8]A+BX&\Z#4
M76MNF30P2"0) DGP4C=)_5]L;;-II-5NRZ38$6>=N()).TAH<L8DEKVMZ<NH
MDB$,@+A<ZW9@#@O9A*N6$D*)80(M@V#7GVVR4,LN5NSM'.NAT&0ZHPEI;A#C
M(@P?'Z2VL6,#BT.$%L3.#KXK(H06_5=,>=EY4X1<_.N_JRO'3+"U"Q1*C++/
MWC;FHJ]:[00HU[M-7 TNV[FUQK<Z,9FU(9)@Q+R9A7>5+J[)PC!B)9"DWFV"
MA)0D02Y6MH6!MT&2]H)@N;!<&D4P-1!-,=Z]%A9-M+UXX-, $ DW7$4-2!&Z
M3X0IHUSL[8ATIOZKVN3K6-<:?MHM2-4#8LDL*&&!2]2T/8X"(:D3GII8P8BM
MVF6_:)@$4PTS#C/J@"4L0LRI&VDF^*7@Z&U,'LAPK$UFI@1!HL.:T7"T.NEH
M<Z?\Q:8RPI)RS4$:AW9OS:5EZ4HZ;/2XN+SI>7M[?(6#09>0\,8-RQ78\>HF
M95J?*!"5QNAV$H!!)MFF(-:IMN7+F22+@_*^;'O<ZRDB'-+GMB( IC,@EQ$#
M" [ PNCV6;1;=D]E]QAO8DUJ,@T&N^6XU6-[4ZM[Q7=@4RL@MFZ4JYJW;EM5
M!J^H[>'6Y<[F!I&T*I0[/8%6:=?JP)K-<% _.P\\34+*E)QPQ2@( :8(+2#L
M-<^H <T$O+;A%3#@'&9I%=QQ&-0JVQ:6WBUY 8'%XP!+;T0!).[%N!K*;(ZN
M[,&ZASFMZ]L_6K^NG-/W_8"#E;!";E9*'(H-.J.P&UF1T;8.2A2/8JQ+LI2.
M>G58)07H<ZIB!%GEVO$P?/CK0AY;(NACG$@200 :B]@1-2 *@ DHRQ!8'%KK
MU\-@DM#KSKH$P*B1(!FA)@*>]"[)W5+LM6UWO)FK9N)K0=;VN7:KL/(^75K+
M.MA@4>J9=ADD4'RH\&!-K8\66@NLLE2X"XS&6_(G(4>%T:74#XO%@=2*&0""
M).8PWSN%>=HQ@!<R8ZPL@U! %"TXQ(.,F"W?*V[YI<4X1/R?%Z/BX1<SF>K^
MZ1SO5XH%==.;<&:0HMXGU&NU=G(.S*VY5Y%XELZI1 S<C9NYI$@:\)AVX]%!
M@6U7)9@57/+<PR<"N<!:UM:M=<:2!@0X3V8!)( J3GA0PO4;%L64M>TO>T$S
M,L, N@M[-:@9$X;M>!/A#=P(V70*5".:QVX)LVV=>T"M6#7-9B^0;;$6NUZQ
M%[#/#'OW4",JM1-/ ;X9E/D HRY0#)6H%XYA0!J!.3C'7/O  M<+]T.: 0X=
MF31QB[>(,!TD$4(,;-A9AI,/:0R\0XD73V@!5HDNNDP8B0<,9]W[UB6FDS;Q
M& ; USKLX'VV:T_K6B[!JZ9Q7:EK!:_UO;</).3[W30U5I:9=]DR+5:B4C+8
MNN00SHO#A@HS!)[?:$2 0TAUUL@=H@-.)< &U@NW>!H<,L00TD%TB\2UU&B\
M1  :274^'YS$QX^K[K+NVF;A*#ZDV%H^TG@VKK7?36HC<*1(L,(+6:MM!V=<
M7K+"N@]<U2;S50((/1 M>E'9\ /L*5.?BQQRR=?MK:%CNRYA[)<6P2:!QQFM
M0( DD29A+*Q:\=H.$N@'*H $0*1)),5(_P IDCITZHK7L+8U?U^:-TG9 *R#
M-\/U[:&O!ZAU?L#6E;EK,+@W$8:/V:"Z.,1]G^X,M^$6>AL62ESUQ5]V7Q"&
MUCRX@$AP(>0YH@&X148B#>BA(D0-ZEK9-:TN ((ZN029%\.,&1B+HW#'=$'?
M_G5>9.$7@8*C),V8,C$8$@B.2PL@/8F1W9L!$I*EQE38B'%/Q4R$(4IA3S:,
M.I2I3?C83G.("' D$$!Q88,P\ $M,8. ():8(!!WA4M<(EI%X7FR"+S9NR,Q
M-)%)IBOE'.!9<=V7%,"Y,5B:H<])CD(CT=D@B0B(N Z\V\IMN:F6XB,J*M6'
MTR%H9RWAQ6$Y!S7!I:00^"T@@AP)@%I%'200(FHC%4M<"X%K@6 EP(,M ;>)
M=2@#>T28 ;4TJKIRK*S2H?\ G'_BG_2N?.Z> >JD _WF[_(OH]!PM/-O_DL?
M-?Z[$??_ /&W??\ _M?S?%_'[_/5T;_A[+_(%YNE_P!_:?YC^)]^&"L;D6*\
MEY#L:.ZB3A.'TN,MK2_A'9XG?84G.'<(\5/B^/A6$]F.SL[,<[^8G,'PST7"
M3F=5Y)(0-,0PW+$#)3<9;CD9$F!%?1'<=7WCKC"76E):6ZY^_<6WA*EK_?*S
ME7IY(&0T0.<,"1Y$C##1?1(H8EZ/)2-@)D0TN(B/IAQ\/14.Y5EU$=W#>%L)
M<RM>7$M*3A>5JRK&<JSVH&0IA3!),$28.(DP?,?(+]>YH[,AN7F!"S*:4\MJ
M3Y*QY0VN0G"9"VWN[[Q"GTXPEY258RZG&,+RK'+ F8K4SODXF?'>DF(DQE)B
MF%%\UAQ+K'DKHL<Y&[6L^3KA1EL=K'^(SW*FLM]K/^U9\7^Y_P"P\7B!A%,D
MDS,F<Y,ZK[NPH3\=Z(_$BO19&5YD1G8[3D=_+JO'<R\RM&6W<N+SE:\K2KQU
M9\97;GT\0"(($9;DDYFE!7=DO@H.(6CNEBQRV^S..[7!C*1V*PPG./%4UE/9
MG$2+C..SL[(T?'9V,M>*B1@(PBGAN^0\X\$#G# D>1/CZG4JN1(I66U*&#U*
M9C9A,JS"C9RU#5V>-$;SEKM1&SV8[6$]C6>S':CT<D#(81ANR\O!).9QG$XY
M^:_3@L8[E2G1T%W*\/)7ER)'7E:9'>^4)5E3><JP_P!^_P!]C/;AWOG?'\;O
M%^-8&023F=3NPT6.U*@5&C#BHJLAF8$,Z<,60WAUZ61D%S9Y[O2<\E-)OS)D
MUQUM+$%A$A]QF")ACPT%N,*'08<>   @"A))&Z2JY[G$%QD@  Y 8>OG)WJ^
MI"ADX0E(D8E+<1<!"4P(N,(@N9RIR$C&&L83$6K.5+C8[&59SG*D9SQ R&$8
M;LO+P4O.[QQG$XY^?BB@H=<?,18D:N)G+.<Q50(JH^<QDX3'[6<M9;SY.E*4
ML_O?[EA*<(\7&,8Y8$1 CRRB/P23,R9SFN?XU5V]&&\8QC&,8QV8QCX,8S[V
M,8^+T>C&/>_-RBH./Y5SR\YR6/XAC0?*OX8&<-WBOQR+2<(H.W,XALSHC"Y8
MF+EW=XEM""E\)4EZ8KS!V(OR0/"'NM-W\LK",O-T,GAX;-AL3; ME4FMQ5MP
M_%9U _M!B2)[+]P^(_X32)-" NEGA:X_W9W3_$W2DUQ$*<>5<U^'&FWFUM/-
MH=:<3E#C;B4K;6A6,X4A:%8RE258SG"DJQG&<>C.,XX1?&+"AP49:A1(T-I2
MO'4W%8:CH4OLQCQLH:0A.5=F,8\;..WLQC';V8QPJ23B2?,RO3PHG]O;Q[]$
M3A$X1.$3A$X1.$3_ "?V_B_MZ>/K[U]T1.$7X=::?;<9>;;>9=0IMUIU"7&W
M&UXRE:'$+QE*T*3G.%)5C*58SG&<9QGA 2*@P<PO&\*&2&W&9 V ^T\AAMUI
MZ''=;=;BJRJ,VXA;:DK1&4I2F$*QE+*LYRWA.<YX@9!632IIA4T\E7W+&>4+
ME^YT#RIS+*G)/DD?RAQ4;.%1U+>[OO%985C&6<J5G+6<8RCQ<\0,8J<3G&"2
M<SKGCJOD\$#2%Q') @8^Y 2A$%;T"(ZN$AO*5(1$4MI2HZ4*2E2$LY1A.4IS
MC&,XQR0#$@4PIAY9)><)AQKC4U\\UZ7H,*0S(CR(<5]B7G*I3#T=IUF2K*4)
MRJ0VM"D/9REMM.<N)5G*6T8]Y*<8OAN.(S4DYE>980,M.4K$#%I5#2/4E<"*
MI*H"%>.B#G&6LXS#0O&%)C9QW*58\;",9]/) R&$8;LO)63F<\3CFOVX)%/-
M]TZ,'NM8>9DX;<A1EMXD1VVV8\CQ%-Y3WS#+333+O9WC3;;:$*2E"<8L"(@1
M,QND8&,TDYG57#A1.$3A$X1>)@:.B83Y*/A1N[=>?;Q'BL,^(](QG$AU'=MI
M\5U_&<X><QV*=QG.%J5C@ > ]^"LDXDG#>=V&FY&AHYAYN0Q A,R&H^(C3[4
M5AMYN)A7CXBMNH;PM$?"_P!_AE*L-X5^^PGM]/$#+P^62$DXDF:F2<<_H%:#
M=0K5BAC(!@/$EPPQ8><%,80J.F 4&.+<B28N8RF5-?O'9$62TA6&)L"7-'3&
MWX$V5'>0*2 8J/ YCQBGD2%0YP)()DT/C.<XKTXK5<Q&\CP "XB>.IS,7W*@
M^3Y<7EK*W,L]QW65KRPQE2O%\9666LYSG+:.R0,@/  0/)2\Z9O.G.3.J\%E
MH]0N-?DU2SUT49K4QJ#&F YD1I8R7"'SHA&,.DQ$X2U(&>508V9 QU*X$MEO
M,67'>BN.LK$ T(!%!@, 9 U"H<X&0XSG/RGS\5E.,8QC&,>C&,8QC'Q8QZ,<
MJRJ\(O-+AQ)[68\Z+&F,94AS+$MAN0SE;:L*;7EMY*V_'0O&%(5G&5)5C"D]
MF>S/$4K73\$!(P,>2^>!H[#KK^($+#[[S,AY[$5C#KS\=/BQWW7,-^.X\PG.
M4LN+5E;2<]B%)QZ.(&7L8*R1@2/GGCJODV'$->38:%#6L0W79$/NX,5&(K[^
M<Y?>C>*UCN'GLJ5EUQKQ%N95G*U*[<\0,ACEAA7WEY)>=F:XU-5CRM>4ARRF
M;>[61#]BL, *--D9$5$A1.+75$<A/*X[V%Q'9(Y!8@Q'G98\M3%D>2*D*BM,
M--RZTF8$F),8QA\Q^0R5ON #0X@ R(I]17T."R;W-'=ZP_[GPN^BY?S&>\E8
M[V/F5G.9.6'.[\=K,C*LY?RWE.7LYSESQLYSRP,O9Q4DU$F#B)-?/-69FFU:
M-8(=IC@AS)X<%GUT<1:CH;='!2I"(4*CQZ$8PS"9*D!PZ64\F;:60>&CE3%O
M8@1,,R!(,"0" <@2"1\R!/DJ7.(@DD2#7,2 <Z G59-RK*<(OD]'8D(PV^RT
M^WA;;F$/-H=1AQEQ+K*\)6E6,+:=0AQM6,>,AQ*5ISA2<9PQQ\_GFDD8'WA^
M!(^:_&8D7+J7\QH^7DN*>2[EEO+J7E,XCJ=2YE/CX<5'QAA2\9PI3.,-9SXF
M,)XWTSF=_GYI)S\/E,QK7S7Z:C1V<XRS'9:REI+*<M-(;REE*E*2TG*$X[&T
MJ4I26\?O4J4I6,8RK.<H]-$DYE8W$H]0A3RI-BNBO+C1C)\A(>B-25.&%0A\
M!R>SB1AU,-]Z.+@]_F&EA+[[/E;J5RG77G)=&0SJ,\==ZU>=A>, 1B<,OK^6
M"O:!0MM2EMC8#:UQ4P%K1#CI4N"GM\6$I26\95%3VY\6/G.64]N>Q'ISRP,A
MA'OP\%+SN\<9Q..?GXKP1:O7X=C+6Z,)AM68Z+#!"QO#?:0FAZ\\6DA1CDA6
M5+Q &R3IF3%BMY0PW)*3I&$=])>6M DF!)H3O(W G(;DDP!-!) W2<2K]PHG
M"*,MU7V3JK3FV-GPAK!B9KG6UXO<41)D+AQRLFHUDF?8'2);3,AV*S.<'IBN
MR6V'W&$.J=0RXI.$9CG76ET3=:2!Y GW^!P6F-OO:V8DQ*UAN/4+-KUAU@UK
M:F:8V,JT6X!2=D-UR^8\^QUZGV"LB[8%JE3 U"P3B4B@5\^9V#<2-L)5J$"K
M@3+!B0/44R2@<R[X;C6$DP:D.,F3 @S ,DT%:XRN_5@A]]SV@ ELB\(&!)D8
MEMT  G#P5KVKO_;.OMND==4G1^KK:-&UZ::KI2/?"[9VI1E*J#.+!?*[7];'
M5UR#;R!ZS!*+4P$XUL#8)FGO1*V!)>ZDO($Y[FNNM8TB"0;T$"!)(N]D22(!
M+G$ @5",LVO:";1X+B 06T=C1I+NT6P"28:!-5=%[NIHOI,L_6=9=6H2?DZT
M7>+71FF3966NV5:))KS0!8R?7TFQ)IHC#C5HTN328-T&QH$818P&2=<:"Q!>
MTV9M2T?#)&)I0U(QDD'*L@ *7']:+%KR!>@.P$&LF#7?%8G")4-WKK]IVL^D
MLEU)7G7U/';-&V6^T*!KHF1?ILARZ4MRP$2PHL1V!6:U8:HZS61,^R%!A$&X
M06N0R*"8/RC05\IDVS19]:6@.J+LX$7I%X@&@DX5F,378L7.M>K:]UR Z:FA
MC!H<<3$&<B5,I#=3H#95FE#-2UZ @"4Z6Z0"MCEEBREVK6O4#L<G573%=A H
MTN !BBK%WA2+!>?2_9XT)F25\@PT);9T7W31@ !LV@SBVT?=) CLP8P^( 3"
MQ<O-;+B26VKG @B'6;) )-20*>&Z9*WJYU7G3A%I51=17^K;XL5YFUN/)"MO
M;C0FPQBP?$^[QMQ7?5YZN,R8O?1YT:)JT-3BPB?DOC,C,+W/1562OE$B*QPZ
M/9/L^CVEDZ'.<VTL@U[FAEK>^T?MCI[+9Y >Y@98].LNC,%7W[3I <P6=G9/
M?[+:ULK1P<,76O1+9KX)?T9EA]E]$Z!;]&LVN[+ATKI%A]\=#VV;!8V K:/>
M+/7&]])F^KC#?52F*/J^KHV_H383^IBL2,;C2RVJKC0E2IH2PT<]30K%"KU8
MJRIE.!V"K2;2?*QF2ED2'+1PS [716.LK;H;WF\RQ^U'=-#70;2RL7-Z P.+
MFOZH](99]&Z18-99WK%O1;5A!=TIUH]KI%K8VC.G6;:FV^R+?[/:^#U=H]]C
M]JN +',ZQK'](Z=86UI;%[;7[S9O!:[HH#+7K'SJO&LTJ'OD?^)_]*_M_;//
MG]/_ .5_]G_@OH]!PM?-G_E^ZN4ZI8F2Y$KR]3??NJ=\3R?"O%\;T^+XV7<=
MO9\?9CGGLNGFRLVLZIKKH !+R,/ !>BUZ"VUM'/-HX7C,!HH,L:^:\OF3C\)
M*_1D_6\Z;3/ ;SN]%C9K.*[E'JGF3C\)*_1D_7<;3/ ;SN]$V:SBNY1ZIYDX
M_"2OT;'UW&TCP&\Y_2FS6<5W*/5/,G'X25^BI^NXVF> WG=Z)LUG%=RCU3S)
MQ^$E?HJ?KN-I'@-YW>B;-9Q7<H]4\R<?A)7Z+C^+_'>]QM,\%O.=?AQ39K.*
M[E'JJ^9./PBKX?\ <V/KL^]_-\_IXVD>"WG/Z4V:SBNY1ZJGF3C\)*_14_7<
M;2/ ;SN]$V:SBNY1ZIYDX_"2OT5/UW&TCP&\[O1-FLXKN4>J>9./PDK]%3]=
MQM,\!O.[T39K.*[E'JGF3C\)*_14_7<;3/ ;SN]$V:WBNY1ZIYDX_"2OT5/U
MW&TSP&\[O1-FLXKN4>JKYE8[.SW1SG'_  7'^3^[?V[<_'QM)W!'.?T^6B;-
M9Q73G='J%3S)Q^$E?HN/B[/EO[?DXVF>"WG.<]WWYILUG%=RCU3S)Q^$E?HR
M?K>-IG@-YW>B;-9Q7<H]5%.S:&ITGJ/*'+/-PUM8<ZXNNUZFE8T%O%.NJ,S;
M0[:Y")8:M(4M+$@Q2_'N+960(@Q49"3CV<9=]HN-TBQ:+IGXB9H1%6F,<1!B
M1@2J/L]@!_M"9$5$1)%1#A)I$&AE2MYDX[?]<E?D\EQ]=V_Y>:VF8_N6^=\_
MICZ*;-9Q7<H]4\R<?A)7H_\ 9D_7?S<;3-?[!M?\;O3\4V:SBNY1ZIYDX_"2
MO?[?_%<?7?\ 7\_&TSP6X1\9_3^W@FS6<5W*/55\R<?A%7Z-CXNSY;\_Y?F]
M'&TCP6\YSGN_+R39K.*[E'JJ>9./PDK]&Q_%_CO^OY^-I'@-YSK\/[>";-9Q
M7<H]4\R<?A)7Z*GZ[C:9X#>=WHFS6<5W*/5/,G'X25^C8]'^>_GXVD> WG-?
M]OX)LUG%=RCU3S)Q^$E?HJ?KN-IG@-YW>B;-9Q7<H]57S)QV_P"N*NSXO)D_
M7?V^+C:1X#><_I39K.*[E'JJ>9./PDK]%3]=QM,\!O.[T39K.*[E'JGF3C\)
M*_1L?7<;2/ ;SG]*;-9Q7<H]4\R<?A)7Z*GZ[C:9X#>=WHFS6<5W*/5/,G'X
M25^C)^N]G&TSP&\[O1-FLXKN4>JQ.]KJ>LZ?8[_>;4T J-3%231XL^/DRDPX
M$1/C+RU"@)ED2$MY>41X(T;$EDB4UYB"/B29DAAAQM(\!OG?/Z8^B;-9Q7<H
M]5#%"ZA^G;8Y(:# [4P(L9>68&P*KL.FW+4MN=* GZ\P1$.5/:8.G6..83YV
M5R3#$R1C1 H.,0R@R-,'.9E);2/!&,_&?T_OXILYG%=RCU4D1;CIV<RU)A;I
MUO,COG,5AA^+<*M(9>LJLQ,)KS3K)I:'#><SX.,"D*S.SF9$QACMD,^.VF>
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M6B/Q6IXR%T;;5V ;E33[%NVCTGU<B/-7>RTRX5HL$K0$[*A6LD!LK@.KUJ\
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M#K6T!B:-G$2),0)& F2: 2LCIENYMX6;8F/B D[X!J8WQA()HK?:NM73=,@
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M)D)))G8462  HL<@,8BUG!TF-79)@DG$!IGR(,EMJ_<+ $--L^2)%!%<))@
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M:F0U6VB-, C@,!:7IT@-=JQ:X&P:J5!O2VA(( 2(DR<W;K.\X.O78 !(:"Z
M28#C4 G$5%! G'++:XPMNS\4$DQ415N!@X1!J9G!1;4^@V?K\(VJF[M--WBF
M[59O.EK):JB/LP/75#"5G8-+IFEB5707#R;72:Q5]IWN&S,C62L'WIQ:)/CD
M1Z1R(C\%D6CLO-X&6.+0;H (:T@GM!H)K0[L%H](#CVK,%I;#P"07.)!<\$"
MA) H;V'C3=[7U>L55J(D);;I/V%98WET@S;R(H2#<+3B1&83>3$"A6&8 H0.
MS,P+!CO'G3(8:% 8)ES1)$LO-Z-!  +KQWF(WG=N\,:165Q>X.=(:&B  !N
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M]4^P7Z,/Q4NGG]3]"_J'CJK'@V7(%>NMN*^O^(^M/DGV#'1A^*ET\_J?H/\
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MA=_8Y.LL^(SF;ZIU5KW':)W#_P @_P#0N_L<O6,[[.8>J=5:]QVB=P_\@_\
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MW]CB^SOMYAZIU5KW':)Y._\ >[_T+O[/'6,-;[,OB;ICI],$ZJT[CM"G</\
MR#_T+O['%]G?;S#U\1JG56G<=H4[A_Y!_P"A=_8XOL[[>8>J=5:]QVB=P_\
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M[!3QJPY.PHL%F%'-O;:W$BZ7QEZF1H;EL'SKX-K;(>-/*15HF6ZPXLC:YD8
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M.$XQC&C:,))-HTN)+B2\$DN,DDDDDDFLUDK'4V@  LR    &P  (  $   0
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MFVUG?^XML:JH4RGO)(01@Z=286MH5NV"U/%&VI2#LT)"R%<!8)DR+R6SPA!
MCNCJ8U#1B6KZ-'T0 UF_#MNT!EXL)(V9-;$O= OR1.NJ<\.-VUQ-@!5FH:VK
M0TL%,W$^5F%HDJ2%? (+%*^_9_IN6Z>D-I7RZSS%:V;5!-0N8K7NFMA3 H:=
M((QQ#.SZX79*5R?->[6I1:NWRD7J!Y5"5F'* 9KS_9B8Y,[2JV%X1.$40[8V
MG H0]\1 )5^+L(W6[.3HD*XY/#:=,(5\=F6M5FM H.2B 1;+BV,OYE.L3)B%
M9CC&WY2TX21:?R>L[9$/H?NO4FG75:G;,UO9;?4[E19Y(W5!(R;1MH3:&;FS
MHLR(8.B2"PT1FPLU)3Y%U@A/C WK(N*AXZ@BN5:ZSK'$V#O")L>M52)K;7](
MZB=B5>?3YQ<E<8E<Z8]F2]9W2/>($U"!_NI:WV6[%46PV66VH34X;-3)D1\3
M%D7[U)U2;BN&W*;6+A5]8#J/<#)G7V& !2R.WT+?:WI6M[C*EI;<Y*@DNDR&
MRI2MP<-(C%&W&*^8>?<;/.#1A/=?94;D^NW;%>SMD7.H6KK"=H&VNEX;"D5R
MV6!FO2=)=3>V(FM M]&SYHM]R\.B9B"PJ$5#8""+!9!Q9K, .,!8DFR?+WE[
MR6]>G-LIVDO:PY\9[E&=2[AM^J#C3:\NPY;H:*%L@$I"=4I2U()TVUUF9.:7
MA.8AATE!1A;49MUPBF;A$X1.$7,NI=;&S"ACJ&9F4BF'&:+JO>.TM8UT.0FU
M\XRK2FVMBZA\R=G&39.<(C%[O/H\:RB2\*&$B"H,HV,DCY^ 23,\BBG6/A"M
MLVR?1'S(G7*JLUO^J:+V,3:I6R*4>FYV3%HJ:7=1E.NAUNTZ^K+5EO4'7\>8
M8#7W-OO$=$/#=*KS\JRC"*7]Q=8FRPUCVR/UA&UI %:8:W(5.N[('V-Z5:8^
M@J#IRYV^L %B+$$;@&;;(W..&5PS)9)10S%5)DI(.P-EHS(XB]>_^K?:FK-^
M *$,%T"OZO.Z^A+'W^^,QI-?QN"P5_;9X)6;S8 NSH-NUG48,'7,<D0LZ--7
ML3,B>[D:2:KCL5F4DBS+IXZGM@7JUZ]I&S05>R_LZG[GM]&N52!V*K";2!U!
M>:57VK-YI6PL8L-<%7D#L8"7KT,C.F/H;#SYSLUV*>$,1B+>[A$X1.$3A$X1
M.$3A$X1.$3A$X1.$3A$X1.$3A$X144I*4Y4K.$I3C*E*5G&$I3C';G.<Y]&,
M8QZ<YSZ,8].>$419Z@]")SE*MWZAPK&<XSC.RJ9C.,XSV9QG&37;C.,^C.,^
MG&>$5/LA-!_PX:@_673/ZZX1/LA-!_PX:@_673/ZZX1/LA-!_P .&H/UETS^
MNN$40[4ZA=0X+:;]Q-V:Q6QG;PS%@S ZAZ-26V@.:7><.N$H+I&1G8 [W2]S
M$+H;*HKTR4N)84R4HK2VGB*7OLA-!_PX:@_673/ZZX1/LA-!_P .&H/UETS^
MNN$3[(30?\.&H/UETS^NN$3[(30?\.&H/UETS^NN$3[(307\.&H/UETO^NN$
M3[(30?\ #AJ#]9=,_KKA$^R$T'_#AJ#]9=,_KKA$^R$T'_#AJ#]9=,_KKA$^
MR$T'_#AJ#]9=,_KKA$^R$T'_  X:@_672_ZZX1/LA-!_PX:@_673/ZZX1/LA
M-!_PX:@_673/ZZX1/LA-!_PX:@_673/ZZX1>V#L[2FQ7'J:,V%JV]/'84V)(
MJD"V5.SNF!RHKN245X''(3ED(2H6'LS65Q7F,Q<.Y?3W7C\(ON*TOIX$$9K(
M35&M0U;CIRF/7Q5%JX\(PG): ?RED5$%LP&TY.BA9K.$,8Q[K#8!'L\LAQWF
MR+SB-&:3K\2?  Z?U<$@E!TP.3AB*!5!L0B)(=UY>+G1X8EEF6.G=PQY7"?0
MY&D]RUWS:^[1V$484;HSZ<*'*MDV'K*OV27=#8@^:?O4"%=%J(U^589H&1']
MWXLQ+<L1+MEED12SB7CCKIF8J:4E=K7=$4@/Z T_-VN;W<4H5>-;+/4RNZ_E
M64X-B&)4.IUEVZN01(=)%F2@,S,3L"T1C>1N(RCD.:U#*9E1XD=MLBRJHZQU
MKK]*D4/7M'I*%Q<P5HJ53 UM*H2I;T]4-20\"'A454Z3(F9CYQEK,I]Z1E'?
M.K6HB^#FI]6NPG!KNM:"Z.=C1X3L!RG5Y<)R'%K[M3BQ'(JAV6%QHU6??K<=
MA2,M,@'G0[:$CW%Q\D7XB:CU1 'MB(.L=>PA3+33#(R)3*Y&'M,L"S -EIN$
MR-1&0VR%L)\0TA+>$MBS9> G&(I*8T\178#0:+5I#,NLTNIUV5&A3QL>2"KH
M@0^P.*%EGB<!EZ!#CN-0B)QQPS/BH4EB656LA(0Y+5E[)%EG")PB<(G")PB<
M(G")PB<(G"+ S6K-8V1@K%L6N:(>C'FBL<Y&-5&OE&#+!UX+(-LE69P]]L@T
M9D5NNOE6Y:7D$'@(9V6EY8N$I@B!M5ZPKI]BUU_7%#!6B* A5.-9 ]0KXP_'
MJPUII@=6V#$(>P1: 0&&&680=N0D?%:9:;8CH0VA."+'A>A-."I$":C7-2)$
M Q2[EJ^4/@QU@+UEW8Y0D9NL.LEC,::1 "#\\P47,#BI,4:J/->A)C)A>)'2
M17.WZ8T]L"%@;?-4ZVNP[$<)$Q MU&K%CAXBUETB_7(V(I@7,9Q' /&"[H5G
MQ.[%.E"+D%+"YLG+I%<:AK>F4.;8)U3"QPSEDS7VYL>)E38^&/JM?@UFN P8
MY.<00->#"H&,#P0B/#&1I<PG.;C)EDICKQ%G/")PBM9L(&LH<I7K$)''0)N!
M+%&0IB%&)"BHR<RN--'D1\QMZ+-A2X[CC$F+(:<9>:6IMQ"DJSC)%'0K0VDP
M5=F5 +J;78FJ$*\.J<^MCJ@#A@YM9$$RIL:"E"V(3<)\9",'315B(ZRII!$J
M0F^+F3+><6170;J'508Q>[$(UQ1Q1_:+26=D'!E7#0"][:3'?B)1;246&U,/
MIQ'E26L8)O2?WLA[X75Y418C7>FG1-:F0S,75U+GVN+4@%&>O9FMA2E]*U>K
MMBV@0HW<)$')TNS 0$#>(J=,><=4*'N/J=<B,+017X3HO2P&%91P/4^N@\"Y
M6D?>+;#%TVOP(UEN(@U$L8JSG&8L!ILH=&V"!"-P"<Q+TN(5C,SX[K<I&'>$
M634ZBUFAQ3D6M#\0L66V66[GGUN*>E%+-;"CQ4P2F2'.UQU:G76X<1"L^)"%
MPX V,EN)"CMH(LOX1.$4=[>V%&U)JC9NU9@Q\U$UIK^Y7Z4'BOMQ916/3ZZ1
ML#PV/*>0XS&?G-CU1FGW6UMLN.I<6A24Y3DBTEM/47H>D[*&!Z[HVB7&SVU%
M,NG4#;:&[K>5G7Q2TWBO:6&2;<05%AF[M;A9V_38DZ&_&AGA].C'IBVVWYT$
M$4(KKM+8&B]#7(;3PW2B"F6#6PR@3=.D U,UI6 J;7O/<%7TY  T JXTF=4,
M9M=Q#3KQ8HXT;!:'NR7(V#Q"))A-$4NT^M:CW+1W]Q6C2HLT7,&Y=N+T:UAZ
MW?90+:6L4S==D9=803:D!6[6PNHMUV'9!#@U1B(*#R,O1DYSG!%K!M'J*Z;H
MG3[JOJ7O/33KN1C<+-PI^!.UDZ=KCU=#SQ.PK=>:M:KW8TD*PI=G\VK)$\V(
M),A!NUK.(A*>?9GSBK9%C^D.IOI_S='IVJ.G<?K> #,Z^U=2XJ!DS6,DC0MS
M;9K%1.7VCT-W7X2JSJZ]>RE-DVPK4SYG):/ K^3!&#+9!09Q%UKX1.$3A$X1
M.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$6*7L!(M='N57B26H<JR52Q (TQ_"\L
M1)!@1,',R7L-XRYEIAR2EUS#>,KRA&?$QXW9PB@;6_23T]5K7E#KA+26C3Q&
MOTRK@R!QG5])DM&9P@)!'RRK<A\&I]]!"1'<EI>?4IYS#N%NJRO*L\(LT^QD
MZ;?Q?=(_JIHG]0\(GV,G3;^+[I']5-$_J'A).:?8R=-OXOND?U4T3^H>$4![
MQZ&M'[#,=/\ / ZJT15F-9;\K^RK)'DZSJ495NKHVC;#K;]2C)A@THE29A*U
M"RB(L[QH*T"''%IS(:C\(I\^QDZ;?Q?=(_JIHG]0\))S\?GFGV,G3;^+[I']
M5-$_J'A$^QDZ;?Q?=(_JIHG]0\(GV,G3;^+[I']5-$_J'A%#M'Z+-#UO:>[+
M82U%HDF-V*0HA2NUY&LJ>Y(K4*N4V%62&'8SX/R>.@L5A29S:H*,,N]N5/JS
M)PYA)%,7V,G3;^+[I']5-$_J'A$^QDZ;?Q?=(_JIHG]0\(GV,G3;^+[I']5-
M$_J'A%173)TV^*K_ %/VD,>C/ISJFB=F/1[^?^X/O8]_/"*$^FSHDT5JG0.G
MM:V?4FB+K8:+KZLU<U;H>LJA,BV,D'&L0Y9=B40!JG2&YKS2WDNRU9?7A7:[
MGQNWA%-OV,G3;^+[I']5-$_J'A$^QDZ;?Q?=(_JIHG]0\(GV,G3;^+[I']5-
M$_J'A%'EJZ6=3LWW1UZU]1-2:W*:BV9.V"<( J37*X9)5J5JO9U D"HQ$(+A
MR&6G"5V'$9&9CR("XPN0E><OI83PBVQ2I*TI6A25H6G"D+3G"DJ2K&,I4E6,
MYPI*L9QG&<9SC.,XSC/9PB_7")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PBCG<&O&-N:EV?JF45?!QMF:
M]N= D&XL9J;)#L7&ND:\Z4CPWW&F9;\!!%4IJ,ZZVT^MI+2W$)5E6"*(B/1[
MHRRE]<V^WTV!.OM R,G/6.IR[#KD?<3T$E7K&X2O%6J%@@AKQ"S<ZL"N0X+?
M$6V&(/"X$Z,M<IA<E\BR^\]-^IMDAE!;J&-FT9J *EH+KNERA6F.-J]G#W6N
M$X=O&G8=G@VT'<*^&LXRYQ"K%IB'!T<@T6Q(3E>2+(]8:BJNH1C@&FRK0BNX
M@!1X\&>M1VT1!2!#$EM^;#E6&:2+/F;',F2C-M.$R) O9CLAXP7FRISKKRR*
M+K/T<Z(M]%"ZT,!KDW2*\H<X&  MK;1JD> X/(68@I;,BK7 /-\<KFWG81Y2
MI*LG1C\,<4\JBB1+<$BQTIT4ZG9-Q;#14DJ847L+7=Q)JDE[5<1D4#0MA@]H
MR*+KVNV2TR*WJ@%;[G60):THHP@=#*OP&WYPN7,8'2QY%N)PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(M)^MG4/5GNS7)77W37NS5VG1UIKT\#=I-Q
MUY=+#<2<.?.'^51J7>ZKLNJ(H*B(!LP!FD5U&T%6<%DD LX&0A1Y:"+).@[3
M^QNG[HRZ9-&[<D5B5L?4FF*+KRUOTU\C+K2R%3"10R,#)I;/E\Y+<2)&;DSW
MT,8G3$R);,6(P\U&:(MM.$3A$X1<K_"-='6WNJ2V: -:W122,'72;M%6FYV$
M@#?UE>[+9]2F:;U"TIF+7SS9&\:P#T:[! S,9T"<PW?I3(TW%A2RZ5D75#A$
MX1.$3A%R9Z7^D'JRU=X1CJKZI=U[1U]LG6>\-45FGTO 1JUC+)4D5/:U^/4N
MC,5LH3( 1(&H4"Q0AY,J*6A5LL;[YQZ'$(.EGR!%UFX1.$3A%K=UBZKN>\^E
M+J*TSKJ37X=ZVGIO8-"JLFUSCHRN,F[36R >"LR1K*DGH,##LO&'I8S#DEC&
M>\PQ)0E<=TBB?P<'3G=.E'I-I.CKS&#P"56LVS" P8&*BC:!5:MFQ;-;*^-)
M$:Y4->T]TQ$'&FD$F:10:93H3_\ >0"OPX4=*G2+>GA$X1.$7)3JZZ-]GWG8
MO4SL_6^O*%NQ>Y.EW6.JA.M=X[.N#.NINPZ;N$I:4+-5IU!@,-UV$K\@98I]
M,"Q((/8IZ&1#VB%XE@*EW"+>#I%U61T=TQ:*T^6&O"">MM9U>GSAC]B@6M4&
M2$'-0W8[9X57ZJ)FQD*;SB(@36@0J#%[D>-%PX,5AE!%L7PB<(G")PB<(G")
MPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PBQ>[-W-
MVH69O7,JLP;ZL&333I=T@%"=2CV3,1WW'<L@\(1$F)85,[N?=%D82ASE1>\S
M&>P[A.,D7)SHGKOAH(]3VYCJ\V+TGM[!=WC:GZMEG75TM-2<UP[7JCFMYU]*
MJFS*+)@4]J5[K1HPVX@\W-HJP6D&I\W$J*]DBW0]Q>O/^$KI&_4GN/\ T_<(
MJ^XO7G_"3TC?J3W'_I^X1/<7KS_A)Z1OU)[C_P!/WY?[8])%LM4&K>Q6@[5]
MG5PG<41,8/SZB*)A*U)G=XYG+@<29,6 I!B=UEI.&9ID@]WB5JR_E*DH210C
M=!75^_9RSVN[UTW"Z8MYK(*!=-5;./6>-'Q'9P\@L7![CK@J:\J7B0MIR&%@
M(3'4RVIM;C:W7"+%O<7KS_A*Z1OU)[C_ -/W")[B]>?\)72-^I/<?^G[A$]Q
M>O3^$KI&_4EN/_3]PB>XO7I_"5TC?J2W'_I^X1/<7KS_ (2>D;]2>X_]/W")
M[B]>G\)72-^I+<?^G[A$]Q>O/^$GI&_4GN/_ $_<(GN+UY_PE=(WZD]Q_P"G
M[A$]Q>O/^$KI&_4GN/\ T_<(GN+UZ?PE=(WZDMQ_Z?N$3W%Z\_X2ND;]2>X_
M]/W"*ON+UY_PD](WZD]Q_P"G[A%IA8*_X:)'7EK*=6+_ -)DKHU;U6$9W.R3
MHMO$0Y-ES=K8Y.1KP#Y^62_+V2S6\"<++D+.'UU@=*&-RA9(G"D)61=B>$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1<A>HO>W7.QU_P!8T?TT#1QW6%9UOT\[&V:*+52@/UQFM; W%M*J
M;-+6B[GMAUB^ I VA4?$ZC0M?U"].SK/$Q%-P88^;W_"+26H>'>L AJETNV:
MLJ5^N&>EV@;*N-E$7,C3\BMI636>FMA$G+C5Y]*<CU;5<$5MQD\;N59)W.+7
MZZ!+S76WI\68$'D62]3_ (:38^O(=_HFN-;:E*V\5TD7_<P[;E8W,'MM$1=P
M.NMWW 67U[7+)7ZB;V]JX<2TT]7CQL-#9(PS1MU*Q+H>ND2DHBD&E^&HGV39
M0+6DC2]%F/L;*&4 O9ZGN9^P -N-6#<E6T]"(])SCFOQZMU2ZD_:V;9LT=-5
M4$54$%,89E3UH0\@B[W<(G")PB<(G"+#-C7VMZLU]>-F7&>R+J>O:E8KK923
MZ\-LP058$RS162XM79C&&84)Y?SYQC&.W.<8X1?RQQ_#4=9%&TEKV^;SH[%!
MN87K"I1;<U8.:9ME/+O=#UQZ;]I=0AS%9K-G3%,R;#19&JMCT&)>QC4J!:9>
MOO="'A]!9:UD5]U9X5WK2(6WI7J6R]@:H$?NP[#M%>ZB",?4Y1Y/32##]0$Z
MI:J?(31CTL-%SU"84ST^@95QD1T#+E 7>X?>Q6B,))%C,SPS76#%U;3[>S;-
M)2BM@MJC!)_]SF9F! O:=6PKQGH-1%9N>76]KX/OY YL#[^;AW3J&?-[$[&%
M9)[]^]VLD]2'A8^H?7T3J0A4??>F9XK6V_:-#';)BZU#BO-37IFF=4!VWZ=R
M,NUV35IFX0I[1(.J@JQL [2KT=+%9A+W)CAK7043"+^FFE&5V.FU*PN(G-N'
MJR!,N(*#\"":%E!42<I!$4EU](R<E3^<2QZ7GL0I&'(V'7,->/DBR;A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3
MA$X1.$3A$X1.$3A%K7U<;K8Z6^FS?W4U&ID.Z%=.:EM-[57U3T )-ICTX;.,
MQJ\_8D"RTB!%?>5(2T]D>01#<E//-PW%N+2LBYX2O"Q])86[1-:G.G_9XK=,
M4K&U]===L4'6Y4[0<E(M%'T^.9+!K?.$F*I;(>U:DB#(IQ"RQJ[7RI0A=(=8
M&!C.8Q%$]2\-7TZSJK5+!LWI.V50TVO6FD)]#!CQ^K+M./U_<>CC^^[  #(C
MV 0PQ7J;1*XZ_P"YTC,,C<7Y(\>)JS9J0D,V1=6>G+=.KNHP5;3^O-<&@-7U
M+M;8>J@AZT5:M@HA6U4*QEZA>R5#@PB1 O!#LGQQ$>LB2'5Z44SEQ:(CB,O9
M01;1<(G")PB<(G"+RS8,(E#DCR,.*0@36'(TR#-CM2H<N,\G*'8\F,^AQE]A
MU&<H<:=0MM:<Y2I.<9SCA%J)UD;E$]/=*H-T_<1C;L*WO=>HM'1ZI#<JXX_(
M;VB?E4YEX3-M2& <J2.CG"3442:, !$MHG/BS#@J)+EOJ(N<)KPU?1O*J.Q#
M>JM"[(V<5 T03;SP2/2J%68DRSQX VZ9H5G)%#SCT(W5A11ZP2K#)%$:9@A"
MEC:[9"UDDCH$XBSD'X7CIM:O!O6FPM ['H5L%]0>R*4^$8K]$MS\%&O[U4];
M(W$<: '5Y2LQ?;0R%=C5E%LL0)L.9L!-[%:@8-ND713IIVOK?JKT32]\5/6A
M:KT/<D2!L6N#-A5VIP3UB%3T1IM;NQ42"+V6(S)+PFX)$<HI.P>BLHC>71H3
M[:&DD6RW")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PBQ2]46G;.IMFUYL*M![E1KF%GUVUU
M2PPF20.P@BC"XI$25@2$J8F09L=:V9$=U*FW6U*2K&<9X10()Z(.D &[4GQ/
M39IR#(HA^=::G)9HH/RH+8B1 46F&&)*XJGWI[A0"!)-ORG)"HT\"#EQNY?#
MC7(Q%;9'01T6RQD +)Z8=,/B10RN!A@YVC!EQ!PBHC["&K8R"RJ/E$2"(!6V
MS5V+%8PVSYM'2=<=0X#ENCU$6QE-HE-UZ-GAZ-60U4%%+'9;>1'@X+(^),L]
MQ-S;):3K[#"4MK)'CQ&<6)R<X\>5.EOOKSE:\YX199PB<(G")PB<(G"*.-IZ
M@U?N^KMTO;E%K>PZHR:#V1@#:!S),?'L%>EI( 34=E['][E TY")HR<RI$F%
M+0B1'<;=0A>"*'4]#?1TCRG#73+I2.F91$:QE-Q=?5V*R_0FA+(!JLNL1X+3
M*A[(*.R&9SE'E#0II ]M],1.&N$7M<Z+NDUXRQ87NGG5#QR/;"5Z:*/4\4[-
M\[S.:ZX6L+CSC"E/DB,RHU8I,>>[S$@W7@QYQ*C(Z+.;(ISH](J.M:?6=?4"
MNB:A2*8#&UJJ58##:'A:^ #Q6X0L0+@LX2U$@0(C+4>-';QA#32$H3CLQPBR
MGA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img109617586_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_7.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1EL4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &5"^9( X0DE-! 0      $<< @   @  ' )0  AR<C,R.#8T,1P"!0 N
M36EC<F]S;V9T(%=O<F0@+2!0<F]J96-T($%M8F5R("T@1F]R;2!3+3$N9&]C
M>  X0DE-!"4      !#2ZC6%B-%@ORP[+HQOJ%R@.$))300Z      #E
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M<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M    0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T
M=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT
M;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #
MO_XU  (  0.__C4  @ !.$))300F       .             #^    X0DE-
M! T       0   !:.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ !
M &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M   ! #4    ! "T    &       !.$))30/X      !P  #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      -M    !@             $?0  !Q@    <
M %  <@!O &H 90!C '0 ( !! &T 8@!E '( (  M "  1@!O '( ;0 @ %,
M+0 Q "T ,0 Q #@    !                          $
M!Q@   1]                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   1]     %)G:'1L;VYG   '&     9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   $?0    !29VAT
M;&]N9P  !Q@    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     (X0DE-! P     #J\    !    H    &4   '@  "]8   #I,
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MS*G$8^,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M      #_X3E,:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K
M970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_
M/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K
M/2)!9&]B92!835 @0V]R92 V+C M8S P-B W.2XQ-C0W-3,L(#(P,C$O,#(O
M,34M,3$Z-3(Z,3,@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB
M:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^
M"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @
M(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*
M(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D
M9B\Q+C,O(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X
M;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @
M(" \>&UP.D-R96%T941A=&4^,C R,2TP-"TR,U0Q-SHT,CHT,RLP-3HS,#PO
M>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^4%-C
M<FEP=#4N9&QL(%9E<G-I;VX@-2XR+C(\+WAM<#I#<F5A=&]R5&]O;#X*(" @
M(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C$M,#0M,C-4,3<Z-3$Z-30K,#4Z
M,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#(Q+3 T+3(S5#$W.C4Q.C4T*S U.C,P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%C<F]B870@1&ES=&EL;&5R(#(Q
M+C @*%=I;F1O=W,I/"]P9&8Z4')O9'5C97(^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@+2!0<F]J
M96-T($%M8F5R("T@1F]R;2!3+3$N9&]C>#PO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD
M8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @
M(" @/')D9CIL:3YR<C,R.#8T,3PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.F9O
M<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(" @(#QX;7!-33I(
M:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@
M9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E
M+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS
M=&%N8V5)1#YX;7 N:6ED.C,S-61E,#5E+3AC.6,M83(T.2TX,C!D+68S9F8R
M-C$Q.#DP.3PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C R,2TP-"TR,U0Q-SHU,3HU-"LP-3HS,#PO<W1%=G0Z
M=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^
M061O8F4@4&AO=&]S:&]P(#(R+C,@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @
M(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(O/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C,S
M-61E,#5E+3AC.6,M83(T.2TX,C!D+68S9F8R-C$Q.#DP.3PO>&UP34TZ1&]C
M=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HS
M,S5D93 U92TX8SEC+6$R-#DM.#(P9"UF,V9F,C8Q,3@Y,#D\+WAM<$U-.DEN
M<W1A;F-E240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^
M>&UP+F1I9#HS,S5D93 U92TX8SEC+6$R-#DM.#(P9"UF,V9F,C8Q,3@Y,#D\
M+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'!H;W1O<VAO
M<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0]
M(G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0'_P  1" %P D4# 1$  A$! Q$!_\0 '@ !  (" P$! 0
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MA1O:'@0,FU<QDF0HQDY'@@!.U +,BAB6W6&NB@Y< P$2RMI_>'+PH(X:!9O
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M2VF"1@@J\020*^R_:[JB0AO(98B2=^GDFH9+NP61>4T89]$,&)0E/ YE25!
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M[#1E?5>+!=CRIJE<8^UN&$CQJ) 02Z@ MKX.-$,"/!V"=>A%2%K\'SX+;_\
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MM[*2]CR&5L99;:U:5K>*48^^M8Y1$9I.!D1F ;7+04#2/J(>+?W<F_T_Z/\
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M4IBE,4KA>(8']W[YUMKWJ]--^\6E'MN*_@H1[6]>TO?\24^JM_Q:WZ;Q3?\
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MX_ 93)Q">T@B:-I6MX3/=V=HUS<*JLUO:)=3PO=S@.FXK=9&!=%(#.H-7/\
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MDF:S'D20HBY2=HDY01&[9!&-L$564M;>&#2Q\MQ:V%(!(\;&DC$V40=M.RP
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MI2XNY5*R>UPSQ9"U-K%(+N&UB1#810R,;6*W_$2-4@ $D$A/HOHSR>2-S?\
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MXS1./N,OC.GTQQA$F'6\L\G')<V]NUE,V1FNUOIN]+'JWDAF1#<#D!);-&S
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M<AGC4!$$L8+*VO)90BL[$ZWJG=<_<"-('DD"*%D$:@A'8DDHYT0#L!220OH
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M%8LS$!0#OTJ1I$5.X6'#0.QYWOTUKR2=Z 'DFNIS'KU8ZJU-ZA(ZY0,G6RQ
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M:O7B=RAFT^-DMWAR#IQ\9-N,-]I?W2J>-NX1KKL*UR]4?MRP14ND\QEUD1U
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M&15A$J"4R,Y9F4Z T#LCQN:VO;OV4RW-G-R0J/<XEY >1:0HW#@JZ T23_\
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M:S)))%,CI$-R,-Z0:)V=@>- G_*H^^N;XO??13__ .^;_P#<\L_467_,9O\
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MDUS''INZ2_;8&.9=NI+_ (O,D[!#'?%$5OCKAU?+2Q2*%]P1.VQP'$.I#QL
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MW]!Z^DOPJL,SC6( N 22!_X<OQ]/]RI!ZEY+<;XO+Q\%T:U/0,I*1VI8$9N
ML,MIX!1+XFGMO0\6>PWOWXSR/=N.(=U[.E;1I*D[W6M,7?7R-):PB1$;@Q[D
M:Z;0;6G8'T(/IKS5BXO[:U=4FD*LR\@.#'QO6]@$#S\/6L'1/)OQ_P"W3R:-
M4;(BT2[PA,FF*/JEA$'6-'Z0M][;LY"B@^TS[:5)2IW3F][_ 'O6]Y)<8O)8
MZ/VF6-H%#!.XDR<@7/@?@W+:)'GX?.H1<X[(GV9ECN0??[4T'-#P\\BLB%-J
M?3?G?I\:\S/+#R=C^7=]A;YP)-?D9:LU<CE-QCMQ,C!O@$KZG6I:<:2T352
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M9#(YD4?(.3R \GQOXFK7:BX&/MQ\#Y*<%X$_,KK1_96#_<@Y1]V= _H=7?\
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M'TT0L_WB]EJ<]_M:MKVK?PBX[HN;CO1=B;OR]Z$1=@0R%R9(A" HB"/M>V
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M=RVN$PUC>W&2LL3C;3(7<:0W5];6-M!>7,,8C$<4]S%$LTL:"*((CNRJ(XP
M BZRD?!PL2_)$Q<3&QQ,R;N1EWP0AQ7I204TVPHZ1<8;0LTS;#++.R2-N/;;
M:;1M?LH3K44D\TJQ++++*L$?:A621G6*+DS]N(,2$3DS-P72\F)ULFK=O96=
MH]S):VEM;27LYNKR2"".)[NY*)$;BY:-5:>8QQQQF60L_!$7EQ4 5!Z;#Q G
MFEXOS L7'#2TM4N[LRDHP&.S(2+,?6ZJ@!H\UMM)!;82'GD"((<<2.EUQ+.D
M:6K6_8XJ>9^B.K8'FE:&&^Z=,,+.QBB,MQ>F0QQD\4,A52Y4 L5!;>A7QOJF
MRLXOIN^B>]BM;:*]N\/](4=U=1PQ)<W,=OC,.+=+B95$LR0"200K(S"(2,$
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M-&2Q(\L!&[(H)]0H4;]%%7.RC5NGIK\V*4Q2F*5\K_@*_P"%7]F\4JI'@?\
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M(A4^A#J1Z ZV#K8!&Q4:L^3/%'IB[PF[[7&":&/'D2KY,W#,@R"9&->DVFX
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M7+=D)63(:$990](29S[QAYCNE$&%/./D...K4O>&9F(+,6( 4%B20H&@!OT
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M*E[9>]-?O+GLV!8WA9%]EN.4@9D7M."X7\8J"OGC\?D2!ZD5%[5; ,>_%I"
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M3%*8I3%*8I3%*8I3%*^5_P !7_"K^S>*54CP/_W2N,?\BE_[U3V7,A_C)_\
MB7_H6J]K_AX_^?\ ZVJW.4ZL4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2L%9)-J'B"9)V)EIQ(JF%ZC(2/^:R9"]DLH0H4'2D;=4.M22%
M*TM.VFVEO:WZHUDD2&1U0.D?+?OR/P0:!/O-\ ?3]).O0UI(_!2Q5WUKW47D
MQ\_!1ZZ]?U52V)8O$IQGI=%#YG;6IB<NMYL#L=:*Y&"BR],M'37Y.2$AG9U]
MZ"<M;U2D22(8.8TD)F5;:44K>F%)WW)# E]:7#7</"."WC#PS%V2>"T"*SB'
M4@B$Z .4]XIO0&_'*3NO:W$ MI>333.1+&%5XI+AG(0R;0R=MB5##0?6_(%9
M[F-7*IO0RK14:EUF/H['.R(^TC=%4J>GI&6AUQOT6C*1J6EI2V:>0*B65)@I
M+:JKCCPB8]E)RE[:CNY1/;+%/-9-<&Y5H6M=1QHCJPF>X[:)!K?;"L$[WABQ
M*U)!&T<YDBCN5A$#+(LYYNSJ5[:Q%Y&DWKER\]LZ&O>],UT:MT^8L\W+V;QT
ML=\D)VM1#$%8 &8^7<(6R*_[J+('E)B.3SV=BRS%MZF$(&;6RM).YS3HSHH\
M5K+<1PQI!DXK98YG,D;%D"CD-NO!&]IC=5_\/S[PT$]X&MIXXGD=I+*28R(G
M!P%;T'XI5G40NA)]_P ;'H^P%J0@*U=0_'3=2LY#D_?6^5G0DFZR^HY^1GUU
MH@/W*"W/96<0LE2!MF.>RHQ[6R%>FW=[RN9;=LF)H@([;VQ)%!'$+&)02>/^
MZ- MQ\\0=#>JF[<HL#$^WF]F9&\[)<QD:Y'7+1.N7QUL^:TVK\T2#>^82#U.
M%' K_CQ(54@A48*EB-FWI&F)1#JUI'HV4H-F;2EK6M^RPH]&MZ2^\E<LMT&M
M[M1.Q:3)), '8EXPDY+KY_%Y=O9V 2%WO0U&D&I8&[8"K9M&?<'A]QZ4^/70
M< ?K^?F,N?U6V\^$H4S9^:62X"/>/T%SSY)%Q\9)2=9L,5*RALE#R(,G("-!
MQ]F".CAG9!*E@LN0;0\DZ.S\,I5J>6*Y-RD5W# RY%[I9'=D2:)T0*Z.J,6>
M)E8B,^\0[,O(EJ@ACDA$#R6\DH-DD!155GCD5F+*RE@%60, 6\C: ,0-5:/B
ME5G*1R>@5.R.H=FX"L1D;(I:(46T,^PU_P#(&B5:U\0S&M[;CVGM?BNMC)6G
M\52=9R[Z:.>\N9HO_#EF=T.M;!8^]KX<OQM'1&_(!W5^UC:*WAB?\9(U4C>P
M"!K0/Q"^@/Q ]3ZU*.5:L4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*5\K_@*_P"%7]F\4JI'@?\ [I7&/^12_P#>J>RYD/\ &3_\2_\ 0M5[
M7_#Q_P#/_P!;5;G*=6*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I6GWJUIIM;*F4B;D3UDQL3"Q:7$LJE)Z=DA(:$C_>JTK3+94H<*V01M
M*M"B[>*4E2&5:R:"+O2K&3Q73/(^MA(XU+R-KXD*"0/B?'QJ*63M(6 Y-M51
M=ZY.YXJNSX&R?)^ \FHNF.S3[$E=1:O07+;'<Q2.Q?)-%C!@76Y14*%8CHJJ
MQL@"1\]+CX60$,>W(R%>"6X0R&.<^1I_W5I+*,K;F:Y[+7>_9U[1D!7N&)7F
M96!C#2(R^XLK  L5UJH'N7!E$</<6WT)F[@0\N"R%8U*D/I&4DED'DJ#R&JQ
MLSY!,IE(@>K!TT^(F*35;L).7/H;5!&)$N+\RB'" :(K$XHLM0\*\2^C;C"V
M4NH;VUM25JU)%C24<S-<*Z3S0&.WM1=,# (^XSD3Q:&Y !H$'6P?/C22]T5[
M:PLC1)*'FG,&Q)SX@#M2;)X_$@C?IK1.?G.O25>F(>*.JP[S:8^DFW$X&R#O
M-0*[[8GJI"M0;+T8,1:FVID=]9[^VX/;48E!0K)A;J8[4,=FLD;NLQ#<IQ"C
M1$=P6\?=D,C!R(3P("C\)MO!X@;J1[ED95,8](C*1(/<[K\%X J#( P/(Z32
M^1YT*D.FVO5Q#D)<0+;$&F5-!@9%3Z7?I!'@*;&=FV&4M(^' *D$',QF_>$:
M/ ''E6G$CG,(U6FB,)5&;<G!6D36NVS>1&3X!8+HMX'%F*GR#4T4G=#,![G(
MA&WL.H\<Q^@G84[/( ,- U%4OU:^2DK>F^8TF'L\1S0Y<1879B?+B).Q6 2.
M$EY2OT\46(DAU%1P)HS&SY@D,4F7>^7M-::9>-U<6SMT2W-W</#)=+SB$<:N
MD43.42:<LR$!BK$+&&(0<B=D+5=KB9FF%O"LBP-P<LY4O(%#,D0"MLJ&4$MQ
M!8\1Z$C:*#U!=XMMH@40Q,6#"53G=F$7)-D!S"OIR#,&N 2L60TVN.+B_EB&
M'65*4YIYQY#FD[;UZPSVO8ABD,@=I)KJ)@A#)_W=HUY(X_&#]S8^&@//Q,D,
M_=D=.) 6.%P6\-^%#$JRZ'$KQ\_IW4BV">CZS$&34GLOX,)"-K0" ;*&NN//
M-CCCB1\<P4:8200\TPP.,.ZXXXXG7IK7JK5>-&E=8TX\F/CDRHHUY)+.550!
MY))'[="IW=44LV]#7H"Q))T %4$DDGX#_P JC"I];,M?-Y>^"T2Q_,(V;L\"
MU21'8T^PE2%<LQM9^'VZV^U%#ND$B?$%*4<Z%&L;>6X<^R.I]=J:S$-RMNUQ
M%Q:.*0W!#K&%EA6;>N)<@*VE' ,YT.()U5>*Y,L!F$+[#2((@5+DI(T>CY"@
M[79]X@#9V=5RT[ILU+7@[G=OJ+56LP]7'N(ORJQCVJ(+@WI#<2XE\],7"EQ\
MH.?Z)V&1&_#E,;40 >6E@I#&)K5$@6YAG,T32F%N<79=9 I?07G('0J#[P;8
M.E8 D"LQ7#M,T$L7;D$?='&02*4Y<?+<4*L"1X*^?)!(&ZP=O[-(U^Z2-/C8
MFCN[C0H!YP^X],8HRC#K!N24/'183M5G%'NL,1Z77EI(;WO9;#:6O7VMY+!8
MK+ L[R7(#-*.%O9^TA4BX N[=Z+B"7UK6O!.SYJ.6Z:.5HE2$\0GF6X[.VDY
M:4#M/L^[LD'QL>/G.H3I#P@[AC3+!:V&5DCCD;*88?4VA3S3)2F!E$M-N;4A
MLA0PZGD:2YMEK:O83SSK9XDE02 6'$D;\$KMN)(\D;.O39JXI) )\'Y>H_2
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M&C9HWWQYQMLHVU((Y,#H,&*D&I()^^KG@4:.1HG7DK .NB>++X8:(.] C>B
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MD:ROR;BQ1(V"B,%22W&LP0M'-)+';&"/ML#"'CY32<AQ8*LAC72A@"77?,;
M W6>N<-/OSEB-3X_UJ[[N%=CHMN97)5,.3&:2(MI^ OSDX]MUR+!*)><8*JN
M[#I0FWD)C5D-LK*CMWC"1 Y*:W[$C.8^$[*QY;$EMVAKFR@<EG,7O#?(>E;3
M*Y=S[%',)452_*(,/=(*S<R#Q4^AB[G@^%WYK-5GD-DCZ#SZKR'4[O%RE1J4
M5 29=6*A&AI@P(9IITMY4_79@UW3>T?#BN;=96H5#>WF]O;6K>DE[$UQ<S+9
MV\B3S-(BSB;E&I)/$=F>)?>WMMAO>WH@>!NEM((88S<31M'&J,8C'IB /)[D
M3_J!&O'K\*Z?2B.PPD=7:ESN"LUI$)$<9M'0VI6A)M4<,VE3:41<98Y6K0Y%
MA/\ 72M2[HCT7%(_?OE$D1M+#6;064CRS74L,)4@PVQ2Z,+DG9YO"DT@B3\@
M$2/Z<U&S6+@W**D<$<DH(/<F5H.ZH^2K*\:%V^#$%$'G@?2L6U"3D7SV&K,7
MPT@^H+=DQ+70Y^T5AZYFN/EL20]C:E?I$?6)U^2E5G2$[N7LH,J04[HY#KCR
M%#$;\XS<O*V0"S (8;F*&<6Z@*5,94PI/&$0*D?"%D ''TT:UXNL"QBS+1>\
M)(7EB,Q)8.) W<,3EF+,_.56+>=_ ][CE:M?.XF7$52S(JOV2^N&5FB@S<+)
M+YG6#HL31[TI($RC8I+15@%D9@F)KI<Y\O7-(&C?BV&GE,ZWLT5U(K&X#RQ6
MP66X>*5?:YE<A0BA&8$1LJK),(@P0ER#JMK9)(%9>R5C>;<<*O&WL\94;Y$N
M%T7#,4C+\2P !&R-27OJUOO <ET/CML75JW8D%4^N15FYFY7V'A7M( NMK==
MN[,K/2H?JL^,B6XUJ.@G/8>:$EI@<618G LX;<K;7\ FEBU/+)%>"4AE]^W@
MXVQ2)&_$>0OSD\@LL1*F(FYEF!FM)3&C[C19+<Q^#I99"9@SL![P0+Q0Z(#2
M -4I4QE4GUCJMI&3O46T#2:,V]I.](,EJPBPS$PZTO>O9>;"5;0XI;J=[T@X
M$\3>].BK3JC,>-I:Q'\<O/<$>NDE[2(-^H)[+MK\EE.M-JK,0Y7%Q(/Q0L46
M_/ETYL^OF!W%78^(8?#S,^5*LTQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*
M4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*51OH@5VZ[W_H7-P^QWWD
M-?Y7Q^AW*O)YZ?$1)TQ;[]-]"%7:K*])Q4IJ>KM78HX8(E8(:U FDFRZYL>1
M5L#05^)D@M8YC;Q3--<2HQE5F CB6(\(PK+Q9C(27\OX4*5V151P\L\D8D>-
M8XHW7@0-N[2#D_KM5X#W2-'SO?C6KG]PZ-?O$?QFMP\P[0KCY$S/":=:KG7Q
MQ4OU(?HA NK+/UEN6'/!!-G&QWX>I$2 QK<9)66(*]P8^,TR[NMO%'>W<9 E
MCM5NG1&)_"&$'@'*E20I(9P-<@I!(!-:F5WMK=@Q1YS$A=0/=$GJRAMC9UI?
M!T6&JE+@IMIJ?7^V<,EKO:ND5JCP?+KU4K+=S1YBUQ#/16KD%+4F8L# @;TX
MF+/I/TABRI-MR5'CK2S'ODD"!@J3#<!)(+>Y6-(FD:>)TC#*C&(QLLBH20-B
M7@>/N[38]2!)"666:(LSHBQNK.=N.88%"= D KR!.S[VCX W+/3.N*YP9' I
MY=UZ_?,PWBOC.;4YNS Q_NG=L_#23ZY6/^&*<_\ 2M,Z0Y[;/X^U)U]F110=
MT$]Z"+1 U-)P)WZ<1H['P)^!T/C4DDO;(_!ROL$[C7D!KX$[&B:B#P&?^)\0
M>'D^Y?&^(K<B_P##E-Z9*8]]9IQSW)+6E+TT0U[7NWVM+7IMU*T:4KT]=S9$
M:O;@;!TX&QY!]Q?(/Q'Z:CLSNVB.B-ACH^HV[>#^D?&K@92JS3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*^5H0XA;;B4K;6G:%H7K2D+0
MK7HI*D[]=*2K6]Z4G>MZWK>];UZ;Q_\ #R/UCT/^5*)2E"4H0E*$(3I*$)UI
M*4I3K6DI2G7IK24ZUK6M:UZ:UKTUBE?6*4Q2F*4Q2GIZ_P!N*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2N-IEIA.T,MH:3M;CFTMITA.W'7%.NKWI.M:VMQU:W'%>GM+<
M6I:M[4K>]O7U_1_Y#0_8  /D!JG_ *_;ZUR8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I4(=1\=N5
M=AE IN[0TPN8"B"ZXY*5FXW.C2,O53R$EGU"QF4J?KY%FJ1I*?B":U/.2$,M
MY;SF@TK??VY8ANIH 5C90"P;3QQR!77P)$$BMPD \!TTVO&ZBD@CE(+ [ UM
M7="5/DJQ1EY*=>0=BLI/\.YK:(";J<[!D'5.<@JS77*KJ<GQ:W#Q].>V367J
MG"!R@\?39:'*T,6'.U5B'FFRXV()^/V_$1JQM5GE1D=6 =&=Q)Q7FQD_'YL0
M2ZGT*N671(UHT,,; J5)4JJ\>3<0$_%XC?N$? KH^ =[ KO\QY#1N11TN!3
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M\EOW3_I38^8_:*?,XW](@_SL?_$QP?\ );]T_P"E-CYC]HI\SC?TB#_.Q_\
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ME>,_$GRBR'RRGW.=5A3I!)3RWR'W5;CM[6Z^\XMUU:M[4MQ:E*WO>]Y;%_?
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M(DAHA3VI2R2S\E-RC[[Z4/@Q6@H@*^Q1\>A2)$9+L1EQLR2$PDDLQ/XO+\5
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M'1\7$"'RDE(2,B6.&$#'A$ED/NH;:95O>_2K'&\K!$')B&.MA0 H)8DL0H
M))) U\:L,RHI9CH#0]"3LG0  !)))   ))J A?+_ )5+]4YARNL(L]F/Z:KJ
M C4S&U6S-QM4F^4%Q,?9*];F3848Z"F6#95#)@<B.(Y"LH8-FM @RD20;8]B
MF$$T[<4$/9VI=2S+,&*,NB05TOJ">1.EV0=0BYB,D<:\F[AD 8*VE:(@,K;
M(;9UH^GJ?!!K3[%YI0U9D^HNG\]FW*;R'ME+X7;;(-.PRI5=EO+%"7%2T)5'
M=-$R\*.1T6!'-;'D=3GHU(O!PQFAD(>D6Q9Q$%E3N36\MRB$-KA%W>2LPWQ8
M]EM;4*?'O>1O1KL*9-HQ6*9(6(9=\G"$,%)!*CF.7G8 ) .C6Q4WS<\>[H@,
M>*NXYLN40$&Z)#0=WE8J,,F9^;K=<#F[*JH 0U>*L$K!&!1C5B?B-E%;':&V
M0V9'OF:26%U'LM$0!L^\T8)"JK,57F6;BK*6XAM [.O.MENX&'NN"?3P&T"6
M*J"W$*I8@@<B//IOUK:_'KR>YUY&U6JSM0<."F;#SRK=(DJH6.\8=4H:X(><
M@@K',1S)%="FCFAWB1X54KJ5(CT?-&@E1RD%*TN;26U=UD *K(\0<$ .R?C%
M58ARHV!RX\=G0).ZV@N(YU5DV"R"0J?)4-Z!B-J&/KQWO7J*L;E:IZH/Y3UV
M<L'2ZVM 0XD!'\DZ,PQ.VFA3/4J6;9IMP 0*$&JD*UIV(N(K NI "RD$*61&
M/G0<?&23I!21_H'2ES;6V+N@SM)<29G%NUO:9"#$WR6MN)7DG:]G;C-92-(8
M9+14]V81W#RQ"->?P+Z5,9D,EU/C"D$<./MNCNIXDR&5P%]U9@I\ID'M(8+%
M,-8IRLLW#'#[3;9220M)9RW-A;6EV99A#624Y]U!5/TS"UV;WUFUPWC<[6%7
MR*MDKT;F)M9$KT?)1M>O(D,W6GXP=,7*6&TR#TW7'HHV4L;,Y$G/R 81'IX\
MGB1?[GN;;ZGM+CJE+I<=+90XO+I=274L4UQCI)FNEE;O06UG&L%R)8H+5K>:
M'M/*GR^[Z;ZM; ".QQV0/6&6L/HO?%'J&UR][U+TG<8N+&6UW:X_J*.Q7%S6
ML8L[S)Y>[:\QKVES>949&RN6NH+>3V/:TI+:-+WZJUKTWOT]/7>M_E]/XO7\
MOIGQC_RK]F#>AL[.O)]-GYZKDQ6:8I3%*8I5!/*BN3L_TN!6V"P) A<=Z$(-
M.6BAS?4:8=9IPD,8.%"JT&U[Z$N0; FI *R/ONN%QA)<*!%23CI*6?H'2MU;
M6V+N>3M)<29O%NUO:9"WQ5_':6Z3-).]W.?PUE(TG:>U10JS)'/+-"%3G\ ^
ME3&9'(]48YD@CAQ]OT5U-#'D,KT_?=68.XRN0FM8H+&'$6"\['-P1P"Y@RDC
MEY;.:XL;:UNB\_:A"T5[NDXCQ7F[!S#J(D!S2S<#1!UIFPUNP2I$OL%.KS8N
MBON3D7(KDXX=IB!C796+#C =.3DM+E OR;# ?=M+G VYZN@M<MB)+C*VO41N
M+HV]U:PK )2;"TQBBWDC$<K<KB589Y)''L\$*2+#(TGA,KC>O,B/HCOLETKU
M9!CNE<I]'8L<4F2QF3O)+UK14S^4ZFD-]:73W-G&$QUM+>6D%M 6R-[>R6[W
M<<<'K2G>U)UO:=IWO7KM._3>];_-O>O77KK_ +-[U^;>]9\BK]=?^7_K]%?N
M*4Q2F*4Q2JA=0Y]']$\B.6UTVF!ZJM<AY7KENM&JXQOZ16.O2$9!4.I'6+X/
MVG&@S#2[23%*-]X7J BT.,N (?;5[#%9"3&]-Y>YCOW%W<S08:RL_:V!M[6Z
MBN)\E>QVO<&B\<<=FLX32>U3>>XRE?D'573T'4GTC=(XV?"1?5&,M+SK++Y0
M8Q",CE,7<V6/Z<P]QD^P=I!/<3YA[,SB29L99!D:V25&CFFPM6GO(*NF4>OR
M5 K_ #N?Z$5+V*:AK*+;^RVRW!',RX+ATL+L\B@1+Y"Y9F1L9ONY.6B80>LQ
M[<+%B'N]*]GNK;INYCO[F'(W&3ML8D%K;SVK66"LK*2)X)%2!^VN3F1! T%K
M'N&WGN&NW-Q*\:^=PUAB\C](^-GP.-N^G,;TSD>I;B]R5]8Y:',];YK,P7,=
M[;M->P]^7INSDF>\CN\G<%;N]L\?%B+9<?:07,GH'GSVOT#3%*8I3%*8I6E]
M%/N492;*;SV"&LMV:BW]5B&,.&C@BIAWV61%&F&/BL-!BK<^,*3LAIQY@=QA
MA6GW&\NXZ.REOK6/(W#VM@TJ^U3QQO+(D(VSB..-69I' [:'B55F#/I QKB]
M17&:M<'E)^G+"+)YU+23ZJL9[B*UMYKU]) ;B>:2*-((F;OS@R*[Q1O'&>XR
M ^7M&Y7+A0_1JUT>)[9'1HWE-4;V==3*O4[L;,FO<YA?G4K+1:3;8 NKFV4@
M_99T/ V2&K^S8\1MO3<=)KB/J>0R\,LV,NL9/@9)7Z0OL='8QW5Y81V\:Y6Y
M]G@AF[=G*MY':*G;2:YM9KD)(S$F:-9_RWT_TC=V]IU/B^I+3KJVM8OI=P_4
M,V<GQ6(SD^0FDZ4QOMU[>6IFR]NV)GR\ET9I[''Y&PQKS6T,:*+6\]BOSXY/
MV-VAR+$[$*C(X"[6^/I13]:#I\C8*.-*KU7K'+5H"/AQ8P^49V\I?NH:&T<T
MVS);C!-F^QGS_J1;5;^(V\W=DDL+&2^1;F2]BMK]X0;FUANI))GECA;0&YY^
MV28^])PY'] ?1S+DY,#<ID++V2WM\YFK;!R/C8L/<9# 17KC&9*[QD%O9QVE
MS=1EBX6RLN^BI=&UA,Y03[GGZ]]3%*8I3%*A/OI-+"Y^0=>ZM8KO#1\M#2(U
M0K4=+2YMBFP#D%PL<3&1JFQC(U4@RR^<BPN(K#33.B)I:!F?:UV^GUOI,DD>
M.N[:PGDAGC:]NI88([6W>)EN)5EEVR2B(LL9M@UVS,$MU:1@#XOKZ3"0=.RW
M&?Q.2SUE;7EA<Q8;%6MY>W&2O[>ZCFL+:2UM66.:U:Z2-[A<DRXE43N9!E@0
MD41Z#3'&_#[K@!#1QUJO-LL5SK?.Z-&V]V$J4G+R$&2U2H*.#CPTRXL*(A4J
M0^]&-0[]D,DY6+$:<:'=;][C;Y3UK@Y4,<5GC[6TL;G)W\MDMQ>PP1SHU_<2
MO,X@>9CV$196F2TCBAE=]L3\#ZEPDH^A;K6VFCN+G+Y_*Y3.8WIK VV:EL,/
M=7EQ831X#'6T-K$;V&RA7VR24V<=C+E9[R\LX(R(RGJ% 2P,Y$ R<<XXZ&0S
MK3+CHY(CBO=;VRY[0YC(Y+6].-K3Z.LHWO6M*UK:=ZWOY9-$\,KQR !U/D*Z
M./(V--&S*?!'HQ_;7ZEL;J"]M(+FV9GAD3W&:.2%CQ)1MQS(DBZ92-,@)UL;
M!!.8R*K=,4IBE,4KY7Z^PKTUZ[]G?IK_ +?3_P"O_N_CQ6#Z?_S_ /AY_77F
M-PF+O\'>^;[M-:18.D&=,[-OJ1I5(G(>5J$ 9](R(BV*Z&IU(ECCI5#-7A8J
M(*)D84^*E8MJ!C ":FZ0U]0STN-N+#*"TNS;XR/$X+ZIC2^MYX;VXB]D2:S.
M-XE[2:(O>W,LR+%.DT,WM$DJW85OS%T%:]166=Z8^M\6N0ZEGZIZY_VKGEP6
M0L[K#8Z;ZWEL<N.I&<09.TNE3$X^TLI9;FRN+6\M/J^UMI,-)+'Z=Z_)KU_-
MGR^OT]3%*8I3%*8I4.^0=8MUSXEU*J4-]0UPL%&L457W$%? K5(F1SS3(Z#=
MJ3H5PSVE"((4M"65/Z<6XVA*G$]GIVZL[+.XB[R"A[&VR%K-= IW (HY59F,
M>CS":YE "6"Z ).J\;](F+S&;Z$ZNQ'3\IBS>2Z?REGC'$WLY-W/:R1QQK<;
M7L-,285FY*(FD#EE"DB&.*U>5UVB8ND'2ICGW.]\/YQ2C(:8A%5ER1OD'*3)
M>]L0[K3+I"*K73!X%Z;99W&'*?;%C#9 >.VXSV<U=PG!V]C/?0Y')#/Y2^6>
M&;VD1X^XAMT!:<$@&\ND>X6 GNQ\&DECB:8!O'=%XJ['6]_G+#"7G3W3;=!]
M,8*6QO+$XMKC/X^[OYB([)U1G7#XVXBQ[WZ(;6Y,BP6<]U%:<DN3GC:^QTQ2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2J$Q/D%U&5NQL5$NQEB6%WBP\Y-I87/;.VX!
M0XB9,CR;<1?6Y%R ')B &42!;93*&25-*$0VA\EG6O028ZT2W5V$D9:PCN5G
M:ZATUPZAA"+8H)>+D\0P8@'SX -<=+Z=I2H*OJ[>!HA!*"(58J9#.&,8*CWB
M"HWK0'G=92#\OD0O*J)=;]5)8\F;IC5PLTO KKL/!@BN3!<8XU#B66R@2=@/
M%:'^++BJ^U+&#C>PX[I+A0[*]7PIDN[F"VE0".8PPQR":61CVU<&1H872)#O
M0DF:-20VO2MER@2WAFGC8F2,2.R<$0#D5(02R*TC #92/FP'DZV*E&1\EJ['
MGVQU-0NQ](H<H?!W#I$='QQ=;@I:+@OI!)M$@(E/I,H&-%4P,?+-0BXX60(:
M&=?TG>W4TUQ<K+"#/;+/<1K)#:L[++(CR=M"&*"+D[;XQ\^; ; ]!5AK]%:7
M\%,T4+,DDZJK1HZH)&!4,90H! +]OB#X)UHF&I'S6!G1H!J@5*9+GR[AS\=V
MO.$U.9+G*M;9 H!]F+.A;63#1-B;(:&9>!GY$!V-^+8?*84.I3K5]<$T9<W,
MR+$(+AA*%FC$<T*JPYK)"'DBXDGE$KA]<5.]55.65PO9C8R=Z)3&3$S/%(Q7
MW"DK(K^FUD9&7R64?"0$^6]?*=F(J)YUT&9ME/$LLCT*G@M5KYQ28VJG(!D"
MCWB+$Q%RJBW'-/0PT ?*$R@^E.LMI]GV=UCAY5".]S:QPS&);:9C/PN7F4LB
MH!"730&G:58PK$#S4WUDA+*D$SR1B0SQKVN4"Q-Q<O\ A--\U$9<M\MFK/U^
M=C;/!0UDAB-%Q$_%@3$85I"V]$ 20K1@CWNW$I<;VXP\A6VW$I6C>]I7K2M;
MUG*DC>*1XI!Q>-V1U^3(2K#_ "(-=!'61%=#M74,I^:L-@_Y@UE\TK:F*4Q2
MJ@=J\/J?W2X=!L]LGY,=F\\3KO)@Q8L= LI4)JHWJ:Z#5^D5N>04DH.SU^PR
M89L5IL=I(Q,2P\HEQ#SK&7;>^DMDC2-5/;N&G)8DB17B6)X67QM&4$,=[(8@
M $ U6EMEF9V8GWHEC&@-J5<R*X/KR#:(]-:V#LU7J'_!LBP?/3>3B=;+?H]Y
MYEP?FO7TF5!I=AM0W!S4KC)>K2K5C0+3R[7$);A)]DN,LK0S32)")V*?MUU=
MDY4M,)S .[%/<36_%R$C-P/*N"NW$;;9=%2Q.F\  0"Q"J8Q)[CQ0Q2^[Y80
M[\J=^[R! (][0&QY)-6\[7Q2=[;SAVAS%U'A%-WBMVEIV*KYBJ]-P-7L8<V/
M1+W77[/M^TUJ?#%W$6X0><A&)IES:FQ@F=+#=I6\ZV\O<$?+\$\?O,.:,ZE>
M[$P4!)$.FC)5N)WY).Q9FA,L? N!IE;PIXLJL"$=2VV4@:;3#?R^%0#R+P8<
MY#;J7>HKHT87/5?IG<KT4"-S@* JA4/WIJIIL=5A:["V4=%<1 .5$'57D4&2
M+(PCCH\I%2CO^U*LSY SI)&\9XR0VT?(REI.5MRXNSLI+%@Y#C0\@<2H&J@B
ML^TZR"3;+),Y' !-3\>2A0? !7W?/Q\UD9OP0J,G>+;U(.Q,1O3IGR3J'D56
MKMJH11,O6%UJJU:E2?/WR%&MESU5LM=A)@4UE\L- A5AW(""Z-BQ7UX7(R+&
ML)7<(M'M'3FP#AY'E$H\>XZNR^@)*KQ) 8ZW-HA=I.6G:=9PP4;'%40IO?E6
M5='T]=Z\5'4#^#C9@8*AUYCK"6ET*<8F(.^1'/(ZM]>A U= EKY-U2O=#@;&
M"3JG6Q4EN&LE>N,7=07PG918"8]1PJ8R1\H7:1C#ONJ5:-I2\#'M+$KM"Z,O
M./CR1D,9WKEL [B6PXA )3[AV'"!90.9D*+(I#%')XLKEQQWK1.Q*OA_X0UO
MPV%8B.>V\\NN2=$@X6]0949MH:V]%@32MM=5:==ESG(28DX0S=>F8<?XN.*
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M#'U=>?9#[V'^I3VNW_+/W<G\E/KP^+WWF.?T&Z/^R&/JZ\^R'WL/]2GM=O\
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MUX?%[[S'/Z#='_9#'U=>?9#[V'^I3VNW_+/W<G\E-^</B]O6]?NFN?;KT_\
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M)757XVK7]$7%WV2Y?+W6L[GZ:?!.MUDIGG=D^E;-O2Y(@04L,IF#W$F.MI!
M LZO<11O&6)['*2+9B698WXR!_>'=CX&,E2ZGWCL]Y,AD),7")Y%8#S)I92H
M<QETVA7W?<<OST0K Z&F7C\(3Y$0O*:ET:LF4(VS]/A^Q&'<]DZB0MSQ_*Y]
MV.KT"O[MC(LT).&M.BS2ZW:!;"Y'%/7(T(B'5&!M.1:Y(\7:M-)"XD5(6@ F
M638N1+ \C<"05 ]WG&T>QPY<AZ,-'O;@1JZ\"\@F)1E/X#MS+&I8;!.PQ5@=
M'GK7@$5N?1?-KRCY[)]F^65^NW*6XUUF5YA'4659H%1WTR'C>0*O#5DB1RNC
MM](?M\_+D(FZU 5JG2L&;28LR.9(D9W94H!I#C[.58 6:(3P";N RRF)C/V^
M!XQF$1H/<=W<.)"#H* IWDN[A#-I58Q2=L(>"=Q1%S+#DX<L3Y555E*C6R=D
M6'\/>KW;HOD#V$.R=B ZG%C^/OBU<!1*VVS'U&L6&]B=*EK$/&0HDM*B!DGH
M:BB%$NN)E'X=,&/)K+>#2:15O88XK: I 82;F\0ER6D=(C$J%G*KRUY^8V3Q
M\$U-:R/)-+RE$GX&W;2^$5G$C,%4$@>H]=,1K?H*]*<Y=7ZT#J?/(3K'/;7S
MJQ.%LP]LB7XLLD!Q#)X6U[2\+( NNMO-(,CS&AS1MNLNL[>'0EYIQK:T*Z&*
MR5QA\C9Y.U$;3V4ZS(DH+12  J\4@4JQCEC9XW"D-Q8Z(.B.!U3TY8=7=.Y?
MIO)M,ECF+.2TFEMG6.Y@+$/%<V[LKHL]M,D<\+.CH)(UYHR[4Z=SCFFH:Y67
MI<Y;F+M<;#7*S2G94",'AHL"O5)R1,%!&CV)*7WLXV6FI.5EBGI!Q+CY#+ @
MH(PR6EVK_+>T6-KB[:U-G8VUS=WRQ/*;B:2ZO!"DDCS&*$%$AMX8846, *C,
M[R._*N7@.DWQN<R?4V3RGUQG<GBL1@WN8[-<?:P8S#->3PPPVJW%VW>N+W(7
MEW=S/<,'>2..&*"*((9PSBU[.F*4Q2F*4Q2H_P"J<[A.L<]M7.K$Z6/$6N+<
MCB2X]U#!X+FEMDAR(+KK;K23(XU@8T;WS+S.WAT:>:<;VM&^ABLE/A\C9Y.V
M5&FLYA*B2@M'(-%7BD *DI+&S1OIE;BQTP.C7G^JNG+'J[IW+]-9)YX[+,6<
MEI+-:NL=S;L2LD-S;NRNBSVTZ17$)='3N1*'1T+*=0YOS74-<;1TN;MK%UN%
MEK]9ISTJ!'#P\2!7ZCL\D2/#CAY&65HLR6F966E2GY!WWI!33 HP(HS;*K.0
MRHN+&TQEM:>Q6-I<7=XL;2F>62ZO>RDLCRF*$<4BMX88D6,<51F9G=V:N;@>
ME'QV;RO4V3RGUOG,KC<3AI+B.S7'VEOC<,;N6""WM!/=,)9[R_O+R[F>X?N2
M2I'%'##"B5-^<:O94Q2F*4Q2F*5$O5^;A7QNF36YSZ,V#FMO$O%5GG&&C 1)
M-F-E(,X67 >)"2=#RL)-R<::PT> 2G1#9 IH[S"%;ZN+RCXX7\)@%S:Y.R>P
MO("QC=HFFAN(Y(90KF.:"XMX98V,<B-Q*/&ZN17E.J>EXNHC@KM;Q\=D^F<W
M#GL1>K$MQ%'=):7F/G@N[5I(?:;.\Q^0O+6>))[>4=U989XY(U-<O(^;QW.(
M.:;&EEV"5N-NL-^L\^IE@5J7L5H)02:^$$.X\R#&CCM"1\8'HDM;( 8^B##"
M=O%.XRV3DRD]N[0K;PV5E;8ZTMU9F,-K:)P02.X5I)G8O+-(50-)(Y1(TXHN
M_2G3,'3%E?Q)<O?7F8S.2Z@R]\Z+%[7E,K,);AXH$9UM[:%$AM;2#N2M';P1
MB6:>;N3/*N<NO44Q2F*4Q2F*5U#T'.!$HC"!19!3*TADFB.GB,$;UZ-ND!,F
M1SI32%?:MELX1;FM>RE]O>_:UO&4#J959XPP+HCB-V7?D*[)*$)'HQC<#UXG
MTJ*<3-#(MO)%%.480R31-/$DA'NM)"DUN\J Z+(L\18>!(OK56*;R&>HL6=7
M(SLD0+)$]2L/3V_AZH"UHB6M\W+3,Y6YR+/M$B^?7'W)E;0#$83 SHC@P1'S
MHA276R/37V=M<A<)<38=V1<3:XEE>^D)6*RMH+:VN[>2.UB$=R! ID:9+BW<
M-(OLZ'3+\TP70F7P%A<6-GU9'&\O5F5ZL62+"1+'+<YO(WV1R&,O[>?(W37.
M,:2_=(!:SXZ_A,$$GMKE75YDY7S9GFD//"*ER9Z7M=QLE[LDJ^,R"R5/V<Q)
M1R8Z-84ZW&Q8R&V!  U$F/H88TX6:86Z^2[R<KDVR<UN_92WAM+*UQ]K"K-(
M4M[2/A&9)6 ,LSDL\LG%%+,0D:(%1?4]*],Q=,VF0A%W+?W>7S>3Z@R5W)&D
M"2Y'*S=V<6UM&62UM8E6."W@[DSB.,/-/-,\DK2=G,KT],4IBE,4K2KU79FQ
MQ8K$%:B:D:!*!2>S&X\*6CY(812_BH.?BS?=_'04FPXMHYD0Z+/3M++PLD,X
MUZKN6-S!:S.]Q:)>1O#+"$,LD,D3R !+BWECWPN(6 :(R1S1$[62%P=5Q\WC
MKW)6L45AEI</<07=O==Y+:WO+>ZBA8]VPR%K< &>PNXV:.X6WGL[I?<D@NX7
M0$ULG?&YB5X[TVAC]%BHV'Z]8Y6VVZ<;K;*H6/7+.0^TCTF)'LX4=78Y"H=A
MY[9ADZY(FF&GDNJ)*6K/2V_5/8S&)R;8UY9,+:P6EG";HB:80&8A[^X:U>2Y
MD/?9%XK (HDCB4!(P*^;Y#Z+&O.DNK.F(L_%;1=:92^RV8N1B0UM:27HL@8<
M%CX\E!!CK=/84D<32WSW%S-<W4SM-,S5;6&9E!XT5B9,!D)%IOV"#(V/?B@G
M_16_=J9 )DI=X?T:]A"TKD2?;<2IQ.T)7IM'DI6C:1FA1XXR=JDDBRNO@;#2
M+%"K>=D:C70(!V1L_6+1+F.WBCNYH;BX1=236]N]K"Y!/$I!)<W;QZ3BI#7$
MG)@6!4,$7)Y'5BF*4Q2F*5'O2:%5.A0849<5FMQ4/.Q-H94),%PS3<K DZ-B
M2#G!GV&BQP3TL'M!G:>"^.%$*6RIX5A:.ACLC=8R:2:S[?=FMI[1^Y#'-^ N
M%X3J@=6,;21\HVDC*R=MY$#!78'@]0].XSJ:SM[+*BY:WM,A996%;>\N+/\
M[[CI>_9R3&"1!/'!<".X2"=98/:(89C&9(8V6MK?C8Y'<QC^>1?8R6J*;;[A
M9[8B6"=.8NXENL$K.IJA4K'VJ$.CJ^V5)N(E6(>2&)L:FE).)0&4>"3Z/_:J
M.3*2927#1M?)8V-I9213(GL#V5O#;^V)%)9W$4ER4A_ M/&R6I.XT[D<4B_.
ME^BNYM^F8.E+3JVZ&$ES.<RN:M[RSFF;.P9K)7>2&'GN;;*6%W:8U)+MUO([
M.XCER84K<2)!/<P36XK46J$@8J(VF(0B-!&!8;@8O<)#M##-I9&9C8G9LC\O
M#9'0VTR+HTA+:4>B%Z3[*4^2N9O:)YI]S$S2-(S7$PN)V9R6=I9@D?==F)9G
M[:[)\[.R?JV.M?8;&TLN-HBVL$=NB6-J;&SCCB4)'';6AGN?9X8XU5(XA,ZH
MJ@*0N@,YD-7:8I3%*8I5?NXT[A5G!=%ZXB#$.GZS9:G'S#ZF&+,/ R >GK"W
M!F:9(,8&&90S('.:9= '<'%*.;VEIKT[>'RF9QTB/C)9@D-W;7CP LUK)<V[
M;MS/&&56;RR)Y#E7=48<COR'571_2O55O<09_'VTTUUBLCAH[\*B9.UQ^211
M>Q65UP>2%698IF'%HC-##+*CF)=8MB'X-5[+R*53<(X(ZDTPVO\ / 7;#'+C
M"(&\O0<:B8=;]VI+Q$N_$!Q\3*I)%&+>*+#%20M]+;>\F1RT]MEK=X2Z9.^A
MN[]^R_>[]E[0ZQJ>6U1/:'>2,JS#BC$CB2=+?I/IZRR'2^0A>:.7I;#W^'PL
M'M*^RK:9<8]+B>6+M_A+F08Z".&</&H$DZ!#W0%LKK\FO3\V<&O94Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5P$C#F#O"%L,DBDM+9('(;0
M\P^RXG:7&GFG$J;<;<3O:5H6E25)WO2M;UO'IZ4]?6NJ[$1;[FW7X\)]S83L
M;MQX4=Q>X]_:=O@;4MO:MAO;0G;HOK[AS:4^VC?IK,[/ILZWO6SZ_/\ 6/@?
M6L:'R'IKT^'R_5^BNB#5:S%C@"1M>A(X2*?<*BQ08D 0>-*>0MMX@!A@=#0;
M[J''$.NC(;<<2XXE:MI6K6\EG;?)F;EZ[8G8\^#Y\CS\=_/UK 51K2@!?0
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ML>(#LC:5.+3M[8K+6W=Z6\ZO6U^UO2W7%?PEJWL68^K$_K)/_OH !Z #?KH
M;K+YBLU#WD!!VNR\8Z+!4CXE5HDZT8-%LADI$,+VK;:C(\0I2D)8*D0$E #.
M*<;2EXE&]NMZ_'3<Q\D,5]:R3Z[23*S$C870/%B/B%;BQ\'T]*K7B226LZ1;
M[C1D+HZ)WZ@'YE=@?I-:+R.#=8ZI>K%6:Q)4[F\E1>?1;$5(UXVII/N<5N9W
M('B0,@& 2CY?728&$,D-!M,%O!-BLO%:CMJ:L7DF[2WCEF6>Y6XN7+K(LW&%
M^ 56D4L#SE6215Y$J&Y:'.H;9"+B5TC:. PPH%93&#*A?9"$+^*A1"P0 D<0
MS<:LWG+J_3%*8I3%*8I4.^0,':[)QCH<'2=$KL\E7B!XT<,E(9AJ?>LK/CA"
M5*0EDJ2C4& #K4XWK3Q*-;<;UOVTW,?)#%>VTD^NTL@+$KR"G1X,1H["/Q8^
M#X'H?2JUXDDEK,D.^XR:4 \21L<E!^!9=J#^FM'Y'!O#]4Z#8:U69*G\WE*9
MSV.%BI&O&U/1USBD3&I20$@9 0$EK0, 37X,R0T&TP8^ V,T\5J.VIJ>[<&T
MMHY95GNDGNF9UD6;C _;X*TJE@>4BRR*G(E0Q8A2^JBMT(N)G1&C@:*!0K(8
MP95Y\F5"%(TA16;B.14 '2^;-9S*O4Q2F*4Q2F*57WO4),2KW)C68HZ>J5>Z
MC%35^A(X%^6?+@6X2?#CC'805@DJ:$A;07!2Y((HQ3Z$AI.;&<^#VI'0Q[QI
M[6I=8YI;1TMI&8(!(9(BZ=PZ5#)")$!8J"3QY#=4KQ7;V<A2\:3J\RJ"VT"2
M!24 )<)(4<J 3X#:.JY_'J"F8*L6M!\<9"04ETN\3-$@9 5V/+AJ5)2FGHH9
M<4^EI^(:))^/DA(HAEA\ 0YAAT41Q.QF<9"1))82KB1TM;>.>1=$/.B:<AQX
MD(7BID&^3*?+:Y':S1DCE!!5&N)FB0CB4B9O= 4^5&]E5T-*1X \">\H5;IB
ME,4IBE,4IBE5PL--<M_?ZM\SK7L4VA5ER],RVXE#8<YT>0DGX2&:(DO<[08]
M5H5B0DV@MN[<8.DX\]>O4896NE%,(<;,%EW/<RBV*\R6CM4022:4'W1,Y1&;
M6BJL@_&-49(N[>1\D_!0Q][?$ /.Q*IL^I,2!CQ/H74Z.O%C\YM7J8I3%*8I
M3%*U"^-1A%4F1I<.1D 20W&' HP"9DR2EN>FF6% P+!$@2,X]IM)3.F7!G!]
MN-F)4*IU.Y8"PFC*,JL&!#,R(!KU.Y"%'KZ^N]:\@$1R\>VX<$J1H@*S$[\:
MT@+?K\:\U1:8K9TEX-P5%)IMX(O,51H2)#K&J7=='CV*/6 MY#L>U$):=^&8
M6ZH8PIMP!)"-J$(^*8]IOOI(J]0/<=^W]G>XDD:;OP&-HF+#8=GV-MK8&F(]
M05)KCNC-AUA:*4RK J=KM2ENXH!\KQV= $@GQOX\J]!H@]B2CA#!VS&F76M:
M2B0CSXHM.V][:5IX"4&$.'W[2-[3H@=I2T>RXG6VUH4KSKJ59E;B2#YX,KKY
M\^&1F4^OP8_+U%=I&#*K#8! ]5*G_-6 (_S _962S6MJ8I3%*8I46=@<@1Z>
MHV?I4_T)J.EHJ1C*I7HN1F"I*<"+01$[)!!]6-@"%H062_+I7$C:82^0VZ^V
M,TNU9B0SA8YX[8NCJ\TKI&J1LI#Z9O/(KX4)IV)T" 2:KW101$O"\^F0K$BL
MQ=PP*[ \<0?>8MM0 20= &H]=Y_)PUCIUFN->D[/2I0_L<]::E#46SEP=,O%
MT&K[D,/%50^ 8FCX=B"!GX1N>:AM#.SLW(E.)!3*.)1V);E7CGAMY4BG1;&.
M&=IX1+<6T#2<S),DA19#(8Y&0R;[<: \N %<Y("CQO*C21LUT\L212F.*>4)
MV^,3+S*!!(@<(??D+#0<U:7QZ@[16^,T"#N31(]ACH7W!0AKVGS !-F%.Q$8
M8[IQ[2BHR'<  )U[YWV'AEH]XOV=*WRLC)%+?7,D!!C:0D, 0K-H!W4'_==^
M3 _$'?CTJ_9)(EK"DH(<+Y!.R 6)52=GW@N@?D?'G53-E*K5,4IBE,4J#.QZ
MO*D1PO/:3\SFY<62A#[\WJK.FT> -T,N1^6 3LW"%2LC)+8'^#!02U$-EC#G
MRJWTALAD7K+V?;-=3A8T*.MN3*%N) 2%#-&CA$79+-HN0>* %BRU+KO: @B+
M.P93,!&3$AT3Q#LI9FT.(V$!]YB>(4UPD.#6R&K'3Z%3JI(E0/4.=\YJ%7DI
MN:@?C*"[4XQ< 6FU[^;NNNI#TM-I"?J[4WHB3=+8TT*Y[AQSIKD87EM;B:9$
MDM+F[GF2..4K<]]@ZF'2  MXA<2F/2+L,Q\51-I(D<\$<3,D]O;Q(SO'RB,0
M9#W2&V0 !(#&'VVUU5^@VECB"L..J?<9'8:6\OU]MY;;24*=5Z[WOVG%)VM7
MKO>_7>_MWGGR=DD#0)) 'H-GT_RKL#T'Q\>OS_2?TGXUV,Q6:8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*C+I47V"3&BD\CNG/Z:6T^2J:>OW/9[H
M YPRFVM"-1H\%T3GKD:\R[IY9#Q!,F@A"VT-LC*:4X[-"T"EN_'+(-#B(IEB
M(/Q)+0S<@1Z !=?IWXCD$IUVFC4[.^:,X(^  62/7Z]FHD^B?FC]^7CG^K=T
M'_4MD_<Q_P";7?\ &1?V51\;O[6W^XD_N*?1/S1^_+QS_5NZ#_J6QW,?^;7?
M\9%_94XW?VMO]Q)_<4^B?FC]^7CG^K=T'_4MCN8_\VN_XR+^RIQN_M;?[B3^
MXI]$_-'[\O'/]6[H/^I;'<Q_YM=_QD7]E3C=_:V_W$G]Q3Z)^:/WY>.?ZMW0
M?]2V.YC_ ,VN_P",B_LJ<;O[6W^XD_N*?1/S1^_+QS_5NZ#_ *EL=S'_ )M=
M_P 9%_94XW?VMO\ <2?W%/HGYH_?EXY_JW=!_P!2V.YC_P VN_XR+^RIQN_M
M;?[B3^XI]$_-'[\O'/\ 5NZ#_J6QW,?^;7?\9%_94XW?VMO]Q)_<4^B?FC]^
M7CG^K=T'_4MCN8_\VN_XR+^RIQN_M;?[B3^XI]$_-'[\O'/]6[H/^I;'<Q_Y
MM=_QD7]E3C=_:V_W$G]Q7"16_,H1AXHGO'C<...TX^^^_P".5^9999:0IQUU
MYUSR72VVTVA*EN.+5I*$)VI6]:UO>95K%V54M+UV8A55;N)F9F.E50++98D@
M #R2="M)&GB1Y9;BTCBC1I)))(G1(T0%G=W:Y"JBJ"S,Q 4 DD 5K=5+\H;R
M*0=3?)GQ3M(0CR1BBZ]P:XS(XQ+@[);8[[L?Y/$(9><%)'*;;<4E2QWV7DZV
MVZA2K-U:QV+K'>XO)VDCKS5+F80LRABI95DL%+*&5E)&P&!'J"*Y^+S-CG(9
M+C#9G#9:"*012S8Z6.]BCE,:2B-Y+>\D5',4D<@5B"8W1P"K G:OHGYH_?EX
MY_JW=!_U+95[F/\ S:[_ (R+^RKI\;O[6W^XD_N*?1/S1^_+QS_5NZ#_ *EL
M=S'_ )M=_P 9%_94XW?VMO\ <2?W%/HGYH_?EXY_JW=!_P!2V.YC_P VN_XR
M+^RIQN_M;?[B3^XI]$_-'[\O'/\ 5NZ#_J6QW,?^;7?\9%_94XW?VMO]Q)_<
M4^B?FC]^7CG^K=T'_4MCN8_\VN_XR+^RIQN_M;?[B3^XK&3,9Y>5Z*D)R=\@
M_&6'AHH1\^3E9/QYO0$=' BM*>),--*\F6QQ1AVD*<>?><0VVA*E+5I.M[R2
M%+2XEC@M[&_GGF=8XH8;E))99'.E2-%L2SNQ("JH)).A5>[NOJ^UN+Z_OL?9
M65I#)<75W= V]M;6\*EY9YYY;I(H8HD4O))(RHB@LQ &ZQM;>\I[@T0_5O)/
MQ9L(XBT-DOPW +M)-,..)]MM#JQ/)MU+:G$>JT:5O6U)UO:?77VY)<6\-FRK
M=XW)6S."5$UPD98 @'0:R!.B='7H?\JK8[+6F7227%9;%9*.)E262Q9;I(V8
M<E5VANW569?> )!(\^E;+]$_-'[\O'/]6[H/^I;*_<Q_YM=_QD7]E71XW?VM
MO]Q)_<4^B?FC]^7CG^K=T'_4MCN8_P#-KO\ C(O[*G&[^UM_N)/[BGT3\T?O
MR\<_U;N@_P"I;'<Q_P";7?\ &1?V5.-W]K;_ '$G]Q3Z)^:/WY>.?ZMW0?\
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MO-Z?4,ZX2VT(3T<8L+7+">\6R7L3%6E6Y:WN' !%G<M:.D\4%T-QO*FPIUS
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MVESU1>7EDZ7-T;*"P1\7.8K8I(93:E1*()9)+:/TT@SER,6&6Y'R$4MUG6E
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MS:).?M][K%:K%E>;A*Q4(><56B9$MNWSU?IT5#P\OT*8<DEM3=L>%:>("&#
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MN;\TNW22A%#-MN+<E!:7"3+\6PYIW21WSD,-$N)=;84M33FD2Q0M,6"O$G$
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)FBD_I(W^FO_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img109617586_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_8.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ZP%,4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *93Z3:*3 ;2K24JT@'4444[ %%%%, HHHH **** "BBB@ H
MHHH **** "BBBD 4444P"BBB@ HHHH **** "BBB@ HHHI6 ****+ %%%%%@
M"BBBBP!1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MBD 4444P"BBB@ HHHI6 ****8!1110 4444@"BBBBP!1113 **1J3)H =111
M0 4444 %%%% !1110 4444@"BBBBP!1113 **** "BBBE8 HHHI@%%%% !11
M12 ****8!1112L 4444 %%%%, HHHI %%%%, HHHH **** "BBBE8 HHHH *
M***8!1110 4444 %%%% !1110 4444 %%%%*P!1113 **** "BBBE8 HHHI@
M%%%% !1112 ****8!1110 44C4F32L ZBBBF 4444@"BBBF 4444 %%%%*P!
M1113 ****0!1113 **** "BBB@ HHHH **** "BBB@ HHHI6 ****8!1110
M4444 %%%%*P!1110@"BBBF 4444 %%%% !1112 **** "BBBF 4444 %%%%(
M HHHHL 4444P"BBB@ HHHH **** "BBBE8 HHHHL 4444P"BBB@ HHHI6 **
M**+ %%%%%@"BBBBP!11118 HHHH ****8!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%%*P!1113 **** "BBBD 4E+10T 4444( HHHI@%%%
M% !11128"8I:**5@"BBBF 4C=*6BF RG+THVBEH **** "BBB@ HHHH ****
M "BBFY- #J*1:6@ HHHI6 **** "BBBF 4444K %%%%, HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ****0!1113 **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBBE8 HHHI@%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 444V@!U%,S2K0 ZBBB@ HHHI6 ****+ %%%
M%, HHHH **** "BBB@ HHHI %%%%%@"BBBBP!11118 HHHHL 44446 ****+
M %%%%%@"BBBF 4444 %%%% !1110 4444 %%(U)DT .HI*6@ HHHH **** "
MBBB@ HHHI6 ****+ %%%%, HHHH **** "BBB@ HHHH ****0!1113 ****5
M@"BBBF 4444K %%%%, HHHH ****5@"BBBBP!1113 ****0!11118 HHHH *
M***8!1110 4444 %%%%2P"BFY-*M(!:***L HHHI,!K4E*U)4@%/IE/I@%%%
M%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% ";: ,4M% !1110 4444 %%%)0 M
M%)NI: "BBB@ I**0M0 ;J6FTH:@!U(3BC=2$T &ZG4RG;J %HI-U&Z@!:2C=
M2%J #=2TVE#4 .I"<4;J0F@!=U+3*=NH -U)NI#10 X&EIHI=U "T4FZC=0
MM%)NHW4 +12;J-U ";J4'--I0: '4E&ZD+4 &ZG4REW4 .HI-U&Z@ I-U!:D
MH ?13=U+NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH
M 6BDW4;J %HI-U&Z@ I-U!:DH 7=1NI** %W4;J2B@!=U&ZDHH =2TT-2[J
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M12;J-U "T4FZC=0 M%)NHW4 +12;J-U "TFZC=330 X&EIHI=U "T4FZC=0
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MH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J
M%HI-U&Z@ :FTI-)0 ZEINZEW4 +12;J-U "T4FZC=0 M%)NHW4 +12;J-U "
MT4FZC=0 M%)NHW4 +12;J-U "T4FZC=0 M%)NHW4 +12;J-U "TAHW4A- !N
MIU,IVZ@!:*3=1NH 6BDW4FZ@ W4M-I0U #J*3=1NH 6BDW4;J %HI-U&Z@!:
M*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BD
MW4;J %HI-U&:3 ;2K3<TJM4@/HI-U+5( HHHI@)BFM3Z:PJ; -6GBFJM.%,!
M:***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\7]ZC[?%_>H&6**K_;XO6C[?%ZT"+-%5OM\7K1]OB]: +-%5OM\7K1]OB]:
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M?;XO6C[?%ZT 6:*K?;XO6C[?%ZT 6*6JWV^+UH^WQ>M %FBJWV^+UH^WQ>M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYZ_K7QE_PM:3_GK^M'_"UI/^>OZT>Q"Y]G?\+,B_YZ_K1_PLR+_GK^M?&/\
MPM:3_GK^M'_"UI/^>OZT_8BYC[-_X67%_P ]?UH_X67%_P ]?UKXR_X6M)_S
MU_6C_A:TG_/7]:7L1\Q]G?\ "S(O^>OZT?\ "S(O^>OZU\8_\+6D_P">OZT?
M\+6D_P">OZT>Q%S'V;_PLN+_ )Z_K1_PLN+_ )Z_K7QE_P +6D_YZ_K1_P +
M6D_YZ_K1[$=S[-_X67%_SU_6C_A9<7_/7]:^,O\ A:TG_/7]:/\ A:TG_/7]
M:/8A<^S?^%EQ?\]?UH_X67%_SU_6OC+_ (6M)_SU_6C_ (6M)_SU_6CV(7/L
MW_A9<7_/7]:/^%EQ?\]?UKXR_P"%K2?\]?UH_P"%K2?\]?UH]B',?9O_  LN
M+_GK^M'_  LN+_GK^M?&7_"UI/\ GK^M'_"UI/\ GK^M'L0YC[-_X69%_P ]
M?UI?^%F1?\]?UKXQ_P"%K2?\]?UH_P"%K2?\]?UH]B+F/L[_ (69%_SU_6D_
MX69%_P ]?UKXR_X6M)_SU_6C_A:TG_/7]:/8CYC[-_X67%_SU_6C_A9<7_/7
M]:^,O^%K2?\ /7]:/^%K2?\ /7]:/8AS'V;_ ,++B_YZ_K1_PLN+_GK^M?&7
M_"UI/^>OZT?\+6D_YZ_K1[$.8^SO^%F1?\]?UH_X69%_SU_6OC'_ (6M)_SU
M_6C_ (6M)_SU_6CV(N8^SO\ A9D7_/7]:3_A9<7_ #U_6OC+_A:TG_/7]:/^
M%K2?\]?UH]B/F/LW_A9<7_/7]:/^%F1?\]1^=?&7_"UI/^>OZT?\+6D_YZ_K
M1[$:D?9O_"S(O^>H_.C_ (69%_SU'YU\9?\ "UI/^>OZT?\ "UI/^>OZT>Q'
MS'V;_P ++B_YZ_K1_P ++B_YZ_K7QE_PM:3_ )Z_K1_PM:3_ )Z_K1[$FY]G
M?\+,B_YZ_K1_PLR+_GK^M?&/_"UI/^>OZT?\+6D_YZ_K1[$7,?9O_"RXO^>O
MZT?\++B_YZ_K7QE_PM:3_GK^M'_"UI/^>OZT>Q'S'V;_ ,++B_YZ_K1_PLN+
M_GK^M?&7_"UI/^>OZT?\+6D_YZ_K1[$+GV;_ ,++B_YZ_K1_PLN+_GK^M?&7
M_"UI/^>OZT?\+6D_YZ_K1[$.8^S?^%EQ?\]?UI?^%F1?\]?UKXQ_X6M)_P ]
M?UH_X6M)_P ]?UH]B',?9O\ PLR+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM
M:3_GK^M/V(<Q]F_\++B_YZ_K1_PLN+_GK^M?&7_"UI/^>OZT?\+6D_YZ_K2]
MB%S[-_X67%_SU_6C_A9<7_/7]:^,O^%K2?\ /7]:/^%K2?\ /7]:?L0YC[-_
MX67%_P ]?UH_X67%_P ]?UKXR_X6L_\ SU_6C_A:S_\ /7]:/8A<^S?^%EQ?
M\]?UH_X67%_SU_6OC+_A:TG_ #U_6C_A:TG_ #U_6E[$.8^S?^%EQ?\ /7]:
M/^%EQ?\ /7]:^,O^%K2?\]?UH_X6M)_SU_6CV(7/LW_A9<7_ #U_6C_A9<7_
M #U_6OC,?%9_^>OZT?\ "U7_ .>II^Q#F/LS_A9<7_/7]:/^%EQ?\]?UKXR_
MX6M)_P ]?UH_X6M)_P ]?UI>Q#F/LW_A9<7_ #U_6C_A9<7_ #U_6OC+_A:T
MG_/7]:7_ (6M)_SU_6CV(7/LS_A9<7_/7]:/^%EQ?\]?UKXR_P"%K2?\]?UH
M_P"%K/\ \]?UI^R"Y]F_\++B_P">OZT?\++B_P">OZU\9_\ "U7_ .>M*?BK
M)_SU_6E[$:D?9?\ PLN+_GK^M'_"RXO^>OZU\:?\+5D_YZ_K2?\ "U7Y_>_K
M1[('(^S/^%EQ?\]?UH_X67%_SU_6OC+_ (6M)_SU_6C_ (6M)_SU_6G[$7,?
M9O\ PLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M+V(7/LW_A9<7_
M #U_6C_A9D7_ #U_6OC+_A:TG_/7]:/^%K2?\]?UH]B',?9O_"S(O^>H_.C_
M (69%_SU_6OC+_A:TG_/7]:4?%:3_GK^M'LBN8^S?^%F1?\ /7]:3_A9<7_/
M7]:^,_\ A:LG_/7]:/\ A:LG_/7]:/8D\Q]F?\++B_YZ_K1_PLN+_GK^M?&7
M_"UI/^>OZT?\+6D_YZ_K1[$+GV;_ ,++B_YZ_K1_PLN+_GK^M?&7_"UI/^>O
MZT?\+6D_YZ_K1[$+GV;_ ,++B_YZ_K1_PLN+_GK^M?&7_"UI/^>OZT?\+6D_
MYZ_K1[$+GV;_ ,++B_YZ_K1_PLN+_GK^M?&7_"UI/^>OZTO_  M63_GK^M'L
M0N?9G_"RXO\ GK^M'_"RXO\ GK^M?&?_  M63_GK^M)_PM:3_GK^M'L0N?9O
M_"RXO^>OZT?\++B_YZ_K7QE_PM:3_GK^M'_"UI/^>OZT>Q"Y]F_\++B_YZ_K
M1_PLN+_GK^M?&7_"UI/^>OZT?\+6D_YZ_K1[$.8^S?\ A9<7_/7]:/\ A9<7
M_/7]:^,O^%K2?\]?UH_X6M)_SU_6CV(<Q]F_\++B_P">OZT?\++B_P">OZU\
M9_\ "U9/^>OZTG_"UI/^>OZT>Q"Y]F_\++B_YZ_K1_PLN+_GK^M?&7_"UI/^
M>OZT?\+6D_YZ_K1[$+GV;_PLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3
M_GK^M'L0N?9O_"RXO^>OZT?\++B_YZ_K7QE_PM:3_GK^M'_"UI/^>OZT>Q"Y
M]F_\++B_YZ_K1_PLN+_GK^M?&7_"UI/^>OZT?\+6D_YZ_K1[$+GV;_PLN+_G
MK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O_"RXO^>OZT?\++B_
MYZ_K7QE_PM:3_GK^M'_"UI/^>OZT>Q"Y]F_\++B_YZ_K1_PLN+_GK^M?&7_"
MUI/^>OZT?\+6D_YZ_K1[$.8^S?\ A9<7_/7]:/\ A9<7_/7]:^,O^%K2?\]?
MUH_X6M)_SU_6CV(7/LW_ (67%_SU_6C_ (67%_SU_6OC+_A:TG_/7]:/^%K2
M?\]?UH]B',?9O_"RXO\ GK^M'_"RXO\ GK^M?&7_  M:3_GK^M'_  M:3_GK
M^M'L0N?9O_"RXO\ GK^M'_"S(O\ GK^M?&7_  M:3_GK^M'_  M:3_GK^M'L
M0YC[._X69%_SU_6C_A9D7_/7]:^,?^%K2?\ /7]:/^%K2?\ /7]:KV0N8^S?
M^%F1?\]?UI?^%F1?\]?UKXQ_X6M)_P ]?UH_X6M)_P ]?UJ?8CYC[._X69%_
MSU_6D_X67%_SU_6OC+_A:TG_ #U_6C_A:TG_ #U_6CV(<Q]F_P#"S(O^>H_.
MC_A9D7_/4?G7QE_PM=_^>OZT?\+8?_GI2]B3S'V;_P ++B_YZ_K1_P ++B_Y
MZ_K7QE_PM=_^>OZT?\+6D_YZ_K3]B5<^S?\ A9<7_/7]:/\ A9<7_/7]:^,O
M^%K2?\]?UH_X6M)_SU_6G[$+GV;_ ,++B_YZ_K1_PLN+_GK^M?&7_"UI/^>O
MZT?\+6D_YZ_K2]B%S[-_X67%_P ]?UH_X67%_P ]?UKXR_X6M)_SU_6C_A:T
MG_/7]:?L0YC[-_X67%_SU_6C_A9<7_/7]:^,O^%K2?\ /7]:/^%K/_SU_6CV
M(7/LW_A9<7_/7]:/^%EQ?\]?UKXR_P"%K2?\]?UH_P"%K2?\]?UI>Q"Y]F_\
M++B_YZ_K1_PLN+_GK^M?&7_"UI/^>OZT?\+6D_YZ_K1[$+GV;_PLN+_GK^M'
M_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O_"RXO^>OZT?\++B_YZ_K
M7QE_PM:3_GK^M'_"UI/^>OZT>Q"Y]F_\++B_YZ_K1_PLN+_GK^M?&7_"UI/^
M>OZT?\+6D_YZ_K1[$+GV;_PLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM9_
M^>OZT>Q"Y]F_\+,B_P">H_.C_A9<7_/7]:^,O^%L/_STH_X6M)_SU_6E[$29
M]F_\++B_YZ_K1_PLR+_GJ/SKXR_X6M)_SU_6C_A:[_\ /7]:/8CN?9O_  LR
M+_GJ/SH_X67%_P ]?UKXR_X6P_\ SUH_X6M)_P ]?UI^Q%<^S?\ A9<7_/7]
M:/\ A9<7_/7]:^,O^%K2?\]?UI?^%JR?\]?UH]B.Y]F?\++B_P">OZT?\++B
M_P">OZU\9?\ "UI/^>OZT?\ "UI/^>I_.CV(<Q]F_P#"RXO^>OZT?\++B_YZ
M_K7QF?BJ_P#SU_6D_P"%K2?\]?UH]B',?9O_  LN+_GK^M'_  LN+_GK^M?&
M?_"U9/\ GK^M)_PM:3_GK^M'L0N?9O\ PLN+_GK^M'_"RXO^>OZU\9?\+6D_
MYZ_K2GXJR?\ /7]:/8AS'V;_ ,+,B_YZ_K2?\+,B_P">OZU\9?\ "UI/^>OZ
MT?\ "UI/^>OZT>Q%S'V;_P ++B_YZ_K1_P ++B_YZ_K7QE_PM:3_ )Z_K1_P
MM:3_ )Z_K1[$=S[-_P"%EQ?\]?UH_P"%EQ?\]?UKXR_X6M)_SU_6C_A:TG_/
M7]:/8A<^S?\ A9<7_/7]:/\ A9<7_/7]:^,O^%K2?\]?UH_X6M)_SU_6G[(+
MGV;_ ,++B_YZ_K1_PLN+_GK^M?&7_"UI/^>OZT?\+6D_YZ_K2]B%S[-_X67%
M_P ]?UH_X67%_P ]?UKXR_X6M)_SU_6E_P"%JR?\]31[$+GV;_PLR+_GK^M'
M_"S(O^>OZU\8_P#"UI/^>OZT?\+6D_YZ_K2]B',?9O\ PLN+_GK^M+_PLR+_
M )Z_K7QE_P +5D_YZG\Z3_A:TG_/7]:?L1<Q]F_\+,B_YZ_K1_PLN+_GK^M?
M&7_"UI/^>OZT?\+6D_YZ_K1[$?,?9W_"S(O^>OZT?\+,B_YZ_K7QC_PM:3_G
MK^M'_"UI/^>OZT>Q%S'V;_PLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3
M_GK^M'L1W/LW_A9<7_/7]:7_ (69%_SU_6OC(?%:3_GK^M'_  M1_P#GK^M'
ML1<Q]F_\+,B_YZ_K2?\ "RXO^>OZU\9?\+6D_P">OZT?\+6D_P">OZT_8CYC
M[._X69%_SU_6C_A9D7_/7]:^,?\ A:TG_/7]:/\ A:TG_/7]:7L0YC[-_P"%
MEQ?\]?UH_P"%EQ?\]?UKXR_X6M)_SU_6E_X6K)_SU_6CV07/LS_A9<7_ #U_
M6E_X69%_SU_6OC/_ (6H_P#SU_6D/Q6?_GK^M/V0N8^S?^%F1?\ /7]:3_A9
M<7_/7]:^,O\ A:TG_/7]:/\ A:TG_/7]:7L1\Q]F_P#"RXO^>OZTO_"S(O\
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MUH_X6M)_SU_6CV(<Q]F_\++B_P">OZT?\++B_P">OZU\9?\ "UI/^>OZT?\
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MH_X6M)_SU_6E[(.8^S?^%EQ?\]?UH_X69%_SU'YU\9?\+6D_YZ_K1_PMA_\
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MUKXR_P"%K2?\]?UH_P"%K2?\]?UH]B%S[-_X67%_SU_6C_A9<7_/7]:^,O\
MA:TG_/7]:/\ A:TG_/7]:/8A<^S?^%EQ?\]?UH_X67%_SU_6OC+_ (6M)_SU
M_6C_ (6M)_SU_6CV(7/LW_A9<7_/7]:/^%EQ?\]?UKXR_P"%K2?\]?UH_P"%
MK2?\]?UH]B%S[-_X67%_SU_6C_A9<7_/7]:^,O\ A:TG_/7]:/\ A:TG_/7]
M:/8A<^S?^%EQ?\]?UH_X67%_SU_6OC+_ (6M)_SU_6C_ (6M)_SU_6CV(7/L
MW_A9<7_/7]:/^%EQ?\]?UKXR_P"%K2?\]?UH_P"%K2?\]?UH]B%S[-_X67%_
MSU_6C_A9<7_/7]:^,O\ A:TG_/7]:/\ A:TG_/7]:/8A<^S?^%EQ?\]?UH_X
M67%_SU_6OC+_ (6M)_SU_6C_ (6M)_SU_6CV(7/LW_A9<7_/7]:/^%EQ?\]?
MUKXR_P"%K2?\]?UH_P"%K2?\]?UH]B%S[-_X67%_SU_6C_A9<7_/7]:^,O\
MA:TG_/7]:/\ A:TG_/7]:/8A<^S?^%EQ?\]?UH_X67%_SU_6OC+_ (6M)_SU
M_6C_ (6M)_SU_6CV(7/LW_A9<7_/7]:4?$J+_GK^M?&/_"UI/^>OZTO_  M>
M3_GK^M'L17/L[_A9<7_/7]:;_P ++B_YZC\Z^,_^%L2?\]?UI/\ A;#_ //6
ME[$5S[-_X67%_P ]?UH_X67%_P ]?UKXR_X6M)_SU_6C_A:TG_/7]:?L2KGV
M;_PLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O_"RXO^>O
MZT?\++B_YZ_K7QE_PM:3_GK^M'_"UI/^>OZT>Q"Y]F_\++B_YZ_K1_PLR+_G
MK^M?&7_"UI/^>OZT?\+6D_YZ_K1[$:D?9O\ PLR+_GJ/SI?^%F1?\]?UKXQ_
MX6M)_P ]?UH_X6M)_P ]?UH]B)R/LW_A9<7_ #U_6E_X69%_SU_6OC'_ (6M
M)_SU_6C_ (6M)_SU_6CV(<Q]G?\ "S(O^>OZT?\ "S(O^>OZU\8_\+6D_P">
MOZT?\+6D_P">OZT>Q%S'V;_PLN+_ )Z_K1_PLN+_ )Z_K7QE_P +6D_YZ_K1
M_P +6D_YZ_K1[$=S[._X69%_SU_6C_A9D7_/7]:^,?\ A:TG_/7]:/\ A:TG
M_/7]:/8BYC[-_P"%EQ?\]?UH_P"%EQ?\]?UKXR_X6M)_SU_6C_A:TG_/7]:/
M8CN?9O\ PLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O\
MPLN+_GK^M'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O\ PLN+_GK^
MM'_"RXO^>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O\ PLN+_GK^M'_"RXO^
M>OZU\9?\+6D_YZ_K1_PM:3_GK^M'L0N?9O\ PLJ+_GK^M)_PLJ+_ )Z_K7QG
M_P +6D_YZ_K1_P +6D_YZ_K1[(+GV;_PLR+_ )Z_K1_PLR+_ )Z_K7QE_P +
M6D_YZ_K1_P +6D_YZ_K1[$7,?9O_  LN+_GK^M'_  LR+_GK^M?&7_"UI/\
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MX6M)_P ]?UH_X6M)_P ]?UH]B%S[-_X67%_SU_6C_A9<7_/7]:^,O^%K2?\
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MK1_PM:3_ )Z_K1[$+GV;_P +,B_YZC\Z/^%F1?\ /4?G7QE_PM9_^>OZT?\
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MX6M)_P ]?UH]B%S[-_X67%_SU_6C_A9<7_/7]:^,O^%K2?\ /7]:/^%K2?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM"?U-)_:,_J:L>2OI3?LZTK(JY#_ &A/ZFE_M"?^\:E\A?:G>2OI19!S%?\
MM"?U-+_:$_J:F\A?2E6W6CE0)D']H3>II/[0G_O&K!A7%,\E:+(?,1?VA/\
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M"?\ O&I_)6E^SK19!S%?^T)_[QH_M"?^\:L>0M)Y*T60<Q!_:$_]XTGV^?\
MO-5CR5H\E:+(.8K_ &^?^\U'V^?^\U6?LXI/(6BR#F97_M"?^\:/[0G_ +S?
MG4YA6D^SCTHL@YB+^T)_[QI/[0G_ +S59^SBFM;C-%D+F(/[0G_O-2_VA/\
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MQQ06.*8O:G4 )NHW4NVFTK@+NHW&HZ<M,!V31DTE% !FGTFVEH 1J3<:&I*
M%S3J:O6G4 -/6C<:&ZTE "Y-)112U *7<:2BF X4$TVD:@!6:FYI.M.VT +2
MYI** "BE%+MH ;FBEVTE !2Y-)10 NXT;J2B@!=U&ZDHHU 7<:,FDHH 7)I^
MZHZ*0#]QI&IN:4<T]0&FDW4_;1M- !NHW4NVC;0 FZC=2[:0BBX!NHR:2B@
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MIZ@,W4 T[;28Q2N 4N:2EQ2YB>8.:<*;MIU44(S&A6-&*3%%[#L.)IE%%1S
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M<:3)IM.H ;DTY6-,HI:@/9J;NI*1NE,!VZG5#3Z %:FM2TA% "4ZD5>:=MH
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M']*\RH]3IB7MM,:GDTP\U@:#<4M.5:7;4C(Z*DVBBG80ZBBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M12[:2@!=M)3LBDQ0 !:4K2KVI6H CI=M)3LB@!-M&VER*,B@!",4E*S"F[J
M';:,XXI<TA% "[J0FDHH *7;24^@!E.6FTY: !NE-IQYHVT )MI<XI::10 N
MZD)I** "G;J3%*JT  7K2XQ2CBAJ &T;:*,B@ VT;:,BC(H 0T9H:DH 7--Q
MS3MII* %!I?O4VG+TH 0C%)3FZ4V@!VVC=1D4V@!WWJ-M(M+D4 &VC;1D49%
M #MM,8U)VJ-A3 56J1<&H:<K8H))"*8:7S*2JN.P"G8IHI])A89MI,4\TPU
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M]T5Z\=CCD6**5J2I9(UNM1U*U-I (O2I*93J $:DI]% #5ZTZBB@!II*#10
M4444 %)D4M-H 7(IRTRG+VH ?124V@ HHHH *5>M)10 ^F444 *M.I%I: "B
MBB@ VFBG9I&H :U)3J2@!:93Z* $6EIIZT+0 M-IU-H *<M%(U #J*92KUH
M=3<&G44 (*:W>E;K0M #-IIU.VTM #*<O2FTY: !J;3Z1NE #:**=0 VBGTU
MJ $I<&DI] !1110 UJ%ZT,*!0 ZF$\TYJC;K0 ZE6A:=0 44C4V@!]%)2T -
M:BAJ2@!XI=U1TNZ@!2*04M(U "TVBGT ,IPZ4M% "4'I2-24 %%%% !1110
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M]:!UIU)Q1<K86HG?:*DW4^.S-QP!4L5S/DOMII@U+/%;T7@VXO.5C)_"IO\
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M6E;I2TC=* &T^F44 %/7M3*<M #FJ.G-2+0 ;:2I!BF-0 E%%*M !@TM+3*
M'TUJ5>E(U "4444 /HIE% "M2<TY:6@!N*-M.%+@4 -I&H:DH *44+3J $I&
MZTZF4 %%.6@T -I],Q10 ^FM3J:U "444J]: $IU+36H 7=1NIG- S0 ]NE-
MHHH =2T@Z4M(&%%%)39)1O\ [IJ]X-_Y"$?^]5&_^Z:T/!G_ !_Q_6L)&L3[
MC^ ?W8/PKZ^T?_CPC^E?(GP#^[!^%?7FC_\ 'C']*\Z9UQ+M%%%8FHRG+2T4
MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#Q0 #GK2[12+3J &Y-&324NV@!>M%%(S=: $+4FZCJ*=MH :M/ IN,4Y: #
MH/2@TFZ@!*>K<4FVB@!<TUJ4FF,U "T[ IBT^@!:2C=2;J !J,FC[U+MH 6F
MY-.I-M  *1CUI:1A0 BM3A3%IVZ@ )HR:2B@!<FC-)10 4^F4NZ@ :CK0:51
MTH 55IS=**3=0 QJ,TI&:3;0 E*O6C;2[: %IE/I-M  M%%!.*  BFTNZDH
M**=MI-M !FC=1MHQ0 E/IE/H *2EI"<4 !IN32[J2@ IU-I=U "M3:7[U*%H
M 9MYI^VEVTA- #6'-&*3=0#0 Y:=3*7=0 E.7I3:7=0 K4@H^]2XQ0 4VEW4
ME !1110 HYI:04NZ@ W5'NJ3;3-M  M+2 8IPYH ,FEVBDVT;J '4E)NI0:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "F4^F4 %*M)2K0 ZDI:2@ 7I2-
M]TTJ]*23[II <AXN_P"/5_I7R!\:O^6U?7WB[_CU>OD'XU?\MJZZ)C(^0_%/
M_'X_UJC9@[15[Q1_Q^O]:I6?W17JQV.219HI6I*1(444W=0 ;:-IIU% #=IH
MVFG44@&X-)3J;0 [<*1J2B@ QFDVTY:&H ;FG[JC;K2K0 YJ2BE6@  I<TM,
MH 4]:;MI<TH- "*M/I,TM !1129H 1NM)2GK0M  !2Y%+3* %--W4M-/6@!Z
MFG4Q>U/H 3(IM%% "XH^[2J*&!Q0 ;J6F4^@!NVEVTM.H 9TH)I6[U'D4 +3
MLBFT4 *:%I** '9I::.M.H ;M-&#3MIHH 0<=:0\FAJ%ZT )MYI13J90 K4E
M%% "BER*;10 ^FMUIU-:@!**** "BBB@!V12'GI24Y: $Q2[J&Z4A&* '4NZ
MDIO>@!>N:3%*O>ANE #:7::2GT ,I5H:DH =2;30M.H 93A3:<O2@!&I*5J2
M@!5I_P##4=.H &H6EHH 0TFTTM+0 4W!IU% !FAFIK4E !3LBFT4 %*M)10
M[<*-U-HH ?1124 (PI,4^D:@!%IP:F44 /:FM3J1NU " T'FDI5ZT )MYI1Q
MUIU-:@!&:@-S36ZT"@"2EV\4U:?NH 8RT;<&I.*::  #-!&*%-*30 W-%(>M
M*O2@!&%)3Z:U "5',VT5)4%QS4LI"0L9&Q7;^#=$:ZNH_ESS7)Z'9M<7"C&>
M:^AOA?X0,S1,4].U8N1:1Z[\(?"818F*5](:;&FG68P<8%>>^"=)73+5"1C
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M+PVL:PDKZ5]-Z+I<268&T=*\J^'.BB&&,@5Z_: QP@>U>;)ZFMCSOXD:+'-
M^%[5\E_$CP>97E(3U[5]K>)K3[4C BO'?%WA%;A9#MS^%;4YV%8^!?$/A%H;
MH_)WK6\(:<;>X08Q@U[%XX\'I#(YV?I7$Z?IPM[H #O71)W1#/H+X0,4:$5]
M/Z;(3IP_W:^7?A7\C15].Z#^]L5'M7G2>IM$\B^+FYH9:^1/&6DO<W4@VYYK
M[E^('AMKZ-\+G->%:M\-VEN6)C[^E;TY$2/ET^"Y)FSY9_*I/^$&D1/]6?RK
MZ>LOABO>/]*T6^%JO'Q%^E='.9<I\<:CX;DM\_(?RKG[BV>%CQBOKCQ-\)F6
M-R(NWI7BOB[P+)8L_P"[Q^%"F38\IW&E9C5K4+)K68@BG6=F;A@ *KF+*L4;
MR' %;6GZ#)<X^0FNJ\,^!Y+YDPF<^U>P>%_A4[*I,7Z4N<D\8L_ TDH!\L_E
M6BOP]?;GR_TKZ6L?AFL*#,?Z5IK\/X]N-@_*H]H'*?(NH>#)+=2?+_2N8OM+
M>W8C;7V1J_PP$RMMC_2O+/%WPQ>W5V\O]*T4KB/GAHRIY%"UT?B+13I[L",8
MKEVEP^*U0F3U')S3E;(IK5MT,PC7YA7H7P\XO8OJ*\]C/(KT+X>_\?L7UKFF
M:1/N+X,L?L\7->XZC(W]EGG^&O#O@R/]'B^E>X:DO_$L/^[7!+<Z%L?*OQJ8
M[9^?6OB_QT<WDGUK[/\ C4/EG_&OC#QS_P ?DGUKHID21S-B.:T=U9]G5YJ[
M4M#G;'9J&5BO2D,F#BKEK9M=, !G-2]"DBE$KR-@"MK3]#DN<?)FNJ\,^!);
MYTQ&3GVKV+PO\)795)B_2L7,M1/%+7P1),H/EG\JOK\/GQGRS^5?3MC\+%AC
M&8\?A6@/AS'MQY8_*ESE6/DV;P#(O_+,_E6/J'A.2V!.PC\*^R#\,4E!Q'^E
M<UXA^$I,;$1?I1SCL?'-Y;O;G!6JJR$U[1XP^&LMH7/E$#Z5Y=J6BO8R,"N*
MI2N9-&=&NZM?3]):YQ@9K,M5W3!:]7\"^'_MK)\N:UZ CE!X1D,>=AZ5EWOA
MZ2$GY"*^J-+^&OVJU!$>>/2LW6/A&[,<0_I7+*97*?,,.CR,V-M;=AX2DN,?
M)G\*]MM_A*ZR<Q?I75Z+\,1'C,?Z4*8N4^?5^'\C)GRC^59&I>#Y+52?+/Y5
M]C6OPS1HO]6/RK!\1?"<O&VV+]*OG%RGQ=?6<ENQ&TU45CWKW;QA\+Y;4N?*
M(_"O)]8T%]/D8%<8I\P6,-FJ%F8\"I,$R;:W]'\.O?,N%S1S#,FQLI+AA\I-
M=5IWA*2Z4'RS7H/A'X827!0F(G\*]@T'X5;(US%^E0Y%6/G9/ $A7/EG\J:W
M@&0?\LS^5?5Z_#5%4?NQ^5)_PK)7_P"6?Z4^<.4^3#X$D_YYG\J%\"R?\\S^
M5?6O_"J0PSY7Z5!-\+Q'G]U^E+G#E/DF\\'O"I)2N8U333:D\8KZK\5^!UM8
M7.S&/:O _&6E^3,Z@52F2>8O(PDP*TM/M'NF'RDYK3TSPS)?7( 4G)KUKP?\
M*Y9PA,1_*KYQGGFF^$9+@ [#^5;,7@*1A_J_TKZ%T7X5^5&N8OTK?C^':)C]
MV/RI.H4HGRU/X#D1<^6?RK"U#PK);Y_=FOL>3X:I,G$?Z5S6N?",R1L1%^E3
M[03B?'EU8O V"M52Q4\U[9XR^',E@7/ED8]J\AUO3VLY"",8-:QE<SL0VX\W
M K6M=&:XQA<U0T.(S2J/>O7O!_AG[9L^7/X5,Y!8X%/"4C+G9^E13>%9$_@/
MY5],Z7\-?.A!\K]*GN?A,S?\LOTK#F*L?+L/A>61L>6:TX_!$I4'RS^5?26F
M_!]FE'[GOZ5U*_!X1V^?*[>E-2"Q\<7OA=[;.4Q6%<VAA8@BOJ'QQ\/19*Y\
MO'X5X)XJTO['(XQBNB+N+8XMCMJ)J2X;;(10/F%62V.6NL\&_P#'Y']:Y)>#
M76>#O^/R/ZT7T%N?9'P58^7#^%?4NCW#+9KSVKY8^"W^KA_"OI_2\_85^E>;
M5=V=M,MR:J8WY;BH[C5!.I7=7-:Y?&V8G.*P+?Q(&G"[JQ-Q/'>D+>6LAVYX
M-?'WQ<\/>3)*0N*^VKK&H69[Y%?./QE\/_+*=M7&5F<M1'Q'JT!ANV&,<U4D
M?"UU/BS33!>R<=ZYHVY=L8KV*<KQ.1Q.D\$P&XO$&,\U]B_!WPZ'CB8KZ5\Q
M_"_06FO(_E[U]R_"?0?L]C$2N.!7GU979M#0]/T6%=/MT[<5K_\ "0;5QOKE
M]=U(6$&,XP*Y*'Q-YL^-_?UKF.OH>FMJS39^:O/_ (@3%[23GM6WI=T9TSG-
M<[X[S]CD^E"W,SX[^+7^NEKP&_7_ $AJ]]^+?^NE/N:\#NCNN6'O7H0EH9,I
ML6'2KMC \Q'RYK2TW0WOG7"YS7IGA/X:RW6T^4?RK;F%8XK3?#$ETH^0FMJ/
MP!)( ?+_ $KWWP[\*RL:EHOTKKH?AND:C,?Z5C*H%CY6D^'LBKGR_P!*Q[_P
MG);9_=GCVK['D^',<B8\L?E7.ZS\)C-&Q6+/X5CS XGQQ>V,EOGY2*SRQ!YK
MWSQE\,9+-7;RB,>U>-Z[I#6,K KC!K:,B.4RE.13&D.[ IT/S<5H6.E/=2@
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M3%^E5*1!XM;^ Y)E!\O]*F_X5Z__ #S/Y5]06?PW2.,9C_2K2_#R,_\ +/\
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MTE/H 2C(I&ZTE "M0*2B@!^[BD:DVTZ@!HXZTO6D:A: #::2GTR@ IP--HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *93
MJ;0 A-.6DQ3A0(6BBDH&"]*23[II5Z4C?=-(#CO%W_'I)]*^0?C5_P MOQK[
M \7#_17^E?'_ ,:O^6WXUU4MS*6Q\B>*/^/U_K5.S^Z*N>*/^/U_K5.S^Z*]
M>.QQR++4E*U,/6I9(-UIG-/'-&VD E/IE+DT .HIN32K0 4VG4V@ HIP%&T4
M -HI6%)0 4444 %*M)10 ^F4N324 ,I>:7:*<%H :M+2XI* "BBG;10 +TH:
M@\4V@ I],I<F@!U-/6C=24 *M+3:7)H 2BBFYH E6G&HE:EW4 *W2FTN:2@
MI],IR]* &MWIE2-2!: "BG;13: '+TI&HS24 %/IHIU #LTC4S=3LY% #6I*
M<U-H ***=M% #:*5J2@!5ZTZFKUIU !1132: $;O2+2T4 .IM+DTE #EZ4C4
M9I1SUH %IQQ3>E)NH #]X4X4RE!H <W>F4[K010 VBBG8% #:*1J1: 'KUIU
M,I<F@!U%-W4]: &-0O6E;O2+UH =3*?3* '+TI&HS0.>M "44[:*,4 +36ZT
M9-+0 VBE:DH **** "BG48% "+3J3%% "TRER:7% "+3J:>*4=* %HI6IA:@
M"2D:D5J,T %%%(: %HIN32B@!K=:5:=2-0 M-R:,FDH 7=24RI!0 E%*124
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M/>HL78^H_"K>9IZ_2N(^*2[;:7Z5VW@__D'I]*XOXK_\>LOTH0K'Q7\39/\
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M4[!T]*Y'XE>&HXK>3"=J].\(W _LU/I7(?$V8-:R?2N-Z2-^A\,_$S3Q#=2
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MO_(0C_WJYYFL3[F^ 7W8/PKZ]TC_ (\8_I7R%\ _NP?A7U[I'_'C']*X)G7
MNT445B:A1112 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% "4VG4V@ IU,W4\4"%I*6DH
M&"]*&^Z:%Z4C?=-(#D/%_P#QZO\ 2OC_ .-7_+;\:^O_ !<?]%D^E?('QJ_Y
M;?C752W,I;'R)XH_X_7^M4[/[HJYXH_X_7^M4[/[HKUX[''(LM3=M.:DJ62-
M^[2[J&IM( IN:?MINV@ 6G XIO2EH 7=244NV@!1TI:3.*-U  U-I?O4;: $
MHI=M&V@!**7;1MH 2BEVTI7CI0 S=3E/2F[:<M "T*M+0&H -M(3BG;J830
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M\[\:^LM;_P"/%OI7RC\:O^6WXT0O<SEH?+EX?^)D?K7OOP7;]Y#]17@5XO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5.W"DUR&AQWBHBQLVQQ@5\D_&/Q%L:9=_K7TM\3M9%O:2#=VKX<^,6O>9<3
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MW]G+]*\Q^*EN1:R_0U,=P/B/XE+_ *5+]:\DNU_>'ZU[%\3H]MY+]:\>O?\
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M(MJ3+OKY)\9:C]JNGYSS7L_Q>\1?O)AN_6OG+4]0^T7#<YYKMIHR;-[P>O\
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M?29HH 1J%IU% "&FTYNE-H <O2EI%Z4M !1124 %+3** 'T4BTM "-3:?10
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M*^D']I'ZU[S\&;Y(I8<GN*^<KB\W71;/>O1O ?BG^SI(SOQS6C1"/T2\(ZY
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M=0 ZG+TJ/=3E;B@ ;K3*>:;MH =36HW4AH 3O1NIVWFAE]J $5J=3 ,4[=0
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M ?2;J6FXH ?N--ZBFTY: $ I:6D/2@!M+BDIPZ4 )MI*?36H %I^.,TQ:?\
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M ;:2GTUNM "4444 %/IE/I %%%% ,****;)*%_\ =-7_  ;_ ,A"/_>JA?\
MW35_P;_R$(_]ZN>9K$^YO@']V#\*^O=(_P"/&/Z5\A? +[L'X5]>Z3_QXQ_2
MO/F=<2[11161J%%%%*P!1113 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<4BXU)114LD1J;3Z2D VBBB@ I5I*5: '4444 %-:G4UJ $HHHH *=3:<.E
M!M]J1JDIK=: &K3P*CI^Z@ (YIR]*;1NH 5JCI]-:@!**;_%3UH 5>E#4C<4
ME !3Z910 ^BDI: $:FTZC% #:=D4VF[J 'M24HYI2* &T^F49H ?36I,T4 %
M%*M+0 VBG;110 VBE/6A: $HIU-H ***<.E  M+24M !1110 4UJ=36H 2BB
MB@ HHHH <M%-I10 E%.P** &TJTM(U #J*9FC- !13:5: %HHI1UH 2BG44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4UNM.IE !3A3#FG+0)#J1J6DH
M&(M*WW30O2AONFD@./\ %_\ QZO]*^0OC5TFKZ]\7_\ 'J_TKX_^-7_+;\:Z
MJ6YE+8^1O%/_ !^/]:S[7H*O>*/^/U_K5.S^Z*]>.QR2W+%)3FIC5+W(!B*;
MD4-24@'4^F4^@!K4+3J1J "FT44 .7I2TRB@!](>E(M+0 VG#I3:=D4 +36H
M:DH *?3*?0 4UJ=36H 2BBB@ IV:;10 K4"E XZ4,/:@ R*6F4^@ HIE*M
MU,VU+28% #:*** "E6DI5H =3*?10!#3EI:* "EP:%IU #*7!IU% #*5:&ZT
ME #Z*910 ^FMUIU-;K0 +3J:M+0 4VBB@!5I<TVB@!QI,&A>M.H 9S2X-.I*
M $''6ES2-0O6@!:;3Z90 Y>E#4+TH:@!M%%% #Z:W6G4UNM  M*:1:5NE #:
M**=0 F#24^FM0 E&#2KUIU #*=FFT4 *U)110 4ZFT4 *:-II5Z4M #*3(IS
M4R@!U%%% !2K24JT .I#TI:* (FIR]J** '49%-HH **?36H 3-"GFFMUH%
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M4;4ZFMUH$"TI--I5ZT )3J6BD ZANE-R:,T@$:FTYJ;30!3J*6F UJ2E:DH
M*?3*?0 RG+2T4 (W2FTYJ;0 4X4VB@!]%(M+0 E-I]% #**** "D;I2T4 ,I
MR]*6B@ I5I** '9%-HHH =2-3J:U "4 TUJ%H EHI%Z4M #&%)MI]&!0 BTZ
MBB@!E%%% "K2FD6G4 - IZTE&: %:DHI&H #TIM%% !S3A2TUJ %HR*;10 Y
MJC;K3J* %6E--I5H 3%%.IM #LTM,IRT +BC!I5I: &4VG4V@!R]*&IM*M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M130U.I@%)29I0: $(I*<:-M QM/IE)D4AL>U-I,TM.Y(44HI=HI -HS2FDH
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MVTE/IE #ATH:A>E(U, ZTN!2+UIU !13=QHR:0 U)110 9HHHHN 44NVEVT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *::=3* $VTY:2E6@!U)2T4 (*1_NFG4V0_*:0''^+F_T63Z5\@?&O_EM^
M-?7WBX_Z+)]*^0OC5_RVKJHF4SY!\4#_ $Q_K5.S/RBKWBK_ (_'^M4+/[HK
MUX[''(MFBBBI9(4E+24@&T444 .7I0W2A>E#4 -I=M)3Z &4Y>E-I5H 5J3&
M:#S2K0 X"D-*&XI&- #2*/NTZD:@ W4VBB@ HHHH <IZ4K-Q3*0T !:EINVG
M4 (6I5:FMUIR]* 'TRGTS- !2K244 .W"CK3:<M ";:2I>U,84 (!FC;2K2T
M -VTE.IM !2@TE% #@:#2"ES0 FTT;:=10 E!&:-U&Z@ VTM)FB@!-M)3Z8W
M6@!5H:FYI: &XI1TI:7;0 E%%% "K3J:O6G4 -VFE'%+33UH 7-&ZFT4 .R*
M;110 4N*2E6@!0,4C4M-H 1J55HIU #:44K4F* '4W;3J* &4JT-UI,T .I"
MM(IYI] $>VE5:?24 )G% :D;O2#I0 _K49ZT_=2"@!RK3MM"T-TH :W2FTK4
ME !2AJ2B@!VZCK3:5: #;2[J6F4 !I-U+36ZT .%+M--6I* &4X4VG+TH 6D
M)I::U #-U%)3Z $6G!J2B@!WWJ3;0M+0 VGTRG4 (U)3FI,&@!*-M.6G9% #
M-M+TI2133UH 6EIHZTZ@ INZER*;0 X'-+35IU "'I3:=3: '9%&,TVG+TI@
M(1BC=2M3:0#Z*** $S1NI&I* ';J3=244 +MHVTM+0 W!I*?24 -HHHH 4&E
M!S3:5: %-)M-+2T )D48S3:<O2@!",4E.:FT %/INTTZF UCVI*5NM"TAABC
M=2TVF(*<#3:*0"GGI1MH6G4#&[:3I3\^U(:!C:***!!1110(=_#32:7/&*8:
M8#AS2XI%[4YNE(8VGTRG4A 1FFTZD/6F E+MI*<#0 FTT;33J*0#?NT$T-24
MP"EW4E% #J<.E-'2C(H <U,(IU# XH 93MM)WIP- !CBD-.+4QC0 AI-M&14
ME #?NT;J&ZTE "_>HP:%IU !3=M+D4M "+0:6FM0 ;J-II*?0 RBE(I* $)Q
M0#0U(M #\4;32CI2T -VFC%.I&Z4 -HW>]!IN* '4H.*:*6@!=U+NIM% QQ&
M:CJ3=3: N(JT[;2KTH/2@0T4[=3:*  TH&:2G+0 FVC;3J3- ";:7(I:90 K
M4"DHH =NIM%)NH 6E!I**  TAYI:!0 FVE"T^B@!E*M!% H 6FTZFT %.7I3
M:<#0 4$TAI* "G9%-HH 5J2BB@ HI<4;: #!I12TF: !J;2M24P"G4VG9%(!
MC4B]:>:3% "K3J:M+D4 -I0U&#24 #-2;J#UI":"B3(I:93J"1&ZTE*U)F@
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MI:;0 NX4AYZ4E*M "%:3;4E% #**6DH <&Z4K-3** %[TX-3** 'LU)NIM%
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MTHI .HI,BBF M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ^DI,FB@!*=12T -:DI6I* "G9%-INZ@"3(I&INZG=Z $HIQZ4V@ HIU(>M
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M9H 2G4VG4 (U"]:6C% #EH(&*2F[J !J%HS24 .:DI** 'TRBB@ I5H I<4
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M0 RG\TE/H ;12-WIN30 ZFTN324 %.6FTY: %HHI* %IE&:* "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSQ0 9-)3@M&WVH ;12D8I* %6EVBD%+D4 )MI*=D4V@!ZTIZ4@:ES0 E%%%
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M3MM&WVI: $VBC.*-U(: #=244JT &VDJ3;32M  M+3?NT;J %;I312DYH H
M>HH84+0U #2:3=2M2;30 ;J2EVFDH 4"EVT+10 =*3=06I* %W4M-I0U "GF
MFLO%.S0>E $>VG444 +BC;2CI1F@!"*2G$TV@!=M&VEI: $SBC=2-2"@!VVD
MSBES28- !NI**4#-  .M.I,8I-U #J:>M&ZEQF@! <4;J",4E !3MHIM.R*
M$VT8Q3J:U "4444 %%+MHVT )12[:7;0 ;:6BF[J %Q2;:44X"@!F*2GLM-V
MT +M%+29%+0 4AHS2$T &ZG[JCI=U #C2-2;J/O4 (6H#4C+0M #P*0T!J#S
M0 9H6DI5H 7%)NI<BFT .H:DW4M #:4#-&VA: ';>*:1BG;N*:U "4JTE*M
M"E:;M]J=D49% ";:0T^DVT (M.IOW:7=0 VBBB@ HI-U&Z@!:7<:!S1MH 2E
M6DI5ZT .HHHH8D4K_P"Z:N^#?^0A']:I7_W35WP;_P A"/ZUSS-HGW/\ ?NP
M?A7U[I/_ !XQ_2OD+X _=@_"OKW2?^/&/Z5Y\SIB7****R-1NZE%-IRT +11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 E-IU-H <O2EI%Z4M !29%#=*;0 ^FM]TTJTDG
MW30!Q_B__CUD^E?('QJ_Y;?C7U]XN_X]9/I7R#\:O^6WXUTTMS*1\B>*/^/U
M_K5*T^[5WQ5_Q^/]:HV?W:]:.QQR+#4+3FZT5+)$;I3:<U-H *?3*?3 :U)2
MM24@"BBB@!=U(:;3Q0 @%/I#TIM #Z93Z90 ]>M*W2FK0U !FEIE.R* &TJT
ME*M #UH:DHH :W6DI],H **** "EVFDI] #=IHVFG44 ,HIS4FTT )3Z93J
M$:DI](U #:*** '4M,IR]* $;O4=2M3: &T[!HI] ""EIK=:%H =2;J1J;WH
M 6EVFA:6@!M%*U)0 4444 *&I=U1\THS0 ]J3::%IU !36ZTZF4 *M.IJTZ@
M I,TM,H 4TE%.6@!%I:*;0 4444 %(U+10 U:D6FBGT -:DI6I* "E&:2GT
M&TTC+3\BCB@"/%)3F[TV@ I],I] "4C4-UI* $;M0JTX4N* !>E(U.IK=: $
MHHIR]J $*TRIFJ,CF@!%IZ]*%I: $-,R*<W6HZ 'TRGT4 "]J?3*,^] #Z*9
M3Z &[32K2T4 (U(!3J1NE  W2FD44X=* $4=*4]**:W>@ HI%4T\4 -HI]%
M#5IU%)0 9IM%% "9I<TUNM"]: '4448H **** %6EI%IU #*=3:* %:A:2B@
M!S=*9NH:@"@!<4X4+2-0 K4VBB@!V13LBHZ7)H <V*:U)10 4444 %.7I3:<
MO2@!:0TM% #=IHVFER*6@!E*M#=:%H 4]*;3Z* "FM3J90 44JTZ@!G-+@TZ
MB@!E%/IK4 )2TE/H *:U.IK=: $HHIRT )MIU.VBFT %-:G44 -Q3EZTE+0
MNZD--R:2@!6ZT+UI*5: '4RGTR@!PIK=Z<O2EH 8!3J#TIM !2;J6FT +FG+
MUIJTY: '4444 -/6DHI5H %IU%)0 VBBB@!RTM,HH =3:*?0 RBBG+0 BTN1
M0U-H ?3#3Z:W6@!*5:2B@!V11D4FTTE !2K24Y: %H7K110 ZHVIU,H **<M
M#=* &T444 /IK"EI: &J*=124 -HHHH <*1J2E6@!*?110 E&:;10 YJ;2K3
MJ &4[-+3* %:DHI5H 3FEVFG44 ,HHHH *4=:2B@!V:0]:2GT 1&A>M/:DH
M5>M.IJ]:=0 E-)YI6ZTR@!V:5::M+0 [(IM%% !3EH7I2T )3>:?10 RG TV
MB@!U#4BTZ@!OI3B**<: (6Z4B]:D;I35ZT .7O2[32K2Y% $9ZTE/HH 912M
M24 %%%% !2X-*O2EH ;M-&#3J* "FGK3J90 4JBA:=0 4RGT8]J &4HXIU-:
M@!2:;110 44^F4 .6EI%Z4$T %-HHH =2-244 %%%% #Z**90 K"DI5-*>E
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M ZF[:<*7B@!@IX:FM29H ?NIK=*3)I* "G#I3:* %:DHHH **** "G+0M+0
MC=*;3FIM !3J6B@!&IM/I&H ;1110 5(M-HS0 YJCI6-)0 4444 %%.7I0U
M#:*5>M*W2@ STH!IC4+0 ]J;110 4444 (10!3P*"* $%&ZFM29- QU**%IU
M @HHHH9)2OS\IJ[X-_Y",?UJAJ'W35_P9_R$(_K7/,VBS[G^ /W8/PKZ]TG_
M (\8_I7R%\ ?NP?A7U[I/_'C']*\^9V1+E%%%9%C*<M-IRT +1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:**=M% A-M.INZE% "-24YJ;0 ^BBDW4 +24 YI: &M3<FI.M(5H 8*6E]*
M,T )2KUH(I* 'TRGTF!0 BTM%+0 E)DTIZ4V@ R:7)HVT$8H 5:=MI@:G!O>
M@ IE/IE "Y-)110 4444 .P*6DI: &M0O6E:FT /IN31NI* "BBB@ I,4M%
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M4C52^UFD^U$T#+P/(I^:SOM1]*=]J-&@C0W4UJH?;*/M9H O4HJA]K-'VLT
M:&13:H_:S1]K-&@%ZE6J'VLT?:S0!H$TVJ/VPT?:S0!H9%&16?\ ;#1]J- 6
M+[4E4OM1H^U&@"[3LBL_[4:7[4:- +^ZC=6?]K-'VLT: :&ZC(JA]J-)]J-
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M-X-F_N&OK;_A4 _YX_I2-\(/^F/Z4>T#D/DE?!TW]PT__A#9O[A_*OK+_A4
M_P">/Z5(/A"/^>/Z4>T#E/DG_A#9O[AI/^$.F_N&OK8_"$?\\?TIK?"$?\\?
MTH]H'*?)7_"'3?W#2_\ "'3?W#7UG_PJ$?\ /']*4?"$?\\?TH]H+D/DO_A#
M9_[AI?\ A#9O[GZ5]:?\*A'_ #Q_2C_A4(_YX_I1[0?*?)1\&S?W#^5'_"&S
M#^ U];#X0C_GC^E(WPA'_/']*/:"Y3Y*_P"$/F_N&C_A#9O^>9KZS_X5"/\
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M^%0C_GC^E'M1\A\E?\(;-_SS-'_"&S_W#7UK_P *A'_/']*/^%0C_GC^E'M
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M_P">/Z4>T%R'R;_PATW]P_E1_P (;+_</Y5]9K\(1G_4_I3O^%0C_GC^E'M
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MR0?!LW]PT?\ "&S?W#7UM_PJ$?\ /']*0_"$?\\?TI^T%RGR5_PATW]PT?\
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MOK?_ (5"/^>/Z4W_ (5!_P!,?TH]H'(?):^#9O[AI?\ A#9O^>9KZT7X0?\
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M #Q_2C_A4 _YX_I1[0?*?)'_  ATW]RC_A#9O^>9KZV_X5!_TQ_2D_X5"/\
MGC^E/VH<A\E?\(=-_<-'_"'S?W#7UHWPA'_/']*3_A4(_P">/Z4>U%R'R9_P
MA\W]PT?\(;/_ '#7UI_PJ$?\\?TI?^%0C_GC^E'M Y#Y*_X0V;_GF:/^$-F_
MN&OK7_A4(_YX_I1_PJ$?\\?TH]J/D/DK_A#9O[AH_P"$-F_N&OK;_A4(_P">
M/Z4?\*A'_/']*/:BY#Y)_P"$-G_N&C_A#9O[AKZU_P"%0C_GC^E)_P *A'_/
M']*/: X'R7_PALW]PT?\(;-_<-?6O_"H1_SQ_2AOA"/^>/Z4>U#D/DH>#IO[
MA_*E_P"$-F_N?I7UG_PJ$?\ /']*/^%0C_GC^E+V@<A\E_\ "&S_ -PT?\(;
M/_<-?6W_  J$?\\?TI/^%0C_ )X_I1[0?*?)1\'3?W#3?^$.F_N'\J^MF^$(
M_P">/Z4@^#__ $Q_2J]J'*?)7_"&S?W#^5/7P?-_<-?6?_"GQ_SQ_2C_ (5"
M!_RQ_2E[4.4^3?\ A#IO[A_*FMX/F_N&OK3_ (5"/^>/Z4C?"$?\\?TI>T%R
MGR8/!\W]PT[_ (0Z;^X?RKZP'PA&?]3^E._X5"/^>/Z4>T#E/DK_ (0Z;^X:
M</!LW]P_E7UE_P *A'_/']*>OPA&/]3^E'M Y3Y*;P=-_</Y4G_"'3?W#7UJ
MWPB'_/']*3_A4(S_ *G]*/:!RGR7_P (;/\ W#2?\(=-_<-?6W_"H1_SQ_2F
M_P#"H1_SQ_2CV@^0^3/^$-F_N&C_ (0V;^X:^M1\(1_SQ_2AOA"/^>/Z4_:B
MY#Y*_P"$/F_N&C_A#YO[AKZS_P"%0C_GC^E'_"H1_P \?TH]J'(?)G_"&S?\
M\S1_PALW]ROK7_A4(_YX_I1_PJ$?\\?TH]J/D/DK_A#YO[AH_P"$/F_N&OK1
MOA"/^>/Z4?\ "H1_SQ_2CVHN0^2_^$-G_N&C_A#9_P"X:^M?^%0C_GC^E'_"
MH1_SQ_2E[0?*?)7_  ALW_/,T?\ "&S?\\S7UK_PJ$?\\?TH_P"%0C_GC^E/
MVH<A\E?\(;/_ '#1_P (;/\ W#7UK_PJ$?\ /']*/^%0_P#3']*GV@<I\E?\
M(;-_SS-'_"&S?\\S7UK_ ,*A'_/']*/^%0C_ )X_I5>T#D/DK_A#9O\ GF:/
M^$-G_N&OK7_A4(_YX_I1_P *A'_/']*/:!R'R5_PALW]PTG_  ADW]PU];?\
M*A'_ #Q_2C_A4/\ TQ_2CVH<I\E?\(?-_<-!\'S?W#^5?69^$(_YX_I1_P *
MA'_/']*/:ARGR6/!T_\ <-+_ ,(;/_<-?6:_"$9_U/Z4[_A4(_YX_I1[4.4^
M2?\ A#9_[AIW_"&S?W#^5?6G_"H?^F/Z4H^$(_YX_I1[4.4^2_\ A#9O[A_*
MD/@V;^X:^MO^%0C_ )X_I2'X0C_GC^E'M1<A\D_\(;-_<-._X0Z;^X?RKZS_
M .%0C_GC^E)_PJ$?\\?TI>T'RGR;_P (;-_</Y4A\&S?W#^5?6?_  J$?\\?
MTI?^%0C_ )X_I1[07*?)+>#9_P"X:;_PAL_]PU]<?\*@'_/']*/^%/C_ )X_
MI1[0?*?)7_"&S_W#2?\ "'3?W#7UM_PJ$?\ /']*3_A4(_YX_I1[0.4^3!X.
MFQ]P_E0?!LW]P_E7UG_PJ$?\\?TI?^%0C_GC^E'M!<I\E?\ "&S_ -PT[_A#
M9O[A_*OK/_A4(_YX_I3O^%0C_GC^E'M!\I\E?\(;+_</Y4A\&S?W#7UM_P *
MA'_/']*0_"$?\\?TH]H'*?)/_"&S?W#1_P (9-_</Y5];?\ "H1_SQ_2C_A4
M(_YX_I1[0.4^2O\ A#9O[GZ4O_"'3?W#7UK_ ,*A'_/']*/^%0C_ )X_I354
M7*?)+>#YO[AIO_"'S?W#7ULWPA&?]3^E)_PJ ?\ /']*?M0Y#Y*_X0^?^X?R
MH_X0Z;^X:^M?^%/C_GC^E)_PJ$?\\?TH]J'(?)G_  ALW]PT?\(;/_<-?6H^
M$(_YX_I1_P *A'_/']*GV@^4^2O^$-F_N&C_ (0V;_GF:^M?^%0C_GC^E'_"
MH1_SQ_2G[4.0^2?^$.F_N&E_X0^;^X:^L_\ A4(_YX_I1_PJ$?\ /']*7M!<
MA\F?\(?-_<-'_"'3?W#7UG_PJ$?\\?TI5^$(_P">/Z4_:AR'R7_PALW]PT?\
M(;-_SS-?6O\ PJ$?\\?TH_X5"/\ GC^E'M1\A\E?\(;-_<-'_"'3?W#7UI_P
MJ$?\\?TH_P"%0C_GC^E+V@N0^2_^$.F_N&C_ (0V;_GF:^M%^$(_YX_I2_\
M"H1_SQ_2G[4.0^2O^$-G_N&D_P"$.F_N&OK;_A4(_P">/Z4G_"H1_P \?TI>
MT'R'R7_PA\W]PT?\(=-_<-?6?_"H1_SQ_2E7X0C_ )X_I3]J+D/DO_A#9O[A
MH_X0V;_GF:^M?^%0C_GC^E'_  J$?\\?TH]J/D/DK_A#9O\ GF:/^$-G_N&O
MK7_A4(_YX_I1_P *A'_/']*/:AR'R5_PAL_]PT?\(;-_SS-?6O\ PJ$?\\?T
MH_X5"/\ GC^E'M0Y#Y*_X0V;_GF:/^$-F_YYFOK7_A4(_P">/Z4?\*A'_/']
M*/:AR'R5_P (;-_SS-'_  ALW_/,U]:_\*A'_/']*/\ A4(_YX_I1[4.0^2C
MX-FQ_JS3?^$-F_N&OK?_ (5"/^>/Z4G_  I\?\\?TH]J+D/DO_A#9_[AH_X0
MV?\ N&OK7_A4(_YX_I1_PJ$?\\?TI>T'R'R5_P (;-_<-)_PATW]PU]:M\(1
M_P \?TI/^%0#_GC^E'M!<A\E_P#"'S_W#^5+_P (;-_SS-?6G_"GQ_SQ_2E_
MX5"/^>/Z57M0Y#Y*_P"$-F_YYFC_ (0Z;^X:^M?^%0C_ )X_I2-\(1_SQ_2E
M[4.0^2_^$.F_N&C_ (0V;_GF:^M!\(1_SQ_2E_X5"/\ GC^E'M0Y#Y*_X0Z;
M^X:3_A#IO[AKZU/PA'_/']*;_P *A'_/']*7M Y#Y-_X0^;^X:/^$/F_N&OK
M(?"$?\\?TI?^%0C_ )X_I3]J'(?)?_"'3?W#2_\ "&S?W#7UI_PJ ?\ /']*
M7_A4(_YX_I1[4.4^2O\ A#9_[AH_X0V;_GF:^M?^%0C_ )X_I1_PJ$?\\?TH
M]H/D/DK_ (0V;_GF:/\ A#9O^>9KZU_X5"/^>/Z4?\*A'_/']*/:BY#Y*_X0
M^;^X:/\ A#9O[AKZS_X5"/\ GA^E*OPA'_/']*/:AR'R7_PALW_/,TG_  AL
MW]P_E7UO_P *A'_/']*1OA"/^>/Z4>T#E/DG_A#IO[AI?^$.F_N5]9_\*A'_
M #Q_2G?\*A_Z8_I4^U#E/DK_ (0V;^X:3_A#9O[A_*OK;_A4 _YX_I2'X0C_
M )X_I1[4?*?)?_"'S?W#1_PA\W]PU]9_\*A'_/']*</A"/\ GC^E'M1\A\E?
M\(;-_<-'_"'3?W#7UK_PJ ?\\?TI#\(1_P \?TI^T%RGR7_PATW]PT?\(;/_
M '#7UH/A",_ZG]*7_A4(_P">/Z4>T#E/DK_A#9O[AH_X0^;^X:^M3\(1C_4_
MI3?^%0C_ )X_I1[0.4^3/^$-F_N&C_A#9O[AKZV7X0#_ )X_I2GX0#_GC^E+
MVH<I\D?\(;-_<-+_ ,(;-_<_2OK3_A4(_P">/Z4G_"H1_P \?TI^T%R'R9_P
MALW]S]*0^#IO[AKZT_X5"/\ GC^E'_"H1_SQ_2G[0.0^2_\ A#IO[AH_X0V;
M^X:^M%^$(_YX_I3O^%0C_GC^E'M!\I\D_P#"&S_W#1_PALW]ROK;_A4(_P">
M/Z4G_"H1_P \?TH]J'(?)7_"&S?W#1_PAL_]PU]:_P#"H1_SQ_2C_A4(_P">
M/Z4O:!RGR5_PAL_]PT?\(;/_ '#7UK_PJ$?\\?TH_P"%0C_GC^E'M Y3Y*_X
M0V?^X:/^$-G_ +AKZU_X5"/^>/Z4?\*A'_/']*/:!RGR5_PAL_\ <-'_  AL
MW]PU]:_\*A'_ #Q_2C_A4(_YX_I1[0.0^2O^$-F_YYFC_A#9O^>9KZU_X5"/
M^>/Z4?\ "H1_SQ_2G[4.0^2O^$-F_P">9H_X0V?^X:^M?^%0C_GC^E+_ ,*A
M'_/']*/:BY#Y)_X0V?\ N&C_ (0V;^X:^M3\(!_SQ_2C_A3X_P">/Z4_:CY3
MY*_X0V?^X:/^$-F_YYFOK7_A4(_YX_I1_P *A'_/']*7M Y#Y*_X0V;^X:/^
M$-G_ +AKZU_X5#_TQ_2C_A4/_3']*?M0Y3Y*_P"$-G_N&E'@Z;'W#7UI_P *
MA_Z8_I2?\*A'_/']*/:AR'R;_P (=-_</Y4W_A#9O[AKZT_X5"/^>/Z4H^$(
M_P">/Z4O:ARGR5_PAL_]PT?\(;/_ '#7UK_PJ'_IC^E'_"H?^F/Z4_:CY3Y*
M_P"$-F_YYFC_ (0V;_GF:^M?^%0C_GC^E'_"H1_SQ_2E[47(?)7_  ALW_/,
MT?\ "&S_ -PU]:_\*A'_ #Q_2C_A4/\ TQ_2CVH<A\D_\(;/_<-+_P (;/\
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M/^I_2F_\*A'_ #Q_2G[0.4^2_P#A#9O^>9H_X0^;^X:^M?\ A4(_YX_I2?\
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MA'_/']*7_A4(_P">/Z4>U#D/DK_A#IO[E'_"'3?W*^M?^%0C_GC^E'_"H?\
MIC^E+VH^0^2O^$-F_N&C_A#9_P"X:^M?^%0C_GC^E'_"H1_SQ_2CV@<A\D_\
M(;/_ ':/^$/F_N&OK;_A4(_YX_I2'X0C_GC^E'M"7 ^2_P#A#YO[AH_X0^;^
MX:^LO^%0C_GC^E.'PA'_ #Q_2E[4S]F?)?\ PA\W]PT?\(?-_<-?69^$(_YX
M_I1_PJ$?\\?TI.H6H'R!?>#9BOW#^57O"/@Z:.^C)0]?2OJR;X.AE_U/Z5:T
M7X0BWN%/D]_2L)2-5$Z+X$Z.]JL.1CI7UIHJ[;%![5Y#\/?"0TU8_DQ7L=BO
MEVZBL9%I6+5-:DW49K(T"BFTJT@%HHHH ?1115 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^5=K11S,+'$_\(;%_<'Y4H\&Q?\ /,?E7:44<PN4XS_A#8O^>8_*C_A#8O\
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M'Y4?\(;%_P \Q^5=I13YF%CB_P#A#8O^>8_*C_A#8O\ GF/RKM**.9A8XO\
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MRKM:*.9CL<7_ ,(;%_<'Y4G_  AL7]RNVI*.9BL<7_PAD?\ <'Y4O_"&Q?\
M/,?E7:44<S'8XO\ X0V+_GF/RH_X0V+_ )YC\J[2BCF86.*_X0R/^X/RI?\
MA#8O^>8KM**.9A8XG_A#8O[GZ4J^#8O^>8_*NTI:.9BL<7_PAL7_ #S'Y4G_
M  A\7_/,?E7:TE%V.QQG_"'Q?W!^5(?!T7]P?E7:44<S"QQ0\&Q?\\Q^5+_P
MAL7]P?E7:T4<S"QQ/_"&Q?W!^5+_ ,(9'_<'Y5VE+1S,+'$_\(;%_<'Y4O\
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M%_SS'Y5VE%',PL<7_P (;%_SS'Y4G_"&1_W!^5=K11S,+'%?\(9'_<'Y4O\
MPAL7_/,?E7:44<S"QQ?_  AL7_/,?E2?\(=#_P \Q^5=K24<S"QQ?_"'1?\
M/,4?\(9%_<'Y5VE+1S,+'%?\(9'_ '!^5'_"&Q?\\Q^5=K11S,+'%_\ "&Q?
M\\Q^5'_"&Q?\\Q7:44<S"QQ?_"&Q?\\Q1_PAL7_/,?E7:44<S"QQ?_"&Q?\
M/,?E1_PAL7_/,?E7:44<P6.+_P"$-B_YYBF_\(;%_P \Q^5=M24<S%8XK_A#
M8O[GZ4J^#8O^>8_*NTI:.9A8XO\ X0V+_GF/RIO_  AL7]RNVI*.9A8XL>#8
ML?ZL?E2_\(;%_P \Q^5=I11S#L<7_P (;%_SS'Y4?\(;%_SS'Y5VE%',PL<5
M_P (9'_<'Y4G_"&Q?W/TKMJ2CF86.*_X0V+^Y2KX-B_YYC\J[2BCF8K'&?\
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MV+_GF/RKM**.8+'%_P#"&Q?\\Q^5)_PAL7]P?E7:T4<S"QQ7_"'1?\\Q2_\
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MUHHY@L<9_P (;%_SS'Y4W_A#8O\ GF/RKMJ2CF86.+7P;%_SS'Y4O_"&Q?\
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M?E2?\(;%_<'Y5VM%.X6.*_X0V+^X/RI?^$,B_P">8_*NTI:.9A8XG_A#(O\
MGF/RH_X0Z+_GF/RKMJ3 ]*5PL<5_PAT7_/,?E2_\(9'_ '!^5=I@>E+3YF%C
MB_\ A#8O^>8_*D_X0R/^X/RKM:*.9A8XG_A#8O[GZ4J^#8O^>8_*NTHHYF*Q
MQG_"&Q?\\Q^5'_"&Q?\ /,?E7:44<S'8XG_A#8O[E*O@V+_GF/RKM*6CF8K'
M%_\ "&Q?\\Q^5'_"&Q?\\Q7:44<S'8XO_A#8O^>8_*C_ (0V+_GF/RKM**.9
MA8XO_A#8O^>8_*C_ (0V+_GF/RKM**.9A8XO_A#8O^>8_*E_X0Z+_GF/RKLZ
M*.9A8XO_ (0V+_GF/RI/^$.B_P">8_*NUI*.9A8XL>#HO^>8_*E_X0V+_GF/
MRKLZ6CF86.+_ .$-B_YYC\J9_P (;%_SS%=O24<S"QQ2^#(O^>8_*G?\(;%_
MSS'Y5VE%',PL<4W@V+'^K%-_X0V+_GF*[>DHYF%CBO\ A#8O^>8_*C_A#8O[
M@_*NUHHY@L<7_P (;$?X!^5'_"&1_P!P?E7:T4<S"QQ7_"&1_P!P?E2_\(;%
M_P \Q^5=I11S,+'$GP;%_P \Q^5 \&Q?W!^5=K2T<S%8XK_A#(_[@_*C_A#(
M_P"X/RKM:*.9CL<3_P (;%_<I1X-BQ_JQ^5=I2T<S%8XO_A#8O\ GF/RI/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 AZ4VGT4 ,HI]% $6,4Y33MHHQ0 M-)IU%(!*
M6BBF 4445-P"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0$S1NI:*-0"B
MBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC
M4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 H
MHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHH
MU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU *
M***-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****
M-0"BBBC4 HHHHU ****-0"BBB@ HHHH ****-0"BBB@ HHHH *;NIU%&H""E
MHHHU **** "BBBC4 HHHHU ****-0"BBBC4 HHHHU **** "BBB@ HHHH **
M** "BBBC4 I*6F4:@.I::M.HU ****-0"BBBC4 HHI*-0#(HIM.6C4!:***8
M!1112U ****8!1112U ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ***
M*-0"BBBC4 HHHHU ****-0"BBB@ HHHH **** "BBB@ HHHHU **** "BBBC
M4 HHHHU ****-0"DI:*-0$S[44M%&H!1111J 4444:@%%%%&H!1111J 4W=3
MJ*-0$!S2T44:@%%%% !1111J 4E+11J W=3J**-0"BBBC4 HHHI@%%%%( HH
MHH ****-0"BBBC4 HHHI@%%%% !1112U ****-0"BBBC4 HHHHU ****-0"B
MBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC
M4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 H
MHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHH
MU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU *
M***-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****
M-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"
MBBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBB
MC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBB@ HHHHU ****-0"BBB@ HH
MHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU
M ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU **
M**-0"BBBC4 HHHHU ****-0"BBBC4 HHHHU **** "BBBC4!,T9%(W6DHU =
MFEIJ]:=1J 4444:@%%%%&H!1111J 4444:@)1D4-3:-0'T444:@%%%%&H!11
M10 4444 %%%% !1111J 4444:@%%%%&H!1111J 4444 %%%% !1110 4444:
M@%%%%&H!1111J 4444:@%%%%&H!1110 F113:5:8#J***8!1110 AS28-.HH
M ;M-&TTZBD!%MI5I](U "44446 ?1113 **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ IK4ZD(S0 VBEVTNV@!:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%
M%%, HHHH **** "BBB@ HHHH ****0!1113 **** "BBB@ HHHH **** "BB
MBI8!11118 HHHIV ****8!1110 4F!2T4 )BEHHH **** "BBB@ HHHH 3:*
M*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ****0!11118 HHHI@%%%%( HHHI@%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-TIM.I-M
M "TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444W)H =12+2T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%(
M HHHI@%%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% #6I*<1FC;0 M%%% "8HVBEHH 3%+11
M0 4444 %%%% !1110 4444 )1M%+10 4444 %%%% !1112 ****+ %%%%, H
MHHH **** "BBB@ HHHH ****0!11118 HHHI@%%%% !1110 4444 %%%% !1
M110 4444@$VBBEHH ****8!1110 44TFA: %/2DR:6FT &3112@4"$HIVVB@
M8M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1112 0TFZE:FTP'T444 %(32TUJ $W>]+
MNIFVG4 /HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DW4M-;K0 NZEIJ]
M:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3<&G44 (M+110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3=U.
MIE #@<TM-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #2*%%.HH *
M;MIU% #=II5I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** $VBEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BDR** %HHHH ***3(H 6BDI: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*,
MB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH 92K3J:>M #J*:M#4 +NIM(6H'2@!RTM-I5H =1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UJ2G44 +111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M4A- "T4T-2F@ W4PY)I>].H :JFG;?>EHH ;LI<4M% "8HQ1F@'- "T444 %
M%%% !1110 4444 %%%% !1110 444A- "T4W=0&H =1110 4444 %%%% !33
MUIU-(H %IU(!0: %HINZG4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !2-2T4 -'6EI:0\4 (WRKFL35-<33U8EL5+K>JK9V[$G%?/W
MQ/\ B<NGQR@2XZ]Z .X\1?&"+20W[T#'O7F>N?M30:=(0;D#_@5?+GQ&^+$]
MPTHCF/?O7RI\3?B;J,,CLLKCGUH _4;1_P!JJ#4)E07(.?\ :KV#P?\ $Y->
M5") V[WK\.OAW\7=1DU:-&G?[WK7Z0?LV>+)]3AMM[DY H ^[K&X^T1@]:MK
M6'X9D,EHA/I6[0 4444 %%%% "49%(U)0 ^BBB@!,T4C=:%H =29%%-S2 ?2
M8IFZG TP%HI:* $I:83S3NU A:*2EH&%%%% !113&:@!](:9NIRM0*X;:7(H
MW4VD4/HIJTZ@ HHHIB"BBB@ HHI* %I-U&:;2N [(HS3:,T7 =FC--S1FBX#
MLT9IM%%P'9HIN:%HN ^BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8^^;9O.C#^M38KG/!OB*VU31HG\U00.YK=^VP?\ /5/SHW+V)MHHJ'[=;_\
M/9/SH^W6_P#SU7\Z!D]%0?;K?_GLGYTG]H6W_/9?SH$6*8T>:A_M*V_Y[+^=
M']HV_P#SU4T[,5T2>6:<%-1K>0MT<4\3QMT84ACL&DH\Q?6FLVZ@8ZCTIE.6
M@KH/S2TRC)J;DCZ**:>M4 ZF,:<.E1N>M A-U.4U S8-.5J7*3S$A-)0*&HY
M2[A13:*5@YA=U+FHJ7)H:"Y)FG+3%J1:BP[CZ***T0@HHHI@%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTM-DI%K-#L/HHI&K9"%IU1K4BTABTE(U"T .HHHH **** "D;I2T4 ,HIU%
M O2EHHH **** "BBB@!K4E/IK4 )3Z93Z "BBD- "T4W-)0 ^BBB@ HHHH *
M*** &4JTM+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %)FBFT /HI%Z4C4 +2TRGT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M5[BZ%ORQQ7.ZQXVM=/C;=(J\>M,\<:B;"S=P<8%?$_QQ^,UUHK3JDK#&>] '
MMOQ)^)UC);S*)EZ>M? ?[0WBBVOFF*N#U[UQ7C#]HJ_N9Y$\YCSCK7BWC;QY
M>ZXK$EFS0 NBZE$FMJQ88WU]Y_LV^-K6SCMMTBC '>OS'M[Z\AO!)ANN:]K^
M''Q4OM%\L;V7&* /VO\ "?Q(LI+>-1,OYUZ%IOB*"^4;7!K\IOA[\?KV::)#
M*W7UK[,^#GQ"FUE(=SDYQWH ^I5;>M!&*K:7)YME&YZD5;H$,W>](#FAJ%H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UJ=2$4 )3J;MIU !
M1110 4444 %)MI:* $HQFEHH 3;2T44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOS:\,>-VL=F'QCWKT33_ (OO#&!YW;UKRJM)MGJT:UC[X;XK0_\ /8?G3?\
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M.*=F@4ULYH 7%**16IU !1110 4444 %%%% "-3:?10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%)FEH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB@04444 %%%% !136-(K4@'T4F>*:S4 /HIJGI3J8!1110 4444 %%(:3=0
MZBFY-&30 ZFM2BAJ &T^F4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BD-)DT .HHIK4 .I&Z4FXT9S0 E.HVT4 +13"U :E<!]%(#1
M0 M%-W4HI@+1110 4444 %-:G4UJ $I],I<F@!U%-R:,F@!U%-R:,F@!U%-R
M:,F@!U%-R:,F@!U%-R:,F@!U%%% !12-29- #J*;DTZ@ HHIK4 .HIH-.H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HI&I,F@!U%-R:,F@!U%-R:,F@!
MU%-R:,F@!U%-R:,F@!U%(M% "T4W)HR: '44E#4 +13<FC)H =1132: '44U
M:=0 4444 %%%% !1110 4444 %%)NHH 6BBFY- !FE6HZ56H DHI :6@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II-.IIH&&:44VG#
MI0#$VTH&*6B@04E+10 FVBEHH **** "BBB@ HHHH **** "F[J=3* '"@C-
M"TM #=M.HHH KW__ !ZO7SU\8/\ CUG^AKZ$U#_CU?Z5\]_&#_CUG^AH&C\^
M/C!G^U)?]ZN@^ +?\3B#_>%<_P#&#_D*2_[U;_P!_P"0Q!_O"J$?J!\*?^1<
MC^@KM:XGX4_\BW']!7;5(#=M&VEI: $Q2T44 ,D7<I%8E]HXG)^7-;U)@>E
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MW_"\$_Y[?K7Q;_PEMW_?;\Z/^$ONQ_&WYTG1#ZP?:7_"\$_Y[#\Z/^%X1_\
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M J]*&H%#4 -I],I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 (W2FTYNE-H 7=0:2BI 1J%-#4+3 DI":*1J8$;-3=U#-3,_C6,F!*K4_
M/%0IUJPHXJX@1\T]<TZBK 2EHHH **** "D:EHH ;M-&TTZB@!NTT;33J* &
M[31M-.HH ;M-&TTZB@!NTT;33J* &[31M-.HH **** $:DVFG44 -VFG444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** *]_\ \>KU\]_&#_CVG^AK
MZ$O_ /CU>OGOXP?\>T_T- 'Y[_&#_D*2_6M_X _\A>#_ 'A6!\8/^0I+]:W_
M ( _\A>#_>% 'Z?_  I_Y%N/Z"NVKB?A3_R+<?T%=M0 4444 %%%% !1110
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M!]79\Q?\(R_]PTUO#+_W#7U#_P *;D_YX_\ CM(WP:E_YX_I1[9!]79\O?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P ]$_2@?&BS/_+5*_.#_A=%U_SW;\Z4?&BZ_P">Q_.CV O:'Z/_ /"Y[/\
MYZI1_P +GL_^>J5^</\ PNBZ_P">S?G1_P +HNO^>S?G1[ /:'Z/?\+GL_\
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M_P">S?G2]@+VA^CW_"Y[/_GJE'_"Y[/_ )ZI7YP_\+HNO^>Q_.C_ (71=?\
M/4_G3]@'.?H]_P +HL_^>J4G_"Z+/_GJE?G%_P +HNO^>Q_.C_A<US_SV/YT
MO8!SGZ/?\+HLO^>J4O\ PNBS_P">J?I7YP?\+FN?^>S?G2_\+HNO^>[?G1[
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M4I?^%SV?_/5*_.'_ (7-=?\ /8_G1_PN>Z_Y['\Z?L YS]'O^%SV?_/5*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH5_Y8C\J]>HI\PO9H\C;X4P_\\A^51-\)X?^>0_*O8J3 ]*5Q\B/'E^$\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFEJH\WIWKU8+0YJA$MB_'-'V%_4UL #'2D*CTK0YC(^POZT?87]:V-M+L]J
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M"9D_87]32?8G'<UM*HI&0>E2%S&^QO1]C>MCRQ1L%,#'^QO1]C?WK8V"CRZ
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MNCZ5YM3<Z8"T445D:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M21W*_%N?_GL?SI__  MJ;_GL?SKS_P#X0R]_N-2_\(;>X^XU1:)T>VFCO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[)X>;]VM>0>%5&Y*]=T#_5K0C'J=+GBD[TWM0&IE#@OM2T44#%HHHH ****
M"BBB@ HHI* %HI,TM !129%% "T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M %>__P"/5Z^>_C!_QZS_ $-?0E__ ,>KU\]_&#_CVG^AH _/;XP?\A27_>K>
M^ /_ "&(/]X5A?&#_D*2_6M_X _\A>#_ 'A0!^G_ ,*/^1;B^@KMJXGX4_\
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MM.H 93EIM% #LT4VB@!]%%% !1110 4444 %%%%)@%%-:DI(!]%%%4 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2OHNOG3]G_\ X]H/I7T77F3W.V(M%%%9E!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %>__P"/5Z^>_C!_Q[3_ $-?0E__ ,>KU\]_
M&#_CVG^AH _/?XP?\A27ZUO_  !_Y"\'^\*P/C!_R%)?K6_\ ?\ D+P?[PH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%+MHVT )1110 X=*"*%Z4-TI@-HHHI %-I^VFLM "KTI],%*&H =28I:3=0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLBC(IM% #Z*1>E#=*  FDW4UJ;0!+28IH-.#4 )MS1LIVZC=0(;M]J7;3J*
M$'%+110,**** &[31M-.HH 85H"T^B@!*6BB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@!0:":;10 44F12T /IK4ZFM0 E*!0M.H ;NI*7;1B@!,4Y:%I: "F[:=10
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 5[_ /X]7KY[^,'_ ![3_0U]
M"7__ !ZO7SW\8/\ CVG^AH _/?XP?\A27ZUO_ '_ )"\'^\*P/C!_P A27ZU
MO_ '_D+P?[PH _3_ .%/_(MQ_05VU<3\*?\ D6X_H*[:@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@!*<M*JTI&* &MTIM*U)0 44ZFT %.7M0!2=* 'L149ZTFZEH *<O2C H/%
M W2FTN:2@ HIVT4;10 VD:GX%&* (Z=2[:2@ HHHH *5:%I: '8%(:7=3-U
M#J1J%H:@!M%**4B@ I&IK-3ASB@!**D"TC+0 RG4VG#I0 M(U+10 RBG'I3:
M "E I:6@!K4E*U)0 ^BFK3UH 8W6DI["FM0 #K3J92Y- #J:W6C)I<4 -I5H
M:D% #Z93Z3 H ;112K0 +3J3I29- "44ZC H 8U)FG,M)MH 6BBG8%, H:EI
MK55B1****R904Y>E&!2T)B844458C,U+O74?#7_D)1?6N7U+O74?#7_D)1?[
MU83V-H;GZ'_L_P#_ ![0?2OHNOG3]G__ (]H/I7T77F3W.V(M%%%9E!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>_P#^/5Z^>_C!
M_P >T_T-?0E__P >KU\]_&#_ (]I_H: /SW^,'_(4E^M;_P!_P"0O!_O"L#X
MP?\ (4E^M;_P!_Y"\'^\* /T_P#A3_R+<?T%=M7$_"G_ )%N/Z"NVH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M24 -I=U)2;J ';J-U(** %W4E%+M- !NHW4E)DT .^]1MH6EH ;3@U)M-)0
M_/2DQFA>E+0 TBDIQI-M "4X=*;3EZ4 &,TA&*=2-0 FZEI@:GB@ VTGW:6C
M[U ";J2EQ24 +NHW4E+@T &:044HZT +MI:**8!1115=!#<<TNVEI=M9L8E%
M+MI*A"8444NVM^@C+U+O74_#7_D)1?6N6U(=:ZGX:_\ (2B^M<\S:&Y^AW[/
M_P#Q[0?2OHROG3X ?\>T'T%?1=>7/<[8[!1116904444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!7O\ _CU>OGOXP?\ 'M/]#7T)?_\
M'J]?/?Q@_P"/:?Z&@#\]_C!_R%)?K6_\ ?\ D+P?[PK ^,'_ "%)?K6_\ ?^
M0O!_O"@#]/\ X4_\BW']!7;5Q/PI_P"1;C^@KMJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%% !1110 RE6G44 %%%% !1110 4C4M% #*=2T4P"BBBD 4E+10 RG+2T4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYXK:>L'P5_R!X_H*WV&:^?D?01V&[J7<:8W%*&I1*'Y- /-,W4JM5 24444
M%%%%( HHHI@%%%% !1110 4444 %%%% !1112U ****8"-3<FG$9I#Q2 -U)
MFFY-.I &:7=2450#@<TM-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME/2FU0QRT4JBEQQ5"&D4VG4;: "C%+14@-:A>M+BC% "TVG4FV@!M%.VT;:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH KW_\ QZO7SW\8/^/:?Z&OH2__
M ./5Z^>_C!_Q[3_0T ?GO\8/^0I+]:W_ ( _\A>#_>%8'Q@_Y"DOUK?^ /\
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M IU%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU-?=_P 8/]1-]#7PA\7O]=-]37KT&V?/8A'DOAEO^)NO^]7WS^S.I;[-^%?
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M\E^IKS2V_P!=7K1V..1IT4451F%.IM/H C:A:?BC% #E[T$4F:-U #6I***
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBBD 4444 ,I0,T;32@8I@%#4M(: (BM+LI^VG4@(MM.%.(S2$8HL
M4E%+MH2L ZD;E312TP.?UC3_ +0IXKAM6\*><Q^2O5)(@W6JTFGH_:@#Q2;P
M+N8_)^E,7P'Z1_I7M7]D1_W:3^QX_P"[0!XL? ?^Q^E"^ _]C]*]I_L>/^[2
M_P!D1_W:0'CD?@/C_5_I6;JW@W[.A.S'X5[RNEQ*.@KG/%FFQI;L0.U4@/F;
M7+7[*S#%8=G)FX'UKKO'$?ERO7$V+?Z5^-5:Y43U3PGT2N]*_P"B'Z5P7A/[
MJ5Z N/LI^E"AJ*;NCP7XPQ_N)?H:^$/BU'FXF'N:^]?C$/\ 1YOH:^#OBO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O?_P#'J]?/?Q@_X]I_H:^A
M+_\ X]7KY[^,'_'M/]#0!^>_Q@_Y"DOUK?\ @#_R%X/]X5@?&#_D*2_6M_X
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M\/SKYJ/QGA_Y[C\Z0_&>'_GN/SJ?8R'[='TK_;B?WOUH_MQ/[U?-/_"YH?\
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M=4:U)6B ****8@HHHH 2C(H:FT /HI*6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4U/VJ7CO7WQ\5=/+6\IQV-?$'Q4TT_:I?E[UM19G4/.O!6?[13_>K[9^!_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH KW_ /QZO7SW\8/^/6?Z&OH/4/\ CU?Z5\]?& _Z+/\ 0T ?
MGQ\8/^0I+_O5O? '_D,0?[PKG_C ?^)I+_O5T'P!_P"0Q!_O"@#]0?A1_P B
MW']!7;5Q/PH_Y%N+Z"NVH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *2EHH 3:*6BBD 4F*6BF F*6D--+4 /HJ/=2AJ 'T4
MW)I* %'-*12"EJ0(VH6GE:3&*=@"BBBF(**,45(7'#I12;J-QJACJYWQ=_QY
MM]*Z*N=\8*39M]*-P/FSQXP\]_J:X2%@)*[?Q]"YG? [UP45O)YAX-+EL2]3
MH+;4?)4<U=77CMQNKG?L\N!P:06\WH:R;9:@:.HS"]4@\UR>H>%8[QB2N:Z.
M&&3N*N1H .16L*CB<M2)P$?@.,-]P5JZ?X&C:0#9^E=:NP'I6AI\B>:*V51M
MA&C=&KX.^&L5QL_=#\J[F[^$L(M2?*'3TK7^'\D9V9 KU"Z$;6)P!TJO:.X>
MQ5CX<^+'@**PCE(0#KVKXZ^(UJEG-*.F":_0SXY6^Z*?:OK7Y]_%NQF-U/M4
M]37KX;WCR<1%1/&9KA?M'6NBT7Q!_9^TAL8KD9M.N3<'Y6ZU/_9MUY?"M71)
M:GG<QZ]I_P 6'LT $I_.KS?&B0_\MC^=>%2:;>YZ-3/[-OO1JW486#VDCW;_
M (7-+_SV/YT?\+FD_P">Q_.O"#I]]Z-2?V??>C4<D!>TF>\#XS2_\]C^=._X
M7)+_ ,]C^=>#+IU]G^*G?V??>C4N2 _:3/=_^%R2_P#/8_G2?\+DE_Y['\Z\
M)_L^^]&H_L^^]&HY("]I,]U/QDD_Y['\Z4?&63_GL?SKPC^SK[T:E&GWP[-3
MY(![29[Q_P +DD_Y[?K2?\+DE/\ RV_6O"#IU_V#4L>GWP;D-2Y(![61[K)\
M79F4XE/YU07XNW'G@>:>OK7E4=K<*OS9%5/(E^T#K2E15M"XU6?7'PU^)TUU
M<1 RD\^M?9?PJ\1->1Q9;.0*_.'X3QR"ZAR3UK[V^"^X1PY/I7C5Z=CV*%2Y
M]7:%)YD*GVK5(S6%X9;_ $=,^E;U>9RV/53&A>33J**+#"BBBF 4444 )1M%
M+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %;4/^/5_I7SU\8!
M_HTWT-?0U_\ \>KU\]_&#_CVG^AH _/7XP+_ ,327ZUT'P!'_$W@_P!X5@_&
M#_D*2_6M_P" /_(7@_WA0!^G_P *?^1;C^@KMJXGX4_\BW']!7;4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2)VG(JY:ZL]LPP:RDN8M:'W+X0^+\<<2!IOUKT2Q^,%JR#,J_G7Y[V'C:>W
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M!N<4$T-UI*8!1111<!U&:6FM2 -U'WJ ,TH&* $VTE.S3,B@!VVC[M*O2AJ
M#=0U(HYIV* (FZTJTXTE !2CFDI5H -M+NI:90 X4M(M+VK7H2PI#2T5C(:$
MVTY:2BI0,4FFGI2T8-:]!&5J-=3\,_\ D)1?6N7U*NH^&G_(2B^M<TS:!^B'
M[/\ _P >\'TKZ+KYT_9__P"/>#Z5]%UYL]SMCL+1116904444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!7O_ /CU>OGOXP?\>T_T-?0E
M_P#\>KU\]_&#_CVG^AH _/?XP?\ (4E^M;_P!_Y"\'^\*P/C!_R%)?K6_P#
M'_D+P?[PH _3_P"%/_(MQ_05VU<3\*?^1;C^@KMJ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1NE-IS=*;0 4445+
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MEJ QEJ,QU*U-(S3 C^[3O-([T,M1[#0!)YN>]'WJ:L=/"T 'ETH7%.7O2[:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%(3BC=0 M%%% !1110 4444 5[_P#X]7KY[^,'_'M/]#7T)?\ _'J]
M?/?Q@_X]9_H: /SW^,'_ "%)?K6_\ ?^0O!_O"N?^,!_XFDO^]6_\ 6_XG$'
M^\* /U ^%/\ R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*^BZ^=/V?_\ CV@^E?1=>9/<[8BT445F4%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TUNM !NI
M0:CI5H DHHHH **** "BDI#Q0 ZBBB@ HHI&Z4 &12;J2F-G% #]U&ZH6:E7
MYL4 3@YI::%IU !1124 +1124 %&ZFTF>: )**910(5J2E6G4#"BBB@ HHHH
M **** *]_P#\>KU\]_&#_CUG^AKZ$O\ _CU>OGOXP?\ 'M/]#0!^>WQ@_P"0
MI+_O5O? '_D,0?[PK"^,'_(4E^M;_P  ?^0O!_O"@#]/_A1_R+<?T%=M7$_"
MG_D6X_H*[:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** ,_5X_,@Q[5Y5XJT!KAGPN:]AFC\Q<5F76BI<9R
MM 'S??>"Y'8_)^E4?^$'DW?ZO]*^CW\)QM_!4?\ PA\6?N4 ?/*^!Y,?ZO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_& ?\327_>K?^ *_\3B#_>% 'Z@?"C_D6X_H*[:N)^%/_(MQ_05VU !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'2@!:92[J2@!R]*1J4=*1J $HI12[10 W-%%% "K3J:#BC=0 K=*9@4[=24
M%%+MHVT "TZD^[2;J $HIVVC;0 BTM)]VC=0 M-I=U+M%  .E&!12T --)3F
MIM "CK3UIN*<#0 UN]-J3J*0K0 RC-.VT;: &T4[:*-M #:44C=Z13S0 ^DS
M2BD/6@!5H:A:&Z4 (&I^ZHZ7)H &I*** "E%"TN* #:*;3Z3;0 +3AR*9]VG
M*U "[:;3MU)0 4UA3J:W6@!,44JTN!0 VG8%-I=U  U)BE-"T (HYI])2;J
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 FZF[O>E/6F[: 'AJ6F+VI] #&7"DUS7B#Q$FFP
MN2V,5T-Y*(;=V/I7S9\:O'7]EP3XDQ@'O0+J9?Q.^,T>GI(!-C\:^7/&WQ\=
MIW"SG\Z\Z^+'Q2FNKJ5%E)Y/>O)[2.]\0W/R[FW&@9Z[-\:KJ8G$K?G4%O\
M&JZCF&96'XUEZ#\([^^A5O*8Y'I4'B#X37^FQLYB88'I0![3X&^/SQS1AY\?
MC7U/\,_C+'J2Q S9S[U^5=U<WGA^\P2RX->U?!KXJ30W<*-*1R.] 'ZW^'=<
M34H5(;.16]7SQ\&_'7]H6T.9,Y [U[[8W0N8U(.>* +5-/-.IH^]0 ;?:C.U
M233JHZM=?9;5FZ<4 8_BCQ#'IMNY+XP*^9/BI\;H]+,JB?&,]ZZ'XT_$$Z?:
MS /C@]Z_.WXS?%">\OID64\D]Z /5?%7[0KSSNJSD\^M<7<_&2[G;(D;'UKQ
M'PW;7OB*^&"S;C7NOAOX(WNH62R>4QX]* *\?QFNH.3(P_&NG\,_M R1S*&G
M(_&N8\5?!.^TVT9_*8<9Z5X=KUK>>'KIL[EVF@#](_AI\<DOC$#/G\:^G/!O
MC!-4ACP^<^]?CU\*OB-<6U[$AE/7UK]!O@/XT?4(K<%\].] 'V!"_F1AJ4^M
M5=)D\VPB;U%6VH *:RTH.*&[4 -"TX"A:=0 4444 %%%% !1110!7O\ _CU>
MOGOXP?\ 'M/]#7T)?_\ 'J]?/?Q@_P"/:?Z&@#\^/C!_R%)?K6_\ E_XF\'^
M\*P/B_\ \A27_>KH/@'_ ,A>#_>% 'Z??"G_ )%R/Z"NUKBOA3_R+D?T'\J[
M6@ HI,T4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY<8;-7%;<N17A?@7XD+J[(!)G/O7M>ES_:+57]:PE'E.R,N8MT445)04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 C=*;3CTIM !1114L!5IU-6G4( HHHJ@$_BI:3
M^*EJ0*&I?ZEOI7S[\8C_ *+-]#7T#J/^J;Z5\^?&'_CWF^AK>EN1(^%_BC_Q
M^2_4UYG:C]Y7IGQ0_P"/R7ZFO-+;_6_C7K1V..1IJORBEVFA3\M+FJ,Q-M.H
MHH 3-%-I5H =2;J*;0 [=3:*7!H  :7=3:* "BBB@!=M!&*44-0 VBBEVF@
MW4ZFX-+0 4A-*U-H ***6@!RBAEH!I<\4 ,Z4N10U-H 7;2=*=FD- #2U :A
MJ1>M #J*** '4M)1F@ :FTYJ;B@!]%%% #6%)BGTC4 -IV128-)0 ^DS2;J"
M<T !-)110 [(I:CW4_- #LT9IC4+0 ZDR**;0 [(HIM.44 (1UI M/I,\T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %-YIU% "+1M%#4F30 ZBBD;A30!B^*+S[/ITASC@U\!?M->+FM_
MM2A\=>]?;7Q"U#R=.F&>QK\UOVH=6+W%R-W<T ?,&J:D^L:T5W%LM_6OICX!
M_#%-8:!GBW9QVKY?\(V_VWQ F>?GK](/V9?#ZK:VS;1T% 'MG@7X&V?V&,M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,HHHJ6 JTZFK3J$
M44450"?Q4M)_%2U(&?J'^I>OGSXP_P#'O-]#7T'J/^J;Z5\^?&'_ (]YOH:W
MI;D2/ACXH?\ 'W+]37F=O_K#7I?Q0_X_)?K7F=M_K37KQV..1IKT%.'6E0=*
M4BJ,Q*6F4Y>E%@$;K24ZD:BP O6G4REHL ZBBFGK18!U(W2A:&Z46 ;113Z
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MF7J5=3\-?^0E%]:Y;4JZGX:_\A*+ZUSU#:&Y^A_[/_\ Q[0?2OHNOG3]G_\
MX]H/I7T77F3W.V(M%%%9E!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** &4445+ 5:=35IU" ****H!/XJ6D_BI:D"AJ7^I;Z5\^_&(
M?Z+-]#7T%J/^I;Z5\^_&+_CUF^AK>EN1+8^%?BA_Q^2_6O-+;_6FO3/B@/\
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M,-(LE)XP* .\:15Y)Q4?VJ/.-PKR+Q1\6(-+W R@8]ZY*U^.UM+<!//7KZT
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M@.XG236OD_O5]??LTJ[7%M]10!^G7@>\-UIB$G.5%=-7%_#=2NDQ9_NBNTH
M***:U "M3:<O2FM0 UFI5ZU'S3UH >WW37+^(M+^V1,,9KIZ9);K(N#0!\Y^
M,OAU]O9SY><^U>6ZA\$_-E8^1G\*^T9]!MY_O ?E54^$;-NJC\J /BFY^!^V
M$GR/TKR_QW\)_L<,A\K'X5^D%WX-M'MW"H,X]*\$^+GA.&&VFP@'![4 ?F#X
MN\-_V?J1&W&#7MG[.K>7J4 ]Q7*_%K34M]4EP,?-73_ $[=6@_WA0!^H'PM;
M=X=C^@KLZXKX5?\ (N1_05VM !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*M.IJTZA %%%%4 G\5+2?Q4M2!GZA_J7KY\^,7_'O-]#7T'J/^I>OGSXQ?\
M'M-]#6]+<B1\+_% _P"F2_6O-;7_ %A^M>D_%#_C\E^M>;6O^L->M'8Y)FFH
MZ4M%+09#=M)3J;3 <M+35IV*8"&DVT_;24K@%-(IU%%P$ I:**+@%%%% !11
M13 0TFVG44@&[:7;[4M.HN PK2;33VI*8#<&G444 -(HVFEI: &@4ZBB@!NZ
MEW4VBA@.H- Z4M(!NTT;:=10 W;2BEI*+@+1244P&TW::?@TE( 5:7;2K2T
M-VT_;24Z@!M-(I[4E #0*=113 *=N%-HI7 5J2BB@!&Z4VG'I3:8#A01FA>E
M+0 W%)3C28-2 E.'2FTX50"T444 %%%%"8!1110 4444@"BBBBX#2*4"EHHN
M 4AI:*+@,*TFVI=M(>*0#%6E IU%.X!1111< I0:2BF I;BF;J5NE-H =2$4
MM+0 W;1M-.I*0";31MIU%,!!3@U)12 4FF;:=10 FWVH*T^D:D S::3%/I&J
M@&TNVDIU !2-3J0B@!M+MH IU3< HHHI@%%%%, INTTZBBX"4M%%5T)$:FTY
MNE-K%E!3EIM.6B*!CUZ44@Z4M:]"3*U(UU'PU;_B91?[PKEM3[UT_P -?^0I
M%]16$S:!^B/[/[?Z-!]!7T77SG^S_P#\>T'T%?1E>9/<[8["T445F4%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 44C4V@!]%%% !3&[T^D:@!JM3LTVB@!]%)2T %(W2D8TS=0 ZG+TJ,=
M:?NH =2;A3:* ';J:33L8%-H$-[T\-24V@HDR*-PIHI2,4"%R*,BF%J!0 ^E
MI%Z4M !1110 4444 %%%% !1110 4444 %%%% %>_P#^/5Z^>_C!_P >T_T-
M?0E__P >KU\]_&#_ (]I_H: /SW^,'_(4E^M;_P!_P"0O!_O"L#XP?\ (4E^
MM;_P!_Y"\'^\* /T_P#A3_R+<?T%=M7$_"G_ )%N/Z"NVH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M $;I3:<W2FT %%%%2P%6G4U:=0@"BBBJ 3^*EI/XJ6I S]2_U3?2OGSXQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% %>_P#^/5Z^>_C!_P >T_T-?0E_
M_P >KU\]_&#_ (]I_H: /SW^,'_(4E^M;_P!_P"0O!_O"L#XP?\ (4E^M;_P
M!_Y"\'^\* /T_P#A3_R+<?T%=M7$_"G_ )%N/Z"NVH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3&::T*-U6GT4
M026<3HP*#I7E?CZSCC#X%>L2MMC8^U>3^/I"P>@#PO7 %N&^M5['[PJ;7?\
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M'-?4GPW^)T6GQ19E Q[UY>(IW/:P]3E/O>SU"-K=/F'2HYM2CW_>KYRL_CC
ML 'V@=/6D_X7; \G^O'YUY?LV>BJMSZ4BOD<?>J42!^AKPWP_P#%**^=0)0<
M^]>K>'M6&H(I!SFLFK'1&5SH%6GBBC^*I+%HHHH **** $HR*1J2@!]%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 )3&@C?JH-244 56TVV;K$IIO\
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M_*K=%,"I_95I_P \5_*C^RK3_GBOY5;HH J?V5:?\\5_*C^RK3_GBOY5;HH
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MZ* (XX$C^ZN*DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** *]_P#\>KU\]_&#_CVG^AKZ$O\ _CU>OGOXP?\ 'M/]#0!^
M>_Q@_P"0I+]:W_@#_P A>#_>%8'Q@_Y"DOUK?^ /_(7@_P!X4 ?I_P#"G_D6
MX_H*[:N)^%/_ "+<?T%=M0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% #6HH:DH ?1110 R;_5-]*\F\>KP]>LS?ZIOI7DW
MCQOOT >&:XO^D-]:RT?8:U]:_P"/AOK6+-\M '5^&[_;(O->U^#]0W*G-?/>
MAS%9ASWKVGP3,6$?- 'L5G)YD8-6:S],;]RM:% !1110 RE6EVT8H 6BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"O?_\ 'J]?/?Q@_P"/:?Z&OH2_
M_P"/5Z^>_C!_Q[3_ $- 'Y[_ !@_Y"DOUK?^ /\ R%X/]X5@?&#_ )"DOUK?
M^ /_ "%X/]X4 ?I_\*?^1;C^@KMJXGX4_P#(MQ_05VU !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4FZEIM !]ZC;0M.H ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH KW_ /QZO7SW\8/^/:?Z&OH2_P#^/5Z^>_C!_P >
MT_T- 'Y[_&#_ )"DOUK?^ /_ "%X/]X5@?&#_D*2_6M_X _\A>#_ 'A0!^G_
M ,*?^1;C^@KMJXGX4_\ (MQ_05VU !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ5A:AHI@[4 <]YS5+9S-YR\]Z6:#RZ;9C]^OUH ]=\ R%I(Z]UTG_CS2O"?
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M: )**** "DI::QI7 7-&:;FBBZ ?124M, HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K
MW_\ QZO7SW\8/^/:?Z&OH2__ ./5Z^>_C!_Q[3_0T ?GO\8/^0I+]:W_ ( _
M\A>#_>%8'Q@_Y"DOUK?^ /\ R%X/]X4 ?I_\*?\ D6X_H*[:N)^%/_(MQ_05
MVU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !24M% !363=3J* ,^XTM9\Y%9\GA:*0Y*BN@HH YT>$XA_"M+_P (
MK%_=6NAHH Y[_A%(O[JTO_"*Q?W17044 <;K'A>..$D*.E>5^*M+6'=@5[MK
M#A;4@UXUXTD'ST >2:DFUVK/LS_I"_6M'5F_>-]:SK/_ (^!0!Z_\/U)=*]U
MTM=MFE>&_#Z159,U[GI\R-:)@CI0!;HIN]?44;AZT .I&HW4A- "4ZFT^@ H
MII-*M "T444 ,/>HB34^VHMM,EC5SFGK2JM.Q38(2BBBLR@ YI2,"A:5ONGZ
M4T!A:OJ0M48DXKR3QOXFB>-U9A^==EXZNVAADP>U?+_Q%\13PM( QKIAH<\T
M<9\4+NWN5F.1FOECQI&GGR;?6O5/&'B"XN6<9)KR[4[">^D8E2:]"G-GGSIH
MXNWA_??C726,(P*:GAV6-L[36E;V#Q*,BM>9&:B6[>Z-N 0:EE\736B_*Y%5
MWA^7FLV\L3)FMHI,JS-_2_B;=0S#]ZW7UKV_X<_%B7?&&E/YU\PKI!1\BNI\
M.7$UE,NTD8K.I35M#6+/T+\&?$I;B*,&7/XU[!X<\3+>!<-G-? _@/Q+<JT8
MW-VKZB^&NKS3B+<37C5*=CMIGT=92><@-6F%97A^0R6P)]*UZYTK'20LM'(I
M["F58"[J4'FDIZK2$*M#4G2FDTF C4E+2JM06/6EI*0FK(%)J-NM*333G-0T
MV(;3Q30M/QBIU*'K2U%DTH:M%<"2BFY-&35"'4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O_
M /CU>OGOXP?\>T_T-?0E_P#\>KU\]_&#_CVG^AH _/?XP?\ (4E^M;_P!_Y"
M\'^\*P/C!_R%)?K6_P# '_D+P?[PH _3_P"%/_(MQ_05VU<3\*?^1;C^@KMJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***2@!-U**;3EH 6BBB@#)UW/D'Z5XUXRSEZ]FUS_4GZ
M5XUXR/+T >4ZJOSM]:S+=MLPK4U;/F-6,K%9* /2?">K"U9.<5Z?8^,EC@ W
M_K7@%C?M#C!K67Q \:XW'\Z />(/&"R-C?6]I^L"XQS7SQIGB-VF'S5ZCX5U
M(S;,F@#U&&3>N:F K/T]]T8K17I0(0\4ZFM2T#$(I0,4M% !1110 4FVEHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &5KG^I
M/TKQOQ@N=]>T:O'YD)'M7EWB?26F+X6@#Q754.\UC-&=U=_J/AN1F/RUEMX7
MD&3L_2@#FX\K3)IBO>MJZT=K<'*UA7R^7D&@"[H\Y,XY[U[+X)D)$=>+:( 9
MEKVKP0OW* /6]+SY*UJKTK,TI?W*UJ4 -:G4RG+0 M%%-:@!U%,HH ?1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 5[_\ X]7KY[^,'_'M/]#7
MT)?_ /'J]?/?Q@_X]I_H: /SW^,'_(4E^M;_ , ?^0O!_O"L#XP?\A27ZUO_
M  !_Y"\'^\* /T_^%/\ R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQK3C^(4PQ^]/YUPRI)GJ1Q2L?<4WQQ 7_7?K56/XZ#S,>?\ K7Q/-\1)]O\
MK3^=4X_B)/YP_>GKZU@Z(OK1^AWA_P", NI%'F_K7K?A;Q<-05/GSFOS?\!^
M/II+B,&0]?6OKGX3>)&NEBR^>E<\J?*==*MS'U;I\OG1@U99<5D>&9O.M%.>
MU;1Z5RR/03(>:3D]J=2KBLRF1,M,Y%6=H-1R+@UHC(%;BG;J@W4Y3FF78G5J
M?3$6I*0";12TW=2T +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 5[__ (]7KY[^,'_'M/\ 0U]"7_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!7O_\ CU>OGOXP?\>T_P!#7T)?_P#'J]?/?Q@_X]I_H: /
MSW^,'_(4E^M;_P  ?^0O!_O"L#XP?\A27ZUO_ '_ )"\'^\* /T_^%/_ "+<
M?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"\
M_P!2U3U%<KNA- 'DGCU2RO7A&O0G[0WUKZ)\8V)F5^*\>UGP^\D[?+WH X>W
MA-6/+9:Z2'PW(/X:E_X1M_[M '+B-J7:174?\(Z^/N&J5UH[P@Y7% &!(Q%/
MM9#N'-+>1&,FH;?.\4 =SX9F/F+S7M?A%MRK7AOAG_6+7M_@_P"ZE 'H"?=%
M#"A/NBAJ (\\U(IZ4W;2CB@!]%(M+0 444S- #Z*9FG+0 M%%% !1110 UJ:
M:<U-:@!NT444[;0(;2]Z7;1BI8Q&-02+OR*F:FJM2KB,/4O#J7ZD,N<UR&I?
M".VOF):$'/M7J*CBG5NI-&?LTSQ5O@5:9SY"_E3O^%'VH_Y8#\J]HHI^T8O9
M1/)K7X(V2IS$H^HKB/B?\';6STV2185QMZXKZ0KC/BEAO#LHQDX-.,W<SE1C
M;0_)KXYZ/'I-W,JKMP37S\E\%NB,]Z^H_P!I+2Y9KVX*J>IKY5;1+@7C?*W6
MO:HRT/#KT]3J;'6?LX!#5O6?Q$DT_&V3&/>N,CT>X*CY34%SH-TRG"M74[-'
M"DTSTV+XX7%OP)R/QJ?_ (7Q<M_R\'\Z\7E\,WC-T:B/PO>CLU<THQ.N,Y)'
MMJ?'*Y;_ );G\Z?_ ,+LNF_Y;G\Z\87P[=Q]0U2KI4\8YS0J:9$JLCT_4/C=
M=HW^O;\Z[7X:?&.ZO+Z-3,3SZU\R:G9R!N2:] ^$=G(-2BZ]:BI321=*L[GZ
MH_!'Q-)J5M 6;.0*^E=/;?;J?:ODC]G>W<6EO]!7UOIJE;5,^E>145F?1TI<
MT2U112$5B;#<TX=*3;3J "BBB@!&Z4VGTF!0 4M-W4NZ@!:*3=1NH 6BDW44
M +1110 4444 %%%% !1110 44AIK-0 ^BF!J<M "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_.+X5?&"/1(809@N,=Z]SL_VEH8X57[2O3^]7@5:4G+0^AHUXI6/JVBOEO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTKZV M$XI-U1AO,Y%+S6HF3 TY:B7-2K0"'4444#"BBB@ I*1J2@!])3:?0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 5[_ /X]7KY[^,'_ ![3_0U]"7__ !ZO7SW\8/\
MCVG^AH _/?XP?\A27ZUO_ '_ )"\'^\*P/C!_P A27ZUO_ '_D+P?[PH _3_
M .%/_(MQ_05VU<3\*?\ D6X_H*[:@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KS_P =_P"K>O0*X?QG;F1'P* /G?Q-&3,WUKG?
M*-=YK^E,\S?+WKGI=)=<_+0!B<J*2.4B3K5FZMS&#FJ"M^]H [/PY,?,7FO8
M?"K%E2O&/#9/F)7LWA+[J4 >E:>/W=7*J:?_ *L?2K= !12$T@:@!U%%% !1
M110 4444 %%%% !112&@!:3;2;J=0 E+12$T +12;J6@ HHINZ@!U%(#FEH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M*]__ ,>KU\]_&#_CVG^AKZ$O_P#CU>OGOXP?\>T_T- 'Y[_&#_D*2_6M_P"
M/_(7@_WA6!\8/^0I+]:W_@#_ ,A>#_>% 'Z?_"G_ )%N/Z"NVKB?A3_R+<?T
M%=M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UJ4
M&C%&,4 +65XBDVV+#VK5K&\2?\>A^E 'SK\1#NDD^M>7(O\ I/XUZEX_'[R2
MO--H$Y^M '7^')1&4R:]?\*ZJD83)KPW3[OR<<UTNG^)C;@?-0!]*6.N0-"
MS?K5G^VK?^]7S]#X\:-?OU)_PL!_[] 'OO\ ;5O_ 'OUH_MFW_O?K7@8^(#?
M\]/UH/Q ;_GI^M 'OG]M6_\ >H_MJW_O5X%_PL!_[]'_  L!_P"_0![[_;-O
M_>_6C^VK?^]^M>!_\+ ;_GI^M!^(#?\ /3]: /?/[:M_[U']M6_][]:\"_X6
M W_/3]:5?B W]^@#WO\ MJW_ +WZT?VU;_WOUKP;_A/F_O\ ZTUO'[8^_P#K
M0![W_;5M_>_6GKJD+\ U\]K\0G+XW_K73Z%XO:Z9?FH ]B6X$G0U+UKG='OC
M.JG-=#'\RT /Q1BEHH :U)3J-M "T444 %%%% !49IS5&S4 +3QUJ+<:=NH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "DI:* $I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"O?_\ 'J]?/?Q@_P"/:?Z&OH2__P"/5Z^>_C!_Q[3_ $-
M'Y[_ !@_Y"DOUK?^ /\ R%X/]X5@?&#_ )"DOUK?^ /_ "%X/]X4 ?I_\*?^
M1;C^@KMJXGX4_P#(MQ_05VU !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"O?\ _'J]?/?Q@_X]I_H:^A+_ /X]7KY[^,'_ ![3_0T ?GO\8/\
MD*2_6M_X _\ (7@_WA6!\8/^0I+]:W_@#_R%X/\ >% 'Z?\ PI_Y%N/Z"NVK
MB?A3_P BW']!7;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(U4 9I:93J %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HI&IM*X#Z*911<!]%(M+3 **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **:6H#4 .HHHH ****
M "BBB@ HHHH **** "BBB@ HINZE!H 6BBB@ HHHH **** "BBB@ HHHH **
M*2@!:*;NHW4 .HI!2T %%%% %>__ ./5Z^>_C!_Q[3_0U]"7_P#QZO7SW\8/
M^/:?Z&@#\]_C!_R%)?K6_P# '_D+P?[PK ^,'_(4E^M;_P  ?^0O!_O"@#]/
M_A3_ ,BW']!7;5Q/PI_Y%N/Z"NVH **2EH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 44FZDW4 .HI-U+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !124FZ@!U%(*
M6@!&IM./-)MJ; )12[:7;2 %I:2EJP"BBB@ HHHH *2EI* $R:,FDHI +DT9
M-)12N N33J93MU.X"T444P"BBB@ HHHH **3FC\* %HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME_WJW_@'_P A>#_>% 'Z>_"G_D6X_H*[:N*^%/\ R+D?T%=K0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW5O$3SQ7IM<TMSTX:H::2G$9I-M2:#J*** "BBF\TF ZF4N325(!13@*,"K
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M/UKGIOBPBM_K?UKY_P#%_C659W D/7UKBV\675Q)\KMU]:VY2+GU?_PM=/\
MGK^M)_PM=/\ GK^M?,=MJ5],N06J=KJ_ ZM189]-6?Q2628#S?UKT?PGXN%\
MR8?.:^*='O+W[0N=W6OH3X6W%PS1[L]JSDBDSZETR?SH0?:KM8OAMBUJN?2M
MJH+"BD:DR:0#J*:M.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ;NI0:3!I5H 6BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 4444 %%%)D4 +129%% "T4F:6@ HHHH **** "BBB@ HHHH **** "BBB@
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M*** "BBB@!*3)I:9S0 [)IK-2BD(H -U*K4T\4 T@)*6D!I:8!1110 4444
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MB^[P[']!784 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )M%+110
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M><FL2R+5-/%^A4C-<%K'PN34F8^7G/M7=0ZQ$K?,PJ_#>0S#Y9%_.@#PZZ^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?X:!C&IJMS3V7-,VT 2*:?4:T^@!:*** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%ATKS*R/:H6/?Z2L%O%4 &=RU6;Q=%G[X_.N"S/533.HI*Y1O%T7]\?G2?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^3SK!6]JZ TF4(*1@.::#2]32 %I]-4<T^@ HHIM #J*:M.H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $:FTZ@T +13,TX
M=* (KJ$3PLI]*\8^)GP_35K>7]WG(/:O;:HWVFI>(00#F@#\P_C-\%65IG2#
MU[5\H^*?!NH:+</Y2.,'L*_9?QQ\+XM6C?\ <@Y]J^>?&7[-46H2.1;9S[4
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M\A*7ZUN_ 3_D,0?[PH"Q^GGPG/\ Q3L?^Z*[BN'^$_\ R+L?^Z*[B@84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM(IH EHI%I: "BBB@ HHHH *:U.I* &T^DVBEH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!&IK4K&F,:GE
M&5Y[,3+@C-9%YX-M[X'>J\^M;^_%2JVX52T$XH\I\4?!ZRN+9V6)6X]*^8/B
MQ\-+?3UE*Q@?A7W7JD@CLI"?2OE7XWW2F.:NJG)G!6IH^ O'VE+:7$H48ZUY
M)?KBX_&O:_B=<(;J;ZFO%=0F3[0>>]>M35T>-4]UGHOPVU46,\9SWKZY^'GQ
M4&GVL:^;C ]:^%-'UA;/!#8KL=/^(C6B@"7'XTITKDQK.)]\R?&A=G^N_6JA
M^,Z_\]OUKX?D^*TFW_7?K4/_  M1_P#GL?SKDE2L=4<4S[D;XRK_ ,]OUIO_
M  N5<_Z[]:^'A\4G/_+8_G3O^%G2'_EJ?SJ/9&GUCF/M]OC4JK_KOUJ;3_C6
MLLP7S^_K7PE=?$Z94XE/YTF@?%"9[Y!YQZ^M3*D:1Q!^IW@7QXNJ%/WF<^]>
MSZ3<?:(%;.:^#_@'XMEU!X,OGI7W!X/=I=/1CZ5R2CRGITZG,;Y-(:=BC;61
MJ0LU&ZE=<5&W6A$DBM0S4Q:=BJ&F&ZGIUIFVGK2*)**1:6@04444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 4M17?&1[5Y=XTT,WBN,
M9S7K,T>]:R;W1EN<Y7-4F!\@>+OAPUW*Y\O/X5PS?"=UD)\K]*^V;SP/'<,<
MQBJ+?#B)C_JA^5:<Q)\@0?#>2'&(S^57%\"S+@;#^5?67_"M8C_RR'Y4?\*S
MB_YY#\JGF"Q\D7'@28C[A_*I=)\$SQ3J=AZ^E?5[?#*-O^60_*B+X9QQMGRO
MTJ;@CSWP'HLEOY8(->QV.BBXM@&7M3--\)K9D83&*Z>UA$,> *+@>=>(O ,5
MPK'RP?PKQ_Q3\-P&?;'^E?5$T(F7!%<_J/AF.[)^0'\*?,(^,]0^'TB,<(?R
MK,C^'\TDF#&?RKZ_N?AW')SY7Z57C^&D:MGRA^55<#YT\/\ PM\QU+1?I7KO
MA3X5PQA"8A^5>D:?X,CM<?NQ736-BEJHPN*7,.QBZ+X0@T^,?* ?I6]]G6*/
M ]*GICMD5%RCC/%6F?;('&,U\Z>/OAN;Z=SY>?PKZPGLQ,"",UAWWA".\8DH
M#^%(#Y&\,_"PVUZK>5W]*^E?A[X?^P01C;C%;=MX%CAD#",?E72:?IBV:@ 8
MH FDLQ+#M/I7%^)_!,5_&Y*9_"N^4XIDRB12#5)B:/E[Q3\,55G*Q_I7G&I>
M 9(Y" A_*OLO4O#J7F?D!KG;KX=QS,3Y8/X4[D<I\DQ_#^60X*'\JZ'0_A?Y
MLB[H_P!*^DH_AO$I_P!4/RK4L?!4=JP/E@?A5<P6/-/"7PGA383$,_2O5]&\
M&P:?&N% /TK;L+!+50 H&*N9 J')LKE(H81;K@4[=S2,U"U-RB1:6D6EI7 *
M***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 W=1NHVFC:: %!I:;]VEW4 +124-T-
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M06GTKH*AE(9M]J4+3J*D8F*6BBF 4FVEI-U !BEI,TM !1110 4444 %%%%
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M 6EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6FMUH &I**5: %'2AONF
MEHH X'X@61FL92!VKX$^/^E,LEP=OK7Z0^(M/%W82#&3BOC_ ..?P_>\6X98
M\YSVJT9R1^;^ID6NJ9(Z-7MGPC\60V4D.6 Z5Q_C[X=W-I>2,(R.?2N7TV6Z
MT69?O#!JTS'J?IE\+_B9:PV\0,B]/6O88?B19W40'FJ>/6ORX\-_%BXTN- 9
M2,>]=SI?[0<D;*&G/YTRC[YUB_M-6A8 J<BO'/&?PWAUAG*Q@Y]J\O\ #'Q\
M2X*AI_UKUCP[\3++40N^13GWH&>:K\#?])#+!W]*]:^'?PT;39(_W>,>U=SX
M?U/3K_:<H<UZ/H-C:M@IMJ"DR?P]IYLK51C&!7,_$;4FM[&3!QQ7HS6ZQVYQ
MZ5Y+\4"39R_0U)=M3X<^.7CBXL[J;;(PY/>O(O!_Q'NY=713*WWO6NS^/T>Z
MZG^IKQKP3!_Q.D_WJI#9^CWP(\02WMO"68G(%?4VC2;[=3[5\A?L]Q[;6#Z"
MOKG0_P#CW3Z4FA#O$4ACTUR/2OC;X\>)I;'SMKD5]B^*/^09)]*^'/VAEW>?
M^--+039\I^(OB1=QZDP$K?>]:]B^"GC:YO+J$-(QY'>OFCQ-#_Q-6_WJ]O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444UJ %S2TRG
MT %%%% !1110 4444 %%%% !1110 4444 (3BC=2T4 %%%% !1110 4444 %
M%%% #6I*5J2@!]%%% #3UH6G44 %%%% %>__ ./5Z^>_C!_Q[3_0U]"7_P#Q
MZO7SW\8/^/6?Z&@#\]_C!_R%)?K6_P# '_D,0?[PKG_C!_R%)?\ >K>^ /\
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M$N.AS6E&VY0:  #FGK1BEH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *0]*6DH @DI%Z4Z2H\T[D6)=PHW4P&EK.Y:&R+N&*S;K0X[O.
M5S6I3U;%"E8=CD+GX?VMQDF(?E5"3X6V;'_4K^5>A YI:U4V9."9YS_PJVT'
M_+%?RH_X5=:?\\5_*O1J2J]HR/91//%^%]IG_4K^56/^%8V6W_5+^5=W2T<[
M#V,3Q'QA\-[6"WD(B7IZ5\G?&'PY#9+-M0#K7WCXV0M;2<=J^.OC9IKS+-@>
MM=E&1QUZ>FA\'>/&$-Q(!ZUQMG=;9<UZ=X_\.2R74F$/6N&@\-3(^=IZUZL9
M*QX<X-,TK#Q)+9J-K$5<;XCW<) $K?G6/-I3Q+R,5C7=OMDJ913)A)Q9ZUX3
M^)%W)<(#*W7UKZJ^#_BZ>[>'<Y/2OB/P;;_Z1']:^O?@G;GS(/PKSZL#VJ%4
M^Z/A[=FXMXB3G@5Z-7FWPSMC]EB^@KTJO.EHSU8NZ()OO5%SFIY147\5242+
M4JU&M2T[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** &4JTE%2 XTVE6G4 ,HHIM QV:3<*;13$.#<T_-1TZD [-+3
M*<M "T444P"BBBBP!11118 HHHI@%%%% !29I&I* 'T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"<_9_P *3*1]P>!_^0<OTKIJYKP0/^):OTKI:Q>YJ@I*#0#2*%HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "F9I]-VT *M% &*6@!-HI:** "BBB@ HHHH **** "BBB@ HHHH
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M% "8I:** $IA7FI*3;0 S;2JM.VT8H 3;2[12T4K )M%%+118 HHHI@%%%%
M!2-2TA&: &YI]-VTZ@ HHHH 2C:*6B@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!]*Z1ONUB]S:.PH-#5'NI0:DH6GTT=:=0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 5[_\ X]7KY[^,'_'M/]#7T)?_ /'J]?/?Q@_X
M]I_H: /SW^,'_(4E^M;_ , ?^0O!_O"L#XP?\A27ZUO_  !_Y"\'^\* /T_^
M%/\ R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KW_\ QZO7SW\8
M/^/:?Z&OH2__ ./5Z^>_C!_Q[3_0T ?GO\8/^0I+]:W_ ( _\A>#_>%8'Q@_
MY"DOUK?^ /\ R%X/]X4 ?I_\*?\ D6X_H*[:N)^%/_(MQ_05VU !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-W4 .HI*6@ HHI*
M %HINZEH 6BBB@ HHHH **** "BBB@ HHHH **** ,S5O]6:\K\7@?-7J>L'
M]TU>4>,&.&H \AU['F-6!#\DF:W-<)\UJPP#0!T^C^(38LOS8KT[PSXV,FU=
M_P"M>!R2,K\5U_A"XD\Y.: /IK1M4^U*IS70Q'<HK@O![EHDR>U=Y;_=% $U
M%%(#0 &DR:4TFTT +2TE+0 4444 %%%% !12;J,T +1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 R1L57=ZFFJJW6JT,Y7$(SS4D"
MX>HE-3QGYJ&TAQ1:KQ+XTQ@VTVT=C7M);@UYS\0M!;4[>7"YR*<7J:.-T?FI
M\889/M<^!W-?.^O;E9LU]O\ QH^'KQF=_+]>U?'/CO2S8S2+C&#7J4G<^>Q4
M%%G'Z.Y%X/K7TI\'YP)H,GN*^:M)&VZ!]Z]H\ ^(!ILD9+8Q6THMG#3DHL_2
M'X/WD(AAW,.@KZ$L[B.2W0HRXQZU^>O@/XQ1Z;&@,V,>]>L6/[14<,('VD?G
M7GU*,FSWZ-:'*?6YD0=67\Z/-3^^OYU\ER_M(1_\_(_.D3]HZ+_GY_6N?V4S
MI]M"VY];>8G]Y?SH\Q/[R_G7R9_PT=%_S\?K1_PT=%_S\_K2]G(CZQ ^L_,3
M^\OYT>8O]X?G7R:O[1T7_/S^M/\ ^&CX_P#GY_6J]E(7UB!]7^8O]X?G1YB?
MWE_.ODUOVD(_^?D?G3/^&D(MW_'R/SJO8R'[>)]:^8G]Y?SH\Q/[R_G7RG#^
MT5%)_P O'ZU=C^/T;#_CX_6CV,D4JL6?3_F)_>7\Z/,7^\/SKYB;X]1C_EX_
M6K&G_'9+B4+Y_?UK&47$U4DSZ6W#U%(37FGA7QX-6VXDW9]Z]%M9/.A#5GJ4
M2TY:;3EJAL6FM3J:PH$ -.IH%.H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MKW__ !ZO7SW\8/\ CVG^AKZ$O_\ CU>OGOXP?\>T_P!#0!^>_P 8/^0I+]:W
M_@#_ ,A>#_>%8'Q@_P"0I+]:W_@#_P A>#_>% 'Z?_"G_D6X_H*[:N)^%/\
MR+<?T%=M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M"4VGT4 (O2EHHH *1NE+10 RG+TI:* "BBB@ HHHH **** "BBB@ HHHH **
M** ,_5(R\;5YMXHTUI W%>J31^8IKG]4TD3*>* /G77M#96<[:Y.XL_))R*]
MY\2>'U57.VO)?$ECY#-Q0!QTF/,_&NQ\((/.2N)F;_2,>]=QX-!\Q* />O"
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M=*/BC>?\]6_.N=_X1MS_  FE/AM_[I%9<D2+S.B_X6C>?\]6_.C_ (6E>?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***2@!:*;NI10 M%%% !1110 4444 %%%% !111
M0 4444 %%%% !13<FA: '4444 %%%% !112-0 M%-R:=0 4444 %%%% !111
M0 444C4 +13<FG4P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1132U #J*:&IU !1110 444
M4 %%%% !1110 444AH 6BFY-+0 M%%% !1110 4444 %%(U)DT .HHHH ***
M* "BBDH 6BFY-*M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>E+2&@!C
M4UEI^*.M,"';S4Z?=IC#&363J6M+IZDEL4@-NBO+-:^+UOI6[=,HQ[UR%Y^T
MI9V[$?:5_.G8#Z"HKYU'[3%H_2Y7\Z7_ (:6M1_R\K^=5RL1]$T5\[C]I:T/
M_+ROYU)'^TA:-Q]I7\Z.5BYCZ$HKQ"Q^/=M=,!]H7\ZZ_1_B1!J6W$H.?>IL
M.YW[4VJEA?+>("#FKM !2T4E(8;J*;3ATH 6D:EHH ;@T;J6FT .I:0=*6@!
M&IM.;I3: "BBG T@(FIHJ1EJ-_E4FJ F7I3JY76?%":4K$OMQ7!:M\<K?3V(
M,ZC'O18+GL]%>&6/QXM[R3:+@'\:[GP_XXCU3;MD#9]Z+$\QVSBF;:2WE\Z,
M,*FVFLV61BI/NTE*>:2&PW4FZAEIHZUH9CUIU-!Q2YH&AM*#BDHI#' TM-6G
M4P"F4^FX-(!5I:1:S=2U462DDXQ0@-.BO,->^+4&CEMTH&/>N:C_ &A+22;9
M]H7.?6JL*Y[I4<C8K@=!^)$6L@;9 V?>NOM[K[0H(-4HDMEU6I]1JIJ2I92$
MS3:&XI%;)Q2&+FI1TJ%QMYKF=>\5+I*L2V,4 =;17A.M_M 6^DR%3.!CWJOH
M_P"T9;:E,$%PI/UI@>_4F*XW0_&J:M"KA\YI^L>,(]-C+%\8H ["BO%-2^/%
MMI\FTW"C\:GT?XX6VJ2!5G4Y]Z!7/9**Y.Q\5)=0AP^:S-<^(<>DH29,8]Z+
M!<[^BO -1_:*M[.4H;@#GUK1T'XZ0:O(JB<'/O3Y6*Y[:14;5@:-XB74HPP;
M.:WX_P!XN:35AC-U2I1Y8IV M2,6BDR**8"T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 5[__ (]7KY[^,'_'M/\
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M2B@ :DP:=10 4444 %%%% !24M% #=M**6B@ HHHH **3(I: "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH&+112-3 6BFY-.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR1\U4A&S25FG5$_O4Y=25CUI@:&:;4<4HDZ5+MH :1FC;2T T )MH%24W;0
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MUJ=2$9I@,P?6G;J2B@8ZEIH:EI"%HHHI@%%%% !1110 4444 %%%% !1110
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M3J:*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ*SO[:A]1^=-;7(?4?G0!I8%&*R_[<B/\0J6/5HWQR*!E^C%5UO48=:7[6M
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M*0S3HJ@NJ(W0U*MXI[T 6J*@^U+2_:5]: )<4M0-=(O>H'U2->XH O4E9_\
M;4/J*0ZW#ZB@#2HK+&N1>HIZZU#ZB@#1HJB-6A;H:D6^C;H: +5)MJ'[4N.M
M--T/6@"?;2XJM]J'K0;Y5ZF@"U15!M6B7J13/[:A]10(TJ*S?[:A]12?VW%Z
MB@9ITF*SAK</J*=_:\3'@BF!?VT5474$;N*D^U#UI 3[13"M1_:AZTTW0]:
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M_P"%,P_\\!^53V_P?AB8'R1^58<QT\I\@^$_@"963=!_X[7O7@/X#QV;1L8
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M/1]4%RJ\YKHXSN3->7^"KMY(TS7IMJ=T8K,9-_#6??S^4I-:%8GB E83CTH
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MAE!I>]5K*3?"#5FI-$Q:**;DT#'44@I: "BBB@ HHHH **** "BBB@ HHHH
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M2_\ ^/5Z^>_C!_Q[3_0T ?GO\8/^0I+]:W_@#_R%X/\ >%8'Q@_Y"DOUK?\
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M;DT4#%W4N:0+Q0: %HW"FT8H =2TW-** #-)NI6IM "[J=3*?0 F:-PI&I*
M'9%&X4@HYS2N N:6F4Y:8"T444 %%(U-S0 [=1FFTN: '4FX4FZDH 7<*7--
MI?2F(=24G\-)2&.W"BFT4 .S2;J2E H -U&ZD84U>M $FX49%"T4 +24M(U
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M&%Q6C&@6GT4#"BBBD 4444P"F/SQ3Z3'- &?<:>LW5<UFR^&XI#R@_*NCHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIU-IPH5P%I*6BJ 3:*6BB@!N31FC!I* "BBEVT"#-(5HI] R(_+0&I6%-5:
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M%<GW4M1AJ7=3N,?14>ZE#4=0'T4FZC=3 6BBB@ HHHH **** "BBB@ HHHH
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M/M7T)2&-6ZJ#^%%R'%'Q5XB^ KPEV6']*\S\1>$KCPUN8*5VU^B.HZ);WL;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH KW_ /QZO7SW\8/^/:?Z&OH2_P#^/5Z^>_C!_P >
MT_T- 'Y[_&#_ )"DOUK?^ /_ "%X/]X5@?&#_D*2_6M_X _\A>#_ 'A0!^G_
M ,*?^1;C^@KMJXGX4_\ (MQ_05VU !1110 C=*;3Z* $I:** "BBB@ HHHH
M**** $:DVFG44 )2T44 %(U+10 W::6EHH **** $:DVFG44@$HI:93 =2TU
M:=0 4444 %%%% !1110 4A&:6B@! ,4M%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% #**=10.XM,I]% A!TI:** "BBB@ HHHI( I*6
MBF E+110 4444 %%%% !1110 4444 %%%%*P!1113 *2D:DH ?3*?3* '+2T
MBTM !1110 4444 %%%% !1110 4444 %%%% !1110 UJ2GT4 -P:=110 444
M4 %)2T4 -VFE6EHH **** "DI:* "BBB@ HHHH 3;1BEHH *1J6B@!E.I:*
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M129H 6BBB@ HHHH **** &M24^FM0 #K3J93Z &TJTM% !24M)0 BT-TI**
M,[48?,0BN"\0>'S=;OES7I4D>^H'TQ).HJ@/!;OP.SR$[/TJ-? K8_U?Z5[R
MV@P-V'Y4G]@V_H/RJ0/"5\"G/^K_ $J1O Y6,_)^E>Z#0K?T_2DDT. QL !G
M'I0!\RZYX?-H#\N*XJZ7RY"*]V^(&FK"KX%>&ZNNVX8>] $2?-70>'E'G+7/
M0]JZ7PZN9EH"Y[;X)7:B5Z=;_P"I6O./!,>8XZ])C7:@% #J*** &X-+BEHH
M 0BDP:=10 4F:6DH 6FM3J2@!M%.VBC;0 VDS2TWO0!(O2@]*:.U.H ;3J;3
MJ %I*6B@! ,4M%% !3#3Z* &K3J** $VTM%% !36%.HH :!3J** &4X=*6B@
M!&J-NM2TQZ3&AE-;-.'>G!:2$SGO$%B;J%EQVKP'XC?#MM2$I\O.?:OIR2W$
MG6L^\\.6]VI#*#FM8RLS*4;GYM>-/A')#)(?)/7TKS6\^'LL<A'EG\J_27QE
M\,H;A7*Q _A7C.O?"](9&/E#\J[(S..5,^-_^$%DC7)0_E5"XT)K7JN*^F?$
M7A:&QB?Y ,>U>->*H8X9& %;PE<R<;'GYM.<4O\ 8_F]JO;E\W%;%G&C"M[E
M)'+2:&(^2M9M_ D*XQ7>WT*B,XKA]>4_-BF]27=%OP6R'4XQ[U]_?LY0+(D'
MX5^>'A.8V^HHQX&:^V_@+XZATQ8=\@&,=ZX*L2Z,M3[B1=JJH[#%+C-<%;?%
M?3VMXRSH3CDYIEQ\6M/CZ2(/QKBY6>E='H&T>E)M%>:2?&:PCZRI^8J*/XU6
M$K;1*OYBJY69NI$],DC&*@W885RFG^/;?4L;) <^]=!;70N%# U$D$97>A?W
M\4FZF[3MHVFL%N="V'JU/'2HU!J05NMC-[CEI:%[4^@ HHHI#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"*>3RT)KQ/XO\ B#[+:S?-CBO7M8N/)A8].*^8_CAJ3-;S
M@'L:Z*:.*N?+?Q$\5FZOY$W9^:F^ =!_MJZ0E=V37):];RWFL-P3\U?0GP&\
M)&9H2R?I6\G8Y(1NST_X?_#=%AB8Q?I7L%AX(CCA \OMZ5T'A7PVEK9QY4#C
MTKJ4M450,5R.1Z<(Z'G;>"H\_P"K_2N6\8^ XY+-_P!WV]*]M^S)Z5FZWI:W
M%LP"YJHSLQ3@FC\]OB9X$%O/*PC[GM7GN@WAT34 /NX-?8_Q0\$^=%*PC]>U
M?)/C;0WTW4&(7'-=L971QN-CZ5^$GC@R1Q)O[#O7N-SJ'VS3R<Y^6OBSX1ZM
M)%=Q*2>M?6>C7)N-*'/\-83*B>&?&1MHF_&OE^\F/]J'_>KZK^+MBTRRX&>M
M?,M_HTG]J$[?XJNE(PJQ9[W\#YMTD0^E?6VEZ6+S2AD9XKY.^"5BT4T.1Z5]
MG^%80=+3/I6=9ZFU&.A\U_&3PLJ1S,$['M7Q'\1IFTFZD(XP:_2[XM>'_M5K
M-A<Y%? 7QM\%2^;,5C/4]JUP\M=3&O3/'-)^($L<GE^8?SKO_#L[Z],F<MFO
M';?PW<0ZEC:?O5])_!;P?)<S0;DSR.U=F(DN70Y*,'S'M7PC\"C,3F/T[5]-
M:-H_V.Q48QQ6)\-O!PL[2(E,''I7HUQ9B"WQC'%>-"3YM3V91M$\#^+(,=M-
M]#7QWXNF/]I-_O5]H?%BV,EO-@=J^0/%FDNVI-\O\5>S!KE/)DGS'=?!MBUS
M%]17VWX#'_$OC/M7QK\'=-:.>(E<<BOL3PI<"UTU<\?+7FU7=GI4E[I>\4ZX
M-.MV.[%?+WQ<^(Q831B3U'6O5/BMXC\JUD"MVKX[\;:A-J6H.H)()J$3.YS%
M[)+KFJ9Y8%J]Z^$/@3SA&7CZ^U<7\-? [:A=1LT><GTKZY^'?@M=/AB.S'X5
M=[&*C<Q-7^&,4VF$B(?=]*^6_BUX!.FR2LL>,9[5^BO]D))9["HZ5X)\8OA^
MMY#,1'GKVJXU"W2/S]TW6IM$U(#)7#5]-_"7XE-)%%&TGIWKQ;QY\/)K&^=U
MC(P?2I/ ,T^EWD:G(P:K<FSB?9&I3?VUIY.=V17S1\6-#:UDD?;CFO?O FH?
M;K%%8YR*Y[XJ>#3J%J[(F>/2FG8F4;GRKX7\1-INJ*I.,-7VC\%?&:SP0J7[
M#O7QEK/@ZYT[5&8(0 WI7KOPK\22:.\0=BN*<GS(F*:9^@FDWBW4*MG/%3ZI
M="ULY&)[5XSX3^)T*VZ;I>WK4_BKXI0O9NJRC./6N7EU.OGLK'F?QO\ &(@6
M<!_7O7R-K6OMJ.H,H.<FO6/BIK4FM32A&+9->:^'?!-S?Z@K&-B,^E:)V.:7
MO&OX=\*OJD8.S.:T]4^'K6\!?ROTKW7X:_#DK;Q[HNWI79^)OATOV%L1#IZ5
M?.)4SX4U+=H]YC&,&O8_@WXX\NZA4OCFL+XG?#^:&YD9(SC/I7*>#X;C1=00
MD,H!I.0U'E/TH^'_ (@6^T^,;L\"NT:0*,YXKY3^&?Q&6S@C1Y,<#O7J<WQ2
M@^S?ZT=/6L>6[.F,M#HO'WB1+/395WXX/>O@GX[>*#=7$P#9Y->\?$3XBB\C
MD1),Y]Z^:/%FDS^(+IBJELFK2L92D>5Z#(]QJ@8C/S5]5_"F_&GQ0D\=*\K\
M*_"FX$RR&$_E7J]IH$^C6X^4C:*MR$G;4^F_!OCZ..%4\P=*](TO7$U!1@C)
MKXETWQA+I]PJLY&#ZU[#X)^)B*J;Y?UKG<;F\:G0^C:HZK<)#:ON('%<6GQ.
MM?LX/F+G'K7'^*OBE$87"R_K0H]2Y558\\^.^J0B&89'>OBW7IUN=68*,_-7
MOOQ2\22:TT@1BV:\FT7P3<:EJBN8R06]*WBSGYKGH_P?LI%\ML$5]1^&?$G]
MEPIN;&*\S^&?@-K.T0F/!QZ5T_B*RFL8CM!&*3U+Y['K=G\1HY-J^8/SKH=.
M\1+?$?/FODG_ (2:>QN/F9@ ?6NY\+?$I864/)^M9<HU5/IR-@Z@YS3+IO+B
M+9Z5YWHOQ/M6B :13^-+KWQ,M?LK!)%Z=C46U-N92B5O'WBP65K*N_''K7PW
M\</%'VZZF7=GDU[9\1_'!OEE5'SU[U\X>(]'N-=OF(4MDUTQ9S21Q?@FQ:\U
M=&VYRU?=7P3T4QVL)V]A7S]\,_A=,MU$[0GKZ5]G?#/PV-/M8@5Q@54I$1AJ
M=]I=OY4:UJ9RM-2(1K2UR2U.Z"T(VMUDZC-)_9L#=4S4F2#3TDW=:SN:V,R^
MT&VDC)V"O#?C%I,-OI\Q"CH:]_O)#Y9Q7C/Q6TV2^L954$Y!KKI2.*LK['YG
M_%ZY\G6)0!_%7:_L\L+K5( PS\PJU\4?A;=WVJR.(F/S>E==\"_AU<Z5J4+-
M&0 1VK:4SC43[R^&NB6[:+$Y0'Y179_V/;=HP*YWX?(UOI,:-Q\HKK=]<DV[
MGH4DK:D2V,2?=7%.\L+TIY:D4YK(ZA,57N)O*4FKFT5E:HK>6V/2@1CZGXH6
MRSEL8K!_X60@DV^8/SKF/'LTUO&Y&:\+U3Q5/9WARY'/K6AA)GUYHWBA=0QA
M\UU$;;E!KY4\"_$81NH>3]:]JTOXF6IMUW2+T]:&M!1>IZ&:\8^-EY#'839(
MZ&M_5/BE;1PL%D X]:\#^+'CK^UH)51\Y![U48ZDU)GRK\3KV-]6DQC[U6OA
MY:FZD0 =35;7/#=SK&ILP4MEJ]>^$?P[E22(O%^E=?-9'$_>-*/P4]W:!O+[
M>E>>>,/#S:2S-LQBOM+1_ :_V>,Q]O2O)OBU\.VDAE*1>O:HYB?87U/FKPSX
MX.DZ@BE\8/K7UI\'_B<MQ'$ID_6OC#Q+X-O-/U!F5& !]*[KX::[<Z/-&'9A
MBLVS2,>0_2;0]:34HE(8$D5L5\W_  _^)J1QQ!Y?UKU1/B=:& '>N<>M8N/8
M[8U5;4[#4-02SC))P:\2^*OQ 6SMY0).WK2^,?BE%L?;+^M?-7Q*\92:LTBH
MY.:VC&QSU*G-HCAOB-X_;4+J1 ^>:Y[P?I+ZU?*Q7.35:+PG>:S?;MC,"?2O
M?OA%\,)(9(F>+T[5O>QQJDV[G>_#/P%Y=G&QC[>E+\4/"7_$OD 3MZ5[QX3\
M,)9V*#9CBLOQMX9%[;2 )GBLG,ZE35C\U_&&FR:7JC-M(PU=[\*_'IT^:)"^
M,$=Z[3XK_#*0R2NL7Z5XK;Z#=:/?9VLH!HYA;,^__AEXX74(HAYF>G>O;+68
M30JP.>*^$/A7XP?36B$CD8]Z^EO#_P 4X%ME#2CIZUSR5SHC4L>NM@#-8>K:
M^E@"=V/QKCKSXIVWEG$H_.O-?%_Q(6X#!)<_C2Y2W4/4IOB-&DFWS!^=;&D^
M+%O\8;-?*<7B6XO+KY68C->P_#Z>:7R]V:5C12N>X02>:H-3JM4],!\E2:O;
MJ1H%+112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7F_C>X>*-]II@4]2\9)"QR]93>/HU/\ K/UKR7Q5K5Q'*X!-<;/XBNE/WFI
M?1G_  L"/_GI36\?)_ST_6OG*/Q%=-W:I#X@NNN6H ^B8_'R9_UGZU93QZG_
M #T'YU\T-XKGAZL1^-(OCB3<!YGZT ?5VE^+TN& W]Z[C2;P72@YKY2\&^*I
M+B9/GSSZU]&>"+QIXD)- ';XI:** $:FT[&:3;0,%IU)C%+0(**** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#V+1/FC7Z5LUB:"W[I>:VZ $)HW4C"D7M0 X"EHHH **3(HH 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IK=:=36H 8*<&IE% #BU :DHI .W>]87B
M2Q-]"PQGBMJE\H2#D4[A8^>O%WPS.I,_[K.?:O-[[X#M-(3Y'Z5]DMIT#]4S
M4?\ 8]I_SR%:<PK'Q;_PSZW/^C_I7,>)/@LUDC'R<8]J^^?[(M/^>*UP?Q \
M,VWV>0J@Z5<:C):/S@\5>#SIK/\ )C%<)<6A60KBOI?XM:3' TN%QUKP62S$
MEZ1CO79"1DXW,ZQT%KK&%S^%:Z>"9&4'R_TKTWP#X-^W^7\F<U[#8_"?S(%/
ME=O2B50Q=.Q\FW'@UXU/[OMZ5RVM:.;56RN*^S-9^%?DPL?*[>E>#_$CPC]@
M67Y<8S1&1Q5;GS)XD81AA65X78/J*<?Q5K>,H3',Z^]9OA2W*W:M[UV+8\UO
M4^X?V=E3-MGCI7WKX'6/[#'R.E?FY\'/%*Z4T +8QBOLOP!\3HGMXU\P=/6N
M&K$]C#2/H:EKD])\6)>1J0V:LW_B-;>,L6Q7GV/4N=%2UY=J'Q0BLY"ID'YU
M)IGQ,BO7 $F?QI\HKGIM%8FF:VMXH(:ME&W*#4E#J3=2TR@!U+3 U&Z@!]%)
MNI: &[:3%.I: &BG444""BBB@8444E "T4F12T %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7)SCO7TYX;F,T*$^E?)GP/\ #\UI!;AE/:OK+PO"8[=,^E9&IT%(W2EIK=:
M$I],I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )MHQ2T4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O_ /CU
M>OGOXP?\>T_T-?0E_P#\>KU\]_&#_CVG^AH _/?XP?\ (4E^M;_P!_Y"\'^\
M*P/C!_R%)?K6_P# '_D+P?[PH _3_P"%/_(MQ_05VU<3\*?^1;C^@KMJ "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/TKV]=#BDZ**=_PC4?\ =% 'AO\ PAI_N'\J/^$-/]P_E7N7_"-1_P!T4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBB@ HHHH **** "BBB@ I*6DH 3)I5I-M** %HI":-U "T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %>__P"/5Z^>_C!_Q[3_ $-?0E__
M ,>KU\]_&#_CVG^AH _/?XP?\A27ZUO_  !_Y"\'^\*P/C!_R%)?K6_\ ?\
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MVT &VEI:* &M24K=:,9H)$HI=M&V@H *7% I: "BBB@!,4M%% "4;11FC=2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY_QKX8\4K_Q-6_WJW39-CU_X'L1<0X]:_0GX/W#+;Q<]A7Y\?!!?](@^HK]
MOA&<00_04I$H]U5MR@^U#-MI(?\ 5+]*23[U<[-D+OI5;-1TY>M V25FZU,R
MV;@<<5I5EZX/]$?Z5<=R&?'G[14S-#/D^M? 7BYO^)N_^]7WS^T5_J;C\:^
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M_P BW']!7;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&VK);'4Y>E)M-'-2 ]:=4:YIZTABT444#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA_*OIB3X<JQSY?Z4L?PZ1?\ EF/RH ^:/^$+EQ_JS^5/@\)S1R#Y#^5?3/\
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MM1'"HQVK1 Q44(VKBI,T .IE/I-M "+3J3&*6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!**6B@ HHHH *:U.I,4 -S3EZ4FVEH YSQ
M4W[EZ\CU)O\ 2C]:]:\3*6A;%>5:A:.UT3CO0!UG@X_=KTNW_P!2M>;^$8&3
M;D5Z/;_ZE: ):*** "BBB@ I,TUFINZ@"2JVHKNMR*L+39UW1XH \?\ &6FF
M3><5X_K6GF&1CCO7T?XDTT21L<5XSXLT\1LYQ0!YG,F&K1TV7RF!S5.^^60B
MIK+F@#L+77WMHQAL58A\:2"8#?\ K7,.I\NJ,,;?:!]: />?!_B![IERV:]5
MT^3S(03Z5X7\/XVW)7N6DJ1;"@"VU-8T]JC930 ;J-U(JGTI=I]* #=2@TFT
MTX"@!R]*6BB@ HHI&H 6BFY-+0 M%%% !1110 444W)H =12+2T %%%% !13
M<FE6I 6BBBJ SM8_X]V^E>%?$Q_W$M>Z:P-T+?2O$/B19O+!+@>M:1,9;GR7
MXP?_ (F3?6O1O@VP^V0_6N'\7:'.VH,0IZUZ#\(=+EANX=RGK5,E7/LWPI_R
M"8_H*UV^[6/X34KI: ^E;)Z5DS=;%.[M1=1E2*X[6OAK!JV2T8.:[Q1BG4[B
ML>,3? 6TDDW>2OY5(OP'LU _=+^5>QT4<S'8^>?''P5MK/36=85Z=A7QA\7/
M#*Z7<RA5Q@FOTR\=.JZ'*&[@U\"?'2%9+R? [FM8U&836I\QPPL]R5]ZZ;3_
M  S+>*,(3GVI-*TU9=1 QWKZ&^&O@%-2$7[O.?:M>=F/*>(1_#RXD7/E-^55
M+SP3/:@DQD?A7WCIOP322S#>0#QZ5P'Q!^%R:;#(?* Q[4U,3@?&4VEM"V,5
M/:Z.]P0 ,UVWBC1TM;IEQCFM+P=H*7DR#&>:TYV9\IQ2^"YI4R$/Y5A:UX:F
ML5)*D?A7V+H7PS2YLP?+'3TK@_B=\/5L;60B/''I5TY>\858V5SXL\2736Y9
M3Q5/PG?$Z@A)[UI_$FS^RWDBCC!KE/#<AANE;WKUW&+B>2IRYC[T^ .M1P^1
MN8=J^X_!?B2!K&,;QT]:_+'X9^.?[+:,;\8]Z^J_ /Q:WQQ+YWZUXE:&I[5"
M>A]KPW\4P&&JR"&KR'P;XQ_M!4^?.:]4TZ;SH :X&>G%W19:FM3\4FVD:(9F
M@4[;[4;:1(4ZC;2TQA1110 4444F 4444@"BBBF 4444P"BBB@ HHHH ****
M "BBB@ HHHH **** "DI:* $I:** "BBB@ HHHH 2BEHH 2EHHH **** "DI
M:* $I:** "DQ2T4 -VTM+10 4444 )12T4 )3:?2;: !:6DI: "BBB@ HHHH
M **** "BBB@!,4;:6B@!-M&VEHH **** $QFC;2T4 )MHVTM% !1110 4444
M %%%% "44M% !1110 4444 %)2T4 %%%% !24M% #2M)BGTFT4 "]*6BB@ I
M*6B@!**6B@ HHHH **** "BBB@ I*6B@ I*6B@ HHHH ;MHVTZBF FVFFGTF
M*0"+3J3%+0 4F*6B@!NT4>6*=10 W;3J** "BBB@!&I*7&:-M "T444 -9<T
M;:=12 ;MHVBG450";:3;3J*0" 8H:EI* &TZC;2T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M
M0O6G5%),D?5AF@"6BJ;:E$N?F'YTBZG$V/F% %VD-,CF23HPJ2@!NZG4AHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ IO>G4PT +M%+M'I0*#0 ;1Z4;1Z4FXTN: "C ]*** #
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M#^%?6GA<YL1]*\*HK,^@I.Z-JBBBL3H"BDHR*0"T444 %%%%, HHHH ****
M"DI:0]* $W4ZF4Z@!:*3-% "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4UJ=36H$Q**<**!C:*?33UH 6ANE,S[4]>E $4F:BV\U89:;M
MH 15I]+MIU "+2TUJ%ZT .I&Z4M% $;4@S4F*-M "+FG444 -8<5$5.:GINV
M@!BBG,*<!BEH C I_P##1CK3: $:A:6C% !1110 8I5HVTZ@84444""BBB@
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M\/C_ $,?2@#5HHHH **** "BBB@ HII8#O2>:OK0 [K3:4.#WI: %HHI-PH
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M^TQ_WJ<)E;H:8#Z2C-%  *6BBI ****H I"*6B@!E*M.IK4 .HIE/H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#FEH QM0T=;K.5S6'-X)BD?/E@_A7:T4[BL<I9^%8[;HF/PK>M;(0J,"KM%
M6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEH **** "BBB@ I-M+10 FT4;12T4 )M%&!2T4 %%%% !1110 4444 %%%%
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M]%VLGF1@U([8JKI+;K-&]JM,N:D8FZC=2;32-0 [=1NI@-+0 [=1NIM+MI7
M>M+UH7UI:H!-M+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBO"UNP\T?G7A_P 4_B)%<6TP$F>#WKY]F^-$KQD>=^M<'XN^*4EW&X,N?QH
MYKXH:XMYJ4F&SEJ[C]GU?,U6 _[0KY\USQ U_J&2V<FOHK]G!/,U"W/N* /T
MY^%*[?#D?T%=M7'?#!=OAV/Z"NQH :>M"TZB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQQVK4K/U@%K<@>E 'B/C=0F_%>622'[8?K7L_B[27N-^%KSI_"\ANL[3U]*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% #*5:7;12 *6BBF 4444 %-:G4E2P&T^DVB
MEH ****H HHHH 1NE1M4E,9>:D!%J1:8!BG+5 #4E.IOXT#$6GBFCBG#I0(&
MIM.:FT@'T444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1_[M?#O[/&AMMMSM]*^[O 2BSLX]W'% ';T53GU:UMQEY0*JKXFL6.!*/SH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU88.*WX/&SQH!O\ UKAY W:HMDF: /03XX=A_K/UJG=>*FF!^>N,6.2G[7%
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MG0J:QEH6F;=+114C"BD/2FYH ?12#I2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%-W4 .HI :6@ HHHH ***:U #J*;DTZ@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I-M+10 FV@#%+10 4FVEHH ;MI:6
MB@!#S2;:=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH _3_P"%/_(MQ_05VU<3\*?^1;C^@KMJ &[J4&FTY: %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW>],HH&/W>])NIFZE!H <K'-/!IBBG+2N ZBBBF 4A%+10 W;3J** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI::W6@!:6FKU
MIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !24M-:@!:6FKUIU "-TIF#FI*3%  1N7!K#UKPW%J4+@J
M#D>E;>>:=0!\O?%3X.QWT<I6$$G/:OD+X@? F9;B4QP'KZ5^IFI:+%J"D,HY
MKBM6^$5GJ3$M&AS0!^4$GP:U"-B!"WY59TOX*WTUPNZ%NOI7Z<R?L_V#MGRH
M_P!*DM_@+8V[!A$GY4 ?&?PV^!3K)$TD'IVKZW^&_P ,8M-AC/E 8]J[O2?A
MK;:;C;&HQ76V.GI9J !B@ T[3TL80H&*YGX@Z7]OL9% SD5V=4[ZS%XI4C-
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M,[U(@JNA*9*M+2+2U!04F:*;3 ?12+2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !28I:* $Q2T44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)BE
MHH 3%+12&@ --9J7=2%: $!YIZU'R*<#\M #Z*1J86.>M $E%1[C1S0!)29I
MF#ZT8- #LTZF[:=0 444UL]J '5&WWJ3FC::  &G4RG+0 -0O6@T;: )**92
M\T .I*09I0* %HHHH **** "BBB@ HHHH **** "BBB@"O?_ /'J]?/?Q@_X
M]I_H:^A+_P#X]7KY[^,'_'M/]#0!^>_Q@_Y"DOUK?^ /_(7@_P!X5@?&#_D*
M2_6M_P" /_(7@_WA0!^G_P *?^1;C^@KMJXGX4_\BW']!7;4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P BW']!7;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9IM*M #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "D;I2TE #:<O2C;10 M%%% !1110
M 4444 %%%% !1110 E%+10 4444 %-;K3J3% "+2T8I: &4Y>E&VB@!:***
M"BBB@ HHHH **** $I:** "BBB@ HHHH KW_ /QZO7SW\8/^/:?Z&OH2_P#^
M/5Z^>_C!_P >T_T- 'Y[_&#_ )"DOUK?^ /_ "%X/]X5@?&#_D*2_6M_X _\
MA>#_ 'A0!^G_ ,*?^1;C^@KMJXGX4_\ (MQ_05VU !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 )2T44 -)YI:1NM+0!S?BK_CW:O(M27_2C]:]
M>\4_ZELUY'J7_'T?K02CKO!R_=KTRU_U(KS7P;CY:],M_P#4K0424444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #3UHR:7%1M0 [-.7I40-2;J ([D;D(KCM?L3,&XS7:-\PJA<V F[4
M>(:WX=>1F^6N;D\*OO\ N?I7OMQX;67/RU4;PBF<[/TH \13PJY'W/TH;PB_
M/R5[>OA-!_!^E/'A-/[E '@L_A9XUSMK%O-,,).17T'JWA9(X2=E>6>*--6W
M9N,4 >?^3\^*U;#2#<8XS4$:!K@#WKT+PGI*W!7C-2P.;'A5O+SLK"U?2C:
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MCJ***8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH KW__ !ZO7SW\8/\ CVG^AKZ$O_\ CU>OGOXP?\>T_P!#0!^>_P 8
M/^0I+]:W_@#_ ,A>#_>%8'Q@_P"0I+]:W_@#_P A>#_>% 'Z?_"G_D6X_H*[
M:N)^%/\ R+<?T%=M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>__ ./5Z^>_
MC!_Q[3_0U]"7_P#QZO7SW\8/^/:?Z&@#\]_C!_R%)?K6_P# '_D+P?[PK ^,
M'_(4E^M;_P  ?^0O!_O"@#]/_A3_ ,BW']!7;5Q/PI_Y%N/Z"NVH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3#_;H ]?_MJ/U%-;6D]17D7_  F'^W2?\)@?[_ZT >MG6TS]ZA=;3^]7D?\
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ML99NU?#'P7@,?DGZ5]/:=KQT^Q7YL8%>;.%F>K2?,>_P^*HE4 L*L1^)HI.
M17S'??$LP2E?-_6M?P[\0C>3*/,SD^M8\IUV/I2WOA<#@U;7M7$^$=4-Y&AS
MFNX7[HK.P@;I3:5J8,U-QDG:DW4F>*8S4)B)=U+42M3U-4 ZBBBF 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 5[_P#X]7KY[^,'_'M/]#7T
M)?\ _'J]?/?Q@_X]I_H: /SW^,'_ "%)?K6_\ ?^0O!_O"L#XP?\A27ZUO\
MP!_Y"\'^\* /T_\ A3_R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!^G_P *?^1;C^@KMJXGX4_\BW']!7;4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% "4;J&Z4V@!<&E'%%(U "YI:93Z ,_4+O[.I.:YR;Q($D(W5>\3
MRF.)J\HU#4G6Z(SWH ]<TO5A<XYS6[&VY0:\U\(W;2;<FO2+;_5"@"6BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBBDP"FM3J:U2 E%%.JP*MTWEQDUQ
M^N>)A8*QW8Q76:M\MJ:\,^)6H/!#*0<=::$6=2^*Z6\A7S?UIVG>-%UIMH?=
MFOD_Q5XKN(M08!S][UKT?X0:W+>W409B>:L5SW^Y\.'4(-X7.:YZZ\!,S$^7
M7LGAVQCDTN)F'45HMI-NW\-0QG@B> &'_+/]*:_@!O\ GG^E>]_V/;_W?TH.
MC6_]W]*0'@*_#]O^>?Z5,OP_/_//]*]W_L6W_N_I3ET>W'\- SP9O ##GR_T
MK.OO!IA4G9BOHE]'@93A:Y;Q)I,<<3X7M0!\YZAI?V=R-N*98:?YTF,5TWBB
M%8YVP*I^'HP]P,^M &A8>$S<1CY,UI)X 9L'R_TKT3PKI<<L*Y%=M#HL"J,K
MS0!X2OP_/_/*AOA^?^>=>]?V3;_W:/[)M_[M '@G_"OS_P \Z3_A7Y_YY_I7
MO?\ 9%O_ '/TH_LBW_N?I0!X)_PK\_\ //\ 2C_A7Y_YY_I7O?\ 9%O_ '/T
MH_LBW_N?I0!X&?A\W_//]*/^%?M_SS_2O?/[(M_[GZ4?V/;_ -W]* / _P#A
M7[?\\_TIW_"OC_SR_2O>?['M_P"[^E._LFW_ +M '@7_  KYO^>?Z4J_#YO^
M>?Z5[W_9%O\ W/TH_LBW_N_I0!X+_P *^/\ SR_2D_X5^?\ GG^E>]_V1;_W
M?TH_LBW_ +GZ4 >"?\*_/_//]*3_ (5\W_//]*]\_LBW_N?I1_9%O_<_2@#P
M/_A7S?\ //\ 2C_A7S?\\_TKWS^R+?\ N?I1_9%O_<_2@#P,?#YO^>?Z4O\
MPK\_\\_TKWO^R+?^Y^E']D6_]S]* / S\/F_YY_I1_PKUO\ GG7OG]D6_P#<
M_2C^R+?^Y^E '@8^'Q_YY_I3O^%?G_GG7O7]D6_]S]*/[(M_[GZ4 >"?\*_/
M_//]*4?#\_\ //\ 2O>O[(M_[GZ4?V1;_P!VG<#PC_A 6 /[OMZ52N_!)C!^
M2OH0Z1;D'Y:Q-9T>)(V.T4AGSAJ>AFUS\N*RX[3=)C%>D>+[5(BV!7$6J@W
M'O0#+EAX?-PN=M79O"I1<[*Z_P ,6*21KD5T.H::BPDX[4&9X?J6F?9\\5RU
MXH#D5Z=XHMU3=@5YEJ7RS'ZUFRT=%X17]^E?0_@GB%*^>_!Q_?)]:^A?!?\
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MI_H: /SW^,'_ "%)?K6_\ ?^0O!_O"L#XP?\A27ZUO\ P!_Y"\'^\* /T_\
MA3_R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *2EHH *2DW&E% !2T44 <UXJ7,+?2O(-2A_TP_6O8?%!_<M7DVHK_I1^
MM '5^#8]NVO3+?\ U*UYSX/_ (:]'A_U:T 24444 %%%% !112-0 M%,S3J
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M !1110 4444 %%%% !1128H 6BDQ2T %%%% !1110 4444 %%%% !112'I0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M :6I0:0]:%H =2&EI#TH 8U*K4C+2@4 .%+2#I2T <WXHXA;Z5Y+J3?Z4?K7
MJ_BIOW+5Y%J1/VH_6@1VW@]ONUZ3;G,2UYCX-S\M>FVO^I6@9-1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>__ ./5Z^>_C!_Q
M[3_0U]"7_P#QZO7SW\8/^/:?Z&@#\]_C!_R%)?K6_P# '_D+P?[PK ^,'_(4
ME^M;_P  ?^0O!_O"@#]/_A3_ ,BW']!7;5Q/PI_Y%N/Z"NVH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6D!)1110 4444 %%%% #2U*#2-UH6@!U)M%+3<F@!*,44JT  IU%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *]_P#\>KU\]_&#_CVG^AKZ$O\ _CU>OGOXP?\ 'M/]#0!^>_Q@
M_P"0I+]:W_@#_P A>#_>%8'Q@_Y"DOUK?^ /_(7@_P!X4 ?I_P#"G_D6X_H*
M[:N)^%/_ "+<?T%=M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "'I3&:GFHV6@!5.:?3%6GT +129HR* %HI*6@ HHHH *:>M.II% "9I1UHV
MT 4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH :W6DI6ZTE2P%%&VA:6@!FWFGBFYYI5
M/%,!U%%)3 :P^:BFEOFI10 ^EHHH **** "BBB@!,4AXIU(1F@!*7;2;:=0
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M7<*3<OK2NAB+FGTSS4_O4><G]ZF3<?2=*-P]:,B@8FZC=3":,F@"6BF[J=0
MC4UFI6IK47 -U.W5$U :F!/13 U.J;@+12$TW=[TP'T4W=3J "BBB@ HHHH
M**;NI0:0"T4447 ****8!12$TFZ@!U%-W4;J0#J*;NHW4K@.HI :#33 6BF[
MJ6F M%%% !1112 ***3=3 6BDS2T %%%% !1110 4444 %-)IU-;K0 9- ZT
ME%2V ^BF[J=30!1113 **** "BF[J-U  U&30:!UJ;@.HHHIH HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O_P#CU>OGOXP?
M\>T_T-?0E_\ \>KU\]_&#_CVG^AH _/?XP?\A27ZUO\ P!_Y"\'^\*P/C!_R
M%)?K6_\  '_D+P?[PH _3_X4_P#(MQ_05VU<3\*?^1;C^@KMJ "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1#Q24 .I:1:6@ HJM/="*L^;7DBZL* -FBL2+Q DC8R*T[>Z$PR#0!8HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<?$:12?WI_.FZAX$O<'$;?E7-7G@6_W']VWY5V4W$Y9Q9NM\29/^>I_.F_\
M"RI/^>I_.N4;P-J'_/-ORIJ^!;_^XWY5H^4Y;23.M_X65)_SU/YTJ_$B1C_K
M3^=<E_P@FH?W&_*C_A"[Z/JC?E7/[MRO>L=DOQ E?_EJ?SJ"^\=3>6?WA_.N
M7C\.W,/WE:H-0LGCCYS71RJQAS.YVWA'QU.VI1CS#][UK[W_ &;_ ! ]X(,M
MG.*_-7P? ?[4CY_BK]#?V88V'V;\*X:\=#TL/*[/OS0W\S38C[5=D[5G^'5*
MZ7#GTK19=U>.SVX[#0:>M-VXQ3J!@U-S3FJ,]: ';O>ER:CHH FI&IN:=VH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&#_>K[I^"^EV\MK#E5/ I5),21Y'#^SFC*#]G_\ ':>W[.:;?]1_X[7V&MC
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M+J$-G/%4]:\0KIZ$EL8H Z3-&X>M>27WQ0C@E*^;W]:O:/\ $)+Z11YF<^]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% %;4/^/5_I7SU\8/^/6;
MZ&OH:_\ ^/5Z^>_C!_Q[3_0T ?GK\8/^0I+_ +U=#\ ?^0O!_O"L#XP?\A27
MZUO_  !_Y"\'^\* /T_^%/\ R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHIK4 +2TRGT %-:ER*6@!E.7I12T <]XE7?&U>6
MZA9%K@\=Z]=U:#SD(Q7(7&C;IL[: (_"MN4*UZ);_P"J%<SHNG^3MXKJ(AA
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MNE,W4\C--\OWK,T#-%+M%+M%,!M/I,4M, HHHH **** "BBB@ HHHH ****
M"DI:2@!:*2EI:@%)N%+2;: "EI,8I: &4RI=M-\L52%8B)IO.:G\H4GEXIW)
MY2+!IRBGXIPQ4W'R@HIU%%!04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!7O\ _CU>OGOXP?\ 'M/]#7T)?_\ 'J]?/?Q@_P"/
M:?Z&@#\]_C!_R%)?K6_\ ?\ D+P?[PK ^,'_ "%)?K6_\ ?^0O!_O"@#]/\
MX4_\BW']!7;5Q/PI_P"1;C^@KMJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[GZ4T^#U_N?I0!XB?#;_ -TU&WAES_"?RKW'_A#P?X*7_A#5_N4 >&KX7?\
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MD7XT1_\ /?\ 6G?\+IC_ .>_ZT>Q8_;Q/IG[;!_ST6C[;!_ST6OF;_A=,?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% %>__ ./5Z^>_C!_Q[3_0U]"7_P#QZO7SW\8/^/:?Z&@#\]_C
M!_R%)?K6_P# '_D+P?[PK ^,'_(4E^M;_P  ?^0O!_O"@#]/_A3_ ,BW']!7
M;5Q/PI_Y%N/Z"NVH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $HW4-T
MIM #L9I-M+10 VE7K0U(*!#J6J\UR(^IJF=74'&:!FI15.WOA-WJV#F@!:**
M* "BBB@!,T;J1J2@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #2*-M.HJ0&XQ3J**8#
M*?44C;5K,O-96U!);%,#8HKC9_'D,+;2ZU;T_P 71WK !@:!'2M2[JBAD\Z/
M<*?0,=2TB]*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBBE< HHHI@%%)FEI7 ****+@%%%%, HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "D)I:1J &TX=*3;2T 4M6_X]S7AGQ+_X]Y?I7N6K?\>Y
M^E>'?$K_ %$OTJD2SY0\8?\ (2;ZUZ)\&_\ C\A^M>>>,3_Q,F^M>B?!P_Z9
M#]:0'VEX5_Y!4?T%:[5D>%?^05']!6NW2D/H(M.I%I: "BBB@84444 %%%%
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M#N'I7UQX4:(Z>H3&[ KY ^'+?85C[8KZ$\+>*1;QK\_;UK*<N8TCJ>KUX/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KW__
M !ZO7SW\8/\ CVG^AKZ$O_\ CU>OGOXP?\>T_P!#0!^>_P 8/^0I+]:W_@#_
M ,A>#_>%8'Q@_P"0I+]:W_@#_P A>#_>% 'Z?_"G_D6X_H*[:N)^%/\ R+<?
MT%=M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^"P\0.RI:%<\/FT62,<K5*2U,;8(KVK7/"8MXV.W%>::S8>3*1BFD3+5&!'
MSG J[#I<C] :T-)L/.D Q7H&C^%Q,J_+5F*AJ>9OHDS#H:EL]!E60'::]HA\
M#AE^Y5B/P.%8?)4-G5'1'">']-DC9>#7=K$RV1SZ5IVOA80D?+5G4-/\FS;C
MM1%F-34^4_CP<6MQ]#7YU?%IO]/E_P!XU^BOQ^^6WN![&OSF^+)_T^7ZUZU%
MG@5UJ9OPX_X_X_K7W]\ ?NV_X5^?WPX;_3H_K7WY\ &^6W_"M*KT%A]S[?\
M!_\ QYQ_05V$?W:X[P:W^B1_05V2?=%>1+<]Z.PV0\TVG2*::,UC8L<*&I0#
M2,I]*8"4ZD"FEI@&:<.E-I=U2 ZBD!I:8!1110 4444T 4444P"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!E.
M7I3:* '-3":=V-,:@!RMS3ZB6I* %HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** &D4;33J* &@4ZBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** $)Q1NI&I* 'T444 %%%% !1110 4444 %%%% !1110 4UJ=36H !1N
MI** $QDT[RU]*2G4 )Y:_P!T4;5_NC\J4G%&Z@ VCT%&T>@I:* $VCT%&T>@
MI:* $VCT%0W4*/&<BIZJWSE8S0!YYXPA01O@5XYJR 73?6O7O&$AVO7CNK2'
M[2WUH ZCPDH\Q,UZKI\"-;CBO)?";'S%KU?36/V8?2@#FO%ENNU\"O*KZ,?:
M3]:]4\62'RWKRJ^D_P!(/UH [+P?"I9<BO8M"MX_+7BO&O",OS+7L&AR'RUI
M =((U'&T4AC4_P (I4;<H-*6Q3 ;Y*?W12^6O]T4;J=0 FT>@HVCT%+24 )Y
M:_W11Y:_W13J* &>6G]T4>4G]T4^DS0 WR4_NBCR4_NT[=0#1<!/+7^Z*-B_
MW1^5+368T +Y:_W12>6G]T4PN:3>:0KDGEI_=%'EI_=%1>8?2E$AHN,E\M?[
MHH\M?[HI@<T\-3$)Y2?W11Y2?W13MU&ZBXQOEI_=%+M7T%+2;J %VCT%)M7T
M%&ZC=0 >6O\ =%&U?[H_*C=1NH -J_W1^5+M'H/RI-U)OH =M'H/RI-J_P!T
M?E3?,-&\T /VCT%&T>@I-U+F@!-B^@H\M?[HHW4UI,4@'>6O]T4;5]!31)3@
MP-%P%VCT%4-4MT,#' '%7BV*S-6D/EGZ4 >2^-(5!?BO-9% N/QKT?QE(<O7
MF[L?M'XTG(7*=]X0524XKV+08$\D' Z5XUX18Y2O8_#\A\I:7,/E-K8OH*3R
MD_NBGTFZK -H]!6'XFA0VI..<5NUS_B=C]G;Z4K@>#^-(0)7QZUYU-PYKT/Q
MI(?,>O.;AB7-/G*L1H?WHKTOP+&&DCSZUYA&Q$HKTOP)(?,C^M',.Q]#^'8T
M6Q! YJUJ<2M9OD=*I>&6W68^E7-6;;9O1?J18\3\<1JLDF*\_MP/M7XUW?CA
MSYDE>?6\A^U?C1S%V/6/!<:G9FO6=.@3[..!TKR'P7(?DKUK36/D#Z4-DV,3
MQ= GDOQ7AOB:,"=L>M>W>+'/DO7B'B1OW[?6A,!GAQ!]H7ZU[-X9@0QID5XS
MX=)^T#ZU[)X98^6E4%SM[>W18QQ4OE)_=%1VK?NP*FS4B&^4G]VLCQ#&%LW(
M':MG-9'B#YK-_I3CN3+8^,_VAFVQ7/XU^<GQ68M?R_[QK](/V@[<O#<<>M?G
M7\4[$_;I>.YKUZ"/$KK4Q/ANI:^C^M??'P#^5;?\*^%OAO:E;R/CO7W?\"X]
MJV_X5K4CH8T[IGVMX+D'V6/Z5W$9^45YMX5NO)M$YQQ6_+XJ2U7EZ\B<=3V:
M<M#K*2N)7QY$\F/,'7UK1A\3)*F[?^M9V.CF.FHKDKGQE';]7_6J/_"PH6;'
MF#\Z.4=SNZ97-6/BE+S&'S6];R^<N12L"U+&,T;30M.J1B+2T44 %%%%, HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *:U.I* $7K3J2EH 93EZ44M #6I*?24 +1110 4444 %
M5;U=R$5:IDB;A0!YUXGT]IE; KR_4?#LCW!.WO7T%=Z4+CJ*R9/"*2-G90!Y
MIX9T-X67*UZ39V96 #':KEKX<2W_ (<5J+9A5QB@#SOQ-IK3*V!7F]YX=D:<
MG:>M?0-UHZW&<C-9LG@]&;.R@#S?PQHKPE<BO4-'@*(N13[7PVEOT6M2&U$(
MZ4 68_NBD:D'I3L9H *?3*<.E "-0O6EHQ0 M%%% #:2E/6F4@'44BT_%2T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/Z"NVH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% "&FL#BGTC=* (P.:D6D6G4 )6#K7B6/3(W)8# K8O)A#;NQ["OFCXV?$#^
MR89\2;< ]Z %^*'QFCL8Y0)P,9[U\C?$+XX27%Q($G_6O/OBM\7)KNZEC68G
MD]Z\ML6N_$5UGYFW&@#M]1^)EY<EB)&/XUEVOQ*O;>Y!,C 9]:Z?0?A5<WT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% "4VGTW;0 J]*6DH)H &I,T9I* '+2TB]*&X4T 8/BR
M^%KI\ISCY:_/_P#:<\7-#]I4/CKWK[=^(U]Y6G2\]C7YI?M0:JS3W(W=S0!\
MQZE>/K&M%=Q.6_K7TM\"?A;_ &MY#-'G..U?,G@^(WGB!,\_/_6OTD_9CT&/
M[);,4["@#U#P7\#X191YA'3TK/\ B3\$8ETV5A#V]*^FM"MDM[% J@'%4O&E
MG'=:+-N4$XH _'+XZ?#O^RKR8A,8)[5Y%X-NWTO5T&XC#5]G?M0:.D<UP0OK
M7Q05-OK>!Q\U 'Z%?L[^+F:*W4OZ=Z^WO!>H?;+6,YSQ7YM?L[7S[K<9[BOT
M*^%LQDLXLGM0!Z+28I:0F@!:IZE#YT)7VJR&I2NX4 >6^*/!(U+=E,YKSZ\^
M!T=Y,28L\^E?1S6J-U%.6WC7H@S0!X1I/P!@C3)A'Y5C>-/@O#;VC_N0./2O
MI6N4\?7L%OIK"0C=B@#\N?V@?AS'9K<83&,U\1Z]H_V/56QQ\U?HW^TMJUNR
MW(4KWK\_/%'^E:PX7GYJ /9?V?IGCO(1D]17Z9_!*X=K2WR>PK\X?V>=#EEO
M(3M/45^F'P;T=K>SMR5QP* /H/3SFUC^E6*@LUV6Z#VJ>@!,"EHIC-0 ^BF!
MJ=0 M%-R:6@!:**3<!U- "T4SS$_OK^='G1_\]%_,4 ,NXS);NHZXKY_^,5J
MPM9^.QKZ DNX8D+-*H ]Z\-^,>J6DEI/M=>A[T ?G)\8HRNJ2_[U;GP!_P"0
MQ!_O"LSXS312:I+M(/S5J_ -?^)Q ?\ :% 'Z?\ PH_Y%N+Z"NVKB?A3_P B
MW']!7;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4RGTW;0 JTM(.*6@ HHHH ***
M* "DH)Q2;J .>\0QF2-J\[O--9KCI7K-Y:><I&*Q9-!#29VT",CPW9F/;Q7=
M6_$8K+L=-$&.*UHQM&*!CZ*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9F
MGTRD 44W)I5J0'+UIU-7K3JL"KJ"[K<BO'_B!I;7$,N!GK7LTR[XR*YG6M!%
MXI&W.:I"9\5>*O",LM\Q"'K7<_"KPY):W41*GK7L=]\-4N)BWEY_"M;P_P"!
M5TZ12$QSZ4,$=SX=3R]-C'M6I5:SC\B (*GW5(QU%)2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4FT4M% "4M%(30 M)2 TZ@!F:<M-IRT +1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%)29- #J*04M !1110 4444
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M-+A?^ ?E3/['A_NC\JGVK*]DCY+O/@3')G]S^E4/^% 1%O\ 4?I7U^VAP'^
M?E3/[!@_N#\J?MF0Z*/D9?V?XO\ GA^E(WP!C_YX#\J^O/[#@_N#\J8="@/\
M JE6D+ZO$^1#\ HO^> _*FGX!QY_U'Z5]>?V##_<'Y4G]@P9^X*7MF+ZNCY$
M_P"%!1_\\/TI?^% Q?\ /#]*^N_[ @_YYC\J7^P(/[@I^V8O8(^1/^%!Q_\
M/ ?E3#\ 8_\ G@/RKZ]_L"#^X*/[ @_N#\J/;,/8(^0Q\ 8_^> _*G_\*!C_
M .> _*OKK_A'X/\ GF*7_A'X/[@J?;,/8(^0O^% Q?\ / ?E1_PH&+_G@/RK
MZ\_L"'^X*/\ A'X/[@_*J]LQ^P1\@M^S_$1_J!^5):_L_P <<P/D=_2OK_\
MX1^#^X/RH'A^#^X/RI>V8O8(\7\ _#--'>,B/&/:O=-+@^SVBIZ4R#3(X<86
MKRKM&!6,I7.F$>5"T44W)J#0=12+2T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%)0 M%)D4M !36IU-84 )12X-% "BDD_P!6WTIU,F_U
M;?2@#R7XI7!6PFY[&OS,_:8N2UW<?4U^E/Q8;_09_H:_,O\ :38F\N/J: /%
M?AN _B"//]^OU!_9IA7^S[;Z"ORZ^&\FW7H_]ZOT^_9INA]@MN>PH ^P--7;
M;K]*K^(EW:3-]*GTMMUJOTJ'Q%_R"9_I0!^>_P"U'"-UQ^-?!VH+MUP_[_\
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MOHRPLUM;=$ Z"@"Q&NU *7-&<4C=: #=28I=II10 VEW4-3=U #MII:*.YH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G%+36H 7=2TRG
M4 &:*:6YIRT (U)3FIM #J-H]*133J $VCTHQBEHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *93Z928#<&E44M%2 J]:=3*=NJD M-VCTI:6F WRU_
MNC\J-H]!^5.HH :>*2@]:* '4M)2T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44FZFEZ  M1
MG-,ZTY5H <!3J*2@!M.6FTY: %HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** $HW4-TIM #LTFXTW=3<T 2YHIJFG'I0 FZC::2GT (*6BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1ZU5U"?R5-8$VL!9,;J .L64-4E8.FZAYV.:W(SN4&@!U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% #6ZTE!I5J0$HIVVC;5(8QFQ4;72Q]33;J3R
MU-<GK6MBU5B6Q5VN9W.G;5HEZD4^/4HY.A%>*ZEX]6&8CS,<^M;/AOQ>+V11
MOSD^M*P<QZPK;JD6J>FR>=;ANM7:DN]PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"-LU'
MS4^VF[* &H*DI.AI<T +24C-3=U "TY:1:=0 44UJ2@!]%,I] !1110 4444
M %%%% !112-0 M%,IU "T444 %-:G4C4 0M0HI2/FI10 JTY:2E6@!U%%)NH
M 6BD%+0 4444 %%%% !1110 4444 %%%-:@!U%-7K3J "BBF4 /HIJTZ@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HI#TI-IH =1110 4444 %%%% !36IU)0 VGTF!2TP"
MBF4Y:0"T444 %,I])BI 6HKA=T9%/:F-0!Q/B/P\M^&RN<UP-U\-HY9B?*'Y
M5[=);"3J*A_LU"<XK0D\RT'P*EFP(CQ^%>A:78"U10!6A'8I'T%3",+TI,92
MOK?SHB*\]\1^#DOF;*9_"O4&CW56FLU?M058\2MOAS''/N\K]*ZJS\)K#"%V
M=J[O^S4'.VG+:J!TJN<@\LUCP.EUG]WG\*Y]/AC&)@?*_2O<C8*_;-"Z4F<[
M:S<V,X#PWX02P92$QCVKTC3H_)@"TR.R6/H*LK\HQ0G<9-13*,TP'TA%)N-(
MS'% !13<FB@"1>E+35IU !1124 +13,TY: %HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TC4 )
MNIU-VFG4 %(1FEHH 3;2T44 %%%% &;KEF+JT<8[5\>_'_P";^.X(CSU[5]I
M2+O0J>XKSCQQX+35XI!LSGVH _'#XE^ Y]-OI76,C#'M7.^&_&%WX9G #,NT
MU]_?%SX&"X$S+!GKVKY-\:_!*YM[B39 PY]* -GP_P#M&WEG;*OGL,#UK/\
M%?[0%YJT3)YS'/O7 _\ "K=1C) C?\JL6/PGU">8!HG/X4 <QJ6HW?B2^).Y
MMQKW'X'_  YENKR!VC)Y':KW@'X$SS31EX&//I7V'\'_ (.KIJPLT.,8[4 >
MC_!WP6+"SBRF, 5U?Q"D;3=-?;QA:[+PWHZ:;:J N,"N=^)VG&\T^0*,_*:
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MZ5\__&%E^RS_ $->^:EG[*^*^>OC!G[-/]#0!^?OQB8?VI+]:V_@'_R%X/\
M>%8/Q@S_ &I)_O5O_ +_ )#$'^\* /T]^$__ "+L?^Z*[BN)^%(_XIR/Z"NV
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II-.II% !N-.INT
MTZ@#GO$,QCC:O.+[4RMQC->A>*N(6KR/4G/VL_6@1Z%X9O#)MYKN[<YC%>9>
M#V)VUZ9:_P"I% R:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!-M&
M,4M%+J 4444P,_5CMA)KQ_Q[J;6\,F#7K^L?\>YKPKXF9$$N/0UK$SD>$>)O
M%SQ7S#?WKN/A?XC>ZN8@6SS7AWC&1QJ3_6O1?@W(QO(<^M-F9]M>&I/,TY#[
M"M>L3PG_ ,@J/Z5MUDS:.P4444B@HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV<?]\TO_  HN+_GW'Y5]7?V#;_W?TI/[!M_[H_*@#Y/;X$P-_P NX_[YI/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M )D44VG+0 M%%% '.>*O]2WTKR+4E_TH_6O6_%+?N6KR74F_TH_6@#KO!XQM
MKTNV_P!2*\V\'G[M>E6_^J% $M%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1112Z@%%%%,#/UC_CW->&_$K_ %,OT->Y:Q_Q[GZ5X3\3&VPRUHMC
M*1\K>,E']I-]:]"^#JC[9#]:\V\93_\ $R;ZUZ+\&Y-UY#]102?:WA/_ )!<
M?T%;=8OA/_D$Q_05M5#-H[!1112&%%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***;NH =12 TM !1110 4444 %%%)0 M%)C
MWHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O?_P#'J]?/?Q@_X]I_
MH:^@]0_X]7^E?/7Q@_X]9OH: /SY^,'_ "%)?K6_\ ?^0O!_O"N=^,#?\327
M_>K?^ #?\3B#_>% 'ZA?"G_D6X_H*[:N)^%/_(MQ_05VU "8HQ2T4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% ";112TE "-2KTH^]10!S'BG+0M]*\
MGU"(_:OQKV+7H?-C;BO/;S22UP3CO0!I>#XRNVO2K?\ U*UQ/ANQ,.WBNWAX
MC% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD)I=0%HINXTH
MI@4-77=;M7AOQ+MRT$N!VKWC4%W0D5Y7XVTDW,3X7-:(REN?%GC#37;4FX/W
MJ]&^#=BT=Y#D=Q6AXB\$/->$^7W]*[/X;^%6L[B(E,<^E#&CZ0\*KMTF,>PK
M8K.T&/R]/1?:M&LS0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/KVO%G8!N]9^G%KR4<YS0,W5UB9NA-.DUB9%Y)K6TOP[YT8.*35O#_E1DXH
MR+?Q,ZR %JZ_0]?\[;EJ\MU*)K64]JNZ'K)CD4%J!GN"W0FMSSVKS3QTNY7K
MI])U030 9[5S7C1@T+&@1XIJ4WDW1[<UM:)KC1X :N<U[/VIL>M6= M7E9:
M/3++7I748:KO]L3>IJKX?T%YE7*UTS^%V$.=O:@##C\121MRQKHM'\1^8P!:
MN-UO37LR>,8K*T_5&MY@"V.: /?]+OUG0<UH/(%4G-><^&M<W*N6KI[C5AY!
M.:!$NJ:LL*GYL5P6O>)MK, U0>*/$!3< U<))>/?38!)S0,VSX@FDDX8]:NQ
MZQ/LSDTS1/#;W6"5S74Q^$#Y7W?TH Y-M>FC;EC6YH_B4[@&:JNL^&6MU8[:
MY&XF?3YO2@#V_2M:691\U=!#<"1>M>'^'_$AWJ"U>FZ)J?G1KS0!T[-14<+>
M8M2[: % XHHR*,T 1395<URVO:B;=&.:ZBX8;#7 ^,9-L+_2@#E;WQ8T<^-]
M;_AS7S=,!NS7CVKWC+>'GO79>!;HM(F30![EI[&2,&KFT5GZ0X-N/I6AF@!C
M+2*M/:DH 4C%5[@GRS]*L9S4<T>Y30!Y?XVC9E?%>0WEN?M1)]:]Z\4::9E;
MBO)]<TAH9&8+0!J^#V2,IFO7-&OD"* >U> Z=?26<@'(KT'P[X@+;06H ]<5
MQ(,BJMSIZSU3TG4XY$&6[5K+(K#(8&@#)&AKNS@5))9BWBR!6I5746VVS4 <
M%XEU0PJXS7E6M7C74Q&:[?Q?,=SUP(C,MQ0,MZ#H?VF8$C/->O>%_#RPQH=M
M<GX3L1E"17K&DQB.W&!0(LP0B&/ J2@]*1: (YX!,IXKBO$^BB16^6N[K)UF
M(21MQ0!X#KVD^1(Q [U!HMXUK.!G'-=GXJLOO<5P+*8;@]N: /7]!UG=;CFL
MWQ5K!\MANKG]%U K$!FJGB"\,BGF@1S\TAO+K&<\UVGAG01(5)6N0TF'S+H'
MWKV#PK:A8TXH&;^AZ:+=1Q6_TJ"W4*HJ<]*  X/%4KG3UF[5;IV: ,/^P5#9
MVU<M]/$/;%:-% #(UVBGT44 %%%% !1110 4444 %%%% !36IU(1F@!!3J;C
M%&30 ZBDI: "BBB@ HHHH 2BEHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *0FEIK4 &ZEW4VB@!]%%% !1110
M4444 %%%% !1110 4W::=10 BTM%% !1110 4444 %%%% !1110 4444 %%%
M% !2;J6FMUH 4&EIJTZ@ HHHH **** "BBB@"MJ'_'J_TKYZ^, _T6;Z&OH:
M_P#^/5Z^>_C!_P >T_T- 'YZ?&!?^)I+_O5O_ !?^)Q!_O"L/XP?\A27ZUO_
M  !_Y"\'^\* /T_^%/\ R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"O?\ _'J]?/?Q@_X]I_H:^A+_
M /X]7KY[^,'_ ![3_0T ?GO\8/\ D*2_6M_X _\ (7@_WA6!\8/^0I+]:W_@
M#_R%X/\ >% 'Z?\ PI_Y%N/Z"NVKB?A3_P BW']!7;4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"MJ'_'J_P!*
M^>OC!_QZS_0U]"ZA_P >K_2OGKXP?\>LWT- 'Y[_ !@_Y"DO^]70_ '_ )"\
M'^\*YWXP?\A27_>KH?@"W_$W@_WA0!^H'PI_Y%N/Z"NVKB?A3_R+<?T%=M0
MUNM"TN*,4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO"?.EQ_05MUA^$1C2D^@K<K)FL=@HHHI%!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4UNM.I,4 (M.I,4M !1110 4444 %%%% #,4Y:-HHH 6B
MBB@ IE/I-M  M+24M !1110 4444 )11BC;0 M%%% "4UN:=BC% $>RG**=1
M0 M)2TF* "EIO2C)H =1110 4444 %%%% !1110 444E !FC-&T4;10 9I:3
M:** %HHHH ;MI:6B@ HHI* #-+2;:6@ I&I:3% "+2T8I: &4X4;:6@!K4F,
MFG8HQ0 ;:6BB@!E.6C;10 -3:=1MH 6DQ2T4 )12T4 )TI:** "BBB@ HHHH
M *93Z3;0 BTM)TH!H ,<4N:6DP* %HHHH **** "BBB@ I*6B@ HHHH *2EI
M,4 %+28I: "DVTM% "4M%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% %;4/^/5_I7SU\8!_HL_T-?0U__P >KU\]_& ?Z+/]#0!^>GQ@'_$T
ME_WJZ#X _P#(8@_WA6%\85_XFDO^]6[\ ?\ D,0?[PH _4'X4?\ (MQ?05VU
M<3\*/^1;C^@KMJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3=
M13:<.E !2;J&I* ,?6+3[0C#%<7=>&_,FSM[UZ6T(DZU =/0\X% ',Z%I/V;
M'%=;"NV,"F1VJQ]!4PXH 6BBB@!NZE%-IRT +1249% "T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 E)MIU%(!N<4N:::5:D!U%)15@4M0C\R,UYQXL\,F^C<;<UZ@R;N#5>33
MTFZBM+D6/E'7/A.;JZ+>5W]*ZGP)\.SIL\9,>,>U>]MX<MI&R5%20Z'# <JH
MI<P6%T.#[-9JE:.ZHXXQ&N!3JDH?124M(84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% "$4FVG44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44F110 M%%%
M!1110 4444 %%%% !1110 4444 %%%% !129HS0 M%%% !1110 4444 %%%%
M #2* *=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%)1D4 +1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[_ /X]7KY]
M^,'_ !ZS_0U]!7__ !ZO7SW\8#_HT_T- 'Y\_&'_ )"DO^]6[\ ?^0O!_O"L
M#XP?\A27ZUO_  !_Y"\'^\* /T_^%/\ R+<?T%=M7$_"G_D6X_H*[:@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBF4 /HIJTZ@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFMUH =135ZTZ@ HHHH
M**** "BBB@ HIE*M #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFM0 A-%,-.6@ /
M2A>M//2D7K0(44M(:0M0,=12;J6@ HHHH ***:W6@ :DI5I: %HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHIE)@*W6DHHJ0%7K3J:O6G58!1129H 6BDW"C=0 AI*=3: '4
MM(O2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!E*M+2T %%%% !1110 4444 %%%% !1110 4444 %%%
M% #6ZT+UI:* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@!K4E/I* %HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** *VH?\>K_2OGKXP?\ 'M/]#7T+J'_'J_TKYZ^, _T:
M?Z&@#\]_C!_R%)?]ZNA^ /\ R%X/]X5S_P 8!_Q-)?\ >KH/@#_R%X/]X4 ?
MI_\ "G_D6X_H*[:N)^%/_(MQ_05VU !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %)MI:* $QBEHHH **** "BBB@ HHHH **** "BBB@!*3)I:3;0 HI:04M !
M1110 4W)IU-VT *M+2 8I: "BBB@ I,4M% "8I:** "BBB@ HHHH **** $V
MT8Q2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M44 %%%% !1110 4444 %%%)0 9%%-IRT +1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %)FEIK=: %S2TU>M.H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,(.I-]:](^#,8%W#CUIL1]K>&6W:5$?:M:LCPO\ \@F+Z5KU!04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6U
M#_CU?Z5\]?&#_CUF^AKZ&O\ _CU>OGKXP#_1I_H: /SV^,'_ "%)?]ZNA^ /
M_(8@_P!X5S_Q@'_$TE_WJZ#X _\ (7@_WA0!^G_PI_Y%N/Z"NVKB?A3_ ,BW
M']!7;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 44C4F30 M+24M !1110 4444 %%%% "-3:=1M% !2T44 %%%% !136
MD5>K ?C49NH5ZRJ/QH FHJ'[9 >DR?G3UF1NCJ?QH ?124M !1110 44UJ :
M '444A8#J<4 +14;7$2]9%'XTS[9!_SV3\Z )Z*B%U"W213^-/$BMT8'\: '
M4444 %%%% !12%@O4@4PW$2]9%'XT 24E1BYB/21?SIZR(W1@?QH 6EHI"P'
M4XH 6BF&:->KJ/QIOVJ$?\M5_.@"6BH/MUN/^6R?G1]NM_\ GLGYT 3T5"+R
M ])4_.GK-&W1U/XT /HI P/0TM !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M-R:,F@!2,T4FZG4 <YXI_P!2WTKR+4F_TH_6O6_%7^I:O(M2!^U'ZT"1V/@\
MYVUZ7:_ZD5YGX-'W:],M?]2*!DU%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %)2T4 ,I5I<"BI 6BBBJ H:M_Q[GZ5X5\3&_<R_C7NFK_\>Y^E>$_$Q?W,
MOXU:,I,^4/&#?\3%OK7H_P &7_TR'ZUYOXP4_P!I-]:]%^#:XO(?K5$IGVQX
M5.=)C^@K8;I6+X2_Y!,?T%;3=*S9LMA%IU-6G4AA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[_P#X]7KY[^,'_'K/
M]#7T)?\ _'J]?/?Q@_X]9_H: /SV^,!_XFDO^]6_\ 6_XG$'^\*P/C!_R%)?
M]ZM[X _\AB#_ 'A0!^H/PI_Y%N/Z"NVKB?A1_P BW']!7;4 %%%% !1110 4
M444 %%%% !1110 4A.*6FM0 NZC=3-U&Z@!^12TQ6R:?0 4444 %-YIU% #>
M:,FG4C"@!,T;:8IJ04 %&:;3J!#6:A6IV*6@8E+110 4444 )1D4'I3"U $E
M%(O2EH 0G')K"USQ%%I\;$N!CWI/$&N)I]NY+8P*^8_BY\8$TU9E$V.O>@#O
M_&'QBBTS>!.!CWKQ[7_VEOLCL!<]/>OE_P >_&B74+AT28G)]:\PU+6]0U3+
M(7.: /MC3?VI#-<!3==_6O7?!'QQCU4H&N <^]?E?'?:G8W&]MX&:].\ ?%B
MXTJ>-9)6&#W- 'ZX>'_%4.H0J1(#GWKI8IEF7*FOB?X3_&A+U84,V3QWKZC\
M(>)EU&!"'SD4 =S14<4GF+FI* $(H Q2TR601J2: ([BZ2W4ECBN"\6>/(=+
MC<^:!CWJG\0O&B:3#)^\Q@'O7Q[\6/C5M:9%F[GO0!ZWXP_:"739'"W&,>]>
M?M^U*1/M^U=_6OD;Q7XZO-8F?RW8Y]#7'>=J;2%_GQ0!^AV@_M)"ZD4-<_K7
MLO@OXL1:MLS,#GWK\F['Q;?:5,I=V&#ZU[O\)?C))'<1(\QZ^M 'ZEZ3J27\
M 96R:T*\&^%/Q&34;>',F<@=Z]LT^^%Y&"#GB@"[5>\NUMHR6.*L5YM\2_%B
M:-;S?/C />@"MXR^(L.D(_[T#'O7AOB?]HZ/3YF N0,>]>,_&CXT&-ID2;U'
M6OCSQ[\5KN::0K*WYT ?HOH?[327ERJ?:L\^M>X^ _B0NN^7B7=GWK\8? 7Q
M-O)-4C#2M][UK]#_ -FOQ-+J'V;<Y/3O0!]WVTGF0(WJ*P?%6M#2X68MC K8
MTEMVFVY_V:\P^-6I-9V,I!Q\O]* //\ QA\;UTB1QY^,>]><WW[3@C8@7/ZU
M\V_&KQQ<0W<P60CD]Z\+/BN]O)B ['GUH ^\)OVHFW'%S^M5_P#AJ5PX_P!)
M_6OB[3TU&\Y!?FKYT74RP.'H ^X]!_:0:\D4?:,Y]Z]B\&_% ZML_>9S[U^=
MW@W3-1CN(\ANM?5OPEM[I/)W[J /L?0]0^V1J<YK8KD?!>X6Z;O2NNH 3=1N
MI&ZTE #Z*3(I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** $VTVG9%(: $I],IV10!SGBA"T;
M5Y3J5LWVH\=Z]CU>W^T*1BN/NO#YDF)VT"1#X1A*[<BO2+?_ %0KF-%TLV^.
M,5U,0VH!0,?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %'5ES;GZ5XC\2+9GAEP.QKW2\C\R,BO/\ Q5X?-[&XVYIW)Y;GQ+XMTN1M
M18A#UKT'X0Z>\=W#E>]=MK7PR>XNBWE]_2NG\#^ VT^="8\8/I1<.4]L\+KM
MTN,>U:]4])A\BS1:NTBA ,4M%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 5[_P#X]7KY[^,'_'M/]#7T)?\ _'J]
M?/?Q@_X]I_H: /SW^,'_ "%)?K6_\ ?^0O!_O"L#XP?\A27ZUO\ P!_Y"\'^
M\* /T_\ A3_R+<?T%=M7$_"G_D6X_H*[:@ HHHH **** "BBB@ HHHH ****
M "F-WI]-:@".EVFG4[;0!4N)_LL9<]!7)ZM\2K72V*R.O'K6SXRG-KHLL@[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% #**?10 RBG4V@0PQ"3K338QGM4RTZ@$1);I'TJ
M2EHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E  R[
MJKRV,<WWA4ZTZ@#+?P]:R')7]*EAT6WMSE5Q^%7Z* &JH1<"G4G>EH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!\$^#?%$^@ZHB%RNUO6OOO\ 9O\ B.UY]G0RYZ=Z_._Q7I[:;KCA1C#U]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O\
M_CU>OGOXP?\ 'M/]#7T)?_\ 'J]?/?Q@_P"/:?Z&@#\]_C!_R%)?K6_\ ?\
MD+P?[PK ^,'_ "%)?K6_\ ?^0O!_O"@#]/\ X4_\BW']!7;5Q/PI_P"1;C^@
MKMJ "BBB@ HHHH **** "BBB@ HHHH *C;-24UJ (P*EIM/H Y?XA_\ (OR_
M0U^97[2H_P!,N,^IK]./'R[O#\OT-?F9^TXOEW-P?<T ?+_AV.,ZXN['WZ_0
M+]F>S@=;;IT%?FU;ZZ+'6\DXPU?9?[//Q4BT_P"SAI0,8[T ?I]I5G"NF1J
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M ^I$U".1<AA7C?Q>Q/;2D<\5S7A?XT0ZEM43 Y]ZTO$VI#6K%B#NRM 'P/\
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M%J\HU"Z(NCSWI"1Z1H-_YV.:["$YC%>:^$9BVVO2+?\ U0IC):*** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M5[__ (]7KY[^,'_'M/\ 0U]"7_\ QZO7SW\8/^/:?Z&@#\]_C!_R%)?K6_\
M '_D+P?[PK ^,'_(4E^M;_P!_P"0O!_O"@#]/_A3_P BW']!7;5Q/PI_Y%N/
MZ"NVH **** "BBB@ HHHH **** "BBB@ IK4ZF-WH *?4524 <]XZ_Y ,WT-
M?F9^U)_KKG\:_3'Q\VWP_-]#_*OS,_:;D#W5P,]S0!\'ZUYJZLQ7/WJ])^'G
MB:[TUH\,PQ6-_8*WVI'C/S5Z?X4^'#3HA5* .RA^*][%8A?-;IZUY?X\\97F
MM;UWLV?>O4G^%=RT/$;8^E4+?X,W%U<@-"3SZ4 >!^&?!MUJVK(Y1CEO2OT!
M_9>^'\EBUNSQD=.U8_PM_9[_ 'T3M;_I7V-\,_ANF@PQ8BVX]J /6?#=D+72
MX!C'RUKU#:J([=%]!4FXT ,N%W1D5P7B[PZ-0B<%<Y%>@-S56XLQ+D$4 ?)'
MCCX,IJC.?)SGVKRN^_9KCEF+?9__ !VOO:Y\.QS9)0'\*I-X/A;GRQ^5 'PM
M'^S7&%_X]_\ QVB3]FF-E_U'_CM?=7_"'P_\\A^5)_PA\/\ SS'Y4 ?"UG^S
M3''(#]G_ /':]*\&_!---DC(AQCVKZ@7P?#_ ,\Q^56H?#<<.,)C\* .2\'^
M%QIT:#;C%>DV:^7"!56WL5AQ@5<7Y1B@"6H+R/S;9U]JDS3F&Y2* /G3XQ>$
M#J%O,0F>#VK\[_CE\-9X[B=UB/4]J_7;Q!X=34H7!7.:^</BE\%4U192(,Y]
MJ /R6L[.\T+4,X9<&O:O!OQ3N])MD4RL,>]>G^//V?7@GD9+?'/I7EVI?"V[
MLBRK$P_"@#6\0?&2[U* Q^<QS[UY?>6=WXFOLD,V378:3\,[RYN%#1L1GTKW
M?X8_ E[F:)G@S^% '.? KX52_:()&B/4'I7W;X(\,'3=,3Y,$*.U1?#/X/Q:
M7;QGR0,>U>N+H*VMKL"XXH ^:/C-JDVGV<NPD8%?"GC_ .(%]%JT@$C?>]:_
M1#XR^$7U"UE"IG(KXA\<?!VXN-4=A$W+>E %CX-^-KR[NH59V/([U]I^#DDU
M+3%W<Y%?+?P?^%,]C>1%HB,$=J^W?A[X7^SV$:E>U 'SS\:O ;7EG,1'G@]J
M^!OB-X)NM-U*1U1AAO2OV1\6^ TU.U<&/.1Z5\H_%?X"BY:9UM_7M0!\/^"?
M%=YH+J-[+BO5(_C9=_91'YS=,=:K^)O@S<:?(^R%A^%<DGP[O?/V^6W6@#+\
M9>-+S7)&&]CN]Z?\.O"]UJ6HQLR,<GTKO/#_ ,&[B^F3="Q_"OH_X4? O[/)
M$[0?I0!U?P/^'I^SP%H^P[5].:3X!A-NNZ,=.XJ#X?\ @M-)M8_W>,#TKT5%
M$:A1T% '"77POM+G.46LN;X*V4ASY:?I7J-% 'A'BKX(VJVSE8E/'I7R)\=O
MA;'913[8L=>U?I'K.TV3J><BOEWXV^&_[1AFVIG.>U 'Y6ZMX1:/7"NSC=Z5
M]9?LS_#U;JXMRT>>G:N;U;X7ROK)?R3][TKZ=_9Y\)G2Y(-T>,8[4 ?3'@_P
M)%8:3"0@!VUY3\;%FT^UG\K(P.U?1NG@+8P@?W:\Z^)_@\:Y;R )G<* /S#^
M(?C/4;'4I,.X 8]ZK^&?C%?6F TS#\:]T^*GP'>::6183U/:O ]:^%-WILC;
M8F&#Z4 =1J/QRNFMV43MR/6O#?B%XXO=<D8!V;)]:Z5O M])+MV-6_H/P5N-
M3F3?"S9/I0!X?X8\%W>N:@K,C-D^E?:WP#^$KP?9W:'T[5T'PM_9W$3Q.UMZ
M=J^M_A_\,(M'MT_<@8'I0!N_#3P^-+MHAMQ@5Z-5'3[%;-  ,8JUNH <:2D_
MBIPZT .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4 ,AA6% JC J2BDW4 +2&BAJ *=]"9E(K@_%'@T:DC IG/M7HX7-(8T;JH-
M'SA=?!M)+G?Y/?TKN?!O@0:.RX3;CVKU/[+"?^6:TOV>->0N* &VP\N%%]!2
MW-NEQ&0PS2$XXIRMNH X;Q-X)@U"-_W8.?:O(/$GP52\=BL _P"^:^FVC5NH
MS4;6<+=8U- 'QY'^S^!/G[/_ ..UW'AGX+Q6;(6@ Q[5]$?V?;?\\5_*I%M8
M4^[&HH Y/PSX-M]/C7]V!@>E=='$L*[47 IP4+T&*:6- #FZ5'1DTY5H 15I
M^V@#%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !12;J,T +1110 4TM3J:>M !UI:!THH YKQ6<P
MO7D&I*WVP_6O9/$$/FQM7F][I):X)QWH U_!H(VUZ;;']RM<'X9L3#MXKO+<
M8C% $M-+4ZFGK0 M+24M "$TFZAJ* '4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E)MIU% ""
MEHHH **2EH HZM_Q[FO"OB;GR)<>]>ZZH-T)%>0>/M+-Q#)@9ZU:1#/C;QD'
M_M)N.]>C_!E6^V0Y]:I>*/![R7S'8>OI7<_"SPT]K=1$KCFF!]5^%?\ D$Q?
M05KMTK,\.Q^7IL:^U:35#*Z"K2TU:=2 ****!A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !112$T +13=U.H 9112XH 0M2;
MJ4K1M]J ' TM-6G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 PTJT'K0#4@+BEI-U+3 ****8!1110 T]:=36HW4@'44E+3 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O?_P#'
MJ]?/?Q@_X]I_H:^A+_\ X]7KY[^,'_'M/]#0!^>_Q@_Y"DOUK?\ @#_R%X/]
MX5@?&#_D*2_6M_X _P#(7@_WA0!^G_PI_P"1;C^@KMJXGX4_\BW']!7;4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %(U+10 VG444 -P:44M)0 M(:-U+0!
M1N[H0*3FLJ3Q$J-C=1XCE,43&O-+[5G6XQGO0!ZQ9:H+C'-:BMN6O/?"U\TQ
M7)KO[?\ U8H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,BEIE)@*:2
MBBI 44ZF4ZK BN)/+7-<_JGB);)22V,5L:JVV$GVKQWX@:L]O#(0<4[ ;EY\
M4([:0KYN.?6M+1?'Z:DP DSGWKX[\5>-IX;YE#GK7<_"GQ5+>740+D\T[$W/
ML2SF^T0AAS4U9GAF0R::C'T%:K=*0PI:04M(84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% %>_\ ^/5Z^>_C!_Q[3_0U
M]"7_ /QZO7SW\8/^/:?Z&@#\]_C!_P A27ZUO_ '_D+P?[PK ^,'_(4E^M;_
M , ?^0O!_O"@#]/_ (4_\BW']!7;5Q/PI_Y%N/Z"NVH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IK=:=28H ;3EH*T4".;\5#]R_TKR+4A_I
MA^M>N>*3^Y>O)=0_X^C]:"CL/!H^[7I=O_JA7FG@_JM>EVW^I6@1+1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !3*?24F VBE/6DJ0"G4T4^K H:N,VY^E
M>&?$Q?\ 1Y?H:]TU7_CW/TKPWXE<PR_0UHB6?)?C*/\ XF3\]Z]%^#*8O(?K
M7 ^,5_XF3?6O0_@V/],B^M42?:7A48TF/Z"M=NE9'A?_ )!,?T%:]9=2Q%IU
M)C%+2&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!7O_ /CU>OGOXP?\>T_T-?0E_P#\>KU\]_&#_CVG^AH _/?XP?\
M(4E^M;_P!_Y"\'^\*P/C!_R%)?K6_P# '_D+P?[PH _3_P"%/_(MQ_05VU<3
M\*?^1;C^@KMJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%(: %HINZE% "T444 %%%% !4,MW%#G>X
M%-OKI;6W9V..*\3^(WQ0BT5)?WN,9[T >O7'B:PM_O3#\ZHR>/=+C.#,O_?5
M?!OCK]I@V4L@2YQ@_P!ZO(=8_:ON4E.VY;K_ 'J /U/C\?:7)TF7_OJKMOXI
ML+C[LH_.ORBTO]J^Y9ANN6_[ZKUCP'^TR;V:-7N<Y_VJ /T6AO(9_N.#4]>
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M** $IN:=2;: %6EIN<4H- "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%(32;J '4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 44E(6]Z '44S=[TH;\: '44@-+0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %(>E+10 RG#I2T4 %%%% !4<TGE(6-
M25C>)+S[)9L<XXH X[XC>,$TW3I/GQ@>M?G_ /'WXMNLUPB2]SWKWOX[>.S;
MVLZB3'7O7YW_ !0\12ZMJLJ[BP+4 <WK&O7WB"^949FW-5JP^%NK:PN\1N<\
M]*[CX-^ ?[;U"$O'N#$=J^__ (7_  !LYM,C=[=3D>E S\R=2^%NJZ3&7*.,
M<]*R])UZ^\.7JAV9=IK]2/BI\!+.WTN1TMU'RGM7Y[?&KP+_ &'>3F./;M)[
M4"/9/@C\9'66%'F].]?>GPM\>KJEK"/,SD#O7XS^ /$DVEZLB[B &K]!_P!G
M?QL]RMLIDST[T ??UC-YUNK=:E89-8WA.[^U:9&<YXK<H C"TM/IK4 )32*=
M2-TH 9_%3UI*-IH$)2;:DI0M QJBI*3%+0!6U#_CU>OGOXO*?L\_T-?1%TGF
M0./:O ?C!;XMI_H: /SP^+Z_\327_>K>^ 8_XF\'^\*QOC%'MU27_>K=^ *;
MM8@_WA0!^G/PG&/#L?\ NBNWKCOA='Y?AF(^P_E78T %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 E&ZEHH 2EHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $H
MW4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -H6G44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% "-3:?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$TM)B@!C
M-3-U2F,&D\L4 ,'-.6G[0.U&* $6G4W&#3J "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\
MA>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^=
M'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/
M[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\
M+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\
MA>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^=
M'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/
M[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\
M+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\
MA>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^=
M'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/
M[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\
M+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\
MA>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^=
M'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/
M[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\
M+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\
MA>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^=
M'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/
M[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\
M+?\ Y[C\Z/\ A>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\
MA>%O_P ]Q^= 'T]_:UO_ 'Z/[6M_[]?,/_"\+?\ Y[C\Z/\ A>%O_P ]Q^=
M'T]_:UO_ 'Z/[6M_[]?,0^.%O_SW'YTH^-T'_/<?G0!]._VK;_WZ3^UK?^^/
MSKYE_P"%W0?\]A^='_"[K?\ Y[C\Z /IK^UK?^_1_:UO_?KYC_X7A;_\]Q^=
M-_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT
M?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ/[6M
M_P"_7S#_ ,+PM_\ GN/SH_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W
M_P">X_.C_A>%O_SW'YT ?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6_
M_/<?G0!]/?VM;_WZ/[6M_P"_7S#_ ,+PM_\ GN/SH_X7A;_\]Q^= 'T]_:UO
M_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT ?3W]K6_]^C^UK?\ OU\P
M_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ/[6M_P"_7S#_ ,+PM_\ GN/S
MH_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT
M?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ/[6M
M_P"_7S#_ ,+PM_\ GN/SH_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W
M_P">X_.C_A>%O_SW'YT ?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6_
M_/<?G0!]/?VM;_WZ/[6M_P"_7S#_ ,+PM_\ GN/SH_X7A;_\]Q^= 'T]_:UO
M_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT ?3W]K6_]^C^UK?\ OU\P
M_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ/[6M_P"_7S#_ ,+PM_\ GN/S
MH_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT
M?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ/[6M
M_P"_7S#_ ,+PM_\ GN/SH_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W
M_P">X_.C_A>%O_SW'YT ?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6_
M_/<?G0!]/?VM;_WZ/[6M_P"_7S#_ ,+PM_\ GN/SH_X7A;_\]Q^= 'T]_:UO
M_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT ?3W]K6_]^C^UK?\ OU\P
M_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ/[6M_P"_7S#_ ,+PM_\ GN/S
MH_X7A;_\]Q^= 'T]_:UO_?H_M:W_ +]?,/\ PO"W_P">X_.C_A>%O_SW'YT
M?3W]K6_]^C^UK?\ OU\P_P#"\+?_ )[C\Z/^%X6__/<?G0!]/?VM;_WZ7^U+
M?^_7S(GQN@)_UX_.I/\ A=D'_/8?G0!]+?VM;_WZ/[6M_P"_7S(WQN@S_KQ^
M=(/CA;_\]Q^= 'TY_:UO_?H_M:W_ +]?,3?'"W_Y[C\Z3_A>%O\ \]Q^= 'T
M]_:UO_?H_M:W_OU\P_\ "\+?_GN/SH_X7A;_ //<?G0!]/?VM;_WZ/[6M_[]
M?,/_  O"W_Y[C\Z/^%X6_P#SW'YT ?3W]K6_]^C^UK?^_7S#_P +PM_^>X_.
M@_'"W_Y[C\Z /IS^V;?^]^M*-7MS_'7R]_PO"#_GN/SIR_'"W_Y[C\Z /J#^
MUK?^_1_:UO\ WZ^8?^%X6_\ SW'YTO\ PO"WV_Z\?G0!]!>(/$444+!6'YUY
MG?>*U%T?G[^M>7ZU\:()HV'GC\ZX:Z^*<#3D^<.OK0!]9^%_%"-MR_ZUW46L
MV\B EAFOC+0?B]!!M_?#\Z["W^-UNJ >>/SH ^H/[6M_[]']K6_]^OF'_A>%
MO_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#G
MN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']
MK6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW
M'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH
M ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]
M^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?
M\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO
M[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'
M_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM
M_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_
M[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%
MO_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#G
MN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']
MK6_]^OF'_A>%O_SW'YT[_A>%O_SW'YT ?3G]K6_]^C^UK?\ OU\Q'XX6^?\
M7C\Z3_A>%O\ \]Q^= 'T]_:UO_?H_M:W_OU\P-\<+?'^O'YTY?CA;_\ /<?G
M0!]*WVN00PL0PS7D?Q \6B.&3#]O6O/[[XV021$>>/SKS;QE\4(;R&3$H/XT
M 4?%7Q DCU!@)#U]:[OX4^.FGNH@TG?UKY9\2>*HY[QF\SOZUU7P[\>1:?<Q
MDRXP?6@#]+-!UV&XTV)F?G%:!U:W'\5?*_A_XU6\5BB^>.GK5Z;XWVXS^_'Y
MT ?3(U>W/\5+_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO
M_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^=
M'_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I
M[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KY
MA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\
M+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK
M?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7
MA;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\
MY[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1
M_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\
M]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\
MZ /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO
M_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^=
M'_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I
M[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KY
MA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\
M+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK
M?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7
MA;_\]Q^='_"\+?\ Y[C\Z /I[^UK?^_1_:UO_?KYA_X7A;_\]Q^='_"\+?\
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M?_GN/SH_X7A;_P#/<?G0!]/?VM;_ -^C^UK?^_7S#_PO"W_Y[C\Z<OQPM_\
MGN/SH ^G/[6M_P"_1_:UO_?KYC_X7A;_ //<?G3?^%X6_P#SW'YT ?3W]K6_
M]^C^UK?^_7S#_P +PM_^>X_.C_A>%O\ \]Q^= 'T]_:UO_?H_M:W_OU\P_\
M"\+?_GN/SH_X7A;_ //<?G0!]/?VM;_WZ/[6M_[]?,/_  O"W_Y[C\Z/^%X6
M_P#SW'YT ?3W]K6_]^C^UK?^_7S#_P +PM_^>X_.C_A>%O\ \]Q^= 'T]_:U
MO_?H_M:W_OU\P_\ "\+?_GN/SH_X7A;_ //<?G0!]/?VM;_WZ/[6M_[]?,/_
M  O"W_Y[C\Z/^%X6_P#SW'YT ?3W]K6_]^C^UK?^_7S#_P +PM_^>X_.C_A>
M%O\ \]Q^= 'T]_:UO_?H_M:W_OU\P_\ "\+?_GN/SH_X7A;_ //<?G0!]/?V
MM;_WZ/[6M_[]?,/_  O"W_Y[C\Z/^%X6_P#SW'YT ?3W]K6_]^C^UK?^_7S#
M_P +PM_^>X_.C_A>%O\ \]Q^= 'T]_:UO_?H_M:W_OU\P_\ "\+?_GN/SH_X
M7A;_ //<?G0!]/?VM;_WZ/[6M_[]?,/_  O"W_Y[C\Z/^%X6_P#SW'YT ?3W
M]K6_]^C^UK?^_7S#_P +PM_^>X_.C_A>%O\ \]Q^= 'T]_:UO_?H_M:W_OU\
MP_\ "\+?_GN/SH_X7A;_ //<?G0!]/?VM;_WZ/[6M_[]?,/_  O"W_Y[C\Z/
M^%X6_P#SW'YT ?3W]K6_]^C^UK?^_7S#_P +PM_^>X_.C_A>%O\ \]Q^= 'T
M]_:UO_?H_M:W_OU\P_\ "\+?_GN/SH_X7A;_ //<?G0!]/?VM;_WZ/[6M_[]
M?,/_  O"W_Y[C\Z/^%X6_P#SW'YT ?3W]K6_]^C^UK?^_7S#_P +PM_^>X_.
MC_A>%O\ \]Q^= 'T]_:UO_?H_M:W_OU\P_\ "\+?_GN/SH_X7A;_ //<?G0!
M]/?VM;_WZ/[6M_[]?,/_  O"W_Y[C\Z/^%X6_P#SW'YT ?3W]K6_]^C^UK?^
M_7S#_P +PM_^>X_.C_A>%O\ \]Q^= 'T]_:UO_?H_M:W_OU\P_\ "\+?_GN/
MSH_X7A;_ //<?G0!]/?VM;_WZ/[6M_[]?,/_  O"W_Y[C\Z/^%X6_P#SW'YT
M ?3W]K6_]^C^UK?^_7S#_P +PM_^>X_.E'QPM_\ GN/SH ^G?[6M_P"_2_VK
M;_WZ^8U^-\'_ #W'YT__ (7=#_SW'YT ?3']K6_]^C^UK?\ OU\R-\;X/^>X
M_.F?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH
M ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]
M^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?
M\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO
M[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'
M_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM
M_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_
M[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%
MO_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#G
MN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']
MK6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW
M'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH
M ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]
M^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?
M\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO
M[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'
M_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM
M_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_
M[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%
MO_SW'YT?\+PM_P#GN/SH ^GO[6M_[]']K6_]^OF'_A>%O_SW'YT?\+PM_P#G
MN/SH ^G3K%O_ 'OUI/[9M_[P_.OF+_A>%O\ \]Q^='_"[K?_ )[C\Z /IW^V
M;?\ O#\Z3^VK?^\/SKYC_P"%W6__ #W'YTR3XX6X_P"6X_.@#ZA76+=NC?K5
MB.Y27[IS7RU8_&^WDE \\?G7I7A/XH6U]M'F@_C0![!2UG:=K4%]&"K#-: .
M>E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^5 'F/\ PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_ //LWY4
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M?_\ /LWY4?\ #,]__P ^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\
M\^S?E1_PS/?_ //LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_P ,SW__ #[-
M^5'_  S/?_\ /LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_PS/?_ //LWY4?
M\,SW_P#S[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\ #,]__P ^S?E1_P ,
MSW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5'_#,]_\
M\^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\ #,]__P ^
MS?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_ //LWY4
M>9?\+<U'_GH_YT?\+<U'_GH_YUZ;_P ,SW__ #[-^5'_  S/?_\ /LWY4 >9
M?\+<U'_GH_YT?\+<U'_GH_YUZ;_PS/?_ //LWY4?\,SW_P#S[-^5 'F7_"W-
M1_YZ/^='_"W-1_YZ/^=>F_\ #,]__P ^S?E1_P ,SW__ #[-^5 'F7_"W-1_
MYZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5'_#,]_\ \^S?E0!YE_PMS4?^>C_G
M1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\ #,]__P ^S?E0!YE_PMS4?^>C_G1_
MPMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_ //LWY4 >9?\+<U'_GH_YT?\+<U'
M_GH_YUZ;_P ,SW__ #[-^5'_  S/?_\ /LWY4 >9?\+<U'_GH_YT?\+<U'_G
MH_YUZ;_PS/?_ //LWY4?\,SW_P#S[-^5 'F7_"W-1_YZ/^=+_P +=U'_ )Z/
M^=>F?\,SWW_/LW_?--_X9GO_ /GW;_OF@#S3_A;NH_\ /1_SIW_"V]1_YZ-^
M=>E#]F>__P"?9ORIW_#,]_\ \^S?E0!YD/C%?Q_>E8?C1_PO*Y3K.?SK9\=?
M F^T.!V,#+@>E?/_ (BT.[T^Z9"&&#0![/\ \+ONI.DY_.D_X7%?R=)6_.O+
MO"7A6[U650%8Y->V>%_@1?:FJ$0,<^U &*/BYJ/_ #T;\Z3_ (6YJ/\ ST?\
MZ]-7]F>_V_\ 'LWY4?\ #,]__P ^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7I
MO_#,]_\ \^S?E1_PS/?_ //LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_P ,
MSW__ #[-^5'_  S/?_\ /LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_PS/?_
M //LWY4?\,SW_P#S[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\ #,]__P ^
MS?E1_P ,SW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5
M'_#,]_\ \^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\
M#,]__P ^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_
M //LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_P ,SW__ #[-^5'_  S/?_\
M/LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_PS/?_ //LWY4?\,SW_P#S[-^5
M 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\ #,]__P ^S?E1_P ,SW__ #[-^5 '
MF7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5'_#,]_\ \^S?E0!YE_PM
MS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\ #,]__P ^S?E0!YE_PMS4
M?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_ //LWY4 >9?\+<U'_GH_
MYT?\+<U'_GH_YUZ;_P ,SW__ #[-^5'_  S/?_\ /LWY4 >9?\+<U'_GH_YT
M?\+<U'_GH_YUZ;_PS/?_ //LWY4?\,SW_P#S[-^5 'F7_"W-1_YZ/^='_"W-
M1_YZ/^=>F_\ #,]__P ^S?E1_P ,SW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_
MYZ/^=>F_\,SW_P#S[-^5'_#,]_\ \^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G
M7IO_  S/?_\ /LWY4?\ #,]__P ^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7I
MO_#,]_\ \^S?E1_PS/?_ //LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_P ,
MSW__ #[-^5'_  S/?_\ /LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_PS/?_
M //LWY4?\,SW_P#S[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\ #,]__P ^
MS?E1_P ,SW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5
M'_#,]_\ \^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\
M#,]__P ^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_
M //LWY4 >9?\+<U'_GH_YTO_  MW4?\ GH_YUZ9_PS/?_P#/LWY4W_AF>_\
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MZ;_PS/?_ //LWY4?\,SW_P#S[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\
M#,]__P ^S?E1_P ,SW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW
M_P#S[-^5'_#,]_\ \^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\
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M='_"W-1_YZ/^=>F_\,SW_P#S[-^5'_#,]_\ \^S?E0!YE_PMS4?^>C_G3O\
MA;FH_P#/1OS->E_\,SW_ /S[-^5*W[,]_@_Z,WY4 >9_\+GO83\TS#\:/^%[
M7'3SS^=4/B?\);WPW&Y,3+CVKP7R;K^TO)^;[V* /H@_&B]F^[,Q_&C_ (6[
MJ/\ ST;\ZSOAK\)[WQ%'&1$S9]J]:C_9IOVC4_9FY'I0!YL?B[J/_/1OSI#\
M7=1_YZ/^=>F?\,SW_P#S[-^5!_9FOL?\>S?E0!YC_P +>U'_ )Z-^=._X6[J
M/_/1_P Z]+_X9EOO^?=ORI?^&9[_ /Y]F_*@#S/_ (6YJ/\ ST?\Z/\ A;FH
M_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z#\7-1_P">
MC_G7IA_9GO\ _GV;\J3_ (9GO_\ GW;_ +YH \R/Q:U+_GHWYTH^+FH_\]&_
M.O3O^&9[[_GW;_OFC_AF>^_Y]F_[YH \R_X6YJ/_ #T?\Z4?%S4>GFM^=>F?
M\,SW_P#S[-^5 _9GO\_\>S?E0!Y9/\5M1D!'F-^=46^).H,V=[5['_PS-?'_
M )=F_*G?\,R7O_/LW_?- 'D-O\4=0B_C;\ZNK\7-17_EHWYUZ<W[,M\#_P >
MS?\ ?-)_PS/?_P#/LWY4 >9#XN:C_P ]'_.G?\+;U'_GHWYUZ6/V9[__ )]F
M_*E_X9GO_P#GV;\J /,?^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^
M&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_
MX9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_
M /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO
M_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]
MF_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#G
MV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@
M#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J
M /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_
M (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O
M^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6Y
MJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:
MC_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\
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M\]'_ #KTW_AF>_\ ^?9ORH_X9GO_ /GV;\J /,O^%N:C_P ]'_.C_A;FH_\
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MKTW_ (9GO_\ GV;\J/\ AF>__P"?9ORH \R_X6YJ/_/1_P Z/^%N:C_ST?\
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M^&9[_P#Y]F_*C_AF>_\ ^?9ORH \R_X6YJ/_ #T?\Z/^%N:C_P ]'_.O3?\
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MSW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5'_#,]_\
M\^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\ #,]__P ^
MS?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_ //LWY4
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M?_\ /LWY4?\ #,]__P ^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\
M\^S?E1_PS/?_ //LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_P ,SW__ #[-
M^5'_  S/?_\ /LWY4 >9?\+<U'_GH_YT?\+<U'_GH_YUZ;_PS/?_ //LWY4?
M\,SW_P#S[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\ #,]__P ^S?E1_P ,
MSW__ #[-^5 'F7_"W-1_YZ/^='_"W-1_YZ/^=>F_\,SW_P#S[-^5'_#,]_\
M\^S?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_  S/?_\ /LWY4?\ #,]__P ^
MS?E0!YE_PMS4?^>C_G1_PMS4?^>C_G7IO_#,]_\ \^S?E1_PS/?_ //LWY4
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MC_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\
MST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST
M?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\
MZ/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/
M^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\
MA;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:
MC_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH
M_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST
M?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/
M1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]
M-_X9GO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SK
MTW_AF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9
MGO\ _GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_A
MF>__ .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\
M_GV;\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__
M .?9ORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;
M\J/^&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9
MORH_X9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^
M&9[_ /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_
MX9GO_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_
M /Y]F_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO
M_P#GV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]
MF_*@#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#G
MV;\J /,O^%N:C_ST?\Z/^%N:C_ST?\Z]-_X9GO\ _GV;\J/^&9[_ /Y]F_*@
M#S+_ (6YJ/\ ST?\Z/\ A;FH_P#/1_SKTW_AF>__ .?9ORH_X9GO_P#GV;\J
M /,_^%NZC_ST?\Z!\7-1_P">C?G7I9_9GO\ _GV;_OFA?V9[_P#Y]V_[YH \
MU_X6YJ/_ #T;\ZBF^+FH@?ZQOSKU'_AF>_\ ^?9ORJO>_LTWZPD_9V_*@#S;
M3_C+?13 M*PY]:]C^''Q\ECGB5Y^X[UY+XG^"E[H\;L86&/:O-EEN_#^I!26
M7:U 'ZX?"/XJ#6DA!EW9]Z^D=*N/M5FDF<YK\POV9?&<MQ=6R-(3R.]?I5X)
MG^T:%"W7B@#?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*C_A7.C_ // ?E74T4 <M_PKG1_^> _*C_A7.C_\\!^5=310!RW_  KG1_\
MG@/RH_X5SH__ #P'Y5U-% '+?\*YT?\ YX#\J/\ A7.C_P#/ ?E74T4 <M_P
MKG1_^> _*C_A7.C_ // ?E74T4 <M_PKG1_^> _*C_A7.C_\\!^5=310!RW_
M  KG1_\ G@/RH_X5SH__ #P'Y5U-% '+?\*YT?\ YX#\J/\ A7.C_P#/ ?E7
M4T4 <M_PKG1_^> _*C_A7.C_ // ?E74T4 <M_PKG1_^> _*C_A7.C_\\!^5
M=310!RW_  KG1_\ G@/RH_X5SH__ #P'Y5U-% '+?\*YT?\ YX#\J/\ A7.C
M_P#/ ?E74T4 <M_PKG1_^> _*C_A7.C_ // ?E74T4 <M_PKG1_^> _*C_A7
M.C_\\!^5=310!RW_  KG1_\ G@/RH_X5SH__ #P'Y5U-% '+?\*YT?\ YX#\
MJ/\ A7.C_P#/ ?E74T4 <M_PKG1_^> _*C_A7.C_ // ?E74T4 <M_PKG1_^
M> _*C_A7.C_\\!^5=310!RW_  KG1_\ G@/RH_X5SH__ #P'Y5U-% '+?\*Y
MT?\ YX#\J/\ A7.C_P#/ ?E74T4 <M_PKC1_^> _*FGX:Z.?^6(_*NKI-P]:
M .6'PWT<?\L!^5+_ ,*YT?\ YX#\JZC(I: /FS]H3X9Z?#I,LL<2@%<CBOS1
M^*'AF"#69%51C=7ZJ?M&:ALT>1/[J8K\OOBK=AM;D_WC0!T'P5\(V]U=0AD!
MYK] ?A#\+["XMX2T2]!VKX4^!MYMNX?K7Z)?!O4O]'@'; H [Q?AQHX 'D#\
MJ7_A7.C_ // ?E744M '+?\ "N='_P"> _*C_A7.C_\ / ?E74T4 <M_PKG1
M_P#G@/RH_P"%<Z/_ ,\!^5=310!RW_"N='_YX#\J/^%<Z/\ \\!^5=310!RW
M_"N='_YX#\J/^%<Z/_SP'Y5U-% '+?\ "N='_P"> _*C_A7.C_\ / ?E74T4
M <M_PKG1_P#G@/RH_P"%<Z/_ ,\!^5=310!RW_"N='_YX#\J/^%<Z/\ \\!^
M5=310!RW_"N='_YX#\J/^%<Z/_SP'Y5U-% '+?\ "N='_P"> _*C_A7.C_\
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MEO\ A7.C_P#/ ?E1_P *YT?_ )X#\JZFB@#EO^%<Z/\ \\!^5'_"N='_ .>
M_*NIHH Y;_A7.C_\\!^5'_"N='_YX#\JZFB@#EO^%<Z/_P \!^5'_"N='_YX
M#\JZFB@#EO\ A7.C_P#/ ?E1_P *YT?_ )X#\JZFB@#EO^%<Z/\ \\!^5'_"
MN='_ .> _*NIHH Y;_A7.C_\\!^5'_"N='_YX#\JZFB@#EO^%<Z/_P \!^5'
M_"N='_YX#\JZFB@#EO\ A7.C_P#/ ?E1_P *YT?_ )X#\JZFB@#EO^%<Z/\
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M5OH__/ ?E7544 <M_P *YT?_ )X#\J/^%<Z/_P \!^5=310!RW_"N='_ .>
M_*C_ (5SH_\ SP'Y5U-% '+?\*YT?_G@/RI?^%<Z/_SP'Y"NHHH Y;_A7.C_
M // ?E1_PKG1_P#G@/RKJ:* .6_X5SH__/ ?E1_PKG1_^> _*NIHH Y;_A7.
MC_\ / ?E1_PKG1_^> _*NIHH Y;_ (5SH_\ SP'Y4?\ "N='_P"> _*NIHH
MY;_A7.C_ // ?E1_PKG1_P#G@/RKJ:* .6_X5SH__/ ?E1_PKG1_^> _*NIH
MH Y;_A7.C_\ / ?E1_PKG1_^> _*NIHH Y;_ (5SH_\ SP'Y4?\ "N='_P">
M _*NIHH Y;_A7.C_ // ?E1_PKG1_P#G@/RKJ:* .6_X5SH__/ ?E1_PKG1_
M^> _*NIHH Y;_A7.C_\ / ?E1_PKG1_^> _*NIHH Y;_ (5SH_\ SP'Y4?\
M"N='_P"> _*NIHH Y;_A7.C_ // ?E1_PKG1_P#G@/RKJ:* .6_X5SH__/ ?
ME1_PKG1_^> _*NIHH Y;_A7.C_\ / ?E1_PKG1_^> _*NIHH Y;_ (5SH_\
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M% '+?\*YT?\ YX#\J/\ A7.C_P#/ ?E74T4 <M_PKG1_^> _*C_A7.C_ //
M?E74T4 <M_PKG1_^> _*C_A7.C_\\!^5=310!RW_  KG1_\ G@/RH_X5SH__
M #P'Y5U-% '+?\*YT?\ YX#\J/\ A7.C_P#/ ?E74T4 <M_PKG1_^> _*C_A
M7.C_ // ?E74T4 <M_PKG1_^> _*C_A7.C_\\!^5=310!RW_  KG1_\ G@/R
MH_X5SH__ #P'Y5U-% '+?\*YT?\ YX#\J/\ A7.C_P#/ ?E74T4 <M_PKC1O
M^> _*C_A7.C_ // ?E74T4 <J?AOHY_Y8#\J/^%;Z/\ \\!^5=510!RW_"N=
M'_YX#\J/^%<Z/_SP'Y5U-% '%ZK\--(FTVX185#%#CBOS4_:]\&VNFWEP$0#
MDU^JNJ2^3IUP_HAK\O\ ]LS4-U]<9]30!\L_"708;CQ-$K*"-]?JC^S[\,K"
MZTF!WB4_*">/:ORX^#]YM\41<_\ +3^M?K;^SGJ7_$G@&>"H'Z4 >GK\-]'5
M0/('Y4O_  KG1_\ G@/RKJ:* .6_X5SH_P#SP'Y4'X<:.?\ E@/RKJ:* .5_
MX5OH_P#SP'Y4O_"N='_YX#\JZFB@#EO^%<Z/_P \!^5)_P *WT;_ )X#\A75
M44 <K_PK?1O^> _(4O\ PKG1_P#G@/RKJ:* .6_X5SH__/ ?E1_PKG1_^> _
M*NIHH Y;_A7.C_\ / ?E1_PKG1_^> _*NIHH Y;_ (5SH_\ SP'Y4?\ "N='
M_P"> _*NIHH Y;_A7.C_ // ?E1_PKG1_P#G@/RKJ:* .6_X5SH__/ ?E1_P
MKG1_^> _*NIHH Y;_A7.C_\ / ?E1_PKG1_^> _*NIHH Y;_ (5SH_\ SP'Y
M4?\ "N='_P"> _*NIHH Y;_A7.C_ // ?E1_PKG1_P#G@/RKJ:* .6_X5SH_
M_/ ?E1_PKG1_^> _*NIHH Y;_A7.C_\ / ?E1_PKG1_^> _*NIHH Y;_ (5S
MH_\ SP'Y4?\ "N='_P"> _*NIHH Y;_A7.C_ // ?E1_PKG1_P#G@/RKJ:*
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M5=310!RW_"N='_YX#\J/^%<Z/_SP'Y5U-% '+?\ "N='_P"> _*C_A7.C_\
M/ ?E74T4 <M_PKG1_P#G@/RH_P"%<Z/_ ,\!^5=310!RW_"N='_YX#\J/^%<
MZ/\ \\!^5=310!RW_"N='_YX#\J/^%<Z/_SP'Y5U-% '+?\ "N='_P"> _*C
M_A7.C_\ / ?E74T4 <M_PKG1_P#G@/RH_P"%<Z/_ ,\!^5=310!RW_"N='_Y
MX#\J/^%<Z/\ \\!^5=310!RW_"N='_YX#\J/^%<Z/_SP'Y5U-% '+?\ "N='
M_P"> _*C_A7.C_\ / ?E74T4 <M_PKG1_P#G@/RH_P"%<Z/_ ,\!^5=310!R
MW_"N='_YX#\J/^%<Z/\ \\!^5=310!RW_"N='_YX#\J/^%<Z/_SP'Y5U-% '
M+?\ "N='_P"> _*C_A7.C_\ / ?E74T4 <M_PKG1_P#G@/RH_P"%<Z/_ ,\!
M^5=310!RW_"N='_YX#\J/^%<Z/\ \\!^5=310!RW_"N='_YX#\J/^%<Z/_SP
M'Y5U-% '+?\ "N='_P"> _*C_A7.C_\ / ?E74T4 <J?AOHY_P"6 _*C_A6^
MC_\ / ?E754FX>M '+_\*YT?_G@/RJ"\^&6D7$#*L*AOI785#=3"WA9N^.*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!K 8J)JF;I4;"@!(S\U35&B\U)0!X'^T<A
M;39\?W37YB_%&SD;6I>/XJ_5'XZ::;VQF &>#7Y_?$+P%+<:M(WEG[WI0!B_
M!"U=;N'CN*_0GX/(5@@SZ"OCSX2^"I+6XB)0CGTK[8^%^GFVABR,<"@#V!/N
MK]*=35^Z/I3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I*6DH 8S'BDZTK4BT *!4E,IU ',_$ 9T
M&3Z'^5?G'^T#;.U]<<=S7Z2>-(3-H[J/0U\,?&CPC)>7DQ"9Y- 'R_X)M7&K
MIP?O5]O_  2A80P9]J^;O"?@.6+4E/E]_2OK;X3:&UK'#E<=* /H_P /C&GI
M6E5#15VV2CVJ\QP* &D48I5YH/>@!5IU1JU/H 6BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BD)I U #J*** *&N_\@BZ_
MW#7Y<?MC6KR7UQ@=S7ZE:PN[3;@>J&OSX_:@\'2:G=SD)G)]* /B3X0V,B^)
MHLC_ ):5^LG[.L932;?/]T5^?7PS^',UMX@C8Q$?/Z5^CWP1TQK'3801C@4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!&I *=10 4FZEIE $=VOF6\B^HKPGXD?#A=<D<F/=GVKWK&[BH)
M=.@F^^F: /E3P[\%ULKY9!!C!STKW_P;H8TRW1=N,"NH71[5>1&*LQVZ1_=&
M* ')P!3J;3EZ4 +1244 +1110 44E% "T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 E1MUJ6FGK0 HK/U*W\Y"
M*T%IK1AJ /(?&/@T:DK@IG/M7E[_  =5KPOY/?TKZGDT^*3[PJ+^Q;;.=@S]
M* /,? /@T:,4PF,>U>LQG$:CVJ*.PBB^Z,5*.* )**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH 1J3;3J* $J.X7?&14M(PR,4 >?\ BOPZ-0B8;<YKPWQ)\'UOKIG\G//I
M7U7)9I)]X56;0[9SDIG\* /GSP'\+5TFX1O*Q@^E?0FB6_V6Q2/&,4^+2;>'
M[JXJVJA1@=* '4@I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH 3%%+10 4444 %%%% "4;:6B@!*6BB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD:
M@!:*;FG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% "4;12T4 )MI-M.HH 2EHHH
M **** $QFC;2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1128H 6BDP*6@ HHHH :U)3L48% "T444 ,I5I<
M"C% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4E+10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 (:3=2FDVF@!12T@I: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *0\TM% #=M.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** $)I-U#"C!H =1110 W=2@TF#0HH =1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !129HW4
M +12;J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $
MI-U+2;30 M!- H:@!-U.IN#3J "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHI* %HI,T4 +1110 444UJ %I:93Z "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **:U ZT .HHHH **92JWO0 ZBDS2T %%%% !133UH7
MK0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**1NM"T .HHHH *
M*** "BBB@ HI*6@!*6F4JT .HI&Z4V@!])2TUJ '44RC=B@!])NIF^DW4 24
MM1K3UZ4 +24-TIM #Z*3-+0 E%(U)0 ^BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***90 ^BF;O>B@!U+35ZTN: %H
MIFZDW4 244U:=0 4444 %%%)F@!:*3(I: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBD;I0 M%,HW>] #Z2FYHH =2TU>M.H *
M**3(H 1J2G9HS0 E.I*6@ HI,TM !12-3: 'T444 )12-UH7K0 ZBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDS10 M%%)0 M%%)
MD4 +124M !1110 4444 %%)1NH 6BDS2T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%(W2@!:*92AJ '44F:6@ HHI* %HHHH
M**2C(H 6BBB@ HHHH ***3- "T4RE6@!U%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %)FBFT /HI%I: "BBB@ HHHH *2D:DH$/HIE
M.S0,6BFGK0M #J**3- "T4S?10 ZEIE*.M #J*2EH **2B@!:**2@!:*93EZ
M4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 444AH *;FEW4E "C-&VE7I1N'K0 FVEVTF]?[P_.CS$_O+^=
M #J*3</44M #3UH%+BD^[0 M+3-WO1N]Z %R:5:CS3UH =1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !112&@"-LTT!C4GUI=Z_WA0 BH:=BD\Q?[P_.C<OJ/SH 7%+29
M%+0 ULBHRU2GI4;+S0 BM3MU-"TNV@!R\T[M2+2Y'K0 FT^M*!BC</4?G2;U
M]1^= "TVG;AZT=: &YHS12[:  <TN*!Q2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4A-(S5&S<T *6IPIN,U(M "8-&VES2;E]1^= "
MX]Z3;1O7^\/SI=P]: $VTM+29H !13<TZ@!.:=124 (RY[TWRSGK3]P]12>8
MO]X?G0 ;:7'O1N!Z$4M #>:5:&I%H =1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% #&[TW-2%:810 BM4BTP"G+0 ZF[:7(HW#U% !1
M2;U_O#\Z-Z_WA^= "[:3!I<@]*6@!O-&32M3&H >**:IIU !M]Z3;3J3<!W%
M #=OO3@,4GF+_>'YT;U_O#\Z '44FX>M&: %HHHH ***0F@!:*;NIU !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %)M%+10 E(U.I",T )3J3;2T %%%% #&I-
ME/VT4 -V>]+MI=P]12>8O]X?G0 ;:4<4F]?4?G2[AZT +4;9IV>M)0(B"L34
MJJ>]+N7U H\Q?[P_.@8N*3;1O7^\/SI=P]10  449%!/I0 UC2!J,4;<4 /!
MHJ/=2[NM "TY>E(!2T +1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4C4M% #=II:6LW6-473X2Q;'% $FI:@
MEG$69@*\T\5?$Z'2=W[X#'O7)_$WXL1:;#*/- (SWKXZ^*'QR:::54G[^M S
MZ>UC]HR.TD91<CCWK&'[3D?F8^T_K7Y^ZM\2+V_N'VR,<GUK'F\9:C&V[>_Y
MT"/U.\*_'F+5'0?: <^]>T^&/%$.K1H?,!S7X_\ @7XNW.GW$?F2L.?6OL#X
M1?'B.584>?T[T ?<_7I0U<!X3\?1:Q"F) <^]=U;RB>,-0(*6EVTO3% Q-HI
MX&*;3LT +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %(:6B@"-AS4:]:E/.:9MVG- $H4"JU[>1VL99F JMJ>L)8QL2
MP'%>'_$KXO0Z3%*/. Q[T =QXG^(D.E!OWH&/>O*/$'[0T5@[#[0!CWKYD^)
MG[0'FR2HD_KWKP3Q%\3+S4I&*2,?QH ^\A^U A?'VG]:VM'_ &B4OI OVC.3
MZU^:EOXFU)WSN>NX\(>*K]+J/<S=?6@#]1/"OQ&75PG[S=GWKTG3;D74:MUK
MXH^#7B2:8PAF/:OKWP==&:UC)/:@#IR**>><4E ";:55IPZ4M !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG'>OOSP'<&XTM&//RT =-MI12T4 %%%% !1110 4444 %%%% !1110 4444
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M3.YZ[3P?XIOUNDW,W7UH _4CPM\25U;9^\SGWKTK3;P748.<U\1?!WQ-/+Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4E+2-0 VG+49ZTJM0!)24"B@#@O'TCI;R;?2OE
M'XD75\TTH3=UK[,U[21J$;#&<UY;KGPH34IF)BSGVH&?!/BRSU">.0G?7SE\
M0+&XBN'+[A7ZD^+/@9'%8R-Y';TKXI^._P /4TN2;"8Q0(^9O#+M'J$>3WK[
M6_9_F)>WY]*^,K*V^S:L%_VJ^P_V?3^\M_PH&?H;\+6W6*?[M>@MT->>?"WB
MQC_W:]#H X'QM)(MO)MSTKY4^*JWDSRA=QK[*UK2!?*PQG->;>(?A8FI,28L
MY]J!'P!>^$;[4KIMRL035G_A34UU;DM$3QZ5]NZ?\"8?.W& =?2N@D^#\-O;
M']R.GI0!^6?C[X12:?'(PB(Q[5\]>(K&?1+QNJ[37ZO_ !A^&,,=K,1$.A[5
M^>GQL\)I8W<^%QR: .1^'?Q$GT^]B7S2,$=Z^\O@'\3);Q8 92>G>OS+TF%H
M=44 _P 5?:_[.,DFZWR3U% 'ZA_#_4C?6D9)SE:[6O,?A$S&PAS_ ':].H :
M/O4M(>II* 'T4VG4 %-:G4F* $7K3J3%+0 RG+THVBEH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV<BOR5_9_P#%#VMQ"N_N*_1SX0^(#>6L +9X% 'NXYI:9"VZ%#[4^@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &4*M.Q29P: &S_ZE_I7
MS3\<&N"DXCST-?2TGS*17G7C+P6NL;\IG- 'YQ^)M!U'4=088<@M5K0_@[=:
MDH+Q,<^U?8\GP9MA<;VB7KZ5UNA_#_3K", H@H$?#VI?L^R"W+& ]/2O$?B)
M\+9-&25O+*X]J_5S7/#NF+I[_*F<5\A_'K1;+[/<! O>@9^9WB+6I]!U#:&*
MX->V? 'XH3M?6Z&4_>'>O*OBUX;,FJ2>6O?M6_\  KPO<QZI;G:V-PH _8;]
MG_Q&VI6-OELY45]"3W A@+'TKY<_9KL9;>QMMP/W17T1XFO/L>F%LX^6@#SK
MXH^.%TVSFQ)C ]:^ /CK\79FFF2.8]QUKV[]H#Q\;=;A!)CKWKX/\9:P^NZJ
MR[]V6H R)-9O_$6H$!F8,:]:\#_"&[UR-&:)FS[4GP@^'<6H743R)G)%??GP
MC^&NGV]C"6C7IZ4 ?+.F_L[R^6"8#^5;5A\"Y;.8'R3Q[5]TV_A+3(U ")2R
M>#+&0_*BT ?//P[\"RZ9)%E",>U?2W@^W:WA0'CBDT_P;#"P*H/RKJ;'2OLR
MC Q0!H0_=%24BKM&*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** &4JTN!1B@!:*** "H;J80V[N>,"I2<=:Y/QQXCCTW39?GP=IH \D^+
M_P 1%TJ"=?,QP>]?!OQB^(C:K-,BR9SGO7I?[1'Q%9IKA$E[GO7RQ&9O$.H$
M9+9- 'D_CJUGOIY'Y.36/X3LWAO$SD<U]!ZU\,V>Q,AC[9Z5YHWA_P#LW4 -
MN,&@#Z/^ K$2P<^E?HA\)FS8P_05^>'P*7;-#]:_0SX1_P#'K"/84@/5M4+?
M86QZ5\U_%];F02A-W>OJ.2U\ZW"XZBN \5?#]=49LIG-,#\\/$WAN^U"\<%6
M()J&Q^$,]Y'EXB?PK[=_X49%--N, //I716GP9AMH?\ 4#\J /S7\:?!5[>%
MV$)Z>E?.7C;PS-HMP^%*[37Z]_$;X61+9R?N1]T]J^!?CYX&CLY;@A .M 'S
MGX/\;3Z3>HOF$8/K7VQ\ OBE+/\ 9U,N>G>O@"^LS:ZGA>/FKZ:_9YDD^T6_
M)ZB@#]8/ACK9U*VA);.17I]>&_ UF:SM\^@KW*@!K=:=3&^]2[J '4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!R_C*?R[63GM7P[^T=J3?9[D9]:^UO'K[;63Z5\&_M'7!\JY
MY]: /AWQ#(;C76!Y^;^M?4O[,^BK+-;DKGD5\K7S;M>_X'_6OLS]E^)6:W_"
M@#]!OAMID5OID)VC[M=K<0K-"ZL,C%<YX'0+IL6/2NG/(Q0!\??M.:)&;2X(
M7L:_+3XJ6OV?6IL#'S5^N/[2UJ/L%QQV-?D]\98PNM3_ .^: .L^ -XRW\(S
MW%?IG\$+EI+.#)["OS!^ ['^TH?J*_37X$Y^RV_T% 'U!8\VL?TJ9NE0V/\
MQZQ?2IC0 VG4FVG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 AYI:** "O//BE>>5I<O/\)KT)CA37E/Q;D/]FS?0
MT ?G+^TAK3K>7 W=SWKYIT+5=VK L?XJ]T_:5F(O+GZFOE>QU9H-4.#_ !4
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M#7YS_M.,?.N/QH ^+Y/^0YQ_>KZW_9]SYEO^%?(_WM<_X%_6OK[]GV/YK?\
M"@#]!/A7_P >,7T%>C5YY\+5VV,?TKT.@!NT<YH\M?[H_*D:E7I0(4 #H,4R
M=UCA=G^[BI*YOQMK*:9I<A+X./6@9XM\<-:MH[6X&1T-?F9\>M5AN+ZX"$=3
M7U3^T1\3Q"+E!+Z]Z_/SQWXJDUK5I%#;LM0!AZ!IKWFKIM&?FK[D_9T\+RJ+
M<E#V[5\V_!WP7)JNH0L8R<D=J_1WX$_#C[+:P,8L<#M0!]#?"^S-M8Q C'RU
MZ#6)X<T\6,"C&.*V6:@!K-UI%[4A.<TJB@!X%.IH:G4 %%%% "&DW4K4FTT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"OCJUU)4PX.?>NYAG2X4,C9%?G1\)?CD97A5I_3O7U_X!^("ZI;Q_O,Y [T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVIDN+;'J*_3/X?:>T>EQ,>!@4 =C6;KFH"PMRQ..*TZ\Z^+NK'3-+=@<87-
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDQ7@7P;^-UQX@DB#3%LX[U]!Z[:GQ)HI)&[<E 'Y/_M#V-Q]NN/O=37C7@&
MPZPAD_O5]N_M#?"R1I)W$)[]J^1=0\-W&@WS,$*X- S[W_9I\16-BMKYC*,8
MZFONG2O&.E7&GPN+E$^4#&:_$[PE\7KOPRZ 2,NWWKU2U_:VO+>W1/M3#'O0
M!^B/QR\8:9)I3QK*CD*1G(K\OOV@)X;V\N#&0>3TK8\4_M+W>NPE3<,V1ZUY
M1J6J7/BBX).6W&@1POA71YGUE2H.-U??/[-FFSQ_9\@]J\ ^&7POEO+R-S"3
MDCM7W9\$_AVVGQ0DQXQCM0!].>!U*:4@/]VNEK,T&U^RV:+C'%:= !1132:
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M"XP* -U.%4>U.I*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %9&O:4FH0L"N<BM:DP&'- 'S1\4?A3'
MJ44I$6<Y[5\<?$_X#RM+*T<![]J_4S5-$BOHR"H.:\X\2?"ZVO\ <3$IS[4
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M$ 0!VKW+3=/2RMU51@XIMAI45D@  %7J  BF]*=D4V@!12]:;2K0 8-.HHH
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MU\$[69B?(!_"H5^!EK_SP7\J /R\E^!^HQ9V1./PJI)\&=7_ .>;_D:_4T_
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MK]3C\!+)O^7=?RI#\ ;+_GW7_OF@#X/^$OPOU*QOH2\;CD=J_13X$Z/+8V\
MD!' ZU4T/X-6NGRJRP*,>U>M^%] 32U4*N,4 =;1@>E&ZC=0 ;1Z5GZW9I=6
M+@CFM#-172[XBOK0!\I_&#P'_:*3;8\Y]J^1?$OP3DFU-F$!Z^E?IAK_ (73
M4 V5S7"WGPI@FF+>4.OI0!\U?!+X6MI=S"6BQ@CM7W3X)T];'28U P<8KBO#
M?@&+374K&!CVKTO3H?L\(3H* +E)1NHH !2T44 %%%% !1110 4444 %%%%
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M!;Q;J0I W7L*X63X):HC8$3_ )5^M6L_!>TNY"3 IY]*PV^ =FQ_X]U_[YH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=:5336[T@- #VIP--49I^,4 ! ;J*ADLXY.HJ;-+0!3.F1>@I5TZ->PJW10
MR.,1K@"GT44 -8TFZD:HV:@"7S*8Z^9VI!UJ1: *QT]'Z@4?V;%Z5;I: *RV
M$2]JF6,1]*?2-0 FZES4?\5/6@!U%%,H ?135IU !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %,+4^F%: &[OFI<9I-O-
M.H :1B@4K4@H D6C=0M(10 M-9:<*",T 1JM/(Q2[:&H C)IZFFE:<%Q0 ZD
MI:* &[:=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4E+24 -I-M.VTE  .*#S2XS1MH ;C%+FEVT;:!#2*7;Q13A0 W;29%/(
MIFV@89%&124NV@!P-.IJBG4 %%%% #=M*!BEHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *1NE+2&@"-J2G,*3:: $I<9HVFG** #;13Z;MH 2D:G[:
M:RT AFZC=2[:-M !2KTI,&G*O% !2-TIV,4E #*3=3]M)MH 2D)IU-_BH %I
MW6A5IX6@!FVCI3]M(5YH ;DT=:7;2JM "[:6EHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 1NE,:G,:9]Z@!A-+NXI=M)M- !G-
M** M.VT (!2[:.E&: &D$4]:3K3]M Q,\TTM[TYJ90(<.U/IH7I3J &%J3-#
M4@ZT .I<FDI=IH 6EI*-U "T4@-+0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4W)IU-VF@
MW&E!I-II5H 6BBB@ HHHH *1NE+2-TH ;3*?2;10 S=3@W6DV^U(.* %-(M+
M2JM "4%:?MH9>E B//-.5J"M&WVH&.I&'>E5:4KQ0!'NQ2]:"M*%Z4  %+2D
M8I* "C;13LT (%IU)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 C=*;3C2;: %I:;NI: &LM,934K4PC- "+VJ1::%YIPH 6BBDH 1J2
ME--W4 24C4@;B@F@!*1J=C-(RT"&TJK2JM.'% QN,4JTI%(HH =1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4 ,*TW;[5+3=M  J\4I
MI/NT9S0 E/INVG4 %%%)NH #32U+G-(5H CW4;:=MIZK0 P+3C2XI,4 )NI0
MU)MH"T /%)MI5I: &[:7%+10 4FVEHH 0#%+110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 1LW%1U*RTW90 S;S3]M.V^U
M+MH 3::4+2Y%%  13:<W2FT ,IN34FT4FR@ 5J&:@+0RT ,W<T]>:;MJ15H$
M-V^U'W:?MI&6@8PFDP:=MI0M P5:>HQ0.*6@04444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E(U
M.HH C*T*II^** "EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;3J* $6EHHH ***
M* $(H I:* "D-+10 W::44M% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 W!HVFG44 -VF@=:=10 4444 %%%% "44M% #=
MII12T4 (U)3J* "DI:* &,II M/HH 113J** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &MWIJJ:DI,4 &*-
MHI:* &XI5I:* &,*;MJ6DVB@!%IU%% "-28-.HH **** &M1@TZB@!M.HHH
M*:W6G44 -6G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2-2
MT4 ,I]%% "4QEJ2DH 8JT\48I:!A1110(2BEHH **** "BBB@!&IM/HH 913
MZ* $6EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH 93EZ4M% #6HQ3J* "BBB@ HHHH :U-VU)28% #113Z* &K3J** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M &MUH7K3J* "BBB@ IK=:=10 U>M.HHH 2EHHH 0T"EHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *2EHH **** &4JTZB@!#TIM/HH *2EHH *1J6B@!NTTZBB@ HH
MHH 2EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1112 ****H HH
MHH ****5P"BBBBX!1124P%HI,T9I +1113 **** "BBBD 44F12T %%%%, H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHI7 ****+@%%%%%P"BBBF 4444 %%%% !1110 4444 %%%)F@!-U**;
M3EH 6BBDH 6BBB@ HHHH **** "BBB@ HHHH **** "BBDI7 *3=2DTVBX"[
MJ7=3:*+@.W4A:DI&HN N[WIVZHJ?1<!VZC=3:*+@.W4M-7K3J8!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444K@%%%%%P"BBBBX!1110 4444P"BBBE< HHHHN 44447 ****+@%%
M%(#2N M%%%%P"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBBDP"BBBD 44450!1110 4444@"BBB@ IK=:=3*8!2K
MUH6EJ4 M%%%4 4444 %)2T4F RG+THI:$ 4444P"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBE8 HHHHL 4444
M6 ****8!1110 4444 %%%% !1110 C=*;3FZ4V@ I],I] D-:DI6I*0Q]%%%
M, HHHH **** "BBB@ HHHH **** "FM3J*5@&4^DI:+ %-;K3J2BP#:*=118
M!M%/I*+ -HIU%%@$7K3J2EI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1112L 44446 ****+ %%%%
M, HHHH ****5@"BBBBP!11118 HHHHL 4E+12L 4444[ %%%%, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBBEU ****8!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !33UIU-;K28"4NXTE%2 N33J;MIU4 4444P"BBB
MDP"BF[J6D@%HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 44
M44 (W2FT^BF RG"CO2T"&M24ZC;0,6BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 ****
M$-)N-*:6@!N3Z4M+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444NH!1113 **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MI*5P%HK/O;X6JDDXQ7(ZQ\0(=.SEP,55A7.^HKQ'4/CC:VK$&91^-4[?X^6D
MCX\]?SI\HN8]ZHKRS1_BQ;Z@P E!S[UVFF^(DOE!#9S2'<WZ*BC;S%!ITC;%
M)I /HKGM4\0)8J26QBN(U?XLP:>Q!E Q[U5A7/6**\#F^/UI&^TSK^=6[/X[
M6MPP G7\Z.4+GN--:O.M'^),.HX"R Y]Z['3M26\4$'-2T4:=*O6DHJ0'T4R
MG9%- +132:44P%I*6DW4F VES24C5" >#F@U&&H+5H,DW4M1 U(O2E<0M%%%
M,!,TFZD;O3<T 29%&:;1FHYACJ6D6EJQ!24$X%0&;!ZT 3YHJ+S.]4K[4!:Q
MDDXH TZ*\UUSXEPZ66#2@8]ZP8OC;;22[/.'YTP/:**X70_'46J8VN#FNOL[
MH7"@@YI 6J3=0U,H DS1FFT9H =D4M1[J<K<4@'4F10>E-I@.R*6F4Z@!:*0
MT+0 M)D44V@!V11NIM-/6@"3=1D4Q:6@!=U&ZF49J1DF12TRG4D(6BL#6O$"
M:8K%F Q7GFL?&:VT]F!F Q[UI81[%17A$/Q\M)&QYZ_G71:3\6[>_90)0?QI
MV"YZK16!I?B)+]00P.:W4;<H-(8ZDR*6F4@'9%+3*BGN1"I)- %BBN2UCQG%
MIRL2X&*X75OC=:V+$&8?G3L*Y[/17S\W[1%H&QYZ_G6AIWQWM;R15$RG\:+!
M<]QHKC/#_C2/5MNUP<UV$;;HU/J*+#'T45&TRK2 DI*C$H:GK0 ZDR*&Z4V@
M!]%)2T %)2TUJ %W45&.M2+0 49%(U)0 [=2;J:U)F@"3(HS3:3-)@/W4FZD
MS14B'9%&13:*:&.R*-U-I&JP'[J,UBZIJRV2DDXQ7%:O\3H-/8@R@8]Z+$\Q
MZ?FC->%77QVM8209Q^=5O^%^VI_Y;C\ZKE%S'OU+7@(^/MJ/^6X_.C_AH"T_
MY[C\Z.1AS'OM+7@2_'ZTS_KU_.KEM\=K60_Z\?G1RAS'N-%>7:;\7;:\8#S0
M<^]=?I?BJ+4 ,,#2L4M3HJ;NID<PD7(I-U0,DW4;J91GWHN,D!I:B5J<K"A,
M!]%)NIA:@0_=146ZGKVI@/HI"W%,W4 24FZF;A29H ?NI<U'FE6@"2BDW4F>
M: '4E+36H 7-+35ZTM "TE&ZFYH ?130:5NE*X!NI:IW=QY"DDXKE-9\;1:;
MN+/C%581V]%>,W'QHMH9-IF'YUKZ/\4H-18 2@_C187,>G49K&T_6%O%4@YS
M6M&<@&I*)*3=13&H =NI<TQ12U0AV:,BFT4ACLBC=3::QH DW49%1JWO3J0#
MZ*:#2$\TP%W4N:CI0U("2BF[J7<*8!FBFTJT .I":6HVS0 N^G;J@R:>K9H
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M#5&QH4F@"6EJ-34E !29HW4V@!U+35IU !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6I*=BC;0 M%%%
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M-2K28YIZK04.7I2TAXI : '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9CVJ//-/7YES3&&&%(0M.5J93UZ4#%^]0!2K2T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !124
MV@!]%(*6@#S_ ,?_ /'O)]*^(_CLWRS_ (U]N>/_ /CWE^E?$/QV^[/^-=,)
M6.::/CW7E\S4F!]:[?P7IBS0KQ7%:S_R$V_WJ]+^'\?F1H,5U<UT<S0[5]!
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M)H3"PGA_XG7+2!!*W7UKU7PSJ=]KFW!9LU\Y^!=/:ZU)%Z_-7W7\ _ALNI+
M63.<4<PS)T_P'>7EN':-CQZ5R_B[P1/9Q,2A'X5^A&A_!N"/2U)B&=OI7D_Q
M:^&<5K;RXC Z]J5Q'YV:S=3Z3<GDK@UWWPJ\>3QW\*^8WWAWJK\4_"HM+N7"
MXY-<SX MS;ZI&/\ :JD3<_2WX.>)WO;.+<^>!WKNO'%T6TMSG^&O$/@9=$6L
M(SV%>O>+9=^DM_NUG(UB?$?QTU)XYY\'N:^>]-UR3^U!\Q^]7O?QWCW33U\Y
M6,6-4'^]4C9]?_!74GFCAY-?3NG637=BHQG(KY9^ \6Y8?PK[4\%:6MQ:Q C
M/ JA'C_C+P/)>(^$S^%>2ZC\)9IIR1"?RK[IN/!D-RN& K-D^'-LOS%%-9W*
ML?!^I?"V:SB),1'X5Y3XTTE]+5\C&*_0/XC>&[/3[27Y5&!7P_\ &RX@@:8*
M16B(/FOQ/K3Q2.H:N2L;Z:ZOEP2>:UM: O;YU7G)KKOA_P##U]2O(B$SD^E6
M%CV3X"V$\DT!(/:OT+^%5J\=A%D=A7S?\$?A:UHD+F/'3M7V'X-T/[#9H,8X
MJ6PL8'Q(DD73Y-N>E?"7QH%_-=2A"W6OT'\:Z>+BW=2.U?-'CSP3;W$SEU%-
M#/BK2O#>HWE\-P<C->M^'? -PT*ED/2O1M/\)Z=93 D*,&NUL?[/@@ !7I0%
MSPS6/"K6<+$KC%>,>.[IM.$F#C%?5/CB6V:"381TKY2^*D8D\W;307/--/\
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M4N^A\_\ Q<^*T[74R+,>OK7CUGKEYKEYC<S9-5/%5\VK:JXSG+5ZI\&?AO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!2;:6B@!JTZDI: ."\?+_H\GTKXA^/ PL_XU]N^/F_T>3Z5\0_'EOEG_ !K1
M&,CX^UC_ )"C?[U>M?#&V\SRZ\EU3YM6;_>KV[X1VXD:*NB+L921ZDVA^9:
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M!8'EV_X5]46O_'M'_NBL9FD-SY^_:$"?9;C [&OS"^-\(>^GX[FOTW_:"/\
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M%.Z/V&0J>U> ?!+XO+?6L"&4'@=Z]G\17PUK2V(.[*U-NIIT/@WX^:U/#-.
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MJVG?\><7TJS6+-@HHHI -:A>M#4+UJ>4!U%%%4 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M60[ RXK],?&'P?CU#>1%U]J\;\1_L["X=L0?I5<PK'QC'XUU:#Y0\GYFF_\
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M1!^E:N=R.6S/"[;5M2UI<.7.:S=<^'=UJ4+,8V/X5]<>&_V>?L[+F']*[@?
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MXPN*N*-HQ2TF: &R1B08-4IM'AFZJ*OTM &(?#-MG.P?E5F#188<;5 K2HH
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M;14<GA^"3J@K6HI 8?\ PB]L&SL7\JMP:5%;XVJ!6C10 Q?E %/IN.:=0 A
M;J,U7FT^"?[R"K-% &1)X;M)/^6:_E4!\)VG_/)?RK>HH R+?PY:PX.Q?RK0
MALX81\J"IZ* $QB@TM(U $4D8>J<^EQS?>4&K].J0,)O#-NS9V#/TJ:'0X82
M,(!^%;%%7<FR*T5NL6,"I\\8I*3=4%$$]FL^<C-9\WAV"0Y*#\JVEI:I,5C$
MB\.01\A!^5:-O8I#T&*M44#$I:** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>M)4 %/IHZTZK **** "D-+12 8:*=1MJ0&]Z<#1BBF M%%%4 4444 %%%%
M!1110 44RE6@!U%%% !1110 RBG4M!-AN*;@YJ2DVTQ@II:*:U*XQ2:CW4ZB
MI 1>E/IM.H 6D-(U)5 +NIU,I] !1110 4444 %%%%*X"$TVGT47 8*?111<
M HHHI@%%%% !3=U.I*  &EHHH **** "BBB@ I&Z4M% #*<.E)WIU !1110
M4444 %%%% !1110 4444 -:DIU%2 @-+NHHIW -U)R:=12 91FGTE ";J7-%
M-H 4FA:%I:0"T4450!1113 **** "BBB@ I,TM% ";J6DI:0#*<M%+3 ****
M "BBB@ HHHH **** "BBB@!,T;J*1J %S2TRG4 +24-2+2N ZBBB@ HHHI@%
M(32TC4 -#<TX4W%.J0%IK4ZFM5 )3E--%.XK/J ;J;FBC%:= $YIM/HK)[@&
M:?42]:D6M$,6BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHH *3;2T4 )2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% "-3<TXTFV@!:6DI: "DI:* $VTM%% !28I:* "BBB@ HHHH *1
MNE+24 -HS2[:-M)#'4QN]/II6F(9FEW4NWVHV^U*P!3J;[4XFF T]Z;FG&FX
M-*P["4^C;[4NVF(6EI*": %HIH:G4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% #6%&#3J* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *93Z* $6EHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $QS2-3J* &4N*6E
MH&)2T44""FM3J* &CK3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img109617586_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_9.jpg
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M\H+:.8[_  <T7+.O.K% OS!<X[K<8J_/EJJ-&\>,I F.+/J19+,*KP0#)%]
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MDFC&M!))-Z[=GV9(65!= D)9DO#?$=%B4<^(^)$=0&)%BQ71(L1Y  TGO<0
M *"Y2KSIKOK1(Q6<&ADFGLQC(! 5);/*"C4[*I.B"ZLA*!!2006[70=NW#1I
MLT%(I--$QR#-%333"BR:BV<J9[$6;F(\*7@18A?"E&/9+L+6@0F1'Z;V@M:'
M.TGW_B+B-A N75@24K+1YN9@01#CSSX<2:B!SR8SX4,0H;B'.+6EL,!OX T$
M"I!-ZADWTOZRR)QLZ+58Q6<JFK$/NEV\AF(Y0@_MEPFZL5$KL.D33)8/*W">
MBI&.D_G<?UVQGYH,;8VVQGO0[<M6$*,FW "'+0P#"@.#6R8I+%@=".@^"#1L
M1M(E/\GE:V+R;L2,XNB2#"XQ)R*XB+,,+W6@0Z<$30C-YR%,.%7P7Z4&M2V&
MVI7(GTTZQ(R>#S/2HP&LBKD1"PD3?9?']D&C"N&20Z!;%1FYC85)R$.9-VZ$
M=,RAB9,"=6S?9F_2W01VTG7=J\U'@=,B<W,OCQ(PT8=7.FG%TSH/T-.$V.XD
MQ60G,8^ITFFJHY.6((\K,BSX7/2<.6A2[M**0ULFP,E"]AB<W'?+L:UL&+';
M$B0PUNB\4%.(;T]ZN9VE90;5<;<MK"#R(29T2*'7H)4'-'J925LHR*V-+@XB
MPE+Y))V=3A;,&D84TUV??.,8QCE?;=K_ /"Q\Y%!EHD)[*MAMB")+M,."Z*\
M,$2,^"VK89CNB&&/\:*,Y.V'6/$9(P2)N'&AQ*1(KH1A3+@^.V!#YTPI=L=P
M#HO1FPA$/^55^D.F/69K'3,7;58P0&G90 F;UTE()>G(VTFB;)09$R8.8:R'
M$MC.T5%K.!,8:QPV*8QX2Z>"P[9DP>.6ZL-N6J8K(QFW%\.%$@-!AP>:,*,[
M3C,B0>;YF+SKP'Q3%AO=$> ]Y<YH(#DW8C8,6 )!@9%CPIESA%F!&;'EVEDO
M$A3'/=(@&!#)AP6P8L-L*&YT.&UK'.:9F@<2K^KX^#K" # D6!QT9OL%B0Q;
M311H.5>+K.7WS9594@YR\).'3E^5=[.'! FY<NGKI=ZNLKOTIB-,S<2)-S#X
MD:)%>.<C/!.D\- #=( -&BP-#6"@:P - : %LI67E)&#"D91D*!"@L_XY=A%
M6L+B2ZA)>XN>2Y\1Q+GO<YSW%Q)/[BC:O(R,*L8;Y*B!*4B,D3+<&X&H,D)3
M)S3@J<<$=6JOR2!@T>).7CWYQ\1R[(O%-]]=EE?K1C,Q7,='YY[^:8V&8@>7
M&#"8&0PRHJ8<.&T!M+FM;@$EQ)P61&RW1X<,1HCX@A%@:(\>(8D4OT3018L6
M(Y[]*CG/>2;RHA:=/.M+&T,W*TJ4 C87E*M--2NKLYD6E,G&-_EI@A$=BVT-
M;RM113=QO(T "9G+S?9]\]^>9ROSN&VK4=*=",Y$,MS0@:&C#TS %*0#&T.?
M,$4 YHQ##H -&ERU[>3MBLGNL6V?!$WSYF=/2B\V)DZYD2_.=&$P3^(QQ!$7
M2_%IZ5Z[D/ZE]<X#9KZXHA5,=!V*^<FWN3[94LJB/?R7&=9"0  G1%Q'(R0.
M:9W2+/XZ(%NR"*RZ+I95)POHIC&MBTYB5;)1IR+$EFB&WFR& O;"_P#2;%B-
M:(L9L,WL;%>\,(!: 0*92]@6/*3K[1EY"#"G'NBNYUIB$,?&_P#6?"A.>8,!
M\45$1\&'#<\$AQ()!X8%U$ZW5A83FTX%4L<C<Y<;F5$2[-4LLV#J2'.V3JD8
M!/"3F/1)0OKNHB1WBXH1L[;JK-5L[MUE$M[,6S:<W+"4F)R+%@#FZL<& OYK
M_P!/G8C6")&T+BWG7OH0"+P"I*<G[&D9MT]*6?!@S1,0B(TQ"V&8U>=,"$Y[
MH,N8E2'F!#AES26FK20K'\UBW*<(G")PBQ)C()PR>"3^12P\D,))OQI?+11F
M_#ZM\(F-';1YG*+H;JU<X3)863W:ZH.,:.? FKC&V;.<#@^'IAS'LT7LT@YK
MR:LHYMX?4590@U%UX7'$YIS70XO-ECV/#V1-$M?#I2)I-=<YFBZCZ@MH:.N*
M@"I>L/62G'!M:JJ\B@%U/@"HPBJD3(GURT0^4^56"BMSQ<PHPB'RSQ-54(!R
MR ?*J-E-V?Q]&V=-C.6K:LZ(8FYF-$$M$#V@L;##(VH1'\VQ@=&HT@1(FE$H
M" [6M39]B6)9QBF0DY>$Z;A&&\A[XQB2]:F$PQ8D0MEZN!,*%HP:Z-6W-I^R
MG4/KD8@4#K)W6(Y&&UCH52@+ 49E ,E%T#VCA.0-1LF"'!\HU9R)-TOI(F:Q
ME9J?TW^*81>XTTQK&6S:;)B8FA-.,>:T#,.?#A1&Q3#IS9?"B0W0JPZ#FB&
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M1K0ZC6M=T;#EP(-JPXS9:-*CD=%AQYJ1E8LE!EXL&L00[2;%@0FS%JL/XF3
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MU&SX:"7$DT %3J6$&9Y0R\&%+P>3DBR# ALA0F?^('.T(<-H8QH+K+<XAK0
M"XDT%Y*S7G0[H?=)J[]5NW]#<X^B6'ZYFOA!_D%R]/Y2_EZ1^/\ ]2GG0[H?
M=)J[]5NW]#<=$L/US-?"#_()T_E+^7I'X_\ U*UF8G^U5@1DQ#)ETSJ8_%Y
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M<1E-0@&FU8SAD8"F8@?<8V<O [,B(,,'"3!P'D[!TQU75(+OO]-ZHJS^"<K
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MFPEV:$MGZC=8BST65.[@,DI[>)S6?\V\*^Q-?\\I^]XJ=W 9)0;^)S77T@4
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MB2][#M>PHA.'EQ1&/5G<5>=5;_)-0USLRL[C-*U[>"\V[2QMK2BPVW-(#?\
M=YBA![R95R\2*"8?&"SIP1'P(A-'^K[V<;L?L!94;?0C42*TVD"FO6!4K/N(
MEVDE5<2IP2LWM4^V@W3'L;8%0.XQB\*@+&+6%7#83KKVG(1+TMFQ)W+XQ7K:
M,!!,5M=X4,6O'MQI^X8":D1!1HQ(* W@:P#6A%#KW<-6PA=<_$IK#G7=I80?
M[%5S.;,[74';Q)]HT[@R^'RJJW_5?K8PD2:)6KY%Y75W$7]MA)] #TNI!SK,
M*Z918!$I (;TM$&X<.4P-UP.%=9W'9?>/$KT_P"EDCFDHZXP@C/HS-XK(FQ.
M? \,K!D4SELA) X[8DJ!Q:3(R*RHA K.+1R4QH>)D$/=V9$A=A*10@&S,7!T
M[\\DA@H=>/AK5J.%$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$7E=+'E5PSX3JKK $PBS\G2W7[LM6]K6,UIN^)4#\KY7/NCBE0Q#>>ZPPS
M%1T9V!PBP"@<='S+6!@"+><'GVHP\>D3\F5K=3 B@XU4:4_ >U CX0NI;8N2
MBA:<@G5&=TAUCV?&['4E41BD:+VMTO<U)70ISM!Q>@EA"XO"MF,:B3QZP>6#
M(RMQ6RT:#'RDM8J%D2-$@8MPP=7:==;SLH O9SA8)PB<(G")PB<(G")PB<(G
M"+ROL-Y54-^$KJ&Q!\'L]62NZBON"6O8C"FKXEX1N7D3OJPE4T43F[6&&XD*
MC"@Z.2TFR%1<LTA@D]F:R(NBQDYV3$2,VCV']LE=A]H_?CL41U)$Y7M]#^D\
M0*?BK\H?N3=EK73."-<3$3%D(>>U['[S:R]+5? 6T(EPSL.C8T:1""@$G-'2
MCZ:Z[%0K%W7$RUB-5QONH+L:4N]U#?=JW@'VLX6*<(G")PB<(G")PB<(G")P
MB\@>Q$FK:=WE*.M0RJK)K^/2"YZ+MWL5?>O7:]Y/I9,XKI]6DAKZ(5')XS7,
M@CKHDW8UY H],[?*R(-%*PCC9<3"=#LX4.E:[+(5 K780!47"^MU=5YNI?4U
MN-^!!0'M0T^$"IFW[.HH6_?R<EV.!EK$CECJ'XU J5;(1$;4<+01\AVF0F@<
M-XUEKP:5(INIS:$SL8@*7'"-!8<05J-$@5V:[MMYU_IN]J]G.%@G")PB<(G"
M+2/*64>KH[^-P_W_ ,M!B/')8U=V?,$\I91ZNCOXW#_?_%!B/')*N[/F">4L
MH]71W\;A_O\ XH,1XY)5W9\P3REE'JZ._C</]_\ %!B/')*N[/F">4LH]71W
M\;A_O_B@Q'CDE7=GS!/*64>KH[^-P_W_ ,4&(\<DJ[L^8)Y2RCU='?QN'^_^
M*#$>.25=V?,$\I91ZNCOXW#_ '_Q08CQR2KNSY@GE+*/5T=_&X?[_P"*#$>.
M25=V?,$\I91ZNCOXW#_?_%!B/')*N[/F">4LH]71W\;A_O\ XH,1XY)5W9\P
M3REE'JZ._C</]_\ %!B/')*N[/F">4LH]71W\;A_O_B@Q'CDE7=GS!/*64>K
MH[^-P_W_ ,4&(\<DJ[L^8)Y2RCU='?QN'^_^*#$>.25=V?,$\I91ZNCOXW#_
M '_Q08CQR2KNSY@GE+*/5T=_&X?[_P"*#$>.25=V?,$\I91ZNCOXW#_?_%!B
M/')*N[/F">4LH]71W\;A_O\ XH,1XY)5W9\P3REE'JZ._C</]_\ %!B/')*N
M[/F">4LH]71W\;A_O_B@Q'CDE7=GS!/*64>KH[^-P_W_ ,4&(\<DJ[L^8)Y2
MRCU='?QN'^_^*#$>.25=V?,$\I91ZNCOXW#_ '_Q08CQR2KNSY@GE+*/5T=_
M&X?[_P"*#$>.25=V?,$\I91ZNCOXW#_?_%!B/')*N[/F">4LH]71W\;A_O\
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M&X?[_P"*#$>.25=V?,$\I91ZNCOXW#_?_%!B/')*N[/F">4LH]71W\;A_O\
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MK#Z[ #!+AZB]7C0-PVE<T-2$MAB#%"1+H.-'-U2A\W(&N!8\+(2MU]3[+O\
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ML'Q 6E:T\4(L&)51^B+>/6.DLRY:M22HHFDP<+I)HO%!S_1ONILS<83(N[K
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M8P838PBH(W*MUCQU:J[U,7:ZQ6,KZ.7[8%:'7+P$^J&>[[245H3%D&,5:-R
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MG")PB<(G"*DO=JSZ?I^.U=/+)JXI;LS"V$MM1L8;B9 _!#;*(Q*1 =Y9+2[
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MNFR,D61-II-&^V=V\OT;/:W71UE"&^VVZ)_73!9+;;.VCO7.<YXNQ/ 9I5V
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M1FHL2A/$#WG4H"[%=^JVH)&V'B31:P=J9IV\K*EL3C NPW<U>F:98=>C3L.
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M1"2$0Z,1E&0Y*9ZP5JI[OCU[:#!6L>E!8[*)/!K%G,?CWFXM[*@H359<[%+
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M"=7ZC;[5LMDW,'AD'ALMCJ3.9.+,EU;0NN&C0EJV820A9IL8P&%]":39]G
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M$<$:NFCM<? Z^KB$UC'W+]5@NZ9Y=RHK%9+.VB>B_P \'QZ6 0IENR."B3-
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M[@,D3R#9>D,X]LS_ .]XJ=W 9(GD&R](9Q[9G_WO%3NX#)$\@V7I#./;,_\
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M?T%,GZFA<@J"'V]()I<XJ,:6G('E!SVFFI2[8A-B4GU=$)-05M W=8,@4A9
MX(Q-10LE)"R('XJ"ZKJ&_4-7L(P(OQ5M_A.(9,NQ0R!=3H#$)/,7DF V;<DI
MS$Y#$XX]BJL!BZT2I&0.R$P/QT8D[C_8"P();T70T>K/'Q6D'>$F#QFS(Z:E
MBTTOVZN.OP%/?K5 F-ST!>';)A<W9B6]"*J\MNAO1$C*8=W<@\'DAY&5B[E[
MQ#+O@-0%IQ:U?L8L=@LL9$HG-7J(B=--2FD2<OV&C=BW;F"RH[1_"''\3O\
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MP7WR@E_H Y]I 7^[B@Q'CDE7=GS!/*"7^@#GVD!?[N*#$>.25=V?,$\H)?Z
M.?:0%_NXH,1XY)5W9\P3R@E_H Y]I 7^[B@Q'CDE7=GS!/*"7^@#GVD!?[N*
M#$>.25=V?,$\H)?Z .?:0%_NXH,1XY)5W9\P3R@E_H Y]I 7^[B@Q'CDE7=G
MS!/*"7^@#GVD!?[N*#$>.25=V?,$\H)?Z .?:0%_NXH,1XY)5W9\P3R@E_H
MY]I 7^[B@Q'CDE7=GS!?A0Y+%=-TE:]6424TV3434D0#?133?&==]-]-E<Z[
M:;:YSKMKMC.-L9SC.,XSQ08CQR2KNSY@ONAR6)Z:)IU\NFFGKKHFGI(@&FFF
MFF,:ZZ::ZJXUUUUUQC&NN,8QC&,8QC&,<4&(\<DJ[L^8+]>4$O\ 0!S[2 O]
MW%!B/')*N[/F">4$O] '/M("_P!W%!B/')*N[/F">4$O] '/M("_W<4&(\<D
MJ[L^8)Y02_T <^T@+_=Q08CQR2KNSY@GE!+_ $ <^T@+_=Q08CQR2KNSY@GE
M!+_0!S[2 O\ =Q08CQR2KNSY@GE!+_0!S[2 O]W%!B/')*N[/F">4$O] '/M
M("_W<4&(\<DJ[L^8)Y02_P! '/M("_W<4&(\<DJ[L^8)Y02_T <^T@+_ '<4
M&(\<DJ[L^8+\[G9;OKMIO7R^^F^N==]-Y&!VUVUVQG&VNVN5<XVUVQG.,XSC
M.,XSG&<>#B@Q'CDE7=GS!?$C<K13311KU9))+35-))*0@$TTT]-<:Z)IZ:JX
MUTTTUQC7777&-==<8QC&,8XH,1XY)5W9\P7[\H)?Z .?:0%_NXH,1XY)5W9\
MP3R@E_H Y]I 7^[B@Q'CDE7=GS!/*"7^@#GVD!?[N*#$>.25=V?,$\H)?Z .
M?:0%_NXH,1XY)5W9\P3R@E_H Y]I 7^[B@Q'CDE7=GS!;OR+)5C[/7A-Z6'4
M\TKF"16P)G<MVQVF@8V;3LO7<8%+G(C.I<J>*R$% K)*_(M&T(6:)L6D6<;N
M5WZ6^SENFCOG<J!KW"N.T#=BM8JKMJ/.S@E25UQL=4=_B[-8U>WA4?D!NS(=
M,GYRH)3>\8DD%GNL'ASA>,FJW@=@.%7,WB4$=C95 I1%,MGKCR9?2=[4IM&J
ME<#KIJ]IV5\#3LF^]76,$S3).)V:?BT0DCE4A* *SM*1C8##(G-I/7)Z=6<]
M!PQ^A64'9S*%3(4E+IWN  D&T0EI\:^>1J*R(P+( 3J]@WG 8_ZQ"VSL#V4C
M'7IS33>01>=2C%S6L)JP4I!X7,)E@,Z*!31G!@GI$8Y(=]$$TQ&$F[!3#9V1
MT6=.V/RS4044;%%]B?;"BYO9.*ICLH,N9.Y-SN+@R+R!6 (@4PE=7.WC&R8G
M!+/+Q=C7,YD\%>#3#>2@8I*"Y-@K'I6G\V4VATLP%*T/WKOU&FNAQWC%=^6=
MFJBAEFH5$7(RYW-/DX.J7TC5869,8Y#T[,.$HW %)[-8G$34/@B<J,AR;4<I
M+#@C1%!IL2([,12S9\L2EU?W"TUYW=ZV#GLN;D9P98#88TMAR0EKNN+-2@1E
M>BF1DC<(:#SW,/S$+$DM>-(W)E#\8@IF0R#"D6EK8>-?.HA*$0Y*'##QU<?W
M&(6 8]YJ3=+R<VN?69P + JEF 5XXA-S-K'ESBX[2LNJ(&G%ZQ?U0R?RX)8D
MC@"32HWT#,2^1V,L06>LH@-C#B&R6;$H?UVBEP!UUIJ-^'MU297_ &EI"S2P
M2.165D<RHZQM1\G$3\+G,2E0?S)F(""M ?+(_*8V()PXU%R%HP#?Q)*&XDJ>
M%2D7((PT-1]3<HF2GA0:QMKDM5CW=?KO+BD$&Q*32Z4HV'&:DEX0_'JCMXM$
MA8*^&2)"H%YS+6<&5CM</)VR<M7 T5/24<*L$WHW8ZS$^-A7STA!&L4O(]XU
MK'=U^U*_46HD+'%UT^M@^[/.6K*"C#/B)^\C40ATMMFUS[5[@0<W6=PRG*YL
M&5B J8[9262(2$AB#P:[D;5^W(!4TK3/9X\->Q0_9_=^4!>RSKKU68_JPYQK
M2]%6U'I-?':4I2[RQ5KWF=U1$#'*RC82DK24F&POS0MWCU^V)H++JS4 R:C-
M]M]5G!4"ZM^LBX5I0 U-XUU\%<&V;PK^DV$8=3QU(5"$T.*1J(Q>#P><6=-9
M2<;!"DD(LX[":[CLFEI9$3'PA<V7?M@N6(D6/6=DG#739+"A0"OW3]5$V.\W
M6)8C%&3&P2!=C+F%7D6TL"5_9!FOXZE=;ALTJ9K8-A#8DYA59EIZ[>CVH,+8
M!V-E_ER@9-^R8Y-A_GY*'[(^R-XN76']\>K9$A*6>+"*C1T.:W0Y,S&15M:,
M7KK=7KJ0,#;Q&A;'D<+%P>2F:S7CYQ62"(Z>*$-6(4T08-WS((878DH;M]-H
MVZEE&?;6OI%F$8C*9T4M*;7BM8NA=OUW=M,R'"DNB4EF 9[&@,NJ74B=7)C(
MZX6%N"24;ABN&IP>2FXF1AMH^Z*?>/W]XJ)4_A(*">6+'00]X<UJXKU_N>_W
M=PG(59L9 D(_6-B=?*]C&:Q9&X TUND-9[Z\5U(D>K,E(/&[D" 9QL;)=+!C
M;S8K3]0.->&I262[R]<@P@>0+2"=CBY6S4:9'U^YI6Y];8<VB[@CJSQ\.UJC
M2 [V$F^*UZR<S$2_7CJ00E'TMR+0HJWUVWU)0^%=U/;JUW>V[6NTT[O=9G.\
MH57L)V&!Q6,63,UYG)8/8$9KZ0Q6GGFK"SSD!L _%QT.L9A"W.^N"JD%-2#9
M5KGQB-U?C-=GFI*&X;3LN^Q[UST?VHC][VU<5;QJ)S $PJ:%TQ*5RD]B$]K>
M3D'MMNK4TR(>U[8T-B,C"HAA]=CB34JIJ\;FDY+E#1)BL(7U<D(H <:[]5,%
MEC?;WKO'(<A/S-AX9Q)PQO4DB6\E)NX^.RZTXD^UV+?,6L:7):^16(=),Y3V
M9ZJR+Q;_ /4TSOSMC\Z)0ZO9XZOU6DK]^NK[,*9-D9A,A:8<S 0:8<I2UV#Y
M=(G=L)23>J7,(A+JO4I?.A%H.8?*!->G(B$,AY?( 9"-@WKP\CXNR2A^_P!\
M-]=6U957NG1K@D5CP4M)7DA:J38$'V+5Y9,:A<AL6OH@;FDLJH999F'MX&ZL
M:-B(Y(<R6',CKR1 GD8F0IV+\=0F6C Q*']_<=OWB,0L/$N\-1%(K4)F7HS"
M*%;/B%%G261]=6A+J\@<B[ L([M HA*;?#07-?B2!4Y)Q(-HH;+!E4]R@-\9
M9A&A\3LZ)2\C"O@L)7/P@%,3N"ZS-X!MR-/"%VWA2,7@J])W,7L*8F:.L">P
MT^9C4'&U[M*R@G07 W4CDKAH%6:5X[>^1,U?"YFQ<B<D+2,-0.L4OOUUI7<L
M1=OPB]#UC5AZP84[-6V28U(#N 4'BL.LET 2CDP>%!<%\X<W#0.0!*A5F!@$
M>$"FUB:A"N"((RV<"DE1;[5 @!)]]-GOIC3<K_<*)PB<(G")PB<(G")PB<(G
M"*KO;OLD\ZLTW)K5'U3+[==1X09.+ HXY9 @XT1'ARA4R:E\T+:+#8P(;,TM
MDVNJ+$Y(31)9L/ QPJIEXHR&X$X*@5-*T4R6K8P&H*SGUJ2C1XK'Z\B$@F)9
ML-2T<%'S./BW)/<:(:J*HZO#!/+?4>)9?*I[/2+EJUTVQNMKPIK4$2'LS(HM
M>?7JC3-+R5!S<RI<5)K#U-M$Z]A4L$U#-[6WBD6(/AC(Y:3S5*"$AA H- QT
M");/&#Q\3T-*[Q70K2XFONVZP/=K]ZF.N;.;3XQ:T:6%Y"2.HK(=5](Q_P ^
MP1;KZ/(Q%[!AYY@\RT8;+-9' )Q%2CQ#YI\F$D2I^+:/2VT?4+/2$:MXK^W[
M*4N%$X1.$3A$X1.$3A$X103?EG3FK(T,.PR(5Z<;JD]D91*K=N,=2%75^$U;
M*?(&)3,-HK/CZCDP94&1T +!0<MH[*$M-BY,"S2T<N"HO.WW"I6FU[VGC\GZ
MF*=LIC&B$(C(B SN?24(S?:2K&!%>.)&@4*0DVFR"ZSF+2MM&EI#6,E1%AO+
MF)FHR=1%C,F=&2!*7T^[_P!\<"J\V5\(&_@MF9JM"&4@A+HH/K-I94;LCM1&
MJJDCNR+#$ Y$M4U%LY! '8:TY/'@,GBSC<U-)#34/+F)Q (VS.HD9"34C16@
MIK.Z[9?>;[M1NH=1]]W(#9S::RFV86X%Y"R2I)HRC)5IE]A^@6#2"* )K$I8
M-6V:,%L#S(>08&O$%FF,#97'Y4$;/"S02@9(%BI2X1.$3A$X1.$3A$X1.$48
M7#:0BG8$4FA-B]./='(L#$XB(V0P?GD[DQ%L"A4$CVKG=-M@S*Y&_'B&KEZJ
MW%B]'*QDV\'@QQ(@U)2OWJWJ,*G[-!)KU&C';6?A4:UCKVF%[GFP1N;5E[>&
M!1,==R22-T#WB.-KR% .Q8/=DG_D\&6?IHZJ>+&FZGR&I6E]-]%"=_\ <FUJ
M#B(:>2&A8,T">0$7EAF,RCL2)CUK3*8EOB[R.FNNM=#*[E+RY+-C&%APQF*.
M$JN;3.6'XU&8RNZP4>%PY4 $TK>3A<!B36X;3KH 2K<0NSFTKG=LUT[%Y"R.
MK#$9T50V?8?:2"(32-MCD5FK+/S1INT8DB3>6Q19BOHHJV/P@_JFX=,,L7KD
MI34<?U^Z<5*7"B<(G")PB<(JR=G:,FMVC*A<UU8D6K6:TW=<>N8 9FM<%K3B
MY-T#B4XB*H$Q% 5F5(6W;O&LW<.]'[*:,U&KA@CKLV=)K;ZZ%00*U%0<#3:#
M@<,%7U3I'9^3XN[-[YAY3M.UOL==I"?E:4+8IY<>(H*QNMH>K0].C[E:2P+"
M04"M"52(4X<76;DN]DD'\A+&R81_M%VY6HPNI3?K!J32_5DH-U^"::-ODG2L
M^IBP3TDK9_5EF2&\.K$<M9=V&WN:\+>$R>L0A.PF$:@DN0S?TUCL@:R438\#
ME.S"(&7L+;-0)"-R(E12E-1)%#372H-VX4U;<;O06_:2-VC&ZR;0&4Q^!2JG
M[1AMH0I](8>[F$1W=Q4:: * C47"2J!D%ACZ/2(JU:;BI**4%D=1S[Y)\T:+
MBGA04VBOOI[U!59]*I%!IW52A>V \@IOK[<%XWA24#8UT\!SH7,[R'VV$>,I
M[8ZM@&1,PC4'CM[6B#B[(37D1)$&Y&+/9*7*%8L[?24A-=EY !PNIJ%+M2Z_
M8WI&:O6YP%KAK!@U?/A*5=MD)H-JDTW[!19E!)@M*7P>"W;";5KY3:,RE)PZ
M8*Q&SX?9\7#.RL@()B28P^2C:I :"FO7=LO%*T(-^\4*A9E\%< '#[-B8V04
M@-BTH#=GVD&EJ'6$"YO^,$^S &R #E64W(_GSE23#("QM25#!WDG%JVEDMC>
MH:.2B8JM$90M,WW]^*M=1]E;[C3=_P!Z]BG:U>D3N?3):Q@%HMHO,@D+ZD":
M\5?P3>0 H_,NIUI6[9(L_)!2$R N)3%Y\UME]#ST18DHN4$"V;DF&F>A=ZP<
M!)2^NX#A7-0&GCMIK 'A2N&(6IC^CMI )OI=<:ON(#;YE4EO(I:TG>4L2)P$
MP&O6-=?X<2'U] _.XS)PLS"8WU?IMI%C4BFE@,'[P;*B$DCQ/:4)(!*K4877
M75PKMIMJ5H#3X,TR*UZWM UOP<4ZH.M>L%;ZVH&I<U%.P;L3US;QUJ1$1VT8
M9<L=:Z06SFX-\B0@5J16X0\71ELQ:(*GQ1M,8P(75)--9)Q%]<0;Q76*:O>K
MB73U7AG8&QH3++.+2 A$(%!Y_&0T#CDDG,"W<R"QGL53.2HO*X'-(V5))-XO
M&%HHPC:[;Q=\PD\H6?K/_G[5NQ*5I[_VV9XW*J-8]#+ZHJ1!#M3]D*7(X#]<
M*%ZUZ^?'JM,+2+IQ7K9-+[-5@9&G8UVMJQ=F:Q$;K9125KOVQA8^5A#:6HNA
M6YMP$8%EI-(H6FE2;B!K#1M:</%6WO*DIO8<AINRJWL",02V:6*RMR&*3" %
M+ @)\+/HBYBDO!'(<(L"OCR>JRGB8^#)#)TS>"B(%NT=^-A9 DU7+$&E=^=<
M"JWFNB%A'5YH$+=AV9^"7F2H&5]E-3M1LM+%L&=4<(@,>(FH+*8S-HS#JS$6
MC'ZPA0>1@E*UF&T<;LS+J*$F14VB0#$KNO&J_5AC6AOU^U;5MT<5UB< C3>T
M6NBT$L+N=/DG[VM IYD45[<O[O?:"GL9D9PO'GK2O]KDPD[;G&1T1/4(ZHW(
MA0K0\LV'$K^@'"E_AXJ,ZN^#A>P@@-<D[/B R-"[5JVQV-15)6TV@M*A=:YA
MMP1 QK#8/+[RM!6!R*R4;59;2DC%3 ^,-1->0L2QA2A5N6E18A-<=MY-2:WZ
MZ#;7BM)+_!<RJ;0BOJRLKL%&)1 J.ZU/.MM*"6U$:M'3<<'MOJO;E<3.WE"=
MIFQ-F$ A#J9  ,\BX@) (S8(M^=W9H0K!#=KJ5TM>\U/C6EUVO\ VIXJWHNC
M!955<Z=E:6C\@KV]S5SDA%&]>!5.0Z0-7W6VS>O(J+:LTYO*Y-L_&ZV80F3F
M82N4S)TXW06BH@/'@KEJH,*5NH*TI377:#^W[J!XU\$O#0D(EE5J'Z@'PK-;
MV=7=:S&'=;8R![" -)VXTVC<AG=QEY=*/+8K A^FHY36/1.O4+"VUU=SC#]+
M9<>N5TKZTK>":FX[J8<:;%=:C:,LZ#6O<%T6Y:D0L67VY#:;ABHV"5:3K&+1
M=C3[JTG+948U-699Q@AY0J68X=N]"1G94<]9.,-W3A@]9L!!0G9O)XT]F"J9
M*_@X)Y, ,FKXCV( ,ZQU ]WP5<A6%*NO*D'KW;:6%L<?SJ4.;958S1Q61.?K
MZ11"/1NO43(-BNRD67)8@V.ABM1==>*;<!3"ZJL!->FVLPO83=6;$U'ZBFW4
M9OB+YB&'>%L]5Y1V?DNJF#'E.VPEF<9['ZM-=<"=_)?,+PYQM(,R'" (I6@I
M[?&F7BH=C'P;8"*V5+)*/(T@I%#=GWY<8@B^ZV "G8$9,NP2]BFY .?7J4FC
MW5Q&(U,+1E)>.JQ^!16;XC:,=@+F9^(1IQ26$K4;:T UW7;O^]=ZT,W\%P7.
M;0X<2N6"R(1#FG4G0"=G%#KS*R(#]%A"L_EX_2TC)VWI':IAML%JXVD,L:#(
M<4E+4I-)EC>7&DW8':-E=+7KOKMNOK>;ME? +:I;\'&4D3T(05F]+2O:OKQ[
M0VM60:W^O9"R8HA'NWUD2:W+7B,^ :W#&\2,X#G1P8O7,YB[V#N @*/>)30*
M0Y/%'N"5W:P-N'N\#5=:0_!O2Q&!V%656W97]:0Z[J;K^LKC8,>N8K1LH=@"
MTK6\KJE 0^QH)%*V'R]*6.1DEB;\'-$TF YF\"&QTE=%Y"1)I7W@W&HOWUON
M-?;K\*>K7"Q3A$X1.$3A$X1.$3A$X1.$57^WE(6-V-I*;4K [+A-7L+(B\BA
M\N.RZJCMIN\!SK##/12-LPUNU.B)),]MEEMG)-:0M7.NR26&#;*>RJHW@C%4
M$ UIJWT_8KL7)4MDVSU=LBIY%*X67M>40F1LA,KC\3-P*"[3-!PY+P%TM%2D
MRLLV,"L";2.H2)+>7'%R2;8H\:88)OD!C(@-"#?0'W[\%'EL4GV(M^QJ!MN,
MVC5M2-Z>+/Y\(K>=T-(;/D;22S.H9=6<E RN:0_L]!XZ20%MYV57:;1H*FW2
M)#FN-#1L?MLNY("+[C?OI@<#@I6IBO9)'I_V1L>5,M13JW+9&OXV(^=LG;AC
M Z]K>$5B >$%!SEXR^=2LO%9/.F26KCYZQC<JCP<VU'GA91@W)==[+_;4_M1
M6%X43A$X1.$3A$X1.$3A%!MV0*U9PT 8K"Q81$\#U2:,GB-I5*WMVMI\+()-
M-F>AL,QEU>2T8:C9%@B_CQ,+-VXCXKLLVD,9D*BH5['RMU]WLW*!F73AU'.C
MEE=3@LS'D#\SC-YJ"Y/K',Q.%1^;W!*YM8;%G%H(Q)'?(VJ8/+9:B(AD";&3
M>\?@(47'MS!=RW5(NB$U-36EV\W7<5HMF=+IA<.+W*!9;%Z: ]XJNA$2[7P.
M45BRLNPQR@R +5X52KBR0-F (O'Y*V@+_P CTGIR-6K$Q$A#,9Q&V*ORQ8=(
M" TIMIJPUUOW<#OU4L[4E=2$':_8FSY*R\5^<63P>.0P=L^:OG>:ZJV$L@HH
MR6W9NGJ*)*0S,S8!9HAL[4>Z11>+9+HCCF2@E@2Z[Q^]WZUV45B.%$X1.$3A
M$X1.$3A$X10;<W7FO[V=U\1FSR?CR=6R K*8.3@-ESNMR :0&8X3B+XMAU"#
MX-1X]S&39P(U7>Y<*,1YPTV9[()E7^JY/W4#1#I.TA/064='VECR.2Z2.A[
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=MN_F3,O?7'5UG^@R?=H'R)UM:OK.T.^S/U%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img109617586_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_10.jpg
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MX5C.<?#G"L9SC./Y\9SC/Q\?_/U<L,>B%_XR)_\ 98__ %1RN;\%+_\ ;?\
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M@RJK2%8I72)6L*TTB(R1*U&C(RBMS2[XMCRTTJAT4$$E5!=%9V4 E8T9@\A
M/)%;?;GMCTU?HOWQ;]8B=PQ8^L@M)L$&S$@4B][XTAKVPFH-.,%:]8'Q=-O6
MPJ_<""81L&4%-)B@W5S9L-<>"F2M3:5\?/Y=)F@)E:12BL(\O/*JEU5E#/'&
MR"U93NPH&S0P7+2F,25&J$,5+S0QDA"5:D>16-$$;+N10O%"737UMUZ]6V;8
M*P.Q<*=7;_69+,V 2@FJE:8BI0DM!GC)4R&[CSC4P82B>>Q."'AI:OF8T$T)
M(P(VF.1)0V@WH=HW%$%70TRD&CX$'DRE64E6!-3(R:=0K4JNO(VK"P01?S!'
M-6!5@&! AG)XCAQAAQAAQAAQAAQAAQAAQAAQAAQAAQAAQAAQAAQAAQAAQAAQ
MAB=ZV_XO'?\ *G_N,CGU_P!PG_F?H_\ Y,[_ -EF,9LW^ ;ZU_Q#'WXZ8+95
M:O6N@Z[%BH@)2=;]3V]6=ID##C# <39+%5=9DZN4L67\^9]%.U<*X-%/2<9;
M=[K&X[6<>COXS]C]TV5S69S'W<9*&*6;.](_<UT(W1D<()FER^7S72469BR]
M;ZH,S,))0I[/6H&/M+BW)21HG1<K,JQPYW-"8M6D.\<+(6ON9$H7SX; <CCQ
MM]4.OK#2M 7OJ ,Q]J;"BA]_56V*F:YUGMRT"QS]VUN:UO#*UW8<D6'%A(4'
MOJS5),=ST@-!?EA@D5@1)EM,S/W-9_+YSIW(] P'HS(/-T%FLJ$Z1Z2Z)RTL
MBY+I&'I%XLQT<LLTDSR=3.:5AIF=4FF9IE0MSKL3QY67--QY@N:22X8<PZ@R
M0M"&28JJJ!Q>&1NH)50%)K)5/J#UV;NUHSH@WIO49X[IBQTIIW>G3WJ&A46P
MSYE]UW;(X]#U,FGJ-"L<-%0R6K]AV@%*UR-+'*$>8ARBT4I#KS70.?AR>5^F
MX.E^E((.F,OG".A/N@Z7S^=R\:9#I#*-(1G$@SSY=SFQ%F,OT9-%F&23C:G2
M)XG['FXFE?JKY>!VR[Q@YK*9>*)R987"_>BT0<",LKSJR C30+ BT=:7BCCN
ML'2EM"[OT?2 =.#:6+=7!:IVD3K#5FTMD5ZQVTE,(4ZNP80"O7+ 0/FM9.KK
M@B+6Y5P:F'1</RI;,QWS.D<EG9/N2Z9RLW0O36=FS<O3,7W*19K*R])]*=&=
M'9C+Y6../-YB1Y\QD^--UC@=8F;,IDRD$K]@H+X9(ATAEI%S.6B6-<LV?*2+
M!!/,CR$F-!I272NC5H4(9+=1OJ.GHNG^S7I\ZQQYVRTRT"C,KI_ 5@S2;+!M
M5:(["EWDE<(C8HQ!SF++*!M> ]@-%6F/*=&-%4LR<MXG-8>^MES?TCT]]R+P
M9?.966)>GLQF8<YEGRN9CZ/3)1Y-^+#)VEBFZ0GR#1%MI&BU+>@U@$?!RO2(
M=XW!.52-HG61#*9&D&EAL66%90P![.JCSQH?S[?'EX<88],+_P 9$_\ LL?_
M *HY7-^"E_\ MO\ X3AC^H#6F4OU'=8Z+V8-R]>PI,'L^!Y\4&N]5,6:,PK'
MZ7E8$0W",A"?]Z -F97_ +-*^?P=)[4)/LB0V/F48*3_ -5#ZR#C["'>/,J/
M:,((\2JRQLX'_2-1^2G%\VK:H(JB\AB=C'F*F&K.AI=2"I9&$XJC ERA=\5B
M!DSS<(@81#79(19N2YC$N*V^.(.^A,)0SG6)APR%*N6G#MN#1#Z+(W O201W
M[C<[ZWS"L)%=U:-$RAC6E8:EX0D*J=F>BX:^8L'LC:$E=D:3+-0XDNLD<P,%
MA,DFR)UIK6K$)0R&0CR9T**<#$O6$)<R.TN,I3.486VZMM:T)5E6+!',-PXN
MC5R.P!((!*E:-<]^_?Y8J:;+-0*-6I2P6&!"5!!(#*;%@5B>VG:&DS\+6=C/
MN6^QH#WB_&GJC@?66%0H3\&I,A14\8R9PQ%K410<3!"067\XFAQA2%(<94AI
MQR"1S*9%72MI&-5MO1:R#5ZC9)/<2",6R3Y5A [\1],DK&.HQ0J/0K*&V0:5
M"BZ*J03C*HM]+MMZT(>&6$^=FA1UR-7IX\T(;7#K*#EXLMIQ8$CILA$&?)'R
M)GF8:,>@Y#2X6$+2Z\F/CFET292%4$HJ!;W?2BKINKHC?OU XEQ(I)<HP=V*
MK(TI?2"$URO)KTV%)4G8=G21C0GFW'E8<88<88^,4D]4JO\ E>=96&]NQ(U3
M#]0'3Y.,S2'F_5PQE@;KU4<N1\[E+?JX/,]&*3_.9RCT2(]Y25)[4Y^DB5WZ
M"D6,$NV7S04#FW;FM16]L+4?,X[ 57-0LU!5FB))( %,I!).U [F^X'$PU]O
M2K:<TY2>FOJ",JF@KCU)]9.K^KVBX>S,ME4!6H7TT#J[MC AU*W46C7NS*.3
MNU0G.1E/D9],L %I6&"1%"DN7>>>3-99::/*Y&;)254;LAS9>'5RT2PR"-QW
M"1'[AC0DJQQI!,;5I\U'F4L:E##+A9*]Z.1&==MRC+R)Q8.X>K/HZ%;]ZAW3
M8H1M%HSNFX&@%Y"=,?39N<0>KDQ(]L7,'7C9-@A625%<Q'>6W!\TH="PK*83
MKF'',XJ@R6>;+9;2S0E8$5HSF\UERKBR08XD*@[\[L]_+%LF9RPFGU 27,Y5
MQ!!*"NP!#R'41L?EX8DW3GO7ITL$C3>RMBS^G5FH=-'4!?\ 8&O6[?8K#I?:
MVJ*'/OD':+<*!T_ZZBRZ9N.05.9GEM=UO7QE$&J6Q:0UMD2:CC,14<UELRHG
MBBZT7S>6CCET(L\,THC,-G,RD/!2@"5Y5MT[2#7A#-"QC>3@Z()G=-3-%)&A
M<24(8QIE-V4$9H-V6[.V.G5G4-1;Z*UH:VALKHX:Z4Q<W>T[=^EKMK6OJZCX
ME?ONV-G[+Q0JY)-A[%>K49R]=62&JK=I<_40=<+D$(M44=-!3B1--EI(VE6&
M+/=<(RXR\\<K=5+1PPQ<1])6-%^]U,DZNS*+0D,%7D<J.$:1\MP 9>+$\8XX
M5Y))- )!9CVP8VA90K'M E23\YNI-48?TW]"5;(I4BWQ-7;<LRHLA25D1NMK
MGO6Z$=<09V<8QEK$U^-<+4.87A'G!-G@DFFTQB3"E^IE;.:Z0<>P9H5L<C*F
M7C$I'U QH2>]".8.,<U"#**?;$<C'QT-*Q0';OIF'R:Z\=).;\9L.,,.,,?U
MH?F2.CKWUNSZZUO^!N?-_2^:]V'R/_$QZO4H?%_,/W</S)'1U[ZW9]=:W_ W
M'TOFO=A\C_Q,.I0^+^8?NX?F2.CKWUNSZZUO^!N/I?->[#Y'_B8=2A\7\P_=
MP_,D='7OK=GUUK?\#<?2^:]V'R/_ !,.I0^+^8?NX?F2.CKWUNSZZUO^!N/I
M?->[#Y'_ (F'4H?%_,/W</S)'1U[ZW9]=:W_  -Q]+YKW8?(_P#$PZE#XOYA
M^[A^9(Z.O?6[/KK6_P"!N/I?->[#Y'_B8=2A\7\P_=P_,D='7OK=GUUK?\#<
M?2^:]V'R/_$PZE#XOYA^[A^9(Z.O?6[/KK6_X&X^E\U[L/D?^)AU*'Q?S#]W
M#\R1T=>^MV?76M_P-Q]+YKW8?(_\3#J4/B_F'[N'YDCHZ]];L^NM;_@;CZ7S
M7NP^1_XF'4H?%_,/W</S)'1U[ZW9]=:W_ W'TOFO=A\C_P 3#J4/B_F'[N'Y
MDCHZ]];L^NM;_@;CZ7S7NP^1_P")AU*'Q?S#]W#\R1T=>^MV?76M_P #<?2^
M:]V'R/\ Q,.I0^+^8?NXE5*_(I='\.QP7V3.ZO+2B7C'EW2N*3V*AOISVXQ1
M\9^+/P?#CX>;>CONLZ3Z%SD72.4CRC9B$2*@GBD>.I8WB;4JS1DG2YKM"C1W
MY8ZO1F6S!X3F4*=SI90>SN-RA'/Y8V$:_) ]+\<9-",6O>C(8E+@3R(AJ^AF
MQA">*;G,BYLV BGIBRI8UHH3:@27VG'H;9&<B.MM,N1ASZ(_^+WW3M(DS93H
M(S1I)''*<A.9(TE*&5$<YW4J2&*(R*I <QH6!*+5G^SN1"E1)F@K$$KQ4TDK
M84D<*B5#, 3N-1KF<8_\S7TE>^-R?7&N_P %<L_WQ_=9^(Z&_P#1YG_WV.?[
M.='^_F?ZQ/X6'YFOI*]\;D^N-=_@KC_?']UGXCH;_P!'F?\ WV'^SG1_OYG^
ML3^%A^9KZ2O?&Y/KC7?X*X_WQ_=9^(Z&_P#1YG_WV'^SG1_OYG^L3^%C(*_)
M ]+ZQ3()=KWHH)'(22S 95]#*%,%9D:+#EDV1^:?F(T0E1(,*+)FH93)?C0X
MK#KBFH[*45_[WONG$IG&4Z"$S1K$TW4)^*T2,SI&9.NZS&KN[*A.E6=F !8D
M]_V=R.G3Q,UI!+!>*FD,0 6KA59  )JR !W8Q_YFOI*]\;D^N-=_@KEG^^/[
MK/Q'0W_H\S_[['/]G.C_ '\S_6)_"P_,U])7OC<GUQKO\%<?[X_NL_$=#?\
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M7X5QUJ3W4_4W[V'T?!XR>8?NXT-W)^2+Z6-J[)LM^LQ;;C1P^H4N<V*MH&+
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M[Y=HM0J;\@A%8L]TGTRM'H-/!/O""^6"-CD#6'XP8W.9RN $+RH54>7EE 9
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M"D!FJS#=<-U-JO[1;RVD%&K\E>28U,]O$K698^(_!S"1D2PEI"2HD@2&-:%
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M*O$8W)A( #8SC<#,N18E1ZH7#F)"%'F)$>?!8[E=",DFN"PXUK,K6BJ00\9
M.H\]E[8(]D@@XOS(9U:/3-10A6B*TQ8$%&!]D<K+4I!/:O;%+[<TAU0G8U9M
M*(&HK ;@6+H_@!ZV-;LL%C7(F@;CTW?=F-@HS?:.]0SK?6)UBM!",ZT1F:_J
M-3$1(+I*M1%3[H9LJ"RDRJ"N<)8E3Q#)#/'%J)W+!'"H#L)'<DTYJMXLP=+?
M>RP;*THU!8Q'+%))0Y474LQ%$QHJ@6HO;#<B)T>V],)PCAO <)N_*+.^SYS
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MVVU,Y0EFB..]58T*U;@NJ*LAOOMPQOON\,O?!2^\LR_)&=F0=U4A7;NY8O\
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M RGS@0.FUR[!?C:YK)IY<Z P"E5@=E&6)O%"IETQNVB<0!=9)))DMR0!VB5
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MJJR:%D[FAX8B<M U:DA.D:5N-#I4<@+Y#Y#;$DK^H-;U>PN6$&6AC7&J=7*
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MD;[$UN-SL=MSXX@N.G31,.JHH];S5:/3UV8':R-;HE&AU,,:) # T[&:+P!
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MCX4UAYN3%8=;X<UFV;4T$K,05+&=2Q4@J19WH@D$71!(Y''1! !0G0"P:$;
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M[31E_EJKNQKC8DRJVY20J#RM659%\H?3XG39YXMWE.+,.,,.,,<*^+/]F?\
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ML]KC7.?2-CV/><FT%J?WPK8C< SI\C0IU>$%!XFP%J[)T56Q+D<@*)'Z_#L
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MM]+$$T7P;/NX2])E"Q4D^9E APN1.<<Y8W2R,F@[6JHSB$B1T2M*,W>!I7D
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MVFD<G;OD=R/!2!W8FD1762Z$O(7-&NY44?H1%!\6L@"ZQ8_=0O\ T8?B$/\
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M:-)L\33NO8B9YG8-CU1:=)VT[.Q#=DV"\1-<VBM2KN60*AYDR"%C(@(9ZP#
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MG/+<]_<-SAUN?WQY5[^7=B2U_95RFEHT:249<9<2_P"6G H.WG/D,.+3^DW
M0O'8I.,_ KX?BSVXY7)D\NJDA#=@>V_[V+8<Q*\@5F!%$^RHY _+%C][3_[8
MW]!@?=N9^KP^Y^TW[V-FMO'[!Z8=[3_[8W]!@?=N.KP^Y^TW[V&MO'[!Z8=[
M3_[8W]!@?=N.KP^Y^TW[V&MO'[!Z8=[3_P"V-_08'W;CJ\/N?M-^]AK;Q^P>
MF'>T_P#MC?T&!]VXZO#[G[3?O8:V\?L'IAWM/_MC?T&!]VXZO#[G[3?O8:V\
M?L'IAWM/_MC?T&!]VXZO#[G[3?O8:V\?L'ICC-N/XQG/IC?P8S_Y&!]VXZO#
M[G[3>N&MO'[!Z8CO?ZT^\&O#AOW3F/0OA]I]<4<1O$>5?3#O]:?>#7APW[IQ
MH7P^T^N'$;Q'E7TP[_6GW@UX<-^Z<:%\/M/KAQ&\1Y5],._UI]X->'#?NG&A
M?#[3ZX<1O$>5?3#O]:?>#7APW[IQH7P^T^N'$;Q'E7TP[_6GW@UX<-^Z<:%\
M/M/KAQ&\1Y5],._UI]X->'#?NG&A?#[3ZX<1O$>5?3#O]:?>#7APW[IQH7P^
MT^N'$;Q'E7TQ$"FS[K'G/M-%64MH\UY*<B RLX\IEM6?TECU*S^DK/QYSV?%
M\6.>C!E()(D=D)8ZK.IAR9@-@? 8SOFIE8J&  .W97TQX/:I>?>['@X3\.Y=
MU'+>X?._KB/6Y_>'E7TP]JEY][L>#A/P[CJ.6]P^=_7#K<_O#RKZ8>U2\^]V
M/!PGX=QU'+>X?._KAUN?WAY5],/:I>?>['@X3\.XZCEO</G?UPZW/[P\J^F'
MM4O/O=CP<)^'<=1RWN'SOZX=;G]X>5?3#VJ7GWNQX.$_#N.HY;W#YW]<.MS^
M\/*OIA[5+S[W8\'"?AW'4<M[A\[^N'6Y_>'E7TP]JEY][L>#A/P[CJ.6]P^=
M_7#K<_O#RKZ8KSFO&;#C#&K^Q:X*F]2_3[-> CY>'*IO-1"6Z+C/^6\W#UJB
M J9(6PORG6TH6B)E]>5IPA:6<XPG.,:$8]7F%G9X:%G8'B77U]^*VWDC/.ED
MW\/8'^6-5RELVL'KVO;'9-AEV:ML#9V[8-^/7/8Y34]6J\.D6JW!-4T^-<J_
M3[#,HXHS!8E$9A3+0^;;3X,.(E6=H?/@UN9H"QEG5(U+)'$45$$C,756D;06
M <J=@-PH);38+"LLVQ)[)>0,2V@ *S!%#*"5!&]\V( U40ICNSMP[-%Z^CMR
M+X41>PG3W.O=4.=];-KV)=K&\;OT>KR*+26M1Q;'NJ]1!5:K\B\@[., TJ/$
M*UXO'JC(RW2R,.4<41<G0-!G",-"OH&E-6M^*5A0EFT,I9]F&HE #QW8*#J[
M0CUJ=10$DMITKP[D>@"RD!18(6F-3:3)(@KKOB.!OMIK]ZV#U =+9#(Z/8W)
M1;&N+PCI]K-OLM;KY;,]ID(W(FV6G-6!D=)@!VH#8++J4C&HJ8@!DA+(I1(,
MP+*[<1..RJS"MSV7TWN3=;XD33242K-)&:N^P3&I*AK OM+=;57=6)*,G[3K
M)L9-$W78%IDA^I>_ZC$5ZSF%3@Q;7Z-876U AAY3L1MTG+B6QD3Z'>"4IVR(
MBP(0N2;D05SF)T:C96!1$'5TE+**;7Q$5BNYJU)M -/,A0>75U!A98CB,H#'
M;1H8BSS.X!#DWW603=-5C:.Z26M3Q>!M'"K@O3$<G?QPRSVB]VJI;7F6VAQ&
MIA"NF-65NKZ4-B6R%R$S-4.$'L%8N(\J $EQZF7-SK&CB$@N*D$U1DJ%5X@K
MF@PD9I0:0B2MCL2-8 K#2%20P#:+8 ZF#EE%E2BB,CM#1W\Z.EFQ.=N#B@8]
M/$GKW=I-.U=OG3=A&V*WWXH!BAHUOHQ9LJNQ7F-%RL?7.]34##!&;'G,U=^P
M3HHQAH>]#$LPC(8 K&FJ2&5654#$Z7%%4)]O3?(@MI%[V3-A56QTJZM;,15@
M@ZFW[);P&UD#;86MLHUO:5:+M.!/S1UFI/3&:V)4=:4@])LE-L^VFBNP8-/C
M2SDRK58M9(DMB&)3*KZA8F%/FR(C4IJ:T,AS)%<8ATH& *OF%1I'72Z1TFOL
MAF"D62&LD ;59&.L9+:N:Q%E5=PS]L*+(4D&AL:%G?E>*/@6:TVRIRFF;\.V
M!66;_P!%Y";''7:W[1FC+EGJEUT\;GSK(7UI11M6)D!4;#UGUA&><<IC@N#-
M:K=5@E'4S[BJJV\>AM&; ["QVG5Y-("B1V8 ^S(?:!K4Y&T020.T"NO+G9BY
M!XRDDDJM&JU)MIH=E;QGJYL>UW+<5: Q+59F!]ZO^\Z+<Z\[LXP5N=="!JOL
MLC6&;#0Q-* U72I!HC4Q;E&D#3KMI.UQO,N>1M,F49)0.-&JPLQ1;2.%T;A@
M(S,R!@KLY:84QUVNE6V&D!;!B9 +.[2*W:)( #T"ND!#V05(.H@;ECJ(JVKW
MP_7-2]-=5%[&CUNB#^F<8B6=,[=L%+D0]ZB1U:A&*-+-":-L&?-MFOV',-@M
M*%&1R"2IA(=(K5CQ7T#Q=C(&DG8QZG.8)TB(-]X)8AP"Z4DG?*-AL0ZAK,%)
M"1#4 HB%DN5J0 6I(5SJ4<H^_<%6TT)CL6UV4]&.!-J7X_!V7!OW2<W0]?@F
M2H(%=J?)?T?9+U<HM")"8Y0I <V)*V5$-EC(Y@G0HE1$CI*ZXZF4T6C$JJ5:
M-%X93,ZY&(8HX$RHA<'2"8PA 4T^LFF%5,L22&:F#PA5&P928F9@I&H@OK!)
M%HJ@6N]_7JJ?KV'_ '9/[J]SR)O8/UC&_+?A1]3?W8M[F3'HX<88<88<88<8
M8<88<88X5\6?[,_X<88B'//QGPXPPXPPXPPXPPXPPXPPXPQ S7ZSD_\ 1_=V
MN>QE?^'C_P"O_&V,4GMM]>,7S1B&'&&'&&'&&'&&'&&'&&'&&'&&'&&'&&'&
M&,7DQ"2:; 93/]8N"WC"58$E<C/0F);,)Q*SN(60;<_S\AO+8EPBDJ]'P[,9
MA.0V'WV^UM>U77,7X\KNOG5=UV1A>]?6>1K:N_EW\N9WKD<93G,,.,,.,,.,
M,.,,.,,.,,.,,.,,2*J?KV'_ '9/[J]RJ;V#]8Q?EOPH^IO[L?G8>^=7ZL)>
MJ;H=)PYK +-J+)#U"YVUBK5/$N1![VW:;4J^<A4>J*E0B+:+);I 4*M(DV^B
M:J.#,/0:H\O+*-2*""V@6Z)J>@="!V4N]$=E S;KM;"]KRQQFG)!TZC2NVE+
M(U,54A%L'M,0-FWI6JW&7FI#34B.ZV^P^VAYEYE:76GFG4X6VZTXC*D.-N(4
ME:%H5E*TYPI.<XSC/*>7/%F.SC##C##C##C##C#'"OBS_9G_  XPQ3MYV!5=
M<"(YJV3Y42-.*0@0J&,#&[(=.&R/G<P@U?K5:'%["?*/M1Y4KT .+FR6H$.<
M1>;;@09DEC''$\S%8P"0I9B65%51S9W<JB*+ MF L@79 .5W5 "QJR%  +$D
M\@%4%B>9H [ GD#CMI%ZJVQ0#5EJ!%PB+7-)"W\2AQ0(4&%PTY\88"G !V$-
M.@#8HA&?AD@YH; )P7V\MR8K><I[4D3Q-HD%-2L**LK*P#*RLI965@00RD@]
MQP1U==2FQN.1!!!H@@@$$'8@@$=XQ+N5XEAQAAQAAQAAQAAQABMK82'ALF2Y
M:=%&"A4)PD3)3GVHL$>/@P,2ILZ9*>4AF-%B1FG'Y#[JT-,LMK<<4E"<YQ[.
M4!,$8 ))+  "R278  #<DGD,8I2 [DF@"22>0'B<570]P4+9,N>.JQ OZR'#
M1AMX79*A<*05D 3*Y+8FPC1EU U^<7KQ%V'*8BG14>8*<DQWHOI>)#:FL:WB
M>.BP%$D6KHXL<P2C, 18-$@T0:K%2L&NKVHT5931NB P!(V(L6+%7>+-Y7B6
M'&&'&&'&&'&&'&&'&&'&&'&&/G]O6@V^1O.%>:I12=Q/-^R]H$S9J/$L58PR
M!LTB85>I.TPEQK5FT:3AQITJ7:5F&B(&TM1H+30"SMR2(AW;"Z\$HSA%^^%M
M+Z6.I0!KB*,LP- )6DH;.I=F%3@ZPRBSV -0L;,22C@@QFCVK[+;;-N# *QI
M_9S%S.S#8FXYV$S:M^E3]P&TZNP!UNJ=H'[#C4,43V>[872UNJ\B";I;-<H$
M8?F;2C( ,AX<$'5=$N9-Y8] "LNC1"JJ68E64QER(]-(P(?4^JG#-18M6(A6
MUDF]6J2V"KVE(?1;W9!M:6K0@6 %!/N*:(OE?H]8$T2GFHSB^GJJM;#B#R#<
M(Y<[/G96ISVUZ\1,R2,5R=>[W0P5PKZ2I$BTIYV2U%64B16VLL\$R%V+N*$S
M<,D6J+PY5B8+1 1'*-0&U71//AC8!0 ?8IZ-%B7C+@F[+.H8:B?TXS@FHV:J
M6X+L*E:LN%9TO7]]B;2+UB$KS HW!"RNG'9^M;3:0FMXTJ.Z)"$]@6^J+DUQ
MB)!GNOASMWR$RF>HA/X65U*/(C2M"5,C-8)$\;JID(HD(K=HD[$)JV   A@P
M4A!("% HT8G5FTC<#4PVJ]F:M[-:6W5FQ2U,KIDOK6U2K>S.ZEIX:GVNA"=M
M52.0N^^;C<*J,E(!7VKV36]SE WPF 6UZS9X8D0'D.)69C.P8"7+$DC#L%D4
M(1EP620Q-20JK$6C+(@;5<94ECW43?"C%02IU7+08!U[<A8#9@5:JIU;2-P3
MR./J<$<(NAA#IB$V.+.C(#A0>S,41:@$5Q6E3H31!6,*G-Q9.76$3%8PJ4EO
M#^<8ROLYYQJS1L6:-58O8UW?5C2+K?GWURO&3YS##C##C##C##C##C#$BJGZ
M]A_W9/[J]RJ;V#]8Q?EOPH^IO[L43?H%RHFT=[V"'K.T[-%[MU-1:Y4$UF*/
MG,L6^GQ]AB)=)MKDZ?#:K->*-6P2:'68EE-;;5-MK9.6/E1H#1F4922*!3(D
M9@ED9]1()1^&P=  =3#05*CM^Q0()TWN&229A&T@EC15TT>TG$!5K(TJ=0(8
MG3NUD$"]C]04XAKK4NKM?%B*2Y2BZZI-.)%DJ<4DH0K%:&!)A%*G4H=4F;(@
MN2<*<2ES.'>U:4J[<8S3.))99 -(DD=PO@&8L!MML#6V+XE*1QH3J*(BEO$J
MH!/Z2+Q8O*\3PXPPXPPXPPXPQPKXL_V9_P .,,:C;U!V!-ET5LH,!+6P?J;8
MYH[:*V!9:F'G %IUA?-?K/@1CKS"BY.MD+3 ER!D1:B<JN/V' EB>43$%SZL
MLR:,S"S+&9XE5'?90R31RZ6(!TAPA&H[!@NJA;##*#JB< L(W)915TT;IJ [
MRI8; WI+59VQW=/U=/C\[DNIT*1J[>W=R$]A *J92PR8!UZ/1-?Z]@++0XS\
MEH:0LSM"E79\8I_,P?BS(B%F8AEHC$8YFG4]7C5@_ RXB9U)*L_%EE.DFK5.
M*(P1L=%K:D$H5(XC$%>)(7"GF!H1!=$T6T:B.[51%@XV$YEQ=AQAAQAAQAAQ
MAAQAC67J9HQG9FH]PZ_KKD9L];Z#80(9,YW+ ^22( G&84 D]A*\LC",C+<
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img109617586_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_11.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X5X_:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9G@](FAT=' Z+R]N<RYA9&]B
M92YC;VTO<&1F>"\Q+C,O(CX*(" @(" @(" @/'!D9G@Z05!42U9%4CXQ,2XQ
M+C N,C(Q,SD@4')O(%!R;V1U8W1I;VXM,S(\+W!D9G@Z05!42U9%4CX*(" @
M(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM
M9STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @
M(" @(#QX;7 Z0W)E871E1&%T93XR,#(Q+3$R+3$V5# Y.C$V.C$T+3 W.C P
M/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!
M9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]X;7 Z0W)E871O<E1O
M;VP^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(Q+3$R+3$V5# Y.C$V
M.C$U+3 W.C P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-971A
M9&%T841A=&4^,C R,2TQ,BTQ-E0P.3HQ-CHQ-2TP-SHP,#PO>&UP.DUE=&%D
M871A1&%T93X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @
M(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I
M9'1H/C(U-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM
M<$=);6<Z:&5I9VAT/C$P.#PO>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @
M(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*
M(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*
M4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!
M*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K1FMB
M,DIL04=404%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G
M9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X
M=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X
M9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T%B045!07=%4B8C>$$[04%)
M4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(
M0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)
M0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%
M,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K
M<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T
M3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V
M63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM
M6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%5
M14)1645#04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(
M=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15
M:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515
M-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q
M*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/
M:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y4')Q,FQ.<4QA
M870W06124F5B,B8C>$$[46Q1>FAA03AJ2%AN5&9R5$125S%E3V5#4C59-#5&
M9#170U1)<D%L1TMH=W)!9$1X64AF<V-#<CA69&ER<U9D:7)S5E%E=&%G*VYA
M4"8C>$$[9F%G:U Q:#=/,VQU1F<U8U!535-&=VY+:E4U57!7;45#>7!E95<O
M-3AA23<S8W,R;GI,<#ET2C9A,TM325AF;4AK9V(P-692;TI)628C>$$[6&8W
M5F$P5VA*>7IW:7<T=VIR5#@V=DQ&-W$Y<' Q<D)026)U47=2=6940F%5>5)X
M>$)11UIA4#9J365B2U)X-E9)1T1W:E-E34PO328C>$$[9C5Q<C5F;#%:3"]4
M4B]O0W(Y5CE/-59Z3$I)-TQ&1DQ23TU$>5)O,'ER>5DX0E5G1V=,2$AA;59)
M+UA0>DES3DYU8D<Q=')+8E5P-R8C>$$[-S9K,%17-W=I26I52D=324Q)-W)Y
M6FA%-TQT>$Y.,E=U05%T5$I!:C@U9DQJ,W1V63(Q:&8S5C5D4E%Z47=22F)L
M>7,X075.=S!Y,"8C>$$[-$DS>%8R<C!*<%A$-%)8:E5"*V5F;$4R.'1Y='1E
M;3-I36%T3'AT,4A+5DI*1E=J5'$Q94U$-T5B-U5R>5=P.$EO-'=J<&9Z3VIG
M,28C>$$[>3DP=5A2<G1X0F-,8E=S<TPR-T=6;4YU;%=6-4EH1T=K=EEG;GA(
M6G%T>&]10C1E>65*=7DO3FI1<GDK=$Q71WAV=4XT,$-X,TI32"8C>$$[,&=B
M:U%&95@W-VU/2G9);&(T97 R<4XX5&I+.%-%=5!Z;3!+>6%A4%5R1S9T-4E:
M6DDV<3%U>5!(2&-3=T-61V572FUQ64=Q=DAL-"8C>$$[06IF2'=I=D5H<G(X
M.2]+:U5%-6IT8G,S55%M-#(X;VEJ2F%*95-"<5-/=T5H,D)#:VIQ44)H.$EO
M-'=I25!Z;C!(:F5I-W-B<3-A>"8C>$$[:VUI6G@V2FEK84LT:G0K2U-02D@X
M6"MK4G,S34MQ9VYF8F-E1U4X8D%F.$%N2EA5<F964$MF;%15<EE-3&4Y85,T
M:$1G0F=K<U--028C>$$[=T))<E$K3U-X:6E732M4-3AY-7)D:7)S5F1I<G-6
M5')Y:&,V9&(V>C9L+TIB>%$O5G)P635B=4@V>D-S-S(P:7=-.%AP>CAQ4VQF
M,B8C>$$[1%1R9TM1>F5(>E0K6$9O.#!Y-F1P.3=C>5%"5TTY;DHV6#%H1&1Y
M<SA54VE*1E-365<Q1DDR:F)H<T%A46]S<D-(;D@U3DQQ:&EG:R8C>$$[3#)%
M;D1J9%-26'19<4ID:V-O,6Q5=#A8,59:869A*TPP*TA9*W!D;$<V;2]+6CE1
M=5ER3T-+2S)G84EA9E!C2%5#:S1E2FI/,3!),B8C>$$[85%C2$%%9G!"9FE)
M<E9A,&0Q.4M1*V1O+TI-8SEM4$MS-WIW96PO<$134GEX3T<R-&E14W,T3798
M;3!D14\S141$1RMR1U9D1TY:2B8C>$$[1'-69EI0;40X=$IT5S%E6%5%,557
M-B]7:S%#,&E.=C9H:G5K:F=I<3<K;W!E37)A<CA&1C,W-UIJ:61"=4U5;E@X
M:TDP;&I:3E9J5"8C>$$[:D)&0SAQ,EE%+TM/2T=->5)Y:6(T1R\P97$W2&IZ
M9G)Y=RM+:F=7<BM21FDQ<E!&8U@X56MS=%!4:U=Z0TQ$>&AU63923#9R1E9,
M,R8C>$$[2U-%8W0R5#,R9D989UI"-48X:6%P-55V8G5U<4IQ3FQF.'!*>3A*
M:6U75E=(<$5C6%I8-4LX;G%/,WA%:&9F27IN85%+6FYK1U1S5B8C>$$[9&ER
M1U!Z13@Q6&YL:GDV9%1T3&5+-6PY6DEJ1DU75F5,,7%F:#,W6FMA8D0T:W5(
M:WAN2VAB>'@O=T$R16MH34PK54Y&944K;E=.;R8C>$$[-G%F455P1G-5<"LW
M4FEQ*T$R1V)$*U1F-E12-'<W;DHK8D-)6$ME54Y&57EK;5-K5D]23$LU3&9"
M=E9K5G9M0C19+WEB+U-8>&@S3"8C>$$[-"]Z9VMJ;75P;R]+=6IP3F9Q-C,P
M:6]1,#9Y;7-G;$E3<FAZ.7)L,7@O:S,K:W9J1'58,T@U>C-D>F1W,VQX-5HP
M<6$X='=O=#=M4B8C>$$[4S!K65)U84)(2VQL-'0X47 P3U X;2\P:RM.-4M5
M4#5T:4<V4S=H.'!A3D9D>'%%:G5%:C1Y2W%P-F%Q2$-C9T%N=VHR,G@O:S,K
M:R8C>$$[:GAH,TE8>6)Q.7).<F0T>#!/>&UI;5-355=D=W%08E)L<'59-%)R
M0VQ3;G%&55IY>%9F:$)P;%=P,'AX>$)T635",U!13&YZ3$YD1R8C>$$[63-/
M:&%43V)I=C%G>5)L+U5R=THU.&Q02W9O>#EF-58X0FU"4EHK2C5.2C5K;&I:
M1VHP3%-584UQ55I9>4-P5# K2D9&,C0K:$A4+R8C>$$[0496.$)J4EAX15!,
M<59P33!J>F573D1K959Z3$MZ,C9S5VM.4UA9;$XR3E1V:G8S<GAJ=60K:W)4
M<B]H:E$V,6,O-WIR,6M&2% R4"8C>$$[,FAS9DA(9G98:CAL4G1B4C!K:F9Y
M-V]Z2DU785I$1%5/6D-R3U=(2&-S,&%%,38X4C19-SDV.&9K."LO4%16-S-5
M=DPR:TI,8E<Q<"8C>$$[8E=--6ET-&)B:T9#=$912T%107%Q239!1$HT>'5P
M;&)X8DQ73'-69&ER<U9D:7%B*U9:.4UH,7E".5-A3T\P2U1),# P6')X>'4X
M3"8C>$$[<DA+,%!'5#%05&M+='=+,$Y+1VY8055H;C$S-6@O2SED43!Q93-H
M:$YL83-*4SAT>&%W;'!O<$)C979C<TAS;&]1>F]9675B<GAO2R8C>$$[4FQA
M:49&;%E32G(O04UM<#5N,4=F5'!,84,P;G1)+S!5.3-A=&-7,7)-2&A,4GE2
M1TIZ27=G4U)/8E)T5GI7<"]V8T\Y23)T6'-B:B8C>$$[.')O>$9*9'=1,T%C
M>&AK278T,T%A-6E&=S!Q>'E"1DMW*V]90D=Z1&HY=7(P>#-4<VU&;')8-5EZ
M>C9D3F17=&A!8E@P4DY#.79D:28C>$$[17AR8E=O;"]U47IY>F5S<W9$,5-Y
M2#1I,U561D9B0T)V5"M5<T]N.$Q1:3=U6G)C2UI(:G99;FAK*W%4:T@K.4UB
M4R]79E-6>E0P-B8C>$$[9EI51&QH,U@P<69M3U X04MR.4-A:3)J>F8W;%)+
M4G X4W!E54U0<7@K:U,X>F-1+V\K<#9W2S!,,#E/:6HT:U=G,#DT,7EZ9S%!
M-B8C>$$[<&)F6#E(;'-B>E59.5-H6CE14EI+<&)X=RMM.%5L=&-W,$12.'9I
M1&<Y3TE0>$-O4W!S25A45TIM=#E042MA8E=%,FQL<#EQ.&1R<28C>$$[571T
M15AG:V(V-'=71FM"-7=K2VI(9CA!,61S94ED>3!K,%=N*V1L,&U70U1Z<'!K
M;6].4$$X8R\V4W513T59;CE1;6@R3EI9=T558R8C>$$[1T-6644Q-5,T;S-Y
M4E)42U)8<U!+=7!7.7HU:6@Q4G W5WI%.%@Q.7)M4C-J:UDS-&HY56LP;6A)
M5E98<B],6'%,1G!P2U8X;W=*2R8C>$$[:$=O-DA*8DIC>#-$5S!L-6)V-G!7
M3S56,EHU3$M19D5B:&%#5EI8,E W>EIC4$=J:%HS-4LQ,U)R8GEV67<S3W!7
M,$QQ<BML1$I01R8C>$$[2&IG36I'0TYG5T)"4T5O<$AA;$UR;'I:0D\O.%1E
M5R\K<G):+W=$4U)&+WI6:V%3=R\X04Y(>E8U96@P1WIU5G8W9317,3%',&YK
M:28C>$$[:6UI9'EK8CAM;T]89TUY.4=,:U(S>$Q8:S503310>DDP=E9T3G5D
M378W<$Q3-78U5VI%,W%/.$-X>4MI0C5P2G)L;5EX.%=0-WA*1"8C>$$[5%I#
M=6))-%)%:5%)24AU+U8K<GIA:$LY:6=,5#AX-TY%=F)/5SAM5%1,<5E*2&)*
M2W)R2&%#,FQT9W9!=6ES>4LX4D$V355&5#!Y8R8C>$$[<TUD:G19*RMW9C$O
M3D%K55I$*UIF;"M+,"MP23=I1DIO6&EN<7!01S-.;7%/,%!R0TES571(66<Q
M;U-!1S-,6D$T8DXR4'AX9G)4>"8C>$$[95-N<5@U:"M7-VE#6DE:-7=:234Q
M;6E:9UDW<#4W6EE9>DU:3&EE4E)B=79.07IY8CE/1T='2VIZ:BMR9C-$;CA0
M:6=Y.3="+W)T;B8C>$$[+W8X06HO-$YF-C5M.&-E.7%O<W$O3%A7=$US=DUQ
M6%4Q>D5)-&\K6B]E2TLX6D5.0E5J=WI!-U%K1&I&9"\V,F-"4F5N<#4Q.'-Z
M,B8C>$$[:W$S,7A#,7<S4#!Y:E%U;S523$=T5VQ:;D<V9S%"<FUM<'5V=E9&
M.#0K4S!C4TI*17-Q>DQ):DPY6%AI9V170S=.5W%Q<%AR.%9D+R8C>$$[6G!B
M0T)V=DTO;&%A,DUC13EU<W T+T8K-%-R2T)Y:W%R17)Y,RM!9D0S=V]+5B]P
M:E-0*U<V,R]!3U)Q9C%W<TMD*VU.22\U8G)F+R8C>$$[04I'<"]81F%9+S5V
M.# V4G!Y-F1E;2]+3$A02VYR,E1*2F-21V%Z;FA35TYF56DK2TXU07<K3F5N
M6$-'561M4&%:*V-/:F%B9D,T9R8C>$$[5U=74W-3>C-C,$YT2DY-22]W0DAR
M2DLS<4Y*>&ML*W!3=3%'4'A-<#5&:'E%:D9S-&M,3#4K+TQD<')D:'!$3VMR
M5W@Q1U-70WAE628C>$$[2V=D<&A#>%AI5#9H4F<W<GEC5E9Z5$=J,V]S9'EN
M4#4V+TQY4G=K5VQR06MF*S@Y>6)+>&QK57,X-U-V2D96235F558T;$-U94UE
M-28C>$$[4VY%071&8DAC>"]Z6'(O:RLO,"]3661%<WI:6$9T1G@Q0FY%241V
M-F-3+T,P9GAU0S9/.5I.+VIO4&A!06M%1FIF<G<O=T,O1BLX6B8C>$$[2S).
M2C4U2W4O2SAF;4LS8GI%-DA2>6MY,TY1>B]A:5I6;T5Q,6521D-/;EA)>35B
M2FHU<VTP-U5F>6]L=$1*9'!B,F-L,$QD8C(R5"8C>$$[-C-).%-#*U0Q4'%B
M=5I61$<Q47,W4TXS;VY6;'E*=&QS;#-N2U0X=48P-DUE5S=I1U,Y5UI05V16
M=31W,%)I3E-I,T1/1G!-1S5!:R8C>$$[+T%9=4I*.5A#0V5Q0T(P660V.% K
M+T8K.%I/,DY/.65(+V9I+V5-8E=N979$+W9X9G9'3G)4=EAH+S,T=C-J1S%P
M.35::G1Z<U9D:28C>$$[<G-69&ER<U9D:7)72W0T<3=&6%EQ-T9867$Q:%9V
M07)S5F1I<G-69&ER5TMT-'$W1EA9<3=&6%EQ,6A6=D%R<U9D:7)S5F1I<G-6
M628C>$$[4G(O-6MV<%=R6&5N<G!B6%!O4#9%1&E6:V%78U%X5&Q!=G!-;TA#
M661'3$AS<'E9:&%,4FYL:GIJ<4]U86DY<V1/:'0T26]V5FQL1B8C>$$[>$LP
M9R]F5%<O2#!:3&%&9V95=#)Q1TMK0VTQ86=*:E-G<W)Y0UA9<3=&6%EQ-T95
M3'%E;U%A9' Q,7%&>'E-1G!%.#AO4599<D=P628C>$$[,$)P=G1H059*-79/
M,6Y$6B]76DQ'-T1*9$=Y;G1W25=K:6Q(1V=.2E-J5C5R>$5B37AR<T]U2&A2
M8494.'DO3%5U:C-7<E%'5V4Q="8C>$$[8G W3VMA;U=K84]0,5=E36,O<V5M
M0S%443!",G<X0EAI5C=J>C-P,79B4E1Y5VPP3U@Q9S-%645*84)B3V1B95IP
M4#-T0T9K8V8S6B8C>$$[66YT9S16=%4X=&5D9$\Q*UHT24Q7-G1*5E0Q46PR
M:4E74VE';T-U+S=-<4YV4V]916)9;4Y+0WE(27!197(V<&(V6' X=#EC2S=X
M>"8C>$$[8U)W:D%,<WIS1596-49257-W1S5!=V=+;#AF;7DP94]X4#%3-5=7
M+W5*-TY)4W-:36,Y=#9N<4I)-&-X:F5&9W1'3F9L56<X2TQ1,"8C>$$[,VYR
M5&].270Y4VYT3'%.3'4V97IT<F8Y=S!J>4IZ1E9+4W1(=UEX14)U9$]H-D=U
M4$-T<48O.$%M4F]T;%EI.6QT<G!O1F@Y939+3"8C>$$[151!=G)M,B]E07E$
M:V9757(K-S5E4%1F1'=R85EE5R].=&AR>C-%8T9V8U=S.7%%86%#-E9%9&95
M6C%!25(S;V8S4DY$,G T-$1';"8C>$$[0E1Z27!15W)A;D9P=&XY6FMI:VUR
M2D9$2$1&>#5V2E!)<U-+3V))=3=/3W)!65%&4UEE9F1-8C9O27)7-FQE-U5%
M26]I0FID<%=G4R8C>$$[3BM5:6IK.'-B24]*2SEY474K2&A28394>GIP-F%D
M<&PV8D\V3#9U4CE4=$%)9E9+=$ES84]X.5@P=W)T3$A1."]W0F]E.4AH5S%'
M.28C>$$[+TU84G)3,&IV1W1R<5<Q93%G=D=L:E--.$9U5FM-2TUR4TMX9"]2
M669#0T%E<$=00W1P:C5B.#%A9#5G:&MK<S!L:4U1579(3W%Q,28C>$$[2#5$
M.6QN1WIX=7 S-G%C4TM30VY/4E9!-GAQ.6QP1FDQ.65.=V=6-#1Y,59&1$Y)
M<V%K;'EQ9T%V56MN66(T44Q607(U>#!A5%9,828C>$$[>'1M3C!L>7%L3#9!
M>'E7-$Q#9&Q8;7(X:50Y56LK>7!!<'52:#155VQK4#5M84Q*8S)D=3EP9'=Y
M6'AG.40Q0D)4:&1'3EE(*T=6<28C>$$[."]62'=R5G=!4U9!1TAG5S S9GI0
M6G)R<390-D5X:TUI=TYC9THV2WI00S%W<UIQ+W%636-:3E%N2#-W56TP<FLO
M35=W:C0X=$UV-B8C>$$[;61R5F=Q44YW;4-",5)Y<WA#;"M8140K649446I$
M=V]T:S%P9%$S9'!$9%%.>6=U23%L:6)P5DA!6E0Y>'E+5F)!<50S9FMJ-C5C
M="8C>$$[9%AI851C,TQR=V5E8E1056-R5&I1<S%W4U)48D)X;&5&6'-V2S$W
M64M&<UI.3G160VE-0T14,FI!44UZ:&9H=4)T>61M<#1K;G9J>"8C>$$[<'!&
M9F]V>D(O=T)80S O-E$U4"MY;D)X3%1V,%@U9R\V=49P+W="26-N+UI4:GA,
M5'8P6#5G+S9U1G O,&AY9CEL3U!%=$\O4F9M1"8C>$$[+W$T5VXO4TA*+S)5
M-#A3,#<Y1BM94#A!<317;B]32$HO=T)L3U!%=$Q:9$<Q>5=.-'!B,GEK:6M5
M<DI',6Q)>7-R0VA"0G5A1459."8C>$$[4S!L:#AG5S561DYV;S-'2VAJ2#9+
M1D9O4U)X+V8W54QS9G!/2&I+3T9%6&9L1S=V23)I=5IR0U-.-59U2D8K<%-$
M;DMO0VAN<&-J;"8C>$$[.$DT;7969&IT:GAP<%-(:U9!65-)=$ER8C Y02]O
M>BLW-'-76&@K+RM':DU32V1Z:GAL949D<"]K=5A4<#)N,#ET3W1*1U0P>C9&
M9R8C>$$[.&$X83AV<TQC:%%397!P53!&96=X33%P35 P6#5G+S9U1G O,&AY
M9CEL3T1I5VQ/-#!,5V)M1C1,:3AS6F]*059K:6MS;EI'53E1>28C>$$[;35)
M27@T;'!!1'E*1T9I55$V449G9C%944Y,1D5K;T)Z6#DO.$Q54F1X-$1$>&Q(
M0W$S6&LK-75R84,Q=4ID4&4Q=&TU45<O,4=14B8C>$$[<CA$4C T0S5#;&5%
M:DQX27!1-#AA855M.&AX345$439/4DAS9T]L9SAF:$-B9G8Y=FA25BM107@T
M>6IH5F10.&XS3VUY4WEA9DQP.28C>$$[;UIL4DI&:'-:151J1U=:4457-4-I
M:&M9-T1V:5IP<$AF;W9Z0B\Q8TQ4+W!$:R\W2V-(171+5C%O1W)89'4Y=F0S
M5FAC5SAM,&M-="8C>$$[:3=O=T)R=7)82D(S1U!%=$E33'E5,%5S57-3-E9(
M3$%A=U-,<'1'46Q1:#1%6$96*T)1=3-905EE37)49#,U36UV27)A1S5F5'!9
M3"8C>$$[449B94)R1B]35E-V2&HV9C%N:59O0CA*1DYG96]'4$=T2V-N:T]+
M5G5C<T]J=3-(:'EB4W=4>$-#4&I5>CE/04,O3&)(:DM/1E<P-R8C>$$[>6ID
M-EE:9C!F3EE7;VY+;5))<DM21BM%54%#:34T<4\Y1DA5:SE38U1.3DDS.48K
M65 X07$T5VXO4TA*+W=";$]$:5=L0S@X=F%V928C>$$[42MH8S-T;SAF3T]1
M1#9R37!$>$]S:4U#=#!#0W)O1&@T;'!4=79+9#%D>BMV9%!P;'A/23)H17-U
M;D8S.4YW47EC;75#94I$1V\V8B8C>$$[-#AA,&A*9GDY='!95VAE1%-05&)M
M84QP;D5G>4%+-TM6=4%66F="=4XX9D5+3T9%>BM52C=I-U,X;D]L>3-C9D@P
M-V@Y3TQ33'=02B8C>$$[84]B:FM/2C-'4$=M:TPO>7)Y,458<'AW85)#=$A#
M;4A45$5Y*V]V1GEJ<&-+>45J=7!">#A1;S15,&@P6%A)66MH:79R3DEO,4-2
M;R8C>$$[=&Y)049554%(*VLY:&<T:S!V.$$P6#5G+W=#<FAA9CE)8VXO04=5
M-#A3,&Y74E,W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98628C>$$[<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6&IN;4AY,68S;FUA+W="6# S>DQP359V3&97=28C>$$[<#)L<DYC:6XQ;7I6
M231Y-4-T46-43%=L9C)F;W5%>%9-1$4R;#!8-69V8C(X*VYJ6#E&=5EW;'9&
M<'5R=F-E;&0R:5(S1%A5>&EJ-"8C>$$[>2]&23AR<G1-3G5V.&]0:4)(0VEJ
M-4YI84UQ=#<U971I.$UC34EH=DA)=$I%34IA.&<U2E%Z4RMK95%54CE&,THU
M16IJ0V5&3&)F."8C>$$[=7)P57-H9659.4AV5G-O4'%S54)U,5)217-I>F]T
M6&=N:F5K<E-F,VM41&IX,B]L4&E"2$,Y83AU-G1O,FXV0G!T:&0V=EE08S)L
M<B8C>$$[1$)-.%9X2'=,>'AH5TLQ24Y+:G=Y:S@R651(+T%"3#5C+S9U=&XO
M,&M29C@Q645U+W=!4RM84"MR<EHO.4I%6"].5TMO3%=T8C!M-R8C>$$[,&4K
M=&)(6$Q/,G9:-$I9-V$T*W-2:C U1U%H2'%R5D9#83%'16,P1FAD,T1R,'1P
M0D)A*UHW1WHY2SA--G-D6&YN2U%U9#1I-TES:R8C>$$[+W X87(V:F-4>4E+
M+T-P>61H1D97=34Y8V)Y=$IP>6598DYD4F4Y;&1,=4Q5=SAN,659>4Y(>6Q:
M24-V;W4V8VQ18F]P0VIF:FI9="8C>$$[9#%8,4Y3-#920TYC<T9J<S=T<#=Q
M8CE->G,O;TYD1U5154UF*VMC26Q734Y-,C0U1&E$4F<R1C-B.&IZ86IP5W!8
M2#9C.'A7;#-A=B8C>$$[1#A"+U-"=54U:F=Q0F988FU(*T-2-4112V590VEI
M,$1)9SAL1$YF.%,K6% K<G):+W=$4U)&+WI6;&)*0C9X<C)K6$=L,U5&;')&
M<"8C>$$[2&13>$US3&DW:FA)66EG+V5!5$90.5E)85E1:&EK,'5T6$9N;W-B
M95ED3FAU3D]J4TLW:VHQ5U=K-TDQ=7I4=GA327E&,6EL46\K=R8C>$$[-3AU
M5F-N65)U:%I9.5EJ.'4R,FYW*UIO2'5J<4UK,'IN5E=K9&).;UI!<TPS8F5L
M2U(V;D=P5DMI=%%#5C-.:3%O=&%N8C8Y9#9D628C>$$[,C%V-7!S<E,V=$9L
M53-I879-96%Y2V5+>7!W2')&0W=66%IG,W<X>E5T>%9%9W1&3U!*,3@K;C9J
M<6@Q6%<W6C='6EE465%T<5@Q>"8C>$$[66IZ;4UI3$Q/=VQB-%=3<DUO.$)S
M=5)K455H;%@K2F9,;B]6,7,O*VMI3"]!2G%Y0U9#.3AX854Y<WDR3W1A9D)C
M;6Y#5V0P;6I'*R8C>$$[.5575T5N8B]!0WAH0W-5=$HY5&<Q935U<'9-5VXS
M34YX2&-O>DQQ56M1<DM%34125W)R8U)196EY1E)X6FE1,TDQ26]:5TM9<E!,
M,"8C>$$[;7 R,G!A6E!Q9FU#=V5',',O<3DS=S%A5V8Q<&Q8:7-H:&M33TUG
M+V%9:S@K6#=60E%M4D-I,$8U8R]X2F(R8FDW.# R561Z9%=V;R8C>$$[>7HS
M1BMB=#1P5U5(,6QG3$-)3D=2>%5*24$O3&TR-CA36D5+058Y:$HU9W-M=&QU
M9DUD;&9)1C!Y3U-63E1.5F$R=4$Q>2]P4T%";"8C>$$[:V=,2S5-:%II2S S
M05%%:&0R9B]!3TIF3&XO5C%S+RMK:4PO04IQ>71K;%!M:EAB4S0P:&\Y23%I
M>FIV9EAT;41#-&I(-W1B:4YP:"8C>$$[=$Q#4U!41%9(359',5)7=5-J>C-1
M57%N=DY1+U0Q<'%).'@V6F-245)5;&=3.&4P:&MD5G5"=RMR.')P2T]:65-:
M1UIM6&AS3C998B8C>$$[1DE30T,R.'I7;6]F6&TX,%=D,T9B6$Q8349M3EEK
M2'%X9T=S37%U;G!S6F%+3W%P1V1W1%5J2F-5555743-L,T]F3F-E<#(R=E=$
M828C>$$[97-K6DYU*W!01W%W*VDP57-8,5I6949Z>F-3:#(K2V\T-T1F26=I
M;5A6:3%V<&9M;3)J:&%4>FAB,TMX96\Q=W$V=DDP,&=-2V=P1B8C>$$[>D55
M66%744Y4;G1'0T]0>$%S,"M+4&-X;W939$TX=S922'!T<$AE-GA:4UAQ47AR
M9%-,4$92<%%O1&MF1C-A=59&;6EF.%,K6% X028C>$$[<38R9B]34D8O=T$Q
M64942$9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-R8C>$$[1EA9<3=&6%EQ-T9867$W1EA9<7=$
M>DPK878V0V)71VTP,%-1-EI02&%1=#9S<4=E6C!J;$MH:F)M0F5-56IT5#%3
M,W<O6F\Q8W-J:B8C>$$[=&E:56Y(;#=Z;S)S-FQ(0VQO:5=&,G0W2G Q-&MX
M:V%63$,U4S)K85-,,# Y34\P;%4K2G1U=$1G36%51FLK45I/>%8R2W5X5C)+
M<28C>$$[9'A.-D9V3$YX3"MK:E!W0E5%.%)79TQL5D9F.&]G92M+<V0O>#=9
M9F]3,#%F.4@S=VEU-3-T5&)T2$=S.%5K8W)1;%I9,FM(>&,Q;R8C>$$[155S
M-3=,:RM$96M7<VXO35!33&92-VY63&TQ=315=&)H<E(W6FQI855Y2D8V-SAE
M16I*.$5F27-#,59+<T-/47!J=T<Q=$5.-7IT:"8C>$$[8E=--# K-TEV8G5A
M>%I0.4A$4517-T]S;VQR348T<4E:1S5)5TA&4V-(0W1T*UA03VUN-C5D4S)K
M9'!D,E8Q0TI#.$XU1VE-1$4T4R8C>$$[4F9G951D96%%*WI$1U5A549K1U)3
M;U@Q,FQN6GI85'AY4W)!:&-X=W%8:V)I2S!64C%*>$%62W!03FQQ=&YO=#5&
M6C-6>$)R;G O5B8C>$$[>D5S4F%0,5EV5T)K47E+-7!'1UDK;4<R52LQ6F-+
M3%%T>"M91VIW84A:-G4Y=F1E;F8S36QL8C)V0D9N.6%.<$5+<W)/<7(X54I'
M-R8C>$$[949A665!,U,R=F)Z>%II1%0U,'-,>5=055!70VE-44TX8E=W8WI+
M-F5R>E!$,&U&67=W2F]!86M62$-T<G9+9FYJ4U!--UA+5TUC,"8C>$$[56QO
M14UY5&5N+W5W=6\T=$4X<4Y4,'I7:#(R>&Q%:%%B6D1K56],5SE79S!F4V)V
M5DQI3U=70WIJ86%73T)E8VA64E4X4E5$-WI19"8C>$$[.$E&;%-5;#AX+VU$
M<&9L*V5+3SAS-S)31U,S*W-V95%X2S!%64EB:6MJ;#$T=2]P:TM/*U-J0S!%
M,#-C*V9T3F=T8D]6<D\V835V8B8C>$$[:5<P:G-614IM5U='-$9Q-&-M55)5
M.5IL5&M(22M)9'-E0F)1,G)F;68U9C!Y,# K-FYG=6YG,4LQ1C=B<VE2,31S
M:&15;S!I;&Y04R8C>$$[:6-Q8F-I06$T:4)+.%-A958O3BMM95I)6EIB2T]A
M27=H0SAC-G%R56-S=&9G6GAS.&)O9"MQ;D)+3DM$860U1DM",797<DA2=%!A
M+R8C>$$[=FTT5S9Y4E)S,597:&UK5TI34S5644%8<7A*,D94:$%T4U5V5'IR
M;VLR<C(R;E=R;3=3-D-L3"LS84M3,D1/<S=+:&-0>4I)<S5F<R8C>$$[<5%+
M8FM9944P:3!R,#,X,G9*=7!8.719,FQW>GHS9#5,63(Y9E1!6F]K1"MR.75V
M<'EC9W%B8VUB.6Y9-%1J25)X0D\U+TTQ<D(U:B8C>$$[=#E#:W0U>$QD4G9*
M1F5C54YT>6I8;3!:9FYY1&AF:31L96TK1&@R=$YS8W1V>FDX=#-L>DI&63)D
M+V51>'EV8B]865EO,G1Z26]Q:28C>$$[*V]:0E%Y.4EW,4-X>5AH;$A%>E-Z
M=31,>7IG=3=D=6-&>D=K<TQD2V\V:&Q0,TA+>7E6<U935G1&,49M6FUF5%=:
M<$1->D=W66MY="8C>$$[2#9*:U K:V9A35(T5C8X9'5M1S!59W10.&TO;S-5
M,C%,5&PP-GIU,V=&<3=7.6Q,16AI5G510FE3-D5D4E0W6$AL5&%T34IK4W1*
M="8C>$$[-DAM4"]L=7,O=T1P16PO-TMC:6PS;V59+W=$;'5S+RMK4U@O04Q+
M8U9D-DAM4#A!-6)R4"]P16PO=T-Y;D9896@U:B]!3U<V>B\V4B8C>$$[2F8X
M07-P>%8S;V59+W=$;'5S+RMK4U@O04Q+8U975%=7=7IW=D1.9%=-<TUQ;$I)
M,W-P1U9L655+<T1C,$E)-FI&57-B>5AB<VM33B8C>$$[6C9+56=P-DMN4V=1
M;$=::'A(<C=585)J=#-*.&-L>$9&3R]W66=S:%E2=S961%I#5F)J-G1$<#=2
M4FU69'525T\T54=O*T4Q-FI9-R8C>$$[63A25VQE2'EZ3D%Q3$%M:WA,1W9'
M34IP<%5+=$A&0E,T,D9*<% X06=M.%1G=&%7-F8U6&XP-F8Q.5 O045B6G8V
M9F]G45=-:V%"3R8C>$$[4F-H55<U0T-R1W!)1E1T6&]-5$LQ<$UF43AX+SAT
M,6XO=T)):W8X03)5-$5Q3C%P=7,S9'9*8EAD>%E81G1+3TUS171I-V]Y;G-Y
M="8C>$$[8VM%66)61%<S;&E7,6A%3G)(<$U%2W-85TM,5%-I:&UJ35)92W1W
M0E5X;FA8*UAB<&I:4E-G9DII1WIJ<VQH,'%/>6EL3397<U=N="8C>$$[2$8V
M:E)T17I.1VQY<71Y:F1L25E5238T94ER4TET+TQL>F)#;'5U;%%J:55P2'!X
M6#1'5E5+-UA!,DM2;W100E%/,D,Q<')49DQ6,28C>$$[<&-K<VUN3G Q;5IK
M4TXP9W-P151J1UA:0457-4-,4G!73W<V;D5M,7!(*V@U:B\U8G)0+T%+4DIF
M*WEN06Q1=F1+,6$K=&YT8C)B5"8C>$$[-W$Q;&]*24IR1C5),D%.4GE6<FMG
M-VEU14950U!*<TE+:U=U:6=O<%)#3DQ'>6Q"1U%0,RMW-$M&*U<R2&E+2V)N
M.&]E=F(R,71,2"8C>$$[<&)7='!Z*W(R=C908U%Q2D%E63E)6$E19S%R46EL
M84AQ0FIX1F%A;#AN4E1%1V$Q,&%19V-16#!S3E)E06IP=E P-$EQ+TE!63A2
M5R8C>$$[;&)44$QD,W!2;2]2<C9F84-C<5I%:'-P150T4E%"5D9Z>%5D-DM!
M2VMN<51G2G1A4B]O95DO.$%L=7,O*VM36"]S<'=*43DW<%=S,R8C>$$[,$AO
M6$XS6G9&>FIL049R37!$=WE,3$=W2S-124MU9TEW9W%P6&9L-C9V2B]R1C).
M3'5B9U)T0TIP9$],=C949VAO*U180E!&9WAQ3R8C>$$[;2M.;W Q,S5D=DQY
M0V%#-6)4<$DW9W,X=TYI-$Q/.%)H6BM1=5%E6FE01&PQ<'1J83 Q3C5A;FUV
M0F5Z2G!5=#9!;T9Y*VY&<%%),B8C>$$[1$E/6G5/6'=S;TDS,D].<E-L9655
M;79*6DIR;5!3,W5*431A-2]2-TQ.*SA4,#));%<T16ES54%(24Y815-+,&U%
M3FQR,$5-8TU.,R8C>$$[6E)X4DM%:E)B3U5"5E5504@K:SEH9U-V.41Z2"]W
M070Q;B\P:5,O.6Q/2W-,.'AF;#5R.3EQ,S92=#<Y4D%M='<V<CE266IH-E5.
M=B8C>$$[1D=X57)#6F972FE)0RMP=W!4=FQO;4LK1$%X4U!4=DQ0-6]Z<G!%
M839P9%=-:SET2F1Y>7I83C5-26%W,FMF0V(Q5BM+6C505F8P;B8C>$$[,E-R
M8U0X3T5Y:6=!;S%0268U<$MK;$YC5FU:04E59E5B.')'9C-N2D-W4E=K-6PP
M8FU31UAJ>%AB9DAJ:C-*;V]M>CAJ+VU$1$IA,R8C>$$[9#%R:VIY,B]O971&
M2&98:G!)249T5F8Y,GEQ<D=267)K;6\S6C%R-&='564U44-K=&HU0R].5%5.
M2W1Z9#9Q<E<Q-5E/:S%N93-L.28C>$$[-G%.8U<P:6-:55I'4FE*2E9D=6%K
M<58T<6%,=DEZ:4-J:$PR6$M'>#)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,B8C>$$[2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%9G
M1W)**V))3W!F53-$4G)D<VUM96@Y5#E2<F-X,TUK8G8V-$-"4DQ,8GA/4'1C
M628C>$$[>58S3E193T9I8E%D<$(K8FET9%=:33!-4G9B;#1,-'9:4S!T6G)Y
M,DU15#%';&5S8T@Q:S!D9&=13WEG2#!O,U$X35 U-G9D,FQS."8C>$$[-&AT
M<%%G=61127-(845Y4E)M571%;TAQ0TM2;D-"2U9P.%92:C9&.51*9DUZ*V1P
M.49&=#5E95=05G)/8C!R;3AA2S-28F=*6DY+2"8C>$$[:5=C=6YP>5A$4F]A
M8F<X=7=R:UDQ939485)83G(K8W=3:TXV-U!#<V]5.$Y/06U:6'4R:5IG5BM(
M:W%7<6UH1WI(=4-23#!O,V5L-28C>$$[57ID:7%Y9' Q9VM.=6EY5&A366\U
M1TUA33%.9WIH6$MI=F9I9FQI<GIU-"\U6$5R>6U!;51L9FMW<7=S55),66LP
M56UR33!31'914R8C>$$[="]K,"M+,S!S9#!C;'HK6DM0-6QU<#175T0V<$Q,
M;TYQ4F)-56Q#5FE10TEY=DDO.#19.&57>3AG86=E;EID,$YB=BM:>C-K3$0V
M-B8C>$$[='(Y9FE9:61.3$%E>35P-G=K-$US:V9*0WA8:4,V,&]A.'9G9E-U
M-G)O.3,K6E@K2V]J<6-5,&5J6%8Q3E-":W1#<TYU234R:55Y5R8C>$$[-6QE
M=3!82FY99D9S3U%.8U1W,&]T;G56<VQK-U1R0DEB9$9K;D-K>%)Y35DP6G%B
M0FY#=59&92]%+TQ&6&XQ9V9Z66AK=$AV4')&>28C>$$[<U8R>C-C651415=7
M,31+5$AT24=2;&9K26U"*U Y=FAL<#173S9-:&PO34\S=%!-13$P,'-V-WE.
M=$I(;S)P:VII33=I6#!9-$=L328C>$$[=D-$:7EE<E)M8F)J-&HP-TQU;S)%
M,S5R2F-7<W,Q<UID4&IV2E1D=UA%;&MT-TIB96=!9U511#9U0C9I;&=0541C
M;4-L=4E,;%!#=28C>$$[-C=Y>DXK6F%E66MJ,3=M.6A/6E-Y:4\R145A<GIP
M-F-K2F54<C982#%#1UE-,W<O0GEX;'<Q<V]T;FU6<VM*<7)A;W5N5&Y3-#1P
M3"8C>$$[+VEF<39Z=55J-4AU>%983S-7;$XK;%(Q=VA71C)&>"MA15AL.')D
M,CEZ8V%V2&4R,&YQ8V1.57E7:#1'-&E65FU%83AE3&=-9'I5528C>$$[<%4X
M2FYH=&IU;61W9D].<'!';UA0<3-&>&-Y6#A#,E9U>3)Z>7A76')X<$M2-DU8
M16QK36HO14<T<E1U1%5B5VYD3$Y)8C@R26(R>"8C>$$[;#%"4F1A5D9,9&97
M-&Y.<$AF4WAM3FI">5-+='5T2%913T4R-5!X54A1;FA13%(S;$=4>C!M<&DS
M.'=03$Y#>5A4;5-32S-24E$R,R8C>$$[;T1L8C@Q-G1/04,O2FQ(26AE;4-6
M9$9&<WAY1$I+9DY&>')&=G!$4V%1;G%8=G(R>6A10V8S8EA%87I(6DII0C9:
M87 T1V<S;V%5=R8C>$$[>'$Y,$9)=%1G+TUT2F)M6%1*;S5O,G8W67@R.7<X
M0SA,34MJ5')#>5%B:&YK9$-:9FE#2E9A<S)32$-J9&1P3V\K96HU>'5$<5=N
M>B8C>$$[4F583'1E1FI(5S!F-G4V>'$S2U)O;6%4-"M,.'%K9TU1;W%..%-"
M6&UO=3!O<T<O3C5D56HK=D-E4S)E-FI-;G!$5$9T-#1"36961R8C>$$[-VUD
M,$U12$@W3"]&=CEN-#5(:%AD3EI,=CAW>#5J5U-3,U=,4DQI5S!&=&)X;$I8
M4D1Z*W-R8VM*.$1"4&I,3$E51$)&571Y635(,"8C>$$[,'4W33AG>61I<D<O
M*V1-+WHY9D-R=CA!;E10."]8>%8S+T]M9C4K=FER=BMD32]Z.69&6&8X-EHO
M;C8K2W4O-3!Z+U Q.%9D+W=!-B8C>$$[6B]N-BM+=2\U,'HO040Y9D989C@V
M6B]N-BM+=2]W0V1-+WHY9D989C@V6B]N-BM+=2\U,'HO4#$X5F0O>G!N*V9R
M-'$W+VY44#@O6"8C>$$[>%8S+T%$<&XK9G(T<3<O;E10.$%0,3A69"]Z<&XK
M9G(T<3<O04HP>B]0,3A69"]Z<&XK9G(T<3<O;E10."]8>%8S+T]M9C4K=FER
M=B8C>$$[*V1-+WHY9D989CA!3VUF-2MV:7)V*V1-+W=!+UAX5C,O3VUF-2MV
M:7)V.$%N5% X+UAX5C,O3VUF-2MV:7)V*V1-+WHY9D989C@V6B8C>$$[+VXV
M*TMU+S4P>B]0,3A69"]W039:+VXV*TMU+S4P>B]!1#EF1E@O+S)1/3T\+WAM
M<$=);6<Z:6UA9V4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO>&UP.E1H=6UB;F%I;',^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N
M<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R
M/D%D;V)E(%!$1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN
M;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z9F]R;6%T/F%P
M<&QI8V%T:6]N+W!O<W1S8W)I<'0\+V1C.F9O<FUA=#X*(" @(" @(" @/&1C
M.G1I=&QE/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @
M/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CYG,C-A,C,\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@
M(" @(" @(" \9&,Z9&5S8W)I<'1I;VX^"B @(" @(" @(" @(#QR9&8Z06QT
M/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+7)E<&%I<B(^
M1FEL92!.86UE.B @(" @(" @(" @(" @(&<R,V$R,RYA:28C>$$[57-E<FYA
M;64Z(" @(" @(" @(" @("!R<C$Y,C$P-"8C>$$[3&]C86P@5&EM93H@(" @
M(" @(" @(" @,3,M1&5C+3(P,C$@,3,Z,# Z-38F(WA!.T535"!4:6UE.B @
M(" @(" @(" @(" @,3,M1&5C+3(P,C$@,38Z,# Z-38F(WA!.U-C<FEP="!6
M97)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@
M(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($%R='=O<FLF
M(WA!.R8C>$$[*BHJ5&AE('!R969L:6=H="!C:&5C:R!I<R!C;VUP;&5T92X@
M4&QE87-E(&5N<W5R92!M86YU86P@8VAE8VMS(&%R92!C;VUP;&5T960@<&5R
M('!R;V-E<W,N*BHJ)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E
M('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($9R86YK
M;&EN1V]T:&EC+4)O;VLF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@
M87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($--
M64LF(WA!.R @(" @(" @("!";&%C:R8C>$$[)B-X03LM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.T9I;&4@
M3F%M93H@(" @(" @(" @(" @("!G,C-A,C,N86DF(WA!.U5S97)N86UE.B @
M(" @(" @(" @(" @<G(Q.3(Q,#0F(WA!.TQO8V%L(%1I;64Z(" @(" @(" @
M(" @(#$S+41E8RTR,#(Q(#$S.C S.C(S)B-X03M%4U0@5&EM93H@(" @(" @
M(" @(" @(#$S+41E8RTR,#(Q(#$V.C S.C(S)B-X03M38W)I<'0@5F5R<VEO
M;CH@(" @(" @(" R+C8F(WA!.TEL;'5S=')A=&]R(%9E<G-I;VXZ(" @(#$V
M+C N,"8C>$$[1W)A<&AI8R!T>7!E.B @(" @(" @("!!<G1W;W)K)B-X03LF
M(WA!.RHJ*E1H92!P<F5F;&EG:'0@8VAE8VL@:7,@8V]M<&QE=&4N(%!L96%S
M92!E;G-U<F4@;6%N=6%L(&-H96-K<R!A<F4@8V]M<&QE=&5D('!E<B!P<F]C
M97-S+BHJ*B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S
M96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!&<F%N:VQI;D=O
M=&AI8RU";V]K)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R92!P
M<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!#35E+)B-X
M03L@(" @(" @(" @0FQA8VLF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03M&:6QE($YA;64Z
M(" @(" @(" @(" @(" @9S(S83(S+F%I)B-X03M5<V5R;F%M93H@(" @(" @
M(" @(" @(')R,3DR,3 T)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @(" Q
M-BU$96,M,C R,2 P.3HQ-CHP."8C>$$[15-4(%1I;64Z(" @(" @(" @(" @
M(" Q-BU$96,M,C R,2 Q,CHQ-CHP."8C>$$[4V-R:7!T(%9E<G-I;VXZ(" @
M(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q-BXP+C F
M(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @07)T=V]R:R8C>$$[)B-X03LJ
M*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E+B!0;&5A<V4@96YS
M=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P97(@<')O8V5S<RXJ
M*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I
M;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @1G)A;FML:6Y';W1H:6,M
M0F]O:R8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&-O;&]R<R!A<F4@<')E<V5N
M="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @0TU92R8C>$$[(" @
M(" @(" @($)L86-K)B-X03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SID97-C<FEP=&EO;CX*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN
M<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E
M<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(^"B @
M(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z.$)&-D9$-S4X.#5%
M14,Q,4$S1C%!,$1$-48Y1D%!,40\+WAM<$U-.D1O8W5M96YT240^"B @(" @
M(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z.$)&-D9$-S4X.#5%14,Q
M,4$S1C%!,$1$-48Y1D%!,40\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @
M(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#IB,3,Y9C@R,BUA-60R
M+31C-C(M.#AD-2UE.#4Y-S)A,&4V-60\+WAM<$U-.D]R:6=I;F%L1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\
M+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E
M9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \
M<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.CA!1C9&1#<U.#@U145#,3%!,T8Q
M03!$1#5&.49!03%$/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @(" @(" \
M<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.CA!1C9&1#<U.#@U145#,3%!,T8Q
M03!$1#5&.49!03%$/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \
M<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z8C$S.68X,C(M835D,BTT
M8S8R+3@X9#4M93@U.3<R83!E-C5D/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT
M240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT
M/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I
M=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @
M(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D$V1C Q149&0S<U0D5#,3$X1D$S.4-&
M0CA%-$8X040V/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z=VAE;CXR,#(Q+3$R+3$S5#$S.C T.C,S*S U.C,P/"]S=$5V
M=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N
M=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T
M=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO
M/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#HX0D8V1D0W-3@X-45%0S$Q03-&,4$P1$0U1CE&04$Q1#PO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,2TQ,BTQ-E0P.3HQ-CHQ-2TP-SHP,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T
M<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E
M9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B
M"B @(" @(" @(" @('AM;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O<U1Y<&4O1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(^"B @(" @(" @(#QX
M;7!44&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @(#QX;7!4
M4&<Z2&%S5FES:6)L951R86YS<&%R96YC>3Y4<G5E/"]X;7!44&<Z2&%S5FES
M:6)L951R86YS<&%R96YC>3X*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE
M3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/@H@
M(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-C$R+C P,# P,#PO<W1$
M:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^-SDR+C P,# P,#PO<W1$:6TZ
M:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S=$1I;3IU;FET
M/@H@(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @/'AM
M<%109SI&;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^1G)A;FML:6Y';W1H:6,M0F]O
M:SPO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF
M;VYT1F%M:6QY/DE40R!&<F%N:VQI;B!';W1H:6,\+W-T1FYT.F9O;G1&86UI
M;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y";V]K/"]S
M=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14
M>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IV97)S:6]N4W1R:6YG/C P,2XP,#,\+W-T1FYT.G9E<G-I;VY3
M=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L
M<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F9O;G1&:6QE3F%M93Y&4E=?7U]?7RY01D([($925U]?7U]?+E!&33PO<W1&
M;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @/"]R9&8Z0F%G/@H@(" @(" @(" \+WAM<%109SI&;VYT<SX*
M(" @(" @(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3Y#>6%N/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D^36%G96YT83PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI/EEE;&QO=SPO<F1F.FQI/@H@(" @(" @(" @(" @
M(" \<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E
M<3X*(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @/'AM
M<%109SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D1E9F%U;'0@4W=A
M=&-H($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @(" @(" @(" @
M/'AM<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @
M(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #! =8# 1$
M A$! Q$!_\0 'P !  $$ P$! 0            <$!08( @,) 0L*_\0 3A
M 00" @ !"04& P4$!@L !0,$!@<! @ (F D1$A,4%1886!=7UM?8&B%6E=35
M&2(C"C$T4;,D)2AT,C4V<W:U,S<X06)Q=X&(L;;_Q  < 0$  P$! 0$!
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MFS'.BF<.]=$<95WV0]9C5+&5-LXTQG/&UN>#Y?>X/'PY].>.<BQQR.>W/?\
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MH:U<$5C&SK00BQ07<IJNU2N[)[H-3;ZJ;OMFCK5KA7+=7&D!'()",0+)(4D
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M88Z^UCX;76U',):NH?O;ZPYVL"$ --&Q (CJZH(3[2]CP]=9?3A)ZM-Y!]V
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MC,E>T3R-6W;TR4D)Y7UDYC4B8AE@ED+*((T<+-)%'*3*K[]^P$11(MD^^-Z
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M4$DT4]?-HDGIIKKKCJ    [  #X\#YGG.<FR3Z\Y3\G&.,8XQE[ _P#&*_\
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MJ:LF =!LXV5W<-T1C6U4F2:"^ZRVZR.B&J:NRJNV^NV5-LY@_P F7Z>LQ9O
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M]9*XTWAND>9BD".55%D0DM0-T+.?F>LT[SZ_Q)E:-5BU<V]I)%C4%YI HMB
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M3ICMZM3?3TODJO#'G]#;.OG\WS_Y\WG\WG\WGSYO^>>? C0V >KW /N>HO\
M7S[4R $C:>#7O#_#G7ZWRAOU!],?!7>'Z_\ D^P?[7_H_P#?'4'ZI_O#_#CU
MOE#?J#Z8^"N\/U_\>P?[7_H_]\=0?JG^\/\ #CUOE#?J#Z8^"N\/U_\ 'L'^
MU_Z/_?'4'ZI_O#_#CUOE#?J#Z8^"N\/U_P#'L'^U_P"C_P!\=0?JG^\/\./6
M^4-^H/ICX*[P_7_Q[!_M?^C_ -\=0?JG^\/\./6^4-^H/ICX*[P_7_Q[!_M?
M^C_WQU!^J?[P_P .=2.OE!V^NVC>_>EB&FZJR^^B/2>[4M=UW"NZ[A;;73O[
MKC95==11993.,[JJ[[J;YVWVVSE[#_M?^CT[?T\=1?U3_>'^'.WUOE#?J#Z8
M^"N\/U_\>P?[7_H_]\=0?JG^\/\ #G4GKY09'==1*_.EB2CI75=RHGTGNW3=
MPMJBBVU67VU[^XV65U;MT&^JBF=M\(H(I8SA-/375[">/ONW \G8630\_J2?
MVDXZB_JGGOYA_ASM];Y0WZ@^F/@KO#]?_'L'^U_Z/_?'4'ZI_O#_  X];Y0W
MZ@^F/@KO#]?_ ![!_M?^C_WQU!^J?[P_PX];Y0WZ@^F/@KO#]?\ Q[!_M?\
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M\)OWV/LO3?K3_P!^/]UCY .VGU7]=?!S9?ZV.*E_7C_";]]C[+TWZT_]^/\
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MD'9+ U!WLKMV,7IV2ZS4N9NI8-M"'B3.MGF]7%!!%[$49@T4=N['50CLP9Q
M^,U""GB;4JU>)=*Z:'JS*8RKA(FAT^HE$6[>+D'5! 8J>$Y7<#9['.=M1,8H
M660%"TBS3P1-+6RNF>FP.P,"3(:8*P 4T<H']P]EY<$ZGRFO^X4#,@[\N-W2
MA(S7U+QYX"T1"Q:U9%K,<#IXUTE$?FCU*!"F4P@97&C*-GWAIJ.7V9-V6NTB
M+3HVI5](X:&+K 22L&.YHQLM"5*#>=KBRR@$\WD&34,-.R:I2)I.D3'$I7@2
M'?3C<&(4!D/ -T:K/7H(T(L PAB8*['BS,8P:%#FS)L-V,D6[5)%Z5V',_\
ML8_8BYT5>99-?^S-<K900_TD].>6Q!8D#:"20MD[03P+/)H<6>3GI@$  FR
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M!8#:$L<2UP-D@TU-!4(D#I]&HCI%B \\"AT=LB&FI [?2T"\<(.) U#L'I$
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M&;F0KJ1OX8_KF1DPCR)%-S,.>OMR371)(UATD,DD:?N2KF)GD]7#4<H>-:E
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M%W2-(Y%42*QXDC*<$6"&613\QO10?D2>X&6>-F,9 -I(&H@T059&^BNS#U8
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MBR;/([G.H*0  #P*[>F5/QE$/XJC?\\%_P!5R+'J/J,FCZ'Z''QE$/XJC?\
M/!?]5Q8]1]1BCZ'Z''QE$/XJC?\ /!?]5Q8]1]1BCZ'Z'((;P.J"4HM%2=)U
M/.XI-9@!L8*UE6(O(=PTEQ 8Y7A]DD-,(/&K=#5A!@I=H505]J=N)&88*H-T
M!S=1[N9R$BV2%&1&C;:Q7<N]I%-@CXN5(_U0>Y.8] ,TG4C5U9E=0R!J;8J-
MP01V0&^YW$?#*.05A7.K\25JJQXY23X?$CT!<:01K TQ+B)2(NG('";,&Y;Y
M%BI"&/9?&8R<;MU&[$B;.JEPY](CE!*5U- B2IAO60;W:PZBN2#;*RTK+8L
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M0(YC0@/(%8HI;W0S ;5+? $@GX94N@8(64.P)5"P#,!W(6[('Q(''QSJ:V#
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M=CFZRHM\OOOUSQ6NI00KTE]G&A9(E#2,[H$5)%7=,TT)DD=2SDNH- J*YXI
M# _4.\]8ZH-(2$50Q<LI.U!%*$12 H56('E/%[[)3N+-YY&99 ;,;OI(-MGK
MVA)&XV]Y>/FPF,'997[ME&J@H5D@T@5H@K7C!QRC(C! QZ! :9/.V.TM*P\-
M&14:6-S&Z21$*T.I*;M,AC9U24%Y]22986A=;50M@JH/35RYM.ZAU9)+;J0
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M]ZV[FV]JW&J]*NLG:EW7/KM%_6\Z=["[.[R;689Z,)ZR'W K&%7Z?9BO$O;
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MUU?2423=R(F9<#F; 4/&O%GS@N+;,\N';KV?1!IS/PLD2MYO*[,#M1=[/PC
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MY(E:8F6-5:%TBZ8EW(3*)PXDVADWK'T@!81G8 LV;12-*CD1@1N6$BL^\I3
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MR@%)VNZ&:@]EFKC1@53T40UOIY8EDEDG>7=)'J$\D:2$G40R1EV+2QT5+[J
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MI7DXALM(LKF85T8F)"M-=SDFI^)2F5$=CU9"["?V]!P)D7$C!>(EIU!HVVE
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M(L;RNTNG,9V(RK]VG4/48NX6MR!2;<JH)&"ZG<MJ(W9G5%$<H<;F5F\[;5V
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MDW%56-2+\J.S,6 55^+%5:\TZQ%5.W<X8C>XC0*FW<6<W7+*  "23V !(S:
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MV8@E4(!S,Z@[!(L9:/IF4L6"CIBR-I(HNR#?M)4 $!F%YE1WLA'1=L4S5(P
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M"3D@MV,</DXX=0*0XXLVU=[+I,Y1'C8Q??3"+QDX:[JH;Z1RM&0*#)O5F0V
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img109617586_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img109617586_12.jpg
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MDJ&QTM?P&B0F-D)S=WB#LK;!X3=6<IBSM+7")2<U0T9'=826V/'_Q  < 0$
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MCC&.,8XQCC&.,8XQCC&.,9CK=>KWI7UOM(#I#8'47I6E;BM$\(+KVK[1LFI
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M ,UM1VOI]*5741:B(N"5#(ED T2*D/CD3?U]#I5_M3=4?\7U _TK\R?B2?\
M=.B_G9?^3FO^B'L_SF_D+_7RUZAZ;CI?!B9<*9JCJ=6\_:+P81F/0:&M&(MA
MNM@/P4J4O:C></(A$XZ)*,)RAN0EUM#CJ$I=6_$LYY&JT7E^FR]1P?\ P?,9
M)[?T"FCWP- _,7HP# _IGB"#].7F/].#TPE9\(6/T_U32YY*7&@08K6O=?\
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MLQ)4*H LDDB@ .22>!US'?\ JO\ I(_;@]/G\=^G/M?G?_0A\+/_ "O\(O\
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MM)4XA*D8SGG,U_97:G93QIVGV;K^S7F4O$FOT>HT;RHI 9HUU$<9=5) +*"
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M5_=O^#_^3];_ "A_RL\=^AOM#RC_ ):_UL?UG;TB7]IFH_QQ:_\ M'C^[?\
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M9?P'?KMU_P#Z>U?^\>R<\Y\*/U/B_C<?]%/GDAY^J\\%CC&9U>C-_5W=-?\
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M4D^VOS 9C9@:I%3]Z7-^W<S?56;'O10?JW=:?_H6Q?\ L&?YI=H_X*_[Y/\
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M_P#JZ;W_ /[2<^6[NRO\3VA_I.F_Z3.]MUO^-TO\Q+_U&:V.L?KY](%T@[+
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M5H=T4=)#H^ XYTZ:C6XY"BK6M5,$94I:V&U*4K/J_ORI6<YSG\.<\CXWJ?\
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MI$0-4[ ;+XB6A;^MJN3S: =?KDBVR2<P9D@R)JL,30&6W)C9.\4-'9#,5]%
M6=56T^5==C,^P &BUFD<2B.E <-M8AJ!47RQI68^E\FIW!5+$U=7OIV\'KEJ
MP)L.Z?!Z V?A3K,,EA6I\ 6_1I+K\VJ6"1&+S)LP:^:JWL^P31\J2IX3F?D?
M*\,F(_S'/&L<S11[CM(0[J)[P !U!  (5[4$"FK<.",M$[-&'?:+!8$ @;.J
MM1)()6F(OBZ/(RP-MV^B6NG"K6&7I&Z#]>W43:OA)L2,FVB]?V06.*?!@_5
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MQ&@6B:_92)2G<2,+SQ1,H3NMTKJ7(*J2&<1;S0MFNP+\$:SP 9/V/M>YTG9
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M0EB$9C D#B2-7W4RJ+=E(Y](J"MV54D?L1D)(7$A*%3&Y7;88FE5@>.+(8<
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M9UO)ZVOAQ%8#EKWKZQ7*HRA<8M(!U4\3JA)49DU&*RXIB<(#3A3D0R4A)BV
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A-62;/   ]@   Z   4!F0*% "@ #H![_ *SR3XGDY__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>24
<FILENAME>amlx-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-13T16:49:55.2818+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="amlx-20221231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="amlx-20221231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="amlx-20221231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfComprehensiveLoss1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusiness1" xlink:href="amlx-20221231.xsd#DisclosureNatureOfBusiness1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="amlx-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet" xlink:href="amlx-20221231.xsd#DisclosureProductRevenueNet" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestments" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories" xlink:href="amlx-20221231.xsd#DisclosureInventories" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1" xlink:href="amlx-20221231.xsd#DisclosurePropertyAndEquipmentNet1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:href="amlx-20221231.xsd#Role_DisclosureAccruedExpenses" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotes" xlink:href="amlx-20221231.xsd#Role_DisclosureConvertibleNotes" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="amlx-20221231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases" xlink:href="amlx-20221231.xsd#Role_DisclosureLeases" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock" xlink:href="amlx-20221231.xsd#Role_DisclosureRedeemableConvertiblePreferredStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit" xlink:href="amlx-20221231.xsd#DisclosureStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan" xlink:href="amlx-20221231.xsd#Role_DisclosureStockOptionAndGrantPlan" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans" xlink:href="amlx-20221231.xsd#DisclosureEmployeeBenefitPlans" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="amlx-20221231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:href="amlx-20221231.xsd#Role_DisclosureRelatedPartyTransactions" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="amlx-20221231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="amlx-20221231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="amlx-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="amlx-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetTables" xlink:href="amlx-20221231.xsd#DisclosureProductRevenueNetTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestmentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesTables" xlink:href="amlx-20221231.xsd#DisclosureInventoriesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" xlink:href="amlx-20221231.xsd#DisclosurePropertyAndEquipmentNetTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:href="amlx-20221231.xsd#Role_DisclosureAccruedExpensesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="amlx-20221231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables" xlink:href="amlx-20221231.xsd#Role_DisclosureLeasesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables" xlink:href="amlx-20221231.xsd#Role_DisclosureRedeemableConvertiblePreferredStockTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables" xlink:href="amlx-20221231.xsd#DisclosureStockholdersEquityDeficitTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables" xlink:href="amlx-20221231.xsd#Role_DisclosureStockOptionAndGrantPlanTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="amlx-20221231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="amlx-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails" xlink:href="amlx-20221231.xsd#DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" xlink:href="amlx-20221231.xsd#DisclosureInventoriesSummaryOfInventoriesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureInventoriesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:href="amlx-20221231.xsd#DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureConvertibleNotesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="amlx-20221231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails" xlink:href="amlx-20221231.xsd#DisclosureLeasesComponentsOfLeaseExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails" xlink:href="amlx-20221231.xsd#DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:href="amlx-20221231.xsd#Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:href="amlx-20221231.xsd#DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureEmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredOfferingCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenuesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueNotFromContractWithCustomer" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingMember" xlink:label="amlx_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_15"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_16"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_17"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_18"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="amlx_FollowOnOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_15" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_16" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_17" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_18" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingMember" xlink:label="amlx_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="amlx_FollowOnOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" xlink:label="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" xlink:label="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromFollowOnOffering" xlink:label="amlx_ProceedsFromFollowOnOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" xlink:label="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_InitialPublicOfferingCostPaid" xlink:label="amlx_InitialPublicOfferingCostPaid"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingCostsPaid" xlink:label="amlx_FollowOnOfferingCostsPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" xlink:label="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" xlink:label="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MovementOfDeferredOfferingCostsToEquity" xlink:label="amlx_MovementOfDeferredOfferingCostsToEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" xlink:label="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" xlink:label="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" xlink:label="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PaymentOfDeferredOfferingCosts" xlink:label="amlx_PaymentOfDeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_ProceedsFromFollowOnOffering" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_InitialPublicOfferingCostPaid" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_FollowOnOfferingCostsPaid" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_MovementOfDeferredOfferingCostsToEquity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="amlx_PaymentOfDeferredOfferingCosts" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusiness1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock" xlink:label="us-gaap_InvestmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNotesTextBlock" xlink:label="amlx_ConvertibleNotesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="amlx_ConvertibleNotesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrantRevenuePolicyPolicyTextBlock" xlink:label="amlx_GrantRevenuePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock" xlink:label="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock" xlink:label="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SalesAndMarketingCostsPolicyPolicyTextblock" xlink:label="amlx_SalesAndMarketingCostsPolicyPolicyTextblock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PatentRelatedCostsPolicyPolicyTextBlock" xlink:label="amlx_PatentRelatedCostsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xlink:label="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_GrantRevenuePolicyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_SalesAndMarketingCostsPolicyPolicyTextblock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_PatentRelatedCostsPolicyPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrossProductRevnueToNetProductRevenueTableTextBlock" xlink:label="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" xlink:label="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AmortizationRecognizedPeriod" xlink:label="amlx_AmortizationRecognizedPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201811Member" xlink:label="us-gaap_AccountingStandardsUpdate201811Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CustomerOneMember" xlink:label="amlx_CustomerOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="us-gaap_UnderlyingAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="us-gaap_UnderlyingAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedDebtObligationsMember" xlink:label="us-gaap_CollateralizedDebtObligationsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromGrantors" xlink:label="us-gaap_ProceedsFromGrantors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CustomerTwoMember" xlink:label="amlx_CustomerTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedCreditCardSecuritiesMember" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CashAndCashEquivalentsMaturityDateDescription" xlink:label="amlx_CashAndCashEquivalentsMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncrementalCostsExpenses" xlink:label="amlx_IncrementalCostsExpenses"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GainContingencyRecordedAmount" xlink:label="amlx_GainContingencyRecordedAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="us-gaap_LossContingencyLossInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NumberOfCustomers" xlink:label="amlx_NumberOfCustomers"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredOfferingCostNetOfEquityFinancing" xlink:label="amlx_DeferredOfferingCostNetOfEquityFinancing"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_AmortizationRecognizedPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201811Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="amlx_CustomerOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedDebtObligationsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ProceedsFromGrantors" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="amlx_CustomerTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedCreditCardSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_CashAndCashEquivalentsMaturityDateDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_MajorCustomersAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_IncrementalCostsExpenses" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_GainContingencyRecordedAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_LossContingencyLossInPeriod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_NumberOfCustomers" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_DeferredOfferingCostNetOfEquityFinancing" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ComputerHardwareAndSoftwareMember" xlink:label="amlx_ComputerHardwareAndSoftwareMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="amlx_ComputerHardwareAndSoftwareMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" xlink:label="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrossToNetAdjustments" xlink:label="amlx_GrossToNetAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="amlx_GrossToNetAdjustments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AgencyBondsMember" xlink:label="amlx_AgencyBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:to="us-gaap_ShortTermInvestmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="amlx_AgencyBondsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" xlink:label="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:to="us-gaap_ShortTermInvestmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterials" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWorkInProcess" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FinishedGoodsMember" xlink:label="amlx_FinishedGoodsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTable" xlink:label="us-gaap_PublicUtilitiesInventoryTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryLineItems" xlink:label="us-gaap_PublicUtilitiesInventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_LongTermRawMaterialsNotYetRealized" xlink:label="amlx_LongTermRawMaterialsNotYetRealized"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="amlx_FinishedGoodsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_PublicUtilitiesInventoryTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTable" xlink:to="us-gaap_PublicUtilitiesInventoryLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="amlx_LongTermRawMaterialsNotYetRealized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ComputerHardwareAndSoftwareMember" xlink:label="amlx_ComputerHardwareAndSoftwareMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="amlx_ComputerHardwareAndSoftwareMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedExternalResearchAndDevelopmentCurrent" xlink:label="amlx_AccruedExternalResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedManufacturing" xlink:label="amlx_AccruedManufacturing"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedConsultingAndOtherProfessionalFess" xlink:label="amlx_AccruedConsultingAndOtherProfessionalFess"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RebatesAndOtherGrossToNetAdjustments" xlink:label="amlx_RebatesAndOtherGrossToNetAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyPayable" xlink:label="amlx_RoyaltyPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="amlx_AccruedExternalResearchAndDevelopmentCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="amlx_AccruedManufacturing" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="amlx_AccruedConsultingAndOtherProfessionalFess" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="amlx_RebatesAndOtherGrossToNetAdjustments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="amlx_RoyaltyPayable" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesMember" xlink:label="amlx_TwoThousandTwentyOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SpecialPurposeAcquisitionCorpMember" xlink:label="amlx_SpecialPurposeAcquisitionCorpMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" xlink:label="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" xlink:label="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfVotingSecurities" xlink:label="amlx_PercentageOfVotingSecurities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" xlink:label="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DilutedCapitalDividend" xlink:label="amlx_DilutedCapitalDividend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNotesSettlementDate" xlink:label="amlx_ConvertibleNotesSettlementDate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_OwnershipAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="amlx_SpecialPurposeAcquisitionCorpMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDescription" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_PercentageOfVotingSecurities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_DilutedCapitalDividend" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentIssuanceDate1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_ConvertibleNotesSettlementDate" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AgencyBondsMember" xlink:label="amlx_AgencyBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RestrictedCashEquivalentsMember" xlink:label="amlx_RestrictedCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RestrictedCashMember" xlink:label="amlx_RestrictedCashMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="amlx_AgencyBondsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="amlx_RestrictedCashEquivalentsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="amlx_RestrictedCashMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" xlink:label="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OtherAssetsFairValueDisclosure" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate" xlink:label="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoZeroTwoOneNotesMember" xlink:label="amlx_TwoZeroTwoOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoZeroOneSevenNotesMember" xlink:label="amlx_TwoZeroOneSevenNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromUnderwrittenPublicOffering" xlink:label="amlx_ProceedsFromUnderwrittenPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NonCumulativeDividendsPerShareEntitledToReceive" xlink:label="amlx_NonCumulativeDividendsPerShareEntitledToReceive"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" xlink:label="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="amlx_TwoZeroTwoOneNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="amlx_TwoZeroOneSevenNotesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_NotesPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="amlx_ProceedsFromUnderwrittenPublicOffering" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="amlx_NonCumulativeDividendsPerShareEntitledToReceive" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_DividendsPreferredStockCash" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockNumberOfVotingRights" xlink:label="amlx_CommonStockNumberOfVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends" xlink:label="us-gaap_Dividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="amlx_CommonStockNumberOfVotingRights" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_Dividends" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SaleOfStockPricePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockSharesIssuedAndOutstanding" xlink:label="amlx_CommonStockSharesIssuedAndOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockAuthorizedAndReservedForFutureIssuance" xlink:label="amlx_CommonStockAuthorizedAndReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnreservedCommonStockAvailableForFutureIssuance" xlink:label="amlx_UnreservedCommonStockAvailableForFutureIssuance"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="amlx_CommonStockSharesIssuedAndOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="amlx_CommonStockAuthorizedAndReservedForFutureIssuance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="amlx_UnreservedCommonStockAvailableForFutureIssuance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" xlink:label="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncentiveStockOptionsMember" xlink:label="amlx_IncentiveStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NonemployeeDirectorMember" xlink:label="amlx_NonemployeeDirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" xlink:label="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" xlink:label="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="amlx_IncentiveStockOptionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="amlx_NonemployeeDirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_18"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_18" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncomeTaxDisclosureTable" xlink:label="amlx_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncomeTaxDisclosureLineItems" xlink:label="amlx_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_OperatingLossCarryforwardsExpirationPeriod" xlink:label="amlx_OperatingLossCarryforwardsExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardDescription" xlink:label="us-gaap_TaxCreditCarryforwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" xlink:label="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="amlx_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureTable" xlink:to="amlx_IncomeTaxDisclosureLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="amlx_OperatingLossCarryforwardsExpirationPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardDescription" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsInventory" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" xlink:label="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusAxis" xlink:label="us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain" xlink:label="us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QualifiedPlanMember" xlink:label="us-gaap_QualifiedPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanTaxStatusAxis" xlink:to="us-gaap_RetirementPlanTaxStatusDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetirementPlanTaxStatusDomain" xlink:to="us-gaap_QualifiedPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_RetirementPlanTaxStatusAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MorningsideVenturesInvestmentsLimitedMember" xlink:label="amlx_MorningsideVenturesInvestmentsLimitedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesMember" xlink:label="amlx_TwoThousandTwentyOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="amlx_MorningsideVenturesInvestmentsLimitedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ConvertibleDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommitmentsAndContingenciesLineItems" xlink:label="amlx_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ALSAssociationAndALSFindingCureMember" xlink:label="amlx_ALSAssociationAndALSFindingCureMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommitmentsAndContingenciesTable" xlink:label="amlx_CommitmentsAndContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="us-gaap_UnderlyingAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="us-gaap_UnderlyingAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedDebtObligationsMember" xlink:label="us-gaap_CollateralizedDebtObligationsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" xlink:label="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedCreditCardSecuritiesMember" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NumberOfOperatingLeaseAgreements" xlink:label="amlx_NumberOfOperatingLeaseAgreements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromGrantors" xlink:label="us-gaap_ProceedsFromGrantors"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" xlink:label="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="amlx_ALSAssociationAndALSFindingCureMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_RoyaltyAgreementTermsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="amlx_CommitmentsAndContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedDebtObligationsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedCreditCardSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_NumberOfOperatingLeaseAgreements" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="amlx_CommitmentsAndContingenciesLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_ProceedsFromGrantors" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RoyaltyExpense" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>25
<FILENAME>amlx-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-13T16:49:55.3058+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="amlx-20221231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="amlx-20221231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails" xlink:href="amlx-20221231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureInventoriesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:href="amlx-20221231.xsd#DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureConvertibleNotesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="amlx-20221231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:href="amlx-20221231.xsd#DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails" xlink:href="amlx-20221231.xsd#DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureEmployeeBenefitPlansAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRentCreditNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingMember" xlink:label="amlx_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="amlx_FollowOnOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingMember" xlink:label="amlx_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="amlx_FollowOnOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AmortizationRecognizedPeriod" xlink:label="amlx_AmortizationRecognizedPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201811Member" xlink:label="us-gaap_AccountingStandardsUpdate201811Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CustomerOneMember" xlink:label="amlx_CustomerOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="us-gaap_UnderlyingAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="us-gaap_UnderlyingAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="us-gaap_UnderlyingAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedDebtObligationsMember" xlink:label="us-gaap_CollateralizedDebtObligationsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromGrantors" xlink:label="us-gaap_ProceedsFromGrantors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CustomerTwoMember" xlink:label="amlx_CustomerTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedCreditCardSecuritiesMember" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CashAndCashEquivalentsMaturityDateDescription" xlink:label="amlx_CashAndCashEquivalentsMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncrementalCostsExpenses" xlink:label="amlx_IncrementalCostsExpenses"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GainContingencyRecordedAmount" xlink:label="amlx_GainContingencyRecordedAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="us-gaap_LossContingencyLossInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NumberOfCustomers" xlink:label="amlx_NumberOfCustomers"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredOfferingCostNetOfEquityFinancing" xlink:label="amlx_DeferredOfferingCostNetOfEquityFinancing"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_AmortizationRecognizedPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201811Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="amlx_CustomerOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedDebtObligationsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ProceedsFromGrantors" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="amlx_CustomerTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedCreditCardSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_CashAndCashEquivalentsMaturityDateDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="srt_MajorCustomersAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_IncrementalCostsExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_GainContingencyRecordedAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_LossContingencyLossInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_NumberOfCustomers" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="amlx_DeferredOfferingCostNetOfEquityFinancing" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ComputerHardwareAndSoftwareMember" xlink:label="amlx_ComputerHardwareAndSoftwareMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="amlx_ComputerHardwareAndSoftwareMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AgencyBondsMember" xlink:label="amlx_AgencyBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:to="us-gaap_ShortTermInvestmentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="amlx_AgencyBondsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" xlink:label="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:to="us-gaap_ShortTermInvestmentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AssetImpairmentCharges" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryLineItems" xlink:label="us-gaap_PublicUtilitiesInventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTable" xlink:label="us-gaap_PublicUtilitiesInventoryTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FinishedGoodsMember" xlink:label="amlx_FinishedGoodsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_LongTermRawMaterialsNotYetRealized" xlink:label="amlx_LongTermRawMaterialsNotYetRealized"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="us-gaap_PublicUtilitiesInventoryTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="amlx_FinishedGoodsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PublicUtilitiesInventoryTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PublicUtilitiesInventoryTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="amlx_LongTermRawMaterialsNotYetRealized" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ComputerHardwareAndSoftwareMember" xlink:label="amlx_ComputerHardwareAndSoftwareMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="amlx_ComputerHardwareAndSoftwareMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesMember" xlink:label="amlx_TwoThousandTwentyOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SpecialPurposeAcquisitionCorpMember" xlink:label="amlx_SpecialPurposeAcquisitionCorpMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" xlink:label="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" xlink:label="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfVotingSecurities" xlink:label="amlx_PercentageOfVotingSecurities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" xlink:label="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DilutedCapitalDividend" xlink:label="amlx_DilutedCapitalDividend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNotesSettlementDate" xlink:label="amlx_ConvertibleNotesSettlementDate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_OwnershipAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="amlx_SpecialPurposeAcquisitionCorpMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_PercentageOfVotingSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_DilutedCapitalDividend" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentIssuanceDate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleNotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="amlx_ConvertibleNotesSettlementDate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AgencyBondsMember" xlink:label="amlx_AgencyBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RestrictedCashEquivalentsMember" xlink:label="amlx_RestrictedCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RestrictedCashMember" xlink:label="amlx_RestrictedCashMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="amlx_AgencyBondsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="amlx_RestrictedCashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="amlx_RestrictedCashMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" xlink:label="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OtherAssetsFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoZeroTwoOneNotesMember" xlink:label="amlx_TwoZeroTwoOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoZeroOneSevenNotesMember" xlink:label="amlx_TwoZeroOneSevenNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromUnderwrittenPublicOffering" xlink:label="amlx_ProceedsFromUnderwrittenPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NonCumulativeDividendsPerShareEntitledToReceive" xlink:label="amlx_NonCumulativeDividendsPerShareEntitledToReceive"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" xlink:label="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="amlx_TwoZeroTwoOneNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="amlx_TwoZeroOneSevenNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_NotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="amlx_ProceedsFromUnderwrittenPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="amlx_NonCumulativeDividendsPerShareEntitledToReceive" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_DividendsPreferredStockCash" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockSharesIssuedAndOutstanding" xlink:label="amlx_CommonStockSharesIssuedAndOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockAuthorizedAndReservedForFutureIssuance" xlink:label="amlx_CommonStockAuthorizedAndReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnreservedCommonStockAvailableForFutureIssuance" xlink:label="amlx_UnreservedCommonStockAvailableForFutureIssuance"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="amlx_CommonStockSharesIssuedAndOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="amlx_CommonStockAuthorizedAndReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="amlx_UnreservedCommonStockAvailableForFutureIssuance" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" xlink:label="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncentiveStockOptionsMember" xlink:label="amlx_IncentiveStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NonemployeeDirectorMember" xlink:label="amlx_NonemployeeDirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" xlink:label="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" xlink:label="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="amlx_IncentiveStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="amlx_NonemployeeDirectorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncomeTaxDisclosureLineItems" xlink:label="amlx_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncomeTaxDisclosureTable" xlink:label="amlx_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_OperatingLossCarryforwardsExpirationPeriod" xlink:label="amlx_OperatingLossCarryforwardsExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardDescription" xlink:label="us-gaap_TaxCreditCarryforwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" xlink:label="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="amlx_IncomeTaxDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="amlx_OperatingLossCarryforwardsExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusAxis" xlink:label="us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain" xlink:label="us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain" xlink:label="us-gaap_RetirementPlanTaxStatusDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QualifiedPlanMember" xlink:label="us-gaap_QualifiedPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RetirementPlanTaxStatusAxis" xlink:to="us-gaap_RetirementPlanTaxStatusDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RetirementPlanTaxStatusAxis" xlink:to="us-gaap_RetirementPlanTaxStatusDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RetirementPlanTaxStatusDomain" xlink:to="us-gaap_QualifiedPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_RetirementPlanTaxStatusAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MorningsideVenturesInvestmentsLimitedMember" xlink:label="amlx_MorningsideVenturesInvestmentsLimitedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesMember" xlink:label="amlx_TwoThousandTwentyOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="amlx_MorningsideVenturesInvestmentsLimitedMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="amlx_TwoThousandTwentyOneNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ConvertibleDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommitmentsAndContingenciesLineItems" xlink:label="amlx_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommitmentsAndContingenciesTable" xlink:label="amlx_CommitmentsAndContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ALSAssociationAndALSFindingCureMember" xlink:label="amlx_ALSAssociationAndALSFindingCureMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="us-gaap_UnderlyingAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="us-gaap_UnderlyingAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedDebtObligationsMember" xlink:label="us-gaap_CollateralizedDebtObligationsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" xlink:label="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedCreditCardSecuritiesMember" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NumberOfOperatingLeaseAgreements" xlink:label="amlx_NumberOfOperatingLeaseAgreements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromGrantors" xlink:label="us-gaap_ProceedsFromGrantors"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" xlink:label="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_CommitmentsAndContingenciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="amlx_ALSAssociationAndALSFindingCureMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_RoyaltyAgreementTermsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="us-gaap_UnderlyingAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedDebtObligationsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_CollateralizedCreditCardSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_NumberOfOperatingLeaseAgreements" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_ProceedsFromGrantors" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RoyaltyExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>26
<FILENAME>amlx-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-13T16:49:55.9310+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="amlx-20221231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2" xlink:href="amlx-20221231.xsd#DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3" xlink:href="amlx-20221231.xsd#DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfComprehensiveLoss1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="amlx-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails" xlink:href="amlx-20221231.xsd#DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" xlink:href="amlx-20221231.xsd#DisclosureInventoriesSummaryOfInventoriesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:href="amlx-20221231.xsd#DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="amlx-20221231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails" xlink:href="amlx-20221231.xsd#DisclosureLeasesComponentsOfLeaseExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails" xlink:href="amlx-20221231.xsd#DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:href="amlx-20221231.xsd#Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="amlx-20221231.xsd#DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRentCreditNoncurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DeferredOfferingCosts" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RevenueNotFromContractWithCustomer" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_ProceedsFromFollowOnOffering" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_FollowOnOfferingCostsPaid" order="3" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="3" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_InitialPublicOfferingCostPaid" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="5" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="6" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="7" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" order="8" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="8" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" order="9" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" order="9" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="amlx_PaymentOfDeferredOfferingCosts" order="10" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="10" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="11" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="12" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" order="13" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" order="14" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromFollowOnOffering" xlink:label="amlx_ProceedsFromFollowOnOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" xlink:label="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingCostsPaid" xlink:label="amlx_FollowOnOfferingCostsPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_InitialPublicOfferingCostPaid" xlink:label="amlx_InitialPublicOfferingCostPaid"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" xlink:label="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PaymentOfDeferredOfferingCosts" xlink:label="amlx_PaymentOfDeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" xlink:label="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" xlink:label="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="amlx_GrossToNetAdjustments" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrossToNetAdjustments" xlink:label="amlx_GrossToNetAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" xlink:label="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterials" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoods" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcess" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="amlx_AccruedExternalResearchAndDevelopmentCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="amlx_AccruedManufacturing" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="amlx_AccruedConsultingAndOtherProfessionalFess" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="amlx_RebatesAndOtherGrossToNetAdjustments" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="amlx_RoyaltyPayable" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="7" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedExternalResearchAndDevelopmentCurrent" xlink:label="amlx_AccruedExternalResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedManufacturing" xlink:label="amlx_AccruedManufacturing"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedConsultingAndOtherProfessionalFess" xlink:label="amlx_AccruedConsultingAndOtherProfessionalFess"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RebatesAndOtherGrossToNetAdjustments" xlink:label="amlx_RebatesAndOtherGrossToNetAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyPayable" xlink:label="amlx_RoyaltyPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="0" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsOther" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilities" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>27
<FILENAME>amlx-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-13T16:49:55.8051+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.amylyx.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:amlx="http://www.amylyx.com/20221231" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amlx-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amlx-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amlx-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amlx-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2" id="DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2">
        <link:definition>100020 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Detail) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3" id="DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3">
        <link:definition>100040 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Detail) 3</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="StatementConsolidatedStatementsOfOperations">
        <link:definition>100050 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1" id="StatementConsolidatedStatementsOfComprehensiveLoss1">
        <link:definition>100060 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" id="StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
        <link:definition>100070 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" id="StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
        <link:definition>100080 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100090 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusiness1" id="DisclosureNatureOfBusiness1">
        <link:definition>100100 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100110 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet" id="DisclosureProductRevenueNet">
        <link:definition>100120 - Disclosure - Product Revenue, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments" id="Role_DisclosureShortTermInvestments">
        <link:definition>100130 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories" id="DisclosureInventories">
        <link:definition>100140 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1" id="DisclosurePropertyAndEquipmentNet1">
        <link:definition>100150 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" id="Role_DisclosureAccruedExpenses">
        <link:definition>100160 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotes" id="Role_DisclosureConvertibleNotes">
        <link:definition>100170 - Disclosure - Convertible Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100180 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases" id="Role_DisclosureLeases">
        <link:definition>100190 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock" id="Role_DisclosureRedeemableConvertiblePreferredStock">
        <link:definition>100200 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit" id="DisclosureStockholdersEquityDeficit">
        <link:definition>100210 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan" id="Role_DisclosureStockOptionAndGrantPlan">
        <link:definition>100220 - Disclosure - Stock Option and Grant Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>100230 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans" id="DisclosureEmployeeBenefitPlans">
        <link:definition>100240 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100250 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" id="Role_DisclosureRelatedPartyTransactions">
        <link:definition>100260 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100270 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100280 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100290 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100300 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetTables" id="DisclosureProductRevenueNetTables">
        <link:definition>100310 - Disclosure - Product Revenue, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables" id="Role_DisclosureShortTermInvestmentsTables">
        <link:definition>100320 - Disclosure - Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesTables" id="DisclosureInventoriesTables">
        <link:definition>100330 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" id="DisclosurePropertyAndEquipmentNetTables">
        <link:definition>100340 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" id="Role_DisclosureAccruedExpensesTables">
        <link:definition>100350 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100360 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
        <link:definition>100370 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables" id="Role_DisclosureRedeemableConvertiblePreferredStockTables">
        <link:definition>100380 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables" id="DisclosureStockholdersEquityDeficitTables">
        <link:definition>100390 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables" id="Role_DisclosureStockOptionAndGrantPlanTables">
        <link:definition>100400 - Disclosure - Stock Option and Grant Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>100410 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100420 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" id="DisclosureNatureOfBusinessAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Nature of Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100440 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails">
        <link:definition>100450 - Disclosure - Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails" id="DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails">
        <link:definition>100460 - Disclosure - Product Revenue, Net - Summary of Gross Product Revenue to Net product Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails" id="Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails">
        <link:definition>100470 - Disclosure - Short-Term Investments - Schedule of Short-term Investments Classified as Available-for-sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" id="Role_DisclosureShortTermInvestmentsAdditionalInformationDetails">
        <link:definition>100480 - Disclosure - Short-Term Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails" id="DisclosureInventoriesSummaryOfInventoriesDetails">
        <link:definition>100490 - Disclosure - Inventories - Summary of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails" id="DisclosureInventoriesAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - Inventories - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails" id="DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails">
        <link:definition>100510 - Disclosure - Property and equipment, net - Summary of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" id="Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
        <link:definition>100520 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails" id="Role_DisclosureConvertibleNotesAdditionalInformationDetails">
        <link:definition>100530 - Disclosure - Convertible Notes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" id="Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
        <link:definition>100540 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" id="DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>100550 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" id="Role_DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100560 - Disclosure - Leases- Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails" id="DisclosureLeasesComponentsOfLeaseExpenseDetails">
        <link:definition>100570 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails" id="DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails">
        <link:definition>100580 - Disclosure - Leases - Summary of Condensed Consolidated Balance Sheet of Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail" id="Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail">
        <link:definition>100590 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>100600 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" id="Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails">
        <link:definition>100610 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails" id="DisclosureStockholdersEquityDeficitAdditionalInformationDetails">
        <link:definition>100620 - Disclosure - Stockholders' Equity (Deficit) - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails" id="DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails">
        <link:definition>100630 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails" id="Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails">
        <link:definition>100640 - Disclosure - Stock Option and Grant Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails" id="DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails">
        <link:definition>100650 - Disclosure - Stock Option and Grant Plan - Summary of Estimate Fair Value of Stock Option Awards on Grant Date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails" id="Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails">
        <link:definition>100660 - Disclosure - Stock Option and Grant Plan - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails" id="DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails">
        <link:definition>100670 - Disclosure - Stock Option and Grant Plan - Summary of Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails" id="DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails">
        <link:definition>100680 - Disclosure - Stock Option and Grant Plan - Summary of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails" id="DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails">
        <link:definition>100690 - Disclosure - Stock Option and Grant Plan - Summary of Stock-Based Compensation by Type of Award (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails" id="DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails">
        <link:definition>100700 - Disclosure - Stock Option and Grant Plan - Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails" id="DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails">
        <link:definition>100710 - Disclosure - Income Taxes - Components Of Net Loss Before Provision For Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails" id="DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails">
        <link:definition>100720 - Disclosure - Income Taxes - Schedule of Provision For Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100730 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails">
        <link:definition>100740 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>100750 - Disclosure - Income Taxes - Summary of Significant Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails" id="DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails">
        <link:definition>100760 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails">
        <link:definition>100770 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails" id="DisclosureEmployeeBenefitPlansAdditionalInformationDetails">
        <link:definition>100780 - Disclosure - Employee Benefit Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
        <link:definition>100790 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>100800 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails">
        <link:definition>100810 - Disclosure - Commitment and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="amlx_AccruedConsultingAndOtherProfessionalFess" name="AccruedConsultingAndOtherProfessionalFess" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_AccruedExternalResearchAndDevelopmentCurrent" name="AccruedExternalResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_AccruedManufacturing" name="AccruedManufacturing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_AmortizationRecognizedPeriod" name="AmortizationRecognizedPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" name="AvailableForSaleInvestmentsContractualMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_CashAndCashEquivalentsMaturityDateDescription" name="CashAndCashEquivalentsMaturityDateDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ChangeInFairValueOfConvertibleNotes" name="ChangeInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_CommonStockAuthorizedAndReservedForFutureIssuance" name="CommonStockAuthorizedAndReservedForFutureIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="amlx_CommonStockNumberOfVotingRights" name="CommonStockNumberOfVotingRights" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_CommonStockSharesIssuedAndOutstanding" name="CommonStockSharesIssuedAndOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" name="ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" name="ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_ConvertibleNotesSettlementDate" name="ConvertibleNotesSettlementDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_DeferredOfferingCostNetOfEquityFinancing" name="DeferredOfferingCostNetOfEquityFinancing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" name="DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" name="DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_DilutedCapitalDividend" name="DilutedCapitalDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" name="FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_FollowOnOfferingCostsPaid" name="FollowOnOfferingCostsPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_GainContingencyRecordedAmount" name="GainContingencyRecordedAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_GrossToNetAdjustments" name="GrossToNetAdjustments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" name="IncreaseDecreaseInAccruedExpensesAndDeferredRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" name="IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_IncrementalCostsExpenses" name="IncrementalCostsExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_InitialPublicOfferingCostPaid" name="InitialPublicOfferingCostPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" name="IssuanceCostsRelatedToConversionOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" name="IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_LongTermRawMaterialsNotYetRealized" name="LongTermRawMaterialsNotYetRealized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" name="MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_MovementOfDeferredOfferingCostsToEquity" name="MovementOfDeferredOfferingCostsToEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_NonCumulativeDividendsPerShareEntitledToReceive" name="NonCumulativeDividendsPerShareEntitledToReceive" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="amlx_NumberOfCustomers" name="NumberOfCustomers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_NumberOfOperatingLeaseAgreements" name="NumberOfOperatingLeaseAgreements" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate" name="OperatingLeaseWeightedAverageIncrementalBorrowingRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_OperatingLossCarryforwardsExpirationPeriod" name="OperatingLossCarryforwardsExpirationPeriod" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_PaymentOfDeferredOfferingCosts" name="PaymentOfDeferredOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" name="PercentageOfIncreaseInCommonStockReservedForIssuance" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" name="PercentageOfNonCumulativeDividendsEntitledToReceive" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" name="PercentageOfPriceOfferedToEachShareOfCommonStock" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_PercentageOfVotingSecurities" name="PercentageOfVotingSecurities" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ProceedsFromFollowOnOffering" name="ProceedsFromFollowOnOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" name="ProceedsFromIssuanceOfConvertibleNotesRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" name="ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_ProceedsFromUnderwrittenPublicOffering" name="ProceedsFromUnderwrittenPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" name="PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_RebatesAndOtherGrossToNetAdjustments" name="RebatesAndOtherGrossToNetAdjustments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" name="RevenueFromContractWithCustomerExcludingAssessedTaxGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" name="RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" name="RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" name="RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" name="RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" name="RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" name="RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_RoyaltyPayable" name="RoyaltyPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" name="TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" name="TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" name="TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" name="UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" name="UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="amlx_UnreservedCommonStockAvailableForFutureIssuance" name="UnreservedCommonStockAvailableForFutureIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="amlx_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_AgencyBondsMember" name="AgencyBondsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_ALSAssociationAndALSFindingCureMember" name="ALSAssociationAndALSFindingCureMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" name="AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_ComputerHardwareAndSoftwareMember" name="ComputerHardwareAndSoftwareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_CustomerOneMember" name="CustomerOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_CustomerTwoMember" name="CustomerTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_FinishedGoodsMember" name="FinishedGoodsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_FollowOnOfferingMember" name="FollowOnOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_IncentiveStockOptionsMember" name="IncentiveStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_MorningsideVenturesInvestmentsLimitedMember" name="MorningsideVenturesInvestmentsLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_NonemployeeDirectorMember" name="NonemployeeDirectorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_RestrictedCashEquivalentsMember" name="RestrictedCashEquivalentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_RestrictedCashMember" name="RestrictedCashMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_SeriesARedeemableConvertiblePreferredSharesMember" name="SeriesARedeemableConvertiblePreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" name="SeriesBRedeemableConvertiblePreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" name="SeriesC1RedeemableConvertiblePreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" name="SeriesC2RedeemableConvertiblePreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_SpecialPurposeAcquisitionCorpMember" name="SpecialPurposeAcquisitionCorpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" name="TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" name="TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" name="TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoThousandTwentyOneNotesMember" name="TwoThousandTwentyOneNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" name="TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoZeroOneSevenNotesMember" name="TwoZeroOneSevenNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_TwoZeroTwoOneNotesMember" name="TwoZeroTwoOneNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock" name="ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock" name="ConvertibleNoteDerivativePolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ConvertibleNotesTextBlock" name="ConvertibleNotesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" name="EmergingGrowthCompanyStatusPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_GrantRevenuePolicyPolicyTextBlock" name="GrantRevenuePolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock" name="GrossProductRevnueToNetProductRevenueTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" name="NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_PatentRelatedCostsPolicyPolicyTextBlock" name="PatentRelatedCostsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_SalesAndMarketingCostsPolicyPolicyTextblock" name="SalesAndMarketingCostsPolicyPolicyTextblock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" name="ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" name="SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>28
<FILENAME>amlx-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-13T16:49:58.0719+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingCostsPaid" xlink:label="amlx_FollowOnOfferingCostsPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesMember" xlink:label="amlx_TwoThousandTwentyOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RebatesAndOtherGrossToNetAdjustments" xlink:label="amlx_RebatesAndOtherGrossToNetAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate" xlink:label="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NumberOfOperatingLeaseAgreements" xlink:label="amlx_NumberOfOperatingLeaseAgreements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" xlink:label="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfVotingSecurities" xlink:label="amlx_PercentageOfVotingSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_OperatingLossCarryforwardsExpirationPeriod" xlink:label="amlx_OperatingLossCarryforwardsExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CashAndCashEquivalentsMaturityDateDescription" xlink:label="amlx_CashAndCashEquivalentsMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusAxis" xlink:label="us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncentiveStockOptionsMember" xlink:label="amlx_IncentiveStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" xlink:label="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" xlink:label="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockNumberOfVotingRights" xlink:label="amlx_CommonStockNumberOfVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MorningsideVenturesInvestmentsLimitedMember" xlink:label="amlx_MorningsideVenturesInvestmentsLimitedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" xlink:label="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommitmentsAndContingenciesLineItems" xlink:label="amlx_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" xlink:label="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" xlink:label="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SpecialPurposeAcquisitionCorpMember" xlink:label="amlx_SpecialPurposeAcquisitionCorpMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingMember" xlink:label="amlx_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer" xlink:label="us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoZeroTwoOneNotesMember" xlink:label="amlx_TwoZeroTwoOneNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoZeroOneSevenNotesMember" xlink:label="amlx_TwoZeroOneSevenNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xlink:label="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AmortizationRecognizedPeriod" xlink:label="amlx_AmortizationRecognizedPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" xlink:label="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends" xlink:label="us-gaap_Dividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromFollowOnOffering" xlink:label="amlx_ProceedsFromFollowOnOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DilutedCapitalDividend" xlink:label="amlx_DilutedCapitalDividend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" xlink:label="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockSharesIssuedAndOutstanding" xlink:label="amlx_CommonStockSharesIssuedAndOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NonCumulativeDividendsPerShareEntitledToReceive" xlink:label="amlx_NonCumulativeDividendsPerShareEntitledToReceive"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedExternalResearchAndDevelopmentCurrent" xlink:label="amlx_AccruedExternalResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNotesTextBlock" xlink:label="amlx_ConvertibleNotesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrantRevenuePolicyPolicyTextBlock" xlink:label="amlx_GrantRevenuePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GainContingencyRecordedAmount" xlink:label="amlx_GainContingencyRecordedAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ALSAssociationAndALSFindingCureMember" xlink:label="amlx_ALSAssociationAndALSFindingCureMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_MovementOfDeferredOfferingCostsToEquity" xlink:label="amlx_MovementOfDeferredOfferingCostsToEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrossToNetAdjustments" xlink:label="amlx_GrossToNetAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyPayable" xlink:label="amlx_RoyaltyPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" xlink:label="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommitmentsAndContingenciesTable" xlink:label="amlx_CommitmentsAndContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_LongTermRawMaterialsNotYetRealized" xlink:label="amlx_LongTermRawMaterialsNotYetRealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardDescription" xlink:label="us-gaap_TaxCreditCarryforwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" xlink:label="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NumberOfCustomers" xlink:label="amlx_NumberOfCustomers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" xlink:label="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1" xlink:label="us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FinishedGoodsMember" xlink:label="amlx_FinishedGoodsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock" xlink:label="us-gaap_InvestmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncomeTaxDisclosureLineItems" xlink:label="amlx_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NonemployeeDirectorMember" xlink:label="amlx_NonemployeeDirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" xlink:label="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromGrantors" xlink:label="us-gaap_ProceedsFromGrantors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedConsultingAndOtherProfessionalFess" xlink:label="amlx_AccruedConsultingAndOtherProfessionalFess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AgencyBondsMember" xlink:label="amlx_AgencyBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock" xlink:label="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ComputerHardwareAndSoftwareMember" xlink:label="amlx_ComputerHardwareAndSoftwareMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" xlink:label="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" xlink:label="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SalesAndMarketingCostsPolicyPolicyTextblock" xlink:label="amlx_SalesAndMarketingCostsPolicyPolicyTextblock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CustomerOneMember" xlink:label="amlx_CustomerOneMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ChangeInFairValueOfConvertibleNotes" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201811Member" xlink:label="us-gaap_AccountingStandardsUpdate201811Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:label="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_GrossProductRevnueToNetProductRevenueTableTextBlock" xlink:label="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedCreditCardSecuritiesMember" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_InitialPublicOfferingCostPaid" xlink:label="amlx_InitialPublicOfferingCostPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" xlink:label="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" xlink:label="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CommonStockAuthorizedAndReservedForFutureIssuance" xlink:label="amlx_CommonStockAuthorizedAndReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_UnreservedCommonStockAvailableForFutureIssuance" xlink:label="amlx_UnreservedCommonStockAvailableForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_DeferredOfferingCostNetOfEquityFinancing" xlink:label="amlx_DeferredOfferingCostNetOfEquityFinancing"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyAgreementTermsMember" xlink:label="us-gaap_RoyaltyAgreementTermsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" xlink:label="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" xlink:label="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PaymentOfDeferredOfferingCosts" xlink:label="amlx_PaymentOfDeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RestrictedCashMember" xlink:label="amlx_RestrictedCashMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncomeTaxDisclosureTable" xlink:label="amlx_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" xlink:label="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromUnderwrittenPublicOffering" xlink:label="amlx_ProceedsFromUnderwrittenPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AccruedManufacturing" xlink:label="amlx_AccruedManufacturing"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="us-gaap_LossContingencyLossInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTable" xlink:label="us-gaap_PublicUtilitiesInventoryTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassAxis" xlink:label="us-gaap_UnderlyingAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" xlink:label="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" xlink:label="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncrementalCostsExpenses" xlink:label="amlx_IncrementalCostsExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnderlyingAssetClassDomain" xlink:label="us-gaap_UnderlyingAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryLineItems" xlink:label="us-gaap_PublicUtilitiesInventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" xlink:label="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollateralizedDebtObligationsMember" xlink:label="us-gaap_CollateralizedDebtObligationsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RestrictedCashEquivalentsMember" xlink:label="amlx_RestrictedCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" xlink:label="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTaxStatusDomain" xlink:label="us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNotesSettlementDate" xlink:label="amlx_ConvertibleNotesSettlementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock" xlink:label="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QualifiedPlanMember" xlink:label="us-gaap_QualifiedPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:label="us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_PatentRelatedCostsPolicyPolicyTextBlock" xlink:label="amlx_PatentRelatedCostsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="amlx-20221231.xsd#amlx_CustomerTwoMember" xlink:label="amlx_CustomerTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingCostsPaid_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Follow-on offering costs paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingCostsPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Follow On Offering Costs Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingCostsPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Follow-on offering costs paid.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty one notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon initial public offering and follow-on offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows provided by financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RebatesAndOtherGrossToNetAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rebates and other GTN adjustments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RebatesAndOtherGrossToNetAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rebates and Other Gross To Net adjustments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RebatesAndOtherGrossToNetAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rebates and other gross to net adjustments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes payable to related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Convertible Notes Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fair value of stock options vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Sales [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease weighted average incremental borrowing rate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Incremental Borrowing Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average incremental borrowing rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NumberOfOperatingLeaseAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of operating lease agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NumberOfOperatingLeaseAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Lease Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NumberOfOperatingLeaseAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating lease agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income (loss) per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of unrecognized stock-based compensation expense and weighted-average recognition period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Unrecognized Stock Based Compensation Expense And Weighted Average Recognition Period Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, cash payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity values conversion of preferred stock into common stock upon initial public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Values Conversion Of Preferred Stock Into Common Stock Upon Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity Conversion of preferred stock into common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of preferred stock into common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of preferred stock into common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock available for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Grant Date Fair Value, Nonvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Grant Date Fair Value, Nonvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature of Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfVotingSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of voting securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfVotingSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Voting Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfVotingSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of voting securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_OperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_OperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_OperatingLossCarryforwardsExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards, expiration period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CashAndCashEquivalentsMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity days for highly liquid investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CashAndCashEquivalentsMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Maturity Date Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CashAndCashEquivalentsMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash and cash equivalents maturity date description.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award options unvested intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Options unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetirementPlanTaxStatusAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Plan Tax Status [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incentive stock options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incentive Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncentiveStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ISOs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll and employee related expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Reserved for the Exercise of Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, redeemable convertible preferred stock and stockholders'equity (deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible debt outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Convertible Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right of use assets and liabilities upon ASC 842 adoption.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Assets And Liabilities Upon ASC 842 Adoption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets and liabilities upon ASC842 adoption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Raw Materials, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of increase in common stock reserved for issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Increase In Common Stock Reserved For Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of increase in common stock reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockNumberOfVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock number of voting rights.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockNumberOfVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Number Of Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockNumberOfVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Voting rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other assets measured at fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due, Next 12 Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements, Recurring</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MorningsideVenturesInvestmentsLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Morningside ventures investments limited.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MorningsideVenturesInvestmentsLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Morningside Ventures Investments Limited [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MorningsideVenturesInvestmentsLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Morningside Ventures Investments Limited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryAndGovernmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Treasury notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryAndGovernmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury and Government [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Provision For Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance or Sale of Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance or Sale of Equity, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty one notes in December two thousand twenty.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Notes In December Two Thousand Twenty [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Notes in December 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Financing Receivable, Type of Borrower [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of Series C-1 redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchases of property and equipment included in accounts payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchases of property and equipment included in accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of property and equipment included in accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares used in computing net loss per share attributable to common stockholders-basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment and proceeds from PPP loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Repayments Of Paycheck Protection Program Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from repayments of paycheck protection program loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Cancelled or forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees, Commitments, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate royalty amount payable to grantor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction In progress</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Construction in Progress [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average grant date fair value of stock options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average grant-date fair value of options granted during the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, renewal term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SpecialPurposeAcquisitionCorpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Special purpose acquisition corp.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SpecialPurposeAcquisitionCorpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Special Purpose acquisition Corp [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SpecialPurposeAcquisitionCorpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Special Purpose acquisition Corp</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Follow-on Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Follow on Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Follow-on offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueNotFromContractWithCustomer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Not from Contract with Customer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueNotFromContractWithCustomer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoZeroTwoOneNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two zero two one notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoZeroTwoOneNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Zero Two One Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoZeroTwoOneNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoZeroOneSevenNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two zero one seven notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoZeroOneSevenNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Zero One Seven Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoZeroOneSevenNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2017 Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Emerging Growth Company Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Emerging Growth Company Status Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Emerging Growth Company Status Policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock into common stock upon initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of preferred stock into common stock upon initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AmortizationRecognizedPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization recognized period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AmortizationRecognizedPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Recognized Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AmortizationRecognizedPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization period recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of convertible notes and accrued interest into redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Convertible Notes And Accrued Interest Into Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible notes and accrued interest into redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share attributable to common stockholders -diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of underlying common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Dividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Dividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Dividends_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Dividends, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Goods and Services Sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cost of Goods and Services Sold, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Valuation allowance at end of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Valuation allowance at beginning of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, $0.0001 par value; 10,000,000 and 0 shares authorized as of December 31, 2022 and 2021, respectively; 0 shares issued or outstanding as of December 31, 2022 and 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred offering costs included in accounts payable and accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs Included In Accounts Payable And Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs included in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Compensation to be paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Expensed and Capitalized, Amount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromFollowOnOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from follow-on offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromFollowOnOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Follow On Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromFollowOnOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from follow-on offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DilutedCapitalDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Diluted capital dividend.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DilutedCapitalDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Diluted Capital Dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DilutedCapitalDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted capital dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes including accrued interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other liabilities measured at fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum royalty guarantees commitments amount payable to each grantor.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Royalty Guarantees Commitments Amount Payable To Each Grantor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum Royalty amount payable to each grantor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A redeemable convertible preferred share.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Redeemable Convertible Preferred Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Redeemable Convertible Preferred Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesARedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty guarantees commitments annual installment payment, percentage of net sales of products developed under project.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees Commitments Annual Installment Payment Percentage Of Net Sales Of Products Developed Under Project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of net sales of products developed under projects</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award options unvested weighted average remaining contractual term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Remaining Contractual Term (in years), Options unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds received in advance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">EMPLOYEE BENEFIT PLANS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockSharesIssuedAndOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock shares issued and outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockSharesIssuedAndOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued And Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockSharesIssuedAndOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued and outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Benchmark</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Benchmark [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Lease Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Ownership Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of stockholding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Remaining Contractual Term (in years), Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NonCumulativeDividendsPerShareEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cumulative dividends per share entitled to receive.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NonCumulativeDividendsPerShareEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Cumulative Dividends Per Share Entitled To Receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NonCumulativeDividendsPerShareEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cumulative Dividends per share entitled to receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedExternalResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued external research and development.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedExternalResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued External Research And Development Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedExternalResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">External research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNotesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNotesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNotesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Summary of Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Revenue, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrantRevenuePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrantRevenuePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Revenue Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrantRevenuePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Grant revenue policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GainContingencyRecordedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain contingency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GainContingencyRecordedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Contingency Recorded Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GainContingencyRecordedAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain contingency recorded amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ALSAssociationAndALSFindingCureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ALS Association and ALS Finding a Cure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ALSAssociationAndALSFindingCureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A L S Association And A L S Finding Cure [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ALSAssociationAndALSFindingCureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ALS Association and ALS Finding a Cure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MovementOfDeferredOfferingCostsToEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Movement of deferred offering costs to equity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MovementOfDeferredOfferingCostsToEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Movement of Deferred Offering Costs To Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_MovementOfDeferredOfferingCostsToEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Movement of deferred offering costs to equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Fair Value Disclosures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrossToNetAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">GTN adjustments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrossToNetAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross to Net Adjustments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrossToNetAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross to net adjustments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares used in computing net loss per share attributable to common stockholders-diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Debt Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional common stock issued to holders of redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock Issuable Upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized compensation expense related to stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Commercial paper</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash equivalents, end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash equivalents, beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of price offered to each share of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Price Offered To Each Share Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of price offered to each share of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity shares conversion of preferred stock into common stock upon initial public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Shares Conversion Of Preferred Stock Into Common Stock Upon Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock into common stock upon initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of preferred stock into common stock upon initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty guarantees commitments percentage of annual net sales of products commercialized from project.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees Commitments Percentage Of Annual Net Sales Of Products Commercialized From Project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of annual net sales of products commercialized from project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty guarantees commitments percentage of grant received payable to each guarantor.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees Commitments Percentage Of Grant Received Payable To Each Guarantor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of grant received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon initial public offering and follow-on offering, net of issuance costs, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_LongTermRawMaterialsNotYetRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term raw materials not yet realized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_LongTermRawMaterialsNotYetRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Raw Materials Not Yet Realized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_LongTermRawMaterialsNotYetRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term raw materials not yet realized.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Twenty One Notes in January and February Two Thousand Twenty One.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Notes In January And February Two Thousand Twenty One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Notes in January and February 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NumberOfCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Customers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NumberOfCustomers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of customers.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Cancelled or forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes secured and carried interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Options unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of preferred stock to common stock upon initial public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentIssuanceDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Issuance Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentIssuanceDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, inception date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other comprehensive (loss) income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Rent Credit, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. - State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FinishedGoodsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finished goods.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FinishedGoodsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finished Goods [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FinishedGoodsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished Goods</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Impairment Charges</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charges</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Asset Impairment Charges, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity (Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity (deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NonemployeeDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nonemployee director.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NonemployeeDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonemployee Director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NonemployeeDirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonemployee Director</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted shares forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 300,000,000 and 56,500,000 shares authorized as of December 31, 2022 and 2021, respectively; 66,512,011 and 7,020,487 shares issued and outstanding as of December 31, 2022 and 2021, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increases (decreases) related to tax positions taken during prior years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrecognized tax benefits increase decrease resulting from prior period tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromGrantors_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding received from grantors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromGrantors_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Grantors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedConsultingAndOtherProfessionalFess_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued consulting and other professional fess.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedConsultingAndOtherProfessionalFess_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Consulting And Other Professional Fess</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedConsultingAndOtherProfessionalFess_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued consulting and other professional fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AgencyBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency Bonds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AgencyBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agency Bonds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AgencyBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agency bonds.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. - Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Condensed Consolidated Balance Sheet of Operating Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Note - Derivative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Note Derivative Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible Note Derivative Policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ComputerHardwareAndSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Hardware and Software</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ComputerHardwareAndSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Hardware And Software [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ComputerHardwareAndSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Computer hardware and software</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and accrued interest-related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Interests DueTo Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in accrued Interests due to related parties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized tax benefits, related to tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrecognized tax benefits, related to tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued and sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares sale in underwritten public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Short term investments held</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets measured at fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Net Loss Before Provision for Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment loss of long lived assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SalesAndMarketingCostsPolicyPolicyTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and Marketing Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SalesAndMarketingCostsPolicyPolicyTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales And Marketing Costs Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SalesAndMarketingCostsPolicyPolicyTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales and marketing costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type of Borrower [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non - U.S.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive (loss) income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CustomerOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer One.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in fair value of convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of Measurement dates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of convertible notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201811Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2018-11 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201811Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASC 842</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use liabilities, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized research and development costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred tax assets capitalized research and development costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets capitalized research and development costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Probability Weighted Valuation Model Used to Value Derivative Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Gross Product Revenue to Net Product Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Product Revnue To Net Product Revenue [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross product revenue to net product revenue.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currency translation adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities measured at fairvalue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimate Fair Value of Stock Option Awards on Grant Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes mature date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total revenues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collateralized Credit Card Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollateralizedCreditCardSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collateral for Corporate Credit Card Program</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity By Class Of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_InitialPublicOfferingCostPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial public offering cost paid.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_InitialPublicOfferingCostPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering Cost Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_InitialPublicOfferingCostPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial public offering costs paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_InitialPublicOfferingCostPaid_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Initial public offering costs paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company received net proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds of sale in underwritten public offering common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C-2 redeemable convertible preferred shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C2 Redeemable Convertible Preferred Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C-2 Redeemable Convertible Preferred Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series C-2 Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Product revenue, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product revenue, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income before income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss before income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product revenue, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue from contract with customer, excluding assessed tax, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty guarantees commitments, percentage of all royalties and cash proceeds from revenue generating transaction associated with project.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees Commitments Percentage Of All Royalties And Cash Proceeds From Revenue Generating Transaction Associated With Project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of all royalties and cash proceeds from revenue generating transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fifteen stock option and restricted stock plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fifteen Stock Option And Restricted Stock Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2015 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash, cash equivalents and restricted cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockAuthorizedAndReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock authorized and reserved for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockAuthorizedAndReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Authorized And Reserved For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CommonStockAuthorizedAndReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total common stock authorized and reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Inventories, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Follow-on offering costs included in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Follow On Offering Costs Included In Accounts Payable and Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Follow-on offering costs included in accounts payable and accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends, Preferred Stock, Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash dividend declared or paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnreservedCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unreserved common stock available for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnreservedCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unreserved Common Stock Available For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_UnreservedCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unreserved common stock available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant change in unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Change in Unrecognized Tax Benefits, Nature of Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredOfferingCostNetOfEquityFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering cost net of equity financing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredOfferingCostNetOfEquityFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Cost Net Of Equity Financing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_DeferredOfferingCostNetOfEquityFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred offering cost net of equity financing.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average Recognition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average recognition period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Remaining Contractual Term (in years), Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive (loss) income:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Unit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Reserved for the Unvested Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Future Minimum Lease Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Unit Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Adopted Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivable [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares, outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Work in Process, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Work in process</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization (accretion) of investment premiums (discounts)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows used in investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 18)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares, issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of common stock for sale in underwritten public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyAgreementTermsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Agreement Terms [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyAgreementTermsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty Payments Agreements with Grantors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of non-cumulative dividends entitled to receive.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Non Cumulative Dividends Entitled To Receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of non-cumulative dividends entitled to receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Treasury Bills</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available-for-sale investments contractual maturity period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Investments Contractual Maturity Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale investments contractual maturity period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible notes , net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Options unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of common stock reserved for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' deficit:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income tax benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-U.S.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PaymentOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of deferred offering costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PaymentOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PaymentOfDeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Payment of deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total undiscounted lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, term of contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increases recorded to income tax provision</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-term Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease right-of-use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Changes in Derivative Liabilities and 2021 Notes with Significant Unobservable Inputs (Level 3)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends declared</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, subject to expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty two stock option and incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Two Stock Option And Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option and Grant Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted-Average Exercise Price, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted-Average Exercise Price, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromUnderwrittenPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from underwritten public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromUnderwrittenPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Underwritten Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromUnderwrittenPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from underwritten public offering net of underwriting discount and commissions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedManufacturing_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedManufacturing_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Manufacturing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AccruedManufacturing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued manufacturing.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Loss in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PublicUtilitiesInventoryTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Utilities, Inventory [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C-1 redeemable convertible preferred shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C1 Redeemable Convertible Preferred Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C-1 Redeemable Convertible Preferred Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series C-1 Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective income tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnderlyingAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underlying Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnderlyingAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underlying Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of convertible notes, related parties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Convertible Notes Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible notes&#8212;related parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of investment securities transferred between classification levels</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transfer Of Levels Of Investment Securities Fair Value Assets Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Transfer of levels of investment securities fair value assets description.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">U.S. Statutory federal income tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax at U.S. statutory tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at beginning of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncrementalCostsExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incremental costs expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncrementalCostsExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Costs Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncrementalCostsExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental costs expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnderlyingAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underlying Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnderlyingAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underlying Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options and restricted stock units vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PublicUtilitiesInventoryLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Utilities, Inventory [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued expenses and deferred rent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Expenses And Deferred Rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and deferred rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Liquidation Preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, liquidation preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New accounting pronouncements not yet adopted policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Not Yet Adopted Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, General and Administrative Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of shares, Nonvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of shares, Nonvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollateralizedDebtObligationsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collateralized Debt Obligations [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollateralizedDebtObligationsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collateral for Letter of Credit Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Options, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Options, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RestrictedCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RestrictedCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RestrictedCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash equivalents.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share attributable to common stockholders -basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity issue price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate convertible notes issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Reserved for Future Issuance of Share-based Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Voting percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Percentage of voting securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Alzheimers Drug Discovery Foundation, Alzheimers Association, and Cure Alzheimers Fund.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Alzheimers Drug Discovery Foundation Alzheimers Association And Cure Alzheimers Fund [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Alzheimer's Drug Discovery Foundation, the Alzheimer's Association, and Cure Alzheimer's Fund</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetirementPlanTaxStatusDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Plan Tax Status [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNotesSettlementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible notes settlement date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNotesSettlementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes Settlement Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNotesSettlementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes settlement date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Massachusetts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MASSACHUSETTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increases related to tax positions taken during the prior years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B redeemable convertible preferred shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Redeemable Convertible Preferred Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Redeemable Convertible Preferred Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_SeriesBRedeemableConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of contribution made by the company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Note - Beneficial Conversion Feature</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Note Beneficial Conversion Feature Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible note beneficial conversion feature policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty guarantees commitments, percentage of cash proceeds from revenue generating transaction under project.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Guarantees Commitments Percentage Of Cash Proceeds From Revenue Generating Transaction Under Project</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of cash proceeds from revenue generating transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_QualifiedPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Qualified Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_QualifiedPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Qualified Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest or penalties related to uncertain tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customers accounted for more than 10%</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Convertible, Conversion Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock conversion price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Temporary equity conversion price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted shares vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory, Finished Goods, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Inventory</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employer contribution percentage of employee compensation to employees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Estimated Useful Lives of Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Estimated Useful Lives of Property and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of estimated useful lives of property and equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance costs related to issuance of Series C-1 redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs related to issuance of Series C-1 redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Costs Related To Issuance Of Series Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance costs related to issuance of Series redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of Options, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Options, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Inventories</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation by Type of Award</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of Options, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs related to conversion of convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance costs related to conversion of convertible notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Costs Related To Conversion Of Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Issuance costs related to conversion of convertible notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inventory [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PatentRelatedCostsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent-Related Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PatentRelatedCostsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Related Costs Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_PatentRelatedCostsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent Related Costs Policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Short-term Investments Classified as Available-for-sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Selling, General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Other Operating Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Board of Director</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, stated par value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock into common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of preferred stock into common stock upon initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain (Loss) on Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrealized Gain (Loss) on Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized loss on short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted shares granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CustomerTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CustomerTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="amlx_CustomerTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Inventory acquired expensed as research and development expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total excluded common stock equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_FollowOnOfferingCostsPaid" xlink:to="amlx_FollowOnOfferingCostsPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoThousandTwentyOneNotesMember" xlink:to="amlx_TwoThousandTwentyOneNotesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RebatesAndOtherGrossToNetAdjustments" xlink:to="amlx_RebatesAndOtherGrossToNetAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate" xlink:to="amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_NumberOfOperatingLeaseAgreements" xlink:to="amlx_NumberOfOperatingLeaseAgreements_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock" xlink:to="amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:to="amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PercentageOfVotingSecurities" xlink:to="amlx_PercentageOfVotingSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_OperatingLossCarryforwardsExpirationPeriod" xlink:to="amlx_OperatingLossCarryforwardsExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CashAndCashEquivalentsMaturityDateDescription" xlink:to="amlx_CashAndCashEquivalentsMaturityDateDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue" xlink:to="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanTaxStatusAxis" xlink:to="us-gaap_RetirementPlanTaxStatusAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncentiveStockOptionsMember" xlink:to="amlx_IncentiveStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption" xlink:to="amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance" xlink:to="amlx_PercentageOfIncreaseInCommonStockReservedForIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CommonStockNumberOfVotingRights" xlink:to="amlx_CommonStockNumberOfVotingRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsFairValueDisclosure" xlink:to="us-gaap_OtherAssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_MorningsideVenturesInvestmentsLimitedMember" xlink:to="amlx_MorningsideVenturesInvestmentsLimitedMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryAndGovernmentMember" xlink:to="us-gaap_USTreasuryAndGovernmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember" xlink:to="amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CommitmentsAndContingenciesLineItems" xlink:to="amlx_CommitmentsAndContingenciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable" xlink:to="amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan" xlink:to="amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SpecialPurposeAcquisitionCorpMember" xlink:to="amlx_SpecialPurposeAcquisitionCorpMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_FollowOnOfferingMember" xlink:to="amlx_FollowOnOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueNotFromContractWithCustomer" xlink:to="us-gaap_RevenueNotFromContractWithCustomer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoZeroTwoOneNotesMember" xlink:to="amlx_TwoZeroTwoOneNotesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoZeroOneSevenNotesMember" xlink:to="amlx_TwoZeroOneSevenNotesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock" xlink:to="amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AmortizationRecognizedPeriod" xlink:to="amlx_AmortizationRecognizedPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock" xlink:to="amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:to="amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ProceedsFromFollowOnOffering" xlink:to="amlx_ProceedsFromFollowOnOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_DilutedCapitalDividend" xlink:to="amlx_DilutedCapitalDividend_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor" xlink:to="amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SeriesARedeemableConvertiblePreferredSharesMember" xlink:to="amlx_SeriesARedeemableConvertiblePreferredSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject" xlink:to="amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm" xlink:to="amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CommonStockSharesIssuedAndOutstanding" xlink:to="amlx_CommonStockSharesIssuedAndOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_NonCumulativeDividendsPerShareEntitledToReceive" xlink:to="amlx_NonCumulativeDividendsPerShareEntitledToReceive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AccruedExternalResearchAndDevelopmentCurrent" xlink:to="amlx_AccruedExternalResearchAndDevelopmentCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ConvertibleNotesTextBlock" xlink:to="amlx_ConvertibleNotesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_GrantRevenuePolicyPolicyTextBlock" xlink:to="amlx_GrantRevenuePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_GainContingencyRecordedAmount" xlink:to="amlx_GainContingencyRecordedAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ALSAssociationAndALSFindingCureMember" xlink:to="amlx_ALSAssociationAndALSFindingCureMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_MovementOfDeferredOfferingCostsToEquity" xlink:to="amlx_MovementOfDeferredOfferingCostsToEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_GrossToNetAdjustments" xlink:to="amlx_GrossToNetAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RoyaltyPayable" xlink:to="amlx_RoyaltyPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock" xlink:to="amlx_PercentageOfPriceOfferedToEachShareOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering" xlink:to="amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CommitmentsAndContingenciesTable" xlink:to="amlx_CommitmentsAndContingenciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_LongTermRawMaterialsNotYetRealized" xlink:to="amlx_LongTermRawMaterialsNotYetRealized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardDescription" xlink:to="us-gaap_TaxCreditCarryforwardDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember" xlink:to="amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_NumberOfCustomers" xlink:to="amlx_NumberOfCustomers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering" xlink:to="amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuanceDate1" xlink:to="us-gaap_DebtInstrumentIssuanceDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_FinishedGoodsMember" xlink:to="amlx_FinishedGoodsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncomeTaxDisclosureLineItems" xlink:to="amlx_IncomeTaxDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_NonemployeeDirectorMember" xlink:to="amlx_NonemployeeDirectorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions" xlink:to="amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromGrantors" xlink:to="us-gaap_ProceedsFromGrantors_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AccruedConsultingAndOtherProfessionalFess" xlink:to="amlx_AccruedConsultingAndOtherProfessionalFess_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AgencyBondsMember" xlink:to="amlx_AgencyBondsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock" xlink:to="amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ComputerHardwareAndSoftwareMember" xlink:to="amlx_ComputerHardwareAndSoftwareMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties" xlink:to="amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards" xlink:to="amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SalesAndMarketingCostsPolicyPolicyTextblock" xlink:to="amlx_SalesAndMarketingCostsPolicyPolicyTextblock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis" xlink:to="us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CustomerOneMember" xlink:to="amlx_CustomerOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ChangeInFairValueOfConvertibleNotes" xlink:to="amlx_ChangeInFairValueOfConvertibleNotes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201811Member" xlink:to="us-gaap_AccountingStandardsUpdate201811Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts" xlink:to="amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock" xlink:to="amlx_GrossProductRevnueToNetProductRevenueTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollateralizedCreditCardSecuritiesMember" xlink:to="us-gaap_CollateralizedCreditCardSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_InitialPublicOfferingCostPaid" xlink:to="amlx_InitialPublicOfferingCostPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember" xlink:to="amlx_SeriesC2RedeemableConvertiblePreferredSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross" xlink:to="amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember" xlink:to="amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CommonStockAuthorizedAndReservedForFutureIssuance" xlink:to="amlx_CommonStockAuthorizedAndReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:to="amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_UnreservedCommonStockAvailableForFutureIssuance" xlink:to="amlx_UnreservedCommonStockAvailableForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_DeferredOfferingCostNetOfEquityFinancing" xlink:to="amlx_DeferredOfferingCostNetOfEquityFinancing_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyAgreementTermsMember" xlink:to="us-gaap_RoyaltyAgreementTermsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive" xlink:to="amlx_PercentageOfNonCumulativeDividendsEntitledToReceive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod" xlink:to="amlx_AvailableForSaleInvestmentsContractualMaturityPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PaymentOfDeferredOfferingCosts" xlink:to="amlx_PaymentOfDeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RestrictedCashMember" xlink:to="amlx_RestrictedCashMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncomeTaxDisclosureTable" xlink:to="amlx_IncomeTaxDisclosureTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember" xlink:to="amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ProceedsFromUnderwrittenPublicOffering" xlink:to="amlx_ProceedsFromUnderwrittenPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AccruedManufacturing" xlink:to="amlx_AccruedManufacturing_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyLossInPeriod" xlink:to="us-gaap_LossContingencyLossInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryTable" xlink:to="us-gaap_PublicUtilitiesInventoryTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember" xlink:to="amlx_SeriesC1RedeemableConvertiblePreferredSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderlyingAssetClassAxis" xlink:to="us-gaap_UnderlyingAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties" xlink:to="amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription" xlink:to="amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncrementalCostsExpenses" xlink:to="amlx_IncrementalCostsExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnderlyingAssetClassDomain" xlink:to="us-gaap_UnderlyingAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryLineItems" xlink:to="us-gaap_PublicUtilitiesInventoryLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent" xlink:to="amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollateralizedDebtObligationsMember" xlink:to="us-gaap_CollateralizedDebtObligationsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RestrictedCashEquivalentsMember" xlink:to="amlx_RestrictedCashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember" xlink:to="amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetirementPlanTaxStatusDomain" xlink:to="us-gaap_RetirementPlanTaxStatusDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ConvertibleNotesSettlementDate" xlink:to="amlx_ConvertibleNotesSettlementDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_MA" xlink:to="stpr_MA_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_SeriesBRedeemableConvertiblePreferredSharesMember" xlink:to="amlx_SeriesBRedeemableConvertiblePreferredSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock" xlink:to="amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject" xlink:to="amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QualifiedPlanMember" xlink:to="us-gaap_QualifiedPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:to="amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock" xlink:to="amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes" xlink:to="amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_PatentRelatedCostsPolicyPolicyTextBlock" xlink:to="amlx_PatentRelatedCostsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="amlx_CustomerTwoMember" xlink:to="amlx_CustomerTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952409392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 08, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Amylyx Pharmaceuticals, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001658551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4600503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">43 Thorndike St.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">682-0917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,716,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 788.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche, LLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant intends to file a definitive proxy statement pursuant to Regulation 14A relating to the 2023 Annual Meeting of Stockholders within 120 days of the end of the registrant&#8217;s fiscal year ended December 31, 2022. Portions of such definitive proxy statement for the 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953202384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 62,526<span></span>
</td>
<td class="nump">$ 50,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">284,419<span></span>
</td>
<td class="nump">45,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">10,113<span></span>
</td>
<td class="nump">5,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">15,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">9,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,441<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">382,133<span></span>
</td>
<td class="nump">104,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,611<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">5,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">391,453<span></span>
</td>
<td class="nump">105,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,257<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">38,312<span></span>
</td>
<td class="nump">13,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">2,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">46,609<span></span>
</td>
<td class="nump">17,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">4,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">50,846<span></span>
</td>
<td class="nump">17,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 18)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 300,000,000 and 56,500,000 shares authorized as of December 31, 2022 and 2021, respectively; 66,512,011 and 7,020,487 shares issued and outstanding as of December 31, 2022 and 2021, respectively</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">694,906<span></span>
</td>
<td class="nump">4,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(354,220)<span></span>
</td>
<td class="num">(155,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(86)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">340,607<span></span>
</td>
<td class="num">(151,168)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock and stockholders'equity (deficit)</a></td>
<td class="nump">$ 391,453<span></span>
</td>
<td class="nump">105,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember', window );">Series A Redeemable Convertible Preferred Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember', window );">Series B Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember', window );">Series C-1 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental payment required by lease over rental income recognized, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123408481&amp;loc=SL77919140-209958<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123415192&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953089568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,710,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, stated par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">56,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued</a></td>
<td class="nump">66,512,011<span></span>
</td>
<td class="nump">7,020,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">66,512,011<span></span>
</td>
<td class="nump">7,020,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember', window );">Series A Redeemable Convertible Preferred Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember', window );">Series B Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember', window );">Series C-1 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953105632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue, net</a></td>
<td class="nump">$ 22,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 22,230<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">93,450<span></span>
</td>
<td class="nump">44,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">127,128<span></span>
</td>
<td class="nump">38,933<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">223,571<span></span>
</td>
<td class="nump">82,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(201,341)<span></span>
</td>
<td class="num">(82,688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">4,291<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(551)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">3,740<span></span>
</td>
<td class="num">(5,243)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(197,601)<span></span>
</td>
<td class="num">(87,931)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (198,375)<span></span>
</td>
<td class="num">$ (87,931)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders -basic</a></td>
<td class="num">$ (3.39)<span></span>
</td>
<td class="num">$ (13.35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders -diluted</a></td>
<td class="num">$ (3.39)<span></span>
</td>
<td class="num">$ (13.35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders-basic</a></td>
<td class="nump">58,495,587<span></span>
</td>
<td class="nump">6,586,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders-diluted</a></td>
<td class="nump">58,495,587<span></span>
</td>
<td class="nump">6,586,349<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953602960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (198,375)<span></span>
</td>
<td class="num">$ (87,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign Currency translation adjustment</a></td>
<td class="num">(69)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on short-term investments</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="num">(95)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (198,470)<span></span>
</td>
<td class="num">$ (87,922)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821949907152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A Redeemable Convertible Preferred Share</div></th>
<th class="th"><div>Series B Redeemable Convertible Preferred Shares</div></th>
<th class="th"><div>Series C-1 Redeemable Convertible Preferred Shares</div></th>
<th class="th"><div>Series C-2 Redeemable Convertible Preferred Shares</div></th>
<th class="th"><div>Follow-on Offering</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Follow-on Offering</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Follow-on Offering</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,675<span></span>
</td>
<td class="nump">$ 64,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,137,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="num">$ (66,725)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (67,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock into common stock upon initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering', window );">Conversion of preferred stock into common stock upon initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Other comprehensive loss</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (87,931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87,931)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2021</a></td>
<td class="nump">37,107,459<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 239,351<span></span>
</td>
<td class="nump">$ 7,675<span></span>
</td>
<td class="nump">$ 64,387<span></span>
</td>
<td class="nump">$ 134,791<span></span>
</td>
<td class="nump">$ 32,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2021</a></td>
<td class="nump">7,020,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,020,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="num">$ (151,168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(155,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, Shares</a></td>
<td class="nump">950,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">$ 2,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock into common stock upon initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,474,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock into common stock upon initial public offering</a></td>
<td class="nump">239,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering', window );">Conversion of preferred stock into common stock upon initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,289,609)<span></span>
</td>
<td class="num">(14,496,835)<span></span>
</td>
<td class="num">(13,150,430)<span></span>
</td>
<td class="num">(3,170,585)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering', window );">Conversion of preferred stock into common stock upon initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,675)<span></span>
</td>
<td class="num">$ (64,387)<span></span>
</td>
<td class="num">$ (134,791)<span></span>
</td>
<td class="num">$ (32,498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon initial public offering and follow-on offering, net of issuance costs, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,369,369<span></span>
</td>
<td class="nump">7,697,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon initial public offering and follow-on offering, net of issuance costs</a></td>
<td class="nump">196,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,612<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">196,378<span></span>
</td>
<td class="nump">$ 230,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">21,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (198,375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(198,375)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2022</a></td>
<td class="nump">66,512,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,512,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 340,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 694,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="num">$ (354,220)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity shares conversion of preferred stock into common stock upon initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity values conversion of preferred stock into common stock upon initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952651600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember', window );">Series C-1 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 19,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Follow-on Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 15,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=amlx_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=amlx_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955742768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (198,375)<span></span>
</td>
<td class="num">$ (87,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">21,714<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization (accretion) of investment premiums (discounts)</a></td>
<td class="num">(2,056)<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of Measurement dates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(15,306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(9,769)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Interest receivable</a></td>
<td class="nump">487<span></span>
</td>
<td class="num">(144)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(5,221)<span></span>
</td>
<td class="num">(4,486)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(456)<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,854<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent', window );">Accrued expenses and deferred rent</a></td>
<td class="nump">26,052<span></span>
</td>
<td class="nump">8,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties', window );">Accrued interest and accrued interest-related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(179,871)<span></span>
</td>
<td class="num">(74,799)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,526)<span></span>
</td>
<td class="num">(353)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(415,873)<span></span>
</td>
<td class="num">(49,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities of short-term investments</a></td>
<td class="nump">179,411<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(238,988)<span></span>
</td>
<td class="num">(46,406)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan', window );">Repayment and proceeds from PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering</a></td>
<td class="nump">200,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ProceedsFromFollowOnOffering', window );">Proceeds from follow-on offering</a></td>
<td class="nump">231,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_InitialPublicOfferingCostPaid', window );">Initial public offering costs paid</a></td>
<td class="num">(2,044)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_FollowOnOfferingCostsPaid', window );">Follow-on offering costs paid</a></td>
<td class="num">(803)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties', window );">Proceeds from issuance of convertible notes&#8212;related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance of convertible notes , net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes', window );">Issuance costs related to conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of Series C-1 redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock', window );">Issuance costs related to issuance of Series C-1 redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PaymentOfDeferredOfferingCosts', window );">Payment of deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,474)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">431,789<span></span>
</td>
<td class="nump">158,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents</a></td>
<td class="num">(65)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash equivalents</a></td>
<td class="nump">12,865<span></span>
</td>
<td class="nump">37,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash equivalents, beginning of period</a></td>
<td class="nump">50,380<span></span>
</td>
<td class="nump">13,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash equivalents, end of period</a></td>
<td class="nump">63,245<span></span>
</td>
<td class="nump">50,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock', window );">Conversion of convertible notes and accrued interest into redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on short-term investments</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable', window );">Purchases of property and equipment included in accounts payable</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses', window );">Deferred offering costs included in accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption', window );">Right-of-use assets and liabilities upon ASC842 adoption</a></td>
<td class="nump">2,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">4,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_MovementOfDeferredOfferingCostsToEquity', window );">Movement of deferred offering costs to equity</a></td>
<td class="nump">5,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses', window );">Follow-on offering costs included in accounts payable and accrued expenses</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering', window );">Conversion of preferred stock to common stock upon initial public offering</a></td>
<td class="nump">239,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible notes and accrued interest into redeemable convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of preferred stock to common stock upon initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs included in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Follow-on offering costs included in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_FollowOnOfferingCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Follow-on offering costs paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_FollowOnOfferingCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and deferred rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued Interests due to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_InitialPublicOfferingCostPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial public offering cost paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_InitialPublicOfferingCostPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance costs related to conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance costs related to issuance of Series redeemable convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_MovementOfDeferredOfferingCostsToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Movement of deferred offering costs to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_MovementOfDeferredOfferingCostsToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PaymentOfDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PaymentOfDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ProceedsFromFollowOnOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from follow-on offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ProceedsFromFollowOnOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of convertible notes, related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from repayments of paycheck protection program loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases of property and equipment included in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use assets and liabilities upon ASC 842 adoption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957676528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Business</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Nature of Business</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amylyx Pharmaceuticals, Inc., together with its wholly owned subsidiaries, known as Amylyx or the Company, is a commercial-stage biotechnology company with a mission to one day end the suffering caused by neurodegenerative diseases. The Company is focused on the development and potential global commercialization of its product candidate, AMX0035 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis, or ALS.  Our first product, RELYVRIO&#174; (sodium phenylbutyrate and taurursodiol), previously known as AMX0035 in the U.S., is approved in the U.S. for the treatment of ALS in adults. AMX0035 is also approved with conditions by Health Canada and marketed as ALBRIOZA for the treatment of ALS in Canada. The Company&#8217;s Marketing Authorisation Application, or MAA, for AMX0035 for the treatment of ALS remains under review by the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA. The Company is developing AMX0035 for other neurodegenerative diseases by leveraging its unique knowledge and relationships in the neurodegenerative space.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is subject to risks and uncertainties common to companies in the biotechnology industry, including, but not limited to, the outcome of preclinical studies and clinical trials, market acceptance and the successful commercialization of ALBRIOZA, which received marketing authorization with conditions in Canada in June 2022, and RELYVRIO, which was approved by the FDA in the U.S. in September 2022, potential difficulties with or delays in timing with respect to the regulatory approval processes of the EMA and other comparable foreign authorities, development by competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, ability to secure additional capital to fund operations, and risks associated with the economic challenges caused by the COVID-19 pandemic and economic uncertainty in various global markets caused by geopolitical instability and conflict. The Company and its contractors may experience disruptions in supply of items that are essential for its research and development and commercial activities, including, for example, raw materials and bulk drug substances that the Company imports from Europe and Canada used in the manufacturing of AMX0035, and any future product candidates.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Going Concern</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with Accounting Standards Update, or ASU, 2014-15,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Disclosure of Uncertainties About an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company has evaluated whether there are conditions and events that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. <br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since its inception, the Company has devoted substantially all of its efforts to research and development and pre-commercialization activities, including recruiting management and technical staff, raising capital, producing materials for preclinical studies and clinical trials, and building infrastructure to support such activities. Expenses have primarily been for research and development and related general and administrative costs, and we anticipate that our selling, general and administrative expenses will continue to increase in the future as we further increase our headcount to support our continued research activities and development of AMX0035 and as we continue to increase headcount and incur other significant costs related to our commercialization activities. The Company has generated revenues through five grants from the ALS Association, ALS Finding a Cure Foundation, Cure Alzheimer&#8217;s Fund, Alzheimer&#8217;s Drug Discovery Foundation and Alzheimer&#8217;s Association, or Grantors. In addition to money received from its grants, the Company has also financed its operations through the public offering of its common stock, private sales of preferred stock, and convertible notes, and more recently through revenue from sales of RELYVRIO and ALBRIOZA in the U.S. and Canada, respectively. <br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and negative cash flows from operations since inception. As of December 31, 2022, the Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">had an accumulated deficit of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">354.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company expects its operating losses and negative operating cash flows may continue into the future as it continues initial sales of ALBRIOZA in Canada and RELYVRIO in the U.S., and continues to build capabilities and develop AMX0035, and any future product candidates. The Company expects that its cash, cash equivalents and short-term investments as of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and product revenue from RELYVRIO and ALBRIOZA sales, will enable the Company to fund its ongoing operating expenses and capital expenditure requirements for at least the twelve-month period following the issuance of these consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822034910528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation and Consolidation&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the U.S., or GAAP, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification, or ASC, and ASU of the Financial Accounting Standards Board, or FASB.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. Management&#8217;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: Gross-to-net, or GTN, adjustments, inventory, determining the fair value of convertible notes, accrued expenses, stock-based compensation, operating lease right-of-use assets and lease liabilities, valuation allowance for deferred tax assets and research and development expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue recognition&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and the Company launched ALBRIOZA in Canada in July 2022. In September 2022, AMX0035 received approval as RELYVRIO by the FDA for the treatment of ALS in adults, and the Company launched RELYVRIO in the U.S. in October 2022.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company enters into arrangements with wholesalers, specialty pharmacies and specialty distributors, or Customers, to distribute ALBRIOZA, RELYVRIO and future approved products. In accordance with ASC Topic 606 - </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or Topic 606, revenue is recognized when the customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To determine revenue recognition for arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the Company will collect the consideration the Company expects to be entitled to in exchange for the goods or services the Company transfers to its customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product Revenue, Net</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company sells its approved products to its Customers. These Customers subsequently resell our products to specialty pharmacy providers, other retail pharmacies, health care providers, certain medical centers or hospitals, and patients. In addition to agreements with the Customers, the Company enters into arrangements with specialty pharmacies, health care providers and payors that provide for government mandated and/or privately negotiated rebates with respect to the purchase of our products. The Company&#8217;s customer identification process considers a number of factors, including contractual and legal factors, and who controls the Company&#8217;s product and bears inventory risk. The Company evaluates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">these factors on a customer-by-customer basis to determine the appropriate customer for revenue recognition purposes. In some cases, the Company may use a third-party logistics providers to deliver the Company&#8217;s product to its customers, but the Company recognizes revenue upon delivery to the customer, as its determined that the third-party logistics provider is acting as our agent. Changes in these factors or our assumptions regarding these factors could impact our revenue recognition</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue on product sales when the Customer obtains control of our product, which occurs at a point in time (upon delivery). Product revenues are recorded net of applicable GTN adjustments, which are described below.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If taxes should be collected from Customers relating to product sales and remitted to governmental authorities, they will be excluded from revenue. The Company expenses incremental costs of obtaining a contract when incurred, if the expected amortization period of the asset that the Company would have recognized is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or less. However, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> such costs were incurred during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">GTN Adjustments</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration related to certain GTN adjustments. Components of GTN adjustments include trade discounts and allowances, product returns, third-party payor rebates, and other allowances that are offered within contracts between the Company, its Customers and payors relating to the sale of our products. These GTN adjustments, as detailed below, are based on the amounts earned, or to be claimed on the related sales, and are classified as reductions of accounts receivable (if the amount is payable to the Customer) or a current liability (if the amount is payable to a party other than a Customer). These estimates take into consideration a range of possible outcomes which are probability-weighted in accordance with the expected value method in Topic 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. In certain circumstances, the Company applies the most likely method in Topic 606 . The determination to use the expected value method or the most likely method is based on the type of GTN adjustment and what method better predicts the amount of consideration we expect to be entitled to. Overall, these GTN adjustments reflect in the transaction price the amount of consideration to which the Company expects to be entitled to in exchange for transferring promised goods or services to its Customers.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amount of variable consideration which is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from our estimates, the Company will adjust these estimates, which would affect product revenue, net and earnings in the period such variances become known.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Trade Discounts and Allowances</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company generally provides Customers with prompt payment discounts and pay fees for distribution services and for certain data that distributors provide to us that are explicitly stated in our contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. Payment from Customers is typically due within 30 calendar days of the invoice date, without consideration to the prompt payment discounts.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product Returns</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consistent with industry practice, the Company generally offers Customers a limited right of return for product that has been purchased from the Company based on the product&#8217;s expiration date, which is set to lapse within a specified period stated in the contract. Additionally, our limited right of return policy allows for eligible returns from Customers in circumstances where product was shipped in error or was damaged in shipping, or product was returned pursuant to an official drug recall.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the amount of product sales that may be returned by our Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net on the consolidated balance sheets. The Company currently estimates returns using quantitative and qualitative information including, but not limited to, expected experience with returns, projected demand, levels of inventory in the distribution channel, product dating and expiration period, and whether products have been discontinued, among</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others. The Company has received an immaterial amount of returns to date and believe that returns of product in future periods will be minimal.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provider Chargebacks and Discounts</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase the product from the Company. Customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These GTN adjustments are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable, net. GTN adjustments for chargebacks consist of credits that Customers have not claimed, but for which we expect to issue for units that remain in the distribution channel inventories at each reporting period-end that we expect will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which we have not yet issued a credit.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Payor Rebates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company contracts with certain government and private payor organizations, primarily government and commercial health insurance companies, for the payment of rebates with respect to utilization of our products. The Company is subject to discount obligations under state Medicaid programs and Medicare. These GTN adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities on the consolidated balance sheets. For Medicare, the Company also estimates the number of patients in the prescription drug coverage gap for whom it will owe an additional liability under the Medicare Part D program. The Company's liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product that has been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Incentives</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other incentives which the Company offers include voluntary patient assistance programs, such as its co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with prescription drug co-payments required by payors. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with product that has been recognized as revenue for each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Grant Revenue&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant revenue consists of amounts earned from performing contracted research and development services. The grants between the Company and the Grantors generally provide for the Company to meet certain research milestones in order for funds to be provided. The Company accounts for grants received to perform research and development services in accordance with ASC 730-20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which requires an assessment, at the inception of the grant, of whether the grant is a liability or a contract to perform research and development services for others. If the Company is obligated to repay the grant funds to the Grantor regardless of the outcome of the research and development activities, then the Company is required to estimate and recognize that liability. Alternatively, if the Company is not required to repay, or if it is required to repay the grant funds only if the research and development activities are successful, then the grant agreement is accounted for as a contract to perform research and development services for others, in which case, grant revenue is recognized as the related research and development expenses are incurred. The Company obtained funding from the Grantors of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> during the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, which was recorded as grant revenue in the Company&#8217;s consolidated statements of operations. Under the terms of the grants, the Company will be required to pay royalties upon occurrence of contingent future events (see Note 18).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss includes net loss, as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. Comprehensive loss is composed of net loss and other comprehensive (loss) income. Other comprehensive (loss) income consists of unrealized gains and losses on marketable securities and foreign currency translation.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents&#8212;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Cash equivalents represent funds invested in readily available checking and money market funds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash Equivalents&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents consist of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of cash serving as collateral for a letter of credit issued for the Company&#8217;s office space, and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as collateral for a corporate credit card program. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company&#8217;s restricted cash equivalents balance was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts receivable, net&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s accounts receivable consists of amounts due from Customers related to product sales and have standard payment terms. The Company analyzes accounts that are past due for collectability. Given the nature collectability of the Company&#8217;s accounts receivable to-date, an allowance for doubtful accounts is not deemed necessary at December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Short-Term Investments&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments are composed of treasury notes and bills, corporate debt securities, commercial paper and agency bonds with maturities of less than one year from the balance sheet date. The Company classifies all of its short-term investments as available-for-sale. Accordingly, these investments are recorded at fair value, which is determined based on quoted market prices. Unrealized gains and losses on available-for-sale securities are included as a separate component of other accumulated comprehensive loss. The cost of short-term investments is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. Realized gains and losses are included in other expense, net. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other than temporary-than-temporary are also included in other income, net.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#8217;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. As of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were no impairment charges on short-term investments.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable, net. The Company maintains its cash in financial institutions that it believes have high credit quality. The Company has not experienced any losses on such accounts, and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s accounts receivable, net at December 31, 2022, represents amounts due to the Company from customers. Amylyx performs ongoing credit evaluations of its customers and generally does not require collateral. The Company monitors its exposure and records a reserve against uncollectible amounts as necessary. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Four</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers individually accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of total gross product revenue in 2022 and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers individually accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of total accounts receivable, net as of December 31, 2022.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Note&#8212;Derivative&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company reviews the terms of the convertible note issued to determine whether there are features, including redemption and conversion features, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at the end of each reporting period and immediately prior to the conversion or the extinguishment of the convertible note. Changes in the fair value are reported in the consolidated statement of operations. When the convertible note contains embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those host instruments being recorded at a discount from their face value. The discount from the face value of the convertible note, together with the stated interest on the host instrument, is amortized over the life of the host instrument through periodic charges to interest expense. The Company&#8217;s convertible notes, as further discussed in Note 8, had embedded derivatives that required bifurcation from the host instrument.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Note&#8212;Beneficial Conversion Feature&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the conversion feature is not treated as a derivative, the Company assesses whether it is a beneficial conversion feature, or BCF. A BCF exists if the conversion price of the convertible note is less than the price of the stock into which it is convertible to on the commitment date. This typically occurs when the conversion price is less than the fair value of the stock on the date the instrument was issued. The value of a BCF is equal to the intrinsic value of the feature, the difference between the effective conversion price and the fair value of the stock into which it is convertible to and is recorded as additional paid-in capital and as a debt discount in the consolidated balance sheets. The Company amortizes the debt discount as non-cash interest expense over the life of the underlying convertible note using the effective interest method. If the convertible note is retired early, the associated debt discount is then recognized immediately as non-cash interest expense in the consolidated statements of operations. If the conversion feature does not qualify for either the derivative treatment or as a BCF, the convertible note is treated as traditional debt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets and liabilities recorded at fair value on a recurring basis on the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Quoted prices in active markets for identical assets or liabilities. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </span></div></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s financial instruments consist of cash, cash equivalents, restricted cash equivalents, short-term investments, accounts receivable, net, accounts payable and accrued expenses. The Company&#8217;s short-term investments are carried at fair value, determined according to Level 1 and Level 2 inputs to the fair value hierarchy described above. The Company&#8217;s 2021 Notes (as defined in Note 8) were carried at fair value, determined according to Level 3 inputs in the fair value hierarchy described above. The remaining financial instruments are stated at their respective carrying amounts, which approximate fair value due to the short-term nature of these assets and liabilities.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inventories&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company values its inventories at the lower of cost or estimated net realizable value. The Company determines the cost of its inventories, which includes amounts related to materials and manufacturing overhead, on a first-in, first-out basis. The Company performs an assessment of the recoverability of capitalized inventory during each reporting period, and it writes down any excess and obsolete inventories to their estimated realizable value in the period in which the impairment is first identified. Such impairment charges, should they occur, are recorded within cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required which would be recorded as cost of sales in the consolidated statements of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company capitalizes inventory costs associated with the Company&#8217;s products after regulatory approval when, based on management&#8217;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory acquired prior to receipt of regulatory approval of a product candidate is expensed as research and development expense as incurred. Inventory that can be used in either the production of clinical or commercial product is initially capitalized and subsequently expensed as research and development expense when materials are released to production for use in the manufacture of drugs still in development.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Offering Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings, including the initial public offering, or IPO, as deferred costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">until </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such financings are consummated. After consummation of the equity financing, these costs are recorded in stockholders&#8217; equity (deficit) as a reduction of proceeds generated as a result of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. After consummation of equity financings, the Company recorded deferred offering costs in stockholders&#8217; equity (deficit) of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. The Company recorded deferred offering costs of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which are included in the consolidated balance sheet as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, net&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not improve or extend the life of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and accumulated depreciation are removed from the consolidated balance sheets and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The range of useful lives of property and equipment is as follows: </span></span><span style=""/></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:49.087%;"/>
          <td style="width:1.835%;"/>
          <td style="width:49.077%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lesser of the estimated life or remaining lease term</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not depreciated</span></span></p></td>
         </tr>
        </table></div></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company evaluates assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recognized any impairment losses in the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses include costs directly attributable to the conduct of research and development activities. Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. In addition, research and development-related salaries and benefits, facility, and overhead costs, supplies and other related costs are included in research and development expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales and Marketing Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.</span></p></div></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent-Related Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as selling, general and administrative expenses in the accompanying consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for stock-based compensation under the provisions of ASC 718-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Compensation&#8212;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations based on their fair values on the date of grant over the requisite service period, which is generally equal to the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues stock option awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company classifies stock-based compensation expense in the same manner in which the awards recipient&#8217;s payroll or service provider&#8217;s costs are classified.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#8217;s common stock on that same date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the award, the risk-free interest rate, and expected dividends. The Company estimates its expected stock price volatility based on the historical volatility of publicly traded peer companies. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain vanilla&#8221; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. There is no expected dividend yield since the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future. The stock price of the Company is based on the closing price on the date of grant. Prior to the IPO, as there was no public market for the Company&#8217;s common stock, the estimated fair value of common stock was determined by the Company&#8217;s Board of Directors as of the date of each option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#8217;s Board of Directors&#8217; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of Privately Held Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contingencies&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability on the Company&#8217;s consolidated balance sheets. The Company does not accrue for contingent losses that, in its judgement, are considered to be reasonably possible, but not probable; however, it discloses the range of reasonably possible losses. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> loss or gain contingencies recorded in the Company&#8217;s consolidated financial statements as of and during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"/></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company adopted the FASB, ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 842, on January 1, 2022. ASC 842 allows the Company to elect a package of practical expedients, which include: (i) an entity need not reassess whether any expired or existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existing leases; and (iii) an entity need not reassess any initial direct costs for any existing leases. Another practical expedient allows the Company to use hindsight in determining the lease term when considering lessee options to extend or terminate the lease and to purchase the underlying asset. The Company has elected to utilize this package of practical expedients and has not elected the hindsight methodology in its implementation of ASC 842.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its offices, and may from time to time, enter into other lease agreements in conducting its business. The Company determines if an arrangement includes a lease at the inception of the agreement. For each of the Company&#8217;s lease arrangements, the Company records a right-of-use asset representing the Company&#8217;s right to use an underlying asset for the lease term and a lease liability representing the Company&#8217;s obligation to make lease payments. Operating lease right-of-use assets and operating lease liabilities are recognized at the lease commencement date based on the net present value of the remaining future minimum lease payments over the lease term. If the interest rate implicit in the Company&#8217;s leases is not readily determinable, in determining the weighted-average discount rate used to calculate the net present value of lease payments, the Company utilizes an estimate of its incremental borrowing rate based on market sources including interest rates for companies with similar credit quality for agreements of similar duration, determined by class of underlying asset, to discount the lease payments. Lease expense for the Company&#8217;s operating leases is recognized on a straight-line basis over the lease term and variable lease costs are expensed as incurred.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company elected the practical expedient not to apply the recognition and measurement requirements to short-term leases, which is any lease with a term of one year or less as of the lease commencement date. The lease may require the Company to pay additional amounts for taxes, insurance, maintenance, and other expenses, which are generally referred to as non-lease components. The Company has elected the practical expedient to combine lease and non-lease components. If a lease includes options to extend the lease term, the Company does not assume the option will be exercised in its initial lease term assessment unless there is reasonable certainty that the Company will renew based on an assessment of economic factors present as of the lease commencement date.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the adoption of ASC 842, at the inception of each lease, the Company evaluated the lease agreement to determine whether the lease was an operating or capital lease in accordance with </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ASC 840, Leases (ASC 840)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. When any one of the four test criteria in ASC 840 was met, the lease then qualified as a capital lease. If the lease agreements contained renewal options, tenant improvement allowances, rent holidays or rent escalation clauses, the Company recorded a deferred rent asset or liability equal to the difference between the rent expense and future minimum lease payments due. The rent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expense related to operating leases was recognized on a straight-line basis in the statements of operations over the term of each lease. The Company did not have financing leases as of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#8220;more likely than not&#8221; that the position is sustainable based on its technical merits. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has not incurred interest and penalties related to uncertain tax positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#8217;s evaluation of all available evidence, including our history of incurring significant losses from operations. Our evaluation of all available evidence also includes consideration of regulatory approvals of ALBRIOZA and RELYVRIO, including revenue generated from the sale these products in 2022.  Given the early stage of our product launch, we are uncertain about the timing and amount of future sales. We may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment Information&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An operating segment is defined as a component of a business that engages in business activities for which it may earn revenues and incur expenses and for which discrete financial information is available that is evaluated regularly by the chief operating decision maker or makers in order to make decisions about resources to be allocated to the segment and assess its performance. The Company has determined that its CO-Chief Executive Officers are the chief operating decision makers, or CODM. The CODM reviews consolidated operating results to make decisions about allocating resources or capital to specific compounds or projects in line with the Company&#8217;s overall strategies and goals. The Company's entire business is managed by a single management team, which reports to the CO-Chief Executive Officers. The Company has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorders. For the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all of the Company's long-lived assets were held within the U.S.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net income (loss) per share&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. For purpose of this calculation, stock options, convertible notes, and redeemable convertible preferred stock are considered potential dilutive common shares.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s redeemable convertible preferred stock contractually entitles the holders of such shares to participate in dividends but does not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reports a net loss attributable to common stockholders, such losses are not allocated to such participating securities. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Emerging Growth Company Status&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company is an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act, and may take advantage of certain exemptions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">various reporting requirements that are applicable to other public companies that are not EGCs. The Company may take advantage of these exemptions until it is no longer an EGC under Section 107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#8217;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#8217; effective dates. The Company intends to take advantage of the reduced reporting requirements and exemptions up until the last day of the fiscal year following the fifth anniversary of an offering or such earlier time that it is no longer an EGC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Accounting Pronouncements Not Yet Adopted&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU No. 2016-13,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Financial Instruments&#8212;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2016-13. The provisions of ASU 2016-13 modify the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology and require a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the consolidated balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Financial Instruments&#8212;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except Securities and Exchange Commission filers that are not smaller reporting companies. ASU 2016-13 will be effective for the Company for the period beginning January 1, 2023. The Company intends to adopt the ASU when it becomes effective. The Company is currently evaluating the impact of this ASU and does not expect that adoption of this standard will have a material impact on its consolidated financial statements and related disclosures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective January 1, 2022, the Company adopted the requirements under the ASC 842 using the cumulative effect adjustment transition option. Comparative periods have not been restated. This standard requires entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet. The Company elected the available package of practical expedients which allows it to not reassess previous accounting conclusions around whether arrangements are or contain leases, the classification of its leases, and the treatment of initial direct costs. The Company has made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet. ASC 842 was issued in order to increase transparency and comparability of financial reporting related to leasing arrangements. The main difference between previous GAAP, or ASC 840, and ASC 842 is the recognition of right-of-use lease assets and lease liabilities by lessees for those leases that were classified as operating leases under ASC 840. At January 1, 2022, the Company recorded right-of-use assets of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and operating lease liabilities of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Adoption of the standard did not have a material impact on the consolidated statements of operations. For additional information regarding how the Company is accounting for leases under ASC 842, refer to Note 10.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954206592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Revenue, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Product Revenue, Net</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. PRODUCT REVENUE, NET</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, the Company&#8217;s only source of product revenue has been from the sales of RELYVRIO, known as ALBRIOZA in Canada, which it began shipping to Customers in Canada and the U.S. in July 2022 and October 2022, respectively. Significant judgment is required in estimating GTN adjustments considering historical experience, payer channel mix, current contract prices, unbilled claims, processing time lags, inventory levels in the distribution channel and estimated product returns. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reconciles gross product revenue to net product revenue:</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:4.533%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.792%;"/>
        <td style="width:1.612%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.923%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.612%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.062%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, gross</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,104</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GTN adjustments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,874</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,230</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954303216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. SHORT-TERM INVESTMENTS</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments, which are classified as available-for-sale, consisted of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:49.58%;"/>
        <td style="width:1.194%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.205%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.205%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.205%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost Basis</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Gain</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Values</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury notes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,173</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,159</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury bills</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,326</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,334</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,795</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,753</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,781</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,798</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284,450</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284,419</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;">&#160;</p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.805%;"/>
        <td style="width:1.37%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.013%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.381%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.024000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.381%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.024000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost Basis</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Values</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,979</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,978</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,953</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,949</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,932</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all investments had contractual maturities within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> realized gains and losses recognized during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other-than-temporary are also included in other income, net.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#8217;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. The Company has the ability to hold its investments until maturity and generally does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> impairment charges on short-term investments.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821958324240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. INVENTORIES</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventories consisted of the following:</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.938%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.737%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.094%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Raw materials</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,151</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Work in process</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,681</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finished goods</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">937</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total inventories</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,769</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company capitalizes inventory costs associated with the Company&#8217;s products after regulatory approval when, based on management&#8217;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory on hand determined to not have a future economic benefit and acquired prior to receipt of the marketing authorization for ALBRIOZA in Canada, totaling approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, was expensed as research and development expense as incurred. The Company began to capitalize the costs determined to have a probable future economic benefit associated with the production of ALBRIOZA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon receipt of Health Canada approval in June 2022. Finished goods have a shelf life of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months from the date of manufacture.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Of the inventories reported on balance sheet at December 31, 2022, the Company had </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of long-term raw materials that are not expected to be realized in cash, sold or consumed during the next 12 months.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954297104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. Property and equipment, net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.332%;"/>
        <td style="width:2.63%;"/>
        <td style="width:1.0%;"/>
        <td style="width:22.134%;"/>
        <td style="width:1.0%;"/>
        <td style="width:2.63%;"/>
        <td style="width:1.0%;"/>
        <td style="width:22.273%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">362</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,810</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">250</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">176</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">803</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,151</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">527</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">540</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,611</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">474</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954264672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. Accrued Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.776%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.133%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">External research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,424</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,666</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and employee related expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,231</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,280</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,596</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued consulting and other professional fees</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,116</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,820</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rebates and other GTN adjustments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,582</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty payable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,358</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,005</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">258</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,312</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821958440944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ConvertibleNotesTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8. CONVERTIBLE NOTES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Issuance of the 2021 Notes</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2021, the Company issued, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in convertible notes, or 2021 Notes, to certain investors, including related parties, of which proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were received in advance of issuance of the 2021 Notes in December 2020 and the remaining proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were received in January and February 2021. The 2021 Notes were to mature on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and carried both automatic and optional conversion features. The 2021 Notes were secured and carried an interest rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded the $1.2 million of proceeds received in December 2020 as proceeds received in advance of issuance of 2021 Notes in the consolidated balance sheet as of December 31, 2020, as the subscription agreement and commitment to issue the 2021 Notes was not effective until January 2021.</span></span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2021 Notes contained the following features:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Automatic Conversion Features</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;The 2021 Notes were to automatically convert into Conversion Shares upon (i) an IPO, (ii) any transaction in which the Company merges with, consolidates with or enters into other similar transaction with a Special Purpose acquisition Corp, or SPAC, resulting in some or all of its shares being registered for sale under applicable securities laws and listed for trading on a national or foreign exchange, or De-SPAC transaction, (iii) the acquisition of the Company by another person or entity by means of any transaction in which holders of the outstanding voting securities of the Company immediately before such transaction held less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the voting securities of the Company or the surviving corporation after such transaction or a sale of all or substantially all of the assets of the Company but excluding De-SPAC transaction, IPO, and the occurrence of equity financing in which the Company sold shares of its preferred stock for new money and which was neither an IPO or a Qualified Financing, or Change of Control, and (iv) the closing of a sale of an equity transaction in which the Company sold shares with an aggregate gross proceeds of at least $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, or Qualified Financing.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of a Change of Control, De-SPAC transaction, or an IPO, the Conversion Shares would be common stock of the Company. In the event of a Qualified Financing, the Conversion Shares would be shares of preferred stock issued in such transaction.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Optional Conversion Feature</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;The holders of the 2021 Notes had the option to elect to convert their notes into Conversion Shares at the Conversion Price upon the occurrence of an equity financing in which the Company sold shares of its preferred stock for new money and which was neither an IPO or a Qualified Financing, or Non-Qualified Financing, and together with the IPO, De-SPAC transaction, Change of Control, and the Qualified Financing, collectively, the &#8220;Conversion Events&#8221;). In the event of a Non-Qualified Financing, the Conversion Shares would be the class of equity shares issued in such transaction. The 2021 Notes would be deemed to have converted into the Conversion Shares if no election was made by the holders of the 2021 Notes.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion Price</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Upon the occurrence of an IPO, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the price at which the Company offered each share of common stock in the IPO without deducting any amount for discounts, commissions, fees, or other costs and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">600.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of a De-SPAC transaction, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the common stock price in the De-SPAC transaction, which would be determined by dividing (x) the total consideration to be paid to common stockholders upon a De-SPAC transaction less the principal amount of the 2021 Notes including accrued and unpaid interest by (y) the common stock issued and outstanding immediately prior to the De-SPAC transaction and that would be exchanged as a result of the De-SPAC transaction including common stock that would be issued upon the exercise of stock options immediately before the Change of Control transaction but excluding the common stock issuable upon conversion of the 2021 Notes and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">600.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of a Change of Control, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the common stock price in the Change of Control, which would be determined by dividing (x) the total consideration to be paid to common stockholders upon a Change of Control less the principal amount of the 2021 Notes including accrued and unpaid interest by (y) the common stock issued and outstanding immediately prior to the Change of Control and that would be exchanged upon a Change of Control including common stock that would be issued upon the exercise of stock options before the Change of Control but excluding the common stock issuable upon conversion of the 2021 Notes and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">600.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon a Qualified Financing, the 2021 Notes would convert into shares of preferred stock issued in the Non-Qualified Financing at the conversion price equal to the lesser of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the lowest price at which the Company sold shares of its stock in the Qualified Financing and (ii) $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">600.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million divided by the fully diluted capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Repayment</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Each holder of the 2021 Notes had the option to elect to receive a payment in the amount equal to the principal amount plus accrued and unpaid interests upon a Change of Control. If a Change of Control occurred and no election was made by the holder, the principal amount and accrued and unpaid interest would be deemed to have automatically be converted into shares of the Company&#8217;s common stock of the Company immediately prior to the close of the Change of Control.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company qualified for and elected to account for the 2021 Notes under the fair value option and, in doing so, bypassed the analysis of potential embedded derivative features. The Company believes that the fair value option better reflects the underlying economics of the 2021 Notes. As a result, the 2021 Notes were recorded at fair value upon issuance, which was determined to be equal to principal amounts of these notes of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. At each financial reporting period, and immediately prior to conversion, the Company remeasured the fair value of the 2021 Notes. The change in fair value of the 2021 Notes from issuance date to the conversion date totaled $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is recorded as change in fair value of convertible notes in the consolidated statement of operations for the year ended December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion of the 2021 Notes</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2021, the Company consummated a financing transaction in which it issued shares of Series C-1 redeemable convertible preferred stock. The consummation of this financing transaction resulted in the automatic conversion of the 2021 Notes into shares of Series C-2 redeemable convertible preferred stock (together with the Series C-1 redeemable convertible</span><span style="color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preferred </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">stock, the &#8220;Series C Preferred Stock&#8221;) pursuant to their original terms. The Series C Preferred Stock was determined to have a fair value of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.265809</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Under the fair value option, the 2021 Notes were remeasured to fair value immediately prior to conversion at a price per share equal to the fair value of the Series C-1 redeemable convertible preferred stock. The Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million loss related to change in fair value of the 2021 Notes in its consolidated statement of operations for the year ended December 31, 2021. The 2021 Notes converted into </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-2 redeemable convertible preferred stock at the effective conversion price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.725938</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> convertible notes outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Notes&#8212;Related Parties</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> convertible notes issued to related parties that were outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In connection with the issuance of the 2021 Notes, the Company issued, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of convertible notes to certain related parties. These notes were issued under the same terms and conditions as the 2021 Notes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of the 2021 Notes</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the issuance date of the 2021 Notes, the Company determined that the fair value of the 2021 Notes approximated the principal amounts of the 2021 Notes as the transaction was deemed to be at arm&#8217;s length. Subsequent measurement of fair value of the 2021 Notes at each reporting period was estimated based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The Company used a scenario-based analysis to incorporate estimates and assumptions concerning the Company&#8217;s prospects and market indications into a model to estimate the value of the 2021 Notes. The most significant estimates and assumptions used as inputs were those concerning timing, probability of possible scenarios for conversion or settlement of the 2021 Notes and discount rates. The fair value of the 2021 Notes upon settlement in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was determined based on the fair value of the Series C-1 redeemable convertible preferred stock issued. This method was selected as the Company concluded that the contemporaneous financing transaction was an arm&#8217;s length transaction. The issuance of the Series C-1 redeemable convertible preferred stock was considered to be a Qualified Financing (see Note 11) pursuant to the original terms of the 2021 Notes. Accordingly, the fair value calculation for the 2021 Notes immediately before conversion considered both the fair value of the Series C-1 redeemable convertible preferred stock and the conversion price, which was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair value of the Series C-1 redeemable convertible preferred stock. The fair value of the 2021 Notes as of June 30, 2021 was determined to be the same as that on the settlement date in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> based on management&#8217;s determination of no material changes to the assumptions underlying the determination of the fair value of the 2021 Notes.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ConvertibleNotesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ConvertibleNotesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954306656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. FAIR VALUE MEASUREMENTS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.287%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,567</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,989</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,556</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury notes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,159</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,159</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury bills</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,334</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,334</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,753</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,753</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,798</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,798</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86,493</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">197,926</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284,419</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">719</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">719</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110,779</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">207,915</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">318,694</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.287%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,271</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,271</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,978</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,978</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,949</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,949</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">189</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">189</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,460</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95,387</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of Short-Term Investments</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair values of the short-term investments by taking into consideration valuations obtained from third-party pricing sources. These pricing sources utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include market pricing based on real-time trade data for the same or similar securities, issuer credit spreads, benchmark yields, and other observable inputs. The Company validates the prices provided by our third-party pricing sources by understanding the models used, obtaining market values from other pricing sources and analyzing pricing data in certain instances.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t hold any short-term investments classified as Level 3, which are securities valued using unobservable inputs. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has not transferred any investment securities between the classification levels</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> other assets or liabilities that were measured at fair value on a recurring basis as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954120336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. LEASES</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its office facilities under non-cancelable operating leases that expire at various dates through October 2026. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with an option to extend the lease for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Because the Company was not reasonably certain to exercise the option to extend the lease at inception, the option to extend was not considered in determining the lease term. The Company initially recognized a right-of-use asset of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and a lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upon commencement of the lease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of lease expense required by ASC 842 are presented below for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.071%;"/>
        <td style="width:1.919%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.009%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lease cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,136</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities are measured by calculating the present value of remaining lease payments under the lease arrangement. Since the rates implicit in our leases are not readily determinable, the Company uses estimated incremental borrowing rates in determining the discount rate used to calculate the present value of remaining lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments over a similar term equal to the lease term in a similar economic environment. The incremental borrowing rate is based on the information available at commencement date. As the Company has no recent external borrowings, the incremental borrowing is a hypothetical rate based on our understanding of what our credit rating would be and adjusted to reflect a collateralized borrowing.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s leases contain renewal options that can extend the lease for additional years. Because the Company is not reasonably certain to exercise these renewal options, they are not considered in determining the lease terms, and associated potential additional payments are excluded from lease payments. The Company has elected to account for each lease component and its associated non-lease components as a single lease component and has allocated all of the contract consideration across lease components only. The Company has existing net leases in which the non-lease components (e.g., common area maintenance) are paid separately from rent based on actual costs incurred and therefore are not included in the operating lease right-of-use assets and lease liabilities and are reflected as an expense in the period incurred.</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the presentation in the Company&#8217;s consolidated balance sheet of its operating leases (in thousands):</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"/>
        <td style="width:1.921%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.092%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br/>December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,524</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use liabilities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,040</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use liabilities, net of current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,237</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,277</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, the Company made cash payments of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for operating leases.  </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum lease payments under non-cancelable leases as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, were as detailed below (in thousands):</span></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"/>
        <td style="width:1.921%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.092%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br/>December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,417</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,478</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,586</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">476</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,957</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">680</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,277</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the weighted average remaining lease term was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.9</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the weighted average incremental borrowing rate used to determine the operating lease right-of-use assets was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ASC 840 Disclosures</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum lease payments under non-cancelable leases as of December 31, 2021, were as detailed below (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"/>
        <td style="width:1.921%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.092%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br/>December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">532</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">541</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">555</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">563</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">476</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,667</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954170448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 1, 2021, the Company amended its certificate of incorporation in which it authorized </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-1 redeemable convertible preferred stock and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-2 redeemable convertible preferred stock.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2021, the Company consummated a financing transaction in which it issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-1 redeemable convertible preferred stock. In connection with the issuance of these shares, the principal including accrued interest of the 2021 Notes totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million automatically converted into </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of Series C-2 redeemable convertible preferred stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s redeemable convertible preferred stock consisted of the following:</span></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:26.627%;"/>
        <td style="width:1.071%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.395000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.071%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.395000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.357%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.446000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.357%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.446000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.071%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.762%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(dollars in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred<br/>Shares<br/>Authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred Shares<br/>Issued and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidation<br/>Preference</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock<br/>Issuable Upon<br/>Conversion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,289,609</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,289,609</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,675</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,730</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,407,256</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,100,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,496,835</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,387</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">246,070</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,746,059</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,791</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,498</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,666</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,710,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,107,459</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">239,351</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">416,466</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,474,330</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021, the holders of the Series C Preferred Stock, or together with the Series A redeemable convertible preferred stock and the Series B redeemable convertible preferred stock, collectively, the Preferred Stock, had the following rights and preferences:</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> On June 18, 2020, in connection with the conversion of the 2017 Notes, the Company adjusted the conversion price for the Series A redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.229073</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2065</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The adjustment was made in accordance with the anti-dilution provisions in the certificate of incorporation then in effect immediately prior to the conversion of the 2017 Notes. The adjustment to the conversion price resulted in neither modification nor extinguishment of the Series A redeemable convertible preferred stock as the terms of the Series A redeemable convertible preferred stock were not amended. The adjustment to the conversion price resulted in additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117,650</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock to be issued to holders of the Series A redeemable convertible preferred stock upon conversion of such shares into common stock. As of December 31, 2020, these additional shares of common stock were not issued and outstanding.</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2021, in connection with the conversion of the 2021 Notes, the Company adjusted the conversion price for the Series B redeemable convertible preferred stock of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.974077</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.6942</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The adjustment was made in accordance with the anti-dilution provisions in the certificate of incorporation then in effect immediately prior to the conversion of the 2021 Notes. The adjustment to the conversion price resulted in additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,249,224</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock into which Series B redeemable convertible preferred stock would be convertible. As of December 31, 2021, these additional shares were not issued and outstanding. Each share of Preferred Stock is convertible into an equivalent number of common stock, at any time, at the option of the holder. The initial conversion price for the Series C-1 redeemable convertible preferred stock and Series C-2 redeemable convertible preferred stock is the respective original issue prices.</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The conversion price for the Preferred Stock was subject to adjustments for stock splits, stock dividends, or similar recapitalization, and subject to adjustments in accordance with the anti-dilution provisions.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The shares of Preferred Stock were to automatically convert into common stock of the Company immediately upon either (a) the closing of the sale of shares of common stock to the public in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in at least $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of proceeds, net of the underwriting discount and commissions, to the Company, or Qualified IPO, or (b) the date and time, or the occurrence of an event, specified by vote or written consent of the holders of a majority of the then outstanding shares of Preferred Stock.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Dividends</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Dividends may be paid to the holders of the Series A redeemable convertible preferred stock. The holders the Series A redeemable convertible preferred stock are entitled to receive non-cumulative dividends at a rate per annum of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.073744</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">share when and if declared by the Board of Directors. The holders of the Series B redeemable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">convertible </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preferred stock were entitled to receive a non-cumulative dividend at the rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% per annum of the Series B original issue price per share when and if declared by the Board of Directors. As of December 31, 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cash dividends were declared or paid. From and after the date of issuance of the Series C Preferred Stock, the Company was not to set, declare, pay or set aside unless holders of the Series C Preferred Stock then outstanding shall first receive, or simultaneously receive, dividends on each outstanding share of Series C Preferred Stock in an amount equal to (i) in the case of dividends being distributed to common stock or any class or series of capital stock that is convertible into common stock, the equivalent dividend on an as-converted basis or (ii) in the case of dividends being distributed on a series or class not convertible into common stock, an additional dividend equal to a dividend rate calculated based on the respective original issue price of the Series C Preferred Stock. The original issue prices per share for the Series C-1 redeemable convertible preferred stock and Series C-2 redeemable convertible preferred stock were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.265809</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.725938</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Voting Rights</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212; The holders of the Preferred Stock were entitled to vote on any matter presented to stockholders of the Company for consideration. Each holder of the Preferred Stock was entitled to cast the number of votes equal to the number of shares of common stock into which the shares of the Preferred Stock held by such holder were convertible on such date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Redemption&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Preferred Stock did not contain any mandatory redemption features. In accordance with FASB ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, preferred stock issued with redemption provisions that are outside of the control of the Company or that contain certain redemption rights in a deemed liquidation event is required to be presented outside of stockholders&#8217; equity (deficit) on the face of the consolidated balance sheets. The Company classified the Preferred Stock outside of the stockholders&#8217; equity (deficit) as mezzanine equity because in the event of certain deemed liquidation events, which included events such as a sale or merger, that were not solely within the control of the Company, the shares of the Preferred Stock would have become redeemable at the option of the holders. The Company did not adjust the carrying values of the Preferred Stock to the redemption values of such shares since a deemed liquidation event did not occur and the shares were not probable of becoming redeemable in the future as of the consolidated balance sheet dates.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidation&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of a liquidation, deemed liquidation, dissolution or winding up of the Company, holders of the Preferred Stock would have been entitled to be paid out of the assets of the Company that were available for distribution before any payment is made to the holders of common stock. The amount to paid would have been the greater of (i) respective original issue prices plus any dividends declared but unpaid or (ii) the amount that would have been payable had all shares of Preferred Stock been converted into common stock immediately before such event. If upon any such liquidation, deemed liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution to its stockholders would have been insufficient to pay the holders of Preferred Stock the full amount to which they would have been entitled, the holders of Preferred Stock would have shared ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After the payment of all preferential amounts required to be paid to the holders of Preferred Stock, the remaining assets of the Company available for distribution to its stockholders would have been distributed among the holders of the shares of common stock on a pro rata basis based on the number of shares held by each such holder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2022, upon the completion of the Company&#8217;s IPO, all of the Company's outstanding shares of preferred stock were converted into shares of its common stock. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> redeemable convertible preferred stock outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954310512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. Stockholders&#8217; EQUITY (Deficit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each share of common stock entitles the holder to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> vote on all matters submitted to a vote of the Company&#8217;s stockholders provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#8217;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the Delaware General Corporation Law. Common stockholders are entitled to receive dividends, as may be declared by the Company&#8217;s Board of Directors, if any, subject to the preferential dividend rights of the Preferred Stock. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dividends were declared or paid during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company had reserved shares of common stock for issuance in connection with the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.389%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.832%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.193%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock authorized</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">300,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56,500,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock issued and outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66,512,011</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,020,487</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock authorized and reserved for future issuances:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,407,256</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,746,059</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for the exercise of stock options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,480,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,339,011</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for the unvested restricted stock units</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">740,297</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance of share-based awards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,817,751</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,444,492</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total common stock authorized and reserved for future issuance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,038,998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,257,833</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unreserved common stock available for future issuance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">221,448,991</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,221,680</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2022, the Company completed its IPO in which the Company issued and sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,369,369</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. After deducting underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(24,24,24,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">196.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Upon the completion of the IPO, all of the Company&#8217;s outstanding shares of preferred stock were converted into shares of its common stock.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2022, the Company completed a follow-on public offering in which the Company issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,697,812</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. After deducting underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954182544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Option and Grant Plan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13. Stock Option and Grant Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Incentive Plan&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2022, the Company&#8217;s board of directors adopted, and its stockholders approved the 2022 Stock Option and Incentive Plan, or 2022 Plan, which became effective on January 5, 2022, at which point </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> further grants would be made under the 2015 Stock Option and Restricted Stock Plan, or 2015 Plan. Under the 2022 Plan, the Company may grant incentive stock options, or ISOs, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and other stock-based awards. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,817,751</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares available for future issuance under the 2022 Plan. The options issued under the 2022 Plan expire </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years following the date of grant. Stock options and restricted stock units typically vest over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years. We recognize the compensation cost of awards subject to service-based vesting conditions over the requisite service period, which is generally equal to the vesting period of the respective award.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Initially, subject to adjustment as provided in the 2022 Plan, the aggregate number of shares of the Company&#8217;s common stock available for issuance under the 2022 Plan is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,650,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The number of shares of the Company&#8217;s common stock reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year commencing January 1, 2023, by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total number of shares of the Company&#8217;s common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#8217;s board of directors. The maximum current number of shares that may be issued pursuant to the exercise of ISOs under the 2022 Plan is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,650,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The maximum number of shares of the Company&#8217;s common stock subject to awards granted under the 2022 Plan or otherwise during a single calendar year to any individual nonemployee director, taken together with any cash fees paid by the Company to such nonemployee director during the calendar year for serving on the Company&#8217;s board of directors, will not exceed $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">750,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in total value, or, with respect to the calendar year in which a nonemployee director is first appointed or elected to the Company&#8217;s board of directors, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All options and awards granted under the 2015 Plan consisted of the Company&#8217;s common stock. As of January 6, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> additional stock awards have been or will be granted under the 2015 Plan. Although the 2015 Plan was terminated as to future awards in January 2022, it continues to govern the terms of options that remain outstanding under the 2015 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General Option Information</span></p><div style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.447%;"/>
        <td style="width:1.752%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.103%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.605%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.094%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.29</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.69</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.97</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.01</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.07</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.73</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88.75</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.61</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The per share weighted average grant date fair value of stock options granted during the year ended December 31, 2022 and 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of option activity for </span><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, is as follows:</span></span></p><div style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.716%;"/>
        <td style="width:1.004%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.386999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.327%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.408999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.275%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.327%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.565%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,339,011</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.54</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.7</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,627</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,237,720</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.29</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">950,013</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.33</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">145,768</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.98</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,480,950</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">201,765</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable at December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,055,416</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.03</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63,408</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,425,534</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.47</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.6</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138,357</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the options and the fair value of the Company&#8217;s common stock for those options that had exercise prices lower than the fair value of the Company&#8217;s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2022 and 2021, was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total fair value of stock options vested during the years ended December 31, 2022 and 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Stock Unit Activity</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of restricted stock unit activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, is as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.004%;"/>
        <td style="width:1.166%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.039%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.619%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.173%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average Grant Date Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonvested as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">752,613</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.98</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,316</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.82</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonvested as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">740,297</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.02</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense&#8212;</span><span style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded stock-based compensation expense in the following expense categories of its statements of operations: </span></span><span style=""/></p><div style="font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.097%;"/>
        <td style="width:1.619%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.652999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.619%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.01%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,639</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">888</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,075</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,248</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes stock-based compensation by type of award:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.938%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.737%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.094%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,844</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,870</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes unrecognized stock-based compensation expense as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, by type of awards, and the weighted-average period over which that expense is expected to be recognized. The total unrecognized stock-based compensation expense will be adjusted for actual forfeitures as they occur.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.053%;"/>
        <td style="width:1.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.042%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.17%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.121%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized Expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average Recognition Period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61,049</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.79</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.25</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954264672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14. Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of net loss before the provision for income taxes are as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.962000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.101%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">198,704</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87,904</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,103</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">197,601</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87,931</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The provision for income taxes for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 is as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.776%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.133%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current income tax provision</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. - Federal</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. - State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">774</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provision for income taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">774</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the Company&#8217;s effective income tax rate to the U.S. statutory federal income tax rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.416%;"/>
        <td style="width:1.275%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.521999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.275%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.511999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax at U.S. statutory tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.9</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowances</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets and liabilities reflect the net tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting and the amounts used for tax purposes. </span><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021: </span></span><span style=""/></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.962000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.101%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,673</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,303</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,628</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,474</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research and development costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,079</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,205</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventory</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,721</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax credits</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,581</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,808</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accruals and other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,284</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,556</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,966</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90,587</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,379</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,379</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,379</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. The Company has considered its history of cumulative losses, including significant losses incurred in every year since inception, including 2022, and has concluded that it is more likely than not that it will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2022 and 2021.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On a periodic basis the Company reassess the valuation allowance that has been established, weighing positive and negative evidence.  In 2022, the Company reassessed the valuation allowance and considered negative evidence, including cumulative losses over the three years ended December 31, 2022, and positive evidence, including regulatory approvals of ALBRIOZA and RELYVRIO. After assessing both the negative and positive evidence, the Company concluded that a full valuation should be retained against the net deferred tax assets as of December 31, 2022.  It is possible that all or a portion of the valuation allowance will be released in the near-term.  The release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, levels of profitability, revenue growth, clinical program progression and expectations regarding future profitability.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">203.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, and state net operating loss carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">164.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, which are available to reduce future taxable income. Of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">203.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> federal net operating loss carryforwards, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2034</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the remaining </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">201.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> net operating losses carryforward indefinitely. Of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">164.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> state net operating loss carryforwards, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of Massachusetts net operating loss carryforwards begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2034</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company also had federal tax</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">credits of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, and state tax credits of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tax credit carryforwards will expire at various dates beginning in 2034.</span></span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The utilization of the net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. The Company has not conducted a formal study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382 and 383 of the Code, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards may be subject to an annual limitation, which is determined by first multiplying the value of the Company&#8217;s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has not yet conducted a study of its research and development credit carryforward. Such a study, once undertaken by the Company, may result in an adjustment to the Company&#8217;s research and development credit carryforward. A full valuation allowance has been provided against the Company&#8217;s research and development credit and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a valuation allowance against its deferred tax assets as of December 31, 2022 and 2021, because the Company&#8217;s management has determined that it is more likely than not that these assets will not be fully realized. The increase in the valuation allowance recorded during the year primarily relates to the net operating loss incurred by the Company as well as the increase in research and development credits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reflects the roll-forward of the Company&#8217;s valuation allowance:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.776%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.133%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance at beginning of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,900</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases recorded to income tax provision</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,241</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,446</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance at end of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90,587</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for uncertainty in income taxes under the provisions of ASC 740 which defines the thresholds for recognizing the benefits of tax return positions in the consolidated financial statements as &#8220;more likely than not&#8221; to be sustained by the taxing authority. The tax benefit is measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlemen</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the beginning and ending amount of gross unrecognized tax benefits</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021 is as follows: </span></span><span style=""/></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.962000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.101%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at beginning of the period</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">564</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">349</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases (decreases) related to tax positions taken during prior years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases related to tax positions taken during the prior years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">481</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">215</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at end of the period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,013</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">564</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has reviewed the tax positions taken, or to be taken, in its tax returns for all tax years currently open to examination by a taxing authority. Unrecognized tax benefits represent the aggregate tax effect of differences between tax return positions and the benefits recognized in the consolidated financial statements. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does not expect the amount of unrecognized tax benefits to change over next 12 months.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The Company accrues interest and penalties related to unrecognized tax benefits as a component of its provision for income taxes. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recognize any interest or penalties related to uncertain tax positions during the two years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company files U.S. federal, foreign and state income tax returns in various jurisdictions. The status of limitations varies by jurisdiction. There are currently no federal or state audits or examinations in process.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954247120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EMPLOYEE BENEFIT PLANS</span></p><p style="text-indent:10.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company maintains a tax-qualified retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax-advantaged basis. Plan participants are able to defer eligible compensation subject to applicable annual Internal Revenue Code limits. The Company provides a safe-harbor contribution o</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">f </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of employee compensation to employees who satisfy the minimum service requirements. The Company made </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of safe-harbor contributions for the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954310512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16. NET LOSS PER SHARE</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share Attributable to Common Stockholders&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because the Company reports a net loss attributable to common stockholders, basic and diluted net loss per share attributable to common stockholders are the same for both periods presented. All preferred stock, stock options and restricted stock units have been excluded from the computation of diluted weighted-average shares outstanding because such securities would have an antidilutive impact. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following common stock equivalents outstanding at each period end have been excluded from the calculation of diluted net loss per share because their inclusion would have been antidilutive:</span></span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.389%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.832%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.193%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,480,950</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,339,011</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">740,297</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,474,330</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total excluded common stock equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,221,247</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44,813,341</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954238944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17. Related party transactions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Notes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the issuance of the 2021 Notes, the Company issued, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of convertible promissory notes to Morningside Ventures Investments Limited, and certain members of the board of directors of the Company. Morningside Ventures Investments Limited is a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% significant stockholder of the Company. These notes were issued under the same terms and conditions as the 2021 Notes (see Note 8).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Supplier Agreements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of business, the Company may purchase materials or supplies or services from entities that are associated with a party that meets the criteria of a related party of the Company. These transactions are reviewed quarterly and to date have not been material to the Company&#8217;s consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957653856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating Leases&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its facilities under non-cancelable operating leases that expire at various dates through October 2026. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with an option to extend the lease for</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 3 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> As of January 1, 2022, the Company adopted ASC 842 which requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by leases. As a result of this adoption, the Company recorded a right-of-use asset and corresponding lease liability on the consolidated balance sheet. The Company continues to recognize rent expense, which is calculated as the remaining cost of the lease allocated over the remaining lease term on a straight-line basis. See Note 10 for additional information regarding the Company's operating leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Letter of Credit&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents consist of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of cash serving as collateral for a letter of credit issued for the Company&#8217;s office space, and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as collateral for a corporate credit card program. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company&#8217;s restricted cash equivalents balance was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Legal Proceedings&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is not currently a party to any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or potential range of loss is probable and reasonably estimated under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company recognizes expenses for its costs related to its legal proceedings, as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalty Payments&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between August 2016 and February 2019, the Company entered into agreements with the Grantors. Under the terms of the agreements, the Company was granted, in aggregate, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. These grants were provided to the Company for the purpose of furthering the research and development of AMX0035 as a therapeutic benefit for ALS disease and Alzheimer&#8217;s disease. Under the terms of the arrangements, the Company would receive a tranche of funds as it completes certain milestones. Pursuant to the terms of the grant agreements, the Company has certain payment obligations that are contingent upon future events such as the achievement of commercialization or the receipt of proceeds from a revenue generating transaction resulting from the projects for which the grants are used for.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of the respective grant agreements among the Company, ALS Association and ALS Finding a Cure, the Company will be required to make royalty payments to each Grantor in the total amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the grant received. The royalty payments will be achieved through a combination of the following payment methods: (i) an annual installment payment of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net sales of any products developed under the project for which the grant was used for and (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of cash proceeds resulting from revenue generating transaction under the project for which the grants are used for. During the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company recorded </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in royalty expense, which is included in cost of sales in the consolidated financial statements.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the respective grant agreements among the Company, Alzheimer&#8217;s Drug Discovery Foundation, the Alzheimer&#8217;s Association, and Cure Alzheimer&#8217;s Fund, the Company will make royalty payments up to the maximum amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million to each Grantor (or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in aggregate). The royalty payment will be made through a combination of the following payment methods: (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of annual net sales of any product commercialized from the project for which the grant was used for and directly related to the treatment of the Alzheimer&#8217;s disease and (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of all royalties and cash proceeds resulting from revenue generating transactions associated with the projects for which the grants were used for under the grant agreements.  As the conditions that would trigger royalty payments under the agreements have not occurred, no amounts have been recorded in the consolidated financial statements for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954310512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="subsequent_events" style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company has evaluated all subsequent events and determined that there are no material recognized or unrecognized subsequent events requiring disclosure, except as described below.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Silicon Valley Bank (&#8220;SVB&#8221;) was closed on March 10, 2023 by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) as receiver. At the time of closing, the Company maintained less than $1.0 million of its cash in deposit accounts with SVB and held sufficient liquid assets at Bank of America to manage its operational needs. The vast majority of the Company&#8217;s cash, cash equivalents and short-term investments reside in custodial accounts held by U.S. Bank for which SVB Asset Management is the advisor. The Company&#8217;s investment portfolio currently does not contain any securities of SVB. On March 12, 2023, the U.S. Treasury, Federal Reserve, and FDIC announced that SVB depositors will have access to all of their money starting March 13, 2023. The Company does not believe it will be impacted by the closure of SVB and will continue to monitor the situation as it evolves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 13, 2023, the Company announced the appointment of Karen Firestone, Chairman, CEO, and co-founder of Aureus Asset Management and prior fund manager at Fidelity Investments, to the company&#8217;s Board of Directors. Ms. Firestone's appointment to the Board of Directors is effective as of March 16, 2023.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821949862144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation and Consolidation&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the U.S., or GAAP, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification, or ASC, and ASU of the Financial Accounting Standards Board, or FASB.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. Management&#8217;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: Gross-to-net, or GTN, adjustments, inventory, determining the fair value of convertible notes, accrued expenses, stock-based compensation, operating lease right-of-use assets and lease liabilities, valuation allowance for deferred tax assets and research and development expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue recognition&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and the Company launched ALBRIOZA in Canada in July 2022. In September 2022, AMX0035 received approval as RELYVRIO by the FDA for the treatment of ALS in adults, and the Company launched RELYVRIO in the U.S. in October 2022.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company enters into arrangements with wholesalers, specialty pharmacies and specialty distributors, or Customers, to distribute ALBRIOZA, RELYVRIO and future approved products. In accordance with ASC Topic 606 - </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or Topic 606, revenue is recognized when the customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To determine revenue recognition for arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the Company will collect the consideration the Company expects to be entitled to in exchange for the goods or services the Company transfers to its customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product Revenue, Net</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company sells its approved products to its Customers. These Customers subsequently resell our products to specialty pharmacy providers, other retail pharmacies, health care providers, certain medical centers or hospitals, and patients. In addition to agreements with the Customers, the Company enters into arrangements with specialty pharmacies, health care providers and payors that provide for government mandated and/or privately negotiated rebates with respect to the purchase of our products. The Company&#8217;s customer identification process considers a number of factors, including contractual and legal factors, and who controls the Company&#8217;s product and bears inventory risk. The Company evaluates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">these factors on a customer-by-customer basis to determine the appropriate customer for revenue recognition purposes. In some cases, the Company may use a third-party logistics providers to deliver the Company&#8217;s product to its customers, but the Company recognizes revenue upon delivery to the customer, as its determined that the third-party logistics provider is acting as our agent. Changes in these factors or our assumptions regarding these factors could impact our revenue recognition</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue on product sales when the Customer obtains control of our product, which occurs at a point in time (upon delivery). Product revenues are recorded net of applicable GTN adjustments, which are described below.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If taxes should be collected from Customers relating to product sales and remitted to governmental authorities, they will be excluded from revenue. The Company expenses incremental costs of obtaining a contract when incurred, if the expected amortization period of the asset that the Company would have recognized is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or less. However, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> such costs were incurred during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">GTN Adjustments</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration related to certain GTN adjustments. Components of GTN adjustments include trade discounts and allowances, product returns, third-party payor rebates, and other allowances that are offered within contracts between the Company, its Customers and payors relating to the sale of our products. These GTN adjustments, as detailed below, are based on the amounts earned, or to be claimed on the related sales, and are classified as reductions of accounts receivable (if the amount is payable to the Customer) or a current liability (if the amount is payable to a party other than a Customer). These estimates take into consideration a range of possible outcomes which are probability-weighted in accordance with the expected value method in Topic 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. In certain circumstances, the Company applies the most likely method in Topic 606 . The determination to use the expected value method or the most likely method is based on the type of GTN adjustment and what method better predicts the amount of consideration we expect to be entitled to. Overall, these GTN adjustments reflect in the transaction price the amount of consideration to which the Company expects to be entitled to in exchange for transferring promised goods or services to its Customers.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amount of variable consideration which is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from our estimates, the Company will adjust these estimates, which would affect product revenue, net and earnings in the period such variances become known.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Trade Discounts and Allowances</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company generally provides Customers with prompt payment discounts and pay fees for distribution services and for certain data that distributors provide to us that are explicitly stated in our contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. Payment from Customers is typically due within 30 calendar days of the invoice date, without consideration to the prompt payment discounts.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product Returns</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consistent with industry practice, the Company generally offers Customers a limited right of return for product that has been purchased from the Company based on the product&#8217;s expiration date, which is set to lapse within a specified period stated in the contract. Additionally, our limited right of return policy allows for eligible returns from Customers in circumstances where product was shipped in error or was damaged in shipping, or product was returned pursuant to an official drug recall.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the amount of product sales that may be returned by our Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net on the consolidated balance sheets. The Company currently estimates returns using quantitative and qualitative information including, but not limited to, expected experience with returns, projected demand, levels of inventory in the distribution channel, product dating and expiration period, and whether products have been discontinued, among</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others. The Company has received an immaterial amount of returns to date and believe that returns of product in future periods will be minimal.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provider Chargebacks and Discounts</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase the product from the Company. Customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These GTN adjustments are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable, net. GTN adjustments for chargebacks consist of credits that Customers have not claimed, but for which we expect to issue for units that remain in the distribution channel inventories at each reporting period-end that we expect will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which we have not yet issued a credit.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Payor Rebates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company contracts with certain government and private payor organizations, primarily government and commercial health insurance companies, for the payment of rebates with respect to utilization of our products. The Company is subject to discount obligations under state Medicaid programs and Medicare. These GTN adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities on the consolidated balance sheets. For Medicare, the Company also estimates the number of patients in the prescription drug coverage gap for whom it will owe an additional liability under the Medicare Part D program. The Company's liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product that has been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Incentives</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other incentives which the Company offers include voluntary patient assistance programs, such as its co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with prescription drug co-payments required by payors. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with product that has been recognized as revenue for each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_GrantRevenuePolicyPolicyTextBlock', window );">Grant Revenue</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Grant Revenue&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant revenue consists of amounts earned from performing contracted research and development services. The grants between the Company and the Grantors generally provide for the Company to meet certain research milestones in order for funds to be provided. The Company accounts for grants received to perform research and development services in accordance with ASC 730-20, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which requires an assessment, at the inception of the grant, of whether the grant is a liability or a contract to perform research and development services for others. If the Company is obligated to repay the grant funds to the Grantor regardless of the outcome of the research and development activities, then the Company is required to estimate and recognize that liability. Alternatively, if the Company is not required to repay, or if it is required to repay the grant funds only if the research and development activities are successful, then the grant agreement is accounted for as a contract to perform research and development services for others, in which case, grant revenue is recognized as the related research and development expenses are incurred. The Company obtained funding from the Grantors of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> during the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, which was recorded as grant revenue in the Company&#8217;s consolidated statements of operations. Under the terms of the grants, the Company will be required to pay royalties upon occurrence of contingent future events (see Note 18).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss includes net loss, as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. Comprehensive loss is composed of net loss and other comprehensive (loss) income. Other comprehensive (loss) income consists of unrealized gains and losses on marketable securities and foreign currency translation.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents&#8212;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Cash equivalents represent funds invested in readily available checking and money market funds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash Equivalents</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash Equivalents&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents consist of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of cash serving as collateral for a letter of credit issued for the Company&#8217;s office space, and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as collateral for a corporate credit card program. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company&#8217;s restricted cash equivalents balance was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts receivable, net</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts receivable, net&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s accounts receivable consists of amounts due from Customers related to product sales and have standard payment terms. The Company analyzes accounts that are past due for collectability. Given the nature collectability of the Company&#8217;s accounts receivable to-date, an allowance for doubtful accounts is not deemed necessary at December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Short-Term Investments&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments are composed of treasury notes and bills, corporate debt securities, commercial paper and agency bonds with maturities of less than one year from the balance sheet date. The Company classifies all of its short-term investments as available-for-sale. Accordingly, these investments are recorded at fair value, which is determined based on quoted market prices. Unrealized gains and losses on available-for-sale securities are included as a separate component of other accumulated comprehensive loss. The cost of short-term investments is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. Realized gains and losses are included in other expense, net. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other than temporary-than-temporary are also included in other income, net.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#8217;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. As of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were no impairment charges on short-term investments.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable, net. The Company maintains its cash in financial institutions that it believes have high credit quality. The Company has not experienced any losses on such accounts, and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s accounts receivable, net at December 31, 2022, represents amounts due to the Company from customers. Amylyx performs ongoing credit evaluations of its customers and generally does not require collateral. The Company monitors its exposure and records a reserve against uncollectible amounts as necessary. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Four</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers individually accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of total gross product revenue in 2022 and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> customers individually accounted for approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of total accounts receivable, net as of December 31, 2022.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Note&#8212;Derivative&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company reviews the terms of the convertible note issued to determine whether there are features, including redemption and conversion features, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at the end of each reporting period and immediately prior to the conversion or the extinguishment of the convertible note. Changes in the fair value are reported in the consolidated statement of operations. When the convertible note contains embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those host instruments being recorded at a discount from their face value. The discount from the face value of the convertible note, together with the stated interest on the host instrument, is amortized over the life of the host instrument through periodic charges to interest expense. The Company&#8217;s convertible notes, as further discussed in Note 8, had embedded derivatives that required bifurcation from the host instrument.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Convertible Note&#8212;Beneficial Conversion Feature&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the conversion feature is not treated as a derivative, the Company assesses whether it is a beneficial conversion feature, or BCF. A BCF exists if the conversion price of the convertible note is less than the price of the stock into which it is convertible to on the commitment date. This typically occurs when the conversion price is less than the fair value of the stock on the date the instrument was issued. The value of a BCF is equal to the intrinsic value of the feature, the difference between the effective conversion price and the fair value of the stock into which it is convertible to and is recorded as additional paid-in capital and as a debt discount in the consolidated balance sheets. The Company amortizes the debt discount as non-cash interest expense over the life of the underlying convertible note using the effective interest method. If the convertible note is retired early, the associated debt discount is then recognized immediately as non-cash interest expense in the consolidated statements of operations. If the conversion feature does not qualify for either the derivative treatment or as a BCF, the convertible note is treated as traditional debt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets and liabilities recorded at fair value on a recurring basis on the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Quoted prices in active markets for identical assets or liabilities. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </span></div></div><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s financial instruments consist of cash, cash equivalents, restricted cash equivalents, short-term investments, accounts receivable, net, accounts payable and accrued expenses. The Company&#8217;s short-term investments are carried at fair value, determined according to Level 1 and Level 2 inputs to the fair value hierarchy described above. The Company&#8217;s 2021 Notes (as defined in Note 8) were carried at fair value, determined according to Level 3 inputs in the fair value hierarchy described above. The remaining financial instruments are stated at their respective carrying amounts, which approximate fair value due to the short-term nature of these assets and liabilities.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inventories&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company values its inventories at the lower of cost or estimated net realizable value. The Company determines the cost of its inventories, which includes amounts related to materials and manufacturing overhead, on a first-in, first-out basis. The Company performs an assessment of the recoverability of capitalized inventory during each reporting period, and it writes down any excess and obsolete inventories to their estimated realizable value in the period in which the impairment is first identified. Such impairment charges, should they occur, are recorded within cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required which would be recorded as cost of sales in the consolidated statements of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company capitalizes inventory costs associated with the Company&#8217;s products after regulatory approval when, based on management&#8217;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory acquired prior to receipt of regulatory approval of a product candidate is expensed as research and development expense as incurred. Inventory that can be used in either the production of clinical or commercial product is initially capitalized and subsequently expensed as research and development expense when materials are released to production for use in the manufacture of drugs still in development.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Offering Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings, including the initial public offering, or IPO, as deferred costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">until </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such financings are consummated. After consummation of the equity financing, these costs are recorded in stockholders&#8217; equity (deficit) as a reduction of proceeds generated as a result of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. After consummation of equity financings, the Company recorded deferred offering costs in stockholders&#8217; equity (deficit) of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. The Company recorded deferred offering costs of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which are included in the consolidated balance sheet as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, net</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, net&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not improve or extend the life of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and accumulated depreciation are removed from the consolidated balance sheets and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The range of useful lives of property and equipment is as follows: </span></span><span style=""/></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:49.087%;"/>
          <td style="width:1.835%;"/>
          <td style="width:49.077%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lesser of the estimated life or remaining lease term</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not depreciated</span></span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company evaluates assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recognized any impairment losses in the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses include costs directly attributable to the conduct of research and development activities. Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. In addition, research and development-related salaries and benefits, facility, and overhead costs, supplies and other related costs are included in research and development expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales and Marketing Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.</span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_SalesAndMarketingCostsPolicyPolicyTextblock', window );">Sales and Marketing Costs</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales and Marketing Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PatentRelatedCostsPolicyPolicyTextBlock', window );">Patent-Related Costs</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent-Related Costs&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as selling, general and administrative expenses in the accompanying consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation Expense&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for stock-based compensation under the provisions of ASC 718-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Compensation&#8212;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations based on their fair values on the date of grant over the requisite service period, which is generally equal to the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues stock option awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company classifies stock-based compensation expense in the same manner in which the awards recipient&#8217;s payroll or service provider&#8217;s costs are classified.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#8217;s common stock on that same date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the award, the risk-free interest rate, and expected dividends. The Company estimates its expected stock price volatility based on the historical volatility of publicly traded peer companies. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain vanilla&#8221; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. There is no expected dividend yield since the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future. The stock price of the Company is based on the closing price on the date of grant. Prior to the IPO, as there was no public market for the Company&#8217;s common stock, the estimated fair value of common stock was determined by the Company&#8217;s Board of Directors as of the date of each option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#8217;s Board of Directors&#8217; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of Privately Held Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contingencies&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability on the Company&#8217;s consolidated balance sheets. The Company does not accrue for contingent losses that, in its judgement, are considered to be reasonably possible, but not probable; however, it discloses the range of reasonably possible losses. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> loss or gain contingencies recorded in the Company&#8217;s consolidated financial statements as of and during the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company adopted the FASB, ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 842, on January 1, 2022. ASC 842 allows the Company to elect a package of practical expedients, which include: (i) an entity need not reassess whether any expired or existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existing leases; and (iii) an entity need not reassess any initial direct costs for any existing leases. Another practical expedient allows the Company to use hindsight in determining the lease term when considering lessee options to extend or terminate the lease and to purchase the underlying asset. The Company has elected to utilize this package of practical expedients and has not elected the hindsight methodology in its implementation of ASC 842.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company leases its offices, and may from time to time, enter into other lease agreements in conducting its business. The Company determines if an arrangement includes a lease at the inception of the agreement. For each of the Company&#8217;s lease arrangements, the Company records a right-of-use asset representing the Company&#8217;s right to use an underlying asset for the lease term and a lease liability representing the Company&#8217;s obligation to make lease payments. Operating lease right-of-use assets and operating lease liabilities are recognized at the lease commencement date based on the net present value of the remaining future minimum lease payments over the lease term. If the interest rate implicit in the Company&#8217;s leases is not readily determinable, in determining the weighted-average discount rate used to calculate the net present value of lease payments, the Company utilizes an estimate of its incremental borrowing rate based on market sources including interest rates for companies with similar credit quality for agreements of similar duration, determined by class of underlying asset, to discount the lease payments. Lease expense for the Company&#8217;s operating leases is recognized on a straight-line basis over the lease term and variable lease costs are expensed as incurred.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company elected the practical expedient not to apply the recognition and measurement requirements to short-term leases, which is any lease with a term of one year or less as of the lease commencement date. The lease may require the Company to pay additional amounts for taxes, insurance, maintenance, and other expenses, which are generally referred to as non-lease components. The Company has elected the practical expedient to combine lease and non-lease components. If a lease includes options to extend the lease term, the Company does not assume the option will be exercised in its initial lease term assessment unless there is reasonable certainty that the Company will renew based on an assessment of economic factors present as of the lease commencement date.</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the adoption of ASC 842, at the inception of each lease, the Company evaluated the lease agreement to determine whether the lease was an operating or capital lease in accordance with </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ASC 840, Leases (ASC 840)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. When any one of the four test criteria in ASC 840 was met, the lease then qualified as a capital lease. If the lease agreements contained renewal options, tenant improvement allowances, rent holidays or rent escalation clauses, the Company recorded a deferred rent asset or liability equal to the difference between the rent expense and future minimum lease payments due. The rent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expense related to operating leases was recognized on a straight-line basis in the statements of operations over the term of each lease. The Company did not have financing leases as of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#8220;more likely than not&#8221; that the position is sustainable based on its technical merits. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has not incurred interest and penalties related to uncertain tax positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#8217;s evaluation of all available evidence, including our history of incurring significant losses from operations. Our evaluation of all available evidence also includes consideration of regulatory approvals of ALBRIOZA and RELYVRIO, including revenue generated from the sale these products in 2022.  Given the early stage of our product launch, we are uncertain about the timing and amount of future sales. We may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment Information&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An operating segment is defined as a component of a business that engages in business activities for which it may earn revenues and incur expenses and for which discrete financial information is available that is evaluated regularly by the chief operating decision maker or makers in order to make decisions about resources to be allocated to the segment and assess its performance. The Company has determined that its CO-Chief Executive Officers are the chief operating decision makers, or CODM. The CODM reviews consolidated operating results to make decisions about allocating resources or capital to specific compounds or projects in line with the Company&#8217;s overall strategies and goals. The Company's entire business is managed by a single management team, which reports to the CO-Chief Executive Officers. The Company has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorders. For the years ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, all of the Company's long-lived assets were held within the U.S.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income (loss) per share</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net income (loss) per share&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. For purpose of this calculation, stock options, convertible notes, and redeemable convertible preferred stock are considered potential dilutive common shares.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s redeemable convertible preferred stock contractually entitles the holders of such shares to participate in dividends but does not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reports a net loss attributable to common stockholders, such losses are not allocated to such participating securities. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock', window );">Emerging Growth Company Status</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Emerging Growth Company Status&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company is an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act, and may take advantage of certain exemptions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">various reporting requirements that are applicable to other public companies that are not EGCs. The Company may take advantage of these exemptions until it is no longer an EGC under Section 107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#8217;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#8217; effective dates. The Company intends to take advantage of the reduced reporting requirements and exemptions up until the last day of the fiscal year following the fifth anniversary of an offering or such earlier time that it is no longer an EGC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock', window );">New Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Accounting Pronouncements Not Yet Adopted&#8212;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU No. 2016-13,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Financial Instruments&#8212;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2016-13. The provisions of ASU 2016-13 modify the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology and require a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the consolidated balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Financial Instruments&#8212;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except Securities and Exchange Commission filers that are not smaller reporting companies. ASU 2016-13 will be effective for the Company for the period beginning January 1, 2023. The Company intends to adopt the ASU when it becomes effective. The Company is currently evaluating the impact of this ASU and does not expect that adoption of this standard will have a material impact on its consolidated financial statements and related disclosures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective January 1, 2022, the Company adopted the requirements under the ASC 842 using the cumulative effect adjustment transition option. Comparative periods have not been restated. This standard requires entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet. The Company elected the available package of practical expedients which allows it to not reassess previous accounting conclusions around whether arrangements are or contain leases, the classification of its leases, and the treatment of initial direct costs. The Company has made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet. ASC 842 was issued in order to increase transparency and comparability of financial reporting related to leasing arrangements. The main difference between previous GAAP, or ASC 840, and ASC 842 is the recognition of right-of-use lease assets and lease liabilities by lessees for those leases that were classified as operating leases under ASC 840. At January 1, 2022, the Company recorded right-of-use assets of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and operating lease liabilities of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. Adoption of the standard did not have a material impact on the consolidated statements of operations. For additional information regarding how the Company is accounting for leases under ASC 842, refer to Note 10.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company Status Policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_GrantRevenuePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant revenue policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_GrantRevenuePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>New accounting pronouncements not yet adopted policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PatentRelatedCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patent Related Costs Policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PatentRelatedCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_SalesAndMarketingCostsPolicyPolicyTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales and marketing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_SalesAndMarketingCostsPolicyPolicyTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954330816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock', window );">Schedule of Estimated Useful Lives of Property and Equipment</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The range of useful lives of property and equipment is as follows: </span><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:49.087%;"/>
          <td style="width:1.835%;"/>
          <td style="width:49.077%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lesser of the estimated life or remaining lease term</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not depreciated</span></span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of estimated useful lives of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954247120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Revenue, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_GrossProductRevnueToNetProductRevenueTableTextBlock', window );">Summary of Gross Product Revenue to Net Product Revenue</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reconciles gross product revenue to net product revenue:</span><p style="margin-left:4.533%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.792%;"/>
        <td style="width:1.612%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.923%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.612%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.062%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, gross</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,104</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GTN adjustments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,874</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product revenue, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,230</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_GrossProductRevnueToNetProductRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross product revenue to net product revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_GrossProductRevnueToNetProductRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954170448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-term Investments Classified as Available-for-sale</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments, which are classified as available-for-sale, consisted of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
       <tr style="visibility:collapse;">
        <td style="width:49.58%;"/>
        <td style="width:1.194%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.205%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.205%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.205%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.402000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost Basis</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Gain</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Values</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury notes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,173</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,159</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury bills</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,326</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,334</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,795</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,753</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,781</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,798</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284,450</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284,419</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.805%;"/>
        <td style="width:1.37%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.013%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.381%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.024000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.381%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.024000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized<br/>Cost Basis</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized<br/>Loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair<br/>Values</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,979</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,978</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,953</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,949</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,932</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957727408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventories consisted of the following:</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.938%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.737%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.094%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Raw materials</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,151</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Work in process</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,681</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Finished goods</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">937</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total inventories</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,769</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957807936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.332%;"/>
        <td style="width:2.63%;"/>
        <td style="width:1.0%;"/>
        <td style="width:22.134%;"/>
        <td style="width:1.0%;"/>
        <td style="width:2.63%;"/>
        <td style="width:1.0%;"/>
        <td style="width:22.273%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">362</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer hardware and software</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,810</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">250</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">176</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">803</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,151</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">527</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">540</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,611</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">474</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957692976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.776%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.133%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">External research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,424</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,666</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payroll and employee related expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,231</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,280</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,596</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued consulting and other professional fees</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,116</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,820</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rebates and other GTN adjustments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,582</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Royalty payable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,358</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,005</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">258</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,312</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957786752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.287%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,567</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,989</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,556</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury notes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,159</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,159</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treasury bills</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,334</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,334</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,375</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,753</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,753</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,798</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,798</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86,493</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">197,926</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284,419</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">719</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">719</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110,779</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">207,915</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">318,694</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.287%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.032%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.218%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.388000000000002%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,271</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,271</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,978</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,978</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,949</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,949</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">189</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">189</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,460</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95,387</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957823712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of lease expense required by ASC 842 are presented below for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.071%;"/>
        <td style="width:1.919%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.009%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lease cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,136</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Summary of Condensed Consolidated Balance Sheet of Operating Leases</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the presentation in the Company&#8217;s consolidated balance sheet of its operating leases (in thousands):</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"/>
        <td style="width:1.921%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.092%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br/>December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,524</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use liabilities, current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,040</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use liabilities, net of current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,237</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,277</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Future Minimum Lease Payments</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum lease payments under non-cancelable leases as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, were as detailed below (in thousands):</span><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"/>
        <td style="width:1.921%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.092%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br/>December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,417</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,478</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,586</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">476</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,957</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">680</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,277</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum lease payments under non-cancelable leases as of December 31, 2021, were as detailed below (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.987%;"/>
        <td style="width:1.921%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.092%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of <br/>December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">532</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">541</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">555</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">563</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">476</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,667</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123389372&amp;loc=d3e36991-112694<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957677056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Redeemable Convertible Preferred Stock</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s redeemable convertible preferred stock consisted of the following:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:26.627%;"/>
        <td style="width:1.071%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.395000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.071%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.395000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.357%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.446000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.357%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.446000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.071%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.762%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(dollars in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred<br/>Shares<br/>Authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred Shares<br/>Issued and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidation<br/>Preference</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock<br/>Issuable Upon<br/>Conversion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,289,609</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,289,609</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,675</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,730</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,407,256</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,100,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,496,835</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,387</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">246,070</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,746,059</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134,791</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,498</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,666</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,710,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,107,459</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">239,351</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">416,466</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,474,330</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957685728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of common stock reserved for future issuance</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company had reserved shares of common stock for issuance in connection with the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.389%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.832%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.193%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock authorized</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">300,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56,500,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock issued and outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66,512,011</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,020,487</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock authorized and reserved for future issuances:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series A redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,407,256</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series B redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,746,059</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,150,430</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Series C-2 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,170,585</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for the exercise of stock options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,480,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,339,011</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for the unvested restricted stock units</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">740,297</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance of share-based awards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,817,751</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,444,492</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total common stock authorized and reserved for future issuance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,038,998</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,257,833</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unreserved common stock available for future issuance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">221,448,991</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,221,680</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952316656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Estimate Fair Value of Stock Option Awards on Grant Date</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.447%;"/>
        <td style="width:1.752%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.103%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.605%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.094%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grant price</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.29</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.69</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.97</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.01</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.07</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.73</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88.75</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.61</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, is as follows:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.716%;"/>
        <td style="width:1.004%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.386999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.327%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.408999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.993%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.275%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.327%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.565%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,339,011</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.54</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.7</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,627</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,237,720</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.29</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">950,013</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.33</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">145,768</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.98</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,480,950</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">201,765</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable at December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,055,416</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.03</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63,408</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,425,534</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.47</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.6</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138,357</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Unit Activity</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of restricted stock unit activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, is as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.004%;"/>
        <td style="width:1.166%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.039%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.619%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.173%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average Grant Date Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonvested as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">752,613</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.98</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,316</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.82</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nonvested as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">740,297</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.02</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded stock-based compensation expense in the following expense categories of its statements of operations: </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.097%;"/>
        <td style="width:1.619%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.652999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.619%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.01%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,639</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">888</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Selling, general and administrative expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,075</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,248</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Stock-Based Compensation by Type of Award</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes stock-based compensation by type of award:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.938%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.737%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.615%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.094%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,844</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,870</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,136</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock', window );">Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period</a></td>
<td class="text"><p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes unrecognized stock-based compensation expense as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, by type of awards, and the weighted-average period over which that expense is expected to be recognized. The total unrecognized stock-based compensation expense will be adjusted for actual forfeitures as they occur.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.053%;"/>
        <td style="width:1.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.042%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.17%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.121%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized Expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average Recognition Period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61,049</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.79</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.25</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of unrecognized stock-based compensation expense and weighted-average recognition period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821949855616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of Net Loss Before Provision for Income Taxes</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of net loss before the provision for income taxes are as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.962000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.101%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">198,704</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87,904</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,103</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">197,601</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87,931</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision For Income Taxes</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The provision for income taxes for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 is as follows:</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.776%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.133%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current income tax provision</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. - Federal</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. - State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">774</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provision for income taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">774</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the Company&#8217;s effective income tax rate to the U.S. statutory federal income tax rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.416%;"/>
        <td style="width:1.275%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.521999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.275%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.511999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax at U.S. statutory tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.9</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowances</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Significant Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021: </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.962000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.101%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,673</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,303</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,628</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,474</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research and development costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,079</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,205</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventory</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,721</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax credits</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,581</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,808</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accruals and other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,284</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,556</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,966</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90,587</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,379</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,379</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,379</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reflects the roll-forward of the Company&#8217;s valuation allowance:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.62%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.776%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.734%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.133%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance at beginning of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,900</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases recorded to income tax provision</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,241</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,446</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance at end of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90,587</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of Unrecognized Tax Benefits</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the beginning and ending amount of gross unrecognized tax benefits</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021 is as follows: </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.475%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.962000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.731%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.101%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at beginning of the period</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">564</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">349</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases (decreases) related to tax positions taken during prior years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases related to tax positions taken during the prior years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">481</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">215</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at end of the period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,013</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">564</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821957699824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following common stock equivalents outstanding at each period end have been excluded from the calculation of diluted net loss per share because their inclusion would have been antidilutive:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.389%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.832%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.294%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.193%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,480,950</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,339,011</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">740,297</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,474,330</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total excluded common stock equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,221,247</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44,813,341</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822046580960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Business - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 354,220<span></span>
</td>
<td class="nump">$ 155,845<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952556800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 10, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromGrantors', window );">Funding received from grantors</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CashAndCashEquivalentsMaturityDateDescription', window );">Maturity days for highly liquid investments</a></td>
<td class="text">The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="nump">$ 719,000<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,441,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment loss of long lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncrementalCostsExpenses', window );">Incremental costs expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_GainContingencyRecordedAmount', window );">Gain contingency</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Loss contingencies</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">5,524,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liabilities</a></td>
<td class="nump">6,277,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_DeferredOfferingCostNetOfEquityFinancing', window );">Deferred offering cost net of equity financing</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Collateral for Letter of Credit Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedCreditCardSecuritiesMember', window );">Collateral for Corporate Credit Card Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Customers accounted for more than 10%</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_NumberOfCustomers', window );">Number Of Customers | Customer</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Customers accounted for more than 10%</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_NumberOfCustomers', window );">Number Of Customers | Customer</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_AmortizationRecognizedPeriod', window );">Amortization Recognized Period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201811Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_AmortizationRecognizedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization recognized period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_AmortizationRecognizedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_CashAndCashEquivalentsMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents maturity date description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_CashAndCashEquivalentsMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_DeferredOfferingCostNetOfEquityFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering cost net of equity financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_DeferredOfferingCostNetOfEquityFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_GainContingencyRecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain contingency recorded amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_GainContingencyRecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IncrementalCostsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental costs expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IncrementalCostsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_NumberOfCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_NumberOfCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromGrantors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromGrantors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedCreditCardSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedCreditCardSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amlx_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amlx_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=amlx_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=amlx_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201811Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201811Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953063152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated Useful Life</a></td>
<td class="text">Lesser of the estimated life or remaining lease term<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=amlx_ComputerHardwareAndSoftwareMember', window );">Computer Hardware and Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction In progress</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated Useful Life</a></td>
<td class="text">Not depreciated<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905813&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=amlx_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=amlx_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821958338384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Revenue, Net - Summary of Gross Product Revenue to Net product Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross', window );">Product revenue, gross</a></td>
<td class="nump">$ 27,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_GrossToNetAdjustments', window );">GTN adjustments</a></td>
<td class="num">(4,874)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product revenue, net</a></td>
<td class="nump">$ 22,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_GrossToNetAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross to net adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_GrossToNetAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer, excluding assessed tax, gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948206912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Schedule of Short-term Investments Classified as Available-for-sale (Details) - Short-term Investments - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">$ 284,450<span></span>
</td>
<td class="nump">$ 45,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(71)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">284,419<span></span>
</td>
<td class="nump">45,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">134,375<span></span>
</td>
<td class="nump">33,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">134,375<span></span>
</td>
<td class="nump">33,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember', window );">Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">27,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">27,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember', window );">Treasury Bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">59,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">59,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember', window );">Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">58,795<span></span>
</td>
<td class="nump">11,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">58,753<span></span>
</td>
<td class="nump">$ 11,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember', window );">Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">4,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 4,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=amlx_AgencyBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=amlx_AgencyBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822053725968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_AvailableForSaleInvestmentsContractualMaturityPeriod', window );">Available-for-sale investments contractual maturity period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Realized gains</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Realized loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_AvailableForSaleInvestmentsContractualMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available-for-sale investments contractual maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_AvailableForSaleInvestmentsContractualMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821958339232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Summary of Inventories (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 7,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">1,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">937<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 9,769<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821950096000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryLineItems', window );"><strong>Public Utilities, Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Inventory acquired expensed as research and development expense</a></td>
<td class="nump">$ 22.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_LongTermRawMaterialsNotYetRealized', window );">Long term raw materials not yet realized</a></td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=amlx_FinishedGoodsMember', window );">Finished Goods | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryLineItems', window );"><strong>Public Utilities, Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">15 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=amlx_FinishedGoodsMember', window );">Finished Goods | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryLineItems', window );"><strong>Public Utilities, Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_LongTermRawMaterialsNotYetRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term raw materials not yet realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_LongTermRawMaterialsNotYetRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=amlx_FinishedGoodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=amlx_FinishedGoodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955818128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and equipment, net - Summary of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 3,151<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(540)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">2,611<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">362<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=amlx_ComputerHardwareAndSoftwareMember', window );">Computer Hardware and Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,810<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction In progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 803<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=amlx_ComputerHardwareAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=amlx_ComputerHardwareAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953159904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_AccruedExternalResearchAndDevelopmentCurrent', window );">External research and development</a></td>
<td class="nump">$ 8,424<span></span>
</td>
<td class="nump">$ 5,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and employee related expenses</a></td>
<td class="nump">15,231<span></span>
</td>
<td class="nump">4,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_AccruedManufacturing', window );">Manufacturing</a></td>
<td class="nump">4,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_AccruedConsultingAndOtherProfessionalFess', window );">Accrued consulting and other professional fees</a></td>
<td class="nump">4,116<span></span>
</td>
<td class="nump">2,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RebatesAndOtherGrossToNetAdjustments', window );">Rebates and other GTN adjustments</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RoyaltyPayable', window );">Royalty payable</a></td>
<td class="nump">1,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses</a></td>
<td class="nump">$ 38,312<span></span>
</td>
<td class="nump">$ 13,024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_AccruedConsultingAndOtherProfessionalFess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued consulting and other professional fess.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_AccruedConsultingAndOtherProfessionalFess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_AccruedExternalResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued external research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_AccruedExternalResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_AccruedManufacturing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued manufacturing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_AccruedManufacturing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RebatesAndOtherGrossToNetAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rebates and other gross to net adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RebatesAndOtherGrossToNetAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821949592368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember', window );">2021 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate convertible notes issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Notes mature date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Notes secured and carried interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company recorded the $1.2 million of proceeds received in December 2020 as proceeds received in advance of issuance of 2021 Notes in the consolidated balance sheet as of December 31, 2020, as the subscription agreement and commitment to issue the 2021 Notes was not effective until January 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PercentageOfPriceOfferedToEachShareOfCommonStock', window );">Percentage of price offered to each share of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_DilutedCapitalDividend', window );">Diluted capital dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Change in fair value of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ConvertibleNotesSettlementDate', window );">Convertible notes settlement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021-07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember', window );">2021 Notes | Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Preferred stock conversion price per share</a></td>
<td class="nump">$ 10.265809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember', window );">2021 Notes | Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Preferred stock conversion price per share</a></td>
<td class="nump">$ 8.725938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember', window );">2021 Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember', window );">2021 Notes | Special Purpose acquisition Corp | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PercentageOfVotingSecurities', window );">Percentage of voting securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember', window );">2021 Notes in December 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds received in advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember', window );">2021 Notes in January and February 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds received in advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,100,000<span></span>
</td>
<td class="nump">$ 26,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ConvertibleNotesSettlementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes settlement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ConvertibleNotesSettlementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_DilutedCapitalDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted capital dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_DilutedCapitalDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PercentageOfPriceOfferedToEachShareOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of price offered to each share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PercentageOfPriceOfferedToEachShareOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PercentageOfVotingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PercentageOfVotingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=amlx_SpecialPurposeAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=amlx_SpecialPurposeAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955245792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">$ 318,694,000<span></span>
</td>
<td class="nump">$ 95,387,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">33,556,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,271,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Restricted Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">110,779,000<span></span>
</td>
<td class="nump">49,460,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">23,567,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,271,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Restricted Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">207,915,000<span></span>
</td>
<td class="nump">45,927,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">9,989,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">284,419,000<span></span>
</td>
<td class="nump">45,927,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">27,159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Treasury Bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">59,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">134,375,000<span></span>
</td>
<td class="nump">33,978,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">58,753,000<span></span>
</td>
<td class="nump">11,949,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">4,798,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">86,493,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 1 | Treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">27,159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 1 | Treasury Bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">59,334,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">197,926,000<span></span>
</td>
<td class="nump">45,927,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 2 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">134,375,000<span></span>
</td>
<td class="nump">33,978,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 2 | Corporate Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">58,753,000<span></span>
</td>
<td class="nump">$ 11,949,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring | Level 2 | Agency Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">$ 4,798,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=amlx_RestrictedCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=amlx_RestrictedCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=amlx_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=amlx_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=amlx_AgencyBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=amlx_AgencyBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952264976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription', window );">Description of investment securities transferred between classification levels</a></td>
<td class="text">The Company has not transferred any investment securities between the classification levels<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">$ 318,694,000<span></span>
</td>
<td class="nump">$ 95,387,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other liabilities measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Fair Value Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">284,419,000<span></span>
</td>
<td class="nump">$ 45,927,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer of levels of investment securities fair value assets description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952679888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases- Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease, description</a></td>
<td class="text">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for 36 months, with an option to extend the lease for 3 years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 5,524<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">6,277<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease, cash payments</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years)</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">7.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease weighted average incremental borrowing rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955135056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,136<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 2,136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952676912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Condensed Consolidated Balance Sheet of Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 5,524<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease right-of-use liabilities, current</a></td>
<td class="nump">2,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">4,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 6,277<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953145120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Future Minimum Lease Payments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 10, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">6,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(680)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 6,277<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,667<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948693792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 18, 2020</div></th>
<th class="th"><div>Jun. 17, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,710,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,474,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividend declared or paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ProceedsFromUnderwrittenPublicOffering', window );">Proceeds from underwritten public offering net of underwriting discount and commissions</a></td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember', window );">Series A Redeemable Convertible Preferred Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,407,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_NonCumulativeDividendsPerShareEntitledToReceive', window );">Non-cumulative Dividends per share entitled to receive</a></td>
<td class="nump">$ 0.073744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember', window );">Series B Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,746,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PercentageOfNonCumulativeDividendsEntitledToReceive', window );">Percentage of non-cumulative dividends entitled to receive</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember', window );">Series C-1 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Temporary equity issue price per share</a></td>
<td class="nump">$ 10.265809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Temporary equity issue price per share</a></td>
<td class="nump">$ 8.725938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroTwoOneNotesMember', window );">2021 Notes | Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroOneSevenNotesMember', window );">2017 Notes | Series A Redeemable Convertible Preferred Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Preferred stock conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2065<span></span>
</td>
<td class="nump">$ 1.229073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroOneSevenNotesMember', window );">2017 Notes | Series B Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Preferred stock conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.6942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.974077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,249,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_NonCumulativeDividendsPerShareEntitledToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cumulative dividends per share entitled to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_NonCumulativeDividendsPerShareEntitledToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PercentageOfNonCumulativeDividendsEntitledToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of non-cumulative dividends entitled to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PercentageOfNonCumulativeDividendsEntitledToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ProceedsFromUnderwrittenPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from underwritten public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ProceedsFromUnderwrittenPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroTwoOneNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroTwoOneNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroOneSevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=amlx_TwoZeroOneSevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952495328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,710,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,107,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 239,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,474,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember', window );">Series A Redeemable Convertible Preferred Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,289,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,407,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember', window );">Series B Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,496,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 246,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,746,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember', window );">Series C-1 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Temporary equity, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Additional common stock issued to holders of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953195184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Vote </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockNumberOfVotingRights', window );">Voting rights | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,369,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock price | $ / shares</a></td>
<td class="nump">$ 32.00<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued | shares</a></td>
<td class="nump">7,697,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,512,011<span></span>
</td>
<td class="nump">7,020,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Company received net proceeds</a></td>
<td class="nump">$ 230,600<span></span>
</td>
<td class="nump">$ 196,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_CommonStockNumberOfVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock number of voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_CommonStockNumberOfVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821949579216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">56,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockSharesIssuedAndOutstanding', window );">Common stock issued and outstanding</a></td>
<td class="nump">66,512,011<span></span>
</td>
<td class="nump">7,020,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="nump">12,038,998<span></span>
</td>
<td class="nump">46,257,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_UnreservedCommonStockAvailableForFutureIssuance', window );">Unreserved common stock available for future issuance</a></td>
<td class="nump">221,448,991<span></span>
</td>
<td class="nump">3,221,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember', window );">Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,407,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,746,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember', window );">Series C-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,150,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember', window );">Series C-2 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,170,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Common Stock Reserved for the Exercise of Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="nump">8,480,950<span></span>
</td>
<td class="nump">5,339,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Common Stock Reserved for the Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="nump">740,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Common Stock Reserved for Future Issuance of Share-based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance', window );">Total common stock authorized and reserved for future issuance</a></td>
<td class="nump">2,817,751<span></span>
</td>
<td class="nump">1,444,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_CommonStockAuthorizedAndReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock authorized and reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_CommonStockAuthorizedAndReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_CommonStockSharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_CommonStockSharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_UnreservedCommonStockAvailableForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unreserved common stock available for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_UnreservedCommonStockAvailableForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesARedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesBRedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC1RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=amlx_SeriesC2RedeemableConvertiblePreferredSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955495792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Jan. 05, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.10<span></span>
</td>
<td class="nump">$ 5.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">752,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted shares forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember', window );">2015 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember', window );">2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,817,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options and restricted stock units vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_PercentageOfIncreaseInCommonStockReservedForIssuance', window );">Percentage of increase in common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember', window );">2022 Plan | Nonemployee Director | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Compensation to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember', window );">2022 Plan | Board of Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Compensation to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember', window );">2022 Plan | ISOs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_PercentageOfIncreaseInCommonStockReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in common stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_PercentageOfIncreaseInCommonStockReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=amlx_NonemployeeDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=amlx_NonemployeeDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=amlx_IncentiveStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=amlx_IncentiveStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821958456272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Summary of Estimate Fair Value of Stock Option Awards on Grant Date (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Grant price</a></td>
<td class="nump">$ 20.29<span></span>
</td>
<td class="nump">$ 7.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.97%<span></span>
</td>
<td class="nump">1.01%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 25 days<span></span>
</td>
<td class="text">5 years 8 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">88.75%<span></span>
</td>
<td class="nump">81.61%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948594304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Summary of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding</a></td>
<td class="nump">5,339,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="nump">4,237,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="num">(950,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Cancelled or forfeited</a></td>
<td class="num">(145,768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding</a></td>
<td class="nump">8,480,950<span></span>
</td>
<td class="nump">5,339,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Options exercisable</a></td>
<td class="nump">2,055,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options, Options unvested</a></td>
<td class="nump">6,425,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding</a></td>
<td class="nump">$ 5.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Granted</a></td>
<td class="nump">20.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercised</a></td>
<td class="nump">2.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Cancelled or forfeited</a></td>
<td class="nump">10.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding</a></td>
<td class="nump">13.19<span></span>
</td>
<td class="nump">$ 5.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options exercisable</a></td>
<td class="nump">6.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Exercise Price, Options unvested</a></td>
<td class="nump">$ 15.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Term (in years), Outstanding</a></td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">8 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted- Average Remaining Contractual Term (in years), Options exercisable</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm', window );">Weighted- Average Remaining Contractual Term (in years), Options unvested</a></td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 15,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">201,765<span></span>
</td>
<td class="nump">$ 15,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Options exercisable</a></td>
<td class="nump">63,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue', window );">Aggregate Intrinsic Value, Options unvested</a></td>
<td class="nump">$ 138,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award options unvested intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award options unvested weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948136144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Unit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, Granted | shares</a></td>
<td class="nump">752,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of shares, Forfeited | shares</a></td>
<td class="num">(12,316)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Nonvested | shares</a></td>
<td class="nump">740,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted | $ / shares</a></td>
<td class="nump">$ 19.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Forfeited | $ / shares</a></td>
<td class="nump">17.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Nonvested | $ / shares</a></td>
<td class="nump">$ 20.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954972656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Summary of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 21,714<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">5,639<span></span>
</td>
<td class="nump">888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 16,075<span></span>
</td>
<td class="nump">$ 2,248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955049840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Summary of Stock-Based Compensation by Type of Award (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 21,714<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">18,844<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 2,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821953113408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option and Grant Plan - Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 61,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average Recognition Period</a></td>
<td class="text">2 years 9 months 14 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 11,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average Recognition Period</a></td>
<td class="text">3 years 3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822053699008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components Of Net Loss Before Provision For Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (198,704)<span></span>
</td>
<td class="num">$ (87,904)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non - U.S.</a></td>
<td class="nump">1,103<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (197,601)<span></span>
</td>
<td class="num">$ (87,931)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955087216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Provision For Income Taxes (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">$ 774<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 774<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948097520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 774,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardDescription', window );">Tax credit carryforward, description</a></td>
<td class="text">The tax credit carryforwards will expire at various dates beginning in 2034.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit</a></td>
<td class="nump">$ 1,013,000<span></span>
</td>
<td class="nump">$ 564,000<span></span>
</td>
<td class="nump">$ 349,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent', window );">Significant change in unrecognized tax benefits</a></td>
<td class="text">The Company does not expect the amount of unrecognized tax benefits to change over next 12 months.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest or penalties related to uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">203,200,000<span></span>
</td>
<td class="nump">115,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_OperatingLossCarryforwardsExpirationPeriod', window );">Operating loss carryforwards, expiration period</a></td>
<td class="text">2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">$ 201,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">164,100,000<span></span>
</td>
<td class="nump">$ 102,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 113,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_OperatingLossCarryforwardsExpirationPeriod', window );">Operating loss carryforwards, expiration period</a></td>
<td class="text">2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_OperatingLossCarryforwardsExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards, expiration period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_OperatingLossCarryforwardsExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element provides a description of the nature of the event that could occur within twelve months of the reporting date that would cause a significant increase or decrease in the related unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the origin, nature, and characteristics of the tax credit carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955699024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax at U.S. statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax benefit</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="num">(25.50%)<span></span>
</td>
<td class="num">(24.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948648000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred Tax Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 42,673<span></span>
</td>
<td class="nump">$ 24,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">10,628<span></span>
</td>
<td class="nump">5,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts', window );">Capitalized research and development costs</a></td>
<td class="nump">18,079<span></span>
</td>
<td class="nump">6,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">5,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">5,581<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Accruals and other</a></td>
<td class="nump">9,284<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">91,966<span></span>
</td>
<td class="nump">40,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(90,587)<span></span>
</td>
<td class="num">$ (40,346)<span></span>
</td>
<td class="num">$ (18,900)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net total deferred tax assets</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred Tax Liabilities, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="num">(1,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">$ (1,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets capitalized research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952943568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Valuation Allowance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance at beginning of year</a></td>
<td class="nump">$ 40,346<span></span>
</td>
<td class="nump">$ 18,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increases recorded to income tax provision</a></td>
<td class="nump">50,241<span></span>
</td>
<td class="nump">21,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance at end of year</a></td>
<td class="nump">$ 90,587<span></span>
</td>
<td class="nump">$ 40,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821955717872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of the period</a></td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions', window );">Increases (decreases) related to tax positions taken during prior years</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to tax positions taken during the prior years</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of the period</a></td>
<td class="nump">$ 1,013<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits increase decrease resulting from prior period tax positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139822034701584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Additional Information (Details) - Qualified Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer contribution percentage of employee compensation to employees</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Amount of contribution made by the company</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821948087424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total excluded common stock equivalents</a></td>
<td class="nump">9,221,247<span></span>
</td>
<td class="nump">44,813,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Common Stock Reserved for the Exercise of Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total excluded common stock equivalents</a></td>
<td class="nump">8,480,950<span></span>
</td>
<td class="nump">5,339,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total excluded common stock equivalents</a></td>
<td class="nump">740,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total excluded common stock equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,474,330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821954986768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - 2021 Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amlx_MorningsideVenturesInvestmentsLimitedMember', window );">Morningside Ventures Investments Limited | Board of Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of stockholding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amlx_TwoThousandTwentyOneNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amlx_MorningsideVenturesInvestmentsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=amlx_MorningsideVenturesInvestmentsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139821952904512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">31 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Jan. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease, description</a></td>
<td class="text">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for 36 months, with an option to extend the lease for 3 years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="nump">$ 719,000<span></span>
</td>
<td class="nump">$ 189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromGrantors', window );">Funding received from grantors</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=amlx_ALSAssociationAndALSFindingCureMember', window );">ALS Association and ALS Finding a Cure | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember', window );">Royalty Payments Agreements with Grantors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromGrantors', window );">Funding received from grantors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember', window );">Royalty Payments Agreements with Grantors | ALS Association and ALS Finding a Cure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor', window );">Percentage of grant received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject', window );">Percentage of net sales of products developed under projects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject', window );">Percentage of cash proceeds from revenue generating transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember', window );">Royalty Payments Agreements with Grantors | Alzheimer's Drug Discovery Foundation, the Alzheimer's Association, and Cure Alzheimer's Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor', window );">Maximum Royalty amount payable to each grantor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Aggregate royalty amount payable to grantor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject', window );">Percentage of annual net sales of products commercialized from project</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject', window );">Percentage of all royalties and cash proceeds from revenue generating transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Collateral for Letter of Credit Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedCreditCardSecuritiesMember', window );">Collateral for Corporate Credit Card Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_amlx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum royalty guarantees commitments amount payable to each grantor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty guarantees commitments annual installment payment, percentage of net sales of products developed under project.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty guarantees commitments, percentage of all royalties and cash proceeds from revenue generating transaction associated with project.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty guarantees commitments percentage of annual net sales of products commercialized from project.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty guarantees commitments, percentage of cash proceeds from revenue generating transaction under project.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty guarantees commitments percentage of grant received payable to each guarantor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromGrantors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromGrantors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the entity has committed to make for future royalty guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473578&amp;loc=d3e63223-108013<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyGuaranteesCommitmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=amlx_ALSAssociationAndALSFindingCureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=amlx_ALSAssociationAndALSFindingCureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedCreditCardSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnderlyingAssetClassAxis=us-gaap_CollateralizedCreditCardSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>amlx-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:amlx="http://www.amylyx.com/20221231"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="amlx-20221231.xsd" xlink:type="simple"/>
    <context id="C_ff0690db-c77d-4b96-bbff-fbb506dbb3a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_faa2db82-5a0b-4d5e-9899-d4b010e01200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_42ba167d-3f2c-43b5-ad10-97d7aff55f3c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandFifteenStockOptionAndRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-06</startDate>
            <endDate>2022-01-06</endDate>
        </period>
    </context>
    <context id="C_67f5ad96-461d-4e37-81d1-e8d93683af31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ba447dcc-85e2-40e6-b77e-267406ab1bf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">amlx:SpecialPurposeAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_5d20162d-ff61-483b-a925-f567b613c421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2023-03-08</instant>
        </period>
    </context>
    <context id="C_2a15f4cd-3251-4bce-9c79-87754008eaad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_170cdc21-0444-4686-8e31-4471213a6c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="C_94da0a41-0a0d-4e46-8905-4827ae10dd95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5f298d27-3cb9-4705-bfa0-9f414a329ed2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2022-01-10</instant>
        </period>
    </context>
    <context id="C_c50598d2-a8bf-4f26-8081-1ada38713c0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ba231c4d-9d94-4fef-ac80-e42200cc6579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amlx:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_08bb19c6-0e5b-4b98-a719-c56d723fcf27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_757a8685-f087-44ba-8d70-37f526a1bd6e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0b327429-7b70-49b6-86e4-f2ad018fde8a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:ALSAssociationAndALSFindingCureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_52a2983c-7983-4d91-9733-cf784aff7361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="C_d36ae52a-d040-4a0e-84cd-85b87bbcff10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_2e22bd72-1889-4145-ab70-577df3f62afd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1b19ab6a-5a41-473b-9be7-fb23ebcb6e9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amlx:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_296321bd-7a9d-4b09-ba9b-7ad1355d4097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_549fc533-bfde-4f49-a811-86f15c3760d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f4747adc-8a33-4cb0-a970-1b814ab522d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f604d797-a8f0-453f-a9ea-26ea1f4f44d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7ef664f3-dcfa-4413-9356-692945d9514a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c82ec6e0-6442-4924-93c4-7e12f30f5bfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b984d10b-9ff4-48e7-8949-0e6695ddfaee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9ad669f7-07c3-4bda-a43c-720981a44374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_84e93efe-e53b-4b00-b1fc-338b910d8572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_9bd71111-9adf-43ab-8fd0-05a1882632a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_642dd1b3-56a8-4be2-8e97-15c6ab673ca1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ee15eb3d-afa2-43be-9739-f6cb7c933259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d64feb49-4e55-46df-a08d-e78148f7d88d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_eba29517-fdf1-4a5c-9472-881601db2461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ccd2bc7d-177e-44f8-89c8-d26a5a47b261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_40b2caa1-f574-483f-8a57-fe01ea935692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9a535ad1-aee6-4191-aba0-d4c01e4db958">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4a875587-3d63-4295-98d5-e68474ee09d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0ffaedee-aadb-4322-b862-e53422451646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8766c930-41ee-4314-b087-45deb048d199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7f70242f-b16e-425b-9687-ab456c6af1c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">amlx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_847bc730-56b4-47a9-b047-316c0d25ef30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_789d884f-c53b-4300-99ea-5e96e8f7db99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9108caa7-2bf4-44fb-ab90-32ee41737a03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_f6313c55-c8cf-4075-acc2-41e176752918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_683b28ae-40e1-400c-8515-d6776df26f52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amlx:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c32475bb-ba9c-415b-a298-afa0b3f8ef62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c2fe59ba-c379-4ba7-bfa5-0166ee9ba79d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f58d364a-a071-43d1-a2d5-b038a25fdc37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_75aa067a-4ce0-4ee0-849d-a679d624a87c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1fe5ff12-27cd-44f5-a115-8904def1b494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:AgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_43c44a69-a3b4-4167-b97c-320dd91b42d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-05</startDate>
            <endDate>2022-01-05</endDate>
        </period>
    </context>
    <context id="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_6e0804e9-955a-4a85-ad28-2816b77d859c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c9812622-5be1-41f9-acc6-5b7dabd03559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_23c45f4e-2e33-4b8f-99a6-4527909a36c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:ALSAssociationAndALSFindingCureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_aabbe5a4-0d80-4d34-9c12-1bc6e30e9fa6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9c2263c4-ca40-4e95-b8e3-4cde9fa39697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a0b1a141-4c14-4d2b-920f-b03009062e23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_28f824cb-b9d8-44c0-9120-7b7fefbb119e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5c14c4d0-550c-4966-97a1-233f1dab5e56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_81aa5a36-a608-4d01-ab23-6149905204c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4df5bd26-0f2a-4551-be73-d1993ae98fe2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e0aaedbf-19e6-4bcf-9bde-7bfed9c560a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f45a549c-ba7e-4586-8301-b2aa4abaaf62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_4805cb1e-b970-4249-8630-12fe8c6937d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_5eab5a92-c382-47c2-b472-12d901ce62a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_02064c71-3a83-4801-8486-d127eb43b8ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1795c86d-1f84-4b6f-bce6-5ee68242829e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_85caa5e9-c564-49a9-b13c-652337260e60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_32feb0a1-4b4c-4d84-ad01-dc752482f3d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_abc06de1-757c-40f3-a5ee-6a4936862ac3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="C_a166ab8c-a37b-4070-99b9-bc8f9b0a2693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="C_d1f4d907-06b1-4446-92c9-69df12bfc090">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dded4a35-c564-4067-87bb-39604cfdd2aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e92dc208-a141-4607-b82a-3789bb5e1d48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a7844b97-2442-4785-bc7f-5bd8385fcab8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_71f685c9-8c92-4d6f-9328-36c56365bbf5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5fa66652-e292-4b4a-b46f-3914e1bb1423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_f1dd14d9-2a2a-42df-bd70-17b7c328d628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_39501136-cb81-4f29-8e8b-cfc14116de19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7285cd01-49fc-4356-bb9e-b960696d9340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_49ab84be-37c3-426d-8cbc-3170c1c749d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b17b133f-82b6-42e9-990f-003823835ec6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7f388b78-2a24-4c12-8623-a7395b18ffe4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_150e2ef8-74e4-47ed-95d8-3485e13c0048">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_00648e08-92ac-4b7a-9c05-679ac28e6a0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">amlx:AgencyBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_16551b59-7779-49cd-bf47-05ce2620a5c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_75199396-3f49-47e9-a99c-3a0ee563bfe5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC1RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_03c3a593-4c98-403a-bc7f-a023ed103fae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">amlx:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9bc9f9a5-11f9-478f-9984-e116f2928e91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">amlx:FinishedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_64429dd7-c70d-4084-9c4c-b6db110ed37a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_dda99674-7cd7-4b03-a6bb-3b26b37d15e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a6f624b0-506d-4092-ac12-59f88d4944f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_678b6484-4368-49d8-8272-6da1055ccb1c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5e174e74-e289-47a5-a2ba-1168ba02dae5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_50031187-fee3-48b0-9289-0c569c7a76e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b787ec26-9aa6-4a5e-a368-bb18c3c09dfd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d9bce4d5-f683-4b45-978f-ca52168d39ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d897e60a-b2ef-40ae-84bb-e64354962e11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6847e6cf-32c0-4a9e-820c-301e7187f960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1e5f309e-abea-4f3f-9d05-817063bff016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_126e9271-cfbf-4f0e-811b-b2e260d1b8e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_18f249a1-455e-407f-aa84-667f43ef7f97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5d394f0f-75d1-48be-a6ab-deb2d20f1179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandFifteenStockOptionAndRestrictedStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-05</startDate>
            <endDate>2022-01-05</endDate>
        </period>
    </context>
    <context id="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">amlx:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e6d67a4d-2001-440f-b683-73f5e52c53fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_96d72263-9f43-4d59-8a5d-034e72d9be8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b214c460-3b77-4ddc-9510-02c9f4c9c9c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_adb5fca4-6b49-414c-ae2a-8352bcf3a331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_638aa53f-8b90-4d77-82c0-fa3b9eb25f93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c14457e2-814d-4d72-8c26-189bdc3fa207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5213ac10-0852-427d-9169-258edff8126e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201811Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="C_13345d35-56b6-4c29-9548-08d0bb84c9d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3ebd36ac-5798-4f88-97b9-7e44c07d4319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">amlx:MorningsideVenturesInvestmentsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_e05504eb-0e44-40fb-b852-5368d3b9651a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_35fc1ceb-01e4-49e3-8c88-0259fd467fd7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroOneSevenNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-18</instant>
        </period>
    </context>
    <context id="C_46b98ed8-5467-4391-ad5a-f70e2d057d60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">amlx:IncentiveStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-05</instant>
        </period>
    </context>
    <context id="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5d94ca99-5668-447a-a76f-db70b18b7074">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_d7b990e5-1180-4f67-85bb-6d7b96c69b5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">amlx:AgencyBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_850c76e4-ca88-4f27-b305-1aade8432744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_f6726908-1236-47a4-adbd-73f904c12140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f7fb78ab-3ece-4f31-af8a-d8d9b755bc94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_39eac193-4dc1-4fb2-9a13-3e7cfe206bcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_553959d9-0a46-4ddf-909a-9d7b7705481a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_fb130967-b508-4202-8fe2-6a4e676525e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0863d34e-dbd1-4004-8428-eacbe8227644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-05</startDate>
            <endDate>2022-01-05</endDate>
        </period>
    </context>
    <context id="C_73f1a92d-0191-4388-a5a7-d6dd11c4cb90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_bd82984a-e7c6-40a2-8123-1c9deb800381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_3abbf489-5362-4633-bc8b-b7daa3c678ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_489ebaa1-e175-4c12-b766-93bc771353fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">amlx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_031b3770-76f9-425a-9800-d1c8d734148f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_70137d1c-ebe4-41cf-9891-6c732ce3bf02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesARedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_dc698754-4dd5-48cc-b030-8ba72e728f61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4e947744-cacb-43d4-857f-1094d22ea491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ee7aed98-f0b4-4a0d-9d1c-9a20e0229bc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_c9061aa3-fdfb-412c-afec-524e4df56961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_abe6a82a-1d40-4eb5-8cb4-6e4904b35dfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnderlyingAssetClassAxis">us-gaap:CollateralizedCreditCardSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8d3cc07f-ae47-4903-9e9b-b86bea983319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_fb6ca0c6-e436-48d9-af45-2ac4f63346d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">amlx:FinishedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_99d7352d-e522-4ae7-bfb0-933bd5a40ea8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a7b22ec5-138f-422c-b0c5-18df666aa608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_61ca1749-7a0a-470d-9b8c-19819b5915bb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="C_91613165-4e43-4b91-b6e5-9c7be336afa8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b59b87a6-8c0e-42c4-b13a-2b0067aad963">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_965b6cf6-b979-4df3-ac71-5437159cc716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-05</instant>
        </period>
    </context>
    <context id="C_3fc7d41f-a882-4639-88a8-f660f437b33b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5b1aaf8c-dd58-4214-a024-8c65bee77c8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_90ba1a94-3a9c-4e3a-98be-4dbb6a1f0412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_32879b2b-a939-4f66-b85c-34c2c940aadb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_56faeaab-7811-48f5-9a7b-1727a455eccf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amlx:TwoThousandTwentyOneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfFinancingReceivableTypeOfBorrowerAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f38b7408-04be-4eb8-957e-fdf39e6193be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9ec1205e-1c76-493c-b003-ad047009b28c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4b1c0dc1-9115-4d8d-97b5-2ec93c4885e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">amlx:AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_268c76a6-dcfb-4bac-8647-bc6361c204b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">amlx:TwoZeroTwoOneNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesC2RedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="C_8b5b9ca1-4558-4404-bf4b-7219032bb989">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">amlx:NonemployeeDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">amlx:TwoThousandTwentyTwoStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-05</startDate>
            <endDate>2022-01-05</endDate>
        </period>
    </context>
    <context id="C_49ffe463-5c72-4589-94f5-b0914efbf208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">amlx:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658551</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">amlx:SeriesBRedeemableConvertiblePreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="U_Customer">
        <measure>amlx:Customer</measure>
    </unit>
    <unit id="U_Rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Vote">
        <measure>amlx:Vote</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      id="F_6b62c9fb-950f-40e5-9d9e-19b1fffed063"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_4c616ba1-bcf9-44f8-ba0d-55b6ca0585d4">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_9f564487-ff34-4d2f-b0ff-436e6a65bf58">http://fasb.org/us-gaap/2022#ProductMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_9c291edc-58ba-4f9c-ac9d-0a380913dd6e">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      id="F_b039e0ef-4988-44c2-972a-7c7c312db5b2"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:AmendmentFlag
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_27fb4f7d-84bf-4d9b-ac32-a8b2960229dc">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7b9b8af2-0606-4a01-834e-0e2c33cc428d">0001658551</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_edacf154-1c65-4746-94df-ccc43d900837">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_26879116-79e0-442c-84a8-bf8d7d6fcc5b">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_cfdd0a8f-ffd2-4f2b-9574-749f84134a75">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b5f51c26-1aee-4867-906b-c1c76420803b">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6264ed2e-a38d-4f72-8922-5308b29d5bba">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7fa93574-cbde-4970-8e4d-3740478ceba4">001-41199</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_733b1d31-2076-4f9c-bc8e-b919e83d6e40">Amylyx Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b8f7f4cd-ebf7-4a85-b474-4a794c9738aa">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_d8f203b8-3ce5-4d3e-b534-e46ef2d5e866">46-4600503</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_07d6a54b-1c02-403a-b95e-4f089c22e896">43 Thorndike St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6d380b7b-a4c2-4b30-a550-4f011147b661">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_30a1e9f1-20a2-474e-8f7c-0ec8810c336d">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_e2844c77-34e0-4c4a-8d6b-a40a7c4cf69d">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7735246a-0914-4918-aeab-c6fb869118dd">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_d3f62703-a7d6-4012-82ef-683d1c9760c1">682-0917</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b5fa9542-4a32-4539-8a7f-3d375620ebbd">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6f4d7fb2-4288-4497-9987-6e9b27041662">AMLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_ed1983c9-9d3b-4c9c-a603-1df1d18f8c58">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_819efd2e-cc9e-4b84-92ac-a2f5c32b66e3">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_2f5d2d52-3d14-41ad-93c6-00426a7fb007">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_e6e1d8a7-c831-4d63-afd0-26b3272eb21a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_bc0e54c8-1514-4869-8e7d-2665ce894a3a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_f74978d2-7dcb-4bd4-92df-1d87bab5b5b0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_e1de8ce6-c457-41a9-9f40-e45e1e543915">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_fdbe3e19-801c-422c-b5cd-0fac636c2591">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_5e30c0d4-6dac-4d6a-a98b-77a8599fe5ea">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_25e85a38-50f4-4f5d-bf5d-3a7890033a43">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_3a07d9a5-290b-4d43-a16a-5569c8c71702">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_f45a549c-ba7e-4586-8301-b2aa4abaaf62"
      decimals="-5"
      id="F_0fd93ae1-aebd-4e68-96cf-94ba6c77f46b"
      unitRef="U_USD">788100000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_5d20162d-ff61-483b-a925-f567b613c421"
      decimals="INF"
      id="F_6e5e3bb9-36f4-4b65-b247-1f9d988ea0eb"
      unitRef="U_shares">66716388</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_9d733a2c-527a-40f8-a60c-dd9f4f4a49d3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The registrant intends to file a definitive proxy statement pursuant to Regulation 14A relating to the 2023 Annual Meeting of Stockholders within 120 days of the end of the registrant&#x2019;s fiscal year ended December 31, 2022. Portions of such definitive proxy statement for the 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent stated herein.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_df27c47b-fbc6-4fba-bc6c-fc51d30467a3">Deloitte &amp; Touche, LLC</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b99a564e-e23c-4639-9457-97ea68963ea9">Boston, Massachusetts</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_d011412f-0431-444c-91d3-9fa9edb5ec01">34</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_8b263bf7-0aa5-4e77-b5d1-1e5145c10e1d"
      unitRef="U_USD">62526000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_2552a673-4262-453a-b851-83b88d911fb4"
      unitRef="U_USD">50191000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_acd8844d-67f8-458c-9258-93444208c398"
      unitRef="U_USD">284419000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_2e5c4f1e-963d-46d8-8bdd-726c0f1b0d51"
      unitRef="U_USD">45927000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_b2ebdc9d-18c8-440b-82e5-013ca539dd3a"
      unitRef="U_USD">10113000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_fa9be9a7-c1bb-4f31-afc2-e5b0057c87b1"
      unitRef="U_USD">5392000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_d86fd4d1-706e-452d-a92a-b283f6f71b39"
      unitRef="U_USD">15306000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_7c9bd857-a519-4701-ba57-4ea182cf9a51"
      unitRef="U_USD">9769000</us-gaap:InventoryNet>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_a9e74d8a-ea26-445f-b590-fcb8882ac152"
      unitRef="U_USD">3441000</us-gaap:DeferredOfferingCosts>
    <us-gaap:AssetsCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_2d3c5c5d-f2c4-4e49-9e01-fc8057e24cc0"
      unitRef="U_USD">382133000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_ae2f8a97-973d-4faa-9939-96c36e171ea5"
      unitRef="U_USD">104951000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_e4718bef-be08-435a-8bcf-b6e58f913033"
      unitRef="U_USD">2611000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_12b127f0-4275-46ff-adf6-6c6c229bdfa1"
      unitRef="U_USD">474000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_32584c5b-008d-47f8-b0d5-0eac6771f5ad"
      unitRef="U_USD">719000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_c91ad058-73f9-449a-936e-cc46644d2f42"
      unitRef="U_USD">189000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_b4bd58ba-a105-4322-9fd8-372057099f3b"
      unitRef="U_USD">5524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a7504176-86f1-4501-ac74-1822e5c1539e"
      unitRef="U_USD">466000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_e4a573e6-177e-4bc6-b8db-be86bb67e0d7"
      unitRef="U_USD">391453000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_3cb76cf7-102b-44ce-aab3-b46bca711eff"
      unitRef="U_USD">105614000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_05372cb0-b316-49e8-a434-633976eb179b"
      unitRef="U_USD">6257000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_a0299c31-a285-47a7-b9e4-698dc2072a85"
      unitRef="U_USD">4372000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_4a04f695-2ca3-45e1-a68f-0f71501623b6"
      unitRef="U_USD">38312000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_25a31934-5b39-49e8-991a-57207c3f4740"
      unitRef="U_USD">13024000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_5d5193f3-1e52-4b8d-bd90-2b052c460816"
      unitRef="U_USD">2040000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_73e93671-9415-404e-be63-4e074a123be4"
      unitRef="U_USD">46609000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_d73f3715-7804-408a-8d3b-57548b29287f"
      unitRef="U_USD">17396000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_5169c1e1-93e6-4441-8a9a-a848b1ebe5b4"
      unitRef="U_USD">4237000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_21ac45e5-0edd-4d45-8333-491d6eac9bf7"
      unitRef="U_USD">35000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_77b554ad-f96c-4202-bdd3-cc7e56db5ce7"
      unitRef="U_USD">50846000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_c1e459fa-5e21-4060-bb41-e9cac085e511"
      unitRef="U_USD">17431000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37"
      decimals="INF"
      id="F_921f8b11-61ec-42f1-ba9e-cbbdd96a3cd3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_85f3c4cc-b4b2-41b6-bb22-efd0e1199704"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37"
      decimals="INF"
      id="F_ca3c96f2-a793-4142-a801-65f1ee450cd9"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37"
      decimals="INF"
      id="F_7fa5bafe-67a9-471b-bdef-9199e32abe9b"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37"
      decimals="INF"
      id="F_d32291b5-ebd9-4dfa-86a8-b70488c5c3cc"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_4f2ed99f-a27a-4272-af16-8175d61e0e0e"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_8ca0ab97-d79a-4d58-8945-c14fe1ef3712"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_3d7436b2-aad3-45cc-90b4-a650e5ff9c85"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="-3"
      id="F_99a59eed-5e83-439b-b759-bb216521586a"
      unitRef="U_USD">7675000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18"
      decimals="INF"
      id="F_57540da8-b125-43be-8210-2403916a02fb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_37c712d3-5aea-4967-9a1c-942052092d80"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18"
      decimals="INF"
      id="F_fd3e1779-4abf-4a0b-abc5-b2799eed7c49"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_53699229-6afc-4b35-8c5f-4a8f6dfa781e"
      unitRef="U_shares">15100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18"
      decimals="INF"
      id="F_e9c26e42-7a09-4cf3-b575-5fe51a0ff280"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_e8ede704-35db-4ceb-9eac-d6536d3bcd18"
      decimals="INF"
      id="F_7b24c2a1-6aab-4ad5-9fe1-6c24dcac70ae"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_5bc0de45-1b5b-4f39-a7d0-2b935869673c"
      unitRef="U_shares">14496835</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="-3"
      id="F_43e24fc4-ccbc-4ae7-bd3c-9655e548218f"
      unitRef="U_USD">64387000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8"
      decimals="INF"
      id="F_eb38404a-fe8a-4b1f-b8d2-ab2898ce50c7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_42b6f1f5-b8ec-4906-a102-ac36c14dfba3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8"
      decimals="INF"
      id="F_8cd87d8f-44d1-4905-9e05-d7e94a074a1e"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8"
      decimals="INF"
      id="F_6a134407-746a-4c9b-945b-f739443bba44"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8"
      decimals="INF"
      id="F_d2502331-ce36-47fc-af86-c0a9fac868c1"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_7bb7f369-53f7-4b8e-b310-c54a5cad9770"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_38e2f816-7236-4999-8a9b-0e1798cfd7eb"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_5e6058d2-564e-442c-be29-309ebe5278f3"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="-3"
      id="F_de1146d4-b76e-4296-a321-80aaed067fd8"
      unitRef="U_USD">134791000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0"
      decimals="INF"
      id="F_55ce2034-82d5-403a-9ebf-11f957e821bf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_2d3eaf0b-801b-4f3e-a101-7cf911c45776"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0"
      decimals="INF"
      id="F_78f5d5ec-1474-4721-bd50-8da2f3eae553"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0"
      decimals="INF"
      id="F_201e37e6-4fff-4d5e-b7ba-45b7e13f25df"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0"
      decimals="INF"
      id="F_9fdd8ed7-61f1-448e-80e8-18f366c10683"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_4e229f28-cb50-424d-9cb8-0ad52b0e24af"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_80b63237-7c9d-4d1b-b296-6d04f3944300"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_58e0acb5-6312-4f59-837c-37cace6ec684"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="-3"
      id="F_91a29295-ea11-4f24-b325-022c227d371b"
      unitRef="U_USD">32498000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_95610720-6870-4490-8488-ec66334a97a3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_af2721b1-7367-4ab9-88ba-474c8ecb5a5d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_8f602a89-fc21-4504-8cbc-168edf8693a0"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="0"
      id="F_98bfd3dd-6a11-46dd-9bda-ab5302dcdb15"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_3a31a54d-8280-4191-996f-070299d3f7f8"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_c3a21a94-5a76-420a-be88-35a830a8ee08"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_c242fd63-bcbe-438f-89fa-dfaea5e755c6"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_588a2eed-6e67-4382-b24b-0afcd818dff4"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_ecc2f9c6-d063-4eaa-9637-3916be559c48"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_4ca54ee0-964c-4663-a365-ec50f8117239"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_5841946f-14d5-4054-8060-215297571c8e"
      unitRef="U_shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_d45352f2-8533-4b34-9987-3c9d1acbb82b"
      unitRef="U_shares">56500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_d9fc2442-50c7-4a1d-8da4-414864a6311e"
      unitRef="U_shares">66512011</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_9ab4342c-3fcb-4c82-b101-695d4e05959d"
      unitRef="U_shares">66512011</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_175482af-8948-4007-92f8-b178d5b54b60"
      unitRef="U_shares">7020487</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_dd220efd-f851-4442-ad89-34781288607e"
      unitRef="U_shares">7020487</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_d504c0f5-8bc4-4b20-864b-b1d5d50ea8e3"
      unitRef="U_USD">7000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_785af556-daf9-4d54-8c6d-3e5a7145a4dc"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_8147b71f-fcef-47c6-ba18-908e3746607b"
      unitRef="U_USD">694906000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_64b3dc27-d79c-4914-9b6e-418c77f08164"
      unitRef="U_USD">4667000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_54af923e-a25e-4bf5-946b-321dee417093"
      unitRef="U_USD">-354220000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_b39216bd-bfb7-432c-a770-bd0b53d77482"
      unitRef="U_USD">-155845000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_77b6a07f-6188-4489-9f64-ab1229de76be"
      unitRef="U_USD">-86000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_cf6bc82b-84f1-4905-916c-38959f7bd140"
      unitRef="U_USD">9000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_edc1aabc-0140-485f-8c2f-1f0712d2fa54"
      unitRef="U_USD">340607000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_1dbde163-98c8-443c-bc91-72e354bb42da"
      unitRef="U_USD">-151168000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_93cd0071-ca9b-46a4-a3dc-27f4690a6f91"
      unitRef="U_USD">391453000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_3d1c2be0-a580-4a25-8652-5c4dba2744c0"
      unitRef="U_USD">105614000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_f6c04ada-a444-49d8-9fd5-46be01718b98"
      unitRef="U_USD">22230000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_1f43571c-57e0-4676-9427-10ca6c93cbff"
      unitRef="U_USD">285000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:Revenues
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_adf801e0-ee0a-4cab-a61a-c6acb1e61698"
      unitRef="U_USD">22230000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_0d788fda-8940-42f0-b35e-4e59a3f33abd"
      unitRef="U_USD">285000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_b8671ab6-02ce-416b-a620-cd3cfdd24963"
      unitRef="U_USD">2993000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_9259333a-46a2-4757-b072-211eb544d823"
      unitRef="U_USD">93450000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_8a30b62a-d511-4b5b-8fbf-8148632342db"
      unitRef="U_USD">44040000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_78356684-57c0-4916-ba47-3739eae72fe6"
      unitRef="U_USD">127128000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_f7625cf3-1264-469f-9fcb-02d38256e2e1"
      unitRef="U_USD">38933000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_5b282279-bd3d-4fdc-8093-99e83c0f9828"
      unitRef="U_USD">223571000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_e2827989-0fa6-4589-99d8-2e2b51d57e04"
      unitRef="U_USD">82973000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_de879a22-13af-48d9-8238-23d33c058ea3"
      unitRef="U_USD">-201341000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_a667ab2a-a046-4279-aec3-32a818b741ac"
      unitRef="U_USD">-82688000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_2cd62184-8684-40df-bae4-450144d9aca2"
      unitRef="U_USD">4291000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_7b9f85b3-fb85-48d8-953f-e7d6159dea7a"
      unitRef="U_USD">36000</us-gaap:InvestmentIncomeInterest>
    <amlx:ChangeInFairValueOfConvertibleNotes
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_96965e58-1623-4aeb-8484-fe0772de849d"
      unitRef="U_USD">5228000</amlx:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_7f74d02d-6d1c-4dc1-8f69-5c35a83e990b"
      unitRef="U_USD">-551000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_fd920260-53ec-456c-9bff-878b96786ca3"
      unitRef="U_USD">-51000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_b0808000-5f7d-4857-b961-8c25c415e5c6"
      unitRef="U_USD">3740000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_4414f728-c1fb-41a0-ba3a-b3c84b7f1573"
      unitRef="U_USD">-5243000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_bfa36716-e68b-4811-afe4-8d59808b58ba"
      unitRef="U_USD">-197601000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_8cd5503a-ad2d-4814-a271-846226410f04"
      unitRef="U_USD">-87931000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_f3ef9d3e-9807-416c-af1f-2f917db5d86f"
      unitRef="U_USD">774000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e27b6b42-069a-46cd-99e6-1a1e9fa1cb11"
      unitRef="U_USD">-198375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_b9424878-92a9-48a6-8ee9-bcacce7adba1"
      unitRef="U_USD">-87931000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="2"
      id="F_d42ddaff-2dae-4d1b-8499-0de4f2c16a80"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="2"
      id="F_3b451039-7752-4db0-869d-e9709144fce8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-3.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="2"
      id="F_48a00a70-6018-47cb-9a1a-8c949ed914ae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-13.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="2"
      id="F_afe2ee3c-bf3b-4d29-8495-43d717c9c820"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-13.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="0"
      id="F_77795725-d3ee-4316-926d-a0b62606cb96"
      unitRef="U_shares">58495587</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="0"
      id="F_92f013d5-efd4-4bd2-9c3a-7dac64b77cd5"
      unitRef="U_shares">58495587</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="0"
      id="F_1357e06e-3ef5-42ca-8b6d-7af669bd75cf"
      unitRef="U_shares">6586349</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="0"
      id="F_96d50733-9919-4026-912d-cd852328724a"
      unitRef="U_shares">6586349</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_10df8f56-bc75-479b-b975-8915c4583a61"
      unitRef="U_USD">-198375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_7db9de1f-9610-4890-9a09-ed43370fc891"
      unitRef="U_USD">-87931000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e1add0c3-1547-4c53-a55b-ff9622f11a5f"
      unitRef="U_USD">-69000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_1d7aadb0-b5d6-4066-a487-d00c316c3bfc"
      unitRef="U_USD">14000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_2d3238af-7a3c-4510-8cfb-b794733082a8"
      unitRef="U_USD">-26000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_c1ebbbbb-0f80-4a80-bfd6-285f78eefef1"
      unitRef="U_USD">-5000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_126d588a-4162-4d04-9580-5d057ce8a5c4"
      unitRef="U_USD">-95000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_ba0c18d7-fb4b-43cb-a5fb-8b281b70a7a7"
      unitRef="U_USD">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_f02a1c92-eeac-444c-be75-b7b88d3d0077"
      unitRef="U_USD">-198470000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_842e0725-2db5-4f2f-ad66-68e32610a087"
      unitRef="U_USD">-87922000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_70137d1c-ebe4-41cf-9891-6c732ce3bf02"
      decimals="INF"
      id="F_a4eaf2f7-690d-4356-af22-d4fc936a8f3e"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_70137d1c-ebe4-41cf-9891-6c732ce3bf02"
      decimals="-3"
      id="F_6a10b758-46d7-40d4-b6d6-4a292d768b88"
      unitRef="U_USD">7675000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_f6726908-1236-47a4-adbd-73f904c12140"
      decimals="INF"
      id="F_b1d49af8-dcfb-49a2-b9f0-01f32e53ce4a"
      unitRef="U_shares">14496835</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_f6726908-1236-47a4-adbd-73f904c12140"
      decimals="-3"
      id="F_120f6fb7-e5be-4610-b712-70355d2ed360"
      unitRef="U_USD">64387000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_553959d9-0a46-4ddf-909a-9d7b7705481a"
      decimals="INF"
      id="F_d67e7ed4-b474-4f67-a0aa-c79004e2656a"
      unitRef="U_shares">6137206</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_553959d9-0a46-4ddf-909a-9d7b7705481a"
      decimals="-3"
      id="F_77d0c028-670a-44f7-9381-dd9d6b21225c"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5d94ca99-5668-447a-a76f-db70b18b7074"
      decimals="-3"
      id="F_482c4b76-1c6c-4066-af1c-4960dfd15887"
      unitRef="U_USD">1188000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5c14c4d0-550c-4966-97a1-233f1dab5e56"
      decimals="-3"
      id="F_6f921130-5e95-4a5a-8e92-e5fe90d097f3"
      unitRef="U_USD">-67914000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5"
      decimals="-3"
      id="F_715c1ce0-4417-445a-9abb-0ead215008a1"
      unitRef="U_USD">-66725000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b"
      decimals="-3"
      id="F_f2458640-69b0-4ee1-a469-34999f1f6d01"
      unitRef="U_USD">209000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b"
      decimals="INF"
      id="F_a428ca72-7c91-4844-b7f5-8585d409c97e"
      unitRef="U_shares">13150430</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b"
      decimals="-3"
      id="F_74ade447-cd63-4874-8db9-a6d84dabb0d4"
      unitRef="U_USD">134791000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_39501136-cb81-4f29-8e8b-cfc14116de19"
      decimals="-3"
      id="F_7025a0a8-dac6-4ed0-b94a-b77c665b9bef"
      unitRef="U_USD">50000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_39501136-cb81-4f29-8e8b-cfc14116de19"
      decimals="INF"
      id="F_52d17210-9c4c-4555-af54-ebae339d2605"
      unitRef="U_shares">3170585</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_39501136-cb81-4f29-8e8b-cfc14116de19"
      decimals="-3"
      id="F_62733c63-a55c-47a2-89a1-bae5e01fe55b"
      unitRef="U_USD">-32498000</amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_94da0a41-0a0d-4e46-8905-4827ae10dd95"
      decimals="INF"
      id="F_b09ef21e-500b-4b08-adba-0cf59b1a9ca4"
      unitRef="U_shares">883281</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_50031187-fee3-48b0-9289-0c569c7a76e8"
      decimals="-3"
      id="F_5ef94586-623e-4bf2-af96-9e147c7ca17e"
      unitRef="U_USD">343000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_4a96d9e3-133e-4fb1-9b2f-b95136cda7dd"
      unitRef="U_USD">343000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_50031187-fee3-48b0-9289-0c569c7a76e8"
      decimals="-3"
      id="F_5b128fe9-8242-4b65-9c0b-13229535fce7"
      unitRef="U_USD">3136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_bfb08a89-ff4b-46de-a4e4-a0b74ce5b3f2"
      unitRef="U_USD">3136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="C_56faeaab-7811-48f5-9a7b-1727a455eccf"
      decimals="-3"
      id="F_2b394a15-374c-4b53-acbe-6704948db3f3"
      unitRef="U_USD">9000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_e2581ae2-dbea-4c92-b4ac-90f201b1a11f"
      unitRef="U_USD">9000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_a7b22ec5-138f-422c-b0c5-18df666aa608"
      decimals="-3"
      id="F_6ba7fc18-fd0e-4d19-a287-b17679e3b67e"
      unitRef="U_USD">-87931000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_9819c65c-70c1-497c-8d86-0c803b10e6c7"
      unitRef="U_USD">-87931000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_cbf8ac07-9d10-403e-9cde-1c1e08c80483"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="-3"
      id="F_515010ad-8400-4e99-b37d-43fbee4a6ac7"
      unitRef="U_USD">7675000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_f4685c34-30e9-4142-8cd2-a3ff51713107"
      unitRef="U_shares">14496835</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="-3"
      id="F_cce84d09-13a9-446d-99d8-0930a28ed546"
      unitRef="U_USD">64387000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_30c75b98-8810-456a-9bea-0540413fad68"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="-3"
      id="F_cf78226f-e98d-4752-bd03-fcdb1bb1dce5"
      unitRef="U_USD">134791000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_2577c469-d2da-4dad-bde9-5435cefa0fcf"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="-3"
      id="F_eff6f5d7-5be6-4838-8a28-543c2fcaeda3"
      unitRef="U_USD">32498000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1795c86d-1f84-4b6f-bce6-5ee68242829e"
      decimals="INF"
      id="F_bb5b7519-4615-44a0-8b91-5c5faefb1ff5"
      unitRef="U_shares">7020487</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_1795c86d-1f84-4b6f-bce6-5ee68242829e"
      decimals="-3"
      id="F_930903ff-b895-4af0-bb5c-5610c0c7a09c"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f6313c55-c8cf-4075-acc2-41e176752918"
      decimals="-3"
      id="F_d37c5afc-855f-49a6-bf36-327856f1c6f8"
      unitRef="U_USD">4667000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_549fc533-bfde-4f49-a811-86f15c3760d3"
      decimals="-3"
      id="F_ebf19b58-9f4a-42d2-bd08-9451de14d151"
      unitRef="U_USD">9000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_d64feb49-4e55-46df-a08d-e78148f7d88d"
      decimals="-3"
      id="F_967a7f2a-abd2-44e5-9f42-40750b765ddf"
      unitRef="U_USD">-155845000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_b19714fd-c555-4d28-9cbb-86c1d45c447a"
      unitRef="U_USD">-151168000</us-gaap:StockholdersEquity>
    <amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_9ad669f7-07c3-4bda-a43c-720981a44374"
      decimals="INF"
      id="F_7b31d0fc-9178-4fad-8751-90f64f4a422b"
      unitRef="U_shares">6289609</amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_9ad669f7-07c3-4bda-a43c-720981a44374"
      decimals="-3"
      id="F_709b3faa-33d6-4812-a298-6d77a670ed9e"
      unitRef="U_USD">7675000</amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6"
      decimals="INF"
      id="F_431b2af8-1611-4428-bf2a-6f9e8a2657d4"
      unitRef="U_shares">14496835</amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6"
      decimals="-3"
      id="F_52787390-f4ae-4c42-bb1e-d83249db6311"
      unitRef="U_USD">64387000</amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_67f5ad96-461d-4e37-81d1-e8d93683af31"
      decimals="INF"
      id="F_dddce9ea-282d-4c89-8f4c-0d9d55ea7d50"
      unitRef="U_shares">13150430</amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_67f5ad96-461d-4e37-81d1-e8d93683af31"
      decimals="-3"
      id="F_cbf32cee-4415-4e9b-89a9-52c754268a1f"
      unitRef="U_USD">134791000</amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_8d3cc07f-ae47-4903-9e9b-b86bea983319"
      decimals="INF"
      id="F_03ebb67e-b5f9-4372-af03-a7363947dd02"
      unitRef="U_shares">3170585</amlx:TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering
      contextRef="C_8d3cc07f-ae47-4903-9e9b-b86bea983319"
      decimals="-3"
      id="F_b376110e-6d5b-4059-ac05-400c1580cbf5"
      unitRef="U_USD">32498000</amlx:TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744"
      decimals="INF"
      id="F_77fcc160-192b-4eea-81b5-516b45ca7a36"
      unitRef="U_shares">39474330</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744"
      decimals="-3"
      id="F_cf16ab3f-e122-4ed0-8617-92cc0b12299f"
      unitRef="U_USD">4000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61"
      decimals="-3"
      id="F_d233e510-f05d-4fc2-94a0-626dcce6efb3"
      unitRef="U_USD">239347000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_7cae7abc-419e-4d41-b925-50d3ad1ad2a5"
      unitRef="U_USD">239351000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_9a535ad1-aee6-4191-aba0-d4c01e4db958"
      decimals="-3"
      id="F_1f7b9033-3859-4f5f-bb26-523da1051769"
      unitRef="U_USD">19639000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744"
      decimals="INF"
      id="F_29ee0000-df6d-42f9-8ca0-ff9b7b66c2c8"
      unitRef="U_shares">11369369</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744"
      decimals="-3"
      id="F_9ab23498-6186-4338-8fa6-c14417d9d664"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61"
      decimals="-3"
      id="F_63981630-3785-4b17-9da7-c53a6aa8cead"
      unitRef="U_USD">196378000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_b92d08ba-70bb-41f7-8506-917519e5e5ba"
      unitRef="U_USD">196379000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0"
      decimals="-3"
      id="F_fc6273ba-a298-45d2-9674-0619faf24cdf"
      unitRef="U_USD">15719000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0"
      decimals="INF"
      id="F_13e24e91-96c2-49b5-8cc5-ff2bde5fad06"
      unitRef="U_shares">7697812</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_d0e62e7b-9299-4973-bcb1-2e5aae91e4b0"
      decimals="-3"
      id="F_6781111a-0971-423c-b47b-b1f46feefb6e"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_683b28ae-40e1-400c-8515-d6776df26f52"
      decimals="-3"
      id="F_902c25f5-0118-48e7-be8c-610ca037d9bf"
      unitRef="U_USD">230611000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_1b19ab6a-5a41-473b-9be7-fb23ebcb6e9d"
      decimals="-3"
      id="F_1870168d-0e54-4e32-aa47-68bf6b837571"
      unitRef="U_USD">230612000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_850c76e4-ca88-4f27-b305-1aade8432744"
      decimals="INF"
      id="F_d218acad-c9b7-4f22-9075-ce2dbe6ff097"
      unitRef="U_shares">950013</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61"
      decimals="-3"
      id="F_667bec94-1ee0-43bc-843a-3516d1cfe034"
      unitRef="U_USD">2189000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_07e85c93-340b-42c0-9c02-5e6b1c0c4a0c"
      unitRef="U_USD">2189000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_dc698754-4dd5-48cc-b030-8ba72e728f61"
      decimals="-3"
      id="F_16e73cb9-2a0a-47b6-b7f0-9a75f3f832fe"
      unitRef="U_USD">21714000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_4a1311ba-12f6-4c83-bbbe-ff516cb498f4"
      unitRef="U_USD">21714000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="C_40b2caa1-f574-483f-8a57-fe01ea935692"
      decimals="-3"
      id="F_80f738ab-c2ec-4e0c-a4a9-8cd02141c0ca"
      unitRef="U_USD">-95000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_bb603e47-4d1c-4cd7-a897-0e84fa99ee2f"
      unitRef="U_USD">-95000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_16551b59-7779-49cd-bf47-05ce2620a5c0"
      decimals="-3"
      id="F_ad04c1a4-ff9a-4b9e-b30b-4332e44b4f6b"
      unitRef="U_USD">-198375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_2445f560-baf5-49b5-9a1e-c220cc668ab1"
      unitRef="U_USD">-198375000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_7285cd01-49fc-4356-bb9e-b960696d9340"
      decimals="INF"
      id="F_2ca360c8-407c-437b-85d1-fecb400f2cf0"
      unitRef="U_shares">66512011</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_7285cd01-49fc-4356-bb9e-b960696d9340"
      decimals="-3"
      id="F_db8fb878-5eb4-4b60-8b4e-cda6a4020cbf"
      unitRef="U_USD">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3fc7d41f-a882-4639-88a8-f660f437b33b"
      decimals="-3"
      id="F_73eefcef-24a0-499c-a3c2-e9624947af63"
      unitRef="U_USD">694906000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0ffaedee-aadb-4322-b862-e53422451646"
      decimals="-3"
      id="F_e240e7cc-8f24-411e-8e11-58129cda666d"
      unitRef="U_USD">86000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f1dd14d9-2a2a-42df-bd70-17b7c328d628"
      decimals="-3"
      id="F_cf21373b-8039-42a5-b19d-ee2b2cf9a65d"
      unitRef="U_USD">-354220000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_e6bf8016-50f6-4983-b648-b35544fec227"
      unitRef="U_USD">340607000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_3ffb7842-4a50-4dd8-adb4-32e745841b02"
      unitRef="U_USD">-198375000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_296184ce-8a11-4b1c-8b30-3feebed60844"
      unitRef="U_USD">-87931000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_67e52394-9b60-47ed-b4cb-0f312508b11a"
      unitRef="U_USD">21714000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_9118c96c-116d-45b2-8dc8-b1a118207cc1"
      unitRef="U_USD">3136000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_cb9d8b50-1b58-4fd5-b20b-9c5ca24bf6a7"
      unitRef="U_USD">487000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_b851dc8e-3a4c-40b8-beb7-509c9f3ea984"
      unitRef="U_USD">52000</us-gaap:Depreciation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_d1b193df-b0eb-4a8e-b2e9-4c78f3ace5ca"
      unitRef="U_USD">2056000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_79476912-474f-4913-9620-359b178ccfb5"
      unitRef="U_USD">-121000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <amlx:ChangeInFairValueOfConvertibleNotes
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_171c28a8-7c82-4212-8bff-2bc8bfe9fef7"
      unitRef="U_USD">5228000</amlx:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e8121577-1b73-4208-a870-3bcddf95ef6e"
      unitRef="U_USD">15306000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_7827ab9e-4fdf-4946-9a6a-30423b0bd566"
      unitRef="U_USD">9769000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e52a35e3-bfcb-46e4-9426-d7915a1d545c"
      unitRef="U_USD">-487000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_a71dc772-bbde-400a-9dd7-64c125494818"
      unitRef="U_USD">144000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_3a348c29-9ead-44be-97a0-66c0ec34e181"
      unitRef="U_USD">5221000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_87f613a8-2010-4dd7-bf30-14d9575994cf"
      unitRef="U_USD">4486000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <amlx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_9ca0c8bd-df3b-4be6-bd6f-c518cd725614"
      unitRef="U_USD">1635000</amlx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e6ad4723-bb1e-49a1-a89c-838c8603e6bb"
      unitRef="U_USD">456000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_df404ec1-b9fa-42a4-8ea6-d29b4a11ba6e"
      unitRef="U_USD">-125000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_537a5951-e101-4a0c-a2f3-eacd154b6415"
      unitRef="U_USD">1854000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_c11ea84a-94d9-4b0b-85f2-9fa2b0ecba97"
      unitRef="U_USD">670000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <amlx:IncreaseDecreaseInAccruedExpensesAndDeferredRent
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_09af080e-e2d6-4f72-9caa-e60143985cc9"
      unitRef="U_USD">26052000</amlx:IncreaseDecreaseInAccruedExpensesAndDeferredRent>
    <amlx:IncreaseDecreaseInAccruedExpensesAndDeferredRent
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_f3d4013b-3d0c-480a-a1f8-3fca49df1e62"
      unitRef="U_USD">8432000</amlx:IncreaseDecreaseInAccruedExpensesAndDeferredRent>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_577a5323-555a-469e-9618-ee451dd4a5e8"
      unitRef="U_USD">-917000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <amlx:IncreaseDecreaseInAccruedInterestsDuetoRelatedParties
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_ec2dd4f3-5bc1-467a-87ff-4fcb54427904"
      unitRef="U_USD">-2000</amlx:IncreaseDecreaseInAccruedInterestsDuetoRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_1d4a0610-2474-45c2-b6db-295183386b4a"
      unitRef="U_USD">-179871000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_da21cf56-10d3-4f54-95cc-6d19c98d6e51"
      unitRef="U_USD">-74799000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_46f9efab-1888-4897-b6ef-f41b64519462"
      unitRef="U_USD">2526000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_a030d41f-219d-4134-b773-20d095b99f9f"
      unitRef="U_USD">353000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_c8b81113-37ca-456d-a151-d6c4d6111051"
      unitRef="U_USD">415873000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_075837b3-975e-4287-8089-02f7c515f7a2"
      unitRef="U_USD">49053000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_24e7ac8d-bd18-4887-8a43-8c56b2471d8b"
      unitRef="U_USD">179411000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_faa8c861-f275-4b8f-96ac-3dcb1f3c8e9e"
      unitRef="U_USD">3000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_bb80f597-532c-4531-bcd0-02a7f5fb37c2"
      unitRef="U_USD">-238988000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_4281d363-8291-4293-99e5-102ddee912c1"
      unitRef="U_USD">-46406000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <amlx:ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_72222c3a-a4dc-4a9d-95c1-2c85a4121621"
      unitRef="U_USD">-263000</amlx:ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_1bafc2bf-7ce9-437e-b1fa-249c2ea525ea"
      unitRef="U_USD">200897000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <amlx:ProceedsFromFollowOnOffering
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_34e6bdba-00d8-4e4f-bd3e-bd6b71dd08ab"
      unitRef="U_USD">231550000</amlx:ProceedsFromFollowOnOffering>
    <amlx:InitialPublicOfferingCostPaid
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_ac2e0395-df24-4706-adf5-677d382968bf"
      unitRef="U_USD">2044000</amlx:InitialPublicOfferingCostPaid>
    <amlx:FollowOnOfferingCostsPaid
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_085b6ea6-22ac-472a-bbb7-f94ee3ad09a6"
      unitRef="U_USD">803000</amlx:FollowOnOfferingCostsPaid>
    <amlx:ProceedsFromIssuanceOfConvertibleNotesRelatedParties
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_f03d42e1-e413-4104-91af-3848c58f01d9"
      unitRef="U_USD">14272000</amlx:ProceedsFromIssuanceOfConvertibleNotesRelatedParties>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_34d823e1-a5a6-414c-a1f9-19eceeb7a5a1"
      unitRef="U_USD">11887000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <amlx:IssuanceCostsRelatedToConversionOfConvertibleNotes
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_a0617186-f960-423e-80d2-c4f9acc5bd0a"
      unitRef="U_USD">50000</amlx:IssuanceCostsRelatedToConversionOfConvertibleNotes>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_46a37e85-b281-42f0-93c3-654d180bebe9"
      unitRef="U_USD">135000000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <amlx:IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_f2e1d7f7-dcb5-46c9-93a4-3997c11e61bf"
      unitRef="U_USD">209000</amlx:IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_1c9a69d5-f557-439e-923f-2bd315bac325"
      unitRef="U_USD">2189000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_49655d51-8eb1-4395-8551-4009e2b20d74"
      unitRef="U_USD">343000</us-gaap:ProceedsFromStockOptionsExercised>
    <amlx:PaymentOfDeferredOfferingCosts
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_17dbdf4f-e9eb-4b5f-906f-1b65ee7e20fd"
      unitRef="U_USD">2474000</amlx:PaymentOfDeferredOfferingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_7c7ce382-9a5c-4338-8af8-49e6f723ea5e"
      unitRef="U_USD">431789000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_fde1c17f-aa3b-46e6-b7e2-9d87e784bfe5"
      unitRef="U_USD">158506000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e4ded8f6-1820-440b-9f11-eac4004f9981"
      unitRef="U_USD">-65000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_fc6dce5b-427f-4db1-9680-6113a06c8986"
      unitRef="U_USD">13000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_3e38ab01-727c-4ecd-beb9-5318bac65382"
      unitRef="U_USD">12865000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_638377f0-ed5b-45a5-b152-d8d146c38acb"
      unitRef="U_USD">37314000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_22a859d5-3d97-47d5-b7e1-24a03e6368f5"
      unitRef="U_USD">50380000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5"
      decimals="-3"
      id="F_31916ee8-9723-4563-bd18-95b866633568"
      unitRef="U_USD">13066000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_53c710e6-d91d-4f9d-92a3-bb937bfdab46"
      unitRef="U_USD">63245000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_8eb89bdc-181e-4c95-a504-b95515847101"
      unitRef="U_USD">50380000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <amlx:ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_54ef2f67-2abd-4b87-9238-ae7c9035e02d"
      unitRef="U_USD">32548000</amlx:ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_5666c126-ef4d-4624-82d1-e5570b919537"
      unitRef="U_USD">26000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_f9cad788-42ed-4816-85f2-82bf67ae0f56"
      unitRef="U_USD">5000</us-gaap:UnrealizedGainLossOnInvestments>
    <amlx:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_f4b7d804-4869-4648-b9dc-6c6268d1a1ae"
      unitRef="U_USD">98000</amlx:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable>
    <amlx:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_16a2275a-4d03-4489-ac57-1c84c7d785f9"
      unitRef="U_USD">22000</amlx:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable>
    <amlx:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_39904bdd-1ba6-4669-bdb4-009ca959e8db"
      unitRef="U_USD">967000</amlx:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses>
    <amlx:RightOfUseAssetsAndLiabilitiesUponAsc842Adoption
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_1aaa4cb2-ca7e-46e5-9468-6ac3ca574f9b"
      unitRef="U_USD">2201000</amlx:RightOfUseAssetsAndLiabilitiesUponAsc842Adoption>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_5d21a9e4-f731-4875-b1be-e60314460cf2"
      unitRef="U_USD">4958000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <amlx:MovementOfDeferredOfferingCostsToEquity
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_dc0b2059-dad6-491f-8f07-baf13e11d0f3"
      unitRef="U_USD">5457000</amlx:MovementOfDeferredOfferingCostsToEquity>
    <amlx:FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_bf21ea94-6fe7-4a77-a04e-6d8d3b59a33c"
      unitRef="U_USD">136000</amlx:FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses>
    <amlx:ConversionOfPreferredStockToCommonStockUponInitialPublicOffering
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_c58d2203-6b18-4d4f-959b-60b9b8f12e64"
      unitRef="U_USD">239351000</amlx:ConversionOfPreferredStockToCommonStockUponInitialPublicOffering>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_206e96c7-061d-4163-bdfe-85a98669b02a"
      unitRef="U_USD">27000</us-gaap:IncomeTaxesPaid>
    <us-gaap:NatureOfOperations
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_06a527fb-e069-4cc5-bea0-19e23bda161d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1. Nature of Business&lt;/span&gt;&lt;span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amylyx Pharmaceuticals, Inc., together with its wholly owned subsidiaries, known as Amylyx or the Company, is a commercial-stage biotechnology company with a mission to one day end the suffering caused by neurodegenerative diseases. The Company is focused on the development and potential global commercialization of its product candidate, AMX0035 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis, or ALS.  Our first product, RELYVRIO&#xae; (sodium phenylbutyrate and taurursodiol), previously known as AMX0035 in the U.S., is approved in the U.S. for the treatment of ALS in adults. AMX0035 is also approved with conditions by Health Canada and marketed as ALBRIOZA for the treatment of ALS in Canada. The Company&#x2019;s Marketing Authorisation Application, or MAA, for AMX0035 for the treatment of ALS remains under review by the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA. The Company is developing AMX0035 for other neurodegenerative diseases by leveraging its unique knowledge and relationships in the neurodegenerative space.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is subject to risks and uncertainties common to companies in the biotechnology industry, including, but not limited to, the outcome of preclinical studies and clinical trials, market acceptance and the successful commercialization of ALBRIOZA, which received marketing authorization with conditions in Canada in June 2022, and RELYVRIO, which was approved by the FDA in the U.S. in September 2022, potential difficulties with or delays in timing with respect to the regulatory approval processes of the EMA and other comparable foreign authorities, development by competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, ability to secure additional capital to fund operations, and risks associated with the economic challenges caused by the COVID-19 pandemic and economic uncertainty in various global markets caused by geopolitical instability and conflict. The Company and its contractors may experience disruptions in supply of items that are essential for its research and development and commercial activities, including, for example, raw materials and bulk drug substances that the Company imports from Europe and Canada used in the manufacturing of AMX0035, and any future product candidates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Going Concern&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In accordance with Accounting Standards Update, or ASU, 2014-15,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Disclosure of Uncertainties About an Entity&#x2019;s Ability to Continue as a Going Concern (Subtopic 205-40)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company has evaluated whether there are conditions and events that raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. &lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Since its inception, the Company has devoted substantially all of its efforts to research and development and pre-commercialization activities, including recruiting management and technical staff, raising capital, producing materials for preclinical studies and clinical trials, and building infrastructure to support such activities. Expenses have primarily been for research and development and related general and administrative costs, and we anticipate that our selling, general and administrative expenses will continue to increase in the future as we further increase our headcount to support our continued research activities and development of AMX0035 and as we continue to increase headcount and incur other significant costs related to our commercialization activities. The Company has generated revenues through five grants from the ALS Association, ALS Finding a Cure Foundation, Cure Alzheimer&#x2019;s Fund, Alzheimer&#x2019;s Drug Discovery Foundation and Alzheimer&#x2019;s Association, or Grantors. In addition to money received from its grants, the Company has also financed its operations through the public offering of its common stock, private sales of preferred stock, and convertible notes, and more recently through revenue from sales of RELYVRIO and ALBRIOZA in the U.S. and Canada, respectively. &lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and negative cash flows from operations since inception. As of December 31, 2022, the Company&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;had an accumulated deficit of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;354.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The Company expects its operating losses and negative operating cash flows may continue into the future as it continues initial sales of ALBRIOZA in Canada and RELYVRIO in the U.S., and continues to build capabilities and develop AMX0035, and any future product candidates. The Company expects that its cash, cash equivalents and short-term investments as of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and product revenue from RELYVRIO and ALBRIOZA sales, will enable the Company to fund its ongoing operating expenses and capital expenditure requirements for at least the twelve-month period following the issuance of these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-5"
      id="F_ffee74a8-87d2-40ed-bfbc-a9a5f501e859"
      unitRef="U_USD">-354200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_8ee9d560-4899-4412-8fb7-e8835b6d3f71">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation and Consolidation&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the U.S., or GAAP, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification, or ASC, and ASU of the Financial Accounting Standards Board, or FASB.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. Management&#x2019;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: Gross-to-net, or GTN, adjustments, inventory, determining the fair value of convertible notes, accrued expenses, stock-based compensation, operating lease right-of-use assets and lease liabilities, valuation allowance for deferred tax assets and research and development expenses.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue recognition&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and the Company launched ALBRIOZA in Canada in July 2022. In September 2022, AMX0035 received approval as RELYVRIO by the FDA for the treatment of ALS in adults, and the Company launched RELYVRIO in the U.S. in October 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company enters into arrangements with wholesalers, specialty pharmacies and specialty distributors, or Customers, to distribute ALBRIOZA, RELYVRIO and future approved products. In accordance with ASC Topic 606 - &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or Topic 606, revenue is recognized when the customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;To determine revenue recognition for arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the Company will collect the consideration the Company expects to be entitled to in exchange for the goods or services the Company transfers to its customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Product Revenue, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company sells its approved products to its Customers. These Customers subsequently resell our products to specialty pharmacy providers, other retail pharmacies, health care providers, certain medical centers or hospitals, and patients. In addition to agreements with the Customers, the Company enters into arrangements with specialty pharmacies, health care providers and payors that provide for government mandated and/or privately negotiated rebates with respect to the purchase of our products. The Company&#x2019;s customer identification process considers a number of factors, including contractual and legal factors, and who controls the Company&#x2019;s product and bears inventory risk. The Company evaluates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;these factors on a customer-by-customer basis to determine the appropriate customer for revenue recognition purposes. In some cases, the Company may use a third-party logistics providers to deliver the Company&#x2019;s product to its customers, but the Company recognizes revenue upon delivery to the customer, as its determined that the third-party logistics provider is acting as our agent. Changes in these factors or our assumptions regarding these factors could impact our revenue recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes revenue on product sales when the Customer obtains control of our product, which occurs at a point in time (upon delivery). Product revenues are recorded net of applicable GTN adjustments, which are described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If taxes should be collected from Customers relating to product sales and remitted to governmental authorities, they will be excluded from revenue. The Company expenses incremental costs of obtaining a contract when incurred, if the expected amortization period of the asset that the Company would have recognized is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; or less. However, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; such costs were incurred during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;GTN Adjustments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration related to certain GTN adjustments. Components of GTN adjustments include trade discounts and allowances, product returns, third-party payor rebates, and other allowances that are offered within contracts between the Company, its Customers and payors relating to the sale of our products. These GTN adjustments, as detailed below, are based on the amounts earned, or to be claimed on the related sales, and are classified as reductions of accounts receivable (if the amount is payable to the Customer) or a current liability (if the amount is payable to a party other than a Customer). These estimates take into consideration a range of possible outcomes which are probability-weighted in accordance with the expected value method in Topic 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. In certain circumstances, the Company applies the most likely method in Topic 606 . The determination to use the expected value method or the most likely method is based on the type of GTN adjustment and what method better predicts the amount of consideration we expect to be entitled to. Overall, these GTN adjustments reflect in the transaction price the amount of consideration to which the Company expects to be entitled to in exchange for transferring promised goods or services to its Customers.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The amount of variable consideration which is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from our estimates, the Company will adjust these estimates, which would affect product revenue, net and earnings in the period such variances become known.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Trade Discounts and Allowances&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company generally provides Customers with prompt payment discounts and pay fees for distribution services and for certain data that distributors provide to us that are explicitly stated in our contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. Payment from Customers is typically due within 30 calendar days of the invoice date, without consideration to the prompt payment discounts.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Product Returns&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Consistent with industry practice, the Company generally offers Customers a limited right of return for product that has been purchased from the Company based on the product&#x2019;s expiration date, which is set to lapse within a specified period stated in the contract. Additionally, our limited right of return policy allows for eligible returns from Customers in circumstances where product was shipped in error or was damaged in shipping, or product was returned pursuant to an official drug recall.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the amount of product sales that may be returned by our Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net on the consolidated balance sheets. The Company currently estimates returns using quantitative and qualitative information including, but not limited to, expected experience with returns, projected demand, levels of inventory in the distribution channel, product dating and expiration period, and whether products have been discontinued, among&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;others. The Company has received an immaterial amount of returns to date and believe that returns of product in future periods will be minimal.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Provider Chargebacks and Discounts&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase the product from the Company. Customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These GTN adjustments are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable, net. GTN adjustments for chargebacks consist of credits that Customers have not claimed, but for which we expect to issue for units that remain in the distribution channel inventories at each reporting period-end that we expect will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which we have not yet issued a credit.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Payor Rebates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company contracts with certain government and private payor organizations, primarily government and commercial health insurance companies, for the payment of rebates with respect to utilization of our products. The Company is subject to discount obligations under state Medicaid programs and Medicare. These GTN adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities on the consolidated balance sheets. For Medicare, the Company also estimates the number of patients in the prescription drug coverage gap for whom it will owe an additional liability under the Medicare Part D program. The Company's liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product that has been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Other Incentives&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other incentives which the Company offers include voluntary patient assistance programs, such as its co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with prescription drug co-payments required by payors. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with product that has been recognized as revenue for each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Grant Revenue&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Grant revenue consists of amounts earned from performing contracted research and development services. The grants between the Company and the Grantors generally provide for the Company to meet certain research milestones in order for funds to be provided. The Company accounts for grants received to perform research and development services in accordance with ASC 730-20, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Arrangements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which requires an assessment, at the inception of the grant, of whether the grant is a liability or a contract to perform research and development services for others. If the Company is obligated to repay the grant funds to the Grantor regardless of the outcome of the research and development activities, then the Company is required to estimate and recognize that liability. Alternatively, if the Company is not required to repay, or if it is required to repay the grant funds only if the research and development activities are successful, then the grant agreement is accounted for as a contract to perform research and development services for others, in which case, grant revenue is recognized as the related research and development expenses are incurred. The Company obtained funding from the Grantors of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; during the years ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, which was recorded as grant revenue in the Company&#x2019;s consolidated statements of operations. Under the terms of the grants, the Company will be required to pay royalties upon occurrence of contingent future events (see Note 18).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Comprehensive loss includes net loss, as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders. Comprehensive loss is composed of net loss and other comprehensive (loss) income. Other comprehensive (loss) income consists of unrealized gains and losses on marketable securities and foreign currency translation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&#x2014;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Cash equivalents represent funds invested in readily available checking and money market funds.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Cash Equivalents&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash equivalents consist of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of cash serving as collateral for a letter of credit issued for the Company&#x2019;s office space, and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as collateral for a corporate credit card program. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, the Company&#x2019;s restricted cash equivalents balance was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounts receivable, net&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s accounts receivable consists of amounts due from Customers related to product sales and have standard payment terms. The Company analyzes accounts that are past due for collectability. Given the nature collectability of the Company&#x2019;s accounts receivable to-date, an allowance for doubtful accounts is not deemed necessary at December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Short-Term Investments&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments are composed of treasury notes and bills, corporate debt securities, commercial paper and agency bonds with maturities of less than one year from the balance sheet date. The Company classifies all of its short-term investments as available-for-sale. Accordingly, these investments are recorded at fair value, which is determined based on quoted market prices. Unrealized gains and losses on available-for-sale securities are included as a separate component of other accumulated comprehensive loss. The cost of short-term investments is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. Realized gains and losses are included in other expense, net. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other than temporary-than-temporary are also included in other income, net.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. As of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, there were no impairment charges on short-term investments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Concentrations of Credit Risk&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable, net. The Company maintains its cash in financial institutions that it believes have high credit quality. The Company has not experienced any losses on such accounts, and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s accounts receivable, net at December 31, 2022, represents amounts due to the Company from customers. Amylyx performs ongoing credit evaluations of its customers and generally does not require collateral. The Company monitors its exposure and records a reserve against uncollectible amounts as necessary. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Four&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; customers individually accounted for approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;97&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of total gross product revenue in 2022 and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; customers individually accounted for approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of total accounts receivable, net as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Note&#x2014;Derivative&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company reviews the terms of the convertible note issued to determine whether there are features, including redemption and conversion features, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at the end of each reporting period and immediately prior to the conversion or the extinguishment of the convertible note. Changes in the fair value are reported in the consolidated statement of operations. When the convertible note contains embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those host instruments being recorded at a discount from their face value. The discount from the face value of the convertible note, together with the stated interest on the host instrument, is amortized over the life of the host instrument through periodic charges to interest expense. The Company&#x2019;s convertible notes, as further discussed in Note 8, had embedded derivatives that required bifurcation from the host instrument.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Note&#x2014;Beneficial Conversion Feature&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If the conversion feature is not treated as a derivative, the Company assesses whether it is a beneficial conversion feature, or BCF. A BCF exists if the conversion price of the convertible note is less than the price of the stock into which it is convertible to on the commitment date. This typically occurs when the conversion price is less than the fair value of the stock on the date the instrument was issued. The value of a BCF is equal to the intrinsic value of the feature, the difference between the effective conversion price and the fair value of the stock into which it is convertible to and is recorded as additional paid-in capital and as a debt discount in the consolidated balance sheets. The Company amortizes the debt discount as non-cash interest expense over the life of the underlying convertible note using the effective interest method. If the convertible note is retired early, the associated debt discount is then recognized immediately as non-cash interest expense in the consolidated statements of operations. If the conversion feature does not qualify for either the derivative treatment or as a BCF, the convertible note is treated as traditional debt.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurements&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets and liabilities recorded at fair value on a recurring basis on the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Quoted prices in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s financial instruments consist of cash, cash equivalents, restricted cash equivalents, short-term investments, accounts receivable, net, accounts payable and accrued expenses. The Company&#x2019;s short-term investments are carried at fair value, determined according to Level 1 and Level 2 inputs to the fair value hierarchy described above. The Company&#x2019;s 2021 Notes (as defined in Note 8) were carried at fair value, determined according to Level 3 inputs in the fair value hierarchy described above. The remaining financial instruments are stated at their respective carrying amounts, which approximate fair value due to the short-term nature of these assets and liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Inventories&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company values its inventories at the lower of cost or estimated net realizable value. The Company determines the cost of its inventories, which includes amounts related to materials and manufacturing overhead, on a first-in, first-out basis. The Company performs an assessment of the recoverability of capitalized inventory during each reporting period, and it writes down any excess and obsolete inventories to their estimated realizable value in the period in which the impairment is first identified. Such impairment charges, should they occur, are recorded within cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required which would be recorded as cost of sales in the consolidated statements of operations.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company capitalizes inventory costs associated with the Company&#x2019;s products after regulatory approval when, based on management&#x2019;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory acquired prior to receipt of regulatory approval of a product candidate is expensed as research and development expense as incurred. Inventory that can be used in either the production of clinical or commercial product is initially capitalized and subsequently expensed as research and development expense when materials are released to production for use in the manufacture of drugs still in development.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Deferred Offering Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings, including the initial public offering, or IPO, as deferred costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;until &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;such financings are consummated. After consummation of the equity financing, these costs are recorded in stockholders&#x2019; equity (deficit) as a reduction of proceeds generated as a result of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. After consummation of equity financings, the Company recorded deferred offering costs in stockholders&#x2019; equity (deficit) of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively. The Company recorded deferred offering costs of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which are included in the consolidated balance sheet as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment, net&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not improve or extend the life of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and accumulated depreciation are removed from the consolidated balance sheets and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The range of useful lives of property and equipment is as follows: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:49.087%;"/&gt;
          &lt;td style="width:1.835%;"/&gt;
          &lt;td style="width:49.077%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lesser of the estimated life or remaining lease term&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer hardware and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Not depreciated&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company evaluates assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t recognized any impairment losses in the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses include costs directly attributable to the conduct of research and development activities. Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. In addition, research and development-related salaries and benefits, facility, and overhead costs, supplies and other related costs are included in research and development expense.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Sales and Marketing Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Patent-Related Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as selling, general and administrative expenses in the accompanying consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation Expense&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for stock-based compensation under the provisions of ASC 718-10,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations based on their fair values on the date of grant over the requisite service period, which is generally equal to the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues stock option awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company classifies stock-based compensation expense in the same manner in which the awards recipient&#x2019;s payroll or service provider&#x2019;s costs are classified.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the award, the risk-free interest rate, and expected dividends. The Company estimates its expected stock price volatility based on the historical volatility of publicly traded peer companies. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain vanilla&#x201d; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. There is no expected dividend yield since the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future. The stock price of the Company is based on the closing price on the date of grant. Prior to the IPO, as there was no public market for the Company&#x2019;s common stock, the estimated fair value of common stock was determined by the Company&#x2019;s Board of Directors as of the date of each option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#x2019;s Board of Directors&#x2019; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Valuation of Privately Held Company Equity Securities Issued as Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Contingencies&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability on the Company&#x2019;s consolidated balance sheets. The Company does not accrue for contingent losses that, in its judgement, are considered to be reasonably possible, but not probable; however, it discloses the range of reasonably possible losses. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; loss or gain contingencies recorded in the Company&#x2019;s consolidated financial statements as of and during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company adopted the FASB, ASC 842, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;or&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ASC 842, on January 1, 2022. ASC 842 allows the Company to elect a package of practical expedients, which include: (i) an entity need not reassess whether any expired or existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existing leases; and (iii) an entity need not reassess any initial direct costs for any existing leases. Another practical expedient allows the Company to use hindsight in determining the lease term when considering lessee options to extend or terminate the lease and to purchase the underlying asset. The Company has elected to utilize this package of practical expedients and has not elected the hindsight methodology in its implementation of ASC 842.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company leases its offices, and may from time to time, enter into other lease agreements in conducting its business. The Company determines if an arrangement includes a lease at the inception of the agreement. For each of the Company&#x2019;s lease arrangements, the Company records a right-of-use asset representing the Company&#x2019;s right to use an underlying asset for the lease term and a lease liability representing the Company&#x2019;s obligation to make lease payments. Operating lease right-of-use assets and operating lease liabilities are recognized at the lease commencement date based on the net present value of the remaining future minimum lease payments over the lease term. If the interest rate implicit in the Company&#x2019;s leases is not readily determinable, in determining the weighted-average discount rate used to calculate the net present value of lease payments, the Company utilizes an estimate of its incremental borrowing rate based on market sources including interest rates for companies with similar credit quality for agreements of similar duration, determined by class of underlying asset, to discount the lease payments. Lease expense for the Company&#x2019;s operating leases is recognized on a straight-line basis over the lease term and variable lease costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company elected the practical expedient not to apply the recognition and measurement requirements to short-term leases, which is any lease with a term of one year or less as of the lease commencement date. The lease may require the Company to pay additional amounts for taxes, insurance, maintenance, and other expenses, which are generally referred to as non-lease components. The Company has elected the practical expedient to combine lease and non-lease components. If a lease includes options to extend the lease term, the Company does not assume the option will be exercised in its initial lease term assessment unless there is reasonable certainty that the Company will renew based on an assessment of economic factors present as of the lease commencement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prior to the adoption of ASC 842, at the inception of each lease, the Company evaluated the lease agreement to determine whether the lease was an operating or capital lease in accordance with &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;ASC 840, Leases (ASC 840)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. When any one of the four test criteria in ASC 840 was met, the lease then qualified as a capital lease. If the lease agreements contained renewal options, tenant improvement allowances, rent holidays or rent escalation clauses, the Company recorded a deferred rent asset or liability equal to the difference between the rent expense and future minimum lease payments due. The rent&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;expense related to operating leases was recognized on a straight-line basis in the statements of operations over the term of each lease. The Company did not have financing leases as of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the position is sustainable based on its technical merits. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has not incurred interest and penalties related to uncertain tax positions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#x2019;s evaluation of all available evidence, including our history of incurring significant losses from operations. Our evaluation of all available evidence also includes consideration of regulatory approvals of ALBRIOZA and RELYVRIO, including revenue generated from the sale these products in 2022.  Given the early stage of our product launch, we are uncertain about the timing and amount of future sales. We may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Segment Information&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;An operating segment is defined as a component of a business that engages in business activities for which it may earn revenues and incur expenses and for which discrete financial information is available that is evaluated regularly by the chief operating decision maker or makers in order to make decisions about resources to be allocated to the segment and assess its performance. The Company has determined that its CO-Chief Executive Officers are the chief operating decision makers, or CODM. The CODM reviews consolidated operating results to make decisions about allocating resources or capital to specific compounds or projects in line with the Company&#x2019;s overall strategies and goals. The Company's entire business is managed by a single management team, which reports to the CO-Chief Executive Officers. The Company has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorders. For the years ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, all of the Company's long-lived assets were held within the U.S.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net income (loss) per share&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. For purpose of this calculation, stock options, convertible notes, and redeemable convertible preferred stock are considered potential dilutive common shares.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s redeemable convertible preferred stock contractually entitles the holders of such shares to participate in dividends but does not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reports a net loss attributable to common stockholders, such losses are not allocated to such participating securities. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Emerging Growth Company Status&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Company is an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act, and may take advantage of certain exemptions&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;from &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;various reporting requirements that are applicable to other public companies that are not EGCs. The Company may take advantage of these exemptions until it is no longer an EGC under Section 107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#x2019; effective dates. The Company intends to take advantage of the reduced reporting requirements and exemptions up until the last day of the fiscal year following the fifth anniversary of an offering or such earlier time that it is no longer an EGC.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;New Accounting Pronouncements Not Yet Adopted&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU No. 2016-13,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Financial Instruments&#x2014;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2016-13. The provisions of ASU 2016-13 modify the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology and require a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the consolidated balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Financial Instruments&#x2014;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except Securities and Exchange Commission filers that are not smaller reporting companies. ASU 2016-13 will be effective for the Company for the period beginning January 1, 2023. The Company intends to adopt the ASU when it becomes effective. The Company is currently evaluating the impact of this ASU and does not expect that adoption of this standard will have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective January 1, 2022, the Company adopted the requirements under the ASC 842 using the cumulative effect adjustment transition option. Comparative periods have not been restated. This standard requires entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet. The Company elected the available package of practical expedients which allows it to not reassess previous accounting conclusions around whether arrangements are or contain leases, the classification of its leases, and the treatment of initial direct costs. The Company has made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet. ASC 842 was issued in order to increase transparency and comparability of financial reporting related to leasing arrangements. The main difference between previous GAAP, or ASC 840, and ASC 842 is the recognition of right-of-use lease assets and lease liabilities by lessees for those leases that were classified as operating leases under ASC 840. At January 1, 2022, the Company recorded right-of-use assets of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and operating lease liabilities of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. Adoption of the standard did not have a material impact on the consolidated statements of operations. For additional information regarding how the Company is accounting for leases under ASC 842, refer to Note 10.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_a4c0c452-cc03-4c1f-8e61-726f7714b3f3">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation and Consolidation&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the U.S., or GAAP, and include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification, or ASC, and ASU of the Financial Accounting Standards Board, or FASB.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_15e0ed86-4128-4146-b34b-20131c07073a">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. Management&#x2019;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: Gross-to-net, or GTN, adjustments, inventory, determining the fair value of convertible notes, accrued expenses, stock-based compensation, operating lease right-of-use assets and lease liabilities, valuation allowance for deferred tax assets and research and development expenses.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_66d2b1c0-f594-4e20-ab43-145bf9ee25f9">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue recognition&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2022, AMX0035 received marketing authorization with conditions as ALBRIOZA by Health Canada for the treatment of ALS, and the Company launched ALBRIOZA in Canada in July 2022. In September 2022, AMX0035 received approval as RELYVRIO by the FDA for the treatment of ALS in adults, and the Company launched RELYVRIO in the U.S. in October 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company enters into arrangements with wholesalers, specialty pharmacies and specialty distributors, or Customers, to distribute ALBRIOZA, RELYVRIO and future approved products. In accordance with ASC Topic 606 - &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or Topic 606, revenue is recognized when the customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;To determine revenue recognition for arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under Topic 606, including when it is probable that the Company will collect the consideration the Company expects to be entitled to in exchange for the goods or services the Company transfers to its customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Product Revenue, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company sells its approved products to its Customers. These Customers subsequently resell our products to specialty pharmacy providers, other retail pharmacies, health care providers, certain medical centers or hospitals, and patients. In addition to agreements with the Customers, the Company enters into arrangements with specialty pharmacies, health care providers and payors that provide for government mandated and/or privately negotiated rebates with respect to the purchase of our products. The Company&#x2019;s customer identification process considers a number of factors, including contractual and legal factors, and who controls the Company&#x2019;s product and bears inventory risk. The Company evaluates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;these factors on a customer-by-customer basis to determine the appropriate customer for revenue recognition purposes. In some cases, the Company may use a third-party logistics providers to deliver the Company&#x2019;s product to its customers, but the Company recognizes revenue upon delivery to the customer, as its determined that the third-party logistics provider is acting as our agent. Changes in these factors or our assumptions regarding these factors could impact our revenue recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes revenue on product sales when the Customer obtains control of our product, which occurs at a point in time (upon delivery). Product revenues are recorded net of applicable GTN adjustments, which are described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If taxes should be collected from Customers relating to product sales and remitted to governmental authorities, they will be excluded from revenue. The Company expenses incremental costs of obtaining a contract when incurred, if the expected amortization period of the asset that the Company would have recognized is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; or less. However, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; such costs were incurred during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;GTN Adjustments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration related to certain GTN adjustments. Components of GTN adjustments include trade discounts and allowances, product returns, third-party payor rebates, and other allowances that are offered within contracts between the Company, its Customers and payors relating to the sale of our products. These GTN adjustments, as detailed below, are based on the amounts earned, or to be claimed on the related sales, and are classified as reductions of accounts receivable (if the amount is payable to the Customer) or a current liability (if the amount is payable to a party other than a Customer). These estimates take into consideration a range of possible outcomes which are probability-weighted in accordance with the expected value method in Topic 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. In certain circumstances, the Company applies the most likely method in Topic 606 . The determination to use the expected value method or the most likely method is based on the type of GTN adjustment and what method better predicts the amount of consideration we expect to be entitled to. Overall, these GTN adjustments reflect in the transaction price the amount of consideration to which the Company expects to be entitled to in exchange for transferring promised goods or services to its Customers.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The amount of variable consideration which is included in the transaction price may be constrained and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. Actual amounts of consideration ultimately received may differ from our estimates. If actual results in the future vary from our estimates, the Company will adjust these estimates, which would affect product revenue, net and earnings in the period such variances become known.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Trade Discounts and Allowances&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company generally provides Customers with prompt payment discounts and pay fees for distribution services and for certain data that distributors provide to us that are explicitly stated in our contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. Payment from Customers is typically due within 30 calendar days of the invoice date, without consideration to the prompt payment discounts.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Product Returns&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Consistent with industry practice, the Company generally offers Customers a limited right of return for product that has been purchased from the Company based on the product&#x2019;s expiration date, which is set to lapse within a specified period stated in the contract. Additionally, our limited right of return policy allows for eligible returns from Customers in circumstances where product was shipped in error or was damaged in shipping, or product was returned pursuant to an official drug recall.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the amount of product sales that may be returned by our Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net on the consolidated balance sheets. The Company currently estimates returns using quantitative and qualitative information including, but not limited to, expected experience with returns, projected demand, levels of inventory in the distribution channel, product dating and expiration period, and whether products have been discontinued, among&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;others. The Company has received an immaterial amount of returns to date and believe that returns of product in future periods will be minimal.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Provider Chargebacks and Discounts&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase the product from the Company. Customers charge the Company for the difference between what they pay for the product and the ultimate selling price to the qualified healthcare providers. These GTN adjustments are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable, net. GTN adjustments for chargebacks consist of credits that Customers have not claimed, but for which we expect to issue for units that remain in the distribution channel inventories at each reporting period-end that we expect will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which we have not yet issued a credit.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Payor Rebates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company contracts with certain government and private payor organizations, primarily government and commercial health insurance companies, for the payment of rebates with respect to utilization of our products. The Company is subject to discount obligations under state Medicaid programs and Medicare. These GTN adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities on the consolidated balance sheets. For Medicare, the Company also estimates the number of patients in the prescription drug coverage gap for whom it will owe an additional liability under the Medicare Part D program. The Company's liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product that has been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Other Incentives&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other incentives which the Company offers include voluntary patient assistance programs, such as its co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with prescription drug co-payments required by payors. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with product that has been recognized as revenue for each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included as a component of accrued expenses and other current liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <amlx:AmortizationRecognizedPeriod
      contextRef="C_5eab5a92-c382-47c2-b472-12d901ce62a0"
      id="F_3bb6a212-5202-48e8-be80-9156035c551d">P1Y</amlx:AmortizationRecognizedPeriod>
    <amlx:IncrementalCostsExpenses
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_c11a6564-82fd-4808-9553-3aeea08475d5"
      unitRef="U_USD">0</amlx:IncrementalCostsExpenses>
    <amlx:IncrementalCostsExpenses
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_2147b744-5125-4f42-bc9e-f0c8ac0d4ca9"
      unitRef="U_USD">0</amlx:IncrementalCostsExpenses>
    <amlx:GrantRevenuePolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_1eacd81a-1574-4b4d-a5c8-0cf52120949b">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Grant Revenue&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Grant revenue consists of amounts earned from performing contracted research and development services. The grants between the Company and the Grantors generally provide for the Company to meet certain research milestones in order for funds to be provided. The Company accounts for grants received to perform research and development services in accordance with ASC 730-20, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Arrangements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which requires an assessment, at the inception of the grant, of whether the grant is a liability or a contract to perform research and development services for others. If the Company is obligated to repay the grant funds to the Grantor regardless of the outcome of the research and development activities, then the Company is required to estimate and recognize that liability. Alternatively, if the Company is not required to repay, or if it is required to repay the grant funds only if the research and development activities are successful, then the grant agreement is accounted for as a contract to perform research and development services for others, in which case, grant revenue is recognized as the related research and development expenses are incurred. The Company obtained funding from the Grantors of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; during the years ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, which was recorded as grant revenue in the Company&#x2019;s consolidated statements of operations. Under the terms of the grants, the Company will be required to pay royalties upon occurrence of contingent future events (see Note 18).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</amlx:GrantRevenuePolicyPolicyTextBlock>
    <us-gaap:ProceedsFromGrantors
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="0"
      id="F_e189312e-893c-4c75-b12f-f45a32f69855"
      unitRef="U_USD">0</us-gaap:ProceedsFromGrantors>
    <us-gaap:ProceedsFromGrantors
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-5"
      id="F_32351270-aa1c-46b5-83d6-c78dab0a5317"
      unitRef="U_USD">300000</us-gaap:ProceedsFromGrantors>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_eb944dcb-523b-4712-b122-77cdf9ac09f4">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Comprehensive loss includes net loss, as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders. Comprehensive loss is composed of net loss and other comprehensive (loss) income. Other comprehensive (loss) income consists of unrealized gains and losses on marketable securities and foreign currency translation.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6b85999a-bd14-40ec-88c4-62fe7096b296">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&#x2014;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Cash equivalents represent funds invested in readily available checking and money market funds.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <amlx:CashAndCashEquivalentsMaturityDateDescription
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_55502d5b-af75-46b4-a9fb-b4323bd824b7">The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</amlx:CashAndCashEquivalentsMaturityDateDescription>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_00d208d5-226f-4e2f-8acd-603d78421473">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Cash Equivalents&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash equivalents consist of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of cash serving as collateral for a letter of credit issued for the Company&#x2019;s office space, and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as collateral for a corporate credit card program. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, the Company&#x2019;s restricted cash equivalents balance was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_13345d35-56b6-4c29-9548-08d0bb84c9d1"
      decimals="-5"
      id="F_5873ee4f-954f-49f9-967e-b8951c63d39d"
      unitRef="U_USD">200000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_abe6a82a-1d40-4eb5-8cb4-6e4904b35dfe"
      decimals="-5"
      id="F_22702601-9360-4b00-811f-7223550fe26f"
      unitRef="U_USD">500000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-5"
      id="F_3d31a67b-3b9b-4682-9266-89429aa6ce17"
      unitRef="U_USD">700000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-5"
      id="F_9d8119c3-8a47-48a4-aee0-24b6780fbc11"
      unitRef="U_USD">200000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_c43ff9c8-42b1-46c0-be1e-9ba0cea339c3">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounts receivable, net&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s accounts receivable consists of amounts due from Customers related to product sales and have standard payment terms. The Company analyzes accounts that are past due for collectability. Given the nature collectability of the Company&#x2019;s accounts receivable to-date, an allowance for doubtful accounts is not deemed necessary at December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6c46f693-7eaf-4b17-8ca7-e212c4e9d057">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Short-Term Investments&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments are composed of treasury notes and bills, corporate debt securities, commercial paper and agency bonds with maturities of less than one year from the balance sheet date. The Company classifies all of its short-term investments as available-for-sale. Accordingly, these investments are recorded at fair value, which is determined based on quoted market prices. Unrealized gains and losses on available-for-sale securities are included as a separate component of other accumulated comprehensive loss. The cost of short-term investments is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. Realized gains and losses are included in other expense, net. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other than temporary-than-temporary are also included in other income, net.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. As of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, there were no impairment charges on short-term investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_76404fde-1459-4807-91b9-90c555cb7991">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Concentrations of Credit Risk&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable, net. The Company maintains its cash in financial institutions that it believes have high credit quality. The Company has not experienced any losses on such accounts, and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s accounts receivable, net at December 31, 2022, represents amounts due to the Company from customers. Amylyx performs ongoing credit evaluations of its customers and generally does not require collateral. The Company monitors its exposure and records a reserve against uncollectible amounts as necessary. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Four&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; customers individually accounted for approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;97&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of total gross product revenue in 2022 and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; customers individually accounted for approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of total accounts receivable, net as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Note&#x2014;Derivative&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company reviews the terms of the convertible note issued to determine whether there are features, including redemption and conversion features, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one embedded derivative instrument that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at the end of each reporting period and immediately prior to the conversion or the extinguishment of the convertible note. Changes in the fair value are reported in the consolidated statement of operations. When the convertible note contains embedded derivative instruments that are to be bifurcated and accounted for as liabilities, the total proceeds received are first allocated to the fair value of all the bifurcated derivative instruments. The remaining proceeds, if any, are then allocated to the host instruments themselves, usually resulting in those host instruments being recorded at a discount from their face value. The discount from the face value of the convertible note, together with the stated interest on the host instrument, is amortized over the life of the host instrument through periodic charges to interest expense. The Company&#x2019;s convertible notes, as further discussed in Note 8, had embedded derivatives that required bifurcation from the host instrument.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Note&#x2014;Beneficial Conversion Feature&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If the conversion feature is not treated as a derivative, the Company assesses whether it is a beneficial conversion feature, or BCF. A BCF exists if the conversion price of the convertible note is less than the price of the stock into which it is convertible to on the commitment date. This typically occurs when the conversion price is less than the fair value of the stock on the date the instrument was issued. The value of a BCF is equal to the intrinsic value of the feature, the difference between the effective conversion price and the fair value of the stock into which it is convertible to and is recorded as additional paid-in capital and as a debt discount in the consolidated balance sheets. The Company amortizes the debt discount as non-cash interest expense over the life of the underlying convertible note using the effective interest method. If the convertible note is retired early, the associated debt discount is then recognized immediately as non-cash interest expense in the consolidated statements of operations. If the conversion feature does not qualify for either the derivative treatment or as a BCF, the convertible note is treated as traditional debt.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <amlx:NumberOfCustomers
      contextRef="C_ba231c4d-9d94-4fef-ac80-e42200cc6579"
      decimals="INF"
      id="F_e71ccca3-1b19-4233-bf44-062b694ec5fd"
      unitRef="U_Customer">4</amlx:NumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_ba231c4d-9d94-4fef-ac80-e42200cc6579"
      decimals="2"
      id="F_ea131083-f5e4-4dd6-80b9-aa580529b054"
      unitRef="U_pure">0.97</us-gaap:ConcentrationRiskPercentage1>
    <amlx:NumberOfCustomers
      contextRef="C_03c3a593-4c98-403a-bc7f-a023ed103fae"
      decimals="INF"
      id="F_2b426b2f-f431-4299-97ac-a6534f99a0be"
      unitRef="U_Customer">3</amlx:NumberOfCustomers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_03c3a593-4c98-403a-bc7f-a023ed103fae"
      decimals="2"
      id="F_e2a7c0ea-59b9-4095-b4f1-f11783f90116"
      unitRef="U_pure">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_1ef299d0-ffb6-4308-addf-df9af63111d6">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurements&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets and liabilities recorded at fair value on a recurring basis on the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Quoted prices in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s financial instruments consist of cash, cash equivalents, restricted cash equivalents, short-term investments, accounts receivable, net, accounts payable and accrued expenses. The Company&#x2019;s short-term investments are carried at fair value, determined according to Level 1 and Level 2 inputs to the fair value hierarchy described above. The Company&#x2019;s 2021 Notes (as defined in Note 8) were carried at fair value, determined according to Level 3 inputs in the fair value hierarchy described above. The remaining financial instruments are stated at their respective carrying amounts, which approximate fair value due to the short-term nature of these assets and liabilities.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7fdfed1c-e182-42fd-8a93-ccc048cac368">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Inventories&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company values its inventories at the lower of cost or estimated net realizable value. The Company determines the cost of its inventories, which includes amounts related to materials and manufacturing overhead, on a first-in, first-out basis. The Company performs an assessment of the recoverability of capitalized inventory during each reporting period, and it writes down any excess and obsolete inventories to their estimated realizable value in the period in which the impairment is first identified. Such impairment charges, should they occur, are recorded within cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required which would be recorded as cost of sales in the consolidated statements of operations.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company capitalizes inventory costs associated with the Company&#x2019;s products after regulatory approval when, based on management&#x2019;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory acquired prior to receipt of regulatory approval of a product candidate is expensed as research and development expense as incurred. Inventory that can be used in either the production of clinical or commercial product is initially capitalized and subsequently expensed as research and development expense when materials are released to production for use in the manufacture of drugs still in development.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_deddcaed-c6fd-4113-ba77-ce5c20cf2e4c">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Deferred Offering Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings, including the initial public offering, or IPO, as deferred costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;until &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;such financings are consummated. After consummation of the equity financing, these costs are recorded in stockholders&#x2019; equity (deficit) as a reduction of proceeds generated as a result of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the consolidated statements of operations. After consummation of equity financings, the Company recorded deferred offering costs in stockholders&#x2019; equity (deficit) of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively. The Company recorded deferred offering costs of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which are included in the consolidated balance sheet as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <amlx:DeferredOfferingCostNetOfEquityFinancing
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-5"
      id="F_b4d7143e-9e60-4f18-aaa8-5116d9b8bc2f"
      unitRef="U_USD">5500000</amlx:DeferredOfferingCostNetOfEquityFinancing>
    <amlx:DeferredOfferingCostNetOfEquityFinancing
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="0"
      id="F_ca1b3bcf-a8ad-4ed1-928f-39d76688e4b8"
      unitRef="U_USD">0</amlx:DeferredOfferingCostNetOfEquityFinancing>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_bce9c64f-7e97-4905-902c-3703a0a9f92c"
      unitRef="U_USD">0</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-5"
      id="F_1c7d8c93-6d8e-41e4-86a8-2c896447c16e"
      unitRef="U_USD">3400000</us-gaap:DeferredOfferingCosts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6545078b-b2b5-4564-a696-64341d063d84">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment, net&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the respective assets. Maintenance and repairs that do not improve or extend the life of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and accumulated depreciation are removed from the consolidated balance sheets and any resulting gain or loss is reflected in the consolidated statements of operations in the period realized. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The range of useful lives of property and equipment is as follows: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:49.087%;"/&gt;
          &lt;td style="width:1.835%;"/&gt;
          &lt;td style="width:49.077%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lesser of the estimated life or remaining lease term&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer hardware and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Not depreciated&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <amlx:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_176b2cbc-8d26-4ca9-9fb2-af1b69f88609">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The range of useful lives of property and equipment is as follows: &lt;/span&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:49.087%;"/&gt;
          &lt;td style="width:1.835%;"/&gt;
          &lt;td style="width:49.077%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lesser of the estimated life or remaining lease term&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer hardware and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Not depreciated&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</amlx:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_39eac193-4dc1-4fb2-9a13-3e7cfe206bcc"
      id="F_ca84df1f-6eec-4757-9c2b-60d5e3123498">Lesser of the estimated life or remaining lease term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_dda99674-7cd7-4b03-a6bb-3b26b37d15e6"
      id="F_50341cb1-d683-455e-bfaf-4470334c9d0f">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_7f70242f-b16e-425b-9687-ab456c6af1c5"
      id="F_6526736a-0be6-45f2-a0a5-ddb1f4b80076">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_4df5bd26-0f2a-4551-be73-d1993ae98fe2"
      id="F_278e090a-5833-4c82-a3c1-c24f6a121fbe">Not depreciated</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_4d6f402f-87b8-438a-bb8f-49e1c0e86b63">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company evaluates assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t recognized any impairment losses in the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_9eba8e0f-62d9-4164-9c37-e56d0f727909"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_669c4dcc-a790-417a-9eac-b6ec950fa3b4"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6134d605-a386-4c94-a6bb-6850541b6763">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses include costs directly attributable to the conduct of research and development activities. Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. In addition, research and development-related salaries and benefits, facility, and overhead costs, supplies and other related costs are included in research and development expense.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Sales and Marketing Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <amlx:SalesAndMarketingCostsPolicyPolicyTextblock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_a7f1420d-0029-406d-b046-1dd91fd88c06">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Sales and Marketing Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Sales and marketing expenses consist primarily of wages and benefits for sales and marketing personnel, professional and consulting fees, administrative travel expenses, and marketing and advertising costs such as marketing literature, promotional activities, conferences and seminars and branding. Sales and marketing costs are expensed as incurred and included in selling, general and administrative expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</amlx:SalesAndMarketingCostsPolicyPolicyTextblock>
    <amlx:PatentRelatedCostsPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7eed0ca0-be71-4a6b-9686-d335ab9c4755">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Patent-Related Costs&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as selling, general and administrative expenses in the accompanying consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</amlx:PatentRelatedCostsPolicyPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_5203796c-5585-4233-837b-8b82a208ec88">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation Expense&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for stock-based compensation under the provisions of ASC 718-10,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations based on their fair values on the date of grant over the requisite service period, which is generally equal to the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues stock option awards with only service-based vesting conditions and records the expense for these awards using the straight-line method. The Company classifies stock-based compensation expense in the same manner in which the awards recipient&#x2019;s payroll or service provider&#x2019;s costs are classified.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the expected stock price volatility, the expected term of the award, the risk-free interest rate, and expected dividends. The Company estimates its expected stock price volatility based on the historical volatility of publicly traded peer companies. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d; method for awards that qualify as &#x201c;plain vanilla&#x201d; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. There is no expected dividend yield since the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends in the foreseeable future. The stock price of the Company is based on the closing price on the date of grant. Prior to the IPO, as there was no public market for the Company&#x2019;s common stock, the estimated fair value of common stock was determined by the Company&#x2019;s Board of Directors as of the date of each option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#x2019;s Board of Directors&#x2019; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Valuation of Privately Held Company Equity Securities Issued as Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_c690a7d7-6267-4e0f-a63c-f3b04cfa5032">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Contingencies&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability on the Company&#x2019;s consolidated balance sheets. The Company does not accrue for contingent losses that, in its judgement, are considered to be reasonably possible, but not probable; however, it discloses the range of reasonably possible losses. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; loss or gain contingencies recorded in the Company&#x2019;s consolidated financial statements as of and during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <amlx:GainContingencyRecordedAmount
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_e64890c2-871a-4058-898c-82d9d02542b8"
      unitRef="U_USD">0</amlx:GainContingencyRecordedAmount>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_d678a744-88d1-484e-b9a1-7baba3850975"
      unitRef="U_USD">-0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_daf0ed07-d667-43b8-97ed-4e2ddb8656f2"
      unitRef="U_USD">-0</us-gaap:LossContingencyLossInPeriod>
    <amlx:GainContingencyRecordedAmount
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_62567656-34c3-4606-b3d1-4d253e6ec0cd"
      unitRef="U_USD">0</amlx:GainContingencyRecordedAmount>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_acaed8ae-1eca-4895-b77d-3472deaf0760">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company adopted the FASB, ASC 842, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;or&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ASC 842, on January 1, 2022. ASC 842 allows the Company to elect a package of practical expedients, which include: (i) an entity need not reassess whether any expired or existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existing leases; and (iii) an entity need not reassess any initial direct costs for any existing leases. Another practical expedient allows the Company to use hindsight in determining the lease term when considering lessee options to extend or terminate the lease and to purchase the underlying asset. The Company has elected to utilize this package of practical expedients and has not elected the hindsight methodology in its implementation of ASC 842.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company leases its offices, and may from time to time, enter into other lease agreements in conducting its business. The Company determines if an arrangement includes a lease at the inception of the agreement. For each of the Company&#x2019;s lease arrangements, the Company records a right-of-use asset representing the Company&#x2019;s right to use an underlying asset for the lease term and a lease liability representing the Company&#x2019;s obligation to make lease payments. Operating lease right-of-use assets and operating lease liabilities are recognized at the lease commencement date based on the net present value of the remaining future minimum lease payments over the lease term. If the interest rate implicit in the Company&#x2019;s leases is not readily determinable, in determining the weighted-average discount rate used to calculate the net present value of lease payments, the Company utilizes an estimate of its incremental borrowing rate based on market sources including interest rates for companies with similar credit quality for agreements of similar duration, determined by class of underlying asset, to discount the lease payments. Lease expense for the Company&#x2019;s operating leases is recognized on a straight-line basis over the lease term and variable lease costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company elected the practical expedient not to apply the recognition and measurement requirements to short-term leases, which is any lease with a term of one year or less as of the lease commencement date. The lease may require the Company to pay additional amounts for taxes, insurance, maintenance, and other expenses, which are generally referred to as non-lease components. The Company has elected the practical expedient to combine lease and non-lease components. If a lease includes options to extend the lease term, the Company does not assume the option will be exercised in its initial lease term assessment unless there is reasonable certainty that the Company will renew based on an assessment of economic factors present as of the lease commencement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prior to the adoption of ASC 842, at the inception of each lease, the Company evaluated the lease agreement to determine whether the lease was an operating or capital lease in accordance with &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;ASC 840, Leases (ASC 840)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. When any one of the four test criteria in ASC 840 was met, the lease then qualified as a capital lease. If the lease agreements contained renewal options, tenant improvement allowances, rent holidays or rent escalation clauses, the Company recorded a deferred rent asset or liability equal to the difference between the rent expense and future minimum lease payments due. The rent&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;expense related to operating leases was recognized on a straight-line basis in the statements of operations over the term of each lease. The Company did not have financing leases as of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_069425ff-2dda-4e89-adb3-3f95e1c6db64">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the position is sustainable based on its technical merits. The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has not incurred interest and penalties related to uncertain tax positions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#x2019;s evaluation of all available evidence, including our history of incurring significant losses from operations. Our evaluation of all available evidence also includes consideration of regulatory approvals of ALBRIOZA and RELYVRIO, including revenue generated from the sale these products in 2022.  Given the early stage of our product launch, we are uncertain about the timing and amount of future sales. We may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_a485619c-979c-43c0-b71f-6a7164f5be0b">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Segment Information&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;An operating segment is defined as a component of a business that engages in business activities for which it may earn revenues and incur expenses and for which discrete financial information is available that is evaluated regularly by the chief operating decision maker or makers in order to make decisions about resources to be allocated to the segment and assess its performance. The Company has determined that its CO-Chief Executive Officers are the chief operating decision makers, or CODM. The CODM reviews consolidated operating results to make decisions about allocating resources or capital to specific compounds or projects in line with the Company&#x2019;s overall strategies and goals. The Company's entire business is managed by a single management team, which reports to the CO-Chief Executive Officers. The Company has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorders. For the years ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, all of the Company's long-lived assets were held within the U.S.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6fb4dbbb-64ad-4a2a-9e98-c29f4deeae1e">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net income (loss) per share&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company follows the two-class method when computing net income (loss) per share as the Company has issued shares that meet the definition of participating securities. The two-class method determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. For purpose of this calculation, stock options, convertible notes, and redeemable convertible preferred stock are considered potential dilutive common shares.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s redeemable convertible preferred stock contractually entitles the holders of such shares to participate in dividends but does not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reports a net loss attributable to common stockholders, such losses are not allocated to such participating securities. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <amlx:EmergingGrowthCompanyStatusPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_727ffaed-b103-4a45-bf3a-407782aa52b6">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Emerging Growth Company Status&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Company is an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act, and may take advantage of certain exemptions&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;from &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;various reporting requirements that are applicable to other public companies that are not EGCs. The Company may take advantage of these exemptions until it is no longer an EGC under Section 107 of the JOBS Act and has elected to use the extended transition period for complying with new or revised accounting standards. As a result of this election, the Company&#x2019;s consolidated financial statements may not be comparable to companies that comply with public company FASB standards&#x2019; effective dates. The Company intends to take advantage of the reduced reporting requirements and exemptions up until the last day of the fiscal year following the fifth anniversary of an offering or such earlier time that it is no longer an EGC.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</amlx:EmergingGrowthCompanyStatusPolicyPolicyTextBlock>
    <amlx:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_a0cd6f3e-2f8b-49ac-b7f8-c2d0be297104">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;New Accounting Pronouncements Not Yet Adopted&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU No. 2016-13,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Financial Instruments&#x2014;Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2016-13. The provisions of ASU 2016-13 modify the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology and require a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. ASU 2016-13 requires a cumulative effect adjustment to the consolidated balance sheet as of the beginning of the first reporting period in which the guidance is effective. In November 2019, the FASB issued ASU 2019-10,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Financial Instruments&#x2014;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which defers the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for all entities except Securities and Exchange Commission filers that are not smaller reporting companies. ASU 2016-13 will be effective for the Company for the period beginning January 1, 2023. The Company intends to adopt the ASU when it becomes effective. The Company is currently evaluating the impact of this ASU and does not expect that adoption of this standard will have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</amlx:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_96cc8369-74e5-48d5-bbb2-6d59fd9745d5">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective January 1, 2022, the Company adopted the requirements under the ASC 842 using the cumulative effect adjustment transition option. Comparative periods have not been restated. This standard requires entities that lease assets to recognize the assets and liabilities for the rights and obligations created by those leases on the balance sheet. The Company elected the available package of practical expedients which allows it to not reassess previous accounting conclusions around whether arrangements are or contain leases, the classification of its leases, and the treatment of initial direct costs. The Company has made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet. ASC 842 was issued in order to increase transparency and comparability of financial reporting related to leasing arrangements. The main difference between previous GAAP, or ASC 840, and ASC 842 is the recognition of right-of-use lease assets and lease liabilities by lessees for those leases that were classified as operating leases under ASC 840. At January 1, 2022, the Company recorded right-of-use assets of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and operating lease liabilities of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. Adoption of the standard did not have a material impact on the consolidated statements of operations. For additional information regarding how the Company is accounting for leases under ASC 842, refer to Note 10.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_5213ac10-0852-427d-9169-258edff8126e"
      decimals="-5"
      id="F_d6dcabda-5c0f-4a7a-9f99-0fb0cda45435"
      unitRef="U_USD">2200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_5213ac10-0852-427d-9169-258edff8126e"
      decimals="-5"
      id="F_a11219cd-2a02-46b1-b3a5-1730fafbef7e"
      unitRef="U_USD">2200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_47295d9d-1009-404e-9287-4f9ad9a9e203">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3. PRODUCT REVENUE, NET&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;To date, the Company&#x2019;s only source of product revenue has been from the sales of RELYVRIO, known as ALBRIOZA in Canada, which it began shipping to Customers in Canada and the U.S. in July 2022 and October 2022, respectively. Significant judgment is required in estimating GTN adjustments considering historical experience, payer channel mix, current contract prices, unbilled claims, processing time lags, inventory levels in the distribution channel and estimated product returns. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table reconciles gross product revenue to net product revenue:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:4.533%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.792%;"/&gt;
        &lt;td style="width:1.612%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.923%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.612%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.062%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Product revenue, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,104&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;GTN adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Product revenue, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <amlx:GrossProductRevnueToNetProductRevenueTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_84dffdba-11e2-49a9-8ca9-db8745f23058">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table reconciles gross product revenue to net product revenue:&lt;/span&gt;&lt;p style="margin-left:4.533%;text-indent:6.983%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.792%;"/&gt;
        &lt;td style="width:1.612%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.923%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.612%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.062%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Product revenue, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,104&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;GTN adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Product revenue, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,230&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</amlx:GrossProductRevnueToNetProductRevenueTableTextBlock>
    <amlx:RevenueFromContractWithCustomerExcludingAssessedTaxGross
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_c6bd7030-fb61-451d-8e66-e05c5cc0065f"
      unitRef="U_USD">27104000</amlx:RevenueFromContractWithCustomerExcludingAssessedTaxGross>
    <amlx:GrossToNetAdjustments
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_a776f693-2f11-4b21-b7ae-cd66baa64837"
      unitRef="U_USD">-4874000</amlx:GrossToNetAdjustments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_3e9851ff-d25f-418f-a813-dfd72b694b0c"
      unitRef="U_USD">22230000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InvestmentTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_f44cbe22-a009-4cc0-80cc-060a9c54573d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4. SHORT-TERM INVESTMENTS&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments, which are classified as available-for-sale, consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.58%;"/&gt;
        &lt;td style="width:1.194%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.205%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.205%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.205%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gain&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Values&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,173&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,326&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,781&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284,450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&#160;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.805%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.013%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.024000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.024000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Values&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,932&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, all investments had contractual maturities within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts until maturity. Such amortization and accretion are included in interest income. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; realized gains and losses recognized during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021. The Company evaluates short-term investments for other-than-temporary impairment at the balance sheet date. Declines in fair value, if any, determined to be other-than-temporary are also included in other income, net.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;When assessing short-term investments for other-than-temporary declines in value, the Company considers such factors as, among other things, how significant the decline in value is as a percentage of the original cost, how long the market value of the investment has been less than its original cost, and the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value and market conditions in general. The Company has the ability to hold its investments until maturity and generally does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; impairment charges on short-term investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b08c19b9-d1a5-4ea2-b94d-0063c26438d9">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments, which are classified as available-for-sale, consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.58%;"/&gt;
        &lt;td style="width:1.194%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.205%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.205%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.205%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.402000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gain&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Values&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,173&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,326&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,781&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284,450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.805%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.013%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.024000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.024000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;br/&gt;Values&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,932&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_71f685c9-8c92-4d6f-9328-36c56365bbf5"
      decimals="-3"
      id="F_735aef08-71d9-4159-b3d4-ce8d0b8163f3"
      unitRef="U_USD">27173000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_71f685c9-8c92-4d6f-9328-36c56365bbf5"
      decimals="-3"
      id="F_e38fcd6b-2542-40f4-b04a-111cf82e52e1"
      unitRef="U_USD">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_71f685c9-8c92-4d6f-9328-36c56365bbf5"
      decimals="-3"
      id="F_32cf7a54-7b4f-4101-aead-dfa931ae5c1f"
      unitRef="U_USD">27159000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48"
      decimals="-3"
      id="F_479b4cb0-640f-4850-9d9b-352dc44c49de"
      unitRef="U_USD">59326000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48"
      decimals="-3"
      id="F_37f40ec1-ea3f-4544-896a-cc5697800751"
      unitRef="U_USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48"
      decimals="-3"
      id="F_a8cc6136-8365-4a4f-b3d5-da70317b9054"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_2307d3ac-a8cc-40f2-8d88-8cddfb86ad48"
      decimals="-3"
      id="F_cfe682f1-090d-49a6-bd2c-83d8f408bbfc"
      unitRef="U_USD">59334000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b17b133f-82b6-42e9-990f-003823835ec6"
      decimals="-3"
      id="F_1037e50c-1d21-4b04-8ad2-ad665f36377d"
      unitRef="U_USD">134375000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b17b133f-82b6-42e9-990f-003823835ec6"
      decimals="-3"
      id="F_d1ecff95-f0c1-4ab1-960e-9be75e16af30"
      unitRef="U_USD">134375000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7"
      decimals="-3"
      id="F_11e7f53e-387f-44c7-8d2e-9cf9c7f8b818"
      unitRef="U_USD">58795000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7"
      decimals="-3"
      id="F_774972b1-cc21-4461-83a5-54f4906dd931"
      unitRef="U_USD">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7"
      decimals="-3"
      id="F_5b6641f0-872a-4063-bdea-20ec212c3490"
      unitRef="U_USD">55000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_c19dfa69-fcdf-4da0-a36c-c0a25da8e6e7"
      decimals="-3"
      id="F_bed0b880-07e4-46ef-816a-8a12768ecd49"
      unitRef="U_USD">58753000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39"
      decimals="-3"
      id="F_46b3c5e9-567d-4b65-aeff-fee7305b843b"
      unitRef="U_USD">4781000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39"
      decimals="-3"
      id="F_9c8ae070-6c00-491d-93f8-525dbbda75b6"
      unitRef="U_USD">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39"
      decimals="-3"
      id="F_bbe2eb48-9823-46aa-bebb-b7c1e3aae313"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b5b9ba47-7e00-4e9a-b6c4-4c3a9e6c8b39"
      decimals="-3"
      id="F_3fbc84be-c35f-4cff-83ca-e03e443e393e"
      unitRef="U_USD">4798000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11"
      decimals="-3"
      id="F_b91ae30c-e38d-4c90-99f9-e40459059e7f"
      unitRef="U_USD">284450000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11"
      decimals="-3"
      id="F_709b1633-c8d7-4b08-8032-94b400954990"
      unitRef="U_USD">40000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11"
      decimals="-3"
      id="F_f6df95f1-801b-4ac2-a5eb-b81bb7efe715"
      unitRef="U_USD">71000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_d897e60a-b2ef-40ae-84bb-e64354962e11"
      decimals="-3"
      id="F_b4332b0d-3233-4504-b292-03057fe5393f"
      unitRef="U_USD">284419000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c"
      decimals="-3"
      id="F_094b6cf4-8bd9-4c2c-961e-44b0eab34302"
      unitRef="U_USD">33979000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c"
      decimals="-3"
      id="F_d2840ba0-52fe-49ca-929a-588072aa135d"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8308b5ae-887b-435c-a9c3-cdac5736ec1c"
      decimals="-3"
      id="F_2c18b625-ddc8-4dfe-93c3-a453b01a05e7"
      unitRef="U_USD">33978000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8"
      decimals="-3"
      id="F_9bcf178a-c6e8-4c21-8c56-19a6d79c0753"
      unitRef="U_USD">11953000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8"
      decimals="-3"
      id="F_9d4332c8-1c2b-4cee-8b8b-513fefa4bb8b"
      unitRef="U_USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5edc9ae9-9226-49c6-8e0c-ca92860ffaf8"
      decimals="-3"
      id="F_664382c4-1486-4d6b-bbd8-0b2505904fea"
      unitRef="U_USD">11949000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_7ef664f3-dcfa-4413-9356-692945d9514a"
      decimals="-3"
      id="F_210705c5-ac35-4d4d-b2e4-dd29e34df88e"
      unitRef="U_USD">45932000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_7ef664f3-dcfa-4413-9356-692945d9514a"
      decimals="-3"
      id="F_f905466c-fc5f-4465-ad49-ffac4d52cd59"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_7ef664f3-dcfa-4413-9356-692945d9514a"
      decimals="-3"
      id="F_d7a54e4b-8a48-435e-9210-47de53d77667"
      unitRef="U_USD">45927000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <amlx:AvailableForSaleInvestmentsContractualMaturityPeriod
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_90084be2-d681-4bc7-ac15-adc92fe5471d">P1Y</amlx:AvailableForSaleInvestmentsContractualMaturityPeriod>
    <amlx:AvailableForSaleInvestmentsContractualMaturityPeriod
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      id="F_78812923-e62c-4f77-bde7-5bbfabd08a80">P1Y</amlx:AvailableForSaleInvestmentsContractualMaturityPeriod>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_c5d966a6-849d-447c-acb3-c6a423f182db"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_d0fa3583-58e4-445f-b4aa-c317ee44ae88"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_8a6ac6ed-208a-4a48-97d5-3e6be901348d"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_ec486df6-53d0-4963-8841-53b6ec3e1c1c"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_6847e6cf-32c0-4a9e-820c-301e7187f960"
      decimals="-3"
      id="F_8e537603-97b5-4578-81b5-a2f8db30a5bf"
      unitRef="U_USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_90ba1a94-3a9c-4e3a-98be-4dbb6a1f0412"
      decimals="-3"
      id="F_a50da534-f36b-4e54-afac-1a5ab297bcec"
      unitRef="U_USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b8797344-f452-4657-aafc-d30ff78669be">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5. INVENTORIES&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.938%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.737%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.094%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Work in process&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total inventories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company capitalizes inventory costs associated with the Company&#x2019;s products after regulatory approval when, based on management&#x2019;s judgment, future commercialization is considered probable and the future economic benefit is expected to be realized. Inventory on hand determined to not have a future economic benefit and acquired prior to receipt of the marketing authorization for ALBRIOZA in Canada, totaling approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, was expensed as research and development expense as incurred. The Company began to capitalize the costs determined to have a probable future economic benefit associated with the production of ALBRIOZA&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; upon receipt of Health Canada approval in June 2022. Finished goods have a shelf life of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months from the date of manufacture.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Of the inventories reported on balance sheet at December 31, 2022, the Company had &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of long-term raw materials that are not expected to be realized in cash, sold or consumed during the next 12 months.&lt;/span&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_92cb0a1a-d41b-4180-bbf5-8545529ca70d">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.938%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.737%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.094%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Work in process&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Finished goods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total inventories&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_e1aa04ae-94b6-4924-bcd6-f8234681d623"
      unitRef="U_USD">7151000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a021fd88-32ca-4f35-9487-d7a40e5e0be0"
      unitRef="U_USD">1681000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_b888207d-7d23-4d60-b906-4b356613a897"
      unitRef="U_USD">937000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_fb07bdf9-15ce-46bf-be1b-c143040b65c9"
      unitRef="U_USD">9769000</us-gaap:InventoryNet>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-5"
      id="F_63e7e0b1-c555-4628-8690-eb2fa55475b7"
      unitRef="U_USD">22900000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_9bc9f9a5-11f9-478f-9984-e116f2928e91"
      id="F_e9a01020-ee09-4a8f-8803-8e631e2fc139">P12M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_fb6ca0c6-e436-48d9-af45-2ac4f63346d8"
      id="F_d0d558bc-3a85-4d9b-be63-c354401b61a1">P15M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <amlx:LongTermRawMaterialsNotYetRealized
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-5"
      id="F_55a0b86a-ad6c-4c08-a96f-4107a8927e28"
      unitRef="U_USD">3200000</amlx:LongTermRawMaterialsNotYetRealized>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_733f8c6c-67ef-4591-8210-ae2999869b23">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6. Property and equipment, net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.332%;"/&gt;
        &lt;td style="width:2.63%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:22.134%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:2.63%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:22.273%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;362&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer hardware and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;803&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;474&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_33f79e84-b916-4c30-81d4-750ccadc557e">&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.332%;"/&gt;
        &lt;td style="width:2.63%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:22.134%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:2.63%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:22.273%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;362&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer hardware and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;803&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,151&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;474&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_96d72263-9f43-4d59-8a5d-034e72d9be8e"
      decimals="-3"
      id="F_1422d616-9b90-4456-bc21-cbffc75a41eb"
      unitRef="U_USD">362000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_28f824cb-b9d8-44c0-9120-7b7fefbb119e"
      decimals="-3"
      id="F_240d2b3a-4d2a-4820-b8b7-523f978b4f28"
      unitRef="U_USD">88000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_489ebaa1-e175-4c12-b766-93bc771353fd"
      decimals="-3"
      id="F_72313716-21c2-41df-93ef-1568a50ffd1e"
      unitRef="U_USD">1810000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_49ffe463-5c72-4589-94f5-b0914efbf208"
      decimals="-3"
      id="F_0fe5244b-bcf2-46c4-b46a-405beb3ecf79"
      unitRef="U_USD">250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_75199396-3f49-47e9-a99c-3a0ee563bfe5"
      decimals="-3"
      id="F_1ab94e21-b8be-4bdf-985c-d71228f7dc2d"
      unitRef="U_USD">176000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_ccd2bc7d-177e-44f8-89c8-d26a5a47b261"
      decimals="-3"
      id="F_8c3a4e88-dc1b-4eba-8c21-fb413d212b51"
      unitRef="U_USD">50000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_9c2263c4-ca40-4e95-b8e3-4cde9fa39697"
      decimals="-3"
      id="F_a7c54742-9b67-4e59-88ef-6919dea2b6ff"
      unitRef="U_USD">803000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_789d884f-c53b-4300-99ea-5e96e8f7db99"
      decimals="-3"
      id="F_0a106d8d-7cf5-4c5d-a8c1-cd2370e2d327"
      unitRef="U_USD">139000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_d147a11f-9728-4338-8c57-5cb729664d42"
      unitRef="U_USD">3151000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_7735d904-4ca3-4c50-89ba-6159bc4eb16e"
      unitRef="U_USD">527000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_3a262cbf-3a93-4b81-aa19-dab60ae00dfb"
      unitRef="U_USD">540000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_9f9965ea-f992-4b26-8d75-724c5cd1205e"
      unitRef="U_USD">53000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_73a9dbaf-d01f-4d13-9d46-28157125d758"
      unitRef="U_USD">2611000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_e957b7a9-f504-4699-88a3-43a7ace7cc76"
      unitRef="U_USD">474000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7ac53db5-ebec-45f5-b3c1-a5da8fe5bbd7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7. Accrued Expenses&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.62%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.776%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.133%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;External research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Payroll and employee related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,280&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued consulting and other professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Rebates and other GTN adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Royalty payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,005&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_113baf84-40f5-4c59-b4f0-8df2bf695681">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.62%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.776%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.133%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;External research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Payroll and employee related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,280&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Manufacturing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued consulting and other professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Rebates and other GTN adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Royalty payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,005&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <amlx:AccruedExternalResearchAndDevelopmentCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_14ab100a-4d41-4460-a112-6d9295ca0a3f"
      unitRef="U_USD">8424000</amlx:AccruedExternalResearchAndDevelopmentCurrent>
    <amlx:AccruedExternalResearchAndDevelopmentCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_6a26932b-e531-4531-bfba-8a892463477c"
      unitRef="U_USD">5666000</amlx:AccruedExternalResearchAndDevelopmentCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_16a4e5d0-0307-4c36-a3ad-9996d01433af"
      unitRef="U_USD">15231000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_5997a5b6-0043-4b82-bdd3-bcf1cdee7472"
      unitRef="U_USD">4280000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <amlx:AccruedManufacturing
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a64431d4-4bd7-4b6e-bbc8-9dfe4ae3a824"
      unitRef="U_USD">4596000</amlx:AccruedManufacturing>
    <amlx:AccruedConsultingAndOtherProfessionalFess
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_8fab4e7b-3a6e-46b6-b13f-14176222e88f"
      unitRef="U_USD">4116000</amlx:AccruedConsultingAndOtherProfessionalFess>
    <amlx:AccruedConsultingAndOtherProfessionalFess
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_e36a75d1-df78-4fd1-9f21-c8a91f5d464e"
      unitRef="U_USD">2820000</amlx:AccruedConsultingAndOtherProfessionalFess>
    <amlx:RebatesAndOtherGrossToNetAdjustments
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_c7dfc7df-80bb-44f1-9f8b-1e89a7fd0ca5"
      unitRef="U_USD">3582000</amlx:RebatesAndOtherGrossToNetAdjustments>
    <amlx:RoyaltyPayable
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_76e5fca9-bd73-43b3-9ffc-a4fde83c83d2"
      unitRef="U_USD">1358000</amlx:RoyaltyPayable>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_75736972-4c36-4dae-8521-56cacc640151"
      unitRef="U_USD">1005000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_fc0d361c-77eb-4825-bf54-30b61b806cb5"
      unitRef="U_USD">258000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a31c3319-f5c2-40af-beac-fc28b72cfa00"
      unitRef="U_USD">38312000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_0d376a30-52cc-45c6-813e-4663e69a8868"
      unitRef="U_USD">13024000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <amlx:ConvertibleNotesTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_3f2281f6-caf2-4919-bb9d-eadcb28b8702">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8. CONVERTIBLE NOTES&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Issuance of the 2021 Notes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2021, the Company issued, in aggregate, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in convertible notes, or 2021 Notes, to certain investors, including related parties, of which proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million were received in advance of issuance of the 2021 Notes in December 2020 and the remaining proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million were received in January and February 2021. The 2021 Notes were to mature on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and carried both automatic and optional conversion features. The 2021 Notes were secured and carried an interest rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded the $1.2 million of proceeds received in December 2020 as proceeds received in advance of issuance of 2021 Notes in the consolidated balance sheet as of December 31, 2020, as the subscription agreement and commitment to issue the 2021 Notes was not effective until January 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2021 Notes contained the following features:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Automatic Conversion Features&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;The 2021 Notes were to automatically convert into Conversion Shares upon (i) an IPO, (ii) any transaction in which the Company merges with, consolidates with or enters into other similar transaction with a Special Purpose acquisition Corp, or SPAC, resulting in some or all of its shares being registered for sale under applicable securities laws and listed for trading on a national or foreign exchange, or De-SPAC transaction, (iii) the acquisition of the Company by another person or entity by means of any transaction in which holders of the outstanding voting securities of the Company immediately before such transaction held less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the voting securities of the Company or the surviving corporation after such transaction or a sale of all or substantially all of the assets of the Company but excluding De-SPAC transaction, IPO, and the occurrence of equity financing in which the Company sold shares of its preferred stock for new money and which was neither an IPO or a Qualified Financing, or Change of Control, and (iv) the closing of a sale of an equity transaction in which the Company sold shares with an aggregate gross proceeds of at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, or Qualified Financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the event of a Change of Control, De-SPAC transaction, or an IPO, the Conversion Shares would be common stock of the Company. In the event of a Qualified Financing, the Conversion Shares would be shares of preferred stock issued in such transaction.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Optional Conversion Feature&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;The holders of the 2021 Notes had the option to elect to convert their notes into Conversion Shares at the Conversion Price upon the occurrence of an equity financing in which the Company sold shares of its preferred stock for new money and which was neither an IPO or a Qualified Financing, or Non-Qualified Financing, and together with the IPO, De-SPAC transaction, Change of Control, and the Qualified Financing, collectively, the &#x201c;Conversion Events&#x201d;). In the event of a Non-Qualified Financing, the Conversion Shares would be the class of equity shares issued in such transaction. The 2021 Notes would be deemed to have converted into the Conversion Shares if no election was made by the holders of the 2021 Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Conversion Price&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Upon the occurrence of an IPO, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the price at which the Company offered each share of common stock in the IPO without deducting any amount for discounts, commissions, fees, or other costs and (ii) $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;600.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million divided by the fully diluted capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon the occurrence of a De-SPAC transaction, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the common stock price in the De-SPAC transaction, which would be determined by dividing (x) the total consideration to be paid to common stockholders upon a De-SPAC transaction less the principal amount of the 2021 Notes including accrued and unpaid interest by (y) the common stock issued and outstanding immediately prior to the De-SPAC transaction and that would be exchanged as a result of the De-SPAC transaction including common stock that would be issued upon the exercise of stock options immediately before the Change of Control transaction but excluding the common stock issuable upon conversion of the 2021 Notes and (ii) $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;600.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million divided by the fully diluted capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon the occurrence of a Change of Control, the 2021 Notes would convert into shares of common stock at the conversion price equal to the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the common stock price in the Change of Control, which would be determined by dividing (x) the total consideration to be paid to common stockholders upon a Change of Control less the principal amount of the 2021 Notes including accrued and unpaid interest by (y) the common stock issued and outstanding immediately prior to the Change of Control and that would be exchanged upon a Change of Control including common stock that would be issued upon the exercise of stock options before the Change of Control but excluding the common stock issuable upon conversion of the 2021 Notes and (ii) $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;600.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million divided by the fully diluted capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon a Qualified Financing, the 2021 Notes would convert into shares of preferred stock issued in the Non-Qualified Financing at the conversion price equal to the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the lowest price at which the Company sold shares of its stock in the Qualified Financing and (ii) $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;600.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million divided by the fully diluted capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Repayment&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Each holder of the 2021 Notes had the option to elect to receive a payment in the amount equal to the principal amount plus accrued and unpaid interests upon a Change of Control. If a Change of Control occurred and no election was made by the holder, the principal amount and accrued and unpaid interest would be deemed to have automatically be converted into shares of the Company&#x2019;s common stock of the Company immediately prior to the close of the Change of Control.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company qualified for and elected to account for the 2021 Notes under the fair value option and, in doing so, bypassed the analysis of potential embedded derivative features. The Company believes that the fair value option better reflects the underlying economics of the 2021 Notes. As a result, the 2021 Notes were recorded at fair value upon issuance, which was determined to be equal to principal amounts of these notes of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. At each financial reporting period, and immediately prior to conversion, the Company remeasured the fair value of the 2021 Notes. The change in fair value of the 2021 Notes from issuance date to the conversion date totaled $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which is recorded as change in fair value of convertible notes in the consolidated statement of operations for the year ended December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Conversion of the 2021 Notes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 2021, the Company consummated a financing transaction in which it issued shares of Series C-1 redeemable convertible preferred stock. The consummation of this financing transaction resulted in the automatic conversion of the 2021 Notes into shares of Series C-2 redeemable convertible preferred stock (together with the Series C-1 redeemable convertible&lt;/span&gt;&lt;span style="color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;preferred &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;stock, the &#x201c;Series C Preferred Stock&#x201d;) pursuant to their original terms. The Series C Preferred Stock was determined to have a fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.265809&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Under the fair value option, the 2021 Notes were remeasured to fair value immediately prior to conversion at a price per share equal to the fair value of the Series C-1 redeemable convertible preferred stock. The Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million loss related to change in fair value of the 2021 Notes in its consolidated statement of operations for the year ended December 31, 2021. The 2021 Notes converted into &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C-2 redeemable convertible preferred stock at the effective conversion price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.725938&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; convertible notes outstanding as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Notes&#x2014;Related Parties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; convertible notes issued to related parties that were outstanding as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. In connection with the issuance of the 2021 Notes, the Company issued, in aggregate, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of convertible notes to certain related parties. These notes were issued under the same terms and conditions as the 2021 Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Valuation of the 2021 Notes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At the issuance date of the 2021 Notes, the Company determined that the fair value of the 2021 Notes approximated the principal amounts of the 2021 Notes as the transaction was deemed to be at arm&#x2019;s length. Subsequent measurement of fair value of the 2021 Notes at each reporting period was estimated based on significant inputs not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The Company used a scenario-based analysis to incorporate estimates and assumptions concerning the Company&#x2019;s prospects and market indications into a model to estimate the value of the 2021 Notes. The most significant estimates and assumptions used as inputs were those concerning timing, probability of possible scenarios for conversion or settlement of the 2021 Notes and discount rates. The fair value of the 2021 Notes upon settlement in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; was determined based on the fair value of the Series C-1 redeemable convertible preferred stock issued. This method was selected as the Company concluded that the contemporaneous financing transaction was an arm&#x2019;s length transaction. The issuance of the Series C-1 redeemable convertible preferred stock was considered to be a Qualified Financing (see Note 11) pursuant to the original terms of the 2021 Notes. Accordingly, the fair value calculation for the 2021 Notes immediately before conversion considered both the fair value of the Series C-1 redeemable convertible preferred stock and the conversion price, which was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the fair value of the Series C-1 redeemable convertible preferred stock. The fair value of the 2021 Notes as of June 30, 2021 was determined to be the same as that on the settlement date in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; based on management&#x2019;s determination of no material changes to the assumptions underlying the determination of the fair value of the 2021 Notes.&lt;/span&gt;&lt;/p&gt;</amlx:ConvertibleNotesTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3"
      decimals="-5"
      id="F_e08412b1-e9ba-4e15-8a07-d23ec0946c43"
      unitRef="U_USD">27300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_847bc730-56b4-47a9-b047-316c0d25ef30"
      decimals="-5"
      id="F_c0732329-c4c0-4225-9b46-549b72766a11"
      unitRef="U_USD">1200000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_3abbf489-5362-4633-bc8b-b7daa3c678ec"
      decimals="-5"
      id="F_b3d0b307-a7c6-4d52-a1e1-97fd6eb168a3"
      unitRef="U_USD">26100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_5fa66652-e292-4b4a-b46f-3914e1bb1423"
      decimals="-5"
      id="F_c9789693-68a9-4ae5-b04d-0933fd6fa51d"
      unitRef="U_USD">26100000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      id="F_3196402d-327f-42f1-8728-4ff4c1745590">2022-06-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3"
      decimals="INF"
      id="F_42074d31-aac9-443a-bdfc-f53b7d1ebc1b"
      unitRef="U_pure">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="C_126e9271-cfbf-4f0e-811b-b2e260d1b8e8"
      id="F_e44fed9e-1022-4e40-899b-2fb48f965447">The Company recorded the $1.2 million of proceeds received in December 2020 as proceeds received in advance of issuance of 2021 Notes in the consolidated balance sheet as of December 31, 2020, as the subscription agreement and commitment to issue the 2021 Notes was not effective until January 2021.</us-gaap:DebtInstrumentDescription>
    <amlx:PercentageOfVotingSecurities
      contextRef="C_ba447dcc-85e2-40e6-b77e-267406ab1bf1"
      decimals="INF"
      id="F_f2220499-f144-4d18-bc02-21320bd7ac9f"
      unitRef="U_pure">0.50</amlx:PercentageOfVotingSecurities>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_5f298d27-3cb9-4705-bfa0-9f414a329ed2"
      decimals="INF"
      id="F_25088cc8-618c-4fc9-8173-9a84cda47722"
      unitRef="U_USD">10000000.0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <amlx:PercentageOfPriceOfferedToEachShareOfCommonStock
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="2"
      id="F_4202ee7c-10a9-4536-8aea-89adc15f46b0"
      unitRef="U_Rate">0.85</amlx:PercentageOfPriceOfferedToEachShareOfCommonStock>
    <amlx:DilutedCapitalDividend
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="-5"
      id="F_e2c4cbb1-f649-475b-a380-3faf3601305d"
      unitRef="U_USD">600000000.0</amlx:DilutedCapitalDividend>
    <amlx:PercentageOfPriceOfferedToEachShareOfCommonStock
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="2"
      id="F_d1b29326-ec3b-4655-b401-f14873b000fd"
      unitRef="U_Rate">0.85</amlx:PercentageOfPriceOfferedToEachShareOfCommonStock>
    <amlx:DilutedCapitalDividend
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="-5"
      id="F_cdbfba96-fbbf-479b-a6fd-e38c2852329c"
      unitRef="U_USD">600000000.0</amlx:DilutedCapitalDividend>
    <amlx:PercentageOfPriceOfferedToEachShareOfCommonStock
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="2"
      id="F_5effb778-67db-46f1-8036-4f9654ff0076"
      unitRef="U_Rate">0.85</amlx:PercentageOfPriceOfferedToEachShareOfCommonStock>
    <amlx:DilutedCapitalDividend
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="-5"
      id="F_3543c3f0-5dc4-4068-b8d5-7d83dd1c36b3"
      unitRef="U_USD">600000000.0</amlx:DilutedCapitalDividend>
    <amlx:PercentageOfPriceOfferedToEachShareOfCommonStock
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="2"
      id="F_427cce55-7768-48b4-8ed3-154f9d8cfdd1"
      unitRef="U_Rate">0.85</amlx:PercentageOfPriceOfferedToEachShareOfCommonStock>
    <amlx:DilutedCapitalDividend
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="-5"
      id="F_9d291b28-e98b-4083-98e9-9e964b8c046e"
      unitRef="U_USD">600000000.0</amlx:DilutedCapitalDividend>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3"
      decimals="-5"
      id="F_08dd2dff-6002-4017-930d-42303430f7fd"
      unitRef="U_USD">27300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c"
      decimals="-5"
      id="F_188ca7ca-3301-48be-ab5c-1f95972da0e2"
      unitRef="U_USD">5200000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_52a2983c-7983-4d91-9733-cf784aff7361"
      decimals="6"
      id="F_29ee42bf-1f5c-444a-8e15-0b7068373f1c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.265809</us-gaap:PreferredStockConvertibleConversionPrice>
    <amlx:ChangeInFairValueOfConvertibleNotes
      contextRef="C_d36ae52a-d040-4a0e-84cd-85b87bbcff10"
      decimals="-5"
      id="F_5b0d194f-8059-4cac-9adb-b66b8bae3a9e"
      unitRef="U_USD">5200000</amlx:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_61ca1749-7a0a-470d-9b8c-19819b5915bb"
      decimals="INF"
      id="F_d810321f-96b4-46eb-9c53-9d33e46c5270"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_61ca1749-7a0a-470d-9b8c-19819b5915bb"
      decimals="6"
      id="F_765ffa29-44be-479f-8faa-55373484a796"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.725938</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ConvertibleDebt
      contextRef="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c"
      decimals="INF"
      id="F_a8f22fc8-d95f-4f4a-accf-1af70fc27591"
      unitRef="U_USD">0</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="C_f7fb78ab-3ece-4f31-af8a-d8d9b755bc94"
      decimals="INF"
      id="F_be2bee61-1e56-48b5-a6c4-a6de815c4f21"
      unitRef="U_USD">0</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c"
      decimals="INF"
      id="F_ed4d0127-7e7e-49e3-ad22-577372012c49"
      unitRef="U_USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="C_f7fb78ab-3ece-4f31-af8a-d8d9b755bc94"
      decimals="INF"
      id="F_98044d9d-c2a4-455b-8d67-f44b8ecce832"
      unitRef="U_USD">0</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebt
      contextRef="C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3"
      decimals="-5"
      id="F_a2a7cb5c-b2e1-4909-9286-ee96fbcabf92"
      unitRef="U_USD">14300000</us-gaap:ConvertibleDebt>
    <amlx:ConvertibleNotesSettlementDate
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      id="F_60ffaf4d-0e7e-4c99-bd8e-32c0d08ce992">2021-07</amlx:ConvertibleNotesSettlementDate>
    <amlx:PercentageOfPriceOfferedToEachShareOfCommonStock
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      decimals="2"
      id="F_8e51ea9e-dd9e-4dbc-a1d3-74b09e0f578d"
      unitRef="U_Rate">0.85</amlx:PercentageOfPriceOfferedToEachShareOfCommonStock>
    <amlx:ConvertibleNotesSettlementDate
      contextRef="C_9ce73df6-d2d9-40c8-8c95-38a3ca0c187a"
      id="F_501b9b3f-3dfb-46e5-8ec1-1d7695bfa9fe">2021-07</amlx:ConvertibleNotesSettlementDate>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_5102b67b-8dd3-424b-befb-388f283ddbe1">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.287%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;86,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;197,926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;110,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;207,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;318,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.287%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;95,387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Valuation of Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the fair values of the short-term investments by taking into consideration valuations obtained from third-party pricing sources. These pricing sources utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include market pricing based on real-time trade data for the same or similar securities, issuer credit spreads, benchmark yields, and other observable inputs. The Company validates the prices provided by our third-party pricing sources by understanding the models used, obtaining market values from other pricing sources and analyzing pricing data in certain instances.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company does &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t hold any short-term investments classified as Level 3, which are securities valued using unobservable inputs. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has not transferred any investment securities between the classification levels&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; other assets or liabilities that were measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_9c5f560d-3505-4a9e-a6ad-bc6e50bf58ac">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.287%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;86,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;197,926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;110,779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;207,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;318,694&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.287%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.032%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.218%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.388000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;95,387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f58d364a-a071-43d1-a2d5-b038a25fdc37"
      decimals="-3"
      id="F_e3eba935-d071-4368-8ae4-9d33474a0155"
      unitRef="U_USD">23567000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_642dd1b3-56a8-4be2-8e97-15c6ab673ca1"
      decimals="-3"
      id="F_fa5503bb-8c30-4758-a29a-897fc61959af"
      unitRef="U_USD">9989000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_02064c71-3a83-4801-8486-d127eb43b8ad"
      decimals="-3"
      id="F_8b72ec7c-4e9f-4154-adb4-53883ca5a5d5"
      unitRef="U_USD">33556000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_ff0690db-c77d-4b96-bbff-fbb506dbb3a1"
      decimals="-3"
      id="F_a5e47029-b1ab-4738-b96c-24a61afda396"
      unitRef="U_USD">27159000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d1f4d907-06b1-4446-92c9-69df12bfc090"
      decimals="-3"
      id="F_bd68c6c6-bafe-4337-a52d-3e991c4f136c"
      unitRef="U_USD">27159000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f38b7408-04be-4eb8-957e-fdf39e6193be"
      decimals="-3"
      id="F_3db2a17e-4a06-4f78-8636-c45fd09605e1"
      unitRef="U_USD">59334000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_757a8685-f087-44ba-8d70-37f526a1bd6e"
      decimals="-3"
      id="F_4e0cfea2-b293-4195-a994-7c41fdf1d1a2"
      unitRef="U_USD">59334000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_49ab84be-37c3-426d-8cbc-3170c1c749d8"
      decimals="-3"
      id="F_c956d4a8-0094-449d-8508-350e003f8da8"
      unitRef="U_USD">134375000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_08bb19c6-0e5b-4b98-a719-c56d723fcf27"
      decimals="-3"
      id="F_726eb181-d993-4ee9-b4e3-cb365438e4d0"
      unitRef="U_USD">134375000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b59b87a6-8c0e-42c4-b13a-2b0067aad963"
      decimals="-3"
      id="F_ba7f5380-24e4-4f5b-8313-0cd2b87c4f0e"
      unitRef="U_USD">58753000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d9bce4d5-f683-4b45-978f-ca52168d39ec"
      decimals="-3"
      id="F_3708dbbd-a599-4134-bc32-53109095d69e"
      unitRef="U_USD">58753000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1fe5ff12-27cd-44f5-a115-8904def1b494"
      decimals="-3"
      id="F_152c4ecc-0907-4094-84d2-c36fe30002ba"
      unitRef="U_USD">4798000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d7b990e5-1180-4f67-85bb-6d7b96c69b5a"
      decimals="-3"
      id="F_2fba2bc4-0346-46f8-9410-23e8092b9fee"
      unitRef="U_USD">4798000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_dded4a35-c564-4067-87bb-39604cfdd2aa"
      decimals="-3"
      id="F_e1d5fcbe-d882-4cd0-91a4-c270252bc945"
      unitRef="U_USD">86493000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_faa2db82-5a0b-4d5e-9899-d4b010e01200"
      decimals="-3"
      id="F_ecfe1ee3-7c0e-428b-8b77-344bf04b9836"
      unitRef="U_USD">197926000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c14457e2-814d-4d72-8c26-189bdc3fa207"
      decimals="-3"
      id="F_b62e1112-1f01-4cc0-a336-5faa88dd53c9"
      unitRef="U_USD">284419000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_23c45f4e-2e33-4b8f-99a6-4527909a36c6"
      decimals="-3"
      id="F_84cac7fa-6b1b-4867-9000-1f1c26063079"
      unitRef="U_USD">719000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_150e2ef8-74e4-47ed-95d8-3485e13c0048"
      decimals="-3"
      id="F_0cafeab0-a5d8-416b-9444-e38ba1b76c2e"
      unitRef="U_USD">719000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9bd71111-9adf-43ab-8fd0-05a1882632a5"
      decimals="-3"
      id="F_40ae619b-1d02-4994-94fc-5c67ee1769ff"
      unitRef="U_USD">110779000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e6d67a4d-2001-440f-b683-73f5e52c53fe"
      decimals="-3"
      id="F_8213a4e5-26b2-485d-8e28-cb515623dd7c"
      unitRef="U_USD">207915000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f4747adc-8a33-4cb0-a970-1b814ab522d7"
      decimals="-3"
      id="F_a563da42-73f4-4348-8d57-4335694272a3"
      unitRef="U_USD">318694000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4e947744-cacb-43d4-857f-1094d22ea491"
      decimals="-3"
      id="F_9f068adc-bfa2-4154-b52e-1eeaacf02d9c"
      unitRef="U_USD">49271000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_eba29517-fdf1-4a5c-9472-881601db2461"
      decimals="-3"
      id="F_62685a84-ed8f-4928-8f23-09a6b2c82051"
      unitRef="U_USD">49271000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_00648e08-92ac-4b7a-9c05-679ac28e6a0e"
      decimals="-3"
      id="F_1ddd124b-b776-4e9c-8680-d63c83c5bcd8"
      unitRef="U_USD">33978000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_91613165-4e43-4b91-b6e5-9c7be336afa8"
      decimals="-3"
      id="F_74fbe4bd-7326-4f6f-aee4-235026029715"
      unitRef="U_USD">33978000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_18f249a1-455e-407f-aa84-667f43ef7f97"
      decimals="-3"
      id="F_0be63c9f-55dd-4c32-ac99-a551bee2f31a"
      unitRef="U_USD">11949000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_296321bd-7a9d-4b09-ba9b-7ad1355d4097"
      decimals="-3"
      id="F_af861a3f-6752-4c1f-aaa2-a0abe907840c"
      unitRef="U_USD">11949000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c82ec6e0-6442-4924-93c4-7e12f30f5bfe"
      decimals="-3"
      id="F_20dfe943-557d-48d3-9af3-99b14e5b056f"
      unitRef="U_USD">45927000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c2fe59ba-c379-4ba7-bfa5-0166ee9ba79d"
      decimals="-3"
      id="F_cf649478-bc5d-4fa9-a3cd-14c5541f96fa"
      unitRef="U_USD">45927000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e05504eb-0e44-40fb-b852-5368d3b9651a"
      decimals="-3"
      id="F_aaa9467a-aba9-47c7-a572-5651aa296c14"
      unitRef="U_USD">189000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e0aaedbf-19e6-4bcf-9bde-7bfed9c560a4"
      decimals="-3"
      id="F_809fa9cd-3e90-44ab-9eb6-2be1de3b6c02"
      unitRef="U_USD">189000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_bd82984a-e7c6-40a2-8123-1c9deb800381"
      decimals="-3"
      id="F_21111aa8-c9e1-4ab5-9f7c-23a872a0a40c"
      unitRef="U_USD">49460000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c50598d2-a8bf-4f26-8081-1ada38713c0c"
      decimals="-3"
      id="F_d7cb29ea-3454-40eb-bc78-3e7f83167aed"
      unitRef="U_USD">45927000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e"
      decimals="-3"
      id="F_32d78d05-1145-4e2e-882e-267ec01027d7"
      unitRef="U_USD">95387000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9ec1205e-1c76-493c-b003-ad047009b28c"
      decimals="INF"
      id="F_19a3df40-49e3-4a35-a7c4-df86075602be"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <amlx:TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_88a53a04-4e8c-4a25-b0af-704d521038fe">The Company has not transferred any investment securities between the classification levels</amlx:TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="C_f4747adc-8a33-4cb0-a970-1b814ab522d7"
      decimals="INF"
      id="F_428ba480-dc0f-4b99-ab2e-298cc60a4cda"
      unitRef="U_USD">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e"
      decimals="INF"
      id="F_0bfbec43-48d4-4dfb-98be-8a3a597334ea"
      unitRef="U_USD">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="C_f4747adc-8a33-4cb0-a970-1b814ab522d7"
      decimals="INF"
      id="F_6555fcc1-371f-42f2-bab8-a1a50ded5cd2"
      unitRef="U_USD">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="C_e6016aec-4ac0-4cda-bca2-71d66715fa3e"
      decimals="INF"
      id="F_db23ee78-d867-42c2-b669-4db86dc0c1d5"
      unitRef="U_USD">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_0a760bcf-5084-4d02-810d-98602ff659e9">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10. LEASES&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company leases its office facilities under non-cancelable operating leases that expire at various dates through October 2026. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36 months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, with an option to extend the lease for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Because the Company was not reasonably certain to exercise the option to extend the lease at inception, the option to extend was not considered in determining the lease term. The Company initially recognized a right-of-use asset of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and a lease liability of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million upon commencement of the lease.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Components of lease expense required by ASC 842 are presented below for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.071%;"/&gt;
        &lt;td style="width:1.919%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.009%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities are measured by calculating the present value of remaining lease payments under the lease arrangement. Since the rates implicit in our leases are not readily determinable, the Company uses estimated incremental borrowing rates in determining the discount rate used to calculate the present value of remaining lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments over a similar term equal to the lease term in a similar economic environment. The incremental borrowing rate is based on the information available at commencement date. As the Company has no recent external borrowings, the incremental borrowing is a hypothetical rate based on our understanding of what our credit rating would be and adjusted to reflect a collateralized borrowing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s leases contain renewal options that can extend the lease for additional years. Because the Company is not reasonably certain to exercise these renewal options, they are not considered in determining the lease terms, and associated potential additional payments are excluded from lease payments. The Company has elected to account for each lease component and its associated non-lease components as a single lease component and has allocated all of the contract consideration across lease components only. The Company has existing net leases in which the non-lease components (e.g., common area maintenance) are paid separately from rent based on actual costs incurred and therefore are not included in the operating lease right-of-use assets and lease liabilities and are reflected as an expense in the period incurred.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the presentation in the Company&#x2019;s consolidated balance sheet of its operating leases (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.987%;"/&gt;
        &lt;td style="width:1.921%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.092%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the year ended December 31, 2022, the Company made cash payments of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for operating leases.  &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future minimum lease payments under non-cancelable leases as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, were as detailed below (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.987%;"/&gt;
        &lt;td style="width:1.921%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.092%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,417&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,478&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the weighted average remaining lease term was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and the weighted average incremental borrowing rate used to determine the operating lease right-of-use assets was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;ASC 840 Disclosures&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future minimum lease payments under non-cancelable leases as of December 31, 2021, were as detailed below (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.987%;"/&gt;
        &lt;td style="width:1.921%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.092%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;563&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseDescription
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_52476e21-1fa1-4500-9ca5-a185a9f4181d">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for 36 months, with an option to extend the lease for 3 years.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"
      id="F_3a47cfba-31e6-4c9c-ad54-2c506c640b49">P36M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"
      id="F_0d14dc60-0e90-48f6-8ce3-5aefe41b8d2c">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"
      decimals="-5"
      id="F_8850788b-5597-46c7-8b02-539d35879ce8"
      unitRef="U_USD">5000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"
      decimals="-5"
      id="F_8b6b6ded-e9ed-4145-a47e-6b412b05e422"
      unitRef="U_USD">5000000.0</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_2c8790da-a07b-4693-ac1b-6812914bd57f">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Components of lease expense required by ASC 842 are presented below for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.071%;"/&gt;
        &lt;td style="width:1.919%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.009%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_a9001342-26a8-4d40-972a-e682c8707ad7"
      unitRef="U_USD">2136000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_92a51a4d-ed37-4f08-93b8-a8f358b80ea6"
      unitRef="U_USD">2136000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_69aa2e62-75ce-4318-8f58-35d62555e26e">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the presentation in the Company&#x2019;s consolidated balance sheet of its operating leases (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.987%;"/&gt;
        &lt;td style="width:1.921%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.092%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_bb7b5e3f-3b38-4f43-8822-efc95d8e0ef4"
      unitRef="U_USD">5524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_1fab006c-0286-46ec-8433-2821b1e92b04"
      unitRef="U_USD">2040000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_01008f24-f424-420e-baa2-28739f75b61b"
      unitRef="U_USD">4237000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_45eaf6c8-ea23-4fab-b1a7-f4e033433d9c"
      unitRef="U_USD">6277000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-5"
      id="F_51d3d463-ea0f-4fd7-a956-3a242737d75f"
      unitRef="U_USD">1400000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_d48496fc-d110-4935-8307-b6c78d6cc9c3">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future minimum lease payments under non-cancelable leases as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, were as detailed below (in thousands):&lt;/span&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.987%;"/&gt;
        &lt;td style="width:1.921%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.092%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,417&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,478&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future minimum lease payments under non-cancelable leases as of December 31, 2021, were as detailed below (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.987%;"/&gt;
        &lt;td style="width:1.921%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.092%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;563&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_b170d751-8782-4c3f-9a30-4651473b948d"
      unitRef="U_USD">2417000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_f60cf76f-65fa-4dd2-8cad-65ca87040b8b"
      unitRef="U_USD">2478000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_9fc3d0cb-573c-4649-a2de-094d9416e67e"
      unitRef="U_USD">1586000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_922246e9-c3b7-49a1-9a18-abb2726ee9d5"
      unitRef="U_USD">476000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_e420a875-9870-46e5-a4ce-8c32dd3e79a4"
      unitRef="U_USD">6957000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_10f8f10d-07a5-4350-87c1-7bd466fe0c18"
      unitRef="U_USD">680000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a86b07f1-00e4-4fda-8f17-21bdd385b4f8"
      unitRef="U_USD">6277000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      id="F_9642ccda-723a-4cd0-8c50-cf0387c9fbe2">P2Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <amlx:OperatingLeaseWeightedAverageIncrementalBorrowingRate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="3"
      id="F_c2a24586-7615-43df-8ce1-3a5099a3385c"
      unitRef="U_pure">0.073</amlx:OperatingLeaseWeightedAverageIncrementalBorrowingRate>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_c4b93dbd-9a13-4f35-ad0b-9aea61eaf553"
      unitRef="U_USD">532000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_788bfb48-5341-49a0-95b0-af456774770e"
      unitRef="U_USD">541000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_01b4a0da-8db2-473a-997d-5e9da910c89b"
      unitRef="U_USD">555000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_8233f865-a663-4e72-b3cb-54aa59ae29c3"
      unitRef="U_USD">563000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_8db59c0c-b5e6-49bc-aa50-0d726038e10c"
      unitRef="U_USD">476000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_55436a36-8e93-4121-b13a-7ae8c6e8aa8f"
      unitRef="U_USD">2667000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:PreferredStockTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_55733ed3-6189-48eb-ab4b-edaed52d67e6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11. Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On July 1, 2021, the Company amended its certificate of incorporation in which it authorized &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C-1 redeemable convertible preferred stock and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C-2 redeemable convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In July 2021, the Company consummated a financing transaction in which it issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C-1 redeemable convertible preferred stock. In connection with the issuance of these shares, the principal including accrued interest of the 2021 Notes totaling $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million automatically converted into &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of Series C-2 redeemable convertible preferred stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s redeemable convertible preferred stock consisted of the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:26.627%;"/&gt;
        &lt;td style="width:1.071%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.395000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.071%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.395000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.357%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.446000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.357%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.446000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.071%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.762%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(dollars in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Preferred&lt;br/&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Preferred Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common Stock&lt;br/&gt;Issuable Upon&lt;br/&gt;Conversion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series A preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,289,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,289,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,407,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series B preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,100,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,496,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;246,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,746,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-1 preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-2 preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,710,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,107,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;239,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;416,466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,474,330&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2021, the holders of the Series C Preferred Stock, or together with the Series A redeemable convertible preferred stock and the Series B redeemable convertible preferred stock, collectively, the Preferred Stock, had the following rights and preferences:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Conversion&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; On June 18, 2020, in connection with the conversion of the 2017 Notes, the Company adjusted the conversion price for the Series A redeemable convertible preferred stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.229073&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2065&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The adjustment was made in accordance with the anti-dilution provisions in the certificate of incorporation then in effect immediately prior to the conversion of the 2017 Notes. The adjustment to the conversion price resulted in neither modification nor extinguishment of the Series A redeemable convertible preferred stock as the terms of the Series A redeemable convertible preferred stock were not amended. The adjustment to the conversion price resulted in additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;117,650&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock to be issued to holders of the Series A redeemable convertible preferred stock upon conversion of such shares into common stock. As of December 31, 2020, these additional shares of common stock were not issued and outstanding.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In July 2021, in connection with the conversion of the 2021 Notes, the Company adjusted the conversion price for the Series B redeemable convertible preferred stock of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.974077&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.6942&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The adjustment was made in accordance with the anti-dilution provisions in the certificate of incorporation then in effect immediately prior to the conversion of the 2021 Notes. The adjustment to the conversion price resulted in additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,249,224&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock into which Series B redeemable convertible preferred stock would be convertible. As of December 31, 2021, these additional shares were not issued and outstanding. Each share of Preferred Stock is convertible into an equivalent number of common stock, at any time, at the option of the holder. The initial conversion price for the Series C-1 redeemable convertible preferred stock and Series C-2 redeemable convertible preferred stock is the respective original issue prices.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The conversion price for the Preferred Stock was subject to adjustments for stock splits, stock dividends, or similar recapitalization, and subject to adjustments in accordance with the anti-dilution provisions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The shares of Preferred Stock were to automatically convert into common stock of the Company immediately upon either (a) the closing of the sale of shares of common stock to the public in a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of proceeds, net of the underwriting discount and commissions, to the Company, or Qualified IPO, or (b) the date and time, or the occurrence of an event, specified by vote or written consent of the holders of a majority of the then outstanding shares of Preferred Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Dividends&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Dividends may be paid to the holders of the Series A redeemable convertible preferred stock. The holders the Series A redeemable convertible preferred stock are entitled to receive non-cumulative dividends at a rate per annum of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.073744&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;share when and if declared by the Board of Directors. The holders of the Series B redeemable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;convertible &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;preferred stock were entitled to receive a non-cumulative dividend at the rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% per annum of the Series B original issue price per share when and if declared by the Board of Directors. As of December 31, 2021, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; cash dividends were declared or paid. From and after the date of issuance of the Series C Preferred Stock, the Company was not to set, declare, pay or set aside unless holders of the Series C Preferred Stock then outstanding shall first receive, or simultaneously receive, dividends on each outstanding share of Series C Preferred Stock in an amount equal to (i) in the case of dividends being distributed to common stock or any class or series of capital stock that is convertible into common stock, the equivalent dividend on an as-converted basis or (ii) in the case of dividends being distributed on a series or class not convertible into common stock, an additional dividend equal to a dividend rate calculated based on the respective original issue price of the Series C Preferred Stock. The original issue prices per share for the Series C-1 redeemable convertible preferred stock and Series C-2 redeemable convertible preferred stock were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.265809&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.725938&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Voting Rights&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014; The holders of the Preferred Stock were entitled to vote on any matter presented to stockholders of the Company for consideration. Each holder of the Preferred Stock was entitled to cast the number of votes equal to the number of shares of common stock into which the shares of the Preferred Stock held by such holder were convertible on such date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Redemption&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Preferred Stock did not contain any mandatory redemption features. In accordance with FASB ASC Topic 480, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, preferred stock issued with redemption provisions that are outside of the control of the Company or that contain certain redemption rights in a deemed liquidation event is required to be presented outside of stockholders&#x2019; equity (deficit) on the face of the consolidated balance sheets. The Company classified the Preferred Stock outside of the stockholders&#x2019; equity (deficit) as mezzanine equity because in the event of certain deemed liquidation events, which included events such as a sale or merger, that were not solely within the control of the Company, the shares of the Preferred Stock would have become redeemable at the option of the holders. The Company did not adjust the carrying values of the Preferred Stock to the redemption values of such shares since a deemed liquidation event did not occur and the shares were not probable of becoming redeemable in the future as of the consolidated balance sheet dates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Liquidation&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the event of a liquidation, deemed liquidation, dissolution or winding up of the Company, holders of the Preferred Stock would have been entitled to be paid out of the assets of the Company that were available for distribution before any payment is made to the holders of common stock. The amount to paid would have been the greater of (i) respective original issue prices plus any dividends declared but unpaid or (ii) the amount that would have been payable had all shares of Preferred Stock been converted into common stock immediately before such event. If upon any such liquidation, deemed liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution to its stockholders would have been insufficient to pay the holders of Preferred Stock the full amount to which they would have been entitled, the holders of Preferred Stock would have shared ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;After the payment of all preferential amounts required to be paid to the holders of Preferred Stock, the remaining assets of the Company available for distribution to its stockholders would have been distributed among the holders of the shares of common stock on a pro rata basis based on the number of shares held by each such holder.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2022, upon the completion of the Company&#x2019;s IPO, all of the Company's outstanding shares of preferred stock were converted into shares of its common stock. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; redeemable convertible preferred stock outstanding as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_abc06de1-757c-40f3-a5ee-6a4936862ac3"
      decimals="INF"
      id="F_f4c4f840-c6d0-4f5e-be43-5e2434b97a80"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_64429dd7-c70d-4084-9c4c-b6db110ed37a"
      decimals="INF"
      id="F_6a8fc1f2-b02f-4005-945d-fba5bb2413b3"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_abc06de1-757c-40f3-a5ee-6a4936862ac3"
      decimals="INF"
      id="F_1f4b8b36-5199-4090-8c8a-c29b94503cf5"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:NotesPayable
      contextRef="C_268c76a6-dcfb-4bac-8647-bc6361c204b4"
      decimals="-5"
      id="F_c77a34bd-682f-4747-9059-95d21778373f"
      unitRef="U_USD">27700000</us-gaap:NotesPayable>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_268c76a6-dcfb-4bac-8647-bc6361c204b4"
      decimals="INF"
      id="F_0c58c78f-b8f6-43dc-8989-8625032506f6"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_0c92309a-986c-49bf-b31a-d664d204a95c">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s redeemable convertible preferred stock consisted of the following:&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:26.627%;"/&gt;
        &lt;td style="width:1.071%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.395000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.071%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.395000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.357%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.446000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.357%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.446000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.071%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.762%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="18" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(dollars in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Preferred&lt;br/&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Preferred Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common Stock&lt;br/&gt;Issuable Upon&lt;br/&gt;Conversion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series A preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,289,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,289,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,407,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series B preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,100,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,496,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;246,070&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,746,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-1 preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;134,791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-2 preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,710,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,107,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;239,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;416,466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,474,330&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_c3276726-bb81-4c1f-84ce-82482a2f7dc8"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_80b77208-8c61-489b-9e5c-91305bea9b92"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_931c6aee-f328-4858-b77a-938c47ab2d8b"
      unitRef="U_shares">6289609</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="-3"
      id="F_a5c13f34-f7ef-43b3-a92c-c3e04c835a29"
      unitRef="U_USD">7675000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="-3"
      id="F_d48501a1-9f10-44a5-9872-ceecb77e2e3d"
      unitRef="U_USD">7730000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="INF"
      id="F_49a7b76e-be00-49e0-8cba-16769ae8a4f5"
      unitRef="U_shares">6407256</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_52257089-83ae-4754-8a52-46a508587a45"
      unitRef="U_shares">15100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_efd082a1-786f-44ea-b7d3-4496d7b1ee6c"
      unitRef="U_shares">14496835</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_79d9240f-f219-4a5a-b234-5b3a3b744405"
      unitRef="U_shares">14496835</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="-3"
      id="F_93c1f11d-6039-4c33-a1d9-412410197317"
      unitRef="U_USD">64387000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="-3"
      id="F_07c3d740-bd86-4f6d-9b22-bb2d341d1f4e"
      unitRef="U_USD">246070000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="INF"
      id="F_fa0ec132-1121-45fa-8b6f-a526a0c8fb1c"
      unitRef="U_shares">16746059</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_141b0cff-a1be-45b5-a51c-3a0b372707de"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_4b6e69c1-dec8-40ce-915f-28201ef19998"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_ead9b1cc-eb06-4d0d-84bd-ba34d361848d"
      unitRef="U_shares">13150430</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="-3"
      id="F_c59c1db0-df6c-497f-8149-4c57e929d9e9"
      unitRef="U_USD">134791000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="-3"
      id="F_e5fcacf7-36cc-4c16-a9b8-052649834fdd"
      unitRef="U_USD">135000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="INF"
      id="F_212b8209-6cc5-4121-a4c0-a8848e62dd9e"
      unitRef="U_shares">13150430</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_cad0a752-62f1-45d6-a6f2-b2df7f9a3c68"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_6b1db14c-93ea-4523-bf19-06003e7390e4"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_2a6a4d3d-17d0-4c98-b5d8-18d405ab7392"
      unitRef="U_shares">3170585</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="-3"
      id="F_15ed1a9c-e67c-4aeb-82d0-ac15de11076f"
      unitRef="U_USD">32498000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="-3"
      id="F_8fe513ab-440b-43f7-b750-c022037c9f0b"
      unitRef="U_USD">27666000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="INF"
      id="F_dc8e49b0-55bb-49f4-a01c-1b8771a4d414"
      unitRef="U_shares">3170585</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_467ce3ee-1bed-4ff4-8b74-a4ad869e2050"
      unitRef="U_shares">37710624</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_08eb0f29-c113-48e7-bd2f-939254f2d371"
      unitRef="U_shares">37107459</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_e12560d5-7541-4e2a-9caf-ec042f90db0d"
      unitRef="U_shares">37107459</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_f2ab8621-5b05-4cef-aa26-db015a5e521f"
      unitRef="U_USD">239351000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_7cee1771-df78-4a37-adf9-2bf65b379b6c"
      unitRef="U_USD">416466000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_a86a29eb-728f-4073-8dbb-24c12f5a937a"
      unitRef="U_shares">39474330</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_a166ab8c-a37b-4070-99b9-bc8f9b0a2693"
      decimals="6"
      id="F_58584f47-2c48-4dce-be4a-d9e6af28d8cb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.229073</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_35fc1ceb-01e4-49e3-8c88-0259fd467fd7"
      decimals="4"
      id="F_200044ea-bb3c-4654-b82a-32379f90991a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.2065</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_35fc1ceb-01e4-49e3-8c88-0259fd467fd7"
      decimals="INF"
      id="F_e17421c7-d435-41d0-9064-f3c3ea9923b3"
      unitRef="U_shares">117650</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_8766c930-41ee-4314-b087-45deb048d199"
      decimals="6"
      id="F_60d3190a-2d05-4dde-81a6-c6a22697e3b1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.974077</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="C_170cdc21-0444-4686-8e31-4471213a6c12"
      decimals="4"
      id="F_acfeb3b9-d370-4bcf-acd3-550726d3610c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">14.6942</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_170cdc21-0444-4686-8e31-4471213a6c12"
      decimals="INF"
      id="F_b684cea8-6666-4151-abdd-f77745b7d079"
      unitRef="U_shares">2249224</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <amlx:ProceedsFromUnderwrittenPublicOffering
      contextRef="C_85caa5e9-c564-49a9-b13c-652337260e60"
      decimals="INF"
      id="F_0f0842f1-312f-4bd6-911b-080ffd0a2e48"
      unitRef="U_USD">75000000.0</amlx:ProceedsFromUnderwrittenPublicOffering>
    <amlx:NonCumulativeDividendsPerShareEntitledToReceive
      contextRef="C_6bdb4a21-46a5-4b63-996d-1fd7fa4bfa37"
      decimals="6"
      id="F_7c87bab6-cb95-4ba9-8a52-3d1885b5e06f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.073744</amlx:NonCumulativeDividendsPerShareEntitledToReceive>
    <amlx:PercentageOfNonCumulativeDividendsEntitledToReceive
      contextRef="C_2a609dfc-a79f-4196-9ebd-2216a498a2a6"
      decimals="2"
      id="F_420f3071-7c66-4512-a747-c5645e5bd033"
      unitRef="U_pure">0.06</amlx:PercentageOfNonCumulativeDividendsEntitledToReceive>
    <us-gaap:DividendsPreferredStockCash
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_7ef6b45e-6205-4083-91d9-97d199a20af8"
      unitRef="U_USD">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_169ebe3d-ebaa-4919-b644-ec350d43f0b8"
      decimals="6"
      id="F_0a30a1d4-f26c-4298-abdf-36d9b3c22b44"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.265809</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_baff8f8a-3ad5-4caf-8ee7-ab95e67c3db0"
      decimals="6"
      id="F_88198a30-5c4e-4f94-8c2b-e554adba507e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.725938</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_dc54cfa8-1c15-424b-8745-5ed82b6f03a9"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_1ff51752-190b-4457-8afd-235219aba9af">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12. Stockholders&#x2019; EQUITY (Deficit&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Common Stock&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Each share of common stock entitles the holder to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; vote on all matters submitted to a vote of the Company&#x2019;s stockholders provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#x2019;s Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the Delaware General Corporation Law. Common stockholders are entitled to receive dividends, as may be declared by the Company&#x2019;s Board of Directors, if any, subject to the preferential dividend rights of the Preferred Stock. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; dividends were declared or paid during the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company had reserved shares of common stock for issuance in connection with the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.389%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.193%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;300,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;56,500,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66,512,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,020,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock authorized and reserved for future issuances:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,407,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series B redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,746,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-2 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for the exercise of stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,480,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,339,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for the unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;740,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for future issuance of share-based awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,817,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,444,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total common stock authorized and reserved for future issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,038,998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,257,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unreserved common stock available for future issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;221,448,991&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,221,680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2022, the Company completed its IPO in which the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,369,369&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock at a price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. After deducting underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(24,24,24,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;196.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. Upon the completion of the IPO, all of the Company&#x2019;s outstanding shares of preferred stock were converted into shares of its common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2022, the Company completed a follow-on public offering in which the Company issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,697,812&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock at a price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. After deducting underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <amlx:CommonStockNumberOfVotingRights
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_bfe95133-c473-428a-8afd-3211cd0c7a4f"
      unitRef="U_Vote">1</amlx:CommonStockNumberOfVotingRights>
    <us-gaap:Dividends
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_bf7f12c0-5c25-4b98-8d1d-5e5061d2f686"
      unitRef="U_USD">0</us-gaap:Dividends>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_9fa7e4d7-cbe2-4c87-9b02-936023df7ac4"
      unitRef="U_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:Dividends
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_a14f7b3e-6768-41ea-bc4c-ceda77ea4174"
      unitRef="U_USD">0</us-gaap:Dividends>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_9a7e093d-8037-4eee-876e-a6954d4ee46b"
      unitRef="U_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <amlx:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_841b385b-3231-43ce-9be3-bf81da0ce0f3">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company had reserved shares of common stock for issuance in connection with the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.389%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.193%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;300,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;56,500,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66,512,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,020,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock authorized and reserved for future issuances:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,407,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series B redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,746,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,150,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Series C-2 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,170,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for the exercise of stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,480,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,339,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for the unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;740,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for future issuance of share-based awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,817,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,444,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total common stock authorized and reserved for future issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,038,998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,257,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unreserved common stock available for future issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;221,448,991&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,221,680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</amlx:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_bab57481-c537-4db3-ad10-13e8f81710c7"
      unitRef="U_shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_1059b75a-d1a8-4a9d-bfa9-1e8f9f060577"
      unitRef="U_shares">56500000</us-gaap:CommonStockSharesAuthorized>
    <amlx:CommonStockSharesIssuedAndOutstanding
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_34841636-5036-4a98-801f-acd695038bf5"
      unitRef="U_shares">66512011</amlx:CommonStockSharesIssuedAndOutstanding>
    <amlx:CommonStockSharesIssuedAndOutstanding
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_af744eac-0c63-4cac-b9ac-8f6b89a8faeb"
      unitRef="U_shares">7020487</amlx:CommonStockSharesIssuedAndOutstanding>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_04bad709-1ef2-43f6-b2f9-748a32b59f4b"
      decimals="0"
      id="F_3f8bd8fb-c0d6-44dc-96b0-86b6ed9c4411"
      unitRef="U_shares">6407256</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_ee15eb3d-afa2-43be-9739-f6cb7c933259"
      decimals="0"
      id="F_f95378e8-7777-4095-9b12-0cc961639e24"
      unitRef="U_shares">16746059</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_03321fdb-085e-4a85-8527-c88ccc6d8f6e"
      decimals="0"
      id="F_06b8e266-aeac-438e-aef1-acdb46e712f0"
      unitRef="U_shares">13150430</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_76a27bca-e6a0-46ac-b8c6-41820a58e22c"
      decimals="0"
      id="F_83d18638-1902-43c1-a17f-4f5c5f894e39"
      unitRef="U_shares">3170585</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_c9061aa3-fdfb-412c-afec-524e4df56961"
      decimals="0"
      id="F_5461c92d-80ac-46f3-84db-69e102191b71"
      unitRef="U_shares">8480950</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_aabbe5a4-0d80-4d34-9c12-1bc6e30e9fa6"
      decimals="0"
      id="F_16c54a2e-ae1d-4e71-af00-c052a511bc99"
      unitRef="U_shares">5339011</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d"
      decimals="0"
      id="F_a73d2d85-6a59-4ace-a9b6-08a42cace834"
      unitRef="U_shares">740297</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_adb5fca4-6b49-414c-ae2a-8352bcf3a331"
      decimals="0"
      id="F_31839ce2-0d8d-429f-a7ee-90ddea9cd618"
      unitRef="U_shares">2817751</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_32879b2b-a939-4f66-b85c-34c2c940aadb"
      decimals="0"
      id="F_8b4889e4-48ba-4bff-a45f-9db560062c8e"
      unitRef="U_shares">1444492</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="0"
      id="F_33b3a76f-11de-4de1-98f6-192eee7ce8ed"
      unitRef="U_shares">12038998</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:CommonStockAuthorizedAndReservedForFutureIssuance
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="0"
      id="F_23809fd5-6754-445e-8422-68de6c78f4d1"
      unitRef="U_shares">46257833</amlx:CommonStockAuthorizedAndReservedForFutureIssuance>
    <amlx:UnreservedCommonStockAvailableForFutureIssuance
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="0"
      id="F_bb9eb6fb-245b-49f8-a977-70c98a2fa7c4"
      unitRef="U_shares">221448991</amlx:UnreservedCommonStockAvailableForFutureIssuance>
    <amlx:UnreservedCommonStockAvailableForFutureIssuance
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="0"
      id="F_7bb4eaf9-b20e-4aa8-af22-0467caf851a6"
      unitRef="U_shares">3221680</amlx:UnreservedCommonStockAvailableForFutureIssuance>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_ee7aed98-f0b4-4a0d-9d1c-9a20e0229bc8"
      decimals="INF"
      id="F_904580c9-6911-4918-b506-924f0a74b49e"
      unitRef="U_shares">11369369</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_32feb0a1-4b4c-4d84-ad01-dc752482f3d4"
      decimals="INF"
      id="F_39a5538f-eec4-4238-9165-f186b78d02df"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_ee7aed98-f0b4-4a0d-9d1c-9a20e0229bc8"
      decimals="-5"
      id="F_b73f8af8-a83b-4e63-a50d-ee36c56cb588"
      unitRef="U_USD">196400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_9108caa7-2bf4-44fb-ab90-32ee41737a03"
      decimals="INF"
      id="F_2033fb0e-5fb9-4262-ac82-79ed9505e57a"
      unitRef="U_shares">7697812</us-gaap:CommonStockSharesIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_9108caa7-2bf4-44fb-ab90-32ee41737a03"
      decimals="INF"
      id="F_65dec296-7de6-40dd-804b-b5b1291f2005"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">32.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_84e93efe-e53b-4b00-b1fc-338b910d8572"
      decimals="-2"
      id="F_231f49ee-bff5-4330-a7ae-41e7ccd7574f"
      unitRef="U_USD">230600</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_0b257eaf-8bb3-4cf4-9165-fdaedf2b53de">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13. Stock Option and Grant Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock Incentive Plan&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2022, the Company&#x2019;s board of directors adopted, and its stockholders approved the 2022 Stock Option and Incentive Plan, or 2022 Plan, which became effective on January 5, 2022, at which point &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; further grants would be made under the 2015 Stock Option and Restricted Stock Plan, or 2015 Plan. Under the 2022 Plan, the Company may grant incentive stock options, or ISOs, non-statutory stock options, stock appreciation rights, restricted stock units, restricted stock awards and other stock-based awards. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,817,751&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares available for future issuance under the 2022 Plan. The options issued under the 2022 Plan expire &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years following the date of grant. Stock options and restricted stock units typically vest over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years. We recognize the compensation cost of awards subject to service-based vesting conditions over the requisite service period, which is generally equal to the vesting period of the respective award.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Initially, subject to adjustment as provided in the 2022 Plan, the aggregate number of shares of the Company&#x2019;s common stock available for issuance under the 2022 Plan is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,650,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The number of shares of the Company&#x2019;s common stock reserved for issuance under the 2022 Plan will automatically increase on January 1 of each year commencing January 1, 2023, by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the total number of shares of the Company&#x2019;s common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors. The maximum current number of shares that may be issued pursuant to the exercise of ISOs under the 2022 Plan is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,650,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The maximum number of shares of the Company&#x2019;s common stock subject to awards granted under the 2022 Plan or otherwise during a single calendar year to any individual nonemployee director, taken together with any cash fees paid by the Company to such nonemployee director during the calendar year for serving on the Company&#x2019;s board of directors, will not exceed $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;750,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in total value, or, with respect to the calendar year in which a nonemployee director is first appointed or elected to the Company&#x2019;s board of directors, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;All options and awards granted under the 2015 Plan consisted of the Company&#x2019;s common stock. As of January 6, 2022, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; additional stock awards have been or will be granted under the 2015 Plan. Although the 2015 Plan was terminated as to future awards in January 2022, it continues to govern the terms of options that remain outstanding under the 2015 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;General Option Information&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.447%;"/&gt;
        &lt;td style="width:1.752%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.103%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.605%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.094%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Grant price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.73&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The per share weighted average grant date fair value of stock options granted during the year ended December 31, 2022 and 2021 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.10&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of option activity for &lt;/span&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.716%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.386999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.408999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.275%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.565%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,339,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,237,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;950,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;145,768&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,480,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13.19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.2&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;201,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,055,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;63,408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,425,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.6&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;138,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the options and the fair value of the Company&#x2019;s common stock for those options that had exercise prices lower than the fair value of the Company&#x2019;s common stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2022 and 2021, was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The total fair value of stock options vested during the years ended December 31, 2022 and 2021 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Stock Unit Activity&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of restricted stock unit activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.004%;"/&gt;
        &lt;td style="width:1.166%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.039%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.619%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.173%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Nonvested as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;752,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17.82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Nonvested as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;740,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation Expense&#x2014;&lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded stock-based compensation expense in the following expense categories of its statements of operations: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.097%;"/&gt;
        &lt;td style="width:1.619%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.652999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.619%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.01%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes stock-based compensation by type of award:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.938%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.737%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.094%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes unrecognized stock-based compensation expense as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, by type of awards, and the weighted-average period over which that expense is expected to be recognized. The total unrecognized stock-based compensation expense will be adjusted for actual forfeitures as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.053%;"/&gt;
        &lt;td style="width:1.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.042%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.17%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.121%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrecognized Expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-average Recognition Period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.79&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.25&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_5d394f0f-75d1-48be-a6ab-deb2d20f1179"
      decimals="INF"
      id="F_1c6cc523-755e-42f0-9c25-c6c9c04186f8"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_7f388b78-2a24-4c12-8623-a7395b18ffe4"
      decimals="INF"
      id="F_24fffafe-f12c-4735-9211-ee8f5f4102ec"
      unitRef="U_shares">2817751</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_75aa067a-4ce0-4ee0-849d-a679d624a87c"
      id="F_71e1c841-9feb-4f71-b581-39bf6eddf1e7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_75aa067a-4ce0-4ee0-849d-a679d624a87c"
      id="F_a7349418-f281-4471-ad56-62a4b7e968e3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_965b6cf6-b979-4df3-ac71-5437159cc716"
      decimals="INF"
      id="F_a488f181-e301-418b-96ae-dd97df7794c5"
      unitRef="U_shares">7650000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <amlx:PercentageOfIncreaseInCommonStockReservedForIssuance
      contextRef="C_43c44a69-a3b4-4167-b97c-320dd91b42d2"
      decimals="INF"
      id="F_75fb727f-3c50-4e72-b9a0-5a62966f7a6d"
      unitRef="U_pure">0.05</amlx:PercentageOfIncreaseInCommonStockReservedForIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_46b98ed8-5467-4391-ad5a-f70e2d057d60"
      decimals="INF"
      id="F_bba16d0a-8993-4916-93ef-a1b8c862bc82"
      unitRef="U_shares">7650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_8b5b9ca1-4558-4404-bf4b-7219032bb989"
      decimals="INF"
      id="F_a045edf4-942a-4b5c-86b6-8071d30656de"
      unitRef="U_USD">750000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_0863d34e-dbd1-4004-8428-eacbe8227644"
      decimals="0"
      id="F_16002ed3-b00d-43a4-aed0-a80ab80fcea3"
      unitRef="U_USD">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_42ba167d-3f2c-43b5-ad10-97d7aff55f3c"
      decimals="INF"
      id="F_1d0c879b-ddaa-472d-a440-59236dd6cee6"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_9686c35f-5e37-496a-9783-f4cde52dd115">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.447%;"/&gt;
        &lt;td style="width:1.752%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.103%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.605%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.094%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Grant price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.97&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.73&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="2"
      id="F_2af5a54e-bb9e-4f61-a323-e2c163bca852"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.29</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="2"
      id="F_1afc7bab-a8f9-469f-9610-125055f4bbe8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.69</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="4"
      id="F_a3dff11e-2424-41db-b45d-206702794f99"
      unitRef="U_pure">0.0197</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="4"
      id="F_c4663eef-3d1c-4ebd-94eb-c2b3be6b88f7"
      unitRef="U_pure">0.0101</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_0ec51598-debb-48e5-8670-890f3173366c">P6Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      id="F_ac50c9ce-9539-4945-b4a6-1428280daf3e">P5Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="4"
      id="F_896510e7-3571-402d-bd14-8cde7a89e912"
      unitRef="U_pure">0.8875</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="4"
      id="F_0386bf07-3e19-4fc0-b3d8-bb99739d1c51"
      unitRef="U_pure">0.8161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="4"
      id="F_4c700b10-1fd2-4b78-a84c-26e458c245be"
      unitRef="U_pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="4"
      id="F_2d094f0e-9afd-40a3-a086-64f9764ab14e"
      unitRef="U_pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="2"
      id="F_3cc80560-469b-4a0b-9bc5-6132452b9e77"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="2"
      id="F_137ea969-a5ea-48df-8873-594500c0e30e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_af0dc11b-0c16-4db0-b0b3-b44407cbd79d">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, is as follows:&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.716%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.386999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.408999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.993%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.275%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.327%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.565%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,339,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.7&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,237,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;950,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.33&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;145,768&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,480,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13.19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.2&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;201,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,055,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;63,408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,425,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.6&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;138,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="INF"
      id="F_054b904b-417a-474b-8ddc-426030c143b1"
      unitRef="U_shares">5339011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="2"
      id="F_fcab25b2-70b8-486a-9109-4150185e563b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      id="F_606e69d6-61f0-4a26-812a-26d9671b76b0">P8Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_38cd9e59-bd9f-46b1-b299-bc5c49051bcc"
      unitRef="U_USD">15627000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_32f6cc2e-6a66-4210-aa6e-305df09a78b1"
      unitRef="U_shares">4237720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="2"
      id="F_39afc636-63fd-4d9a-b0bc-9ae966f4536c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_c022b9bc-fce1-47d2-bfb8-31eda789f4b9"
      unitRef="U_shares">950013</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="2"
      id="F_a369ea70-c8c0-4334-835e-4b110614a8a8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.33</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_a57c5bd7-a5f3-4ad1-9670-59f834a2e375"
      unitRef="U_shares">145768</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="2"
      id="F_25a146a2-12d6-431f-bc55-0527d8a4044a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_0c6816fb-bd20-4734-8822-089a2943809c"
      unitRef="U_shares">8480950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="2"
      id="F_84bab803-ed6b-40c5-9283-a908b06c14b9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_0b212539-1f0e-4b1d-b981-7d74c8f51e7b">P8Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_1b90b51e-4fa6-4989-9e72-99cb5081ae19"
      unitRef="U_USD">201765000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_e2b88f8d-fa3b-4544-b283-bb4b18b0f56b"
      unitRef="U_shares">2055416</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="2"
      id="F_aedc4a16-1669-4cda-9320-27d75c435a47"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_eac08500-80b8-47c3-a615-56b7880d4f76">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_6d49e4d2-46a1-4130-bc5e-14b293258fb3"
      unitRef="U_USD">63408000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="INF"
      id="F_18047e32-e744-4f71-ae1c-d1afd003628b"
      unitRef="U_shares">6425534</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="2"
      id="F_1a045c03-b144-4c59-a91c-44cf1d2bf7cc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.47</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <amlx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_e6a06a86-a9b1-4253-9658-5cde8e01341e">P8Y7M6D</amlx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm>
    <amlx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_613e9654-1026-4556-9c28-05cdd6b42de5"
      unitRef="U_USD">138357000</amlx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-5"
      id="F_e6201678-888a-4181-906e-6fefec86b1f3"
      unitRef="U_USD">14200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-5"
      id="F_33e96eff-2b59-4828-8c35-d576d68297c5"
      unitRef="U_USD">6200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-5"
      id="F_376ac7c8-85d9-4589-8a3b-f077bbe2ea35"
      unitRef="U_USD">8800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-5"
      id="F_9e545de8-c2b1-40d9-8152-429e6459b5a4"
      unitRef="U_USD">1300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_20b79d32-b929-4e38-8b8f-5eae852dce50">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of restricted stock unit activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.004%;"/&gt;
        &lt;td style="width:1.166%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.039%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.619%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.173%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Nonvested as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;752,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17.82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Nonvested as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;740,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2"
      decimals="INF"
      id="F_83f61cf1-564c-49a3-81e2-627460c221ba"
      unitRef="U_shares">752613</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2"
      decimals="2"
      id="F_433e06a1-370b-4198-8756-b28adcba7c2d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2"
      decimals="INF"
      id="F_d54af78f-9195-4b7b-ba7d-fe26d50b86fe"
      unitRef="U_shares">12316</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2"
      decimals="2"
      id="F_baa9dd61-b2db-4941-bad3-9c97f26ae88f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">17.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d"
      decimals="INF"
      id="F_ffb51d28-713c-4724-93fe-e49df97b11bb"
      unitRef="U_shares">740297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d"
      decimals="2"
      id="F_a69356c5-497d-455a-9b8a-dfb9703be61d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_cf41d2c6-073e-4248-a12f-1553561ad070">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded stock-based compensation expense in the following expense categories of its statements of operations: &lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.097%;"/&gt;
        &lt;td style="width:1.619%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.652999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.619%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.01%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;888&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a6f624b0-506d-4092-ac12-59f88d4944f4"
      decimals="-3"
      id="F_92c7bd5a-c70d-4906-b154-3289f5ffd8f0"
      unitRef="U_USD">5639000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fb130967-b508-4202-8fe2-6a4e676525e0"
      decimals="-3"
      id="F_35c62b3c-e7e2-4782-9988-3eb3b2a3d562"
      unitRef="U_USD">888000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_73f1a92d-0191-4388-a5a7-d6dd11c4cb90"
      decimals="-3"
      id="F_19031b5f-9325-4a24-a2a0-eef40019358b"
      unitRef="U_USD">16075000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_638aa53f-8b90-4d77-82c0-fa3b9eb25f93"
      decimals="-3"
      id="F_29d587ce-4638-4948-8302-db51a33da546"
      unitRef="U_USD">2248000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_9d085b87-c382-414b-b34d-60bdab1a8fce"
      unitRef="U_USD">21714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_435b3303-8677-43a7-9985-014cebe9e793"
      unitRef="U_USD">3136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_21aae312-89b6-4555-bc6a-4fc2d9b24a03">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes stock-based compensation by type of award:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.938%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.737%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.615%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.094%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,870&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c32475bb-ba9c-415b-a298-afa0b3f8ef62"
      decimals="-3"
      id="F_9c1c1d79-69d9-44b4-a1cb-c262e7b63ec3"
      unitRef="U_USD">18844000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f604d797-a8f0-453f-a9ea-26ea1f4f44d7"
      decimals="-3"
      id="F_90253bb7-fb3b-46be-9ecd-0480c0792b34"
      unitRef="U_USD">3136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2"
      decimals="-3"
      id="F_152be67d-b172-4465-a737-e3a8f98fe7f1"
      unitRef="U_USD">2870000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_8f600cc1-7657-483f-a32d-7faebd17584e"
      unitRef="U_USD">21714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_d4fb787f-501e-4777-8f50-ce9c705611c6"
      unitRef="U_USD">3136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <amlx:SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_7012ed4b-ab48-4e0a-a860-5cc5f416e9ed">&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes unrecognized stock-based compensation expense as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, by type of awards, and the weighted-average period over which that expense is expected to be recognized. The total unrecognized stock-based compensation expense will be adjusted for actual forfeitures as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.053%;"/&gt;
        &lt;td style="width:1.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.042%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.17%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.121%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrecognized Expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-average Recognition Period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.79&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.25&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</amlx:SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_c9061aa3-fdfb-412c-afec-524e4df56961"
      decimals="-3"
      id="F_90f2529f-c59d-484b-9b37-db3fb6800163"
      unitRef="U_USD">61049000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_c32475bb-ba9c-415b-a298-afa0b3f8ef62"
      id="F_1ff96206-42eb-484d-adbd-b81ef5f489be">P2Y9M14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_53d17c7f-1169-43e5-8ae2-8fad7891e10d"
      decimals="-3"
      id="F_8b19d172-e114-45ac-b860-57ac0dba03e4"
      unitRef="U_USD">11950000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_81aa5a36-a608-4d01-ab23-6149905204c2"
      id="F_4e3e22e1-aebc-4c8c-80dd-f56125d6e767">P3Y3M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_5a2456ca-7e39-4c70-8bfe-07d5c70b0bbb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14. Income Taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of net loss before the provision for income taxes are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.475%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.962000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.101%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;198,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;87,904&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Loss before income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;197,601&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;87,931&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The provision for income taxes for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.62%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.776%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.133%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Current income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. - Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. - State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the Company&#x2019;s effective income tax rate to the U.S. statutory federal income tax rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.416%;"/&gt;
        &lt;td style="width:1.275%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.521999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.275%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.511999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax at U.S. statutory tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income tax benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowances&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets and liabilities reflect the net tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting and the amounts used for tax purposes. &lt;/span&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.475%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.962000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.101%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,303&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,474&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized research and development costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,079&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,205&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accruals and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90,587&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. The Company has considered its history of cumulative losses, including significant losses incurred in every year since inception, including 2022, and has concluded that it is more likely than not that it will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On a periodic basis the Company reassess the valuation allowance that has been established, weighing positive and negative evidence.  In 2022, the Company reassessed the valuation allowance and considered negative evidence, including cumulative losses over the three years ended December 31, 2022, and positive evidence, including regulatory approvals of ALBRIOZA and RELYVRIO. After assessing both the negative and positive evidence, the Company concluded that a full valuation should be retained against the net deferred tax assets as of December 31, 2022.  It is possible that all or a portion of the valuation allowance will be released in the near-term.  The release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, levels of profitability, revenue growth, clinical program progression and expectations regarding future profitability.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;203.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;115.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, and state net operating loss carryforwards of approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;164.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;102.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, which are available to reduce future taxable income. Of the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;203.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; federal net operating loss carryforwards, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; begin to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and the remaining &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;201.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; net operating losses carryforward indefinitely. Of the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;164.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; state net operating loss carryforwards, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;113.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;of Massachusetts net operating loss carryforwards begin to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2034&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, the Company also had federal tax&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;credits of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, and state tax credits of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The tax credit carryforwards will expire at various dates beginning in 2034.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The utilization of the net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income. The Company has not conducted a formal study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382 and 383 of the Code, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards may be subject to an annual limitation, which is determined by first multiplying the value of the Company&#x2019;s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has not yet conducted a study of its research and development credit carryforward. Such a study, once undertaken by the Company, may result in an adjustment to the Company&#x2019;s research and development credit carryforward. A full valuation allowance has been provided against the Company&#x2019;s research and development credit and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a valuation allowance against its deferred tax assets as of December 31, 2022 and 2021, because the Company&#x2019;s management has determined that it is more likely than not that these assets will not be fully realized. The increase in the valuation allowance recorded during the year primarily relates to the net operating loss incurred by the Company as well as the increase in research and development credits.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table reflects the roll-forward of the Company&#x2019;s valuation allowance:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.62%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.776%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.133%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance at beginning of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increases recorded to income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance at end of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90,587&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for uncertainty in income taxes under the provisions of ASC 740 which defines the thresholds for recognizing the benefits of tax return positions in the consolidated financial statements as &#x201c;more likely than not&#x201d; to be sustained by the taxing authority. The tax benefit is measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlemen&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the beginning and ending amount of gross unrecognized tax benefits&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended December 31, 2022 and 2021 is as follows: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.475%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.962000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.101%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at beginning of the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increases (decreases) related to tax positions taken during prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increases related to tax positions taken during the prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at end of the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has reviewed the tax positions taken, or to be taken, in its tax returns for all tax years currently open to examination by a taxing authority. Unrecognized tax benefits represent the aggregate tax effect of differences between tax return positions and the benefits recognized in the consolidated financial statements. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company does not expect the amount of unrecognized tax benefits to change over next 12 months.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The Company accrues interest and penalties related to unrecognized tax benefits as a component of its provision for income taxes. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t recognize any interest or penalties related to uncertain tax positions during the two years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company files U.S. federal, foreign and state income tax returns in various jurisdictions. The status of limitations varies by jurisdiction. There are currently no federal or state audits or examinations in process.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_870988fd-8d8b-4250-afc6-df6ad31edca5">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of net loss before the provision for income taxes are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.475%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.962000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.101%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;198,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;87,904&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,103&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Loss before income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;197,601&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;87,931&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_f813747d-80c9-44d4-ae5f-b9ff290cb83a"
      unitRef="U_USD">-198704000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_0bb8c8be-48a1-42fb-bba7-c0ab30828220"
      unitRef="U_USD">-87904000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_2fdff5b9-4967-47b1-a182-009d1ea75882"
      unitRef="U_USD">1103000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_ad42f842-cc5a-4314-bd6e-b0984fd169be"
      unitRef="U_USD">-27000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_7aefe3a5-650b-42b5-82f1-2eaa7311a735"
      unitRef="U_USD">-197601000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_effbc121-7e4c-4035-8043-55826f3a0283"
      unitRef="U_USD">-87931000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_aa1e8007-3ef2-4da8-a6ea-e4fe94bad4a7">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The provision for income taxes for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.62%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.776%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.133%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Current income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. - Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. - State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_205258c9-1ad3-4be6-b37d-9f921b8716cb"
      unitRef="U_USD">774000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_f46fee41-e1dc-4ce1-acad-0568491d8127"
      unitRef="U_USD">774000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_795df624-f5f8-4835-9e01-831f0943c0fa">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the Company&#x2019;s effective income tax rate to the U.S. statutory federal income tax rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 is as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.416%;"/&gt;
        &lt;td style="width:1.275%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.521999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.275%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.511999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax at U.S. statutory tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income tax benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowances&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_080afa34-7642-4744-ad7e-5cdeb76b6d8f"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_a5c78284-5c00-492f-8aa9-7e56a4079d77"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_d1946569-8c88-470d-bb67-de3b5fcfdece"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_40df6936-9d1b-4906-80c5-e0512b0b419a"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="3"
      id="F_9fada5eb-e6db-47a8-9a5c-05195190ee28"
      unitRef="U_pure">0.039</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="3"
      id="F_8effe5c3-97ec-4ffe-a032-c77491c68825"
      unitRef="U_pure">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="3"
      id="F_4c06314c-f0a9-4f03-ad71-b9ac3f4235ba"
      unitRef="U_pure">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="3"
      id="F_cc6dc8ca-c27e-4d66-8b1a-ac370c6f6ea5"
      unitRef="U_pure">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="3"
      id="F_16d5d9e0-4a8c-488d-8930-944530483e17"
      unitRef="U_pure">-0.255</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="3"
      id="F_9d35c7a8-a5b4-494f-9715-4d71fb4b43ba"
      unitRef="U_pure">-0.244</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="3"
      id="F_d76a7894-9a2a-4903-ac5d-7416a247c710"
      unitRef="U_pure">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="3"
      id="F_54c6b3f6-1568-4591-8cc0-5da30b543b05"
      unitRef="U_pure">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="3"
      id="F_7a7f0b0b-b687-4c0f-9e08-01af033250f1"
      unitRef="U_pure">-0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="3"
      id="F_e0944f62-3aff-429b-a206-1b8d1b2cd2d4"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_1090a1b6-a6ab-4c79-b533-dc593fb2d781">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021: &lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.475%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.962000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.101%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,303&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,474&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized research and development costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,079&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,205&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inventory&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accruals and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90,587&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,379&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_da2ca7ca-78df-4aeb-89af-148601e4cc16"
      unitRef="U_USD">42673000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_1aa52fa7-a609-495c-815d-347834855573"
      unitRef="U_USD">24303000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_924ef26d-9fef-41f2-908c-8e21dbfd71a9"
      unitRef="U_USD">10628000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_0b989797-c5b9-46d0-b5cd-29ded0f91699"
      unitRef="U_USD">5474000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <amlx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_bd8a5832-f5e0-404d-8a0c-6d94f8262123"
      unitRef="U_USD">18079000</amlx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <amlx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_6b9b8bc0-faab-4578-8e73-890f3033cdc6"
      unitRef="U_USD">6205000</amlx:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_0f4af233-ce4c-48cf-87ba-b0b9aa2c25e0"
      unitRef="U_USD">5721000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_dcd6c50c-c85a-4e88-ba4a-6b15e707f5cc"
      unitRef="U_USD">5581000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_08f60998-dab1-49cd-8fd0-c4990d7f5c5e"
      unitRef="U_USD">2808000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a21a5078-bac5-4375-b59b-8a4547943d2f"
      unitRef="U_USD">9284000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_1f20938c-df6a-483e-b372-bca2b1cc1ff0"
      unitRef="U_USD">1556000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_93e710e0-435e-405b-bd62-052004e4047d"
      unitRef="U_USD">91966000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_ee6de6b7-0992-4deb-8610-cf77c4d446f8"
      unitRef="U_USD">40346000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_242dba43-8349-464b-9cc5-26c471efbb9d"
      unitRef="U_USD">90587000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_8f0d4487-52a2-49ee-96cd-b944464838e4"
      unitRef="U_USD">40346000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_1145ea92-5bf4-4bcb-9f84-ca719e662634"
      unitRef="U_USD">1379000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_d395d61e-b023-4934-8993-46ba24ceb9b9"
      unitRef="U_USD">-1379000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_a798bf77-1411-47c5-bb88-3b2aea147ff9"
      unitRef="U_USD">1379000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5"
      decimals="-5"
      id="F_6ac2c514-870d-457f-82f9-7ecc396e208b"
      unitRef="U_USD">203200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_b984d10b-9ff4-48e7-8949-0e6695ddfaee"
      decimals="-5"
      id="F_521da9cd-c5ce-4ec9-917e-ddd1f6d24412"
      unitRef="U_USD">115700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_2e22bd72-1889-4145-ab70-577df3f62afd"
      decimals="-5"
      id="F_bc16ab1c-669b-492b-b8bc-ef502b7405ac"
      unitRef="U_USD">164100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_4a875587-3d63-4295-98d5-e68474ee09d8"
      decimals="-5"
      id="F_618d24e2-fc53-45e0-a290-cb30e04bbd52"
      unitRef="U_USD">102900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5"
      decimals="-5"
      id="F_80b71311-6d65-4bda-90f6-3e7cfd092f2d"
      unitRef="U_USD">203200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5"
      decimals="-5"
      id="F_5ac2caf0-70d0-4d19-95a0-7df884875452"
      unitRef="U_USD">1300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <amlx:OperatingLossCarryforwardsExpirationPeriod
      contextRef="C_a7844b97-2442-4785-bc7f-5bd8385fcab8"
      id="F_e48a8c4a-d77c-4c4e-932c-12ae96b28b8b">2034</amlx:OperatingLossCarryforwardsExpirationPeriod>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5"
      decimals="-5"
      id="F_fa3b5f07-a110-4b98-8471-65a96ceca967"
      unitRef="U_USD">201900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_2e22bd72-1889-4145-ab70-577df3f62afd"
      decimals="-5"
      id="F_cc70d20c-3f68-41fe-9d4b-5adfa3fb8dc8"
      unitRef="U_USD">164100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="C_6e0804e9-955a-4a85-ad28-2816b77d859c"
      decimals="-5"
      id="F_b6adf0d3-da9e-4c21-bd01-696bee1c8c76"
      unitRef="U_USD">113000000.0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <amlx:OperatingLossCarryforwardsExpirationPeriod
      contextRef="C_1e5f309e-abea-4f3f-9d05-817063bff016"
      id="F_13d44073-5c7c-4792-91da-6ce46856594c">2034</amlx:OperatingLossCarryforwardsExpirationPeriod>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_5e174e74-e289-47a5-a2ba-1168ba02dae5"
      decimals="-5"
      id="F_8a9832c1-deac-4afb-a425-0526bb211f17"
      unitRef="U_USD">4600000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_b984d10b-9ff4-48e7-8949-0e6695ddfaee"
      decimals="-5"
      id="F_e312df89-816c-4ca0-99dd-1198552121b9"
      unitRef="U_USD">2700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_2e22bd72-1889-4145-ab70-577df3f62afd"
      decimals="-5"
      id="F_64464562-f7e5-493a-9c27-9cd8124399c2"
      unitRef="U_USD">1200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardDescription
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_a878b807-6a1e-46f4-8b57-2e3016009bbe">The tax credit carryforwards will expire at various dates beginning in 2034.</us-gaap:TaxCreditCarryforwardDescription>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_38d90570-fb79-44ab-86d1-3cbbc397f2c5">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table reflects the roll-forward of the Company&#x2019;s valuation allowance:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.62%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.776%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.734%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.133%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance at beginning of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increases recorded to income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance at end of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90,587&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_a8ce3e6b-6cb8-402c-8c7b-99279889fd13"
      unitRef="U_USD">40346000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5"
      decimals="-3"
      id="F_30321fc6-5c91-480e-99c9-2cdb67a0748c"
      unitRef="U_USD">18900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_9cb757f4-f7ac-4b62-9551-de5e1adde53a"
      unitRef="U_USD">50241000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_08a0d779-2ec7-41a8-9ef7-177e886637d9"
      unitRef="U_USD">21446000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_f03ce93b-2323-45c4-9ef2-0b6b8fc72ba9"
      unitRef="U_USD">90587000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_cc0d140c-8faa-4f8b-b807-7f04c272cf7f"
      unitRef="U_USD">40346000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_97f7586a-467f-4d67-b978-964cd4ab4577">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the beginning and ending amount of gross unrecognized tax benefits&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended December 31, 2022 and 2021 is as follows: &lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.475%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.962000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.731%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.101%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at beginning of the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increases (decreases) related to tax positions taken during prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increases related to tax positions taken during the prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at end of the period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_e3fba3e2-fdd4-4a87-8610-90b9b0b7f4d1"
      unitRef="U_USD">564000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_4805cb1e-b970-4249-8630-12fe8c6937d5"
      decimals="-3"
      id="F_5d247aaf-4801-4728-bc98-9339edcdb938"
      unitRef="U_USD">349000</us-gaap:UnrecognizedTaxBenefits>
    <amlx:UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_3ad52a36-eb00-4be3-8da8-7e22f470f500"
      unitRef="U_USD">-32000</amlx:UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="-3"
      id="F_e312262d-9de3-454f-a6b9-e09f21c98bde"
      unitRef="U_USD">481000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="-3"
      id="F_a2b23c3b-f518-40c7-b773-23604dd20908"
      unitRef="U_USD">215000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-3"
      id="F_23ad9cb7-a659-4a5d-a70c-631023423904"
      unitRef="U_USD">1013000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-3"
      id="F_076cbc64-1b49-41c2-93d1-3cb2a2527479"
      unitRef="U_USD">564000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_55119ad3-939d-4bc2-b32e-91e7d0b34665">The Company does not expect the amount of unrecognized tax benefits to change over next 12 months.</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="INF"
      id="F_80d512cc-5fe6-4f32-8d0c-325212067ae6"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="INF"
      id="F_e09ac029-90b9-459d-8dd6-68f96ecc719e"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b91d9e4b-536a-4fda-b870-17d8ac62fc2d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;EMPLOYEE BENEFIT PLANS&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:10.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company maintains a tax-qualified retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax-advantaged basis. Plan participants are able to defer eligible compensation subject to applicable annual Internal Revenue Code limits. The Company provides a safe-harbor contribution o&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;f &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of employee compensation to employees who satisfy the minimum service requirements. The Company made &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of safe-harbor contributions for the years ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1"
      decimals="2"
      id="F_b80ff7d4-9eb5-412f-bb63-52199f6b6718"
      unitRef="U_pure">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1"
      decimals="-5"
      id="F_992bd047-8702-4f7e-8553-65bb5ed9b2f0"
      unitRef="U_USD">1200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_c9812622-5be1-41f9-acc6-5b7dabd03559"
      decimals="-5"
      id="F_88d4b39a-8d69-47ae-b5cb-953b37e2014c"
      unitRef="U_USD">300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_0a108695-9467-4668-9978-3fb618e6d823">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16. NET LOSS PER SHARE&lt;/span&gt;&lt;span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net Loss per Share Attributable to Common Stockholders&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Because the Company reports a net loss attributable to common stockholders, basic and diluted net loss per share attributable to common stockholders are the same for both periods presented. All preferred stock, stock options and restricted stock units have been excluded from the computation of diluted weighted-average shares outstanding because such securities would have an antidilutive impact. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following common stock equivalents outstanding at each period end have been excluded from the calculation of diluted net loss per share because their inclusion would have been antidilutive:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.389%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.193%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,480,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,339,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;740,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,474,330&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total excluded common stock equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,221,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;44,813,341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_b724ed5b-32c8-4782-868e-b02c6820c713">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following common stock equivalents outstanding at each period end have been excluded from the calculation of diluted net loss per share because their inclusion would have been antidilutive:&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.389%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.832%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.294%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.193%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,480,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,339,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;740,297&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,474,330&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total excluded common stock equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,221,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;44,813,341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b787ec26-9aa6-4a5e-a368-bb18c3c09dfd"
      decimals="0"
      id="F_ccef4132-e0f8-494a-aceb-6f50e55df2d2"
      unitRef="U_shares">8480950</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a0b1a141-4c14-4d2b-920f-b03009062e23"
      decimals="0"
      id="F_b07e2c42-a0ed-4cd8-82dc-798f0bb4a2e7"
      unitRef="U_shares">5339011</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_99d7352d-e522-4ae7-bfb0-933bd5a40ea8"
      decimals="0"
      id="F_06140410-4d9f-4d49-bb47-ea2208d9c702"
      unitRef="U_shares">740297</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b214c460-3b77-4ddc-9510-02c9f4c9c9c1"
      decimals="0"
      id="F_5f78713d-37c0-4172-bdab-eec36ea3e724"
      unitRef="U_shares">39474330</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      decimals="0"
      id="F_c6989da3-cc49-47fd-b3c2-72a01b451204"
      unitRef="U_shares">9221247</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_031b3770-76f9-425a-9800-d1c8d734148f"
      decimals="0"
      id="F_1e5bf542-c6c9-483a-a40d-690b863cbc2d"
      unitRef="U_shares">44813341</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_cfa6df9f-3a8c-44fc-81d5-7d5849a89c97">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17. Related party transactions&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Convertible Notes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with the issuance of the 2021 Notes, the Company issued, in aggregate, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of convertible promissory notes to Morningside Ventures Investments Limited, and certain members of the board of directors of the Company. Morningside Ventures Investments Limited is a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% significant stockholder of the Company. These notes were issued under the same terms and conditions as the 2021 Notes (see Note 8).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Supplier Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the ordinary course of business, the Company may purchase materials or supplies or services from entities that are associated with a party that meets the criteria of a related party of the Company. These transactions are reviewed quarterly and to date have not been material to the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="C_3ebd36ac-5798-4f88-97b9-7e44c07d4319"
      decimals="-5"
      id="F_865c8ad9-e1be-4e8b-a0b2-1121ee51bb2e"
      unitRef="U_USD">14300000</us-gaap:ConvertibleDebt>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_3ebd36ac-5798-4f88-97b9-7e44c07d4319"
      decimals="2"
      id="F_4f3e3572-a431-4f99-8c66-48396a56f252"
      unitRef="U_pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_d0970a6c-bd10-4ecd-82ac-325f74ad8f49">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Operating Leases&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company leases its facilities under non-cancelable operating leases that expire at various dates through October 2026. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36 months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, with an option to extend the lease for&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; 3 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; As of January 1, 2022, the Company adopted ASC 842 which requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by leases. As a result of this adoption, the Company recorded a right-of-use asset and corresponding lease liability on the consolidated balance sheet. The Company continues to recognize rent expense, which is calculated as the remaining cost of the lease allocated over the remaining lease term on a straight-line basis. See Note 10 for additional information regarding the Company's operating leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Letter of Credit&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash equivalents consist of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of cash serving as collateral for a letter of credit issued for the Company&#x2019;s office space, and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as collateral for a corporate credit card program. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, the Company&#x2019;s restricted cash equivalents balance was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Legal Proceedings&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is not currently a party to any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or potential range of loss is probable and reasonably estimated under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company recognizes expenses for its costs related to its legal proceedings, as incurred.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Royalty Payments&#x2014;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Between August 2016 and February 2019, the Company entered into agreements with the Grantors. Under the terms of the agreements, the Company was granted, in aggregate, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. These grants were provided to the Company for the purpose of furthering the research and development of AMX0035 as a therapeutic benefit for ALS disease and Alzheimer&#x2019;s disease. Under the terms of the arrangements, the Company would receive a tranche of funds as it completes certain milestones. Pursuant to the terms of the grant agreements, the Company has certain payment obligations that are contingent upon future events such as the achievement of commercialization or the receipt of proceeds from a revenue generating transaction resulting from the projects for which the grants are used for.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the terms of the respective grant agreements among the Company, ALS Association and ALS Finding a Cure, the Company will be required to make royalty payments to each Grantor in the total amount equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the grant received. The royalty payments will be achieved through a combination of the following payment methods: (i) an annual installment payment of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of net sales of any products developed under the project for which the grant was used for and (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of cash proceeds resulting from revenue generating transaction under the project for which the grants are used for. During the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the Company recorded &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in royalty expense, which is included in cost of sales in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the terms of the respective grant agreements among the Company, Alzheimer&#x2019;s Drug Discovery Foundation, the Alzheimer&#x2019;s Association, and Cure Alzheimer&#x2019;s Fund, the Company will make royalty payments up to the maximum amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million to each Grantor (or $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in aggregate). The royalty payment will be made through a combination of the following payment methods: (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of annual net sales of any product commercialized from the project for which the grant was used for and directly related to the treatment of the Alzheimer&#x2019;s disease and (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of all royalties and cash proceeds resulting from revenue generating transactions associated with the projects for which the grants were used for under the grant agreements.  As the conditions that would trigger royalty payments under the agreements have not occurred, no amounts have been recorded in the consolidated financial statements for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseDescription
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_6736fc9e-9c97-4af5-9805-7b4fae04ef23">The Company entered into an office space lease at 121 First Street in Cambridge, Massachusetts on January 10, 2022, for 36 months, with an option to extend the lease for 3 years.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"
      id="F_7c030abb-58ea-4366-a194-bcd58b7cb63b">P36M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_3ebeebf6-9ca1-4107-b3f7-9b2c7453703f"
      id="F_388077ca-a4df-4f1c-83d0-d35052bb6d3f">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_13345d35-56b6-4c29-9548-08d0bb84c9d1"
      decimals="-5"
      id="F_1691f98f-7897-4553-9c0b-d81ef7669259"
      unitRef="U_USD">200000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_abe6a82a-1d40-4eb5-8cb4-6e4904b35dfe"
      decimals="-5"
      id="F_9f2f9218-b0b8-4237-a5d4-8a236388e5c4"
      unitRef="U_USD">500000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958"
      decimals="-5"
      id="F_b2a51ecf-2558-48e9-aa1b-dabf94fa7cbc"
      unitRef="U_USD">700000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_678b6484-4368-49d8-8272-6da1055ccb1c"
      decimals="-5"
      id="F_62d82ee0-6362-464f-a0e5-36b7a70d509f"
      unitRef="U_USD">200000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:ProceedsFromGrantors
      contextRef="C_5b1aaf8c-dd58-4214-a024-8c65bee77c8f"
      decimals="-5"
      id="F_2f5736c4-65b8-48dc-af5d-b90fa451ba70"
      unitRef="U_USD">4300000</us-gaap:ProceedsFromGrantors>
    <amlx:RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor
      contextRef="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3"
      decimals="INF"
      id="F_d8442ed6-d7da-4c25-b6c2-5126e5fe4d63"
      unitRef="U_pure">1.50</amlx:RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor>
    <amlx:RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject
      contextRef="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3"
      decimals="2"
      id="F_94d35562-4a2a-4deb-970c-34981ccdb75f"
      unitRef="U_pure">0.03</amlx:RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject>
    <amlx:RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject
      contextRef="C_3ac946e9-ff1a-4285-ab0a-5ba0ec6ed4b3"
      decimals="2"
      id="F_b3536379-6fef-438d-be77-bb84e79e8dcc"
      unitRef="U_pure">0.03</amlx:RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject>
    <us-gaap:RoyaltyExpense
      contextRef="C_0b327429-7b70-49b6-86e4-f2ad018fde8a"
      decimals="-5"
      id="F_91ee0b70-883d-434f-8802-a08f4ab269f1"
      unitRef="U_USD">1400000</us-gaap:RoyaltyExpense>
    <amlx:MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor
      contextRef="C_e92dc208-a141-4607-b82a-3789bb5e1d48"
      decimals="INF"
      id="F_1ddff995-d10e-4e3e-83c4-10320a3ae1bb"
      unitRef="U_USD">15000000.0</amlx:MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount
      contextRef="C_e92dc208-a141-4607-b82a-3789bb5e1d48"
      decimals="-5"
      id="F_9eb3768e-5d2b-433c-aa1d-faa4e95641c0"
      unitRef="U_USD">45000000.0</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <amlx:RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject
      contextRef="C_e92dc208-a141-4607-b82a-3789bb5e1d48"
      decimals="2"
      id="F_24d8741b-3043-4009-b1da-43dc4828d9bd"
      unitRef="U_pure">0.04</amlx:RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject>
    <amlx:RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject
      contextRef="C_4b1c0dc1-9115-4d8d-97b5-2ec93c4885e8"
      decimals="2"
      id="F_2cdc4d57-7f40-434d-aaa2-f4cf06073418"
      unitRef="U_pure">0.15</amlx:RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_2a15f4cd-3251-4bce-9c79-87754008eaad"
      id="F_293071b7-0a0e-4563-98da-fd325f396a25">&lt;p id="subsequent_events" style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Subsequent Events&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company has evaluated all subsequent events and determined that there are no material recognized or unrecognized subsequent events requiring disclosure, except as described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Silicon Valley Bank (&#x201c;SVB&#x201d;) was closed on March 10, 2023 by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) as receiver. At the time of closing, the Company maintained less than $1.0 million of its cash in deposit accounts with SVB and held sufficient liquid assets at Bank of America to manage its operational needs. The vast majority of the Company&#x2019;s cash, cash equivalents and short-term investments reside in custodial accounts held by U.S. Bank for which SVB Asset Management is the advisor. The Company&#x2019;s investment portfolio currently does not contain any securities of SVB. On March 12, 2023, the U.S. Treasury, Federal Reserve, and FDIC announced that SVB depositors will have access to all of their money starting March 13, 2023. The Company does not believe it will be impacted by the closure of SVB and will continue to monitor the situation as it evolves.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On March 13, 2023, the Company announced the appointment of Karen Firestone, Chairman, CEO, and co-founder of Aureus Asset Management and prior fund manager at Fidelity Investments, to the company&#x2019;s Board of Directors. Ms. Firestone's appointment to the Board of Directors is effective as of March 16, 2023.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>110
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M2#"<(?D#6+^B5.P7Y 8.;T/=_0]02P,$%     @ T89M5A[Y.TA*!P  DR8
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ME"PH+P3R^R?&Q.M)\1JC?FTU^1]02P,$%     @ T89M5D/4B)YG!0  0A8
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M%!H]!0U0M 0J!8LJ/0 ^FU)M@O(WD3=,IM-;7Z[O!*[K>X?D^Y93UY_:3C#
MOE-E8E;EG\[>-/-](1_BW[?4\Y_LG<9EK%BK0TH!P,I<UL=:[=OV(/1<'?\=
MO+_ )_/Z.+,+4Y^NWM!BG>0"I6P%(:UC#U 5]8%E_2#Y1IWY+;F4/%.W,:.0
MC,H _E]QV$<T#]4 [;'Q[#]02P,$%     @ T89M5LCC9@8Q P  ; D  !@
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M PBN2-7Z0NR*;9<0ZO^_NG6"3K5P;#7#JQ[!\Q55@.FN")^1/D_QCD4Z^5=
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M^^1Q6=WDSQ[=[="DX<WS9;GY7WK>E95'TORQK/+5+KBNP2K-MG^3[[L#\2I
M47L"R"Z , &:V1.@[@)4-L#J"=!V 1H3,%%Z B:[@,FQ ?HN0&=WNJ]*QB[
M./8HF;L DPE024^ M0NPF !B]#6<_-)R,GM@];Z0?6.SK:WV9GEI;H5M;]+;
MHUX:7-FT^'C;%S<=>994R?EID3]+15.^YC4;&S5LXNO^FV:-<&^KHOXTK>.J
M\^G5Y]NKR)]=W-DSZ?:N_A/;G^]NI2M'NK%GMAU?7$:V5)?ZT[ZY\YOMZQO;
ML6]N-L6OIJ%T\7FWY5U%,_OF]A^2_:\O_MU_I-]GMN-/_;L_I!/IR^U,^OVW
M/Z3?I#23[A[RQS+)%N7IN*IWH:G(>+ZK[N6VNJ2GNG=YE2PY85-QV"TM4EI*
M%](-7=!ZY/NZI-(TSYYH4:7-]G4]6M"BH OI]B$I*"?![*@$ET<FX.VY?52&
MZ8GR$SF<(W.0G\CABG,X^;*>+$[J,?OJOD:EV3<.PQ,SIOEJ50-NJWS^%R?:
M/SY:.JHZ@1AXL5BDS2R4+*7K)%V<^)DT3=8IOZ>&/\HZKJK1&_CY_''UN$RJ
MN@6OJ@=:U*V[JF?\AV8J?J)2E)>\-HV/I\[H?3I/JS9D7(]*^Z&)[(<FLJ%J
M/=1+^BW-LGHWI<MDF61S^F'7Z:2DJM/,/TJJ\D$B,I%YXXB0W9P.?2K7R9R>
MC>J]+VGQ1$?G?_^;HLO_Y(TN6]AD VM.A9[.=6):NFR=CI]>#Q+=<HJF6;JI
M3MH%;63M'"3,1<(\),Q'P@(D+$3"(B0L!L%:^E7W^E6'Z?<HW0J90W6[A1FO
M]&CH!J/%6;>0KJFFP2@662\'"7.1, \)\Y&P  D+D; ("8M!L)9BM;UBM7><
M<87LH<I%PF9(F(V$.4B8BX1Y6O>41U$-(NOM<=%')@V0L! )BY"P& 1K:7RR
MU_CD'6;E26>./-%U@S!3Z528>JAJD3 ;"7.0,!<)\[KMI#!Z1:8+..D4TVQG
M#)$9(R0LYO5JPU*T_0ZT%*;O%:8+%>:7Y>-&6/F]--^N-92;M8;'=;U)O]-B
MGI:;3[=OY^OF@K_\T+^D<BE,.'1J1<)F2)BM=R^?564B:ZK<[E(.,JN+A'G=
M73!-E9BL"I$Y R0L1,(B)"P&P5J:-O::-MY#TSPM&YT>HFHJ,X\**S-4HDB8
M;71'?%6KQTQ&H,B<+A+F(6$^$A8<T3%"9,(("8M!L)8ZS;TZ3:$ZMW<H-O>2
M:P6N]_<HMEI,LRKGB#;-TBI-EM+Z\>LRG=>!VS5UT30LK,70:1@)FR%A-A+F
MF-U>K1CRQ&0N'5QD4@\)\Y&P  D+D; ("8M!L-9H8.U' ^N7C0:\44"8?>@H
M@(3-D# ;"7.LSFF#2C2+N5)TD2D]),Q'P@(D+$3"(B0L!L%:8X B'WPMLG 4
MV-S>/VD\78M&[FN:E<G&*D:_-]L\C\?E#MF>K%1FQ7,J3CQ4LU":#:4Y4)H+
MI7E0F@^E!4?UHQ":,X+28A2M+=Y7IC1%*-ZM-67>LJ8L^=:4RQWJ]<&V6,4*
MLPU6+))F0VD.E.9":1Z4YD-I 9060FG1CF;T=_ 8E; MUX-12Q$[M3[3JE^>
MI+O(;AJ6JK :1?I>9E":#:4Y4)H+I7E0F@^E!5!:"*5%4%JL='V$C&;:0CTX
MLA2Q)<O.%D>X.Q2NCM7N.8VAR(8VZ<RVW9)\MR2G8(]=DE>2?V>(5TWN>I/X
M2 W6#=0W!:4%4%H(I4506HRBM=5U<$\I8OM46UW'J4KKS(Y$M=1)9W;LEN,X
M&3FE>%9&3C'N31Q..=ZJC?BH#%82DN9#:0&4%D)I$906HVAM)1T\2HK8I/0S
M\]2D,P$8,I$U5@53<14&GW!"W4I0F@.EN5":=VQS^="T 9060FD1E!:C:&TE
M'[Q0BM@,]2-SHMZ]8E0FBJ*;K(*A3B8HS8;2'"C-A=(\3G.Q;B=HPD#I>JPT
M73?8U56HD8F3L[,&TRU2=]N)J4UZKMH.WB/E7<Q'(B>#TC6;6!-95E@CDKAF
M@R4&M2)!:0Z4YD)IWI&MY4.S!E!:"*5%4%J,HK7U?7 O*6+[$M!<N,O4NIY4
MS,X*#=1[!*794)H#I;E0F@>E^5!:H'1M6]U^%$)S1E!:C**U-7WP("F_SH0D
MG,BA;B0H;0:EV5": Z6Y4)JWH[76L"W-T%1VM=N'Y@V@M!!*BZ"T&$5K_Z[%
MP9M$Q-ZD]W8HDJ[_A+NJ+*[F4+E#:3:4YD!I+I3F[6BOS]DT1N?0A$%/]]#8
M2VAHU@A*BU&TMH(/!B4B-BC]JNE=7(VATSOI6J5.>G[(AE.R[Z=L>$7Y-V=Y
M1?EW9Z'[[4%I/I060&DAE!9!:3&*UI;LP:1$Q":E=Y]TL;\XQ;%-<>[X\HKQ
M;OGRRG'O^?(*\F[Z0O?6@])\*"V TD(H+8+28A2M+="#.8F(S4GB9; >)4I)
MMI#N][^,=YA3,UHUH/0%.L_+2K@D+J[=8/TB:3,HS8;2'"C-A=(\PO&-*:IN
MU?_8,^QN24.W#%,A[8(!M((AE!9!:3&*UAX.#FXJ(G93_8+A@#L,:-TN8^FJ
MP:ZABVL_6.!(F@VE.5":2WB.-UEG=>9QRK&WE=\N$O2U)OL;-7VU8G@1]%C$
M*%I;80>7%1&[K'[D*W*DZ]<ABJ%HK#J@YBHHS8;2'"C-A=(\*,V'TH+C.E((
M31I!:3&*UI;OP5I%Q-:J(5^2(QQSBL7^>ILXWV#10OU44)H#I;E0F@>E^5!:
M *6%4%IT3!>/42G;DCTXN8C8R27ZHASI_K32B6*9*KOF,Q7G&"Q3J"<+2G.@
M-!=*\Z T'TH+H+002HN@M)ATG7&L:-I2/9BRB-B4==Q7$ A7R5WSC,QJ^,TB
ML[>+V&\7<=XNXHH/Q&!=0%U-4%H I8506@2EQ2A:6SP']Q,1NY]^1CQ=\XNN
M3Q0BL]?B4W$=!L^#4+,2E.9 :2Z4YAW=7CXT;P"EA5!:!*7%*%K[(1X'LY(J
M-BN)O\'#U;#:=;2HFJS+[%?PQ)F'*AA*LZ$T!TISH32/TUKLE^^@"0-.0MW2
M+/;1 B$T:\3):C(98TZ9$W6B$2(SIY/C5T_<:QYP&2?%MS0KI26]KR/ECT8]
M'A;;9T9N7U3Y>O,0OJ]Y5>6KS>8#31:T: K4G]_G>?7RHGFNW_[)G>?_!U!+
M P04    " #1AFU6[7*&ET8#  "."P  &    'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;*U676_B.!3]*U?9T6PK;9L/"K1=0((0-&C;PB1T1OMHD@M836S&
M-C C[8]?.TG3TJ'1,.T+L1V?XWO.(<GM[+AXD"M$!=^SE,FNM5)J?6W;,EYA
M1N0Y7R/3=Q9<9$3IJ5C:<BV0)#DH2VW/<5IV1BBS>IU\;2IZ';Y1*64X%2 W
M64;$CP&F?->U7.MQ(:3+E3(+=J^S)DN,4-VOIT+/[(HEH1DR23D#@8NNU7>O
M?=<Q@'S'%XH[^6P,1LJ<\P<S&2==RS$588JQ,A1$7[;H8YH:)EW'MY+4JLXT
MP.?C1_91+EZ+F1.)/D^_TD2MNM:E!0DNR"95(=]]PE)0T_#%/)7Y+^S*O8X%
M\48JGI5@74%&67$EWTLCG@'<UBL KP1X+P$7KP :):"1"RTJRV4-B2*]CN [
M$&:W9C.#W)L<K=509F*,E-!WJ<:IGC^YBR8WXV%_%@PAFNG+;7 WBV R@C 8
M!L%M?W 3@-[U)0AG8S.>AL$H",-\^\3_!_IWY>C3Y&88A-&?$'R^'\_^A9-A
M,!K[X]DIG$R)0*96J&A,TE,X@_MH""<?3N$#4 :S%=](PA+9L9669 JSX[+\
M05&^]TKYK@>W7#-+"%B"R3Z!K;VH#/$>#1EXM8Q#C,^AX?X%GN-Y!PKR?QWN
MUI33J/)IY'P7K_!%*"A*\,]<"#%!_0S/4P2?LRT*1<UXJO_W* 0F$*VTS0=-
MK#W#O"FNY9K$V+7TJT"BV*+5^_B'VW+^/F3 .Y'MV7%1V7%1:\=8R@UA,4+,
MI3HHM19_K-2"K)V3F1?BMN<Y5QU[>T!!LU+0_+5 O;<$6GO&L2K?B6S/CE9E
M1^N-@=;BCY7:^BG0IG,XSW8EH%TKP.=9IC]'D>+Q _P'8T85)2E,-_.4QC!9
MZ"@I6QX25LM[K+!W(MNSX+*RX/*-&5[^9+M[U6H\/4F%AMI3?E/#5:7AZI@8
M1SS5#<Z97JE+L);RV 3?B6Q/O>L\M0'.&S,L"?9";+;=ER'6GW.L#OM99Y.A
M6.8-G]1%;I@JONG5:M54]O-6ZL7ZP#2;><?T1%-TJK=$+"F3D.)"4SKG;?TZ
M%$7S5TP47^?]TYPKW8WEPY5NF%&8#?K^@G/U.#$'5"UX[W]02P,$%     @
MT89M5F+KR#66"0  :C$  !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6RU
M6VMSF[@:_BL:[\Y..U/7Z(+!V20SJ=/.9F;39.KV[&<,<LPI("]@)]E?OZ^
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MU>.2!Q'/90/X?2& DS5?Y 3;?Z^X_A=02P,$%     @ T89M5M&BNJMW"@
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M6^F%L29M.1.1*F[-NL[5XXZC6Y,825XM.PZ]%;KDA<RMC/T8/8"3>G7D9!%
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MYQ:04GJ9LD^*\R=?JN&P :^7P[DB[LX5[#P&V8[JF;HT7!@&*7]I\P!Q,PN
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M;W)K<VAE971S+W-H965T,3 N>&ULU5WKC]M&DO^^?P4Q>[=G YJQ/<[K$L?
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MN:88'VS:Y1WZ'P@G.5#TM2K^,LZ] *3JLG/"P!UWD>9>]P4K]R6IR@GOW-:
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M^(9ZK)'PD=-%!$:1AH*1><<ZP*,!3&(I:7XX>1BW0W\"A=:(:9'N"0.H]DP
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M2T_6KDX,^+_KB^>ZNQFK_$LPMPHK8DZ:<* ((841GC1)U-LDLO!,1M=S#=_
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M%TQ?5G>)*++RWF$9*V\.1VFU3"_MO]CR[@/>/)A0SQP'CHOPLJEVII]//1/
MB1[#L</PK['=PYCA(P><WG-CT]Z!8\N0MU>A<T<'GLI2765SU/ \U1TVVQF7
M5.?=8= 2NQ-;L:3E&++D]-,S$T".^SUYY.B D,C8!=?<X#)(!7*9=(KSL1=Q
M<M_2L5!(/%>F?!$U1&%Y@' =KU$J/L;7F"N.\0PV']FPC(KE-C'75JP<B?>-
MYKD@<,Q&$YJ76L;:U.OXM+', -'O!T B? KJ581[5%LACQ/CZ$C-\DR?'S 9
MAHZ6@!08@G0@(E_S5P#-RR-G7#S &L@6WB"QJP0<+>"H#GD&:ERR=J_3Z7W!
MTCOV[EF/C[>(=_6K4&,;M:/33(_T4%#=4DND;9GF,'T$A8N>7;\ Q(+_ )')
MQU5/IB1%(4=UG#%:>LJ2,9>3*YQKPL0/T;/W.XT"/\7PL>971B]*EF O];>W
MN?@Q<YS,)3_S:4+RP$J;EQB&1#\CZVUFMR0QB$H(9A$NZQ&'I75P-S!N]IA(
MXWX^RY)$.%5^H+B9+$0MO6/S_QA!I= GJXA(64B8WG..J>PE]4>0AAC$8,M4
M:3"K$TXE6NO)#V(XV['(EFC/Q5+)C_6\H* $J48;,N8\QVG;.0WCJ%QL=I&?
MK9QAT8F#!]R5G?C3K($QHD)099[*B(V:/KFPDUIU$H<[+@RB(<#I.IP"YFK%
MD59SF4Y8@G^ :Q='*6'D"U;S*H<@"0#^(_?]2MSW(SE:7>:DO9KO*7@$&7$=
M*+H)*2+*S1<^FC?"+E_X?H.=RZ+GDJ*,Q#$8RT5"QDYZ8TN1#^E^0">?F* [
M7DS4F3K'($N.CA[J]Y.BR;'0SS1ON=42_"S=3E(E:!,HF0ZEA50&9AD0]S#!
MZ4,MKM?[*=.0^H7"3L  5(!95EC'6FZ<'T(,.0D6C(]*XW)#+<H^:0Y9<:!*
M('7YEAW[=X@A^>F[M-DBB'^-'>UZM]JV]>]8QSXFI]EL:B:X*\%.X_0&:@+(
MU?]HA5*403:%G$>8\S^Z<F@GUTJ:5=8M-'87]9E+RBPAF*3R0#TXP-@\!U:U
M6U]LX3-F"!RTDFW5L!5-_4WFQZ4FI50\]'6!A^+RBV^*5\20CPHY)/_._G5)
M[J^UT;-0GSV;W&MEQ;EYK@]V)ZE]:S[VI8[]\X26]XQK5B?RNYW!_91.^/L=
M9A9@5YJRFY_78CJ$WAO1/<HL&3=?Z<<'5Y>OKBWU DC+QC!8V7*5:]?Y)45\
MN*(I722,CF6'8U(^5E*^FS);>F 8]F(E+3%HW??\Y-;KT)(C<S"W6"]RLO[G
M&U7&(SPE0G((()'Q7VI3!K^H?M*0Z1I]MJSZ//9HT6Z#0N1T;*G7G5B0T?SN
M!>C$EE$Q0,3/H\RB$5DX5RK;C-&9-9YO 4)9 7I^LF*:&3D/5)Q/(U\P""8:
M93+??4!?8. =LLB8>KTFVJ\SZ;XAW1=8CEIKR^J;6D_28\3)<SZ2:(BP+C*]
MSV;%R[AV'FN!L,!>%1E/>S\DQ\B(F48C&XDT;Q_-^G6RNA7@G\6,E_I$5/Z8
M"WMQU =G?M$.$QI1LWFF\TLXYB\G; !X8AKT-$&K4AD(B:=2$9^MXE09>T+:
MM&FI!T^Y!+0Z/TL*9/Q$D>A[90(/T>Z\S]&-/S3CQSK+4ZPU.\ODN9AG!!)7
M;-ZS(*@[DT9!L^56%3MQ\XO;,?EA[62,?]QLFF0DL*P;M<^UBNYERL*?<[PR
M2",G]TR^/A?54;Y9(#24B@O0!\P1;6(\XR"9:=[9FXCSZ%&3?COJ-C>I'UH@
M&1LL#QAVY#1 -'2VKL3&,-3* !U58(@MY"^L!2=<G,\M1A*R!-R4E\I%*"G-
M0\PZ$5]:5"J9B+/.1VDV#V@6<!6V\L8>)YQ 3VW?*"]M"1#=]2XC/6]U;6D]
MIG.$M.SFK&W_5A/EJX/X[;3S'-K?%(6?A@(7VOFJQS)%\@HL\A2(V"=($@<P
M#6>N!XI)4DZ4DOY/,=4QKB>JJ%3GLCR8'MJV=<0T'AIUYKJ\ : B'31:4Q.<
M#;:P%COMRSENRZA4.!9SB\O*=I98YBT1,F)\HFEJV3&Q5Y@0;<[X.M+$#BY>
M]]3J<8/I'SA&[/:,'IZ%P2#37NBJ^A>Q<"@&!#5AHT[M"@FD2M>2Z%J15%3-
MZ&1?F48K>4/8.:VY,$D^85!*"![=]*3O]E(8.%T2.9 T!@:JO"*:Z]/:X*32
MY'2>,M4!Q2SE-!V""@*%M=VZ\0_(<S6/L %]("#<)D-I:78P80XK2PA/V@:?
MGS1S\MH9X4C'E9JGVXPY;;4\! ,@5822!L&Z(T $?4WOM+"/PE06:;#^,SK<
M4+Y=(UO.9J0:+M8:#FI2217V:\Q'H9-GWB"0LG-M'S.J.8^@.%9ICT]"W9YK
M$TW).Q9U3)DG">>SNX+(7^P'L%I77#:F[2)>OOY96I')4OG@<?X29[G$<25?
MKJ5W&O7(,5=TY.)7IFIC/"G-,I-S/2IGNE,Z];1;1(S7<(P[.K8EYUKS:&2]
ME"1(+7+:4^1#GB^7L#F^U5AA)(X.-9+ID7%'GKPRULI[T__?]#/\%)DY3^N9
MS;<&2R3RL27<E?B40/RY3>8%[J4B!?4:_:%ZA(M1)/PCL\T+(QY??)92=6V]
M8MZ.ZI0W\.-Y1/EL7W>X)9(;A;G8>]8:)@LXN\3I)2-<S E8VK?3Y"Q6F"."
M!YV2XI^;3\+P<V.C:I*J2'1F1F\V->K"UTQ0RIFV85/O>,)8(!TQ";>AF%6J
M3U+,SO :WR%"V6!$/TX&020ETJKRY)T!=(5=G@DOHT.@FCCB%:QWYMQD_3HO
MBG?HCN5FBITXUV,!(MV]2*A:K+Y9 HJ<V5';Z1AQ.Q& X-%:&T3%]!;RHTBA
MA32#^UB,>W1\1Z@U00 RJ;2;X7@?CF^W<17^Z;NXC^_X_E= [3^]0E6(IUJW
MA&?U"B-[7932\5;>H<Z8=_PB$D2W?WHQ=*!"- =H77^@C)'B,S[S?\+C.Z!P
M F%7W99R6?#KGCX\CI>1F;B2UC><Y(\2^"=*^)9M@[F\3 @=YOG*MYOS5^0*
MYPC!G/I-2:W"7E3?K6EX%O,3JVFY35;3DZ>E8,Y0?!E!M%KGG&R(F3E%+1E/
M#:7L9I84OZZ*ZZ"7!^X%$8NY\$U^:H_FH\>^>8(A!6>BZ,#ZL:G7SKQ*8G34
M%(.JMB3[0ORW\4*#<1FN,NU4%1I**IJU[7#M"FD&W-5G>3!6VO&UHGGHJDD<
M92Z/L.BS\KPVRTZ6E$(Y<W=43!='ZUA-H<U'JOZT%)^U50)O/7<(L*U4T9)#
M>$SX_J/%DA?%=_B,JN:39QO/'K_;2MBQU:RB]B??@D0#3F)C!J-"J]B51$J'
MJ=DD'>GTT@?33T$-!.',NY9^YL*?N$#]WJD9'+LJ''6/B-?QA%+WJ1@J Z:.
M\8IXM=;&('>6E<O:]2^.SO;<M-0M.W5_BU&'_5O*%1UKZ30LCAC>^ 6Y^!N]
M25]!H$4)"H M3OF8N0/8-9;^_!C?P)19(^F"](JFR)BS&<6WY6:T+H[2S P$
M&Q%\;!AFS!E.)HPMKARERU3H'P^4W4PAY!)=CNDE6?G0I'(KBB2'A/0TK)2N
M VJCU*(L"&QFZ'NUJ%*]-+X9CS,CE&'1-2.)L,NNI(+;BUE2I7VQ9FALV,VY
M\&G#I$_50M-K91G9PL= __A;(8^C_M<EZK#S-\(]V8[+;SEGQ1ES7^M67@A+
M1N.Z;F*7X,YCC0UO+HVC[>.3=VF6$,8C.[1BZ2)"6?I!6VE)4K]BC"2X,)E9
MRKPB72=MJO]O*"N<.RT0>DMO<'M&?H1K\P8W%L!A-H,WZ[1P[!5PID4/]6L(
MFK)-K10>?77^Z.$B>Z(\B2:43V7:2@$D<0#TY>2Y47YCCX#=OO$'.IB861(_
MLJ@A%35ZV8;TBD#?'F<W[1/)3!"'?ES,P(!/P<4V=I4G3V1)57 3EZA'ZX76
M'FIJ&<<OU5'?<RQ02YGO68H5!GQ,HNR,O0.PM:(N3VLG"G<V%SBYBR^*[_59
MN?U-F5\AHR,/+U6!U#-!%B![I].SKMZL@V9D?].Y2<8\;?H=+2,\RK*CQ"/J
M.+/##D==[GB7QR."W]?6KPJ,V/FFL>\^TNYO)N%2)6\2!#S5/*XMH8841/2[
MG1?W!<^@,,U%JWG^R6*ET[CY-!G4/,/+VRJ)#*DN<V:6LM.Q2<E')I6V[5E3
MPDZ\7=&K_W28+%8_.?L2R(L+4^^CM((3 U[?C#+V#4:[@)?(F4@W'N$EPYOL
M(HJ^*6:_I3?=TMFIP_OS-4;18\I:)P6_5;J9:C <5;5GIEL,?DBUR:GYY/NW
M!8W@._(]FTNH;!\]G9RIA I[[Z3! 77?X^?/+FH2*<X$8,2E)KC*W?F4G)0/
M\O"; ,8(]\&B+QY]H\X7DAQ\6(B5- $/!I9;]TU)M8$MH.M2[Y8)B+M@GMKC
MDES[0F61?/1&RE^TR)E?\0K2B[(=)?51HY]4QY>DKMERECKU+K5:S6MH,EE[
MG'-H+9J8/&42F5VH]05QF?F';>$Y$8[,WLA9Q/^96+ U9*DM)G4((Z]]=K<&
MPSW"<4<6$1LU3'C+DCF_3+(P,-LKM3&=._3H2S05&>J'[[ELD6U<<=B/TO-.
MR:C%R*TS?H6M(<UM.>:7N<'I?=;D)%6D($Y3NZ")S%MHD +S3LCQ9@.1ZF+@
M0Y-"'S.5;-E>IGXL=YNI.K/S(+<)@_HD(3D6I1^ULG=4ZEAQQD5\"PAW149I
MC#X@;E9*_B3C;;3OPJ;,2[16*4]J9N&%EB^,[Q26^864_1&:T=R2Q7SD32<I
MP7'H&TTHP1^N=@Y%:0OV,1=[TL.OT2XC:/Z:F5&:8)2:N OTO<IC6BFY\WMX
M%FB!] 4,^#J^<>X'/.!Z@+[C@,/;5/?_4OJYAAS[4H$$]_]9F;R.%T1OE$IX
MH.K=J*0A[8^^""4U$;+)QA)XJQ/FH<R9DB+20\>II$O4UY3'8/PS(WN@&Z39
M%/F-5W;*[)H0'Y6\:"$+)[/76EZ$K0J27(HO%:M.WI*MC*)N:GU'#HX'DD3\
M<":9C'^6L@[J\Z)#,>4HAW;8C5ZY$>_*7XY@6K#=H774L:3_)P_ZIT\>U '^
MLX+_=_X6_DL7/2_[\ND38-"-NZ872A+#?7OVZ,Q\B_KNV[.K1U]?79X]@#O3
MY4^?[$'X_%AV&ZPE:]P:;GUX\>7G9]S"7S_T?H]#%DO?]WY'?Z)3QW5X ?R^
M]K[7#_B 6]^]I^D]_5]02P,$%     @ T89M5I(HYW:I P  K <  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&ULC55M;]LX#/Z>7T%XP[ !1IPXV5*T
M28 DS>UVV-H@?1EVA_N@V(RM598\26Z:?W^4[+C=U@;WQ98H\N%#4J3&.Z7O
M3(YHX:$0TDR"W-KR-(I,DF/!3%>5*.EDJW3!+&UU%IE2(TN]42&BN-?[$!6,
MRV Z]K*5GHY59067N-)@JJ)@>C]'H7:3H!\<!&N>Y=8)HNFX9!E>H;TI5YIV
M48N2\@*EX4J"QNTDF/5/YT.G[Q5N.>[,DS6X2#9*W;G-IW02]!PA%)A8A\#H
M=X\+%,(!$8T?#6;0NG2&3]<']#]\[!3+AAE<*/&5IS:?!"<!I+AEE;!KM?L3
MFWC>.[Q$">._L*MUAZ, DLI8533&Q*#@LOZSAR8/3PQ.>B\8Q(U!['G7CCS+
M<V;9=*S5#K33)C2W\*%Z:R+'I2O*E=5TRLG.3E=:I55B88WW*"L,X0+M.+*$
M[,ZCI$&9URCQ"RC]&+XH:7,#2YEB^C- 1)1:7O&!USP^BGB.21<&_1#B7AP?
MP1NT<0X\WN %O"8^V&I5P(*X:KH/E&N;P\)G&37\,]L8+__WN0S4^,/G\5WO
MG)J2)3@)J#D,ZGL,IF]>]3_TSHZP'[;LA\?0_W>5CJ(\SW'0A=7Z\OQF<0WK
MY>WRXF9)Z,MKN%:0,DNN;(Z4L*)D<O_FU4G<'YT94%+LP:A*)PAJ"V5#3S=)
MSIF!#:*LL^T #!-HG.IZ^?G;[?K390AW4NVH*PW,/L])\/<,N(0%DRQE(>QR
MGN3 +<%D3(+)>5ERF8%5;;G,HSXPF7HW-]VKKA/_51$_=W/\R65BU8;JZP0A
MD30E^ED@]EVXXIGD6YXP:>%[E68T;RQP0UH_*JXQ=6AH+*?^=_X_7E\ 2[\3
M!:=H(%$TGE+4[BSG1$P3E !\*$F&,J'\E6Q/OI.<28F"6O@AI+[6VOE)#O>P
M)#,T(51RPX4@KXE@O" !998.C ^=9B$(EI&42\HS^=J#H(P+GPD7?DH,--]4
M?MX=/+H,-!$0\&.I;*6EZ<(UV6V5H.'LG;"-0#HD9@EW)<NT,N:W E,9)-I?
MQ:>=;\AT/0* &A@+EW5JXHXO!7WZG;>>JJH,T3+O.JN?$<+&WVN(1V&_-Z2%
MOW/Q6>?7S+^%87@R&L*[5N,W+$>1D.(P'O0>D>"Y?HR>3%"Z6YE_)UQY*VGK
M8=I*VZ=H5D_@1_7Z'?O"=,:EH=)LR;37';T/0-=O0[VQJO3S>*,L762_S.DY
M1>T4Z'RKE#ULG(/V@9[^!U!+ P04    " #1AFU6>WJHXH %  #6#   &0
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MXU&'V>H574V\68>7Z\)XO(/#,,<?#V%) /M+@P= /2$#S5^9R_\ 4$L#!!0
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M'BOZUD'+!K1?&N/7+WQ ]_4T_0]02P,$%     @ T89M5H%3_S;2 @  3@8
M !D   !X;"]W;W)K<VAE971S+W-H965T,30N>&ULE57;;MLP#'W/5Q!>,:Q
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MU^3\91Z"'L?9*%C5^Q&R5I8&DM\V] = [0SHO%;*'@078/JGK+X!4$L#!!0
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M7Z%=AP9W9&%DT*8[4?OJ9W>5DVETCBX(S?>SO/Y:DA<R.](O8=UW1?FU]"V
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M690R)TMA0Z8K&B1=,C=0H?1&2VN!*?Q !6RA<95UHW';Y'P66 3#K<6MQ+,
M<@ZDB14[81Z)>0-"J?+D-O'<@#)1"\M*P6%+!2W]N)^V^R90'QR="X'QK$5;
MQ%L=<7XA3:Z:VE),R1!#@4F"M=Z5A(B_-P""I83HO'O_$]UYNG".+) OJ3&E
MW/.05#FH30TCKHTFWX%=@#; N9.SV+([A50+_;#W&NZGHI8CJK\<F/T72 V[
M#0^)D"-J.8VD/GL3P,U\P[J[4?$MLMZ:RR*8_75EW\$ZR/BBS@EP#UZ0MG1M
M""2A0*C4JGZ>-U53<D).F['$?4QC&+!4\AHXTM70M ]=[G0TBDKH!MV&T9)+
M5H@<DMR% A6]45S35O:-A#6MTF;?F'V'G%]:Q F#^"F3 H%K7XHG[$_[INVI
M<8PQO\+BDS6O!L+A9A4YGBQK90*0$49]]H-6%:W(E]9G<1&:BOW3DWOVBS&7
M(9]C407?&0%)Y)=,8+TMT35D.#>@%"1X*8PY=U=Z-(G*$JD-.,6'*10$8!U>
M"]48(-3VT<X7R+!8VP]2,CZ6.2SX&!IH[XF'H,Q#%,'(I_)9VY1Q0Q)V"RV$
M)R^KY:*Q#E+[E4!3+P ^ E>0>VAUY'17S0*IK[@]VG+LMQ:H1M2!M"!53G?S
M?'<NM8 HT))/Y>-,0%FMGMJKCB%_0#>^UR"VJK6>Y+M[E$Q01'/,-J>K6_B,
M!N0A(#F>.-JZ1)GXOVZN*#UAPY#VL\EXELY)S!,VZT^S\7PX8TED=KGMLY\5
MU<4/[M@CG&T<8<"CK4K,<*ZPU01#Z%V0!>BPOO9P)?TZ0D.RHY?H8!$>4EO@
MFV8W_*0*0!&Q!CEV!3APUS#?T5%K"XW]AP_O*.Q>MW9,AY4HB5EIE^O5)=?$
M04+1^!P9T;T3J*A-C]W=%5Q <?;)8+D,;JU!A-);0H.3P9:"VT9CO_SNL!G]
MX?KC#;O^^)I]4FOHS48SV%B_@1STAQWNG)4O9.FZK26RN']WDQQIW&E_0X(C
M!:)=);$+\1\P(G*S]QH:H579#3OE!M_9B+M1_!\)]^=QU'UB L#Z970P3!T6
M\IE&MM(.!PL1(2_2)$:@/_8FD@-CGQ8"=L'2/@ODL.1YK+U1)2Y)%%*2>^G]
MH-D[2G<4YCJ]8UCI..4L=7!_+SY_YK6L17BZ@!U*8T3@6N<#1+%WWRD_09?K
M7YS0>PH8XFX[<,)*W&\)-*RI;X5.7'C:#2YX ;<6"(# \T<#FYR1.&[SO>+
MOF"/JD3,</=L9CLN#VGB-F6^]O@W"%"\FM,*>#J(L+8;'Y]9P8XI%_>A+ZA
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M@.=+!=L0_P,7:+\/O/H/4$L#!!0    ( -&&;58Q$9X<^ 4  #@/   9
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MV&_$F\^5<AOQ[04M5:+<RZ.!@PV6'"0-WEF-%S^!%\7BK2[<RHHW14KI+L
MY#J&<<OP+-Z+>$%)7PRC0,1A'._!&W8>#SW>\ F\QL<_3A?6&13%GX\Y64.,
M'H?@1CFTI4SHN(=.L&1NJ7?R]8MH$K[>0W#4$1SM0_^"E.S'B^*^V,;\^L4L
MCJ:OQ9M?/EY^^+U#%B_%N<YS=(H7]E(QI&2R$G8E#0F]%$DM85E"4.&4R\@*
MMR)1@PNGA2Y(W&H'>31=EJ%:G8-9]/TB5WA,64@V(DNO#,.E+#8-,UOC-W1%
M:?2M0BT%L+&F6S(!=*0+!-TE5#HAK=  ,6ME"7,"\3*PL=B(3*X#T:(\) ^7
MP*W03BRH]<0SZZ@7&R$Q?E+\'&\\1O2<C%,(GZQ]N2P2;4IMI)\XS!*$,FS"
M)9U1MFEQ$)#<<^)@:2-RS?&MG'6R2%5Q(U!4BKS$%<84&7;)YT6HY5:\O82M
MD"*Y7&+00:K1Y(2U;B%4BB.$O5*"'!/1G*L;\J_7V'T(ND.L5F8S-7K0!8IW
M"+Z6E;&5W K4OL  ]Z'\!<*T9L[?4T%&9HCTO?Q/<MUOBW.G-+:=9"1#"6'(
MBU1QQ10IB*(Z<KGA)*>49+(IC<=R>::E29GL!0HH<=I &\&&2,"U^Q?>M6Q+
MGQ.V#*:M,6'X!+!M33_(6U_\K.]YB374[QEQ0*1*15H93CZK;TC"0>(ABN D
ME"^0@G8,@E3*#U%??+CW1*PD2-3S**U[]M]UCW-<*,NQ3TBH IM%T9R071DL
M=8;#&DP.#[9-'WC3;/9@.QE"5FZEC?H;1H=A&(3U3XPGP;A^W!5GZQ!E%[8K
M?@+Q* ["*!+3((S#8#2;/FF'E3M/V:5EY2I$M/7,'AY<UWUP"KF4\"6SR(B=
MO>7"Y.>RRT^-W@Z\23 *IT$\GK0(9\]%B";!=#0)PO&\A3A_%3T;9!A$8P1A
M&-Z#Q,\% <8T#,:S\6X@=R+'":<[,@F/3YXF7D277!)6S)"&,)B/D<Y@.)QS
M>OX#JP(MRX,(.\ZH>B9YT:I0:(_I* SB^;3EN ?M04X].2[J5_P9AAK O$ G
MQ<$LF@;3<22B8#0:!:-Y?/!!.S1F\H7%([@,A[-@/I\)Y#$>3X/9<'CPL>B4
M=I%OI<I\2A[#BF.FQ6 1TL&KR2S$/!0_RJ+"9[#OYV![(#%ZF1''C>-U>?6.
M^W2]4LEJ1VRKCW"XI"**@N%DSK^MWF>$7;8X,%$OJH[G5R*:]]&K)<]W5NJ+
MTR4.)XRFM,)40%]6&$%F;91?I,HFNBH RF89&"Q\H? :"5<X[7F@X33RHXSN
M<'VP_L38HM[,Z504N';@?$^(4D]7EEC=>1"<4<QNTA_ANS?+8*0O/I;^6*4V
M1/XPJ<<MPA3XSXTG/BEV#M<N/ \;QX_EIK,X_@4&_M/![',>W^&HX &Y+X^R
M&:FO_$FYR%1R'Z%]N9T&DSF*#Q_5S\CH,/X_9S0>AOU)E]''/I<'6[>9G,R-
MO[.QSV!97VRZM]VU\+2^#=V+UW?*M]+<*+B2T1*J87\Z[M6G=+MPNO1WHX5V
MN&GYQQ6NMF18 /M+C8^<9L$&NLORR3]02P,$%     @ T89M5O"ZK)7&"0
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MQ>/[=ET)X$AF\*U]US,/X^DN9)]Z0CJ;>Y&#JJU3SV3GIXT04U:5L1+?7W_
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MX8!I-76=PL;N[$3^$LN@L5%%W+"%=2Z_&OR;P&JW.SM=S\#R 7[B@6NA28T
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MM"?85J([<_B!H.R>BP PLV VZBP;7.T_)$F"V33JL/>(NWYQO]?MINS.6IZ
MJ0/(#NX%R01=8;C7_?FS$SJ-<3L42_T=;HV]]+N0>>\T*.]3YO=9[KM^=P33
MGE& JFC+V/8%3;M-A]&@MPR;['!PX#0.Q;JGO$W7V[;'>WKEQEA#+JW7=Y#1
MZT7O@62"7=7H&&W,]/@00H"DV#8D*?5Z^\[(CWH?-M9"+^WG&ZJ035F[;QS=
MT^X+T;G[,'([W'U>^H/K)2HG*\0"4R.TQD-W!.IO:E79SR1S5==J;2]7@F/C
M0@/P?J%4[6](0??=[.Q_4$L#!!0    ( -&&;5:YO$Z-\@P  &PG   9
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M>0ID5NBKRC7HH@5",$IIW<K(S/TE Q/O8$K=;7 0RT)5TTJR]\-J)36"'>I
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M]7LIB2;*P<G7<'M4\9PB3[IO5E:&G*S*:Z7[>-3H_.]_N?E6IKT>P CB^24
M.9G2*\?1^++E <\2Y7\^]W&$G8&]H,&&JPI\ $+<@3A.E&=B%+5&\FW'>@PI
MA^\]N3&]LP@G;6F\;W7D"(-A./+R'-9)U&NIK9^*]ASM^C@&I[_6;CZ_=PIG
M+TYAN.<XB]W+8VKA-LKW_1)IP:&$2H(>:/]R$A#(YA1?<]_,K58T[?(]NWLU
M2$+WOMOK\]UZOM*BWYS[6+_NEIQ)H5S-Z69R!SWG::1#,77+1//C7-V5(HR0
M+^G+D\%A+#05OY* ZY)C\T17H7CW;TT;!)T^CKV_>>M8E\*G/S,X$%*C"@%
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M85G16$?C!>C[1FMWV'@#_1^%V7]02P,$%     @ T89M5F$/7-A^ P  X0<
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MUO.3$)<MO\%(08'/:\O-, K!P?2J;_X#4$L#!!0    ( -&&;5:[2/_U/0@
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M6-QV:T]?.C)!O-GBUY]- L+RRXGJ0RQ3B/P[(6:Y>&M-J+QX8PHJ[@>8 ,\
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M*Q!:>U>**%(DU8>FKPB*4O=H0MV2Q>X9[SK\ 57(8F&$ JIQD*KYZ_W.S)=
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M@,'1HJZ@H5OX1],>5["-P&N!>>H^;O.RS6[S:J"A =7<.J!"'!LQS!620SO
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MAWRL7+(UE\83[]\.Q%?34JC2O$+EE# 4Q=!:U'X.3DIC45%K[C\YJ0FT*6*
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M, R]]RL(#Q@V8*@3)^V*+#&0M!TVH!V"IMT.PPZ*3=M"9<D5Y:;]^U%RXF5
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M85GQ1$;K'?B\,,;M#"_0S_CT+U!+ P04    " #1AFU6-A!/2J$"  #8!0
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M9<FIS32GIQ&U2Z!XJI3=+MP!W6,;_0502P,$%     @ T89M5N,4$5G< @
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MUUP:$)B3:W Q['N@VY'5"E95S9A8*4M#I]D6-.51.P,ZSY6R.\$%V/\W9O\
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MXRUOAQ4^JT :!5Q?"FSHC6 <# ^U^;]02P,$%     @ T89M5C=PY!?I P
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MV-Z!=;S[0!W+6V[Y8J;5CFAGC6ANT*7:>2,Y(9TH*ZOQK4 _NUA9E3]4JBY
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M-/&([MM>/[%JV[6:M;+8N+IAA5\*H)T!OB^5LH>)"S!\>RS^ 5!+ P04
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MC/P"4[8WA&=L1\/>+5</9S/)&.&%9H">)A)==NUA3%[#PW')Z]Z[KRNH*F
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MH/ON$UE]IU<O6JS,M_%4:/C2-L,%HQF3N '69T+HY@4-M'^6C/X'4$L#!!0
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MQ'N"*CX?% ]&+NV5?2J-D9D=+H!C1Z,-N#Z3TFP>2$'U#6?R+U!+ P04
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M8V;5=K'Y6ZU5#FI9-9":5-U1W66U3]LF]:QNS3;+ZP[WAJHE$QJ+3(JFP=$
MJY:JF\9Z8F11-6KWTF#;5PTS;+1!V07X/I72K"=V@[9U'_\#4$L#!!0    (
M -&&;58'&A]F?@(  .L%   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM
M;)54VV[;, S]%<(KAA9H8T>Y%9UC()>MW4.+H&FWAV$/BDW'6FW)D^2D^_M)
MLN-E71)@+[9$D><<BB+#K9 O*D/4\%KD7(V]3.ORQO=5G&%!54>4R,U)*F1!
MM=G*M:]*B31Q047NDR 8^@5EW(M"9UO(*!25SAG'A015%065OZ:8B^W8ZWH[
MPR-;9]H:_"@LZ1J7J)_+A30[OT5)6(%<,<%!8CKV)MV;Z=#Z.X<O#+=J;PTV
MDY40+W;S.1E[@16$.<;:(E#SV^ ,\]P"&1D_&TROI;2!^^L=^B>7N\EE117.
M1/Z5)3H;>]<>))C2*M>/8GN'33X#BQ>+7+DO;!O?P(.X4EH43;!14#!>_^EK
M<P][ 80<"2!- '&Z:R*G<DXUC4(IMB"MMT&S"Y>JBS;B&+=%66II3IF)T]%"
MBJ2*-3SB!GF%E_!@'L(5+.L:@4CA5@JEX(T?:.$\RS?F\SEJRG)U 6? .#QE
MHE*4)RKTM1%K*?VX$3:MA9$CPKH$[@77F8*//,'D;P#?9-FF2G:I3LE)Q#G&
M'>AU+X$$A,#S<@[G9Q<G<'OM%?8<;N\([B[W5(H"9D:S-$_-E%%G,',%1 G?
M)BOE[-\/W42-WS^,;]OR1I4TQK%G^DZAW* 7O7_7'08?3JCOM^K[I]#;!R!W
M#V!MZWU(98TS<CBVUS<1&76#?NAO#M /6OK!2?K;IP>@R0]S3Z;3]4'>&F"P
MQWO5OQX=X1VVO,/_2YNC/D0^_#=I0GK!&W)_KP%-N==NS"B(1<5UW8NMM9UD
MD[J!_[C78_">RC7C"G),36C0&9G$93U:ZHT6I6OGE=#F;;EE9J8Q2NM@SE,A
M]&YC"=KY'OT&4$L#!!0    ( -&&;58EZ(LU$04  -0>   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;+U9W6[;-AA]%4(KAA:8(Y.4+#MS##0.N@7H
ML*!.NHMA%XQ-QT(ET2-IN]W3CY05T9)H1G&4W"22_/V=0^KC$3G>,?Y-K"B5
MX'N:9.+"6TFY/O=],5_1E(@SMJ:9^F7)>$JDNN4/OEAS2A:Y4YKXJ-\?^"F)
M,V\RSI_=\,F8;6029_2& [%)4\)_7-*$[2X\Z#T^^!(_K*1^X$_&:_) 9U3>
MK6^XNO/+*(LXI9F(608X75YX'^'Y% ?:(;?X&M.=.+@&&LH]8]_TS?7BPNOK
MBFA"YU*'(.K?EDYIDNA(JHY_BZ!>F5,['EX_1O^4@U=@[HF@4Y;\%2_DZL(;
M>F!!EV23R"]L]SLM (4ZWIPE(O\+=H5MWP/SC9 L+9Q5!6F<[?^3[P41!PXP
M..* "@?4U@$7#C@'NJ\LAW5%))F,.=L!KJU5-'V1<Y-[*S1QIH=Q)KGZ-59^
M<C);,2Y[MY2GX#K;4B'5$$D!>F"F)LQBDU# EF!O).M&TX0($2]CN@!$@(];
M$B?D/J$]-;EZ@BC7]U=4JH?B@XYGC]$#=[,K\/[=!_ .Q!FX7;&-(-E"C'VI
MT.D:_7F!Y'*/!!U!<D7G9P##7P#J(V1QG[9WAU5W7W%:$HM*8E$>#Q\C]I&_
M/Y>&&J"F'IAI:F9TON&QC*D ?W]6KN!:TE3\8X.]SQ/8\^C7_%RLR9Q>>.H]
M%I1OJ3?Y^2<XZ/]J(Z&C8!5*<$D)=D6??$S5%(C_4]-ERH0$ET3$UG'>1XGR
M*+H-;2=H& 1A?^QO#Z$TS8)PA%%I5:DQ*&L,G#7>9:H9)GF1OZDF:"MO'R \
MS%LOS9GC1);#$D'8%L%G)JP$APT$O0C6(%AL0CNU@[*P@;.P3R3FX"M)-M16
MTZ"13P\Z'-7*:IJI04>1O;*HK"QR5C9E:4KY/"8)N"%KRFWU.2,\]RWL*%@%
M[+ $.WRCQC3LDI*.@E4H&964C#II3*/&Y(,XP%%8FZ--,XQ'T<@^1V'?K-3]
ME[[8[@C/'9(B6J4'P",H#O0&?$$7*)R?I-ABISD>'JG.+-K0N0!.;A7%8L-_
M@(Q):J>XT^6XJVA5N&9!AOB->@%T+OW/IJ6C:%5:C : ;A'0MA_ IA1 $8QP
M?;*^AAR 1@_ %PL":%GM85"'X4QS*@RC'N!+Y .TZ(<(AG7YX,YQ*@:C,Z!;
M:)3MY3).$OM(=*HSNHI6A6N4!GPKJ0$[U1I=1:O28M0&[$9NP*:0T!\X@_J<
M=F8[$0TRL@2UEB7'OIA04TC ^B>3.\NI*(PL06Y9TJ))HJ;FZ*$Z"F>64U$<
M[#FXY8N[1Q;.M?F$ZWW>G>-4#$:3(/<NP93Q->-$4G!%[^5!D[!"ZE1V=!6M
MBMS(#A2\U9911XJCH.4U] LR^@6Y]4O;=HF:(B8<1J/ZIX/%#,)1B.V?#LCH
M$^36)VWZ8%.DP+I8=&<YE6RC4)!;H;3I@Y%E:ZC!LL4H.$*QT1/(N3 _U=Z&
MMO$/&P0/&_N&:OR#(Y_GR*SJZ(E5_8%F<Z7LV)'=:[?[L]_)UUCTL5GT<?^-
M6A7N=,NBJVA56HR*P&X5T7J'NRDE@FA8WX)U)SL5C!$3V"TF6C0TW%04,*JC
M>)4CAX,S![><:-'0B@B'*!IG#:^A#+!1!MB](>%N?(5SY20D&@WK$#I=Q?V#
M(T=]WOL'X0]Q)D!"ERI\_RQ2;/+]$>K^1K)U?@IYSZ1D:7ZYHF1!N390OR\9
MDX\W^F"S/,B>_ ]02P,$%     @ T89M5E 7[+3Q @  T0D  !D   !X;"]W
M;W)K<VAE971S+W-H965T-#<N>&ULM59K;]HP%/TK5C9-G50:$MX=1.*Q:4BK
M5)5U^S#M@TDNQ*H39[:!=K]^US%DI I9*[$O$-OWG'O.]7.X$_)!Q0":/"8\
M52,GUCJ[=ET5QI!0=24R2'%D)61"-3;EVE69!!KEH(2[?K/9=1/*4B<8YGVW
M,AB*C>8LA5M)U"9)J'R: !>[D>,YAXX[MHZUZ7"#84;7L !]G]U*;+D%2\02
M2!43*9&P&CEC[WHZ,/%YP#<&.W7T38R3I1 /IC&/1D[3" (.H38,%/^V, 7.
M#1'*^+7G=(J4!GC\?6#_E'M'+TNJ8"KX=Q;I>.3T'1+!BFZXOA.[S[#WTS%\
MH> J_R4[&]O%X'"CM$CV8%20L-3^T\=]'8X 7O<$P-\#_.> ]@E :P]HY4:M
MLMS6C&H:#*78$6FBD<U\Y+7)T>B&I686%UKB*$.<#A:QD+KQ%61"YND6E,89
MTHHTR#B*F"DTY3A@5XLI^\4,-&5<O<>0^\6,7+Q]/W0U"C%T;KA/.K%)_1-)
M/9_<B%3'BGQ,(XC*!"XZ*&SX!QL3OY9Q!N$5:7F7Q&_Z?H6@Z<OA7HV<5E'5
M5L[7.LFWU&0!X49B#4%=DO$6BT:7'!I8RL:"<B _OB"(S#4DZF=5"6V&=G4&
ML[FO549#&#FX>Q7(+3C!NS=>M_FAROZ9R$K%:!?%:->Q!V7ORGAG1TLMQ)4@
M<3=O<*7A(C,E>R(92":BJK+4Y_+($U!958'7XTIF.X793BW1'5#.?D-$UGB"
MJBH#%M_+\>:,W0;-H;L]EEH741+5+41U7R:*"U6IR<([-9KJ(DJ:>H6F7JTF
M>_#H9P=/E;A:GM=NA#.1E2SW"\O]_WXJ],]9C#.1E8HQ*(HQJ)W_>9)1)LVD
MDS"F<@V5<S_XYV:IB[#"W*/;,0',9!X-YMS9I-K>,$5O\2X9Y]?QL_X)OE?L
M\^(OC7WLW* !W.Z$PPHIFU<]W"C2/B!L0XLLOX.70N.-GG_&^.8":0)P?"6$
M/C1,@N(5%_P!4$L#!!0    ( -&&;5:'4LR.4@(  (L%   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0X+GAM;(547V_:,!#_*E963:VT$1)(*"Q$:HNJ]F$2
M@G9]F/9@DH-8=7R9;4C[[6<[$+$UL)?$9_OWYWP^)S7*5U4 :/)6<J&F7J%U
M-?%]E1504M7#"H196:,LJ3:AW/BJDD!S!RJY'_;[L5]2)KPT<7-SF2:XU9P)
MF$NBMF5)Y?LM<*RG7N =)A9L4V@[X:=)13>P!/U<S:6)_)8E9R4(Q5 0">NI
M=Q-,;F.[WVWXP:!61V-B,UDAOMK@,9]Z?6L(.&3:,E#SV\$=<&Z)C(W?>TZO
ME;3 X_&!_=[E;G)9405WR%]8KHNI=^V1'-9TR_4"ZP?8YQ-9O@RY<E]2-WOC
MT"/95FDL]V#CH&2B^=.W_3D< <)3@' /")WO1LBYG%%-TT1B3:3=;=CLP*7J
MT,8<$[8H2RW-*C,XG3Z*'0B-DH$B7\FR*0W!-3E>N)R!IHRK*W)!F"!/!6X5
M%;E*?&TL6"(_V\O=-G+A";D99#TR"+Z0L!^&Y'DY(Y<75W_3^":#-HVP32-T
MO(/_I/%.9DQE'-56 OEYLU):FKK_ZC+:$ Z["6TO3%1%,YAZYK(KD#OPTL^?
M@KC_[8S=06MW<(X]7=#:%%&#9)1WGF(#'SFX[:M=.@JB(/%W':+#5G1X5O3%
MM(<M7R4Q ]4IVQ!$1[)!?'U"-FIEH[.R]TPP<S]SLD'LOC+1!]7Q8-0M&K>B
M\5G1)]24FV3;.]RE&W\XY/$H'O\C[!_UEGVFOE.Y84(1#FL#Z_=&QK=L6K\)
M-%:NW5:H3?.Z86%>2Y!V@UE?(^I#8#NX?7_3/U!+ P04    " #1AFU6JJ^*
MNP #  !I"0  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6RUEFUOVC 0
MQ[_**:NF5NH("4]M!Y%*'S:D(J%6W5Y,>V&2 ZPZ-K4=H-,^_,X)I&R#3*O:
M-V [OO_]?&?[W%TJ_6!FB!96J9"FY\VLG9_YOHEGF#)34W.4]&6B=,HL=?74
M-W.-+,F-4N&']7K;3QF77M3-QT8ZZJK,"BYQI,%D:<KT4Q^%6O:\P-L,W/+I
MS+H!/^K.V13OT-[/1YIZ?JF2\!2EX4J"QDG/.P_.^D%ND,_XPG%IMMK@EC)6
MZL%U!DG/JSLB%!A;)\'H;X$7*(13(H['M:A7^G2&V^V-^G6^>%K,F!F\4.(K
M3^RLYYUXD."$9<+>JN5G7"^HY?1B)4S^"\MB;KOI09P9J]*U,1&D7!;_;+4.
MQ)9!&.XQ"-<&8<Y=.,HI+YEE45>K)6@WF]1<(U]J;DUP7+JLW%E-7SG9V6@@
M%RBMTAP-?(#S).$N6$S 0!8I=Z$[O$3+N#!'< !<PI +0<.FZULB<#I^O/;6
M+[R%>[P%(0R5M#,#5S+!Y'<!G]!+_G##WP\K%2\QKD$C.(:P'H9P?W<)AP='
M%;J-,BZ-7+>Q1W>4C06/X=YR01%!<PR;2#W!MQN:# .+J?F^*P:%<G.WLCMF
M9V;.8NQY=(X,Z@5ZT?MW0;O^L8*[67(WJ]2C9TH6/V9<8P*XHB-LJ,$,.(=,
MQS-@,J'-NZ!3.:<S9C>3=BVG<-C.';I#OHC"L';:]1<[,%LE9JL2\T;)*5C4
M*6BVI/U,3<Z$ :DL/-%=1!>,X#_^W"$%3^LOGD8MW(W3+G':E3C77'(Z0PE\
M4BHQ\!.&;,73+-WEOE+IA=GME)R=-]N5G3?@/BFY3RKC>V4L=TE.X-[@)!-P
MPR<[]UJU3-""-+\^*I!.2Z33_TPY#>Q)>:72"T,7U)]OZ/J;)7TM_<KH6\4E
M>)V\_T.'ZL;^Q/M;U2]%/<UKO(%89=(6A; <+=\1YT7U?)Y>/$*&3$^Y-"!P
M0J;U6H?N&EW4]:)CU3ROI6-EJ3+GS1F]A5"["?1]HI3==)R#\G45_0)02P,$
M%     @ T89M5H.R4$&? P  2!$  !D   !X;"]W;W)K<VAE971S+W-H965T
M-3 N>&ULM5A=;YLP%/TK%INF3>H*AA#2+D':TE6KM$W1LH^':0\NW"36 #/;
M)-V_GPV4A."R9:(OB0WWGIQ[? S7F>X8_RDV !+=I4DF9M9&ROS2MD6T@92(
M<Y9#INZL&$^)5%.^MD7.@<1E4IK8KN.,[930S JGY;4%#Z>LD G-8,&1*-*4
M\-]O(&&[F86M^PN?Z'HC]04[G.9D#4N07_(%5S.[08EI"IF@+$,<5C/K-;Z<
MXT GE!%?*>S$P1CI4FX9^ZDG-_',<C0C2""2&H*HKRW,(4DTDN+QJP:UFM_4
MB8?C>_3KLGA5S"T1,&?)-QK+S<R:6"B&%2D2^8GMWD%=D*_Q(I:(\A/MZEC'
M0E$A)$OK9,4@I5GU3>YJ(0X2\.B!!+=.</\UP:L3O++0BEE9UA61))QRMD-<
M1RLT/2BU*;-5-333R[B47-VE*D^&"ZX<P>5O1+(8P:^"YFJ-Y!G*E(->HF6U
MN(BM4"OP[3[PHPI\?@62T$2\4"E?EE?H^=,7Z"FB&?J\8850"6)J2T56_Z0=
MU<3>5,3<!XA=072./'R&7,=U#>GS?T_'[71;2=3HY#8ZN26>]Q>=SM B(9EL
MJX"^OU?AZ$9"*GZ82JVP1V9LO5,O14XBF%EJ*PK@6[#"9T_PV'EE*GP@L)8,
M7B.#UX<>?F:2)"@WFL94>(46E&CZB;(-/>RK]=@>%M0-\MV@B6GQ'#4\1[T\
MWX,0E^H9$15ID1 )L=K:2HZ($OWP,#&M\/P#$B_]D7/$U!3DF9GZ#5/_OQ4M
MMZ&)K-_AX8[QL:S=H%$P,I,=-V3'O62O"YY167 H>5[3.STV;NY>G%,=/Q!8
MJ^2@*3EXQ(T?#"G#0& M&2:-#)-!-_ZD8SYO[!X9M!LSF9C]>=&PO.AE.6=I
M7DC@Z!WA\8[4/EVRE=03$\]>O%,7:""P5NG8V;_)G4=T:@T^D!)#H;6E.&AJ
M\*!NK>$.K8@G^/CI;XAR?<?L6+QO+'#O"UN]JE07NF%)C&Y2Q7@+FJ2Y81JT
MC1@*K5WVOI' WF.ZM;=-.5F*@=#:4NQ[%=S?K)SLUFX;@H/QL5F[00]Z==^K
MX/YF9<XR(7E1G<!N,LUYK10QN[47ZN0E&@BM7?B^[\'CQW3KH-W04&AM*?;]
M$.[M,TYW:]!I[R>.=^S6;A#V+H[L:A\<<_5_#!\(7]-,H 16*LLY#Y1'>'5L
MKR:2Y>7)]Y9)=8XNAQL@,7 =H.ZO&)/W$WV8;OX\"?\ 4$L#!!0    ( -&&
M;58(\\L70@,  $ *   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;*V6
M76^<.!2&_XI%JZJ5MN%K8$@Z@Y0FW78ONHV2M+U8[84'#@.MP:QM9C+_?H\-
MH60@*(IZ,X/AG-?O<S@V7NVY^"ES $7N2E;)M94K59_9MDQR**D\X354^"3C
MHJ0*AV)KRUH 34U2R6S/<4*[I$5EQ2MS[TK$*]XH5E1P)8ALRI**PWM@?+^V
M7.O^QG6QS96^8<>KFF[A!M37^DK@R.Y5TJ*$2A:\(@*RM77NGEVXCDXP$=\*
MV,O!-=$H&\Y_ZL%?Z=IRM"-@D"@M0?%O!Q? F%9"'_]UHE8_ITX<7M^K_VG@
M$69#)5QP]KU(5;ZV(HNDD-&&J6N^_P0=4*#U$LZD^27[+M:Q2-)(Q<LN&1V4
M1=7^T[NN$(,$=_%(@M<E>$]-\+L$WX"VS@S6)54T7@F^)T)'HYJ^,+4QV4A3
M5/HUWBB!3PO,4_%YDH@&4O+A#AM#@B1OR0VV2MHP(#PCH\>O+T'1@LDW&/CU
MYI*\?OF&O"1%16YSWDA:I7)E*_2EU>VD\_"^]> ]XN$2DA/BNW\0S_&\B?2+
MIZ>[#]-MK$9?$J\OB6?T_$?TKNB!;ABR(DU; ,HD^>=\(Y7 KOMW"K!57$PK
MZJ5X)FN:P-K"M29![,"*7[UP0^?=%.YO$GL [_?P_IQZ_.%.@:@H(UJ:BB0W
M54AAAPN^QN6KINA;R:61U/O&+HX6WF)E[X94XZ @#,,^Z(';1>]V,>L67Y7@
MC!F/4-:,'P#0.:,*>Q:ZGIURW,H& S-NX/GND>5QU,*+G&G+06\YF+7\F59-
MAFW4B*+:3ED+QI,&I^&1L]DYGMDB84\0SA+<[PD)KR1NEHAAZL]5#H+4@F<@
M]2://93!=/7#,:+K'B..@[S(>Z3XR][Z<M;Z-6RP->3 [\?;OPE-?^!&JYM[
MTNUR9,0/(N_([>R\SWPA44\5S5/Q V7J0.IVXYIBB,;]CA!'#+.S/)/AM&<X
MG67X8MX&[5IK;NF>CE$<)SA"&0=Y ]P'#EWGUZ?2F?5XRQ4V]5,\=D+#S<Z/
M?/>X:2;"7-\9[)RM47OP>==GJ\]4;(M*$@89YCDG2^04[7&E'2A>FR_^ABL\
M/YC+'(]X('0 /L\X5_<#?8CH#XWQ_U!+ P04    " #1AFU6)$4(."<)   J
M6   &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6RUG%MOXS8>Q;\*X19%
M"V1L77Q+F@28L2X[@YU%,&FW#T4?:(FVA='%I2AG NR'7U*2+=.1F1ASFH<9
M6^;_1TD\XN60XNU3P;^6&\8$^9:E>7DWV BQO1F-RFC#,EH.BRW+Y2^K@F=4
MR*]\/2JWG-&X#LK2D6-9TU%&DWQP?UL?>^#WMT4ETB1G#YR45991_OR!I<73
MW< >[ ]\2=8;H0Z,[F^W=,T>F?A]^\#EM]&!$B<9R\NDR EGJ[O!>_LF'%LJ
MH$[QWX0]E4>?B;J495%\55\^QG<#2YT12UDD%(+*_W9LP=)4D>1Y_-U"!X<\
M5>#QYST]J"]>7LR2EFQ1I'\DL=C<#>8#$K,5K5+QI7CZ%VLO:*)X49&6];_D
MJ4D['0](5)6BR-I@>099DC?_TV_MC3@*L,\%.&V <QHP.1/@M@'N:<#T3,"X
M#1B?!,RM,P&3-F#RUFN8M@'3MP;,VH!975C-W:V+QJ."WM_RXHEPE5K2U(>Z
M?.MH62))KJ3X*+C\-9%QXGY1Y#O&1;),&?E/(5A)WI'W<9PHG="4?,P;M2O5
M_.PQ09.T_$4F^?W1(S__^,OM2,AS4*11U.:W:/)SSN1GD\]%+C8E\?.8Q3WQ
M_BOQC@$PDA=_N /._@Y\<(S$3U4Z)*Y]11S+L?LNR!P>L.60./.SX=XKN=/<
MF+MO#O=8= AW>L*#MX?WY1Z^/=PR%(5[$*-;\]RSO*60DBL%KV1M)\B?_Y8)
MR$?!LO*OGK/[T-#&_315B=^46QJQNX&LI4O&=VQP_],/]M3ZM:^8D3 /"?.1
ML  )"T$P32SC@UC&)OK]8D/S-2-)3E8TX61'TXJ18D6BHQHM5S5:GW*,Z$N5
M@X1Y2)B/A 4-;%;#5 ]G=S]QG+EER2=_=RP*4*::*"8'44R,HOB-9=N"RSX5
M87]7B7B^(N6&RFQ(4I95;WOSP0B\5 I(F(>$^4A8T, F1U)P9[8U&T^N3[0
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MT719.)TL'*,L&A\VHZ+BC,12'KTJ,#(N5@&2YKUR?9\JY7E:5^2<:^E#3R>
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MYHLHMO6^J,M"B"*K/VX8C1E7">3OJT(V=.T7E<%A>^#[_P-02P,$%     @
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M>*_"I<KK$ZKCMUE6?O]2OQAT^R+8L_\ 4$L#!!0    ( -&&;5:T^.:[PP,
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M_H0VF2J[VG)@9.$:PY4TU&:ZRY2^!%#9"?1\+:4Y#NP"];?%X@=02P,$%
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MU8I2VZU;$F#KGJP--%7H@Z5!ZJJP+.@; ^L#:']E#!X-3]!\C.EO4$L#!!0
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M,\D-2_/5 -(&F.>%$/II8@^F[CLD_0M02P,$%     @ T89M5D@[2GBD P
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MN,8HQDQUD->7E(JGAMJF:/:QPO]02P,$%     @ T89M5OCCW/@4"P  _8L
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MA4*3>R6LJZVWKJTDOWJ%OT>4ZXL8MP(2+0!%HU!H<KN$V;4]X)MD0&TK*%H
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M&EU]X81K5VZA^,JVB!E7NN'8Z5)W>!1&0'^?<Z[V"^.@_,\0_P502P,$%
M  @ T89M5K2B,Q@W P  S0L  !D   !X;"]W;W)K<VAE971S+W-H965T-C<N
M>&ULQ5;;CMLV$/V5@1H4"9"L;K[MUA;@2YH&:%!CG<M#D >N-+:$E4B5I.W=
MO^^0TBJRHS4:0$!>;)&:<WCF<$C-]"CDO4H1-3P4.5<S)]6ZO'%=%:=8,'4E
M2N3T9BMDP30-Y<Y5I4266%"1NX'GC=R"9=R)IG9N+:.IV.L\X[B6H/9%P>3C
M G-QG#F^\S1QF^U2;2;<:%JR'6Y0?RK7DD9NPY)D!7*5"0X2MS-G[M\L?<\
M;,3G#(^J]0PFE3LA[LW@?3)S/*,(<XRUH6#T=\ EYKEA(AW_UJ1.LZ8!MI^?
MV/^TR5,R=TSA4N1?LD2G,V?B0();ML_UK3C^A75"0\,7BUS97SC6L9X#\5YI
M4=1@4E!DO/IG#[41+8 _>@80U(#@'#!X!A#6@- F6BFS::V89M%4BB-($TUL
MYL%Z8]&43<;--FZTI+<9X72TT2*^AW_*RE.>P#O)N(9USCB\@4VUN2"V8 /?
M+,BQ!):BH#)2S(+>/IAGA)<KU"S+U2O"?=JLX.6+5_ ",@X?4[%71*VFKB;%
M9ETWKM4M*G7!,^K\ #X(KE,%;WF"R2F!2ZDV^09/^2Z"BXPKC*\@]%]#X 5!
MAZ#E_X?[%^2$C?VAY0N?LS]E$J'#U;FD?=@A'1@-BT=HQZW9HYV>'YE,X.O?
M1 GO-1;J6Y?!U?J#[O7-)7&C2A;CS*%;0*$\H!/]_IL_\O[H,J<GLA.K!HU5
M@TOLT4>A60[*EN&=-2)N&=:5>L4WMGSF.CM$@3_V!U/WT,[IQZC0#T=-T(G6
M8:-U>%'K+67/9)S:$[7" ]V6I=VS^K!T'H6+E#^[4SV1G60_:K(?_>*B'O5I
M54]D)U:-&ZO&/1=UQ3=LE>MP%%Z?U?2/09/)I+ND)XW2R46E&_K29GSW&MXA
M1TFB36G/$_HD94I+9C[&%ZO[(OO/;EE/9"=&7#=&7/_BZK[NTZJ>R$ZL\KWO
MW877<WW7A.W[F-2,AV<5WA$6!(/S&G=;C5&!<F?[144:]EQ7/4,SV_2D<]N)
MG<TO3*]J&Z[O-%6C^X')7<85Y+@E2N]J3*=.5KUC-="BM.W7G=#4S-G'E/IM
ME": WF^%T$\#LT#3P4?_ 5!+ P04    " #1AFU6%1+)@!4#  #5"P  &0
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M4LIP(D"NLXR(W0A3OATXOK-?F-)EHLR"&_979(DS5'>KB= SMT2):89,4LY
MX&+@#/W+D>\9!VOQA>)6'HS!2)ES_F F-_' \0PC3#%2!H+HUP:O,$T-DN;Q
MO0!URCV-X^%XC_[.BM=BYD3B%4_O::R2@=-U(,8%6:=JRK<?L!#4,G@13Z5]
MPK:P]1R(UE+QK'#6##+*\C=Y+ )QX!"TCC@$A4-@>><;699CHDC8%WP+PEAK
M-#.P4JVW)D>9.969$OHKU7XJG"D>/<"G51XB%L-[09B"24H8G,,L/RO@"[AC
M B.^9/0'QF"]SD<Z&C%<\4RGB"06X?K1C-$BW=N(8'P^W*#0)PS3', :3E!0
M'L/I&!6AJ3R#$Z ,/B=\+;6O[+M*BS,4W:@0,LJ%!$>$^ '<<J82"=<LQO@Y
M@*NC4H8FV(=F%-0BCC&Z@(;_!@(O".!N-H;3D[,:W$89\H;%;?Y!R"N%UKJ;
M,KV4*Q+AP-%U*%%LT E?O_+;WML:<LV27-.B-XZ12XC JI,="IT82]0%J6"^
M@T.["=G9Y>&6B!B^?M20<*,PD]^JU#5?0%VK5->J#?VS)"YRM8ICCM*Q*.:_
MM@G;OM?L]=U-Q>;M<O-V[>9E/9"C]5#%I1XT@!T2(:$'69[]?A-BLI,UP>J4
M?#NUT%.42M!([>M=_P*HJDS86IR_/-)NR;+[GQ.V^P+J>J6ZWC])V-XO">O[
MO997G;"^]]0<O)=(V=^@-HJ<;10Y6Q4G]Z"E92B6MG%+B/B:J;R[E:OEY6"8
MM\0G\_QF<4O$DC()*2ZTJW?1T=4M\F:=3Q1?V08YYTJW6SM,] 4'A3'0WQ><
MJ_W$;%!>F<*?4$L#!!0    ( -&&;58TE1V6M0(   \'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<P+GAM;*U576_:,!3]*U9639VTDB\(;0>1"FQ:I;5#
MI=T>ICV8Y$*L)G9F&^C^_:Z=D $+; ][26SGGN-S;GRO!QLAGU4&H,E+D7,U
M=#*MRVO754D&!54=40+'+PLA"ZIQ*I>N*B70U(**W T\+W(+RK@3#^S:5,8#
ML=(YXS"51*V*@LJ?(\C%9NCXSG;A@2TS;1;<>%#2)<Q /Y53B3.W84E9 5PQ
MP8F$Q="Y\:_'D8FW 5\8;-3.F!@G<R&>S>0V'3J>$00Y)-HP4'RM80QY;HA0
MQH^:TVFV-,#=\9;]@_6.7N94P5CD7UFJLZ%SZ9 4%G25ZP>Q^0BUGY[A2T2N
M[)-LZEC/(<E*:5'48%10,%Z]Z4N=AQV 'QT!!#4@. 1TCP#"&A!:HY4R:VM"
M-8T'4FR(--'(9@8V-Q:-;A@W?W&F)7YEB-/Q+4]$ >21OH B%V0LBE)PX%J1
MSPMRCZ?HDU"*C #/"Y"I%&MF_Q^FD.Q!SR>@*<O5&R1YFDW(^=D;<D88)X^9
M6"G*4S5P->HUN[I)K6U4:0N.:/,#<B>XSA1YSU-(]PE<--JX#;9N1\%)Q@DD
M'1+Z;TG@!4&+H/&_P_T3<L(F^:'E"_^:?#)A*LF%6F&6O]W,E99XOK^WI:QB
M[+8SFIJ_5B5-8.A@42N0:W#BUZ_\R'O79O<_D>V9[S;FNZ?8XZ?.K--FL$+U
M+<KTH'5\X5]=]KWNP%WO:F^)N^Q?[83MJ>HUJGHG5=WCX<83?$1;A>WM[.G[
M7G@@[,^@BZ#?KBIJ5$4G5=DBG%=%R*I#HTW9M6F,VO+7CSS_0&9+'.8O] ^4
MNCN]I0"YM"U7D42LN*X*KUEMNOJ-;68'ZR/L]E5S_DU3715W5"X95R2'!5)Z
MG3[F3E;MMYIH4=H.-A<:^Z$=9GAC@30!^'TAA-Y.S ;-'1C_ E!+ P04
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M-KZ>R-73(0'#_Q 0[M5]B7KIN]M JFI)30NTN^T#<MWTS6MX\_H\,+WDTH#
MW*9V.R/+KYN.;A:D*M]%"T6V)_VTL(\@:A=@SW.E:+=P!.VSFOP#4$L#!!0
M   ( -&&;59<+"!=9@4  .D>   9    >&PO=V]R:W-H965T<R]S:&5E=#<R
M+GAM;+U9VV[C-A#]%<(MBET@M47ZEJ2)@23JH@&Z;;!IVH>B#XQ$V^Q*I)>D
M[:3HQW<H*9*UHIDX8/H26_+,&<[A<'@8GFVE^JR7C!GTD&="G_>6QJQ.!P.=
M+%E.=5^NF(!?YE+EU,"C6@ST2C&:%DYY-B!1-!GDE(O>[*QX=Z-F9W)M,B[8
MC4)ZG>=4/5ZR3&[/>[CW].(37RR-?3&8G:WH@MTR<[>Z4? TJ%%2GC.AN11(
ML?EY[P*?QF1D'0J+WSG;ZIWOR*9R+^5G^W"=GO<B.R*6L<18" H?&W;%LLPB
MP3B^5*"].J9UW/W^A/ZA2!Z2N:>:7<GL#YZ:Y7GON(=2-J?KS'R2VY]8E=#8
MXB4RT\5?M"UMQV"<K+61>>4,(\BY*#_I0T7$CL-QM,>!5 [D*P<\VN,PK!R&
M+W4850X%U8,RE8*'F!HZ.U-RBY2U!C3[I2"S\(;TN;#S?FL4_,K!S\RN12)S
MAGZC#TRC[]%%FG(['S1#UZ*L*CL[[V)F*,_T>S"YNXW1NV_?GPT,A+<@@Z0*
M=5F&(GM"88(^2F&6&OTH4I:V 08P[GKPY&GPE\2+&+.DCX;X")&($,> KE[N
MCAWN\<O=(T\VPWHJA@7>\-FI0#'722;U6C'TY\]@AJX-R_5?+LY+S)$;TW:-
M4[VB"3OO05O03&U8;_;=-W@2_>#B*R18' BLQ>6HYG+D0Y_=*+GA16^"(D:\
M9-;8(G=Q6&)-"RS;*#>SZ70413"IFUUVO"$/92<06(N=<<W.V,O.7?^VCVX-
M-6LCU2.:LY0I6/$-34A1PUQ,E;@XVJ$JZMO%TR+J15:Q=XRO9&!2,S#Q,F 7
M6:(8-#N44*4>H4JV5*5'L&7H1/&5[7JN_)]!79;L.9 U]/4L0^QAQ6%14X,V
M5'&YUB@%IC6Z9PLN!!<+F 3H)\-1W[4\O=$/+<! 8"WZIS7]4W\!"L42N1#\
M'Y86C-TSP>;<N"B?=A8GCO"PNSJ[=N-)=Q''7;/AZ&37K)70<9W0L3>A6P[)
MS'E"!4S[DHH%LQ.YWI.FLPGY ]C2NI+YBHI'E$JH&"&-K2:03\C ;S27:X@M
MY_N#(B.?QB8W3"'!'@R"33DO-F5GP7G'=&C!!0)KS<])/3\G7OJNA6& "@0I
M!)*99H8#AXIEL/I22\Q:)$R!QA$%92NI"QGDG*B33@5]78JEQ7B_1>P=[2NY
MP%&C^2(O&Q_*AN^4<%[/0_5$4+0X%%J;M1VEC-] GU6@H0@-B1:'0FL32AI"
MB;<,?X%C+1Q@06O8C0_XU.TMTTDGZ:PMV"[AE-O=$!RF&(^G#M/8/]#7$M$(
M?^S5PK-?/20<P9'\_N^BS<M2/M!]XJ2*TMHJATYF@NK\4&AM\AJEC_U2WT]>
MPQCT?5!<J9,X?P2KQYR+,>B!(!1:F\;F2(#]9P(_C59MO+P.QYTZ)!$^<59B
MH$- 1>%;'"EP<Z; +SU4N%O7I-./1A,G*5U#XFY;;Z'A<2/BL5_%VQ.D\Y3H
M]SMXSPN)%H=":W/6G!/P\5N(B)!"_"HH6AP*K4UH(^RQ7]F_2D1T!3J>C+!S
M+7;5/HZ(JY?%_H&^D@C2B'KB%_7/=)_*NY6S4S;YPQQ:':'0VJ0TFIUX)6S9
MHM"_Z"/5FB;+M69F#SU!97I0M#@46IO#1J83\@8MBP22U!6A(='B4&AM0ANY
M3_X7N4\<<K_2^YTU'53PAT)KT]<(?O+F@O^9"/L$O]_M8!J#"O[!SAU@SM2B
MN$L%=NR_!<L;M?IM?5][4=Q2?O7^$I]>E;>N#4QY"?R1J@47&F5L#I!1?PJ;
MB2KO5<L'(U?%3>.]-$;FQ=<EHRE3U@!^GTMIGAYL@/IV>_8?4$L#!!0    (
M -&&;59SM=6P)@,  ) )   9    >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM
M;*V676_3,!2&_XH5!!H2Y*L?6T<;:>N8X (QM0PN$!=N<M)8.':Q3]KMWV,[
M;=9V:<8%-ZWM^+QY7OODV..-5+]U 8#DH>1"3[P"<749!#HMH*3:ERL0YDDN
M54G1=-4RT"L%-'-!)0_B,!P&)67"2\9N[$XE8UDA9P+N%-%565+U> U<;B9>
MY.T&9FQ9H!T(DO&*+F$.>+^Z4Z87-"H9*T%H)@51D$^\J^AR.K+SW83O##9Z
MKTVLDX64OVWG<S;Q0@L$'%*T"M3\K6$*G%LA@_%GJ^DUK[2!^^V=^JWS;KPL
MJ(:IY#]8AL7$N_!(!CFM.,[DYA-L_0RL7BJY=K]DLYT;>B2M-,IR&VP(2B;J
M?_JP78>]@&AX(B#>!L3' ?T3 ;UM0,\9K<F<K1N*-!DKN2'*SC9JMN'6QD4;
M-TS879RC,D^9B</DLTAE">0;?0!-WI.YR9*LXD!D3F:02I$RSJA;<#/R,<_!
M+3MY"B,SBD!0DGM_[I,Y4JQ0JD=R"QDHRI_-/+L!I(SKM^, #;^E"-(MZW7-
M&I]@C6+R10HL-/DH,L@.!0)CO'$?[]Q?QYV*-Y#ZI!>](W$8QRU TW\/CSIP
M>LUF])Q>[\7-(#=,IUSJ2@'Y>;70J$R^_VI;LEJQWZYH:\"E7M$4)I[YR#6H
M-7C)FU?1,/S09O<_B1V8[S?F^UWJB75-L4XCW:01FE%E\J;->JT7A4[0EJMU
M$OIV(];[GEZ:=0 [:& 'G; VSX&P>K\LXP($Y S;,&NE*#X "'NC(\Y!&V?8
M;^<<-IS#3LZ9V2:JTH)0D9GJMC95>V5J,#KF5$'&4+<Q#UN9H_X1\XEI@W;H
M\P;ZO!/Z.^5577,H-Z<,%2FT0G:KG,4#?Q"^;JLSTY<B^W[_6>2!E8O&RD6G
MU%<L0+6Q=X>=17Y\ OV%P-B/NLE'#?FH4^FIUN]E^:DOL5OJ+&Q9SMK-J"7I
MCY(GV#O<2E!+=^9KDLI*8%WIF]'F6G'E3M.C\6MSW:AO!T\R]5WE"U5+)C3A
MD!O)T#\WWZ*JS_^Z@W+ECM"%1',@NV9AKDR@[ 3S/)<2=QW[@N82EOP%4$L#
M!!0    ( -&&;5:SL#T^# 0  +X1   9    >&PO=V]R:W-H965T<R]S:&5E
M=#<T+GAM;+5876_;-A3]*X16#"W01)2L+V>V@=1"T0!;&]1M]S#L@9%IFRA%
M:B1M)_OU(R5%MB5&< SMQ1:E>X[N.10OKS39<_%3;C!6X#&G3$Z=C5+%C>O*
M;(-S)*]Y@9F^LN(B1TH/Q=J5A<!H68)RZOH01FZ."'-FD_+<O9A-^%91PO"]
M '*;YT@\?<"4[Z>.YSR?^$K6&V5.N+-)@=9X@=7WXE[HD=NP+$F.F22< 8%7
M4^?6NTF]P #*B!\$[^71,3!2'CC_:09WRZD#34:8XDP9"J3_=GB.*35,.H]_
M:E*GN:<!'A\_LW\LQ6LQ#TCB.:=_DJ7:3)W$ 4N\0ENJOO+])UP+"@U?QJDL
M?\&^CH4.R+92\;P&ZPQRPJI_]%@;<0300NT OP;XYP)&-6!T+B"H :75;B6E
M]"%%"LTF@N^!,-&:S1R49I9H+9\P,^\+)?15HG%J=L<RGF/P#3UB":[ HII^
MP%=@0=:,K$B&F )SGA><8::DN9+B%18"+PT*W$J)]6G$EN!W@AX()8IHJK<I
M5HA0^4Z3?E^DX.V;=^ -( Q\V_"MU-%RXBJ=O\G"S>I</U2Y^B_DFN+L&HR\
M]\"'OF^!S\^'>Q9X>CX<GL)=;7KCO-\X[Y=\HQ?Y.BZ^!Y_U2O_K]D$JH1?$
MWS:+*M+ 3FJJQ(TL4(:GCBX#$HL==F:__N)%\#>;84.2I0.1G9@Y:LP<];'/
M/N(E%H@"IOW3-5$@1=@:4"XER) 03[I [I&P/W05<UPRFS*YFP5^%(\F[N[8
MJFZ4'XQ@*RKMS?)"#X+&@Z#7@X5""E_D0,4;'FGS8.0G+0>Z46$0!RT#>E.\
MT("P,2#L-6"."J(0)?_J1678D<@V96%:XIW>X J]72F0<:FL)H1=$Q(8CULF
M=*,B'X8M$WK3O-"$J#$AZC7ACNVT3"Z>;!JC[A3&IA:>2.SE?VU1&(CLQ(JX
ML2+NM<(4UDQ76&*?\+AK1IBTS>@&^0ELK8RT-XT+12:-R*17Y&V6B2VBU0[,
MU08+F]:D(V/L)ZVU.^\&>6$8M;3V9G.AUG&C==P_H5PO;]/551NGTO.+RHW3
M)GG<E>R-HY:<>3<J@*.@+;HWK0M%>_#0HL%>V3\0W:*J2Z:Z3T<LP];F"7:T
M7(UAF,0MR77<\59V91-MB_.2,81-W*F>HY;3Z]5CFASUFJFL^4Z>S%&G-/??
M];6%:RBV4X\.S:'WBN[PJ+$^IT7T!NT1!V5+AV([M?70)GK]?>*7EPIDC3M9
M/+9G;* &KS;C_V@7O4._Z/4WC)9R2@]/FM6EP%(2+"X-U 76+@W:4[I'[\KF
MR\8?2*P)DX#BE::'U[%^!$3UL: :*%Z4K\\/7.F7\?)P@Y%^W3 !^OJ*<_4\
M,&_DS2>;V7]02P,$%     @ T89M5KF(E0_% @  0 <  !D   !X;"]W;W)K
M<VAE971S+W-H965T-S4N>&ULK57);MLP$/T50@V*%&BCQ;*RU!;@I45S"!#$
M27HH>J"EL45$(E62LI._[Y"2%7F)6Q2]2%QF'M^;&0X':R&?5 :@R7.1<S5T
M,JW+*]=5208%56>B!(X["R$+JG$JEZXJ)=#4.A6Y&WA>Y!:4<2<>V+5;&0]$
MI7/&X582514%E2]CR,5ZZ/C.9N&.+3-M%MQX4-(ES$ _E+<29VZ+DK("N&*"
M$PF+H3/RKR:1L;<&CPS6JC,F1LE<B"<SN4Z'CF<(00Z)-@@4?RN80)X;(*3Q
MJ\%TVB.-8W>\0?]JM:.6.54P$?EWENILZ%PX)(4%K7)])];?H-'3-WB)R)7]
MDG5CZSDDJ9061>.,# K&ZS]];N+0<?"C-QR"QB'8=0C?<.@U#CTKM&9F94VI
MIO% BC61QAK1S,#&QGJC&L9-%F=:XBY#/QU?\T040.[I,RCRB<SJ9!*Q((\T
MKZ@-]2C'7%.> #F=@J8L5Q_0]&$V):<G'\@)89S<9Z)2E*=JX&ID9;#=I&$P
MKAD$;S#P W(CN,X4^<)32+<!7)33:@HVFL;!4<0I)&>DYW\D@1<$!PA-_M[=
M/T*GUX:X9_%Z?PPQF3*5Y$)5$LB/T5QIB57\\U#(:L3P,**YV5>JI D,';RZ
M"N0*G/C].S_R/A^2^Y_ ML2'K?CP&'K\6D6TK2*JR1R6C'/&EZ;27H#*0T&H
MD<\MLNE&JSCT>F$T<%===?M6_L6EY[566[3[+>W^4=J8,^R)"N^$A$1(K$NB
M!1:ZS:3&3)92K)AI98>(U]C]#J6^%X3^#O%]J\ /._*VB$<M\>A?X@T\/1;I
M:"^&EU[_XGR'\+[5=CYJPFZG&14@E[9'*Y*(BNOZ#K>K[3,PLMUO9WV,ST/=
MS5]AZK?EADHL'T5R6""D=W:.091UOZXG6I2VY<V%Q@9JAQD^<2"- >XOA-";
MB3F@?33CWU!+ P04    " #1AFU6XGF *QL#  "/"   &0   'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6RM5FUOTS 0_BNG@- FC:5)^@*CC;1N(/9ATM0Q
M^(#XX"77QIIC!]MI-WX]9R<+7=N5"?&E]<O=X^>YL^\R7BE]9PI$"_>ED&82
M%-96)V%HL@)+9HY5A9)VYDJ7S-)4+T)3:62Y=RI%&/=ZP[!D7 ;IV*]=Z72L
M:BNXQ"L-IBY+IA^F*-1J$D3!X\*,+PKK%L)T7+$%7J.]J:XTS<(.)><E2L.5
M!(WS27 :G9R-G+TW^,IQ9=;&X)3<*G7G)A?Y).@Y0B@PLPZ!T=\2SU (!T0T
M?K:807>D<UP?/Z)_\MI)RRTS>*;$-Y[;8A*\"R#'.:N%G:G59VSU#!Q>IH3Q
MO[!J;7L!9+6QJFR=B4')9?//[MLXK#E$PV<<XM8AWG3H/^.0M Z)%]HP\[+.
MF67I6*L5:&=-:&[@8^.]20V7+HO75M,N)S^;7LA,E0A?V#T:> O733)!S>%&
M:LS40O)?F+M]F*+$.;<&#L[1,B[,(3G<7)_#P>M#> U<PI="U8;)W(Q#2]S<
M"6'6\I@V/.)G>$0Q7"II"P,?98[Y4X"01'7*XD=ETW@OXCEFQY!$1Q#WXG@'
MH;.7NT=[Z"1=H!./ESR#-Z-@RHP+SOSUW1?@(_AXGXDZYW(!IZ6J)<7\"C7%
M7+HEJVB?T5UHW69H:RT-?)\I(8 N]XKI_,>N%#0,^[L9NGIQ8BJ6X22@@F!0
M+S%(W[R*AKT/N\+WG\">!+/?!;._#SV=,L%DAL LW.*"2Q\7"JDM$"K47.6[
MY#>8(X_IJMLR'0S[XW"YKFK;)NF_[VR>D!UT9 =[R=(3H_IJZ'T=Y-@.#ZD"
M"F8I@Y1-2TFLE.'N8AB:W:&$O-9.4T5:-#P@TSO?5'/P8(WMVR3>4+27W#_F
M:=A)'[Y0^LOD^OSMESS<DMQ_%VU(WK:)H\'N)(XZ):.7WCB4^=_OVFCK'D6]
M*-G@N6VT?B$;GN%:;2]1+WS+,Y"YLM 4PVZUZZJGOIELK$^IVS;-\0],TZHO
MF:8W9$#@G"![QR.*G&[:7S.QJO(=Y%99ZD=^6- 7 VIG0/MSI>SCQ!W0?8.D
MOP%02P,$%     @ T89M5JB<U]:Y @  \P8  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S<N>&ULK55K;],P%/TK5IC0D*!YM"MHM)'Z&&(2D\JFP0?$!S>Y
M::SY$6RG7?\]UTZ:=:.M$.)+8U_?<^XYM\[-:*/T@RD!+'D47)IQ4%I;78:A
MR4H0U/14!1)/"J4%M;C5J]!4&FCN08*'210-0T&9#-*1CRUT.E*UY4S"0A-3
M"T'U=@I<;<9!'.P"MVQ56A<(TU%%5W ']KY::-R%'4O.!$C#E"0:BG$PB2]G
M%R[?)WQCL#%[:^*<+)5Z<)OK?!Q$3A!PR*QCH/A8PPPX=T0HXU?+&70E'7!_
MO6/_Y+VCER4U,%/\.\MM.0X^!"2'@M;<WJK-9VC]>(&9XL;_DDV;&P4DJXU5
MH@6C L%D\Z2/;1_V /'P""!I <E+P. (H-\"^MYHH\S;FE-+TY%6&Z)=-K*Y
MA>^-1Z,;)MV_>&<UGC+$V?1*5%QM <@4)!3,D@6GTI!W9)+GS#6:<G(MF]OB
MVGX^!TL9-V\PY6M-.2L8Y!Z$@?N[.3D_>T/.")/DAG&."#,*+>ITU<*LU31M
M-"5'-,4)N5'2EH9<R1SRYP0A&NQ<)CN7T^0DXQRR'NG';TD2)<D!0;._A\<G
MY/2[IO<]7_\H7X&1G,S0I6;+VG?6]W#.3,:5J360'U\PAUQ;$.;GH1XV)0:'
M2[B7_])4-(-Q@&^W ;V&('W]*AY&'P_Y_T]DS[HQZ+HQ.,6^NX*:9/OMJ$!G
M("U.$J(* KMKFBF! \PTE]&J[N#@-6OJQI$O[.;9.HUZ47\4KO>]GU3WC]XO
M.N\7)[U/A*JE=0Z?F1<T![+<$ELVCJG<'O+7< _W[,6]Y(6[/W.BWE,'&M'A
MWOP0H%=^K!JLC-J:EZR+=I-[X@?6B_@4)WHS@)]HFL_!#=4KAH.%0X&44>\]
MZM+-B&TV5E5^2BV5Q9GGER5^E4"[!#POE+*[C2O0?>?2WU!+ P04    " #1
MAFU6X;,";)P#  !G#P  &0   'AL+W=O<FMS:&5E=',O<VAE970W."YX;6S-
M5VUOVS80_BN$!@PML$6O?DMM 8F38@7:U8C7[</0#XQTMHA0I$I2=O;O1U*R
M(CFVMFPJD"\V2?$>/??PCKJ;[[EXD!F 0H\Y97+A9$H5EZXKDPQR+"]X 4P_
MV7"18Z6G8NO*0@!.K5%.W<#SQFZ."7/BN5U;B7C.2T4)@Y5 LLQS+/ZZ!LKW
M"\=W#@MW9)LIL^#&\P)O80WJ2[$2>N8V*"G)@4G"&1*P63A7_N72#XV!W?$[
M@;ULC9%QY9[S!S/YD"X<SS ""HDR$%C_[6 )E!HDS>-;#>HT[S2&[?$!_;UU
M7CMSCR4L.?V#I"I;.%,'I;#!)55W?/\+U Z-#%["J;2_:%_O]1R4E%+QO#;6
M#'+"JG_\6 O1,O#'9PR"VB X-HC.&(2U@57.K9A9MVZPPO%<\#T29K=&,P.K
MC;76WA!FCG&MA'Y*M)V*?]61\I%+B58@T#K# M#/:*V#)2TI(+Y!5TR1E-#2
MJ%UMD.CV,:%E"BG:")XCE0%:8IJ4%-N3T48WQD _/X'^Y@84)E2^U>^1%F[N
M*NV(H>,F->GKBG1PAK0?H$^<J4PS89I&%\#5"C0R! <9KH->Q!M(+E#H_X0"
M+PA.$%K^>W._AT[8G$IH\<(S>%W1(2D%4:0M_'LC_)+G1:DJT3]OT"T6C+!M
M6^P_/VI@]$%!+K^>DKEB$9UF86Z02UG@!!:.OB(DB!TX\8\_^&/OW2F)!@+K
M"!8U@D5]Z/%O7&&*X"!/PO-<BZ*S)WE \*TD.TR!J9.A5@&/++"Y]';Q+ C\
M()K,W5W;O>?[HFCJAV'D-QL[U$<-]5$O]67%=6VYWE7*Z,SBPB;6[2.(A$B;
MBM66SX4Y\).N]+[HI<<Y$%A'DW&CR?A5Q/]X2,$& NL(-FD$FWRO^)\\B^MI
M-/5F(^\H_I_O&X7AS///A/^T83[M9:XC7@F2F*]%%=]?&#E-M!?GI8<U$%C'
MY5GC\NQ51/=L2,$& NL(YGM/58KWO>*[1FX'[B3R@MGQ_=[/X+]ZV*K#_'_(
M@Q1TA7ZOJZXE9SL0BICQ2E>U(,0A.TXZV O\TG,>"JTK0_ D0_ J<J.F,91H
M Z%U17NJ%OW>VNI_9<>@)6"-ULZU<!9-HC#TCKX2;JMER4%L;2<G-?62J:IL
M;U:;;O'*]DA'Z]>FB[2MT!-,U8)^PF)+F$04-AK2NYAH6J+JZJJ)XH5MC.ZY
MTFV6'6:Z$P9A-NCG&\[586)>T/36\=]02P,$%     @ T89M5CZ+<Z7< @
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M#LE@3E?<W,C-)ZCC&5B^5')=_I--;>LY)%UI(XL:C!X43%1/^ECKL 7PPP.
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MV7#H><]MZ+RPKC8D@C5L>+*QX8G3AA<?;]F%UC(693QM0V][[%*4MN5LNE+
M_L,%&5=7]-.W.$Q;;>OLIZN+H(2%E+"("-80R_?J',G;8R1<P8DT(J6%I+2(
MBM:4:2N5]=W^73[QU&#T^KB$7$.K%OXS7^2/6ES-U-U59S-3TB(J6M/,06WF
MX$UFON%/U9288_1?;A81_"^.M<#-[CP9*&DA*2VBHC55JI-W?Y_9NT^:OI/2
M0E):1$5KRE2G\+X[Z^X>3;F!G:4A39@KVG8@-VJ+Y"*J;IM6K]-AWYW5O=F%
M80CVMEBM52G2#)J4%I+2(BI:4\XZK_8/]^GK2--L4EI(2HNH:$V9ZO3;=^??
M-Z!BU(C/P:8TA8_;^+U682ASYBDI+:QH-N*M(\G^>-?-[2-1]^M,W7>GZDV#
MYV"8MGFDW5DJF:QBG"\)W$,JE[CRX$H$RO[P+\3M%1%W=YT%H:2%%:TAB-?W
MAKN*["/M]^N\WW<G_DU%BBH4&CP&2'2Y\BN4(U\!0^>U+A8:G"B:QR]5]=T]
M=A:%M 90T5X591_I?5"G]X$S+^T6#:3?%B R4#]J%JK5G(5"Q_(>U!.[E#B#
MBACAH'A@L7WJ5@!Q4#YHM?6=[3-L(-@FK_O:N\I+2@M):1$5K3D*ZNI!X.\Q
MB @H,_PI*2TDI454M*9,=?4A<%<?KOFCR%896T]:GN&T,VS)G_A="L4S0QXO
MUAE4JU2D)0A26EC1&D\3QEY;!D75;U.&NKP0.//BR<4<?>2<&V#J12%<&I#6
M%TAI845K)+$O:+"/VD%0UPX"=^V@&4SP/%_Q](4H+T;GAF<+GHIOZR)#%>FU
MRD-:8R"EA15M-Z88[6JSCPI#4%<8 G>%84>;-*WFB5U+[/I/$OJYKZ&S3*0%
MAHJV(Y._FR%1==J4J:X<!.Z'RU.9INC$%$X<^V;)1S"X8Q6;*DB$85=:K]J3
M4S>XL^U)JP:DM(B*UI2HKAH$1_N,RTAK"*2TD)064=&:,M6UAL!=:]AYN:)5
MB^<O @1MS][</76V,NE; U2TII7K^D'@KA_L^*NI5$NI;!16^:LI5PF[41)#
MK]8WBMSXSM.!M%A 2HNH:,U79^N:PG"?KPP,29-^4EI(2HNH:$V9ZJ1_^,HK
M Z][K8JPG0Z,V[R6NZ?.5B;-V:EHI94'6Y\;8%8Q+[[SL#D&YG_EN_:;HYMO
M22Z*+RAVCG_P3Z?E%R$UIOQ Y9JKN<@U2V&&2*]_A(N&*K_Y*'>,7!8?-=Q)
M8V16;"Z )Z#L"?C[3$JSWK$=;+Z\F?P/4$L#!!0    ( -&&;58W?8CV2@,
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ T89M5A%"3*@'!@  QC0   \
M  !X;"]W;W)K8F]O:RYX;6S%F]]SVC@0@/\5#2_7F[D<P3_33M.9-"'7S"3
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M4$L! A0#%     @ T89M5A\2G'V8!   PAH  !@              ("!=!@
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( -&&;59#U(B>
M9P4  $(6   8              " @4(=  !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6Q02P$"% ,4    " #1AFU6R.-F!C$#  !L"0  &
M@('?(@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ T89M
M5H)PGP!@"@  Q7,  !@              ("!1B8  'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;%!+ 0(4 Q0    ( -&&;5;M<H:71@,  (X+   8
M      " @=PP  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M" #1AFU68NO(-98)  !J,0  &               @(%8-   >&PO=V]R:W-H
M965T<R]S:&5E=#@N>&UL4$L! A0#%     @ T89M5M&BNJMW"@  <AD  !@
M             ("!)#X  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4
M Q0    ( -&&;5:4!&:;[B@  %B&   9              " @=%(  !X;"]W
M;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ T89M5I(HYW:I P
MK <  !D              ("!]G$  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX
M;6Q02P$"% ,4    " #1AFU6>WJHXH %  #6#   &0              @('6
M=0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( -&&;5;G
MEFW,2 0  $D)   9              " @8U[  !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L! A0#%     @ T89M5H%3_S;2 @  3@8  !D
M     ("!#(   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -&&;58? 5Z_(0P  "LH   9              "
M@8*@  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ T89M
M5C$1GASX!0  . \  !D              ("!VJP  'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q02P$"% ,4    " #1AFU6\+JLE<8)  !#&P  &0
M        @($)LP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0
M   ( -&&;5:YO$Z-\@P  &PG   9              " @0:]  !X;"]W;W)K
M<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ T89M5G_[HX\T P  XP8
M !D              ("!+\H  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q0
M2P$"% ,4    " #1AFU6\ZXP?IX#   T"   &0              @(&:S0
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( -&&;59A#US8
M?@,  .$'   9              " @6_1  !X;"]W;W)K<VAE971S+W-H965T
M,C4N>&UL4$L! A0#%     @ T89M5KM(__4]"   E!4  !D
M ("!)-4  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #1
MAFU6@([9:SD%  !V"P  &0              @(&8W0  >&PO=V]R:W-H965T
M<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( -&&;5:0$[5L23D  $/,   9
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M970S,BYX;6Q02P$"% ,4    " #1AFU6XQ016=P"  !#!@  &0
M    @(&B* $ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (
M -&&;596("FP!0,  & &   9              " @;4K 0!X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL4$L! A0#%     @ T89M5I?G$=,&!   M D  !D
M             ("!\2X! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"
M% ,4    " #1AFU6-W#D%^D#  !E"@  &0              @($N,P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( -&&;5:M+8WL,P,
M  P'   9              " @4XW 0!X;"]W;W)K<VAE971S+W-H965T,S<N
M>&UL4$L! A0#%     @ T89M5BG-)9:- P  AP@  !D              ("!
MN#H! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #1AFU6
MCJG0VQ\&   X$0  &0              @(%\/@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,Y+GAM;%!+ 0(4 Q0    ( -&&;59IKJ2@[@4  ,\1   9
M      " @=)$ 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%
M  @ T89M5OW/FX01 P  HP8  !D              ("!]TH! 'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #1AFU6#B(\+T,"   A!0
M&0              @($_3@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+
M 0(4 Q0    ( -&&;5918)34A0<  %DW   9              " @;E0 0!X
M;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ T89M5O/.[C$J
M P  Q@L  !D              ("!=5@! 'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6Q02P$"% ,4    " #1AFU6!QH?9GX"  #K!0  &0
M@('66P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( -&&
M;58EZ(LU$04  -0>   9              " @8M> 0!X;"]W;W)K<VAE971S
M+W-H965T-#8N>&UL4$L! A0#%     @ T89M5E 7[+3Q @  T0D  !D
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M=#4Q+GAM;%!+ 0(4 Q0    ( -&&;58D10@X)PD  "I8   9
M  " @0IT 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @
MT89M5G9L(8A;"   %%8  !D              ("!:'T! 'AL+W=O<FMS:&5E
M=',O<VAE970U,RYX;6Q02P$"% ,4    " #1AFU6M/CFN\,#   ($0  &0
M            @('ZA0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4
M Q0    ( -&&;5:DJ7!.Q@,  &<,   9              " @?2) 0!X;"]W
M;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ T89M5CBQ>9%  @
M) 4  !D              ("!\8T! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX
M;6Q02P$"% ,4    " #1AFU6K,LCL+8"  "3"   &0              @(%H
MD $ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( -&&;59(
M.TIXI ,  -,2   9              " @563 0!X;"]W;W)K<VAE971S+W-H
M965T-3@N>&UL4$L! A0#%     @ T89M5OCCW/@4"P  _8L  !D
M     ("!,)<! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -&&;5;YW[V,0@,   $)   9              "
M@>ZX 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ T89M
M5C!36&KX!   .Q@  !D              ("!9[P! 'AL+W=O<FMS:&5E=',O
M<VAE970V-2YX;6Q02P$"% ,4    " #1AFU6ZE?_V?P"   _"   &0
M        @(&6P0$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0
M   ( -&&;5:THC,8-P,  ,T+   9              " @<G$ 0!X;"]W;W)K
M<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ T89M5A42R8 5 P  U0L
M !D              ("!-\@! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q0
M2P$"% ,4    " #1AFU6NGZR\/<"   ^"0  &0              @(&#RP$
M>&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( -&&;58TE1V6
MM0(   \'   9              " @;'. 0!X;"]W;W)K<VAE971S+W-H965T
M-S N>&UL4$L! A0#%     @ T89M5A3BV9%N @  8@4  !D
M ("!G=$! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " #1
MAFU67"P@768%  #I'@  &0              @(%"U $ >&PO=V]R:W-H965T
M<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( -&&;59SM=6P)@,  ) )   9
M          " @=_9 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#
M%     @ T89M5K.P/3X,!   OA$  !D              ("!/-T! 'AL+W=O
M<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #1AFU6N8B5#\4"  !
M!P  &0              @(%_X0$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM
M;%!+ 0(4 Q0    ( -&&;5;B>8 K&P,  (\(   9              " @7OD
M 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ T89M5JB<
MU]:Y @  \P8  !D              ("!S><! 'AL+W=O<FMS:&5E=',O<VAE
M970W-RYX;6Q02P$"% ,4    " #1AFU6X;,";)P#  !G#P  &0
M    @(&]Z@$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    (
M -&&;58^BW.EW (   (+   9              " @9#N 0!X;"]W;W)K<VAE
M971S+W-H965T-SDN>&UL4$L! A0#%     @ T89M5J[(L3Q#!P  A3,  !D
M             ("!H_$! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"
M% ,4    " #1AFU6-WV(]DH#  #V%   #0              @ $=^0$ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -&&;5:7BKL<P    !,"   +
M      "  9+\ 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( -&&;5810DRH!P8
M ,8T   /              "  7O] 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " #1AFU6M,4*KF@"  !'+P  &@              @ &O P( >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #1AFU6+ %G.QL"   .
M+@  $P              @ %/!@( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    6 !8 !\8  ";" (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>178</ContextCount>
  <ElementCount>408</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100050 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100060 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100070 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100080 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100090 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusiness1</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Product Revenue, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet</Role>
      <ShortName>Product Revenue, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotes</Role>
      <ShortName>Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Stock Option and Grant Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan</Role>
      <ShortName>Stock Option and Grant Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Product Revenue, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetTables</Role>
      <ShortName>Product Revenue, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Short-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables</Role>
      <ShortName>Short-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Stock Option and Grant Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables</Role>
      <ShortName>Stock Option and Grant Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Nature of Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails</Role>
      <ShortName>Nature of Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Product Revenue, Net - Summary of Gross Product Revenue to Net product Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails</Role>
      <ShortName>Product Revenue, Net - Summary of Gross Product Revenue to Net product Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Short-Term Investments - Schedule of Short-term Investments Classified as Available-for-sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails</Role>
      <ShortName>Short-Term Investments - Schedule of Short-term Investments Classified as Available-for-sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Short-Term Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Short-Term Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Inventories - Summary of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails</Role>
      <ShortName>Inventories - Summary of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Inventories - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails</Role>
      <ShortName>Inventories - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Property and equipment, net - Summary of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and equipment, net - Summary of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Convertible Notes - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails</Role>
      <ShortName>Convertible Notes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Leases- Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases- Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Leases - Summary of Condensed Consolidated Balance Sheet of Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails</Role>
      <ShortName>Leases - Summary of Condensed Consolidated Balance Sheet of Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail</Role>
      <ShortName>Leases - Summary of Future Minimum Lease Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Stockholders' Equity (Deficit) - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Stock Option and Grant Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails</Role>
      <ShortName>Stock Option and Grant Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Stock Option and Grant Plan - Summary of Estimate Fair Value of Stock Option Awards on Grant Date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails</Role>
      <ShortName>Stock Option and Grant Plan - Summary of Estimate Fair Value of Stock Option Awards on Grant Date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Stock Option and Grant Plan - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stock Option and Grant Plan - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Stock Option and Grant Plan - Summary of Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails</Role>
      <ShortName>Stock Option and Grant Plan - Summary of Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Stock Option and Grant Plan - Summary of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock Option and Grant Plan - Summary of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Stock Option and Grant Plan - Summary of Stock-Based Compensation by Type of Award (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails</Role>
      <ShortName>Stock Option and Grant Plan - Summary of Stock-Based Compensation by Type of Award (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Stock Option and Grant Plan - Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails</Role>
      <ShortName>Stock Option and Grant Plan - Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Income Taxes - Components Of Net Loss Before Provision For Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components Of Net Loss Before Provision For Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Income Taxes - Schedule of Provision For Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Provision For Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>100740 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>100750 - Disclosure - Income Taxes - Summary of Significant Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Summary of Significant Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>100760 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails</Role>
      <ShortName>Income Taxes - Summary of Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>100770 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>100780 - Disclosure - Employee Benefit Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails</Role>
      <ShortName>Employee Benefit Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>100790 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>100800 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="amlx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>100810 - Disclosure - Commitment and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitment and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate -  amlx-20221231.htm 8</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="amlx-20221231.htm">amlx-20221231.htm</File>
    <File>amlx-20221231.xsd</File>
    <File>amlx-20221231_cal.xml</File>
    <File>amlx-20221231_def.xml</File>
    <File>amlx-20221231_lab.xml</File>
    <File>amlx-20221231_pre.xml</File>
    <File>amlx-ex10_18.htm</File>
    <File>amlx-ex21_1.htm</File>
    <File>amlx-ex23_1.htm</File>
    <File>amlx-ex31_1.htm</File>
    <File>amlx-ex31_2.htm</File>
    <File>amlx-ex31_3.htm</File>
    <File>amlx-ex32_1.htm</File>
    <File>amlx-ex32_2.htm</File>
    <File>amlx-ex32_3.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img109617586_0.jpg</File>
    <File>img109617586_1.jpg</File>
    <File>img109617586_10.jpg</File>
    <File>img109617586_11.jpg</File>
    <File>img109617586_12.jpg</File>
    <File>img109617586_2.jpg</File>
    <File>img109617586_3.jpg</File>
    <File>img109617586_4.jpg</File>
    <File>img109617586_5.jpg</File>
    <File>img109617586_6.jpg</File>
    <File>img109617586_7.jpg</File>
    <File>img109617586_8.jpg</File>
    <File>img109617586_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="691">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>116
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "amlx-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 691,
    "http://xbrl.sec.gov/dei/2022": 38
   },
   "contextCount": 178,
   "dts": {
    "calculationLink": {
     "local": [
      "amlx-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "amlx-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "amlx-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amlx-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amlx-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amlx-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 638,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 7
   },
   "keyCustom": 71,
   "keyStandard": 337,
   "memberCustom": 25,
   "memberStandard": 41,
   "nsprefix": "amlx",
   "nsuri": "http://www.amylyx.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Product Revenue, Net",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet",
     "shortName": "Product Revenue, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Short-Term Investments",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments",
     "shortName": "Short-Term Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Property and Equipment, Net",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Accrued Expenses",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:ConvertibleNotesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Convertible Notes",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotes",
     "shortName": "Convertible Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:ConvertibleNotesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Redeemable Convertible Preferred Stock",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Stockholders' Equity (Deficit)",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Stock Option and Grant Plan",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan",
     "shortName": "Stock Option and Grant Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Employee Benefit Plans",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Related Party Transactions",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:GrossProductRevnueToNetProductRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Product Revenue, Net (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetTables",
     "shortName": "Product Revenue, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:GrossProductRevnueToNetProductRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Short-Term Investments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables",
     "shortName": "Short-Term Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Property and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Redeemable Convertible Preferred Stock (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Stock Option and Grant Plan (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables",
     "shortName": "Stock Option and Grant Plan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_031b3770-76f9-425a-9800-d1c8d734148f",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Nature of Business - Additional Information (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
     "shortName": "Nature of Business - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "amlx:GrantRevenuePolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromGrantors",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "lang": "en-US",
      "name": "amlx:CashAndCashEquivalentsMaturityDateDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_39eac193-4dc1-4fb2-9a13-3e7cfe206bcc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_39eac193-4dc1-4fb2-9a13-3e7cfe206bcc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "amlx:RevenueFromContractWithCustomerExcludingAssessedTaxGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Product Revenue, Net - Summary of Gross Product Revenue to Net product Revenue (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails",
     "shortName": "Product Revenue, Net - Summary of Gross Product Revenue to Net product Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "amlx:RevenueFromContractWithCustomerExcludingAssessedTaxGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_d897e60a-b2ef-40ae-84bb-e64354962e11",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Short-Term Investments - Schedule of Short-term Investments Classified as Available-for-sale (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails",
     "shortName": "Short-Term Investments - Schedule of Short-term Investments Classified as Available-for-sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_d897e60a-b2ef-40ae-84bb-e64354962e11",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:AvailableForSaleInvestmentsContractualMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Short-Term Investments - Additional Information (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
     "shortName": "Short-Term Investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:AvailableForSaleInvestmentsContractualMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Inventories - Summary of Inventories (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails",
     "shortName": "Inventories - Summary of Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Inventories - Additional Information (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
     "shortName": "Inventories - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Property and equipment, net - Summary of Property and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
     "shortName": "Property and equipment, net - Summary of Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "amlx:AccruedExternalResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
     "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "amlx:AccruedExternalResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_031b3770-76f9-425a-9800-d1c8d734148f",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "amlx:ChangeInFairValueOfConvertibleNotes",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Convertible Notes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
     "shortName": "Convertible Notes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "amlx:ConvertibleNotesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_d5ef4a9b-1f76-4f71-89bf-cf15f2f47db3",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_f4747adc-8a33-4cb0-a970-1b814ab522d7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_02064c71-3a83-4801-8486-d127eb43b8ad",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amlx:TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseDescription",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Leases- Additional Information (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
     "shortName": "Leases- Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Leases - Components of Lease Expense (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Leases - Summary of Condensed Consolidated Balance Sheet of Operating Leases (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails",
     "shortName": "Leases - Summary of Condensed Consolidated Balance Sheet of Operating Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Detail)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail",
     "shortName": "Leases - Summary of Future Minimum Lease Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_031b3770-76f9-425a-9800-d1c8d734148f",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DividendsPreferredStockCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_70137d1c-ebe4-41cf-9891-6c732ce3bf02",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_553959d9-0a46-4ddf-909a-9d7b7705481a",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:TemporaryEquityLiquidationPreference",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "amlx:CommonStockNumberOfVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Stockholders' Equity (Deficit) - Additional Information (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
     "shortName": "Stockholders' Equity (Deficit) - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "amlx:CommonStockNumberOfVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Vote",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "amlx:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "INF",
      "lang": null,
      "name": "amlx:CommonStockSharesIssuedAndOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Stock Option and Grant Plan - Additional Information (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails",
     "shortName": "Stock Option and Grant Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Stock Option and Grant Plan - Summary of Estimate Fair Value of Stock Option Awards on Grant Date (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails",
     "shortName": "Stock Option and Grant Plan - Summary of Estimate Fair Value of Stock Option Awards on Grant Date (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Stock Option and Grant Plan - Summary of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails",
     "shortName": "Stock Option and Grant Plan - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_81aa5a36-a608-4d01-ab23-6149905204c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Stock Option and Grant Plan - Summary of Restricted Stock Unit Activity (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
     "shortName": "Stock Option and Grant Plan - Summary of Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_53d17c7f-1169-43e5-8ae2-8fad7891e10d",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Stock Option and Grant Plan - Summary of Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails",
     "shortName": "Stock Option and Grant Plan - Summary of Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_a6f624b0-506d-4092-ac12-59f88d4944f4",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Stock Option and Grant Plan - Summary of Stock-Based Compensation by Type of Award (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
     "shortName": "Stock Option and Grant Plan - Summary of Stock-Based Compensation by Type of Award (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_c32475bb-ba9c-415b-a298-afa0b3f8ef62",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "amlx:SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_c9061aa3-fdfb-412c-afec-524e4df56961",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Stock Option and Grant Plan - Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
     "shortName": "Stock Option and Grant Plan - Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "amlx:SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_c9061aa3-fdfb-412c-afec-524e4df56961",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_f1634ec1-ce4f-4cee-8af6-bc2fab85ea4b",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Income Taxes - Components Of Net Loss Before Provision For Income Taxes (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails",
     "shortName": "Income Taxes - Components Of Net Loss Before Provision For Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100720 - Disclosure - Income Taxes - Schedule of Provision For Income Taxes (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Provision For Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100730 - Disclosure - Income Taxes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:TaxCreditCarryforwardDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100740 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails",
     "shortName": "Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100750 - Disclosure - Income Taxes - Summary of Significant Components of Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes - Summary of Significant Components of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100760 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails",
     "shortName": "Income Taxes - Summary of Valuation Allowance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_678b6484-4368-49d8-8272-6da1055ccb1c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100770 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0e6f9a41-1e4c-4d18-8f0a-b0aaa1740958",
      "decimals": "-3",
      "lang": null,
      "name": "amlx:UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100780 - Disclosure - Employee Benefit Plans - Additional Information (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails",
     "shortName": "Employee Benefit Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_53ebdae0-8ae2-4cbc-b1b4-a91c54144be1",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100790 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "amlx:ConvertibleNotesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_a5e6d38c-8475-48a3-bf13-4ce677a7e92c",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConvertibleDebt",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100800 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_3ebd36ac-5798-4f88-97b9-7e44c07d4319",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100090 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseDescription",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100810 - Disclosure - Commitment and Contingencies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitment and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_0b327429-7b70-49b6-86e4-f2ad018fde8a",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Nature of Business",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusiness1",
     "shortName": "Nature of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "amlx-20221231.htm",
      "contextRef": "C_2a15f4cd-3251-4bce-9c79-87754008eaad",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 73,
   "tag": {
    "amlx_ALSAssociationAndALSFindingCureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALS Association and ALS Finding a Cure.",
        "label": "A L S Association And A L S Finding Cure [Member]",
        "terseLabel": "ALS Association and ALS Finding a Cure"
       }
      }
     },
     "localname": "ALSAssociationAndALSFindingCureMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_AccruedConsultingAndOtherProfessionalFess": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued consulting and other professional fess.",
        "label": "Accrued Consulting And Other Professional Fess",
        "terseLabel": "Accrued consulting and other professional fees"
       }
      }
     },
     "localname": "AccruedConsultingAndOtherProfessionalFess",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_AccruedExternalResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued external research and development.",
        "label": "Accrued External Research And Development Current",
        "terseLabel": "External research and development"
       }
      }
     },
     "localname": "AccruedExternalResearchAndDevelopmentCurrent",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_AccruedManufacturing": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued manufacturing.",
        "label": "Accrued Manufacturing",
        "terseLabel": "Manufacturing"
       }
      }
     },
     "localname": "AccruedManufacturing",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_AgencyBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency bonds.",
        "label": "Agency Bonds [Member]",
        "terseLabel": "Agency Bonds"
       }
      }
     },
     "localname": "AgencyBondsMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alzheimers Drug Discovery Foundation, Alzheimers Association, and Cure Alzheimers Fund.",
        "label": "Alzheimers Drug Discovery Foundation Alzheimers Association And Cure Alzheimers Fund [Member]",
        "terseLabel": "Alzheimer's Drug Discovery Foundation, the Alzheimer's Association, and Cure Alzheimer's Fund"
       }
      }
     },
     "localname": "AlzheimersDrugDiscoveryFoundationAlzheimersAssociationAndCureAlzheimersFundMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_AmortizationRecognizedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization recognized period.",
        "label": "Amortization Recognized Period",
        "terseLabel": "Amortization period recognized"
       }
      }
     },
     "localname": "AmortizationRecognizedPeriod",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amlx_AvailableForSaleInvestmentsContractualMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available-for-sale investments contractual maturity period.",
        "label": "Available For Sale Investments Contractual Maturity Period",
        "terseLabel": "Available-for-sale investments contractual maturity period"
       }
      }
     },
     "localname": "AvailableForSaleInvestmentsContractualMaturityPeriod",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amlx_CashAndCashEquivalentsMaturityDateDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents maturity date description.",
        "label": "Cash And Cash Equivalents Maturity Date Description",
        "terseLabel": "Maturity days for highly liquid investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMaturityDateDescription",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amlx_ChangeInFairValueOfConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of convertible notes.",
        "label": "Change In Fair Value Of Convertible Notes",
        "negatedLabel": "Change in fair value of convertible notes",
        "terseLabel": "Change in fair value of Measurement dates",
        "verboseLabel": "Change in fair value of convertible notes"
       }
      }
     },
     "localname": "ChangeInFairValueOfConvertibleNotes",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amlx_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amlx_CommonStockAuthorizedAndReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock authorized and reserved for future issuance.",
        "label": "Common Stock Authorized And Reserved For Future Issuance",
        "terseLabel": "Total common stock authorized and reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockAuthorizedAndReservedForFutureIssuance",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "amlx_CommonStockNumberOfVotingRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock number of voting rights.",
        "label": "Common Stock Number Of Voting Rights",
        "terseLabel": "Voting rights"
       }
      }
     },
     "localname": "CommonStockNumberOfVotingRights",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amlx_CommonStockSharesIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued and outstanding.",
        "label": "Common Stock Shares Issued And Outstanding",
        "terseLabel": "Common stock issued and outstanding"
       }
      }
     },
     "localname": "CommonStockSharesIssuedAndOutstanding",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "amlx_ComputerHardwareAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer hardware and software",
        "label": "Computer Hardware And Software [Member]",
        "terseLabel": "Computer Hardware and Software"
       }
      }
     },
     "localname": "ComputerHardwareAndSoftwareMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of convertible notes and accrued interest into redeemable convertible preferred stock.",
        "label": "Conversion Of Convertible Notes And Accrued Interest Into Redeemable Convertible Preferred Stock",
        "terseLabel": "Conversion of convertible notes and accrued interest into redeemable convertible preferred stock"
       }
      }
     },
     "localname": "ConversionOfConvertibleNotesAndAccruedInterestIntoRedeemableConvertiblePreferredStock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_ConversionOfPreferredStockToCommonStockUponInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of preferred stock to common stock upon initial public offering.",
        "label": "Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering",
        "terseLabel": "Conversion of preferred stock to common stock upon initial public offering"
       }
      }
     },
     "localname": "ConversionOfPreferredStockToCommonStockUponInitialPublicOffering",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible note beneficial conversion feature policy.",
        "label": "Convertible Note Beneficial Conversion Feature Policy [Policy Text Block]",
        "terseLabel": "Convertible Note - Beneficial Conversion Feature"
       }
      }
     },
     "localname": "ConvertibleNoteBeneficialConversionFeaturePolicyPolicyTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_ConvertibleNoteDerivativePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Note Derivative Policy.",
        "label": "Convertible Note Derivative Policy [Policy Text Block]",
        "terseLabel": "Convertible Note - Derivative"
       }
      }
     },
     "localname": "ConvertibleNoteDerivativePolicyPolicyTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_ConvertibleNotesSettlementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible notes settlement date.",
        "label": "Convertible Notes Settlement Date",
        "terseLabel": "Convertible notes settlement date"
       }
      }
     },
     "localname": "ConvertibleNotesSettlementDate",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "amlx_ConvertibleNotesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible notes.",
        "label": "Convertible Notes [Text Block]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One.",
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer two.",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer Two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_DeferredOfferingCostNetOfEquityFinancing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering cost net of equity financing.",
        "label": "Deferred Offering Cost Net Of Equity Financing",
        "terseLabel": "Deferred offering cost net of equity financing"
       }
      }
     },
     "localname": "DeferredOfferingCostNetOfEquityFinancing",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs included in accounts payable and accrued expenses.",
        "label": "Deferred Offering Costs Included In Accounts Payable And Accrued Expenses",
        "terseLabel": "Deferred offering costs included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets capitalized research and development costs.",
        "label": "Deferred tax assets capitalized research and development costs",
        "terseLabel": "Capitalized research and development costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_DilutedCapitalDividend": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diluted capital dividend.",
        "label": "Diluted Capital Dividend",
        "terseLabel": "Diluted capital dividend"
       }
      }
     },
     "localname": "DilutedCapitalDividend",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_EmergingGrowthCompanyStatusPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Growth Company Status Policy.",
        "label": "Emerging Growth Company Status Policy [Policy Text Block]",
        "terseLabel": "Emerging Growth Company Status"
       }
      }
     },
     "localname": "EmergingGrowthCompanyStatusPolicyPolicyTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_FinishedGoodsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finished goods.",
        "label": "Finished Goods [Member]",
        "terseLabel": "Finished Goods"
       }
      }
     },
     "localname": "FinishedGoodsMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on offering costs included in accounts payable and accrued expenses.",
        "label": "Follow On Offering Costs Included In Accounts Payable and Accrued Expenses",
        "terseLabel": "Follow-on offering costs included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "FollowOnOfferingCostsIncludedInAccountsPayableAndAccruedExpenses",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_FollowOnOfferingCostsPaid": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on offering costs paid.",
        "label": "Follow On Offering Costs Paid",
        "negatedLabel": "Follow-on offering costs paid"
       }
      }
     },
     "localname": "FollowOnOfferingCostsPaid",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_FollowOnOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on offering.",
        "label": "Follow on Offering [Member]",
        "terseLabel": "Follow-on Offering"
       }
      }
     },
     "localname": "FollowOnOfferingMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_GainContingencyRecordedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain contingency recorded amount.",
        "label": "Gain Contingency Recorded Amount",
        "terseLabel": "Gain contingency"
       }
      }
     },
     "localname": "GainContingencyRecordedAmount",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_GrantRevenuePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant revenue policy.",
        "label": "Grant Revenue Policy [Policy Text Block]",
        "terseLabel": "Grant Revenue"
       }
      }
     },
     "localname": "GrantRevenuePolicyPolicyTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_GrossProductRevnueToNetProductRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross product revenue to net product revenue.",
        "label": "Gross Product Revnue To Net Product Revenue [Table Text Block]",
        "terseLabel": "Summary of Gross Product Revenue to Net Product Revenue"
       }
      }
     },
     "localname": "GrossProductRevnueToNetProductRevenueTableTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_GrossToNetAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to net adjustments.",
        "label": "Gross to Net Adjustments",
        "terseLabel": "GTN adjustments"
       }
      }
     },
     "localname": "GrossToNetAdjustments",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_IncentiveStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive stock options.",
        "label": "Incentive Stock Options [Member]",
        "terseLabel": "ISOs"
       }
      }
     },
     "localname": "IncentiveStockOptionsMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax disclosure.",
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amlx_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax disclosure.",
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amlx_IncreaseDecreaseInAccruedExpensesAndDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and deferred rent.",
        "label": "Increase Decrease In Accrued Expenses And Deferred Rent",
        "terseLabel": "Accrued expenses and deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpensesAndDeferredRent",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_IncreaseDecreaseInAccruedInterestsDuetoRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in accrued Interests due to related parties.",
        "label": "Increase Decrease In Accrued Interests DueTo Related Parties",
        "terseLabel": "Accrued interest and accrued interest-related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestsDuetoRelatedParties",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease right-of-use assets.",
        "label": "Increase Decrease In Operating Lease Right Of Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_IncrementalCostsExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental costs expenses.",
        "label": "Incremental Costs Expenses",
        "terseLabel": "Incremental costs expenses"
       }
      }
     },
     "localname": "IncrementalCostsExpenses",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_InitialPublicOfferingCostPaid": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial public offering cost paid.",
        "label": "Initial Public Offering Cost Paid",
        "negatedLabel": "Initial public offering costs paid",
        "terseLabel": "Initial public offering costs paid"
       }
      }
     },
     "localname": "InitialPublicOfferingCostPaid",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_IssuanceCostsRelatedToConversionOfConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance costs related to conversion of convertible notes.",
        "label": "Issuance Costs Related To Conversion Of Convertible Notes",
        "negatedTerseLabel": "Issuance costs related to conversion of convertible notes",
        "terseLabel": "Issuance costs related to conversion of convertible notes"
       }
      }
     },
     "localname": "IssuanceCostsRelatedToConversionOfConvertibleNotes",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance costs related to issuance of Series redeemable convertible preferred stock.",
        "label": "Issuance Costs Related To Issuance Of Series Redeemable Convertible Preferred Stock",
        "negatedLabel": "Issuance costs related to issuance of Series C-1 redeemable convertible preferred stock",
        "terseLabel": "Issuance costs related to issuance of Series C-1 redeemable convertible preferred stock"
       }
      }
     },
     "localname": "IssuanceCostsRelatedToIssuanceOfSeriesRedeemableConvertiblePreferredStock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_LongTermRawMaterialsNotYetRealized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term raw materials not yet realized.",
        "label": "Long Term Raw Materials Not Yet Realized",
        "terseLabel": "Long term raw materials not yet realized"
       }
      }
     },
     "localname": "LongTermRawMaterialsNotYetRealized",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum royalty guarantees commitments amount payable to each grantor.",
        "label": "Maximum Royalty Guarantees Commitments Amount Payable To Each Grantor",
        "terseLabel": "Maximum Royalty amount payable to each grantor"
       }
      }
     },
     "localname": "MaximumRoyaltyGuaranteesCommitmentsAmountPayableToEachGrantor",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_MorningsideVenturesInvestmentsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Morningside ventures investments limited.",
        "label": "Morningside Ventures Investments Limited [Member]",
        "terseLabel": "Morningside Ventures Investments Limited"
       }
      }
     },
     "localname": "MorningsideVenturesInvestmentsLimitedMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_MovementOfDeferredOfferingCostsToEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movement of deferred offering costs to equity.",
        "label": "Movement of Deferred Offering Costs To Equity",
        "terseLabel": "Movement of deferred offering costs to equity"
       }
      }
     },
     "localname": "MovementOfDeferredOfferingCostsToEquity",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New accounting pronouncements not yet adopted policy.",
        "label": "New Accounting Pronouncements Not Yet Adopted Policy Policy [Text Block]",
        "terseLabel": "New Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_NonCumulativeDividendsPerShareEntitledToReceive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cumulative dividends per share entitled to receive.",
        "label": "Non Cumulative Dividends Per Share Entitled To Receive",
        "terseLabel": "Non-cumulative Dividends per share entitled to receive"
       }
      }
     },
     "localname": "NonCumulativeDividendsPerShareEntitledToReceive",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "amlx_NonemployeeDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonemployee director.",
        "label": "Nonemployee Director [Member]",
        "terseLabel": "Nonemployee Director"
       }
      }
     },
     "localname": "NonemployeeDirectorMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_NumberOfCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers.",
        "label": "Number Of Customers"
       }
      }
     },
     "localname": "NumberOfCustomers",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amlx_NumberOfOperatingLeaseAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating lease agreements.",
        "label": "Number of Operating Lease Agreements",
        "terseLabel": "Number of operating lease agreements"
       }
      }
     },
     "localname": "NumberOfOperatingLeaseAgreements",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amlx_OperatingLeaseWeightedAverageIncrementalBorrowingRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease weighted average incremental borrowing rate.",
        "label": "Operating Lease Weighted Average Incremental Borrowing Rate",
        "terseLabel": "Weighted average incremental borrowing rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageIncrementalBorrowingRate",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_OperatingLossCarryforwardsExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards, expiration period.",
        "label": "Operating Loss Carryforwards, Expiration Period",
        "terseLabel": "Operating loss carryforwards, expiration period"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationPeriod",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "amlx_PatentRelatedCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent Related Costs Policy.",
        "label": "Patent Related Costs Policy [Policy Text Block]",
        "terseLabel": "Patent-Related Costs"
       }
      }
     },
     "localname": "PatentRelatedCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_PaymentOfDeferredOfferingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of deferred offering costs.",
        "label": "Payment Of Deferred Offering Costs",
        "negatedTerseLabel": "Payment of deferred offering costs"
       }
      }
     },
     "localname": "PaymentOfDeferredOfferingCosts",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_PercentageOfIncreaseInCommonStockReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in common stock reserved for issuance.",
        "label": "Percentage Of Increase In Common Stock Reserved For Issuance",
        "terseLabel": "Percentage of increase in common stock reserved for issuance"
       }
      }
     },
     "localname": "PercentageOfIncreaseInCommonStockReservedForIssuance",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_PercentageOfNonCumulativeDividendsEntitledToReceive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of non-cumulative dividends entitled to receive.",
        "label": "Percentage Of Non Cumulative Dividends Entitled To Receive",
        "terseLabel": "Percentage of non-cumulative dividends entitled to receive"
       }
      }
     },
     "localname": "PercentageOfNonCumulativeDividendsEntitledToReceive",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_PercentageOfPriceOfferedToEachShareOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of price offered to each share of common stock.",
        "label": "Percentage Of Price Offered To Each Share Of Common Stock",
        "terseLabel": "Percentage of price offered to each share of common stock"
       }
      }
     },
     "localname": "PercentageOfPriceOfferedToEachShareOfCommonStock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "amlx_PercentageOfVotingSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting securities.",
        "label": "Percentage Of Voting Securities",
        "terseLabel": "Percentage of voting securities"
       }
      }
     },
     "localname": "PercentageOfVotingSecurities",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_ProceedsFromFollowOnOffering": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from follow-on offering.",
        "label": "Proceeds From Follow On Offering",
        "terseLabel": "Proceeds from follow-on offering"
       }
      }
     },
     "localname": "ProceedsFromFollowOnOffering",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_ProceedsFromIssuanceOfConvertibleNotesRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of convertible notes, related parties.",
        "label": "Proceeds From Issuance Of Convertible Notes Related Parties",
        "terseLabel": "Proceeds from issuance of convertible notes\u2014related parties"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertibleNotesRelatedParties",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from repayments of paycheck protection program loan.",
        "label": "Proceeds From Repayments Of Paycheck Protection Program Loan",
        "terseLabel": "Repayment and proceeds from PPP loan"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfPaycheckProtectionProgramLoan",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_ProceedsFromUnderwrittenPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from underwritten public offering.",
        "label": "Proceeds From Underwritten Public Offering",
        "terseLabel": "Proceeds from underwritten public offering net of underwriting discount and commissions"
       }
      }
     },
     "localname": "ProceedsFromUnderwrittenPublicOffering",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of property and equipment included in accounts payable.",
        "label": "Purchases of property and equipment included in accounts payable",
        "terseLabel": "Purchases of property and equipment included in accounts payable"
       }
      }
     },
     "localname": "PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_RebatesAndOtherGrossToNetAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebates and other gross to net adjustments.",
        "label": "Rebates and Other Gross To Net adjustments",
        "terseLabel": "Rebates and other GTN adjustments"
       }
      }
     },
     "localname": "RebatesAndOtherGrossToNetAdjustments",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_RestrictedCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash equivalents.",
        "label": "Restricted Cash equivalents [Member]",
        "terseLabel": "Restricted Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_RestrictedCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash.",
        "label": "Restricted Cash [Member]",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_RevenueFromContractWithCustomerExcludingAssessedTaxGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from contract with customer, excluding assessed tax, gross",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax, Gross",
        "terseLabel": "Product revenue, gross"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTaxGross",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_RightOfUseAssetsAndLiabilitiesUponAsc842Adoption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right of use assets and liabilities upon ASC 842 adoption.",
        "label": "Right Of Use Assets And Liabilities Upon ASC 842 Adoption",
        "terseLabel": "Right-of-use assets and liabilities upon ASC842 adoption"
       }
      }
     },
     "localname": "RightOfUseAssetsAndLiabilitiesUponAsc842Adoption",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty guarantees commitments annual installment payment, percentage of net sales of products developed under project.",
        "label": "Royalty Guarantees Commitments Annual Installment Payment Percentage Of Net Sales Of Products Developed Under Project",
        "terseLabel": "Percentage of net sales of products developed under projects"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsAnnualInstallmentPaymentPercentageOfNetSalesOfProductsDevelopedUnderProject",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty guarantees commitments, percentage of all royalties and cash proceeds from revenue generating transaction associated with project.",
        "label": "Royalty Guarantees Commitments Percentage Of All Royalties And Cash Proceeds From Revenue Generating Transaction Associated With Project",
        "terseLabel": "Percentage of all royalties and cash proceeds from revenue generating transaction"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercentageOfAllRoyaltiesAndCashProceedsFromRevenueGeneratingTransactionAssociatedWithProject",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty guarantees commitments percentage of annual net sales of products commercialized from project.",
        "label": "Royalty Guarantees Commitments Percentage Of Annual Net Sales Of Products Commercialized From Project",
        "terseLabel": "Percentage of annual net sales of products commercialized from project"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercentageOfAnnualNetSalesOfProductsCommercializedFromProject",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty guarantees commitments, percentage of cash proceeds from revenue generating transaction under project.",
        "label": "Royalty Guarantees Commitments Percentage Of Cash Proceeds From Revenue Generating Transaction Under Project",
        "terseLabel": "Percentage of cash proceeds from revenue generating transaction"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercentageOfCashProceedsFromRevenueGeneratingTransactionUnderProject",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty guarantees commitments percentage of grant received payable to each guarantor.",
        "label": "Royalty Guarantees Commitments Percentage Of Grant Received Payable To Each Guarantor",
        "terseLabel": "Percentage of grant received"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsPercentageOfGrantReceivedPayableToEachGuarantor",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "amlx_RoyaltyPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty payable.",
        "label": "Royalty Payable",
        "terseLabel": "Royalty payable"
       }
      }
     },
     "localname": "RoyaltyPayable",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_SalesAndMarketingCostsPolicyPolicyTextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales and marketing costs.",
        "label": "Sales And Marketing Costs Policy [Policy Text Block]",
        "terseLabel": "Sales and Marketing Costs"
       }
      }
     },
     "localname": "SalesAndMarketingCostsPolicyPolicyTextblock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of common stock reserved for future issuance.",
        "label": "Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]",
        "terseLabel": "Schedule of common stock reserved for future issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of estimated useful lives of property and equipment.",
        "label": "Schedule of Estimated Useful Lives of Property and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Estimated Useful Lives of Property and Equipment"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_SeriesARedeemableConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A redeemable convertible preferred share.",
        "label": "Series A Redeemable Convertible Preferred Shares [Member]",
        "terseLabel": "Series A Redeemable Convertible Preferred Share",
        "verboseLabel": "Series A Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesARedeemableConvertiblePreferredSharesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_SeriesBRedeemableConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B redeemable convertible preferred shares.",
        "label": "Series B Redeemable Convertible Preferred Shares [Member]",
        "terseLabel": "Series B Redeemable Convertible Preferred Shares",
        "verboseLabel": "Series B Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBRedeemableConvertiblePreferredSharesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_SeriesC1RedeemableConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C-1 redeemable convertible preferred shares.",
        "label": "Series C1 Redeemable Convertible Preferred Shares [Member]",
        "terseLabel": "Series C-1 Redeemable Convertible Preferred Shares",
        "verboseLabel": "Series C-1 Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesC1RedeemableConvertiblePreferredSharesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_SeriesC2RedeemableConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C-2 redeemable convertible preferred shares.",
        "label": "Series C2 Redeemable Convertible Preferred Shares [Member]",
        "terseLabel": "Series C-2 Redeemable Convertible Preferred Shares",
        "verboseLabel": "Series C-2 Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesC2RedeemableConvertiblePreferredSharesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award options unvested intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Options unvested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedIntrinsicValue",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award options unvested weighted average remaining contractual term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years), Options unvested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "amlx_SpecialPurposeAcquisitionCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special purpose acquisition corp.",
        "label": "Special Purpose acquisition Corp [Member]",
        "terseLabel": "Special Purpose acquisition Corp"
       }
      }
     },
     "localname": "SpecialPurposeAcquisitionCorpMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of unrecognized stock-based compensation expense and weighted-average recognition period.",
        "label": "Summary Of Unrecognized Stock Based Compensation Expense And Weighted Average Recognition Period Table [Text Block]",
        "terseLabel": "Summary of Unrecognized Stock-Based Compensation Expense and Weighted-Average Recognition Period"
       }
      }
     },
     "localname": "SummaryOfUnrecognizedStockBasedCompensationExpenseAndWeightedAverageRecognitionPeriodTableTextBlock",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amlx_TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity shares conversion of preferred stock into common stock upon initial public offering.",
        "label": "Temporary Equity Shares Conversion Of Preferred Stock Into Common Stock Upon Initial Public Offering",
        "negatedLabel": "Conversion of preferred stock into common stock upon initial public offering, Shares",
        "terseLabel": "Conversion of preferred stock into common stock upon initial public offering, Shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "amlx_TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity values conversion of preferred stock into common stock upon initial public offering.",
        "label": "Temporary Equity Values Conversion Of Preferred Stock Into Common Stock Upon Initial Public Offering",
        "negatedLabel": "Conversion of preferred stock into common stock upon initial public offering",
        "terseLabel": "Temporary Equity Conversion of preferred stock into common stock upon initial public offering",
        "verboseLabel": "Conversion of preferred stock into common stock upon initial public offering"
       }
      }
     },
     "localname": "TemporaryEquityValuesConversionOfPreferredStockIntoCommonStockUponInitialPublicOffering",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer of levels of investment securities fair value assets description.",
        "label": "Transfer Of Levels Of Investment Securities Fair Value Assets Description",
        "terseLabel": "Description of investment securities transferred between classification levels"
       }
      }
     },
     "localname": "TransferOfLevelsOfInvestmentSecuritiesFairValueAssetsDescription",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "amlx_TwoThousandFifteenStockOptionAndRestrictedStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fifteen stock option and restricted stock plan.",
        "label": "Two Thousand Fifteen Stock Option And Restricted Stock Plan [Member]",
        "terseLabel": "2015 Plan"
       }
      }
     },
     "localname": "TwoThousandFifteenStockOptionAndRestrictedStockPlanMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty one notes in December two thousand twenty.",
        "label": "Two Thousand Twenty One Notes In December Two Thousand Twenty [Member]",
        "terseLabel": "2021 Notes in December 2020"
       }
      }
     },
     "localname": "TwoThousandTwentyOneNotesInDecemberTwoThousandTwentyMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty One Notes in January and February Two Thousand Twenty One.",
        "label": "Two Thousand Twenty One Notes In January And February Two Thousand Twenty One [Member]",
        "terseLabel": "2021 Notes in January and February 2021"
       }
      }
     },
     "localname": "TwoThousandTwentyOneNotesInJanuaryAndFebruaryTwoThousandTwentyOneMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_TwoThousandTwentyOneNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty one notes.",
        "label": "Two Thousand Twenty One Notes [Member]",
        "terseLabel": "2021 Notes"
       }
      }
     },
     "localname": "TwoThousandTwentyOneNotesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_TwoThousandTwentyTwoStockOptionAndIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty two stock option and incentive plan.",
        "label": "Two Thousand Twenty Two Stock Option And Incentive Plan [Member]",
        "terseLabel": "2022 Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoStockOptionAndIncentivePlanMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_TwoZeroOneSevenNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two zero one seven notes.",
        "label": "Two Zero One Seven Notes [Member]",
        "terseLabel": "2017 Notes"
       }
      }
     },
     "localname": "TwoZeroOneSevenNotesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_TwoZeroTwoOneNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two zero two one notes.",
        "label": "Two Zero Two One Notes [Member]",
        "terseLabel": "2021 Notes"
       }
      }
     },
     "localname": "TwoZeroTwoOneNotesMember",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amlx_UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits increase decrease resulting from prior period tax positions",
        "label": "Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions",
        "terseLabel": "Increases (decreases) related to tax positions taken during prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits, related to tax credit carryforwards",
        "label": "Unrecognized tax benefits, related to tax credit carryforwards"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsRelatedToTaxCreditCarryforwards",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amlx_UnreservedCommonStockAvailableForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unreserved common stock available for future issuance.",
        "label": "Unreserved Common Stock Available For Future Issuance",
        "terseLabel": "Unreserved common stock available for future issuance"
       }
      }
     },
     "localname": "UnreservedCommonStockAvailableForFutureIssuance",
     "nsuri": "http://www.amylyx.com/20221231",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r724",
      "r725",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r237",
      "r238",
      "r354",
      "r371",
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Board of Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r303",
      "r705",
      "r780",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r418",
      "r603",
      "r632",
      "r680",
      "r681",
      "r702",
      "r709",
      "r718",
      "r778",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r418",
      "r603",
      "r632",
      "r680",
      "r681",
      "r702",
      "r709",
      "r718",
      "r778",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r303",
      "r705",
      "r780",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r399",
      "r418",
      "r446",
      "r447",
      "r448",
      "r579",
      "r603",
      "r632",
      "r680",
      "r681",
      "r702",
      "r709",
      "r718",
      "r773",
      "r778",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r341",
      "r399",
      "r418",
      "r446",
      "r447",
      "r448",
      "r579",
      "r603",
      "r632",
      "r680",
      "r681",
      "r702",
      "r709",
      "r718",
      "r773",
      "r778",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r237",
      "r238",
      "r354",
      "r371",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r301",
      "r302",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r704",
      "r717",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r301",
      "r302",
      "r661",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r704",
      "r717",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r759",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "Massachusetts"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201811Member": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-11 Leases (Topic 842): Targeted Improvements.",
        "label": "Accounting Standards Update 2018-11 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201811Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r18",
      "r716"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r304",
      "r305"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization (accretion) of investment premiums (discounts)"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities and Other Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r88",
      "r204"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "terseLabel": "Less: accumulated depreciation",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r33",
      "r34",
      "r210",
      "r628",
      "r640",
      "r644"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r31",
      "r34",
      "r139",
      "r564",
      "r635",
      "r636",
      "r742",
      "r743",
      "r744",
      "r753",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r753",
      "r754",
      "r755",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r244",
      "r245",
      "r246",
      "r247",
      "r256",
      "r306",
      "r307",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r456",
      "r457",
      "r458",
      "r478",
      "r479",
      "r480",
      "r481",
      "r492",
      "r493",
      "r494",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r546",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r606",
      "r607",
      "r608",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r119",
      "r120",
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total excluded common stock equivalents"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r55",
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges",
        "totalLabel": "Asset Impairment Charges, Total"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r156",
      "r174",
      "r206",
      "r233",
      "r285",
      "r294",
      "r298",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r496",
      "r500",
      "r523",
      "r716",
      "r776",
      "r777",
      "r886"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r199",
      "r213",
      "r233",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r496",
      "r500",
      "r523",
      "r716",
      "r776",
      "r777",
      "r886"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value",
        "totalLabel": "Assets, Fair Value Disclosure, Total",
        "verboseLabel": "Short term investments held"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Loss",
        "terseLabel": "Unrealized loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r309",
      "r327"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost Basis"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r73",
      "r308",
      "r327",
      "r622"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Debt Securities, Available-for-sale, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Voting percentage",
        "verboseLabel": "Percentage of voting securities"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r57",
      "r202",
      "r683"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r58",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash",
        "verboseLabel": "Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r50",
      "r57",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash equivalents, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash equivalents, beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r148"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.",
        "label": "Type of Borrower [Axis]"
       }
      }
     },
     "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of entity or individual who borrows funds.",
        "label": "Class of Financing Receivable, Type of Borrower [Domain]"
       }
      }
     },
     "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r233",
      "r259",
      "r260",
      "r262",
      "r264",
      "r272",
      "r273",
      "r315",
      "r342",
      "r344",
      "r345",
      "r346",
      "r349",
      "r350",
      "r368",
      "r369",
      "r373",
      "r377",
      "r385",
      "r523",
      "r682",
      "r731",
      "r749",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralizedCreditCardSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a pool of credit card receivables.",
        "label": "Collateralized Credit Card Securities [Member]",
        "terseLabel": "Collateral for Corporate Credit Card Program"
       }
      }
     },
     "localname": "CollateralizedCreditCardSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollateralizedDebtObligationsMember": {
     "auth_ref": [
      "r72",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a pool of assets.",
        "label": "Collateralized Debt Obligations [Member]",
        "terseLabel": "Collateral for Letter of Credit Issued"
       }
      }
     },
     "localname": "CollateralizedDebtObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper",
        "verboseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r26",
      "r163",
      "r181"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 18)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r336",
      "r337",
      "r666",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r94",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock available for issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r753",
      "r754",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, stated par value per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Common stock authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares, issued",
        "totalLabel": "Common Stock, Shares, Issued, Total",
        "verboseLabel": "Number of common stock for sale in underwritten public offering"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "terseLabel": "Common stock, shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r9",
      "r716"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value; 300,000,000 and 56,500,000 shares authorized as of December 31, 2022 and 2021, respectively; 66,512,011 and 7,020,487 shares issued and outstanding as of December 31, 2022 and 2021, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r36",
      "r218",
      "r220",
      "r226",
      "r623",
      "r629"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r66",
      "r67",
      "r146",
      "r147",
      "r303",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r66",
      "r67",
      "r146",
      "r147",
      "r303",
      "r645",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r66",
      "r67",
      "r146",
      "r147",
      "r303",
      "r665",
      "r899"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r171",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r66",
      "r67",
      "r146",
      "r147",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Customers accounted for more than 10%"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r66",
      "r67",
      "r146",
      "r147",
      "r303",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction In progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r4",
      "r159",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "terseLabel": "Convertible debt outstanding",
        "totalLabel": "Convertible Debt, Total"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Change in fair value of convertible notes"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r4",
      "r159",
      "r176",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Convertible notes payable to related party",
        "totalLabel": "Convertible Notes Payable, Total"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r7",
      "r8",
      "r101",
      "r104",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Additional common stock issued to holders of redeemable convertible preferred stock",
        "verboseLabel": "Common Stock Issuable Upon Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r706",
      "r708",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r40",
      "r605"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales",
        "totalLabel": "Cost of Goods and Services Sold, Total"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r752",
      "r873",
      "r874"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "U.S. - Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r752",
      "r873"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r476",
      "r484",
      "r752"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Provision for income taxes",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r752",
      "r873",
      "r874"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "U.S. - State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r65",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r157",
      "r159",
      "r172",
      "r239",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r541",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentDescription": {
     "auth_ref": [
      "r2",
      "r4",
      "r101",
      "r157",
      "r159",
      "r169",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.",
        "label": "Debt Instrument, Description",
        "terseLabel": "Debt instrument, description"
       }
      }
     },
     "localname": "DebtInstrumentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r150",
      "r151",
      "r351",
      "r541",
      "r698",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate convertible notes issued"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r23",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Notes secured and carried interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentIssuanceDate1": {
     "auth_ref": [
      "r24",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt instrument was issued, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Issuance Date",
        "terseLabel": "Debt instrument, inception date"
       }
      }
     },
     "localname": "DebtInstrumentIssuanceDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r214",
      "r697",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Notes mature date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r25",
      "r239",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r541",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r25",
      "r101",
      "r105",
      "r106",
      "r107",
      "r149",
      "r150",
      "r151",
      "r170",
      "r239",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r541",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Realized gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Realized loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Short-term Investments Classified as Available-for-sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r772"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRentCreditNoncurrent": {
     "auth_ref": [
      "r189",
      "r733",
      "r883"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of rental payment required by lease over rental income recognized, classified as noncurrent.",
        "label": "Deferred Rent Credit, Noncurrent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "DeferredRentCreditNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r132",
      "r872"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r871"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r132",
      "r872"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r132",
      "r872"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r132",
      "r872"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r130",
      "r132",
      "r872"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r132",
      "r872"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Accruals and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "periodEndLabel": "Valuation allowance at end of year",
        "periodStartLabel": "Valuation allowance at beginning of year"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r124",
      "r871"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "totalLabel": "Total deferred tax liabilities",
        "verboseLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Contribution Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Amount of contribution made by the company"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer contribution percentage of employee compensation to employees"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanTable": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan [Table]"
       }
      }
     },
     "localname": "DefinedContributionPlanTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r55",
      "r86"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "totalLabel": "Depreciation, Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r423",
      "r452",
      "r453",
      "r455",
      "r459",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Option and Grant Plan"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r108",
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "terseLabel": "Dividends paid",
        "totalLabel": "Dividends, Total"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r3",
      "r5",
      "r158",
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r108",
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "terseLabel": "Cash dividend declared or paid"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r227",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r257",
      "r259",
      "r262",
      "r263",
      "r264",
      "r268",
      "r513",
      "r514",
      "r624",
      "r630",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Earnings Per Share, Basic, Total",
        "verboseLabel": "Net loss per share attributable to common stockholders -basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r227",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r259",
      "r262",
      "r263",
      "r264",
      "r268",
      "r513",
      "r514",
      "r624",
      "r630",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "verboseLabel": "Net loss per share attributable to common stockholders -diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "totalLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "verboseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r235",
      "r464",
      "r486"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax at U.S. statutory tax rate",
        "verboseLabel": "U.S. Statutory federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r869",
      "r875"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Valuation allowances"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r869",
      "r875"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r869",
      "r875"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r869",
      "r875"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfEffectiveIncomeTaxRateToUsStatutoryFederalIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and employee related expenses",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized Expense",
        "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average recognition period",
        "verboseLabel": "Weighted-average Recognition Period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r868"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation expense related to stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Common Stock Reserved for the Exercise of Stock Options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r100",
      "r195",
      "r222",
      "r223",
      "r224",
      "r240",
      "r241",
      "r242",
      "r245",
      "r253",
      "r255",
      "r271",
      "r319",
      "r386",
      "r456",
      "r457",
      "r458",
      "r480",
      "r481",
      "r512",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r564",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Percentage of stockholding"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r516",
      "r517",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of Probability Weighted Valuation Model Used to Value Derivative Liability"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r141",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r359",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r517",
      "r576",
      "r577",
      "r578",
      "r698",
      "r699",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r516",
      "r517",
      "r518",
      "r519",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r359",
      "r401",
      "r406",
      "r517",
      "r576",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r359",
      "r401",
      "r406",
      "r517",
      "r577",
      "r698",
      "r699",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r359",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r517",
      "r578",
      "r698",
      "r699",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r359",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r576",
      "r577",
      "r578",
      "r698",
      "r699",
      "r706",
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r520",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Changes in Derivative Liabilities and 2021 Notes with Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r329",
      "r330",
      "r367",
      "r383",
      "r502",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r696",
      "r765",
      "r766",
      "r767",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r55",
      "r85",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment loss of long lived assets",
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r83",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r234",
      "r485"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r37",
      "r154",
      "r164",
      "r183",
      "r285",
      "r293",
      "r297",
      "r299",
      "r625",
      "r694"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes",
        "totalLabel": "Loss before income taxes",
        "verboseLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r234",
      "r485"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Non - U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetLossBeforeProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r235",
      "r465",
      "r469",
      "r475",
      "r482",
      "r487",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r236",
      "r254",
      "r255",
      "r284",
      "r463",
      "r483",
      "r488",
      "r631"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r221",
      "r461",
      "r462",
      "r469",
      "r470",
      "r474",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r52",
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "negatedLabel": "Interest receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories",
        "terseLabel": "Inventories",
        "totalLabel": "Increase (Decrease) in Inventories, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r747",
      "r880"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets",
        "terseLabel": "Other assets",
        "totalLabel": "Increase (Decrease) in Other Operating Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r736"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r212",
      "r684",
      "r716"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories",
        "verboseLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r201",
      "r211",
      "r270",
      "r331",
      "r332",
      "r333",
      "r604",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r738"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r737"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesSummaryOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r43",
      "r283"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r314",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Short-Term Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r764",
      "r768",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Short-Term Investments"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r556",
      "r715"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of lessee's operating lease.",
        "label": "Lessee, Operating Lease, Description",
        "terseLabel": "Operating lease, description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r882"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r879"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r20",
      "r233",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r497",
      "r500",
      "r501",
      "r523",
      "r693",
      "r776",
      "r886",
      "r887"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r14",
      "r160",
      "r179",
      "r716",
      "r751",
      "r769",
      "r878"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock and stockholders'equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r200",
      "r233",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r497",
      "r500",
      "r501",
      "r523",
      "r716",
      "r776",
      "r886",
      "r887"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fairvalue",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r774"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Loss contingencies"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r274",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusiness1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows provided by financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r230"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows used in investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r53",
      "r56"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows used in operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r38",
      "r56",
      "r165",
      "r182",
      "r198",
      "r216",
      "r219",
      "r224",
      "r233",
      "r244",
      "r248",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r261",
      "r285",
      "r293",
      "r297",
      "r299",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r514",
      "r523",
      "r694",
      "r776"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r62",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r250",
      "r256",
      "r268",
      "r306",
      "r307",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r456",
      "r457",
      "r458",
      "r478",
      "r479",
      "r480",
      "r481",
      "r492",
      "r493",
      "r494",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r546",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r606",
      "r607",
      "r608",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r4",
      "r159",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes including accrued interest",
        "totalLabel": "Notes Payable, Total"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r285",
      "r293",
      "r297",
      "r299",
      "r694"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r552",
      "r715"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesComponentsOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total operating lease liabilities",
        "terseLabel": "Operating lease, liabilities",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease right-of-use liabilities, current",
        "verboseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r549",
      "r553"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease, cash payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r547"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfCondensedConsolidatedBalanceSheetOfOperatingLeasesDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r555",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months",
        "terseLabel": "2022",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2026",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2025",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2024",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail3": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2023",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesSummaryOfFutureMinimumLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r190",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.",
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "terseLabel": "Summary of Condensed Consolidated Balance Sheet of Operating Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Other Assets, Fair Value Disclosure",
        "verboseLabel": "Other assets measured at fair value"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r136",
      "r137",
      "r138"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized loss on short-term investments",
        "totalLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": {
     "auth_ref": [
      "r32",
      "r35",
      "r215",
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign Currency translation adjustment",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r217",
      "r220"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "verboseLabel": "Other liabilities measured at fair value"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net",
        "totalLabel": "Other Nonoperating Income (Expense), Total"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense), net:"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments",
        "totalLabel": "Payments to Acquire Investments, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r399",
      "r400",
      "r406",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share conversion price of preferred stock.",
        "label": "Preferred Stock, Convertible, Conversion Price",
        "terseLabel": "Preferred stock conversion price per share",
        "verboseLabel": "Temporary equity conversion price per share"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionPrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r8",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r8",
      "r716"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Preferred Stock, Value, Issued",
        "totalLabel": "Preferred Stock, Value, Issued, Total",
        "verboseLabel": "Preferred stock, $0.0001 par value; 10,000,000 and 0 shares authorized as of December 31, 2022 and 2021, respectively; 0 shares issued or outstanding as of December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r741"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r228"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from issuance of convertible notes , net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromGrantors": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided.",
        "label": "Proceeds from Grantors",
        "terseLabel": "Funding received from grantors"
       }
      }
     },
     "localname": "ProceedsFromGrantors",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from initial public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r746"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds received in advance"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of Series C-1 redeemable convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Proceeds from sale of equity",
        "totalLabel": "Proceeds from Issuance or Sale of Equity, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities of short-term investments",
        "totalLabel": "Proceeds from Sale and Maturity of Marketable Securities, Total"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r118"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r198",
      "r216",
      "r219",
      "r229",
      "r233",
      "r244",
      "r254",
      "r255",
      "r285",
      "r293",
      "r297",
      "r299",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r495",
      "r498",
      "r499",
      "r514",
      "r523",
      "r625",
      "r694",
      "r713",
      "r714",
      "r744",
      "r776"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r668",
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNet1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Estimated Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r87",
      "r203"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Total property and equipment",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r89",
      "r180",
      "r627",
      "r716"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Summary of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Public Utilities, Inventory [Line Items]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTable": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detailed information about the type of inventory held by the utility and the carrying value of this inventory.",
        "label": "Public Utilities, Inventory [Table]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_QualifiedPlanMember": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Qualified Plan [Member]",
        "terseLabel": "Qualified Plan"
       }
      }
     },
     "localname": "QualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r760",
      "r761",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable Convertible Preferred Stock",
        "verboseLabel": "Unvested restricted stock units"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r409",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r409",
      "r567",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r565",
      "r566",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r121",
      "r185",
      "r894"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "verboseLabel": "Inventory acquired expensed as research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r662",
      "r663",
      "r664",
      "r732",
      "r748"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r663",
      "r732",
      "r748"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Common Stock Reserved for the Unvested Restricted Stock Units",
        "terseLabel": "Restricted Stock Units",
        "verboseLabel": "Restricted Stock Unit"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r11",
      "r108",
      "r178",
      "r639",
      "r644",
      "r716"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r195",
      "r240",
      "r241",
      "r242",
      "r245",
      "r253",
      "r255",
      "r319",
      "r456",
      "r457",
      "r458",
      "r480",
      "r481",
      "r512",
      "r635",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r281",
      "r282",
      "r292",
      "r295",
      "r296",
      "r300",
      "r301",
      "r303",
      "r395",
      "r396",
      "r605"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Product revenue, net",
        "totalLabel": "Product revenue, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNetSummaryOfGrossProductRevenueToNetProductRevenueDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Product Revenue, Net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureProductRevenueNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r745"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Grant revenue"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r225",
      "r233",
      "r281",
      "r282",
      "r292",
      "r295",
      "r296",
      "r300",
      "r301",
      "r303",
      "r315",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r523",
      "r625",
      "r776"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r554",
      "r715"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyAgreementTermsMember": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terms of the royalty agreement under research and development arrangements.",
        "label": "Royalty Agreement Terms [Member]",
        "terseLabel": "Royalty Payments Agreements with Grantors"
       }
      }
     },
     "localname": "RoyaltyAgreementTermsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyGuaranteesCommitmentsAmount": {
     "auth_ref": [
      "r609"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount the entity has committed to make for future royalty guarantees.",
        "label": "Royalty Guarantees, Commitments, Amount",
        "terseLabel": "Aggregate royalty amount payable to grantor"
       }
      }
     },
     "localname": "RoyaltyGuaranteesCommitmentsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Company received net proceeds",
        "verboseLabel": "Net proceeds of sale in underwritten public offering common stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued and sold",
        "verboseLabel": "Number of shares sale in underwritten public offering"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Stock price"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r303",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntidilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Shares Excluded from the Calculation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Schedule Of Available For Sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule Of Available For Sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation by Type of Award"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision For Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Summary of Significant Components of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Reconciliation of Effective Income Tax Rate to U.S. Statutory Federal Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Components of Net Loss Before Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r15",
      "r16",
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureInventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfUsefulLivesOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r420",
      "r422",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r111",
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Estimate Fair Value of Stock Option Awards on Grant Date"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r96",
      "r98",
      "r99",
      "r101",
      "r102",
      "r103",
      "r105",
      "r106",
      "r107",
      "r108",
      "r207",
      "r208",
      "r209",
      "r272",
      "r368",
      "r369",
      "r371",
      "r373",
      "r377",
      "r383",
      "r385",
      "r702",
      "r731",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r712",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Summary of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative",
        "totalLabel": "Selling, General and Administrative Expense, Total"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [
      "r734",
      "r735",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock options and restricted stock units vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of shares, Forfeited",
        "terseLabel": "Number of shares, Forfeited",
        "verboseLabel": "Restricted shares forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of shares, Granted",
        "verboseLabel": "Restricted shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of shares, Nonvested",
        "periodStartLabel": "Number of shares, Nonvested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, Nonvested",
        "periodStartLabel": "Weighted Average Grant Date Fair Value, Nonvested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "terseLabel": "Number of shares, Vested",
        "verboseLabel": "Restricted shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Fair value of underlying common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationExpenseDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of Options, Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of Options, Cancelled or forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of Options, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant-date fair value of options granted during the period",
        "verboseLabel": "Weighted average grant date fair value of stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding",
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Options, Outstanding",
        "periodStartLabel": "Number of Options, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding",
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Number of shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfStockbasedCompensationByTypeOfAwardDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfUnrecognizedStockbasedCompensationExpenseAndWeightedaverageRecognitionPeriodDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Cancelled or forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Grant price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Compensation to be paid",
        "totalLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount, Total"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Options expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockOptionAndGrantPlanSummaryOfEstimateFairValueOfStockOptionAwardsOnGrantDateDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years), Options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance",
        "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance",
        "terseLabel": "Number of Options, Options unvested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance",
        "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance",
        "terseLabel": "Weighted-Average Exercise Price, Options unvested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years), Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Temporary equity issue price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r161",
      "r162",
      "r173",
      "r740"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments",
        "totalLabel": "Short-term Investments, Total"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r61",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element provides a description of the nature of the event that could occur within twelve months of the reporting date that would cause a significant increase or decrease in the related unrecognized tax benefit.",
        "label": "Significant Change in Unrecognized Tax Benefits, Nature of Event",
        "terseLabel": "Significant change in unrecognized tax benefits"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r207",
      "r208",
      "r209",
      "r233",
      "r259",
      "r260",
      "r262",
      "r264",
      "r272",
      "r273",
      "r315",
      "r342",
      "r344",
      "r345",
      "r346",
      "r349",
      "r350",
      "r368",
      "r369",
      "r373",
      "r377",
      "r385",
      "r523",
      "r682",
      "r731",
      "r749",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r29",
      "r100",
      "r195",
      "r222",
      "r223",
      "r224",
      "r240",
      "r241",
      "r242",
      "r245",
      "r253",
      "r255",
      "r271",
      "r319",
      "r386",
      "r456",
      "r457",
      "r458",
      "r480",
      "r481",
      "r512",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r564",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r271",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Common Stock Reserved for Future Issuance of Share-based Awards"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficitScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r28",
      "r100",
      "r101",
      "r108",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "negatedLabel": "Conversion of preferred stock into common stock upon initial public offering, Shares",
        "terseLabel": "Conversion of preferred stock into common stock upon initial public offering, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r8",
      "r9",
      "r100",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock upon initial public offering and follow-on offering, net of issuance costs, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r8",
      "r9",
      "r100",
      "r108",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of Options, Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, Shares",
        "verboseLabel": "Number of Options, Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureStockOptionAndGrantPlanSummaryOfStockOptionActivityDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r29",
      "r100",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "negatedLabel": "Conversion of preferred stock into common stock upon initial public offering",
        "terseLabel": "Conversion of preferred stock into common stock upon initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r8",
      "r9",
      "r100",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock upon initial public offering and follow-on offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r29",
      "r100",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options",
        "verboseLabel": "Number of Options, Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r9",
      "r12",
      "r13",
      "r71",
      "r716",
      "r751",
      "r769",
      "r878"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' deficit:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r109",
      "r232",
      "r369",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r381",
      "r382",
      "r384",
      "r386",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureStockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardDescription": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the origin, nature, and characteristics of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Description",
        "terseLabel": "Tax credit carryforward, description"
       }
      }
     },
     "localname": "TaxCreditCarryforwardDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r1",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity By Class Of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r342",
      "r344",
      "r345",
      "r346",
      "r349",
      "r350"
     ],
     "calculation": {
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Redeemable convertible preferred stock",
        "verboseLabel": "Carrying Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Temporary equity, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r1",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary equity, par value"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Temporary equity, shares authorized",
        "verboseLabel": "Preferred Shares Authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Temporary equity, shares issued",
        "verboseLabel": "Preferred Shares Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureConvertibleNotesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "terseLabel": "Temporary equity, shares outstanding",
        "verboseLabel": "Preferred Shares Outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r1",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureRedeemableConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r310",
      "r311",
      "r367",
      "r383",
      "r502",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r765",
      "r766",
      "r767",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r244",
      "r245",
      "r246",
      "r247",
      "r256",
      "r306",
      "r307",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r456",
      "r457",
      "r458",
      "r478",
      "r479",
      "r480",
      "r481",
      "r492",
      "r493",
      "r494",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r546",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r606",
      "r607",
      "r608",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r626",
      "r706",
      "r898"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Treasury notes"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r691",
      "r706",
      "r708",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "Treasury Bills"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfShortTermInvestmentsClassifiedAsAvailableForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnderlyingAssetClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by underlying asset class.",
        "label": "Underlying Asset Class [Axis]",
        "terseLabel": "Underlying Asset Class"
       }
      }
     },
     "localname": "UnderlyingAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnderlyingAssetClassDomain": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance).",
        "label": "Underlying Asset Class [Domain]",
        "terseLabel": "Underlying Asset Class"
       }
      }
     },
     "localname": "UnderlyingAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedLabel": "Unrealized loss on short-term investments",
        "terseLabel": "Unrealized loss on short-term investments",
        "totalLabel": "Unrealized Gain (Loss) on Investments, Total"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r460",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of the period",
        "periodStartLabel": "Balance at beginning of the period",
        "terseLabel": "Unrecognized tax benefit"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest or penalties related to uncertain tax positions",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to tax positions taken during the prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r275",
      "r276",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increases recorded to income tax provision"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r258",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders-diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r257",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders-basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amylyx.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r721": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r722": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r723": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r724": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r725": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r726": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r727": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r728": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r729": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>117
<FILENAME>0000950170-23-007609-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-007609-xbrl.zip
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MP.;PV>PYL]]F:ZION73ZR[>0E24V%AI@F[(  -Q$"4D#'1"3:@[>4R1LU%L
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MG_CU*Q7X]U\I?TTKQ:5. O@? 7' 7@%"DM1J&$@L@C0-612*WB;C]JJ^=U-
M;8T>#Z.AUH&,2,Q$"E)F0I(:<(""6#$A61*IEUT;_ABYCK?&+D5]CI&/2Y%_
MCZ;8&KG6F" V,M)$6!%BG:O!?7).+%,R43R*PKBW69:;4RVROLTLQHTT0"XC
M!?CF/.!$@N-'C(IB7]/(^C+=;'(]5_WJXXB79M0:":X--7%,* .K0O@ID"])
M YK:1*=I?S<?[Q=C/C:-R JC]T55@.+;&%$""0IY'"3$:AL0*F)%.$T M-.
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M!D^,)<;5 A!3H12#CXD64OM1W-^T^V/39"WLH2H%(B$UQM=\E/\9BQS?HY]
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M&R>_E4!+[JOW^X;UO,50F5S XW]X_A#9H 4'+3A([3WI_;XK8')&C/FLSO%
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MM+>\C"NIW_?#Z#<MUO,!3/*OK$KO<'A!^\.L\ D_O0I?/1]W];GF2'CG%89
M_[L>&4Q/^[TH&_.P,RV[);ROKG&#TD9A?"$KBQV7T)MGA7DT ^NDG:KW'J>*
MT2E1N2V8@[*Z@C])7I:?\//)+ ELQH>BAUKK+FTT5P?/Q6QN9,\2#UTOXP1W
MZ:,>,$6?E4U_7*J>2/! K TBUF:KVYZ0\*NLMT$NGV%/\5%C?A]VCT^]P_[)
M]J80O(]64=^]^D%A;XK"7EQVMIW&\/!'%NG%2'KWQAY(^0:Z1H?@*7O!=O^4
M0)\U^RSX(J?=)U]TW&7:8W.(I@S1%!A_-,#- #</@IO= 6^^#6^JK/[TNQ6J
M*:L7CCG',%/OH)WI@#L#[L#X:3P SP \#P*>7P;@^3;@&1>5J<O\TNC?ZT98
M^SO6/N,.Z\M&H8^S:>.FLK6N#'#86!X@:;JQ'-RYM3Q@TH!)7\*D<("D;X.D
M456.<-@O/>OIPVR> ^@,H#. S@ Z#P>=: "=;P.=W)R)_'> 'F4,CO2%8\]O
M.%WOPWRZ P0-$#1 T !!#X<@.D#0MT$0K*KYO1;6-)/?=59CC\)Q]=*=H'?P
M<._$3=I[.Y_T $<#'/4#CIY1Z; -RF!EWT4":Y]Q9,A*[I567[_P?DM2\EK%
MLA\YR2]?>C>TB&2H(AGT]>;JZZ&*9(CH;*!>?XJ(3CQ$=+XMH@/3N/@]?N$!
MG/8(#&S$^H7VZOONN(XMN"1W'4876IIZ[_"D0NQL6FCO$ _GJKP/XTJ=B[KM
MVM[>BV>,=2>1#<&A(3CD@D/A@&P#LCT$V=B ; ] -O:RD>W8P.^71@]P,\#-
M #<#W#P<;I(!;AX -\G+AIMW*PYGQQWQ<5UGW9'NNPL'W![,SB_>*PN=-=-K
M +7&>7N \M'(M*,?/*8!PEH(&TK\!PA[&(0-)?X/PC#QLD'L?_"(J:P1[K F
MA"/X(I]^7LCO\H0LQ[/S<[$GP !1 T0A1$7^ %$#1#T$HM(!H1Z 4.G+!JBY
MVS1O)N^ ZF0\&N7NLZ@FWEO1B &1!D0:$&E I(<C$A\0Z0&(Q%\V(NV=B^(,
M;LO:^!TX2>*L,ATRX3&[WJY2,-M&X!=E,?WHSJB'&^:(-O>O!N@:H&N K@&Z
MU@!=0[SO0=@E?L<%K<J\_AV4==M@0+_\LLZ];M(.H3[,)CW@TH!+ RX-N+0&
M7!HZ?CX(E^3O97-NJM^SPB*U$!9>-B(=X72]P_ET'Q.+UJI=OAV>GE_EO!S$
M>O9&! -B;2SWM(BU-R#60Q!+O6Q\F@?OE@] AF$5WE_&55;K3+ED/J\Y%PTX
M5>82[@1$PX.BARR_ :MZA%5#TYRA:<Y&8,S0A*%76GUHFO/R%/(&NP5/T31G
MZ)HS*.S-5=A#UYPAWK.!BOU)SB3SAWC/ ^(]@?_2XSV5<8=@;GG[GXT:NPJ9
M(VLS->V%LU=6(QR/\7XM@8R8Y34D=@TAGC;$,_0B&.#I8? 4#/#T$'@*7C8\
MS3%IK[P8F:)^]#WS 7XV1H$,\#/ ST/A9S@>\T'P$[YL^.F:?4Z\HZL"_*'S
M;(0-;?: 7"(KO%],8<!1PIJ7]G?G+\T;Z'2-<&YM-3K V !C XP-,+8&&!L.
MW'P0C$4O&\:F@.6P"%.T ,CJ)70ZK03X5FW^UE97 -H&!KU#&!YX7D"A(>XW
M(-: 6 -BK06QAO,Y'X18]&4CUH<J*U0V L]JWG7 .S"F:Y)CJLM,#76< QSU
M!8Z&3.,ATW@C8&1(7.N55A\RC5^>0MY@R_\),HW_UC_1WA2*#_KZV?7UD&@\
M1'0V4*\_241G.)_S01&=%WY Y_[G\TQF3;WEK>A][)VH<Z/'^1#2&4(Z74AG
M.")FP*.'X=%PJN:#\.B%'ZMY "_V I_\U3L97\ *30;D&9#'(4]\%_(,$+-F
MB.F)MSM PT"L[T(M]X2$7V7- V'Q"3^]"E\-,OI%\ZV&;T7S\IM[G\SF.9AN
M@^GF3#<VJ)DG4S.P[G699QKSAW^WTYC>[_7L/+.7K7WV%J:_*J0Y**5!*;DX
M YDRPH9/Y(O=/.&_0N;&_7D;Q_SA>_-5AL6XMACG,_P=B3/3*C B+&B:'9%?
MB4G]YI7W>L.6+;IEU78K@(/96HFB)IO#/5/M[V7ZIU?8UQF!O2B;!WH4/<A!
M.OFPOW>X^YOW_NATWSO>_W7W^.WA^U^]@Z.G4M*/.KOCO\-\R&]'1W_%29V<
M[I[NO]M_?WIR'ZYBVXPE7^:K%8/]/O>73L^SVMLMBC$8?,=F5%8-'H@XVU'8
M\LIJ^><M#V\665%[MJRN!%AO>5E^PM[J<WO9@VFI<T]4QKL0VGBC<57C.?9>
M4WK-N0$E8HUW+BH)3Q]5Y656NS;LI?5.VL[K7ICLXD>\N*M<SV!RNZK!;P,>
M15N>J#UQ@=5\VHWRYJ5;785%]\1@?\43]S\K=UKDPJ/IRD<O7KCM[>;YXG3=
MR2_81;Y8^M9ZL+I-6:'1ZEFAX+MN\<#0S@JXX<;BXY+=OJ[;WB&\H;PPGA*U
MJ;>\23F&/PO0;O!S9B=?HHF<>* *@1& #<\F7CU&"M7>'__[<^@'Z@V0)\,Z
ME<9LM5_I-[/?I,DS<[GB!YQ.5HQ7_C+.]<VO3=UD%RO?83YCU_V;WV?(JBN>
M="$F-[\<Y:)8\6V)W Z:?\5/E<%3 %;]4/YKY7CJ\]4S:T!?F!777^'ELV\[
M;BK,F7"]@%J.K(TC38T_M[RDRHN1J- 0723:MG?J+EZ@*C(,X)EW-H;+8:F,
MXSL[QFB25YEZG#?NL2-3N8-Z"F6<6&3%99G# .JQK+$D"3V^*JL_M65)8[C,
M%=JBD&RC/KB-JU:S<5:H?*S-EB?'S6R(>7:1H8O9E%L>4!L&YT:678R N_32
MI&0Y;G:NZ7J=7:[:^XFWF1_^X?K>SQ_>Z*P&;ICLV-Q\7E3];8;XO\8URLM4
M$[JK"(R@:MXX_4YPY[C>D2!FSO=>A09SG1INAXS_X<7!P]*:SA8T*W!%B%O7
M+[[W.J)^8<T7EY+Z$8M#%O D3E,>_<%9E" ^83BS*1=887E4&[_DKWXNQQ7P
M?Y9CKQ: RPL40JQX-Y\!2Z9'%)?2?8>A#P0WE%US-LX%@,W$$R/$5)$[3;#[
M[A^^'\7N+E%,IIH!KM!C@#P #^TB/_7<8(?5[?X]B-T@=M^GV(%UI "?[#C/
M)PC&%Z9"UQ'>ZR0)^/*3:>XO7%M>9CNY1)L2KT<S &PAE&@04[Q[\34N]KOP
M*KS,6$#P9A#4WG#-(*C/+ZCN,&APK;RKK#E'4Q3,5+"<&W1P1FA88C]H>/@8
M_2\0SJZU66MEUVWU?>N#ZNEO\%.V]([.=@:X-?\>@SB#2G#7E9VDHQ6-?:8S
MS/_^-SJZK7,)<JU@U9W[AS?,!7PZN$&8>\-9@S _@S C",Z\\RFJXGNVO'*$
MGN2X !G<\K2Y:#%6>S##*Y#T^5T60U3?!,2#\/6%$P;A>WXDE>,LUYW)V?F<
M>$5Y!7,4>=>O9FZ-*C%J;\Y0JDH$4_,)DTYR(5WNPB7('ZQXX1#8(?6B%3U(
M[&:SSR"QSR^Q713(PA10(A$(G<2"O=HV1QS$I2^T&\3EF:Q+<+_ 2D1IV.K"
M+5L(,F=N]P'!9[9'8IWPP#AG/EO=C'76 =_LRP:S(1"5W!:'"]_ ;1_.@;V]
MZ-IEBP%8VVW]-)41C:L4QK#/Q:1LJG)TGBD/VY=6^%:5FZJLLQ95=W\[V?(^
M%8C"HG8/^/#GH_WWA_]HW]#&DG $, \C*MS3@R^TN31Y.6I;=RO 8@?3@SKH
M"V\.ZN Y&KQ<@\_*./A$F9KN8^M92*A3!Y_,!-6%!6WA]EGJ:>1GNN.^Y9UG
ME>DTR?5-F7^/@6<M;FXN/6.0P[XPQ2"'SV_%3F4/_Q;ZTF4H+'F'W7=?]!(!
MCC&M *^_OG4SRDUCMJX#^""#?6&(00:?7P:79 8LX&J<M6>^F*(J,=<-/KMD
MI!&8TM.\'WS&(%4])?$@5<_D<$[W]"LOSSX! YZ7I9XFG@KE\"BKSZ<.X*6H
MLG)<@].7.7LR4W.DVEI,ZK$@J\59:W[.$WSF6YE32%ST_$J)*8S9I5ER5Z\E
M'L =RN7?N@11S'0=@T-J@ [O,#42"%-[NV>F4!/GC^Z_VW7C$I5[V-6Y:7-?
MRVF,]@Z'5SMGVVW6@FL[Z(N^,.^@+YYK^[-"(3OK/,CL0HZKVDS%92I+G9OZ
M<?MD>\O;$X70HLOB=69QJP+^-:ZR&K.973(]_-1FX<^>42]D(&4NY:B+'MF%
MAPP;,!O"/8/ /I/ N@/DVR#K665<I*A+7 !X-Z/&.:M?DWF+P#LZG]1X_B*>
M636UL;>6TIE&8E(N)B_54Z5P@3 -%CCNK[ITB4%&^\(P@XP^UZX/1GT01-L\
MVBZ8*\<UFK.U=U%J ^9UW: LGV7*P[JA>K:!.KUN:Y6PNOBO4>=M1<X@:WTA
M_"!KSR1KM0)W$44,A*7IBBVOC*OZ:NO72L_4&#T"MW<YO0CE#<O[\AQNP^JQ
M$7J>"':N90962U["Z[LMUD$6-X8Q!EE\!EE<B/S4X$GB^:@8[2G;.&UY,3)-
MULQ,R#&*GH:%K2:+P2$T5!>B3HO/',2K+[0>Q.N9=DRFU>OU0@04Z]8+5XQ?
M@;!@+3RFQF:-J\G\]SBKVIIF_!;PKQH75Z(M'^G\0?RS,$:WYN="\D#7B*PX
M&P2O+UPP"-XS"=ZL*=]B'X,WWB 8/:'2(!C/Y'P9:XUJLU>KK$8\R@J;MU&/
M:NXCM2$1+)/$:$B;'XXU'&6-R)1G@%,:4P%<K-*E KC,'&R.XFYQ^P/M'B9(
MGSDKNRW.=L] 8&.M>0KM+,RRF(@N*^_USR^D?^"U!F?+RN?;&IT%X;HZG6W\
MZBYV9QQ:[7U#J[T!_@;X^_[@[RPO)=B'!BXH+S*UT,*J<[=F)F2W6W=9(DZZ
M##@EQK71N \WN_U+P-KNO(," G^P1=DM!XU[1W\[?$L"[L'":G.!N3QGIAR5
M6"2).W19@7%0]TIP!UT[.;>+YYY5B,[O:RILF=<&<  ZS[-15X%2P@ RA8 ]
M[=V&+RV+%HVG/WO2-%?&%-[QN*ZS-DW@XZ<*F\YM/0#*E\K*\*&#[=T321B4
MSW,XI6W_D&LMZZ8Q'0P$-=>2[LK:@*%=8P,\U]*];839[9<T69/##].>@<=9
M_<D[ '.]K.KM:>_ K[$W[],"]<$6YXN0GE<_[Q9?;)NYNL%A92QN6K6Q]7%5
M8;[696:NNM1&0 ;4H^A$+;&$T\;7KW !CO:JE7&.K:6&C5TMH&O2V/[MVC9N
M+?=L7,@,M2T?87O2!K"O0[NV&*K==NM*(+>6FD1B,%*=8]O/=AVP0P"V<P6H
M@O'E$T]G )%NXK8J+Q937.[UO*X#)'#]0@_(-@6U_G(/U(/5$UJ>#(ZW'>'B
MF-U(I_1J.XZ*:;I<U[%27)0(B%U'5\RYW>JD5YM:59F<"? 'T(G>X9;7GM&X
MN[52?&>=/UTV?5Z;*WBP6<U5V]ZO&;!)MP1+]&Q;O;:]1UTS35"G"J_18V<K
M9.T:%_=8OOW/F*6$YD,7GW;+GHNK+;=M6]?C"^S7Z942I+PU>& MQR/<<D5:
M5>8RPX:E=[RH#6>[[2118_4M2@"F$A8@GF!+(5^XATNPN5!LQ:7(<K=CW"4V
MM=RT?<V[&?3=0_5=GD_-NR]0SVW?UU-+L:6]7:4)RR*?N+[$!L3;]27>NBZ*
M**.WR**S9*\/8X$[MKV_&]?A^ S[B0!7(G]6CMF=^+O[EP2Y_.*TKK+<I1E<
MFDZAJ1*4@6OI7'BE:E5#5_[9LN]TQ%B'9BI@^:X/-!; %$X@+L",GBX4ZN*9
MQD5A6=U2%_'#5)5I2TE7(HS+C7 Z24^+;;H,W3$(IH(%K55>UGAHE#=M_-#^
M#L,M-5Q1N0<M-!76I1IWK:FK64$!_-=TF(3?CJLBJ\_;@5WKE8VSF+7!WBLO
M+C)7T#KOOKV_A]W!44,MD+DKX<.EPT_.K;J99=6Z'5L+  @,VVZ%W:C2G_DA
M=^DR73I5Z;1U(SXY8F&FUTI]AK1>R8T+W..*AEO@OPZ="^Z<2R;;:C7IR UT
M:V'GL&UY_B^C9NS:=7S.*J!.[=)'ZVZ=W.OO&%/+M&[O'F-B=XCK7 V[Y]X8
M?GE](!>X;EGCJ=R(JI4YL<)@6E3H3L9PX25"DVOWHU&^)E/671Q]M<3(0+PQ
M(D>>EU>MV7Q#+EK4!P:WD\YRP+#VLE=[VUK=U7W=C5PBTL,-3@3F+ZK'(^1A
M;=J5N\M"'&!KS;#U=^-PQ*$&R)+3W^Z_7?/&N8AM+0G8W!!>Y%%X+JCC8II;
M-D^%00XZ,X7KQ#&+?ICB,JO* LD];][:AI%:.Z=3[<C+INW,/W?]5B4-+/>]
MP]5JN1?-S.ESI^^9WH],J[#M0-?!'8AP*?(I6DU',,\&[]2G.S1@/G$G/L"L
M&#/1:# N+!O&@P# F^45W)H&S&8=1E :,J G*(0+ X/6F'Z'")&A,)P[IR!'
M;>KJSYRV7;9EVVTFIT"GKO*RUH$W%.,+Z5J'+20GM;=TB[RX /.MKJ4>@E\P
M/-K>,/-UZ?3Z;:IAV_M8Y"X0AJQTA8#1.3 X4=0%VD%.VY()=<>Y6XPI6\U8
M:>&=LX4%=2VV%J>S.+ Y_^)E[> [9-^:DP34YZ698&APH6?-E$CN1GC\2'0
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MGN'1\7#QX>E,UF]_[X#^@8R#C;W?D(E^0?;A1W'N_:CEN(7BIU65A,;AJ(E
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M(#%9O 3MN0T(] "Q@RICOR@0I\+EU IVM)N+5#,2J 9.H/5^[I9 [#;W%Y7
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M#PEC3U*:!!O;YE)C36!):$HP1@#9M@53QB17>L\RN*M&\UX*7WS5<!MA>\N
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MJ4G56U]7A(W#$F+\)Z^?T>C_]P36[]HC_][DAM> AR[',1S_FY.3 *S@6I;
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M"JOIDBL36%>^^F?/U>EQ/1MYLD*/=,FVA'MAVS;4W=*HG6C\(MQM4 ^[J2&
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M"3UW[\1U8)$Q>JN_77//FDLK,GGU7.,9#A_,XTI &IGQ'=;IIN1\)T4XQO;
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M@\,+^,F0G;(S?]USZT2P DRY677J M!Z?S1MQ1NR+J:M^"E*CQ8"S_?2/QY
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MY^S#EV59SZY*<NL_LP<\NLM$H2'!@<78:=OPQP3"?5 3"\1Q6" #L%E88%U
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M:*'-(H.4"S,CI3U9H :5&:8)ZY0/W^\52\#P4/&*N46N4LW,IM]Q-QU<A/
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MH9#%!=N3-^7B#>^1;+;**^:N0&.+6VZ,_ZP[)DY'"1?SI@*98+NAA7;%*IM
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M1K:EGOVRV#7LYG(G0]SAVLV/53=<S'Y2NG#QL;,XH)XWS;*HY(M(C-.6W(7
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MO@W+53\0<&U# %&FO6['@$194/[9L6*NM62@3<:W&'.^K40,$WN^T=9=;:,
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M8QQ#8!L<IN[YPVU114"^/8KRC.2P@D@E-B[6FXG@S';7#1"QM+9 #/K,@?0
MT -G%$ WP^@ZS%*$",HEW#7PJFV-@@) ='M.*FZY3Z]P^U2_ST.49[/R[*)I
MN L6?7F:S-2FO>.1Z\'FT967YINP",@B)A]UVDF#9E.4F9.($M'PX"URH1^L
MUG&IW#IOF":Y!N&RN]5MK>.W%%/H*HFK#<_^LE@5+3 (_HNG8:[]9%G\6T$M
M#/M^_+YDAU#%H5 Z7TK^(W)QAV2$7^+)6AL\;])@<].<CZF_Y1/Y<A<OGSU_
M,GOLN&?#^7#3ULCDH'Y*!_4YV K(N7RH#NKSLUF5]_5B+3I3*BH%7%1CO(U
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MC![+C 6C5#(QY4S@ A6__C8)1>?<4=VE31TE"^Z]*629H,\Z,EIP/W<-X@&
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M]OA#N0=S>/]!D'!OK";\!>>CCO6Z!#_WE92^3VU%?> $P%>S"WKK3<NTY)/
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MM7&A]<MH5E\3;>BR\(;,>E&J$3!\;/><R[^^?.T[SCJN*\3O:RHA"<O'3S<
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M9NNB,X3QU/0U/>.@[1M7'^CY%4^>X9$;LB:T;-U)=4:IED[(>)8LA.',B4@
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M88#%09*<<)HTO@"86Q3($D_!IX C_'63H5M4R"7T6_0^D:+GB_DWXE;Q.:U
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MD#8PAT7%DL% *N@RB516F;XJ<Y$B^G7>//_;__W'FQ>O1BP7%W_[WOWY_[W
M!RPIS9PE3+W! 7;9RH6D8'V)[C(T.*@QR&,3H'@>:L^0+@Q+C*+#HBCHO48&
M99XZ"(NDTK#U?QX]^N(K+WRB!L@'^/_L7="8JTPMLH9>,\@M9F=JA'9$!5#H
MV1:%Z9283="I;(?9!-VE"<H\MU#0@-Z4W5YI'N!!D)D2$Y#JYDP)5AE;, 99
M3A /#2U!_#-I.LTM"T+$$$2).Y]UZ8+]2$TG"E5.RKW1I4/MGS-\A;(C<3+'
M"]Q)@\QE*:*FQZS"C![_O>CQKV;T^)V@Q^]-[>+3YD2>3FE1J]OAC(-PG[T6
MO^>I;R^[GWC/#^35B$&;W9K9K3G).0]NC3HU3,A9(!="+=HF9%'5-?@CL5!B
M"$?@:5CZ1[@FQDI0<8DMQ40C:FF5M23>X1^Q+C(4DJ6W/X?L57"=4CNH!2*D
M4;)F6V2 $&*,>FN)V.;(YE26XVP"[@2:+_L3>V>5E00!5E@PTWEJ;9[##?<A
M$J0,.#V8IJ14^=Z)"V)2H8U2#GZGJV8T+$9? W4;-)-77'U6XR,FAE (',(L
MP15G[%!(RYKTJ6QQ2GDLBB7:V.:4QNDMPGGCWXF2Y4KS#:G0%?DL ?7'O[P(
MRN*WID'6,YGW8[E, )3AK./JMJZ P%4[)1>D;$<WE>8E!"1S)9LA"+T-@>IC
MTD>K5L&$2S0N\ ZB,E.#Q&U9]5UY"6NT -6'ZG;#E9EZ)DMY(=1PGI0G^BR
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MB\"4?4_.ZYM=X/OM O\RCBH;N]YI/_A&G9B"0T1W,EBCO]P;T?-9[GPNR#W
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MTJNK#2-UA$RP 6M=('N!M!2&;4A7?09H.'3G_M7)?_=U(3 #S3=\ /[MH_0
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MX7Y8L3E?N6F;'%IX)?Z!1X?V(#43/ZBPFCXP@SVSA]Q'@_V)^27>"*7T1#2
M/<:[ES-!K!F++4Z>T,8-M&BYF6O?ED)[9#PJ\D<9B\+;WWBG!IS2Q]"3I)D
MKCYT_H[?GY/ZX_@;PC2A,LNDQ#P@&_! "T[]UL4R$)02K8RR7!M6@9]98HQS
MM/NRDI;\X+1D$SP61K:+L8^WC5-30UCM!LRQ2A%IQ\&I85Z>_:8E82PIA=$&
M83$WR>MZ:1NW&9M#5NT/9RCG$HTWI8!]XI=HQ#2\Y?PZ1XDCI68?2(OGX+'E
MSF];@*%'(G/R8YJVH/+ @)Q!#NKA :T&1NH1(3(5=2#+@@YC@^E?4PV0:;9U
MY$:,+')"U?$T'A[[!*J:(:X%B<3Q; =/#VOCE D4/]"N_*"!5?(0#^J/;.E^
MBAHQ=%T?3=VIC:!VZXS)]VS>@K0B+HMV7V*C 1[3>M8LWN=B2\)'1''O/KUR
M!K#;E+M0#1.GG]P"<'MI[Z=DEE;"VF[N(I)>(@/*U3LQ(:W'IQ;.BJ$TUWD.
ME3/O>2A$A]0U,!G"%,T\J @2F GU8/):A!^PD\ NR\!(Q0:20>T:0*5"K4;%
M6G>8K,I?H<^:<5FO<>9X;=)'K'1*C:])MFX+L:3,YBV/KLY2261+SH!E_BLD
M##+4.]NCJ$<T_BL4?9=B^I2UWUW6V;*! X<GPLC?&:T0&[7B$$!#+3YV9K,F
M'RYWPV6YAT;2M,6R8M6/O+Q$S30G9<J)J3>LEV;DJM(1$=/&4\\+!#23OC#)
MU_;RLT?.7!<4BZ;EGOI_5>L!]W([+.-#S+\4$H0#NSL0-&U#C)0-D<R92U*S
M8KA>=N5^2!?-LX.S3&<Y^(2L\J>/?T>+,!Y&8(XWL]/03]Z#I.>VGL4#"W+G
MK.1\=HZFE"G81F<E.X%Z4L9^<&)9B0<=AKZ4,G*21:($XC&[K/6*P+8@9H)>
MDG+#\7L\^DUU8VM4T8'Z8'LD*B8)YQ:,;%+JZ09U),.L:^H_*-P],#,QY\+N
MHYGXQ+F:I\AXBZI2]FM295?'O,R(&S?&NOG@]8&GK.:#^3[NN(\=U*(\V*/8
MEQ=9Q?A9=X)2G6]5(+53I2R"E"95HT2L%'=RQHE *L2ZZ7:HP#5;IJW=<Q7)
M30>A/RY+-[3%(=FYG<LTLIZ1B)SNJEB7744X$)RL2]W) KA]P?=$-8X/XK=%
M>PE,@,:Z-.:?D&;LVT/R#'THK-6<J!FAZ(W,2)=\QM'"4C[R#D);[-LFXW#0
M]*A\?LSP]'3F2^I]"I] $1:+7"80O*-N%Q<O,).#W#[(4FZSG!])/R+D2?D.
MMQPD51NHN>GLL9>":B$G*T>64T/^]Q,ND5KNJFJN)@$<7%.8@&\0DJ=OUZJ:
M#>2.%AQ=Z*Y2<B["<^]=>8+=2#-H>6$J6_?GUJ.=2Z.T0'U&GF9JZDD),VPU
MO<MZ_%YF?VOVMT[=^G]B1^-";(')?W1BZ'0C!AO0L?W%SLM[%Q4=0A),J)$%
M*48(,Z#LO='G/)<T#"#AM\K8@K0N.*K/G!%984^A +,XF%NB-Z+<]SX^)!T2
M3L&Q,!/."!_W7>,J:KU!>@W!QX'6#B^N$*/02D!))FS?4>S:[&G.MF;N7AAW
M+SR>NQ?^,-T+]W#]743'DCV*6 !^XDA*1P>2+X]E4X<E@\7YH)D^M])K3ZUP
M^9&F]#4G;R*LK-=]A6$3%82R[8$,_[W?PCOGYC>$)GIN:]GP78DT;< ?N.FJ
M,A3UNG?N<2B@D#'N +0,E3<3F0"$2>! SNGB_12F:= =PHNJV+JPX0=TQ_V:
M03*!5'Q?4L_ XT<DX?M%FKPMW0'F_OX/-&8>DN^S^AT]T=M_?)\F5\[Y6%:-
M[=-T*]B]N[K,3$B(1_O!S]5K7\FDH;^HZ^8R$[P$!8DN#FP0\G*<^0.'Q;A<
MTY5[]WT7<-+2>-JT.TE?I_I*?GCVXBE16@LE5WONGH#FC]Z$?[XGX?G6+K+&
MC.'1:$3ND=T/URB//97B(6YUGEP![E]D[O?=5;%#F*.D8I=<(3Y/+JK]AK+K
M&8?Q]/@R-_&$X"\:/J?1D[XIL)Q"I(UG2JPR,@0'<YZ.AJ-@]S:D]8#C398F
MARB=UR8LT=58%P>!XC8U.AWK(GAAJ.^A:.[>IYL.VW?*=8--017LI*]+O((B
MUS'@=M0IDR:+IFV;*\23G(;0QE1?#$[=PMSO)78WO;+:9LQ+/M[*;L.$8@.M
MN\%+BT@?)\V U*"[A#1)\_&;TW=$<RWE_= P)//IGJG-KNJ@X8/^#WI0ZEC-
MN'6#(]_(RN 2FH.(G@@+BO',QP9FA1U' Z(+TML9%)9+$361^]/,76V:+6.E
MN2X=\K?MQ*7YG5,#2\8(\='H4182QH]Q44BD"R??AD0N,CHM#]OJ\"X[R)JU
M& ,JW-!.;Q)RTGBZZN(J$E>T8^%"^@ ?(/@%O:"791O&+D5.TTK8=,Z/I!-O
M%GMOM,ZY.&]&HB 14RKS\=O"G14 :F5MR6T XSWRF5MS0,ICR76?,RPC-)(G
M>=GB"&0@0A=TRV4SJXD8-F"W!9A@.BK&F]/!A(]TE47;9'FTM4;GG3>S?@QD
MB"AGUH:D(PZL$+?F#'[ !T\>/?KFS"V#1S;R0Q-Z1X0!;OS#@XE ;CEWB1'(
M_3\?)VX$E< %:!<BE\:="U&#Q/'VB&21503SQU&AYBW8'7JIT&8G6VC@/="V
MPJ%0[-08*EE6L8\ &?*AVU?+#2$4M1J+U[/H]<LT85VQQJHCSAPWR4W.TJ%L
M:]E@Z6HZ1+=J3QF_=U\#R]FK%VQ!S!/A'*0\9GZ(.2/8#E3<J9)IZZ#: ^>;
MT_D!9$ AA%:7H.X JJKK>O>S-8Q33;O';#C:DX,[+5Q<<.5S38*EC;]C'#1?
MPXC=LN"2D2N 9QSZ9=\W[B001\LYKSTQ>62L[I)MZ?AJ&R#&DGZ'__K/)U\E
MBV"9JB;CL^Q(HHV>DCUJ[Q6MV&9.SP49H^.).P0![HMK%5)#'!'G]-TAH= )
M@YX<GO?H',N+SKVA#*Z?6S""*";C!'*1H-INPI=PK#"8&T3ZTP/%M4IWC.>@
M%W0+(/R23[ME(2$!^*V70KS-G@1//6G-N]/.'==UDZS[#-"0PG3F_9[W36US
M^F*#@QV\8?:8XBA,_HLB/*\1'LYDGJ&%\V%IPHY%L!3;\",<Q,TGT6\^=H %
MY.ZQC:VZGYZQFRW__;;\WG2"4 $6@YOHL7QAPXG?#PO612U*"ZIM"8&1![$:
MN*]W;4E5;@+-^MVDK%+:K1G$W=7#MLY]&4(QYY_^JR<+9YI)6@7_0E_U>!U"
M]NI4.<*'!G&G)GS<4FRTBLS;5%3?I8,$463H)!P3]F(^2.QSL3<OJ:-;Y**8
M08DR0))V(DO8%7YP$?P\36PPD6K^2;WR* Y \TDIP=XJ*RM&3S,[08C6.%\7
MQ6H<_RL1U_ZP*V+3G^H;;>P180(H+)0H?C*D6/C0$G?=+F4WXN,:I>9JN-OE
MI78F:4V*,G7,BB#L"GSNO4?*\-@+8;#\\9+;=8\4[C^QH,(/&P/5BO9H2@&'
ME.TJ.DX8HZ^##"G;,979^Z1 YS-I/I,^)J JU(0G2N#2?<(;#0E/I7?S^?9)
M(^D<*QBO@KW, -^I?8G;9SH$P_-^16[J='RO(K=8D($IYYR!1SEK;67?R G4
M5"XHLCJQL_SJ3+'[@"AVGX&!"_&Y]S$EK6="U+ /*8OF#[<0VR%"QG:\^;?!
MO,^4UO-^>WC[[6^R4\)^:POU(@-M$;O^[N 5E;*PGZZ:-FK;-)'@GV1;NAT7
M8H^V0,R(OG]4.E''H(+VOI#BZ19U0LX5D;L_K!O=?B2>0VC>XJ>RW.8M?A=;
M_+5/')/:$H%\@"5ST2<UW=?[5OX:%6]9>M'RX:@,1:AWMB8K$.5]NGZ'KN4H
M)?"=^]:\%4]D6<Q;\4["WZ+=&BX:JG/;<K/-*LH)2I2TG#NE(YH(^/P^5D=7
M..2"=N)UESX_L@M/*+4QYWGN]T*/T4W2XA22/''W$I7YFG;0-V=2E8<.%MMS
M;2B[R8!QV&"* C^'Z%D$<!Q4%(IV6(NFP06I7S=#<:Q86W)-SX-"'BJ/KEQR
M+D=[L&KC41O<7$B=>YHJ0J4M#LI_ G&$2.R <M=\ *M48GB\"?&.2+NC/M@2
M?B#:U,)-8ZLY$08GC#20<=(+B,H1BG*]B5S%TY6&650R--LX9QT0(KNJ5BCC
MT@_I=N8+J5D)[,X4VF'XL'K7YA:*T$+Q9&ZAF%LH[F[]12?&GYKV:'3E^X))
M_JALJM"[*WWE3"5([-,@Y8=)WL .HH/7TLZ'PH9G/&13J>4.O@]5!15FJA64
MO.B6;;E NI6XZXT8 6O_-:&=07^#PL7@=]I+2(7,4>?TH.P2*R$-"C%_8MJ8
M&VHQOZW9\/06^.SDWN_='CFY3')&7.1&[0I+4] &VVS9-EX\2S$@-V(&L+&T
M.4B!?VWH"5[<LFM FW4PF+ZMHRU[(]W!>^_0XY(54\0S<5-3)@CIZYL@4$,%
MP(7S4N^*T"1PM2EJ4+7Z+C7!M@AA7D"LT T _5D4Q-!1UAV*SLRSRFR"!:&E
M &-9'MCHAO\64 O]9&FP/XRZN6Y<S4J(:7UK@C:B=/XR&MA3'TH ,PT1(<.0
MR+](62K<,:$M9S?99D][>+IFXL':S$_GHW^0IOJC_.V(%Y,WXE^XY?GT!O)(
M86QY+61R3SV9W&F1",R4 ?=G*_U!Z4E4<$TQ1:;?S#,+2WY,U(DC=1(&)'4]
MI8-6?<5D]&%S(H*XM:R9$<1)50V'?\0B7$75%=+VF//)2"CC2V5GGFJB],SV
MVR*#%#K&J+<6^LF9663FL+MW9N+C2U POQI:=+*^7D*/^.)OW[]Y\>K_O<!&
M-6)5;Y[_[?_^PWTP%+3BK>IW*!H*&(#,N(TF,A3%4!;K^<_28PQ:</J&^PU8
M8M-D74(3@56XA-RNS03_X0;Y-FXVYX8<26\X6Z.,9Z(8N7?OD_APB5V->/:\
M)I,PPU%)H'&.;EGE5@;:4^ERKRGI>V&(E'SGZ,US[?*GHOML6'=7MU<EC.:3
MFI:;EF*4QAA@&O74M.J80+7K&Z/<9*7)Q3/3@F%F**2&5E:S8\)P>QK>11&_
M\*T+2'G>B)<A0[&A!:'!X6QQ.//_X0*DKB02OWB^8HKB5#M??7&%P0/9CFL&
M NQAA>CK"8QM0X/2^',4G=YXO.4--Z_<XWAGMKZG;7VYPQ&VB"IE@=:35K)[
M^ TT\YR+4[J('E4U5K P1B:8IFA[X",*"47WO?GM&V60@-&6%'=JM#UYDE04
M16,1-<[2H6"<R:9=.W],@C?),G52WBN5%\7-W1G+Z9%]_L%V83$;SJ9<B)Q$
ML7*#W'?'SY6;U8JBXTJR&YA6P>'_Y;Y6"&>@U R4>@A J0G<,!FCE.V0))G)
M*_2MI'6_70@+"Z>O87RF["A3+-=%]5TRXQ%/Y)7/V^PDMAEPN]7!1#Q!A#!O
M^[6>M190Y6[6HSC,Y$ HG=BH:+D!$1U14(LG[KY;S)#\4UD#\[Z[^WT'6A0Z
MIOS!1&B\!1]O'IZWVQPZL(XQ1XP;-H,P;O"*58F/=,68BW,^]DYF*<S;[RZV
M'[8)]#:X>VQ7UI1%=!&KVU-"CHK<(W-&;/N:-JF)<BW'1)>MJ.F<PM9RF2T/
M)A,X[[23>>OS3KNK@Z[*EN]$WG5747I*B(6ZPW;G5J#;4LN0R^Z$8)4THGDO
M#@Y'*V6YZTEC!GAWNKX+\"CL<Q.9Y9>9N]7:E!8XH61)6 AJ3^VGG0CKT*&)
MV>_FS7LR"VG>O'>U>:5EQ#NJ/MN")I@6NVMQD&Q,N5WT;<?M9@0U-O2'GDSW
MC.%NN^S0M&Z'N;_/F^Q$7OB\R>YBD_7URIU!'<3-0@>:]D:!I*19EH25H_/*
MZV"3@%=>0",;^VLJS6D]UO-C9]D)5??F4N?]7LFL8FP(.]ZC("D8@1B&$242
M0U4?R<@![DODAMUX]*C27I=N+$U<=D8Q$!Q<4$!@3O*2'D%I_B4#2HB0HJJ8
MHO\(9.+**YT0CKNH+HLAR?]U2(3WKN3*@'2_#Y- -^(\"%TQ -@Q26VLR(S*
M]5"*&>@:F4%BV8U0A]3QU BW"W%4#O2F%1S#:)YMA.1W4]@([7&@( W]I_13
MKWA_\RP<?WQ?(*H.I 6!U]?0J_'5^)M+\!:JDR9%R1VJH=A,#0*Q;O=U"MP?
M%('YP/0;YP-I/I!&4_HJQI(4;HLHJ;I""QEW5A>]VT"% (PE?P""_ 3LYDL&
M3%,>4)$W'+\H!3L+@G"_TZU-$+:\\NO$'3[6W)%A*&!+(]-PGKR%:=6GL]>B
ME$:X")UKA(X\[/ HE?]FCFXD4OW=%)*<^57[,MVS_JLON+7K]L^DHBG%#>C,
MYP!]EN\Q5_B]XGF(R* ^/"S[-O?X^PG]ZHNYQW_N\;^[]??/OBT[9]V\<I?8
MM^!'1Q!N\4Q-T#)T'!%QP(T6_V_4[A(?#A3+B&24BFG051^8Q_=XENR^CYOS
M$_=5O9C8GL6O.Z6>,%T*,8QIE'X8MB;8-,>@I7P4JT_E$6*OZKCG@UX/KQ0@
MD!"3)2&?".H,:D2F.^9LYF)NE9L#QOMJ/3YVL\:U[5=F$YG&!>%>H/.88))!
M[Q@DC>5EZ9,\=5%(LQSUHEUCC':;S#WHLKDLUR4)'+Z7?3J2BV(D)XG(D#A!
M-%1)&.*KUR1A.=Y,2NVM@L6Q3[-P [VN\8/;^5@1"[R6$6N*+[Y3D^)Y\M(%
MLL@BTMPM(=U&_I%V VK:5<V>SV)*&I9D0/VT'*(W2RE,4BD+9CS*TUF*0FJ4
MUN!SPD2'><7E2K7Z;L9HV3#OB$\K%OEU$QR_QDUS5>@$C+*U9N@L!62T>&J;
MLQ4&Q)5G!13M6SETPG,3)11G0;'RB<87F*:RB-(2OZ,M!ZMP>!R']V63OO%Y
MZ]?Q30>=&?"P1$#SU'$CJ>4ZP5)@Z$@AF! F9U&<"*VST$A*R6Z/&$E-EWTN
M_895=09ZQ2*?ZGP<UN@".XYM<G >1#'1ZC#5I>IA,=STBK9<(*P#&H89B/#(
M74&:K-P^.O!1LJYSHP261GR8Z=8)33C]CF;77TK(DNVY@DF$GQ6WVDI7JU)'
M VP0809,N6AJ(MR<+Z79=6J[Z"N.#'RVAI[N7@I%# 8R&]4O@OL36WT8[VB.
MK>ZC=_2)'?&?0I,(3(KM3I=F]#3YI:E6$%GM#G7>@F3K%DEW(0J[,2D<@]IU
MQW=;-)Q(/?=*I>'F:&>.=N[=?O[XQ""K9MFS*B@@2.0=B!P:;;8H0*@M1M<=
MSL?W+WDBP-*9L,9Y.CC5&4OOSMARRS"$.A9N$Y91VU]&'>'A!\P!PKV>)(M<
M-#MWPE]M&G;-^"C7H;"J6I!.[I;.X])@9^34.S^XJ.0W7;^ 0KNY@_A%YNK1
M7<U=*!*BDJ#@4#Q1!UWD]OZRZG'NVI+HOKME4>-/$G_A(8C<T/DLPN>]&@ Q
M=TT%?Y@326W6FL$[KY <P&4/?E=B(VSAZXAP79ASYD%$8T13LW?LO,5^NPNL
MC@3%QESBO34MY%!YA-#LZ?;N1?J"IWM&GBZ]/HGCE7DA$K!0%'?^'/W7:C#?
MY\ES_A'W'0[6%>[A)@^'0'@N1/'2@D@4N#H+$3F*2JD2NTS-1TOP^+,\;XE!
MTWVCV+F1;DNWF]=4%W;O*0.@J%FY=\\.I)?TPP&T4O5"?:Q]5!JE<-A]36NW
M"A9B>3(_Q>R?HQ@;UMC.78)?\*ZO5'(P)M(42=]U68]CMBFFG_08+9 LV &M
M J(*.LEM14169N6,B<P'M\K(V\H/M;-;2Z6O6 - 3'O"A=MX#"FJFWD(3SQ.
M>PH8#*T\NJ<U04,0TL???N=&6?)\#:X3&22)*(D&5.KG*[!=C)DQL';JYDHO
M"R%OV% R(FYEMLXF*RH@J^N>)&+]ZB:6'NPOMV) 8M9)K;P\-B[K5]T89TUZ
M0,03U.R)\Y.6,<5#$[?B,%?UD[/E!D+0.<.XD,11F-0UI:[?EA7@]Y_MB2>[
MO)P87*FHO\$U?#%LZL$S][*7Y0X&)AC+B#X6N8*B/4]>RT["6]I3H<WDNCIE
MNEI5/;W$@9:RS"JQU@XW)$V97H:L[>2->$8-[ L2R[@FL[/B+^,G6JFD,B4'
MW=+-^J[@F%G[;?(R6]=-A^X:7F*873I:/8A?82[9E1L$30QK.VR*K-IOEAE/
M]@JR,]B,G,&A37]5=D6$7-.)(-/N1MK*B4XVU6XU7D)=4;PC+,@%YHZ3J*G.
MD'^C003#3;5,&P-4N"U6I*W-RAZ_A2DNPE1YR<@,55W!K(2X*]B1$VKN&X)#
M.9(@0IDV'JED)OW$N%DL_!89'/[62*7(QV&2I,+#TLY>2D/4R>W"3:<(E%4)
M8XIOV4M@WY\4QEP>?K@ASR>.KO6,LAAD.?K(0KCPIBT*5I3F&BZ+[> @ /.Z
M[\@/IBN=Z',*60_/C#H$%AY,[EO$ZI5?2TX&<KC84"QALXWMO1XJ D%Y=FT4
M(E_-U=\Y'W+_C,-'/GB&J-1)FDVXLB&"2V_R;@.OOW/Y?;YAP0P[]-\N;,#W
M?/SCCOU^OVE:CF<I?AP5.U)2":/-7Q?N2B*$QO8+)0U;!_OHELMYT(&91!RW
MMJC</, ,L8_L)Y7AQF5PH'R@%J;9S85[?SRYN-Z2?-3??B$7Q7&)V3B8%+ _
M,)=HQA![#/&7,X9XQA#?(0'-<EE1\E/;+X8V"W\\#"BL]RP029@11FE<&0-K
M4F8F3]_7E03EL)3!3+<%.9CN4N7>F$>ZZZAT/FEV1U96NTD"W8<0!%"XKAF'
M*#L]:) LY "6%$$ B&Q=-+LG!]?V?H84DC?]0L9#4;VR\;@K_$CIC"CV_^'9
MA20!7EZ8HF1(0Z93S#Y>P/2H%X_)VY0D.#0Z>,^35[$JIGN23+H0?7<2IUZ2
M<>Y%^H[B!(DFFWUZ/N(J1UY@WTIBEOIFA' ]QK 3+_M*FH,X#7X0"3A=GZ90
M0$62D(6-W!GGN=-;DX=03^8P$VS/IO1C>>W3#7[CG3E-03+5PC>0//N]?7P#
MLDQ5Y$92?2")9G[B>_^&3<&45+YE;CT..OJ].S<*5G#4)$=F^',K5'LG<QWI
M[9,-(\K]8>)!D*?'\RJ_&5HVRIM0I$2E'2;*X&IS*!V/B\U_.=VM.=NI^VVG
MJ"ZB?@0'\BM3(I&U_=U]#4EGNJ:9KNDAT#7%0!_/,=@-]C%#AUOM]PC$A(@R
MLIW2"#1Q/!!5TW?] M"=?RNDR=ZK=3'&>E/A@9E$A7OBC>>O4I\SB^'IK)YY
MQ][9C@V@,N["O"Q49(P%=G.5/)[WR^F\NWF_W,5^N=H4E JSIYF+(_,"\1[A
M-5E/VV<332IPW;N=1.2Y+#FZ*MMN?X8[ JQREFCGT1F^(V?A8=YQ)_/VYQUW
M%SO.>(%>_]U2[A[IU4Q))0(8QFBO(@N"U$>2[2//$QCRF=3ZA%[\O-GNSAVD
MK:)EHPYUG<NBIBY>[*K*G4NR_ZB4E FT-G<7+:D21;W:)L3+*NIDY1#/E]_F
MS78R+W[>;'>UV9" +^NU<@E2M9NH *>PVH27/@A@?W5,\BB-4J;S)CN5%SYO
MLKO89(0!$,@_"#:RMG;[+2H[QD+E;=(3+;;!!N!JK.\KR(;1$>FK;%K_G_?=
MR:R!>=_=U>$&3OEZC;:>U6TX[)G:9-XY)_,6YYUS%SMGN<E($5;.&NI>SUKR
M^ CWYI'WY"?2H11ZIO5#[_YAF\T;ZD1>[KRA[@1/;%6Z MZ6M2@C(.[U,EV,
MB4L%II8+"K7*:M,(,@&BF]6%9OS4QU[B%S6W:"(-#GW6@=X-,T@&=HQCC5C,
M<\!$NEW4=26<$K8%= *<.-69>9O&[0?;B#WW8=_'S?R)NWI?K59GE%>@S,1D
MXR4),J^2U]^K_"NPS7SLH=:%:C,AD\MEDK?]&M0*8++P;):& PK%,?1( ID<
M<=?@!C_]_.;M*[V'FQMWSBF=0DM6I*_?U:#)93H*.6\-5+LJUM1(T;DI//HH
MQ!O:N&?M.^FPT>8=-YQW2CI*9D4HD]"&@DQ/K0AW8X>.4,;,3=ZS&W'O+,_'
M)[TC$C1FMM,L#6$KEU9?C0R*VV(+;#C*FHIIH.^__O[<_;]DX[ZU@'+GL!7J
MAV>3367CWNZ1;? -7BSW*5S7SNEQHSDL*Z+L:5I0OLT]5?,F^4B;A!=ZB<4=
MF/:X-A"=B,=.PRNE>%:?^NB)/GD,V\J%,C>!4I)XK?$'G)%\1!XCJA)&0JD7
M8J\>'0)'Q=H.2U<-+ $LN)'9P];,0# *U%/EF?'(E1&B*#]YQ[T:[4"KRF+%
M V#N>F-]U!6@#DMQ "94YSR9V5E>MD16-:2?XN$*1R_-$O&;92UHJZ W*18G
M]HM*KMN^W@ )\46RK,J:NNOVK=!="CTATX:/>W#]/ 46-+%P& 6P@3T-UIG/
M'WNW3)U_T"4ORS9S3E21O-U=:*KP^<^8!&KX<^X3 YN$_,HMD4U9*5I^1VQR
M2V&OQ.OQ[SB8Z>DF02+T9&=N8-H1:4X8\X-IG+:,',S?QM3K1%'NIN%W\RY>
M1[OX)Q"34=L F-(1M,HBU5/-W)0BYT7;9/D<D,X!Z<F?>)]>-\JS!$RP!X T
M0)D0!0=&82BDW-VL'//X9 _[0!7Y(CU(;]O2&^6QG$TK0.HXE<BBTX>9;<T0
MA#EBW:)KUUWH88>(,R6.G]"OOIHI<69*G-/9X%YIR[*D06JGR9E^OJG/P(7K
MS%CQJXL6.BAM@1-EU7BQ8 004[8VTLU,C=C-\#-#B#Q([A?Y''\_W+WPD6WQ
M"QL;--RUF/S]V87E\X@PL%SC)=)Y]S^+@_!N((?%"+[E=VVQ<A_A6E79(=9"
MEIP_S+_3P,#Y.P'QQY&$\!SJ92XT#'GF?IZ\UGW"L27U<Q4]&*>?_ZLOM>7R
MN?M'+US[_HX2#;]J 05)OF^:=^?)2Z]Q![Y!XN@NBG<AC>"VY]1VGGPT>$CN
MK:\W4'+8EI08(!#_PIUDER4ULD&= -]5ZB*)I! <N]EFQE4?+[VH(VFJFKZ3
MFK+#UHQ>6%)( +CO]DFW::[894/ KF]MDVG(#"H89C]W-LN]2$3(GW6?I\Y?
MZU"ZA^I5ZM%F:>*>;#_1DY#&9%N!JHGO,SE10HQ#68>1:TI)H+(I]&WNE1!J
M\E(IL=J3@J&(2Z3ZT+1T%UW3+@+&=-'DAT3N2U,@6J6YWH3^2%IK^_/DKS(R
M;YN5]3W0T+C9IL![V71$F-8D"U)+#!JLGA/_^%0,E-_X=F%BPKG4%N8M*UF9
M[\?:XLF8/9P[KZR@(8EH='M6UZC<M[#F/(E0O^CVY;[7X'T?MA7=RKP,6_'J
M="I%//(@A#[*JD8S[G9;K@];=B%#EH.7IP>]>(/A:.:MK/?\N+IYAC6VB 2(
M<@Y$4:! ?W^JXGGUYKKZZ9&GWH)RFS6=7VZ#V9_/WOGL_5BY;RG?>%T#B=G%
MX+,NV7 ])GV]+RM5"E46//96KW%6-24\O0UP.A2_[IQ)R)DUZX=G3R](9J?,
MZ6@/UU_AY#@467N=:\PC]V>>0/[I>*"_+IW1HG0H9_+I'/S[T^>L@4*&I6]1
MLY8V'C(?;BR=G#OX+EEYOKQ4L&L&VM2-GF_;AK2>.'N?D0FZA,91=3A>2A-V
M$TZWN)=PGES4@^N5?,)MFZI8]A65RV&SG'W;N3.]E.2,V,=#%Q1\D#(5M5W]
M4[8TII>?AFPR<SB^-6R)=,XM10JJ(-OMH@<[Z;Y$2!D7UB+AA60@ ZNR*O(
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M9:4R,OU'S+F%TVF[@'AE?V)WV(;>VIBT0VIBOV?/+P:\B4M6AK*C-HME7<G
MFH0[O2@]4,N_N2.A[)A0,QL?%NKJ$3][TI6_AFB$?/7!X:<1.)XA?DOBA%(^
MRHWE[PUZKG"9IVX(54GUM,_^_NIIZ(2SV83/:2#A''7>X:O:@X?P%$W- <PJ
M%!,^Z]NNR9M?2[>>]UG?EG7Q.9U^H\?TJ:J60<&_K1Z1]#MDYA2)[(8M&F:3
MDR2M=7(C\F^YE/_?O7NRQX]2%Q]\\2B<]N;A0U&'M=O<'3%S&"SG^V;W=[;#
M'P_U9&)]7S_S !_3F*BH2/:#CT6JL#MJE4T>L$U:RL=R^#_WL,\K^B-CZ)__
MG-IC(3@(?E%^%IK-W91L),.F0#(F/EL$O-CX"I^GU,.^IU$2E$])X3N+3?$
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M#FR-;]8W@]XUW?XL>!]6]"2U@$263G%>1]YF5W#OU.GWKD]^\WQJ1VJXO;%
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MG<"=HJ6$\#2>>=JA-)7Q-NW=:9.L"BDJ<!*.4H6<1T(^;))@5-IAG"TH]ZQ
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MI%YCGB*-98)O&#=12^]*/Z^#"_%#8V613.TW4-09FD'$W!O,TKYU0UKUC+
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M?>9O><VLG-%ZF$" ,9/9IER4H/4-+\9;@): 8*R3J8./+-?41;U@A2]+4 &
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M;5IH>4W7=5=[R;Z!^PO10+L9HGK,]XU;J.I^)J]?OG[S_7PNSN?BQ^N&"'L
M43K5-XAFXR!^LC93JJ*?*%XDT@-@JR?'0"6^6S$NAS3M\=(IJ$E$U?MV !@.
MU YEX0P3.D+=H%4!SL07?[FO'>UY>:G#E96)%?B7+\^_>O+-?WTW6OON)3I;
M??C+RAE6N^[_3&/\)W(TJX/>CKYUYF*T=O\=K>ZS$K6YOP"$[8ZV8G(OA(&[
M,7SQ]7_]X39'-*=^0LL:,W)&\WKM?8?VY)HYMU/Y]5=/'G_]S9^__/;)%U]_
M^?63K_Z+[-ZO &1XRV?60CRL>S_G__&_AIFQ,;YB" W^+FP5-S'R_\];9MXR
M#WG+>(67J+]^WCHG^QKGK7,*6T?CN1B<10B4>:^<S'N;]\K=[)7I8O:MB_3S
M#CJ9MSGOH+O805(W3JIBOY?\1Z_DGO*W>8^<S/N:]\B=[)'0:A>S"'3#UKMY
MJYS,:YNWRMTX9*N^8WD")7O6/BVK6YM0\]!.:H-=Q, 5?2\N/<_;ZV1>];R]
M[F9[0<K1XD_G+7$RKV?>$J>0+J,Z,9B6"-M0MOD9D$<'067,V^5D7MV\7>YB
MNQ!B-R4 KI=M)WS%NFF#3!FS%74,U24&HWGGG,Y;G'?.7>P<(1Y$,P6"?NTZ
M&( 3UVVV[3R-.^'I&+TGX+JLS.>==#)O==Y)=[&3NKX#>Y:</7%V;:(_:CYZ
M3N?ES1OFCK-J+,#!C!1;<,]0P]^O_*\Y+7""KV_>,G>Q97Q_2U'^NV^+[[!-
MYBUQ(J]GWA)WL27*^I]]O?3U%SU"NE)[;9?E95D12*8MM]PAK#2@YT?VS@EU
MNLPD0O=^A7[US4PB-),(W6'GV4JI+TC%#YP.@T:OF!_F:-L7M3.C'948> ;]
MR!K61C2E,2/)6(Y*H^3:TB=PP^PTH1&UJPEI'E/Q9*V;'K";=$WJ60$-O?PT
MX<FQ$:7XB4AH#R4GF( H--X>Y5 5L>]I#E51@ EW(=:.D>:@[;<>T[%H5[![
MB4(* 3H>)FCASZ1W$$R,JU6Q'+'N9\M-65P6#%GHB.(R(O,_3RXZXN1'7U\:
M*8P/R0]OM7KHC0G'K6H+@"&J8$5%:D$'8Z5RA!-I+S%2EJ#^1#.Z;X>?.?\?
MKJW\Q,SFW&U/R>ZR5HY:7XSE/GK3;I]R^_S_S]Z[-K=Q)-NB?P5Q(N9>.Z+)
M&<OV>,:*.!&T)(^]MSUR2/+VO>=;$R@0/0*ZL?M!&OO7G\J5F559_0 A6S3)
M87^8L4@"W=7555GY6+D6BT9S#ST3&6R58E;;Z6V"'5=VAKY>=C3#5O/KO-@J
M$\\H*QHN'!0OC?*I,KK^-CI_^N@-.O7=MG&I>=GE[TD?<[$JB.2-5 76:-Y@
M 57B7C5LI\9PL8?.4DK!X&P/,_/]3!CPZ$S1'\#]V'1,LV%873Y4DH,5NT*[
MHE@3]@.(F''E#VFF#)LR:@H'[J-.SA??N&5.[&,GCXV8Q?WA3A>%+B.-TGLB
M+I!@)7SV0MX-G5*F(/3>WI5KV1-EW6-0@2C?SI%G4-Z0Q)HR9=YRV1&IL'>5
M"#ZPH\E@TD3P6<.E 5@ \Y!]P,.J'VA,H2(_R="+ RCT?7#0O;47]UQ5D?3U
M;.G##=>2D@.GY]?)BEEWS$@8E%."4;9MJ7:P88)ZCJ-;L5#ECDA_:B:!I[$L
MZ$%P(J03S51NQ&;#9X]?Y-=@70&7GLAR$L-<5]=XS\=H!].96GSBSJ_.LT@L
M:0C<!KQJAB*;"@S^(^2&LDZU,JK5) Q#]#1AFGL+7]4 PD-80K] 'L\'.^T)
M\EP+UAB-#(%'O'!Y09@F/_TGJRL,5I E%Y$_ELXE<09MN/3Q=M7*KRGB[/!W
M))7%EAB90) 7%QY1<;OSQ4],_X,+\[;#2D6EDUF9Z+VNJKVHO=/=^/HR.SS_
MZN'$A>XGQM]<-(W]&S&JA@@X\ =<4B['2D;*LN5V("UR>:W[:.6(<IWH?@8#
M@4@D;8^\/K"L9MAW<=_0=,B<"?W8+A/-'^% $BI-\[0ZD_1Z+[N&T$C,(]@/
M7;(0V]!JY8"G"JYA!19Z0_HTMAF_[8>6D4_4 @5'?%,?93)%KS!".FV)8G+1
MY?-O9.C\\Q?/_P&^1:R5-X%>2?_XPMXI(9WB3ZR>LX_J-]Q%679^J&\@*S%S
M+,TNTQVY3#^IE;G95 O#J[9B>E#TQZI_L0Y4289F+Y+YUK3IX#/UW1ZVDK+<
M%P"NUPD/()FM(9L9WRO<GTB@3_2\KL(N#,"L!)>5'0=F!4JYH%^"QXC?ZH6D
M&HWB:_*[1(.EOLI+(1ZD;!91#5-R;LFE?+*W0>;"V]0]3L/SA;$EEK Y,@R.
MS/3*+?W;$S>#&759L$0F4;Q"N"Z8Q:"ZD4YCOB/UDO/%B^F9)C[8X1#DE"4/
MFM6_\T7902Z*&'KS)='YS?9LMF=WE;FWB>>R\FY*08>]]Y.V!?/J'[,=E>&%
M@Y!U(V)68Z%<DNWEX -4F]/7'Q>F@<7*C<V*M'7#W46^^,*'7$I8K5S)*DK
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M%C'R^>(?P7#Y$)*"#%S:^2>S,4K(I#XM%V6&W$7(W;,9<C=#[NYO_<4*SJ!
M3R W0B.GCJ"06<!-#$:ZL0(1E'SJ&@U6N9-$=,ZR<4M.#3G;J@$EIYKO+ F?
MU613$A=) &1MVMS4N(E]Q4?9'?%$2![OU:L+C/?G_TQ@W7H!X:&AZV1@'4@:
M;Q;_>/G3&\XUTK_H W16G%&^E^]G<I!,%=808M'51+N1N*+ 0P66%DHVJ).;
M/$P*S#;?Y[8S2D]7=C)D_(8FA?+F"./Y<MP&I 5S2KE()I-!7G&^_'61B$ "
MHS>_5!X$3Q'E,.A:*^>ON@7&,AZK7/P.%XRO!5<Q@\Y#HU,6T?CTAW"<-[;X
M*<U&<>WYIU@S.#)4_WN3&$=:5FW0Q ,;!HV%+"I1-DE(D;]'ZE..],"B>+-Q
MU-UTE0O>P/1.\K,$,1$L#N[.DD4@F+>ZH^8\8<T(7LE@!2.0"3E,PT/G5^^?
M?_Y/7B^46.$$$//F,,<+/M51%YBW02]"?UJ(E?RW+4*G,5.C_5JJ;1!Z>F3B
MY9U.KL\$/]=34]":*"-:%0DDT,24X,4O5_^Q;<4\F&;;-AO.!FE66^>O&4X@
M$W90_,=72R8TS)Z9.:(K(B1I7D9IAR CH>NU50NER>G0O_N6?G%D//H.E9\L
M&*&%I,<0 OMQ="6JY01'V18K7DAAG>P<U22*9K?X9-TWH*/O7%M>WK;^;J03
M_<)DN%]L25Z# 1!O7[QH,KM&OB\%SH-G>$G/\$Z'<:%YYS]?K/RN6Q$2Q5^#
MOO7RW<6G4>ABWW&3BI]9[_[^ M"/-QX'6&U^KW3CQ9_EJ\Q*A0V@4QGJ%@(]
M2SF"\IJH9/Q=PA1)33]O_),U;"FYF8=F50$(TDC-P):>E:=U)W45T38"HQ;#
MLT()[0 H=],,]H.("26S%_=Y1.482+/LZ=XB(W.)PQN5NK$\.).V!^(@FS37
M)$S7 "X@QP0P2I&R)O!M:9$*667N0)<QI8L8P&-^E%H(H*3-F3'Z)J=]PZQ>
M?I-#NDBCHO34'KM)WW[NJ0S1-H/9L;5,Q&$\/US+X%*%&'CMB?4VP\_]!KM=
M9*CBK>VQA;.S#DR?IM#*Z2%ZF%"^"V@8&G( )7-]H]L#* 4$AZN7<LY*6BUP
M"_FKP=#FR^?/_K+POMN6!O$)^;6?/__LJ_,O]7>?RN4I9*1WX7<A):+8UVAY
MNN@D! M1T+BJ46VB(J/,B#IOO.2U:XTJ+W0M?X@ME8H,NV%U)4 =XKAJ-+&V
MIS<.?+]Y$1ES$_^K(_H]/"(Q\>FI*G19="T'#J>JE/V.0IN!^\%XC\]PKROC
MU<_>)J)GH6'Z.\[0";%[V(#8S93JZ_;:ZB<DAO:M0;F+2O0YUX>NT0_ 6#_[
M:;62>)(6IZA9C'I>C3$,!NE@O5AB$9HMO2JZ=;$&@QO]6U"X3)H53K&#'$$X
MR6Z<UNACP4C]=RBB==YD$!D^T)%^,LI5L\SWSAZM?5FA$6,42^T76R)DN-KH
M65&H;P=@DK\APQUTU,;2Z11.'5AT<I3>VH9VDI6WTHW@$"MO^OXG^!G_F?HN
M48\I#GIP8_9+VE@</'9B^XV#^B>[]3I1$@?XVX?4CS8T4-WO'?_-]'72(VGO
M!!X)9^E/QI+YY?32WXO*^=\;,_1-L=WJN<K_U@XG^HTE_];  780;YH_I$V@
M0^O)9TN @.[I?%P)JP;*_"A3!X"E#B$FP=M$2T1IX8 !UC<D56K>%<H?J*_.
MWY=F<^K,XRT&^Q:^<X$W["/,E[HFXM8<+B6[J96]+BE)&"QF(P2AG1I#@ ,M
MB \$C'0,%\U[?LFR5V3Z&;/:C$%/>LL/JX/^;=DB 2J,4!/!U'!GFH/(A047
MA'RHHI]EPD(2DF;\B14XY_+!G,<:3.E;Q<DL(PS+%9+]YZ@$GB =$S<XGF-
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M[:EF7)> L";@Q[3S)6V,]C\%=H@=:A<N7VYPQ%<E[:5=_IZ.:(Y+M9=;>A?
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M;,M9[FRDW9_%!,? ,$.^ ,IZ)/0(H]V5PMD(84"W.%1=U%KJGXK"NG@%=K#
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M_R.$,J,X>G-MM0Q\[3!F38??;)RRF9NJFVDG(-N2]/I*\\*,VYQ]C,=F)/Z
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M5*)^ZVK7/H@2+)&PD;[D'-C0_5ES$;NX+E:=U':A<<@%*>9 B]+'.'N]MT7
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M5VEAB,M=#$K)KT"?G9T49V%5<WEH9FI\JAC0O\X8T!D#>J],C9'<!(0=Y*Y
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M#@P]2=H)):OPUCJEG_"Q'SH55(I- X3"D9,I@/[9A?9/I_0BD?'LQ#Z5F_Y
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MD,^F4$C/>Y_FI"K8LYCZIK2[;8N]\'"$E9T0-#F6F8TG'!?^<N#]MW6]EMY
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M^Z6,A'U*''A& )Q@V^>,'O$\&_?QLC6](:@-M?JKLDG)XWK3M5!X?TY@[N)
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M,<9R&*0L^KD@;A+56'MY+F][:^A5,F72[><0 @#ZMZH9X?TC7[Z#FF>!9J:
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M,0KLK1Z6K-9^=!T+;,%E4*X=XKFY;#C#AE04.Q6384S #(N:7S&H0N^@-VZ
MQ5WXF8"*E2S[=A;4_.(B7TXG_8?E\>B7,2*W&-W:CDO*S.'S,N4B+Y%C5TE
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M=DQX;1-4!\ W(!K'X:HTK761OGDO+7X+K(/9E%H.-LJ/JET)&$HJ7'2DAKH
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MG=;=+6_1"Z?-!(6& 0O>"LD1R0[+>OQ4UV/)H/QN[Z\7;MZM<SOI1P[?W'\
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M!0-EJE&F;<VT"YG<=X0&>2>S]@:E*=D8%3$%$!5)#+6RIOND2VL$YW%$YA
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MA4V+ZK(8SKMO?>TO7YKZMF<NU<?0MC0!64H^_ 7KK#(2%)OW=->5QF^DMEO
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M8X0CYN4YO<;[NZVG,,S-/L6'/K(/E9LX[S;P8T/W.,H96/D3*;NG$N:E4 '
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M82&T!G(J>%8$3ORM8<&*%RO0;=*GM@GU._@ M?Y3O'$Y&V+"3SI<^K:+IJ5
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M-]MA$L'KBM.%H>UQ)"L!L)J$96\6;A*6:SFO!!*=$ZL^C  D"X]Q\5M/LV8
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MBA,=95KYHV5=YJ9Q)IO6S6EE#^,;KA56,.L4BI#OSI$*$,U.TK8W*S])V[6
M1$00YV-B-XG(WBS7)"+7'!?(YLQ5)W6?X,B;FECW::TF^;B>FFQ7VB.L?@N-
M7'>FJ;A8C@DV)D'9GT6;!.4Z! 4OU'<FP"() ->U-XAI$FLD3]=-86@*-TF#
ML46P>"@.JCH&/>F*$TDFK<#JBKX&2SB[#><@/\.].Z6?6:@S1?]>5C1C)U,
M8I^VS"2FUQ* ""K%@6O9%V/2Q]U&/@81B.(D0'NSF), 78< "9UPF:QK",4<
MF.:>^1O_8M8SNKY>,6][E=M6C)@JN%C1*W0VF_3BW7^^>7GO\!G)'RTH_3)-
ME@5)8(-[EANFCP.[A\"&I>"BQHW8# 4/2.-*FW WR[E$3U^4Q9Q)KG_Y!*YM
M\YPOFF1X3_;3),/7DM9E^Q1TX-)8Z[@45VA0OX!+\>!J.V"OHPESHA;=\PT:
M<'&FBK4J7*)<M4/:7$\A.6W6RXQ&,S<]GT>^?"=AMZBA3_LR:^A$R4X-5XN3
M\U6!]Y[F#>CBREZ*6VFD/"(@Y?P2_[9>T/A().C_^LJB/0!3A10$^71UPS14
MG2N+]9T<VP44K?$#/4C^VM19;M\/ W&E@98>%%DM6Q=(!V+&49FPEFDG!6L*
MX/:LR<L@?F,[4L8&>' E6_EW,W9/9/&WGZ_[EZH5R$C9PZDS'%-O7[(XA"9F
M8%2R5+!H6DP62QHR!U_P;[V1D@PAO)KU9#22$*3)HJAHIQ?AO?@QHF98DB;&
M[^E8OG'B^XV/Y>.6^;GI^)&*=I.3\U?6,\A18TB.A.76"9<6!^X^>)4.')%,
M_)+.T:9?NY9(KO/(R+MK#=<A)AN3-9$CR5]@/'E!8R[:)=V[+'[KB]S>TH[K
M-"M*#9JFH!&")<\/@:*@(Y_-VP6]'(TOOL#YLM+,S(]O@"KCQF@;T9Q_JB=X
MZ)L.?M979K4N:P&*]\XK0 T:A',Q>FX6<$^'HM3A^_=?U;B_ 08,38*\3:7A
M7X;5#KWA+1_;^<LC?O)!\C.SEL\S&#Q)52=9V_8-&S!L$"WZ1J/<'52O0)GR
M$,[;"4+[;B<ZFMY JY\59<G4,%S&<Y"\0RNYQAVL$K?(#AO+,*^:W]E&@@\$
MAX9K@]QS\OH,H ]D6#HR>G=/4YT635U9$E7L_*+J#19FC=>:RVDE2Q4=7<'P
M9;SNGL)RGY5MC5%*V$/&%NS^>=:W\B&==/[H4Q>-7R!K>:W.LL;N.[=4;R2(
M8OF8M>PPV/YV^OUB&8:\R&N>9AH4H)YI9W4\FZOLD^&9H[U$KY Q\U94TJ@K
MRUN0=DE>+!:PLND$YW_/:5^6&['.]8*RA^5ZD+R6?8-/4U_KI=8K'JZRE^2]
ML0:\M:>#"=.X4>07V.ULM\K6DE^-93L=C=/1N#6EKP/,6I3[#N7'"PPJ39*.
MGB%0&;15):M7D:MW2J+)E%HD(%9S\.&9(05H&*K,6KB2E[>VK1Q.3BF&)F[H
M>PZ,7-7'>(QR;:$($[#N8(JE=R8E1.J1ED/=7*L1MYCAY48>G]<UP=45UVRR
M%E#G<X3-VI+3RO=]@[P,+E_7F-^"J9WO"0N$7!VB_) "',0+Z%E%"YKHHOTD
MQ]7(,*RZ5%@YV].J<3#/1"'+PX>=Q1 2;[Q&V2G]]M2H0^_4H%<]6&BZH034
M9*9SFN9YYWWX03XWZSB?BT^]>WY2@\$0'OV<;)Q>SR#Z]ZS/3TQW-8IM J-S
MXGQX_\$$1O?[P.BFL-'=.5R_<XCC7X9S$^!.I@/GA!6DG'\24A7;-TM:4A&E
M:=1;E8P@?Y\Z6Y'LXQX>J;\D(IV,:2['GV9YTW<]K=">!+:JM_H>."I+.I\K
M3D^-T$<#BJ%NVBD&-1G:-TX7?..3^4+93^$IYX;L7Y-;3_D?[_[Z,3F>=^1^
MPG9LD[*FW]%_STSB35IVT,^[L<*@=.P>YZ=9U3'0'2"(S$KC5HP@#&@O1*-W
M:!6V2/DM(O6B-B:#2 2ZPUT-@W.G"@K#0KAP9H+'"KDN74I6IXL+971QA^GH
M.C#3L,$>#9->[*,&DQ[>?VA=[H]9,\LJT]Y[][DT&\PJOD'NW,$N;U^2.D4+
M)Z*L6V[EHA<]T22;I*@P9)K+.<<*!&^S:EUDB7T#Q"]RFA^'J2%P-I\WB)!U
M5FVC!F6P)J+MX]=#>9=,6#4C0<2?M*Y%"^+PT[J3U,&. 3E72FO$+#<Q[HLC
MZ 0?<_PBFR_[SO%"MKP\)#JGV"*E)]HZ2/YEU$4X=Q\F:%(HDY?D6ZYF]. '
MARFF_PEM_+);UOT)75DT\WY%$\+I#[DGAYC4O:,%T# >)HT^,UD#JKUP$Q4+
M[/<9$$C@?W)]Q.'\>4E:QC#;5PGGQ"#*1W_)U_GS@?!]@*MR>#2[=T2CQBSQ
M]O#X)*\^2P.&W4:'SQX\9 '.@'J"^+)NJ?!"_E"&Q\YQ5W><)JJ0TJ2Y:K&=
M3@UDFF[YQ^3PX.C!HX0\K))]4O4"<QH#UAN0_ 4<70XOTPLO\"U/#IPW3(EU
MWSAZ2T\]XPFM:E8CIKE@N3*'L;2HR[(^PR7!XM& 4GT;-!$;&1T]OTK^>'AP
MWXV;AD';%)J0_/^N@,[@H%SP'MVR,49>0^3DHK?Q+S-GG/2+5&!2D(>?%[3L
MY>8@>45SG+ +A/OXZ?B-UJ%8\(M?0INV':*]X6_<7MMIO]G=9AWK,XVQTNSJ
M#M_6T;:VA<.&M+VV%$2@F4(]<9V*E6'NOJ/B1"1%;4]>&Y+C_&*3E70$ZQ9=
M4$[("$=N&\XRZ[?Q\U.S'FYY$'8*W[BU"1PY*,^SM/%:G#_ 1M;KMQ\H8QMY
M#HKFV]K9!WAW.@A$P'(60/UG-"-+4W+P'M]G"U*(!4>UBE;F2H3YZ!$90LE*
MQ7E% M=C RF;<(E$ETL:Y-G&AJE:Q))RJZ,4)C2UG=*J]:R^BY]X>#]\HBH*
M+AF)\D:\?XVH<J\(;:O!5;W^D_M7]_J<\FAQ,#E?Z9)[E?6+X*K:2*'-'^FU
MZH9IZZRF%FPO171O.T/##,9,=;C-+TUIA\D;^EZ%<M;3L=%LZS[L/M*1X=U6
MD/C!YXYM,,A"I;BK:E8LZD9//=R0#SZ0M=10R60^TV^"9EJ8H3F=42URRJ03
M>&0MF] XL,\S$EPJ0L[5O%[;M,+8_8-*/43BC21#;?MB(IF&A>."T1.P.$7Z
MWA\@8EV3(8T#PMU:+ P/@)DQ5RXW<PUNP,><5#R4DH9&4!_'%Y1%:\I3HP8A
MS84['<4$N<0DNM!5(Z8=+#B;+B?%T_:S7[DPL/:&3NQ[UC*/EWD6GX"_QRF=
M2@GOKN;[SB''XX@$1&MQK1$A'F+==[RU>8\OLT;CLI :&BL*=NJ@H#9.VHF%
M>YER6]%94L,0# GE$##2X.J%Q8BPDG*NSSDS93E%?"<;Y\9)^C>V<3Y:S*@,
MIQLDF L"JIX#*,#M%%D>DT5;12C'ERO5XK,<M67,7 \[@P;&)6\X]/&\= 1H
M*L8.E9@*_=OB5/$()3RV-384 U:Y5(?082V?IJ[T A[^I93+07+,#WK+H+]/
M.?#W()5(6!XIN,>/TR>'C],'3Y\&\Q.W!8A^4Q5(5X@2')FP(.K#QAX*$U':
M2*,4R[.OV'>R?B [ILX//$C>DJ$"*,DTFBN$/3\S*#G=]O#1P3/G')ZSH&Q8
MV:;YP-AIUV9.FM;D4<LA?1'7M2!6B9!)P84R_"P?-68,9761B\:-HI&<'&)
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ML?BE0$"C$?<.NLERC*AI-.A((W51EXX+. A;,%*"7?:FRM3)Y#S0?*,/7?N
MNW\-]-6F$<"Z>(>*,6$O]G%4[J^):/H<(95"F,\V%M@A#4 PRGK.;"PNYHKM
M9'M$'-H#KN0X<?@:(S]*=5J4%=)\7DLHEH,L&K28HSD"=_P+;-,&7CBHBRW
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MO[5EH>=F4;)U3B=FN]C8LO_S9$^]RG,@:U('0B*W&\%-B>\H<7,::;'J5PD
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MOXX/9\<<L4;"B[L&N3:Y9:K)MM5(,-?@<.)=GJ:4E,'MI3>#&R> KA:N%K[
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M%R^C II_F%-<P1ISRK8XA?9Z9B;R52V'LA'"3-J2:1DRN[B".F:7;;$+;OC
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MFO&L6@7OUULK@0ID5JV8QP=6.^.IN71NDYU]Q[WGK/>B4Y<B187@)VY/8>W
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MUUD[*."Z_F#08X8Z2(9R#.2L25S PEX G#7)SDV?99[:;9YR#.2L3%S PEX
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MQJ/E;:3H4Y>K5/\.G0HT!.B!,WFJ&('U%4F-Z[+.KBS8DV'-+"-(&F^0DM^
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M</Y<1:&TXTR%;7LC5J9QX;E.5-VDV7?JQZ !I1A4UQ>68*'$5PC4(0)*A#T
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M]Z,;;.<ZCAUB1!:'+F!A:TX%<XJ;G,)X>:+5;HK1US;;VZ=^M]\&_'6?AC^
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MH6CZ%^8WPC6'CMGPT8JJO?E]5/[B&BMZ;;WYORDW%MQB/7@,P98N._+<<6V
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MMV("OPB(/3_\(QQU3X/^Z?!H- Q.COJCH3B"?P1'H^"X$_;:_9-3T7M%=26
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M[@AQ3FAU3NAC B#%16K6H?&^XF&5=X$KM-&3\3T]X4%0YNC/13SS= X&_BO
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MVP?'H]>KP1I!.BZ5WU1<24W_1V($GWLNXALQ4V]?>3\] ?C/0LFKP4BGZ*T
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MU%?>P^4!4^:3-\%"SS[#H$14O[WHJ) E@DO#[JY?U\H%7_-JON/V-[\\HH_
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MK[QQ00N%K" &<84)<C;_R*,EFOH\=;^](O5'IO17L'R99_*]3.'-2,G>]GP
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M)9&6B2 N,$'6*XZ(IC0*3P0SL9?9_\=3RWNNN7#9V]F8F\0P:#:V=3 KR^#
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MPH8&H/<LP2#2>!(),NUI;IQS@K0U%EF=11B)+@K72[KCGB48?9]R/Z(,&HT
M A5G<*#=[?M@%\P]]!Z6PZ/-DA9!['D\P0$ NSBQ?W9U5%>K LO((9?ETL%H
MAS4>=@@+,HLIL,""S*%JD4W&)RS(W'J@EF5P8#%@L8*" _82[E@BFQ+KN8@"
MX1@"XH$+I!ECB!L29+3>N*3Z6$YP-5UYDV_F*/]=SWO.83-1Y*("X/LR5B'
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M89^-C+/K!/^%?1>7W()LREY[8L?_LI?-TT?5SP.#/7:/P0YG.4JNS60G#0+
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MGT_;9YSZ?YQ-QSGTFNJJAN!L4_O*3D(5ZO%B'D,9]:7"QL5PQ/<:BSOT@+9
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MV^XA,(<3F+#I"#8=[:'WR@B^[;(B5 .WM.ZF;3U2R.DE4 >$:<B^^04 =\\
M]_ \W^N\C#@%P 7 W3>_ .#N&>""PMV/P ; +=,O +A[!KB@</<CL %PR_0+
M .Z> 2XHW/T(; #<,OT"@+MG@ L*=S\"&P"W3+\ X.X9X(+"W8_ !L MTR\
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M<5"XN8<>!\ K$$\#BJ>R# XDLGT?[(*Y@42 1"">()Z 5R .( Z 5R">()Z
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M '@%X@GB"7@%XJ L<P\]#H!7()X@GH!7( [*,O?0XP!X!>)I<_$$W?1WG7[
M,84Z!G ,X@!T <03Q!/P"L3!8,T]]#@ 7H%X@G@"7H$X*,O<0X\#X!6()X@G
MX!6(@[+,#<T2A\9+=S=+I(X9;HE 3'&/N!,,6>\BD@ISPW5P++%;I[3(9*.U
M#BE-".(Z"62L<H@HJBP7(GI_JUEBUQCMZ&9?M!<3/SV/+Z=-<W@^S6/H_^M:
M(WYLJOA\-CT_/#EZ\;I]>_[%)'37>#UMYK,XKV>Q?=.O<1+S8[X>VTGS?#I[
M%>>O9_5TMNJK>)3?>S2+H9[G7YRDM_9#+ST535_]% 'C]A/C@.LA#@9D[J''
MP?"X&N:0$$_EQA/P"L1!T7$ <\B-SB$C%9K82%%PT2+N#46.6X\,3IG%'+&$
MI#X:[L,<$C!N(#WY^SI[!'KR/]S?.6X?TH._YV-DRO+F8*1<KT>/K):K7QOJ
MOO7J9?EJ%]SRE>#X5L<4/T4:'DJ6=,;?5X;!3<V3W0&!"BP&+ 8L5DQP (L!
MBP&+#2!0RS(XL!BP6$'! 2P&+ 8L-H! +<O@P&+ 8@4%![ 8L!BPV  "M2R#
M XL!BQ44',!BP&+ 8@,(U+(,#BP&+%90< "+ 8L!BPT@4,LR.+ 8L%A!P0$L
M!BP&+#: 0"W+X,!BP&(%!0>P&+ 8L-CZ Q5.QMAU_@,54H(70(44Z190(:!"
M0(4,/U#+,CBP&+!80<$!+ 8L!BPV@$ MR^# 8L!B!04'L!BP&+#8  *U+(,#
MBP&+%10<P&+ 8L!B PC4L@P.+ 8L5E!PK)_%-M4B?7@T]OAJ"/0XYH9GA;L[
MO4MG5?)$HQ1P1#P0@RS5"CFBI#*1.:GBYYW>K7*41B\083HA3JE'#K<_ZI"D
ME-9*K#_O]/XJSC^V=O_V?NM-'H;YU1<;KVLU,HSTU7T=1,N#0GUSX_FG,H"]
M+(^!Z@'5 ZH'5 ^HGB^J'J.)\5)XI+ GB!OED0Y:(NPU9H[@*+WJXWP;4#V@
M>C:@>OH[Y::O [_VXY0;-QV'=3GZ5SNV$Q\KVU33]#<WJWY>,?O-/Y]%'\]=
MG%6,C"J**2GCG+>R/#\830P'?Q5M;CC<<#?$GW=)6X\5,H%@Q#&+R/@0$?$D
M8IT5(-?LEOCCS@:%#2(Q4<19DLC1+ ,5UY91)TSB[G/Q]S:>7TQG=G9Y_,]%
M/;\\/;.SV)PLYLW<3D(]>?>)'FRZW]X4@B]>/?^B )0CJLU(8CAW$."G.(,#
MYV[?!T7/8_Y21M0 :0^$M 41F& ;D.8XDW8T!CFF0DO%+D9NI;TC8_-PTCZR
ML]EEYNK#\VS"^>%\/JO=8F[=.+Z=OLZ,/9GW<G:P&DDE@,>!QTLS./#X]GVP
M"^8&&MX-&DY<:N$91PQ'@SCA%&D?*+(L)4$4803?HN$8B8B.!623;6G8Y?FV
M8@8EZ9WRAC$JS(;GSH2/N)$CS8!T 7^*,SB0[O9] )-G8.V=86WOH^:AG0@S
MFUF;RX","1IAP["E.@;!Y1I8>T.39\E'3"L@<B#RT@P.1+Y]'^R"N8&'=X.'
M&?9*.*.1UFWE64B+C(L68<$Q)RS9(/7M98>,DA0<PEI$Q*T62 NJD-?:>R^#
M3C)N>O;,1D3@$6<82!?PIS2# ^ENWP<P>P;6WAG6]DEI2F5"T>B N!(4N8 9
M2O[_9^]-F^/&D;71O\+HL]SNB(*' ,$%/>>\$6K9GO&-;DMAN\][YGZ9P"IQ
MNE34%*ML:W[]!4"RBK5(7D1)()43,6Y)5<4B$\A\GDSDH@06 BNITP= [4?R
MGG%"9SD;K)!@PD9M"A@"2!["*L"F#VG3 Q"/!(A)FN>29@PIHCBBBMMU5YJA
ME":IU(;'1II](,XS3G(A.=(9MRYWQB42A<P0Q06)>5IH0N0CN\_6>\[C65K
MV3.8G^ $#IC[]&L WC. ]F1 6QN3F53E*!7:PFZ1%*C@I'"@+8F17"M^4&TU
M &@_DO><D!EE!0#Y!( <YKI-G0( $0MA%<!HA;3I@4>-A$<)D8H\Q<S2(9PB
M2BTQ*@3#*)6IX=H(;,S!*03.62J+3"%L"HJHR P2TK*P5.NL()04A!V<0IQ6
M5U?5XOVJDG\,'?C(9S&)9Q1R]<#TA"=PP-NG7P,(? !@3P:P61*S.#$6<@MF
M 9N;&%D,ERC-<"QCF?.8R2$ VT/U936WSFO=Q#Z&R0L D :0#DW@ -)/OP8
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MY[]])C&FH$^@3P'J$^ *Z 'H > *Z-.H]"DL@0.(//T:3$'< "( (J!/H$^
M*Z 'H > *Z!/H$^ *Z 'H8I[['H N +Z!/H$N )Z$):XQZX'@"N@3Z!/@"N@
M!V&)>^QZ +@"^@3Z!+@">A"6N,>N!X KH$^/IT\P"V3J\ ,+$^C"@!V;AAY
MXX 'VA['"TX)TSJV_T/*9 I18A@J)(^1,4SD(LLDD<6#SP*Q3^)?NN_,#XQG
M2<;<_Y^J\!2LT#2L$* QZ,&(Q UH/ TT9ER0A+("9;C($$V2 A6&9TAB2G&N
MF,HR^M S/XZ#\7?W@0 D!@L$2 Q(#'H 2#PB),X25N LB5&2%RFBP@W>4CQ'
M,DUXQGDAM6N.]["S/09&8I;-[,, 'H,= CP&/ 8]&(4>C ]/O[?E.B@2*!(
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M?0)] EP!/0A5W&/7 \ 5T"?0)\ 5T(.PQ#UV/0!< 7T"?0)< 3T(2]QCUP/
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M]"!4<8]=#P!70)] GP!70 _"$O?8]0!P!?0)] EP!?0@+'&/70\ 5T"?0)\
M5T /PA+WV/4 < 7TZ?'T"48X3!U^8&$"71BP8]/0 R@<?Z#M<;QP7!%<<,GM
M4S"1(VH(02S.4R0U44)GQL0LWR\<+])8YIFF2/*B<)_)D4CB%&'.E2YH0G)*
MOVF$@W_QK*D0?=56E*I[CG-@J14[3H:J'P=S]#S-$< RZ,&(Q#UV/1@?K'YO
MAS%0)% D !30@\#%#7[>V #IENE 62ZT9!1AK6-$$R&1]=0X2E*<*2R-CA-Z
M,!U(9JS(73\QI5)$"RF1B),8%8+G1.>D,!G^E@9A7W;SOKM9V P7#%P]L$B
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MP '% ,4"4@Y ,4 Q0+$1*&I8 @<4 Q0+2#D Q0#% ,5&H*AA"1Q0#% L(.4
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MQAH5&F.4%I@P%RG),K5/?&)CN%9:(\Z5FQI#"!)%9LE2FE!":(HSFCT2\2F
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M7FX%E5ZOHKJ:ERK:W>QAK=44EN4+RO&U"P,$)S2"\YCZV?\RNQR@J(!B@&*
M8L$HQ\.C&!P:P*'!=W0JDT0I:A*4"HD1S7*.BMP81(T4*:4D9_%!4_7A,E6Z
M0=7UR[5>5>\:W^R\<<V&/3T(,V=EY*1F?(<-CY$E0QXR3D0@3O2]&^*M7D62
MUY?1NO:!H:C:I,TXD_ 1\F7&3J4'C:@#E0[T) NH-%#I$*DT5I3'&8X1H3E%
M-)4$B4P)1%B*BR0I,D'Y$/DW%L=.+8R=+ZN/I=+JEYO?:\>DMYT#-V V</?
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MP'WZ-9B"N,%_'YG_#OH4HO\.A_+A*-B;X\?PEFW6JSJZYJ4*(S8:UCJ/AE!
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M")Q:##AO(>"7F]]KK=XL7G<P<+)!@4&H)TWP+ \TEV;DY/,96+FP! X4 "A
M0,H!%&!B%, HC27.#>(\$8AF.D,BUY81J"+7>4&%T0<YM-^3S//(% "GQ2R-
M,Z  $[!RD HTQ<#0*V.T])E ^K.\Y(L+'2WY2D?-SW5D+92+&\V:Z)'^Y[K\
M:*W 8E5'?&$U1=>K92E=XYG]U\,X7@IK>XR&14ZX '4*XAY]"O?X["2<E=Y.
M7C6U5+(P&<(%B1&EL4#,8(PTES2.J6&L.)CN^#WQJP:KSLRK%JG>6: Z6S@^
MZ_[_:HL][S:PY%XX6:C=/_3>^?4LM[:;V?YT)]W-TB!/6L,RP.,[. 7: K3E
MJ==@"N(>/6T!O&^"53)34J<"49(;1)7 B&5%C#*,$QYGLF!%-D2PZDGQ_LY>
MQP#SX1DLZ-,SQ?B42UPJ%](*OM;VA\<-1L&19@@T ^IY@Q8WL+JQV=3CK"[1
M2<%%C%%.<HFHEG;=M6 H37!AGS%+DX(,$<6Y%W\[MP]6J3<M(+S4S7_M[_.U
M*A<7?:;8L,=A"!^9%</%=L">C=F>A25P /&G7X,IB!M ?!H@GB5%DN<F1EJY
M^$S*4R1P2I J%*:9M @OQ1"AF1&">)+/$CQ8*1S8LQ C-Y!9%(Z!.OVN2,TL
M$MK*9N&JTBH377M3$<;Y1%@;8C3,#_HX!,D0H8\#,,F[F"0AO$A=5^=$L1S1
MW/XD<HT1H3Q.=)9DA3G(2,_R0F2TH(C:EQ%EJD %R0G*%,=QFDHIL!R426XX
MX\NROJYJ/O^+E?RU_83]W=U:N5AK=69!A/N6E8/PR#2>)<5@@TZAI<*S,I-A
M"1PX!'"(@)0#.,3$.$2"&<ZT+A#+28)HFB5(*&Q_346195F2I%FQSR%H$:>6
M)V@D6!XC2BA#19;$"!.C"YFQQ#*1T7,(G,SB;+"R.. 0DPA>0=I1./;L>X-7
M>J'N';:" \L0N,T#UAJ3%\19556MQ5P'33J#KM7X]S#TZ^O7%GAK<';^.&]-
M$YGC6&=(,:P0-4PA1K@EK\+23V$4%_0PP5UGAG&*$=94(NIH;F%BCD3,.<<Y
MC5E:C)ZW9HEEFF$F0GU1#8&Y/KFI#$O@0$6 B@ 5 2H2-!4IM"B84!+A FM$
M)4L13V.*!$M3G!;4\I2#VGHXA@O<Q (5@0RP(()HHIJKA[)G[]?7UW/MYAOP
M>:2L(9A7]7JI77C,Q\W,O/H4E8M&Q:WJ_AS&(518BQX01[4R=Z_\]P_DA['T
M!7BD 68!+1(L#"P,V#"P8: JL#!A$G0XY0XGY'!:+:Q4:Q=M<*S<_[8JG9NZ
MJ%:Z.>[F4BZM]VZ9NE4.7;MN'*LJ>F^O:]]PBLA_B67TIW;G]/]=:J7U%7<7
MZU_8/F4[<+IVL^3#B)N%M8_"T/CG70,'T>8)0.?X#/(]!TM/6"&G8/\ A4)8
MA1%M>D A:$TQF9/,E&I#3)8CPH5"5!0Y8B0I$->Y9'&2ZIC<?Z+RUJ,Y,Z=;
MM^.M<V=.%NJD<6;>M+Z,_6_U;N.G]-Y_WGDI[YV3,DS["3)+:1'D>6581F_$
ML0TX? S'"/V^L#*?V\NJ:%[5?I!-?5DM5\BJ_E546E6O5U?WZ T*(?L0R-^$
M&RA/DOP%$[T'\O>XY"_+,HE)AK2AEOQEA**"*(QTFN:Q8)BE23Y$<]&MU?\+
M+Q>_6L-_MGBSM?6#,#D29N%F6-9K"F !D!W"*HQHTP-D V1/!K(-DUSE18$H
MT1:R"YRA(C7$XK8P6<YU;-)!IKP\!F3#7+8 $1MR2J88=SE?+^4EK^T'71^$
M975M17SC,TE<HX1KI]-NH,M\K7Q2B<LOL8^WJJ-K?N.BL&&<*H2U"T;#[28<
MEIXDMX.SN&?*[:C(51%32^LRR],R6B#!E$29S$A6*,PQU_<)Q_BSN T2G)GS
M%@=.%NI5AP)O6A!XLSAI(>"\08!!&!^#H[8 *1\ .0#Y4Z\! #D ^62 '&><
MD#SEB*HX0906#'&9Y@C+@LI<Y45JV+V3:IX4R D!( \/R"%G9HJQFY==;4YE
M[ ]N!(NLZE5]9[QFITA(?[[6"VLHPCAJ"&L[C(;[33C&/4GN%\P!'93U/$Q9
MSX05<@KV#U HA%48T:8'%(((Q&0B$ EC,15*(2QXAFB6,224H"B.F>0L9;I0
M]YHXZR,0G6-RUOHEI\XMN37NL"WT>=7Z(\,<*60YI)&$A^B01C+%4,0[]QVH
M,FA=ZXC7M6ZG;\Q++LIYN7+=1];7U@J=O#^-"DHBKJIKIY)A!-##6O[1D+X)
MAV@G2?K@V.EYDC[,.:=2$"1YKBWITREB-"M0QF4B>9I3PPY(WS?GCW@(.#._
MU_K$VW]+ZW[=6O_?K?$_J:4U_2>MY1_FN&E&8@PG3N'1/,!PP/"G7@/ <#@^
M&-_QP805<L3!!LA["$?!C@4;*K'BY:+)>="?Y25?7&A''*.YYO9=O3A$& 'S
ML/; :-C*A".QDV0K<,ST/",.J2*8,TV1R1.,:)&G2&"AD<[B!%.:Q=*0(1J(
M[ 4=SEH4>+-XU6+ ZVK93K):7/SJH*"+2=P,$G^@,Y8.5KHR8>,V!2P!1 ]A
M%4:TZ0'1(?XPOOC#A!5RQ/$'2'8(1\%^JS[Z08FN98:ZI09C5?D&&JN;,,*\
M82WY:,C)A&.QDR0GP1R.0+CA4<,-2L:"Q"E#BJL,488-*DR<(\$-3C3&*C;)
MO1,<.K-_9H[FMWZH7GF#/TP'M!E-!TM?G; 5FP)H '2'L HCVO0 W1!7&%]<
M8<(*.>*X N0UA*-@KZOYO/J$_'A7:.CP;)G+A .PDV0NP9R(0-#A48,.PA"L
M.:,H,SI'E.<YXC'5*%.%2D3*>)+(>P<=&DPX6SQI*2U.8(9*@"P0$!T0_:G7
M ! =8A'CBT5,6"%''(N '(=P%&P[F;D9#-*E.=1NPK++;I#5U94;TNI_]ZT=
M2DLT2SZ/KM=B7LI-#".,>'!8^V$TS&7"0=M),I=@3E$@%O&HL0B9%HJ0.$&9
MP 6BBAK$4B90%@LF"H.)SNB]8Q%;3'"=Q5M$>.\ X$-UZN' _^):/;QIL.#<
M0T$7NQBFXT/"9DD*/1\"9(* ZH#J3[T&@.H0CQA?/&+""CGB> 3D1H2C8&\6
MLKK2T8I_UB[UH51AA';#6M;1$) )QU\G24"".1"!L,*CAA5(G&F6R1S%&5:(
MXBQ!0AF-BI2S(LN8B D?HHU#8]T_..-^;FW[,($":/\=(#L#B :(?NHU (B&
M&,'X8@035L@GBQ'8_[JT2?_C;?+XCX>EGUOM^@:8P(=?.Z2<@A/'HRC[L$+]
M<*E]K<:5?8P;5\JQJ%;V*GSI*C:BTK[M8NF2)?C2]Y%87>I:.R9=5_-2\956
MD2D7?"%=1D6]LG]PI<?UBT%6"1-8IJ[F!G42'?F#Y'L[XW(3_+SF%[J!"L2-
M7;6?^?P3OZG__$/TIZ?4].]@Q\DM CM96BW9B(DO:@0&[W #BFJN'FS[G?SV
MMU__]K_1^5]/WOUV<OKJ]P]O3D]^?3^+WKP]?7%,P\)[@F@8TSK8AO A& \:
M?U]5?^\CP]\WR/!MN\9_R6II]<.%37Y>7U_KI>2U#G [O3W[\.I]].$L.NTC
MXNLW;T_>GKXY^?4[;/:('CYZ_^'DPZO?7KW]\/[8@X[I2?9T2I4?#SG_]WWE
M)F3Y=GUE_R#;B&6<\93D1B =9PQ1*5,D-(\19IHD0G&<835$Q/(M7ZV7^LRT
MS67M+OTATK7DUVZ!EFM]AX/UT-SL.T(>(]I2^$74R-ZQYE_6=;G0=3TA-3F^
M;;(7698'N'%"9,(G5S?SF\_1^26W7R/UVH<_:DM%%O+%+%I5%]HZ6\OH4[FZ
MC,I5'7VZK.;SFZCZY,8'U&M1EZKDRU+;C_RQL'^->!VUUZR6SE&SH.2]NEE4
M6H?.9\+;K67A&%E'[4)'HK2H+2\75C87-U'K C;?QZ.KLO99]:LJJA8Z4OPF
MT@OE+UNO-V7_?%W;FQ$WT4*OEY72%WKA[<Q'^XFR=GVLZQ?1A^VMN#LQE?2?
M<A>WKRC]4<^K:]^HT/4(N*Z<?)P[>3&OA/W/]K[+?WD3YC3*">3:?N-:KNQ=
M+)1'WEET\MO_QG&21C_6E2K75]'UI5[<S,5Z=6/OJNE!L.+KY7KI7J_FL\A*
MO-J*S_^]^ES:[>+>9G7V)S^<P=WGRGHFJZZ=(K^ZJ5;+ZOK2&O2YO;)SD6LY
MU\NJ+NUZV(]85ODBBL[62^L?+^M5=[.SZ-VK7__V/^_>G%ERG],_?^V=_C1S
MQ0T?RVI=VSVP7>_V><M&EK^_>/^B6>UK^WT?FTX,W0O'G\3>IV_7H-9SZ[9O
M+U@WHME<R&\+NWE5Z5'$K?E?-9_;/Y[R!5?<W[%5W#^T8T#NUG[]Q3[E_W=R
MY]<VG]W9(DWXD?VYCG[S5W/[[&2]NJR69=TL_\GU]=SJBOO9B_JWDY.9_Y;N
MYF_]QJ6^XJ6]>6LFK&8Y>5J5M4_2*LM5N5KI9AS';UJ5TM+7>73>+%SM__S7
MM57OZ/=:^R\^_>MOY[,V*A*]L@IPK>VK[4>M03BQZB!O_%M?_79RH CMSO</
MV+OSRJO][0KE;GAN/[KD%^ZC3A/6B_*?:^VWQ5RKBV;[+/6\0?S+\KKN-L+A
M9;T!?/%%R_YE0G 8$PW4K@^"D<WGW4W^7*[L_<L[QL#4?S139G]?2+UTG?_[
M\UW"\#:__G& ! P=?NV9! OK_] 6TBSJ+C?;9MW?-EU!6U/:9C_G_M8J]RZ@
MV]58UZNE@W_?A\$:BUED <9%>*-Y:8V=-=2K:N8_6JU7/G&M*:*3\W+AV(@5
MK/V<;FYC\\>5"V-9E&NLO8L>Z^N5=?1;U/(,P?ZMKLWZ%O3NL&%F24TI+ZVI
MDKIT*'.U,?F\,?GM9_;19P,=[J?_=VT)"HD)F?D;Z "VN_@GWL/#UMB_?GFR
M XWVY_?V(?25L*:WN=26AZC2F%):?'22\'=BK;2RUO6FD;P5I;UA_\)2U]?M
M^KEK+_7%VAKA:GG3WH&+I"\K)QM[J0XX?COQ]]W8?;^H2]\QR8*!W8.+3A0K
M3_7Z=$DTK,T*S'Z%O]["[K[-%O"+52X6]FN]U-R'K[734;M45JA_Z)O(.AMU
MM5CHN>,7;O>L-J64U;4EERMN[WV[J6;^"^>E7VW_Q!=6K,N%OYWV:9NO:J>7
M.$G46CH_B*MF]1REX]?.RK@7S=H]^L8[;9:PW?MU7=F-L^K8AQ.6MIN@NK*L
M2U[R^5PO+IQ&;%BHQ_&S_WGSTOK1D=4-I=U;W14WG]LJD].0Z*-ET)93=5RS
MV7_]2U[HZKIR$[D:85KFW#Z85XEJ8:RM7.U"NWO%H;+3<I?2X];FRO'GS_8Q
M2R]]B^7+]?5F+]?6ZW/4WO%:?57;Y^ K?P3C-DJS"1TS<!>U.TSSI=W6[EOV
MN?-6V2*72O2QW3,]_7>7T9^Y74-+89;\D[TQRUZ=/OL+B/7\CT@MUQ?>P?!*
MW=[-JF^HKJZKI6-$R^JJY3W^TZU*>M&UVF4-X=K8>UE[?\&I?L-TFG5V%S-K
M[R4?D/GZRYSD:X &6,EQX/E+Y1;DM'+JL !('S0%W!^H+M762+;MCYS$WUNE
M4GRIZNCWZ\9G=8[+^]]GD4NZ0#B=C>R@[QN8X\O2^LA5W0;%=MAP="(L!7%'
MSJ_L[ZN>%WBR!1*[6ZT,UVZ88L2CG1T<_?A^+>PVM!:>Q"FB\4\C$^-M0IOM
M6-Y+^^3:LHAU@XJ738C(_:,]7O0HDD>]C^XPOC'@2V[]Q\ZL-[RFLB*S0.T$
MOSKF@/<P7.Z(_J)JFCXVHG=;W)I[%R:ZL=@4^=/;)K;C0AGNAR\F#/B[+^MZ
MK=6+Z+_$,OK3_YG( AYF]X"%O:=(WY?.LI9-QU%]W02"]M7$<J-JU49*VQUO
M*9;]IPL?:F,\BW&^UEVDRCWAH1=SE%\Y1V:Y+KVAMT_#+_3F*IY#MSX5-V;F
M];&)H7HN/&L94//1CI,YNO;5_EA#X,JYOY-R89;<NG]KZ>F5H^&69-H'=L[9
M9>_V7T1=#SXKMH^.B)5V%]D5BH36"W\'=XK'AYFLG)N0TKSA=<HN76F_O0DQ
M^>ZPS?U]<DS1DNGRNC$-UC!5ZZ5=[_G<\],[KM(UC;7V9C[?&B3[9%;^2S\^
MMR6=+:6TF^"3^V7IC>3F3>[[+C57'I+[@G$O=)=5O8?>B.K@^;=\MKEA_X5'
M[VS[A=X[6%B/J'7X:JN8I?4OK5C:-KJ=1%WHW=_2[7MOU_%PV[Z-[/D'L-9_
M[?F[5>^+2VMWK10OEGS147<G*Q<6/6D=+:]'[@^OK5'R3GATZ@3YVEF']F7_
MAY/YORZUU=SE%BM>V[?,CKWPTGD3#OF=HWC3NY:7Q)$/[-R-W7U_<7=L?:@7
MD6-6K1/IA'-E$>=F&SOPC^04NWG$0XO@ ]H-^.C&0]OZG1LAN0_M=0;J#$:_
ME9!3U_*CV\,UGS>^_%[SH5GG(?K,5N?/^R2)YL]7UK7W=[Y8S6\VW]VN6/,D
MF^MV\8Q&7EU4O1^]V/I>LRX"824ROP$D!23]QNS/+Q,U#Q(>&NP-7_-E<Y+7
M<D+4<4+!_4%8$X'SWW=U[:Q:W<;%=L*![6QTMXW=$4]M^"8,U1N(OCG"\"*Q
M%UTO:^](B/9T_= 8>CN[]+;0_> >T/H?=6O)%_JBQ2=>6^LXKSZU=K%G%NJ&
M:G0TXX6U3NXK7UK5];'"!,_:>&'/V@P6VG_@U=\)Y9>??]:??;_>ITL)@73=
MT!ZDV,V,BKXZ8Q?2=5T=1PA*-1&HNN0N7NS0:GVU;@BRTI8WEYZ&__LQ?;OO
MK8Q02L?KHRV1U3GE!2IR11"-M4+""(DXXZE)8ZR+E.UG&\8Z,XQ3C+"F$E&%
M"S>KCB,1<\YQ3F.6%@=C[G4SU_X57RXLV-8GV\5ZV:S5K273V4[)=/J#]XOL
M3W?63B<I?4%N+9\>^8:/[ 7F]GDF\CB[[,PY\RZIIN>%W4+.MJ_V:)H[3MOX
MV>6B/6[=^OWE:O-RO6GXNO&H^DY4+WMIXVCM9%.U7EQ[+?M-/L3BPC9;9MJ+
M"WS+ ==1B?B8B'<W[>/.FH=V(WH_VKM?="SYLEJND$5<Z_!:_[)>M3'4X]QT
M(AMHUD;C&C'N^,K'762_WK,F7*07_DB]'Q+H#I_]%EPT(>WM9MM$F_SZM^?5
M_H^J].NY=(NR;)TB%R6SRS;7O&YBZ:M/>OY1HRM[]Y?ND+VLK#OE9V2XB[MW
MN&"W/R'ZOJJZSNJU:>7V=U5^[)+7C^><%UHSE68QH@5CB%),K$47.=)%D:0B
M4XG)\1 YY^^W$:WMP=>Y?3)I=>6#O?8O\TK^,50>^E,<\(XH9YN\B-ZOKZY<
M&H?=:+VEZ1]*=HL35D[:5[FM#U^JP:F,)4T)DC).$)5N:*_.,,I)9O(<4Y'<
M;VAOIS:_N)#)F=E3F9OFWV]4FTG%P!XY,\*O@U.6<W<$L%AM@]7;(B_[E_TV
M"2-'UV$B@98YN9PH>ZONW+@I)=B:F>ME:2]R[5A8>\[C3N1\^N!NJGH3]S\Y
M.9]UQR7.A?8O;^8*MMES^TE7MU9)O(A.YG-?T+[L2AT$GS<93OZ SIGSQH/H
M/YIVF9(+OMH\W'8'V"LNW/F#T4O=1 E;(&]*Z%<^>]YEJCOF<;$NFX00N[>N
M-&].GOQGNV3!+LVOH;WNZ1VA,Y7G*(ULCN:1G%;*F_3-@<G)^]-&;B?O?^_$
M]'JS@$>O\4ME_^,__/KD_2]?YAF/8'9QJJV?6F3(\I3"_D,S)!(JD%6Z!,LX
MC_-DD)Y>O]?ZS+RJ5Z4[=?W*ZC@PK]]O7G]O@O8;B4_0CC;F<'.\\74),$=,
MI[<!K9]1'T_1Z649N!-1_H?+&6TEVYY)U^NKZ^Z,TZ65&N,SE/TQC#OW=N4Z
M5QN;VCN+Z9^]M!F@/J&G?:3C:3QM!OC>I=UG-AZ5:I)!MV_SV.!])&M2Y6IM
M+VD?V!4DN5,>ZVR[#&QK*-M#ZZKN/>2+Z+>M")R42Z5]OJWSO-OD6Y=AJ^?N
M5-2=:5\WJ<WN2;:/T$>IE@R[C_5*='SV\1=$:]W"?O+KD7UPU*WK/\+5VGJ0
MW*<#]S,#_K%6%_YU?^FR[M+(^Y_=[HKV/MWWMN^SWV\WJ(^;W)3:BI1'%N\N
MFH3_+M-][M",UU7C*^\^[-7>+38"]1'99H6]!(R]2-TEA+5I9^VW'+ORBZT9
M.!#>UEOF[J,S]SW.0W=)$_7/T5^655U;2XL6>M70A0]O[7O4/]9M-&3F0R,N
M<^#&);Z[8$FYZ!;2\'(9N3PZ?VO'#NGW)A7/FD-])+B[19]UOZ@[R-W&KWRN
MA^\#ABJ#[./LZ)-_M:=5LZA)Y?/\TCVM)PC&5Q>TJ00K_KE_B5LS<;K['*Z)
MQ6.>/3X5Q\@R180E$\BDC"*J28RXH G"-!6&:4U2<Q 7_QZ.\:X)5KW3LKI8
M^/P5\.H>NPJOC1<NMVLP,>;Q9J<2JLM+^^;2JG[I[D&1[VV5M;,-\'?^V)RO
M%_)2JV/!=E^S9<'&W:G/ZMJOO3JX^4WUE+V[3;"W5\OUY=+F.^[P6-S?_7QF
MV4-W3\,4HXQ&.1^QZM&G?-3-(0Y?>KK04$F_,9T[KUT@?^D@^%H[ZF3I\773
M-*$[>]F^H%R^:"G6CO<U-=J6#U17_N/V"S8OZUX-XL[I07>&U!4,MN<-;?;A
M?EW'^]/H@R\ZR.(L0M'(+,FW6T_/P%T9ACMK;9=H(^&1/?WMYTQVVVQ6=;8Y
M:2KK#CS^U=1>--9"MH\?56+EFPOXLK]JWA917I6.,%Y4E:K==>U7?RQEDS2^
M3YZ7VLS;(T"]<65:(^WSZ+P+XLMCMJ>%523:/\Z;E&%[7?U97GK:W9A%YR\=
MW  8M$$-6K5Q,?1FP_2H1G- V+=N!T65F\\WKM#&A])1+5V!I=U.O4W9_Z1U
M/US8H-YSFWRZ=[W2U]9;^K'\R5)>MTW,3;>]O [_6/_4=7SI-O+,OGO_[>U7
M-.>5PJX<W]2N]J_F/VH_NY5% \J;R*H+ 4OMWO;Q)^_RR*Y"Z.!-75CTJ[_:
M6>\?[64W2KI9"*^K/[H5L$_;EUR3;>I1Y);OV3VCKQ;SFR:HV\9CG(R1DW%T
M52GM"YH/5_E*ZS9ZHDW9[@<7:=G<>]N/I+>\VXH2?^_E*FI<?M&>8N_MG;8B
M8C[O(CN[UJ/_UF\Q'$?,QNX)NC\!=>CM/NZB->T6>A&=K+9/URO2<=G!.\O6
M]$%I=XMJ[^H;]K[SC7W.R/&[W1C@]I*:M^G(_KL;)WJC=HVEW$1R;MMX;>BG
M^=JN!,]?>,?<]^[#/Z1E'E80>Z7B*[>ZFPWKR7>W:?V1P"9X=HN*^%R1>J-)
M:MMXH*L"N.4Q#G7BEO>YIA2MEJAG5I']Z"RK;344M6QK9J^X IA^(+_#E9PU
M^6<'7+\S9QMFZY76VH;-'_S)HO[GNJG?<5$Y5U>X7NY<XL!=N7$O?_0!ZEE;
M_;5T&9/SGC\S<Z5BSN.6O$D:Z][?%DM;-%&^ZD^VCI-586NW?'Y2Z^1>6WUM
MXLI[!5/\8JG[SI4WI#W_Z*N]LF..V"TWWM[1C8O#>W/5ON(AIM<\Y,H=1?H#
M@X7ZDZ]Z].55<]=:[J):E6U)F_"QXF.]5J[72PM>S>%2?R5N:2ZVH>TMSVD/
M4#?Q\NU1 H\6:Q^;L!=N3Q3Z -VAR;JM6ISK"]>NHWNC+WJ\K#JOX)9CG"ZK
MS9=P:NXEWP:O?3.4O53!M@)\N'P=*#09J46;3*$).R@T@5(3*#5YFKW89/%T
MI\>^NK&#"R1NT 8Z?)&C#RON^+O]$^;->YLZ^L/ @(6MZ\JW2;5@7;L6;"Z1
M= ^-W;&M/TQT9[]+A=PTCIO(M?BR3H6L>VCK;V9N>?_R;J#9<]CJIC-<_SM[
M7DEWW^OK:M%=_J;#W6W8@#=TJN_.=8[JW;?M79CV=+[VX&VU?6%=I5/OC=;;
MS*K-FBR;M_5.X)<6=Y>J/>#MO;7)("CM0\FFQ/_(*@#)?B"2?603-1S+;\*F
M(&,323V](Y+:8W1=57$EY7KI,U-X=%V5;6Z$O>/HQYV-^M.+KH?KMB4";\KO
MJZ72KM2DZ>F[3=;[RX>WNZD$S3>Z3RE=RV4I7',X/:\^01AUT"-,TTY.KB^]
MU@K=1;6Z_@Y;#ZQI;^O4O=K;4$VBA&_FZP,B6R_#4?1^,T6[Z]K@F8N%->C9
M?E&[50YK='P*D^_KT5ZQ:=KA]JC?MDW?C$V,J8G?M77HUF]H0CE-%*Y)CUJN
MNJ/8MDZD#??XM(\CL3XO&9^@VCN.L!;T(2H@;\F;2(3(.,$$I20FB!:Z0$(7
M,6(XS>(DE6EZ.+T@U5RDG!$DD\)^)I<$"9H3A(EB,98Z(SSN\B;XU?SSSR<]
MT;S;/.FYE]%.5:#E2O)GM5ZZT7*U7HQ?#;I.6AO;LI\>,PG&[T!\[E/8_EI]
M<OVL9P^RA4<HF>-%O!)CGJ49104QRBI=7""6I@E*N-8\+FB>JO0^R4I>Z=YL
M#=NILVM=;ZBO&W7\YNWK0\U<K*^VFGE\?#.FN<@I12DF*:*&6M,@F48FE@67
ML:*2'Y8G)U@D>1ZC/#,,49)RQ(HX1@K+0N4)Q;0PC_EDB^I('?)$"Y-]![$&
M]CZYSH.;-BN]S-X;'\5RW8;5V-(B;GON@\):SS3L#Q@.1AZX6:WEXR=;/@Z<
M>\!=_:[SB3SMW6/2?3>IY:'.6VI>;<X@?SPXEORI\Y?:NJVZETINN:UKN>V]
MK-U#ZE[7N^ZH8\\->^$YL"5';:G"WLO;,K$E5[[%=ELIY@]LN_3J>A9M2\A7
MZ^7"NP';Z(0_JN@.&F:]QNS;*VR/B'V'N.WI<D?Z:^M.K#YIO7/R/ML]4NJ?
MB_1=&7_H;<5[]!BC/N*:^E:7[A"I<TEG_M::1/7V\+^K[[ V>:&;.J_FI%W.
MN=TSF_=U:]!6SGO!+?V[ZKIT)\#- ;6[(1]S<5YS5X_7Y&KZA?VQ]7+:XVN7
MNL!OFLR%:L?3_\G=B0NN6?18K#:I\3=W7X%'S5)5;?-;ET:UO60GJ.V>6[FJ
M&'^2M;OC=DH@[ .ZR[=S$.J>Q]^D7?C[:E6R*5+83P;<\>N:VH(K;9U-_^9M
MEF 3")SKCZZLHPM2-3TYZXTD]@^57+'(NCD-ZK4=:#,BC;UR,Q&HG<C0MOUM
MJAHM!/OSJF88A*O@X<W*NO$"DM?N;K<1S;6O_6SWIC^8N^;6C[9JX@.4G6;*
M<BG75VV#^+V,C%YZS)7E"'95_W#'>,=DT7C77<"0=^>4ZUK?(<TV->78M>O=
M;;^Z:7)'=G6F/9+SB3G^8U997<-B:WQ5V:7?;3,O]A+QNKLZ3*!Y$9U]]#6M
MLS8"N6^?VOR^+G/I6#K'[5]LOVZ;!/@=R3QMJLZRJ<.]+2WQ\.0;L';H(NO-
M M\"A"UV;O!,W;YAW+F :#YO7_0A=U\'??C9?=3VF6RM-;9BUET.ZK%,,[Y3
MB>8"8\O:#\,XDJ/4]GLJ/QZD0;HH59/GMI/_Y:-O;B*-#^=ZN[KIF+-;$M@K
M4MP5F)O,<M7D"O2J'6YVJ@8=E/;*SMXXX-HI--QM'?S1]<LX_."NI?.WWBAX
MJ_&]-[:S9WRPKBVYW&M=,_.+XMNTM^VR-G6#31S0@X+?))YU".TG]'A+#P['
MPSH<'SR%?+E#(4\V!!!LX@,=%VV[0K1'@WW"[$F6@Z[KU8:<[))\^]?(:-VT
M8]J4>C@3L<&WEOALB(RC0XV5ZU>.;)*4/!G9\GV+MZXVV.5\^?)=;UZ[MN$-
M\^\X\]9M<AE$&\[<5,*V!04[VM[GW_M-KG9*#UY$Y^W3[YV(N+/HFVN7'&;O
M3ZTW>;1)'+F(EFOUX.9X;EIGE(N/E<."9@R)>[.;!'% .YI*YN-B!SOT6!FA
MWE4%PS.@X7'=?*S.N_W<S-CM7*1K'Z]U90JKH[;)>_T[KOQFG)XO_6YTW"U8
M.[^A3;EP5L1UI6Y:YK3IBFK;BK_[IAT?IOUTK[;_\W79*F>KN!U?],>%533G
MU_5&]WGG(CJKTM**C>7J$S%+LS;SV>9N9JFU:K<]E>^0<--$1!ICJ^W&\/YS
M&U,Y,$U[+J,[%NWU1'0C^MR8TNOFOJR;XA(\EO[OBE_QB^;O_BU^3$1/K)]\
M2,)]JWO$]=)UU?-RX,[8NJ:C;M2-&T+@W-WY'#R:!ZODW$9<=OR"W9AB4Q+3
M."Z;=1,W?L/M1L<:"*V;?A?=Q8?'TUDSMV,^WPMNN2UT&-QJ6'NU49YM5Y>V
MFY3=I5KOI1UW<9UY7TB=JJS]&)A_NFW;-7]R3V__,.]^+Q?-T9,_,KM[F.<F
M9M*;-MBF2[?13BN,?S1O4=IE7<_\-.&YIP7;K.-6F#LLRL43NE&17IZJ"5MZ
M'V9KEIH%Z%*?F_J835[\MK.6)Q'MM)6VNP?D,T,^\T0."W$,"<V0T!S(9FR:
M)AW.1]GVU["X<M6-'>M!=X=1+JW8@Z^O3YF7%C"ZFO7F#3V8M\BQ$\"K-QEV
MK@&3?4QP&A_<:6S2JD\OK02T>Z:&4&WB64"!A_0C>U)VOI"/0/G2XDUPJDE1
M;5/TE_JZ:2P;]5O*J9T:XR8J[:OXG2/5/PYT4\C*]D3)#]>>SW>J#CUO]/Y>
M4X^W7XZW:DX ZL@Z;]WQJ;N1N65ZW4O2/Y(_2.K%WRY=_Q1K,AR-W53;]7S4
M T_V1>_3S25W_-RNR+R)TWNFVIV;?VJS7F^:F%[[QGZ5G/N]"_QWXP-W&P?<
M+8A;SM/;J=LK2_7+^G+K)M?\JN=9\-6.>W&+6[%=1.^([_@L^QZ)#QO>XFV\
M.+A)'\'L;3O9A#+\T8@[Q>PZ#VS%[VFW\Q7:$__&>7#7:0\J^N>:?@ZK?]&E
MQG7S8ZVS4"[N\@LVWD/;,-+7Q.]W>$1ZT4IP^Y4=/EA?2GUY"[<C&7J/?^Q9
M;W_.C2AN]*H=.>MR$+S< )H>&)I\=LV[)KL&4.B! C';TXBFN5M[UM&KMFXF
M:30#+)N,IVIYP1=MMKT/$G138/<^M9U&VM5[EXMZO?21CZ:OMJ^LV)CL]L3
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M_AF'H0\S]$X:]$$Q_&T[]W%E%&R_YUC?^:U-RH+A%2 \9HSFLW>N&5QQ:,_
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MT-UOO;"= 9!1@%?KU;#!UE570]&C^C/OI6T UFLIC%_/&6CGHC1O>AH]9>W
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M!UYI$Y9LU\:>1A!L*H 34V,#EZPOUR;NM_4L>+I./=<F4W=*-STEX4IE!?S
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M2T/\ZJ(;SY2U\>6P''FP0AXLD6?7:&+!CK<+\/$7"CWXQ)A];8!M\/3EQW_
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M,@!K4A8\2YBDV2BR(N)\%H7):+L\.NWDS+,SS^-9B<E,NC//4S'/45I07XF
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M"S 9]SRINB4&9[$O61Q14D0))U3%E##0JB1@,>,A#%>H'0R>^YP%+*<D8KF
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MDUF<XU.!.*0W%CV\'^FQ5,0TI2')>9("TL-ZGDP5),F#7"H6\J0H=FJ !%8
M"4H$HS[<D\>$9RHB5$B5%RS*DSQ]CL1A/QKM8=B=Z5.<AG-0P$$!!P7&*B@.
M"DP."O@L\!.929** O--8TE8)@(B9!BEO@IE%.ZT\$ZS7&89+8B((TYHY/LD
MSQ4CL<H3A4<V/,^?X_@E.MRD>^2*S4&!YTFD&<ZL?=KQ(D?#]AW!8)9=,.F.
MF^13M6)S#"'MZ8LSGI..D4GL::%(%V(_@4EW1WVGISOWHSX9T)0%04'R-,P
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MQ@&A7"B2BQ1449K&U/<SQ=A.ZYZ70H#4KIH_V!5N#/BQ7BOY6\EX.2]7I6I
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M&),PJF+I$S_R4T)%E! 6,4GR/$^D'] H8@\*QK0%HZ^MVOY@M/:@7/288"V
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M@#_*C0<SQ*@K^&NS\FK8-FA$G0V]WH;2T$^IC +"F #1I1&8#%D(4L01F,1
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MY2*2URUM/NI(]]"Y""IC(U<W-OW2C-JLG"9)8/PE^*[(ISV;M--FT70Q^RB
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M:U)2$&!!@*\( =Z1;?90Q'<\X2S=Y4B.1(&&SW%$*:SU+.HWD9I<2T.!](X
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MQ,C]$30OZW42,F*,%[>SSX:]E&&=><+ A\OI? '2)*"JGES[9I&&^Y7"K,$
MO9(6-X2\JY(65]A3M%K1:D5L"GO.F#U%JQ6M5L2FL.>\V%.T6M%J16P*>P86
M9]T.AF_2N[O;Z4*O'?'S<&FT0?L2C?W2[J_S/ #^III,%[X4;PW%!)93J<$3
M??#&K!R6=X?EFGDJ(%; (&T %40"H[@%F&J.='":*+Y7>Q4@5] 98(5P@,;K
M@3$A@& ,@]P90_93M-L6AL]6:R5&B)6<[**&^DSV8H?[PHFS(?K@[?  [6A)
MJ2ZRU3^R%^/2%TZ<#=&+<2G&I<A6,2[%N/2'$V=#],$;EQ)!["*(QG%IN>7
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M8R!P20 UE $E9 !6,XRX=$1Y6YR\HH9*\6\Y =[;)&\_^8F]J<QTXLJ@W_.
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MF""?B)"/* ZI#<YA_<*03_(1525SLZBA/I.]V.&^<.)LB%[L\-G881L\\IX
MT9:\2P.D$0(02DV J4$>X;MV.&B-G8EFFVEH '7, R65 HX:B*"'"$/XPDWT
ME!@IS(LA+GJHQV0OAK@OG#@;H@_>$ _0D)8Z^2);_2-[,2Y]X<39$'WPQJ5X
M>:MF:!Q[A! &*$ $J+40:$(X8-&5D](Y1JS:]?(LHI0)CX%$U$4O3\2?+.8
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M\*V]]S>'\@JOZZ8V];A>W+Q9W>-(=F'[6 8OL!1_3+0]A@BZ]5U@)!]T'7S
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M">$Z:%F<O**&7KC IAS\#D$-O9O.9].Y7O@HW681+[;+>;VH_5/:3)8TJ/Y
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M&(?8^%WPK[Q%&#(/D!4\?I%88" D0#M(!83*8'GJ$[>??OEQ"_V#J%:2!Y!
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M$$ZV0YQ/ B5+M*0_4+),?CAO,%DF/Q0X>1^<5%@SI*D#WA$!:( 2*))ZE,E
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MY7]M2_<U0_D;V=NC*J=C3TH/BZ'8OQ>,7O6,$R5@?S:FL 3BNT \"MI R"V
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M>;@R2C+I3Q)6S_@YK#/HD^;S](P3YWNR_.K*-TOD?]4\"@GH!$- "HD!M20
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M\/:)S(>=G*A*:9 4 LL=!#2P:- \)8!Y3 DU2F@)=U6P-A9RYQ$03%A 82!
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MW"E#+,:&[HW-0SQ"-D\<\$9K0!52P'!*@;>$04=)@$;NVIK-_*6<H;B**[Y
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M@+!-6<0XM=10$DB''&">08X<#ESR4[@/Z\*L)Y5A'7X'%;3PU E@C<> 6BF
M,A #13C$Q 6A[5["_V.B(+?%9>T1QKO<A&GQ=N)^F4[:CDR+9W@]C6@0AGC
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MD93SZZ][D$PQDV2NS$R/H E5$I=@+&9NGWUN;F[VXPW+<1MS:>U'UV#$NRN
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M;4!]<PG<CVP8SW 6\.K_@ZEZ@$,GB4.5B1T<<2V:Z(W0P1'WQ1$3+(Q3PJ)
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M;SF2CAO$"??(1FJ19H(ZGYAE["631>A $S50HMY%J5OL:/MB>0@ W@$Q &(
MQ*!B0P%BT#MBH!W7VD2.N'86<9<R,> B(9.=O\184J_C=6+ J%;&48>L89D8
M)"F1T\(CQCWUAF.;F<-+5AX9<,X'W% @!KW"NR=/;SE>\*D"'740H3Y.%W:<
ML68KWF0OX:*QDW!C^*F>)8+*1D*W^.11X_C )ZM>2P,^V3L^R9AC5LF2U1(B
MXB$29'22B!@:8U0^ZAAV*ME%F8SE!)'(??X-T4@G;)'+3-(258KJZY?DDW2
MF1X8HZM-A@%"V0W JTSLP R &=1I*, ,>L<,*-/8I""05((CSD5$FE.*I Y1
M>J53=OS7F8%4VDFN\^%,:L1-R,R JOR;8 D6PGM'7K(Z#9=YP*N!9@R80:\
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M^@<8_#>E!!DK!-,)Q>CS0*9,(T.D0(EHZ90.F(:TFV*>HL,VVXIK@S69E]F
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MVV9#&(^G7U'6PGF>18_\=_R\B8\#$[DI!0DSEAR.2"1G,A.1%%FO*5(F@Y_
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M'Q#T4P$F$P47(6KD:<F^P!F=-!$TTVX3)1?&"<N/1M!K!28R/%QQJN.COV?
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M2_%E-<2"W;&^\=V.NVM]8TZ/6'R9'+&2,QL22J#V\E56>GI5 ^I-,#J^+AZ
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MV1.1 $;=A%$:.T48(4@&*1!WP2*#DT0L*I\"-C31G4;L$ $"C'K,X]PU*#T
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MC\W>,CIV&]?5/DSJ,?OJ_6OMJJS.I,'C=M+C4O"X)^%Q2\2U'ML$S_JTY@U
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M%6DFB.=B5^A8<2)"0&E.H$(N?1I+JHX!8 &JH;T!0.T2($+Q/B\K6)^D,$Z
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MDZ'CD!EB<3*CG+(7:ATKFF_<NN2*!V&P9RKNC37E&\.D'X\2G!CKK;-]DRQ
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MD=HJ9_<A =4UIBVZ;,HTH-BN7<WR=033-89-PVG*,*"8OJ-1\B@&JLTR4E]
M.<$?C[,;W?KN1!AOGNNMMZI=,_C?;Z%W$/X[=*VQ"VW:WL!XP=:R04?$A@5A
M??"PE6$[8XW_>':*_X$KDO!*HI^&:Q%%C23(_7"2)9(A[W-J3=T?Y>]LCPJ0
M Y *Q(R2:N.EK;D0+?@8:JM5'<Z!5>G&C#QTYVP+_K2N# >7A/,5I8(KY=6
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M45"P9)1YMWHT5I:/7#6RLK!!"*V:1&2;\._B&&9O@?ONST6F\HGAXB)5O/
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M-=;TXU$#! $-_'CT]L0<^W(-'JF 1>B-H&ML^!'A_A,7MO"Q?9^8YV]"4!M
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M;G8ANO;MF#.6Z@VBADH:K4^QU[S6!A56T0"AWB\NA%!;10,$)=^W$(E*32V
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MJ#C(G.%B>'$NAI@%9]#!"T>(;FP>O#B)F^1<"7]W!158( Q%5O"[$RS/0S\
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MF: )2X[/DCJ\"L$^QK>.YZS"%7^7G-&/U)YVK7?#HORPA-4IK2$6*075NG?
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MYD3MEX@#YNK(MV '4OVOZ.* A?&<W^*2YVN,,KS2*HN;- F4ZUW?SX45(4
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M0,R!O[#>%S5SX*^P]T33'.@;[6[1. ?ZJ+M;V,ZAOP8W1>X<^N-P0ZB/93&
MN^-V#PZR+$%P]R(HJ!O;@@9W =G"^+SK_ U#.90AF8-)G\-ZMN^"G:O;L?*1
MRN;W(;^#MXD0WL<+4B]3(7B=3> 6+9;G_?JZP4J:+6L5"NE7=GF?K[P=9-X!
M_4IX0*L/:'5P0+-F:'6!=064\P&C?GA(DP&./2"08?FVU(:BM\S# 1H.T&.
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MF_M+^AXK71)6>'A-'Z9ID:$D?'BEWUJ,D])\E <5=%VLT78_QSS'=4'F]/+
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MB4OBA%VM\"W_EG?LZ=U@:UQ8"R<54'&8;7F=IZKVXET@/IC,&T>WS2,Y2@4
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M(_XAO:64;N _ZMDQ&,<]L]<1_5_('RN6\X$3*5S4J.O[AHH.H#.O M,#9&6
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M[_=^D3B.T_L=!A*G+P_! )_O^TCL'1_E+2@$WO5\P.CWK*H,?0<'$HSGO^^
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M( \&W+W<$O/7J:MY*&?N .&.D1I.FGJ,9/VYQOSBI,+!4-EDN"1XZQWOS?:
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MWYRNU%9PIA3"1X] <_3X9LYT07*%QWUON4XA#@<V YM]919O3V)&L.@]=&W
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M16)*+%:%M!W+8R4-(TD55:6XA2DORVD0:%X(K1[8-(K0]ER;+W$ZQ2G>4;7
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MN5;YBP1/='X\*0]#UV^F+7\BB_I]W%F>)V%>^P4P,U(:(6,'FG1%:++NF2M
M^BE8D,"7N BB.!K0\M)69FYVS(D]EN-%D">,_KC&&EY&XRU8;X,D C5O_0:O
MR&'ETSO46&_\2VHS7:_49!#S+U EL2!+8D:7P(/-U64T!,CAX8^EEMJ* XVV
M&F(OX"I(<H33(S F88-B@':Z"E4M-=N-QUN-@NOPD^!?W07PZX]ZTWBX&(4
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M<:4DY&/H2S/[3QH&\!^97S98@N$_@"[+'TPS"S5F#@["A-A6.'FDQ]+^LH1
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M#U/*E17@8>-P)QEL)\WI1Y->.FE);*O0G,XKG_$H$NAA1N1 TT+QHU1NQH.
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MEZ2$Q]#J2@F;2]]A(6C*KTY5[,IYJ,RPS2/<;L< M]#"7D[>+V2E,@8#QJ"
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M<LW9C#&N%N9,TDFSNO#2G<(_!TX\19'+IIX#<LHF3W#V1$S_5_XU<L_+T$=
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M<FN/@!+$_R>0L_&>&0^%F4J_[4"O&J_R9+JCYXP:=3O0MSOX4T]5\&KR!6H
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M^?4+22$J!% %HTV<QF#NAX@29;<8 ^B+#\0>43&4@!&L##8!S*Y7=I/#.9U
MIG;F7P]T$G54%9ZSRTAH>3<IFR$7@@2$YM,Z3*6H=T=EA9GCC"OUP*12E!2Q
MR&>!'N WNSIFI-/_7Q\_NIS,\#2F*O"'@H)-ME1K]'S]VSV;!O+[C&S#.*K!
MW+)[BL]4)+\-]0W\H(;[D:NS8D2-?PX7EU@6,=JI<V]"9!RY!-Y0,R9:B?\M
M5B(EKY =?*L>+,%TQ6'"$9T#615:)CGZ8_N2)I"OS(0"B"*$,(O%2Q*_"C#!
M04)'E7+ (S@,VA/(&1YX,^7'DCS'4;LE12&>#(EL 1D;7I^+Y9I$NX3(,K)M
M#T?N>CF&8*^K\77UW8ZG(>^(6?$-UXZV7A6E0RW:8A7TB6#).T)8?"^:CBD9
M+92KC%*9.)Y+ 0%?4EY_5@"F/L3Y"%4N-<9PA78 Q$^&GZ23E0FN[!&+X6&+
MNO::C'-WXP]>0+>F:5N0[WXA[$HEPE(<5032O.-$[>7M!)5#!Q=3]5W?%$3)
M4H4%P/I!EF,N&I?TV"7!*$Y@-1Z+C2H,D(47/^FX5])A>,W$B# !!)1K]I=C
M57-%+1#D!*(*)SCKV5?6?D(6N!/P06=E7(;Y&FP[;V$R#HI*23H VH%!_#28
M2>Q\D)*N[[(I(S-4\\\;C"UKC,T A@FV_M,[G1)]B0UWLGS70)?^>4HSFXP:
MYI"L;$\]D"5A&PG"2,G@$.RJC5'%)ZNA@G(L]DX1C]')GKBV&A4U=YFFZ1%B
M0-80NR>9DJ;CY;&@ :H$&B,F%*NS@-.;^?0KM6%</'BW7X_"2A6V@VW%(($Z
MNNS:$7ZP("S8I?^R*WBH!KL"H3HVTXIY3B8@AK%[)/CPXO>C:8 *DL/U.RQ<
M@Y/AU_AL)VR)QRCXK+=>9RT<' .-?1+"<@KSWK#Y5O)8//M<&D4U;\ORJT<\
M>N;] T=69]P I(5O_]'(O&B-V%($U.L++5UQ5B??,/S\;L^F=_!Y#\Q5$<30
MW9@"?4YXW+CQ1SV#0\Q(N73AG0E[4OFFGP ?;;D>O!H.$::\\FV?RLYT'2[)
MH.(!#1,34/16.6!L)BH/S>MKQF7W9DTB\8U\>H]!9#--XQ S-RS*T.8+,=PE
M$WB/QN.IZNCG0JY )7D01:<C[O._WA7@O;PQJDN)57CAJ\#]"1YOO>LX9</&
M85)NS $E]S0UXW!Y+YXW$@OFY[+Q@1#,.K@$XBU-7S_<QF]<#$I?^=T@8(!\
M?Y2+71ZG),_/EXR9/.8G22#PA:]DL?J)@@U*V1E$*R:L'0OT( <+C-$TXA\;
MC^<+\!&UX4:VS7S>C].L@;EO)9-;/<JI,U>#"JY\T3?!;(GL[S,,K!8?<;&_
M(.ER#36)!QQ/2WR$)NOMA'+#_GGRZYK$&[9UKK+=*T314+;4^VLFCD0R94<U
M8/<%74JDSS2ZA.@=_1L4>![%%5"2#&!"@9Y14$[I+#!:&;,Z$S@G\(H:#6!J
MOI+YT%=/F49ZK)ICT3AZB&W-?+N4T->N(CTK>K]KW7< 3FHV[=A\OQ,KZ=&5
M4QI(V,(\&I93$1P_A@7+&..,2:P1(1MNL36+OQK0[5RPA:4P9_,[%:S_PQ59
MQ<NX^/'TUB1I+(=."H(Z4Q-8)9WBX8@IL?=FO5>CW&3JUV#FA[&DRI.CDB8&
M$-@#*6(!D0I3>@J_<<#J88"E)4W.)[=W"K(3Q/^<IT4<Q<D.\O_*,D^#PYE,
MLD9EJ\G"FL9FJ_+FM/$V@0?I?%>L:08WXO&"JX&NKLEY5RD;?H(1'!W\OY'=
M'>/[."9/^=>" ']W!\FT=9EBBESBX9.O^3),#KR^GZNXN#T>60>VBCS*/P"9
M'P$ =)GL>#6H>YJ)[5/SU]\QI94RI97RA'!M4)DCFU70#Q&),,MYUFZEL;Z)
M]XB1&L38: D^C7JN$^?Y5/R:H\0O:!?MZ<R_FIUD.F'_Q9-MP- M[\"#]4B*
M(N&B[=41A61J)J;+AG\LU^0#IND37]:B<;DJ38>:&TXU*,E"/7H/C[T'9JHN
MLH[O,SY'>;'-_O/K^9!9?V4G(ERN=S!7#V_+D3.4F^3K^>/C^>6?GQ\_/ST]
M3I$5VY!MF59O6$YXING8V%:/\6O*:S^S;0*.6YKRR'CVBT4\YD8 8T8GORCR
M2YN)U#W8GA0I2Q=]_DI">,%YH+G^XY]CPA[ZY7H_R&!@E+S6!#G3=^<_36 O
M\,IBQ3'=PN?D-:=42'K^0/)= LXXJ#)YG\4T$W"5K.T]%;[!X86%8* @(X"7
M$(',"[KZ5E%G__4+28-H!Z"HHI@83"/8DS#S6GUH^H61.]Y9N8OK"R)W00\O
M"G/R"4C@4]Y%S\&3L/#(AB+Y1>D],-[X4NOF\6JC>!'%>,$%VR;:7V&&16VU
M9BX@F7Q)?-[Y5K>^XK?;/R."$3W[]KSS7<7>.XSY4^6Y&@)Q -=^C4_@T4LA
M,SX5I@@9*O=YLTWHGF2@L&<$_LK$-+/1""&/G )(.DN#;K )(P)X"G#Y+YD<
M&*;[[X7[TMP+@P8F0>[S.0O4P$%EY&I+W^&M]^$>MB.(MSPU+4R&IGXHB@)L
M4M*<Q(!B$^BN,_*/'4F7PR15@V"@*2*)J ,YJNC!-K:FL4$(P0>B-<4/.=OL
MUR2$L-K1H:/K9I?@0U .'Y3C!W("W\<*.&Q.[:Q/ZF#'6)4.^Z(L!<Q79UFN
MSDJNCC>X>7?"L,[]O@RW<1$F@U&XK"G29<:['&:2"]L?MY7COX94!%X_@FHV
MP]+$DI0F%E\V\@>Z#Y-B_V47\KH-)(?4@KC@%@<S !< &^XSNB0DRD'[?"!O
M)-T1 =\,\WYB_7.V'FQ3\B*QK/'?R>'+4\=T$-,+7O7\>(*OG."9$9K,!3B
M?=C*60HE-1/S#%[U1(.BG&FP@ZE"%YBK+_UM;FLL#YQ:VW)>@3$Q,]Y]L1)0
M(6IR <PND-,+ROD%Q@0#/L- 3O$WLK(5O_VPK>GO;JMB=N0B8^AKG,:;W<8
M[KA)G]89X?@=!QN5JDKFIS]\^A\GS8X\,#7P%7;]R&PK.9K*,6,_L 'A5N=#
M<C 6CU;#"19@.C26!V&1O0^S8F\<RMN!I6DEV8#3K5Q3TQ2F'9NM*C 5#F^
M&?8Y+2!08X@&*TA,5I($@F#@"0!;1ISNV+&1YX>F^059T8P8X!AL3E";_'
M%N/S//_^T:]8/A53I9Q>1A.)EZP<-BC'90H+#!R8L";L8I2#^UN1?]^%2;R*
MV6$;)=56D^.FL5E/.['-V*.1'BZ 2TAO&:CY<1J3J'5N!YLX'/<D9?*DR/E0
M46\2HV*8PU$"8%&F:Z@A3.<CE O+"G;]5=V0W\5"]'(PJO!O/2[7?_6ZR:&_
MB_4PHS/'6!3O49F-;-52L_DX!D1YKJHJ2@B##;P:O/K*QS_\M]-@J[1HUA)P
MS;1QG]+EDHT<)R*'<+%R[.;/WV3@KW#=@(8,=PZHO_3SMW #WB#6_($P!2+-
M'VB27-,, "..%KK-:8$6W++?]>2D8XD;(.3TX(I4$^3=Y!2#O\$D SE+C^_&
M(6"7U_';H,>"Z5?_ZW0YD9_^*+Q2&&^JO S#O%Z:\X? ?-<\Y6>F&_W,]&=X
M1@+WQ:8])87#+)K^B,D@G'SQ635=-8"J,%CU5X7M)U[23)6#'K94#R7\L@B'
M"DZW.MVP=9$WPG3%Z<1TRS+DO[TEMQ<E5Y42?_*\$74!H6NH7[HFT1=*H^.3
M826QLT"1"S@][\7EQV&C!GPE&'@%2I.@-8R3956!JY@RU6H\3FSY5GX=RGE6
M_.?7\!OX'089L"0-CY:KP3.MYNQP0A.F>.N#.LPH)8F<PL3ESK!FJ$_#2%M\
MYM>P6*XA-,3\7>C]BQ7_<<B'TL&8E?C4:N0#$6U$J*H6-)B&I7[PBT P[>*4
MFZ$S?E4-7FFDC3*P<KS%%'E;<D[DD61O3'%P2%))(LO9+U8/VE0B9*)+FA?Y
MZ.ENH#W9A%3O)M?9K(Q%7+> Q9ZI%8D$1)>( H,YG$F+U219<"))H%RZO(@W
MX$5XSLEJEP V9[Y8*:@B$P1IQ&1)(SE0CQ^("01\!O"+'0+JNUF09/A:?,_[
MI9Y)92P3T<NT$\N4J&7:FLM$U$0\.L_O2"$CP][BB$07>[8J3 6]X:7>P4Z^
M+.(W+BT/0$11D7-\"-#W?X!1F++^8Z '"LJ13I';.N (#W;;"2[9_RDF0X],
M\GVN4*_Y>R##8IZH^NMB);*=.G*KBD.VN[W>D0+?7L(\3#]O;,)RB]2KRP\?
M>^07^DF^0EHTFS+R_Y?L$!.16A,^@4 %@#W1$O=]H5<+*[,/=Z5J#]!!^ZO?
MWO+X+EWOLC2&*$[V(%_'W^!?(V2X:JK\?55T3X&+I(V!*:HX:/G)CN0H?-<D
M$B%XF^VND(I*O00:%ZI&$#4=H(^!FH@*R]-3X?)IHQ*<E$"_VY6S:BV+'LMW
M75^^!=+RP44C:N]<<2P*H>^*_&_^H_2>?/Y&LF6<'UWR8,SJ\FHN^20.*>\K
M9!53>+9X66@PV&W9/XD<@KN>^)^I6A-?F '3+4.M$&.S<+RF?))<6@5Y)"[U
MG:DMV])_XP7P2@TR$7S5N#Q9WD;#?ZH==QCP5#<I>SWR6_)&DC\.%]XXG>"/
M)S%O):YI<"GPT0#1LT"R,:G,9KYGH(=<TZP9HU ^<[EI:;;;HKDV<[$7H.L^
M,.A<1GGV D,))RX"PJO[&U^^OI9[&!#63N1#3'@9/.>&S?5H:*Z\8E[.<6H-
M#&.EDA!5X\<C;JV(*\_+6N8CU'B1-(U2[?-G(''.?:H:B$VIC;\,H^HP7.06
M P5B)*E^G*EG2#21XR%*K./Q/H)V<L+<ST(I(:_PRCR0+:"I,Q['!@F2 S 9
M:D6S3>@7', +-TF5$4U\VI>LQ2!=QHR#O%.%I/;CUC#BR 7R7!6L^F2Y[VUW
M[U@ 7U@L_E>@TT=CY(( L$H=>?WT&*_:3I[FN?\[JX2IB(C5(#.S)0ADY34+
M9G1NY/[M*'<V#7>[%_8L/!<R9%E;=@:5FI(T4.I+#8Q*=Q9HFB(R7=0<YV*;
M,+C*4EV_'BVPFU7,E8D\**F>!"N6JNRYX$<F086GQ4]5HC8YFH231S9"P5Z0
MS15Y*<#4-0A:AE/[ .0"H'<FC&?^D69&XJ*B!'!6BBHK?B ]GK(0\K ?]YL7
MFAQ;<4G0" 21&<[37%O?DX5LD\5[RD9<Q]L!;Y>FX;>8]ST37T #Y+(:%Q='
M5VG%$!^44,P'.2UN$I.1H,+(]$JM)QYKNEP+KQYCH1S9)4,B:9R)(_X#.N#N
M+@-.SM_".($1P:<2)F04;P@,42D$JT?YL*+9!QAG4A^(3Y9=:0G&:RG"FT7N
M]&42YKF Q@KSVKKDH4]#_B/AI10%X&@"D/;1!G)C.5;,&QD&K22)GTDDUD3@
MVU<&F""=QPN'53NH9//58#.LC')R[!F!\P=\16^03R"I/,6%B-.(XK<XVH7)
MSW&QYI<^F-29]/%$1T!]Y*.(< TUCD?!? *^*@)ED[D)[0P<66'(]#F!N4^X
MS23BF0&(9<C(FIU$=B8%3ML=*18K-H7C+2$EQ7J]7EF!FU$_:U3JO0\S+UEU
M'E@U[[HJOW[K**L=<KD.LU>2CZC%Z+VW6+%_B"QC+XJ,'U;J)TA2Q0DO.1I8
M1L>ML<._VPB_+R#O76>$**C$AX&U9('>AQ5 ><<*?#'S4D%VMJNA#6J#P\2-
MDI/&',\X6B*4^B$EP.6#US56P3"R*I2,%1T:62.IZ=C3N<_?&MJT%21G/W?C
M17%^ ._PJ'6-MJ;O+I>[S8Y;3#AZ$R!@"M@ >-T%-O?Q<D,/7?\L,*8@$*2"
M<A(!S.),076SB7QGZU2).RRY]BMQ3,NI-7.A]H4G+90$PK?&_10B^<@EH3@$
M7@DM*L8X-1X;&I>L_'1R?!BW\$$?S/O-/#*_UH,VS9<#X_1=N"$#G$?<O@TT
MO <^#)ELQ4FD9CQ%EH.C0$M^L:_\,E+^KK-D"[S%^]K/$R;I>EP%5RZN>RF"
MB\E6PFH?''#8K-9-3\=NM+FC63 ;2/R# S^:0/R^0S_@*US%&5D6-!N4HZ&(
M>$:_'#97<ZM<4*;7PU91)!&B'0=OF%N:OGX -"PP)*>O/!"5BP<31 L9T5OL
MFEMDCP5<>=Q$HM /1@FP8\2A (T@+TTP&LO@I-AK";H3S&T9JV^<08_P[&7]
MLY])DOPEI>_I(Q,S:4HBGO,RZ%3)JFA ^<,O0#I0M$6&DX=3-CH_"1HK?1*0
M'*'OI:+N+PWMLA+\;F8 E*-_)XO2K':NV*[!*8%IG5K2UN*4C<O$IRV/!6<=
MA:OEU)?'JDR>Q@)9?(*C!PA6'81^35B^^$ELK CZ2"G<VBCXA4DTL*B+U B/
M&E#839H:@:PJ#,EVID'[9)AJ,1@#2WD96!:?(G>UVG.=W\V[C6XL!KNLX%@?
MT%_!E"]0\CSW5;OGE1=4/\E*,L,61DEQDQ7O$=,][>(]PY:\O7C/%U\[D8?.
MJR*43^]TN"E$$0L8M;G.-VE.U:.I:9PYUQ(1]-R+=^HQ\\!I;;J*\R5[3W;9
M.('K=G1X'O=WFLPE5;ZL&<1!.4[PMTFD7R?'-DS\[R$%? R^^GS*,T?E W\L
M,W&%A-ERS;B] D Y*O@5P?%EE=LEFV'&:\IE=$GR'*(SCUP -2+GW!A31>0'
M/QCU:^6X_$D7(_/ T!^_BP6I"HYE.GVHN":Z3 H /AC+%AG+1KRGHW3).KE+
MV+&*-#^3^'7--O@Y8S]\)0I6:$C!V#X29MX7<[<N1)X%:L:!G+*&0O)=@';&
M*V_>THKN!_OZ>)0[U4)5BS#GUSN ,_\:IU!,SJC$?)-"760HD'SP[5T]JWX+
M2_OG1IZ;6DEIMOG%6($<3)T1]@,;#XX$C,@K3'M\DORS7ZL1_C_]9FR6RMYM
MG)*;@FR._5X\1K4D%_P-" :<HN>LTQ%XJ*9[8# R$#=?E"8;% H"!D#V8$MH
M_(H# HHTO86)7Q,:R@K(S3M2H055(LZC$R/,0?J#__E<?A2=#E)J6X/L&U#7
M:9)O[HV=Q.!$U/%C_S"&J"2HE,.T<GJ>+2N\,8E738G]LV-6LL4_+2%D:5M\
M$!.4W6%WF8[Y\RC*0&YG_UQD3_0]U8M*6YOQ5?JGR2=NR?@TZAL;>%@F&[T[
M(3'%35K7-$GH^R)5F7\"=".,(Y.3]I;(W\2H"<AF!I79I.^3K3<D7D&-S73)
M5IU?:U68!MOG&D(/:2G* _/Y&P\\C65M6J9VV ]6LQWR5[3<B'G;H6IKC\S*
M'7F725P0<Y'1E/US*13&17:Y!NWQ)C5;Q&P[;26"B(W70021%Z,AQ+1\4U?;
MN6Q-HZ#$1V'_;]V9S>:SN2G99LEV)#*>HT/NQ:[>F._9TSM]6M-=SD2BIW=V
M0O:+5(# -C]8G_;8\@9[=O(B7E["T<[V[DUG;8B]W5KBS]B5QG_)K3NM3T=D
MYEH-U2(6RL9:CV[HKY>UN.YUG(;L53&+Z[9=Y8=3P;PT'L@+U.]@'X7' _!L
MUB<*$GKT]YV,K&G<''TZ89_ ,=$78)-"8,T5I-&0- )9V'IZ?0^*O*AU='&9
MIV];"D=31"WAG*UV!"M^G82O==6@\N,<MNY+]RYZ<?A>?F+/(7<0\J=#;ZV/
MSAWK82STC9H7BQ7D[5N$'V<CY$E7W0\/X-I:K-CCP7.8; RT=L!\5*H3JWG_
M>$8WCP1*+FB6T7?6KGZA'D\%6VIMX*)I)M@;>1EFV7Y%,SA .<^A8D_H+5V&
MB>WS'DL+?0E,KXU3L[<T0Y]X[_5F3]KC[N7O['U^HNR=CD62ZL"/:">*>8Y%
M(.=B53V)YZ\9(7;!L*L#\A>^)>P3D.KDE"J_?TZC..>&)!)]_@:A-<+?8_NJ
M1Q&:F3FJEAG3QRIE2Z;!5++9I==ZQU1;S.IYU[OECO44*%?=3[RE$^;U(*N=
M,IDCS<B2OJ:0I<$M& T=2*KY[(FJO>,/HF-IC'=;XZ8:$_T9:L/:?C R;5S/
M:K_>LSH.*KRF^PRHELC3OU>)G4;%EL6NR(LPA3!-&Q\=75!-QV2SI1D[5R)+
MA.MPN9DH6YW[35I0 Q+@>4O3&Y'!*JH]*3]IT^3L9QQT;5-/\3+<QDPE$1\7
M+)[9&XG8X1.Q9*J4FET;/9 (IBEE%\4%FT^<;6X:7M;*C]@B@K=LJ3O*,P])
M_6WA$:=73.S0MI!1#84CS@OYT]2N A>LB&WU>G;%]B:$<%JU+L2^C=5;T&B%
M^0ZPI0/,);9?%JN?*+RYI2S1N,S;&B.OO8Y:D4745$$ VQ=PM447 VN& _:/
M2_;?<5$Q&O2R.=B[SL-"6+>"E):/9A#/@5TQ&;0'/WZ%TPX[C%U65R1?9O&V
M;C@ZO#>J"GCL0R:?JV?Y6MU %:<TCY>-)]/C,.A^]"(6-FQ1#.L;O&&['&#_
M[/YS9W/,'7##4?H@K-LH!N^(.&EIBVT<VVP3NB=$8E4:\3V7;N-,9Z<9FCOS
M5H-?>X^9?"-C\[B=>\[&Z+IB#2?S8@_ AZY#W])\5O:;AH4-)"CU(U11M7J?
M#Z6!?9[* \X>9[ZSUC2)2)8+1<1ZHCKZH O*,O>WAS? U1;;$B>AJMT2?K4%
M^JO/5G%'1,I3RN._H(B9PL.XSVBT6P(&P"/)WN(E^?RM -BQEX3<QKGU&1I&
M$?\^5'%"8+KN""6")JC1<M48"SC2Q@$'^^1YOOS3/W\ZCZA=L#^4P%RNAX?P
MG6D?3*L*$^L[96V(GA("JGT&IB)82FXADD'"ES2J*!D]NZ!_#;!4:*=F6Q"J
MH^E<;$NJJL--:IB]#4NWS5!^-!%4,T Y,Q4;(4QE_")HVM0ZVF/+?&!L%A>7
M)0G)*N&U]L#V#NQ>\CB*P9V<"6GL*RG6-!+8A4QW""'E0SB7]\W&JID[_&!$
M^MA+54X5)*G%RBCRX!:\NGO-1Z)OT?-GI]CW<_*#??3X$ 'HC7W=."V][<ID
MO37V)FL+%C-P10!1Y&F=$>M=<C"1V7R[5BR5EE-W& 5TK4Z!K]9L]NWA73VZ
MS24#]"O["CMA?\X?X/: P(L>J: M_3 %LZ]4A#;&$?F)30URJ W(XMMX$[./
MXC!C']!W%AK#4_BMEWG'WA:9!2.E# X%.R8<K>>)*C "*&8MYG[+T]!LR7=E
MN;A>*7R^QT1>TN?'IXR?ROUY&GVA;R1+@5?W86[M@&W^LT3524\^DV*LYL#6
M'NBBG0TQI</+;[3$UA-TICPX:FG*0Y16^FJ1(;D7)"6KN#@D\?Y@<D@+ 76Y
M;+J>W4+=W1K]=-$E(5$.QF5E3UED0J]S.SVZ>Z&;!A\W89)<[/(X)54MR=$$
MW4Q>ACU(=[, (>I^UWMVG25RQ4UZ19;\E6DT.134HI,4NJBF)$AP\%ZRS_0*
M#U+8[N;N[H7]() ,S";5-]?-3TMS;#F4&S%;]-5* _QKVXXG?JM -!W7=D<O
M[%LP"7/V_FLH#2:.$Z8QP[//QEVL1"8PR=P6R<,H8'L.8J&#0"0@Y?A6A$V:
MY-:/V+L3_M9LR@:K!Q(1LH'O8'A[J[= ;T&C#S%41]@N6Z[!I 7I+N+$F8>-
M2;<<EE3CFME@-@810MX!M3@?Y>=J)$1=A'F\M'WU@P@@2IJ W7G.%&>;M]G\
M#?N)'AA<:ZRX.XS7^V"H)]JXAA[(5AJGV:D,]TR!7?["?B\(]WJQ?[UFX>:6
MALW8D*.HG/C>N:;9BL32A-H,^/<X#+:=1SO!A6W#IJ$UD'=:C9;#*&+[R-IM
M7?@&+KBSKV0)*[&!/J?150VVQMD(6^;2=XG&%P1)B6\)JUC5TA[;T4;W85+L
MO^Q"7MH#LH=+D=>)U]'="UNSH3RED]_N-^)^)WDK=I6[/?;-1E9,U>#*1Q:_
M[/A[Q13*\GIJU4'[]\9.[SP2F;B5^\%$3UP<:"T;Y#FU^K@I8+^;EK"0!Y*2
M]S"!C(F^D21&%VPS6RT<J1:LM*%,F_]52#.@WEE/T:$T4!,HMV3)\2RR+<T)
MK^XFH.DO:;9UV+A[])E3704'%_9FB&Z[![@AZHE8E1^P91^1Z'%'"U>NASW&
MJ*L7LNOG/TA&V?]THY5;&Z)_$ZY=W8=9L3>B6_.+O?F+.Z>W;V_L:YD[-]QN
MCQEL(;8M'F&K]]A$EJ:8#'QF9_"5W8!?,OK.3B436\)T+[*[A9.VQ<M[% %L
M*=$.<B_LMR8:E&&^M^.0C$,1\]M+:41::A2@G0/ZHJTQ^C<U$&C_C2UL'L7+
M=M]U1Q=<YYMUR_#[@LU85@&Y20O"]E<!,&4'.K#\C7(:<=\WZ37=9;R&IFUK
M'$X%&YN@AI1Z!?4&[>&'CJ;8Y[<L<3.L5&/?0CHCC8*];.-6?##J(H]JV^@<
M#=MF*&M<V$V"ZD?TH$%9D_&>YD68_$>\=:<1VUK.P'-Q'>?LK97%&MC?&I&/
MSH;H]G&HU?"%TB@O@0SR1YI8KUAW:VPV1'28(X#9RDIK#_2819&!?454)K:*
M-"GCJFQ,]>F'?2-)F:I2\M/AL&@VG,GD-0 @W/WBK0";FPN"MD<W;$=F1=1U
M^@ LS;#M)V5&T1-ECP,WU[(+-HR9?&_B_39J\3P08=XE\AH3=[(!8>Y<!=]C
M8BIHUE/G#'@KE2EY?38C)X<2G(,<>DP=)[,Y\#QNE:@&=?0'2X7+BP=5Z=;V
M1\K>%M-#0;8RY%.75.'H-"3;@IW8G6/4N^.LK <ZO[W;1*";HD<%]"W^:'?_
M]^T]EVC'NA.O<:^V-9[59G,:F0;8IU!?2&%6DN^\TJ&;[YZU&?8IZB@N.8.*
MDA6 (R,\\1!<I/9NZ!(%S0H("('HB3:(4FM#[,DKX#.=ZL/D7BJ")-IB:/OT
MFU?=!.'B$JXO&T<MS='-:=< I+"KNX=LOZ,BA83?X%KO#B&5%](3_1PNUSQ2
MC%JP0X90F\^I C'EFCWFK1'I;>U18ZYXDNEYAS.-GQ17!-:A%%!!2]OV6IKN
MP@3JR81)PL/6A?1BXBPRJ907R>599@ EF\OZ[21Z3B,., M%*QN+--&XWT/Y
M Q?TM8K6VC7#.3'&1[?^V;(]7;#![M;8; #Z,OM*:<2E0/ 19;JV@S3LYZ4<
MV.I0/986HA'CD;S"Y+X0R&';KN,E4SNL1@MG0^P8T>:C4/MI/N]T$W"^YX/M
M[HB=%"_A<4U)%K:_O?9B_U[8WTS#OQJ@J4Z5R]48OR8@!'/5D<\M/V/[804,
M!%^W3K (HQ7V)@%Q2,5SDQ; -FM#Q,UQ2U[#1$9&U/:TY6?TG!HF+8&WHAN?
MS-$4.QBM@2C&[_3WE-WEZWA;RM@VEGIWQCX+[ XD_]BQN7Q^ZTJ-=K6="[9J
M*:"UEV=J[8#]/8[U$2XJX6APCGIJ(^.Z*H^?!K8Z8>@Y9ETU%=_GP,#LZ(0I
MY=W1]'*WV24A!(?JZ#\5^LG?B81$'(V5L!8->>_ _JCA_RJ*H"!9&B90O8)U
MA=J/TM;!7;5-T+&#.^-'TY>Q[>Y$%F=+_#-F1T9K5\X[>\W+E] M[[1V0,_$
M:RV#U<I7W[[8:@LT,:L!BJJ^\"^K_N)NCGD=<&>&7/%^^6V=/;"C^X8E,USL
M[01<ZK_'X5#W!1.O2LC"/80;9HR?)JI+=VOTY\*,/SVDM'V_GMC;O1U?8;D4
MPA>)OF0TSY_33):4@4]V058T@T!VZ\8>@S"J.'?[>)[G=!D+K2.-V!^N8VY?
MO(0((;LWL5<OW&(9;](L; V3?:)-*/!#^N&_JF9]29N2[7A=N[IAJ^0ULT=[
M:IZK,:ZHP,MKW)'""&:WB >65O,$.97A=@VH4ML7.9 $]BFJ%C!J@2ZS-9Q!
M?(0+9;?Z,_8JR^*DM:>Q#2BNI0.VQB965J906/6R2@OLZ5KM*X9I4:F.3Y0)
M:DP:V3 QAKOE<PB+=/N91B&,OC$=> 2FQQ7J&Y>@!QV/:E\RV,Z6S3:A>Z)2
MI>P1.7=4!MIP4S-[JXHPJ>?&W-'BKZ0H83U,LZS543/%P.B[:K,!@S1DK6U)
MUG;-61IB0G\+JZM(HP: "@=:K*O=;/*DVB*_FZW0\UZW&9%JE&W"YN_8IE=
M^V+W6YF@SD0X(^K\AN.[BN1--I'<_I/[31F3/O8EP 3&FM!8K9O)6'06TA0I
MG(QWII9M:1XF3%G8;>&E94>.FX_8@R+3>1P7[93CSR&;1>1^MQ<NM39$3RB0
MJ!OR?V[CE'RL7[C.AJ@9=4;4,X=CX682<%%"\#]_V3FFNXIB:^@HAQ*8 12)
MB !_($P[*>H?R=8&%6'0ED1CHG=5955 ZC(6&\35&\B;!\C6ER1>.I,E/8V#
M;H;:;A.NQS#94^:!W*2@QH2=^5C]NLY&6NI59M?1&/TK66)*;]O RMM[X"OK
MQH-\2!5N]/?,0,GIBQ)T*O! !^3W]^Z,+9T:A6D; #J ;EDF^;;==$>0P0[$
M=Q2:>[):4;LZX&]5<8!ZYMVTM9^5\[DK/]C=>A:JB(AP,S9_2P'.]A[87T6B
M0CQ1CM>?$6=PF/4K]>X]OW/4=NNU-)^!1\B:N6JJ6D(_:>:IEM9(L*="0,XQ
M.;*#1CJ%Y9-A73P(-ZKFNXNNEOSY$6EC"]QMF.5WY)W_=#C:N>Z)N0-N:?H*
ML?$/X?O7L&"S"Y-<N1G$5FU\V.XNV!;;\)N(G[P,LVS/=%#PJ%R1?)G%6Y?!
MN:L/MN]JM8*"DF]$W\,/;.G!$\0$LT38R<6K:H^^&$('N6*$JTC\OX7LHLV@
MCNXU><G@G[;&AQ>?/X0NND:3<R'=AI7H:C.73*J+O?[GGV.F+F;+]?X6?.HN
M'U:_GOAYM0#15S>3&C]A7R2=J>7SR2%7<50JN+\93]9H@2TI=*%\Y(>7OZT%
MEPV'GA]Y#MC:I[(UB1?MEN;M=2K*9N@N\)>B=. JS%)XCD4<>7OR;__><S\2
MKMUH6CB\5)RV#3"'Q1J0$ZN#B-3%*'AT+MOX0Z$[$\IB;&UA?/56V'D:=LQO
MAR.Y?R]L1:SJ)>6J%8#C\LR?\T+4#1;Z/OL6#HO:P43P$VAM+N"GXQS-0PG.
MZY&3X%X0-V?%!&AICJYJU3(T+TBZ7&_"K V5IJ,/]J73,, K<#+C3]9[IT]'
M]! CP"3-+MG6>:59Q6_I:(+M=C!Q'D)>N.!K6$ 2P'ZQ^LKV#.&77'MUQ8.)
M8 OOL&E _LC(&O#QE%T*Q/,[4BQ63^&W>ZBDR"23GL_%0)+H]Z6XX1\@EX#;
M(]L#(MK:HY] Z<\346'L+1)U3NU'T=YV+L8JX=S_2D+P>T4+*.G)YLNFR:N2
M/Z?T)2<9+X9TDVYW1=6>>K'GW3E&F?NQ\#46NIL1<A39]<K.GBO(2OV._<2+
M+5@I=GI(Y:_VCHBG\6:YRJ0%DEUY3&GC6^4Z"5_K9]'=$E.HOH[3.%^3B)>)
M<]6H;[:9P<Z7.1?]H@SG$I8R(C#7#9-^8_8(+_G-YAL&K#8:MG@-%_'-9LON
M=9X9R)AX=<C3UI8SV+[\8NX=9^5NCRU:<XWXN9":B9YI>ZYG=R_L<]H _@4/
M9L_/U;OS[)CLQPWVX2\14%P*B3M%LG=G[&^CZLF4;UA+?KN[-:9L88EKN[6%
MTG<VQA9>W5&[/5(=^O=&1ILD,I7Z*L[(DMW&#FG0V7)>!G'A,CG?%>QHU$.M
M>G:9BX9L*IX](CBJC6>0Y ;IGPJ ([K8/X!=A1T ^R-Z4$=T,PR[KVXB-M-X
M%0M(][9*3H[&Z,(H7+RZZ('"IG>GNSN;HS^91SJKQ>DW$KZY9/"T#M-JU(8G
M7_GAP\_@/92^,6?9Y7H;=-]UP90*$BD42$,,O"+L.-J-3]V],)]L0/Y3:"7L
M:E%U;NHI8P\DWR4@<XBX^)AF8A-Q6[THZM>4QD:DC7TKJ)M*NKAUAIFSK$A;
MAYGZ=#1DY(IF>6@ZH<I8XY%]/B,-B2TT,NJ+U7E$^4WK5K!L[; M+X8_4E9&
M[/1;JG;8#XB "ZF!A/31I?ITG$/AE-8LUVJ+&0#O,Z54WN.ZA%I&5R3/>0#4
M-<F;#T3OGN@B^N<-R5[9!+]D]+U8PTT6IHZ8!6M3["M?!=>J)(.VG>5LC+K)
M.#3U!4V=#J9&"^PUAXU\1U-:#6R6B]KZ 7KUQ+Y^)=P:B=@D#W+#NKI@?Z]J
M(?K%ZI9=/*2ON;Y_;_SH1UT4Y(K)V6^\M$N_X@&'=4<&5=CN"I+]F:G&3#T&
MK_\C717P3\?UT=D#7?GD-1LDMB0(D#U$G<Y.V&>N)1;L? ,"_Z_" **U 1!
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ME1D\%0YM_$#E?0:,5-XP44&AUW,GFF++'B*:\_PU(UQ  AM82_IO2W-LA=T
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MR-8.^^*N[/Y<V*^D'\<XWS?ITSL%X"XK7P<30?<-F=GOK6*.HRDN_)<)[N/
M5[(UPG0;AG^GF<KF;7@<["VP-;M&'F>;U<#=&A=_7-HJC7K?=8-@:T/DR=<
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MZ.T]T*,<>1W/D%\H5V$17C;M^5UMD;^(QKXR;=#N\,:6YNC?0DBZUPD-'1_
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M=0L2J(#J.8_H%NQV7<_3<&K8^V>WV;!3N%@U\0K:BQ/UZ(=]?KE.K.,^P7S
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M[]$-?2-I4Q [D8N,@]<+*WD;,%F/;NB9&3\SK>LO*7U/']D;09G^S+T!C:J
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MI-]>!4Z20'8 WB)9O$*"D8"\C>)G)Q"%;$@:M*&H4FIU''[ >^B1U2L_D]Y
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M]#;+PB\\-]$!M+T2RY])B<V'U4-GT*#HR4]IKL,,#38[O)_W42QK 1/K:T"
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M1+H-K?40F9/40OM6NN<\7:&UUD[XK>."Q2[*J.9M:G-+<IO0=E&N1'Q\ AX
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MY?&R%"&&ZPQ!TW9CV2<JA/UAA(*;-8ZRE$7X+K=F83BRIVL"\(AE$"6>SQ-
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M9T$_Z_<M+-2J\1&4IV;(N>=LMW/B [ZX>$C >? O213X'I3RWJ43H"KCSUL
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MKJ/P''G1@)O%.$R^MG!0"<C2,J-G8Q*LJY'BCVB Z4RZ+P_D 1@FJCZ_: R
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M-O6N3.+[G-/#T[((?D$(HALN]T6G?KZ@?!@G_4:4H!WNF,()#>:5H2DS9$>
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M!=COB=#A76'S(?%^;-R-4Z08+VLW\"V<5 **70YWY$,14D?R9O"YGI>)_?9
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M5,<F-#=#XG SQ*K.9'-D9#>X%!5;1%B9O!2)CIW4T!P5,M>"N1)77^2%*JB
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MS8W1F-YR%3>Y*A9AA30*Q69:"H5Z;Z1.49L1XB"A=C2D""96)"S30%CGCK)
MHB(6:DRB0FB=)DD?J$G/%VHP'=*-K&/I%+D![#K6$)L6HV6!*I2X$XC&01(
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M[1,1O _A:Q(1@E]4@GU6_OUOD2D9QZD/ WAIL9;<PY_KAIVK#^)OXJF^Z##
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M5$5N.M6K#'O<AS+/TRS7D\77+6?H.?/@YP)4T*?S_,;#FW0\$<GTF=>Y.AZ
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M4RR%9"%92/:U$P3(K7?C%2LX]@^U:%N+!8@!,  &P  8  -@  R  3  !L
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MH]E]H<7?]G/-,_VI &&?FIOD_2'/1>'++%7GHOJ!%P0UE.834!>(RM0@LE\
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MZRJ'\#9MU6_3'A\,530;?#@^&.LD'OP#4$L#!!0    ( -&&;5;RJBG,$ 0
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MC"@QUL1C5N@.C$3<[0"K*F2JA3%$*><:SH2H#<ATG7O+RNY;7R"5:I6J,2&
MIFP2N, 8RP@5N/:*F--]J[5=UEI/]XS&A>1$"$>LK'R8RSHV'^'Z>K*SU6??
M1X&WFMBEG.=2DQ0=LR)HS>*\UDBD_Z]:V,LI^A66PN^;PLN5]L\Z[4&4)QN/
M7&VY5"Q#*U+([BV6FL.KQXH%:_2JJPMZ;2\X.#"]8=M#_@102P,$%     @
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M1_*9OLHT= "+]U@8EQ* %$]</[B?=9M,S"<DFDOJB"!/]6_!7,F3%7PH(+$
M78R2@E'K%!T8P035 B<@?$'B4J0$>\H,%@F..HVK*%P"H0P'A2PD+-@HA9@1
M828IYCTP+:?$;;$!+7SI,E]QP;\&' 7!L=">LS52D9)HMHYH!EM(-&LO^4M\
MLWZRL#;M %6-!4,VH48E%+,B:H")<&,"*89J5L ="$C0@9#"3K$\634LDI]C
M!@=ZSUMW1.<V-ESR=9-/*,UT"J1C7#D5ADHSIX#;XACR!*HD"=P#3WB*I(8B
M66(]OP#YB13RGY)A-B;D-XAAPJU@F-Z8RLRM]P@_'D4\M&(,P#$KMA*@5EHC
M<_&7J_<5')5 0\@ZC-^]&*C,WC_V.KD5G4ESW)J)OKV?20;%IH]C1^YM /JT
ML?.2#38E/#>(#=A6L,&)A]LR;/'8(]\V<$\66.$[\@LL4U089AIA.5<3W.DO
M5L;"'7PO!'HQ(73Q-0,_0:<[2\(1< JL]@MRN9HA ,B=S^#1C3L$];KL>DU&
MU,R*)LP3' =QYA(H-_L\N9D2*:ZYS ]K%N0KCS#(FHQ3TLNKH9=BL[6U%8SR
M%S9;W?L+K&"BRNUBC;G#/#/<KMN(\.^HCI8V0D OFC%AE3:S4L3=@,[B6%C+
M^<IL:*"@S,$G3(!.KOD., <D'P:3&_B-VS %Q?&OF0"5':EE2>B.;W;+?=2-
MB=8-2C>V8Q^U*Z&PA_ 1P !XMH"G%*'@@->\C)CM9TXXO<:ZP!?ZKC)P6Q3N
M/8OB+/2[6"#?>O0G.RM6><J@H>&S17X%8^1;&B ,X%<:J,J5)09J$I/% "&P
MF)M&GD2M/"\N2XZ-"LH-XH#MV.+L0F41:5AL*X!([I(#P+1[8RD'?\6GZB(9
M*SGFF*\G=)B_>*7S?(+'J513#D\G(^4S"'J'6H *'EFZ[-T#TI6O:%?!IP<?
MWA;?[<QPVVP^\ZOTJT!XOXN]%LMOBS_"GS__L_ZNUEYXL=JZ_>$55(:?.;4'
MP)U<.P7Q&Z=:VXE7(<Q5!I 1-YRU_5#UFB.ZO &$LZ2IX8'QF\8SRG+?*/F^
MW;=2H( N1L<M;$_<0=$^%P(I-C.9!V9K[^!=$\'8V;?L'J'67LUG] _(-->0
M.7BW-!C\0R_J/_*HS$-G6?/5%-!HM2K%_P#Z(BSSD*N+I#T!FU8'L!1>!^YG
M%6^L9H<Q)N]0:^<AYT-QUJ<W?MXK3.:^3QB*D/N12'B!_'@"<1V0_U -R4J]
M62&-6J,YAZZ5 57&P ,QL(E.)DNLN2%^A4Y>A%-?(+ _3H/-\W>.XWR!G7F@
MT4K!U/AJ"+EKQ)6QL<)7?U>L_+@O"Y\Y6O;-/BG"Y;FG\JP?2=[]'F\5 LJL
MIUSQ2K^6?GU:O\:",<E?KU^?E;0WUJL/H;5,0\K5NV3YD@]*OY9^W72_EJMW
MN7H_/[R/5?5X)'A$>C<\S/!=6W+NW[YY:"6'WW@>\W?^@:B_<JKUI)9;>:HU
MFB4X*1UR#X$JC2!6 BHG=&I<JM/9Q[_O=_139]_]7< _ 5!+ P04    " #1
MAFU6[B)<(2H)  !/4@  #P   &%M;'@M97@S,5\S+FAT;>U<;7/;-A+^WE^!
MRTU:>T:T]6(Y*:7+C&++5_=:.V/+,[F/$ E*.(,$ X"2=;^^NP"I=]M*8C>R
MQ<G$$LD%L-C%\V 7(-0>FEA\^(FTAXR&\$G:AAO!/G0_>XU:^]!=P./#_'F[
M+\,)T68BV+_>Q%0->.(3FAGY#QZG4AF:F%9*PY G Y^\3^]:;VRE:5'$L#OC
M\21DB?&K!]6WK4@FQM/\_\ROP75J6JY2S\C4=S>L1$1C+B9^C\=,DPLV)E<R
MIDDAW)?&R#B7MTU0P0>)+UAD0(,V5E%H$$@AE:\&?;I7K>"_VGYK/.2&>3JE
M ?-3Q;RQHJEK=\SX8&C\1*J8BE5EYW7[^4LF3:NC.!7N:X5HFFA/,\6C5@QJ
MCGEHAG[$C1= .3 !Z$9^_F?MN-IJ'V)5']J'Z8^TE\+.+ANL3X/;@9)9$GHK
MMJONM[[)GGTIPDVLN:3_U*X/FK1[-^1];DBC=M!X$KO6WG^O80-HAZD7;]F3
M[E7O_.S\I-,[O[P@GVZNKF\Z%SW2N]R.X?M*K'QU\T?WFM0:U*L=[=%]TKDX
M);5FF%_=7)QVKTCOMRZY[I[<7)WWSD&X^_GDM\[%O[ND<](CEV>D]FOCJ%(Z
MY0F=TKDFG=/+3[WNZ?RX1Q]8+#2J=;2[=4OGZF/GHGOM77[^H_O?PB/U:K7^
M-&14?XY9\3G\L?FD^4T>.:^0WRF6^_. G"EJF*Z0@"G#HPDQ0VK\)7.'?'2O
MP4.N4T$G?B38W1IC_R_36&W1N!7SM*'*M*Q)/;!$K/T^U4SPA*UUP*P;1P?-
MQKNWK\XC"T:=6I0G:!'/&O;!=I<'\0,V7S'EFP][M?W"W7-^7E3BQ5L8QCP9
MTA$CBHTX&[,0QCG7I),D&17DBF$ 3F1"SD )4JMZ_R$R(IUX(B9WY-.0@F8!
MRPP/J "HG"?!P2SL!*/E?TNHO':HU'<"*A]AA(6(AGA";A,Y%BP<L(I#C')0
M"254FTA#L!3E":')A&2)41F#CL.,$D-5B"%*8KC"S(Y$-(!;BL@8,@PCG=R*
M0,("IC55$Q2)Z2V#=N?JU' O!&6@28&VP#90(. JR&(02Z X:!(R1<".P9#H
M#/_,RH^98GDEV(&8:P$).F3=9,S-$#JH4Q98!;'>%%23(71S!,5"TI_,FZ$D
M@5TD@<9NDP C$4\ 9HC8&:PJP  @#H_5W'.>1*BEX5 /3P*1A5 G0'<.0Q6
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M%<3C8-66%?=@F,L,$,/O6-AR3=6JEN?R C"<!4TU\[5;,)XRECV>Y.JVQ\I
M 56TCLO7CK?]HGPN!%+AU&0.E\V#H^-C!&/[T(3W"#4/JD>/B#0.JHW'JCDZ
M/CAJOE\0@B]J6?VA V4^<E857\\ ]6:S4OP'S!>C,A]Q-9ZTQF!2KP\3X:UO
M_WIX8STYC#!RAT0['W%N)$[K=+;/:X7.W'=XH1AQ?R<07B ]GL*P]LF?5$&H
M4FM42+U:GS^KMG9 E6/@QQWK_"8GKY[MW!*_0B4OPJDO$-@?)_[V^3O'<3Z_
M3CU0;Z9@:GPIA"P:<>W86..K'S56_KXSA<\\6@[U(2F&RW-WY5F/1RZ=Q%L'
M@3+L*:>\TJ^E7Y_6KS$/0\%>KU^?E;6WUJL/H;6,0\KINZ3YDA!*OY9^W7J_
MEM-W.7T_/[Q/AIQ%Y&RZN77IWKQY:!J'3]R-V;9?YWML3^M)S;9-/[WWE,;X
MVM\@7&N'X33*2^F .1[P: 2 \:D8TXFV\5[[$'\0\L-/[4/[0Y)_ 5!+ P04
M    " #1AFU672_T_H@%  !4+P  #P   &%M;'@M97@S,E\Q+FAT;>U::W/:
M.!3]WE^A3:>=9 :#;1Y);38SE)#9["-T IWI?A2VC+65)5>2 ^ROWRL_R(LD
MW3:TI/6$ +:OI*MSS[FZ%N['.F''+U _)CB$3]375#-R//I@M=U^JSB RZWR
M>G\FPA52>L7(KWL)EG/*/80S+7ZA22JDQES[*0Y#RN<>.DJ7_E[>:5HUT62I
M+<I#PK5G-^U7?B2XMA3]EW@.'*?:+SJUM$B]XD1N$>&$LI4WI0E1Z)PLT(5(
M,*^,9T)KD93V^1"8T3GW&(DT>- W750>!(()Z<GY#._;#?/G'/B+F&IBJ10'
MQ$LEL182I\6X"T+GL?:XD EF=YV][MOK3YG0_D!2S(JO#:0P5Y8BDD9^ FXN
M:*AC+Z+:"J =0 "^H=<OG9[M]UNFJ^-^*_V>>$DSV=N S7#P<2Y%QD/K#G;V
M@?]%>,X$"S\'S5O^KW%]$-+1,J8SJE';;3I/@JMS]+7 !C .D<\>V>'H8GIV
M>C8<3,_&Y^C=^XO)^\'Y%$W'NT'?'P1EYPB];TZ:PR::C(8YTDZ[:S?08((&
M)^-WT]%)#?V6H*\ ?V/WT/@437\;H<G@XNW@?#2QQA_^'/V-!L.IN>+:MOLY
MR'>:W7;[D>SB;F.9VP;TG[\*?A'X9QS! 2>!IH*C!=4QTC%! \XSS- %,?4%
M$A$:)"NV6J)W,09W I)I&F"F&NB,!TVT;YJ\?KET;2?PAR)),5\5AZ%_@*#?
M4Y@$<FSK#Q0)F0^0@E<B1(2;J@6=D( D,R)1VVE F%VW@;!"$64DO/)I0H),
M4DUADIB':+0,8LSG!,& "57*^ \O8QEB35!,) '';_A6S&?M&KB/ B(UC58-
ME&9295!*(2W0538PE<*A7R8#\ F'(M7@U77KTL;P%P;,7<5RACE1UGC)R H-
M@AQ#P]\&7,?:NT7CD%[>K.\L0Z^<R(>O_#M9):0J97CE18PL-[#ZGTR9*551
MSLTLI;'4?LY="RB7*&^&%6&4DXU,O^++=2=^(.K? '6-*.4&$2L']L%Q;V>+
M!S"_#N5AU^VYO=ZAZSCM(QN2U-[QOG-0L>$:#6XZ].S1WCN>@BS*=!)EC*T@
M[20I,V)>"UR23QF5)($&RNA%E5G):>]C2",2.=W]\&"ML:MTL$X%I="<-^V.
M;Y+$6F: ;/E>R^TGEYO[T\B-\L@,DFO(7,$PM1#.YO*IM(BI!#&"B\K(KF$N
M8\80-"/FKAI$J5+0H6KDK2+*,0_,>>@PI'G79C$&JXSEVA.PLN=#JDJH94'0
MO$>,&TLX"V+7>?.JVM:XTN<C==U6=B_NCV7AQ=U:\BL"MW%K0N,9(YM2EMD%
M\F="AD3F#IHM(-O/S2W@L\A &G1)0K\8RK'SA%8V -XRG"KB*9)B"-HZ->5;
M$D7?^582.""KT2^I@AM]1O7*J]J71F 5KB$K!-AM=GH]H[I^2X?W&'6;=N<1
MDW;3;C_63:?7['2/;AC!%WG;_;A07\F<NXYOEKK;[3:J?Q!WQ<J2<0[E_@(@
MM6:2X(]>_FZ9$YNSP*6I.*%Z+AE7,''=9X%]V2M,YKY[RXIQWU((SS /G@"M
M/?07ED$,=41^<]&^)JZ-A*HY\/VV<K\HR'?W<W<DKM#)LPCJ,Q3VVY6W>_$N
M=5RNK^L(N-T4H!:,0J%T \2-W-@0J^_%E6^WP[AEMK14"U5T>=:;I;\+%6<8
MO6U"61T3ODD"==E3+WEU7.NX/FU<$QJ&C/RX<=UJUM[9J#ZDUKH.J9?O.LW7
M":&.:QW7G8]KO7S7R_?VY3T4UC"F)$*C)0DR32\)&D<1#8A\:"6'3_.#S*X]
ME/O8SUI/BMP3/G&[G6>WGBL:.T6-__L@]D8<XG79F^(Y*1*CA2/((!YF"[Q2
M>0'<;YFGXH]?]%OYT_3_ 5!+ P04    " #1AFU6TU81C8,%  !$+@  #P
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M\H"L56)3TA> ][8D"H "(#P8F/Z/RQ,#NL)_!#2"DG2F'@&;R^TK$@-:X8^
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M]0B8X\MGRO^YR7 CL)<3$3BP^PA0X[@/O=7RE8"++3YLPH)U_U>O;6(Q^ C
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MJ?(M+6G,H=UG_LB!FFX28=DL0>XB=RP2TBGJ63*U*;H-$:MJGSH;0QB&<F\
M3\O$<U7^7.I?.</_+W,&:@$/V\YF8+0X/31U6#WU@&D]U5-SD;N48-<\8\AC
M=[+61]+:Y<RVY^[]G7BQ)W\2L*F@KM%Q,3 ))PY 2A-%@<@BTJWMQ]0*3=FP
M.*O(MS5U9VCD'G3.#I+==265V14\8FFNAII7VHK3U,W G"JZB_ARD8CJJM=?
M(**-#?W O$+PW$S=3ZR9V?^]'65?JW\C; 3:, Y:K\1CCRR.+-KFO.US(OOV
M]4,<SDB+!#LGPE9$7:['Q;M942Z7#3RZ^E0W<#1%@A&31GS,&^1=H1>4*OF>
MJQ$T$9O781.O,ND2> C?E?K+O'$6O(N:C>W?_ZCRW+HJES/X5,(#]>U;"JNK
MLEN"ZA/KT9E5<X753= 7QNEGI7R77(D!+G1(PQ*)Q+#9%C&3GE3ET)Q'P&>3
ME1S=N'QZD[1?RT/!_8;W.B\WE43D8M? $VCK!KJLN=YFPJBW[G&^\K2'B8?&
MLAL8D8-MQ![L(LF)1WZ^XZS>SQQ)SI]!E-YR_Z;8IAQ-VZ#N:47J,T9+'NT^
M5C6B_V7_JBF*V9)T\)D\Y8.+47YA=.TJ,HSOK'4T_]E2L9,UH0U;O&X@+A60
ML\2$C/4H&VIK7W_VMJK3"7_Q6.V<':WKWGRRB3KLQU,DS3Z3/-YFA$<03D8E
M&%LT,-7#8LT@')&?1=G6+V<=3)L2EN<)69_GGW?3!G;XU2[&DGVJ%R>J@Q!=
M=>O_7I:)Q8UWH;4G?4[DDMQ?X'U-U \SHX43:370?G\:>US)$<XF[IYR-CJ[
M]PCX(59F,!-#N-5'_H>_T'C!$*^>II29F TS/ZMH*N[_4 ZT8BW#9VB)UC**
M??.\JG\SIJX3]A8:30?"_9SS$SQC5^[:U*,SWL\L_:WL^V>FSYRTL6E$^WZ"
M$S!*3TL+'^4S_5Z,S_5Q@]MX_<O([AW[QX:,O6R%&PZ!U_7;RR@X11?!@LX7
MGYDOG _&#,;=2D&X>\G-=3D*R3?,K<2J2 $)0H#XQ=D2C[3>!8$OGQ-V=9JX
M;K^$Y4BSGN/- 4 \_2KZRY7XD*].JSY^XW9\N%3CLL0#6Q+,]UM.)YM45^EF
M:;QI3K*6Z^V1QB\@_#^2<>5=K-U>+N(;]9'\$O<OQ<LRDS:$4/?8X72UO:R;
MN))NDF<,_W@Q0]@3H1?Z"VA5DNE_74&^N:0]+IEM+%4O)O=^0T J]#= (M>N
MO\#W4&+CM6_A)D?09G.TR4C$@$)4$ZH 3IQL8=VG;)*/'W?IW?:\&KZ S0N@
M0Y,[A^]CMDT;OG6]WR-QZA "$/3A^/BRY.0!F#I>("97N^]]KOR#44K]5;?W
M?P6_E)#>J^ .5I37\PG1W(NH[ AP;5'8C:[\<(F:7@@I+;3F8FV.?BA/_^Q>
MNO2^*M 7P8S91&-J<PI4:]%6;T"9W38Y612+O$8YW\<CDS/>W03U7&=IU;H2
MNA2Q:HE+.$Y^WG-%C["@XK/)Y[?:U4S9$)KX1DF883)1Q"[_5P1W;RRK_'U/
M9MT'VV8IX_Z/? 8$P-<A,0B.:4M4DACI\>HV9!49>3W5!P+7]4Y5"Y5.W'WH
ME\_""CV?3W#S2B!ZF'<#&785)LT"UR [-;Q1XL&#M&>E"SJAKN7$LR>+*G7G
MIBU)!=]]^NQ&.U"$Z.([*)[O^O!ML#RH; B$7PXZ$-L)C]#8:FH9LF\CQW58
M["ZE1F[X-95]FO5Z_6GN*5JGWJ@J6J4,RG.6X7Q$=NLLJ4VKZ_7(=XT)Y$#=
MPX7:P813G2GIJY5:1!KH=D7"E[ ]1SV.U18]&+OK'??C)0L_QRHF%=10N88.
MN0N9#[LD'J9N^4A+Q(ABY8FW2X3;70TK B7%RA:\#&!EG<YEH4*#_85"G14;
MU/A[IW:$U0?:R4?7I>[FJ6ZR<M\020.$D-*M\K$/BQA:\*5^["??/8PV$=4O
MR^R\)*QQ,&^2X>3?13J)"8S$0GT_Q<Z'?LSV5KY(P;*9?OY+E$MBH!RE"A)B
M7N.L:XOBB],*-Q9!.WJ$W$SY&7-'&4E,96R/?6V[B@_@AIB-68_=0,DF^N@@
M%AQ5663- ^U0 :NSW2YBLJ+I\EH6BV;MI3)%[N)124W&3[24;XJO*I$\K'J$
MOP 7*A*)>G]],%/Z%5PUY3XIX'J:.MDPYQHYO%-5/_/9JN7]22#+%VL22N<?
M.XT9$NK3>=#0S5*MZ06FX_*7M@ZU _H8[EQ(+=:"2*+I6NQ6Y8,^I8J4]FGK
M2CAR(7!R2G'!#],OZGZ)?,_U"<094@9T]@$0BV3/3KNJ]AK(WEH;?&9G(!A&
MRS0V=!5:CK]$)3*7G!$?6U]F.DP]27/S=;FO:PK1U#TQK.J(_6$^[B@D%FRM
M=TAFG.O$UYJ<:^W"RXC?CWEP3"UXZR]$<3<)CCLFUIP#LV1#,^EB]:9RFO$>
M^NA**UU"U-'V#Q4+H2;O)FL]+].PQ%F\F<?SJ@I<:&A17:R<!#?I=DJ@9KX*
MMAE6QW>C6<6OC*L[DBWEZR4? :Q;'>NAV8,WE_\[G22W(-9OH:]G4$E@/3E^
MT>1OD_4O8+%\\'TA6G>@FWB=7]_0JM+/AJK:V.'ZAFBS< 'BA1).%!7&6/U(
MU5G>$7JU.C:%R1'#=:R>0ZK3@@T>PX9>2@5OE9#FZ.OOWG3<0>@Q&POJ>4BO
M@T(T]N-[>=/<429UCMPOM8S$OE\NZICII1+29<H+$MGDY0C]LR,K;<;_)>/7
MF><&]?QQDIXWS3("YP(-,':O7I,'/0(DO2XC=L#FZRI0139>J/CBM4G52C^P
M9>A"X!C9[H K8]DFY^AD,+6Y6C##6Z86@MJ7%OWZ"DG2*9M0U+G070K'T5%V
MLHG-10<<^7Y2E+8L\:$TUU8UITGB<*W[LQ/T@^_SFQ%OO+-DOY>Q1 \-^5GS
M?B/;WKON#ZL%+!)])MCEHGIEUJDERVDBPXS/TJ7;1]\ GXE&X;H$G7B41LVF
M\'REJN<N?P1LK3^QJ"-,B4NZW#X3,+1U+2Q[Q_5B&3+-('+O.)-;[D&@!89\
MS:2?%%5Z2'*^[EJJ_$T,^NIV/Q+C**(=&PHFIXHM'BM;/2 AJZ\1-1, 9[P]
M-CG)P2:T:I 839J%2]4L_E(2,81HC58GS[5AW5,&N&-Y/A02IKU!1?U *K1F
MO@+>7'>/W5"2E9RVG #K/"1^;OY:,@ZRDA7?7?A2OR-$@<MU?&J\:6R=ZR,(
MX0BUVZV? +M<*WH66"](''W;NAT I-<03+R!,44E9;WY:C1G<KBE#HVV](KW
MH!IZ!*@G'!P=3.2E5/6]_$@?^HO0@IEJY>MB!O%89SNQ#Q]5Z.YB;PEKUQ49
M,.[]&SKB)7E&1K[Q92BYYHS9A'+EADF]X7YJQ$IX6U?5;03_AEA)!W;HSFZE
M,HN&WEG6=4-DK9CW<9O.M<GW^U@68%JC^:F%.;64DCR]@^JVW<IRK##D.=1<
M'8)2-J<-9X"(;2D/59H2\.J[@-S<JP,6YTXN1LR65E9LV[%$B1TJ=CQC:FDN
MNOW.F,P0E@]00:;&<5DX#JQN(KL3,#5@H;77EQ&QF:_N>T=&;=>#Y%_'?L)L
M F%/QAAAH#">90CB4)G&6DMEL8L9 GWQV;7>@BU=;T;8.)TH1K60PE^.'XLB
M;("P#ORH;2-=BDS*\R^51 ;8I;+ B^'#SB "K:=D,+8]BOKJ1.)2<V9VT0/[
MW %WP::-!D+9][/9FZ0ZX#B!*.J:K>'TYV8ZMNRZ.D< __ F*GQR#$;G% ;9
M O6W#QUFM5[XPJ[W%;^[@6;ZA^XX#OJS3!8?*J6@6G:[BFC?>S[*&=@6B2!T
M'CFM-$A4'8M20D(EZR9$[[WMU-%'EMAX!NA?EW5D]*1O(:4_\3<C)!_Q98?U
M%^UU$EO&CK?W$C ?<X=[$X[EFW(QE:ZL!7'^";#L]2K'/;\0P1%<VV?D0 9H
M%64U/O&KG7,+%-_E0=U=GRDX=>JC5Z'DQE[,-AVX('=BS/.I1%PU30X0E0EV
MW:QPAZ,GK&)G?Z1+=&&FNQ*=Q<Q].W'J-C?IX\T0^=&>WO:8+5N%=T#0@07T
MB^=WD5@[=N+:<GYO87>D1.V[B>]Y"1:8G H$G7=4M=MG7\3I@)=JTF:?59N?
M5 D%K4F,5LY@5$(? :%P)-C!@V:]C":<^8F=J-O\6;;2P1#HN2><Y</BGGL#
MP<X6^U) NC T8JDE1./JX^_H%">L'9.R.4*M_7.ZXJ5!4>%4CK5]6<7+\]VH
M9V/+C)15<^4:D>^*&=QXM4U"KUH<\#]I-[>F*E&V#K!&<B+TH5/XRQV(V:KG
ME7?]R>)&9MV..;IG36QG*G-J@^A0XL[[2;L"!@4IGVF<C46Z5A(O+BU9X[#&
M&0QO\\:2OND'G.$([C82'AT[&1GW71&JR?VMBO8/]EO\^A\.4I.ME^W[?W22
M.J\S_RPT5F@D'Z6:(#[_LPA'U#4"$>_EBY9Z7S<N*E6D8LH<XEY=HZ>E+$=)
M34-!88']==+!5(B^:5G-L/[_++\-%&10#V$(MBV=SYM87 H<J %0?(@?0([)
MG0U)72)X/YT3P8SY]Z)$E8_TAAU/-['3D@UW(X]$"C+72T\&T$E)3,&7"JS?
M"SE-2AC]S<9-I90OR]TH>31^6R@J*?SNIOT!I]^*-;Y=N]/142IHP+<^>EJX
MEW_CN_]\G7.;DDR^M/\G4DPT"$WLKQ<GGSUV#7<=T;Z[WJ%E5?O]ICH!06C3
M4>A6?LVU8%\"M[9543M2L:EZAC=M_V)+JGCAV_OVD_3XNQGG%L-,2V]*-Z+0
M'&C.L-'TE3>&;@6^T6LGY!TMU;*E\T9&VFTQ)X,D6N7U)^UR_JW,6F)#%ER1
M5#@&\N7NM$4D29"!XXJGPXD&%GTTQG<:&TB(]>NB,Z:0&Z;9CS'=+PBF;'?;
M#>.$*392E8X8Z1I$4IERXOYA-&C_@P.N/V9P0#)[]S'#!>1ZSW:<8VWA(*V6
MJ)=)!-'.VL0BOU=1PB][*Q.>\ &I%+L'4?8MCO'EWVWL^!\V]B>(@C= A'H>
MRD.S!W<LX;1-S8J:N*^K,#OBE.4VMWGIG03L1A:8<@+^H6U"WI4$/^K9RADL
M@;RLT*O2*XVEH=B.__6,AR7Z+"7BCS-:0H_2]\T1RR\G[=69R.@__$*/HYRG
M(SC']@?FS\"T?$TAM))G1VH&:6)O2>F2E@U^/=,:6)#L/XOY\;0POS,M;3.B
MG[:TZM^JO+J9S!"^E"^ULC,.&XT)S]S>_GR=/"CJ*$==;@F-[15HEHT$<^0;
M2-O/WM4FE(V\2C@@9.>/>T/M<37"1]RS%3\W(4T80JBF-F2!)Q2NE??</400
M^7KP!SI3&0C+T!:H3\$-#1G%4'J??&$:T,!$N@F-_0SDJWJ3V/CT<$RF"BDM
MB/15;$\&1G>\M/WG*S3Z!!U+!TXB'5KK4:[SI^EF44$#3[M6L-IF6<U#%,,P
M3;4=%2A'2YP14+/%]L];10=W]-OZE:2=VW%@VG".,S#P!J^?Z,@9+, E@X:V
M=HV<P(TF.B=4#)-K"]K(+PP^LCLV[ABF("&0)R?![J9CQD1%HI0UG-H&_G0I
M9?"R^[M2G,51(-(WX>WU\$4B,,ATFJXN<E";5'K/@.[BLM".G>70O.+O.[0*
MINA4H;^7,+Q^*.(](L?])02XD&=/'JNV*-9_22-@;A9A8?E+SD*ULM8>L(6T
MDO5_[:B(0B+8C^HIS>39.#8PAD_?JUR'?O.)K3DZOY%O/[47ZE<.;(FX> !N
MD@3SLMRR1J7HU,CTTA$[A6B*IWWS!R':@KJI>,=A)DAMB:[&<C\M0J297UE-
M4^4N66C)RQ\,1$;<J*4405&/GS9'F8_!0^'V0Q*1W_"6E3L23GM+;.N^$6H8
M+Y9$SP+OG7$^J;>GTU Z-^?>D#>>?JUZ"TN2C2>W#Z'5^=&IJ%'QTJ<)3J[?
M'_P;Q<+-<MNE*6UKYGPP<@Y77H2^229X5MYH4L-KR$LO@T!ZV"DTIK]?5+#+
M.)V$ECN0#Z47VXECK02;%AF]<&1[%Y^(B12UP;V;COF46S:W:JP?)]>L&>!@
MKAC)*44YE>FH_=!H(K$_SLM$&R.M&(JP=_Y0W$LE+] I?^H*JC*!=JNU>(3=
M<R61Y@1X#."EB&Y&!0H>&RGGGAV^GQ4E*O0 JJ7*\N.]D@+BHJTGN6\AQ0<*
M!V7]0C)*(DS?N@LL)/3T#>U<<R.WS<+S2'X$& 1.!SVK[0QD%Z&H<9H*B$EJ
MVFP/K8?S\@,QBI0*5^>SEI9D6GYRX]#2;.%U(INU*##M)IU0Q-=%C2 I-4[R
MBAA@M,K8R7AHAC:GB6P),3+294(/O+0%HF#/"CPF7Y#MR-LYV+5/&[V5V3X-
M%(FZ6/Q]55$=(5][HA%A\^O"B'J=U=%6^ZXRS.U^V<O;C S!*:Y$<F!4+[QS
MEQ2QUD?^[ *.3TUI3<4 G[F7N 8FPF.O?>%6*<R)I_8O1H]<^98F5#)UFD3C
MZP(C-GQP($AP C$I[5KXKWOJ:^_7)Q>P,1[Z4*5<:N!JN?MTJO7\UU2;O?_V
MD09+)UAD@SK<CW/F2M&(L4<[KCPQ_:%@A9-3UQ_EE9D7L**R:T5\MARF]PA
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MQB1,>;!)7!3=*\:F2LE\KNX/3^%;\;_7A"0:V7>7<BW;UXYEXAMQ?C-4E?A
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MJACCXV-=CFS==]?M>E9QCL",)&&I+SY\ST]6L\X2)68EK( #&,54) V$&4/
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M"7":K0&M\T!28F"R1;H>K[U%,#"0+HR6F!QX$E"<RV]^R@%<C974SMYEG:7
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M=OBQ/8-K'>QJY5RM_6#4I_B 2I #.)TSV)B^M+"@GZ)7QZBX&9_PE2"UZ<&
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MCIGBYP]AWH*&$EY!?&<37'"4>VYJ)J6#*1]E^T5%Q((=TVT29_%>X:Z54A9
M+/#"RW5&/U*?;SR1;'U%36D1F%;MOT_&K+6(?!0KVC>\-!A1>,^6]]7-]%[J
MA<]7;+MRR)#\D1;I\E"KU)$Z)W[7L9?3:B%;-@[7*82NT)H?D9QM3BCGCXB*
M-@>G:7,</AFZA7<Q[D;;G)C@BKX6?*C.@;Y!GX-RT)_Y?=GKU^0E:6VOG8(<
MQZ^/4^ZQLKZ.4CC3P/]6N[6Q[UX)V2!_OO:'RI<) 5>#/YQ3U?8.235OSL@
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M1.8?+4TX^B,&2(M'8;6./)D]XB-1K)81?^0L%D@T]<;M[]'_'OWOT?^+1\]
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MBCPT.,)9:;/HKX6>.[@[=?0)>271CRUA^Z\X;_RKA3 6'ZT/F@8-EEA026"
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M-"=G)W=:#2<%SEV4EKE/**=@7O'^$[."C=R@4G#.S@J2DMNLW#W^28EB@KG
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MLY&8@UWF'//F0Y0OV27S4./=?"*\,ZT>&SCQ?$CTCFF5GR#GU7"R^Q_F+Z%
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MD5*OIB[P""&88JFB9:JT^9HL$"/K4=VLW,?JB3>TE2V^]+!HHYB6'\)BY_A
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M6@1^VK*?@1HKE^$#?&7)0[09RUA-+_TK3X+CFP,JU:LLG[G\N'>9$AX+,5+
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M&@$LGV4VA]':<O%["970PK*?=]1)WK"@P4"YL81\)SC61]/2SC3[;?F)YZS
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M!"J7@9NW&UF&N\0-LU2Q8U'/IB9J_2.I '+E^NUURRB5-IN^!C#D@]'<JQX
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MA0:[&+D#8-X!0'\2'MY@V!WF(-IK/?E=A!Q"ST0OS*_O +]91A<$01&4?R-
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MU3WSVB_$ JHFHJF!A]!]K6XG38@!9JGM*  +4 41H9B[XH]_5_L9XXTO!S3
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M-06S_Y0:_UN2H,?TCO3$8H@Y3(@AB"\:[9$&2NIA>@UOF(*G2,>B(/MG9K
MBWNP[WF-?8B\]6D?"_C*3T#?-5_2C[;Y9TC(_*6+%"0O9B0\GTY<^'O$KD)
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M<J.9ZNAPPD9B 1.96,"T.1;P?+!Q8IO$Z' ;-ZE0=NLG\U:A'0+;:&$T4%C
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M-?!M\[:37N5GJ5ZRUO,VN=O7;W=(:7*9N-[3HLKVDBTJ*>JVL\Y;@)4-4,6
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M_SO 27X8;TL,K,I+%@4-/_LRNA-ZKEN5Z' LM%]D',>ZQ2<8$ HD/Y(5)$$
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M**^JJ:^M\YE\M,?D='&4]5%#.Q/)%HD6*0?(XT#TY?M&2TT[>6!06NQK* "
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MV?MNA(J7_9DO%/P^7[62,VOA0=S&_X2TF>?W/$)5:/\;1[3J-"NH7:3W?^*
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M!EF;"/19&\]?C25A>X\?L&B'!2\.*,P+X0H7F3W3?E&=[C7R),9&@S7T:R>
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M6<M8&+R(@62CQVNC>W;%#?O9"^4R>>0 .+YGITL[O%6SNMTDN3=&N=&<07;
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M6P0D49,KM9\:>*-C'7@I GPK(ZOP\5;/!7(B<-E"0O.?//S\.2I'_;9[A$?
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M0&#3+ E3F86E^>/A7.9A$Q%9D0 6-I'XC<1;THE&H"U/N!=ECIO+^+8Z[V7
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M++'W0J?+$]?CQIMQL%'2WM+Z$*%C>[KE3/K*PL_3K?E( D#C+;#JU 7.J*V
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M,^9!240Q;C$Q9@V]!CH;5IHP_5RVLHG2KRWI*XX3.B/V]DBG/1"A-LL0VBW
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M)$0G?<;<S?T)3.>FBIJCN$:>QE=SLJ9G;\5*<:G0. BV)J,B=1A6$-UPRFV
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MDW8A!)<_&T_72Z>0(\1.6+X$KS6Z<LFQBJ/"BJ-[,V-DQGTU4:.DEL/<IQX
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M@@UG=#*P<A$)+?-[9'UP[$B3"P](6O%DNPL+C3_,'N=Z1[_/F[?FL[Q%" W
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M37N?AD^0>E-K'=X*K!YR_/$Y;NC:SXZ=KN;>)<?42C#RIIT>4J5"& 6*8!?
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M' $?8,J^%FA]7DG=0PRS#K&?LU[OWS*[EHN'>C(AEE?"TA*]U_5&GNOF=B9
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M0.#X-O^Z79E*CLP^:2%7NPA[D/GP9,&>EOT:SO1%R;36I2BM8(R.L@>&>1T
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MV<^H%?@ZJ4T+N,/TT]67 [BV\?3%"RC,F76D?H!#!1R\]?LJ3#(+H2),?#4
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MK,4S]&E6H/JT^O-GM855]EA#LI;,L%L+BYIHS]:4CGSJ\=4MJW;87\ #\5\
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M]'1I>=;&;]>3'FW?[^,:?1?T&)Z]J??[W/9\.5[H9.M-39GW5_!&N2@GX5^
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MIFP\U0;D^.?Y5'.)[6Z24/5GP2N.CV[??A!/H21H=DI>?J>^$B^ZO,R58KA
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MP)$;(G%.N&T\]%WO;"F#%0M1\YCB6W=7TMSJ9F%B;&0$E1+-N38Z\\.3AK^
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M/)9SW]R8XY<T.G)^?ZXVC\Z\X1845A)FBW+<S&-4<2OW9%$<9F(*'[ZS?6+
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MW8C@* )Y&?2PITJE*P?I>?C?3SS:'LJ$BBJ-&JD\P0T[< '7UWJC%92!E=X
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M<)PJ$?RV"^N.TSQHK9Q-*F, Y<Q_TLZI.2["3 :)<]+S2#JZ&Y4/&O5Z'YM
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MOHS^S+/XIQV9Q$4ZWJ8<V/O:OW^KX%V'ZA\/>P9PH6,/6LJWKV")-6J%#JE
M=J X##B5B&E^YBP;#I7L[B#-[&F%-93-[S[=2:-+_];6T$\Y/?1!(.&+,I %
M(#"1 =B\\:\FEEP5"\4[LRDNAWX7$XMW+)F[/-H(BJ6I5GYFW5)A=%;LO<H=
M(?7!3SJPT.#"![6S.SJY0F[\?O.%;NQ'"H6M),V\ZBMF4IH;1\]5";ZV'MX8
M+^VNC;5!7;?>@U$)=M?@\=S589P;]97,!4KGX3R$KLH/E;;0>4(B*T] S%;,
M'[S4FG"17/P+E6XP^J)0#[3F;ONYU<^YTN%ME1AK#/]O.=YC 6EB0TQ_([\G
MXF(%)>7HBI,N\..&W[Z>6T7W\MMX\G%6$H2%R+*L1AG5)I[1MQGZJIE<OM@D
MNHXT#?&;E?:C+9NSF*W4-+=LC[3^X-0>CY^]MVVA [%4IX6:ZA![4I*&]76?
M6\"_?A4?0'\;2LK0%[W5G19_VR32/H]SJA9+(BQ61'[='A0GE)7*E&*TU ?W
MP?O*MS%VNJ#9BWNH#:)_<@"===S5[Q*L+._R E#D+7OLFX0N!8NH6DS0]RQR
M-8\=?-ZSK$N(ULVAM93O.LI: 4EW2;D"W='CJ$!20HZI&AU=T.$^:R59A\NL
M:^R&,I:Q*_P/*13@MDC4,:V/U,-W88Y;GSA(-=M_NJJF5<?ZQ)#NN;AF9FQA
M'5/*OX[GC6/D>TWM;DH&)S![UF/Z=9(>9Z][P%,O4Z%DI%%\3P954XD:1S]\
M-3K;9B5Y2,NI$!Z)ZYX0(7/>(A*_.OIX=Y$%PYA3^6EUK*0X([!P3B8CC9LA
M>YU^CK[NI_BO+;QD.:H;V:+AP%7$*,WBW]LP4+1N?2/<7&J)173U:*VP#CET
MPZKBYII;IE)V,=V741WK EW:IM-(J%,1VAYYGN.] ,:P/JZHV*?!3E)WN;!5
MQ>"F\@7"_30\&UXL<=_B2GZB$LIM.6](G!ZO%]'$=G!958-:]BR^:ADCR6_8
M1T,K-!HHZ17Y[@'-<Y!?>$T <X<WIG!+O+ ;H:J'K*L02%:4>D[2.WB64/Z=
MIRC.C#LD(&OJ:85C!BS;(=5H>*'M:CIJT^ %18,W5>W!8-DV_-P,G#_OCD)$
M^%&DSN9$@TF*)8GY%E>>[M.F JU_ *QM>0< 3 )+,5BZ)RZ %TEWU",%MNJX
MM%,?>^+?&$+L\>==IYJW#CWSB+B5.M'A\37[\1&G3A^Z/"0\N8LF2RB>9,D\
MJWZ&@T?Z\T1F2E\^UP1#DKFR1,0'+S.B'IO6F>(??S_?G!+W:UQY9.(\SA<'
MH*];=<&D;KK;F\8\FZ.S^\;/B_P>4'AP_89O?ZE7S'G>7^!0VU'F,2)7NV%*
M2G*5ME%:F5"I/DD7!HK8#/76LK3 E3^4HZ7VND*&")M\F#WOI_Y@:#Q$80]^
M^G8Z(\@R5_#U:[$DO$%O)'L<-W57QOY^:9PU[.G%T!ZV>L[1#NG3BC <0Z]&
MR+^VQ+_ZAF5^;S+6U.M% ]@[OAHU(L2BRT?I1H;9^%"_;0GA+EC*@/,M <Z>
MRC-_A\WCOJ>+9CL99F?>+1E3\N$<D58$<H3'_F-QOAD .'IQ4!&-U*!0>ZX9
M^"Q-DXM!L/'W:(*_\N%XVZ[Z!)^'"^ BL]?+Z PN<I;OS1OZ(^/RAX!0U:M7
M+(^L+P/N :6/VCLUZ]4EU9IJ(^X.%I^%/J%9^8AU4QD^?D=G8F G2L=^QY9T
MJ%DWQ=8>)M:H^US8XD[;?(:]9< RYP= "\?^9/>6L*^#9H*^M[7]! X77#25
M'AYXPA9&(1JJ]2C?5N=K5N*(J[%9M)^VVY@#W4AN-61V8]7+41+ZYK=B,>=P
MJ-X(..ZK*Z<$S6[4Z?4]@+"D</4[BK/5A4-X^[/>C,YC6AHJ_\L3+8%XOVGV
M3H(F_;%/8\YM]NZN1;-#Y+!&48&*)V,]CQ.^MFH\(UJWK);4PDW-LID,X)5J
MR,U]_Z<@=GK<<'T>R=@<H]-4+D+Z[*)[JT?4J!V5;/G)D>&\8>:UX88W_I.H
M7L8@KB15VG6]N\25>\#>L*_QE.GZ*%\ECR;<9NF5I5Q4R\"H>\X;E$S[,E3A
MN%>]^B*P-]D./-%=:^+4I/8M6U\R0'_Y]8C0Z#.L7@<WAXS L#L6.VHFMBEG
M\S&+,%^U8QD^P7\&"D=8QT2AHV[T,,<_;7@KKBN:Q* 98A6MMOF(=5/U-@6O
MH \"P4U"?W0EX\-3ZR\T_$DD+Z,7350\_;W?7":9"+8V.*];2LJM!4GJZY1U
M>;J7S'?9>O Z6\4F27YEN@?P1OQT:J%%FC9B;9CR3-U(KMY:@FHGF]H%%X>
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M!O' T^ "SL<"6X\QAT8=-&C_D=#JG8R^NQ;72E.S/J+/Q[WEM2_VEOD!% L
M&J2;NQS#8:\9I9EB#>C"N9O1KQO5OWGEA#L]TJIKPQ55A$Z?[86;_JAR8M(D
MG[]0[-.ZA?>V^L-RGB/&#SUOYN:=M7YOLVV1,GTD@?2L-7DMLJ-U#TIKE&K^
MF;+D*DZEDC:H<<U588:IU !C==@LR<-O-'%-37LL[2LNPG:UZZ/<W<'/QK@R
M6]Y4)!7AQ*KBF9L^6-7Z4F]&3L.RNBT2"I;.[CSS2[#WTC)F8,M-&+S6( J]
MT KXA]TB[$@GT[E"[T+J:(9.VZ5.&_9VM'6U]61Q].ZIU=.-(0J[!]BE.I-*
M;R\*H^OJ)FS^Y'6ZVJXZ!<PC79[Y&DVS2_6!V,FOVWN"O^YF_&L<?;2#;=0X
MZ0=<]<T&[Q&9]E/#5"E>]&/7:G8LVR;ORC$PU:RVJ_6V=A3<Z<=_JFUJA?!H
MAO,@OR\:SIH"\8>2?MZT 0"'&?/C_'Z::X\GI"1]RY;^C<]M1WM6S"N$T)<S
MSJ0*TS*S<A7_",Y:A3U=V81:EBT&6D!&KM^/U7!Z;]2JV:U;@S?:6D <6%++
M)%R;\&6HPJY1O,$?*7770@?<!2=G*]%M-SAY.8=;S<_/R<<!W['Z(!/=1AOQ
MH<X>0TO/=L!>.CM49U>NCH5;JB^L5=2^PL^C)+BPKJ[TB_I6_IT<X@$+'D#"
MH5\D=')IP+UU6YY]'1CWA(%$'* G6HD^4ULBF3$PO @Y6])NFGSZP41Y!:='
M:C?'$!^; 5T(,'?=G9K_V[09*YHK/92:L9#O/8EC\6Z?![#\$+'7 DAADQYF
M^':1I;M&$0_H]:579'[QLU?BQKJW]I.NA!)!33V)ZHQ9Y$<TN)?W4;<LA<-L
M>TD]_-$F\;M/KR+Z,WLCY.CUI2Q+16SXP^"5*^K\:LF]Q]F:JFF_)YI>0LF)
M".'FBDRJUDCCK%RC&?3Y-YL)$:JI4ZB%DXNAW4U*:RI'I$6\Q!R#8_?Z&F=Y
M'A%_)!-WQT03KYC<Q"<4[4&A;W2YL*^V]+A"$58M$S7/%X.3&\?X:!"&.#[T
M1M,%&P+CU@]9Y'T32%:HX@&G&-BH!>)I_Y)9&AUOTUF^SG;4:4 )QSH[41LT
MQN:K%07;Z$=&<!C2?_WU:^NXS!JMNW^07CJ[$\#>TIG*J$Q_G6X3+)<YM*X<
M4?1D,KNT4],'T)W[#B4EMF9&4(>QJ2L;+AME%_,ZI^"?F16):!#LQZ5^3.(M
M=5H%(ARVF>OF7PN;;E++C$9LIZE-%&5%:V^]&U/9?+7QW>HU+0#PFGNL*9>P
M [I*KVYL]L1T?'!S]LEO2=C :^S?(RM_^ 26)G4-I?!M7=%'T]TZ)N\I9I\D
M\JW<SE4E+D<^LUH^H.W7G&X'N%WUQ]= 1/V909K4.U?9&_WY.,4+Q9-!<R/U
MK_7(>P%/5+24?>@&IN:N==YC0 >R&"F,-"PA/*O^[5@^]MQ&( KA3]]%]\VG
MN*1P-?"IL>,Y%7NFL*,5/.JYLMAWXP,_6R)-VAM[&!- U*N52'#'PF5O6-E)
M^8/3V6T!4*I;?-YK_UCZRBL/>[6-_49\BB/N[FH8NK88-FC&\PNY;C"'_9TC
M3&ZWSZT!HKR*-$#;?MOS' ;*##/VY_/^'L>W_L9C3U'D3:^KO I 4OXS?8W>
MNN$(H,\%4M=8'4FYL>\$GPF*6P_F%')/B)BIH=NG:B*?3WOR&NQ01Y:\R$7L
M[5*I^A^^P/HY[_J3P;(\CU0FS62J#8\SN@KJ::)O#+*IA]=>N_N7Z+9D47ST
MX UNW&?J:1?K,8IKD[(N>M#\G<&!]:NR>X"+X>,F_-J;7]01(WNN5U=GX$Z2
MO$DGD;\'3;1*_<5EU?G$O:_J]@TIWYI;9<]YG:Y)[.O?2*SL^ZJW.&:[]\&-
M?@>_4Z%IBIOET(E[5PT65?E@AYU[T5(<^/FOW1O(I,M^[$$Y97[4K%/D\[KY
MOGZ2_7Q\,\5AFQU]> []I,@%"TI$LM()K^>SHLF"<#Q';_5>]59,+0% .G@5
ML6#6<P^8G3T++6N:3J-*$4[V9C+U0]D-\@_GICD#_[GO&[36/)RQ;W>C6N\0
M&@CGX\W16;>U>KW/I'79,H+:BF^#"&-]=2^$P'LZ<./N1@VG16+U[*#C^U)]
MB7G?W-GD:1F&X@1[DU%UC9M/_YFRB]X)8:R\4KUP?2NE-93CM6'I)*?<K RL
M!!^#L]:GBR&E/?H9_^ISWT_S>?@K#,SDY[!3L!*][EJ3$D?6O!LT"X>Z%NQ^
M<6C=&+XK?Y" _2EN*-ML%,F?Q!HL-R#2[S0/7X;ZPJE-;#GS<=+5U2JHC*TY
M23(]NHIH*"FQ&G=J0,IG6LBRT.&.=\+SUL&,QM''C^U#JR--U8&H"MW;=\0S
MM-Q'MG8LG@>.K3!0#>$%E_*4I]D^_AZO59):?_ GHF<4,DK+YN8!E#\A*BL'
M#=[+4#[\-K,R^8*E66C?X@\8YM#RY?S.B^O!4O![L$PC8"B7TF3'% _]&^S3
MT=P:NQ&?ZVZ?9WB9-DUXKAB^37?*OFP+$X@:J)L6&;BAKMY.;4UM)T\S;)SP
MV&ZRT+NC2LA/D/A HB*^55KL0U*^+-D_G3\E);%*Z_&<U[(^@V:?+=OT&7N9
MR3W@R_*:U-EJWH0,W3W MBDWNVK B_>T123</O]RTTNA@A;N:8JH&\W+(P$C
MF0@S!]%WZ?Q1;4I@T<+* K5-DR"$5[@7 36V2\IWYFZ#' <G3>-)/Q'H[FL#
ML\4ET?22O]NP<E])5:8=;_K/]5Z\L459M@S@ZJ&^CF<(#/%BO.\GJ$P*N$1C
MO*C2N0&7"&'@9!FSEK]%*Z6K-AJ.NHIA8E5#7$HMF!Y)-F^&BDHW*%>P]0,7
M0EI&&7VT<-3,<"[BU:9.%C2F^]]DWW3XW /L03M/;195(R[;RJ:^Q(@CCT\W
M>4]Y'8W'&U]^/AW:M3\=)3<92<-G$U)Q)$_>T-(0_:2_(<M?5SWQ#AU01S0,
MKH;4[^JWQW%&376,P- ]S>9UL:0CB^NW L:^%\J[=Q2CI!!'X/2+NF;T9MAX
M\8T6-ZFH"OZQ<F\(#7=2R\EFD#"+[])CR($C_HVNOV^QL;V0V>!56XYKDY4Y
M=HCH3:GXK(!QA>-LD2G;&!^OB"R#L:F9 YG<A -5"+'@"FW'E\1<Q-%Z7.G7
MT^H+/\&H<V64^;1()E3SXU2^@>VD(95@1*E;!<O*1S'Q0Z#],J/UJ3^U-NK&
MTK6B(TTBY;FC<)0H/4%\BB:14'8O7&,2*YXDO0+2H(4)O>G@137N\\U>[N\7
MU.8.S7Y2(IJ+8.?;NZF,R9X9=M\"3DI9R##&JO7238+!9Z.N8C/57CR.!%2&
M07/!KP19%AW']_P8>>.#3YE)2TKODOW/2GS'<%]/"%$H.._1,_KJ>K<1"OOD
MAM4(M]OOR=9!0S.5>5/E7?$&6@(LCRB>TJ[_P;YC-3&Q9R9U7JMMR9$<>"SJ
M=1RIFB 55Q<V+S'*O@6U"+1QR.'"(",^3_3.=F07;8^!C)SJ<AT'^+KW%%]+
M:OX6_ ^+N6LPS.'W@!56$S[1UJ-/#9//VQ-%J8[;VA+2?_U<>,@!'F4G9L0=
M<1EKA(>B6[KMJ8<C1[!+T'>N:D'WQI=;;#*36)GH_H.KXZ[7 _[^(L>\O1A%
M=UE^'B ;5P/3%N'D=/:+.(]HV0A3=A.P<8OOBTR-\'TQ:Y0-.0Z3.<"9ZRBA
M/?2AQ4(;V='(,.%;*HFW0[9/XH=G&KQW0+3B ^QK+UHT+_32E"=T)W)[-?E2
M LLY+II\17Y;J6^VICVFFI>CE1;X\P>7(8<1Y<?(&1(+CSP%5ENWP6HSNOX2
MFK&P\E&]%F?5/Z30;+?<,>6=O-'T#_1*A%S1&SBSQVO< [[Y_/;/#J% K/MM
M*A@PU  \:D!3?C*>FN3_? H7/D>_LR^ZEDW+%5D0?;60(QHR;[XE79D)N_"N
MV(8WR!=!!J\U_]BD;_J_D328F:SCZ9:(?RGH2VH&!7RVS^C/=T&/\UJ"5+YJ
MA:N+42NH_O[,J)6<L@<9X1XI'F]3*[[ ZUEDS>RG6V_M&;"CF-ID4L3/5AZ@
MIG7#=C/(R<;QR8WTD)"27U&[I9#L^3S]A8:X1V63C/1QRJ\!-FFD4;@1NMMA
M.[^;SR_3B>^,NY-[:&'STD&!STU@ $_J)(]4!,,<S7]Z#R#?@0&I8R?>36R)
MUG:&\:H<<FAV6'T_[G%M]-J2FBC",-7(?A/V9333QHATE+)D%]>-GTS<EKH2
M_/H@9@&)C@,BA_]B1@WY@SQ!)@Y7ASUW?(AQGB;ZL!9$ TBUY'?L>3KMW8JT
M#_-X\>0-?CFP6K'2KH.[;8)/9H@Q>T*Z#<PK90?$XS\W2SXVOWV)'5PW?=JS
MS/]TUFB';N?U)+3Q]HV)<4I'Z,9+!DE^"?I(AA/DN]/LISW']E1@;<UJ!Y^8
M<Q7W8?!+&9 3\F 20.Z[EEM>[=6SDM\ @\,SC9*V+:?CFKB'\$8EL4*5)5N_
M?D4PK.557P5)<2H#VQCS(+G]5*TY\/*'R,>7:^WB^<4&%,)H 63\0M@ACY06
MI[24GVQ3D#(L4G>68?DU,1\Z&0C;TY/D?UD^/UC9:\5 'G\/, -9HP<*T=7%
M*W.W 9L[@[ZYC8;"7ZH$#3N.7R@^4LM&2LAD81G1Z8=*J;@P;.ECH*C25\$K
M083BRY%B1+C6IB;AI@:!1H!EH2K9'G_]_O&+3)#@*,?81-5:"S=%9)&=Y=HA
MA1BNUA/"?AP'1R/22&%>RQYF*PRL3K2P;/XV:<69UG2>,_7W2*(E+3V$D[-$
ML\:0,UCWAKH 8N_2W5.JYG TL&X[2O[:0@"Q,:]BG.6+*BE<62F[J%%&%;5T
M;]O+IKEL;+D/YH.=1VD ,98/\)A!'%>8YZ?CSRBE6+D#T[%7]_Z2\7W5C$OQ
MI>ZKH$=;6\N!\J;QQGW(T!H-1+4CE='/IO9)7M8F6/)>@6;]WKR:.8R9HR$$
M5V"Q53PEB=V0X=>*G&V_&-/6,RR._^>_?O^?.O19JVZ4T6>)%49_18O-QT7F
M0":'K0;#>>2(5'/_R9<,5G#32:SI,>,'H^^]!Q 9+1@HD4!+?\.I<5\M5*?*
M-O"GCK8',^^%8L>D[LY&WP,B[VB:6FNC&$&:Z<Y\1#H($YY &S/>7-]'LC,$
M>+2\TTT K^_Z$@60:E['W@Q8&G$SF4&7DY2^POOH;^EJV'!L9]&U\M$F^15-
M>B-(V:[F8U-U6+K'IZ?"Z4]?+'2_-S=G<IV.L\.N*&B!4O>+@N^HO_;298*V
MJ< DBXHFQA5A\:Y/>FNU"$E<#[CS0E;IRRA\O0LS:''7DT2)JJ3E&>@ J5$C
M[=.-_F\.N-7VC?I1FQ:/M4;=(@Z /V>+UN^>[2[8JDV86=\5VSLL&J8]'2GS
M>H3EK"FG2GN>1WBBY[F(*-S>Q/*M-)CS+V12R?X2N;E5,I_COF\DK01XIA=X
MMIG@*;O756&0K7CG'_ GQ^46DW678D$XIY;.J<J7G[*_-)1NF2 069==A:?X
M-8L.4*=D?0_H5LF/AG"^066Q-JLDT<I,9EI]O-XK%6<!LQ4_OTB3]WJK[J)N
MDUCX]M$^ODT";@R)-\\3%O!CBR 1NPIBZ#9W!;% DR1KV>M?34(U&2K7Z:/;
MV@L77Y5JC^]FJNS/'I#,&MBV^UWSU0\KW('E!'G ']QLRD%((;)5-JRS(?%@
MSSKC:I6FUPF2N!<Z@.N>=1/TR/W/R3#AZL6#48JV3+"WU$6_"^G&#_AS@.6]
MZ?4D/]J)I0(MD*1I!-CY5W%L9@0RGIL;]232F4^J53["L5>E995?3Y!833J[
M&WW?Y%AYW<SK-'VH)I5/Y@\4SR,4UJ4Y]1>T@W+$:S="#NF=&JIVWFX]7B$)
ML S29$KA23MS->7-2OO",:1L;6 DQY"W7&N\A8T*XADS1-$=)%:J"[_QJK3T
MYF'>_3"[PFYWB?S]+,M-$B4;YJ=[6P4?7QJR=:&=LJV;F/;JS[84/T"Z4S L
M8_W<EF-4IS1>G"7$F#M_HHZE_0&Z_/K[)0FATRY<RK98#S[=Z-L./-EU,NIV
M_-?%[\0X*%R!9UPFP:@$L!LS3LW&8"M-WNB7V:6>S_KR5N%SS?/NO$Z/L-BI
MD&VFYI$7'Q6OO++I?.PCTCB[""WDF$_=W%Y$K7OC\MR>\+AI/>H4>Y_K U@L
MJ)C9$7T3^J.MOAW>TB31BQZLSO*\#.[3A6&HPGT&4S-&<B5I_8*>MRJ_>/^T
MX>MY+3[2E!C@H&T\&N-G7WHAT__*F:/)L;PX3AQ:W&J0GI+%+2LA^9$"B'2>
MTC.C!W'&4"'W9QWL(HL)MUV*?N#P'#G%<!_,A>3'!TQB_=76+>ALR.ESR4>$
MJ"FK[WY)PJ8UT_JYQG3*E%UIW]J+ZR^DU=@>JD&4.L$315KR,5&.VJ[J>L$%
M.&$M8+:3JE?/8^H*/* 09!L1,\]%Y B-)QV;C)U<[J^T3U4Y%;<@$QFFG\3R
M0>CE)9P+2Z$/1?MXRJBO,<[R=$?_#*:5'"^X:1WK?FKQBEYW(I7>/N-N4LEK
M51(LQ#>3M440+BL@+D7Z#H!0TD%,\52MVY6TAMJ2M:T^92'YU>D=<LKB,XU?
M<J/3:"+9O6:0JQ:M-=5__1U4'.G$]M*$]BN%-SU@@)8760SPD:;,!5=O4U$G
MSBPZP$3//]P#*L,<OZD$%B0G7^B%/LC3P^@@4;3LRLH(&I,18NM9,,^:XCKZ
MDD1EPS@PTL_7+>?EUQXFFE;T]8YS:'':!T2O:P>Z@*P,3(L_.C3IV@?P(:8<
MND#T>\F03N2G'CFJM&6H%JIY\^E1=&5QBX]H3#U.^N(3(&+Z?^-95*OT!?!-
M-II8JH\+FY$R.MP=O;(1\*_CO6E4*)0PEQ]P<4[!C5[+W#Y-&Y<"K@PT<D\X
MG[_&]D@3&*:S]&*4 \2<Y)&@HH[5A9!W8BB/.7\5C8O/-@W-\NR"C&[/YDOS
MNXSC^V&>LO2+1O/RQ?8=C,V3-W*H 5=W2^)N'B]$./"%[$N)$?$MVD,YQA3*
M(8A^W_$N/*W5M+Q0L]"12MX4!.0P_-@_,_MKMX=$EL!Z*<YIO\W?<L6JT5OF
M3Q5'&_&W,)-0E!"21Q>X(X"$ CR_ZPNM:E(!"Y<>+N:CWE]7-?I4(_7+K[K0
M& 87L#,EV'6IW0*)X7)TY'42Z215+]ZYT@WN%-7T2&+'K(=R/X_Q7\9:BSG/
M(Y4KJ*\62;1=,11!-/OE$R<B4GDOY[[-ZWO)$JVVS/CYNYT96;T!AU>+$'M=
M]?''95-V5W31DQ EU0+<D>]S('DDBU$;?KRKEP^Y;IA;=\QVK"GZK:%U4Y)U
M^OO/JGKZIC2NHXS^]B\P!_',<;QM@G O7IXZ22#_'!G-!E%%[?[!>MV:Q%I^
M'DEU5&\S1B;A3&C NMJ>6+"+O2Z=;V*('L+3R[!'W,,TQ8IR\LA^/K+6^Z8Z
MW5XXL?KR??=+T_=6>WSN\1H^6KCME,.0AEX=NROIV)$?3J4Y5U>SX\27'BX"
M/]F=V&3YUJ:;G$>]'9UXR(V->YXE=_SZH$)@]=F6@%0G2 ,'8%"0!T+\M\%T
M\[<%Y1"5;^*+%4"LJ%- @O>92&P9)&I1LI+-ONJ?O1U'VC[4W4WLR9I.YU!7
M_X83HJ$[9BL#\.]EC63N:FPQ\JN?4I5]K,7YF\^'.&TO-JR/'\+DK\$BLFID
M<(Z*HDEJ;M7V^81(EE%*S#FZ3(Q,_DV#LN^&/#O1U1_<%$J<J87VV*HT,3 Y
M:*X?D6-H_/SE*3L:1Z5T)R.@TO$,^N9J]FB)W1MV5!69.)W@*D?UK^J:V%UU
MBL\&/G&J1M^R? \ ,;9WJXX=Q__ 3AQEF#(1TQ])]R[;\0E+/A,_X#@ZX+7]
M#22 X?W8<VTS/T ",+-!HF55_TX7GCOQ["0ZP/A+7W4A0-\$2%S/C^/:/(NC
MC<<Y$<V-X1_KDC9GU#0)C%DA00>#)!_][; 5HM:$[P$1/J9U8A&\>TW$'/3J
M>+]R0"<"OT5Q!45E]C[]>,62<WM1=4@.N=M2\^=6:.A$K^<\;XT7$S1>^+'O
M]$M7*DCMIB]L;/*!0\9>5A%C:TW:A%VIFUXK?0>]Z05I>,T]K2 5!C9G%\E\
MD>03&K:S;QU)J^H]VO9)R3YQS:Y&-53E:^9S:1 #S HJ'.BRPY(_.WO2SSE*
M?I$3G!^LR^/,&R)[A3I'I7D!?9T\'Y]5(U"0(J)0?T7L&-\_.!G<<2@I=UO&
MD6BJR++MM'+O,O^<3=UT:P,+@UD@B6XM#0Y##JXWY7A'>2FR)!9XN*_7]5V\
M5>AE1/D_\!:-!,/U'YQ![N<3VJGJ.KI"9O9.I4:7#B&T^*DOYM*.(\5-*^1.
MUD\KZ9P;BG<%I%I-BVW]Z42G?0U16J75^!^^V#VZI<RF0A2I5\BD4U5:OLA+
M7["#/[$V=A_$3KS4YFLO[/)R>C%59=EB^.$IX3R+*UM,Q3ZG9,2_-QF L8*&
M.$01\7O[<-TZNN!M!^>GP_> #J'<\9J&QQ]^RVD/O AB5+(U<&Q5A@K_V9Z%
MQJ[7!D+5'+\E%FXQO_[@^NOP;<99/%59AG$&-,J!])R7;N4Q].3]^HET&;9R
M5(VGMZ,E6>K!)CUD)@5[< 7+1AR;LT4*Z]VYUP"8L7"^%RY8*?4E#6M!GY;5
M)T%0T-=*Z_&)KN8^-]%"8"DHL( ,SMQN-I\DB'U\A);?C)7].''JZ-)H#S^#
MUUK59#IQ_6HY&4QZ^6B!4E-KRF/_^=(^7<HM]+L$,MU=L+_EJNY1#OS,Q8(_
MZ0"WD;O-&!\KIJ9Z;XWI!,LFJO!3E7T&M&%^>S:E>*.501AV7!75^0'_47Y\
MKP_#-!4*LVOD/NJ1#UT#%?&^9F/)&S&P' \2>5E!?;684@Q\YA-7:FW+CB3G
M[>M6-KX'U-/$3(J=3^-7;.O!P$8.57N'POH4S**J*3[=>4>*E -2 #MLO:@M
M/\756VZE"4\]$^6^4WINH#-.>O;[<(<DP:"#?D@YM.G:5Y;$?C8\HJ9*^+*:
M)79#<) U1O4CE>[B8NGD']P-2@U_?8TF5:;5.]2SYM&D\?<5[#_GO=:/D5)>
MQ28:72=+^^P=,$=2GJ&S?*X?,*RDN>/_^K*56Y0X4+FUDXKJJND;/!0<#3G0
M+N*>EI0?D=X^_U_=S1^<*^X4C&U<8PU!^S>A^9FFX87? MZ""T7*XED)-I^/
MZ^2D3O8S9CH>@%UPECY;4:^N$9[)]!%._8H.V*\\KHH7!\DCIN,JNLH.;5"
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MFZ6T.8J'8W+_CDG5_CA *7I4DEFLJ$@JDK4\/MX&!3!B.&"EEI]<O -+B=U
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M956AVF'&!/G=]'V&BC;SPQ(NP<U\);?2J':320?MJ'^E[<2K,$5/L<-SK%@
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M82?D]Q_FN9S G>*^Q(DN^,IVM4_-9"$=F;H).$^W7[.)]0P*FM>7[%\A-;+
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M150YWHKDUAK^C=-I-LERX6<]6TP2Y<31Z;VDEWBLNE29PC*(O\7#:OIKV>8
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MS(--LE4$\\_A4+EG(=Y07/$!^_OWL[\O_1/Q]S,HO*])S4#/:FP2#*LX"%,
M*F+83-@^Y%,0CUYS>G3*3R%I'DZEC"C7L6/X5".IVU'F5,<,EXN7))'2+Z#
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M/-K?8OZR>79&VOA E@<4,G[.RPC/SKLO3!)\?\H8WBF+VK.*,YM]V?GLT^#
M-WK!!<(B$F)<ZCR@5,ZLXJR4VE;,Q2BM\!182)BRN;[_AYU_G=D<&,OY36@R
MM-JL%/Z#V @2W)NI#?\(=O$7_L+MP^+&T5G;(BN)D=YKC6@RZ#,F#*+-@$\[
MU"L6_2S^U/*YZ6/H8;HVL6:-AW$*4D$X=:D]&6O0BJ-*]XB9"IL.*ADNQZ L
MFV ]U^D26*ZZ64OJB#3[KFE=JE9B2%W DM(XTIHDH++(GX-Q6:%_?5(1@#US
M84NJ[.96IEC0+G#D%G/:!,W[;:Z,Z,K2F*T6RI98UZP+M6QJD:?[P*OX87;E
MK[JE(R-Q)V?%TJ2=?S$U=VD7^(W*P%@%$9Q0$ VGIH]BF,/(.A6YHI826*-L
M3&&;AZ4TIS>WC8)97-PE(O0(W2$;>I/1WN^"*$"("@(N8X_DW"M*IG^ +9@_
MO!L7O1!!G?MVA@F6'$G89I?*D+68/M0,<CR;(;A[_?M89ZRE-:$@[2FS>UTO
M-=U__[P/NURRG\"D:5'T<[\SS1)NC8W;V%R2K))M,QB/5.0FBZP156JEHQP0
M(Y=4VWP4=Z"72>O(-HO]#$NPHEX\8_YEK6)N'Y)[(AR</VZ94&+B&Z37_0LC
MH '_C%B3R4OJ>L)Q?C#9QJMBZ<#CC?G9R"<37]$Z/#K .KN8.,!=$>"+?=6N
M"(TZY>W7S_3Z(JC@P9/KP*7ULNG]2\.LCUA,&4G;T*Y#30NT1D2!X0VG9MU,
M]8LY"_TF!>_Z1+'H7M^G 9_0V4^/I3D;7!XQ%#1ZUUC$E*65]JJ=DRN6Q<MU
M8T,$=TQ [L#O5[/S11SM7Z6^AT??^]6[>I3K#X@?A4$Q>C>VDOX[ B5<1P]1
M=;FX[+U.<M-.+T9F1:! W#/$_-V*K08:3&3?[C)0BS]0Z-", ()M?-S$F^4B
M=3GJRP* 6>ELKSH(@I_:>Q?T*WR2JV]+.5X75%FV2?6^$G?YFCV^( VI#%>I
MISD$F2O?OZ=9-/ZSO/Q7_VC9>Q?KUW^SK&X/K]7,/% \49O5NIS[MA.@69<7
M?:9C5145\)OFL/'8K4Y-ANP\D(Q@*WJ.Q&AQ^<9SV8*[X$FTF<J=-:U!R*;J
MA'3@N%]M]#UK/J09(1GHHPX]$_O:9/,M+2FGU88I?N,3UKC$0E\F44;4NGSS
MS-'6S+9VHA-E%&[-UESN?YM@^\06-H<KH#4_;Z1P7XLVV[\D&@DCH?]*W/H'
M,-FENI$ 5$-XU9+<%)QKMK1VI!JE<=MF\OUBB7)R-)#UW'DZO%M:[+3W#T!X
MSYAG8;SND,GB?:U?-4FVYA3?TY FSC7$C(WV@,YW%>U32%!\3Z?QQ*&U\7'-
M6IKX936F:J4Z8N4KA#$$FD+>1*%RLC>/C$C-1);?@^7!-O\ !A[\J98K7;2.
M8:X>UY58 \:,D=5'+DZ=$J>#R(ERZQ)S(^,CPV>?LY;Q<;"<<&56*Q^1:6,=
M"&D72S6;9>XDV1VU&H.V'6"]QL6=%;J18LM_-+CFJULG+7C)F%T3]*6>=5(8
M@27CU\U$T\L\(/\I2Y26!<,([?UM9+%U7O_/H#U:K-"3NZ%_@)?-L$1">QI>
M:  YJ&C?.UV'I8528)),WG2 3EERD;#9*",%U,CP;*HG/C Z*3-FGE)0_!]
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MXQ_=*VR P+*;OXH?4Q>> TDOZ]7P=^:0=^D82]D3)D\[RH5+B_^;3(NI_ <
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M0O1J5^HMM'F1AKUF\-Q.?:IG*0%WF.PT:D\%6HR$:RU/<P2J\'0&&6PS$:E
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MXKK=",U/4MZ'L4(-<'S^)VR1*?3Q<CIS@WD?YX2ED:B#G1'DUUST<H:+$F4
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M=?Y-8%RR%M8ZE@Q9C+:I(%=,FR68!)<HL#U@'I).[Q_&4G1DT?7]^I+Z59R
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M%H!66?)R9Y:&N<\&]*QYR@WKK ?")KY/"[(LF+X9'/_)NPZL>NGPF3MYX_M
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MET:*<T.-^G-1-7X^)IN%7<\MYK>B-N;!;.;<1:32)C":NA]&.PV9Y_GX8N;
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M8PCW_1-52VN+=0@E91]X( B1M=M*" 0A!5*?8+V[5A4ONF1."O+&^-G7]/@
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MQR8,_:,!2_&'? J#V^LMF.!5)Q[/B.WB"-QB\W9IM'B?%??@3Q_N"/ID#<I
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M*]4OW_,P>\F&0_P,(M^KP7S6K6GQV:P71&K3=LG?_$/=:46)W01_@:/-QQ?
M=\(:_;5^E'V58KA4FGE5*?XK.);S;#A(__;:.C$LP"")(,FX.5XGJLSGB\3B
MKY\-NN*\,!IF(RU;6H]<Z:DL[5/N4;J%.9LOH)P?79$EO96/U)VV:";A'M5Z
M9=K@KJN?,?IG6G*G:O,M,]B6/N41(_(M-I)T_E('%VI&Y;GLJ.-C&W<P]XY)
M?U2\EJSYZV<Q^:G/TQ-BY2&,>\B8.F#@B26?AB,.S^$'73VS1L+5%<>ZN&(^
M #XF[?[MAO>6N>MYJ])K2\M3+^=M.+J;TFM\V<>KW0W?TST%&LC3)];(?/<O
MO$/7AS62U5$[B3" 8 TD5PW5CQPH12\.C.=;?WI/_&\ FJ\]AXFJ_Y"UB:S!
M\0EA=3UU@*]LLP13CN4G[W5,5("+_;K(!K\=8I>:@KPG6!8?T[_,UZ0G\:GJ
MQ03>G_W.JF*4B5>5Y5A))6%#LF3> VP7(-$?W>?., VGB'PP?SID8)CF ;8/
M8.T+^/;$L0?%RB-^FPWV90L8-+-EJ,W1#@TLM$3ZYK_E*LCK34("SIVANOT/
ML)7Y3P>Y%YAJ#*@=7JEQ>,^(M.R)!-R,U"U-":@_L&B^*_J-7UL-%-0@40WJ
M@W:V=[.5KV ?6367'08$3]SK5F%E'"8*QTW'DVK%EFGJ!%\';-Y[Y/QF>2/J
M J'D6WOJVT#G+LX^[%#!Y;)3KE8(07#2D7B?Q$I4M4MAS8O+'*U9K_?X>C)^
MC&E<E0+K! A1 L0Y!26WO$M$QKI".>><AMJZE!/6]@$?1H]%6F2W^\X./K[3
M2^%[C\IOX#@>DS"OS/=6P=3==-7ZC*C6$:)[EE-^.SCQL9X>[<T5F73<#.=M
MQ#G#)K//J^\Y)5B[6]BC80;\0SAUCGQ9Z2+\92K3P$)0!DHO+N2<8[Z(0W80
M=F;K\]&O#FDH/5#0WZ0UBC^P:815#PP<IX.N7P0H(.463&;1]_@4G15KLDXI
M1;35Q ,(+ZG%MV[CPOPD0+VU2>B[(S(>EEE2)<,K5NM(F6'B]8=5-%4C(*DP
M4&C'R,@+?:#62"8H<-71O4C9TN 8!NN0W#,-/-7LFQ\1*UWONB7KD#[)F:AP
M3U\'0@<5G\-Q'WMG0EB_/P'O*W\SVT0ME=A8 77O]?$NB6.452KZV$N+E/SR
M+:=GMVA>W@WGNOM$:-9(])R_J2N-SFR-9\%4;Y!QD]LQD)T&EW0/R\=A2+IO
M\;MHT94FGT=WGBZ8VO=L>*.H0^+U1091VJYF[U*C^3!M%L3!NU;+1H*/%G_T
MZ<DH] \-W7NR;+'R#51PXAZTSE'0PHPV/8R %?U>_@9MT#FDP[]0TJMK&(Y1
M['&C,4<LK+Y[C_4POB#MQ5(P9%JBT,WS=8B0C7C8'_W4?F2C./6Q'SHR%E&@
MR_2]+[G$KOTVE 'G#'SIVM<UOS)K)*#D8UR.^&S)!WWY .:NRB%X%:(8;ZER
M=SU?+!9'Y]2P+:E42'9P]O+<!T#31361!E),"J=GS>QZNY N%Y-M^N6'"HI8
M8JI]</J\F0L@%%W^@NGKT!L*)Q5,*UUN3,!?73E3^Q#TJ<&^0. $R*!\L$7W
M)=ELO&JVX[Q>>"K<6<^$X-* UD(C4AD\2H&L.F;9;HEOG6A=\MZP<MUB>QTW
MP[3&KX\UFF?57 A3@@0-*T%"(1.L(*UP#2*9;*"TM?7Y!9.OAI.6)O+Z>GT+
M6O_,>Y3)DSLQ++-F D]378>*QNG?,43?Y3;)T%-1<%HYQL]^+T\Z$&K'7[#S
MWMCVG-,<+0C;+GR<;BJ+_BTG6H 3)RA<G%S(H@-A-(Y3,Y^,!9I^7<\U-.Z0
MRR]N3E^'J;DZL=SCRE8@A-=FF7,3;C2JZV2AJ>5U PTFT$[O49Y35>R3]BB6
MX;<9V"?>GZ$IBR #*%=IQ\/RC6>$<C$)9NX>:FQ%]4B,\PVY,BM<^J@.L:)Z
M JVK^L#OU3>Y(A'W1:-<TAK;D7Y6SC:$]YBA+8]VJ*ZZPN&87R\LI]"7P)T^
M<R1Z8%/OT599X'=G)%Y%J,38(H@31QW3G[N)J-+=K+6S9BJ]U-[_<>[4#V>+
M+.$.X(V+4ZA6B0[#W(0B:FTNX"73HE*@A1F**@;'!TM,N47[NDD'TW1=M[K@
M>%1EEA7KHNE $6W\F7D:K,^717/;/B5R\K:&0E^I#1](E-;9K<"?\.KLP**5
M.G[CMK/1J,%LQ[ETF#7-HOX*M;D"T^M%\WOX+I@H3>IE:#2ZP<1]^&G3+4'V
M+ 8RZLKU\=(2[#[ =:U7ZWVX21S@P!;B3D/X3<,C9AO72PJ+U;QS]SIY7U&U
MEB<'"LOT[*+>R/NN%F0TP@QH^3W'I9HDB_617F[YL3K/L<,9KQ@F$>U;!N6.
M/=4Y2'^CDOB]#@8F+\\N2;KSE:/LOHHV-_8!@KX8FV=Z@_+&KM+ 2B/ZJ;?0
M<>5CE-=+GS%I)/ L6(+2TN"2W[X/$)?#] 5'D*AT(_VT(A5AYDV99VMY:Z[>
MNGG3:\$J_L 6$I(Q,Q):H(-](6!EWU8'%+(7H]_[%NN*8)L[0HWA:YE/@D]>
MZ,6\IKD!N$NJ2?PA<<W=;)7K:>]WUO?-C))2:Q/KWI2W<0VN&(F[I-K6S[B/
M.$N+ <L+\!T;RL7E.ZM#!:<[F^D6P3FC1_8$HT&D8Q"/-)^LL%F$L(@?81SH
M)3<L9?29/_L?X+Q)KI(0)"Z]M'0]BTFV69[XQ652KOE8@.-R;].>3]J[77]B
M=S ;KNOM^RLC,8P!EY8]&O7<?82?=0GB=QA%WF4*(>[)&3^O!U:LEQ>2$S%Y
M0724HRIQ>^!\Z.;VV$)H;=_$!4?$]LI7<'B_"_]%!?I529S<N?M^'/;'S'P<
M411F=4Z7&CO7*R+E183$R =95/ R\$4A#X7,8+H?S>_59?'RN6_^; ']B4"=
MM-P<EX2P2K9*XZ283^0_\<;.GR;47?=RVB%?LG*HM:=TC!EZ'%TH*\7HTQK'
M:3Y/,5Q_H:)X0;-GS6Z($6RX0[TL>=JRT'6\YE++'M\V4_ZY$[&(=\QAU:5E
MM4]<FQD#+]XO,JY:MK#L1MNMCKZOAH] )%?B0ZT9_9@_+)[<S=%_[N/-2I9Y
MZ_<R#,QCI/C6<5;:L>-H:T$VO''XS]Z4^;LA-VM5FFI\'W"VI*92<)I0*T$)
M]YFVN=8%V]J8,!DZE[J,B:RQDXPWN)NQ-C]F]BP:#OO22_&WFQK5<"?5?J&H
M0+Y=/\L3'A"^]('HU:[)TQ3X>JE<0IR]]O';)JT:4:^JV0.SQ,^Q^'"G0O!R
M;BL2]'\F<_RGASP<0![N1+[]TVPYNB<,T@$!)A7]F-.=&@9K52E5R(">-/.!
M#-'8]@I7J:: JN5'C2ZOQM^]631^QL*5,\7%*K.5U<('#+R[)+Z]J]6%#"AS
M9TXJXMM S60^-E>X<&"7X.77'UZ[LJ6U?;[Y^L5BQ\%B,_-G4RL/)K;,T ';
MPQML[__)K.8_&0YS2N>._![1R<XWTLQ:9B YS=V2X;U)_&?SR!WH\F-(HM38
M<HC_9]K$ $]*\0N+#O;4HT?DB5-US8N<M4@_Y8'CK4KDOCVE #,_<?&3NLWZ
ML$W91LYM*)%)UU'P\<M.["*P@4UNJB3*U@%5;/&@]T(RZM[CUHM1'Q_*E8S6
MRS,D^;C;'Y\J#9#-+4=>C:YJQ2"#6 /D1#]7Q:YFW5K=!SSAI6;DOM6]E[!*
M?%ISM?QARY.6,2M,0R:36)3DXTH,I'NU^WS)L:.)GDH2WMWE^!-JW1\6%* Q
MH3D+@^[6_=')T;1G3LD3AF^&P1,ZA8WJQ&ZTJ=+7]!7AN.\ASP \\V2EIZ0_
M :+02FQ)+L<JLP!IQFH>>@X=YS\?G>L;,\1 7QC\+_;>.ZKI+ET##:"@*")*
MKRJ( @)2 J(T4:2)] 1""8JTA"+2.XJ HH#2Q- [(81(";TI!%0,(*0HW="D
M"1%"+S=^Y<S,=^;,S+GGK/GN6>O^\;+(_B59.[L^S_L^^]V,GWYMKC1Z(YDR
M:'.::7*:Z#64'"R91$I*I*,OGA]14K#T'W  H@+/,=?C;[@Y(_I/.8T:DBK/
MO01*3W6=0WQ(G,C"5C(ZNW\I0VL);:)02JY"UU/RF!*:!KKE*,APIVS]A<D*
MMBQ)Y@&=0E.F%%O5> *M0CVE7P!PQ>RED7"*IC>R^.0@NKTH6W\L@?[:0UKU
M&('AJ6?1*@6+7M#LX@JZ8F%'O&1<':'K;J&C[_.B-/9&G849WK2NA5=U0*BC
M[@4(J>?#TVS61(=T9R9,YO&*"FYC[) 0_]Q&LOA6T96!19I16@@Q3VS1_L5=
M]*$<L%W*A\]S#!5)MM)Q??8J!9TQ^.)HEMAV@L\H.Q>)^9ADX53=O8 "I<!X
M5-&+QMA)K(#I,SB19JAQOY:K PX)&QD&/8Z,K'/@4ZQ9M[9&&R"U3.(</26)
ME=>NL"D;#^H /[LBBAAWB%-K_M:ZTPU20KKE*CGLMV(L#H;1]'U/!9,/'RO7
MHB&CL4N6[QF^[%98-QL(H,@"PA4#"&(54=D!D1HQ._$$DKWF956S]5A2!75G
M4W?>S%[L8JPJMH2?&@I3"%#0TK09K![GKL(OTXJ4<EB"[.%2TK)I*,MB4V'L
M$5C8Z@+S9IW)*(+\=-YF'F9'.PFS6UU@T?=DODPPA;)#9@1,U*O':A1,7=BF
M6W]> Z4VSZF/-^M*BDV-^!+_+8F$&1KF[XA4!<4U^A3:*Y]*\I/<<<<Y#+UC
MEKK!%V6@)?V=@KHY!#,<CXWU1%0YG+>YJ>UL>#\0S?>U!ZX>[&!F+Z'VU8YV
M%/%$:-9#^C-K=P/(9D#7$0DT"BH?K-VV2/"2DH%%VBC-^7$0VY$>:O [/?-^
M*N7B/4X7I)#]GVL&JUG,G#9QKC>&0>ZQJ^BS-M*G<S%GP8D3GD$R BYEC4\?
MUI>^EM^V2X D+.:3*NXV 'D&>]%.;2/*[:0T<B3I==Q76E%Z^[PI<[<M.R2N
MF*79 ?NE0#DZY1&L.H?@^*9LJ<8T%#6:&?'I ']0#C#CI3K-0R#"R[B/FS0L
M3&AUG,6I\S&@O,8I*1$YI.E\%WU2:S(_@M3>GQG1^X@+6 @_;6,.=1Z$N0RX
MYK6Y088YXN$@ 4S03-[].M2+GE"7UT('_+-HJG3K17<UZ]:&T:09!G3\V(.P
M0IW?:1_; Y<@%VV=F^^VC5BYCMK3RCKJUY%17<U2##YJEX!F5J4!HP6'2R78
M(4G H_B;1^>G-PV]MKKO$8DP]A^("5K,-K%:D^(;/85*)!SSM@65!<*F/)F]
M(3GR8CVN3P>+$U4'0.KPZP>6*U NL&JIV Q!"P"%>!)XC'@89J_/_]+W1C7:
MG%$U!>1Z><7T'='4[#T:\*2@,-YAWD1^<F B_CG/Z8QGWN#Q!G5L*LHLGZO8
M7OETTSIJ>328K"SX&24WLKBDI>EK8K=-H&R/U@<L):#U:[M(*1&SI&5!;Y!#
MFA+\9?0R%>_R)G!)EVW*L7@*?MI34\C%7?/8JB6;DV/)D+L3FV;0P-[@,96<
M(U'<&:^1B^8X4C#ATW "1-,F_HL1+'WAZ:P%I4$8JS%()A4F2]1:%+?S^Y=6
MCK)#'O@"BM'<Q_'!^O%K/+8YD^">;&YU@4*"PL5GPNRPK>MV%S).VO0^K=[
M2 O:"\;VF'!L>E&MVQ:+>R4X)C"P94-]GMH&1U%!\K=SG9@#Z*Z,#UG-J FH
M0(#)PO>"*W*1-F9Q3W78>(>;"-Y[B_<E]9+;<*YQV[@2;0&[(^3""H+HZ7=\
MF&8-9Y$GV8YPW\#F*^09WW0!U\AC*AC'#2B5;36]+N;5,Q'(@=XA=H: 06E0
MCZ!>=K(_1C?VJABLO3GD]+;:CNE>7_P(Q&9U">H1X+'KN?INY-:M\PK DC\5
M(([<</FI1]+DXOHTY'EZ#0FK*1AR<])8(![:M)X@E=D;/&@4@G_U%( "IPLF
M5+K!Y+%J"RJHCHXE+Q)XA^<F19; G^T=7&QVUH$O@0;"A<O..@IV6KA@\C?/
M-T,':P<<+NWQ;Z#&PY+Y=?6XUCW; U0SU5BV@5/3)QLK%NZN;EKTD&+/8PYM
M52CU?](&<(X0YCS8 .<5JXF<<__B+\ +E/Q!497D"Y#F3"_!T__^M>K,U"/G
M(/T9W^]2;4,"H-K4XX]!) GE7](_IO[T:XYH'M$6=W7Y[U&7)%_.?Y"W1*\A
M@CN6CB#_]1[*]P7(WUTY'KLB^P3!BG>0&/J\AC$I#^_DUIHQ2)[8@$/N3R7*
MH[C.5X>Y[<#Z#Z)7.V14@#.C!PELY261ES91PQHNTHK:WBI=WE"5;[7,8Y8V
M@B'$-44H4'0EPW3-M[>EA6T^6O>T0"/KEO6U])X:LT4H;\A)XI$+HNHI:^R1
MDRL7KJYA$)TZJ3I?IF@J.?'1]/ZZM/8_\?W_6^U%RVQA@6>#"]-,:[SA8Z<=
M.&6)4\E7?(L\*"*X#R#@-\BXEG,:5'G/==30VYUS,4\V$G0VS'/P/ 3PEW V
ML!O'KM2$9Y3&_)TM\A<H&_T37:ME<CJW.%?I3*>I:N G1SCI#KB3^O\!MO>_
MMBC\/J4\YM1IO(HH3>9!R%]:]*@11_DW@5DH, 3R+/ ^8LNZ TK]/J:_V4KI
M3Q"'S.?6OX<Z3&6:^,WI[,ZM:T1>"/D<SKJ\:+VGY4Q_S1ZI,7][1VH M2QL
M*_)L:Q_P%K\730> Y>%OQZC?4OK ,=*]@6[TJ:+[]L\>./]7#$&8.\^0O/7S
ME>015'5-W*N$JPC 3(@CQ?S3PF1WU*D@<GMXM0[N^:?AGV$7S.W=7/4S;)='
MQR_4M:G-KYA-G.LH;FG.5.V__U-7)KM12'D"E)K5#9E$K,RK''VFAY;6]UP\
MS/>D%PBZI)J24]G%F;H5;'L+P#>=%VWX@\$N:=SHZ#[ U4;GAW,ATV5,E#";
M I[/93N>N%;;KG&PBZU,IWM&.&5J'W DA&'R@N'4EA^F1)4O?S=+S+;ZA-NW
M!MGGYI*49N7VR[<=;\9^_.03KN Z9!>3.WN'R^[\6<2679:H-@5+]'MF=MKP
M\4$]S4=%\H1DXP,P"5<"$"#78&I6DL.8;P\+<I!59#ADYSI7O5R]6 WHNVSV
M[>^%7UX9Y94PYJ;=@\'N/JUW?1 5^ISM_E99NK>M^]8]^',23S3:6+ \UPN;
M $PX.X8' V](=M;/%IU. )8R@:[T!!$_>S Y(*83QZ/GP>CO#=Z@B&\6#SB5
MI&2N+ 6%#ZG-M368FZ5HFVQ#FT7<<MC,SQ19<<%Y%D=7E7+C5]L^)X[+7K-P
M:CHR6GF78*1*E, \]2\2U9\P&5^Q4K[\8 :! G[RH-UP?;)D")AOG)BWX@'/
M9+F2306%X2=^N#FEO2\DL*./PUCN35?<31]-Y8N?L_?;"BM<#RROO4DXW 6<
MWO(IGBKOTGN>8?9::"JS<\$;O+8$Z1C0.PT/.KL)N^$T.OC]&=7F5K.34BW7
MMY<PU2H;\&,Y;"F%)07^/,JIW&Y\$3:/71- U'5_N=C98/SD=K;K/ 2TGAY,
M5JH5L$9#HI=&TX3TH8*^Q4<HP21!L%47T$FERNJB4FZ36SS<KF>C7*7<8Z0J
MEO"@C@O@TP>+ J.M;2TGT-Y'3G.B[FG.F[*8[*+WB(ISV8O@RS)LPEX%S"NP
M&%*^N^X62;Z*/\4BG9,A?VU:;5:=8!2$$6H$VL1^S"+J,A]^A9RO+QV&!*J5
M#@=YK:*9G23E4,::D&HSPS74O<]1B[J.EN['#D(,W+'N#ARQT:[$*P0Y.0LM
M2E&\II2,P7CSG,@B1R/ZM)"8_U78L'(6K5L\=\FLJR28=)^IS/JU#B1\D,F_
M_+:O45"FKT;0QV.1]V!P+?Y*!T+SW*3RF\8^1ANK:+N4IZ$.Y-AO(5..\Q;%
MC_4T!;6GGLS$=@?+'Z8TUE?W;5*JBOJ#J(8,/8-O+:)\$ [N.+-@65E5TR[E
M1+CY4QUGAXL4+$BSV\:PO)1'!.@V./>@-3;ED>OPT4@K99.3B.:UG FT7#)0
M_&A[ZC!!^"IZNI8%R&3-KO\F\=F-1P3WPWB/T)>#+\JZ"DWY'O5AY?* #20[
MHH 5N_X=.=4J VP%!.^\>!.N ;O ['RF,%X+ZXZ^3#76.PP!,7: @[WPT.@-
M+[SW#Q5][2:IT:<,9%R @" Q.4TY:/(KX= 2^#:A^=MK(>%K9I^DSHSN* ?U
MU]:QC:9$U%0,;$(L/P/9M2.,+L8:71E-^U+2XZW7<81J(P)I/=A["\XF-@02
MK:>3WQZ6:T+D9DL#3%!;_/?B^/E1!%-._,PH^MH]J:SXF2SL?8%(@V0V8ITP
M]L *K91QGHNS]L!Z,6]$]V:+F4U\A2SDF\?D!\24KY\J*94ID2@V2;[B^QY8
MCSQ91Q*;3P5Z\>ETXQG58?>JTZ:QQV,;76 W8'0 UWE@0(G09'HG[=!!-H.;
M'C3=NZ;FQ[".I4J03X?*1*<+XR\'0%Z 2I@7&!%CTOH?8$VO. &DEYQ'(A$8
M4?YG<GB JXZ<VMQ;?=@CX'U@SI'7'T-AP_X'@TE!7F;,9Y[SX+\RH;768[)@
M^7K&50@0X]9H-B3KRL"\Y:BC;M6=IPQUM5DTR3&'YMNA^:,O%^U6RUBT&A[L
MT2[-.8L$U??6! \8KMNY?F;;!)X))OH3=)<L.Y?4YB0\;HUB8:+*/"#),)IV
M:,DF]44&65EZUF;%A$VSR@&8D2>*H'8^;'@D+U2/2=R[$"!V?>!BPBH&N\1I
M8YVQ@@O([E@Z^K3$\;1"5^%]\\>]O=DG7>/@]]L]5,I<P!5T/A+S5=13,<9)
M914CWE*[?>&1 U>7NR%KY:E#AM>*YA*M1I%'=8#B^P YW=)]@./N-S?S)]FV
M>[T:'%F=E&'%NDE_S(!L)/2$*.'"[6OG5:"0':-EC=AC<;[<(A[LZ% \G<E
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M /9 5OZXT1$QI8J=S*B@\IC"3;<<UG?+Z,?QBC;@ A>$W;19[&&GI9C5I92
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M4$V=3=G#0L37 Q?:9F*9'>?7*8=$LH@K71V8$P8"NAR]031//OC3H_<9/V,
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MJ)E;8,'95E93VHP<LI XVV"Q9+7.\]4;?U&Q:0H2:SUE1XM1*F$)ZFXD7=(
MGA8 #[ZVH_7,\9,45D#JN:B3V8CZ>;Q>NBHI2J!J7B<;@0J'*0AC>X_$O"C=
M+9 ]S7FH?]M +]Z5CU^_RMD>'R\%8;N0$8+5],;?Q0_F)1FJIWP13UJ\Y2Z:
MT*C=MH)JOI"B"CY;YE*VN0G_(N/C%?F#)#T3\^C5INN#KSQV0MZGK\"OZ?4-
M*D%3F[4\6:-5OMRJ77X7%]-]:T(JX$Y7]UU*LW/[F*3T_<MV25,<.+\@FQM
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MW;6U?JTF%63]@'\X,8B0Y0="NCO"[E=@(%*:0HHIA@572MN1L'(JOZGF995
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MRXMEO\+=7"=TQB1X9J9= #G1D."E!E\,C]K*WN*TSR*P">=JRZL<B#U4W*?
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M%Y\"CH)9CHD4Y^FP@Q_^F?5S_T,]\]"K_U//_!^L9V9T1^]?ZMY&?ZK_2[F
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MHC%PDW;K.8B4+8<$T^#BFU1!B110:FT@*L>B%.^4PLQH4C1CDWWI&II_&+B
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M$V@I2LJ,506TZ[R'4M&?RRO&-HOF?>%U(/$,ERK@Y\"C-@INVC:&9+)Y#%_
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M/ANYLC3]^!WE"-N$UJ)8\8_.<N_T47XS.:=1X1R/I,ZP$/8$\PCT;;#7P>;
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MVGO+N!&^XU$TD"S=X%]\C<$@WBW:5-*]:&\]$9@\ 1L\/U&@"'F86WFYQ(>
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MK_J4DY!NQ%7KH;O<P[3[X+^]@,A_$[9"*69G4[=] .D]^/B:$,O39O7X2-1
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M6N?['$!&XLPZ9&G_N@B>BC2YAVDY"A$=7?CZ"]6Q%/K?&@(MU6N<K^A_6^F
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M_ 3H$:9'))UCYGN6%?! ;XOP\YY=IP*]:H9:Q>,WT=)L4D2'5#D8#ILH(M=
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ME,',K'E:MIV&=:!CHT:NW:PWBYX8699R/->JQ)8Y!B&!UGB&T[OSLX<JXY_
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MC_A88]NFO/=(I Q1I!9&>,L6FO9T&"9!_?QM]=RK(D[OO!QH%J]W&B#="E[
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M]NCU *4"%[M]!%BEO_O^$6XQB[=_=W4?'@VIXKOL;)/:X"RMR5HRDYEO1F^
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M[7$O) "7@]2G6R.-.W"/.O&5HIZ,+%KE.\FNZEB!CI%W.60S$3>WT>_DC A
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MSU&=;OJC>'6(JNL2/R<BW;T&YPG3"U?\WOX;DZ<@)/\!>/8(%!"/TG3MGUS
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M3G^ 4*C#%XV%-W<\RW=2)EE>&)J XC3KH$!K[9Q\M"'R</)C:U_2@I@?2JJ
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M%1F35_82L_T.77^"HN0S1#O7M9Y_/5;:""J[6VZ[7XGW!,Y.7=K!XD:5I;V
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M:9P9;TC:]&G#;(L-]<O?.@7$>A^ <)-,C8-=%IY2TJ)L7")_P_[V#?\S.[P
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M&OAB-&O[0WL8W_KE;.\[UG^3/3![5%],QX_R9@:KFZ\_V36A$&][QD.I9BL
MZ_3L2\09.=SH5S0S%6QU-T7>?A+C/$X6["4ZBGK\N3]YW.B\@;&WB]&&L;K
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MZYR'9YOVH 94_/'+KN99[/@ E%S<5C'=M9N9:C_O;).J]I%N0ZUR\NZ$.H+
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M.9+QX\EZ :DL[>+GC6/^QQM_;=?_H&/\NTT# !:0_)=\B?^PI3F2.?ZE\+_
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M 4% 2D#I%CI()QBJ("VAB/0.HJ !J2(:>B\A1(10$Y N B(0$CJ2("U2(BU
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M@/>-"16G%/Z)L3(#,[H*#"4V2)3*"V1BN]:5$X;XK!=AI_ZAOV82<;^$5G,
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M4U#!99(57&I \Q?NNZ^YR^MX8=W3#61DH&0XY#-.68,P7^*0\.X(8'LV!]Y
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M"2ZL STL-P2WQ[7M@%/>T;WQ#8![3ORV]H9O"I[K=N)H&:@KNJ5LCJ$/S$O
M$QLFR-"LJZ24=HZMZSCXLW:1R24[M5!]3*U>[.\O9.V;OFHLH=J'$'&5X-4B
M:<PPRYU=Z#PJ=B_&ZSO]='/24,20W&!V8*[K[@#1/_$FX<)Y5E-;OWQJ^.-0
MU6.I^):2'7OI]QTQYF=P4$P^%_0W2\V9*:I7?B]OE[8* C]CIFB>T^<=91[*
MD]?-\?&*EFXK-2_4=Q\T[AUE(LO0<2BWKY\0==!(8 @HM(::7/APIY*7W-GG
M9U)!\T1!J%ZEXS::,?=*2L!YE_3#Z3 F#_&T<LPX\%N.Z+=9V)X8:/B=O-KQ
MNF;EL06+J[;5=(D\]XNM2Z8'!D^UQ',RWDU?(=O='B7WG.K^.D4N.)8(,!WD
M.C+[AG0!BA*0H+RRC-HCO(,8J"*OC.OT*VZ5P$VLKCG7U-QX'*.QX4W]KI,(
M_1'7E)C!# O[PU;?M!_;=N9#X%XI=#?@SO7;"N?\/8J\1S>. &?E\#NBW-GH
M3;5H3\;Q2D,(I5_*4+/QE%;PMN!9J_>S=U?4^9W8W];\N^^@_P<:]=\)&F5(
M+#K^_,T:;_#J.NJ#\M!XO> *:+B%JV"*";TA>[?.8F#?7/M=F-!ZV/W[7+.V
M/;82ZPE>DMSD<?,Z20T=K>S *1T0BI%R(:W>?8\P*'"C2K:+RO%#]7;DV->Y
M>%,VD1?OP_*"UNSN!<I%%-S81J4IJQ#EGF^9U07OJ<VN8M(Y%Q7\BUL%7FIH
M+%1.;I<3>"LL?J1H: ]<H_Y\\=RP*+0*ZGT$N-@7@;:['^I!.6&M)<H,WVW7
ML:C'MY(WS,_L#<QJ]3L*#C6R7I+:$P\3%YPU:- [0SWD':,,'@&T(HJNY,@$
M+H\5U:=R="X="L")/^P%T$OAUUXZ8>S#H"ZMJH*P^5F9W W]U.RA4![?[\\Y
M$.J!PDN)HC-I85=RJ3(XR[(GE_8MTFE7MAVI6C\UND)GBZB<7K<X[^^"2@,-
M6Z$";3U[H'RMV1#M;_<2O]9(;%*1AXM%3S_V,LN+W^:X%T^0H(B^VNSJ%I3P
M'VD+-?%HM(IHTG;ISE94]2\D'91/4"-R,\HN_NQ_'%AI,-[$NHW '[*Z+2EI
M),/S6?)9&>K&M'HFANIG. (YW3A>'7<Z;-%X4\TEGF/%:(IJ@5\Z(R:[66B\
MWE4T&U1#?MY7"( BUQ\B.3*_)*C?08&I'WZ8U3W7U*;8W8%(R*>677H"P+4[
M_D(!IEN#SCF>;OJ>%\P$ZCT"G%-^ZOA[9&Z-;*?A%KP9L)YW\H+&%?C65^JD
M<W]S&HX@3JH=<^@^@)\7O!U8SK;=M8='/1\M1%AFBS:>WHW%>E(%9&\B$L&U
M.JNV/&]K=&R"#P:MZV)6OK:5C#>F[>=7B_K]OQSJQCW]=QXW.VUJW*'*Q)*=
M0BCX>+5(^'V?G.MP#VWXASS91-Z_SZ.=91?Y>Y'F0IC^9T!4PQ& ,:(['W37
M]N+DSKM6#7:3?P\K04=]G'<$0'*LMC = 4A$L77DOTZ'-.,@KR;:1M/>=YQE
MW7O?<FYG,0)7,H1A^-=GS5)LE)S"8XTN1D>#'71C\B^A^K;&B/Y&K^;XO\5"
M:/*]C;8<3X]U;&:X? D_PDZW0&AALF]TT)5P5FL=Y5[HM?N*-3E>PFBJ&N (
M\ ZZ:Y&=L][%)W_R*B%W4)T'[IP #XX'2(-]C=4Y)']9+)[7\ E.CWK<_,W<
MP&_3B"&K<[WYS-Q4%31WF':#'Q[)#M+1 #SNGZV?6\[/@>9>;WI"9R5G1.]H
M SNE"!,]D36?G:Y[]T1#EMYG;[N+:;;03_F1ROW-%S[WYTA$B&6SOOS826.T
MC=, / N.>.Y0;7\/MB3AH?'IASGLK\H&FF:$.V5457':S[N5V3# 1E S1ZNX
MB\.A615-/$HM*D)L,UB4_G4U-8P9<8(-6CR\6?/)","1IP&0T>YX98;_JRI"
M=1H#<-!87<#/;[WV[(029T'BK/X9GZKC_\)O1'4\HBG'3$6-H@>7]L0>B0+.
MX?(C+\-Q^AG0JZ1VZ;ZQRQ9;[)&=Z/4]J\Q(<0ON!U#8.QB@S,^^3NPN1_^R
MZJF8S11S*.IX3..&+V_)NCC@DD,E8M1^@#?!HO0QT;-];+>4..MJC@ LW0ZG
MV2VFV.D>0MFN>G0ZZ\V^GW-?X6C1 #A:+8HSJ(MKBBHW5FD @&ZXZ;=/_MX+
M\(_'?VWV9E&[QAO0N<3OITERRP\Y4_N,1R)IKG2X]\6[/7\%ZOP)SO,%K-34
M#"C^B;O4RLR9L?L6*:@A^\WPO^;4]C%%=_(@VW3%]L-\R0YA W6'FA?!.O:$
M+^JR!:[YF@^A3DA5D%KSPD !W^Q!X5U-[L:&W: \>Q)4W+IF)T^-G >A/K71
M1&DS?!39#.U;';"6DAELYN>8J[F)<*T7"\!% ?"P68AA^\RKQ,=R]CWQ@N"]
MA5F73HWZA.MN/L/8<!]+.QT7F:0.']OV]34B^[L+74SOEZ8QF(<\!C8"TXQ\
M8L]T<LJ:^2CLBFGEM!^9%K\_/D[^@DIMYJ297[RF.W2(WDR,4;[+6>+9<OL:
M;%<79R,?-B_(QCOX?=&U,+\AX7OQ\)+\=X"BR; /S,CU7Y;SC1L0\0_*]8^P
MI?0+@N,.U B7R?AC30SU)2)Q>&W$4VT:N%>RK[O,5[$:$\)+RZ621#Z4&QY2
M<NNS]4HN52&?[(^DEL1+(RT/#T5%E^2X _HP :B\0\X)CQ1)\5:,%.=2*ME.
MBR9=.^Y(K%2*VA)LWU4N=5CI#'Y3F5>E!?RIRJIJ+7T@7LN58>9CDWPE*S2X
M:X1L4EFW9GT?\B"" ^AWGPP>99N11.<0RTAX%?+S1#-5M+.*]M[WESZ81,N=
ML@AT74 E!U#V8+E:H&3-0CPK=OM=R'"Z47?P3Y#10'#$=HS2\$=^",01GSF>
MNU4IC?9HZ326KSX<,8CQERI/!+]$>P\ NWHJC@!H(]5/0;ME+ L0OT@EG >2
M):B2'XW:+A?&&ZH!I?F'H??Q!1ZN/OU/D14Y:V8R4*W]$0NV:?E:-:RY,X%A
M!Q'KX7H$"$;T5W >BKFR-)+LNL(A>5*OU,8K[Y',1)3QH>.IP2-T8[U$UNWR
MEUV8"*QU/#QYJWQH^>1.B;TB'_9I)FWD90CBW4#_HVI;S@%@CG)GT\BUDSO@
M*(>@<HEG5MC[0KROG,L_@W5TD$HW%"UN>O2[CO5\R>M65T3P*%IT2%EOQ6>)
M0Z;(F<S,.#P$@@8VXB*WW'%Y >9/@!#Y)?W3P.80,P^OA)& >#-#F+W&I4 $
MXV<.WH/E=(];ESXY5&AYP\IJL_/C3KT)"6E3&J'ZG:B?_\A697JM*XYNN+V,
M=&EDT<_=$3['.;> U*][$5!DK_0*F)!YW-!^BAR9:"2> )E3S-LJ^_AM3T7'
M"FM;A[%8LPWCK- *QE7C%7U,B R^%9\DM*Z7JT$ZT/C3@QOFHUM.7L12[EW?
M$97R0KCE)H(<BIPNO"AN2L]B(!0 00C'9H_@G)A/F41EAL(%U&(0S6\21L;E
M1*?*A=$6*^H)_)LI2F82)9^V*Z?U3JF45S2Z;A:+7\JW^K2-D&X;:3A(']!]
MIR(7;.$1E7K)8\FTPB5!W-A=>CQK6]F_S%$V1=8D'VW#B;XZ$6+VJK0<1^*!
M8&HW*1Z=5_6#K@ ?5?3Z(^=KMXL/W@:;\D2ZLQ9I;E_SKWP[GJB+DJC?1#K(
M?GC7MV=VNJ,.LCA7:Q)L4O1>I?SSYT0]$;1*374-Q4;.'X(MOS-K#G:\;:-G
ML&O(T0-IU/J0+3X$E, 0E/S.-?DBC4729P+=>W+>->ROG>4<.-;9:IAO.*T\
MR.9YQ$[+*>+Z**AF'?BX0,UGL_R96XS R*IB^HN/)6?W0%S(0-_N)L:').4]
M&<?'5G"G^3/SY;9NR$NQ,*?R&@_UA*%O&U']OG";GB_S]5">1 Z<FX]O&?UP
MJ)K?UPW;EX53H?F8] >-XUK F45" SW\]66EM(QGL">ON,V5'NW0]=N:-D"O
MQO,_G'D&GP62(["=P0:TD+<$5I35^J1%E7U0#$( #XP28;:QJ&+AIE@7S7SM
MJDCN$6'?$.%0-XC&YRQXJ\?J'ZO3_2;:8Z6B/ [""!W./03#-#*..R"M](05
MOYH/BWC%D%QSIAFO3<PO;YOBY)*H.I@^(^_#]#<8$,C)@4.+@R7'E<N+ \U[
M$AS)7?4*CYBT?M5:YNE\K@2^L,6WTC"?=+84$N73[Z/XKJ%.#7@7 7G@.5^/
MM3)3WC"1-3D"=(3H["*$#2^$=L]7&AKAWE?-?WJ"LPH UR,?!!B@/ _%D,(5
M5E1$4J*10_#(^]4X1_BOA,^^S*6<:^HM=\B6".^U^];V?J5)_0,K,M@ES8]:
M%-!M@NUFJY)TI46'W_;>X.&6AR6906B^\ARNVJ&17T40IAY\.@=Q,0'ZC)%T
M-0'Z:GB$6EE@:''9(MD1R*.\G.=7&#2V"_7\-O.4(X__E>=('3#R=W](>TB!
MUSM,7.<T_UC+3U3)UAN@OL1O0A)U6-\&]1M?E=76W<];_,[Q/<5DR?_GDTL@
M4Y3;K+.GN/PW@GLT;.R+EM,L>AQALYTES YBS*O\CAZW5-!=<%08_%2#9I+H
MU+8:^I0,0"O[60,-+EIH<#D@OB.-7XR,CA<R>L.RQ&H\UDP11B?)0X6E]TW;
MC4[V/BQ-*UL^WH=-8#8U@/$;$VYND2,EQ@93IC@&S^+58L[2L:4HM0\F-S^4
MG]9]-NF(O24ES4$/?XEB0#[PC%)QHW,N-#872O?F@,@3(R_UZG?>@1=,]0,,
M^2WYERL\+#A*3]P1:QJIY;#5R#WCMEN\4I1[JE\3M^=H=%+*&*B-^PIP4C;Q
M8$?3.[X=)J"E(1HK9E?\!VLS:W[<B!(8ES99*70J/NEA4/)IR*.0WK5,?K V
M\DH1.-5)P5/V3^+L%!C 0\%/\8/)9^LA8VW7CXP:"MXE1B?Q1X! BZSVB+RZ
MH4]Y:D#7OIG%DB5U046:>]V&1PFI"A4=+N*V[W7]]II=;@N7!*TWJ#FF^1*U
MQ#'N]4/Q;">A5LF"WY,C=UC8\<45&=>\D$]T9ZY4Z%W_OHK!ZMQ9LXLX[-F9
M**Y9&&I1VNPYMZRSA<*T.#%BZS@Q.^QG<Q#3C*E]W^WW++:>Y;"4;-1PQ^;#
MEA=E_S^I ]Y#4: ]G]NS0/\S!D>LH.$B]=%Z^C_@;)9:QOD._+I)=C)N$;^Y
M!== HX\C7H3[)!Q*;ZVU"FX]#>?8VHD^MBKZP]-^L_[#A1^D<.$P3ZOU+'YV
M8]M'J_^A:20@RS,XM\=+)1,OT:&U_GB%.BDYM.>"BU#2S*MG[B.":M/%0I^H
M0 ?F/NL CBV#_%W_*JE\V*[/CV]YO-8:*8JP/=@X\8X$R;[]E%;P:6/*A=6J
MJQC!+DY WP+':OAU3 +?5<9SZP,<R\D]LI&N]$EQM]0N660&7"?PE!M_]N03
M!Y&J7;NTBPWZ>LEW94$&/\*4M7QC^<DLL\_1?MG,26%YJC5,VQZJ7D*&W)NH
M&]37I5Q!I\.@PRN$OJKC"V*4K;CJAA-) E /=TDIF:!Y;,3GX&<=CK=1UVN2
MP%/,TVAR.,,(T2'Z::'0Z)4C@$F.;A_EWNJ0$T<>]&F*5<%I[D[GP.+EV[X?
MGK7#SZF:4;:>9VE\4\*71')]$8=]I:SF(DL_,F"A@:?T.T.^"S7A4:QCWMDC
MK7(3E4< WE6_"9/:%R1TT/[MA+74Z;(SFUZ,VF;7?<$_9_<962$_0Z5\>,P6
MX$M^3RX\JE41TPP=H^CY5G^!?ML\ZU*'/26+QSH23R7LQ_8[4-7:>H("&_B7
M]\XLU1BRS6BY(MYU:E5"=PCR/Y]U8:VTJ-"+8T(>95ZJ/!H_+QB9Q>\^7S!L
MQ& F[_NA=-95TX&-99<)+B*1'K,9J[!EN8ASG4QV8K!3CG'XNINW5=.^N1T!
M*)NJZ"EJT\-]98\HZ^NIIS#=V%O+P19QQZ8#:<G<;["!V_P-1[6G:MKI&LUA
M$]D8>(>.3V8 2I\: ;F2S"(>-:GZ716]>'CF<8/8:Q786)UZCNX/59%0_%"8
M./;3L4GL5\E -#X":*4NF3SZO8W)H<AZ(8-WVM@V-&RU4+<.A_XZD]_-1W"9
M+MYN&2GY;KJ4'($PS"W!,26X>\PW8(-F+2=N]T/)($'G6HD56Q42*P^?O]]4
M8E=6Y !%8URSSXC Z(TR9(]]#+PY3L457Z[UL0(;QIB:M';YF#NP.-BQVZY<
MYJQTL<:OEEA,@K&MX;Q=W^>*O,,EUJTMC*LF8!J6O_E5M5*HG%LHO_6;+SU
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M@K8KFG)\(]K6$@]#PFMR_KXY9\3N8H2B(=4R]6_-#;<K$AO59@-$:#L'KD>
MEY,Y&S-;J!BU60?#(X"*X8(6[:;.,7UEM,6]YX)_;NUS!&A;-=Q=VSM66QD;
MU/Y0SA31UI%S&)SSAXY_N;'@^*?5L(&_M=&B2<[]:[(C=I<C%/]7)[CS$9#>
MAAVU?VEU/,S4PY!#]'KWO_1_3-QKM3^S(FAT]P AN3!Y!/BG1C6L;XZW9I4C
M )CJ>,AY[0BP@3OT97U5_7>4#/^A1/X(@#J OJ34==9@7W=GY70UFZBQE4P<
M?CSTRPDCO:YDC[ZB]L;LEJ[DO)_L'1U+LG(0\7'$M5A_'UNU\IX%[6ZDJQV4
MU2>S%GK58MH@&#?[I2(0"%%,^*D]#*^"02IO;%5],_W LBK6&9-W/3/RN89R
MJ2<:/"N_P-YN7O:KA>7P<H^CG/I7359D6,@ZBIC_I4K<8&FZY?;F@<ZO.1,6
M<4*S0.C]E&^!K4D)6L$;TK>=C*VWGUH2=,9RRL)Y*.S@3.A&=+(-?VC&.H*8
M\B7Y])\<94*S1X +W64: I<N_>5\N",8\A?^) 8F6NE8XSEN)*WW-T&DH\[X
M:!PW;9Z9N8WD75 V]_XYWC(4J:IY4"A59S49OPW<#:$D8_IU(W;>A">'#X(F
M\NN/]<?^B#BI><C%,(-3!?WNH'E@$=O!CXI]Z1[$^A&@@IT]8)HET7?P +H4
M$?/1L9?8_&S]04AQ0G,FU>?T2#RQ)J'"!1/H5GLO1W>QN+YMJQ)ZWZ-*:@CM
MDOJS<O%#U9J_#QY>=RT;?;=0J5S;2K@BU8(GD<-#^':Y/!G>6-9I<L*I7A4M
M%Z"%+U/H-=BXY4H/42H@/PRIKD,Z:2E@;Z;22N !;#<)'0)H8S1]-MHD*!%I
MYL;BRI-+6,#GIE#W1CA3\MV8 =90$MD8O;15KM^54?_]5#=&%6VKUTXVJO4V
M5@'CSAZ.3M>T^_9/E]?ZZ,#]>63[PB UGWA]5"S@=\T?L_5<F<]S.UO<<WF^
M8$/LUXDJX,DT^>4$702=B6YD-J0/@2]'VT0:C0+]\8;O+;R"T9Y4N:*/_!KQ
M6/'@$<2[X;DYD);#6*<W]C,^_KL&&Q,L"*RNB7:0-8KJUXXMDLRU'.@U1O/5
M%\N:.@C$SI<1BLPL$&?&BF/T:K-JDX.'RR-E80:;\2-\:.F4H,RAH.-QR9CJ
MF3A(Q$6339"#6Q4KFS]3<IG-,,H^%K.X<]GHF&K?DK,#2":6?'Y[%,6<"JP^
M6":^["F[L!4;W.>2=Q<9@0:?)PLEPC'C*D:H8+1 C1;%V%Y%3,4^(KC8YE$$
MUM9;H#X":RJ)B<!JQ 2++>N132KS2[!!0]3H@_+D4(W#$4[Z[X?3V37Y/_FP
M0<O4U!SLWDBI\@,^02!(E'^Y40"B\838<,;OQTRG1:J5 %H2X#NF"Y4AJ!U\
M4G'CLQ2<+INC#PD>?J>Q51FP;QD1G+CRF&SZE4'WDQ12K<\./)]N+CA==#@J
M4-.@H\B9#%&[HQ6\D/%( $T/%=BL8-"[/K0W\J@R/1N:G6IY!( @=! N5(1K
MAXLZ0:\)J<<_E+#54UN"F\]LK%4:&65I19FQH#]$E(E%1UM>(-M)35>$W7]T
M6PUXEND[#JAQ;$ >?F<Z@)[8M[B6#<E4C')3Q+_(CB[1_\1F8_[FDW8T;"-+
M8'WU$B'7M<XJ+:AB[E0&DNVZZ<M*<;OU+QZCAD-8DS$+\_+&F)3J&\0J$US!
M_(I7NZ:\XZ<&/J1<VT(\:%#@\OKH:+?7DJT=D9FKQW\7^F15I\-J7IZCR=&7
MZQ(>V.?,P\K^94T9XZ.OE>^Z%]MW!W7WNY?"L:EDIX53"\002JC.:_[3KCS+
M8-^,-.@SNK1*J$[J,Z1O;<E/CA>P*TV)8M D@L0G/MA*L<U7:";>_FL=^P.7
M5"C^9X"WM7!AD_7Q'6 S?/4H!;SC^'S=M5:W,Y#@+V$03,D\\)KOF:HFN:D:
M"<5(X3K!6Y7I.HG>X/F5\/7*NON)/A+:_ EQ$+Y+(&C1.!.+>,[WE=\,'.-N
MZQ[FQ+RWMG6QKAQR;] &HGP69=,&:$.Y%X-:QHWG2N!S0*LU;+_;,J$IP,?:
MN2Q40<#-4C.\+*@I /AEV91S (@(\VM2QC/C,H[MM,?3<U45#71(Q,M) Y,4
MWM+<&^(<".-)C]+"1-?R%>'Q9:LS0_MV6"!*=OH3>&ZX(*G:X@*]^1-)R &R
M6EN+ V18*R-#L<E.+/@@W>DCG>36:"6O"E[>G.*F_,;7)AZ+QJ;?A,<EBU?4
M=R%6]%F?AG1)/Y%D?N7*V\@OOI'EMQ'>HR]6S,^+@ZT\NCD*V*\F&TF(Z]2B
MO/-C/A9\]2H*8GUS8B5X2^49F4UA"./5E9X3 <=S263K$0'-/F%0WBFM#]01
M;/#&3G^_RZ/>QKM;E06RU8/I17[;C)\K0??YGA-LGK2(5HSVBXYGV^:;PJ J
MCE<NQ)01(85("X>*#K=[(\_DR\^;+VI<EM2RX$1TB7T]YWC-N%^[ *8!3I)B
MC]1@X+@:W7D5J8W0/V4^GU4;><,-D.'FK2$Y[L"KH0EQP)BYUU@^8396A3C;
MHGG )T$I9?T^/^=1?2T2/GMO7_JHLZ2;C </.^(4!-#]D]/\4V[;=0^238S'
MQB<].R%M8\;6WS*NW*Z$X>;.:3-JN&5 G%;TE4W/+R[[E5Y$/JP!2)=>*\O
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M<^4P]LYZ[UM;D>4@N655!G0V+[H\]KTZGF1*W.KYZGP,1P[[/Q1^FY9["8/
M"NP\%DB92'%@\@+3S8NP4MW]'#26P?EB-R(<CUI6OQ5#<-T??S'EK^F1$'L*
M0$+>$%.>N%#G()E(IQ1)AY;2ZK6H.BM\ZD0.QN'P>_41=Z0*R7!Z)K[%I6GE
M@3  ]N[9S_.WV/^FE_5J+?L>4V4K2,=W\1L1L<8K,WAVHE5>Y>^M(]79J=\F
MN.+E<!^I3M#?)R0*ZQ+C,WF#Q5?LRR&AVQ-=;CZ%YZNOHXS/9?X2U\*TO/:9
M:5Y0L#>E/1B_YHH7'=-T/G8(V7AN*,L2^&P5?\P\?^&]Q_G#@_&"[[YM,]S[
M#5A2&\P*BH_XJC3ST3?N^6:K)HT%\H<&5AF<X!)B:J8152.Q&3[M+^9O@VVW
M(\(7F_EG#^W=CXP(Z2]Z3SHM]APB.0/P8N9PTW#VMP,&1,=Y\O<8>5.9,5#G
MDC-:3A:6TZ;;K?L@P/Y2R>?[XMFV.72[%8WAR,<K7L]IA&6RGU<7X^\63GIA
M6<>7TMX2FE7-K2F *-5S,?&03Q@,T_Y2=5!=NJ=D8 W)VS+5*U,_H:;S2-4N
M"\0ZD,-0S<G%#YSA_<Z ]XCMO'N6HRMF>*]Q/-=;4E?LKCOT?B=FE#A>2J20
M3A:GWHTVR*!?T;]"81#U?$;)U.8&@7$0CN'1D/T, ZS$]#2;_9W(%])BGD>^
M@^(8SDL;=46\7N1@Y WGP3O!9X\=1I?8:./.#YNUK)F?9);=G'H<5D@>RCNW
MI@O5OA:3-2Y2ZOW*,2/V<S&%1;UOE'/&"V*HBTJ71MTO#;N/&/QLVF?:@^''
MLCK]!L.A0CZUL0ND/MSLU8A-PGX3D53W?,,_2"]QVOR#"L#T*>"/.@%^7P*7
M/]I.BG4T_4D+O3_)OV&K:;E#I!6\=7)M1_UX6$.UY9G^>"]7[E6*SOA]LI;#
MXA9IC*3DP9-9 XM\+B;0MRN_P<^;Q+.S<B4':/GM>R[WVDES@3X&^<]"O-?T
M>D_>8]#7=U E<M>NB*A#E%8T-"V5&/1_+QOY_[%P^VU+$U/M2DN( BBM:1>'
M:.<JJ,[>Q0XKGLM*N.(FT!E*2'-[SLY21CE?-L@ZR#"T.\HYLK4Y3_^YC^4N
M'7%\'$05*'![N /Y"RAN"/Q+P[<?17M+A/ZC@<MWK7,@/]_>,](SY_ST.X5,
M-BN>#/*ZX6CA'O)@7^47 \TK2^/T'52!/W">;^=>^C*%W,YV:FG#T\-^N>O
M_+BH*+XJ@YI?5RG8+\>K43MF4>0;X"/9J28QT4?(I7TI!S)[,A5S,-X6"'(<
M=PN K^?$&P1N+^1 B-'=0@VK.DCRB&_<FP:F.820G5++3?W)LQ*_[=B>=9V+
M>F%:QFBGI;TQ:*J[&[8O/0?;0(BT85J(?IQ""P?&;ZYEYQ6WAS(&/O(NKZ6
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M\GW)&QD#%X?M$'I#+8/$L0)8#1G-3)[OJU6F8C(A/41B.:\36I['HW2R6=#
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M3P&CJ"$P<$'+WL&X*+*;(7AQ)X!IF"6)Z8U-&KN$]!U1,\E(##_E!BM9"](
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MH&C24I12+D*>U\&H7 *FA7MT8?3]VF^EWUSI&WJGTB]EDH9/<8_(;(N,@>Q
M 80#B5P@)$P3]VH>T6?*+2#G$ )K+WHXI6]/(<+(!RO'.A9GYJ)?)K"Q-Z^J
MKHDZA2--P[YR[B3+VRLWC=9;2X<:UKE\1FH\H6XKO/1"0;'YK/*VK@5642B&
M+T$V"+N3+)5=L8L-DW&PCO39]S)CU.DLL@X#;OXM;<7M4D'L9DYQZOL5W8.'
MO8+?+9A[(+<.P)^RY3[M(>>UEU]? &%!; 04R1%690=UFSIPF#A>[B^[7QB_
M9LK]EA#TW'J?!_4(.[*G ;7XFG(\Y;%Z #OY!K[Y()I#4%+7.66LP%BY.-#
MY+I)AW>43FK%QR:56_VC*Y@;@>R([18ZR?[1QZY[.C\1J'I<'<@?IU[3ZF(V
M5IQ.NWE>/TYF;":9XA/ZL1>4)7ICO.0[_B@:ZC=7[UK;+**BD^IP-_$]K,GH
M=4V?S7S)4R';KB>K?8?%J)OXQ+9FWZYJWL^(IJ"ND5C4@,-E&:^.9"N5I7HA
M[84E)W@%7FGH"DAV;1 H^ OZ*%05WW]JBS2IVF6,I\Z<:!#BG.I1@O%XJ50+
M]_WZ#D'H?^=J5A=.P/9G@<N]G;4FZZ(BG_)ZS'",/"C'FX]EPAA5&,/S)U\J
MS3=DZC)<G$N(3JR:,HSY#+'=.*]R(\N00='UIHV9AK&3365%I%318_8;HZ1:
M>FHW'T"C2035$$ZKT1X"PX]OQ249?1W)*]'8T]*]&A_1O3'19-$YN\;97-T!
M/ZQ%,>/=3O!K#RER5-]GXI$#_/>-SS+#JB.XNX93:BZ'4O@T8V&LR=BM$(CH
M;KF\*O]JS75<.=KXG-\S)-QPOMIR'BVDPT!2X-0L^("QW/.XX@'G\[P0<:M*
M%3UEM"VP,N-*D69-!R3CXD"P8U%^ @Y0@^U*1!1,JW^ET97T34!8&]13Y[^N
MT:O1S:!AV+FJ;Y4E$ QQPY(@$IDRR"?,V)(=SSL$CP)OO8H*G724WV/9E&>"
M*.B*C1HW% <4>/D"JG44=+LFR_NMB^YPII04"0'C(0#E6PQ36%'Q"7D9G)!.
MH2 "$%J&Q!;9E'XV((G%9NI,*L_"Y($P)?'IFD4&[IO&)=]P<.TI6'"@EFCD
M 'M9I;8]R9?\5\G*"YH4;)8PLQ%^:I>EK&;^X/ET#U%:IY0)IU5)7=(RY%@L
M;LS)GH0=>9,:A\4!5FW8RT++J'VS8<YSY1^[/1Z=L+&PL@T>^;5@,39$7,M[
M!"9[-/V8XR3U)ZBK]!3@*CDT1D^WE=X11#Q*7C-CD%UK(::(^HB,U5/ZC3,;
MZ&L$$?<9-T&4.@>&7) M^&]'7)1!"ZNT2,#@T&;(;?]ZN>>8CBW4D3<*B[E/
MI#^IHLU%O?47/ N:@H3<@<QG>DKG_I45X96T/QNC1$Q%'MTF&ORM-P?R=[TY
MF* NS!/L+ZYLT SJ;5L0Y=$"QY'[VN!ST.K7(\&U38I30#?B6/";R',+-[:_
MP!=_:<VAV_GBW!;W7P]?_'_"_CID]-YPQWF?0N=D'5B?W=WQC]H2!WN_EL $
MM&!QS2RHQ^P4T&QA?5:R[7=9'QFL@/[0(,)\/$%T_AI^T!.8C_E&##I+B#O/
MDMHF3<_E$1N+"V-Z2HS?N![^RP"Q?[;%[FD)7?MN3[J<\W?:$FHMO^$4PI:_
M<(HFW7I<YAITAGE.1E.GPU?E#^-%J%@Y1LG-?-0[#%NM9?2*&?'UIRS^[S@]
M)9_PPO_R>_M764J-[KF_HF^W\/I8_2%RD8@67!T6XTQ$GQ1##D =CA&T6(PC
M$7UK8_$ ;$/SZ?XAE\CJ']4%O#U+)]&_Q =R/H0>?S-:,2+2WHWO"O#Y'9@@
M;>L["<M1GT5=-,TF>%[)U"E>+]05@7CP\MM?_L]C#>H%C=9A<[22CTT#^$@'
M9<SW?F$44C_/WH?9^6CWZRV,WR:6T@9$YRLU\^:R]OMVJG8/3Q36"576[0T.
M:N"XG8D9D[2W/!SE"IQ4\\C9"8HU:/16NIR_!6317Z- ;):^KMFKA?K9;IC]
M.]&!.[+S(CL.!,8E"];J7?+NO: BWV=!J^/?!3^=")FR1S,![!;+6/$#79OK
MFT2. +&M M"7%<))ZAPSVUDYX^@T>61$ +4=TC,BSDD;4>;A^4T_.A=Y[[S^
M<.;8.9 #VFX$?WV=%;,,.&3MOM_GZ;<?K@Y1O/.F-2079ZV*[QSQ0<"_+B^B
MN+>@-4,]T0C"ZP??9QQ*,,8)@UDR#CGKRK^@)+&O&']B]9I94%2-<::N=1T(
MZ"O29@Y$+L7S,/3*A44?0P+.^UAT-8:'=6F5$,^NO_+WZQ=8L=-%NY![E_$1
MO3J8Q\5@/][?FX8.;D6KPEOX6H ]\!DJ;P]>=]:U%>B+K5. KA8#MW,ZXY/L
M%=KP^>?M]S@$>P.O:Z9EXLW[LV7B-&1##L'IQ#';T3K'92#/_Z#N/:":>M:U
M\0 JB" B34!%06I$0 B@(J!([QU"$ZE)!$1Z!Q74T*1#J *!$ B1$D"Z5"D1
M"(0@2 N* M);Z'_XG7///>=\Y]Z[UO?_SCWWKJQWK9F=O??,GCU[9IYWGO=]
M/_[46U!=3-W&JJWLR'P0\U^O"V' ;V'&=&TT-D-.SV&X<C_DJ&&*?JGVB%9]
M3*X/DIZY<@?KGMY*)I.6MK W5U^'?X]0<5#:,:SYTM0L+[#.207=HMOT9+>M
M]L8F2YW;D4KK4+]4^GU?$0BK"%E0#EV64Y]A=JFAQ=XAR3GP#_]@1#0/X;J\
M[IP?%@0)I$SO+.>?*KJ3HW*^\!3BI>0%'=CUIZ/=C]6P]F4K2JP["1NE(>U7
MF6'/V@04Z)495ESSL;S"V"<$VPC-9YU7@#\SI=6EZMYGA"$VKMSK5'"JIK?!
M\9H/4^#S0-FQ4Z89$[Y%?!\[ @BP"1$7Q=O%3J#N]OQO-I81@"QH"6V9KX(U
MA]II(TITVDU[/D)"\R$/8OS"!]#[F<B+PSH27X2]A':&V\U@)RP0R1;.$[LE
M6-NBI\DAB=9MU;2>8MW?F1\6.UUPPS>DO?>@Z+ RD*]O-$$>5[:JI Y9L@S+
M@C2=VZB*F).WWO!DGK<6"NW*RV":QJ9O_K*^8AZC &\L;R0$$Y%A4?NXZ2RI
ME9>JGDLL#;S1V>&CS=5KGV2Q[K&6*E7C=1FF/?[:Z[_6J#ZW>U=ER;E5+$Z.
M#:?Q8^%<6Y.2C-82,(P<B=+GOR!G%22 J:.]4PI37OF&\;Q4M*#%I+OR+<+"
M2P [K^%MN"^#K)2>IUL$<X6_M9<SRI&]E_,HJ0AI)04SL)Q[2@@:)0QZ<KAO
M.SM<]HD2<XAG!V0E_31AOST.I;FS8(TGZS)6)[9AH5-D'%?0K%H'(YUJR;[,
MRFZ)1#+;!"7L2<5@^J4Y:[=I&_9.V,72*:"AS:K,V**Y<44[.^<4#X>7UK?/
MM!C'0,$:"$CH"#!1?"@WX#!TRRQ<4*#RD(/R1!,VTJ5$(J3&YK'^?' $""5]
M.92CW=,O.VYZV19#E;%#O*]3E%1RNKY=S,8U)^65E'NY^"!!Y/&*)C<(V-QX
M:0YS3C6I/> PH\XE,<#@<:31/^#)_:OY(*<5_E,^B.YR^H*!&'C7@\S,NX',
MMTZLC/@O9A8:>J$\5H9CT5.K0XVKJ^D(4?5"2_#+.G[^0VJ8FZ%4B)S3X;./
M 7B?JXPK&;6O!J)?K>NLA+S*'YI]\"%CSW0H^^PA<[)SYOL#8$R#E_;5"(YS
M(@2E0Y9]OG4PNW/#/=/AJV=6'H&U(*G-G3C-*9[3K<BQ]\[-S1NEJW9&>WEL
M:[Y1C]"2RRNI:@/P)^A7>CF/Z<'"P-#-4^.:VH7G$P&XOU&%7#^,E"&$96<>
M :[\X?!C=3(RY>#Z(6Y+K--FD\03'>A#7J90$DYT(7R7N;S^4(&D\_C_*?$B
M-J>1Z1@WO5[!5M13APRPS-E<"KSN-JE$,?V:1:7P*^X Z,S,U\^2@XPK@D\*
MY2HA?K^E=BT$&ETC9Q3@E 3&*0/:8#"1FADM,&> >]A1J?@9\1X:-YK[_DV$
M,NH*=-I:A/-B.77"2_W;F\4Z#= SQZ/ZA?)!$4?P&XSXI7&H  AH)&H2ZCH?
MC4BJ'7(!YU /C0H5,[,8B1G6H*ZF?N9Z[[IYCS[\-=B9?LT8&-9N'5^D/5&I
MZ/!-U-'2'3%<8XU+\IJ(.,5<C;= V*T!LQDC,"[2NJDFMQ5]1N6RO>NT0>6Y
M-5>X=.NL.I*/ $(EH9.Q2X/\K+]T>]1%G:X!MXOT:U#J;#=<S,.$9].J1[.'
MHXS$>1W(>0Y%%D@)%+5HY0_R.X)KSED9PRM%=6AI?^<S7<8C1B5?47@]1N-"
MSW;J.$01H*[(Q^@>:AQ\36!<!1))B"8J*DAUY(]KCRLR>&VAS*'>]Z'2.?3?
M]=CS@2JCB@*0DHF-DGHC%^50F$R#.(Z/*QJ!H-;G5_ R&=<9-SH=O4$@LL^?
M+:+6'OH!.C_O7\UZXS0<_+IW.Z\7HV@NDM\7-52NWFZ8MMM_BJ4O:MTHOY:O
M0;2'"Y_V!7:6RLLM%F.%:YC#>W1W@KR)Z?#VL.&1\24^Q)SG5QF74CY=NSBK
MF,ADH!YMP/O"\=+N@1 ?R]*7'..E+>/>'2*7!JS=&E17])\_(W*DK7%1953#
M6<0; O=6J7G2%GXQ7>R6J\924\*N[<PO\75M'0&0P:#CQ=3YP>TX4N(2?G+&
M^N/*C^<#1 ').9[3V*49K-&@[M)K0GW=I^*]FH7!C<E-NSDSK?(9#T0GD>,'
MZ,,XD-ODJ7!)',/ZY$5/Z%K?A>=XZ_=DU>F%'J_9G5'<C>]+'+-21+!7:^!L
M*M;H]F+M=Y)Z7FLR^.?-,5$K[XBZ-&>:^I7%INYZT_<0]\4'EDZO9Z9AM8.#
M="+F:H-OJPCJHKR8!\_:/?1K>J/]9YYJ]T%7W2Y;AY9[6&/(ZE4MQ*D)^2'I
MD@S2(^-7?0*K)GE[I-GZP]V5BBR84]MNF*0L_GFP;;S&UXNND-#/Y :F5K#?
M.RQ;!P7:UMW3'B#XRM-J[/QH):WV]+C@4B!N#BR0_0.]:EY[)AIG^J/T2W?_
MHP;@'37'F.Q+RFP5#&'N9@-=Y846.?=(P"%&[_1"$$.%%UI@+3=^8:*@Y8H[
MOZ/._M"@+@)Y,RV?YM*@Q#%,W\P!B-X:C8-X]U/QL&I-"N<8259W0]]=_OEF
M<EO;6HS<L3/1$- 6'[Q8W+YO+O-E$TT3&=<4"+/33KA4ZJW>%.B'<9$_T85D
M1F70#\9HD3\N<-9<'JZ\O3%;V@SK(-[=0HLW6*H4\'Z[KPP9\RY!62"(N$4]
M29,QG'-KOXE7-73@=4[18XN80A7TG*&H?3..V^@]NL2%4&!2,G*1O: B@"!I
MR%EK)'X9KW7BP4K&ZQKC4&*B'I6FNJ;1NW-5F57QV5I4)IF$,)5OY-2+0#V\
M6FZ\<L%IB[?2P_;;5S>]%V1!<>X9@U08KV4#)0D[\]\Z\V5N&?UGVNLVBE>K
MJ2L632KM- #!R_X0Z"5W+:E0GXD\-QP(G#^N=F9Q"SFVJ).;RB"LY3P/%:)N
M2E$O+QS3*C@5(#1F8""CH2BYA-">V)"8S1LW"DWP:;@.=9R7T7]\I6XE!R2!
M2*]-[=(T]- :5YE_=Z5N(GIBDQ.J37QX8WQ9LVXB;UQ%&:!>-Y'@)<F;X$5S
M&:\]K@9.X T]4^!:B%-QOO3#%4HX&$4U^6.PX_F?$D&VAU'$==6.^J LM_=8
M),[["*!R//'A5XN:!F9+(?&!_*MBAPK\NZ3LUHD&&K(^_GL3>.KZLF6FMCY_
MTWX@?#O[%=^!"!/&%W2<B\4$D#X= 2B[+^>%S@2'[Y_EJ7OY"_C;AOYX/GYQ
M )SI"_M#Y?!;X5S(<5Y(TG'\SZS%?RIR_[,!$Q!<(?<P?>-C\(DAT].^ET<
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MAZE<]@QMU*EBD>7-91L92R>#H?L/0/W[CU:5)JS4WJ_W81PI/+H)>@T/3>^
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M[K_GD,B<2?$1X*8)9D!YQ)PMI,(EY.>+8..?/"SU"M"JTNY0>\<&E?H^<M+
MGES>* X9;.]!THS[1GE-'H]ZAI<?L)'U#?/N'L'F!]]2 YLWXM;=WJ1O8VT<
MPBGZ.QTR9,<;CDA(@+%#?$&8%@$ K%_KYZTD ,[XE2Y\.F1.,$!(?,A R E.
MS8&$$^ATCU$M3XO;JTZ)>TISHS4+)*.!7]//RC'7*/HK414/%SGF;"PHM)_>
MS7G_,I<(F]-9$7OQ>%!4'R$N?A]8"V<+]T8U8^/_?5]7RUA9MU9")Q<^?5_Q
M[[LU]A[E[?D]\^"D7TEME%F>V\,V2$ @U9XB>&:1]BIN1;#-8<Q/;+CIT1'
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M'&=U,<^!V]I>P>(N)*;-4D.*]O.*!\DAJY0F\&[Z%(.\ [%IR+1[RV9U__C
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M-'1UVMFD\G!R] PY'@%\^XUT)2KVB,$\FR\J2G1[82K'B3BG LI%[0I5&Z-
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M4LYN%[1I.Y*CNKC1N.3P*,.^L9WH*YJ9WA3!M%C"':;[9:M6\(3T_>3"# .
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M+B"8-E#-)S-M/I0Z" [HJ@1^;!RL<$[(.FZH6/,8SVWZAN&&Z4M>'-@ W7M
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MX=8H0SO)G-E+E5+4BOSF?G?$]YS2:>@03H2P!R!:^@NF#Q%M/1AFU5AO8%I
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MP\A3!U0$Q,[^$)W)UPW2^(O&U7H!9?H.O7_V!SV]KG_@)G+X5,/8@$L&(21
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M_\JHM12&\G!+\ XL8+CEB-#D+N)3XLX6^7^Q]]YA37W=NF@ !141D29=!4'
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MP*P9Q%8P82GU8(+3ZY7\5Y=S7+<+3M!FS;8/S*1NE($''5:&AJ_:LL#UMB&
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MO47O.]_LY>SZL;\XOOH!2*X]O#N7QYO&NC_"4T&1YF VGX TQN7$7DA)[NA
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M)6C2\AV;3?*D)=5_S?#L]UB09<IT"3=/X6T&PS-<DR%6I07,1F".M5OG>,!
ML7Z3C<@U2R/</9)ETSU':/E9$;SE@4Z;8( <G2PXH"M@ :UWW;0QQ$GV9R;:
M>4H5:M_F-*6'!_R%SZ@80R3;1-42RQX2+*.&ERIVX 5U_.<6,<?$8<AF+O.R
M&@2I5<9!,X*]DE B>$ITH36V]*(<]!,+P[<$KHA WH9:TN>TYT4I<$07;(AK
MAHXT7@("M5JFTVU1#TX ;_D?O@/3"V8FA9"P*Y+XH3&KQ9"Q-X_@HAMMMV1^
M*A$=MF!S:/"QQ ,#7N*+4N&RL3>7D.FP=IC'#_K/EOWDO,1B!Z*&+E:" #<'
M2@*VEK27]1_"7@DT9QKUE5A&DJUXBHH@ "/,5#OQNGP9'9\8Y.5<A5R/ "RR
MF$8,%D8S0IYJ4=!TZ7(!VAY4!Q>JI:@^X?S+@LJ] JJMK(ZE6!SZUFT7!ZR@
MK_5U9'F?H+C=&9=4 )%G@0HN'@1E/C*1HX- FU2(;CG3+^M2K=:A47Z*Y9/F
MCRM_1%&J/A:_X>8L=2N6TF)!7>R>,@=J/3,7@^2E2A RH17&8DB]5+^S0>7L
M!B14PTE]EXVQN1>@353S+H4V5TR'3!EZ?B%2(2\5Y*X.=+/5&\$(>R(UU) W
MRBY;O."8'4F]F GM-"\M.;U=*)/+/[J-LL>L8I[?LUQX86&^6N *N,6 "G*
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MP!F:U!4F\_#%!<E!H-QO@-+*+0$J"<'G\_TCHPQ..8I0_F+)*)@^H&1,&XT
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MJ'3[_J0ZE&;]_'CD_DK57S-=;E\<FY :7QS-1E#*X4RPP:&5^0-8O"!VB:6
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M1-?)Y$KE7F$)7KW-+,5SI_QRBJH&)!HQZJ]Q2=(R7S\J9+14)'.@:,;4[77
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M6M.CB5X^]3M%98TR#E89[\M]/_<6(QU/%O-^'YU/%I$107->60<;AR-!<][
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M%K;RQ:#DTX \T9K K"M1P:MRHNQ[E/[]5[-XCO-U3T[8@5\[D"RPPS_J9G/
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MH15!KL(MF9F+FR8#]?1/3MY?6"U+I,9'@NX9Q>H;B/TCZB^N2B/\_V\J_,]
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MH JA-?I11T;@/L^GJ$M]B&N$B7,CD[6&ZGV(:K%,+VQI[[1JF_ZA<<7TTV&
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M)Y-3'1YU<&H.IYE@W?M@:>Z=!A5#@88[8)UKG<>=VB*^A5['3ZE!TC8P=@*
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M3)UC0S53LWRMK+8!'\GXY\D?1X$?ASE>)L%[:AAGDA1^JD: ZWCZR6*6%C#
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M9]XHPF<M2L_H^4AW)5!_DSD%HJ=XU$==36FJ';J9TI5 9A3P.@44@))>0AV
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M(N:B<1$"4&G(+$>];'P4_+-?SNM[%E9S&X!2:8\J9[$4:\%"X28+61]DL$$
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MVP0(E@UV[]V2/R"3$R=U7.30VD^AD_"H]5'TX);KT6U(X!0=%5Q[)^=[YK[
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MN:7.\-:"3B\=.H4,=W_QX"M2[(+*\1W0-DZ=>4CNB;+I P%G55E:W'O3I :
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MA:%* DH7^9C)0_H/NQ%&T6"VUQ:F--T:4]G/R(0H#7F4=,^U-->O\=/LT>B
M!*R&^NB2_K1^ST:>VU0C%T=07/CI%0/-W=KH]FP_:>1'3\9:V:]+V,Q.1=]0
M< 9>[QONK&MHOSI>SZ%Z4C'R)GC\GI,/)'.U?X;J^@885^GJ$)1B[H_%=RB*
MVO1%L[$%><00*L/T<@MK[.J^J91+%*\7$70N080:6#XV/:&V.:Y]-82'=O@#
M5R B)-I;B[FDZ3U,TIBD=/R&N:Y11RCKOIFP*')>^?ZDAH=#EX0\-KNC"4&M
M2!'YG.2D]1K.FV:+YE.DSC_ J32L0'HG?P).Q27(GV^<:N"1'?&K/*<6V[K2
MZ56)L'IWQ'DRB7$M+ K4_^UEPRSN@"'.[T15L'86R'^/HC)IIR/6X=)*0]R4
M/&_@5'.9ES0G6UV_':ZZ-0'1D< \4IAJ?+<YE<E5/1$70?GX+JRF@S=]9D*Q
M&CGEW"%/0&!3V O.&-ZN#( I%4N&N]FZ) 98=NYC([PF6O&="#&I,4E:^2KE
M%JM-Z]?RW;Z\7&N/W]V"';H]&UY+?V;CCR\.>#F;.;<@P#+1VMEE>76!D*V"
M[D6]7<A;%7%0JCJYJ\GY4?:]/0?^, ,ER4X)X-3</[-&;<R+T6_V$T&D>8,9
M,>5V%:RY[J3:JFAT")0;G_>VI;W#JV)!MV&GJMC7NO!H((F1GD&F*^DFJ84>
M&2#&RM[M;L:C8D4;NQUV ?KHQP/:$UZQ:YYL/3"Y]'QMFHK%)($NCA6;"5:2
M[+M&(!Y*EN3N(A'..4=9L'5LEQ!/DL-IJ8WUP^"CE9+ 4C=+<0%USL46%4\N
M6^&'<)24S$\ X$=&4'P(FA!Z.<# JO&*%R%$PWE0VT$!DC[5SHZ*&=V>>CX@
MM>H0%X1C(+>"%U8%L]\L030+WCFV39-;F4K<Q-2W\[7S AXOZ%:=.KF%$;^@
M'53FK>4F(;-V;=;(@.(_V2R?,J[1?8&V?ZN*N58\QV+@[">5G X7=NING%&B
MICS[^['Y6868$W$1'S^Y]SU<:\9Y>YQ=D N']V+XKK2T< ZM+J6$8/010UY<
M8+6(MB&7AE+H9(O/I(;3TOI46^S0T<"YEV/%@1>Z1<OB$]EB)4SF>)FK?P+N
MFB1N;?H_\5VM>^<%.?VE1;=,DMR6OMIU1693E4B#C:LU*RM\_D]39K*_\D64
MFCG]!( ^ZP'6U&+#_, _4KO:US9_ L![GG^IZS'G^Y[]"L'E#O-#@:O/:K*9
M_D.Q.2A86FW"<#C_GW,_G.G]MQ/ MB3@<'?Q6]Z9GP!\Q:'HG.=?%D4NZ7PN
MC!71^D.CO_^%OX#NKRPGTOKJW"Y=GDS=E6ZF#V@$6(;;E7X"7*LB!75A//>W
MENQ+,^NF%L:?QU.B@ZUVO7A+7:0#U7-XB4Q\,:JRJ\%(E:^-MVZ$B$:[O?]0
M2Z'FU5[H9'4$=HK)'^O^Q"T"K[X2F4[G37ZM-E]_86G4;58G"U<;Z!=B_&?Q
M*R^UHM$OQK46MIB9%G(=L(8!=CD]PG3^N5SDECJ3IN954J-=EMB.DNZ3'I%@
MBG@A]*TK$8:-$?B410CA?M!7>_DEWRR&2U<1))D5Q5[@<EVO)'Q>W&D>_*BW
MHU+?$B/T\0L(=AFR(6Q1\;JZO!!*^$;7L/ 5;LI9E]88G@6N[-HRT33D8U.(
M*.!ZI%#*4?%M7$0/_X+NNDQ:K7DXN6RL56]<Y/J*P9GU7-RM+UOH&CEP@=2B
MQ3UIF!))=I^$>$"P2(:&)T UH4ELL(H3M[98>PU<RK(J!IDW5.;?D^C=%K6-
MQ="FRV7DY&SV_#-+%D[0(%UC:>,K0UN8(/JO(&47)*D:E@Z (WQ618MJ8'3>
M3>Z^6&1WFXEQCWM7*#AT(9&O^:ZC<8=6*AM:#0*M38IUZ"57WW,5?[.%-O[$
M^5YK'E08##)@LFC8*9;CW;ICJ#-B?D,RKE")],PS-A>7-&<V_!#D1UM61WR&
M!U:[H%D2W:-L,*T+GQ1C()N-6@AX5/4(\MMW^+V/LRVQ U:B2<@F.SGP_(;)
M.WZ2N.<3&@+$>L<?RW>7Y.\XBWU,WGG$36SXR(0+'EEK*K\MN[SEQ:Q'2& A
MG(+VM=8P,K/7!I:A(H& P"-,R9P\>]<B9Z#I)\MJB%NAIK(E/\:UD=%OI&'H
MZX7D6@,H5] T%QR;:CO"&)0HFM!D=A8IH?MQ7K&7L0CNKZA:/DLWV^)NU/+@
MN8_=3K3G68_9S!N\5:6V,!."Q]B']=@9F4!]$8JFYW6]H/A6)=AMV[K6<]_&
M8K^-UHL[08=@D2,ZS,QK:4H&Z=.0*VEX?LNF@"D>]+4 N=A0:W"]R:7(>I0<
MF#RRDIWHGNEV8ZNTM,];]*X&#PXSWS&+N](BCP61IP&@'#G(IC?-8$A9,OG%
M"++/IAV1#)/S+WI^5ERJC.JS:+)" %8$WC&H9R!7:CX*F"T[AW/@)3:JDZ(<
M%RWYGY-#ZJ&#,3ZQB<:"UH8V]3E[)(LD:NG3<YJB-%6>"EL84?_K[*G0TD11
M"$G1RW20$_1U#4RN#*ALN' 1H^37(T0+&6] *U6D-UO@YO4ZSG,^K7!F9Q7G
MH*$I+X*E,ZF(.-'AH*$+$>#B3Z+G[M$:.)=NEV6W&G;8WT09(0LL!$ACKOJ<
MMAV&GI?D,>B+=[79Z5[F>G7#1D>GN4UG3Y!RE,]0GLJST]5R@;!7IU)I.APR
M8D7^CP;XWR(2-H^?=1]UUNC2)Q;I%1900$:LQI_30UZ9C04#8%2G5#'1%"]3
MRI5I#R_?;/]KVU^,^?FFY.(=1VI'M5_0 ':J!L*HK%/-HK8BAHL3K4;3]3V:
M=8E3P#R>(,K<Y^X\/M5JN*S >,Y.?JTWY,9:)++X:Y:WMQ%B^F4P9=P""4)^
MJ59 Q[XQ-[:FZ\K56P/)N/(9-YC3*@!//L>-W&.DE 8+K]Y!/CT0Z-'YI&3,
M4'+ O@O:2R>><_@UG8ZRIPF]5)+I2>-:W;$$N;^O=""L&3N.Y'ZD9$E5O;#Z
M'6%1 2AX)'2EQIL\[O%%AWA/J+RL\/&M/UP3_Y=K\)M"-&XHL[)\^HB[OWPY
MTOJ&8 #<HJV)8ZUZ (JSK8K=8JX9:Y>?JA!9[M*SK9B+// CRU'[:1&4N?:N
M'_%-D=$3;;V[0]C Y#XY!*5[0BFUO\6'@MS[=#+0Y,>1NZH;=U3NN05RY3Z0
M2BJ =*KZ*1V3%?.TO[)BHZKSI68"^U$O+E5^;N<#;_T$/.5H"R':NB1#Y/&'
MPJ&XE;"3#P\6WP4LBXHL#RK>0",+M:EJIWP]-P/N3KQMBQK&'#PS=\0%9K[U
M$)#(8_7X+DI.OB5THNTZBZJ;].8G,85[T:;.&4C5->SM!OA_ _?[7\&"F.V1
M$TW%6'AH!'^P9*/96.D2UYUN>,2,>+-:E/VAFU&:X-<&7.W+S&2\-8?$3#*?
M[O7P1I4HE!@F6:V6I++Y06<TY#$AVH91"^-I^?U"PU?6Q4A>B2)+5Y-8UZ(C
MAYS\68[2N_&/?,O]$J7LU7>?Z-B\L(K(%<6W:$]:,[T1B<98WCHE#M=N,VX<
M8#<R'QDU;V1OGLQCTHF7$\9F@E8G]J6?SK%?RQ47?/W0&:\W-A(,<:+QMY!D
M"5#U:W H0Y#L)-]F"DV+D/P$%C@WEB9^E-\?/%AY(6X[I"PG^:'1T+_));J:
M3U2=]P$<^M \QP$]NOONHP']]WN4H*FD<QE/ZS"!LIC)H/0&CXIQ-QA#T/4N
MK5PB]F@"-WLD2#I^XZ]C#5VM=OT6G<_@[)+>U!A>OL9TX_*J'=H3U W?^TY@
M2MX#14>UB'BD/9"R5-;.;\GH.[%=?B]@97N^KGTQT;UMY,#U\_VSS3@O9.:3
MTGV3*\S@X>K5\?=OZ<DE#'+3*O=72B]S$W-/CT#<GK!,U#FOVE)8'SRG!'[Y
MS'"8)BR<]#9<U-8ZVT8YF=JPF'3^I>HB]H;[1SB!$9=UIA7=?: _J1_UJQ>&
M;ROQ,$R)>EA\WB,3*#'9)M%<-<CU<;[.3*\;[W$(^NB"/K]E,_5$']MAR&J-
M([!?$$DVA?&W!D6&7CJO^=Y2"1MP9TG)-%*)6Z4]YJ@CW(5=<;?O$T\S6MIJ
M%8-_X8>V\)!\6W_5)!U6V[$DDR(YKGNIRF"U/X.?ZF4;'7F@)!#D+UQUS!=:
M7N#9+T.U9//9LZKZ[M<)($ 8IX#'K,!&VN&(W-M3XM94D.U.A:)A%15U,O8C
MJ45-@,+HMX,)H>TD\-ZL[;(9F=P74&:TE)M:+$'*@E><1_0ZPT4S2+5R+Y,^
MZ+CD?D,$NG_YN +I+.VY/^)U1/"AJD49F-&+3C3[5HNZU_.4?V(^N?MB8%95
MQ3UB<.OTE29\:Y!+0HO$3N6N 87.\XNU8^- !H)T'L[)TVEW*Y]<20TEC<?F
M=:IR!]QZC"/;NF9C!CY0G_/Z4<M?/X^?PNI.X=R]3R\94%J4A)-CR[%^AO1S
M)SUDK( *1I<6F6027E?LJD[Y-9GZQ),//S]Q:4I-$VQB9@JXLO35U/%0Z(+9
MW<FLS:,0T8&9>F=B4QA[D$ ;GZ-[O8?/XI=MN: Z__RBH#<<W^OT\_3>[L:<
M/H5G_];&-:SZX2'])R^K-IE!\+HLC8\Z+U<A-*IGES>'4DH-^%%00QOF"9Z"
M*7/)^)^,5(%:KAZ^2X*14?QZ/P$]IO9WM;YOF+UYZ#DI$#];[?L3</83L..:
M(<(S^D#^PRG&UK)[@<PQ,M)<4F>M.;52EAZI0K:6FG8B#[Y/BBKIKGIF2NCY
MEX3/>7RG#C,FQT:IL?.H/I)S9/\&SHQZA[LL"5TGA'5>X'/UJ$ ,-VJ[>:ZQ
M]7K6'[?FRX%=E6SA7,YL'/.Y\7 :$+I]]9FA$M,[0ZF+H9>&)Z:^R"I1"@R+
M:SFL\=#AU:0GA$;37CL_='Y4C<@%W&758#*0UL4W%%=4N%OVE!;HV1W*A-2/
M.AX8G-S:6!ICVJ;A^9>&=2NYL(JSM3*M2DOB+W&6AJM]8YDB[D/*2I,;G-B9
M$OYD8NV&^VGY)=N\ P%MHZ;%>,YM-197U0<U@):I%I<N7M8&.0,+9K 8@^/]
M-0 N5VZ[2F6M]!GOGO,<,,QH=688_QBCZ_-E=%F@][8ZRX$2*&7[IC9B+ZAS
ML=XPL<7QC>KY((7G:=U!?NE\J<YH'=?&8\7[3UN-\6<%#O]=C^<SL_[5%'I5
MR9'PX:C[K-'Y8TD\<@@=$GN7M$R,,\'_GKBQUD3S\C^T\E9K7E]G7.B$VA3&
M0_+P7F7>GX[YS ZKS)\3VV)6JPX05<-M?G]9*DA+V!,J1-W_(R/$_H6_"+^
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MJ-<?AIOMF4=?LTWA\$^WV\<Q+^4TUZO71V9H+;7C*S">G<BB!VXS$=UNW7S
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M9@<8>D*M$D4=WG>6LBVI4OSDL5'ON^YYJ;-8?YSF!G6WU@T-YS$U0$ANEAZ
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M496+BNP@#:+W9NKJHK*X@_!.;XPG#74WF8JRX&QA$KU^*BU35]FSY]1?5B-
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MHRB_7'H"#@'HI[W%C_1-; 6(LZW:A>#&Z&"'6^!*78(H6_XP3_PP6T[;9S[
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MTMA*S.O88P?$<HXF ^6W0?69]" SQ$*"@41Q4.#3,(M6^XP?L%E)/6T1+K(
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M4'&T5D>,Y-*E]ON9J+T^-"W!C$&Q;[OL)?F Q$DL"S!;J-?[P(#BT*@T+_=
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MNNT_^M6IL/,=&NR-V(H'9?Q4RMNQU?L[XHHKM$C^K7)9]+LZ!_S;AJO\0ZG
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M1R2 ,=$I$;WVP5*I%3=&#JBZ"=8[(]W#RSMHW_KQDT9M0:(=4^X0VV=^DL%
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M.)@=5W;V$T>A-I,A2M^&L+T#="SF78%6V=TRW]IATT(9+.AFDL#E&J^?E#E
M,"R3[F3/D,E-14!*=+_S>WHO:E^+N&Q$M56#'EA]$9?3]7Y\]VBG/V0PQ@-O
M(X2]4*89Q>PH,3[_:",D(%;4,>E 'FMY\&-^8&KVBI -[Y95BL-M89%YKEUC
MC_4WW 6^XS/4!;SCL/Q6&RI?2(F*9-<G?XI*S\T:D6IJ ZG')DG1.*S-@T<P
M\WB2_@G9S3=>/(N";MR\%7K'X$B'9:>7E>77]BY@C]9O;)9I>QW[%79IEPP>
MD^^'*74&-+5>J>F%[TGR?*_/3%2="%JP3DM< @Y\_L'0*D33(D1*FE)-OX2Y
M#5.%#*AHH+!Z3"4>Y;1ZOC5\.KER4?2X%S-/B;>A.O&JY4)V_[2R,1T(/X$T
M7,"-PA P"*23:1>2@<0WYY-0&0MKH(S+\DD65'[34G $"M5=LM#:&NECVJ:^
MSN2'"N#INADR^^X7@%%)9K"D5[QRU6='A>47@"E"3+U8[:YV9)?BSJIRO"V;
M8T>*W^^*0=,.B0OO#.-T?XOCUU^KTRZTJQ>A&;?[AX=/\^MCE?@/B>=QO;6/
M'H7#")<9P,/EPJ $&5"6**J?A*+)HX(.-;0JS)>YSV](%1A!=O#@V\<^AQ'A
M%'E#(H6KJZWQSMMB-:_S=+Z[K!ITI0JI[).50A-7;;L>[7KN>WT.,5ONI.A@
M[D9:JF=&WJ2>OC['U[/_[.!S0ZWS;3MJW,Z$1LT K0:@9&&AN/XAK0IA<7X4
M%:^>D+'=..'D5*#Q?T&5YO];@<55DU0ZIB8(Z33M<]B&)^!&??JM0$LO7C?;
MSVVL,"F8*HW)[7^!K?X"Q+(\G]]SOODIU5;MPN[0F3LK\-O7ZE<7EF7A;UP^
M*<SB5MV.4'E$6>"SA$&:ZQSU'&CHX%=U$_-?@&!$2^S1[)NQUPG1$[H-*7\O
M,JRMJ_V W(RF?E9US3QBPOO)<G/LYBU4'=[K:E/'"]I<-P.MA+QV>8X'%[<.
MQK*YA1LG.X;QP<@?"<LB8EW5U'B.M5INT=I+.EDPX;?F=CU2#(Z_<+)Q,_]!
M)U(T0H^%WY/050_6;)/QD/L7*&M!+NBJ VZN/\$*TP.6ZK?_C4P2<TEFN_V/
ME ")$'ZDO,K >)+R2U#5S/TE$.*=V =#,@K86O*F(SJ 1>1U0X42I)4-<0=:
M4T%O1VYW>6'_K@LTSXUQP@F])1UJ5P)7I.3KW\T0/TQ>GM+RG4^X//4/;X9(
M^F,X_?] @4G?[!D+O9ZI3ZSG\K$6EAJ76X4##M$./7VM;)A4FN?O'H7/G\%V
M>7C'1LSW\ZE^=T:\&VM+&1M'B)ER4Z(QU_)(F]CZIC.@H>Y1"6-9I20'H$OG
M8\T;HN"-ZGR2@'J3$..]OY54_W>4&_VU ? O_)- O&.NQ'GPC@73&AV9HB@4
M 0?@IS8"N\WW"W)2 "%GU6.=<;:DO%.>O$Z147DZ/VH/R9X]Q.TN HF3;84O
MH'@>X(F$>&]N>[FYRX8SJG@8^>#M2!R(-71,K-96/\P1+R2=YRO/S4UYZ>3F
M%J^=^V4_IT3:34DRUXMO9DXR+< CK6/DH?Y]L8A[S>WY0=&Z%HR;G.VEW4IR
M"S7,RI#SC<QF8&WASC[LYGDMQ"0[EDYIZ6 E]OK6-:^Q#6OLZ_4U C*I(X/H
M,#^C(LK3?7;@8<J#%Q2;[7+^GGJ)VD=!6+$,TJS2[:O^3-U8F^^R$;!B,>#]
M8*0K]/,3#P$X6HOR4R*00?"D%F3_&F=%OL\&0@B..]TMXTXHHWQ95/%('3*E
M#G*$EU%N)F0W8BR#MKG8('::#45.*-;P"FG;2]_PIE/9''3D#D8L/3;*M%JR
MX&YY6$M00B8PRRU' HR0BTI'7KT5H>[^7GNRIFA;"-)?HZY&5/[&,PW-H=-3
M&Y'62.%(WATE/2\]#6^F_Z@S'-DEJ%Z\L*L/VC(FC"FM."DV+4^3,R:HP/#.
M/ZK&:#'.1W(MZ(/6D4=;.QQ .]6&Y/3*\XCIF814PH[Y9*YR!CG$W1WYR+Z$
MO(\^)I5^OP!WX+*1!=P@B-:.OM9V93*NG"!W^,&<&8M@XEM4T[6*J;-I%)O(
MO B1 _"AVXL.G!R:D2 >5 +T3YH65S=\SS15ONB6I'E,WBJI+"5^)>*A8==6
MF#SC.\P..TLB.693B3V1\O?^/8,T&.E;>4N>'OAD+,:HSC8-I@&L=(QY]$[*
MR>QCV4-(/6I09T@C_,-C@2I+<"(Z0,;H(RP;=VO(4S")/1@E0(E[9^,OM0"=
M66P$OK6U7$7,WWPXO%SDA+5 W*8S\CA# \JY@RNJR;"0"&N9H1$30HJ[2@^M
M ^!-"^8!#;\ HNLM'IPW@&6N+BY%CZD"((^7@$-N%/&8]^8_)LR'S37JN>#!
M$*V(75VK+]9:EPM=3XN5A5TEX"2OB2ZPP<E-Y_- _,5"379\_B#DO&XL*9$<
M_X0@!*$)TQ0B"PYPHV]U6W!;CV1"&12758DPS(OO>?,3:MCEIW95*?='2#W7
MC#98)NDZK6"7P,=[(.>;J.DW9CKNX<<.<0X6/08[RU$Y9OW[";7SO7+H ;FO
MU4^51,.<,XP1(.WAL7:[,$-\MU*!9-<#?>U]&[IR6 HTD+B.3C6L<">",\^X
MQ?Z=%M\,JBM:Y2K2$N3IAKWY+"HA^UHUT$9V/EB:VM=$,[L7HP%K/%#N;3Z%
M#1TRW\S3(9;I5B+,MFQ)I&48/JFNCR )N^HL*K_P+0!E2ZA$G.[*KJ4H;[;,
M017!V(V<ZWOP.[EQM9FQE^.9J)MT3?I+,Z+)]D?S,_*FY$_H(?/%E0^OV9?D
M)_TV6LCBPDAF?0CDSW=K_E50S8,?1%&$RGJ_7V^_]^W08^V1_MWJ;*6[^*3P
M7#N6EIK#3<1='W]Z@;H/-+$_>82#[ZXLSKXT"/)TY)/=;%F!LR3G_K3QQ7J#
M'UB@=LMZTZ]<#-(:O2T2OOU8&MHSY2T <Z"=GN='WOSW/UF27NR99H$\+X^B
MZB.UD'-!G"H_#9'0?GQU8;DI7*1WU[B:>;/C.5YQ[?')"TLO'ZO3;?[NG$R(
MOC^=4C^>H^C%ES6>4/*O)(;M),$K/>W*7QI\XAP^_DS[C#D$%F.E([*?)0I+
M1L/Y*ZGS_^S%_7MHV+5?>I-E+%OTIZ6WMY<^$T($.NQ.R^;7P)&\A06,6CC!
MAK5D%0IU(.4L!0T$@("7M+QR?X^%:%X740<(L>4CQIIQ#$3#J$"]-TMCF.",
MEVVJ9V[FGH.27?M<,S,: ]OM5&/9";#A>L7@JA*B -CD2?CD?>0X:3OP1LJ+
M#$3UCV+V+\Y)C/QE:YD/Q 5U+AW5S*,K WH )7C9?#01',$\X_F*0)C>F X.
MD!X7D('_UGJC(-DQ-/"K+=B,O-4VS;"B@",Y))1P\/?-Y9U1J'DO-3RW8\ S
MSKROPC[HYB?">'.S<H;L68GXO:N**!O+OE@TP+RP0K-,XQ,S2K#[F3I #BX@
M<4DC!7F;0/MZC#JNA"&"4J^DE"(9_B@*J#A:YK;6XS9[>:LKGT**?NI*AM0M
M90&I,1@B,24>"[#(MC)?8*W YI8T,G57WY[V'SA.8&UW#PJTO+V3JL*>H6Z*
M:;,HL@E&^0&,U#6Y1S@@@!1XR?PKJ \B7:@^HQB@VY">?NF>E]1'A2"B]I/E
M$( Z=;.$0^XM\.^[ QNB0U].L.Q;M$"_-G!>=S*2[_*V$0@H8'Y^+BYS;-/Z
MA@!D\MM$IQ<D?'3<,JXC8;YTN4&:TUQJT5 MSQ3/9Y&\G$G"<I<_@!PJD7Q;
M3\ #-%^^N6\\*#X\&<E]>?<]BG@O+[3BZ^?G]/B]%/U7!(KTK^H!1GH!5YJE
M0!A^7*W*Y:WA;-4.,9T&U/^EI?<7_J4!YGNA(,]034&JH@UL5 >$Y1S&KH;)
MC.OW4+YF_QV51JV^;G&?>J.B,KQK6\^RG,I>#AT:NMH?]NG0=S4.@JD?K2%*
M"C5AQF>C@YS#I;>><%%RZ)3$?_2&?7D<KTSX8<HQ*X7R4:C96W;^@_;1;+]M
MPTB:8LZ)C"8M@4+%U_ $IGDEEM)%)OLD+)L0)%26D0I^JDR&/USW(S68:0,5
MR;\14M/K#+4@6((W#9=([!J0XM><XPD>S[3;:L\XM,1[=\WVYC(>]D)>D3Z(
MD-JSN8)_RG/4J_UMMD"G6L-YXD0ZK+O_3CJ,KO?;B5ER];NK52_>QK6900.Y
M2[G]+0K.49J>>],#L>7]QD1B166."?7+<E&%J"9F<340\ED#.P<T6O<Q%-G5
MER)8-3%3/XZ3=4 ]()=W*X;V\DGF6C,2UFD^<-U>T-03&X^LX"JM]+^;B A*
MJ"<LT@3],5;Y;?],^K1@-*O:4(43%->Y3!_YV=VRV'.^X?]@[SVCFNS6=>'0
ME6HA@'0!$0A5"" =D=YK(%11*8F 2(?05$"I @(2I7="" BA-Z6)B-00##TH
M2!.0%JH'W[76V6N?L[]O[SW.+NN,\_ZXQL@,"3/S>6:Y[O)<MUKEH^Y&8+O+
M-(B%NA:>5M;2E#C[ X>%]D4"$@LMRB@1HUU^O%)619;+1A9E9@H 6)%.]5@<
M#U:O>MB)S_K0(H[+H'JTR[<#\\V,K1R?8?33+;W#_,)8']#FPI'Y4\M>83+:
M7OWZV-?WP>EO[E$%L:!J+?W2"]Q6C9R$9< \J9!/B)V"/K0),R()IO7TT.I9
M='+N7C$590RA0D#)8I4&:U1M0J45_6I\M^#KD=EKQ%Z9D\_VY)BI)A;EO#++
M59Z4$5TQ21&NSG8?8[:Y,:WW<P!816R5ZWR+0-E(*AZ)/H".1<%9>HQ?6@TT
M6QG0):.-3;7-/"LZ$OVF0.RGLP]A4YZPHB[%FNYSC'06-:O=CX(3TL\36T&F
M-=/9H)<XT> MVRY&ZL5)=R5+EB0N5%%K[3LE*XOTX_$^LNRSZ\"D5UNW6&P;
M#FL&]%L'0[2+.C]4]+L%<4+42WKCK1XPQND[-ML;)JG;C2-;8E=$(45W><%7
MC_*+BV^WB^G7-;ZZ6 ^US,M FH#.DXE8])MJB?@!SYUG12L@6]UQI53,4TC+
M8G+P-<4K!1X L7\UL&,.C>#2E!.,1_Y_*T/PFXU"(\C&,SSX1DO)9$>&+?S$
MH RRU$&<Y#0&0Y1XUB%"V0UY-@R(E+9U:U(?FV9F:5\PWM >FW/EZHB51TUD
M1 B^ZQ> 5=6-I3$HV9,IG)CKZK[U>F%4.,UL81>3&'85895CB51?NIRZ:NT@
MO[5#:$E$C/AL.,!]!.IO7#(*RBU\ODO7.W;-V?8FV %DRG%O=#[)%9K\.H#\
M<>=G2^(+F]8%0(',A.]RY7TR]9L8.Q)\<WP!TA#WA^+#>:E3[N.;#3CQU'T#
M=7YLZ+M-B3F)S+V E-E1K"?BXDG.$]%+RNTEFWB" SG)AS&&WK&)+D+1Q/!C
M#I,*FWK^Y&U$;@-WVHK5IEB+.K,3+<*-WZ1<DDKA\:U_ '_%/QZ$SQ/.YS)R
M]+(O38A].ZCN1@1MI7:?!KQIWL:WAE)LH1Q8_+?O5.-;$?Q;BMU:\#)(>#AT
M?U,F"*MB+M/U:.9Z)JDG'&NOZ'H3_/E++Q9U:V]AW<#(QY*8!(>,]MY&W,:F
M]2V[Y;\XH]6Y_G]U@T?^GJ,]??NP)[K/(U _0T=M;I![THPC!:'<27/*JNL9
M%^-=D4>7YWX!GI*BZH(AGQRI=VI\_!BU@H#[OP#O>1BH:J)B_8'S=U=^?@\U
MLM3.,1\]YG?=T[_/U@L<L80K>GM&D,56X;8O!02H+(+2K*'"C3(K*8__VR_U
M/X&V/N,Q[I$1Z$W;EIUI-4?ODF5+*"KT,0WO GE;.*[%Y_ID)D5V[1I-B]SS
M=(T7.+[ //Z57P!T$'<"6M^;FJA;,1W2;68C=?"LD*:Y)+;@1>C6P1BK@X!E
MW[3#Q7S2B/YSP(SQ@NU^TUB.ZW3#3LD=NYTC1V;1E,CVW<IZ_3$6MQY#!+Z$
ME)>^27YR L>UJ!)Y/<BF"2^X$_S*.A\\3;]2J6V])5+#A;9SC6UQVOQF>4;P
M%D7!97[G;SJ[7?G^D/2LXDU]\*JOZ@5MA2@Q!]5PT?2AC:^6AI=[F!B(>6&G
MM60[C'D*V)=11H$8\JW=;>V'4_L8\U&_I+KE);$WL3]YG@WGW'RV6_Q4=\YV
M%#S4-PC>0"HM<R%30B"?9FA;6?8UKK<&_R25W:F>/PH>O3@&A_[L?<'>6%-9
MH_L"U[VB(G)T^RO-X((YP>$\_S0R)<EDV*];?@HWHAW ''$!-_\H,&--(F%W
MQ$WEQN4YUA/W"2;C[/6K=JEV,VBBSL('>M!ENRW!26?+9LBKE6S!='A*7A*4
M,I@_,-7W#=AKF9M//6'@$)\RH2O:WXQ,6;5&=G%>$GZVK[I^%-I(+[U;R@'5
MY8@&SO4OE%GNU2"_[X0#.8IY5-RM"_#H#<J8)Y"6 13RFPRH0)(&C WU^SJ9
MFCT6$6<ZSC+%B?6!S%QW4 O^=FQ/%(P)8V_Y:0R4-E#W&<^*\FD>QU($O.'$
M,8A?JB=+0IL/_U"93O1!?F?_--G;SAS)U?:\_!JV@:K90J&N$0^'(*<",]'W
MOC0#/6>MCYSOU;DG+D$\B/R<;[!^P59-J4('J"Z_4/B:QPM<WKPJRY5BR]EL
M-XH9E8G'REWCL@5$'?1/N4C2^+7Q6JNNNA!($JFY9Y"A4\AG/$+Y>8M%BBS%
M*=9SU&J[^HD#P_POP&7]4,F#YQCKS56E9T\77W#MOBE6APKOP^4,GZT!BUZ@
M!@#T\ZP"XT8%E9J>A9[DN7BL'S;J](&W@SHQB:7]U<<*]PG&!;.M6YGGF,S<
MP_@X(L4<#.^7#03Q?D5.L5ZVU6Q.-M"N["/JM*1N,Z9U!R9UT0FN@1_*S8@@
M.<N<0=P+76+>N#)KK6_CN0(OWN!.KEO]O,>)!^Z5)+\5F:YX"Z(8 (18Q1 !
M[]1AZZ*[0HOQ]U'O:@=L\GK!8S:!6<G>32\&(2E[U\P"(,HHN+IT=*7EL8F!
MZV*%XDG(I^N+)4Z-[7+/.#X=X5"%\.97]U$#IS-<-4T5VA4G.6PP45;EREFK
M6)T>6Z3'9PRGTWQ4$'V8M-16^VYAPU9R,B//;OX[G^$-)6UVX8-VZ!)&R43N
MX>^5.KW_O"CY&3VL$#)J]*4OUQ6]K,)'OR VTPQ2UA.>IPD S]41"M,;!))M
MD>$)+57,;:KLE"$@>ZURHY5.'+@H21[V575>1NOI\4DK_ U.R43@;DPAC:4/
M)OW%/$I;=[S-.QTCCQUK6?R\TGJ"V3/-&B-;&V]ZZJ/%^ .FB[D$_@S_L#-[
M!?$NX!1;[T?T&.^*7E?[G/\+T)5\Z]P4**MI2^'#+P#H%/NM36#K:9PT8 EM
M-;S;*#YY+>&&L=LH0JV%!3;2M"409GPVX3&\37CVSTH_NETTB,OB@N=;=G<+
MI4<V6M00GSEBZXL",P,  W9,F0)#&XO5@GB!MXT].HNO>&Y/K#Q_^ 09.I[[
M0OAF=U#&4X06_F(EM#*PH,O1I>YN,Z>)=$E&US!J(;#4=8O\QE=PH&5OPC3F
M'-/L>+V8W[*XV';#3JYVKB'12:!G8[Q>QM[-0'O X9IWA<+ ?H*?"B?^G*5B
M*<67TR\L0_K.-;O*SD(%5Z$MVU9;,5\*5%57[6JS%5BE/;95H:(T(2&5R5<[
MO<V7V_@Y(L3LI,;2W0)^# *3!=OW@C9Y6EDN;B##2FM*%RNQ8W!<M8/M?,[%
MH.$D9"VX_:+,A13V9&US%#PY/\VJ\M:JW1U!#6^[!VTB[C\D;5MM4@[NQ?C_
M\%;CJLLD6M)3J*[:N^2@KKV/EP1OXWI:]O;9K#;L-Q[O]HE?(1-\Q=U0\G!
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MG\HH_;7%I!KD0/45#QHL&'V"@JPMC2#'>Q-%/*6YT"=E+$RP<;@C##898M8
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MH?1[(Q<L8D\T245'BMCAS)19/ G^K9TK;#! UIB?[I$JK0$J1P+:7&\*R>"
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M27_' &0&+/"0N4'!#;N>6.E17!L*>VKBMBQKV1/[^IL))2U6":Z=84P>F>2
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M8HDJ3"2TQXWBY8QMC/G(*:_-(/OI;K@"ZAD^U4B8D']T$^J]=:WU?4(E@VB
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MKE(KKP<I0B&1YXNF([Y?9*560E:Y8S)MI3R2I=/C-#GW&4W?E\5*\$-ION@
M_5#U3U&A*V\PAXDLV6(6DJ,PA8GXRM#C+POHC)N9IN3'YJWO;G#I]-SB+@1P
M!61G9/X#=R9^X9\*&MDD1=S!(3)C7P.Z_&S.LI]?KPF/68$OHZ:!4X 8W2<5
M"WR'H!5HY5%/N5]X--:.N'HH2NK]]&[YYJ:Z0AF8R>P&,ULY &X-N[:7HMKQ
M#E79)D=6(("0JNQ?';M$OFBUE\.[B9V3RQ4Y LM/3^R">VPN[Z5-]\.Z*D@]
MY7351!*:>&M]T$[(DAFHTVRM."5*BA_Z,12-L*-]HL$]3ESV T6ITG?FNI^F
ME5V^JD4JO#@B2S!^U8[VAHOAH]N2/JF\DUVV$OP./E8MH$?/+6)$>I_/S<CU
MCC&[TM&2[S"F[8HZP!KGS>CR5; %'/B:?#U1?W07)[MJX]8N*%'V3DN9'[!C
MV[P/$,PI'5%9!_%O IDIO6ZM-%7[@/:BR5/^#]#-_%][-Q>+?(SKPZ=UIASV
M%/#(=OIZ\5<$XE Y$3RE4(_+G=><@Z*^<1%CKSP3N2\LM+E(X2?BM^Y<3>?=
M1G-&E.S$9?@5=]^W^H!-]1X<F<D2:Y:"N_FY;R6L;X5X[ .0X'P_WZTHW=2,
MK_84>OV79JJ#<4:/"(\EBCZ\\,+0X/<!;4<P6Q0BL*U>^.I:/$^RY\E+VWD>
M@NG#S[PX@Z+K);XE!KD^R)J%C)A4WN]6YZ%+L?01+%0/W3'KCVU..Y+_R7!+
M(?GN!7+I_"WV@=DP#^WON\95D99!!2H8IP8IPDCJEO&\SH2!^8+Z$W102DQ_
M@XW8]5/F005-$LFN,CG6'T^MS_OTS?OT/V+7@4IGC^H4F=!QJZ).0DPA\'&G
MZP(5*46MEUVE *?15\QB'1<7C0P*ZQU''4T=??I+F$=UN-,KHNZ^;!G5U?T]
M5?(OGJ2E_G93%,O''(A>6<;=8.X75/[A-J)(Y?V'ES/0RI$ N[Y;.=EV3!=N
MT0.D3MU6?@[B;QU4T72_'>H?(ORM;JX%RCE9PA(1W%X/")BOB@[XD+56N,U?
MGE/X@B#67@\KF9(9$;HL^*6*CD)O8SNE/Y(A@I=&K"T =O8!K4#V-TO3KN_R
MV^O]D-$-%]7O82H0@PU&:_K+YX>N-E8?? IM==9KA:YJJJ*B!XR]3U5Z+[>K
M5(M[;A\@A.%; RU?DFH^OTL=T1N*9O4Y_' +:^/'E50WFZR=$CVUM'WD681_
M (_#')*-QB(B>NK]$^JGJLL%Q^M$53=;-#TN!\TJ."G:+5Z];]F:Y'.F)/].
MI?<ED7(M+HCKUPF#0['G#3\6*!T^P=]A][*"-FD(YS6:7,#I(HK/N*_[S.+,
M;D:2E)=NP5? &W^,#1[9K+WI^NIIRBZXBBBSY1DX?B[YH2>EZ]!74FF3#4UM
M ^IJ1$Q0T0_W\'':G'[F^QFB%RG\.Y*-^X!2L4J'+Z.(Z?(-\"/XT>;<<X$9
M=+S+5Z72Z"?TAU,M;.TJJ-7@/%XG@!<2/'?J/ URRWET \@\,E^Q^#01I//5
M].AGF@W.XYXV O@4_IO.NV]EEZUE;AW8B0'*C'V-\_\RW&C\/3OH_Y,1=^#J
M(+Z,VANHLWPKBQC4_(/L"[-ZVG?E72K0:R91:Y!K5N^J45H$]2Q"T33/8X&>
M5W4-<^6P2;2C79O=H;M8]8;S?H(0ON3.I4!P<SJGEZ>MM]C1&+T@']9*Y1+2
MEFWXUD,7PMG$N5:(#0HEH)2B6>^DN:T>\ 9O7+4@EIE]Y]\?RAET,3CDR[+.
M_]KI9J):X,"\JG=C0=D5J169N*/?4I="? *H]"V=)9F42?*$NL-$\+<KGG"+
MQZ06S6&#*5P7M!GO[4FN@ [_<+2_<V!*.RL[4%ZR13(3M'R5RIWL)H4V56NU
MS*9S:!59P+,5"6KIT<;F\QXXFM_XX]6O_[F@B2OZ,1\0/M/E'_ZLCO8,^#0(
M5Y]0.&Z1TW_C_,=<AC:*)-YYI/0.2(=0M"RM9857#XJ>2J='XRXQ[H"C_8H:
M<X^W:.Z8YFI/7;:P3$+IN3A#)$<^P*&XMU OURC3(R4:?7H1[R1T &Y]&GVZ
M-=']@&0] 3T53XT1-3G'+,<<D6!/-0#G02_@3"YP^,^QFGAJ*@"=WY;0Z7"O
M]'.7<VD!CCY)AKIJ+",.(X[]!G0^28I)WIR 8(,Q<<_U ?^7&YP O>5;E:4O
M['BYKH3%C5WDQ=S 8T,@\_'Q>^(TT9/8HQ\]3\_($<$E1-W&RQ4<P'E+. >>
M]]D=60IJH48D7##%>7VCP,7.+F32Y)W)99#.HG"4QB.UULMYM D9OPCQ_P^1
M:_PCXQ#D7UDJB(L![K.\YRM<=ZSHHQ7B4K!]D)/!JMLB1%?2__KAVV*//JX)
MQ#$*8[/?NZ5*!CRFT DU&.?NF[JX8\ PJ]3"-MR@&_X<78%@PB,XX=U*W)_F
MECZ!F/90_:I"\T,=5]4_;G+-J9XG"CMZ",2'W0JBIW+CC\4PL2I<B-UQ*L4]
MC,GIO-O">1IK!#\#HS.S\+'<!TR7$QABL/:C2-F.T?3=V<?%,'NIT:R)D%LQ
M$Y6&-IUH,G-=12SR>3.^V&QWLK4KQI.#.=# L*V-SJ<@GKYH.T!WV/[A-%>L
MPN>(I_(T+N,J(*^I3*H*^GA6N+G<F*?H[$4);;6N9T"^;]>:MZ-)0QE^ME.F
M [72]]V[Z]!20VC($UN&ZY&,JB5X1)NCU)9;"L5[B<*SEY' DER,@) WGK6\
M&)EV9@>?(D9XNT=IC:<>^K)GCE]=%J<-._P#[OU#67^9Q?4!8%<GO0T+]%I]
MEOB\:H\ ]QXGND];X][-VI'GOYJ!+,M6HQ2W7ZKZ7=HNQMQ<^ZH4B BXM(WY
MI'\4]C#6YR#/10HW$5]4ZK4/(&Z>+-EASW.*M:8A1'Y[(B]Q9+;A$KZG?=>;
ML68",6ZZH Q<IKG7D=&-33UEOHW.\,ERV,!<*"4.Y5G97CA%=K89GPH*:SN_
M2.JC*Y<M6+[I['U%,CVD;;!TXSYY80E"EO.ZH\9S)I0I+"%=L*GK\P"J\A#S
M9TG.BKZ*@5ZF ".2Y+SI@Q)-UTMF:.JC[HQ,CNKM$K KB N44-9@GO.@Y/"(
M8O\NO73OO-81+L?W?@4^D8J1UX\9%RA&_OZYP)]G#AES,H/Y;@G^C3B)\SV.
M2J-R8*Y;KCJ\ 6\+.8B%(R=F$@D9+#62+ZJ(8?<9S*#=I=*JTHZ#>]8'.W5,
M,8XXKK-/N6:4D>U!BF-:%K; Z ?PTWNO755A5C)[FVI"\_E^A0)J"#_ZASN)
MK1?/$78G0/PDWU9@&>=- =?& U+;7@=>6ZK8JP02-^E4!_LIJJ/#*_L K1.!
M0WS%E+Z$M2*V<IDY:%J:%''YP>A6-T)Y/=IS^OY2\3C6O?O1ESW6-?"RU(G1
M-2^0\IH[#QGF'/9<JGT1RF<%,ZVK$KU00G8*_:9852UZ@8/X^;+0P#3;LR&E
M<[OVU.\LT9H8$:02'6%)>,/G+5JSVZY@I'4CU4$PO&MJ\>/+60WR@OR@:/*J
MK((UNC?0^&:$()TTZ0FTODMVVJ:JL A>W6I9:>L1?-B!]LV+([LF(OB8QS7)
M(*:NH.C\6T%%V7UP]K'QVT_-YT:"579:LZMN Q2^.,"/)1O?I[W@N6R3-0D-
M5GJA%3I:"=7989@<7]J3D ]<W@>LC0!(?52ED=9-0>3ZUD-JS-I)MN&TA[TE
MY2!44 E^=>*&^ G+"2 J,.$9/E&_),*W+6-/[/1<>SKK/L!^_-W+[5%;/":W
M[B@^8;#[XO:U+*&!^2TX>TEI6PL0Y?S>+6$QE#<C3K&]:4M1C+8I&^F$BQD4
MHRPY24!^&YP\];,S#O>]$^?_RRX<K5VDQN*USW3Y?X*C*']VB!]AR*?V*)5]
MP)3;DT2(2Q3/I<,-=,3IR8>)QL]3>YSVSJXIY(UL;%G9-6@3NR;B9%]5!&QA
MH'26+S2[9^.O9+LA>Q:[+J%7+(5/X(I<>8L)[4) 2D_5\^4V%O_^/M>7Z""7
M^]W%L$.OE\9>>9W ]3^HF"D0?_%O-5\NEF97+@63.I!X[J'!HUL1M)NS]?:3
MXR&4,6_VX918&\-)[#>;D]L8M"K3C[6O*H>0.C,M/2]$?5B3BA0\QR@L?N<L
MLL\9 \."9&V/5)9' ]KH/8!L&_)/<!<.7RPF,C.#V\#I*DC<^3*4V-&;>;U6
M[0[/KAOU4OG/WTR<?^$/ [N>6YRX&60:IC=I4FW69(\O_I;U@NOEG;#SJG9K
MOL'=5D_W 3KK5Q#-,G;+ZW<;A@;KE 3[7:Z%V%R?!M&2DCORYLU>B7;V25J6
M''YQR1?L/N7.\-%=^%@HG*M=SV[PS57.%E&(@01(+BF@''#%45_'E1,PF -Q
MO>1 X\BF Q&C*5OXSRFE]!"KOM]3V\7Y2M2.&I:]S'84B[[9%7E;<Y;;Q:PB
M.?L*(4K:J0TU.2S]W4K\$L82#PT>CN1&;A3PQ4Z":.K>A+;O@"O\]-\[NQ6\
M7".:K3Z!"0O6.>C0M.?X*&YYC.8S26A<M\U5=^8E:3C]H E@@DAH_.$''G[A
M'X:_&0C?3%!XQ?3V@_R.&%WB0!V':\'<0_$NCX#VQE')&?>Q4Z(C]0\C :3+
M;:#2Z(IV23?L=A=L>[IG>.\N0=%R9Q_  D_X9M'NSPXV< Y=8VBN4A <KV%0
M[6>=^PZ,:6#\>@WG$DPQG4K:;BKZ<L_EQEB0Y)9G"Q!PLE\)D467[K0^S@GO
M+%&<DF*8N>H+.B/0Z.NSY*LQCI(MXW.EK,="7\//[R6KYZY75)$E6^JL\1!G
MO=W;POB"MU8D.RUR&HO:-N.BS;.I]'!?GS?$B/!)F\"@R< O5D@IK,1KE$7"
MK8V>=T4FL3\JM0?XWTB%EFP>?LEE^V[$$\+]0J'AO./C"ZF.?.'HD\H"( Y=
MYZA+P&BW$9AN57G;6>$UC(IMVN:AV(15-:$N^[6FE2'>U/!I:^G$776;&QVJ
MG\>W!V C@RL!'/J1?(8-:]D,PTD,RZ<>6G@>V,=MLK'"/^,^%"4C![$@^=UY
M] =2M#?$_EEN>?NJ%MGQ>>^._N0^ /E8[U75GC-.'AC#KETIA^S&2GN-1W)
MIK?;"<7I^L3)*PT@.$+Y=NQ.<R;L7GF<FQVTNS9:9JHB_8*8OPE%@<251^DM
M'9W>.T/Q[OU"Z>]31VYDD7!'@>C/Q%V=EXABNC6N^S#;W K9\^3%]5*]O2*[
MB_L 7=#V@/<(=/G&^G+7T*+:&W@\)M)%(#N+4)#8PNV.,X2FU[@OG[[7YH:
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MW-!NIR99) '[#4+LH_#X[0/2]@%H(+ZVG;R]Y[ 3'_)_EWO9;^6)!OU6CGW
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M+</D:JB,=.[3=Y60G<[)]!!^+F1 @-E<\VK(6X@Z!V]PXP;&$D>694T"F)X
M=]WUT''[L&O%3=.G_2%9'9<P2#_-57RX-U+=NA"0!XX9ZWFM\T&\:C957:LI
M4BSWOWJDI3OS7*-:X3N"KWS-/:^#SG8&HSTDH]IS],0T;<,=XLP48L/Q":6M
M]OSGV225I?LV.BXDX/3ANB$P0<QMMEH&\,,U?T%+9VZVH,Y":2LF?_I2)[@0
MQH-_6E455F&?KK,S.*!L/]<;@C'? 4U 0V](TG%N8 J67,T&1Q3H#DGYAS?K
M,2PIXE.K)L!%F#&@#NG$#5(N/"PD9VE"BM/0*CSCCW:Q_%_FREGJ LJ!IO^O
M(:'V(=0)T!_;JD?O[G+OE"<*\XBB0%1I]I [M!((GA>-/$<9=@+S3348$(<G
M>L]X*B52^5H*BYNF[5SI35!9="_^6XCP?,U;P?,#6WE+NU-NM^GK);_KLSM"
MAT=*3]BR[#F/-# 00Y:VSQ<O/93\VJIN$M:3T-C56V2[X:R)M2P2B_%L=02G
M^!VUVK6.O^[CA[D17:F1VZ#L,6/_HVRN2R"ROP@7"?G4_T<[^OV%?S22^@%E
M91U! -.JMS&36L)H#R%1_&-]@3N2GYTDGWFG/G!\M-X>I<)T_1+CHHT>VN^A
M[B6!F=:@DF(_L\OY7Y9Z)FTN3^O3(%/>('+D6VUG9S^)'@Y+]/:BG,+7);Q3
M/!;CG.1L%IP29?K4Q]%)X;E=FH#\$8A8MB@GH*PMCC/Z9+;IA0=B- UVLZTV
MI;AORT\..P4I77\Q9=H4UQ6 #($=Z[O C=S(;6S'8QX+^1^+QSS$(QYS<^E]
MM+3AQ-]\T)9-95@S:4D)&;>9NJ<EYW?.F95@>-%G#;)H4]6UK_[1G/87_OS0
MNJ6,&Y#2F5O"O_";>IG\KKJ9K#=X2-FE**T->Z5!Q4G#.0(_UA44L>;><L=U
M3J"6GPB>&GR]513AWR/2\$PFS]YSVM.IKJ,]7+]&MVVNWB9&9$2"!3M_:'<P
M17>=:<>L)RKR)'L2]-Q I(2;!4."XS7^I(1GC[C[=+BS,X,%0C1&O$4GM0#,
M1CA#T\]T.=<]$FS$S\:Y.CI4(-Q1)LRS"2,13DMV%O.>UCH (^=^V%'\EO.\
M[:=[WW? 4/SVI+.3OH"_14]YT'7\]L3(R)N;GRFHV2E9)Z8/6P]>,IHXEB*)
M[GB7BQ%)0%S#<SRBV:_L2Y:J >]6\;.F!HYPO>B'(9&+IM>B:!Y!92W9):)V
M88JLG*BEZ_9.%6]##2/3(B6?;O[+LH';@L'?[PO@'X6I.N^@K4!__W:N-40[
MRX/8\V.+4 C,J$K6LJO'%LI$=NK7U3[?@PY\R3N6-2NGDU+BL/;!ZIL3!:L0
MY(%GN'K<_U!Q /@#A0<*,K,B$,#?0*7=2<R*<X)A 7[##QOQZU6> ]4;R/"-
M7E=[(9X39F.*O"T>A3%-Z= S8\,[G*:H4"<Q87F3*(A89C![076>D,.H&KW4
M'_S-_I-!ZYK%F_.7XO+KE0$6_NIJLRKT9I7*4#3LWN?K7SZ-!@H-+'LWD8U*
M.1Q9OU X+'L3S_5V/44J*,+OP\S>[8KDR-*=2%+E6IAEN29;>R+RA^I%<Y)O
MWX2OPIPJ7?7YA:=RWQK:5#>%"1&4E>H=(#[.G("^(U#+M+W(/>X4/M)@2!3/
MYXD!Z.<$F697+/+VE,-R)11CM[_P>:I5JW."V>?_Z&WV7_@'0T2.RH!%1GZ[
MH/G0G:K;@ZPEDQOU9B1/RPT#AE!B>R,-ZHOF#CC"+ZOI(>0#\2:<:RL&G9OS
M75/RX%)SE<.53$O'"V2!I[^:?SR:$O*_V#OOL":W;5\'42R B/2N( A$.@%!
MFH4N'0*$)J*41$! D%Y$0$*7HH1> H201(30FU(5(C5! :D"TH300<K%M?9>
M9^^USSW/O>?L==:^]_C'[WE@YDOYYC?+.\8<<PY2KDWR*QBQSFB\ N]P$4C8
M$)%;^L+'BJ8WL3R[_HY#43B]9/XCVDMF^6$S_.[Y:X_3LK%Q-U?V7IP7ZTQ'
M?%P9"[/^BC4"+7(SK)S<?6V'?"BAP#,N)72C]R!Y\8!CQ1=RJ_ .3YBC=U"S
MDSTZ&9MCS!M,=<+!/=RBJ8(<1LDDPFC(:@@2N<B63343W;>4YPR0_Q?P^_[4
MO["J<6Q6 0A"K%OK(WR3OV'==U#H6EQ*>0'N4C2T]GK9]%BT$O_P+/80 -GA
M:*N)&"I,3%^S[B2GM;RL3G?Y!INUTM;_?IOPP0=7^K9_.J;[0RG1IZ W;OI@
M!5&3Y95CLE-FA--:MRZ,/C*T?]E%QO4$+IBO80 7ZNQ+O>ET&@EU6KC]/&;8
MPZJ]V<+ (^"<[6A56MAGJ\IF-+*L(3*R'012.H_"C0*S OS/K 34MXB77?@*
MG(OBXAYZRV\<?>\L?K6[:9GSIBN-L*77LHV^D_P7^21'XR<:&SAXJX?'?&!J
M\,--Z##BSHFO$MJJ3$V^.;_,-_Q'IL"1!2R97E[^WS.[V<<,Q&BJT.7^NM!/
MV7X@IO-ZR!7I3T^&C^-;\A0) 6/DA%)GV9[!IC$6CGUA&Q0NM[,[EI YRS1N
MMD<P41[%]=A\F@>(+!T\::#<#JPF\AT"_'8'OUY>/*BJK-PU5;-=2:]6;@M@
MT-36\#-]G^4EPICZ:ZC/<8+ //OSD%AD/@1R_,_V0/QA2BLJZ*%$.;$@17[9
M,D,U#[DO'TS36Y-09'U$$].!%]L;58-RL,7503R'@ ZF@W LSWDIU(K46O<4
MONB[U9MV#VNAB?#5C?N' -_ZJ:GBH/SNHR+:G+V:XD- O8W3S6WUF9<8((_#
M'G75E5<><S:VC@[R#VRTMCO'M8.*]H"+]2</KKL% &?<LM@VJUU7".R"^;BK
MFV&Y_P)A)3_US];?A&J;^*&O?N,3-C8YZM9==>;CZU6F%Z6L^29QQ\O=E?CV
M@0O:4<95AJR>6+Z6!GKMF!8!:"*#TO7:E?Q,-XYK@^H3C50*ST7M]H$?9U8
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M,M+.2-ZXRM5+ECC8 -5I!-5;*@_9D.+*E3&<BXW%+4N'@(E+RJ/(0\#3^$.
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MV<<I&<O_D85I7<K%(*>RS_R7@/J4D\S1%U!]0S*..G7^,5:,96/<(>#+F4/
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M<4$.&9.J!WG5"X]BS9>ZT:GO:.9A)9,Z>9.;:GXB]=F<-E,S:L$8:7<FB<\
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MN;N2)D7K@X%$37JAHF]&)SUU.$]T3.+:\QI\P<F9SQ_38%S/^+>G6K#FE&;
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M>A+C &4),5XS6RY>6C;WC2U=S4(4QI\9VD2&N< ^@ BW*K[!["R(E2X[:/B
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MM#G]I30%?"XA>A-'0RI'27]B9>)CVDTDRT[XF\:_!U]P5P1.X2(/ :?Y*U+
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M\.2H:.YRZ+$%:74S@70I$9OHB]21"0472[?L:;2'.I@??+_2J),,K:?-YW&
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M[7/PUMT2C./J*:V>?<P$+JRW:_RN5 F.>+/N49MF^QE5SO*(&F<HM*LNG$(
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ME"Z"* 2D!J2#2)<."00(TDDB(+VCJ!21(B M]!)*0A(00F_2!2)2DDB7($%
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MKO3UD[?-L&3B1=&RS&0)'K#+;LDI;<23_@W93JV0#:\K'=8YD;#VH ARWLX
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MX (FX1^+*EE>7)&B<)04>.+T\$_[*(U'^JN/E#^<$O],DP-I$-5S5U0,,Y<
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M?MXFO&B1+QF4*\@\_1TR.5<S^^PZL5%PM&7HH6-!J/7#TA6A</0GJMN;N^%
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MUT<K6ZL$P*F;2T?PNMGKK',AE6Z!PA,9H(2*#DP)V2;<6W\'HUA:BV:3[7Z
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ME[P_6LI.+#L@[RCQA[LWO6J+,O*UN:BUZ=I2/]_6O(L-VIQ8AI4+L9U1)6\
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M4!=$B.HS70Q433H/7NG#5H9F@* N=/S4'7>-74S]^2VN#3:+#./4P5>0@J!
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M![<"+4.2YUYZDL R^&MM0'(,8%SXQ=@BSD--ZWQ2>F$_<ZY$UT'?H)UEXG.
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M,#"97J.-14T(,!!PXE.HZ0U8UJ0[7191+(/PIJB2T3_RD1-7M(PA(5MQA;@
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M556@19T*.F,(HF;4J)/.U:U\#UT?#BV9IU.G,F!! $ME*?,MJPBWRN.N\-(
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M &QZ4]"AQW*:(.@&8B5535<*(I-513L&/G00^9]<>U\#S@H/?H(D<*_2\A*
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MH!._6?"_U&D]N+>L;5:W5X8,%DUM.R.-TT$BZN7$$-0ML\4U>CLF&[H3E\T
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M[$)ZPXV6E0[OK(N2P\!K]FAUYC/+9H$O?=#WGHQI5A43VL&VQX+@I $^TB!
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MU&=WOQ-S%<?Y%5L+K0?-B136-/K1QJTNT/>XY_W8/"*A+Y4[[_?_W$!&RLE
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M,U&P\2H74?U+EK*=\&P2ZCMYO#OG%LX1DO9*EZY[2>JD'?D-GI")-1LJ/$P
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M<N2%K^/JAHO.:*+AY>J0Y<*Z!"#@<Y\K@^"$J/%K%GH=KX5"5XV6F*6C"NJ
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M_L14*<T7S% CDO:;31O1C@TH/^^GHA,@T@GCZ.:KJ[KJMO.-,- 9;S1\T)^
M]FUVURDDSJJ4R-YY/PAUH_D2RB_@O:.D4XE*QQ=9P"U!DP[*=91WL^&Q@WWE
M40^;48[D_DY@%GZXDD^1[UO^ %SHY?%;=%?99'>1U_I< 8&4=%^;062HZ[33
MJ M:'$GBE  6BJ>.H-1H_/2[F/J<N@2(#Y2YHU"KU-M),R%%-T_5)'5(E[N9
M 8Y#U:FNV7>"6]@D=?4X*OY@C;GL/70V_UQE6!VRH&.SW%:+-6>EV5G'Y9#
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M/!9?%^Z>)=6O\()D^RU2ZV2<97WND*MI9D=/CN;4<$\(BXHX_01X$ 6.!9@
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MBX<>N51BP4LXM4&&[*1S9DCS-8H< P&4G<7Q.Q8TA"2P/Q=+D,TBWKZ;B?"
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M-+WJG0.BI(CR^:JHL[!;!+#\_^I5X/[QCW_\X_\+Q#DT]#19GB(@PL_=@>2
M!UG;KJV !>C%CUPK5NIA\GOXBT#Q5HW^!@@R%G.]TE:2K*!&_8:'??FT,ES<
M[U:@)V3!X_G(W_2RU%R\_"7LU<K+&-G^S-G'?"[XRY)F,6%;=S;DBU;+&0H^
MC^9!ZIU#%@?/V$U:;_BD:C$X%6'1<D9.(.%NV=ZVL$3'K3S_7+/<U2_.VB#+
M*-W.X&*HB#M0\;+>O*1TBBFO&XG3)OBOWI<,NROL,(7YWHH!_ZDA6JF;QY<H
M4M*'?'C>>/ZC(:"J^Y>MW/$DW'W>Y3+=JG,0Z^I8E$*.LU:RAPF0AGH,]YW,
M9YRT@<R:B.<5*>J2N'/X!,4'<ACB%9G7Y9*/G&K+,7<I%Z(O=<M>6V3B5H>&
MF"IP$AP)<^C35J."-J.*G39S?MF#)@/EF9[[^4);?A22SS-XCBI82$#++,,A
M$)G&,13D.F./_@M&[>QN>O5-E:TJ'E<V&V$^29M-=?H\TEOC,?;W=5!A:>!?
M=V!_LUV&DH6@&-LQ99!?XB+CWB%+4^WUQ2=SD'.^^:?)LEU@B2$H@Z!Q9P:T
MEN*.SHH4Y%BQK9M5K<;9+_A#&X*XJR^IF("_R]%[?QBK&."R<"?8*WX2TZK]
MEMV\0C]]\$R#;RPGI#ENJ#G)UNTZ;(,[#:0;MC[F$7\.*N+0*;OW9HL'2+53
M(KA7=PZZ!*V'#UF*M]:)-LR@Y<9=]HQ]VJ _%/>Q12OS-H;O1%Q_ADEBZNR8
MY3,Q#+<(Z<4/+A7!>-KJ,[E6'$HP--Q24Z-9T?*-=+J$EB\1&Y'L] K=E)O;
M&)N6FL99*UA]]?+WUGE&=0)H./2%;H@5[_ZIE>S&DOZRSU=T-HD<*])UM,3!
M?"$<FIW?%%:"B6I^OF8\_6:4ILXEO7C5*:%Q):^R#.-! DE81*'G>]UKCP^>
M,;RNBI883EL6=)NXD]9>J4H Y-8OR$@/.<4QG<"55.F+A?8QMB8!-Y8SM(0=
M;0VIEO6'+*P&,=^<D1CXEM!9WV>OFAX4<Q><-Q23A6B7O:YKY\!JZV6;?[C]
M<(+D1VQ*85ND]>X=!1,V>$65]!$_B_?C.UY!]I.?Z@"F:4.PR7?!E!\?AT]\
M=HJE'86_^J6E?XW@:.SY.XAUZ19;]I@GT'U:T-D5V\L!["Z9+PL#8]=-D4A2
M9H"AM&2:HCS'I65BE/17B:1?T*]2%3YYL-$X%4AJVK*RLR-;FRH:V"VO'BS-
M]93[AZX$-;OR+#=\<^KSFF*$O&52J".CI4@%]-5*<C4ZFX#VRPT0W'UXR)*[
M+Q&7LFR[L,:Z&J0K$HZ1?+_*B/*YSM1^)@J\,HKX3?JIYW);_7?^(<L9IMSN
M'>FV"*@]&K=-"Y9A5(?%<F5[SA6N6XF_+!XC1O+JKUGKD<"P-3#K'Y]SN>(2
M0X@C5^39DSZ@?<;$)J?I3J\'O1-Z7L$^.9&FNY$[GO[-?AK_G'K3,J&;:>&X
MTGAA%/''@V/O4P$:^&[YQ_NC,67_7Z!WV@*^'*^&K9J@A,S>9\UJ=5:@:E\T
M(P]$EQDVEC\ZDL/F]9.PT<\M+KX%IDHV_?UB2LO^><ARN59P:8W'?A\XL^_1
M6,;KU@@POH,&KI]K&N;&/(ELZ:1C?)/&[E0Z 2\$G=TL9.*!<I/("O^8Z3>K
M-<2/TJ^&3]QIMHYO5>S3+JD2:JFQ-V6*7W=LNKF:_R?PG$'YB3-[^.[-_M1L
MS(;5HU?:G^7C426#2W=!?VQ.,8-N3*X4MX#58O^D"C&E>G[BONT#?U7?6-Z0
M7W[?'.$/!;DZ&)<8=BI8W]5=XQP;>6/<PCW@J+1>,&!5NJN:=$L [Z]'BNJ]
MR-(,H4D>]/"QR-EPY7GJ+NR>-C*=_2UT8^]I4=RH00GO=@'ZPLRNR3WP\#JQ
M)L!B5'W18*2J"XWO<F "*^>#8HZFBSSNG 8%IS9[V9U8N#5WVO&%&R&/?4XP
M:NG+>+?>[J!B&\!HT+%#%OOO1Q.**IXA7X4IMCRY201>-3*-[5G?=KOY\(J3
MT,J#\Y_45($3ZF$PJUXKO6!5Q!('I\4AB[/(><=JSR-].W_(4N)@/^6D1JV]
MG)==T9PP-F5K/_&#XT_9T1!@H.BTH-.+F5'#=^JB@,J-HW]C7@BU_9VUR1T3
M.GO(\CPOLKS9RPYY*2<?HW[L;0J/]6=?BI8B Q'AL$C\7"OJ*_&H\G.#8,6L
MK?>PRSS2]4D4=:I6BNE=^<9S:D:-2@DA+/P>P=3O.@\)<0SL9VLGO=9B]X9Q
M- $[ L0VB:9TM?,E^<W/]H&7Z:/Y;0H!&?3>&A]8,BV[4_O,!YSTJ^RC0:U)
MP[L_N/T2V%5MGS%H?<4MJ_9#]P&7SN77=NJQ+B,!UW<?!33N0.41#<DE]VZ^
MP\/45E:=@DLL$SR^++J3-K0;I16X[4X*ODVR7W9:6 M9]=^!9OIZU#N!S?AD
MPI*UA$%70@W93BA++80VZ:ZY+"BOV +WC'N=XN8><FT02SSDA91'W =7;)S&
M,<%'SGF9\[\X=H06Y-88=GKS'IT6 HI'!01]-T1O@&&[0F,I5=J(*]KPB1*.
M]T'VY9#5(@K.7RBD1&B!:>0] ?#-FTOOIDC5=X5O165U!KPE%)*A[]V.9PTU
M^PZ!<RQ98#PNIKVD)P#1J%Q#$NY:'O1XR0?NLG!:Q?X#)5"O]1OR4ULB[/>Q
MGW"CC0++)Y@8Z\#,&D1L_U4"XN+=I))YB^@".=C6:T\+DZV"A#>ZL-QK^)=F
M%D#G-\8/S%+@@^%/E&DY9R,%Y#KP[ 8@B)QS7D=8W%#@,P,4]M?SX&>B]2+9
MW28SL(VTLWM5P(Y7IP^>$TV7?[:T3T4K?IQC\%<9(=)U:F&3)3[;5RKU7EIH
M(LE\8A8C,49D,:K\#^_<87"P"IU_75F\%:MY;KZF8KIP24S*P+PVR9.7?-O
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M^&&BT>-,ZW!-$@$NKS!/LTATN+>ZYU10ANCSB^.ZCVO3+W1?8(X'!MS] F<
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MYVSN1R&,X.P;YDT-ZF)I&<TOTC%#SQ-&#?U9#$9)O'.V8*#M?2Z>+\U5H]G
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M>R*C2/*8%VD#ZNM%"F@[BJCH;+,QA]9QS4T4/6FDOEBHQ!Y<X#I1O?\TB0$
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M52A)VHDM*G/I+TD0]2AF-*MGQ/^T$1I8G/N7DPS.8V="! F:W<>L1*5=
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M.MHZGJL8YD__N0D     _WKL0RR($!O*-U"3?P8H$^:@$G=!=,*QY 68%@T
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M_$S[2P&BI+@_8MMEW1'A02%@9DY,0>L?VJZ54*0;W_=';#D4H+(PL=AW27B
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M3<#^@THWL7G^[8I/L&B>O\:JH]X/]P.LDW *V7!*?_QPAC_!R)]@U/KJ0B0
MX3^@T)_!WY7]K9PV*;+][Y+R<\G?R&"&]+CZ]\CX1<EOR6@'JVWK'\_ \TM_
M94SBR__@%J^D7<?_\1>BOE;XC2PKGYOH%1;U^ _BW\=_73B,J74 P%^^,]*Q
MG8<X_>YW%;ZV]#%[/ZQ%,N4_(CCQV:]?7/I;E?+T S=^A#'RYUI?K_VM:E\#
MD*1QMY_K_2XJ_;Y>T83/]$?P6H(81>EF%4C&DZ*I)T>9%"U2% M>=&JT;_F2
MW*[O\'9=1?8^WRD*TZM:I0"(^GS1U%'^X\51GPY(Z1^5CY=.T2" 46S%5Q$B
MU=3-.BMD8$2)Q\VGSM&4S=%/FZ>?U8W6?8E9GS?Z^518JI69M3W!A*6I.TNM
M'W\Z2V$:1Y$/EKY;/*U;W+9&MVV,A8W,_OJW<@*]QBI+0?[1@G_+;8,WVL][
MGP)_5?@?_ /)8Z#ZDZJ/X5(K9YQ#ID2#TN_&,32."C]'+U ?H],YZN>7SE.K
M>#O4(C!4=0SON/<4V=^6^ZI#BCE&>^@E%AF]58[;S-$ 2SUUYKAV:.00]+H?
MDW4W#OWSHB%NNL/=.(0K8I^S[]TMIS=WTPN-/H/Q).3W+2A(QMB?"U?K;\.J
M>GGW48U1;?U5$8^WFB=V(%@L-(NBU-XE)G\&N72HKC<A9U(=F1YV#-2X3X'P
MPX("S^7KT(6WQ*NO;H#D7=A,8^3BBX\:</)*L-3K+ID  QGZX'(_% JQD0ML
M5\L68"K<=.HN]9O@4V ?O20D?>%RV<ENTQ%%U_?S.(3$TAJ'?H_ABRRM'^:B
M^QQS&$3TH;.<8VF&,^\VQ]N&FHO/8'L&W/XIL(V$E;\+!F:J#.](1;QP;XDU
MV&<>FO;N%OY%86A4,]54XIY;8E?K\W/(4AGPMR*I$MY&R?[Q7O=G]RD0 K1W
M+IG5=+=L7#/JQ'>=+O)X./5@HPZ:I W=;HAN\!PA_]'P/P4";"VY;HT70=/-
M\2L@LJI_5%T8OGJYZ7MBGX8>6,#P,#3VPR*X#Q-C2>KYB.A-\/L+[_WU[5/@
MSU^=\ VB![W%=@7<Q$ 1KOJ5&!?HO2^#VR$]JM;LC8SV*=KH#A/1JC:<H"K+
M*O$JGX816_@4.#3(JRDY*(-&FJMGG.P)/'+II?-]4'=E&4N<US-UQ [0NIF4
M'U OHVJ"V$EL-(7E$3!F]NZK KUHAC\%\C!7,6NC$!L S!>7SAGO>C?OU=@_
M>GYZ;OSC53[K5\&ZX"X7M#UD1X>G+2[@?$ICO)RZY_*X9W2JWDY60?=N1T96
M1_87"%U?*L=<+N"(@_'".,$B+0UGBL]GD02TN+[*.4I-BA%[Z1$3ILJ]N'E*
M+;;7!!HCM?5$F^M.TJZ$&^3V( GF+:9H]"1X#%;N]E57.&:].C.-VR4>1=>[
M5JX7&&-*4-1 P9PUDBI9<)MG_Q5J$/LI$.V>5\G3KU;B[Y4>P9HE]V,5^(S[
MHL8V[/,>G(+#;E*N99DM*?I.HQ5:(N*>]+ >EI^71QNDKX*Y.^+IRZ23%,/^
M>D^!YUQPJ)H44^J&QC<DGGOVIOG< 1IQJQ(^6C6A<<L\$6:L9\.$LBNG$B"U
MZ,WE.TZRKY\"=79"=U_M#9-:6T\<'JMC.(U("7/L&,A(\/U<H#*"=&OFX A;
MV[@(0/%[U>;<C\QU7J"4OU.B;,HF^"F0R1%YWIP_?'-'\$I@&G O0-*\F1MH
M:^GPF#0201\-X%W2;7S<DPN?6N@)L+.7YY4\2#Q3I!59S&3TW%1[L*8%BTR7
M,ALS=9SKA;/:^[,DWR';U[70Q=![S=Q(WL=+8YKHU-*<<C\%WD(=#6<( D5=
M7<LD=,3+,S"P>_LJR#T-", 38R#2"AHQ&>NMLFH27E2)VZ7>:97'GINYRW.'
MZ4NL?0XY,&6V/-0(KM0M%W;UA0O7B"WP;NN65Z1?S!!>W'QVYXWOZBDQ:/NJ
M^E>U>58!AN!PT/%33DI.F#[L]XDV9,&H_=5#4&"JI/)25\)K1L('?+5WQ";%
MV<>%<4CA*UV_JC+Q4E@T;\8L\S>:(N2P*IGDG@"+TEC7LX=JQGDJOI-S TQ1
M\WC74P4=2 'Z.D+&=FB9C<Q[7"^O+J=*40X^<9N6H0NF42^#1S>FO"YO?-AR
M*C5N9_(6#LD]'0RN>5G)5F<?%H^._F*WRUTRR1&A9*1B$*PQ;/T!MG*KNL)V
M?Y@7)U*UHX;8:&^VVY%D8OQ3A[>4S6>=X>5MS(.LZ-R!S@WC CR8BM23"/ '
M1@J<]&$F+U$Q]_YAMPR=WI\&Q,O@.P8/91NB*KR%X$S="II[QXY.50J R_I-
MJ?EE-C<\@@@?6K@*Z- X@5-5O1U-MHO4QXW<\\IDA0/G/+@[$^DSS[XS3PW*
M4V!&;K<%]TN5J;+.,OI4N3U2Y*[43%K2 >-<R;E0BNI6](2 H^1$:)$>/J(4
MAQ4=#D-\SCSS(;LFGK32F7^FLB+)G'&;>*?7[+RYYH7/7<9<I.^#1<()QST.
M<R'2"ZI.6OA& ^.F79!;$ 270ISBM"8J^-9KAGVYG)X2TUM]V*V"@6\60KP]
MTCJWE1+OT5N*TZ$M&30NX0:!#/0]B/I8M/$;Q))93F/JQ=@ND@KX0E-LY'9F
MR N?(G8\VJ82RT[#Y L*7V/4!(-@091<S]+EO=LB=+N7T>W>'/@UC,X?O7T*
M=)Q! ].9!4MQ ;F\&C.81?LW2''"#D=AW<'%+<J3<.@+(N-CCL^9XL DE.+U
MS7\KL.;C(]G8FW1IMT^!$^<CG+_@L:?" AT30=K@XZ7@+,.< O2MZC,9T/S
M)OVR&4(/A\F8 R&%B.@5 TU]R:^[*-2@44-.=+(O]P7@F M?-#5&.?YRR_E.
MDLW=5!6J &?LR>.Z2KIO^X$8I.OQ"=!L:!*2Y95(.0?O8ZT&]TL2UG@T?0J,
M'K*- ",R'N#\Y@:) (>WWJF;TSBI<EC1 ^M@](A>RITQ-%("=69A%*%9A_O6
M'WJ3/J(+14-#"99G3#E0)AJ:Y6( S_3ZHHFQR5WH/?#$07_H<*O(-'NX%WMF
MKUU()WG33#-F/S(%)I2(6%F;UU?;\&[7%%5.PYX%B.Q30&TQ>YTS^9U'#/.X
M&0=A+- 1Y MV<P2 2V&7@0#8HB-QU8$Y]"*7L!8V6J(#E6G'4QS96L] +P+*
M/&P3V-Q%6:)%4J$1>7E<;6A&8(W<LWZ"&+@7R]C:>O.6/I#)?064,3-8B5W2
MAV>HADD'!ISC]W.I:$+1>H>7MIU5D&TGL$];/6VO @5,7609S\F[OI6H'=@V
M->&!=*E=!?EZ+2JA W$/58?T2$.'&:J?VXDVZFWJ^F39(P@)5;>>%9-1G6"E
MWO$UMTLF?L5/W;I9.XIKT X!,U'[BJ2FNAMMR'6<X,RM[N,XO06Q,,\PZME\
MZN=ED-J7['!-ERVD(!;]Z;#7>0V#P-C[*G;>=,^#78V-RH.T3+<T#CTU1A.5
MV_RX@2NK++-U<AMLGW+Q[N\1?^C.RP"'SJX#"G802("!AY7:,P'W5@$IQ5M
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M[1FMN3-]0]O]N9B&.HIF7AXIN-QDEV2>LRY7527WSU2YZW1=Z<^.#X%T4F>
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MT)@8M,1$]-)%KV'*Y4[>E"\[8V]3=AIVSIO)_@!,#(IE"?9V-2#J]$94"\M
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MYL!K4R##72W4K3>D?F)4,\^\A\#EW*[.1BV3#SYG=Q,I/Y[ 1:Q=V^<^9V_
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M<$BIYS&%__$I=-^J],?"XSQ\/=/D1_"GBC]=^/L"Q/]'YNP_A+[_YCG[^<#
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M_X@J9;\Q/IFA4_V1G:;]G8V.[KZ<'GOXDN]D)'N]WH?<I/-H6I%1B6ZLB-3
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MSATM]JTH%XGY:L1P'P$,=I-[:CDXR]/UCP"Z*##V#J6>CG"^>U(A5OYUD<"
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M5N6@H*_CZ- DY?-H/! ]#6?N_H66PPK'CJL0\!B*1UEPQ0;);JDO@),R725
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M/C/USA]8DETI(G\55W;7GKMQ/-JH#640=#DIV-;(03E;,6O <SJ:%]>F12]
MJ K)4JJ&LGV*=CB,;,9[F4KS^K9YP]M60_+:Q+4D2Z\\7*=8@(BK7DB8]\'<
M-&4DMK#]<T5C<BF*1/$<(T&Q[?O;LAXKKI$?POH"FGWJ]O=U'@Y)9\P"'?$B
M3]/>9^/'9'!>+K7TDE4J@:[[1DE?+?$BZLBK&_5Z):Z2<^=,5I<78E>:#G"%
M9P]9I[$F3H\AZ6$:<*6-60XWUTI$T3"A?S^=>,=B2&?-0I>EAF4TKMV+H8!\
M#/6,<E9V8&<CC$_E]4*1(BR8K[:1Y4>&?K'[U"S<(\#$?O[DFAD]:7DY-T3T
M%L&F"1E!]>Z0I=5J*T9KUSIQP:/=UQ+#+K$OGZ=1.C6*"U-]S+*.B3Z<K?X%
M7V*4@#O5!.ITZ"BO&S#FJX8?K;?.FA"(9P-UL@:\_7G?W]I]=@P'DN-"BVA.
M9,EG"6L5X&E8URCH8:TV:[A?86-OXU 9172@9+1V(N1U8-_84%56?)-P?[JX
M=,^.P[0=9WJL6Z:>WNYA$5S:9.MVA>'1O8T1H:4^(Z%"H\QK %K6#F;Y9D3-
M!KP88/;0F.I!-9*;UN%^T3X[)-@&C)"4@GLNQ\0O"SE?!5AN]IY%\>O&RG-#
M2UB)5)O;Z$O6G$!KQ5VDE?#(DL^\D]2N9=1@/>/Q7*UC8@FBM9 ]LL^\:L5<
MP+"V)N@WZ%W8,F*52GZ.N0>[]#G6MKZ?ICOIT-)AMU5BH-HJR,$56/B<DY%<
MC3.'OAUQ%YUS3!(U-\M!CIJ<%(T9!\'ISHJ<KO5L6L6YW^'GKR0#5SFWL8*"
MW^:/[XX,?\#OC3VPIWXS/1<[XSR\8O!],2KF]6P4,K70T62]8+#^E8]<<;=]
MT3?ZNY)@O"C[+GE;R"YH_VC=L.ZHPOF&.+K@XOFQJ-P/.E(%<OR+9VL]%S3N
M'E\JEJ[FF[ZC#4S?5GF24S\"L-$+GD7<AIQN_*/<K0/?A;9GD$= 6(A&2-_W
MGF\OOP^1DKX^\GSC4?$(@'&Y[+!?"QE\!/3VE$AM_C"];WYK$175?M4FVCK_
M"'C??/>"Y[1G^]VFZ6S.V3N.AU4QH)S<\[NU+&/[=UVK;W[3B.-0[:8S^>TI
M>0IU7M4;IXG*AL[/3J))8Z^K;\EODCW^7]8V0:.3*DGNZ_'+%Q;CA^?38:\&
MDMPK&47"@^_<5B+5S[(BQ!!ZHD/2?(1.Z_+O\ 7P03O4P[QFF%39F8QD@HE\
M80U,8X3TBJDGR-Q>.U%5LI9U"(&[:D5N!?%DXUNN@6ZWYJ9$WV-$V <(N:GQ
MVO<'S30^JU)1ENU;]6-D,K:,1J3Q0C,>1##IS8=CV\$F+;OL.T+20X\<@=NF
M$[EB-^W?5*9IQN+WJ;EM:5R&7;%3J.45"-5)]CR80&:A@Z7B;D1XL+ES6<>G
MTHSJ=#;,& IGFO+,IO(D3+12'+"G/$2[+M'?Q][0OMYR?>-2^0B <YWX-O!-
M_R8J^!$PM?ONV^+>O<#4CQ_6=[T_\,A3JO*K?)U4*WG6/U>*K9.O66\*$C\"
MY%*>CF2F/\;=WW6F_*@1"PK9M3]@7B>..P)[W3!'_S.W=W49Y%]VWY6K;IA3
M5 W!3-_U 9$\V_>S(8/R+%V6+Z08-.&L9"/0]7GE=K.2P1@)6*@,M58Y\4-O
MN?G+!3=3HX;57]Q_NB_"2NG7S X<(^J=\4"ZJ<#B$I2U.&H=M3L]+E9)L+8"
MX-%\>\@8/)CI';.%K7[.9(LJ#E<6I",.2*T%D"X._+#JB&T_:Q%M7GCGWV)]
MOW5?_EU.ZMW^A=C]L=M#^OXCX!W7@]D[E&>C"].Z'7ST"T1?ONJ2?XD^K3LC
M17L$Y(T^G::K'P'6@F+K3[=Z6=T#)^20SOQ^G1 U<Y=;958V^L:-Y^/"^=;(
M TZ<BOUN4:OF3:3--V)9Z<[?S>[++"TYW'DXF.SI4UJIHA\![3W_())8';O0
M#A:AA@Y)*)*1P/':A8JR^>Q3CT:R*TMB]1&UVBXQA' OKR.2><@[Q,ARE+$)
M)_V'I!N;#&YD-'1^-/GK :)@20P'[NQ3%@[XT%R1S*\@46H'[\[8^8:'PJG-
MF$[D/9_9S,.WA0_';OLWPA8_W>:6U?[%LB,9(\K72L'?^D2C _I5?[KQ_Z';
MJI _+3IT_M3S&]E H9C2+&)R3'+@*:<F$+@QTNOFLM1;',7:1!)!C096(8_<
M G,W5'^)GTZ<L=-PS:?G]R@2GN-==? 4%9T7!&)$%,;KY:G 1<,LK3KPWIJ/
M?4]LJ#KAC<8)NM$EM5/U$--\>RUPZ4L&]'YRW7_11R[W<8O^9RP9LC?X,6-S
M!GH1Y#*?_TWSBN^+Z6]D6U)>]-L1!^9VQVFL=Z.&3MPO[X+8W,PJLLVZ5.1@
M"*C$\JH?1 TKMCCEJHN$6]"]52W[BH84J@,?X.4*N#!WS&3T2CSFRK _1+TY
M^^02JQ0ON&@XMU O++;3BS&Q;7Z@TJ]A.X+6\RZ#6_[[$)7)>"^J6@X24S]6
M"39(I5",3?-002.]]7Y<()V>8+B-,\KN><(H W)-5RD<G-XB0!B #B#7X7=U
MP9('8GG15--D88'6"2;^,?8)_4<0&OB?1[\M.L-SSLM"'T4N]%6^VQ+( /(S
M,GW'4(+(1%A_8AP.3H=.8/)%!3HJ%2JE9':.;22_ W^U&?>HW@EW%/K3N"G-
MWTNP]"(N0H\J<A&]=>BM([.(5=DC%>"/VLFG\ZOM.@8 G 0  )AF 'S/_TTM
M]C-/#I\975Z3H858[F[AX,QBN/3P5'A[MT5@3,Y%.>Z5NQU\1I.IJ+THH.*!
MFHGJ<HCKB%G%!1G)Z]G#JLD+,)/%RCB,ARJOUY(FZ5)[>*Q/$)')1!K&(H3J
MF BX,2&27+=V'.M<^,Q-?Z4/0]]OGS_;PFTP3*Z0/-AZ-5$G56G6;58YI<FS
MZ(X?&1#!,$BEOL%2S_ V><9A!+QG-AQYT8B:GX_MHN8H&/DUB#6?!YY=>@8E
MU[Z39+/@_4HMCRZZY)R%/A2+TS,.86_," 79^[G)*H,F?8@8A?$W5UT4@V)M
MLQPT,(NXN 0(J#CO8A5MZC&-^=GRZB[_!P*6RS[L)A^N1HB29>H-$#>AVS^F
M6M=D6)SF %>NGKW=P>D9]:L##]1292Y_+0R);)9%:L<V,&ET,&6V3_7L?,3L
MR1OCB'JE)$(?GDK$)-*"QMY6:11']U$_!(K13BY58UYNTR"J3C)3/G"V/8%<
MIJN&_K#1Z HK4[;GAI\:""J18H? #I:NW6J LO"''A).C7IQ3)\R=0(J&H:A
M2D8TE\=%_Q#E?/I(F&/_?&'2[EHW7H)EDW Z\Z ;TKAKT"V3PH<$3^8A':ZE
MI73KE#-A[=XFG89G366I- 608B'1-4U*CXH%"ZG,P&1H)JWDNM5 5<YVK>UK
M+F3W]+#+42PM1"[Z7*9<68_91:J8WAFXYCE_+KW%U#)\CV9\;0N46DZL0Q)9
M90$XO_67 E,[[YA;8>>@7:CS7Y2V8=4AKVO1IG0A0GCI2(8P"] -9XX&AG60
M!Y0T4/OC@H 6 H@5.\JF0(UQ\N@D/8\B_ %9<#A'(8 (EC1%"J9I.^:M\<UA
MM:F= _&ZRV",]_=^.N%@(? K^](W=+=W&9XBF;XI29).X0B\(CK3-\(?RB#&
M/F3JU"<(:B[0)TUJ@4>SL;V[,J0OTXA'JN0I<7=IA-[I)L.;Y<;HG[#>0XVQ
M+C%%$G;!%HMD<Z)3Z0$^54K#5]D4-Y82)6/DISKOQYEC=;6-Z"\B3(^B"%]\
M]*3MNL)*M/T(3XU8K7=T4\,DA1$ZY#_[0IPNM:1/)U)X2](1*;S?_@)TU^M<
M*-U#E02K#M9>U*-AMLT37P-+J>VV'4*#W053*8Y'M8BX074UE<9Q<I!3NKX5
MWS*LWS[:P6(J.EI\MQ9W7[9:ZFSR8(Z_TXDL6OCCV+N17HVH1R<VD6E5I2O%
MO^S$L%R_4NU+DDT#<MHYHHS9A'N64@59@"KL?3?*CC^O (S>6PYSMY3AS[#L
M3+CJ.SOQ\.+UAI*'L=SSFQ5J0HR>1$FUC5XP:0!/X:E^V[!J'MYXK^FVZ_3<
M:IG%TUZT,&)H6<^S9IZ.%C HZ66]##&YA1%3O* B)#>6ZQ,*SVH\)T]RC08Z
M(6T#;!@T!G7Y<?T # R7&3\H73:_NJ&/,E9R R>.2#C:@BU!7#]L5O8SM'N$
MN>S[<OEMZ:D2OTW!_G@4.VL*!B*);'G2/ 46?3PVH[?]>#5X)#-N+FC^\)*Z
MV=><=)K3HWKA,D\!\=7D$H1V;BB+,[YUDVB$(W=3@G!<EAS=J)"B5"\&;M)*
MC"([UNLKS&5&4"P\C1ZK?AFEW&B<N..%6+:3)^QF=<@L75F6EPP\99PSGL^P
M2@+)."-^_&3!FG\-S_GEXFM.C]ZC)<_W'>7T>":@>6OK6BU;"COK!:FB9]&V
M(\/8^MH5E$<&+M \MFYDE12:Q1C+=J'.%@'AO5-)4U97. A2^VQ0M-*I[G8X
M#G9M<&^R93G?^R3-TSM^+89L.-8T^INS%,J*UUU^ZV0<Q2)4CR:3\=<[;QRS
MPY&>_[QI<K.OI#_>PNLM06U"I0[=DZ=P,*)0^GR3"=E?ES/)A\U6 HD9\_4%
M,4 ^&XD$NW\4^\O[4#,>"4%__&6*>A.BFL$T&B@+/Z?LX, EZ- :J"R"8JX>
M"B)4%:+OQY)4X3)V+V_/C(X'TJ/9J(\'+=\DGZ>Y,!T/.#-:,O7I:3(R2>PB
M<DO<1;'"<J"B^4/!NE)$P+XQ)U1Q(QU OJE[>,HGT3GZV-\NSK':L'@K6BP=
MYP^%SGVFAO87L:O1BU8$ ]V@CN;"FV?P8"Q$GO-#!%#1B.DY L$TSSW-44EY
MC7Q=I"\XM6!J"Y+KF*@8*.R\7(MSE[3P3!V&<Q?]7(7*3?#H77$ *%R<M0!M
MV#CQC. N+!MH%T1=]=2TUMR*<B(!0<XV3F2UX:_+//O!']]NDK94I98)5%#.
M?UK$B((-Y76!>4D_O]E*HF6-$G>I_ERISP 8EV0QG5V*A%(/*3?BK6#O9Z-B
MZO7+%T = #6N8&[)Y7/0K. B8XXD&LZV0A_!JM/-JJU.KN.1BE[H=FAO&MG3
M)#' ?HAUGK:.ID&V()0 *6$Y>,?LY41R(!9+YNU% AE&$6&#,(*82&YJMCFV
M; M!G^@YFPMQJRG?H\(PZF@,#W?YE^>702/2D"B3&DLQ+JYS2, 243S-+(8$
M+#0Z,W!-_O C,%!*UI,G7'[XS=L'I%*RV#5#0F6MBEA4V0I\YE2\SEH:+'1A
MP#Q\'Q_D8H?"H<@P(C%U^-9UA\YDX(L"GEQH"A?AJS:7(+:RO@0>6_1&G:Z:
M#F;;*1 N-59.&R;HLARDX5Y2H65#)$1:<U)WA59JA\>H'5<(YN36D&0:E26E
M.C>H 7VA,G"GXH7K4G9U- C>OCFG'KO0V8):#>95TLC71+4HGE[;M+2&P)16
M\%8 1K ^I(I4XCAL[.29?[&;[RI=@>:<3^4Q*P=1J^05A%=6&BPR:IV*Y#)@
MJ"S6!RX&D,2_Q6A)C@-66K?M;3&&<:X3&5+U$SLQGPQ9)C _"P$RI.NC;@S6
MYJB"J83&&W>YAO4))1-Q2#U*JAT]@)]Z'P'R^B A?T1J;%2":@0/0;U71 CW
MH13?OIGS#&[JN00S1Z@C4AFQJ.4/]@2#0VMA0<IOFB<_?PR! ]*.)M'N4":?
MY<DY#F2]F2MH3)5<-8B-W^._=O5+I@9@R9L 5F.-BZ$^J7 JB'O13,+&JE((
MJS"\;)>QTWS) L?AWDQY55I;14.[QJCK0ZS!:#,2-E9.[UN6/6<&$Y3#6OH*
M!^+81-,EE2P9!NYMKTA*4 !31O#Z84X-OG.IY[)UCM-]][Y4J@1V"8?',R&I
M[@N:N-YM!,D'F1&&-H6LFN=<Z*VWS3OVBT0;V7BI&95@2U*,&8WGR HRKKLX
M2!^0.$(UISE**8I]AZ@5).Q4K,-IB5B>\T5%V!:VLU16%I;VYUL9XK$81\ 7
M^_L0&NRGX9H$:[ =60&F\F2+I_!-WD]9KM0CIVM,1R3'-R#4116( ,2)T0)'
M[[W5.<:[*P"(L.I4UYK,: +^SMU5W33;!* 4NG=Y0/[PS41ZNVP^C6M]+3C8
M$BLK"H99IL4('J.^"(9=;R(*:.5)"@ 438RS_8J;.%%T63&KZ2$E@AZE57I>
ML-*"G$Z(_=$M\6&4+D>#GNSH0LP1NW'?!Z1ZVLWQ>!AD%GB:+@B5) &=P)#Q
M9_GB"H9L@AH(M*UPJ.M' K(3FE@)7)/W8_;B2[R@['*# 0XMMASC:V:7=@P7
MII(3)MJ-U*VK@"&J"). PJZ-CSMR(FRD>A\X>*U>1*J@,L(HZBJK1C)\QG*4
MXF=Z^SR"W^V93'RPV50K'FI#?K&0/WQ.B1>L/P$**@MFL]!63H(?18!)#%\K
M+(PG+T7,4\1;!$>QH$O]NM_:?3'P8&;]4C#6IUX$EV561U(I'4[!T.]&Y8V$
M*$PEN10YSA797%\]4KE'VGPL93=QX2:K/L>%*1136BY/'W,,"2_2F *5LB1D
M([SEJ2L.;\_ET^7\\B/[,&SX]8.0#I-#UD$C%W/,0R+\:%MJ(OKPQ6&W-B[$
M;4/9,?":&25V^B*SSTT:M5VOL+RC4H@WO>^>CALJL>T8<Z.F3\.?;D[C8*.X
M^8,4)\7WXDA=(2^=*]PZ=IWQ,KN$>)37!FN7-1DO2BOB@?NK.D11160'KRD^
MT^6MY<)7F)VPVYZ8T$(-EV7%NM28+=F4RUBAAM:%@ZAE1KA>8-)A@2KY%:9C
M<*H9].M?YII(L<4J!S0/D%J866FOZ2-3(NAKP=8&E";I>^-48'6W2?;)M_H0
M.RR\?F%-]5'A\*1%IS+OVU"V^< SVPPHNO9JYT2$LD1_ >_Y_&[;C]OF*;&Z
M_#HF("FN.M)UKD3MH6%Y'(,7K(LCW>7RPB\' S3 H4+A,)T)6R7VS,MCRXF2
MO/=K7+%(#_!?#OLD9O*%G.6+CO&!/GQF*D7]>0BE!LBQ\QL,]U;&/^8:2SQ2
M*\P<_<CZM)^5 "^L]$>PD^JY]-^;2&,NVF$VB)EXM@@.75J)JW.;CB2JD69R
M$O6.CA7D+20!&$@X^ISON',"S>"I!J1LD7%BPVOQV "PP3.<-+%&#-P"U_5;
M#H)^DW@/-1W#^D=*HH '12EM)3NTF.\>#-JOW6=Y@P)O3,^?JSH9^ZMI#4@N
M#]RB]!X&!=8[Y.B_(5.QL0)M(*]ESU0G('"AR);V^G[$*UI7WXBPB/P0" X%
M*XBU;H219Y\[1EMD5-84;-7W#R54'0"]G)6;RN[A+F4/8507<OH_5H-FVR4,
MFZ(^-G*[:KHABUN5<:R]7%,N_3'ES)J/8_<]83MY=L(9JR'%?%,,@0,"8:'-
MIRF.A0WFR1$_G!Y>SJN<SZDI5\,,K\*B6B .,D"0#AIJ:]60P*58<K_ [YQE
M?<-G+51I=6A($6'T)DEN.IY2\[I$6NKTZ=24DCL8:N6H-R)-3B&K1LRP(V+Z
MUN8&R?:<(SURNUQP,^TB7:XJM."5,S.$H%V>X*461RF@)!M*.)K%7J///6V^
MV*^E@J7/IIK7FZ,6<?D[9RX-MR)Q4Z%37,B1SUJ,Q^;;\H6[NSE+?_=)Y <"
ME4SB6.ML8ZJ/R;VV"S[7_?YF#>*7A;JBG;Z\"HL%_&.>=ES52F:C5DJ1!?RQ
M@B7:5FZ,!0R@=GA@Y:4M1-N^GE/NF9'ZT_$]EY%77%MYT(YJN)HI+]G,\(Z>
M$ II%?E@.J+*V>P98@W?[ MY;3 UWI!&I88#-%DQ[AR^(P3@\;8(\=7I]M&N
M79L!K4-3KA!W 07Q4;Q"#QJ+7L37K\VG^UI5NJ/U]<>?C_1U@/IA@NM:,D&3
MGJ6:=C OT+3+R6@H6<4I&,'I@-SZRJ0\'35BUCKR2I(+E[+?OK0'E695F3X"
M/%5/JUQ+V@.N(E\D?F>X2[NOD;TR)%MRJUSQR/=1^6:$S7T+GF-)-6HW56/=
M0^UB$'1D.B-8308!>+G 7:,M>+1RI?CH9I(XWF&8>Q_-6XP1A^B:6?CGZY@-
MF&*D^L4%HT62&A&O012;WP>M=:*59M6";,)G\&!Q3-Y AD<T8E3MKOO8F[A#
MM.C-=1P9WA>7PW_6:Q7S(VOD:6/!XQE,A=^:\5I+7F08NXZZ0CUZ8^81/BG)
M58&94G7(PXE)T:K0@*EY&NQ0S)(_G%WY,I%6%6,(]:RO.&,$]F4Q>K><J[)
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M6!'P61'!&5)TQ;T^ 8RPZJ^V\22,3?"6!]_K%%RW88/TT-(479 /* )\2)$
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M^)#H%?( H?OO9G3(IKVL[^GW.? 54=CKVS?ZM6*ZM,9N_)^>EQ8\V$V->Q?
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M8NT@BZTOG#M]#GUDN#9S*_ =,\=/K@,^*'LX@X>T6[#YUB_MN8-R>&<K/NT
MR-(Q0:&U^1+<,]U=7?/=+7/:! ^^.9W?ZOYP6I\!<Y#\,HS1PKQ0U( 96QND
M%40RI9H$Z>Q3\:4E)G#/;1/.1@2*B#7&,^:*ZVC)2N!,OM)GM)FDT*M.]R83
MYT6HC1AYL$#U/>KTLHG+H'3JIOW&P6#0+_Y5U%Y;4C/?I 3O6$]NY]WW0J,T
M+;91H?O.*R76[7RYA$V>DX33.JW+7'<Y:N;?^>DCA/B.YH2;KZK':/1ZH#;9
MIC_RX&1;VGFU2^+>8UZC#'\!90G8MC/[CL*4#6-45(1?G)]]6PAZY49R%=C1
MZ3#?7NGGN$F)5T.8NSRE79;(."9 ;W,PEBQH+H&7BB>%P7T;@5&Y+C#T!M1=
MGQ?D5RR$9V@-TT5R7"M66@KW.A> J4W9TNT[V="VV,$JM91;*T%CEANJ[FBO
M9Z//BD':\Y^\\<G&ATY4(#R[6@/?-8+/H^7;A#_%N/YF7\JKZ'/T; ['^PC\
MW>C*09#>8^:US8%R):=XA]-O6I-6CU80>S6<,,4*7&D7:"7R5:+JY%.9$K#&
M(W/5(A-"HV2U%^/.$26: :"'0'!NG'6>M3)83(=K\'P9RX5B%O*"'R)V4^TM
M]6&P/\PX)?NQBH@IIE*88SW^RP;"TI2!0&J+S8ZN=<>E_@IS@.$7>CKU\_TU
MJ"F9T 2D#*<YGTG$]-0@VXUTF(;;: OGF&]LV@UA*S= 1P5]TD0#%#HHL&BO
MG?ORZ5ZUQ- IN>CM9PEL:>1APF/3H%02F[_9 _ULW:2O2M6>J:7Y7 !$]<J-
MLG60282*LXYEME'R7654V+$(*F]:M&A]S$46/2<EA)!L%18T;C//X&!R!DPT
M1;$5B]295M+;8([D0T<K%;@6D\YD^CVT55W#HV):BL.:BUU/AB/9'F3%_F]"
M#&'XPFKDSV71KM6)?LBS"YKW_#]T[R6^VUD\EM7IU$_@1=LD88]]1.Z^#9<N
M365:EH0V:![Y:E70YR]'"^#=^\.2TA//KA \^FNV5ZN8J]5\Y)+3O,=.68&&
M!.HJZ&JUIGB12T^<49 ?E1'+-&C&ID$X^M66TF7"5LNS4[J5I9@6$W03^V.%
MQW)EY4#3RSQ5!X( PS?M]>M/:K1/V56/A7(-C)Z>[B6G4<'/7M[ERXD<:1*3
MZ9DZQ\Y\O&DZ4)N(8)S_/<!/]Z.2@(":P54PH3>('0Z.$OKBJ(Y)/RO=(\7J
M0V4!F7%"!8^GKR<6P/PT+S6;:[_E;/#JL!@I'+'M@-T"616:>>FKVF9R_=>U
M#%W^Z'S^OMM)FQ1%^MS<)<!@5ZL%UD:2/.WRVF].RK<D(H.[CU^+#(\O9U,-
MQO9IH5X7:SG7ISN%5^-7=VD\ZB^@9(,8FQD^+@X=W]>WLV@;?*.IIU;Y%W"J
M<&1-.GEDQ%<VM-YI%;=)P1?NFQNX^T""&4CHY6PB\*1J;<IW#X\5OO)RK<Z@
MX1,)B+%:B^FYA&;C(YUG]3#$.."F"=@N/:<5? L?*/+:)P V^,HU%*[)R6RJ
M>N:)4WNZXA>@K]8@&%[+\)F*E1&V(>*=JJ,Q'2T4([;!/GRN"ERA@X\CD.VX
MK+W1#U2,,QT!]>IGH[8_>BML,0NB/28"./4L\#*V%,W0G*3!8S:[%>CI6G6$
MQ_S*A40!!>SH36C['62)"5)M?4$M9HO*CCB:FO!L.Q$T<E<5O!W@D:;[(3A6
M%53GG:0W8()U!4*)E:H$%"J[OX[,2:_4PA2-YJZ&E.:L30;@K16VSV+(1F%V
M!FRMJ^?):+OR_.[$;5(/^JG]@M=E-!.H#&WGNK;(Y"'UF+1H*5M]-A(NC;P
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MGE'[$#!< V0T.%CV+\TH0VO<IH0'KT9J_KQOAHXABEO.M#3ST0M]GCLU#F8
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M)_F'/-/PQ".L>T\Y&3-\YL'72$/6$]<RK4 E=?[I36D+QA+]=7U6893'EK)
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MZ2ZL"XK189@N(:!I-KW!6O@<N?FU Y^J+:)P\971<66QFMFF&J24IC F(L3
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MJJH1I$7SY6^]L4.6$[XJZ3R"5I)^+.^ON&QVQW#+HV311GUC!E,QO.B-4WW
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MJ&%Y-*F-I'&.ZE;(!?".M8O2"Z6.(T9G2'*;1*AV;; *(_B;7' Y(CIHF!A
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MLVO92SWS=<6$U$P;I:ADMH?B+T3K2KK68[7V%<H5L32;0U:,B!9('P<^V8V
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M%]F"M5M.T-7=XPY>562^,DB8_8^6_-MJ7M1WG<C$A5889O6@1:?.C(I;:8E
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MB<V@BH3O_T6,_:?S@%APYW45)7K]J,]?*B+_:VXB\=?&?P-02P,$%     @
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M73=457_&3&<S-$^B66D.J(6B-=8UHKFN8@T,K_6B6=GKS%A53:JX+@B&5MX
MY NY6BJ..>V!WS>C?D-0(*-K$ (RK""D7E&(/A7A7HNQ%A&N-[)AVXS'1(3)
MNAW%JP^^,*&3DJ_V-@!-=>+V(*O:A;V4G"#CGL2)Y,)G' F10F7:) J3:"@
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M9U$SRN$2;C;@1<#(0.B(O9*"P@#>%68FM(@9O33M4 "B1>9NGT*W0F! JD,
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M P($4![IE7*_GK'].3A )@":DF%11XU]8-1W'E\,6KE9\[J]9M(%!'.Z"N>
M647Q ;%- V6I@HE@M4:6AD4V\&CQHK[1A!WI+2A7.I7"*^6%]DL1W8(\*H\C
MPJK74[79'&*[$W#/PB8*(I.=>0"W&,MIHPQ)!J*0 6958F,S[+8=IDLV!Z;7
MJLZILEVD*X380>24)HM H.$S 6'YX=A9+3V,JDSG<A$C.ED8BFU7QH<BE5"1
M!M9P(%B6JI58&5@EH-1R.)'1E\XZ7_40<--!/RS[8"WI)G2K#RY1<A6*8&KQ
M,X_9L<6+1AA*(&E,,@X*N=Z3>-6P%:]; 5E%FY(5UL;B44#C<C']V!^UI!J_
MVKJ?(A255;P0;^1TB[0E'N4+QP(-^0Y+-MV@OAS4 (R5!#VK-!J9UR9F\, M
M(6FD$E!*Z[W"\D\17@&@%K_:Q(BPA@!6"(3PC*;#9H7EJ6"J*DTQ*^.:#1[M
M"NUXTO4FF&D1FCFOS2U!+O%X5LD=2]9[F ]WI[F8JR8;KHQ#,/($FK3B4;/O
MM)01WU00PK;<8;4QMT=AV%[I%#1F^T#8<($J,VXW$T:&@E8T*!;A7(=E:UQ$
M]:#+K13;K@:+>I1& [H.MPKUH$0VET IEF(1E=LLKBY$-DQ:O,=;E>: E$MU
M/H6'^-#@HKX.(]QT3D5J"RE2[.'*8O.D9M0C$A!E<=YV4!/R;3FH8S39F1A!
MJ]=*F+'O=ADY'<==)X7;5JZ)BWY&$#U'6M:Z. &PVH9:*>!J8SQW='0X,D&S
M,U0"GYD*5,0(9*DIX82-5&;=&MF6W)HX[G<Z%+POI5^7/8%A<W5NK$98LL9P
M$F!FM\LWT(@+&UDW+M9K A)$%#2L0@'ZZ9S1(7U9FNN]T,NZ5-EJQJE/PK7.
M@L_'TY0PZ$:1,FJKO2],!2W:S&M).%0LHR'V^EIA]T*_.<EQIEK,%9='DWK:
MP<SF^GI9EB2Z:E=%S.]Z.3PVVV#5JG59D5WT5CN<:E=SW"Y="*0U=5D@CW*H
M.0BSA2H029N8MOO]9EX*YF3NA&.FB++3L)YA?%"10 L<#*BA:]GSJ$,%$"&L
MMOL2G\))2<+;);=F32HN6"1"&VMD0426:M;6S0S>VK ;OB*(CX5S^_A8G9H]
M+<D^/AQ_VLXA$_:GZKK) ^$E&W+RG#65=&4/RU[4&=L^-%W*5"5'B(0?]UG%
M,\MFD#8SF6LTRUXQ9'.NE;&2[PQJ9#I<>',R3*/YV/#TLBW C8&4V<[J+" '
M2 J+HH3KI',LZ-GU-F$[2,=6N5E2Q!")C7%CCK+F;2JAFQRM8A.$YI=BR35X
M2:B1,(TT'8<P2%8S5_8PC4(IM@QC6&O/Y3CHS6*IGD*"T(SM99 ,)KYCN)%H
MPFZ_X61EP-OHLJ9B*9H$91^MAXFEH_-A;US,=/?Y,H?)67O!9IFE,!#589Q%
M[F+E8;\-X'46&1<6+/$!T!5,#!HV4Z#PCZ5!;V/GH$8W!T!'80)6231PNEHI
MH%%*M/: [9;GHPH]K*J54BPX(-+BK?8LDDE"A5K-,4A:.MR(P"2LU]72J-I:
MUAB,0V-]X/L,G^H5NTK%N].*$%,CU!GW<XH!B##7+9)44J0VUO*$#G-CJ'5T
MP:AY.INRT@+S(6.8=]JY-Z*(>9"B8X_7@I!P3,<9[G:CT #JB!54(#KCF'3B
M:A)69UJ-6\9 T-%;$B]Q9LD=4Y["=;AR!6G8#6%2)F$-<Y:J$RKAH(V.L4SQ
M8'6^XB%6!\1Z*B'.9%8W!]JT72($I,$SQI"P;;!!33"OT3&Q1QFW9\O%T^@Z
MFD5E=]#R8(GT(G*UP]G6Q8R+6;OJ6-30GA2!9Y_LU8:4.N0MVP739$#Z0:P9
M0[UCI9VN(S)5UX$4Q:U24+KLSS.1RDG(]OB@M-@ 1+!4'OM#(;5&P]K0P=)R
MV5^41D$[=6:<"RY]67%UK1.,\)B%-<-C!-1OA3)C)SPAPQT;"A+5U]":CNJK
MI5>&YD@81R*:D)X$V^J<,]2<,9@\7+0CDEC(@]$$7F!+*<GDYB0ANST:*E8,
MZLPL:*!4"X&/AOTAG\P&T"H4&3K+*6>S;'?A:15%C+@ J\>IX/*2Y0U*M,GZ
M@ S%0,FU60"G9SDA$S4L4Z5:G)>[B6K6QU.?4'1PZK1*&X U25&:O@;@1&81
ML930M?X$,I TG'.*#W.=K#T.ENQ,<OF(:7(-08FBL< ;=DX*V<CF80JB@I'"
M#*,>NTHKIF&Y'*JCWLR<$@NC!<; K 8O(%4QH= ;V+%EN6*7FP#JT,5*@ZI<
MYZ<"88-DL80R6BMK=A4#RY*^U)7YRA[F2Y@L:4DE5*0VY$U8@NJTA$RB*1Q@
MIV44$T=-!I=K%HU,XFGBI2:G>R9%@GE7E#O]CJR64QS*@5#$ZZO8QIVP#,)9
M(YL!89QO6GK9!/#NDWF7N%YOZ@PTL0):08V"[*4S-P?)M$%4G'8UT>Q.:*TL
M-DL4;J0AMSFY!0E**A:I(B_-_'F'!_I0.*.P#!T57!,D;R)B!FBYNIS6%Z4(
MBT*F.QJ*H]9H.K#B#CI<.2F2$@FBC"V5:6 .IABHZ#"I#=@!1TX[0[<]RR:M
MF)NE?AB/5*8["UOZHB$Y]%B2)(6'/;AK=L9&(8>YTEAE 4;LCCII*>RU9HN2
M780, V@D&^1R.1:M<HD)*M6&24WLZ4"VH7EH3J=EQU+[2TN#F<P(H,4,G5,@
M..&82;C*Z)=-::@J?*?O)RVBV\OP&"PQO7$6S$6=PQ:HT Z3L&V@V4@<S/@L
MTD6V1PHA'Q29(0FKJ4Q.[=5*QU:'K3.TD,+Z<E_@4!'YM_] E_6XCQ4/GURQ
M:"S9DCI'"4UI34%0Y-%1KZWR"1K/6L8(=+PB;M:F=8.3G*0/B? "& 70.'96
MAPN)/9+\ME==!N48+>))+[ 5LIQ4Z1"JN)FKRBR!B&57%5D0K'%=T)-*=)(F
MC0FG2J1;XD?=3"XSZ?K'*I/2LPY*SME.QI9<I[>H2TU,4":L)Y,F%DR,$A/K
M0%8=FH$(0F:M2)_L%(&3OI:T6S$FN>.(]T;#LMO.QM!JI32E&*FR;JEAN$KL
M UQ/9$VAZLOL%$HK4J)9D5 =>;8JY32)5K$BS*6QIDG%!"0S,='E0V?1@I)F
M!UDFUIXCI I8JE)S+56S4:_6;O!]I=J- R_BR,J,&K402FF3XKA-)$DAR^[4
M1Q&]8((>ZF49(F@"ZR MNX@'*JL$7# G1E\WU&9IV6A)ZWQI"6(P@,J>/UH.
M^EDN1K@USA:S@:L5RU,6(#K#92;L=;Q9X@<)0HY@.:M'?@C(N_4P%M0>-)PK
M=9?/&21LM8:E::LLE:#1F&'Y)"L-6\Y";8_0]8C:\$V8\SRM/*^3?DWMA$TF
MCKJS")/HUDIM#%(=&C@LEN?:LC!PC3X"QFRN]*2>4N2)/(=IRF*\9% C6O8:
MX)0<+A9T@*NN7+ @FC.F[X@]KCI@%&Z\LH>2%S2YO&_X0+I(@TK2Q&:=(B]2
MK'(Y\YH6KXT:KE2$!C5E IJB-I=9NZLHQ-)15:5;-\:6+$B8(#6J2U[?G9J1
MGBAY6 9,&Z'IE0RFB\75LM@2X5(\-_B, 9M#2K-=QX,J*1"Z3+<D.@38!.%Q
MR4PZDT3KRE$759'YRMK8"NC$<I.>*DJK0LXJXZDD2+61UW?;5(G28Z.N\>7(
MG)J(">8@6$+]2>I/( 8BJUIL"U EMG0I &W/[ZVD;(]GVMC&U8I=9S!1-62@
M4YH:(VHTTIBN2BTL ANCLT@:QXDY&64QI@5Z:>;7F0[34'6$9.K07(G:0M)3
M5QOC\VE%07-!B"%9L::N0HLB(O/X8);19;)OX8DHS?O+*'#+4>&QE6A:%5'"
M8TNPRHCE1C>N,M:XE]-4C)CQRMKPC.8.C29H@Q$(8^4YG8:#6C(L>XOE$M81
M=EBNF7U\%+B-4E1+YV$^GA1SFFHU?UCI.Y20U;L(P$%1'=EM'&J$FR 9JPMS
MFC3&4B?)G<$4')E^WK!,N^(9TU+#*B>=>)S,ES:6P-Z2)H=E'2@$EL\U8# <
M!N5D206SU:9N*1C5^;Q&+2 BRP>6UVXNQ65:8?/E)*WJZ9A<MMR8U9D M;P>
MW&;R7(YE44Y(B)R.IF9?&84-;ME:#-U\%<ZU4=KME5Q3Y82*C&)Z.FV!TB19
M/Z</8*D,L7T/1)<I/"%G5:7FL4W+EE.^;HMH4Q?ZU4';ZZL)1[MB0J\ T?:T
M!WAI7(1I8=-;3U]M#PZ,8?'W>FG)%0< SC)C65^GQ'!$BWK .N6"R'UR8%B(
M4[A=!5T"Z"H!ITT,C\-,WB>(TE>4=+F8-SJZPA7.SZ,I. Y;LC>4F+@Q!BD*
M=4@IUO*!%KMB9W5 @S+2)$097YSP7FMD9>VH*JF"D\ T-O8RDNP"B^$DMH;"
M I4;(T+6'#1IA%5!F,IZ*BC=BM0*2DT(=88KXS L#+1GM/-E!Y^Q^-3-V-:\
MQ=%A*#%)FZR+E3))A\54)U.L/TE4!361@0\6>76M!^!-;31'S6#"*YRKUKLK
M>SBV) 4I4ME62)']9!!P?08*.9,O5C>60/[ZKI);Y']EJ=*<=: PC6%]3FL#
M/1L.R(3I<G$SL:M![L>[I3QVFT--;BBP9RN0U>Q$[9 K;-Q 8=B^:%M3AQ.&
M3%+XFLRW!J6!%CHC09R8M-U:.K%G@;-N;GL<JL2*OUMM2-01DN:RT_+R6:'4
MND<-)0JM&%0D4@G >DN-\-+4XQU;"MMA-JBT9(FI#O R(P1)K\YWRP041GV3
ME5<[G.'8C:=^)X2FHT).X"0.U[='!B-\?7N$%4*ENT#]YA0*VZ5U#=G0&IP1
M:+.4^[C'SW4&4DN)GQ2AXNJ ICJ#O("FZ(A$J#+>$7(Y<B=5.VV2$M&C8XIQ
ME=2>!&&1Q["MW*NW^!Y<6E08LJ24VS;#:#X6&$6F"B5L>_>1NI*$RU)4GJ.]
M,3^C\2*-I 84/X$BWO;4]JSN9*2J>I@O])LM%0)5?C+F!V#<$0S<"><]L$+-
M  I?UY8-0$_K]U@=#H4I($2HJ1+CV:AIK4^\(O!UF5QFDHXR../ZL_Z$3E0!
M6%\!&/[H"HC#!<W7JJ$2K[ZS!+:#00<>S<FEX^'D^J[((F?9UH*!>8I))]1B
M,@L'IH>B<QJ(R'*'3;6)D!!TJ'?9.=J?6$&I/ZCWR$DV6^GAM-0)0@A&]#F;
M$RJ!:/V0JDYB;-&Q*VP7$ZQ1B4]Y8V3W&AX4)HX*0AU$]:?SNK&D0RE!\8#,
M2SX9\KN_2-:@NJ.T.UC$ 067NYU(] Q#FL[I$1U->R*<TGQ%10"ARG9*6!\L
M%TEDI6G'$MZF.H.FR(#39L>+P&:1]G=64QX)F< T'4'K2G7YT=T1<5YK+-M%
MS+B^5D!;!&I>EXE9+#,])*K59C J)-6:@$^3!1K5A*%CH5)GE8V2K4R*B)&I
MT#9%E,)%V)][P90I-?"L".;G; \)EE'85-&P,#AN+:'U/%\..@A'J8NR:Q(:
M))>8$=*337!U8%T6HW$?ZS9S>X('4(\RD9!QO<Y8GHYP2C(E#8M:)NS3Q$)0
M7,0#M:G8&CC90#/;C@/303!=8D[ATQNT"N].P"/7R<N%,B1DVQPX(461B6S6
MRODL:@G#R)T&\ B**I.69"!\X7\<A  Z?:G#)$N]\*\*A R[+N0;L%?;_46R
MSE@![?%(&K4$FZ8+(Z>Z,[DR4]DYM;0)QV++ Z:5[8Y2G_9C==CZ="235D27
M-*H;FA+<$"(]GDX-J]:O"=$X@SE7FZ,5HBZPK)9U>\EXE2_G11;='W9)6^/U
ML%[2[$171AS("7/-J["5^4@$DU&4ESF^#[4\(QZW(1?4]0G?S2=M,(!YC.LA
MZ%PO>_%J(ZAB)2$_276>BMMJLP@AIE+2#-HS@A%\HL[((28+#DK6^K3)+4MZ
M6"/)!#$,I5=$2!H833&5@05M0H\Z3'MWL#0N\JY\T! "59M@Z2)RAY"!]E5A
MT(E*XX7H=M!JCX@#">MT\>EHD);MT40NM=V9,IM:K64[)02V&*KAK4[ I:5N
MSW(]A"9N)[7SOB4. Z3%J1S4F2RM 6//3=OT[*AP_@ R:$;Y%)_V/=-=S!:Q
M)+!#%Y2F$0>*C3F_BKX2P"UR,1B,=7#L+4LCIH=X:5A1E 8:LFS0F0D:)WF$
M;/,$E<\I *L,,4/)L8DZ,?R1#G:T>6FTA%VV@:X.:)*H9MI#6^^PN)$C(;IP
M*USLFO3Z]P (% Q4;#XQQ12-@AI<&@V*=-*9C270< 8RU!'K;D+$G91"RK:4
MK^PAXADI.*#]H4G&7;XS[B_ (/%3.?;<:C^J4YI.NC[A9D+.#<'13*O[1)$P
M&D 38,F!#TW,Y=!RD_:\%Y&KLX!8+B_A\;#?;RH*5&'Z[81J"06/J&F]U*O-
M+:^8?A?E+ _@NG#2XYH0",;S:MY)Z'90#EW'YJKV !Q66M[J&^-SHF'G1B1,
M-<VI.&"538-R$T8B>JS$,12/])XSI_OZ8M#TW"(#U(P)/I'X!IK64=N;]*3&
M>%IX18KU>L1JRQ2M%D%#::0:0]>!JM.:U1V)N=TM-YMJM S1L4L;_0@=M"&B
M->2*Q+.>9]X"B@NV3.78I6>1&J1^WQ<KE7"U=0_8YJP(UR0':1=K;="%%:]3
M\@1H815)*9F5U.; PR*]7%N.U7G;*(/^;*QW"@E8E5;%EN5I4\4,=L+I2TE:
M>3T)HWTK<=*IOC"[G3!L!8/>#":S<3[ B+*<YN5EGBF#* L9 >769\XY0+-5
MB?II0](47V<[E(:5*:V\VJKRH+J@JS+)ZJ92*1Q^VQ2S:<>IYR)3I,5MF>\V
MRT@OD]J\;_&L 'NM_A*<AC:,+7ILA\@'_:DH%JM/X,LK>Q@T/ V#T&3]W('V
MVI1E3 E9)\DXRQLT8W;(+"+G84-4>7\VF$?EW.()$]8&3779'M%V'1VI8:4U
M@0-56FWW9;,:2%))?P)P":U-!WTZ0(+RO#K,RK4%1F LQSC]B,AYS?)=O? 5
M-D'+:EP6VX2CZV$W*!D.DJ6-F>(O5^&<,6 3@W3:"FBB*9K-X"((FJK]2HG%
M9NZ$XX-9!Q/K@VF0@D'< CJ(+CFE.6&(90-U.#]L],FD4JESIKSZ9EIUJH,<
MWVY768"<U_P*TK8&>F?$SK%%ACB**,(**[!% D<F6N;1 Z&Q+,51H4U8H]YS
M6):2&G522O(ATEYEHV!:Y;!)OOX=9:"D<\"R9A)1$6#Z_1X&#(K8&^@6>5YI
M;D?SW=7DP,30$>"C)28%$' )]*#U;T M=G__<.\:O/$$\@7QM!C+T"^94656
M!5;=KX12C %O/*X&?R(Y3C\EQN.FL,JD'AL#_KC)+? GD/]N-JR6WCYX\60V
M $"9W['CL<MVJYMT3[I "*QN$#[AOB'PY N'J]N+3[ZA^$>[B1KN=5GWB5=H
M]WF#=OOJGJP1[;X#VFN0:YZM16J4KT'@-A#:N#K[&-4?>\#Z^-'QAFGD;5PM
MUL> 4>3:AI_$Q9BAQX]9'^^Y\JB&H6>/U?5>@#"(DU6?IP"/43R^66(GGO$'
MW@DM!KG=4_W)CBW95MTPU=1+MNR<E&&U#/\A4M]'[^LCTI_,O__&N"(C5.UH
MRT[2]HRUCCHUMC^AT6J\V]35IH04&Y'_9*HH@FIE"%R=Y;'!6/76^O83J2!X
M:\,8;UV_G5O\?SL(;D=6%J0I]O=!_GAZ="]Z<6/>:[(1Q<7D'VM5WK:JW_LJ
M\MY$$+JM4,H-DE:DAI8]7DOR<.]N\2A9!-'J.&WCXZ233NI;QEH8&44$-K&2
MM;%EC-TU.UXKUD7H&8FQ;:WG&6ILK!E^G$;&VE3UTV+Z&W3QFEJ4[*'4UT(C
M*J""L1''VPKDQ[I9[\,,/"]8V/ZD^%^AO!M-BW[C0I/7;'\M*4CT8)RN:_;V
MC4:/#9N,5-_U;+\5),6DMM:#P'TJ[''@!=$?!$YP0^8)175/'>_5P];_)Y]5
MJO;_OG;"VW<'';^G=CY*_R?M_)-V_O&U$WU,VU;O- "QI]7.O>BA\E[T?]+.
M_[]IYQ\8:NPCK/ACONJ$XY[^G273Z3[?=Q(G@O$4P>F>EO'ZFS> /2_>*,B/
MWS=0<Y[\(4#->2'7XY_X$A6.V][8+7.JL;,HV*;;^G:L3J)DHXI@&-)L$A"$
MPR2$@XT&0M9('(<:&Q'\XYL^"9;RXT3UQ\9N6/L/@-VKZ9-@NY$]L7W5VZOK
M-"VP-0BNF5BYO%5%]/+6RA@M;\4P'=EJ8$BM6E9! T7T/?C[P'A2/X+AZ_:Z
M+A">&L<[=X>]>Q">4/MDGAJ1/3=T,@JFO^<;54[9T(SM]CZXAO\NKCVIZ;Z0
M]7V(^?=$UO?%I\>0@_\CD3PEQKZZBIY"*ONL?4+&^7BQ/%EF;3LNG$6^CQQ$
M-&9_G/?E;"S:[>K&"YEVQFHQE/6A[U7VU(WVH1@X2H)0DR2)*E)?%Q]&XG"-
M(.M8LT)B> /=@_U4BO$X_(5E^(^]< CNKX>.E>TP7 *1[3"X!VJ#ZJE!XL!,
M%H5;P2>%"'_W^Y3VU>BIP<=6D>H9^DY@3\,]!;_?3L3_'3+[W2;PORVS)[\D
MZO_S,EN5/G[Y[5G+3UBN?TS?WN_]CA>2)4 X>0KWWK"GOX]7+LB*6+$83OP4
MWIWT?R_O3@;K3OTI7JSVN]ZJ]L1@H)CW]DY/G1CQ3FB#S7L5/)FRK<:R'=N:
M9_2+T#,N%I3AC_.=_2@U'FW\%#1/!]:=&U$8V85:/0728P1/AN'4;'VXHKTT
M?G^_6\AB^V(G"I6W@1O/NJZNRO9%:>VLUIY(:>V3,O7M9&<O*$8:[R'<*'J"
M+C]AW/N8U;J0]_4>M[HZ^6/9N$+=MJ^G'.O9W\Y]I!+K$W@<S=/#D.K4]O*=
M5)]X-"]96Z'M#;2;ZG=!C8V=3QS"1N'3MUN?]\[UCS5H[Y8;Q4_=<KY*%<6D
M4+#)3A L%@H([VG_^,JG!EE/]H+83@I.JEYL[&G^6/'OF'&1AJ_D("BO7G^V
M]<CZ*];V^HM['"_VD/\A-O7QJO.H'CY1T_9H8,]3DXU.]J6&3Q,>[21RU?]=
M_G@GMWY>FZB_DVYHK&>POY-L(S/] QW*4TYR#P?$A9J,K584I.$?R(,__)6*
MVR?KW6S(M+&*<-=6W:]M]+\ZB=F+Z.EQ-C0>W+O1/M? ?X-A^^+)OOWPJE1H
MD#L/+5KO>97KO@;^QW_^U,F?.OE3)W_JY$^=_*F3/W7R?U4GAS[V,GC#UW=L
M66PY=><C=VPB-FW^/WS60?Y/,38_\L5-1QR\Z4N;O[7_YB,V[7?$YOV/V/S(
MES>]>-/F39L/V+^HW[3G.>B  Y]Q\'[['[+YF8<6!)W#B_K]]MNT^9 #G['_
M@0<\XYF;#MS_@&<<M'F_30?_W2%'//LY1S[W>2\8/%_YUK=O.^HX^9Q;;GWA
MEN,/A2K\9U[RTA.2,H+&\\_!50S79HLWONVR707>T45/^V\,Z-$.-^^W?]'E
M00<7M70QM/TV[[]?T=.!!_W9?IL/W%Q4'K'I@&<?]QSHP"W\D65<?<]SCW_O
M3<\09C??<A!<%]]X]C>?]_R^-H[>]\$++[OU!R_YTADOK<1ONOS?'OG.IC_;
M?W,QSZ+UJ9M^^UOLFJ?^$7]T!_N*6]]RVA7_\L =/WM0SH>GO.+V"QWK'6>E
MP;W+^Z^XR7@.DUYVL7AKLW+S*\;3AZXQWWGZ45=^X<V_>O6G#GK>MD]=\-#/
M/W7:O>V_N_7?KM7;T"N%Y8.?O^OL^5WLX3=5+K_\?.C&=TS^_*&;CC9.?YCX
MUKA_V3GHC95KXFN^]>,W_>@_/G_*7]7^_<=G12?/KOOQ%3L>V32Y5(G*\44+
M3HS^9L>='[SHBD.V?69^U2<NN%1I[KKNOA_IO1MOD_KGWW_W88K(S6_:^K>M
M0R>G??PC'ZY8YU5.^L877^V>NAWY-33^W"_^\EFC!]]_[-4Z<M%;[WD5\IJO
M7/C*2Q_XZ;</0:Q;#_CYO2=\YJVEGYUWPH<O_L(7TB._=SIR[8-W>.,W'+*V
MB3IETX%GOW;3,;\X9--P;?.=%VSZ[9V_NNFGU0<.?]U7[IA\XO3C+SKW&Z-M
M[SWWK%=^[-(JEQQ]T=4_^<0[SIN\Z">7_.4#%W_GQR]R=\T^<.H!A[?7SL#6
MWK'VJ\/_4OO*Z>]XZ#]?&W[]A^7#WK/\TLV3K]WIWGO%_.O)^W>]NKLS_?>;
M3C_F/ZC37WORY-ASSW_@73OA=YWZ@1=^_XS##L>/^=*1K8>/?C=^SXN.O:AV
M\KT?3U^TY:KW'2']X*JUFUYZ+H<< UQXTN?O>MYW@EU7;;OTD_]S^-KW,B\*
M+CGADDO3:][^X*XM[SIE?L]OWGSK!QY8>]W-[_KMKR>O?\&U&S\WQ/%^Q[SG
M=<=]#+^1.?2FR__ZFNI?W:X=_]G\8FERU</4QS]S[O(5W1?RNVY\=O>9]Y[Y
MLW,7WW[A-U[R\4TO.&/SE2\Y"OGNN\:O/NJ!]VC773;^_-7-AR_[7S>\Z_B7
M'SW>?F1RZW/OV"5=?T@M/R>\Z<J_>?F%/[O\C-=][J^JS/33%_ZR>;+1#,^]
MRJ@\LND;7SC_U=_[ZD6-FSYXYV\.?/@+=[Q'^^)EDT__YWD/OOHSK_CE"[$?
MOO"6*W^RJSG9)E-7S>\]X<J?7GKQV[><<:)]SG.'1O_&*U]V]M+===^)5W_G
MWHO/^_'T,V>.:]_?C]NL_]NFGW4O?L7BQHL?_/M7W)6<=XIS+_G=B[XC^G<_
M]XK@@1.L'UWQJ9MV/'P[8'D7^H<_]'??_M8'KW['1^Y]^:ZKS/:6MQ^P?])^
MD'SG\J;O_^87)Q_[Y:,ON4>_YY7YZQ\Z,7QDTZ]>^9I'-OV6_4+EK;^\[0N_
M;3RRZ;_^[.._?N=O?_KZVWY\SWN_<3/\@]DUT)-^X)LV?R>][U,_?613_Q[Q
MZL\UI]4%<8?-O$S[T'WWG77[F?_RY?O?J?W+39="+_I,2_IG]O)G[OKU62-)
M_MKM_WCBA2<]5_NO7==7[_C&RW+DJ ]S1..XP__]9IU[(?#"\2UWGG_=2^)=
MC;73C_A*^L9G-S]B_O6IXL?^Z6?OWE%ZX$7HY__B+QYPOGC!+R^?_>SLFZ3I
M#6MO/?W/?WO2.VX]^_4GON%#IYUQYO77'WGY:?_^W<^0PV._]<_>C?=?>OCS
MCMAUI9<?_NGGO^?X?SWX'SK/63NGXJA_?<EQ-W[GJQ\^LT*,Z:M??->[#_ZO
MCUU_1><'9]_V\)UWO^_0U^Q"=UW]C2-]N0L2'[__!0_^9.VD8S_4.6C)?>A\
MX=;&Z)Z[L \]@)UN?O+HZ^GCWG;C%[;>SIS]*O22]S[_LK=_[OUW77[4]<\Y
M\ WUOWGX==QS3CI?.Q0^\KKC7LZ_'-\2?OOF%[[T4]LJIU^W]:5IW/AF^I/W
MGOJ9+U\L'7'I=>>2B_3FM]X3C<Z/0>GMF_[IF$ITP+VW';/M,Y^NG_;@>\[A
MI8^4KGW-R;U7VB\X[[H7?/LO'GKG%9<=?=X5?#<\^\KR@<H9+S[HAE^>?L[V
M^U^[V/K^;_''U^=_5WG1*Y_W[%^<=!_BON:RF[>^YL'SSN^7WG[EU][PKG/\
M*W_Q7SL^_=T?_?T].[HGVP>\XVQP>N[WWW+8,2< KSG\#9>==M;?VJ%^_TT7
M'K;K] _+^@'/>,7!)Q&W'V>]^Y5ON/WN=[WL./DY$'C+)S_YE8^^\[,_./_O
MC[U _MG==[_R_?1QI[[O7O23O N<?=TG+OG8CI\.#_[FV<H;UGX1WG[<LY.'
M#[M4__I1'\9_0/>N:+_XJOLN^= ;;SOCYQ=?^UF)VOEOA__#E>>]YL5G_N--
MAU]_(7W%;5]YWPD'N>B//J)]]4=;KB.?=\BKHBWNS9^'L']^_L'G?_H'_Y6]
M>,!X]IEW/42_Z9E'E]Z6?NR@BT_[2EWZZNWOJE_WU1>_?_@_G_7F[_[C9X^_
M_[36.P\'COMN^?O/_'E^RWUW0F_[Y^W_VFS@6R\*WOFC.[^9/%#_4'#E1<[:
M@7==!3^<WG'+LX\]]QKM*YM"Z5L[/EB]:5>R]N!^;W_91\_\VL<_\/(;F*.K
MU]P]_<7+W$-V_,,[I>&-=]_*W+[E6:Q]R!LZ^LNWOK'QLO=\^+[;;CGPPQ]\
MUO[;HV.^?N[I'_H Q;S@TU1VVW?_]<4"]WIN5P77![\Z^_CKG_>6_V@><?@[
M;P%N-IDCSKB*.?+D9PPKY__FAI=^\+5ON^]O7]?73GO>Z6\D/NIL6_B;#K_B
M@ORK%SWX@X@ZH'_IU]$3CT)'.QGSS__GZZZ=W/V!SQ_]O\SN'=.K)I\LWWWY
MWWL/7/WK?_C1BW%]U^T['KKQ+V]]TR6?O]+XLY/YBY]W\E\==BP9@2=]I9N^
MY*A[!I7HJS?HXS/'9QKW/^LWVA=^.7UDTWT777^J^NO7_PK[QJT7_.S^?WK&
MWY3^_&^>?]BI%PS09[SUF"^7ME_P CI_!7CLMO<B'_KF*6]3W_?*P\YZXY>.
M^.@7MKWF#0]?]4];OAP?<\'AT?FG_7;QD6]2'_WS^VZZ]LA7$C? ;_NA_)<'
M7_7.L[].GH-7#JD<^./;F>UUJ;U8W"ECMUSU[@MO_^A\OZ^<W7K)YLF9-USR
MBJL_\T_'K7WDUGO>L^6X[J[RY5L/09-GD-"7]<LO^V7O,S]_[XEE[,\^*__%
M&5^\ASWX<IS7;WXX_<UMTF&W?N@[>?*+2O3!/_MP?N3UQ*7WG'2#<_U/_U5X
MUO$?..VST;4GO94\X)B[[@>_,_^T4?GBQP_[Q,%'9K5OO>R7'SGK=O*^PQ\^
M('OS6X]YR[6?V._G#]^X^-[M/RB?<^.%AU_^TM?*^UW]+^]O/;,6?O6-SV\<
M]"SN@V7NA>\Z8>L-_V+_>'#N_.U_S3YPU#\><Q?ZL]%_O-G?[[I-YV\Z^^#-
M%>ZXMVW_VT./_NBI-[D7O?9=XR^^Y(V--QS\<O!KOWKF)^+A6\SWG-R8B[>Z
M)W[MS)W'GU]ZH#:Y[Z'JWUYP__47?/O,S_T[^--O/OQ^XUG53UZ3_FB[$-S[
M[]][_7W>]+\^==?''_B&?^?#-P3<55=<^KUOW8G^QZ7_<?I_/OB]D[Y[PX5O
M.@TRR>ZQK[G_PHMZ+[CUW@]^\K0C!M?<^-G#_^;(YT?G77IKZ:J77WD8=_4E
M_J_-LS[GOCFZZS1[\]%GU*']OGH<M6FK__*ST-NN>D#[]?<O?\<N/I7_XJHK
M/W[*74<]=-'PYR?^%35[\SN//^&L3QR]_UN_=N.Y[=N^\HP#Y_#7'WS9AS_P
MDQ]O)3__XGO=!ZX[17KN*/_Y3Q_J?N,L%#OIPR^*WR#-SW_-=^_E9?P_CUC\
MVS4_NG"Q=>L97N_XS[_L)\HUOS9NL:&+!Y63UMZTY<+O??"BBU_REJOP_W70
M)\^Y]D/O?<N[COKHQQ<GG/BI!V_J]^_:\?-?/W0'=L_A_7->([WQPH/7WO03
M_)X7WW'VP6N'XP>]&_]TZZ/'7RW_HKRW&X*O>_5))U\XK)]WX:^A5YWU5P_+
M]^SXX:W'",^Y^(X=<_?3Y]QQ1N5?']SQJAW _!U7_?1MG4M*_^.RMYQW?G1A
M=KOQG&MW?.J0QBW;+J).W%RU'[K WW1ZY7,[PGQ[KO_@'[^SXX1?7K#V]4/>
MVGL'<\2V\]]H_I@Y\P-OVV]P\P?>\L,OU7[<?Q4?/73QCH5RQ%\?3;WT5=1Y
M9]WY]B]]Z-IKG7O/^P#RO+]^P3FO-,[Q+D6._?E)#W[J_A]]^=O^U><=]A=_
MV;KRZIOWW_7JYFNK;:3[D7-NO.7G?W_WV4V1_.RL_;*W'?O#CW_LA%VU*X]_
M-_SVT>G;OW[4&5^_^Z;V)8/!(YON:;_EQ-(/+]_TKU=M_MZ;SO[EI3^8_^PE
MAW_VB/]Q:5DX%L_2^Y[UR<]_\G]\*S_Y5Y\[R"2\7Q[]T5KISU_ZJD-_^IO7
MVG_?KIQ^CN>?_LQM/T#?=^O-6]K/^=^$NF50' K0)3H$=W<),OA <(?@,+A;
M<'=GL$!P'Q@TN P.@[L&#^[N[A \"23WOOOMUJOWXVW5UNG_75W=57WZG/8\
M)#OZ;"@'AQCCJ"&Z0]0*"/'JF#)+ O0I%(!UU2&)3#D&HH#0;,8:F5Q:@VJ]
MJE0C@7DVV$2E@T(JT)Y6'FJ).LDF>PF)$8:TQ:@$LVZQ/(@Y#R7SXOMNSB=L
M3?+BH JA6*,*>'.TQ4R\3JO_C03*DBTRO&MV9<-XL2NE@$H;81"*YV%CQ+:D
MN"O/S@BH<\<A[GG% FR_#@,=-^R2!)I9$!A+5>;*<%AFR .9XQ'7!$>'09$.
MCCL@2T'=.1;UO:OS/-%-(X=X,2JD&&F;3="^#WR#\ZU:S*\PM3E8V+JGO28&
MQ=)'Y!.YB=+.Q29EXGKD\0$.]AH<)1JJZ0\#68!K'>&RX</HU)82]UF'I<6F
MP<*I9>H>;9>,B_(,V?$V,.CP!A.>6+2=O7T<FWE.R R#CC[8_NR;UJ:'0XRZ
M7(X-FK#,B=3\B;*T#8#SEA6RB4&!)D ND,:S&XQ_%;/2YH4"ZZE_TUR_XK!P
M&'W-:NQQ]-=FTV& UT\O$'KSR'9AD TV45G5*F&-^3M0QJ45K7NSU7^\97N+
M^#MK'6)H B91+5T<295JI-#HT*$<6!9)=8/'/2#_WK&)M]BU%-42D[:1M\Z-
M/_8WXR7"!0'9>:IU9;8](;_U>IK?BO.W$,(9[8@'GM,)!&-LF,HEUJKMF%AK
M/^AHY]P*47 XI:F0M*'_R!P_/)KO;3S4$\15T).02W4B 5]Q^UG1H)$>\$/%
MT !\(KOUOE +B9I.J*<YNGY?#!9(&2(Q\S[ZF<D E\2CP_N55WS@S+M*^%P%
M%BH*U2A0N>:,1?BYRO7*<^L/0'9BX/72L,V9G7"S$O:+@A^,F>$C<228==0<
MH::R[N-R>BY$(HIHLRI3QC;>;\+HL4))0"WGBA! F%#<;7A9AA*[>F@.X4MK
MK%:8(#KJBBT;A!2UAJ)E L>IEM]M!2L#9'>$6YZ3X\_A:YIJYP26'O:[ST89
M[J*--$$BB3_\%Y 152!CLS/"SI65HEGOIQMH5/CMA4Q3<Z@R'5Q>3?P5B>6G
M]OWJ+V$]?5+/0R(^3=.\+\!DG'7'2I.*6/65U+X<*M'WLE65FQ5LFU ^3:#7
M=Y*X_4^!]KDZ-0 M!-@JS[ER/7'5\SPW;1J%,(9@>H&I9QQ1]OOSPB@%L& 5
M'F,Z\=+2SH]5N'3-,[6?P=7'O)B<^J+0YO0^PD#CT"<8ZS1&N5P(L.&$B2(Q
M4BWB)3#090T+N+B+HJA7Z+D_I71E%IKCZ)8D4B?+N!B)"0G]IF+GQ()/HZ5<
M32E=7V7JWC>-P"70NVT4*U!5 OZU+J#E3@O-A;OZ9QIU6FNUCY4.-3*.$IHN
M4=^@[EF_3+I0X;K.J'$IO"A>>;9147D9&0AF9/54<AK+Y?9SBR("RH);(*10
MQK8%E$5]?,[JRUG'%9UL;]IMWK!8=V;?W(!6[1XYBA<H=SZNG)+ $K!ELL">
M.?,I5;'Q]F*\QUX655BK$6U9E:4\0_FL1*)LB([MR#=&F V>< E,+<>BI#IT
M=U,!>'L\!$ ^-67M9+Z3'6]C6A5P7KFJW7*7QW:"<GB.<%NFCB?@T@W9^ G(
M R.P4=; F"+Q(M!V'05V9U]=4B*!:D7OBC>KPR!U$*&R=30\H$V6U+VP1'\>
M$15/YV^7ILG8&2#+8""E5<[OA@</!,H $ZZ M++"(Z.FI"=D@@;RCZ3LW*>H
M2KG#.&L)!N1>"HB1(_V?MBP+.19V?TK^ME>[<6KON*T-K6*?NQ&3=#&SU8^L
MMB'C/L/ 0DD\:Q:!EQKL! $;R5;:/$BZ]"A%&G!E<ZY%)QO?Q5_F"0%61)<&
M#"PE3Q>3SW.9PH6C9H.,2O85%/)IB' =B$'1IZID,([G5W:LR;^OLAM5>&YZ
M"_K8SK;ZXH$A;0%$GU?_K/?^8[/!/;/ EUQRC&I=D4D;J(?<#4F>TY(ILU#E
M95<#M_GC%TT>I_F,E#3S+F6,50!LF,.=IL=B-63B+A)&<LU82@2W*MXN[!V%
MO]MUB]-, 1UKX J\NR_"7\5RPO%8.IR>"=IS2]]:H7:5)'W2%TV4B;R*.S(*
M26->;C_9J4Z.4]T/--:8BECH9_]AJ^"DHN5*;4.-_?RFC$WC9&S5+(AI>[=$
M!)BE$LON^SPH;.. E-O'QGN2)$;7OF>5W+\J16WFIL2355_RMG6%!VED  @L
M- 'B+B\CB&\^V RO&8>(@"^7 M%WPJP%3]&GE4DN0;0%-XCPD?:5!WL:9N\?
M:]&GEUL_XHT._L%2N+.S)6%$R8])Z6V. I<<O:<S4PNW?-K7N62NG3,0[1_3
MMVS^G,N,B9]0%;G9;0UH$M;)<Z^(Y(E.4\22&.'D6I/Z-//,U:V.3!E$_=I!
MOXYU&W-.B<P&<I*A+W0,K(*"<OTKFV(X''LJR >+^=;], -,-$\&"*YF+(B:
MY0<\J.D0M>[O8FX<E^_!+4[G =@Z@94<;#0>.JJ4:OWI+#;']TA<P4=W-QS3
M Q<KI2$:A03)?CJ]BNH2NNH (W.IG*0)\P4)Z"?(TP08\R3$]E20T9K2,DMV
MDAY* UI4H"F;;/@6.B"OS;@A]6LW#,S??V/!@%#&C3/?U@MQS/]0A8X_Z!RK
M1^E >/B57KD:7#REF-.R^?TV?MAXJ4O.8#Z']KWU&2$AEN,C((D2Q]<'83WO
MM,G.1! I]->Y=E:0@T)ZEHEG#M.1B?>&1;Z0$T+:R<EE]NR##L8I4VI1,68\
M;Y+CJ!4V8'UGN->)XF@Q+KHY0F!Y$-)Z@SNJ;FP+<CI''ZROK_6'[D1J?_NZ
ME)Q5;QB]TA(+R%F;9[.5MNO!\4-FF\D@\H;V<*39;E;P&;IEDX'SW%XU$L$H
M=W%PS\T0A]BX4\(YG=A<GC%CLVG\%=WE%'A\A_LFIP,O58%\$WC9C]%,J+'7
M#MZZ07VS'A>AORZM=-G4TT\5H];$OC/4]H!5A'#=J:Y8S9Q;#<#IML)KJ%E;
M8H6-A:I_:#V[$>)BCZ8;).Y_3FI;_,B0RNBU[(_9;+_!?'3]@!H:R!0F_:B.
M;SJ,5R.OE&49(7?81P\I2U35\.=PPYV0LNET36'/*Z<IX"[K]G603^JRL-PS
M&'==?V@Q-@<\0+NBWM]^=0=_YC?_VWB!.\+2>_W[JR%RJ5E([:X)T:MJ"\2,
MF_"Z6M6$ $*AIJ=(C94T@5#6=R?C<7SK2GY?+,U3!G.I2"R9#UM\$GX&+K)%
MM/%CI&N7)6H-BO&!$LQV%MF9'?0Q]68"%5><X_6(;C;H2KJC!LFUX<M@HJ^7
MG.P8576,BB3M5XTB<X[Z&6 '6FYS)SYI.2??'H3J1#F&TK)G%<HQJ_/,).4R
M5?*3^N[!W_V+,46[Q2#1%U!)+)5S1V52 "B>KJDTJ4E^.4-V]V4EZZN?5W?8
MCJG9&N55+;\T8@#-48Z'-I*D&?4/*/>WPPGOW$++T?]1Q7&GI_U>: C+/:09
MZRL')CO]?&!L^SSF9U[)DR$[,9%\J'9_]X23:4X/-HCU588M'VOSJ^=V*M!<
M1W1?0 .G6%*!@303?,^R\:3OK3OU-Y$8_)':!RMH9WVY2S()A11W^%3X64YU
MOGO5BFM*).J:O85G5]VNF.)0"-HWQ; 8RC38?>KB\<LMQ\WZU*XE?]43EQKA
MTOU\C)6!6F&*\[GCM72JIHE4LL&/KPCDVYAN27JF(:VK(IDY-0*H![#$_4H6
MF?0[_@73W#-FG+BJW\#\2*1$_P>_WD#QS<PV3,WH._R [SQ8Q0V*Y8P,>G=R
MK6)CBETHWA+5F%HF4E4*SB$4\]R59=&D$::#)4%$TUR5B_<^I ;CED,16[7/
M29>7RQ,,,I2<E@EL0IF6 Q&N9GKQVUH,QD'6C @N8V0/P +:L#<%@8+_#PCX
MO>VU[J$M(%<X7BZ*IHD36[#Q%XY5DDROO9S&"#.!\V^1V0CO9*-V@G<FFG@[
MW5./9TDLN_*?-_@O"8#_3%5 E8$]J32I:3>=S9.7MR9O:7J08G0 DK2<V@C!
MNRKNE!-JQ[%RHJY]@/H?\'&:MPS[CCC#TV!F&!^^FOQI3B9EH<IQJLE%\5#Z
M[Z[SIQ@!%246,\/;.V']]<EC[A;2B"O<\&O+K%.]!'>%'F'<%BJV]@R'G#5'
M!4,8+ Z!()5^=UX#G>L[-[ADN?;#^^1IM()H(57AGBY7%6;IM!?H,9@0#[9G
M1[I13P4DQH07BU&S-,1^=TA%UG)R% 8R/1K5Q3/'J>.A9!X'\BJL@/.'D/$R
ME.(B.##6D5,/1M R%&R]\G>>%L;'9,UL04GU96B*4#,D511L0S]+.30<&5)8
M2W>5BDZQ6*:55>9D"]HQW7D9*7T$B&82=EN0\JV76IF^%3%-EW;P."ZAH?^I
M.9"HAEG66CN X.SY*23Q $'\'L&'C9J<E3B5_E7>#LJ0VL'/P\=H<_=7)9C&
MNKUW'$*QDZ7BI-<C2D2$FW9[S'=CMSU(*8-H7/XHE,JS3:D/(Y4EH5]']6K3
MTW77;25#29Q1AEPXS.Y(^K3GB00<.&@(J9-\JFR>)=FP@RR@793MX/)5O#GH
M:8$%=-=FX."+BNZKY&(  &\ ("6!GW,F.M&LV2"J.?&_? ;S@7\!8YS_ K+V
M_JF1*'UYW_$OH#3IKY@'/9F=\58VOO.AG\#D?;3(U9^>AL>  E>$OBH6U?WQ
MZT>K,1; T#2P2681$&.&%TR;(6AM]TZN71[3M?@^7<FDY"X7DN!&DBN<*RE1
MN)B;O:OUEQT A?O:RT,4M>1*./1[IP:9I.KMTB15G U8<\3PL1'!PB6[S9QA
MUR61V@9(")U<QD?E$@$+>[:-?_JB0M8N7._^/M/^8%G$JNA--?RAO)0N-;'Y
M;!9IK%1>H3'%-&"(ELU&=,.JL[Y5"D)6R4\U%OJQ43^QM">KKOA5F[R%NYS)
M3#P@=*/<&% H">)7XE2L21KL4,9Q/%"EIX6&C\/FL..GN6_85LF2A62M0^13
MQ3C)[,QZ;,1SP$CQ$LEJ](]E/Y6#]H&V%L:[4@7K=)JA^:L-<Q@N%O@#&W_)
M?.]WA_3YJYW/8C.3R3MJEF.6N? [EN.,N57P 8[#EA';]<->#4NMB)F:*O@]
MEV\)&+8=%(U=D<OVDNF%,S*KMV!6'I%E%2B4I16.@M*;*RE@ET%?&1V?*QPR
M4)W%PX@#$HP&D1@5J"QP;YOP8'=^29]5X:RS0J@*'I<BP%=&I.G@XV9G]][(
MX0;]U^L'FW)^BNF ,F]#S)\!QE2+K-/X5];I5.G168;F7M6TE )G(ZEM]B*R
MSO_\UB9ES0+3OQ07^&_3TFV\>]?',Q;C;,4BG^V8+4TGN_F%P<$^GI"%A^R"
M>Q$19>QLQ>Q?I=V0?GABGM^SH7'^HB..VY#^NXPN6F8K>SH_T]]2[-N;L)W\
MY;AM_"!J.B5;+4-S0I9(SOT':JA+8X5;.*VG)+ZF>!%1F&8E[R76R&?EB>KB
M<^8DI]94B44V.MM<^9S)QI;.+"UU>Q=X>BE;@-S'IJB8R2;%*XTKJB8) <<%
MKDC9:-YW#TK7'Q2OQ]*NN+!T*K_0E&ZH=W^0Y+?0WW>&/MHDUL*_3H>.:P@C
M-?KIM&5/,E:HZS5'##B4/K_G7^01E31D-(N[\9M3/R0D26P0<9H.9:":XE?_
MJ>BPU/KI.*$<:JN?@ZSH+GD\K^/^Z 3<857A:_RQT*4\8A.0I (L^\+$UP1-
M&&=_208C"WVO$)]X/4*\2^77W\(AOH;VK-?R</@(/[T)9PJ(\=,DD*VW1B!K
M1B%CU8=K'-_>U5+(*\FI,RX&IH6^\L5CHI6LW[NT.W=WAPNP;E@M#NWP\A*/
MWUZI@JX751:*2YENN%-_&WSU.E_,BJS$3)9F30LD]TJB2-57;_7B*'.^#E!H
M1!SYN#O35?J,SRG1V/Q_D-#HD&@KD(R9+7\V@RI#0!.38Z%JA$)7JZ0E@US,
M=Y38,29D!+572C.92A347TM4SG=:1H07T!T/FG^-";RYD3\$OKH@%B^>-S^@
M+(,K5IV.EIU.U0VB439#Y%V 'FUMC@>VT,'-RPHH7Z2-Q,9GPZ&%778_;73H
M9+> =_N:(EPD+M& =E B$9W']T\O+27X8(A=.R15.:J )0YL4:EC0"4!*QZ$
M)U' O5;;*\A!Z2P<-3-PCY]>I?8);#NTODHAK7.:OUO^2I6_M[QT A6_S.&7
M S<X))NSYEAJYD0UVS\S3KR,U]5Z7<RXR487?A40(;^;MDK)JIV8Y&-4! C7
M=FC]HHPV-&IEAF*KM\9E&,]><!Q8\[:"RH8E]8?BZ.&7HK;UE[<)GZH+VC75
M#K__%OI'2S4>/\)Y.G%HW&_SW;[/@$W=MGCA]\,0[]+17A)VF>HP)F,VAJ].
MK&DJ3XX;/VSR^[ ?3I]HZ(I;L=?ZA] 7N;G._]N=%S5EH4WS41WV)03[;4Z.
MI>'OQME$@E*44H8AR1V6<W8+NO95#LH>QTM/?SO<[VAU/1B*(!W#LZ?D:FMU
MCX3V\<V@U^,4BCN_FI4A(6BMMII0=>V[DGTJ&CP1NAP'KA/$@T]A2FQ\P>7?
M=6=.NBVS,$55K:<#BE^2K6!YP741ARR=X1BW&HZ:Y"[;#9S+M 36I"/UES';
M+RQ[D^]:Q'[1U9GUG5'= .S_!03&M,^]Y$<>[N)(Z]:$U;S56&6$OR'%Q+[8
M;3*=3)X# 4&'] 4!UR1 W<J>5%\^)C5]PJ9;98Y(R.1',YB+3+I=8=5&J<%;
MMS;7UQVTF<4-M8J$H"O\/[FA1>,RZ0-M.@1LY*OG%.&[X6Y.@K:YOX\;D@+$
ML-1-V3";R=@SB*]D"6=-8P(#Q41(Q'CWG_SM4+YO%;?H(255U[(@S;L>V?E[
M[A!"W?1R6"+>$.U73'"JBOK)VO;7FTRA6<M_ 2P6E8C1O %!T,B&#>+N8>0U
MS>]K(-/89P9I_55Y$D] LB7@":!@G!+VL!TH<9@4E9SX7/$$30$87^RK ;3;
M," R&FGVYU[$LB;)+=3T BWW/PH;@Q1R'7M]9XXJ:A%P/-*E8.$'ES_%HLQ_
M\ U&,SC)UAPIFB,P=#1:TXK#I"7>(?VR,QS]0RF-71,NS1QF9 ?@[;%$D2"V
M'S_>F+0V-_G&*EH@[VA3NV;L9G,*5AZX5(FI?.],)&OW$#5-1QAKH--)95O-
MK$^O7 IB_/UX0@*Y\#/<L^-[/]'Q$-'3_E^;_-D,ZB!A[OHD-2MU)WJ>2(WH
M ,M?'9%4?6KH3J .G$H7.E7LV A-8++F=\ZTA[U *2V*/XR2[OW:.'ILV0<R
M[#J"5#:82F'P'DM+B\;%V6'#<#EA[Q,DQFU@*>%XIQF+(Q.\QJ7U2Y[%R;OA
MD.B:;8I&#[=Y(_N3[/=NC=/2P&1U;Z^7;Y$+="NH!"3)&:UZ9NRT5/3&Q0%D
M+@(YW+>_^76;"//9*7\<%=>Y][VA+;;Y6#S/*-=^D@OL?Y'"*N=<N?UJ<$2<
M^Z-IAFEJ"QMMR_78>7H%NUWQ;/Y? ,.7#*FO:J%0V'?-ZPKMFD5TGJ?73RHA
MY=<_EQYNSV__@3%TS5JXWIE7_ MH!?D%#?&EM(*_A=R^N->YGWGHQ#IONDCJ
M)OQ6#3HB,QVL,E07IZ;TY_',B<<46=&6BPAD":@7-N93HL7M,A$%/7HXZJN)
M,77?\C9/GHD?V0D__N,/HMK988\J&S+A2:&WHM1MRW0;!Q":FXO,J?L5TK5/
M"*A83(_:^($T1VMXP+\+O;OPV<M15I8,9[J#-R _C')Y@;;W6$.)"DNB)-'H
M;BE%S@?BI?J?<D4VWDY/L4K[4^*+GS<U#<V$.5WZ<,3@& SC'%4RGC(*\)K/
MVS4PH08KV;"2])M<@ RQ/ 9S^/H+98,/?L_MJNM/(8]^K8L3^JL(;SEB+C'C
M]0+F!\+^4YA*:[6CI&TL\FO9PD_MR.PN'K7L/9TT<##VFFK;,YBEJ.;)=XVB
ML+#!N7+75:Y+M_K$X(=S3Q7UKS \I;9?H8=_C?P;*]SS;IGF.S3&?Q,;:Q>Q
M6Y@W[W'Q+YF/GU0L6(1#7'+KXZ8^#TGBE-]!M-_LGP,37GM//L:V-'1+XIQI
MVCSYY'LMKNS\/?EQ:?Y/4-&J^8\O?SV"S_XK ?\*_A,2G'(;6OD8^N.UK]]X
MC?$AW6_5DIU>9S<;(J2%2Q:,)R^04%FBGJ <^B:P!6''8_7N=LR3?*$;=LL]
M3R;8LE?G+^#/&C^35:B%=K!J4_WP!K<U%+KR"$^<G89X;L[A>[6=QF?5Y I;
MF7HI\G&&?Q^WPTQA^VI49@2UEEG$_G/*$&^%$8JC6Q#*&@>GD&'I5!2,[<#Z
MA9)%31_YF>7#AN\01MG7TLNE)5.5BB;_&[X&K:T;&/3T=C?;77A.>$X4W?!@
MIL.WL7W.^\BFX^"D\T^OUZ@#.9TV7J/X!PJ8V/GSZ_$3<Y[,_+ [>W\_PIQ1
M,J8_D8PP0L547 (P4]@Y5D>58 S'??Z>0ROP_7:?I9&SBB\:ELX8CV'(VN75
MG5T4[_(M&:]V.-Z 3]88E8EB/0.Y47>I#?G$>#,VPP)QHSPY+73!:IF752A@
M%G4,)_D+B*?,(P??IF?I=%1OFW2E"GBFY97U6%_V*MC^W%,0V#)K2>H.FE3H
M<N;#L:D>L86P">NDWG$J(1L>[+=@6N$<%D2Y8J<H2HI;O7EP+CQD^=TTD> (
M7W38:H%6CG1P59CT%S )7?_": ^GB^A_JN89LO4Z4>@K'QFRU];,#%1W1G7,
MA[X)3U.TV6I?$LIK!Y-\"B3MKOJ6G9(8F")Q_&8?\:..=%VXZ79@$_?I+?HA
M\N*[:QOY0ZQ?J/1(P/ .[3=<*)';=;;6P].:!28O)1#XV]O6%GE3HM- )K49
MI4"4_JG%=C'TXC%ZI_Y 845;O5S7*"J3KYJ#(!,6H86%I6RI$@; "@#H&\BL
M_/(!4!DIXW8B4Q-0_?!$DZ+ZW33S&#BV\5!M,%93R\,?V@Z9:3ZIO<@>H1&/
MU7-J=:_]=<!2#3KS=5]976C^5%M_Y9J&S5YC<I.QJ.MJHS82%#B26IAS,']G
M\,ORRR?0Y@VE ;)6E@SR%.O(EZZB?(^/BG/IWRG^_YAS#+*E*FT4O( :1/[3
MCQ^W3O25IW!#]CJWT?AM:(@7U%F.M$6!L#]Q.4J3\?K1+ QKY"E]OCYEX:YO
MM$D'^^Y(<WE>RAJ.K^1H71XS>I^7/,W11%M!#7B44^5JLB[1' P5^9@8*XX&
MG@0.**0CRTCCC5>.<)FRO)&92$'D=JALDTQV]M:BHBGZ[IS@T1#Y9_=WCA(F
MZXTNG#QHJN#7CVO5Q<;RO7VU_NGQXU"++)X.<OJ%12.LQO5:IWQ,<EGG.D '
M2'#J;!I7")T/4_]T>;R\%,S(;&@HQE>53##9J!BDD/F3%XP[T1D!X/2,$#(Z
MT"'=H#%>&ADH>(#-<"87HPH!)JP _<KT9O!!)VKN.#NW^!1I:U7]!1W>SJTM
ML594VJCXU ^?M%?R$<L%TQ1JF_I^2'6L9S0:!#Q!(.F8=NB*YJW>IWDB;.->
M=X1]LGLZ?X=VN!=-=$%8FI,>FW<ML7)BBZ/53R]5>4*Z*[;XPTM4!8XR[F>L
MFBTF12Z9I'"*'\WXA?)-BNK=)2M8\;#9><T#,H2(&EQ;R>!O968' K<BOMA[
M*BBB"A$H'\IHE6BGY\&"L^I *!^OA7%[4-9JZ2 MM#(LNW7QS;Q&9],VH"#3
M/EVM0J%QBF1Q##&0XIOAC/N7R","S6>0@EBL.\9QT1XC$!?H.,)>>DK6(;=;
M<TPU/4O#/N=&H<3L3VI-Q413S]B7FZ?LYFR-BE0%-MUWJMD5M.'42D3"CTJL
MHYYFN,7@6PC&-LK1\5IWBTOLHG!B._?U%?O=1*4S@5.>J[@$'^7OA9-E;HB-
M%FR\--*=GN!,G' 8Y3<G=^(R @CMK>]K%&TQPE]TZF>FOA<YE;O+E'Q="1I=
M77A.W!TE'%WKLU=MX.6LX=3KR)>!-<+$E%H>"IOIXNE:#&JS4!IIQX<3U$L?
MR4AU[99I#C"NJ@Y_Y(IS-CK[H5DXT-(5%QP&0J1F2C5::D$AJCL:I+!QA4=+
M*N*%*(:,9XAOEH+Z.-UT'2;JB_8GL\E!=!HWH+GZN\M)C;2&-V(2=(*/#!E4
MUWM*5W'06"X#> 9!TLI.<M4MIUUOH"<QE93!=V\;HA1^*Q$NFB_DYNY&KMIW
M?2562+30&2^'7/_PG&6.BV=O/OI,.3!*TVB/MUI,O%!))"IU.)Y*\T4S6U15
MS4B.[SEMDFU4KBA=-=Q]14V&.DY'*$Q.;_6O5\F!9%JM\7K3;[<4QJZZ?V:Y
MJ, QF0,U];S4U6=9M*$@TZ$&E0YO*2WIBTXO[^-U11R#A7.2P&.[7YYHA&OO
M!!$MLYM.*GR*L.%*'$VMR1F05Y<M;!PK&@<  CI8#L "^6 C+<5^#GRJ/,CC
M!"#726&EQICF,E@YJ8*6H/$[C>Y8Q8&+)W)>^]O=(Z_5H+TFM9V_Q4J[42R*
M$XDCUUY^WG[(5,]@QQ^ZJ%D=[_,H_]L*?RM*,QU/6:;%;\R;SM5-?PAGB<=N
MOM?X'$7 9"_'JM6IX\_U-.+?N&ZM0).+D27^0<=71_N41#7:LX G.C:S-C"M
M(UD/>02N5-(J,;2?M9!IF[;Q+K3]IHUT+5!B%V+.P$+.CNK[K3#YL[DH1LHP
M/&50V7*N))>'8F%[4FWS^]2V^$HOKA\A<5),MV\\2ZJUW5=5@?,X6I5623YD
M<7XT0WS[3(C^IY]3;P+J3(I)ESJ.I:#K,IYTO\4H$[LMV?78?P&&X:G,^FL:
M[6:=.>M>!=S.EXTUE]7YEQ8TK0YWD'H[.]F-%5(K*ANB/FI])L8([<^OE\GD
M>;R!NN,%0P2XU^R]$F7+Q"4F4U7+<LU"/!/ 9L;_\D!BDHTI6B5U1I+34205
M\/WE7,R(*&P[S.&,3/SH?H^Z<-QFC)?P,]0;:C=#\1B7S".SM97RTK#GSRU\
MZUYQ HH&$_H)';"^E/Y4=+JG;87KDC",QASW^R6I[='\1HD M@OZ B4*->GH
MG4Z2J8"R-.5ZA?4K)H8C]_VRL#=_7O6A>)V1ZB;[!IX<,F$D:N_F6CQWA'=Y
MM9PV"AH6$HFCF<-EZ.47"@>KB%I3B4_&&<F4G$7Q[V/<V]U[K4F\*6EA$MLQ
MU7:YV(*<4DG%Z8(&"TMU=* >WPQP7D':GR?Y4Y9LI"5C(A8AD$0B4U7],2GT
M]S5'BE>1I9E\(J441-&3,Z)*VVC/';OA/?51TWB%\29'#257JOSDJ>,509KT
MNW7O1K^G@2>BK@]L5#3S,DN! 25XD=%FEMX$Z GLS5?MB=]G,3YRF1+HX%I4
M-SNQ^!K2\B[C+#"I) )KHC.3'(WX U,S(-R7D^'9A#GM<$%[W<YK#MH(7N4I
MP( X4MMG!,)UL1IG&8/5*D-?H&WVLAIN8D,YZZ\;\A]Q'.O:$IW=<J 8XZWO
M<2N2^@+IG/5Y:RKT/OT]GWBJ(0P6H!.T\,L]?Z8E_(^*(";4CO1VRNOS;C*I
M?K1O7I5">3/:9[V@_K,^R>J$VX0SD%_)1R]_FFS6SOX6=CV30VF"E:I\-[[8
M?H+<_E6Y8+^N+:_O88M,D7/K4YFX:N]QSRU,?G5I[]HRM1&9(PG8?QP_ZI2,
M>^XU>K[9$UL B@ZK6Q3_3;OV7U%O#4HL(W'JKSI0JVNO]]6UA:R @/5ZL\*S
M D,J#JY'5&ZGVMVEH1D>A=N?KVV-GM^;UH#UOH(%4[4%4XTE2<%Z'2ORF6!U
MKVYGEHJ<V;S*_IRQ38]ZG_K_^0S./Q*98^KXG+^VM)./D*LDF_?6=6H"UP;F
MB(R$]H5/LBBIC-4^UMFDY:2YRN%98,AM9C(R$WJCN]!/:E;#MA3:!=-<GPW+
M?=/:WWC'F"YBG8#R6@_LOLGKCPQ8J\5$>9]"-T7#EQ6%PF@3;SD(*>/UZ/GO
M<-F  '7WIO9KL_Q*=PZ#9/H9I+9FUOIK9?X>.J')OEK6M,/W&#QL$IR+BF-0
M]":*S>MI$GNN\Y89=%)K)3NC7MN=+0>,<BMX=CPV12FA,J,/:*%X5\:2)*L2
M588A(Y,)YAAA>6G=BMTW59(JJW@-B2!) [3!I1G"Z.\4CJ>(&TL?T5-0>98[
METI+[]EEV*Z3>#'^A'F*]@C/VLQ98+)$X&U93:6B1W:"S02-4]<O%KB7P.LK
M3V/XU/0H-QS&\WR-=ER42&&6R@*41H2#A@8TA+FUM42H,5@(O0@*=)1J^@?N
M[,\)L$#*?!^)_O_]Q/X%IP!640Z)=0U&^#+]"K#4"ATVVB/,S54##$>WZ*C:
MJ1I'N^<-SU$!3X;7D'<NX&QN_:^O#:J?7?YKT<>M]Z6['\KO]A8\YM=94@P%
M7O<6_@7@O03X!H&?TSJ7 MQ33ZUA3)EZQ@1IR[CS+44Y5P(_I+Z-Y)@(&K7Y
M>#@!C9;)<Z7AZV%@CM#\8[D.W3H(F,J+T<=,SCA:C$@R3>=-%@M'-+;9J(<=
M$3CM>!29AY:*+DP,E/@U#+?H)KC^M'J;'IS1\=1TA;]8A.V#=;$V(N@A0.PL
M%F2!LZ8N *Y<D4K4ZHXSP&LO=!34!E=F8=H8I^G9LENW%*T[($UEVV!,=@#O
M.9I\B1B4=II62AF&8]CT(KN;>0U*BX1:+);QARQ][\#>X=,X 7]"DT8Y,-$U
MU5,_.[%RQ,YCE+@64@73@Q]*GC V=*DDM4)YCCSD ^JC>X4^DH&[<RFM$QS+
MY6&]<(A>C$!45?8<J!Y6D5^</3M$%*');>W[$)^<7ZZ"T,_(+-_$M.<*AG!$
MC/YPE#:YRI_3OU+;X3BIJ[Q74$9H/R3R.V1P!>B,T5*[T@2N:4?)G!L",S($
M:?2"D@$'WWJ)]!>579-)MQ;."/XR+KPG\,!Y\2"E*L/ZT3/T#">-KDA#6<Z9
M-F.H<&*$@=ZZ;=DM(8^Y!301A!]U-6PDL HE1R-J2;;\>SG?Z79VUTY+E'-9
MHJ5_:D(_W"R#)/L^9R9MZ221*NN&OPB$5OO5*K$W-*,VE:UJT(3VX.V,];2;
MR5*=@6#&;F*']U"430_,E>^<%!)N3%_P;$C")IM_^?[#$;U<?]Z@4)$E"\22
M8TOZO<X^T_I0>TE0M5,.8J&.S4!,5=)35[RMZ3_LT;D//8H6^AFL-SQ]M7IA
M(%+*_'ULHSLPKXI'+9 JER0"NR!4P$3QQ(QU,"[IK3:XK]O;#T)0TP:(Z%:R
M2;*(DIN*O5_\@K56P*IVY7MQ2$"K$>/F$7LE$!1BJUHIUFRYK(DE?7-=TL8H
M59Q:#&;6MTU0-+.;G\/7>=6P\DQ#Z"HQC8V^6HIQDB%7*ZMK>=<H@Y!:U;N/
M[ :-OWG+&>5\ERY+8FAN].QJ-;=CB%7%K+EI 1#QI"YZ[+5!3A[1X<^^"^1#
MZ7Q;GK4$:NWGS89N[R_P8UW,R/AKHAV6^EM4I5H4JA<NGH.,AOCG*O.T21PG
MJQF5]2=5K-P;DT:P$\!EN?3@]1-3)<911I5[Y9&PY*II.7?4 %3_=QW=,5Z%
M?I-3]8-Y$FXB)2B,S.O?SZ896P(0C2N^OEFW!-;<GD DPQ](H);5Y&CW"_D5
MJOE#+*4]*5?_!=H6N5>9@UT& 1Y9/^T"4TVI&'6#1/WRV!'Z)$Z);G8_0L7T
ML*3F:!3E>9YE1H'W@?&^Z?*(F25)(6R.LJ;Q^28@:J9V=AW,X+?60(GEMBWQ
MG(=HT_^XO:_@AGV6,E@[NDEO"A[9G'1)AC\]+/Y=6E1!PM0(56F7$E>K;LA6
MN[%9QU-C;M!%?G5_Y_>BHJ'NW^^N_%35P,L:3GIM>+78@G??_@7<;CQ[#LT1
M=;+5"-7UU.".NN+S(C=^_&!:\Q$S79$O.1:-;<)O*@>]U+0FX5;R%!G"GB:W
MTJ[MH6HFQ+C$M:;I-A\([]2O260^W9.XO-R]Z$9J.%XS^Q=@U73WZ[A7\WU_
MVZEM+<JM"HX(:_N!4M,O<QLC]R..ZST,KLRGV5\[-,S]^FOL-J[5T/2Q_L(N
M3:J;@OL"KW,;LY:./(HY+IN^^ZN<A1O35P=:'4/?94.]Y0U@'[Y)1;=;LU/0
M]*M8T,Q]TE5E93L_5!)TM#@KL?YXEF2W//^NZ2=&.]L66U7GO(+NEOJS,6VN
M\B!>&M9<O:HX<W06@7YZ-,'L;AMNYJ3*14VN1ST]C[O20.K?FE'-/X/O)5J8
M&)"B34J#[L[K>U\S+5TZK[U7NE4JHQ[@SJS1OD/Q#B%":UBL^6>F[H60,=[^
MG-FN,:&UN88BRN]%<TD/WEUK_Z\I3U3T+^ :N/8O(*KLRY^"'Z#"UW\!O=]^
M4LP=0]HN1],=UV:N]T\O Y;5DLYGG$EWOGH:Z@?%5H0AC0$5Y.)''F11NSOM
MN>VHC;WQ:-K)DD?2%QRJ[02;BY; -<GL8G9V]AA 29$R& <_7XPX:6V&N_C]
MP$P:>JIP#-302Z9?0=8(H$P=UT_AXS<GZDR\^BFN+V:U;%%DWJVLK[)-[+!?
M+( ";%2=8/38H[6>IKF%8.'Y.%W9,6T1E#VEQMA^F3[D=!8*7AYJRO$G?J^*
MH-5/:/XL!!.UN=,,/H$QP#I5D*:>7M*0T7ZM]V!)<6V=Y;,60/+78 -+PPH,
MFM*3MB='6KU(&0+<.F[%K.+)G,Q0#!D0@3^)LQWSH+/5)D[C^;"#ZT:'5U9R
MAWQN]K%W @VIUJRQD\YOK)EU7IJ50@S6SA;9\9()$Y"^$Z+-4YGV98_,!:;@
M!2OJ47[320H)_]$.KS\'S6T8OI1E:2X]+6A_JWW>Y*RLU5W2=./M[V_X(L5[
M?G.ZY;UR2Q),3?*E@[_43_$O9Z'X?;ZP]6^!7.Y281/Z?P$<5A%;'9_T"D^8
M>1(Z'2LV;91$U5T/F'F2_9](9@6V9CINC[S_(U_?F%*V+OYV_0\3VSI[D_2Y
M'=Z[K)47LOVAOU<1@=#>:%[7O]1HGX5F.!;ZCMT2>_7SPZE+H<^&K@YZC^U>
MIX>#W4S)?Y(_>E2PO?K?Y*=3*1CBF0 '+Y-S' ^4H.G._;=4+'-S-\%=2GH/
M<"K!)\@+-'--7>O18?7,0BA@NQ4W00+9.EXR["/U!-P]7-#V?AWO^)^YE IM
M;^__/6I\GDD0L9<HZ:]U\!>U;!J&(R=B(&J;=C\IE9A)S'0%$Y-]EG/)^'B.
MB]NJ$Q<Y-0O(-Q5UN]BKY7B[<T&-6A-Y8MEQ)9\4F'?<T&GLX4+Z3[RERA].
M >-RO?7ZP<#]S\+!R\%5'A< :8F=C5G+8-X017H+>VDN3)%Q\PB-[QLX[@?]
MYNC02?^ L@I>6JE:.Z!V56NIM_S/M#%I,BHLF2Z='G*Z1^">W6#K//\S%?.'
M+J-"IQP7%[[(MAQ'-WN4!!(%2W4VL_!U+D+#=>I&?$_</$"8Z_KQ282X[R;L
M3+M<5C6NZ1>?A G3>ZJ+JD.&=24\&B9F'M*1@!;R$C#?%T:VZZN,1+S@@L3+
MZ1C^6#G%FL49' VJ9=IKVC@@T62)S'89#X/B@KQ6T[TP-C"QPX6PE51[$$!D
ME""$ ?* !9;>D4(Q&AVD6;E \^F8;'FD48F'ISY9:'&"F>T9)R\C[;"R0%:J
MM.6A*.&=PS+)RDU]3WA"5<6;1[^/#14?Q21[4OU0U+L>Y_8UYWI.>GZT78H8
M=,B^QM4/_]T?1VGAA4LO!$^[3-:P-MO-*4MUC)3H?NH6@B0FIIG+GV",N_M]
M1.QWRI0,%K4TG55VS&%C:Z R$Y-RKJ:98[V-:B7&?=Q7&Y@I-7/<3["UJLG\
MIOMJS&;)5_[)Z7K36QD5!>YY]P$L0*F#/YV+L'_V=ONOCDJ529),3=PL#5L\
M47(8WY9]':IHDCRF("\9E ]GL$6;P6;A,"E/BH" FF%H7413O,.E$F%(O4$?
M(]G#I+_^WXWWEJ_+RYIE3T-F#7X>=[)UV\HN&)2A05)QDP8  !)A /*[28>?
M;HVZ6W>RD)"]/J!?;V=LO5?%[AIS%9,]PW-J9N^$S6(P=I(R+BIFO\1F\7AB
M@?"*>OO8.H8UJ3(J*$[\K;G1"3UT=H#W=U(D4QK8&LSV_=0&5>N?%93PM\#I
M7<$MC7&Y/#(7JHYRN*\P6^H,'6)G6'V/F34G"&IOIT!D!A\!U/*#:Q4?29"Z
M:18-%DH5O=&.3=K<$WS=N O&N8AR]55.$\JO<9 J-AS<]U5VJBF])*;\F+"M
MQWIN/0(B#82_J%2]AYY*?+-V/].'ZR,G,BK60>+*2C>57HR_E6?W^!BE"<?6
M..#>A02H.M%U*YL,K;*5&3<M+_&$18U7Y!6X"MQA!@T)7A+W^$N][/2\[.Z\
M?>ZY\C/J9N6P@U6J=6WH6USNW/2_>11TM \(VG E-W &;CAIG[B"%2M9'D5V
MXMEYUM,0">3YPSN9(629-7^+JGS#!_#5,R%<;X*?$ M3*P:J;GIC>4Z,&-(*
MA'6, HX<0Z5AM(Y_*  8PEM,M<Q-NVXYQM '8S#'VC8!&,[);]C7>FV%65R+
MM%+'L*M!0MDYA9JNK&KY*P6\ZGVI1WJLW[AL78XV92[A^VHZ7VP8-UG4T/,;
MK:S0 ?LP\K\9TY+O4>4D= O.T(&M=9*2D$0(A;U;-;UD =&,;X5QX).V(1H9
MJV)89B(=TAV8CM(W,G/X6/D*Q^,G;4>R6]R/JQ4::]9MF4N1&,8$5-5U726D
MM4$Y&%CT0;B*Z$03V8-0JB;GG6[(19DCD2!627S)I6N:IC<8F/8_T3M34)#(
M"QKKD@K30MX'O NC01HX^J@I'@T>X6\59&XF*VURHX!-$CW43]^87F![RPLD
M6%@]OZJ^7WD3_3S[OGZZ"#=\@O\&]#6PF;,-S)RVA">P5X2)KO[D([ND0%R@
M4:A_^0,IE7&Y5%L^5"951-#_N^OKA'\]G-V -56>G\F5=]TA@-*CZAR#4>@:
M3&-T)KAY&[M5=KPJ<)M5V4.I9Y%NU51*>KS9W\+0LTQL4S44A@^MWNB^U.0S
M)Q%!,#RJR5TK4 T!T8O6]A4[PC2!/]JHZ%DU"O;UXEGS5(5RL$%-4R0% <OC
MHW_3]&08C)'V2,=K@/9\8Q'K!WR3:BDDNM_YHWF[E0N$W(K9EQ7G&DGJT@*-
M,K0()XJ%]IHSXZFU_.@)':=$/<-^+N.IBY/U0TD(LXL;%S-PZA7"F9_58&[Y
M_8X;^YF"P3<WM*XK4\)N>CX5 :W-<1HE'1GV2\JIJ<$=6;+%A!M51/@D"NM'
M8@Y)XPRH<DA\_,F<C@8]Z)W-2#3KDBWJU,\L'G34.'[Z@RBK[4RA$S\U%1]+
MXE'I'JC5UTF_NT3IO![LGW0$[7;;<?(K$:"C$]9 D<0=40^]3K'BS!1#OG^B
MID1I%FBB98DY<AN1N)\J=?IEI:A3JD4E-_5NV O%XD-S=\T33(G50E^#8Y$U
M18?A])K>!A-#1(=\DFW9@^ J.H\.8?LZ5@W>5&JMY'2>], H5.K^)<3TP9A:
M!4W%]7>9<R<]MLNDH<5PK!'ZX2G"*1AC>6<:ZEAM=MRM9CL3[<)2PY(I/$=I
MWMNB!/2H_D#!,\Y$?6SPXILYK7)%8G>$08-R4;?@>]O4:%3DKR&R8^9[\.F'
M5M<6I7DM(R:E:OOJ3NN/;>F)_3Z3;(JL.%JVFN3.RM5;5^O-;9IK4AD:A67V
M(@V0\Z^RI)T0PS9\'*H1:':9IV[563<--<?$_IG.BPOW\2%.-4N]8%)F3M"1
M]'P,M-(9=G68P3C%?8%)B&ZY%5'=1%E<MB%P;806WZVDU^SF%Z\X9^?;G+H8
MOKR)P3@.'^[SL#"KS1%XEY<SX,TE(ENU^3=+IY]J#R>=EBX*7-]#<V+3:&]#
M8EP\P'58/BB&0=D?YTQC8(*]D$@C, R4^*M6"[I@N:W<O@B*VFF-KXRWWS9)
MY/6SG/;P,6Z!!.TK*N=PVJE*#=[I.9E^;\5[=\/9B@<HD:T5I$3PLN,R+WL'
MZ_ZT.=DG$?F%UH[_Z;HAHMXYQIO 5(5?L [H]?>$9[79*.&L9 I;;/2MNAA"
M+/+)E#:N#4P6.W_#1[+LHF2A(98;R9"B3ZZ#>63O#]9O!S>KUV/!F)B!XK:W
ME=DLYZV5Y>P;&.IWRCI&VZ@&T)BG[:Q6F5WD8E!IY^A3?3#F?32Y6*^5&2PO
MFU+&>+Z:,%?1GS!68SV5W0?]HWEB\\ZPJ_.EA(%"PHCEC'W-R!HSH;GO=%[Q
MZTE:DN',=+<-'5Q2(M=H^=(ZU2!@YXA>VD Q\;-.HT:36_C%JYV<CPV]DM0O
M<[V<\1AY&VJX,K9*'85WLV+9T[*?$%'/:#+;Z<4H75_F2Z H-?WIT8RL7Z[4
MK"OP!?$,&G@Z]6WJU/-\.<(@HT D<W/S"GBJE_*5^5%E5*?7F5;-7[%R_Z)!
M670#U?48G KI0#*3>9K%(DC;10.&<LD;$]KH_=BYJAJQ;L+](PTH=Q? J%^]
MHZV=H.[H, ^ACOS A63>_T'1:,&*HQP].7Y&F4#61\*<[*P7;=/O#.F2+")D
M%EID)\GG4S>&T>.,#8N>E.AU9$OZ<T(R%DZ/P?S35P6Z_XS=>>"LNO0R_1;+
MTZQ:.3]8#(4VM+H(."BMQ,T=2-$TCAD:HU5C38_O9X9GN_5-;/_C4UTHTD;'
M4Y\ZONCR.75B>7.+-;NI<P>#TZ8GL?\[J/'MD4Q0SX\=-%6?ZM3.=1[/>Y_H
MWFMZ#=3WP:]5&CABA".EAL_EX=,AP5*+[V+6EUO&N-J-K^ :VZ*>_9O?WKV)
MCS*X":4\1>K#WUCU:7*+L.Y1(XT_Q#G_T5"'5)B9SC3,]Z9I/(*E#GZRW;01
M">KIEP75M^+WJS."UZ 1S@Q<%#$B*,I-50E:I/JR:[W2*&E@5D!OV3VOK7N/
M/9G^O;]D9"95XL#TMPFHF3W:FCU>/2:L &B\JC&.,V1<P'G.4<&?QCFXT'@4
MJZN6:(CILK/?[:;7]$LXVH51^>N 0..EWWREDD>'L/9G5B7>I7\!]^8A+&G/
MKR<QI68N :'P=]9^K)*J\/:*@.R.MAZ@FK^%:F15JMQ2#9AU1Z%[(DZ=&CK,
MD#1C4_5<P8RGEJ R)?]"9"'HB[\BNN+&U% L>->. O'*D$QA%V.A2%3761B;
M]=UI?ZN*B7?/>GM#5JKZ6&;29Y4$!?4CERZ4K?9HP"7]XU3N;W;Z5T5+O2'1
M#&$XRO0^S\3KI<G_W/MY*QOFK5M'RW37&QOY]XO;3VSIBM5AIKBY>9+UJIC.
MM9P]W!(388Q99O2+#2FM&]$>@D<NJN/&FP 9B="8.HK0G9*TF@PQF98PJG2T
M]+2J/S^BSO]HG?\+D/_#\05[Q>G3DXM&==W*# OL0A"__ [7/T*^FR56%[2$
MJY8[6*T88$TH0PTZ99\<VO&9 'PA*&!-EJGWMH;*%\@3.1^M\&;P<=0/OE<+
MFS:.8^_B:K[W?F%L*DJ]*74\RNZ#(!H:;^QD'?S^F&:EN605;JX(&46B<^8&
MWF",&Y']PML@6S*\:T?+#V?,27)\\@2:V.S_@W1H@O%-X9-6=T' 8FA*>Y8;
MWC==PJ4 I<04[!B*8VVL&T=@XE8OA\$&(B K8-H@36/.3:.>\I-%8YF9NH.V
M78+0I;/O*<0:[Y ]L]LDC)MK5-E=-APFU>U\_EO(8#23$>X^1<3LKD]&Z\)=
M7>Q03!8U9[0"HU/E]_=,5F'%CJX)7_<A<E/YK#B=M#)]<=X!524F+5E,YM%$
MNV<__()U=_,1^DLXUOD/ZZC$QQ'??L[Z2(N#[H].=[];-P7NXO%JC>MPT>J.
M'/L*CA:XHYD5$]C5"+EFX:A653E/W3FERS*@#RB:.(NN.>9R5>]$X Q'.-1!
MK3&R943"0C+VXZN94;HM&H"MU"WMT5_TOAPX;$R4U@H;WS,ZK"!3O\LC=A7H
M<,8QF^KVU6SB4=VE6YZ3QS$D[4O#(OW8_@5LQGP@O)<T/%\O&O*C(^M'!>7N
MN+: RQR+M"18C0_ I?.T4G#_0DIJT]=T?B4B#('[TNA"C8S/T_-#N8NYT46;
MF3;Q>LK4#JT*57QJM 1,;'$L\\:)/80G6C-E^6\2CU[_2W;R:6"A']2)BX/0
M?63B/M0FY]B6>9J]3@!1RX^WZ^6:GW&\5W]1GSP7W"!W-V7N3[PY<^K_N+ST
M2],TZ;.<GHP=K9GLK5E'"$1P7/"[$$#"T^?J()58A:1&G)(PHO]RDXF^(_/K
MH?1QX=]F(V3K9)%M+S!)I?;#SJ,C; N3^T5BU#H-]\ )E^JIV !+#(UV?U51
M0&F[IWF/@FY;-B66+PB^?N@XWECK\M-F?^QK"(QB@3XU&.&M3L3OEV/$*9')
MNM>!"G/W(= 'U:BP:^W>4%&#]5VFFKK&=0(XHIP_\W%QA>(UKQA'^J>SU.4S
MD2]JS:HA\<_FI6:Z99+[D;#M>%/N>=<Q*3-?7!X9J$%0K#I\[3(H):(8:CGT
MVR/(]X>3D5QN9HU/%+F6LI48C$+O**7%Q1+.:2*9?:C?:>9H?79T</G$(1 G
MU&D;*M1?NM;DPZX\+.I(6Z$)1$ON=K105C.S9=+,&Y?NPZ-D:"!;(GQ6<DUO
M,\&1R8,6CXUVX<[.M+4^#44WTO8.Q*"L-Z]9$@<0%VNWS2_D55$HQ\C>'@MK
MB"7%RM:VIC<V#$J+RMX.))_ ZZ=4"=)&LA <Z\V"NSR?-HG3%4<&\DCW0*;-
MRJJNC7J4WTW&B0.;DW7\P]DX*FA[9##7=R)NW,N@RT>9UL?8Z/[BL:1WWPIE
M<C@V-<I"<"5"WO.(+UCCCJ)2J_#NXL)D]X XYC-9*6SO=&9&%GIW;+*H16G8
M!?@L7.7AY\UIP+_]$\36,SP!G"5L6S1*Z&>0FW]HGS(6@)38VBNE.I3*LAG1
MYE?3JZV.Q-W5R8]79A,UFO1V,#_YGE-\"NK^&T PR:"L^W:D]?J#CUY'_9\]
MD?O_B[!V2H<VU-P:Y(56HV'Q+"D)BH,D[S?B"K00MOAO!>@MUI;8P),Q5?KK
M66LR9LOI'Q2O<#7EX\\@3E9D-9<77"U/1)2,JQ*U*,VU3G"H6LC'$+N<A+3;
MS.'J_I4"9<*GRQ@]:):#]7N_&]ND=T*U%AP!^Z?7WX-'=04[2XF-ZHH8HZ*1
M-ZJLQ?(^@0DH15]#.RXS3.+<+,&IR+5]"P8#K-B.GZ^#M^(DI$NB=2!Y=9^N
M?[@++TQ:V3H.-RU]I.%#-#N;N"5H7J+3"[^+3IB-7E9:QJ.I(F:5B-"FO\AB
M<(\DP/U\M>]#7!'<SSLO1B#9YC]NNUAB%GI=9I:S)>3A)8%N8JZK2J37BF5!
M_Y'<^]*:HD1E.5Q9>N))V#^FI(ZE2DS__& :TW7U\7R"GZ)$7U>J(%LQ%2V-
M- E= 4>(APC5&RK3#@$FQCTSN<J<,$?I8D-@49G94?8<_LB-F7CM>L(#YC8&
M#9XF//6W!]J<BL#997Y3O_J.7_6E3!Y=['Q69!G;<Z<WF6V([YH.?#;T)<08
M*_80JZ]A1CF1K8H8Q& 4[=)FAU,N]@^8CMMCP&5E(FT*#&,FC""OL 3*E7QF
M05%NISAL8U8D9FS&>"S9O-*]T\U%]\=O.7$&^ES6:Y-<2N)B_MT".E]/W/CM
M)*H^S3>(0U>HI7")U7_8 !_%5.H0(&T'\BV>+OZ"*ZQXY_YO[GU>S+3().JB
MB7;+&G@B"#^@!O\9%;B;.T94;:IB6?': -78-A7K[>IG6CQ=&>KXIC1(IBFW
M'<[$"+M8XI<^_Q9D(J"$<O?=-IAL/IK.Y2$"%6I>*>Y,IV2HE+?YM?8@)&KY
MFV_I2EL3M]\'^G\R9&?KQ#:ASK\SXK2&3JP6D.U*#4DXQ!%@KL7Z!-5$\ (5
M(#C6CN3\JXJ!W%(8A= %E7(&/5'V<5$55A-2@9S\3>=6]+N)([YDSW&QM%3!
MV:8>,DDIN#Q)Q ?G-%J%X'9U) >@V%OSO:=7]8C5G'WMAL)3_FU2*KCAM['Y
MH#X.J^>XI$WC^YCH=;TM%@/2K#91]MG-7B_+%(6=NDR3<>D4F$0RVH[K\5*3
MK5=EJM4&CQ&!#+M2X >O9 M@B/Y-XW)((IO-5^,PG#Y;/O2DUKIEZ<MX/:J/
M$@5\XGV4( ),9(F$[G*&,V':!H$4_)0$Y/^'O;<.JN/Y]D4W[AK<90,;V!#8
M6'!W=PON+L'=738;=W=W)[B[.\&2H"%H B&\[^^^4[?.J7KGOGI5[]ZZK]ZI
M]=]GIGO-3/?JSV?U3/>PMS#AFY::F^Z/T\U*4Z:^ PW5.7/+A9KC+<KQ>,#,
MQ?I!TI->9)T4K=\4>+<"7_6T820IL>"4$M@L:2PZW.X@8&(U!$XH!-E5;N@D
M)5)3D&,;E4"O  X8^AV-9_L6\K5;R2W!+>%!H[>1%24PL/&;%UBI/&L?;V7G
M>@4)6]14#],\9D[\"0 F8*HVQ5;@,4V)QL3IFZU"E)]UL<,VQF<H_;E<J7Q2
MUS<%A*J<D<?,YG31V6A)[)#+S?M:\0Z&MN=Z;</'A55VTTNB]U8']OB6H1L]
M7NNOR<)%PJ-A$M0_->T[?I[\3E8EI>#F/.CW=7PUA33IWNY& :VX-ZO._K/=
MED&4"Z2I/"0E3F5KNX*$NU#RN&E2=C15GN37XR.\I*6_/*9 ?&.[CJ\B4,,>
MT[Z^KGMZE$RR,IT0KY,V@3)A_D5;T9'!*W&+$8B^#*:3T%62$B^C%:@:RT(R
M/7%1J\'@T-C=:W!:*U]_1M8,,%SA'PL*FN>R\17[41.G1R>"OILE?[&98.+W
M>F/FZDVH5?">%,U*WE#9RGI4GLT--JGO$DEB/\R5$L(DWW\:Y[N.FD(ATVQ[
ME*Y(DFZ4-4DRM:IC+;U=HT.7@.&^KM'#$,6;O@6=-%&;7&5@(&!1,XH ?>IJ
M@B!K2L9A%?C./;_H<)PI&O9P8?GWUX0O<9[A1D,DC*$]*6/QK*2$5Q5T69"?
M+XC@NS#2)<7H@-XN+<NB: TM9/OKE0:CF&OY4X&!5-$]7'V5H=E\;K:*O8X&
M#J7.D29!E^O]WU1 LJ"2Z@-37/DCR"61WZZ#+[R B)K,X8]ZW_X%V7\;[_]M
MCOL1Y2^GR9^.-\"#^BEUT^OG5PJ;L_&&?;75-771+)6LJ_/5 U7%DYJ;B<+%
M'8'??PY$?]_Y_MD/YBL4<?G]K1">FQ?N_ GP4E#R!C 169V$H[?[LM$G.I(?
MU#E-_H"R0HWD'7WQ!DB]I+X*_D<>'U"*/U>^C/SY\#"@=E EDO6+M4_4Y(\_
MRHO)L^C3A%I0]=^;-P"VL$L:WSE.A0CZ#YQ_V(AJZ._&W^37GZO4-<'_U)QL
M>(KU''Z6'-8[\O &F&@*;G\#E+X! CQ1S@M_X-P<K_^6#"IZMOC2</,:_//_
MD5M/^L8TRH%>V_W7,W,RYYJ9'R7"3+T:&YZ[K#W71#M&@B\-O-J>J^I6:?-<
M/34_>G*_.3WN\/OC_%.)L&"P*J7TJ^;KX5^*J_^Q#Z;&-%+*#776N_)8T)F1
MKGM)(%.OQ][P=DF\DXZ)D_]+8H:NSM6B2TV<C=--'&IYPB'W_89N4X'(2R?"
MU*8^M]#?LL)M%8'XY\J"OV;_=\[^ISU'_N/VZA/]@?I>WN&VA2?V8E.OB9RI
M;XQZT>? .5KPM$)"'^_OJM&"Q]]WHYLTI^?5W$LK&\X\DEH/^M/3%E:\KRXC
MHNDFRZ+H-WLH4>)E-[+A(VU^3ICO>3.-K7S:FLKPVLJ%E'$GIT.ZM:3!*FOJ
M8@%__L(5KRJ#?S#6<2\+U1'I>45Y@27V\W(0<Q!3C:9^9!'_PM@--E@KC/!5
M/5_)/_B6>E_YBC(H>B@D^P9@S0Y.-:9^=6[]:?J77##]%F?/P7:/I[?W8TVN
ME)?S&H]?-EA39M*Q9[Y#?*#7:T.@)&G^8Y=;B]VQ$:3G@BT_T+SWJ@WG-/D^
MCXA>_%D$@W)6)GD4SAJ]AC3FI['*FG:KC7W5)6#B-U\1C_O%!P*11RJD5,DW
M0.)@B[(?+(A_Y2_\$_5ZN\TAE>9SV\D;H$!UN?">&O"/R/I)_:=!=*H1YV^G
M_J^F8*SD&^*NO^VUHJBWA6N5U/_Q#I)O'4;> /7K06#J$8L_2->B]?8+PT*5
M#W83OT]>F=\ XC<XOU3QW@#3QW]R_FGX"\_">)2;S3< G'_RA4'K33+SJX';
M7U]1A>#% (2_[T:#;[O> (Q]HL][-D=#?WA%!XV/G]?K_M!/!^OD!?]O>('.
MGT29.AWUN>WGV#<?#BRW><5;_)E7:ID$KTK0[#-R7?+]&QNZ#P3.$J[R/3=(
M%PKG&CA?NG]S-PJU3+$*B9>GG)C2^2%M-L-_90P5TF<<8!*,CK03 W#? ^#W
M!8LOGNA91,0$[1Y,-DQ0>$TN++)7/S=2'_+]: F:60EJ^Z?3)S_I_09<5:X%
M&P50; 77)[&8;"3?Y#YMOKQ7?EYY P2)[EF<('04:K]ZWGRR^MOQH3K86'38
MY<#BLI_O0O7UUQO ,QF*O1VH^[ Q-)?YO'E4_NKS!D#[')C<<G]0+_IT_+K^
M'_S'93X<_V%\?13YW\6]OC/GR=656S&2)/]5IG&JH]ZGPR0"R4H=F=J*\,?I
M=ET/+\V>&J::'L:&':;\%4TEEP0;)]Z-A09+SU!$H0#<X!R7Z#? WG]W-^^K
M_O(>?Z&1Y$<DODGU@)^)W84P]T'X^Y^DHE9GPI[4L=37G/_^!)&5=3^[S\@F
M1YR/QJD;ZK]2_AY3M_P$/_],^J7.\)Q[?"5L4Y%[8_67GOJ_BE-?0RXJ7R 9
M DX<0Z(@14J2\['!6<A*'5.[76A#H:WRXB7?1ML'6<R/,&4(-IF%JHW^K9^@
MNG#FAC8GM9U]P^.9\]! 1*:I&M\5Y> 7ZI"I%S[EG:"*JKCSB<U<^M])H[>R
M#M_8Z46WZCN'!=5_N8!NPZC![VR7&V4\!U2&MIOG<BM63-'Y[;8M,W89YS3D
M.X8[#L#N>\"E::I&9<]1:MS5I@IE6N*>!'R\WH%K3\H?QP= 'Z\\<IP:Y([-
M;+B=Y\^SC[^]YL=-+K<^6O"DV/)-2WT)@CV^<&6<SS1H9.1,D[FD\V[5Q6L)
MJA1@=>Y8:>]8HAU.ZT_'V0A\$[SZ%GY$%MYQO)3?5W]V(JA:\_H&H-[2>Q%4
M72C4_DIP$%!@]CWH6\J+^\8+Y%$GL'3A%,.FT!%_$^'S'T[J-T [O,UET#CA
MQ%_0YPW\C;V1URS[@51NX<C"&EE5*\G%SFV!!J$>%32S)WS7\:M_.C1]F./6
MM>-)8&[%:Z"JT^?YB>OG8,Z=T EGR,J_;T'5;;\%9;XO,W]D9+?\5(UDCV1?
M$H)F1ELOQ@4/I3+/79+;'@IR7(8R?R4$9I8]K 8!@[LF+OL41?HL!@CD@RI^
MO:CJGU7\(0V.F?C?I'B=Q=]98#>LE[71OS3WF^5M8:ZP!E."!>F.<M\;H+>U
M\"\.WQO@,\VOC+HXD;E?&F\ O'\BOZ G>33YB?35M><-$.OVSW'#OQ6[=RN[
M)D^Z?T>$B:Z#[=X  Q[N6R3'_ZN-=/_B+\/$WU>7YUSWZNOW+[5O #/8WL*5
MZ--\DB']OU_>_+_&N%5;-AC"TK].)X5OA54U<6Z+N&V^F.\'XI+R@P7HJ=*:
M8E"2QT,IA@]QIW_L$O,PL/PQLX(2,=32UN_TTEY]N%@>+9AG])F=799%=',&
M84"(&;+EG >1 $FJ3/P\^)\-RV"HVN8P7P801:0..GSXZ0E,#SH> A\[YY3J
ME?1,J[:D ?521%#S;NGUXO3S4JQ;[<ZM-MV1H +.=_CV?U03)VXFL,8B\+J>
MT$:]',H3^S4G@>Z3JU%OS+#<8^O7RIQ0&Q%;O'+.@.>\SRZ^AHC,XJ.BZ\KK
M3_'-26H<I&^)A"'7JHJHS.;8D'W6)(@ KQ25Q0H@6)I&><*Q.AT2*&1N?(E$
M@&#_Z=I;CDC86.WS_<*&AT'4;FDPZRK@LR$O%63[ ,*MT$0E_6@[S1MX6%&:
MN97J97!%QR; 6VXB=U@<7X<(:[+H+B5G0],(]]T^F@$AWODB*TMB"3)6R^6H
MI'".EOO@4]X?NYH3($L.\LG4"ONA+L8#ADFR6)N/9L<Y;-6^SN9B;4X176E(
MGQE%<[T!FI,WX_,)?3.4@R_GW#O4)%^!]]\R1HF 6$4PB2U!<2$,H1P*_9-O
M%7  >,<0.&ZDG)/%+R9^%)C=_W%'QG]+MLB:Z[*!?B;H#33JIK#NW57@]L>]
MMA*M9W(*4KS&S)@DZ#L_RX\:MK+>-?F%DI*)%+OH6;H:C?+@,Z"4\];7I?&Z
M9/I6%GJZ[2HO\$L,@%A<7#U6<  0X&@%3*A+*8GRQA[D(E2K;N,$LN9VJB$%
MN!RF?;E*Y?*S1<HW$:<HA$[A$NS5D11_I7&E.$[]/E[F6 83XF&,%X>:&V08
MR"E]*%W(H,"Z;?X230T>_-0< YPCGR34F7(MVX[<+=<9RR1LES?6<Z;1AZ/U
MR9!2M(:'0D&I[9U\0K3]H_"VE$4YI!2L6YU'11WJ7*YF%WJ+&)B)&NSD))DU
M]H(BV6T1"$W<O^S-;]EI;TTC9!/YW41IOM+W3D*:T<[)L07;G(2G;;D/"S@:
MI)S#)"[3EJK="RPQQ1E"-A%\1XK;]\9MU-N!X-*J) O41OMK7-'TZ7!QU;RK
M-I:CI'TK0K;1U,K#C"3QW_OS4>MZ:"1/A;^Y@.TFX\,3"!^XKO_\*'K\6G:I
MP6+'B5ZUJ(&C<,[PL?C2WVKY92/>&]6RH_'[*$ES[;5$#O%4L6\QK$2?-1-O
M^>"^C*6&O1=^>,X5O"Y;XD^@%P'%*/]RG*N-/Q-E(S-1$3OS\4-:@ TZ$T=B
M%Z,U<9]^UU<\^D\@BB1V@G#2%(W>JC;35N@9ML"+[6,4$OK^IS4]F+5R6B\%
MJUK@NK[Z6@P(I0^NG;R*T7SP$IXWI40'RZE;D2V]!EV?5!Q3M4<.D%/=_O[X
MQH*(U;8/+6*0C<THMO5*=X&A=B*N"-!AE?2 A82;H'?G*U1?%D3@>G2)1123
MH.G-62Q'K"ZINB^[)-9 SWZ*.;\T"N],'K7D[ U?HS^\'27$V8!\DIH&01(;
M)AF%P5;%!!-IMB5Y5\&.54_2MPI'S4&;K;G; B-TI5_>6V#,63Z\X"=?CLDH
MQU+&M'!65SJ:U8P0HI;R?@LEH(I1KO2;IY[(ZL_CC&O 0FSSM%Y.2_;/Q,2S
MI)$AA6\FX$/9\]?#W^%%IL78ZHM<=4ZUCV#1A[YCX&?UCS%J%PL#'/2%Z+%A
M>RGT97<TF864UV]5\4@D;LA!(S/6IK\DQ_N<",%$3N=C2W(S.7\CP)OE=<FS
MX1MYL;!D=*D&^B[0.7H9]@A1[:2%:(?<6]$D[^26HJ@-:F_2]^/*F04S(@9;
M6^=5&/YK1*4AI]K)#,GL"5N_H>6:PF7Y.98/<G8V_T<KJ*$3^%$)T-!=F</Z
MTE(5"A%A%?PH4U'8,V(*UW+#(IL['W]0*$P-R(+J7GFVBZ?L$3.0,M+%#6E2
M%Q X8#HZ6V2L+97JX?P*AC1(Y0[6M%6X@ :YYDQ2AM6E?(KU'Y'2V)OT6.+1
MJO0TXRP?%"L/9V4]4SE\]&)EF9L1V>#\SR][K_J_G-6054&;K:>K1C6_ZSE;
M8'1)-*AGA?EBM86@ %,'*7 TD%*L,Z_]JNJ^%'FJBT%U75M\U(VF>G[!VU+H
M3/2 /_2;$+71MJ\R:BR+4R<,:(@"VU1'DKK2E--1ARDQXFT9R_*Y1%0D?"XX
ML*@(O(EMX[]A:7N>ZU6=K9#+8CK1C]X*I%N39S!X;N?&"^Y6:8$,N<GC?ZVM
MRQM9Z./AA6H+&DA$M"Y*&20.@4=!P*K6!2*I:OK<GOBVQNT4["W]C\\:R#2S
M[^BF68;P&Z3Q4Q6>G)W<E--\EKEP$V>2.[3=$-+Y0VR;'^ W&!KF6K1VC9/3
M";.:*:"HVD=S1-;:UPZ>M\BV\UH,R5Q-:D4W:$BY<T;IVHF+/0WO:3=1S!45
MYW0:T(<F$!K?(Y4GGI,J\CN$HRBR4I(8J+'B3PXWFX&/>V:+ENYNOW03,Z1:
MI;H57++5VC1XS.?*5Z("X:9@N!7:K I\A)KMG?@*@DB\M=X6*Q#YF:PI,?I<
M;_EP_ E;,%_#(K%[+4>%?1$.4\1$LW2I!@:<%X?;F(-!F -2R#;^!/X&@F6X
MLC*2!!"[4*9$0#H&1PB=DK*%MJ(,^T!1K,\U/!9![9(J!1#.9;D2I=5))Z^^
MSX.*#HT<Q-P9TKA,($H/*9('P"JSTPN@)$>6\B3-6,ZX^;5M87A&^K%F 2'@
M3W&#_N;7LRDIY-@)8K,X/I A?Q3+]/J,NVQX:+FN,[]&2J6K!WP2-4B;\;RV
MS,^((T42)2=1.'V"]*3U\4O#LW%.V.R7<!)W\S:C>V4.=R>79[F:$PX=(, ^
MIZ 4MR8"]Q1%<WY,T" -@'R\9VV)I AJ(78PQX?>Q>09.U"9>-,PXBW"H,Y:
MJI9:KE1B/,UF\55)^X&P/1V514W+QWFO%:?6AN @_NES]6P237I"L^]:4-E5
M&XDF3UWCV>+(..Y!O(F1\!T(NR[;O[ZWR.FU\R*9Q2S/[P*QHDDIQ$5$-[$C
MJ)PFB6>;XJ9:5!PTA8>X$'U(J!%#IJ;T!_F--F>5RA;L(H*&L8WQ@KJ,L[[H
MXEV[UW.U2!7SP0^'L.]DVK<VJ8F9"\V* 9"_P:PE&5<QH46^\N;U,E.HO- Q
M;45<A;U(Y*EJ^(F6A/&Y05JH[8VOY?J8AL1W28M;63>]S5\G2AJ(JI/H.904
M&=!INP\,U-A#\0#V=1^Q.VE"[5SD!<I2N6,=[.O9:JI%A2IK\&BD&@;HDB2U
M-^0SOHRQ/'J:E-H"XQ$"[QIZR58L^L11$:!B!J/8AK:D']JR.TR;JL>@BBC<
M5J-PU*;#S-2E.F:E? U(C06B6V'A;O*\YR-R!"KEJ8BI_^DV'[J[V:2?^!AJ
M.FGLY5:U,DZY=.JYW:\\@VK)F::K YQ-P$!6(V"^PP7O6]JDFD/&HS]Y/+;5
MU3%@3WX'1 YIL8SV)[.T$@(L7X1:Q@9C9&0_2VY<.C&KASGXRTQ^AZ=&2^P5
M9DQKK*C/ _WL12%%?"=C>\B000ND[JQ31MQU:< ;_X=-ZWO%CO>]36LZ33%.
MMBX)?N8*A:*'[W52;U:59_=^^HC^8);2;^(K7WZKY^CG!*!$W5^JG3)L'S^V
MNE#(?T^._)=D\9=\JI7YS_6E+=<T1SW-^BV48!;L.^^O.Q#N%K<?3LQE326L
M+7(FE31QBLKA;IA:C=FQ&NH3M')%<G=J99^X(+5%*F76>I.!^VHZ:WVU[2$>
M0D3(V\D9<XU!8T3+DE=O  2<_=*YA7Z,V [8VAWK[#=)0PD.R2^))<^)HX;^
MLDH;/;V_-@ZHMEJL;\GA'W?6%EH3V_L>_(0#>X7RA7LO@B[V5N[6I_\F[LM^
MO.X/+U_[_F/7VV6OY=&I/E^5X4?O-R=+;<.GV+8_2E7;>*#6-K/V4$,56VQ:
M<^'4F9KQYN5CLH*&!H"*J:D;2J<';EW*+ST=*L(I"]Q8-9X8+*K9@+R.%MLX
M0J1-%ZA,PB2A);BL=E0JL8=.(NP$';M>"E:;8S\21:MUE3 YW:!?BB[&#-KD
MG3&,4>15CUS$]#YDT#0"KDLK$TI;WFLS:.Z05Y38.R2NJ L_S'L>*#_,\VXX
M?<IS:G#+L_FP\,'?>W[VV__Y5A8M26D9-NU(\L(H$B]PW_1A"3ZWYZ[J6D4%
MPFXM9J\D7$BB#.TZ*:$ZA 1M-IB(@.6C]%LG38PE+G-U>)FR$3@(MR0)D']T
M6SFSAL"U!J@;?A(('<8M>VY6.X'[3IB9>P+[T&!Q@;V:%9E#;[P.%;OK-K2E
M9:6XL+ACXJ@ #W:"LM3")H3LWF6R2,BS,J9X(/&Y+]I&V2($G61[O3B/M?;3
MQZ)[ MWC/LJ4:_'O2L/$K<K5=:5@<@!O?GF@ZPZ]V"5N-^8I@%@,'F_*^DX7
M@%4Q>72&?J!4L.'1MMZ'45;\3[Z5+T6V%J9"H,$QM-XRR1DO^KY,VA CA1]_
MD2>8/*7 MY03*9_?G9.3#3;<R.,1(^$]F^05@T"*GC@Q?4$):D?,M%*WQ';\
M&<XS\:X(TWIG!=,KO!LS0PY3FJ[5%6LMP%$ZQZM"1ZX:U=3@FF1[. JG96K+
MPEJG-:M-BLMOL8A(I9D@H]*8Q!NT^&6*@U0 1U[F:(Y^Z78D,\V1.WS\6&MC
M"PKX*LOY64E&@V->*22E7['*J%Q?F<N0&<,B;V9;#Q87NRKV5>SV2OLL'<4!
M=<II*!Q>6Z(:Z1$&M\WRU9ULH=$T0\M;UT#V$N1H[HHC.V4?OH<P/=PBQ"<;
MX]"34_)#QF5I;=J@>J"Z/O%^_,7"1%%HF39)-K'_^UY*;7LU2_!7KG(*N5BZ
MEX::HY<5P/ ;H.F$'/52W4[^_-1=S6WH(KY"G#M!:[FC90,)R" _&C%=CK":
M)DT8CVE%;<$5)6ZU#%7$3I/+M%[]1,1(SA6DZA%]><-2EW8RA2J3KA!2Q*\M
M2.T&UL[7VHYOT8*"CU(S+-O@^151-SG!"E%FW5XA""5<\"1KZB<_?=N<^4^=
MU34,U^GVUTM/"5>E5Q/O[Q"L\>DZ*"(HW(1K?TE^:*Z(7D;]*\53DY@T?12)
M]5ELAA/,JQSR%'7T04,, 'U G]R1P(_!??>4W$6X2U#(TJ3>UGP2F<W@,W<_
ME !A-K\_Z=:^I=$@@1]4MP)N(H3V4FTTM?0[?>/!OHFAWV)M6AF!*S6]>JRH
M#"4=RP'>LANOQ;=%G^;[DS6E>O'@,>*),F@YC(B3.0O!&JDME>Z)R]?V#\7%
M]$8E."V4Z,P'>QGPQ;5[A)+8!:[6.)TD1OG1@9WDTM4I$LNL8:!K'E/U5D,<
MC S4@I&25"AY?1=SFB-%%>^UQ@.V%R$-R6K3GV[)Y8/5KD==.[_[0+86V$".
M[P[_QL(LI8(@O78I).?*7H[GMCF7'D7:\\E($F=S>.S/]ULNQE/WS7]--=1X
M>RHCME7B&8J\]\FH<*IB1:.PY(DUSF[<'PC&2A,PO;P44$)VQ38D2@EQ%9-;
MP<2CH;813VP1@W8ZI6TM.WNNG$NIDVS19_"AC@'! $\*2)J5E3V0C%N\!(<T
M[?D3:UW<K32=,P;03)YE?+JEIP4"@R.JB&F2Y4<=[PG\* 9 E&B_DJY$*X1/
MWX+5LTE9:]>%*=+O[T&&)06(!1$88]-#E4A2A7BJQV<^QY8IJ4>\UFD^^K&<
M]2;N&/4G:X HT<?[N;I8[D.U0-HC]?#B<%5)6.OF/6QQB.[S290[U?:S>Q(8
MT3H226B VPX<FJ2MO'&!&1GI<"U)<@,&^92:1GT^"\JIV>DC]N3-CH19J>]:
M1;-K,J6DF ](WH7O?"_=FIOOR4"CAEXY96N$RVXRZURD\GBA0-9*=##8K5BB
M6&CT9Q.&^>C6;^T-F9KF>&C65[L9,O"MR.OL7S5^=F60\7"K2Q D)IA0Y@U0
M@/&W-J]#^!^MHDPM>?_AUS3M'VWROS[OGQO ?LE58_\?Q?C?;8H=XQ__9*YS
M7\-#R1_>G(9'A;:[D0ILC5H[73,PX!V%QC6>4T(")-@(/ZQ97Y/V6CM#:)TR
MW+D8$%/7^=,)E\+ZG+6SO0GO&*_J4$]P2:-'<2>.I2Q_<K7T9,B*39.PA35V
MND/]X[5%X=&3(\,CNNK'L>O7:R_^CN.%A"Z34\0E!O&LDIZDA!(Q*1!E*S73
M;+5JY,I?>I7U[_H>ZX(UT5L,\Z(KJ3X<>V_OVN-.K<* *9VM4+U(FBK47,?$
MYA3SH;WK]E!]X_"(LS(8780VBBV;*6RA)W3W24E:U[/$!5QO*^![0B'%:R1,
MI"S72NH:8U;U,7U.Z2LOE>.LN0:RKXO)C#2CKWD$\KEI[19Z62;X]TBDG-\#
MA:#V6E+=#_9073<=UU'%;BBL8D]E&SG$H'BGJ>:%+@W],&EOB)1/2NL#X":!
M3Y](T:C@=RINF"2"!M1^@)0?\VKNXV,C#Z$O*/ME;,JFW:-&&"0?:OYCDB!@
MBQ0B3A&F/=[3)X4!V8>.4TWSY%*"F)!M4B;AQ>F:C$HBXF8&"83*PF\8NX7R
MNB-B8#R[2M:0\DY\)<=ZJ5P:'D+A[U1(  C44QV.DI'JIZ!3#51-1ZGC*''#
MOR_VBT\NG7U=]N\6!?*)O&H:9KD*C=B0F(NZWU'3Z(<+?1_1B' YM@1R-9B]
MVQPPY'M3R9P 3E>]]BQ$UUH!:,#!%>APO*.N'2%O'/9++)^.%K$UQHW%?@BI
M8ZH67K6F>RSL<]I(]:L9=77#$59':)NGG:S8]T!1W[)<WKGL(2O$G1DK21.B
M^'9YK'\(N)7VBAHQ,16'M5J;+D7D6B8#5S\FIAG%KM6YJ 9*\H0(D^3@V+8V
M==K?YTG2;!=/T?6>AD)GT=0W;^  2>NK#SXLXJ6A.M#'M0M%GKGU]0;;-N92
M\!9K7;<V\6BI5M,GN?/;R+5,1W*6P_U_]/' !!?>Q' >I9Q5!<8J9TQ"9*PP
MI^1N?V]'8N>.R[VW;_/E"4_8CD"4<<'2G\.O3SKG>T[&%8TNF0P"R7J7R ,H
M%&R06 'A]"2Y<FR] K.FA_(5>33]O'[Q7/8:UA/C98O3P*V+9>4 CL> ]Q4U
MQP&?F"WU*;/PC+6-I:^D43L7 FO>?\N1):=#HMEKY4$PS(]O-^'I3@QHD?MW
M06=CL1HH8R>[^(HM\N\&E7BJTG/._Q24X 4*<'+"K$U(NZ$-92Z'R1?9I!S)
M=-)\7-A^+^[*'O+T>A[0*:#="ZS!W"9U;41]FHJG6JSRG>L2KZ"L0,F5E3[!
MAQ1)'B174*K16@A<VM,V*,F%.#*[LU: 4Y(<MV@;)G>-!8$I% S/A0=XI$;#
MOX@*ZHVQJS7;.DP.R@F9\I)+3O-%2"*->L8*(E-:47 '29J#;',O<05^I89>
M<P]C<=:*0DA2!#R)9-6N2?.3;C&ZG8:274$_Q3!^W<UCLC6-UTWW2H VL=<P
M.J(!N3\L<WZY%2(/TVTFKYA:9GR/Q4[;;?/(\YMB_B==C:51LQ."" &/@=3\
MBLRH;C0V(.4=HV5]S:6?]M^TEH:K+^TV/.IJB&LB50N]EN<;1M\9WVBTWV"Z
MTCHU1X']'$DTUK_43!<E^>.3O8K-UHP](6:_FOM(]="'K;6G"5BOM9X![@V$
M364XP0T,H.L:A;J*AAU)IEN(V?T]1VIJ'5*;1ZM.$K%'(GV*EER=#PR2AV<:
MI4_P9_Q>+4BJX(M5 :\%*6!;CBR&6UQ'YIFU%4<'0/6>[ONK*%9B R'MAE=.
M6*.ABILBHKJ<1/4Z$A,F.OIJB[.N],=IK<A(B X?DJ4=)H2:#'@?$,DLN+>3
M[E1K'XY@FUL&LA9,WD>D63/)](4K2,P -"R-6W./V6>'5?R%71&2NDK'HW@-
M*A0)(0$I=W7=:I)P7;O7\C].7I 64H8J.L54Q(]P[ >S-\I*2[5P-E-JKLWZ
MMN5I4=%0.5(XYS:#*1!D)#BIM+>\I4:T  9:>R0I=$[CQ_(8E.U!3I&[Q4)A
M$UY? /@>)ZF.+T8I96I%+I;H<#WMF'B2H4/:Q1U3O$.>8&O"KF@W135:-Y[P
M%VP+>5VD ZGPD"05)CJ&X\!W+69LWB(&0FQM^PHDK$;+PZ6CV?I3R7$)2;BO
M>?D*_5'H%6KQW*&QUE(L 34JBZ,EL""@6]L[5^[+-JUFO&PR( V@X3 :#,<@
M\X@0#[CK"G'WJ/<(UUE;A>^QX &\IB$3$D9R!7R9+-OP6P>CA?!>KZO*^MOF
M-*B;E4S;->PX-+Q<-73/<R;<H0'QY:YM7;S\>NMG#1I/?>O<LHZE2KSHRC<"
M:Y#> #-<)@DEU&/JG[^%O0%J3O]%?S-+]Z*2R?\./9JH>DY0_\_ G"M+;2@Y
MXNC2LM>*[2:Y.1TCBJN,K$A<K].'N.BG'8\=[J G%I$$0A"^E#G(8_)UP^C2
MSJL*(F<6:C[7^CU9@QX5O91;R9B1L8.S=!)E%@%DI2G&\X08'I'C?CGQJ6:R
MF$$-;K_D/):H+(IEU-MX=9"C3\'<W)(!47['&!-IM@02BQ9#NZ")ZCXO3)(&
M;XLZYO=+P*!Y69S49 N/J[32A7RR[<.D9%[V'O3 FS\RGP"2IB.KC=V[260%
MC$70KS@)8W5Z-W8+7NS%W<D2:"40E&9I HQ+^Z8M\JI<#9(7RS;P&VHWY]>H
M6C63"R]7,(FDTL)D+6H:F?/TV9*86'(+]SK(^)1^H\"FL@DAS$6/ A_2,\1;
M>6<[I%M<M\/V#+<%B@F6BJI)C:KZ"D'HX;/RMV&.=Z%()*_'*^R[R;XG_?,^
MUXJ<1_W'-S.7-QXJFIR-)V=3Q8WD" [\,8I(*2*BJ.DAFZ8[0*=2(V[#0*W@
MNB0^K$_Y1.H$G=BA99Z:[.E.%4L4Q1K2>])Q E!9?)GULKL=AP^_<ND/?=^3
M6LOL>%#JX?K*PE\D/=8>' 93)-/SB('&PW6=-J7S<R,WV%G\2L2>"%]@N"#-
M6W5SI/YR)BQBZO>P'!4\7 JUGQT^\C+JZX)M!+/QK2XS>^V@C2=;PH-JNA_V
MWG!ACS0UU5ZTXM?C4P XZ966)>R3$I)C\UK;B&K1I0HF\S"YRY(07E4ZCSE7
MO2$@I:'?F2%A4_X.>ZUU9*GCSIE9_W#2.G!=8TNJC W^@E63EX4.UT2V2O5G
MM522[;N/LK[TVNW2+)Z(YK2T?$\6AYU[;)U3-HEY3I]YL7.FB/8@7XWS=?/N
MS")Y7%ZF7X.<^[JI>RYV[2*,U,WKOP]!BNW09(TN)LC;PD;;$H>8LA.3N<WE
M^IP:XA23 %;4UA_E'K]/T*O(=?HV=FV)L%:[/3V.@=$(,&<$$R]?\OEPB=UN
M:XEH<MFT'<5*"UN:###E]7(0;Y'0D[0XG4KGQ=3$;JMI?EJ/?X>D2J"TV@Z5
M%?"FZK!!K;?>!V/MK'4Z9L24%):W]EUU%A7D7'S;X9\/V _XQO^-UE0>&,^X
M0-\]7U0&  BA7YVEBY)*B<:5!B_\$XG:D\WG(J6,R<7/% %6N']9$M\ 0L2O
MND3_*&OS_Q0,(Q\\#].(EY9?]A2Z9N;)@FL.:T\W?T^[RYV)2W+J$PB35*+Y
M6>O!8X:,;E2L1?A8Z0RT)F$)]T#A4[_^ZH[/!B.PE$GL:#::Z2_3-$V.3Z=_
M5?-/S;I'X,Z76UO+-I*DL7>*2QQ"]!)SZ=Z5'0&=$$9^JOW)8%]+Q2\O0HTO
M#.=6AE>'Q<E.IT%W-DG!.$N>\9N(18+DT80T(<]Y3^92+E>@VO7;,GT:?OKJ
M(IU"EHL^\I,#=DDWS0XK&RM;/$!=XSV*JI9YEYV^4 Q@>\*MO :3;$O955&/
M+X]J'5=(MB0EZZ%EG)N]]A.<OQRO;1__LO:G+ JY"')4OJWQ@BTF8E <\7NJ
ME%:AGS8BW\#B71 X8]#6B]IJXNQLS;AQI5X&?170]6];N1Y\N:PK&DJ';&M^
M38V^E!4FO:VP<)SF$5LX,\M.++<RKFV"V!X6(@?))[8&,?2<;57VG"E@M 4/
M0?L9<][8"!)Q]@1>2F10'J/V.TN>+!#&3Y8/5 3HJ#Q"C%H/O>[,>O:#P$MR
MKQ*66$LU//:4N*;].GEV+/S Y9*A6CM% !_/M;6U[5*L-<VUT;079!%5%@!G
M%M.7PSK>O/VT(8N\R9F@8VJ^"(JT0U^-H?A*PTZ%I_:#=W>\2ZP8G*FH;GN^
MF=L2-%+ER.]X)>K'/M< 46CQ3?0DS2_S?YII3P*'?GR$_Y%;.Z?!JPH:R*D!
M.WRLTBZUKCN@G+HZR)F<)91$3QY BR+6T$L2HUK 6ODY1A3)DN@"+,1.0=4;
M5DV7ERZ+'954M%SZQ3$\90:=_-TY,G_!8,3Y(\O6DS:T77D>S\IIX@<1Y)\P
MY;T&E4_RZL'W^I**5]+$V93MFQN53LZC]M8Z%6>!A !R3N,Q1P8=FW/9%"VH
M7M*AVG3A$BW)$TE(H?B86"]FVTVI4Q(\TB/(%N6?V+1I2W]3-W6!2>R(Q>@;
M(D-=[S]-&2DIDLLNJW<U6^-S -_9E]TJ5!)T*LE\15S"];@E)9*DIRQ"TB2A
M(8/+@A/CNG.2JF+0BFSRWQ_"'<U"W+O:GP]X;O#F3]5J[J;_9>NBSI@A?9*2
M)COSM7C+T7;7U2>;]<OQCNU4PU1Q: 60;#HY@DS\P[N*Y5 -3AKI]/18).UP
M@V(@JT&8JM FN3@]4]%+^HQ@UDR;_2 .%[.!#497%:8810"&,PMJQ@7BH6>]
M$Z 1-T\VMA(Y2L9<C['838Y%U?;&6J(36"/0=Z"E'=QKE%]3T'O5$,?6T;7S
M89QKMCQ-'@ASY>OET3MV8VP\UM7-D25-XDZ*W8S+-'H,>?]B?\?_[S2QQK_X
MM?\_RTZ?WI$D!>^Q)-F\ 2:_S+X!7@7^.Q_GB<CX*=_[KA7BM+\_I/(A7;)9
M?57Y#QCG?R'_A?P7\O\OQ'VC-!"T(1+H%[A6_^GKG>_#Q8-RPN_/I]]&%:E[
MGRP2]!]$-7/EQV7^1S^L_Y]EYHW?U$+=!]7H/H&JSE;+8^G<L@Q_HT;!IG 7
MM_U6$.%D*824AKSH-.<)@)?^?%B;9X7*R[$.+[_=*"+)Q)(L)! F">.873RX
MX-H5 ^!H"J.T>I!1]26;&-2:, >]:9TGJ?%1J"G.'4P'"^7*W9 U?<*G+/&@
MPYHQO?H@&WR0[;'2*AWIGSH656\&*DL]/X4!DN^]UK:BUCE)!E4U9$X#R,SP
MI5F[P(B8W5(D:'4%ZIJ2UHU$JFSX/$*QM=JY/H"].-02$TQ$;(]ZHD?$3QJ3
M>XF%11HN>WE&N:,N>Z%OD:8O7<?EI<2M1:;P<Q@GKVA9%!QDUX7 KNL(SHU0
MHQ"?KJ'AO^VQ:W&B<,S?4*[R)6-8F5TNZHPU3RD30T5L00*73!*)G22KIW%)
M5+5P+X&=AKM3X#E/EIL%50$%:)>!D*OXI)(YO_K.^LJ/5]HT&]XS^CESQX*Z
M9Y"E<=+K*_F,LCO*I8Z&NZC>]\T43-'\PZ0[Z]_(W 7>/?@)D_J-+L97O!K^
M,!(X\)S3,:REFJ]4%PA\SMVP\KON_WPWH_(:6KQ2W]9-T%,3R,+@/6RW+;B9
M0NDP1CB3F'U(R>C[/N;ZXO1K+_<P6<KTP%K#7#^.48/'6'^N^MIW#\:+-X#F
M<E"CPQ/O=<W7\]J"+>,^89%&'9',A]P-FZ=&ER#!IV/V\ ;[@ '6/W'MM>;!
M#F2$&G5/ 5\Y[JZ8.92;;O9O,/E %=8"478=E(3;@C\HL%WRP'>KE86*Z1PJ
M_8I1ZDL[ZUV['IUDQN7)O;L^1FLVH3"&F,MJ>F'%LY7J<Z?3#O6[Q9.KGE^G
M0P^%!@D"06"%D7"<5&FZ-P#Y-'UC>1$99>+PJ_#RK[Y?T8CO:*C>7[Q3%PU.
M<=Y4K2AX]C<I;]@<1;5B::"#EGY6)J$G]!55UT/_AW.U\ _ J4"S;,4B*Z-_
M>!W2>,'1BW$G%'";U-%Y[@!5'%DC+#0Q$)OHWW2X(]R=%N0F&4WJ,5/.Z@NF
MH).OM<E2_:"YE:DKW9*Q79W(5;%]E9V!5F3:.@(&2T=F\":DG".$R$TFZ94;
M+<G!V)8LK4QQBEF4J3/D^F:X_Z^V,O]_VQ9P^TJ&@>:]-IHF3>.6U#,]F>O5
M&Q8H6)07/'I_S&F]M4*NOG?F"[=/9T,UW.-)X[U^C;^ WP#6>ANJ(IP# V^
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M/*KR!$<5#=8H]]*8O+*:&K8^GZ0]Y3N$-IT+&@L:$W''.2/:Q]]-_$T6VE,
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MMIV!0TT/UETD'7OEXP<DW8>,EFU$^XHFHLTK;ZVNS8$.<P8S*._\G53>J[\
M\@%)5>!"GYFY"4.:WTEP38G'O<ST)GOB;^3C!ZH[WQ@;,>5FF6;9]FK7)-%9
M,F599>'+@ETMC\-/(,GX]U:VZ9K*Z1M%0<6QXZO1';@[%\^V"J_:G75:?OH>
M1?52PV,Y$KX/3*C\CJ^ERX 6%649N#51*!Q=+P';UO2(I/V0<<4G;(E^8Q7C
M*#E8B<O3K[^=6Q_VYJ\"L.(:L7^[<97YJCJPDG[Q@!RJD#YG2HQEQ&->#.*Q
MX,PG5<@#381;0-WY[)\&1HVS%QFY-]=3S7;J^1@:(^[1L-RUPD24 %S*4ZW9
M?[?S3.QFL)H[THR@!,#3B!ERWWQ[M[3>\&_+_FE>]%]6W"RDJ)M]_%G6?A<]
M<^61<UO5A6HC5&,S=>7-KN1)UJP\3\;MNMBH[VCNJ.BL0,&N^*BXY73?J>!V
M(.CUYSU*Q8W7Y[KO+KQ0SAHM0:V>4ZZQA&OYRP_"_@NN@TM!(KYSH)=+HK-F
M>U3Z%EV(UB$$J;'6PARA%8//H/]H3^*,Y84H43A\H+OQ+<[/WQT5#_=72>\.
M"^C7-DO\PZD^23"R+5@YM9L[^TF'5V?+>9Z+W-#6CK#)N^8KFSG^43D!+TG/
MK?SZ<&C^]N+)RR[K%[UD_(_;=;^^*Q3]6G'6&_MUE:5H[?O6<"E>J)=F[BOP
M65A:\FQO;H-I_?B&0XT!RS;8\[/3,_(UW.GYH0@?X[5Q ;W59BX)ZI^GRONP
ME+3*.IB.C=,)-!1GC#GO1[B2'B#4T EGAF0H#EE.XN^F]ZD_'F< R'/IY)L-
M'1=?08:[[S4[LD)')8F,K#P=2K+&65.QW8F7I;4HP)L4+5[->959CQS_&-O:
MJ/4GS)D75O;QHLX+1?X_OF87%[_C/+R[GO5 SY\S?H.E;B,519G%L6F3W[5;
M.?46-;K4]X75K76-\]8O80O_!7#'E%3&?FOXZ;LB]GO#U8EUAA&"4GI(7=UU
M,I$E[9=4#CTBNLQ:,-B:9F)@H]) (JZV+!G&:6C/_M$R G9-LTJ>)+VN2N5X
M.(QOP?;8VU3<]?:Y2S#<T+;;QZ/^8;*;2X$:_=*N3\[2A:%RY2.(5/7K,WDE
MR_[M'$IK;#*\^IV&=ILW;P1_+'\Y#Z>:61,\NH8GK)7$&R72WHDVR:.,9A:6
M0'3M\LQ=H#@\MLK8\K3 DSS'T_H\Y_JN7>JP?XU28)^02M/QU!DN:.4\^T=+
M [;_L^;^?Z)E/>O5<^V&+(X&Y54GM2G;-3&6I&%HQYMNX?8UI3S>;QC2@75I
MV\'W6D2+:WS@;43K LVZ^/1:">]G4>P\W,5G*]?C%=\NI<A;/*4E]WMGPM?
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ME#K/RRM,?1@I(NNU!YW;68*(YS??1.'9Q!2+TWNNBIKHV2436%QUFF_=.1/
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M&G:#IRUVG9Y]9;^0977X&7@L:]%F3F'*.M@V]106#X%?F^1!4SPE=%8*%VH
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M^JE5SAL:G;A=N0SEZW\!N]UN=[9STT+F_\I_E_^,*IP[?J\R<=I@\)<G\;6
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M46*J1<XWDS5L4=;[NX S>1M+(][I9?Y[.@IQ< "Z^UZPL56W^]7H(8AAN03
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MO]:P:N74P@FILM;I0*L7-!4ZGM1U/%[>C?'\M_029(4>!&[OE+_,!QXMM$7
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MFPE+XY9.WX^MF\U-]FN!/<I&!:&.C#'<9E&=K'[OB(GP=""NG*/CL_>\@+R
M$$GKJ@7;5 DHVKZZ-='?L= "J@8,D<G:S62(-Z],+-;3BM=[YZQ&<<6JE@>Z
MCS&.6<H?E_L[9K:Q4I'Y"EG%<MI>YN!-VWO4RJP#R?SM0Y&+$%UJA)&3SWJL
M^CZX8>^" 461IBJ8:455$QCE3%S^=+'KSYEME0*0@0@[."&E\&/$\/G6,EK1
MCWF5#(/!%HX?M5.?F2]QW![4+'67OV!\XV)PUL:-$@DLL]ZWE3J=$;6-EI>1
MMKAW7W:8W31T"[G0.RQ8+:'7"X!%ORP"9Y$!B$2B[[NIS=6Z3?6ZEN?:&FM9
MRCJ!4=75=+;\F^+<SSSZ^M98G?AOTZW'[M!GL.2ABOK"&+@)3J]Q-8E"KE,U
M5'PZ1*5!CE*OSCJ@I[/_[;;8[?J6UVB]G4@F6'F$=E6;IT.FUDG 6-N3I2H4
M!)U/?73SBJ,=Q-87:^PCV&8:>OA&5R+YA^&0Y1BD7#(>Z_AR)%%XV@<+34:;
M8^=D.-D@<[.K#F80!!H;+HI#:H]T5-DRS9E9/%957(1&1&KZGCA:EPHGM)_/
M2!'9.%P_40$.SX0K_.3-1:T*\LKJ:0)GT,:#T\P(Y;JOATC'^MS;B>GURH90
M*L'"1.RG;(V4C.>L8+[X6(FSR^!'PKW@!87ES.HB]WH<)U/F_9S"HWOV)1[(
M@E$W\I%DB/5ZM+K0"+L_G4H$VNLGQL0MC.NM0J:6;BZB4@$0IXT&5J5_+@;X
MJZF^.!50[/A?#%P^'[T"T:W?_"5WU,47@C027WB)8Z(;(:<RK7UW";K?J?..
M:C9O[?P\EIDHI7;:BWKTPA8LCP[^*9P[@6S4K$Y6X\U L-;E\?:M 9^NI=J2
MC*4LZU,KIHB]CJ(HA.&W?A#P?E^2&T=3US\K[Y,_"(0.*=ZE.E(K-XMANOL*
M]\E#-&%']C28/L4<8-]3^W90\;WYS7?VFJ8BCWMP%AKA%WH0>'CLAF?!/K;8
M^T]Y*,5&VYKK=ZC[>C"SIX 1?YZ!X>?M;ZA6*I;L-OL\6=0S'_/%.O"ABXY\
M+,X%-'59!;',L]K&?'B4VJ",:&$SDE"C%+H1R%KIV'RC5"*P_N4'O>SS1KEW
M5I+>C$D:T[UM%2%2.'$-1FAO#F]O,O&J0^2TZBRNQX+RM?U'KQ#*02-JF;Y?
MO:PAI7J\A+Y>.?^MGB\J6P#\0=G^^7*YD^?PGY'IPE=)VU$0TL(CPZ((,>.O
MUC]]5&+-;]:EJ0L-_)]NM','#RM7GCGL^7HI>VTGVK\=CN 87YB)R8$WREL_
M+EV[^3M3&=HWN%Y:O.7??:-'^UG?Q?N"](3%7NZ_9-?W-+\*!$]@CT-_-JZ$
M_CI\/]'-=#E6Z]E_)QPZ^T_'?M1_N!@G5(H6KCZENWWKM]DV'8V2.14:!E&&
M)#S!T42PG<J5'6[<9]N$*#KJ/PKT+U3JDZ0OD#'IN-[TQ; "&3)$>_[*/V9W
MC+T7KZ+Q )9@4Y42]\6)6?PK(7%+F#Y+QO&;>9UQ$'*^SN>+D-5].*020V[S
MZ1AQ]H2L(9"@*,"LWK@5P>@$3PTIV-%$Z3G0MFHL@YWD".>ZN[$M&S/%8Y9W
M>?+1+XZHOKWE<WS/PX6H9\F7^&GEIHRDZ;,QR%#(<O]@V7',+&N@D&6]>E0>
M-9=R2-V]V=0J@O=+#Y;U[0MBT]=,GAH[55,^SBU($/GGWA3JN=C9"Q\E2;W8
M%P2+K)LZ")HJ:^'B8@FYMW[T6R.RL$WPVM!>2L9^"?L.XY3LT/2A9LM/[4D@
M_O2=_;6Z)%*SEMGP$NQ<*$?;EB?;H&*J;36IS*%W=SLFZ@*;U  :F_.QA4IJ
MK(\>_^VA#'"(ND\@H(/G5/XTOFA><A&K@Y[K4_9,B]1V*[NOJI/CU[Z'MG9V
M3_V:BDDN)_?\\N;!]Z3:>NUAC_+NY)>D+OL@49.EQU*)!G>"IB86V[)? 8&Y
M=G'V-_O(Q08.Y7=*M5?V24 \=_S?>,B'9\]L/%N4'G"WZ,Q7VAHQ@1:3JOUT
MK6V; :TH#[*3B0'>7IF,*X.HUMDC=L$SHO/*D+GZ^XRUC;$OIUGAFXLGFV9U
M4#G^I=JE.8^434<;-M']S!T-C$HJWX7(HD04=V"D]#1SJ\JP:7S;#Q$_RL_%
M8NA58!W,]67-6&YP<)3)HV&O1.@'>4S#XNFN25O;V.A.EV8(L^_!A4AP8!_M
MUSZ,://FO>[-$\+G?!/XLI'L@49A=99IV;J92%Z9$9BAX=?AMS&A5-$8">$T
M$< WM#8]G0"%YX7Q_Z*NPI@CJ^>IU@)-0^WN?"'_]T)>=UEB<U-R+9VBX"L7
M7E5#A1"*S'T\<N7]=-6<"3\2'O5C^#Z7@E=?K5]58">6'EB\4L@8O866M='M
MB[-?R/FC3O.BLLP_0JB[/9'-R[\BM%7T^9^<C%S7OI(30+U78>$)1<0C/=?%
M:/9&[>8,T<[<!AX=<46M5 ?)MOJCV?3PW6PCQJE4E5_Q/FG<80*!$ZRUL2:?
M&?5%G]>%> @8N*1CT[BMY&KK\%/)!$N+% LK3]%-YZC5-].QY?Y*H5%OWR-#
M65JD_ZZN;Q2J$R9F# ^AHW@['X:YXU9[71"B-L_L#EAX"- -V/)N)L)KE3F+
M0/EYF=0FKEO#)NY.QQ;SR?H>-65D^+FL5^]HY-C:*C-F.I_:=2+;"),*9LL)
MY4J!BW?7A9S_2Q:.IK8DSGU65>/L7K$0LK32KX F$]M-!/,] =M8<A]14HRY
MC\FA+,=Z)F;N>,H5<Z<@J]30]37D0MN1Q;8'2:2_M5VF/?)&$SN 41\%]B83
M#[!2CTE!N26OGO$KR54HR1%&7WM^&XZ_+ H.7Q7==Y]'7R)O(AOMA^MJUG/*
M1,LTX>#\T.H&%*M(?AAPBP/>I>3)PL#B$I2U.C;WL?(WK-N7"[[:X*Q)GFYQ
MVIB<8TO%FK^A_")ITI':;6$ZDC_4[C^:9'PP6SE/BY>+]+1<!I0SPGJ#$QZ]
MH?$\Z$+.I*:RBT&&A@1<!,%4)3WSC BQ+N%BIY@R>\HJ=8CK])?7J6*'_6G6
MH;/A@ O7BV-Z;1@:Z^=L*'WRD&24^O%G04XQADR/<5=385ZRSM1F[AK+>/%D
MLV$?V\4FEARM-!TDX&/#%,PIY=#>8I:)E6R[0R!E?+,=W?'3,(P%-N4S"KVO
MT&4RK =&^-V^KIK351KZ6&E*4BJH;S-K?9U.4ZCHLQ;.K\9>93"DX2G(I>L#
M'MXZET:W]: G,#4?+3'25:X7=#FZB^S.6AN;TNP^CL:7@;IM& E<@IMG)OZ?
MYRQ1W'RJJ6QA@G<*5 R09HF@^7/>XYF^^Q2B*K>[O^H]1:S?<Z3,(()M5ES7
M#ZTUHW<)OA2O3,X1!*HFN5I%MY3"5;5CL&%%@^R3')20J95["#@-;]3#,R2:
M.Y?JFVS9F$V)H?%2P5O)5CE7)PU%](.G>"/;]A V"^.5B369NRZ6-HT/RLB;
M6+#)*[:EKC->CE^238:C4#;6\W<DOLK$!)>)6B^S3@K>E3#(]L1(1K!H+N'(
M-E&@L7Q+@[Q -3+RX6@J<BTR*M>YR_^9<2/@I-6T:@\N*%N)"VO2+C= 0,PN
M*$*/VJ" TSVDW^W;4GT#K\2#I55;I%AST_@+8Z\D6YK,V'N)D((3WFKZ1/OO
MB>#J'.ARG= J"4T]#O%[;_G(K'B,>T+9(9KQ473ET[J+4LV-A@Y*+8W?5[]G
M5Y:';8H#V<ZC'(N!Q][+U6"BKJ\Z7[I.5SIJ_V1UKM&GADZ1O1NI5/A7\G0@
MW,FN3)N&N.H43?]AT_GBGHXZK^<P0H['3<?M_0R$Q5OPMC^2[6ZF9IY+OH:>
MVW%=&,QAKZ?0(K3^Q_3Y_ONAIJR(+OJ*$Z:3'S4,UJ\:7+JS79UXR+-QW>9-
M^RV;K2\PWJAKCE$J@,2?Y("56K](E434\6B1WSFG81PU=4&&H% ,ML) %P,O
MW(7@(7]/&-*$6<RDR0E-&JBB/XN^DEQ *X@0-J.FW;BF1;C(-? /!9I6HF(<
MY4E&:3TP*QY9-HJ=)<))4V]G7+N31AH_,57"4=(*E=(!<*91"FY^Y+D%$I;=
M"$575M3HZND]%-S=DYR?^*Y)E>:!<;6RKDRC1S%=E&^C#TAQ<#<Z;N)P@G$J
M&8</GC684$<DQ:D4:[+;IU+$LE%)'-Z L\;.>\B :X._EX)X8DTR7R*]@>:6
M)?%D2?E-AQ8!_=00IRE!<3"'O M:'F\G%_B)NH>-V2X>$AFD05R@0GNK?;QX
M.4H>P/_E>E!ILC934RSBDP>']6?K$G".;WC^LQ)/H4)BM7WCE)AN@_33!R6F
MF>59TFV"IAD\2OWW<K$^[6\=:P$ZZL8&F6C3WMWFLC?3-L;B-@-YD=PFW+T<
M_=5-8]9(U[;>SK;(='NSLWJ3ES+CY/N,(4Z"=YJ+X-Y7#RH"9JR:00X(;&K$
M;,@B;55\E7<:34<Y7'M(]@2\W4.0*;8\1Y'Z*DA64L&U6 RE BYGZK5*SHR+
M^R^>+]K2IW=RO$\- _*OYGR$Y08VTD@@-Q<T;#^G*P8J;U0NS"/4C,80T'%(
M2K[54 'KY5CE[/@BZ-4-1M_Q?.Y5B$ABSG1 [9WX%1W\$EPQQ=5F7_M%N8T&
ME?/LDL_4K;H@(*0>]<A+EFD\G*B5QI6R_K8'P2&!;/[>V52"P<E[UT1S[6#,
M)!_K02%!N4M,!&C)2\=)9:$ZA&'#[W"NS\*SO"$$KQ<DD7NM-09V)]U($Z?A
MT7\>8?.?-B!SBGSK=09\CXU4<I Q$J?EN:CC^%3$ SI'!0X_WB=<&7+MHGFS
M641*K3_3RH\G*+?G2Q5GB_]]BL)2^ES]EG-U)^;I"5(\A;D!6O>S8O5+=$=;
M\]:DEAR4>CF?=(@D#7%4/O1B-JE]V;;7@'BV.[]482@\.J):$"+)4B$_MC#)
M*BC$654Y:\B6N:9?E4B6"C//#,ACS[2^Z,&&.,N3?2\V-<^D_<5,7Z0B[4A[
MT@(3&Z6;'-Y<?YW,4Z*/RZ/*C1<??#O.-(4?K9@_&G/>A<L^U>"GEE7BY7L#
MGT:#$R!5%C"M^)CB"R^E%8F%"?9(?0Y9]%ZO3R[E0,9@GZ.R8BC9F86ZFA@9
M$&P87U(&V2DQ@E [U^,[_2 4\1R2>![D?7AXU%T/<O*G"??]M'D5^G;TC;KD
M0?6SHU,:4-.>LN0B:-*YX4Z!L+Z[Y:X-T55(*VG(/./ET.<?FO.:>D,5'#[*
M$DQ*/&P-,\WMPLJ*I@"6!>=1CG:R?0^5 TLNBAE@?63_;"-.5T;46'OBFHW,
M"_^066%2RL H7E%]PIWEY#9/P;E,TJ@]<&&HYR=:@WF<N7NZVROM>\V#F-A-
M4?Q3L;3GBRLJ?H3GQ87@T[Z<96)O7LB+V*A#$!WMO4/4/:D%L80R7K'D4?&/
MU4@F54VA:6A\^WTU"9HYZ'?W(PRS.[Y0RV+66^J1=#.VD97S4*=)P N1-2[#
M''Y:\,D^(TL@U7":3FI'Q''M;OPZ(U^G;7+GJ7Y /Z+C+$ ,?:#I1%T!RA@@
M<Z\8\)S2;?4"'X 1^F7*]8D,O?I.A9P6/ZJ _09XH,6$K)4'10/JBH*1MVMO
M=0!IY!@3Q6WX*:J59I4O&TJF:Q9(RI@T$+"VJ>L;,?8L;+N3S)Q>]5#84$%X
M*4P)^9.VQ8+FD8C&MSZM-WV4X:D0_TQQ6/,! :2;2>EP4(F:61/1Q<-T&S^^
M-#][?Z"G/S6S;-L?J[L"\HNMA$DHT4^TN]0()9T+PK0;==\_=+##?#$&:J"C
MH/H3\)R\%G#EP<AR3(.X5J_!O!M,P//EG<!=^0"Y1,6%$'N1Y;>L*1S4'WB;
MP )/=24SC743[ICAF(Q'!NB?[&5I7(CIY(9.<E=U<0)7G%*E SK\P69TR)VF
MH$"2"U"25RY@<O8([]8=U7AL%[ULM;!:&4<>^P96^Y^PP)(H*@X%[AZ<A+T
MRH)&4FA;8V-'_=:O6T:I_35^(I4Y_D*R" /UO7/<64WS.F'G^ZR+:8VE"A=8
MTLZ?'23WZ5DKX6'MSF-@7F^ZQ[^O$9D2@57:U0D>=U5' )03I[75(\S"*5:-
MRSPB?O::)XOE)&GL65]Z%W>3[[!&T2?ICRZ?#GH$*KU/^<:KYR_MC.N+L"D?
M_=60B380(!WO8_,6?J?VKS,R[*DE&MJ)1)P9ULQ;2Q#_*W@DDF_%CO>+50N+
M9O17]^7=&XR"UW7(]Z=-U&#@*'^5W( I Q,7.WK4>TGC%NC.02%9//,J\@TE
MHST+5CTU3> ?S*=;LP:/(FGVSH53/?J]Z4FAJ,9^[\YX/*".+,[1G),]#Q=H
MK7];A!=JJBWWL3W.I-2BH .8R+LV]IWNE<$?BM&U0\3O8;=B)##B'I-BN-1N
MEXHR-2%?I_T/>C7Q5L[&V=&B>0X!-?U9&S6<9*%REV2Q[%X>71HA! R(*4<2
MQ#FL?8B0C9E OQ:DAHE\M&\5[+!#D2?W8CBO("#DQ6*$!A6, 5Z!'MPYSJNE
M3]H;5"!:WC"%LB)C/1!-7EM,<C93/"NVXVZ(7F"SZD?_X;]))5]D%+MZ2H?^
MICN)&=#.Z-G(?ND+NIMR= 78# I; W>WHZ"3N)1#P^ZC!9,WN,6W2PY)>?MZ
M$4B=4$J[0Z]J]R_$I6 /01V6LS W4W+23_Z6(M) 0^_8WGTD_V*MP'J*1=(&
M.C:I0^R+ W3^1KWV&8YE,.-!PJ2@*2-0BX6($E#D, =V#C=ELDM1HTWB-1]J
MM4]D^(\F2<C0]DU9%(DMO106/XVJT,H-[;4DC]/IUI6&6?MPT&ZB"20$IP01
M>>7<OQ:@H^G5BP' ZW&""T.TTERJU38PIM28NT'#O*,H].&UQ!R=7'5::?Q<
MD\=5:N@D!/*40SQD;>H+&YGCWJ265YS? =DC6)8IG5D*H:UU9#_2ZA%C/[)$
M[< E55%D&3;)"Q]M S!"2TP&<W5NS$7X+2B$< HDV9QRG$$Y:8<?BHW@F\Z#
M98T?F!JNK_?P7W+X<QJU;UHP*)K+=595&\ADZ W/>OUP'#VTT#R*R6,F[8V:
MF\^H>A,Q_"UHMAQNOG(4)QJF4]BV<*]%O5.A!6'H-)1*)9'&2U+G?;,\.6 Z
M$-Q)(=827J="#4.Z]Y7.P87L5)XPZ!C';WHW;-E(:%^WBN8R$DE&JUW'8;+F
M-C%+(-$H2=XVAT-U881Y2K:98LT()9WO;&\0S7LX-4RA<5 #&!J)9RMESC@7
MM[C^V=TD5VP.O4Z"U5\.:'K6)UCO=WO!&KSG0&DVY"V_%=$?X<'F<&R*W18(
M$UHF"D*3ZP6$8,.007X1;TG_BKPX][E^??A.XMS_OP_7?S?^'U!+ P04
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MG"+I(!TX%(GTO1A;*G!>O514^9'8#(5\>5A*>>5B.F*FB'13K8:0OIT C8J
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MXZ)9;]#W#;5C5>+A!)=I=**VC1* FXPT8[$F['$\D@VDJ@T(:4'J3  "9',
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M$<2X+-:)%O4T&T(AF;<E"*A, -:'3!@J0G8,CQE8HN:7J'Y_(#6S\1K'B"9
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MQOI6G$XQ;J)L5U@P378]CT,CS6X>0*@L6XHS24#U]49RK4F!(8H!3:#3YYL
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M6HTT,OE6T\TVX[V.4DOUL6Z19K1 L:J@B$*X##@QJ2*DXHYM#D?VL"46*=G
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M>?.@@[)5<'_*Y"E3-MAXHRV^ML4FFT_:<,K4#3::O/&D3;;>9MM-M]O^&SM
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M/&?N)5=<<.<.VW+;@DL_C._^5'MR.GGR_8^<,7W)/N+I2^KS3CABH^\3L'S
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M]M:WGK\.'MOKF :CWG[4SQ^/WK]7?<N;-S^-.X ^X*&Y%?>MASM$]:P+?MN
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M #5Q+7<HE8R:XRB0O,N-_'&U#?Z0V?9$H>;]#&@4)$5>N;ERNW7:&5O4_(%
M514&4A((*O\$&/D_&H\\(AC)@/^C"$WF-3%1('.N$CT#3!Y A C8>FV-)I!Y
M& 3J> ; AR#O:!%<$$P<\).XIWCZ VCE<)!]Q#[;2\U3]M?4_NG36(>HY+'
M- -)W2H;HBO@&4 @WG(CCGSDN?EC3$1NDG,9PITM3XR#UA.WP@E?/052(@Z?
MFJ]=.Q#9"Y3EI,B/U8?B(+(-3PRO.@@)YQ'4!=[(??KT#.AZ\$.VV%%;/4;
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MO_)IP1<,-'YL&MJ]&.LF>F01%GB5?HZ[CRE%LH^+K]QH9!<EYTXW6HL:QE7
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M3J"4FXA+>4H@\B;]>WF>SX",,Y0<X]'H2&UV:%:>5R2"7I'#I4@AY-0T%?Q
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M-5:K/UL0B4J9JEDRMUVZH*\W>B-1AD1,2(O&_9;(B;4WI.?S12FZ0TA\8J4
M@KA2-<9\ON@2J6Y0,=%"@F;D"#F5QV]LC1;+>2BP64XFR+IJNE%&%Y]10W+&
MF3Q6*=EXZK6]1UN5@[,]<H&4.[T7[@)C[[Q(NUSCZ*,1MY6A^3\#2%:AXHJ0
MO<<][IN/FD^J-DN/I3><CV9^%$\<I<\ ;]OSK<RFN_**QSN0#,47),J%A6=
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M2T=7\2H- QR2B.Z3,MPK68DS![ ;NX)? ##T#N+>*+ORQKD$YN&^WDELXL.
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M!$SQ3[0O?(I896J9'_3C-1;.,0%\WI(3=EL=[?U:]FLQ4AS%IMB!P7_&2U?
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MW%<+KD8W*]J23\T*&B6A<\0.=76,G8+/7$9GN^AT:WO^M[] U:H Q-@R2K?
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MSD?-<*,K]88@L_3<OW$:1_GT,0K5Y1'NO<3*[\27/9)Y)/*5?/W*@_Z@U7H
MQYM@[.4I;(*(W1V-]>/<4GX9VU<M!YTH^%>6?5R&:HVM%R/=@FE.^*0E[L/0
M:S7GX9$G&62V3H*L#0J-:_YO+)QE5QL*L+43W(L[%((G0'&GQ4F H D.A>!:
M7$L/4ER#!"_N 8)+@.(.Q1V*MD5;:*&G=LY[[KWOA_D#L];,L_>LM><->2K,
MO_8#!O9&N0W.063-M3*\Y@42",L)A&I*04,1*U-=(KONVNGV_3Z.O1EVK9<6
M-G:19E@SSW>7"Z[>6+@G>(;MPSW-9B+M59-X::AK[068YW+DHQ-"9',&+=,
M))X9,=%PH%B(V!)<=FQ9:TM7?M:QK_F]O;'0ZM&<AM[KLOZ;Q5/]<#X2OUEJ
M$F/:1N6S8@NLJ04^/2F-S@0JSYPZ<  (J;%0729*GZ^^H9HM#+-36KJD3]/X
M; \'U?AT>:%WB5.R'/N57X3]K&G?:.70HH@WX0;Z=K1A2^H0C4&1CI^]5 .3
MG2;62]2+2$@QOV0R-2NR^$(SDD52([FTGAUX+H_N5N\E'R2&HIGQ@Z7;@U-I
M^(LN8;L0B(QC=PQ57KW#G0ABYWH_%Z'QXM7Q :'X3[F_+P@#3"-""WVD:=X$
M_0NPZ/ZIR4S]BN860?BJ =FOO1^)&KA5.F=;G2X@97"S2'R$(R9T5**92[&)
MK9[3VA;R.KF=J5M5%ZP&Y2.7=06WV>7=]^_[PYY[$0,M1\>;I"!"X;T4.Y-S
M,BO5Q!F3/B;PZ9:*-8\:M ^,/X8'F"M)W9ZIG.L81EVW;E>)/V/8PU/:7T9_
M[#SIMJOPR1_T7BC;7KP8*C?IOLPR,)55)3DQ -BO;13+3/:+<7<+EO@[76)=
MN3H'!NTGOVI6Z9P8,;:WOVMG_+L_+W%HE=6R:0$,G2UCM;_7[Z@7]Y405*J$
MZS_2LZ*76+9-?\^U$AKXO9PQ11XIMD_[&MQ0<Y2<9L"HNKH^8?:7QP^6F%_>
M+95;LTN!/H@&>JP1]V;D(P=SE_&X!CB3D+5%9_6*NEW\7G?6M!5@^^^=@[=^
M*N[A7_$$Y5@I]<HHF6-IBG<LDQH*Y-V6E?Z!C4T_03IIU?R8'1=G;>&V(6=8
M%T1&^W6MB'+VN7/!_F;25EX'3L$#0-FKPXH36-K#9[K[HFM[+LJOABJU;FXY
M^%Q229L:UXZE[_W^D#SEF;BD#/( 4W)"G?.<>,GE7Q)9KI>??3I+B7G*5W&4
MI:V3I5D'J>WMG#)<UK)VRQ*=,H5]SDJ?*!KDW6]O%-5K)V"-_9X-TX2;&@K0
M0XD\7T_R,NWC9#4FN XQ;JX:PER%Z(H0L4V.9Z]6G'?J#GB0W23+.3:5N4P.
MO 'W4+.NX\-JUV65$#$0M;?UE=:49C6]1X>[[?0I3XZ#\$?')ET3QJC%(K58
MJ=MQ=K59OG\!$R1'2"D6940A<'>$B%F^6 +_/8<7=60/KU=_,I(Q9%+ 8](;
M_=KWPTB%E>D%]W:;93P"-XS:A%F61_(DR)[XVM;D;#.;/".H78/0>D?X6CE6
MSFW1%M.J^5/G%XM\3)H5(4GU48/5L[$[I^S#8&*57->"6VC\\(VI'Q:IRHRJ
M4"NOU=HC[[P6@ #F.A5O_BBC$T:;^D%J8N< <M^>MOKU$YOM=N+//DM2R_XJ
MAMAG=IYCY2.-N)]32$/41,_A00R!)2!S3DF'M3>(O)M)2>WJ]S0?C9:1*0-_
MV-^=8>JK'MM.R!",B^N!V*8SB9S/@AXEF\:7RMQ]',K%&>2A*<U(-X[PEFGN
M-[Z0B[6,YA/*#F=2V]#:H(PO'$SN-2-*.&XW4;N ]_F+2XA RN?T\SW%VFOU
M>LSCF"YD]<1[(BS'MRZM1YDXTTMM,LHN'RY%"U<2U24"I29+UYAY8.SN)E:O
M78@"^!("(J<^N^>%I\4\%?^6JG9M:W!]H&]WR9-BSL-"?<#7LMZ<O+_5E>GH
M>R]6=.D_O^!C*V]:L=[4[<7YRR?-H>"ZK(T^#^0<Z_I\MH8A./^L>::0<VWS
M((VWH76VF%5?HDJ_4$[?<#92Q]P"O<T(PB@C "*Z!,/'GPC61[QX@),^DS5T
M_XD+X!R#\YNZ5MDH\6E&<J&2P1^9_RLFB@K>_V)P)[K(> #EO]RC:QE;7HD(
M"FEMI5%Y;FUOT_'<^TMH(/.1>VLV5HX\Q3ND>D?,68^HU"".JTHS5:MH/.0T
M)&A98P>Z SV2+,MXB3('MT^URRA%)?I%35R! ",S.\-Q3L7*T[(T=&<T3\7V
M)LL+]J1Q^7X[YMV9L&1B $Z7)2E'?#^\>$+C"OPC"C/N>9#N,6CXM*[M"-[9
M5XH<D-O^8NKM[>UN='K6?HWUNB=DAFGL2<PK0VEIH&HA>K%]-TF_%$*3G-(B
M(K)=GS 0$_BH@$>HM'R@']P0U-W+.ZE,8?>I7F09:I^_.O[@::<>UQ;%UN 7
M6VX;)9L/LE.;9^]JG%IH!K!Y'-2O70<W)I&&FQQF#DJ'U\K=;_>Q_?.J#$1(
M=X0(B^4T]S7BPQJ>N9U?!)(L/=J%_[:U?/E=#MM*.KI#LVB!]!"PO[-TJE)Y
M)LAY0:E,QY5U2>4H3S;:6;'X39@#='&?@47R*9M:'"L"HRII&0GVF#PXNWQ%
M:<LI#M&!:_U+E]Z37,^^JY9;-=V[6U=0D%!:7!4(?.=L;NA7BMYH^[CF?>IS
M3F>>:@=L/G>M:^'1_V3:/M>+ G[*JQK=C=-=^L2</YAG-W^0HT]G223A4<.[
M)-#GBM&V<=\R-L6OM\PUKA>CDF8K'VL[9;$9=,"YFIAK*.J;5]1\O_LX:#]]
MN_G<0NN)4@:>IE6]=_U:IX$ZOT][^==0)O/ZTWDC6^TA+[U30L&%N4>H-3KO
MAT3][9/: ][?(]'WL0+^_89SOK+%'9T:BEL#Z'[1/+8UCU-A.A?)V3.D)O\9
M@R=7&E!9_SN:,W[#,W4<;X(N!+[ZX+QG61ZV1N]1N;?Q3W811^Q5=GT4]%KL
MCSW'2YR9',EJT47WOP#S=<\N5&W(":!LG[WQ/YV8D"'EMQ"*B\EJWFQ/-;"0
MZ7P='^K*A),R06],0DCYU+J+N*19UT]>OTQ(WC^UG/UN=, %<U@9'RE>4OU[
M?Q^<)\9]+RC[2.G&_33K=VTUN,'K,XM#0I*N:=.YK0Y^5)N$PG,#\N)BY'BW
MG6B_+7QAX8CCZ;(#"]+KY2,G_='**R4KW-K6L9!%4>MB63?D;P'HAE8P-IP8
M]G>N(4[G\W,I!YP^V'WT?#I6M;A22SSHXPD)M-H\8"052'F=C<R-?NKUW9M1
M-O0"ELMF$P4=%RX@BX76F"?M&*1^FMI/E='+-QTW0#2?K TFUC0U/CAQZ.2U
M@_=U5\!_U/:]_*H9(*;KIR$*69&\"_8J/CZ>)!-2&8K" G+=<M-7% W!-\")
MJ)9PG_@QP3)H4>^O*BKT4XSNJLXXX"M9824#_>_/63]YM]6#;\AVJD*@9VMR
MA?C%6WZK95?_&<OY&.>;R=4>SPR]A!K53UXJ9J17@^7;E+:'-DXO63=EFS:K
M]@>MO+>.Y]8_;*E[&P[*9S0.MNOPB:7GO&RU#'9.Z96E5V16;.K2(::Y,&=P
M%<J4Y$>EGHYIUM&KV-4<5!NT,%5>?1),B_76N90(J1%P"N3W=&>BN=-'"114
M#J7BW;I$6[$8(1PDHE-;.XNR7M>Q-S8D7NWM+LUJ< PR%HU#>]6NP5FW\OQ-
M9*_MM3J,MP+"+3LY_C1'$N )A9]W%;>BU0,)*V#N7BMNC)F\K&<P>M$<\2/F
M&2YS(2=(=%VT<\K3\W=7H=2-4!P!NI0HQ#EMX\]L=7]Z=,[:5<C!4"0<'03C
M^2#3A-JM,=HY='M_(W!)&X%IUE%&T=-;2JW;<6J:+3FC/<O_IEVNG6S2V#6<
M;>#J&(T(7U*OV:/1:QO-%?@:)Y<&):+ATW:J1C4N]#TW%L3T)* H"PCZ*VI<
MMRH,K^M('GZHV<TFKS%3:J,D>94]="L%ND3%HD5#">0I[[@^O]!;R2(D( SK
M]&[(9N&Z:W[4LME<T26"3__F(N^ZX/E'*=\2_4J@M9%.\)F5QCZ8^9N?P9RJ
M$BLI_^2B-">AL;Z*!RTS<0>?00-;-N]^HC\K>OJ]NK6L0V9_$BX\LIR@ _;R
M#2%9X1Y_XJL)<1-UB%8B7X#/I?XJ^58^_:#JXX[%G?4[_R!BUZ]="5N4\RG\
M"].#85&6JB_37_$WY"6<S1:GIF_,<0LUE7(B[)[1_X%G$^OTE_5KKS6267)I
MZE*"8Y%,J1TD/*KFTRM_Z&LNIHGX#CZ0.('0% /1V822QA5ZL>:? [L"R/0/
M-US?R01Z_?\ +F1=UR1T/W2MZZX*^3X O%&T47:>L5KU\X4O<P?_>^.>J+A>
M^7@GAXT-J@7HFQ6%N?N?Z0HO*_M_OGO^XGF/ ',<S3%!=:VNFVY-AAU8^;RG
M"MX(UVD\>\R<H< 3MNOG3Y&U>$IN@E_]1 -M<:T-9S"^R,ES235<5B-R&PK%
M((-W$-,^2.TF0)G";7@JZ4_,I?6PJZ12QD&$@#WM @>Q+-W:;*'^8-Y^<F]$
M=H*C_YQKR];9+KG&DK>9=J.PPG'%9KJV3PQEAW,>QO=PY1.3W@"@3REN (_U
MV!^IAGSZ/'1M6#WMD\IB=NY=P\H>948[)T)!I.F %-\_[8CU3MG34E;?[13Y
M49-P];:1.^>?*E^F!@S@IY$U9IC:;$">+6SDFE94O)BMT=-:=',8 "[W%HM5
M4>V%[4^@Y;;E M 4FA22.<["LH';^7INC*4Y->FCG5_%?W1^(9@V\RB":WQ/
M$TB1FIXA.26K9A;0RNC\<+[#T(^AT_%4K.&UE$W: -$RA@)C, 5M_1PI$&O*
M?O0Y]WMSVV['!4<LV=JEKLQ2$\,]GHB#S2Z3(>B>CZ4.Y]P50QW9]A#R-KI"
M.@443I9A_\)'Q;S3DIY,UZ\C(-K4<&Y5J.I@ON526?P>W,;U-/_$0(!>F[%V
MF(?[1HJPR802[KQI.#GO?VU&AJJF/_; 9YDY9X.N58I#O^6V7O6(]3Y;R>MQ
M95H;(UF6F3AB^0BIAM+6VN(D(HFP;.ML N6'>MO,C9IF/?'$'+098I(BX.VZ
M]B_E5]EK]_)ZEC9U=G@0K: @[.3F>S1_IC^O\L4:FAZJ\\;^D[<4F06FH<PS
MO_Z:C3R)*/G70G6N'VG-ON]KEB"N;U%'>PP#@M&2-6UZ'Q%<T)MKWYM5Y4<!
M6Y=(?YM-K^683$+INMGK6#J][O2-A\'G-D#IH,VBEBV(M(^N&/$+IH(<;^78
M-2SAXQ:MPF3:3VS(%0^9N^^0/3Z\1SDZE5I?Y%%]GF#(S>,(!6UU#JXLH6H7
M%P$;L88WEK\F/UL9ZX.BJ<##6.'EQN_E$!'4Q,8\-B1I!)"61K<VA0PTM#^Q
ME*\'ET["';I*/@P]]JU5US64_?.*TNZ]'&=IOH;8RG7"+\UX5(M\:/7E=:SA
M>=N$8B .^3&CR7H*[<8;\-L,RBS5[^;^O5$T+?MQNDRSJ'^H*;7U%*_NS2F&
M!RT?TE*SU+!OE.9)*3O?.*'/2!/72T;W?D"S3C0F5TFT^(QC6Z^)QMQLXP_J
M<Y.%GHW[_5YI1CQ>&&]CNA%RGPTW1*/[&>RMNW%PDS;1H\O;794YDOM[4%W8
M;K>P,H]MJ_/ *^)+4,V%1I[DQ81XHD'1M+E$ML=I@EL,X4Q$H2GS&W[1D-+V
MZ=OA!$&.[H(KPY: \\;"SA5F 0$8R,K&$R$Y4*G(IEL-3&<Z<^21,?PSN"O,
ME62GY7TNZ+,D7&KT9A<!3NE_7F:XE6[B3F 6P!9YB3JKN[YU+4XV6PAT2"W4
M<TQY$T)-0^Q'=[59P=XJ3]9"E?/$K"8)S":32I1YB[L-S98;XXY5/.'5_YP<
M5_IG+;XPE,G+KK%"&>-0E)#'>-X]- Z,N]@1(HK?.:RK&B2(ZV2J<GZ7_ZI*
M#I5P02E<7,,;?$G2'/*[P[I[G/+PG]-.21<F&C@'HO)?0,MG@98S6_I:?^OJ
MU!Q-5>\<)S,8/L[R04"VE1L#*;16#!7=/]@VZ1F.)Z>'[\^P3\K;G[-"ZYE_
M=1/%E7[,KG0X[ZIZWR]GUXYSH- =Y'Q+Y&-L4NQ?9SWSS,N7[RBD"QD<E<*,
ME)8&J]EN'C;+"C/OIE<,MH0D_L7)"-O7#BL-CNCNQ95O$2!;<S6"\ZC .0S$
MV/(3"=P80>>3(4%Z,QP:/0L*A?&[%+JFZ7#/F(>=/O+J9 <'P$3HQ;>!-L@M
M;''AZWA.@%/ !)P$&0318N>GTSPG#/1>*'BU3>K \;#+6F-V=<+ ;<>:HK$(
M#CEB+1@;:UB?_6%GXXP@.Y3F0SQWM<.J2;/;(@[>O6-PBF39&&'42Q#8O<M(
M1VF+$DRJFU[-@;<]BR39<95.QK-2_1YO=!P^_"%V$*-9L8JA8D),KG>?1,UW
MZMQI<K[C#NP(_#]DR+#4RI.:!$ZXUS;8L 3M'W20KXA<</LN$ :)LUC[0DB-
MV=O[&(T5[W@1R?K1UDG//0RV$.[,'LBVBHOU&3,<4P<XK*?J#9>PCVXX(]UK
MI<Q4LD*FFAB95451L6&0]FM=7K6STMB;7?VI%*O9L;8SU"CW[^D6K8#.Y68"
MC2)A9_&8[NA&* =VD@E^OOE/&1UBRZ6%OUO<YV>./@S\,+99K(0T>LZY<[\P
MTFD(>V+WN-UT_I*ANQ'I90-R!5&F,3-%PSWK06W@L)T_<9#S7W*A87E$ZH)E
M+X)%><^@UF3Y7JR]\(R[]384=GX1Z#(IN*'5>#9?7)7J'W:ZRX9V">FB?WG]
MJ6V?@@@<ST^8U7W0'?&EE;1I^Y^SG0>5R/0I3XH8^YS&[MV,Q#SL#&+2HJN0
M?'X+Z<3[8I=FZ\H,6(A*4[)57[,B8])1,;1B'0O.Z?BE6+@ZE/7=?W3B]5*$
M!C)@)=K"(8.K'CMXQ,(C!JHG.O.Q;]/H"7F3HT?P/2!"4*K"22CD>,77TZ?J
M];$4C."D>,/($LA'M8!SQ3>3]3JHWWNKN-MU^@F6D@J7F8U6$72M$WI;);X@
MPDY\6\2VC(DKN9B 4GV"E2H8BE[U,.W\UM7:<)+JT.TS>,X6;^U*68V:7J"U
M7-?ZJFCZ.&#L:V*U]F(3HJN7AXHPM'0^#60:3%"(O)Z1U"E/[W3F#.K7>MK6
MWSITL=BS&5:GMM9Z^:KD^Y^6RB\40R-8.]GF[H(F0(HAC*NMX6A<8/?R=FM+
MC2N"R7C<]?C8H4U0 WI_V_UW1H8B_AD^:UY@W0,]IO*"LT%P(\>SAI8N,V1T
MCZ,6'.;YV\OX]N)[?:JSM-1*_X!W=:.5+\W]#VU^D9;HAC:W&_PFLNMZLUMV
MLF?(>T9R,F4W2\^:">)92JZ^9M+_E_[/ ;Q,S,^LYM2C<GA3-&5AEZ>;K]N+
M@.02XPG+I>5EI8>?8=]>U"58.;WV=8?JQ5C#,FIKN4X,F_8[E1M9H!L2S \1
M8J(&/V-DT)-W?OS=?9;\4<,WB\MTRJ_S B#*LD7[TQD3G=X9.,WURQ!JK[;/
MW7ZTXIN-(LJ49B%.HSX_*U6=(UJCU./*_B)VXB?IL7K2?K'N-P7O\$+KO_5T
MRS0CMJW/Y\#[B:/="[<%4O@#.0.(ZN/XS]X%USAR .:/A4(H]Y-!Q5X%I]#/
M'+ &BF;.M NNI:Z9KBH*^<6:L?;&SI3R[%_LJM-<; DN#^N[WR.)5Y&/(4X7
M3Z"KU_L*GOA_, U+GORBW?HT/SMM^9_Y;=IPHL9G8ESDK1KZU-C/Y#XX"%M,
M;3WI%J'G4R'^FO='P2'=J5#C//@1=Z-[73:, 'R.!BNB>&)3;O@=^3T7O.A-
MJ+L>JO/F)B?JDJW)W@AHB5J[HJP5B<VDZM7;4E+<Y, 3RFH^/F^Y;ZM/[.3@
ML9R[-QVM+6L,#A8M/<PIN8%AWNR7_N.D# I.0<HB$:? I=W^_(QK7TZH 7;I
MO E-/6Y8RZK<K [-3?K RRZOM?.6)3W9U2%R@@9V,[('^P:MI-+DKSAZST=]
MFWYQL> VZ ( Z$R"$KY^NCTG=)*RL+/W_1+R>K.YYLDC3?WB[?0"SB3-N\OU
MT,2;HO70NK(X_ZH$_P*QDLW79(/$#J:8%L"JX)F;V>JD*TI6($.:=HNO?S54
M2RK!;TG9,S1[0V^6Y/I]31?(V'/^TPV_0.KZW $!:^-:A>,.)'W::.''V(I7
M><!JJ5_G\>9@2:*RO_6GPWO5Q9L"@O\ L,L24;-5#&&N.<S3JHU:,."(/LDK
MHK9.N*X5NZGF#FZ9_QKXGD-IU2_)S A%A*Z#_K"<#?7%Z]_REUXTU*)/R9Q"
MR"KCB!I"]B6Y+D'CG]5Z?3YM,'RHT!A[C1#E4A>S95X0"[:5-JU"7F(@;)3!
MT<9A6,[VG*S?A3I4(HHO<SO[1'QG#43G@S],MHG\D$*E:T%7!/3"\Z9#=2PL
MT/O&H [Z^G) TQ*-L%TP#P!>Q&+5G8)DLDJE!8A&Y!R__/FM'1XLU&)?,H69
M(_D>GJD?4,QUJOM5[&'/PCI/\?<DIQSKSL2;'TX"BK\=]7PDP3)XRJRVURX]
M^I&JR6!7OM9I-W[_[Z5'?RI]*V;X^W7*(^VUWR+_/N-ZN/X7<.,S\ T 46:X
M0GC>;^A&0OS$Y?!" 6OF[ )%?AW F$K.WW!9QO6$Y:=< 56FL9]0Q]DJ"Y@M
MWP%N_F.I=B5!,I<?#3YI8$U%5.P9N10TNDDV4ZN11_Q&$^*+T';EH92=4G'A
MQU0]X>#EB:^D]'7E-=&66G9U >38?L6\YKH/B._WZN_?1B:2-W$-&;Y-J ?Z
M^O05QG5NPW$/HZX+*IZ>TB*3KA;>B*5#E$'0B70%R#LV6W"LPZ(I5,E90F;Z
M-$]=I#OMBQOM=Q?@ 9<FI(.N,PX!U(D@+]!K:X_IFZ5X=$27-71,<"U@11 +
M3]UWS//JMJO#:?D<[>PGR;*.M8!\*.I*>:2NT54SFQKM]F"X5;46M1F.XTD2
M)OYM<^/I5W?2YRW0[ADA"5>HE& 3%1R(V2O85IZ@YLJ:MUA6LUHW7SVS"Y%^
M.@RLW/#@U..K 8[YH-AC3%ZVU;@^S9]IV&/29["P&"H=X.[S'"ZF.?\20>AV
M9-A!A6%J^$+\5B?[\JLGAIPN=;Y8PNM#X\$['/PQ6.\-0^&/QY Q0;[?4RI>
MG N,D1DKM#>5D<. 8"( F447$87GG@*?&$.'#M=#*G$,(*:CL8L>*N"1-"2>
MR2=*W?.BTOI\M-DQO]HW[OYZ#=YT)#B>5NP^^)<SLT+=2-R]VAC(0$S:"2XM
M16U?'RU-O.74,@>VM*!\YY$R<H6; BE#7J*D^;V+09T>)BF?+5!J=,0]42.Y
MU\#86#L/"!\8=U/"E[#/LT<7K6P%("HD5[;PH)*G)Y=I'I8/]F;TYE*TZ5[1
MV>"];DL+C\;LUYIX6KWVO,L_SJ*V/WA$^!S=,:Q M ]GGU=N%Y,":)C/:_TF
MSD#PM,6*7X3 * M@WQ*&VY^\!!$[[3F3(?-^;=3L13;N&XQ OJ,APB;"/X;0
MX,CV4Y8*-@=U^ZL(;?4LKO*8_38?NV@AW\F-Z[$ZC<>>A#[%IC@&MN 'Z/9]
M$I_;I/MZ$<(XSTLD1_+6/0\<A^0OIG:6==6.]0#QE11>35LZN4?N!IAD*<5Q
M99W&=:F[:9OAR#E]0OS*"4C./3AA^RO1LQ.6B>6(1R5K3 4_=?%FO<2B<#N_
M2Y_5P*?*=GTN#=I2FFZK:5<48XB_^)T*:C,&30%:"J;$:[^9#QUW?.<:#O0H
M'N8^)$S%N)*2 #NNR)CU7&)EI:X#*EDLRP8Z[A(461L+UM[/:MW&=8H(L.:9
M3L @M,7Y_FC]EEGNZ"#C<66*;\X6?/X\) #F<F_-R.BGF*V'63%"$Z(8=2 /
M\9A+=AW"D-"E:A.[A97_Y:@)\+3<-"&S@#A=;OPBW/C%4_6P5G(/-5)YSGM2
M.(V3N>5O-YC4V4.3!J/,55/IP1W?JY7SM;?2&KK?<72?2&%-E?@]Z4(&XA'U
M>V=I:5 [3"-3<2!)U!KUDLI'I>['CFD]G7@UT:&9BNN%[  DQF:9M%_:2+IE
M3P"1\'?=^P?_5/"#<=!XF\'\%M.G)=<Y#-FB72:+1+^@V=VOU:"L\0KMXI(Y
MPU"@9^FJ=8HHM)8QP,:4XUMIBX8^KRC4.A7?V;;4$R;21P$4,"(4__-VR'"E
M0I/7A$ \D$ZF=O+]9%&GHDQ0<I>=W[[J.1.=1T8UCT_:9<C!#V5%+=(-6_8Y
MLU$&6()='#3HDI=W*]8MU0 O''WWN8']GP#Q=T7"75_F$!L85.6Z>OT;)WPJ
M8M<=4B7WN73:^I3C6#&PT:NXIL&I$GGIT],W?T!X2?I!=)8% 2?T1W3!K/!<
M:<UY[[+TB+M2G6DKO]J'L!7H;S) 76VW'M;._JYVM,U_D477.6Q1=S#\53AI
MN9R"470WQE2 (,9@,OB).T'K;#[=P5&G+EA+_W:F;K]GN5(9WX$'=_U3%0)4
MAI*DKU9N?A(M>V%OXYOV&NP.*98</&D/DM-,A%P?295G*GO76G"1#9AC;U)1
M5Y"CP.'C1D4VXQW+/%9L?#7816NO<7]SXGC-1GR#J!&Z.RA#-!GBJ^+<4C%'
M:5S/@0^IU U_#R,F[#5VT][]U,8Q>7%96+- M?N_J:79]0Z--7$@).$L@U[<
MQ7#.6\Q!1%(21.TLV1\5YO O8/EE]]J/AH>)WKVT@>HI-3>G%J4]7JX/TORB
MMQWUHB/+3 @K98R.4$84[1O;FWO.R17B8#,U)E?1EW)Y@"B!H5;+N:"'O:R%
M'MWA1AIRERJ?XOB4.KF+B7C%Z1^.]Y-S^'%WGMZL&IYNN_R6FDR(N!4=-EW_
MJI)/P%F5;QMC"82K!\SPTS4ES093BTJ6SD-WQ\OK*39U'E+Z.SN_Q .S+9S?
MXRLL3U\1<_P1C7-&WKY<SUG]YX]T;VWOCV@3B(9WGK RJ?UHEMRTS-Y.6GNV
M3N^W_-GQX9S4Z'P"X?&VEF3+41<TC40.4\]ECY?8O9)+M+'/F>V$"%5:Q6C<
MY*KGHYI.KHTFESC?= C5I-GL-57%$JTZ&,X]P/[-.Z52EUBO0S>XI?7XJH]#
M??]EI)%FHREG/7-<*,[VSBZAWIRDA7;=YXDUX*O4\US7*0L.DCI;A\/M[!A;
M]4)>L&+W?IUJWC<=ND<1.?DY$07K<K\KO[NA\ 2JC %VW5EL;&J0\S,6LP,V
M.1EU,T>:YZ'ENPG'E7VBG4U."42E!PDN B%_XB_9,<-;./:-[/GU)A)L>2;\
M[A^R(A4EPJ^0G%J#--4)&+,A:KPA@%<]:G/[ZDKAG8B!?/WR[Z8).JGX4(0+
MRR BBQ-@DT 82I2B:F2[V'KG?D=SE6<Z:[3@"L@32N4I.C]:E6RY7Q//635/
MR=H/FJQT.#A_NYKY/ED+8MW0B] >_2F$4 TO^LU<5!S0"Q/O.<FT_89/)A Q
MGW(K2+\BP[E=Z]:N&6:X?)X=X<!Z(M][0'=\KPC'W9F36[>AN77^?)3O& TJ
ME)M7^O-Y&K/9QFT6*%WQ!+_IL%^ .0]/-_M60M0D65M1<NUSC(]?Y_<Q'9.
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MR2V5GEP30SDRK^"MV'B5>A614R#F?]K//,U3Q*WRV"6#G!-M$23];:BAAK.
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MLV^;&%[MRDK^H(%+P+>ER:&YO_OT(R+/0WW%]2V]9,*16P-T]BD_P>!<8P!
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M=2E=?L=!E9"HV6J&*:&L(\TT>DAQFG=J,ZX@](PR1!F"3FG ?^HM*$%4+\
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M6=+:]Q3#E7V*=I#VM)$U[^B#YKR]SXAO,J;KLN5W!G3A %: _F.2%V:L=$^
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M9?],<"$<EN[S3X:S\R_^*03_M,^94:T9U('O_WZIR&Z'6-PM8#W'AXJ9^+1
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M6T3"K@HB\7[SBN1.5+\M5 Q6=4B^<8@2VP,W;ZO_00?0-;0VX#)@#H<NJ"]
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MZB]X[-INKDPBWJL5@1QOP[MQ3K%/.YD:Y_SI@EEM<]LU/K%4-[7J@BF2/Z4
MJ]NT0H6&G?%PNI**8O7$J#$T')T+<8:3,C^RQ9.4Q,'7&2H*1[%WVLA9.@+S
M?!]T&>=#U56LNNZ9I6QD@0:=8.%A5=<74K+T:R?V7!#EF:AG2:+'8=7+Y/5
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M.1J[9"S_-3;/;O42H!.;.2TFA@NJ<7T("<O+]PU@=VU;9O5[2*; 2\NHI<=
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M&4QE9Z%2I155ODV(U.[>XHO*'][D4Y=2A-["?SS;"-/;3$OLE[X@*C(Z%SJ
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ME@&RD2Z=U $SFR9/7Y]S':[4ESF'KRN=5-.E_A)0#=( ?DXKK>G"3LPV*(>
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MIJ+'1L>JK>5S#T^<0JO9P"V,^E7856NV^O("8,XT+4(89'_%:0FF+-FV1W2
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MVJO7C-*:+H,LA!400G?39;]#!!!N,X&;SE7M/^NDB^;J3$ G14@&&WO'!QV
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MWCMYRC@"<()USU;; 791F462$OG6%E*?7OV0-Z71Q>W Q$E'W3+*P4V5WP$
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MU-G]^ABAK7RV]@AQ*,3WS[T"0>=C<\-S*/NZ(8-*?DU(16%"4VIVLZ8%7]6
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M?79:]%VJN;\B B,IHSUF_H'C*H.X2((((\C[!3Y^-LW-" MK-2&:0T_/!EX
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MF&_Y73*<@M^Q_'S\;+?3PWR(&@6P5QJ&%'K.<=7V3X[7FF0;D%=] SJ71"R
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ML[P^W#JE<LU2&7[K@-(:29Y6?$)2\IX#A,>L-6]QO^\?9" ZJ7A-3R';;(Z
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MS+M#E9%ZBH>D8V=GC\N=Z"E*H;G9")SNI!^YWZ^\7\4C]RSYU&.A_OY^(;]
MM26E:DQ&9=ZZTU'7@BS/ZIQ/__Q\!GQRI^?3AOK]D. 9\ZC@8Y<+)-S<Q>K]
M':!66S6Z#5?M,<J8V]?\,K&U_91OW_C5.$2$5!O6S,&03DZ%<W;4;Y/+@(B=
M-X)?!].\/TZ^\6H."5/ZK%0H(#[R8^[N1W+&=9VLT9RO&*C6))9/)<;KO.6S
MQ8F+?N5"#T^ &4G?'7/Q)^.B*Y;@)$UA3)04D3<DA]R\7F@U!I6'9II,/ J_
M/IBA?#TQ^#Y7V<K.%:;SH,,;[,KQQW"LC":V>]+IO0(<C*P*,Z7^:L<:/WY_
M'NG!D]AJ&H;/);$XIX"/=W:RNR[52<M]7>4MB\V+?)GP%6O8^A#+RQI*D9CR
M+<::;+1#IGQGXG6L.J]7 2#V;M!;LPG9;3G!;BSJ MSFN66V005EWJ"G6FS)
M]S1 JEDQ\<BKRBS/X<;&_?_P#* Y!!@M@[2-EEQ">R C:BEKFDU(!J\U?4++
M.\H[=8>V)M)ME]=$.9?\28L$Q7%9O7_N@*"V(+A*/DR6?AK>DL[Q.3)(IZS5
MI8@7D@AW;P6H.LB2F!]5'E23CS2TGA3RNE43RHYC'YU'E1[$@[\PS8!NI#<\
MPI04=<"S*]F\0@;W="Q,T&JG"?N#F/VP$U-HTJ+EQG9 F97Y0JFF Y\GQP5G
MX=@Z9+<CQ?*S=]%';_>B?_M'3NZN%[6ZV1\M'[[AZ1'<+VZ8W\R [X^TAJ4N
M7*KS3]HP9'#F]7.;(C=O9\ ..=A_JI8-B@990_0C@SB"X5*VU2($_Z3[H/?9
MHQ?6H$[38D^: SKE<9_L1_>3!]""P2Z3=>8Y,:J+._X,QVWQ@R'>+_FWHH\&
MR_<]7*Z> -?K'Z!8/%B^'/*9!ZBX>7@WFP4CT:/@9%WZ>M$W[T1<>V$(]TS=
M>P;T5YBP^M46A)Q.\&/&_+B,FL@2I^P#'7<F_9W"U,I3"';!2;B;%69>B+#\
MOI6\VI^^HVP6)@2WO"X5]S9OO(YU0EDV+/ZP\SO3>ZPU\XII^J.*NS#15OC6
M6G!U].;4!4S?#B,3(W\#(#R)NZJ]L\MO9&HD4-!!&B>EGAQ6K+#4%\!KZABK
M'+JE(ZPY'H7U[]:UV%4+"\_K1"\',,>Y:YDGH-F@-R<31V@AX2HJ]XIJQ_F)
M$^.@ZM"BMPW"LC*N G%2G<:NBV8)?5'>=0@.^U/X:-5LB5,2,_9WCZ)FU^Q.
MB%<+XF,]'BCSQJM(K5;G -"]R!)H&#J, ADPL)+BM"TOPRVM4\1<B/[G?J_=
M_H(E>]F%'GC@6+I_6T<B^NLYEY;-[Q$"S+_:[,8E1!7_@,R_X_]2V)(-_\7<
M5H0\Y=[7+HPM[SY-V%&,*SGLLDL']M3S>-N\KHC_5!2Z&QE?I;_2.:XH4?OI
ME[;:2X2:QH!4,3,F79[$0IE<)W3.;TJX_3N8E;F2[>G\8KM&1BR+L&*#L].M
M9KUG6XZU73"+S44GZ"TX\BW RC>A"G;\FH.$V"H8']^ ,"0;WOWY$-PV_*UD
MD:".)4(@Z'A2<7NC7FNH%;Y9FH3GUE'FU=&VV45?B\^-+-#BA/7%P,LPAET7
MM3=V"FOR2QB<7M8AQ&85&1R9K\^N"6^E Q,ID\-Y@)$QM<'064)8H*B.EV%Z
M3N57E8C&1F^9-<OG?D#*AX.G!&_@K_NS8Y$[8]XB9I)W'PA'(G!Y:]S6(I^.
MI+2JM5)O=WL72>PGY!STMH'A<^^/]1Y_4Q%)!V8-EFWD#^//RP!F#>M8DF0P
MBMZ_]B>:6;2:O5O9%\VO[4E?K.-O#6#:?!U3;E7;XBDI%M.//+'F;=GBP?EY
MBE_R<D.;-#Y"6\<!>HP7.1S.@_!L&<+^FTEBBIZ(F%_UO,1'LP4MQ^0VJ$*!
MNG[E#,PD2&\ PRZI0BV)!87-V(E@8 <IU!+'R<W7E\:KCS"63SB -PXGVMN;
M7=5WUPD$GCM7N']LX[2:AM4K(0]LR[.KAW_;X@CYM5&Y"#Y_'(=9GZ+_!F/\
M>NDK1 1"!OG[.@=AV[;B]Q^ZLNEEG*]2L$^JHN6"H76!FNCO"%E]KCL,[P:#
M'#5_5K%CTM?7/E[ 3<3=+WK>7ZA2]J\UFX$:MZUBW9OKPJWPS9OW8*<[F.&=
MKOO)T$3OT$'WB&:VYE;#L.(2X4?4:O5ESU82>O@G=QP*<=#8F9V\'"&77%'"
MZO=[0-+B@;?->0\ER,&/9C<#H!H?O"I85I:#.!EXVZ?&E3P_[+B?*$KT6Y@\
M^7>D[1O!MS7(HT?&R D[Q4U$<QCVG7>^U\X]IET<U_4,ZH<WO<]G6\:VG7N2
M,5QV_+4?=A/^4K7/5CZ16J#E;"JNLF(T'8FT#9)///$N,!R*],;.AH!-0[X3
MX6F?NFVIO6[-MF:F^3V 7DLQ'")UX/&'.>1\Q)!0]ML"\5!B*C-(:- T>4O/
M_Q11("H.+%X)_0!NX\*5^>2/LV1+ALMUBO)YX^R,^I_V ,;:+UT*;1K NN:%
M5L;Z1*(<RM*!]/:[>-P:%#^]89:V4T[RQN67"@#C,]^ YT<\;#>QD&]Q,>9L
MPW?O+.*U(;C4@(Y.HLV#L5#\U>4?^7ALS[.^'>US<>9@7$GF):*%+B+?1WJV
M+&LP]/T6Q."_55]#A+("0DV+7,KU>S!!#<?H7&>N&[P67B("(DJ;7)WKY;@Y
MD)(B4^2X7AL$-AO\X'W!KR6T[NCG1DBV 6+.A36Y?73!N3!1RT!]Q0*T<5X'
M;'(9L P=CE6[.+I;)+D!QRZ[6B/GLOD97^@FRVOGLN8>4B;^6[LY?,NN3FO*
M'Y (^9>@]L-SA9T:Y;M;5?7;?D?A=*R6*+)>='L_)+DR$/O.*3WO2,CNB$!M
MN/.DXN8.SO?:N&!*RF_#\H4 V@[[P^L_=,JZ*#_L[RJ\=^U>46[M;9?3H S-
M<-CC-\%4HU]G3W9</[:J5(*G+B)6&KZ(V3:?)JP/MEP_*7!&8]>O&4JGJ]D]
M1!2UU%E^QW[)+N+%_Z&+^KA39+!N>%O"8W7@5PHGU$_&D;)Q<@&QO[[2/WT(
M86J4%';F[(5,-'$FZ=#<2Y,7D[-G)NY).^H$6R+K@),OTTLTF%M]-XMNTPZL
M=UV5AHML]Y4C\"P[&S<&(DQ[#^6>&97B#2/)'?M+S?242^?P^Y2NI''5C!^M
M@,F&NX39*P\8AFL%G\REYS3]EG>9\D1\H8O;P3V>:+DY.]=U@HC;\"S>-%?J
M\J5<P&ZM7@)M]V95O8SOR?(3F)K]W"\60%B".3>!8_LOOAPG;*PF%=8**<*7
M"H]?;ZA$B>\4VGTR&.C65Y"B2H7>V;"<)?HT!-O<A3_]0T<PVZVC9GO$-(#<
MON^I(IID>B3&E.RN79'CM#A^<LXQZQ#ZCGKE@TD&RJ>AT:=CI'4;U] TJ+,K
M.4?P&],--RW]6<\//P=[Z8^8(]H9<MH'O!O$'AO4.I*VEBP5$$P1NXES=>\J
MG3^1Y5BDF$;BMXQA\3/O9[^6)L*"J&*+B+[0@6X#GO5NG4-_Q/+-#PM'E0$?
MZK76F^M%:,OYH.7%4V/J,?"Z5=GU\;SJ<1OW<07@]WKN46WL8Q)BWJM"W&%_
MMPBX$?P)=C QW8WXF:VO"OO"/3UQV\(\)?5"-46G,"E\HMGB*' =A>/A[S@1
MV.6\U#UY5$2JTRW\V1*#IT:?E(:OHJ>VPB*&BGR5+E]]H9MP".6D<OZ3)OIE
M*#2$')X>U)XM_O/):HSXDJ7:L53Y^8ZBM&.E5 3*XNM@7P:#[74\5%)0EI$2
M7&RFJE2JOEN4H@B",=YE\QWL[W^"X/Q9[[=?AYA5$VVU-I/6X7-KAOM!J4 W
M]JV-<8*\]$3M,]T-?UQGZR$Y\.:T=@/L<-S9O8KSA9_HT0:T=]?5L?_2$6&K
MI_$&/@"P%M->H?.'[K]!HE6 .*/W7--2E^;Q'L[P1T7CRE+<.*'^$?$+YY(9
MY^<=T1O?JIQVYOLC%ECX,W>9/C@!L(8<"=E4\S6G$7]@Z+Y7(4]TRS7/(GU&
ME\5;GC* 22.STH$>]!93U,/*.^JJBUOV.-S*:G7Q;'WQAE+C3MWH<SO0'#+X
MYP><L<HA-%.SUN=--XK7.F4]+W2N GR]I5K!M'G< W,Q8)P0Y_:[W7W][2>K
M*LY;*5C]8*X,(=O5\!E;UP"9@43/Z-G:5(-4,98E>2WOY>XK.):-E.1!K-KH
MBTS\,9&H/B\*MG;-S;OC!%LUF+WX@ABJ*QV:VCFF[KAXH%'*4LH),V_.WW0)
MC>&Z5Z5S^THW7'VJ'5V+U*MQP%Y4T!/L)89&H'(O"L%Y']XT&B?GO4*T43&P
MG[KP7X0H)VF<ABB2PO@>W^P\-,PU%=I<$N<$U!>1Q-I8Q52PA=W*SZV[X&(<
M![]$^7;TRKJ]<!B?F2G[I=0D"<*-$YR6.L^&=&S^F;!D^C3HWR[Y.'WL[KBX
M*NK1'."C0KN!#RX_I12E]7UL$6P#GWE5_[ *E'D#]9],;M>RHX26SC#&9&)8
MF1U>6YU4]T_J'4V,T6-<Y0,( LY;0Z+OAX@E1'#?N9;2"1*[]_@G]N1]\AS
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MHH>DN-,S(KBK3>354K/=.3S&=5:A \'H,<(+([,_D7@S\>!J!<^[Q-)E6#G
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MW,R#PN"?_>6?AFOY\6YT(Y\$O5*]WCV'7P85?/HW!/&&C7JVF"NM9J-7V".
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M9WHM<O_<7&S!X!=/:(V2%/'(2&Y.G+N7Z-9VO[>A/[PDU.K)VPW[%;9S\*4
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MSO[KK&1?,S_\3-FZJU6]TD94&7[^M:U:O%:/DN@Q*+Y?SD<IT7VM9X4B]P<
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M43]%42Q(0+I2A0#20A=4>J])(#3ID$CO_;-0#$VZA-X)*8@0.ECH)=04I4J
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M,]74(0I_;H,,7K\Y1B,!+5W&<.;=ULQFPRT5&A.%0T9W9?#\ R#HP#'&7C<
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M@A_4!?:<DKUDO'4'1O@W6[8GK.AUNZJ+VSW$%TF!.2D$YZF>7GV:?38[CZI
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M>)R\AG)3TNMAY^;L>^LUC?P5?D:XBLRU B-&Y57=0?HG-X>- JP**[R A\^
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MP4\_M/%= @6=+V8'*7;I<8+L.5<@'%_,O+"9.!DC40R+]T?#AGPQGN@)+_E
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M#'!O:E5R<Z\.^W_Y*Z:V.%BY7:W_ZS^6SXM>K>4GJ,7+05F,9A+<@6/ ->J
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MMBW+C[!US1#%&>M=<I!&+K",QDEZ6O^\C5SEZ2@Y<.C>/;FZ,S;:7*#Z3#L
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MT4[09)LO26PIK4Q"<JT&R%ZLXQEOGB<0S$9_/[Z:BB?FCV$,8O)DA5)Y'WB
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M*5/%8A5M7'/PZNY)_#%5#1*2E ZQME*4W&A[;WL49U&-H5[RKRG-LSH!!2E
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M-.ZR.>0]A] "I,%T*-2*+;2)[BR0B:I;U_ZZ9:7FG%F/(._BBT%6 I'D?76
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MX@(*>'9$KW:HR:$L5'E0$@D73"\-H'ZGEGBGUF!N:N;I:YL?2]VIC>Y3FPM
MX9L#7&\'M#ABPJW;:[-HUQIL/@Q ?,S?AF$LW?B>G</<4W3![YX5Q[X>>P>*
M7E)F/4*(4X;H4\%UF/U6L:77!M*AV;?@L< R:H;\AT&C?;<S>>?I<XO*QJ:V
M4KZAJ.C;C[R6G\HXOX[V37I_4SZK>5(JZYVI4"ERQ>W[VM.*+Y<?#53SW6J/
M:7K0Y@:A-0FO#8*^WNE_*\2S=_>.W<&R5YE[P^]][9$/%D&S/X&H*8&?S$PM
M1L+[7;/^?BVETQX6 ?C^M\YW>XR<3J\LGMB>&+J^+M,[$MGE':,]T^KWZB>=
M,K?8(;GE9-X]5R6VF1#Z'M%>/N^KWRCJ\2D738P3 !/ )#5T;W/7(FZQM908
M*F:\7I*));65$F,!ET;ZRY#3J-%I/"L5O$Y3V$ =[G'\;'0NA<1UB(N-I]H5
MA.D0>.@DH6HSF"J7C;G,%">(YY$WN$DF=*H1=$V&DVQ?H'Q_ET-X#/?)3+ZR
MX[F%%,X.%FG,7#8!*J])T:DW0G\65O#FX5:;"#IYH8.@CQT3O^MQ[R-'-:<N
MX'9J#BXX&9H^=)?SWY'EZ9EA)_&PA?;81_2;TA*T-%JZ8&6W9B;?\O]VEG6>
M20Q!"3MIY-]$[:9F%^ED7AT'[)]]!9&89U[B[DNTB#S2@%QI-(\5?J7.7WI7
MEJ?^+L, (&"4?D,_YYV8$8U_8IP65__P\V!^[TREQX9O_VH9&L^:/ A1+8AV
M^O3&+?)176,"/4XGVA@S$*J@--?74+&P6P$4OMJWK[./WUA]E;W<0V&H9DHE
M6<1(9_7JM(B>F=M-M+&TL9Y=D9AA_;TR]7MVU1"[7BF.!/5FAN+VRX(3U5S<
MNF3+.G*<[J(XE$[?3M93C?%[V(;I2,&] 8C7<E)I*C[TQESNI_LS1RAV;_UE
MC;<ZV>HY-7J@ETO*S+"DMN7T4"A"][=LW9\6[R%F/"+EO=7O@B#ZVM)1^FF9
M4/<5XM"3N2QBA#DF@6W=D__TA61EH*,?S"J&"=L5:GL2O Y8CZM_?#\XZ0Z'
MGA^AH')PGD(M\Z6XS=.6*[3<?>J_#UE?_-\CKIV(1,]@M,1:M<QK]*LD,:2N
M)'VP,?6):^)"N/M+DDO:RF4 8U/(1>XR@&I+\(^QTS@S=S!^=K@ M?M'Z(["
M5>!TKU:,N#\S:&+-KW[CF2;O])P.QZ3@BB+0)0G:]3,__=?<VH$LI]OP=;CK
M3E4?-B8_%'684-<DNIM?BMR:C_S^+.P_+O"7<4D?T2WVR\T;[7J=.X=,U']<
M@8O\H=N1[2M-<;/WMB+0^(-\.[_J()>Q8J?H]]C$>>S=9L,ZP$:2H)U0,ZV9
M<&;?[B&&=^;^,@G9* L(@,1,&4PK1"VWAB3=PJSHHDA7%F$"F6BG5CYJJ'MT
MDTML8$R3T[.'85+ >[N S.U!P(9#03I9]<PQDYFU)@5)#/%#5Z:9';V(/\5M
M+]I29*W#L$7YU24V9KL7*Y/.?M;2""RH:40OW/"&58+7#ES.U ,6C9\P?#S>
M'#^!Z^SA&=?+Y1:O4/;Y16]MF'TTK$>U%I'UZB$]1>M8H'^TNACXO,W)Q%[R
MYK?R4XS1=JRORF1&WM2XRO28SF=>;#2\V:WR4J''3>#&#VO0BN/C+H)=S6M6
M+!HWQLG#X*=M5JU^<H3H"=1Z_"-&*[8LF#R+=MZZS'0ZL.[0H!)#\'T&&O[B
MJM:71QUM9S'X !/4N!>2TGW3['3IH:XD#U:.D0H\ 7E0C-OX%&B#ENE</9DR
M&DVJ;LVN2.T(_,K6&Z*5NJF9+#>'-9.8\\CA04 UH*SL-I;X$/(H"A!F*-)'
MT;=5"S^%ODS4IWI( BF_5&PV'(;YG+>1X2>T]!Z/ZKY8?J*NZA:>XYX6RQ=C
M#"QE7\HJ0S1[MX<9@NFHQSO3P?G ,FA_3.-LR6Q]4@RH,D1!3AK%8@E_H";K
M#,/EJ]P'D<0%KIIVN5X/=5J83GC!4=IPS'S<C&R:T4ID24IPH\'AS26QQ:<E
MA.-=HV,[VCG6"UWUD'TGZY!]R^].E^K_%TKN<[\TW^F&A5/O0SSEU-Y<NYK7
M0CUNI"1*HUX5G$;S4_C$.^7,W8@].K""/8--6GJG>4 -#'ZH6JRB1YG8V+0$
MI^J;NZ9^Y&4NO.'/@[CU*3]@Y#;&T%(B> ^HY=?711F6AA90_47P8NSSA@B:
MD;7>2I]-Y*6<#(S_E;\',90>__4XK:XO2[DD@3)$._%V^^VR4(9YG=V3^2RB
M9TR>XP]G;F=L:.T%%.=T*Q>V4KQ1;GBM7%:\I"^6EJ%KJYJ"XQR"TH,-(=/1
MMY:[@1 CRTS%9OK>\^6VHM.X(MD6C2>E"71JAMV*/X@8?@6^Y?J:%CF#OT=(
M?[Q56;R/%!86W-K*O G*"0T?1'$N2TQLJ#T-;FM>\FJIZ]QBPK$MAC-02V!!
M9AJ=ZP2J7J>ZQXBCY=8:7>U6V@=_=/C@/ZZVO*6ZS(]W.:0;]  T(#3-J4OC
M:>1G*W71+-1-6>U8D;IE$R@+%HY_QC_A&NZ\#K1>:^$$RTMJ.Z5P:(Q(_(?:
M;MD^-WK?:CALA.\3E;!@'H&/W7#U+0GMS,0V3KO<=2VPPX<9N"!$*+;]K4&K
MSRG' Z,;#1?+HT5CDLQ<@SO_8.O[NJ20:YVTL!7]%XW%JK;>X='H>#$7EP30
ME4J-+8LETWRQSYF#<ME649:N2S3=R_B/(823J5VJ8,AK_\"7)-21;O#'MMG#
MN\Y"'EO VO\Y!;2<2V];T\UMUH1!UX55<:SFY*&7N$+FB@ V_OH"N_#A,)A-
M;STM#:ZE7,G40NK ,SV<.]^ES\A&, B@/C*D;XB*K%T'O37W]U2P%%G!!T[Q
M;-C&ZL#UZQ>1[&DO-97<8.V/UQ1JLM9DFN;[^<,'[);5 WZX(J:&]SCP[D\,
M5X%=W$[FJ[#\ RX74'X0$M\MW?ICH-'E8\^/>9B2\Y*&?F?@;!1%"C')C)2>
M[7$RQ +MF_U?/*?^F$RHXYGF)\#%8WJ'!SFT)8L7&6*N/(W"LGU.FLVEEE7?
M#>WXVY;[3ON]"6J=QJTE2)]T9BUWN[D[2))^.O$]E=5*VU4C.]UFQOXY> FY
M!.I;MJ%-ZQIOE7F44,@:$VHNT[,D6J>W(5:&R?6"]OBV'OD?7!7'-[VYUI6*
M403$L[\CT6O$4A<S\$FX$\@&EJWB)VB=2+_-[^/A6B*X[X 6"ONY\*!XQGA?
MI3(CHFCB,QH)1>Y/$8=K IV;NY5Y@N86@P=!KZF^!O2@VPZID!#A,)1!1HTY
M]=>\:7X9[--G[EN^32UI]IP4O8SK+,H%7+44&K-%YS<-R\,][VQ67%04^5[W
M(]1A;#[#? 1F6^!OWH.8Z^^@>B_BUF3S^%WB M]>:8Q+;?9#^IWYC:#J).I1
MM]6N7FV\)W'+Z?3"QS0'VO7, G<?7CKQ]@M$LWKCO6\UF@8"%D%?R[&ZG^DW
M0W76C%BWE[M72(/P-X6>R6AMVQM>1:_/TWPQPB]/'.^PZG\?FMAJQ#[.ZMO2
MV?S2*H5IR&ZNOMND4.72YX1-S69I#+C"M^(%9I>[%N@*+X/0?IXNASJS1VM;
MG\QG B&AO$XW?*IU9(L?33T):=054#ZLCIW!]^?>U&CP;8@(+<+,-*?<Q=?[
MB>C1'@>JWEH-$D1FS@8-DSB@S&(%+D>!A8,75,ZZ6<N-C@M<0 ,+E8#Q2[F$
M5,E73M<MC0@Z2P(#=)KG:5RJR'7'##U4X.L9D$P.&F4=,D)Z0<V+20P8&0 /
MY^<8+K9EV&78E@<\F5_']_ 98K5B<E0[XJ+?6!)=X8*?',,EE74MS!E/)Y%[
M ADN^X.=8B/=*:3Z<-UCUR1GT-:&IP39^LX# P]*TQ&3K'YKT>YTV7^*EVB8
M$2G\, S_JO-AN-/UM"*E(A$@ZHH-[L'VX5K-ODZ[<FSZ7'/56SUR"TF4Y)D7
MI6PMNU#79J%": D"^8J2V[+QYB/X5)P%D_I2IMO89 -N"1J\SL""3[?;ZS=&
M2T*F#4VWY<VWD#.HF;Y;]/VR?3BA8('#VJ@I-3B=Z-IZT%@*89T^PKR-3U!Y
M#6R>VI['[#I[>5'#A\L%EB0B:RBGH[[6]"9!@Y.>39H#=B\K_K_^1?]_4'YI
M ,N>6RG:H3TW64)))+(Z(&Z"FZL^4TEGNN$(S1;]OZRRBA?$N_&OIO:M_JF.
MDQ#601V,@U?"601P,535_ID'#<,D$<<@#H$[E%!3%&1UREP)!3ZF*+C]E'6O
M\KK(XE-64+W]HG(QGW8IR86H4_U_IJV:8#+D96&=_+YKQ4Q.00\KD)5<WW"'
M@MDW%0I]VJ?V_>^G&?SWML3-J(E:9M/_$C:[Q*E_X<C/_OGQD[/T^+=V]NO/
MX%\U[4#9_T63IX<ZL"9\!!V@5O_&3E;DUH:F0+B"",1%:\<C8'YY06?T-^A.
MPT>BI\!GPJ+#N\FV*<!#X7J5@M/_MLN3-@K3G?:GB/S'I5DTUA -M3<4TDVQ
M[JX>KHVT2NL="1N&?W/H+A8^UE_T&F 36M5<\\YE'X$?XX<O!,QG<,MA0@3S
M2TG)^U,U.;J\]JS=C:OI\X\>43<(2B[3EIUBP]UTHUT'F65XYL>=5<Z#OB&]
MM>;5] '61S\@4BC"U%^D[D_M&C4G=A %[QZ-I*0)6(R%Q[.V0-XO=39[Q'VI
MN>OEG^V0?S:)BC6KL[TMW ZN5^8P\IC 3U%X6X+/6RM]:GL0TRE$*P^Y\AFA
M,"SD>;PM:-^15D3$F$D!O?UD7@5>)44[RN+<6$,*2SRRUO:M8D%<8&^B@*/V
M^ZL7CA.'&CY6>9<F4[?6?\2QVX/HY8D*F&O 5IF LR5.@<YL8=<^CQ:HAG-[
M1 -^4O=H'?\@^)[&'JY(6E7;&KK[%(:$7.+GT(-G9%I\(#2[E>9:/UUN_,2^
MUM*3[=4Y+%A4%_&HWYR!R1L3V;)75:JS.LR;JM64F [(O]CL(T=B,QQ@4*"4
M4GK+'F\: 2">9]\>?DVE15XPMH9,TNXB\%2#C""?';_!V*3TKK5I6[9'I 8^
M634V>;I#;:Y&JG(M]&JCSD;J-&Z@,Y]$ Z8N-S=VXU-NI%WJ7*=A4:,]@->O
M!B.#G-M#[9;]9V%[TZBK;6^O\%!_4:JZUNXZYVY^5(\;JEAMC:QC1CY+9X76
M%[,N-FOSC?73MX]KX$G8D*DV-(3BJ.."/(KC*^"1/Y:G-16R5FK%O@AN<:RX
M11[%NTY?A?1"8^]5K>46"_RXE\=L^+?R=Y!U,0_-*O>VS6SYMU"5%%P34RVF
MRILIKS76L&\%<>:=8L<J$'.>*.=/'5 N(A7(OSI@-D+:WSDT+HJD*ST+GZE-
M*=R:JK'U)U(&_V:^!>_^QR7<]%FJK]39XVO43Z?,[R_NQ'Q=OI&IR?+R/&@<
MM<Y6QJU<7 X9Z$XT^7?E3Q.R#$@SUVX?/2#@-UMDNG_$3=$'L$WY[X(9PVI:
M\#FT_8]2TNDX>$/VAVK%O*74.W$I8]J<0OH'S35)V7AV%$8,Y?MI<D2B7V@@
MH&>#N525TVS^(.RF[E*9/-D"'-8>SW8VWY67A>#N0OB4[EZ>TZ\GL*W6\O4%
M3SY;6ZO.WFD0PL0$L8[P/;8]C0"S?/PE&9DT!>6:,L=1>6X5"4<!52L:!',,
M,;]]<WX;&EC_(XG%E^*C44C59*E>Y9^?*AYF@I7F$_VU-J$QKP-J#+HG#QI&
M[/WE[J@B,^T*3BP2$546Z9KPSJ46=&ZCN?RQHI?VKQR!\D#KJ[S;<-\[<1&Y
M<*0WDULV%^R[F6E1%U+E0\>4*..M$;*YA/,^ ?-D>4RH7I5!YJ*U-5[+JEH$
M"J7+'Y6JJU &D12/T*9J?4@BTS>U3V)H>G@>67MA41:K6?5&'V8,:'MJ,J;&
M?+FB+3>BP:>F]J#.&T9H^"CRGFE+L5<B33;(A:*"]1EZ= 7,3RX.*M6<8AR0
M62"CI(D/<O;?U$'IB$KY(PB>#CL,^(LB64RYLU<K(M"1$CJ5K'Y(WI<WT(]V
MD/7-'ML0JF8@\57UH9LR-(,R"C36,?6Z",W8AQ!#-B:(H56H)0SD@VZXXB8K
M:*J*_R1FRJOAI3P2J20P\<, 'BM&B"9_6IC0Y@F'S.-N8\22Q<YJ_V9Y2TQI
M5'D-RR-R[=I:-!K$+VM/\/L:-L!5;UH]!B$SWQHWW#+@F&#=%Z_4D%^>68#/
M_G6  O-RN1J\,8C<JJ@&M+P%A5>/G$-WM3._>)XL!,4L#_8 5*)>-..YAO?F
MC95?*0O3L.)Z['#&+2SJ/D*C>>&XTB=Q_.0X'WKM(B*)UN@R;V'WQ51L3UTH
MP1ZB'B. ECI8E9+[OHDLN?&,YKM)B+ HS?GT5/O[_4+,+Y\_V.>_W7;Q_H1(
M9-:Z:R9M9>-@X!;5#HLO[?^&9[WA'00QE3-=))\0:KN2]I=]ENJ5'&0E?K$X
M>+>91U>LT-U-WT/>\[-R@=J!=WB_W3SZ6^N78E;"'>+U=,*!,BP]RJC(_#L0
MM 4421NGQ]UY\)>W5"!]8N5+4_R7SP^":&BW(5/ES3NM0=59#R2-@77:#J/*
MG_:SSL28&!L[*1XWIO0T[ZEF\QVQ[3XE%<4);#UGQQ\AES/V82R"/UHX$'XZ
M#;"/8UH[?R-U:0MH@M//XBL6-Z\L3#@$ R@Y@W!:DA<0<3*:ERL#31+THHK<
M-H"):B!;4E4-HY3R9_2JCZB70S3AOGDTK3'RT7>8;%UP78OCYAN"3.)7NM@T
M";="UMF"PISM=:ZR\@_KH(#DIW,XZX9\/$563.32V#RIPF[%1GK,W"WU2H 8
M ,KZZ3A\1OG+?:AVQ!%!+.(]^8^R\SSQJ+:G+*Y+TJ^?':=0Y?T+(UI(7'08
MO2I:9,-IE7?'>KV/XR0T3_#<<,?\:?4B!Z[59[1/'&?V%F#' #D2LY\1)I.?
MKUYX_9QCO"['WE!8;MT1C_(_7Z3YF[45N4;(T62#>AV/U'H;(/#M0@US=1H(
MYW?VFH9I,61^!0CD-MLIA E]94MCF ;I@-[!2IJMO+2]:C7>L>9)Z:SGMX+H
MVN%PI C+/>!XMOBI*]K$5N2D72)FRKI'D*\4Y\86Q01O\LJI0HQ8\1_?6G-]
MH6N'?FVHQ;2*PX[>R"S( \AT'BW>.TYXWKA<'<SV[&H8000=X8XDHN(MK].X
M; 381'"3 )M.%N7#*;?=:[2B(\P) T[:!RB=*=JE/$N&G1B% OL6/]VY8UP,
M4SH-$^W;2$_Z' =AG[:V:K$_MDQPL*<X;EAE6 ,"YOT]4%J,DVTW^FM]2:[L
MZ'I/;8VEVE\L792@O?A)1"D^WA$R3#DO0U=W#Z! >9:S^8 .FNSRMOZV9%H'
M/HP&1E>CZV_QN.?_AI*_$N=M<TK]Y\U NF-5-ZH#Q'&0OU]G,,?_Z=A!]D5A
ML(66DV]<4UD%%B[(J0N(GS%:>>5^05@\<V&F'+-TP1_YI)*8>#X4DZ<TU.CG
M^&5S/%>HEXH0TC0I.HVW.4,M><=?T]VNP\J)\:GWW'.B6;];:(^"CYJ>H@9J
MTC^\/.$;]W;KV';7>K=TBDYW;B4Q3B&GFM:+_D";-P9<XOY J6$[534E99C<
M2%@RE52Y"5/Z'[1PH\U,=4B]C;QZ&/E6L&1_XG'?F+X*O&B'8U==_>/%$_K,
MGZ(@$&VFD_;C5F'=7I[57J)-OZJ2'NIEZ8NP2Y>#XM%O!A;)M(%2<?5%  /Q
M0/F^15O-."#HC NL[#PNUW"8NCLLTF3-TH;?NDT?V922]GTMU&O09:NPD_-Q
M>@"L$&BBB9__/KZ.$OJ/2T ^/7WHCL'Z9R-=71]0D>[#'<&OH'7'8;4VR]J;
MT@L'_*;+*<%<PS]GG(B_K030FDGT=PX;T><ZXEBMN?$)WO@?Z780O;[S$\W#
ME;8;3_5PYJ*A;O)%.-55[C7 WD'3H[J. 6<.\5D6H6-PW)VOY>>7.$F'QKI$
M$Q 6641FVU0'Z1(3?IQ@*-S\$?"34][$4)T=JZ1Y/&D"D+K;LI#=D]OKK[FH
M&[VB/ -)5['9K=^S<]'J;D*5*T,NHIZH:W9BK:*SJ?OO[PMS_W'^3>'=?_<I
MV$Y&NB!.OC(]B,"M D1()DT%;[F7&RW722(U39K$2BO4_^/B#1+\CXLD76 M
MW4]_2/ @QL>]15G_F0O]!8QS@&D7 JT!!W#^K#-Y[U]/_FWZ2H8EF (K%_\6
M?%8/"7RS ?>>WGX[U?+X'KOTVLCE%.MWT&=[XU_)V^_:UU?_ !??6M[MX4W_
MGB3T"6B-J M2<OU2^=W,^<Z1>O64M[\*=DZ\?/*3]^9W2\^O@"SZW<)ZG'K*
M_*]*(O@I?V#B^%1?=8+IV2K2G2>>D@^D.$=9N^K?K\__RK_3+_1VH2GP+R-E
M OH?E]?5EU7$[5ON]0^?I;RYD_*5/!4#F?EN"O[F]^7WY2<-XB\U=#UOX@7.
M^,;85HA&_CT[1;&NLGKVTGWW\@,9XP>PTA>[[4D.EMT28U_2V@*$OV/RYP(I
MOQ7ZUCRX:^^<),.^'W'Y[O_-?&R<![_D\PE3]EAS/<5](_3+JNX71,);OG$]
ML/O''^,"L9<]4/<7Q@S%#O7_BNJ:7MY [O_6CAS?V8SU"A)[6$1D+1U$B9.,
ML:V5S]7/)(''.[^\?%%9^"3_?+VFKZVN93J^I2BIKJJK.9=O%ZE[8?A,3*/^
MBX<:4X,QQIA^MRS4LBG=#0(1>K)ZT.AD9[9FZ-,M19=9X%[J<@;I!(8[O>M3
M76K4?D-U>_W EX3 #&9N&6_V+YQ%!9?XUC#M!#BHA?AISLI2;6&_=@KK,:Y6
M@NTI1PR]$/25>-J*!E7'4#)7^"*F <[S-BV/[]X<)EQACZOEC=:L*&E+L2^X
MQ",J\RI8E7Z4=+K0FB'JER,$N^T""=EV /6% ,,R&,ZOXCTPZ?._$*^RXQT]
M_!H-PKYEZELS2N[XC&/0J%^(P3=_2+200?#7U:F,U]UA:POKP=3[C].=3.^\
M?]OF]Z%QFQ8-*V2X-#1B8O,_VBRJU0EIH2H0?_E_M+8T(;^CAV4__ %.SM_,
MFJK5433@_7J'OLF:;'W]=_Q>M'Y\HHJ%!J[R4W(4C=/&37?*Y8NB$AT<G?P<
M WZ!JHL.$QQ6L\"]DZRSC-A(N>6OEYC9(L\;*D]#>QQM3SO</'=H$-#H0T*@
MDJ^[L@_:U9U4(_9FE]O#UT[)P5JG1Z\L=QN;0@;T2)\BELH0V_1B>SUJJ5PJ
MAZ4H ?_X?GZN(GN;!#= !"5_G*J#$S+B',ET/H-'%"AY&HZ!H\R>K+H7:-)D
M:%84ZQ:S$(#X+K1"65_13'F(#?6EP,2(6K!CT+(#ZFC=%@I6 53>[X/-LC^A
M/:PY7>4WO]WGK%4K:#FWJ.,/&B7#;9?S6%WO#35G'H4N/2W^(I$$(4MCOF2=
M".AI/+?2E\C]?NCON)=AJ/MK^;!IS;*("P/X;!Q[(-Z)6:'3\POR,GT=?ZC^
MJ+NC2#R#_2Z.^':N2<3/B!,+,<$,5R3)(-+*ZS8^U)^0W&+UJI\M$G,"UFS,
M/PEU&R@ZFTMA)"T^S%+53DCTBY44]/L@J*/</<J0A;CHA%=/B=U-A?"K*FPR
M\=4ZT_U3CH]O^/CJ-.H&@0J)#%E5+'0J+?>;\]!WLEB[K2IN8A[>6+WOB%O)
MZ@X8(XQ?WG548U"8D3Q*2LSXRD=M(9HZ>DT7=\U37'IN>?5*#)21:6>G].(!
MO)I.FM2= CLMF+OK*=DMUVDWHS OFNJ*YKY');Q:S_;O@^=K@AB8=;.8&5]/
MJ]NWNPF.0<&R/+O?9_!+(U%ECG$F]7+"X&O&F JQ2)F$PD141GE6;Y+D=X*[
MF5C1^(H[4:%2JMK73BO'0_:WTJZ-Q>3Q$/#/IGZ#A6B$_VGO''?)0".2864V
MG%S69A2^_/#!]4$EQS_ -=,+SL/8J!61M:>?=QMQ^(S6=WZX'W>6U5/$1 FW
MRK>:^*&;8Z&0"K\J5\#%"V[$\G](O5,)T/;CT4:*"\J.M'9%E-QTIIX(H4A^
M("SJT^*1/YVT?'0<$7W412"S6<O )J ;4:8903V-C$-0!2((0R!T4H%1D",Z
MESK OH@Z7NEPB12@K2%6XPG39-GV!3QJW(+[NM,3"\EC=%G--7=Z>:@DEBD-
MLE@V()PPC9<^WI4('@^]#)A=LN0TAUP: LW8(<Z_@I0ZC8,_)9Q=MDA]+YP8
M-O=)/AQ77[5HW#=7]JW)[O>D5I[)ZR\F#>JJ*\?6.HRL:VCL6LFNY=['[RL?
MW:."47W]XFU/FP?"<]P!-OW1>CY2Z#731RA]>NYU2B:6J;I3 :1>6'J:\3WK
M_7]<QMZ7L,\CW>1IZB+;@Z"?[F:9'\"J%2;*F47&I_NCD\G>,_$!M^7L@8,1
M_#:??ET#?42I$>3FF8F_B=N \6R:.'A@AU:GRNX)G>N57K9\D(;DK=_PL#"3
M89XY2PPS4?FRYW']/RXU[!D8Z_GXFY[*L]@YU_9HOJ@<IM\@V2;XBG53PN[#
ME\M[^N=G"C?_GLP5"KSTFZ*0U5%;/'!^876-(V4^ ''LZ Q0.\%I5_@RUOP?
MUZF:\6N1Q9)M%O+C4N2 \(F$X_6KRWUNOAIS?P'K)F>:KWP:!WQ4Z:(/TH,+
M,N/W,;%O,^@667= RS__=F[))BQNS1A%!C,\ .\K+G7<T4\UG I3NA!@(I.W
MS;UFC)W]+4PK 6BRWQO85?R]K==D\V7Q)?+3,,,OW#LKJ36R\W[T<C.=<H;*
M@_@R\$0!#L42NSN$S_G--:J\MMH_0(?HUH,68CR@/[)]NR"(H4&-B]&4.,!P
MJOEZ7P3-5O["HK;+E\E,+"$U:(O3._[R9^$'!_SGB*[?# G6B,XE835A?:K-
MQW'01$OJ\9;/%[<8ML@HO8PXZ86.J=ZSRX+Q*/!/=?>'WU0',5_4'Q6N?RO8
M]*RH"S.Z_AZW($T+0"V<%UEKP)P'=)JBG%?G)1,E I?#K3Y^'6Z]\G.FX3O4
M3J@WQ*;KU<N*@\VGYSM_]<[P1 1PLP-+-7"=](+Z(3XLRH$>,VTP*:MZ8Y>U
MJ0L;2T X*8YVI83A/QQDF,8$ SOPIH7-!Z=OC\0TXL-8)9A8M29"]B!NW;?C
M2O-RGRG\"7\/;A6DJIMWUSW?+R)<K[APILX$:">^O;AE_)6#V("9!8]"2L2>
MWO(A%WE< <DH$6-.LW2]IKJ&,1^M@H'9O1FORH'3P1'AIAA&[Y>>L"C.UTW%
ME+27YIV1]2UK[2':OAWC@*S;=5KI3B%MT!MAN?/6J^WA+NVHF=P33-=2VX!1
MK9\<.WR.9?@_*1$%?B,_6&OQ_NPZ-?:W;>52\%?VL902H1TUHY<<\H]2C$(X
M?!5/;WFD+T0HBK3V"_;)AEN%RSJ9$>=^/\]Q!M]P7IK4?A*5"ZS',;Q<.>ZE
M%Q^8^QM_>7/7M='\0F*U)_'OW/EOU/C'J5Y8$T0X>$95\N9ON6MW<$5_!>X<
M4C),/#? LMG3M\T^&$I_M]XS.;"\G&8ZUXCTS$V]!ZZX(5'''GS4O>\\@Y\I
MJ< 4O!) !'YYID^3%1!3Z9LI7L1LMX8Z/R'Q:;GHH(%N2LXY18,?J!4M",;/
MWW7-X0\I\>>Q^,*<'0>GI-$N3'E9,6HZT_.N:^X"YG@DNV0NIC'<@:X<YQ2\
M*8<:8*FD^.'.+02&V2M9G^!TNZG9\?@.^]!_(E(K2JT DR+W=&:#,YM#!N86
M,L(EO3&/!\$B.[XO36:V7!#1E8K#C2%Z>;CIMNQ=Y.RDU4?$^E+1]@VX8I(G
M BK SK,H8Q![50S8+J33[,Y/K^=2UR3[L,("KNF,A^$(3N%3%VYDZ3VZ6^JM
M6EJ02+%N5*1-P[&'HHWASIU:&NO:6?%[*R"'U7VQA]Q65=-!-N!3@#<;[546
MP/)I])$'D4*Y/ ZN4PM;]U0_G>2YIOTK?@H2QK6%U"U*.G#(8)9153^LNV-+
M6<$=?OCFZ,@7:T_4&[OW7<)$1GRCJG7=L<?7MD37:!AA?29ZC(%O2[>S'D,4
M-Q.<1Z=>GD>CSKE\,2GH3AM8')F<JSCP#/IR N#GCPK(CJCW)("<@JP(:X14
M4RU E*$DVVBA_H8#Q)4U$@U/;0;::_Z(Q#B!I%=W"%C4C<X7E-"A1N5/)<<C
ML@L @F&:H,#A0#E4-:@$\1JHD];54;.8,)KGME:@62 Q4^P\=LO3#5%*V>;&
MOZ<(C:93X_A@7$JM;@].X->6.9I]&,-REP]&'(VZD-<>SUC'IYEAJ((7.5G:
MO_IN=,35G2JAD*]<R)'LC<?3]3)-^VON2?:RG#K$!6<LE=()OIL=R=Z^7:5I
M1L/*.Z0P9(8W10B3!A3Q@'Z@!'FZM*<[\S+:'K7R;D3,:\XN/S$@4? ZYX1E
MNC-TIH//*->5>*:'NDG2GEP%*FFU%EUW>^H*']V:3J"YN?5OI\\ EH__0+5N
M^LEF]>9IBM7+_F[[-6P:@[D_G4#?<"C(8>A<"Y>W]Y6;7B_]GX]0>[6KI&#'
M.;D,]Z9U&]E^N)X)M%M,> )4]_,:'?R 2O,VW+V6%\5C@PWVS@.1BY05YZ9N
M[5LM=\^+'VF30%@\QG:(-K:\N=[0J)S78U#5>#7BP&?#N;LN5_3FJ)O7>7B(
M+ +F7#>H6.%)"A!WWH4'JO1V/93<:F.K.E4 N6]EA@QT9(S)1?T5?16*ZU@6
MI[IT&%-DS3KG:O%)STQ^A6>!F?7A0K%9CX*S*MZB1CLZA[<0D5]0OM2>6]%.
MMFXYY:]3.<$%]1(?S+UG!UP K?S-/N2N7NN57B!"Z&O% 5^4'/O1)ZOJMH@S
M2+[\)JD/:T2;.RHP^3Q_QC%MG\7K^M2UAPKT8!$=3'T1="5<,[_]/RYU<+V<
M#W]0;#Q9*4@WJC[)03!H3;F_0V6GI9=CA@(8*_N[#L*WSS'W'BMS(M<JQ"\#
MC&DSMNR649F?;-K5E<\J(WZXX1PD)&JF\+KMKG,T*D!TF:Z5\U!<DMV$5IM2
MKD46&"M;[4OZ:#LB9P.BJT.9$84SHVWA[M'8&)@$I\R@"[[E&JQK@)9M[NX3
MCYL!-2RE5V#*YE[X#&"E-G^WQ]:12O<_NND:EM+L\CRQO(;WG.&,XH+&[E ]
MS"B4S7[/34.[NVJMT89H\AJ!MN64>&>&EBQ:"TZ)AX8R,"^)OQ#I8OX.4RTY
M/N(V:F4(!KW!-11J&2R[;68KN^&Z(VM^#P&B;HU.5*5/JZGK&7% K$_;*,OK
M5&&GX]=C&\Z?";<1$S9B?P\*=QP16&R',SIE:H78RO-BPZ_HP+/"?/X+J++"
M@7HK'5983TJ#G,;.O[ZLBP"7VYG%,VZM+K3SXH5U9:K0@%$Q].A3O%#UT*3,
MJSL:@-K@6MPPTJ@7-E#=VF<=9:"XZ C[.T%9ZBKDZ'PC;],B?S1\D 9E,H)G
M.$7;-ENN'H?KOQP/9HPW)?@+W,YT-0JNX^O#WM^E6M$S%C?O=)SX[-PB:9.S
MJ#Z&J96D^P:8G:%;Q%YE8D^=[Y)\Z0W7<:5;[:U.QRCTA%3AIBU?++>L0ZE8
MC/D06?C<.FB421)(@XJ"\<_X2AE^VCXWP86BO%+8F*$UW\I<$9C)B&X$ ?<Q
MFL2YQ28VFA^<I(4B<CFUUN;.F:N\K\$#Y&N'1M.<T8H"F04<_S+-4>1'AIO:
M4+"$4Q#1N9&]W&EL"H6',J/P=M0>)_S**RU]2;'91@,'>W[D;?V:7DJ)--71
MP3SA6O;_GYOP?P1SH:EJ-!P)OWY0!R6M)<O7E/0LX;CX=;6A]I#^E*G"W.R)
MN=L;YH(#@A\(->7/Q6HPV=.8J^:"NU,/:I*Y(?7VBXI/^.MA_H2O1UBZX"#!
MS[?/?:V;)K7]&QQP4? A4560>@RR5(-Y@E'PP-SR>WN'$D*,??;8%->G_-U+
MRQV[/+Y,_HA<FZG<RN*TMWF\I[K\GSA3E/H75I7AXN4=W.Q?L8&II(^TRO?4
MI0\YD^:")Q7K':R.3X)90=H#\FIS46\Q;C5WSR_CLIN("F\Q/GS$0>UW;3T!
MYW1PBE5>('D#W%4=7*3J%?'VO"#K-OO^N]ET>:N7V@NP(VVPCT1/OII*<Z$C
M^;!2HDZR- 03*9B,F3Z<:&O;.:H.$IQ(A<%@<=-QZ8/=K5L,GU'1# JI\-P;
M*F74KA-0:JZ #C96=F0:TPX[P&X]YA8#/86J<W35O[> 4MS[B#[2.YCM:RMZ
MQP<"-S[O>T#?EIGXO6G?7W6$AOI?;8_3\J(==7ZS@[?_!M/=-;K(*MBP#_BO
M-&>G#V1$,R??(XHF:H55U0VR[2]M@YV_H*HP5Y /B\)Q^<ZAHB9MKJ8<+W/Z
M0"2&=/N+VKUO7VO9D5MT"BD-0@\KH%I]<Z2:=S#/ DM#X55NLY2))O"KCT\?
M#'7S%JL#)$">3G-MFC[(V@5Z4:20EDN8NB109S<)!H7Z6FS34(B0[I;57VM-
MLQU@CLIK!QWAG2FI-F!"#7X1DWZ?H3:"2@2F/Q:I5\= E933.E>FBE_.%>+N
MYCB 6?D3_04!B,(&GLL?&N;*;3$(.3O68)Y_/=PF36<M3RQC@ ER*.CP+3$>
M!$F$!5.9N=(2=T !J(Y".LK(JX P?U78M[?_@/IX]&GOU+ &AJ1BOKE=)7,I
MM(MR_;4GPR^QH'6*:B:NID>4[+<T._82U][B^Z3*5X1F& 7R-=]I<Y!>)!H'
MY*H*0D%6C!K\6>W-:AZ%?[R:.V[9GEL6!PNX(E3^3UR3E6AV=;IQMP0',<JB
M!(9_FBP>3)3UK90K:6 %TXZI8)G(#*5FHC.<H#%$QRS ([<0U=01<PCZCUDB
M<##!YV_SUBP]ZX#?';2B\&.I+7.Y</""N%?(0/NV0C]N/6'\K1B[H_1#$PIG
MA!N;=VDTF&9PXCFHH=";UF>P$SBC82U?I7#H#M//[#*X1Z*$IN(U#^AL\$;#
M-  7SF#NG@_/N0DGSC.M*%"-=#UR./N-(1N(,Y<IU65"7[&Y$S<3'/DF<,0W
M^*93E$?F7$XQFZ>$ 54CRFVC5P6_.39W@#.*!"ESR:IG D2@E\&(JM)SS2\(
M N'@=RRWCXJM$OF?-2E ,5TQKO86QVHRKL^JU9ZG1(QLQ:*!KH[C>;S,X\KY
MH0B0KT+5:< %QYK:I/PC%Z"\(F)Q371NB<<(]%##),8'=2.7(H:(R\QIM46(
M;<,)P725 NX)Y 7'2"71NM@D%A?0<9=^K9V8!5(Q;Y@'@:Z= WF:"XOD0^D:
M&<#D37@=S2K_))QHK%C7$7<<1#+7G2)D^)\+JGLV"D,#^-IX'J7 '^%)0FO$
M3!0/^@8(A*]&:H&9GZW:-,%W,TPL&D0W,E?);.4^QT4HT,'+>BS_'OA!1>G3
M'*O.IIO\^(8F&,6>NR3<09/%"F)J@J&JCKETN8>X>FUMOBJFC7C9])Q8Q&U6
M?</H%0V*WJ*#F90&@F-0IUF6XVAB39/EO]*O?"*LQAPAI!QCK^P-<#I=()<R
M1QD^ T36'HL@3[TT'_#[\W\1]E]133WO%S".BHVB'Y2 %$5!$!**E( @((*T
MT$L"A":=)!2I"MB5%IJ H81> J01*:&#BH0>P) $": " M([@EA>O[__S?_B
M7>N]F'-QUCYSYIEUSEY[KYGG&4[H6TB&21K.\ WC:'@>0&42JHBPQW*U+_AF
M:A*^6U@*H[DT/,L-6HKOAMF].PV6O+JU)9<&<$F]E84I$W3Q=;Z#2#H)+A]A
MR$NIN9RZTDA,O[UJE:K31.0Y+BQP(2V0+\0VW=P'+],ES^S/]E#;I2K0CZ=W
M:9)!CFW]Y#TO"9GB3$>S,TXU:+W@1SG ;VP8GFA<62+]E!8F.MQ%=%:[W']R
MULULUBK)QE3\F<QOI/35%*G3JA\?WMZ$\>LXBNCUM$>=3.H 7YU@^4H4/"A*
M>1@5%@-*^.959. B'HH4Q?3<[)5IEH:NI.Y;F[H6C"6UN8:05 ^"+!^!8EU/
M6C-]A\8TP8N%O!ORG$0KY=/#U!C*R\=G.WMQ)1(8R(OTH'+$]X>_O[Z-OZ]B
M$F<RL44I?BB\,:20X)VT#5C$NG^X&2-M*WELH[JPQ]!,FDOV0G7"Z)QFI7-.
MS\>V(PANY$/<+V*DSE$QET!KX*_0"]VR4;P\BS;&"N/.OZV.YDH/"+"+9"P<
M?,IW!."^OC+$ Q_"CRPYF("YC_\T_E>'EOW A1E,]M%7_2IDV,0V=#P6!MJV
M^RXF+/\3/4GMYKQO""R'M=<W"5;KT$]T ^O)Z/NY&$*F212>"Z'%M)!!"F62
MKYMBY56,P;P:X&O(Q&PLMZD8JXF#)V#K+JCQ-9#-6DIARQ9^-&4A[7X#::C*
M2*UO09REA4:@9 '+\\:V208I/1-:CJ8F:X=778U[]JE$=%62W+5?Q=&ABH12
MI44O1:CU84L61-.]99[Z%(SCI:JD^H@V%"J7([JZ$UGN22KS?)85BJ!8;,LJ
M8+G0AG1HEB(UNNS!SY$3SL9HCP/D2CI+,QMP66-XPFSO;30>)$IBB):?R&W]
M484-9!4MB(]FF8\<I]U,<6ZTH5F_W +^?HOD^IBP"K^:50H[0)XNIW&=TYTU
M:4>^S=VV)[#DO0_QJ5,(S7(?M9?7<B%OP<;U:T1K8[U>K"2RM?,V^=D)6$G6
MD4632%4;$Z)-IH%Q P:1D!UA1#>AVZA:6__>(3!9MO\"?U1E -!BEEK4=U@>
M-U"WM^8FAZ7N#-=_VR6<&XRJ>CF/2_CD5/<9!Z-[]X3 9K"OA";$1Z$(PB%^
M6>]<-U5KIRJKJ.7IB4/J,7O2+B\8))2 S<"D2 L=N6_34E::=$1F"24J%%?!
M;<Y$(YP>5<%Y9%+)1DB2;P6,=M3G%3.6H*22&7'4((=I\;F(G9);82,TB+V?
M;2<?_KO-6L8F8MDF\( P2W;PJ;QG<@<O][Q0[O2+\(J1J44B.^GY52A=D2.$
M*_UJW(!%&H&/-<@EIK?K.V-CJ(9H[T_I;G%JZ':Y"80+#T..L-)$K*8>DW90
M)M=+F;,25F&6I650&CPQ@20-RE=MWQ'[G2MR$7BMYLYWX'HNS4!JC5 )""T3
M$=G2%RJ9& )^P[ALH,CEZ6U>C[H<:5*=RF;SGGE762^J9L[( >8LJ3!#XCG=
M)=^I[AJ,DTFA,^9A+>+QD#/5W00(C:LN^)FY\O$5QS^SBL#P1_[E^N"J\L%
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M@-AR3L;T0@:B?XK0BOAZ_IGS9S?$6S\^5DOZB\242_E6R-8SF:W40/BGN!Y
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MU=M2<LS61_A(QI'Z.<% G"#7:CTG<BF02[ $(3? >'I>\/6L1?$)6Z'*U;+
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MWE?": \K-T$? E%J+Y6B#VUG_'=YM2-Z*8+[F*_KU*O)YV_%1CW0\/&-SB=
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MB.O#>9@Z':K[#5Y!/H?A'>U5%!  68%!NTRRY'QY^+(%E!9401N\1366LIO
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M"?Y%L2N(#2)5>*4)"4$IH0LHO9.0! A%I9,(&'I344$A]"ZA]Q02!!)Z4;I
M0" )4I4B2)6N8#O^S[WGWOOI?I@MS\[.EMGY/?-E=NJ1O:^UU0\7ND1Y!Q2/
MW5QS"/C+P2,A9YE]Q.H\%TNM<BE92R\IVM\OB*>4W^=*&FI*4('3F^ZUT+=%
M<K:A"\GN3G_H7[6$?W2=_N#V&R-P'S.2,6'RB%B]=U!6/C5K$!3I!QJ*,/[\
M[A&#KFB^]:F+0#^EXWI&:_^35_TE-/K<?TM$EQO&$S5E)@J&PT?MSR2B:D_^
M!J6TU:99)&_'V[#5ZU_.-43.W:GZ;[OBN>400MODIVR5LLGTX YH;EB:SAI:
MY[$/&K^K+\R^4%8\\$#Q2BD'6N.Q46>T5-M\IA9 L%;K'N!.+SS0C-F#M6-_
MGW7>)_YBL-9E9 R^[JQ\PG?M:"&K][GNJ6@BL] &\;>*>K-M]VV:J'Z*,K5I
MMT'DK:>Q^%E7QX]+;_;CO-_.UP0<BK _B^2.=R]-/*69?QQ-E!JMWJ]_$?CL
M\?\DOZ/\Y;CDF3)K5SUY03\DJ_,O!^^A% 3LM%"^^IY@]ZQ9#7 8&.9[47'C
M%EUM/F)L6Z/S^-5D4MA!U6DF>';V:[P(_: ^J47N9E$05SYHZ:E@"'S"0>-A
MS\6R %BW 5M#DH?K?WZPN@$8NQ-2(CR>UU;V.[_;N-NN;ON6[SRE-7Y;75_@
ML1=T>L^3;M7>;2_XI+SFOD\5T-'?_Q'&WG3[=(\ NB>4^RFN)TZU?*]Q_6K-
M:2M_&P0Y=N273NTI(3*YMH%'^K_Q;)OS6T=&="B2)0AD*; "(4K>#O6-34C9
MFR8RI&EK C_[&Z(,5<,2CM,97$DE&0.\WE]#IJKS-MIFQP6* N*"+THUV;\^
M8D.8FOC8ML?1_ADL\*Z0#4\X>@"+W\L9>/QV'/*T(CX-MW<K>=Q:0#<;_^04
MDY&[DI:(61D^]B/6O3[!-*@JJ;C]SW#N_07\_J=7(F#9;>K1/FDDJA@.B]T3
MC:6,6]4^/+]HP_ATJ45A0..-T_X>->X_9N6XYJ*-T,(P%[EGHZZFP]R*6*(Y
MZ :!BM[\V,%6$=YF!.-%RO)*(,_F,:)OIK5.JY'P(H5Z_8KW*K_064;B"VO0
M18_JE2PA)I*J"_:;O-;S-0O_M2@M"#1&+.\MD-(-ON@$ GH>X#]E!Y^P"[;:
MIZR0B\\O0>L!#$Q=\\@;4%DRH'*J+X(%B3:70*CM]"_G3*->+]T ^$U:9GE1
M;J-ZW2U .9@DH)D5^]78 ZSP^^OXV=SZR_(]F/Y?YN4Y0<Y\@/5MYWEQ_/PO
MQY)07!?GEY1]7E$%3:3#80,%I#T3B3;7-;\U9*'!LI/8&>=-Q.'ZUI1N8_I3
M#%;W?2^LBBU=.E=54.F#&[S8&O8JBNY== Q2:G%Z7^,WK,]40)5J,7_"5QXR
M,34-9HKGLD6JO>*300%=IL6K^:;2C###5_N6MRY@NJ\W>+H+?Z?N=@IFS2SE
MQ7C43 Q)W&&88T6S!2JYQ7;#JB CO;N]=](,!:H\Y^?LOS!"/B6T@)H'KX.^
M#I"M5OU K[;E7M9S_N4 !XP2^P?+>!:2>#S!ON)SX4<V4OT?JN?;XK=?O?CN
M>QW4!_ETGMX2?W><;D ?/+0P=K\!"&*[&YR!G*PK/[UH';%]+0Q+>QEP(-BL
MFX1OXK($A(8<KC'^3(=#?Q?_H?.4OF[$WT9K"V"__^5 9?WAT=+Z'2JX"@O#
M)Z-A8>/BQ3C8P[V?25=]_Z@/Y71-_ %^;J=)^.RQF_UG24H&P=I;:4_I%DG=
MHBJSU&/4>VQ\_15D?A\YG^PQ/]-PN.9TD?^"UE-VBX_&Q!E_FSFF*_]23<:Q
MW7P&9K[P4Z]]4-A6FB@D)*.\<BT1$S;09:#I1L;#N:QO9W+?<>V%/-CD[66W
M-(UUOWO$A1S4DK;C^8;4&NK>Y:/_I)!"J5+S_K*E'IKLQ&KRN?1?K!>^*MDJ
M"Z@>*3_WF;+V 7Q@UW/);COZVZC'(%%X#N8R2H^1(>>ZR\\\N!3Q%E_A<SX)
M]>;/"GKJI&?H//\1^_9!N6TR-U]6*.Q8Y3"X+ V2@7,E<\T(UE](G,T(-WMF
MQ<TBC>G%W='L@8<]V*NH2W4(('_RB4?$A??EC.9E"R_?5D[<WL51J6R&8WR^
MPT /Z 1L;#?U#&]!=L"B:<5JZS'(*.K>:2@C=,6=GI8/LK9D;>E(U6+5F8G;
M;N>!K4."M>! [GXU8FF3"%W&-J+'O>*L&Z1[-67#G3I@U7#*$M*S.IS:T[12
MFV_&>&EV&WVW6)^*QK0#3=I=2-QO>1QM/BPW-M39-P+4;>O+M"V;C".7ZC:*
M;*BA"LQX_=&)G\CHBE=Q.\@FKG# &NY#TD T)KMZE__#UP&?1K%:NA=[YNSI
M.@@8*@X[1N5S8+8L/11DYTWD!-^"4'3]Z[A=IZ9]?=#V#2AW*;+N"8/I\:=W
M97WLI0,!6!=.8$)ZSB.0[J,IJ(MMFJXTDH)Q,*(/;0)99!=L/-(O=H+;_&G-
M)BJA\C%I@WR.@SS_R6_;(34C,=$ZI6VL7F:^,4_7%)0/&I.JYLX'B?TT_E>B
M_*L3C$3<E,#G5J"_2\L"FU[&A':P3[$35RT!;++PD.3IYAFSW5J+S.Z25>#Q
M:(P^5$"A][6,(!0QD:!TG%6,5VC4SL/C5<_WENG[H@<[<;-CZ]AX7+^?S*6)
M%<DW6/L@O,]0<97=%(DP3[MZ/?&4GXD!3E+U,WS#6OB8M9(4WCMGM&9)N1IE
M #BV5&GN@R35;*RA#/3D@W XR\Q4XX[OI&"^YW5FSUQ?RT#XIHY_KUR+&[*$
M&%-C;WM-?@Y(6;T3/C8%GV[%X.WL2(/7IW@;#3P9\ED0P:G,#8N7VJAF?BYX
ML3[.H'>R!&/>2K;#0LU*KLE,A_/O&-9"['*\*.?2L*14^UQ!M9CI:"GRK>ZE
ME&ZXK1%Z9A0<7+-4;B]H(-EZTTS6$/#1J\G32I6PUWR9AG4$4!H<L XP]84K
M%ZNCG3(,YC_YA%"?ZQT#R:V$0G#3;=;*JHJFLN'(*MT+Z+IBS8;)NKBKO1"2
M8ZA)*%7#FCFLR>YI#ZX/AG0[F3F2R^XN74D1WLWFWX7*_+>K]U2>?'GJ\!5N
M-2K4(M0H<\;L-:#$MYP6B;5>47\0)&SC4OZU7;J?#4#;-H!R7WBN\Y5Y.'HM
M:;%6Z@5-2 '48/B8SIGC;ZP;RGBBY=<A0.,ZZJS=ADLW#!/$0+D'W; C(5Z[
M$P_-3FE!-,@!GG&K4\2(8F;=A\QN)]L@7)MSI<>A+##$U74-:7?*8 1K:^S@
M]M.^\C,/RB0?S3[5"&2UWY]*/V&+ZL[^GAGE=PI9/^CM*,M^KK]B%ZQLH)@,
M3(]QW1H4P"*^@7^]1?,ORM<!IQ]*H+[&-;Y0(S=KRL\7OYQ^N>)XK9N +OUP
M=JK,^J[9<Y _CGZM2+4L@15"3C$J <09$(PJMW%TX>MH;1J!5^A-&#*BITY.
M=E[=%?_J 4++2QT1HU2?GBC=F$X3FQ[GMEG?"\I^UGVO>H0SV8CZG#T!9KHB
M_;+N)Y9Q@<\;/M='D\&5 2M5)0FJD.'5L/SU2 QH>D;"DKA:<O*$ WVQQUUS
MK"+["SK.1YWE^<HY/?,WP\/A5A*$@OUOQ<[ZKJL/R+9$1BSKJ-.Z$QVB2JYK
M\NJ30+#K+U$"NC\^3\>N5P@HC]UH.(<OD_R\C)_0>.9CW+I*2VB&V%%OK[1[
MDAKZ-L7!^/(!.FG71) \>"*@K.&EOMPLMUW""V="3;+7=I^- ,'S?18S$KU/
M>8L$)-?^9,9AGZM5NL;%:9AK?14^/Z[O.<>TR?_XR?L!(U#=O:CA B;3T,PU
M\&PD<^T:C)ZK*LR.>DRZT-=ZZJ.,@-=$.=VX6,^,]@^$)\UI8]*QZ>=9IMG'
M*:CL-^75@4)YA;LHU))BD#RD.=X#OWP]9[! X!MR/ZZU:]>N*71&56N?YHPU
M\7@\]_-1_P50<4.N?>=*M[.GV=7KII6SWO&1:+L7P?*:=XA7IX]1@0L!HTC6
M^LM0;LFZ@J5;$DB%B))X$V18N*HP,CWLS@)NLGI,!]J-,70NO"#38^C@[%?P
M\<<?P2KEM%Z3]5*Z%3"7O9 /@O?,/PK&8\VV[10,H.0FIFSGB6Y_]>ARMB:R
MW^!*0GPR<[2Q^$XU <E YPUY79EJS^RHW]N .O="&._?$K1&1_)IB[1;2\R]
MG^#'=Y/P5&6:A)-@2\>PU1,UZ@O+!B]YQB.C59RZ3+DB'.1CR\RLWCP!*4R.
MA\M<DX^]XQVR8K2U 2CYPN0QP)3+UE]YJ4Q'O2HD;3:X6"94V^\I?A%]I$!_
M1M!MAK3]Y5!@<<4]GJ!Z-&1'^YZ>. ,86[DGAAM,'.=&L;$;QXMK/W08O'D]
MCZ.DZ8?^Z@G6]I2N\.;UKHI2B_KGOS-IY_]/%)I!^1AA4IJC[/\-2OM_2$;>
M5)]#4CRP N;\[#+=8(*8[15/.^O,C#/K$2Q%<5[-MG"!UEJ=J-4W;,H53/UP
M!N9=A@+6'U/&*8^.Z%RF"Q01@1P.>!/IPN,X:=(Q"CMZS:*;_U]'IA'RGWJN
M.CQ4J9G(L418L2-&;9N=(2ZEFCC3U5X+<KQG7=R<6G%RF:_\Q5HYJCBJJU+8
M-OK)DO7(=WA*_84)UA/&=3>)MOW"^.JOTCY<F\WX?LK[Y@P@KO3WB+WI=WUW
M1N8[?;"DLM&D=''I<=S_7O[_0S*-2ARK,E<S(R^3U%-(ZAS2I:4,#FUA:T]N
M"S2'^ZJ*H*[)J5LBM/T5,U30JHYZMFE3:B2G=/'_H8RW&+#>UND-:Q4T!L)Q
MYP"[8I@,=&3ZE*3?=*:Q%[SF:RMBR%A[PR6"5#WW9$6Z6GS@/92_\F1^2- 2
M23F<J:@'682(2I5--27=!)P??7=QEF+O]+QF["4%A*2(Z=&4TG_1QM@I3S8@
M3>P>%<GBU]QR"[!;:#Z*)'#DWQ5;9Y:DU"U%G0R^$E'^QG=QVMQSUL$%DJ!Q
M&,6&?9B4L$K"UX%MGMFQMR,ZZ!OC'' 'YIOG%?&""5<K>^A> @-W;5<#":R0
M"F2LP"98/C.?5JD(%XL?R&6[=0E(U;FA*K"B@&%QU_MF;79$,%7#/6ZQ!QTO
MAXA6C4I,G?DN39PJ\Y@8V&%]F"*[^O>%'52,Z6A:OW FID9/F8-P]Y0X7]I'
M"RS5RB*3P0JF9<<)TS,N194351<LE7+DY!N+ H/' 3D2W?@BK[A\NM@#,I^X
M#W2;%?46P/5 7V><_YNY1GR34WG4LD#EC\5I]+2?-VI$7,JKMZX<B>H)W\C[
MF@2=GD$/?E?)ND;D%R1C H1:'6;YH8\\DWA7%:1)$@YX3&!9>3WJI$'7!]H2
MRN3T;;AU'<X9'U)X>I0"_K__9LU,#JRP?F@F77I;AA;Y&$)$OBQT!;,SO*KN
M+N&/U3P>@R]=0Z_Y<=MD8_1,@2<8MC%,V0:(;*"S+.4V&@ 1PT>*6ANRBYSH
MSH*<!CZ-?SE$-IS "_?:]C?"EH]>5O%NMW\*:]CT$!\:F'?9IX2KA0"BQ9_\
M^(V!=3?95.EMK^4!:ET1/W8P6H.NG,P$U:H[#T.KL$;S) NU>2H$D>Q3?O:A
M&L/S;B_ 0F+%QH4?=5H[4(A(@=;.1THJP*\80VDLKO<Z/8/[T!ISBR=H^ LL
M[[F,EAJO=T:4LQL*,@P/'7&EI?Q$?=O4CXFL$X9USS+%\>4S3;4L'#Y?3?JR
M8KD_PO4EQ??0*Z&OD),L,O:#1;#W 8JU>IUPCI0[9+9Y#,!_34(E3UVM'[$"
MP?L\)=*\(5F3Y:A$79U+M];,^XH-",$?3DYM6]HU(9#H$X*GO21F]Q:D]*WL
M@&YA)VV=:*L)0(N.2"&\BA73N]!9V5S%V[0>)Y.&C:&K<SHS!Q*EK\Z/6J\(
M%KJ:T84,D0A_TR^CTF5?1FH!#WO-7,M/N)"A=< FBE%CZ:F\"0 74>G'+LR[
M2.RAM5LW\( HZ4@_]M!*H1^B6F]263/6Z9[<"S&T*'T /PF&*K!>HF*C[^@%
M;#+9I3,6'8VW?,-2S)'<2+'RY(L@/,;06KHH^EBU+54&B.PV\+PLQHKYB4"@
MJP5*3V6HENT"_PLIE4K1HTCJ,?!)4KG J%>)Z0MFIU/R2_E3C7'/*@C+F42E
MWMMH \]SM3#9C *N3'(U%:L3]Z8OA#Q2+49XF_$$4'%?+W=,M-4<]]PG70D1
MD[V-3QKD?2](KA74B0/?0$7G%T^;:W@M15[.+U& ->'C91BW1*H8J/KX.B _
M98*TWW2H27>'*B$7_<T;FNPA[R& @\93N1[^QY+"=GT%(^X^G[W!)3W,3DO5
M[Y$S1%!"#F8[E+G_.[/F)+-]8K[K88VL_\6WXYD1.C\*0._%>J^O?1Q/?T]Q
M6K.QE>WB<4@ECUQC?MWWT)W_QN^(]M?.7/=[C!'2&_D&P41/5]Z!3/]0F5ML
M:C0(>3],#V]_\>2"A)BR_),,S@LH?'_I_<K$BW-_.3J* ER\Q(:9-JTAOG-N
MK95&LU;#HTVWN3JP*YX-.O(;CHXM<>?O.S>5F(L_#Q2.;U7IW/XH/5GH7.>2
M-N  $^BTUMKWKHY9D5" &PB/UIX]E"I,LT[4XN*\>V,G"(^J;$HU>B0$47C?
M7';B:FI&V%B&I_ZE&KQ//_W+F-EC=&0L,KWJFLS:-0W? :M3QN*D#3Z&C2OI
MRTNOB@=<Y\4J8R)1KK+ QTP?A6;*W1%69OE&^4EC;MM$>9,&@9+!;M Q]0L9
M_T$1J>@\427;4V[SY/=(?N:5\Z/2S@4F^<H$!%J_KU M3JB!D$<L6TF0/#X=
MY$F(Z+?:PTF H;3TWC#J,.SZCK'59NE#O,]9B!&7_"Z2#V(L=7F_XG?KF;#3
M]KN<(\L(2SIH3^F+!N%X;P[>KQIRI8B(, >EOQIY88$@GGPL?2PN'QBR4JR>
M@8R42BR'6E6A,U"1XBG^B$GU>C,WPG$)!_C )/YJ>D"I@AOZR;>PJB589?K;
M KH!\_1\FE(D@H@P+I=>RENN?&PNSQW21ZK!6IL^R:<C*BY^&!,0&TF6R2')
M2'0?EPV-Y'SI50M?;)JRRLF;63E?PTBSB!=\KCQC\P#%*9E@;G>G6QY9YI3.
M^SP9C_*^Q<'<=S'_)]Q+_J(#/C7C:NZ W=EHTE5B*> $HBA:@Q<'M*)%N@F9
MF_XSU,G(Z^^*RR?,W;HY[G92%'WIEG5I;L?_JQBK&ZE+.T87SA /)DQ1SG+N
MP,'6?6%,;A1'->LCNC301U&'9Y2B&*@XV'U"UF<>;P\YDV<B47QPTJB#;$1W
M?MV1T:^X:!)U Q)FM L]>UAX,A8X"E: $-EYT8]ZZ<!M4Q-U9DV*&#YHP>R/
MH&#1"TD[( )-+:ZXTVT5(Z?!-OO+$4;?/-./$5NF2)R$UK<Z1N&&K&TH4TH]
M=E-X1/UT&+RZ?+7^O#@.R06X.CSYFCT5CNSOD+>:UKL:*3\1-*;WFBB7.,TZ
MG<.M'_G!3A'VB%4@S/)188C9SK>,L3RA^ P#F=A+-0B[JS0!/V#E .J$])L>
M+[IL!@!V:=P%L4AT) D(/N?TYR1- ((LT*>3*+<$A.#-/PA= ?OQNT9Z?JZL
M(&N;KE-$0>:1M8!NRAU_'.V@IPCCKY-M80"V"G4C[=[9L+!_BG:6+M7<(Y\3
M0-'J?FQ8R#M3KB#4 #QTVY0PEATZ5F#)^?4HTP^B,VI=JY F&0IL240KYP!.
M3"<N1?MK5*_W%+F884KW"4X;CS%N$M'N1AM0VO/"\,B95:DT-8K:O'!\[1+.
MQ0Q8-^]56<GT?XLM_W@H!3CA<.J;KGUS$$%DR'JRK/_L^,?JC2#@U281NI#M
MP%>O@HE=D9Z*R<Z&WR\D?EKME]D7K5G]Y7!G?/6J,,_Y6;%#")R;+GOE5E!W
MDR+J YTE*>=H?S>7ITTE;>+[$>+B:M;8H)M//6]JCCYN?(S1_JFP\&$LR[S@
M9WD-8HZOT41.\B_'OYF0;UG7T!4';KW?S44GK OFT!N)0&X?#$KND5ASPQ49
MJF*7U4L#5>K4SZM!9[Y LD@A/J$NVM>K-'A@5\QZP; 2.\5.>F6G^&-T7B)!
M#)N&^Z9YYW/VQ^K+!?T-.9_.S>CTGNW<JHKNL;(.$QVQD_(CCAG7NG]R,B_T
M(7R#2+Y^A,D5-%_T3J"@)I_$^2N>)U8I9UZ>/LIU"CT'&\G:2U<8; FNLMW*
M*^C/!KP/">Z\<AH&:]70'3-ODC, K>_\T@8G=2@.>K"E& WWI_CG2[(M@*O)
M1 8\7Q]P /^<.OWKH!3&$ACM014K:WF@:6-2:,]%5#;8PDW B*'.:<S2UU5Y
MN0#-HW\@GX?[:ZW.RE=(?A.W[8>JQOU6[!L:L57A4YRJ[S</ [!>Y]#=&',C
MRA:@H>[[!&9BS+[T_+29-T_7^-4:.5O<_K?3/PZ?Z8S:I#MY:KO!= A*,W=-
MA2(5#"&'2]J2_LVXVWB[5[KK8)XN8X)>29"_-49$*,ZZWME*.,ED^Q/'C^S7
M/5PV32N"SZ?M$G_9= ]P:<H..^=FN 5%C&\KOI7O7+J5M%=5 /&^N1[\D*,7
M<I#4-1"8>NZ"AN"A80]R7J-WH37L(L ^]7U>=8=U6,(6,^?X>*!+X-NEEF7#
MALMOJ'4]NZI+;>XM)!,;EP"X%D]=;<.0&B4\5-&AKD#;9):>\\P>%H8.'-U5
M%D>_H8P2#"4M:@)(*7ZF18'VL[F"9#(<Q\K.5L>GDHE$%E%"_BFG3##,_;5#
MV 'Q.>X9JG0&UJ4MSILALNK(C$RW;B!D$(,_7/\A0FN!AZ]H]I\V;8"F6!WF
M[Q4EF$>9-U];T85+$D^,O:FTM[;H(Y$EC9?@M*N2+F;NA,'TGF1_BW?.WM/6
M=J2+*K.OW2DNO+!KXJQ0B?E48W1E+0RO)("]B6+D>S<NE3?D4%P=I[V'(<MT
M4-I_#4T]H95@$U^(T9#7>-;K88CNT&Z.R/[7!\S->,GJK-^)-^74'':=HC]_
M.E8Z*L[_E\-D>.M/XC@/<2H?,ZTI5!QZ^3H(=Q3F1S[KM)P&,VX6;!/:F@[S
M;M# /K-[HCP>'=U,>(AUM""3#"LFZO_#.IW:!G6;WGA-^M.ZEC)+JV1<MX,R
M=]N%0XJH5,?@9?Q20//3.I-SR_AAED3X0+G:,&0LQ&F0.JK_F&W^S(J&UY3M
M%-BP :J#;UI>DE:E&$M--C#.%KD 8 ZUSNUWT^"?(^*]&HV",WU$<6N:BG,'
M^8C#</;35P&=_L!M_('ON1^!+G!G^O;K7\% ]/+(G+13]U\.[A^!WG-(MUY
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M#%JIY__,;,K#S^B%,-Q!0J'R]LJUYTJZL<:B_E'DHB]/I$=^I2[[@(:^U=0
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M]_SKM(I4S15=&< 3MF(W#*F$4W*)=D0+4.[N 9S%]&_W?"$O5U?(X"M=T/6
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M<5\'H];]IVFC?%JTKV-21='1=G:\R)A25+2^IP[9EA' UVK._4T<7YTS0E@
M*'296]>\-D[$!(U>E@*I@,Y79JZ'6TO5/PR@IG)K*NR5SWC]L.YV7KHG.72'
M,K297L[T7D&-7VVV+[/QW *.-30^=*43/HW6*V$B;LT3'QZ2,<969TEI'S#^
MQ#'G#APSZ4OE3QZZOKV7O .,N1ZKF<I-SU'T04?4B^S;E0[ "8DP.?N]2DJ0
M>77];=+J=)0UPW_R]P_I3J5 M2_B+\;=P>(VM\4VE^ATNQ?]K%R=[C!:H*&B
MF^TXQKE>J?D>Y!4@MD4V8RSDB;X'JBDI?9CXT;/)JF/;T8T2HR^,]$FHOT]]
M+NP-6(1G3'PR$108S_S+(3/?2#'Y^ ^A.E;\Z$.KQN_F\Y3,YK$V=2^P\[6,
MPIG1^JI'_&P7]4TJ+=$O;C+))%'#<C;@&^H&MV5]O")NO% ,(R1,F*>\=P[:
MHX"5IX6QJ&6+\WF@/&8MQ&@>-4T.*-W9=>3^4U![ Y"XO8$>,7V=B;"]Q0H;
ML@17Z\3AXC0$<V)21B?F]7G7FJ^MAI#P9M.XKR51IM?\3&?<,U7C!G2%1(!G
M%R<<D67ERYHV*H&>+NBO%>(">BFVJJ1Z:*!8IAKG%KKW"CA@.M_ZZEVK4:$:
M^I/5<2(@35,256P4?H4RIJUK4[G@98O@4JWIA+"\D ,]F'PHGYJ+^=B BUA3
MN)#TB($^_(4K4*86[63[F2U+:TRH]RQVDK=3&?_I_\+.'SVX3-&K'&/N9/4K
MS/^>SD?7,T#^*.C*S^H4V.\7 \N\L]$"Y(?J*?!O,0D8V%R4"2:713W:M:*[
M.92/?4L#4,I7_@2= PQ/\DA\2@ANDFRX] +W%25@G(%G>(^I5H)A7Z5T(!_6
M:D/E\;L;)EOOKPM0%HC9J)VM3%6(S<;)97S:.N6F*M':[*FN3?BQX^]-&U*0
MIW/7)LOL%4K*+&_Q!D. =#O\)3KTC_7=Y'53VBV"!'^%1/KO9G*QUG8ZCM0%
MCY.42)DO^>J9;FS6>KX[G,TN(#P4QR^+H^G</;/[W=)YESV*5IH*%_!?P=].
M/&.$!N:7(EY!F%YAY>NN;,T*N&L01FHUQ1Z2C0D1,.!V2#1G*:O/#_!.J)8A
M2[-)LFJ\/J63Y8W>3@M5D%:">33D/3K51ZI)# M/&;YGY.H"\_+Z^0[*N.P.
M\;<TKP11Y3_,A]56C2W)=P S*=@&$2_VCG=B[?Z9 :1?K#'O7-)@:OUZ9<](
MM_/'WT<K8-M3@.[;0X1BIM&5\IENI()U1BPYRB)*-@%/$</7LI,)E).#.3'!
M[F_V05KJ-G82+EZ5<3^>H3P[4+FG]MMZ(/KV&!M#$FI_OG$@8V>2!E.3B%5L
M*DX5?*C 2FH!A<\(_VJ*K_NWK?+1-_(.BRX8=SKM9T*IC6QQ0->&;-\DR 0R
M@UO>^YGPD8H;7H+:-N3)N["/HV4V_EBC1@R 7-W'S+UX7'(:'$M9@3YHQK=9
MB(46JBFSY[9I+$/9:&5DM.\CU2Y"KP;P:HG"%1YQ0$I^,V./!)X%)'@41<6T
M#3Z6IMR3]*Q27PK2?B!=C/N1]AIC'6S]T3VG[ME9P7S:6]I^H?/(_U^F.>.F
M>!P'2D9!NJ_P^&NO0]Y.G9C):+3!M[NCTDAT-+[T 3N[[N7U9N*JY\Z*US&Q
M468X<8Z4S*7/*WC?@)E>.@KG@.%,H.Q(/L]2I4;>EX23A2-W"D_S=*LH[=!F
M:)%F8Z],S&F?:9&8 $)V Y&?*<N,]#D2-'$!&S"/V<#2OGL[8>9?_F1]G8P<
M=&_YU*WI4]IO>,KOZ>,?[*4X%N;X7/N_UL&K7Q#H1X%9+^T Y(>O(#[3G\5U
MW:[?Y<2@QG@5*_E_Y[[+>9=)8W_3X4 _(K#S6Z6/>>F45EQ(YXB"P:K+-TEO
MN,S+9LR+W\IYSACK&W&-4ZZ7H73OR&)@@")\ K/GU:G]H@2I;V&6K1:=0I8H
M<]H7WB@P+]3R3C0OU"#R_\0+GKE-*,:ASD7+9U$T E742D\HC]05U&423B?2
M_BB/!8W 3BI.;3+<'>PW&#X(4T+P"6OGE%=#JUD_O';>T6MQSS[Y G)3*FU[
MO"FHJS?MW&I8?D/FM.)>2?_0)QN0+/Q+@1?'K'^OKA@J(J_DRAMY,HXS!5-Q
MTA]<F,S@\\<%5>XC,(UM,$6K?H/;>Y_D22F_&!;-WL/ZI%\=;]+4Q>(.M@,H
M9Y&%T2%DK!P:)I-FD$W&5O#VN:S8N.#J<+?2Q!$+97*?T%GN,@GVE[$TJ+ZN
MH/@#Q%+2%[(9_1_B2J'C33^JN-=(Q+G8F&)%UMF017M_*]L!N[IM%'O'AXJ5
M ++(&.S.,J14(#VEQO84:=?AU##$8,&*LQ6C[&T8%$I.3\EUWG0JL)KZP)*!
MB,VLQM?R:0I6,?P;KP%/OW (S1!(PC+N" '(E]_GPIK=,XU\&#32%S3"D;E/
M!]^-E=/COO[ *AV,PC@_EEF[;X@N$[H\:!5MPES,1737'I0IY[.*)3]V-X#_
MR:BA/QQPMM=$V,D:;9AEFGH$V BS<4[A[+L]+L3+B>@4%17G@D!;ZV9 UD-S
M+_U1@NYW01-DB?=Q?F;Z?,L'/CP'P&L^^;PUX=C'<KJ<OKC5]7\OZ#18;M5;
M;DR'BYU0G)A.XY#FG9>A-98;\\99I;$K(<A4XGF$CXR$PZ@,41X_8:NO8G)G
MAQ5[E0SA,*&,EEHC6$WP_AF98\!<^(?Z5IL96 ?:MG]RY"^'H6]92%5"UG+8
M01[F?S+5]6BB&SU(B8M&NVH\WWO74$<1CX%)6=G#U];\+5]M;CNU\O10T1][
M=W!C)[@08)=)X)C*@--SS25=1?@IXBX$"3;C2KF,S&A##>-,&H5<K4XL0E!(
M\I4 4IJ5PM4P7[!A6 0F3>=5KP@6.?<R1OR?^A.3HQ-%<N$)IPU-PBAFIZX+
M[$PAN&) ?CKR</>D0*O-!^]%N,6^8.Z:_D.7C0NS3%[])>?TVPKZ4]#-[I.I
MM8%+1>[?*ZX27EM9;3&_H)TI1F2=BTCB0ACUM$S_QT+]$4D%8^ QR?/!5F"C
MQ; $M($)0)K_%$-C@'@9:-YB=?+8([1^Z8.[>(Y:(7CA(N)_@L\*SRE_,)!9
M;8$I;.M<YBO/!LKD^*#)YHSCU84U<$(7Z^P]+'FKBO?L:XAZ FV#+G[9BQGI
MG!EW7J99T:+"NRC>N1<F:U<!W"-:P<FX!:0FK!T@:9/= +F/;$@ETG+'*E))
MFTLI^AGH6CX(3 1K4^0D??D_E $J1:><;E$Z'9N%P^D3I\ITKQ.9-&1J,7$F
MC&F/IO.3AX"#"$>T&]I3/YG)#DMZ"A!.]+POFQI(^.X/K14>[>&R$@LY)&/A
MM[I'J1(A1&F$DPSGV+MNE4>%I_E7U*T'X!:LNY=S "=31\01=OS,FJCL[PCO
M1A<+=X86A&%DFSD#N@LX('T .T5['A\$C5)[$>)D(-/![#7^I867*19:.X*=
M?FZTB\CGL=EN&&M)9D8.)XJ@^Z>VD:F?VH"!+_'7XAO!#(BWQ69&_8';;;1&
M1B+_>PG.4\PJG^J>1A\03Y?3?R\LHX>VSHK0AW]T]J1X76Z3.'&"W1;XX]EV
M;':I?M84Q46-D'>I?'&H?IZO^V9-[''3H_%G(7'SB*$RQ>(^"TN*RVK3QGB,
MU'TNY064B,"/X$"B XCVT.\Q*/;]^Z]AT*C[=&FOHVOC,=1CUW.P5;9;]][5
M!QEZMIMLMHE&W/QY,WU4_\BF]4=P9]#!&\+',W/V'07^^64^,7._!#Z?'$,H
MBLAO.!'+)_4Q_$(Z1/U*Z,U^F82=94 34M7M!GC WR@Z!&!&5\'VHBQ1Q<8(
M4M=3"!R&WB!M5C0(-+%Z)QZ <[%.B/F+U\"YZ\W;PY2P&TD2/[4*Q /FV^1_
MY"T8UC)=H5)J^Y5 T_39=+6D4DV5!?VV=.[#7Y@QI:DDK4NSK.VJ#E^^UOW%
M^VVA^U74%I!,9O>Y/8K,>^,+I:%V;12&60/)P)R"%$\6_-!7(S/KM&KT$>(8
M#6=.ZVO?P"7>H2')/<T8A:UHQBW%38DIN* OOB#X!JK\E3_L#8,K]!QYY3LZ
M+]>9EGGK*H%S7::9N!-(V+9^Q,WL<;&<,A%C:$3V[2)+&!*/6 USO YGU<KQ
M#2,$ ,H,;-3W%0RMA38]7W^E")?=VT$KT,7$I[U6S=6<ERJ[.2!W_.I&F3U1
M2W3D!-8" ]6)SZB7&%$20?&@XGQWX<%;&U&Y,&?5O'NPGW*AW?ZI(>2'KV>.
M1G\,S97<?.'T $LTDL.FL=\LU:J[\$S06GTW3D9,4#LM?J_BMMO/?=),;(2L
MYU_S'I'#Z&WJ922(BI\H _;:"!A,QN'( E+R+D2D>D (D85\WA?1] B5_,RX
M+IF;RZ(BNN(!UNQLK:E)-_I&,NR8<;DBUF@4_I!9><M+VDZ-8#N6^CH.6V^2
M$=I]!V#_RF<.=F(BJ!R3MGVZ038XXF-W4!8G&=T59O,B LY.B,GBQIE_)%!=
M;'_,H+R;?QZ-ZY>NW=V^PXT_M- 64F,J'Q9TKSFQMOYRV*M >S,9KF7^H7?[
M#HP*PL;D%,W&<@;C!:NQH@/VPNN]KW.90@GV>*T6N ATK_#<QB(%%'H&D%H
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M#-KHU+.\9UI_',,]MNA:RQ7'=J_. SQAT"K%]Z8C2#6V6:BMN)" 5)1="WL
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MFP6?7/2F_YD^7Z.,L+C96A]C$^Z4_[31WGE3H\N?SZP;?+;Y[<U?*@>5\"G
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M'%9IC !S/H/Y7=RQN@;_GND8[/MEMB&+.G>!L;:7K%U,\9?9JZ5)VX14$X>
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M-'!._&(=3)*KEMFV,EG$BM%* ]9M5OQ]NI>F7;,,"'BCQ')!SB,'\V6"=?X
M]THC!81WGR'5_8S^;EXMLA]+?N:L?K>_0]G0)3YX8C/6#92NV.OB\U#2JCH=
M!&_I,_U= 9\H;A ;BR]0!GZN+B^>GJ>:@T:>W>[$S/0'W(*N<=#K3^!'''Y,
M!-6H&V_S=Z]6V4S/P=Z5JHBTBY!*R^R"?XI.^"-;:[\FU9=.LDH)/SI15@]]
M"#02AN LDRNJ/L5&\\\\7"V#S$L_ATDM[2!KBE7K(NWX/"=)\>J\1Z6I15;$
M<-U*ND)$.2C#:F+P4&A5.',ZFQ[;!/UFRU$/GLA)>G(+F*-2:O$M1M>V2>AI
MU6\.+#%!@\JWQ+WJ*],>Q# [ZH=GTLL>O0K2+Y3+RAKB6U8*?T.A9#^KP'R)
M'NS1-O53V8FS]6;(VB]TFU&/A4LV*!Y%5-&V2 <;-,$0FOM-/]U>S,22:%C?
M%[E9S]VL1'0E]?=/7<Z](ADWX.'R.Z)Z&=R8)EZ7",MKS&V#? FTG R=WCB<
M8:%TER%(HYPR &DO2;#<VL4=Z<V:P^*NO*8Z+I'@@LFO?</&L&Q.*<,( XQ"
M8=W7U@$W$A'GYX:CAG:B"FJ>*=N"4CY)>2K3HV4J:\>.+CU@)Y6DR))O%L]G
M?+E9EC2F-U^(["C$B O/_^=TW=A; I'4%CZ1)7!+]*_</QL\%:0$&Y]5S;P[
M:]-5VB?G7\]?&Q>TD")AZRV[^H&B)U_&MV7M:D.A0MRO!W\/+@D\Q6H^M#,]
MA?UZ8:ZG6E\[,IFQQ4G4V?=B91W."/):K</;[D"_#+@!O.8R@E>.K6")];6/
M'^(Y#):[E\&0=GLO\R(;[A!3K4G\@**J^)T."=7RV;X._U-+1-Y5A+L%6MN"
M@/KY\&42L*!FS"Y.]7)6A2K-A&:V*?]ST'N4E^G(%..M";H*U6W3N[#K.=!*
M:.S<A@%_9P>I<\#.LBUK,?GL>8VAYMIUO*WVYS@O-D&0T:QDJ+:[%J(7QGPJ
M[(O?PL'8\D<V3'? C!3%X+5'CG%QLK2M;'C;D6+08/K 4##,,BAT(U::+5+)
M[ZD^J3"ES.[YQHPBHB 9+#)?-T6X^0CI*R$!'OE8YJKN:[^C'Q2G_W(*\%H
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M0_7O91,AHWQ&GV5)Y3%-@SVB#J7=T&#66:>5LN"EUNC:[-2?A@*_@ H+)CG
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M)2"X;)Z> /[2@RG3;5.15.^L[L_U>3PI? T&%#,(ZT%OUOC=K9_=3YT-DPC
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M<A*3,5I:;__K/'0Q0\[_FYY6?4E;<TKH$F;H?_KQ/&6.U=:%?^9_Y52FS[P
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MX&CK1H5O!VVMP5=N8J+T!6+_[%0UY6:,G.V@\%\),/A0@51TZ BY$SB6 7=
M@4IS3Z21VF^#\LE#+3'#05?W:J[F]\]:MD1O+%R7[)0ZA+;;5KJ[JJY^]5LF
MVK[NY]V(;R.UN43O8"TW_K6/.@]JJZN(K*SM-#H_4FG(9\DJ/6B8T0=?%NIJ
M]EMA'QH8KQ#'.]CW#B[Y- 3$A+.7GVIWD,8#,B79L?*;&@29CX_-KBU:R5%F
MHM:_[_4>D2.M\*"A*KE"M1XKC3K$#+--+83:\)#\Q2^)4IS1^*85$W1,8?@T
MW -@D#GSCG6EU+O.I#U4WMU-5]85U=;3R(@EB,HK,72TJ""?CWX^\UX<CXPI
M3AEU5<G2]>:HBWY2$>"LF(Y8V;10X31HCN=E0'K^($MHE&E[32;"=V0%Y[ R
M2-F$NCA .7[(YQ(A2%8DT[&15_=YR$!'[<#EERF8ZUXL5B.M5^.F1YR=@]'M
M*7I=N;VO;=H+P]=@MT=W*#A;_&*A><3P>.7>KT4%QSYM%7CVA7V2XOK'BRX.
MW%X,'0ZWA[XS=@S)] D9@5]<ZQU_-/)S=/6TK.V"F @+-%Y!@/_\> 3I'R\T
MO_BD.2C]S6F9+T=RJN6%B?2/XU.'Q[/%_,NT5>V8!Y/V5.!^>(QU=:#A7L"?
M+/7TOL>C?>;6\(0WIV@UY],RK]H]#+^R<V\Q@$/%3CEY&+%F'D:6B>@?CT*^
M\6K48O\$]QPJ?X#%.T4;+NFSS@U]U,CP1!K.!W"TVC$7$0,@\4EKFC9[A4);
MJW<'"^SPK7AU9\]Q_%E_-A%EOU>RX*IN(_C'[J:(7_4>QJZV.#CS586D.7+8
M\J</OH@+1@X,<!T[18<XBSJI\'./[5+R$1+PR6,5/*_=W92DO.R2Q3BL$4H^
M9#WO\Y+M4 -#=3P(\6S-J%<HJ[*8%7^AU1/C>0AK^$SBC%)9H[DW!1^-\.3\
MI&%+7WY:=D,L&.V]]M_YB(2ZDVRR+RF VRN!S;C")Q,Y<Q5?FGCD:W-@>)Z)
M>KL8U0+!3E=A44Q"%CQYU0N)%9/=3\H;(U=4_P]7WQG4!!.UBP54!"M!.@J(
M0 Q*"4C'0N\M@2 @("4)17H'%0$)O4/H)92$$"FA%Z4C(#V!T*0+"!)Z]_K>
M[[M_[H^=V3TSNW/.;#G/,_/,69X.G\72WIC4L1Y7-[W'M/W7T"HOWM<(^T*B
M,L,74#7.U@U$).7?GB;$+G:7;G@NH,9K@C&W*!L;T-PP0(05?TT,"U[#HU.H
M5&07?]6Z^"Y_I&&4*IV %5RUSR&J"N(X=?)\&?_CT,#8]].93VF^G/;G-'32
M2I]/Z:'AE"JM2H#$"I[[YN31R!/?O1*5U+1,PD=W;@G['U,[%DJ'"FJFINY6
M(A_,K7^"!&X^GF^*GCJ+[QI!_4H<$^LM)O)0'WU.T2%:-G! /WD/=&T.2^/.
MB8/^&E3V5_$TXX1+H^!'S8V\4LLXQC!O=*@1ID>SJ=@;/3__,A1LS@F;JT_&
M:SUI:T'HMD/:S>]>/P4?TW$+?GJ3KM(3X*E7@LP8'WVT)QZ$>/W$LZS<7TCD
M (Z?TSNCS)X(W_$LGWVL(NLNI;.1GK0Y2B68/:&"W5NV4#<WAX-:^14:3 Q[
MYI,_ST<+Z_JE/CU$K]Z<<?Y!_.UOZ<+.4!GH?K!5;#&'W;:G>_"5P%.H$QB6
MRV$AL6**.=Q6I:8H9'K4.[<[UO9EX[W;2=NF*ZQ8483;MT'T]MK;BE_1Q?-Q
MNTDM[=[?=QZM0X+FK%[\>](]=JY2'WX/NEURK^.>Q0QBWD=.M>E&""I\MRK[
M5MY?FJS@G=(3PN=BIGD=4K/_OSP0O]H27E($JXM= )F^?(P-7K??.S.8OZ2*
MK]8AU<KY=;KU--P(DNZL@9?Y+N.K/QYH=)?]LC%(GMLK[GWYB7H%51;HG-8B
M_=/C)E/?]BUC<HEWS+??O&[5C3'M;(+$M-H.(\V6<5Q5@+F!=B8<E^( ON3>
M]@A<FVSUJM_%5^MKZ.N[9B%9!5G&K 0V3)!=GH)S[Q=WP[OWZT>Z9 UO36 E
MU5M</$MO@FD;?"K>& [IX\1_-'[3"^6"2#O?$(E6ZO#C#K&U?=7OXQ7J7IT4
M.]_DU8;V";F'.GMT@?5%5M&V>8!=A*<,B\(HZJ-%DWZG9Q<J*AK69 /2N0@I
MUUZ3^XZDG^>><2^+MYDBQGAP]YM'ZB_:NI_S=$9LJ[; ]A1N=#/P-&9U:L6#
M?'5"[:;9SH#;OT_4Q%:W0IY\%JSO.4_:OM=N'#3"=TP>;Y:(Z*L(POBG4]E&
MSH2U9<AM0X<QN=%=6:O(<%H/3VN,FZ=:A?KJ8U.,KQFC%LYH%4;J_5K:*S)<
M#5)1WT%L&D7L4Y>K>&(PD&KSI'QZ$NVUI>'?.'DS.ND<@6ZBV=IIN.$23/$%
MHR;1+%IP;1=Q>4GI!=6.J-$@OG14'.G459<)KO:#V"P1OGN7Q>5VKYJ08Q?
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M3S".RL<J=,0.</>K 61-6M9H@% $XPC]M*-(Z>_GEI'T"W_ B=6U][]PD$,
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M@KL@?D2OA4/<9M!G7>;A@NYSML.1+N;\$Y/#<Z%?O=-Q[@MN=G,AY?I)&RM
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MY$L1HQE*OX?VSF,6KCZ<3+NR8E:6,G]=C<F&U S000VOGKWEY=K+MSYY+M=
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MZ3Z,1N\[V9@$']?OHL<8&AJ4!^,%*C]2[X49X2>O41IO=LVP>?A(%*U:F%C
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MZ@M-S=HP6E^[F5LDU<L!S3(0],2)88_UAB:]2!LJ5@7:$=ZECG-OL;N<)2"
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M($1=<MSG"ES&EHNPR+XJ%?+CI^.'YG2C6M_LZH2,]9(3C*;ZT^/U$R]:&B3
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M;KY=*"=G# A1;.:N=5=9J$IVZY).A$+B2*OAM!,TH/,!3)3,WFRUKQ$N0_)
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M%(LK, $DDDV2F8O)D'W4E=TKW)9"A(OO%.;)8X<O_!WMA*:Q.NV$U131)]B
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M>C=JG_J.!S$G+8^BZ:3_SCS)7B$"Z\<?Z8DHMX<EK[K(=A'VPC=Z%3T3WS[
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M<:0[2 ;'N^S%LIUR_R-(C=$10][_Z#Y#NH@_ L%]/E!&5WV*RW38>MJVXNF
M<&,[<MC2YI-2RWZ\;,?'Y;/;A!MWNBM9UZ/]>Z9P_\FN"QY8E3JX^O7,_.5
MF95^AU,.(1M;KH-2Q]\C?M 5U"H]N*0N@JHM_"8?\!Z^?-&?J0._WZT7#MBZ
M_OB^K$S1E6=6<-S$H4GJXI$M->MR<>Q0_II5=\SX<;G4ROZ/1)'^D+\<#W9P
MZ>+)&EY$XI?))_3HC<TO#SY662P,[/[^R\%Z]G ]2"-0CQ6&>=X9TA"U<N9^
M##DVH.!@)TM9+ES4_R2[NN\\JV/KS_FHOQPO(814J3][.&3H",#N)T%!COJO
ML3<//A+.BLK]_,N!4+18-G$00Z6,XD-*-XK-_FN>\G[!NR^2E9$$>$<?T6MX
MC]I\D#14ZI-WHJX&LS5_[$[?Q^MK[OJ;P/Y3]TYC)/1@!U+^G6>+#ITF&!\E
MYFI>OE*\0^M;W>_L\OU7^_Y:HPKDBGD6^9G5K'^\\.<-8GLL,_ O!Q.J&,N4
MJS8OH/ Q5*A.*2BC3"+)TR/?0; J[3OW;( W:N*J9!M=*0:N1-CYCXXC^]3%
M&^/K1+G'X]M@T(Q/,)P;9;ADB7.FZ3D&]L5!L BM;BGO6HO ::$Z0^:(+WKL
M&?P?1NMB/9MN!V?#KZ,FJ.VPF>/A_5ZI]_*NX*<M4E$#%P2R/X^F[Y1Q"B0W
M+I:W.0A=1(0+.)PK)!GLB" -<=>F34<LP3IC=9HBC78P7%4SXG;+$!BV9F'(
M8U.%";]D_*B2JE&DP',. PX-JQK[;]]S@GR(A0V"ZQ&LR(0''.,@) *!T&2.
M3<A'0NP-CRM/@>,NIT@!SCO2[4'JQ]"LZF[4BS6''IBN4->EOQQI$;_@3Z(.
MOENX;]4^Z&^/ [Z^?TF3+N,:J5;2G_Y1\_M[%G5E?8"L22U\LD/YA?J"V;WR
M-4HKY1W!<@GPP4ABV&G*U>]H\V=7[N]F'"5NFD$*OD3GMK&+ZTQ)&GP6(A56
M=HJ)\O% I>HT"+,?I4Q;-E7QC9GW<DI.K]LFW_K@#^OE<$ML<]RGVUDHA.<^
M-K.JQ)*DHRE6TV3]UC(3C2=368/3\%U'F^PC+D'RJXQKO9(?('+)S/PI<I]"
MV/Q#'QI*J'/U'$.P+#T()9N*Z_,O._G4L\III;V50+$[FDTL48%\K_I&YU2P
M$(/?QGP(HT,S=3BH6;8(4W LVNCF2%6(K?\>P1BB">:HE&0H=C!)"F*-1X1K
M:>8D0X#JF>PCXN]1IONH"*)WV<F"5CQ."ANC=%04@WH3786[SU2M.7Y4&K9B
MHV2_)%!(/)<)@F7\>Q7[. $\&C1M&[1SGO'PNZY A2O3EZY]%LSEFK+Z)M"Q
MDJ)"NZ1$Y;6"$311BD ^\[D==],UF!B*RZ81(WGL&V'ID>D,1*6,JP0YT/AV
M"R*CDG5U&((K1 D'?;6_=;5Z5M[J,>F4?#=8434"%=\VA@!K0J2AKHQA,5,"
MWJ79;J+B4U^_! CE-*IE*:Z%SS@&;&N5 $35ZQM,]FV<% AU"<&'GNT75[66
M%>+(NO@^9C]XWNR-' ,?-7HCM!_!VJM=8+=D.IJ]E^N,^E-X[!>K3)7G*/H]
MQ7YP4IPJC%+XVER^K"G,W/#$/4:O?'_ZY^@YG-7FGYS$C9>?EZ/F(]*V:RLZ
M-,NJ"ODY6EX1P*4P'T3M3?3R+SV878W &: ]CKL%(&(N>.TX7%5T'/FZA>UI
MK1!1105WDHY(*EWWKZ+<LN]Z/,I'E@V.N4>#9Y!.5?AD5B6SB8I%.Q05"\-,
MY=,0$,A[OB+3U0X!P%8$.$*LZ9KT,JNLHT64T<JS$/D5B"04H,H _D9YX_HL
MFO*"Q:X@TI4N7?[1<&-ZB>;BM I-K5D$5#3M5D3M4CV@1TES&@)CG-R[UJW5
M)&5M4*A=D+7GV_YP3I.];]J ^T(-3BH#D=RCM"S\)=^V(JIY'0-V.%_;+XXR
MNGP;0ZWP3%CH4PC*/OD8C->,Z92!9>JQ<:=WZ2!'9@.OYA#Y7'J1XQ]?A=.>
M6#H$(8<DJ;51V%7@\EPI2L@"P A!O<%XB@!:!=AW52*/JZ0$HV[%0M1\\V,8
M"311&E*VFND%J<X^W2R=<\.7)(P@J4%NJ6!3F.=!"B#I8R79VZYC"F^ H]4X
M2]%HDAXV]^+J T7(T2033$INC;F*7>",_U%I@"KUZ#4UTT]J= ZS2V0Z3"C>
M<$']R*DUAQLO06;-6"S?Z,.K+K5':Y0<XNLP]?60H]85!0WA<@6V*0U67/OJ
MR_-BJ]VRGZ%7@XZ3,Y&G.X5E=1@.@4*O:\!;O2/3@XV=%NAY]8X^$74WGIS"
M\Q:#;$H#%Q'?,I1+]W%#K9W21L7V-&A8W6($7L![]=3VK:<P:7[76KY .KM[
M8.=M?JP9?_W+<16<4L%N\#G738N1)DJE 8+X;C \+<Y\=E16LJ '*M[++9 ^
M2N[6_M@ ",K14\&^E&FA@SQ[S7FXF3G@ /1HM9+ED4+D=--H'=$;=8Z_,8>G
M":4FA[!BYY_L*_<E(2@#C%="*_9DWH\@RPOJ1V['. @34K3**T@O '?\CQ)4
M1@/*CP"DA#/R,!APQ%$YU*-G*-,@)&4+Y&B8Y(-H2H@D>34?#W6>JL)AP[QS
M.0%6FAJQ Y]<,X^'BDMO/D5X!]Q\Z#77<=#[$5 Q!NTO2.OKD.O[*)0RWR;=
M>H@6LA;NYBW)60A.O3'\%EI(Z(Q*2_BC;DTV'ZBO>]\97=-,<4>/\[YHX +Y
M]=P_VM75"O/V/%4M6I1*N]B+<NMH;M^4+A!)765^N,\[^]&\QM.K%+4;_-R#
M9R]Y^ (;N.S!<WB]L3E1T[2U'P\A,#-7I[V67G(>BMU3$XIZ /[Y@'M/EL=\
M+,SX1\UFK#8ZJ!+UR/::(N<BM?+\*897=5BADQ>G)Z;EQ8UBCNJ^5I\%]9&P
M.1HMV?,;LD%AF_S#%;",:BYR"B?BTD?K IT%Q9=_C1DPXE!9%O9"^JN*=[<H
M$Z,']CN$N(H&07 6?3Y)3.6YJK+ZI$#W)+D;G"$"<JT*M9$N@ZP3S$9+3,PK
MX-YX1R&"FD/L*UUF]K92;SQ)^,N5->?U.P+A9$WX@1&[.($-^L(X^I,\BO(Z
M8-)=5PM#Z;ZN:)][8XL75)AN*&,DNW76&*+WB743^SDK>=2L;6NN%GL-GN%:
M<^^<*RKHK2DRO?MGLA;5Y0'OH"YG4UOGV6Z7B%S$IDK+L@-"K:)8R/75Z*'"
MV#GP.+IR+T0I(M<.>'?<]MD[O2+NP7$]$ZZ2E&><@ VMCBGK2;7IRIO+"]BY
MOLN9E8!W>TE]@KDC+V9HB_>!>\2FU=7Z/[0%]RM[))G7=^J7-FN%6"3GDDZ=
M*SO!@H>F-.-+9Z[K;+X4B)H'=G_V "WI_$Q2#II]\67<( ]^@?^N==@8?F;-
M<51SQR)^BU^;[EV3U]J 88Q1)U_- -U%CO0#JJF LE:K)'UU>0FEH*F)5"V*
MQJX!DQ#L-X99R#&UG@(:>6K--UYN6.E%/!XG .Z+N!?!4('9!1"1ZZ@/S\:F
MJGO0Z_#_CAU!JA]7IRW@G5/?3]7^1Z#]PVJ<3?M>;"GT(-?A4C2*?<\8AB8*
MXHM00 +XQ\7(;R)VD+=)@@H$J5+'@<IG>">43RK>::TT#VM:].Z-!:]-G2?>
M:>7 )$;GBM-@QC$">:SIP_&HT:0E4,)>KX6]DO+JMN>X_-T?HDAY30?G32?+
MT-+\.!"IR^?:H%%LST_[MC(D2DVS4U< A]B23Y&!(7^O7FV\Q[R[[+[X4K4<
M^\FTE6Z\=(]UGQ1:+XDNMB;A$G,3:DE1#UV6V#6(@_XC%U/^<E!#_RBRA%4G
M4%OH=92%S'65-0^J=X%+[VN-M)(W"P)B:2X>HES!+W^QFDKGR[4Y(]?<SV&S
M*XNP<R/AS7 AT(JOJ.Y)HZ'^4E$_M9F?%#=#JU:ZS<^+WUTU$JL%4^ZBW>,<
M>%@O+_5#HIRGY#[<7M66"JP]056?2T-\8;,2OMMIM,2A=41W8(1[&>.TC1VB
M^V',N#+H\>S*\/WW;O=?9[Q+??3]]RI7EP$MM[[!D9P\2^Y\FKB;T!3.N6:E
M\\01B%J?*E'_J4]FB9N0$T3L@A$I-*X=D.:N2PGC@=?+GRB6X$UPQ:4_'X(=
MS':?./[EF/B^8K:K^Y<CC!GGG+%N[W%@1.+=<ERR> !.:1QW9W35#$.L$N;.
MSV&#4H#.];M$<<'_P"&V27P+W;SA'@L=Y,X4R'NFQS@0?/XVY?6U'4)U):OU
M.8O[9U5-ZW?GEFMLG=[T,]N;UW9JH*#."3:UAQS<#WJ26$HS7WXZM[VIY&46
MW0[PU4U>P!8*F[KVE1::CQUQQ ;G:5</K]L9EZ!1U\)]AAX'&KEA&U \%]?L
MS*J/3LRZ!OY,X%0Y0L;%C,P6C;\\G=NX$):FOW#[ KJD.#BJ/I+">ZGFK.TF
MQ\7CE/)&YK%7H>Z^P",.O)M2,5'YC(G)+7F8C0)YL!5Y,V<A%#CQ=1FQI8!_
M/83-"C>6FZ689WMY7$4,%!B@9MO<:5GJ#T"!'QH'*A#U4G,T[M/"K;R^\D+-
MN0>.1;"XIJK=/,X3HN/&X2?]Z:&:K(!ZP:-MI(&E$+^&6+W-:&>IT_\,*N["
MY[@8X##T^*/Y+I$/X80Q/_<0^KVTAX?1+:;X%5@2VG"TORTJR2S)/OY%&;O#
MK,_]E/_LI-=OX'2L+ED6S_]E2;)J_% ?\(7WX1E4_:\&O+WK%M"A[<.^LOF7
M4;;4,4_:]L=S&I_PE/I-PF.L1H1CK5K+BSS;_"]\F-_H$_D.=RP:V"H"/J$C
MU>%N0V=61]+L9N<Z6.\1*AO681HZ&86BXS0;>Q)9"SK_]1VU1C.R*KJ0C*\N
M\558R@6$(BR<1B$PZ30NJBEI9OSZ/3*UHA3[0ODP7*R=K^M%]NC,5(X\=,_6
M+,5KA\12!WU9VY0$!>_DU%9%[>KF<L:%MFU.K)3PXT$1:<8_S%!03$,CU?ZJ
MP+E0%])%():E9.F0.36!T=J$>;DZJ& BOF7/]9&QJS;YI%%2=8ZG+/VN[LSX
MI&EOCEMW=K^EF&53,^;;;074(J1Q#":$DD6,] KW2F.^V]$LY "<H)OJOK8A
MM= J(5(Q^0*[B?CML6GLFF/5=X3#52ZB5=$HOE(++Y(M]U0U"[-(2]3+U:?4
M9^J9HI]OJ@&4[%/3&@G>8;<_*J8$GUQ]OJZ@-M?9;O&7 UPGME=;>*AT%[9Y
MG[9M^\3W/*+,(&=?7/?,BG7#VHL=!YC>SWF;Q]*IQLV@+3/,5X/!.X=>V -X
MO[ =EOY.%S[X0$#Q/EW]*??6"M/6>!+3IK<ZM?:SS+=M5NGGE5K=9Y^2.NZ-
M1U<,YN?F..D/!?5;!/5@F$VHOD>M5$N_%=<$.*@\*.<^G_,+3?!(?)OCT"57
M^UXED(V)+B#GV>SC=*J23GTVXR;.<)--L>#U7Z>K5%+<#\,T[+NJK'+_,!&6
M[K07&SOSY?YHG;!U)8N<D>=*^=KS)$MO?6!YIC!%&K32E*F]CP\MR1R(<;3^
MAX:OKPK^<^.6LX4DM=.3:6"_B7Y\(.@ES33P-WG?GK=!)M ,#V[ZPRS??8 Z
MIK5NISZ4=(*FT+,.CR7KO42-@/N>JO1# GJO7\3Y ES'CS(;CI.%OT[?"A!G
MB-1>[?1&C3\SGX#MQ422"[777H8:T_7LP];4;HWK!\=="JIJF_6R19/.'/?[
M?TR]9U13SQ<N#"KZ$T14BG2DB$) ::$WI8=>$B TJ4(B(+V#6!!#+P$)O:<0
MD!(Z6.@EU!"D*J'W+E5\]?_>N];]<,Y:9\Z<^;#/GEUFSSR/U;&'IF>37=."
M9"&[F^3^AI/+DH.U;6^__+CN' >&_MM"3LW<G!#/-?MSG*?6$)1(VNR YPJ;
M%&R("!2SY=3-624<^/:4I^E&1A*#R.D8#ED2I&I]ZI@8H41^$^<2ML@>;ZP%
M3;],+M5-"%["^S%(<I)3)7?)#<LA.5FV42/$;9.R&8"H(.YVGV42OX83!KGV
M6@=RYXGNQ^0U@E(<Q!QS&6R="/M +I(BXZ8U+"&8_F;VH218V0=R5!Q?/QQ]
M2@:2PN %]0ER99G1P638D51C93_,R"-VG"/$17V!TG)SZ\=+X. /RYL& %+A
MDD]WY<]-]>]$;@.YBL+S:Y1(@8=-9\'C/7^H7DC[W.#TL<7L++?KC6HVX1KQ
M#3?-&5>(+N+H2>X3YI\7RCMUVP+NN<4A7>_M-LGPE"S$TKE?/DZ-WY%@_PJ_
ML;:FOBKT-5<L2&5B/]A<IW!M0EC2TE:L3CJ=(3(>_D"MV;.&.N?P[*:=I=GK
MRI,M^R?? I1B].OW;_E <X/@V4-%,W?&-1@ MD@=*6&&F<JG>R)+GSSOR2F:
MFWO=U'"T?4)&"BED(1V#6)5M1TT+38L34 Z([09.C'KXH 0:!N'O>\",N30<
MPNI*5$_JHTV./5 <-_.Y4E(TZM$\<!T7O)5C^3'2XF4:(24'D*;]F^%1>19S
MW^32Q[J7=Z[">\XUYO9OQ$[!)]S+62A*I:@ON]+)54\WK@$'I4(,=#8"P[Y*
MGT!QW$[)A',-AZ'^Z8"RIB=U>._#Q_E#KJC(:N=EYK4<UEVJ#+"N>73/2T</
M 'JG%3O<VZ (&78Q4?I&D6IZPY\#B"5+C23?H?%<"4ZL?_=$"=M9[%K-*TOT
M_:;=O5B3&56;Z(,X\+RYSN/K40%LCIWJ]8(VWBPR496$]DQGB#($CGBV/5RJ
MVURZ"2#6<)EZ/P9.N=59D7PL)K*ZQY,NWT2FA'DB%2&-8L[8(V,/4_4 J88.
M&,MG<4JE!_]4#J"")'HZ+A=T\WIY?=7P!ZF0:FMRBV.K-*5Q@C'%$O6N#E4$
M6?TN\#>N%V&[[XCHK<KZ*D@?;-N2?Y(9#?WI)RJZN2! >R#4(^7H\&/RRNX\
M$ 2_0T1AZ'O>?8)M_T*Y+S4J75&_G<_EI9=V@)T'TI/S\%D0I[H0[#Q'1B]$
MH+G>39+HI,_F(H<S%'LQYE9^::G1D8-MW[I8(L@/9*E F[,U'W IKRZR--%H
M(0GRPHD%KQ O:2,=-S?/?PE2OB)_'9F*K- 8#E7D-]X;YP*A1Z0F8HJ/7PC'
M5JS:<)6\O7O9W5>Z$5H0#W@*N"?>\;(7,T;K+^8P_/0/%3W41NHQ[(>5<7PJ
M\%.'_0#16L^WDAOIPB&^"HE5<.M[5]K?O<C^K_)HJ<KT*Y$6)S7W9"FMS*&2
M:5!<*WBP_C/=;/4C8&+&"3;5LL!UY7SQL&@_\:A<V? V]3GX<N!'!DH)Y2N1
M*[/Y>3VVZB10"9#ZA^KMQXC@C[-\UXXQ#ZN5G7R]1=S!]^LT>RB5*G61%\)V
MFX2I(YR&-X=&PV:B$UEC =10.@W7J3D?^Q""%QH$8E]$#3.3GJ6807F-K6$(
MG25,#Q:]_3=OOJY=*<6'E7K&_MK=)@Q6#4,80D=D')8?@2A 13)X-L^<7\K:
M+LK4HBZ%!38K]7UZRR+YN&<VWW,6?*^S6*?2QCBN3LS[ 9@.-.J.#MV<$9*#
ME8RKJE?6_L+///KA<Q/ /<*#:@P3%&$NEX_+%I=W?]3C'Z\ &9D2K@#ABM&3
M !#X!!YCFF\Q@-34+A%Q?*,K'3!:J B)_F"19.6*3=>S8$^S% =;UD&B!SK8
M^'M*-BCE4D'H?K\"1PTY?K0QHEOX/ ;,%@ZS[F;[7#C-30W$^:LG\A3[3/HP
M=[Q@"] BYV?4>.7P$F@^4NIQ:.GNP IULI$8C$+XK]4'.AK6O2CYLQA5'"\L
M^';<U!S*HO6B 4:.YTFNWG1L@S2K+:Q:,Q[I2'KR3UF*=-C659CS%SOHY39C
MW]1;IHM4?<>E:.WY8D^#?7%'=&>-ZU9W'*O.#^L*)[?L.YR%+_9WRTO5HD,)
M/>!LJ>&159; +N:QR<FXUU52]5\N-7*$LS23#Q5,&#<*N0#\9C4VI8B58$0?
MR>P6W/63E^(?*G E30+S(+$D*P=01^+CB'/2I5IJ<GA)^M!-=#(GN$P_U8*M
M;^$[&9AC_#Q[*#A4)TME@N?=P9':3<<3#7#4U-(JM';7'G92;FRP*@M,>%DJ
MV"@T-Y,#4-H(D $%?.KW,\PLMG['4.RJ5I2F!'C*Q5PY4IK-KBDCP<(78OJN
MP6-L2*N@KM@R1D,YU:?@=\9 EXN!+*83947PN[7R? 1?'A<_EBO!X.)5J"-P
M@#'7^E7>X9NH8(8K3@"E\X9(>^5.J&R,1#B?F;_PK8Q'VKK+/H;E/%N4_37J
M13+3?W:7X+L/?8>5^$;#N2#[,<*9;C+R%I[-$1M;#X3E9T973K[?-(T3DX%I
M"]#"(1-CK_!,L2<@L>_1G[R@9,G_NDLS7\XC*NXW:?H8B^KSYY,L9@'41'B7
M1%4\_&W4\3=- P"("QZY;ZY0,C'&QE_8@/3/@:>3[U\+ -X?J-S+@5\]_4-%
M%'"I*=4>[F$+N.P;A9]HVUO*MSBJA1VH-$'7%[4I&'1?U'>"KO^O#HNF%#_S
M2!U[O8^%)M](XISFYB53Z,N(Y;)P(X#'P K>BV03'ZV^ZCYO*_RCMZ!*=%L6
MX]3R[;!<&>*+I_/1NZM(%LP/6\0L%32/22^CE@Y%3?V#\ 5Q<B-JAUQ&M:I
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M^#0P$!QFU01_^;Z24&Q#*5Y1T/521?JF"992M+<RA<B,3A(W\3*Z6AJ5YT
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MRA@[U.[?<+Y>N&Y9W44F+#'GOFQQC69-O_T2SF'TYN@Y8L7#%.\TJX4$3AA
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M#',?B>2,HCN<9VR0,\2 6:F:>%*K&*"70#=FR>K2F'<R1GSL:T:JR/ A.GV
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M.M(6E*900>[*SSMR[W$*E8?O\5E0&N%ETG!AW3#B"%: ).G^HD\&-![?!3O
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M :7H@OU*I\02KH<+BEZ 7D%H>)EH@=:?(FA%.K]CV@FF_C3 DJ[@JS;[Z'V
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MR&)J+D0;*].XO&N7!KCXUW^J<:S@0KUO /+A42-[R;7]S9"1OPR,83)8[RN
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MUS@R-\-Q_W8>0"_/&XR"R=&O%:F?SX:$FSMO: ,;RZ<N,O"LA/*;#W ]>+J
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MQ6L',3[ZCHN/O.:GJFL$I?:JGIYTC%I6'WDC3@#FVPF<IM5,S,&1\:V"FQ
MOZJFI;$C1"1L07C2^E4049<1U[!?E=49<05Y1? R/#5-.W,D:4XS:# ?]51K
MFC"4/8,'A([+7ES^\%BD=F-?V'.OT7 39B9MVBV_N7^W#L;'-!6",^9_UH &
MH[Y5@=I)& )?.*:]2M.1?8NC%M CL#;45&TE2WQ9ZP_56:/=7 0+:J22Y#8*
M/P"229[W:CY\T,$;M;P.=@6V!2'ZPZ8@-6GS^2+N OXAO>?I@=V@'_V%W[47
M[%;G(A$YX(<N?^"+5U%!SL)PN ;MOX.77Z79CSF$8K_Z#C@NEW^4C+ N*#R[
M19L*B?GF=$EM?^5@>W(M\W3N%Z0]XB(]Z6!'B\>8TIJXK=ZYV*!#ZCD>7_S8
MSV_PR%H I^3;G<TOE=@JV.%_+=KQTC8>V1R^/;^0^K2:5J!W(M('BK>LXWN;
M8O,5$7:=?\^H318YFH"C"71=YS>[?B\B9!W)U_0R,:,+P"W%=%K6FD'/WE[N
MW67J/H:\@:EQ9DYL)Y9SXT.91>7#2ZA*3[,D.C3&>([]%8> FQ$,PXE?,_6H
M#?;G5PIU<J)#RV-?@KC&SK>.7]5:6SD= G:KVDR^W/!S8OU6,E&+?$3.>QY0
M@;-4<[0KEQ+;R6VNK*+LS4JQ8VY?A(E)?%(&<>L&$:VC,<UQ=>_2/,XUEJ8O
MF5H(Y:-VNV9J+T=.PVKXWM3D1]3&^2?MWT-^?I%.L?VE-,2N&J@2"WW9SPW[
MD!WESR)K5=5,&5A2JFR\-&#^[AD:&9R\6'Z7E'@(?^8JD>1E1=B]1;.Q72Q(
MN?,24CS3Q<7S"[CR#-8)SA##?) IO\]],\C+YN1!KX(C\L"+95W=L\YB.A^P
M)+K/=G'IW)9=W_:6A>SE-N"1?&CTJS37B3DX .81=/CTQ*/RG600/BU"*,@=
MMYS^>\L^8-K=X?@;+1^P;!^?SW;Y\R=CZ*Z/7B][:LHTPF9[^.BF>VN?]"4$
M><SK&4()(_"P!JY?S]4---9(R7Z-7^G_RJ;Q U!0X"!*.HA]GL;?P4ZAP[0D
M"7WN!V5:T$U5=>?%#$5\--7&D/M)1?X@8^[(BK)^Q"K<RAKEL(HCF(-+/>Q?
M]][TS]'^.;R$((U&8T:115<M"+"#%\)<:WYZD <@,PLTN<-L)N1F<<SH1FG;
M@ Y!F%6&](#@3BET+KL88%?;3E""ND.Y>A=A\GJ?P&E>[*:L>L_6K0Z!>+DP
MGMYF&S%LYK<7]G6R-DM%]Z&SI&3&1FQ'+MDD\$.EJW7WDNUU7*A7AX2J;)?W
MJIU2N1;/:@1A*_+:BPM]IX"5DE*CD/<'.!EIN,-U(T!_JS"<41%U#CM:^J'[
M!1T2%Z:5^T4'\#9/KSA>=2(+T3BG)M&2N41KO(_,:J=HN8+:*V'@N_!4G2W;
M2S%^VPG-D#4KM9M\"+!:(.M[+XT0?GZU037H-XI?YK(;_FE][?0-KHJRD<Z?
MW_%EZ)AH39?D?#3(--!@Y[IXJ)+O=V+ &2O-/-/GMJL0#1OR-9;5_$/SN!"P
MYL= 2C=P;D'FHZ)\RNIS[S%#D7"IN;\,7.$H$\X_\+'?G=#H*B,6S;#D>2DV
M0N7WJPXMAVVM#SAO%&_AO\M>DULAJVUF6)*B]/^E=C?=G,0S=OXR))RJ".>-
M?2CUM?>PMTH$3=%R$32O]_E7+CH]3P?E9SY'H7=C<H(HB6^[@>35B<(LMP'?
M&:'12>.&L&N^%G+QU%0&0_,%7_W\;"\U<U_HPX$QY.)+KX[;2P3<INQ,(U0^
M;N2)@E[+M>Q*WN!C<$;S%-.RMP+0 O,X EK.EZ%,<*'>^:V(^2P!%2E*+4G7
MO#*.Z&\R H!A1:]:X#HK0HP[:LS>$XN-+\>]@_+@.23<H2MBLT02XL,]Y%;Q
MO-%LR^YD>QFZTUS=U QTW'$:")AAIJCFO./>LB78UR4FN0N:3\Y<_<+GJ@I)
M#=,;"R/[(C95A2O",62M4 LIGM56_R]\ 57B-_Q<?5P%W JDIJV.%+H3?&VS
M8C;?P4J >51#]>]-O@F^%GLY>,G'LO95SEQ);O?"7)15/S]R-"SHOX </V-:
M#%/W7A*M0@4GM6:&K 6[#36OP,]OX?P@^FV5*A5'<L6=_6BQMSCC>W[Q@L Q
M#D?1]V@D.('\?@%]3:[4M3I+N"*MHI(9UBG.AOC-P_.=[!&(IM8L*HN9+[I^
MG(J)\;56MJ4L,B ]L>4;#MY6'Z;"\PW ,MIC+[ S79G5Y3B2@7<^H"],OR0\
M[V,TWH:0:Z.=#%M6-2N]4N1PT>?[,52F256>ANBI*_ 2/(<UMAJ%<D\F[>MZ
M\\Q17/7EY*9U)GH9X215L<K@WD)"4#TR[)MF@  7>>!+A4AE^T3^U#"N7S#:
MEP<5E1A'='=3;I_2PN;2H#S1'QL24E;-LV6TQ1Q#/'Y= ,[2O2RGZY?PJE\)
M;L**[$5%:UJ7&)#K<7U",[4Y<RO-E#V)%OB JCKNTH2L+24O>.GV4K'I+?TL
MUE]@( E8UQU"YOU88WHS^^T]"Y#.NAV5GU"@O(\;+A&2<9XC<W/42C*[&I"+
M%41MRQ;O-GK AGRJB?X^_#\KIY_.AKD0XFONY&M4/5FL@2A]D8%$4@TE/M9=
M?'7(D7CM78H=CMMF*>4!@ B-<>3&F/;?\M6P80FNJJMR2DH:M_R' 40M9Z>0
MUTP5=Q5O==F?ZEW*9[^4I@"58,)&QQ;8=JG2Z=)25>#&2W>U86,SL]]QZ7%X
M/'?-P M;FQI7Y%?_AY.6NP:5=&RB;%[O+\!5P]M5Y4]&.V[H5&Y(DO2^49O^
MJ+%Z%IZ 4JMUR#%<&U1^ ">8G,GWVOTXJ=3B,F,C[U'^_*!2Y:BH\UG%3G4;
M,+O)BK<%9K7J)?T+/("/]4W J84R/UMRK$]I0GRJNZ9]]\OE,)7D>2Q@_B_#
M 5S)O+$XKKTNTYH.D_KMF$MM.5<K\;7# C7:Z8ABS1$Q40)X/)""D6,-P38.
M580ZRIQ%CGF7K+5M[@&IJW&4DWO2XL48I'_5]ADMQLSB3MV?+;TND LM+E!K
M9*1Z9UR?)9[+= <1JUD_P8F8_4GPM4G-D2<DD$<=+VPBT,'_O3KO#57@?"JL
M5&5M36X%,XS<^B72JYQ9B/[ [#L>&&-W#C,^GO@@%JEOV9>O&:B5S2DVQ)>,
MQ!THW$>N7FQZ+2,NQ@&LJEC1=R/JRZZ"<!5[V%0=K*G<.K112.4#H:'T1'0/
M'39BQ'8.5"J3F^DZBB7D@.N1B?H[0)/!"/C-4 ONVH-+BE7U/>"R'@?<1!1?
M0D _;A1'W*&0D/:%%=;ZGNV)EQNOR5Y<A\Q]L2""S_HB%,LE\T17F!T!ETE)
M^X;WQL]E8K0=1?>QWJNC"HY6;IP/"8P/@C"L$W*#BE75M9P?]K!U:KSBWS)P
M;#J!,K7A?-5\$%.._#O)*-OZ3]862Y@UGC?/2B^ %KW+'& ?#:*LY->7#-0(
MP(W9W%\7S-P#%DLOW?+=R3-5,;[R$Y_-?;<UBV[*Y]US7>^H[]E?!NV?=LO;
M]>9_&73>N[8$<^%#A'MY!!V"/)\<L N0B:<FK,#<+]7#XT_FX_M7UR)_XF7I
M1'QX/N5%[BOXX@N.M1^[^<L]@AP"]YJSN-;@"=L>A<U?31A]W MN-C_V!%[1
MVJ+BU-_U'."T'NQ^QQ/*\I05)"<$G]*-Y^FD![>.@A=&RUOI>D)9WO%[>">Z
M?:G6Q$LKTV&(!A6N$FKY8XX%L+R(R%+1Z5V.FJ"K2<@+9C-T$[Q;97;N@$T1
M>^H\]!B XB^F;PZM_K2L!-7)LG-?QFTO#Y96]2)(7J="?5C;%Q EX(H .]U@
MB'!:I98Q<"K?FK2S([.L.DXZXS[A4PZIGAPE=#H(ZT]K);:D=+JKL2;K/FED
M('I44K9??Y4PI=4C[E3/L+[& YIH1[O?K\\T.G*3;?HI<I.D@]>?;+2C$(NJ
MAG.T2-X, YJE&C^M(._N&_)O 1[+_2 M+1] 9G$&I\]] ;.%OPSO!1A2)_N]
MI))1P>(_"8E+H](#X:LTC39I^0+ ._Y'@ 5U7O<WW>;/&=5@AY\4D^&\7%,;
M9X+0JXN:7;YV]5[;8R=/;\R ?1X!^L^8NY<,;Z@5M_9N1Z1=L+SS7!DB*5]3
MML<)3&8BT.TRI1J++VQ7I1G6UXZ2 !Y<5;O=9I.K=9M:C!?#B OX. WC!G\K
MZ2%<,&E9O"VTX(G5C)7MC==5, ^SMD^PS,K>U[]"( ,"S/2*0\CW,CO9=7LS
M^B4[0Q!10]Y'S,*L>)-EY0A/S>J8_7Q4JIW4@EU^Y*CAYL6TL65?&'G+CVMS
MP^G.$VJK,4T[^K3E2=+,_L9S&E\?B#H(:3MC4QA\ZQ+)=*C.%"8]R:,4OX=1
M9SJ53[718CK$8_8$&;6:0)^>Y!$R9;F__WX#JEY@=?^P\EU!E*O\+X/GA$)/
MQL!]XE(XGWY] F30EWX&#]=P]TTX'F=7[/V\=)^JEBP@^-;&C&"^U%# $R8X
MZ[EY]X_X5H?Z>U;=Q3B;".!Z2/G[2BFYL=YE=KY]=Z/O8#<Z;[?=I7!)=S6#
MY\>0"W"' >\:_O75K_$W)J?UQ1*NMS<G:V]OY:&O27'C2THL&NRTGYEZM:M?
M1Y%+GPH-AF,G3\6VXS8<M=U:CB&NVZ[?1G12.)\,0QK70OBKLLI2V9]<M1.X
MSRWI:>Y\'[V C$AF3"U4CD(T.=4V'#&.V<1V2K%+%L@A$A-XJ')> K59B*NT
M NC'L=SQAQM%:\CN*$?R'8<*EG!LYZG_-F[.]06GH-ZQ;%NKT)L=LL:G55-Z
M[\SH#N=M,<7BC."QO#B0FH3]I4<M%";' KT]K\OT^QLYC/UG["-K2#Y[^+US
ME)9+\X.(1+GG%6N 8=S[L'K>N]M;[0_7$E[\ =3&?JMVKT[\?FG>KJUHY>#@
M0+R3):/M5&.\:(Q]^S$Q*(+B[^R@5.63E0G>1G.Q]\/ WO*O+OHBOW;*G6B(
MIK4H&--D9A6/:I ;"<+\@PUNB9:UZDH-T'Z:0JQ!0$+  ?[Q]G33M,<C6'?\
M7K3MHT$5T$&B7F>O:[> :#4@ L*_/JS&3M>!@;J87-7(L0M7'S95<YV)'PR]
M#@'UR5GQKX_AU* 0Z?2D+6.ZEG ->"<TQ$(IC*G)(%LL(10R!O7,^$]9+_72
M-)Z'GH=I<Q">>$P,^Z.\F]MHD#&II&\='_I2B-60]$""H//>I!1)VXCLCIE9
MK?O*O8_;NDC?MC-Z/Y2+W,RX(MP/_S[::$_\RW"U]2?O9\V"]N9+7?;71<9<
M'!<_7")$O F*U']K7?W?:Q] 7X14F"I")9C?43"#*\PLH=&R1#+V^\QU,]<@
MQ-3S\?&_#(R;0LZQ*X!%?B/2*K2(X3DCWH^N0C66U$FO1_E3QU4EXS.[)\ R
M4@=!W:A@"/%*NG5?VL079D[HKM]P8 #^-KV->NX_F=-I[/+VWB3:\6+CKGJG
M2J6=;NTAYNQ\?>H.C:%GJ3&2BQ[M">3DK=F%H$[9"/J3WY/MX&NE+1F FO"4
MW\C(&!MW%<1?!N8@8R+JA%>G!;!Q<7@AN:-Q\I2=5MZ=\3-<7 J-5[D$R2^*
ME2^/L9ZL*PJOO;9KU[/]EV$>"V-FXZJA0\2VQ]LWT&LZ>LO($_UY?)1#=4W<
MM'0W*M!1VF[ BF7I_KL(/I$<)A4MQDLH_PU_#U3WIPPNG#T;+//X40[#X]N0
MP7PU>KK')M^#C\N49H1W_IVI!F(-A6"H-VD"0OR#ZA_'^;6UE?[J937RXADO
M/=T3GP(UV%VWUS]]1)+8US>?>G+/%"3;L?:L5NTY+;:#6VYC:W%A&_^ ).2A
M-H?F6FK=H\?-AX;F<#J9!.&3SN[0/7!>I7=>R=K5L7PE@%T-E:[,F1WT#/OC
M4:IL<U_K)^_\S$W6.QJ:3T3SO-,+UPPG;^=H:X]1'50@:FH10XY6I$7%1(WY
M'S&/NE0CV/,\BCL<[_<SX%UI),JQ<TY:5)2]'/T+]18X2Q)[>WW=SI;;"(VH
M^!42G4>H[*M?K/QZ(T@-\/TCYD**G7OAJ:'5?=.E",)Z*R_MEG*E^-7S.I@\
MI;' NX8ER[/\01>+))]%HH*RWLN550=\[P)L#G$$P536P<[_%,E2$PNRF:@M
ME50>1[_K] VM]$[9I:!\V-]7QDE^(N,JW3?K'TC/U-P;L_?TMMO2T,^J[5MH
M\+7->->N0WPE_ZI64M;6+L>7H.4NIRU=$LHR;\YVZ 5Q;KK6 E?3U=HD),2!
M2#]KFKH8X= 9PSF(!%QZ"E X]FL0P-8D_-.A%]E?<.AAK;VD][TEX1<EQ?F[
MM54-T2KO<T;.5798PZBG*=1R,45S4*#V@<LDHD0F=PSD)5GC?=-5^R"JKL:K
MJOWM ,A#1WR_LF]R2U:5+,J+9IVQ<WX_8*I2"C-R@C5Z7?*%5J2(W6ASL4R@
MY-ZXO,+K6%'6T/4*UF@4>+<SZRH/LITLU;2K[QL0#F<Z]OF)*W)2214>235B
M]FNR<7D,2!LC-;]IN?"D=@I+?!&7&2-#^@CE,[4]_R.!110O]#%>$&^^N*HU
M 9C[SH$0+3R/$/M2<<X]T6C:$,:0E%N&U!)EC&(3+?IBIF#:])IUK3EO+0 6
M?50J\T5>5@^G!WZ=<>T*.\:B(@/V+T%D-AR26RHS>ZY3FZC#S'[[?\P_MTP-
MIQ^S%.<TI9N<'\4)LS\7(K$0'$J<B]OO6J"S"+*>S"K "P+N"=URGJ7_.O=<
M,]7\QJQ%EI## :(NN)2T8464';4UO^$'= 7<G-!"T.<Z6/VZ_)+S*9C'<9G9
MQC#/"0:.TC+,6,4Y< 8:,^WF0OW ?9QU7+.'?TBSGPG9V] Y^_T'T-]L<>K'
MR3;D\I?!ECZN7;@/72ZSG_W?WT-"&=CWOP*/M:?8/[< !'5/BNM4F+(:CB_>
MRFXK\9=[7/O%76Q/NNB+V_D\S<L0MENUTR27F MHG-::*%>ZJ;[!?\5Y=8FU
MM>=JS>I&ZM+^5XVY/;YE:F3ZF+FX]*I.GPZCN0^QV;QE]2=7&2.0&+,PBOW+
MX'I=;U:4!_E"((-9>FI9I'H!98+L?SO:U".A$8#9L63<,$X/ZWY0MPCS<\C
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MX'RKQ]Q=&V_*9.O3Y3O-J-?N:#AO4QKW=_LXX$$P?6ODWWKK](M56G7[MA\
M0Q4%'@[+9]?C7"8^;*/,M@B8QD67$X2'BI$GM.PFO0\G/FDV08?YB.1=[B#&
ME)XQUAMQM2* 1Z"^OH]#,T@-2V5/^*%[1&9&A#Y*_S/3O_@"T5?:WMGL@-V
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MX6X4TQ&DB?]4%'7LXD5JY!,VC:FU&5P[4LESK+M2XG5.=TOLCQ46#UU6XS$
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M0VMRF?@#V*)G0F-,O'X_*J0EL5.?7_&,\Q _.PS8:>7<>G-.UR%IE2^S,E8
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M#_'2C!A"JP"K]QF98Z)@?[OH"PLXF.0>*,M1\D"P.6.BGIT;%E&F"9XO"MN
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MK&SN""+84S2&Y]D)2G"YB3-2MD1$/"&G1*BUSA5%+Q$= [%\O(^*:</;%--
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M*"1^*9."[G;,)]CJZPN5U_7YZ[6OF 9WZQG!IQD\(6E28U.W!6(^EK\D:5$
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MSB 9OXX2;":QP5H<^ Q302]EY"!^K7=Y/*2-_%7$(';%4T'U?4T4.$[)V^9
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MP)HR)OVQ*>>[35)* O_0G66/<-VMEI4!TO8,A7I;YPYD4#JZJG8<HP^SA,C
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MV\K%^\F*6'MU5T@EJU 'I.5$VVQ,CRU>PU- \[YQ+L5<Y6&\@8:J(=V]">8
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MC46S\V?3O8FG3HL8EWJ?L)) 2-)W>6<3!Y9]7(3/Z4]U"EHPG4J7IFW4:H]
MD':4F%NPHA,\?QN&]P25%.[50BF7&&+0'@T!#7C01)L(5\:M=EB!-^=8^>FG
M^0F95\IL/PCZ,9KTGH^WK*Y@+XR2=2?3CW"/34XCA)K_0Y4)B=BMAQ@OC5C^
M9]8V.:W]R;#[K_X#MM_3%@GU/B/KS#],T[GH/2BS$Y"8 EG_!SD[:<=Z3N<E
M.B8E_N</&KB^* 3$+J$YGWE]>RW6*2GQ6YC<MZPN1LT+M0HL;C-L$OX& ?_T
ME13_:%8^MW:W*FY\;WJ[Y&4C6S+\V3UXRM<9K8K($AO:_2N%VKXTQH)CCLK"
M1L/40.K:AA/<P9=+%K;PLH'LB1ONO=O:1WC_4WT.?4GSZNFH1TL$>0^:8 '&
MCK+^/X*7[;]*N.M=5;\I N>"&>W<R2X=A]@0NV?(5?&KX:9:)0D)E@Q#?RDX
M3J]@[;VX>Q>M;#Q+LF1-[\2QG1<ML;R!:!3;<&U8B_J?=&#M)-_SR9:PSJXE
M*XR+'Z)O=["C2B1%F7Y XO%S@-=\W=';*B;M-D9R)A](!(ORPJ7JW.G \@WP
MO7OFR&G?RFVG5;]_MK+%A=N*V>BT7M N)\5>W3;2^@B/6HV>R49N!;/@%5L[
MZ.;65_C/LSJ:REOB98F^!XF'P1-1%Y)[#Y)EOL"/[5O,_T?3=P<UU7W18L$"
M(J(B'3ZE*$2D]Z8BO4E+($!0.@E%>NC2(33I$GHO(8D(H1?IO4.0#D% J@DU
M(.#C]]Z\/^[<<LZ=.;/WNFOO-;/OV=%O0K(!V6KW-^ZN4A\XLZPB3E=[LGD3
MF5AO=_G^HXA%@U6M_@,-FM,Y6#W4:/NCSYC':K H@P3$'T5@T9[9C\C)I)3!
M'#0\X!OZWM!1L7U#=>IN!_-.Z /3ORH=.8\/OC$%@@]W;_=H^)53;\@?$3VC
M5^]^3+CR^#2:+$%XI-Q[KQ5MJR?.]WP&* _,8WQ^6RP-2Y:G[OT:>O,",'+.
M2:)A%KW8V(8D%<-CQ2AO?)+"Z&'@"G$M;#3?Z>,/L=0D@>!?N(3A=@6JOXV&
MHX3) H474EA>4DG'E-U"J'F1_9,G\@(-$[-3O<_*:J1!*/)TVZX]YXH0&?05
M8M3TZ($RH/QE O_:OLE_A$;G.^2BW>(WK?3MO8T&DTC_MN /;B %;QJ1'?.(
MEE<'>$%SA5A?2)9[FF=!)LF< 7Z[2\$V4="<_K DN$GS5>Z;5K$5P]Q3C+VE
M91>S:CIK$')_05$;!@MV66R>07<=WER5HO]!1BD]V'/$;7W8^LN3D!P'4YF4
MC;D.*Z]I??2B#2M65R=>>].6=5HE%WI+*Q?YUX\_P-VE"INQ'C/-B37VGJO#
M5)KX692:@:-$NGSVH;J5")VO!_H6CL4+,6YFK:$>(U6JT8WT"1CCR.0O@)R)
MHUNUC3<DUUL$!-O<($"Y'7YM_<VLYP9_'4N91NA[X0>O_QHVULR3U);-3(9C
MKT'WC@#T397/F0@M]QN.A>434QQIXV3-<B_BO!SKUNO?->USS66"ZLZU1SLA
M'ZG-Y;=^=,!5FE^TVL76UZ?/V(,@-E)#[C7Q0:82$>N23)ANO/I:&0N;T,_%
MVJ02L2*G"\ 3O/IDC5-*AZAQ&;UF,U_U<\1WW&=JW3[V%?W=0NO\5=RPK\'$
M$P]9$!,*[FCRW-''=&QOUS@-^%:3!!EF8.-C$1G$AFU,9>L\CSBN72@)_,C7
MDX5;,K6')779FH$I]83,C&+ZBPQA:1$=RL\S%DTRC+\WN4$BB%>"$Q;9YN!F
MNEY4XAVG_6+<^G(D7=MER'4BO@9H@R.L5A['?VYZG?9D+'@!Y=SU!.9MUWF/
M!+E!_---"19=.IMNLO?JT*]FW7A6!_BXP'3 *2V@(;+1RF8GP-;QI7D[<U0#
M/'^/-.2[%-/TBB=VSAK>76DA.A<NV4WCGVT85VW@Y%TW*Z>C1+PL%W\QY F4
ML%"Z+4:0OE_SKKP1-7$H\T>87@K;FO>W=_Z4&3$N<TV"_AXV<XJ[_E1%5'1F
M1$SLJ8W'6%QP[]0-9J#?Y*LI]_;</A=#-JFR1?7(&ICGH*4%MS;4 ZP$3H&^
M@GW#@X/5JY6A=Y]\3TX/18D:?)FD ?*8&JH0\H53A@,=>3A? 5&#3<Q?6^D?
MQW9!YT,G$J)*C:."5L5ZMV9?:WX!-*?=JCP"N#S+!H#=)Z<*'94A0YDTZ.V?
MIO=8/TR7PSF[8UF>55WBUF>SD891UU'V9R'_;ZC/YA2:Z(J03Z.-->$PMVMH
M\DGY=C,DP?0?14P3#S+TU=L-L1]PCFXE3UZ?8RV^,SF]^>MO>K&#MMH&MC:^
M=!?K)7T!LD01DS[.JZ]^D*?64=[B3C=@-Y 5+B;P-"'EVNIXBSUI(\2J*E7Y
MSNN1(L^N@W>+PC41G,5;YH),F.SQ;=<XV$@*I-^")0X6J#UU;5;$2(VEV!-_
MPB:%AGF3Z0>-32-ZQ+#.+A/(=EWQJ-$.,?-P'9\?P:M%]F\DU-==Q,3IJO1Y
MRQ_T 5<=1A5Y"C^J\S('JYJY(=%<'HZ-D\+O;_E5XCT&38&#T0;K\5(%KG&N
M6\R]3;6G6AX,XA?PBN@Z'Q*("'73WLC:%N?^FNE5\+9.G('*+0Y6TCS1F4ZH
MSU+_.9OXNLMGDJ<<P):<N":WL7(%EU9^KTO<'MBFY*+,X99;@ODCL@[$UZ20
MI7+(7X*XU/F6(-FA4.+3C>-F<!ONE ?E%:W&WXD>L'5,/P>LQ4>Q/WKBVO_6
MDHAM</X8=]93[ K8P"(6'XN\+-*?QGE\A"E+LY%9K4H;Y\G#I%A<VY4I6,0E
M[B+&2.;AB[.[PX-NFJ,.\5]S$6<(1C@!7'FTM"U150)+K<ZZ6YRN/7\ Z5EN
MYIHKM[+X[@?(K2@O<?11SBB)-C"]!YI?_@2[CPG0[63JF691WBT/"Z4R]9NZ
MJ>^"2#?Q\/$H7S#FH Z/J^76513 \8T.F:K)S!]"'12?3=GS=<;CRP:XG0I=
MW81BM6@T;0N'H,CG64D5*0)9008G%@6)JVR;TE$TXAINOM4>%:CH\UJP=6=7
M7]<;MHSA50J\:R=W?9-^:JCKK;I-#=J(HCI97DR)(G%N<" %JSQZSI[QQ@I+
MS1 3"MS(TZ&:60,'AG!;W.\X!1D6DX7"A7.*?)(#V&MK-%.N9W":@/]1N(-Z
M08,>8]E%LD_[9N%*\'Y\3,"C^+^M19",3N HJQ,8<X4RG57P@>W7D0(YQH_O
M"]I=KMXRT(<K"[>Z'99@8]&M+3AI>/OLU:1?<?:Z<D.V$;HJ,O[+8]4K"NJ_
M/ (IZQ="+P!3TV8U=:NNDR@:W'K )E8OU?E5Q<%:Z(:\1PO1O5_[P:7AP'8
M2S9CQIK840A9FSJA/<1T*3* 0X6+/[)G#9+LIFU=;_ )\;!1GH-$F8P_$']3
M/OLJUW&=)=9W)$Z>65"8/OH0RX27Y72Q%'D0(PBUCC34&=UOJ%ZQ&EYZ1[H9
M (Z=&F\KXQK -VFS1.V8WNK%1&N0GFK>@A*0)CF%[V.E$^1>?4 /*5$[?@%2
M8B.?6'.(V<\LW"UD%-O\4.)M="J[G_STB1?XX>E7S->?ZZ^R4#<Z %FX^1X*
M.Q4VU)X=H("8Z9<F(XG:UJJ 5_0]*!.;WGKB^Y5D! +"1^CG*@G]$C][;#A%
M@]6S35Q%ND!V_?@Q6PY =+VT&C"O,PLF)\PW*>Q8/+K4I%)N5)' +H65F*X^
M8(UYC=5)-1=R,6*N2>71<S%2?YX7EE;E)7O<O8G^18$_=..?A,OBQ;$6CIE?
MA'0WTV*PP;!4U;^FKP32C<H(6I16RA]P:\SK7T?5?]+_J5)^E;>!7);5R=V;
M;X,]B;?V[=]([6!?K!;--OEE>*$^.5O)6(%MF<H*Z_>X9,*#F1CX(;C<;0T7
MYF#8#_2Z^*\'+F;8L*/]F (/,0 =)QY;D4H05G)I2(DVZ56EQV]*!R^\%7;K
M4D1M$JRYJ#9#8YB&-B6ZF2AXFA^]G:JE9,**UM6*[S\:KQ$U4^WNOXN)GA]6
M^3YC>I<!;?;W)T9%:3(D=[T!YOMYV4VUUV_,"3S8$(%VI)_'Z1%80]1$K-P8
MWN]#0Q..T']1 3KT&:)L<+3^BY$YC;7S*:GX6TG.SRKLL,]<C,'!*S2.:J-X
M^8(3VO'J\'57VZ_D)FM($\S<?%$"WUS0-8^Z /3@?EVL@AK#!1.B+7*:SF&8
M<?2[K[T8IVZ!19!Y08PP8@M5F1*[;<9DI9UR*V]EM?H+;O+WERAZ6*XCDTW\
MWG3:KI1QA>Z*3W@<J?(4)K'#[8,XYC?IX$SZ7L^F\4;(EMHL>?MI7>:[R(=Y
M]J_1L%VYR6P GX;$PGB#P834XJ\ _^?9O/\H/@:J?ZQT^3GAJEK]^9L8"YTV
MS!,<WR]5P0W8N:?5&&N$F,1IV=L9Q0&<\#\^6.F!N/KC.L\,<JQG3%IM#-GX
MF/@[/%$\ZRI?+3=U<=L;:#LU"Q/<6_=_%- QKAY7@+^VZD\W,\\@PBW@>W ]
M$[_X)-Z5D95Y Z6EQJP,E!MX-WT340^=;FI^^-I[%Z)4L&WSDF8*WX'V'EWU
M\/Y>TC_D/<C!H-8Q_75)[>_J$5:)Q.G=/[4!#K6V40!O%7#R##Q)2'\,1*<F
M[TN>VLN*P([+Z%V0Q^;4YPJPGV.AWN=\VP:ZX'21R/%JO?YKX(F,MEAOCKLY
M[<WJ'!'?9Y=/K6B+W&>?A[W_($UUP/Y4Q4!K),.IA7FPL#8UD._'5!. &\&:
MQQ'F7[%XNZ8N(E0O(&6C19QLN:[<+=FJOE40IS636N@7J9M?URTTY 5Y_-TW
ML8X)K05:R>J4"#U583K$+/T(H+7C>KV)^(T&R]8JF<:-M%?UW7FJ)1Q(/<3
MK>5_+0\.OE7[WL =)1WQ>14I#)2=CCIJA4/S#C21WK5_VTMJW;5QOUM>$4UF
M4-_BZ7\U=,:7]/X@(7;"E'3M#/<\%SD:=' \M#YG@2N:';V:/J!N=H:I68W?
MW;[3TX%W;/F=.<;KA"JK-6T\ Q]Z;+YTKZ>J$<01:[L$$%Y G]!<]8ZDQ981
M<N6!O7!@HWGF/PKF!Y@BA<FI-?=5_L$"%B0XL!M0_(\B=>@4'WQNTFCSCP*\
ME 6'9/<$0HXF[(]WQ0&_GRLC?SOE^T(B2.KK&J&W]*?Q+4BR#*&@K/JM\K#_
M-L&?6BM0ZLYMM+\:45LJ+Y7UQFQ3IC7COGA4,BWF5;6D&-MS[C?<L#6../:[
M[VU?9#>CMMF>V+-HO%]:P'*2*TNX.UWWF+!9[7WMN64]^LNIQ &3K58O,FI+
MX'.-UN,O][SH-Z2S@W-F5:C/#??,;[FW\JC&R0'FNW20Z7.2OB73EP_# BM7
M:3:O$J!.?RJ67;G/[[5GD3U@9J>ON9D?0!)E\&&9F7M*;;OFO'<&<M+9K7'R
M<N0QXJ_J).F>[=D6$Q([8M9@W-HEQ+P8(DRL\)F*B7L@KN1G1L+^V+7D6K/L
M63&W_MSE]DK9\9;?XDD0YOIZ,^"'I+VE_-':]).'BJ4/WFQ#2I89^ZL#P4<D
MZH71Q0T\!S79J"5EVR?)<6)DO,EW)?I!90#]UFSU7_>)RUT_QT "8VW904[7
MP!_^HO46> O^^KS$T&)STJK6)3X#>9JD-YFQZR2RV))TE_K'[^C136>/Y=8N
M,Y7/>PK5 IQLWE@NI#W/QQCD,4<P$C8/?;"F+4&U6/WXPXRP[70@M9]$S2*O
M^/&0[V-IPB9=^9,>^HAE.;&7AZ(6@F]!6><:I+1CZQE#OP]GTWV2#5/,4EZV
MU7W^[(U.()GO@+9+03B7?[;]=4\Y5#%9?_5I60-*WANS0>!)1(;'[3Q^"(R4
MB"A-</&K.%\D.:7B:_>$XJ"!M'-AACR-K5'9;'_E\WCGXF#AX1]MZC;-WY>[
MO6'SOQ^]"[ONT64+@2G>O%5!O6NW?P/X<C9)QJ.$T8T6V;V&+S6+%\L0ZQ#:
M-N3,K-77=[K"';,G@UQ/![7F3S1*@*:Y^WZ[O:R,4RV(JF[D2GM3$3F.0U^\
M\^X]+$7IZH'3U55B59:/.=K.@+$Y0>#ESX\.L;E[+0S5NB%K 2F62D3P&\'[
M7\\!4:OTU<+KLFP!#(.@9R*G0*>\9:;=-Q<SYZB=+(5V\<2WUY0JL _\9(/M
M?A9^F!;N@5DX^:F4P0-415+$1DQG4BR$S-_#&U?J8Z2,6M5)"U[MPB:#';8^
MVV%*<EKWKR]V%3I1VG7EJ6ZW([<.S6G2>2C0/L (XM]=W6+.D143Z?[KLN"Y
M]N^#/QP44MQ]G#MFBMOV^\X!"X>!8>]Z"SO.0'F;'#06M3%/(FG;Z\H)XS]!
M\A;Q*SO?BC5M]RLN%-6D?3)C+%HJIF4Y*9L;/]Y6)^9PV#\3_\(W7A"Y(1%3
M+>MF\-6)#\#K;MORQ=%T6KN% [F_?4VM#ZM)-.\ U=T98M@T<ZTH0R7P>"MG
M+#.MM]T)Y%LPCQ"I\-X?63-7M_M'0?NQUG")D2/,J6]Y#AAQC6$?$[A[/]RO
MIQM9&V9=-?S^TG"P[VZP)MUBRW>25T>;<&L:>R 52>>AGUSVK++SBZ!#3"3!
M4JRLVLK[3'ZMXN_:%LSS0-.7-9RQPB3\H= --.RN61+71RT>?!=_<PBDEX()
M'6U.,^ O.%NXWBS1%GC/!OF.GZYGO*8,**A,JX@DQG?,.+/1INJL0"96_E&$
M.SL_K(RY--S,H;UDZ7%FM29PI/A4!#RN#9^G")'$WL*(+'Y_F' @C\MOR;A[
MZ@+1)\2JK=@R85%-'BN/N 0J >O_*%C(XE:)BM]6-\W@T+'L]4K;9(VRZD1V
M^Z&GUD4M8[]P7]=449[,EF8/<FV:>=6>]0O.9D104"U5$AUJ$8*A&[,-?ZC.
M%9!;[YQ?)AQBH<36#ERXV 'G!2 57D03Z2KOV$"&N50G,)VC[F^WN<TD)2ND
M^-<*!.W*9C).BW61HU<&]0&G+B%D(%U/S1&#T+YFJJ-S&SW8AA'[@03JJ'<\
M28E<W828H>WVC46N%X)0VA50SG>#3$5=PM0%352Z3 DU)^A=VO;$)<VZMW:)
MNE/1R*Z+6^,:[;G78:/5.;=&/I5[<O37-%$3CZ8'!#@V(9LK2W?G%*G"7]\'
M]*&CWOLP\T6$2 3;1KI&[%?XFR@EXJ^ ?:0T';9;9,J'6/$S6W[$]4I/?C%E
MZ)[98L%Q1%_#8;:&. SY]],!8,+/?WEF%Z*XE@#1\+#F;^Z^PXD\?M&GHV>*
M<>AY_K7)H'*3W_,'Y? 5%VPZP_N%D$=+=\[E?&-CQEP.,?53L9);%B/"W\B!
M_&,WE756S.ASVD\3WNS'KYF_(P?^^&12_B>&:GN5F)*3]#D:2>*SQ(V"Y-\G
MM3G;->6=EV<BX;62G/2'Z[7+]$CQ_=61%8@N 7M=!VH<:KN/MK>8K+:IM+WF
MU%L(TLKK13TCU,,&I!S6_@L&>+7_+<I2:?;H.P @C8Z&'IZ]JV640S%T32?V
M/;JNH[Y]+I"'ZVK(:BXOB6Z2M@R+,@4E[1U\71P\_6,0]JO.26;,&?K7!V3B
MD?>G@=/9Y[<H]F;S^#V5G/;&-5TEJ..@]P4F>U_U%HTGDB,,LBPP8!:0020H
M>?!PGH+RR6YMVPX,KA;U?!8/P;29!V+$E\$O0Q52/FRU,*?.*?">HS9_-RG<
M4(S-K[]P^['I7J$K8NK2M5WJJ[@&^&O\U.*.6$[XD*]S5 M;W_UCNH"4=6E\
MG/NQ T8(@I8NA[U-JA_J[7(S<'IU/'D" C25BK$R:R)#/B.T826.;2CZ5/$F
MR1MH8YU;6O#Z.U?FW@B]Y!@2X12UW<=:$$\^6\1Q+S&>H^(P3Q4ML_4J]Z>F
M.^8B)[-B3T$*WBLSCD;!Q2U34TW4T(__*==W>0=&R;.>?J_I;7UJK/AHJ)ZU
M9T2\04.$-K5Z0E,0HXHUK22;"SJ</M\O9^<BNFT>[ZA;7F\HFXX7^S+VP]CL
MCBG5MGNSXB?6Z6RH,(M)?K,@S/?-I,2U(?O(V%4WQ18&O_MV%;K>/]81^U)*
M;L</"Z">6Y9B?FJ=RI/1BLQ/OM+^*-XM6NB2\&K^[QXAS4.E<3'-0SM7E07A
MR2=HOS7UFM.K%%SL9%]D]XTNO,2Y$*!6\^4^C88J);_,YUC=RFT].J2].90"
MD>8AXTAI;W1S006L59W_Y=:8*KPD"$DU>M.[9-SQN.C_=QPK^_!_J__P13SQ
MS:\?X(2@0' TN?3:Z2GT^;8>;V\7)__UI_I#FN$)EB7EHS=^%$@6#DN6SOQF
M$K<K?:+N>4:1Y"&>?K5"K^;K;&^*]TX*^5\'9:!%1$N06M7W[I3^ G_5-Z*Z
M9;FE\;<*8D^()V#?3Z:=V#2-=&D,O$=$M7W[OSMY>45$ $PS:)<"Q/#PP'+\
MP(>$WSXZ"_35K>[ 5TDG2HX""_1)\S?L"NP*/%C*H$+5NMISKVGRLVJ2')]2
MOIK59/80K-O-3TA-\W@J>L]23S]RB(?FJ:G3+-AS5GR4@7$R>;?:\3@WH5J_
M9L)%T\KQP("?0JY\>%:0-R98\NU4F.B\F\;XUPBATI\VV<5Q?,I"P$S)$I+F
M\\?&GW5KDCRD/]?IJC5\=M-,L-M^S51R#0&Z5E>,4],"O.X$@[63]?@(8TJ/
M.X61]I,9=M21S?:3>?9M/N/TW>4(A U5<6%",-IFT<QW@AX!FH:/B*7.I)?;
M5W'J[RZ?UE<4#A4\J,5M)(!<.<&2L="PJ>EF"Z?@_0VFMHIZ;F$QJ85B*,[>
MPNJ#BT&!BY21-3I#W0=8")9?&<?,_(PD=<&4F$O1C^]E#M+NZ%[,HCT*=F\2
M&H;R<[/IGAVB?G%F9?M[VUE:=ND!^:9FH,Q..YD@*6\+B^>(C62:E??A4N63
MKC;?TQ%B1N'./AL_?Y-CV2:3>TT\^1QQ:F'A]\83[>=>\ +?/-$2RZ!_JAX<
M0*G!%EF8A*AP'5(=?^@">NFH6<&K+,&G]_VE_?':5Q<SI3#,%*NAF8+.7!S
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M,5<3COI'02<YQ=US4IX6OK)0TS)<T"QJMY8W7K$;A$=\JVE]D=\4(N]VK%T
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M5LBK]K"BD%=581.PKHWG_5[Y%KV.T:[UV[(\^]D?K*/RW#S5>T_T/:!&/CC
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M*-%M%?1T0C Y.#%XT%^S/BSX$O_;6'T=60N^B/D?24RH/^4 YJIT1*TS.C4
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M<,,9V[!]S5Z[$8#5N90-YXQ5'3L#-0Q;G$\>)V*^YFSQGXSA6KG1SE(_Q,^
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MW6HP.88VH%\J!&V5&105Q6[!3]@U_[KXOX"U[G=3IWPT(;1NUW-#M:QRQ,_
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M&\JG@BV$:BQY]2MVJ6^]+R"\4T^&EAOCB_R6K==>EE^ACW-QWE]E'].RGP'
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ML'C$QC^:6Y,%RWG/7%#'>^<IB[,O\2UXQ$F&I*DCY5_3<[U+_>W@ >TJC4&
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MXN4B5FII'#[#YGZ@!CXN53"A1X?M);25")D1=_('G_B*4Z!1!9,1%N1:+-V
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MW5UI<AO?'SHLO.N+5Q]3L/O[A?WR7D[ DH?4C!@HFT,873[$MIM9!WFV")"
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M+NV&;/PY6'^I>O*DAW7GZ1EH4OW:TO9]?YU3$W+GQ^7HD(/0%J@, IC_@#*
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M;$Z-5:8X,7>T)/6=)[H",(D\0/=&8AP<@,*!K-TOM%ZZK?P\&;NV1,Y96<G
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M12E?K75ON**P>D;*-C9ODI^J'%LW6W3].-"GN*^ ^7;TY]6G+K^SCWNN@^[
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M1N3C4_02K$8$I#4"-_G\ ]+J?BA8T.2PC@Q,N76Y =[LA,^2Z0&MT:D+,]U
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M= -5B@ ENG;HBA1AB.155-EX\@M18'O;$WC_8^]R#^A&J-[BNPN\B=?IV)O
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MZC+,;M)?MJ5?&BM6A^+=@%?%=G1%Q.#<?#ERH&M_>LJN%4HDBAO+'X8*CG"
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MH<?3A55 :M*;@HFC>CA<E910T3\@&-^_9WHUI:B!^;!BI=J)J$@U%E\HUJP
MG'AB8@7='P3L*W6$+#Q.XB.VI>\0VGMA;0U5BMH;Q9Z<]P_\1+_['U5ER?O9
M+;\X82>$I2QBO(1:/C@A3GT6>'//>^\^14YFOA[DK>TCG(Q![.?X :_K*4^C
M#K%3'*-DK8B-63<MFJKDB57PQN*T8$CY425<]E+K?)CSE&Y10/!QQ+6UOU2P
MA$NN8S_D0@GL0RNM(4D=>:H<9KR-O!+C6QO@A:%_0^ULQT$?7E9A;-T:\,O\
M'@8DM#UT67!>^DJ0<98,]5AHI@=T_ RH2%#BGTL(YDR4]*Z5G;+D:K=-*_%]
M[CI5&YZ!=YP!YM5&9(-_I_EBOTO96O4)>@@7XL\+L6BR&]US.\)M=PEB187O
M[P: YJTG3GN/K4?7K&^2WHO?&4OJ?61^+?C&:W?]#U&@08G _'T/S@+X>E=0
M0:>09) W&P3E')A*",_HN5"NI;GZ :SCO1&:MGC;1MAIL=6;\2_5.F98/LBC
M_E\M:,F.B3/!3[E;P[0TOAR+"3RI<)/80LSAK*^Y'DEP/HYH!H$GE0X^'6)O
M,2VOFF*-?_,$;IM)..>/[71YU;3VZI_=F+?FV^D*7PXQ#JU7BM9JK9-76D@+
MK?D#VNN)O_$_-H<(0K\3MW?\/AP>>T9.D5UNC"NNVK[F[R^PA_4.5OFS W%Y
M62!(^AZESO#3-!KZ* E14WU0'#]A7H@.,+@H0XS:=QDUV:2/6CHOXF0B@D[(
M23%I;NV_8?5E2>)5)UX^GE^@M84WOH0JV-6+6>/)@SM5CT]"6*;8@_O9ZR.B
M?7X0-5(N-+\F:I_&=FL<;Q]6E?SAT;WJ[;-N(Q;8IC=V[Q =&==N&5%9V=]^
MXSC.,A33Y-'=+'*K<H*N/N32@5)'_5\J4^O#DGU[Q8R?G'=[?_AM3VK]I7K&
MJ;V4OVSV\\)?$5PEB7.U#@>MYBO*@*N$\&F_)7:K+*[^7N0-CHB=.@8>8+=&
M"8'^^M-87^T9X";JB^^ JM-Y++&Q55LI>TQ/6L!,[FV0'=17-''9[;%;,J0L
MT%$_ TZH@+B^:?[GL'K;Q[XYT4X?[Y1NQRG"><\@/VSH%W\?9!S,-DQ53*W:
M2%V\2#I.A72HA?0,C8SOGCM,^9V,.90J]0%3$OQGPD&D5>P>8AVN6LFG]V_#
M_9=/YZG#)+YBJB0(]^*MQR1X%&<[@=>>K'?/^'X]/DS0 60M]=.D+Z@BFPX+
M%*(6&#\J-KR"!6? ]D6L!>O>]VBK2 @S8>UF1*"S#=:XE"!.:X$#6L*:5C;!
MLZDDQZ46<7#[UPF(8&WAJ.)E,1\NIN=LO?/T=^;\K47D&?RKW)#4KY)F2'^3
M98%33HB/=>]/]I=;:C/6;=QF;.SZKW8%F,!Z!U7(MD>K99MWO6;;DAW/39.J
M (M*]^OF<@: =UKW1I^/6@[+%SQ/ZOT0!A]ZLO+[ZPK.2ZQG:9IC>DS-P6<O
M$OF[2*1 DG:7>7Q2U:]LNK16$O*72I<3.DQJ\ZW8Y*&>B=J&+H*BQ-NWPJ[]
MO/&[+PR(V>7:JO8H\9R]TG";E7H;9+QBEG\!66ALL:E3'*,^4#0X^7)K1GK1
M1F1].*)4FMR&/VEUZNSAP.U]>>=V-"O-_JM_^=/:'2+WJ9I;L2R:5=Z&'_M]
M<=4J,!.JYH<OD6K<A"S&@L2G=HD-MMP.=OF-U8KIZTPALN*WF+&]0@'^:(B4
MT]5("\L!S?_>6N.>E"C;]RS:Z%PHG;S%BZEC>2-83Q)'B^O3'BZT<GX+ETSM
M-ON6G!@&OZ6^\J0P;-[#ZRX*/KX$X5PHH!9J;S3Y#<P\"5@D-26"7"1.QJJA
M+:P9]=YWU6Q?'*S\\#)-6 C-7=R^VYJ<'-T5*/T.)X#EM4V5K6I0Y [4<O^4
M!7-*TCY57;@1Z9#HPJP>? 89&_[Q>]8B2:2PM9 BO]9C%)(C:@'Z0E._=+WZ
M(=&^.C>C!]3JX0E0EEPV[3<^NG/=G'H8"JB4H#%F?<]M!PH_B+M4$8,7XC%]
M$A*U[,3KDM)^WUMS[4*I0NY[F5^(R)L+L*WSM^"=!''&I.M-6&ZCU%G3)<0J
M)OIL*:@B7"LN H+J&ZR1YUNP;\(;6,B;SM&ZB*V1L7M1*=:</Y7HQ4]M"P!;
M3==1[,M-;YXMM#T%Q&;2(HW1:*%['_YPA2I,$F62#JJ82'6]DLTQS-S7VQ9V
MPZ/8#YN37^_:R(8J[\ U'L=7_\D@:%?5#>?5+3KY$ ["E+<,]/R.\+;I/I9W
MR-ME ]YB!)A+4]4/)E"))C\F;W88VA/DX?6=@G-;.:ZT[EX)CD*.X0M*@@;D
MN_5\GN;=D3#]OE1A$=2ZKL(B@2AXB_M47*7S@42+TRU-Z/%Z4 ))D0#OZJ8(
MRMZW'$ JXG+\[OI8&/68\L;Z.V>2U7U"T2O2DC*$5[#Z/Z]H$>O"V+-=LZSD
M%7F((V<.VUIQSLHQ,BA1Y2MX,$9>^<RM/6&<4K$&CA!8:!08G6_XOHC<C*9L
M]'L[D97NAGJM%,-L0.M]U6OU0>LI-BPG5SJ%X.+70WUL] .9NFBG+0JS!CGJ
MU@T-++\OI;I2+H+FQ>K5;YU!W@:^8:IN>"D.7/]R']I3#JVF8D.<GO?,,CJD
MC/,!QC(=C8L,U5< ,+9A^7.=-N&O]%9TH@Z OK"\"L>'\2_)K7E'&W?&-F18
M^UJ,%?E8GG4A'6 )YP!5:'(D5Y3Y69U2,VAMT&Q\_N/I8X/A;>I9$87U7TJQ
M ?GV_+<V;:3-4#J?P]:GP]G6+HLQ\WZ1'MC);$EJ_&;:I "W'.DBYT_[5V4K
M"CES*4EN'E9A"G.$7<4^[%H_V/71VG^4CCX;H]2M>8_6*B* .9SW3W+T6D<2
M/Y!8K3_V)L(#>J 6)>L7K02?3*F2%S3AF/3EZFXUR].-<(%YG(86'//9EN G
MIXAJ=M?S$IT*_4H>*'@4'1W2\(<CFM6M.(C9E6+*US>Q)N?V-47- [J/F*][
M2IQ2AS>.A/M!+U0E"G^-^BO^BU[/?UF2\9N0(L +GBE$\\U*;3\;H00^#K!9
M LP/:@\' V"YC3>=LK2639/3VZP>"DJ"K,W@6D5'Y?:)K\4?QTZB]:ZYMOQK
M<TE@.^SZ8@T47YBJ HQ86IR#_?ZK.G_')FKO#7K*0X30+M'9/R&?IBT\ RO@
M_>P3"\V/)&39A# *;S_5J 47O [U/O+N+M7U6;>\CBW+N!IIWA36F>D3E2H*
MM]AGVXL[AKP)M4>^%</(R'+@R+ F5VC>IX=74FSX0Y_N%EGTLM858,,$YCD9
M-"+<$98<P%O6K)WMAO+XGG :?GL'?6*+CU%U:M_/'76:L+1*9R^8_X;*/Z.D
M7=R^GNN?DJ&D?2Q^T>=+27-Z'_>)4/WU5U-6IC(?8&HU^',HU>C2,8&WP%.#
M^WK3/9JUY8EGL-\V-VRF1A2]L7QZ^5]<O"C\E,K3D"X?J-4O!VMX25VZ',*T
M<)&;O\V-6CHS9Q PN,88!L>EWN\W.XO.?[907\95$DM<N>?E48=$+6^"AF:A
MFX. %,D0K<H2[H$/0>KJX^4B7/0"#+_'BP(8QHVS@#*M=CK="]=\W(#0?NL$
ME,ICU2XO:"4R@.Z:[>,P#GKZ/FOB=F??)<FF[NRLY.HK\F">B@38Q:X5>\;D
M0#9O8W%2><D[([!\6:<BAYC$?5SWK+KM*S'KW2H7H/SS2&O#!2'VPI2&"NA3
MQJ8/J=\::R$;530?HFX [G:P?"O/T9$&7-O++YBWH>?,T($4F\^6+'$G^]@\
M71U+</PO"8E2](5>*@):R6L4-P:;U$RFN^:]KTRNX1B=F[34"+JYPEM]F/=$
M]#'U6NE "$NP>K'A5][F/#ZC.T7(?3XP+FT$.3E\^*KB$HC,J&!-]ER3Q=@A
M*9()SS4Q!%_1'\S4*4DIP:,/WCTCN$ASH7\T$AZ*/WX;;&IN>P,'T^'DQ6@!
M7#S%)\>=2@0MDK1;;(^*]W9-?YA;V7)D/'P7;)+==?DURW*2-EQ=0="MSJWX
MFKF0JC^Z9CQJ$M>^@J6Y?U":0R>;FZ T6;V%57%";+H+=8]T>3<MWC1-<&/R
MM_?,Y[)E<_NW0, BBC1H+K#(B%.&$!1>+?UAP\<:QYS=F]/N]B.HQ!6O75YA
MB@%W3_]H;[U1*.9J<5L"2+U>U\KF=A6K6K(:XJE9F3GQ7/N:9Q\TK=^;H9KV
MK@ K_60=TW$L%3BZ--6Q!Y!55UWWTK;K-J5*%4:8;-(,?3JRC/G\BR<BIF14
M0R6N#QOI3IJ0W&O%X*V8.#L,K%P>F>P:H:/B5O"9R\\6&A-4Z(B^52JCV,M+
MKQIS#OY2B;_(P"O\>*PQCS&F5+&O$X5(&O 3B-"GU3\Z5^(A:@&>C_#<"IA;
M[H^].?A;J'](6#YIR"&XG13^JL-&68Y6Q!,ASSDB[50><,)"R:Y,B"^.S>G@
M0O-;#%Y0&C;='3F\=M(/W\KN1;4[,H"$D.+T@6M&GR<0PMG24/+(=OUG2DWE
MDTD)XJ>$6:GRU,<'MQ4,W-A&%P.)\5<L%=[6-%-)6"?,<]X;1&E&V<I6V)/\
M[!J0UFF@BZ_7^$#KUC=/#'F+OT/I(J@WVE@O>. H+L?8$5R8ZL^(F*,S>V=K
M$#-'QOS";I_<\VXC>4R'S17;1(+YQQZ.C&\79B=^;J43_>^^?E7 K/^V,ZH>
M=C5S>':Y[<7)\F)ND%T>H"=X?P<'&\U!-"OR['8A)M;$KS%34*LTYTVX1?AA
M"XD]<A"DH>61V4:67I*J+I*8CW9S]G%SJ&!IM(7*60!L+6L2^A"D@QGAG\P]
MH+!L!>])MPG3*R#<-?*&CUE#7C5W&X[^2I?W9.F;Q\;1E3-B/$\R=;CR!8,J
M9#G$4,Z\O'QN/F-2V <<P$D_O?N:9;<MP9CY/>8\W-B+3P/#7\4Y#A^HT+C-
MN6#O!E8$C2;G ]M =Z;=30.5T9O,J(DD$+T3L4".;R)9\G+N4J315OE2:G[\
M>S.XIR"C5>?(^R72T<Y6>6I;Y^RBT.+3:+<),4L34?-$&2PP!-KU=9:5E1&O
MY@49,7#8-N&**M%;(G,,&KN_ZH?IK>O":_F"*X98W8FX%H@ S?3G.9"Z+4&"
MP%42HS=:E)S SKNSNG?]!G.5*C%<0*NL_;Y._#WH/@N3]ZXYDZ.#^ZU*:'J&
M7GM/16#4 O?:<$V.1$'P/N%9^"A0&OH=C[2:3D.,1A_?A7&KJ;ZJ>WZ;-K&B
MYQ$TPW;&2.B+]L1SE8XL& E72_-&S1@ABH44M9A!L-)T3V!3FW@;[2(T_++D
M0U9""_D-BFH,5 [3$Y G=>=HZAD;N7S8-\&:?#\%72>GK+\88&]8P"U]3GA@
M2HL5&MDR$L!\+:O@U1Y0*\HC<3]&]CG_@:U72?ZE2O\ 4?+SJ#XS>D\R>I@@
MD'K'9'T/@?'\2P4*L%&5TH?]I9*IK-+0EW#S!BM)OFE.N,S9;.UG0N#R/6*T
M-6$S[76\7RE0+9,HV$NJ3%R,,E=CT)=?,-:OCW<GV%L,F$?#IWHCH0VYG>18
MZKK^F >PSPT+GY"+LS7+4@)KS-\J=0S.*4WP7NDKEIL'(7'H>%U[4URH*)8Q
M38QL#\>A>W+VQGP98QGP7*FZ"LYF@]\)#KHS>O>GLZ>P3I(FAN//ZM50'!-F
MK%W57^1]H+O36U"*<-<#C*A/EZ-^6=0DGO(4'3].J7_/U:UT%'A0<D[%CE[L
M13CE0N^EE_!\M!ZUPJ[KM<&2^HI[^IS"D@)@*;X71UC^>8Q8.U#J*<O[TG/C
M/SUX'.PGM?WK5X4;H:4>60C_;>&2[&L$PWQ=X\_#_@JJ?=M0?^3$(J52K?B5
MGM:=1'ZO*T.;?L^X]ES&Z"H0\&1<B_,NP46CG)'=Q?ONHD<;6*9BT;-O!JZM
M/V>B9$M@Y!2SLG=B&WV* V&/;)DKSC>HO$R9UQR7' 1I1NV<3<NEW6 ^A/.F
M=2AS36OGAY%'> EI[82:/?!6RBL;%@!]9G279>*8/O<-0*"*G>4K_,.1<-V%
M'%"2-7 PC;1F,/0UF0-VB_LQ>,2,;D: 4_]I,+@ZY>TGU* ZX4Y.Y9>.<!XX
M"_U*-_!#2ZU OF!J;?<T^-@(;+]7H!4(62@R+Z18YQ_.02\\]XJN$'[#EQY8
M:3O_I7J'&,./\J5=":H4S(9Z3P\FG^E;G&S-6KRR(;?,69Y,@3KCK\YA@UJ)
M^O).%%#?W/C@BA\HM=TXL=.;H]5CL1&D3M%=F<U!B37%5\M6WNLP['T0/^:-
M_9,T6 )G+E>@,1P U4_$LJ^7#$_U&YK37UH!9T2Y72ZB1;,0A0;[9 MK6R:!
M?9\'R7<0*BX"]Z"GCSW?JTE+.D;>_5Z8JZ7Y"L0#]"M&495,J1R6F5(90[.X
MD 1E6IR&$3[838>J$"% 9:C&\+]B'&"<H!YB\OIBQ!P%SCZX] #WG+012CK4
M';KZ5$_!Y5Q,<]J BJ")U8-I7WOE-B<$0DF'#".I/!4$ HP%*O0E[Z2#E/S
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MOH5ICLE+>+PO5M+Y0RTIP+9-E8%-Z6>IC8U8CI3*%[YV80"@'^48)N;%A/6
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M?M]1T?:7WE9]1L5/$H5U\JG<G &2<^ECCUZG;AP[CBF]HI";@5MEWM_7*P4
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MGSR%ZY6W+$@A,/8!^S04*V%$SA'OKBL3U3SI[I<9JHV[CD]Y0Q;=.W3;,:=
M?DR_A678L#605],&'RU.1I=UL>Z R=*B5]JR1S-+IF:DRC]-UICN_S'[8 UG
M@L5._BFFU[E4Y ;]8HE K93M79Y0P-%9L\*6BKX]NP@L*(7F]HW_YD$(! 51
M5(MMC]*H-0_=OX.!*#8@\U=C$[HBDQ79X:=R'E"_X=0LG8].HLR&$D4$Q61F
MN@DA2'KR4P:D[ "C@NN%VL)BH 2*#B+4$*?XEOZ)D<9%]I^)6C+4%9VG'SQ2
M[IJF%_!\NH9]F22Q"OV\-65FY<Q?Z/+C.R[(55=AOL'RX^GW@+(G:X\=Y[]]
M]H"SF7<C]6-T9$X:1DQ*X]""YWZX-S"?F5_=-BEV0 ]6;S OX0I!._*/2U[*
MBL'...P$8@8MZQ.NTZ8^/$%P_F8/[X>4RMPHRC53*'[#E$IMDYO9*W0/8 JB
MO@-@9 ]N,)HZ/L_SA;]F@V';TDE&$;_6BY4^-)!ISIYVH3MF'Q=*>*BX=D+N
MQ0764BU=5P@D/+X(93-R^\6E4CL H]YU:C*[$#SF/'YTGDN>NS%H_\R]97"B
M4;W]+]T:%YJO<V>$NP47\2/4R)SAO(6&B^S80.X+9BM[Z\@7));VO$AJNA2X
M&+AFK-E0;B1J'E7R5:,AP!LBT6HFJ@_5;&5^#\Q'5XI:^P%>.G^EEQ(%)95U
MCAJK/^U,VRLR+O\JKGOED2#DDR@'8B+<"H;T93XUE%*NJBV5':Q^RTY0LL^_
M".!S8:9?7*V:%P+4%DX__9@.S8#^@7YW#K\=Z#,\5"9%,U(<,.8A*4/RG0J_
M7I<S-586E?S]G]3($LQ9"KI:]/8Y$JIG["Y#9OWJZ$4 3Y/T'ST=N6UO3GI!
M,&,OTQQ5Y\O-0 H"']THA.CJCUP09RWA2BDHJ1EYK^-@ QO" R[7DFSBY M,
M'&\(992#V!7C\HO:>.H*7>0+)I'&59&:Y@-\[4(0::,4GC26.[KI3F@15%!Y
M <]F!NAA4J4Z.\$STY GZB/_)$.(R$^ED#?GWYR;\,2;H.GSE)V.!%Q"^H-^
MK+>I8@G60*:1RW=NDQ04U1IC7:&)L(%"N;,"#RF5I\H5K9H(J]T#1;2J7T=#
M@+O?!'Z(X+1F6L6Z/XD?JG*&[)([OHQ$9+)'0NSD2[]MO, :"Z&[1X4)^N%W
M@.!$:9-E)!3PA-G8%;K&(MS_1:^&V<I?)&5"*)U:Y#2?)T*28 9*?E$H!4 G
MY65NE,:RU[E-"U^!!"L!+W-(U/08P/ ,KX5!L"0-(K]0X<J-[-T;G-^$"X;L
M"Y-T\Z4-'R;ID[2HIF[7BQ\[1W2!=-.=T><6$ 7F,E$2ZX;PB-=&F>\_J%\\
MJBO@N >1^EDRI6G"1TZ8N".S2%'%PK]-YCN]+>+CJ^FYODB.3RYK'[I0WYAA
M2\M$--#M&:C3ON^TV\:.>.=[.D\H)[37Y%:57E-MM64X=1YE5]:U3=L#[AE\
M5+)CGM"+^$O7:LMQ:MNBA]75+U:B*+L416ERR09EA%W=TTPV3*!NVKH=BOT*
M<VG7^2,RE_!.(J?F><C:GUG&609WH-0;D_QRLX.!C4?U5GM%'HQ6UAW1B?P_
M@D:']WXO=Y!0*W4=W9[HD1A4Y,R<\\4KN,=AHCQ:6B^A_XU:X-XK=)6]V;RE
M=8W7]QX[6"YT1#IV>,']3"3&X#9?TMGJ[ZII(S8I??T?17&([1TCG1(^97VG
MU= 'R!DI_PM6-PD+CIH/5-?4DY[F+0:Y["_:->\9W"RK<&"TN2L0'_^7KL4R
M2#S^=I:ZSC'9Z@"XZ%*E]3"Y4"$%DSEPJG_Y)[Y/VEIQJD,FT 3T\<&.WUYI
M?AK0814<,2L@7^9$LS+LBGPM-.7WY$.RZY5$ G-"!/Q31GOJVKWC'T<4 ?3I
MLVB^!]JJBB^U"UGZ+=@_>[V^5@IXGR72)1-V7[3MK2<IZ&9"V:.V5QOK>J@%
M1'G=4J:Q3+8M)%[_I6 R'T44'_"3P<FND3[WD7?Q.3E>K.RRP966VPNO\4RC
MS0_0=9,":Z:/SWE#=YT-R+F=P^.5O\<VR6ZOAOG53BGIAYX="/TJF7<[^*?E
ME ?UL7;AF)=4=QDI[>YLZ*"HWL,[F5@^^#\J<BW=CL]PB"&T*%T,RU@5)GW!
MRO]C(_1R[2L^ "\DRWLM4>L'3(.<]WGK9Z.XR>'[2\5N*;*)"WN!5QS/H-[W
M_HQOT'KY?\.L)Z\"?[B>RX;G<V2:G22P62:^7=@I]J$7  U?)$KW_F->[//3
M<HRHNL"2:SQ3^A)CHR?FG"MK$J%[RQ05":0"\@MG"-S_.25IQX-#IN[3GSXL
M6$8F@)KEYE\"?*)5IV^(,[%HK*_Q+!$+HBC@8/_]T!$ =&LME"3]$D]3/!Z9
M:5VJ6SE^_U/[IK)(1_,#2?,"W'Z'E;7:[)+;(IB!]I\H>2,D[@7A&2=G0NII
M8/#@M*KRJNJ%U1N4P8@W([:W'%1A85C0%GW.^K5S0L_(QHG > ZC03KT']&]
MZ:KRS,9SJUF_.G%YJ(GEQ!1Y+9 WW#IQ;&>ICNGV-HP-J#VW^K,NRZ7]EB4F
M>&$'KTQ1X=$LFW0\<_4JUQ7-;I[A^V PPYVEHAPD]+&5_NCGVOPSIO/*/:P^
MT[Q:54R] ;DX#:?^NY9_I][;Y.BY?:TXPR&9X>W73J8%ZS^*[\$2$05<(NJR
M98H6[U^7JZ3LM'08 /[2N4QTF]%^;-I,XF'<+M7>F0A;[O,!U'+&C6X.<GFI
M""\,;M+F=)@KM[\_*[/@CV\*"3E1/:P\T13T5_&.WSMJ!;:&>6Q,GYKM<_]9
MFU>M?$Q74^@]G%IL;8ZS9FH47[2H:E9ML)4ZA0S.K.J\%IFJFGYMO8*6<_E?
M-SV')5%L>PP7[1:X=6"QTQ\9_(0/DI=4$#RZ9] :$->4^>H8G CUJUX+EHRE
M-N7_%&:Y-&E!9!])Z?LYUR.(SK98,]$^N2<Z5#*]]MI2TU\"4!K!E_3[V<A(
MV"1-\S6DUO9VP,0U_\N?0GV7)Z+:."LR=8X'>UV_CN]>"IHR><UJEI),6@1'
M_&ZY]4Y;3N>84O!;1:8FB_D>=Y9Q2MO\(+FWV-T)A@K+\9CRPW2AB3Y7R%=P
M1SQP9_EU4Y?R[:L=<>)=D?97'6P%QV>5FQNOA"4<4R9;N*M^D2L18Y16R'<6
MR)Q'6MB:E9F<,KL8367N+(<0OF_N+V=GJZV#?2X*IG**S(6]LY&+;[]&Z>U8
ML)G_2W>'1?OI';\]',I[X%>;L;=+!2>,/ZQ1:"VHT@<XIT>[=ETAJ3[N:@?B
M1?>-'.R=Q#AAK_"5.+906%5Y2A$4-25G%,'*7B-=]HZG*D:Q4 3#YJ_3I(V3
M:U.DGQ9Q\CX$>TIMP84/_V,T7=GAS9;RF1Z<4^'9TDVUO[N+XSKY&<=Q_U'(
M[5+SQT?S=9,M-\H:U_'"YL_'UXWZ8(.@NGER*(?7+P"N1G.K9*J@>,6Z(/2>
M^>03.*1?[]8"<BT_*E;QMJTBQ@*RQ,BK86G&+2:2%[5H9=S!:GA9U3TH,2EZ
MQTSX97[#W29(33(48-8P@#-%/GJ2PM#A_960B0"3%R]83<E=A@TTJ!!Z&IXH
M8T?C='#M3,!T[\!-(QT%6#%O<A+LR**O0]\G$(T-K"DM(@FR42O%G-?>Z;1_
MSX/C\II(6L!?OK\HP$=M&;48LF2/] WRS?HBGW:^+]K;9U,C?O560YU2C+X3
M+]][T$T1ABT./>2_Z2+GL+%4D):6:+SW\ZT5]\+4!@;KFX(.ETKR++X.+_1?
M!)#6;)0BAV0O=  6NBL%TCD.O@Q 5P,O MKAL[=Y*T'_&9 ;-XDYS #U_UU/
M*S#?'\WX,/C?Z2^6[V"L#"?. BZ*A(NOV?#.]W\T>-T?;;!LQ56^H"/&UNQ]
M1 $B2H'#]PGR5>TP6+9@TKSF45>9#KYW.?D%7#9MT?33[V3M5E>@Q[4KC_ 3
M3\Q.;!F[$'%H@SG+<^ZM.&(;DIY]W_;RJ?0;;$;>F;!"H+:14I3Z%F/OD/C&
M)-LNWFE+M?6ZHVL/\1A," #/W8"5D.ZMV'PI/!2>U(OE?&M?/&$^J-G!."?^
M@2;\T#5JR2:NZ%!STL#L";-]]@2Q.?6]XPVP-"Y8.W+:_.I_6!6['=ZJ9..:
MX7L1^8"40!J]H->E?W!PFR9.U#@J_[=!=TRPH7W'G7."5/A-EQ&O8"VD9D>:
MJF(2-XN6;ZR\:EQP4,O='-)?.LMC"G0NYV,[^*GC&3SR];>ZA!)W/,L"*S!J
MOL<$6+DP5#?+<(@5NQWJ1K&K\[U&HP#[]/L_JP@%>%B@C)D/\%F$?J:NRZVI
M)N269\'6OX#-X9/.\&75C[8W(=,%=ERJ]+^+'P*]E_G>=7G -6=>7  #L3?U
M=-( O*@^,\DM>-&B%TJR"]7"Q%.Q/@DL])@6]KC\>X'THGSX%0:6GO?K>2F(
M5]<L 97%6R3)HOA9R^!Y:012[8$I41<SE/G]AHE_^#/>_:%Y5 6]'/*I+L$9
M2 +%H:=,+_!TO-Q>6<U'!MA B^WG)1V* Q4@B: ",TR=)G"TA03>M8PDI.O(
M4\N4<<?8Q_P7$RWTC,O>@,.#M7G'Y"B$W\>?FL(UO6T?'=J"73V879I"&'\I
M6_8AE0B(EP]\;/@'-48KL^KFF[T/X^;^TCTJ>!BF>US_YS'99<7F(8U;:R=5
MC06=GIF^'5]X/7(Q/J6XH"O6&1^0H24Q54=T@M0DC>%&>C=\_;:7 2'W>+Z5
M><C=MDQ=WQX69;)0J@'\GKE8/RUU@Y+6-VD%]MTZ=]A_CPOD?1[R*!>?X:KR
M/\T'PEDK;:*!B:%Z#7@,NII@/^TIP(F^I7VDUR&Q7ALJ$E,Y/]]TM6/@_/SE
M$\H%6,L*=YSG76G"4-@H<CS.'Z22U-( J*/?Q3YU[/H U%6@?R$"<=UA*POD
MY?%L+__$A?W%T9*N@/<>LNRMXCS$9S4RO79(5, ';2W]@ONRK5MY.W]<"GTP
MMA'Q\@FX)UNI0D0ITQ^/5[+S7+9LX<10\1\5P9M\\GN8=WRTGH!]TB%%W7&,
MZ*SON=@+FRY+XVG@X2TN#TUI@GDCJ3Y'TLC?93GAD%LPS:I]@\^#3/*EU:=5
M%V)\N6RJ@Y]L:Q-TY\51N!75!H35L&STG_/;M6<3L10#3.CVR,%\+??UZ9!!
MU":_IQ2%:S0:H_7N5+.J/YT8$'=J8_UCH2GD-HU^V*L%\*M^4<6Z%3%3_\N[
M$]G^PK[>6KF"I4Y/MI5^U:<E X#A:1_Z2X<I6?]+MS 72E!1T45.A16(*</9
MI%VS25NSAR+DC;"%[V<B72KW_])=#IKN. W(*709F=KB1G)O4VAX5..+EA7&
M/7Q1LX#6>0T-GZ'T(N>?C5TH[Y>6TTXX2)E<H9UBK$+C<QIQLP8&*3"^9Z7_
MS<$@VE^0WJ93I!0JK+?9<QHUD$FSD(M+ ;K>4> T9*D]A0^$LHZGB^4O*%$
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M_8&R4#_LL_MO_?/<.N6I]0OEV?,:LBNJ[*M5IHS()??'TP4KUNWO[+^+ [I
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M;%X<6+_:[NP\,]]8V2"%:*%U] X<FJCL@2?LSNV(&KNJ"U>BS[9.PG>QLY&
M</D-SFZ<M=Z9F67KE-F_^>:JK1OA?Y,0'SW7B.=H)OWG])+UL4#\MAT+IBCA
MLG58)PYK=EPF68:Q[$X#E@=JDQ(HJ58]D6R,!%3=?G$?U0X2)HWEB2YP+_CU
M3\+U('6#V[7?^@H4'Q"7*KIF2J^]9Y,Z83VJ%E7*-)=3X>R#I+D14#-UK^U
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M38OC4/ (5F1C-L]].*7,URZ<VGH?3(B-\@'^*8ZWO3CKY 3?1GY:DT[*;2N
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MH'HX,T<@I#*3;1X+F.E3GKAP%ENQ@8YU+Z^WKERVXPU[2(S.F/A=9V<4)#G
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M_'X;='K@2RQHK)U__%EBPQ!$BC#,6AG[%%=JZ"0Z]AU!BY%Z<T=$>,'YE2S
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M V+AR8[.#PO&?B&BZ\?,Q1OSGA8Z,$EDB.2_,65[2/]JP"2M3'G04\[Y86+
M)'&U, [:[?)$%$UM40PM9RT/,WW)_ZYBW,N,N41Z_.K7F($R-NA!G\6R;D'T
MK/"6H'!E8]FT+%7/!Z#22(4 4;?&V,0U%\A!,QFXX>M=3L$%]</G00P,N.Z+
M"Y>2RN@KC*2_W)NH$>G(U.4ON5[96>A8Z/. +>^&9;G%9H<N4QF;^\\3J'Q
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MI**Z+AT/<YM;FFL2H)_9N-]XC-@;M;UHZW%6]]BU'1&,Q,?;3@YB,ADQG@H
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MLU?#6BN8>4'XBSQ/21\E*1'ZZ(-01G+H3Y 2#.<4]@YVS6KB>G4#TP2EU5I
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M3+_@MB_V&A]O7$#Q+1HQNKB*YPMAFZ:1- N<H'SR1ZFC$U5TE!^BH3@X1:A
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M+;Y?QAO,PT[F)*,\IXY<?YZC&>8O;K41GEEPY5X^51.3H[P_]QM(P@U>+QI
M?B\=F,3.S["J"(/:(Q#CH[C2@AAG%7211F_W[;2)'3X\4W0Q)&U8#4II#+T1
M>OXOG=_P%\Z3F*YEDF%"VZ0V]B85\G9X34/JCH(*.L=P+3'6H$#J5(2JJ"_,
M\N0N.X8GF!RW!N[/UZ.N6[W[=0,+-4CFXM-)5XLYK)2P_O?TV0]T:/"06D4H
M:ZR]!VI?#7KZ8>U:)R]N"YH1=3;(%1AGY7KLZCF34-#\1"X./'2H%O'M*,SP
M&/)3L3C%5Y\[WA%H\_"4UX3[I^<TA 3C^,8&=8GF(#>@ULH]37].T[+(M1VU
MEB@[YL-_QV/$0X@R]EVY8L0F($2#P@G3O,L<F>MR9$-FZ]!.7I3"AY^S>"X7
MQ#F"#)+V8#SU@#\DRLA);5M?_$O7U3WFUOO>.WG=1F4Z0,:HMD')Z)AD/V_#
M,%MIN#8F4J6MH91-ZKI:,I:NP7&'E!E@H)YQ8G_UR2%ZC6LP1C+8HS]P8;AJ
MS^;=)N-Q:]JOX:*V6D]\ODYWY>GE*KD#PT5;Q+X'Q_G)8":7E19.6L!J#?5M
MW?>*[DZP WFT0@EB:I;<=R^03Y!V1BAL"%,:#E'Z9M?T7(E42"MIPWHK\60N
MI[:W,,%UHX2D!HML^U!8N1@W5:1[M73=/W@)7)!\ ]-=M=NI&BP*[2Y:;2MO
M9YYLVB7S=>R-)O](NK<*N3_#@0\IIU5]W\V]/BLBX#YBHT[S7T",6XJ%^3W<
MKZ#O:KV^)6Z?7!";&'QM;IE247)]_!JMW(SL Y69/@9[).B'O!.;^+&/!=$B
MR;H)+K./.++XZ[%, =Z&8HUIZ-9JBE6MX?Q0CHKHUJ*C/6M(*RK G;QN+&&8
M _]M$Z&H.]YWR33QF2NV/5?ZQ2PD7&<OESZ N7HE_AU>I<SV4F9A,;)R3RU2
M0MY9JW6#E'KJ]U-_/WO<B@(?4Y9DL)PLR]4A4 =B04 (EW>RM;XU=Y;6:1/U
M($(XMUQ;N/W!!%:=)K.0,>R>_WB\#;#ZBT7U=O/H\+=GN>U-?4]H\,"2M4?E
M>I="@7%I79^;>HU41RE)"3<P!67;@WTPAA-U9X(_=S^; F!5C:$Z.%;L)[>\
M3A55H"VA#%K;DZ,"=/1+=)J45I6@A1?U>) %E;2.UO<8YAE;/Q<\+0R_@LVN
MYHO:@:[-GY:'S*;M&W2H**\>>.:Q?R]Z+L?C?*^2$&),,6RN_?#N/_TZOD3E
MVQ*Y 5N5R9&K-OG0LYP,XL:5RP@*EB]$5;?HW_VAIH/J'/BLRP<,,.G<#0B;
M]Y<R+&ZN5:?].> R>R+W0 5."+&@+)-G'?_;Q[#PT/G0YR)7S%X#!:>?9VEH
MUM.Z%RS&YGPM:AUGFS3-4T+#*,GITR[XU'E&C>5'/)S-D+9<1NL93JU_0#[H
M1]@&:[1FAUK,CK;G[6I';%&HYUPN R8QIU7B 6Z0!FSS-"^W^_(OG)E_2Q#?
ME$O262WAXD[-E=H=[$8;BSD8*G'2WI[H?J#%?B[9)OTVZ/K,OO:AEVX OIR5
M&RTM5VJW\Y<N;K@2S565GYVB67(V^*#Z=3L[9"0HZIT_%';E\A*6B6;R12Z5
M^T6%%&Q20MXRZJ "H?LDO0+[9#D\/H>>+7G 6'E_T^9:")@B1I3W>A"?& K<
MM^Q$WG*YV;)TF;_%BM9%:7,'@\VK:*;$(E]O%Q"FX-\B^6V6K!FA/:.QK2T7
MU[7<7EQLO$:;W6WS<FI(?A'U2#5M0^U&B)>L4(+UP>9AA8Y;VYJ;A3>&J5&M
M>@'NN7LC!Y<I5\!NNPN)G#RU>T^F'^#[_/#4%*'QEPZJIKAY$+O[)TNE[T3=
MLL 4PI8%N4/*<&I1U.VFT\[%-\*54D/9)[V33<N\8D2$\.A=9J2=4D46;W7!
MDW1GF6J2;GZ ;ZKS2ZM]*6>!9WJ]M91UJP=* 15).A1:Y,5H8&'--\3L TM
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M:B-_M;?H49PJF!:ED*BM$4R*<R$EK,BKK!-5^6W$4G4C9YLLS;)DY(DM'8R
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ME9 /#'$<;DE,E/):@Q/ROI]RT,+:=X2E#GG0&]9<3_25GG&PWX4/G +FQWW
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M00>D::)!X C20E.;9S$JDWFL)KJ41G;*#W1\$\;.NM/7=?RORW9^IKG<"?I
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M]1PV>(I%7]2&GGCU+*E!R[G=G["G+2\MT_$-_8:_7X\_Y1P\VG3J3#NL2L(
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MT/4]=PV79&LW*[ #A6.ZEB\E>] !-EJEEVB1AFX"U'A\Z/(>) MT52(+<=U
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M5R"^X\G-;:T,_)K-FH?#9VFY;ED\4/S(WB?4(A-R6..\JO@"':NKR5'5%=Q
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MNK-S;"K'>(W^1ZI>4FW.>@H17*H$BR,^51?:D%AM<1Z"*WM;WWJ<2-=V.GJ
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MLW 2TJ976=GT_E<YK#8GY/*NPW/FKU_L#=KGDPT7B$TC6?JX!KXH$;OGU7?
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MGRH$"IJS>BI<_2U[J)Q*E5Q$YNO2&P@04"8'F=)C/(M0V#"V[L_!>LP$&E4
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MNY8IED A)3RH4?T>3OMLS\ /CY[CDW<JJEDN)2CG8*;S)17@,ZW)6)<9W%4
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M3/1_DFQW[(J5'>&6FFMO/XZHK&FH=3O"QYRS!_EX)*S=G*0XL9P;G#5E!@>
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M+_K=F,.4*,Z)B1\]1B,>KZ&7?AR)C.@C<9>!LH:;'IO6O.)J1W@_CHV*)?!
M=6.(_O[]/N1X.W#Q/P99"&KJ=9[KG_PZK1I99EF[#R4;WGX77!1ZW4Y&[4SX
M/1EK[5O?;7HWXD?D@5V=DF%?9 9*_FW1)Z:.!HZ%A]Y5^,MW3[*6EL7J7OS'
M@ _;SDF.#@@(S( +2=#X+5N>!9*M*+>'3"\">B_(1+S+_*ER.*?SE!.U&?0[
MNM@?<CACJJ^&Q]D_*X"H-[5,B$<G9J<>XA,?:D#L#5NAO37!HW<O/JA'7C:F
MDMY4 I@;HH'F\]I9W5*X6=QU/2$%6)F3#$\V7I]4[NYFE@!!!,'=D%  ,KVR
M_5/W^#^Z[A:L@>KU8JH>@Q9V2%7<8J@8M/Z/@?.^= 6S-U_5K H8GDN53KZF
M;*"#UZ/KZP,'SV"EO$WO6HAN[99=J-4C'Y '=*ECNTA@EV2CYA\6#%?1CN@<
M@ZLGS,PWMNNXZ%7U!K?.HTH&V2W7IWV_YJ0<_:I?,I!!J&K?7YT?@6E)+AX7
M_1X8 7Y3_A*%8SPD2IT\=^/J[XT4,:CKWB6.UD?I]K35;\@K3UY=T;E6T;>'
MWK\@'+RV[%2VI^&@G+7R*_)[YQFB3FU_<DR)5\Y>Z'5Y?RX8WFSJD<RMV:6=
MI34;_&O%_;OHP<:=*/+] QBXA."(9(:M$3+T+-XA1_L_S"E-?,);6.Q._UV)
M!@+[/;D#HH'(;ER\ >7]WYL"=H.'Q#[_#WW:HY<:M"U/8OYCV+".1B9/S-PY
MF8+M7?R/@;+R:TJT0F#0WF#A;DI=3Q#AU4!0#?OE10)JJ)@@[6M5[Z$!)5<7
ML W4[]BK=#"[WRK[1U;,9Z'1S1MP2QI'Z6RP9K#C74CN;]M^_?.;,F8-7S8A
M&.B$OIF#%]RQX4\#5'E*E N2Q]X/P:"(?'%@ ,DB:B<I+5\,9.Z%A$*JZPSL
M#&8E3'('T-\"T*O!]'U <JBUWCYZZ0SB"U?M#5IT'[63"(2\K4\>E9T*EAT9
M0J\0EP\RT7-3^#D)UY2CF EF:\YGO],6-LS1/L*7W^*DVP3^GLKZOA3@F*J-
MDM\+G"9?\?Q^=RK3D3E4HB%(T*B&<(-58,HC-!;#)C=P\#0CT^/9RS/-O0A'
M>!_FXP+L,?YA?S4\G24 N'HG]J_BTW&Y_QC,CXYNQ 3?JK*76"Y _8WNT[>J
MGK5H*SY=Q"X[:>S: ]MBB$KIW!3ZS:1'4[2_,F.ES22/Z<N @[=O&_1\E&-A
M@,.O0NI8J8']O4FY!BGOB+5<77IKOKHFE16T"H]ZRSG 2NM@![>S*&0XU^@B
MK,R$I0<_;_O=OM5*=33NA5_O1[3XW7QBFW/U-"T-UIDTD8%=15/S>Q5D%,B(
M$PMHY-V8\\OH*9KR^U,U@OEB9[>*@< 4F1X&4FM,6U^L%2#T3VBS[8F0V:1]
MJ1U+G-I:UN/O&0>(#+LZ"7D>X&_?:!V_NT-=+9L<"O:<LURP&DJ>$^,Y&MK!
M)UD+-JVPJW^S%N%9^=ZAK*(\H)^P%$U5P5[<NY9E2J?Y2=[BA-\_> *_(%;I
M534A55^6E<FN@;'D$+[H_MQB>GLGU6E^BY76EBQQ<)5@9H: ?G&8?I?5/@=T
MH?E%K.)]5:^2?:9'NPAJ&RTSG"EQO!J0S(C/3?FKN-I!*ZMC"?>N0*/&LA33
MR4WDFZS90>#5G2JWMR!W;!)IBBMY8FRX\)OZ4I6)7]*>?8"!;06*M+K-'GAI
M28@TN@E]/+GGZ-ZCA938_*:%1=C6C*^UQJ$A"4Q8^.:UA\/J?9RA-V@RG\,(
M=V$3G]5OPLQ49Y<R+<QW)5/X>$59+&B=R;O.J/1]Y?]E@8\"56Q:>Q_<$7LT
M57?"VH^_KE]A06L5\&U0K#WRQ;A>PO@^912#O3U9[LH_Z[/] VS=?8NZ89G,
M&+4VWTK6,WEC29)D6($L;AG'$!Y#T6AM5:IRN/+@H Q8I1\J\]&(Z+KW\]7'
M^8%_-*L"6SY8.=MTG@%YZ,"B96ND$G4LRCY4K3$#?"ES#MU:I$!O_J,*W=\M
MGS)['+BV\-K9B.V=2Q35L'F@0[S42-AX)7A.X%TO./1JY9!I\T2VFSI@?0.J
MDC:A7RF]<A\S01\51?]H%UUF;7*S/EFCU0?O< 1 D#DV$D4JX3R@/;M"&*\$
M13LN3J*?^NSZGN*\#,MS6AO_D*'?3N0U<%3OP@\>4%OQ'=1/8?:38F=]E#/H
MM$*27491RW!T6@#6<YDI,38M2\?X=*UG_D:.67-@0Q+?[^PMT[?6)+$7 < ^
M;9$P7D<W-PM*0YDX4HE2<7KU0+:SG(9OV'.4R*DZ_4*O:S=;_'K;EV?GIB>E
MRGNJC_K"U:$Y7O*]>J#2N ]! TJJ^?K#P3<?>]&?')2=$03B<IW=2'J2$G=1
M:_-0D29P0U =MTLN/ *DV_,!^38D.TSYJO3$X<FXY#E?2)K+JP8J(J(169&?
M"$\HCY_62"C#R5J1U-4.%7RX/-[@+='SC;R!$ E4[6Q5[@WYX*6Z[SX'TZUW
MXR-H0<='Y4%R:\!P-QXAX+O)AC/IF[!0?[\I5%]G/<>%WJ!(?4]9"Y5F.UGZ
MP "!^$G[=HY%'F, @S;)V6J"46RI90B#M%-4HS=5 M='I'M^;2W^Z!'/LX*;
M_@5MAZC*;]*64P. "]]83UKM>7/D[OV:HCR_]/?FQ71Q;QTX1-3'RM)Q9*9/
MZ)I124#UY46GBTO_,7!TU!!T_V8=@3IZX*3W*P*H)4WW!6KS_U0I'+]H.F"-
M' MRT3*&IQ&\Y?7YK*BMANA0MF*2P5(1!RES1'=*K,G/6T+#Y8/AT-[G4J/Z
M984@=;GQ+>[6XLQ+B"&'.$'D:$,'<I47U":$ZS  '34L#Q/";6<Z\O !'^L?
M_C1*1SQO]/T!64D%J<O9>"O;>)U6UH#D&+%E5BC_4'&INI*F"F66AK/WWOC+
MI&LMUU\9K_<4CH9I>K1T.)LM+,!":$>)./L7;T1:\I21:I_[T0ZB]@,6YD@;
M UI4-D,3X%)#=<T7@M](V,H *";O^*&T1H)0-V9SW!27#O0RNY&3AMK[<\<N
MS#^;4/BM!US6MTD/T/JM5E;9\>'AP6L'>@GN^P#9MI7*T;5 $Q\>)M/0J?K[
M;DVA++KA-:=N,P43A3YE&79-4_:V!WIYFU88'T,0^\N&*=DJQQU)=%,5@C^0
M'!#16#F%IF<2(N7'KVS"LQGI+9%#$Z)"WG[$I"1]I$XVXF6'4=EP,DRT:;9#
MIJ-U'X@8$=Q*LJXMDM%W2,U<8>LHGQ_TD]I"4?_V']S B*S'\EP!5A2TF',\
M4'^KN_LF'O6$&3>EK/74%*4*&X7#.\HN46?7M47DZUY](0R,K"5K^ C]=E4<
M+BN@TDAVK,8+9W>7&.6M6CO.F:::%D]9>W+EZT/FL]HTH8+T=)@FK 1477=8
MLT76>AB$%[7N\0W'T-#Z837Y^#LA^L#Q.\KCHX LE9PIU#J$L^SZT-&=2^'%
M9Z3^S<[+'H,7?\':.E/XJZG HDM]0S^18=3WQJPC-PJOA^V'/,O*44G9/8+_
M8K?>K;ORQ7CER((M^!/L";* P/K6A-U@&CND #\4-/A$S(C] RQLW^UYK2--
MB(V_9).-+$/'S_KB[9-9#/=#T"/HP9)-&:JYBU@\;T)5?K!6OA_\OGS%ML?-
MM"E:C4'4QNSDW=<VQO18]MAI#5E)J)]"P#_&>K>:$Y?A=!\IF=TU98;9TA?@
MI"9M9)9'^G0V)%RAXQP1+%LOD#&UU,)E!KZM0Q-8LSOYZ6# .X6?B2H1R-&;
M:J.@J?5?L.P;(I64H"Q; >@AM%3S$>QV19!4&@E= _F\16-\[>]87F#@T->F
M6$TR%2K-M+A#Q?=<,G/#'//SXH6O.\5Z?"3<_:WWLP-)J^0ORS8P\D\H ?5O
M<1>U:\*,D(%TL&WPA0?)Z(D<F[Q<M&."MP;,I\+[]C@1D%C15SN@Y$C("KQ6
M^AJ5UVF]U$L:-]R!T89UVU%MG+.1D;:J,+;/_@[6H1YQYF4BY6ZPPK#T1Z$N
M;3Y6>5FU3M%$T2AJAR*?VA;!37E]!H'RZ?_5;=@RTQOA_VPC PIJ^/VBCFW[
M,#%VFM1E]YK.MAV4.^-%U*Y8?;#)MQH"A:P.B"T5B33#<<>PK&I1Z[Y5.XG9
MR6\=\+1UPMD.QN=6V2:)RI=S/2%9L9#Z[BG>D8/6QCA0DUAS#M9,49*?J86'
M2)EP4(/N]4 Q-?9/D>"2@K1*W^*;%4-33&AB YOOSK",./!:(O=QA1Z<'5,0
M5.F-:.$EQ(',.H"H8%Y*WN"<G7(PV-W+C=Z*6X?4OW28+WD"$V.C%9PF(.BT
M--PE1M!7NR'!2;T-)S#'Z/G7!3#DXI^'9\5HB(BHGO,X[8$+LW_18Y6?@G>G
MR@=%YO2V>@,ULN*AMYE=>8,DNI_X:39WD14CTX!'-?F)97YI5O#YT_1+2),+
M.T'@T]B01N_?M0X6;U;F&MORY2QA@GJ-V3V+WG^8[_A;F<[<K[D=5 'VEV"L
M21Q*::?FXPH\:NFI TBOGNS//Z_Y(<I S1DD1_D,@QS4G)(JEKS)]\A=$R99
M[:TVR-0A%-8-!1\7BK&B:+=7,RUNMY"\ONQ9L@![0] I\>;+C>]]E>.LPPA5
M T.IP[\_%:<+SE4?3#=$5[/P6X!:0R]9O[9;(]UL$"&&)YIY<Q?)B/<0WC^R
M>3MD??JJ-(.^87Q\3=2[%17=+@'=>!""%X72<RK/NM+L/KO.%IE0AAZE.884
M5<9/_KM,;04GZX.]3S^!:NQ;&EP,1T3A)<%/S:X[^&Y8GKKC6#G-$[^\H;O:
M&'!K3"9<@8NGBM"*V+@J%.UBD+3:'\1^30KBQDP@^9&#(R\_7ES+W-MXI=[4
M'9%-F:S=L+*;R>-K93>QD T A^CKWT(^$75(,V]NO4)DR:8OZ%:2'LT[\?(S
M3'[6KWTPQ9>A=(53MBE/*;2ZL1&O_ Y80U$NB!T@/ NL4."M_-KF*M*X7'L:
M 4W.1E>S DJ.+6]@ C_#0*OJ2)Q2PYY#9PV>70!6,F^?7-$\>D57?2F^7OU!
M'X4DF>*?,=^AT_TK)X_M520LU>!W6XH6LFEW9P]BA:[D+QC5#_[58Z+LT2QK
M/&MP2Z0M)'_DS2[!Q,$1D^P0)& 'LVB>7O!H_2/[6HK 1'MB"FP<K_B<@A![
MJ\OR[O!Q&:A[BQ;9)  +E1PFO:E^>(HRE]:[]V_MMR3U2AJ_)DNBUH.CE7$"
M;&L223W]J!])A[7=XBY>_>HXJZ'&JMN_O7Z;1TX&'"C*>2M_C(6BM4ZK7/-!
M&B0DGX=U&E?(:RV9%<OXKHJ:EV 59-H76N,J5[!X^OK-!:JTI.)U2Z-;J=1$
M^\!;&PX'>74OWMOG\4"I647#:I5V7U/4\%X^GY;JX/D85PN#MT- 1UJ&/ 2^
M](21 XB;R-T!],?#=#-J*8F%K,K09P?@\*B80&%L ZW2!MZI=I";:06^N<YE
M!6:Z#^:RM+3VP9267_B*D   07JBEN>?>.=QI7BW3\H+>:N7%N(,F1TF4=X
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M7- J.<WYXU_V%!K7[1?^&XX^/6,;EL?GV7#!^/N83_KWNHAW]C[TG(<$V^G
MYSF'Q;:=]CZ\Y>:9@YH^ RUH2^VYM<9L P;II7O""9A)CT<\Z+*R]8#-ZTQ=
M!5,8@\N!V:9FPF89ELW,+]5!6TZ W5R(KG7Q[H?79_@8XH83IM1;!&"%.L8^
MIMPT QI<*7U!:N),4>AU;*A?\(>G?DU1(R1$QI9;D^K[$1,IM_@FARXD(_BQ
M,4@[_;*,VFLA;H&S%R8/'.AX+#.4CIDDW<RC-W<@;><*0*'5,L;;HC\ I&1#
MHU3.P/&NGTJ[=R<Z(['OU>EM=SA.@H8'>I&?>VBVUVNGV 2&FQ9U+F=/#Y/6
MK6HB@@D6/%SHZ*2(Z$[#<ZCE*/^EE=I7X,M);&<_>1UI[T:+NR=6#+3V1/M,
M_#BJB2FD_0\I9]8_<RZ=6T-O:HN$C<T9R;P9U2:MA%J##GO6U ER;\*R_?-;
MZL+IK60E,_9_%]$&1TVL ,S[L5^L $PS;^*\7>T;Q$M[E?=49!@22I/+2O2\
MCY@6RL+Y")O+=#1H >'S0EF#THI&.[0&GRG,?0[(,YY?4#D]B03$YSLD11!V
M'"%W/HT:6Y5J.S2=P03!PC#Z62*'5;6WX<$2S++W7A6C:UQ7JR36O5_J&V-
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MV 4 Z_CY1>6\(JC2)5OVUN!"*O1AQ!Y4B6E)B)05[%>PYRC;(QA6,Y3X'-'
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MN]TF*=G6U$[V%=6H]!B?EQEH=R"+R$4K2M9?"_G'U %NHT..5ZW0NJ](=+>
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MDI<<[O?JJ%OTIJQ3?WE62Q/O&FKX\H6]'[&?:OXG;<$^)<LWLMC<#SJ63&Z
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M"1"J.1G8#-;$^FE##4A@YVKLOHZRAW,?WP%V7R-G ^*LAY.DFB0\.<)*2!T
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MO&;Z.*65"\VXT8A.BK)Q G_S]F=O#[5<)>:S\Q,<P>._$M_Q$>]SQ%K%R2$
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M(4^BTEI=@-0#J!C99E/+]%U[:?RJ@F*:.^1,_E,Z\9B]ISMGM.B0>)?!DS,
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M[M?:4(B<QTOZ/0%L1LCX3-<)EQU?Q%QR.NAKU[5\]($QZ_'-0:<[1>5AW&Y
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M22-).O^]D+R<?=O;UC9."=>S]#;D81&3! =RHS2A2_MI*_(E'NGFR559$XM
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M5Y5/W^;)*HX2E-(:H.CK-KRX7@[UL4,HC)S&R']%N_&5OSW75Y%57B;Z@BN
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M^P0L=X<(#1#%GQUYH8""WBH[ XV^*0^Z1,MAZRO%<YN=:G5W=WM[_HRF0G8
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M>O(E,D]=+YROG]4X+[M=PWQ_K?K\HP=IE(!3<-:RDU"S:_H-;^& 38&!3G)
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M0#]H7\!V&3_,HRKWU8P&]DQ<3, F?!TIQ_@TK3>?!F#@=W8>6F$O8F1V9Z2
MF[6S]SZ,J9J\K7L/CD_\0E G2; W_0;1BNH"!M0D.5#CR<N$$?<U'NEM3TN
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M@/O[KW>]#'C;X-K.%=-->_H]4J?K=W2@+!612/&XBC;/<?E84&+!YLVY-5R
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M/Q*BJ:_J=7>M;/3SB=.BE:E&CV/[N?FIYM86H[ECW*_UW+G^JV" ^+2:?SJ
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M=#?XVM4LO;U/:@A&VW=VE6C+3TUX=@/P+*/49N[%A&"],/ *[[!8ZFUZEG<
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MSD9]41NN2M#Y$'HY.ZKC]EI_"#6>F(6^4@Y&4[>=.>4LDJKYO"WP)"O'CP%
MD\E )H08G,#_8:U#;^@L0*;,NB+PXX/K6)>>4,[US(<H!N%4<P+08&ONNQX
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M1^7^3/P(&G1O81O[FH;GJG4L'%DN?9L2*"W7++ FG4;R!ZL#SIW!>BX=W@V
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M"EI%7LA^#CWH;%*SE0<<-+[S'_LJKKSSO2M6H:7G&=Y(W-+?3^ZP$+O"S>4
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M0I&_*Q%P+3]=KO*#;H[!P(T&RNV*.IM.V/=W\BX)5S<*UA%\6V93D!6#MU@
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M0,'F5A6\O1?;XXT<WRE.+4U8R4,^/>#JCE5Q9U_HYA0";Z-[6X'4ZK2AX![
M&]J ?.5)&:Q.,N_S'B)-*WUP:DE&K'R3=FU699&EM_\O^RQQ;?K^"O#3X )9
MHNNQGC9SZ%*G*D3S%QXP^3/O .6\#I\K.Y9W6.,TNO@N'1S$:'W0EPV8_%[K
M[*&I4>*/C.@:E,.Z.XM<LZHU;0#GPX#)6N-,<@.HR,$;&V4&%O.Q<X.]9,F?
M6!9QO4^=/ X^]IK3]Z:5JVRSB%ZLS_G])O6):MT!MLUXD461>GI\Z[VJ8>>-
MLG=F0FK$)_Z1YC;TPD=='(WZ;K:>O;NUY#8&ABTN#*/=]%MLY-A0JD.ILVOC
MR;=5+BNN]3&[+[IU$TN3B*._5"QPVR"JJ8X5>^<!L,G4.F2CS"VU90]B7DGB
MBO<$T10^&8&>K(JFVWC+;&!U- ->:B8)Z<SK2L>$6IBZ(7([8<3:F=&TY6YO
MZ,&BLKY XVJ^>=J"J%-WQAO]@;L=_$&'/[=AW9"?NT9QQN>O"19,LHEB7M_O
MCK;XPB<;N U$*@Q#(O,8LA';CSR1CQ_#N32KA2=KMX8P8N-'IG:\)Z472.#
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M9A4TECFX?TQLPHO,8I6!9G#=NTC^.&^TY-/!<X!D4F^8>'0XV.J9J,-0\?9
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M[CNZ-WLF=2;#?J9U7/2"YCI3;XS?78N8),>QCDU=N@W3@EGZ&3FCJ-ZP8HS
MO%0Z?>]<*[,K9%^\>&QJ5'4^KN?".@BHYA3]XRI[WI5ZX\D.NM0^,P^NJ0Q_
M$*#=^_B;F-X$HP4+X0[=FG>9/,!> ZZ.>CLDYF="Z%>%"T,JI//':*M6B;"D
M?9"2"K+QIL([!EEG63&UU%R^6;VT:J7_1YOXCN[,_H<V\8$?)OU'#@'>>W"*
MRO53Z/SS<0\WW?VQV];D+Y6#75&\>EQC7*? >.#')A#D0SV^!61S K=?ICZJ
M-(=BE>HNRZ5GIU<YC2,M-QX%OKM<5H*$4)4@1:E,-5FMJ)'WWE&GH><,P>AW
M+'FMWJKAEA%QLZ*)Z"H[[\0#6S5"H'4>:IV >%$=A@.9Y05PU2?#$TN:TV&;
M@0IJ&[T!V7X_4Z&NI9V-WG) =_/*"@& *[FDCL/4G. 6F&AJ5(*\PFJJ24UO
M.I&.? (R,]4T?/;( )[^UN/+M>.)A$=FA?7%M:9/N1P9#/MF(\#2:"IS<NGG
MRK@RF@VN#%D3&JXT4:)..SR5X:D,)TZD1W*Y$-28=V&-<X8U+F AK],^R>^L
MGB-*QWV5&,ELI73)&O H8?\/EU!U]W;"(7DB;TOJ;<J=/#[X)"%\":X!3D#_
MB7&]3_\N2 K9[BED-^@)Q:IV+)Z9?747PHE<:1:-_\D4'$XYKV@ZS6'AVGB6
M)*9.\-)0 "15'F,_JZUCG*\Z9-?MM)++BH+KQ%O'KFCVFUL(8WZI;KXBU3\^
MU+3[!O:PEA\&R9]4'Z6=QMZZ_2,P8Z(EPGR??J6^J 541?A=TG;J8PV:TL;J
M'0%N<TV1T5(HC0[2;:UVS\5:K>X-K<D'+#XEN48P*DC%9%7E>^K#RDG1PR^T
M=V3!DJM9S^B*/24]2<X\]6 Q 8N@&[,R.E.9GX+4WK:+#CV@,?<\3#*CNU:O
M^\M35'!#EW7P0]0F>[E U*;EADV)H";8C3A%3B05J"]@Z1X)_"8%?R.8I?RT
MW(HF2=__T"[JR5XN]J '[DP?8>Y!#11=PX);R#FW$?\UJG-E-7'2$^AE4C.5
M.6M9_?ZZ/<&)CT ]M7M<=K>0\*>X(XNR\#\<R+;2]%G<&?1-Z.B%\T3R\I!S
M;/P?-76N_WY[:P'E)/[Y2[6'*S+TH0T_#%:I[EMILWF&ALV^T9!#-MJYT^6
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M"V^(F)\>13+2T._8)M@7?CI)D4]$74E[M(2-NKH4*^9V<HA/ZQ"!$8]SPX_
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M:%X,0^J\F?JVHIS-^9HO&>IXP]X&DU(=_^8<CP?K"1CC=,<>6F0/AYH#$FQ
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MT"Z[^MN39_AU1T()",4T<?4)GU<EX1%T?LR]S8TV,2EPJ0)4;CR1>I==!/U
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M9Q5ORV/RGDW,GTXY A<G#!T/'AK8T_C_>G_!_SQL(V=E!#8=3K5W/D"N2SE
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MKP#3[D85K>$"^:K/T_M2+^D#2 9OCJ\Z&Z[8=F;\4%5T%SFS>%A'AN,+8Y0
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M@)IT!2B(6@SZ-'*7-\9/5E^LC3':SOG=L,@W\%K<Q]^;@8QS_,E8R8_0I9T
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MPA\Q"L *R8DUIL3I*DJ62FNTI;WQSH= CHXJ\\HN%"CUK8,;.,-+G<>60C9
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M$O:PR7O0-B^_G,$B&/,L+H=-^R;$L[.^=Z[&*5FWQ9W_.IGG\;*71,BVY6'
MGR!"[=P/T#M_MUQJN5:NQ7[)KVV;KN+BC2' STR(6A N%*^A--=T6U9,J&^?
M^?K"+((C'%0@BMH/Q4M8JT(X"CY&,T<1RB@5:<;R>=KQUQ%LYO63)4T)9@]?
MY##9M!86] [UFZV#I/]E4[,RX,M<B;_WF,T>^EH#;3JG$T>D51##A2JYJ;'Y
M/%XP;IG@TBR#<(P%=E0_^Z+NHZJQ+_"<<Y@U@)1K@LD-[4%4'3.6.Q7 !'5T
M8?=EJ"#5 E&4EV\0@V8GCXC@5X@!/SF<Z_=BGS" ,2@N.,2JD:(?1U5;;6Q(
MQ\A(/OL^R3>/W@A3"2K(!+71)O+J"3'ZR6UM#>):/=1[!X8WYA0L".4<FC>)
M8B/[KV]RP5?7PQ[(_S.1W[\4EHOJ^V%JQJ6QGER=$EW-Q<:#EIFT#SFJ5!^#
MD5]:O#%?"8G]2S'YX$6\==B'DW%CQPE'_*BBR+[2)S;K"^C%7V0MA7G;S+=7
M7$ =DWJ+X @2SB13NG7\7$$W"5F7DI&,)C&/)#OB[A#1LO'CIB-\TH&WQZ .
M@'IA?ENW>^K&<.%Z6OV@@X1503K1,,H#RA N[<X"HJ[)>@^!NNU>X$2GF\0>
M]\T]5C#+-I0HW\ K_C*(RX7\OC79J31H59?DLX2SL<P:FBJ%=>^:(R_%W:=%
MK\,@(4$!O*;678IXE1N : 1W*E=AZ4^'-%[(ZY\/S38H4Y*SYU_"-D::PZ 7
MB\N25,DUF_?RQ/$)#3>@)KA'S7/5]]:[<Q7QA:8]DG#:Q-F"CQ4MBBB*6L%[
M_J7S!<J:Q[B+H/.*;P;4SBB IZH?=CIW?8&1?EG*WWW7R"V/F_WQ$G9P($00
M3X_FI*_II'6U(#*TXIM)6O'C^4<9DV'?"$-/R)IB=./ <BF:@EGDKV *V57)
MF$I<V>57PI" :@0C\?>M)EAR*1^#ZT9@%X+_3 -=,^/9:R'E- 71EREXYP3I
M?#\$[GEFM#I<6>?:!<SPK99=];CWXVY)3;HPQ -:K/(+OV+!)60JYV0\97H'
M&V+^R45Q!:9T&W#-\'X!UO/:-.5BZL6OAL 2(5'31]?'906K;9RF&Q,>^;L(
M5CK&#-2O3,?=6E(6N$KC%-<E'$S?OJH1]?3(L4<<T^FG,'#[S<%<@TM]/#/<
ML*^MWA \%O9FW"P<N:2K'4KU&(XV??8 :>_V3;QF&SW>^"37@N/).NRQ:V"R
M(3.#"0QXI30N_ _VX\$CF<+T0CBYFLSE,ZCF%_WN([F_4/DO'4.9?T;;Y"=Z
MS)@(X<Z6 [6*TR@EE#M/D4_%0@P#<#)Q93::)#T,E- 8 $$??VNH-UDJ*S<4
M S 9!"^5F&J"EU[;,#K9QE.1NH,&QPD&=P*@MS\Y^2DPKM9,O'QIHYZ'LX3:
M%G=-:"'G;%,D13670T<L3JM7M()Y%WSS\7[44C/N5O%E19I8O+N"B0_CU$K-
MJJ=(%[N9,4P&[G4>[>XEIB5)D[P@X]ZO38,]8#8LAH/IQ'B*)60B63$Z\  9
ML6=T9;2BDHH/5SZA\DJRR!)T:E&:@N1]WC16WWH[0W!)EHZ:F/:S>TC_4B(<
M/O;SW,TQU2]Z0/_RSL35BU:[=Z>>B&G (@PO"'_,8B@>I%-&]VN[-Y6=J\?<
MR-9;\L2<;S<WG,Y9OJ#?FLQ01\OT/(<Y/GYVGJ.H5 /F.';.O2E![Q3$$UA
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MK.>2X+_V\J^5Y&&CNH ?V=<;TL&G?3W5LYN,FLSEKS[XK%BVRFW%(R?JK[
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MIT150<^B (:DMIJWATI\4J;'#T0:F1!1+E\1;S+#<SO\\"VR)I.1;+;2?+A
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M#0(#",4VBB2RUGI+W[/)&!^NOW7FO6?9%0KM.[OA6:>_3RP^$S ^R5I;86_
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MYNW\SNN 8I;@G)9$Z)/ZR6YT>X-M-PB^ZCW-'TIFWCUGA^,45_JVKJ:@>RD
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M[A!]CL4'Y]>(#]2B"-C(_.M_N,AJ GQ<PX.;R7:U>:^MMXHZWMQ6NEM>&9L
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MV V:!5*K1?;COW-!Y&#^ES+0Z_MGSWW#T"/)G_[0E;]N%,:WI:O_!)]5]L@
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MP? /W3W1 USHK7N- /*A3NI*,;1O>2*NP--:H*E_'CV3:,Q-F+=4JO6@:+2
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M+7OU/%*CI%MRIM&MK6G$49YJ?6&^9[,Z:B#PB'"].AN>1P <J[F\2-3--H[
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M7_;9O3!U"?4-@%(?AJB@[7-WA M&<BSG(*-+-33#XMI8!3=6=&8G'@SB%@[
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MTS^:!/5]G4QKA[UH?N-&QC(7%;<W39=?QL[8A3<1[XUQ1\,W.=R=+Y_^J!.
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MAS4-LTCKV=4XLO4WA3\"P9_Q0L>E-/.EKTJ!>)U=U^,: C(/Z2@;;KI[)\T
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M4C)X %E';J#H8TLCFP0F(;'TAC/1IWZO*KAJ_YKA%H%903&X.G*KWSNX^MU
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M))G$O#?J$*(]:YW&US[7X%@-S!>PL]V-;%I4/3.YU:>ZZOUR<[--^UBS:(L
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MQ,PD&@&]B8\X"R6DH7PEXT<60I:32(C3&$Q/"*N G2]O4N?I[FB1+2!424W
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MX?5&BZ=6#YO9[\,C!LQDX165\RJ!*(>M95]QQY'&KCH@:GC-&^AJ$>E8!^<
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M,B: -EKTAY(B_Z+'Z!!S=^&, F!39;Y0^T_;BN7WF>!PNW&[0Y&#8<F2 /%
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MK/C "/,Q:/&A_P'I ,*(;@'/9D/7I/\$PJ'#HP,<,B%8CYZ7I4$@3O D:HL
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MLX#\Z:6<PH14T,5>7.-3/&/M\EY13-D>:X7R:+AZ"S7ZC&LKI+:473DY\^7
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MT$!";"IIJ"U<!PXU6*@!:0U=OW^$=,S:)G$9QSEH@?T 4ZX[<TGPU&^EM6R
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MX "]^* 9;^<DUJ<$SQUP;HF!IS<D]-3P(ZC4^-'3==8O[V:2HL;(GF-5CT>
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MX<W\T]BWC#PS>M6?]EN7;7UM]/.9BTF#U.FKPFW'7."H3))+Z\;^:SC6ZL[
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MA+ZI87'M$[VD,Z+69'5>T],$G3@HJOM1X=D9S/)XCJF)4(&D+Q31H1]3>K]
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M*J3M*+@R5)>.DEQ(_X;$RQ-?:?/VN:P,6VY2 ";F]6'<3[#X]$V/7Y[AD;(
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M1Z]X763G?%;?!S^'Q)]9A DFY.[5\USQS(,,I=4DRG&UAGS/.7J7]ATO;OR
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MO:UN3LL>G!2P.(_Y)?@>21G=#,\YH/3YNY W!<FO[W+BV?T ^M>0L;%62OQ
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M6FBA(!]<\,/PIW@=3XIP<-FG;(I2,8,=V9BDWT?-K"N]6&1.4I40,=24VJ;
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M5RA#5 M[[Z5%\O/X0,V.@]TVR76GJ<@$'7M[J/0D1"5%=I%L:\_F]*T#KB,
ME7#MJ2BH8&#N;Z8T?PW$Q-L4@.6]P_4_X>CQ&#)PQ/\[4WF$-MSY 6>I^+.0
M^YP])7U.))4P2%.*&K)\J#:B0<@JDG_DD:<0Q)ZMNNU5S;\'3K>GA>(J<:0H
MI.#T3+L$LTB4\$O9 ^E*9,T\ C_!3E&Q,4\I/5VX3'Z"E[61(QM;H;-?KV[G
MJ1B0Q]R.*;QKE0C$D:8+8([LF=VB0.X?QH+^Q1>=,;*&.O>?T)/CM4=>D/2O
M?BNQK!O^P2!*H&8;(Y[>%^32W3+^-?R"UZ2TS+CS!3M*)$]S2K268/Z#8:7(
M(B%UW4PBQE/.4^Y/K6=>$&?MR'.$?>TD,UVB)S#:N$.Z2K-[N<02^O)]4TRQ
M'\;W,.\1-+D(X4DGCPJ0?Z4W#)1'O7Q+3ITWAM(%R!V4F&MVFIL6UX>Z7\06
M6]8[X5;IP"F>*L%%<$;]J\^,2U(^6I@Q7(-C$786ZT4";-#GT!3/^P^Y%X=#
MM(L*??(@G/6\N"*KVBPX/0=)#1XX#*03M)*QG)!K$V4%!Y $NL#R%IYK%O0<
M; "KNR-'EI^NAD;76.; XWF%+\* 8A8>'4KN%PSC<12>&,P%A10V!D-181C(
M)@'Q(FE@U9J:468,C5&FJV(FD]\VL";XZ#/5!!0O%;KF0S/862W;=LRQ!DWQ
M7W6WS*L7K%(M+KP9 GF+;!+ B0':/U!/(?$^)@@?^]KW)#IM2PG+=K[_2L0C
MQ*SLK.+0D1O %7@\%7,#8+$YETGB+/H::"P=RXHWZ<YC'A8MVZ)6&+5[6J [
M&-@0H++5@P>96V"!MKG48AWM:N8:;J8BQL"$7*ZY<HZ5SX'D%]-M66=60&$6
MQENB)63D>$[M=V64[WY!QEMHP13)A'*%F4[!DE]HR'0"HRG-7BZVHW^'M3&/
MJ7I$GKR?!;_ZWI/['WK-S.[)%\2$$3F&%:OPU Q25\ 37H$N2_& NUT2RFAP
M6O8;^13W$HRFR",>_'!VG%D+CF3T"'[=4!?AM:K)8@(:$&4O@CZ5PS[LZC D
M]]*Y3@9BQ^'DSW"Z]^/9.JQTYCIL=UG-=>A8\<8(+>.[0FIBEXT-F@HU@'2@
M0!7<SFV+$)L2\3#$CUL!4+:0(C51"!$FD#'QY<"U@>"WA5G?G#AR;6A!;F'6
MVC?]NCL<#OJ/2\]76M$C4IP5D([*.N'*R)PNQD==X9HS7[P)LH\L7*!>#;\K
MH(3C2+5A";A@)E_*;$;W%8?8DLK-KN&&RFM:NY5LTZ,=;SN>>IB20 U>1)^T
MTBD?C*N,; 6TNL*V$ICO/X44\^LA"#CW^E[%6 ^GCJ35R3R("Z]==<H1Y2Q[
MPO/=DA,AG_RQ$N/D=.)/M;/Z?T!7H JF352B8NZPW=4O^D$N:[:HIOSW\O.(
MM.D'*_MED2HN5*8@1]E.G9BY).,] 8L"?/>$>\AJT8A93)N-#AB9&)I@(U:C
M(/<=NE=CJ7??S!(LB*#G>DZTM0-[R(!JDU\FII7V3E+>.9/,4X=O+*1@/GO?
M=V$ /TO.B"]=P!ETEQ^[XI_<IU-+*PA-CV*[FGJ5((XV,6"QQN!Z-*V]5C'R
M2WAR%>:B^V-$VWZ9.=&DV@+&UV?N>8A[XIH19O9")R%[T3(9.R[R%+7!]K +
M?#@B;Z%S8Z,(D=M77!O@S(;)K!\O<2GV+)(N:R7/FDSHCC\5V\=.;&@35)DO
M<^ LQ/W+&/5;Q )%O/HM;5&I9 NN&/LW_^\(N5GR6N=5^W(1E MS45""N=8R
MUO!B)[K4^2L.@S<DLUR=ZL8Y(? I3<7QN%0[%OU!\ZUBV6'WM%AODACFA0)0
MW W+("Y&[A5C\W#"0G#WDRV\EK*:4(%":(=B<!EY>[2#X=.)"D6T6FQI?0G?
M6VMW$^)#,N7).;@B);< O%H]1U0+L_J/(G98=+$M/4#/>$KS]A+*B=RG>1/X
MD"MSE4FQF#'#V,;.J51/6*RM3_^R<RDG;N" 04&.7GA6$T@7&EIO"!,7+<$S
MOP[@+K/102,"(& <"/<?>$UW!B%*>20H2J(7,Z1;>L$(C9RT*"WYE,>\"S+@
M3@$7JR'B8C%/%5J4_/2;,:D2=]E"K5YEFK#^E^EC%,K64*Q/CK_)K2 W=< 3
M;\XI<F$T]+F76%F/*23OBA))I!2T"D* Z=<L"+I$$>A%-81_V8$,D.%!:1&;
MB%R<*+VA$=ENJ4+9M>#AGE$62WP=)3H-OSZ!88*SOW\OH<^' UCA[S]LE/7#
MO-+!H6OT^XQ<.-GSS\7J92A^1V6/]4B"_B4CW"WF5WSU5_]\!OL'A#(,UR2-
MW#I&X/PGN3XJL)G,-I&_"[E,'0#3%7FHV;30O@8-T8HF5^%KV 3X*2#R&!1A
M_,E812?EJ*W9H\MI+G#C+QW?E^B02]\3#WPC@6OM2T0-PUWOMSOGFX8G7%$W
MJW:/XC3F9\^)7>WG=9]-.?-M9M;L[*+6\!5AES'X(T:O8[?_1^RMDRJ6.SR/
MPST;++<,,=+JZ<=N4GW\LPY3_%OB7YA/?L^2IF?$75M^&64\<55' UF:^.QW
MV&?\_]VXYXW*^TNG'ZE"HZBK$??N?9@GAE/F ?8I/5VAJ+ / TS6G2Q@N\XQ
MO%]VN8Y6?4#0OM#TCP J$1WI :DYENIBE&=XL.:H]H]V@$/+H>WCW5^ (6@G
M@\/TF'"K>O/2&<RJ@Q!9\( 4WO5SAHOC[)-#2TW;^<.$ $V'1E:H'/?<EXM8
MLI$V0Q<V^$%\*U^SIZ!X%#;"J=Y\IO/2)6!T9; Z8-EZG8GXGG,[IB2O#R;=
MF_3:3"O@T.^UH];QUNSTH'2:\O:?L'99J-&,*%N3$[];&4,"THFZU]\%[&R_
M,I&+J5W?^NY\ >DL6!4/UEG*:R!>Z2YC;\H#4&LMGLF@JJPK6=JU'C!]EKIZ
M_&[6I0_RX'X#S&*\JMZ#*O,VL?#L_MS@P__7J6-M[87S/>B76FVV9]ZR-+_;
M@U0'0SI>Z8 D[-9K/8+Q;3[3VK]<HYA/MKJF&7?'M07_ %8;O))/9V@"#95W
MCNV]!3]$DX36OX>K$>!2;K+A#67@=";YI9:2KIS+[E#=RXEMS4%6(] !5XZ.
M -W'7'5!OS_)0JGK0FMV 7$=MIP5"0-K+TG^HO1EMKT+$)W9%I^-)<>L%M_5
M<W=\6DCT2UQ:7L2#GU&WO:P8\>395ML^#S<EMMWZZ/#'G@OF32V?VR(%?FO?
ME< L83[=/J[7O)/4.('9'F0/=EO?5?&H+,4P-M<_X.RNE-FAQ08!/A!?/0V?
M5SB5>^/_#5^GP%U%LMEA3]BV4^!=DR0UIRTU.<D61)^"4MO!=@KTGRG'0@.
M9^S@FRL6XGS_B++ZO=E%418H2AEDF DN^@#J0D #V/29EK*U5HPD'M'OQW,D
M8XK(J$ER/&N%7$=*:?E8+:M3I.-P_;CARTD0J]]?NE'WV,V1PJJ;,-28*U.>
M\R#B(B1!'>W+6EP4X KL%*%?.X)/M*Q<-W2-?&;SQ$PH90G:V_3:;Y]@4I"?
MK$9Y?L'^<O,["#%T)CI "JV+["I(Z7EF7QD-U)B^2W(S&^(KQ$45V>:<05#A
MFL-[2SR0.IN_=$701.QS/M41O]L[=MN3M>$M!-L3V7_RJD^O(>DQ*ZK/D(O&
M#Z@-V-3RT4HM"<;[?I^JLI[S4#]:^%<$&:<OLM5<1<O+2*6?A%(,*EZED R$
M<C\#WP6(RL"FW[/&?U:,'+M+Y]KB^%6=1]W9LZZ!GV&E<]=Y7I4V'/G?]G+,
MM#Q@/+-,V9/O)LQ=MI/1Q_$&<(A'4@'B6.G HDZ.^Q]'UQW4!/.TL8"*(H($
MI0LH4@2DA%Y4I'="$@A-B)0DTHMT+( 2FE0A]$X(240()105I!L02$&:] [2
M!43>S]_WS\W-[<W<S.W>SO/,[#T[=[;EPJQ0G++BZT Y0=\Y:9L)>VW-M7<-
M";WWM?;]+9J4H1=R=R%[DQJUY]!38MN)% KOX (_5%> 0*N"/16$)4D% :[*
MV>WR_9%7%^_-8MTC7O0HGGFW0?%3,TMURS806/L1?KTTQ"@ZP;K>.(ZV#),?
M:Z_P4JEL>5@5D<G--(<>;23;&3\3,MH5NH%R=/9ANV1O=%=U5N#)A$F'ZF*5
MQ[%S2SJ_6^4]ST#?_!9&T:&^_LPEV'("JR\P7+OX2-AL;+THN3^9"S;ZMN3F
M36QV$*/$3,P4<)L?@Q/!D/LQ<26$UV)N!N55!A5 G&($,KUFU_2:Q9@_!!^Y
MK]A),>3= !8J&/UX_@0BF^#9-ZIZCN1I4Y %"C=\)G./'TYZ(#I=D,Q+Z2JX
MUWDSP:W-(6W6=;*\]&%&+!^]K??P[\SUP*4/3K!#>-<4GZ?6L5[7?12Z;$23
MU1/6W1"L/:?XKM@K-[FK-:==F^?\PID"[<3(2,-9Z/# N3G!_;%@OMG;B7XO
M#$*3]DHLL"#]E:7HE@#R"_,I=ZW]58SF-#F!?[%-YE!]UM8[O"!'4VJ-R%S;
M[Q7-L'?U3_6M&==A65C1T:\GV%5LKK908H%NEP!/[<&&,+R!/[C4?N2!54HR
M\ S LWC-\NCN<%6[2*(9<@+I:VH0@I,KL[QG,U)F%X.\;6^]G=)H_=&R C5&
MPC=#I)OI)!RZ9SG.Z_$$*;X*=H0.QN_?PH/)KWWVL8VEA)"HMXH<(C7CCH:S
M$0(;I2XX]+&ZY<A)IP;TW*SVE?@7/Z51ZZ)6:GF*$2.==7E(!ZUIU[>+K6'M
MCIJZB?]3#,$$)W=XNME4,:0%L;X5_0GO%)QN9"\TUR7#\N!K=MK7'U:*\[VD
M.*GIUA?F<2VV>6X-)I8EIOEC]ATNS++&6 PZW5A?TM.W1DXL[YN_.=B5$ &>
MX!)H;?SE=AS)?<WC47SCW[)D).SL28VKNL]U.,I+$/WP+F\M_MQ<_6-(R*'?
MC_^8H,?0IB-Z6E10[H<QY=_(?&&.]1\SJ*V-W5/B'LXB7-O5^<^GX59L49W3
M)O4*/>[O6/*SURGYWA6'-[SD"\H"8=ZOAA[TL?<U:-=).V\69]^-VYCFOX\'
M!">"7..=KHQW)%31DT<W/*$JCE+OVK;G+=VO2KVGG8J<X$EKJBYE=<:D!DUV
MRVTV$CI7/@'*3@@W13-\..>VB5+;RLGE*4XH1G(PKNLW7\X2<' ?-IIH5,$L
M(4B;-4>W>4U_/"4M.(ILES8DC/I%\>Y>"G>0_MHH$TIORQ%NZS)#&3SYF_11
MBR';3S/V@-)DW1KAJ:A,<JQ>C@:CN#ZINJG3U6'YM>\M:(51G<1Z!(6_2E(=
M<"+J0Q\1O@O8N_$J\.=DX:3C&4\OSZ<7RD*U7^VS<-ZB1"0YH<G:JK,:'R64
MX<L4L:@Z3^ H8NNDN%&;10ZC"%Q1JO%,@'[_@RIX9X8I$Z$BSU(5M":H.8U5
M#6SV'_-^>#4TN[2D65U2 +M&FG*T>II@C/,R3_<O7S4W,DA"3DA@L )FW#P"
MGTAV23]O8D7CQZHE]ZI_<(O8;*.SH5S-B%"K1ALXR,\/8;-?#FJ,\4-6%]+(
MB7,4>T.WL'-K%A_6H*6QN%Y!B;=E=QY?99\#?6M%X@++F4=AU;&SM7-I .4<
MXR<"/C^J5^8FKB)WE6; 8F6\F-'.33\MD9I=T6>LN])6709NMUD/['HTIO6D
MLFEUS(%WO8&D9QJH![]*U/D+W@16?$CQ&^T,[7X3>>L>LNKI7U37/HJ[UDVJ
MTZ6;8(X2[^"@1/IGNT;N(@1IDMT,V'/T+>JULY]I6$6<PP-W9"Z#DB^P3?WP
M<=/?,:?XY+%#?-/_NMHT#F5P!_XQ+B%\VC*M:VJ77;"G_>Y83C)(B 37L"<+
MI_'X0D6W=>LF;5%%LR$!;FH-14L,;78],]&_DCG!%X1V!O>(EJ=TTKM &-P)
M)K0YDB01I"[,<SODW9:,]D+!"L3SY*J\EOEP\V(;:1^F2]V -E8=#Z^[JFHF
M(0>_2'7W'D-H#:]++/M8V\A_ZYR^2JIJ.'O>_#.;3"@U0?3IQD==^MS8E]Q7
MYWFB_*P5C,I)ZWYW5Q\ \7X[)!85<DPUYK='4-0%VI?I-0<PM(?GD].-D-;?
MG5P)0E/L TV:=K/#A'7C8\;M&OG,;B?: FKTP#C1BOZ33-=<2I N'!! ?0XT
MC[]R=-:)WA3_ZZW_Q/4W8N6*J]:A@H'&7U8CK@=N7[VY&W=AR?9&%">(_U_:
M&.0,+EZ%_\9@R)1O>89$HTP'2&@:[XI7F%;9-D>.2MH^P=QJFSI\/8Y]R=[>
MWU39"KG.BQK00XV59324/#87 !1)_T3+N U^HV5KX0/O!A$R1]H7G[FB7,:_
MB)C/$!V3]"^0-<:R^M=#:DT#[_ZN,BAJ>K>'W _6$L)%,2/L3C0=_]UEJ\T\
MM;A>E7ZGMM=S[\?$#AMJ;%G>D(:B;9R<Q9T(E2'&#^_)/L;#7U68%Y54S==I
M$'ZV+]2DXX8.07_1^S;ADC<.)8</W?]BUA(D9-YD6-+:WJ0T1!_^R3!;:E^P
MGHDR.BC?ZCG= #=N53K_1GG#C8Q=1"5Q_DMY(/U,_FD.&^D[E):"3J>'JXZ7
M.+%'4BG4D[,W;M]=<303E8T^T ]4&[;+38X],=:LCF]Z>X+ZT2*T?5&F$Z$-
MVV'3Z?"$I]ZX6;VF:>6I->WW@*7-[GKZN'4R)%^TZ<#L_>S%?15KKPN*R'S^
MI%-N]8?$JUO*24:*R%_'C*9EK=OHXPFVSXQ^1D*ENF"=)%:TLR5JVJ?X4<WQ
M 9%YFR7Y3L+&3LIK)\_#UWH.1F+M2R(MLMUMS..+]\V'FP!AS0+I\\&9:>'.
MS^0(A'XK3B8%^_R:BOH"N3G^H3*G#)]+A((X@7M[QF$)TXMUGDLK%'^EYR_3
M_6'U#0)2Z#(%]=6 ^IVGD&A3FZ#:;9@%Q;X\-M?32J+*MW>X&HN%Z\94S%M+
M3NW]I38]\ ?9E?$EB@I*/CO/*0U.B:A:BQC#W<+IO<7>L4[#VZ?B5*H>9]Q)
M#D()'O]4G:V?KX)*-/(^\;OQ;@-NNZ,UP="IM-LGA&[*EWZ_E#%F2G/TT)$H
M<[$>N9VS4*R>HI(%3>,+D6</W3P5/$PI;$S@_F7/7=H&YRW0:5%2P [<1XV]
MMH^5TYH[C)H]3VY(X!X$4(-?FR8=TSZ<Z2'F: D$S_7*_:\&H.WE]_ 'Y#QR
MXH\>(BLY%1OP>,Z_HTTXV)0VF?&/F;TAA?$E9\$Q?\Y]G>(Q?329X^4G]?G$
M<WJ)E/+#JFWW3I=?&??@A1MZRTM[K98^A9CE#===+@['Y[R&[KZO4UX[>*55
M5G6=T6"L'(8.I>KW61>/J%T;1WHL5@_6X_: +A+*T*H*[B1]ENPH2F5I#MI=
MI5P)A2Y-E9$NTIA%ZEK>^K)8.&[UM1,I"I3F(=;YCH**N[7!%1TSP;5YQ?@O
MO@V 4*DO1F47^T$><^X"6?W:[-V"6I9V2L?A/B\_5TE5,O\R..XCABY9BV09
M\UB%VE,Q@3'!P!@L<K1G$DPDO>OS0160&U%OIFF]71>[Y-(GNWXZ9I>J $N*
M5O"!(O-N52O'&N_ESZ'WHBX'!W3791 +NF>I3]8'G=AU)QA; Z^$=5U(9;-\
M"R/KX[E/P'.2B(.3[9>.T.T;71+\\N*1M*-\$1Q1*0(BJ%&Y\POM*+.HRW[,
M>(&$_AR[P9:6CZK87B1[$X38\E'Q(S,(F3-:I#SUF9_RFI?NW'$S(VMG]\ ^
MN9=^_'"$*AD)V-HFZ#X;6YX311]+ANNH!1QYA>QT?*F5-1@VTX,TXP6_ZET
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M,U:<T &^(5YS7L'$S#;I<.T_T-S'(2=2K"EDY0II<XHLMT>#R,(K[!KL$WN
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MI'2\QVX8%9?XSV0T-VN=>[K3Z+2>\WK-8(RM(T@Q$WSK>.]J_M+LXY;3K=/
MM,!M5O>[O]_L5L=N4?Z9O\SPC!^:!NA+O'?^&\I]]WW7]0FY(XK^WQ)-AA62
MTO#:M>>.J:?-H6V)J)1CQI5L)^L04BUSQ%4_!V[CGL'SC#-S0JQD*0'2GD-2
M-+<,I/$7_W))3[@L\O=I$:O%D,!1I(0U1LNLI2;,KJ0 MA:N[%LG8ZH[FR==
M0@Z7#2TIJVW_[-)V0[Y"<3)Y4EZERU>_J&PXG9_*^;$>)38UDXW84&#=\M"S
MG]K^O2D7;>C:<'4""IW^H_3G400J?\09%<<%UV!4'JKKJ+_;(#9_[M"%;[?=
M[=23*&&T7+@Z"J>$6@?;= \W.ET9_XNYO>& G'266I48\12*A6 W[A8A"J:J
MS*@COOE[[>/8O@*)7*PZ8-(/ 4^JX%@LM5D5E0*\":\V  &*O$@P8*=C XR
MRMMY?J^+=!]F [^)K;?TO_V6E6KE"_F!;,$9> )LR2/G_,W26O4?GE]%?'8K
MT;&2D8-]C95_7)4F[0 'ERUB4]U,6I&E\3"K"EB%9&#IBVH\.BK;Q$M2D_;
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MT1>RD'"OLQ]YB45OHM8E7E4I>>,N/("/HI%S,W::2+0[6?UV6,CEX,:=!?9
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M?$L93UWV[MM[)GE4@]Z(33'NM:M@<)/6,X-:@<Y^Q<O>5]6 PN["DY T;6B
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MYLJCC#7G@Z #9BC6[#3]Z.F1BD\QQ[<1BV9K7R';?<G1B)3I!>?]N%]'&A)
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MK;INYV3,D*1A(AG?NIOZHLJ(Y-C,M8QX=F"X[]Y0FUH?E[/6); -M>!Y^/X
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MK'/UF@EM$#'XJA?>>"EBMM8\!&&.77,I8_9B%D+@CV\\Y-5>Y3<%W<.TBYH
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M)5B2[C?Y M6/*O!:$$HVYHJ?X[:V<Z/L&A$9!5_A.>"3".1\%MUJ8>Q9U<W
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MX$7*@U3)^S,M+R;[4[4U;W%[/+E"YFRWHM9"G;O4,^[[R%7W'6J#^P:4<.9
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M\[0BZ -N_&&C([X 9D!HL7-29J88+;09D!^BT0]<L6%!4]7O%E3%/XL9C6L
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M41+J2OW\42Q2 ):;5)/?YA5TK27APNC$U>/ZY6;2!R76;[\6/=@=>GI\JH$
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MNF.WSXI8S[YHKC$9C/@]K-D9:Y7_/# QBBZ6%.!4X_7XD[(IK7=K*<,X0'H
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M^M?K4('A>IH#_\76AUBD!#73#LF#1:^DH<1!O@M0 /3WF,7F"XRZ!!),<YR
M&94S!"PZ<##OW"YT?/!PY@GJ)HDZ;#V&_[M9)B-#%B]Q$R-MY2^3"$Y2U==4
M%*.JL@DFPLEV?JE:=FDN(P4,93>DI2M@KB(5UL0O%%U?8,@CQR'^%<)IBLB
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M6*OTHN',?F&>"0R"9%SF/D121V1*VN%%+2-B,HVFZ#?!*V[=R%I9Y_VE'[3
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M\"JRFURB'<;RG)WS=$MA@?W:2;B)^G=F'=]XL>0^]._$'F'VSKDG_U>OO;S
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MY;8*LGX#HT2A;T*8,L@;R!GD UM'_0NUGV$*Y5V+,@R=^U(?<(V7P]%"/E"
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M0FETXQZNA<%2^\KP"K'T.U=8<T=/TV'!%2#+1JX,TW3)%.R."@ZP;O]T3'G
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M!P5D^^Y/RP3"[E",:UVRLHK >%K[#<=P>">5]/V#P)LXF(RH1&S\5K"W,*)
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MR*EF 98^LRH;.5FQJ@)IX>;AXE53](G -?LXI6@;XSL,3<Z_3FFZ('V_ROR
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M(8HGCQ1'$I.F8#@L/86*%-A2_Q0$GGCQ90^[0I)DO)*55X +U4J.AI:28".
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M5B^>XG07U?BTP_'_*4QOR(4FD+[=<35!+NZ!D ,'E8Z4I%SE1U\"Z^9@RI&
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M3O7#<28SH]8"&T:IG6\WS'U6%2)"# 4F,X[C 6XUCR=E)U8; 2MVP#KAD=Z
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MGD--INFFF76M>M:O)I;O([?X##0XN .$9E)@,67\K=?K[ZG$(ESOB.G\%@U
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M\Q!*:>W!A#4Y8W9QU"64^W0_#D5F6*!:E''A$"FZ*D0KAA=[,VW>?:&1'+O
M!=#EQC[MD,;7LD\5[5>KAZ3K'E0DT;>\Z)=:RF/-\;4^74L<'>CW]/>C9_2W
MZU7*8U;LAZ!-VSRFN"=UO:NE=1.H7?VA CS(OW0S_86@>GR?#F;=%(\:$59
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ML$4/GB 3F.PL]^O_TO%'97?HE\D&5(Q"D4Z]TH$R@@95PW W&[=*>1Q]$Q7
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M 3?BYT[IIDB>ES ZJ]!D_Q3,GWYV<E)!08X!+',P(L^(@&;F(!X=NDI[#LA
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MF>+&,@R[91]U=:S6S'N5FV _A-O>%V5&^OR&!TO*2FJC>$0371KDKO\6&HG
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MSY*\I1XA8,=UMT,B;.=;WQGETGU]^(G1#T,+1PUQF-721VYS%O3E%^\; F5
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M+\Y6H#[ !40I+4SR-_[U$VE[D=TOUD8)/L>.%E%MC;E3_HC1 R_(7+O!XRZ
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M#GD-@ A8DY!IQK&"##>F[N)?PV4K&SFJU.P0"=48=::B5BWGC#E&+O_9,?L
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MVB/$SEL&JB_L_-&7GFGUD9MB-B0893) D)<M'^O;?D?0#_RI].261?.]7HB
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M[=I">WU#/SH?),(O*#CUQ*?*ZA?E-PG'>,S?36G@^4VJI.S0Y4_M8=O_8[H
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M']I=?4Q9:RON%)MH'C:UQ'TSKEI9R^'0J+R>;F0JU"D *KF71C*;F^PM+IG
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M5];<8 ^N2I:L(.=PF(%C]4?(>R$&FU6SM3_X]HU, &S'RHAAN5"I$P>6QEB
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M?R&,5R;B5;J=CX7AQ1T8U2__(?JJW8NW=<W=)S(9\[FWHE371"?V9DC9&/A
M79CNI?(.T')GF<)??Z@N.QST/9W\EV1%/, ?QAHC+%NF*D.=^I)J\Z,F7ZTR
M;PSX5KQ."@0;0[=KE1L:IE5^U+%U:RKI60^=4+X@HQ+*<;>5F7OY ?S%YLN7
MXKS>K[K^ 75WP#[9WDA_48*/+/(34,6F/PFP#XE7/P=8:KCR[- **K,1H1.Y
M^,%G>M74U=[VR.TI:.,25\2=RZ1_N6FX=Y2?KS8%O[MR"!_,OU,<(%-.@64&
M-;R?7#GV;GC-BB/YN=B& 1J1?+HX62S^9?IC?]!4Q[6=&\MN''\_YY*?B_.*
M]?%CLEABDAQGM:E!<.M/S^>O;XKU>+$_VZLW;*"7T<L$GN$.E=^]OINQH,NB
M<S3U.I1_R>5%DN(;<MC>LWA:PQ:N)&ZY!?H6\A#W.0XG. MOU^#N37/2EO^T
M5F^/[*UA?G(1O0[+LO6,IV+ [<44W[ZC"F^Y>FW&;W%>FYBZ<S:TRE?![Y9>
MIW(DKHID\U]&GQ^:+-Z53NSULUPP%LA3(0^Q;4W/8;Z@7%K;\M[GH]=FAT<%
MX)#))-$1>%NHK2A2-,'\GN/3+(^ ]IY/=1WRU1(^]S^B].@9%8 -_YEO5KTN
M:#[9HI*<5I+SLJ(UYDZQ=UO6#_(3@[J">SMN8VW? HR#%GVH1902I:3)PFCL
MD;0C$O](Y#5/[*C3]O>4;4+K?TS(;[41SASOGM@+][VV/Z'G#+ZXP$..E.C+
MU+^Y2HW 1[3YA8N\SC;N-*\1L8LT5!.8?%SVJ<77.NW9;KWF=G/*R1?/>I,)
M==NS/?>Y <O6W?2J1_L>M6&3G9]N__]Z;FYH_=M=8A/];G;D/<6<GPMQX$1B
MJ![_ZATM3/U9JP]4E;,/'DN\TQ3?3G[W_K/K8QBUNX**D;@^-?/ZYB%"@+@"
M.49DAA8L5B!? ?YZQ+1\QT+1'=M7RW*A*,.Y':]=XBDR&?!TH(J,=@04\YX_
MC\I1-1EKG@>O>MIFU'9.AJM$WG(8U=_^LZWKB*EVT))/P8PJ-H=J47V[:^[[
M8W8[W 2MUM?Q <24[W\7#U0?OG:=SOWK+]=?W'3D9JQRA5_Q6A=I_4FRG/-H
M_?+@'-DA=G.AW9E-QLB''R-S=ZM<L^HE;A\HA+D&G3JCNT@P>D:JM!Q5U[V?
M,ABDNXXK5EO-[ RS"B5YET1U>J\[BEZ]?99DX![D^ET1&#I@.+T/]J$G3=>V
M"QJZ6U+M,OPV[1G_,055@$F6X#+-'3,X$00VRI@"J+0JL$+;Z113]RKIK#\,
M^D*<_4 ^FL6HR0RMA'QZQ;2B!@GL@%>X$744*N-FB$,/D"G%#+9NI)3-A,Y%
MS&-T80ZC4QJ -(Y"A[#E79UA\)(C2?B,A1KJ@RWC %Z!WMZZ;W(V/W$6F>H(
M5W ]!8J;J >,<[_W?/\P1$CX3"9VJ*U!J; >\,4*>;#4 )91'K;J#=:CY)3[
MC:UL1>B DPKE>.KVWI5<KHK5'8ZK)_LIXR[,F0$[E.H]/O#RD*5:Z!ZL/S4;
MMA_T[%"8_])[\I<3U=C=ZVS/#J>Z?FB""LS3G =ZPV5C'DL8\E^7+QEY6:\W
M*RA J/A:?XL#]DA@4JCYTQU?5X_S=X&+'=P[@J+6\W\W-ZGZL&[FQW4VPD =
M&@:T\BQ!8CWC0TE='A_#K/^ AL"I'*/LR3%_G2Z,:/.6(-5U#MR/_GB)MFC[
M/.PW:./E;\;;R@\K]'>$0$TD5\;LF^L'9/Y';R_S@M<?2V[SV\6!A.ZR[FYY
M&N,FM4^G.Y4[-VS79'_8NU,K8JZ+ZB> 0DB@AZ+K]H$R\LHJY +^<KE,QSF@
M]B,AQ9H1\;7'2+.#TPY2CG^Y@5!L8<6T7]M<GDLEC(JX:MWP!EP"3C[*3@0V
MMGLET0M0OW1X)61B??"7FG)]Y*+)UIDB'QJ&?[40)VQK/PP0%*C&_+1@<&K;
M_870(%%H\)0(Z8L'>S9R?RU-?NEE?2.C]1QV+>OB>YLXKC#V"5.,. M&WWBJ
M,OF)!WA\XS$WN^&L/?5'RF3K=81"POZ=B ?Y'U#A-'LFGLDAV]D%_3%_T, 2
M'?\JDP"@?UF0]&4&NRU%"K+KNCE,J2LEU<(PHT%%+!"/&<KFV,?^,)XS*>@+
M^W=\H]7NU:ZD6AK)ZT<[>.U*J2 KQ/.X:^I1D^I 8B5QJF03J?..&E,;[W<G
MGPS7S+:85^?8S0 Y+HUH]UQ&DU#>\Q#OV(XA5:<$C^BX8<Q8A-JR.'_(W4U'
MQQ]"",4&I\ZR3XQTD+"1UXEXRJ(UUQ],>8J!;U8@> ^>NK1^XS[;5.5A2%_[
MN]BH28)"47%"4!7IEE8M_Q BJ9"5WC"UU)KD'DTJMD<XQH'+TPM40JMRN#8@
M/NO'W?I)%,U-0QY1UOZVYM +7>1;'DO!3:^O"W PZA_4@G[6 U-V#68)9#L9
MYZPDBIS-P?D'S#\)O[<8O=,8K9HA^/SK2G(J[BE'F"::H&A'&)\_UP]6=8Y1
MX\S/%*OZQD :7UMW$/[0?3&;,^<UG9YL=7OKZX!SKX_M[$.I\9F(;BR=0EGO
MU:WT5+%_-EC>^'H4XCH<((R8X&VC9U^3B?C0(_X]G+=ET[2RZK2"G\FHXI_&
M@D@B#UO2!&\H >;E;,"ZBFHA\:.2!9GTV_),#89,/VA%ZZ%A2(B]]7.7Z 2S
M6=/J,>;@,3TI^F0I2[.1CPJAD<D2PLFN5T51(23?NVEIV)9,ORHC J6!F7FZ
MR?I6@*6\H7LZ "($S*U'X'HB".$M?W*%* X 60736,#P(C,8?M9 Y[94>R1A
M+2,Z5HHOF<ZG)4=0MH!G^LBQX5RMGM+D::<*"#K6WI*.]"X<UDO1MU*.#O7%
M_XM=9@:=282(B2]KQ5F:SNMM:*EF*KI9>/%,F+ZMWJKPL33KUA['/I[1P>HF
M0#C;4>>-),NC_VDR)=W%-Y#.2Y7G8O'S5(3'6@Q:R[QPPC:TS%1JW>2\;;B?
MZ2R4(G;[YJ_&8E_)]!? K(Q%0G29P!PCYOHSFW'3O2#R>8_WM-.V7.6ST)QY
M4S;:D\LRJKD^_&BMOS,\8;4TA#!)H5&\>/RLUI6M'Y4@:#HVN9WQY,G$3^O
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MS!)&+JC#%;PZ\Q_34\BR\F#)NQ?0%TL1F:Z+AH]G-'6F:)U[BU%/AQ0A%7]
MOJ.+\=PW.NI.LC<=.;:)J(8RJ22$KH=W2EQWFT!X$*ZH]#[\ 3;"4*B(_\ET
M?R=F$]D8'EG --U57ZPI=D@G&7"93[;)^AGIF?>8"WW;T\H\J"_I,%R2Z$A_
M[;UG=?BJ9S1(]%DP)L50:,DLC&0IURKZZ'.F>//^+\TX ,+\Y1>#NIP1NH\
M-$.4XNJKE +RG5D@VG8GP7L[(EB[=!83 64L0!Y:K5YCUR-(B_4C$QE<,]^.
MY9Q^]IW*,S)U%&(AV'U#")@!$0G[O9X[6?>AUTVS0$39Z/X\-B3WZD(S%/5#
MU5C!#<MX10M;@:^2L>7[I:-Y!%<7$<M^L/<[IG4$U^7R] J\\USIV(3F*%+3
M5$B?(F=?WG3"4-76 ([%EN5WU#(X8QNU+F;#H[+\3#.VUVJ1LYW+KKQ4>;I)
M#DY'_*SWEV/VMJS$W<_@,930A4>#ISZ4O.OT?/OQDJX:;\4?*5R?Q-U/_S'%
MB6$5](\1#8=1W7*HACIK=OA(:L7LM+8\$Q'WHYD#J\3#;N'CEG"@ 174G-ME
M.1O&G=(1WJ!_,^$N<G2GO^<4W\!?2[^.V(E+$6U+[XHX4>0UTBV^L_/,P>23
M9A3?GFTU)C]A)*Q\]X?Q8(*$.J-3LZ?I B=/ )^JO03SS::E5![B#_B)C0 <
M2[[IJ_R TX< DUI2=<M^/\&+'I+1'8(>2 '>3P33/V,3)M-U;-AA;*0HA5)2
M#S3F'%G\G)I8A8@;;$A0VUCIW!TR;^F9P-IVDK\JZ^61?LA.Q>S+?ZJ2</VX
MB,CV?T*2O1;4S8C)OMPZ8^]N:;38U?$?$K&_'03>^O^[><G55LEM><#R6GO[
M/Z84I."_Y'FDQ0>"8;WW,@]JOW)KV-F.N[Q)?E&ZUC'4*\P!7[1]'H4/]X@C
MB2W5V:G483$\OC=6F'MO83@C7)>BXDS1P[I1^+"ZAG)#]+ 2[E=4K] E[+HP
M^M+[#M>_W1,5TH77]1M%CQX?,XYX:E&U!1+8'T517?68EB//5/0GL*GD3 ,_
MIBGI>ZL^Z,&:G>8],./+8]E<\_3'$:X+K;^>7R\&W0H*\DZ:G,"FC>+5N7>T
MDK&T$\JWDRL[PPBC@LIS._71C9$N&!7NM9N=3N^<K@A-W9=W%3KH!<*O:BXG
M6C9W)O*>N_GBH/X2?JG!LG J+=1X*30_'>DTV1FGM2.@^AR4<PZ<JQ _<LYJ
MNT!W^"^S?.;'GN,SAOVI1M9DJS'D ?=BBKFO7H5AQLJP?G/M7@_A,Z]$F##!
M?=NF29-!/^,<YQ-F817YM<<[CG_8W4=4>C:7==W+R-GM"(T'=8&\Y$3CQ=L"
M4^UF+S-4Q*YDVM:KP\7Q50FGWDU!+50983+//,&OGKO9!ZH/66QO#O2SV>IW
M[VI_>%MOEVFNMV7;/./]R.RLL[J,BHB[;<]>RP/\1 &!A]RIUD^S>\&B<T3G
M&TFQ"V;4P9<-BI5%F9W4$H<6Q<K5UEWY-$A:AS%K\JO_,2'W(Z_UCLVYWN*(
M('LJ_O!6$0%,H![+YXSR^LM]=^*/[S*ZN*,1'IHMLI'=0>E().[9KS4O%CPZ
M\)94J0?2'HM=MN:]B_RV[\0/"6M4>'8XE2F%J-Q7X[QA\3E(-E9*[:K('U !
M79,WLO!?:V'_UR:F\DQV]4=4TY3D0Z[FZOBL-_'FKRRFCQ#6V\,YMN]< =1Y
M?45I/8Y(V?I0);7D6<1^W27KPV#;A O'"&3@BL\%A7[7CFP.+[L-=KE,!_?O
M3XJY)#S7;7(?"V=,'8;#%:K/-="K!GV"F#>1;#5G!3$YV<4?P5 ?APD1\ JC
M&O3EHF\_(JSNC-4>0H*$*4@X>H/LHX.KO7<QA:\9 IG42 ^=:!CQ5L!:PX$G
MH P?5 M(^\T@E!]&YT".2*-ULOD%9"^OGS)KLN#C'Q*29>RR\OJC%GVFU@W?
MBX6GU'N<<&T##]1[!:8R#CW6F^K!'U$_HR37WA2_BE!-#D[_>0C?T/ZZ#C7*
M=ZMMJ8L]!W91>X))*3K?IZR6%69Z0TRVP+IC$:O^W6@U@SX^\%H4+PW$4<WW
M-#9!-H8YRE"^)X;F'PT:; -,W C*4+ \EJ8+[$A+->I@L"=8)WB/9 !)HKQD
M_90R+^+$E72Q>@JTA;+9^Z ##/72!]MW!03,!BW54#']1NOB_\2-.5,:Q-:Z
MYR/(M1Z!'9NI&=_5.X 9JN>6M4>#4':@V](W\,5JG)/7KJ\HL^6,]*3O17/
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MO*O?*FM,LL*RKQN@V@G)$HKS]*ZT0EI-51T:MH1C0B*=O2W?+-2<H_$!:C2
M3*Y6/'P9R12M>PN5J8K?;Q62L#P7_QJ 22K$R@ZO2&$R;L/M)^+X\J[\Q.])
MI5IT9)U2,+3,5V4$9Q2L66G9SIOK$8O=C?G'SJY6HKU]H-9/$HTAG%W^$P5X
M.93=M_'[U]/H'-!!BV:D*Q^5EC>J0X]<C\]VPE'8BX#EV&)-#AW)-\W#]G E
M<CFYQV=WC5(6_N*]J+U+H?O]AL43Z>TW'V^ 1F[5XAOR"J\XF6[,W)R7.L(,
M=\ 69<H&S&F=K."+87J?!4LWJZX"<.T%IMIJ UT#X%7$Y$O4GL!I$$)G*DD:
M@.O$!JSILU>XUD\&PEJ2XY%[R2$Z7K;QR ,[03VU@2<2H@P.#,0N?N@L&2FG
M[C2,L=4 E8T?^%2Z38#_<)0&JV&*4SPHF0 N9D;@'P--%?+FHR== 8[.%1MS
MT;BOM;(_:]8R;Q3Q9CXD[LHH\898SX98I\'<*W>)@RDEJ]B7ML4[UB;M&&W=
M):()11OTRMHDP"Q3,=%HY6D5VFL"?Y,U7]]("YR+K1<-"O!%JXAL:O%^S1J3
M@[L9)?IR0$\--/Y 0JHI!O%&-*N9<O3+_@=K58; >I5J\CWVMI>LX0/ E&6C
ME[A*P[(U:[,/Q*4'X<%;]"Z^&)9"$LX?SW2]FE"I(8DLZD-:&:SA*B?<?*6F
M=>4[82BI"0VK]"^\KB.5>P&P[FMF,,6^1K&/1O6F-E0U9\(5=7]83$9-$MF(
MK"W:_+JH.-O!!E?D)1DI IVP&;^O:R*E] M:7%[8F,:^;HK.CM%EN(A47\R:
M\=^O9-Z+-FS+P/630?'9!J5T-C$A'TL#0^+S86 /#7:AN,;5D+<*K!!"-7?"
M19\FVS?? 3O \:FK>)=DGH$E?!?1;]#J0BC!19Q5:IAR=1#J2[U^(QW=3K8-
MC]G @K+QL&H%J[_FB>B@\:![0JL!G$^J!K$P;^N7K+54K!<;VRW@/1F+C]!^
ML=NR)(\JQVPD%V&R-%W4?HUH+ R.\MUPU<F$= WMMI(NX\W&'EDT;%6I9?10
M[LL@S"BJ%/8,J3:^"N4%TH00L# QT_ TL)A#>;C75#2(64R-+]7V(IHNC2ZO
MOTG6EK)QGS[BW&J<WD#KILO3>/:LGE/5(;3HZ:IQ7').(_(6L&/<.L,:/FO5
M+W9/8LC45DZ+.YL(0U>^A.7-XJ]+KT#]3#B,VV?R+G;A9X :]+)C"YNMQ@(4
MC+ )Z?*8, '?C\8FY)1(LB/#<28N6.FS\0.$T']*2U,&D_XMX"M9L'026G:I
M5&<</1QTFDXRN? ,*D=5%L\,8N:FZ,VO'U51;LRYW_6YB<WU8>8W.YTVD1-M
M[] 89DNP1,-2\MY#=;9@Q=?6[5@$?M2X-?VH8988NIF+(J6R2!6;RF7W1##B
MG4?1.7=4UA$WGE5S,DU?7^]U2I&&0H2 ?K2TRX:]EOG$WQ0]MY6)TUGYXCE@
M GL46$.D\G1MX <1$K##RHVSF;?@IO6Y6%( S!"8();<!FN9Q7M4P.)72E\N
M*P.@KN9[FLA8G;;*\W:94+TL'Y*</JWFE A!'5=\9\/IUA,IGAU#&GE0$);F
MDGFJC&@S;0T 6IQMF2FVPT8;<M8R=.Z)6+/3#<6T1PW.'537!G%ZD+5;2V\9
M<@:YP].Y\8:&6<^1^6A@.D;!>C"GN)-X]D%XNA,V1\Z-&,#:N-6+2)OTX7\'
M![Z<8/6S M^>4D_?&"=:XU1'6I+VD-]:B0'=DZWX:Q\K;'FL]#"W?MS-FKKG
M=PDYW!JGLO0BZQ(Z&2(2QW!]: >@CNSV]9/#9=9PHJ. 433?'=X[=89:ZX56
M>AQU-=OIF78YFC?7<^K\CP?+)0 %GPW90NJDNG:)5B%C^[]\+&_)92*%=*UD
M71W=G6L5W=RF#%V7[G7)V$_>MA\'4P2OB%K%U-V%;P^Z3!MM^1S$?[;,Q#6]
M@ 2J01L^F%]>"NW\'.L&E_#QT,1N'P"^Y2(Y?2NW (.;.'GM6JW2 X)+:ZK"
M[N_BQM6T0 *X7&;%V?;R_+<(CV=?;K^T C-"H%^K=,3AE7MG/3Y\-<H2,,"I
MUHLU?6-XOZA2? +K+99!W_8NGWGH2^^C6?\@ _(#S*\R.T@5>[](]^"<T3Z&
M\3:^4.@-DBXC7I#1@04( &Y;?O67M_'9LJYJ=E]W>-YTHQUFJ/ABGAB6*E[E
M6**3E"[JF,V+0FA@ZGTXE=$)C7+K9I_97_X*5)%3K&C%<UM=7&OS&.O'Z\WP
MC!JA]=5?>'?9#7::JFWY_YK<_5(Q@0OY(;E/THN"1J8\G!O:0+T.I,Y-F?Z)
MU9"Z^Z(?[S#>^-"\@4H:6*"X* :3&>--/PC+M*<_"/[Z/M(7VWEVD#E;\$SS
M^9DFD8EW/PB3<S)N*^$OWHJ-]:4:"67["\H@!.!/8,CP@?*R5V/5,098?K 9
M0T3R'O0"<V!U9.'0&!SJV:Q=>--:P:=:7WRC23%,] O%?[2;EB,L5>L]>H_^
M_(J1&E=)*2GGA"\#?@Y5UZVW/?Y^%=,X$:'&)RF&SC*_!$A>12HD;O_'%&/T
M,@>Y+Z-@B)V12SL'D,WDP'V.QO;3.W1S-K30M/Z!R3XSLP$&75:$XG@>T(=Y
M+#';<JZ6[-G+8O*$T?L1;?[P,PO%DM6BR)-01L#(!MWX# 84^H@\16<7O3+Y
M5(RIF0C\CRE+ "99@GC6_4O#MJQZ]G<%=KJY^3->WQ/3R#K9W+S>BTS8'*D'
M-HC5"MXAV]RH(7]:1][NI;6YA!YLL@D$H47+1 C+1AM)YB5D!-0&7J>7S6X,
M'T/\CZ/KCH?"__]2J40#IQ **2XS9X6&K+//#<[*S-VA[)&11#E[<V3><</9
M9]/@R,RX.S(S"R$KLSZ_OK\_WG^]_WN]7N_G^_U\/Q_/UPLJ%KA+9@.GPZ-(
M9@B$U (C:W^8JDOCP\#%D03>7I)8AV,I,DKJB.+LL\V[7DJ!V1Z/,%?BOGJA
M841Q=+8Q.Z#)PH"N%O^H\]75#<7L):@[DW^%*]9Z11D=;SG,7\*>@4=)*Z-C
M\*7/;TV9P,F?P,&M5VY7L?)H;.CP;&U>&2#T%:F,IMC[Z/)=J/%THB+N"ROZ
M@Y1@3E,\P_+L@C"ZAEFW </;##E<6F^'5GU&*R>.YPO.Q?+%)H.,O-%G=:QA
MQ8[8%!D%*+,T 5?%>*M/-Z$8P^C@VEBA.ERO!=0[@'S7Q>HT(HSF"H[('*<X
M7!YAHOC84/27!*^(9;//C&H#V+C1\"5"C5$P; F_U8TL3*_J-\HF7![YS7CK
MW8VMX9O>U9GQ4/!4*QH5J*[VW-"?9*JZ]B/A4SIEI]Q+"H)K>V$+2)<BT"K\
M!GF>:BRP;"SO^EK1@^(UR?^A_ZDN4[%N&A4!VL7:/=)F\P9^/@[]M2+\2$K_
MK>BGUJ=K>FQ0%7AO$"_[79RQC>S(?<V_4B%W7TC=#)SK//<#V%T[T?O^P@Q7
MAAEWV-O]C=D%9*ZBZ!V>4,KB,ZPHYWC'YV5^K5>-+N?1?KH!@ZMMET+L^%>Y
MO(TCNRSLX?N&79<QESI/O?R?&7"Q=7?FS;-?YV];V.N$B.PW+K08W)F.3#7A
M_=&=%ER\3G^H9!UEUA![:E1FUE1T8@5>%7%=(A&YDO+0MSFBWS=WRN@@6KI&
M!12V)';7:D3*9E!1)Q-P:YP-.1#DSY!Y[H-]@-+L7*&*KQ/-8Z&K F@VQ^\@
MSVN;YF4@1=EQ)\DINE(=*F[*#7G.Z;=KUA LRDX*S(@P:E_3YZ-:NY0H#O(#
M,^BWLA^GGP2=<!S--ER"P5+RFY+<-1?IYU5:$<GQ((/^TSAV.RGJ36T1+_"'
MN5=)HYD .\/$8*MJZ;A^HR+7ACTB;GZ:<G=$(%XL627?Q#J^DW17$-#_L%JW
MQ<(+ J*[X*=W-+M:;XD;\DOF^"%F4F%Y8<'#$NGO^HOB52VA_3?-L>"T;LC7
MD'J)NY"#O[M6N.RF I:\;!!C-!6$Z,,KFKD7.FS!K-"A7\DCD,9:1P2*$Z>3
M5Y0#$O0K]3&Q *L%.);P>,%NK%EX$MW5#+BB<<.BR+<T!5PL3E>BQ FGT<?T
M.-XM!9HAI("@AS<U<\2*?"!:D+LL?"+M,3(WWLB&L(\L[SR&0[UA#8NEWC:&
MA ;RB+*.B(?"A-\5Q<6[ZYG4IRTV.]0@"S^86RB)MP<>+9(>=J,6"A093ZH;
M0HJK7!XVJ(5)E1#RT(5W6IB2KG/6!FWH9J[TQ&NYS'WG.5IC9$PH_@##"PM/
M8\5V;[%D";<XRG/VX@B\/-I'/9-#]M^1WQ>>Y=%V@NX'TA:>7EHJ\7- M 2?
MDFD:_55Q:S_C?5/JLEVIZQ$UG'-;+N9\DQ1P:Q<\TOB;+[,II'?N-'T^%.UQ
MJZ"X(S:V[G!$J:X3.)2ZIY_"6'$/HOOR X<KE=:90U8[@.^JJSY%RE4U3\=I
M5%RU3")XN-XSG0<N9JY\'=THY&7%6ANNZ&3V=2]*RL!*2%;DEGC].Q;9WL8(
M<0ZJ@1G(YM$GJK)ILPE?_'#Y0G7ZAQ[<(HW^;=3Z_A2H;]5\0?!'R4"0V)LW
M$Q[#?S _PM_LV3?'N;;Y#^ME^EYL?1'P<N/5@1-H[+?:(N^H'Y>!:UCZ[/M+
MQ6/#B+JR/+_,6;M[FV*\1P- +O%%JD_B95'?+8K ^Y$SK-;PCUM_US#TM:WZ
MF?C@C<BE#E1_6'T$I?]48@I%!!ZL4Y9_FQ(>A)$<MIFC%1YDM&:[^]A0->Y+
ME5G_"![54SPNJ7J62?6:L1#0_7XS_(*/I4K&@O-<TP0Q@->R*:I-7+)I.*3T
M&N'S@.O)ZF^A&.;Q1<E%Y!;*NK?Q&#,2<EK9W\?^8H[>BWR]EQV2 <B?]\H2
MA2E+,S$9X1HMB)'#UUHN,1OTD*--]2X."^SQ(60QORE4.]?&/81)L3YQUSF@
M=)F_X+,J1>2ZO>QL6RU.?#T)0:YB%IZ7]-&^*-#S'4- 1L'FFF)O?XJP%$0=
MP.O7K E!(&EHV?H76TB4:@[_%,6.V00'52TC65T$9P<&*Y)FFTB#U"\C+ A.
M-S***0HX8KK&4\*#7C!3$MU418+7)'/Y^!)O;EC4:\,6*&_%XJ:,7:?@>&:.
MWR K4RH+T47U4?F/+7#4,/P8-F GUX>ICF1\SP;SC\^OVD5\.W@?F+M7H>XZ
MQORZK_S][O6]BH+$#\];OSC;Y_7^JI#<_'G_WJ8=S>FH]_).A=HFL[3O&/'N
MRM'PTZI%EL):DRARIX*[OJ=E-)\NFNFW/^HW^U5K+:PB_?Z4J'#L_@!3RVVE
MJ>MH"$Z-_D&72XVY:ZL:;Z'<_M-C.=P/Y=<0TNMZ:*'T>_RT;9N]XE1;^M;5
M=%>8\1><EM37D.I->[G](N%ZXZ[@HY-SZ=$_%E77[*4#>[ZXC&Q.-XKUF=R[
M"O9/I:_\0?U\+T48<:(/YP<O"^SL?7Q1(:O?N%-!U;@7WD176[/G#[G3=J21
M[+-L;Q%X'[[M8>:Y9I-^LG#"IB+W>ZLN#FS(1+'6EIXP"3F]Y6=D=%_':D?)
M^V,-O_+T\-;'<:9@YF+I7GE2HRU9]GG,5C7^!:^92RV63Q+^-W<Y\SAHKK,A
MN_-XVRYR4ZYCHN5C4UO@)D?!Z!7N@: *70X$<-)&B'1NP ?ANVJ?DPQ3.@J_
MR]$D! S%(QY='ZJB?;@&7RS38NH.:*73,"(*5@81GN/7'&MO(*GL.Y0A.7"'
M\R8V6T>7ICA2&<.#GVC*HMV\D9P#"BM*_-FQ0^%DRJZX>DO]B7?Z(077I+DT
MEKQ=3N91$!:!&==[*!#.0^QO=R:R4[HE>]Z5IV')OVCMPBU#WHWZ?\?.")0&
MZ:Y&]!MP1&H,R..Q:QJ@;U]=72;S"4H>5W.IB:\7FY[X\]I^B3YF/V+4^BU/
M"_Z2EI9R%DWW?_[CDB7QW@,Z1/>8=&TF.D1(N 5M==K?\!E'_D6'""O$^*2Z
MK[/G2<"'P,PY]4?E149A2NO:Z0G%'2+RAH GHE?W*@0WZSL2VT[E4[WM%/?C
M7&9B[B,W_[R@\TSKSZ@I7>YS#RSM- T2G]VV = [,B'7%ACD"C])$V.T%4KM
M>O+#-+Q%Y4BOO 3"\*DC0 ]PLSQ/7!@(OJV0<%M>3-^?T2ML4GD$J8XJH%Q>
MHVLK35N2!!T^$_LI-G^&])L!R%\^8,DI^/U*U]7:$6O3P&#L@\?&2G&#7RWT
M*W#:ES-R/I/V04(RL@6/@^:* [7]2%E^)=OPTP)E:;_+5F-]!%2I?QH!7'6%
M/P1=3P4,6U=^%&N^S[F?/9?LO=MK.[8]G-&EO'6!F9NL-S)];M,AV>GTZNA.
MJ.6D[GMES,+&Z57C:V]5$(-AYQG<':@OZ*64D\.L*4_Q!=>J7=,+VNKU/=SN
MXU5;48H&YZ_!><[G/9Q[SX[O.7+Z Z1K6/U:;%?[WY3"(PYC&<_#.!9_S;?
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M3\#FR<,Z:X@QZ 6:V/\,>!2#9Z/8$6<B3MUK4CV;![D[1S)%C6)GW- MK'G
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M%')K/\7>.=4K!]((!YEQ;\.:_9>AI\=8N?^QW2:8I'WE-F2O3>P'V4_'\(W
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M@[7',VI<L .-(\G>_LQ._9L&<\+;W[%BHY/>2\BYMA>=FCP7K7E*_V ^[%^
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MR"4,035WTS(FC?R$;B%CP:B0PQ5;QJ$DRIG5G! ?<YTQ/@1,2?ZU;=P>X1T
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M-3# N0(UN#3$Z8'F\ACF2?@?6U/H'@5Y:80.L]G7/+T> KXX0=12G')7_S>
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MVAZ27%X;$(F*\5)#KT<BV#HY!J%47JC2PJG,C71:4JWYTSD%!BM_PRQ53^N
MP5UDC?/?DF _@W !9_^JJ/\D"R,:,6D(_RFVQS.CRN4\*_%UYQ+=E>&9W*2'
M:%5W48U_;2=%/X.&J1(G5F0A_"=!$0J$2)^^ZE\F-]K[S\*+3!LOI\H2(Q+]
M%/TXS;96BM(,FM-\S,B&L8RL2'A>?3YITZ F,JX8_V,MM)D-FT0V6!X%CSSC
M<42\]H([\IQ *'"I24,>>)F*Z@5Q1SC&PV;?DDZCQ>-&SSQJSR<S7@D 2D\5
M<>H$CT6D]21R7R/WC9-U  W@?$6\F>Q_:)>59UC%2:OR+Y<XVL?DR++!?T&
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M2G,R[.VSP%O'V>6$\+QP+D9+RV,[M!9'UIW(^AJY0E>-I[%#?<M_@":^3)$
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M>\Y\^0Y(47 ?< =BFC'H9?;0%,B/*\E V]P^HYL-81:!5HJUI& */'/FMTK
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M#_JD1_+FLQ*TF7LT(9F.!303G\] +UIKD3S436IMUWZ3X]QQ=6?%@.;QGLT
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M]6QXF#MV4GEE]KTC5\K%U7]@7&7H_6:Q</0@!E.RD%V5JDC%KOOB/' ^:8'
M_B;;3[BPF4Q13/88L:@E1;CS,'=*3#RY-G12L:($']# 'K)Q7VK5%GPZNG\$
MT*YIN^:M:%2OV[$R,M#T*:S:>/]!P/* P$CD9QI(H<Y;=#VJ,_#@HLQD"Q#V
MRTJQU$XO>4P$XG6*%BAV_=7<V0)$W^/O;?VVWC2=GJV#R<H 9AO1M+.DQP95
M\F/J^6A7^$?DV%:47SKJ6*T&%'X41MB'1#>_>&TSL%+.%[TIIQ9YG/*Z!?E5
MX=!.IVS@-VVE!62I7UW<[?3CTY]/S:F!DQPEOI,MSR^!'"Z-A2PVKYH[6]U"
MWE[Z3CV&.?G58')T[8K1YW>KK&P?JPKMEF:E]PFZ&+D\/4Z]=CA5&VX,/>#S
M:KOK.) FECVS;PSO?J9A]V5ZCGNDI*M'=>)(_[5/C=^1W= -@-K$RKN =5<K
M2@RY;PJ[[?^<*9ZW(DK;4AM_3+N^YK*PP]GIUGH#N1:\GDS4(@OUI$[[Y2Z)
MT$/#'$T$JPXSH"E/+6J$[+_)+\]A/];H<B[_;-9P:W'D_V27]\UO:(G2/(IL
M-&,T@A/1<R"7Z198MAC,]![Z5B2\?]CZ\39B"=S_$:1YF.,._M\QXK#Q3&_7
M6R'E!*IVK<=Y4[CT=SLI<B9G )MV2&4K\7"2/CA9MUEZ8%J5^TIKO7S=*?69
M ) 6@L-WGF-\.9:@&_BQ3-&>E ,S3$6R/<J:D]FW$M:UOKNT__N\NSG+.=:V
M=!(S:C='(M=T)1=5?>_'-8#6;]1YK<[W90/'_(.^Q<A87T+$>>O:"2\EJPU?
M3 />8%DONI>@W IFKC&M9A1,9PI!RVMCP6CT):B>5\<$<_Y;05C58&=C*4L>
M^$:BVHTZLR]^H!<-';^EWG@#?N49PM^E*ET4EIR^!SXO01Q&'>@%1U2Q=446
M%=AZM?/T--X"K8D4I+(J?=1ZZ79#1J;<<[4EW>'-2.3\-I].>HV3!WITUGN^
M33[DNF*J0<F:4%!,+0MO>6"'YM9H4V-0(PVS[VTM##>E_D&>;*N_OE^=2@KO
M]^Y^?4%79\\[[4D?<EOTUD71MX ]WIX;7 >)H).[U;E'D%(P;>*H?9U0\#C(
MIM_=QOG&XY#0A%4]O]W!H?)PRB$H L91->C,IM>Y;[=HE7'9<;PC;F(7W%+'
M=MTP&O))_&),^I+PMJO)OE+W7Q9T O@C;@=$N1!<*#/._MF_%_,V.FSA@4+!
MDVK"TF/GF<\[Z2XA2R.\SR4SS_X#L[(.?$/T$RI2V"'7K8[Z<:7J=R].$.M]
M$#7%X?9#"KSN;)_!Q.&T6!G*UWH,K[Y_OYL*_E")&@CH V#,:1B2/ALX_P[A
MA_XI\-H\VU:4L]EC0F0H=:Q2PB^<]ZU"B)1'><RE3W]9./J\6545@17Q;6(O
M[O<.Y2Z-MSK?.E10I,?IOR&$@J0N3:6C7GPYR<7YPTIH?]_1G]4B%GPJ)?;R
MZ>B>?Y/#3G7RT?U?7/N9NT0O%:_J9+TK:LMO,G>K+T^"!_R]_',+<%0B.L/%
M)/;>2E'%ZLI"O,2C%Q;5*+\=T\SAX$DADSN:%'ZA:TXB=C>]W>M$8*J&F.M2
M+)I4DV]'E0&(DB1I38HCV\_B>ML4?5H@^TX*N[R0;>:KSBF;XGV$@ZBI06HY
M1[I%SZ.N0.=KG2LM([S[/ C/JZ"Q-J5/:6_-959=GE?L>YW5? MD-S>^]5!S
MA'L?? <^FSWK^'5OKR8I'OZ=)J#&T+SLUO0G:)$K=.V-R:DE$\72T+"IO3W,
M6]:F.>^^].G-$V^J5;<O]?"V_:<^O/&\XXHI2._J'_189M[Z\97]RDOW+TSE
MAB<NFL_ZL5H<@Y>1%8G23>Y/I6L[YA2Z B$V(E^,*?L$1X)_[I06^'.=\@#8
MCSE,6 ,A/AIPI\BEYG8ES"W?Q<W4C+,M2="HP?I-BPT*P:--;XAN]T;JQ^B\
MK<BTU=: 'I2CP\_%ZC[O#>C-?.Y"'7C_!OEK(U,;>N'"0Y,77-:##45[3_BF
MTDPT*38RT,K,@Q#>&38/^--7$2U<](9881S*^)T/NG?[N6GP5$= ?,'4W84'
MK*8!$AG9$^'&;S9 5WS^LICMI?*$ZX'LL[+$LZ5">F6T%L1/4LDE'CUABC6H
MM#T!DI*BQ(2DYIN>B.IDW> 78TT7>-]GNKUX4BT0/JW@=E]<)')J1$][^^ _
M*FZ2M+^^R&8Q?D)FW469BOD>H7Q09_@^=%#L\C;;O,E']4 ,N^U0(,H]Z?VT
M[F1V>Z$.[$JM<)13*&7 ?P-J+(!L/7F7=&[3T-]_Q(S1T+CXTA_32O.982[1
M5$XF\*(+##=@QOQROX&.-88/%-/+*(:HI/KFQS"?U5;TA,*M0<M/!HTTH[VW
M=3V60<9JFRJ9]M6Z"*,2WISQ%NGO#CFO$M:1<GRV8XKSPD^^)$TU']V8M-I\
M"U[$Q>3N&$8VQF_,ZH8#!J%V:B:'2EV_"H,Q(^BULD!2P93@@J99Y^,IJXCP
MAJW @)Z(3857/B^<+?KFBWT#M/FK+G:+R9LC_ MB0[I=CXSL<X]_QH;@435E
MLR\.SSX: "A]\*TZ==/E%&9;T^\OB^/AE"GA"(*X+/@ .9-=.G%=['=GPTY)
M)_6^B\1^E,C;AE[>!<?#!RE+3=9G'^U/SG60N+<$+S.<LX>BEQ:5GOA>N6=X
M:/=R[2_+J<^#L>L_JQO^LKS:^'[C"036MB5:_RY X(B\I/Y\N7F+IVRKT,3A
M=<@A C 5QYS22NE8GXH5ZGS7??L&<,?U7+3:[QFW/R "^%'6 ?^.@?KT08!]
M6'[Q>_88X>IHU4R%9ZG+3OS4K?</\G\9_Z"VD]-217VA]B,GZ7O'5UX*1/>V
MZKQ.V+FB]>P8_E+FH8O(\NDCN2#ID_QZ"DVIXLI5C:;;1Z/90X]CP7T#Q?D/
M%LA!7O,E/=>:-P]E>N2N]'K^P;2-Q2INS/S' @K_]C/15J8@.J[A)+N*WI=]
M(*AN)LLLCILF#1Y.N1*.S![>:4Z+#=G2R]]F#>__LWJT_FI<3WI8T.G= ^U4
M"F_N[T'(=DQ[KUZ ,WM'^<EUNEW/L?A^Y7JC:BQM55N\Y\F=YIQ=XOW[2KF'
M*H98O]S*F6&PQRG6MG7S_7R^#T-E.U6%?;VC3B=^OSU@])V7332Z>OQPW)NU
M>>8CE\E0+/([E98?%:?G22&^^,6VCZD2()U-%U,-6GANMP_QAI2V.2P!-B\A
M;ZNPQ8&*Z&W:%9K(M11%<V)@]P\Y!:98:3&J,Z3J"VQK)NA)%?0OBWZ>_0(D
MTC9(1HR@@E456A6FJMZ#AA(@>,N*31SZP["X-6:R(M<H4C4AP!U?\_SI38=?
M2/NW;ZBVQBZE>*8P-:3:TRX(:_WRO?I:SY0F(#U 9+M1L-HP2O/S!AP_5IKY
MJBHR2R[T.J?J?60!//E/3VM2IG/A\Z4SOJ'+_4?HEY,)B1GL;B[(]HY0[%:-
M_6DZ JNSNE3@\ UIU5TF\!\+1YTXOE+>>^(?E.= _G1SOP63".$9B]*"[JXR
M=E=PT9/76S27%48JY4/VE?@\'B%K9F;FE&ZZ:OETJ&<H-#^8;)V[U+?$R55$
MC<B6I7>UVG_-MN__#G;EZM(ND*W6W;X4_VN3F3V[>JR(_<KB)-Y+RWH;7592
M29^M]]B17*$ZO@GB<#LW=4/CB5?#O0WP;L$QW\/E,TQ0YE3T6;%Q^ VS,4-A
M(^_WA3#FEN%9<H0W-6S^RA:F=YC&N^RD\)<EH>)Y"M\D].%7?T&5GHY7PNT^
M!C&O1::NM42_TKB,;>;J%6NS$R'5>:HU:N?ZJ::@/P=%32GQ$R^U.S^%<<\W
M7STK;&3C?:L.UC8T::OAV$I?UV@W3%3:+"=3P":UUB#E;[2+AE9SN##D";Y"
M7O1#$Y#IBU*?'600B'>:X#Y\R@6DO3@1&EZ58!)#QJ?9Z9;.R&3T@0+*$]9
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M]%C&;^8_B3$VO<!AK5(UY<MK)Y]7:,$WI\!/2?NL6GSI C>>V&R-I$HT3><
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M^RK]PV2%?1CTU7G8??0BTX]D5*1?Z36&Y'5O( ^*,5D2LB-'*4V,7&J8]4F
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M$Y=) _/SO/7NWWS9-6[.KYMKFPC6>4??<[Y'4UN%Y+@)O6GT<_!3=7Q_F_Z
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M^E(F!N%@T+C]I LTMJ+_%<^Q=:-TD%*7S%2HC2'ILSUH4!@ZI_8!XGH;G B
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M47AAT=ZO8/^:ZS:?)Z%WH:[8]G=>W'3'(:REX82F73_H6/!7GN7P"4VH1Y-
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M2K=E8;J"D-N/1M&MQ;.<^A+W;BL6L^2[VUR"#D?]L"WDZ8\(U<C5U/+@P-]
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M$0 ER\4V^O-%J((F[E[P0,/4G[7^V!< S0/-#AR03NX2^WE#AOU(4M)T]%)
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M)67SYQWPL-6%I-=B6Z/4[@]IE@3N^+X+-K4],/XBSY*Q9X-X;%_JFT3]S:X
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M^98SE":)LZ6T)2X_7MT2'RLSZ>)+BH$=$7@PHM/'L: )+L4FBT 0YU-4TI4
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MD#_MN3JC[NLD9P]RR'Q<9;H8N4@S?C%,=ZR"86A9-<Z$NHV*:+K'9_03<9Q
MY0<075$3@E<OM]WIM6.KUK%MTD0_E29Z?GI:,?Q=,)IOQ-ES)12^!'N[8O^!
MF91@JNB\\C'<QN5],.!@+Z[9=XSYAOYD7N9!$O&@-P+HP7V$8IX$1(L7NV?)
ME0%<C;0W]0=TC>JKG5GH7V39N58.#%!6)>M^G8T7JI/Y5_U5N5L]\X'25;1N
M!3Y9'S:3Z>H^!A_[P&&@<+<^LH0Q^-&L7GVL;9H7K[70K8]IKRO,#S3LGS),
M%SJXW!D9_:],K)!;"* Q*2'B?.:2+G67)B G[(+-P?Z1<._'"\;F LG@U.TS
MKDBF+[<?/<<8CJ9&U7+?[2WI9*EZ6C39K,J5Q4X="O=MQ FZO'G-0MO3+(*C
M2+AQ^MW^TIFU3[6-V^_45^-?QI<0IVB)E6R@S>E)8/+KTR[QX%8\P^;,Z3\Z
M[-Z0D][QZGOEK7.2?%_/"ZK5JRL:!I?>E?YS$[[E\EC)0,)(:QQE][:> S@@
M<^Y?EE=#-5.9T0Y^.X5DBVL'7L4L'P3Q7#16?F=G1GB0[%EC\.==#FJQWX)3
MS$8E9"XHED+$^VU3=]ET*P-<&V[:W2@8ELZHW#5)[67,PL4%*]S.(,<8MNP8
M$$JB1T>92:LQL%D"6<_:C"GMV>2U^]1G=SNXT;9MH^27 $[:7[YR.3#_T6DD
M F6K6=2;6\]\XV 5RE,V-5/[[0:T:LQ%IA17=#]&/JAUG#&_>I>UJ"[237B@
M>EDH[3D?"X9/_MU,,0MKN>O#@VJKWK##9']A>P?$R_DOJ*YGU%U\KO4M0:P%
MEE0*]V@Y0&1+;7>C'@)GK=20?H]=HWX]$9+2C5? N;4RL:K]Z6E]18RN]*_1
M#+.>)RATFYL_=Y]L?4MXN]S8X!8X^DK&=G:.54S^I*I&SVH$Z<4&$_C%..OL
M>9%?*^&0VNR31QTD+.*WM>,,%WN8I!X^:#^GB298)-F]J52(\4WR#%THA!5C
M(__+V:7\9 ?8"Z&]N$O?'Y13Y-_;9<7Q4_$5*N LO1-LZ7L,T5J!.^J8)MIB
M0)KU9,6W/)44"0$8LK@+7!,MZ]:F'=7[*5RK,S%FA3?31/-L6*?0*^=>L[6]
M/TF(]1'NK#CW)#G;>Q!"##,-G)Y='P(DWLI2^*"J^6E;5W'P Q2XJ'Y<<8WC
M\%-DA9,J]+Z11%NUWZ9AR-M3%Q'DO;@O(I*;'E,WLA*;./,K5'A6)EM*VD&T
M31+)UH9Y9NCN_M"%EMYV,!DJS1<KO>)5&2@;(<5'B?C-KULN(O6B_EQ:^#;&
MR<:*1P",2Z%>E1')X[1, )I:.C0JM-@^_7G:!NYM(+QR"B9>;#-3_G=SZ$66
M03P,WMLZFM_ZRX1MU8[P7V#;).TO="7,G,I.3%E^5"(1AA$%+>_(:H7XTOCO
M12LQ\6-YQ$=;ZA:[@0>"IVDQ1?6M+Y_<A>:+YAU8$GLQ-G>Y[O\K-^M'Y]P>
M<AO\=][I9J4?/_N:+2^%TL3Z A_1**XYJDWK=VP[L2^(WRP@S.0MFE<.E:MH
MBE^=B>RV*?*7^;Y\ZFKO_BFA$[W.AUO_2C.:>P_]W1[X??8'\H.$@:[;X S:
MZ(:N<G?2U),N.NN$9?'HI!<\9 \OMG^X/<Z2KAMZ5'"#L@RR%(1<RH%3R;2/
M!J-WV;CC'C:'O_#PMLE6XB04UHFU-?-R'>UDTQ#S.PK(;2:K4Q7B-Z9%.>13
M8*_7&X/>=4)YTDRKO#M"[MDUQI%I*,L?5K@:+1I$EBJ"Q!6*#QF'&"9K9>L<
M.G&-/?$:.8@3*[L7\=N/0("N;2Y&B3\/12:[<*N98CD2/> Y.Z3+[$ E.KP,
M_-/Q83M&_6UP1SM_:P5-S/K<>BH[)P,A MPQ7@F;BP7.25'R<HQ+E;I@1T=2
M'-"*IZU6\?0&PV>?@;P]QY+V]J""^>><&ACO@+0D^U^W/'%?3;:0-]*$#=_J
M\F+NS_PH\&1!6>#=$^ZDS!WAO)S%Z>_?LJP9YQO[<1J%"0Y*^+E:-:I401D+
MMCRG52%8RB8*/KX+^551@BE3\R#]@<J"B:Y@(UX!DX]04#PJ9J4YCNRI<APL
M7,LH=V>H()Y'4AV 0Y%&,TX);%J+XE"W?SKMO$RT>:W+P7Q\\7H51(E+N/EH
MJY%N U]9H.18]CG'!!9%T(:*W54'U)1 2$W< '/$FG97R*]^[DUKFTH5,<3
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M:M_Z4YF:[Q/(X_>]/,V+/6VWW8Y$!VSMB* I)7JB%_DPX2IUUA(F4M=0O_Y
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M=QM7HE;*8A+E3"HS-^Z2*CG<F0%?@5?3V^;::229A!8B,2( 8+R>T%K-<S*
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M^8VS)I:6;RB80>9> LQ.7>,,"E#'P%R;>#<GM3-ER$;+[UAR5!W.?%.,I]O
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M.\#H?'AVX$DF DE0:N6MLF$50*Z2:.O4&:1"VF'LBJ*K/S'7@K=\PU";K\=
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MP<=@>;XBALOYU#8&BD$/Q[20WT?G#5MMT)(GDZ^2T&2*X:>HN7U#0JIGZ-O
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M\<S]V%/9?AM#E8E0W!:*'UE$%+QAQ4/N)[44ITO27 ?\"&79KU,3H']'ZE3
M+Y7H0+5^MSQM:LI3WUS@CX:$Y>2O0N,"MY8S1'_6A*9M\@'V4Z&&%741ULP%
MSO1HKZZK LT_["M>Y<16W#?+NQZ8U>5C.=*KH:F4]JVG%!>;'0LE7SPZ#:V[
M^HI_PT:$LGBEO5+"M'_9.LU7CAQ7[::**M[Q0>D7"AI>KT8N[.D4H99WQ!SK
M4E=OP5 V18V7XH*/89[ZZ^U<@Y6\L3YF&:55YH_3NKY6?B%8>?*@XO P*M%X
MJCB8]$+RJ')LT.IBMB!NQG'$*6<FBYO6Q*[>B$K<C*T7,?"B^E<8NQ;)X3VV
M 3PQ4,)3=V\B<J['[6Y[13'INR+0W_SWE/:K47BTG,'K,J5H95#'<TKM8^FO
MPH'5%2Z*%;%C9+-GN2-;WE1-VG*79>V[$#6IZ48>N]8_P\I2"E#ED*+=40"V
MX5=6[IL-BYCE3G:PL^3Y*K0]D(4"F8J#V9(Z/#Z#W6S4P66G\=8RKZ($ 2W%
MQ7'H_B*EL_%@-Z:C&PI=VH#*^\6PPMQ+A."X)>PG/0Q7?1[F[6[$^5O>7K?F
M_G4K7_V8%EZXJ%8K1?E*OT#=M:VA\^?+<F+3OPH 1T*PU&>I+QUX2'XG'R;^
MT0@)^V[;D%@D4]\HA6(8I*@:8^MSH9#"CH_*3%^5-__1Z #G+B8_^^9]SSW1
M@Z=X:$P=T?RO<W+Y?Y8X,0$"=VG /3>-Z[-<YVC]N,MG==@RF @ X1D98C@O
MZT']I-:5PL\>PA(J__L/R034@N3H&M)>GDC"/TL\*J5UP;-6JEQ7UZXWWN;(
MO^9M] 3D@GDQK'4CEDG*7S2(K;(6Y?"=L;Y2>#/A%5HP_GWTBM^#S\9T>#$:
ME?$)TUZB4_ZU/=<A$6\MD;O\1D_0LL8>! E&(V,QX1DCE:Y)5^+,J]>E=GE:
M\R+7F5C/35R)/Y\42]<;7\HLGE<S"3#AV".V5BA,3-RYA<ILE-ZN/X8Y)$;B
MY4NT&U(\:&3]Y&"9.LPBM=$[!>A\:GHBS:ZVC@@3K_;-B4E72)::ZO86>-KX
MW?5B]!W!68V9Y C3:TXB;\<(>%D_+98YD?HLM,M-XPAM=5I:\(PKT1#X4<2E
M,(P6++VI43JDRER_Z?&LCL,8) 9"AV7M([TR1#F%9LU0[Q T[4U<,E-:U&^B
M0PVN^;RYK@%.*'5^_RA#26I6(T8I/4G(KKATNTC!1(V5Z$FD^((=BZ_(MV]L
M$DDP=9ZI>[>9ZX^+U0D*8KJ7GI?6[AN8E3A2PH"UAQ.?67_!P/4TA-(T*.HU
M1TG^%7@"#S%.[T*4!H$1@:E+_YQ4D;X!LS)J"&-+3_$3WE1A L_J$QA,:67&
M&TIFM\$"I4NR'N(_C5"N^5<]J?&NA=DB-,NZZJP[- ^E_0MCPDC%\[LZ?1DN
MES:)K>@87=/+Z?\YP/9@^L0[]"5FI8_AH=XJS-M&@T@W;61D*36,=R%V4M8X
MJMBP:HI[<B8_"9W/AG1QG^RFAK')])@US2*K/Q$LX@(+;@_*!M<O3?%)Z+G*
M3 HEH2-V39U@;SQ0CK>Q.OXK6H41^&N)8EI\J#Y4::F>8R0<@5.MW[?P%%)&
MHV6BU(R0H3O 4JY+(Z<QNNRW.@&K2L)C,'8G6L#1%1+%\2Z2$FQ6\$G0CJW5
MWJA0SJMY^?6B8NKW!P#2CY:AD7R)ZK>]+?*S([WBP-O]1LG?7E[O!_T81X=\
MTZF?4#2F]LD/M#@U;?OVT%)%<76%@>%._\72*>1M\P+!0S:M^J9OTKLK?8*S
M#T>&YI5K>\Z[C?GE,7^25*4V,VPS8;XG-E4'W)X:'W=I699_#O]Y]%?O60*J
M+91S8<) 9W'2CU)\&2ZG0U7T7-C6EZN,>0)?/IIWT+I*L&;"[+V6*S[B<JJ*
M\#-#\8F:93S9TG<'"0G;SVG&3V6^;G?+;XKV=WOVUJ8-\BE3VO?D6E %"R?!
M:PYV3*DKC7;=@ D[C$, 7P$^RJUFO[9! HVP(A&!@5=ZKC3E,!CVT<*Q]LT8
M)I#LMU%$_B$_C T^T2.FD'8UT^@S00*%36.LKS,=ON_\2=0QN5#+<5%J(1$'
MO6W22%+C(1C5&8X:UIDPL(CE'N6X%A:;Y3N\?7A L#"OFRD^\)Y)N5];V@,&
M;D-0"J;N]=7B=CQVV>WE?2Z%% "JR//H<")C7C21J:R\U#3&- P%*I-^\T#'
M%R21EHF8A)7 X]+?ZV#U>.'^\2@T,BE9M5UTJ$_"4- #G6Z$=+^47."57NQZ
MJ9RS4CI*!P,IA!?CX,]JV(N\$%E^D+@*ZSG3'[0.\,K[YIYP&9B:B#:O9AVJ
M4<!4'3&I/F>W;PPT]=!N*>>T'\D?- N8C)A@5X52"QRI>:UETI'E*A]_39)2
MI"OU.';J(UTA.5I)%:E_ZUO1VI0RH\1!O*HMX!'!M#@4CGQP^!!"@$) =A(J
M=QX2S.-<DS#F9OET-B)GK',F%N5"B2\GB<%3E]L5'<XJ'"1YH3%._27!)_N&
MY[6AH"/A_XT8(QQA<R]$'P\_7K&)NKHB@:XYE/WX;F6[ P<C[TSEW?Q'T[\2
M L=AY[&U?Q[D$&O *3LH:V+""5B+TV=]E!_VR_:#*-.<Q3&6)S'T/,1M6NEF
MM6?A;])3[#+*Z#1A[/%[#:'&B->\E;,@$0$92?J[[Y]B<SO8YKDMG\9[=V$U
M.O=E[*8[.F5[37PJWX0XBMRG[>EXYN(:6 > G>;U+?#*D)-YFZB=*N>.3B#+
M@*??W-;XD0O<?^1U9B5('9_%JU9V<C7$V8EG'5YS#:*XWKS[%F1EWS?#DZAB
M7P$H2:PZL*IS&2]E<_<$6]5Q/=#/4S@L;53GS/=K@QYYL!_QQVT)C"J;'F;1
MV3\4.>A1:[W./?![='GG$U-N1O3+;T &RJ0:[X<B6GFP?RAOTKU)Z%5<D"U^
MF$(Z9/P%VI/&BI*=)TU/7/.8SAUFR"GV1/+G0,2?GP'YZ^T( WSTHI_$"6@-
M\J3^L^UC3&ATM&U+G9)Q4?#Z>"[3Z:=?W"#K[Y3F?S0?+Q0N)L+)_KZ[5J2(
M(JMAFAGN$J?3SQI-"?+A>)^^-) Q=:>XV?VUY'1#0;DGK1SHYR*3@L !QT%N
M3F7*WKMH_-0!O<WQ<5DW]I*@^AWWLMA>4>\OAB4C.Z\:/RBTRRO9RH< U__1
MQ'"IS=9G6$$7?G^.2):_+>./S;IX',BJ=5]>T6WH*P6J5.:(>/Q9C<*91MH(
M/Z[<_T=369V Y^/^PT3,$Y>K=K7W^*."Q1J;0#61%$IO$F>+F3\NIT6D>K:G
M@S/%V/'L.@&1%WW!@CM /[E(&S6YQ?46I9%:5G-8_J7Y8BO4=-GYV;&)K;EL
ME_?:^N!?(*WYJ;2'V<?HHRK(L^QZL65JTF&Q=\N*0!400?:F&-!W9+6>.-C/
M-,GCWP9=$P1,<59D<1P<[.AJ35D+/1(9]TQ6H2' P;W)LIYIUI@'GDBWUKW%
MR%5BID:WKTU!P3FO;!):PGFO&I'QT62.))W]2\GG#]/HB>5!F5CVUA0XQ+SS
M<H!X<-[$%]QBA-.0C #_Q!?S31]_X.8!+.]9O6<EP3#L'TWI8U(["UX)D**_
M(',+>=B.X<O/C_]_?+T'4%-;^#V*8KF@B"*A%P6D=PA(5^E=:B"42(=$0'KH
M-D B1;IT*:$$0J2$)D7I':F1#D% FA":H;_@O?_R>V_FS3!SF'V^?'M]:ZV]
M]]DS)]G[<WI0K5_+\4M.N+E*,V5)Y@AD<$I1)_T)9^<2NV<3WVF&XY0DX.#M
MU_Y/ST+]CD!MCI".NCVXTD+VC;/O'Q+\%8>F<7V[8+V1##Y,Q9DHW I[8U6M
M[V?:[@S]_&'3A[OTJY#'86T=F0^\>M&:/0'L\D+1%[B+%ZM3/3[ UEP4R3<C
M_!*FAFN;:8($@X$6=^S8QL987&5^15E1J!",#65'6Y&P=2:)B:ZO90)T.@5>
M[3Z%_2BQ'W'OBNQ-W9(N]PT0 <._P%PI&WF.7BK9PJ7:1JF!+NF?N/..J7J]
MC0Y!7XBA"W9S_ ET7IM6Z-BOV3*/27IV"[H^=.Y?C$B,3:+K6 @H+HYG!!5Q
M-&6-A5P/3A-744+Z#T8JLC5E-]]99!LS:&\I:$EB5/?J!7&B-="F/G(40I:O
M:TL39$R_E25M,3RWB-/V1J%OULTSS0UY[P897TK;W AAZ_9@<.?-;LDUL:/J
MIV6IEL^WZ/WEPC3N^ZN@,? ,T%LRWWX$4L\]>2#]UE%DN!Q>I&Z8Q"BQDF?G
M=3I>V D3W[_65,Q^6>+6%D\-TM.:BZAU%%!^08Y8QTCRNSJ;)5;SA;@2$7"B
MZ7)=3K<-)U6^[6=F@0P<& K.R[99"E.^)S2<XQ*9<+EF3X%U*]^@1B;7^G>I
MM,PX-K7^,A2Y%#TP6#^V-<M,!$^^_FLME/ZKP)S!A".00,?(^THIXP=<074+
M@19AHPF>6=B#PJ\_#J;::T&94R?,QP#\Y_<Y>Q@OHL="^,C]QS4,&#G6=]%F
MSKXVQ0^UC;X0^-M/DZ>IOT!X3_1,CE5J6==7S\GH-(9^/%1,VMEJLUO6?^!?
M2_UNCF9/7LG<:%E*@-'V0\WE+P+1DM-]CQB7L56QY-V^:IR#"Q"C35K3PH2>
MGWORZQN[;!TY@0+A\N36ZT[;V)\=MDI)[N8G3"XIBOJKYO+V')#/"8H!(YLK
MD1V/UZTSYQN?_]!XFV%;WV^W\'CD>[8 PT'9$]U;VG+1GVPKDIQ-P51/C"<V
MP:%M-JP?K68:8?UG]XEYQYJ0-,2@5EW\[4?/04#\>T8;TUDJ+T/D/P._)KT2
M(E= Z\N6E8'#J,Q: .!GF!/G;'65 G K56UZN3%] OH";?[^00/Z.U/LAC1/
M;MK!X*T@H.MCXT/S0:R?E!)YT-*5UB,02WGB0IYT-(6VT5+V9\MS,I_B7MC?
MB:1[FT'0?R=4:\EG[LVF8ZF*@@**,Z90VMY%4#(7JQBP,Q,P]L4Z#SA.C&CQ
M=-F8NT^JQU"CC^89P:H\/KY>)FW)*?]$MG,J=Q =W+R-MI.U]R='!HEL+^O,
MJ>X##L[)6JJ5)LIW3SB:W"7 ;&5W/C:ST(D5]K[Z@?L:HGA.]B&_]FP_>)WP
M.:&P=P^X#8J]=#::LFXE VIQB)KN'CG;M)HRWCLG^P*"S<0MYY0V, TFG/HM
M@H7^Z#IIGWTA%-ZI'%.D)ZVL;1#PL?+"QW,RU?>K$/H@L>>6JON82D6FWK/W
M],--,'$%%IEURKQ>P$V$V)/>'<H8S8>8Y+K5Z5=YM(.\1G]VM>L3;#FF$/HM
M^5"W2=J7= 4&NB;%)B[1&GI0*7RA0/OC!U>GZ72,"=W&%5Y&JH:<:E+X_ [3
MDG93=:WGE#M%*,/.33#-& A\F\MH)QBEL?EJTTC0QQ9X.:E#E;5:SN0=_G*^
M)25,D6_ZT8_+1=->IFQ:&)Y^#4H:]01=L^TQ[\ZLT3D1VM_,[ZE[31<_F AN
MYCBVTY/KB *9@: 8:,C&, .2M#NZY3(%#6>844]("T";1WMIJ-+5'!3X XOL
MBL"RSL*&9FO&,?F35Q5XG:\= L$.4VE#4R9EG.N&S PU=P&H.9@<JGU//:TG
M3@O[--I,N#(&IL98 U)P:[/%"F6]RM-,1Y0HZ#4@8E3[R?K^/)0D_LQU7KOS
MP65:V$7EL,1@W%L(M A]R06-1JD!;P!%GUPRS/E:]*I?"_NHHUMG]OWX^TA3
M2:ZTQ2!E_+N]??=LAH)/RQN1S<(KYA[!-V&]E!U?</=CE40QS+@S >07T=U0
M\")&42B<Y\\<VF_DZP#X8T^#P9X<//[>7%"(MTAD+GN'DNQA3A._UUG-?@')
M1",RYV061SC]47N[_;?!4K.\[X\7=XNFVN^$!H7X["H'&9%6F6:T6!-?Z(C[
M>/8H%]L,NW8-(N_LG&S=0!IAI]1YA.N';%=1G^R?NC3_>W4^BGJS_L_14V*6
MR%;L0"Q1,_>,B$E76G!F/UP_&CHGNR%_3C8(&8\MZE*H4$R"W%7-;E"2_9S%
M_?X8WV3/3OLB=/RL:I^(/"?3#05###X$V[#K81 <9\23-6^""F2./3.H09$_
M= 0RG@]!-._A]O/6Q*E+.==4"2I*I)M\!)V_,5]('=F=I8=4L2/.R?:F2%$T
M[#7J(VC\N^8F)=FP!@/Z/YTK$/&:=O<CV-&(T@+TG(Q486R11L@,NVXVK>KI
M.=EX&$%'F7A.!CZ,/:,K/ 6>.I^3A9$>2'6;P8IY'"&?8XNN(W(OF-!CX[^@
M#9,2N@!C/]P\&B81.ZJT^Q>: (F*1#CJ@HH/1-+E#+NS<V*JM#NU3ZHPK#1T
MI69=?=1>R2VV,/TOZ=[M_Q79$2+@<5:=3BK#XBSMK"I8[<E1BV(.&_^[4(:3
M5>;VH0N!=OZ<",5>X-=O-PQ=PEQD8C=3'\'@N_XM4O]N*/LZ1#P;D4WB"0E!
M0/XW7:MA!"[(W"G4A,"E3"01(2'2KD1*=(%\G"3Y')K=X(/@$\4,-IZ__>F3
M"B6>K"^S$\%S)#+SE0#Z_RD]E;=:)V]PAYV$Y@;\K^)-+DJ OWXHQ*>>DV4U
MHT6*-$))J 3P\ M4J?+_4B\2BP@EP2FFQ_^E]NCMA6E>PG/_9>KOI<F.1!'Z
MKQ%<B.B_Q(=.[-"/W]G;(?YE-/^<["U*,)APB.O-WL9>0')IQ9=W'FU="'G1
MY^:_<K\_HRFZN!XFG-%A3J5.7="$IW]-F#)J+T(B8XQ@?,&YW!G-W_##X)"_
M!LM2Y,\FR3ER%!5!&AQRYV04*O^%_9OMS44V$G8E0.S)P:G+J9K*J0V[OO0%
M5_D7EL WV9 *0(6N8-8U23H:7>C8E,?11'*.^E]"?RF2QMLY&3JHF70;='&[
M>1O;O'IA":X+7,7RNA=</96._)?^ZHLCETELV 49_AV7_S([7()WKB2%&5+?
M55&* O6UXE/^,VO^1=?Z_PI>CB^*()Q5+>"+8@DD:B^0(?]2"B&"(\X"+ASV
M%WXLK4IH5(@W ?\NXB(. D'\O;M%!#>3E$?N4URO41\E;S>X\&KS=I+J*0$B
M$MHR]M<T(B="RN=D"J1Q^_3#V>?80F926.A^06C+?Z,M]&)8D,;B&5W.7V>P
M&\1!2"J5X-_5'I+P8_YUV=+<?X@6"'^M?Y9SGP3,@&1-DXLT!MWXHG.R"_XC
MSNAJ_E43=#'2@Y^H!CNP:RLA<GE(WDA6NMU^G_TAB35.@L9?L0MKB*6 B*U0
M<.2S!ZXW8OAY1@W6##1C/QI-VKN%-Y!K$/,K =<@XU].J3LH@FM6!F!]Q6&9
M"@-'\'>]RK5QC?QTW.]EDI<>]YO%WQ3R:)24HZM/W1%#26BH!PS%*T$':Z-V
MVSESY0 WE_3!$%'-C#'_Q.*BL7?<E8X$ 1B3I=^'SY,RF#O$5]NC$,&H\K.D
M+93R-E2NGUN@2(.?HETE)L;:/N@2'G-=/V=: A7W9E5GNSFZ3/++6S5/48_Q
MIG1BPO:^.^>'?/,CRL.$]BR*VF$WJW'Q3TQ]*QXO_-2'YFZ=P&LB&5R4P ?!
MTH8Q:X!6\C2B0$N(:+IJK;&CP!N(ZHD2,5P$0*YY]#W 6X G3V'8X68^HJO.
M4,)4<M-0KN2%'WF[+![X3*/(J82<0P]+ :U\\1%H\JIT L=(L6PTK!5!N]2O
M4BV]7.Y@7TP^]FRTR4'E@:/W4$*"Y/V4-%QE=B%P0%T:B(1)<]0[)N;*VQM%
MXB8LO9?K7177_P3#PBIK95APVH73#E<]E/'E/T?RT5YR';A\"\U!Z&%L9\J&
M8VAZ8S#58B0%-F$5(@9?4SM6/H5M5929_3A)1^0! VF#I$52@^H4UE>;PZO%
M>F_Z7VXRW6YK=Z?-!A]!%@:JDK<[D]L#ZI#TL@'L#S[8 F2KXU:S.+8W:%8W
M?&\E[6#:FV_EBVN9!,-63R'MMT_#P@DCXTUNQ.(2]1?#\V_&&TH+$O/DV!TR
M086&D7@P+?><\5.E1HAID AI!_SD\29$>-4CU4?TT1G_4<2";GIC@QUK6"!C
MJ<E#JVSV1/T_U9%V>$%78,DS7TP&%JUP-MT6LW\@_>Z$&Y=LOS$(6#CCW]:V
MZ-E<PJ6FV.7.<2HT#-Z0JAMJ)^H174KS"8@]F8:@\HF-N:GQAI:S'@NI^X\!
MJ9(I0IW]$$UY!?Z2CX<!\/K/0:6AT?LCQ5H_69;KJ!3,-#31)=&*FIJ"5(\/
M]._=C3(=M6,*4#'),ZQH>.UR[:IWR)VXD.%L,-Z]S+=:X--VV) TQ6! @Z%A
M8?&*3=%#D"Z[(?$6[W+DI<N-BKC6[;Z7&^Q)_DJM@:\JY-,.3H771!Z$V PW
M"W4>5SK]]K=/R(TS\6:P8?RAQ ]3IY5_9HH=:Q%_ <MN3$]X8\VR,3986'BE
MJZS VL,LQ= ^+0UO-PA\HCX DY6JFV#(YZ@!RLNGE39"E^I/QD9,Q[^']*,-
MRNV;>?-';6;N%#__C)(P@*9HLO!P?\Y1,TP:ZG]7FL>LL9/-;!&$L:;"_U!T
MPG@3JHO9<(=A<$@DADZ3/>U4@L<( 5("X+4U:\@'?J,C/PQ/%L<X'(TGH+ZD
M1>9<ZA#8L$RL<FI;6.15_[A/'2']V#&*Z:AYX>>0I-@*J\!B]I5I?XD"_8 C
MB6\AW!9F=T5B%&"[TSO9.]F%/\T*>XOW6%N5#T)F!%X2=+ZC:CC*L2+OXEJO
MR0^-C#?TMD-HZ'2_:A[ANA9>&*&%8OWN9/#33(^/ ?])-NI"><QUK*#]P[:B
M=8:SL^+GVML]4C".3>H&+:MWU=^M[@;V[?^8E*%+Y5+&ODB#1-&ID37ZRKI]
MJH'>\H)0O^MU4 O(^^UY@L^T3S072=!>PF,.GY5!Z6(:CF(D%^TV7$8-0?=-
MIPQ+"\?3E]("VF Q-)Y$C<2Q]ET^/R9]WN$-22T:=R,3H.L501>98A65D7'R
M5:,-\X0OHZ@N*,7=-V UIM?.SDD/D3F*0WD<#J@H;+$D:3^\L-[NT<V3)^GC
MS@Q(\M":-BZ0-WZ.[9?Q%*+FSU%;7^ZWF;/8UO664$\;:(CX"0R3D1:H;$,S
M9[BV=]>DOT'L#89/CO@/O9Y9[_4IZNGQL))^Z7Z3WN#G8MK>!O)N5^+S0<R>
MN(@@J!G0!C]6N6K^>OS/*ZQ)\AAM#;01/^53B[6]!B^[,L,WRVW9T'7XQC)J
M8EK:S7D(>WGX5=IWPE)JN/\_@-Y?\8#:E?%FG6Z/6YJ6A')C?Q\%(_W:&0;T
MU0S'SY+K+S]C@%QIKW/6(:!WQ;VLU&QBB9EQWTL$*.U[Q-J?<5==N[:&92NJ
M\"OC!PKORYZAY:S;<#<R".;2OB%N<'283T*C2#P#T\%]+G\3)3\A/7:#RAUQ
M#X3C^U(@=CCZQW(-\-?UY!]E0@9Y]8.-</\R-N"G06TJLR/EKP'-DWF/+( 3
M,/ 3:[.$&GE0U(G"6%!RE 2HSLP:.1,CD25 :'#E40M@-U(MB$UN$G2&..Q^
M%%:B/(QMHZ>FFA+1@_T6><]$/?GI8]@@@/ GND&:BS[&UP]3U#4JH,N7Y2:;
MGULE6E7'I-H-+ $,A3_NMYL\)\LMHZ9=]&G2HPI9"._>'N.=R<,O1:$* J3#
M]^WJU-;V^MG.R8)@_?#L"'MW,=BH-U]L,I:(NVOC8H,"DJ]YKHT4C0W\GM7]
M@?XGVO9'[U>T<UK3Y>R&X#;;NAOE6'#4&"T4>P/$DFY4OMQ_/$F'0VH4Y$:-
MM/L(O5=)+XX>3D;8WHN#-KP',4(IZ#[TB L99 :,)Y88%^@U/)7@QLLO5XC<
M7[?851^O_&W3+]FV)Q-8%$"P', Z6^E=]?UC>@HOU5Y7F,!_<>G.R_(PG-YM
MKPGT_^.]W$C_]8P+)O.4KA/8!S6U-N,!)#G!#W#*UUEPN<B!TH$0:]W8\B!V
M?%A#F'$UK&"TJFH4W=WA*;""B0CAXA\*#]4Z8FY-R_<S1=T@;]?*_W08EZE9
M)\"FM*ATX_#F!OT>1KP^<Z. LQ"XAWM?557_JB?J)^@5O.81W-&6OC$XQ"(V
M,7A\D*F)54'U.Y#S_E-=/U//\"A0PFH\-N,EFTP9Z:FLX6L>\(\W+% E: S^
M\+G[]"3%*,'2Z5U5LZ#8Y2_'IM0,I9F>77H1EQ%[HW@G-;>C+)"KWP/T]Q46
M'(HH J;^+ '*A$YJ*]]_QG?$5C49M';#+HU8:GVGV(JM)#EB2)\%E)P9"_@)
MN7W"SQUC6'P$<EJ T A-:R&_F/Y&YW<638F1JAVP7HY:'E]IF97<GK+06W%3
MHIPORW/V%%@;?'=&R=Y@PQJTCH^^L^GH4<,RU@%=3I9Y;^KPX<ZZU4J8SW)%
MG.+S$&"K,J/:<IG%=)5G%-O^W)6/[&;$ZQULMAVDYT'P'WWJ-1</RG@O" V<
MIRT:QN% Z ^^,]_,0,$9Q:@$GF\;&7FB;XJST2XRNY1&"&6!JUA2,/"L6C?:
MP&MZ9/J5T<ZK'FYSPG ,-U6':MXB]5VB?VF^5PU@I::/T/]F'6) /&ZQ2#8L
MMKZ*A]Q2:.CS?>;8^%#C^_ V78%0051"#.Q7,Q5\5<C5V+V3#;OCF^UY0'/+
MP\H*\SX_1M"=,Q:\87J=<UK>B<#<%_DRH08-%T$$J?P9;N[/&+,"M1G.V+MS
M?_X:&"GNGY/'4]0+GW2I\%^N;Q3^?I41D%[X8_->G)50E,TC0%8;?2G^!F(*
MNPA(H=Q#,S C=2=22RA*//9*?]GCR]0?W$].3LX%%8;G"QOJ#(_P=9(9<:B\
M1.0%2WWWT*EOV"$6W3=M^D FD:;V00<Q8U^?XKQ,VG!2$!^7I3(4A%+J4Q 5
MRKC4^*QQ"Z&W.NUHDBU-..OO5/^T9MVN-^O(+U"B_.7FOE#^<N?:5<UBZU8G
MMQ>/VOWIHQN@U;WW:$*J.OG,&A?9F1_4UU(?X5[#1SJC)32N9*,=B+V=0I(Q
MI/_\8Y H3?AF-U!=$ND9;&$9OZ-V&%D:%K8<E.6RW=(WP5&%7K@1A3"]%S,[
MXG:+_\1C$:O)1*U5":BS?5AL;Q554S,]5F/G-(*(&1B<K-EP#? P1VS$#^ 8
M\-5H/&55EVM+F8=.UF(W'DT%5?RM+\ABHF'R.Y_RFLMVB;4&&6/9>HLU-2P2
M@# Q^Q5U93O[S>3J$"(D:3.$<;O-5RR'+[8%N=T<;E<9>4-8(-2P(;QC>OX5
M(C\FQH3&XOVOYYN#CU]9FR^Z,SVH[R)?)*!FQ0DMDR6O>-8A"L1%4JFU) ;Z
MECCT6>&'^2YD"?L8CC'LJCN7^\<T3"FT8K9K3@RH-S#V\YE&O^; DH<-]D)M
M]*:<-B>[D-F(Y-R7."M@YLM.+5MLE^2Q0BV^9F/S92=M\L'C0)."TY[O8(3@
M(;2<8+X3X2+*;_:;R:BZ'G.+:+5/<7MCP%D*P4MT;_6$]+TM5@H+K'EU<KMZ
M+:8[MB5[?NXRND*MGTV)<@].QRHU]_F>H52%(/A0]CG#5P9 *W&QW>/;C9?S
M'NM/X:T=%(YE5SYBLH/\"&3=R[P)^SGQ$_KXZ]'FDZKF2F!"L-'3^+/YDXGE
MTG79MK2W_;MW$PQ6ZP.U[W$9L^RP%JP^WZ  3+@DWZ?UT!OQ_EJD")ZNJ9R:
M?/W/LYJ.AVB&G*^%G:Z(I/ Q]!WY&GN=8SBJ8Z;,S"Z-:WKX&4A_(9@1PV59
MYE\<-\1 %\2YD!QO_R!4Z\_</[]<8)0TM?B*!O8%U>@["-LO<H6Q.F_*1/FI
M0FB$/(_DY(S>Q A\4[Q/;.TQO]R\;@6*;7#\W,D1*4;$]67)$>PLN^]19^G"
M6'60G-F$E'=I.TX7;SC=M(5%2HP7?JF%I=:OI'T?V?A#YF$\X,?1$0NK80%9
MV+AGF%IG.V$C *,N![-C49%"X*D%5>=V-KYG-2TQ_,/*Y@4<#>]U8N2QYJD/
M\R,5H6/WT\]8:]@\"=9S\WL4ET\%.N7EV+<,&U-:R5WK3P4HY"0JF._"*^;1
MZ;N333;$N!?VR8^SEIL^$-YF_XK=PZ0JWI/>RD>]K\M4[MIG\.N#;^F/N![4
MEM!KUROO7QPF9V:ZRM(QFTV:3ZYFV*@Z_E"NHJP?.?06'W)<5EA_!0J2RV^H
M>=\9\$;;R)\C!KNN>'T[.Y-#3&\_:5^6DSESJS7ZMOI-A^1&V<.\RHJ'BY<K
M)%G%O*<<NCJNVL-[V[1A,(ZM3@!J="@KF'"W#3_C<(F :PSJ78RE ?95D!VN
MC'_!1%KSBI.87)]MD#!M"$P/7Y$?LH_JJ5##&:Y@@"7('QN<'.G(*?<.5>]D
M7W@GX):IA'UU\CD9+[YJH?H 68T]5 ?DL3"K:\58V]U"VK]&FJ&&6X?37T@)
ML50#$?Q=GX3LYYPR*&L>?'.:%##2_0XQZ.S-&,O3,WI=OTNQ:IYR6V-LPRA(
M(53$+^4()%8"MY](2$+?=4Y5Z\P\%&%VK/(^!6NKL4OQ6SVY<_<.HBN.(0'!
M5)<YJ+5]3A:='Z/"3%H>#D2NP[\.?J8_A2V]E^%"V.#0 1&O?9RBO].5N:B,
ML4.(7L;F>4]TO3%<7MS_8-BVW2KL8\3J&WGT:\7Y=RWCOU<D-^9TPM$[H&1X
MR<*PI4 <^ZHUWEAT&35CIBKO=(^I=U*R;8*@%-7$BBW;(6V2?Z9U1#XH?>L*
M_%.(:+C+NN?^;I<("H./+*1&9[Z%( -H"X/;8C\N5SY_ANA+ZT^JM$[%$!TV
M,BL^MGO\24:*BUEQ24CHC.:7?[!YAS';!L6RS2Q>TPD!+NZV3-4"%+.#'^2C
M/%55<H5BZYO8B8>.QE3<H4P'0DI&$89O/6_!YF.O$!<VK2XEL$<'L\ZSLPNN
M,[@HR.'DPFOX=+-R2 L8LN_YD[.DQ3.N[6,+N=O8W_4AR%M(MVN/NTKU:> N
MPKF.)OW>1J6KD65V*S]^!OJ+PCZ-[%/U7)+<HH$'H[ELZ0']G2_&=YX1K _H
M&:8TXWK\DG<BVBT,!3*'MZ1YN]$?EV_*XGX\]4AT\^J_JQMN*&86D/3N(POE
MY'%+'+KU%A3E*[\:6+:2N28KX<9%67A#TW;^M1I5 .L8XK,\"(AR"9*Z"B=&
MT<+4[<IB^&8[FL,:7$D%([M6QAM[OYU):=<.F9.&<4_TE>H*.D86G/Y",[UF
M8=?+.I8CW,I$.(BW>FCO!W0U^]DY6=X:W6F,ZHLLOFU+/\1/[E#*CNW06+HE
M [#6/I7L,NN3._&W5(-*WN<)Z;L):3H'81?UR;#-'R^.L=,N!O<7]JG]\PU3
M*V^RX.R>ZUIT2Q4N'7W&(EY9T7D$LN<J"$_05^[<:]3L)>NH_Z+]J4>F#&8P
MY#"\K,3'4 !>TXFB'0<6S[#&)91/JTIK-=X<ZS>;_4V>AJNIO0[ ][S7^14=
M_<NQ1( ;QDT!_>GI6#^?85 6MO]\6!I(B=5"9YAZQ;V)[I#TN1(WUN<8ET=E
M5O! EY/?&1KUW73C0Z")IM!IB<4N4['9M_CI !.*335JP% W;--X&;O>3N$9
MN>8Q&1:S) \2*'+>JOT@,,Q3-0 O72^YZB /LH16.95_-9_6+=2YI=$>(/WV
M)/A!"4<J]8IE3#$RH]RD5-7\^=+U."OJ/W&C0?V_@L/F(6Q"G<D7OX_UVYIY
M;+Y>A>M-'.0*7*D]WIQ$.F KA)H8O=21FK)?E*?JQ9*4&_P4XUH5/"G0-H+W
MW&1O/'7&Z$]DL!0.71G5U2\ !B^L4.4B>"]^55^4DC<W_S*"KR=_Y!+ CRF]
M!W %_;/8SBPM H&O[!*^OJA#]3[RBO]R7OB\6 <,44](]"QOC1WX%-M!0?V
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M&OC)6A^HU[\G8^11Q%U-0_^0T42R21]:P]L&_QW>9Z#*[7S)A2DYKHB)6;\
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M,!2"CZ@F:ZD1$HQ"2,6.B@9R?#96K:09F+>X->>R(WT,W/U>V TRPGDMOR)
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MQO;8O\U=1N)5EB2(H)IW;:@7RP_Y#):3W@5=WY[K,G:*):E$EV+G@OQ*'L8
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M;Y#F-6+BI?=5%C@])M^[U)F5V 6"&<N.S==@[;)&A:S"OB^>F./M1Q9"TQD
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MUSK>./+U[(8%_'N]W?;%SP8*RWF;VC,>@4 >DF!C^6?/C*3!]$P,WL?6HO\
M5MA$"0$3)2^))RY-?(2UJ8XUKLY%:_+%03;&FK"$_2)'SX^#;'!BUP"I6/@
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M=&$I52\%__3.+;->MC, 5GM-_*/$:4X6]G9=A&%34^3GO:#SWYM&IH=K;3D
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M> ,CW>3T(P#B$%E4>,FY ZTHSI-[=2R78)ZTO 7Q/6$EP\+2!2%8)/W\]!G
MXXYF*\3AY$;FV)5/L%39DF+ZK'EAXF !TA,=5F@2D:4IC8PDWS[,2!% '.EU
MLM9Z]HAAD3,+2S-!8F,M2 9+QVA'4?O."(9P$T--=%@OZ2_E06&I9@?D&E+E
M,.CVN>PU7[D+Z3A&1-7^+ Q.>);X?1ZG0<&B-]TND+]AHI!6"Y["H]DAT1AT
MF-6QMG&_KZ8&EC3X-FV@[.0,P!YJZW#[6&ZPVV2';S8#W3HPC0V%M!^J]7V(
MV6/?Z8G"XPR/Z.=-3Y#:>^PX67&=\5@FRS!(0?+I.\T93)Z&4MG/TG7(?8]2
M;OTS0# .25D21<YOP)9)L(.>2KO?&O : F-4?H<S:K=5IB?C\JB$\JJC-G^.
M]&QIY,6ERLD3&M)?[P="T]&TD[@,YE[V$'XK#;>->$9G\U&@\8)?O_]S1_;6
M%J_/P#"__!/.A'ES<E*GU?K6F_UZO].ND\I^FS]Z^CFFC.+0P906Q=^9\RVZ
MMQ&$<8&+=0<UB;SQSNQ]3%? $],,$HFP,0V!"9W_/H(7NIW4JQA)NXW"P>$R
MS0(3#)H3F%C<O0LBBZ73A/%9>=5 PC]&%"F?(H:+!LNK_&>$/>,1O+2O"Z?*
MQ8[Q^WKM<X>TI<,X%5+2223KZ=HQY[SOR>N158?,Q!X%S@">!>N3UTMG@,#_
MDUTZJ\G=MB@@<UR"8R1/:$ZFG,(P$A1COZS,?ZFF>&G-O_C) Y>0[[K')64&
MU+HPZ''8B.VVP!R=GWAN!FDQXG_S2W%\/=0DSF&</@7:MLI\JA/VDK2L-M6S
MBT']3-)F0*C=.RFHDD*:=PC\D-"&W!W4UTDLL5D#^F!EL6XT;P(WZR0M>@P+
MH@*+I!^YEGSZ^&[.E/$Q\,[:Y3@V2PW7F^G)VA,U9ID2RL)E!\,W/%U*+U?\
MP$L<_Y)UA2;; >V"3'@LOGRHDN!PA/;K]O7KQRY!Q>5 L2/<4OA+/_?-N_,8
MA/$UWDU5';X-6)J'SZ;(YG7WZ>IJ-L&QCV[S8L7U[S*"O/"]$LW2MZZ,)H.$
M$)$9;+_&^R\):2FL@JZ/>9GCORQ]U"F04  C/LFCXQ_?JD3KU%>U(=Y@^A\M
M"8*Y$]^_6?Y@;VQI?EM^&1HS6>15^ RKLX,:27[N5F%P=;<D1K(G>RP2"TID
MS4WS9Y/4_F\C[)*!F=YP\<=*%K?D!&5/[DQU?7 >RW)R>G%4E$U*^&: /20>
MZ\Q>]5J]\A/.NP:UC>&W3V;('AMU#N$:'1)0/K$=C=^4Z5^'J*R]P(X((/;/
M #$L'"FFW2T6CP56:=<A06_L/ZEQ3]:,5033U3S^=J!CXA#?>XG-?+](]:H.
M6U8T^C^.6)..L83V#_0ZBO"]XFEQ0&-Q;XDOFR]_W041(7-?MN;:^PQ0PP +
M?_&7@FQUOWZ;+=/=E[0 OQ8LJ64" \3W^.?73:?5/2YX%,0";I^/,-F,(!$:
M=@^H57[9A?=U9O=?_?_>%;&W^P%L9CK_;SSZ[P6/CE*L]_].E0*+GNJN*5I\
M8IP4]RAX]Z]SQ?\=[>?+O6X79%^ZF%"0K:/P@LX>9?CO=?+M_ZX63GON%[7_
MWBV]6U;DC76XB/!]"8Q*A'?_)>+**7YE(:2N =@"T^5IYN#L PP:Q_83S-6X
MB_G0+YC2^'=IVP>DWFMWRALF>>V0Z@S^<0;X4[AJ\QR]@Z+4K@_E^>T +5S6
M045E)@Q_8F]>C:WA*K%X3_RX&B.I,(WWO*.PG#V(*KU7YFYLJ%(DB8C4'X#U
MJ7F2-F7R@YE72!BPL<]R7A",KZO17$Y_ILL BA1?B*#I+9Y6?BA$.]QX!F!:
MXPQ6C&U\^AIB!Y_[:E3.>4MM9;*EVC=2AG%L7B#"D$DV,-LU,#""::^W*(&&
MU7&DT-@](<#18AY"W_KRL377/L;ZU^9/LVH8!R)0>'@4GW*OOD(^J*@OK2Q\
MP&#5PKGY0]&G%:SJ!@Z?SU>^6TGO9@IEG#?O5IG<&49K^\;[@6]]/[*LF63?
M-)/6 2$[%4B[1*RWM8_$;31YLKJ#">O:5YZFO)VQB; D<$CZOW'*]+U!Q**?
MKB8[6*Y\_X[IL[+-YL?^=FUE/&ZALG= (?2*RK=DAG&QL;,*D \6KB/>62F7
M0@-KQ8?! F)QO64@?.%R7T2D\'<YSE6'O&CJ#72CN=.IY%AXAR?S $>179^1
MWS<SF[&?$F,@O;SH7M*H:X"0'JDE&-HF*AG:>[T:4*;9@#ZZS(:NT+D]7^L(
MJ<MV6 R[5?CH'O9>RG3:5JP+(FIDK,+A$?H[,$^XI+8<* >U+.8;J)BSN=(*
ME38"L79: W^&56$0,1B#+9N1]T\&]29V]"PRR>GO9:P&I@G1\-+VC>I%D3#V
MD/H@P1W[W)KYQ:;!/HCIZY_L0@MRQOE.=?J'KXX?IKEHBE?T?>P3XS$)W22\
MY- 3<U\UCOMJ6/HW/&UC=%"(ZR^R^ YGY0WO_ 64Z1M'@\OFK8H=_$S;^REI
M>%NX@?3W0TW#62S6R(K7NI]86VK],&S9-EF;T=. OG@\3MZ> 90W65\M9YG[
M^\)+*Q01AS#?3\K,"]7*=BZX8Z"P,(9"IUHAIT>3L8$CT#'93NT*F7:$Y8$Y
M^XM3B:([BG2ULG_?G(IW\Q^Y"U<H?2OLU1#4MQ6^@:'#HSL)>AK8K7 -K)OM
M7<GVO;>Y/ 5^LVV/?DB(7$SZ]B4I:TJ93^]EBRK[Z/<;#S"!PU2^R7XGIO16
MR0XD4R6/;:I:@.-Q/KPQO/N">F6>?(+=K%2(93DH22IY,8]5C8:QXCOHKB;=
MX1G ?)C:&_B5X0D!+W =:]F2L+XR>!T<]<5?'?J)-26IQ?$IEP7ED4I()B=[
MAIQ\PEB]+YILF\#/& ;D_)F4[MG_)U"#J9;%0:]Y#%=-L2BV2XM[QE>Y),,X
MX+ULX;C^.X+G#.!>@1SO@MOFW!@%Q6P\$:%C:4FJ]@H\EJ_AE3'<;HMY/%7E
MOSEE>_<$;%4_M;R_5TW?S:]!_65]82</<8CDMP8!&Q?#0#(J167^0C_57+FS
MHJ?6+4]D?+KGP[%W/FZ6/3*U1ZVIW?Q8JU^$687XQ91SP\-!2 X62KRUK%X%
MG&5\,^E6*WB8<" 42VP1*OG KM2% %:/1J-.[.ZF[*,+CSBET1N?>N5D]3N]
M4_6F;L7[ZU@2L,+UH.66*0?RIP:W?UD;M^=%XC[KQ[@E%\Q,K"6O/:YUOH6I
M(LN'7+1^"3[1FE%0&Z!B)SQS%6SS;X3/8B?LA+*% A-]-]<LFAI_P;.L.&IJ
M:-D7'6^2 R0_,=F%WR'?ZJ5_6MF#A74W9?]>01TQ%$K6U^HM'RZ'W D'>XVU
MD+VB-94K]G%WDUW.73ZXF_HSW?7[1;S[T')";1UA1NH:Q^.ET#R.6@8H*L5K
MSX2VJT3W,03X!Z5;=.=] .IPSB %%F+)2ZB&*Y"+QAG#/7.7##G?,XW!(X#E
M9K='U9G1!R4PT6W&*GAU[)CZ_N]CD$_^M:O$-MDT58.2</35 !VY;)0&-N]9
M*\R-J('-#&R%Y19YB3\PN,%)_XW8R!=2O\).F'G&Z(^8UCFPEG(M7P(5@$BM
M$XE[(5L0$Z32*$T'ERC.8?CQ-W^FUM#G':?/M)?*H;-F38V+EDF2ZGWV]7;_
MV\7U9QM[G3_.DWX=HC>Y9A3B'K\2NWT&>#MYM2E*BQ,8+ZGBK_(,MYOBW@W&
M9J'G^?>&X#Z Y@!PKA3I$-OD;\T[)ITP-P&Y2&Q]Z\2;?!1N&Q4MX;%KQS7:
M+2&M]5TVFVYP.,@U2  (-0G\K#?V.0CE_FO@O7=Y[W3WT]38/R?WGLTZQ8^I
M'X6D^-DY<M9K^)_#A>WWDYHJ1 :@HD$=XN\KG(LD* @6-B10S,\7[46_BY;6
MXONA$QX9[;C6>![A@M72,I<0Q3&V,3V(<5)U_KYXAA@O?L;.]-"&V"@9%U6;
M]SH1UMM_N^*=>WDD^L=&F/KO09:J=P5_-^WXA;'<.5E^S;=:%+]JW-)P@=K%
M'M$^<&FKO;$2>_*:/2JP0EEHS=/$1$ &:4@R\!3VE2%@X=CES-.<9_[W7D-\
MD%JD'T:^0I<V0JU[SP#7ZZ+JOF30)\(*HF3-[!M4G VX$ Z4:4[@V/BTJQYP
M&8'\F<&E@9U9;:#I<X3%L=^P&ETU>+BVL;P(.LUNE4RIRRKVF9@.K#:D3TL6
M"RB*,FQE2$OP5=@ O9$%X=-^:8G6>0]7B5=17"H-1/R^KB[_JD>;5UI907.X
MZ]S5L"(SQE!%\WOE++\B*SC*IU )Z66NMIQ 1_VU=6EMX3#/C[(K26@W^PY"
M[,RY4N7X<;*7 M\BLI=&U5#=+0TSR;%K=YZN=[G:3ZVH@<C)67KTY9YVO8(@
MK5K/[5=*R\V54[[OR?916*C_,\G/+&+OMUIH%T1?V8RV(8YDVC4$3;0N7JI-
MAG!X',BX/RM56F[MFS^(.RGDSMC=LONA]F,1W--(>:UKU.?_+: +GA0OS]&0
M_!V\/R-FE_08"\@FV_!+_0)M<[HZ%J0+,$O(Z?%!H?J'U#'=ACS:1%C]T-ZE
M[6Y38"21D7UCV8F3"YCI6@YL>6G0 SSJMHBU$JP>3.TR6W(OT;N;P=:W_E18
M++9W:._"K6H3'_D^83C&IZXQ+7E99R+7ERA]KZ'FO\]UC:@!OUQEC-YHX+=G
M1<0OTL'?)VJOWX,HQ[3O5.;4(/CSY@68[^#-\9/V7J/>I_Z2*Q%,ZX.^SRKL
M>,_WW\C>Z,-C.??80PG*\\N>K%'D,\!KG4[_NZ;#.%]R7B1XV/KF/8C_.H@9
M8J< 4+-^<ZXD$1^$74V'&\7[TE!Y8OU>3EGL$M^?/G[0%:0A3-J9_+GB(_FN
M2==<!S&ZY#\T# _M9/)5.9E9GPOGIWP)W_A7VFG=9*@>UD3"Q( '+'EJ^EW?
M&AII-9HV[ I<%^F\3>/64/32-U_-#1=&DHE_.&LCXSCW<=VLG^YD@MB"O1SY
MPR]<@531S_,N;6<E'GEW;%OY:B)L0_(X$!<?[QZ[/<A#43/@C6?=1:='/:+]
MX3^5]5PPWHRW0QU627X>/3L :E\@50O!>FY>;GIZ2]D$OK@*FD=]SD]--+&/
MK/0/,?D@NH!VC#+LCC*V^N-2=+E3SNJ/ZZH-J=<Z/[78B,:'MEPT%3KF]?RF
MGFB>]-?D9TSR;P0\9 UB5T]4\[-ZV38'@0.>B-!I^SN70S#>)*;H1T)2=0.Q
M'G_4!.8C:KOCS9N[FY),&Q9?OC3R90,I9/]^8IT'G^H:FNP19$KJS@+F1@KP
MP_N?)-[GQ_F1>Q*X0WBO:H+;%@:Y>:+?T0XN..J4.[8N=J[()W>)ZH7 #U)Y
MLX<?N*=?3AD;_]N+MG'^RJZKI<V/KV0N%WV3!$3,CM;P6EZ1WCQ@[H*!)W:)
MZ6.#Q=Y@,$FI8$$+/$%20MN%AA46J\P"V/Q <#!CBF#6HJ-$@7**"1;J._M,
MHCNIJ+6K?3YT++VQ(J9Y/H_I'X/]H::1:G>D"[7,:]08YT]C(]-;S=EC?Q#$
M:/[+23"O8740S;NLQ,6^'*Y"3K'[E_8&/0,DM-BDUWPY9Q#G<ZY>"?']@DS_
MNL9:D G_OEG"L0M')1\/:A65>\N!WF9;(KX?<J'8M"P#06'+[&IMZ;H=H?]T
M E%N60V\EDWA62.Q?[R\VA=B7=0??L9>C8\=L>+QQ#W"$W-@OL+#@ OR&[ K
M28DSBUX74*N!FDQ]S];?BV)/).<5FUVD\HI#F:).&#Y5W#,=+GW_QTRYC9XB
M\/,*6'.X55.'U *2J'K, (K*<[^<P_7]OXIU1_%7/Q0Z+L3667R^,P>[OIK,
M?[\K)#I!0[! \J78NOU!HL8MB<K(U#W,9;)UHG!C\M=4S83+]MTK\6KP$8-_
M?"T=I6-$=O/@J.*04.F-TI0 T.ZI=-$3_:K,]Z_Z3#P_L,@Y/$HK/H032X=W
M6RM:K/5@K@V\YH)&JNH52FB/IW0J9@PW=8S>U?5IR5VJ&&$YO9T5P"^IK3=<
MU)RL.STL_M GJ;@W0/:D:,>QZ_<<[=\K/_.*M7^? 2Z?=KN<2N)WUY7J^OS>
M7;YD.\3^=!^!1'A_4:+YKS&)#8Z5(@8Q)4H,QJK9LM<QT+SL02/WR#0]0H$O
M74X]_QHO6E,B%S!R/_\S'6NA[<P5#&W,6NXW)2:QJD\GTJP ?UP*C>Y=SDD$
M]>C<^)**&J_]-/4Z-K;]9[52==3PG!(QX>UT2CNAE'UH_%\F;5I.F^'$*Z%$
M<1]SG7572S27 TS$*?43T(GYUM[E AW4FHY^0;GVS2W0V(/ZVOO:05_+I.UD
MP^77)Y0JZF7=_/;0Z5\1UF^(T[V.S85=]>-ADGUJG!S;:>N3R'"'TD?X0>G^
ML>BK"ZL*4[WGD$[-^\YZ]!%A&,)<K= AHUZYM,5E[],4'CH2$Y\Y^+5YBHRN
M5$+XV2(0?Y\Z\%5!;E>GWHVL_\0^"]<=V307[(9%;1L9 O8PEA0_)T?+[^5N
M)+T:N,Q]>E[O^F9&K:?.7J%/+'&<=39HMN3)3RTA96AL\^^%V/X,:29)2C+1
MN_+6%B:S!5+&TQ=]6)OJ&$T6Z[Q4_,X'PX_Z/6//N]-O;^QCT5 K<U=I$#CQ
M9S_+TL_V*"QJLY1]U'.L^3ZQCKVOOGY&"6WS=+]D2GLDMJF&6),L_;9FM**N
MXDM)K^ #+5TWG[(V&78+':SLK S?NNX\DDH+;)AWN+K8J-V@-J+BA)CK"./U
MCD_;=&R^A<Y)1_C9)[W</0-\GLI_FB@)Z^+^;#?Q:4"I0M%7NP\G!,_;6+\]
M,XES)F?$F/1WO@X.P>A32HF,PX8TB -,'M"H]$NSV@KJ6@CG4^T@4<384DY>
M>HY$^FO8%P:">7V^\\+P*V-W59?_FK:NCI]66''U!YC;UOZ\JTHH.U$< AND
M2C[>4XA9"Z<E_1W_M8DQ ''<#>B^I#<?)NZ]>2Z^6C7W"G2\S.MXNFB6S)?$
M07;TYX;!V&UU&/%ZHMNYXM7@;E)^52HQ'1%BH#B)D%(OS76SC8$0?K(SF36P
M4):*_9-[@]QNT/#OSCSA-UDX^?NU'<)8*TV[AGQ0X+],O=X17K/]]-1J:>+M
M&50>:-AY]*;F;66,$$DOCD,G2>:(4+V*Z'S.7#;@6?S#:O FN>T%R"J8F9JV
M<Q#?PC4VK,R\JY%V(%I>VA5VX3=O+'F0EW+;^//UO&+8C:0 XHR%H4?.2_8D
M8'67&/O&[%U2W)3^BILFW0X?J&O>[1(LWUA7(P\Y5OO?-64,A$2;P#UK\^W<
M3G"GX*-,'(:QXE+5G-D!MD:SW!J[)(&$=")73V;V,:%8)J-\:E^9G1S=D<?#
M-?GOZ>(H_V6RY?/'NO2O>]!^/^Z(V R>.V5MR;N&9#3TVX;/M0LTP#V.<EY$
M9.-7VMAMIAL4E[_!]$?6CMS-\<EO"IZ!^3^"="X2GCLCT5S++418\*</^\OU
M\JW.PHSX R5CTZ9$:[Y'Z_TS9M\G*A0:-)Q>HVJ;@:L2 V"6U0(%^Q$P7P>[
MI]",.;HUJ#UGSUTUH?ZNC/S39Z5+U3#S7PDX&VF$TWV%W:H9"Q-6\:_5:@^?
MX!-CK>Q-56KPPB.+-,).K7+?9A7N-5U.:3D#@(; "L)T_=C&]/;[_CI(1SEI
M*Y]A=912=YW&5])<?.&7&,LOF@F^L^".RJ]PVELX&])@ O^LSB4RA=! T>P>
M&GA[XWQ7*<8@CD!7F(".T?5B5H%N 2;0DXT::AI10X+DE>XUKJ5)=WP#/&?1
ML.$O^8;\_)50L[5$YHGD*UD_!*K<(8^G'R9=U?)*8C^GS.L)%Z$8WOS5U&?@
MH?LV1FJT;J+*5<G\+JQ&PR7P_KJW+[ZFWZ/+K[DUY#1A-T;P(FI-2H;F=F^5
MV*.C'*B>'D.:O_(E9^UGZM#IY_Q[O3]447%B[%+>ELX92I5FO19/I"WX/&S%
M)RZ7++&[)%;T,7I\_EOFDACW]GLZ]V!CPWI7((NV9;7T:66Y9B#SZWUD@V&C
MKW,SUM;.-ZO8 SRU@+6B+8\T3]J/P++7[D= )4<;.\.V]$?K$B ?<X5X=-@>
M"P.;1X)'RL5EHUAC+_0S:IVNO9.J.,$.4@JMN+VD#'K8AZS?GWC@K^64_OA6
MLXV_L)#'?@(7-BAD021B=ZS&<H]FT5\8)Z!91*9$;F^0_LD@L0>\3F5>-4+/
M/.QZ[C)",ZYQ&?YPXO!1;U([+B-EFX=/7?O)$VO)WQ%TU7GNK!=[V/6('&7[
M'-4TSH#A-=F2!N*Z_E\N5P0>ILEI)\<@2QC(E2(7#<TJ[3!!P*9,E';/(IJ?
MFCF"&D6ONY(K%H%6;90WZ14&J0()\'^'=S+]#L(Z#7Y,C/,\)O1WJZ]>V'6L
M)&=*!\2T@>?W,).W)WTZY]#(2K'.K 3P[P+#1Z9H(]&X<IA9^OW-9&/F79KP
MT?C/SIL"E+V@</;3@JA2E?(\90TL6;?Q=ZOC]]KW[YBZRRF^]FV_]BZRR-UA
M9.1TWH.UA\LE@1KT9J_IH6W([O'=&= ! 2[V[89O9X"8+C11-R,;02BA8,PS
MP,-S?2*?6RM ;P34PH?GN/C7E(DLYR8RZ@[2V)T07P6?0QVI+A"BML &.6DU
M$/'IU>&>\LUO Y[OD_?;OFK&O/,DW8_O^(C)#S(5 *]-A@#*B;@;%)/Y4RW?
MV]T\_/A=DZBX"%\WM:\SJK\D>5>2P))Q&4]4\6> R."%8T,I)B)[)+$HZ-W?
MZKAYHTNC!8/HQX/-5(ZTUR;QJ2= -'&+0Z?D_IP2%S]V!2= EEA%*'F/MQ.B
M3IPH0XLM-573VRICP8);+;;DWL"QL-K  XP"[K1T]H;^SK]W3&< ,[+(2LS*
M4QXY'Z"6:;1*Z];617]>/%O8#:9-W9\=<F> !?P$!;+_AOO]VQ+DRBQ.HHW$
MCWF:8OX@"6U'VMS;C_/'.<O^_B6T.]7N"$RRL=)XHGQ0O9D#GH.K5Q)-WYP!
M6'[ZLJBUH<,L\BGY08S"UP\/H5RQX1+D5ZL7/E-Z6D/P/=UO%SY@LC55%L/5
MX.6[XV*N2&<@N;J<[.17*7LU:7:OY)T '(+TL)F7$CV%O1F+\+Q<^RY)\UQU
M+L<1Z5O]QR^Y><5VDV7>[!E%NELAI*R2BNI\)R&;UG0EX6> 68P[R;WK]A[\
M5^:#P=9PUP]!ZM?6 [;LN?=\H\\ G"[#^\*IS$D(*86D7R:P[J')R0R6:[E8
MHJ,LY20P,_MJ31)BYQ GH5#K7B,RK;^'N4U.3RI;3Y'3Y6MX_%:O=C)\E%'X
MV/CT#-#JF# OD!A3H?]B\-R4?VO(9<+7C<G*?@<LUZG)+<#0EP\Y#&X\"T71
MUQQESK>Q]%1H5?'R)H';*J&O!CB\%F(/\W[G=>:7:[-D^C]3)7R&5X*DBVJC
MJ-PI=$W1G8'8#^6IO$=XVW!QW9O2R_\:[%#B%GKEIU9.Y\]!>)<V&6STXK&A
MP=%(37#C+B$&IQ+A_K=S1GU]L%H3>CEVP3=O[AA/1-0=3&ZGWG#K?Z;2\!H8
M]*[WL[&[^NI'3P%?N.;^"^[*CYY-QP3,:L3U6TU8QF6:'G2X!R7 &D?:Z%NN
MO3,RVQKP@#+\--+9\W!U+)K%M II17X@O^LDTK/@:%H=/J0[H/N?3^[>$JHM
M?H5\T45WJ=8QA"A O_8\=EBB\7).M/,?28')@/YL\2];IVM[D$LG3B8NI5NU
M>8B3^5'Y4PO]INEO7R^W6L^;)OR5]G$V$!:B;2QB%"BA\N!,'@D_"4!-M,5(
M$Z51)$PD50-4%Q>8$XW8:+$B_W>[RB9&%3&:.>X>V^+*GU+U_&42@KS%@H1S
MA]YE/5=W94H-V:Q!OU(F GQX=*[SK82_'X3D7/ V14D%6V< SYXHK8MG +3"
MR'ZN)Q>-\AD 5[EB2K%6P7ULQ@MK1KI#^2_AZ[!2O8)=ER8$8'#3A<FU@%N9
M.ZGKCO/S;1QZY7:56[1)X).OI/K&T$*(8/+X$\*8 #U5."2]IM!H0-US/$O@
M 7RAN\.XYEUT#S^6)+9Y@PS<$O[R0/3<AI2>^)495:X.+J7XJUIWM/'4T6,T
MW%V]7$;N)UVO(;N\6]<RF>M"'0?L^U$Z]]<OZIH^&,-=-1$%C2J\"$ =!?S6
MC-QJ^>-@59-LV1V>#]?NUK:KU;)39B]%0Y,G[&K3:6+/ 1? Y$Y22;>K\)/G
M5;XQ;6PIW0,/67XOC-7( 9%/R4'RT<]$NM77?P1A)FW1+D_$5JEXN&_\R7,_
MM*-^S??^U'5[EUEV?%#\9\GL$?U* :-QZDB__(L;;>"M%AGR./31BW["+$[D
M#/"&TWJ$&FQP6=+Z 4$F4+7XW,XR(4I>OS^5(6%B%_#.VBV\QP0'X?+%O_\*
M45F1]?X3"8D 'W%W=,>$.-T3%./'<K G., Z^YQ,!^-#"?1HI&7BX/.M^SVM
M_@(L+39CR=^_D<=P%N2YKACG+\D7>S!H<QWA,,W*$X1=L'=M.+;?Y%B?+94_
M8ATBTD&$]?MHUTS46O,\P(N:S#N^J@J#>![K_7W&< :@["$XWX3+B:)O,2F=
M4[0"JM$H+,39?.D*GJ.C"MGKE3U,NKFF.B+:LZ87':2#OPFB54;O-W1+=N/H
M*>^A'(^7=KYB?-Q ,:98EULU;Z1<"'F4D:[5_,J<8[\MA^[B\/I]S( 2)I6J
M ?^&'GN6M#[[YL7Z/.7'9\>0\.<1X#TF.GCTL1/0>Z(_//"/QMW&+P3 ;*<O
MIH%*.VT0Y,KL V>;O+$AS<\)O X=03$\E%0O7#>_U<D<S6YDF2GM[)QM482S
ML]E^)-E'O4795M>X&@&_3(M^?)W23&3QM",+<AU@! AM'DPU<A<431';@V_/
M *S\VYYF(H-BK2&68Y-1K3<G&FNMG%(T(I/V41%*,CEG@"3KD'E(DO9C%T9%
M"(+R!ZF,Q[<,WC$.JAS+X*3R/'&1:@[SJ %I:LM'O$V>?<B$8N+'NNWT&-&E
M+H=CR>YOPJ7UJVLR'R&",-I-Y+H&#M'[*\6FX@P'P90<[KZ&_JUU!XW7Q*Y1
M<O1 V/J\M#/1I1X5-2>?E#76VO,[+R$1+76_-Z^[8HQF;1W^,_DO&X$',9;^
M&O!E)+F);,M]TC[H)\95]B6^WP[LH"$[5>-HLN ;;U32<RO&+PEA^G96YKJV
MH*WR-TPR501>L/S75DN5OU5B^ :!LK50:!\2*SJX -& -Q/M,ZREGN?BL)EA
MOF&A0NY^U1 ;TNG 1AJTH"K)B,3429NX+==V[J1*20%$;1.VVY"1UO!PN$#'
M@4P(%]T,;'WPS200_]Y/F0'0921\;-@#MFO6\9\@-D(XX#_4;RGZRG$=5$NW
MN,G',6)$K_!CB1!6C=L\Q6E"&9K:%D_Y"&]QFHP:NF;G6[+PM\VS/J%FA8K=
MB4('1:#MZ]M_7JTH_#J)'?Y[]>;)6A58;XR;=I/7U^6QV]:Z8]_OMIC>2EDW
M^Y79-K6-76G3AT\&^(()A11.HDN3SK2G<-&3A52=%Z="V%&AED_?G\ Q=)3>
MZQYN&GC-CKR8F J;@LR 'K0Y)1_> /*_J_R];#QUT92]^_+'D^?5<_/Q#TKC
M$HF-3&QZRU#IO>JM^6PMY0*Q1)A64A65O[UF2C>L$DT 4G:/G8PNO'3T^TAY
MI:YJ:F[/(!W2UL441P_C*>@?'"M*Q9(YNR(_9[XW.AH%TW;ICHI:[<BEKD.$
MYRB3"W:C=(4UO1A'BEW!K(,!6SS70>D3C51O/[?:V15LR&SS@JID:'M\7_98
M=$Q)JOZ03?8K#IP*)9+, 0L+>6<8?H!I%8Z&Y?G 51WK<5;WDNTF#V(OI_K8
M!2OM87+"_Z.4F.AR'2BK(0CNY C[4&F1<06EC[J=>5R%1BE1/E0LU#?NBG1?
M3"B"T,Z]TGF(#HJ"R)]N@==W(7R#%>!(VZO?"]]+A9X'?&T>0J5R3E[.LXVP
MB$ED[S.VP7.'.9][>VB/S\SVG7)_R :5$U_E0Y_V#@"-^ZQQ0DKJ8</?N)"E
M?(!Q(9T!8H5&"\UYS\W)LF(D$O(\?UHP;>)9*&&T[0KU-OV@A-P=T['B@AO[
MEW)%2Z$ZTD^E'DGFD/:_?+:MRFIV:]1\&W&=.+(Y@_QZ31TJ=:LMGBHHFBC
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M \"X]]/9^"; ?9PF[0UR=^)'R[?SKI_8C"Q2?[V/5(?U!(G M5VL)_.8<5S
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MUH[I]YB/&FP]3<L"[=ANI-3=XSRS5>D$WHAFB"H2FHK<E@Z[63QU!NC,HM)
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MFTH(R]+B^P8O4&N^%>X4]0LJ@;?REX4*K^#"9]KU]!P;XWE$S)NO[47W)7W
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MY;K--8+1CA8)6Q!!^KGA#AU:%B:=>2%,4*>%"$C<A1++I@DB=#OD \E@U4_
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MQRV_0!'5NG&GY1UI>YT?.W$;2H@0+7SKN97)?F99=W!@0&^PN^!%HF+:*_L
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M;Q06>),PWE@#XRRF.X!%GC,%Y6DK5LCYZXC^X1H5HE?L-G0M]_+PND]=@Q\
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MPOB7X$JO."L\.<@1T5TN&\J6[(_7<5!MQNFX)M,*Y^+9.]YR1&4:L?2^Q8[
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M4!4J5G]?M##RHX+O<#!+Y?=IAG735 [J:Q\2E[WWT?D\!'-FAZ,DFI9RKZ]
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MWO4=O6ZB0TE(V1GD-T9 UW@\RMI\:S5JQ;!]SS*AVUI@<#7('^6B)]_1QO&
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M:1O+,$J_3LLK3FP*QT149P:[DO8Y/IVJ,DLUNXW5V-[/:D:V))IFB>)\W=I
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MNE]2[,PD+'SOMD.!0U%^R'G3VR<LX\#:]]%P",<K%\6?CU3F"1PV'SJCJJ#
M5?#KY>O!XT$@-\:-X.O!BP113& &<?Q4P>88W)5+=T;UWT@F<3HXOW,?F_$C
M_MD-_Q=*]SY)2YX'4@#-]SW8C*H-3Z"6"0JCWE"BS5M23_]LJ+S=!/#'$E7@
MAN&M</]5C/XE-;WVYY(U3G,/K/5:">3.'AEW_ZW>#A4%'D*2[@@S06@=CZO(
MWLZ\;W)+S0]#/I53^%<RTW*2HJ=A-\F[LPF5(P\3GJ4&?C[%?7? RZ((!\&^
M>HJXK?8+OV>R1!DQ\;7[T-N!K2X<,A7XP>:?]+XL[0KFOPNBJNU:5M6<?^8=
M8@&,>HF_=HI%7L'47!,$]:J12>)20QDT&+\5#/.K.JX4\^W-YY4')1E//EU6
M)WQ%NV%4:PY<_='7*]&=H#0,W4-.1[9(#/?]:W?*9+W0[J!G7V&T/''L=4R2
MWT9,/GR\QA-FC+<6!"4S[4C,9DA7]MPJ&6"!#/UM^Y@J2^/!I=[O:.!F6A2/
M>5+GS)W*C09RP0KM9RM4V\?2&36<466'TV/)C":%]T,$R\V*RVA5$_0?<.'X
M$V>M'3<9-&'U!Z7,)QM='%2E//%>RKL!H]%2TZ/W580-$.E: 6 4.;0S5"_Q
M,YD"'Z(8_&UZJ#BZB^UT=M>2>=5NTW*=4]1AZR7$LN2 7H+@">>'2@9Y3:WG
MR,9MJ^W0*!X0W7V/?475]QB@D/W@:Q2ME]6>K1C_E,\G(G%F-J!JQ:ZZD3L[
M"1-H&_HO["0H'4(%^=QJ*+Z_A4&']$&:MO6Q4JRO%[_N]9T80G]*WI3VNGY[
M&6__HPFT6^>*.S#3I,&&QQ-]B-$7+F669TP!J>2!KIP,'H,3*<JNTSW[6/"(
MQ1^[YOCNOK^EP&H&$@]M$T 8H?H_55S%2H*[VP/A$Z?W ;,:UA+!9U0 >JAK
M!%GO2L7BQ[\X816:F5)XR3>G7,_1<PMCK8@+TFN$(<^HNK\<#S]5@"^@;0A*
M)=@*_-W.58LNA7!$)'$:4*-VP'S(TK9[A[5Z'2J1GH-G^GT@>CVP<832@OXF
M[TC$;FNO]@XL0-4LIMM2%]TX@>FD*Z6O&J9-F]E!Q31YZ[I9KW"*8*4KP?YZ
M*<<F*62I-TI>Q^!&J:KB'27QD=YR1XI[RMH)K+1OZX6OD]+E/\&]HD,E<"C-
M:2^==,HQ>+"VL2M+KLB67&U6"0=/]@Y]<#/Q"Q=\5$62CFT6/D%]1M1WX_Q4
MYT3UJ6?Q462,U_4(YS ?;$Z%TM+#;DR@]1U=_29Y2)5!:N1P[@6[J0<\T^")
M8X7WK4,?;&4@Y,QY7<2:V ;P]QQU"KMG0&L3E!>E:#[#-<M@EB-,8EA(ANFN
M]O8'HKN]1-^ZZ_  'K86!197Z+QJF*MM\*NHZ9O^4.'/^KT*PC[2WJ9GM/3\
M)&?);B A6-#T)&<YMGH)\!W?/;PR5/A"47/#"2%=#&-<9J9W%OI>[L/]DELX
M/I["0_RP[L[M4!4/.]1Y^.WGMJJR)>T^]J:O(MU5\T&J+]A</*_OVYJ4%),J
MY'>0M?"'^9+[KER(YW&LG'>>#(_AH>2W!.RVP"N.O5S_T&Y%^53';$3[T7CZ
M#%S/3Z#7'G5LR75[ IVC IO^@?'%OUKZ.UQ@A=:C]I'<LFF)Z!?G" V7;'3=
MX:.>?=^U+.G8ROOEX5C<NXT T?86-I>B>)XA/)8<L.!@.BDE* O^GGO#*VJ[
M,/[A$!Y#I'F?#W<8>;0.%8U?70M@=3&"=MU!V[Y:5GT$7-'C]"VSH.N^$/45
M6RJOPP&K=6+)0AZU$EC:,]$3,ZE22N'N\].N.YDVM^L:/?"WR2C;1N5=MYP5
M?!@1VP&WB+[).5Z,09S[N+1_#(97A7C<0M<MQL"0N&2N&Z2WUN$PI@V*T%*1
MZ9OI Z5HZWNXYHBGX1Y0A2>!=:;?<PEHO"!)I>.[R:]Q[N(Y-M$+#UN\%];<
MGW:!8![?5\>5KGH1T#=GUJV/^+"MNOW!$7A=LA'BF4KH.O29FF]?4=SYB >;
M[BB#8=C)< ]>:'/6_(,+]K*.Q;9LJD0NJH5A47A/*&G/FB=_5A+U<96,GFX;
M/AD=D&W>D=B$AHXQSDBJA"@ UWLYY (4),6H?X__4+K\&ZG&> RNW\RY!P_D
MK?QU!%\5<W-'VXZV]ZBR/(Y_GR,>J6U_X4MWBZ]W$4GF86*")L.BY5RW'H?.
MW6&;9T?C_:EXJ1QG+<>$K#I,X T&ZC[=K3T@P1D(4+'6.6D0I?'6\6=IS[TJ
MJ!VW?@S.H #[RP9=5A]C2Q' A3G!/G,PSL.F>"N-&\>Z][>+,&/A*.OR^)*P
M+Z!3-(K.9>@2(@BTP25>UVAF9>2C#>[G4B"VG.;Q4,H]+'_)ZKNO)(LT+Z4D
M]D$HNHG8JA6??^>2V2[6-)BUUWI Q:80,JT6F%D+KWVL.5$TTG6+72DE! MF
MUDV.B.1EZ],RVCC?!ZLW)OV^7$J$2E/,B.K>*:-*FG^@5R>G>RZB5XL,R.$+
M!P$L=M:C"S]+MV#F$C_1 $>.7#8'?YJ)@W##^B/T=O#;()8(0O^M[PP7\1:C
M>3I*D(>?V/'I9([%JYB%]])OOV"?/?JPJKFVTM:IZFW_B:+R<W&XION5_B,<
M"=LA>ENK>.X;-6,HU(&\J,_>E?X]4@9R!"0PM*.S-7?!ZK^6CL&Y:9)XB6)F
MED-=VZ^YC),<A;,G)_ U40:*=FVRGO[O%@7X"C=Q3K\J^4ULA +Z"=AP:.'K
MK)@USDE!=H[N\?I(ML* 'CF> (<O)3L:H8B9F9Z-(^(T_CIP:(/0UPDTC\X8
MS62:VXZ5IX.LV\_54J.,7#4*!W'+0^,.N"50[(SJ*D6J4?=IB/=X'X"F685)
MF.6'''C(;5,K\).S:;\IWI5C8)L!2M_[';% "C -E#+WONN%91D^Y=:Z\O&"
M1\SQ.!YA2D0<-ZD;7.N'?\$QA/L0IUG,,K%% :SFAI[;/ .8_J*\_8?MP>]_
M'HF]?\ IAUJ3]UJ4DYL!$7N3\+@]W>RB#<BCN[*$#(QOZH'P]R:0'3$Q1=>A
MVB0J*3RCEZ)9KQ7=0^L_GE5&Z:H[V%:I>&735<5R:?RG8;R0H7RIHOT;:J9C
M,23PJ2I.C5=]E GW-("3(6S@V# 0OJ$7OOK'#=RK^/_G_K:.=D+E4!2A/^YS
M48>]P>0_ ,WRS3U4$RRC#EKT?) R>G30LKAC2TP4\KK?;5CN)=YM97'_3ODK
M Y-OV^2[!M<18UEO&$0?5\C(57^>KFI0?WMSI?(@UEG8!.]D,G 32O?XURHS
MP?HQ*2WIU46]L18$'^.(?=^BV/<T(VA'CJR9SP*)/)XSAU#OB+SE\^_G5D#T
MJP:?"STK#0*B(B)W$W0" ^5K:65SN2W$2Z7S?J-<.Y)71%Z=P$<0 B3.&S]Z
MCL>[?\Y86E3*@'ZN!YW'$FDBJ@IKI1^>%GK*1ZV8.(Z,_%U\2MH75VUM!F3#
M9GS;^&*R%_>P,?)*)(W%R>NM&*]-TN,>AN/96=Q"[\/EG,BQX0$9QXT ANAF
M\]M/%WVQ68K<UFJ^0R]6"DDT\5PO?B6#OL)D!YOM>NU:MJ0@ZUVKO00/D^C2
M[V[L[:#FY;2Q@FJ22B>>RN-H++44?OA.QR96Z+TL&,UZDD%+S./R[$\=Z/2Y
MQ=^+PO'5#XO^F*AP>[G+4\8BFY;ZJ\]K.._JAF\*::A#T=AE]AL?#?./C9N<
M1YW6-:VWYF^;\H5I2UA= V;U,LLJ;K]'", ;%RYP;DXCY#X53WQ8Q/G11+Z\
MJ5W,NM("UAHSI'MQ;1LJD?'=<?+AR#*.VSQ@:?:>\=L;P $<<" K!![0@5I+
MO@=Z4P>VMDU&E5^RAW];ZJ\D+3=?T_EBOS2V$N^2G&CI-!YD80\JS?<-YW9+
M[?1_C!H*"QSN_"Y^1N5L-*? [/G!S,<6YX%JZ?Z5/D^H*2!IZSC'MA>YRQX6
MBJ1ORU1<%W;4M28=U%,D']7L4&MID)YUOZ%R.<7];KUQ4->P^Q9VU/1T>"EG
M79<!<LRSD(,B^3U'+O25#G^0%.7N,$XQC@\:2NO#73HVM:OB&@.A"X-^CU"O
MFT_V](".PA9[I8*V(X.;P#) W*8YR[6QNHJ"37./=LUN3[:$=9T)L#7[2V0H
MQLED=[U-MK+*3==LK1*98W51L)&[V _T?(^IN16F@POH*=PM.>^DRB8:EA])
M+D=.OO-#3CE.P0:2MS66_NH_2[SA:%JXNV:VX72W@XB#QL8:ANM8O7>T;H<@
MM[Q'Z<J7QA+CD45N $@T"GWWY(R*:ES4S^NS+FX4YA@.ZH29WV+O*G>)0SES
M-"HLV-T=?R*VQTT!(@=7!!=16_<2-*YRC>Z-)D<KF#T8[5>SCBFUM:Q)/G('
M.V/;4_CJZ=7$O@>8,N84X/I#-9KE(D&3Z^#(./@/S\SD>@^KBDRO/WY8348=
M+F>MV>YBA_'PJCZOFQM\3/WP@7U@1=;8\L&?-!>_;0NC\%7;GLXZ799[I-P8
M]MG1+T&SN-WQCEP6+1]YY-V# ZP.^2WF4=R31GS@V*ITVH]K_3I!14GS+(+)
M2AS]52[E#6S9G]8EX"RV][)0!_'7*<(!42DQT"(-8EV[@)\;HR!]H-6"TJ6V
M6D%$U?!0BU#OG<K-5#X_.RB;B!UB-)"XN?4F=V8Q7I. $[YN\4-U]IQ@G"2K
M<QZ"?QTJ[ULV8;A<*3?T?:._MOR(<J(:TV!C1P9K:/!98@)6W^WSITK*J?@.
MA(T[;5IO+\AX=Z2LKAKA1@=*%F(D84\TLLO]$6_:'E&5<^IOV5QV#?R8CLX9
MY?!@IV!O"YL?G[##!%BE#6^C.IMV+%A,4MXT8&DM<CIY;;GF303NU*S&8XR2
M9#,=/*MEC0DE YSP7@"D0-*K1[C?O#N]J[Z.E:]*1(2^N1FLY0;X#D\?R5-\
M[364A(L',-)QA1//_?37&5=^'^RGA8M>7BZ[Z-&)B%R 8S_W%S]>P4<0&:(B
MT]A3*RQ5'@H;+-;/9/M$[WNESD1QHE=W6"&9YG/4=\>'_I2+E@\$ ;OD_3Y*
M2-1.[G^>!E<FZ61YK:_YY<1[SCE0*VP.2C:T>LIL6P=RYE77R["N-,9*ZW,H
M]P45AV&W\SP62<"4;$A?EDF8TYA5><X+5E#!3="P@K; AC;+>40KDD+#+(YY
MW#495ZC9QVF:-!?D#M0HZ)/HK2A17$WCG\A:*2TNB4D 1C;;US4^\!\_]X-=
M8V*\*T1-AGK5^Y KG2]'S21:Z15-/<^H& ZZXIY?1J\I,5CS+J/>G4M;6C 3
M;*\KTPW:RJ$CF2X_GX,FK/R2,<Q,4OLYC/;P(=P)Y1RM"1/QQ2;C[Y&=\QK<
M6<Z=] (WP&%1Z4ZBM33I]M> 5-7=S2\%UN!E>T3@XO*)E!0N,T>FHEVOY>[U
M,?NHFC.JK<W(Q;NC]%+D#*J^ +<BKQ\N+<.#3O8S<7"7,6U"_2:PKRH4-50W
M9BK%!MNM8MJ0"2A^#NR2RRZGSSEPER(T! @[ @ @IRGK:U1?^]SZ0?=Q:M":
ML,0JCM%ZM-0==&4+DV'R2)>^GLVQ<=DH1+HT%/R*N-[][$J#QC/#4 .7XE(L
MSX2F!$]6PC!'D9R\D4613W[49-Y+5$:9U)5TYD((6M+++QR<Z,"HW#E6V?R$
MX5C.IE'5&I>,?K+2U<Y6OF@R7)*NM2#/T3G8^&.TYQG?F!QZ#&'P,:,N ;<*
MB8A\(/(&]]?^AAW3D6$B\2A%1F/-!F8(%&7.M?4]_$/U3@U4>6R<=)=9,CI/
M?*\6/P! Z1MO92R]=-#1W=H?B#P5"O".8>E>A*J1)3JACO\5%23OJ<W9WL])
MQT*(]M&Q-5%TIS@RWB'O?::;XN^PAI=V@=9HY@/LXP?(O59V7W,[L&"*1QM>
MA,7@WAQJBWT&Q._']@W[D(9-/[M?DW08V0N9C>1-^2JG_K5D_^3Y5*6AFW7O
MHNA5-,UK35*?O5I2OT?X/;O6IVV+HTD-B\;MNQN>WM)S#MV@_,/-!_;RXYQ%
MUJQF5T!#[:5"452@ TFX8!1A(FLGRK-R*HJY;4;YL/J5&_( ':72EA4SSHMU
MF$??Q'4C"W[$;6CG+<S=Q#65"",/.&DL60Q*A%'$!NX C>J?=HVM]+XA4Y\C
MG,"=-I7;$D/QS0&\*SEIJ:LQ2^!4\G ;\'[#-:O31"QF1%/:'EE=XK@>>&T1
MU,ZZFY/"^NN(IR.($^X'7=ZQQ'38W0V%JI+;VY[4):0L*MXG_K7X=KYF@'G&
M:M5T9DNW##F0TT->:G6O5SY#1KHZ&+4XG&']ABM,I7M<K0NYS)(!%X+'6ES;
M@WAO"\:.[IYFEDH*-8_GDZ$=75+ZU@V6NFP+ T5.+G?6575A?PZ?2WCIP_L1
M,H20[[D*/G=DOR6J]:DOIW"P'YYRU/9[8^"3Z\1)['>J<E\OGCJ,V>F@4 OL
M0[G[]\1BT&H*&]5XEN^>H:)VUF%%14#2=W@(J1;"<@S6MG/_GK$7W$&WXKBT
MVN+7X>Z7' 1:XY(/.QH"YSYMLJ/ /?O]C*2$%S%R7NO&POZTPW7;VE^');?5
M-,?KY-S,[VQ#'O4,982^QUW*ED%7]9E5]0VCZCB[>\<B7A&LD_9Z=XSMFO^J
M72R%3N=T%?[$3.XNJ$KT7:WOF"'^#OF3INF]BCH671B/N-QLD&H)%B;NM%U\
MR<&$=:H:!FO]RZRMD5RN\MY0WRJ/>TQH5B)((YOC']'\*WB<ANPL%Q>A@/M:
M;\H;'98^N+!GX,$FD4B"ON?:\.&H[GMA-IG9(ZX*JYFJJ+BVV>=E#1@^#%$O
M?&4YM-\J2L,\--6)4Y'B>!,]5"[ZO:;KB?RL->SJRMX4)XQ>\UF?U@(90E@_
M9U3#0/:,BF[MRL8KN8#Q%E^EYW<2\H!QP ]$ALCV!TZF+4_5T_1P ]JTU<5I
M3U!C):G>Y1>ZF?=:.^98G/>4@\>:H #?IBW2-VD"_C5I'$D_/41_5"J6V..;
M:QV CN2H3C;W1R@Y."7J][ UIN?@?CJ,<7B3C.W=5W*+P[N9?TY.[1,RX/"0
MQQ@+7X6RYQJN-)K#[[A2F!A-/LZ:?7P5UV1:TB,S@ZSB_?:RMG!XO[@Y_84]
M2D65=_NV!GP=O-P7\/!=\UT66_&@E,QYZ-7$J@S@+R$GPC#&(^0J<[ZLX6>^
MZKIHG3K."Q?K=SA\JX1?OL'&=^63(J-3.RUINH"K.UP(97&_$(WCD71-%;TH
M+GE[\0L/-ZTY*C:'K+7GQ$!*4;C5Y@R\TTHE=U@?GXX$S3WU2;L>3 #0H)OI
M+YRQQ@WB/985)\#V6\O>/LO-PKO63-]-?V)JNPMN?2O/31O&<S,*YEL@K1,B
MH5[KZL''!'9; %S5<+M_*Q);Q&-"]WY!Z6K+2)2F#]:'&!R:-"O)*T8VSF$@
MND]UA7UZ7-%OIR/%U8ZLSE-Y;CZDH#@7<YUV;X"%_ W2-:^HQ)[<I0C2\K5"
M_'"#RI$WNU7M$ZX)W%JV40+X3E2P*P.48OWH3Y;2JF\GN<.<M0P#CN+[LE"X
M3XYV3K<D# ?#BMQU6'3WI)* M<.>1.0CP8J4HJ, WXHDCD#DXT^)<M%, :9E
M,Q9'D47F2:Y"A/)?3PX;F&Q!MJIIH9Y#X]<29_%(8F!)Q.@-L4Z_^'<4>1\>
M9RRD&EHY&?>+.29CF)-1JRNMC4-Z%8<H)CTS$WX0 @HH[M"[>>G=N?]D1EHI
M/2R=RQI&/LH<F?\M$C-NGW,PYB#F8E*A.4G-VQ6XV?S3^3"?9/KCMZ?4S1C:
MH8 7/4/HR2Y5H :+^UM]B?21[5_4-6"0ER-/ZS/K>%!(FKS)PT&FK&W,+<;.
M"<<'E0_ .I_6\Y2_8=3W4^)Q%LCQWF[FZSJQ=;6T-,S^DE\*XV2S'C)SWS0I
M\QGRNX>JXOT2Y6'.'CZ>W8:RZV%&[?4'XH;)T/9/QZ_E L9NA.?W^'D6._*
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MG'][GB/R<4F/1]V03FR[<W&*-XJZ=N^? 'M%%.^ 8K\"N<ZGMOY AP]8Q.,
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M\Z^._!N!MPUYF_'VXO.+S#N &\W>@^DIN4BBL+2Z7_I->N])85QGQ-B%".!
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M?&(?U]>MKY$8%K[BS&GY@&M*] AEO9M/"]XXMV42!FY\*H)M5\MPI4C"C0N
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M-IB8&]%9Z.!-: BF7J_ZU'\YX$:V4^)4S 6H0%RGINZ/OW>+A<(YQ!+KDKF
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M'T&RT@&U0[^&/UW9,G\$<^)8+G;XE&T+V.;F(W:^:1/VKD)_J[S-DX0\!*C
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MX_38M-:ZC76W=W?7\E7R(D>62,J5?YAMM=&_" /862RRITY/8=UPI[:S_?&
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M;7>CO!E7#=PK;G\\L&9V>^$TWO<ETJS5/%X+@S08PZ9(-IFR54@N5$_(#6_
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M/K-6Y$=ZT==?F:E *G8@ZK)<*:U:9;:>N!R@(HX$I@*LT@8('P;JE3VHW_"
MT?ZC3=,RD^U,[>@@ZA',@=5EB834F"_7=Q/>BTU.-C]@7(/P^^^L*0WS#LXT
MM!-1[WO&U;8L#T-;D3\RUPZW'O^)'<^=H;:O.H$CJJCJAH;5S@$);\T.9#-7
M<' 1N"['"*%L6_L<D,TW0- F0\YJ!8YZ?RB35E%:B^G]RC'*"]-G*;OY+3RG
M"Z/](8(78_V.P#VA=S+^)IE==B%UZX;Z#W="\GMM;+.ZXJR7?H<J^GP/S]W6
M[WR%LCSRF]_+[TA8@XB109YRP; U_>C-=PM'9J;4"Z6S&]C:5D+*KE^+!_DP
M%!O,4>QM%Y*RBVKQ/$NZL+_FH>_:U$3"6!@*]W'9)U*S_U*+/I\P7.A\S#XN
MJ_[B!F8/5__CA/>>I/O1L&/A'QK0Y5$?E7O^1\.KT B?P/L6S#;FE7*&6M&(
MP#S=QREC?36T(PAL+O?0!@P)Y@"*QS7B^<:U?;$)I<?&D05[1:KM:O9""7@%
M"WO\R^#/-^,O!)^?S@BL9FP526?D,T$-[7U#[6BC3(F/&X]U_N4PG8E/] H<
MB=S[X=W]?-KV4B8,QFB"DI$P*?6V<(-+^V#N0&[+%J;F#CIU>2X:=X&T%)^H
M!P9!M3<LC<,(Z"&$X\_LY0KLPIP9JUQ2ZH:E[]]?GMVNQJD_U&XOH])4GQR4
MJGJN^NV@GDMKO5]WJQBQ/,R9>&A;L<T_Z>K;=\47X3LA-3!P:=*UN,%ULK#8
MU?SZ1%)*(3\@/<=-B'<=H/;5)SMR0^>:L;=>GO&E9K20M _5T!NS//<<'Q[Y
M-TZIRI\:F;7@5_Z&?;BOR\YEOVG+3])NZ<YMYZ>.!5=UGZ'/H@C@TRQA)*.P
MJ.>/O&LIT$:FS!'2Q][X8&AJ/BEKL<*M?/<BCDEN9^=$LFD]9MW?+U20#_#!
M1.J4]M(BY$^=B<,GHRW<V-BCT?P3( E]NMB?YLL%^N&O/D_7AO=D2>]TGB D
M;"O_B.[?3#*F%^O5>APD$@[773+/T9A:J"D^![#!GR%&1G3+WGANV'H2M^Z&
M-O%#.QK=^R$*Y$;B+L1:@?/E;CS^@3M<AXSU6='@_+C_&_93^(P;NE-'EZ3?
M4XOE:][QKWW^RLH3IWNAH'YO'8REQ,KVXN7?S@?JM[C9RJ<(<:?W%N+\R<XD
MH]?^+0.)^R"I\F.Y<X#39$48ZW-GM/]?A'WRC[2K5\I=<SPYLI0 Y$B*TWJH
MHU$(?A0F#0QXV96O %X9;8+$QAVL9DGX7<$&Y\R= ^X)EZ)S&'K,4HJY?BD)
MJ53RZP$70^^+G.BR;$#LX,_;QY?:T?!@HN,YX'UY:(.)Q!B!LBUD^-H0>&KF
M_B?._H4ISU:X_K;P[-]M%#I8.X!X-V>U9KKJEG:AHFX"AW\MM=3PL,.5*R,7
MDII%,M*8,*0E-%!+$%?:.&:U[V1,8OUUD!&9CVJ_VTW&7<?0[>/>'WT>5.I@
MW=TP=R7=LMA].\LKL0X;/>';-KP(JOJ=_?!^]T*Z+[G%9JI[:#'V2F]SM+*,
M.2;TI$0K=@>K;Z\07_L9MF ?]8X0C$CM;V=_'(\)=^/?SO4BQ%UKDYXZ<E''
M5[PY5>S;3]_JUW@.<SK:D8?YVCTF$H+)3Q9^%(ZWZ'SZR;;10$I['VOIO>D^
M=,^[\6[(0Y6\]@?WWL;^Q:76!Y#"S)"J"+N0J Q23.MH4J] CI0LCG%@+V/V
M#A0@7NXNV=<9V-[RQ6S^?;SZ";6]^L4FXLIL=8)U@V_-H<:7]C-\G,-EV5,P
M1([QC^;C$H>,,GMYDO[ZT4I"L\U>89I6.&^(-AQ(_NK!_&!GA81+.W&<H]_>
M'+Q3YXNLNN"+5B-7O_Z2'=%@5VI4?LC=D1P"7J6:76"YKH G5V>\U1_2),*<
M46<>=;(M/VI/NM7".ZN9]'CLT-N@JT>%R-=2\)LK\=E7#BR\>0&%\$N[I_$P
M)<$VJJ8W!G*?XUA+HWYPE V*:VYXX-_VFLKOCV2;-T.(P@AR[L..O=)^D#[Y
M2Y%EV6&2S EL39MCO!+8"4KKN)J8F;(2HDR^SYM48A_#>) 7HQ;=C(L9Z)"$
M<;=?;,;\1(X4&_A1;&E'@VUCM[)=O:'?!W#YVR7,6F-XX'Z7V\T:]R$QB=^-
MLK93HGLE'K8D;LN7(C5OOA<(^C224Z*<SI@/-Q;\6G"_4](%JQ=&<L-66G (
M[9N_2KLD>@,/8]I0]_$WG$(%U)15K _R2;=M@HQ<(M!E8QLV?\//&*H07&"'
MZ;J)DI%'.T/DR&+WWD^\$ELV(E$A?%"Q*;Y/7/9*^$WJ8VF*<+_$R8'JQKLG
M'&XTWN\.-@]RY7/&E!A.],0/[2Q")2":_K#65S.3^3TWVK$AKYX0_;8;^HR6
M?(]':TZ Y'H1;H2RO*)\G^8!.)UOT4@\A2YQ;OHQ-+7@L$?U-4/B[P+N/#57
M*>-(.21C=W5>N4F<80- M$J2W&;YU7U8D&^%]CMAFSA5A?<7:1-A8+O-I!%<
MC?O*<V&XZ(_ [1QXBMTG;I[A\17FSE?L22GHX9-&:7+I""&%[$GD*AIOFRQ/
MA"#EE*H>DD19>F?/\']'OUOE2*7=X%,6NN*<1RXWDQ*EGXX'MBEHDC3,)<*%
MQ;9LHTE:<S_R:ZYQ",%%2/9M]RUGM+*?RBJN/K7,K,*>. 98I/">PGKKGY"
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MN4KU=9!]=/[3U4-Y(E\TL1SY&(/8L>JDF)D"?X,_'1XX6M;-5QA%6ELJM'P
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MW]VJ.T0+5M15]LH/>(C&[TFN'=G-PH2B/.D%_:X8IN>=W32(A#XE4NI Z<.
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M*CP/IZ#A;C94[?=WFQ.WOU'D^P9F<BT&?BW**#;Q3A<I+T^@F6:$2H).H0/
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M+-<:15IZOVAW<(.C9LZC\=][YBT =[!.?Q^6BQ65D.7,KO=KU,\G;M6PPOQ
MD_4SB<0"I(Y/<C()VNE<X4O*U$T,4]#5_+$VWT\/,H]$_(.L8+']-7Y!D2W,
M?LM/LNY[[Q!>KX#W"X8]BS@*1Q^0=YK]'GP\\IB=OG/!^3/OQR*)>T X CE$
MZG-JEUFVL!II8XF2LCS[G'PJS-H=AY<VI+P>-QT563:'&L6WJ9>9X1X@H8#)
M;^4O31EFAJKEIM5;6%<EI4P>'X%G4V^06YJ_%]VD+;^O&LJNBEJS0O4V30J<
M[>R&?TH09U%6-_#+;QSN 2]@6#UZOOWD%,=N?C+S/+]L!O?,&LIX-EUSX>-
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MY8&RE8U^9;B.\MK.W[G2IB=A,NHXRXSE'UNBCV>?]BO-C9HXKG:-?3F5N%A
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MFM!'0_QB+RS1(U]]? 9>;:/H@Q^M08T@^\QF;GL7^.B=O1*4^'M7R@70GI<
M?VCN#FA\2BGY*2!IP8>;_OVW%1Y;.:V5\E3*24F86\31QMS;^N<1UXKC3KN-
M?GMV)UFW^MDOKU]X4;1Z<D_FIY*6)_'7@,AM4+BXS0*([^#!)/FA;?I.=^B,
MMEN7@K5)/BG1/B@2H!&P,IW_:6<#/W!5V[A-*UO\VSRVWX1%>]=BVYQZK@\+
M3Z:5U7CGN0[CM)82VT;R=%Y&#)C/YBPVS[XH5B(;CW15%B::/5,T-KW!0WXR
MW)FBX.#693?(#0<[E=ZPQ8:G\\5]KLJ^QH*')^VJX3T?+#X>418;2IO%WCWZ
M,?YQB.@[;'R6J%$V]=VHU*,_FY,#^-+7=;0"?\Q0%*FE5QRIY0(P!\JVMYAY
M9?M< MFNS/1%?^&+^]JV8VG(UKS=Q(T=OA.I95_.]U%6N]&\59R_S[_PT3K<
M%1ZIE0DF$!_,#S9N1F&06C6+RWBMNI8GFDA_L?/BGSSSB#VR1BRA:%5^S)7\
M#4IE+!#L*GD-&]C\AO!Q*V^J1R6DM;-B_Y@!WEM&GI& ^&YB[JKN9(MWYH_U
MZRMA*SS]_''-_U0<SB];7,*1F;/7H?#]<64MHS7D86W-;4PS2M?P9YQL9/;V
M.I_ C*0%!#>CD<3I@A =IA1KD+=PW64%-!]![\,IVB*\U>#]#AZ'%9\ WL&C
M_*V&C)= L]R2[R]].EQ?MF#'D>7#;!!#'SYIB?0]'NI_VU>R+O-4PNTUJ$-F
MXGU@T6<,?*FTAZ]-5OH&;4%^+IQ%I9X\EMM($L^EW;[V(O0DYM&!-@_M,;Q,
M2%QP+%R5N)[WR[5]O]R 8F MN(_)=!T)>3U.@@J#EOUJ($-3NO^0;N*]=;G#
M1XU,BJ)!AK/,AWS:5@'PADI3ZYXSM5%#$+[]EF^X3%>O"6:+]\V83%1GB'63
MY9*Q\N*9KZ(KJ"$)"$"[8EI@WUB6 I/%# )_X.X";\V[6/P4P;O#^7!"*UBI
MH>_<DD$E+VP$]NE/'HC@U=.A<&@?[MXE@[HW2F=L['YG+UK2PS\$<U:24T:A
ME+ZW=I/+<.OGQ]8C50?#5X<Z5^NG2S[^&@]1GA9WD1DUX2X*1-Q#:Y#GN$XR
M;5N4-Q\S7"%6NTX5(42]EUM89399_BRJP13&L*FB9*4$5V@GYMY,N7+S9Z4^
MYN J5\TNY-.1L'E FL"G6+TRQ4#^*A2'6F_+D_+7%UW@0Z@P8[<K;@9]5TSF
M]P6FOQ(=+OCW.VG!Q.;<8>JK-VQK_(!-WGTVD1[>J8WEG'N$1QO.H0FZP_&M
MMQSL/N\DA R-CP]JMFGI(%ID=[7NOP*U8*;LQ6L*>R7D=PI%FA%L7(Z_$W:R
M7;;X/D\?,X0N<[PJ#B!.IXI2L%O._SP^ G>@QN_$KY1W8^Y-KSG-5D5MZLF$
M=5F86<935;:N)?8$#\X[1.M]*[+G.,E#OUW/YO+XPHA-0C]_U0<6)0GYC)(2
MY@B03=]ET5.[96\C0+K,_A5IYX+%>BZ4!D/NL'^MC&5N41$?&LK%WT2U,EQX
MF1,]_'#/(#",E$%1:9B;BL8:8\Y3E+.B.;*!6KN$2POZBQNY+QG_>1>>SLWZ
MJY1C>]E#T/J?K^3KH6G?RI]Q,&*3FN';)NP%C*<"$5#T0S(9(?4(AV?!ZK9
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MKXM<CM+T]G30@0<:_J.1K;5UN,/'N+5$.N[=Z&?Y+CIAE&G@_J5CAOK\Y8E
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M?(J!!;;Z-Q;\^AY";E'>WW"^7'>PLRVW,@"Q \T2.%#1X]Z!WX;I 1_>7_]
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M2'2'!DAT#@^>6@Q,/CLY,X_+:^">Q4DRGUZ'JW:S",2[O "SQ^8ZA7( UW=
M+04*C7W=V5TOF-7D^X><W8XZ=.\2\1'B;^V>K)8_FZ)\_]%26R<"EN_ETJ0
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M?QPJ72YPDG:S-7O'H,=R#A=WM^MY\ 3[//*MA.6T?-$SGU6++^&TS=4)CXD
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MK1.3(V <-)"#W'=?=H.J/6Z5813-YS+[0JWZMU=M5EZ%4A/%U;6AM\8RA0Z
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M5*=X'1-4R4I2X#A8PEIY* >>46T'VB,F6S;"/Z1N#UF,.?S1TX[)P-ZP!V>
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MB!*?1ED5C.MYCL**Y=FM>80-MK:#T9:$4R0IU.RLFP2/E\D]RF-_K,"L+QB
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MK]Y343GOJZ.KSKMR5+EFP2]H<1C?R,4+*8R3Z:*:$(JP!)^K=$ MU2@3T]-
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M:0-@T+"<\5^W$:<X(0O/(#X(/X2CX&UJ?%)6G-5&'E017X ?<XW#4!".#\J
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M1H?"SP3_:N,_)T"V.P\EMOZR*;X+$CQ<IVF]/Z+IM8;V2=O.'_O7G$CXV=]
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MIE+$.$42!"XA2PU:D)>@Y4%VB02HGB3DR> 8KL,T^6%I0^CM/@JIH6AC*3Z
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M72U]%2&2'#_KXD=L,O!Y&B\D^56O8K9,(KW7F6;CB/Q:%I; 2JZ3DMK%1HU
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M*M-5KPC,<5'#=?+;JH2VRAB/E=F@C+R#RL4XT./C1ZP0*>,>'F7(F]A*[3F
M_/0%:M89R5B3,A3DRI>:BR?]J:?GJTAY+UYT,&N NEV EH7MT[JW%V/C.F?C
M^G*O//W2/YK)GSUS %[[K]KOK.E=-Q[W!>B'^<AEG@]<2*='_AP=!*)OUJH;
MKE?&2LH3 /B+Q@@'.^UF22DG9;ZQKK&P40]S*]O?6Q=BF_M<-'D,+4VJZPSZ
MOE<R6'H??-]\#J V]:U!7==#7V[N(N_^V7--=5,W1\BO E\_]!+6QX,O;:<%
M[^#>1RFJ/8DNY#K *1+/Q7@3[]_.^H)]MNP)S44Z.1XG3:N'QUZF@;P<*SY?
MK3+^VHR!V%#K U.=ZE(SP.,B>[)A\C5K(_]#KN)":0,%/8KXNMR/9_$G)7#R
M"]^3DE)OGA)O,V\(#X=NGL"<0,8%ZO[;,(2P2)Z(8$:.5S/Y G6KJ)X+\4$[
M!,5!7779>]+8+P>Z1O47^MNX3/.2"QI,-W2S>5S<+O3/]GEROHIF?ODB%#F]
MND/@B/PZJK3_CV:.7;KLHHW'65D;Y%&C'UCJ*SEIZ,=)2:5T_D6Q6]E &*D0
M^CRXPD-P-_/E176 F;&8=K.$2(MHFYXOLZ1<LH_6A7WZ[4<(S+%_% <*IGG5
MTA9.;?VC";(\BZ,]%41\0R*D"1S/^.IE+S1]:_[Z'\U5]/HO<KDA,X>KP/Y5
MN0/=.]47XGVJ[M(58IW_J/53R?C"F"4J,U.B@RP)<N@T$Y)]C.OOD3!&4,/;
M$1!]#I)-F8]DGU5<S?<X9L0ZR=6BR[U'*&P,KK=7X2%W<#.,IX3( 4DSJ2ZO
MM%?L$WXK4N>SN ;"+NQCC4.0M.WF &>##=N!(T@E=41!^AP,Z2,8O\B'X'3N
M?]P:(.*^CZ=>.\*8_8#3U(2B7]$!(FV7T3L]!DPY"O!,=BE=@Y&(<8_K84\$
M>V+,9FPBX*"XE!L]W!AQ?CDSN_VQG#>P)P]_^5CE')/&-*VCX:^YO$$H\1:,
MK)2DOV4<.@:M&_;$C-"E$*P<?)=&^U6;=O"#YOP6F(E7(%!DW6/=PF D(Q3U
MDF1HA3.Z=@6<:AD+N TNZ7Y>#D#5C]8C3'"U\#"L(4Q,V @*U"IU+Z+_4R9M
M4@Q'%DD/@T'EP4!!J\:>*_L55S;,+,QOK3_J=5E&IQN2L8[\S!YF<UZL[&D>
MI9?AYJV0D*=#XJ^%W4@#S.9\@*?/REXTF>ATB35@VNW*6&%>NKH-^QBYSDW+
M)U83[/T\HPD@;XXJ#J13@.D=P?+I%[VHUF;H73H>8<&XM&Q2MZ_XU:B+P/2@
M.:_NG;U-,;S$RM1S0S?F/V\)^MSY'.$,T K0JV0BW]RP;4-[4'$Y9<RM%N3)
M%VBVT[8A:^)-@0R\T(O/)3 #+7?$9Q(5Y;:-'__I*Y, YZ7DP8H #X :_O T
MR8CQQLTSY'U8?UTN9$8'EEA:1F+08>DUQP<4R(QGF<8,_7[6_(]&SO7=TC[N
M^D6*?<?=6YPY2=/;N'$1HQ%/F4AJW8/+B>+"CCI\9)P"K6=IG^.]0@:ZTEP@
M2;D?!L(FHK<*.[6GQQ[]SND#]$5YO,0%\\=N:7_SF"OQ3+ZE;CMQ+D!\FO2-
MUH+8^NMKU$TG+:ZA6?\UYPJ/B,:'L U8C:K'48[1?C?0];6D2,C+ LFPG[Z5
M4\4$^ROJ+GMOZA&IKG7/S"&][ML.HK!^*L/[-"*A^[?_AH%^UND3:O+^\X#8
M]%OA$WW\(E1K.+EH].]<.FRW,*E 0IG-B'5GHBTD_MWO91(>T2O,466H:=;L
M7].T\84IXK_IV.\!V3M#8;:3T<P1&LU.K:Z^LE="_]%\\V/ 32X\RX^''&"<
M%.V[BYAL1FT4/E5!C&]OT_!G9(G. UW])2W8L09"H/V*RJ!E<(9-"FMH,*^N
MK1(,JB=^M;R:4IX(,9=);$3<&3 @&#=GS\)IH-;25K+([,>"<F;7'V(UI"VY
M),8.2WUXO9Y<IEH 3>M3,]\)UB;A.;/@]:X;1I_'':^ZQE6P4LKMJ$8;,1;^
MZ0Z&>.C0N9ARCJOL?M6^4L<$+?6:26;-F;AF_*UAV+F@71Q)6.5<R.I4/;IV
MML(7:DL!%!Y;Q]_:H.NH.2M8B\(/U*K;](RW7VO9N9/@B0]S_Q1>RC#=ZKJP
M_"N[.F&B84VR>392LER=6UXY?@5A5VWK80;18"S1Z\8_ ZY92)O$E]T6380$
M R[5B\^[>Q">]3D V!,NTH%PDNE=#XC^BUD;GP&/JL'Q0B $IGL-W0*T@V.
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M8"U4U2$AT([C8%#X&W##665KRF?9IC7]\>=P];>IL#UQ\DIB]CA[_M";H<6
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M3X)F(@1T !:.:YM:D+$XM5_/]X0=W<A=[2AN@1!;WE*M[L3N[DJHC6OEZE]
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M=%XMDAXYC53:A_1/IC7!@ABS?[7'[(Q/BXZ_X]A"V)?&<U_XS-9!UHA!./D
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M'4O_1>N*P.F4X+G?/H>-YX1#GXY8F\(D]?3=L<Z(.X%=.H"#OS2=*GP^=#:
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MZI2)!()GKVD=,#L%42S@M&*9GNGU\"-'UC/^5,^W3!F%WK6BE,9/\$[*?/"
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M:;('NZ_[H&X50UA!$Z;8_^' VEU(V."610,J5<90-YY>&%K@+5>>A1GAL+K
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MN87AEAIL1,DXI;2))XWBX^HJ&LO>?"Q"1:BTFH0UEF;2$*_DKD)@[[78+M\
MU?J@=20- X(([Y*6*@O!;.J0V^(JRE($-U(EL#R[C?$R_:>XNJ- C,;M"D),
M]Q.W!YP5[VQ<?Y70ZCNB1*IVOQ#Y<[=-LU 1'T_ZJZ],@YT]4(7N+E2&B[_3
M^OP+_2P[\,VZTZ)V%(0"";N+2IQO^I?0'3'!GV]LQ?W^Y46R51':9GT.Z+G_
M;]P6$Y#P?M,373"T;7:EG0\??J#?',(H_<K^R*QT.A1](MQ_QM#7W,-=@#5J
M/P>8_=?&Q;DI.\]US<#]L,(4]O*33PG,'D='B%2_K]I<' (#O:Q>)9SV?(*F
MT@U+*?G(RP YQ?/"TN7''?J0V"7#EL<%MV3 7./9S&[%AO2/G8&"&7JWCXUO
M6V> &=)2S'2"1N6;G_'&RYLV]H >-9:A"FA!OPUZ$3"VMS1V$"2J#[)4\08,
M>'8A?1!24ID)-/).#B_L4UH[3-5P2:N&"$G)JQ,FT#4LC8ZL)CH8]_2$W67>
M10$KFG%:Q4OO[D.SU*XJ8XP\"HJ%_<JM45"M]VH%#B?];_I,_=B2S(<EG)(+
M N3PU6 J' ^C2 XQL[B")@!ML%\J<83C$R\GC"9(W9QG+9_4&C!LT+JFW9S#
MAG8O0WL^O8J((Z5!4W<+PVY!0\898"K$[$N5J9,YHP?&:5XZU/4C]65CFC7O
M^"Z70G7KZIC?C;(5%T]HQD:YB2=7;A0-#%+3W-<5!/L4E(]SM1H_J!):%0IJ
M-2:ZW%J$9ADE,9M\2^N1'*C8$;5PJJC!T='\J*.0D+U@D6!7\^=HEC(I;Q0^
M#YH;85_4:1@-6K$:KL:S\<1SF!R_%II]X"Y4G;:P8B@&3=>RWRN\P<@[6AR?
MSZEES)OYHX]OS7 #O:-JBI0SNTSGI6_*_$JV[(I4ERPDPTU0RYHH%PT7?52B
M.Y[B=O5V!3%ZOK2"F)G^7I,G"NSZXA,0C2@"JA8I:OBOF)1&UK^,1^FR%*3_
M". K3PM [XC9@(KH#*CFT<*F217?=E&K/,<NMT?T#4W$VZUI\L'FM$CW*1?@
MQXW5?P]5#:,67T!?TY7"M.XW)*K(8A]3JN>NX$:=.NUFR)ISHF[>O\S3>X27
ML#'3MQA=G&*UUZ8^Z7TGW6Y1]*#@YE /P9JWK?*"8:$?FFGA9M6U#]>1B[@X
M16LO,Y$F.VA[-(5VIKXA^8[+Z1,S.6*NT0C7Z=;TEQ5G.--Z#V##IAKVB72O
M#<1]<^Q^>UXXRUQ)T^M*51^^CY-IFS?WP4:.A[#OAW$2LZ_K?OR4[-9?'&_:
MQR:>2?NGK4."%.7(I#,IM_KD8/H@I>W3CY;QP7"Y;$[F T5=2OCV-8]ZN<,H
M+.;I3.A=<#?>/6AGS4H]0?1EAD%0("&/[G,CXN4]+MSRY._=RLK@<\"6,312
MGX_?%UO;2AO G+Z]T?O4-H?[N@\M.L#NNI^AK=>)$/$^DOH9TWC+O2'%2A_%
M=V$-*J#6CL#<TOHU'ZF5NTM5X;FWW<H<QHO_K8@CDM8EF='/P"KXF5$FD<@R
MM[X*^&M)4F7W WXC1U['^.+;GMKL-/E\;N(2.1\1E41?!U/SEZ.WB!M&8EJJ
M4%T"(-;34-*HUN25*YWOJL]S'&A'^4;#>&*L28MK[(/?ST4UZF2@3NOVF0.&
M]2#3P$\U)FC1>R(MGB95LF6M1(B%;"G/",9+4>30;7K%6E[I495ECUO]V%EJ
M)M\R0W3R"9XA\)]YT70PA5P2]+SQ="?V *N G]_!7B<UY2V_]%7HF#5Y[-*(
M+9-7[/@3<U&3A;! W?XU8HN\6;9A'5KC HR_@_'_8+$#7S&6F4<DQ][ &IUL
M;)NI$J+J]T/-B@E%V+4/S!BC5T4#I2Z(RKI%K;1/I?-P X.]"\.$X308@/<_
MM:))J!^X0%@96!NL:F6'R%,DWI%%&=7*\>J/?TII4_)K4Q4:Y'MIYEL^8,A3
M2D?268OA1+I:C58CK7'9,K'1%B#I2,S5@EZ-M? FXW[4';EL1VV.$.)=PI_G
M<(\6H!.[D1QA),*F3C>4F:^<^:_P'R\"ANUMAB@/L,D!_AW<#UTS#&C\+5Q1
M3>3Y]_2WL*9A3GJ9(+EP)/?R(">N21#?VC&GA$C^[[^PQPJK!S'R+]-]-X';
MW4';\]-LX/GOA3L4LA/552$3,_7PS"7/6#:=G?R/>:#D.5?ED#/<'/G'@;&X
M_(Y-1-6$8B$?5U/EG:UCL?OP/2V60.\5OG^_U4!>*+_J,.<;5B:CG>UU$_KB
MG@BEVDERF+DZ4E(F#6HS]*.OH<%\X0I9M<Q&Y)[=W&<QS&+#\A53X6#-=!TF
MZU',G<HA::EETRG!4DO_CS/<PJ:X;4)U*"MWW&M2@^++8!AM*5]AE8]:FJZ1
M5"QZ=JIR]\/V?'^C!/?/VK\XXW)GT1QR7J<G;P?TC]3 ^ZZ79+K/JSE5?@-W
M09\77ZWL!O/K/N)W:GFPFSE?OS+>A.':MO\ZZ-%>@^'Z3?+A$_H3%?4>L>1\
M=RXF5#3;[<WK]!WA!E+&AB4Z,WGLA3V\_H.C+LS_%[(?HV=B.^K9Y&73L76V
M], Q-OF)673)5D0DO;><3$Q<BA #8J&G#"JMCLK FY06#S4$"55-E#3'?<.!
M%2!"&>^%%VT93@Q=OB7([%4=:VX?3-0OZ9"7'U=R:O35[LO7/BJC+L^+"/JF
MDV1NEI0'ZXXO>#C,L532',TLT!J@BAFJ+8DV!:O+RO3K&B)U(!'_-APL)&4$
MJCT5 HV:F.,,Q,MDRRV:259E=IJ&;!"8RQ+.4':A&YIDE'2WQ/QY176* T0N
M\?X3-P5(>?=W(,P4:@)-@V!8M)[=Q>AR\F*TV8:]FIB>MX$6/ F/,-8?50UO
MJA2;/M)Z(ZI=C^&[H7$15M(ODH@Q&%[6D;=]W#2^U 25#L(5QA:;::S^L!45
M2@"R2X^WY"0G%5X)1PQ'T9N_'D00:K,?HZK#G:+&.H7FRJ=<)VJ[X1.)1$=,
MIR_&WGY(B;!KT!\"G<%-TJ$9K[YU6WSG*&\FC/X38J<D:H5'L;.^5=<W[IF'
MU&3Z?JTZ^!;"?_SD@:AY\UGT\"8//*^A,?FG>R,VO\LN6??79E'"&U_%C!&?
MKO8(DYRE[#D&NNX*:/7X3?62 +\/0?J+-=<"]R:YK1";0*,O"V:=]B4@R>&]
MT_$8XV7N:%MZW[K8ZK.T.?(4,+E_89$:<&0V%;@<Q4L4_;5^'3S')4<)7:B+
MKPY)6WWA22QAMUKR#W2=ZOVX0EV_>FF&;/;"^_'7*@](=89^5B1UMY)..ZC3
MLTK$Q%'&U_MI^9_X,])\V*#K4_";=+\O88.O+"??DJ\XO(1[?8J$M='E"M-,
MS4_5%6:4./ +([?Z(/.!_9'0-KJT&,E7PVI@4(JI RP76D.;@@*#$&'L)7IU
M5WLW"A ^G!4?656%C6^@[E=3ERHH)D6PWS)+EB>Z\JV999I(B'J/+B;!()+W
MM8H\[\!M-%:+1XQSJ0?LJXJ],B"G<-#2-!:(GU21G:NIXJE<Z1RKD;W="X.Z
M9,N;208X[$-$K@D/;[H=;5NU-\#37M'LS5I#>XPY9Y48%>+ZZ7\MM6=0?.:P
M.'6VVN5M;*+;"&;STLI@X$'G---IL@:A'013S[7J=5ACCS'?HY6?ES>+/5'9
M.LA8DL $BD4$:6345[34=LMT0Y4)HK\C?JIZCJ! IE*/J\6-/_[#$#S<?-7O
M.;4HT4T&H5/TMO4C==LZI7] 1..^UJ:X>R).WS[H+KN2K:A6S]ICIO#P1O@#
MM,MO,[%BF.)K*MFJ^#O]B".VE*5?\WF(;AP,1VOZ^!"=6 6_\H.'MDT[:; ^
MCPP$0-6 0;VO7+KX4WS LC!WH;X>$$?/2K'KN)@6N=YJKAICF63I&_NXRG7J
MN9I<^@< 'ORY5RM/F@5E1J^5(]K4P>L$[HY.D8=<*YFM?LTP@-S\P(-B&]2'
MK1^\4A=6CX7E45E(^(:D]<%L:(X5-?3Q[9'-H\2P0SB2Z"T.2KS3M*K""(Y3
M9UJV?J:?/A@_K.I87^WUZM<5<NT:U\V=K,_Y)6_,IBXYV0<U;WNR/##YXV?<
MW;CY)CWD85-T0BX:/7(2(.7X9GFG,COA2JO%(;WSX*<!>!XU-JOKY5_O^+]5
MJD6_=CVB,R>:]4G-$TK1AA*QWY7D#A&Z*G#)K[R9[1*-47%+K4*+.+O=JX@8
MQ<^V[)9]Q-[EI]O@NOPNW+_6T%N"MH<NL 6E6\OS!Y$E+X1]Y JA@J-%5KB0
MN;SF-FP%>3#QY'EV:V39.2 B[M$Y(#UJIQQU$;F\74'#BK%N,&+H1YC MD)=
M:%=';M"B6%= QW)AQ5WNVX*OYIY9;95 ]8U=3&+4\6_\YZAWHKAS7\"F;QL:
MS#T]) \Q4E;G].>5<DTRNLAW^=@_8MWC&=U@\6S$3UDKBL*4Q E;QA#<W-0#
M2IQ(\N,=AF6C5;R^)VL?>"F$MR%1HVL)APZ#$+E(9K :M>IMR57&-X<G<)6I
M8>N'^N!OKI5&+U*LIU(\CZNM%+])#?VJ^<T!57535[>.NMS4,_I#<H'.R[J-
M$$98JG:*@&KAP8LW7((?"E+I_VHI*M[2/;;4" ?O<H?O&4N)QY)_AG!]J!Q(
M@![H7T9?C6]?%JE<AN?__*VIQ;QTJ _%1?V,98M<'1VO\TZ=I$8]+.1*VP,R
M+@Z?+$FX0V3K:P^;C<]^7-[%L/)UJ]X;CVQ=#?K=L_E@ ?>!1E=_-B>X$-;>
M2G'0G@WHP)NMV;B["BO_[<SK+CVI#]C'2E.RWZBVYC^S22HY^_<C6/BGH@"T
M]ID@9US(T^C6BGSMJ(_;TUW)+QLS\O86A[_&8'O:X'/WJRT_>JW9V%5<[9VW
M(7%K<+T?7O'&G8Z3".+.P+12L<UN#VBI9[<7*;W$'=K0\/,Q1MM?S@12_1:"
M:55X7&69K#C%,8?M]-C0=F/0$U9C49,S$+[5ZY%'?"%:07A-+-\XK;#D1W%B
M<7KU[40?M],*TZCQ9)1]:J7S:<9X[KXM#&^N4/'48\-8+LH*YN*@Z=#H72'I
M A<(@:Z&#&YHU<_CF[CK,KZ])M4Z\R)IBH+':[FRZ[RKTC#J)6INZB56#L8;
MMW7+:R]5GE:PB@:C"][:PJKVV_RK8GYMI.F]]/KKNF& *\-YB[KV:D6LGZ)0
M61P[T&,3-]<-RPWG#1VX$HPD294'A[[7EM^O^KB^>JUN'Z-0,#+8]Z*12UAZ
M36-'LMN7 ;YAH.DDCD>/L_19S3R4EV-7$C7VN$E]V!W(-,:@A08G+B-P$HR/
M[U3#0Y2+K8TLG6;C?,R03C/^E4\PMY+],;RI,9_3S\3S+BMZ'9)-"T^>Y4FS
M)I[Y?&N//%S1YOR0OBR/F![K"BH;/F.AI(98XT-PJ]"[7?X+IM<N]+ZG_J@N
M78$%\>LS)0Q<>VGIMOG S;QR/>KC]Z,]=PZTW\^<@3VA4\?#Y.^!@MU"P%36
M4.B>&.V)#N.K2;$UJ^18U+H#R#5O4"9BII&5AMY^59'^^94/IR#KN[T&>NBL
MZ\O6 +);5<9?*N1JT44]E6/ZZ,\_C&TGEMH-;6534C;$SD%E<^KC?'5FALJ<
M'$(7/\/(!-[]%339Z^LY0)=PS7PYKFGPE>N!/I>$ITUXN3^#DT;";I6MR=;Q
MN#.-FO#:HZ94F*C%/+G3X@^TED@$#$!2 ^>\)VV"O4>_=-D17J\R75O(P_T)
MADD\/HU1KQA?[?^U5#?;3C_5.J!/^.T@T&S):>"98K9A$NWIL@ZQ)LSO0$3;
MRZ,H%7,PZLD5:6??&#<6W@I=!IQ. T^4%5[2'=5"_V-,]+2B+KV=6&4,9E)M
MKIBQU[P$9+J,P]VO7]\V=:K=QS C),:-<.R:S9@!6#"(NS9?:S23[K!2M=<=
MI^)!W>N94Q5*LV(?Y0'#<=TI[-;PE=__.WMBSB^X8D5"S9P#:C=Y0K7V4=*-
M/<+L!GC2#'=ZDZ#J(WDJP^IT8OPE8)Q D8_[[SO S;MG]$S+"U6^Q[-+Z[GY
M):_U:;)<\X++_.M7K[$Z5:T]W=Y%-W@A>UJWV"T7/E3&Q($L.69N6QE]+;4%
M)[S&A_ (&?Q'?EC!R+M=^>+8NVPKVE=I95%/Q072#N6P4NE<ANV 7D #V81^
M'S6!8RRK2G1E,2*;;X6PV;O3T;4/)7FJ&K0IB2=.6@._I$SQ"H'Z=..Z)\(F
M[O(,;O<>JYZ@,T?/>*[WV#1LR+MQ("3FBL;J%%\:-5-"+_WDXTZSGPI23,A1
M4P)M.FQ+,3*T@O0WX*YR21;_:@*J E3)G;,IT>< K8'\V6W6T^D5&Y( +J49
M?YJ'U]\D]6NR"?A+Y5UZ<0X0N1A3-779XW#YR*Q#,==E,KWH; "W"ZUZ>3U<
MK//@') 76J++W;G_OYNWV'VW@O6Z60>7MO3XE]<_=FZ=G .&E/#U(B'<6-:$
M7:SIL<*G<X ODBS]^0 JFQ@OW3M[8N4D?FCVU'%&V#.VX*1BQ__].%<LJ&Y*
M^OWM3H2NU4-72XKT3P[&&(A2[:OUHZO 'A@W8U&<'C]WKN?X=+=8ZIPM*<=5
M7)8+YXF%_L+2%0'#4$$:D9/F(N]"P#-LRUTK+YTN/[/R.8BK<L^)V["FB7$*
MZJVG9,R%.=K5A. 6N?BW![M'I3G.?"*8#]C"6$6\+.\H,B;OL!IY0=5O;C[T
M2@Y663URU^8@G47--HF]-.K7@]?ASSA.OL:&EOB.RWR C'KTV2S2R57'%GN-
M,[PS3-/4Q[?DBGVK'G_P;1>#IC5M,) FA6M4X#:-"I)^+AB_%W_UZ*JYC*VH
M&=)QK\+8*H*#;37HLW+:@)<-G4\E.COAT86&-SJ]HFDH_:7I/1]+IM<QL?<=
M+?DA3?JZR>%IG1!U(O>F&&,[+/\DS0C20OO6?-VA#V!GUK_$LN?L%"CU^9OY
M6$FJ79XP7]<4*+YG\HO=XXJS!]LFD$?U'#2'!W/7NU0&>2OS,2%^T5C0J$+_
MK46&Z#,EL250W]I4*Y,EB9_PD'U)4  #AQ*0:9U!70M$N.B#'U^CJYJEO%L4
M[L-OE*XXO1('$EWKN?0>EXR^N@)[C&D4/?(T-T.M[]_O2A]7O.HZ\<QP?.(8
M@FOKX!2.&O=BCIIXM@%-_VP"V2*5U$EEBR"GI@LQU"]*)SK-/B$^)[G2TOG
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MUX+4CU6Y*5FZ>Y7Z88)G MNAK:"##<[79L;9:^:V@,TL7&;'5$%5U$K"MW/
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MM:%O=PT6\1&5!;OV5Q?PSJG8?,<0A4HJO[0&?.*F (TLH.:LN.X>2*@Q]>7
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MGRE?GA$;VK@<2 T&F6;VNT!LY$Q=F3 VM,AX#2]CU* 0L]D]XK&%=)(!R^M
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MB5SI@G7U[:J2Q>KE9-Q/(OZPQGLN8KQ][3RM@DO(2>_\,=FZ!@#92D6,$?I
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M4FAXWTL4)87J+(BH#[V)&(SS5Q7H->"O="S@JPSR?+=_1Z /L[D%>A<L*S<
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M_QB,[+YQD(+4H\9_P>4_?%A%/#Z=&FO>'K--/2N!9?D6:U69-JRZ\:XTNMO
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ML(: O-*&WL 6JF,B+@WJU_*6_D*%#I'!0$VAD@><4S$;_A9ZG:AF]OZZZCF
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M?A0[A4%.+TO^.,V$)JH6#QE9^L.^'U?#RZ4B.W]MG27#!T(L+O.3U)L+L;[
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M/71_MRSM\<$:SX#XQS#$(7TUD]&H:HJ7Z>\5^)%[_Y@E(Z4XD;]*9VGX[4D
M7QD+<^;Q<.G2L8?$2[ILT)3].XT;CA&ZJ7HJY\2_V_8/P*D3\NR-_UT^TB].
MFX5,-R]^_KQS. :WC;:J!*.O_ .\#?\'^%_-'#%:[T.OPA\ZJO!%?)S@GYG+
M_P!A1U2PKXL6;_RG,!?7SB4-AF-KS=KSP8'\J(.JO8!#!-U.>>5?7Z':@>&[
M!ZCEI1B4!YRZZS@(BW)[UM38WLHN,&@5F7Y);26^PYCGFN["-1'E_?*$)J_9
MZ(P_!*"00]+(+[&1NK;T(_79O3>ZCAHMITCNO?=Z^:#%4-*66G,9GB _/^$#
M'VX[J@;514E;^51Y.L<'T*0Z'(> K0'G:J>O8"OM^C(7SS=0OS?N1=WR8!W7
ML$+>-2%/X+'S1045ZY/,#DP^?&KH5:G(BID)C8+@W,V24P%7X^:0I]-WV?Q<
MN^) KCQ#U_LLLMS7>ECB0#VJ,!J;&G_8!J"KV8KV#Q"77U'CNPU0W"U//A/P
MI[H_0EJ(7>W^BYH'L5P9V\W2F1W0N6.OLEOZ6UU#?'OAC+3-C5B![_]7ML5D
MZ\FPDJB356YS\G?R=_N1@^'!2=+W"VF[Y=J;?>WIN[:M3:L;]@QE283E2H\G
M4PP[S'0',^[*T[?TKGQ=1^N2$T0E(R>XW%<F1&\O"M1.56ZS@&=RF$Y<&V*\
M8@\U$'O'W'/';#-!%LMC"PD))3:2V051G2!RL![MD9J4__:Y]#8'N3,=%1$&
MZAI<!XLS"O%X[ I,C]D>\<.G@J3HP[<;0CM3=+QM>$2Y=JPE6*:Z06UY'&>H
M;_XA1=('87+PTN):HUOZ"9K/C]R,57]-N]LI1$F(_'AN\I35[-N&C\Q>NHC4
M\3Z4*FTYF[;:.QH\_&JY7T >&[A?L<9W^:(^[FB8^@]P+;==&OZ=GW%==7E6
M?7=/HXTG)%OJ$_&VD_DN*?Z4Q\+MUQ;:2G>+WB0'.."=%Q[I:]KB64D US(^
M+<FF^03(E^GPF'W^]6.E1=%0Z;U4?.?G^8-&U@ ^UY/5KE Q?ZPUIU!;0GS@
M9HC^C-:W,9E#?#GQJ7BJ0HQD2'C1B4?<#2^I59N.C35 1<7IQJJ]A%24IZ\1
M,'T!YW[9O)G[=3UAT6TP07!YU7CTJM#3<Y[];=*@820>I@2/+4ZT"-4-^!JJ
M>CR9!19,YW#:(FO?5ZI<#\("=2AJ6)>ELNCR0AQ&TP5<KG[KUL30=NNW'+[3
M8L4W>DE=@?OR0ZDA&L\]AOJS?I%%MZKX$32SY3^5!QW/1VL[%4LYSO8Y]LN,
M9X:C[(WCS+AYT7/Q7">0NF/S]Y79+:28 @=7G?2CL]6]]W&3YW1 )?-7?].[
M;ZRR6XZ1\'77M^ 75.HKL!O<"7DRGO_,P&4B/POK+;@#_YK#.MS.'?8_2N1S
MSQ]+I1N[#7?E7 K][5SQL9:9&%13-:OU>>"]U&MV*BFZ?S[95]*_9$8.H7)?
MQH%O=^$(W_5];21>8;<<>)!+8[ N(5@H79W; <]+B.27Z$(\E4K')C5=!RW4
M2^Q'>:U:AT-)^2['#_+O7_*DMNC'MP5^YJ[IAGFPFPW.<=?&F&]7U@N$'$Z'
M82I6CG72KX>L4N1"]"0=KC,C3O8.?&:MHT'OVQ-O]OG8P_U9NJ)]T1PRC+/4
MVI@8%SYH?[!O^345A<-&>"<_1Q/*(J#%$W%DW04W0[%)FBP*DH(=:-%&==O.
MBAZ[68^6!<-)M/V4HM.S,]+&.=C.!,6V.H\.9@S5%X\U7XVC_YRQ(8>=\J9+
M.&I]"O4L3R]M,D>_FY..G4A9JK(O_[V?NF:O$JQ@]7<J-D<0.(G.OF^M<NO:
MU"RUH3RWHX?@V1%V0W  >!9\/GU761QL\\C(1+4BMNTQZHJIRSC+N9-8_Y!V
M;%R!MU_:;>P/,W LN%$]*V/OC;GG;BO19C#,5>CCJ^U6Q&'0V4TUQ/1+^@\4
MC9'1PO27]S\\R\]*ZV%9CV<Z@<>;_3D^1UOS7=TAJ GL3E6"?4X+$RVE-\N+
MJ_L.S_[_Z@ R<T=WO.>4/:!6I/S$7W,+ZOH=]@)1E\.*]CORV+@?CEESWV!S
M5_RLT68O=Q),8VUP\TE^=I\)>=?1A6,\R[8UOOI0LN:2S4(S2]M1*?QY1$S\
MMU:EZIPHN/L,( (:.T':B_PZCMQEDI1W[@-F.OD@-9-WUJS;'8S-]!V 9&.:
MMJBWZD3V+OG$9,BN=^(1,0ZTP,\2_"B;BKR<KJ->70!BX?#A-SQX,RMGHCV2
M5DL,7J/9SPI,:(E'^1P,)_I'SX!_3O_O1]C"*+7@98FL-QG;"ZUO0N)L6VB8
MOF+V\1/8SMVO_%$5RQNW/DH/M!BK\S>.V:/AFM,AB%6=AH>I-ER],E5RR5"=
ME:ZWH0)=Q0CM/(.YP&$7S]L-MK_)P3J;GET#ND_A'\Y\=Q??[!8TD#0;E8"_
M.6VF$^==S"K6P,I$[1BA90L@JOLS]5*^TUVPFL@O7:<PR7Q__Y)&L;)JUIAN
MP0X+#] CIU5S883S&\V= J0X'Y(S%@#2HV*%BD:PT5ZX'JVE.<)0B;J\JOFJ
ML*9\]-T/0TH1*(O$7+\IB@Q&5@+JNU!.'BC6%3=*_["&+_YEC'A3?$\;X3QF
M/K&3@3(JBL.4/Y#%X-X /=@$66,I'BCK;_A+M2_F81U/K14 0T--6W"BX=%-
M4Z'HHX5/J34_];J V_CSE:L6UX_&=X'L\2>F>T%Z]\=+9ELQ?/=39Q9@S)/4
MEGB);\<N/O.TH=-$/Z5X+K2F29TO-!O]WOX:F6#XX>T<]2P<;TBT9WSMC5[2
M )S<93?)E[,Z 2U7 )^^"=^ZC[]GJY^C.AJLCA5MXR#KB;S>.Z1'KV;!IX/]
M_!P/+6<'FCP[['BM]2.YO<@.X5W'+QUXVNC_E@9P_N(R&A)2YM9NPVQ(5%-V
M\&1\W@YPA: @VT-\@\G_^<SU",GQ'UR?[[5+?('.TUNXU\W7VKA0$^X<9&W!
MFW]3>E5;KQ>;5\R/1K[C]/X#RFRM9/OT6MK>$)5]A<FYEZ6VP%^J74WA&#P9
M\^SSMP6^ 0OU:-[D[<'ZQ;2H!7EZ\V@CYP\\T$NX5M?;V;OU#G+>[JIPDH5-
MO[KSVU"BNH6?.GWXTP0%>#EW>E@5K=/+3B5_+$#HINVCU5MR03[V_-:7Q4F2
M(2D\3HIF2AK\UJ6#2J83]1O7VN;LRG0"5W>#?'P3M=$Y<6.C8Q<O*95_:C.%
MY(C1#C)]C=U]*W;*OY&U%:FWC0M"A*?7M.5K;?B&:!KAP8^I?1SC<>BEULO^
MGWH8F'9I2IW\J7 -X^]>-TOH?09WT:^^3 WS%AL$+)!:1CP$>]',YFKH^6G6
MD)\"&R]\AA.ST2+3Q:>SWFCQZ=5LG&__T3V--H*=Q2H,!Q:*-5%S^N[K<Y,D
MZPN"7A:IB7%S$;O5B?KIBP OPY\:4(MF/NQJ0@1+Q( :W<L/HQ-X3%^4)'09
MQ$I;F/Q?:02'/=R6-\K7=DC5Q/ECEUAL;60!\J'GFE9S+:0?PYM7M+C(R0,P
M+^$ BLA3W$;(TCXV%HAWU)R&- _4@&R2>&5_B86!^:1XM=*\ )C :N9&,$7B
MGLWI<5'^E\2U5'R(LP;N6-344-=C"LSK=/]PSU>\PTP[2]PICLBIEQ+CRR(Y
MVM0-$P$B.6T<O=W!N>Z^-95Z"P5Q9M6*'Y6RA)LGC5 K/SG1&:^G:(@;XT'4
MX+RQ*K_PY&$E@O4;[$3 &PG'21_LQ*5;_;-@:^"3,3B0B+R3/ 7/F^S*I/(.
MI2<) L=[.$&R.:-R?7>:!ITBGCT@YEQ?'4!6EBUT@8=0" %6AUKLMCV+WBGV
MY\-.IN S63J&-)?:M^W=KO&YJG=G*8Y:2 W$3I84](WIP]3+X,V6--K5OQZL
MG-)O5NUZIG(PX:GWG4[1VR=^[".-^4N>RN^/Z*PW3]@_RP/ L^KR!SZ+LI4Z
M1W#<05BGZ0KD4YW2?EGCL3B3&>,4#X8F^#[9]F.7J*)*#BOJ[&IJIX4*TU-R
M2_M4S+.6.MK+MJ6YN$<59RG3+>*;K G?CQTT4@(K8E#:BUJJ-OFYBS4-7R]S
M$E=Y-7_28=N;-O]2O6^98S#7\I&O_,OT!BA_8>6$L3]C+Q:J[S3LE_%-VER.
M':I $CR[P#WB#HOUPVT^<,&<B?H>-'%DH5JP?IGL Q%$9$1Y;4"%)G8Q:7:[
M*)7XP#CK*R-QGH%9SJ7IB\L6@MB/VA\2TT),K8JU$L,M:\BF>OT#5\7B**]>
MPXH5KL%QJ +ITH*ZGR5O5ZW@>M0:R2 J;.C%+UL]9]Z5X,*ZK !=!]OFZ:EA
M_M*N^MB7VH4U][TKT%^VY5Y&[9:7GG%/KI-B6$9;]#<;#E]"0E:7F2-?%CC$
MN PT.AECV84;LPDSHAT=&?RHP^$9IO(T6>P1UY:G<OLIZ-N9X",%M>=/')=G
MKM^S_Q*0G=CA>9G:'/UM*W1>/66VP?^/OSIIE8\S:1^T4_Y[$US_*3X^TU=%
MZX.7YDD/[,FSD1):5[U6$,OHHBI&$B]7L8AIH"X.8&L.UNP,LG/9[CTKU<%:
M3I?<;$-T.>2U?QA*L:&8=M64=M;AO;SC=%?:7>EUZB3 ZQ?CJM\\&P:8F\D,
M<4I53)3HA6T\*+,+N(2,F)(*_)YA]F>BR@/\*:?#@K!]9?EL1 VI3E5#1R>U
M/PW#Y/.)\$^6'#7I5:E4^*NY*GQY6<8;#-%H-@R[Q;QA=M3TZ.<:OQE=\Z/1
MG.;G6P<?PH)VBS2FA;A;]E<UV]K!:@QJ#_AVO4'3JW:>_%$Z^\4__#])T2C'
MBE_JLC%2%S:,CDW45OO2.J)/5[ :0% 8+U->V4L-5[[J05'P]ZZ9VY,=%OE4
MS9>E^\(9T,]NU!<C11DF8\I#2$_9B2JOA/]B/F&].\7SQCP\2"A.V8EBZ828
MJ%1IW>X.W5(Q1 TKU,DY?C3%@> W..0*G@>I^MKF+U3;*1,%?$QD*HD@*=85
M;:)  CT251H;,U2O X0X@662HOL[=7/]\[0$ZFWM#:]SA-L&=2**QZRB6.=@
M1<714%V]CFPK7]1>U2W%K\1)9O]*0WDG^O=$6Z@.(R[<1I[H)-STMDB@Y>7]
MGEE3%<$_N>_GU2,W<]KELFXBC*G-UZDKD^8QMQZ2@]'Y_J]#U)UZ;IS[WPYX
M$#N?=REIM[R7IAA8%Q"$[^_/!$D8PVGL;]TW!-U$E?;*N6AAWW[)*EG^ T!V
M#:4Z*^S=Z;^>H'&O1R?-XC_@P3\J?$@X6XC^WQQ.U.2U^=J$]S%GL$B%",>*
M%1Q\M*$VW'U=\)D@?TI 6E0+SYM&M[""%X/S1;M*B<E6VUX):_YXD=*VYD ^
MTN86S+G=9:O,;O$K]%O7G$!#\=-9T:5 N9*B==/:H:@-Q%Y#N.)"9<;#U+&M
MPLR*)E[_<JY"8*'[O<=.%8-? S+/F7M.Z<<H=2,9+R.N3;O=G,^.XFDJCQOV
M":FK$W4CI*GQE1WE+VX^5I ,K6U>Y3&79DC5,951^97'KI.4LH_E5L7HPMQ+
MOEWQ,4??4G#C/F&V81__+*&RRCP:["31U:Q;RVK)!,N0VY"I8IN=*+".#_2C
MT_F)0RH6A_KR^;+=?(HKWJIQG6Q('X*P7T<#17C1ZJ$@;5-JT9@DJAE[W4%>
MI^.!RP*^SHB4):\)VV*8)]6=B^8VB^V2?8:+F\7ZR4$6OM4@9R\5=2@T&U4>
M4T:,A/XV01GZ*YW3?-F$WB7FN:Z0Y8AT%09=AJX^HT36_)Y/C(=W]HHK-:FD
M; U4^'1)2R2]94^&IO#::3%;+=$Y(M\5'6<6W.4++"QT3'V2.U/W#\!B560Q
MTWPU]Q"=3 ,F)%ACCN]ABZ$V77RREDL!YA7B8R\V$!_<;]"H&47(TLJDN)V'
MW/0=H:OA1,T15*A/%%X#F1M54K6N@BK+'CQ\PUF6<WQWC5&1C$*>\<"^_CF"
M+_Y>$,B1G5>/EX*:4L@5#751#[O+X@UI]_9P3K&0%[[FQZ24 &>'7OK0 &6,
MP=&U1K[XO!.=Q#\>CJ?H^H%027<&QE9B\"]P^^?%_S!Q:J@%^6GLYSW5#NV[
M(T=A'6_3.--VR_(-#\*9.F6FSL T<"2F[-G3[9S>1E[^+FC'_S("U,;2A3[^
MM1<2_YZX+KW-,(Q9&7U*@?\(U&C'QWN<1Z6*P5 Q^DZG4U26 @OV1<)&(L+Z
M9].S*H]J1=QE #SS=[!);,5'G47KU-:;M], WS64!\#"+-GF-T.WOZT<?BG5
M[[N4ULO6 /)DMS:,SS)$_EFI&09X%S;,QF?)9EN^"'C7%9Y5M37$MLGZ\3AE
M[3FQ='(<[(BD#O@AEN-\%'?O'Q6K\C8Q"_P#T)LV;$)3E"!'-W=T.9[G%1M.
MUUEKB)8_RW;OX[5:I'ZKK=AJ:9YB3S#^CN[S-8[8.HR\F?.CA=*\^<+LS1;S
MC\\>9WQM@OSC;P[@.=:LQ6I]A.Y550%UY<CIDU^U8QHIML;T/TKV02M1ZEP=
M_P"J7?,PIP/O-V=69RF=!=S9NP83-G]R),A3AS[[S/-PN7*&[XF,N:OV6H:;
M\\PG5:>BD=.CG6W[806!YB6/[EZ_*Y/EZCVVW<?LV@FT(?JE5ARB0/FUFR\3
M+W?'?\/_ [QU3SM 4R.><A#[(HF1OG=_]GH8_I2&"9%<RCI4E7\?DYZJ*IR1
M7;<5]X6?&@%?='H,/973?J)8ML5_/?P$G'O]=5:'XWDC:"4R@YFI\1^ 23?[
MIM\9UZ[N"\4N$_$=98-K%(9(K$Z]US<^[9:KYRU5S*\M^1OM2'L@W[^D_V+=
MV4+7 E*J(JH-5N. @J^K-T-_.J&?#;<1V&1 1MN6M;5]XJ L2I.[IWNF<GQG
M$V+DB"0O-2*(KZV(N- KWF9G_:?<U Y*"#;&W L7/5E-IIR!Z!K=6HD!34,N
M]=5BN""C@IF2("?%)Z#WU#-!+<_&6\R]3=;6!ZE;'NWGO=;K9S\6CD<Q+R(Z
M,U8"3=ZZ^XR2^C"S"Q?MJ4VK=@<)PKU30GVS=H9!,Z"H])/.XB[?>VO=8'RE
MC@1D7?+[TF[\S3Z_+L: 4F,99(80MA[MZMBIY6:-1'EUF&&BB,J]UA_9]MRE
M3"TB,-Q9I'YK9*Y7!U(DFV&G7(<Y_9Z*A0(A$I;GU?IL*Y#!^]& O+2M6F>B
MY68U8@GO?XC^NT03SD7G*,!!$+@8,M T(1+X>SG02LM.;-0BD9T';HI\!M0!
M;ENE.E9<70FT=-.HZL=[HFO_=[=^D0?VKFJOQ&^OK@MXN.:Z#5FLY7"5GQBM
M?O*F0%DTI'C,=-A6/+.XT\SB2B[PJ4.'LARAA@HLZ$5?NB^L6Z(/8?+I>O11
M8+#6W)K 923^5I=L*DOQ%'ZT9?)?HAX,ES.1AW5S+B+[QNUDO]/Q#BA3IOH.
M+8QMP];+:Q:Q/=A]\O=+U?F&%.<!Y!V/W8N6&,S$T(80!^<"KFJ0;^MA>.9P
MOC_TJ[L@2"8T90/Z;0M4U4V$33Y*>]=T>[#R%NDO'_=F Z(35R9MT:0Q/?(W
MSPP.1%M0<P>F%9_<!XFG),,2>CB[F_6YWLTIV_PWQ\BP%<\=K&7](H'-F%K5
MY$OCN.=1<G?5[O*,,8LAP>;^=5V1^N5I?%3JFTR**6$FC$V_V."KM1(X%K\L
M,V' \3J@<"G0,2U)[(F182 ^,E@>@X$,+QT:61"$YN*OU]PU#1:<_I(KTS1<
MXMJ@W%D2;J4LF2H "K?MS$"3=("[*4I/2N/$]-.?#'8JFUH_^A.7#+]<+3OO
M4O/+@,Q9?G\W<L"DNAKPPTD_W/#3)?>]? Z"?+^VZ$5EL1T3.E'\KP>,>9E:
M\J\81 O7/UTBB8A1GIB_ZF0=37,7&7T@S&KZ@)ZU!!)H0N>:A\%=T&*% O(2
M" HF=$6%9NN?7MYLI+@;HY"<13=&0S<"D1R%ZX7_)9M)2#A>-'<WXTOA9AR\
MR(:"<>+=\>*#%V#(8Z2R&=NG2Y^!" ?,9T.+G * .?(Y2M>);)ZF0NA?> 46
M]!"WP>"YN=*E%U[Q#?%*%4B. CSH=:O;C* = -UQL5AJMJ'.N4302,A5;BV0
MF9DHTD-<9HR"+P"GXC2E87/Q8!\@B\1%D X?5UG7ER)@*"K%&N-T3="<R4P:
M]^?!>\)WY!_I1\0[21*,U?W(/T4W.@O[R1T"_1=_:2G(,4(0$-$+Q(D$I"67
MTW^)$7B*2K$6BH%7EU(=^^"J42$T-?T:!BVAYHIZ\(B2O+=A^ G 8K1FT"%I
M>.4>:U:'A+!TM)9X/Z7_75[^.(3XH!V%&EQF2U!@BQD R_K2"1=F5T<;=5QQ
M0);6$T0%TC%E*>Q@KR3P-1U=ABXY"?WY;2/+0.B-I:@271\3G#]!IT?W,DG^
M-5+![$;UP1\DD /?3Y_K$V[2(S^#$D"* O*PG4DOFP'J& _D2Y.+ VSGME](
MOXX#Z8I1KKPGBOS/@8,/=8$HP^I16PHCQ&_4><66$L5;;5J3Y(\;?]"!@CRB
M#+ARBLSJF:[C'8?<[E#FUTS7"RP(%QU,2)(KS')?WE7I@.5[D[-MU5\[68G?
MZBS]3KJ N'S3 54/-(\-*#&M$9-.2BE<8\TH&M=]9"8+I1D(I-_0'8)589M^
M4=ROX.B>\(JOP%[8F!=3KEC@"LC" .74=ZM&>*]8N^K&(E5S#]=+:MP+A+E_
M  L4EA];6GO4$ 5DB:%)T>"LDZN&?MDB2T,="D>#=H7 D6^$'.(_0%=C"*@K
M&'9&*AG9+3_8]RSPW\=$;O U)Z_'R[BHG<>2,N#2!+>&=].D\3^ _<%P_H'+
M >BJA*Y. 5+CN477)M4BX8R(-JEE+;.B_UI\"VQ5C^K%&AF:QGQH+!;CRI?Q
MT5MP)G#(B+&KFHMPD:AI/<5B0*HJ] ])?WY IE_>XL,Y(@+8<M5<;WN3#!L^
M,1F//^A?1,6_A$#)"NX 16G\MFX)]-Z+"[;;,,=>]"/=XM(/V 1@\K:%X)II
M@'-A;"",%0'Q!8L;GH<=',J+M;-8DU-8JU:D /6 9'"YD^1DD1>+LGO]@6%<
M_"H'=,*(9(9TO5&J);X-:YI 6?X!(]\(@V +D*HD3 3BF6PAXEDYV%F+#!8L
M>"X<CIJ83,U[A^I"N8_= NF2;-]9?X YVR%O!]Y<.^<?/7[M$!EN7Z#';6YV
M4CTR=UAT,]B[,#<!2:O1 DD S)X:$N;B@=='M1B:"5:N"(MEK0AX8BY8]74)
M^+Y;8"T93L0M6V$FP=:U206,VA2)@<+BYWH#1)"%Q06B*>6GN#ROZ^>+V'3]
MFI*%_ !I"Q +V0M#KJL;QXI@BV79P+>50IU+3+XV AFEYS"4VOCYD@??@S,9
MB.(SU>.AB-S["Q'T\CA\Y8 [3KHZ+[8Z^8+X'B$!)7H,2^^@XRF!# F4L\94
M7[Q-%EW6#R<KR&&$$%GBE=@41,K[>\ZY'S":P@_EFET_?R\,)67)^EB(I!&A
M"54&N9E<1A$??,QP044<T=B/K)2$/Y09'H9G J8=T@VP"!OS(->+<C9#10YY
M'%7P_$@,P!$)A::JFH$?TEWCHN-"FYG(V R*T4$C$;J/? S<*-7G[GHL8=A-
MX$3*;YO_X.<$>R@3N79*I+$9#!TXH Q1D[/$JPQU3SHF$GB-:.LT\RG!]6*&
M! -)]J[<>#5 "I4D-U1PEY71(C'?I5#E69X4V?3Q"LIU)8]D&;NB5X_T,E(L
M^B][AU,<PS=2M'S-M"'I1G4)-4FNA(K3I&897F;-(%AJ"@-AL0@?;.FJ06Y&
ML>5H_C6H#J\*8X+CU" ?)/0GPVLMN5?&LEBL?/%7(U0[R.":*0FD)NV/< #?
MYFU=*!&[RU%Z.G3/^T4A'5A%H_K1&+Q7@TMNLJH-Y%!17I0?HW]AEN0OU17$
MO*/TGC?6R=3576\EV.$T?R\$S=E%MK<)IFO9GHW,@1QT63)=;PF;+"_^!W#)
MTD0]NKI3IFQ_<])Z6KTEQID<FI)V_S#6NJKAEE49,XHHVEW^8.M'):,Y?:QE
M8J[38L&=:&Y8T6B)-LE9&I.0M)[WKD!-[#TD(71-QTP"(*&]>Y^5:M,O4]&+
M[,:F]>0Z?+K<.83D+H"98CY:LUX_QZYCEUPAY+6>Z']:(N*7GAJG0DK[=!U&
M!JV)<F!%GP<W?YFYXSKN<YL)OBB*ZKA0@?FO)Z$;>B]%RY' !GGP\;F"W$I9
MN=GZ#.X)V:0ZN0S%Y7?1?[04!+/L%'\R*7%;9%N,* $/D#;Y6.0D^-"1;( '
M9_"0O)7$;)P*UC0'@0VF@ER2_[&HG4,,^M/'Q&T,]0I% *-$R??N#WV?^8*3
M$8[++B$;5K[*[!<P/T[I.W@?.M^2,E <NE[?>C.,$%8@^:I6'770?%9HW]GB
ME!S6/GE&;V\8;/</ %.8M9?5#9MQ_P>X6*;G\5+3827L5:L?PU'E4&L_?-E>
M[.2RQCV-=R&F'I-+H)VR(C=O\['>.HTF\$M#&Y*SC=[QZ*\!>PGSF(\)M)L:
M,U"I8]+A*FW$ 9JQ@M[1F.'X!X@R:%T?7DSK>A,+\224@MQ\^Y4VWH9ML4:?
M3MM_RKGZ#S#'S7\^:'LS9M$\^G3E]-(!1&/&FOV8Q&H(XOP'X(J3JV\=!Q^2
M:-ZR\E6B_P"H5MT6!7FY^M#(0_CBW?9WV^#ER\>^X*['OP]DIZ$AOC= F=AC
MV:^35V:;*F.J']"6[:X=*R_-6$T+!V&.^[[)BZ'Q75M[>(C"8UB&P183=$JB
MNE]ZBQU?X"_5P?Q.>LGK^^H-&Q=2R(:7G#,;!W [OJON9JG+;8<W"(AX.S2C
MGJ865S1J5"K(%",/6C5^H] %JW[/DHDYF+0QR[ZC>'8:@CY6D=YZTD=ZRM2+
MR>#+G\VA[_+%R[)>CH<<7IZ!ASM$;!G<7EVV]S\HU#KKUE@?[N9GQ=F3>G;!
MN%\I2GQZ4QOT!1U;DE\"=LI+SKA/P!'<EG-;7V8'F@2G#^W7= _.Q(^.OPX*
M(2 Y>TBH;D-LYF*T9-*#*E]H[<46FX/8F67/,J$8)=6CX;I@AV&&TF*FX"$O
MM]%47- V)'])&4UP^!K*'N)QJ%_V%WN4/_T/\!44U*C[.Q?:51#0]ZV5\;UC
M%&:8&GH%JZ)B;N-PL1H/I&"20IAE:)>_-+JN]=ZQRTZ95E<]@,CMO;2LB$<=
MQYLUQ2W[3<'3@A]NKMA:0;ZJ6"2^7G*Z6C5M7Z,1L5$S5S9H__B$_>#M,)^Y
ML\'.AKWZR;/!WHPBW0==X))-D&78&D?:2R^;M*J*(6$R=X[=B6[]L=_KM<QY
M]-0&OT[\#8WC?P!JRQ1-*,*3,3'@$#03]O[:/P"0Y1^@]115J"4XUG+A;.T.
M>$>>-&-?@<1Y=/6LVJN>W#B4R%<?FC@XMG"]9WFI"^@UT@O94L7/I&$FMI#F
M2DK[Y?*;_P"1]C84=N_U,;2^=?(*^YR+$GB9_]J)'%.[![Q9^^]2J[@::-KS
M*X?G5$S3;=H8O #="G!_,OC[[;7,0+C[9J?B7_>9_QPP.Q*!6TIR>S;74RHQ
M%=UBC3F9K6PM7&6I W_C.?I0FYJ%W<@BA_]\[%^>V/U*W8$\.AKNX;N]V9<4
M3*YM]NFV7'E;%O_@0*:U*1*\\\?NFAK_<\5#]$+\NY(]JUG@^FC'GAQ+WZ;%
MYY$?03GJP<X';_?V;VD+;:S:64T38;ZK4[RUCD-2\5QORG*ER&/#_)M]%OZ[
M_REM6.FM>*0UYNZQAY_0N?C>4A'(/(83EO^7)GCQ+1W7BYUROLW(&'(6EG>\
MI))T4#(7XTF$Q?#^^ >XI<XW,F+U?0ES!;@%Q^S>R4?]+!JYT @?4-<X>._+
MS<DJ[PV::^724<\MEA75"*S*2<"QK(0P;VIV_MUZS)AUBEYY?^*:@-1</.-'
M'$"GF9H[DK2-M(*(^U&.M8-[J6H@W1Y-I2ZSUHYX3O!P>O%IR.J7SH\B)(*W
M;)(M_/VN/,7CBD0V^N674&Z6<>UY'[+SZ8)K,^5EV-4SIJZB]]'MU[TH\$:]
M8XW1LJS&[^=@1$_;QOC=[$CI J[YH&Z>1X:U+M3$?0NE @6?J;#H' :'P<<%
M G2<:_;WT0C9D15&P!<F^[PP]GMFA\[?=LG!8;-AU]XV^?V9J,PT*O;I]_R&
M%Y.SVBVO"N4<BZ_JZ'MJSW/ Q5QI\VF9'.*P^6-V7]IG!%JHI3DV6W?Z99%D
MGF@X]!\T= Y*MXY:5OJ5BQHB'_PY4YT[@NL[@])IO_ZXW!U(L#6.5Y>67!;N
M"/[]$M_M5?3APJH]Y,3\=+X]KZE*9W-C=!?@MXB=36Q4GLU3MG]GS_P/4%WX
M7C6@CQ3B/M47SC9L@4+0JP;"Z3;CVZ)=GS[+3MG%O_$0K*TR#1\@Q1@%=.<H
M!$,.V#U=7.Y8FGLMV]_V7_UFF+=R'>:W!C[RHG'.-E9]<.<%S;1&VW'=,@;1
MK[L2>!GP=RG;K1&A0HG?_"D5'.JDW<N1P:9[1#5X:"CB\-*/2X.>$8J<Y6Z;
M\M5D!C&/H1M^DEXM!?RQ@^Q5R6]&ACM'"THF5IV,-< A\30S65^\;B#-7D8S
M?WWXD+\+JO8#GZ=6,A7VS9&:_[;Z8=6:O3[BK+?FUVAICHO=QV7+L"J/')[G
M?YQ"0*O6.><<^W1,:A(H=5!JS+DW>:#-?TW[CXG()(H6'\4GXVJFFW#:,-P8
M[$A]UYK).DL,#IF]1J5(9?ED8J.0N:9PRM?7$[9A9IP]%]%+\>\T+L]0$F5H
M=)E^Y?('/M/QRC,*H&ST7ZEW-4A\&QN<A^%YO!<E)?6=\P$=JN;VX?]XG!C\
MX. N;^7W[BL<>^65K=7Y:),Z7E $S3D=^_96\"<:7#0_5>:EADJ35JY&Q'IZ
M>"VR##_=%\^E4C0CPU>W:JO097\]VECIV[EHN]/NIFN^N[8C;<,J^U9_:((;
M:_1PVX$V_@R!)NM9]C<F ?@G)R5#ZLPK_*Z_!N]J2/BT<OP.KE=/\31WX!4*
M_N@^531/J?@<L@$YDIK6:*O[^$S=\J3DA]PA_!B*I\$'<ZXX0GF"S;6X#9?\
MO/U#Y$)4GML\17]1%SV8&I%+.$Q?41X>:)%ON+DT<+.KQ_YBL-<PI]3"A=;W
MU,1?+(:V,;;/T6D95E5)=A534O2C$W)N*WB1%I=-NZ(M.[K,;7L=?X4.IJ>,
M+N 8*]RO'9$WFVV&J11GN5XU4.Q!RN;ZMTZJ]F,3KV7M)-J3/]_8PU +J@$T
M3A+(Q>3P.Y&WU >W'DR;P1L*FCV)Y$#MA+T-590>>UQH3&V*[ SU/9V]?SD)
MP<]L-D/=D_V^4!E=I<S5H*'9!)IY&%!0-)Z3VJ2P]S9^C:V*W\'6I4UEF>\K
M'<M ?5B<1*-Q<HZF+=/24R"2GVO9KS'80&/RC+3_\LMDFE[TZ>B!=]>9MNG9
M/\!N>>W9E8JS[OAE*^A80P:[NE0PU3L$-!O/9=UHJQ>S6UZA#I)&O^0;VI:L
MQT5G1 J]Q,LI>VIV2);RX@Y+\C9;(_*;$S0! 25V0H/4#LM9UA;ZH<B]UR)!
M5 L*=?%3VV:+6&GME4ACR'8?JS__L?S<A_2OY_$Y6!!/W$O%>X0BMONB)O@M
MQWM'ZW4>L<8K':"?[RF8QLQ>:NDX\")6_6E7\ -N78X@!F?,'PT/AC$Y"BBV
M,C0X^S+GO?C8M$2AYLN#Z-JV0N=!""2Z )2).W-AG50FD+J:'^U;$NX-'#\H
M5-U-'L[>R4&1Z05V$CV*UQN+I>6#!MM,K!-8= RVBLFZ"<X?A2_5*A9Q\5@,
M_SZS2[%#A]3/).3)POP&UCL,A?R+_XH;/A/4,Y#0A#(CHKD8D["OM4H4BWZ[
M*C_[02F!K&)<"<XTX2DS-A[H-2_3ZI2W"7\N_OA,R$\J,+$2U\J8J!CBK?Y+
M[D&JF\)V5<HE!=^86(\]@87H_4RH'7@OB62^:?2K?JZ5!:R]Y<3Y%SVOP29=
M3[&_JSI,:;UYSTX7=X)>L&>UK%;XJ;MA'Y;2E7IWX7>!#MGA\X%Q7H<$1>O5
M"NCO)  IOVG9^;R^(]AZ<]'*FOO]EA<Y1&HZ[+UIFW.^/T_@\'4TI !IQ3F_
M2Q@<RGXSJ_U:!4['"UI@YFL@]<Q2FS4Z)M3UW]M<!;63R"8H=L,WV>A:T:_*
MJ+^T[9AO,FGW#!I=>Q2 0IORLIC)_FKMAJ\7:\I.1&9X_IZ"* 0[N45GG\$"
MZ,W'VYXJWS\X-_-/KQ/Y,\-CO907WLC=>U[X\9.-<6'OU>\=7L\62C0?3BTU
ML#2J?ZIOJ0T1S8QOM+\7[-H0BTL6XUUM;:(-MN%3I$[ 4RVJ-#I46DQ]KV%
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M4.KY[P9Y5=1F6/\=]$P;XS?OK7\ Z$S.O*_Z^T.'WS&*NRH!)RNF](XPOW\
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MM_JB"%4>+SL] @_&.$H$>6/G6U?=C]3K]>VRO@!)'CNWBZJ$'##^[JG!NY4
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M"K2;VBU98Y;AO@Y-T,.+%6_C(B)QCT1!^H_+''1=524):?F'1**H ,5>/Y#
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MQDEOL/GA?7HH\K+PQ'N?%1AR\9;[Q]>GJ(105!'GUK4'\RV=_P>(3W:MR%I
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MBYJ?<Y3FPK 9.;Y4)MWZ[ )H_L,[NEP6M_%*1E&RS1:R=4WEI3$_V<1+7[S
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ML-7T7B?Y.;!(<G5^PIEQ;^GSK5F_P'ALCXCB2XH-FQLJWX!)L1.L!ADBLW-
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MU5K5W&+0^@6#QR 3&5$[:^Z.8GKT%2P <M>^1[UC:KT*TINC.XX7DF29#1*
M,@P/7TC58=V8>!J#(].8!KDYC;&JIY?@,9YI@2BW2X%8!:1YRTJE_D2=(QUA
MTXB45TDIP.#";8[RF;V?]R"MKZT0\)*BC49#<0FB9IN_7R.?K7:;+F*3GSJ
MJKH$]BVO;KSINZS1#]B3S.RV_H''F/]EI)O8"T%<PX/[NZ'(F3K,G)=$E\NI
MP\LQ(A_"]G$A0BP'/BM^71V-53&7/[T-P#YQWUIW;/D\]"T<@O]0G\FRTUKX
M)Y?[NCL@\Y,PCTI4CL2W@W5=_GW;#/Y;^9\6A)3L-Z^7ZR!M?CZ :'\1CCT&
MTA,H:4;:Q.Y<+M1V1<*UZ^Q>/ 5KIWO0;PX=MUY3HVZ%&^5:PPW6:Z9/^88U
MRNY,IL0UAQ]/4:(8A[-N_3.]#H?S]8(NMSG3/.MJ5@RL'6FB+BC1VSEUSG_)
M),EW(L$!NP,5?;UZ]&X/I8U[Y[D6#AH-MV&D0(+,$[O5=C'K'BX+B(WM[4:>
M",+G,I3B\>8E\YW\(5OFX'+R)/Q0WAQTD7*>ZN93SEQ L7_##:&W26AU74O_
M]#*96>J:Y41/H?X.Q#:KX>HEEXOF#>95<Y^:' 7VOR?I<L,7O4<'RV-]X*&:
MRC)YG34;7QY<"I(N;$OUXA=?;-)2J[_Y [7\@QI<KK-C,SW;*WS5UC0_?_A>
MP]=KDCM#,.32D'!9Q/>47A&5H=?B?WSB_\MSD+-J8,_E E]KX9><:& UT0!2
M9-K"C'P10<3F1[\IEX,&LJAIOQCSPI3"BYV%89M.\IG;*]^O7W ? 90M6IX9
MJ.T;NI@&(=_ UR[NW_Y^_OBNE37\A(/@MW^E,H[ %SAC="4Z C$+[H%, @<?
M$Q]I(<33G2V6>A 6=:V>4*GUD%@?]O-^@]&VY1%+L+\CZ<.!J(V8V_4W%LHO
M?-UQ=MA!;;_UD67.X RE_FY37^]?:%:7_9[BXMDEX_%]$_XCCKM@\>-ILPI2
M#'%) 6#*BOFD\9O1\RDV:LGJ@=.[I\YQY/"F]6B 3_G(HBZ?I?QB1ISF<LU.
M*#V<7W[>AS1V+"N!/W?#A&I0'Z.1LZ"TJ'P$55FHMI#5CWO=JR/U_C])C+]Y
MI(Q:!0J^UH4?=H';2^X4[4+D0A=.'>8MKH@I_3P@B=C,*&OF-31DUA^;XV*K
MJ1_*&;MKE)(!\/!KX+=?J@W ='6>Z?>-4H>DRJ.Q#WI$_'<Q3>?-IEV)GDA9
M%S5)4NC"Z=X<C:77]2,7OTC<7CV*GH1^TN;HWME9Z#Z(+L]#K^B4'GH00&/O
ME'QFZP..V_45&T4.@ZL%(]S=;MOZ+,JYAG1=VKN_V'/N2Z9,U(M_3"G=",X\
M,_;X?E)$8ZJ.:&3:9_'C](?"/+TW0&T\HA_B-#_M.\&7'#N9FJZC/T#EOV8D
M6[_HTMPRI?P,,@-UA1[4CA][A+)+>P4,=\I=_ORU<#M)<6T;!_S'Q&3B?NGB
ML_LP/VVJ@E &]DT<M^K[^.4_/K,QDHN'C=RL.T>3[]IL;06T)V%,)P8@Z27W
M-8ULN,M$0YGI[?\;H9;/[?:?.3BM>QD\ R:25QH<7O^5<+H[<")HQX_O7O*4
MJ4X8<F;(U@Z:EF8_[4DY=EAZ_]D6FN6UZ2RYF"E@J96YTJ&;_E!'_#!O?(-3
MN*0\<*(M1M;G!!4S@7^VV<I6*(]N08Z 'ER'((4"LV^^L3XNH)VO/W;EC\[]
M0F]6?"[_';NHPUCKE=G.[T,/69_#?+\$69+C\MT.>/<@_[^RB-'AB3'Z@*\^
MB6=1APIWZ8V^_HR@MZR]F8<NB^=7N1/=X>-EP_"\+?Q6KW0GI,7S+#GF^Y("
MGQQI">\;[$Q=3%W]V^\I>>BSI(LJ%_>)M=$3% 9J9KRI$2P_^*1[*77PV5&S
M\U[-1ZEF#DODX<M/P^T_;;E7FJFQFNC79-I;__Y!J/D7<V,D\K#FW<Y,WV&,
M;6+$8/\0_QN37PR79&<-[P6#/5WXSN_TB(UPNX^EZ.%@-:S%AZ]S="V/<.76
MR8!A_,QAYZY&O/S4KXFUI&[)/W6/MX9]+"&'0=MOG-S7UNVFO_E%?$5&6"XJ
MMCW@,<GLZ\&^>7FQLBO]\A#_K\F^!='$/8.B+8Y;/N&?_S&E?G\T+:"LJHS"
MT7WT-6S,G83#U]4&8Y]<0/3*-?,@7@3.=.@F"CQ=<+CG^*/A]SN0>)/KEI,I
M)'+$1/C<\</10:</=W\"5YU9.+$;R997D+\"%ML2J$N@6>6)WNCN<8O,V/;T
M=B!%?7KN /%AI^F@[2W7I5->/-^VG#N\(G_4GM5HS.H5/'QN)([H[:W<=OHY
M*[>D,0)@F,]?A;I[ACZ5M8#5%H?A@$X/2!S97B1]T0.L+.V@TD,M(R&C7FF4
M('4CFS">"8+[(Y*#0O'Y$;@:?#^([6X(KIA@"&2VF:M3(6O#2RQ!#R[)@8CF
M&;6GGV2]D5']#E8#G$G$5&N:MQ2OENFQ:#R@&%*M58HJV3>UC3VI'I%S=*(V
MDV-<"9#9R"+#G"$_-\H2VP(9:IEOX6&W]*P;T^/PQ$JKE"@A#3(2K<B"D%FD
M!(!9%-O7\M8R;51T61:6'T'(UH;;5KH+(?DV8>>HAK!4CF?HQ+N1Q)OY@OIW
M#)P/5-P*/ZR6$E%G+(6,+0%LI>#40.,'P= @I+U I3O5Z@+5F&3U@)98E=Q:
MEYBICLO?\/ =5>K2MTY&_J5.U0Q4)1.:3MR&YI7Q,#JO_@H]N]^2'6PD#"I0
M) J!FN@I0L9B5;R&?&B&(CSEB]L#3G-X\,\ZUKIG9BVJTEUX?D*RP#'DYA36
MF.%L6*?XU\^X.9HA1S^<R4IGR<G'$#;H7VF^+=KH(GH"7ME*]8:VW;@14)1T
M6AP&%"4KPLJ)5&N]OFJ@+#CLM\WSK*%H\&,L2^VZF3OR/.$M1)F#QJSIB2NH
M'Q R6!D_'6'NF(%_IPBKV3+),9/RP( M*ZO/9E1Z-]DFXXJ]>62V7F']*1J%
MI'MS5DKF!Z(]T %LXKJ9 6E_(FN/JM^;&PYG-5V%I-Z #N#Y\E\UO42AC&K(
M2G?TQ=U-K%ORII5D^/Q;KHOOX;6HBU58.:MO(F2>4,!-51FL.N_A+$!IP)A;
MW#KY%UO%, 6*D$X$F?'[FN]!DY?K*;FKQ(=DD>H?P=::-*)-.3)59!94 [CN
M["UKEMV!F^X<+Z\"WCC'N$1?0ONFZE\GF"QBTM!:O4CC)8R)4@A6V4:&AL8H
M=OU%9L.KOEO *A]TX<]1E4.U!)C2"XIMR'>GJ2)<9I!-*)3@@81QBP'OB$%(
M5L]7B:YS#8.=U:J_NZ!9MR%C1NB[RN;ET6"!_IDVFSFP\UR4#7^R7.!,;<;<
M+^B1"$5'-I8!.]7J*Z(!I![?F^33EM<3)"-]U%Q<$XI.ELR1E'(5%PGCX^$%
M,L\HKN_K4<"2)^:G .;5U6-Z#._XS!(X^?EWZ#$4&4HU23YZX4/7X3@T(/E7
M!Y51@FHCA7)HDHQR9MJ$D+QR!F/,Y'I"$Z1;]:77>'94H $]H;:!TO0&^5KU
M5ZL&(-NS'S5N$S;VT,TD'K**+/>D6&4?5=IREY2WL-;9J!HH)36S!9%AGAK8
M/CI'?A?#RXR1T5*BK/?5-D.SBVO0S&[#XC&XYYV9R^D:A(PJ,@5=E5P2JPTG
MLN+=)>(+\L;;((%T0F*VM_L^CK^3D:0/70:;\ZF%*A1;M?&^H?.E<@+OT3R+
M!&NEX ;5:E3;;.2W#XG&&_PO/%@SJA49?1G_E=>AEA@:N,B7K5R%OGNJ30 '
M6!VH6JQZOI$B!NFG,<(=(=."]^)' # ;Y*S<O>U58M[7M.([S68>P%#2.ND4
M)N!RL'8>_4)BBWABE;>/Q/0H6OK<QCU4_;GU12WK,-L6[V=&%K.HD@"R(#(T
M^BFN3P[4PG!!9L,R();J.R:=!24&]:8XRJ:EM1D\&S'?+'FEQV0)7F93F5%?
MRW8N_9DBW>:&/:X(?/FV@6%&23.MOF@=)D.3^@#V3;G(> 8/HECT+9"K#1U?
M6\RBO;7H8VGCM_**+^E;#7 BZB,QT7'(&HFAS)LD^\=;0)4L=[*>X4SN93$0
M?Q1T:IFU2:P0\(@?S]]L^ITM)I!^L?<K]/T.BLBC_0B.0MPBBSTGV/)$CYK*
M6JH!>7I7 1R[00@1-SNPH6%9IS^QZ2VT?E*=9&=;>TOT8J"%'7(&MU\KI2WM
M&'X=2C$U=T69,]S<FB$\X.E.NCSCWHMN(F09U/LV5%\\Q,[#^^^!<QNA6@MH
MEX0ZXZT "G>UZF-(J9Q/]Z#:YEQE4/BK:JC*MXN5[EBIZ# :MNE<G,Q*:"T!
MR WD7!9=0LOJ\HU$B_P')A0;Z"Q8-O .)T]W_K5?[MK*H;>+IUI+QXN-0$]4
MB>Q[D*"J_ >HHN<3287H@%PC&2'4-2<U?YG?1EO6*E"3KEP/-Y9%;#I!5[ZP
M-L1%7\C?)<,1VNZO: \ZQ.?XPGRG34J>SX40LS\(=!PV*-JZ=OVLMX]J=O=V
MM1XXITUH"<]7F[G3#Y2V3S?@)N/V<>BA*&B3$CI+B>PS-#C:C^X/1PYVTLX4
M'_F0%(EL[@[$L)KB+%K!6L7<H9/'R(!]<X20^%\N6L\=TF5:T01Q'?2U_%ZK
M%MHRZ<O'W9%]G.#G.;]_3#?[5YR[?JCL8W[S1%G=;HD4.-;(_!OY-]]3(0GW
M\N2W1J@#<!_/4OT+;/%VS:M8_U-(IK#DNFW5]E32%?CWOQ_*\WD+4M=MM_BU
MAI9>-K=R^.%F^E?7G2"MQ!& A>E#+E#BU!"PI1\)R_0F2:;)0=#)K?=RE!HN
M,.H'ZF;,O1?"ZQTJ(TGUGN*%&M^MO\]#WVO@786D6!T2(HE-C0!GEG7;2[6W
MS !!FC##]J*$WOS65/NH&?^$]BU8S5!*3_%*Y[.^V[T]FV/=S)'ME=3(;XU(
M@S'U[TZZ3[[K4$4?+/;*JC\U*>_CJ_KZ<\)MX]5.N>R:9:KSU46;RY/D6$',
MQQL,G.,:ZM-?L8BXK8+=BQV?)M>R_XI\)UEO<Z76"RRL'_8#]0T6[Z /+)-[
MN2,:;MQ6'*F-?*?J.>S+C?HIYF\]#O,R\?AIX#M[(7_$;HXY'OW%3S",,_)
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MY7Z3;[&(1#7H+6\Y%7:9>+N]?MF/[*:A9G5F!=]R 7$>(^)==R(Q9G&X(]T
M#\6=6D&D=4/RK%@\X=!%C*OYK%[1 3(.P$;/>P9,D/B&@->(R9G1Q):/<CK\
M8A^2G."- [2."FYY.G*F?!7*I=LI.:P+K\')?Q%H6(AKT(4WAG15 K^-1ET+
M&1';"8GKCB,%30C+O?HU&;PX:&-_V" *W/VF*_"U9'1-^_+;H&.\<W9-ZPI\
M-^#"G'L <'V&=S;?9SB'3I.$M,_(L&<DUB:\J"YY6 J^(R:PU.,U0)\@O7/R
M4?7>@8NIVJK(20OA -Z4'#E5D!5"G A(^YU+\3(I18^W$\ROP>.KU>FKC?KH
M!ZI'6[8U;:_6(1)JX8-6)C!QIVJ"\135$Z3/[\U-"Z""2#"KCPJ\(=C5HK[X
MZ[PK\/M 48&[;EMUBQC<-/Z4H"HGNV2/$LAM]4F],PK4+#@1\X#1;@X=D,/7
MJC"JT#4X3D]<\9=L @^=6:@SPURI%EIY"E88\-F4E@^//]]:TEI7!Q:_OU@+
MP]GCS^0EFHH0<M6 LB90C"_CNIB26VDC.B5!AI%6U+!A*:F-_\ 0S=873QW
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MDP\3>"(8*JI@6<J\5Y+1U8MHR!=S=VCH:I^^2_F.E6GTM4SG)L8-DE)T,BI
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M-+*D-O\=]A!YVW?=63.X\:I=J/W*UBQJ+@8XM]'"(^Q2!R_%IZ$CY=P!W%@
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MYI]!?I=FV1K>_GW6_#"WJSZ\4U$LY#>D\<VW+$(YQ/,X;=N!?'BP2EI@_K]
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M+6>]+XRX2P_3JUKVF8*N3I_'GX$C*5JX!\IS>.@N2<*H<(6FIYV2QCXF6%V
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MKHK5SM*"'G\[C:/L5O/T.>&>*1BE;9ZCC&T)%$HY!I=5B<RC.GJTL"!^B^H
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M#Y\VYKJ92723G+6/Y"<\E[6P]7/1M(N?L';5<24/0S$3\1[@2VS4JZ&+<2W
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M'8V=)7*%?6V8W(XK1D.C?R"^!_?7*(L/CW$<_X)/OKXQ_*).WC=YAV [<JS
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MRA%Y@%!-)\EAV+P-\[&J*6I6#Z6Z$0^_0]PPS%:/+J=@FTFJ^N@;V!BM0%!
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M$D0_)<.VJ_XDF\D&'.(^\>:3FCH= .LP921QA\24L>QR&ZY\C?ZE[#GHN1#
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MK&=NE2&4,?2BU!33"K_IVK)5&-F@"6ODBV)#@FA5DZTZCR:M]8F?6ODS'JL
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MF]YT0^H$RT+J0>#27//3S&SHV-ZRBGVO\G!?!$&,X PLGF3.2C-Q6:?RX>\
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MO_7N$30W[>+3C-S9COR<DX-?>XM$UT1G1 0>W3OHW0F]W3%W;K_DH8;U,"-
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M;,\;KL%@>;"M-<+-)_W?@[NT!U%!*VYR_]DISDCPOI<VQ!GJZ;^F5SI\WBH
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M4@6>8\(K><4QB$-*\K>R'OZR,$Q( RCBS:CS%4R@4X(2*RI%,G035%60%^N
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M0O"Q.8O=L@R/#C\Q)\/,EUM"PA0HO"PGQOI" 3N>"4$[^L_GJ98TT>< 2)0
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MA1\<>I'[KL>R[>"1]4+M2%[_D1;E,)>5#]8]%4WPWP051=HXY92>B9%F"^K
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M#_[@=L)K!,WC89I_\6'%C$QC*^DATIVX A5%&%*N5C>[L\43]X3BS@'S[>>
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MK:G00LWB;D15K_(UA -EHG5?P6?PR[#&K14U]G/ ]>8'AMQD88&HDDUHV(D
MY7[+UT]IO>JA%M2+<OTOJ/Z:W"%N$_UN?*W+#3 UGLRPH<HDWIC-HVER CH<
M.%8[>8XV:,PV?R:OO+;9%WWONO[EY^A9PJ_-<>U?JT.Q%[E5&!DO^Y3Z,1@+
M=664Z-HCF _MGAJ:$V_G7< 3P^]0FG, ',YPN>X7>'FS->S]$UL73ZG6.Z9^
M>7'+"*$Y#]K5D=4>XEILY8BO*.N6AR. XU26,O--5^[?Y"%M_SXA]DP<(16C
MC;+C"OB^6PIY-W,%88F2,Y=)66);L^%IFH/C@R8_C66"=IK3*B&K3^_==R>4
MA-)1K8X#6@5LQCKHU904;;?<*T*D%,HBF*PQBXDX9R?OJ)? /=FGIVCIXQX0
MC]9+5NZ.@"C2.2!\OUXTMO=S^+M@8Y:^%!6N$ZVZH<V">&VV5T>CTZI7E1Q.
MBSTNB6?-M4B#G.-CYB1CMM^= T::^T\S]DAIM&^M!B-E0DB!Y0^;LRPN7/1%
M!11 ;14T#8/L*[NO6DJC4] -T"<(@_Z-/6"TBOG]1<Q=Q,H\/;/MJG]Y1247
MJKB0"C4?KKO4"Q^6YOUHZ!]:I!6]5$O J'"<\%9HF?1$AS&8&E&4S@%W0+[1
MF79;P.CAJB83K;K#FEB.TQ?#S?=<GHSI_/\<P%,^?*\/R?QI9&HGG3-?M_B_
M=ET'3R=OQA]_O=>@=E39CLX#0S5>(98MM^Q6E_K/#%FO1H?0UXE%37?S7..%
MD:2G%-CTW'ZON77B!^@-A/6@DQ76BQYRJDZY\=&N9<!RS'O['*!##9N/BLB/
M/'MYUU<9>VD;_;$J& MZ.,Z)#TG?TFP[^'G_H147. LANL4L6Y\5J!;JH7,\
M.BO>>AS@^N;UW67%E[\WW -D_ ?_]7=U7K-'/*/&IE5_O9]\@X?80+G\8'9*
M^>=)@SK"C *>LR,%/K;U8"=!Q+3ZHFTE:H?%'EID9>5T-O;.O!@&R4>_7 +U
M!QBL*ST-:.C]ASK2G5UJ.Z:-B,N^AX8Y\(KI;LU;)#Z_&A0NK6SR[+-4%!MA
M ,[[\4@OK53/96BPT6K>,'SW5'+<,9KY%4_*^Z4$A!(U6@SMR>6EI7%S$PH]
M$:>TPEZVRRY1"#WK3M9GI!&=@E?7"06A5Q%/'_<+)^_EZAUO<'Y$36GMEK"'
MPA8:1><8@N&\/3G LMC#&%225O4@0X=R0K>+7/%;OM?:U87\*#WCR]<AL5C<
MXZKW2D/L-!@M7(]>Q> Z"Q_[8+8.N=/5#/HT/O\+1[;Q@UW'3 VZ*PRH?!=A
M^QZPZ]!E0]GI5(>#DL#"[ST/+*J_FN95FJ:0*16Y]KN96.&&$@;!67T8;!\C
M^*5<E+U#T%GYT2._5<@GTYCG@ E]>ZPP7OV=X[C?#$R8;'%S?S <&<8\PB_]
MS6N_.">5@ZC$D<A ?$)"I3-/%>%R[WYQMH Y%-\VC8VSZU!TF<M.5'NM1B>=
MLC/#PNF8P?=!5P^2Z$)W2UT!->7,9I).E$F%U0/.4IGC#!U!5XA:9=)$D?V2
M";PRK-R@/65!^CO*'\1('A3HVC&C>T,_F8QLH9]>S,"*+1L.IHAE&/^FG .8
M-*O-RQ0-K%B& _)G)&59>JQ(7W4.MK:55DM M*HR_!V!2Y_*E*KMD'OFL4HA
MBF"6.9SJ5%U'4'!!E&-@(YA'[W?Y?)ML0_6.;6"H'OC&FHWF1[%FA\6ZHCB^
M8)ETP>61:G!JN9-Z[13'CLWC&U[(1=#D^UFX@J_22&,7JL"36_JU@+U6$^PZ
MI$4@!%88,U*MJ0@D/NLQT7[Y==@Z\[9H#[.;] *+/^W-1S".I&3:WW;^)?OD
M8Q=,X(I6YB<<,AW$(K;QZ))-Z2T!C%_IH+)$'D2'5:=8H+:(-AZ&!!4D%7.-
M6,OR[ 4)R[[!)/+95/6D/EG1K4X2('S-P1DX=(CT7S*J-,4;*9O_T>@SUAB^
M98)*O,>-M2C\983*XL!S*W6%FPHJH_(<%[_LF*KX]^A\L\2RU)LY)!4R&A,C
M]7I(D.BN@NXB*;-\#:ZA1)>&4O77QIW1E_N_&=6:&FOK);&CW4Q0D*1 A6%V
M+E1^G3O=0Q'0\Y&LNKGW=;J)1 .B@0PV(N56/@+Y_.5A56!&(9\#EC77',O2
MM'([TY=?&QF'1D;GH"YKH/)WM$O&2FZ@].F8@*A0V,/B(28&;%5M 0^YP[,L
M:(AM*+-)8YB?C=Q?+'WT%I++8/YA)-NH(N_28U^80F%QHKD=S$XTC$[]0;%[
MD;)^=!VM,0T'*FA(RR$"ENIIEEIJYB[\A/NA>5*18^GZ2,0#HK0OG3[W$U'-
M0<R4&9EBL"-L(29?R@H)7=5YSH$S_CB'JL5,=1C=)\](L14UF/DGY:5[S77I
M0$K*AA6:86HI \AKBDB %UZ+"?DFT1CHJ1;YU?2.A+D%DO 0\((\SI.!^DK*
M2>4TJ?'4MU-C&$I+0M[P<L"*,&/3/D>!7@P#?2Z2^&J^DK>QIG9U5M7/QYW#
MK^U+17YC677T:!LJU9_AC3\8O;KG4B2)2DM\AWF=WSRNQY'I]H3 #.A&P3F\
M3>@4;\+%8(W8$;RIL2A?XC.]#WJ63V"!Z>,XR:QA%J]=)A_\3:BOW=.LD>PZ
M:4:K\4<=S!]+M;FUZS,;II'J=(Z%$,XF/N1U@Y0D_SS]VR[AYF8EU</I[$6'
M/A\]^7%OJT6^EHLXR'5(I*<9/)HR2UTYQOXG9-ZAV%TZ@>704=/IJ<=U&= E
M/S>^_.B,BNO9:4-B^LD#79V/KG2'\@6\@'EJ^3DA#Z&D'#H%O6TM)C:5U(..
MSK2:S]4+?2P[YX!.C^N$L2('0]OA/F-N@WHS!5[Y -5.-\STXV#*!^31T"PT
M1K4J+T8<185;5&3J#D<#WG$TS?SIBSW[M<"O6AS4F57VKQ?YV1BL.?ZS5??M
MTW73[%!8Z]9F--/+&C5.); NU\-1T"11:;T*6$I&ILPUZ,N]O.H $\2B<F$T
M;#WZ/4#?PG&7FXDB9B7WB'I%R6K:!A!WEV]#RX9&7*;7,7XE;#O:D@/2OC )
M,WY8'7O1U4R8C$Z63Y%V!RN#P=.7((O4CVKD.^VF)BL2ZITRR!"VKD(MD>$O
M!2OZR,?#/V9S'S^&(RNY^3H,S3KX/K[N,$?A9:=*DTTNXXR!-*YQFT:;V,O_
MW$S"Z$SB#6 _B4\X^8;-;6&3D;GNQ/MW":"\FZ5&9K43E]\).G: ,[!]#\&)
ME6IWN[I O.DHM+O+"Q]FC0IR#(^$<9G/HO6;\,]#=,H]H*!^0,4&CI:.(=PD
M_M$E5@7;E+A'W*OWLH+ZKW:4,'J;<<Q/HP1SZ:XEH1>'KV5.8V;4F*K(.0[F
MCUW,2B[[!;'J1'EB((",6:;;'%CQJ#>U?TM H5+F!<G,E]XI\=/\[UP?2)1V
M_$3^'''<5N06+Q[(TFU^7' YT>*O22;*X_*7+YL"^FUFBGTW)V:$'[\;[DAW
ML[1JO?Z(X3L,3;=N):"A*K*T0/7P6 S#\:8&D9,"FV!78&7>R$P^,DIITY *
M=ZMUE#@$FQ53[XQ,/67 >Y#88G=Q?'\^8NR%!+L3_J54SFH(^_,V@(L\)'%L
MASV2.MO.%=.$7BE4V[ *S[A!X2$LC&:U((5DF+04-%?\+'_LKT)Z6Z:OW2?2
M@JE;,T_;HC?;"6ZD'-^>(5<:9G=S2MBKP, N>R"4=QQK; ?]V= CWB:S[QE7
M>LV$F/R3GX7@@="Y^#C1-:2 '.ZV?P-_0)AEGO) \P@^(P(SG"' -A6A\:J1
M[3]^TIB*0J-MP^@?F::OPIIL:[8\VNY"?['^O0%:K-^/!L)B_=!-MDM;*M__
MI'$1@I:0Y)7TUN!>]-;(N"X+G\308.DYH+6B1FJ';6W%%I-WWTWY$G<I]"N]
ME%QY#'_\.E=DXM;BX/#S0/@A^"EWK +L72V+DRGY.MI=6XYEX8R/FLI2V!WY
M4GZO.'<O<84NI.&=B^H(.-/95B'&^/.US[R=35<,:W<*;@L+LOYW''<=N'"8
MPK$$\HBLK@&@1<-$UA]\*1=Q$9RN+2Y@&9L[F+F]/N]]X3!MIZV1B8!NNVV"
M66.->5>'T6\^]U3A!SM2-_2WN/'_7=60VL53?;ZL@VEJ._32K0(P\/?#5C1_
M)0DPC$I:.OL/7)D73&OETU+15JPDUS_F]JU_?L4BM>7%_K_,BCA+-;')O!L!
MS/CC#3I] 540 ^F#J61>_YM:I1*0- ]3N($?#;EFCJ!!MG#0U0>)>H8C![3,
M';Z7[!AJ^YEH):5>D*;U3=,T-6_K>/S6R(@^Z==%0MUL!#%_#4Q!J7M+!^S.
MT+F-&/#SICJ[M-"Y942^N7@ND+9*DBMN9>5YGRX"S,A &;[#NSU+Y$AHK9D=
M&NQ1,T+Z^$\$Y)77'!3#F8*3I"-BS5RJ=NN,V1S1BR8C;E7MKZ!4P?$U>37X
M%[(*^[B$@$9+:M#3^M)MV0SC0>X^X7/ 1P^/%AZ+$YQQVVQV_F<]W4.P7_^E
M7N%?0NF#13^LN]NJMCXV?>9\2=,H:L[P3F3>AK6D:\J<K[H/E<4_5S2F,4GS
MC V+3+VAXR""<F <@J3J\YM.@OE[1(@:BTE2M7/O1#4DU6W-:&^!;!X\>%J6
M[=U^J]BJ>9'$O''S3ZAPP!<7F>W9"B1U;>Y>^Y42FR[6D[]'HSB$-Z4?)3\@
MT&>[M]WNHE)1YG^?Z&WJKY#'+>9O>WL+!Q^-%NS^.SK*>^ODKO2/V3=?_O@1
ME*GL?][UM_9F4<:;"P=]3(?61VGC1?(X8>K:NS*BIL]A]\:Q/\X!\L6@[RMF
M8S4@'[9\WU!A?[)( &9*FU&W.0MO5C-8EG+/:WK59AC:70STUF.P\U7U5<-K
M#1JSRP?I[UEW:2^^!*8-[YB(FL25#H*>U#U8-])RL2R5@='P%RT6=CR)5WAY
MCXX\$J31(Q&>^]E%Y'I2SD_8#1.MW!V8>C+(&ELLIBYSK0/FM_I>IEC*>%FL
M,,=!*\E,53+KZ\MKE(?\('-+88A.DC8[5M94L61*C916(H"5=*$Y-KE<@)=R
MI[-V7E45^QR1 /)B*>&/+V_COE+;#&7A[ !?]M1W7GDO_ EF,8]]@1AZ'ZXU
M?.\Q_XK%M R4FMZUBY]@!-[KG*'\N2 I=LW%)%76Z^Y_>18;ZX?T+2?_@K$(
M\W- 0I=*4>,Y0.NPD*\ND[R\''@AD@X3DS0UIW_'OKX7<(P87IT6&3@;NW3H
M;>V7D)O)K:8R^8JL3 JA)S;?A#W_]^1R,+C6QEJXYBK/\#:AU28 \EBX@667
MI1F_'W/7.P=8I,CE-4F8H_.!?)OW R[Q(H/2]]__S%W"^U]PYD;]_2?S?@H'
M!.8&\CF@6HS=.PME[/C9QO 2I>C=D+6BVZ;E&>=01]5:XG130WLH_8[HN#X:
M$U@XHOJZL5.BQ_M?;ZHHO3/5%I FWMJ,V9I;'_R^B3PTG'6=*(K9(N"4%,8&
M2<?$8;IXEYPKQVI4E)L,>[4$V_5FYZV$=L6&! 8^=K:X,^)F2U6653YZ&;Z
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M]OU._,OBG%?EEFXM%>6E-Q!7N^QL+3?]RQKF9RK+\-Z9H+)/I3S,2J/WKAD
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ML-8&B25ZBH*5T,8B.R7>]XFNX)J-4=AK V21J=VBE."MG0+H,KYOKV2 %U0
MIDEF(;L9)Q>EZ[L,?..7)B85QY:X.+DY('%;F C]#;U7TO>"7=Z R$U"SIR&
M\TVM^O"=G%W"LTUTO"AH0:8DCL5Y?S,E.?9$XSTQR6^^Y16U:IZ&OH_&?(A7
MZ ,^VH[48DCMDLF2:U7 <D)>*5<F,_O]&;25'L^<WU*KVRWE?F3WTBN@J$EU
M8*^[]Y^9;%1-$>&%T<<\>V]R8EB57&GI$W^\_^U?GI8U^TJTKI;E*'.!/&/>
M;2WH-9V4.V&%0#\.Q-[FV\O 0 XEW%6=?N^ +JT7(NLG)22K(U.*FEGB3*64
MF'@K42_E=-33;:7=BEPN*EZW@V4['<VO(?)/^LQC>T/3Q(.*VX?LL"[B!*+.
MGK*"Z;:41<_1?:)(S1^L2[0*\F55X3<0)\@EDWP&J#@RJYPX,HUV6M<I7Y3J
MRB)JUP2/EM<$DW>K]O)E!"V/3$B#F<FEXDHE3ZKWBHG[- _=@L_=MFS%7>1D
MW/AD*;9H0RSO+E-$'[:^/Y;1_:@5:U5+>N>T,:XNKH5]Z*89"&UZ,A.;L/8B
MYJ^;WP*ZO.9@W=QXMA H/75DYFXNKME%2]PK7JC9P^%HM3\<F2O6\J!Q;NLF
M0JU$F#;2 9W<WN40 93N6C<IA?+WJ&GX1DQFWL%=5/#K4^>W6('&9;+E,UB&
M7H<%]AB+F4;S2 I8K&C$82V6CT1#>?L"\2IN#S7T(FY#EY\Z%-Z':&*'C 3?
MH=JKUX_,K,4'G*=J(7\[W#5LHJM-'K\>MNV*N[DL7MW->CQBB=O):[_^7SDD
MBG[VY?!"QQQ8LC.@+4=#X;_:%4FR@.J/U1\OW"0_,UV?R:AY ]103DP,9<Y-
M"#0>DLQ%BUSX.+;ZM* 6!G QT0?YY@22G@E/RAV9_,T!3+J8%&73X4'&),,W
MSUEST6)O- N2"X<-:=2/#/MU&V+)7]ZGO&D6LZD?X XJ476<O#@REHHUO&EU
M,F*JJ,L\*9N>1(9^S9]$U.+^M)N,I:HJTY_D*-*-)QG<CE?,'-W*]^R="X+[
MT;LA3U2H2;_ H^*+RK;^.X2(8&F4%*9O'B$0&?>:GD'OWRG]L;78ICII(7L5
M[HI2HEP*)&+D-G5XB0="<\VP/QT*B1OW<F MY53S(W6- JLGB=;/0J?)%3+_
MI',:8LAN+@R^L09D\\%)CW4AA/3]0]7C5>O@H3U(_?:'4]-_OW76X0X1I_X]
M9P 4>AL>#?/+HLO<, *B?Z-_^S)/NG?/"'=6A%'-WQV;GN0)C.8ELRWX!?U]
M%O"JJW_*>0-[M;:X[/X7=F7WT@PMBMG]2.(R2B=P2L>MN_GFW.70/W7-4=^<
MBM;5M'YDT7N?1/,=$1?. -4]QX$#.^"=NV^.E2>#8RY8/P<M#4ZBCWK?^@[B
M^0U245R>\VJG9X!=0FL+TW9^U^E?PO=6VI7739#6_S+P)ZQ4]HQ8B6MG )&<
MF"J*I?;(;^71S9Y.ESS>\E_GL5VKVJFH,UXX]0[#9*MBB\Q42U9)WX]N#I)J
MO-/))R=+7X;_E7;< 3+D3]$N5[8*GUX^UM+G-HY 9;S4"CSJ:3]_0>"GP'OT
M(Z*W7\F.S=G]4'3OYXU;Z[E,UW*7.E!V3UJ/YA5XM95%60DV@U@T=CAJCD4Y
M471[9B=-=(G;B:^'R8Q3^GK6R+Q/QZ.[A6W,NRQ\6)3,7)!1P>CUI//8_/*7
M]*9^BQ#Z5R([?&ACM^'?9P"_%GY*TL98ALH,H5Y9""8[J9C&>> RYQ$EN'Q8
M&N/?5BRXE_7V>G[2?Y/>':G!HW=(P'#E]6#O8Q%JZK6,@!O5:6T\JVOQ5X^-
MWQYI02W5#H*<6;J"AWBE@H1G',Q[+C>CP/,&[#8N@56:@G8I/;!#^%XD.<L8
M;1PA@#D0:V-JJ6\PZC[=1;#&/Z,&;2XMP$36\O]@#DWFS@!MLR(]+2JD.N:P
M4[$1O-O<#>FP4+B6?TC/I*M(OD*P+[_X-$HF?%;742J.G=2B1Z7D/RZ0_0&P
M ^_&1[6(_^@J@.1"EU?A3*=#?-<%R$MIF@>]2G]IOAT_*A9;I<\^ [#O$FJ"
M+WT5"J=9AV=F<I)Y]9];936?N&R< 2;V34X&ZNZ6YSYV.K^9_53T0&6:,'!_
M\O+IXZJ09GA^BV(]T]P$\Q$?J57Z#.#LLH[9:?UG')G[:K9R(X3H=@:8 1[&
M_LHZ *CMG"8?F!^!9@(PQ-JC]E:HXG7ON2F[]1.QAC@M%8I4R/#4,OS6L?%7
M#!P?E$21B38.F2!$G]ZS=DOQP!L8"?3+?CN7SXP/DM]\=6IQ"MRJ20TXAYT[
MYVBKLVEKLWYY[C'G[O=W4@5=.X0;)_GCIT+>9X &EZD=^ %=QW]-!=R."5)G
M +M#D[]1*M**KO44F9#6$Y?E?Q.+J$8+[LD64TK7Z2QKZW\_L5KR3S(E4*L<
M6D3Y\D$7RK]H/GW2C\L]_7"^XR<4A^_% ?R@I*15N"[*I#+%1@D=MN_RF\"B
M.=:0P4FG[+XKX@QGH"JO6C29W8G3#WJ\29CC5M"T52$UA<T1(M?<EF(>&OH3
M2H-YJ0M/:]]?V[EE2->( J&9E-*Z'_ F_X(#JQ_($E/?2,&UJ&'SQ'<*J!(A
MVTSB%GLW(9(%7MTN/VB[XWM#*V$&KMD0/J0%VY]]JR>8<H/9$RXP@&_"9'IY
M8@Z]?_&6<6E?4%H)'RS;I>V)&#Q*IESN<10P3CU9.4*;'6E%4$\7429'JI;5
M\HDMC\A7.5II3>6PYR0(SPVAGS-82ZOG\VL55^:ACLK:&-'(38.#!C<C%EAO
M3'3P861B?'/"%+(F^0>_D9:F!OM<MK;GPQ/_=$K?:.T.^1R<>ZS:8G 34<:Z
M,4VD:'7=CY  7W7<:OR#E95U0%TD#?5>>;X,=_9W:MNTG>R6"^M"F?\*>HZZ
M[Q?Z_6=!2S;U-25QI#\6YG#\ERYP!T[_+$%MZQP#6M''S'1)W#?>O&@X4HG>
M8T#F][5^#C#HBH\QB_<0T3%7@5WRQ!1@W9Y[F8L]+,.U37:R2]^^Q'7P&D9]
M<QA7],1=6WS5=G@3-8@:JN@=8*-9:65(=AZYV)AV<]^WF_JT;:%670NY?N?
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MY8_7+#XPX#\WJ_O:SQ;K<\RWAEK,?);>068.7;RCS$"9/M/?X+6-*G?5U,^
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M@V#Q@ICAPL_<;%(:U[T=T07^IZ&.6/.B:CCRFWF$*TZ6FLR*CA<<Z]:IK$=
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M-%&QIPK5S&:E>$V:*;X,X4 ?]RM+LMK5 <_+D%2U\\5NPQ&;Q/C#JU]"B$=
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M1'5*8K=D.\T5S:J_O;'>($I<[T$*4&,FXUD_CU,X:K&/=4@&W&Z<B[ ^XIM
M\V3_^ZDOS+C+3:_@1XV2+R17-X*(ZK)I/DC4MUB]XO825?-XN_0.8>K2H3D(
MB5; M;21D0_(/,\)J167>:LRJS!( TCY_8 @@OG)@[0(ET++-1+17TQ5 :IS
MQ-6;C:#1?#MDL:RQ+$:+F!]CB<* %_Q(SF0(3TTRH/@VW@&>3M84N054%4!Z
ME<@FW$<-"+AE427)0B7*%]*\U4%<BT;=)A?'$<7.GW$5WAAZ*T(FW@E'#94E
M*WO?K\3TOV-Y@ON-,TM!ODSQ(UVJXLD#$\Y\T6&63^=:MQS]'7$-2W^8MPZ#
M:7: L.>!VJ_U/<TJU$QV&VG7?C]2$M4ZR(&U1,MQY[H$ 0XZTF9(^R1O'+0Z
MWO5T@JW$(63WZ2/9S^7[.2F=D)QJ54F0?'GF6FY'B5-?86=TP-! $\NZ@W]*
M@WVPUZIM3I2?>L1J>==+E\GCRX=:-]:%.Q<GB5DKA7QZ+P;XG;1YOG ]7C07
MC7+AZ5HK>UO81#9.=T M6,',/Y<6ABTXW6H3_9TBU>(*LB2?NM]%G3:]B4QQ
MIOL Z>^'.)]*34QK!+!OX2BI\4*^;5;FQ#YTEB([IX(>00SDI-5]]PN:X3GL
M,>3>L'P)GW9,)1WVPH1DB"(HOL*5Q-J;LYDN:GO9Y"'1K[+)5:>S&N*7<B9C
MU=!IV>B#7O\6'FU .>_T4OS=Q1\4'W0*&T@LS8 )BVA^ 5*)0I4(>^.$P&X2
M[U6U>,)5G;G98P;1)>C@+L_6NV&QN!5#RW4C^?#P"C-C>3DS18CT[*O^%2S<
M9Y3!8ZW$>6P6E<_W(+3."_QJ#G,=>FA'O#>@=BQ.EUC- =$F_'R$Q*2(,".4
ML%IX>#;?6? GI)<BQZEJ]CDWB62P?#H^<!(AS<M-S''OOEN*O#=6#C,/AO=4
MIU;:/\7G:5[?0]:#+#/1!*$_SG0O* -$#@[9$GH1(Z2C#97)P^Q&<K&0K71!
M H/ZU]D2#7FRPJES-<0248D-0W.KR'PZH6[(C0%(F@=.3DN"V-^)[@K7(U]-
MID-D3B;F7S8;(%A^2T!0!XK*X(!GRQ:_+*0EBTU_DSQNO?G1[_"^I_0+0Y(B
M.;!U/:F]U=@J63>V<7DB$#&CLU*YQWCH87L^\/FZYOB#K_B1N8K,]PI%O%EG
MWI*+AK88[XZ]'UA0OZ!RFF)\%:>VM_C0?NW . TZD/3LLY2M>R!P34\DVL@L
MBZGK?";,7;&KV"?W8F4^;O03UB/TP=;7T,(/Q21K.@<BH T^;FE7=U$P>=PN
M6VN""D -."G@4^]DV L1/UC"\LL-'HH[892CW21.IX/8$\V=,OD6HRE6B(-E
M2>4R_W=)#M!$JZ=0-[ ,=J; #R_!YD[@(,9ETXX^3O@ SFH/D\](C?Y"[[R"
M^A\S&3^I8Y+@V%".PURD?SMRIK6-\<YIV'E#1]*%&OS#^+?P%%B:&SR[ZLU9
M/2WYE<IVW"E3 Z<VL8R[EYTP,+PF)'P&<UZO!0.1+.CLQ\4LL-UPG<L0VBH"
M>AD;@$R5.5+5T44ID-LO> (_/K;) <:M/T$54E9LW &A&OIF_!W7;L7I5\?[
MI0M/-FGOUJYSE_% =;V&&ET/[7;3OU*$=*<&F_Q=ZN,N+7']# 5U*SW7MI$8
M@XGFVGN5(N].IW.6X9N8#Y65'[^(HI"]^,\=<Y$IFL+@U?ZF]VOJ;V;['\7]
M;&>X% >33%I .JOQQ1E7&XC>WBQ);2GML[@^FO =%A"TM*#T IB^ ])+H S>
M29;B/']I9:;0@72#S,U%Y&;J@ A1PE3!@A?O$U+O(-'!^Y?:D]E;%"AH#5/Y
MY#?*WDK66(UZM/]V'C@,F8)D()@3DM622G@)X-,/WE[.?I_F+;W$S,HKI87\
MYTE/P&1>@C_E#A75*/'610+$#2^OHDW<IP3&5K2FD)F.HJ-,P"H$ENAD1#XO
MT7W*SJU(/!^26\U^ZFI!MB$,.R[.US:Q:CBAY66 M3O#23L85L/U[._G."I[
M:QKE%1A0X*G9U?)T;$[I2-A#2=&9) &W?96NF!@Y;R"=, B$J,7"F41@;3HE
M]27WR;)20OJL8X5T"692Q9J[8# _%R%YW2#O#_0Y>Z@6 B%G]D@T5MZM$"0V
M\ETXA</B:X>_BT$0(O1ZW_WFYTPDX4?K_1&9JDNJ(SC!#XS+1@I]BN8<7-W*
MHGAIB]1!M2[)VC= \\'3E,!F=#QK*Q-_@V3OR/2O@H)A\%4*W==\?Y,:540M
M[C>FZ\:>A^P?.N(5]-/+?P%G"8K\\.>N=8F/[!4C9J2R7U7>V'Q;V/$9J &%
MAKH8GN-C;C M S %$+=Q#/);9A!ZSEO66(.JOBP'$Y*163= _5?Y33![>XP%
M5MU;!IU7H-"MI/ "5]Y];X^]D\_K@JQ$%^I3'44PH6GAD'1/"\0J?S;_8AQ3
ME0]+5Y7KC>\QP0O$!:3A#RFA!+MI^]%G#'83-[]Z6/RP T,RLP;>AM.ESE4]
M79E^)%M03EF%Q12_L4?;@8)[+\<E,\4D)BKYLA^-X&15"VOPTJXS"3J2DD_P
M7%>I-A?.KUSCYLI^_8=XOO!3S [#\WYMJ%.TV?F4DE^"-H$%91WV+#M@B^BK
M \.(EQ2'[#"!ZO/?S,E%DM'?VK4OJ"N"@KF$?C. >5!)6!T;U(;Q*[ Z;>R^
M]H!3J(,V.+LJ^Z-#AVG)7.5K[(_IK"]U,(FWH'JG%HVM6$I.W>SJC)4LK.[6
M,A3Z)F_(>+O[@4S;]<!0=%[*G:2[T0<KTMR6AZ](U@OO2/3O@LW)%:K.K*&0
M+L[!]K-#O^.Z2N1O,1P4D-R$;^/D^.& I^L=P^8*IJ.X>/1K-$9GHG)0+QN6
M_9-2P_U'>S"]<&ZNM),/]OBU#JP6"8B)1EG]$DP.ZC.?13:RW,Z#R>"^/;;?
M.?/3S&JA_/Z'%1IPOT<4J[MY!6U9M]H9H="=\_0W)SBR&\K\770ZFMDCR^';
MD\)9=%80Z]+?#,BOYXB)-T$:CZNJNCH2K&';EU;..!^2%,;P)9DA]9"/\;UN
M"65=,I9#T1:@QN?-4H\FR^"7HC,RO<Q6IF%+$N]O=L.DDN9P'_K)E5'T/SE\
M[Q%O<Q$'"T-AZ8=D@?M_&#!6PF+H5]-U,P3YB!?P_+32DN\)P0O%B,J:P*\K
M'"^^JE6V/X8(#OJ\ZXC&D[[&<QP4O#]LS9&T_ *"?5!SMOO%8.[[84%R/A&>
MD)_'U$?@<+1V%4M#.<14Q5^6W\58QR+?5)A==L\LD9=S4YB [%D34S 9;<A/
M]7CN>SJJ1'XQ/A),IUT2@Z++8ZKWN(NTXBE<A@!3A=U2G-311"VR/P=[NW+7
M9V+%V $L<=956XC>(#/KZ),(,LG1Q7_FPER%8]4\5L@O RX'07FVP+(K. H>
MW1O!&UHZXJV0FVS<IF2= 59LON2J1^&J^=LKH@7@/>)* _1*5Q1LR7>FK*--
M\X*WVCAT1#8R]0'YCHU]XY.*%<QE'IMR?CE0ZO(D3C]_V?*+!.'T)PN0SIB]
MSM>I\!_^ _AYQMK/O\^2XB<"!CT@ ;&+F1<^4"_2$9<]5K6S5%UL[3+@K#9:
M7#SMC17,.4#''\07IZ\.M*,C,Z.-('\^>;79VUB%Y@!+ZDV[[2;N*Y76Z*?9
MYSR?\>JW+L/>7<M;@2?=\R-"[KNX(T=ZNU+;;;:[1F;>EVXF2 ?#%U6BR:JN
MVAY6(_J>?C_YXE3KUVJ3;L,[:]:LRS_#M\K>BWEH#]NY3V-_"0KL=UOF*$PR
M)QA/X'*9O[CWG"USN/-4>Q?\Q!8AWO6,W&%]L\@LO\^8U]S-#[98')   <\L
MEECS]LX_D"[+O]+#X'EEDB>YO&4HS%8T:H2OKT.?T.BX+F0YS'+KV)N"R&6S
MCN[<'TI6#/_-4<.(BS.L><WG,K_L0(G]O%H4%5VM]J8O6 @3YDF;ME_PV$9]
MKZ&_H7YGSVAP/T!6UICC&^)8(74(T.C']F59T\&_<JD_8>O>$F>UN)(9]'?E
M@4N*BI0O..+3QC6ZI*W2../=G,1'W.KP^6VYN$]/J8YKV:GYWQ?<*L+.K)6Z
MF.PZ)\ZS'J?48W9G>+-K/1ZXAI>X/B],@/Q(_?%'[A.()?S:0YVHS5)KR)KF
MZ/Q."#9(%X0E=^76V_PNF79V8Y\&/UD1<L[4_J(X:E-5VY)@,XF5[WL"&.I'
M5[<.9-[6F_&."_L]\LF[&)Y05%F^$5SNIS0Q6'.PZ.2CU!UTIBQ0)E%UJOX(
MV O*I>]TJ=\)4B5M'E\EZ*5DQ<5W"RVILBA53,U=&'I04 ^\"<KPP#061_PD
M^5Q<?_=]:&3.+^R<V7NE9_)B;)0&=8^7#4->11.'I&X_MTB?+LYZ5;7=E:M#
M&W/>7%3BN'%]2QN6,"+U;8M@7[M3ZJ\\/HLF<PQOE0EEN?+R49SV>U<A4AVJ
M+M=H%T 9;D!N,:_3OY]>'[!3JH/=>,&G1#+MA25HM>CW8ZR ,F($&#(PWPOL
M0##?A_GKFMW(!BJ\;+A>%$%T$=%Y;VKWU$I*MRY_0Z)KI*"U_!;R&3=^,+<N
M)?(J=?3!" 9SJP E:2E0@!)G!*5F5(]BD'KU;Q_#7X&788A8LK,S9ME$E^^!
M(QY])S_C?1NT*+SJ>BS1D$,P76YL:P9OZ+[RX,*W+:*9]8%9%%^LIXM_/JA4
M8Z9.HJ216#BZWE]7"*1K<5$XAE=SS*,IOYTXEN%;D<YCIQHZX)01!S&.[0PI
M<7/TG$J60PE;\G$W(E.H9*1]6_JB!ZJ:]ZWG6>*.!5U%J&W5XW?/@U*+YH<C
MC7,UJ]968Z]3?FC,L>X.U>RRS(3_!4C!;0>;=!AMY8#HY4#%$F.[)7U6U&%U
MY*W*PF"S1=D18_W<O!R>=2C/&V#:&:$J\GF=F_G?Z1-LQ7WY9S0U_[EQ>MVN
M;0?KE.2IO4.7/TO/?W(O!*GLV7@+K5]Y%?;!!UHF/=0 $GGS)DQXK0R[XO!J
M?ZJ\V^N:Z%K6BX1R\^X@-UZ>1:""K_>[WT8+>X-3D-1^0TQ"MP_/M1I+:7C!
M^I77#N2$="DOO7Y$]^MVX/(MWX6>T9SG"Y7^W3F8]^)[Q)V<XD:OA]9%NS&O
M 8;>Z.#R>;HD6VO=]@*5I:CDL1K>T.+%PJL#;5DZC<B&KQ)=:*-YH%*C)U^?
M(L?<*)8D\E'@11F,*KC!CIHEQ\@'=G"$^>MA>!2+8-!V7W4K!3D!J5B7A9N,
MNZ5*^>";N>U-4/1T<>GM6<;Z7(;=\MD$NN"M/377T&=)B&O'O-R]^9NQ9%Q;
M\6@5X"EJ;VHFHI4?Y.@=-40.J'Y#7E@5O-N=A>I?9XQD)+B-G](I8V..3#EC
M/V$*L7@RMX-J$)'.>+9[[U80D,UXZNJ8-6I_?D:[9?UF^A?^15NUW8B/?Q!>
M2L-:JJ1APD/S69+\FT<9ML;IKE<'5XH+8UU0UA'528B2";7==]QEUZ#%F\KL
M 7S>#=G >U<6+6%>C&W(5H&9=VEUS+R<*VW.+5M1[E+.'T'V7W7+V ;PHQ6/
M$TNTQ1J-90JTHEV-S<SM$W&PXC873A/JEU&2(&$POI-!AV0 ]T>?>^I?QE[O
M#'_!_@L84^1:B(*G*H=W*5#:I"7!7T$PS*EX".JQ!]45B_U<,/WLO!'<#<Q;
M;JG$YJGW4%)UTYT($4_R5A0JE&4ROF4V[L.OG6%2F;/%GVG!5:M\<913$>*7
M3EQ1;+Q/.1B 1N%*/T?-^4C)I_#:2&Z!'NJ^J^WVVJ]Z+_7:RZKO+\ Y[<8]
M]Q%2A>>LB<[!@.A ?)6B1?92CNS93^[%GP_MN)O^ I9M#8T%/^E=[;SF4"'I
MX:/JHTSU&$QT"1T>RD$<W[C\R+UDV#OT6>%<&2_':T*$3\*(7J6+%#-!NG$I
M>2A]U=RA9L\+W=G0!$1_;QR(Q?[.1/@J>I.V=_PZ0*T=!(6ET?(ZGU/U:Y4V
M&3'PMXO' ZM@1[^R57! LT5":T]<HW@!Z@BP?O*+YG]>:.J2BPF@T1FIYPV0
MRZ(,QE0ZF)SJT]6_RW#R''/AYUB,6S)@5"(D/#%4X'\?Z(G_/Y_V_?/KYY+!
M;,,\1K*(6@+1DKD )0$P-2B2 DBQ0Q3U *[L9DOQ%PK"%PVQ JR$-QM&=A+A
M%70OT#XS 10&G8+T<TDZ\*S6DOM4P J5S+5L?,P#<.$Q1\80H-\8$@R!1K%9
ML)?"N"J)7[A,%$ O9M^L5\\5 ,WP,H\.'-CCS'/,8[PO8R&L+@73@%W! @R"
M5[3&S0AQ=U]_;0/E*N$4$ ST/".B&:\D76LQ,M].(S]!,V,E:MJXV0'M<X7G
MNBV9F*6[I.E-D>:X?C=Y0*7;#HZB'T %_*%2='#)WVY]+J(&&$K)7'S:;Y>M
M0WWI\AQ'61A;N<L\CI S'EL! T (JNE=0!%$<@XS<I>5+**4QCX*T.+&9T@B
M]1Y9L&Y \&WJKH)Y#%(H3KV8R'ROMEOGU!R+E]]&P7 3+>F#!_40^G/Y2H3"
MZ!($KS&2<_2E8-SMHBSJ\4-Q&0JK28DJ#.N\AS5OTVD/*[K)510V\]J WAM>
M\;C!B6@V:U?Y,NE3B$+.=^^V0(OU ^V&V@/M9-YFO0.MA:,"(5P-/UO@G0B;
MB;I;8XV$/'6Q!LUI5<>R\; D[AU\28-P<=C!^V#ROO&+ V6K<1WK7\M[9A;;
MWA6V>R]L#^9*OP=[A+2(%/\%^.AI3O,].7AOL<A_*->8HSX[$2+I$MRSG;OQ
MNSGE7'*PF^(;[[C?G?O](2W"Q2$^QI^'%NF#>SE#3E:+T;;(/3PH^VF<;J%^
M.V2:;5"]7NP'8FHMTD5](ND/:%_U+^#"*N(O0&UY#Q+2JC(:TEMW;"ZMX;41
M<<RJ:D_#!PUI$3L!8=S5K-T\G2.E/D\KKSZ=\_0OX&1)^LK_THJ('0K5]>XX
ME/6U'^6X_A/F?BC75G1279]672DBS#OW!.9? "TC#>=@LU;:MF_E7T"N]R$1
M?)1SX]^,M$G[</HOX(VVU?&OY).63A@XXO\+"/>K.(G]"VAR_G__0(S3.E.?
M9AT,J15;UJ=-B#D51R/J\/]GBT/\R>*_A? U_)E_ 6N1RVJ)P97_9:<AT0Z9
M_@^S[]'_M79F[B_@4.A.[\[U(UK%-\96FTE;9?V,_Q?PY'_MZ4W___G2.[I&
MJ_I?>R< 7E3^#S"!H;>'=5J5)FEP93,-BO"NPV%,<.Q?0*O*R%\ 30#H_Y2
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M.W82$H^'#(A*K]K\RW,A2AETA0%41@]_&*7[N:PRF?;3F/#%V&Z)O/>U]/&
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MB39*BT#\+C7]<-PCTCD,G:\=3*=41BGD&D\C+!%O(]UT_;/=21T E3JQ'<>
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M)#\'9[]$B%Z6,4/;.E:"\T)=%):J21PTVQ'"+3:UB]R.6Q=TS/X-*UH"7,J
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M/J_4N7]W[0-N.-BJ6W[ZPKPT/Y-6J&7^2'=+V?5D<Y[S]\<DM G8#R,>5HH
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M,WZFHCLR&=U>[.#+5X)NVS>>'1<6^53G5[@,N+C-UF+:=>:86"W8OIMP!I]
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M)"*H&+E^AY4[4^?SF@-A1BGO5#=!5HIAE7;%^A%8JJ#T#2_-C6EQQ<IP,._
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MA.?.6P.[*05C]:'J1Z\L_2N[6N?+U:HG0Y.F<GIH:FYN*T*>4H,@8P-T"@)
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M4 L%G2DAE,?@H4%RXSBK5RMU)W5@-91E,"JC4?PU\)T_=:"=9M>O)E 2:J7
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MG6@Y5XMO.!IH&$_S)+E8:"<$3V>%B)+C[J ]6:3?/^?<K"8=Q48E9?%7+_;
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M=; U]+G0C,4OV6H@VQXZGOON?3W+IP/O539_ 3E#G%JL$$P*5FA[/;J66E6
M!0+893>2P]RW>=TM</-X>O6@'ZMO_$;GVQH) %HD9J(XON3P]X7JF\78[Y^/
M$J/*]VCKA2FNI9,'O]J-,/5PRL*N<Y]K[!\^2R>^@M7.3V03$KT*^/&>A,'U
M(+'KC1MC_3ZLBPGF=*$EZRBIN?L*R (QTM,?ZSC>)NAQ$Y:;#3QJZD*9\[G
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MO7M.$Y%9W(EZY:\N-O]D/L2D/O+G<%>^Z3^JJ X'U'E+N")9Z4+\!LINT8.
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MSY@O^LI948-/\:*.D=]/^%K8]8!JQZG73]?88X+4@6HA3\K#/=?%R/,MKLO
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MC""O%U_P>'9X,<B#W=>\C$?X0BK!\52$RJ1T+,,62>\:1MY3Q\<D,YN6QLA
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M9$ZS%2\KXT>]$5M<W+N8_M@*H_>SB<'^'X#.EAX$_K_:.Q,59,FE@!D7FHI
M3M<_Z!@NML^G5P(3?9HFJN\:^HAD<!AFOUV,DES*[DD7388B:\E=ITQ,R6&/
MI*8Z<\F("JL?ZW\_"W&8K_VCZDNF!^1O#:*3]*T[QI^<Z@]0](E.TP(.='F%
MX,HBBH+[ZY=8GS1;R%+X/7:4FH=;PO1$.-U!+$^2]/>:TAV/MX#!AH<3852H
ME68!U86,1.)H1,_SJ+)[RUR$??D8BJO];9&;MADXRG-25#XV,D(G#3:.M1C*
MF3N^];LKQO,P>O:#[?)N?'_D 'V.TLGTZ.(]C*3\"Q]NE!W9M1;G^B:&W\<2
M^P.N;<-="J>+I]=7,/A'M72 %B&W+//0MK?9'=1J]9P_]JU[X;"]::W5FQAX
M<,/Z&LY3V,6G3[% 85F27K\:>B<B;N@UIIUQM].3_G-J5%,P2*"P>""PYK(Y
MGV]HU"Y?]ZX6AZJ#/>9EEHRBHZ@XG3CF+)??RDOPXT4,R!,-(^M=QCOY^+@(
M)T)PVH^37[ZW])<'TO5ZWGKBQ=!FSWD*JLW!L26MK2XFU-3*'K,&L@ D>P(K
MW'64TXZ0A#") .4G_ E\_:H9:ZJTC:=<U1]8>L+!/9G#FQWC1_+="K>#'/3/
M<6!R+E'8O2;?M" C?S?,$&@8IU7^=N'Q;O &:.OI&H P]JNSM9"+W+BQ:='A
M>QPK@'0!TE00*D .@JJ$[52*S#U;YK<[ZS99,;)6^C(>*T:P <U3N,*A\EI/
M5SVY)<Y?8W8B"VM7W_KC1UML75^0^3A8*U;,S?2R*0B8W.[[^NTZ@_0:8VFD
MV],T-PJ9U!5EU>./:UJ9<6TCRQ#7FMI@TF=?-JT7^PKO:?B&RG4KJ""IE\QF
M&Q&LU\G(+(C+6Q50Y6]@S"_%U=12I<\8(I"]D[,A<V^@OC'(O('"Z:ED&"NO
M?*N>!.MCFA!0TIJOK60OA4MF%&9R2>W^P!"X5)I7.R1_=O5D$FJ+>612_X^N
M[XYJ:@O>C6)#142*TA4$I7<0I*A(E=!K*%&:D B(% $#$16!4")=0N^$$! A
M]"*]20NA(TCH/:$&"/"X]_[>>VN]M=X?)^6L?6;/?-_,[)FL?4X>F]"'FB[5
MWWU[F6S6KU+*ERS"5S_/J?:N32%%,J':_QJI;R84[TF9$P@7R]$B,[8TD"+'
M-&O*_YJ56N#JBKY<_:BLMPSF#1A ;0OJ,F"P1_E_(^9%]!C)IX"6=H+8U#TQ
MHTA<RDS#U0K$?5,5V5D;$0ST5B<VY;=>'UB=RCC,$_%J^TJ1Y;:2[G"5:;!>
M#I66GJT$N8/VX@Z\9R?,N[YL,Y9'R>QZ[-5I$\>WB2C,KG"/6[:^*E$2+%T$
MBR+JT58$I7RGJX%,?SRYCXO8>NZPY#Z,4Y:'1DE+W:D[-.OQXZI0V=OZF^Q:
M>/_ )OBYF23A^ G%9?:<OQU[0A\7+F-VFETD)>PC97:XEOOO*2#$'JD57LH5
M9T;,"T_K\J*W]'!ZMS6EP4@6:L5#$F[QU/ON%LL-4MG=B_Y\+DMI*P9I'M9G
M?-ZV'^E7N5;+$NVK2SZ)B[9J5SLP:/4Q^\M1\0,MP9@&J2*Z?7RWO!=^8G"6
MZO;>?X+).U^XPB:SO&P$>]+OP@WTSS_S<I>UH4@X9"/ D#+8?&LI(5(VZC.(
M^X8;>'T K;0ZHBQ#L0X8DWB^ ?U-9<V2*<]-$Y4O<BSLK:S)6IT.LOM='G)T
M==^?7V6R&%\K- -:JPCY<'5_G?/]LP;MY<AVX2:B@D.MBCAFA&'0)>L@R"2\
M1_/5*4!-19N4%E%E*5^R!)W.8G?1P]?#*?-W+2WJOX:^>;0!8R9S^:IG\=.N
M&E-YG3W\)8L?\)?7.KOL80W:I+;-/I#2&D\!3B@>HX:<=^-K&W51N!EXD >4
M ?U0UQ^#KCY.MH^>[)Q+35P&/Z?*DF)9R&K5$OW>Q:]<SG<?/4**>""UEXV'
M(K5,H'9;V^W<=(ZD;ODK9FZXEQ2YUAAGOVAUJW YK+_7T1,?1QJ.$]"-7;)W
M1D[G:^RM2Y=6FE[$)359=1NMIP6E"A]Y)5NF*?J-F,U^0$KI>5^F0!<WOR@,
M6C;?*O4S*X&"TL9WVEC[NBU;EQP>CJ7=ASD.Y52DZA=JR!!1)G5M%?E?.N5E
MUE58U\)';MU\/")VMD(376R4.I-_%#F[NG$R3/C(_;4:'_JI$JNKD>-W*8%T
M \BO]JU%70FSO/F9BP'GHLPY4/R'$U-)3@A>%RX<#2&\]#-=24V0SS&8:O]M
M&G8*N-*3BO=>9YY/8X"]W3\W:_:@ K19+PP5<L1G<G@5IVS,QY@0)*+5(>Q+
MT"N[=M+3]),^B*,,E[:ZL*:&TDE42G552#)2NY^B]G?>-_,]4B7(/XVTW[SG
MO>?^-<+/S^39[4DCM LR;'=SK/<%N_<KVN5E&U4B?7#IDMG%3\SC_D*[]*W5
MG,G#1>=%W9?!8E13DA60HS#J)'8>>%6&??)@\=>)2():Y?/70I]7P=H4L=9F
M$.[Y=+0&%N9+')W6("1QB]+YC?PZ!3!)CXAG*?N9NGM[2T?C%]%4'5)H?4DT
ML(I8+T()F^'ERN!9WUP&9Z(.6[UFMEIHMD;:&ABQ66PMR7!FD^>"[QYQ?YV^
M =K:DBI5/#0;5;D1P(:+*W0UXO S^TZ]71*T<:\K$K>G\G7M'O*%(9/_N"=1
M34NJ=[=F<^V:+.M$H,VYV;, =72^C_Q]#!T^D8=PO\*E.;>=*PZ&61+1[,9>
M4^[5L?,NEW45QU-JS"M"1*52)B*\Z]DIRFZ?HE/\,4@*%"V<*TD=P7,QCJR[
MV.FLHQ&&DVC9,@T&=])U_S1XP@2^=J*U_J(RN_==EPFPE=ZL$'=)5%ROT*);
M.&I'[CQ8C'-E+JY,*CQ[*N_B##=K?1(LQ+Z-'NMO1FIO(V[=:8R1IZD+@)?G
M"/OE&J?5@9_#[I&E"WBNM^.>\Z%S-)?\+8GK+];9[&8:OM;S40:D&UQC/_F-
M#'FL +UR.)*IN*W-MH>-U=^.A@A^#'KOD(T6.2>$$)8'J*,;\O14WN:TO\7(
M$[J/U=GP3;,1@P:JYN6C6*-1$SEE$*53,<Q+E';51BVW3W'?\IW?R ^JE9["
M!AC[-O56O\Y^E_<BJLLR12)@>8AB^2L&&JALZ+%N$PP]DN_TO70*N+^S4_R4
M IRIS+JY^70"YZ\Q\^=&WY&BHTSO^)1TKP7!>2G U>?H;V'U]?_*3Z"=KVQP
MP85)]>'B 6XDBO/G&+#D=L8Z.,U&ND1\%5EFMU#XFLO43?<L/E?</G&)^L;?
M!"L]'B& '#$+X\5*&*)8H M/K2KJ\!307(@'Y?H+92;U+V"J^H%O+66T1N,Q
M8:[FGKG'WS:607?X):=E,*X^!:3Q]7;F=P_)6K':ZBM!L_Q80<?D5VA6W4<%
M!*B>^8J)]DNSQ ";N!A?;ID:89BI"T%^_<F=E6P9$/*QTU: :YRBN_N3#@L@
M#[K'AF4GS&W=6$)D),?YV2-FT)T21#D&<4D^PLSOK*]U28^6L1JLK<?Q% G<
MP5\RBWUI(F^)M4RL'O9JU@]EP^O_''(,*"LI=PZI+D8E8,TB"T4TKW2B[)Y6
M%Q8LY)JO1)E*!>7J:>/HTG VD>>63;.^^!D)MCIAWRJ8A,RTFE\!9/\U9&47
M%2P;Q1C*@?(>&]W/D_(J:"W02EHH.$*'(AUZI+K0S.B=SKL,!(0 *"A=5/,.
MXFTLX@O*=050P]FXBWG[)PW48;J0I\[+?(O@-!FY.57(-[I;>$[>9F?&-W(W
M02!/ L_7A-.JE/$@37\8HKCNWRA[%SF_&"YC%M]CB9-WO8S5Y#<RZ1)*C''N
M>DHL%2UK>1D 6AK]FG^_@LXXIXNK+\GH,V%'YAN'B#NH[XOB^J@>OBX7J 16
M-!'8,7XS#_62_CW_(O:@QI!T;>/^@V5S*:=;R^O)#(A#.X/^S-& IS;^1#UZ
M])^@(@6*SY#E;5W7ZUL^5#59U.BDNE#F0,!]S7 :K<-AKKH9]+42$YG>4X!=
M'V2LL3BZ=6YRWYD+)VQ=IAQ!:D"RS+HN'D,'I?\X3FTQ1-^ SJX_,$_2XQ56
M%ZKI#[@O+5Q@?PR=ASILI^]HE.AF.R+3O?Q9IO7#9Y[V^%:$*+/G#&_Q'@N]
M;DY5C"0]=#Y7_&1P0Z0XZT*<?&'6 \Z.I/+V[M1[E+?#-2'_/--K2+K*<X_W
M@FT]8:16QLV7W44?VDZU)JU^D#<_!6A7&&B&$.+Z4E_5Q=UO['$QGV8,1XT-
M*S+P)95L]<U;X>8,S4ON\#*'HP52XP2F/0J^'CS;S1?=S;B:+/-VA(O'25(*
MT5-)9@1&5=>0Y!^W )WL$&T?[BQY&U)^M(W2F95-W_8-/^<V7%L/38 E$[RK
MLQK%1,#PD\(<]3UE6XNRG,=6A]Q:PU]F?(OBIQ;?14);:X6PB;+GAU;8K!<3
M;RXT"/6(_VPD.'/K?2Y<45];4CP%^$79]S@6U@Z%S!7S2"9'C<A;]:NCHPIB
MWYF$3&'5=N^Q!!XXK^H+I^[L^N7* M7$Y>I$/2S*: ,74*:IEYPF#"65Z@E)
M?H0:YQRH9L@7A)V(7L79B\G9:N:0;RWXSYXWM?9W21H&M5YOV@W*/+^S#JH9
MYP0K86PT5\JBC$+NQ%AZ$4L7<:O63/U')K0SJY;W..;VIH92W%W%?8JBB?20
MGLJ*56L&^^2 K#S?1&)5TKI(5.CY.C:H>Z^:W;3Y5Z-6SS;5I7=L_FLHV,<Y
MQ,[F1>J3#\Z\1OSRN\7RA$+MQ?.E(J[\I4EWSVJD?'2BI=$&F(:R\GATUO3M
M.R4HWFSM,*C8KA6F]#>-2\ON_JOL-J75I3X:V-,7'5$@JQ/I1T<B!G&@]VI]
M'#XB;O'/T&E-]6\HGTECF9+B9]Z PX+H=&]J799II0PV_IAJH3QQ;A>/]9](
MCC6[OQ'@O:H@7/VF9RL*49PW7?L. /2G(S/.9*CR"H-S?/CK,KIS)N6ZGC"/
MZ8Y&6!R6 [\+.O.[@JQIF>P'/'UZWI4K8#3N&EGS8=BSF?_HT18%XV>EOC>Q
MAU?8XL\A-JA2=@MQ'44?7@R M,Y-V"3,I#SH,NDH1C?^!96J</66.H!6%M6R
MEU>BBIES1% _&1"EKUU9)%HMS>7,1@VTD]\$ $/#,$+)7GNABZ_/EVPH\N#A
M='[FI8:^S((6[9.F)K8%3B[! 1U;<J07NQ,ZIX ONIJ^C<5V1]>?^P^8N$HO
MC;[-K#UP>(O&:&3LEB,%V&#E]66;ZP+8&M2&6-G;L::1Q_XS>V]FH'V8Z*<[
MLI'2W5PBJ=RS,CR4+2^55?I%DR)%*2$X;8'>C,4IH!K:G:K*ON:EP>6F0;[E
M<")U,)1_<E^GH0VN,-<75*12[8R=20JD\E>EJC+WCQP]ZUBWHR3>/07$!V^C
M&V9>=R)WT[!O54B1D_0STH,S1VGJ15KV4^H[Y*BH:7A3[[=30+?>< XXU!#>
MIWHPDBH6O.$Q4.#=[VHJ^18:;:%J33<?'JX[/$M,TAC6&R[-IOQZ>@JP/!R)
M\4EQ%1ZJXJD]<;&9[6N;':Z<3]CBJK\JQK2&S('/N#X^DPL>SJBD8/CQL.GA
MV@= E&_L.^@SI\6M0]1<'#,G?7ZDEJ'VGI+@$9& T-N$@[K<PB0U3P&K<-"6
MB^'CH#Y0\W:>5M4#K*=^XR!:J%11W4+A9ATR'0OS%QF6N">_C_W@;PIM/6H9
M^>8#=*B,.M=9_):4^V50/;L(NDH:LQ;@W9YT%36V)YJ=]*&6WN<G-=V:A--2
M,8/", 6FZSF>+*#K/MQ\'\2[T*+!0<)6N3XHJE)4WZ1*G&7PS&K1C>8#L]JG
MZ:WM'2J"B66:L?Z--K'B3"^+HKH%MZJ(\0'7Q&<%#LU4\RCON]J[;8+X8]AV
M#(#6,F8XY\X[2Y]3.II*\<,R1SC;%YYJRY9@^ZMU@BD]58N(]W0Z%LQ/E_6"
MF9;7.R":=A,F;TMR('5"-E,*W:4V<350[O,QS,'"BH:*,@&/ D!:]PKM#1]J
MT,MDN%T9%Y1!+C"_8UZVPBO8<@&9'1%A[%PS:DQFY\;_W6_VWYXS_0M E..4
MA]%Z]L23ZP:Z>2XYZ1=R,A& A__/H2VE28B]XNT<,14[^/#.%T.C?*6'-\->
M /.*09>4%(Q$+=\(^Q>HY1=]7;KS0?]R.%6/@!+2^J@4 6,@-QF]=Y?UG1N9
M:F"2WHL>MHL<(KUORP_H\Q+=-'HR, ,2334R-#7H73E4^24W8AI?$B3\J)B)
M%%%M W%*?[U07'3"1E50"(K5X>U]LF[D_MW#!T&!,P9XV:R:UU15./!%JOG]
M&6EZW7Y8C$=KD>IF#'5@_@*3&NT-MQ2Y/;"_%YWE96XWI05YC*\,=-CR+NP4
MY\KT77SJNOC[B?P.5N7BDK?XGUQF#Y09ZZ8*8&=QL/#E,XDVH7'73$;+CN ,
MYB:87*GFR_#TOU?7O5YDO':X_V460:OL39F8J7F/2^D*_SNRD-8>%I@%UIMW
M_^1GMF36KL>E=EVJ?>'&\>IV,W'N0<L(?HW]YP<3)E^-SS #F8W"J-);<F;3
MTZ5%GR]293=^W7('7_-Q^U7JG+ L=8]&?AG\&D9#]G-6?JY#X:7!JK(>,O[E
MY'G,_OPAH&G$(%]V@K7OZ%*EVU?E^T#387%V>2[<)(37*WSV^+-QB,JC!NAJ
M4X4<KU(/K(*$KA\@A@2> E+3ANNSCHM=7EA-DB='NANNFG62GUO,[J<-)SH=
MOSI.V2$@GR)T/)]2,6.CZX;0ME/ ZP^-_(&W7A?0S]MT#D?=YW*/$1HOL')B
MJ8!U)35<K9L+ZN2$I@[7NKADEMR*FR7T\^IRTXU:SMI?I?.%MZ\:5Y"H.9<N
M=:U)3X<>.J9/J(IN.A:QS^:BN3)F#F"E<6.M-"JB 0+EFXQ::9MF>.Z?E<?S
M%02S7FZFV0FBL\IT<;:*@]MN_"G 0.,9LL'E>]$GB>.^93#G"3ZZ?.P4P';$
M,GWRA/>XBS*]%^OZ@.I\"QE;*]I^<LOD%  _'%EZT"B/4F+A4:D6VMYL@EBV
M=)^< G:+^_L^R8KPA][F;A*T '*< MKJ3(:GU/H@!_1FX6!(\'L5&?_/Y!H-
MAXIOLSB8;Z&NL)?IG_8>'8U2ZMW^+*V9EUDX?_1?AKE1GAO?B\.4;ZQJR;0(
MTKN#W_C<4!J'-+PQO+\"B2]UK5!XL]1, =H4*!"(TR\J;=VW4$6HP(.&(ROG
M93K"W(V%>F^*REL[,L=+.,RL?QJ'H\2ON*?N;H\T4JA]M]3A$R=EG@^/N2CO
M/:=)D>U])+-XV,M*6[R'319IC[.>$WG<M84,YQ;2VD7?4@0#OY\"(&)'0[MI
MC8G(,:-E,.^RMJ4)>!^S6OR996Z\?:>@<G0Z,J&'*T9,I0GZU\5O:=(G]#,'
M=7=_NAW*XL*OJ_+E%"!(N=;"LC#1HJ-YHA!+FV9\TG>H^*[]VDUZ[2/Z9A9B
M[Y4]<BO,C41C;HZ_V)?C'S$#199;MG].%7SN?<W]^[X=:HYJ0C]QSW^2; V9
M".2:'.$CMAUQB.KEF&8J:U/F,]JB?D^H^Q;'?&GKLVHB;X\,<W/@LIT6K Y'
M.I?IQW?_:J@H7<E:=QLKV"VBJWR KZ_?,IC5[Z)GWA);&WGY\N@QPS(8U.//
M7'@OI:156FL[;YTA796YKAN@P B.5^%V4RG=S!MKHRT>=!L7:C-X0=<5S$GO
M1VVAC+T9[]F94'\'O.*T=0H(/N&/=[&^6=*VN0K.5BGEBF')C__]]RSP4FUH
M2#KEA]':^K-OU\'^)[TG/,#+:QWK%7=RNUXO/?A:^_AB9!JK"6 67P26B&0Q
M6+8:^0QS8<FS8\-\<E^U!OY6_^#MOFSQDSY.Q<D-U3NK_+7^=B*<F'L*"!SY
M RY[MEY:><A&L=$[8&WX"Q]&"?"NNP6^B&#A/>EQAY<YS&JX/.QYKW+>S#N8
M^PC7$C P'+0^_RC=6B]1D?$D@7CQ\M'0?EIC"D- (\VY4;/&DTO@4DJ@UNQ"
M<</)U6DA\R=5:P]ME5#=_@5TM2;399VR3*F"K4'(<;M+V.Z< TTK#F+V=0I5
MPLU_6SO]A#G#92;IF@G[*];=HO>&Y&P0._-[&JX=%+SUVK6^A'<;AX,1U8%-
M5.]!_(1>PLM?K0$^E*,(5[U]S&9?A T/4G\P1_!7N-DO&T67P\%30!V0CJN"
M=*\!GWZ(.,IJVHK*O [WKK]-N=6P+.ZOYM\Y@SPXA]R'F"-C&R#HT(JJ,Q!B
MFC8T$ G'9\LU&'(R!#Q!>E!&6DZ8#JBF#;N#A\-AME&'[X_$)G\N>S<KNC#O
M*.?7%#J #<"* ;^]\XY$1T\!/X66NO.I'>;&^PS;EUN+SYIG)^&>4I4@6,PL
M)Y.3W.\)[[\C2PUABHJB6+[''JTPK:,G2XYM6HEF=WKNLI,^MT\[U""D^.7;
M08=0([+DE(]7))7:@&]X1'U ;,=[Y5PD?]TMSML!AX2]3_\B^7I^-UTCC/J6
M, 5T?$)/-E,[4E[&^OO3ODJ%?B>O5^SU%OY6?H/[ %[;G/GLYGZ->=.DO\;)
M'_X7?J.0[0VP@N/JBK;O V:Q8)$6!7M5SB#9[6,'QZ>,LLY?DV+4@1(WLB':
M+(%!?,J)FA=S0+=S1 !,$2\,<.+LY<E9"#?Y/)%[-$9 >;3@1[NK$06FN7*@
M;PRFR1*MK$QM;_0-^&=ZI*/T6>5S+*0,)=8$:@E9EZ7_E+4],Y.>UX7HE]6H
M2=\SRU'.S"N&7.AD01'L#:6NVMY91T1D9\=%J%8N?!^07;$>8EM(^ZQU,91I
M,*[$(!PO91O%%P?Q,M$2='#S>RE?C7>,0@M<]^?5+\.]E*K3+.LCYF$U@W)E
MY-$13SJ6?QFN[^78E'T1$6'2%[K()\+$Q']1A"F]7^)AN[0^G<2U\D!\1%/T
MMQL]K+D#YA(9LSB+"-4;D"*(6@)D.,I. @:TY0OZ(64C073ARTH,L=G=V _=
M"^)E+>)MJ;YC[SAA'3MO%^^7"GSUUL6^D5B->=R:JNA8%0$9'=<9O9,SL$M3
M<V&D1-WLD>#S"J*(.)#]II3-*XPSUDWBT:;-T'Q8OM]K!)$*S +<";0>OZ,N
M^ZA'R$!V[=RCHFW5H=J>!AE?_Q5<87N%3,/,'WU,/G^N@0+#6KP<>ZR'6=,&
M<[?3X4<'&V@N+L8/0425.$5"84,"+KW0]]UT)@L5J]K";9GB*"4<>[G@;HNE
MAT6I ]#-XSMKJ4&%=,_.W[%<?CYIK(H7GP3_\V-!6L%N8TDQG"&CP,_D@?(<
M@1YV@=$HC.Z-ISD3.@X%K(X"@OB_B#[5SZ:F.OJ:I><L!K$VT3I# OEL#^MD
M(!J;.MD28T044%2@!J@?9-KSR,C8-ELMFR8*HB>:PD:H@80)'?@+=,5)B? +
MRMU58RJ3D4 %(O_H;@M6)&HM&%26B[BEHPKXT2;;.L]C=Z5_&\4!Q87;39D+
M,G':Q9N:PGJHT.7WAG+2YSCY'COGECM;V;M"RN(4$_/OL+U41:(*+7?SFP@#
MX88TSUB(.7],>-_8YIAFO>57$HC0JHX@M,AF1*VH%VPY?NO(CL[XH_L6PI]N
M7S DB3.U&9)DP]S2;$=@>0F_(85Q%Z_^]##EC4:+3:%G^;^'8?A4>@JZ"",)
MV-L,;KVYK%+&*&+<ZSZ_EY9_M(8SS7ITRJY'!#U9-8UXMKJN]U;(DS];2\'(
MPCE%T+Q[0,N4QN3*>"'&7>O>I&<*A%]Z8>'[T/-)W;(=$&3;2+VL;8SGJNFR
MKDDVY'G<7/X>*G%$&L,)[/K1$[N.$QUW;N5HB=1.>6SBA6$@3-(*W,'CGM[_
MGOGK_M<"3>=-$;4:+YX0Q$(<2X[YMJ&PM4#D#-M0'%,+*"$0^'$X$]6CI2]T
M]8^@',3_J8@XDQ*0W1']51XCCGII%9GJ7((OO:I::22EOJ*^_N0J6X)TK_-[
M$_.:S\9O"/_\=]7S2:@<R/'PS1=$,+Q',YJ(TT)AV8UW59F3$$AXG7QISS,"
M:'8RRA%M"LJ)IE.Z,^SV+.S#DB)!<$AR+_N>[$ 9H:M.X,1:_.X$$/*C$Y_A
MM9=N)V>;\#M71HK_6VAM5\!*$9UF[L=+$-?9%^KC+S611D+&5W&""%5N-28Y
M;8<K;8G57S=U>N[R&QD*$@P(*X)%-",(7\BK7"G]"UV[#PL0;;FFQ/3G$?I:
M>M,&CXV>"*)*F8V,3.T@=[I?J+XHS]H6I.7/H)5TK.6MDUI7JQEBY5_XSJ^,
M4V.[GJF+NQ#_\$_!/:_(G0:(#!\=FY_84].,($.,?V9>I OA8NAW*L[P:>50
M2DZ0::41-W^@%>3LV\0'16+)W)#AY);S[=9OK4/MBYKR47ALG.P+A<53P(Q<
MH+IBXP%!TH=(?["DHB L:N]YB6 433 3GGI4<5;-?M[.>Q!Y=W;_\W8N1_LK
MSAR=<IG.]MD0E7H5A9_U"A7MAXT'_7J2K]6'I=M*F?LJ(K'DDQ\!7HP^"],G
M?F*+FN\5:%YK[1E8#?JLT&\6+QI41*:?"0T[( 1+$(YCC4.A5@G4!_KP/C7J
MBB;5R^W?.Y7381VKP%2(;$F1.\S+%3Z?3EV&S_RK3-C!X U[-UR0W)IYX25R
M:P-U!]R;Y<9A>0J !7A>ENC'Y4BMX7KE(D5. 6?ZN5$?W(3W/3WH5[;+/1)Y
M!!H1.P70MG!O]P=X;E)T[_ZK.D>[_ETTRU35)?)O[FEP;VJJPN<3/_K>[QZ<
MG\87XK!"<<AV?;@_7,'#9^6Z_RYUZ89=SI'RH)ZY!G-[YVP-_!_(;K=_^V<6
M_ V[TB/1%;T?&T6&*IR-Q^2#H>]G%AWO4I>#!O!G57Z_YW%FU<PL!GZ&@]:#
M2.S>V9!^CHZ)Z#[F:Y8>5FM3"A6+B^!>3!KGT[3ZAI1SO[V@SCV:PAY6V0$*
M_QE_)M#C'X%+_?*184?*J&'S0A9R3[TRA;I"J_@O>)?/R(T,PCKG]E9ES7[_
MAR25,^1.*-1EID2\?^3W89FS#H6VKF&_?5&#RM\//X,M^+>K_]?D>)F^-+:G
M9QKABR-<_D7OVX)"I3"$JN#OWD\A3L+O4%>HR@H5)X<G7FH"O/DGO?E\/UIM
MX4UG%I(/"(P^*].7%[E3^#DZAJ-'G/.:KW04@> <9X:H*(3"O"YMGKU'RT=-
M6_Z2,&TM,JU\#.?ZI7)&[ HU0/D_+\LVC%9(%"ZX]/.,V/EZE6'ZW@PW3LOM
MH\:#P=N2"BHEA/[Q]2(=RLKT/_0@*7IWN;?.> SZ'9ED4+K-([/(=9_4;'.;
MW</ZS/6FU!JCX I%)_RX[\D_3SQ15=I:7#;3U]0(!TY'AV8.,_ O_<^Z=%X<
MF%)!ZZCD#1 >1X[#UHMWJ;!!^(Z,,O$P=KI8H2 :9LBLWI8/\R=EGE^WN5Y2
M5[#MR/5IE5KN%*7K51&)=V7.X1:JEF'_ <!-2K%</'Y)71+1XC0<-UY^;17]
M/[KFZ7'^YY]A"QJFY<8-MD4.L/?_7#/8,//X/]MSE>T]1>P,ZB)>GL7/O^ '
MU?YO.JTZIH_H'J\]*G+^/Z>F'O]+@^RUK$RHLO/J:RO,&?I'JP>#">W>IX!I
M[I3'UQ(Y(6,#>PH+M]OC*:< <Q4%U=EN^":R-U\T,F:MK,&NR/*$\3_O-2$/
MG841=XJ6G(9YN0G/Z(A@O>)_6J'-VL^ZPG^B9<"J8\6T+;7<MLJ-HG<66XN9
M)Y[TW&=6_1M<]EX-=DQI]LQ=R']//5%A@_H<_J,/_HRX>%S^.+X*3M'#_G?9
M,'G^W^G,JZ(5D#\)&"<AY"G@R]Z__O6<?-RP/[*=[^#!6VJI$/<&$ZD7PC*]
M/0!72 FX:_E/CEBF_\>PP?I.*R15^)K;P5)#BMP)R\5_)=(L:-B\:;U7RMR)
M#&'Y3^^9V2/X/V/.NW!*F4="+N'&\#_@,PH5;@=.*@I^E +6PT?4E6\>O%:E
M#U1UI"JPIE]W7?TXA@@5DM<'123/VG[0UQ=?=S%2EK$]KWNB4*J7OL< 7^<?
MX;EVO@6B$AMS']M)"PW>+!1DZ=$%2B1(?S'K1-OVL,NC&;P'WHJH;AJQ,)O]
MG@!"D7ZB/-Y^CBO8/00\"657Q?N^(.8]AKW40+.FX+G^-QB!Q[%0&BRC]*K@
M'$\XX42/65AB*"?$L/)W7D6VIB8/CFU:ACOFLX[J2V2.=?A+8X;\.YBKD\:!
M'.M!A1^JY&4P$EW#)BT.I3I7H7(]9B]1:-\'7GI7XS)_.66GB?!JZ6/<@2*:
MN?*IR5A\.IHW5\M5RN@JEE,W+T<RZ)6. ]K8,74 ;^O TM%CFKCZ3!,2VY_J
MG!&;V.L\4"&M^-I+&(JP%5$UC2YH-\(87XE#12<E#PZ]-U*[-T"(@97,#;"M
M*P[1,T"N01U[DE\:T?5"6U"XE(*&[Z:U:2W*"C]PCE=6Z(<KT\)/ ;>R!\<=
MM"0H(SVEL&=U0[CSG]3EE7%] A9)SQ)W4C9;FLQ#YF9'A^U3I:MJ%1]SMU6"
MKR[)5=="6B1Z_&R"22?^W57T\R],G1T8(\A\?^:',,DEQ/HWY./::5>7@U6P
M^\K49?.R/>&4.J%YE;!J!8LIY4ORA8N<=/=$@'IC)^)B&7U6B"/!0[!8\Q?D
M!ER;TO?7*DGFT<>37?\H+]:DYC02_;*9GIU@ \,6N*6[Z; 9N8<IHSRVK6!\
MKEDD171(1)I]FZ5@BBA*^=C:@?/N/7Q5;C/*OTA!WRHJPO/7;<+RIA14PT=2
M**)+UI9MY_J8EP^]8_%/D[V+LMU+^P+N.A*G= [-NNJ5\7;04%H:K/\K\JW)
M\8E.U($0D>5'R62'U.2PD6RN!QOPYX35]1N[RX>BV0,3 'K(5@07U<KJ.M?N
M"AMGDA8TV3L_-#M2B&@R,L[[UK>(IO'03PN#;B>;N9$%@+5NJ+^*MS&"*TM2
M5!/)R<HU_VZ2]W1G23#7I[IW%I:!-GHD6P-WNQM*0J.Y/Q\;$ZNS2IJ-WET+
M>Z44MHBOES[.]228;]RXZ!^5;WW-DE72O15F>?0">HUGDFX*EP(,RZG:FOYL
MUDV^V[Z_NJD75 IO^:JR#_V;=DEKP2=4[\AK/[AI\^"<QLFZG<X4NHWZTF7U
M83'-IU9[@J2&WWY:6-H6OO993\-@ ]N[R?PW'Y!-$R:!&7??,^\6?]R\[ITO
M-5ZO0W'G5RPX_- HQ7W/=]VRD6/H2H XF'NM2A?^M4'J1''EP9&N>^I"@X:R
M:(?EBX3C<>HX9=K5?HC_%. S;!+QD$/C8^)"G:$2="GB<M_7H:L+M7HS 0D+
MX ><JRO%UREZZ[+.6XN(WF3=Q(X%WA&Q>W^E3$0LC6KJOZ"%H828F5)@!W(G
M?Z.>O>Q:O!Z^S-W1JN-@T("47/WE"!'3XT9Q^X6?<'$)WBHV@5]OAHJRJGDJ
MZ":X_ "PY#QWU4C#U@Z+ST8A%G:3LJ1N#JT>;H1\91'$S2D+5LB^DV@3Z+S@
M]8"4F\A1$3+*"5U)"RHGCC\J)X/Y?#1 YIL&6IM@$.QAY9&]_M_%0-WSJ<%E
M(K/'R=?WBJ!6%4?&8M75K8-):^FSN'<!=[^#U/B!7I[R?FE2L-<#=@Q=;Q^/
M].S)GNB6 <Z<F9F<9J7*@:D9KO?%V]]6&&W?QR#TC,K9N<'4&QWEP<IQZZB>
MW3(6^7=9"/(_/TDMH=ZX#5XSKA>F:BH ,?DQ=[APU7%1OP=CI*F6LT+L&C"%
MQ54;YWR8=H0]C[P*B%3, -.I&BI.N?7LG3]DX?,K.$:RY/K30JO-DNH\ESX;
M9+O1Y'&[2HJ=3Y)Y734NP'S.M.\SE=;=O=2/NZO&Q7*F$ZDK/+"W4S 4XYE(
M.@5$IJ="%\52<0,P_I().)>&N_7E5GKZW#0O?K,[,B]FPD.J8U_Z#9L2IO8U
M)J>O)#B$PY^:*HM+G+2?D8^<$:4+!VLGS+)<BI([P@WMZ:J4!7C#=/KVMD\!
M=3;K1W*]=C[B'Q"DM-"(4P#C/O>Z6<U)3_F"UMWV_"(GF(;.">-:(D[.FAY]
MA-M2:0\K54E!'6ZX\$VH7N9N!O-2?7[*GGBK>1)&Y_.JR"<YT!IC6Y4ZFU;2
M2,^G1WN+.;Y? NV'NDX!./!S*C^I82(C)*C7'Q,AHMNI1%<^))H5_A+W9'QH
M4( 5LG.@S"'U[ IRIT"$-*X;H(<OGW?DZ#@X:CN$'9:Y7GD@T^KC-D/ HC'?
M^\#:AZ]!I&?CZ*FTG-=+?L"<NOX+HA!?+[$TX+4IAH$T;;RQW1W0UB8"%!.:
MXC%5'\[B#G=(^>@_?M!-; V]+<GQ'H/ZR7]CK8WB^FG50&>[QS^1-/WB>6GH
MQS4AXG2PE'^"H<[AR-@I@ ZG%MU[+[4I3CS_PXT8B<\ 8RZA:F?A4<;Q'+R=
MU$<U4[)#C9KCXGBU @?&8QZ.B!=2Q$<+=9>ER-QK,+SLMW,*0)@UL>9<&$E8
M5OC4&0!06HVW3(D:/62?J1J-NKJ_?F'A3T#<]F)S_!\.];K]IS''G %QM3KW
MH5;&;RMZ@%7Q&9%@5%E)8M4"/#,M![9)'@;O.-=_K3L%])P"U-UR8&1R3X5E
MSXZ,Y ";JL?L']U[LC^?GKDW(PFL'A'/& A^##'T]6M463<; %^243/YXE@U
M4U4'1.;7JKP1(0+KXP@RS<>QX7M%X.9M_\S[C>O6KT<GUK*/S Q:^F@HC6Y[
M(8X]L" B5H27P%HR5?^+TBJ.^_KF:*0]0'#(9/<RZZ;5M@+ZC6?JY2K9M70.
MLV)5F&-)HQ*FO9:>MM+^KF.=ZV,/9B0OCH%CC#C-B#6U2./)AXF4F SQ/CH1
M'*1\FZYWUZ>>]1O?DN&;5\,^M(7-*&]1GB5)4^!_F$O)@H[62B=Q4:24DE>W
MCS)QRO>IXQ^0D-6EM[O*C)3.?)4)/M8-:%\MNZOH[OT^Q1$X.9J0U!GY&'7F
MUI>LKEEK2;7+=!+6++DM81+X6P]M7PI-[0B@II@!Q-K;,Y'YI:HW+YWAV+R7
M2V3F.<OP?2*=7M<2$M\"?8N1TJVHMF<:D-T7QS*95L3:P?:1\^RLYY30XLH,
ME &G\NHOV7YX&$.#PQ /UZY<&_K+_M8L@:!R8:UO+UN#<S5AG1-L?W1^82:M
MN8%T]8";^"%M/51EJAA;%---FE:9+(XZX2]?M]7;+UAY Y3"4<0$CIZ##<#V
M/M[//*-.UF%>)--;(^(GS'OPKX5]>YJS%*CV!U;CR8/NO>!* :C[C@R).U04
M!70)/C(YI#G2 *7]G'0?'?DUWA/EXOM3!7DXH@3L67[CAVS6M'>ZB=@-V1!U
MZ;?C12S4WUQZ]L&GWF9HG41AFE073\NQLLN0C*Y:P$/-@KPW('.*:@[N!:X=
M#V0V@:3.KL7NV64+N9.+EE9G63[25$]R"39_N?G H9*NM"''KZ+Y%'#UQ>O[
M< 'F8=!2^4#'.9.BU68%1?;8?";UNW,6D9V9^%Z-LR20=B?!I?L8NEIGV&H[
M:$E#@<XA(P3"JI3+5MX\='6 <9ZQG^VS6XR%+YQ7F3R)VW)KQ)T"0K/A!F K
M7SA9#[D/SV':H]V =9(%WD]WT&,U_G(J<<T_VC2":1]XT:I,H0,XTW:^'!)V
M98X>X&UH<%MV2!I\78-JXO!O>@AYFD9TB5CL-&#'[4 5*GC ,3#;P)Z879JD
M'$<*#L>:X(([3@2/!F??K?],6@;3^C3_>S>NA_'D5'P[ALJ,.Z_Y5FBU^+HE
M/"N/>2NX4>*HH^'JX7[3BG)7LFGL'G_N E6V04S[_6B;G\F$%[OS[TQ<2>^
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M@@]#SQ0_I!HGG/BE]::< JZ9@@]6H.W4*G^@6(*(RKKY/OTN(\/H68E- <7
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MV_J4M40K:I%*Q/^1DTT18^ T327OW$GQO!)O>P'[S:O'J^0U-Q+F;TSH"H5
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M<*OC@WP*U7^H0O$GA&<%-!3-)BDFA3D>_(A6](JP_N<AQ\O1H:.)T:VP#IS
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MD?73XQWQ+6LO@F8TS;?FS4<G.,S<NM]8@R9+S9E*[]]NJWQ"*IIC1\RH7VY
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M;YN_?)(<E3W/QYDE4SJK::$"CU_I=A!I/!)#]<EW0<HB;FUG!;^]Q[BP72-
MRNH5U3!7\6+LXA7,'YA[V!U@9_>E:F.I6<VPE7XA*4P@3?)"/F[M5F^.P?T
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M 4#8@CW07JR !IC%EU_ )G(\'XL3(VK>@+F(&@X:.:G_A#B9O27\!*C@=$.
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MV#[[.J>B SOL>]?.DJ:'O5MWAD7_!Y92941KX6FN)WN5>!M,\YRV,.,KN=3
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M0Q1=E/@NWHK9=+(OLDF/XG*8N<;F0H),248H->S>X>?+]OK^A^J"=X.8L^-
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M2^F\ 1N.9O=-)A$ET7-3XFP_30/T#5[ [,I7Q"JW8//<RVZ)E%;SG>]"*TM
M^1 O*(;2&BH)[3S$?@$^$9,YD+?R9;J2)1=:WG%$N8N.4K'XN56W!Z-VP14S
MTEMVX=EU,2\%PR$>+NZBEE1 L]OX;TYQL$E-QI8"UM#U;X0Q.R5!G1JDWP1E
M6]F\G?=L*HK]D"[ZV[H!4K"W]!B818CB)?Z4?Q8%RJV3 ;' E[=X?KSR]AU(
M<GPJ%Y+!/%J[@F_O3I@;:LH\-B57(O%1/,1JJ4LGEH\DCXMV/6)46=I>I==I
M'4+PO"R?KAC%W;6[#[&&S@&]M+A-F2S*<+;1S4 M]LOG#5YT;VNAFM^ZT>(B
M>K:OS.7!&HP[3W_E?;Q.9X6)UTMRH7/+7M::&GG33]NN_&,T\\E5V=SP5!>*
M:3;_4$W]H=H6V=DFRU<_GN[<(LJ"J"K_4+G9Y_D9 SZ4 ]<B^A:B$T0C W\(
MC*AF&W2I72 .N*DZ*.S5(#>5E9A[]4QAL5L_[EQ[RJX<NZ%X;25>NLX=)9$,
M*;*V#PLFC<"Z4PF:GT!9SVLX,>"G/GY_J%BQF96V'PH]^-M])]I9VR8*'0<H
MB??).<#0.UTRUZ*8&])C)1[#;O(Z+]RZW-E^C:SL+9$IL< [OJDHD]@0IZT(
MCBN/G\/1PJ@A/8TIH>SZLO3 1):!1K1<@-E&CPKTN>+K%K8G/\=LX>E)S:\J
M$<DT?A:] /UKM7OE%6.Y;%(60M_"+2]95HUS!Q4R?,3BY'*-7'NDWR4%">CI
MDBT5*GB[B*=OSY=M?(%II2&IY/Q0KOZ 09T>T$L_]8&W!I,(6'^F8:[RF,"Z
M;A[7'?*XOSRI(GBYIIL0=]^M3(Y=*@3% ST7-XW1Z),1P$AY4\G0V2;@( X
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M<8->]&KY"XY*Y30S'V'#7I0W@T+,I6P"K!J_Y Z7?*QH77Y55H"5$:W<M1
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MS7FYR!6CBKKC3J_,\%+#[T8=B!VC3,2Y$'3@_QM$R:=;,R.O[B#U%]&\M,&
M>&*:7_"BVKM4LYCP*S[N_?^&\/*U+G>P(O/YSCIK[K+W>.KM*WLW/"C1QA],
MWJ8.Q^=Z/;OF;IJ1?&C7A-->SDWJ#<)[\Q._C-[">O6TU;OBMZ=W'=W4B\^;
M/'OV/@8@BZU/2X\9F$T2ODYOT- 0?D-DD>[L"4%!+3\C+)=%ORNS,M&W#<9!
MZDA:G0/0&E]]V?;A!)#AM?44(R(&?V[QNY%K& 2,&M5701-%T%#+-)83OY#%
MC^D(V6:J3RI;-''GZ^W%N&OH_A=D3]OC^!#18+[PF<4J&<[R)4Q?DJNM5[G5
MP@<3T:XO,Q1\WXW/A]E_":NSV;@T?;W8H!0OOS%6$=WV?KS?\-D_PWG;EDH5
M.."Y.WA77O-*]CFO9VQXU5QLW'PP/=I>,+4]5?=$:N+^!X*1%Y].65S$_#HG
MX< TF?@WN8S& 0?U?LX;&;Z'FW?R8?+/8Q^N)9Z]Z+SR,XKMNGWKD&W6 =[+
MD8Z777]V(8P45?03YS [?ACF_E**.T%)L]"8WE_;$4;JE4*?#5=X+XW9UF3:
MC[,YADNI4(AB  F_(8":Q@\Q/-<#L[I:@30@7TK)[@.T,VR^ED7*OF5'K%TW
M!"71Q94R24G%X0POPET2!WZ/>[)Q_&ZDRF>_8[_LQTE.V5U%H^1!I%1,E4(4
MC;<G@^L\@8IP>0\/DZZ%U/R08GIX"Q7LG(][&"C! G>)S@UV2S?L&W1(C#]U
MZ[Z[M^MLN/L2C:MQ"CB^I\^$@<\X/^>*R[M,3$@J) $;D \513R)>@T"N>0"
MS9HHC)3-;K-RWXPFMGO 5,[PH?II90UEU.@3O=>-2M]ZRZ[7Q6?=O&H74Y#!
M.=W4,QU&&/2K:EENK*MP^EWC(OC!&O^C,&ZF=CP5,VGS8?97UW\9PL4ME0_G
M'G[9U-_ RN-*%/*&YSM5_P*016NU!9<]%TI'IO5Z*[GM71[ (8ZIIT,DEVD8
M?;;#1BT?*DJ=S1':O@V<M_TE))4$_Z+=@0:?=2"-I%N&[#)M%#4OS>6G^8+;
M[(F5DT$=\(9/'1*Z/7HA]C*W$K"V$9AG_OR=*?FUNK*D$(5O8D?,L"T?,0XY
M;)1&]R_=[A%V]V7\'-)!U>Y197>+]CLEX.X'N,)!A"))AZ<+&9_8ZS6,>35:
M8^VP^HG$TI HA?P9)SG::'UYX^J0>O4[+FDT1Z/^^[3SQ7_JM/XI Y^CZ!UU
MO"]L._&Q1,P-2&X$)BF[<!_H\S30_D,3JFA^)RAQ3Y/BQD>>;9]F'O$B(F7<
M6ZC"Z!%>O:,-#\=H:LS6")&ZA'O\2#,!&M.47AG\&6K[?3$5RVY_)5Z/'Q!]
MUH Y2,#:^5WD":%^)_$"7T\M@-(+"<3A=0":\RZ<.P(KRK"#@M8<LLXQQ=4Q
M"]<@CNC-B32.5$6X9195,\E PCQ'KG[@ 4K#L0AA@)W*THSKSL&LD.MAME7D
M^FP[)>+(4YZ&#%8H#6 .;7%=I@YR&9J0DJY4D(V^YGVV-6,5LUE 9C>1,X_>
MY?JD-0.10%86VV#[;(XBQPUSKXBHB>,VC5=FA<./>^!)046WG0PQH6O]L4JC
MN$P^6L3 .9X_+L"@CO$=M%&*8= G33)!P* P+.M-G6,KZ]N00>H@YBP[^'F>
MW=AL>69ZK6T+L[X.%BO%\#OJN6J57&//^<VU YIE$/--8AB$A=2A.Q8F\R@Y
M>>$TV;DR-U/HBPB&GA>&JL+WG%'U="<1J1:%=_!N\-]$+ SG:.>95EJIXW+!
M/8]FRU&$R9I0,0RC<'105.!$7V;(P;EP\F?:W9F:XK8K$;C#^JHM%9ZB JXI
MY1=XC2GOS55F_'E.H$G,N7R$)Q; )/I:Z^YI_3*7].PEC],1.W%S&MQI:M"$
MUR\LLTNO<)&6]9C4 F-(KKC5''5UY&HV'JUDS6E?WF5W?L%7!6V-"6FX.P-$
M(?V#G\& AYDGHOM]#5K-XC<I G\-?S^NV:GIT4=%-@X9O3F\.86J4NT^;II/
MS=).[-=SP,+W'UAG1.]9Z)K<W8^V5%<,3/,4^W^.L>;(N;@>@,(NN_BXZ--]
M(V\F#AO(OV3?@"U_FC+Q3X66W(W=.#E\]>U=08WVQ[8S](VRI_KO[)_O.=35
M?JSO(" D*K/FGP/0J=JX)8<$[-P.*YZZ),MCV'\\;/J]9D[8F;HZX>T?!V,&
M/WK]_!WX@!!K3)M<[@-^M3#:N#Z3HHS_K=VS957NA#>\ *]]S&+,1]KC5,CQ
M-37E@4TZ2TUBMWT)05>7X6(FM4W.PMN'^VN)N9N[[I7<,=[?!XM_.VV^\.#6
M%V,;'+9AK0Z"F!COLY+E7@%K']S)W#)88Q^N#= @5 F9OR&Y5ZXRL(X,;04?
M+./:56;68\>\LU1_@ZZF#CBDE0MG>\'E81:5<JZ37JF@2F(!VS@4)[]+ +=S
MQI()B1(GN'IL%^&HXI)!0QW7<G#10YFX+YTLB?:G:R37/D([YP5??)XO_;+Y
M[GCCQW0&?Q>Q5OO )/^QKS9DZAT[TO#-^M2CI=#6%72-?=^)B- V4D_GB&V1
M26WG?PV#Q>';5;4]&^_&XU]$RF"Y.1!]7*G*RO%\0UU/TK"0\_C4,>#SMYXJ
M1A/;M.N=BCPS_']8Y&]<G_[0J'=NO>[J<+LE^0[$.$BM4W;Y':G,M<0J[OS/
ML:'3NSN/'"_U))S&S>8>VQVK5:TU_OR'#]X*82T>=9L7_2/53 D?%. ZTG'3
M;D7#8W3>6"++501%"ROQG .CS<Z]5$AC4,:];OO8JID8=H!@R512^C/')]@>
MH.-S+LWLP(6W X5;VH.7E'PLWJ=;\N/K$OJ8#SV"GH]6SG7L1M8+)3>>LEG7
MIMK'NG_V3<J&-#<(L99Z(9\5JXY6?'J#NO15.L2&[!1CC'DV/>GEJ+EB./YN
MO.CC:'W3=YHYU^Z^(08RV3HT-,VU.)T[Y#\<!00:#9/J#N0=*^)YCH 6K.L<
MC<,8ZCRUGF]SM)./RE&WI//=O="D$F]2IHW3C+ 1!T\="'<W1*=R973L*_P=
M5 +976W,!R$>BV-4@Y31 \(K5D]9]Q&9Z!T#^:#;_:;LG?N@HKO0=?'R.]/4
M@XA@F9M$O TIK@M<@X'T(3>OSJ27Z7D&CHL+:8:D"][(63%[\/.N\D"U*@+"
MXL+NW-OHCT#CH@=H)$9AS[*H(FSJ45XGL44&-)LED'!Z7LF*L N\>#U/T=W[
M+OS_#S%'_['#I+"E?%M3;$H^-6RMVU(>K\B<$!01VH+%NLG*!#&>"@.@Q=@.
MW!]&>#\D6<P@<.;/ZRBZ6TK]=QVA4H@ /#I2'65$MH0QE8A%S+8?%+$R<CZ9
MJT8"6(*["D(UM<3>!Y8@7H!K7M$DQHO=H;G'\PX[V<%P)?\]P^7]/W9KS92!
MVQ.,406S- E7Q2XBDKM7!Z!?6C3KMKX33[;TQ#*PK#/8/0)+N+"+\!<02QYT
MEIP@O**A\IB6T@+P#"/W"4(XL@:S[:-:*BS1BQ@+S@'EVS9SU[(KWKBXDP"-
M=>2;.&8=Z5K)5TN%1T)G3F<@@4H7:R,8#;>66-Z%"-J0.CH2ZE'T)M1'>K!X
M)#'^@WLOYS<'D#H)-G83[372DM>U,U2K,$39<F3KLYPP<>-7G. R:A5Y$/@;
M:$T[^MZ++,*^&<8,[GZ FYS!<%OD08<UAGHRQ8^)GM>W9NL =$UHCP0\R<"$
M_2R^14ZH;K 8!QF82@+@P. G@0D*)8D.C;>$ $[O5_N?B-?EDGQUF$D$(J!\
MQX\/S%-//]EC*?X5'J6$Q$^E&LLWO]\W[G\P9AJRW"+Y--7\M_:;:4ZZS3-&
M?+=T^JV2)Q^N'MK!\V/]>GA:^DO-M--5@"SJ(SJ#ZD$P!XL%!DUB2(*\!L=)
M+3^\T8BTCQ"R:GGD*2%J)%VKW(^Y8B.-F;-!BFO2?E0_&@FM )0')N/<])V<
M;3TK2[N*K/<C$^W'W9VE,-0W#FTDX^LC &V'QCQR%BY!\0S9I[E:VZTW =+O
MGKB*'M$Q##V5L)2G4L\()^-MFH<DM^N04_+9,=%T_TVB94TTU4O?.:]5*'=4
MBBQCW''J!5/["$-1(!]KRKQI2*HX2'PR9Z4QPS!T!JJQH48Z<DZITO:4(\:@
M6*YM;Q;NEA,:311V!ARY-SA:Q!'\"$R5OA!>2<*!95/9$+:)("\8>(?"UX[C
MRO23).&XA-=,OLZQDJ^8H8!VD@&DNL35BVGO.>GDQ@JDX/#[V/NI%+Z:9Q7;
MG*@C'"T.%=>1/L.\2?A1??P77:N(44W5W!I9ITF&.G*HA*>$G>+LD^FYW >%
M_>\OD/I7I,J;DY(-><%5H91L?8,L'"JO2.>@^E2HY&;JFQ!R(N)!LYD'-_K^
M&3F5 U%UZBM2]4U%#T^--3@&0:<(KR=3\+TA*CU8M>!7B?8Y^I.WSQ88=87<
M[.HP.?7@4<H4F59ZH2A='\NY_NY( O^JA:8@2LFD5I6JATA_,$)/]5K *57-
M2LVV:9O^.#S;7M!MW),WVW',J7D2M.K="#)Z_0B2]NP9[(IA"U'FSH*#A#[-
ME]B@X]WBO1<]WNKWW,O7CIG-]LUF.7*ISP_.&/(@'0HZMKT)=@G"#F)K/Y*%
MGL W#C?FDP!I^563I*QQ%GR2V'_, >)ZDLX"Y80SYMTO4*?*">9S!@B5"+1X
M3'+!"VBG XT3F)ED0";D0'N]D4B;AW\X:SA;7 FR> ^3D\K5U$<0X0&!+Z%%
M?;B\_,H+V,.3SG@GAU2RLY@'#&)'5G=LD8TL?)8/PC9]9ZWP7/5^H>1SAP1F
MC[3=V3SKY16T6ND$,IFA^D^H;7.N0VUGWJ+B)%T?" A*^0E[FG"IY)BOB#>6
M._;!U*C2'1",8J]QP+$"5&B5Q&CFO5P_"LJ!@PPKEPID?H.9DRN)QT^EO82N
MXRS;A4R.I[44K0FH.4ZRL=S9FG.MP_9Y,!;J[2]2JP,JAJ(8Y3:@DTE5+!WW
MAY5/K!I+E6ZO4[=EV>0*Z2(Y.*<'0;:_B(IP>[:NKF& &G$AYCCPU?B6ANXJ
ML&/ !P5 @XGK(@4<!&PDU#9WK"/;J#:2!U$G3"B1-*G [>2D7-%+7?+0Z$79
MUXK"LS&L;S:8(G#%1)R9'^="6%[9_H^8SZ>0]4?+.MSZ476.R7;EP<QU'Z:
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M[XDV'*_^U]!C]7 >+$:EB(.<R?]6ND#,3LZ!?'($T%^-LOXI^"X0 U]#(MT
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M[>)TXHO!M_Z*./;GPI]!D8I1 [65[IV0Z.+NC:($"5FT3<:>I#LES+4AZ@#
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M'0!>XJ*;W!U^MJQQN__UF^./.P"LG;7^2U[<$Y3X=7=_^=S5V/]%L7P3UMO
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M4.1)"S3]]!PB68K+0$GQB(JX+KYCU2DTA!2WG>#)9[WV+P/"@;/V2?+M:MW
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M+\XA-?-0EI=%2&<UU2&F?^K+1^^S[-.Q0:R;0<8HII)"AY7\I*OP$7J#!Y#
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MR*?2($EEI$.2)*BM-PJ>>+8\"R65*&/%TK*1)G 9I U/ ^E<XL2<:TR#+ .
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M^]/-K\J^,9M*=I6U3852&R;')E=50SV.)]_0??L2L?F$=PA=UN6G(/(.266
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M8Y*HJ;9_5TR%\1H.7: D+LOF')7DV>+F1"5\<.Z'41VC82L=8A;.=HRD>K/
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MD0%ZIC=PB/HV.#STMH-G0 4'7O-E8"XJ]NWH:ON(MO'FI^&9'-9RJYS/^EG
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MM$*EB%PVW52/(N'N/^Z'%N"N2E:J99FZ9L$)3DYD<G;F<2>HEDV:,P:5R%
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M?ZV]8. -.T0W]R5WD>)'1-(B\2W[^N23AS:CSH%L:9 ^0X6[Q3F.Y$_\A5>
MQ4HATLNSL-K\*B"X=09-5*>7Q#=M6JC?G50X,I]S;3YK,E'9C7(;1P8HY'F)
M'8KOS7*TB1T3M\^=",3X*&H\@&M,DFNW*4@'FR/80J][4+U09_D<3.UB*$2G
M3B!#[(!80K;O.(-<@NG XYNQ$T'R K0&HALZU;HA"5?8OXA(^F.=/I\_*T:!
M"<7G@<.AW>CDZV[ SQ0*P\C:FO_DMRY#*0H]=VN>B$SMA?"0Y-%T>F*0\&@)
MJ_N&J? -ISI6D=BX0J'(K\K@+AVL#%)*9)[RE:VG8>%3RF=G>$I_7>8BJ/0>
MA^ JPK&68O5P.7;VU<6_J)HBA[I\DY:L"FA<@:2H7U-91B^06^MA_:Y1WB3>
M'GYTSM?-A$O!:B%G8B%'!M@-/\GC'VF/DZPH/+ ^]1ZT&BNRO*2)+'[%9E;,
M3+P\2PV>7\AL3@3V BQ. 4)?D(I431\W>F?A\3F8)%P.KR$ND7T2Q#6<[ :O
MW,Z[;J=^WA.5N*U$&3JO_UZ6>DG*/*=HJ?S+1^II5OQB)M/JVYUE!WJL5)^+
M.B2&>+\:&;/Q_2+I7#(!3NQT1:F)!^+T;*A-8R<P>!:GV\Y:N!T]#V]G"PM5
MU8[]9->'8)+& (KJ?^O4T^HXCJT19JIO&6X5O=31,DJ5CC/&"GT52FNT!]8^
M9WH^$L;4N;E_K1PMS_\4%,C7K<;H],;G2!8$&1OJ.#1Y,MPCA;F0EAINEDQ_
M\-DVCQ2*:1/M6G-%!JX(GN7MC6/[],_B1G \WNT?QO+5"OHK5U^5_G$29?V*
M2Q.Q+KF4Z-,? AN("_"V"H<I/9HD]>9.+)#G,C$^FL"+T#--=<Y/(R#"ED5P
MW3$9MJ!EEEDO+E.D@79)U/?3>WYGCH?)XXTS;SNU0$NB7%>J@FQ8ME4Z5Y\9
M//PZQ,LZY\MH4A(*OV[R,()(+SILH![BOO9Q9D"\R?W?^;&;;^=P:Z';WK13
MZK*#4HW C<:D>,=L,XJ'K+H/[![(];ATG?J79_Q;C+(BP-.VCC<[7Z,RJUUE
MU=>%@B4_XX<B ;E9"UXG6GGK4B0L=UR&GBJM[2[5-XBE2>WF=$H%1OU<33J*
M67-X+,NOL:B=L4'J<&E/&_W0<W^IT>YTHDYU=_=V9'I T;A^C/Y*\H5N8>=&
M=IH&G1$$D7W_HV(8>^'-^9OXJ4]JOV@!=V!<<J"8QQPNV"ZKBW,%OLO^9"E/
MOK"N%%/7W2W*&/)]X&A]4:I-N#MNH@!YH+S.QT-EC&Z*Z*:'>UW"OF*_N>8S
MUC$K[[K\?SC[SJBFNF[=4%4$%4TH052J$ 0%$A %I1-B0DD# J)T$@2E%U&Q
M@!()O09$2D@E()  @M@# D8A!92F@J" !>Q@>2]^W_GN/6.</V?<'VO_V#L9
M8^^U]YK/,^>:<SZU93 BH<WT]4OPS>W73'*O^1B$)SW)B8Z;YB,:275\)(5@
M$)])XYFY2@U\7%D7O1[W_64/:[PP4I:,:PARDN&!/:<92HZ[\G%)A&Y=:3(A
MC(Y-9/J1Q@V<A\6:J!$V2IMXX"N[M0&M603U9U,>POCZ.(^4,QQXR_;)Q[["
MD&/^']>1%\QJGJ0T5EX]1YJ_NLUM ROR3]!N4':IF/YHOR --'EC+*7)TT=\
MI&67#S(4V7[0$Y#R_#V=<F0UN9EQ:^/THX]!.987!>G6$?K4])<7<\#?-E^N
M/F#UR96[>Q&1(!E^&M6V:$H8.[@8;+].]U9$[Y1V6 2D9/Z0ZK)^6D.7[/-'
MW+U;4LX>7 P_7K/LHM2\63]>2J,>\BU4XW7::,QU:>]&>Y^GWIDYN8E?E8N+
M#=!7]XR.DYFA_O8T[F4/N[?-MF!A=A?=.S?S+A[-JMR-^'Q8><&A)$[Z8KY,
MIOWE:$_@>'W6]<XGO9(/WNC!3;/LKO0*;P);SO247AOUC5WJR?[&RO+8HV'2
M]G?+OAVEM CR\-;':DCT.9 _=6L/N]YX$AO>7\\JK<U,Y41>@US9SA5QG:5'
MT0P*2<4[SHIU&=%TC>TU]44Y-4""O'"MB_K4?DO_)PG*<,RPD-6_NP=PU#\O
MK23&<JK5^?(((Q?1=&$ARLT,SBF@]I]? 3$V1H N4:8'@=XN#LWF"PG>+K':
M?]M9_'^,8L 8$BT:D@.73RZXTO?5.*E=0_WDY7Q9[QI#E,-HS)60$(;>@B/M
M=:XLI@S/8OBB!UV!"/SL52X,"%M$/3,^+\N%UUUOI_ R3LU[/*(/8V4/)C(U
MJ"4+5H1\,+B:BQSWP$UGR;51S0O@QHMH^1.WI3N>D(06&7JX&G+J?F;%JAC
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MI;FJ[#/>2/)LO8X8\8\5V+P7Z&A03I(C2EVBW->#</7 NTP.F@F<"\!$AIV
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M>[;X@()7',;MCD5!\---X":=8%J4T)^2PL0E28:IXS6-2 ZF#AOI@FPT4;3
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M50=HQCYC;+PH'V9#O!*@Y#12+-:H&C+7XAK8$"-EBC'+[CPO.6+>D(31X&(
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M>F/!T=+%\)5]5OE;5=$'8/B%KT#3 Q6>-1E_FW?C2RNI*(DRP;@ATSI1KL4
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MH-25XDPR1WF>N_=P KGZAXVG;TY&H;:9Q!Z%&;OR8+#ZW6JI696L(XS)37#
M*/_'NEZM6_R(WU']B4>WW)_-J'<>V8GJ].[6@*V,1)<NC+D-!RVK#:U^F$KA
M']FWWP8T>UWUEFS'TL#@CC@[R#FYE*=/X%)JSWXG-6[$HR<NZ;W@8YAKSQ?=
M(4.'#Q_:E2+S+J+@4LJ]+\U[NRB-$[73M]__J'VIT$EVQ?XV>?U1*\7LB#]C
M9;WFE^;AI73'>L_2-T+IX$I#/%D4;+U-Z>OFC?XK.BJG5JVN?R.>#3KZH>A
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MHU%J>-Z>D<(Q-.SV.D1ASKOM(A,P7Q^VN4QHDL%!0T2Z6#8O0!['D@O.X.5
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MZS+NG%B3K<FJ9,V5WZ>M,TE@?& FHS_4K/M $T+!IPBM651*&=?OTSQ7V\'
M-9"XT -QS:7P[CH(S!:LAO#EO6W5D?B&3_V,/>$93C-:[$0$?(:CQ,MRQ(S5
M%9 &8W$TTKK@;C0'XP]]33AN1Y2PB[LCY75S).5W@8(9Z*]E>(7JX'=2CC0M
M,(LI1+K@62&P;9@9H=Q$=5U!"QJ+,:89NLW%8YRE7K.D2,)Y\*D.1&L/I-A4
MQ#7!YE1TX5(A9R:P%DHAN^H3E8V-.C=V99*.\BI)&06$*I$R]BC$D+3':T6?
M_F'2J\V+^]%A3V5,Y*>V(YHL:1I:MFM<''H5= 9?6W$6@PS'WC%U;A;Z=A*X
MO[#*=V)^D469G8V<LU+6NOTU+I0)I1!ER?F4ORJHFL0>%;A4RTMG0/+[J^*,
MA_S0P:TG^QG-,#"Y(%)5EVL7\HW.26"!.AFQ!;?2<:EZ'*YW:WC)?8&<MDT(
MQQ7BN1>H0'[,U_9= \)8Y!Y#XR2QTVG)5;CB>_HT3;<R9TC7ZJ/ R< WB,PU
MD"^AV9$487M*5(%#YG(O)4M/'-COZ!E*5 V]0*W<*BFM$T0N!'',D:03I*B3
MD\@PIEX9;+\-'2Z\)2'SHAF;C#06R$X"]ZZZL\1"?&'= HFH5C\N/!("3*#S
M;;W;"R7X7>/NK8SG(\5[^>;/+@XR+@'GIO/Y^X"F9F,D_GYK1.%EB(2L8HY"
M\(;WI 2(+V%;OK&&<,^2]7S/,"-)CPBAUXP5R)X[UO"A$2'UJZ1FH2YD2)24
M_@!W.4DI\G/E"H>826N0KY8'.\&U'OQ6@P*)7NC'XNLZOK%"<G#%7@J[6K8^
M(">-%5QA5MPFV9ML@MSJ6>@C7< M.A[')M'P#%Z$J"0$9F]S&M-E>FC_*K;Z
M&%!&P= 2;3%=";\&?YQ0C?(=1T.4ZAZIF958-"#T:$'DJ^<)@25^[(="7'8_
MV]'P$N[M$P4TN=$D*%*[__MGM)L!FFB\W&\?<$LHP)72? ;$?O'V0'V,T/XY
M=UUN;63D1LU6<./KD9PAJ8UN#7Z7"EYG-TR]3.BIE- 0UQAXD>_O+<!>SEG[
MMM??L)"8[H0%L2@N64ZS0W@:C73<A]2L*\V&*"[:-SJUTK*) S=9]0A%U&90
MG"5N"W9 JE\:2\V%?QZ[IC5W?>3"P%8GK_)E@H6KBOVRJ-.W2::6<F1V>':N
MG(P)9\/I_!U*F>^?-NPS,HM'-V:2SK7]Q)[< &S2<7XHFDDT#['AY#^H\CZU
M*_?OE+ZZK,U.><FR[>'I#KW]P?C&9-UC%3\/G$_&PQX?-N?>Y%C,? 0[6N38
M2EK&7^="G"A26PVAMW[IMYOO\8=Z[2""UER(>)= 02-N;(;OK'./ZY^Y7>JH
M&+DE7T!0-<!?WH[[<;=&\<9=MG5TSDCEWD'L7CU]L&)0 ,(!)A^O/4DZW9D[
M@RU!\.4M@T>0TSR]U_@P<A'Y6>[APDOR%C!LOO3F*,C5M4;1G&Z-2,8XN<'W
M[ ,G+1#11H+U!7W4\_5SC6R1A5A6/K>QUTJ<AFESWQS[)]R8[ID69$BU1&Z0
M"Z?GUKJP9@B*ODXBVESEU@A04)!A_J.-&$VVV)^:62?0\;W$A_1_1.4'U^UQ
M,7_&:T5_$.)=YQK[A#JJ/6YML+#ZZ0)T/EFH2;^RPD$62_.HG!R=W"8W;2N-
M%<ZR0*"L)-2V+($EP=FTJV@ME<\H5U%X5B#OO(J:S*&E&N,YNN_\E \?0&Y4
M<5[$O\ZM"9NKJ-TT4* 'Q%Q4"C^1ZHUZ[E:!WBU$3"L$!#/RR"#CG\2)T"M$
MN!"*Z?:.?48IS$_GZT![@1EI/>[=,"4)F:APKY33KTV@6XA5D2Y"%'B:]FF%
MI7:@\+*;$^Q@M*ND/S(DD0YBH#'(:K05^Y,9Z0$6Y7-JUJA?G8\O! ^'L3^9
M1I;?/!$![V2_)VQUPXWM).E_N!S'1(J@@=*3_=]J!.\#%@Y4??*QK#X$R91V
M'D_A5NBQ"_L"*39^O@,C^[GQJ,U:05%/OIJH9P7;]\'>=8Q,N^B!'D6!S69#
MR+,/O7'!3ZY(9L.M,Q,9+14R)^(#O[[\J$;+KRM[?PQVU/6;9:P@\>RV9;T'
MNK)?5Y).9E3%3)_9 >8/?SG+.JG6'.,J%^J3F>[Z(ZTU-;<E[5NSSU+3K3)S
M9OA34'TS<9B$?Y^Q&?0I@82HNNDW;V+YRE,U<F_#Q"%U#9@3JCLL7S;JQ6V=
M%.6.\L6=\X&:C9$B8GS'8&[46^(]K(]U;J4V+//E,QMNY>G&&>IGCBF6HV#8
M);1:@M=3/YM[S3Z3XJ*<FOB=\\(H?Y28.F<:\9U[U6_5ITACX:1Z?&U68$F<
ML0EX0\_"%XL1BGJ(.X'NRC8V\,U%;-CK.H&]QVZ,QL0P.V^ZWZNK4_&81%9N
MKBM*-*+MJM=<HY$H7B51XB5_@O<8^X/YG#BQWA>[AQ]46A?&OAGFMY7CKGTL
MC$G+X^KK02+3I!NOGB.-%QYH@/IQD)T?XD?5IJ05\=$=MCY';.VB( L[;OD$
M@%OBI-M+&T[>A MBTZJ+"8YW?>H#_=_P0Z9\*;3I,DM/IZ?%VD\P+K?.F+U*
M[54Y_>+!.>WWYO7N@7*<<1XZS(68XN-?V/LJ[J'R:(-[[Q%,Y+LSKVI)!:12
M3N$FE^"4P0?9L7(WD,N!IY=F>@?ZM_*N<T]O]_%>**T)W4Y^U9PRL&S#=H&O
M) NZH*7Q+;@^6$GME*VUTH8^V(<IJZ7(3I]$Q/*9$+<SD%>Y$\='QT-__ -(
M='5[.GWJ:;SHUT'V9M.SI/<)DT>2]D7=_9*GJA&ZWO^VB=C6FI,ZP$@\\_#,
M;$(*^M;1/&Q;YU0]E?<CK.DTJEO!#=8-/)^/;D.^8["-)]U&V@R/TD:D]V=1
M80$,PZME^EY)XUXK)7L&1SA6D1,/V[0^^^C$E%S;%@?Y8BHZK_;M TBK#ZT7
MBY!D-'< S[/>>Q7!S3Q:8YT^>W' )6=/X#($A Y@XG:B3U!N2\&P:O51T,E!
M(%:=M0C\6TOVOTE DC/ZVU"(Q_N?(2]5.Y=V1EKD]B$=-A\B\K;O&_XK7$VS
M^Y=RM*&*$>WOYK"Q5H,IC"G#%56Z  '_DCZ0 Q>6L"#_<46. [T1/9& \2/M
M5;R;=#DKL1\I0 0#^)BXCA46R69HME-XO^O*H@&P-#'K%-$X T.XAB(!HM!H
MOL'_"[.EH8^+F36*[Z'%JU%80#$ZG"*Y2TAZY57ZG;XBD;&!EH#[NZKI&=N-
MDS'62C$?TP!EB>NH><D]=BB FWXB'DY:H4-3@3+77O_TNB']:#)6<<-+?J,V
M,OM(AO& 9/TI(#J\,".$64=>KV1$(REFB2/K+OR'SOX=#J@0A&2D)B1R[9'B
MOM3E6P-C@  >.@9XLV;=7Z%K&#.0!]LX4KZICARM<_4\*FBDRIC1([M@M?;?
MH?^;ZE/,$QFOM_8"4^\.\<C:(QE&A$0=U0/A[,'-A!ZRYQZ8;$O%:VKI_D>P
M='MS4?Y#&49L28L[3_*NKBA:9X,&RW$914B!*EPV-;4\:^1GI&$AB>XEH23]
M!\6J&\%Y59(<%>OH72"2"YWYC2&6UT-C6'RG[;Q5"@F1_U^;S__>^J]+.P-C
MZI]O0YF2*S+6%O65/"B'ZG7K"PM]X/@A&(L(#"XM<(IU'4L;DLBL0\1]H9'4
M^?OT@:,,$4P73LB()"%4G1[$>FBS;<%I0PKEXMG&S:J&SRKGCRKOL1K9>T7O
ML]X)O.2[W",^:_VUVWQ09>K5BSZV#N%XU_V-_J=KE<MA"Y@(.V?KHR*%AWMB
MJ<LOU%/.#4;H1$W55YC5]Q%F;QUY-9RHM87_%F,[4' HLI/"#?\RU\X[X]67
M&W7Z8:!J0L$5Q%QNF0$G04 TB,\K?O_E=]3^N2XM.W\&; X_JK)!<YK/_=J\
M]P<;Z!8B>B6U6 >+L3MBM_A$9[1O)RS2?_%FGQ A\/VR_F-'"+5#^\F'KP_&
MHV368#)P'*OR"_M![<"CUXH-4R9*+[SD$SF'8[XS0\P>?T7X,&G=WYDYW4QP
M2"4U1HRX8\XJ-'W&-GQX< /MT\*G\;EKW\Z1-.(J_KC3/BW[C&U/8NKGUE3[
M@U8Q?BQ1.G_3!U*3FO9(%0<5R-<=N8+?K@+G>@>7$3F:ARO<*KSBW;M:\POT
M;-B?W$>J>VN+>O2S'/1[RPUI^>"KBLS",7=T#)N#CID^7Y1:/'N6U+10:EMD
M/S@,\\4+\)DDQU/&@&_4.F*\5[^!V^VKZ]NYF#[L#*E-Z[1T?2NGP*T,3O&<
M1$.=^[UZ?.-QK^M>.J>1"P]$$ I(EY";=V;"*(8I='.61@BT)K@@,IRNLUVR
M9T+TZ&L '^"+GT=GL9G2_;57W%4P!6Q)B0=BB^J'.?+)9<P(DV:]YF(L)!)2
M<FE[<*'3%>U_PT"[H0]=.?@0V3J<P(9 %]1-!S>Z*GCG(OC;2_#;]KK6DRN"
MV<.#HL8]%T<NN-O>,,[3H!&[Q+8+2$7W323%CF\<TCV6AA(\;._>Z+V(4B36
MU'YS8''_IK&C$XG,<!* 0FOP83^9$,\8EE]EDL+8R]1KA"RH36E]*&.EN#<6
M$U2@2HXA^F6Z"E%*,Q5L*]+&TV(-Z>::/AOFLM!6%)Q_V142-N_=3$I4WF."
M,>YKL* EZQ-:M'!("?FK<YG3)N,4]L!OB L)X,8,)527#R)F09JQ*!:-D)WI
M=5F1D<4D+L*=KY%VY\$@WQCOA1ORXJZ7D1&\?B^+GQB-#/$HWQPK8?+6%YS&
ML-3)&B*-FW74-2M)_.C=%N]!RJRLYAM>NER%!@HWCC"<)^$NYR!5>IQ#1ZW#
MS'.P+.]('$AW2*ZTFB=@<'4U=;\P-A5+YSV9 ":-1;(BT"S:DFD8SP(BV8:M
M2=HAC8,]@13#DBSOLG;%&]CW"_TFC'/JJ8!+9F.)!Z/-V0/.:(P5M8)5F]KX
M+#.7OC-!$ES<H1UE<;[%T8A>-4?+ =<6LK'D'B)G[+K]98R^+?K#=^94/O##
MP9$$[D5"O%F\P*OZ$)&BQEMI'_')B3D\]*):>E8(;SRL:?[3Y+=QRQJ23H=6
M-AFLCI:/_P-H.DSX<C)[[Y^"O2.WID9_)_[MPW2]^=36?P"1KN^.)6"+'YU]
M^V\9Z^:59-4U4QK^OTV/A?Y7]$I6Z6\M%-G=2E+!3M:<4% 0!-P\J=EY_, H
MKN;'(91#V>O=AZ1'[G4=.1:PJS>UF7%H^Z]#/F3KR-^K/N$[+K*?ECZQC'RI
M^U7R^;W<*Y/';.2QAH3%I>O]>>7_ !#?.6=TQ>X=6O=SE'JEL,7UGVI+>THR
M+ZDQYK8^7?:M^%FY0SUYJ2_^I=NJS[&7.R_OC4B@M&U?]2%&,/TFD3:8HD#*
MJX-'\&-8TZ.VT.U-N<BSB=F9ZAM4<@6\W[N)&BM1L\VYHUHYOU9'GYTUH@2)
M*T]^CYK^!Y"[B> GL$WNWJBY5-S3OO?:=8NC ZB?F],6?]F\^BZU MP4'A]_
M^S&1=8KV^9CC+\A2Y$FC6V>O<>;>HA,-0KX'C.Y4UMX4^M4B_?!2X9%,_*>\
MV:.4Z_?K93-"^EX%?JY[VUYJ1?+#;C'1"QQY=\(WARDX/;AQO>N[7Q<86X);
M<-N/I]K>49$SL[TCNI%X[%*T;HOJV9+%I#]F+:5>W<6?CYXM/<$W2C-^Q/B:
M%O\L.T+C\=X>_?2@Z;V7XXC=>:5NKP(4&S1;\B^8DW]&3:M?JJ%.N3IKF\SN
MO!*H=3JJ8E^G9O/N;9>_^>^L#?6[WZ?/MLQK*WJ_1R&1NO?2=:^@2T_.<*J7
MIJI[WV-SOWZY_N"P4L/]WL?5)25*AZ0+::F]QV_LBW/3KONU.[7$_<H?W"@A
M'?()&WY8U//DJ5N;.-HAS%L02IK2N<$?R/(.%-V_OQ'SJ?_-LT;D>_G4G',J
M3NG=AQ'-S'0="U?XU2_-SBW+N"+4]S)NTAB^(8CIJ@Z)QX&AL[5"'UCOJQ>P
MBD_JV;<UW,.;TMM6?"I>1.Z-B',(\'D1"%E*4!]IZM>P3?-Y?%WUEB[T)T/'
M7'@J>-\M:OV[3X=T4N[$G<04+QTJ^I8]HR$\X[TT>#\B](3:[9-+>Y;'7_1R
MSPO/9"_=7E5LOUHPY..AI'IBJ;-M&UXUG?Z-40NZ89(K_=S\\!^ DF8UIOUV
ML[1)]Z?QZX3F=3\HR;(K%;H]>[#JQDNW#E_E@$?='H^LJC_[V)83'_A^23C0
M&!7H=R9VVS'MSL7 EJ7>;?H%+WWR+KM[.GTYL>98!C5;2F&F(+ZI;89E02!H
MQC/S9&+<^]GO7YHYT.[](W?5Y1IBJ\VJ!R8KDX8#!23SXIBG3RP>C[2#VRAZ
M<]>L7QTK??9I;3V(;_ZPC]'5=UGUH;MP?7_7RY1QD_]H1YF\=4VBOLX%5_'<
MAJ?;'H=I89,/[5^VOL_: QH?U-LAG5WMS1VQ )F0?_[LJP:U=[;%76&05]RF
M]V;>NIJMQ-@^>BW[_L__P]E[!C7U1E^CH=BP($I00$&J)!0%$Y B10PEA)8&
MA"Y2<A 4$ 4$!13$T*0* 9&2A!0"(@D=;%0QBB$!J4I5P$93P';U]]YWYIVY
M'^[_W@][,IGDG)GGG)S][+VRUUJG,NMZ3GQ/^PZ<Z+I[A)_,<[P>&C*6J(NM
MB.5&NRM2K"=<$"2-\H3_/RJB$O^GP^P__:K_E-_O)UAOGHGL\OI/%)[S]>C/
MV.YUEZ:[L=8S)KX_9>)P7P=U9SN]/E5TB6NNUDBL V];4K_67.(K?M?\7S+P
M+/?U%PV1G1:RC.H6@=2OA5(M^J)-'_H(SY ?#VF0Y@E5Q["&E"X;-K^JZP1V
MB.V97+!?ZU):GEYF?I&:Q2[F(BD LAQ)?S)7Q3$+M:G4BJ;@P= '%%V\7/@S
M1Q?I->#L6:U+OS@0V<JYA/+6+"%19:ZF ;[?V@(A":5F0&MG5AQ<E]#*2H=W
MY>E#V-@M(:W\)(;^3\$LX5S>,)3RFBP(6N!D";)?/#HZQU"Y-<+>,!'T21Z&
M)$*W1]%LI3J#-DZ79YMJ:/1D&]ET[?;,AJ;[SN5(J9YB\E?I%:DA=OV8@Y\$
M^\FW2Y( \4[_,C_& 7(6-@RME'H8GEUU-NON*;IH$=LES(5"J%&]Y'$%4A_D
M(:">HF-+M_T;RL=->^"2V'M[K<'2X[OMFEF\?L%#T@FASR,X(2M<\&9ZCN+W
MJ7^0VKS*O-/-KWG:*$HOVK\GMZMRE0874_&G%V [!"%8VSTC6?BD0P)F&Q39
MN*5TR;&;"T^@ANFV-%56Y>THBT %U<O#N*)<L\L0U_)8C =&/#==&W9;.0NH
M8SLL2Z0\@'4@'I:P'!]3.Y5N_^TI)OEW0[;:Y\T0V*H!-9_&44& G4WO)=AX
MWC4;0$QAI%1SXU*RT8,H6O^6<,YZK_1R;DCG%M>ZG;B>$7HW'M=8&DN])^!*
M<&TT5.-T6P;H "@AOV(4+TMLB6/LNGD,KLPVOL UT981/<P9Z'3U_T:G$'QP
M>4S1;CCL.7"X$K8]2P_P)YPG8IB"7)BV37D."4<37RK),PE@E3(.P#YKRMS
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MM$AN&M23,\XYKH*;HUG8CYH#=Q0$J=83U$Z0-HR\$W/%29.$ /V3JA()&ZZ
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MO4O>O<,1Q[-/!4-]B,P\9;8,N/L8(<O>:HL1_4P+8YA^!7/#R5E-?8M!Y!%
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M +#W.C-:CE6'VQ[30)#@:]ML<:B0;1A);Q<>0^YVJCJ-+VH8H81R<F_V_/Y
M*]1UN);GN6+>;PNW;B'[!21)=[AE4,>_X%[7.HZ;=W-R&4>1"0R,B9-MI#LI
M"DB XFC.4-(]F3+D@]R;QGUT"K(VR[G7S@?Z<$!?\&JPHE-?[X0-ASU19%>F
MFHK1-N<:H2W5.BVT79W_5IVG(0_[&>A/E>*E?OH_.5V$PB0KX5:*;S3#;P%2
M!N"D.^P/H[@2 [F"6M=H0K"VSH(5X&,@O49 R#*F":<;27G*2XZXJ40(:!;
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MA%G;2WYP*W++'GHQ]LU4A6\G3',O7,V0P3TM825;$:F^X&,)O0BDO5YC+1N
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MW8BH"9X3ES^_1?2JKUD0G;'XV/11Z];EX2+$&"GE?MOD$U/_!HA\6R(S^/T
MW@T^-&9G.3 @B$E+OL%U924M-M7K7/P3NOJ)XCLRUCAFA26FDD[%&C61SX];
M(CR>MEM;"R(:DRSF0E*$;_<U-9SWTY[_?ZD:^IWQ_ =\S7/S'TP D,SW?XHI
MBC9[Z)^_?>CO?+KE']# XS^)<\UWGUU$/$O:]\L^]!OYT^H_H.P?5[,/7WK*
MN@C-F^[[XM?S1N>SX7JSU)=3?Y[3?!7\M?;&5//8W2,-'^N_$FZM5'!LQ!?X
M$:'XI7NA>R*H)#@A6/&(MH^6[1*^M#;<8KHO$FKAN_@3('L0")[D;;HL""M+
M<$B%$6#C/L8@L /;A>,HF:"W:$-?6HE9E7#G3B)IIL'0UVSD?C["\4%# F+7
M?H1N :2A"6DR8>HPB!/5BL^(Y@L;?)4AK"7QT3 6A)V)&B!S#PQ1JG!Q^XEU
M%>=V;K"-5:>B@B/;\,%0Z9"JJ,N$>HN_]H,YJY0"90P#S]0!JHEIZB.CG04Y
M5@EF5R-*B!6=Q0A00&XC3 KB'C;I9:7RP4W^\>RF>\#_&JU9OQ.QI*J+W:[H
M6X"./# %[QIP5,6'+G ?*FJ["HC78QT&CU^E$_U_$7-M%7!W3H)ER<BWN'DB
M7P<? "T?,D]@^GW "1.8]<<H%<CA<*[*[&(?EA]<4J>)DGS8OH+B>#A^HIF^
M(N6INZF!L %,25H!+OAH()"31HL8>GR;^5TT=HX)I6RQ(](U$00""[*H4%):
M#Y>6\8+O*\V_BG !]"G4M:5,?XL-" Z--7J0IJXM3I:9:+F;<,24M5/>G>PP
MR8:IR11:VP,AQHVI&8:![Y>]+R_T!>*E21)%>DV'L+9<!C_L"&X.U?+>$G(?
M<E'Y'MOM )!P'B?;K5'9A9 <]"*PC96B:1;OA,1+F7Q]TO/Z:) :Z_[/1<LQ
MZ86T?3F=>.8$VX4?@:#=XS&JY]\S7'K@#\B/2_VBSJ3BDXW?>I O'8=E/RHU
MYF..D,=N0RJMB"$Z/X#(9PC)#<[-@2I\6B4LIR_05*3$=?LCD^7;YH,;(3N7
M^I)>'K5!S- G'88P^XD<K;[(1R6HR#?JU_ YQ!QV9W^\GU:VT'C'$>R 6XOP
MTS)KEQ[6$T"_7,\6]<7Q&*R[Q(Y]*4V+;IYI"/2>DEUZ\GT^T#\&"?C;C6_"
M.+'M)- BI8U1Q#U:V>-3X866U Z 3^W'B641$0<BMQSUFZDO:(55YECP+?"]
MDP)WZ$P!Z46? I))I)^"UNI->@=F?Z8=*G370!]PQ1C*-/P=<L6,EI4&="5P
ML'BK&. >P1::6_W# CYBJ/@<K96]0L#8$+)]I/6),>^!9&7.+2*H[/%74D8'
MPX2TJ &XH+?-X9_GX'),"?5LW5:N!R4K0<?=O=C=,9V2];@N;"'WDO% /_SH
M*X ZZ+:&V6E4%,+Q0" MQ 1WDL+Y0EQPN/,8U@FZS2B&M@;+HJA9*&Y?8R?-
MLUT85RT>S&]L\@@&\@G\0I6/= "\C7NLT*9I=&PW#!L#.P ,NWI&+F8W"=!K
M<'>ENO!::G@AG?"(364X.88513-:*2EK3OLAQP_@"D01M#PFS>R!7%(P[TT9
M.5D*+'LU^M!I<'8B7VX]O]]=D\A>$2\LL 6>LF7DBL!TW 2:41)12S VCZC,
M$3W_!;3M":BE0LAT_Z6AOK[]97W:;N)8K[[#9!+# J+&(*W/!Y$]57WK::M+
MDZZ>D\L^LM=#&S8IHM"]3R_63#^8)RC93\2CZORO^T'@5;ZMY/ =TU[$'-+?
M8NG[[&U !'..*#,4=XZ!:^*1>4IP.=U@.)YX*LL!3(?@KR+BD,SS=TBRN0>2
M.+%TLX/L=5.L!$<3W 6_<!O\T,-7T1>36P(YE" ;&K8'GQ@,1)Q.R<CQ>6\-
MB-"X$O9C,ZSDTIA;%<9E_9,MSGC(8%C=SW3-3Y?]+A9=.(!4@9#\R*P])2?"
M!$Y;E.P<GF(/3ONT^J0!/2BNSX4);W/P0-P2)8KOMPOSE0=J@ALS:-.=52T+
M+)!C9O.#;MS. 7+K76.)$X\O$ED(KP]]^!*F.GEL.PE""NBH"Z1L/;'$@^+K
MF+JAOOTNL%@*A)0[,V:&8_-6J["ZU%%A/<2<:XJ,V--(L:E.Q9F*EGB7'J8S
MVC BC"4,4OL"6AO!>+2A_(,267B<KSW@ZR(^060ZE>[$-#J!R:*?Z_?(_E\:
M.8^^C??F4.IC-=Z-7(E?[3\']1\9OU+:L>S6/IF*N4V>3&)8)/SYB,%#4,T+
MS3W/)N,3ZIED?#ZF$%H7OV,K^5D!4-)[ 2C2G><;[M2N,;RRLIWB8RK9XS*C
MH1A/[*_1)ZAP Q<(>I'OD\.[5XE3V]T6>H[=NZ._2CGP-$B#0[7P]-^_B./]
M1*'MCYNY*)Z_>#+]M9?KK8SFD6]OD<^HG>UXH^W(DU_*'/((Z8^"5A:#O7^K
M39J;P5(^V>T@D%=!*I?[+D8%;\]NO*"@36LZ/[VRZ]5*!CTA;[UYN[B1(6Q2
M.9ZF>.&OF>;M?6S'+S[QQVQ_.'R)"R6IA_XT9&<M$$N>_/U4>_3T$X=0\CNC
M#S);$7T ]#S%L_=X-K['"G?J;PIY(C)WXO1$3 J$/C*KSZ^]D^.JW_USHVY+
M\G1 F8;9:J[4+_YHQC \A.\VL)-8+9V8JF!#N\BO.WTQ+QNZ8G@8NOO$VC._
M^B^53P8$W\9O-U+YD-0]M\\_@.B%"F?+K5+:U/P0C"7'\#WC&]V5:<TU<SRN
MSD1A=OW98RZ;,)XZB#6,X%5+1]7G*HE:-6JX>#$;CQB..:H83+LW)L0)F7O1
M/)ZOTVUI'<Q(I$0UJ3)%U$62&XTM>0%T%XC[4=>?D7F'*E9=\6&Y/!J*HXW/
M'J;8\RMB%6/0ZB>G7,<I4&+5S\=V4=JK?\W;^J%C=Q"'.J]R3S657CW6EG7]
M-66C(OP@I(A6/S%MF/KL-,O_NGE??%GBW9/1]T+X]?KS$<E\[9EUNQNOFLEW
MAD(P_X"X%W;5?;F^O_'>=!7YR^6'*6^)4[73N5%O[EX-UO[N''MITR+%G^GZ
M8FK^W%+"+XO1C!\FCJ\1KX+W?OS*ZXB8S(U:TCE5UI[\MB]9LU=Q#W+A#_["
M_/.)8DY<O4UQJ,'4VE%#S'?#C">&=T<2O ^=MF[6ZJY8?G]M47#.?F>7T6[]
MNQ$/9NSHNB]6RRF$DXW/!25$<<XMX_C.\P^!M<!V;N>MV([7_99AA<;X D/7
M"*![=*;)1GTT!<QV>Z9/^<MXYQU%_)/D]Y&!S:C.;@G<WOQ8POFGI:S66A2Q
M*,%A+-ZCLV,NEUD4\YE*G4:>'(I,30#[!FWU_RU1^#__Z$>":(!C9*UT,&\)
M$#+_6P$:"N2"V(6=*-(0@8825#Y1&?? 2]'@>Q=),!Y6 EK13JL'@P3%T?U
MD%S4.?IQ-8H\EEB8E=; U0/[GI&##7LX*%!O(/=*!\,>D&'/?Y>"-WO*[!*
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M;2<EKKBKNXDD@I%,J DPB4T4[I1[N.R]NG2<>LE 4M.DBN5=;W'E #D3^99
MJK1C3=7;N.4@=!#4D9&;Z6[.IEPO7G)2+?FX3CQZTFN"-,1+0Q)=HOGZ]L1F
M$U+:!QZVT%-L7B4:C4@OP[,T*!VT4/?KV9/HA+<>G46)\<Y'(!,VYZ,PT8*#
M)M*F:0W&>O+C:>KH!BQ::P?8%/QX%">E'N_S-:(QG7*4%V,F>Y^SS5/>FR99
M>H\Y$>ID->SC)C:FZ,4&.%<#W9U!\0E!(G9_8W^41N+5H;C.@<S00OT'<JM_
M*B<Y<\SA?B-%CKHJB Q.T@63T--E""&*8TW?-5]A-"]\_<9!D!"L\4RNA( 8
M^_+PP<7@&=8WOYJ?I1YJN5<4GG6YT)^0G#=D7YRNVVARZOTF&QXA[\=3])-C
M]]\ZK>/QR#OE7:)U^*[[" ]SDNG! 81]#@N2K_ ,/].C,%]!N)V0P=WW.C?*
M7-Y_HUKR>UPSXH7_\.WM48-GU?U=>;N"T^N7'-'=(@O?YP^Z2JMUG:()_-L*
M5"XOO5CT3L=DR9Z?E51/F>Z,X6=<>,GW%)0_4U\J8@#+_7$ -T AO8[!@X2%
M7)(F:O<I7P5?UT0 2 @TC\)T'LG&7_K+V \5;P5^OF,-9CNQ":.F?0*.5XL>
M:BPA@9) NK9+HW:#_Z<11I7 4[K/($@4?%* ,?31DA/*]GEXQJR#Q*QZA!*+
M126J5.A/D9O-\#>[<5AC751$T$.N SJHPD8<D5L1.H.(L&0/R;+P+0[77WS#
MJK8J.C]UO!.I\D*9X\:/9NOG64BXEU$\H;P3"QF9:5JJ-&N.HP;L/$4ZI%2(
M<=) ^Z\"_B=>TP]=&BF438(<?[BZSM+*@YRH_TJ2J!F=J?S=^FYU4:XWE23>
M5]:G1DI[[#N"_20Z_3*]+EN\RUU@E,DYY&-VVB;/'.&7S-*)B90<NP5>M^A=
MQL)'W#8:EAE<%"\MY@DLUEL7Y_FE=DLAYQ'?Y,?(<&=6J6\!7 9U9T6DY.JI
MBHVV9)R2NYXCJ9')4,07BX8=[B_)S'#-ON.3E4LR=]Z!S\7'!G3=!'#Y8@EJ
M.%/WE"A*GS1-\M_R%&&4H**^A*3=JR")[B75VZ^_.Y1%B<,9 6Y/4=)Q9WH6
ME[J%A!J>5H(&QV7"=ZP@Q]VII 5C*(X E%%A[[QU\.YL)SWG9=3#CJ,L:6L6
M;T1.O M7W/_!TUD76T)ZWL >B3P@5*$49!P@2\?9H,5:P7!++*4@C\ QY>/Q
MK+'TLGK@EBI[)X6OALL?CG*"AO 5/?V@H@E"+4;%@%5"8L/Q#(PB#\*2,3C(
M,L@!\&\]UQOV$[<,+-2'D-8S(J&P84K3$/IH@36S]ZQ"1N@G5@D<F5O-PRDA
MVXL@AG*AV#_>/($?_X&/%B47I[7=N=')N@Y/FJO=:H60-_9_BPZOW=;XI>GT
M@-+OHNC.J!-!S;E_SHI_%7]3>EIDO\_J=Y_E-<-C&^+%8[L.S\X<XR;363\_
MSQXSK#R_[YVM]*^/.5]<A^ ._#W[YB&(BW^*;SP[MOI>)[(!&D$JE_]W<73#
M]N() PE_81P,6IBF^3_N;@M7M"&#LA\T</>]>#9&IZ9/%WPU7'0MY.MM@LNK
M@QK%&PZ\;["B,S2XHC&XUW7NLOO<?KH'4KLH+-CQF^^_KD&3*CJ2U1[(+99Z
M%OV*]F09YQ/'4-YZ=G# 8'N$ZQQW?S%LW>=0ZV$]$N$ [YN!FIQC'2NRMM!<
MCN*M!T=%2RV$R-YK2 [)>.M5:V(^#/[;U -Y0,[Q#O6&F^B*ZSS9ML5[<U;7
M9 P>T1D^6B_H#*[-_\UY7?I_U*T8U/I!@$,W-B)HORM%W6N?O:OBOOZV]/:\
MTN&QT&_/M)(>/FD:OC?<N6#SV>P?T'7-_)7?F5+_@![^N1'["_*!N.OB_,62
M5S<47]GC\.\I-B&0YA'2CWVKW-.SYI@(9O%"5B:S@'6-4C0\C>+;1E&.XY+L
MV+3192XC:Y[M]\<&+5\UD$QI42@!L_BL@O8):D[D!*/Q2\0B8;;((LCI!>D
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MV?MXC>; !QX3P1 7[9_]@=48&LWWV&L;_P$]-\:9QN\==H<^MJS(D+S"C/X
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M5VIGSV7XR3)7<K=M0X>D8E"W26%13N>GGTQR2Z&^CN&BZ6 ]8M ST.31_(;
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M<%>^SB'-P^+FJL@IGVL=8!?'2:B"-1,6\Q$&TE)(O6?>MJ#MP .KI N]0=T
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M:+QY@19U-#:A\2SDBT[H&10@"P59LG:GK=B\EG//$X<U6J,,3?HQMJHX>VA
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MZ/&J-LU23;8^XP<;H>:@.7;D7!F);-6S6-ZJ?Q6?"\%'%:YA(K6?AYL)Y"R
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M>C^^4W[4/"KQ4NRIOZ"K<0^E#QD%3-SB)F3&'PIN@; GFG-C<X@V9'5<XNF
M'->Q^8;F4_ 3ASDI"^^JE)(,JGOB#P]*C<Q=B<)WY3]O?*PRZ:+Z2SA[T'9"
M,?@M%$B\W?\Z^-Z>P%,-@%>2X9E_(>4J,*+"3\3J9_XE]6O<[CZZPOQ!^=%
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M6 ;"FP)!.N$L$[/"",'?8]OOD4:$TE=H+6C1%DS2#U9\@.#RZ6>)E ?[6'%
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MDX+EUYEZJ^%1AWEV_?B_H.ND.:5I8F?O]RNZGEJ_#2W_**Q/W5EY?KP0'%T
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MI0H@:W:V#6WY2#<D8H:ZMGEK6P"A,BRQ_L>OX\UQIT<[.^ITPE!TP0^V]VI
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M*=X,US/QZ)M(<*!AY<A%D4CFU]FN'H,WP]Z&GQ>,7:ML=)ZM$'W]ET6Y.0J
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MQ#*4$.\?\RKJ7+D%G9R[#D,I;Z$VQ5=QGT6X9S53+C@>S;*@;V;5'8<4;'?
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MTZ*_\5(Y3>LG79?F$;YT4.;6'@O;-,80G=-@+9:F%^D@ASK8N59=,%#.*V<
MZH><U=A^,%U)EX>;KPC-M_XXKZ&% 9R:*?.?DH0-(*"_X;]5:A]!H1K91GCW
M"-TBYOIRA8Q<R]!=755V&!7-45=YJG--*A,CQF>N'D1Y4;1X(V9\!_Q]Z9V@
M8[64ANY%GEVHR2+/NK5,13XDXXP/D<N]M;C]D%LI1LZ(?M>F=<E.F!MI1)M4
MIG='T]I93.X-()1:;SWO"P59]"+6P,LSA*JYV0NP5OO6P+4H>HHH\0KD0NZV
MKT)_5!R^04K0J4#CW$AJ7(3;I!Y"MB<92U+S&#3M,>F[-(QX:!7-;+-YNXVJ
MP%@T(=6.#49LWH'\ANC]E6;H/4J.+Q<X9^ Y=31=LIM!*+NSN4=<.EH?L:IL
M<MJ6._])F:K4-D-6_I+3T'7!%&T_H9P[U01K6G.S?GIF(]"(@KH)FO1YCD2C
ML[V2M<:")SLI6H)$-2_O,^EQV%*5I;+3/Q;'.A%#@/;P4SEN:*#47-)7?P-O
M>\V^WDMP,B/,B-#K]Q@=**5J1%>KSO#=8,W..;_$D$=!7T)4.%:T!0OX!553
MZ"H0K]L*U<.2F3W-5Q.<X3BZ?+297&ZZ_(O3?C?5Q?.4BV$K]_"9_ "9C5.P
M96:^]<C0+K0F5F^<4JV7W*A."B(S>%5-_F0V<)W<DLB-@\J1LJ!QG M')U7-
MB05\9,AX0?P"DP:DN!JE0H:Y<H_2X64^(I./4(XUP-<4)NU.PMZH3HD8^TZ7
M$-R4!KYYKQ%FV&!68B&K#!JLYH(UHY<P5U)P:-ER&$I_%+\:LJK-"QV%R<4&
M28+,'767P^9Q#H3N"%_&4_%]F8,G):_NZ<7\UBS'$],V0*>%?CP$/>0Z/'OM
MU%!D;6?H#>.< E:]RB(B8AC(D;D?1WZA5.F)E/U"D;2G>4VRC\OT8WH_O=S%
MR8O JK41^I.LMY/XR+/$\2VPN%SB*K@UKS4K[HU(NOZL0R0[%G$S.=(F)OYB
MJ42#NE89N;QT4S>E",PPQZPU])7O+3OW9HY>&1!(27 *Z2J5:/D]9=*_>W$-
M)[=!80!UVO=7FIFWS"=L"42AXDQ TPO.]&RBH &QWVH_&FXC6K:B2[,.O>"%
MP$7$?@"W%86X.[2=71=(HG[+H)0/#5'GG=U#0WD/P@+DD=1O(I7TC/"B+=K^
M2@G8=?TY8':><F3B[=6W;J<>H-H]4='/YUGEZV5X263*HR+BQ<GW;\(/IO.Y
MNNB>Q#?D0!0&A0"4*<3H;>K60&-@5S5K0#_BCN$W%(66'"$8(C>@M29V7Q55
M!'XV?]@3)MNOJ,F_[9)\8(L*#UMZ&8)+#]'NX752J_^D5TYN+W+',85=K$.5
MPZ0XD/I7^?$J4= C08<=E\7YW/,V^NT.3'6:V,]?@24=^@,?-%PC75.U%QA&
M["*WBOZ6:N/WDQ+?4HQV0/%!K\V,.A8D@ZI#"6J)WU9,:/E@&WKW.']8!CL,
M;+IOC&#M$B[U"&V&M/;N6L)961/9%>8.HU:^4R0UI:"%@]_&< &>G(,76F%6
MPRS\^T5FYOE WAQRU+J.U8(\+3^8@(/*UR2MSL^[HD?ZX%PQ+K)MA8 >JHN5
M,Y3RH#U]I!AB/[TH+?2D7< <8?C%C !9PP_<-^#:@CNA;&6+T"<0AW<CS0OL
M?)5_Y!1Z-97B"-;X %G29C T<>\AS]39A@[2RXH4ZZC?'_&/BU(\=D]VXO6B
M]TSB:QBLZ_53Z6#Z"-@:H9;9%FI$H[[HB-8G5ZY3" /SQ),R+0IIH=8V\TLJ
M_(DY&O+48(3K^[5WF7+1A6Y;%%]CBI];7B8]=J4\U$=4!,KU2@-9-P:$QHC:
M!+&.?:P, @)/9Q,",0N]UZQ5)TTE:VU$&3LH!ZS)0F:/2(Z11,89!8.B+QH]
MR:UC^?EW-*)CKLAPQ>U^04J9!7'IWR\ZT]WQ-85;LHU;Z*+5 (/#37O$Y,AU
M90<DA$"Y5I#,K1O#(.>GL&MM_TU%W)Q6&CWH1I'4\_O]_Z5B*9?4(I>_Y93L
MJ<E@%TJ \.O?TF%*/CXI 3N/OS&M_]GW\OR0*X?/W"7ZI,Z-NE%Q1G7Y"#KQ
M6S\VJG@IU]P4"@'AQB^0CSECT[ZXGK-4D9GH8)5H8.FRSXW!IE/C5(GU2V+A
M!II9?4J/X"9#<O#P40N ,_5< ,VGG.60EQMWM>JE,"C9U;N&= />'3E"J$43
MP!>+;_%(I7$0&A:+V&Z'D0QIN:%%A';*9-P0B;5'G6N6#F_>C$IJYMON4?AZ
M[%I*PI0EW&[.G^5MBT5DIB*:CQ&J*&7LWY'0,55F>:M#6J@_/I#$L0 ^)T Q
M+P;\'-L4\:5!@/T>Q4C]Y-'TB732U9<B4(:(6,5^#+7(XE+(UOE1JF/FC5Z(
M.@\#)+9X16';ZU@+#0BC<#][XE/D4:E^737CY.@3B)N5H#FOU8X<*Z-ZZXU6
MRW87KTPJ75L?V9IQ":'(E:84XV;A''<_-&PO$/^(F]&8C'B!ZD6>$;LM/)/H
MO8^7LT1+P1*Z4^<L^_L.'\3E,<,#P9)UIQ!!R]DOP&[+,_2KC)3;RWC'*.%M
MR,S"Q:']8,,94E(J0 3*@VTI7.0YX!6%48'R/6KZC6^MJ@+SP-)!E)!)3RCF
M&4X6F*Z&,PA002W-#&H_FT;Q4!A:!(;2@$D(%.H'_^?:;$NYDRQSH:D.<H'S
MS EQGURUGU62LFWGP2=EQ<GDF:5>5;PL=1UC8*D^?ES=YWWUO;8NJR;(_'IS
MWQMY+/@"->I]+F\\PQ<&'.[,7XX80447^R9#S= ECYF<3OQ&Z+6L^/[P\8./
M#"+DJ>9]I$#(8;_+2FF9)C)[D75<_]OW6^&*@>R%^Y8?HZ?IHL<+DLBCCLU.
M#WZZ];MV6<GH7^28:QLV[AC_Q^&UR=2+X\\%ME,MKQ8EQ]>^-WQ5\'GBJ3;M
MSK=]F(F>WSOO3 6U-Q]'(A'G*>HO6S?D/QB/D;E4 IF[;6)Q>[Q3O*-RJ$US
M;HU?EKH;-SN&&77.W3DV\C[RVAYV95>@?QICR\^03@VBZ74S_7F_A_R<L2*.
M^-/IRN^1FT<7&H?_HQ6[:VO'N*<DZ)9Y^8L_L3FD[DMC+UY*^K>N6S5,6&D;
M.YVRZWT1MT"]IWSCE0^NB_LP<].WS$MO?_N9>\:@Y,I4VB?R8AO#_,5B.QY"
M)U L*P2/7[$V7D2W/?MQ5B,]!W.[*>4?!^ 9%OVO^0"T)E;5+EM\]&H&G9P<
MT;,@C;N*=XRC/SU"&2;)X=/*LJLX8AOU-C_DA)>ZL\U^_FEETD16<#J;N?)8
M'O?$*&J&.YTJ/SJZ)>,0+G<1P^N",9&K4$=&@A<71%^];;8DG;BZ(''XC91E
MRIW?[Q1=O5"AAN:8R!-&=J!:4I_HORJ[&?(80CPC$"!]+H*P-IO6_Y.;]?[W
M3R1H2?$&M1A5%:9\&4J@+<7Y93;IS0?)L0!&*YM^>]JX&GFAC-7RHZA8)?XZ
MAWT;@@O3N6#650]17LN#1$7:S-)F 4P )&K-:S:XZ?XL,P=?AI%J27%H%WT8
M^\+_; F>%#+/,Z?J-E:9RILBG-#'RNQA<YC? KN89,Y<,/HVAH)Q1]^FG!)\
M#J#U&+D**/4C8(J)CH\TY4<)LZ]34F5E_ 4;KR%W5DTNR,C3,3?PK@V3ZYHO
MY^).2V\HK5X;)AVTYY-%0E9MAJ_17PH!AY*E:[)+AW609=YB.ZDG901)E[12
M/+.\A)7Z=P5L4.<.&A)A_(.XZS@T9)5&!DV.J'YE"G[+%PM]G7M.891#TJ/K
M@A(K:WF=B@U2[6WJ:GHS7:DU03 #@%""V:$6GN@,22*=KS2R/4N<ZQ%TA%3X
M;G#"IDHK(US8(%PK <1*/SSG<$:MDP2/@6S.7"B[:SJ<),P^@U_F'K$HAGLH
M\T[QEOEQALRFG2AGN&1(%QK)W9V".LCU8NB8@2<HOCG30_9ZQZ0(91%<JH5/
MX=[G^,"+4FGW.0"FU)9"8=#'9QHN>+ \6%F0=[KZBF4^(1_AFY</[Q7:"NB/
M?BJF9T\6XE'&AH8++72X8HLLFI5;3)T/=577%[+J X/028=DR'/":-CA*I:9
MQRQU=L]L7$W.]'6C^*KF[[Z<[[Y-_BO] +(B&T%9;3^+R?)$1NF </(%HVHZ
MERO4KAQ67\/Z 'GI;M)%B#2SU7:<4FY[1KSCH.R?<?.YBX*WP'H#BJ**,^:]
MQ6=AZ_R$J@X8RH5V+-#^HW5654:]DG5&23VM@A8=-J)\*_.$+E)4[=6N+P;.
MD#N.W]H<&[V0?*AH!/HX-2FCK);B,U*]33VP\^[)NHN?8]''/:MW_?6P^4_R
MA^RGR:R3!?!&68+SZQ$4$%Z;;!-2EYDL/[9C0E;B[JP^].2T/%&^YLFIMOP%
MQ%AOB=Y#_X/4=#=S0RP,<6\DA5 >0YZM&5UK_1<IVICO1F4]41TJ2V][2I]+
M"P>24;NO]PP?(Y!Z>;L3IQ=B%,I$3=2[!3$XG$9Z19$&XP/>XJY\$]HO 7:I
M]/*#E(H4/ZNP 7@E;!DO% C'?6L3,P4<R$L@V.(2L72,D$:R!;I1^#*LP_J"
MQCIUQ'CH)[G>(YG>%6OI\D%NHK\K.-EUKJ>Y,L4/9(4Q,6L'EK+K'**U\>]O
M\/:AZ$^L'K>./E0WZ17T0IM3557UI+?9W.S5K$:X>9U%(I'IG6MJSR'SEH?L
M@ L9YA<QS,H%=EG.U!&'#OZP<I@",7=<]9HBV0&T&,06<HVUO]._P\G7P 9_
M34Z21M[25,Y[EQ2]6Y4M-B)%LM^MBI7%>_,L5O.+,<ZW^UJ0#RF S]["#NBC
M,X0<4CZEH!K2-OB;1&,E9NFFYCE%":B ,/J[C<@)0N0F'!K&%QC,!7=Q>"S,
M"XNN>G$PZP2@%2'M%_8+\X0 ,J1/DWF9> FK&KG:D!E^!<[]S/262R=Q?6QJ
MBSW#[T 6<!X!1<&:D(8B>Z0:R&.QH*6N/$4JW\GU-4(2RJXS%1+/$(+\<CG4
M!9#1AXO;K;L/N5I08SFMHG686"FG57"<-^GJ"^'U]X&+'[&TC^3!-&P2SW*(
M% M,8+LAPY#Y.7J4,RW0<V#/:%\G^1BQ,"UB\CT6>494/_.OZAB69:'F"KX5
M55WZB>N]KZIMU%1TPQG^^(IKND8B(PUE,S>JL#+$@Q$*I:2F_'DG\? '4H'M
M?(0GTIR&37T$S'27=RR\C6RI3M&9G"R/15S^1&7R7DC(99]#(L@03U2\MW@K
M*AOZQG=E:TD5N[SUW4)S+?Q0X8%;YX$. U)<OM"F C+2W&S*=UD1)+"NJ74)
M0F/3?P"W>T1)A SY:'(1*(L5O^=&MN +=PN+YNG]PE8Z8&Y ;:;4T%?3E))U
M^O_ *9C+*#T6RM;J3;.PU=VWB=;H*0PA92WC0;W[7*!=?40Y3?*R8*&L"J^'
M**22.=05W<^4KAL1-I2]%ZOV#P5N_AA.O<\54B!MEFW)WL$/4,V9O7(JUHR;
MML;>GL]88@< RF3T[8%U)&X%V+(5JHEV&S"3U^4XUY8LU]G"Z]>+E#.E.<I4
MU>9@]$ABT*<L@9F0%ZJN&VV)N&%+?B6AY TLL=H,HHL+\\JR#H+'\EE%M"-8
MW6W4.]S@CJ=UULJH(?,BV:M$PDFE UX[/*+#^K];6\;Q8IR 1I'O'/"7X!T2
MB4L^.A59\!&)NW4C>Y*BS7O/.UT)N"FN"TEYA$BA2IB[=VD7RA2YI.N;)+ 5
MUH!YKPWT/V /#^#=%"E-R*U;H7&4)I+0!%EC'"D+E8!M3)A0)^4_6DZNC8Q?
MG#R/(R$8!KZ$Q68@!@-]KSX^)>K<(#LW(YR F37LI,1W&6#=/BN:9FF&.6M[
MQ;$GH54,J?+6<<CZ+D4J)Q8;&>U)NLIP"WY!J2IW70ZS+AU^!8)H>3"86+F^
MQ4WE42*A!9,>H]TP8SW"*M9Y@F\J79NZ%WB2I@K"TOPF(US'K8(ZIIGT'/TX
MP3-G1@^'RGO?E/ '(63Z),$"N<9LR4?I0:]7Z)"$+=!#%'Y 4^(=.N9CD"2L
M:4TT<+.0/#?@9SVY^FR9BEHT4U00@<Q<AV\BX+K0,8]QP5;:PO7IFY(/K/4F
M:6^5D]EZ$<C#T?!@ 52$_G$^QOY0@H(3*UV'LP"I[P@<%#G8E:755:[?D+AP
M8R85R*SC:L5218JVI8COPFQUS1C#!/GZQ0@@6R14[85O>.D#;WTDC 9^NL^-
MB_$D*)46MP"F>37L?4@_Q PNQ8V9&*RP:XL!(F<%O@&'&R5#3_%&MT(@1X-G
M6@AR2OD6V=8*WRN#PY)A%667/)J!=7BREDYFDJLAEU$BCU<H)Z3$Q&P3IL,R
M<RB6&8\:VFYD/?DV?!DW:@^/61-]FH</<1&<_7M&<-(QOJR28!RZP%TMT%=(
M2!6?Q)WZ?.OIZ^O)PA<"*# 1HB'%2I-5@!W=8()DVY,+BE0ND&J@:^='$&<*
M3," "GK3.D"YK JF"LM#)X-MUJM.4F[ BZ6WQ5W5*3Y"<D-^9+EW^XYQUJVW
M1#4!,[C]LRM^Q..,RG-,X?@(^6XWZV.IREL2T5V31EDSEV>\^MY\%V/%FY6@
MB[D'RG&[";_3R^'\^+9 =0K?:6:W*KI&0CQ]E3V(^G>Z<<4L(QHW 3Q)C<+%
M/;E^$#FOK+&O.2_5^AU(HHBVLCHL\-?;PHPO2A<!\\(-+[%!\!NH %O^D=YL
M[RI1("I$K;A>$$(\]IAGPAGEQZV)Y'I%<IT0RD=LVE!TK"H:D6G/'!NXXHF1
MV$4!!=4H:\0-18IXRR%4-60:<>\4]P&%$H=\OXT[3.\7S >MA6;@'3/OS[;:
MX-*:&\-E.TH!Q6<P>PH]N)@%<M>!%30>2Z_ B(=^0V**)K!!IA(KWX^JR?X\
MU O>&EY'!MGF"NCQF_(U>GOE>YM9WO4/_3/_S!GP>K__&MP4D#VO(#/K3XG*
MVB<<#CQ;%+LG\7!=@I@-P O/\1E14#K@RQN5>^_JQ*=\%290DM9<WX@Q:#M#
MJH2Z!;*T?OV^CY(^& @HOONX-@^YE<6Z=DF&YQ&=!M*U'I.XDQ/0V*."O_^C
ME=/N^'3%R"U;3G)@99:GLO=B'8KO+A1+1JP\3)=F^5!;Z8'1T$_?Q(ZWE/,W
M65H%"=S,H2@B[_Y- K2HKNW+@?U5*'XZ$]WR3=!+MF'D$/OI),1AY[9[T$.T
MH&]B>TO%MS/T1ZNNI@A',)?3PLG<(] J<1^I2'G<;S)1*TY$8S4!F<?QQD@;
M-6]X%3$_C)GP,T2K]5%SHJ!!* JC&69[(4[-BN[U#ATJ=@^B93E/3 ^FA=E
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M71R7?E$29-RRFD/11!W>]9R%,G20":CQ*INS=M;0YI:#QC4*5O)Y;/K\Y#G
MGL+(;5H7DAF84[O3YZV+6A/;!ESJ]S3^XRG7Y-:7"]UZ)_G_B)]R3GK>FO\0
M_/5!SN!WW!?NP6LYB4O'):_" '3?@YP[!QOK55=?[1CP^2DC:CYMIN9A[)=
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MQH5M4_>J5CQ7:I1EGB<;Z[=R<$D3N7Q&DNWG[%M<SEG;K,,/EC&PU^.K IC
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MS:^*!71+S-I*8PNDN7C1HZGB\/, YG=M!-E3<717^*H )Q2D.8$X3U9V]FH
MMVM9 U3AI5_FTT\T?*ZI)IG/_14\/D?-52?)N3WDUP]6#*ICZ,Q'FC.>>C;S
M=S[E2C--#<X)DV#, "7VRK5)VT:UIEJ%0;-W*'7<7">#47P^55U5/R;T.X)E
M">D=K#UA5_*3,V*E-B#JVRGN]@)O<(/'O(U=BC,QI;KLX9GISM2&?M#P]4.$
MT/0%N[>&WRM'0?ELC<S3\Z(#RR'=(Q(/F3U.Z+UO+&LF?[>\W%[/;9Z9]UCQ
M'@=$^O6"[J<H3\RY%6W6]M'!U4G:#,T<'-SMV&Q<.'$MNB]O?&L\SQQW./X^
MC@U*"V62,-JU^14G*'_D<FE&!M_2JOQD+7/O96 1+J9A7+;LG\B;]T?D^?-]
M6T^/*L#O:MTA -_1OFU(;GB>HA#FWL(N0LK,+/O'9[YDZT>>8,O1BF#L1781
MD2HI#O=-,VK0R$@A,3)O=R_)DF??3$2OQTVUO_#56>,XWB[B.@XM[+0@SPF)
M@PV*V22^>[/8OJ^(*&<TLE W#(,;+.DXD^H)NM&I[1K0T)2[4%J$:]^Y ,?\
MW"!M%_'!MTEA60<@G=X;TYW'N,&;%:0^-&(0DEF6?&MI")->U5'3TE/G%T"B
MCO6- /*@8"Q9&M^%$S;Q)I9@\6#6-=.+"<ZH4:7.*I^9+)1$'(QGSGLTX.IG
M,8,*L.ACE06:#_]8>'('Q+M'F<N[%)E_*K^W(3]&$HH_QNOQXU5XAT9^U)K-
M3Q\()!*?)@9(,!ZB?7U:>A\.F:$$T>O&VEZ,!X)*W'"+D'2*S*SZLJ]]>/+.
M<CN8?+/#FDC/;#C<<NN(<\,0^ [EFUIH=N9!'[;$7"54/A??.J-UJ9M8';I]
M^XNN"9#AI=O7X.G/'0QZKRF2T76QTTB7H4B>YK&NS=)L,-Y%;AHAD)B$;;F!
M^F<C14=T7<:QY,^*W9^ >NO8]^-PY>\,N.(WDQ\35AU?%!_XWB1I\F4B\JQX
MEK;J/^:XY)!9V!G="4J&7JY=.7=:B81]'8C8C*W'VC\&L?C\A1_.]>UK8USD
MB[;<.;_,&]_6 AA35H2\,B>V3X(I7T$X.0A967#3N ^<%,(G'KTRX[&0WO'$
M><_WP(;]HLT2&Z6 0B-<NNE^FK(X@6HH)^=!+-[Z]#BD ]Y$=172X&R-IFF0
MV"42BU7EAJ:-R=>48$-.7=9@QGW'')@5]?=]/ &(;' S/IE'YE&K0E1[!C2;
MTL&MMV2:6SORDB,N+=[*0L@?^:Q3 -J!5OKC70'7Y[T"2[YO+DQPCX5NL]J<
M 3GII>N).3[P-]>F,%;-L%PMY1@^QH_FP+:Y\$N51X7&A_N*F]FXW[*[CLJ7
MS-:7:G^GU)_E1&LNB4<$=FP>Y)_R+G2)*_19X.K#%G.GXS[>)G-6#X^5-7P\
MQ<KKY;DGV\R@9')&P-&Q*/A,M&^DU.D=F<ZJ-&VR'LEGL0;-HB-^*]^8M,MG
M_+<O\__UER.-*.Z!YG( I6Z 5OX=@P5=?<IUZ)W'L&X#>D7.KN7>&JX)Q6>6
MXR(&B0J8==,MX!J_?5.@AJ.KDB[\O&AK'SP"-NNQ6ARMT_^N66+,(+-?!K>
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M3WVZ)MGT^]9%.LO_TI3Q%$WG+S#T1PC^)_!OKOK_N\!I\L_E'=:I^;FO5)J
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M?K;A__SS7R'_%?)?(?\5\E\A_Q7R7R'_5PE!_<MO)MVW# *4KI1"@G<S #$
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M).E2!LD<$U?G@D7 MU277D=;Q)BB$@>4'D=AF$].N]N3'T:-F4P$:4+:'+/
M[!G,1W0G68(YJ6(8)]M77+E*;3T.NG#=J;I$1\R(9PF48WCF@XH^(^E[;ZL.
M<YC.>:&HN:0Q&QF?S>\ @47^"G> ,@=;;96388(#]CY^,.'V6,59 E5QD:1
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M' N*\U!FNY??^>\ H75G*%[CK#"VU0ONSV35*Y,)L@4"CK<4E^.OC>*\'Y6
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M( QFKK.&97E33.DOCVR,5&P:$-N^WU<<9\?&+E+D^;0S$HE,,\#R^0X07<+
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MC/.:<%-(/]]6SUX=" 2Z#H2KS3LUDTX!\W6K'-BI7VQ]8"='4'*.LEZE0X5
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MV8_ 2X#!("H*[(IX)EL=[8BL,T)9D3KOY]/VU#0O(OUL2AXQ65 C9GU8"4%
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M"!\)6!Z%,O/!1,J$(,=KH>2K6<DOL^8EJR^])7JVZ,U?[>JEG9I7@-(8/41
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M-@&U;M%A.\*I0:MI% =!TL_FY8\?K\$QW7F4K1 7.I.%UUD/L]$;I 275B^
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M0.R2QXQ%"8Q\&^9G?HQC:PWIM%9)^\\C$N,WX[(><;5MVGBR%G (P)Y^1,A
M=P0&;@'XU]6#6,64YS%^/43%G+/8^X^,5$EG_/72&(]E*5Z4D0BG90_?X0'E
MV<XY%3Y$5)3%3(L5!5;BJ1TR_!'\S('7OG9HSP&.1J7%_D5K+DUH0>JQPJ T
M@/)Z7;:(&MH+&-F5GD3)J+4\?S^D<Y'!Q6K.:+XP3M"ZR=M#"/K5^;$5"BU1
M*\A$? VX9S9?(E</F>6^KER?UK%M1!(F*>N_ N"%$$4]: F]\E&610W)"&/]
M$*J:&I(C;YFR=>"KP!I]3S4B@QZ,/.9@;L8FZDJ&A=<@"GL*/6+V>=L/$RK2
M0PJQ,+2:UZ9/9J'UQ&Y+_*U4J:^5(>P+S-1X?*?J[M3?N%DUM5,ZP4BZ(@C%
MG[9[<RWJ?0OZ:4AIEN.CF@Q-6</7:L;:D/3CN+(CT>7T?QWXG;D<7>/RO)8M
MMLW4\_](EN 0B":Y[CZ$CI=*&@M>C\W!H30@W]RC'[,.E<% @0=H"L<]YLO_
M\,\4U6>A &/^::W@RVBT,X>@WA'[EI\KZ-';26@_+]$(P D?PEP&)0V;-Y^>
MO_.O8#&HM\^++>'TXLB#TMBPZ&O3.\37C5JUPZ13XT<P5'-DY*.'N<^9"M0Q
M;W['2Q4>9,4<A#< 6ITKV(JJ](1.A'GR*^@9B$\^2^-%\P-R'..S+ ^LX090
M&>'?&:H9\SWS!643E>8VV8M02J@F((2%AI.Z3#Y)WA3?M5OT\X=;Z\"5ZFBF
M<$(\'"X5G6,35U)M\% NW1:1<.SJ&X^-Y%G_)\&*F::&ILV<.2L[X\I(S)NJ
M4CQD7,%0#^PGB,02%4PD@XV 0N%F F')*0R61%U;$)9R?G?'6#548H1JFD5?
M;@4!=F+?=SI_>Y-86:C*0T*G4:SQ(<>>7;I#WWK;!_2Z.3D.SU8#>W5/]"(P
MCX7R//:YM+AVYP4\F5WWVTG!AX7&)(NC+>\=1FF2'(0LLX;K$F]A2@)NR@VW
M?"*2E2(5'-]%2]_R.R(_-&I)JI 1.[M2VR"_?I6A1!M%,8R<8A;[=D2*7+0J
M+<12&F#]17OYT\F\,A,50O9,G92(*8,>*R[EJP*+G89+%OI;2IO!%F/;P%A,
M4O(GM(F*5_ "%'9?G^;J4:F9$B-'Y=SELQ,@%7:;)@XEWDKJF,R&86I/+Y4;
M5@KI9_<!D-$)3 P%784"-BE/Q([)'T0L4JD@RBC\,26^2#XFXI"[?# @35.G
MS>6Q<R50)["!7IM9^]QU,9RT<4*8;O:O;3/A;YAN 8/:+O.'<RP1(@3*+Q1M
M?Y-O^55)^F)Q('[<J$D"=O;/XQGHO [T SD$H MX/##GPJQ>TP14G1$30Y#$
M.S52B./OA,;ML>]<[>/G""H,2VO=5/;;8<$9H2,1I8]G^TQ(**.J9F_8K;!U
M)F=JQG8XHYQ"/] S>4X44\]^;C%U_M[$_4QWM/XAC.3U"T!4\3F=*?0_<WP^
M@D#Y9S#+KHJ7XC$,A6-J$?F03\2,$YI4!@26L<NK>I(9=JHA/-EMX*Z%,O"8
M,'1V\5W( I4,BU>5<5O=#R'/S T+WV=C;SM7"V^Z@ Z*D^]TDJG(+Q[G"21L
M%@X)"NI%0S7UE WZ$9_(H%-17$JO8;\#*[>,OFPU=SI\8Z;-[3*?7%ZX<CE[
M\ J0-@"7=FZ1.7<>>J,>0$^RX%#=_=,,I]*K*I< _:6$M\Y_\D!.[YL/?9V%
M.Y+2#/4C!7 EPNCSA<#-6# T8-G'15J;:^"B1>R/S.].#M<#RR*?&(?9?-N<
MS;U@GV"%V>H#UA:-IXQLE9O@=QIPDY4OX\4WN(%S5R97V[WB;E2;AMH"O?Y0
M$*!%J]YL8(32!-_S&)]YW;XAD-U'8YYGDQV>LBE9?&2T!^1H:X)U;;87=4G_
M&W>#A'5]RJ$G"3E#05>"S"IZ _]E/$DJ#5I?JL1KCRB#8Q%.1P(4),0@32:N
MF.5Z:F(8RT"\ O:.+I'.Z<KUR<) []\@Q<)A4M^E/I;;R'G^'^L6KD851W/I
M/F0*D>K^27YI99E&P" TERR29.\$97<>LIH#BS\B-1IQW1;Z<'.!I&WOJYI.
M,NT;OB*.0EPFS#6)Q&N.=DR]_T2=1G=!\:/K$BL/N3\C][-*#:8N;Q]N)*3F
MF+W'U\]Y'6J>IDC/3HNO*I297)2J14BS(F%K/D'QC4T_6MHV-_]9?XS[SP*"
M'@FIQ1\;O */:#6/B>?J/[=G"UO*O(1N\&+K6.6R9Q@(V_"U0 8,:+JC\DL"
MI#*N)-@P'<(9!3^P]E4QUU6Q+.ZKYP8IW> VS+G;%X!44 E=FD1D^2.Q5O!_
M^]7_CSHHPZG=M_S>Y-1>0HOBD# 'B,C;6]AR1Q;MN!MU0$+?NI3G)V=GP4-L
M]V\<%-S;"ZGMM7C%&XE6]\3)_+[I2USZKS"&Q@'1FBD7Z,J ZU5</]K.\Q=
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M\XCKK@?M"Y'1&YR%XD0LOQU!!?%4\S[]LA0%]U&50?>7(1:N/NA#/VS!$
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M5)QP%4G4R+7A[]P"YX4MI@A>25@0#I2<X((//!V$5K^(\8MK)26@LJN5DD@
M*2V(QWF\J5N!@C4(DB0D]E!4G#[-Q6^E<=_?)&55%Z$DZ]Z I*A #8@<150D
M$$+\=NAEEL%+:=)(TJ_J4,C(YHF<=-L&N;>N7;E6MU95,%,$Z0 #!TY!P!JW
MCUJ07'CDA>\<;NP>@,1IN(Y39L6F8XYT#;MM/"OKZ@;]B8PW]R=ZS25%=5QK
M@D>%ZMKX$"U:-BNB%#]4^C[Z1^-=E;EOAZDW/%N"+CO+$J#CED"N5N6*E$!H
M05*[DK+2CN$F%)U=V[;L)+EPX&P02%$P  //WA@@ 9KO%JK;>$;DQ>-E6#V@
MSH9BV$^"\@,VM).,/,ZVX@^9N1);?RHDBN19;2))@R944VWB^Q.%\6L.,V;5
M]P^X0^PX ?"1K;5 U-NH]YMQ,PI*@.HE)!.);W+%TV'K=Q+K:ME)_ @Y!Z@B
M:<SUL:O4>E*/2E0@P+_K(^5G^Y!]/W_SY^IAZ5/(>I_!-3?]*BCTI6#R/)L=
MP^GDY#E=[48U0PG83,RYO;&)55<5VRGQ:NO;DSYSK$5@IME-AP(J.NC[TN2Q
M';\G70%5*SGI2M*V-L7#=385?[#V!<C08CC,9F3;67V-G:R!67,C5M?!KJ>D
MA65W>7%M:3853245)6V-U=V\Z%55,";8S(T9U3>F@UYR\X^;9S/'-?ZYS>PR
M[)\IU_!V=7QZG =D'55V'V4_(ZF&_EN3/8BSC&!WKMMB.2U)89F]QCV9L6E-
M-KI&/M36T8)4P1OZ<OWSJ2GI44>E*YG<--W:FT#],KASGNX\\Q_ ,6;X]:<K
M(TZ[E$DNZNY^(UH5>-8O2PVY5YEN67+PK&HL3QBMM\DO)BC#J*N;*,&25)$J
M('4_C6R?K_+KEG^WAT').$''R;^)YQEM)3S>86QZIS\7"PW7=Y&N\.XW4]@R
MJE$R+9\'-ML_;N.,O:IUC=LQ+EM4X$<S]P\O/SV ZFI/:.XYZ>XZ4=I3:IQ%
MJGEY+/"ZSC,;>RM<LV1LG(Q:]D\HV9LC*9MOF^P,D<;[:2XRN]M)<>-X081Q
M:]F/%:5!).YVV\O0<J9#B+_SL?43_P!]Z'_\E?#7TH=D^GYFIJ39L*LA2[&Q
MEQ:^O@1GYL^?-D-1(4*'%:-^5+ERGS;8C1HS#9O/OO. TRT!N.&("JHJ*@)+
MY<Y]R!E2<8X&852['J!D/0+;EILL+>MXKXRXRX3,IS7YU;T#+>4%W$,'!9@Z
MJE5.KW)3;]?=[QQNTC.5KBJHCWL'IS^/3XY\J8;57&6LPCZE5%E^V<YR?DCN
M4.'E_DC6T=IP:-W^#KF7N.DII,73&#U,"-B.E,9"L?EUK<##835_:P)#BYME
MF9W#TFXE*B3$8 \N?KF3'+I/G73C,-P:JU\IAF^Q<+Q=\!(EAW61U4*>J"B$
M7A7NR4G.JB$*]-QS5?(41.R%%U][Q;A?#4ZN(<1L;%/6[NF+>?3O5IGX5<;8
M>=_LVG%_X4*5^ J/=IS^XI5J.HWLMZW-KR[&DP[-[)HB T A&:UCHUR*BKY(
MKDP ($(A)>E]<G=?2=V"LU*2]VFX>I21)]G+UTGS'>6S3K4CF"L$<XQ64CAE
M^N--LY!YF !ZR<?&N7'+[FSE&>;NXZ9GQ<J%I_[+Z_<$#*=F[.Q<+>JHX6S:
M3'*.//P[7=?F>.6.;Y#6LTDF6U7Y'DV"X^R<F$]+L;-&9=.YS-W].OT>VH.B
M_O[U0) 39\-N7-4<TE8;20< $'<CSC8-=F^*K@]P E6)*QU!S )'+,'&U)]5
M\B]=:IRN5M5G4.:[YY 6M<_77?)#D-LBEG;#2OE(+DR@PJKH\.+#]/X$^_Y$
M>O\ 4-/AN)2E;8G6L2XN%DVK_*7O\1_9]@*-IP'BEUF$][<V-N3C!* Z\M()
MW"DA6/=R*S6^R=\M4..M-HB5:?$ F2)RI.J(YF3'3(=6\^I/O^>)I0X+K7'&
M%(U27/C9'?.M-IV@^*)=5+3A#\DKIQ :-/%1%![[Y2Z_B6OE^&S[-V=N2<+N
MKYZZC) EMAE@ C$@N<B08.,UOL@@B57:UC$Z&TC&)W48,3&\=#4<=E<E=\;9
MO=9Y+DN9QJFQU!F]ELC7\G'<8K*=JBRZTUKL/4<VU!N7&M)D\"P':F<4S3%E
M.?BLN6K5LPRMI75LV-QW$OXA>WEPHMV@X;9X(FTX>%JR=]=XY=I24B(&D2),
MS%;:V[)<*!2'7'3J ,+<TDC!Y>$@F">D1F:;6KRO8\:?FEM"VGL"MF;"RK^.
M<UFQ,VR"F#(\K7'<?Q1;Z975TZN@G,7&<5QVF]W[=IO["G@M"VZC7DO&WOTO
M_2%>D%WM)Q)*<C38*:LMLY+#*3F8!,F !L$D= SV6X(V"$V:5GF5_6[#,:IT
MB<XQ.8ZZZ]3C92RGS7_U22Z1&];6L])LYXB+LS9>FF\2$I(BH_T($J"HHZ*]
M^N*O^T/'N)*5[?Q/BETHR5(?O[E],*C,+= SSZX)DB:V;-IP]@)[FW8:4#[R
M$MH)B")E*YB#M$>8-*&:J$)(L0 8)%5')GWL!UQSY[46U<D@JBJ?R+KV 5?$
M&SZ5!TY=>CWUJ&^-*B-AS5,''E(GK6:$ ;"/,)$G?TYR1T(Z5D&6F!0FHS\5
MI/@'I!I5NF1#\="93_)QP>U0C55!I?P%%42 ;*TK5)5*I/NE:0D R?=DC5U5
M).2*R$NN(") \)F0 F=\&)C?[NM7@:C=DTRY%3Y3W9/N 1^7RO0G^L*CCR_*
M>2]HUVBKVJ>WZQ5MJS"4Y5@:@8D\CJR8@=.9$P*R!>%6740G>4)E4^9TC!DY
M\AB:6-.BWW'B.)\=$\[]Z*H"DJ=D7N2)/N2#1$_K\O!/$W/Q\!<@MNZ2"HA,
MC&K$R?,^N1TG$&KOMS8  0\0.13C'/>=B/G/2KW[9$C+?VZ.*GD;[LB(^0>7
MPKKI'7NFXZ2)T*$I*?79="*IZLJ:*1[LXY!)P<#<;X)Z_*JVKMMPJ!\$'[<@
M3YQL>@ 'WU>5MEE!886(X\:*1$:Q"44)50GWE;IT(E[']L5^3(?$5$!,FZ @
MCQ=VN)_I&<@9\.^WY1O63[0V-W6X\U*_$S%7?<2( LQG&T=<4B14>5LB+I/-
M]TH]4V2"':=]>**O@TV@]@B4JM@N7"VL@QS<!Q SI4D1@'83UR*J3> 8#K82
M-AJ)&=XD=>O.!XJ])(6**"KSK\AXE7R6=;J;KJHB$X:M101 $112_P @!!;;
M%?P#T%L-!/<RGF$H,0.H*E$G$DD\H@9%2;V?=?0 8\25#PGUB01 ^.<5<26W
M&;7Q64Z^Z2(OYY :OO*B])T*((@(CT@]*C3(JJJJ"JKCJM%J.H=VE $#4EM)
M !VA3B20 9F *RD<1&$I"'# !(<"R3@<TB)/0;9WQ7IMY([9FZKK[KB_DI5U
MXXKAJO3;+:..BG@/EXM J(@IV;B]J9E'L9()2\0D8/=):*9R8,%S,<BJ8Y#<
MW#>JV+48S]8!O.WAP?#OSCSH$FV <D.-,JZXH*XJT%@X7?:"TPVIN(1()= "
M?U&X1&J(;A=E6H5I^L<&G!,I3(F=NYB>4G,\\U"+M40$)F>:E$B.:=*DCGS"
M@3\JN  @)29 ,>X0^;O5$ZB-@B?BRVKK_P#V/^UT)*XX2JB(BB X[ML%*.E.
MI V4I\@QU 2PD#;[4YG,&LE-RV0-3JDJ.Z<&#RY@F?2E,5/MT.4XV;+I#VJA
M"A-HPR/9("*X1"*]?F\H_)'^*D0MM=67+!3FG2I1@&=-PI 3,<@@]#[W_JMK
MB*6=4K2=6G"TD[3L ><CK, XJ\U)F$2R75M [%4:% J!1B/WY=+[W:@Z[TAO
M?">/B+2^2M>92OAR3""4G2)E3B^8!.$]W$QDE2B>@BJCQ,R3I.=OJA,["(4,
M1N,'(ZX]QSF/%]TZMDB>*I&$UIQ4&BZ\C)!3M#=Z0NE^6VT .A)74+&5;M(^
MK1I)2224[]((SB<S,G8U?]K=@'4L YR('+PCQ<I\MIVQ5E'77G4D.E)5M/QB
MH=HS%1!7R0WU2.J*ONHGBTJ)^+/Y"O;QBE*[94A*2V20%0&U.*&!.I*$DS)@
MJVF 22164W=0C6LJ5'A@9SUR1TV!.350DL/N(^;H^VWY"P)9!-%5<_(''U4%
M^4\>VF5^$4%<-%('05*#:+ *#I4E4J,6K\B9Q&D<C$XR=L@4_F*020E0Y8)2
M8G8X.\"1Y51N8W)>\P<B&PPJHTA7<Q]7'D^"<4/$E4&OEMKR(>S5P_R%&B]0
MFP;0@A+9!)__  9WS@J"HQ&0#L8B*J_F+A_K*3D)UD C/..69P=AL<U47(\I
MY"-J(K#!+THULZ:KKZ*J*JD HJA').D555">_+\58!2A5N6TZ4)5J6-H81M!
MRF'' (!$$'S.F8K;NBM2BI91D2"X5J'*=!2,?':#RK'6D*UM'ZW]$EU->Q!M
M(\FR*;ADJ<EE#9]W[FMC$]<5007U<5D@LB6<W'=:\%@/$*JEQGV)M+Z;^VN+
MA;UNMNW2S?ILO9K@JE+[FBS<-R@ '4QJ9UA4%U(!U7%./$M*MW4IT.ZBZY;E
M\+;TE*FH+R DE6-6E4$&4RH$9PWR<,FR60Q':/HE :=AMY]LD+VA1UPR]IE4
M0G.A7MWII51&G@74KM4)0GNSK7I <#BU.)U#<H0D @'DE).G GE6:BZ(6HN2
ME.X(;QG[,R"D#TV]21;68LMWVDEJ4=HD\T*RCMG(=3^EL4A12<\ 7HGD[\2-
M!:0E0'12D6"VT%?U>M8(@MJ3&K;^T)48W)@#D(Y5^UMS*9G$0HI3(ZB,YG//
MRKT4EZ4Z3?G,]AHU1TT>OY+;[B*O;?[3<<" /CWU12$R5657H7A]8Z^&H8(6
M&4.+< 42$- RHZ0!J<!D1N4@;9J\F]"P"7-.0 GO")SCPP0<C .\1&*]NF](
M^'!!R*)+[JRF7E1YP/\ N42=;MJK8$G3Z$"":_L?/[PC:6RA(*0AMIP@DJ;6
MT5'E"@A*X7Y!0,<MC5\/E4$$+B/>"B<9(&E21@9RGUKQ]TS*4FR"$# +X/DW
M'J&E)17K[=LBL7E45^4?-.^D[9%?-7/:LHL6DZ5+6\HD'"D+&?(I:2(WR9_$
MFZ+MQ0E/=QU[O$_?CXB:%DQGB5AMN$C*?B\XT-*/\D5/984!-$-/Y.."7;*=
MB">ZO;5D\/;;!4CO2Y]E*W24F8DD;$B1U$XDU";U:E!.I(! ,]W,=-SZQGJ8
MJ[]S#\D8888:$$$7'1;I5!D$[3P;_: 3>5$_$%7P:3IQQ%_!MZA/#5I)<)*H
MS"5N+&9)DI2J,QDB?+4#-7M22(P>7,;>4'\^HY&J.3(C2?;P4B>Z*>7:MUKG
MM(2]^X\XU:1R4U55)$7IU\D-544\S&4V3Q)[PN-MX*B%J.H=([IR(&T@9($U
M4;E @H5F<@I V V()S,\OES]MS28!$!'WW3)2ZCOSQ-]SI$(R2%8S0 1_'\_
M9]MEM! !1$;;]5+L4NJ_ME:0F$AP-%., @J+9F/7H1,@4>TZ3[A(.#I6I),P
M9)TF?2 )G.U6RDJVGOSW&S^>NI)LDC0^7X-MM6L&.\O?QVHO(;SB(2]] #=Q
MOA[1'=-I5),K+8=)49DK*4J6$@S)"$Z4R ($33[0H%2_=&DD!7BB23$JYR,%
M0DY)B:$=<D"V3HJQ'4D-AAD)L-E5[[%^2Y!?GP_)/@FV3!&P7IQSMQ!1K)1P
M]=J5%"2X5'?0'$I!WTZD)6@C$ G'4XBRJ]#HTK4E/VI)@3/(0=Q,[ ^?*T3G
MW+CA1U%Q6U5),T&H\TFRZ1!:C/UOL2_>5.Q]PV#]A55'!4@42RK>VUK*G9 '
MNMK40I9B-24C,))D@8(!]!C/OI2D!LA4QJ4) $3@3@B,3\YH5T&FQ:01D>VO
M;3*>W:D)%V9=MN^Q9@\2]DX1$:CY$1DB=JF4;(.JG44DG"T$(3$?:2003I!
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M7%+$I$=T'X@YG M&XF5<F[V$;;1.V^WV8>N#F-,VF-Z2P^S928:HF-L>?/\
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M49&=.:MO5O<'<]P#_>SLO-QEW MVO8L,3W_>?#:P&A IZ99X4= C^,[I)?=
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MG_G\:ZY8-*+_.-"&EX+[S3*3>]1VB=<@UR>E.=U^+%R!&"8.TD/3V;/'#]O
MK#[F(#ZL)RPR$-YE#!QE&/%\+.[9$*%\!D<>ATL:RWX+T;H]4$$QD_2'!I$6
MZ>.VSZ/-J.Z2C;".6EV@M!;CJ$Z_?\IT=7Q*Z(8_2/!-_-Z^[\LD6/O(RBC/
M>!I2-1Y5RO$+.) @\<%*LPUY(ARE&(X!_)2ZT@_<SI+2<9#=<A+.-C);S#B4
MYXN$'1I9NK:&QF;BR9'%GNRXW?X'L%.^@0<]^7[1? WU ?S8;DDJ M444!>
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M?RULO(]83]F2^3R%PP:GORQZ1M(_^*(0_%(XF/6/OEX,HT",,VV-?JX$Q\O
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M%'6N+6R 23@=#"XSQG:2@,YIH:V%O%!LI[.JH\;USG71@[]ZO,J5#@N+,FW
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M(<OWV>J@6ORS/TS3X/ABO*\^=Y%"MVES_DW"\8W*.C&Z%^INQ!OOGP $,ZF
MF 0L>4 D+7@89AX=*7G;% -&N0P(4M15'->B+5U,O=5&?8%@A:C+WIG*)9.G
M<RQGN11]M[']N:D2\SQ"7GUYM^,$$&'[K_]48JDGZ(2>Y 3*G'L(4EMDYT2K
M@]60TZ64!U$0K0)Z9:G[%QP804,LV(@.LZ2;E''D/5YYG\D>U]\ST#=8=%UC
M#;<C.RQPH7OFU4>(9WG&B*,W=)Y.B@Y6,X&UK=PR,A*%-?-^ XHZ\,%QM[2
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M$(,& HY2J<"!$;J.(Y7BG:)V[2&+9]*K="R'%I)4FX6@Z2AP$Y2G^D@I)&H
MTJ_4 C-$[),/:41\713RCRQ+H1#Q[7I\B7Q;!%)75)/:5SLFAK<L%/K"&T%:
MG%A @$Z9G*H$A(ZB2# B*HM>,HMT*6XL(0V@O.H5X&PVD05I@R$IP%!("E2"
M 0,:^Y+.4ZCZ^ZB,+VW%3\I-<!(B(3*HI(^!H/9](:*B*T'N,@C =+:<&9L&
M2TXD./*@K=*01JS*4Z@"$C,1$DD1B*X_B?:-WBSZ7F%:;1HGV=H&$J$#Q.)!
M.H]"H&),$S K(LF(K/NO*VCC_0M-ITL6R<)%\ $24D:D*B%Y&B+^V*FJOM@K
M39OA+S]RAEEM;C:R9=$D( RI2A$%(YR8CE5E?%[>UMW+B[<[GNB% @A+[IP4
M!N5 J$X@J'H08&$&2;YK),W7"%1\Q[7[N!_/Q%C^LG(@_EXCVXKGYJJR4,P'
MHVN&,632F$MY6=17[VM4;F=XW3@Z>6)%<G=<9>XH^F\6Z5I0"AIL'2$"9 4D
MG"H!UQ(F22>=JPNAB-"K9,K.E(B,FGY090+^'NR0%?VCZ7Q;Z52</Q;;,P5U
MIN_9<'=NW='A[@RIQQ6HKPH2E"M)E1))@E((!)VJW>]H&;"U4\[#C\)[ID&%
M%:MAK!"D)1.J0<Z0F()C",N>2$0(X:B2./,F2_<LFO:H_'<3Q]P%7OQ$5\?'
MMMGP0%C+TAM$6[:;?N@EL"$>!,$#&L0" HX5DA6<<A7&F_<NW5WBKA2W7%2I
M4J2I1R=*DCU@)\21$ 0:06U\;:)&8<1'R\0>L6T\15OOXB2FP\4"0XB^)D*M
MJRAK[:QG76T3,X5V?1<O%U\N"V:T*:&@!3A!DSN%M@B,DSD!(C-CBW:(VEL&
M$)0;Q0&HE146FB!I6DSX%';PY$R2.6.CNBX"MM-^!(B$Y \T'Q\%3MZO=10\
M$!414%%;0?Q7J.:JI] ^RI![I: 4'#8(E! !  &1,>%.V0 -A7,,W(>)=2YI
M6!J<\1"TG=4F=1"E$DD$R#*LR*P-ED!S%$([W^$:)066/PL@VU[5B<TGC_AF
ME^/-$#R-2<46!$'']GPKLZVA:[JX0L+4E)90M,=W($D?WIF!MD0>5:;C/:9T
MA-G:+2H#%PX(4ETC(;1G8" X?#*P1!]XV DM@).=I'1D5D.QU<0! &_ZI$!Y
M5%!Z1>R1?!![3OV5)?//>M' H-%LNAQ00B)(451 F)!ZX&01*@:P+>]:+8=0
MZ&E)25.!6"V$D@DC T9D"<BM6M;Y^U3Q%Q AHJ@A>)-C+(/Q']481$5MP?A&
MNQ% +Q5P1-083J.$]GFK%7M#Z4N/S*$.(2I" 8(*0I)A23)2H"9S,BN=XOVD
M?ODBVMEA%L)UNMK6E;BP3.4D0@P I)(SJD9@J:%BVN[.MHZV#/L[>QE1J^M@
MP8[LZTD2Y;@QXL-B.P+C]BU(?(&VFV@=>4U007W$[8R;ZS2VA=RVK" %+0%!
M,"3*D@G2=CC"IP,UC\':ON+W]CPFSLKF\O[Q]+%I;6K:WGGG5*2$H2$)60KQ
M"5J3H0#J) "H[^<0/I?T^.L5&PN1\&-<Y (C+JM6BXW*H:3R$5!<HD,D07,E
M>A<6@8<.EBJ -RW+/LH['.NW*G,)E*2,G91Q&3.!$8WF<U]^?19_#QPO@+=I
MQOMJRQQ;CFE+J.$JTO<*X>M201[0A6MOB%VV<:U3:MJ [MMQ:0\>RL.'$@18
ML*!&8@PH<=J+$A1&6XT2)&9 6V8\>,R(,L,L-@+;330"VT H "(IUZQJ^GDI
M2E(2D!*4@)2E( 2E($  #  & !@# J%.!?\ 61\K/]R#Z?O_ )\_4P]*JY#U
M/X)J;_I44>E*X#\W^4^T\URC>'"S7FQ<0V+>65U3VM<?'%[:F.\B-;4N%WV*
M[$S74V;X+CFQM;6NZJJUPR'88_G]CQ:Y$X-R(HL(O)[]9I6UF5T^3.']/Q^'
M[Z[56 (!@_&"#RWCP^4@@]:Z+_3G@LUG$?7->UNJ7OG[:TV KF93HNVJ^31G
M*V#DTT=8'6[]RO.=Z5@ZE:E-:Y:K]P9;=;!B,XVVU?NPG1;K(*J5;G$?+IY8
MSOC%/[R%W+5\>]*;)W5<TT_(J[7.,S,A>HJN3$B6%N;)M1XM?%?FF+0NRI<A
MAI!9:FV#J$K555VUF<2LEJ 20.IBHBZ)^HIC^]-J:AUO!U#G&'5NW=5!GM/G
MN5N/0\4DY='_ ([>O=48O;#2?HN69OC=5@<W(KRA;NZG+:K'Y;DVUQ"O?H,I
MATBI(@3(.8@=.OSQ^Q/1[TJFCTI7&CAKS#P37?"SAQIO7>.Y/R(Y'EQCTY-:
MT1J :RRO\;A6.&UGZ9D6WLLM)U?@NC\+DJJ.LY%LR_HY%U&;D-X339A<--TS
MZJB))DP).3^FY_<P,U(]GBALSD:\SD'/#,J;*<5-QN96\/-33;J#QNJ!0T<:
MB[=OY\>FS/E+9L*#:2H^<UV(Z;D&B&WH_P#4(K%XZI,>[\SO\.GPSYU/JLK*
MVDK8%-35T&HJ*J'&KJNJK(D>!6UM?"9"/#@P(,5MJ+#AQ([;;$:+':;889;!
MIH  1%%4U\Z7)#:,>EON:NL M&(SV6\]ARBZ;22+"/4N,\*N&4>%'>$G1]R-
M*M[ 90(OF/OT@FJ(HIUR7:YQ2[%JQ0VIU5V\G4A*%+.ADAQ)TI2HSWH04DP)
M3O(%>1?3%QX\,X'8\/:NF[9[B=XE3JEN);/L5FKO'M)*T$$OKM].X.E0Y$B#
M(6E"<J."/1R%GSDFD>*Y([4.FV04F&'%%"<<]X#141281/GOUYV_PF_*1W?#
MWFRM2B)9""0#!QN$G!"2)C) V'S39<9M I;MQQ-D:5*2DFX4L&3A1(D%1 .<
MB9@YI=)R*M)Z-';200*XK[OC%=;56XWB2(*."V2]2'(ZK^/2BA?/RG>*.SO&
M%04VA@[2XVD@9Q"E@IB"(@<Q62KM)PA)*?;TJTF/"EU2?@0B"/,2*M6>357L
M P920^[=!DO*'*+]L45UY"5ILU43:;-M51?A7$[Z3OUD6O9WC*7@HV:RE *C
M"VU;RD0E*E$F8Y8&>1JS<=I^$(MW%HX@UK*=*4J#J2"HQ,J0$@B9F<8/,4DE
M7-,[&-$E14<=466UD"C"B;QHTA]20;7\/-7/_P  *O?2*OK,<X3Q%LJ"[)X)
M'O'NP1*@#. 5&21,)F>0Y:]KBMJ^D=U?LK$ D>T)20=S(4M) U3!,#F#M2Y'
MZP&#.*Y$+V&NA2*\TCB>(]  DR7F*ET@BG:=JJ)ZUZ[0:E(=MHQX@XPH8(,2
M%)"HZ?=//8,7[Y5+=VM6@DC1<Z\GD"AQ1)!.0)(C.Q%*X[;L2.TVDR7TT';I
ME-E$A&GY.FOF\2?D7D2_'\^^U7UAKL+(J)5;H! @Z2EO;GH("CZA.>1QC,3Q
M7B*2(?=C<!QOO >LJ<3JCJ-4;Q%7(DB>+ D4^2!NJ3YH3<,E%724A R.*:D3
M0>#/:GWTVB?[.K9X78*,ALI&T201F<0(\I-9!XWQ), J:7B9[M*3D;  $D#_
M &,Q1$F3C1R1]XI>^X1 7LL$GLC^VRO8MCT)@/O(B>(HKI*GRI+ZM+X18$@?
M6>FM0Q,9B!GKMY15:NT-[ $,F,'ZL8CE,>H\N5>8\ZS<=DO"^P0J?VS:G%7I
M&V"5#)/&0'R3ZNB2]?D -KUV@]/Y/9#<N<Q"5*.0>N?AZ^571V@N2$PPPI0]
M[47$^G]FI,SS)G&W2E<5ZQDONOE*8\&46.V@153Y+Q<?)%-YP5[5&F_E%439
M-/\ :GK$N>'VC:DI'>*.9AQ7*(Y^9C_<BMC:\5N%M:W&6FUJ6O#?>K$"(/BU
M0,^&"!OC%7/NG1ED;L]MH(H^"$0Q@3WWA0G/AP.D5IE6T$D_R?<%47I?6(OA
MUNY$-O*@Y 4H@9B")Z_CUB,UOB]RR MM+0U2)4$$XW U20#SY'$U0+)EZ22E
M;J;<1$/P:^P<59#@J@] S$<=56F2(E1?YK(;45\@^,=WA@2E)9MG5F2""KW0
M-I$CSZSY5F-<??4GO';NW;!\(00 ,>B8GX;=17HID>7(%!>LWQ8_<- &3$$W
MR3]D5^(C7[8*3IHO71%'(55>_&V>&O""ME+>T!1'/8;&>>3TSRJ__/0=KQ!$
M;I&,_9&VWE'*K@_XE]$&(^XTQTX\DZ8IM$\J(K(=*],[]L>WG$]M%$OMR_S^
M,6ZM>Z"4%3:5*@^ :I!Y&$CF<[Y$5E6?$M9+BE..$3I 40F)PL22,#:.1WVF
M[[[$B0C0I6-C%(7'!CLK/<5Y$\FV?!I&#%6OQ>/\/A58Z4D(O'"+!2<940"/
M#$CK VQ\<<\SM&+]+P<4Z2T4J^T\5!68!*>:N<\JO*^ZZ:$K\E(\8OR,FX<2
M.<D>E%M1E@3XBQ\&I=$JN^V@D2M$GJA;>I*D:O(A).K/(XR(@D=/C6:V^B-;
M;J4J!("S$*F)B22=X'/?'.@7D?)7C-#C,=J*FY,GQGW$3M72<D.1( @PJ=!V
MX8JZGFB#[39%AN-DPRVA/(%2Q&F,S)$ "()Z'8XK96SZ4@.N/2L @(&H8,Y
MV"C, #!V]/8R!4?O%0FH_P#5&0?;8$U)"#W?*-]FV9N*O@PR-BZZ@E_01NJ(
M:UYM03H(\()"B@ H4)D$$!.K($9_.MW:OH0H.:2IU:04!U4%$I(3"23&,XYY
MJ^A.^3:D*+->5!9 O,3;'M%-4<%!FDC8_F\X(SVR5$;;(U0/+7/LJ(UJ6=""
MG2@I)4HGER5&V95@=*Z"RNVI0VVDJ=*07G"1I0F-S_5 V&)S,32E8H(Y]N1?
MO/ CDISQ7WU:1?$5&-&(GD)TD4&G4<@DV/O.."IBOG@KMG()*3XME$>)(.$[
M01$D@@B#)YYW*;U*!I2M*DA4*( 3D8,]1 R9YUE&6Q;>%5]F+'A^V7D^K1=O
MJ*^V@,#U#;=8#MQ#)'WB)QHG.U'LL-VPD:=*EKW.D2HC;;$'!ZF=YK+MN*J0
MYWH/A;!;27"0A!@G4E*ID ',9.D@S%+8TQ"DOR&F7)#@(D8)4M2!>R\79) A
M)[R@JJR(M VQ'4FC]LD0E(K;W"E.A#+@2PVVD+!"1WBUG!)B"/#CR(VQ-7VN
MT3#277BI5V^ZHI&A6AI#:=QO"CKR(&T[1FZRKLIV2Y)<)U%<%D 1%;C^#(]K
MTR*J)JDAUX55\GB%11!/M.DI-C:L*: 0''&DRA;H"UI!SX"9(Y3!/+UJ1QKB
M%S;*3WG=(>426F5%OP@DA*B"D+@=<)DZ1F:&IL)DY9F^'N>Z+*-M^3KJ-L-@
M*"C+:$YT+YR$[0.OGM2ZZZK<LKJZ> MV''4A*4ZT).C'0F.9,$#,'RFVWQ"R
ML&2;R[98G.E:QJD3J40)R9',DX$5XC7'DY+<CQ3<[>%H77S1@/;99;5$$11Y
MU>G7'NQ-MM4551>E]5'L]=.*0'76V$@ +('>*)Y^$I!!CGN?*,XP[:\-8056
M[3]X5*)EO2VWB).I<ZB9Z>L@U;"?8.2)A>^RRB*RP'LL"1^(->^*J3Y/@OB4
MHA^&@[5%7KI?64>S'#U*0;AVX>T)R!H:0I4SLB"9!.58C8$UA+[?\3;2I-E;
M6UL'#_:+U7#B8! D+\.-SIC/017J,4A^1,<<D2CZ2.PJI(<80B:1QX^@BFPT
MB>,AKX0$\OA5[7Y]8]WPGAC"D(9M4" K5WJ4K)),@ZB.0C!&)K,X5VCX[<LN
MOW'$WE=ZY*/9TIMD@)U2(;TJT@D !1((@D32MF.R<EXS;%PFV66_(T]Q4-PW
M7'$4C\E\E$627Y[Z7Y7Y^==<,V[>A#;+:"!)TH2,';($[ 8-;RUN;BXUN.W#
MSIDR7'5J.HDDG)(^_'3HNC- ,M5%L %B,*(H"@HJRG%(D5$%![!(HKWVJ].?
M[.O6"ZH!(0D@*"B2$B#"LB8'*/42:V=H%J6ZM1)& F3XA \1$G;8R,]*')D5
M)R-G(:0H[!.*UYB3J$^OBV0M"I.=H#+Z+T*JB.)_)"7N@-.J\(;62!T/BDB-
M(W5 WQBLEQUEHC6ZVDY@%8F=LY\H^ZO'Z@T],;!MF4\,9LI!*+*-(+COG'97
MN4;'EV*2>T1"1.A7^?7JW<6+RVDITZ"I1*M0SI @!0,<P2!G<'%7K/B-HTXX
MHJ#A2B$:0%>(E)E/HDG//E-*/NY#TEH&XH*+"%(+WI'AY$J$RP)"RP^B(2DZ
MXGY?!,)_FGK 7PY0:+9>"2I0.$>$)B((')1DQS(DUM;?C+167 PI1;( ).F5
M*&P$&  3GK)Q%7GI,YYUECQB@B+]PZB(Z^B"TH^T*_DPOR^HN"J](2-&*ITG
M2X[?"6Q(4X#J2?="@0?01F<SS@Y@&LQ7'EGQ)M]O[\B1D2F!/GR/.!5'I,PR
M;CG(AB!JKCQ>PXVB,->*D"]S/Y.F0-DG?Y-$[TJ>*]PYPRW9&J''%'S4D [
M[S,G!GEOBKC'&+BX4J64(0@ E4C<F!. (F,[CE5N39DOC'"RK!<>4A54%4)M
MI$[=<3_'_BJ(J""]?Z4VU_DBJEE-B@DJ#;NQ@AR94)@^\)R1OMS&160>(*U
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ME,R=>/\ K-Q>EFL_"")MJ'D$B+XH@CXJXOBB ZCYD:#N4VK26PTE("4D&0D
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M5DJT&WHH*W-DQ+54-)$3'7P@S\1GX'YF!4_>.>2\O<S<R')>3.K=+Z-IID:
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MB%@F=27$D8 @D@ 8D',9JPEQI:#I6RH&  DME1)@C*<S!WGKRFKLL&W#BM^
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M;&1$B^[).#!,U)YQ#-Q_MQPD56A)3AB1#V++2=*BH()TJ]=XPL$YA>L_:.F
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MHV-F&@Z->JX*5*TKR@G02 8@P/=R.6?<9M7ON'7W'7U>DN]"ZX7@@M(,7HF
M\(WR3)F/32)XGWUVJKZI<M+9M0#2&]0,#91Q $C.3B,9Y<ZRD<6X@\P"]<KD
MZEJ2@PD)Y!, $ <@<_C58DR*TCZAXDIO. +45OW"%&%2.@G[:>#?D;9FGN$
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M3*%A2CJD;I5,J@1D$P.>,<NYJ"0V0/ -*D: "A87D*$2#Y&)VS5L&VW)$DR
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MC"UZBZHI*VHDH,20">K8TI(SIR#A[^["!5+$[11LO.* %\.0V^T"4KB=]BR
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M2-159W;.LS. DAM1G3&E)D[ 3)I.W&6M1^1+@28GF0H!'7R!(F6A1!<\D8^
M)UQY1<)4!142\D_GZS?;^$WKBE6=[8+"04M?7L-IE2=]+BD29,3!.P&8K 5P
MSCMFRA%W9\2;@J4Z5M7#@!,)7J+862C0![LIWTB2HFD6U5WWGX\;X(D:$Y#H
M@B-1_CS0&4=4NW2>[53:51\.N_Y^KZ^'N/N^!^W+>C2.Z<#I).2?"5S$X!(
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M9S$_ YH=](<ELA^GMK[(./DGWI_!FGL-=K]EUT0%(^/\_!>_Y=>I'9Y:1 N
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M.=N(1HPB'N"TW'N>-52VSY-]NM-"(*ZTA.-(0"1)U*0E("4ITI @)2F  ,
M 0/0#;RKI-)\O\R?UI4GU'.'[:H,W9.44Z]^/>1:0WWC*>7AYCVM_K&M1$<%
M%5I57Q=43%I3("1*J0?+YC]?V<5#W7'U!>%=?SDY4Y9;\DM8X_C>2<?>&]/1
MW63W1XO L;/&\LY=RKV&P]D,:M1'JQC(J,I*.( H=G%: C>-6T5,'2,3D[9Z
M=*F1&^I=].F4X# <\N'3$EQ!5N)/Y*:=K)I^:$J(,.QS&+*4D42$P1GR;,2!
MQ!,5%%1I5_2?D:W>LYR<*;OP_1N8/%NW]SVE;_3.0.II_FC_ '[*A]IEKOE[
MWB7M>/?N>*^'?2^E(/0_(UO]9R,X]W7A^C[WTU;>YX^W^F;/PB?Y^9^V'A]K
M>.^7F?X#X]^1_BG:_'I2#T/RZ;_*G!K<SP^Y02I\KQNU0T4@6MO:N<A"CGM*
MHK%E.H2([^VJIVGN?A_5\>E141(G_61Y!_N08?\ ^?.<^E3R/J/P54W_ $J*
M/2E8:^H*3)ZJ=1Y)55]Y26$<X\ZKM(C,V'):)"0T=9?$P+\2_%?'S D0FR$D
M[]6W6FGVULO-H>:<24.-NH2MM:2(*5(4"E0(P0015*DI6DI6D*2H$*2H @@X
M((."#S!KDSR?^G<BU=AEF@UE.$UYRYNO94@I$I8WB9/IB%L^2RG#1$%4IK-V
M4])%76XE@JK'KR\SXQ]''#U/F_X2@M+1*SP\K5[.I8E14P2K6THG :U=T/L!
M.!7G/:WLC=O6%T_V:4EF]*5*-FX?JGTP5+0PI7]DXL^ZDGNR<#1BN&.98M;5
MD^2;L>:W,KU<@V%5+!\)+10R)EU@(TG]]F7%<!U7X+J(ZA^\ ^:=#%V_9?C;
M'# KA-ZR6.]=A-P4@*#Q&@M/@@$-(/NJ(/BC)2!7PUV^[*\3N[AVZ0FY]OLD
M+3=\->04K:[L2XXV@0L+D$+$:"D$I\1K07+IF%7/O>ZV\R+2C!=0O(/N5+VV
M8AD*JHDDA1%LD5";\2;- <;%7/1FN''B5TS;,]VI-RXAI1!*D)2J$K<U&20$
MA2\8.PY3Y>KB+G#F7'KE"K:XM6.];[Q!;4X4I/<PE0$I44I']*C@^>FPIA/%
M[+[I+)%/<1Y/Q.0J%Y*\))_3($_$G?#K\U%T43R\6_0;SA3-FRFW0F+502TV
MVJ#W:$I"2DJRKP@'Q%4J&9)FO-K?BYOWW+\+T7:EK>>@Y65+*E>&($G/A&)P
M ,5YO;Q;)^-6N&(28+*2G5#H5-QX_%B2 ]?@3(-KY@J=";Z*@H!"BT]FNSJ;
M55_<N)"K=\"VME$DI"$J"UA*P9U!13*I"BF$ZBDD&[VH[0*N6.'6[1*'4%=V
M]I,24I*$%2)(*5)U$)/A"@#I!(B]!L%1M9*J /Q!)9(JJB!M>/D?RJ$HLO""
MD))Y>T8=+YJV:%3Q+ARTDLX+A4>X7E/>YE" 4\YQ \4YYR8X9Q%MQOOS(;PE
MY,CZHD>)1"C'NF9R('.,:D[;_JDHYIJ019KB(P*KTY (#Z9;_P#U%0^U>1%5
M!G&X8HJ.EX]C9]GD\'L4VZ@"\K_[M60%OJ )D"<H!2F<93)YSRG%>-N\1XBM
M2M?<M*T6?B.D,H , 8$J)6HS,2 #M&3*R&*R],<_TD9OM]M$1$ELJO3:M"JH
M/N&X2BUVO0.D31%[3@N+K+CAR[EUNT93]=<+[MJ!JA4;9!2<9E9R 1,UGVE\
MVTE3BU!+4>,DJ 0?LF1XLF00D1)SU.F!9%,>]Z0XJ&^X),/BI=13%/!J,*EV
MHM-M]--(7X_ULN"JFB%VC7!FN&6;=JVW+;:=5P09UW"O[19S,*(\('A3]G2"
M0>6O>)7%[>.7*E%*DPVELG9&0F!A.$D>+)F29)K*R+@X4=QYL1^^519^V5>F
MY2DA*+PIVBH+2"KA$O:IX*P9?(.)A,\#7Q&\;M1X21WJG")3W8]X$1I,X"0(
M4#,$$UE-<02RVX_$-CPJ$DZ5JU!$1XYP<#4!!D$9K4 <1.C5TB:(O<![Y%QE
MXB52,R7QZ_<4OYC^TJ^!"C?0M]P[8-6[*66&TI8:;"0TG&A*9.K)!U$\P=4[
MDUHUOK>=4ZXK4\I6M1)DK28&/03L<IR2:ORK)XA^U;) FDVJ/FG8-OQ45444
MZ3X)PNQ1$5391'5!5$D0\6RX,+FZ[QQ)-LWX@8\/>#*4$@R5:<D$$8!/G=-R
M6&UNQ&OPI2#!0O2/'G[($C!R3L""!8 VR B;1197M'F13]R*Y_4IMIT7CXK^
M7B**B?#C?:?B6VN[)*DJ A!6D@@ %04$* 6D'PB#! V/3E5AI:5$&0HDE25'
M40OHF$E*C)&9V (@<L=%>FI%@0I]H=F_!'VTNG6(L=ZTE(J].2X\-IF(!("B
M#B166([SR$;33)@ C8X+P1;#"+JX<-PLITMO+;2A1C_J]VVE* 5#.F !F (B
ML_C/$K.YO;E[A_#V>$L7*DNJX6Q<7-RQ9,B$I:9?O7G[M86H%Y7?.N+0DI25
M$4M)Y$1UQ/!IQH5.0R2H0.@G\W 547M51/Q)$12Z]MQ._$@VA;<)T!)4I9A"
M=BHS(CD#ODQL,==:-"DI2"940 HR2E4C!P) WZ?#!QX=.^3QB1-.IT +Y(]"
M 2[; 50O)/;7HBZ_(54E0E844;Z=CA3=I;*26PI;H2MX+"DK97 ,"<G2DIU
M$@&2-0K$N'>\<"$*T+;U!LR"V_,)43("94   ?"I("2E*Y*I/\2>-^5<I=V8
MMK"C63%KGC&XS#)XS".QL>PV Z)VL^4J-DT$QY%"MJ&GQ]N5;SH@HH-$ZK?
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M0F.8KV/LM]%_TA\:*W&>"O\ "&7@$>T\6"^')0W()<2EY N5 D1#;#RB#[H
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MCU+60F;236PXL-^:VR,AYJ,RCCA*V"HJ9,')W',]#^@^53$_X-OA""]PN/\
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MZKPHU$DI:;3#;2))A#:$)'(5]U=ENQO9;L3PU'">RO ^'\$L4P5-V;(2[<+
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MV11/=-$1._+HA;%5Z\T<3KX05'%79I??;4HALH4"\DQXP(*2<>][HD0-!.)
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M28762A-;S)*IAMQX%5 $SZ;\MP=_2F 7F)JSE-W,Y6\P,#XN:4E(;@<5]8;
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MV(2H&?WO47B:2Q_4WT@.:2UCBK'K9%&3;*JE4(:'8$-4<-):) X;[A/\8(I
MG:F 5,VW?^N=\6_=-X\SM,44#($8;FP)$,9N<'2)7++5EQ"BD&(BWY@)XH\'
MRSV%SC#9:_) F,Q]Q;ZF\ROES>)!R5B4J)/YFE@P07SQX]>V8M[UB9&#+^\
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MR?P^"%*"%!F28]TU&38PH4=[B0ALW-G)59UOVVNN&TRMI85O?4K>P !9:2U
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M2E,HR10P12QTGUG\F[J&-TPAJ1H\B&R;&6[0]FTMC3M, Y5\(<]H2[V2RZV
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M[$]=C!9<2TZ'J<;]-MR4>IJYRN'**XG#.\ &S__Y#?Z2ZC:'_P)02P,$%
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M#VX-U 7;5353[P_\!66@*L:"[BW$5F:;JJ^N66!-5?;4A7B%!+'W'\E6$ _
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M;"]OQ02UC!-A0Q.- G TG*4=<\ J<K*/W145QI]5:Y6Q/J0S%8'G/#P2@/(
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M/M]>S!>IZD;H\&*^R*81L8MC+.?JEL-"A:3+R!":.&/ K8$U18NC:RB,P%'
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MKNBUFUFF5*'R?2W9NI=[=0ZW<"7K\$UQ JM8KY---LUTV_/::GOJY5KDV 3
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M8CUWW'G7W:]^T]X4+W>=DT[^W#ZKA"]^Z>O?N>>WR$=^]NA^^V=$Y:/GO/F
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M=2V6M]EX6 5XGSD"6G=2U.J;\.T.U[*/X]-))%6.9&!Z&XT=2_(\*YYXU8"
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M>3W3.)AL<#J[-1W,TE'Z9GODJKG*K>P>45#CO=E*GSM!<[O>=7M-:X9C@LH
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M$H4F4KOF53KXH1$R8W(KK.-F\V$D;QWKK%7,9J>G;75,.>A7J]TM%C=?PQK
M3(.J9D#-OH\L(<+:Y'UPVJ/2[&G48S$["DEWN<B3@TU0PNJ,=VRE*:((\C"$
MT)U9O^[C *_O3*AW467"H?2N&WVEU3!MU2$Q.)5-@)BKLKQ,S)OYJ1?O.QO]
M;,'G:XU:S\4A;/IM4$XF6PK)O*Z1W*ZA<ET84"^< Q@97%LWW%427Z1-GU?
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M,.H8J()L8N>7"K3Z*>DM ]C7JGW0C1<%I8.QJ=]EBPU!K$!86>>@Y!<HAP,
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MZ!05:W<#IGF$Z$F'J+S[C2=:H_&&8/D#("F0Z6S(\@ &/*RF"+!/M.; ;<A
MJ7/JF7Z/+1[Y'^R]9U";V;(HRCA@$VTPP42;G#/"9-ODC D2"! ,&00B@\D>
MFQR$$1F1C  ! I%%$ 9L<LXYV29G3#;YS;YGGW/VG_OJG9E;]YWWZJXJ5:FJ
MO[56=Z_NKN[^OM7-ES  >\#VT\W0P9O(/TM>%$_*[1+P^T"?0N2&KM'K:#A(
M)8*2(;/+_E^)5R7[)W-B!O\W<:<M0^1;?\;+%B.?]Z=%$(Z*O'W,D)KC?P^Q
MD&:?+HBC4/#@^\;%X/S+'? ES\^$!];P@XC0STOBXY_1][R95Z$ A[8F87\*
MN *?% 4,L5$#YREX;2N7G+AWBD])5"6(=G=//'0K0)[Q%>2V)W^4HJ%O:V98
M8LL07S7TERMMT"L^\F1=-U@*WBKQ=%CC+)8@#BZ&LO6\<L:AL@MG>P$?"X>^
M%EEF)Q5V):=550W_:$\.S&R?E:=R&(10ZPU:6=I.+8FQ+7_Z+YN\/P<WVM-7
ME6+/M'O?2F32C![37E_XM"I3A+54[=B5RWX>'M:-9)=CG5:>C4-7C[5)SJ(R
MN[AO$(^^=1T;B122K6>P2'[(ZWPMR:<TL#286E:^@_JU=U1PGG"9:*1'8M01
M3E'?Q;Q4*QHC]?I#4>@,*MFGJN][9M(2:\4GWZ6JACK3 P" A6?TT%1?WM%[
MI316893C3"&A.;*.C..-UL*!QM9-<[E$7=K/ZO^:Q9-ZVH\L:!+-]ANA__QY
MA.]2W>V0C"Y:V!9=%M:@>Q;8!@O.]L]]\?660%<CYT9(X]W:U;+)!(U]LU@:
MJ#!"-9B)R.98IGP@Y-E0&S9&OF%37G-T4%#7.3A="[D9=Z#NL'#\W@FB-R+^
M,JN0B7,EV?CL9O:+-O$MP72_2ASCW&EZQR^T]"U!C9<0<JKDTD;K<)L/FP#;
MA_DK1DA<H]V#>>):=DG6<%LW,Q3>R9,]$F>U32QM&<%CDBU471:G84<F)^^<
M(_&]VS89 7/F\3\&6APS+:*MRR\5SK'^+;5*$%OO*NVFW7(UM[5O-8-"'2)3
MU[F!DTT6<ZR"5?@9SL73J7Q)3]=9>]JEM.V;X68G\_)=!"T8XISH&N TRBA5
MMRL6<Z#E?4O@8 $H-SKMCBDMJU6O:\)MDO\+ZO^&N?*DD2G[W.+L,9Q+IMF#
M+GS.KIA5<(V5):PX@=Z.0?B'W!T+?G>.=;8Z4VC//1X=H>!=DN@5*M="E'F+
M-KMS<9J0U\F<LF.C1_9*C+52##7KV8#)C'I7G9(7BE7)ID95$;0!C2Y79>47
M?WL,O:Q$U1Z+D#A**2/B\Y4*7W)6+'7B4C1TI,=688HHO()'"XO02W)I70EV
M<404#R4?%^0W!ND9V\A-KBI;EH87]N2P2ZVE*P.F=[/2;P><)JZK."W^.S&7
M#L_HE%)F<PG=K:49224&;NW-UJ##$41\7 L-5DVP;W7.F_>6[Y>4#0P ZGRB
M7;:!^.-)Y/$H%C#L*4JFP>:N& () !VKBC+F(3'(X@ ]@Q<?I1PSRE:6%&0*
M"DND'B>D0P&#J1GI.-&1V2F45)P7]QAI9.0:1@J#5?+@Y34/W9VYCCN:G=2H
MC1O0VNEPJ<AXZ*+ZVR'XWDBLD(K+<N8W#!UA;P&1HR'#ZKS'NIH!H#!,)=ST
MPFWS9^ %9*/*X&-.>+4;)C:$#,%<+$-HH=EA)LE -FT:=-:BY)J5/J"8$@"S
M7G5FO^+C,^Q)VK7*?<'"02@06VPT9XYN'3E><3SW_BBZX4]#I\TA$M1;L0Y:
M;1$]YKB&M\MC\MYU#\3UT94EI\S_?+G1MI%#\TO/L1EAY&N>.TOZE>SS'S-L
M _ :<9\+5R:WKA>Y:$IUMJZ%T2S!;RNA_+2579#1:/$&SY@?4P7B/S%3(84A
MR;$VXJV= 'CS%3\4( 0!-E!0G@AX>E8G'M2T'\_W[P0*V'U\P<S?[TS60B*N
M-A3PL_:D==Z(8]N#8[V"5_K+7[&A!IQJEL?S.]T/\C\R=NXO;T2PUUZUAV.F
MADXBS0<V6>2I%,/C9"F7B=TK=Y"SYKE)6LM"EUU?#Z-7-K#&'>-]T:DD%-2L
M!5."N-ELOOV)]NR7S.4Q;RH##?P*7A[LB7CE6\27STA$N\M>-U@ZQ"2HZ;B_
M2)E@**MYD1@FN!E:T-%YE,4#>3B*UPOA@<HNJ->,<:I#*H._A_5_GLV&F=W,
M7ZPA9Q\ %)VU;+H==O?Y.V,W[RAW1041RUOA+6 ^ESW'M6M6#1G:-3Y.EF!#
MU%R6WI?E%MO?*.0>1RU#2XRP'(CJP!.OZ7%-/5>M/DSHYIWX__FWHQV$WLQA
M&_W\L;GNBN0")6.\4IMZM:>1U=2V<Z^Q9+<$ 9KO@0DY[OE!NMKOMK3J]D#I
M'N69.)-1@+:EK<RF''R\)C@M*HI-$PBAN;PEJ-W@R>7#3>0  E4Q,VSOH5F)
M?.2;4H%%>*#SKMSOTHD.A]8"VL;^SP; //ZE/N.?^A9N"009M_4MBY&LYLKD
M;G]\WGQ_2Y![OC#S82XP9?!CDY/<$ZM-)_L&C[;.TOC3]X./:;.$7QZ_E&D4
M%DJ8&3G#VJ/$<=7S#9;+(+6 5^L/20;3GET\RUI(H^UQWKB<K!ZA-YG9,ZLX
M*&&7^^09>G]=Z]'UH\&]?I*56J^@;? &7,#Y3-#8=R*!>5BJ]<X1^L%-Q/I;
MN_N'IM+R)Z7'*BFU :G\LM">1PZ,/W[S&[M[2Z!XU%A]YUP@ZYG_I#^;IJE<
M7PHSP":BYE\1?_]/O"D*L-FK?8_HJQ1G'TB^,O?Z<DLP?+6W\Z59TUYU$9<=
M.3HYY+$: 0>S[#[X\@D'7X498X&>!"3&];Y1'A-%"ND#=A,=;(18L':E51[/
M^(C>]KI3M0.\Q'\[>!.#U;-"EDVH( \5U=_R)1"/SJ]$4)C'K_)!BXFPP.BR
MUKEC<2O>=N!YT3C0QVDP3)GO</B3?&E_\:OWE/XJ]ZHQ$BULPKGRA<Q0*FF;
MI^3I2"<F.7KO8<ONMO 2$4K'X0S!&#KCB&__PFSW;QS5>?LF0TK[_PT.XX6/
MW&LR+52B@16WS^+0:E=OE0>^F/U$K0Z08;-'J<AA\@'>.T%+@M#%05"36V4+
M)>$\#?Y8<=0$P*@,23Z?E,D;VF9;$-#_:] I$^[59$YOUMZ^VGXEH(D '/V*
MU9F=W4K1+1+9%2BZ)7 ^](KR/1P=L?Y2OH+Q8;,:Z% 3ID\X1+!V>DBSHOB0
M'2J%@QXHUN)I.]97[0?ESZRG4T;OLM1CPM/!78X/%^N8M *&.)PFLCV*)#9]
MZ"5:'(4ODN?0)#-O&K7G#">^CDXTB8]F27B+:K.S?])D8Q'IAQU0$D;E\AL)
M<L=%H$IRPLPPQ5&N1YRY:R!];*BIM_,V"#Z6[+CI6+])G$%?G\ #@@F"HP@5
M2"_&+-L2O=J?DCDQ;PB &O2O=,Q6DIB.[O\5X_B/0:P9U&Q56*MBZ\^8:>HH
M'['LB*C]HEE(92:C]*@#/9=:N4@<- *9>WI1&2SMA.<U#.(W-E*'C8:^U9\<
M,R.^5PPR$<9\XAWR@-I/M97AS_N,WE/FK4A"I52BT\N>7DAK.%,\'[&7,26?
M]"P@>EY(/H :Y#SZ5:G:P-$XQ5T/T[FLFM"A%@L7XBUY*N%ULFP4QG<QY%=:
MG2X@HDM:U:7,OL1+3]W9T[T)>T0EZ*JP3M0I&,)!-CUZW8@$BQIV--J16-1]
M;;0ZP0O.EB$WT=A_)E&+_F^3J&%K3E]O-'D+JZ)&F5^A$4(<DECJY_-S(C'#
MT12:XG0_#2QYV7S$XAK81KW>A:'Q(]7$1/AWWL&[P,!E\(2U$DS%O9C9NPCQ
MS4,1)WZNPFI1-.,0#Z&\\R[\C"^C".,/3+@ ,DOH\@<:'VO2,?-MZ M&T0<T
M>'+35'FPI3"_[3?1\-8GA;OPWA) <WF(XCEIUT6*0FTWQ].W%;FD+WZ>U7_X
MEM>Q0$TN.28=(KL/(-DX>?]+MM=U_6ZAOCV6-'-[NVUQB? CK9>AY++6U@._
M(@O5TD=?UPS>23)))\HYV*Q;F#.?/1;W;43E=M';OY$94+B0^SWXD6C&^9=_
MV>/]OV_Q?A%*.[)]]Z=?TK?!!SKY0R9T4E-3$4WM9,R"&T7NG>GCY$=OFC\:
M/POI1]^X27MS^@_W##9_EMM[[G#P5EDQ3GSPTUMDV+'_ERMFVQ='[\>*Q2;#
M=;Q/?NR[WU6-P?,RNJ.][WX>%\J;?/#]B*<EDSQ+/;M&U+.\_%% )+TL9.3-
M,ERLB&DM-XBYXN6#=.VK[V,&?GX>ZBXUE 8VZIDG*T0^+,%IM1=S01&N5-L\
M.W1$OTU^@CT-<]#>I33G("HP;Q[P=G"XUC9B(MJNR2V#JB+[3U?6::C4RJ+$
M)",WP44PX]JR#"9QM7A646::6@9JA$B)EV0O)M["2]GIYP\ST!383R,4+D@M
M.CA##;\S-N.W&8H^XUWEC*!M.@3T\& ^]&LI966J]Q#V*D17'_M446FTHY0+
MVY#)@:VJ=JO_PL^0XO\X,][_K6=&XM$.R1Z5O7RZ$&_''SZK?H=>SU# +SX%
M4?-;%""O:3I:^UBYQNA0YBN"GD8)RV.WE%[5<^H\;J_(H69B6 '=5+YSL9EH
MX( HM#WV2Y_=26CHR07@TL1@\/O]UC-,"$M-7)I%E%Y1ZB*\/;IH11[6JP/>
M\)%HGA5(KY0BJ7W\7;,IV3$J,W:2/W^"L_*.CXN^"QR@56*$TL[O+[']T2R6
M&3_)J#:8&BC1\>%P5.0M\=B!=^NZ6V(/8WG&MB<J61G+QF+;2"G*RL&AJQ^@
M3'/.H)TO9Y#LNJW+*>QJ.G5<;V!2>F"X74YJ0[6EZ;@?>9Q=-+ 1JV*9E:ZV
M8]L7S,FJ:$<KB,)N9P"ZAB9O"7C=L5=)H4FF)(DEG E/]#@3[#K A<-K:Y/L
MU"&?=#J]KF954ZT$([M]P>&\;)6"N8#[TQ-__%7320!"J]G*/B/C43N(U3^6
M'.ZAY:^F%)!.3!MV+N JD5M\ >N [J%Y(&!$X@+9C*BDNQ_6[IHT_[+KF79]
M:Z]90M%K?+<*=@G)0>'M;? 23KG_,ET( E$VF\T_@>?;>>%;'=4K#SMC^@M;
MZ6B?N!OI\ZH;P3F+3$9WL>3Y_$FZ8!5] 2-2#(IWU-^_51H>HAZ=KUY$+6PR
M'*+U7^W3(54-X9[8J>YFJ'F>*:+MX12'<9V;<7VJ*0X9,[  >/5H=/+H^V^6
M_SK^8U?ZJ=PM@6B3+)OQA-["81:>AGV,0NR7C)!8<-#P?A;M+4&69_'FH ;:
MLHZ+1J1$ZG[T[+UH/LC"78OJ.&B^[*X)537-?=Y=;0XB8/P[VX>-_5UR#"_'
M-Q\'OJF;ORZ\F4R6(,P(:_P4J&/B4NHI,J0R="*M](R*]J7C+0&N0.7_0Z!)
MCXQ<%4D5%SZPW1.]8G^5N*?>)I"9EZ3B)-.UUWYL.$%F=M\>;VEJ&K7AXN)\
MNZ9&CEAI*ABMHN"G'-]=PEW/5ZE13$-.8++H;I$\WO9J4:PJ^T.7Z%)H6<DB
M'%39,NN!\NV3<QGM?;.ZLL;6_E%BIK>)-:[3X#)_5W;<6*^$FLC?BRYM1Z5.
M,2$E2GAZK)H8,^-GIQ1;5-2A:/>?:$NZ!(_=$CAII,)?D+Q]]2NS9L%XS3H;
MGK/E%2G/+?AOL/\ @2M1DHX=HNI:OYH>8MB\+3?*84\_S"W;!,K..W)^:[ [
MV24M*S,KFB#*=T0/&([;H<Z\1O%%A2'E)&V%LC4UX**?!=/=;@O4W9W-@/3D
M""),W7K GAE/!FB5WR=AO'LFFEJG1>*\>!-J6(W.T] /R(?)GFC(T*_AP%S<
M4636'4W=1>T!KE IUW[S6D'G1)CJMDX;6"TB6HH@&I62"4&GS'<\[13]/&]8
MX7+=\61-YWD^&%_BO*FQ0UMKW(DS%0)B74;0R49%?<6G[O$6%%!^M([( %3!
M6=JFAI1<&>B9;-QN9)[*RKJFM14(3V+>)+KHQTHSZZ(/HZPY/VFI!FE8!7#C
M+H[L"[Z1P=\3,O+TI-9"AE%LBY5T'DV,<+/NL+87#$4"A(<DZJ7QV=^< 2,)
M<]AVJH3:* [6YRB*BK3X^#2-#G%C[FQDMG&#J++SB#9JM70.YX)TR-,6[\EM
ML^$4I9+ Q?^HK/A1610Y*1()=S*)2J>?1+&RVBDI*:Z!-S=[,W=6-7+%Z'V"
M<P$B<G)28A0C=ISKG,ORLOW][4:89GZ' Y0\OW$<T'-);M #@RG>B1XL^FO&
M[;?!FSD;AQ-ZG4YU%2>A*-VGI8G28$N:V*IEG@+?^\U^I\T-C/R%S4\C]:SI
M5AR_8.:4% W5O<L%DIN38N.7-'$!AM%[IA)NH/Z-XJ-RTVI<77DQZ+@!   $
M^H=-+-]Y?8_1(T1O-*.?!J7WL!AN*5!'+4?%[CM ]R*OG>^Y\A^W!$!V9/ZQ
M_0P/,(MA,"2?^*F9YC@&WGIZ(O)U6!]?4E*R/'%]T3"P=8^*EJ<VL_=\ P^,
M$-0Y*#$LLY>8<D!H*#W]>1 )!O^Q.7,!?YI@DU:_YC\FRI\OM)R7+-.*RP]V
MC$UEDQFC.-\*:1^8UZ&^);"7Q\TV['4$;:8;&$EX7R^*+HNL/4/=C:!SEX@+
MV3>%BVY=8:?1F:^?'QY&;[\']Z+S@@3XM)\D_EJE#C'34_!WM.I PN;RUO*)
M@:ZF)Z1"__JI$^%6(5;^4.?/,-Q$,N;X8';@<J7CV4;SLSM&>LWE'9J"=PCN
MQ@9^^SPY)EC%H/AV:8!TDUO*JP75[-KX5,/?;-4"E[MF*5.3#$L;N^)3KT2G
M1&]?BE^U@292G@6NNX(#CMLU#X!+7WW*XRCMPINCH<QY-EG)]WMPT<;.-21D
MSE?A]U-[Y"3*?S/-71O&( R4LNTZ;6\)I%GM]?D.=KYQAU^TF3?_,JW\M[9_
MK5\-9G=?L(Z76795!Z(8MLG\+[]WD)B;AB^34LN5C7D(:*PQ!KSH96FNF"IO
M)GV#6ZUW$?[O,D6$*U%?.B!>0P<D0S%;$;\);8PQM' 0^Z/#FT><-K+>0&!*
MXRN'*<V.F72.7<Q9[PQ_L=4D#J*IIR.GG9CB]TFK%C+D*8XL51/Y),-DQX>@
M8V;(E=.C%96B7VW=!>%7M3; VX9TT<>?\VNV3 D5$TKTG=Z #-C&9^Q+%VAR
M[Q1P=I=;65""QRB'1^T@WT2MB)N?W#@E]?F>NB8I!EF66P1*_EMKQ8[E^[I.
M-?,Q^@T1S .'D:ZE@.W]$"H!/Q>&6&'#TT;M;AQ?V@:#7?9]E>C^7XV\\TVB
M:L$47L62::OT=,_7DI:IT>=,4!T-4(O;B1$_KX/#D/2T1$XPQK':K0!?+^U4
MAMQ.'W;X^8S8/.^)LK--Y$:\/M65>OK;R@;D*K!_>XJ2STCOS:\AP7/+LC[#
M74*=%<ID,;48W?<<H!C]BE$)_Q8>&9J-(\I^-6,+P8H?FV_;8MN!GE8-0OJG
MX;\'AO]E=^D^\>XCKS[:0K1X3MR.[!?[ 9$CJ%-7V ,2"Z*G?A#F)BM5R#3L
M^W>W? G&(S,;=V%LU_T:?=B#!@[Z2,$<A0  !):X6?#0K/CB.H!XSL?+M&QB
ML,Y^$-D7W')C6*/US!; %BO;"7K"F/$S1#WO81?WP_L<]X['HVA&_9UL99N:
MD7EYC&]45#S,,-%[F#__"\<G01NC-KT/[W1LYO]I4;8AVMKZ!K_=(TDX#>C4
M-XO>2G#I\WO>H_^V9R J79E0-AD'J^GMV:6Y"Q)3]N- C?_Q#L%GXE#]^.%B
MN:(1OSG>I)H:/-J(^^U%><9T=A/,PU:4?K;*Q$%;V\RET*?(QH%MU B/XROK
MB+OO/=5'"]SDUTE<Q_SXR=>2:RKMI$QE\&4LY,?XZSS/_V(E#G:ZN,E4[57^
M/5LZ>"J&R&@E@JSU 3CCQ?<HJ2(;G,J[QL_OG]>#=@0:QYS&U@7K"^UFJFMN
M%F;%QYU,\GF2BP;Y?A^?GX@[457(5>]7-&P!(K*/ T';<CW^OX;412W?5+\Y
M#+"> 1CUE-*%OUG)H*?6%?3!#XVSM*N8K0WJV:P^X]-*4[XE2.<17%<(W1D
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M'!K! MYLLB]L@CSWB^."XNCYUV9 /QR9_QBE,>B985LIFSW-'55O'"U=_V;
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M9J,=8C07J&UW"GP*[:&#?92&Q6)\?)()*55#VGWLAM;,>-)^AA\J=K1UZY5
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M5?YV-8/'*&U5]( F#H+2/$O(>:"D[(1XHF0CJ]VZJFJ.K'<QZRWL]ZG&0W.
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M?112Y9^1:D8NJ2H%?$IP0W,TZ@L^EXI,DE/!S?+7PGUVMZ,P-,=C7P,+WKH
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M9RT^C1>A-^&8K*/F)$7(*MORP>(,'M)-SPTT&AYVF4<O9*S3;<TAEB"J?>"
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M$>VL=/CEST/IUQ*HVA@G::=OM+\&:-CUO*1%/QZEE@:ZB^ OX6H,19JITLN
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M_\%?!A_U5VMX*_RK(AE7U748%R3=MT_JE\E*SZV6^_7W>O>466F7G;%YS7O
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MZ_"FE[:OQVK)*!SU3'Y+OEVDTU-23:J&UM$-"TLICX7 2Y#P%+O;SE2S8[P
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M+?0=ZPTCJ.3S)W>X@"[&$W+U/1'I$6&P8*06FV! )2@7]'73MI T7TRYN+_
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MGZ18"D\5!N!YKY59&6")@@;)4;#W2Q':QH-;!$2QE+PV:91"^W-E%<WN-_>
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M6VA7%^F!\ PSYWLTJ[XJ.E/WJ[@Q24UYY#32YQZP\7ZB@0M3'I+E=J#]%4G
MI7)P=\[&7;4<#<*4>=KN: 82 =90K:];A8!1U_IJ@VBGEJ:V<[O&677G0;L
MTP#'</*S"J,YJ^OM 6Z/QN:.=2ITW1K9VD9<CMVC_TQE6K0#IV*TXAX+UVBA
M9I/S:;)P$BEKL?C[LQ>\H2.7W*]>J*XB].RYITSH#>:4$'KN?!%,$/DD2D:$
M"DA!2LF=;I;HM2$USB*;[.5FFA&ZTU9$TI6J8CX5\HE.8",2C@0>IR D]*)E
M2Y4F:#FF1769F L*5CIYS3BJ1TR'^MJS$UVM+&MV$M88\N0^%9^UI?KD<>^4
MRRQ5C?Z=F 8 $#SCOP><:T7> S#A4K?! ^Q6\*M68I: O-_W[!';CDNFW%P'
MS75)=. 50<D]8+(GYHEM.3+@.*LA?$OCV_K+F%\#6P>X,'4!W:/F\+R 8:4C
M<.IJ6CE#1KRLE=9[RHZZ3RM>JY_TH4<6R3O1LRM,V.FCO,J'-5XQ2W]JTAHT
MN+\X7(WO+7GM A>@*DES=.\)2\\1ZX*'!U@T@MS=E?I9'3@#@*-F.1_39^/-
MB,^YE%YS3D+Y5]PZK[+TIR*KY66X$I@YQ!P+!&CPV[=?^WX2>U\YJ9D^3?02
M!!Z47PU&?79U6,[+%"K*7C':RA8 CFN O6^FIX!!Z2*L+[GD*CF7]&_I5+3)
M$S$/Z*($8ZX#9_ZOYKX[JLFEW1?WMH&" E(%47H-THL(@H22"$A)J!$%@A":
ME-"D; 64W@,"@M)"$DB0$B!$P ^D!1 I2>@H4H30(2!@N=OSW7./ZSOK6V>?
M<]:]Y_[^F;7>]<[,,\\S\\S,FIGGYZ9\JRNUXN/C=9- VV&QA#=(2_TJ'TG=
MX(SLBUB_AN:''P\J861KE@[3-WQ2J;L[@%;B_L- ]]&M&82ZN[^;$MW[J28-
M>EU1$-TY=KIA^S&U4!:PQ*J6L'(CVFC]X8.^E.:Z>Z\*(X96>BO5TV2*M;QR
MSI65JA NN(J\;Q^Z2U)362%W5B4$XPYW$&A"I(&M:^M=T^V"%?;RF4="?/?@
MW%Q^T5V8@8M)AR;^]Z0]WP\;+X;I4/+SYG/OH6*7?)(X4.*J4"!F^KL=F6T[
ML WH96[PF$<%0( ;MKUM+*G^6 #='2RP] X]_0^=X#__5K9*)FK$%ZNTA"5;
M=J&1]BW=B*K%#%,,PYG/JX/2)W&G7'M@]E1,A[Z9*O'#IE?%(*$THXD 1ODR
M-9S?-3X'X8&.DU'(P?#O+5&!CEL*>C6)>AJ4HJ\6[^C.KF$]+621^M($SV_)
ME@>M-OL?=XCTL1G_A\%ZGL9<(T?\I3L1V(V.):_JFM=S>ZM1PZD2%7M*QHL'
MUK-/_R5[Y]K8MW(AL,6J2]K =D7;N4)":]=.TF3-$4@SY\58ITC!@D64R#58
M9,H27Z/K7G9O?G+2N3A0AD-\1@"E_(1O(:8XY'D>8C'.VQ8Q/3DE9NSM^&$(
M=F3#0*,VB;06G0L,=#ZC3):D!OFS! F 4\]@?1DYS;^FI,B4W6=TJEAM+K^T
M) YZ>YI#+(%7\;PE[A >3 H[HLYLCM<[?$P*(1*F;9$DOYC.[SWE3J3AKS-E
M!O4(Q'3 (5UCX_7T1AUG;] HHFQRM8"5[Y+\)/OABY#S>$GZ96?_"H>TJE+$
M!UPF4<?O&LZT8: !#(.N:ZZ8%W/E9S,5T/6H*%+_Z%\>^"PNA#VP_6$>7& J
MPQ.N_+=)D#IHIM6[156X[FZOE^UN5<9C.A*7)-GO.)Q/\/*# 1B$>B]H-@/$
M- ,VQ1G"G!8;#]3:+_V1\=4LFOCS%=R:98"75 U[5W:./J>2EH!TBP0W5P*/
MN84<, 1@99<AI\JGX)*_81NP%C11YYNHBEN@K$/*=049.#R2;B?>_3GM&70,
M!:2-L[.)R>;3[9C&-NH96!<;2FNN@\1BI)F@J<<L%1_&N^#)YWA8L9+E#VCN
M@5I;H;R\;E\='MMBX8X2R*;HO]JRUUR)6PC,5 H=R(7O^=A09'+&42H AD=]
MDR+FF>]S]9B(M4ZVY!F@*ARP,!$_2W9YV8+LCWH.[D0(2)4Z*)6*?$Z%"*D+
M4VX)7FE:R;&*J<*:<5-([XCUOAY//-OMGN1S H@1*9URQW??XTM5[4; X:PM
M2+HZ.G":G/KL(')X*&+V<7'?(/28>%"76/NJ2V_39[AD8Q+"[-CULC8K2=Q
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MBG-6O9/@_O;%>:%P1<6<5EQVAJGZ!?U,SJG8[W8EAZ1V*/L=8\1E6<SX+;F
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M,QQ[X#C#H-!6A%(8LT%<%.%I'.1!JC\"VYC=DNLYK5WO&P-L7*G6@9"*C"5
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M46H W'B)"2 J=))!@4%JKFKAM.]')!B#;)W.L5-O6AN-T5090QB8A2FS46(
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M,6MUS#=#=3Q*<WHS2-@T99-@0 ]B<FX/<;96CW.H(H$<Y4)46&JZ2D5OU"+
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MR[$+Q5ESDU_VVB0Y3% V=?C!UF*_Q7RS.I/KE5&;;$<Y#0Y'OB(-7*'F<J3
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M4^MJAFZ-!R]/4_ \9VORNY[KA?]0 \A:A]VLJ."JW1=(6/>_>2U)^&<U&$;
M'(R_<@V&-V#@!BC_BC48V0#_C?Z_K<'9?VGPOS1XJS88S,(0\K(:#&77%8WN
M)HV<GX4'7TZ#7T2/O(#^OZO!B^\"6 _]2X/_[]3@?S"LV7((<]C\!24;ZLTT
ML!UMA)8"U!<4O)2RK(XD:V1IKM%*1WCDIZ,V["8;J33\,_[&O16BET-K3(S0
M#ZUAM%6HYRE>BE-3X\4&"];,>(6O@SALZ>TJ&Z8;\]G4S"]=AP'/E6V)LK\1
M0S>G[&^1<CRTHHU-+VWIZ#G"I:+-\H#-VKV%7BV^CV5++\,HJ+W_F9=A++T9
M9L/B^ELTA1NWN*X6N_ BJI<'HM2!Y29_@UJ88RV\%&L3X=]#ZQH;>:,W=M7P
MQ<S=O]>0Q?YO;/C&<&'QVPN9EVJVSCR9FU A2G6MMW&305W UH/P<R OIM@Z
MTJ(E]$969#RGTYL7_YW.ISYJ:<3-4!WHZZ/(?-$0/%?[RM+1A?\5%5DTJ_\S
M"K(YTO]AZ@$O9>?_WZ@'Q1,%=GVK1?T3ZC$O?;%A^9N5VMP./6>?FJX:+0G9
MDI%ZN=T#,E&'?T]--]92PSB,MK*E\ *ZCK'HR/\NV9*#_D?V)UZND\^-@#!5
MHVZ?#KVQ_P^.P3_^UJ(-O44Q2W-:G.]P+,S%+RS)G^]2O8#HY7&6M!Q\(=,6
M]?Z_,6!;&9/#7O"NK^=>226,M2V_Q^HPX&6H7SP-M=J&XJ8PC2EN3 O6ZY:^
M(=_-(1 .PNOT?!9;I^51>!V>A<QUN(%U,0SM@AB.+;7XQ>PO@6:&HT@==HU-
MT-8_"/T"]I= -T*K9PU5=PNM-[(Y78>T[#K(Z,+K<AIJK-/PO+8.050$T;1L
MUD3!YT1L >8EHGACJ%N+H1_IJJ/1QDT;9,\A;%;[TN$U0FMBZ%3H#5YY<,4;
MY@;KI8.7S4%Y$,>0=4A>RZW+8VG/\CDD'3R]"ZFX9H(Y%5\T8YNQ;PE=?^FX
M_2/H^I;&ZWET[Y^=G:W";$E:N)4)VF+M9FONQ3/TTNDK6Z-T\23_F^9IZ?UX
M&]3N4G8Q4M.F+#;]!65;9]J"CKS2\=V,?>LRIGUC.'\S'8BN@]$6!&T L0TH
MFDGOR-^@EJBV#C+RS&B:)C+$HE?:PIOW2'(!!B'LA2_?VQ+CU@5T^^JP9^@;
M@><8GROXWP[P_B?G[I49Q__6W&WYK8+_(W.W^5L3_U^=N*TZTY>NW3EI<;-4
M?E[*%ZF-.Z=\S[TZ=DL-_I^__B7D7T+^)>1?0OXEY%]"_B7D_U="=G[^Y?-I
M_G#XRNG*-V]\]OO+R&7+_\EK$>2?Q5C^[)>7[;[C<FN;HU<LWWW9-KLO7['[
M\F=O7?:&9<N7;;/-BK1^V7/7]CMNM\.*;7?:9OG.:7WI-<N6;[MBV?(5*Y9M
MO\-VVV^WW?+MMEFQ[?;+EN^PXQY[[KW[7OOLM.^!\@<?7 E)\;G7?W>_@U9E
M<1C-$=,;5B.%:(RU3OCLM=>E, >D^"N6FO$W,2G,\NVVWV''M+:6-FCYBFVV
M7;'MBEUV69'>ER_?9L6R;7??X\#M]EP);;\7<1#,J3OL'2 %7CCAC ^<]=E[
M[]MQ%4JVM' 4O>.:2SYS[3[%KW;?>>8M^W[DE]BSWUNVZXJT3[NOV'W9FY?]
M]:]013OK:X><+.QUV2%5_H.7OO3/L\GC_OCK=UX1?_>NJ_:X8;SF<W?/+CUQ
M\(VOG'_II:O/.?3(+YTQ^OF_57]VN5+F"T\<?-4VA5VN_NZ>5^X&/W/-C]ZJ
M_N',[R55X.Y''CC]!^6?_(0^>>_=KXSN_;#[Z[7-3S4/JE^V_J^7[/[>9\[_
M>A*LVO&FL^0SWG?=.=_.!P<Q!T6GA\MV_M(/C0=_=^5;Y5^'Q^QPV!KH6Z_[
MY$67_5%X:,U9?US-WK;PYV>^L^ZF8R^.[C[QJO<=+ZV JN7PFKW7W5SZR'?0
MC4?^]/?+PP/>OP8]\-I=@0>.8E=?L-LCK>/S)Z'!WL==N9JZ[)F//?:J/Y]\
MUO7;'7?E^]EUMU[QKM-'ESPZW<ZG=OOJS10,7?CUT9UW';CVZ,-&/WOMZ]Z'
M?O!W;[_\H?Z1[=577<Y>M.=YO_GCN6_;]_2K/O>?Y.I3+SKX-;??LJIP6A8Z
MW5ESW >YCZ/8C>SI'VY_?]V=U^P ]T_<Z4WZ>U>L?<?A!YW[AHO?8J[=:<,1
M.^_WE*M]88P4WMM:?^7J\MD?6T6]^]?CFW?<0%UPS.[GK(&1\V__]1YOZ&S_
MI<K'?_>)7P\O_]8W[OWA-=*A__[&Y6\^[R^UDP]<?N?Z4[V?/C \X^[+3R<^
M<^N%0/N&^Y[>@UY]O'Y,F]KM[+6M*R^XH'.M^LP?O_.- S+?O_,K1UZY[6_V
M:)V\@)Z^]Z/C5YVS';OLEF-WO_'5EQW=.N/L^ZZY=6?UA-?O>NI!'[AB#_&^
M1UUP_ST[-U5^]M=_3U9_';_^V(OL7_[NB_6G/O+.[YUT_X&_^H]['C]GQWWO
M6'=F]Y@#COWBS>M6?W=G]%VW7+1PV >KE>!<_2UGWNL8WY(__<N?=YZX;J?9
M+_:$=T"^O-=U\$YO!2[,'[20#2[8O77$'<EA055Y<-7Q$+?7Y]_QA/]J_)0?
M'[#'CG]X?^498?:+#Q_^WO>_/?_-;\7OVOZB;QSZHV,>P[[Q[#+RB2^^^]['
M?_R;/8_XMWT&[WARET]>L^!\K?N)3["K]SCG+_%NUD/,:W[#W'<DL\.KCS]B
M[56SN[!K]_P"O>IUK3MO/+#;'[_F\D_#VQQK_^<GUUY_YGFGF ])^4M/$N_A
M;Z6"<XRSEE_TWJ-NWGOO5SW18WYQ\*]VN^KVO;]Y0^G<.WZ8&3[]KO6OOREQ
MO@.MYT][X&?O2KX.7_WNZWYSU&^=$_9\D_ZA=ZZO7;%VTG_'[X_YSDG?/KW8
M%@[;D EFO_G-)_>Y)SI^]8WMAVX\^=NKSWYH]>,+XLYOH7[WGOHEIWQXEZ^?
M^\VU1]YP_D_>=-:U-_KHWL(!]B?><-VJ#UQ([H@=\X1S[U?8/^ZR<O4WOOA8
MS3QCO__B;[USYZ^7?OJIPW<^X_Z?_:9$'O2&KVWS0?.K^O7-4T[ZX%\NWF?#
MKWZB/W+U*>MV_^0%:]9KXU??=<,1QW2=WNE777;T(;[^[EL6KCQ#W*-TS(J#
M#MYAA]T^3OWI$>3TGV^XV' S7[^F_+%M]CMD]>GO'Y]U)@Q?3=O/+KMO=M?9
MU''7 H_>M<TACS[3?Y7S]:/__:%OGO_T7F\X-0(.^^*]E_[GAD,_<MO'S[WO
MBN8CI[YGMW=M5/9<L^N-E;/7F_>O&QQR8O?)D_<O77/$52>$3_^>__(^KUUY
MRG:G':S?\=U=WW6F?I"V_;+O?Y%;=?WV3]ZRT[L+7_[ GFL./?-H9L\5Q?>F
M-O_I8R_\^3%_N.H'LU>W/O3PC7<=M0O[SOO^DCQU=_*M:Y^ CKOW+]][^*'/
MB^9?M_W!X*I=KCEUVPL>=(KJ=?:5>U#Z"<A.C[DWW7;IM><X-UU_VN[>VK4_
MW?^#IUQQS5-[7';>&[+RO>]6K]R)7DX>\GMJS3>3#Y-PY>.KWE';59#777/R
MSV3IQX\<;ZSZ\9_._\Y1?_Y$\M"W_ORI?9] ?PZ<U!"/>\_/]OV&N/>?<V]\
M6GAZKT?V/CKQGVKJ1YB[_$=AAW;YYC57?6:/"W=;NY=Q^KE77GVK!N?V1X_X
MZE<?O_[#,OOEWWVF^.OMSE_VR;O6%*,5P\JIC2NV7_N6_>XX]'Z$G1YP-_6)
MP67)ZX46?^8EW 7VRF/V^W'WF.6'_GARU;\9OY8NO>76>^P?%A\^9I^G3_SY
M9^\Z:_E7;WSS$5^X$6R>-#OMZ!^_^4)A87S$_<-3#O5N.W7-+?I9O[SLB=5/
M_FG]C?]6ON(;YWS*UX_MWWY"^V#GI$M.V>:K:T[L[ I=^YYMW\U=M=^&X(M'
M?W>G'4L7GG#6E=JGOY9Y;)OEQ[QWU9@X'8-N>]OH<\YN'_U3(?[B-M]Z](#7
MG';NDZUGEQWT^'X7[OP;^HK?7O7>S[2>1/=_YN+DR]^ZYV#IG&<N^VG[RJL?
M^ :_\,WWV9\H7)B]T]6YPJIGIN17WW3V^F]:)SU3>.<![]\#*>NG[GP]7/S.
M)?H#JQ8^>OKNS-HU-P(:=?QZO7/2@7?KQ^Q)?EJ]9#_HOO,K*ZXDUKYEF^O>
M0_WFS5__L*Q=^\"Z<SXD/';PVL+9=U]V;_*FMSZU]R>- ][[TVIQ>MD1?WQ\
MC[M;3]S\XP0ZY8;[;[I]^NCV'SC@ULO.V^=G;QQ><?70;$7%6V]\?*<WON--
MY^[ /+[JFH.^>=_.I^[\T#$MXX2]]7.;U)U7?^NL9;=+^==WM]5'K]_][.R/
MKCAEUSV/)S[YMM_S]_SE4T\\7%V369W_P?=O._399:']S7WYQS]XEG3]W3?6
MFCN7]CI-4(^^^LP=WG;0X<\<=^1YX<>NA8N%4XKDKQ[_S3>ON.;,1SYW4O<+
M)_^(^/+RHP^Y\'/;8#N\:K_7?WG%PCM\\H+C[BF@9QT[_5#SCE57GW'QLG>>
MNBJ?O^5IT!X]<-/QC]]4^]GM?W[DG1_Z]%%'KOG!QO,J'SWZ3V_[T]T75V\[
M/2ROV1?]Q!'#;>EM;7?O\]9^6=QES]__,J)TL7;JY<Z)W[/^\X/W1Y==&#*K
M_-O./VGGUS%'O6:?6^ZY]!K?W^U5]<Y'WU<.Q]GH(P?=_LSEK[WGC*N@%0>]
M:;_7OO;0^X=//[OL8P>=.CIMISV_(%Q[[$=.O>@>Y[ [/GW&4V_#\V]YXJ?1
M^1?N\R3\,^S(O[S[/1<]^-2GU_*G?%;ZPK)MCKZ3VG7G+YL7'!Q-[O_X;OL?
M=OWV/_CMK<7:(=U5:Z_^R)O.1/8?%<K7[+W+)[/&6]CK*^=_Y(@'S]P=MGV]
M_94G3W_-;25J-W0?ZBVW/N5?^MY[<BNO_M;G?W?<];M<_]LAM--''K@^N?3\
M>^\\\0<_SUY\]\F=KGSY75?M]EF1N>QR_X1]DHEZZRJ8.N&\P7LN*$SWH2]E
M;C_CXP^O$BX\>'7QK-N>O/7 8P[XZ*G]\I&G4Y?>=:OX]-.JM?*UPR-0]?[C
MU^YU]JZ7L[M>L,V&QH/V.\;>/8>N//MK-^WU-/;YVQ'RN//7W?GTVXX"KB-^
ME__ZZ]:][HK,54=L?QG4_Q1<>/?XR>B,G:-WO(\X[<Z3OO7MDW]]W\.W__6L
MP]8R;W[-"3\X^Q/%*U_M.?XN'VR>^3&M_),SKKNGOGP';;>\=S)IK?GX&?E3
M+_UV< !=/OO$_[K[!_L>=^KO_W#_9\YX;..)TQ_^H/[I;U\AQ5]:_L@%O[\D
MVO^1[^JO/NN-C[X-^8[Q\6T_NP=SW3ZKW_XEXJ/48;7=3GWX%S=<<\KTL?V[
M][[V+]IWLP_\QPD_//9#)VDGKW[M=@>U;WO+"LX\L_#1'?8CKSO6>N($]/:O
M20<?>!KS^NN^FC_]QV?Z>W-PN/$/WE/\4'A\WWV>_MU.V ;FSWMF3\S<?D/I
MDS^\\?KJX]1=P@'GW+G746NZ&TXM7 3_J/GGAZ"57S"OAMNHM>?%R!N[ZQLG
MGOL(]K%?KK]Q[XKS^+FGM2\3/[#MKQ^^]3]V_^6KV:>Z[SS>M[F'2QF+.N9[
MX^VB,[.9"QQNY97&P^/U;[G]CM?N??P5R7F/GOVSG[SN YTOWG5>]MO]SPW/
MT\\M/'G+'\_^ZVT[[7GANK<^\;;X_O*_KWUR^TNN!=]YT?[U&UYW]NH;]CQW
MIRLWO!MPF:>''Z7.>'39RA//V/8,]#-7=5^U=N>?]L]ZS%MY\&M?>QNE7=\\
M=#OY3=R:J[E;AU_-M\ZZXM0'CWGZ:N:6V_Q@SY]^6#[E[*-^\;MOW['Q"\WM
MOG'3Y9__PW_)\<'?W_8K^^RS??7C[[OLR_U5\M7TVN]>M?L1^SX(PY_,#3_P
M[VX6W?,(\OOBF0^!CGX\<NT#P<,W?^3B-X[/77W:V>7[A=47/'/S$9^C#CV]
M^,PAXNX/7[O+\;=>=\?'CK'7/GW$?MR7+K[JP/O6W?;D3=_[U?CJ>TZ+CMW;
MO,)]_.TG'/7;[.0Q<]GO'WO?)W8[XBG^H J$[4K<]QYE^LP>O[Y(>/7@4T9R
M8.G,]J/)/JNFHK7_N+1J^]%ICU#UP]]^T!??>A!\V]-7''4VT]I_GV/@?=_^
MT*''W?R&L^E=)P 8KWOG\?O_>L?W+_O\O8=>?^3'?G7$=IES[OG4WOOWWG3#
M;\^JFU>MW>[FK]T]7/'Y3QS'X,>^QPMKE??2S>Q_G7+$NJ^\>U7XMNW>\8W'
MA]*#1][VNU_>X5]3^=7G:P>T'WC]/JO +ZPXZZNWW_CDX';LC$MO?/<ER'Y'
MF6>O/.1UG[^V]L;HJ<EDCRL6MG^2/.73#VJ??^O'Y#N')SWZ_C=_YOT_WL9^
M8/WGI(OW>/J[G>P?A#ON3WZT>KO#MWGMFG#'KZS4O_'I*'/$*:V#W_'VPOK'
M<[L];D@_?$_UO'WDV#A%YB^YL5=^ [?M;,=7K[T3L_A;CF_?"QQTS*,'7_C8
MMN&??L;&WS]S[TN+\,TWG?W_,.]647% 3;=@XTYP=QJ7X [!:32X0W!W)TAP
MU\8)[M"XNP1HW-W=);@%DOO=63-KS<OHO6OF?SOU5G76KJJ]3]4!+1ZPPB!Q
M\2N@Q^UMB"+VL,TPMRW\'XJ3_W&S3K#V/;3)ZQ^ K>XYYN-RAZC*-4^3-&H!
MF?@(ACWD.WIO684194,Z;.R@,GHJ!M;PG4+HT4 ;9T:<CB.5Q93BX(F$_:)\
M05MC#%^\M>^Q?33LI%HQUC$C?H<O=:-5 *N<(JTY/,FON0FVR83:.5:U*,W,
M020N,WG02BL'K6'<=347A[O,R/+;;YQ#,;+[B3J.:\(*,>S )!8VB0T,AO@'
MEH989SB,"6&"UQ\J2$85,/P\:7KX%T<*&?0VFDDDS/WTJ@S''P^6U,;!/@S9
M;Z#CMKA;3+($ OF#>/6CTLA<7.[&H+<#7X #@38Z(H8%&E#-0/:,!4UQOC.=
MWVRV"F3N@L?)4KKDQH>.O('OWVD-!KRM"%%%B,A>B4:")1N#4+89R75&V%/4
MFYG#38--O/#;<MW92T&$;Z=>$!M4_#_*;K71(X/(F7.N#71XH%4W_],:?6*=
MUZMN;CRKMG32BES!&$V\=)L2L6_ZW#;6OYHP@,%@WC&A">+AYA1I(A0PB-Q
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M>K/0^MJ#/*28NY^I0%#2D63JA2;H*(2%)CDC.3F1+;(*X9OO_66BU&GRZS\
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M<^^L]/.M"  Q14M)R2U&*Z$G:G9*?;>/6I^KX=BLO%E5[^UK&,.P/_OXO/9
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MS\RY049:52FCB8H*5PR/1T:EL7W:']\^2NSVTW: B'H==X1SX!\(,H+\$]+
M#@,[1/U//8Z;=[?-&<BA*MU/"TU7FV,T!OCFP?46BL?<I_>OR9($-- D&VNI
MN"07PV4/W"P[3K$58M@E'ETU3DR7@T1)MWM-PV==.SL(>IH*V-36AR=:D#9*
M,]#9,]Z'L'G_O@W9VDFA@AB.9<O'/ABF7/1+.D8)R!#T)#NZ3N/6^_E^I3
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MYHS(%+"SOD#"24"J=EF!CT 1&(-W[J2R1#%91%&X'D**N6-SI=A3YLFRK''
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M:D(1LN"\%[3I1P)J:Q\$B5PFQD%C?@K ]-#S*M3[3T8T1X)D(1"A8XRS)2^
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M>9,\P#AB73M2<F?#+DF:KH)C+4CWK4H$''8/Y=7?W 5Z#!-VWZ,_&([Y*L=
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MN)RD"9WX/EC'"9B2146QK%@S7]M:0VRNK@_YO_7#]1/I\&U5]G#U<A/ 8OJ
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MB5%!<&0M\Z\(KZ*O<;97DXBF-9B6OL'_OBOYWX5-T8VT^URQAJ$,P=0IU^%
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MLXP9)^W;^?B2N[*SLSL)S)A]N(E%O":<;V3K^PU=A+>TJ$Q#*KZ6LK%O9^N
MY$9W]SV5XHXTWBX5CUC4XY#K"+A\YQ[6*QIK@>_=K[5V=O@RMM-JC9ED%-6/
M! FM-WWFLNS1I_C#RMG-_\%+Y.F7_\+L(XF%K$]RVQ\ X959Y+9H([V]UWM6
M<5'-RB_*UV!D6CR0:&"E@::)Q,:KVKEIK6GOV$]]/)W-7BX*4>H?+"28QC)(
MCB%!S?[OK"G(2X3\F$V-2]/?<$]+%OC3@2B6:\FY(YRP*9'2O?;,QYY^VO-K
MJ4#$O<:9*V/U7N:1)<:5PVK0M\/A)(G(KP(O7Q.J'1%!<5"F SKHHN/NQ E
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MJ=>1&I/.H"HF=UP]1H[R8:=64.*V7%,9V^(/QM?-C'FGTI8293!:1!WN9=,
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MM*D\V/],<G5/,A17-H=3]AG=%?Z%1\RBEEJOD2[MIMER%9?B+2(#RKTZ(3!
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M0'_$Z1'4;\ZC:/@Y/5&K*7-KUFB)]'G2(BH/:6Q9\I>(-2^:;(DJTQY3M;/
M-UM)XQ(:&V!VDFI01Y9$'@GCA)4JRW?Z* *X%>B& 1SS^"%Y> V)"",4=UPU
M*BQDIF;-*;&D&GX-HXI5N<RN6=Y>SRJW^:[.*T+@\Z7&_@^Z1?E)3<@,24G:
M":!@_;;/>U7+),+&/4;FA%Q1 TD)PS.[KST$CZ6YY1+I7:PL:!,W4S\P/SU[
MURTJK:Z5N7A4-9T23^O3!&U,.K@=K$D]QPL6)TVF!YIH+*Y3Q,-M> <_Q.,
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M6S2_4#B?SD7=9ZFU6I&3;A12[MKA*CNV6O<BK45(H,BQ,0=]!,]A-V*Y7-4
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MILQ^'0/,K3O7CG4==?!M0YDRT][S$QQ/Y:YAS+ I?*BQ,S;=P-&7(GJO6JY
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M$'!@^$MK>HYXE_N+>=9,3'2$$A;.T7%\F>#%3>A<4PXD5[R2WA2>9+H-X[H
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M$\S47617@K+HDO1H,C7RVF3WHQEL:!JTQ4?-)5D+&>K',=K=OZW)FB2*5.M
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M(L_U!TF+C2'#YB.GIQ\!&S=1H1GCVC@4=&?30&D9XYKW=-6=3,$QC)L-!D/
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M"Z<52[<A]-Y3 <K&2BO+5B;KY\?Z0+0]=,4I[D=UCQ2-ZIN,8N6<I;LVD5-
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M$RALG^NF\3M*K/G^V_BBIIG&LWNH)P+C#")Z]HFV7$5%U0ZG?$C*LCX#]3P
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MM'9: D&?Z-"NWO0EZCK)H1T;G^DN7"_V$FN*IU( %<N,B.\5[]@RJG(Q*\2
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M>WR\D[K/(P#A"1R_U1=W&R_LGTFCC-.&97)<7.O#LZD3-3/.ER:S"!6:D)N
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M#'BJ67/=-T&2XDUD!)Q._0S+K[^6X"E3QO7VF.^>+>O;V52,BU?!SZI%@#U
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M$B1M;/_ZFS$%KP3I(?,_T:\WYH3IP@F.+.\$[CTX7P -4N(?$KYR/!,-_;T
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M!(HW/>=8+E)=Y?++"W@;\L5G=SG9WT0K(3G9IDG1Q2S(RUY17X[WVG:<['\
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MK9-\.VXU.7>8[0RC<\+EDD=O X/>JP94XN_G##EF#=[Q<T9+<*<4-')$/<Y
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M1H9J0Q292N+ 5W Y48TW/X]@AJY\6&"83SAJ=T1C[$*L];C-BN]>3BI^FQV
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MAAD7PXX%5443&I4L. &36AMDN*3(XN'5HD,R^)V&JW3^EUT2>'R,B7(MU(W
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MXPLA-UW.H"YIP)T6GR2[]%M04 $5O;O]VLO[A5%(G>6:O1LVJA$8P9&=F*9
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M[2(AVVJOO16LOG37=4)T6BQH?UH0-5OK$T7%UECF45W\JV%.7:+"3GBIF]!
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M\C([>#CDA\OM?V8,* $++#UEONW(+D^?.V/^"QCY?I5J$&%Q]_M'8B;@X%^
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MX.XW<4.BD'YN2&^0A+ H0$9-UQ '!X &[HI'*3I_3@&B+$!; #8SMS8+%@"
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M5>EA]-'T9?0C]'L,S PJ##"&&(9RAG&& T80HR:C)V,"8SWC+!,.DP#3&:9
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M$UE<6379"[(/93_)2<FAY*KD-N6%Y#WEB^3?*O JP!1R%984.10ABO<4YY5
M2N>4LI7FE4\I0Y1SE!=5.%6<5?)5WJCRJWJHEJB^4Q-5\U6K5=M3EU,/4W^L
M@:VAK1&C\4R32M-",TWSI1:'EJM6L=:6-E@[5/NQ#JZ.ODZ"SJ0NJRY4MU!W
M2T]:+TRO4Y]$WTP_37_10,# UZ#)$,M0SS#)\(41MQ'"J-X88*QKG&0\:\)K
MXF/2? ;OC,F9]#/+IF*FYTU[S*C-',V*S';-U<QOF,]8\%GX6[1;DEO:6Q9:
M[EEI6"5:S5N+6(=9]]DPV;C;--CBVUK:YMONV&G:)=N]M@?;7[&?<.!U"'+H
M/<MT%GZVQ9'<$>)8?0[WG-6YHG.?(<:0',B.DZY3AM,65!UZ&[KFK.)\RWD%
MI@A+A+UQ471)='GKJNB:Y+KBINR6XK;NKNZ>YK[MH>.1Y;'G:>Q9X/D5;@4O
M]R+P.N?5B*!">"(ZD6S((.2PMZ#W%>]Y'SF?9)\M7WW??#^@GX-? XH&?9GJ
M]^?SO^R_$* 4D!ZP'V@96!U$&80(Z@\6"(X.?A.B%?+/1\H)G, )G, )G, )
MG, )G, )G, )G, )G, )G,#_=^'K@LKL'__'A/ 3AC@CG6#"4*272!#$6T1,
M6%0$H* <Y V!>L)0(">8JSM"D6.SN94#Y.ZLR&$%-A0U]%:'N;GKA/C"S$*,
MS*$AGE!99PYE)2*%(+D@+V\O& H""O*"(_SD@A0YCH7+H<<8M @'Z)@$Y:G(
MH8I9 %D;FH#4D;XP$%A80@@J*B8&DI(2%I,$2TF)G0:)BXJ)BXBB?Z2$Q"3E
MP%)RXM*@/X!#B0C]J>#K[")GJJ'UASKT3)'CI_\["Y001OJZBHC)RLIBQ(B+
M"Z$IA/R"$2A(D!#"C_.;D.]R-&!^4%_WX[>H0)@YQ GICU+DX" "_01_^.7E
M_4/1;P/X0S)&.)I:3MT7!D'!--"_2N*BXF)"8N)"8F!S,0DY43$Y"5$A4;"<
MJ*B"R%\H?R<#Z6N.1,*53,R.;04+.\/A($N8KQ_&:K"PN+#X3U+^H/V+&$.D
ML[M+\-],D9$#B\M)B@N)2O\PY2?*O\I )],9@H+\IZ3\3/L]X")_B?A_-Q/>
M/Z7\ETR@%]"9D/@U$VBDG(DOTMD?"O-54H7Z(IT@*)"&NQ_*'0Z'^8+$T:D#
M\5FY(YR1@7[\"B*_D/^[+7>&_C#<V]\7?ERISE 1&!SF!4.@_-#&B_UJO#-4
MS@7IZP5!*;E[05QA(C!O/Q<%D3^QOY*BW%'PG]/VW4)5..I7[/<%N#O&,#DX
M!.&JR!$D],>[(!Q*OWE?\UL,X.Y_$2_R=_G']OW5%(QYT&_U^1L#S6 ^_V2@
M$N8ETG^E_%?>8^5_4?1O2Q^ZL@T-__4FX.4E\CM./Y1F .I?<_IA7J\1,87Y
M(?U]H3#- '0*.'\ORA3V#_7_>U%H<LZ_[DV&AG(:2*@_INIT-930"&%G=V<Y
M=0DQ,%A&6EU,'*RIJ2XF)JLJ*JDE)JLAJBHC(ZHFIG[<V[^R_DVL+L(/!4%@
M7ODZ%NN.$2LM"994U5#[C\3^Q/HWL3KHAD7Z!O_7:N<XG]X07[_CU\,4.;Y'
MA.-O#!B>XQS)0:#'%0)%(C!O3\&<%41^P?\S(UH/!'W>H;=E)1=?I!<(XNT-
M=X=",%R8306$0OZ""D X_Y$Y[^^O6']7]9.DOSGVVT;XMWCL!PGX+WCK_ILT
M_X?5\S?6?Y8?Z 9#_/60$943E?A^R/Q$]<]"_) NJ$"(+TS5%5VL2M\N'W^^
MT*YN)O7SQO\[EG\6#75#[YDP9R61[XS?$?]/94S]?W/&?KX6G&3LW[VK_&8+
MP>PR/]\4_F]N*,XP7_?_2H'^9.6/.('^7W/Z?]Z3_^%A>=*3OV+_>@'\IPO#
M'S>);Z^50^ _76+\_=&!!XM"P)(28C)"+E).,D*28A(N0C+.4(B0)%1*3$I2
M1E8,["SY7?AO9/S]?O6M_+4P!?R?JR>%XZO=?W>C_@OK[R0[_W>N?']C_9UD
MY/\HJ/\HX^]I_2FJ__[GRN]%_0]/E]^7__ZT_V-)[OA%>?0S-$P)[=?OT/_2
MZ&]84PTM)2*TP]__8>5W#?3OAQ,E)TI.E)PH.5%RHN1$R8F2$R4G2DZ4G"@Y
M47*BY$3)B9(3)2=*3I2<*#E1<J+D1,F)DA,E)TI.E)PH.5%RHN1$R8F2$R4G
M2DZ4G"@Y47*BY$3)B9(3)2=*3I2<*#E1<J+DWZR$Z,\_50!#."MR!'(H*WV=
M :@#@/]#P CYG\H ?GT,H"0 4F,Y8 ,I 5B40&Q*X-=. !L " #B8M9__$4&
M?" N'@$A#C86$7K=AP( Q,$" K'P"8@)\4F)B?!QL;!Q\(#X  )*:D(J&KI3
MB<.T8JIGS"!)HPR,IN86UCX1MVZ/T'-8):14CHUO<7*)2]R[/\D'5E/7T$%=
M2FWK7-CFYN&5E-)T@CI'1DG+:+GX^E55=TRY!N7FU39TH54R?;?XSS\2 43K
MQ,5#KVE1 H#80%P< FP\;#P\;#0-$.W+*6PJL3,)M*IFB3C4'*80G^$M\8A[
MN#25;2,+:HO;G!).OI$YDNI)]]M'N:*JH'Y?GP-(L#%\V)0 9<"7+S(:"]27
MC"C_CWWYA>S5U>41%P_LF29;K9K/LD-0D_>TWOJFO3&=W3QX13=WPVG5*S[J
ME%1*A_ZXN:!\@LXJ;7)6Q;-)X--XMH:5$=)K%]>VGW8IN7@Z#"]E$NNA6*Y7
M<P8IAZQ@J:^7R==AKU&+K#A$!5QM%ISQF*Y87L5G%"&W6SMZL'W48ER)TQ ?
MS3\A*+WVI?:4K[+@'H,8"9<TKL90-/4E+3:&A4R&C*&Q^''XPN4%, V'(E&L
MU&K3=H+!M$K(V4-))X\9HH"X,%6O%Z*!N4>;]E[FI"S#*6Q78<IGITF(A3P2
M*L^MOD\_4TBOPDT)E5:[I6 .VE3."N^BI03'3T&N[R=<<8PKV3.>5>"3TX;'
M3XI[6GJ5ER-:M!':!(X!R?JA-J^*'2[.YH(?J[09ZE;#3S75U1&K3^!XV0+U
MN2H 4O?2)<3$G;I@'S*VWXQNL4>;=)J&4][J#^IR'F-1>*"XU71_J_4:O7[O
M +]9!9OB<'IS2>H^J_S&_/Z-1L.WK+45M*4TZ\2L):*" ?4O./RUBBXXVJZ?
M*[W=_?1N"LC.U.BQA60AEI&8F+CHD!'.PL/S;QXP'[:#F-W([]OS\9^R8Z]9
M'Q^^'7/;(+!*;7?JE=ZP1/LU4(F7Y+7A\:#:F6?3[?6DF8\]&@7"" GB27JW
MJ NMU)ZM]Y-NV_:;Z,[IY(M=FT+BI\RNSOAZ-"O&%L^&"#HXY-A<5J-BPJ7Z
M"BC+U>SX6#0L&,1_2F1[%-0IE[?L%?F(;NULIE.U*R-I,HDX\@F;@OW5EY\.
MR#L,Z+X"O*/;>0DR./Z/?\7:-37/I @QCC[JFK8@2."VO5QK@VOO'4MTZ[1N
M\^MGS:J,,#%*8G<SK+%EF^?5=Z[.=1M4.G'WV#=$!XK;<BPLO]S*W&%7J=RY
M2:0T,5;EO-8G4;GS% M[DCQV(EE5T6L%D>6B6'UM)H 6,5@LU+\VD"XQJW-7
M9:CX%K/_=9K9RR4!$@?K)&]'B,^\B?@TXO[AHZC/6W:],"AK[7.P-6ERO7_R
M;FW-Q_&F8;PMJL'\)^24U0*LJE;^*JL>&TV(%>\)GB=PK;I:46YKD/I(]&*;
M,8^R4!,\MVU(7P9Z+099?D6/;_HL]9I1]1HQRCQK<J+/U>!@TL:+Z1PG !P_
MSM?@[YB_ V'+/DUS4_[RML<DEXN-V^)&6K\7F1C^!F>=)IEV,.'^,L4,MY/&
MDTE45^"USY_II/VWLC=8;&LSF*9>9K 4O@29Y^36-;XL]R+):AQ<4RZXBV/O
MA34@8AV!ZT4DGER7F>4>SW): L*M([!FFNK;B/M^-U,N_-.G,+<8*F<M<07"
MSZW*N!L5^]""R*)Q. +5KD;=+04K,&*,\'R^5%AY;\/0V/3^L]F0Q:;SX_RG
M3ELQ[78V4(TW[7+U^B\PLTRT/DJQ*:IX_.#]K="=O848+? !HG]?@YT0,#9:
M_SGFWUXN;5+);4?!);O<!Z?%N&"F?!-]\#,])3F%$01Z9<#,LY+8]-BQ<"%S
MYYZ%>J:PN*8A42XK!VY%ZUC&%UNQU\%? <1>RV64B<S%&KU[I@6\?M0ODAW"
ME;H<6CP/A$M':$AGT@W2\E\%W)2"HZ[69.GQF M;;5F=R]9BRJ$'F7S8,4E1
M<IQ0?%MB'M0)M1'+/^C^"LCL;EDX,XJ$-V?>+_,XZD ]M-@5DK;'BS([>JI'
M^LBXR29@0(O?8^"JO.9-2KQ+BGGO*H4H-C2*4YAVK6/:0'%4;90=3C?#/K=H
M\&5/7K$S91P-.+KZ /7N=:,-QYK7U1HW4%QTOE7'],Z1B-GMYPEU\([1\F&M
MK@(Y*1(>_?&IC.4YAAS*F4"'O)Y4T\V%=ZG035RGRB5VZ[W]LI9)W9+Q\XRW
M;=7)4LA$T^/J2@I)RL[S< OE\CL^,F4V:U0S+S?RB7-5RM2D7?H/#I@+8*ER
MDK;FTKJ9T>7VE<5+>JWI2(=;8;5,9\R6(??/N"MBUP5DWJ[JH<F-TY4-C=^0
MK2EZH\57@]>M=Y_UB:^04HKC#2C1$KNCS&?+LB=<C-D<"3PJH+M#.L\N,12M
M$&P2=J<,%%KDA S""6U(8YG-X^J4.*Z]#I]#L(]]25UAZ[R7J1M^U_F<H15L
MLS18SGQ&!D+67V0@*,.LJ4.0**:3>\BVY'N1.EGCNNEZ\WT;1N.K%O[E(X,F
M#H8D$UM@UD>L!],.=H ZGL>$!K3652):+Q$IJLDA?IW"QG2U],76ZM;(RE']
M<GJ30$XMR>#M9]<@PT]R#S^\U\E](,!^:3!<8*G&SJ]@00,<QOM +4U5^J-5
M(*XU:[@S6<M.@?;"#"^J;ART=O=FP(IEPXP4CLQ!T9"=Y.+'8!6OH6G$A3!:
M]DM'O'/+"24&9LTAM?D+]LNG##XBB>JN36GZV-_W*"T)[Z5ZYFQ^1FT\WYYM
M!Z!HVA(D41_E0%UG5J[GN7QQJEU/3<V.UT;W26@7X]F,,5UQZV@<0LF==FE+
MU0-78G+I!>=\:WC:1[+,X5!EJ$O;F!+8/'7TGIG@YO,UHK%9V]E[#CONT/J(
M9(-;FO5Y(^IOK*0HGUO<A-EW^B5&UG)5,(R>#OV2?G0K[KPRTK&/T0Y[=/!2
MH-8.V"W[ZL3X46):W3B;[@"R<AT(B"M^O@X"MXC ;0HW8A$#XA]IGA!9K&M,
M4Z]; ,'1'R"WF4"?",7FYV_ML7T%%&D8="F$G[6EUGO#"ECX-U]YZ*[X#T^\
MJWK[5JF%O=I=*93TQ>:<8*E*5N HBJC]G(6 T11<[+1VX.75*,.PJG:ZK7W
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MH[AASEHXE!2NMHBR3Y+8K\N99A[/CN>R7FC<V=F$K6G8!VX]2WF<MLIGF#C
M\:G$9R3C94Y1;?J %&#??Z2JG*Z4EU/=TW10L_KB]:G#S!G]]UR/J6D<[F[.
M#=NUW\I.@\29IN<;/SF?5]P:Q5PH>)0Y[8I(&+V,S>,.IB+#*K7OY3M5,5][
M0T]2]BZ%W$S(LD*J@U1VC_%M]79]8^^&B7OKE/W-93-9Z515NC3=2869$S+1
M1^/K]5$2(8RQI7CJDZQ*(Z]P1H[,S-<#B3+[4NGZL.K'6#T?5"9?O_,X,3:/
M.YG=<A3I=5![P6X.8N@;0U1)M:5Y!-)[UMV:PI M1LMS?X7UOKV!I72&DY5I
M$][P[KL,.:^RU=@:(O\0'4_+-E[[0K/9,H,H@]RI,A<C<X_+<'"(5AVQ=]45
M4CEY.F9G6QW-5.[;&4F)57:H:0Z6"XK+";9970CD^<FG]6L%,^W1<^#WI0<K
MNUL_!K%Z3<-OGS=..+@TVRB&WC&( ]"MX[Y\3(KSCK>R"96\I'?3;MT@B[!F
M_C1Q350<^/DB[Y/(%_CO.\3I#E$,!T=N#\0^'E!<X,Y/%WF\4%I6I]\5V5@#
M,F5LM%FGNX0;50K*!] [(TI=6XHNXCPMGN6'S8^KS]0N#:VKXU+2BS_AZ)-5
MC1EYINDV,\P[Z(BE3*)(U)LP'SE2N4-:;Q??D@CTJ.@9Y51#4- .^]2!:<@J
MQA<_'B766BCI1/M1"A[B17%"K%A8JM8,S<]V"SS)ZTV4X^K1(9RSSLI(],S<
ME'&\>IX6U+D96FX"'BCEL*&B:_+OOE^27MI5.JG=/=%<8( D@I&V>Y/<))$Q
MMSE @ G30;8T6 869%4ZZ\P.<=2=QM,WRL?4#(B K3T^C'$?HGN1O%K/JV9R
M#AQ'#FY#'F 'AFC*1EBZK%UV9L 9MN(UNGLJ0=.5A/!TG-3Y4B&PN$K$,^5+
ML"YU:/>V&(V=Q/>8QXRA=/1%U6FKMT$IN.=H5$[=,S,=W8J.%J1\BZ/=!PE[
M$'+ZB2];_*F\)7Z? KK+4)EG/NTB;R:,H[X"VID-HZP32@-I-:5%K0#F.(X0
MKX%TO6KYD:\ PP<%EU8"JIV>D/20HGBA!,NK-1L5@912,6M[+1EC.D-L47<"
M("3C8IOBNDHJ)N2]>A4A1EOQ(TMIN1ZE]2;YX\8)=Z'X4*2[=1*U'7-"R)IP
MNVK#\T^2O2:G2VSG7C1Q])Y3BR&+YC\*%#V_/SI+=<KOFHY\U:<A@JW';=M%
M<X\NU?:8V!;HM-JM.BUOU!WQO'5K6->?FC!\L!-2R>6M<[/-Z0/**Z!]0\:)
ML _;D$4$<E.L>HJ1HIAC486 I:!5^0)WDXP/T<:VY>6 T*.8[E!E$9<@S7P[
M^NRR*\)X&S/R,-1 KO%4G)+IN$^#31$66YJ:[<WUQ7Q#FIL3OGG\?+X&O4A7
M)0'3>JNLEV\4!'DEBKZXO65>RBUB]9Y&Y'YF.SKU<F-"7X/ ]H,5:J[X=6^Z
M/:EX<M6NG^\@?*HNOJTT(,QY ^LJF1?3GCZO+0B^$HAOYS^ X^QJ**HK>]?R
M>7VE A,NYW5^QRWH*F_;;$!-J42)SK2!NQYJ<7?;4K !FTM*T[Z1VQ:U(Z7\
M#E+YAK1Z.JKO7)7[![Q\2:B&.AD((X64]\$@KKJZZO3,UEF+S_U*5+G7M%TM
MP5/31:VS<OX%_F3",17(AD*QQ3C62O\CM<& C,]RC\T"8WI9=%+)[ N']'3[
M2SBNCEE%132//[I7K\ 2ID3TWK"G3N#^;1U21V6V@M):A/"XC522]G2T#&DO
MCXB<1-CM&#@J[3SWL">EPQ66")\/SV^I*H_VO @JK1F*VU?8<^D;8SI[(;*L
MH$SJV<*DN=<*7CRD?,T49U51<59UIC=\[;8-EG,SB8:H2YNE^Z4U(67QQ\66
MG24W;K#V=U:>EI]+J_*3*STWU;B2TQ&<9#_**KH/KL75\K_PP+#<=-K!S-.3
MF-;O8*Y@MH:]0&-,-&9CHD"9WC"I'FI/+N%R:6S_XUW_Y1S[>W;&U'9WN#*>
M%3-F>SV[[N(UD&Q<'20GY]P4PUYU.F3-]O*D[;XH+K7.1O2X2L,D=3K''#(1
M_'RJU&^DMFSFG+D'02/1=13.=F.PQAV<1-W^5?.(T=WY+9]->9*'<5NHMT^2
ME]ZOOO:,W+ X\BG1&>/GOX=:5MO_Y G+GY9JKA(61=Y54RV/># )&HLV]"@)
M9X8/I%U\;TQEY&I!;1]R\RW'K&XSRU X&>*NUE3MQ;"VD JL:=L/^)0^]TPD
M+8B=+;G,Q0G]W8?Z;,I"6W7'LPP:\CB6I*27<&W.]U^RE.7JU&4'S\C7:V62
M;L'7B_:OQ]7R9GUTT/-T<Q(+(X0XI:=N=>DD*@F4QY1WW+]UZO436 YMQ6X/
M'*ZUF15 X\)L?Z675R)3_H/CX#F%]5&YS?SWCIY9]ZX8^<OI/=2V=K!]&X70
M8W:/5,_K6]ZK&+[H7G<0I3E?DS8;4^Y8<A\9/$V4>@Z<H_O /[?^;&:]'I5?
M'_7[+['( Z\;V9MA%L--]G,O2<\F@QW*=NI+D[<9R,L<1,@,>1U155"G]:>'
MEEK]@X3Q"25[<12/#8MEK4<.=N<<4T"FRX?93OPVLLDO;M3>F-__;"S)OOI9
M>FPKT8]_M_(S.WOTNTM'CE<.,G48<9+NC!4\[]DZ'\[;1/T)P%Z_?YCYTCSI
MSK@FLWQ;Y="U]VGQE8J<[OOK2<^7KC+IA%$0O>K,7BMP@#4SO.IA-G*+H)5C
MP;_;7+TD3Q7*>1$BJQD==@G-K3?GR=ZVO9_YUO@5X$(6.^>'K40CKJRT\I\T
MK5ZH7^XAY)4H-#^T_D)^P_C@AB1OP7#69W:T751&,*L-Z+Z2(ONJXE#FC= O
M6]A'QFC:\H>18247\ <70^\IWP1^*;CT%^M7@]!MK%?PO/MG?[(.E<@O7$J2
MX/%[6?S=^\\? 9^^!(2QH&LZ3VE".6II6V$H/.O"5P#^0HOR<I"ID?MWROT+
M!P#VA:^ ^:^ VY>=E_UZPG\L?5'!/\BZ\&9O7U<V8WLN#6-9ST^6C1\+9M]4
MP'B D?SH3RQ:W87BK3FS#V_VT=Q9%\96L[X';%"%/.N-ZR^>#7\%C &^ LS:
MT:UCAHF+,O4LX>>+Y)^4M ]#OWP%8*)H_"W1*-[W &5,HN6*PDJ0^*V+P?>4
M1-"DFZ%'68MHO\+93R>''UN@.)3U!"-T\S-: E%O_VKA3WY]SN(\JE[!>'97
M[X^DI5'OA#.CD^:B)(SN/,=@'$S:XD)GV=X:C^]?*%S@6O;_PP9)7DRQ?04@
MC7LP%A_+9=N;0D=&$:!TX2XZNZ[F@U%H=[,NW!\@/&@EWU$XQ;6H^^&8O:=E
M>/E2SZO)A<JO@+=;B5HXEPZM7Y+?Z/R@%E[><62\?=X1GY!7_$<B][\"T [W
MS+Q74.F;J_)'VVLA,8^VUW7N[9[:!1"Z; ;1-HP2?:\)^D\ SM5'"+0)IL<1
MOZ$E]ST0:(,[-C$:+SMB#/EXX<&>6HCRP<5O566A-"$=M:2,SN;=S!O:J<!#
M179IOW;==@,8NJ4>LK-E[: #8=SZ%1"$SO[<IZ,O&"][HIC1*D+OSQ)N[GX%
MH%OAPENTK&3'GW(U\!50^*D!$^?C^FG993ONF;[W"NC:/ Z=\A^EAHF;Z1])
M6KZT[_,5T+M_X>K<5X [)O:#K!:_YA43>G0LT&Z['KU)P_3"TL8G]ANCT^V)
M?GLWEBQ^&'&\,Y3\T0AO?N7_7JQ9Q5M? ?2N3S[;8ZS*PE/^%HI?T*TB[=&8
M4&"L.W*\>I!EI(0,1=>QQ7%_=^YA$OC%.&&_X5LTOPG.O/$5<!7=7B)//D]]
MSD*G5J+H6Q\%WU.V6FA%H\]S93S%E'+WA9?'N"_L%XX*%O;#E=#AN##)&E@^
MH<#(1I[[IIZ5W<W>=:D+1TD)&5%V'*LL/.VH-[(;@]K/Z67W#OU4R#,^G_UB
ML]_"+OVGGN-^/=;_ NU#T9TM:)"2Q)</ _@'K:0[RDJ8ECE*+/ZEY3>RC%L[
ML:\E._]:\1V;7P$UGY7),45_W'R89+IAF@-]+XQ"1WW[TW*^H>Z(JR$3\S/R
M%ZXZGG?=WS@VGO4-OF<7R3[;ZMTRLL<^R\ZC=K[@Q5R WB?>&S,O/IW/HJ]N
ML2+D6H3!.4:N4N0*\=O2)9]R.RN:*R30;9I;*-OMG5O,^(PF8TGFF42&*VL&
M/Z=8T56GCVNC'YD^U/+92AAW%K6Z>VP=N4C5Y(L"U^XSJJ76R[%F%[(T2\AZ
M,;JMWG^5'LYQ7E>WW6=*ES%>;8=BR):OQO.2>).C.55T15][A6/.S<EDQH1W
M;[1%6M@\GG=&D(&A0KAS[VX^237H]<EX9MGWQ-(O(U$+:M+RX>.C+,%(!OZB
MVC86NG/]IH5W=4KU=?DF0&W%*00?MO9[Q(2BD@\VSE,&Y$*ZGUS% \%K6DC@
M4C9<<=WWH-8K-_+7N3S$1G>3VM4)Q7'4?(KY]A]G!T@/Z%;@L<9A]]R,D>7H
M@9Q_O#\[IF;,*OZJ^ZR-;./YQ!?=]QP$;46LQ^J2.U!7RH*:!3:MBH?U;5P2
M>73?2MI"DUY;%8*O^;U^PGZFL)W+_,YM%<N<6%:9:4+N@DH>WYOO"3G%'E@V
MH:_G(4QU'"5D=(6YANR:C2_J2-GI*+#7WQ<&$N\\GGT_A,A3:F_C'^_UVZ#C
MZ+1]$DU)"12G),."JL4SR7,EI(X)OO"BSH4TWLYQWW"@7<]W$E\/(;6X+1Z)
M38B;F=$PE5O,G\;2&V&Z/3,-\C$UR=Q>,KHUDXOF$P#?_WB>'J#4G3-^<[:8
M.<NY^.$L67Y'\@RE=1PY3Q!U-,UE0G$M'.NA NJ(%)Z^:,9KFX^63M==&B)\
M3/V*\#-%XWUZX+):N\6(M(';8WNBX9!'-4/Z!#,&EH4U\^;+L"0:HT<A1/HY
ME026I#&Z!_&2APMZ+M;1W86U'!+W=!/LJ1HJN5S Q!"89JS<Z50S:*4X2S=;
MK#!7?GJXY(,J9C.1GIL=A7;&HH?Z=D8UB^8S\84ZMK[)KHS'*3,8>KN=8(A0
ME"KI"%EY],91:N"\F=M]\#O!\4?OLF]IZ'EZ?6KA4&&GD#I5\"+P)>/T*Z/2
M9"ITH;3JY)@R\5,LH0Z:7;*9!5TB'0"X7!GRC,.>>/#/-BO1T6<&&(@6.VGX
M1A^D*SB-XYF]Z[*T7<#8*8#Y)&S7Z?>@OH0.'A]UH $UQ::Q&]]KGWJ7S8IM
M'*<V6+55KHR-[1KLX8Q_ZLZ+17!F3RK<T(RVV#C>YKRM/FW"#7\-@F?HK!=E
M[F,JWCM1@NG2KV)Y,35AA+$T ^.GS/\?R6SPL058)&O/59) ]-;?%X2*+;E6
MLS\:O,]Z9[U;";GT<??#1U8&LIRG4?/,MQ^O.._LWC3B#>X__,S7&#'N:)H>
MGM1:^[+N/DEKQ%B"!KG6AQ?^33K$?!X:I4U:86018A]2N VCSMXNCZEYUBY3
ML!:@FJ@NIR3VQ*=;SU>+KDPHU)9)_=R<M]NI:E5K4>VNRYK2D4*QV*GV#L^3
MQFL:8B<UTG3 ^UJ?'K1IS2KYD]862I&2E-UOBO8>0"+C5GMQ7. 5MAUG52.@
M8Z'7$\IW'IQ+6JN-"9&0?!U@<;&C@J=%[DRPL6XX%G,48>JZ5H/D],YU2C<A
M?#=)@*TM PX -AFO6R(D>[O\BFADATLH=V=*8]XSWMHF0'9?L#5=[NK>@UB\
MZ5$Q$?K757@]"K0(&(";[F'4+N/57=PIFJ5N04L"_YG@IPU#PVMW7"'NZ;+>
M(=NJ@WK3J$A*B/&MACZULWV/5455W)*$029MG 1"DB_)!(VKST&?X(6:+"X!
MP%6@?MTH->X1T&,!XSK_OA:^&66OH:Q)_U@>@73/%T3.J!8G-L1K*U%7TXD.
M"P$*I\>I]].Q6K'>0UUM$\O9!(I$%_+%.562^?8-T]58%GRNL.J91]KB<HA*
M7\O@B"R2ZBKS)-WKN^I1!;R:J)M+]@3 %$4MPR"BM:\G=W'Z#)A4J=>LL+O>
MFFW(!&DI,(,[<SZX&=:LKGC^,D?]N6C2?<H4;*>9-2H*F6"QY,7QO;N(MY^F
M\M;&7QK4"3>,3+R4YHJXU%C-@:.OR[Q*F&0]6L(DTB [)*+"-::>'05N=_&.
M0ND])ZV?E.J>E%]]G3^=8T8ECK-Z'D1OFD(XBFW5,46R6LF#/-12P><1N.U8
M_N8<K>TE6XXQ.C.@IBXQE$^T<(26K*S&T]%WS<V64)E8-:8))P*_@\33R*#R
MT>/#=W,@)T-(:88NR/4Z@Q&(O!W86.+J[M\F5W29+V^W72JW3PP>>'M4TW^&
MIZBL-KPA!R:C:[^V=BA/,'#;_-&^[?HA;7C1S C=3)[N_R+NK>/B:K8VT4:#
MN[L%A^ :W*'1X.[N%MS=W=T)3N,2)'AP=W<+! L^Y,WYSCGO-_/][LS<N7?^
MZ^K:NVK5LYZUUE.[?[7;O2[>4B90+-,X#;I%OL^"M/H=B 0(/-?D8 @XK]N$
M'E62:I.=M!/;U!2I*P= D%0E''TH'PN>A>V,!3^J6,H3+F_ 4RA%-X%6:'"'
M'%L) I:M^$5SZ$>[SB+Q6;MKC&8:0][AUU+BG=1.<A= /2SQ/V_-A:R%,RO)
M'N,IA*4525* OW=_D$TSTD#^T"'G!R&B;1R(#JD\CW6\9WDV89@<,WI F-TZ
MV)DS$;O^J[5^*DZ M&M-]4T&TN;PO!SI-GEW" Z9_]9 _V^:E1P!^^!J4=CO
MM-\[,O'#3X>J!,4A,<4?R5(UUM66+H:%0Z&)1KW<-(\D!B+B7G>^;WAY! =
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MOQ\6EJACZ#.<FK BV%=?M\? <$X?+I'_?J$% H&<EA><PZ"-PVVW'5B@\>=
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M:'J#%",K?68:'S5N764I9+1,>;R#;[T@KWU&^]-QCSBJFOC(#AFP;HG-:@/
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MS:"3SS"B81EFNH1IZJJ=H2CE;02A7RI-'H-('=]#8LUNH^.09;39Y:T>:_I
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M6-U9LT EQ?)R4$ATJO*/Q089JD9C#;,N/7)35'+#V6).40\=IK2%.#QT=:H
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M-4AE#:@7MVY*>F(MR<XTM?WE; *CV#B&-PAS#5PX$B2])$D !R@(];6F\('
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MS.007% %RG)F)9?O'"_-'J^O@0>I2M16Y9 ^-2TAIO89E=.A=W7/!A21U=Z
M]@S61S4=86F>]!6#>&%C)^HLV5OS8CTH/?3@)N2 !(YFVT8X\,ZP!F+X>F[A
MF6Z$EJ(EL6COT&_J<M8R?9&W:J9#:MA%=:(L#)+!U$9<,.0+/H>\_%PG1PD+
M9DKG.6DWT]"5C>]RP(XZ">6)[Y=_W$@3D;I,_3QC>FK416HC%2L%L"TB.V0/
MQN?FQGHMTDI7\N:T$P4O6BQA49;#HZ(FTD& G:E$TZ?-3 D/B+QD['%PKQT9
MR6FA0U!RR<P$.1^3VCE6=VKUF+B>ZS&IA+MN.B[5HJ2R2#"9T@2AZBY\SDP/
MM&T4DTF.\(.T75*2E* 0T:WG#]K07S$(*6BM+$]X</"H7IT319@Z\><=@D50
M=N'BQ-K;IWWA =&M$&@PB]\,,,Z W:0\_>4_W+;R,M)X),O]C1XOG2Z G"X=
M>BG2F#!1R'Q:HR9O(CF9.*.;MAY%;")S]90O[=F;%5HY/C,UURCBM7JG$O6*
M5*JE01*Z^M>XIX$+;I 2&1CPE1RQDBP<B:C'FZ,+[9Y1O=0   4D\@0T+A5\
M_14"*$+ASM%^LT*1P*Q\!$S&#F//Q\AMQ&J;8_PED^W _3'D^&!WLK;=D$H@
M?RB'AX?>';'=!T:NG@Y/O4UW,18O#_U&L=%5YXW_  G4?^[,LD&:Z+L,#0D8
ME1B\\E',\B76D5P\  &PO "!HA_!,D!9M"4L.KER-\66P;U'QMR\$ -)@BH/
MR08KN626M)_?*WA;Y;;BNAHJT)OW%:[1@X?LA_MKK_16C0WHFK&<<OD((^K5
M?J8H-KM?\C)"Q#-?[2:Q,Z;<'T+,!M/+I1$Y#&Z)0+TIHI# ?XQ?_A#<V=:,
MC,"AG6.EZ!NP[Q,<JN4.M8SKFW_HU)O9.@FDMC:T:_$0%+=5A5@%%].E=QC/
M!\M_Y*.L+F$T+MM46 1\>-;0].'(3:LWFQ@HQ4D^D$5U2A2!AI/)1C,U31U%
MTN+L[+ZWA@0PPB+IRP"U,5"<J:?VNWQT]G+@K)G!JPM+;@3PDT&59&+ZL-N,
M' ]:]#37?D-S.W;-0WS$SM%!%P($@JXV<3C8ZR!21$720AH(0*>8AG_.]N7@
M4?@\GPQP)U%"BA%:"*$0#2#/;\F:\4$W3J8;69:##1G#N-D4@<T\C.[Q^_N;
M[)QIN\2XJI@)RF)(#38_8(K\*M[>/\IX4[LNT&_X-5Z;=D[&CR$%6NDSYV0E
MKAQK2T(_+!?-_JO<XRAO?3+@*M%XYL#P%#.P?\:T;,1T<:'>'%*A!PT^ILY.
M7*2(HE]C7JNQPRA/&WH?B_WN)^[+FR^O=+B06HS(N2#C59QGXX^TGI$^=4],
M Q$MJ0\^O:TU=Q'BT_O)3Z7M%'HD=<$%.9SZ?OQI#M$"ZDFJJ8N2,L$_OITM
M3"L<,8PSN[6M#8N7$,]CXK9"0N.6VRU>:J5OM%]FK63!5/SLA&)QYCF$\S:J
MXUW"'FO 6*7T"*J6\MOX?!77U0RK(?>1AMWXAAX-L4S=:$-M^,*?#][VF/Q+
MC#Y+&C22?R,STIJZ&1:3#D=R96R+%W*?AZCK-D26<^ B95T@!,LZ.@JYL^I3
M+-E T<A(G9DL0%R4<IUW. .7&DV4'! 6?BV4^UPV?;,*B</WPY_O5[O\A@/L
M;4MY2#/1TFJO1<VE&J<D]C9=@U^6%O9K-QE$1BL//G)R6_D0![$YWL,V'3^S
M19%K_0ZC:Q1WE TCHW7W(KY):4<KK3C$,@A< S"A7"2 J 6T\O#N%"]^18CP
M4#1E&?#Z47R6_+P<%S\41>W>YE,#AF83&/F2(_ FP:8Q*?6S1#-,-  3HO':
M_"?C"'1;%DI2$ /?R+IXO/$A-@-F")C!P%H1A.^,Q0D(W"@-\6F4D(@:UN/W
MT V2YNW/'A*)X*VGQH06G2:!\3LO*4<IJ?2H,QQRZ.ZUUO"9?67UXPUV+AMI
MVGQ&.=5)@C"(.3*Q952V36;7QZ+F2;=)&Z^DL)63B(^/.B:0-",<@SSD:,V.
M0/#-%H&%8(%(@2P7R4;>W&R[(H6DMP20([/69Z!3 9-D>1#'4Q9VW0W-YTKP
MYD8&&6UKW%%S4&<$I5(T1+ZJXF[.:E\SY+OX-<^=V\'P-?@;M[F+%)8BZK&Z
M1F:_+2B1/!N2OGZC;"?RCAQN8#EG>*OKD_?'L[  +^+/([A>,?!9;1(A+APE
M,O6V]UEUC00*\,WN3DS[YC+BSIF<.7+%MK1D8(+G?W 6L<SO)BUUHR1L$N'5
MU30T+Y5L=ALZY/#+X[!.DTU[AVY?]GA=[-@GS7B'VWN*Y0G+U6A!ZBT:,5_N
M%M8&!<'U9%/RM7X@:U&USYD%29!ZX\9E]*M0V&/F-_6G)^BTM%O)6$ETF-EW
MR[S)+5W-)F]=^S(PUMK_0+HV'.-J?_+\/=]X]N2T*K2X5>L^NJ[;O>'BGB*9
M(=MA%E/+$##3_B8U<0]7ZJ[P)GK0C\QP363UY-[6Q>1LW<C!U&[39 !QH@V3
MK2'\D/!3_7?:K[ZKT[GSAU^ITC^G)9X%Q'X(0I(O6F'?QLW>T1-S__Z<]&CU
M!T#@N2OW1<!OM\#*2E"0X#?QU,\@[Q\Z@OX5^88/B!OG+VGG?P +VBUY:_FH
MT@I+'2?:U0U6"' ,"A\X'G]-]FKZ[7'_,A(F$0[X R@6'3^_Y;A^3;NHV1@4
M'7][KL-<NJ=?T6X)#<&$_<_/;A>A\P=EY>V:?X2K^*CSN?X&3<-9#%1IB=<W
MK%<_3=^]D7?MBHJ#?^U$GE\095C=FPLDC \3%,;HU?3E$5MD)3X1O QNB,LU
MX[F:&SN7ZZ,>^=4RB8"^?RE<<)P=UF@^'432MX;U>GWU?%_P;EW2^*AF:^O6
M1/?]B?NO/TD+8K[!#N1X"W4GIJ:6 1=8"#2&_1D2T\>6,8W 5T32T1@R?G0[
M!0OA.']&5=.98;\-'$JF53R;*Y[561G(W\!1%.>AE\8:SRC^]'5DD$K^P&^"
M%9C/<T,G])]]LG_=!NG\K-+^^7*RQD.!5K/U\#?P,..CJJV-.ZN./X"6 BM$
MT4S-]_1]^;1;LS'66+=F;G-[^DTYI\F@#R?Z;] 4Q16.,W\=_QARN]>BH/F)
M[8OPG>:M7\ SXL#XOC"S"?O9\]U[VN8.7SIE>(DP'^AWK_\ 8/Y)HP"WY7]/
M6=0[@ ^_OQO&?L+Y:]5W]S?[Q>D[.E-[\49_H;K[ VC2'KC]20(W-(@F=6M&
MQ/TW\2._$?N81^Z=$EWXJ"L.YJH;9N[\A.'&[MXO"/UZ"WW\*?==\VJ?],A_
M09C+7_^-1X;7Z^TYS$GC^K7E'^RQHK&,E(?_#>N/@ #<"L?IAD\M/[%\_P!P
M>F_O$EUX3?HHE?8B6@0S7_PT?80GWA$_JWGW]1]U_GC9!P_ZE;F6CH5?O5?O
MJX67[I7_RYZR=T7O[:%@ =SMNP_P%&AB/@&4/M5/_W96>^PWXK\C?_R!]6[N
MX? =[K_:">_;\_Q-UN'C.R E/]\7Q;$6_X_*U0T%)#@S^7_)^'-C;N!,R?7G
M^CZ &J#^']Y3Y%?]X^7)ZY=/)R\O[^8$3SC_\<V(>^;79^?!OS7 DM?']I>G
M,IRLX;1_RV'_^0OJWTQ\+<@R3/CUCQOXU/^Q6.SC>D=_^!_T)'Y.OOP!#&CW
MWK]MOT?Q4%S1]WM$]_$GPNPG(7\2N-/CUQ'!Z( )Z*_4VV\(6UMW5L)O74\N
MM'![";W6_TE@HU,(3[7'VV[LCP#[IT\9)%LM2V-] <^E))?*(_P!]C^J7SYQ
M#_TVQ$ U'"\8$'*8?OI)5#5W]-(T2JSWK$H:@@X*8!&J"?5'L@;WJ3(V>&S]
M")Z@$WFVIS+?,FQ"K,\Q$*VS<:XNF%^T>6H)G);@\?27E5IQ"R)C/3_*\V]9
MNE;\F( 7X9>.XM1]L!24(0-+VMH:+/H2Y ' H_2MVUY<XWHRR 3"P7.7<MQ<
M9<^>[9825_KP7L"^Z#E\EA\9'5/M<J3;';=M/_[= LQ:)7-[<:BF1+]OE.4#
M8"EE=1;4):<8Q@>%FD!A_PJ.3+\>"IXUK&.X1G## !D20I#.F0>)BT!-^8E@
MT$&F:\7:@3Y8#)2UP+F.7-%9E*U4 @?BWBB7=WNW=D0>)_&CL&/!EF-7<M,H
M.?I1?)T"==V?)?*X>)M;L9]H,VBUT#SDX>\I!P<WV5/0RGC/V:VD%-.*(D>O
M\8VL($O1O1!^$YK*P'I"VK)6'UOJ6=D;=!."C/NI 6<?@TA'X1!IPL<*/7_%
M&+GI0X<W,%.#K86W/7CS<O,:R8W1,2Z4+S8Z7ME-4EN9)O4E6W4N*0/ M?+L
M3\@310@0?K95.+2E<N*69TUHLN"MV=Y0 Z8DTC4$@@& *(P];]'3,&^A !^!
MV[1'8# ,Z4"W1:/$LEA4M^)YBZ5U[T*9>D#ENG0^HV\W8;9$:O;W9'4O(^61
M ?O!ZYQB(14!1,'F9]04#HW/I2];^+O^M-1NEJK6C<2.R"9F6QP9?%T<'+O3
ML!FP1[(8QG6;O TM_DLA@$G%W^.5R2*]+,;J6-LD!4T&!23O74I0?N@O>?^K
M?FB*45/72AA/'%F@$^/,>*I>,\BH[9$B"&#'0QC-[%7"DG42ZT"1JX-R;1QT
M'SET=@)7%4RM8F^]9]JY[%M:FR#MZ_0/;2Q-IGT-;!:O]0<)D3=R#',6ZQS\
M!"U:<D7).GQR]-1.A "NY(2KZ1CW5A;&4](#$$\S34W-318U95<MX%'>.B#N
M]4T\GT,^.8UX=B-E,<TB)YOHT5:SV+(^+,UPR,<JQ :"1CE2?2PO8",4)GXG
ME;U(3?32_)&H#T-7G' Y"^NJ,L:E'OVGGO:-NS=MO9%$KM7V>)BG]K!V;$;F
M5M?<DPT6GDS-]VN7040Y ?&_XVS[R<('UVYQ,G'Y&5,6NT5MC.TR+Z6Q$T$4
MEK_^N5?QEHVB2HNUR$7\=G[^ ]C.?#QL6?KU\&"V=/[XTXA;R',3IF]#X=-T
MM++KC#]3(!%V$T^['=$QF07M7 6MDNO]*>Z3Z]'$],674N3P( $)_TE_?5^>
ME*SE_W^*8CG!#*?39R,B,2;^G6^U&L%R#8L#>F9CA-G8@S83V#;A*A55G--R
M'A3*VT%>%>2I;C)<FI%PXV:TO'G*,Z3F'.I&D0E=RC4)5ABN?*E!B?/4_Q.*
M--Q5@IEFBN?\LV,-HA^ O3XL;I))QA)A6@.%*Y&" 0;M\YG)QA,&H SDVAAP
M%G(B85LPHB@/D+^#74=V^D(-5ERD5>0/P$#[VERWCYY[:4RM%?2V;F=JQ/'J
MLDS"[61E;9WGAL^!GH(,;J2T)^US/Z>\"M)VQ4,94"&=$&TRSW,CB/*P4K](
M9,/_$# W!5WQ C+?'MR*B9P_**<V6IZ^JHG'7^^ 4!A>:[O3: G=13C-CZU,
M:M+36&FS1PQ!UM,PLXG =YJ)(?5&GHC\-ZR@.D-<KFH76/&4PL*,#-,:Z'5C
M_-IKVG2.H7+<F)9RWZC&CQ3:LK/=6TF;:XCRJ>*9+CVCLE.)TL:H(8:4]._@
MRHF,6[?S5RK#T^/CV('.E"_.L%5:XY1E-DXI6QIU@IJB L[(.W+OBFTVZZ*S
MO%>M!_86U1:<F7*@/SB%ZZ"9TAQ,A]",_BN_2WLW7XBHW1^,+S(LUCE_"E)Q
M%:'&X]ODU!4K#5%S%E ;N<TCJU^.<.99#NI!6\HXT')L%<V710_;?"L6YT0B
M+\4VY,U3@Q4+,(PF1]^7[.RDGD7B5L+:?%&SO_2P<QS=N:1Y&&E_J@EJKY)M
M/9&J1!-J,B0P2F+,"S*UCRI=)8F*HH#;B+"4&*\98S\55O!_+>4F*]0HV.?K
M58+RR=&:7\X@*9]<UZA E=N^S:A5V'#;[%/3@J>'_@IVC+#O7L_N=F*H!;70
M0%@,MD,Z9Y_ZXWYV4OL7;QB#SY5KII[.-[7!FDUM(W+M+VT.(8\U[DS[=/U<
M8QHK.V(@CNS#5&01P&DHAB,%C%R\$JM+DGVD_F(6@?;@.G)H[FS9>PDA%>Z2
M"QT+U0OF_IM-^?\?B8TH(4VV/E_=$+C$AJ G!#E%[6P8JI(BT(2NM/?"8&UP
MS<:!&M(NLZXTJ>4"V02XSL<OOZD(U)2LU-Z9"S,7SO=U4^61^*$+KU"3\MI?
MN:_M)@H>NX?JZYU=3U[Z2;$./Z5EO9R"^!.\H_0F!E$5)_:X$.QP("I$>YSZ
MP3IQ)(S7B3LM%%FA>H&2@?PNMZJ_(_% O:BFB&&W.U:''COV$)6--!,/#QI6
M<V7UTB&>&_R/Y<$O4AVR'[/59*7*!_5UKI EOE6],S>1C>#96_KP4:5-NSYF
M9\AIH+*_>%%RH5AQ.2'-+XF"2=\^;>8/H+.]O&*-_8*!##UB-$LOK@ZOR[!D
M-E:6/L;4"=G(Q7QMETJ5FKU*!@^1L*FBY\Z(:&MU]G!9BZER"'F5;_?A+?GQ
MO+D[=-4[SJ(9 MO:L%R8$&4>)GWSS'0(:;WFWF)8T!X"1 3I+Z6+QO&*BI7H
MRL4:]4]1F24^&^QZ,5Z4&T42K^MAA.OKO,2O0%[F>,DV$OEOH]78DYT62PU@
M[SDBQ!MB52>YQ+8?\ARBPO7+\@ZYD"3F_YTUT3]N_;'I@.)&_>)P8_A?%$+X
M'T5$BLTM$4UHMR!51,VB*RBL*580SU9JL9@=T%)[K-KLAH ;X+>,@H<Y:C/A
MK05*(>MY1GLS<J83^S>4I8KN'4U(-D2J%IC*Y0B;>DBN-SM<)C6Q2#)R>0+Q
MT74.G[.RGGR6'O!:UF1 $.=]Y'$&R1X^%R/@)*)$PQEDL47-]\R]$VJT0/8U
M02"C0LI+QMHW6^N5.;!$5(,C/JC\9L))+0#!((H5@]2H[,K+G YM)1G"9%E&
M Z\!Y5D,:$IE2;MX%ATX<CDW\W<<VGNI,7Q6<Y=NK==3R])N7^,L11P9?NW]
M=..$9Y7A >=29\-W<D3CH9X"_,($YA.3GZF5,.E$.VT^ 1 XQ5SG]7?*STY?
M^/]E>%%=U.J<:BO:F^WH[I>%U<G9^CQ\ERM-J [7&1T6P1R&N)B:"S%0&&[8
MX$#EH4B-PD:.F^V^NNW\%=4">>)K->L\W=\QFJ0.D'XB0\+>46%]W49@]K8^
M=QZ'&&L; _6.Z^[:05PMPS!.,?+P9@ ]PG>/8QMJQ;95RUD[WNMP@T46Y\W,
MB=GW]I%F_(Z2[3WZ,^UWYZN#?^4=^O]2A)F*@^CV^/X'X'DKZ.FU"4.*P,1N
M(1J!5WV-*XN:=SO C3U4=#GI+N97W1*K,[7M3N3FL1D#^WMD47^-M'X*)8%M
M=A!C\=U4AI2X<L#/5;@JZ>_Z*F,RR#D7#0%X:6U7_#BNNB-X18_G'P4"<BZZ
M$$$=NNO*L?.DD0<7WEQ@1^V<[)Y-C<X$?0?V0W)0=:-&Z;^;U]*RMBI!,&6%
M73N)+>$"A?M.C#U\48)IA0QG7%G *OZ8K#YG>1/H^CN%"Q5GSR28(&4<7<\'
MI6=]TKHRM06R;)3OZBAWME)DTJVB;T*]KKZB_7?E.B#R7#%4;ORPN\%BA+6T
MNON%<=,<"4CDV!&EW<Z.AHWR&6N2!25-$<6PK0?V-R%JESTH5)^NHL)H>*Z^
M@?!?;M&>I50R'MOQUU02V(X@64RTJ7?'Y"I=D6V>]\_2*UU=>]$56,.Y5:FT
M%2)E\KM[6O-@&(1C8>0+B6:[JH:O'4[&NYA Y\Y609$I0YPJNJ>M,*.3N!1H
M$\\"_]6DE/\?B)K_/DUTE/7G-H82L( CD 5 ]XWN__RC4D:O/7K"&#C%]0*Z
M!KR1[ZA84.KF#F==:N-6NM><Y(SJG' $X3M%JBFT)SA>0ZFU\,:3%ATIU0U5
MT'H?_H\-,L=&7LF;G#5G6BK8,/(,1WXC$)\6&JJ<<FA^8*)4[%ZJ5$L\M)-+
M;*6GU6*//24D'RFTNT K4H5 *M6 #25><P8((,Y;FQ:QWJ2Z\EB2OMSE1.'5
MXD1]K">P2*6 +I'.B_669^Q.9J:9,:D3&TX"</661(8P<8RK%2%70P1A*+!]
ML%1X2::0")QBELHCTTUBC4 K+^W+[?Z&?>)2CR[)=UF:7^#NVP%W"?J&?(Y3
MHX&4%ZXX'^0?0KE4=())CG"&P8QY]0$A'A!4@ADDCMO9%*9 )Z9!M1F@-TL3
M+::4LZJS<=)!W_IU\4GU(A&1X4WCI3)?% NTG:/05#16;4@LTCGE<6H\P.R:
MA">YF;Y$B<58J3(_@*UH4+I$A[X9HUZY:H>N$]W)(-4 \1$KW+B+311FR":I
MR8QK6W,N@\[EL(C61NVHCU)F:HZG#3U 4[J,CC]Q1;FFFF(A!66]NB%JVHJL
M4+X0'7V4'9.1B4U4X$ZCL?2X-,I[85V*K+/=1?(E0;Q$(K1_O76SUF3!3"H"
M']KG+MQ$.@K9?GZ!O FK,\JD<D$\F9R.'Q[,R,;E-XY2Q&HAM#C>6VR;YH27
MD*C9".&* 8Q$=P'R['?%P>IO)V<@"IF,6C$,ITKS%I"S!] S*\Y:\(0)YS^$
M:O_^WWTT[;=KD<7PF5A<49CH*=?BB1C,] YY!8U[!<CP8P2^,Z(:(=A&32O-
M@F[4.?<P=$3TSL?HO-/"% RT#%D*J2H%D4\@EJ* 52+T<S>\.<]#4Q@8G%'B
M4[*2JSEE/]">36D9U :^4R:"Y.A(S9I.D:]^7HM>4^[:/WK'NSO-.S!(&LD8
M2S=MV#E[W<-XS*2I,%L?5\Y:@Z,%IDTB+I4U?K_O8S0;P9)4-+&$:A7^:*[?
M=[>RKV5J(S8-\$WK52_K([$Y[=%5>8R(LJ 7-O9:JL7$0XLF1 9RM0@IFTZD
M83]T0S)K%&P^\%'F+^Z:0HR-_MU:>Q>6,_?(EMNV"18G-AF"V%%8<L5$B: )
M!5JH6'XVBOOD= ,;:SGG8(9&&%P8AP'G5E0'4.RN)4RRK417@IP\:\T >3 R
MH3R3%2,2 D0XI9*QOD0' <PT 6WJB:ZN T,,RWM:M4H*Q4"0:?6ZXK&-VO']
MJ33K%"KDJ6CZ^B?:Q-8'9I:M/WGO+*6=1RDE4J=J92SL;%97PVAYR2/WSE,J
M:#6-6$O/_$6ITHX.R2U+* PT\NLL>=3*4:/M2+<QBKH4H+0HCDN>1F=5)/:]
M\[H2Y<P2T&5OE^F:]>DNO_?'=WOT89=;K"!'9,AID1Z5FVA7=&WONP0/3;3P
M1G.NT ']TLC2LZ4L^M*2)-T#LMP$E<RAG-HL",-&L60HB:XC'6J,J)MBM>B;
M0L316+[O[&<VXMDRV)[!+E<]&.HG.,/P4C-U0;)MD3>/G5V6KC>N"N9G<\@9
M\U@2A:EH5U<Q#3][!<"7HZ>.>M''%N::X]!MJ:N$CLN;5W3L>B7OR8>J_6**
MT"V4X,5H@4*[MVC?:( K9?1_;&[7,Y&>3"=C$VL*ZZEE7"T<%'M3AU9 'Z)X
M:2(= T/K)KQWJ7)?Y]A3XM^L^;-[OAVA^C'G./6_EGKK/Y;?AK2N3Y9%;[$;
MH'W0"[+&<X_W<,AKNBU<DYG+Z"0@CC:^Z(_<_)GX',;+,M,"M+__ $U"A$4X
MM[=CMC0B^/9<W+;>_>T"%HO;:G/PP_F!>?3=N2]3F:Z+1=(4/N>QST1/?]Z:
MN527 WZ,TKIW',UYU='(9*UH.12U$]F)X*92>__G-LE>O1 +M&*WVQ:?N,7'
M2??5P[>,4S.I:/.KBT9Z9%*L#.0FCOWQ0/A,_\;O/V4"@ *AQED24M$HCE##
ML4KXR@'1;!?<E==Y-1ZPP3B:(2IQ]6"E%F[7+61X/$=&HUC0<1VM.XOQQ?1-
MG)TCP2F9?,_9[4[H<ONTW%7F 0&%DG_4C:Q]07(,1X.J7O;>9^O*%HEY+KFR
M@U/WE0;[.B.=SVPABIIM(SD6;)!IX.8M<^]Q)$-=T8Q:@BY6HP<[,S2F9LZ!
MY7/-P>+CE+T^WS7EE__J#SB'3!VQIWC.N+.">*-:N59X+RVQIPM3<!1%:E)F
M*E5[G-_J?IP_W;_+?^<5>L[XU01T^_>(CI_]_3OOP8ANK[[ $<V%[^/?"8=^
M:Y,=EQ5;PX3Q87]''_Y/HDSSR4X^=0',&LFLR[*U%6@&]-OJU+:]3Q74J%E<
MB]%0KU)_1AQ+Y2:8I-/<+AX =G2>Z!AU#2"4R? 2(<I,VWX<^)\DSO^E_+^4
M_V^5Z2Q676/?>\)&KA7)?L7^SY__7M;F:?AHMX3:]0%9YY>B1+-"F)IP@U[;
M;HW[5-S^+W=S)HD)1F^AK];F(</6K\EJZLBKEC-^:L;'G?72[O#7:JC28LGL
M^+69$7*_&-(3K,*U*\"(<I2;6Y!_ *YQPAHJ5*S@7J3I-)2N#5 BS.@L**+:
M?D2L$5.A>*&%24LW/7;<<^S??I0&@=Z,PAK6+T+LL)[HN;YY##X%HDHDT/!^
MPZEJD=DFHA,R^H1MYD$;6M&M1C]#QY ZZ5W6M-W ^$_T#F8J325\%.+K5V*,
M3RC"U:A;]$_4C%_M3VC<R3T Z6.A$9#7N:)9Q7OD7/UG?&> &]P(LF0D;&0)
M&)EIU<9-BW_;*-ETE-[AN.3WY]NO^FZ H\(O1V;."=M;5:-9YZS";-RR1E@E
MWP2B;T,7,UZ?%:V7(P>R0LIZ#S3)*<OS3.;+Y1C\JW%@S_Z_B6.?CC/B];U6
MF(?OK^A17V%F2R_26%%B&]*OHBK[#=_7$ZSV'/X 7GJ%CU_Z"CH*"L_V[IZ,
MCI"^/O;=7@O\\O]AW#6P7*'Y+&CQA89OM %F(!5V#,;P8N/!_5?R*F(,M7U&
M@<0*DD&H6V2:SU0QHVI."RB[<S(!&ZSIK!O^:'7*3?O9QOJDMPZ2 .-Y.'R7
M98%TD5QA!)4M78O1/\NY)BJ<R_3[ M-TUHN$L:UUR371RFB_Z4#1X>UU40T9
M8'O0I]Y9 AZ6J$XGW%/RALZAK0+N T]9N[WWMRLHQ"PF,8R[HX[CLE81<=5B
MW@B45N&-/5=??_/,A-! 5C<MSX'2$RS_E ^ZSO7I!*1T!MP#P&$HT;?1LQ+=
M%U&NG10;F^B=VOJ6<$QCPCIMZC!X#/8G1Z8FPP:L5%X!,G D\5.D^D$H>O3W
M"@/5)P,>@4HM2GLUK/4K!3]L OM3WL#TH6D1K)%YXRPV &D4)FEB^R42RUCB
MF@RJJ\)X>/B(Z16&0LBF\)!(:=J+Z*U8^Y?+59*N--L]?MTK7JRO3EE=GS4Z
M]"-(A*WJEF'5Z%&UKVC;IV'XRI@\1CGV19R#8!AA_4R^K>"+(ZWIB^<S11BX
M(0Y%ND;:6.]!B\?V5]5BI2QL@L;D<[P+\V>^PEN[-N"ALXF+0*?()D..V1-C
MDRK! SW"*LOQ(2!G;C"U:MS;)L$JJ1@?+\LGJP@##;J+?O)"'C94J2/'.H.Y
M(M4B)2(EP611CAT?9*T'0B?B%QC?;V(#UKGLVPA2CV(*.(&FQ@@<I.CQ!\8'
M[8ACJTD_?B<V.62X\^.&Q8TR*ZN+,>U1;J JD;D[A'X/_@/@0E'2!Q6N5WQL
MP"K,]WP5TT;EL^ F-W6*(] Q\09#A9BZDLI'$B6!#E]KD0"&N"0_88[Z*P&9
M8+N@40I-A)&[%)WKYI"P*MOL=38'UD)[2]1M+@I'-:*ZZTNI.F1S1?L7Q)_3
MF&T:^T9$^=X=60G8G1]'6YKG'/2XSXI)1<$^ 'L_Z&1S\1@;"J],-S]R5*J<
MM\^2\J4>@>!%Y*C1+QCL]5^U$,4'YZT5;=/,\Y:6K; \EHVY:DF=N5H4,2TY
M%\,\U]MH9G@,H]E895"BRGJ(EV4L+>0P?#2F4="LC65;<B?.62 N)M+A)&Y<
MY<.AR'0&6>A^S1,LV(1$UKBX+PE6:[6QHH=6W]PB&!ZLKNP$"_8*BV,VT6OZ
M7]@VMSM:,6D<N'+$$A=*X0_</,7)LV- YU!EV'JECYE, *&QQ=F/8!*GU@W\
MN^QC@DV./$KE'57FS3R;811>Q-A+&A/E<_5\IHEG%IEWZH$BT!,\HDD]X$#4
MUN/U2B)Q?=)+9-("Q?XYB>ZP'$]\!K^\7$2#N&,U8Q!RU$<BLM-E4@WF1":V
M7%/VMKP(D/< 6*@B1UG4%LE07-D8KU86DQ13C!1.(0G:N(L C7#@TV$P/Y5#
M)H;$=+ ,.41Z&ISB778Y:24P27K-H>HUD,ZQOZ!=22OVY-*X$:U!2 W 3UQ#
MJ*5543:!*\U]^;90W(E)6H=$B+;-8ITM3^05Z! ]@A0)',=%Y_;,$.GO#Z*O
MV GS59[V@$@?/B#"B2=5%,7$J,,4H-:RE-9%&%URBXC0XF+?S!=]?]Q-27-I
M;UJ)21OT+JR@L'W.3!('8L?+S\A#ATIEVGPCSTL$NDG*^M?^.B0>A;W:+1W@
M8+$!)'I&\HX0?<2 >6#"">R&*@Z$1 I%DX%#HV,U4"K577&I"&KG0<[SEH9K
M%X68.B$(-6V_T4QO;HM/XR*HD[.#3T,Y(3$D#G]#943N;FM<J]1L@9:!7E8S
M0[]QQF4F*&M@'$9(%CA_,3DK'/,I!TS5M^4)+B]^6ZJQH[>KJ$N_E)_$2;4
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MWA(HB;T+VGWC=4?+=ZJ>AT59H9C85C3@UL1BN4PRF8QRR9)CHNJ>GL2L*KG
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MD"6.>IQ$86Y??H91F9RN<H1_B#4[(#,XI=^@SRKTA];]*5/RHA_E.!AE2UV
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MTY0$.@\C(614U?8(#JM4,$3EVE7$MV&6U9V-[-Z1T)$<W.U(54(-NB*(MB(
MPZ$_W7_=J_2F[-,Q0R,8J *@EQTJ!:5[ZKUM57<) I:A&#""-QW^82(\#%Z?
M ,K;X ] F]4U2N'-&OJF@+K"&S,[U6EZ_%G;&*HE-W5*%7G\(A64?HR%=!NU
M8+\EF&Y/W1!=,,%XYIC^XP!^[&3$:9>[\RL5Q,8'V)C6AO2)!F6J2T_CD?G$
MF>9+D))L)?DA.1_EG<+$)(*^?A$5.5-1Z@85*G)Z\*"A2K*@R7>V;\'&N7]L
M\57I0,(-4<$6;JS#;'05IW[5GAD<),-N^&&@7UL427&@F5 ?K5*%\H.LETYO
M1+Q/O4WUFBI%$:@2EE=77Q3OB2/5S0GK9B7UQ]U,9IPQ#BJ*^]B'1\<83E&C
M_!L.&S"MNR7=2&]KPMZ:=W!'D;.SV4*,N8+F"LT4D<XOG-$W/!>ZT^A^UKUE
M@0+<*3?C<V[5:"'B%6$6$.9SX7F\BGC^N.]XHFFKO=O$E4- 8:Z+SL,#WP&&
M<D>&TR5GO<EZ^*_M(81-O[(I$Y>04)!RFT790UZ:()A<B'Q>41DMOR104M1V
M_>8H*4V<7@X=02Y[P#%D5H"3E%"96YC^_/A .?P//J$B.F:%M?/BO+-*"23#
M+W@L)0IC/30L% X71US3I]M5K(A[]VD*F#:M-W3!K#)\GJ1U1HD(5<?H["M_
MD=R["+/99HF9$O\UGD7"QG+D6[!]:_H^*908^2+J+_BZ3G;0:WG>CF";*.PC
M+K$V$H)TE?!K88O<2N_A!'W JBG0"C; \^L.=ZR!5^5"G(#Y?8*TZ9829$JZ
MJQ'CU\O+C<6\W$^!Z02Q9JE-ZB3SCI/]F!5%GIL)20EC(E>Y=[:B7(K<H!#*
M5K)6D:MGR?8WBKBJ_(+!6:;NM)P%C4["DF:6@FP./E&G.2[R8,'>G!16KI&^
M^W*QCXG%VIA -!3+[]QZ+61_X]YF&IV2#A,"UA]!JB*"J2(Z)2Y;NOQ4%HP3
M&P9OX>TNBL18QTP?BXI1OMDN7VL<#3>DZ7_JWT/114LG5,"!E1MH3"M@]?[)
MISOS..Q#(3G2X)AC6&"<C,3">&U?_!ZEE5:_]:KC\WB_-SKV<-9[Q<F*K5%A
M=S'#7A6T5VG(QFDJ%3E!\$63ZEBZR>_4KS$ D6@*^J"?C%KS:92%5[4R=O[B
M%(_L+IH 2R'.:ZR<?@Z<P/\ UIEP2%V58.X#!*_^Z8-Y61$%EGH;F.U,-26^
M66R9OGN]D[T+L@JH0&=5#/-GBV6JJ\_J'Q2^E28QA[3*D%"HG\0T13;-FQD4
M(0F5LL9TI978CK"5ZK%.BQER=!2>8AKM]WA" D\$KT4%$'(3.C>&?VYF8QRH
M$*Q *9/47#6DDB(SB5,.GP+?:Z'SE49M/ORTIU S2]7+:(L>(;_1-\X !RM"
M(_*EK-A""7@.3<94"8V=K 9%N,Y*=T&IO V4+S.? ED8\;TQD596)J+)^LB%
MRL@&P'2**4(Z@2Y^VZ'_H^8M24-%_'R\8WBM-=_]W+&*-"/Q)$=^E3P(_D-Y
MW1MJ.QXP<"!1OGN:@]@&Q=P)@HTP_"*]HSFSKZ!!M7SI2VL.'&64B>V<D<'!
M\@B8C4!5+?W+5M(T"H4^Z59]I&3.(^PSI916\\.S_"P70=T?$0EX?>#2-7OO
M>7R#_=Y'\?CFT8!:3DTJJB;5'(S%[DAE=0=@%!")Q.'/+X;WF-@M("R_+44T
M))8I<'8O[QBOA3X2LX1:416_S<K79GD7AS[I'#_3MMS D,[8GBB66YA0HG#F
M9^5MWJ(9#QCLNM'T HP6)SE+80$!NQOC6G2=%KU'&_8?;SD;3BS!(3G_X!25
M0A#'F],@JXKEISYD]"%?/5)KH);?0SO="]1 ,M?ODU58\:=Y5ZDD_(Q* 7>R
MMZTVN0&,-#AY!OEGJ""S=Z9K7@S'D(D\%8.5QQQ7Y3<X@KH+8!SX]SJ](]W7
MI[9MX(< KT5"K;@85#77$A@&/T3ME<?,,8Y9.;^V-:L-A0N*-I'JR7V)O/7L
MX'FZ(K^2%N 8>1-@X5$&#>$WP_:@218(L@G]BR=2J$]9B)+<BQ11>@\=DK)?
M7+Z(SX]TD*$>MTF:3X*8AT^]V=,="LN8]<M11C*U+=;5KEDO"?6&_NR))E(V
M_%ZUZQNROK@]7Q"A]-,TE??_\G7VO%91!.SS0>:@V5,IQ"V]X411#IVR^7GA
MUCY5Q%1D@22)3L^>Q-+9_$[#Z&#4]KKSFHM*'B#'?"F6P1;_=G_^O_WA>I:1
MAU]KUCTB29%%P3O-7LJQ;S-N1")(%,N!")^"AT&@HLUC>T>K^QF?G%U #O]6
ML2>\@*IYQ9WV@K_ A2E7K:^Z7J!B<=MLCE:31*'NGLUS+1]M-:2\I'3F[EW]
M.HC647TQRE-GDI9JL6ESUD<VDMXDQ#L?',MOJ@O/?7C\8>?J?@WQ4ZM4%E4M
MM &L@Z?J\;4F)J7 T\6\HR9K<S/^!T!EFJK@H7<RF-U&90PFLE>BA9I7Q.71
MHDT:[Y,^<OOR-V$BJZJ68#:[YRW?)*MT/WD6Q+<HD5&D:7>^#!)JUZH?6X)$
M(]&:ODDS=@M:SH0@+4 :!PL/BA8,DG>-\55^I,N>SGM@1IFV\L(L5U4V<Z0/
MAAJPY+^4>QPLJ9I!(.:NH*I>P=^<+_DJ4*?V >SN@%Z$;S[Y+4/49,$(@3>W
M[>?&&]3.E@S3A3,?V78[;N$.X!# 7N"S%_!)FD[0$>VH_23YV#L<&^70>88-
M^Z-2ODPD?,RG<?RT2G[#8\(L>OXEN/^405X3=6-!K+*R L&YU _+(G'K]\,B
M-DLKZ0,TH0>;$_HTX1O;!S/57RAJ:W1&UJ&380 $(M_BUQBGAZ=.8(U@B6#<
M.,ZRO2S2-(Y.3:QQN!IQ==T*(Q?!IC]1VJ_J,T_UDT8A:\1IDB-(X:/$*HT&
M$< 5IX!NE52G^-][&N'Q?Q(?2_?2GH&KJP4G"4OE"Z(!%@#630;Z0)BOTM3@
MEZ*MLPTL<0^>S]2/!)7=L-P\-V,["!A,;80^*T-)?FZN0.<*80C-R^2HDZ:1
M%=?E<'3BJ0>>E]]"CH8$!,K Q?GBS=[KI/F^S;FD=8;U#*IWXPL?)/+Q!9"X
MTLC:MD<+AS!.1NIZ(2(319)E!'X;KBV;1M.>ZU4CD^E=_$"JTX2G)928Z,NV
M*N2,77A>14@QXL?N^N6K8"P.([LV"&1?["=7PQG"3STNN 9+")!UKN@$89W?
M^ESAQU'A/]>;A*CV S.YHR!!AFT'(%1G<) ^'\(?? ?@G+N1/K>V,$X$&6T)
M/#[)+C.V]1\_DJ;;O-P$/'UV][C=^.J1$&.@=(F;(V.X?(=5<9+N_/EQ&O?;
M>0@GA-/EK2O+WE*]JL)$S(]1E1NYJW&/]2K."3<+DO&:;4Z!!Y*INC,FC27V
MJXR[TL]7ZW?3WP$6'OL[?]O0:>)QGO22XZ;5]/@3X;5%MAF6^H[;4QR-3<9%
M;\"Y*\Y=QW7['1;K1. S5D#;QD\7'[^]NOC,N1[Y8G&YL?=R^!U@,+'RI85U
M),@HQ]W][OY/L_AWN9Q7+QE7Z1%?+VM,&^M3RV[$<TQ6S3NJ*W[$&/3B<NS1
M<' MGF;0ZQ[V>\3I@/-<T2.AZGS_W./@A8K1+@/Q@8$QK,*N0_9'>)'? 1,Z
MWP%S$S]=PC2ZOHO^X;'=<RQ:D]E',8;L^"_SNZ7F9\@<>0(+A>TD6$-9ILR+
M<50N9_?+Z^0JL?4*E3L>KCQV^R6*)\:3Y_B/+-XGGR;7;:4R.T?[@8V(M/D_
MB#,5+".\C!"742$)=8;245OV;C/Y,>M??=S4AK>82&AO2%ZJ=SE5>^GY5GKZ
MTW0<^[>$KPCNN'[G+IO? 68#!A/GES44]^6ON!3_<BYF(DD#&L'-H+UF)F/L
M=&\IWJ7LG=.GNLS+#+Y?.2?_=O5A%^_'KWT=+Q8Y6T\=$'U#-:;W$:];=+ W
MY/\&](<9C[#STFN/A+ 4@SZ/B*[KLI]Y/-^M>]2V&YGISUE^R_&AIH&Q)/NT
M+#M+>,'YZXA^,-6"S5#-1P4^DG8"OMQAPFA2G7824DL_AYED%:A^A="=1 ?N
M2A,?-7/>-$\F$\5\NXCD%6<#(1?5VR4(AAK'4% HMH8WWRB]KO85!GGNW=$Z
MF!X-+J]<:">"SV^=2_\(,$@#'^)^_6'C]-ME.J-9!N+&R=UYUVO>K-I?A ]&
M.R)]GBQ<-QXV1EX^>X0E&?0Y/'+\9F#1ZVC;YHO$0KM'0.M3!L3 R"MV%1'7
M[LC??L3=<%3R>[F;Q<#2E_L6#_JE>E<%CYH%RF]3O_8727<=.;FN@MBX?E"_
M:T]XJ?#8.-G1?R5Y2]/Q6>SO%"3,3 A_N\ONN>?@B'C20'/Y#N"\<M8?^W%.
M7LAJS5S"[KXJM@W8!&7Z]@4O$0 \E^A4@)+&JSAN(Z77=-!D*BK/"(CO,,RM
M=GCQBF4"Q80<8_;H-"(0"W(9.0V6Z$7+U,% U\!S/4&!DI[F<#XM]8-@BDNP
M>1+M-7Z>$M1J[IXI2(F]>/83&E7DM] \D(@7YA6$IRPSTSY$8R82^O'(IX_!
MM2D(^+4B;A6VZ?@H4TXI.+-MH\_]/:%?HJ'P,R4]37R'WN;31\G5S+!R]0]J
MPF@;0R& )GJ*;>+YR$4K-L<NW A?^J;6SVK'QVD5ST435RLFRK.,M,["%?6D
M,D)/ZX=S#X6(4NM_UJ8GI?/[2(NTC)H[,TD!!MOB%4E8+2XF^\8/0KS!,DH?
M,B@IURFC!\6H^4:I[.:PF=]]21N;W;_'F4[.@3"T$A7]2J8@'(G524=K"P%6
M&4FRRXK;#[WZ,Q)%EC6U/U<2@<D7'9])"A7 \C*PY8DW:>\9"@I+CK-9BT^(
MZ3*O53GZ&0-)(A3Y&7P1.5BHV>IBB-TG(7$+8TJAUA0E/GY8I3H@35L?[F#4
M^$>0Q6@R8LT:SD^2^=DC3I+K=DB+;O&'CY_ZJTR_8@J18 ((^WAGRKI 2I V
ML0%%>)N:P Y.%:[AF851RE:'"FXN&/$EI2IK=H^2_LGF!62[@F&&*B$DL=DM
M!+R!X5UY!B#J;HIZ3>0VS)]))JIVL$E1MS(.]N3<'Z>9E4+A".W1[[4[I.^>
ML5W21H_+.WSO'/%3&:BF2>C2;OQP]MS*3[<--9RM6K>Z8&\==U,F(J#A"V;Z
M)ZH3C]5:6ABZT]EJ9,[GGRCN<&;9&A"X1YS'GJ[3,NXH/E]M*(W4E-Y'3+6'
ML DL-*YYZ/[0M,KO@*#SLE^R[(;\4\IEKR8#7O45/O[I.^ T\?1;1T2"_I(5
M)8O*U[N6OE^L%]V_V1>S5XM\I,;0\I^_FF!MP#+*3Y&0WPFGE-AZSVLH(9OW
M@5E$)O2 I9]F9>BGU:):RA\\5^Y'[@::V0LF5G9,N5C84BU3-P#$WU@?@]/[
MP-7(17)\JY" P@$Z/E!LE\(N4QXIAM4>"VD3!(A&CH5*$%_AP.<DOBS=T%P<
M!KXE!=;$Z1T^<E8006841_CX;H:?W*8?*"H,%N7A<'X^82&^IK;$K]<P!,>2
M9R36/].^R6HR-UQSF(N7%*!:Q4]5X1N#OBJ"WE1#90,B$BI/C:;9/NMG>(T%
MGFA7TT>ZA>A%0X/,*YQV_WX]85IUI7LH%QD8,E5;6Y_$;Q(3CHAGQ$1-\OC1
MC[RDTB0>B*^X@;>I5,% &R-Q>G\)@U:@7:#]BU%4#B:V(49D_^9B/Q(NDIY9
MI_ZL52)L($%CUR0%)!SJ!'X_A*[L4!3Z8'#8I#X^[XPSEY56C:&-,5\HF5*G
M-Z0W%$JRGU;,/&.!B5Q'L^8R^!)#B[UP'?K\&\T4G"T!"I^SKW:C60Q3*.@D
MXDK$VGMPDOK4H$YOAU7@1(,+,@N&:SYS5<&VS2^CS@H9,B1Z HBZ>OF^X1W&
M[SUKR$_N-$:)B*6"HQ3ARMWBS[T4PIV@%YAU?? E.1YT4>MB9/;W3($M/\""
M4-5?,(14IR"HHRE+J0S#H90W]%;W?A#6-Q%C?-N]&<%5B<@X$;TR92N$!&8D
MYK#@A$CC_FT:#M6,HZ2& *H?W':=[)ZLBDGI2 (EL++&3P>CWVK# $/"C:-Q
MPN5BAZ/Q.Z!BJBQ-K[=VJB1]LNYMXQ+ZB_MW (H&^Z#;,?R/?U;I3%TW7;]6
M#B,_[V(F7)>7H%>]+'LH'#&VHQ2:SLQ:K!>.VH2((?'L5C)TZM$7?RNKQ(<&
M2NP(*AT@-A1,"P5\M8+.*B\(CLG7>TZ*!:P;3]@,%L+7/+>I=>$M7 8 EG"7
MB;,=3[$P%-)+$086UX8(HN:0@%Z$+VQF2&RK17%?D*:2]J7'<,F5VHTA'?.Z
M%9() G5<&1L< 4E@-SS458D@[A4V!U9*OA+OC\%8\#EY)*0Q?@"(@\Y**)D<
M\'$PKJJE,(;TU@KW!H+"$_!;2@&H.AX\JLL;!T5GR:;-4,7F(+C%E:^GT/5D
M/:GXK?M9+L3%B\#>SY47WZM0YGG>[$25H2P10(UI#MX1Z=I2A6M3I@O3 &7N
MR8@ 0WIK8F]Z-[^+F>:V76+$)-'E1NG<:MQBIDC1M\LH9  ]S/EXVP@L#-N9
MA^0%BE,^1&U#@I?\$5/L?BY*;ST(B9IU:P3*R1IA5E-NJB*=]AJ1Q5CYN!G6
M1QA\>3J)U@&Y$?>0%,9R/6E:G;C>C! @# *9*I3'=94;P^]89:=7:IRPG%_#
M800/MV>'"U,(-.1K+LL0\7Z+A$>8Q/ZM$AX@>P"/)K N%8>$P5[86[@7/.DK
MWI!9R1TT@%>\9C?H+:(J42( G89:3"OT5?KQHO2G,86HC0E($A.CB"#1$]7'
M/.9(ZI?- CTT5([F"^?1[:L9#GERA9PI/>TPYT\)EKFPX_1@XKW!QU=X#D8\
M&Q;-9""$>X(#Q5R^@F0JLE*ML \22=4U<[%LBN'B9JTQKM4XCT)ZFOAM$>C0
MR'UP^L)[+N3!R-FB,W7U'6 [4?#5 Y?A5XWX7'2&^KMP2,G]#O FXIS8>*V%
M)TZ?3M/TVJ=G!/XHFMX7Z-KQ<L_6'.U\S-<.R+!*/.&2(O2K3G$R&XC^]+8Z
M-QH8Z+-E2<Y^ B),7.(^A,* R'M6]FDQ-D96[*''3WV5L"6]D:#TV$:-DK*R
MD>3DM>LIT[B.=:'XV>)<P?I"&7C$KH9K<B9JX52K]EE&X'RPF++Y% &ZE8K,
M0E/:U-<)<-U41EX]HW.J^O1]_ W@D3Q5;-20)(@&<\#J&'!>VMP$<_LT)YX0
M@32@.E+1Y8?UIWBL8YDM0+0.>EZ%6=Z5A6ZVA]Z,:N**Z,Y&1ECCH+3*N8O)
M[_J(11K[\"B:&AMQW?Q4W6-GX_Q );NWQ#E058!WM%U.F%#V<>S=^KN5P<JR
M/B*M]\&1;@.\N,0U[_4JVJX]%QJKO+<"@+<("&W''Z2+S\V.>3]+F1&2Q8<X
M5MTB!52IZ!/R4.SF]!%O+&Q1]H#ZA252 ^*#E8^U<-FM-2]"W]% 8O4BR(WV
M"J^!=]6^JHHF= YNK%<+MK ?U@PK;V6U4=X)5U;JMB%4J*88SY/*P^R,[ ?^
M]#3SQA!HS<*%*UT:."$7GB59HMU/V)YXOE81X55*2GWAM3MSF$_5]OY*50OK
MECS*]"S2$)F+P-SUCI;(:(+3<<R2PN58D[;CD?L!T(R18L"0ET7H7CS0H8P"
M;/%&7$<",;7*HK$VWK"LF004(UZ)>X*HP6]79[0S1?&P2ZA%PN7%Y$_P]?K2
MX-B[^KWB$7C8I:F)^LTC:D[4T,S2]1N9@#71OV%K"@4I.8@W: 4H>2D.N,$(
MY5_D9K ?O'9A3W=]WP'KSFZ<,5._;^:+ZTNE7_PBH;)Y0:]\=#?EN.E ^]5O
MI/R^M:=?.Y'+ZPVE")>G#B:JL9HUH]?61_F9_7=-FSW<(<. %7:T5WZ\1,K8
MPVU#<_)5-6\=;TY;7(! [W+2@JY'("_Y _*(8N\E]V<$0B"U([U^ YI<!Z77
M]I&E+WM^,KYWA MEC4B-=+_^M7A27DAA]#SWSQ8:IP&<$2GLH_@WS$O$-2(5
M0):8%F-\=0$><BJ2SGKS(:F:XL N'>;;-VQ:="MU-:3J3+!D KD,=&G<D,#3
M4:M#&A5GM^[.1-1QH@0@@?DSFKV3K,,T/&#Q%"X <[0#V]:W9!GLSC[7CVKZ
M1SBFXEEHT*I TW&::L8Z4<#*XER@PH5S2]()AN]AM/#CN"U5&N92\*P'*!05
MD4J!M<72>XM*JW->U4O0>'E2'EX7 98&#P$4@Z@3ZTJNC2Z77=1TV5T3F0X!
M!DD,'5AXM3V!JHHA#&F/30.7DMB!YB9NY5VY9[[ZJ:X&9N", 0GZ[='F*%Y<
M-%=7;DAW(;RU7+&A5"Y,+]S]H#0QXVN_8M1LEN%\:#<Y*0;5#10#K(-;S)1O
M&P#8TI^<YHKF HS*"X66H.33*U!RS[FWK'>M,)5!9_8R$7!R4,14*!?G62$Q
MA'=)1^%WQG=EP=#.H+(677[46WP_8AW0&'=?9.7':L%5Y0A67^%-D@D2!.X+
MP@-)KFP[XD++6[I,D#@F!"HKU/GTPB^FU#1Q3]#S]/RC28[X^F)N\K.&D_^C
M[4E]V7B2Q_WQ7JB&[X"QEPVFOY)(3^,G 5]'PFXR</?^I2O_=EYV_?0N0O"O
M8^>[/\:F7\<RO@.4OG'@0A3,I/_9)%LUOPP_09YX)\5MT(ZX]:-?NE3@OF-R
MV7!<9PK/<UE;9V.CNWAPVCM40ZE'HVI-N<N_AFQQ@!Q .?JR1C*]^DF9C;@1
MV"J#WQOK.T MT*,[[3O@TN;(UN+>Y>-7L"MGA;O;C'W.H"=J9:5&9V7\6B:.
MCZ8PBU9&C179:>C=$%."3>[1M$E&2<:Z#"J&8=20F]2H"05"L/:ERINFF$62
M%J*&0GB@@3&D3.8UK9O'"YH (4,J3V'/'4FH7EE)KE3K$9-0RA;.MTABLOPJ
M7CZ^W$5)7?QUGWP,CB_"BE-:Q)D<\T_E+5B5AXP+(VI %F2IX])\1/.-M.5L
MT>!)%H1+Y6[3SK#H")4^0*RG*A/=[PKF6A-P@D49GK2N@RMN3YI[0IH(D=9B
M0I7!G:!&",%QE% KJ\ #(E6WN6VZ@'TCWUMH[8BO+\P=H\AG$Q'7'W)J*>DX
MV?HP?B7P];&LW>;31W:B ?;32@3VA1L=A09G&TBC13>41"=1G2(2_<B4PPT
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MQZ91._ZJJ)!Q4ZB1D1XCCUFDC_P4G$\7]DV9Y93B2RV1[@#J?I;!=&][!YE
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M>75!/ZBXJV)[C&\LX_1^,MD"QN#ADH=A-UB;TQ2X*XF8)NDW<7N^;5FZ!'W
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M\'O3WFU%_QCDM6(-[>74\'W6#H0I=,RU?$0%3PZ60)D;JT#*ULRH^TF>T!:
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MH,97Q<3,J-[UOU)T4$+\NJ-6_&H7:N'8+%#9X&+*BTY+/1ET[;__@IQOSER
MWS)KA#;BT?[WWT>$$]8/:+:IOXX^'33 @N@U8&L?+TJ;%+LB3AZG0;Q-B9QS
M'61[-H@M@MQ7+948AJ$MCMI&(JYBYG2U=N]MK4;$>>Y76/UVH\3T5-$!;6^V
M8;YM>:(>T5$>E#&Y3%>D=C[8>$9Y7H(_NK#/I*?#/'B%(UU>4\@B9C<_")K5
MSS*2DW^3[IG,B"N@3XV(VAQVBF-+MA.5%;6T'EYLO4-(3+-SH<-62_$*?\Q
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M(!L>L#,8 G:!NY_9\?W6[BQ"#8W_.48(Y+>6[G %3_C_;.E^?G^-1Q?L#O6
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MM\G_KW3:W>I_TV4'%W>XE<OYTQZILS'B=G  B?'S"X+ O()@+A$;41LN*Z"
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M1;A546QVML5R Q^+9OB2D)Q/_QS)D+UVHJ^'FU"CIER>>:T7WZ(!:R%A6+'
MTW@"KO>F$CM(@\]M/LJ;4*%V>.V1TA:!2')UKKET/T3<0$;_.)MJ][&NJ8&
MA&JNBJF7H+:]1D+GH>_F-?;7U0OSRN^)FEJ[@I5'49;6C#,>+.(,4HZXW,M]
M3Z\S\"6=*'^L."VQ2FK/D&3\5FQ)(PG@R*""PFUR.8ZQ.^_:S'-3@LRHB!@$
M?LO#N8D6ZX>?!!#5MK/*"*EKHM6N54VX(#;"URIH':.W:@4+IGA-9+,.&%4H
MJI;NS!4STXJ[2.^,O,K$8/,]RS].BP1]"<_ !-S3W"A_K,2AM;_NT&GC\TCQ
MMQ[?K0'+U+UI=W^?D;QWSS_NH*^2C+78_EM+ZW^191='+%!_N[ETD[>X['!=
M6+57/M%+407XE<S4W2"/P_"*,G7K8]3V*G:21?RP S3R4)O]CH?X8_=SGJ&6
MX8I!W")G;Z+(BHKNZ@IF=Z7YB#,%8KP?#A40']V[M=1Q#!Y.]OFDA"_AS=2(
M2E1'R]]*2X5OW!JBI$H'$#%NKR.PKGS4S"D)F\$*O!,<C+_2+Q]<(CM1T$>D
MX_$E5/8>6I\^[YNJJPH1QY%>KF]"&.@3V::D35(HA6T99.S@MH:V+,ET;(&.
M?% ,\:O+ )0X? #8 T#*(%L6#'A/^?EYW/P'UV-J:L?;<-I=SWQ%<^A]]295
MO6QG4J-\,,7RKG7<+<I/$=UIZO(&[Q+-^$'5/D+ 5]3+:_'1TKVE^<"-]"K=
M&='QU@UJU<)B ^2H\9@\;AL(O<53/N1U/$+E3QSF&C98;BF#_(A<.:&3_7F?
M!#&#T86MF,ROE,Q;+L*YWW IA-?QVKV@=#BV[R1+4T3>BF\$M"LF^9-]W,QK
MDMG<V$F=KWSJ(9$RYOO%#0'#I6"5:UD/=U!2'Y1+T,XTG8I"P["R/XYVWN3M
M&9^?P9LM("23!@@(EB+>(-3?9\B$OLI$ZFW:1KJC^V&+("O0(RUFXW;(L/Y<
M3H[X2-1=&A:7J4_])!.KRGK[0]ID75[ '$&HG+W?,M&#XF7/]W<^B]7SR#DJ
MF?*;8CFG1F*9O1'Q/ 4TJ7U)GSX%T"0?%"\OG0)((%.ES!F?Q;FZOY'<)E<:
M_S 7J/3*]&G2[<87A)S9T=,O'6V*"4JWA>R5_)-!$?-O= 1?UCZ452V*ZTL/
MZN,C^6*<F:7E*)H]1P/P :C0JE#Q^R67];Q),RMJ;8FM"PM%2\^!>LNUAWI:
MOT&0$^9/;9N&<Z)S:9 F YKJO6.(KQWX;(\"[(-*BT(:!*?$<P)Q390/LA<D
M[LR4^?*X=R 0L3OR1)Q$LN-,3$\*^=SW[0XQU_G?N_/QOB_=P><GM&TBY.3D
MUT2J4T#Z] 5_07_'3.U)UETDVT;])YSW]"H;38P1%/HTB;M;-/-=UC)7[)4E
MJFM>QS2I7UTJPP"X?::D1)$S._1/_*2#.H"M%1LHOISA?UU&+_UDW$'J17 :
M83*C*?B&JB1"8%V5D';04<54IP2"J59?['+#IOUH;HQ'D 'M%+#9?]0LS' *
M&/IR\/K+R'K125:OH]^G#2&R3P_F;,)/ 7X+<STR4V0]T8U%^FL>PEQ3:QF;
M([[:0.2>H2V$^R!*[LJ]4$F?Z> I6EO%5,YYTUZKU?66?<&<%]WN:J0&16^#
M@_*CFM@_O51S"%;$8-]&C>%8;W"JS9*E:@>'(;Q6YE-#U5ZAQ?IHD-OU89/'
MLTC@@E6TI:5$(YWF/A4$D+1\D7S^6%\>E5J@1U8L"DTQ@0W%.HY3YGJ3NK1)
MEE14;ZLZU[PDG;AQB4;3:/ -=YU^'884NFM-/1N..78O5>CB@.T@'L:RH.I9
MG9KKVACLW84Y;@QA]$.Y$:0&LTC:K_6#;Y-9!>'4K9.@"NT+?AR9S']XK.M"
M_U3%T:475YU#'K[V;I1S.;X"!<X0O,$P87L_Q=9RF+-/-E1%SE@#8847C)(M
M]#8(SQEM<+4Q418SGEWD"88-*H.T_EWVJRA155>G#^10Y>WS&K%QNR A:S$V
M==6,2!+5\RBK['!(!7"<$FK9!7ER33; JP%\?;@BW7=KQ._S<&6)Q9;?\5'G
MMTKAW(#9_[,U-H$6SEWZSD>/9.00IY:VI, C#S/.R%8^<KGCR"!1WONIO7$,
MN5SK(Q/%^+?F7]R&W\MM-$6YWC+V#YV/HK#E9%0,Q'AW^%E?I\I6Z@X []F.
M/QYKA0^AE,0H#ZN^Q6/.;C@QGJ[*#;QA?T/+;=]G[HXY+=.[(B0N1<C J_%)
MDII^0>]W-S#%-2J:H(0FH>32,TIWJ%!IZ-U0[N)OQ<MQEA"T[HJU$29YB1G0
MYB^M90*H.#6#[ZC0HYC8Z>MVPPOFXQHR[D?KE7\$7&5[,W6K)MIRJ2Z*_.L[
MGQLU3QC!%B$IQ"^?U:[/$S<Q19EFLZT9VH_Z$1-T8KQX!W*P?S'%C((J J]E
MX)18[&]BQCXK#>,KNA06%IJ?VY>['TH05-K,4PZ+ZAHL4#E#E:SB0];R##$[
MX3)]*(U3*E33E5^]BFY_:%"/R"F$RW<K!(N8A%$8C[T,B<E'C@\3,;DV1R7W
MP,&)^..4MS5^DIE;Y?5\P_B7][+]^A%%3IR%.07(A1+X;X+QVD/F#9&PD70Q
MI.[BRYS(>Q<F6I=;!OHP? %*2.X$3A"\+WE=S\B?V3)J[8PVR9Z-1!Q0I&/'
MZU1JE$E*H9UTK4:>_P5H0)Q2_\&=VCF4#LST)=41K@#[2&)WTK!G.E2(MY+!
M2 _7!< !1@_01G?RGIG;;+B0*V\_C<%7>PJHJL<5D$.6H GV6%90-CVFD\*"
MGBT(Z&TXIX")HVB=&QTWA!SV\M1VCQIF6;XY3HPZ1S\&WSD%?%4Y!;QQVM<[
M!;#U!G_H0&G#6_5]\$TEN@AX\_'9GH* ;5=OE+-!,&1SY.3Z*2!NJ1$Z'S1W
M?T]2X13 W#:<PM.[>0H(B_OZ;)WT9FKC@=.W^%- Q^['ZAWI[:;#C*Q3 ,)F
M33UIZ>!VL\KQX#X63\^MH\I3@.KM^:^?S+[2>\^<:.G<[N#[(R[F;XY^:$F+
M+P+&3P&YLG4HGY2\J?J@%6:%T5?RC(*R'K"/VP\JBS@*"HV"8NFE.@Y<"PA*
MRX18%)A)^"FI=B!*N>78*K+Q$Q-0UFA!1)0H$QE0-.;99F</<QB 22>)F;4#
M-9U.-7S;4W.Y%57[SE$8<O9ZR-8=)(@/@*B(;LCRWI"CAR^7+WNN6O%;_=7W
MLO3DIALP7A%[Y<R)Z?T@FSFF,6H^\O[XW*,J"EG/RNM^P\.Y4/\VK]BQ>4\O
MFRHOZ^[F8Q7FN+-T>M.R[SS/NJ> ^5R 1!J %X/RIBA$L.C9_]4VZYPMD3I>
M87T9%N%N#>N:ZLTN#9S5NV7\]-AQ[3:0-5QG2^)P!8[D^;S2UBK9]IN)";O)
M*#KS%6Z+6UA5R%PG80GPTIDNE2_&_=Q#;Q,0WG-73+ARHX0VVM?:0UU1 ++K
M7VD=(Y< ^/M3\WA$5Y0S9 ELE=PZ#"IG/*5W_.WID*O>[0I!=;/[UHE3E10R
MW),_U_-/L#KHPL4%36T'=,/*XM<?ZDN3?AD5 A4-;;?ZCO>HM.EP3U80XQ='
M,2!*-45IRL) L2!O?362EI>Q(!,2DSB9\(=5L>%SO9TK*4'T-%O\7@0F)!/5
MS+IE\6#.H'#Z*RC.@(4VA= [[YD-H<&E/"[K4[W5E7J5_0YDR5)ZFH5M%DYE
MQ&LT&7*/<=Q\ S]!=,%WEK+0.0Q':Q_YK@.4.C,DY4 Y-^,W60ZV767-)LQ2
M"%68''+<J0X(4'.16ZD)<T*HQ%&9<3^B*UF78_!PEKN!E8R'Y)XILHCNN+"I
M(V$3PP 94JF"G/!O.J+O>Z*$V*H]:0T'7;6P/WL)\#_&1BV;]((R=PA,UBR\
MSR7MO.WM9$5,1&EGVM_FUOL!2&YG'(0#@4JUBZ?558XT^NFV"@1H'ASNS>9Z
MC[UK[E=Z4L0&E3_N%9G<VL-G9_Y$DH SBXY' \*W;BM2YBWKFE"]5ED.3H/(
MQU51TD3&* Y4/Y[ YGTW9;H_P,4T!N$':6ZYX-Z9"'E2AY/UA8IY[;A'R580
M@C\&N4(EE?\!REI\96^M:&UW;>"Z06I>0'ESD!BJQ3?KE#ZQ2KT<$]FXP#KZ
M7HOE[:%K9BCK6](-GSU9G:0?$'=U* [C2V_DL/E-V)1\H=K_PEV>1,$J-'Y
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M@AK'G#YDPB0E@/1Y'B]L3>N)CZ_UR$GA(149N4M>DS'(:%5S8=KVPW.F5TY
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MT?NO,FS;%S:V\=L0:@=5"HCE-FJ\:.6'>;RRBF5NMOW/=CCN]=U4-:I#[[/
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M*>*;^ ,'!&="AY,3!<1M1YD+A.A)?3?:DC6T63IRK=Z^@;[6_,2Q0BEB,"W
MT,:KQI?)D^,K:C>>1X;^:X$<N8&J+]KD!;6H#GA)57J<.DVM$MM1M5-'!12%
M>5VX:<T3%I-M0]7[7J[8SA1$#E'Z085<S<+XDUA.HO-^I<R=3Z_>(\C5H0QI
M;+7=X">MX_R@7&> :)FC6TY#26VQI,VL7QG=L9#CK(Y=*N.Z;>5EPZHD: .E
M9<BL0#@\M-XW"RNB6/(B:[NC:F[[)9\G<?D:%YD*ICZ2X8UHNAD\F,+HOGX9
M'ID*=$;K>EV52M-1U4DC5&)X'.HP3O31-Y3C&G^*O5L+SD.O@^M.$RYN87<+
M2:P#,MSR$R+W?>@-QZ;7MFXK'9BD38>OF-4_(<*>>H=%(Z0VSK@^6=DUP>##
M;35;5Y"BF)/!39"\X"5'23++<CPW4O+?^)NR&>]0](/ K\/C!P4#&D<MN;03
M$=\P"3:@EOT'QRI:SZN/33_D;6N< I;,(TQU(XO,^G73(:J&!T5.IB,3=5M^
M1X)%MVD/&C1NTVZK?@'O*T,UH]:@%24WP:V)251&>2?"ZT54XUXK#>6!:1_R
MOG4'1D=WIJ&_WZP?.4:[_;9D??JZ =.;L\N(ZAS=SO7;6_K[YNVW'S[^QG(*
M>.)85_+%^PSW%%#T?')!K/0WT</Q'D3&RQ(PT6('FX[']VO@P_K'$XH<S!3#
M(#U,CL.5N1"IM.G*(JC?R%@:!Y!0)T5ECUTU[K"=\86!61- J?W.[8,AM8B/
M=9C(Z 5#%+%S^Y21]7.W7@U^W!2X>O4%8\ZZX9-\#,HVVF=Y<[DR5R29L:A'
M9>_.$5[%[GE5E6*&M8&=P^C$$2^*Y53@33AMLL&#"A1P:[:A22'E8W:>W]CO
MQMRQ\!F=F;*RJJ]XW?9AP@9H2*:;4A?-8IU4U3VUD.*WOYL4JD-%;[]_)^>.
MB#A)WW9G4JO8TK6@EYIN[P@78M_FS1:J&XD.:1#,=,KUT*+7O(\.]9$66W8.
ML[YW+:$V/OZ^8%W5F@^4+?'=V+0*LNUN>B:3]\,:CK<MS)%F3841Q2B$3X*C
M-?!QU^[9O*^[ZNZ"N"'_^;9DF4AT/A^2'!-!$94ADXU&EE8PWA,2P@/*W/(6
MM:G['=.B,G/KNWVBZ=;1[L^.T ;F]X_J"+C9+:G%!NDZ([F&\Z1MH,HQ_?U!
M9+D,/4*=!JN\9)[I%E%5*^K#:@(PC837[<93&SQ/9E_68;#Z%01QVN.\CGPZ
M%/HAL'#\RX'E;-DI0'Y*#G%HL/SN\7+?@!N\BBY_-_EVTPP/:N3@0NIA*[:M
MX/I2R@@3E$X\)8O!RK4Q.%,J3F#796T(2_5;#S2PLZ)$Z^;L63'U'M\^<E]$
M)5@5;-#X4C(@$^*+?UL'?62/R/QEX<"O=Z8L%SCP#<*O=WG/D: 3AW8$(*3E
M$>D!FLRW0K%9!%8C8@7***Y(V&KG=_#F*3J9F8T/;XRV>$AV:YN4Y^P21G0Q
M/%#+>M=+ST[(K !4[99]SL'O;;I@NUGJ*=)5,/E6@>5>5F$9\PNN7E$LC,PH
M<LR:U$6''&6N+ 6@FL SXEOE=ZR?970UBU8TQS,<J5__B(PD-/+_L?*647&
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M@IJ''NG%P.PJF%0]1VM997P[.8+6H'V'=>TM<@;^?A@U"<9%N>%U=4*JA*6
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M*NY5Z<.&CTH<9O:_5F3=&XWXO$911OS3=+)/BSKS%V?0$K&D)KV8'9]CB$[
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MD7Z6<M;6S<[49)2X3YY[$=$%[99K,S6!$>6_DU@M3S/#S?NI $)*&/_!./]
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MF*&.?:6Y>=# R=29XO#E_5I>"Q_>SMB-*C5LJJ;_P!T6M79T?O=P3_'?4\\
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M,90!7V2Q'+O/OS3_OUK]T#>XS3\,-:&)I3;,.I/U<;$;?$[Q1YU0+,WA<BI
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M_P#1%IM].G6*$?\ EUEC'_=U_@'@M>?=:?\ Y!]_J_X#R*P&6US?_ /,_P.
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MTKA:9W)+?Q]/  R4WF>T%IE.GYU/]0ER=4U.'F0:\:3A-&K1.<<GGRI]\,-
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MX)M_R_4D!-[A!Z"\EE1K2_RB:%>F7?YMWWV_Z'E1V69AO>FOV.*+'/SM<6-
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MDPQ^%>[:XXQH.V.K5-'69!&FC%NGT3DT@&S'MQK95D/6PS3FDGL5,7::3$L
MJS:BDR2!KQ.JJ3@YE#*YP2H&$-B?HORE"P)EFK4# A)T_@Z"NI&CE&P#5F37
M0.ZLJ8S)D.#A(,7L476N/GS;F]MY?TI5%RQ_R#S7C)*I0/9-0_1ALIH72L!J
MEIH[^CL0B,2P*9I7I1KNLNK\A&-HE@#9M1%=L:$&%4RUBG*0A=0<JBC,N3T?
M$^'2_KJS5?O>B#'(L;9A]3GEL;_P,10ST-\FKSM_FII;QV#HX&>PHWT"BE)5
MARWX9[&6/GA'TW,A> Z5^-;O ^_]6>S(X:LXI4/>J;AY3L=_ZR N):(/BF;O
M=7=@!S;9ZQ0ML'2&Z<^L>/+\[B*%,6G$&_61Q7S?YO]KNN"^ISN',B4HXW2@
MC\8O6PG3HEL:EZKM;E3D+I]I:NM<3N*&"66QZ(PGP6]+90[&WQ36R+)"K#2[
MAF0R[Z/>RQ(@F(67QH<$)6:X<N.F1JE'EV2:Z6VQJ,47E:9AG(83R86 <9E:
MLXG/J&17 #,3Q024]'0 DTIK,@(U5\N'?(4Z'#?_XAD7]]X<J76EE,&=WNN9
M.Q_VT@!5W.?T['U(8PM*]M.99_N(P81;R/]A6*AZ'V'MQJP_4I1.Q-3Y_B28
M2%?%MJ  U-MA;Q][/<21ZIBLTLMI!>KF>:OU=C&6O9?*!QU)2#9AJHX2 OQ-
M#J8GA"RJDFC53L/OPP E*1/UOPIAW9KJ'K=G1,WSZF%NGY>-*L->72PRS/__
MGZ7^SZ9,*/_XG.X:<_V::J<"L[U)FWNRU2VC]:YI+[:B<O@,$#'Z11I5NJ-6
M,<5=DJ<E2JF-U\0<LK;0N]9-.2URD !WD,M22:,>=\U6X%-  K3A%:H>%[_+
M0?342V;U#U> QQJ.I3?U)<*QWGX8W(],=Z=+#4#JJ2M<NEA]_@Y *="\J2^;
M-F'W:M.>C!&HB:O)BA;F=\K5:Z!J'E%.^X0OMJ$6PG^3+-%)P>'DN7_BX='H
M[6$7"G8ZF()5$ +=9@,G?HQ2\<;M*$DU_+W999 V  9Y%'@(SC;FIHBCYROM
M1,A6J(M/_4Z'C-0%4/FV=]Y*K.V._HZZ:+KYLR5VA/:=VYSVH-SM66_(W7Z.
M8W":FL4AZ%M0/=+ ^)@C_BA=J,3=J<_@RA:EPK:.5?\88O3*?I[1N9:% ;EH
M;EN-G-B*H#1S8LXX3R-\09QQ[!#2W_NHRS5;N)U6\R22DT8C7\&Z+<)^C$V@
M^0] J3L7I ^J,;#F7,TH\,U3,E*&6L,#U&>&>2V3G0U$G%JB@<TYN<<>3#L"
M4*(<PE.( 2(L<9?Y=,U%N9@\\TLJT.I^$,C;K>BX^>56:QBT0/>:<"PMX8_?
M$/>9''\*+%KJB_5U@$6N%A7T!T3\_2 H_S_IP@59_RU ;V'_<%I1"5J#/GHL
MKX/&YN=:I#Z4TJZ]>7CXTZGX.^<ZOV2S:U&BMSA3&+CQV-Z#%4R<^P/0K&H:
MGRQ"&]^!(J)*%Q%O7/>I3$;7OCQH*>.J([.S^*JRY_#I70&Y:\('EZ+,@$GL
ME39E[W<)JH31[7Z?$F[BPI.9L&E2^G=-GBV64A?\2)N"F%XUJP\3RZ-$$U,J
M(*G$3BX>R?USZBZ^;W)X/*B[P495+M6!!U#'2U$GR"NZWE'"7ZRP@UF+6/\P
MG3F]#Q8ZK0-LIC>5C0-/O XX'MK:W\6P?$XQ9'_^M>*_"@7K<TZC6U4F0HF+
MMR3OZR.F&D[%9.#WJH$NGO\ <ZE[YJ.%V8=.H<4R\B.F(P:_E;7?6(_:KOWE
M6MA]-#XKS@&/CB_-R:*?;R1!)(KS$N&16[?7MN^*FM?P'&TN>\W7T[!K073I
MN1'A78*'#S\_JMQX32-2];I?:-1\W=_.HL\<<BY4I9/RS",N^*!(MCMU1?0$
M6F\-=0D\FS)_UW-\/@175UN+B"WTO[I^-K<1@VS5\9)(<K>9F6UMVY5V%!D$
MM'F9C%OC>]C$.!Z SWH)D,\SS6?[6,!0NC"WHE?,TX]EKJF+.0;VWS),ELF3
MIVR"3.XX[/AA9O>KWTS.!)FVK-QY. \[(DDX+]TQ.^\]6#HMS"Y9XM,,N[;G
M^V_,\]U/?Y_5K5ZUMVJC"2PR'*)\,);":AT*TH+DRX)T]%1G@#E;3EQ,MZ#U
MMF0QF/^U6K6F@Z=V8D,5S1TE\C+9XA$4S!K<1"&-P7\U(6]=9U3,KC$7WPRG
MYKF/7M@Q%+<1<ZB__B,?ZN38/H^=]:=_]B=4,06E-ULDX$*M30&8CD<'UJ<P
M5V%WFJ,.#KH%7;>;]JCKYMTIG/D:%;P3^9MCP*VUZBROJ[T&>SG-;1BO_%KT
M[&]]SF8[D'VXN8A%)$;IMM,P1MC<\@?7V+KI=E/7-U"P\=ZH8.*'E#6>JITO
M/K0OPZ.:T.0V19^JB\C>'J#@_X+T=_VEN&K4IUJU2IS8*6UPV]> (7CRP>L_
M/X=1;^7$'M<7N3&A]LE'AXC"TFS1,CT%AV)!FH*[Y<;;S(2^K%<Q;IHC>DP:
MMVP&<MM><D).K8MOII9-V8@*B30J;VNN@^:@P#537PI9%Q7"V[XD/VT+N'Q*
MMO&Y=5>VN/$11MOL6UZ]K%6 /M^;&5:D.#KJ]/;7@FJ'F1W+5F%)>3<GN\*N
M%D@)AYWU4G]ET?DB9P9,ZHY_DF%+G$PM:;QK8NYM_3O*;)VFV?\* =>YXO]1
MW= 24L8L)*9Q\?9;(?CRMS5TX>T1*<ZT,4K6)Q;?A)G6NU5/^Y+P7#7U4X,*
M]10\MF>QD424DDMRK0IXBZUA7EZ4!OV*(2YID+B_$YX_M8RHN;,)4T8DD1\R
M;ERM3X-<T+OU[JN1YL%*#>S+6MA5_&]ZF8'W.NC/AM[#IX)[6;A+?X,UV[U>
ML1Y^YFFH3[K[6S6O.6.[]6RSZKI1<F,]-'U@5<5N"(P_/BWTK0H@0U$S[.)*
M+MP/4-UD2"]C/Q&H)S<^4II19?22\*G4:M5;RL-@_! SN'8F5'/<A"&@9$I6
M%BB>E#B"!-E_Q=JB1VJQ$%L[W3N@^%\NT;]8;$1[_ .4?S\?Y9CEP?Q==/-:
MCZ!E:3;J615B<&=G-G4B6[;MWY1.KY?;>UR>_=7_BV-)K^C*_'M&T-P%G(5)
M<*9-T4Y\[,"8BB=&)[%,XC6LYT ZO36%2)G[JR(5I&$ 'VJSK[^)VW4KBB&1
MJO*?DFS&'(MG7[Y_H4Y9*1OEOH-=A/7R8:X_)_0^W.V7F,8_ %E,YS] 9\-A
M9_3I-E<Y2(7;U$LIX"]^3.XY;G96RM.UH(_9%IG)#W7R:(U\J8$:<22YWY.,
MLNL3C91GP0B>&[\>EG\ XG^ O\8.IVK00U+:[G^ /S4?.L;# E&O$N!-1>/I
M=YE#37>?FU:7K=%UW@?G\/]\8"80F%M3*HEK#ECRD177^3:O&90ZG]5XSL.=
M] 4.,^Y5']/ _(;]PC)Q=_:+W:F9R^W9OSJ%VP;L[>9%(Y'\MV=X52+]IW#>
M-?LJ3KE.RX8=T:W-'J.MY$MEC><.UQ^^]5Y-Z&6,U5'.XY]D2&>8N@>PA#0-
MDEQ5O.189N;E9\9^'B[DC["-N&VT_MZ>-^)I.LH(N:_;8I'*^/H*8'E ,NIE
MR3*76&&Q<R$Q;S2,+8[B'6"RG@[H *,G79GX^'=$&"2+)%^9KX$K7<R_YP@G
MXF84"^1SB)JS$?&)_*S2/5;8"GH.1%KJS&"T(>SP,AUKBJIG.VA1K!'3$>*P
MKWT*DP_ZTFY\*CRA?(SA6"\TSXJ96N-H!2**+ R9[1IV42&@B_K>_Q7SST76
MJ\OZ,BC!-?2B+UU6LB]]4A230 A*STGT;I$Q)([&]PPT&NS"IPS49:R0]7H/
M3W,L*HI 2)7<UOPZ*]A[VOV?:'O+H+J"[UWS(,&"!PON+D&#N[O;P=W=W8)[
M<'<_^ $"G!""6_"#NWMPA\GOWCLS-5-34_<_M^9+U_ZT>]?NM5;WN[K[65(B
M[X"+W'? ZM7DG%[PN-4[X$4DI_AI@>QQ+KBI)Z.,[_QD^ 3G$#U4Q#\BKD*?
MV++F-:*23#&@-.*+F&*1)<TW/D@';YE @V.K_9*M4=<,^"C=?&A]0K!M>J5K
M$HE6=XA4%N<;]1EX*PON8&[NPM>16$Y@/ XG9_/ A*>7RNCK(?*5,&[E[T?;
MG818,U;83Z!Y"RO:)&Q65D'ON)7]8>(G!$QMCV+L_,[G<XHR6WEE2+G]@M_"
MRO>1R%')).H,MQ+INO.AR'1-/#./E2G ]Z</DMD"GTG46-7R%QFKT)K[#S$&
M'@I)@[C3>QY9^GP=OWD"[R5B0(M$F.:9!"8S]=TIJ/)IG"NZ(9B3S<?JH$JC
MZV4H^&%D82D':':%[WH/ EEDL$KY5HORL;8)-@I_O0+M_VQM#UJ=+7,N6M7E
MN0G$^$8U>5)_SW?U*>%VA $IR-TOH75$*O1:#D:,5*X\%K''QCG&53J"R5^F
MQ[?B%1/,-N^WT7($NM!?,W>N2S$Z7MN2"4+1K5Y)!B:F9UV(%BK9M7PX XUQ
M]'(,CW9GL;%]A#@/PT%;$5^@EQ[6!21O/8"5OLX=#)ZB2DC%FJV=8[_S#)W?
MK?QLZ\6L/_2^H<5_825#&I%5>B"^4U@&0G8]1\>0!!_N2=I+_N"LZA&\5HU6
M\ X8VCB0]*QPQJH],,O^"Z_/)9C4RV4]""8[QX'^GLXU'A2>)8OEF2UGDU]_
M3=*RJS6_T#[4R_7&5^R.$% V\,E8?W1=P*5;V-)XMFR*6/7.;,3X1)L;+0!G
ME'M+M=7 34PWT8.GU5HN%-D#J?6;\?RKL>%TWZ-D_PZ8$"YTNL](1&05S/T<
M["=R4"4,'GKS)#L-W@.] \I]L08?85P!-_95X)+*$,T\!97!":(6&(F"(TD:
M-=>*XM:CR8$[(PW[C;T9[X9V)OT=M@:M9>A:N>Y*>/)ED3;T1C'QI^=5=24$
M#&:DRS9GY:.G&*'R6]RNW-'5QT\7Q*C4"Z^<]L-TOY-#B O@;3-SH.1]%HT_
M^L; )BL9S1@X-=YY/M,^4VY+-,-5[D?G9K#-P9/"=8\WR)M697TN_L0L7O];
M=F(OF@C:_0BB&%Y:E:6,=#D7HQ#O^(LPLD)/]GC>A*?"_N)8-3D&93;D(EA:
M_ Q;4A[BAOWGJB\9>?Z+ZJB'C4R4JQ+_-PH%RP6B]5M(N=W"2NY Q*@*MA)N
MM<VNZN':(GYJXR(Y5\TOK&O8UH#R"*=IR._:4ES++8I9!O*$"*JY (Q"_56[
M=4G7,9#P?%"=H51:M3K0=T6RS[5%D1MG<>O%?]3%;4>7_95<9:/];ZG(24._
M2FUA3+)2PL_V B+;(HN<'<.T R+W%5="2R^Q"Y^KOCO-Z?7E"9SO,O0VVQNN
M81W;@*5%1J+974:NIYN'ZOMVDG? +Y:-W<_.KX7C058;@<X]2^MK.D\;)(\S
M;[L](^J6[<-.?-+5<Q<\M45-W, ^%BSM#"\>F\@]/1^>24?'1&I;!(SRZ!-G
M/SS>9VAZ&9.^^SR?.K'E6?\UL,]ID@L^)IG+/%1=\\K*Y2<251^9<+H9<$77
M+-'6$IFX\ZP)5<+1%^T#_)/O3=5N,%. _=&Y<]XO3XK8G&X.)2,NERV'THPC
M#8G.CWZ?K[8(/E?>MD,J\@+WEQ5RE.= ]BP\9 PV0C4*XE3ME-:TN@0?XB,%
MD!D<?19"5(8)0RP<6#$L636[NQ)$]6!H>M5*AA%>'JZ-@@=4Z4F9/6IQ!!MR
MVV,=0Z0WA:+5&#@YJ7X0YYR8#GXU1XH^>IIK#HL+C*1(C>#/FL8<)5* _U)H
M/BTT\,=LAN%3Y59'S'CE=X,ATMQ.A;M%@GW#SM1W0-SX]T8)DDM)[8>3*)TQ
M!9Q8_%4L 0<78HEJ#") &3S9>8+-D]W.)>LSL./F*-1<,"7Z<![+!E;XS,^L
MO,9A$T_T3SQ\3-&P%QAA+B+@NT#@MKA<_\_^T$,;454J%I"@PDM VUU*-KNS
MK<L",YYDX<\D9!TGU!(=^F'YFB95%-JE'W@;ZC-7?/5DWYY6)2DT>DO..(91
M&KC-"1'0>627!'-_H0"([+HO+I50U''G=6>2RVGTGYB\GW'R+X +2\";C8K;
MGG;C?[-#7% V_K- ]LM(TCL@W_G5;G&_J12ZB[% 7/H.V*R63*)X^-O=+SS\
M"D&[#A][P&+VCRI4)V':D4V\-V915"^??END0'UV F2\ N]>&[S*6+00.![6
M<K$07P_9./'=V#[^$G[,/'MC0+SLN2=L=09)=71RO,'D1G^/>Q2,?6,C-8Y'
M>M&/U[UN&# CM?#RRV45?*ZR++.K]8)"=V)G, NUM&_2GN77P<>@(_[;V_7;
MAG86TH)Q@%RS"8#ZC7!CRN])X6]-'V>"&: #/A7QC;B'3.6>4>S82,'U)QL;
MV8=ID(KHJ+R,G2Y6;DCCF.TFCL*V[1D$ \\?[6(C_DIH)9%BS9]?>[JL6F#-
M7M'P]HHKHS$&BRB<=->^8LK1=I%,'*.B>SXN[ME>1S-'O&YL&!TUP!FX"(\A
M@J'?.RV8>_D.:%>A35!KIIQF_1LQ4D'_5!XA!N4*2FY?7VE)+@D_XSPKEY//
MG\U=?P?\B^:I!F97NH>O%;K+'U _=7RG(S=X( MW6Z;V?0@XQG)/'"ZTLDS<
M)0L&<Q%/_;T>KHO6L O\>A!42'C-.89!9_[H'?CMIPOUPJYE+;<;G]*@@"O'
M%^<0^:=\.WW7LE8ES1 +&59&G =OZ@%@5[R8DUQBI383<\K-6^+@HJ6+3D=0
M<4='J%5GP$#IU3E5'8']8K'0-#^.ST$. Q3NC2+%<9)TR^-EY*:'3L^C07?S
M:>?P!#&I1[<)[Y4JY1NJU^S@HW#3+T-9H33=56_R'^"VC%'[F6+7IE6Y9+/
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MLM.RYR2>C93)2>1?IE'$_LJ4.PK.#I]K+7QHR97-^IY,6O!1G;.&HUT(LWC
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M@1LSP27)(GN/=."U-W?7^YE@;MO3NW> *<8:W174I#-!\V%J*Q$D2H1!TNJ
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M!M<P;P?5Y^W:(NDNF*0 IO[^@C7&AH>D&)ZTV4MGIQ)6E!-AK)^9+5"%2J&
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M?'N4)M\WJA6LH+A'J/"[W(N  >;G7TCR>[R74UF,7Z'8?$Q%=#LE*PZZT@"
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MPTML!F6C\_E@))V5ZCJ%(46'@"X]BT0B&ETD1W5ZD%/G'CA%MV]&;]OJXZ)
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M=Q+GXDE1S2M9*?+!R\@X(#.=!RK0H?:5R#\ES"/8)V@QUM+E:W0< ]UZJWH
M%T[5Y;/.W'.W$TPG2+1P@_0#_5OJ%^-%L?%&RFI.RB]J]TG/M]\:5EY="<]0
M@F6Z>5^5C:5^=51_^&QYC!:]G_H"_0T0$4E<NO;[YJ9UQ/:S[<IBFW)ATO*Y
MBU+?2DPX_YSR\?#$YUO.T-/'? U7]&^IA%BOM8Z4N\N_OE,_[OP&^/T&3*M9
MMCQOO%O#^Q7OY_R<V1Y]Z_G'J+P%+Q)C3C,\@5\#_DZ/LK^0:_LR/N:#'G["
M;\#K-_U? [\!4'^Q#?[?@(>$OT]"VWE4#%'O$W<VT-GC=)!_Z&@8F/>UL;KD
MNIVG5]^3H*(BTVVQ*(HQKY2 1!Q)MJ<M+8&'+($S8WG>F<;^RA>D.$T^<4F-
M!.M+VJ^M8WF63G$-NY$#N5* U- VM&FC7 R>H%+(("9/Z&,*B1Y0!X=0 $CP
M@2__GBY68O] _/C#_P)B_TX.1D+^X"1V/;]\^H$O_A[A/W"EX39*ZGKT]8]
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M)"4^Z?)?98NSAS3'L+#] V%LY8_!K@;'BK:IKW,B'<=X7NHM]Z-*M+PT"\9
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MO[=2>"W\P:%M</!XW/U9,"'3CI^/[6*^7Y>>EC(W!0-(4&B[0T0=TR&@-4%
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MJQ4@+DVGJEFUH1G+PA'LR=N0!I]_CEJ\/[Y^6,@<2_][I='FZIU%NE%O>8C
MZ\&'3O"9+?E3X9&)9W;+F>EX![F" $-%>D>QBZ-%$&?Q32H?Y<7FV]51U3OZ
M^1H&MD#O)<>&#9$O9$)!6DGDCE>^/7Z[O69EWF80\S/?0,N.7N/6U8W' %?3
M7N^:D 1=W9+MS21M)9 @@A1(R_'NYT8*$%G_89TWT\(&YXA.L0[,Y!A7FPY<
MW>'U9Q<']QI9XZV>L2%@?>:@V_U1L0KRM:+Z$^6;(U$).::&%7P=/)8R34]O
M#3,6'"P(6Z8*H)04OR%].$#_\9A>&?"WE3]DN&;U\SA)$2A\(Q23KZ="T$B-
M6J4]X51HKJ6$6E'U+N\XX/:)KP8Z+[<C05GM3_DXD_ 1L^#"H>,Z'ZO;8\<S
MA4#4?8*6V>."A$O]7';<@)<=6=@CDH-U.)U;VK;QB1ZWA.Y]E:%1I;>@4J?B
MK8O1<<<"R"!;)D0XG-GI<HF26LIOYN$U2;&.O!J;W0Z*(GM;ZHS^("K@.'WT
M^'SD0I!O^&:!PP^'3)8M]6(F_3!VD"Z 5Q*GW7AVQKVNRG$UD(2]"P\"9\]6
MHN AG5"A.)=:O/AVEX!SL###6BW4!L"%F3BBCID?6O&QW&(+0QDV]9):@2KD
MJ_[Q;7Z>4U:-\]^L2+]!%?YJ+EJ+X2HRH56-:L2STP^T95J%P;%0Q>#H06$X
M4C^+3'<QBQSO%H:E^8#%]!I7(UI.SDX./4V41A"Q_!42[0A/%7-GNCFQOET%
M*7Q0C"A2>6495.Y-T=)IB\,2:P4"0A#F;ILZ2J(R>*Y\DO/A=$@-E[L#%[@=
M;0[*P>%N)(?G3E,=(D\7/5OB6E\;.3CGROATQHEDBKA7(!FJ-M32= F$T:C&
M*FRLML,?SG6TCB[-S ,A?K<%?]=IOGXK-O'P0V(F:#@'4RTA+7FMNL@]0;#0
M&NCS71(($8!=IY>5C@HG<XMVF\M?[L?@MWPJR+(OMN>^FNHO3<D-&_*M8=RX
M^0K <P)YO1D%/O(TN\MA04DBX4]^@=3*0 H,4GV0"V%,?.".#MW?-D#U.C4=
M3 A:F%1[]"R<O>U+<QPT4=SHU1(Y6$5GI=CZ-R7GRR+8HM#0(@+AD2S1\+AJ
ML,95&;Q2MMTNFVCKBIBHDL*N1.']:&<^2BSS5!5VIGNC57-K)WS$Z*6LAA6E
M2HA+>"]LM]5R))*?,^0Q%J^=4U5.LPFO[6"5W02:BIXI4<L"%NY8Q\-)(I</
M)')<6=Q0?7OGY1IEN3YV[_N.1G%>S$/DPMQ+*W 3"Z#1D_=PWRM4/M3-',5!
M$N$Z3$)QGQP,/5(+V_\1Q&/DR[W3O9DDB6^ZY_40$*1P]79\E -OH/FYNFJB
MD0ODL9_<MD-7S,LX$%T$C&-,>\-82#V8R,5&JV"3X8/)U?P)$4NU&_U<'( O
M^WPH3GI=N<$_1SW,@X(,@0M1FTAM=) >J0IXOEW:7WIQ5WRY7=J]?1(3_>_=
MUI?.I=W-?^XX1?HN;/=]B[KPUA5#@L\;1W<RV"2YMV:YJS((LZ6W;L4><?G&
M/8NEDSXR_5-NG5[/Q3O,FDAQ]^QTB=$46BXL0F)Z<F]%%_U0<[* J)PXQ($>
M2D".SMHP@"""J]\C[;SWU-VPTFAA,F.8>N:F-(4]SMA14-Y39&9 0$B!H6W<
MMPBSRK7'3QY/A*R""SN($E=PA9ZJ[N".T!EV61[#TODJWU&<DU1"4GG\A[U*
M-]S8'\\-'J?\"CNP /=:T:,?:Y_;VS4MJ+(L6N,6F4K;<YL2_PPO3C-$RO%V
MM%B\3)S#PLNWI.4F@>ALV-"?'L0=Q0X#@V^<86O^E;D> O2GLDO5ZLN/D,69
MTGL;MM=-67?#LBE/6<_KC438\0R_*?SEIV>*SEFL63>Y38=,WQMII]PBJ0@K
MX^YRCT1^6%COZ2R,&AW^-M-K%4]XCD%S&DF@=<I;G6P&5:0)*9@>/,TWHQ?H
MRN_2NRSXK7U3._DQ8%(*F(%Z.UNPJ !NU5<*))Z2HHNP];.E+RZ4K-MS49YO
M/T/5I$_#5EDUT\59L3SP(((G'-\XPG6&,!R8\]B8G60*V9(G,[-$8%-TO4:&
MX^DT7PS(W!5M.F#M7*E;M^)V3:ST1$F;Y1A0B"D=XH1%,\,,GQR[AFEC,G?:
M0.:#Y>8C([W:K3<1C9W'ULW:!R0)!V:1$7X8+*/.P;\!L3>=Z]-%E]E),C4C
M@ 4 <YD\L^JH9N'DR&#OR^V>_X)S%5TGLTDL!<@*H*R-ZJ!S-7>W@GYH/9#1
MGL=62^WW\XN\B9I7-Y!V+&Y0%KY: \4!:W#T+.42NU2>5:/Y4K!IH)&)#%9>
M(8$HH>,T41-6J$1<S2]/9]QS_*'X87KQ.3*]6+^"]>HA7FLUNIY8/Q<%3(M-
M(.!]Q<R;K7R;6.4:UDQ*2TB.RX3,>62<'/RP34+4G^>H+1+;4TNJ02-O8PV3
MQL],'&-^V0F,&8$CT%7W2SCYM5#D@="=BF=U6B'H N2  Q/H>EM;B,/C""\0
M.4Z+,14]FZ>%R$8K-O@+J5Y15$#W941+;PC*=;Z[ML;)'K;RCZ"BCZ%UI$$<
M?+]*1$C2S5*(?*)1S/=#*C6=BAV&D/976"DQL9D>83U_JFVH#EO(HC'OIJ Q
M6H>O(./3?FG<,6J%ZG8H188]X&^59(LBQ@N>@WJCNP%4&=O,LI'/U&VOIF9!
MN*.]"M0FD3\W.]B\<^"UP3P4+M/!A^[8+%$U67A\RAFA6,?&N5^FXEB9?*IT
M8K F Q;XN<+YMRV<C#U1+6T%FXR1UZI8UW#X\\+Y+7$:L"LOS25LDQ/ADE+;
M>^TFMK<YJY!C_6'#LG902VC;]9R,'*3<=1!S8(5/84+P!%DA"ROI>LE>I'6:
M]=XV'20"ZV]G1]E(+1PDX^EF?I9E]TAMCN^#%]#J!D=9#SE8XYG18D9YK2V7
M]0/F?_%26*%=J>&Y5<-">X"^2/SWTC+**EAI_!;<W<$7<N0GNM]I2=VUX^12
MBD^19@LM>R')?!P,=A4Z0M0O<TCF2 OVO4K^)=Z[&S*;C[E)'KNBH@L.ICSS
MG3\P.O%A?/U9V+9# HX)G"U=P<;O":ZE2F$Y,B(C[ 9&J3[CD-:Q7=[4G#I9
M9BP*Z*XX=E"<R9.VO',"*J;4I\H0/;Y5R_,CH?*G-8IO3?2GY9*!K4:FN9;<
MS8N'_4+N^U D[IPXU</BE/<,=/5P,9@X(Y^.7G/D)4[D4ST289<M\S^5-YS%
M'9FCISIB)Z<X-VS?I-_J69W33!\;5&[^Q*\&"U,GP/X;,& 3'\NEPNUSS]')
M]OT[,C)WY$!*6<IV+#26="IK!+V49<L/4O>D4:2"RD*4H8#(.!]+!2IO%.R.
M<+1B%(1W.EE\"7JFFL$+K#.(6,(])A!D0$_>@[O%:$ ZQ<8W?! Q?=O#9)9,
MP&RZ2NR<,P.W/.CCQIC)J92$78:Z0J;TB7ID>Y@[96!C'G;<C8Y=?$#5Y3UK
M=<E'HA\-6GU-C!:224*+YP&T]A)1NO+*%@J$T?AG (E9MT& [,!'N</R\\Y7
M+/L#Y$OJ1T*>1DKUFD>SB2"W@[Q&KX#Q[@NF"H,'W0#\(*1O)>_7>965C0N+
MB%OHNT^(6G5_H/3\\HHV!FV25.>6IDOUY+9IK-9Q\ 'J5GSHN0CBW]'D?G>C
MR@O0337#=Y;^I.-B$;9KWM.38>H@<A824>XBB(997AV[&?G?*'NKH#B8OGMP
M@GMP=P9W=X+#0-#@[N[N00+!!W=W&]PUN+LSN#O!+>39YZM]W]V+_[<76UW5
M?=,7K=7G=)W?^>'D#BZ.GN%CB*[:_]G8DSPG0XS> F:77)*/$DQ0 1WN309&
MPAVXG*KI>76BA88UK:XH$*:F%(7=G:/5L[!\"*-TIQ1%/K.X#>(-V6]N=>2&
M,G/C(IW':P(YN6_I_98M#FF0-VV.D,9I!D:#KR.7NN!)6TLJ:'W##WE/K#J'
M_^)4K'%=7>IWF]RDJOEV6_.T>G1(C1^&AR@6> X4#13KQ6@8RW.^JF,$W+71
MZ(5929K19OC*H<A5(TEU&(!<<MA9<R:LY#60PT L@$Q,MTC7.7*REVH' (C&
M1Q#0W0%5[FD@D5>Q^0'R' 83(7\A"X>+(PNI2J#_,YU6 CY,3=Q@>?Q;VO^6
MN?0N<0ER=PI@%6,Q"I1J1VG.=NB.O>K KMW$)'4/10).WF5IF)EZ7P'.&FB#
M$S8H4ZG],_RCD;*4+2:I_>2PKFZQDJ ;M\\=;R$T6QGO5_TE.A8,0X3%!R\"
MAQ1@RI->/^+G&)^#4^7XU3V>"&RC7$2'VXOJN3(V]T<_C\"@$^L#U38^R*HI
M]I4&[YS1Z7MGAT%2(K40UGL290LB&;5]'^&!F1RY(G:.%%[B06>H9ISA^G[\
MWOX>$=6LAQ3TD$<>G,^'(A"J'&M.*4C=C"UK4'7K_4/ &C;^X/H>U@)F4R&L
M7GY^I5C\#[76-\;NGX7/*/:;7CWVO;Y46#Q_?!Z[#%@@YA':G981XM/8Z)NO
M$V<<IJII5-?G8DI>R ]"&0D_0SG<L[>_ZB'31V^K"0.U:KK829@W11B*MZ/4
M!HE$8":'Y8%W\/;( </FO@E#-<^?XE/38YDN08MIZC#VMRITMP5(O)TZWY$A
M>LF:*?7&+P1VI>,]TU4?W_,U:7'$A=S+[M^5GLIG,[D07;Q! B_9N 8M&^T:
M$.4IBZ\5NV.-%WZ!H$"TD8STU&6SSK9$?PA<(V-R+!?0F2T[Q:21:V3/0EE!
M(1=K-W?ZC3HMB2CA:45#$B>Y6*@\F$(B3"BT1H*$I%I[4"3B8XW%D"Y.=)HM
M)[G0;8 )VK18&ZYQA+2IN4$V7C4UY3',-F@1QB.E0W@+LJ0OJ0<"@-8;&X'0
MVF_M+9<LZBSSL[C]+R!"%T'934-="VD3"<HWFU"4)*8A[F<]:<YN=6GMI"_8
M'@=)]0Q32#0/;Z$\3*-'>GG_'V+#Z=YHS>(&WY"%]IH=NU,1LZC) +\R#^(Q
MD?VY:6JS^2\^^9TR,Q[(NCW19USU.:]9FQ;NF"J0B>T2"U(Z#ZF> Q::2@HD
M%K-V?1LG8-;9OCD7$1XV;VQD*!C%DKW5>71?=*"W1599?;-;UCJ<)L30WPFS
M2=#%, K1G@+K.M_C9AM. _F@/#-(^;' EY9W[:\])?=?!HK--VO9?+MQ HNF
M,/2%&X,U[C-7S<;@6+3))4TKZC6XL!TD-/5#5-H0>=,Y&*OIK? 2LF<$R^7=
MUFC@KAJJ!.FPA36:?%1NL= .ZV>QKM#M\WTUXO,O^!]G0)-?"4 /]0(\\K<"
MQU. \F,1O*Q!\>P7&K_" ,24^S4$*AR>T1B6+=I$^(!S0]*)4;4"V0>2K0>2
MN$A=I^]8AI4H4JK)BJ=<25KWB&J-^Y#DJ)\O464C&P-MW!-'+^^F<5(R:!)[
M"<.X#I%:6KZ$V#VI6)6&_%T]<F2'=X0T,BB$^NXB%DF2C;) +XS^!'@XA&OR
M[[$2<!#W^7\ 2.P)B3F=9CN?5$ZX'N)!PY^N/CZ?]607J>Q8#^;<?)CGI>M5
MSY P^*E*<?#( 8LM:E %?.YZR<DHNXCOF6-6OCI6)FJ69%KD[4)'H?(+0$9[
MN) MR<NKP_V)+"&1J.U72_8RE"E\KD19R^1L86Y8D?%A$NMY<R ^\0-Y7N[,
MZHML9R;6EEB/OE51=&YOZE$WHD#/_:E3+TNI\O#PJ^?Q/+(Y3HU.=4)WYPWS
M;2H-8L;/0B'%99 WO&V'K]<O@=SC'3PD#N%,P9(T)1;U;+?:-AS9V#*XQ),X
M<1<IQ='V@CR:A$^LEWT_9/:&DPYE3QNO] BW.I")M/C%SM P_2&[W#99AY6^
MJSZ[6_Q%NL(\XT]!L+__4'>P\U)^S8D=_=*EV_VU]B'K;Y'<\P6B6B[=,HG9
MSV3)'R_EM=RISYB2JFK(VY#X^&/"-'ADC\#"5-E0$*EW'<[=RUTTGRRBWVX-
MCP>\I3,Y$= VRN8[3$EN4NS*WB)X4+W=\@NY99!5FPI5Y\\@_G*?< *[NB>/
M<8, UZL/YJK;&R(_U3]WFC&TW@9SO]4SA?%FJC(ABW)9"=$^^*530NKBZ9I$
MN.;VBJRVCNAU=B_%^K>*U3XF[3T_>UJ"?J_BQ85F"L!\QM/\!^";/@XI2S*G
MK;!,=X:;!6K=18Y97F$UZBKB0ME"A(7G*C:$9VMOQD1LCI(F<DX"[7:_Q"T:
MR>I&9L5<&)*?T<O138L]$M.->+.5?S8JPQ25QBI@Z5%^LL$\- 0D6*I&D^H2
MR1X+0&VOCU4;?T6<.6)I]*,ILN-B<[',3H]RZ9I$XNO,4I]L?2/LSF+VR4YQ
M:S.9\44FF[($ X8!J+LN7'V=QB/=OOF7>;Y/&8HMUT/+.-G"_;X[6K=-V4H<
M1:S*C^- 7V3E F4G29J][2UM%8V2FP)Z\P2N7C]4E=@)\PDR6A)-SCD>5WHO
M9[LLDDJ"(3-,QSQ-E%_!)^W4JQ&D7J M96=:M.D!L0D1I( VE^=$$O-9"N_T
M\EQP9%4_YXN$2$)LF\O,GBC%[*+"91Z/+IO!8,J*PU-$(4+V:6!=I/L&UE;!
M 2+0,O6KV?4Z#A_*J53KHO3Z/CS &L%FP(F-:S[M>$M/^:AG0X[G.FHR5M5
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M\?86,5YT]4LR\T9D5@:-58/(DP8<+."I2NIPTTQ()@SGVG2SL.758E96H'6
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MHHD,GX;^?*YT20(7.K6T9@G'Y/1^9TZ9,?>SAW7,2AO\[.GK:LKC@^;9S-=
MLN90:.R0],V:++9#]X:=93<V<L(O_!,+VJ$XE^N,P*D%-X3KH#B))OI9'\KF
M+Y4Q=MC2(["Q>'K!L/T(8=;;\(;<'"5+_YZX'0-XBDEV"MSQ\<PW,?Z6*Z:
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M7,OL663C\)QC3[YU/FX$\Z1^9GOJR04I\ZH$A[ H5'=B"CEVHH(BQ0R/6-=
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MR41<)R>PSNSH!YD_N^^2AH"(U*:'ZD:JA?7EITP@;[I9>BR5U[V475G+5(L
MR:B:PUY8U1<<8]CHQ39T/PR.4\OJX"7M#5I)P7"+^[35;EX@G&_]7[_@:YMD
M!90K"48&OH2W4@@>)A&M*.'LV8OX\B?L<8T4RR0*&F,VB501XY/)3PR:*3"!
M #-:Q-:+5B;CQN]S8?$7H>%3E;.3J8S,'O)>"/Z[I&%'^!H%_XQ>YG^ 7^_?
M02\]56XM1A 00%J>[J'J&+6E683 HC:]=9->WJM3KXQ;B"]U^AO7"MPR!T,-
MPOIF;JY'TP^K.G,HLGHMGE=":934B=$UY-UNJ!><*TM#;HY!*2W X'U[<-A%
M']4R$#,VYKR]499ORGA8T1Y8UO"B(TB*5P8&X>VT1/)*:41D*<S&)4LTS(*G
M:;G&%I1>NF'TDKI8#VU#T>%B_H@DZ82X'E9"C)\$QKK2?-=SZB)GWC(W*\$E
M3QXS/JYD6'Q'?L*#:+;</0;HO*C?3 XQ*RD4[70Q87+>A<=WEN(K'T<4,'"P
M&T8I3(R3O4*<B7P/A?8N>W9[WYYDY$@I\2[(U[^M_74Y(_\M^5,L8C)S,5V$
MM R>G;86 /!J8YFJ,2I:JMA/&;(_!8% K+U8IR#*L"D(?5OP/Z->YN^H3F?X
M?Q*L(.<9;.+VVM-')?>_L/#IOWE)Y:'P.#962*/<:OY)!EH,JJX-=3V='\*G
M*4QCK]%6>[.Q<'(MS\,-VO0.?':")R>Y4:$[1_L/<#]0M#.BZ.9:)$E2+'%C
M_*VW>!CC)KP%.E#DE,0!/"%GZ(G:J+"O LGC0.X,IBFE?L'?_ "UTZ /WRH?
MM2) I-3_#.+TOG_H0?F_ \KY?V#'K2_=OY1W/IPN_ &H_TVRNM^]JOWG;2]2
M?[U-AM/X=,#@;C]@WULB]0]@*FH%[."*J/T<BO,V6U@A7SODB+&=V="4#M3'
M..3L_UB)5C)KS@7':<?6[20]H4@N>Q35T5C:A!P"89:J6YO85?7A(!3[D*+-
M-E;YUIALF-)8OW?$*T%A0H,O-6"5.#(46I!%D<4(2-%H_S<6"(_2GMEK,7.1
MHRJ5D&_ACLGA !]Z-2%:^"Q2*%N8+&T4TPETB=K* ;JT7%MFJ[/0Z^?,9TB^
M;^61%%>$4=,L2:J'(X$(:9  A(G1-2SK3)7IM]6@T@S3(E(CXJB%O9.HU2G;
M_Q%)D!G'W.L'_H#YAIOSPVR-YW@5YO! VYXZES+U6^-DKNC*;R(/@XEF#X-F
MH]N^&,<_-@T.,K;! O#:&I^F^K5K2TR<ZYQT^+39][%4Y.@ B$=PZJ-L'Z73
M0'B?>F*GSH=ETP6%FEW?@]COT!@,Z6MT^2]^5=?QLU^*MC!_B28,VVAJ1[".
M_JD]#FI%JH>LV Z_NVQ!,[PG5[7[['ETL;ZV_G T[<R*)/V)H $<N \-K?T-
MY.L-$JKFFJ;(W5E?:F^8/#W^^<5YX;O&A93&PO_<,73A?>;"^:^?95QZ7Y^P
M5YAB;0.BS@B&><6D'MZ8YU#3OB!Q*6,GOX9EE4>-!?4K:4KMOS,M9RJZH6[0
M)/BO!PA+//H^P$U4>B5&V>JCA54-I;#Z(3BHYD@:+"5_$6^J(),J_Z@9CTCN
M)+3@ 'Z [=66V!LX[UXO"P9$Y'-_96@QF4F6M01;:&P90$C@=02^\B;VZX5K
M2#:2B;!7G& X0SQ^OZ_B[NU/&M17]'=ID&TR4@ "Y)!Z',>:C(P4YOKA>8I[
MYNF:*\&1]1*GPFWKCM_03N;23LNLWS3;T9%4 <#Z?.T.$@FCD \T\*]1!*P?
MC6IX*V<XY\.34?RMY@=!&OG-P=%\&5Z=).PEO8W='=TM^O-,M+87-?'6>J6Q
MZHTSI(7Y#(A1B:H^P.K"0U._6K?5^ J5[=W#01LN'9*:EC9W(\/-43$>3G:\
MI9.UPVU%!ON+B8>1&SYISHWU<S);^C [>HJ]Y8;_T<,M3IE?37VUL6:_GITP
MJ'G*MUMA.=)K/ T=,TL!P]#17=.$7 ^Z!"3:]J9:FN3MV(76^,K*?W-0NF:.
M&5A !?QE]B<QK&59R/";YA7Z]6I<"^U IC62+#BE/__3ASO<FY#T"W]DJAG%
MR8BPM[!=M1R]G?:$;"+%N)@< 1I9#YT,:8P3-+,:-;_1^75H<:BP 7>!YZ>!
MI9JR04(:C&9D72@T*VM<X F'L'SKIR])IZV=Q(99&1H=?._$)&HH1M#T;YHU
M_35+T\[$AY$+_V[I/"",2+$:B)O#1)<,]941P1_HSQ+1P)*@-";.#CEIG3RX
MZ14-C,O%_#BD;]Z4JJ\HVKOAOL?#XL+&?EX''=,7]N;3;=-U;;$UZVQSPN3%
MD^)-178]7?D?\:D>K'3\W;V@J/""LVH=6Z(="5+9'WT+S_@$"TW)!._.@$WV
M43NRY&,@^GB]<QQEH:)?PX@,IQ+[RGF(V177+?%*B3K6F3@NZRCUA]1 *>*A
M0%5NQ;=#5X-D4*WF\TT<'FRN;YO*T(4"C2]04-_8/9$U!A'9"'$LOFL@6^_B
M63WOS4O&0X87D:YW)@]2A@0!$FV871[0R<1P =@53E&3W'@P,*'+QD>F70QX
M1/894WQKN1E!_V8,<SF2T?MM&W825QF#S$@.*;-5%*4AYAY+?":AB#H$Y#[L
M;@<-='#%,4U=VQP"QXK7(0 Q6]QDUYGHA,Y.;439OK7E:5IXNR.U+.GJ3?6I
M(J6/;F3E.U#4T1_47A3:T=C193# "^?JIT?Y+?F +6,VBR$<@NG'+?\3Q>N*
M#FQQ8GD<DU4BS)9_4\CJ0%1?2J%!^V9S/R_%?E0T+$#NUI9;*I9-^CJ;./BU
M]N/&TWWE^W%]<?C. I@3SK.>,7,2;?2*82;KX^NR01M<V> @9L-P]4K6&[Z6
M:)%F'!%G3ZW6@WC5KP .[ 4KH"YP[:#C V<3C(XFI6+WL+R(P'=(AH<S[\TQ
M3I*SE&PCHVK;"VMS,>'/]?N*4AM2-%:B!S1I/4:><Q'UST1M.>B^+^HU(_#&
M.M\E[,A \\UX*+%/ L_ZHW\ S0^KRP-;!KEUW7U')&=.%S3Z%N/ZEMPD>ZXB
M&7%^PMR*B<DU.G.;2DHIQ:Q1UC6B;W8H3UK T<3%)K91,X334@H7IA+C@/8P
M1KDW>NJSO"[AW#L_PN6!!'#0+EI,\%)ZS6WF@YN>46]+''>ZWHKW]S-A4'1=
M'0Z$.6N#GW%?G]12LJY"6G>.4]\AX(*/(J%[=0PF<LW?:.SOR#7IS-//R\8C
MX7@JPBT[M]'/BJOH+-2#5^AAO^&6Y_7? -P@;V8HT(30+>4K2.\]!+ZAB"PE
M)II"1SZ0[3,3 P.WJ3D2/LG,DE'<>8!9%66K+>/M^S42[6IAGPL;7(A+QF3_
M>JX<[]2P5M,P@1JP>YH'CD)A \@J)Z@N838Y]5XYOLF_.B @FY1(WH*S;#C]
MHRL(A@B[.#EY]J$-FUE$RS]8^.Q")_O@[Q"C,+2X]GX2-;I.T/VTLD3O0*9$
M_\<GV'6*Y0@>^H$N*"<Q.3NNV3%<1G[IH^O# T'6L3H8]Q)X3Y%*PE3T2D$)
M%EF=Q*#]W!JK%%%;^XU[(K6D>'/(*A'MW(>TN$L-%09LT?X6IA$?T><>>%>?
MU'14\Z@?3Z1P@I4_OG^MV]96;P?"4XSM5'3(75>J<-'?-%_IRF+?W6AZQQ)L
M91A]D"ALN?:Z!^T\/CXO8KG[M37O4:_Z2S209SRE6*XNAO ^?0YPC6!*:>NS
MLE5]R:7_WZBR0\:I)2%9*[]3,]6&(V&00#:$AW(^O3R2D&JM9=UV_J/OHW9+
M$^<T6!5/*@%K@N@T6N5LS<#H_::$C1UIQNZA=B0!-;%[(43H3=Q!WOB;:'2N
M-V@49WV:U&$C[ZVY4T<=DD8-%;V]A<.D7:7+<A6*\O8M2F-!.C!]?;H$ SEM
M3D+BL7&5=*DJXQ.*XF^EJ_D]Q>+D:',-&%JXTJEB%$N.-XJK55@:"M)L<<1$
M7\([*L3 LGTX.\G/_D]8N4F$*3T-O5-Z%ZN.&!H&I<ML_N?7<MQO2\5I88PE
MR2)-/(7HHV%C,Y\"D!&.B7Y\$@K&SAOT"'JOK\]SZ@I-S9^EZ)!8>,SDXQG-
M[*1W13I87.R,7)IGM X*7'"YDG%FC>-RNXC 77RZ5RT1;[!M>/BI=OB%2*9\
M5< Z5O:A:$*1 V=DTVJHMK=#^!+K(;5"SG-))XIP9&*O8LC2V363#7_6RN7A
MAI?5A,]2:#]>$E9[@L#<L)6M'8JP<M>NMG+OK?*]*Y>28$[?NH;F<WOL,5 Q
M&F:U[:2./XGK83IAPF09<T?%1,6G(_R@5O?[?U^5,'<_,6VF#W0^W7YM$.K8
M',<RS>D5!1TI0]X:Q]+U6Z2G<"R_AKWI!N#"-&0OWR?>2,12KZ6D(U4$,BCN
M( <S$+8.SS;L+<GCW3Q&\>!V9;/5FL6@P1OF5F<#(TD>=TCI V4PXL6<[_XR
MCR[T<SH%FB60]OS*>)S_?A6F\J6;9%*P25"XN^HN,)<R?M1PUMO;338.W5^@
MT]AD78X>_F6EBX"$(F&M@7=5&,6,O974H'(LCK^XY<GEN=&P'",;3QL3[?VG
MY14QI3 Q#:D+ML*2EG1\NH%4,6',I(Y4;@[+GLAU=,J-9=U&$0J!TM^35O#B
M5QG^N9,9L6!USC>UH,\QZ BJE5V?*UG9GB4:B7X:UA3H;YB?7?LX5/M?7+HY
MO*NYY6_>EO*H1A;&C8\]O-#'3.T6<3%(F/8FJF5O/4D[-UA:/*Y_KQR8WU?@
M7%%?]RH:S%#GJ_!<^ >PG*"[](^=?O]=3<G<[IMDFE_U,W>_MKB6"VS2M-QA
MHYX3DA_%MF-55 ZT:T8:A8SD"'W]&05OJ(S'A%&+Q7UKZ_IF/K7VH)I0MZ=%
M#BZECE9'AUQ'X^1-P]P*L)_L#V"BL,M:T6X5HM$HWQ]*$X:3+$$E@:*]S[6E
M\\3SI4:#XN* 1]"UUV6;$)JA!O4*E$]1/FE9]];^SFGTH\?0XH. M>49[YNS
M@PVJD.WA1 .L3ROH$B6C*WB_O2+2R\;PBL,3=^_QPTW=(^99/K#U6$4N6GG&
MCR@<H>$X2':6'_J0#.UW]SM=CL?L,1/'R_$D(=B6#85P"6O(11*>Z"8&YDR[
M]C[^]G5L[#<R?U)^KM(I]XANZ(^R/\SE$ SIFI04$_%E'\Q^I\FM/)?@A:_4
M4GECX2$.)1E7?3?6%0I,7-*2BY_%[QZ"."&!;0?AY6CJB$WYARCQ1-"O%"YN
M2YH:8A;5ORR+R=?(MA=K%3RJ5E12E7=(WR7EW'& /YY3=MU/LK=0,U:ES<CH
MU*U,8^\*'JO=F3]],]+EA7;Z.*P8^SP)"S0WS;^-&7Q;825&I(!^E H:-.""
M(RPPWQ*<-^2'>7MN?Q>4!UFGN=K&O\'Y5,UX]_@^%^'->/O'29:1<9<JLFK*
M*]HWC$ECKDP@_*$"]=;ONVW8/Y;38 &_,UW0<A )9I6H<,'+9P/JL?Y9D].^
M##.=C'NRWTXWI?NB3"-C0MN4^M<V.Z5T08#>4<"+ @8/523>]F*;V;ZDI554
M"D;>[&!E:X:;@12QE7XVX=YY<[7L$!&(B-/?JE_:;!V3/A2#^,K1"1@-*%;9
MPV*7V/\D!5"E/'+221+T?U60JQ+Q^ -@2JZ^FEQ\+G*19I4'>^KNV2_?R0QO
M6W8&]"XU=S[;7:FTZS/E>UL^ZTSWLLN'(K%R9W_8@"2V)8O#S]2[$CB3FOM3
ME,99@[,M@KA1'J.\Q)"YM;H*?,X>4VF34XE1\V5,1<;+TBK=23W6"!\#1SEF
MI5D0BLI-WJ&JIN#TE)?-5=.K)33?_0P:,MMX4"F6W+C^51>X<G+WYO=Y?!PO
MZ'NM$.O\J5>H([L<P?W8U^@H+5.H(%$G<'BM95YR5T;> $"OS\<NW2"2\"59
M"]O[(Y1J%,LHJ@23ZF%'MJX'?8P>3*JZ(^S.:J_GB-\PK$=)Y;<<(N,42#Q=
MS_AT5F#]9!74[9:Q9VRMFR6G;J5?J.6]0+OG"U^/J4\GQU+2/D_=/CN9'-/U
M#<D^CP492L\Z=BB?DK>J$6*')3:C'4)D&WZ%UATRR103_]J'$F^-2X;MNKDA
MD/RAL)!I2[$[G,=..U[#:X *;4.=F'LP-8I5-5U;1Z/$D,%2+QC;KW>]^ EA
M1:K)BT;HH]YOL9^M+@0*ZXZCWQR(R%?RF V&1"P98?/%R) C>\8(O-.8M"!*
M3HOQFO8/D%+MWDB!VD(FN/#<W"'PN!TE'1<SD5OUI$F0A>7UE;*R W"<MZ<,
M+PAYLZ4/5W\HOE\+#Z7R?@&W]OG-786@9U +5L4LK="H:.MM-7Y$,[9C3!!K
MD[@K1C[1<DL/:PA[U_HTS=@M&<5<VRE[<WN4I(G=2%L+2U'LN)'9#9^OL#JY
MJI705 PC&T$(?#U!J$)CHM[JGDLI/Y$0S5$BBM;=092NQ\7[\ALHM]XAZWY+
MCJ&-WH4IJ]2PN]-979QHRSC%57-)(>SM87RW9H5[HEVE0WIFV8QA5K>1X]N)
M::95-2!*9!Q\KX:;=+\$F6@,4^#9GE5YZ8%5K)_$4,<31@--83RW@7'UK_86
MO;7=\UKEO(36Z<V;H9O<F-*N'IQ2F,@(HX1TY!:)F4P\H'+J$OB9^6!'2/FZ
M<ZI T_*FP,C&S:=&%O/"HMDHL(9DBL=$%8-SK79XW;N.PXTXT]M==!#%%YA(
M4AA+$^DRP^8O])\"7?D'\,F]0Z5Q%FIT,G1L,62PNY$(ZGA4Z]_I+&N3=Z/I
M.G5J204FF%K(/D[US&Q1DOE6D*_-]46R@,6H@3:I;5IV-8=XQ0KH<C1SNK'B
M;V"PD6GRX_2.Q@6$$I/@3UUNH]5=WAP+^@SYPJS#'S-@T_:GE-/=>$U2_^FS
M8\(A\-Q")UZ4G.2$)Y;SM">F:XM'9[<#L6%$QF?]"E%F1)>K:QK=$V&1%.!@
M(I6LO@'KN%VVOIU&0;+W5K*FTAM.NOAUYN;DB;@X<B6KUHI&O34CXRU6*%.^
M/GN]/Q-K$E,L[C!=>R1)B@6%-FEVWF9.9P=56H"7,\NW59&*I:>I.G[\2-BN
M\-O1-<,]EY$+/9KV%OQ-S@S_R9?)R<[\[R\PA91A"LZ!&,T@U^K5O^<SZ=[W
MN1$!3MEO.V=+^+ <G/&NM?-=(^,1(7P65C0S1$8H,6@,4A,#RN,C.8-R(0H>
M4I9O;"\Y(YRKXR;$!-X/F!+S=0HS-/2$-":LT>>01^]'JM59Y*#'^5@EQ+L!
M71FONSH)#X0JRG9/@&'=AJ.CEL\V_%C^N'Z-;$/JF^"R0S$?]G,#^<#RF5OJ
MY)[6?%#^EOJFOEF^(%#3J"<I=]0]6K!\),,X3&?/J6&[YO;$*M0@L]$ 38*^
M#T>JXY9F)%%84FX$I5C1D 99+)ISP.M:98\M-95)M+N%Q1DS/;U-:'Y3/VO0
MP?8CCOP%86GV2D^SO#8"!)@FOQ#+_LJTP.DQG/X+XO:XG!T_HUC)_3@31]QZ
MP-V,YD3%B)L'/2^2_DM-B+5?2]F#&V.=[[0_R_R#O5?F[XU"U>XH=J2+.4-E
MDC59Y"US@!71_>3+)4[)^/1R0IKRNFMMA@(RG;7^3(&]EVM+UVE8Y=HV\9SL
MT;O\5MO)=>.,DG(E)!O8)@SSQ1^5OHZUW<@0')!(@>9XKT'A_K4@IK?=$R%'
M3:S71%2(<:?:YKEC-I6--KI 89!XD_0]"[:J\_>3D-9B<.VMVP)/>N=8\SD>
M1X%1X'AZ"P)N^)>9Z)U^W-MB@DQ#X,)[&Z@;,9HK'^4J,;Y#C)7_,9I>36UA
M6UMW.TQ8+]R;1KQ<-IN=;8,W[NS(8_)6B5C2ZHJ(F(@O4)_"F4/'RJ_1,@X-
M;Y1MQAD8F#)FP7'^8VSS[0Q7Z6>/$(/9Q,_A_8CY:P?&)I8' :OY=M@B=&7C
M^9FM&XZ9W:#J/6YTL.KJ%$2.7NAMA-"&H]X8-!2 *9WU3&*A0F07T?7$?N/6
MR3<^[?2:UAXY/[%,[?"F65YC:UX,-QMLBM$LR'HS/DS0C)-2C"1S+\JRP.4Q
M72Z)Z\WVNO6>/_4$(WTCI12-78Z%W\L5"B6U;&V-T1%@V[E0VA48G!99$(&U
MY'V<N+O[#UVH9;XWSFX<CATBK,Q)*51 8F@F3WIC("9O1O Y]D-!'/_F+P^"
M7"RVDFR<H^:%EJ:K)BF!Y4\7>AO]#CR]P\4FLE>3J%*LR>/X8P#%.%^+;?1H
M/>3H<8HY_%88,8KVZ/1>O9M.HXQ91B:V*])F[[(O6^TEVT5Q1)+7(*V#"US^
MP 6?[071EK]PV2,H[()87-DQ[[HSQD1XP=;B3J]R):C7(KUMO8*\MJE2[WY2
M$+LE"1)#-4/@Z27X)LKL1YM9:IU\CED%["2&R7Y6T7E1-'Z$@7YE.4.)K88H
MPR6WF#Y+W)KV\H)L<;\S^7&5./8+70PP1ES^2WWNOE@<V6UI5W,YW>PPE-C
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M>18JMUT='_W.UQWR*&7IF=+T/A&M64GM E4HL[[QWMY(=>U&AS%%=;635-'
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MUHX>;_.JX0LKO6#M$DD.>:97#H3E^_@\Z53>RJEC'S\'BE[^I^.S*1V]%\>
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MZ?)>#_3P[LDFUM@^\ZF4&8TY\[5/L3PBCU>^%':;]WOF/P!02P,$%     @
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M.TUF/(A*ZM,?E.6#08;P,R^B=-@A3(9/8'\=5Y1,<>MX(Q0LZA\0\$>F_E9
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M:U=S ;2'W)(1(%GDD3^AP^'*,A 5=(Z8%UK_!/(+\B_Q \*>IOO?2XV,.XP
MY:8%?T?>NK)E!A6M%$P8F (JT<KW6>;Q('O:&Y:EKW/$S#'E7S\#R;\C=1T
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MZ>Y80LQ;;9J%H#K6DIK3IN[YAB<E:*O\Q_-WCX.](A\TW-X^4OYE%_2E!Q*
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M&!:%<M:+HW24N 0R;]M&KV!F6_96SN7=VULJV#9EUY913,\'I"XUJ\FC1IZ
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M.^MECE _+"ZD4O;05_/$!$;M *[<S[FN4U#EQHT7_=*8X,U53KK+2B;8?E=
MZ:7MC'6KE>*B"\72E'2'C\XS#S>AH+B1/Z^MM1AE+Y*4U)@?=V2.WR]#-O)$
MSB=6SF<,8SZ?3.5D'1BA%PN9(.>4L,66 G\9:J"^5XY,;8'*N4I:QVKDU(2Z
MB8U _]O(%V+XM[2NMJ$'%<BF,(&9;&G";I=XW/T&L=^R";()XS$E<B*/GEN
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M![S@$ZQ.SAZM+9@\/:S>[XO7'/@VQ["H50)KTG&[#3"JR.8>8.#^9SH6M5P
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MHM!>IPKWPMC%UQP_1G>\D<L+HIO$0+[6/<#S-=A^C@&%7S]Y3&B5RTGD/;Y
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MY4[K+\H;Y7EP8U?JWPL?!#_JP6^NX#FIQ?@C:R[4XDQA_2SY9W/?]\^'V)+
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M#A _?S3)?='-E/+4$J7&_>H(E2)-1XN1)\W3L[6ELB_0 V1)3O-;&V7JF\=
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MO TOEE-J1$]3\1G$]*,*&3TF=7GOJ8*1_:-]+IY!&U@L6)"N;#?1V:$9#,U
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M;X_?--<N*+9[UAFCQ9*SC@+T)X<*,A3B'FO+9-+-2?X)5^U<M*"UYH+?-O:
ME("RN5]6,:WNB3"*NQ[__7J1%O[Q&U(BZ>66]-0R^\X'WQN:CMG2.-YN)3^;
M=)5Q6CK+TWZJ-J$T565JW#5@/+7B>LD7;"*3FWQLUE^4/(E8@D<SLH;'<Y'9
M4@:RO@.[EY":\>7S#S&U!4A?VJ56B:]D$PGU#2P!P^]VG=&Q5D_&Z]$[2%?B
ME1YMKD#-]'QBUA8BW.8F ?U@Q@V2<U8ZAYQ,:_; KX:G0ETJ+!KDS-^9$Z?
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ME8>>,KGDOK%Z^ ?/KQ$&]#Q-]>[8QU"9>(IX6'0;A$^9QCT2?GSSLZOJ3R_
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MYW(,F14.LNU7S?ALY!YZ&SRTCWMN;:J1,>G*5CZ6E-I L&!/RYZ45BGRS.7
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M3/8CWY:Y6PT$[ $*6L2A'-'3N\.0$6+?G]-_K5W&&F817#&>\PD63T1Q*WL
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M0-Z?)BCA3_P;K1V91?G85Q-JLT::J8/;A93GP4\9Q#KD1?S1(=\?T$CWNWN
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MEYO[,IU:I\<S$J]NPRJM]W/#)IGYT?QWJ&#25Q B#V47&!2S2QQ%"EV\Z,R
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MG=V'=8+,61WJ](1%AB9BI\K*99>"!EZB1B,+*Z2.F!(\2CV*? $WAVU1:K&
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M=T[J\2XI9 .>"BK]P73\I6D_QOL^ 0-X,O1DT+@V_&Q*Q9[;1PQ@A&)U\I%
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M(,#_8; D\];HIU1HIU^-U*EZAKN(KO=JZX:]XYDFMR\?[75F1A+('@H5>&P
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M]0E0Z7[[X$8H-3Z8V!"@3R*^+3\US90Z*ZV2$0WYIY45EYG>L4'KS ]#R4.
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M)F  64II0I;:)W356>W',):Z@*M#0[*R -XL5E&!TPIT=:.P'  )T<^VG]H
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MJ L%LUAJ8>)BL]0(#+9>(D%X\ODE2O?N!&#XV_4&&0_9"2=R ?<UQI6)P3H
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M\ZU&9XO&\HCT>L0COWM)(OD1Z^#0A,9"0LZ>PG1K T1TIS/2"DTGVB3M2*4
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M<3!,KJXGW1;.T%AOP)($-.SG_XJ<Q0"6@M7BAE5J KF6J,H6,RAVH:LG-X]
MG(M)\*A?FJ\[5.#'Z\2 6*EVLNLH$8NJ@''=S1G3QH?/E,EPP+ [PQ3%6RN@
M/E#)8*@^*(2LCU1.U&1PF5$XX#[VI1M$M%9@?\ZVQ!?A=&5@C2JK7T>K#W1U
M,^E6OT08-24&Y(XT6*L)#_F,W63;*$L4$N)A!2FFW5QF&-3-X35J4B"XWYW
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MAX;K,JK%^U<+J$RP>*X(?PBP?<#.<4R6H/$Z=QD/HRMIKJ1"=A) B3KWVJG
M[$4?C>Q)@O:5#[,08=P8+1Q]#AX+.5OK489+*:Y!VQ.:&3(Y,.8QMKH:Y7@>
MO42K0;:Q1A!M"9P1T%.@QY*N "-&X<-4!WAT;X?4 7.8;O\P@%V$&0ST& <!
M-P(O\<ZVJX7 MJI[[>Q9&N137!8&KM0ZWABQW>J-S$$)6ERNE5H?;%M$/E".
M]2CUJ$P87 Y7S*LCR;2),QP57+%$S>\'-JD9&M[R8F!\ ._$@08J_0F2A"VH
MW&&"]1Q*0&<EY,Z@ =.HG5;]K[V:_E^!R6 Y^.;_*@=_=>I3GX&^8N!?P_Z:
M<>/0+6HO*OR GO<NJ?)_[A-^A,]"U,?XWYN8",0EWLA4\DPG:Z;%^P_^-,_)
M76^1%P.[##MV/3GV9L6G[.>>^]XB=V^^*7OR%KG\[;M)&_H=7_[W= W+"]V1
MA@7MYI__:EMU/F?V/8DL$VN-%UT=*P^0* +T--P.9YA;^*:=3OZ[U*T04-0@
M5"\"(M>9W!%_QJ%$157J2N^)4@JC=8[4:*5H&$"JI;*4WJ0UG%%O$9]YN-<S
MW@@&=2%9W"C>LIWL PJZ.X$+X7J@L+'BL8"&9^$Y))SA#O3'TI[7PTM5,BC?
M66(.)30J)\;'-ZH%5#;-@HW77P;Z=UL3CC,H%XO-RPR! JJ08Y+K/-I@+3?/
MW2U=.>:(\"/-5AE"+P&^FI+ ,71PW-F:BN""#*7_ZZ5$]4YSC@J1H[V$ \&N
M\PVMB'?B*N(MTARO0K)(&\.;,[)&VZBF(U@X;K^&I&EXV%(!5=3'.FN<I*8$
M!45,5;.1&)4[$PEB!K!(._)R#>L.'FFE>@&VU55H!VN41(5$1:I?PP%^LY<
M (@EH%J84VHWZ6C!)2H _F\+&XX0 BXR=< DQL(9E$ODNC:PJB'63L8K0EM'
M"4M"'3L1=MU$&#S-P2*M$BUD9$T:2>0K ?68^&M^1Y+.#;@IA!>+ C0F=VT'
M-]3! R"FPL.5D*5)"C2BB/@&Y5A61H7<GT\]!7:/AM(E<O3:1!5@++SW]TLD
MW)K=NM9@Z108.YHC#] M6N=:27"I]VB[RF8+MNKU8?WB+-Q^*;B-;^B,C0"P
M[B[K2$Y1/3*G/G*_7>QWOZ:4E:D/D&@3-##0:]XN8M/&0,F<Y6TGM'@'/H27
M14["&)1^]2'6.O+4B%;VEZWC667+5H^O#58/;VLH&JIA +ORG +_'9:P<3PW
MNES+&::1R$/YXU;/KF<U2.^U-93]!!PD/0+L3C$N4V(,6:*&$P1W<77H=K"2
MPKT#^N7 I-VF8R4750Q] #=&P^CDC# MW<9JJJ.TQO.GDX67P<*PV#$'W8."
M\84ZMZDEAZ4=G,NV;O4A-/]*?60IB^B+$_*P'!4GLH $;Q,N;74U26L"IOA^
M;]SUUA#@(V!TG:IBM !%B+,/R7$JN)J-+'1^J3SX+L^;BIRW=1/:YNX"<;LF
MMZVQX"/-HK'!99\.^$N!Y+XR:^NNULIGN7<GQ/\A[8R#>63@OA&G))//T+GK
M9=[!4@J60XJ;!&%<]").$U'N991*J_DQ^Y!K  Q<)P\.B\L%>/42?',M[M)'
M)C-2Y1$7([)O-V_9;@UH39Q:$5VSN["FDA!+1XGZC,^6L"[%5*![+3%[]D!D
MKI52"(IF):%++_JL(QZ"]\]Y]#Q Q2_$D'=$,P$I0,5;Z.$XP@X"+P]4>9\2
MT/$*.: 1(@QX@<H&+<<#=VD.,XK59&90H(.,-5+;$IFQ3@Z&JON DH5L$P0<
M2ZI%"Y<BN6(\.];QWIPOZ##OT 0>*M/ TDIOK]$(26W2*O60-#*L5I.$[[\H
M3"#:&HP7Q^A7E4UDL.-_&CK4*/[ '"48H, LGQ)++20V&ZDV/ MLFW=+-)[3
M!H<X"2CQ"7RPU8-J*PD'E&5\DH1/U.R^+<'H1?2QIT88ZV-*QQ]M_L.WALE$
MTO/-?H36'-$2-.?T[312)8_&AW@'\[WY\^I&/=(H(HY(LJQ4=M <M!#J+V"!
MJ]0.=V1^43\,@2,.; FK][P8"(0^$%7GSQ G6V;;-DK]B$Z[$RAG7%M22JV?
M0>(Q8ZF\O>KF^!^E?O>[>;/UDB(FE1XC?MZV'TCE9S4JOATA\DL5_G7(5?W5
M=T4**< 8+!;0ZO3&<IAN235T<H;Q6X&B(HI D3562@'N50ODAN/5&1)IZC,6
M<ZB:7!L"/0&,E=24PR2,6*.%I K:36!@_>LH.'&N-=0!3 2=00GC'6L-(;N4
MOE 0#NH\[MG*"XE*!@4/Q_ULV6 )@?E-+<\SS=(-><:=F;M1@G#A51=AQ -8
M9"2F5S86GA=09\K RDM2=!["Y!FPDH-AH &G).J%Q]WH42)HH=H/?@.(F8)%
M9OY1JT B 9II09AH?FFP<DRIG(DB!TU>O!2=>T<LUF]K5T[D9_9G_F'LT[F9
M1"/ WV7@=KG^1P;%;P"LN>M@WSVR%YK$H$!1G_Z5'0%?R@R+Y2/!TII*U;LZ
MBV!,JO-,UW1V;Q$66-TVBZ^1[CJW!Y4NV9UU6-A85JYM4*+LN9N-C =ZG9O>
M52"".;%C22CBW, .?IPK1P*B6Z?T) ]+@*&FV2HY$LJ'2A#+1_.5$\^2-@K@
ME? M% C6/;@S6;;R@][1$N5:,S ^ZO#_JF3:]?VB!1:!W?.:["VR=]>]@,GM
MYQYL&-NW2[D@9^3%;YK)77<O+S#LR/N?R:WYVRN+0P&=*];]8"O7NF92_?\@
MP?2__<%-8@8ETE9> D"Q'2!PJM>25X O%;TV%DW8M4_[EV^R8<?N)R<AOAGX
M8]^!E^\=X?TY[.ZRUPTGC@:+YR^$^:M$"&X6,([]$C*8V!JVH''&K?U7)NS+
M4#',Z_*"F$%3_*&+K#!XDWG=0.< ^A#_#G2ZFV^0(*GZR]*YI 69[;68YZ^*
M92$D\,K.6!U-$?EN_->U7-'7FQ+U+,37 'B\@.IK2(7TJ5_G:</Z?[ ""J@6
MT,YXQ0"3S1G:4&+H35S#&>(A[0#4$.DDU$XY@NI((6>$Q]XX+)LS%%B]2BX2
MY)91:,_4T>1,V D5FN8H"9)2;3YGT'ETJ3<; )"!]@@P-!A11SJ-ZDT)_'E2
M2G:L4XXBCU1R(*D)*JA5-+0P@:]SDZ5(,&"PA#R@ZI[B'%N=SD-D\6XO!81Y
M$:':9K*Z;<=3\'XUX-,4LW_SE&[.R!YA%?&7?8]RPK&DCD4 C5 LI)8'/)0H
M7P^/Y^TG'+!&,M0I68]XE"J8[$8K+2_4QI>4 ).+NAK8ZH/+ >YOM8O >OH>
MI@/6M.47?<<BTDH#Y%6!! (#5>JA'%-(W#>M$] BR7[#-'$RD'37L3RJMK%B
M*F!!GBSB)EC622X"-+$X-H)OFLE;'>!7JY@AQI&70$K& LP!L9&3;X>)Q%HY
M,.Q1'B5'XETSVB@+#9Z !^K<65H^^$4PUZ\U\G S@S*D)<A%]KJ;^#$'O=<Z
M2LH:K40^N"PS\N">P]Z1*@[VT. OE2AH_@VEA@7S[?G D:H8HX1<=,B6?]KB
M#3?\C/35L[,35-S>I$QU?N211)-HU&B-/*9HP$@%!M!$@[M)V.KTM$][W:QV
M]05LBPALM&F$NHTL4"'9XB$FP84NL%H=\;\<]D;\NHIL^\1^5BJ=3ZQ;JD9^
M;8IUPNEM,W^I]<B#90$="<4)G"$$7;)!0&DL-)8<@3$H%0]9M(G#8D^UTI[$
MVG@Q(BLM1Q.6!,\J.J*V6^&!3-%>E=2@<^],:-1R:1-B93&E8"7/JHA>XABY
ME]SMC?;"69 L748)H)M::4>2OA4)=J2IP,;.$& ,G6>FL2V^4>FKIO/ US[7
M2-S!KP7$2T!OCRU$O6!+8N!GHH%OOV"E+&3EERB](#L&N@.=F:'%7XK\PX 2
MA^#D/$M\(K62;UHGHD"^^* 418XE&2VA7"12S?9CJ9$(4:9N0!^\Y\MP#%<[
MAXYN)$7UP5*DIG1JY<)% !.0@@#@E'3]NH7%\0TEE4"C"D0D&PG&MX@EQ;E6
MMSWEQ7 67RVKD./AC"3%7S$H$?L9TUF3B-4DQ7V.(NI=/:AA IF1-]=*'2RW
MY4EXDM4!L "VZ._R5CD+UM5JS:V).L\^@S$$*(+?=;Z9'ZY$Z1MEZU'DN0QG
MJ0649.-)B6*H$N 88Y?2VYY9ZP%>?Z/1]CM%_XPW#_>W#./TQ6@;*_GKNTI&
M==H),BQYE?W"(BP2R"K8*=[.<.4$@CT5\.M1XN>DN(X"X$@V4&4_5S($8$J^
M:Z,-DI%@V6-4B6W%' \N"N4YD*4%8 J6+*H0OOVS!WO;P9W3!(1S=7@%^%.E
M"%S&W %\;=!L,=Z/J L7 UX O!FP YW$+V5!K % &V!.C^/E@6W9Q 5OIN'-
M E;J4HL_CDLI37QF*&94>A@?:B2+&*-\]1T\]]GIN_>H<FW9"1POX W50R1X
M3X(F$7"BKC(I"^"AC3BF! JBQ&#)"R <)55A'.^.6,?V=*T&MIH%UF[V9H-^
M(F-0%CC#&@H):-.J&"C8?J3)C-=4L)!,?>="F-P&M\@&5!?.)$5AF(*2!/@%
MDJ^,@/%@77IY*>!2)%AX*[4/_;Q*#=YD2&JI/)Z+A*LD/&1CIOJX_1J#LMVV
M%\Y(_%H$Q)@SXL>MP *YXLX7M5PD1BU.+5>B]2QR-7G'2OU[VFFTP0$(+/C'
M(44\WJ5@O(,0!NN<$?@"6"D-5"12E:B2((*(!#(/VD.-!-;8P.05$A3JG 58
MZ<_Z>7A$?#%G!(TEK^8SD<C*QE(@'8.'A_L(K2OH7EG,!P39S#!,E"(="6<<
M:E&?;DAW:GZUE)+,HJ@D$%(7F\^A!')0/R-!,T= DW8^7CA!G&.E?2=LUQ #
MW9RA  ?R[+?!YNY-AOT".$ 9Z"6 *S<4 </;)!VLZ\Y?A0'C?0&[ )P-7%D!
M$FT MKA*C5S$EY+T%  SN6@X+^;SV^_*K7N6LD>>E?TQB%A.'3J>W#@?.7D5
M5EKC'\)*ZV_>?T%Y<V*D[N1)UK<P0K-J\X\_E?]>H_K^M/J^D51Q@+"J,"7Q
MGT[?_&]_K@&-]DHQ]OT-Q5>I?_ZT=[[F;@B^?$14R[=/>J:3WRQ^ 7 A\UC/
MXW$C^S^87_9T\N43I<M6!F)'IKPX-M@]^\WOELF#!_4WS+^E.RF!>:)Z+MIN
MWEX4 W,:(L0H[F; BH] T7_W[[;$'.*-9"$9)96[^2SDOL$HLL#.VHGO6@BD
M&'0T*8P4X#V+@#]"+(GS<#N%@WBBXHNO"1BUZQ$RXV$HL90_CP\>'YBYE[%Z
MF%;YTMS37K0?@.HHGGRV -!&V+K;SS[<]B06\HF[I)8SLLX!^(',9EXJ D*U
M+WFBJ]([UDC6#\X]7F:)@15*FEPK0ABUBR<!^.3*3L&8BC!IJLN%B&P2P%7"
M(=H3)NK<96L5)J$*X9IL2\6_(P!6*8(9%")?KY]K==MA,^>05BK)9@8!500V
M&^"#PS$"*GM8>WYU[F =VGH4+,"P!&Z@@"JN,"QYO70 -N'PAC5R&+"(A%BB
M](!.:J<KI$9NTP'.R+<[8;EVJ'=H6U('9W1;DNRC)P*JK8Y:KO3"+/$:Y&_D
MA]24O1LP*Y;DPR;?KOS3^FB<N \\D $P3VY,N7)TKH@-HY^ 3+-SW]5\H\?:
M2^!-;VL4"(!-1)3$=[!N/M%$"JA,S*"'1>:1I#7,$L_KQ%V8 Q&M%C\![K^9
M,1B)[C]H@&-O8XKK*!9'GN$R'L89*9&LC\X5P"5!D6L[ :9=80F:H=## L#M
MF^O:*QN5=+M:M!M0=DMRQ^(1#&K(SN"V!+#N.+AB-Q8.H*9)F,#QEO%2P?L
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MR-![LM\KGM_K;UYAB"P:60-8.!+,Z.".1X%+EJ/KA ![=L2E5FHV1,%*]EH
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MI&U03FPO)"@)KCWQ []K96F$K4@H?WPM[#"8TT8(BX&6^',#17VUC],!8NL
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MNE!MJ'=(OP&*R6I;G0Z6)I@!DZBK!ILMQOK7.L!>S89%ZZ@&9BJY\P]Q1DB
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M.9@\>?R .*[S;.'P$S()_'D#UY/?&\V6 C80@8]5*$HF?DYA&("U;GC.T1G
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M"@]9$1F(!XBL (?^_[W <Q*8V!$^"S'%#?5D!K$!&K0RZK/>.@&L@?YW;7-
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MC9_R3T7!3,?REOW:XMP#SS\'R$"2DB<K,R"*\#C_ (!:0UC8 $@"D5D,->Y
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M_<Y<4'XHJZ#W$0JQD%_XM;= X NB&)2I62/ #&MMS@4U3T0)(Y(JOQ&P[FN
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MP,?\#8V'B%;19!LJ$5-0WFX\Y.(XD6?"T.1'?U":\F.0/>JN:'A#\D'2R.[
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M[#XWEA '<_$IKF/*#5P";@KE\Q9JLT9&LDH]@>5_8%CD2/G/T/T 9R>AQ6;
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M>H=Z3[!E=&FL/E-\_:%J#J;0)N4MCF$O0^XI8Q\&.X3FC.^)KA)=,:@+KHL
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MK,#.[LDM-IWN09SSAI**3XR#>-V[Q&]?L7XRS"8=FF6SB$J(_C>'I+"ADN&
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M=A01;$<CT&%*KX :%8C57W!P921\:D*[J;VI)&8Q?-&^$;ZCLH_CE<$X\_(
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M-N SFR^_!:428R:!'?S<9K#O'EGZ-+[E1ISD4%7%S6?<R(VGQ8*P<5[RZJM
MO65;6=:V3Y%Y?LU3O[ET0R0@B)4I%[AV=,K2*L"0GTS5GE\%L*%DCORQH"K;
M7WAJ%B[;?NM^HSSH-M4W.,$K\*E^V_@K49M7L%TA5_Y$]9,#W37VF?=-665I
MU16[/6Y5:OI:Q, ?Y>!CKUH0 SG'H5 +&#X7O3EA(Y;O\?Y'%Z3ZD_Y+M)%,
M]$29";!SVQ[&(VF)K^)2S(PX3[?XMM#5S PE-0]RY[VH_M-3$3Q]VK+'D+YI
MY976Z?:W>P,;M)O:V/-[C:NZ(?"^'RZ,FPUIB]7.$5,G>'"%Q?9'6.V)3;[-
M/L:_-G@*$@F[X2J[<P;53[S68').L1?"5?99E\1K7!4.U1@AJ(XXO:Y3V3.,
MZL)E/C+!GC SP4\G*(Y@"7HD_?0-%LZ)NRXC&6:/8F=D//M0G<9')!H4M#5&
M=,)WL=$R%LRK=[TA&-C5!-/'S()=?18;\5>WZD:14TKB PPNR2,41[0Q S+;
M-5I'$8+1EYZ.P+1ES$DZ8:<]F1>(L.G-K^/-XH>/LYH_JH%+KL&E[9/4&JU;
MG^@#V^1(Q]H>ED0V?]QK"PF_K[E/<V??4VN3S7@<9L<(-D9CG'WU7H01/O)M
M,/[JW4L&3"8'Q;X:O @+;GEA^< _@V2K\58CY)GQD7O%E".T[[2DS <'#$)1
M=IF*:8>JB+I-OLT?%"%C[ M1;[,>J9J:L$.R&[ /0) (6:@3'K6@#21?9ZA>
M4]Z :I"]XZYT,S1!W8P4G4IRZG4=:E#W5ASQ_WI'!I9 )CW\+=?,7"3Y.N3J
M5H@,ZFV\YM'JIS)72)'-)=&7%"@:3>P+I =\2%IQF0@#^8N*]<<]]6;6H9;@
M,]Q@@NLT-3[B<)R=@T] #PIZPABH3C/;#U+BUDWHL\E/J1_5<*!07A)]]J*>
MQL,9FB=5)/IR#*0?TFSV&#8MW@[I?<#VI&0^\!'WP-!UFTPX 8H<;&PD.;4P
MQ?1N+&YO+$J'E%2S;S\Z+ZLG?_DV>;%=)<<>,]G..VX=X$&ZR#FP(K$"\H ^
MCGQ5141^*MR-SYE#AY2'2KXF#:*E0#R_XX_V8OR3_LLD /)=GCX_HR4(IW:U
MK&P*$/L]]G'Y]]C'8+@^[^^52Z^XKX+6$BZ43PI7]EX67:H*AEL90%:!=T7R
M3?8$)\NJM 6IOD7Q\>S_1SL)18,9'BS;]@ !2B+,IG5G<,KH<4H'>MT9_ P_
M9D8/2"#,91&H-*'C+!;+2@BEK?C(+IX *'+$V42U8P/!>]>L!O$$69R@?@6[
MWUD74\AJ$O)90A^>8E$HZ>L+EZR+.)0.(PX0XU6P!YM,T$P*WNU^X4LHAI"N
ML/?NT9*X(W.%[N>Q3E;&T.2=5=5L^UO+3I/XMKZ$BQ\#<KN^+21+1F3CGG6Y
M71D@$<2M!^!ZR]9+\)3ZP:!].@:)%K5SUZ&54Q.K0'1[=\L-$8[=^WN6/;\%
M28PG\TY*U)6<L<Z\19,VX<)YTA.\U%5@BF/)=>M>/,-OWU4Y&=(1U*A *PH>
MYP=(VN87G3,6W?;U]9+!*M!2.6RQ"H3[-RX_!04;C^_@I#,<?\%C!"GY<C=W
M\&X>[,>,?_8"6Q>N/ X:[EX%Y&CRGT=_7F)ID/>+G@L_U%*S3-AC%3C:_B/'
M(=RX=<ND\;)Z^XH>+U&)]W'!A3O//_/$GJ_*7ORV#I8"G/%5P*8R$?[D<)*D
M_&-LUBOY%QD&QCP])PO&9 #C4\Q^^;# > \>4(3KV")15Y;UQF7S6;PL^#-S
M=&-^3F:/J<'VXOWS+E3-P!V5RS]6E,>D*V1H?4OYK =IFS"75MJ'[7>>./1X
MQX**@53AAP47ZFF/+B$MM6=J?;M:YP\$;6QYO__]^+"S\13F=80K06U+7PQR
M/,PU_-I-2Z)FKK7''K2:K<:"8+'FL[X9K:)HH%;QI8?8O;PA-F$G.BK&=))7
M1I"^]"G?<G(B6LXG"D11_BO"+49?9$8T-EDO?Y,M;5?P>$&+>&% FYR_1RT1
M%XH_5?XH_HO19M1-B6K#=H*\[Z)C5:#4$JI$[F5O&7U7J]9'79,!%RS$K%MS
MN+UKTY8\'WN] '*$_W+QDU^;AXU=8\_??_JM+2_IN9A4ZJ]*^5B9:Q[%=J<;
M#2<CM#":8X]W>74R;HJ&V7@B9SN%5K!-D;ZIJC<H$ZAQ0_?SFS>,FR$@?"SV
M;^+5U\J(:# !:]/8/XNX_T^G]7AM- E%"]Y* M'7>OIIK4=, G6#X68JA4H3
MO$ZE\)2PAE;L58!=  *RNZM 9@,HQ*I2>=2U('+)5< X9<C#W>_A.Z[]3S66
MYD#;G?FL4>?DJ6-!+0J+I&E'ZZ7&M^4WQJZ\8[N4(G./KS0CF5<>;BB,2XU%
M:8SI1;U/M[(+@XQMWPZQ0BF..&46$S3(1*S.;Y $IG7=GE+400WP6ZV8NM,:
M!$=U J:%J:8DIW39 +HOY@7*W>>7M@S?)O:M:"MY% =_W;HDVCJ*BE5#,A<,
M^;I_:ATHA5O7;9=AJVPZ/IN9( JRBBO1?=?1H::AAGV,G>3B_JP+#XO!PZR*
M5\@D_&=("^)6CPD>EYF@JHW/%$E%J%IOI&9"2O$_$B_)([%(%/OEQ>W;"2H0
M3/]O=Q&[&W2)3NF0%#Q"3V/!\ (TO4A#"%GCM+Y!L<6"'(T^_M"2UIL&_:[$
MDJ(.P;)(.L=[<S$YA]0LY7TB@+91PP9(KEG"\1!P"HUMWWJ?A#W.O)+PX$LS
M"<T,P?5O/]33EFI:F!1M-2 ;:HHFT)XWUUF$&ETU*TP0QSI1-]9 !F@MUK^4
M#[.;S1#!6*0VNOET<2>3H/&2G P%1)*(L!^14'*\]\Z,RW@)#71SG=!E,S.S
MHJYH]/V$%@O:>&9"RCTS9A,YU2SAA \)BX5]N@[.WV2HL,(ZEF?6:? UI%N;
MF24(::24#\O$I08'0*P1M_I,*0VJ'%1%JZ%T%IJ0A08H'68(N]ON$'5KE.9A
MA#0IT1N^*>C;ONU+K74CMJW+FB"C37"Q=GIN] Q^(A (JBV3/^9B1%RH_RJZ
M[/=Z1G(&-^SL/Z]+!I<)JS^-??_$]&^-?4_^L;'/:\W8MS+2Q15:!?;<A7=)
MAOU]$*65Z/ J4!6S(-4+8J[<>W\S_/W7^Y; _,?*.1,VTTI(J_EY&@)0AV"&
MTD6\J1P8VTJ0L):E@KGV(T5@G!_DW!^#/)7)XD<::\6L);/F?Z:+%R61KQVU
M5\F^<<V\MC_O8R;.-EOH8UJ51]I+E(M87L^/P,0A@GO%K90YS1EZ\9/+HSVV
MOVPI*KBA72LA/OXB38Q3D?_#1E7-V78*4^UJ59 @_/%8'NGJL_=VC^]\*ZJ)
MD2C3_K%<WN@^[>>H=2\:$1 _Y=?CQYP^$O%RW$5GE"=%T#(6OASC/@>M&[R#
M??@66FW'"UT%Y,5FG^#/?MXCF9^IG7PXS7?HD6<TSBPQ#>6_NV/@1)K[DO*K
MO?+/:Q]=RP\-E./>NX@]6JAKSS+8RJ7*/5E_M.G(;+X25='OFGOF4.KYT[\\
M<J7>="$>W'LO99V=%GWJ"FS/O@8Y?8\/_J@IF&+W/3CVV]R!L1NWKQ5AJ\2>
ME9:[#RW&O:L/;[@AV?Y&6%M^5&^QW>-KH]2&E_>]&N!G61 /I\7K59LJS_MM
MOE59BIWRNG,E@+I/W^/+-1.3>X&)#=!/0]&T9TL%<N;U-2>>?J?;0^_+J)N:
M8C<FH-D>9B:BS>;D8'G$82(0H$F'I@NFH9R9(\!Y'3SX'E\@M,#-_YZUF09;
MH]R1X&$(2<,_>G;\23_I,!%*/ZW40L^UR "%-DG#_5-H5I"DRF[U6?E9%1<#
M?U">B+E9P4]3\Q?G,;XP%[#)R^S*K_YJ4X:K (V/, HK1S?Y&M?(<Y>31YT]
M/'@OIO*Q>COC-.V_$['G(1_NG,.$VERS$AJB89*"M]!O46A;S$65,3FJ^%'$
M*V^P'Z^@%%KS)7%;*A9[74"6JO6(S;$78#,3F$ ;A>J^G0$H0!9A7]8Y)S#K
M;"E"V3\UZ:I"V+!1"XIGPG=!<"3>EZ 5**Q)GDZB%R*)! BP"$O(-7RB&^\-
MX0A6#U'(#T+HS FD%0QRBWC=/8H.C, 2P(%JQ!^I,+NX1-R.$2BMX+!O-/FA
MA4CPZ4Z8*!;#2C'_A7%LEI+E0]E(@(Y W9VF4<%,-)JU01B"@18[!$#J_OJ9
MK!%E/4"\OF%SIQ$^JBV,+JUP.-6D$R=@%TYK-A3790VD@(^\'_PM06G0BJ4'
MK[ YAOS[ETHBL1.<1$,;]/:2J>_)7_4T,#"VDS E@\X$67R=-R"=Z7VH2:P!
MT*&G8Y*2(2""YT %L/>MD>7XX!$H^3XXM6SX5CFKMSO!J;7]5ZC&B/*I)FF9
M^Z.G+*LM%\00LWFNZ(E3QC]_/_F5J16R*+]FUBJ31RZJ5ES[J861H/)-7/-Z
M9T'6?S+ACQZ8?])_G?YX/Y__<X*)@4(K28:?AQCMF;[.711K,*O* ?B"[38-
M3TJ'23T:8-EYTJEY&=)H]5C[S^Z('9(FX7F-:8%*_GKW&.>#E(NH_@>G[E1/
M#1=M XI?:RY>GCJL29#[J,/QF(Z?"[]E6>!T$<-NIQ[W.5K';DR:%=NBNL.M
M7&K^O:P0J;9MS\LEQQY'AO6/O.(%;/E=E,ED#H+F:Y#6V^QV2UX^RJO#W];O
M$I B'W7C0])\R@V[G"A"0&FF;3&">#A.O\LR OVA>+H26U?&#5&H2NMRF\I7
M*"HJE??SQM7NS+"XBAFSTF7IGEP^#RN6AP=A9[MO\Q3\(K)# GD%T[=C*Q\;
M%(RYK/],+HG87XY XO?1HNROSKCU;)J,XVRUI 8(4T>V_*H<IVO_/FV#]VL/
MM\V.!;Y/IYK"1.1G\P6?OS (C\R+N4A 2SI]E[0M>/!B/NS&A[1?*EQFTQA6
M\;T2#3'JE8S+7\;N3:B-/'O?1'RV<W3_"6>US!M-7TPJX:/.]S)&@O"V.CFR
MQI:(7Y;K28'=[JDFTF86'>-F19PGZ\BIA5%, 5EO"EUKB>^ ^ HW:@%*(*>8
MN_=E61=QB )A$!D4^[U<O)EYIT7GL1/9?RU=ZCFB;06P$R+9L'0Q*+A5Y#%3
M!7RE-7^J)/X'T$8R4<E!G,DO560(KB%68LLVS+0:,Q-QF>3%I$5[<.FH[.OR
MRLA/GSTXJS*3GV9PB,\_ND\XMGRY)[_!W\IEYGT@K:RM?87@ZU8C\+L+>4Q7
M>ZY<M(Z,#3JL-_)L]H=3Y'B"+)T-5"/T"'MVI ,R6(*>-Z#(T97QUBQI$H@_
MWB2"OTP$L.=51Y  K!Y%;0"4K]%8WRGIHIAAIKJ5H+8O8O08'P_HIL2#$G.Z
ML.#]*592;#;P/E,QC@@XD:Q169L3 &84ZQ9>VTJ0KXI&,U0Y!N. *%4KV5L!
M@&8IM2@ACEH)F8RBLM1H30((_M#=B/7PSM1(6']IV#+[-;5SPG!S)XK2:30"
M;!($S^K3? SB24U?SPG3.#R-S 4?5RFNPU",GWGX#G)]AJ]5)RR8P^?#6FF%
MI'I#\7+8S&ND3+"<*1&+8@-1IDB<D :(8YR9/YA-4(%7%Y()@K=P.]JP '6_
MQF;F>N]#+<,)8#>!"\G?FP!?#/XZVDJ(+H'5QIQ\F2ZJ(GR#8I?EI@$T,)GC
M3 X?J1"!R\,H2H,*H(>C@$MANO#.6>HK"M8;!'.GF(1T(<(>YX1QMG<-L'<V
MR[HPI21X:R)" :H!%*>S/*E+;. +ZUMS85SP3F8Y72JYP$I- FG>0B]UWW%_
M!%9*1QP7T<=11*):BXY)^R;[CAC(!+TS.LBXLKCV>Q5XASS(.*..D\]8!5ZL
M LM^QV;RR:.#EI_YRO[T1?MF[_[&JX5[01SR\-C_ &^//^F?U4OF_Y1@3V!L
M*R'#+&M30Q$0X2L9VF:A550TP)O# +0"W=@<0U=T.&7O?2'#G=U1A$VS$;MG
M\F,-E)>5XAU(Z'T?KW(JVEX6;-_ C&R'!WPM/NB0%"E?5;)/>6?KGJO3<*N5
MU(&DGIC[OHNVYU<>#;Q;>;V<._-@^>"+"XUQE8E'_%6?KP*/E1?L'G>^&5S,
M21H<A+B\\&>L JJ#/W*2NU^4)8V8AL[DMT #I3]!!S3EP\YP,WNH<9S2 T@C
M?67R$9I9E;)\DNXJ4%7(:GTAI3;N?/T)'G[FPHZ:@(ZIJU6_G'Q2:B515:''
M#<6I#"8(C#I'Z2[7QF-C8/U7#SE&^K73_34>&1^]4/:X#^Z^[%$ZZ9DQ9W3<
M0AEO]G 'ICGM'/>@TR\<XVE7XK!J&=(//NIB@#,XXNCAO>O"D5F&"]=!;)]$
M5V#!MS;:YQ$,H\Y/=[1Q]Q([@F["VGS5V2N32_<\I-U^GMJE4GU0<P"9<F^(
MQ?C0B)Q,94<IG6LOY2+>1ZD[2W\=JC8)+V^OBBC8FJ%UO=RZFQ-0]\R685FG
MU'#R ?H<&ESBGD/?\84A<BRX@$(!Q7AO33I30$41EMX2:B5(:)"%=61W&H:/
MSU$[+,C!OUSFFS7X+_;W1'<[[(*9BU !&.X/2/[[)_U#DD9 ;)Y*XMFM65;!
MX)M*W\:EX^'$),K&%>,5L_;&M!U!?T40J'^+(%@@@MCH;P4?CEM!W:3F+U8[
M)_YT("%-F[G,5D;Y-G_JB\TIA[IOIVZRN:"5BJ)V&FX&YS")#2200;E=X!.M
MP*0<%F6XGOF2QLK' EK_+JO@X7AOG1Q=(-E[#P7LIS#(M8NL8U'D8+F2^ DT
M)N&RH1@1>16#$_ A.;%:'!F O&\44P6F 7!0[%T)'"!!&Q*%<DY@ NAQ#17=
M8&F+3O!82!,,FBYZ;NT\VR$$#283^&!MX4Y8$[]4H1R\75*P+"N*_:1 >M1P
M,Q7KSFH"Q_O/SK$PPXRV8(B,&#CZA2$/(4Q@T0-#9QB*(84W6*2+?*=0.XR@
M FH66*FD8'%/#G@C#RD::"L!4-R'&6,![\-IYAI ?T8V5B98UJPP;!0\!F.)
M]?.FG0T6'K7$>A["U[<%RZ%>KZ59Q$OC9ZS6^>'Q;U/68)XX\ZLZ"NO;)%"8
M8NF9*&LEB$DNT (?X;AYC0H$X*@A=' "6B0K-2/\!BO!;Q@<.4Z@WLR$69 N
M1D*Q-8U//I6WP!)T[S]@6B-<0(#PT[B@L+WM)0%9DA9>^6-KQ*B#C5;XX%#0
MV"JP"NQJ"E >*EEHF0L")5*<0>+,J9OQ7\;O@D=?L/H?X*/P)_VW^';@_R/?
MCK^##%"AF57@KZFKWRS#5H%83WAZ'N?_NV6+;SU(P!02M8A) ).9P-P-;LU>
MBU2JD<7C8?RDHP0]#2"%?O2UR0<U:T^*,.GME#JAI6,8.W2%_/RH>>D3!S_;
M#/V8V$ M"\D+RQX]^?>2S>;H%;2*(6Y[ENGA!J9O>W7:UF6]RPH?BC'L]@RD
M<=1=X\@OI[(X03*?6F8M?Q7<=*&QQZ\2KB?+<(PY7AP6>'YON;M/[#>-%FWC
M>UV:@,[RB-]!2!TKYA'/^T.#>_.D>X#6EX572VT?23B=,3^74&^ZXKF%*+_D
MVS2\?UE[HX'8FXL/\P,F"=_<]TGG*Y7_&KVLC[+TG;0QACGW]%R^?<Q9_JO?
M&\(#S>_.VT_7/<A71'Y8W%$W])U@##+G8QY5Q&=H-5# ,0*E=641#OY=EB=-
MW4IJTR=*-^D>B223^,82H89-0]2+.['0(8A7.M2!1+MD@IJ8)86S5MH6MC9*
MZJ#DU%?@>H6T'?TSS/Q_$ DD6"/,!.Q245AO*SY#^%W.1XL$4GGTBL3IP;?R
MW'E^@1S]WYDV7^Q_6T1]N=5@.Q<4^N1_9]+=;\N5_QHULPJ,PF5F^Y[5[CL9
M.$2EP88M:1?VV;@QS% =AH*L(B125 -(P-RE-0D-D4F^34+9%"P4H#4C !U?
M*_9#RII^2!3DO=(:"4"N!8VA&RP.@_&K)612M>X70@7>/C0:\08@3)"CN7M@
M2''!TI:9N"PK(1Q5'P\%;\:<^CY]'3G52!C88&9J!C*Z\'C%X*V/F#E,RME@
MF4X8DV$*;AP!V7/_N"$D%2HPAC#R!87A=,%'Y=!7Z5.&0M=HK($X\*H="%D$
MH!5+YT+.!N_+0H__[)M@(@Z+!7R$]U [S4'L07&7"D\7:4;"3-(%8^E/V#T?
MH0)0NB#K<),0C,VY-&RX8<V6"<WBXP>8(96:+E*@H(SFVS\8^CB!J+:XQU4@
M>-G,'#FOB@)T29VX]]0: &3#[L<,)6B8X4-0 :8UD@FHZ,93%5&  F0$W!)E
M^GMB<&C6:0R00<<S;,_^1B8J*UIADJD[($Q%11![.$0VF)5[R__.DP/^^GNI
M]?;<GUSY7YS^=;CRWXAOW#)?FX+W9Z@4$)3ST^*S!+6R25G*YN=S[PEE>B7E
MN#??G)2<H\\3:#K3L.WU&;V!!I,N<W'O?[@9M$ZW1QBL7WGN9F!T==SE<B=>
M[<O@I097IQM:8BD/VG\P,I5W%L"^<#=[?>[6\7JQ"O05O.9V]$C,'=WL_\B5
M4XE*>>739;K"FIG)3ZTPX*)E]72(;T5%"WR:&?1!=L:Y0!R7_ X_O['X[:;S
MPR\V?<Z+Z2U:-* >VGG%@\@:5"'.[[.^\ECNMQ9]^1-M!A_J/RJSEM7[#JHT
M>:UXO,XLQ;U[S5B1L/%^:.#:5C;RXV6YZ(6 ZLG&FD#_V$VSL_*WO!7B(#KY
M(8&2H^;/3R3-Y#/\)7HORST_OPI@IQ0+#$B1>3$9/>PM-E<Q<DC]2M^RU&5<
M=N4H'!O!VT9=!1ZG,5SI[:YME<SX)780;G]VOL(J</M;4*-E6PS78OO2K"Z1
M[QB"JUWI,9Z[I3UE'U<4#6[ULIPB-NR6!:_A&SDK>=^417%HI+H.;1^]D?O1
M(_,5]<+>8HS% (T#K=GY1$2)Y,/QED1J_1)A9DK"IO]\:90&0&4/[3MU'"V$
M#:.>S["+ **.D^RP@DU"=#S,/?@?JFPHG48X =Q?M\0%2Q%1;.;?AO?/XCA_
MO)#[KT;_F=".^2O_KPAE5[9JLRK\N=7@BC+]N_U?9<IX+<Z#Y!CT)-_L=W3@
MT: 2U&:?+Q=M*N/1A"E"*RV3B1>.?Z<T:%^F-@#2HV@5([V6UA(K(5)F5A+-
M2BB[1G'D5%7PQK-)\=ZRV4 '"L2;30)($5R'&2MX$Y.0N3>2"*"8NV#L-E X
MIFY"Z>.&#24Z35&=%NFB& =,V+H+P3N8XVQ")@%DI=A4<#_0H "Q.I3%/O,R
MJTF >,*"5B"X%5Q"A#O-3 N3@@5Q(K=@!N, ;!A%[30UE+#+\LY^G>69+I#T
MT%+%G-\*E(W3158XNJQ8$V% L=O]%',$Q0:8;=1T(D" E.(X(#+AAZP )U"=
MR ;3R":!DKAD@@+ -R5L3F "#ZB43&] Y7!J28KA!I*Z*0* E-*AZ4*$(RJ@
MM)]!W]%L:K@)O+9I2;!<213[%A$XQ4Y CVL GIG>"B##UYNP+@P#04-+*)H
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M0$LA7>_*) #:BL13?&R"%%;E (@,>N#X_JYTD5W,?G<?CJ>:X>8,NK;U?+8
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M9Y^]O^'II;5P;#8_E[=IB.[;U'^556$V67;>>]TJX%OQCBN[/ZDI$#)B<B
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M]2/QS7X)KW3K0DLGY>!-@(6]F':<=>UAR 1MW%Q:#5"2AN.VI7#!E#2G*3@
M,1)X"/.1WR(U_]4;B\?5<]S1WUW3RPXA!2!LU("*9##>,!,8?8,01H+*,JD
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M=!LW3OX5%P07%\W(<84V4R'42O0*/71=)XL3MV:U 9Q;W$RA7?HMA1;Y.\;
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M>6^UDH7\ 1;;'ZL7[85[$MW1W)#-.36'Y3I!<^TD^,4,4$*9$%;:I^"76*C
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M8^=ONKV+U^L*3E6+4!X[,-'ME@ZS"_UBV-3C9,>4=ZV8%B\Z<UR8KV?/#1K
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M_D@[%F",<CZ *MKXADS4CFX;8XZGP>O>*5?DD0*)5"H>NA%A];_HK0C$T;W
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M>D]^JD_&FMR2DI"BA]819I8QF$[]J1UH&A;LAKQ5WT10TO'8Q-%-)MC)(&,
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M?W9Q8I*AL9IZ]_P,E,XXA6<Q7$8=(J7O3N)K/$MW#? O/9MVK7L8C[!0??U
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MH7.77YH?ENOUAF9J4)#5.P1G\>ER62^:H.4T+P0*IXF:?J@/'GK:H8/T&0N
M*UV#@).Y40BI6UF1@5WNTHJ7.*N:B)^GJV-:[N6** ZN1+<<+GW-F!SA@_=Q
M(A6 (EAND5&!BWZ"ZL=)X@OZX!93/,U,H+NV( ZC?S.2I8</'&$O%> UAO1
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ME^1TB'I?Y]33YII*'WS)_<Z-<#=_2(=>R:?X]KSL(773.%EO76T *U$ 0-Q
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ML);J.^8UL>FD,?[H*U#H7^P'YH5K\FORZ*:38]7XI!;+@/E_$EC)$MU?9Z1
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ME!F+^^RSRS[X]CBQNC/OQ3?%<OU$"8G(]TO@0XY9L;I!E^O\$-1C%H3'%_<
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M83HAF118.RZ_1"L?M4=P!-T!^V[COY8J>UF[J@_+(C6=V,W-<DY<+_@HH+V
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M.LJDMY:/ <$[H036&/KX4=,(N,)=^/Y0>ONG:K7TEV;%1VYY2$7TBVIW7(1
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MUL*@E-'//CP?XX2?."XA[SQ,?16M_92@4[^_W$$Z_$X])TUWH[@H^A6NMOX
M8?T0[*Q1;G4/0A],E4O>'*0S 1J9"8#\PLS"5JF\!!)$:@-/ ;6":1M9,_"
MO2XMF@JL%<.?]?WK1VE<X(E1"NX^0IZ5=.U7TJX.%M#D,LT/>SN&7.-4(-;
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MI4T?SO)1/&;;I7FGG$]03$,JO/>PP&D0YC[2[15^5T9MW-=U2)^DJG>NL,\
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M4)G76/=_&"G^4R^A-W.!('A[$8*=Y5PU<[:<X#@%!Q9$0\5<[+:#CV:4MMU
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M8^@!)@_.K6UN>@KI-?4:*9.W^-0/.'N,P\2X';R/#J-#EAPN:D[KVH6DF%R
M>IV&1S47XC4R&VX#*C/N?/]<;.[?Y?\KDBP>(9"TQ<>Q+=ELBZ[QYE(1]NUS
MF;AP]S;]MG-5=6?N)R7[JU35*9:W*4JVJ:*@[CXA@5" 7=BI)\+OPJ ,,,SH
MR;F\A)G+'](!KJ]@K*ZD_3PVMB>/SSHM:IN >/*GE0)X0OZN0,N:+#T++@>^
MG&L2UB*EBD<7M8H6997,H3JG5&6N6WL(1XC6L_(66AI>S9J>*C4PQ[H\[RN
M0FV?G1/$J_NHK,O<]W8?-HF1N<_6ML?7Q!!N_^YU3ZQ1C,P>D3H5)=:X;;.X
M^ZE@>$Z_RTAG=TU69=IC):OMYQ$]%9.B'@+9'Z;!X!,>I9)GK)@ MQ(V22%C
M[NP5#SZK.;XR]M,%&%ZS?*6 KE4//\.6AWOM,*YY4'\5=G+)Y_Q"V_N!Z1YO
ML<]D/(#O73599N\+MZ5-/D+BU5+=][W>W''$A7QAVR.O(W$2*G.%C]P+<CG\
M]+1C /?9"__V+_NO"0[)!,1^1IIA B@/1E3]O;\)-9/#!/Y:>[B$8&5_F$^
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M5LV45;;0_B^/QZ_W7^,#UF4R\E3^^/</W(XR&9@_F&%^&FQ8M= GFV'4C;T
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MC^]&4!?F?EH&JKOTG7_HO(SO&3ZQ_]C^^2,O+FO>8=@^1M=W4//$\,I,QP&
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M=@K[3=0O2F.=SQC@.^(Z.VF+#+?;)QS_<?BGH[.#"6N \VA '4H12% !PB"
M//Y;!7"")TT,9H=W,!!24'P,/Y^ZL%5Z / W7@5??L!"VQ"3'$^,#D'Z=Z\J
MG%AZ+JND3FAJ/5^2YNBJ,^[BWI<]8C)R/6/%K1V\ID2QM]-2@ '_+XA+@M7B
M[16U2(42O>KN(V3YZMFUILXV!7#C.1J_"Y>%TGGXO=VT3R4>$,%ULSNK%C6-
M(XV18>0<4HQ<4<&>_<CO$NS1[>M.G<:K,-GQ(D^L _O^(=RB6' [=-:X:^;'
M%(C%(',ZGFA_  @PWI^S^!BF2;5T':@VF>Z]UOA^NO=LMF_OE=\E-*RV)<5
M4 NE-1[8H(93)QSUQ-J>6V)!2JN.]\\AY-J-SS=7&'O7L*!2=AAH^=?NG['5
M!X!#9UX*-9MLPE[8EW%R^QZP?0 @J "L&V+4[:)*HORX1E.WV?1D'/TM0*O&
MAF2BY=3?'&5.Q>]UL2*!;)/G*3/V1@:PSNAQ7_#77[RIEJ=\)E:%E[4#((=V
MCNZ71/FRN]L3N4*29@JB[$&_Y-EI,BRY=8BWTXW<Y05<BDK*\/1(5"2%A1G
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M@$%GP+.(^N>DE5E,,R$QGV(?XOP.M!A]9J)F?/)859'BTGV]&9O$D<>'&#\
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M(Q=\2A2FVT?N==_K[&)>;FRYRF& %%U3H9D%\ O Z"??S0J5-.8*?->+@O_
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MPP6\!%&AGZ2@%6Z\FEN_?<%/HO\G_+6$0>;]9TQ=+CTG66#J/7_&9BT7&'5
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M5)O<CX:^XPUZ CD#/-J%;/$I!R,I^/P^\6BY?:0UCCX*7,$!ALL>(O^X7B/
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M_^?6J7 (ZA2>@ !7;Z\:\T)*\0U5H<@*A] EJ]0#^E#PE:7$-7[[:$OUPW,
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MEM&%^^%@6_6YTI=Z;\H6NRE]#S7<1>!7-Q>2O&S%/.QH4BY]L)G()90E"!2
M>N"\JT,])S)H P*)VKCMT6W$D5L7<K QXM%P>6(9L:<?N[+=(9QLC4IRX-)\
MOR>KA\&+\&N*SP@M-/C;X/A;3A ?*KV8=[>#W\?X%:!#^GHMWQ%I<%^,9ITS
MOA6RN"3TY9XQ.X!MR\*72&D$N?FZQI5B=7YDC%*LW<,@S?:+T6>8+>WSJ=4Z
MATE*NO+];&>P\[.6Q/__NS+_C^C8?%>L8 7Q=.HOV9K#_@U,>9"@N*## \$@
M:YUJ7>[RY$PJ%R8]^TPJ:UU7ICH'Z:'^Q_4Z]7K/.AS*0]5021[2,(#GFH1F
M5A!0+=69";")(:F??SV3:0$B?&O/4]4!'B+B26Z95+JZMG&2@ W8Q5BN5''!
M\DSM2\N1&#U[LHD0R0I97SUCAR"J/&L]0+O(,[0+DTYE8O+'N(>(')=X0,;+
M[+>YX@.*-P9M0W(< >:8\N'U%YF7OOYDJN#4)M]5YAG*)R,)'-+(M'SZ5"OM
M<C(^!X?"%YF7)P4Z<P?&/X17ZX;VJKZPP%SQYU-FNNB/'"\%8'+)'5"DFU*6
M3N)+IIQ3F5,9IY[_2A.CXE"N?6F+J2[D8F+VO0]2F?HOQZ=DQ=3V7QH<<E>_
M:+Z<VT^^2IK%5_JL%&4Q,W^^-1=-IFOFF)H<FG;*();(EC05 3),^>0@#""A
M5IM04 ZH*\!T^P/X["<%.6*#N&)4YIX)K$B67%I.3/G/II6*%$R1FKT .0_V
MW,'E("ZU:EV7G$R*24%W3<1>[FU,/+Q5[9E5%;5@N39YF5IM;#PU0$:G-B9$
MRK?_<EH(.Y,($Z \OCQ2\6JU[G)*9;PV^>I51&X%@+. ]'Z+<L":PTM!DRQ'
MP%=IAV$.3#P@A:D\S9[DJY 0SM5(]6P$ .S!SN2<%42+*>_V + S6>MQI'($
MW>UE9QH7^-=D^I).;2AISE4ZM6F:4XHW=(<,OY$L'LXCB4O)5 E%NJRT.$5)
M0$UNHFS>Z^2>7L!#*1$)9UF2'"9]4C? G\]!G"0^QQ"YNEN92ELY4YHBFIG6
MW\LT-$T\_N.3%*(^F0A3N(;BU51-3/%SQY=@R8@)AQL)9YNW'NQW:<4/ST_+
MN%@TI)D#:UP1WLC(:%'"$'FGA\W4VX"*?F\5+2%KT'YP@;N<OY.&<O6.\0N'
M2?IL>=:2>P\R^>I"1C;''O.A? >(SYPQM,/E\O9-9*@/W&.G5:[KQX.!SLWK
MQU@8,J*/I$1,XLX8&>&-QYB( ZOB)^M*ZPPR2L(=IAU/ X'KAGOG !9V:Z "
MP.^:U^L7H46BCHOE7!J;%U^J'*V)X% $Q4E^&N1X>7].H_HB672JJ957GX@R
M-<G S#&]Y41M<H=B+4>G]SF7;--I>6 FER\&ZMLF.)#=9>HV&V*KR>9)4P;(
M24I)>,@I")");2H_2E.DFQ0@031D4F!24+#.GKE+AEJS)3LKJ.;^G$XGQC;"
M-HZ=H5=$(3$RZRM:M5WM>3;?I\N/@H%E/[G66T%\]O3Y]Y+-EANFGQ';>4H]
M@+1H__02=Y/V44,0%3ZP53:WVI,A Y6P4EO5^F7>\.*6H+TG>@1+VC]:\?1S
M9O<;<5$\Q9]5E\R%2N.SHO\TV#5+M&S&@Q->5D;?+7LGO&G)1A1X9M"7$-U2
M3],1P&HN!5_J$/[!?-_]C[1\"K:'3>J;9VOJT/!GF,JEFO4QMBCA[X[OI%5O
M&SI6V+@@8>C)B4([#7[878;V;TDA;U3'X]8M7T%I*ZC[(9W3K/&J;S\=8X>!
M5,0GS-E/:H)*A&(>S?N7S>U/Y*)-#%J\[="&D;:P'5$MD^$TM*'.G@=Q_:.&
M7HD<EY148HTWT<.!]^6CD8J,,JYEZ9]2=UEQ#O2.,2KZ'$[4@->P&(<49I[^
M#EJE_3Q=[4___9W\XM,J2S0!K[QK77FU;/\\1'Y%B1+R6^\4HE"9A)A"$53:
MK:D(:@)P ?SYT%*=_'"_9%RC8/DUWSN)SO&1[U$UC@?T8>!K9Q-+-='@$._M
MUJ/875U--%C*OQ27.STB]_ +S6"M#6]L:MU#("M4FL77%"AZTQ?RFUNHU%G4
MX,VU5X7;YX#/XJ;2J6O2>\@O(&'3CJ2=VF,,>EJR8.O;=K,6DW^&D7Z%?]SL
ME+>%28>,'8PXC:/Z$@H/"&^\>8P=@U^I-S@8G>?<)6#T(V'9NBN#8EP#P6:-
MD7037L<0M==G-D7.:\)I^*9S@#)8?3ZZS3=VA+]KAA7E*H='QL@[OSH(_T(I
MA\5:LC0N52U8BCM)M\P3(KR0=O1WHNFOE_2)5.!,)S6K^9RR2P<6!]E?B,$.
M1"D)@J)?N5*(@E#W6?C/B41]])SI2&KLPVR6+V=,A*;Q*:60$^RDY=7].7]7
MUMX,B@![@N?17H.QBAMI28&Z3*B6?"L8^&)_7C_/7TLWY(7>^HT90=!P.Z'.
M^(2K/GT!]O?V,(OI]=E=&%XKG%N Y>UOF?FR3QX*@OJ&-?- =GD+RU[MLX;U
MY;K>\>*C[3AS;'3]X],\'Y[0/UK%M@355E>?=\@J>6PAO0>W@LTFY;CW'36[
MZCQ7]97[>V*O_)K04GM/+;A8QNV$B5*+H/M5UV>D*67S!,V6(F58?,'-E6VE
M]&Z6-@3!<T#_PC&D_1Q E7;*)[8EO'$.("]9%T EH+7W\[\-UQZ%][ISB^..
M9R8>3J3#UHJ3' >\V&+%KUQ<<BU+_$N SU>U6J58&YWZ07I!? Y$6>$%8=@I
M)R$RJUDD/2?_#RV4%]^C 6/G&P>LF\?#Q59&#K7HA@-X)LM1ELF^"\7O453&
M'NOYAS:_G+I$9ZGTF\_V_:EP8*W(O&!>!>'^Q4,7GQ^(17\IG/M<UF\>=V">
MX[&7!J[;P==[O+JI1&MV&GYCO#WH$:1HYM;)S2#Z.21/3L,Z]Y3 M S(AU!<
M(-50_X/>RI*;L+R$%$UGS'!:IX\PG@ O6-[U3G'/EQFI7>7]6!E*6M,H<)D<
M\*%]3\+F%/)#!V_2M:#D"6;!FPS^3INBH2]IC% )"5Y6;T!%>[YJH+ECO0+.
MK=3=D942[YEV83#H:O4^,I(T^RS9G(?;EF^A3R,X?9P6X.%B08/S#8_X$\R-
MCK#&J!/>2CIAH;XV^CMI7KJ$.AZ[8ZQ,SN+DM6.L3;18C]Z8/"?K1 DO?WKJ
M\>'L=.SM'4[F':]6;_0W5@QDK/%J_)4YHG!H25AVF-U K2@+0[1Z@_[[:,*N
M)<("J9!1"B]QS^U6*%P 1IN\3,E[N(\LEXHFX.)6+?F@+I_%>]'%[W5EA3>@
M:C^,3Y,,^/-Z+?9Q$#/I7449JU0\DNE)E>X;7ZP/#J42-7\/DBWZ";\@"CV]
M@A,-YSWK5?ZZ^+H2*>]CXY0><X0-]G;5SQ!YZ,R/>#=]'R^U\7S"N!"=U.:'
M(VAEBP8(&A>)5&!N^F)AT.>$[TPQG2R/C[ Q9MY([9>M[A"X=YEQ0_JW]L*L
MV+H'A7[,1*=BZ9KW<R_>.1ZV(LG5//QOILEAQ;X79."A?1;[>\B60KFG#(Q5
M4M-[JG%.G0>N(0&<C_R+?,S<S+TBB[U62[)/*F1"%D,?7N=[9)A1X7S08VAF
M!]O-W5=XB)X"D1$6YHQ=\I)_Q'4A&7$S(79EP\R5,;N^D)D &<*[VC19L170
M\/(OZ"V60\ZVARN#)1)B!R9?<&B])*VR+VJ\EQJ$+-GJQ191PLF#]7<.! !*
M8&JIXOO6'W[2"CJZLNVDD<\'57REC -&>J X"<AK?S)[CK'=T_=B=_ZH"%>_
M_BD9R&VV6N7(K7+S>%"'BG?/21EO#<$C?],S-S+-VW0B8U"<1.T3U?CB^UHC
MJ*^XW/JJ_N^T&4(W-;-Y2R:>N^SYI"7!K/PG1^Y-/9@4,IIT7C>&0%JX][_Q
M?^$-NX42NH%Q3DO]-&$E-6_)*AIA*/'RH&1;%_])3NL/^!'>$C9]!S;?H7V3
M6QB5_H(C%G2?@)QGYQW.(6N$U6X'U2[T%BC1<&?5-\['?_375:+'0\QQ]_^:
MK#V(=>LL7B(/3]/;FYAK0*?DM,<1>>I4W-8M9' K[5];<Y_21-?*85V!X;>_
M!MT,\$ _'-T3U'A2R!=2Y&3^BJ^#UJ&5#]_^3J)4?%A9DD>9)\<BOL*-SR3#
M ,_9FG4PK94DST$XF7=MQ>XNV40W(OQ/"U?7O2.N]/I81H"XT- 2:-'*>!TO
M;]\W:2B%G95;UM3BI0=.(_7T> Y-J6S(.S'8NKP5+KVU(5%TL#[8#-<[G2 V
M6B2FOQAQ=%.KA,B*3V6.)%<'/]IW9IU7SL@!W,LY==IUZ6LS"4T3X$PFLRB<
MM?P"N=Z989WCK_GJKKLW9@ET5([AJ=?6QI@,.0\M@DB"CI+PC:F0S4<EH.+O
MH[SPS-HA3J>"SOV<K"W734;5WS-<4N2<&KU0U.;!E!X5/+7A9 %!2%5[)K4[
M'35187,.\*U=*%W!5/1E!UPGN%EV.:,2]AL_WE,NK@6(M4.7<!Y4"?3]D*$
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M^;5'@:?4D*N' !9!9WZ@ S#-!0$7G*A[<&SB "S+9U]A9.W.W?@S-UPN96=
M'4N)/75U[H'4JAI:V1]-UJIW4/3]ID39[O?<5;- =7W:^UFJU-+M!>V"DWMH
M,_4Z6>6FVU^_$W+T56QJR#45AS#4-A68IH!R*'YX")!HF=<0!5GNG$5OSQ_P
MW1Q^"NFN3W-&J AF_FF$#+IRF03ES:9.@B\; Q6V2HH&EKH F[DW.O^2_X#P
M+SH>3.Z9%&2>*.]=GLK-=00\2^4H\KPC(28!4#9/4Y/XQV0T_R<0M/X0$ 7%
MIQ]<1[40#@%WX+=I0+RE>+ +Q:,R/83*RF3K0H4#USB2EBP. 0#4C"33;L-[
MR'745V,XSFV/[A 070-<90;LJ_QM?XV[RE]].__E[JK_MI3]T:44DYCUD3\Q
M6$'OZ<3R _%OWM\?58ZB-SJ-&]O3Q06HJ(Y% MT$1+C;SJ6%L6;Z7M_ED"C&
MNBP*\%6L?.KLLK7DU++R!?NI8'EE.FO%A)W![GJ6[S%<@<5?9#[VN[X:J!V>
M_ 2LSF3SZ3T$3/<[]@D6.=:E'@*$"LTO[>8%R^-Y'!G'N!6:D,O346?KDQ?Y
M:L=;OH[;QPDEK*U&*GWV. 3  &WAK466M@JM)17JU*"M-M:.^:%*U,FO]8Y6
M8\0-MV=</R:CY#/99.,F+<.XCHPI/9_/O8A*17?TSK>IL;Y?^2L;>$'JZ_+)
M1Z?0 /(P?^M5U^#6)>M!\KRE'R^=(\7IJP]<,*?6/^.+D_WZ.31@1^=.U0T+
MG MZOD:1W>)1%]9+?(O&HR-3:;J. //M>/1TC5X.?^,#;H62SVHLKE%;H0X,
M\SB?R8XD8RGV>7*)J]O+7IIR,MN!DESR+2KN?<X]:"\_.F@B&&)A\/+#BX/B
MC=QJJB6YT2 IJJ$.>]!&/'I8.7YN>&C8HIZ9UI7P&JO)I+XMY,<FOZT$R:$G
MT@.U\U./N@FQQUO\UUFD=;BA.0Q*W4R/R=,Z"3/AT?Z#I+'C1(>'NI']LW"6
MO>M<\I%#6RYG&V'-.8(%##9_#QND&.09TD]%XQ0<A&4 0U8DE]Q,ICZ10X#I
MN+8'QGE\<7A!54B9PI\S^-SI[GYA'7&#NY%'IW@PQ(GKJBM_Y 9=#+\@44;7
MK,CWEX6;=O)].2Q QZ5 R6IQ<2E6DF+N]H._%^,RWAL,5JFX=+ )'(Y%^7^H
M^W80'YBV+\H W?4P6#7:K[RR%?&8=@/4,+K/ G!$N6KM3VOM5Q_=!5?O&)_R
MV<AD@2\OJ-0X'(S$[?8GE[LM&#A!K4DG^OAF4@TZ$/7#^/W%YIC[:N8WTDBG
ME[V6'P_=6H=F^UI3<A^WX@5['T%L!HM\U0X>9;+9]$ <!A<LP&\R*U:2,,.9
MQT0B2.$@;B) GOF/"U<7+?JO!N. < -I>HZ !_F,>4:JK!*JCMH@P/+89LB4
MSKG 4Z?MT4/8M9<O8O0G;>?QW$CIFW$J*S0+;CU@-7A9YN4V$!L8.^3%UB]M
M= BP'4)U78!Y,K<TU9.[<%T[*@N6+6\@I\"Q4FON48Z[\[L7^PY\<4]09Y2D
M77[[,6<N0/G"$Z.^L7'Z*BV\.P2(2%E>;LJZSSQ5ET0EYK8PZ(2TP,CWKS8F
MY=K6/KVMKB\G_<Z+JZJ96R7$*?_YH\=,[?OB?4B&B?&*;92(I_476W)&QS.#
MA.'>-Z927K^0J>X3@Q$&*[O^4 F<PUR_A3AZ5_H^%3K3T-*VO&#-1A%N4'EP
M/\C25D9=@],BXX9OS,N'(8]]K5XL@EHHYA7A65(=2ZOWZS@JQ)_B5JW";#O=
M3%: /WZ8R/Z8Q@8N37A'_9):NPF=F__<Q5$2WTW_O5G\5ST J?]F>1I^W6NS
MA*]4.5PF*JO0*:X7>2\III %4X:: E>$ESI#,VQ)E3W&@TF.0(Z+9=&%T4'>
M(BF4&^*# *V,Y@S1$G\7SC=Y3DZ^F:&X>)<V%JT[A7+&?4?9PCZ17#.9>K2J
M$H/YR^..=L@ZY!NIT3.+9C\+X3 VI._1BOG7-RW^E4X&(Y2(!S^/MNA^KQ\%
M)ESK6="J"N\^YGRS[RF)$(K-Y"U_3O@5Q)'/T9W"E(1)>*CK(:T3WI=TL60F
M5\@8Y66\S$"\F?,TUW"Y>$&]Z>!GP:DS"!JGWDW5P%[?Q(X$@A0R54&?C\MA
M#$F-BNWP%;0LFZZQ7[P]6(Y>92J?6;9'[[2OT9\W]PI%1QP^L@XI@YA!RZHB
M+S   Y!*%0A):UW>3,_';OH/S[I- SWUYZ)/VP6_3]63-](I?W;OZ3A,B;C!
MX:F^R/1@;7 W&]-V7(E/G</RJHPZ&PQ.JT!%#.2!&#$_UVZP(CFK,YN_!5W+
M'4'XF(X\)*)H#UFYHDOSUM4:%7UJY;PO<S3S>QJP2V;*#)G9JK*N]>T6;QO-
MXK<T9M47]>9[@[F/#CP-,B6,SO<FN><!.M&.>Z,.KH2>)H 6K93:E?@,VB](
M%\%?6PCP ^TW[16LQ>V&;1O5]-3T/'E?#=W-6<MU9N:-4/> !0MB;O:*RA!6
M&/:(&YU",!2MVL[F)#_L$\$_3<RA-1<_J_6Q[UGFL3_C<ESCH7Y>N0-=! :0
M[X(=5FMZ6/\T64\)+S-@C;CQ$A:T^, :T<]RVHI$2$6H%M_F^U&0"GX43G).
M0*00[A)OI(LI$\B$&[$<1!FBA%31-2D?D_N%?.%\7%,V^"N8>/7\]P6J,F0]
MAUM78C-&@ FTD75'B:G9ZM0/Y;[_TPGCP'25%3J-9 0VXL)W)_7BWE2=3@5U
MQ#J3V&UFCY[>$$>;RO,P9M!B=@0I)$*S499280IO2_U]#S6/Z5V1Z=7C!HI.
MNIW=4-LK'(.Q30(3I.[U56#H!\ZJM>B#PC#F-J1BW50TWUN^.)<+/+E2PV5:
ML\7>'"-]/B:";Y#Q!S]S6J-HC3!E--$NXP-SO:R[BQJ!MR6U'HVIWGJ$9(IZ
M=C?\<J"4X=<$R*^^^SZ&XAPI>CJ"RCE8TUR]-[;Y[+?)( >9,T<._@NYH]JD
M/RG]_F7+\_]$,@MH'N8%VQ0M A<->C$,K9#+2VSV"!!+I/CD(2 ,?L[5V>WR
M*=!1TBX5;KI=@?$[\+1# +^PRM YSY&!-A$]C#4+%>_C7I"=DKR^!+?9$Z;H
M5@Q0$CU\-_'?NN@N\.4BCX)UALDZ!\H/=XP=4M,7II3=<1L#+M^GZA2I/RBW
M V]HE;=I7*D-A$\YR7WL'1'M:H>?1?J3K49_Q7&H*P<8&DUB6EJ*"U8$ K/J
M;W8 "<=[G(^NIC=70_G"K!38Z^':C6ZA_N$N<?P'IK_4NNZ_F,:-O-@/"/)^
MA'2L$8;0+F;<J>J+'8_[0T#O8R&L3FIG+:/,DZ8#I^RWEK?[M>J41@M4ZMV^
MU;3OLCKEK#U'' +(^-42C;9P%'.A^$43TO+,?F9)XZ? K*J=P?P]6>JDIY_2
M@V\&$.*Z90;SIO!UB,GF!MZ4"B<O'@Q-*?=4P+4_]0,?+V2<$XDS8)D32B?.
MC9^!7+.$)37F!H'+<JCZRUYD+/_*( :I3KX\^QDI[+.L6_T64DJ96E3@WUH>
M'"CEG]X<^^6WO#TH5X*4(O'9791=6K!<1TJ2S,IF5680V9?\D2J"KK.'@$1:
M!T*H/;Y^Z\/K^*N'@)?75IJ"O!X:$<-:/N-<LL*<-Q$0.6L-&MP:7B^*0_I5
M1QCLW GRGG/*ZO3;N@66VQ-O7\*VY0 ;L-DYPJ5QOU]4GZ/[';JWU _AV7.M
MK*M\S=LZ/U!GESJIC_T=C,Q?.MH)ES39N8\;4<MQK4L(CXCJR7AQ<#W../2L
MY=$JA,)D97AW%B1AS?[3(8"M$W'\XV/EXB7)4PVV%;H[YNKYMS1'00C<0/#9
M#-W\[G_SV!B7' ["?X/4YO\^.A[PSY;=P1N7_WG(!&!OZRA8XH)6$+&>S'1P
MFXRJ$6>@E0VYO#-P"/@$W#[U^8"<R=9W" A169-HV> <AIXCYQ^H?3QX7NWX
MOQP,_?]7 H5+8[RO8P"V,-H$T&/+LVS.8-S-='):_$F,BF#Q?(8 $G\YD'=:
M?;]O\%NZ_"'@_F7 DR&:I.L"85MNH8> M6\UXGHTN/UY$^]#]3P$7/W),.I5
M=H F.F\4^</W O"]):P;=&V^Q;J[IM>DTL7G5P5\P2DS+AG80 T_OBJ!P73?
MJ@;&$"H'W5K<_;JX)_I2+ZSR0_=\G64+D;9CA;Z+0_*YT5@_E_Z9[HZG<:I
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M,XK'NX9*#+OL]D4,=-8Y@62,2M=:>W,8PT7MUMW)H;EO9+=F\ H;C=(N@HD
M=0K54G>:I+4'/$]'U5JS2M[;$'^,(I%8^LQG&!O$R9LA,Z*KJ]^>0QQ#YD37
MF,98=GT;U]@TGW8]"J$8^0LW>^C^?%S__.!<M2-]LM;7;OH!FQI4#W@6%A=7
M2-LF,C!0Y_MWBTCU"VPH#TCW/L6F\;W&?9J/I/; YQQVG;^!.5!MUGO 2$%/
MJVA*^_+%/2!#=1W7[?;4@<(+3L5U10;^=D6R#9#]*Q*^\FUPD74/R(-CY9/
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M[?(]P*ATBLH:&..JYJ-4OQV7>OAW<R8LJ6N?N9AZ6*0LK;J@+8])-_F11BA
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M2%5UFDM'"3ZV?;C_!PN.F8QB=\<L%KH.1S:4B]V+/WY99('M_37\KS$SUSG
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MW,&'NW:-W?> *M'R5/I0W3[0/^0T_(F_!;U+6OQ+- #3ZW/%IC(L8MF2$&H
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M&R [3&1%#'4FZZ34SD]!%AR7I'4[![?RAI#R7LA%R\2/>;RZ?OW*42B$E][
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M:\*,*+%$Q.%36=0M7(_,VW)4[1%,0[J\4M3\/4P<@'36W1'431%+HFX5HIK
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M^\E)BQK&<_!U.%:GGB6Y?C)A%FZINAP&HNC/FI\<XVS=CMHR<\)&^$>1@O:
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M%+[):KEE>Q#1[W*M; A-X[V<L'QG@8->&]D/A\$%OI#PP+L^I 6]OM*>B5K
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M:^,G]Q8T7Y[D/D#L>.-W$*&];=$W[%M_=X=[J_P^S'72(: "?7:92"XZ97B
MK1ST.#L^1#VH(YAT^HV$K=)Z*9*#<D4I7GQ5+IY@N9+AJYI0W<C#'&H^5.FI
M>GB ?=K)._4[S_?(3RTL"_H8EQM=^NW:P_$^HGYY<H8IC^\9]^OTKRNH78S\
MW6?:3_S$?S/L"_P;4V>%M5-_NTL&4#9W]\>$M!&53416VA4BLEZ*^>])VW_J
M:N'/7CO[5X<$?]*3Z)X])KMADH%!@KZTKL;$K@,,,\S(DAH4N"-O?*?"/XJ@
MQI&=RBNXMOA?>Y:$LSA3;3Y'PFX4#.G?-0!V]PH)S(B6AJ2:-:Y/XIX94)-E
MHG3S_KG-\UG[I1))MMO5VQ9ZCM'>]1:R^*B'<4K#WNHA)#"WI\@04U"K)_8*
MR>RU7.V>^A7:N/Y<9'A(OL ^E][J_H/@MNL+<+'GN7'CME=-0T9HHVY- 4_@
M^N@&2Y!C6D]_%%SV>1X+ 2Z-:M@>\*^\,M%VO<DAN:</T2UVQVG/E,VQ99WJ
M?2[9.3)RQGNEU7A,#*7&<_E;F3:+SY9.=^QY#O</9@?<D&Z*B'7Q0:N=@;"-
MZRA[R([\>'B((H-X<&X6@JM0F\4"WU8#^#V^Y*W),U527R ;=*D5R 9+M$-:
M3^^&<P.CA(Q;:'PN[3-XO 3RJFO>:4?Y]P($=OJ1KJ!E<]G=>]$,@7ODO'<L
MZ4! _(XU"E\"$?:XJKO!D(%9L6DW;].(YLY Q(;_JQX<-=7CJEH,=BF4N@AF
MR%',\ZTO@/]'X8=K%.)W+S+DXORV0@?N]F[X(^N<F+UWG!@%HY9RJ(NMQQCR
MVK[29^A='G^XJLBX"A&VU5$7F& \J']YB5%.LY5_ SOX75I/W\DOM&'P.*,6
M%W8&HG:K)5Z5IL)^1K&]#$(R.=D?A>1VD*YH#']:.GTBYK)ZH4QTQB)8B=VP
MQ)53GAJ>*JI>L/PQ>-%G(&UG(*FG=EY"M?O7O(]=F %&J^YK+_DP$?"JJFZ]
MR,)@I(@]^YX@[\"S[USN6"3Q]/A-T6"I6>0O24H2Z]@<"LO(39V:2$UX81F!
M3[,RR(=$!UI7;/=O%*H$6GSA8?X8%E& %2-UW&\O;Y)(WS%_X7M!4NK5RN9;
M0:::BZ%/!7S6BE,]'LB8GU%^M64Q<C&B&9,YF?:N>Q)223Y2!.Y')/;GW2Q$
M\U8_< ?//:,4U8]SU$3?>DXI7IHE"Q8U+8)UYH*N$GW<LNRGIXCY2\Q?T,?&
MG,]9W5$WM_)U:)<:HOA/"N7K3+F?7;)63</X#]WW',>F)^N]J^[!U,SG#LQ3
M!+S%M$96L'>(D-;R F&0+#@L8!Q%U':(@<1OFWHG%*)/(%O8[VIN5U&*^(*8
M[K92K1!FFY*4 VK@?EK"%%%1NFD1J0/K3[Y&/D*8'.L6ZP0G,M25![.5[\4U
M)VV?!T2\$8]3I+ZC%+?31(+D4)#P*R+M*L5Y&5;I?;E!SOXW!BF'(U]/O@YF
M<*32)H$%?/MD,^_L2V4QL6TOQ\&ZVU(YB5<^;A=/2E>]LU=83)U9M;(\?MP3
M=IM8-GED7#ES8)1<M,3_]NL&5A'Z:BC[&TJ<Q/DX5[==H-L62E 5A"\K?+Q1
M';"".GI!J31T_#5G>+6@3;^_2IL#_NXJVBM(MD[N,@\BD6"?A>4D&Q6U/%%/
M/O%ZJ*(C\."C7WPHA$PMS[A;TR8&ZO+6&F.\_)Y/!,.SVT/E=*-Q/NX2S48W
M!'")^B+WG@>:O#@2"55?T-7ZA_7'G_B)_XOX>8CL?SH2W)_7F3@QW7'6Y#)6
M &1^G,OO[I>A?<J=K7U?KW7DBI+9\M$/]H^+/RBP:P_.1V]F<5KCUNV\8[VM
MRJMF6.J'6I3<1$=3UZ(\UJ^$G,K^IRW!29S9]59;:KS'2/UB"5NU_DR[ON?V
MW..P!^5CT1;7BX.J\NKE\.99Q*L2K"><GQ_SD8U<\!!B*+?YSN/R-LY5$6.I
M6^ VF%1-E.&-X]1EZ!KR(?]H=;41RTW_8NYN9"UQLO_7<9X+90&$9KV/D&38
M^\D1WFD<WN&$NE-5O/M$JV&[G[ ?4P3E%54"^Y6%#F0B,8$3&RI-FT@=CA@/
MZ@3NB>">)LX1FC\M\1P%#%[M7L/>H[55TY87#&P$1Y'LS,I\]4 K6G:MA+#,
MDF*:D8+-MM6\GS )3R*)QA_W5.6I!(+F"IR1CEZ*^&=V^5LX>^X^OVSN6-_F
M(H1@M$IS=RG@9.FG-ZJAJC<8Y\>4QMI)E>I5EL)TG)9Z:E-Q\31;CE07X*>S
M^^@/X60$<BXC<&A#OVG3B?:^FK8$^(E1I%;I@/(">-(6O36W;=% !VY9T0'O
MM9P=X8D=-.:O.>B SG^>AX\<-,&H6@Z->P?9#<8UK/Z6 /J\00?&J.+,S71@
MTK::LDJ5F"!B4905JM0XLGR)#KS>-FEZZ<;X5!/<QWCUMYKFT LZ39QIN\VU
MC/QRC Z,4L5I[W:;2TWP ",'F0YTR^+B:=Q;?VEJ]=VF!K^4WK4D,V1]@&QI
MVFWD7(9*]D,D;-#N[7,+FKL9P3H $4RVZ/IK=908(DE-_'ZW$?6I![4;%Z)\
M,$C5@U%/8SKP6V'8P+\K0X[X0U)-BA1##<ST64;_0=(YAJ0LJB 0HP"3IA\-
M!EO_K6#4MRCD=T0"TU<T$=N]VQ::K;\W[";VMR3D;K/Z9C03460U2^:=QO%$
MG>4WHF<0.MN'%HY-@Y+*%3($3\;$]FHY?N+/#'?S7L&_G*H8$ST+>XK?,7U4
MM<_S6!%[L^ :LXRE7]"HC._ EWI)(^^7=73@H&7NTS+UNQ?#4Z/VGU^Z_&QR
M.^G91A#)NA(?,FV1[Y<]9N*[SS\)L_(149DF?8+GH<7F@NU5LM@CX\9 HB=U
M)1@^;\OX?0IUG&,RYL:A,253\<LR+K=W0A?TQR)[#]_D_/;:8VM6HC-_!*N5
ME#>Q9, J;Q/[KFPX^/5!?[BU;:Q\RK%/5[CNELU>5XR5BB5Y*6]\4BF*%\+T
MD*.FE*78/XYH>L-4)C>DB\1%R,7S=" R\W#J-O[*H4SX1WE(1/+A1;;QZX0%
MJ/=A^W$:Q^<.>2-W6YUMC\N]2U.5YI_9_< M&2Q6\BC)0(O&SQ\'JW)4PARF
MH8\1<*N[QM>YU1VZ%!+@%(7W?AWM:#N-K7)4 (GJ@9_[,A:1MMWW2&ZD,K!3
M5KH6EKB:WRY1.CSNA@D<A&%(.5XO5IN@*^@301JTWO#+LXZJZ[W,F2YS#X+T
MU#;CEM85.OQ\Y=A[W-.'(/@T;+7U64+7K>M66X["KX_V3"5PWB1&1&FD'7E
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M^Y<"+<2(U;.WN@(\'B?(I-ZY9,2WT]8&DO;#?[ZJ'#I>_]HR_H;+NL<C \2
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M*-_(R$#9C01_^\WB[]T/-H5*[48#V8ZKWPU\0.W5U2KANWQ" BX4)B9OE I
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MMNT(@<C@SBY=5X3S?LZH,U$R>=>EU+E9TL4L;[S$]5K]C  DMTWZS'\XB.I
M=0"HA(2S"Y-VC3'.+6M/4CPO)HO%1-*F8N*TF9#EHU2/"X64Y]HS^(SW,\)O
M\L7S\>EG33Q7'D3Z<!D:_MFN G_B_QF88']W3B%X_]]%S/OKJFRI!^4O^]G-
M?[_I_7--]K\M=*#B3&?U1='Z(VH'QR!0_<9^0^:%UP6CSN*'CY=O/2BJRCS@
MR!UD4L!G?L#HQ/7CQKV_&3_(K^_&A=T+]?F5,7#\PTNONXAWPF0_85_0T&<?
MC,O=QY*A#ZM8S.(GU!6..A,4O23GY2N:YQR('[T4?1&)"GDA2=.'FC#N1FH'
M(\'2GI!<T:3_*\TB(,:@F&!2V+-G(.;*@ /!?9;#2:DR]Z?DF5:3:B>'XAPN
M0:#=H:V<]U?0'QKPA#<$J:,OLR$L172 =4%-\&20/!T8!2<JT0Y7TQ:P=SQ8
M4=\1"7U?UW]X;Q0.4F3,00H"?K>[B8R[.VB'B,@'R;1# [OQAUW(-G2@!BF9
M3#M\SVPGO*%66; ^"(U1A;"6=?]P0&GMY,:/3GHI(ZWGB F$U4Z6LU5WPFYC
MKS^Z91<)S-E5GU,$2N$V[+/')3"]2]?Z[L>N+X[S$=_5Q!B,]K"F(EO.D7?R
M4I7/[4KP'4T,QVZ"=2#D*T,[H2M9G.P,;NI&!^J0DN!) >1WAG"=M$.5M*\Y
M/_YF<7(PTMTAWU,A9(V)G;S?$_/0+-A-<>:W%JT>U+ZM7:>6/ZJW5/RCN@:,
M6Y21W@QNSJ$J$+^3%T\[7 NN@8\R"(KM=V-D"S^X5DWD+6OX-&TAUX/]/75X
MDY-\57-3HO1K+_4#0%(G$NB ;QR$K3[G^U&R126C=$%P[;8ID:SB2^W&I:#2
M%%!,\D5?4&MEG*9DA(B7'A(3'%5$5CDVFH'&^(.CY.]6.VYYFN;*M;@&G:M:
M"1ZUL,^=?U,5;1K74GP!,*=%\(Y7!DU^B%)49=97.YB'9)M?PX:>O<2R@M0A
MU OM=:L6;G#4KGQLMU?\DZ1*#H^D,J&5#G#8]_GBE>V'7W<IZ1U[!W!7EB/K
M)%ZKE<R43=H5KT1J<%4T.&D]+ZJ17^#Q.FQP0/T@AR.T1WWQA53Z4!I#T6>;
M:GSZ. H<%H@8<,]^6CKE7B31KI<FN#^7(APY>*/EN/<"##/9Q%F6QA]2T^8#
M<HB^>]E@94!S3^'[%R]D/V09S\:G2@KP;DLP&_<QG=G=/?UEM+!,MOW@L7$(
MQC=F4]\?_5;:R&UIYGT'%V[S45+'!_3Q4X+6=" F2)8D,OLZ 07=.3JE6!/O
M_T%@L/$:*1?D4O,DUA^;U?I:I*6L\KS^8:T:!M]DR(G]/J2:.+L-2[=/.7X/
MJ]D#>F_&/7 QW'0AXUK4*MLZ^B'/GDOS7H%#,96#GEWW$,!@6$:_H^\%K&K.
MK(J3$ZJ7#H1#T_4QV<>89[A'%*8EY6;9MJXVTX&C<9\&6--B5> %:7B\VP_;
MPF?B+G<+YX,!'S]6$AMDZ1&X'GQQJZM16HRR076.(7GRT*P0%8%G Z\N'"Z^
M3)TTL#%@H9VU5<2V37=O+P^6:)*<.2E55.= 1<&>;8E*<1YRVPV_-,NH;^[,
M'(E3["2[L[37ZR4V<'RDKGMKUQ+!@M?2P)&=5$2Z[?PB&#YWOINBM[V)U2%'
MX9\C<':K,)WDIH6T5^.OA2OD9E71Y,N^3Q]Y!4L1("PN1@HO"V^<D_J*!?P*
M7:\A5<'\F]B#08:Z=R'C4RCH3*% JH9FO_Z](X67VH+62:^-8BWGWJP7SI)?
M9&I3-SV@#.V$H:Q>ODV=]<Y<3[]Y06NK&R]ZLC$H8'"BY8A(O[#88*TMC^V!
MXKP+RU!5I@'5CKL1YV?K3.^>F05?11QW>=J1V[X?Y%OC$1/P0-?QS-Z["NUD
M,)Y_Q%)X*V5JL!;[6%#1BN#/^@S=_ORJ\59WAK+;JDNL9FD ZYO":_>>Q"$?
M63PCQQ$^-3A\\B]#3VY4G'87.54>:B$^?TID+7D2D<^Y 16ZH6IDTUO_$-EY
MV?:D'PC_X,MP]E;-U&#=!KD&O3JR7J9Y0C^A0C6<UA.Z@\_8F$<V2LTEDBMV
MD_(9K^<P9&MINW]%3OU4__;1)4,ZT*U>)H5W>'X(9W-UC^_0,VQ;;@?C%ZN%
M"# :K=/"5DDY8* ][6B<,N?4WN)3TY]5NOSI0"BQ[@$=:+ "'U)X$^PI-)8)
MCR=2R>'$XU.I"QLR[;!>D!N%KS%6(?2D19_YO9[W<+YQ5FXBLK7IN'1D1W*[
M"F'$%7$Z>R1+#E'9+:G/'W@M^.A&#7(N&Q=<=9@.2.\+6A=K>[MK#LSH@"N<
M6V[;_5YGYC1[P<.'D-V7]2YB:G;[5A<ID='K:)5FC7*::,;K4&KMK'B+<#)8
M@5KJ025!^!-KZ4#2@T8[.A#6"0(W49T[29EG&:73 6C3S?<;\]N!2T1&<9HC
M7^E 9I3M.50,X]G=R,%P<B^(LOF_V'OO@*::/6_\  J*!96F"$1!0$!$D"((
M!$6*(-() A(%!0)B1(KTH"A(C70)57J/"J$WJ8+22Y3>D28)-4 ([PD^M^S=
MW??=_>VS]^YO[_/'%T[.S/E.G_G,S+?LV'@&0HK]5_$#2=#E3H37  -YU7@S
MU$M"=1>0!UD\(U\$MRHSU?.J'RS6B0HQVX\@*YW6>W]MIY&DNV)[O-!_>HC^
M\&:G4"O]%QN%H3UFL11V?138+$ED:S3%G5+H?NK00/V6Q6('F"N-]6_0F63\
MUVI"&2^8/;!T5RGLMZBQ4[Y]-AL6Z(8\]J&X@2/Q '0F"1L#HC>GWS*F1$R&
M;BYM=2X\@!6I=D/ZV7:!E0Z=G7=(,'B_1^LN<.A7./B0\"OBV\H*K71H81Y8
MG*142D\QF-Z+*DNPVKXFKHRL44TIM^Y52&4@>[%J-[P_ZA?'K+]PC/H3QQCH
M7HT\V+D/N;4+( :H0LNJZ_'5Y%76%5'R1>N]&M/^0LR7!-L&+)3 S>1>BSG(
MHK!#%UCDSP,_,9O1FJ2OT2=H9F:(V)N$]F"5M *J5U.YY,Y"RYBYZYH]A)'@
MA]\&-SM],)WHM ?YB*^:&"=I+L'>S!>8GKGKEQ4/WDX=^,,CZ#\#_:%6];^<
M:,X/*3FF=]!]P%!5J^@0L+PC:N>/S1EC)3^CL[*M8-KV&'#!UU]<>CDT]TWF
MSS(;-)=5YE12DQ@Z_XO[ZZ[S [>34^DG6.;.I],)KK$$XVS%5^Z8:-]\I$=G
M'C!A19R\5-0U;PANG=E5W6KHZ9]S">O^S'P7WH9^DM$AUE,8V/7[;WZ.=1;J
M=C$K'OS@>7X9OYT<[G35"1"(JAYB23!&.>K]2*+?M-WI5*6^F#M/4V6,'F-A
M,3Q9D]9ZV$M/D1,>,&:@6H,]1+07OCS15[E2_T2B91#VAA1[S37UD>"\(J>?
M[R"N:\?V!YRV,>]Q#%=.8R'T:,4S1F?,>C7# *Y",.%*TM%RZU46.^X740&
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MFY087>CLW:!$VM&FK=!-F'!6EGK@A\W^ZH/YJ)E +W!31-+'PU?J*09;K+L
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MS*<+1"53<<WG&'&9S5.UFJ[0$(_K?3IJ2A:T\2^=8=QR+PY*1;,BM8B.L*_
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MC6\QRX(SY,Q4JYMG\58D5HR ).#3^W>!+.-CWR59=&Y=^QWD!&AU'W1UV4D
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M*7"_W/T_['UW7!-[OO:$((@T"QTA*M)$1$I0D1+T($7I"!J:%($0 17I+8J
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MU&D(JZ,'2H(Y]!.KE[:M+:,#_Z7 &.,!2!\<BR0XH/:Y*$737QV; F6-H0C
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M<ZCQMC0UOUR1C!^@FM5K/ 4Y \M<5Z;1]L4[3="I65,,E]3;G-M('NJ,+BV
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M1ZG(-5O%$6SR9I?K![/RJ$'J/G$W\5UJ(3UGDZISP!QJ>[0%;S962$/J ^T
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M,"QF#)S[VFFPX_Q;Y6[H@V/1 A=&*HPJ0TZ\XY^$\<<K'MI_ _[^>,D#/GC
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M!9.4N^[C3P82X)<51$^9P0(??UA?S9+=@&55,'_>\]>'.PV8-38R2.<CQEY
MDY3[SS5Q%V=,7GME;_JA5^TIR_8 V[Z\2\KR^\))<RT+YF]!A97F<S7+AT7=
M*1-N2#'/$90*KR:Q[ P(&AAPZ<@XM.[2VSG4D8&&484 ISW9 2,R1Y]!3<LH
M^Y2#T6,S/-H94"_=+GM'9BZV&:P'6$$\N?N-]Y3\85=D:=?7WI,^0OF<];V(
M9$4^#&>RAQ#%"H+UL.+M3A9*/YDOD!WR<8:%93"SJTKM,*-0"6C"]UA-GYFT
M>61AX.RL9^'>UD$M8*2P!%?&!3*K[XW1K62&-C6Q]NM32<8W;%>DNZ!>VG/O
MCK'  =?@='[NF_AJCS27N[3J_+2.1<-=$5AG2\1P:N-I ^90[V!=I\^VS+ZI
MZ?W5!:-ET,FUV3 :N<GE1IDPQ,G^L#3@J<11Y9^Y(S]ULV=CT,OL64]!_-<=
MR TLK<KA=@(>MULH(C6_%?H@K.II)4G=]X7%*:X-M3KLC0.B[K (:58-A!@C
MUK<L3 %W!#J2VD%3//BZS](C\DD(T !<+HMJCC I2=JQ_:3ANIWKQ" 5M>10
MM04T[GDJXK]KD27T2X/[6F/,<J9-1#MSFU)A,OF6WFG2U4]^YR*[#E6<QC&M
M1N\KKK[F5".X+@6FGPDB0OE,K4YGGF+1JG:4\PML)^JPL\,@ M&#87H<GNTA
MJW'XXMBD26'JL2S4*6GD93__3Z23RJ:;#B>\L$-[$&Z'2G=<)PF8%'W0XX0#
MB^P0*WE0?.%M#U#Q*9QBYX/7$<0Y@J C')APQ;N$!SH/5^GG\W.CH XSE!YA
M),]8QTS/G"YPLR#JQ@TJR6:X^FA-?[AGXG#T!Q;XC((E%RS]"V979&HP\P#9
M0N;^HESE/?ARR@M<0H39::R3[;#Y%PPGHTETZVCY6&40._7V:"^K";HI1.=M
MO:B#^>1-<ZV3#8!O<D*!SWLY)/S\7-$23JUS1GBWW UX]-0%NT:G/>DYR$#3
MZ]VOJ0_@/BN \TSJ]7F'%T'%5E-Z3S&.BJ6=EKI=RB2WX0#.L3.F!0A5WE-&
MII4NXMH\PX%PH-+FB@B*S;- ?\^DJK_+/,E:(,3"A-?TSE5EA]O".PJ=L&P%
MKV^8W%I_*7T8?-@,BQP4VAMZ$!E2/=>G>?"@$W\[-<C*)8_5S-HEW]6PQ0<;
M61!/_41<JAX]=!N]K8#!D U_3:B"V8FSFXC5.%QP>.&:'CT<!0>Z@^OUYNT\
M/'PUUB^DBY7KJFD_SF#F[I\HE1:(" <F1ER:C4QN'.O^KO'_#_P? $/U[]*!
MV6L":WO_0S78CW9E"WB440L?HH*W@(/>:H/<M[\QTPUDT"?.GP==?];=_:4&
M_$-W]W\:GG)MZW-)BRK%HW;?RJ03T3&:V69F?M.2J!I2#;ZT!7!M ;G72#'.
MYS=C TM W=33>6;9VY.L\ 4W9MP 3KML"S"18/C.$W$)!O0?3[@\'!J*<"S4
M)T'N,IW579>V@"CW11P;-5Z>L5:G@U]K]72CS&]3'$&+;P/3JA8:]VP!]0TU
M^(D@9E[>1QL:;+$!V&'];],<Q9>2]WW3NE(W]V#[>(W^\0^&?&_627BB,"4!
M*E?H=S<R,@ +W<PP/9::S5(1/I"EH)X#CK9D9&[M)99TU9\<P6M4C*5\>4@
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M0==AF?HJ: 0AL]Y=.[>C=N3&G[3X5_+]?EVR#)BG.'_7MFWXU]NV[X[$HPE
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M_0;,$X,/MH #E6XK4DVU3DQ2=B?6:SNK@S4$;^7;;#;X\))!$-KY,;6O03H
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M_170VP &!AUN$D;39L".L Z?M@F.FM=BJJ!=<,50/L8X]/9.QM:Q!:!:9M:
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MOIO 5XBP^N"0PY#^O !P+0"O141HW-/.12?$WCM,$LD%>T*'C\L,(*]CS!>
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MKC^!"4[FI0N7 ?+8NQEP@@]WW(9^NP(\HABP2BVF)Z)?Z^N%1>P"L*8:MP#
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M?O!%I:.3SQ":KZT9C 57<US$SF/]&!?&AMI?[N>^VU>D\XSF)=48Z&$UZFG
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M:$17+<E0NUPY&[<5A75_2L":PX<=H-)QQ7\UICM.RO*592'N&^YE_^M!Q\.
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MZY=J$[.K8M1R;G[)F[N,LI2V0N(GI$:XKSS^MAGNO@.P(P5;\N"729P7U&-
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MR^X[%IM)O7O7C&Z=AVQ&G6+FC5[M5JK!#E";T%59MYE-"W>V0^]SEQ"S:K]
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MA3'>O>_4&99:'G(7KWO0CM\JW\8Y[<U6/$?FK324I SZ\&HND3L2D_N'3Q9
ML<!^Y\FH7Z]G_\.3R$T,)?IQ@4SR8XNBKFPWA_UB*&@O,V:4RVR8%E>^9?VT
MX$$(D"7_N8I1=O6A]5/L9-CNRTZS&F[E6I$9TP6N1@= (""1YZTX2#PM6K4-
M#!NRQ)Z;E]NXCNJ\9[S/P"&T[5J2!_&'J1R&*5K#Q8?/,^MHV[YF Q.LWF^7
MINP.]W4[O[$ CSMR&:4!A8G#[MQ6Q=2!G#SYI"#@.KV3M%V+ZFN":)I-QJ$.
MN=:DT9VJ+5;Y59BI,7@F4N!+I]DTAB4R6WLH2.%)6? ="SO,?AN\[@9+_'&[
M08FP@1S00)%^<4/V[UV;L8L9+%FW$R3HGFEFZ+R":@/WOV57T+:G-@#[F&8E
M^4]/1.?D%AEH<'U_PXO)M%)6F)<<X@(^3W 6 -GM6H!"N-BL=DY?#@/\;,+<
MI$>&D(,6AJ7)2&>6$=)7Z'.]' ;DEW#*.KRQX5S))BH 8K.W.OT;C&" .Y?9
M7WL$_H9<@?1&]KB=WN=8#1W,S^>\R0%A#T5CE>;W^UX+H2J(W[9CX"[6FI;8
M].A88[&7!PG*S ;EUR=KP;)9@-2MN.!W(5[$\>WIO#=<]XP9C>8_5Y=+0#^,
MKW![A  9_;=TWF?0FZDPD/<Q_03JF($K1#\N*C'*UQB<T\)5:\=@U8G?[Q#U
M-Q\MM,?_G-K.C3LPP'DQ,9X_8Z!%&26@+<Z%U15GT$IW9]75 J05XMZ*B\B#
M!+"J8::DU!R&L_:S]IGVGUPU#N[..PN6)/]-8]ZFID1CL+UB1PG1&#B/638(
M:R]!"8:93L8["=H=(DIX4+3.&X,]B/?,/F<Y8>Y$:6N)RO0#C^1G'4+^3#&A
MY"3.E_D;9TZU9PQT[1@4,[+/9/3;@21<$Q43'X< BNU&623,O@P'9+^C-/#<
M.=U=IE^Q#:1?)7'&_FNE,4AW2**W010X&^T.=1+K!_0OVG>.C&- ]D-VU[.#
M,$Q.Z9E0I^/6=J"/\NZ9 _IY&JPE<7]#C+&+]LP5!S<!VV$,TQ&#BA"KXB1#
M@+]%'".MX@0<XZJPF]&V V5P&L&N%F\5LUU9-I1>O.IPG^&HBME,J@]=2 7E
MGKMD>K 8F+V5J&^5A>*)>_W'<:K@_V'V/"6Q9,-^.V#07C.CW][\WR+IJ')3
MHI(^X'06K5=L#%8R"W3/&"#IGL<PRH<:T$OI@"8,V<_O8WQ"=?FJ.08KZ)?#
M-ZLM-'/=7I^BP;G0( MC(0;-: !<Q1EW7Z-8%-NOM@#'8.[_> #@;T+D259'
M.+U>83#G61C@*"T7TXF](B(/A/9GP.S^S),A(0X2>!W3X6F\+R9<5S#DP&YC
M\3BGVZSQG/B.^*XCF(O-64Z_.,-4_/<?\&1JVJ[!)F4X0#+M\&@#\AHD,C:+
M;>6!F WG_MT^HE>. AM*&[PE<F/VKYF4))>DY&FPL5Z5+\MHH/LGX\XD.U8-
M#JXD>_,X>C>/WSV\7F_WT'H-.8._;ZH+)*C$+:3?;-BGP3;0 G52<<'3>[5A
M5HRT#/US3L-L)7TGX&Q2M*D35Y(X8)Z:B"H^VP96<C.RMJ]PT(+M4W+!0SS0
M)5%Q 6%BT4S))3'28$:83YCQ^4R,YO^"'%9[_-<PF"HHAP!A6)8L-#VBR?P;
MK.!_&=@5S_[;#C_0?@P+C!Y5R?]QE-3?=4+&'XZ**3PKF?Z?/<;]'P*" UIT
M]3:4%4/OPOL[8V;_7.7%]]6>H6,:L\_DGW&FN*-GUKO$U]%<P-WP78GN+&%.
M_]>&Q;D_+MH.LP_F3J\N!3%VY;\N-@F\2E<#N_<E@>VF/X["GX?W_$9$=JW9
MKM06E8O+R, P278T\&5B[M";S7'Q?W#TG+F[&S5CZ$'$/MC?E&Z?R2P^DUX[
MW>E<L_\:?X.PA@.FIK>-P5I<]*_/^Z=4D'NJ3T?.GW>5.&3?:0RVP"KO[E2U
M2T,=:OOK<,M_&J__TBWW)7>',]5VM\O^T699M'=E8G%'SI_5<WAO"&Z//?;8
M8X\]]MACCSWVV&.//?;88X\]]MACCSWVV&.//?;88X\]]MACCSWVV&.//?;8
M8X\]]MACCSWVV&.//?;88X\]]MACCSW^F4CL)G) B:>%8/[:DQU;0W\A ]+B
MBJF!29S3MM]-87WFK\]>,7*]X2K>_8V:_\8>:(O=KRQCY#+1VOWMV_]Q>[U>
M(F#8F99T%0; Q#/^JV1K^A9 QI"^H6(HJB+7T\PN;53%_;B#OG;:J,RBC\=L
M"%JKQF-6Z<_WI15\.G)1?W?.][\HH!>;R2-Z087^RS?6_(?GWBU:%+&,]:\K
M<QC^F?N^]]ACCW\F&;M]7H/>]XW_RHVA^\<'NRD@OM[FRNL.RLS5D.8RN?9'
M5A4] RTQL$0S,01VB'[EE?_&UV7>WK4^NY;G!OU5UG_(V:*D[W2AW,P.R.Z0
M6#G [J!OGI$AM_)O!O[?XVB6DWF;WR@C,ZV&JWON:D9:C6*(.]<-IG:C?_EQ
MGW7QK#[L/S'E?PM2__)<]/OYMWN.W?5>IW<M[Y_/;FK:KK_[N<I_UT_]9UAI
M_.<N:X\]]OA?1T=WLJ%S<<(!@S*BB2G#CX[<"OLN#:X_;48TD)94'O=Z-]TP
MYO]W8L'_.Z]V[?O^(8GB#0G4UT?I5=(, ITQLXIM<G;_?:OS+[>,.D1TEL^*
M0PE&SQC\C<FM_HG(8+C^;UYGCSWV^'] 1N8CGI#6*@+/.[WS#8^5F^KW/YG_
M6=-P/<B-D%:I8TR=<'2HYX]!*EP=F?B9$1FIYJ^,2)M4FPU9:H&,-Q P-0<T
M6ZL\$EU>O%[79']+%&K9D!0?^&9L_W_8>_-O*,/_?WPD5)(4LD\BDFPA"3-M
MLB6AK#$591E+0AAC1MFR)Z2(D34Q)C%V0QA#LB^3G1D1$V:L-\;X3J_W^P_X
MGO,]W_,YYW->/SQ_N*\S]WW=U_-Z7(_'XWG-/7/W7R+*O>'/J5FR;#W\..]=
MF^+K(=:%[X5EW'?55NX_>K 1H]@T!^RYB2^IX^:M_K)T[,95#_@S__SFS:*:
MNJ]AP93;5Q(.M!\+H94-X,_6W[W69:(OYE<\_#;F#5C_8F:2*:C"TBA?L,G.
MV,YT\#U??M=9F7NGI8ZY:HJX\UJ%R4Z8F'-:J!A;'Z]@\\U)C8PB\08M#0XY
M?=&"OO2$1PGY>79V95QG#T[?X_:0JN" N'ZN[]XPWKTK7/;VSCG..S%K#KZ4
M!U=L'_:_3$1\CZ5Z5KS]NQ8U?YO?-:?:@9]D[OY^='JN=E?GT[/LL/2K=GD3
M-RS/';C=E^XIFLWC;#$87/1CW()C\(.@5,KH0YTS[S[<R>;*>=-; :KX(&CI
MRC$BZ%4P8&8'2O87%23F9W--W%I\(EHD*J>O=#'3Z)"=(J<=XX!;#/']4>LL
M.%@46['Y\"FGU$9^>+"0T,QQ)K(BJ6P>-^\@G,SPFMQ+.7R-Z?9+&8$5>ID/
M1*L,'F^:JS*O.J<1>269W:\A^VX&SBLLWSQOI,'Q.&86GRA*+%0\,?VXVL&>
MZH^-/?X4G*ES9+Z\#P;56A)P%9="L/P_%2(#\/5)]VX7,G*^^XZ[EJJWL#02
MK<;PW[M>"%3^&=R)N< N'<PK?E2$OGV;>R*R$ MB]Q6Y8)K-TV=D\N\?K34_
M<P28FR?@S_1RW-*7L;C+667A58"7<SUP.T;=-*]+CG/+PBNO2^B,9-(M_4LQ
MKD[?SDV8YKE_!=?&#2L7%2N]?7M'[8$5CG&%3^_U17;^+YBI+6SG:LY8PR2Q
MCV1%2?/W&V=0HYAM+^B54G-?J3T3QP,0R&CBOV/H3+82=+Z:^6?VT<_@):7
M$TQ41<_.!G/Q=Q4);LN_P]CN^R%!JNYS="A@.E36/]3M]5UQ0*51/N-!JDW]
M92:6.07+!0:J2<\5M.X=3?87+TIQF8R->R-F%VWWL>3<;?8 :]_;O>2?T->O
MS6HH"MU1X/6Y/7'U!'MX7H(?LGF6\[L,TN]G'SZ7-V&4Y<HQF%(QG,W5I:2)
MZ.\]T&]>FY$."A'L=;//5PSURO\2$"!U_>T=Q91AI*=P1G4Y5<A*8*S/4=V'
MD3,J>NE#U+S=#I1X3E,89,Q/U8_XB? 7+?&$VM@3+8[YVO5]#'4WELV;T%?[
MS#%6Y'O;W.2>]$CNF0Q]Z83V7/]+Z6VALA.W]&]A5^[D<?XI"#,TTVAR&*SY
MO'##XH"Q0EU1P)&'HCD9QA6@Q>MN[I>Z0,H[+Q;#Y+*PZ6Q$"K8MV(J]^U9Y
MGLT%(,\^1^M2I$U5?R?WFZ/!9#TPJ=@JV3L+>N6%4(]_3OW4-2"3NZC*(W1^
MLLX3:F%//"@Q]Z;KO,*Y;,[_Q?S;I,\<ONPY!H4(22T^SSK',6CA)3CL;BVR
M-,A.6;9? >?JN8*!=R]YC9)N^.4=")7\3[VJ^5[IG#;[[&\;GD8>,A?NJ#GZ
M4OACW^V8J+I=)35PZKG'T ^A74V,Y$;F$PCX"<"%HG%EQ.$;)P;Q0G;=V/A)
M?9:'\63%VN@;8AX[^;7LW _H*\\8<N5-&+9:\ML]A/HKN^OV8T%0-BT4YLN?
M"97M4KJ(,9X6M!3];#7WGC\G^<P;/(CK,Y]YV2>C[,-N[IJ:9T&"']B9#94T
M,;7S_S]MHOX;_XW_JT.S2.%7KB=(Z7]VSHPX6@.'@='OTCP2UAV84Y#3IH7;
M8\XRHBLP2^1-"\_\'>N61HFEB7!@"YM3^D0NT" !=7G"KNOTR22 #,YC]9[R
M?,$S*H[#/L.<N) /CP[2,PV:RW#2"+#MH-FO?AC?I<TDMA65SKW6F*]"[)Z:
M28Q/R#UJFZQ-0C"Q@%N1D8N_L,V&T!:L:4I ] 0(IJ<S;'&K##+;-[^V)/3%
MU-A,>2C]&U+<=S->\XXOT9%Q,,LQ0[H$D=9+WP?%2%WPA(@^ Z:W<'$$!:1S
M5IO;JY^WU"<)+X'?)4$^W5I.6"07X_'"<JE+BU1!9=SM#.EAJ*MB]7+[*7D<
MUB]+ %@*\#GS=":1"E.B":MKSFCKP;_1E>)R7+?UX"8G?Z*BF6>!5$@>/4Q!
M>PM7QI)<O+4Z>>9.(*X'^O)=Z;=K&'?VX.Q2*V,AK\K>*DF5F5=-%O;%M \^
MM'LQZAB6I5#@[%C"!5(>-2?J;U:CYW-8?CF+,OWZV3Q)M^<^?E/TT\X5+SJD
M@+W6)7CQ#9=N_S9JG>">4)#<G;A+"9=&-B)>C%X[DQ4'O:+%;P?REQMU^W"J
MF,-T]R9LK0]]Y2'44USA8/N$B-@+WZM\1+E^4R/3I[P=EXN^'C&\7[+;X"[^
M8/G,%[CCZ5=MPITO7SKR,W@I%59\IVW+@"%I]=%2W4?<QE'@3*6LK\KO'Y7#
MI,>83T].>J[M[I#+D7J,"D1HW =U#**_=4WJMY2=[JZU)#5VKOQ;TLLV+O\K
MJ'R)X>E(GI@9UEE#\3MI/'AA7HPX\AF0"4G5^/Z$C1S'PWG,9[7)5H?G,0TT
M!Y<ET9,=/CYAX^2?.T(?&\>,GZ,V5*%&D"/ JH.YM)(T&PH[ \W6?#Y>X6M$
M)'A7MY5!\F;G-JUIZTAEV2L?HLDUWZ\%?_/6WJ#%6'Y3%:2!0.:BL>3O 6-*
M%CN+&B7J5P4L(FF&/]SN^]I^2C!/?S'*)9UD772@A--3^;RZ[_%%VG9_2"EX
M^T_%H31/D0+>UV.Y8<! /?&O[U57KB*%.*/\.<RUA%Q!R]#/'-4YF3%JQC^Y
M50L2Z]VZ#'/GOES5T[_D=M!'#9*R0V1P9RMY.FN3!/LYB1 -H&GAQ=IQH"V8
MW(06AFB/VTS\%)Y."($O[(-&P:U2SEH@+:?)QDLL)5&<_^'*,FVY*L.N\KK^
M?9"K3F7U/BCQ71NZP7&$3J:F5%D+<%?+)TT2A ?\,E(\IS01L- -A8K=/]\?
MJ[K]RL!@IPXCG_D;?OKYH:<AA+^P8VXT%Q$#G-P,8-@F__T!&V@(&9JQ[_,O
M:+O6070YDX(OPQN9Z#]UE?X#3V(\+=L4#]!FSYNO<5G;SSNJBBTL)>"3DN<<
M!^/[BK6 .HF@Q+2X@OAQL)K4@(RFXN+)IL\6D[,(^ 9&79N2QMKGY)H5F*Z!
MFQP>_<HWV>Y75^;O1"*?Q:K9.VMH/ +V4M?A2Y>_\#SRZ6>D&G!=\VQ\7%"W
MCG4?2@  2WZ*9V9#CU@)]=P%U(L=[B2)\EKWOT.DF(]\2BI[Z:@PO<<-YA\K
M.JW<9PX,4/SL].K.=\;QVT7J9-45!1)&QY>LP9DN!A3]6G3J&DS&'2W.I%%R
M4"S\'Q0'$)Z>+/>DAWIGE-=RP?.2TV5NO&(:O10K2,?]U"[-5O6*TOSP1:"V
M+^90?I[JF(FIFP#B*SA>?4D W://_'/ V+1B"J+.A&\/M'#_82^@L1B%MO<C
M@J"-!1-3*Y'<G^;,ZZ&"<0/(VJ/MT#B47P_>8&_&S/R$9][JWD*C>^)N<V(%
M<1^D=VHMC[/R[KA%$",K@>_H3*V%R*C/@FG>A(7:PE;1[#V?C2+WWD1%X,,7
MS?CZ/(F'8D +A=RZL+Z=?\!"+6MC8ZJ-2V[8 R'&W )^\U:L36]I5OBKO9O/
M L*HV'%+U;4Q'/9Q"V-Y*8,%$5_#76 (9VJ055XAADQ5F@,"E%:+Q2;5+J94
MZ*42=";V03TOF(M0P)&,69MHO++VAR4YU<XA4/7;$M<B>74?U'F)651Q/6D*
M1[+OV5Z>RG1C@U3**S72BWUA%>_(]%?_^<B7"A9/8_EL[M%@*X\A]478069
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MOHYZ\H*#VJT3+IPNTP&[D!65JGQGHP*C AAGW$,R^1WZ*)IBCU$$0A2)!)G
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M#P['(['3X/BDB6UW%_89(71RK,S0H]N7M;?R>BG=.2]&\\B2%+  GYX]>YW
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M*8[AJP?&BY9@&'#Y2F+,>\&.!9C[GROT08VO 2Z*=[<.]O !OZ431'N&"4>
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MMCQN:,Q[J?SIC(RZMJN\$N3:0'3SJ?2(SV=%& LVC0=98.SZFR?J'ZW''0\
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MUF>\30OTPX+!+#MM1P!SQ 0UL4NJ]]<JK.M O2U2(%:%G_*;5,SGH&G/,:M
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MEF&MC)H.M[K2WG!P_U0+PV;>HD3[HG4Q83A$O:4-(3$O(U\M/UIM[X35HEZ
M"<5.GF=ICJTKG$>]IG)0NY(U1=I.K=U9*&:F"(\D#V^>L1-$'O*3.&;O*]15
MR?R"++A&*,2MUFG0W6Q$5X( %'7@[S^+P4^S.D&4Y'F]!ZL<5NA/]4I'@,+4
M0T_\$^@9U@E9X]4%SY9Z)0-JC.RNPBD;\T$2ZVSC$<#XP^%*/@'[65\F+X\J
M-<4X>(4\!(T(?NYE+HN:+;CH!G\'[^NBQOAL<V^/4+X? 1H\%\&C*Z:[%4<
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M_-W3#5W(0UEB5"-IAWU>>P1?Z]."*/M:%=@"S(9<+X(Y V,"W$"FFW"7E"/
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M.!_$J& 5O_>LU[.QUN$ 7+Q5?69GM]#P&@SH,]MC9W"3_4)[G2,4R=_H4/\
M]3E4-I_:G?UKE@-7=F[W_N.I%;#^4^ZXU*M$[\+\ST4XP:$ZT6:EFM:F#W>4
M%;;;4@[D/LZ?:"1#LH(@NP@#:\W[A^+C]KFQ%"F2X<:U:S_)@6@T59 "MCLI
MTATTAT.3=&:R@FUSUY_3Z ;^(3<[]1YCJ\N\^_V*6T&8:( L)$K_?;R7KHT+
M/B@C=I!N$<7UJ2?Z>R@[C)G8U+F^XOXB4LUSV[65K#%X@1;;4+6@L1GFW:P2
M6-$2/E\W!9CRDR2\OF79$1/7LPS5H_"0?"[[:]K*& _]27ZZ2BV=8+Y.HU\G
M KCY!"Y9;L%9> C6LOF9N;GOI%1=ZK/H)T*%N L_^P$"ON:_;?U&&PIX^;C1
MYO,@"_$G"1-[VGI7XP4N"FB[]5MT@RRZ8 $S)VHP\9Q+X?AZ2=("872\VUS&
M<8@LFW^W>/#:R3[N.3B(Y)?\#;N^A?(8,M"X##=9<3SQO7PP5N3^5C"DAG*N
M]'M9]?,SS>\<]XM@='HE!B=5R!"MZ8UPZ&C\Q<W2\&6+;L4X(\+E;Q7)865[
MGN](==D= 0^EF?S8@_LB:Y5W50(<JF;3B9"7;9G>797*7/Z<G?"[%!N"0S?Y
M9=8=$U BBM#>^-34PRQ>('1#_R"^%<4P8EH5N.D?OVQ5*T>0>N2=6)M&3?#G
M2%BC I:_V=HV5CF'00UTJ,7PQ$4J R$/=S':JTW6\7VJ6)[WXFM!+'*[KWSL
M9EL0^CU(/HA]XT2+3EI=X=J;+E_5!YR. ;-' (:</'1";VA!PDNX'N4V*23
M,T#DLJ'R-HV[B"NWC!H -QO1_=CS,$8CC=3]\WV89]U39:9GWU_86#;YV%&8
M9D>H;+T5]_EL&>B&Y"HVZJJ#;:_L56/U/X[0&9GG:[F]49UM'-FA M/ 4T>
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M?X#]T+2[F[I39934+UI7"FR>W+S_.WRSV%:B1/),LW?I$VX%+G,^,VTNP+]
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M S1HEV+3H<6S(@Q#R>^G+52Y)H[."K?<QW*0.R_9O+@%TX OC/,D;9'J]X\
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M.[@B1I=0E9V=[D1S/?0LGA9YZ4RQY2O__5\W_+\!'$>C_QM02P,$%     @
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MC19IM9XM-:*Q:",9I:.Q3#2: ,/%J%-)-;MB*C+@4I%>)I'KY*+18%'5J"@
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M$VKK@0I75<F>F[%9F E9C U&TP&ND\I['23G>5&EXULNP,AH-9O"Q'' 02V
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MS,G, *,KA>HX8#A3A+,,[Q;Z8=]=BX9F\Y(0-C/!$)GS-+53Y2&^GL755H%
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M, )@W78$)OLAD485T@MSK*<X1J3 $;EHDHY6(U",POW\QU\Y'@/TB#1>*8M
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MI:S;<B..2 2M-@KP8):*\"4CT([WU687BM)QSC=KWP:23J/BT=&<)%0LU\L
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M6^C[WK$N^:N1A/5$?3! 6R3*@$DUXD!"4NV&V[2>HLOK?R3<CF03?0#.>NF
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M"_TE.*<YFX/:B.B+:%1A[,;^$O@SSO4-7Z3,<=[8)5H92/]\_N K8U%O"1J
M%D+CQ]BZ&[9MCK*Y!(,WI6QNEK*C*^Z2@N'/D/,IX7C3)NMRDW%O1JHQ+6_N
M#0(QKO&O\M>^O2T:>_/'V$M8EFSF?1UC FQ$\]4P.-=6M/Z23#G^V<L_1H=H
M&P*MI_HZ*$%:LND0QAN_FF],[B5C'Z/PAISCS5_.V1V^L85V?<-N+($@?Z5
MR*?\&U_\<I"Q=ZX8CN)*GQK\ILU?(['OUX9Z*"6^/W8L+."Q_48W.,MM-!>?
MDO]OQ_2OLI&QM[[\7[:138?P_ZF-!/[OV0B[D8VP_PH;&;9N[%X^\U6;>J-/
MO51!X]SQ3C;GJKZB'%@2[W/ZU]GJDAPWEC9Q7TM7D\9>)?2U9.-O#?J&"=27
M"OGI#- ]SA6:*=OHF-]P#K[Y"U\6-<:Z&==I8EC1C0Z['QWO?WA#: .BK\89
MMWAH0Z;-KH'_QH1M;D[^9<F:*7[)_2#_@I_D!#9.<?S&17[:*'8$R5Z?M!<2
M^*BF\#9G]T?'HKKO!C:B^LH!#UM+"7S)UKZXG[ZS<7,S_:\__MW)OSOY=R?_
M[N3?G?R[DW]W\O]4)UM__M9G21<7S^W-/6#))R^-Q$<F_ ^/,9#_*<:$3^X<
MF3YEY-8MYDV<,'UDB^D3)DZ?\,F]([N-3!C98HN)8P0CZX\MIWQK\L1)6TW8
M8NNI/L&!TT8F3-IBBY&1*=MN,?9EXLBW)DZ:O.6$+4:F3-]QYG<8]HQGMYJQ
M_0X[[5ZIGG[FRF>>>W[%T_#<>?.+>^P9Y9"@Y2/,'L,>ZV+DLV/"%N,@4_RK
MF>G^V<1)WYHR9;+?R[<F?FML0!,G3?_6[L4G9\!1[I3)V^^P8VG%!1>6*]81
MIS_U]+MSF6OO>O8-Y+UYK\R<'XB=ND?PR%"<MU_]Y,61;2;ZK-,G3A\Y8.0?
M_\ 2KVR_E)K^S?]+KMWM[OX:Y9(=#[[SM1VE,[:]_+HKD:=GW/-&X\;)%S'O
MG?7PMGRI2KBO;_/@MG?5W!/2+H0^$OS]K"4G"SNMV5^]X^^#J[-KS 5;K5KV
MM'W*7GOLL6K"B3_9[IQ)]YUUXH-D'UI^\ 63IYVTZ^BVDV[:\=E#YIVQ[IE'
M3]\+F(QW=UCZ]NN9E<>O7/[HS&4(<JV\VS;.HX=&'EKVVUWJ<P[Z1_'J>?6K
MUOU^\ [^ 775;]Y]ZZPC?]9P%RC=WY^\EHNOT&_>9\&O=[N\<7;KK:BQW=R_
M[XK7S[@Y4=QA^X?O7/'\#[O/2^7''J/N7 &U^SN]&WQG\HO;EU#7F?[.W/G[
M8-?;?VT>RIWQ@+C]H2^FIT^^Z, ;GCOFNXU[[SM*(<B57?K*GP/4<V=J>^<G
M;Z/&MCG^R:?V=0MO]59/O>#V\U?*YQ]W%7[+VW]6Y-!)A\I/W79?=:OC7MTN
M_OT5ZY:^!G_[J,2$%R^Z;":VZ*'7<O.6[X<LO6[AQ;'MKC[D[0/7';T#?]N6
MLQ:O$0]Q'JTQB:WNR-_YD]$]=P[ !S2H,_"3+IOS_HE' #/:%]_W[:-_<-_T
M2Z?H2Q=/>_GE6;'?W7#N+?KJA^Q+9?X9Q)K_AG9V_;'MCMB7>^3N\\1G7M]G
MK_"JA<OV'-VY;]Q[\ [)???MGAZ_^,$'E%\<2EU^\>.JB!WQT'[T2P_<&%W[
MWKN',WL\=_-AT@5G_.GR5[;*7@0(:/0$X6>G#KH_F'WAL?H/.Y./R]TZ[_3G
MKYCYT/6O_V&O5U;)J^/7[2L_%H/G)K:Y<=Y]^\YMK]VAY3([77+",1/>WO+L
M"8__W#SXS9GO7'' /#GYUM4K3M#?/^K]Z4MW*A!OUYK?/F[.[MN==_@K3_/.
M[G]:'MAV]]E_7+[[X3OA,[=?<^+]!YVZ[#N'G/[+1PX\;\I9?]MB\>BO[L9'
M?U=<\^W!NS>O>[=SBBQCU*Z+]U@'G?;08_$CX_;/MOIH)K'LV:?OV^'UDZ0U
MIQ8N;2]<^M#1=WQK^8P=SYL1_)%>?C%Z_P^^@\R;AYVPQ9H?8L<<>/.96[YY
M./9&^PK^B9/V$6?A\Z^X8/7[QVVCEG;8ZI"!6_V3(*6U*KS'RNVPW4*/WCW[
MY6,N?#[^5,=R]*?6,>PS9SU__?1#6]FMF:>NVI:I3;SZ!SL>@;U=/_#A^H$U
M0/^(R=[RT76ABV^><MF)L0?^^((]]8;*7OF#]/^ZU;OGL/-KZ/=F\:V'3]AK
M\OSO4(M/EO>\5%XS<]^]HNJ:O1K+<L>,/!I=MF[9*7L*)[]<W_;8\'N/'G33
M,P_L]?I5-V__WLNK47S6VCW$-^9_?_(D^8%#=SN@M7)M\,%35BY]8-'LG3/F
MVI._]]1[_]COON4O[/<B_,+<P$=SCM*6_\>#__G=(TZ\#F9^<A'%7!%<=<_Y
MU)3SC=K<1UYZ\805Y._/:4:+Y+K1D5EKKYZUX/H_Q'?^\UT+Y#7O:6L?N?O,
MTWYXY5L'X<"J\(P?S7["G?+![I><\\2,>N%\=.?FH3?P"?6(72;\:<[/'SGD
MV2/4>\\^(=Q$[A+?.>U;I\SG:I;XB"Q=,O7>XBXW'7[,KM)[NWRPC7+WTG6W
M7'S+ZM:O?_O+MQ]9>/6SCU]VT+VO7_?J;6^=&]]N^DXKSMSR\C=_O<-O'Y.0
M*6_:5\W-H3JQWW:>*B^;,3AS=5V__*.7<H>]<8)TZW-G:[]>O/74 _[K@27[
MSDQ<H#ZX]H+[#MVF4?GUL=?\97G=77;IKVL/3U5NFKU\[?&_ZB];\<G("2>_
M3":.*7S8[ATP<QOLA#/;NWTX9X<;?V$^H>S1>_L1ANE=\<%+V5.BS8^?;)9/
M?V;"K.:\XUZY9^?M]P(G(2^\>=#.(]@V=_SY)?UGXAM[7S<CF?S6U7_^X=(E
M=S\L /M,GG,5N,^2_H-;[+_GZIVQ(YN+=I[PIVF_WY=73M@^?<Y#SHL3[VFN
M>T):O!B>><_9/[U^PD\02;BU4)]V[ORUN.*B*Z^Y;-+"YIDW77/+NP\:>\XZ
M]Y.169<?=DG[-V?_:2I3O^9I^J7#%KQW\8G+3MSS@&O^NL=@_B7I^Y\XY:/
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M8;_&/;@<C@:BJ7J(6(Z54'O\0[\OC,MM:8*OUS)_?&PCAWOP59I2K2;\*[/
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MG$TU"<2_21%>PR^OSR*X6SN&&.C6-$%K,[^O;27U/#;L=YDX(K)CF65\H2S
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MY!0D$@..S\>0X?^XOP+>%,8MHX+:N+E.K'[BHO;"5U2S7+J2=;Q1-[VQF2'
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MK^UM0H[R9DB[FTI8*Y<@ZU=H3H6V>@K$*RUR)A.;SC/SPYK(X=M62'\NQ.2
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M/X!X]JORUV>&VU? N?YL;(#TF5#P>8?WJ9<X4^Q%;E,4S2%!]5WVW?>4L5=
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M*?PLR9M.<,M8*LC#J<-#Q?54)-ZE*A]6GVH=8/+UK,5VS'L1_L/A=')S92Y
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M\]C@#I&U ^4@6AP2*N7)@(.^&%>.I"9);/I;G$DU-(2+YRPHX6U!3FG]QFO
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M?;+5P\%$I46#JR!)^Y!"C+:K\^NX1[IP)6695M$KX/'%X^%2YSM/31"C'5)
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M9_BXR'//VL[]3^B;[5O]GD\3K"*W8HTRK/-YL]#Z!PFLY>EMD?BLS&VGN/W
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M'CW(]=A0%>*-26H_,OM>;-T?,?2\@_1# =E,ALK^#T-K9B&<:>)V-U=VZ2G
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M2-NW@&;#RK*AO9DIF[R_['AV?IW5^LV9B ^D,:3;[-UX[QBH_[4RGBQ1S4\
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MY'\C_QOY?S+RP)_S_PU02P$"% ,4    " #1AFU6B5HCQ91Z!0 Y]T8 $0
M            @ $     86UL>"TR,#(R,3(S,2YH=&U02P$"% ,4    " #1
MAFU6TH%&?3D8  "#&0$ $0              @ '#>@4 86UL>"TR,#(R,3(S
M,2YX<V102P$"% ,4    " #1AFU614QGQ!H4  !^%@$ %0
M@ $KDP4 86UL>"TR,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ T89M5M*/
M5*ON-@  <48$ !4              ( !>*<% &%M;'@M,C R,C$R,S%?9&5F
M+GAM;%!+ 0(4 Q0    ( -&&;58Y6P>\BM$  #&("0 5              "
M 9G>!0!A;6QX+3(P,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #1AFU6IJ2L
MLU5>  "/; < %0              @ %6L 8 86UL>"TR,#(R,3(S,5]P<F4N
M>&UL4$L! A0#%     @ T89M5HKK%C$*<P  #4D% !               ( !
MW@X' &%M;'@M97@Q,%\Q."YH=&U02P$"% ,4    " #1AFU6\JHIS! $  "+
M00  #P              @ $6@@< 86UL>"UE>#(Q7S$N:'1M4$L! A0#%
M  @ T89M5M6_5@"I @  2@X   \              ( !4X8' &%M;'@M97@R
M,U\Q+FAT;5!+ 0(4 Q0    ( -&&;5;O%X]N-PD  %A2   /
M  "  2F)!P!A;6QX+65X,S%?,2YH=&U02P$"% ,4    " #1AFU60XDB[A )
M   >4   #P              @ &-D@< 86UL>"UE>#,Q7S(N:'1M4$L! A0#
M%     @ T89M5NXB7"$J"0  3U(   \              ( !RIL' &%M;'@M
M97@S,5\S+FAT;5!+ 0(4 Q0    ( -&&;59=+_3^B 4  %0O   /
M      "  2&E!P!A;6QX+65X,S)?,2YH=&U02P$"% ,4    " #1AFU6TU81
MC8,%  !$+@  #P              @ '6J@< 86UL>"UE>#,R7S(N:'1M4$L!
M A0#%     @ T89M5O](0%U6!0  #"P   \              ( !AK ' &%M
M;'@M97@S,E\S+FAT;5!+ 0(4 Q0    ( -&&;5;P*GH1G:(" #N[ P 2
M          "  0FV!P!I;6<Q,#DV,3<U.#9?,"YJ<&=02P$"% ,4    " #1
MAFU6I1 D(W7%!@ +U0L $@              @ '66 H :6UG,3 Y-C$W-3@V
M7S$N:G!G4$L! A0#%     @ T89M5B1'1\0RYP  L"$! !,
M ( !>QX1 &EM9S$P.38Q-S4X-E\Q,"YJ<&=02P$"% ,4    " #1AFU6C$\/
MLGD: 0"*6 $ $P              @ '>!1( :6UG,3 Y-C$W-3@V7S$Q+FIP
M9U!+ 0(4 Q0    ( -&&;5:N..J'$P0! !PQ 0 3              "  8@@
M$P!I;6<Q,#DV,3<U.#9?,3(N:G!G4$L! A0#%     @ T89M5JR8W7'D=Q@
M%*L8 !(              ( !S"04 &EM9S$P.38Q-S4X-E\R+FIP9U!+ 0(4
M Q0    ( -*&;599[F3=B80" )NW @ 2              "  >"<+ !I;6<Q
M,#DV,3<U.#9?,RYJ<&=02P$"% ,4    " #2AFU6[(9,[2\A 0"LJ@$ $@
M            @ &9(2\ :6UG,3 Y-C$W-3@V7S0N:G!G4$L! A0#%     @
MTH9M5J%SSI)"FP$ X]\! !(              ( !^$(P &EM9S$P.38Q-S4X
M-E\U+FIP9U!+ 0(4 Q0    ( -*&;58Z*E0W,"H! &*< 0 2
M  "  6K>,0!I;6<Q,#DV,3<U.#9?-BYJ<&=02P$"% ,4    " #2AFU6& :]
M-Q^? 0 A! ( $@              @ '*"#, :6UG,3 Y-C$W-3@V7S<N:G!G
M4$L! A0#%     @ TH9M5M$"KS^UC04 ;^T) !(              ( !&:@T
M &EM9S$P.38Q-S4X-E\X+FIP9U!+ 0(4 Q0    ( -*&;58FT54K_N@  +4Y
M 0 2              "  ?XU.@!I;6<Q,#DV,3<U.#9?.2YJ<&=02P4&
/ !P ' #S!@  +!\[

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
